id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
33400529|NCT00742235|62779783|FG000|Overall Study|Lost to Follow-up|0|||
33400530|NCT00742235|62779784|FG001|Overall Study|Lost to Follow-up|31|||
33400531|NCT00742079|62779792|FG000|Overall Study|Lost to Follow-up|0|||
33400532|NCT00742079|62779793|FG001|Overall Study|Lost to Follow-up|1|||
33400533|NCT00662792|62779799|FG000|Period 1|Personal Reasons|0|||
33400534|NCT00662792|62779800|FG001|Period 1|Personal Reasons|0|||
33400535|NCT00662792|62779801|FG002|Period 1|Personal Reasons|1|||
33400536|NCT00662792|62779802|FG003|Period 1|Personal Reasons|0|||
33400537|NCT00662792|62779799|FG000|Period 1|Refused continuing medication|0|||
33400538|NCT00662792|62779800|FG001|Period 1|Refused continuing medication|1|||
33400539|NCT00662792|62779801|FG002|Period 1|Refused continuing medication|1|||
33400540|NCT00662792|62779802|FG003|Period 1|Refused continuing medication|0|||
33400541|NCT00662792|62779799|FG000|Period 1|Lost to Follow-up|1|||
33671903|NCT01404325|63107791|FG000|Overall Study|Lost to Follow-up|1|||
33671904|NCT01404325|63107792|FG001|Overall Study|Lost to Follow-up|0|||
33671905|NCT01404325|63107791|FG000|Overall Study|Death|2|||
33671906|NCT01404325|63107792|FG001|Overall Study|Death|0|||
33671907|NCT01404325|63107791|FG000|Overall Study|Graft loss/Retransplantation|1|||
33671908|NCT01404325|63107792|FG001|Overall Study|Graft loss/Retransplantation|0|||
33400542|NCT00662792|62779800|FG001|Period 1|Lost to Follow-up|0|||
33400543|NCT00662792|62779801|FG002|Period 1|Lost to Follow-up|0|||
33400544|NCT00662792|62779802|FG003|Period 1|Lost to Follow-up|0|||
33400545|NCT00662792|62779799|FG000|Period 1|Other adverse event (AE)|0|||
33400546|NCT00662792|62779800|FG001|Period 1|Other adverse event (AE)|2|||
33400547|NCT00662792|62779801|FG002|Period 1|Other adverse event (AE)|0|||
33400548|NCT00662792|62779802|FG003|Period 1|Other adverse event (AE)|0|||
33400549|NCT00662792|62779799|FG000|Period 1|Worsening of disease under study (AE)|1|||
33400550|NCT00662792|62779800|FG001|Period 1|Worsening of disease under study (AE)|3|||
33400551|NCT00662792|62779801|FG002|Period 1|Worsening of disease under study (AE)|2|||
33400552|NCT00662792|62779802|FG003|Period 1|Worsening of disease under study (AE)|0|||
33400553|NCT00662792|62779799|FG000|Period 1|Not treated|0|||
33400554|NCT00662792|62779800|FG001|Period 1|Not treated|1|||
33400555|NCT00662792|62779801|FG002|Period 1|Not treated|0|||
33400556|NCT00662792|62779802|FG003|Period 1|Not treated|0|||
33400557|NCT00662792|62779799|FG000|Period 2|Worsening of disease under study|1|||
33400558|NCT00662792|62779800|FG001|Period 2|Worsening of disease under study|0|||
33400559|NCT00662792|62779801|FG002|Period 2|Worsening of disease under study|0|||
33400560|NCT00662792|62779802|FG003|Period 2|Worsening of disease under study|3|||
33400561|NCT00662792|62779799|FG000|Period 3|Refused continuing medication|1|||
33400562|NCT00662792|62779800|FG001|Period 3|Refused continuing medication|0|||
33400563|NCT00662792|62779801|FG002|Period 3|Refused continuing medication|1|||
33400564|NCT00662792|62779802|FG003|Period 3|Refused continuing medication|0|||
33671909|NCT01404325|63107791|FG000|Overall Study|non-specified reason|0|||
33671910|NCT01404325|63107792|FG001|Overall Study|non-specified reason|2|||
33671911|NCT01425463|63107813|FG000|Overall Study|Adverse Event|5|||
33671912|NCT01425463|63107814|FG001|Overall Study|Adverse Event|7|||
33400565|NCT00662792|62779799|FG000|Period 3|Other adverse event (AE)|0|||
33400566|NCT00662792|62779800|FG001|Period 3|Other adverse event (AE)|0|||
33400567|NCT00662792|62779801|FG002|Period 3|Other adverse event (AE)|1|||
33400568|NCT00662792|62779802|FG003|Period 3|Other adverse event (AE)|1|||
33400569|NCT00662792|62779799|FG000|Period 4|Refused continuing medication|0|||
33400570|NCT00662792|62779800|FG001|Period 4|Refused continuing medication|1|||
33400571|NCT00662792|62779801|FG002|Period 4|Refused continuing medication|0|||
33400572|NCT00662792|62779802|FG003|Period 4|Refused continuing medication|0|||
33400573|NCT00662792|62779799|FG000|Period 4|Other adverse event (AE)|1|||
33400574|NCT00662792|62779800|FG001|Period 4|Other adverse event (AE)|0|||
33400575|NCT00662792|62779801|FG002|Period 4|Other adverse event (AE)|0|||
33400576|NCT00662792|62779802|FG003|Period 4|Other adverse event (AE)|0|||
33400577|NCT00662792|62779799|FG000|Period 4|Worsening of disease under study (AE)|0|||
33400578|NCT00662792|62779800|FG001|Period 4|Worsening of disease under study (AE)|0|||
33400579|NCT00662792|62779801|FG002|Period 4|Worsening of disease under study (AE)|0|||
33400580|NCT00662792|62779802|FG003|Period 4|Worsening of disease under study (AE)|1|||
33400581|NCT00742001|62779817|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
33400582|NCT00742001|62779818|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
33400583|NCT00742001|62779819|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
33400584|NCT00616902|62779832|FG000|Overall Study|Termination of study|6|||
33400585|NCT00616902|62779833|FG001|Overall Study|Termination of study|6|||
33400586|NCT00741611|62779842|FG000|Overall Study|Death|0|||
33400587|NCT00741611|62779843|FG001|Overall Study|Death|0|||
33671913|NCT01425463|63107813|FG000|Overall Study|Lack of Efficacy|1|||
33400588|NCT00741611|62779844|FG002|Overall Study|Death|1|||
33400589|NCT00741611|62779842|FG000|Overall Study|Withdrawal by Subject|0|||
33400590|NCT00741611|62779843|FG001|Overall Study|Withdrawal by Subject|2|||
33400591|NCT00741611|62779844|FG002|Overall Study|Withdrawal by Subject|2|||
33400592|NCT00662558|62779855|FG000|Overall Study|Adverse Event|21|||
33400593|NCT00662558|62779856|FG001|Overall Study|Adverse Event|59|||
33400594|NCT00662558|62779855|FG000|Overall Study|Lack of Efficacy|4|||
33671914|NCT01425463|63107814|FG001|Overall Study|Lack of Efficacy|1|||
33671915|NCT01425463|63107813|FG000|Overall Study|Protocol Violation|2|||
33671916|NCT01425463|63107814|FG001|Overall Study|Protocol Violation|2|||
33671917|NCT01425463|63107813|FG000|Overall Study|Lost to Follow-up|5|||
33671918|NCT01425463|63107814|FG001|Overall Study|Lost to Follow-up|2|||
33671919|NCT01425463|63107813|FG000|Overall Study|Withdrawal by Subject|7|||
33671920|NCT01425463|63107814|FG001|Overall Study|Withdrawal by Subject|5|||
33671921|NCT01425463|63107813|FG000|Overall Study|Unknown Reason|4|||
33671922|NCT01425463|63107814|FG001|Overall Study|Unknown Reason|7|||
33671923|NCT04655586|63107836|FG000|Overall Study|Physician Decision|1|||
33671924|NCT04655586|63107837|FG001|Overall Study|Physician Decision|3|||
33671925|NCT04655586|63107838|FG002|Overall Study|Physician Decision|4|||
33671926|NCT04655586|63107836|FG000|Overall Study|Withdrawal by Subject|1|||
33671927|NCT04655586|63107837|FG001|Overall Study|Withdrawal by Subject|3|||
33671928|NCT04655586|63107838|FG002|Overall Study|Withdrawal by Subject|1|||
33671929|NCT01388647|63107861|FG000|Overall Study|Adverse Event|1|||
33671930|NCT01388647|63107862|FG001|Overall Study|Adverse Event|2|||
33671931|NCT01402063|63107937|FG000|Overall Study|Withdrawal by Subject|3|||
33671932|NCT01402063|63107938|FG001|Overall Study|Withdrawal by Subject|3|||
33671933|NCT01796301|63107946|FG000|Overall Study|Withdrawal by Subject|15|||
33671934|NCT01796301|63107947|FG001|Overall Study|Withdrawal by Subject|15|||
33671935|NCT01796301|63107946|FG000|Overall Study|Lost to Follow-up|3|||
33671936|NCT01796301|63107947|FG001|Overall Study|Lost to Follow-up|3|||
33671937|NCT01796301|63107946|FG000|Overall Study|Death|0|||
33671938|NCT01796301|63107947|FG001|Overall Study|Death|1|||
33671939|NCT01796301|63107946|FG000|Overall Study|Decision by Sponsor|0|||
33671940|NCT01796301|63107947|FG001|Overall Study|Decision by Sponsor|1|||
33671941|NCT01388335|63107966|FG000|Period 1|Progressive Disease|1|||
33671942|NCT01388335|63107966|FG000|Period 2|Progressive Disease|2|||
33671943|NCT01388335|63107966|FG000|Period 2|Sponsor Decision|1|||
33671944|NCT01388335|63107966|FG000|Safety Extension|Progressive Disease|7|||
33671945|NCT01401361|63108013|FG000|Overall Study|Withdrawal by Subject|16|||
33671946|NCT01401361|63108013|FG000|Overall Study|Lack of Efficacy|6|||
33671947|NCT01401361|63108013|FG000|Overall Study|Physician Decision|1|||
33671948|NCT01401361|63108013|FG000|Overall Study|Lost to Follow-up|3|||
33671949|NCT01401361|63108013|FG000|Overall Study|Subject/family decision post procedure|2|||
33671950|NCT01401283|63108019|FG000|Overall Study|surgery cancelled|5|||
33671951|NCT01401283|63108020|FG001|Overall Study|surgery cancelled|8|||
33671952|NCT01401283|63108019|FG000|Overall Study|preoperative arrhythmia|5|||
33671953|NCT01401283|63108020|FG001|Overall Study|preoperative arrhythmia|0|||
33671954|NCT01401283|63108019|FG000|Overall Study|no central venous access|0|||
33671955|NCT01401283|63108020|FG001|Overall Study|no central venous access|1|||
33671956|NCT01401283|63108019|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
33671957|NCT01401283|63108020|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
33671958|NCT01422889|63108043|FG000|Overall Study|No Data Entered for Study Stent|9|||
33671959|NCT01400971|63108047|FG000|Overall Study|Death|82|||
33671960|NCT01400971|63108047|FG000|Overall Study|Lost to Follow-up|196|||
33671961|NCT01400971|63108047|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
33671962|NCT01400971|63108047|FG000|Overall Study|Physician Decision|57|||
33400595|NCT00662558|62779856|FG001|Overall Study|Lack of Efficacy|7|||
33400596|NCT00662558|62779855|FG000|Overall Study|Lost to Follow-up|13|||
33400597|NCT00662558|62779856|FG001|Overall Study|Lost to Follow-up|10|||
33400598|NCT00662558|62779855|FG000|Overall Study|Other|9|||
33400599|NCT00662558|62779856|FG001|Overall Study|Other|14|||
33400600|NCT00662558|62779855|FG000|Overall Study|Withdrawal by Subject|7|||
33400601|NCT00662558|62779856|FG001|Overall Study|Withdrawal by Subject|12|||
33400602|NCT00662558|62779855|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
33400603|NCT00662558|62779856|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
33400604|NCT00739973|62779871|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
33400605|NCT00739973|62779872|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33400606|NCT00739973|62779873|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33400607|NCT00739973|62779874|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33400608|NCT00739973|62779875|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33400609|NCT00739973|62779876|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33400610|NCT00739973|62779877|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33400611|NCT00739973|62779878|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33671963|NCT01400971|63108047|FG000|Overall Study|Withdrawal by Subject|158|||
33671964|NCT01400971|63108047|FG000|Overall Study|Other|422|||
33671965|NCT01387789|63108051|FG000|Overall Study|Adverse Event|5|||
33671966|NCT01387789|63108051|FG000|Overall Study|Lack of Efficacy|2|||
33671967|NCT01387789|63108051|FG000|Overall Study|Lost to Follow-up|1|||
33671968|NCT01400893|63108062|FG000|Overall Study|Death|27|||
33671969|NCT01400893|63108063|FG001|Overall Study|Death|21|||
33671970|NCT01400893|63108062|FG000|Overall Study|Lost to Follow-up|0|||
33671971|NCT01400893|63108063|FG001|Overall Study|Lost to Follow-up|6|||
33671972|NCT01400815|63108103|FG000|Overall Study|Adverse Event|3|||
33671973|NCT01400815|63108104|FG001|Overall Study|Adverse Event|0|||
33671974|NCT01400815|63108103|FG000|Overall Study|Death|0|||
33671975|NCT01400815|63108104|FG001|Overall Study|Death|1|||
33671976|NCT01400815|63108103|FG000|Overall Study|Lost to Follow-up|18|||
33671977|NCT01400815|63108104|FG001|Overall Study|Lost to Follow-up|11|||
33671978|NCT01400815|63108103|FG000|Overall Study|Protocol Violation|0|||
33671979|NCT01400815|63108104|FG001|Overall Study|Protocol Violation|1|||
33671980|NCT01400815|63108103|FG000|Overall Study|Physician Decision|1|||
33671981|NCT01400815|63108104|FG001|Overall Study|Physician Decision|0|||
33671982|NCT01400815|63108103|FG000|Overall Study|Withdrawal by Subject|15|||
33671983|NCT01400815|63108104|FG001|Overall Study|Withdrawal by Subject|8|||
33671984|NCT01400815|63108103|FG000|Overall Study|Subject in jail|1|||
33671985|NCT01400815|63108104|FG001|Overall Study|Subject in jail|0|||
33671986|NCT01400503|63108158|FG000|Overall Study|Withdrawal by Subject|1|||
33671987|NCT01400503|63108158|FG000|Overall Study|Study Terminated by Sponsor|58|||
33671988|NCT01400503|63108158|FG000|Overall Study|Other|1|||
33671989|NCT01400425|63108174|FG000|Overall Study|Withdrawal by Subject|10|||
33671990|NCT01421719|63108180|FG000|Overall Study|Withdrawal by Subject|4|||
33671991|NCT01421641|63108187|FG000|Overall Study|Protocol Violation|2|||
33671992|NCT01421641|63108188|FG001|Overall Study|Protocol Violation|2|||
33671993|NCT01385995|63108196|FG000|Period 1, 2 Months|Physician Decision|1|||
33671994|NCT01385995|63108197|FG001|Period 1, 2 Months|Physician Decision|0|||
33671995|NCT01421017|63108208|FG000|Overall Study|Withdrawal by Subject|2|||
33671996|NCT01421017|63108209|FG001|Overall Study|Withdrawal by Subject|0|||
33671997|NCT01421017|63108210|FG002|Overall Study|Withdrawal by Subject|0|||
33671998|NCT01421017|63108208|FG000|Overall Study|POD|0|||
33671999|NCT01421017|63108209|FG001|Overall Study|POD|6|||
33672000|NCT01421017|63108210|FG002|Overall Study|POD|3|||
33672001|NCT01420627|63108257|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
33672002|NCT01400113|63108267|FG000|Overall Study|Withdrawal by Subject|1|||
33672003|NCT01400113|63108268|FG001|Overall Study|Withdrawal by Subject|1|||
33672004|NCT01399723|63108276|FG000|Overall Study|Lost to Follow-up|0|||
33672005|NCT01399723|63108277|FG001|Overall Study|Lost to Follow-up|1|||
33672006|NCT01385371|63108286|FG000|Overall Study|Adverse Event|54|||
33672007|NCT01385371|63108287|FG001|Overall Study|Adverse Event|19|||
33672008|NCT01385371|63108286|FG000|Overall Study|Lost to Follow-up|16|||
33672009|NCT01385371|63108287|FG001|Overall Study|Lost to Follow-up|16|||
33672010|NCT01385371|63108286|FG000|Overall Study|Withdrawal by Subject|52|||
33672011|NCT01385371|63108287|FG001|Overall Study|Withdrawal by Subject|39|||
33672012|NCT01385371|63108286|FG000|Overall Study|Protocol Violation|25|||
33672013|NCT01385371|63108287|FG001|Overall Study|Protocol Violation|21|||
33672014|NCT01385371|63108286|FG000|Overall Study|Administrative|2|||
33672015|NCT01385371|63108287|FG001|Overall Study|Administrative|2|||
33672016|NCT01399099|63108293|FG000|Overall Study|Lost to Follow-up|11|||
33672017|NCT01399099|63108293|FG000|Overall Study|Physician Decision|1|||
33672018|NCT01399099|63108293|FG000|Overall Study|Protocol Violation|1|||
33672019|NCT01399099|63108293|FG000|Overall Study|Skin Irritation|13|||
33672020|NCT01399099|63108293|FG000|Overall Study|Infection|1|||
33672021|NCT01399099|63108293|FG000|Overall Study|Miscellaneous|4|||
33672022|NCT01398787|63108298|FG000|Overall Study|Adverse Event|1|||
33672023|NCT01383499|63108304|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
33672024|NCT01383499|63108305|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
33672025|NCT01383499|63108306|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
33672026|NCT01383499|63108307|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
33400612|NCT00739973|62779879|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33400613|NCT00739973|62779871|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
33400614|NCT00739973|62779872|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33400615|NCT00739973|62779873|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33400616|NCT00739973|62779874|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33400617|NCT00739973|62779875|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33400618|NCT00739973|62779876|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33400619|NCT00739973|62779877|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33400620|NCT00739973|62779878|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33400621|NCT00739973|62779879|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33400622|NCT00739973|62779871|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
33400623|NCT00739973|62779872|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33400624|NCT00739973|62779873|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33672027|NCT01397461|63108323|FG000|Overall Study|Withdrawal by Subject|2|||
33672028|NCT01397461|63108324|FG001|Overall Study|Withdrawal by Subject|1|||
33672029|NCT01397461|63108325|FG002|Overall Study|Withdrawal by Subject|0|||
33672030|NCT01397461|63108323|FG000|Overall Study|Lost to Follow-up|0|||
33672031|NCT01397461|63108324|FG001|Overall Study|Lost to Follow-up|2|||
33672032|NCT01397461|63108325|FG002|Overall Study|Lost to Follow-up|1|||
33672033|NCT01397461|63108323|FG000|Overall Study|Lack of Efficacy|0|||
33672034|NCT01397461|63108324|FG001|Overall Study|Lack of Efficacy|3|||
33672035|NCT01397461|63108325|FG002|Overall Study|Lack of Efficacy|0|||
33672036|NCT01397461|63108323|FG000|Overall Study|Not treated|0|||
33672037|NCT01397461|63108324|FG001|Overall Study|Not treated|0|||
33672038|NCT01397461|63108325|FG002|Overall Study|Not treated|1|||
33672039|NCT01382251|63108335|FG000|Overall Study|Surgeries cancelled or delayed|16|||
33672040|NCT01382251|63108336|FG001|Overall Study|Surgeries cancelled or delayed|16|||
33672041|NCT01382251|63108335|FG000|Overall Study|Lost to Follow-up|4|||
33672042|NCT01382251|63108336|FG001|Overall Study|Lost to Follow-up|4|||
33672043|NCT01382251|63108335|FG000|Overall Study|Contacted after study closed|1|||
33672044|NCT01382251|63108336|FG001|Overall Study|Contacted after study closed|1|||
33672045|NCT01396525|63108341|FG000|Overall Study|Withdrawal by Subject|8|||
33490741|NCT00039377|62868727|FG000|Initial Registration|Adverse Event|2|||
33490742|NCT00039377|62868728|FG001|Initial Registration|Adverse Event|0|||
33490743|NCT00039377|62868729|FG002|Initial Registration|Adverse Event|0|||
33490744|NCT00039377|62868730|FG003|Initial Registration|Adverse Event|0|||
33490745|NCT00039377|62868727|FG000|Initial Registration|Relapsed|6|||
33490746|NCT00039377|62868728|FG001|Initial Registration|Relapsed|0|||
33490747|NCT00039377|62868729|FG002|Initial Registration|Relapsed|0|||
33490748|NCT00039377|62868730|FG003|Initial Registration|Relapsed|0|||
33490749|NCT00039377|62868727|FG000|Initial Registration|Received non-protocol therapy|11|||
33490750|NCT00039377|62868728|FG001|Initial Registration|Received non-protocol therapy|0|||
33490751|NCT00039377|62868729|FG002|Initial Registration|Received non-protocol therapy|0|||
33400625|NCT00739973|62779874|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33464749|NCT00356915|62838243|FG001|Overall Study|Lost to Follow-up|34|||
33490752|NCT00039377|62868730|FG003|Initial Registration|Received non-protocol therapy|0|||
33490753|NCT00039377|62868727|FG000|Initial Registration|Withdrawal by Subject|3|||
33400626|NCT00739973|62779875|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33400627|NCT00739973|62779876|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33400628|NCT00739973|62779877|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33400629|NCT00739973|62779878|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33400630|NCT00739973|62779879|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33400631|NCT00739973|62779871|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
33400632|NCT00739973|62779872|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33400633|NCT00739973|62779873|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33400634|NCT00739973|62779874|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33400635|NCT00739973|62779875|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33400636|NCT00739973|62779876|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33400637|NCT00739973|62779877|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33400638|NCT00739973|62779878|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33400639|NCT00739973|62779879|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33400640|NCT00739973|62779871|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
33400641|NCT00739973|62779872|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33400642|NCT00739973|62779873|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33400643|NCT00739973|62779874|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33400644|NCT00739973|62779875|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33400645|NCT00739973|62779876|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33400646|NCT00739973|62779877|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33400647|NCT00739973|62779878|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33400648|NCT00739973|62779879|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33400649|NCT00739973|62779871|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
33400650|NCT00739973|62779872|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33400651|NCT00739973|62779873|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33400652|NCT00739973|62779874|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33400653|NCT00739973|62779875|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33400654|NCT00739973|62779876|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33400655|NCT00739973|62779877|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33400656|NCT00739973|62779878|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33400657|NCT00739973|62779879|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33400658|NCT00739973|62779871|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
33400659|NCT00739973|62779872|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33400660|NCT00739973|62779873|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33400661|NCT00739973|62779874|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33400662|NCT00739973|62779875|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33400663|NCT00739973|62779876|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33400664|NCT00739973|62779877|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33400665|NCT00739973|62779878|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33400666|NCT00739973|62779879|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33400667|NCT00739973|62779871|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
33400668|NCT00739973|62779872|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
33400669|NCT00739973|62779873|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
33400670|NCT00739973|62779874|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
33400671|NCT00739973|62779875|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
33400672|NCT00739973|62779876|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
33400673|NCT00739973|62779877|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
33400674|NCT00739973|62779878|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
33400675|NCT00739973|62779879|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
33400676|NCT00739973|62779871|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
33400677|NCT00739973|62779872|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
33400678|NCT00739973|62779873|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
33400679|NCT00739973|62779874|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
33400680|NCT00739973|62779875|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
33400681|NCT00739973|62779876|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
33400682|NCT00739973|62779877|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
33400683|NCT00739973|62779878|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
33400684|NCT00739973|62779879|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
33400685|NCT00739973|62779871|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
33400686|NCT00739973|62779872|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
33400687|NCT00739973|62779873|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
33400688|NCT00739973|62779874|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
33400689|NCT00739973|62779875|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
33400690|NCT00739973|62779876|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
33400691|NCT00739973|62779877|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
33400692|NCT00739973|62779878|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
33400693|NCT00739973|62779879|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
33400694|NCT00739973|62779871|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
33400695|NCT00739973|62779872|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
33400696|NCT00739973|62779873|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
33400697|NCT00739973|62779874|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
33490754|NCT00039377|62868728|FG001|Initial Registration|Withdrawal by Subject|0|||
33490755|NCT00039377|62868729|FG002|Initial Registration|Withdrawal by Subject|0|||
33490756|NCT00039377|62868730|FG003|Initial Registration|Withdrawal by Subject|0|||
33490757|NCT00154102|62868740|FG000|Overall Study|investigational study phase ongoing|7|||
33490758|NCT00154102|62868741|FG001|Overall Study|investigational study phase ongoing|2|||
33490759|NCT03687502|62868764|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
33490760|NCT03687502|62868764|FG000|Overall Study|Lumason not available|1|||
33490761|NCT00035555|62868773|FG000|Overall Study|Adverse Event|5|||
33490762|NCT00035555|62868774|FG001|Overall Study|Adverse Event|8|||
33490763|NCT00035555|62868775|FG002|Overall Study|Adverse Event|9|||
33490764|NCT00035555|62868773|FG000|Overall Study|Allograft loss|1|||
33490765|NCT00035555|62868774|FG001|Overall Study|Allograft loss|1|||
33490766|NCT00035555|62868775|FG002|Overall Study|Allograft loss|2|||
33490767|NCT00035555|62868773|FG000|Overall Study|Death|0|||
33490768|NCT00035555|62868774|FG001|Overall Study|Death|0|||
33490769|NCT00035555|62868775|FG002|Overall Study|Death|2|||
33490770|NCT00035555|62868773|FG000|Overall Study|Lost to Follow-up|0|||
33400698|NCT00739973|62779875|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
33400699|NCT00739973|62779876|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
33400700|NCT00739973|62779877|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
33490771|NCT00035555|62868774|FG001|Overall Study|Lost to Follow-up|0|||
33490772|NCT00035555|62868775|FG002|Overall Study|Lost to Follow-up|1|||
33490773|NCT00035555|62868773|FG000|Overall Study|Noncompliance|0|||
33490774|NCT00035555|62868774|FG001|Overall Study|Noncompliance|1|||
33490775|NCT00035555|62868775|FG002|Overall Study|Noncompliance|1|||
33490776|NCT00035555|62868773|FG000|Overall Study|Prohibited medication|1|||
33490777|NCT00035555|62868774|FG001|Overall Study|Prohibited medication|1|||
33490778|NCT00035555|62868775|FG002|Overall Study|Prohibited medication|0|||
33490779|NCT00035555|62868773|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
33490780|NCT00035555|62868774|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
33490781|NCT00035555|62868775|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
33490782|NCT00035555|62868773|FG000|Overall Study|Withdrawal by Subject|2|||
33490783|NCT00035555|62868774|FG001|Overall Study|Withdrawal by Subject|0|||
33490784|NCT00035555|62868775|FG002|Overall Study|Withdrawal by Subject|2|||
33490785|NCT00035555|62868773|FG000|Overall Study|Investigator deemed not a good candidate|0|||
33490786|NCT00035555|62868774|FG001|Overall Study|Investigator deemed not a good candidate|0|||
33490787|NCT00035555|62868775|FG002|Overall Study|Investigator deemed not a good candidate|1|||
33490788|NCT00035555|62868773|FG000|Overall Study|Received cyclosporin in error|0|||
33490789|NCT00035555|62868774|FG001|Overall Study|Received cyclosporin in error|0|||
33490790|NCT00035555|62868775|FG002|Overall Study|Received cyclosporin in error|1|||
33490791|NCT03894046|62868787|FG000|Overall Study|Protocol Violation|1|||
33490792|NCT03894046|62868788|FG001|Overall Study|Protocol Violation|0|||
33490793|NCT03894046|62868789|FG002|Overall Study|Protocol Violation|0|||
33490794|NCT03894046|62868787|FG000|Overall Study|Adverse Event|0|||
33490795|NCT03894046|62868788|FG001|Overall Study|Adverse Event|1|||
33490796|NCT03894046|62868789|FG002|Overall Study|Adverse Event|0|||
33490797|NCT03894046|62868787|FG000|Overall Study|Withdrawal by Subject|2|||
33490798|NCT03894046|62868788|FG001|Overall Study|Withdrawal by Subject|3|||
33490799|NCT03894046|62868789|FG002|Overall Study|Withdrawal by Subject|1|||
33490800|NCT03894046|62868787|FG000|Overall Study|Death|15|||
33490801|NCT03894046|62868788|FG001|Overall Study|Death|21|||
33490802|NCT03894046|62868789|FG002|Overall Study|Death|4|||
33490803|NCT03894046|62868787|FG000|Overall Study|No growth of ABC|2|||
33490804|NCT03894046|62868788|FG001|Overall Study|No growth of ABC|1|||
33490805|NCT03894046|62868789|FG002|Overall Study|No growth of ABC|0|||
33490806|NCT03894046|62868787|FG000|Overall Study|Physician Decision|1|||
33490807|NCT03894046|62868788|FG001|Overall Study|Physician Decision|1|||
33490808|NCT03894046|62868789|FG002|Overall Study|Physician Decision|1|||
33490809|NCT03894046|62868787|FG000|Overall Study|Prohibited concomitant medication|1|||
33490810|NCT03894046|62868788|FG001|Overall Study|Prohibited concomitant medication|0|||
33490811|NCT03894046|62868789|FG002|Overall Study|Prohibited concomitant medication|0|||
33490812|NCT03894046|62868787|FG000|Overall Study|Transferred to other arm/group|1|||
33490813|NCT03894046|62868788|FG001|Overall Study|Transferred to other arm/group|1|||
33490814|NCT03894046|62868789|FG002|Overall Study|Transferred to other arm/group|0|||
33490815|NCT00033371|62868798|FG000|Overall Study|Adverse Event|1|||
33490816|NCT00033371|62868799|FG001|Overall Study|Adverse Event|5|||
33490817|NCT00033371|62868798|FG000|Overall Study|Lost to Follow-up|2|||
33490818|NCT00033371|62868799|FG001|Overall Study|Lost to Follow-up|1|||
33490819|NCT00033371|62868798|FG000|Overall Study|Withdrawal by Subject|3|||
33490820|NCT00033371|62868799|FG001|Overall Study|Withdrawal by Subject|3|||
33490821|NCT00033371|62868798|FG000|Overall Study|Disease Progression|0|||
33490822|NCT00033371|62868799|FG001|Overall Study|Disease Progression|1|||
33490823|NCT00081731|62868811|FG000|Overall Study|scientific integrity issue|8|||
33490824|NCT00081731|62868812|FG001|Overall Study|scientific integrity issue|8|||
33490825|NCT00079937|62868820|FG000|Overall Study|Adverse Event|2|||
33490826|NCT00079937|62868821|FG001|Overall Study|Adverse Event|1|||
33490827|NCT00079937|62868820|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33490828|NCT00079937|62868821|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33490829|NCT00079937|62868820|FG000|Overall Study|Subject no longer requires study drug|3|||
33490830|NCT00079937|62868821|FG001|Overall Study|Subject no longer requires study drug|0|||
33490831|NCT00079937|62868820|FG000|Overall Study|Protocol Violation|8|||
33490832|NCT00079937|62868821|FG001|Overall Study|Protocol Violation|6|||
33490833|NCT00079937|62868820|FG000|Overall Study|Withdrawal by Subject|21|||
33490834|NCT00079937|62868821|FG001|Overall Study|Withdrawal by Subject|7|||
33490835|NCT00079937|62868820|FG000|Overall Study|Lost to Follow-up|12|||
33490836|NCT00079937|62868821|FG001|Overall Study|Lost to Follow-up|5|||
33490837|NCT00079937|62868820|FG000|Overall Study|Administrative problems|22|||
33490838|NCT00079937|62868821|FG001|Overall Study|Administrative problems|11|||
33490839|NCT00909610|62868829|FG000|Period: First Intervention|Adverse Event|0|||
33490840|NCT00909610|62868830|FG001|Period: First Intervention|Adverse Event|1|||
33490841|NCT00909610|62868829|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
33490842|NCT00909610|62868830|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
33490843|NCT00909610|62868829|FG000|Period: Second Intervention|Adverse Event|1|||
33490844|NCT00909610|62868830|FG001|Period: Second Intervention|Adverse Event|0|||
33490845|NCT03126110|62868852|FG000|Phase 1|Death|2|||
33490846|NCT03126110|62868853|FG001|Phase 1|Death|2|||
33490847|NCT03126110|62868854|FG002|Phase 1|Death|4|||
33490848|NCT03126110|62868855|FG003|Phase 1|Death|3|||
33490849|NCT03126110|62868856|FG004|Phase 1|Death|4|||
33490850|NCT03126110|62868857|FG005|Phase 1|Death|4|||
33490851|NCT03126110|62868858|FG006|Phase 1|Death|3|||
33490852|NCT03126110|62868859|FG007|Phase 1|Death|4|||
33490853|NCT03126110|62868860|FG008|Phase 1|Death|5|||
33490854|NCT03126110|62868861|FG009|Phase 1|Death|2|||
33490855|NCT03126110|62868862|FG010|Phase 1|Death|6|||
33490856|NCT03126110|62868863|FG011|Phase 1|Death|0|||
33490857|NCT03126110|62868864|FG012|Phase 1|Death|0|||
33490858|NCT03126110|62868865|FG013|Phase 1|Death|0|||
33490859|NCT03126110|62868866|FG014|Phase 1|Death|0|||
33490860|NCT03126110|62868867|FG015|Phase 1|Death|0|||
33490861|NCT03126110|62868868|FG016|Phase 1|Death|0|||
33490862|NCT03126110|62868852|FG000|Phase 1|Lost to Follow-up|0|||
33490863|NCT03126110|62868853|FG001|Phase 1|Lost to Follow-up|1|||
33490864|NCT03126110|62868854|FG002|Phase 1|Lost to Follow-up|0|||
33490865|NCT03126110|62868855|FG003|Phase 1|Lost to Follow-up|0|||
33490866|NCT03126110|62868856|FG004|Phase 1|Lost to Follow-up|0|||
33490867|NCT03126110|62868857|FG005|Phase 1|Lost to Follow-up|0|||
33490868|NCT03126110|62868858|FG006|Phase 1|Lost to Follow-up|0|||
33490869|NCT03126110|62868859|FG007|Phase 1|Lost to Follow-up|0|||
33490870|NCT03126110|62868860|FG008|Phase 1|Lost to Follow-up|1|||
33490871|NCT03126110|62868861|FG009|Phase 1|Lost to Follow-up|0|||
33490872|NCT03126110|62868862|FG010|Phase 1|Lost to Follow-up|0|||
33490873|NCT03126110|62868863|FG011|Phase 1|Lost to Follow-up|0|||
33490874|NCT03126110|62868864|FG012|Phase 1|Lost to Follow-up|0|||
33490875|NCT03126110|62868865|FG013|Phase 1|Lost to Follow-up|0|||
33490876|NCT03126110|62868866|FG014|Phase 1|Lost to Follow-up|0|||
33490877|NCT03126110|62868867|FG015|Phase 1|Lost to Follow-up|0|||
33490878|NCT03126110|62868868|FG016|Phase 1|Lost to Follow-up|0|||
33490879|NCT03126110|62868852|FG000|Phase 1|Withdrawal by Subject|1|||
33490880|NCT03126110|62868853|FG001|Phase 1|Withdrawal by Subject|0|||
33490881|NCT03126110|62868854|FG002|Phase 1|Withdrawal by Subject|0|||
33490882|NCT03126110|62868855|FG003|Phase 1|Withdrawal by Subject|1|||
33490883|NCT03126110|62868856|FG004|Phase 1|Withdrawal by Subject|1|||
33490884|NCT03126110|62868857|FG005|Phase 1|Withdrawal by Subject|0|||
33490885|NCT03126110|62868858|FG006|Phase 1|Withdrawal by Subject|0|||
33490886|NCT03126110|62868859|FG007|Phase 1|Withdrawal by Subject|0|||
33490887|NCT03126110|62868860|FG008|Phase 1|Withdrawal by Subject|2|||
33490888|NCT03126110|62868861|FG009|Phase 1|Withdrawal by Subject|1|||
33490889|NCT03126110|62868862|FG010|Phase 1|Withdrawal by Subject|0|||
33490890|NCT03126110|62868863|FG011|Phase 1|Withdrawal by Subject|0|||
33490891|NCT03126110|62868864|FG012|Phase 1|Withdrawal by Subject|0|||
33490892|NCT03126110|62868865|FG013|Phase 1|Withdrawal by Subject|0|||
33490893|NCT03126110|62868866|FG014|Phase 1|Withdrawal by Subject|0|||
33490894|NCT03126110|62868867|FG015|Phase 1|Withdrawal by Subject|0|||
33490895|NCT03126110|62868868|FG016|Phase 1|Withdrawal by Subject|0|||
33490896|NCT03126110|62868852|FG000|Phase 1|Safety follow-up no longer necessary|1|||
33490897|NCT03126110|62868853|FG001|Phase 1|Safety follow-up no longer necessary|0|||
33490898|NCT03126110|62868854|FG002|Phase 1|Safety follow-up no longer necessary|0|||
33490899|NCT03126110|62868855|FG003|Phase 1|Safety follow-up no longer necessary|0|||
33490900|NCT03126110|62868856|FG004|Phase 1|Safety follow-up no longer necessary|0|||
33490901|NCT03126110|62868857|FG005|Phase 1|Safety follow-up no longer necessary|0|||
33490902|NCT03126110|62868858|FG006|Phase 1|Safety follow-up no longer necessary|0|||
33490903|NCT03126110|62868859|FG007|Phase 1|Safety follow-up no longer necessary|0|||
33490904|NCT03126110|62868860|FG008|Phase 1|Safety follow-up no longer necessary|0|||
33490905|NCT03126110|62868861|FG009|Phase 1|Safety follow-up no longer necessary|0|||
33490906|NCT03126110|62868862|FG010|Phase 1|Safety follow-up no longer necessary|0|||
33490907|NCT03126110|62868863|FG011|Phase 1|Safety follow-up no longer necessary|0|||
33490908|NCT03126110|62868864|FG012|Phase 1|Safety follow-up no longer necessary|0|||
33490909|NCT03126110|62868865|FG013|Phase 1|Safety follow-up no longer necessary|0|||
33490910|NCT03126110|62868866|FG014|Phase 1|Safety follow-up no longer necessary|0|||
33490911|NCT03126110|62868867|FG015|Phase 1|Safety follow-up no longer necessary|0|||
33490912|NCT03126110|62868868|FG016|Phase 1|Safety follow-up no longer necessary|0|||
33490913|NCT03126110|62868852|FG000|Phase 1|Survival follow-up no longer necessary|0|||
33490914|NCT03126110|62868853|FG001|Phase 1|Survival follow-up no longer necessary|0|||
33490915|NCT03126110|62868854|FG002|Phase 1|Survival follow-up no longer necessary|1|||
33490916|NCT03126110|62868855|FG003|Phase 1|Survival follow-up no longer necessary|0|||
33490917|NCT03126110|62868856|FG004|Phase 1|Survival follow-up no longer necessary|0|||
33490918|NCT03126110|62868857|FG005|Phase 1|Survival follow-up no longer necessary|0|||
33490919|NCT03126110|62868858|FG006|Phase 1|Survival follow-up no longer necessary|0|||
33490920|NCT03126110|62868859|FG007|Phase 1|Survival follow-up no longer necessary|0|||
33490921|NCT03126110|62868860|FG008|Phase 1|Survival follow-up no longer necessary|0|||
33490922|NCT03126110|62868861|FG009|Phase 1|Survival follow-up no longer necessary|0|||
33490923|NCT03126110|62868862|FG010|Phase 1|Survival follow-up no longer necessary|0|||
33490924|NCT03126110|62868863|FG011|Phase 1|Survival follow-up no longer necessary|0|||
33490925|NCT03126110|62868864|FG012|Phase 1|Survival follow-up no longer necessary|0|||
33490926|NCT03126110|62868865|FG013|Phase 1|Survival follow-up no longer necessary|0|||
33490927|NCT03126110|62868866|FG014|Phase 1|Survival follow-up no longer necessary|0|||
33490928|NCT03126110|62868867|FG015|Phase 1|Survival follow-up no longer necessary|0|||
33490929|NCT03126110|62868868|FG016|Phase 1|Survival follow-up no longer necessary|0|||
33490930|NCT03126110|62868852|FG000|Phase 2|Study terminated by the sponsor|0|||
33490931|NCT03126110|62868853|FG001|Phase 2|Study terminated by the sponsor|0|||
33490932|NCT03126110|62868854|FG002|Phase 2|Study terminated by the sponsor|0|||
33490933|NCT03126110|62868855|FG003|Phase 2|Study terminated by the sponsor|0|||
33490934|NCT03126110|62868856|FG004|Phase 2|Study terminated by the sponsor|0|||
33490935|NCT03126110|62868857|FG005|Phase 2|Study terminated by the sponsor|0|||
33490936|NCT03126110|62868858|FG006|Phase 2|Study terminated by the sponsor|0|||
33490937|NCT03126110|62868859|FG007|Phase 2|Study terminated by the sponsor|0|||
33490938|NCT03126110|62868860|FG008|Phase 2|Study terminated by the sponsor|0|||
33490939|NCT03126110|62868861|FG009|Phase 2|Study terminated by the sponsor|0|||
33490940|NCT03126110|62868862|FG010|Phase 2|Study terminated by the sponsor|0|||
33490941|NCT03126110|62868863|FG011|Phase 2|Study terminated by the sponsor|0|||
33490942|NCT03126110|62868864|FG012|Phase 2|Study terminated by the sponsor|0|||
33490943|NCT03126110|62868865|FG013|Phase 2|Study terminated by the sponsor|4|||
33490944|NCT03126110|62868866|FG014|Phase 2|Study terminated by the sponsor|0|||
33490945|NCT03126110|62868867|FG015|Phase 2|Study terminated by the sponsor|0|||
33490946|NCT03126110|62868868|FG016|Phase 2|Study terminated by the sponsor|0|||
33490947|NCT03126110|62868852|FG000|Phase 2|Withdrawal by Subject|0|||
33490948|NCT03126110|62868853|FG001|Phase 2|Withdrawal by Subject|0|||
33490949|NCT03126110|62868854|FG002|Phase 2|Withdrawal by Subject|0|||
33490950|NCT03126110|62868855|FG003|Phase 2|Withdrawal by Subject|0|||
33490951|NCT03126110|62868856|FG004|Phase 2|Withdrawal by Subject|0|||
33490952|NCT03126110|62868857|FG005|Phase 2|Withdrawal by Subject|0|||
33490953|NCT03126110|62868858|FG006|Phase 2|Withdrawal by Subject|0|||
33490954|NCT03126110|62868859|FG007|Phase 2|Withdrawal by Subject|0|||
33490955|NCT03126110|62868860|FG008|Phase 2|Withdrawal by Subject|0|||
33490956|NCT03126110|62868861|FG009|Phase 2|Withdrawal by Subject|0|||
33490957|NCT03126110|62868862|FG010|Phase 2|Withdrawal by Subject|0|||
33490958|NCT03126110|62868863|FG011|Phase 2|Withdrawal by Subject|1|||
33490959|NCT03126110|62868864|FG012|Phase 2|Withdrawal by Subject|3|||
33490960|NCT03126110|62868865|FG013|Phase 2|Withdrawal by Subject|3|||
33490961|NCT03126110|62868866|FG014|Phase 2|Withdrawal by Subject|2|||
33490962|NCT03126110|62868867|FG015|Phase 2|Withdrawal by Subject|1|||
33490963|NCT03126110|62868868|FG016|Phase 2|Withdrawal by Subject|0|||
33490964|NCT03126110|62868852|FG000|Phase 2|Lost to Follow-up|0|||
33490965|NCT03126110|62868853|FG001|Phase 2|Lost to Follow-up|0|||
33490966|NCT03126110|62868854|FG002|Phase 2|Lost to Follow-up|0|||
33490967|NCT03126110|62868855|FG003|Phase 2|Lost to Follow-up|0|||
33490968|NCT03126110|62868856|FG004|Phase 2|Lost to Follow-up|0|||
33490969|NCT03126110|62868857|FG005|Phase 2|Lost to Follow-up|0|||
33490970|NCT03126110|62868858|FG006|Phase 2|Lost to Follow-up|0|||
33490971|NCT03126110|62868859|FG007|Phase 2|Lost to Follow-up|0|||
33490972|NCT03126110|62868860|FG008|Phase 2|Lost to Follow-up|0|||
33490973|NCT03126110|62868861|FG009|Phase 2|Lost to Follow-up|0|||
33490974|NCT03126110|62868862|FG010|Phase 2|Lost to Follow-up|0|||
33490975|NCT03126110|62868863|FG011|Phase 2|Lost to Follow-up|1|||
33490976|NCT03126110|62868864|FG012|Phase 2|Lost to Follow-up|1|||
33490977|NCT03126110|62868865|FG013|Phase 2|Lost to Follow-up|1|||
33490978|NCT03126110|62868866|FG014|Phase 2|Lost to Follow-up|2|||
33490979|NCT03126110|62868867|FG015|Phase 2|Lost to Follow-up|0|||
33490980|NCT03126110|62868868|FG016|Phase 2|Lost to Follow-up|0|||
33490981|NCT03126110|62868852|FG000|Phase 2|Death|0|||
33490982|NCT03126110|62868853|FG001|Phase 2|Death|0|||
33490983|NCT03126110|62868854|FG002|Phase 2|Death|0|||
33490984|NCT03126110|62868855|FG003|Phase 2|Death|0|||
33490985|NCT03126110|62868856|FG004|Phase 2|Death|0|||
33490986|NCT03126110|62868857|FG005|Phase 2|Death|0|||
33490987|NCT03126110|62868858|FG006|Phase 2|Death|0|||
33490988|NCT03126110|62868859|FG007|Phase 2|Death|0|||
33490989|NCT03126110|62868860|FG008|Phase 2|Death|0|||
33490990|NCT03126110|62868861|FG009|Phase 2|Death|0|||
33490991|NCT03126110|62868862|FG010|Phase 2|Death|0|||
33490992|NCT03126110|62868863|FG011|Phase 2|Death|6|||
33672046|NCT01396525|63108341|FG000|Overall Study|Death|14|||
33490993|NCT03126110|62868864|FG012|Phase 2|Death|12|||
33490994|NCT03126110|62868865|FG013|Phase 2|Death|25|||
33490995|NCT03126110|62868866|FG014|Phase 2|Death|11|||
33490996|NCT03126110|62868867|FG015|Phase 2|Death|3|||
33490997|NCT03126110|62868868|FG016|Phase 2|Death|2|||
33490998|NCT03126110|62868852|FG000|Phase 2|Progressive Disease|0|||
33490999|NCT03126110|62868853|FG001|Phase 2|Progressive Disease|0|||
33491000|NCT03126110|62868854|FG002|Phase 2|Progressive Disease|0|||
33491001|NCT03126110|62868855|FG003|Phase 2|Progressive Disease|0|||
33491002|NCT03126110|62868856|FG004|Phase 2|Progressive Disease|0|||
33491003|NCT03126110|62868857|FG005|Phase 2|Progressive Disease|0|||
33491004|NCT03126110|62868858|FG006|Phase 2|Progressive Disease|0|||
33491005|NCT03126110|62868859|FG007|Phase 2|Progressive Disease|0|||
33491006|NCT03126110|62868860|FG008|Phase 2|Progressive Disease|0|||
33491007|NCT03126110|62868861|FG009|Phase 2|Progressive Disease|0|||
33491008|NCT03126110|62868862|FG010|Phase 2|Progressive Disease|0|||
33491009|NCT03126110|62868863|FG011|Phase 2|Progressive Disease|0|||
33491010|NCT03126110|62868864|FG012|Phase 2|Progressive Disease|0|||
33491011|NCT03126110|62868865|FG013|Phase 2|Progressive Disease|1|||
33491012|NCT03126110|62868866|FG014|Phase 2|Progressive Disease|0|||
33491013|NCT03126110|62868867|FG015|Phase 2|Progressive Disease|0|||
33491014|NCT03126110|62868868|FG016|Phase 2|Progressive Disease|0|||
33491015|NCT03126110|62868852|FG000|Phase 2|Started new treatment|0|||
33491016|NCT03126110|62868853|FG001|Phase 2|Started new treatment|0|||
33491017|NCT03126110|62868854|FG002|Phase 2|Started new treatment|0|||
33491018|NCT03126110|62868855|FG003|Phase 2|Started new treatment|0|||
33491019|NCT03126110|62868856|FG004|Phase 2|Started new treatment|0|||
33491020|NCT03126110|62868857|FG005|Phase 2|Started new treatment|0|||
33491021|NCT03126110|62868858|FG006|Phase 2|Started new treatment|0|||
33491022|NCT03126110|62868859|FG007|Phase 2|Started new treatment|0|||
33491023|NCT03126110|62868860|FG008|Phase 2|Started new treatment|0|||
33491024|NCT03126110|62868861|FG009|Phase 2|Started new treatment|0|||
33491025|NCT03126110|62868862|FG010|Phase 2|Started new treatment|0|||
33491026|NCT03126110|62868863|FG011|Phase 2|Started new treatment|0|||
33491027|NCT03126110|62868864|FG012|Phase 2|Started new treatment|0|||
33491028|NCT03126110|62868865|FG013|Phase 2|Started new treatment|0|||
33491029|NCT03126110|62868866|FG014|Phase 2|Started new treatment|1|||
33491030|NCT03126110|62868867|FG015|Phase 2|Started new treatment|0|||
33491031|NCT03126110|62868868|FG016|Phase 2|Started new treatment|0|||
33491032|NCT00905164|62868918|FG000|Period 1|Protocol Violation|0|||
33491033|NCT00905164|62868919|FG001|Period 1|Protocol Violation|1|||
33491034|NCT03181958|62868926|FG000|Overall Study|Lost to Follow-up|17|||
33491035|NCT03181958|62868927|FG001|Overall Study|Lost to Follow-up|21|||
33491036|NCT03181958|62868928|FG002|Overall Study|Lost to Follow-up|15|||
33491037|NCT03165110|62868936|FG000|Overall Study|Anroid phone software incompatibility|1|||
33491038|NCT00079781|62868943|FG000|Pre-implant Period|Withdrawal by Subject|2|||
33491039|NCT00079781|62868944|FG001|Pre-implant Period|Withdrawal by Subject|0|||
33491040|NCT00079781|62868945|FG002|Pre-implant Period|Withdrawal by Subject|0|||
33491041|NCT00079781|62868943|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
33491042|NCT00079781|62868944|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
33491043|NCT00079781|62868945|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
33491044|NCT00079781|62868943|FG000|Follow-up Period|Withdrawal by Subject|3|||
33491045|NCT00079781|62868944|FG001|Follow-up Period|Withdrawal by Subject|0|||
33491046|NCT00079781|62868945|FG002|Follow-up Period|Withdrawal by Subject|1|||
33491047|NCT00079781|62868943|FG000|Follow-up Period|Lost to Follow-up|1|||
33491048|NCT00079781|62868944|FG001|Follow-up Period|Lost to Follow-up|0|||
33491049|NCT00079781|62868945|FG002|Follow-up Period|Lost to Follow-up|0|||
33491050|NCT00079781|62868943|FG000|Follow-up Period|Death|0|||
33491051|NCT00079781|62868944|FG001|Follow-up Period|Death|0|||
33491052|NCT00079781|62868945|FG002|Follow-up Period|Death|1|||
33491053|NCT03176966|62868953|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
33491054|NCT03176966|62868954|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
33491055|NCT03176966|62868953|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
33491056|NCT03176966|62868954|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
33491057|NCT03176966|62868953|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
33491058|NCT03176966|62868954|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
33491059|NCT03176966|62868953|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
33491060|NCT03176966|62868954|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
33491061|NCT03176966|62868953|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
33491062|NCT03176966|62868954|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
33491063|NCT03176966|62868953|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
33491064|NCT03176966|62868954|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
33310217|NCT01165281|62685617|FG000|Overall Study|Adverse Event|12|||
33491065|NCT03176966|62868953|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
33491066|NCT03176966|62868954|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
33491067|NCT03175562|62868960|FG000|Overall Study|Adverse Event|1|||
33491068|NCT03175562|62868960|FG000|Overall Study|Lost to Follow-up|3|||
33491069|NCT03175562|62868960|FG000|Overall Study|Withdrawal by Subject|7|||
33491070|NCT03175562|62868960|FG000|Overall Study|Other (Not Specified)|5|||
33491071|NCT00079391|62868967|FG000|Overall Study|Withdrawal by Subject|1|||
33491072|NCT03209570|62868975|FG000|Overall Study|Death|1|||
33491073|NCT03209570|62868976|FG001|Overall Study|Death|0|||
33491074|NCT03209570|62868975|FG000|Overall Study|Incomplete Data|8|||
33491075|NCT03209570|62868976|FG001|Overall Study|Incomplete Data|10|||
33491076|NCT03209570|62868975|FG000|Overall Study|Protocol Violation|1|||
33491077|NCT03209570|62868976|FG001|Overall Study|Protocol Violation|0|||
33491078|NCT03209570|62868975|FG000|Overall Study|Withdrawal by Subject|0|||
33491079|NCT03209570|62868976|FG001|Overall Study|Withdrawal by Subject|3|||
33491080|NCT03209492|62868982|FG000|Overall Study|Case Report Forms Uncollected|5|||
33491081|NCT03208244|62868986|FG000|Overall Study|Death|1|||
33491082|NCT03175172|62868990|FG000|Overall Study|Death|3|||
33491083|NCT03175172|62868990|FG000|Overall Study|Withdrawal by Subject|3|||
33491084|NCT03175172|62868990|FG000|Overall Study|Lost to Follow-up|1|||
33491085|NCT03175172|62868990|FG000|Overall Study|Study Terminated by Sponsor|3|||
33491086|NCT03172364|62868996|FG000|Overall Study|Adverse Event|1|||
33491087|NCT03172364|62868997|FG001|Overall Study|Adverse Event|1|||
33491088|NCT03172364|62868996|FG000|Overall Study|Protocol Violation|1|||
33491089|NCT03172364|62868997|FG001|Overall Study|Protocol Violation|0|||
33491090|NCT00078767|62869005|FG000|Overall Study|Withdrawal by Subject|1|||
33491091|NCT00078767|62869006|FG001|Overall Study|Withdrawal by Subject|1|||
33491092|NCT03208088|62869012|FG000|Period 2|Withdrawal by Subject|0|||
33491093|NCT03208088|62869013|FG001|Period 2|Withdrawal by Subject|0|||
33491094|NCT03208088|62869014|FG002|Period 2|Withdrawal by Subject|0|||
33491095|NCT03208088|62869015|FG003|Period 2|Withdrawal by Subject|0|||
33491096|NCT03208088|62869016|FG004|Period 2|Withdrawal by Subject|0|||
33491097|NCT03208088|62869017|FG005|Period 2|Withdrawal by Subject|0|||
33491098|NCT03208088|62869018|FG006|Period 2|Withdrawal by Subject|0|||
33491099|NCT03208088|62869019|FG007|Period 2|Withdrawal by Subject|0|||
33491100|NCT03208088|62869020|FG008|Period 2|Withdrawal by Subject|1|||
33491101|NCT03208088|62869021|FG009|Period 2|Withdrawal by Subject|0|||
33491102|NCT03208088|62869012|FG000|Period 3|Unsatisfactory Test Article|0|||
33491103|NCT03208088|62869013|FG001|Period 3|Unsatisfactory Test Article|0|||
33491104|NCT03208088|62869014|FG002|Period 3|Unsatisfactory Test Article|0|||
33491105|NCT03208088|62869015|FG003|Period 3|Unsatisfactory Test Article|1|||
33491106|NCT03208088|62869016|FG004|Period 3|Unsatisfactory Test Article|0|||
33491107|NCT03208088|62869017|FG005|Period 3|Unsatisfactory Test Article|0|||
33491108|NCT03208088|62869018|FG006|Period 3|Unsatisfactory Test Article|0|||
33491109|NCT03208088|62869019|FG007|Period 3|Unsatisfactory Test Article|0|||
33491110|NCT03208088|62869020|FG008|Period 3|Unsatisfactory Test Article|0|||
33491111|NCT03208088|62869021|FG009|Period 3|Unsatisfactory Test Article|0|||
33491112|NCT03208088|62869012|FG000|Period 4|Unsatisfactory Test Article|0|||
33491113|NCT03208088|62869013|FG001|Period 4|Unsatisfactory Test Article|0|||
33491114|NCT03208088|62869014|FG002|Period 4|Unsatisfactory Test Article|0|||
33491115|NCT03208088|62869015|FG003|Period 4|Unsatisfactory Test Article|1|||
33491116|NCT03208088|62869016|FG004|Period 4|Unsatisfactory Test Article|0|||
33491117|NCT03208088|62869017|FG005|Period 4|Unsatisfactory Test Article|0|||
33491118|NCT03208088|62869018|FG006|Period 4|Unsatisfactory Test Article|0|||
33491119|NCT03208088|62869019|FG007|Period 4|Unsatisfactory Test Article|0|||
33491120|NCT03208088|62869020|FG008|Period 4|Unsatisfactory Test Article|0|||
33491121|NCT03208088|62869021|FG009|Period 4|Unsatisfactory Test Article|0|||
33491122|NCT00078377|62869036|FG000|Overall Study|Adverse Event|2|||
33491123|NCT00078377|62869037|FG001|Overall Study|Adverse Event|5|||
33491124|NCT00078377|62869038|FG002|Overall Study|Adverse Event|1|||
33491125|NCT00078377|62869036|FG000|Overall Study|Lack of Efficacy|2|||
33491126|NCT00078377|62869037|FG001|Overall Study|Lack of Efficacy|0|||
33491127|NCT00078377|62869038|FG002|Overall Study|Lack of Efficacy|2|||
33491128|NCT00078377|62869036|FG000|Overall Study|Lost to Follow-up|0|||
33491129|NCT00078377|62869037|FG001|Overall Study|Lost to Follow-up|1|||
33491130|NCT00078377|62869038|FG002|Overall Study|Lost to Follow-up|1|||
33491131|NCT00078377|62869036|FG000|Overall Study|Physician Decision|2|||
33491132|NCT00078377|62869037|FG001|Overall Study|Physician Decision|0|||
33491133|NCT00078377|62869038|FG002|Overall Study|Physician Decision|0|||
33491134|NCT00078377|62869036|FG000|Overall Study|Withdrawal by Subject|3|||
33491135|NCT00078377|62869037|FG001|Overall Study|Withdrawal by Subject|4|||
33491136|NCT00078377|62869038|FG002|Overall Study|Withdrawal by Subject|4|||
33491137|NCT00078377|62869036|FG000|Overall Study|Miscellaneous|2|||
33491138|NCT00078377|62869037|FG001|Overall Study|Miscellaneous|6|||
33491139|NCT00078377|62869038|FG002|Overall Study|Miscellaneous|1|||
33491140|NCT00886600|62869051|FG000|Double-blind Monotherapy|Adverse Event|1|||
33491141|NCT00886600|62869052|FG001|Double-blind Monotherapy|Adverse Event|1|||
33491142|NCT00886600|62869053|FG002|Double-blind Monotherapy|Adverse Event|1|||
33491143|NCT00886600|62869054|FG003|Double-blind Monotherapy|Adverse Event|1|||
33491144|NCT00886600|62869051|FG000|Double-blind Monotherapy|Protocol Violation|0|||
33491145|NCT00886600|62869052|FG001|Double-blind Monotherapy|Protocol Violation|0|||
33491146|NCT00886600|62869053|FG002|Double-blind Monotherapy|Protocol Violation|0|||
33491147|NCT00886600|62869054|FG003|Double-blind Monotherapy|Protocol Violation|1|||
33491148|NCT00886600|62869051|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
33491149|NCT00886600|62869052|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
33491150|NCT00886600|62869053|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
33491151|NCT00886600|62869054|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
33491152|NCT00886600|62869051|FG000|Combination Therapy Period|Adverse Event|0|||
33491153|NCT00886600|62869052|FG001|Combination Therapy Period|Adverse Event|0|||
33491154|NCT00886600|62869053|FG002|Combination Therapy Period|Adverse Event|1|||
33491155|NCT00886600|62869054|FG003|Combination Therapy Period|Adverse Event|0|||
33491156|NCT00886600|62869051|FG000|Combination Therapy Period|Protocol Violation|0|||
33491157|NCT00886600|62869052|FG001|Combination Therapy Period|Protocol Violation|0|||
33491158|NCT00886600|62869053|FG002|Combination Therapy Period|Protocol Violation|1|||
33491159|NCT00886600|62869054|FG003|Combination Therapy Period|Protocol Violation|0|||
33491160|NCT03172130|62869062|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
33491161|NCT03172130|62869063|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
33491162|NCT00870688|62869079|FG000|Overall Study|Lost to Follow-up|2|||
33491163|NCT00870688|62869079|FG000|Overall Study|Death, Unrelated|1|||
33491164|NCT00870688|62869079|FG000|Overall Study|Granules in the Stools|1|||
33491165|NCT00869128|62869082|FG000|Overall Study|lack of Compliance|6|||
33491166|NCT00869128|62869083|FG001|Overall Study|lack of Compliance|6|||
33491167|NCT00077675|62869089|FG000|Overall Study|Adverse Event|1|||
33491168|NCT00077675|62869090|FG001|Overall Study|Adverse Event|2|||
33491169|NCT00077675|62869089|FG000|Overall Study|Lost to Follow-up|6|||
33491170|NCT00077675|62869090|FG001|Overall Study|Lost to Follow-up|3|||
33491171|NCT00077675|62869089|FG000|Overall Study|Withdrawal by Subject|1|||
33491172|NCT00077675|62869090|FG001|Overall Study|Withdrawal by Subject|0|||
33491173|NCT00077675|62869089|FG000|Overall Study|Other|0|||
33491174|NCT00077675|62869090|FG001|Overall Study|Other|1|||
33491175|NCT00077675|62869089|FG000|Overall Study|Never received study treatment|3|||
33491176|NCT00077675|62869090|FG001|Overall Study|Never received study treatment|3|||
33491177|NCT02576444|62869107|FG000|Overall Study|Death|1|||
33491178|NCT02576444|62869108|FG001|Overall Study|Death|1|||
33491179|NCT02576444|62869109|FG002|Overall Study|Death|0|||
33491180|NCT02576444|62869110|FG003|Overall Study|Death|0|||
33491181|NCT02576444|62869107|FG000|Overall Study|Withdrawal by Subject|0|||
33491182|NCT02576444|62869108|FG001|Overall Study|Withdrawal by Subject|0|||
33491183|NCT02576444|62869109|FG002|Overall Study|Withdrawal by Subject|2|||
33491184|NCT02576444|62869110|FG003|Overall Study|Withdrawal by Subject|0|||
33491185|NCT02576444|62869107|FG000|Overall Study|Adverse Event|0|||
33491186|NCT02576444|62869108|FG001|Overall Study|Adverse Event|0|||
33491187|NCT02576444|62869109|FG002|Overall Study|Adverse Event|1|||
33491188|NCT02576444|62869110|FG003|Overall Study|Adverse Event|0|||
33491189|NCT02576444|62869107|FG000|Overall Study|Physician Decision|0|||
33491190|NCT02576444|62869108|FG001|Overall Study|Physician Decision|0|||
33491191|NCT02576444|62869109|FG002|Overall Study|Physician Decision|1|||
33491192|NCT02576444|62869110|FG003|Overall Study|Physician Decision|0|||
33491193|NCT00850174|62869121|FG000|Washout: One Week|Withdrawal by Subject|0|||
33491194|NCT00850174|62869122|FG001|Washout: One Week|Withdrawal by Subject|2|||
33491195|NCT00850174|62869121|FG000|Second Intervention|Withdrawal by Subject|1|||
33491196|NCT00850174|62869122|FG001|Second Intervention|Withdrawal by Subject|0|||
33491197|NCT00077207|62869133|FG000|Overall Study|Adverse Event|5|||
33491198|NCT00077207|62869133|FG000|Overall Study|Lack of Efficacy|12|||
33491199|NCT00077207|62869133|FG000|Overall Study|Physician Decision|6|||
33491200|NCT00077207|62869133|FG000|Overall Study|Withdrawal by Subject|6|||
33491201|NCT00077207|62869133|FG000|Overall Study|Ineligible|1|||
33491202|NCT03206918|62869138|FG000|Overall Study|Death|11|||
33491203|NCT03206918|62869138|FG000|Overall Study|Withdrawal by Subject|5|||
33491204|NCT03206918|62869138|FG000|Overall Study|Study terminated by sponsor|12|||
33491205|NCT03206918|62869138|FG000|Overall Study|Lost to Follow-up|3|||
33491206|NCT03206918|62869138|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
33491207|NCT03206216|62869145|FG000|Overall Study|Withdrawal by Subject|0|||
33491208|NCT03206216|62869146|FG001|Overall Study|Withdrawal by Subject|1|||
33491209|NCT03169244|62869154|FG000|Overall Study|Lost to Follow-up|1|||
33491210|NCT03169244|62869155|FG001|Overall Study|Lost to Follow-up|2|||
33491211|NCT03169244|62869154|FG000|Overall Study|Adverse Event|1|||
33491212|NCT03169244|62869155|FG001|Overall Study|Adverse Event|0|||
33491213|NCT03169244|62869154|FG000|Overall Study|Withdrawal by Subject|2|||
33491214|NCT03169244|62869155|FG001|Overall Study|Withdrawal by Subject|2|||
33491215|NCT03169244|62869154|FG000|Overall Study|Physician Decision|1|||
33491216|NCT03169244|62869155|FG001|Overall Study|Physician Decision|0|||
33581372|NCT03839459|62978654|FG000|Overall Study|Withdrawal by Subject|2|||
33491217|NCT02486042|62869163|FG000|Overall Study|Physician Decision|1|||
33491218|NCT02486042|62869164|FG001|Overall Study|Physician Decision|7|||
33491219|NCT02486042|62869163|FG000|Overall Study|Hospital transfer|2|||
33491220|NCT02486042|62869164|FG001|Overall Study|Hospital transfer|2|||
33491221|NCT02486042|62869163|FG000|Overall Study|Withdrawal by Subject|0|||
33491222|NCT02486042|62869164|FG001|Overall Study|Withdrawal by Subject|2|||
33491223|NCT00057941|62869172|FG000|Overall Study|Death|1|||
33491224|NCT00057941|62869173|FG001|Overall Study|Death|2|||
33491225|NCT00057941|62869172|FG000|Overall Study|Adverse Event|7|||
33491226|NCT00057941|62869173|FG001|Overall Study|Adverse Event|9|||
33491227|NCT00057941|62869172|FG000|Overall Study|Lack of Efficacy|54|||
33491228|NCT00057941|62869173|FG001|Overall Study|Lack of Efficacy|53|||
33491229|NCT00057941|62869172|FG000|Overall Study|Withdrawal by Subject|6|||
33491230|NCT00057941|62869173|FG001|Overall Study|Withdrawal by Subject|1|||
33491231|NCT00057941|62869172|FG000|Overall Study|still on treatment|3|||
33491232|NCT00057941|62869173|FG001|Overall Study|still on treatment|1|||
33491233|NCT00057941|62869172|FG000|Overall Study|insurance, symptomatic deterioration|1|||
33491234|NCT00057941|62869173|FG001|Overall Study|insurance, symptomatic deterioration|3|||
33491235|NCT00057941|62869172|FG000|Overall Study|Ineligible|2|||
33491236|NCT00057941|62869173|FG001|Overall Study|Ineligible|5|||
33491237|NCT00075881|62869188|FG000|Overall Study|Lack of Efficacy|18|||
33491238|NCT00075881|62869188|FG000|Overall Study|Adverse Event|7|||
33581373|NCT03839459|62978654|FG000|Overall Study|progression of disease|3|||
33581374|NCT02630693|62978660|FG000|Overall Study|No receive treatment|0|||
33581375|NCT02630693|62978661|FG001|Overall Study|No receive treatment|1|||
33581376|NCT05059301|62978670|FG000|Overall Study|Adverse Event|0|||
33581377|NCT05059301|62978671|FG001|Overall Study|Adverse Event|2|||
33581378|NCT05059301|62978672|FG002|Overall Study|Adverse Event|2|||
33491239|NCT00075881|62869188|FG000|Overall Study|Death|1|||
33491240|NCT00075881|62869188|FG000|Overall Study|Withdrawal by Subject|2|||
33491241|NCT00075881|62869188|FG000|Overall Study|Protocol Violation|4|||
33581379|NCT05059301|62978670|FG000|Overall Study|Lost to Follow-up|2|||
33581380|NCT05059301|62978671|FG001|Overall Study|Lost to Follow-up|3|||
33581381|NCT05059301|62978672|FG002|Overall Study|Lost to Follow-up|3|||
33581382|NCT01938430|62978698|FG000|Overall Study|Randomized but Not Treated|0|||
33581383|NCT01938430|62978699|FG001|Overall Study|Randomized but Not Treated|0|||
33581384|NCT01938430|62978700|FG002|Overall Study|Randomized but Not Treated|0|||
33581385|NCT01938430|62978701|FG003|Overall Study|Randomized but Not Treated|0|||
33581386|NCT01938430|62978702|FG004|Overall Study|Randomized but Not Treated|0|||
33581387|NCT01938430|62978703|FG005|Overall Study|Randomized but Not Treated|0|||
33581388|NCT01938430|62978704|FG006|Overall Study|Randomized but Not Treated|0|||
33581389|NCT01938430|62978705|FG007|Overall Study|Randomized but Not Treated|0|||
33581390|NCT01938430|62978706|FG008|Overall Study|Randomized but Not Treated|0|||
33581391|NCT01938430|62978707|FG009|Overall Study|Randomized but Not Treated|0|||
33581392|NCT01938430|62978708|FG010|Overall Study|Randomized but Not Treated|1|||
33581393|NCT01938430|62978709|FG011|Overall Study|Randomized but Not Treated|0|||
33581394|NCT01938430|62978710|FG012|Overall Study|Randomized but Not Treated|0|||
33581395|NCT01938430|62978711|FG013|Overall Study|Randomized but Not Treated|1|||
33581396|NCT01938430|62978698|FG000|Overall Study|Adverse Event|0|||
33581397|NCT01938430|62978699|FG001|Overall Study|Adverse Event|0|||
33581398|NCT01938430|62978700|FG002|Overall Study|Adverse Event|0|||
33581399|NCT01938430|62978701|FG003|Overall Study|Adverse Event|0|||
33581400|NCT01938430|62978702|FG004|Overall Study|Adverse Event|0|||
33581401|NCT01938430|62978703|FG005|Overall Study|Adverse Event|0|||
33581402|NCT01938430|62978704|FG006|Overall Study|Adverse Event|1|||
33581403|NCT01938430|62978705|FG007|Overall Study|Adverse Event|0|||
33581404|NCT01938430|62978706|FG008|Overall Study|Adverse Event|0|||
33581405|NCT01938430|62978707|FG009|Overall Study|Adverse Event|0|||
33581406|NCT01938430|62978708|FG010|Overall Study|Adverse Event|0|||
33581407|NCT01938430|62978709|FG011|Overall Study|Adverse Event|0|||
33672047|NCT01396525|63108341|FG000|Overall Study|Lost to Follow-up|4|||
33672048|NCT02849652|63108353|FG000|Overall Study|Lost to Follow-up|104|||
33672049|NCT02849652|63108354|FG001|Overall Study|Lost to Follow-up|35|||
33672050|NCT02849652|63108355|FG002|Overall Study|Lost to Follow-up|116|||
33672051|NCT02849652|63108356|FG003|Overall Study|Lost to Follow-up|22|||
33672052|NCT02849652|63108353|FG000|Overall Study|Withdrawal by Subject|10|||
33672053|NCT02849652|63108354|FG001|Overall Study|Withdrawal by Subject|2|||
33672054|NCT02849652|63108355|FG002|Overall Study|Withdrawal by Subject|8|||
33672055|NCT02849652|63108356|FG003|Overall Study|Withdrawal by Subject|4|||
33672056|NCT01396447|63108368|FG000|Overall Study|Did Not Receive Treatment|3|||
33310218|NCT01165281|62685618|FG001|Overall Study|Adverse Event|14|||
33400701|NCT00739973|62779878|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
33400702|NCT00739973|62779879|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
33400703|NCT00739973|62779871|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33400704|NCT00739973|62779872|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33400705|NCT00739973|62779873|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
33400706|NCT00739973|62779874|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33400707|NCT00739973|62779875|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33400708|NCT00739973|62779876|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33400709|NCT00739973|62779877|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33400710|NCT00739973|62779878|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33400711|NCT00739973|62779879|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33400712|NCT00739973|62779871|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
33400713|NCT00739973|62779872|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
33400714|NCT00739973|62779873|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
33400715|NCT00739973|62779874|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
33400716|NCT00739973|62779875|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
33400717|NCT00739973|62779876|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
33400718|NCT00739973|62779877|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
33400719|NCT00739973|62779878|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
33400720|NCT00739973|62779879|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
33400721|NCT00739973|62779871|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
33400722|NCT00739973|62779872|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
33400723|NCT00739973|62779873|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
33400724|NCT00739973|62779874|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
33400725|NCT00739973|62779875|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
33400726|NCT00739973|62779876|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
33400727|NCT00739973|62779877|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
33400728|NCT00739973|62779878|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
33400729|NCT00739973|62779879|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
33400730|NCT00739973|62779871|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33400731|NCT00739973|62779872|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33400732|NCT00739973|62779873|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33310219|NCT01165281|62685617|FG000|Overall Study|Death|3|||
33310220|NCT01165281|62685618|FG001|Overall Study|Death|4|||
33310221|NCT01165281|62685617|FG000|Overall Study|Lack of Efficacy|4|||
33310222|NCT01165281|62685618|FG001|Overall Study|Lack of Efficacy|1|||
33310223|NCT01165281|62685617|FG000|Overall Study|Lost to Follow-up|0|||
33310224|NCT01165281|62685618|FG001|Overall Study|Lost to Follow-up|1|||
33310225|NCT01165281|62685617|FG000|Overall Study|Physician Decision|8|||
33310226|NCT01165281|62685618|FG001|Overall Study|Physician Decision|1|||
33310227|NCT01165281|62685617|FG000|Overall Study|Protocol Violation|6|||
33310228|NCT01165281|62685618|FG001|Overall Study|Protocol Violation|5|||
33310229|NCT01165281|62685617|FG000|Overall Study|Withdrawal by Subject|8|||
33310230|NCT01165281|62685618|FG001|Overall Study|Withdrawal by Subject|7|||
33310231|NCT01165281|62685617|FG000|Overall Study|Noncompliance with Study Drug|1|||
33310232|NCT01165281|62685618|FG001|Overall Study|Noncompliance with Study Drug|4|||
33310233|NCT01165281|62685617|FG000|Overall Study|Progressive Disease|10|||
33400733|NCT00739973|62779874|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33400734|NCT00739973|62779875|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33400735|NCT00739973|62779876|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33400736|NCT00739973|62779877|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
33400737|NCT00739973|62779878|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33400738|NCT00739973|62779879|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33400739|NCT00739973|62779871|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
33672057|NCT01396447|63108369|FG001|Overall Study|Did Not Receive Treatment|2|||
33672058|NCT01396447|63108370|FG002|Overall Study|Did Not Receive Treatment|1|||
33672059|NCT01396447|63108371|FG003|Overall Study|Did Not Receive Treatment|0|||
33672060|NCT01396447|63108368|FG000|Overall Study|Adverse Event|15|||
33672061|NCT01396447|63108369|FG001|Overall Study|Adverse Event|12|||
33672062|NCT01396447|63108370|FG002|Overall Study|Adverse Event|12|||
33672063|NCT01396447|63108371|FG003|Overall Study|Adverse Event|17|||
33672064|NCT01396447|63108368|FG000|Overall Study|Insufficient Therapeutic Response|5|||
33672065|NCT01396447|63108369|FG001|Overall Study|Insufficient Therapeutic Response|5|||
33672066|NCT01396447|63108370|FG002|Overall Study|Insufficient Therapeutic Response|2|||
33672067|NCT01396447|63108371|FG003|Overall Study|Insufficient Therapeutic Response|4|||
33672068|NCT01396447|63108368|FG000|Overall Study|Protocol Violation|5|||
33672069|NCT01396447|63108369|FG001|Overall Study|Protocol Violation|2|||
33672070|NCT01396447|63108370|FG002|Overall Study|Protocol Violation|3|||
33672071|NCT01396447|63108371|FG003|Overall Study|Protocol Violation|7|||
33672072|NCT01396447|63108368|FG000|Overall Study|Withdrawal of Consent|11|||
33672073|NCT01396447|63108369|FG001|Overall Study|Withdrawal of Consent|9|||
33672074|NCT01396447|63108370|FG002|Overall Study|Withdrawal of Consent|4|||
33672075|NCT01396447|63108371|FG003|Overall Study|Withdrawal of Consent|15|||
33672076|NCT01396447|63108368|FG000|Overall Study|Lost to Follow-up|4|||
33672077|NCT01396447|63108369|FG001|Overall Study|Lost to Follow-up|8|||
33672078|NCT01396447|63108370|FG002|Overall Study|Lost to Follow-up|7|||
33672079|NCT01396447|63108371|FG003|Overall Study|Lost to Follow-up|9|||
33672080|NCT01396447|63108368|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33672081|NCT01396447|63108369|FG001|Overall Study|Other Miscellaneous Reasons|2|||
33672082|NCT01396447|63108370|FG002|Overall Study|Other Miscellaneous Reasons|1|||
33672083|NCT01396447|63108371|FG003|Overall Study|Other Miscellaneous Reasons|0|||
33672084|NCT01678560|63108444|FG000|Overall Study|Physician Decision|4|||
33672085|NCT01678560|63108445|FG001|Overall Study|Physician Decision|4|||
33672086|NCT01678560|63108444|FG000|Overall Study|Death|0|||
33672087|NCT01678560|63108445|FG001|Overall Study|Death|1|||
33672088|NCT01678560|63108444|FG000|Overall Study|Withdrawal by Subject|0|||
33672089|NCT01678560|63108445|FG001|Overall Study|Withdrawal by Subject|1|||
33672090|NCT01381549|63108484|FG000|Overall Study|Ineligible: No organisms isolated|0|||
33672091|NCT01381549|63108485|FG001|Overall Study|Ineligible: No organisms isolated|0|||
33672092|NCT01381549|63108486|FG002|Overall Study|Ineligible: No organisms isolated|1|||
33672093|NCT00159432|63108495|FG000|Overall Study|Adverse Event|1|||
33672094|NCT00159432|63108495|FG000|Overall Study|Death|1|||
33672095|NCT00159432|63108495|FG000|Overall Study|Lack of Efficacy|8|||
33672096|NCT01396057|63108501|FG000|Overall Study|Adverse Event|2|||
33672097|NCT01396057|63108502|FG001|Overall Study|Adverse Event|6|||
33672098|NCT01396057|63108501|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33672099|NCT01396057|63108502|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
33672100|NCT01396057|63108501|FG000|Overall Study|Protocol deviation|4|||
33672101|NCT01396057|63108502|FG001|Overall Study|Protocol deviation|4|||
33672102|NCT01396057|63108501|FG000|Overall Study|Consent withdrawn|3|||
33672103|NCT01396057|63108502|FG001|Overall Study|Consent withdrawn|2|||
33672104|NCT01380769|63108519|FG000|Overall Study|Withdrawal by Subject|7|||
33672105|NCT01380769|63108520|FG001|Overall Study|Withdrawal by Subject|11|||
33400740|NCT00739973|62779872|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
33400741|NCT00739973|62779873|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
33400742|NCT00739973|62779874|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
33400743|NCT00739973|62779875|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
33400744|NCT00739973|62779876|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
33400745|NCT00739973|62779877|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
33400746|NCT00739973|62779878|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
33400747|NCT00739973|62779879|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
33400748|NCT00739973|62779871|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
33400749|NCT00739973|62779872|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
33400750|NCT00739973|62779873|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
33400751|NCT00739973|62779874|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
33491242|NCT00075881|62869188|FG000|Overall Study|other complicating disease|3|||
33491243|NCT00075881|62869188|FG000|Overall Study|other|4|||
33672106|NCT01380769|63108519|FG000|Overall Study|Physician Decision|1|||
33672107|NCT01380769|63108520|FG001|Overall Study|Physician Decision|1|||
33672108|NCT01380769|63108519|FG000|Overall Study|Adverse Event|1|||
33672109|NCT01380769|63108520|FG001|Overall Study|Adverse Event|1|||
33672110|NCT01380769|63108519|FG000|Overall Study|Protocol Violation|0|||
33672111|NCT01380769|63108520|FG001|Overall Study|Protocol Violation|1|||
33672112|NCT01395901|63108528|FG000|Overall Study|Lost to Follow-up|4|||
33672113|NCT01395901|63108529|FG001|Overall Study|Lost to Follow-up|0|||
33672114|NCT01395901|63108528|FG000|Overall Study|Randomized but not received study drug|5|||
33672115|NCT01395901|63108529|FG001|Overall Study|Randomized but not received study drug|4|||
33672116|NCT01395901|63108528|FG000|Overall Study|Adverse Event|0|||
33672117|NCT01395901|63108529|FG001|Overall Study|Adverse Event|1|||
33672118|NCT01395901|63108528|FG000|Overall Study|Withdrawal of consent|1|||
33672119|NCT01395901|63108529|FG001|Overall Study|Withdrawal of consent|0|||
33672120|NCT01395823|63108537|FG000|Overall Study|Death|4|||
33672121|NCT01395823|63108538|FG001|Overall Study|Death|4|||
33672122|NCT01395823|63108537|FG000|Overall Study|Physician Decision|3|||
33672123|NCT01395823|63108538|FG001|Overall Study|Physician Decision|1|||
33672124|NCT01395823|63108537|FG000|Overall Study|Lost to Follow-up|1|||
33672125|NCT01395823|63108538|FG001|Overall Study|Lost to Follow-up|0|||
33672126|NCT01395823|63108537|FG000|Overall Study|Transplant|1|||
33672127|NCT01395823|63108538|FG001|Overall Study|Transplant|0|||
33672128|NCT01395823|63108537|FG000|Overall Study|GI symptoms|1|||
33672129|NCT01395823|63108538|FG001|Overall Study|GI symptoms|0|||
33672130|NCT01395823|63108537|FG000|Overall Study|Withdrawal by Subject|5|||
33672131|NCT01395823|63108538|FG001|Overall Study|Withdrawal by Subject|4|||
33672132|NCT00158184|63108546|FG000|Overall Study|personal issues|3|||
33672133|NCT00158184|63108547|FG001|Overall Study|personal issues|1|||
33672134|NCT00158184|63108546|FG000|Overall Study|failed for follow unit/study rules|2|||
33672135|NCT00158184|63108547|FG001|Overall Study|failed for follow unit/study rules|0|||
33672136|NCT00158184|63108546|FG000|Overall Study|Adverse Event|1|||
33672137|NCT00158184|63108547|FG001|Overall Study|Adverse Event|1|||
33672138|NCT01380691|63108555|FG000|Washout (7 Days)|Protocol Violation|0|||
33672139|NCT01380691|63108556|FG001|Washout (7 Days)|Protocol Violation|0|||
33672140|NCT01380691|63108557|FG002|Washout (7 Days)|Protocol Violation|0|||
33672141|NCT01380691|63108558|FG003|Washout (7 Days)|Protocol Violation|1|||
33672142|NCT01380691|63108555|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
33672143|NCT01380691|63108556|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
33672144|NCT01380691|63108557|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
33672145|NCT01380691|63108558|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
33672146|NCT01380535|63108584|FG000|Overall Study|Adverse Event|3|||
33672147|NCT01380535|63108585|FG001|Overall Study|Adverse Event|3|||
33672148|NCT01380535|63108584|FG000|Overall Study|Death|3|||
33672149|NCT01380535|63108585|FG001|Overall Study|Death|0|||
33672150|NCT01380535|63108584|FG000|Overall Study|Study site closed|0|||
33672151|NCT01380535|63108585|FG001|Overall Study|Study site closed|5|||
33672152|NCT01380535|63108584|FG000|Overall Study|Withdrawal by Subject|1|||
33672153|NCT01380535|63108585|FG001|Overall Study|Withdrawal by Subject|2|||
33672154|NCT01380535|63108584|FG000|Overall Study|Protocol Violation|0|||
33672155|NCT01380535|63108585|FG001|Overall Study|Protocol Violation|2|||
33672156|NCT01380535|63108584|FG000|Overall Study|Lack of Efficacy|0|||
33672157|NCT01380535|63108585|FG001|Overall Study|Lack of Efficacy|3|||
33672158|NCT01380379|63108595|FG000|Overall Study|Pregnancy|1|||
33672159|NCT01380145|63108599|FG000|Overall Study|Progressive disease|4|||
33672160|NCT03420222|63108625|FG000|Overall Study|Withdrawal by Subject|5|||
33672161|NCT03420222|63108626|FG001|Overall Study|Withdrawal by Subject|0|||
33672162|NCT03420222|63108625|FG000|Overall Study|Physician Decision|0|||
33672163|NCT03420222|63108626|FG001|Overall Study|Physician Decision|1|||
33672164|NCT01394185|63108632|FG000|Overall Study|Withdrawal by Subject|2|||
33672165|NCT01394185|63108633|FG001|Overall Study|Withdrawal by Subject|0|||
33672166|NCT01394185|63108634|FG002|Overall Study|Withdrawal by Subject|0|||
33672167|NCT01394185|63108635|FG003|Overall Study|Withdrawal by Subject|0|||
33672168|NCT01394185|63108636|FG004|Overall Study|Withdrawal by Subject|1|||
33672169|NCT01394185|63108637|FG005|Overall Study|Withdrawal by Subject|0|||
33672170|NCT01394185|63108632|FG000|Overall Study|Change in protocol|3|||
33672171|NCT01394185|63108633|FG001|Overall Study|Change in protocol|0|||
33672172|NCT01394185|63108634|FG002|Overall Study|Change in protocol|0|||
33672173|NCT01394185|63108635|FG003|Overall Study|Change in protocol|0|||
33672174|NCT01394185|63108636|FG004|Overall Study|Change in protocol|3|||
33672175|NCT01394185|63108637|FG005|Overall Study|Change in protocol|0|||
33672176|NCT01394185|63108632|FG000|Overall Study|Protocol Violation|1|||
33672177|NCT01394185|63108633|FG001|Overall Study|Protocol Violation|0|||
33672178|NCT01394185|63108634|FG002|Overall Study|Protocol Violation|0|||
33672179|NCT01394185|63108635|FG003|Overall Study|Protocol Violation|1|||
33672180|NCT01394185|63108636|FG004|Overall Study|Protocol Violation|0|||
33672181|NCT01394185|63108637|FG005|Overall Study|Protocol Violation|1|||
33672182|NCT01677936|63108670|FG000|Overall Study|Lost to Follow-up|4|||
33672183|NCT01677936|63108671|FG001|Overall Study|Lost to Follow-up|1|||
33672184|NCT01677936|63108670|FG000|Overall Study|Protocol Violation|3|||
33672185|NCT01677936|63108671|FG001|Overall Study|Protocol Violation|0|||
33672186|NCT01677936|63108670|FG000|Overall Study|Adverse Event|1|||
33672187|NCT01677936|63108671|FG001|Overall Study|Adverse Event|0|||
33672188|NCT01677936|63108670|FG000|Overall Study|Lost to Follow-up|1|||
33672189|NCT01677936|63108671|FG001|Overall Study|Lost to Follow-up|0|||
33672190|NCT01677936|63108670|FG000|Overall Study|Protocol Violation|0|||
33672191|NCT01677936|63108671|FG001|Overall Study|Protocol Violation|4|||
33672192|NCT01525550|63108702|FG000|Overall Study|Lost to Follow-up|8|||
33672193|NCT01525550|63108703|FG001|Overall Study|Lost to Follow-up|2|||
33672194|NCT01525550|63108702|FG000|Overall Study|Death|19|||
33672195|NCT01525550|63108703|FG001|Overall Study|Death|28|||
33672196|NCT01525550|63108702|FG000|Overall Study|Other|0|||
33672197|NCT01525550|63108703|FG001|Overall Study|Other|4|||
33672198|NCT01525550|63108702|FG000|Overall Study|Sponsor's Decision|30|||
33672199|NCT01525550|63108703|FG001|Overall Study|Sponsor's Decision|11|||
33672200|NCT01525550|63108702|FG000|Overall Study|Withdrawal by Subject|4|||
33672201|NCT01525550|63108703|FG001|Overall Study|Withdrawal by Subject|0|||
33672202|NCT00211237|63108724|FG000|Baseline|Withdrew|1|||
33672203|NCT00211237|63108725|FG001|Baseline|Withdrew|3|||
33672204|NCT00211237|63108726|FG002|Baseline|Withdrew|0|||
33672205|NCT00211237|63108724|FG000|Baseline|Refused random assignment|1|||
33672206|NCT00211237|63108725|FG001|Baseline|Refused random assignment|0|||
33672207|NCT00211237|63108726|FG002|Baseline|Refused random assignment|0|||
33672208|NCT00211237|63108724|FG000|1 Month|Death|2|||
33672209|NCT00211237|63108725|FG001|1 Month|Death|1|||
33672210|NCT00211237|63108726|FG002|1 Month|Death|0|||
33672211|NCT00211237|63108724|FG000|1 Month|Lost to Follow-up|0|||
33672212|NCT00211237|63108725|FG001|1 Month|Lost to Follow-up|2|||
33672213|NCT00211237|63108726|FG002|1 Month|Lost to Follow-up|0|||
33672214|NCT00211237|63108724|FG000|1 Month|Withdrew|0|||
33400752|NCT00739973|62779875|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
33400753|NCT00739973|62779876|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
33400754|NCT00739973|62779877|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
33400755|NCT00739973|62779878|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
33400756|NCT00739973|62779879|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
33400757|NCT00510874|62779914|FG000|Overall Study|Withdrawal by Subject|1|||
33400758|NCT00510874|62779915|FG001|Overall Study|Withdrawal by Subject|1|||
33400759|NCT00510874|62779916|FG002|Overall Study|Withdrawal by Subject|0|||
33400760|NCT00510874|62779917|FG003|Overall Study|Withdrawal by Subject|0|||
33400761|NCT00510874|62779918|FG004|Overall Study|Withdrawal by Subject|3|||
33400762|NCT00510874|62779919|FG005|Overall Study|Withdrawal by Subject|0|||
33400763|NCT00510874|62779920|FG006|Overall Study|Withdrawal by Subject|0|||
33400764|NCT00510874|62779914|FG000|Overall Study|Lost to Follow-up|2|||
33400765|NCT00510874|62779915|FG001|Overall Study|Lost to Follow-up|3|||
33400766|NCT00510874|62779916|FG002|Overall Study|Lost to Follow-up|1|||
33400767|NCT00510874|62779917|FG003|Overall Study|Lost to Follow-up|3|||
33400768|NCT00510874|62779918|FG004|Overall Study|Lost to Follow-up|4|||
33400769|NCT00510874|62779919|FG005|Overall Study|Lost to Follow-up|0|||
33400770|NCT00510874|62779920|FG006|Overall Study|Lost to Follow-up|1|||
33400771|NCT00739661|62779939|FG000|Overall Study|Adverse Event|2|||
33400772|NCT00739661|62779940|FG001|Overall Study|Adverse Event|0|||
33400773|NCT00739661|62779939|FG000|Overall Study|Physician decision to withdraw patient|1|||
33400774|NCT00739661|62779940|FG001|Overall Study|Physician decision to withdraw patient|0|||
33400775|NCT00739661|62779939|FG000|Overall Study|Patient decision to withdraw|9|||
33400776|NCT00739661|62779940|FG001|Overall Study|Patient decision to withdraw|4|||
33400777|NCT00739661|62779939|FG000|Overall Study|Disease progression, radiographic|33|||
33400778|NCT00739661|62779940|FG001|Overall Study|Disease progression, radiographic|37|||
33400779|NCT00739661|62779939|FG000|Overall Study|Reason for discontinuation not available|1|||
33400780|NCT00739661|62779940|FG001|Overall Study|Reason for discontinuation not available|1|||
33400781|NCT00615030|62779946|FG000|Period I|Administrative problem|0|||
33400782|NCT00615030|62779947|FG001|Period I|Administrative problem|0|||
33400783|NCT00615030|62779948|FG002|Period I|Administrative problem|0|||
33400784|NCT00615030|62779949|FG003|Period I|Administrative problem|0|||
33400785|NCT00615030|62779950|FG004|Period I|Administrative problem|1|||
33400786|NCT00615030|62779951|FG005|Period I|Administrative problem|0|||
33400787|NCT00615030|62779952|FG006|Period I|Administrative problem|0|||
33400788|NCT00615030|62779953|FG007|Period I|Administrative problem|0|||
33400789|NCT00615030|62779954|FG008|Period I|Administrative problem|0|||
33400790|NCT00615030|62779955|FG009|Period I|Administrative problem|0|||
33672215|NCT00211237|63108725|FG001|1 Month|Withdrew|4|||
33400791|NCT00615030|62779956|FG010|Period I|Administrative problem|0|||
33400792|NCT00615030|62779957|FG011|Period I|Administrative problem|0|||
33672216|NCT00211237|63108726|FG002|1 Month|Withdrew|0|||
33672217|NCT00211237|63108724|FG000|1 Month|Additional surgery needed|1|||
33672218|NCT00211237|63108725|FG001|1 Month|Additional surgery needed|0|||
33672219|NCT00211237|63108726|FG002|1 Month|Additional surgery needed|0|||
33672220|NCT00211237|63108724|FG000|1 Month|Non-medical problem|0|||
33672221|NCT00211237|63108725|FG001|1 Month|Non-medical problem|2|||
33672222|NCT00211237|63108726|FG002|1 Month|Non-medical problem|0|||
33672223|NCT00211237|63108724|FG000|3 Months|Death|7|||
33672224|NCT00211237|63108725|FG001|3 Months|Death|3|||
33400793|NCT00615030|62779946|FG000|Period I|Protocol deviation|1|||
33400794|NCT00615030|62779947|FG001|Period I|Protocol deviation|0|||
33400795|NCT00615030|62779948|FG002|Period I|Protocol deviation|0|||
33400796|NCT00615030|62779949|FG003|Period I|Protocol deviation|0|||
33400797|NCT00615030|62779950|FG004|Period I|Protocol deviation|0|||
33400798|NCT00615030|62779951|FG005|Period I|Protocol deviation|0|||
33400799|NCT00615030|62779952|FG006|Period I|Protocol deviation|0|||
33400800|NCT00615030|62779953|FG007|Period I|Protocol deviation|0|||
33400801|NCT00615030|62779954|FG008|Period I|Protocol deviation|0|||
33400802|NCT00615030|62779955|FG009|Period I|Protocol deviation|0|||
33400803|NCT00615030|62779956|FG010|Period I|Protocol deviation|0|||
33400804|NCT00615030|62779957|FG011|Period I|Protocol deviation|0|||
33400805|NCT00615030|62779946|FG000|Period I|Subject withdrew consent|0|||
33400806|NCT00615030|62779947|FG001|Period I|Subject withdrew consent|0|||
33400807|NCT00615030|62779948|FG002|Period I|Subject withdrew consent|0|||
33400808|NCT00615030|62779949|FG003|Period I|Subject withdrew consent|0|||
33400809|NCT00615030|62779950|FG004|Period I|Subject withdrew consent|0|||
33400810|NCT00615030|62779951|FG005|Period I|Subject withdrew consent|0|||
33400811|NCT00615030|62779952|FG006|Period I|Subject withdrew consent|0|||
33400812|NCT00615030|62779953|FG007|Period I|Subject withdrew consent|0|||
33400813|NCT00615030|62779954|FG008|Period I|Subject withdrew consent|1|||
33400814|NCT00615030|62779955|FG009|Period I|Subject withdrew consent|0|||
33400815|NCT00615030|62779956|FG010|Period I|Subject withdrew consent|1|||
33400816|NCT00615030|62779957|FG011|Period I|Subject withdrew consent|1|||
33400817|NCT00615030|62779946|FG000|Period I|Abnormal laboratory value(s)|0|||
33400818|NCT00615030|62779947|FG001|Period I|Abnormal laboratory value(s)|0|||
33400819|NCT00615030|62779948|FG002|Period I|Abnormal laboratory value(s)|0|||
33400820|NCT00615030|62779949|FG003|Period I|Abnormal laboratory value(s)|0|||
33400821|NCT00615030|62779950|FG004|Period I|Abnormal laboratory value(s)|0|||
33400822|NCT00615030|62779951|FG005|Period I|Abnormal laboratory value(s)|1|||
33400823|NCT00615030|62779952|FG006|Period I|Abnormal laboratory value(s)|0|||
33400824|NCT00615030|62779953|FG007|Period I|Abnormal laboratory value(s)|0|||
33400825|NCT00615030|62779954|FG008|Period I|Abnormal laboratory value(s)|0|||
33400826|NCT00615030|62779955|FG009|Period I|Abnormal laboratory value(s)|0|||
33400827|NCT00615030|62779956|FG010|Period I|Abnormal laboratory value(s)|0|||
33400828|NCT00615030|62779957|FG011|Period I|Abnormal laboratory value(s)|0|||
33400829|NCT00615030|62779946|FG000|Period II|Adverse Event|0|||
33400830|NCT00615030|62779947|FG001|Period II|Adverse Event|0|||
33400831|NCT00615030|62779948|FG002|Period II|Adverse Event|1|||
33400832|NCT00615030|62779949|FG003|Period II|Adverse Event|0|||
33400833|NCT00615030|62779950|FG004|Period II|Adverse Event|0|||
33400834|NCT00615030|62779951|FG005|Period II|Adverse Event|0|||
33400835|NCT00615030|62779952|FG006|Period II|Adverse Event|0|||
33400836|NCT00615030|62779953|FG007|Period II|Adverse Event|0|||
33400837|NCT00615030|62779954|FG008|Period II|Adverse Event|1|||
33400838|NCT00615030|62779955|FG009|Period II|Adverse Event|0|||
33400839|NCT00615030|62779956|FG010|Period II|Adverse Event|0|||
33400840|NCT00615030|62779957|FG011|Period II|Adverse Event|0|||
33400841|NCT00615030|62779946|FG000|Period II|Subject withdrew consent|0|||
33400842|NCT00615030|62779947|FG001|Period II|Subject withdrew consent|0|||
33400843|NCT00615030|62779948|FG002|Period II|Subject withdrew consent|0|||
33400844|NCT00615030|62779949|FG003|Period II|Subject withdrew consent|1|||
33400845|NCT00615030|62779950|FG004|Period II|Subject withdrew consent|0|||
33400846|NCT00615030|62779951|FG005|Period II|Subject withdrew consent|0|||
33400847|NCT00615030|62779952|FG006|Period II|Subject withdrew consent|1|||
33400848|NCT00615030|62779953|FG007|Period II|Subject withdrew consent|0|||
33400849|NCT00615030|62779954|FG008|Period II|Subject withdrew consent|0|||
33400850|NCT00615030|62779955|FG009|Period II|Subject withdrew consent|0|||
33400851|NCT00615030|62779956|FG010|Period II|Subject withdrew consent|0|||
33400852|NCT00615030|62779957|FG011|Period II|Subject withdrew consent|0|||
33400853|NCT00615030|62779946|FG000|Period III|Administrative problems|1|||
33400854|NCT00615030|62779947|FG001|Period III|Administrative problems|0|||
33400855|NCT00615030|62779948|FG002|Period III|Administrative problems|0|||
33400856|NCT00615030|62779949|FG003|Period III|Administrative problems|1|||
33400857|NCT00615030|62779950|FG004|Period III|Administrative problems|0|||
33400858|NCT00615030|62779951|FG005|Period III|Administrative problems|0|||
33400859|NCT00615030|62779952|FG006|Period III|Administrative problems|0|||
33400860|NCT00615030|62779953|FG007|Period III|Administrative problems|0|||
33400861|NCT00615030|62779954|FG008|Period III|Administrative problems|0|||
33400862|NCT00615030|62779955|FG009|Period III|Administrative problems|0|||
33400863|NCT00615030|62779956|FG010|Period III|Administrative problems|0|||
33400864|NCT00615030|62779957|FG011|Period III|Administrative problems|0|||
33400865|NCT00518284|62779975|FG000|Overall Study|Adverse Event|0|||
33400866|NCT00518284|62779976|FG001|Overall Study|Adverse Event|1|||
33400867|NCT00518284|62779977|FG002|Overall Study|Adverse Event|0|||
33400868|NCT00518284|62779978|FG003|Overall Study|Adverse Event|0|||
33400869|NCT00518284|62779975|FG000|Overall Study|Study Termination|0|||
33400870|NCT00518284|62779976|FG001|Overall Study|Study Termination|2|||
33400871|NCT00518284|62779977|FG002|Overall Study|Study Termination|1|||
33400872|NCT00518284|62779978|FG003|Overall Study|Study Termination|2|||
33400873|NCT00614874|62779988|FG000|Overall Study|Protocol Violation|1|||
33400874|NCT00614874|62779988|FG000|Overall Study|Withdrawal by Subject|1|||
33400875|NCT00727415|62779992|FG000|Phase I|Dose Limiting Toxicity|2|||
33400876|NCT00544557|62779996|FG000|Overall Study|Adverse Event|140|||
33400877|NCT00544557|62779996|FG000|Overall Study|Lack of Efficacy|196|||
33400878|NCT00544557|62779996|FG000|Overall Study|Other|98|||
33400879|NCT00727259|62780000|FG000|Overall Study|Not all questionnaires completed|1055|||
33400880|NCT00735371|62780009|FG000|Overall Study|Adverse Event|3|||
33400881|NCT00735371|62780010|FG001|Overall Study|Adverse Event|3|||
33400882|NCT00735371|62780011|FG002|Overall Study|Adverse Event|4|||
33400883|NCT00735371|62780012|FG003|Overall Study|Adverse Event|1|||
33400884|NCT00735371|62780009|FG000|Overall Study|Protocol Violation|2|||
33400885|NCT00735371|62780010|FG001|Overall Study|Protocol Violation|2|||
33400886|NCT00735371|62780011|FG002|Overall Study|Protocol Violation|0|||
33400887|NCT00735371|62780012|FG003|Overall Study|Protocol Violation|3|||
33400888|NCT00735371|62780009|FG000|Overall Study|Withdrawal by Subject|0|||
33400889|NCT00735371|62780010|FG001|Overall Study|Withdrawal by Subject|2|||
33400890|NCT00735371|62780011|FG002|Overall Study|Withdrawal by Subject|2|||
33400891|NCT00735371|62780012|FG003|Overall Study|Withdrawal by Subject|0|||
33400892|NCT00735371|62780009|FG000|Overall Study|Lost to Follow-up|1|||
33400893|NCT00735371|62780010|FG001|Overall Study|Lost to Follow-up|1|||
33400894|NCT00735371|62780011|FG002|Overall Study|Lost to Follow-up|3|||
33400895|NCT00735371|62780012|FG003|Overall Study|Lost to Follow-up|1|||
33400896|NCT00735371|62780009|FG000|Overall Study|Lack of Efficacy|4|||
33400897|NCT00735371|62780010|FG001|Overall Study|Lack of Efficacy|2|||
33400898|NCT00735371|62780011|FG002|Overall Study|Lack of Efficacy|0|||
33400899|NCT00735371|62780012|FG003|Overall Study|Lack of Efficacy|4|||
33400900|NCT00735371|62780009|FG000|Overall Study|Sponsor Decision|3|||
33400901|NCT00735371|62780010|FG001|Overall Study|Sponsor Decision|1|||
33400902|NCT00735371|62780011|FG002|Overall Study|Sponsor Decision|0|||
33400903|NCT00735371|62780012|FG003|Overall Study|Sponsor Decision|1|||
33400904|NCT00735371|62780009|FG000|Overall Study|Protocol Violation|0|||
33400905|NCT00735371|62780010|FG001|Overall Study|Protocol Violation|1|||
33400906|NCT00735371|62780011|FG002|Overall Study|Protocol Violation|2|||
33400907|NCT00735371|62780012|FG003|Overall Study|Protocol Violation|0|||
33400908|NCT00735371|62780009|FG000|Overall Study|Prior Vyvanse Exposure|1|||
33400909|NCT00735371|62780010|FG001|Overall Study|Prior Vyvanse Exposure|1|||
33400910|NCT00735371|62780011|FG002|Overall Study|Prior Vyvanse Exposure|0|||
33400911|NCT00735371|62780012|FG003|Overall Study|Prior Vyvanse Exposure|0|||
33400912|NCT00735371|62780009|FG000|Overall Study|Exclusion criteria|1|||
33400913|NCT00735371|62780010|FG001|Overall Study|Exclusion criteria|0|||
33400914|NCT00735371|62780011|FG002|Overall Study|Exclusion criteria|0|||
33400915|NCT00735371|62780012|FG003|Overall Study|Exclusion criteria|0|||
33400916|NCT00518206|62780024|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
33400917|NCT00518206|62780025|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
33400918|NCT00518206|62780024|FG000|Overall Study|Withdrawal by Subject|2|||
33400919|NCT00518206|62780025|FG001|Overall Study|Withdrawal by Subject|0|||
33400920|NCT00518206|62780024|FG000|Overall Study|Drug Supply Issue|1|||
33400921|NCT00518206|62780025|FG001|Overall Study|Drug Supply Issue|0|||
33400922|NCT00518206|62780024|FG000|Overall Study|Reason Unknown|1|||
33400923|NCT00518206|62780025|FG001|Overall Study|Reason Unknown|0|||
33400924|NCT00518206|62780024|FG000|Overall Study|Completion Status Unknown|1|||
33400925|NCT00518206|62780025|FG001|Overall Study|Completion Status Unknown|0|||
33400926|NCT00586313|62780031|FG000|Overall Study|Lack of Efficacy|2|||
33400927|NCT00727025|62780035|FG000|Overall Study|Physician Decision|23|||
33400928|NCT00734747|62780043|FG000|SRS Procedure|No staples placed|3|||
33400929|NCT00734747|62780043|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
33400930|NCT00726557|62780047|FG000|Overall Study|Screening failure|4|||
33400931|NCT00726557|62780047|FG000|Overall Study|No end of treatment documentation|37|||
33400932|NCT00726557|62780047|FG000|Overall Study|No follow-up documentation available|55|||
33400933|NCT00726557|62780047|FG000|Overall Study|Treatment less than 3 months|17|||
33400934|NCT00726557|62780047|FG000|Overall Study|Inclusion criteria not met|15|||
33400935|NCT00738881|62780054|FG000|Overall Study|Withdrawal by Subject|0|||
33400936|NCT00738881|62780055|FG001|Overall Study|Withdrawal by Subject|2|||
33400937|NCT00657020|62780061|FG000|PERIOD 1|Adverse Event|0|||
33400938|NCT00657020|62780062|FG001|PERIOD 1|Adverse Event|1|||
33400939|NCT03921723|62780074|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
33400940|NCT03921723|62780074|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
33400941|NCT00544167|62780082|FG000|Overall Study|Adverse Event|21|||
33400942|NCT00544167|62780082|FG000|Overall Study|Physician Decision|8|||
33400943|NCT00659438|62780088|FG000|Overall Study|Withdrawal by Subject|2|||
33400944|NCT00659438|62780089|FG001|Overall Study|Withdrawal by Subject|2|||
33400945|NCT00659438|62780088|FG000|Overall Study|Death|11|||
33400946|NCT00659438|62780089|FG001|Overall Study|Death|6|||
33400947|NCT00659438|62780088|FG000|Overall Study|Lost to Follow-up|1|||
33400948|NCT00659438|62780089|FG001|Overall Study|Lost to Follow-up|0|||
33400949|NCT00543855|62780099|FG000|Overall Study|Adverse Event|3|||
33400950|NCT00543855|62780100|FG001|Overall Study|Adverse Event|1|||
33400951|NCT00543855|62780101|FG002|Overall Study|Adverse Event|3|||
33400952|NCT00543855|62780102|FG003|Overall Study|Adverse Event|4|||
33400953|NCT00543855|62780099|FG000|Overall Study|Lost to Follow-up|0|||
33400954|NCT00543855|62780100|FG001|Overall Study|Lost to Follow-up|0|||
33400955|NCT00543855|62780101|FG002|Overall Study|Lost to Follow-up|1|||
33400956|NCT00543855|62780102|FG003|Overall Study|Lost to Follow-up|0|||
33400957|NCT00543855|62780099|FG000|Overall Study|Withdrawal by Subject|0|||
33400958|NCT00543855|62780100|FG001|Overall Study|Withdrawal by Subject|1|||
33400959|NCT00543855|62780101|FG002|Overall Study|Withdrawal by Subject|2|||
33400960|NCT00543855|62780102|FG003|Overall Study|Withdrawal by Subject|0|||
33400961|NCT00543855|62780099|FG000|Overall Study|Protocol Violation|1|||
33400962|NCT00543855|62780100|FG001|Overall Study|Protocol Violation|0|||
33400963|NCT00543855|62780101|FG002|Overall Study|Protocol Violation|0|||
33400964|NCT00543855|62780102|FG003|Overall Study|Protocol Violation|0|||
33400965|NCT00656474|62780112|FG000|Overall Study|Other Reason|1|||
33400966|NCT00656084|62780117|FG000|Overall Study|Adverse Event|4|||
33400967|NCT00656084|62780117|FG000|Overall Study|Withdrawal by Subject|1|||
33400968|NCT00656084|62780117|FG000|Overall Study|Patient Request|1|||
33400969|NCT00656084|62780117|FG000|Overall Study|Investigator Request|1|||
33400970|NCT00613938|62780125|FG000|Overall Study|Withdrawal by Subject|2|||
33400971|NCT00613938|62780126|FG001|Overall Study|Withdrawal by Subject|4|||
33400972|NCT00613938|62780127|FG002|Overall Study|Withdrawal by Subject|9|||
33400973|NCT00613938|62780128|FG003|Overall Study|Withdrawal by Subject|9|||
33400974|NCT00613938|62780125|FG000|Overall Study|Adverse Event|1|||
33400975|NCT00613938|62780126|FG001|Overall Study|Adverse Event|4|||
33400976|NCT00613938|62780127|FG002|Overall Study|Adverse Event|8|||
33400977|NCT00613938|62780128|FG003|Overall Study|Adverse Event|5|||
33400978|NCT00613938|62780125|FG000|Overall Study|Lack of Efficacy|16|||
33400979|NCT00613938|62780126|FG001|Overall Study|Lack of Efficacy|18|||
33400980|NCT00613938|62780127|FG002|Overall Study|Lack of Efficacy|5|||
33400981|NCT00613938|62780128|FG003|Overall Study|Lack of Efficacy|9|||
33400982|NCT00613938|62780125|FG000|Overall Study|Other|1|||
33400983|NCT00613938|62780126|FG001|Overall Study|Other|2|||
33400984|NCT00613938|62780127|FG002|Overall Study|Other|1|||
33400985|NCT00613938|62780128|FG003|Overall Study|Other|3|||
33400986|NCT00655928|62780140|FG000|Overall Study|Withdrawal by Subject|2|||
33400987|NCT00655928|62780141|FG001|Overall Study|Withdrawal by Subject|1|||
33400988|NCT00655928|62780140|FG000|Overall Study|Physician Decision|1|||
33400989|NCT00655928|62780141|FG001|Overall Study|Physician Decision|1|||
33400990|NCT00655850|62780147|FG000|Overall Study|Death|2|||
33400991|NCT00655850|62780147|FG000|Overall Study|Withdrawal by Subject|1|||
33400992|NCT00726323|62780155|FG000|Overall Study|Withdrawal by Subject|3|||
33400993|NCT00726323|62780156|FG001|Overall Study|Withdrawal by Subject|1|||
33400994|NCT00726323|62780155|FG000|Overall Study|Physician Decision|1|||
33400995|NCT00726323|62780156|FG001|Overall Study|Physician Decision|0|||
33400996|NCT00726323|62780155|FG000|Overall Study|Progressive disease|23|||
33400997|NCT00726323|62780156|FG001|Overall Study|Progressive disease|16|||
33400998|NCT00726323|62780155|FG000|Overall Study|Clinical progression|0|||
33400999|NCT00726323|62780156|FG001|Overall Study|Clinical progression|3|||
33401000|NCT00726323|62780155|FG000|Overall Study|Adverse Event|9|||
33401001|NCT00726323|62780156|FG001|Overall Study|Adverse Event|9|||
33401002|NCT00726323|62780155|FG000|Overall Study|Death|1|||
33401003|NCT00726323|62780156|FG001|Overall Study|Death|0|||
33401004|NCT00726323|62780155|FG000|Overall Study|Participant wished to discontinue|0|||
33401005|NCT00726323|62780156|FG001|Overall Study|Participant wished to discontinue|1|||
33401006|NCT00726323|62780155|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
33401007|NCT00726323|62780156|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
33401008|NCT00246571|62780164|FG000|Overall Study|Adverse Event|7|||
33401009|NCT00246571|62780165|FG001|Overall Study|Adverse Event|0|||
33401010|NCT00246571|62780164|FG000|Overall Study|Protocol Violation|0|||
33401011|NCT00246571|62780165|FG001|Overall Study|Protocol Violation|1|||
33401012|NCT00246571|62780164|FG000|Overall Study|Withdrawal by Subject|2|||
33401013|NCT00246571|62780165|FG001|Overall Study|Withdrawal by Subject|3|||
33401014|NCT00246571|62780164|FG000|Overall Study|Lack of Efficacy|84|||
33401015|NCT00246571|62780165|FG001|Overall Study|Lack of Efficacy|21|||
33401016|NCT00246571|62780164|FG000|Overall Study|Death|17|||
33672225|NCT00211237|63108726|FG002|3 Months|Death|0|||
33401017|NCT00246571|62780165|FG001|Overall Study|Death|3|||
33401018|NCT00246571|62780164|FG000|Overall Study|Sponsor|0|||
33401019|NCT00246571|62780165|FG001|Overall Study|Sponsor|1|||
33401020|NCT00246571|62780164|FG000|Overall Study|Did not meet entrance criteria|2|||
33401021|NCT00246571|62780165|FG001|Overall Study|Did not meet entrance criteria|1|||
33401022|NCT00246571|62780164|FG000|Overall Study|Laboratory abnormalities|1|||
33401023|NCT00246571|62780165|FG001|Overall Study|Laboratory abnormalities|0|||
33401024|NCT00246571|62780164|FG000|Overall Study|Crossover participants|0|||
33401025|NCT00246571|62780165|FG001|Overall Study|Crossover participants|74|||
33401026|NCT00734591|62780173|FG000|Screening for Prospective Period|Site did not participate|1604|||
33401027|NCT00734591|62780174|FG001|Screening for Prospective Period|Site did not participate|1488|||
33491244|NCT00075881|62869188|FG000|Overall Study|missing data|2|||
33401028|NCT00734591|62780173|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
33401029|NCT00734591|62780174|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
33401030|NCT00734591|62780173|FG000|Prospective Period|Withdrawal by Subject|11|||
33401031|NCT00734591|62780174|FG001|Prospective Period|Withdrawal by Subject|9|||
33401032|NCT00734591|62780173|FG000|Prospective Period|Lost to Follow-up|37|||
33401033|NCT00734591|62780174|FG001|Prospective Period|Lost to Follow-up|33|||
33401034|NCT00734591|62780173|FG000|Prospective Period|Study Terminated|1|||
33401035|NCT00734591|62780174|FG001|Prospective Period|Study Terminated|0|||
33401036|NCT00734591|62780173|FG000|Prospective Period|Other|2|||
33401037|NCT00734591|62780174|FG001|Prospective Period|Other|2|||
33401038|NCT00569270|62780180|FG000|Period: First Intervention|Protocol Violation|0|||
33401039|NCT00569270|62780181|FG001|Period: First Intervention|Protocol Violation|1|||
33401040|NCT00545103|62780200|FG000|Overall Study|Lack of Efficacy|48|||
33401041|NCT00545103|62780201|FG001|Overall Study|Lack of Efficacy|45|||
33401042|NCT00545103|62780202|FG002|Overall Study|Lack of Efficacy|31|||
33401043|NCT00545103|62780203|FG003|Overall Study|Lack of Efficacy|27|||
33401044|NCT00545103|62780200|FG000|Overall Study|Withdrawal by Subject|6|||
33401045|NCT00545103|62780201|FG001|Overall Study|Withdrawal by Subject|10|||
33401046|NCT00545103|62780202|FG002|Overall Study|Withdrawal by Subject|18|||
33401047|NCT00545103|62780203|FG003|Overall Study|Withdrawal by Subject|22|||
33401048|NCT00545103|62780200|FG000|Overall Study|Adverse Event|11|||
33401049|NCT00545103|62780201|FG001|Overall Study|Adverse Event|12|||
33401050|NCT00545103|62780202|FG002|Overall Study|Adverse Event|17|||
33401051|NCT00545103|62780203|FG003|Overall Study|Adverse Event|10|||
33401052|NCT00545103|62780200|FG000|Overall Study|Lost to Follow-up|4|||
33401053|NCT00545103|62780201|FG001|Overall Study|Lost to Follow-up|6|||
33401054|NCT00545103|62780202|FG002|Overall Study|Lost to Follow-up|3|||
33401055|NCT00545103|62780203|FG003|Overall Study|Lost to Follow-up|4|||
33401056|NCT00545103|62780200|FG000|Overall Study|Protocol Violation|1|||
33401057|NCT00545103|62780201|FG001|Overall Study|Protocol Violation|2|||
33401058|NCT00545103|62780202|FG002|Overall Study|Protocol Violation|3|||
33401059|NCT00545103|62780203|FG003|Overall Study|Protocol Violation|0|||
33401060|NCT00545103|62780200|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
33401061|NCT00545103|62780201|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
33401062|NCT00545103|62780202|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
33401063|NCT00545103|62780203|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
33401064|NCT00545103|62780200|FG000|Overall Study|Difficult to open package|0|||
33401065|NCT00545103|62780201|FG001|Overall Study|Difficult to open package|0|||
33401066|NCT00545103|62780202|FG002|Overall Study|Difficult to open package|0|||
33401067|NCT00545103|62780203|FG003|Overall Study|Difficult to open package|1|||
33401068|NCT00545103|62780200|FG000|Overall Study|Investigational product not taken|1|||
33401069|NCT00545103|62780201|FG001|Overall Study|Investigational product not taken|0|||
33401070|NCT00545103|62780202|FG002|Overall Study|Investigational product not taken|0|||
33401071|NCT00545103|62780203|FG003|Overall Study|Investigational product not taken|1|||
33401072|NCT00545103|62780200|FG000|Overall Study|Wish to start a family|0|||
33401073|NCT00545103|62780201|FG001|Overall Study|Wish to start a family|0|||
33401074|NCT00545103|62780202|FG002|Overall Study|Wish to start a family|0|||
33401075|NCT00545103|62780203|FG003|Overall Study|Wish to start a family|1|||
33401076|NCT00545103|62780200|FG000|Overall Study|Diverticulitis crisis|0|||
33401077|NCT00545103|62780201|FG001|Overall Study|Diverticulitis crisis|0|||
33401078|NCT00545103|62780202|FG002|Overall Study|Diverticulitis crisis|0|||
33401079|NCT00545103|62780203|FG003|Overall Study|Diverticulitis crisis|1|||
33401080|NCT00545103|62780200|FG000|Overall Study|Personal reasons|1|||
33401081|NCT00545103|62780201|FG001|Overall Study|Personal reasons|0|||
33401082|NCT00545103|62780202|FG002|Overall Study|Personal reasons|0|||
33401083|NCT00545103|62780203|FG003|Overall Study|Personal reasons|0|||
33401084|NCT00545103|62780200|FG000|Overall Study|Subject's decision|1|||
33401085|NCT00545103|62780201|FG001|Overall Study|Subject's decision|0|||
33401086|NCT00545103|62780202|FG002|Overall Study|Subject's decision|0|||
33401087|NCT00545103|62780203|FG003|Overall Study|Subject's decision|0|||
33401088|NCT00545103|62780200|FG000|Overall Study|Noncompliance|0|||
33401089|NCT00545103|62780201|FG001|Overall Study|Noncompliance|1|||
33401090|NCT00545103|62780202|FG002|Overall Study|Noncompliance|0|||
33401091|NCT00545103|62780203|FG003|Overall Study|Noncompliance|0|||
33401092|NCT00545103|62780200|FG000|Overall Study|Investigator decision|0|||
33401093|NCT00545103|62780201|FG001|Overall Study|Investigator decision|0|||
33401094|NCT00545103|62780202|FG002|Overall Study|Investigator decision|1|||
33401095|NCT00545103|62780203|FG003|Overall Study|Investigator decision|0|||
33401096|NCT00545103|62780200|FG000|Overall Study|Subject moved|0|||
33401097|NCT00545103|62780201|FG001|Overall Study|Subject moved|1|||
33401098|NCT00545103|62780202|FG002|Overall Study|Subject moved|0|||
33401099|NCT00545103|62780203|FG003|Overall Study|Subject moved|0|||
33401100|NCT00545103|62780200|FG000|Overall Study|Use of prohibited medication|0|||
33401101|NCT00545103|62780201|FG001|Overall Study|Use of prohibited medication|0|||
33401102|NCT00545103|62780202|FG002|Overall Study|Use of prohibited medication|1|||
33401103|NCT00545103|62780203|FG003|Overall Study|Use of prohibited medication|0|||
33401104|NCT00545103|62780200|FG000|Overall Study|Does not want to take study drug anymore|1|||
33401105|NCT00545103|62780201|FG001|Overall Study|Does not want to take study drug anymore|0|||
33401106|NCT00545103|62780202|FG002|Overall Study|Does not want to take study drug anymore|1|||
33401107|NCT00545103|62780203|FG003|Overall Study|Does not want to take study drug anymore|0|||
33401108|NCT00545103|62780200|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
33401109|NCT00545103|62780201|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
33401110|NCT00545103|62780202|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
33401111|NCT00545103|62780203|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
33401112|NCT00545103|62780200|FG000|Overall Study|Death|0|||
33401113|NCT00545103|62780201|FG001|Overall Study|Death|1|||
33401114|NCT00545103|62780202|FG002|Overall Study|Death|0|||
33401115|NCT00545103|62780203|FG003|Overall Study|Death|0|||
33401116|NCT00586157|62780213|FG000|First Intervention|Worsening behavior|1|||
33401117|NCT00586157|62780214|FG001|First Intervention|Worsening behavior|0|||
33401118|NCT00586157|62780213|FG000|Second Intervention|Withdrawal by Subject|1|||
33401119|NCT00586157|62780214|FG001|Second Intervention|Withdrawal by Subject|0|||
33401120|NCT00586157|62780213|FG000|Second Intervention|Worsening behavior|1|||
33401121|NCT00586157|62780214|FG001|Second Intervention|Worsening behavior|0|||
33401122|NCT00586157|62780213|FG000|Second Intervention|Adverse Event|0|||
33401123|NCT00586157|62780214|FG001|Second Intervention|Adverse Event|1|||
33401124|NCT00246337|62780229|FG000|Overall Study|Lost to Follow-up|3|||
33401125|NCT00246337|62780230|FG001|Overall Study|Lost to Follow-up|0|||
33401126|NCT00246337|62780231|FG002|Overall Study|Lost to Follow-up|0|||
33401127|NCT00246337|62780232|FG003|Overall Study|Lost to Follow-up|0|||
33401128|NCT00246337|62780233|FG004|Overall Study|Lost to Follow-up|2|||
33401129|NCT00246337|62780234|FG005|Overall Study|Lost to Follow-up|2|||
33401130|NCT00246337|62780235|FG006|Overall Study|Lost to Follow-up|1|||
33401131|NCT00246337|62780236|FG007|Overall Study|Lost to Follow-up|2|||
33401132|NCT00246337|62780237|FG008|Overall Study|Lost to Follow-up|0|||
33401133|NCT00246337|62780229|FG000|Overall Study|Protocol Violation|1|||
33401134|NCT00246337|62780230|FG001|Overall Study|Protocol Violation|0|||
33401135|NCT00246337|62780231|FG002|Overall Study|Protocol Violation|0|||
33401136|NCT00246337|62780232|FG003|Overall Study|Protocol Violation|0|||
33401137|NCT00246337|62780233|FG004|Overall Study|Protocol Violation|1|||
33401138|NCT00246337|62780234|FG005|Overall Study|Protocol Violation|0|||
33401139|NCT00246337|62780235|FG006|Overall Study|Protocol Violation|1|||
33401140|NCT00246337|62780236|FG007|Overall Study|Protocol Violation|1|||
33401141|NCT00246337|62780237|FG008|Overall Study|Protocol Violation|0|||
33401142|NCT00246337|62780229|FG000|Overall Study|Withdrawal by Subject|2|||
33401143|NCT00246337|62780230|FG001|Overall Study|Withdrawal by Subject|0|||
33401144|NCT00246337|62780231|FG002|Overall Study|Withdrawal by Subject|0|||
33401145|NCT00246337|62780232|FG003|Overall Study|Withdrawal by Subject|0|||
33401146|NCT00246337|62780233|FG004|Overall Study|Withdrawal by Subject|0|||
33401147|NCT00246337|62780234|FG005|Overall Study|Withdrawal by Subject|0|||
33401148|NCT00246337|62780235|FG006|Overall Study|Withdrawal by Subject|1|||
33401149|NCT00246337|62780236|FG007|Overall Study|Withdrawal by Subject|1|||
33401150|NCT00246337|62780237|FG008|Overall Study|Withdrawal by Subject|0|||
33401151|NCT00246337|62780229|FG000|Overall Study|Lack of Qualifying Event|8|||
33401152|NCT00246337|62780230|FG001|Overall Study|Lack of Qualifying Event|2|||
33401153|NCT00246337|62780231|FG002|Overall Study|Lack of Qualifying Event|1|||
33401154|NCT00246337|62780232|FG003|Overall Study|Lack of Qualifying Event|1|||
33401155|NCT00246337|62780233|FG004|Overall Study|Lack of Qualifying Event|1|||
33401156|NCT00246337|62780234|FG005|Overall Study|Lack of Qualifying Event|3|||
33401157|NCT00246337|62780235|FG006|Overall Study|Lack of Qualifying Event|3|||
33401158|NCT00246337|62780236|FG007|Overall Study|Lack of Qualifying Event|2|||
33401159|NCT00246337|62780237|FG008|Overall Study|Lack of Qualifying Event|5|||
33401160|NCT00246337|62780229|FG000|Overall Study|Site Terminated|10|||
33401161|NCT00246337|62780230|FG001|Overall Study|Site Terminated|0|||
33401162|NCT00246337|62780231|FG002|Overall Study|Site Terminated|0|||
33401163|NCT00246337|62780232|FG003|Overall Study|Site Terminated|0|||
33401164|NCT00246337|62780233|FG004|Overall Study|Site Terminated|0|||
33401165|NCT00246337|62780234|FG005|Overall Study|Site Terminated|7|||
33401166|NCT00246337|62780235|FG006|Overall Study|Site Terminated|1|||
33401167|NCT00246337|62780236|FG007|Overall Study|Site Terminated|6|||
33401168|NCT00246337|62780237|FG008|Overall Study|Site Terminated|2|||
33401169|NCT00246337|62780229|FG000|Overall Study|Abnormal baseline lab values|7|||
33401170|NCT00246337|62780230|FG001|Overall Study|Abnormal baseline lab values|0|||
33401171|NCT00246337|62780231|FG002|Overall Study|Abnormal baseline lab values|2|||
33401172|NCT00246337|62780232|FG003|Overall Study|Abnormal baseline lab values|0|||
33401173|NCT00246337|62780233|FG004|Overall Study|Abnormal baseline lab values|0|||
33401174|NCT00246337|62780234|FG005|Overall Study|Abnormal baseline lab values|2|||
33401175|NCT00246337|62780235|FG006|Overall Study|Abnormal baseline lab values|2|||
33401176|NCT00246337|62780236|FG007|Overall Study|Abnormal baseline lab values|0|||
33401177|NCT00246337|62780237|FG008|Overall Study|Abnormal baseline lab values|4|||
33401178|NCT00246337|62780229|FG000|Overall Study|Overwhelmed|0|||
33401179|NCT00246337|62780230|FG001|Overall Study|Overwhelmed|0|||
33401180|NCT00246337|62780231|FG002|Overall Study|Overwhelmed|0|||
33401181|NCT00246337|62780232|FG003|Overall Study|Overwhelmed|0|||
33401182|NCT00246337|62780233|FG004|Overall Study|Overwhelmed|0|||
33401183|NCT00246337|62780234|FG005|Overall Study|Overwhelmed|1|||
33401184|NCT00246337|62780235|FG006|Overall Study|Overwhelmed|0|||
33401185|NCT00246337|62780236|FG007|Overall Study|Overwhelmed|0|||
33401186|NCT00246337|62780237|FG008|Overall Study|Overwhelmed|0|||
33401187|NCT00246337|62780229|FG000|Overall Study|Protocol Violator|1|||
33401188|NCT00246337|62780230|FG001|Overall Study|Protocol Violator|0|||
33401189|NCT00246337|62780231|FG002|Overall Study|Protocol Violator|0|||
33401190|NCT00246337|62780232|FG003|Overall Study|Protocol Violator|0|||
33401191|NCT00246337|62780233|FG004|Overall Study|Protocol Violator|0|||
33401192|NCT00246337|62780234|FG005|Overall Study|Protocol Violator|0|||
33401193|NCT00246337|62780235|FG006|Overall Study|Protocol Violator|0|||
33401194|NCT00246337|62780236|FG007|Overall Study|Protocol Violator|0|||
33401195|NCT00246337|62780237|FG008|Overall Study|Protocol Violator|0|||
33401196|NCT00246337|62780229|FG000|Overall Study|Reported as completing trial in error|0|||
33401197|NCT00246337|62780230|FG001|Overall Study|Reported as completing trial in error|0|||
33401198|NCT00246337|62780231|FG002|Overall Study|Reported as completing trial in error|0|||
33401199|NCT00246337|62780232|FG003|Overall Study|Reported as completing trial in error|0|||
33401200|NCT00246337|62780233|FG004|Overall Study|Reported as completing trial in error|0|||
33401201|NCT00246337|62780234|FG005|Overall Study|Reported as completing trial in error|0|||
33401202|NCT00246337|62780235|FG006|Overall Study|Reported as completing trial in error|0|||
33401203|NCT00246337|62780236|FG007|Overall Study|Reported as completing trial in error|1|||
33401204|NCT00246337|62780237|FG008|Overall Study|Reported as completing trial in error|0|||
33401205|NCT00243919|62780260|FG000|Overall Study|Death|3|||
33401206|NCT00243919|62780261|FG001|Overall Study|Death|4|||
33401207|NCT00243919|62780262|FG002|Overall Study|Death|6|||
33401208|NCT00243919|62780260|FG000|Overall Study|Withdrawal by Subject|6|||
33401209|NCT00243919|62780261|FG001|Overall Study|Withdrawal by Subject|6|||
33401210|NCT00243919|62780262|FG002|Overall Study|Withdrawal by Subject|2|||
33401211|NCT00243919|62780260|FG000|Overall Study|Lost to Follow-up|6|||
33401212|NCT00243919|62780261|FG001|Overall Study|Lost to Follow-up|7|||
33401213|NCT00243919|62780262|FG002|Overall Study|Lost to Follow-up|3|||
33401214|NCT00243919|62780260|FG000|Overall Study|Administrative Error|1|||
33401215|NCT00243919|62780261|FG001|Overall Study|Administrative Error|0|||
33401216|NCT00243919|62780262|FG002|Overall Study|Administrative Error|0|||
33401217|NCT00243919|62780260|FG000|Overall Study|Physician Decision|1|||
33401218|NCT00243919|62780261|FG001|Overall Study|Physician Decision|1|||
33401219|NCT00243919|62780262|FG002|Overall Study|Physician Decision|0|||
33401220|NCT00725621|62780270|FG000|Overall Study|Adverse Event|25|||
33401221|NCT00725621|62780270|FG000|Overall Study|Lack of Efficacy|46|||
33401222|NCT00725621|62780270|FG000|Overall Study|Withdrawal by Subject|57|||
33401223|NCT00725621|62780270|FG000|Overall Study|Physician Decision|19|||
33401224|NCT00725621|62780270|FG000|Overall Study|Lost to Follow-up|52|||
33401225|NCT00725621|62780270|FG000|Overall Study|Non-compliance|8|||
33401226|NCT00725621|62780270|FG000|Overall Study|Continued treatment by other physician|6|||
33401227|NCT00725621|62780270|FG000|Overall Study|Switched to other study|1|||
33401228|NCT00725621|62780270|FG000|Overall Study|Switched to other drug|1|||
33401229|NCT00725621|62780270|FG000|Overall Study|Prepared for elective surgery|1|||
33401230|NCT00725621|62780270|FG000|Overall Study|Reason not specified|55|||
33401231|NCT00613626|62780281|FG000|Overall Study|Ineligible|0|||
33401232|NCT00613626|62780282|FG001|Overall Study|Ineligible|1|||
33401233|NCT00613626|62780283|FG002|Overall Study|Ineligible|0|||
33401234|NCT00725543|62780290|FG000|Overall Study|Adverse Event|10|||
33401235|NCT00725543|62780290|FG000|Overall Study|Lack of Efficacy|3|||
33401236|NCT00725543|62780290|FG000|Overall Study|Withdrawal by Subject|10|||
33401237|NCT00725543|62780290|FG000|Overall Study|Physician Decision|5|||
33401238|NCT00725543|62780290|FG000|Overall Study|Lost to Follow-up|4|||
33401239|NCT00725543|62780290|FG000|Overall Study|Non-compliance|2|||
33401240|NCT00725543|62780290|FG000|Overall Study|Other|119|||
33401241|NCT00239005|62780296|FG000|Overall Study|Adverse Event|6|||
33401242|NCT00239005|62780297|FG001|Overall Study|Adverse Event|6|||
33401243|NCT00239005|62780296|FG000|Overall Study|Withdrawal by Subject|3|||
33401244|NCT00239005|62780297|FG001|Overall Study|Withdrawal by Subject|4|||
33401245|NCT00239005|62780296|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
33401246|NCT00239005|62780297|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
33401247|NCT00239005|62780296|FG000|Overall Study|Protocol Violation|1|||
33401248|NCT00239005|62780297|FG001|Overall Study|Protocol Violation|0|||
33401249|NCT00239005|62780296|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
33401250|NCT00239005|62780297|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
33401251|NCT00239005|62780296|FG000|Overall Study|Lost to Follow-up|0|||
33401252|NCT00239005|62780297|FG001|Overall Study|Lost to Follow-up|1|||
33401253|NCT00616434|62780305|FG000|Overall Study|Adverse Event|5|||
33401254|NCT00616434|62780306|FG001|Overall Study|Adverse Event|2|||
33401255|NCT00616434|62780305|FG000|Overall Study|Physician Decision|0|||
33401256|NCT00616434|62780306|FG001|Overall Study|Physician Decision|4|||
33672226|NCT00211237|63108724|FG000|3 Months|Could not comply with protocol|1|||
33401257|NCT00616434|62780305|FG000|Overall Study|Withdrawal by Subject|1|||
33401258|NCT00616434|62780306|FG001|Overall Study|Withdrawal by Subject|1|||
33401259|NCT00616434|62780305|FG000|Overall Study|Protocol deviation|0|||
33401260|NCT00616434|62780306|FG001|Overall Study|Protocol deviation|1|||
33401261|NCT00652340|62780314|FG000|Overall Study|Had not progressed.|4|||
33401262|NCT00652340|62780315|FG001|Overall Study|Had not progressed.|3|||
33401263|NCT00613314|62780321|FG000|Overall Study|Adverse Event|5|||
33401264|NCT00613314|62780321|FG000|Overall Study|Protocol Violation|14|||
33672227|NCT00211237|63108725|FG001|3 Months|Could not comply with protocol|0|||
33672228|NCT00211237|63108726|FG002|3 Months|Could not comply with protocol|0|||
33672229|NCT00211237|63108724|FG000|3 Months|Withdrew|0|||
33672230|NCT00211237|63108725|FG001|3 Months|Withdrew|1|||
33672231|NCT00211237|63108726|FG002|3 Months|Withdrew|0|||
33672232|NCT00211237|63108724|FG000|3 Months|Non-medical problem|0|||
33672233|NCT00211237|63108725|FG001|3 Months|Non-medical problem|0|||
33672234|NCT00211237|63108726|FG002|3 Months|Non-medical problem|1|||
33672235|NCT00211237|63108724|FG000|6 Months|Death|6|||
33672236|NCT00211237|63108725|FG001|6 Months|Death|0|||
33401265|NCT00613314|62780321|FG000|Overall Study|Lost to Follow-up|46|||
33401266|NCT00613314|62780321|FG000|Overall Study|Other reason not defined above|90|||
33401267|NCT00257725|62780325|FG000|Overall Study|Adverse Event|3|||
33401268|NCT00544869|62780333|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
33401269|NCT00544869|62780334|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
33401270|NCT00544869|62780335|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
33401271|NCT00544869|62780333|FG000|Overall Study|Adverse Event|6|||
33401272|NCT00544869|62780334|FG001|Overall Study|Adverse Event|1|||
33401273|NCT00544869|62780335|FG002|Overall Study|Adverse Event|0|||
33401274|NCT00544869|62780333|FG000|Overall Study|Lack of Efficacy|1|||
33401275|NCT00544869|62780334|FG001|Overall Study|Lack of Efficacy|1|||
33401276|NCT00544869|62780335|FG002|Overall Study|Lack of Efficacy|0|||
33401277|NCT00544869|62780333|FG000|Overall Study|Physician Decision|2|||
33401278|NCT00544869|62780334|FG001|Overall Study|Physician Decision|0|||
33401279|NCT00544869|62780335|FG002|Overall Study|Physician Decision|0|||
33401280|NCT00725075|62780346|FG000|Overall Study|Use of Excluded Medication|0|||
33401281|NCT00725075|62780347|FG001|Overall Study|Use of Excluded Medication|1|||
33401282|NCT00725075|62780348|FG002|Overall Study|Use of Excluded Medication|0|||
33401283|NCT00725075|62780346|FG000|Overall Study|Protocol Violation|0|||
33401284|NCT00725075|62780347|FG001|Overall Study|Protocol Violation|0|||
33401285|NCT00725075|62780348|FG002|Overall Study|Protocol Violation|1|||
33401286|NCT00725075|62780346|FG000|Overall Study|Lost to Follow-up|1|||
33401287|NCT00725075|62780347|FG001|Overall Study|Lost to Follow-up|0|||
33401288|NCT00725075|62780348|FG002|Overall Study|Lost to Follow-up|0|||
33401289|NCT00725075|62780346|FG000|Overall Study|Withdrawal by Subject|4|||
33401290|NCT00725075|62780347|FG001|Overall Study|Withdrawal by Subject|5|||
33401291|NCT00725075|62780348|FG002|Overall Study|Withdrawal by Subject|4|||
33401292|NCT00725075|62780346|FG000|Overall Study|Adverse Event|2|||
33401293|NCT00725075|62780347|FG001|Overall Study|Adverse Event|1|||
33401294|NCT00725075|62780348|FG002|Overall Study|Adverse Event|1|||
33401295|NCT00725075|62780346|FG000|Overall Study|Worsening of Disease|2|||
33401296|NCT00725075|62780347|FG001|Overall Study|Worsening of Disease|1|||
33401297|NCT00725075|62780348|FG002|Overall Study|Worsening of Disease|2|||
33401298|NCT00725075|62780346|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
33401299|NCT00725075|62780347|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
33401300|NCT00725075|62780348|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
33401301|NCT00725075|62780346|FG000|Overall Study|Other|1|||
33401302|NCT00725075|62780347|FG001|Overall Study|Other|0|||
33401303|NCT00725075|62780348|FG002|Overall Study|Other|0|||
33401304|NCT00733499|62780358|FG000|Pre-operative|Protocol Violation|0|||
33401305|NCT00733499|62780359|FG001|Pre-operative|Protocol Violation|1|||
33401306|NCT00733499|62780358|FG000|3 Months Follow-up|Death|1|||
33401307|NCT00733499|62780359|FG001|3 Months Follow-up|Death|2|||
33401308|NCT00733499|62780358|FG000|6 Months Follow-up|Death|0|||
33401309|NCT00733499|62780359|FG001|6 Months Follow-up|Death|2|||
33401310|NCT00733499|62780358|FG000|6 Months Follow-up|Adverse Event|0|||
33310234|NCT01165281|62685618|FG001|Overall Study|Progressive Disease|14|||
33401311|NCT00733499|62780359|FG001|6 Months Follow-up|Adverse Event|1|||
33401312|NCT00733499|62780358|FG000|12 Months Follow-up|Death|2|||
33401313|NCT00733499|62780359|FG001|12 Months Follow-up|Death|1|||
33401314|NCT00733499|62780358|FG000|24 Months Follow-up|Death|0|||
33401315|NCT00733499|62780359|FG001|24 Months Follow-up|Death|1|||
33401316|NCT00733499|62780358|FG000|5 Year Followup|Adverse Event|2|||
33401317|NCT00733499|62780359|FG001|5 Year Followup|Adverse Event|2|||
33401318|NCT00733499|62780358|FG000|5 Year Followup|Non device related AE|0|||
33672237|NCT00211237|63108726|FG002|6 Months|Death|3|||
33401319|NCT00733499|62780359|FG001|5 Year Followup|Non device related AE|1|||
33401320|NCT00733499|62780358|FG000|5 Year Followup|Revision of Study Implant|0|||
33401321|NCT00733499|62780359|FG001|5 Year Followup|Revision of Study Implant|1|||
33401322|NCT00733499|62780358|FG000|5 Year Followup|Lost to Follow-up|2|||
33401323|NCT00733499|62780359|FG001|5 Year Followup|Lost to Follow-up|0|||
33672238|NCT00211237|63108724|FG000|6 Months|Lost to Follow-up|2|||
33672239|NCT00211237|63108725|FG001|6 Months|Lost to Follow-up|0|||
33401324|NCT00733499|62780358|FG000|5 Year Followup|Death|13|||
33401325|NCT00733499|62780359|FG001|5 Year Followup|Death|19|||
33401326|NCT00733499|62780358|FG000|5 Year Followup|missing, unable to locate|0|||
33401327|NCT00733499|62780359|FG001|5 Year Followup|missing, unable to locate|1|||
33401328|NCT00733499|62780358|FG000|5 Year Followup|Withdrawal by Subject|4|||
33401329|NCT00733499|62780359|FG001|5 Year Followup|Withdrawal by Subject|1|||
33401330|NCT00733499|62780358|FG000|10 Year Followup|Death|9|||
33401331|NCT00733499|62780359|FG001|10 Year Followup|Death|7|||
33401332|NCT00733499|62780358|FG000|10 Year Followup|Adverse Event|3|||
33401333|NCT00733499|62780359|FG001|10 Year Followup|Adverse Event|3|||
33401334|NCT00733499|62780358|FG000|10 Year Followup|Lost to Follow-up|3|||
33401335|NCT00733499|62780359|FG001|10 Year Followup|Lost to Follow-up|2|||
33401336|NCT00733499|62780358|FG000|10 Year Followup|Withdrawal by Subject|5|||
33401337|NCT00733499|62780359|FG001|10 Year Followup|Withdrawal by Subject|5|||
33401338|NCT00733499|62780358|FG000|10 Year Followup|missing, unable to locate|0|||
33401339|NCT00733499|62780359|FG001|10 Year Followup|missing, unable to locate|2|||
33401340|NCT00652028|62780369|FG000|Overall Study|Adverse Event|1|||
33401341|NCT00652028|62780370|FG001|Overall Study|Adverse Event|0|||
33401342|NCT00652028|62780371|FG002|Overall Study|Adverse Event|0|||
33401343|NCT00652028|62780372|FG003|Overall Study|Adverse Event|0|||
33401344|NCT00652028|62780369|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
33401345|NCT00652028|62780370|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
33401346|NCT00652028|62780371|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
33401347|NCT00652028|62780372|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
33401348|NCT00652028|62780369|FG000|Overall Study|Physician Decision|0|||
33401349|NCT00652028|62780370|FG001|Overall Study|Physician Decision|0|||
33401350|NCT00652028|62780371|FG002|Overall Study|Physician Decision|1|||
33401351|NCT00652028|62780372|FG003|Overall Study|Physician Decision|0|||
33401352|NCT00738101|62780382|FG000|Overall Study|Physician Decision|5|||
33401353|NCT00738101|62780382|FG000|Overall Study|Death|1|||
33401354|NCT00738101|62780382|FG000|Overall Study|Repeat enrollment|1|||
33401355|NCT00733421|62780388|FG000|Overall Study|Withdrawal by Subject|1|||
33401356|NCT00733421|62780389|FG001|Overall Study|Withdrawal by Subject|1|||
33401357|NCT00613080|62780395|FG000|Overall Study|Ineligible / no protocol treatment|11|||
33401358|NCT00732875|62780399|FG000|Overall Study|Adverse Event|16|||
33401359|NCT00732875|62780399|FG000|Overall Study|Withdrawal by Subject|6|||
33401360|NCT00732875|62780399|FG000|Overall Study|Lack of Efficacy|13|||
33401361|NCT00615264|62780409|FG000|Overall Study|Withdrawal by Subject|17|||
33401362|NCT00615264|62780410|FG001|Overall Study|Withdrawal by Subject|19|||
33401363|NCT00615264|62780409|FG000|Overall Study|Lost to Follow-up|6|||
33401364|NCT00615264|62780410|FG001|Overall Study|Lost to Follow-up|13|||
33401365|NCT00615264|62780409|FG000|Overall Study|Adverse Event|8|||
33401366|NCT00615264|62780410|FG001|Overall Study|Adverse Event|5|||
33401367|NCT00615264|62780409|FG000|Overall Study|Death|1|||
33401368|NCT00615264|62780410|FG001|Overall Study|Death|1|||
33401369|NCT00615264|62780409|FG000|Overall Study|Protocol Violation|11|||
33401370|NCT00615264|62780410|FG001|Overall Study|Protocol Violation|7|||
33401371|NCT00615264|62780409|FG000|Overall Study|Not defined|7|||
33401372|NCT00615264|62780410|FG001|Overall Study|Not defined|4|||
33401373|NCT00615264|62780409|FG000|Overall Study|Dermal Hypersensitivity|0|||
33401374|NCT00615264|62780410|FG001|Overall Study|Dermal Hypersensitivity|3|||
33401375|NCT00732641|62780418|FG000|Overall Study|Relapse or Progressive Disease|65|||
33401376|NCT00732641|62780419|FG001|Overall Study|Relapse or Progressive Disease|101|||
33401377|NCT00732641|62780418|FG000|Overall Study|Serious Adverse Events|12|||
33401378|NCT00732641|62780419|FG001|Overall Study|Serious Adverse Events|3|||
33401379|NCT00732641|62780418|FG000|Overall Study|Physician Decision|6|||
33401380|NCT00732641|62780419|FG001|Overall Study|Physician Decision|0|||
33401381|NCT00732641|62780418|FG000|Overall Study|Withdrawal by Subject|4|||
33401382|NCT00732641|62780419|FG001|Overall Study|Withdrawal by Subject|2|||
33401383|NCT00732641|62780418|FG000|Overall Study|Unable to Complete|1|||
33401384|NCT00732641|62780419|FG001|Overall Study|Unable to Complete|1|||
33401385|NCT00732641|62780418|FG000|Overall Study|Other|18|||
33401386|NCT00732641|62780419|FG001|Overall Study|Other|5|||
33401387|NCT00737711|62780425|FG000|Overall Study|Adverse Event|2|||
33401388|NCT00737711|62780425|FG000|Overall Study|Death|8|||
33401389|NCT00737711|62780425|FG000|Overall Study|Failure to return|4|||
33401390|NCT00737711|62780425|FG000|Overall Study|Protocol Violation|1|||
33401391|NCT00737711|62780425|FG000|Overall Study|Withdrawal by Subject|5|||
33401392|NCT00737711|62780425|FG000|Overall Study|Blood transfusion|6|||
33401393|NCT00737711|62780425|FG000|Overall Study|Other|5|||
33401394|NCT00615108|62780429|FG000|Overall Study|Adverse Event|122|||
33401395|NCT00615108|62780429|FG000|Overall Study|Other|370|||
33401396|NCT00615108|62780429|FG000|Overall Study|Lost to Follow-up|15|||
33401397|NCT00238303|62780438|FG000|Overall Study|Withdrawal by Subject|11|||
33401398|NCT00238303|62780439|FG001|Overall Study|Withdrawal by Subject|1|||
33401399|NCT00238303|62780440|FG002|Overall Study|Withdrawal by Subject|2|||
33401400|NCT00238303|62780438|FG000|Overall Study|Death|1|||
33401401|NCT00238303|62780439|FG001|Overall Study|Death|0|||
33401402|NCT00238303|62780440|FG002|Overall Study|Death|1|||
33401403|NCT00238303|62780438|FG000|Overall Study|Other Medical Problems|2|||
33401404|NCT00238303|62780439|FG001|Overall Study|Other Medical Problems|0|||
33401405|NCT00238303|62780440|FG002|Overall Study|Other Medical Problems|2|||
33401406|NCT00238303|62780438|FG000|Overall Study|Poor tolerance of study treatment|1|||
33401407|NCT00238303|62780439|FG001|Overall Study|Poor tolerance of study treatment|0|||
33401408|NCT00238303|62780440|FG002|Overall Study|Poor tolerance of study treatment|1|||
33401409|NCT00238303|62780438|FG000|Overall Study|Adverse Event|0|||
33401410|NCT00238303|62780439|FG001|Overall Study|Adverse Event|1|||
33401411|NCT00238303|62780440|FG002|Overall Study|Adverse Event|3|||
33401412|NCT00737633|62780451|FG000|Overall Study|Study terminated by sponsor|44|||
33401413|NCT00737633|62780452|FG001|Overall Study|Study terminated by sponsor|55|||
33401414|NCT00737633|62780451|FG000|Overall Study|Lost to Follow-up|0|||
33401415|NCT00737633|62780452|FG001|Overall Study|Lost to Follow-up|1|||
33401416|NCT00737633|62780451|FG000|Overall Study|protocol non-compliance|0|||
33401417|NCT00737633|62780452|FG001|Overall Study|protocol non-compliance|1|||
33401418|NCT00732251|62780458|FG000|Overall Study|Lost to Follow-up|3|||
33401419|NCT00732251|62780458|FG000|Overall Study|Withdrawal by Subject|3|||
33401420|NCT00732251|62780458|FG000|Overall Study|Early Term due to Site Closure|1|||
33401421|NCT00737477|62780462|FG000|Overall Study|Adverse Event|9|||
33491245|NCT00075881|62869188|FG000|Overall Study|Ineligible|1|||
33491246|NCT00075881|62869188|FG000|Overall Study|never start protocol therapy|1|||
33491247|NCT00838630|62869196|FG000|First Intervention|Adverse Event|1|||
33491248|NCT00838630|62869197|FG001|First Intervention|Adverse Event|0|||
33491249|NCT00838630|62869196|FG000|Washout: 7 Days|Protocol Violation|1|||
33491250|NCT00838630|62869197|FG001|Washout: 7 Days|Protocol Violation|0|||
33491251|NCT02996474|62869201|FG000|Overall Study|Physician Decision|5|||
33491252|NCT03667924|62869208|FG000|Baseline Completed|Lost to Follow-up|0|||
33491253|NCT03667924|62869209|FG001|Baseline Completed|Lost to Follow-up|2|||
33491254|NCT03667924|62869210|FG002|Baseline Completed|Lost to Follow-up|0|||
33491255|NCT03667924|62869208|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
33491256|NCT03667924|62869209|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
33491257|NCT03667924|62869210|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
33491258|NCT03667924|62869208|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
33491259|NCT03667924|62869209|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
33491260|NCT03667924|62869210|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
33491261|NCT03667924|62869208|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
33491262|NCT03667924|62869209|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
33491263|NCT03667924|62869210|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
33491264|NCT03667924|62869208|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
33491265|NCT03667924|62869209|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
33491266|NCT03667924|62869210|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
33491267|NCT03667924|62869208|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
33491268|NCT03667924|62869209|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
33491269|NCT03667924|62869210|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
33491270|NCT03667924|62869208|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
33491271|NCT03667924|62869209|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
33491272|NCT03667924|62869210|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
33491273|NCT03205046|62869222|FG000|Overall Study|Death|10|||
33491274|NCT03205046|62869223|FG001|Overall Study|Death|6|||
33491275|NCT03205046|62869222|FG000|Overall Study|Withdrawal by Subject|1|||
33491276|NCT03205046|62869223|FG001|Overall Study|Withdrawal by Subject|2|||
33491277|NCT03205046|62869222|FG000|Overall Study|Lost to Follow-up|0|||
33491278|NCT03205046|62869223|FG001|Overall Study|Lost to Follow-up|1|||
33491279|NCT03205046|62869222|FG000|Overall Study|Study terminated by sponsor|2|||
33491280|NCT03205046|62869223|FG001|Overall Study|Study terminated by sponsor|1|||
33491281|NCT02339090|62869231|FG000|Overall Study|Adverse Event|1|||
33491282|NCT02339090|62869232|FG001|Overall Study|Adverse Event|0|||
33491283|NCT02339090|62869231|FG000|Overall Study|Lost to Follow-up|0|||
33491284|NCT02339090|62869232|FG001|Overall Study|Lost to Follow-up|1|||
33491285|NCT02339090|62869231|FG000|Overall Study|Non-compliance With Study Drug|0|||
33491286|NCT02339090|62869232|FG001|Overall Study|Non-compliance With Study Drug|1|||
33491287|NCT02339090|62869231|FG000|Overall Study|Withdrawal by Subject|2|||
33491288|NCT02339090|62869232|FG001|Overall Study|Withdrawal by Subject|1|||
33491289|NCT02339090|62869231|FG000|Overall Study|Poor Growth|3|||
33491290|NCT02339090|62869232|FG001|Overall Study|Poor Growth|0|||
33491291|NCT02339090|62869231|FG000|Overall Study|Randomized but not treated|0|||
33491292|NCT02339090|62869232|FG001|Overall Study|Randomized but not treated|2|||
33491293|NCT03524092|62869253|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
33491294|NCT03524092|62869254|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
33491295|NCT03524092|62869255|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
33672240|NCT00211237|63108726|FG002|6 Months|Lost to Follow-up|0|||
33491296|NCT03524092|62869256|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
33491297|NCT03524092|62869257|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
33491298|NCT03524092|62869258|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
33491299|NCT03524092|62869253|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
33491300|NCT03524092|62869254|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
33491301|NCT03524092|62869255|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
33491302|NCT03524092|62869256|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
33491303|NCT03524092|62869257|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
33491304|NCT03524092|62869258|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
33491305|NCT03524092|62869253|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
33491306|NCT03524092|62869254|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
33491307|NCT03524092|62869255|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
33491308|NCT03524092|62869256|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
33491309|NCT03524092|62869257|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
33491310|NCT03524092|62869258|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
33491311|NCT03524092|62869253|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
33491312|NCT03524092|62869254|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
33491313|NCT03524092|62869255|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
33491314|NCT03524092|62869256|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
33491315|NCT03524092|62869257|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
33491316|NCT03524092|62869258|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
33491317|NCT03524092|62869253|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
33491318|NCT03524092|62869254|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
33491319|NCT03524092|62869255|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
33491320|NCT03524092|62869256|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
33491321|NCT03524092|62869257|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
33491322|NCT03524092|62869258|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
33491323|NCT03524092|62869253|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
33491324|NCT03524092|62869254|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
33491325|NCT03524092|62869255|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
33491326|NCT03524092|62869256|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
33491327|NCT03524092|62869257|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
33491328|NCT03524092|62869258|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
33491329|NCT03524092|62869253|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
33491330|NCT03524092|62869254|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
33491331|NCT03524092|62869255|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
33491332|NCT03524092|62869256|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
33491333|NCT03524092|62869257|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
33491334|NCT03524092|62869258|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
33491335|NCT03524092|62869253|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
33491336|NCT03524092|62869254|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
33491337|NCT03524092|62869255|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
33491338|NCT03524092|62869256|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
33491339|NCT03524092|62869257|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
33491340|NCT03524092|62869258|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
33491341|NCT03524092|62869253|FG000|Loss of Response Rescue Period|Adverse Event|0|||
33491342|NCT03524092|62869254|FG001|Loss of Response Rescue Period|Adverse Event|0|||
33491343|NCT03524092|62869255|FG002|Loss of Response Rescue Period|Adverse Event|0|||
33491344|NCT03524092|62869256|FG003|Loss of Response Rescue Period|Adverse Event|2|||
33491345|NCT03524092|62869257|FG004|Loss of Response Rescue Period|Adverse Event|0|||
33491346|NCT03524092|62869258|FG005|Loss of Response Rescue Period|Adverse Event|0|||
33491347|NCT03524092|62869253|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
33491348|NCT03524092|62869254|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
33491349|NCT03524092|62869255|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
33491350|NCT03524092|62869256|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
33491351|NCT03524092|62869257|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
33491352|NCT03524092|62869258|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
33491353|NCT03524092|62869253|FG000|Loss of Response Rescue Period|Pregnancy|0|||
33491354|NCT03524092|62869254|FG001|Loss of Response Rescue Period|Pregnancy|0|||
33491355|NCT03524092|62869255|FG002|Loss of Response Rescue Period|Pregnancy|0|||
33491356|NCT03524092|62869256|FG003|Loss of Response Rescue Period|Pregnancy|1|||
33491357|NCT03524092|62869257|FG004|Loss of Response Rescue Period|Pregnancy|0|||
33491358|NCT03524092|62869258|FG005|Loss of Response Rescue Period|Pregnancy|0|||
33491359|NCT03524092|62869253|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
33491360|NCT03524092|62869254|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
33672241|NCT00211237|63108724|FG000|6 Months|Could not comply with protocol|0|||
33491361|NCT03524092|62869255|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
33491362|NCT03524092|62869256|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
33491363|NCT03524092|62869257|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
33491364|NCT03524092|62869258|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
33491365|NCT03524092|62869253|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
33491366|NCT03524092|62869254|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
33491367|NCT03524092|62869255|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
33491368|NCT03524092|62869256|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
33491369|NCT03524092|62869257|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
33491370|NCT03524092|62869258|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
33491371|NCT03524092|62869253|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
33491372|NCT03524092|62869254|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
33491373|NCT03524092|62869255|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
33491374|NCT03524092|62869256|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
33491375|NCT03524092|62869257|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
33491376|NCT03524092|62869258|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
33491377|NCT03524092|62869253|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
33491378|NCT03524092|62869254|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
33491379|NCT03524092|62869255|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
33491380|NCT03524092|62869256|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
33491381|NCT03524092|62869257|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
33491382|NCT03524092|62869258|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
33491383|NCT03524092|62869253|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
33491384|NCT03524092|62869254|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
33491385|NCT03524092|62869255|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
33491386|NCT03524092|62869256|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
33491387|NCT03524092|62869257|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
33491388|NCT03524092|62869258|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
33491389|NCT03524092|62869253|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
33491390|NCT03524092|62869254|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
33491391|NCT03524092|62869255|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
33491392|NCT03524092|62869256|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
33491393|NCT03524092|62869257|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
33491394|NCT03524092|62869258|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
33491395|NCT03524092|62869253|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
33491396|NCT03524092|62869254|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
33491397|NCT03524092|62869255|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
33491398|NCT03524092|62869256|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
33491399|NCT03524092|62869257|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
33491400|NCT03524092|62869258|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
33491401|NCT03524092|62869253|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
33491402|NCT03524092|62869254|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
33491403|NCT03524092|62869255|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
33491404|NCT03524092|62869256|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
33491405|NCT03524092|62869257|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
33491406|NCT03524092|62869258|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
33491407|NCT03524092|62869253|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
33491408|NCT03524092|62869254|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
33491409|NCT03524092|62869255|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
33491410|NCT03524092|62869256|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
33491411|NCT03524092|62869257|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
33491412|NCT03524092|62869258|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
33491413|NCT03524092|62869253|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
33491414|NCT03524092|62869254|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
33491415|NCT03524092|62869255|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
33491416|NCT03524092|62869256|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
33491417|NCT03524092|62869257|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
33491418|NCT03524092|62869258|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
33491419|NCT03524092|62869253|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
33491420|NCT03524092|62869254|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
33672242|NCT00211237|63108725|FG001|6 Months|Could not comply with protocol|2|||
33491421|NCT03524092|62869255|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
33491422|NCT03524092|62869256|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
33491423|NCT03524092|62869257|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
33491424|NCT03524092|62869258|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
33491425|NCT03524092|62869253|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
33491426|NCT03524092|62869254|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
33491427|NCT03524092|62869255|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
33491428|NCT03524092|62869256|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
33491429|NCT03524092|62869257|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
33491430|NCT03524092|62869258|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
33491431|NCT03331562|62869271|FG000|Overall Study|Adverse Event|2|||
33491432|NCT03331562|62869272|FG001|Overall Study|Adverse Event|0|||
33491433|NCT03331562|62869271|FG000|Overall Study|Death|1|||
33491434|NCT03331562|62869272|FG001|Overall Study|Death|0|||
33491435|NCT02038634|62869284|FG000|Overall Study|Lost to Follow-up|0|||
33491436|NCT02038634|62869285|FG001|Overall Study|Lost to Follow-up|1|||
33491437|NCT00836056|62869293|FG000|First Intervention|Adverse Event|1|||
33491438|NCT00836056|62869294|FG001|First Intervention|Adverse Event|0|||
33491439|NCT03200912|62869301|FG000|Overall Study|Adverse Event|3|||
33491440|NCT03200912|62869302|FG001|Overall Study|Adverse Event|0|||
33491441|NCT03200912|62869303|FG002|Overall Study|Adverse Event|0|||
33491442|NCT03200912|62869301|FG000|Overall Study|Withdrawal by Subject|1|||
33491443|NCT03200912|62869302|FG001|Overall Study|Withdrawal by Subject|2|||
33491444|NCT03200912|62869303|FG002|Overall Study|Withdrawal by Subject|4|||
33491445|NCT03200912|62869301|FG000|Overall Study|Non-compliance with study drug|0|||
33491446|NCT03200912|62869302|FG001|Overall Study|Non-compliance with study drug|1|||
33491447|NCT03200912|62869303|FG002|Overall Study|Non-compliance with study drug|0|||
33491448|NCT00835666|62869313|FG000|Washout|Protocol Violation|1|||
33491449|NCT00835666|62869314|FG001|Washout|Protocol Violation|0|||
33491450|NCT00835666|62869313|FG000|Washout|Withdrawal by Subject|1|||
33491451|NCT00835666|62869314|FG001|Washout|Withdrawal by Subject|0|||
33491452|NCT03200366|62869328|FG000|Patient Navigation Intervention Given|Death|0|||
33491453|NCT03200366|62869329|FG001|Patient Navigation Intervention Given|Death|2|||
33491454|NCT03200366|62869330|FG002|Patient Navigation Intervention Given|Death|0|||
33491455|NCT03200366|62869328|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
33491456|NCT03200366|62869329|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
33491457|NCT03200366|62869330|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
33491458|NCT03200366|62869328|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
33491459|NCT03200366|62869329|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
33491460|NCT03200366|62869330|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
33491461|NCT03200366|62869328|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
33491462|NCT03200366|62869329|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
33491463|NCT03200366|62869330|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
33491464|NCT03200366|62869328|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
33491465|NCT03200366|62869329|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
33491466|NCT03200366|62869330|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
33491467|NCT03200366|62869328|FG000|6 Month Post-Baseline Interview|Death|1|||
33491468|NCT03200366|62869329|FG001|6 Month Post-Baseline Interview|Death|1|||
33491469|NCT03200366|62869330|FG002|6 Month Post-Baseline Interview|Death|1|||
33491470|NCT03200366|62869328|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
33491471|NCT03200366|62869329|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
33491472|NCT03200366|62869330|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
33491473|NCT03200366|62869328|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
33491474|NCT03200366|62869329|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
33491475|NCT03200366|62869330|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
33491476|NCT03200366|62869328|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
33491477|NCT03200366|62869329|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
33491478|NCT03200366|62869330|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
33491479|NCT03200366|62869328|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
33491480|NCT03200366|62869329|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
33491481|NCT03200366|62869330|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
33491482|NCT03200366|62869328|FG000|9 Month Post-Baseline Interview|Death|1|||
33491483|NCT03200366|62869329|FG001|9 Month Post-Baseline Interview|Death|1|||
33491484|NCT03200366|62869330|FG002|9 Month Post-Baseline Interview|Death|1|||
33491485|NCT03200366|62869328|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
33491486|NCT03200366|62869329|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
33581408|NCT01938430|62978710|FG012|Overall Study|Adverse Event|0|||
33672243|NCT00211237|63108726|FG002|6 Months|Could not comply with protocol|0|||
33491487|NCT03200366|62869330|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
33491488|NCT03200366|62869328|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
33491489|NCT03200366|62869329|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
33491490|NCT03200366|62869330|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
33491491|NCT03200366|62869328|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
33491492|NCT03200366|62869329|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
33491493|NCT03200366|62869330|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
33491494|NCT00835354|62869342|FG000|First Intervention|Adverse Event|0|||
33491495|NCT00835354|62869343|FG001|First Intervention|Adverse Event|1|||
33491496|NCT00835042|62869374|FG000|First Intervention|Withdrawal by Subject|3|||
33491497|NCT00835042|62869375|FG001|First Intervention|Withdrawal by Subject|0|||
33491498|NCT00835042|62869374|FG000|First Intervention|Adverse Event|1|||
33491499|NCT00835042|62869375|FG001|First Intervention|Adverse Event|2|||
33491500|NCT00835042|62869374|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
33491501|NCT00835042|62869375|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
33491502|NCT00834418|62869412|FG000|Overall Study|Adverse Event|0|||
33491503|NCT00834418|62869413|FG001|Overall Study|Adverse Event|2|||
33491504|NCT00834340|62869419|FG000|Washout|Adverse Event|1|||
33491505|NCT00834340|62869420|FG001|Washout|Adverse Event|0|||
33491506|NCT00834340|62869419|FG000|Washout|Withdrawal by Subject|1|||
33491507|NCT00834340|62869420|FG001|Washout|Withdrawal by Subject|0|||
33491508|NCT00151996|62869426|FG000|Overall Study|Adverse Event|3|||
33491509|NCT00151996|62869427|FG001|Overall Study|Adverse Event|2|||
33491510|NCT00151996|62869426|FG000|Overall Study|Withdrawal by Subject|1|||
33491511|NCT00151996|62869427|FG001|Overall Study|Withdrawal by Subject|1|||
33491512|NCT00151996|62869426|FG000|Overall Study|Protocol Violation|1|||
33491513|NCT00151996|62869427|FG001|Overall Study|Protocol Violation|2|||
33491514|NCT00151996|62869426|FG000|Overall Study|Sponsor's decision|0|||
33491515|NCT00151996|62869427|FG001|Overall Study|Sponsor's decision|2|||
33491516|NCT00830206|62869435|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
33491517|NCT00830206|62869436|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
33491518|NCT00829504|62869442|FG000|First Intervention|Adverse Event|1|||
33491519|NCT00829504|62869443|FG001|First Intervention|Adverse Event|0|||
33491520|NCT00829504|62869442|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
33491521|NCT00829504|62869443|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
33491522|NCT00829504|62869442|FG000|Second Intervention|Physician Decision|1|||
33491523|NCT00829504|62869443|FG001|Second Intervention|Physician Decision|0|||
33491524|NCT00829426|62869449|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
33491525|NCT00829426|62869450|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
33491526|NCT00152464|62869456|FG000|Overall Study|Adverse Event|3|||
33491527|NCT00152464|62869457|FG001|Overall Study|Adverse Event|6|||
33491528|NCT00152464|62869456|FG000|Overall Study|Lost to Follow-up|8|||
33491529|NCT00152464|62869457|FG001|Overall Study|Lost to Follow-up|4|||
33491530|NCT00152464|62869456|FG000|Overall Study|Protocol Violation|3|||
33491531|NCT00152464|62869457|FG001|Overall Study|Protocol Violation|1|||
33491532|NCT00152464|62869456|FG000|Overall Study|Withdrawal by Subject|21|||
33491533|NCT00152464|62869457|FG001|Overall Study|Withdrawal by Subject|22|||
33491534|NCT00152464|62869456|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
33491535|NCT00152464|62869457|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
33491536|NCT00152464|62869456|FG000|Overall Study|Eczema deterioration|0|||
33491537|NCT00152464|62869457|FG001|Overall Study|Eczema deterioration|1|||
33491538|NCT00152464|62869456|FG000|Overall Study|Parent decision|1|||
33491539|NCT00152464|62869457|FG001|Overall Study|Parent decision|1|||
33491540|NCT00152464|62869456|FG000|Overall Study|Investigator decision|1|||
33491541|NCT00152464|62869457|FG001|Overall Study|Investigator decision|0|||
33491542|NCT00152464|62869456|FG000|Overall Study|Lack of Efficacy|1|||
33491543|NCT00152464|62869457|FG001|Overall Study|Lack of Efficacy|0|||
33491544|NCT00152464|62869456|FG000|Overall Study|Eczema poorly controlled|1|||
33491545|NCT00152464|62869457|FG001|Overall Study|Eczema poorly controlled|0|||
33491546|NCT00152464|62869456|FG000|Overall Study|Patient relocated|1|||
33491547|NCT00152464|62869457|FG001|Overall Study|Patient relocated|0|||
33491548|NCT00674440|62869463|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
33491549|NCT00674440|62869463|FG000|Overall Study|did not have surgery, so unevaluable|7|||
33491550|NCT00674440|62869463|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
33491551|NCT02742766|62869487|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491552|NCT02742766|62869488|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491553|NCT02742766|62869489|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33672244|NCT00211237|63108724|FG000|12 Months|Death|8|||
33310235|NCT01165281|62685617|FG000|Overall Study|Other|6|||
33491554|NCT02742766|62869490|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491555|NCT02742766|62869491|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491556|NCT02742766|62869492|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33672245|NCT00211237|63108725|FG001|12 Months|Death|2|||
33310236|NCT01165281|62685618|FG001|Overall Study|Other|0|||
33491557|NCT02742766|62869493|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491558|NCT02742766|62869494|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491559|NCT02742766|62869495|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491560|NCT02742766|62869496|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491561|NCT02742766|62869497|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491562|NCT02742766|62869498|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491563|NCT02742766|62869499|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491564|NCT02742766|62869500|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
33491565|NCT02742766|62869501|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491566|NCT02742766|62869502|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491567|NCT02742766|62869503|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491568|NCT02742766|62869504|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491569|NCT02742766|62869505|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33491570|NCT02742766|62869487|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
33491571|NCT02742766|62869488|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
33491572|NCT02742766|62869489|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
33491573|NCT02742766|62869490|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
33491574|NCT02742766|62869491|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
33491575|NCT02742766|62869492|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
33491576|NCT02742766|62869493|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
33491577|NCT02742766|62869494|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
33491578|NCT02742766|62869495|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
33491579|NCT02742766|62869496|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
33491580|NCT02742766|62869497|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
33491581|NCT02742766|62869498|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
33491582|NCT02742766|62869499|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
33491583|NCT02742766|62869500|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
33491584|NCT02742766|62869501|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
33491585|NCT02742766|62869502|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
33491586|NCT02742766|62869503|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
33581409|NCT01938430|62978711|FG013|Overall Study|Adverse Event|0|||
33581410|NCT01938430|62978698|FG000|Overall Study|Death|1|||
33581411|NCT01938430|62978699|FG001|Overall Study|Death|2|||
33581412|NCT01938430|62978700|FG002|Overall Study|Death|2|||
33581413|NCT01938430|62978701|FG003|Overall Study|Death|1|||
33581414|NCT01938430|62978702|FG004|Overall Study|Death|0|||
33581415|NCT01938430|62978703|FG005|Overall Study|Death|0|||
33581416|NCT01938430|62978704|FG006|Overall Study|Death|1|||
33581417|NCT01938430|62978705|FG007|Overall Study|Death|1|||
33581418|NCT01938430|62978706|FG008|Overall Study|Death|2|||
33581419|NCT01938430|62978707|FG009|Overall Study|Death|3|||
33581420|NCT01938430|62978708|FG010|Overall Study|Death|0|||
33581421|NCT01938430|62978709|FG011|Overall Study|Death|0|||
33581422|NCT01938430|62978710|FG012|Overall Study|Death|0|||
33581423|NCT01938430|62978711|FG013|Overall Study|Death|0|||
33581424|NCT01938430|62978698|FG000|Overall Study|Investigator's Discretion|0|||
33581425|NCT01938430|62978699|FG001|Overall Study|Investigator's Discretion|0|||
33581426|NCT01938430|62978700|FG002|Overall Study|Investigator's Discretion|1|||
33581427|NCT01938430|62978701|FG003|Overall Study|Investigator's Discretion|0|||
33581428|NCT01938430|62978702|FG004|Overall Study|Investigator's Discretion|0|||
33581429|NCT01938430|62978703|FG005|Overall Study|Investigator's Discretion|0|||
33581430|NCT01938430|62978704|FG006|Overall Study|Investigator's Discretion|0|||
33581431|NCT01938430|62978705|FG007|Overall Study|Investigator's Discretion|0|||
33581432|NCT01938430|62978706|FG008|Overall Study|Investigator's Discretion|0|||
33581433|NCT01938430|62978707|FG009|Overall Study|Investigator's Discretion|0|||
33581434|NCT01938430|62978708|FG010|Overall Study|Investigator's Discretion|0|||
33581435|NCT01938430|62978709|FG011|Overall Study|Investigator's Discretion|0|||
33581436|NCT01938430|62978710|FG012|Overall Study|Investigator's Discretion|0|||
33581437|NCT01938430|62978711|FG013|Overall Study|Investigator's Discretion|0|||
33581438|NCT01938430|62978698|FG000|Overall Study|Lack of Efficacy|3|||
33581439|NCT01938430|62978699|FG001|Overall Study|Lack of Efficacy|1|||
33581440|NCT01938430|62978700|FG002|Overall Study|Lack of Efficacy|1|||
33581441|NCT01938430|62978701|FG003|Overall Study|Lack of Efficacy|1|||
33581442|NCT01938430|62978702|FG004|Overall Study|Lack of Efficacy|0|||
33581443|NCT01938430|62978703|FG005|Overall Study|Lack of Efficacy|0|||
33581444|NCT01938430|62978704|FG006|Overall Study|Lack of Efficacy|0|||
33581445|NCT01938430|62978705|FG007|Overall Study|Lack of Efficacy|0|||
33581446|NCT01938430|62978706|FG008|Overall Study|Lack of Efficacy|1|||
33581447|NCT01938430|62978707|FG009|Overall Study|Lack of Efficacy|0|||
33581448|NCT01938430|62978708|FG010|Overall Study|Lack of Efficacy|2|||
33581449|NCT01938430|62978709|FG011|Overall Study|Lack of Efficacy|1|||
33581450|NCT01938430|62978710|FG012|Overall Study|Lack of Efficacy|0|||
33581451|NCT01938430|62978711|FG013|Overall Study|Lack of Efficacy|0|||
33581452|NCT01938430|62978698|FG000|Overall Study|Lost to Follow-up|0|||
33581453|NCT01938430|62978699|FG001|Overall Study|Lost to Follow-up|0|||
33581454|NCT01938430|62978700|FG002|Overall Study|Lost to Follow-up|1|||
33581455|NCT01938430|62978701|FG003|Overall Study|Lost to Follow-up|0|||
33581456|NCT01938430|62978702|FG004|Overall Study|Lost to Follow-up|0|||
33581457|NCT01938430|62978703|FG005|Overall Study|Lost to Follow-up|1|||
33581458|NCT01938430|62978704|FG006|Overall Study|Lost to Follow-up|0|||
33581459|NCT01938430|62978705|FG007|Overall Study|Lost to Follow-up|0|||
33581460|NCT01938430|62978706|FG008|Overall Study|Lost to Follow-up|0|||
33581461|NCT01938430|62978707|FG009|Overall Study|Lost to Follow-up|0|||
33581462|NCT01938430|62978708|FG010|Overall Study|Lost to Follow-up|0|||
33581463|NCT01938430|62978709|FG011|Overall Study|Lost to Follow-up|0|||
33581464|NCT01938430|62978710|FG012|Overall Study|Lost to Follow-up|0|||
33581465|NCT01938430|62978711|FG013|Overall Study|Lost to Follow-up|0|||
33581466|NCT01938430|62978698|FG000|Overall Study|Withdrew Consent|0|||
33581467|NCT01938430|62978699|FG001|Overall Study|Withdrew Consent|0|||
33581468|NCT01938430|62978700|FG002|Overall Study|Withdrew Consent|0|||
33581469|NCT01938430|62978701|FG003|Overall Study|Withdrew Consent|0|||
33581470|NCT01938430|62978702|FG004|Overall Study|Withdrew Consent|0|||
33581471|NCT01938430|62978703|FG005|Overall Study|Withdrew Consent|0|||
33581472|NCT01938430|62978704|FG006|Overall Study|Withdrew Consent|0|||
33581473|NCT01938430|62978705|FG007|Overall Study|Withdrew Consent|0|||
33581474|NCT01938430|62978706|FG008|Overall Study|Withdrew Consent|1|||
33581475|NCT01938430|62978707|FG009|Overall Study|Withdrew Consent|0|||
33581476|NCT01938430|62978708|FG010|Overall Study|Withdrew Consent|0|||
33581477|NCT01938430|62978709|FG011|Overall Study|Withdrew Consent|0|||
33581478|NCT01938430|62978710|FG012|Overall Study|Withdrew Consent|0|||
33581479|NCT01938430|62978711|FG013|Overall Study|Withdrew Consent|0|||
33581480|NCT01937884|62978768|FG000|Overall Study|Withdrawal by Subject|1|||
33581481|NCT01937884|62978769|FG001|Overall Study|Withdrawal by Subject|0|||
33581482|NCT01916824|62978779|FG000|Overall Study|Lost to Follow-up|3|||
33581483|NCT01916824|62978780|FG001|Overall Study|Lost to Follow-up|6|||
33581484|NCT01916824|62978779|FG000|Overall Study|Physician Decision|2|||
33581485|NCT01916824|62978780|FG001|Overall Study|Physician Decision|0|||
33581486|NCT01916824|62978779|FG000|Overall Study|Withdrawal by Subject|2|||
33581487|NCT01916824|62978780|FG001|Overall Study|Withdrawal by Subject|3|||
33581488|NCT01915732|62978788|FG000|Overall Study|Withdrawal by Subject|18|||
33581489|NCT01915732|62978789|FG001|Overall Study|Withdrawal by Subject|18|||
33581490|NCT01915732|62978788|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
33581491|NCT01915732|62978789|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
33581492|NCT01915732|62978788|FG000|Overall Study|Adverse Event|12|||
33581493|NCT01915732|62978789|FG001|Overall Study|Adverse Event|4|||
33581494|NCT01915732|62978788|FG000|Overall Study|Protocol Violation|5|||
33581495|NCT01915732|62978789|FG001|Overall Study|Protocol Violation|5|||
33581496|NCT01915732|62978788|FG000|Overall Study|Lack of Efficacy|6|||
33581497|NCT01915732|62978789|FG001|Overall Study|Lack of Efficacy|11|||
33581498|NCT01915732|62978788|FG000|Overall Study|Lost to Follow-up|22|||
33581499|NCT01915732|62978789|FG001|Overall Study|Lost to Follow-up|26|||
33581500|NCT01915732|62978788|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
33581501|NCT01915732|62978789|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
33581502|NCT01915732|62978788|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
33581503|NCT01915732|62978789|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
33581504|NCT01915732|62978788|FG000|Overall Study|Drug Release Error|1|||
33581505|NCT01915732|62978789|FG001|Overall Study|Drug Release Error|0|||
33581506|NCT01915732|62978788|FG000|Overall Study|Recovered|1|||
33581507|NCT01915732|62978789|FG001|Overall Study|Recovered|0|||
33581508|NCT01915732|62978788|FG000|Overall Study|Pregnancy|1|||
33581509|NCT01915732|62978789|FG001|Overall Study|Pregnancy|0|||
33581510|NCT01915732|62978788|FG000|Overall Study|Poor Perceived Efficacy|1|||
33581511|NCT01915732|62978789|FG001|Overall Study|Poor Perceived Efficacy|0|||
33581512|NCT01915732|62978788|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
33581513|NCT01915732|62978789|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
33581514|NCT01915732|62978788|FG000|Overall Study|Got Well|0|||
33581515|NCT01915732|62978789|FG001|Overall Study|Got Well|1|||
33581516|NCT01915732|62978788|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
33581517|NCT01915732|62978789|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
33581518|NCT01915732|62978788|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
33581519|NCT01915732|62978789|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
33581520|NCT01915732|62978788|FG000|Overall Study|Job Transfer|0|||
33581521|NCT01915732|62978789|FG001|Overall Study|Job Transfer|1|||
33581522|NCT01915732|62978788|FG000|Overall Study|Improper Facial Procedure|0|||
33581523|NCT01915732|62978789|FG001|Overall Study|Improper Facial Procedure|1|||
33581524|NCT01915732|62978788|FG000|Overall Study|Poor Conscious Effect|0|||
33581525|NCT01915732|62978789|FG001|Overall Study|Poor Conscious Effect|1|||
33581526|NCT01936948|62978799|FG000|Overall Study|no 30-day follow-up data|0|||
33581527|NCT01936948|62978800|FG001|Overall Study|no 30-day follow-up data|3|||
33581528|NCT01936948|62978801|FG002|Overall Study|no 30-day follow-up data|3|||
33581529|NCT01936948|62978802|FG003|Overall Study|no 30-day follow-up data|3|||
33581530|NCT01936870|62978810|FG000|Overall Study|No Visit After Treatment|176|||
33581531|NCT01936870|62978810|FG000|Overall Study|Protocol Violation|12|||
33581532|NCT01936870|62978810|FG000|Overall Study|No Drug Administration|1|||
33581533|NCT01618864|62978814|FG000|Overall Study|Withdrawal by Subject|2|||
33581534|NCT01618864|62978814|FG000|Overall Study|Lost to Follow-up|2|||
33581535|NCT01618708|62978825|FG000|Overall Study|Adverse Event|10|||
33581536|NCT01618708|62978826|FG001|Overall Study|Adverse Event|10|||
33581537|NCT01618708|62978825|FG000|Overall Study|Lost to Follow-up|3|||
33581538|NCT01618708|62978826|FG001|Overall Study|Lost to Follow-up|3|||
33581539|NCT01618708|62978825|FG000|Overall Study|Withdrawal by Subject|17|||
33581540|NCT01618708|62978826|FG001|Overall Study|Withdrawal by Subject|22|||
33581541|NCT01618708|62978825|FG000|Overall Study|Lack of Efficacy|8|||
33581542|NCT01618708|62978826|FG001|Overall Study|Lack of Efficacy|8|||
33581543|NCT01618708|62978825|FG000|Overall Study|Technical problems|2|||
33581544|NCT01618708|62978826|FG001|Overall Study|Technical problems|0|||
33581545|NCT01618708|62978825|FG000|Overall Study|Other than specified above|1|||
33581546|NCT01618708|62978826|FG001|Overall Study|Other than specified above|1|||
33581547|NCT01618708|62978825|FG000|Overall Study|Randomized but not treated|3|||
33581548|NCT01618708|62978826|FG001|Overall Study|Randomized but not treated|2|||
33581549|NCT00790933|62978842|FG000|Overall Study|Adverse Event|94|||
33581550|NCT00790933|62978843|FG001|Overall Study|Adverse Event|119|||
33581551|NCT00790933|62978844|FG002|Overall Study|Adverse Event|65|||
33581552|NCT00790933|62978845|FG003|Overall Study|Adverse Event|5|||
33581553|NCT00790933|62978846|FG004|Overall Study|Adverse Event|69|||
33581554|NCT00790933|62978842|FG000|Overall Study|Protocol Violation(s)|8|||
33581555|NCT00790933|62978843|FG001|Overall Study|Protocol Violation(s)|18|||
33581556|NCT00790933|62978844|FG002|Overall Study|Protocol Violation(s)|7|||
33581557|NCT00790933|62978845|FG003|Overall Study|Protocol Violation(s)|0|||
33581558|NCT00790933|62978846|FG004|Overall Study|Protocol Violation(s)|12|||
33581559|NCT00790933|62978842|FG000|Overall Study|Lack of Efficacy|192|||
33581560|NCT00790933|62978843|FG001|Overall Study|Lack of Efficacy|176|||
33581561|NCT00790933|62978844|FG002|Overall Study|Lack of Efficacy|130|||
33581562|NCT00790933|62978845|FG003|Overall Study|Lack of Efficacy|1|||
33581563|NCT00790933|62978846|FG004|Overall Study|Lack of Efficacy|121|||
33581564|NCT00790933|62978842|FG000|Overall Study|Study Terminated by Sponsor|0|||
33581565|NCT00790933|62978843|FG001|Overall Study|Study Terminated by Sponsor|0|||
33581566|NCT00790933|62978844|FG002|Overall Study|Study Terminated by Sponsor|1|||
33581567|NCT00790933|62978845|FG003|Overall Study|Study Terminated by Sponsor|0|||
33581568|NCT00790933|62978846|FG004|Overall Study|Study Terminated by Sponsor|0|||
33581569|NCT00790933|62978842|FG000|Overall Study|Withdrawal by Subject|123|||
33581570|NCT00790933|62978843|FG001|Overall Study|Withdrawal by Subject|120|||
33581571|NCT00790933|62978844|FG002|Overall Study|Withdrawal by Subject|52|||
33581572|NCT00790933|62978845|FG003|Overall Study|Withdrawal by Subject|6|||
33581573|NCT00790933|62978846|FG004|Overall Study|Withdrawal by Subject|50|||
33581574|NCT00790933|62978842|FG000|Overall Study|Lost to Follow-up|13|||
33581575|NCT00790933|62978843|FG001|Overall Study|Lost to Follow-up|31|||
33581576|NCT00790933|62978844|FG002|Overall Study|Lost to Follow-up|10|||
33581577|NCT00790933|62978845|FG003|Overall Study|Lost to Follow-up|1|||
33581578|NCT00790933|62978846|FG004|Overall Study|Lost to Follow-up|15|||
33581579|NCT00790933|62978842|FG000|Overall Study|Reason Not Specified|8|||
33581580|NCT00790933|62978843|FG001|Overall Study|Reason Not Specified|16|||
33581581|NCT00790933|62978844|FG002|Overall Study|Reason Not Specified|4|||
33581582|NCT00790933|62978845|FG003|Overall Study|Reason Not Specified|1|||
33581583|NCT00790933|62978846|FG004|Overall Study|Reason Not Specified|9|||
33581584|NCT02161211|62978865|FG000|Overall Study|Lost to Follow-up|21|||
33581585|NCT02161211|62978866|FG001|Overall Study|Lost to Follow-up|27|||
33581586|NCT02161211|62978867|FG002|Overall Study|Lost to Follow-up|21|||
33581587|NCT02161211|62978865|FG000|Overall Study|Dropped|12|||
33581588|NCT02161211|62978866|FG001|Overall Study|Dropped|5|||
33581589|NCT02161211|62978867|FG002|Overall Study|Dropped|9|||
33581590|NCT01676701|62978877|FG000|Overall Study|Protocol Violation|1|||
33581591|NCT01676701|62978878|FG001|Overall Study|Protocol Violation|0|||
33581592|NCT01676701|62978877|FG000|Overall Study|Sponsor Decision|3|||
33581593|NCT01676701|62978878|FG001|Overall Study|Sponsor Decision|4|||
33581594|NCT01670279|62978889|FG000|Overall Study|Adverse Event|0|||
33581595|NCT01670279|62978890|FG001|Overall Study|Adverse Event|1|||
33581596|NCT01670279|62978891|FG002|Overall Study|Adverse Event|0|||
33581597|NCT01670279|62978892|FG003|Overall Study|Adverse Event|0|||
33581598|NCT01670279|62978889|FG000|Overall Study|Physician Decision|0|||
33581599|NCT01670279|62978890|FG001|Overall Study|Physician Decision|1|||
33581600|NCT01670279|62978891|FG002|Overall Study|Physician Decision|0|||
33581601|NCT01670279|62978892|FG003|Overall Study|Physician Decision|0|||
33581602|NCT01670279|62978889|FG000|Overall Study|Participant met withdrawal criteria|0|||
33581603|NCT01670279|62978890|FG001|Overall Study|Participant met withdrawal criteria|0|||
33581604|NCT01670279|62978891|FG002|Overall Study|Participant met withdrawal criteria|0|||
33581605|NCT01670279|62978892|FG003|Overall Study|Participant met withdrawal criteria|1|||
33581606|NCT02627495|62978900|FG000|Overall Study|Withdrawal by Subject|4|||
33581607|NCT01670045|62978904|FG000|Overall Study|Withdrawal by Subject|3|||
33581608|NCT01670045|62978904|FG000|Overall Study|Adverse Event|1|||
33581609|NCT01670045|62978904|FG000|Overall Study|Death|1|||
33581610|NCT01670045|62978904|FG000|Overall Study|Lost to Follow-up|11|||
33581611|NCT01669421|62978908|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
33581612|NCT01669421|62978908|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
33581613|NCT01671059|62978922|FG000|Overall Study|Adverse Event|4|||
33581614|NCT01671059|62978922|FG000|Overall Study|Lack of Efficacy|1|||
33581615|NCT01669811|62978938|FG000|Overall Study|Investigator decision|0|||
33581616|NCT01669811|62978939|FG001|Overall Study|Investigator decision|1|||
33581617|NCT01669811|62978938|FG000|Overall Study|Withdrawal by Subject|1|||
33581618|NCT01669811|62978939|FG001|Overall Study|Withdrawal by Subject|2|||
33581619|NCT01669811|62978938|FG000|Overall Study|Adverse Event|2|||
33581620|NCT01669811|62978939|FG001|Overall Study|Adverse Event|6|||
33581621|NCT01669811|62978938|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
33581622|NCT01669811|62978939|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
33581623|NCT01669577|62978945|FG000|Overall Study|Death|22|||
33581624|NCT01669577|62978945|FG000|Overall Study|Lost to Follow-up|78|||
33581625|NCT01669577|62978945|FG000|Overall Study|Physician Decision|34|||
33581626|NCT02658175|62978952|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
33581627|NCT02658175|62978953|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
33581628|NCT02658175|62978954|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
33581629|NCT02658175|62978952|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
33581630|NCT02658175|62978953|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
33581631|NCT02658175|62978954|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
33581632|NCT02658175|62978952|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
33581633|NCT02658175|62978953|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
33581634|NCT02658175|62978954|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
33581635|NCT02658175|62978952|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
33581636|NCT02658175|62978953|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
33581637|NCT02658175|62978954|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
33581638|NCT02658175|62978952|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
33581639|NCT02658175|62978953|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
33581640|NCT02658175|62978954|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
33581641|NCT02658175|62978952|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
33581642|NCT02658175|62978953|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
33581643|NCT02658175|62978954|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
33581644|NCT02658175|62978952|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
33581645|NCT02658175|62978953|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
33581646|NCT02658175|62978954|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
33581647|NCT02658175|62978952|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
33581648|NCT02658175|62978953|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
33581649|NCT02658175|62978954|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
33581650|NCT02658175|62978952|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
33581651|NCT02658175|62978953|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
33581652|NCT02658175|62978954|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
33581653|NCT02658175|62978952|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
33581654|NCT02658175|62978953|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
33581655|NCT02658175|62978954|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
33581656|NCT02625623|62978964|FG000|Overall Study|Participants randomized but not treated|9|||
33581657|NCT02625623|62978965|FG001|Overall Study|Participants randomized but not treated|1|||
33581658|NCT02658019|62978973|FG000|Overall Study|Adverse Event|1|||
33581659|NCT02624687|62978979|FG000|Overall Study|Withdrawal by Subject|1|||
33581660|NCT02624687|62978980|FG001|Overall Study|Withdrawal by Subject|1|||
33581661|NCT02624687|62978979|FG000|Overall Study|medical leave from work|0|||
33581662|NCT02624687|62978980|FG001|Overall Study|medical leave from work|1|||
33581663|NCT01675765|62978988|FG000|Overall Study|Progressive disease|4|||
33581664|NCT01675765|62978989|FG001|Overall Study|Progressive disease|4|||
33581665|NCT01675765|62978988|FG000|Overall Study|Adverse Event|1|||
33581666|NCT01675765|62978989|FG001|Overall Study|Adverse Event|2|||
33581667|NCT01675765|62978988|FG000|Overall Study|Withdrawal by Subject|2|||
33581668|NCT01675765|62978989|FG001|Overall Study|Withdrawal by Subject|0|||
33581669|NCT01675765|62978988|FG000|Overall Study|Death|1|||
33581670|NCT01675765|62978989|FG001|Overall Study|Death|0|||
33581671|NCT01675765|62978988|FG000|Overall Study|Clinical progression|3|||
33581672|NCT01675765|62978989|FG001|Overall Study|Clinical progression|2|||
33581673|NCT02625233|62978997|FG000|Overall Study|Adverse Event|2|||
33581674|NCT02625233|62978998|FG001|Overall Study|Adverse Event|0|||
33581675|NCT02656693|62979007|FG000|Overall Study|Pregnancy|1|||
33581676|NCT02656693|62979008|FG001|Overall Study|Pregnancy|1|||
33581677|NCT02656693|62979009|FG002|Overall Study|Pregnancy|1|||
33581678|NCT02656693|62979007|FG000|Overall Study|Bariatric surgery|0|||
33581679|NCT02656693|62979008|FG001|Overall Study|Bariatric surgery|1|||
33581680|NCT02656693|62979009|FG002|Overall Study|Bariatric surgery|2|||
33581681|NCT02633293|62979017|FG000|Overall Study|Death|56|||
33581682|NCT02633293|62979017|FG000|Overall Study|Progressive Disease|12|||
33581683|NCT02633293|62979017|FG000|Overall Study|Adverse Event|29|||
33581684|NCT02633293|62979017|FG000|Overall Study|Withdrawal by Subject|41|||
33581685|NCT02633293|62979017|FG000|Overall Study|Protocol Violation|1|||
33581686|NCT02633293|62979017|FG000|Overall Study|Lost to Follow-up|1|||
33581687|NCT02633293|62979017|FG000|Overall Study|Study Terminated by Sponsor|24|||
33581688|NCT02633293|62979017|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
33581689|NCT02633293|62979017|FG000|Overall Study|Lung Transplant|5|||
33581690|NCT02633293|62979017|FG000|Overall Study|Lack of Efficacy|2|||
33581691|NCT02633293|62979017|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
33581692|NCT02623829|62979023|FG000|Overall Study|Lost to Follow-up|1|||
33581693|NCT02623829|62979024|FG001|Overall Study|Lost to Follow-up|1|||
33581694|NCT02655679|62979035|FG000|Overall Study|Adverse Event|0|||
33581695|NCT02655679|62979036|FG001|Overall Study|Adverse Event|1|||
33581696|NCT02655679|62979037|FG002|Overall Study|Adverse Event|0|||
33581697|NCT02655679|62979038|FG003|Overall Study|Adverse Event|0|||
33581698|NCT02655679|62979039|FG004|Overall Study|Adverse Event|0|||
33581699|NCT02655679|62979035|FG000|Overall Study|Withdrawal by Subject|1|||
33581700|NCT02655679|62979036|FG001|Overall Study|Withdrawal by Subject|1|||
33581701|NCT02655679|62979037|FG002|Overall Study|Withdrawal by Subject|0|||
33581702|NCT02655679|62979038|FG003|Overall Study|Withdrawal by Subject|3|||
33581703|NCT02655679|62979039|FG004|Overall Study|Withdrawal by Subject|1|||
33581704|NCT02655679|62979035|FG000|Overall Study|Inability to Comply with the Protocol|1|||
33581705|NCT02655679|62979036|FG001|Overall Study|Inability to Comply with the Protocol|0|||
33581706|NCT02655679|62979037|FG002|Overall Study|Inability to Comply with the Protocol|0|||
33581707|NCT02655679|62979038|FG003|Overall Study|Inability to Comply with the Protocol|0|||
33581708|NCT02655679|62979039|FG004|Overall Study|Inability to Comply with the Protocol|0|||
33581709|NCT02655679|62979035|FG000|Overall Study|Lost to Follow-up|0|||
33581710|NCT02655679|62979036|FG001|Overall Study|Lost to Follow-up|1|||
33581711|NCT02655679|62979037|FG002|Overall Study|Lost to Follow-up|1|||
33581712|NCT02655679|62979038|FG003|Overall Study|Lost to Follow-up|1|||
33581713|NCT02655679|62979039|FG004|Overall Study|Lost to Follow-up|0|||
33581714|NCT02655679|62979035|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33581715|NCT02655679|62979036|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33581716|NCT02655679|62979037|FG002|Overall Study|Other Miscellaneous Reasons|0|||
33581717|NCT02655679|62979038|FG003|Overall Study|Other Miscellaneous Reasons|0|||
33581718|NCT02655679|62979039|FG004|Overall Study|Other Miscellaneous Reasons|0|||
33581719|NCT02623361|62979054|FG000|Overall Study|Protocol Violation|0|||
33581720|NCT02623361|62979055|FG001|Overall Study|Protocol Violation|1|||
33581721|NCT02623361|62979054|FG000|Overall Study|Withdrawal by Subject|0|||
33581722|NCT02623361|62979055|FG001|Overall Study|Withdrawal by Subject|1|||
33581723|NCT01675531|62979102|FG000|Overall Study|Adverse Event|9|||
33581724|NCT01675531|62979102|FG000|Overall Study|Withdrawal by Subject|7|||
33581725|NCT01675531|62979102|FG000|Overall Study|Lack of Efficacy|1|||
33581726|NCT01675531|62979102|FG000|Overall Study|Protocol Violation|8|||
33581727|NCT02532543|62979111|FG000|Overall Study|Lost to Follow-up|0|||
33581728|NCT02532543|62979112|FG001|Overall Study|Lost to Follow-up|0|||
33581729|NCT02532543|62979113|FG002|Overall Study|Lost to Follow-up|1|||
33581730|NCT02532543|62979114|FG003|Overall Study|Lost to Follow-up|0|||
33581731|NCT02532465|62979126|FG000|Overall Study|Protocol Violation|1|||
33581732|NCT02532465|62979127|FG001|Overall Study|Protocol Violation|0|||
33581733|NCT02532465|62979126|FG000|Overall Study|Lack of Efficacy|0|||
33581734|NCT02532465|62979127|FG001|Overall Study|Lack of Efficacy|1|||
33581735|NCT02528331|62979133|FG000|Overall Study|Withdrawal by Subject|2|||
33581736|NCT02654977|62979137|FG000|Overall Study|Death|1|||
33581737|NCT02654977|62979137|FG000|Overall Study|Lost to Follow-up|1|||
33581738|NCT02654977|62979137|FG000|Overall Study|Adverse Event|1|||
33581739|NCT02654977|62979137|FG000|Overall Study|Withdrawal by Subject|1|||
33581740|NCT02654977|62979137|FG000|Overall Study|Lack of Efficacy|3|||
33581741|NCT01362517|62979141|FG000|Overall Study|Protocol Violation|1|||
33581742|NCT01362517|62979141|FG000|Overall Study|Lost to Follow-up|1|||
33581743|NCT01362439|62979148|FG000|Overall Study|Adverse Event|1|||
33581744|NCT01362439|62979148|FG000|Overall Study|Lack of Efficacy|3|||
33581745|NCT01362439|62979148|FG000|Overall Study|Lost to Follow-up|2|||
33581746|NCT01362439|62979148|FG000|Overall Study|Study medication non-compliant|1|||
33581747|NCT01362439|62979148|FG000|Overall Study|Participant who withdrew consent|8|||
33581748|NCT02653495|62979155|FG000|Overall Study|Lost to Follow-up|2|||
33581749|NCT02653495|62979156|FG001|Overall Study|Lost to Follow-up|0|||
33581750|NCT02653495|62979155|FG000|Overall Study|Screening Failure|10|||
33581751|NCT02653495|62979156|FG001|Overall Study|Screening Failure|0|||
33581752|NCT01675141|62979162|FG000|Overall Study|Lenalidomide outside NIH|3|||
33581753|NCT01675141|62979162|FG000|Overall Study|Withdrawal by Subject|3|||
33581754|NCT01675141|62979162|FG000|Overall Study|Physician Decision|4|||
33581755|NCT01675141|62979162|FG000|Overall Study|No treatment, per protocol|1|||
33581756|NCT03367819|62979197|FG000|Overall Study|Adverse Event|4|||
33581757|NCT03367819|62979198|FG001|Overall Study|Adverse Event|4|||
33581758|NCT03367819|62979197|FG000|Overall Study|Progressive Disease|15|||
33581759|NCT03367819|62979198|FG001|Overall Study|Progressive Disease|13|||
33581760|NCT03367819|62979197|FG000|Overall Study|Withdrawal by Subject|1|||
33581761|NCT03367819|62979198|FG001|Overall Study|Withdrawal by Subject|0|||
33581762|NCT03367819|62979197|FG000|Overall Study|Other|4|||
33581763|NCT03367819|62979198|FG001|Overall Study|Other|2|||
33581764|NCT01597193|62979241|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
33581765|NCT01597193|62979242|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
33581766|NCT01597193|62979243|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
33581767|NCT01597193|62979244|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
33581768|NCT01597193|62979245|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
33581769|NCT01597193|62979246|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
33581770|NCT01597193|62979247|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
33581771|NCT01597193|62979241|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
33581772|NCT01597193|62979242|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
33581773|NCT01597193|62979243|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
33581774|NCT01597193|62979244|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
33581775|NCT01597193|62979245|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
33581776|NCT01597193|62979246|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
33581777|NCT01597193|62979247|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
33581778|NCT01597193|62979241|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
33581779|NCT01597193|62979242|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
33581780|NCT01597193|62979243|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
33581781|NCT01597193|62979244|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
33581782|NCT01597193|62979245|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
33581783|NCT01597193|62979246|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
33581784|NCT01597193|62979247|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
33581785|NCT01597193|62979241|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
33581786|NCT01597193|62979242|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
33581787|NCT01597193|62979243|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
33581788|NCT01597193|62979244|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
33581789|NCT01597193|62979245|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
33581790|NCT01597193|62979246|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
33581791|NCT01597193|62979247|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
33581792|NCT01597193|62979241|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
33581793|NCT01597193|62979242|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
33581794|NCT01597193|62979243|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
33581795|NCT01597193|62979244|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
33581796|NCT01597193|62979245|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
33581797|NCT01597193|62979246|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
33581798|NCT01597193|62979247|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
33581799|NCT02649439|62979270|FG000|Overall Study|Switched to alternative treatment|6|||
33581800|NCT02649439|62979271|FG001|Overall Study|Switched to alternative treatment|4|||
33581801|NCT02649439|62979270|FG000|Overall Study|Patient decision|1|||
33581802|NCT02649439|62979271|FG001|Overall Study|Patient decision|0|||
33581803|NCT02649439|62979270|FG000|Overall Study|Patient going out of country|1|||
33581804|NCT02649439|62979271|FG001|Overall Study|Patient going out of country|0|||
33581805|NCT02649439|62979270|FG000|Overall Study|To start finasteride|1|||
33581806|NCT02649439|62979271|FG001|Overall Study|To start finasteride|0|||
33581807|NCT02649439|62979270|FG000|Overall Study|Physician Decision|1|||
33581808|NCT02649439|62979271|FG001|Overall Study|Physician Decision|0|||
33581809|NCT02649439|62979270|FG000|Overall Study|Disease progression on study|12|||
33581810|NCT02649439|62979271|FG001|Overall Study|Disease progression on study|13|||
33581811|NCT02649439|62979270|FG000|Overall Study|Refused further treatment|1|||
33581812|NCT02649439|62979271|FG001|Overall Study|Refused further treatment|0|||
33581813|NCT02649439|62979270|FG000|Overall Study|Refused further follow up|2|||
33581814|NCT02649439|62979271|FG001|Overall Study|Refused further follow up|7|||
33581815|NCT02649439|62979270|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
33581816|NCT02649439|62979271|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
33581817|NCT02649439|62979270|FG000|Overall Study|No treatment, per protocol|1|||
33581818|NCT02649439|62979271|FG001|Overall Study|No treatment, per protocol|0|||
33581819|NCT02649439|62979270|FG000|Overall Study|PSA DT makes ineligible|0|||
33581820|NCT02649439|62979271|FG001|Overall Study|PSA DT makes ineligible|1|||
33581821|NCT02649439|62979270|FG000|Overall Study|Rising PSA No Mets|0|||
33581822|NCT02649439|62979271|FG001|Overall Study|Rising PSA No Mets|1|||
33581823|NCT02649439|62979270|FG000|Overall Study|Rising PSA|0|||
33581824|NCT02649439|62979271|FG001|Overall Study|Rising PSA|1|||
33581825|NCT02649439|62979270|FG000|Overall Study|Signed follow up protocol|0|||
33581826|NCT02649439|62979271|FG001|Overall Study|Signed follow up protocol|1|||
33581827|NCT02622113|62979286|FG000|Overall Study|Adverse Event|4|||
33581828|NCT02622113|62979287|FG001|Overall Study|Adverse Event|4|||
33581829|NCT02622113|62979286|FG000|Overall Study|Physician Decision|0|||
33581830|NCT02622113|62979287|FG001|Overall Study|Physician Decision|1|||
33581831|NCT02622113|62979286|FG000|Overall Study|Withdrawal by Subject|0|||
33581832|NCT02622113|62979287|FG001|Overall Study|Withdrawal by Subject|2|||
33581833|NCT02622113|62979286|FG000|Overall Study|Stopping Criteria|1|||
33581834|NCT02622113|62979287|FG001|Overall Study|Stopping Criteria|3|||
33581835|NCT02651467|62979296|FG000|Overall Study|Withdrawal by Subject|0|||
33581836|NCT02651467|62979297|FG001|Overall Study|Withdrawal by Subject|0|||
33581837|NCT02651467|62979298|FG002|Overall Study|Withdrawal by Subject|2|||
33581838|NCT02651467|62979296|FG000|Overall Study|Other (Not specified)|1|||
33581839|NCT02651467|62979297|FG001|Overall Study|Other (Not specified)|0|||
33581840|NCT02651467|62979298|FG002|Overall Study|Other (Not specified)|2|||
33581841|NCT02620787|62979327|FG000|Overall Study|Adverse Event|1|||
33581842|NCT02620787|62979328|FG001|Overall Study|Adverse Event|0|||
33581843|NCT02620787|62979327|FG000|Overall Study|Eligibility Criteria Not Met|1|||
33581844|NCT02620787|62979328|FG001|Overall Study|Eligibility Criteria Not Met|0|||
33581845|NCT02651155|62979336|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
33581846|NCT02651155|62979337|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
33581847|NCT02651155|62979336|FG000|Overall Study|Voluntary Withdrawal|5|||
33581848|NCT02651155|62979337|FG001|Overall Study|Voluntary Withdrawal|0|||
33581849|NCT02619617|62979343|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
33581850|NCT02619617|62979344|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
33581851|NCT02619617|62979343|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
33581852|NCT02619617|62979344|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
33581853|NCT02650921|62979365|FG000|Overall Study|Withdrawal by Subject|4|||
33581854|NCT02650921|62979365|FG000|Overall Study|Lost to Follow-up|2|||
33581855|NCT02650921|62979365|FG000|Overall Study|Adverse Event|1|||
33581856|NCT02650921|62979365|FG000|Overall Study|Due to Medical Condition|1|||
33581857|NCT01596335|62979373|FG000|Overall Study|exacerbation of primary disease|5|||
33581858|NCT01596335|62979374|FG001|Overall Study|exacerbation of primary disease|9|||
33581859|NCT02618759|62979382|FG000|Overall Study|Lost to Follow-up|0|||
33581860|NCT02618759|62979383|FG001|Overall Study|Lost to Follow-up|1|||
33581861|NCT02618759|62979382|FG000|Overall Study|Withdrawal by Subject|1|||
33581862|NCT02618759|62979383|FG001|Overall Study|Withdrawal by Subject|0|||
33581863|NCT02618759|62979382|FG000|Overall Study|Other Reasons|1|||
33581864|NCT02618759|62979383|FG001|Overall Study|Other Reasons|4|||
33581865|NCT02614079|62979398|FG000|Overall Study|Withdrawal by Subject|1|||
33581866|NCT02616029|62979404|FG000|Overall Study|Adverse Event|1|||
33581867|NCT02616029|62979405|FG001|Overall Study|Adverse Event|0|||
33581868|NCT02616029|62979404|FG000|Overall Study|Death|0|||
33581869|NCT02616029|62979405|FG001|Overall Study|Death|1|||
33581870|NCT02616029|62979404|FG000|Overall Study|Protocol Violation|1|||
33581871|NCT02616029|62979405|FG001|Overall Study|Protocol Violation|0|||
33581872|NCT02616029|62979404|FG000|Overall Study|Withdrew Consent|1|||
33581873|NCT02616029|62979405|FG001|Overall Study|Withdrew Consent|0|||
33581874|NCT02616029|62979404|FG000|Overall Study|Enrolled and Never Treated|1|||
33581875|NCT02616029|62979405|FG001|Overall Study|Enrolled and Never Treated|1|||
33581876|NCT02614859|62979413|FG000|Overall Study|Physician Decision|0|||
33581877|NCT02614859|62979414|FG001|Overall Study|Physician Decision|1|||
33581878|NCT02615249|62979422|FG000|Overall Study|Withdrawal by Subject|1|||
33581879|NCT02615171|62979429|FG000|Overall Study|Lost to Follow-up|2|||
33581880|NCT02615171|62979430|FG001|Overall Study|Lost to Follow-up|1|||
33581881|NCT02648347|62979438|FG000|Overall Study|Death|174|||
33581882|NCT02648347|62979439|FG001|Overall Study|Death|167|||
33581883|NCT02648347|62979438|FG000|Overall Study|Withdrawal by Subject|16|||
33581884|NCT02648347|62979439|FG001|Overall Study|Withdrawal by Subject|9|||
33581885|NCT02648347|62979438|FG000|Overall Study|Lost to Follow-up|18|||
33581886|NCT02648347|62979439|FG001|Overall Study|Lost to Follow-up|21|||
33581887|NCT02648347|62979438|FG000|Overall Study|Missing|1|||
33581888|NCT02648347|62979439|FG001|Overall Study|Missing|0|||
33581889|NCT02614703|62979447|FG000|Overall Study|Withdrawal by Subject|7|||
33581890|NCT02614703|62979448|FG001|Overall Study|Withdrawal by Subject|1|||
33581891|NCT01669343|62979454|FG000|Part A: All Patients|Withdrawal by Subject|7|||
33581892|NCT01669343|62979454|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
33581893|NCT01669343|62979454|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
33581894|NCT01669343|62979454|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
33581895|NCT01669343|62979454|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
33581896|NCT01594931|62979464|FG000|Overall Study|Adverse Event|3|||
33581897|NCT01594931|62979465|FG001|Overall Study|Adverse Event|1|||
33581898|NCT01594931|62979466|FG002|Overall Study|Adverse Event|1|||
33581899|NCT01594931|62979464|FG000|Overall Study|Withdrawal by Subject|2|||
33581900|NCT01594931|62979465|FG001|Overall Study|Withdrawal by Subject|1|||
33581901|NCT01594931|62979466|FG002|Overall Study|Withdrawal by Subject|1|||
33581902|NCT01594931|62979464|FG000|Overall Study|Lack of Efficacy|7|||
33581903|NCT01594931|62979465|FG001|Overall Study|Lack of Efficacy|2|||
33581904|NCT01594931|62979466|FG002|Overall Study|Lack of Efficacy|2|||
33581905|NCT01594931|62979464|FG000|Overall Study|Lost to Follow-up|4|||
33581906|NCT01594931|62979465|FG001|Overall Study|Lost to Follow-up|3|||
33581907|NCT01594931|62979466|FG002|Overall Study|Lost to Follow-up|3|||
33581908|NCT01594931|62979464|FG000|Overall Study|Protocol Violation|2|||
33672246|NCT00211237|63108726|FG002|12 Months|Death|3|||
33581909|NCT01594931|62979465|FG001|Overall Study|Protocol Violation|1|||
33581910|NCT01594931|62979466|FG002|Overall Study|Protocol Violation|0|||
33581911|NCT01594931|62979464|FG000|Overall Study|No defiined|11|||
33581912|NCT01594931|62979465|FG001|Overall Study|No defiined|4|||
33581913|NCT01594931|62979466|FG002|Overall Study|No defiined|7|||
33581914|NCT01594853|62979476|FG000|Overall Study|Withdrawal by Subject|1|||
33581915|NCT01594853|62979477|FG001|Overall Study|Withdrawal by Subject|1|||
33581916|NCT01594853|62979476|FG000|Overall Study|Lost to Follow-up|1|||
33581917|NCT01594853|62979477|FG001|Overall Study|Lost to Follow-up|1|||
33581918|NCT01594853|62979476|FG000|Overall Study|noncompliance with exercise|0|||
33581919|NCT01594853|62979477|FG001|Overall Study|noncompliance with exercise|1|||
33581920|NCT01668797|62979494|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
33581921|NCT01668797|62979495|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
33581922|NCT01668797|62979496|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
33581923|NCT01668797|62979497|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
33581924|NCT01668797|62979494|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
33581925|NCT01668797|62979495|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
33581926|NCT01668797|62979496|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
33581927|NCT01668797|62979497|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
33581928|NCT01668797|62979494|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
33581929|NCT01668797|62979495|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
33581930|NCT01668797|62979496|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
33581931|NCT01668797|62979497|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
33581932|NCT01668797|62979494|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
33581933|NCT01668797|62979495|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
33581934|NCT01668797|62979496|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
33581935|NCT01668797|62979497|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
33581936|NCT01668797|62979494|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
33581937|NCT01668797|62979495|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
33581938|NCT01668797|62979496|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
33581939|NCT01668797|62979497|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
33581940|NCT01668797|62979494|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
33581941|NCT01668797|62979495|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
33581942|NCT01668797|62979496|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
33581943|NCT01668797|62979497|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
33581944|NCT01668797|62979494|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
33581945|NCT01668797|62979495|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
33581946|NCT01668797|62979496|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
33581947|NCT01668797|62979497|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
33581948|NCT01668797|62979494|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
33581949|NCT01668797|62979495|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
33581950|NCT01668797|62979496|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
33581951|NCT01668797|62979497|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
33581952|NCT01668797|62979494|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
33581953|NCT01668797|62979495|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
33581954|NCT01668797|62979496|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
33581955|NCT01668797|62979497|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
33581956|NCT01668797|62979494|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
33581957|NCT01668797|62979495|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
33581958|NCT01668797|62979496|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
33581959|NCT01668797|62979497|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
33581960|NCT01668797|62979494|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
33581961|NCT01668797|62979495|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
33581962|NCT01668797|62979496|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
33581963|NCT01668797|62979497|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
33581964|NCT01668797|62979494|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
33581965|NCT01668797|62979495|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
33581966|NCT01668797|62979496|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
33581967|NCT01668797|62979497|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
33672247|NCT00211237|63108724|FG000|12 Months|Lost to Follow-up|1|||
33581968|NCT01668797|62979494|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
33581969|NCT01668797|62979495|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
33581970|NCT01668797|62979496|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
33581971|NCT01668797|62979497|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
33581972|NCT01668797|62979494|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
33581973|NCT01668797|62979495|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
33581974|NCT01668797|62979496|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
33672248|NCT00211237|63108725|FG001|12 Months|Lost to Follow-up|0|||
33581975|NCT01668797|62979497|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
33672249|NCT00211237|63108726|FG002|12 Months|Lost to Follow-up|1|||
33581976|NCT01668797|62979494|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
33581977|NCT01668797|62979495|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
33581978|NCT01668797|62979496|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
33581979|NCT01668797|62979497|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
33581980|NCT01668797|62979494|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
33581981|NCT01668797|62979495|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
33581982|NCT01668797|62979496|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
33581983|NCT01668797|62979497|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
33581984|NCT01668797|62979494|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
33581985|NCT01668797|62979495|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
33581986|NCT01668797|62979496|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
33581987|NCT01668797|62979497|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
33581988|NCT01668797|62979494|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
33581989|NCT01668797|62979495|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
33581990|NCT01668797|62979496|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
33581991|NCT01668797|62979497|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
33581992|NCT01668797|62979494|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
33581993|NCT01668797|62979495|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
33581994|NCT01668797|62979496|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
33581995|NCT01668797|62979497|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
33581996|NCT01668797|62979494|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
33581997|NCT01668797|62979495|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
33581998|NCT01668797|62979496|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
33581999|NCT01668797|62979497|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
33582000|NCT01668797|62979494|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
33582001|NCT01668797|62979495|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
33582002|NCT01668797|62979496|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
33582003|NCT01668797|62979497|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
33582004|NCT01668797|62979494|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
33582005|NCT01668797|62979495|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
33582006|NCT01668797|62979496|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
33582007|NCT01668797|62979497|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
33582008|NCT01668797|62979494|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
33582009|NCT01668797|62979495|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
33582010|NCT01668797|62979496|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
33582011|NCT01668797|62979497|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
33582012|NCT01668797|62979494|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
33582013|NCT01668797|62979495|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
33582014|NCT01668797|62979496|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
33582015|NCT01668797|62979497|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
33582016|NCT01668797|62979494|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
33582017|NCT01668797|62979495|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
33582018|NCT01668797|62979496|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
33582019|NCT01668797|62979497|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
33582020|NCT02613221|62979504|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
33582021|NCT02613221|62979504|FG000|Overall Study|Adverse Event|2|||
33582022|NCT02613221|62979504|FG000|Overall Study|Voluntary Discontinuation|1|||
33582023|NCT02613221|62979504|FG000|Overall Study|Delayed Treatment|1|||
33582024|NCT02613221|62979504|FG000|Overall Study|Enrolled but Not Treated|1|||
33582025|NCT01362049|62979512|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
33582026|NCT01362049|62979513|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
33582027|NCT01362049|62979514|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
33582028|NCT01362049|62979515|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
33582029|NCT01362049|62979512|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
33582030|NCT01362049|62979513|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
33582031|NCT01362049|62979514|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
33582032|NCT01362049|62979515|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
33582033|NCT02612909|62979547|FG000|Phase 2|Withdrawal by Subject|2|||
33582034|NCT02612909|62979548|FG001|Phase 2|Withdrawal by Subject|5|||
33582035|NCT02612909|62979549|FG002|Phase 2|Withdrawal by Subject|0|||
33582036|NCT02612909|62979550|FG003|Phase 2|Withdrawal by Subject|0|||
33582037|NCT02612909|62979551|FG004|Phase 2|Withdrawal by Subject|0|||
33582038|NCT02612909|62979547|FG000|Phase 2|Pregnancy|0|||
33582039|NCT02612909|62979548|FG001|Phase 2|Pregnancy|0|||
33582040|NCT02612909|62979549|FG002|Phase 2|Pregnancy|1|||
33582041|NCT02612909|62979550|FG003|Phase 2|Pregnancy|0|||
33582042|NCT02612909|62979551|FG004|Phase 2|Pregnancy|0|||
33582043|NCT02612909|62979547|FG000|Phase 3|Withdrawal by Subject|0|||
33582044|NCT02612909|62979548|FG001|Phase 3|Withdrawal by Subject|0|||
33582045|NCT02612909|62979549|FG002|Phase 3|Withdrawal by Subject|0|||
33582046|NCT02612909|62979550|FG003|Phase 3|Withdrawal by Subject|1|||
33582047|NCT02612909|62979551|FG004|Phase 3|Withdrawal by Subject|0|||
33582048|NCT02612285|62979565|FG000|Overall Study|Withdrawal by Subject|1|||
33582049|NCT02609633|62979571|FG000|Overall Study|Consent Withdrawn|0|||
33582050|NCT02609633|62979572|FG001|Overall Study|Consent Withdrawn|1|||
33582051|NCT02609633|62979571|FG000|Overall Study|Protocol Deviation|1|||
33582052|NCT02609633|62979572|FG001|Overall Study|Protocol Deviation|0|||
33582053|NCT02609633|62979571|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
33582054|NCT02609633|62979572|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
33582055|NCT02609633|62979571|FG000|Overall Study|Reason not Specified|2|||
33582056|NCT02609633|62979572|FG001|Overall Study|Reason not Specified|1|||
33582057|NCT01371981|62979591|FG000|Overall Study|Adverse Event|12|||
33582058|NCT01371981|62979592|FG001|Overall Study|Adverse Event|17|||
33582059|NCT01371981|62979593|FG002|Overall Study|Adverse Event|0|||
33582060|NCT01371981|62979594|FG003|Overall Study|Adverse Event|4|||
33582061|NCT01371981|62979595|FG004|Overall Study|Adverse Event|1|||
33582062|NCT01371981|62979596|FG005|Overall Study|Adverse Event|0|||
33582063|NCT01371981|62979591|FG000|Overall Study|Death|22|||
33582064|NCT01371981|62979592|FG001|Overall Study|Death|16|||
33582065|NCT01371981|62979593|FG002|Overall Study|Death|0|||
33582066|NCT01371981|62979594|FG003|Overall Study|Death|0|||
33582067|NCT01371981|62979595|FG004|Overall Study|Death|2|||
33582068|NCT01371981|62979596|FG005|Overall Study|Death|2|||
33582069|NCT01371981|62979591|FG000|Overall Study|Lack of Efficacy|69|||
33582070|NCT01371981|62979592|FG001|Overall Study|Lack of Efficacy|61|||
33582071|NCT01371981|62979593|FG002|Overall Study|Lack of Efficacy|4|||
33582072|NCT01371981|62979594|FG003|Overall Study|Lack of Efficacy|8|||
33582073|NCT01371981|62979595|FG004|Overall Study|Lack of Efficacy|5|||
33582074|NCT01371981|62979596|FG005|Overall Study|Lack of Efficacy|0|||
33582075|NCT01371981|62979591|FG000|Overall Study|Physician Decision|48|||
33582076|NCT01371981|62979592|FG001|Overall Study|Physician Decision|63|||
33582077|NCT01371981|62979593|FG002|Overall Study|Physician Decision|1|||
33582078|NCT01371981|62979594|FG003|Overall Study|Physician Decision|7|||
33582079|NCT01371981|62979595|FG004|Overall Study|Physician Decision|14|||
33582080|NCT01371981|62979596|FG005|Overall Study|Physician Decision|3|||
33582081|NCT01371981|62979591|FG000|Overall Study|Withdrawal by Subject|12|||
33582082|NCT01371981|62979592|FG001|Overall Study|Withdrawal by Subject|19|||
33582083|NCT01371981|62979593|FG002|Overall Study|Withdrawal by Subject|1|||
33582084|NCT01371981|62979594|FG003|Overall Study|Withdrawal by Subject|2|||
33582085|NCT01371981|62979595|FG004|Overall Study|Withdrawal by Subject|10|||
33582086|NCT01371981|62979596|FG005|Overall Study|Withdrawal by Subject|3|||
33582087|NCT01371981|62979591|FG000|Overall Study|Ineligible|19|||
33582088|NCT01371981|62979592|FG001|Overall Study|Ineligible|13|||
33582089|NCT01371981|62979593|FG002|Overall Study|Ineligible|0|||
33582090|NCT01371981|62979594|FG003|Overall Study|Ineligible|0|||
33582091|NCT01371981|62979595|FG004|Overall Study|Ineligible|0|||
33582092|NCT01371981|62979596|FG005|Overall Study|Ineligible|4|||
33582093|NCT01371981|62979591|FG000|Overall Study|Did not start treatment|2|||
33582094|NCT01371981|62979592|FG001|Overall Study|Did not start treatment|3|||
33582095|NCT01371981|62979593|FG002|Overall Study|Did not start treatment|0|||
33582096|NCT01371981|62979594|FG003|Overall Study|Did not start treatment|0|||
33582097|NCT01371981|62979595|FG004|Overall Study|Did not start treatment|0|||
33582098|NCT01371981|62979596|FG005|Overall Study|Did not start treatment|2|||
33582099|NCT01597375|62979624|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
33582100|NCT01597375|62979625|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
33582101|NCT01597375|62979624|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
33582102|NCT01597375|62979625|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
33582103|NCT01597375|62979624|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
33582104|NCT01597375|62979625|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
33582105|NCT01597375|62979624|FG000|Washout (2 Weeks)|Adverse Event|1|||
33582106|NCT01597375|62979625|FG001|Washout (2 Weeks)|Adverse Event|0|||
33582107|NCT01597375|62979624|FG000|Second Intervention|Failed to react at both Aspirin|1|||
33582108|NCT01597375|62979625|FG001|Second Intervention|Failed to react at both Aspirin|1|||
33582109|NCT02527161|62979632|FG000|Overall Study|Failed MRI|52|||
33582110|NCT02527161|62979632|FG000|Overall Study|Withdrawal by Subject|19|||
33582111|NCT02527161|62979632|FG000|Overall Study|Delay in or unfit for surgery|16|||
33582112|NCT02527161|62979632|FG000|Overall Study|MRI contraindication|6|||
33582113|NCT02527161|62979632|FG000|Overall Study|Consent violation|4|||
33582114|NCT02527161|62979632|FG000|Overall Study|Only Recruited to Part A|27|||
33582115|NCT02527161|62979632|FG000|Overall Study|Physician Decision|1|||
33582116|NCT02527161|62979632|FG000|Overall Study|Adverse Event|1|||
33582117|NCT02527161|62979632|FG000|Overall Study|Lost to Follow-up|6|||
33582118|NCT02609399|62979639|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
33582119|NCT02609399|62979640|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
33582120|NCT02609399|62979639|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
33582121|NCT02609399|62979640|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
33582122|NCT02609399|62979639|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
33582123|NCT02609399|62979640|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
33582124|NCT02720185|62979648|FG000|Overall Study|Lost to Follow-up|1|||
33582125|NCT02526693|62979671|FG000|Overall Study|Physician Decision|3|||
33582126|NCT02526693|62979672|FG001|Overall Study|Physician Decision|1|||
33582127|NCT02710669|62979690|FG000|Overall Study|Physician Decision|2|||
33582128|NCT02710669|62979691|FG001|Overall Study|Physician Decision|1|||
33582129|NCT02710669|62979692|FG002|Overall Study|Physician Decision|0|||
33582130|NCT02710669|62979690|FG000|Overall Study|Institutional delays (including COVID)|2|||
33582131|NCT02710669|62979691|FG001|Overall Study|Institutional delays (including COVID)|2|||
33582132|NCT02710669|62979692|FG002|Overall Study|Institutional delays (including COVID)|0|||
33582133|NCT02710669|62979690|FG000|Overall Study|arrived in afib/aflutter|10|||
33582134|NCT02710669|62979691|FG001|Overall Study|arrived in afib/aflutter|8|||
33582135|NCT02710669|62979692|FG002|Overall Study|arrived in afib/aflutter|2|||
33582136|NCT02610725|62979700|FG000|Overall Study|Lost to Follow-up|197|||
33582137|NCT02610725|62979700|FG000|Overall Study|self-reported contraindication|9|||
33582138|NCT02684461|62979707|FG000|Overall Study|Adverse Event|1|||
33582139|NCT02684461|62979708|FG001|Overall Study|Adverse Event|0|||
33582140|NCT02684461|62979709|FG002|Overall Study|Adverse Event|0|||
33582141|NCT02684461|62979707|FG000|Overall Study|Lack of Efficacy|1|||
33582142|NCT02684461|62979708|FG001|Overall Study|Lack of Efficacy|2|||
33582143|NCT02684461|62979709|FG002|Overall Study|Lack of Efficacy|0|||
33582144|NCT02647645|62979734|FG000|Overall Study|Lost to Follow-up|2|||
33582145|NCT02647645|62979735|FG001|Overall Study|Lost to Follow-up|1|||
33582146|NCT02531373|62979750|FG000|Overall Study|Lack of Efficacy|0|||
33582147|NCT02531373|62979751|FG001|Overall Study|Lack of Efficacy|0|||
33582148|NCT02531373|62979752|FG002|Overall Study|Lack of Efficacy|0|||
33582149|NCT02531373|62979753|FG003|Overall Study|Lack of Efficacy|0|||
33582150|NCT02531373|62979754|FG004|Overall Study|Lack of Efficacy|3|||
33582151|NCT02531373|62979755|FG005|Overall Study|Lack of Efficacy|2|||
33582152|NCT02531373|62979756|FG006|Overall Study|Lack of Efficacy|4|||
33582153|NCT02531373|62979757|FG007|Overall Study|Lack of Efficacy|8|||
33582154|NCT02531373|62979758|FG008|Overall Study|Lack of Efficacy|5|||
33582155|NCT02531373|62979750|FG000|Overall Study|Lost to Follow-up|0|||
33582156|NCT02531373|62979751|FG001|Overall Study|Lost to Follow-up|0|||
33582157|NCT02531373|62979752|FG002|Overall Study|Lost to Follow-up|0|||
33582158|NCT02531373|62979753|FG003|Overall Study|Lost to Follow-up|0|||
33582159|NCT02531373|62979754|FG004|Overall Study|Lost to Follow-up|0|||
33582160|NCT02531373|62979755|FG005|Overall Study|Lost to Follow-up|2|||
33582161|NCT02531373|62979756|FG006|Overall Study|Lost to Follow-up|2|||
33582162|NCT02531373|62979757|FG007|Overall Study|Lost to Follow-up|0|||
33582163|NCT02531373|62979758|FG008|Overall Study|Lost to Follow-up|0|||
33582164|NCT02531373|62979750|FG000|Overall Study|Physician Decision|0|||
33582165|NCT02531373|62979751|FG001|Overall Study|Physician Decision|0|||
33582166|NCT02531373|62979752|FG002|Overall Study|Physician Decision|0|||
33582167|NCT02531373|62979753|FG003|Overall Study|Physician Decision|0|||
33582168|NCT02531373|62979754|FG004|Overall Study|Physician Decision|2|||
33582169|NCT02531373|62979755|FG005|Overall Study|Physician Decision|1|||
33582170|NCT02531373|62979756|FG006|Overall Study|Physician Decision|0|||
33582171|NCT02531373|62979757|FG007|Overall Study|Physician Decision|0|||
33582172|NCT02531373|62979758|FG008|Overall Study|Physician Decision|0|||
33582173|NCT02531373|62979750|FG000|Overall Study|Protocol Violation|0|||
33582174|NCT02531373|62979751|FG001|Overall Study|Protocol Violation|0|||
33582175|NCT02531373|62979752|FG002|Overall Study|Protocol Violation|0|||
33582176|NCT02531373|62979753|FG003|Overall Study|Protocol Violation|0|||
33582177|NCT02531373|62979754|FG004|Overall Study|Protocol Violation|0|||
33582178|NCT02531373|62979755|FG005|Overall Study|Protocol Violation|1|||
33582179|NCT02531373|62979756|FG006|Overall Study|Protocol Violation|1|||
33582180|NCT02531373|62979757|FG007|Overall Study|Protocol Violation|0|||
33582181|NCT02531373|62979758|FG008|Overall Study|Protocol Violation|1|||
33582182|NCT02531373|62979750|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33582183|NCT02531373|62979751|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33582184|NCT02531373|62979752|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
33582185|NCT02531373|62979753|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
33582186|NCT02531373|62979754|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
33582187|NCT02531373|62979755|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
33582188|NCT02531373|62979756|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
33582189|NCT02531373|62979757|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
33582190|NCT02531373|62979758|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
33582191|NCT02531373|62979750|FG000|Overall Study|Withdrawal by Subject|0|||
33582192|NCT02531373|62979751|FG001|Overall Study|Withdrawal by Subject|0|||
33582193|NCT02531373|62979752|FG002|Overall Study|Withdrawal by Subject|0|||
33582194|NCT02531373|62979753|FG003|Overall Study|Withdrawal by Subject|0|||
33582195|NCT02531373|62979754|FG004|Overall Study|Withdrawal by Subject|3|||
33582196|NCT02531373|62979755|FG005|Overall Study|Withdrawal by Subject|0|||
33582197|NCT02531373|62979756|FG006|Overall Study|Withdrawal by Subject|0|||
33582198|NCT02531373|62979757|FG007|Overall Study|Withdrawal by Subject|0|||
33582199|NCT02531373|62979758|FG008|Overall Study|Withdrawal by Subject|0|||
33582200|NCT02606279|62979781|FG000|Overall Study|Lost to Follow-up|0|||
33582201|NCT02606279|62979782|FG001|Overall Study|Lost to Follow-up|1|||
33582202|NCT02643355|62979796|FG000|Overall Study|Withdrawal by Subject|1|||
33582203|NCT02643355|62979797|FG001|Overall Study|Withdrawal by Subject|3|||
33582204|NCT02643355|62979796|FG000|Overall Study|Protocol Violation|0|||
33582205|NCT02643355|62979797|FG001|Overall Study|Protocol Violation|2|||
33582206|NCT02604017|62979805|FG000|Overall Study|Withdrew Consent|0|||
33582207|NCT02604017|62979806|FG001|Overall Study|Withdrew Consent|2|||
33582208|NCT02604017|62979805|FG000|Overall Study|Lost to Follow-up|5|||
33582209|NCT02604017|62979806|FG001|Overall Study|Lost to Follow-up|6|||
33582210|NCT02604017|62979805|FG000|Overall Study|Other|1|||
33582211|NCT02604017|62979806|FG001|Overall Study|Other|0|||
33582212|NCT02640547|62979812|FG000|Overall Study|Failure to Return|1|||
33582213|NCT02640547|62979812|FG000|Overall Study|Withdrawal by Subject|1|||
33582214|NCT02640547|62979812|FG000|Overall Study|Death|6|||
33672250|NCT00211237|63108724|FG000|12 Months|Withdrew|0|||
33672251|NCT00211237|63108725|FG001|12 Months|Withdrew|0|||
33672252|NCT00211237|63108726|FG002|12 Months|Withdrew|1|||
33672253|NCT00211237|63108724|FG000|12 Months|unrelated medical problem|0|||
33672254|NCT00211237|63108725|FG001|12 Months|unrelated medical problem|0|||
33672255|NCT00211237|63108726|FG002|12 Months|unrelated medical problem|1|||
33672256|NCT01489358|63108746|FG000|Overall Study|Lost to Follow-up|0|||
33672257|NCT01489358|63108747|FG001|Overall Study|Lost to Follow-up|0|||
33672258|NCT01489358|63108748|FG002|Overall Study|Lost to Follow-up|2|||
33672259|NCT01525238|63108759|FG000|Overall Study|Withdrawal by Subject|1|||
33672260|NCT01525238|63108760|FG001|Overall Study|Withdrawal by Subject|0|||
33672261|NCT01525238|63108761|FG002|Overall Study|Withdrawal by Subject|0|||
33672262|NCT01525082|63108782|FG000|Overall Study|Death|1|||
33582215|NCT02640547|62979812|FG000|Overall Study|Miscellaneous|3|||
33582216|NCT02530905|62979826|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
33582217|NCT02530905|62979827|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
33582218|NCT02530905|62979828|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
33582219|NCT02530671|62979852|FG000|Overall Study|Lost to Follow-up|2|||
33582220|NCT02530671|62979853|FG001|Overall Study|Lost to Follow-up|0|||
33582221|NCT02530671|62979852|FG000|Overall Study|Withdrawal by Subject|1|||
33582222|NCT02530671|62979853|FG001|Overall Study|Withdrawal by Subject|0|||
33582223|NCT02603393|62979861|FG000|Overall Study|Patient/guardian decision|32|||
33582224|NCT02603393|62979862|FG001|Overall Study|Patient/guardian decision|18|||
33582225|NCT02603393|62979861|FG000|Overall Study|Adverse Event|17|||
33582226|NCT02603393|62979862|FG001|Overall Study|Adverse Event|15|||
33582227|NCT02603393|62979861|FG000|Overall Study|Technical problems|4|||
33582228|NCT02603393|62979862|FG001|Overall Study|Technical problems|7|||
33582229|NCT02603393|62979861|FG000|Overall Study|Lack of Efficacy|7|||
33582230|NCT02603393|62979862|FG001|Overall Study|Lack of Efficacy|2|||
33582231|NCT02603393|62979861|FG000|Overall Study|Death|3|||
33582232|NCT02603393|62979862|FG001|Overall Study|Death|4|||
33582233|NCT02603393|62979861|FG000|Overall Study|Physician Decision|3|||
33582234|NCT02603393|62979862|FG001|Overall Study|Physician Decision|3|||
33582235|NCT02603393|62979861|FG000|Overall Study|Protocol deviation|2|||
33582236|NCT02603393|62979862|FG001|Overall Study|Protocol deviation|3|||
33582237|NCT02603393|62979861|FG000|Overall Study|Lost to Follow-up|1|||
33582238|NCT02603393|62979862|FG001|Overall Study|Lost to Follow-up|2|||
33582239|NCT02603393|62979861|FG000|Overall Study|Non-compliance with study treatment|1|||
33582240|NCT02603393|62979862|FG001|Overall Study|Non-compliance with study treatment|0|||
33582241|NCT02603393|62979861|FG000|Overall Study|Sponsor decision|1|||
33582242|NCT02603393|62979862|FG001|Overall Study|Sponsor decision|0|||
33582243|NCT02642653|62979870|FG000|Overall Study|Adverse Event|2|||
33582244|NCT02642653|62979871|FG001|Overall Study|Adverse Event|0|||
33582245|NCT01659567|62979877|FG000|Overall Study|Lack of Efficacy|22|||
33582246|NCT01659567|62979877|FG000|Overall Study|Switched to Pegferon|6|||
33582247|NCT01659567|62979877|FG000|Overall Study|Adverse Event|12|||
33582248|NCT01659567|62979877|FG000|Overall Study|Good result at early stage of treatment|5|||
33582249|NCT01659567|62979877|FG000|Overall Study|Withdrawal by Subject|64|||
33582250|NCT01659567|62979877|FG000|Overall Study|Progression of the main disease|1|||
33582251|NCT01659567|62979877|FG000|Overall Study|Other|13|||
33582252|NCT02605967|62979893|FG000|Overall Study|subject / guardian decision|1|||
33582253|NCT02605967|62979894|FG001|Overall Study|subject / guardian decision|2|||
33582254|NCT02605967|62979893|FG000|Overall Study|Physician Decision|10|||
33672263|NCT01488578|63108789|FG000|Overall Study|Protocol Violation|1836|||
33672264|NCT01524770|63108830|FG000|First Intervention|Withdrawal by Subject|1|||
33672265|NCT01524770|63108831|FG001|First Intervention|Withdrawal by Subject|0|||
33582255|NCT02605967|62979894|FG001|Overall Study|Physician Decision|1|||
33582256|NCT02605967|62979893|FG000|Overall Study|Death|4|||
33582257|NCT02605967|62979894|FG001|Overall Study|Death|2|||
33582258|NCT02605967|62979893|FG000|Overall Study|Adverse Event|1|||
33582259|NCT02605967|62979894|FG001|Overall Study|Adverse Event|0|||
33582260|NCT02605967|62979893|FG000|Overall Study|progressive disease|66|||
33582261|NCT02605967|62979894|FG001|Overall Study|progressive disease|35|||
33582262|NCT01668173|62979904|FG000|Overall Study|Adverse Event|3|||
33582263|NCT01668173|62979904|FG000|Overall Study|Trial suspension|4|||
33582264|NCT02600351|62979921|FG000|Overall Study|Lack of Efficacy|3|||
33582265|NCT02600351|62979922|FG001|Overall Study|Lack of Efficacy|0|||
33582266|NCT02600351|62979923|FG002|Overall Study|Lack of Efficacy|5|||
33582267|NCT02600351|62979924|FG003|Overall Study|Lack of Efficacy|2|||
33582268|NCT02600351|62979921|FG000|Overall Study|Lost to Follow-up|1|||
33582269|NCT02600351|62979922|FG001|Overall Study|Lost to Follow-up|0|||
33582270|NCT02600351|62979923|FG002|Overall Study|Lost to Follow-up|0|||
33582271|NCT02600351|62979924|FG003|Overall Study|Lost to Follow-up|0|||
33582272|NCT02600351|62979921|FG000|Overall Study|Randomized but Not Treated|1|||
33582273|NCT02600351|62979922|FG001|Overall Study|Randomized but Not Treated|0|||
33582274|NCT02600351|62979923|FG002|Overall Study|Randomized but Not Treated|1|||
33582275|NCT02600351|62979924|FG003|Overall Study|Randomized but Not Treated|3|||
33582276|NCT02640235|62979938|FG000|Overall Study|Withdrawal by Subject|7|||
33582277|NCT02640235|62979939|FG001|Overall Study|Withdrawal by Subject|6|||
33582278|NCT02640235|62979938|FG000|Overall Study|Lost to Follow-up|4|||
33582279|NCT02640235|62979939|FG001|Overall Study|Lost to Follow-up|3|||
33582280|NCT02640235|62979938|FG000|Overall Study|Death|2|||
33582281|NCT02640235|62979939|FG001|Overall Study|Death|3|||
33582282|NCT02640235|62979938|FG000|Overall Study|Other|1|||
33582283|NCT02640235|62979939|FG001|Overall Study|Other|2|||
33582284|NCT02599961|62979945|FG000|Overall Study|Withdrawal by Subject|1|||
33582285|NCT02599961|62979945|FG000|Overall Study|Subject Non-Compliance|2|||
33582286|NCT02599961|62979945|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
33582287|NCT02599961|62979945|FG000|Overall Study|Other, Not Specified|3|||
33582288|NCT02640157|62979970|FG000|Overall Study|Adverse Event|2|||
33582289|NCT02640157|62979971|FG001|Overall Study|Adverse Event|2|||
33582290|NCT02640157|62979972|FG002|Overall Study|Adverse Event|1|||
33582291|NCT02640157|62979970|FG000|Overall Study|Withdrew consent|2|||
33582292|NCT02640157|62979971|FG001|Overall Study|Withdrew consent|0|||
33582293|NCT02640157|62979972|FG002|Overall Study|Withdrew consent|2|||
33582294|NCT02640157|62979970|FG000|Overall Study|Lost to Follow-up|9|||
33582295|NCT02640157|62979971|FG001|Overall Study|Lost to Follow-up|2|||
33582296|NCT02640157|62979972|FG002|Overall Study|Lost to Follow-up|7|||
33582297|NCT02640157|62979970|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
33582298|NCT02640157|62979971|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
33582299|NCT02640157|62979972|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
33582300|NCT01673347|62979981|FG000|Overall Study|failure of allograft|7|||
33582301|NCT02528253|62979990|FG000|Overall Study|Adverse Event|3|||
33582302|NCT02528253|62979991|FG001|Overall Study|Adverse Event|4|||
33582303|NCT02528253|62979992|FG002|Overall Study|Adverse Event|4|||
33582304|NCT02528253|62979993|FG003|Overall Study|Adverse Event|8|||
33582305|NCT02528253|62979994|FG004|Overall Study|Adverse Event|18|||
33582306|NCT02528253|62979990|FG000|Overall Study|Death|2|||
33582307|NCT02528253|62979991|FG001|Overall Study|Death|2|||
33582308|NCT02528253|62979992|FG002|Overall Study|Death|1|||
33582309|NCT02528253|62979993|FG003|Overall Study|Death|0|||
33582310|NCT02528253|62979994|FG004|Overall Study|Death|1|||
33582311|NCT02528253|62979990|FG000|Overall Study|Insufficient clinical response|7|||
33582312|NCT02528253|62979991|FG001|Overall Study|Insufficient clinical response|10|||
33582313|NCT02528253|62979992|FG002|Overall Study|Insufficient clinical response|13|||
33582314|NCT02528253|62979993|FG003|Overall Study|Insufficient clinical response|12|||
33582315|NCT02528253|62979994|FG004|Overall Study|Insufficient clinical response|16|||
33582316|NCT02528253|62979990|FG000|Overall Study|Lost to Follow-up|16|||
33582317|NCT02528253|62979991|FG001|Overall Study|Lost to Follow-up|9|||
33582318|NCT02528253|62979992|FG002|Overall Study|Lost to Follow-up|31|||
33582319|NCT02528253|62979993|FG003|Overall Study|Lost to Follow-up|16|||
33582320|NCT02528253|62979994|FG004|Overall Study|Lost to Follow-up|34|||
33582321|NCT02528253|62979990|FG000|Overall Study|Other|21|||
33582322|NCT02528253|62979991|FG001|Overall Study|Other|22|||
33582323|NCT02528253|62979992|FG002|Overall Study|Other|58|||
33582324|NCT02528253|62979993|FG003|Overall Study|Other|52|||
33582325|NCT02528253|62979994|FG004|Overall Study|Other|76|||
33582326|NCT02528253|62979990|FG000|Overall Study|Withdrawal by Subject|25|||
33582327|NCT02528253|62979991|FG001|Overall Study|Withdrawal by Subject|20|||
33582328|NCT02528253|62979992|FG002|Overall Study|Withdrawal by Subject|29|||
33582329|NCT02528253|62979993|FG003|Overall Study|Withdrawal by Subject|48|||
33582330|NCT02528253|62979994|FG004|Overall Study|Withdrawal by Subject|73|||
33582331|NCT02528253|62979990|FG000|Overall Study|Protocol Violation|1|||
33582332|NCT02528253|62979991|FG001|Overall Study|Protocol Violation|2|||
33582333|NCT02528253|62979992|FG002|Overall Study|Protocol Violation|4|||
33582334|NCT02528253|62979993|FG003|Overall Study|Protocol Violation|0|||
33582335|NCT02528253|62979994|FG004|Overall Study|Protocol Violation|4|||
33582336|NCT02528253|62979990|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
33582337|NCT02528253|62979991|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
33582338|NCT02528253|62979992|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
33582339|NCT02528253|62979993|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
33582340|NCT02528253|62979994|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
33582341|NCT01672957|62980025|FG000|Overall Study|Protocol Violation|48|||
33582342|NCT01672957|62980025|FG000|Overall Study|Death|2|||
33582343|NCT01672957|62980025|FG000|Overall Study|ICF Signed After Transplantation|5|||
33582344|NCT02525133|62980031|FG000|Overall Study|Adverse Event|0|||
33582345|NCT02525133|62980032|FG001|Overall Study|Adverse Event|1|||
33582346|NCT02525133|62980031|FG000|Overall Study|Death|0|||
33582347|NCT02525133|62980032|FG001|Overall Study|Death|1|||
33582348|NCT02525133|62980031|FG000|Overall Study|did not meet randomization criteria|1|||
33582349|NCT02525133|62980032|FG001|Overall Study|did not meet randomization criteria|0|||
33582350|NCT02525133|62980031|FG000|Overall Study|Lost to Follow-up|5|||
33582351|NCT02525133|62980032|FG001|Overall Study|Lost to Follow-up|1|||
33582352|NCT02525133|62980031|FG000|Overall Study|randomized not enrolled|3|||
33582353|NCT02525133|62980032|FG001|Overall Study|randomized not enrolled|0|||
33582354|NCT02525133|62980031|FG000|Overall Study|Withdrawal by Subject|1|||
33582355|NCT02525133|62980032|FG001|Overall Study|Withdrawal by Subject|0|||
33582356|NCT01659255|62980059|FG000|Overall Study|Adverse Event|0|||
33582357|NCT01659255|62980060|FG001|Overall Study|Adverse Event|0|||
33582358|NCT01659255|62980061|FG002|Overall Study|Adverse Event|0|||
33582359|NCT01659255|62980062|FG003|Overall Study|Adverse Event|0|||
33582360|NCT01659255|62980063|FG004|Overall Study|Adverse Event|0|||
33582361|NCT01659255|62980064|FG005|Overall Study|Adverse Event|1|||
33582362|NCT01659255|62980065|FG006|Overall Study|Adverse Event|1|||
33582363|NCT01659255|62980066|FG007|Overall Study|Adverse Event|0|||
33582364|NCT01659255|62980067|FG008|Overall Study|Adverse Event|0|||
33582365|NCT01659255|62980068|FG009|Overall Study|Adverse Event|1|||
33582366|NCT01659255|62980069|FG010|Overall Study|Adverse Event|0|||
33582367|NCT01659255|62980070|FG011|Overall Study|Adverse Event|1|||
33582368|NCT01659255|62980071|FG012|Overall Study|Adverse Event|0|||
33582369|NCT01659255|62980072|FG013|Overall Study|Adverse Event|2|||
33582370|NCT01659255|62980073|FG014|Overall Study|Adverse Event|0|||
33582371|NCT01659255|62980074|FG015|Overall Study|Adverse Event|1|||
33582372|NCT01659255|62980075|FG016|Overall Study|Adverse Event|0|||
33582373|NCT01659255|62980059|FG000|Overall Study|Death|0|||
33582374|NCT01659255|62980060|FG001|Overall Study|Death|1|||
33582375|NCT01659255|62980061|FG002|Overall Study|Death|0|||
33582376|NCT01659255|62980062|FG003|Overall Study|Death|0|||
33582377|NCT01659255|62980063|FG004|Overall Study|Death|0|||
33582378|NCT01659255|62980064|FG005|Overall Study|Death|0|||
33582379|NCT01659255|62980065|FG006|Overall Study|Death|0|||
33582380|NCT01659255|62980066|FG007|Overall Study|Death|1|||
33582381|NCT01659255|62980067|FG008|Overall Study|Death|1|||
33582382|NCT01659255|62980068|FG009|Overall Study|Death|0|||
33582383|NCT01659255|62980069|FG010|Overall Study|Death|0|||
33582384|NCT01659255|62980070|FG011|Overall Study|Death|0|||
33582385|NCT01659255|62980071|FG012|Overall Study|Death|1|||
33582386|NCT01659255|62980072|FG013|Overall Study|Death|1|||
33582387|NCT01659255|62980073|FG014|Overall Study|Death|2|||
33582388|NCT01659255|62980074|FG015|Overall Study|Death|1|||
33582389|NCT01659255|62980075|FG016|Overall Study|Death|0|||
33582390|NCT01659255|62980059|FG000|Overall Study|Progressive Disease|2|||
33582391|NCT01659255|62980060|FG001|Overall Study|Progressive Disease|0|||
33582392|NCT01659255|62980061|FG002|Overall Study|Progressive Disease|0|||
33582393|NCT01659255|62980062|FG003|Overall Study|Progressive Disease|0|||
33582394|NCT01659255|62980063|FG004|Overall Study|Progressive Disease|0|||
33582395|NCT01659255|62980064|FG005|Overall Study|Progressive Disease|0|||
33582396|NCT01659255|62980065|FG006|Overall Study|Progressive Disease|0|||
33582397|NCT01659255|62980066|FG007|Overall Study|Progressive Disease|1|||
33582398|NCT01659255|62980067|FG008|Overall Study|Progressive Disease|0|||
33582399|NCT01659255|62980068|FG009|Overall Study|Progressive Disease|2|||
33582400|NCT01659255|62980069|FG010|Overall Study|Progressive Disease|2|||
33582401|NCT01659255|62980070|FG011|Overall Study|Progressive Disease|3|||
33582402|NCT01659255|62980071|FG012|Overall Study|Progressive Disease|5|||
33582403|NCT01659255|62980072|FG013|Overall Study|Progressive Disease|13|||
33582404|NCT01659255|62980073|FG014|Overall Study|Progressive Disease|6|||
33672266|NCT01524770|63108830|FG000|First Intervention|Adverse Event|1|||
33582405|NCT01659255|62980074|FG015|Overall Study|Progressive Disease|2|||
33582406|NCT01659255|62980075|FG016|Overall Study|Progressive Disease|3|||
33582407|NCT01659255|62980059|FG000|Overall Study|Withdrew Consent|0|||
33582408|NCT01659255|62980060|FG001|Overall Study|Withdrew Consent|0|||
33582409|NCT01659255|62980061|FG002|Overall Study|Withdrew Consent|0|||
33582410|NCT01659255|62980062|FG003|Overall Study|Withdrew Consent|0|||
33582411|NCT01659255|62980063|FG004|Overall Study|Withdrew Consent|0|||
33582412|NCT01659255|62980064|FG005|Overall Study|Withdrew Consent|0|||
33582413|NCT01659255|62980065|FG006|Overall Study|Withdrew Consent|0|||
33582414|NCT01659255|62980066|FG007|Overall Study|Withdrew Consent|0|||
33582415|NCT01659255|62980067|FG008|Overall Study|Withdrew Consent|0|||
33582416|NCT01659255|62980068|FG009|Overall Study|Withdrew Consent|0|||
33582417|NCT01659255|62980069|FG010|Overall Study|Withdrew Consent|1|||
33582418|NCT01659255|62980070|FG011|Overall Study|Withdrew Consent|0|||
33582419|NCT01659255|62980071|FG012|Overall Study|Withdrew Consent|0|||
33582420|NCT01659255|62980072|FG013|Overall Study|Withdrew Consent|1|||
33582421|NCT01659255|62980073|FG014|Overall Study|Withdrew Consent|0|||
33582422|NCT01659255|62980074|FG015|Overall Study|Withdrew Consent|0|||
33582423|NCT01659255|62980075|FG016|Overall Study|Withdrew Consent|0|||
33582424|NCT01659255|62980059|FG000|Overall Study|Investigator Decision|0|||
33582425|NCT01659255|62980060|FG001|Overall Study|Investigator Decision|0|||
33582426|NCT01659255|62980061|FG002|Overall Study|Investigator Decision|0|||
33672267|NCT01524770|63108831|FG001|First Intervention|Adverse Event|1|||
33672268|NCT01524770|63108830|FG000|First Intervention|Protocol Violation|1|||
33672269|NCT01524770|63108831|FG001|First Intervention|Protocol Violation|0|||
33491587|NCT02742766|62869504|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
33491588|NCT02742766|62869505|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
33491589|NCT01468922|62869583|FG000|Overall Study|Screening failure|0|||
33491590|NCT01468922|62869584|FG001|Overall Study|Screening failure|0|||
33491591|NCT01468922|62869585|FG002|Overall Study|Screening failure|0|||
33491592|NCT01468922|62869586|FG003|Overall Study|Screening failure|0|||
33491593|NCT01468922|62869587|FG004|Overall Study|Screening failure|0|||
33491594|NCT01468922|62869588|FG005|Overall Study|Screening failure|0|||
33491595|NCT01468922|62869589|FG006|Overall Study|Screening failure|0|||
33491596|NCT01468922|62869590|FG007|Overall Study|Screening failure|0|||
33491597|NCT01468922|62869591|FG008|Overall Study|Screening failure|1|||
33491598|NCT01468922|62869583|FG000|Overall Study|Per patient choice|1|||
33491599|NCT01468922|62869584|FG001|Overall Study|Per patient choice|0|||
33491600|NCT01468922|62869585|FG002|Overall Study|Per patient choice|0|||
33491601|NCT01468922|62869586|FG003|Overall Study|Per patient choice|0|||
33491602|NCT01468922|62869587|FG004|Overall Study|Per patient choice|0|||
33491603|NCT01468922|62869588|FG005|Overall Study|Per patient choice|0|||
33491604|NCT01468922|62869589|FG006|Overall Study|Per patient choice|0|||
33491605|NCT01468922|62869590|FG007|Overall Study|Per patient choice|0|||
33491606|NCT01468922|62869591|FG008|Overall Study|Per patient choice|0|||
33491607|NCT01468922|62869583|FG000|Overall Study|Switched to alternative treatment|1|||
33491608|NCT01468922|62869584|FG001|Overall Study|Switched to alternative treatment|0|||
33491609|NCT01468922|62869585|FG002|Overall Study|Switched to alternative treatment|0|||
33491610|NCT01468922|62869586|FG003|Overall Study|Switched to alternative treatment|0|||
33491611|NCT01468922|62869587|FG004|Overall Study|Switched to alternative treatment|1|||
33491612|NCT01468922|62869588|FG005|Overall Study|Switched to alternative treatment|0|||
33491613|NCT01468922|62869589|FG006|Overall Study|Switched to alternative treatment|0|||
33491614|NCT01468922|62869590|FG007|Overall Study|Switched to alternative treatment|0|||
33491615|NCT01468922|62869591|FG008|Overall Study|Switched to alternative treatment|0|||
33491616|NCT01468922|62869583|FG000|Overall Study|Enrolled on new protocol|0|||
33491617|NCT01468922|62869584|FG001|Overall Study|Enrolled on new protocol|0|||
33491618|NCT01468922|62869585|FG002|Overall Study|Enrolled on new protocol|0|||
33491619|NCT01468922|62869586|FG003|Overall Study|Enrolled on new protocol|0|||
33491620|NCT01468922|62869587|FG004|Overall Study|Enrolled on new protocol|1|||
33491621|NCT01468922|62869588|FG005|Overall Study|Enrolled on new protocol|0|||
33491622|NCT01468922|62869589|FG006|Overall Study|Enrolled on new protocol|0|||
33491623|NCT01468922|62869590|FG007|Overall Study|Enrolled on new protocol|0|||
33491624|NCT01468922|62869591|FG008|Overall Study|Enrolled on new protocol|0|||
33491625|NCT01468922|62869583|FG000|Overall Study|Adverse Event|0|||
33491626|NCT01468922|62869584|FG001|Overall Study|Adverse Event|0|||
33491627|NCT01468922|62869585|FG002|Overall Study|Adverse Event|0|||
33491628|NCT01468922|62869586|FG003|Overall Study|Adverse Event|0|||
33491629|NCT01468922|62869587|FG004|Overall Study|Adverse Event|0|||
33491630|NCT01468922|62869588|FG005|Overall Study|Adverse Event|0|||
33491631|NCT01468922|62869589|FG006|Overall Study|Adverse Event|0|||
33491632|NCT01468922|62869590|FG007|Overall Study|Adverse Event|1|||
33491633|NCT01468922|62869591|FG008|Overall Study|Adverse Event|0|||
33491634|NCT01468922|62869583|FG000|Overall Study|Infection of blood|0|||
33491635|NCT01468922|62869584|FG001|Overall Study|Infection of blood|0|||
33491636|NCT01468922|62869585|FG002|Overall Study|Infection of blood|0|||
33491637|NCT01468922|62869586|FG003|Overall Study|Infection of blood|0|||
33491638|NCT01468922|62869587|FG004|Overall Study|Infection of blood|0|||
33491639|NCT01468922|62869588|FG005|Overall Study|Infection of blood|0|||
33491640|NCT01468922|62869589|FG006|Overall Study|Infection of blood|0|||
33491641|NCT01468922|62869590|FG007|Overall Study|Infection of blood|1|||
33491642|NCT01468922|62869591|FG008|Overall Study|Infection of blood|0|||
33491643|NCT01468922|62869583|FG000|Overall Study|Patient choice - surgery|0|||
33491644|NCT01468922|62869584|FG001|Overall Study|Patient choice - surgery|0|||
33491645|NCT01468922|62869585|FG002|Overall Study|Patient choice - surgery|0|||
33491646|NCT01468922|62869586|FG003|Overall Study|Patient choice - surgery|0|||
33491647|NCT01468922|62869587|FG004|Overall Study|Patient choice - surgery|0|||
33491648|NCT01468922|62869588|FG005|Overall Study|Patient choice - surgery|0|||
33491649|NCT01468922|62869589|FG006|Overall Study|Patient choice - surgery|0|||
33491650|NCT01468922|62869590|FG007|Overall Study|Patient choice - surgery|1|||
33491651|NCT01468922|62869591|FG008|Overall Study|Patient choice - surgery|0|||
33491652|NCT01468922|62869583|FG000|Overall Study|Refused further treatment|0|||
33582427|NCT01659255|62980062|FG003|Overall Study|Investigator Decision|0|||
33582428|NCT01659255|62980063|FG004|Overall Study|Investigator Decision|0|||
33582429|NCT01659255|62980064|FG005|Overall Study|Investigator Decision|0|||
33582430|NCT01659255|62980065|FG006|Overall Study|Investigator Decision|0|||
33582431|NCT01659255|62980066|FG007|Overall Study|Investigator Decision|0|||
33582432|NCT01659255|62980067|FG008|Overall Study|Investigator Decision|0|||
33582433|NCT01659255|62980068|FG009|Overall Study|Investigator Decision|0|||
33582434|NCT01659255|62980069|FG010|Overall Study|Investigator Decision|0|||
33582435|NCT01659255|62980070|FG011|Overall Study|Investigator Decision|0|||
33582436|NCT01659255|62980071|FG012|Overall Study|Investigator Decision|1|||
33582437|NCT01659255|62980072|FG013|Overall Study|Investigator Decision|1|||
33582438|NCT01659255|62980073|FG014|Overall Study|Investigator Decision|0|||
33582439|NCT01659255|62980074|FG015|Overall Study|Investigator Decision|0|||
33582440|NCT01659255|62980075|FG016|Overall Study|Investigator Decision|0|||
33582441|NCT01659255|62980059|FG000|Overall Study|Sponsor's Decision|0|||
33582442|NCT01659255|62980060|FG001|Overall Study|Sponsor's Decision|0|||
33582443|NCT01659255|62980061|FG002|Overall Study|Sponsor's Decision|0|||
33582444|NCT01659255|62980062|FG003|Overall Study|Sponsor's Decision|0|||
33582445|NCT01659255|62980063|FG004|Overall Study|Sponsor's Decision|0|||
33582446|NCT01659255|62980064|FG005|Overall Study|Sponsor's Decision|0|||
33582447|NCT01659255|62980065|FG006|Overall Study|Sponsor's Decision|1|||
33582448|NCT01659255|62980066|FG007|Overall Study|Sponsor's Decision|0|||
33582449|NCT01659255|62980067|FG008|Overall Study|Sponsor's Decision|0|||
33582450|NCT01659255|62980068|FG009|Overall Study|Sponsor's Decision|0|||
33582451|NCT01659255|62980069|FG010|Overall Study|Sponsor's Decision|0|||
33582452|NCT01659255|62980070|FG011|Overall Study|Sponsor's Decision|0|||
33582453|NCT01659255|62980071|FG012|Overall Study|Sponsor's Decision|0|||
33582454|NCT01659255|62980072|FG013|Overall Study|Sponsor's Decision|0|||
33582455|NCT01659255|62980073|FG014|Overall Study|Sponsor's Decision|0|||
33582456|NCT01659255|62980074|FG015|Overall Study|Sponsor's Decision|0|||
33582457|NCT01659255|62980075|FG016|Overall Study|Sponsor's Decision|0|||
33582458|NCT01659255|62980059|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33582459|NCT01659255|62980060|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33582460|NCT01659255|62980061|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33582461|NCT01659255|62980062|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33582462|NCT01659255|62980063|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33582463|NCT01659255|62980064|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33582464|NCT01659255|62980065|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33672270|NCT01524692|63108837|FG000|Overall Study|Withdrawal by Subject|3|||
33672271|NCT01431287|63108856|FG000|Overall Study|not treated|0|||
33672272|NCT01431287|63108857|FG001|Overall Study|not treated|0|||
33672273|NCT01431287|63108858|FG002|Overall Study|not treated|1|||
33672274|NCT01431287|63108859|FG003|Overall Study|not treated|0|||
33672275|NCT01431287|63108860|FG004|Overall Study|not treated|0|||
33672276|NCT01431287|63108856|FG000|Overall Study|Adverse Event|59|||
33672277|NCT01431287|63108857|FG001|Overall Study|Adverse Event|57|||
33672278|NCT01431287|63108858|FG002|Overall Study|Adverse Event|53|||
33672279|NCT01431287|63108859|FG003|Overall Study|Adverse Event|33|||
33672280|NCT01431287|63108860|FG004|Overall Study|Adverse Event|41|||
33672281|NCT01431287|63108856|FG000|Overall Study|Non compliant with protocol|6|||
33672282|NCT01431287|63108857|FG001|Overall Study|Non compliant with protocol|6|||
33672283|NCT01431287|63108858|FG002|Overall Study|Non compliant with protocol|5|||
33672284|NCT01431287|63108859|FG003|Overall Study|Non compliant with protocol|6|||
33672285|NCT01431287|63108860|FG004|Overall Study|Non compliant with protocol|5|||
33672286|NCT01431287|63108856|FG000|Overall Study|Lost to Follow-up|0|||
33672287|NCT01431287|63108857|FG001|Overall Study|Lost to Follow-up|3|||
33672288|NCT01431287|63108858|FG002|Overall Study|Lost to Follow-up|2|||
33672289|NCT01431287|63108859|FG003|Overall Study|Lost to Follow-up|3|||
33672290|NCT01431287|63108860|FG004|Overall Study|Lost to Follow-up|1|||
33672291|NCT01431287|63108856|FG000|Overall Study|Consent withdrawn not due to AE|29|||
33672292|NCT01431287|63108857|FG001|Overall Study|Consent withdrawn not due to AE|30|||
33672293|NCT01431287|63108858|FG002|Overall Study|Consent withdrawn not due to AE|34|||
33672294|NCT01431287|63108859|FG003|Overall Study|Consent withdrawn not due to AE|19|||
33672295|NCT01431287|63108860|FG004|Overall Study|Consent withdrawn not due to AE|29|||
33672296|NCT01431287|63108856|FG000|Overall Study|not stated above|4|||
33672297|NCT01431287|63108857|FG001|Overall Study|not stated above|2|||
33672298|NCT01431287|63108858|FG002|Overall Study|not stated above|2|||
33672299|NCT01431287|63108859|FG003|Overall Study|not stated above|2|||
33672300|NCT01431287|63108860|FG004|Overall Study|not stated above|1|||
33672301|NCT01274715|63108906|FG000|Overall Study|Lost to Follow-up|1|||
33672302|NCT01274715|63108906|FG000|Overall Study|After consent, met exclusion criteria.|1|||
33672303|NCT01274715|63108906|FG000|Overall Study|After consent, met exclusion criteria.|1|||
33672304|NCT01274715|63108906|FG000|Overall Study|After consent, met exclusion criteria.|1|||
33672305|NCT01410227|63108910|FG000|Overall Study|Adverse Event|1|||
33582465|NCT01659255|62980066|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33672306|NCT01410227|63108911|FG001|Overall Study|Adverse Event|0|||
33672307|NCT01410227|63108912|FG002|Overall Study|Adverse Event|0|||
33672308|NCT01410227|63108913|FG003|Overall Study|Adverse Event|0|||
33672309|NCT01410227|63108910|FG000|Overall Study|Withdrawal by Subject|3|||
33672310|NCT01410227|63108911|FG001|Overall Study|Withdrawal by Subject|0|||
33672311|NCT01410227|63108912|FG002|Overall Study|Withdrawal by Subject|1|||
33672312|NCT01410227|63108913|FG003|Overall Study|Withdrawal by Subject|0|||
33672313|NCT01410227|63108910|FG000|Overall Study|Pregnancy|0|||
33672314|NCT01410227|63108911|FG001|Overall Study|Pregnancy|0|||
33672315|NCT01410227|63108912|FG002|Overall Study|Pregnancy|0|||
33672316|NCT01410227|63108913|FG003|Overall Study|Pregnancy|1|||
33672317|NCT01410227|63108910|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
33672318|NCT01410227|63108911|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
33672319|NCT01410227|63108912|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
33672320|NCT01410227|63108913|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
33672321|NCT01274559|63108925|FG000|Overall Study|Adverse Event|57|||
33672322|NCT01274559|63108926|FG001|Overall Study|Adverse Event|13|||
33672323|NCT01274559|63108925|FG000|Overall Study|Death|1|||
33672324|NCT01274559|63108926|FG001|Overall Study|Death|1|||
33672325|NCT01274559|63108925|FG000|Overall Study|Lost to Follow-up|3|||
33672326|NCT01274559|63108926|FG001|Overall Study|Lost to Follow-up|3|||
33672327|NCT01274559|63108925|FG000|Overall Study|Non-compliance with Study Drug|2|||
33672328|NCT01274559|63108926|FG001|Overall Study|Non-compliance with Study Drug|4|||
33672329|NCT01274559|63108925|FG000|Overall Study|Physician Decision|2|||
33672330|NCT01274559|63108926|FG001|Overall Study|Physician Decision|1|||
33672331|NCT01274559|63108925|FG000|Overall Study|Protocol Violation|28|||
33672332|NCT01274559|63108926|FG001|Overall Study|Protocol Violation|23|||
33672333|NCT01274559|63108925|FG000|Overall Study|Study Terminated by Sponsor|79|||
33672334|NCT01274559|63108926|FG001|Overall Study|Study Terminated by Sponsor|87|||
33672335|NCT01274559|63108925|FG000|Overall Study|Withdrawal by Subject|25|||
33672336|NCT01274559|63108926|FG001|Overall Study|Withdrawal by Subject|13|||
33672337|NCT01409993|63108934|FG000|Overall Study|Adverse Event|4|||
33672338|NCT01409993|63108935|FG001|Overall Study|Adverse Event|4|||
33672339|NCT01409993|63108936|FG002|Overall Study|Adverse Event|3|||
33672340|NCT01409993|63108937|FG003|Overall Study|Adverse Event|1|||
33672341|NCT01409993|63108934|FG000|Overall Study|Withdrawal by Subject|0|||
33672342|NCT01409993|63108935|FG001|Overall Study|Withdrawal by Subject|0|||
33672343|NCT01409993|63108936|FG002|Overall Study|Withdrawal by Subject|0|||
33672344|NCT01409993|63108937|FG003|Overall Study|Withdrawal by Subject|4|||
33672345|NCT01409993|63108934|FG000|Overall Study|Lost to Follow-up|0|||
33672346|NCT01409993|63108935|FG001|Overall Study|Lost to Follow-up|1|||
33672347|NCT01409993|63108936|FG002|Overall Study|Lost to Follow-up|0|||
33672348|NCT01409993|63108937|FG003|Overall Study|Lost to Follow-up|0|||
33672349|NCT01273623|63108951|FG000|Overall Study|did not meet IVUS criteria|29|||
33672350|NCT01409915|63108959|FG000|Overall Study|Adverse Event|0|||
33672351|NCT01409915|63108960|FG001|Overall Study|Adverse Event|2|||
33672352|NCT01409915|63108959|FG000|Overall Study|Withdrawal by Subject|0|||
33672353|NCT01409915|63108960|FG001|Overall Study|Withdrawal by Subject|1|||
33672354|NCT01409915|63108959|FG000|Overall Study|Protocol Violation|1|||
33672355|NCT01409915|63108960|FG001|Overall Study|Protocol Violation|0|||
33672356|NCT01272921|63108968|FG000|Overall Study|Protocol Violation|2|||
33672357|NCT01272921|63108969|FG001|Overall Study|Protocol Violation|1|||
33672358|NCT01409837|63108979|FG000|Overall Study|Withdrawal by Subject|2|||
33672359|NCT01409837|63108980|FG001|Overall Study|Withdrawal by Subject|1|||
33672360|NCT01409837|63108979|FG000|Overall Study|Lost to Follow-up|1|||
33672361|NCT01409837|63108980|FG001|Overall Study|Lost to Follow-up|0|||
33672362|NCT01409837|63108979|FG000|Overall Study|Physician Decision|0|||
33672363|NCT01409837|63108980|FG001|Overall Study|Physician Decision|1|||
33672364|NCT01430585|63108999|FG000|Overall Study|Death|1|||
33672365|NCT01430585|63108999|FG000|Overall Study|Objective Progression or Relapse|3|||
33672366|NCT01430585|63108999|FG000|Overall Study|Study Terminated by Sponsor|3|||
33672367|NCT01430585|63108999|FG000|Overall Study|Other|7|||
33672368|NCT01408901|63109022|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
33672369|NCT01408901|63109023|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
33672370|NCT01408901|63109024|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
33491653|NCT01468922|62869584|FG001|Overall Study|Refused further treatment|0|||
33672371|NCT01408901|63109025|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
33672372|NCT01408901|63109022|FG000|6-Week Follow-Up|Death|1|||
33672373|NCT01408901|63109023|FG001|6-Week Follow-Up|Death|0|||
33672374|NCT01408901|63109024|FG002|6-Week Follow-Up|Death|0|||
33672375|NCT01408901|63109025|FG003|6-Week Follow-Up|Death|0|||
33672376|NCT01408901|63109022|FG000|6-Week Follow-Up|Cancelled visit|0|||
33672377|NCT01408901|63109023|FG001|6-Week Follow-Up|Cancelled visit|1|||
33672378|NCT01408901|63109024|FG002|6-Week Follow-Up|Cancelled visit|0|||
33672379|NCT01408901|63109025|FG003|6-Week Follow-Up|Cancelled visit|2|||
33672380|NCT01408901|63109022|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
33672381|NCT01408901|63109023|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
33672382|NCT01408901|63109024|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
33672383|NCT01408901|63109025|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
33672384|NCT01408901|63109022|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
33672385|NCT01408901|63109023|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
33672386|NCT01408901|63109024|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
33672387|NCT01408901|63109025|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
33672388|NCT01408901|63109022|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
33672389|NCT01408901|63109023|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
33672390|NCT01408901|63109024|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
33672391|NCT01408901|63109025|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
33672392|NCT01408901|63109022|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
33672393|NCT01408901|63109023|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
33672394|NCT01408901|63109024|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
33672395|NCT01408901|63109025|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
33672396|NCT01408901|63109022|FG000|26-Week Follow-Up|Death|0|||
33672397|NCT01408901|63109023|FG001|26-Week Follow-Up|Death|1|||
33672398|NCT01408901|63109024|FG002|26-Week Follow-Up|Death|0|||
33672399|NCT01408901|63109025|FG003|26-Week Follow-Up|Death|0|||
33672400|NCT01428713|63109041|FG000|Overall Study|Non-compliance|2|||
33672401|NCT01428713|63109042|FG001|Overall Study|Non-compliance|2|||
33672402|NCT01428713|63109041|FG000|Overall Study|Withdrawal by Subject|1|||
33672403|NCT01428713|63109042|FG001|Overall Study|Withdrawal by Subject|1|||
33672404|NCT01428713|63109041|FG000|Overall Study|Adverse Event|0|||
33672405|NCT01428713|63109042|FG001|Overall Study|Adverse Event|2|||
33672406|NCT01408277|63109050|FG000|Overall Study|Adverse Event|3|||
33672407|NCT01408277|63109051|FG001|Overall Study|Adverse Event|4|||
33672408|NCT01408277|63109050|FG000|Overall Study|Lost to Follow-up|1|||
33672409|NCT01408277|63109051|FG001|Overall Study|Lost to Follow-up|0|||
33672410|NCT01408277|63109050|FG000|Overall Study|Withdrawal by Subject|2|||
33672411|NCT01408277|63109051|FG001|Overall Study|Withdrawal by Subject|0|||
33672412|NCT01408277|63109050|FG000|Overall Study|Protocol Violation|2|||
33672413|NCT01408277|63109051|FG001|Overall Study|Protocol Violation|0|||
33672414|NCT01408043|63109057|FG000|Overall Study|unable to collect cells|1|||
33672415|NCT01524224|63109069|FG000|Overall Study|Progressive Disease|1|||
33672416|NCT01524224|63109070|FG001|Overall Study|Progressive Disease|0|||
33672417|NCT01524224|63109071|FG002|Overall Study|Progressive Disease|2|||
33672418|NCT01524224|63109072|FG003|Overall Study|Progressive Disease|1|||
33672419|NCT01524224|63109073|FG004|Overall Study|Progressive Disease|2|||
33672420|NCT01524224|63109074|FG005|Overall Study|Progressive Disease|1|||
33672421|NCT01524224|63109075|FG006|Overall Study|Progressive Disease|1|||
33672422|NCT01524224|63109076|FG007|Overall Study|Progressive Disease|5|||
33672423|NCT01524224|63109069|FG000|Overall Study|Withdrawal by Subject|2|||
33672424|NCT01524224|63109070|FG001|Overall Study|Withdrawal by Subject|0|||
33672425|NCT01524224|63109071|FG002|Overall Study|Withdrawal by Subject|0|||
33672426|NCT01524224|63109072|FG003|Overall Study|Withdrawal by Subject|0|||
33672427|NCT01524224|63109073|FG004|Overall Study|Withdrawal by Subject|0|||
33672428|NCT01524224|63109074|FG005|Overall Study|Withdrawal by Subject|0|||
33672429|NCT01524224|63109075|FG006|Overall Study|Withdrawal by Subject|2|||
33672430|NCT01524224|63109076|FG007|Overall Study|Withdrawal by Subject|0|||
33672431|NCT01524224|63109069|FG000|Overall Study|Adverse Event|0|||
33672432|NCT01524224|63109070|FG001|Overall Study|Adverse Event|1|||
33672433|NCT01524224|63109071|FG002|Overall Study|Adverse Event|0|||
33672434|NCT01524224|63109072|FG003|Overall Study|Adverse Event|0|||
33672435|NCT01524224|63109073|FG004|Overall Study|Adverse Event|0|||
33672436|NCT01524224|63109074|FG005|Overall Study|Adverse Event|1|||
33672437|NCT01524224|63109075|FG006|Overall Study|Adverse Event|0|||
33672438|NCT01524224|63109076|FG007|Overall Study|Adverse Event|0|||
33672439|NCT01524224|63109069|FG000|Overall Study|Physician Decision|0|||
33672440|NCT01524224|63109070|FG001|Overall Study|Physician Decision|0|||
33672441|NCT01524224|63109071|FG002|Overall Study|Physician Decision|0|||
33672442|NCT01524224|63109072|FG003|Overall Study|Physician Decision|1|||
33672443|NCT01524224|63109073|FG004|Overall Study|Physician Decision|1|||
33672444|NCT01524224|63109074|FG005|Overall Study|Physician Decision|0|||
33672445|NCT01524224|63109075|FG006|Overall Study|Physician Decision|0|||
33672446|NCT01524224|63109076|FG007|Overall Study|Physician Decision|1|||
33672447|NCT01524224|63109069|FG000|Overall Study|Sponsor Decision|0|||
33672448|NCT01524224|63109070|FG001|Overall Study|Sponsor Decision|0|||
33672449|NCT01524224|63109071|FG002|Overall Study|Sponsor Decision|0|||
33672450|NCT01524224|63109072|FG003|Overall Study|Sponsor Decision|0|||
33672451|NCT01524224|63109073|FG004|Overall Study|Sponsor Decision|1|||
33672452|NCT01524224|63109074|FG005|Overall Study|Sponsor Decision|0|||
33672453|NCT01524224|63109075|FG006|Overall Study|Sponsor Decision|0|||
33672454|NCT01524224|63109076|FG007|Overall Study|Sponsor Decision|0|||
33672455|NCT00219349|63109094|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
33672456|NCT00219349|63109094|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
33672457|NCT00219349|63109094|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
33672458|NCT00219349|63109094|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
33672459|NCT01523756|63109098|FG000|Baseline Period|Adverse Event|0|||
33672460|NCT01523756|63109099|FG001|Baseline Period|Adverse Event|1|||
33672461|NCT01523756|63109098|FG000|Test Period 1|Adverse Event|1|||
33672462|NCT01523756|63109099|FG001|Test Period 1|Adverse Event|0|||
33672463|NCT01523756|63109098|FG000|Test Period 2|Withdrawal by Subject|0|||
33672464|NCT01523756|63109099|FG001|Test Period 2|Withdrawal by Subject|1|||
33672465|NCT00218257|63109107|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
33672466|NCT00218257|63109108|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
33672467|NCT01523366|63109119|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33672468|NCT01523366|63109120|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33672469|NCT01523366|63109119|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
33672470|NCT01523366|63109120|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
33672471|NCT01427933|63109130|FG000|Overall Study|Withdrawal by Subject|5|||
33672472|NCT01427933|63109131|FG001|Overall Study|Withdrawal by Subject|8|||
33672473|NCT01427933|63109130|FG000|Overall Study|Lost to Follow-up|1|||
33672474|NCT01427933|63109131|FG001|Overall Study|Lost to Follow-up|5|||
33672475|NCT01427933|63109130|FG000|Overall Study|Other|1|||
33672476|NCT01427933|63109131|FG001|Overall Study|Other|0|||
33672477|NCT01427933|63109130|FG000|Overall Study|Investigator's Decision|1|||
33672478|NCT01427933|63109131|FG001|Overall Study|Investigator's Decision|0|||
33672479|NCT00217087|63109140|FG000|Overall Study|decided to have esophagectomy|1|||
33672480|NCT00217087|63109141|FG001|Overall Study|decided to have esophagectomy|2|||
33672481|NCT00217087|63109140|FG000|Overall Study|completed less than 12 months return|10|||
33672482|NCT00217087|63109141|FG001|Overall Study|completed less than 12 months return|18|||
33672483|NCT01406873|63109155|FG000|Overall Study|Withdrawal by Subject|1|||
33672484|NCT01406873|63109156|FG001|Overall Study|Withdrawal by Subject|1|||
33672485|NCT01406795|63109172|FG000|Overall Study|Withdrawal by Subject|1|||
33672486|NCT01406717|63109178|FG000|Overall Study|Subject non-compliance|4|||
33672487|NCT01406717|63109179|FG001|Overall Study|Subject non-compliance|3|||
33672488|NCT01406717|63109178|FG000|Overall Study|Protocol Violation|5|||
33672489|NCT01406717|63109179|FG001|Overall Study|Protocol Violation|1|||
33672490|NCT01406717|63109178|FG000|Overall Study|Lost to Follow-up|14|||
33672491|NCT01406717|63109179|FG001|Overall Study|Lost to Follow-up|8|||
33672492|NCT01406717|63109178|FG000|Overall Study|Withdrawal by Subject|19|||
33672493|NCT01406717|63109179|FG001|Overall Study|Withdrawal by Subject|15|||
33672494|NCT01406717|63109178|FG000|Overall Study|Adverse Event|1|||
33672495|NCT01406717|63109179|FG001|Overall Study|Adverse Event|2|||
33672496|NCT01406717|63109178|FG000|Overall Study|Lack of Efficacy|0|||
33672497|NCT01406717|63109179|FG001|Overall Study|Lack of Efficacy|1|||
33672498|NCT01406717|63109178|FG000|Overall Study|Non-completion of visit activity|0|||
33672499|NCT01406717|63109179|FG001|Overall Study|Non-completion of visit activity|1|||
33672500|NCT01406015|63109197|FG000|Overall Study|Withdrawal by Subject|3|||
33672501|NCT01406015|63109198|FG001|Overall Study|Withdrawal by Subject|3|||
33672502|NCT00215683|63109207|FG000|Overall Study|Adverse Event|15|||
33672503|NCT00215683|63109208|FG001|Overall Study|Adverse Event|16|||
33672504|NCT00215683|63109209|FG002|Overall Study|Adverse Event|15|||
33672505|NCT00215683|63109207|FG000|Overall Study|Lack of Efficacy|5|||
33672506|NCT00215683|63109208|FG001|Overall Study|Lack of Efficacy|1|||
33672507|NCT00215683|63109209|FG002|Overall Study|Lack of Efficacy|2|||
33672508|NCT00215683|63109207|FG000|Overall Study|Lost to Follow-up|0|||
33672509|NCT00215683|63109208|FG001|Overall Study|Lost to Follow-up|2|||
33672510|NCT00215683|63109209|FG002|Overall Study|Lost to Follow-up|1|||
33672511|NCT00215683|63109207|FG000|Overall Study|Withdrawal by Subject|9|||
33672512|NCT00215683|63109208|FG001|Overall Study|Withdrawal by Subject|4|||
33672513|NCT00215683|63109209|FG002|Overall Study|Withdrawal by Subject|13|||
33672514|NCT00215683|63109207|FG000|Overall Study|Physician Decision|0|||
33672515|NCT00215683|63109208|FG001|Overall Study|Physician Decision|0|||
33672516|NCT00215683|63109209|FG002|Overall Study|Physician Decision|1|||
33672517|NCT00215683|63109207|FG000|Overall Study|Difficult to attend visits|0|||
33672518|NCT00215683|63109208|FG001|Overall Study|Difficult to attend visits|1|||
33672519|NCT00215683|63109209|FG002|Overall Study|Difficult to attend visits|0|||
33672520|NCT00215683|63109207|FG000|Overall Study|No study drug available|0|||
33672521|NCT00215683|63109208|FG001|Overall Study|No study drug available|1|||
33672522|NCT00215683|63109209|FG002|Overall Study|No study drug available|0|||
33328299|NCT01200290|62704703|FG000|Treatment Period|Adverse Event|1|||
33672523|NCT00215683|63109207|FG000|Overall Study|Intermittent therapy required|0|||
33672524|NCT00215683|63109208|FG001|Overall Study|Intermittent therapy required|1|||
33672525|NCT00215683|63109209|FG002|Overall Study|Intermittent therapy required|0|||
33672526|NCT00215137|63109217|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
33672527|NCT00215137|63109218|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
33672528|NCT00215137|63109219|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
33672529|NCT00215137|63109217|FG000|Randomization Period|Lost to Follow-up|0|||
33672530|NCT00215137|63109218|FG001|Randomization Period|Lost to Follow-up|1|||
33672531|NCT00215137|63109219|FG002|Randomization Period|Lost to Follow-up|0|||
33672532|NCT00215137|63109217|FG000|Randomization Period|Withdrawal by Subject|0|||
33672533|NCT00215137|63109218|FG001|Randomization Period|Withdrawal by Subject|1|||
33672534|NCT00215137|63109219|FG002|Randomization Period|Withdrawal by Subject|0|||
33672535|NCT00214201|63109229|FG000|Overall Study|Withdrawal by Subject|2|||
33672536|NCT00214201|63109230|FG001|Overall Study|Withdrawal by Subject|0|||
33672537|NCT00214201|63109229|FG000|Overall Study|Death|0|||
33672538|NCT00214201|63109230|FG001|Overall Study|Death|2|||
33672539|NCT01486784|63109243|FG000|Overall Study|Withdrawal by Subject|0|||
33672540|NCT01486784|63109244|FG001|Overall Study|Withdrawal by Subject|0|||
33672541|NCT01486784|63109245|FG002|Overall Study|Withdrawal by Subject|1|||
33672542|NCT01486784|63109246|FG003|Overall Study|Withdrawal by Subject|0|||
33672543|NCT01486784|63109247|FG004|Overall Study|Withdrawal by Subject|1|||
33672544|NCT01486784|63109248|FG005|Overall Study|Withdrawal by Subject|2|||
33672545|NCT01486784|63109243|FG000|Overall Study|Subject did not meet entry criteria|0|||
33672546|NCT01486784|63109244|FG001|Overall Study|Subject did not meet entry criteria|0|||
33672547|NCT01486784|63109245|FG002|Overall Study|Subject did not meet entry criteria|0|||
33672548|NCT01486784|63109246|FG003|Overall Study|Subject did not meet entry criteria|0|||
33672549|NCT01486784|63109247|FG004|Overall Study|Subject did not meet entry criteria|1|||
33672550|NCT01486784|63109248|FG005|Overall Study|Subject did not meet entry criteria|0|||
33672551|NCT01486784|63109243|FG000|Overall Study|Death|0|||
33672552|NCT01486784|63109244|FG001|Overall Study|Death|0|||
33672553|NCT01486784|63109245|FG002|Overall Study|Death|0|||
33672554|NCT01486784|63109246|FG003|Overall Study|Death|0|||
33672555|NCT01486784|63109247|FG004|Overall Study|Death|0|||
33672556|NCT01486784|63109248|FG005|Overall Study|Death|1|||
33672557|NCT01521884|63109262|FG000|Overall Study|Non Responders|10|||
33672558|NCT01521884|63109262|FG000|Overall Study|Adverse Event|5|||
33672559|NCT01521884|63109262|FG000|Overall Study|Pregnancy|1|||
33672560|NCT01521884|63109262|FG000|Overall Study|Withdrawal by Subject|1|||
33672561|NCT01521884|63109262|FG000|Overall Study|Physician Decision|2|||
33672562|NCT01521884|63109262|FG000|Overall Study|Protocol Violation|3|||
33672563|NCT01521884|63109262|FG000|Overall Study|Participant non-eligible|1|||
33672564|NCT01521884|63109262|FG000|Overall Study|Lost to Follow-up|4|||
33672565|NCT01677858|63109271|FG000|Overall Study|Adverse Event|0|||
33672566|NCT01677858|63109272|FG001|Overall Study|Adverse Event|0|||
33672567|NCT01677858|63109273|FG002|Overall Study|Adverse Event|2|||
33672568|NCT01677858|63109274|FG003|Overall Study|Adverse Event|3|||
33672569|NCT01677858|63109275|FG004|Overall Study|Adverse Event|13|||
33672570|NCT01677858|63109271|FG000|Overall Study|Death|0|||
33672571|NCT01677858|63109272|FG001|Overall Study|Death|0|||
33672572|NCT01677858|63109273|FG002|Overall Study|Death|0|||
33672573|NCT01677858|63109274|FG003|Overall Study|Death|0|||
33672574|NCT01677858|63109275|FG004|Overall Study|Death|1|||
33672575|NCT01677858|63109271|FG000|Overall Study|Physician Decision|1|||
33672576|NCT01677858|63109272|FG001|Overall Study|Physician Decision|0|||
33672577|NCT01677858|63109273|FG002|Overall Study|Physician Decision|2|||
33672578|NCT01677858|63109274|FG003|Overall Study|Physician Decision|0|||
33672579|NCT01677858|63109275|FG004|Overall Study|Physician Decision|12|||
33672580|NCT01677858|63109271|FG000|Overall Study|Progressive Disease|2|||
33672581|NCT01677858|63109272|FG001|Overall Study|Progressive Disease|1|||
33672582|NCT01677858|63109273|FG002|Overall Study|Progressive Disease|9|||
33672583|NCT01677858|63109274|FG003|Overall Study|Progressive Disease|3|||
33672584|NCT01677858|63109275|FG004|Overall Study|Progressive Disease|43|||
33672585|NCT01677858|63109271|FG000|Overall Study|Withdrawal by Subject|0|||
33672586|NCT01677858|63109272|FG001|Overall Study|Withdrawal by Subject|1|||
33672587|NCT01677858|63109273|FG002|Overall Study|Withdrawal by Subject|1|||
33672588|NCT01677858|63109274|FG003|Overall Study|Withdrawal by Subject|0|||
33672589|NCT01677858|63109275|FG004|Overall Study|Withdrawal by Subject|15|||
33672590|NCT01677858|63109271|FG000|Overall Study|Lost to Follow-up|0|||
33672591|NCT01677858|63109272|FG001|Overall Study|Lost to Follow-up|0|||
33672592|NCT01677858|63109273|FG002|Overall Study|Lost to Follow-up|0|||
33672593|NCT01677858|63109274|FG003|Overall Study|Lost to Follow-up|0|||
33672594|NCT01677858|63109275|FG004|Overall Study|Lost to Follow-up|1|||
33672595|NCT01486316|63109295|FG000|Overall Study|Device explanted with/without re-implant|3|||
33672596|NCT01486316|63109296|FG001|Overall Study|Device explanted with/without re-implant|2|||
33672597|NCT01486316|63109297|FG002|Overall Study|Device explanted with/without re-implant|0|||
33672598|NCT01486316|63109298|FG003|Overall Study|Device explanted with/without re-implant|2|||
33672599|NCT01486316|63109295|FG000|Overall Study|Not meeting eligibility criteria|0|||
33672600|NCT01486316|63109296|FG001|Overall Study|Not meeting eligibility criteria|0|||
33672601|NCT01486316|63109297|FG002|Overall Study|Not meeting eligibility criteria|1|||
33672602|NCT01486316|63109298|FG003|Overall Study|Not meeting eligibility criteria|0|||
33672603|NCT01486316|63109295|FG000|Overall Study|Withdrawal by Subject|1|||
33672604|NCT01486316|63109296|FG001|Overall Study|Withdrawal by Subject|0|||
33672605|NCT01486316|63109297|FG002|Overall Study|Withdrawal by Subject|3|||
33672606|NCT01486316|63109298|FG003|Overall Study|Withdrawal by Subject|0|||
33672607|NCT01486316|63109295|FG000|Overall Study|Physician Decision|0|||
33672608|NCT01486316|63109296|FG001|Overall Study|Physician Decision|0|||
33672609|NCT01486316|63109297|FG002|Overall Study|Physician Decision|1|||
33672610|NCT01486316|63109298|FG003|Overall Study|Physician Decision|0|||
33672611|NCT01486316|63109295|FG000|Overall Study|Death|0|||
33672612|NCT01486316|63109296|FG001|Overall Study|Death|1|||
33672613|NCT01486316|63109297|FG002|Overall Study|Death|0|||
33672614|NCT01486316|63109298|FG003|Overall Study|Death|0|||
33672615|NCT01486238|63109309|FG000|Overall Study|Death|0|||
33672616|NCT01486238|63109310|FG001|Overall Study|Death|2|||
33672617|NCT01486238|63109309|FG000|Overall Study|Withdrawal by Subject|2|||
33672618|NCT01486238|63109310|FG001|Overall Study|Withdrawal by Subject|1|||
33672619|NCT01486238|63109309|FG000|Overall Study|Lost to Follow-up|0|||
33672620|NCT01486238|63109310|FG001|Overall Study|Lost to Follow-up|3|||
33672621|NCT01602744|63109318|FG000|Overall Study|Death|17|||
33672622|NCT01602744|63109319|FG001|Overall Study|Death|15|||
33672623|NCT01602744|63109318|FG000|Overall Study|Lost to Follow-up|13|||
33672624|NCT01602744|63109319|FG001|Overall Study|Lost to Follow-up|8|||
33672625|NCT03598777|63109330|FG000|Overall Study|Study Terminated by Sponsor|3|||
33672626|NCT03598777|63109331|FG001|Overall Study|Study Terminated by Sponsor|0|||
33672627|NCT03598777|63109332|FG002|Overall Study|Study Terminated by Sponsor|0|||
33672628|NCT03598777|63109333|FG003|Overall Study|Study Terminated by Sponsor|0|||
33672629|NCT03598777|63109334|FG004|Overall Study|Study Terminated by Sponsor|15|||
33672630|NCT03598777|63109330|FG000|Overall Study|Withdrawal by Subject|1|||
33672631|NCT03598777|63109331|FG001|Overall Study|Withdrawal by Subject|1|||
33672632|NCT03598777|63109332|FG002|Overall Study|Withdrawal by Subject|0|||
33672633|NCT03598777|63109333|FG003|Overall Study|Withdrawal by Subject|0|||
33672634|NCT03598777|63109334|FG004|Overall Study|Withdrawal by Subject|0|||
33672635|NCT03598777|63109330|FG000|Overall Study|Adverse Event|1|||
33672636|NCT03598777|63109331|FG001|Overall Study|Adverse Event|0|||
33672637|NCT03598777|63109332|FG002|Overall Study|Adverse Event|0|||
33672638|NCT03598777|63109333|FG003|Overall Study|Adverse Event|0|||
33672639|NCT03598777|63109334|FG004|Overall Study|Adverse Event|0|||
33672640|NCT03598777|63109330|FG000|Overall Study|Lost to Follow-up|1|||
33672641|NCT03598777|63109331|FG001|Overall Study|Lost to Follow-up|0|||
33672642|NCT03598777|63109332|FG002|Overall Study|Lost to Follow-up|0|||
33672643|NCT03598777|63109333|FG003|Overall Study|Lost to Follow-up|0|||
33672644|NCT03598777|63109334|FG004|Overall Study|Lost to Follow-up|0|||
33672645|NCT04348591|63109389|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
33672646|NCT04348591|63109390|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
33672647|NCT04348591|63109389|FG000|Imaging Session (120 Min)|Physician Decision|0|||
33672648|NCT04348591|63109390|FG001|Imaging Session (120 Min)|Physician Decision|1|||
33672649|NCT04348591|63109389|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
33672650|NCT04348591|63109390|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
33672651|NCT04046250|63109409|FG000|Overall Study|Death|0|||
33672652|NCT04046250|63109410|FG001|Overall Study|Death|1|||
33672653|NCT04046250|63109409|FG000|Overall Study|Withdrawal by Subject|3|||
33672654|NCT04046250|63109410|FG001|Overall Study|Withdrawal by Subject|3|||
33672655|NCT03841526|63109418|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
33672656|NCT03841526|63109419|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
33672657|NCT03841526|63109420|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
33672658|NCT03841526|63109421|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
33672659|NCT03841526|63109422|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
33672660|NCT03841526|63109423|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
33672661|NCT03841526|63109418|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
33672662|NCT03841526|63109419|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
33672663|NCT03841526|63109420|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
33672664|NCT03841526|63109421|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
33672665|NCT03841526|63109422|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
33672666|NCT03841526|63109423|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
33672667|NCT03841526|63109418|FG000|Outpatient Phase Treatment|Physician Decision|0|||
33672668|NCT03841526|63109419|FG001|Outpatient Phase Treatment|Physician Decision|1|||
33672669|NCT03841526|63109420|FG002|Outpatient Phase Treatment|Physician Decision|0|||
33672670|NCT03841526|63109421|FG003|Outpatient Phase Treatment|Physician Decision|0|||
33672671|NCT03841526|63109422|FG004|Outpatient Phase Treatment|Physician Decision|0|||
33672672|NCT03841526|63109423|FG005|Outpatient Phase Treatment|Physician Decision|0|||
33672673|NCT03841526|63109418|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
33672674|NCT03841526|63109419|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
33672675|NCT03841526|63109420|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
33672676|NCT03841526|63109421|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
33672677|NCT03841526|63109422|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
33672678|NCT03841526|63109423|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
33672679|NCT03834506|63109446|FG000|Overall Study|Death|268|||
33672680|NCT03834506|63109447|FG001|Overall Study|Death|285|||
33672681|NCT03834506|63109446|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
33672682|NCT03834506|63109447|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33672683|NCT03834506|63109446|FG000|Overall Study|Withdrawal by Subject|12|||
33672684|NCT03834506|63109447|FG001|Overall Study|Withdrawal by Subject|8|||
33672685|NCT03834506|63109446|FG000|Overall Study|Participants ongoing in the study|234|||
33672686|NCT03834506|63109447|FG001|Overall Study|Participants ongoing in the study|221|||
33672687|NCT03734016|63109455|FG000|Overall Study|Participants Remaining in the Study|260|||
33672688|NCT03734016|63109456|FG001|Overall Study|Participants Remaining in the Study|240|||
33672689|NCT03734016|63109455|FG000|Overall Study|Death|48|||
33672690|NCT03734016|63109456|FG001|Overall Study|Death|60|||
33672691|NCT03734016|63109455|FG000|Overall Study|Withdrawal by Subject|14|||
33672692|NCT03734016|63109456|FG001|Overall Study|Withdrawal by Subject|16|||
33672693|NCT03734016|63109455|FG000|Overall Study|Physician Decision|0|||
33672694|NCT03734016|63109456|FG001|Overall Study|Physician Decision|7|||
33672695|NCT03734016|63109455|FG000|Overall Study|Lost to Follow-up|3|||
33672696|NCT03734016|63109456|FG001|Overall Study|Lost to Follow-up|1|||
33672697|NCT03734016|63109455|FG000|Overall Study|Adverse Event|2|||
33672698|NCT03734016|63109456|FG001|Overall Study|Adverse Event|1|||
33672699|NCT03535740|63109463|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
33672700|NCT03535740|63109463|FG000|Overall Study|Death|34|||
33672701|NCT03535740|63109463|FG000|Overall Study|Lost to Follow-up|1|||
33672702|NCT03535740|63109463|FG000|Overall Study|Withdrawal by Subject|13|||
33672703|NCT03351049|63109474|FG000|Overall Study|Withdrawal|26|||
33672704|NCT03351049|63109475|FG001|Overall Study|Withdrawal|22|||
33672705|NCT03288506|63109496|FG000|Overall Study|Withdrawal by Subject|52|||
33672706|NCT03191786|63109504|FG000|Overall Study|Death|236|||
33672707|NCT03191786|63109505|FG001|Overall Study|Death|127|||
33672708|NCT03191786|63109504|FG000|Overall Study|Lost to Follow-up|9|||
33672709|NCT03191786|63109505|FG001|Overall Study|Lost to Follow-up|3|||
33672710|NCT03191786|63109504|FG000|Overall Study|Physician Decision|1|||
33672711|NCT03191786|63109505|FG001|Overall Study|Physician Decision|0|||
33672712|NCT03191786|63109504|FG000|Overall Study|Study Terminated By Sponsor|15|||
33672713|NCT03191786|63109505|FG001|Overall Study|Study Terminated By Sponsor|5|||
33672714|NCT03191786|63109504|FG000|Overall Study|Withdrawal by Subject|26|||
33672715|NCT03191786|63109505|FG001|Overall Study|Withdrawal by Subject|16|||
33672716|NCT03180684|63109513|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
33672717|NCT03180684|63109514|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
33672718|NCT03180684|63109513|FG000|Overall Study|Physician Decision|1|||
33672719|NCT03180684|63109514|FG001|Overall Study|Physician Decision|0|||
33672720|NCT03180684|63109513|FG000|Overall Study|Lost to Follow-up|1|||
33672721|NCT03180684|63109514|FG001|Overall Study|Lost to Follow-up|0|||
33672722|NCT03180684|63109513|FG000|Overall Study|Progressive Disease|1|||
33672723|NCT03180684|63109514|FG001|Overall Study|Progressive Disease|0|||
33672724|NCT02747927|63109558|FG000|Overall Study|Adverse Event|5|||
33672725|NCT02747927|63109559|FG001|Overall Study|Adverse Event|14|||
33672726|NCT02747927|63109558|FG000|Overall Study|Lost to Follow-up|22|||
33672727|NCT02747927|63109559|FG001|Overall Study|Lost to Follow-up|43|||
33672728|NCT02747927|63109558|FG000|Overall Study|Pregnancy|34|||
33672729|NCT02747927|63109559|FG001|Overall Study|Pregnancy|66|||
33672730|NCT02747927|63109558|FG000|Overall Study|Protocol Violation|2|||
33672731|NCT02747927|63109559|FG001|Overall Study|Protocol Violation|4|||
33672732|NCT02747927|63109558|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
33672733|NCT02747927|63109559|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
33672734|NCT02747927|63109558|FG000|Overall Study|Reason not Specified|11|||
33672735|NCT02747927|63109559|FG001|Overall Study|Reason not Specified|27|||
33672736|NCT02515227|63109571|FG000|Overall Study|Adverse Event|0|||
33672737|NCT02515227|63109572|FG001|Overall Study|Adverse Event|2|||
33672738|NCT02515227|63109571|FG000|Overall Study|Progressive disease|2|||
33672739|NCT02515227|63109572|FG001|Overall Study|Progressive disease|9|||
33672740|NCT02369458|63109582|FG000|Overall Study|Determined to be not eligible|1|||
33672741|NCT02369458|63109583|FG001|Overall Study|Determined to be not eligible|0|||
33672742|NCT01930539|63109591|FG000|Overall Study|Withdrawal by Subject|2|||
33672743|NCT01930539|63109592|FG001|Overall Study|Withdrawal by Subject|2|||
33672744|NCT01266642|63109604|FG000|Overall Study|Protocol Violation|0|||
33672745|NCT01266642|63109605|FG001|Overall Study|Protocol Violation|1|||
33672746|NCT00792948|63109611|FG000|Overall Study|Adverse Event|6|||
33672747|NCT00792948|63109611|FG000|Overall Study|Death|4|||
33672748|NCT00792948|63109611|FG000|Overall Study|Withdrawal by Subject|3|||
33672749|NCT00792948|63109611|FG000|Overall Study|Ineligible|2|||
33672750|NCT00792948|63109611|FG000|Overall Study|Insurance denial - not treated|1|||
33672751|NCT00792948|63109611|FG000|Overall Study|Physician Decision|11|||
33672752|NCT00792948|63109611|FG000|Overall Study|Protocol Violation|1|||
33672753|NCT00602641|63109631|FG000|Overall Study|Never started protocol therapy|6|||
33672754|NCT00602641|63109632|FG001|Overall Study|Never started protocol therapy|2|||
33672755|NCT00602641|63109631|FG000|Overall Study|Still on treatment at time of analysis|8|||
33672756|NCT00602641|63109632|FG001|Overall Study|Still on treatment at time of analysis|15|||
33672757|NCT00602641|63109631|FG000|Overall Study|Adverse Event|62|||
33672758|NCT00602641|63109632|FG001|Overall Study|Adverse Event|53|||
33672759|NCT00602641|63109631|FG000|Overall Study|Disease progression|38|||
33672760|NCT00602641|63109632|FG001|Overall Study|Disease progression|55|||
33672761|NCT00602641|63109631|FG000|Overall Study|Death|6|||
33672762|NCT00602641|63109632|FG001|Overall Study|Death|5|||
33672763|NCT00602641|63109631|FG000|Overall Study|Withdrawal by Subject|15|||
33672764|NCT00602641|63109632|FG001|Overall Study|Withdrawal by Subject|12|||
33672765|NCT00602641|63109631|FG000|Overall Study|Alternative therapy|5|||
33672766|NCT00602641|63109632|FG001|Overall Study|Alternative therapy|2|||
33672767|NCT00602641|63109631|FG000|Overall Study|Other Complicating Disease|5|||
33672768|NCT00602641|63109632|FG001|Overall Study|Other Complicating Disease|2|||
33672769|NCT00602641|63109631|FG000|Overall Study|Physician Decision|5|||
33672770|NCT00602641|63109632|FG001|Overall Study|Physician Decision|4|||
33672771|NCT00602641|63109631|FG000|Overall Study|Administrative Closure|1|||
33672772|NCT00602641|63109632|FG001|Overall Study|Administrative Closure|1|||
33672773|NCT00602641|63109631|FG000|Overall Study|Other|3|||
33672774|NCT00602641|63109632|FG001|Overall Study|Other|1|||
33672775|NCT00070499|63109661|FG000|Overall Study|Adverse Event|6|||
33672776|NCT00070499|63109662|FG001|Overall Study|Adverse Event|6|||
33672777|NCT00070499|63109663|FG002|Overall Study|Adverse Event|19|||
33672778|NCT00070499|63109664|FG003|Overall Study|Adverse Event|15|||
33672779|NCT00070499|63109661|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
33672780|NCT00070499|63109662|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
33672781|NCT00070499|63109663|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
33672782|NCT00070499|63109664|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
33672783|NCT00070499|63109661|FG000|Overall Study|Progression/relapse|4|||
33672784|NCT00070499|63109662|FG001|Overall Study|Progression/relapse|2|||
33672785|NCT00070499|63109663|FG002|Overall Study|Progression/relapse|1|||
33672786|NCT00070499|63109664|FG003|Overall Study|Progression/relapse|4|||
33672787|NCT00070499|63109661|FG000|Overall Study|Death|1|||
33672788|NCT00070499|63109662|FG001|Overall Study|Death|1|||
33672789|NCT00070499|63109663|FG002|Overall Study|Death|1|||
33672790|NCT00070499|63109664|FG003|Overall Study|Death|2|||
33672791|NCT00070499|63109661|FG000|Overall Study|Other - not protocol specified|7|||
33672792|NCT00070499|63109662|FG001|Overall Study|Other - not protocol specified|3|||
33672793|NCT00070499|63109663|FG002|Overall Study|Other - not protocol specified|12|||
33672794|NCT00070499|63109664|FG003|Overall Study|Other - not protocol specified|20|||
33672795|NCT00070499|63109661|FG000|Overall Study|Still on protocol treatment|10|||
33672796|NCT00070499|63109662|FG001|Overall Study|Still on protocol treatment|4|||
33672797|NCT00070499|63109663|FG002|Overall Study|Still on protocol treatment|79|||
33672798|NCT00070499|63109664|FG003|Overall Study|Still on protocol treatment|57|||
33672799|NCT00070499|63109661|FG000|Overall Study|Did not start treatment|1|||
33672800|NCT00070499|63109662|FG001|Overall Study|Did not start treatment|0|||
33672801|NCT00070499|63109663|FG002|Overall Study|Did not start treatment|0|||
33672802|NCT00070499|63109664|FG003|Overall Study|Did not start treatment|2|||
33672803|NCT00070499|63109661|FG000|Overall Study|Not eligible|2|||
33672804|NCT00070499|63109662|FG001|Overall Study|Not eligible|5|||
33672805|NCT00070499|63109663|FG002|Overall Study|Not eligible|3|||
33672806|NCT00070499|63109664|FG003|Overall Study|Not eligible|2|||
33672807|NCT00066573|63109684|FG000|Overall Study|Did not received protocol treatment|28|||
33672808|NCT00066573|63109685|FG001|Overall Study|Did not received protocol treatment|28|||
33672809|NCT03594955|63109691|FG000|Overall Study|Adverse Event|1|||
33672810|NCT03594955|63109691|FG000|Overall Study|Progressive disease|5|||
33672811|NCT03594955|63109691|FG000|Overall Study|Sponsor's decision|1|||
33672812|NCT01677624|63109719|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
33672813|NCT01272219|63109740|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
33672814|NCT01272219|63109741|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
33672815|NCT01272219|63109742|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
33672816|NCT01272219|63109743|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
33672817|NCT01272219|63109744|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
33672818|NCT01272219|63109745|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
33672819|NCT01272219|63109740|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
33672820|NCT01272219|63109741|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
33672821|NCT01272219|63109742|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
33672822|NCT01272219|63109743|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
33672823|NCT01272219|63109744|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
33672824|NCT01272219|63109745|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
33672825|NCT01272219|63109740|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
33672826|NCT01272219|63109741|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
33672827|NCT01272219|63109742|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
33672828|NCT01272219|63109743|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
33672829|NCT01272219|63109744|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
33672830|NCT01272219|63109745|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
33672831|NCT01272219|63109740|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
33672832|NCT01272219|63109741|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
33672833|NCT01272219|63109742|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
33672834|NCT01272219|63109743|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
33672835|NCT01272219|63109744|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
33672836|NCT01272219|63109745|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
33672837|NCT01272219|63109740|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
33672838|NCT01272219|63109741|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
33672839|NCT01272219|63109742|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
33672840|NCT01272219|63109743|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
33672841|NCT01272219|63109744|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
33672842|NCT01272219|63109745|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
33672843|NCT01272219|63109740|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
33672844|NCT01272219|63109741|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
33672845|NCT01272219|63109742|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
33672846|NCT01272219|63109743|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
33672847|NCT01272219|63109744|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
33672848|NCT01272219|63109745|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
33672849|NCT01272219|63109740|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
33672850|NCT01272219|63109741|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
33672851|NCT01272219|63109742|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
33672852|NCT01272219|63109743|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
33672853|NCT01272219|63109744|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
33672854|NCT01272219|63109745|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
33672855|NCT01272219|63109740|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
33672856|NCT01272219|63109741|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
33672857|NCT01272219|63109742|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
33672858|NCT01272219|63109743|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
33672859|NCT01272219|63109744|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
33672860|NCT01272219|63109745|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
33672861|NCT01272219|63109740|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
33672862|NCT01272219|63109741|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
33672863|NCT01272219|63109742|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
33672864|NCT01272219|63109743|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
33672865|NCT01272219|63109744|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
33672866|NCT01272219|63109745|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
33672867|NCT01272219|63109740|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
33672868|NCT01272219|63109741|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
33672869|NCT01272219|63109742|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
33672870|NCT01272219|63109743|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
33672871|NCT01272219|63109744|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
33672872|NCT01272219|63109745|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
33672873|NCT01272219|63109740|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
33672874|NCT01272219|63109741|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
33672875|NCT01272219|63109742|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
33672876|NCT01272219|63109743|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
33672877|NCT01272219|63109744|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
33672878|NCT01272219|63109745|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
33672879|NCT01272219|63109740|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
33672880|NCT01272219|63109741|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
33672881|NCT01272219|63109742|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
33672882|NCT01272219|63109743|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
33672883|NCT01272219|63109744|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
33672884|NCT01272219|63109745|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
33672885|NCT01272219|63109740|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
33672886|NCT01272219|63109741|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
33672887|NCT01272219|63109742|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
33672888|NCT01272219|63109743|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
33672889|NCT01272219|63109744|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
33672890|NCT01272219|63109745|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
33672891|NCT01272219|63109740|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
33672892|NCT01272219|63109741|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
33672893|NCT01272219|63109742|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
33672894|NCT01272219|63109743|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
33672895|NCT01272219|63109744|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
33672896|NCT01272219|63109745|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
33672897|NCT01272219|63109740|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
33672898|NCT01272219|63109741|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
33672899|NCT01272219|63109742|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
33672900|NCT01272219|63109743|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
33672901|NCT01272219|63109744|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
33672902|NCT01272219|63109745|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
33672903|NCT01272219|63109740|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
33672904|NCT01272219|63109741|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
33672905|NCT01272219|63109742|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
33672906|NCT01272219|63109743|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
33672907|NCT01272219|63109744|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
33672908|NCT01272219|63109745|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
33672909|NCT01510028|63109762|FG000|Overall Study|Lack of Efficacy|1|||
33672910|NCT01510028|63109763|FG001|Overall Study|Lack of Efficacy|0|||
33672911|NCT01510028|63109764|FG002|Overall Study|Lack of Efficacy|0|||
33672912|NCT01510028|63109765|FG003|Overall Study|Lack of Efficacy|0|||
33672913|NCT01521494|63109786|FG000|Overall Study|Adverse Event|1|||
33672914|NCT01521494|63109787|FG001|Overall Study|Adverse Event|2|||
33672915|NCT01521494|63109788|FG002|Overall Study|Adverse Event|9|||
33672916|NCT01521494|63109789|FG003|Overall Study|Adverse Event|6|||
33672917|NCT01521494|63109790|FG004|Overall Study|Adverse Event|2|||
33672918|NCT01521494|63109786|FG000|Overall Study|Lack of Efficacy|0|||
33672919|NCT01521494|63109787|FG001|Overall Study|Lack of Efficacy|0|||
33672920|NCT01521494|63109788|FG002|Overall Study|Lack of Efficacy|0|||
33672921|NCT01521494|63109789|FG003|Overall Study|Lack of Efficacy|0|||
33672922|NCT01521494|63109790|FG004|Overall Study|Lack of Efficacy|2|||
33672923|NCT01521494|63109786|FG000|Overall Study|Withdrawal by Subject|1|||
33672924|NCT01521494|63109787|FG001|Overall Study|Withdrawal by Subject|1|||
33672925|NCT01521494|63109788|FG002|Overall Study|Withdrawal by Subject|0|||
33672926|NCT01521494|63109789|FG003|Overall Study|Withdrawal by Subject|2|||
33672927|NCT01521494|63109790|FG004|Overall Study|Withdrawal by Subject|0|||
33672928|NCT01521494|63109786|FG000|Overall Study|Decrease in serum phosphate|0|||
33672929|NCT01521494|63109787|FG001|Overall Study|Decrease in serum phosphate|2|||
33672930|NCT01521494|63109788|FG002|Overall Study|Decrease in serum phosphate|3|||
33672931|NCT01521494|63109789|FG003|Overall Study|Decrease in serum phosphate|12|||
33672932|NCT01521494|63109790|FG004|Overall Study|Decrease in serum phosphate|0|||
33672933|NCT01521494|63109786|FG000|Overall Study|Decrease in serum calcium|0|||
33672934|NCT01521494|63109787|FG001|Overall Study|Decrease in serum calcium|0|||
33672935|NCT01521494|63109788|FG002|Overall Study|Decrease in serum calcium|0|||
33672936|NCT01521494|63109789|FG003|Overall Study|Decrease in serum calcium|1|||
33672937|NCT01521494|63109790|FG004|Overall Study|Decrease in serum calcium|1|||
33672938|NCT01521494|63109786|FG000|Overall Study|Physician Decision|0|||
33672939|NCT01521494|63109787|FG001|Overall Study|Physician Decision|0|||
33672940|NCT01521494|63109788|FG002|Overall Study|Physician Decision|0|||
33672941|NCT01521494|63109789|FG003|Overall Study|Physician Decision|0|||
33672942|NCT01521494|63109790|FG004|Overall Study|Physician Decision|2|||
33672943|NCT01270971|63109804|FG000|Overall Study|Withdrawal by Subject|24|||
33672944|NCT01270971|63109805|FG001|Overall Study|Withdrawal by Subject|11|||
33672945|NCT01270971|63109804|FG000|Overall Study|Lost to Follow-up|18|||
33672946|NCT01270971|63109805|FG001|Overall Study|Lost to Follow-up|5|||
33672947|NCT01270971|63109804|FG000|Overall Study|Adverse Event|1|||
33672948|NCT01270971|63109805|FG001|Overall Study|Adverse Event|2|||
33672949|NCT01270971|63109804|FG000|Overall Study|Non compliance|2|||
33672950|NCT01270971|63109805|FG001|Overall Study|Non compliance|2|||
33672951|NCT01270971|63109804|FG000|Overall Study|Non-specific|7|||
33672952|NCT01270971|63109805|FG001|Overall Study|Non-specific|3|||
33672953|NCT01270503|63109832|FG000|Overall Study|Lost to Follow-up|1|||
33672954|NCT01277211|63109849|FG000|Overall Study|Adverse Event|60|||
33672955|NCT01277211|63109850|FG001|Overall Study|Adverse Event|22|||
33672956|NCT01277211|63109849|FG000|Overall Study|Pregnancy|9|||
33672957|NCT01277211|63109850|FG001|Overall Study|Pregnancy|4|||
33672958|NCT01277211|63109849|FG000|Overall Study|Lost to Follow-up|14|||
33672959|NCT01277211|63109850|FG001|Overall Study|Lost to Follow-up|9|||
33672960|NCT01277211|63109849|FG000|Overall Study|Did not wish to continue|17|||
33672961|NCT01277211|63109850|FG001|Overall Study|Did not wish to continue|0|||
33672962|NCT01277211|63109849|FG000|Overall Study|Withdrew Consent|9|||
33672963|NCT01277211|63109850|FG001|Overall Study|Withdrew Consent|9|||
33672964|NCT01277211|63109849|FG000|Overall Study|Non-compliance with protocol|13|||
33672965|NCT01277211|63109850|FG001|Overall Study|Non-compliance with protocol|4|||
33672966|NCT01277211|63109849|FG000|Overall Study|Did not meet protocol eligibility|1|||
33672967|NCT01277211|63109850|FG001|Overall Study|Did not meet protocol eligibility|0|||
33672968|NCT01277211|63109849|FG000|Overall Study|Administrative|3|||
33672969|NCT01277211|63109850|FG001|Overall Study|Administrative|0|||
33672970|NCT01277211|63109849|FG000|Overall Study|Pregnancy wish|0|||
33672971|NCT01277211|63109850|FG001|Overall Study|Pregnancy wish|2|||
33672972|NCT01277211|63109849|FG000|Overall Study|Discontinued prior to treatment|24|||
33672973|NCT01277211|63109850|FG001|Overall Study|Discontinued prior to treatment|13|||
33672974|NCT01676220|63109858|FG000|Overall Study|Randomized But Not Treated|4|||
33672975|NCT01676220|63109859|FG001|Overall Study|Randomized But Not Treated|1|||
33672976|NCT01676220|63109858|FG000|Overall Study|Adverse Event|10|||
33672977|NCT01676220|63109859|FG001|Overall Study|Adverse Event|8|||
33672978|NCT01676220|63109858|FG000|Overall Study|Lack of Efficacy|2|||
33672979|NCT01676220|63109859|FG001|Overall Study|Lack of Efficacy|5|||
33672980|NCT01676220|63109858|FG000|Overall Study|Protocol Violation|11|||
33672981|NCT01676220|63109859|FG001|Overall Study|Protocol Violation|12|||
33672982|NCT01676220|63109858|FG000|Overall Study|Received Rescue Therapy|14|||
33672983|NCT01676220|63109859|FG001|Overall Study|Received Rescue Therapy|22|||
33672984|NCT01676220|63109858|FG000|Overall Study|Personal Reason|34|||
33672985|NCT01676220|63109859|FG001|Overall Study|Personal Reason|45|||
33672986|NCT01676220|63109858|FG000|Overall Study|Lost to Follow-up|11|||
33672987|NCT01676220|63109859|FG001|Overall Study|Lost to Follow-up|18|||
33672988|NCT01676220|63109858|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
33672989|NCT01676220|63109859|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
33672990|NCT01676220|63109858|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
33672991|NCT01676220|63109859|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
33672992|NCT01676220|63109858|FG000|Overall Study|Perceived Lack of Efficacy|3|||
33672993|NCT01676220|63109859|FG001|Overall Study|Perceived Lack of Efficacy|1|||
33672994|NCT01676220|63109858|FG000|Overall Study|Non Serious Hypoglycemia|2|||
33672995|NCT01676220|63109859|FG001|Overall Study|Non Serious Hypoglycemia|0|||
33672996|NCT01676220|63109858|FG000|Overall Study|No More Need of Insulin|1|||
33672997|NCT01676220|63109859|FG001|Overall Study|No More Need of Insulin|0|||
33672998|NCT01485614|63109889|FG000|Randomization|Not Treated|1|||
33672999|NCT01485614|63109890|FG001|Randomization|Not Treated|0|||
33673000|NCT01485614|63109891|FG002|Randomization|Not Treated|0|||
33673001|NCT01485614|63109892|FG003|Randomization|Not Treated|0|||
33673002|NCT01485614|63109889|FG000|Weeks 0-20|Lost to Follow-up|2|||
33673003|NCT01485614|63109890|FG001|Weeks 0-20|Lost to Follow-up|0|||
33673004|NCT01485614|63109891|FG002|Weeks 0-20|Lost to Follow-up|0|||
33673005|NCT01485614|63109892|FG003|Weeks 0-20|Lost to Follow-up|0|||
33673006|NCT01485614|63109889|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
33673007|NCT01485614|63109890|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
33673008|NCT01485614|63109891|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
33673009|NCT01485614|63109892|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
33673010|NCT01485614|63109889|FG000|Weeks 0-20|Withdrawal by Subject|3|||
33673011|NCT01485614|63109890|FG001|Weeks 0-20|Withdrawal by Subject|2|||
33673012|NCT01485614|63109891|FG002|Weeks 0-20|Withdrawal by Subject|1|||
33673013|NCT01485614|63109892|FG003|Weeks 0-20|Withdrawal by Subject|0|||
33673014|NCT01485614|63109889|FG000|Weeks 20-54|Lost to Follow-up|4|||
33673015|NCT01485614|63109890|FG001|Weeks 20-54|Lost to Follow-up|3|||
33673016|NCT01485614|63109891|FG002|Weeks 20-54|Lost to Follow-up|1|||
33673017|NCT01485614|63109892|FG003|Weeks 20-54|Lost to Follow-up|0|||
33673018|NCT01485614|63109889|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
33673019|NCT01485614|63109890|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
33673020|NCT01485614|63109891|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
33673021|NCT01485614|63109892|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
33673022|NCT01485614|63109889|FG000|Weeks 20-54|Withdrawal by Subject|5|||
33673023|NCT01485614|63109890|FG001|Weeks 20-54|Withdrawal by Subject|3|||
33673024|NCT01485614|63109891|FG002|Weeks 20-54|Withdrawal by Subject|0|||
33673025|NCT01485614|63109892|FG003|Weeks 20-54|Withdrawal by Subject|0|||
33673026|NCT01485536|63109942|FG000|Overall Study|Withdrawal by Subject|3|||
33673027|NCT01485536|63109942|FG000|Overall Study|Adverse Event|1|||
33673028|NCT02658630|63109946|FG000|Overall Study|Withdrawal by Subject|4|||
33673029|NCT01484912|63109952|FG000|Overall Study|Withdrawal by Subject|1|||
33673030|NCT01484912|63109953|FG001|Overall Study|Withdrawal by Subject|0|||
33673031|NCT01484912|63109952|FG000|Overall Study|Physician Decision|0|||
33673032|NCT01484912|63109953|FG001|Overall Study|Physician Decision|1|||
33673033|NCT01520870|63109959|FG000|Overall Study|Withdrawal by Subject|2|||
33673034|NCT01520714|63109965|FG000|Overall Study|Protocol Violation|0|||
33673035|NCT01520714|63109966|FG001|Overall Study|Protocol Violation|3|||
33673036|NCT01520714|63109965|FG000|Overall Study|Adverse Event|0|||
33673037|NCT01520714|63109966|FG001|Overall Study|Adverse Event|2|||
33673038|NCT01520714|63109965|FG000|Overall Study|Lack of Efficacy|0|||
33673039|NCT01520714|63109966|FG001|Overall Study|Lack of Efficacy|1|||
33673040|NCT02659098|63109985|FG000|Overall Study|Withdrawal by Subject|7|||
33673041|NCT01508936|63109996|FG000|Overall Study|Adverse Event|11|||
33673042|NCT01508936|63109997|FG001|Overall Study|Adverse Event|32|||
33673043|NCT01508936|63109996|FG000|Overall Study|Lack of Efficacy|0|||
33673044|NCT01508936|63109997|FG001|Overall Study|Lack of Efficacy|1|||
33673045|NCT01508936|63109996|FG000|Overall Study|Withdrawal by Subject|4|||
33673046|NCT01508936|63109997|FG001|Overall Study|Withdrawal by Subject|18|||
33673047|NCT01508936|63109996|FG000|Overall Study|Protocol Violation|2|||
33673048|NCT01508936|63109997|FG001|Overall Study|Protocol Violation|3|||
33673049|NCT01508936|63109996|FG000|Overall Study|Lost to Follow-up|2|||
33673050|NCT01508936|63109997|FG001|Overall Study|Lost to Follow-up|9|||
33673051|NCT01508936|63109996|FG000|Overall Study|Other|0|||
33673052|NCT01508936|63109997|FG001|Overall Study|Other|5|||
33673053|NCT01508936|63109996|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
33673054|NCT01508936|63109997|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
33673055|NCT01508702|63110018|FG000|Overall Study|Adverse Event|7|||
33673056|NCT01508702|63110019|FG001|Overall Study|Adverse Event|3|||
33673057|NCT01508702|63110018|FG000|Overall Study|Gout flare|2|||
33673058|NCT01508702|63110019|FG001|Overall Study|Gout flare|0|||
33673059|NCT01508702|63110018|FG000|Overall Study|Protocol Violation|2|||
33673060|NCT01508702|63110019|FG001|Overall Study|Protocol Violation|1|||
33673061|NCT01508702|63110018|FG000|Overall Study|Lost to Follow-up|1|||
33673062|NCT01508702|63110019|FG001|Overall Study|Lost to Follow-up|2|||
33673063|NCT01508702|63110018|FG000|Overall Study|Withdrawal by Subject|11|||
33673064|NCT01508702|63110019|FG001|Overall Study|Withdrawal by Subject|7|||
33673065|NCT01484834|63110033|FG000|Overall Study|Lost to Follow-up|5|||
33673066|NCT01484834|63110034|FG001|Overall Study|Lost to Follow-up|8|||
33673067|NCT01484834|63110035|FG002|Overall Study|Lost to Follow-up|1|||
33673068|NCT01484834|63110036|FG003|Overall Study|Lost to Follow-up|4|||
33673069|NCT01484132|63110046|FG000|Overall Study|Lost to Follow-up|8|||
33673070|NCT01484132|63110046|FG000|Overall Study|Difficulty with time commitment|2|||
33673071|NCT01484132|63110046|FG000|Overall Study|Ineligible|1|||
33673072|NCT01484132|63110046|FG000|Overall Study|No pre-treatment urine sample collected|1|||
33673073|NCT01484132|63110046|FG000|Overall Study|No post-treatment urine sample collected|10|||
33673074|NCT01276041|63110050|FG000|Overall Study|Adverse Event|2|||
33673075|NCT01276041|63110050|FG000|Overall Study|Protocol Violation|1|||
33673076|NCT01275339|63110058|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
33673077|NCT01275339|63110059|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
33673078|NCT01275339|63110060|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
33673079|NCT01275339|63110061|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
33673080|NCT01275339|63110058|FG000|Overall Study|Withdrawal by Subject|0|||
33673081|NCT01275339|63110059|FG001|Overall Study|Withdrawal by Subject|0|||
33673082|NCT01275339|63110060|FG002|Overall Study|Withdrawal by Subject|1|||
33673083|NCT01275339|63110061|FG003|Overall Study|Withdrawal by Subject|0|||
33673084|NCT01520402|63110071|FG000|Overall Study|Withdrawal by Subject|2|||
33673085|NCT01520402|63110071|FG000|Overall Study|Physician Decision|3|||
33673086|NCT01520324|63110086|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
33673087|NCT01519934|63110090|FG000|Overall Study|Lost to Follow-up|3|||
33673088|NCT01484054|63110094|FG000|Period 1|Withdrawal by Subject|0|||
33673089|NCT01484054|63110095|FG001|Period 1|Withdrawal by Subject|1|||
33673090|NCT01507298|63110113|FG000|Overall Study|Protocol Violation|0|||
33673091|NCT01507298|63110114|FG001|Overall Study|Protocol Violation|6|||
33673092|NCT01483118|63110123|FG000|Overall Study|Lost to Follow-up|12|||
33673093|NCT01483118|63110124|FG001|Overall Study|Lost to Follow-up|16|||
33673094|NCT01506908|63110134|FG000|Overall Study|Adverse Event|1|||
33673095|NCT01506908|63110135|FG001|Overall Study|Adverse Event|0|||
33673096|NCT01519778|63110143|FG000|Overall Study|Withdrawal by Subject|3|||
33673097|NCT01519778|63110143|FG000|Overall Study|Lost to Follow-up|10|||
33673098|NCT01519778|63110143|FG000|Overall Study|Physician Decision|1|||
33673099|NCT01519700|63110151|FG000|Overall Study|Death|1|||
33673100|NCT01519700|63110152|FG001|Overall Study|Death|0|||
33673101|NCT01519700|63110153|FG002|Overall Study|Death|0|||
33673102|NCT01519700|63110154|FG003|Overall Study|Death|0|||
33673103|NCT01519700|63110151|FG000|Overall Study|Lost to Follow-up|0|||
33673104|NCT01519700|63110152|FG001|Overall Study|Lost to Follow-up|0|||
33673105|NCT01519700|63110153|FG002|Overall Study|Lost to Follow-up|1|||
33673106|NCT01519700|63110154|FG003|Overall Study|Lost to Follow-up|1|||
33673107|NCT01519700|63110151|FG000|Overall Study|Physician Decision|1|||
33673108|NCT01519700|63110152|FG001|Overall Study|Physician Decision|1|||
33673109|NCT01519700|63110153|FG002|Overall Study|Physician Decision|3|||
33673110|NCT01519700|63110154|FG003|Overall Study|Physician Decision|0|||
33673111|NCT01519700|63110151|FG000|Overall Study|Withdrawal by Subject|5|||
33673112|NCT01519700|63110152|FG001|Overall Study|Withdrawal by Subject|3|||
33673113|NCT01519700|63110153|FG002|Overall Study|Withdrawal by Subject|3|||
33673114|NCT01519700|63110154|FG003|Overall Study|Withdrawal by Subject|2|||
33673115|NCT01519700|63110151|FG000|Overall Study|Other Reason|2|||
33673116|NCT01519700|63110152|FG001|Overall Study|Other Reason|2|||
33673117|NCT01519700|63110153|FG002|Overall Study|Other Reason|0|||
33673118|NCT01519700|63110154|FG003|Overall Study|Other Reason|4|||
33673119|NCT02656680|63110172|FG000|Overall Study|Lost to Follow-up|0|||
33673120|NCT02656680|63110173|FG001|Overall Study|Lost to Follow-up|1|||
33673121|NCT02658084|63110209|FG000|Overall Study|Withdrawal by Subject|1|||
33673122|NCT02658084|63110210|FG001|Overall Study|Withdrawal by Subject|0|||
33673123|NCT02658084|63110209|FG000|Overall Study|Study Termination|1|||
33673124|NCT02658084|63110210|FG001|Overall Study|Study Termination|0|||
33673125|NCT01482962|63110226|FG000|Overall Study|Progressive Disease|65|||
33673126|NCT01482962|63110227|FG001|Overall Study|Progressive Disease|53|||
33673127|NCT01482962|63110226|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
33673128|NCT01482962|63110227|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
33673129|NCT01482962|63110226|FG000|Overall Study|Adverse Event|18|||
33673130|NCT01482962|63110227|FG001|Overall Study|Adverse Event|22|||
33673131|NCT01482962|63110226|FG000|Overall Study|Withdrawal by Participant|8|||
33673132|NCT01482962|63110227|FG001|Overall Study|Withdrawal by Participant|13|||
33673133|NCT01482962|63110226|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
33673134|NCT01482962|63110227|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
33673135|NCT01482962|63110226|FG000|Overall Study|Other Reason|1|||
33673136|NCT01482962|63110227|FG001|Overall Study|Other Reason|5|||
33673137|NCT01482962|63110226|FG000|Overall Study|Study Terminated by Sponsor|5|||
33673138|NCT01482962|63110227|FG001|Overall Study|Study Terminated by Sponsor|2|||
33673139|NCT01482962|63110226|FG000|Overall Study|Did not Receive Study Drug|1|||
33673140|NCT01482962|63110227|FG001|Overall Study|Did not Receive Study Drug|6|||
33673141|NCT02655666|63110235|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
33673142|NCT01506596|63110239|FG000|Overall Study|ineligible pathology|1|||
33673143|NCT01482884|63110258|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
33673144|NCT01482884|63110259|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
33673145|NCT01482884|63110258|FG000|Overall Study|Protocol Violation|1|||
33673146|NCT01482884|63110259|FG001|Overall Study|Protocol Violation|0|||
33673147|NCT01482884|63110258|FG000|Overall Study|Lost to Follow-up|2|||
33673148|NCT01482884|63110259|FG001|Overall Study|Lost to Follow-up|2|||
33673149|NCT01482884|63110258|FG000|Overall Study|Lack of Efficacy|0|||
33673150|NCT01482884|63110259|FG001|Overall Study|Lack of Efficacy|1|||
33673151|NCT01482884|63110258|FG000|Overall Study|Adverse Event|2|||
33673152|NCT01482884|63110259|FG001|Overall Study|Adverse Event|1|||
33673153|NCT01482884|63110258|FG000|Overall Study|Withdrawal by Subject|8|||
33673154|NCT01482884|63110259|FG001|Overall Study|Withdrawal by Subject|13|||
33673155|NCT01518374|63110265|FG000|Overall Study|Withdrawal by Subject|2|||
33673156|NCT01518374|63110265|FG000|Overall Study|Protocol Violation|3|||
33673157|NCT01518374|63110265|FG000|Overall Study|Lost to Follow-up|2|||
33673158|NCT01481324|63110272|FG000|Overall Study|Missing Data|0|||
33673159|NCT01481324|63110273|FG001|Overall Study|Missing Data|2|||
33673160|NCT01481324|63110274|FG002|Overall Study|Missing Data|2|||
33673161|NCT04591626|63110284|FG000|Overall Study|Adverse Event|4|||
33673162|NCT04591626|63110285|FG001|Overall Study|Adverse Event|0|||
33673163|NCT04591626|63110284|FG000|Overall Study|Withdrawal by Subject|5|||
33673164|NCT04591626|63110285|FG001|Overall Study|Withdrawal by Subject|3|||
33673165|NCT04591626|63110284|FG000|Overall Study|Physician Decision|0|||
33673166|NCT04591626|63110285|FG001|Overall Study|Physician Decision|1|||
33673167|NCT04591626|63110284|FG000|Overall Study|Death|0|||
33673168|NCT04591626|63110285|FG001|Overall Study|Death|1|||
33673169|NCT04591626|63110284|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33673170|NCT04591626|63110285|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33673171|NCT03583333|63110293|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
33673172|NCT03583333|63110294|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
33673173|NCT03583333|63110293|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
33673174|NCT03583333|63110294|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
33673175|NCT03583333|63110293|FG000|Overall Study|Withdrawal by Subject|9|||
33673176|NCT03583333|63110294|FG001|Overall Study|Withdrawal by Subject|5|||
33673177|NCT03583333|63110293|FG000|Overall Study|Physician Decision|3|||
33673178|NCT03583333|63110294|FG001|Overall Study|Physician Decision|2|||
33673179|NCT03583333|63110293|FG000|Overall Study|Death|12|||
33673180|NCT03583333|63110294|FG001|Overall Study|Death|7|||
33673181|NCT01602510|63110300|FG000|Open Label Phase|Adverse Event|46|||
33673182|NCT01602510|63110301|FG001|Open Label Phase|Adverse Event|0|||
33673183|NCT01602510|63110302|FG002|Open Label Phase|Adverse Event|0|||
33673184|NCT01602510|63110300|FG000|Open Label Phase|Lack of Efficacy|22|||
33673185|NCT01602510|63110301|FG001|Open Label Phase|Lack of Efficacy|0|||
33673186|NCT01602510|63110302|FG002|Open Label Phase|Lack of Efficacy|0|||
33673187|NCT01602510|63110300|FG000|Open Label Phase|Protocol Violation|15|||
33673188|NCT01602510|63110301|FG001|Open Label Phase|Protocol Violation|0|||
33673189|NCT01602510|63110302|FG002|Open Label Phase|Protocol Violation|0|||
33673190|NCT01602510|63110300|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
33673191|NCT01602510|63110301|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
33673192|NCT01602510|63110302|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
33673193|NCT01602510|63110300|FG000|Open Label Phase|Lost to Follow-up|22|||
33673194|NCT01602510|63110301|FG001|Open Label Phase|Lost to Follow-up|0|||
33673195|NCT01602510|63110302|FG002|Open Label Phase|Lost to Follow-up|0|||
33673196|NCT01602510|63110300|FG000|Open Label Phase|Physician Decision|19|||
33673197|NCT01602510|63110301|FG001|Open Label Phase|Physician Decision|0|||
33673198|NCT01602510|63110302|FG002|Open Label Phase|Physician Decision|0|||
33673199|NCT01602510|63110300|FG000|Open Label Phase|Withdrawal by Subject|57|||
33673200|NCT01602510|63110301|FG001|Open Label Phase|Withdrawal by Subject|0|||
33673201|NCT01602510|63110302|FG002|Open Label Phase|Withdrawal by Subject|0|||
33673202|NCT01602510|63110300|FG000|Randomized Phase|Adverse Event|0|||
33673203|NCT01602510|63110301|FG001|Randomized Phase|Adverse Event|2|||
33673204|NCT01602510|63110302|FG002|Randomized Phase|Adverse Event|6|||
33673205|NCT01602510|63110300|FG000|Randomized Phase|Lack of Efficacy|0|||
33673206|NCT01602510|63110301|FG001|Randomized Phase|Lack of Efficacy|4|||
33673207|NCT01602510|63110302|FG002|Randomized Phase|Lack of Efficacy|4|||
33673208|NCT01602510|63110300|FG000|Randomized Phase|Protocol Violation|0|||
33673209|NCT01602510|63110301|FG001|Randomized Phase|Protocol Violation|3|||
33673210|NCT01602510|63110302|FG002|Randomized Phase|Protocol Violation|3|||
33673211|NCT01602510|63110300|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
33673212|NCT01602510|63110301|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
33673213|NCT01602510|63110302|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
33673214|NCT01602510|63110300|FG000|Randomized Phase|Lost to Follow-up|0|||
33673215|NCT01602510|63110301|FG001|Randomized Phase|Lost to Follow-up|1|||
33673216|NCT01602510|63110302|FG002|Randomized Phase|Lost to Follow-up|3|||
33673217|NCT01602510|63110300|FG000|Randomized Phase|Physician Decision|0|||
33673218|NCT01602510|63110301|FG001|Randomized Phase|Physician Decision|0|||
33673219|NCT01602510|63110302|FG002|Randomized Phase|Physician Decision|2|||
33673220|NCT01602510|63110300|FG000|Randomized Phase|Withdrawal by Subject|0|||
33673221|NCT01602510|63110301|FG001|Randomized Phase|Withdrawal by Subject|6|||
33673222|NCT01602510|63110302|FG002|Randomized Phase|Withdrawal by Subject|7|||
33673223|NCT01675596|63110317|FG000|Overall Study|Death|6|||
33673224|NCT01675596|63110317|FG000|Overall Study|Exit with other reason|1|||
33673225|NCT01675596|63110317|FG000|Overall Study|Missed Visit|1|||
33673226|NCT02653326|63110327|FG000|Overall Study|Lost to Follow-up|10|||
33673227|NCT02653326|63110328|FG001|Overall Study|Lost to Follow-up|7|||
33673228|NCT02653170|63110337|FG000|Overall Study|Withdrawal by Subject|3|||
33673229|NCT02653170|63110338|FG001|Overall Study|Withdrawal by Subject|8|||
33673230|NCT02653170|63110339|FG002|Overall Study|Withdrawal by Subject|3|||
33673231|NCT02653170|63110337|FG000|Overall Study|withdrawn by study team|2|||
33673232|NCT02653170|63110338|FG001|Overall Study|withdrawn by study team|4|||
33673233|NCT02653170|63110339|FG002|Overall Study|withdrawn by study team|5|||
33673234|NCT02653170|63110337|FG000|Overall Study|Lost to Follow-up|12|||
33673235|NCT02653170|63110338|FG001|Overall Study|Lost to Follow-up|4|||
33673236|NCT02653170|63110339|FG002|Overall Study|Lost to Follow-up|10|||
33673237|NCT01463696|63110359|FG000|Overall Study|Adverse Event|0|||
33673238|NCT01463696|63110360|FG001|Overall Study|Adverse Event|1|||
33673239|NCT01463696|63110361|FG002|Overall Study|Adverse Event|0|||
33673240|NCT01463696|63110362|FG003|Overall Study|Adverse Event|2|||
33673241|NCT01463696|63110363|FG004|Overall Study|Adverse Event|0|||
33673242|NCT01463696|63110364|FG005|Overall Study|Adverse Event|1|||
33673243|NCT01463696|63110365|FG006|Overall Study|Adverse Event|3|||
33673244|NCT01463696|63110366|FG007|Overall Study|Adverse Event|2|||
33673245|NCT01463696|63110359|FG000|Overall Study|Lost to Follow-up|0|||
33673246|NCT01463696|63110360|FG001|Overall Study|Lost to Follow-up|0|||
33673247|NCT01463696|63110361|FG002|Overall Study|Lost to Follow-up|1|||
33673248|NCT01463696|63110362|FG003|Overall Study|Lost to Follow-up|0|||
33673249|NCT01463696|63110363|FG004|Overall Study|Lost to Follow-up|0|||
33673250|NCT01463696|63110364|FG005|Overall Study|Lost to Follow-up|0|||
33673251|NCT01463696|63110365|FG006|Overall Study|Lost to Follow-up|0|||
33673252|NCT01463696|63110366|FG007|Overall Study|Lost to Follow-up|0|||
33673253|NCT01463696|63110359|FG000|Overall Study|Progressive Disease|0|||
33673254|NCT01463696|63110360|FG001|Overall Study|Progressive Disease|1|||
33673255|NCT01463696|63110361|FG002|Overall Study|Progressive Disease|0|||
33673256|NCT01463696|63110362|FG003|Overall Study|Progressive Disease|1|||
33673257|NCT01463696|63110363|FG004|Overall Study|Progressive Disease|0|||
33673258|NCT01463696|63110364|FG005|Overall Study|Progressive Disease|1|||
33673259|NCT01463696|63110365|FG006|Overall Study|Progressive Disease|4|||
33673260|NCT01463696|63110366|FG007|Overall Study|Progressive Disease|2|||
33673261|NCT01463696|63110359|FG000|Overall Study|Withdrawal by Subject|0|||
33673262|NCT01463696|63110360|FG001|Overall Study|Withdrawal by Subject|0|||
33673263|NCT01463696|63110361|FG002|Overall Study|Withdrawal by Subject|0|||
33673264|NCT01463696|63110362|FG003|Overall Study|Withdrawal by Subject|1|||
33673265|NCT01463696|63110363|FG004|Overall Study|Withdrawal by Subject|1|||
33673266|NCT01463696|63110364|FG005|Overall Study|Withdrawal by Subject|1|||
33673267|NCT01463696|63110365|FG006|Overall Study|Withdrawal by Subject|2|||
33673268|NCT01463696|63110366|FG007|Overall Study|Withdrawal by Subject|0|||
33673269|NCT01463696|63110359|FG000|Overall Study|Not Treated|0|||
33673270|NCT01463696|63110360|FG001|Overall Study|Not Treated|0|||
33673271|NCT01463696|63110361|FG002|Overall Study|Not Treated|0|||
33673272|NCT01463696|63110362|FG003|Overall Study|Not Treated|0|||
33673273|NCT01463696|63110363|FG004|Overall Study|Not Treated|0|||
33673274|NCT01463696|63110364|FG005|Overall Study|Not Treated|0|||
33673275|NCT01463696|63110365|FG006|Overall Study|Not Treated|1|||
33673276|NCT01463696|63110366|FG007|Overall Study|Not Treated|0|||
33673277|NCT02653482|63110390|FG000|Overall Study|Death|1|||
33673278|NCT02653482|63110391|FG001|Overall Study|Death|1|||
33673279|NCT01362348|63110397|FG000|Overall Study|Protocol-defined stopping criteria|9|||
33673280|NCT01362348|63110397|FG000|Overall Study|Study closed/terminated|5|||
33673281|NCT01675128|63110467|FG000|Overall Study|Disease progression on study|1|||
33673282|NCT01675128|63110468|FG001|Overall Study|Disease progression on study|1|||
33673283|NCT01675128|63110469|FG002|Overall Study|Disease progression on study|1|||
33673284|NCT01675128|63110467|FG000|Overall Study|Refused further treatment|1|||
33673285|NCT01675128|63110468|FG001|Overall Study|Refused further treatment|0|||
33582466|NCT01659255|62980067|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33673286|NCT01675128|63110469|FG002|Overall Study|Refused further treatment|0|||
33673287|NCT01675128|63110467|FG000|Overall Study|Pulmonary complication; off study|0|||
33673288|NCT01675128|63110468|FG001|Overall Study|Pulmonary complication; off study|1|||
33673289|NCT01675128|63110469|FG002|Overall Study|Pulmonary complication; off study|0|||
33673290|NCT01427309|63110515|FG000|Overall Study|Lost to Follow-up|130|||
33673291|NCT01427309|63110516|FG001|Overall Study|Lost to Follow-up|145|||
33673292|NCT01427309|63110517|FG002|Overall Study|Lost to Follow-up|122|||
33673293|NCT01427309|63110518|FG003|Overall Study|Lost to Follow-up|135|||
33673294|NCT01427309|63110515|FG000|Overall Study|Protocol Violation|42|||
33673295|NCT01427309|63110516|FG001|Overall Study|Protocol Violation|69|||
33673296|NCT01427309|63110517|FG002|Overall Study|Protocol Violation|125|||
33673297|NCT01427309|63110518|FG003|Overall Study|Protocol Violation|124|||
33673298|NCT01427309|63110515|FG000|Overall Study|Adverse Event|0|||
33673299|NCT01427309|63110516|FG001|Overall Study|Adverse Event|0|||
33673300|NCT01427309|63110517|FG002|Overall Study|Adverse Event|3|||
33673301|NCT01427309|63110518|FG003|Overall Study|Adverse Event|1|||
33673302|NCT01427309|63110515|FG000|Overall Study|Serious adverse event|52|||
33673303|NCT01427309|63110516|FG001|Overall Study|Serious adverse event|45|||
33673304|NCT01427309|63110517|FG002|Overall Study|Serious adverse event|50|||
33673305|NCT01427309|63110518|FG003|Overall Study|Serious adverse event|61|||
33673306|NCT01427309|63110515|FG000|Overall Study|Withdrawal by Subject|148|||
33673307|NCT01427309|63110516|FG001|Overall Study|Withdrawal by Subject|148|||
33673308|NCT01427309|63110517|FG002|Overall Study|Withdrawal by Subject|61|||
33673309|NCT01427309|63110518|FG003|Overall Study|Withdrawal by Subject|55|||
33673310|NCT01426373|63110528|FG000|Overall Study|Adverse Event|6|||
33673311|NCT01426373|63110528|FG000|Overall Study|Lost to Follow-up|14|||
33673312|NCT01426373|63110528|FG000|Overall Study|Participant Convenience|10|||
33673313|NCT01426373|63110528|FG000|Overall Study|Miscellaneous Reasons|4|||
33673314|NCT01426217|63110536|FG000|Overall Study|lost sample|8|||
33673315|NCT01426217|63110537|FG001|Overall Study|lost sample|14|||
33673316|NCT01425749|63110545|FG000|Overall Study|progression of melanoma|0|||
33673317|NCT01425749|63110546|FG001|Overall Study|progression of melanoma|1|||
33673318|NCT01403987|63110562|FG000|Overall Study|Residents forgot their secret PIN|18|||
33673319|NCT01403987|63110563|FG001|Overall Study|Residents forgot their secret PIN|17|||
33673320|NCT01403987|63110564|FG002|Overall Study|Residents forgot their secret PIN|18|||
33673321|NCT01425359|63110574|FG000|Overall Study|Randomized but Not Treated|2|||
33673322|NCT01425359|63110575|FG001|Overall Study|Randomized but Not Treated|3|||
33673323|NCT01425359|63110574|FG000|Overall Study|Adverse Event|9|||
33673324|NCT01425359|63110575|FG001|Overall Study|Adverse Event|8|||
33673325|NCT01425359|63110574|FG000|Overall Study|Revascularization|0|||
33673326|NCT01425359|63110575|FG001|Overall Study|Revascularization|1|||
33673327|NCT01425359|63110574|FG000|Overall Study|Death|0|||
33673328|NCT01425359|63110575|FG001|Overall Study|Death|1|||
33673329|NCT01425359|63110574|FG000|Overall Study|Unsatisfactory Response|1|||
33673330|NCT01425359|63110575|FG001|Overall Study|Unsatisfactory Response|0|||
33673331|NCT01425359|63110574|FG000|Overall Study|Protocol Violation|1|||
33673332|NCT01425359|63110575|FG001|Overall Study|Protocol Violation|2|||
33673333|NCT01425359|63110574|FG000|Overall Study|Subject Withdrew Consent|1|||
33673334|NCT01425359|63110575|FG001|Overall Study|Subject Withdrew Consent|2|||
33673335|NCT01425359|63110574|FG000|Overall Study|Investigator's Discretion|2|||
33673336|NCT01425359|63110575|FG001|Overall Study|Investigator's Discretion|0|||
33673337|NCT01425359|63110574|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
33673338|NCT01425359|63110575|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
33673339|NCT01403051|63110595|FG000|Overall Study|Protocol Violation|2|||
33673340|NCT01403051|63110596|FG001|Overall Study|Protocol Violation|0|||
33673341|NCT01403051|63110595|FG000|Overall Study|Death|1|||
33673342|NCT01403051|63110596|FG001|Overall Study|Death|0|||
33673343|NCT01403051|63110595|FG000|Overall Study|Withdrawal by Subject|2|||
33673344|NCT01403051|63110596|FG001|Overall Study|Withdrawal by Subject|1|||
33673345|NCT01403051|63110595|FG000|Overall Study|Lost to Follow-up|5|||
33673346|NCT01403051|63110596|FG001|Overall Study|Lost to Follow-up|5|||
33673347|NCT04115748|63110611|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
33673348|NCT04115748|63110612|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
33673349|NCT04115748|63110613|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
33673350|NCT04115748|63110614|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
33673351|NCT04115748|63110615|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
33673352|NCT04115748|63110616|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
33673353|NCT04115748|63110617|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
33673354|NCT04115748|63110618|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
33673355|NCT04115748|63110619|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
33673356|NCT04115748|63110620|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
33673357|NCT04115748|63110611|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33673358|NCT04115748|63110612|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33673359|NCT04115748|63110613|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33673360|NCT04115748|63110614|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
33673361|NCT04115748|63110615|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33673362|NCT04115748|63110616|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33673363|NCT04115748|63110617|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33673364|NCT04115748|63110618|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33673365|NCT04115748|63110619|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33673366|NCT04115748|63110620|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33673367|NCT04115748|63110611|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
33673368|NCT04115748|63110612|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
33673369|NCT04115748|63110613|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
33673370|NCT04115748|63110614|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
33673371|NCT04115748|63110615|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
33673372|NCT04115748|63110616|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
33673373|NCT04115748|63110617|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
33673374|NCT04115748|63110618|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
33673375|NCT04115748|63110619|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
33673376|NCT04115748|63110620|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
33673377|NCT04115748|63110611|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33673378|NCT04115748|63110612|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33673379|NCT04115748|63110613|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33673380|NCT04115748|63110614|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33673381|NCT04115748|63110615|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33673382|NCT04115748|63110616|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33673383|NCT04115748|63110617|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33673384|NCT04115748|63110618|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33673385|NCT04115748|63110619|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
33673386|NCT04115748|63110620|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33673387|NCT02652624|63110677|FG000|Randomized Phase|Pregnancy|3|||
33673388|NCT02652624|63110678|FG001|Randomized Phase|Pregnancy|1|||
33673389|NCT02652624|63110677|FG000|Randomized Phase|Investigator's Discretion|0|||
33673390|NCT02652624|63110678|FG001|Randomized Phase|Investigator's Discretion|2|||
33673391|NCT02652624|63110677|FG000|Randomized Phase|Death|0|||
33673392|NCT02652624|63110678|FG001|Randomized Phase|Death|1|||
33673393|NCT02652624|63110677|FG000|Randomized Phase|Lost to Follow-up|0|||
33673394|NCT02652624|63110678|FG001|Randomized Phase|Lost to Follow-up|1|||
33673395|NCT02652624|63110677|FG000|Extension Phase|Lost to Follow-up|3|||
33673396|NCT02652624|63110678|FG001|Extension Phase|Lost to Follow-up|1|||
33673397|NCT02652624|63110677|FG000|Extension Phase|Pregnancy|1|||
33673398|NCT02652624|63110678|FG001|Extension Phase|Pregnancy|1|||
33673399|NCT02652624|63110677|FG000|Extension Phase|Adverse Event|0|||
33673400|NCT02652624|63110678|FG001|Extension Phase|Adverse Event|1|||
33673401|NCT02652624|63110677|FG000|Extension Phase|Withdrew Consent|0|||
33673402|NCT02652624|63110678|FG001|Extension Phase|Withdrew Consent|1|||
33673403|NCT00249795|63110688|FG000|Overall Study|Not treated|16|||
33673404|NCT00249795|63110689|FG001|Overall Study|Not treated|14|||
33673405|NCT00249795|63110688|FG000|Overall Study|Symptomatic hypotension|127|||
33673406|NCT00249795|63110689|FG001|Overall Study|Symptomatic hypotension|64|||
33673407|NCT00249795|63110688|FG000|Overall Study|Other Serious Adverse Event|84|||
33673408|NCT00249795|63110689|FG001|Overall Study|Other Serious Adverse Event|93|||
33673409|NCT00249795|63110688|FG000|Overall Study|Qualifying condition not present|26|||
33673410|NCT00249795|63110689|FG001|Overall Study|Qualifying condition not present|29|||
33673411|NCT00249795|63110688|FG000|Overall Study|Withdrawal by Subject|678|||
33673412|NCT00249795|63110689|FG001|Overall Study|Withdrawal by Subject|742|||
33673413|NCT00249795|63110688|FG000|Overall Study|Thromboembolic / outcome event|39|||
33673414|NCT00249795|63110689|FG001|Overall Study|Thromboembolic / outcome event|45|||
33673415|NCT00249795|63110688|FG000|Overall Study|Oral anticoagulant required|2|||
33673416|NCT00249795|63110689|FG001|Overall Study|Oral anticoagulant required|0|||
33673417|NCT00249795|63110688|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
33310237|NCT01165203|62685626|FG000|Active Phase|Serious Adverse Event|1|||
33310238|NCT01165203|62685627|FG001|Active Phase|Serious Adverse Event|0|||
33310239|NCT01165203|62685626|FG000|Active Phase|Withdrawal by Subject|2|||
33310240|NCT01165203|62685627|FG001|Active Phase|Withdrawal by Subject|1|||
33310241|NCT01165203|62685626|FG000|Active Phase|Migrated/moved from study area|0|||
33310242|NCT01165203|62685627|FG001|Active Phase|Migrated/moved from study area|1|||
33310243|NCT01165203|62685626|FG000|Active Phase|Lost to Follow-up|2|||
33310244|NCT01165203|62685627|FG001|Active Phase|Lost to Follow-up|0|||
33310245|NCT01165203|62685626|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
33310246|NCT01165203|62685627|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
33673418|NCT00249795|63110689|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
33673419|NCT00249795|63110688|FG000|Overall Study|Non-compliance|71|||
33673420|NCT00249795|63110689|FG001|Overall Study|Non-compliance|69|||
33673421|NCT00249795|63110688|FG000|Overall Study|Study drug intolerance|3|||
33673422|NCT00249795|63110689|FG001|Overall Study|Study drug intolerance|3|||
33673423|NCT00249795|63110688|FG000|Overall Study|Other adverse events (non-serious)|188|||
33673424|NCT00249795|63110689|FG001|Overall Study|Other adverse events (non-serious)|159|||
33673425|NCT00249795|63110688|FG000|Overall Study|Physician withdrew consent|71|||
33673426|NCT00249795|63110689|FG001|Overall Study|Physician withdrew consent|63|||
33673427|NCT00249795|63110688|FG000|Overall Study|Surgery / procedure|4|||
33401422|NCT00737477|62780462|FG000|Overall Study|Death|9|||
33673428|NCT00249795|63110689|FG001|Overall Study|Surgery / procedure|5|||
33673429|NCT00249795|63110688|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
33673430|NCT00249795|63110689|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
33673431|NCT00249795|63110688|FG000|Overall Study|Lightheadedness / dizziness|15|||
33673432|NCT00249795|63110689|FG001|Overall Study|Lightheadedness / dizziness|11|||
33673433|NCT00249795|63110688|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
33673434|NCT00249795|63110689|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
33673435|NCT00249795|63110688|FG000|Overall Study|Other contraindicated medication|1|||
33673436|NCT00249795|63110689|FG001|Overall Study|Other contraindicated medication|1|||
33673437|NCT00249795|63110688|FG000|Overall Study|Event related to cardiac condition|17|||
33673438|NCT00249795|63110689|FG001|Overall Study|Event related to cardiac condition|16|||
33673439|NCT00249795|63110688|FG000|Overall Study|Patient not wish to continue after May08|4|||
33673440|NCT00249795|63110689|FG001|Overall Study|Patient not wish to continue after May08|6|||
33673441|NCT00249795|63110688|FG000|Overall Study|Site not agree to continue after May08|1|||
33673442|NCT00249795|63110689|FG001|Overall Study|Site not agree to continue after May08|1|||
33673443|NCT00249795|63110688|FG000|Overall Study|Lost to Follow-up|0|||
33673444|NCT00249795|63110689|FG001|Overall Study|Lost to Follow-up|2|||
33673445|NCT00249795|63110688|FG000|Overall Study|Missing|0|||
33673446|NCT00249795|63110689|FG001|Overall Study|Missing|1|||
33673447|NCT02651220|63110698|FG000|Overall Study|Adverse Event|1|||
33673448|NCT02651220|63110699|FG001|Overall Study|Adverse Event|5|||
33673449|NCT02651220|63110700|FG002|Overall Study|Adverse Event|1|||
33673450|NCT02651220|63110698|FG000|Overall Study|Lost to Follow-up|8|||
33673451|NCT02651220|63110699|FG001|Overall Study|Lost to Follow-up|14|||
33673452|NCT02651220|63110700|FG002|Overall Study|Lost to Follow-up|14|||
33673453|NCT02651220|63110698|FG000|Overall Study|Non-Compliance with Study Drug|4|||
33673454|NCT02651220|63110699|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33673455|NCT02651220|63110700|FG002|Overall Study|Non-Compliance with Study Drug|1|||
33673456|NCT02651220|63110698|FG000|Overall Study|Pregnancy|1|||
33673457|NCT02651220|63110699|FG001|Overall Study|Pregnancy|0|||
33673458|NCT02651220|63110700|FG002|Overall Study|Pregnancy|1|||
33673459|NCT02651220|63110698|FG000|Overall Study|Protocol Violation|0|||
33673460|NCT02651220|63110699|FG001|Overall Study|Protocol Violation|0|||
33673461|NCT02651220|63110700|FG002|Overall Study|Protocol Violation|1|||
33673462|NCT02651220|63110698|FG000|Overall Study|Withdrawal by Subject|5|||
33673463|NCT02651220|63110699|FG001|Overall Study|Withdrawal by Subject|6|||
33673464|NCT02651220|63110700|FG002|Overall Study|Withdrawal by Subject|8|||
33673465|NCT02651220|63110698|FG000|Overall Study|Miscellaneous|4|||
33673466|NCT02651220|63110699|FG001|Overall Study|Miscellaneous|1|||
33673467|NCT02651220|63110700|FG002|Overall Study|Miscellaneous|2|||
33673468|NCT02651220|63110698|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33673469|NCT02651220|63110699|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33673470|NCT02651220|63110700|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
33673471|NCT00247611|63110748|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
33673472|NCT00247611|63110749|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
33673473|NCT00247611|63110748|FG000|Baselined|Completed baseline only|9|||
33673474|NCT00247611|63110749|FG001|Baselined|Completed baseline only|8|||
33673475|NCT00246753|63110772|FG000|Overall Study|Withdrawal by Subject|2|||
33673476|NCT00246753|63110772|FG000|Overall Study|Physician Decision|2|||
33673477|NCT00246753|63110772|FG000|Overall Study|Adverse Event|2|||
33673478|NCT00246753|63110772|FG000|Overall Study|Unacceptable toxicity|2|||
33673479|NCT00246129|63110789|FG000|Overall Study|Lost to Follow-up|1|||
33673480|NCT00246129|63110790|FG001|Overall Study|Lost to Follow-up|0|||
33673481|NCT00246129|63110789|FG000|Overall Study|Death|2|||
33673482|NCT00246129|63110790|FG001|Overall Study|Death|1|||
33673483|NCT00246129|63110789|FG000|Overall Study|suffered primary non-function|1|||
33673484|NCT00246129|63110790|FG001|Overall Study|suffered primary non-function|0|||
33673485|NCT00246129|63110789|FG000|Overall Study|grafts failed|3|||
33673486|NCT00246129|63110790|FG001|Overall Study|grafts failed|1|||
33673487|NCT03182868|63110813|FG000|Overall Study|Protocol Violation|3|||
33673488|NCT03182868|63110814|FG001|Overall Study|Protocol Violation|0|||
33673489|NCT03182868|63110815|FG002|Overall Study|Protocol Violation|4|||
33673490|NCT03182868|63110816|FG003|Overall Study|Protocol Violation|1|||
33673491|NCT03182868|63110817|FG004|Overall Study|Protocol Violation|8|||
33673492|NCT00245583|63110841|FG000|Overall Study|Lost to Follow-up|1|||
33673493|NCT00245583|63110842|FG001|Overall Study|Lost to Follow-up|5|||
33673494|NCT00245583|63110841|FG000|Overall Study|Adverse Event|2|||
33673495|NCT00245583|63110842|FG001|Overall Study|Adverse Event|1|||
33673496|NCT00245583|63110841|FG000|Overall Study|Lack of Efficacy|1|||
33673497|NCT00245583|63110842|FG001|Overall Study|Lack of Efficacy|0|||
33673498|NCT00245583|63110841|FG000|Overall Study|Withdrawal by Subject|2|||
33673499|NCT00245583|63110842|FG001|Overall Study|Withdrawal by Subject|3|||
33673500|NCT02652156|63110851|FG000|Overall Study|Physician Decision|1|||
33673501|NCT02652156|63110852|FG001|Overall Study|Physician Decision|0|||
33673502|NCT02652156|63110853|FG002|Overall Study|Physician Decision|0|||
33673503|NCT01675050|63110900|FG000|Period One Treatment|Withdrawal by Subject|1|||
33673504|NCT01675050|63110901|FG001|Period One Treatment|Withdrawal by Subject|0|||
33673505|NCT00244881|63110920|FG000|Overall Study|Withdrawal by Subject|3|||
33673506|NCT00244725|63110951|FG000|Overall Study|Lost to Follow-up|3|||
33673507|NCT00244725|63110952|FG001|Overall Study|Lost to Follow-up|4|||
33673508|NCT00244725|63110953|FG002|Overall Study|Lost to Follow-up|9|||
33673509|NCT00244725|63110954|FG003|Overall Study|Lost to Follow-up|2|||
33673510|NCT00244725|63110951|FG000|Overall Study|Withdrawal by Subject|9|||
33673511|NCT00244725|63110952|FG001|Overall Study|Withdrawal by Subject|7|||
33673512|NCT00244725|63110953|FG002|Overall Study|Withdrawal by Subject|7|||
33673513|NCT00244725|63110954|FG003|Overall Study|Withdrawal by Subject|8|||
33673514|NCT00244725|63110951|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
33673515|NCT00244725|63110952|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
33673516|NCT00244725|63110953|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
33673517|NCT00244725|63110954|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
33673518|NCT00244725|63110951|FG000|Overall Study|Physician Decision|3|||
33673519|NCT00244725|63110952|FG001|Overall Study|Physician Decision|0|||
33673520|NCT00244725|63110953|FG002|Overall Study|Physician Decision|1|||
33673521|NCT00244725|63110954|FG003|Overall Study|Physician Decision|2|||
33673522|NCT00244725|63110951|FG000|Overall Study|Adverse Events|3|||
33673523|NCT00244725|63110952|FG001|Overall Study|Adverse Events|1|||
33673524|NCT00244725|63110953|FG002|Overall Study|Adverse Events|4|||
33673525|NCT00244725|63110954|FG003|Overall Study|Adverse Events|4|||
33673526|NCT00244725|63110951|FG000|Overall Study|Withdrwal by participant|1|||
33673527|NCT00244725|63110952|FG001|Overall Study|Withdrwal by participant|0|||
33673528|NCT00244725|63110953|FG002|Overall Study|Withdrwal by participant|0|||
33673529|NCT00244725|63110954|FG003|Overall Study|Withdrwal by participant|1|||
33673530|NCT00244725|63110951|FG000|Overall Study|Liver function test abnormality|2|||
33673531|NCT00244725|63110952|FG001|Overall Study|Liver function test abnormality|0|||
33673532|NCT00244725|63110953|FG002|Overall Study|Liver function test abnormality|0|||
33673533|NCT00244725|63110954|FG003|Overall Study|Liver function test abnormality|1|||
33673534|NCT00244725|63110951|FG000|Overall Study|Sponsor withdrew the participant|1|||
33673535|NCT00244725|63110952|FG001|Overall Study|Sponsor withdrew the participant|0|||
33673536|NCT00244725|63110953|FG002|Overall Study|Sponsor withdrew the participant|0|||
33673537|NCT00244725|63110954|FG003|Overall Study|Sponsor withdrew the participant|1|||
33673538|NCT00244725|63110951|FG000|Overall Study|Mediciation Error|0|||
33673539|NCT00244725|63110952|FG001|Overall Study|Mediciation Error|1|||
33401423|NCT00737477|62780462|FG000|Overall Study|Treatment Refusal|1|||
33673540|NCT00244725|63110953|FG002|Overall Study|Mediciation Error|0|||
33673541|NCT00244725|63110954|FG003|Overall Study|Mediciation Error|0|||
33673542|NCT00244725|63110951|FG000|Overall Study|Rehab Refused to allow participantion|0|||
33673543|NCT00244725|63110952|FG001|Overall Study|Rehab Refused to allow participantion|1|||
33673544|NCT00244725|63110953|FG002|Overall Study|Rehab Refused to allow participantion|0|||
33310247|NCT01165203|62685626|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
33310248|NCT01165203|62685627|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
33310249|NCT01165203|62685626|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
33310250|NCT01165203|62685627|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
33310251|NCT01165203|62685626|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
33310252|NCT01165203|62685627|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
33310253|NCT01165203|62685626|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
33310254|NCT01165203|62685627|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
33310255|NCT00960661|62685642|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
33310256|NCT00960661|62685643|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
33310257|NCT00960661|62685644|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
33310258|NCT00960661|62685642|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
33310259|NCT00960661|62685643|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
33310260|NCT00960661|62685644|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
33310261|NCT00960661|62685642|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
33310262|NCT00960661|62685643|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
33310263|NCT00960661|62685644|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
33310264|NCT00960661|62685642|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
33310265|NCT00960661|62685643|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
33310266|NCT00960661|62685644|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
33310267|NCT00960661|62685642|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
33310268|NCT00960661|62685643|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
33310269|NCT00960661|62685644|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
33310270|NCT00960661|62685642|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
33310271|NCT00960661|62685643|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
33310272|NCT00960661|62685644|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
33310273|NCT00960661|62685642|FG000|Interventional Phase|Adverse Event|0|||
33310274|NCT00960661|62685643|FG001|Interventional Phase|Adverse Event|17|||
33310275|NCT00960661|62685644|FG002|Interventional Phase|Adverse Event|8|||
33310276|NCT00960661|62685642|FG000|Interventional Phase|Death|0|||
33310277|NCT00960661|62685643|FG001|Interventional Phase|Death|1|||
33310278|NCT00960661|62685644|FG002|Interventional Phase|Death|0|||
33310279|NCT00960661|62685642|FG000|Interventional Phase|Lost to Follow-up|0|||
33310280|NCT00960661|62685643|FG001|Interventional Phase|Lost to Follow-up|0|||
33310281|NCT00960661|62685644|FG002|Interventional Phase|Lost to Follow-up|2|||
33310282|NCT00960661|62685642|FG000|Interventional Phase|entry criteria not met|0|||
33310283|NCT00960661|62685643|FG001|Interventional Phase|entry criteria not met|3|||
33310284|NCT00960661|62685644|FG002|Interventional Phase|entry criteria not met|0|||
33310285|NCT00960661|62685642|FG000|Interventional Phase|Protocol Violation|0|||
33310286|NCT00960661|62685643|FG001|Interventional Phase|Protocol Violation|7|||
33310287|NCT00960661|62685644|FG002|Interventional Phase|Protocol Violation|2|||
33310288|NCT00960661|62685642|FG000|Interventional Phase|Withdrawal by Subject|0|||
33310289|NCT00960661|62685643|FG001|Interventional Phase|Withdrawal by Subject|18|||
33310290|NCT00960661|62685644|FG002|Interventional Phase|Withdrawal by Subject|29|||
33310291|NCT00960661|62685642|FG000|Interventional Phase|Physician Decision|0|||
33310292|NCT00960661|62685643|FG001|Interventional Phase|Physician Decision|3|||
33310293|NCT00960661|62685644|FG002|Interventional Phase|Physician Decision|5|||
33310294|NCT00960661|62685642|FG000|Interventional Phase|sponsor decision|0|||
33310295|NCT00960661|62685643|FG001|Interventional Phase|sponsor decision|1|||
33310296|NCT00960661|62685644|FG002|Interventional Phase|sponsor decision|0|||
33310297|NCT00960661|62685642|FG000|Interventional Phase|Lack of Efficacy|0|||
33310298|NCT00960661|62685643|FG001|Interventional Phase|Lack of Efficacy|2|||
33310299|NCT00960661|62685644|FG002|Interventional Phase|Lack of Efficacy|0|||
33310300|NCT00960193|62685650|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
33310301|NCT00960115|62685659|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
33310302|NCT00960115|62685660|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
33310303|NCT00959647|62685666|FG000|Overall Study|Adverse Event|2|||
33310304|NCT00959647|62685666|FG000|Overall Study|Progressive disease|6|||
33310305|NCT00959647|62685666|FG000|Overall Study|Study terminated by sponsor|4|||
33310306|NCT00959647|62685666|FG000|Overall Study|Withdrawal by Subject|7|||
33310307|NCT00957931|62685670|FG000|Overall Study|Death|4|||
33310308|NCT00957853|62685677|FG000|Overall Study|Withdrawal by Subject|1|||
33310309|NCT00957853|62685678|FG001|Overall Study|Withdrawal by Subject|0|||
33310310|NCT00957853|62685679|FG002|Overall Study|Withdrawal by Subject|0|||
33310311|NCT00957229|62685689|FG000|Study Start|Adverse Event|0|||
33310312|NCT00957229|62685690|FG001|Study Start|Adverse Event|3|||
33310313|NCT00957229|62685689|FG000|Study Start|Disease Progression|1|||
33310314|NCT00957229|62685690|FG001|Study Start|Disease Progression|0|||
33310315|NCT00957229|62685689|FG000|Reallocated to or Continued Vismodegib|Death|1|||
33310316|NCT00957229|62685690|FG001|Reallocated to or Continued Vismodegib|Death|1|||
33310317|NCT00957229|62685689|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
33310318|NCT00957229|62685690|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
33310319|NCT02604511|62685696|FG000|Overall Study|Adverse Event|3|||
33310320|NCT02604511|62685696|FG000|Overall Study|Disease Progression|4|||
33310321|NCT02604511|62685696|FG000|Overall Study|Withdrawal by Subject|3|||
33310322|NCT02604511|62685696|FG000|Overall Study|Participant ineligible|1|||
33310323|NCT02604511|62685696|FG000|Overall Study|Intercurrent illness|1|||
33310324|NCT00956839|62685704|FG000|Overall Study|Lost to Follow-up|3|||
33310325|NCT00956839|62685705|FG001|Overall Study|Lost to Follow-up|0|||
33310326|NCT00956839|62685706|FG002|Overall Study|Lost to Follow-up|3|||
33310327|NCT00956293|62685716|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
33310328|NCT00956293|62685717|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
33310329|NCT00956293|62685718|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
33310330|NCT00956293|62685716|FG000|Main Period (Pre-randomization)|Death|0|||
33310331|NCT00956293|62685717|FG001|Main Period (Pre-randomization)|Death|0|||
33310332|NCT00956293|62685718|FG002|Main Period (Pre-randomization)|Death|1|||
33310333|NCT00956293|62685716|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
33310334|NCT00956293|62685717|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
33310335|NCT00956293|62685718|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
33310336|NCT00956293|62685716|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
33310337|NCT00956293|62685717|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
33310338|NCT00956293|62685718|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
33310339|NCT00956293|62685716|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
33310340|NCT00956293|62685717|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
33310341|NCT00956293|62685718|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
33310342|NCT00956293|62685716|FG000|Main Period (Pre-randomization)|Graft loss|0|||
33310343|NCT00956293|62685717|FG001|Main Period (Pre-randomization)|Graft loss|0|||
33310344|NCT00956293|62685718|FG002|Main Period (Pre-randomization)|Graft loss|7|||
33310345|NCT00956293|62685716|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
33310346|NCT00956293|62685717|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
33310347|NCT00956293|62685718|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
33310348|NCT00956293|62685716|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
33310349|NCT00956293|62685717|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
33310350|NCT00956293|62685718|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
33310351|NCT00956293|62685716|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
33310352|NCT00956293|62685717|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
33310353|NCT00956293|62685718|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
33310354|NCT00956293|62685716|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
33310355|NCT00956293|62685717|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
33310356|NCT00956293|62685718|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
33310357|NCT00956293|62685716|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
33310358|NCT00956293|62685717|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
33310359|NCT00956293|62685718|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
33310360|NCT00956293|62685716|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
33310361|NCT00956293|62685717|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
33310362|NCT00956293|62685718|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
33310363|NCT00956293|62685716|FG000|Main Period (Randomization)|Adverse Event|0|||
33310364|NCT00956293|62685717|FG001|Main Period (Randomization)|Adverse Event|15|||
33310365|NCT00956293|62685718|FG002|Main Period (Randomization)|Adverse Event|0|||
33310366|NCT00956293|62685716|FG000|Follow-up Period|Follow-up period was terminated.|20|||
33310367|NCT00956293|62685717|FG001|Follow-up Period|Follow-up period was terminated.|32|||
33310368|NCT00956293|62685718|FG002|Follow-up Period|Follow-up period was terminated.|0|||
33310369|NCT00955825|62685726|FG000|Overall Study|Adverse Event|15|||
33310370|NCT00955825|62685727|FG001|Overall Study|Adverse Event|2|||
33310371|NCT00955825|62685726|FG000|Overall Study|Withdrawal by Subject|4|||
33310372|NCT00955825|62685727|FG001|Overall Study|Withdrawal by Subject|6|||
33310373|NCT00955825|62685726|FG000|Overall Study|Any other reason not above-mentioned|7|||
33310374|NCT00955825|62685727|FG001|Overall Study|Any other reason not above-mentioned|9|||
33310375|NCT01164579|62685736|FG000|Overall Study|Lack of Efficacy|0|||
33310376|NCT01164579|62685737|FG001|Overall Study|Lack of Efficacy|0|||
33310377|NCT01164579|62685738|FG002|Overall Study|Lack of Efficacy|6|||
33310378|NCT01164579|62685736|FG000|Overall Study|Lost to Follow-up|1|||
33310379|NCT01164579|62685737|FG001|Overall Study|Lost to Follow-up|1|||
33310380|NCT01164579|62685738|FG002|Overall Study|Lost to Follow-up|0|||
33310381|NCT01164579|62685736|FG000|Overall Study|Withdrawal by Subject|2|||
33310382|NCT01164579|62685737|FG001|Overall Study|Withdrawal by Subject|5|||
33310383|NCT01164579|62685738|FG002|Overall Study|Withdrawal by Subject|3|||
33310384|NCT01164579|62685736|FG000|Overall Study|Protocol Violation|0|||
33310385|NCT01164579|62685737|FG001|Overall Study|Protocol Violation|1|||
33310386|NCT01164579|62685738|FG002|Overall Study|Protocol Violation|2|||
33310387|NCT01164579|62685736|FG000|Overall Study|Adverse Event|4|||
33310388|NCT01164579|62685737|FG001|Overall Study|Adverse Event|2|||
33310389|NCT01164579|62685738|FG002|Overall Study|Adverse Event|5|||
33310390|NCT01164579|62685736|FG000|Overall Study|Reason not specified|1|||
33310391|NCT01164579|62685737|FG001|Overall Study|Reason not specified|0|||
33310392|NCT01164579|62685738|FG002|Overall Study|Reason not specified|0|||
33310393|NCT00958789|62685747|FG000|Overall Study|Death|5|||
33310394|NCT00958789|62685747|FG000|Overall Study|Lost to Follow-up|14|||
33310395|NCT00958789|62685747|FG000|Overall Study|Withdrawal by Subject|17|||
33310396|NCT00958789|62685747|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
33310397|NCT00958789|62685747|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
33310398|NCT00958789|62685747|FG000|Overall Study|Subject terminated|2|||
33310399|NCT00958789|62685747|FG000|Overall Study|Revision|7|||
33310400|NCT02445391|62685758|FG000|Overall Study|No active protocol treatment|3|||
33310401|NCT02445391|62685759|FG001|Overall Study|No active protocol treatment|0|||
33310402|NCT02445391|62685760|FG002|Overall Study|No active protocol treatment|0|||
33310403|NCT02445391|62685758|FG000|Overall Study|Adverse Event|0|||
33310404|NCT02445391|62685759|FG001|Overall Study|Adverse Event|21|||
33310405|NCT02445391|62685760|FG002|Overall Study|Adverse Event|12|||
33310406|NCT02445391|62685758|FG000|Overall Study|Alternative therapy|0|||
33310407|NCT02445391|62685759|FG001|Overall Study|Alternative therapy|0|||
33310408|NCT02445391|62685760|FG002|Overall Study|Alternative therapy|1|||
33310409|NCT02445391|62685758|FG000|Overall Study|Disease progression|0|||
33310410|NCT02445391|62685759|FG001|Overall Study|Disease progression|7|||
33310411|NCT02445391|62685760|FG002|Overall Study|Disease progression|22|||
33310412|NCT02445391|62685758|FG000|Overall Study|Complicating disease|0|||
33310413|NCT02445391|62685759|FG001|Overall Study|Complicating disease|2|||
33310414|NCT02445391|62685760|FG002|Overall Study|Complicating disease|1|||
33310415|NCT02445391|62685758|FG000|Overall Study|Withdrawal by Subject|0|||
33310416|NCT02445391|62685759|FG001|Overall Study|Withdrawal by Subject|4|||
33310417|NCT02445391|62685760|FG002|Overall Study|Withdrawal by Subject|9|||
33310418|NCT02445391|62685758|FG000|Overall Study|Financial issue|0|||
33310419|NCT02445391|62685759|FG001|Overall Study|Financial issue|0|||
33310420|NCT02445391|62685760|FG002|Overall Study|Financial issue|2|||
33310421|NCT02445391|62685758|FG000|Overall Study|Still on treatment|0|||
33310422|NCT02445391|62685759|FG001|Overall Study|Still on treatment|7|||
33310423|NCT02445391|62685760|FG002|Overall Study|Still on treatment|16|||
33310424|NCT02445391|62685758|FG000|Overall Study|Not start protocol therapy|0|||
33310425|NCT02445391|62685759|FG001|Overall Study|Not start protocol therapy|12|||
33310426|NCT02445391|62685760|FG002|Overall Study|Not start protocol therapy|9|||
33310427|NCT01246986|62685776|FG000|Overall Study|Lost to Follow-up|0|||
33310428|NCT01246986|62685777|FG001|Overall Study|Lost to Follow-up|1|||
33310429|NCT01246986|62685778|FG002|Overall Study|Lost to Follow-up|3|||
33310430|NCT01246986|62685779|FG003|Overall Study|Lost to Follow-up|0|||
33310431|NCT01246986|62685780|FG004|Overall Study|Lost to Follow-up|0|||
33310432|NCT01246986|62685781|FG005|Overall Study|Lost to Follow-up|1|||
33310433|NCT01246986|62685782|FG006|Overall Study|Lost to Follow-up|0|||
33673545|NCT00244725|63110954|FG003|Overall Study|Rehab Refused to allow participantion|0|||
33673546|NCT00244725|63110951|FG000|Overall Study|Headache|0|||
33673547|NCT00244725|63110952|FG001|Overall Study|Headache|1|||
33310434|NCT01246986|62685776|FG000|Overall Study|Withdrawal by Subject|3|||
33310435|NCT01246986|62685777|FG001|Overall Study|Withdrawal by Subject|4|||
33310436|NCT01246986|62685778|FG002|Overall Study|Withdrawal by Subject|3|||
33310437|NCT01246986|62685779|FG003|Overall Study|Withdrawal by Subject|0|||
33310438|NCT01246986|62685780|FG004|Overall Study|Withdrawal by Subject|4|||
33310439|NCT01246986|62685781|FG005|Overall Study|Withdrawal by Subject|0|||
33310440|NCT01246986|62685782|FG006|Overall Study|Withdrawal by Subject|0|||
33582467|NCT01659255|62980068|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33310441|NCT01164501|62685816|FG000|Overall Study|Not treated|2|||
33310442|NCT01164501|62685817|FG001|Overall Study|Not treated|0|||
33310443|NCT01164501|62685818|FG002|Overall Study|Not treated|1|||
33310444|NCT01164501|62685816|FG000|Overall Study|Adverse Event|18|||
33310445|NCT01164501|62685817|FG001|Overall Study|Adverse Event|4|||
33310446|NCT01164501|62685818|FG002|Overall Study|Adverse Event|21|||
33310447|NCT01164501|62685816|FG000|Overall Study|Lack of Efficacy|0|||
33310448|NCT01164501|62685817|FG001|Overall Study|Lack of Efficacy|0|||
33310449|NCT01164501|62685818|FG002|Overall Study|Lack of Efficacy|1|||
33673548|NCT00244725|63110953|FG002|Overall Study|Headache|0|||
33310450|NCT01164501|62685816|FG000|Overall Study|Non compliant with protocol|1|||
33310451|NCT01164501|62685817|FG001|Overall Study|Non compliant with protocol|1|||
33310452|NCT01164501|62685818|FG002|Overall Study|Non compliant with protocol|4|||
33310453|NCT01164501|62685816|FG000|Overall Study|Lost to Follow-up|3|||
33310454|NCT01164501|62685817|FG001|Overall Study|Lost to Follow-up|0|||
33310455|NCT01164501|62685818|FG002|Overall Study|Lost to Follow-up|3|||
33310456|NCT01164501|62685816|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
33310457|NCT01164501|62685817|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
33310458|NCT01164501|62685818|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
33310459|NCT01164501|62685816|FG000|Overall Study|Other reason not defined above|9|||
33310460|NCT01164501|62685817|FG001|Overall Study|Other reason not defined above|1|||
33310461|NCT01164501|62685818|FG002|Overall Study|Other reason not defined above|4|||
33310462|NCT00958711|62685830|FG000|Overall Study|Withdrawal by Subject|0|||
33310463|NCT00958711|62685831|FG001|Overall Study|Withdrawal by Subject|4|||
33310464|NCT00958711|62685830|FG000|Overall Study|Physician Decision|5|||
33310465|NCT00958711|62685831|FG001|Overall Study|Physician Decision|7|||
33310466|NCT00958711|62685830|FG000|Overall Study|Lost to Follow-up|4|||
33310467|NCT00958711|62685831|FG001|Overall Study|Lost to Follow-up|1|||
33310468|NCT00958711|62685830|FG000|Overall Study|Other|2|||
33310469|NCT00958711|62685831|FG001|Overall Study|Other|5|||
33310470|NCT00958711|62685830|FG000|Overall Study|Death|1|||
33310471|NCT00958711|62685831|FG001|Overall Study|Death|2|||
33310472|NCT00958711|62685830|FG000|Overall Study|Adverse Event|1|||
33310473|NCT00958711|62685831|FG001|Overall Study|Adverse Event|2|||
33310474|NCT01163721|62685839|FG000|Overall Study|Adverse Event|5|||
33310475|NCT01163721|62685840|FG001|Overall Study|Adverse Event|6|||
33310476|NCT01163721|62685839|FG000|Overall Study|Withdrawal by Subject|3|||
33310477|NCT01163721|62685840|FG001|Overall Study|Withdrawal by Subject|4|||
33310478|NCT01163721|62685839|FG000|Overall Study|Lost to Follow-up|0|||
33310479|NCT01163721|62685840|FG001|Overall Study|Lost to Follow-up|1|||
33310480|NCT01163721|62685839|FG000|Overall Study|Physician Decision|0|||
33310481|NCT01163721|62685840|FG001|Overall Study|Physician Decision|1|||
33310482|NCT00958243|62685852|FG000|Overall Study|Withdrawal by Subject|0|||
33310483|NCT00958243|62685853|FG001|Overall Study|Withdrawal by Subject|1|||
33310484|NCT00958243|62685854|FG002|Overall Study|Withdrawal by Subject|3|||
33310485|NCT00958243|62685855|FG003|Overall Study|Withdrawal by Subject|1|||
33310486|NCT00958243|62685856|FG004|Overall Study|Withdrawal by Subject|1|||
33310487|NCT00958243|62685857|FG005|Overall Study|Withdrawal by Subject|5|||
33310488|NCT00958243|62685852|FG000|Overall Study|Lost to Follow-up|2|||
33310489|NCT00958243|62685853|FG001|Overall Study|Lost to Follow-up|5|||
33310490|NCT00958243|62685854|FG002|Overall Study|Lost to Follow-up|11|||
33310491|NCT00958243|62685855|FG003|Overall Study|Lost to Follow-up|2|||
33310492|NCT00958243|62685856|FG004|Overall Study|Lost to Follow-up|8|||
33310493|NCT00958243|62685857|FG005|Overall Study|Lost to Follow-up|5|||
33310494|NCT01241760|62685879|FG000|Overall Study|Adverse Event|1|||
33310495|NCT01241760|62685880|FG001|Overall Study|Adverse Event|0|||
33310496|NCT01241760|62685879|FG000|Overall Study|Lost to Follow-up|18|||
33310497|NCT01241760|62685880|FG001|Overall Study|Lost to Follow-up|22|||
33310498|NCT01241760|62685879|FG000|Overall Study|Withdrawal by Subject|13|||
33310499|NCT01241760|62685880|FG001|Overall Study|Withdrawal by Subject|13|||
33310500|NCT01241760|62685879|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
33310501|NCT01241760|62685880|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
33310502|NCT01241760|62685879|FG000|Overall Study|Other|1|||
33310503|NCT01241760|62685880|FG001|Overall Study|Other|1|||
33310504|NCT00958165|62685887|FG000|Overall Study|Lost to Follow-up|5|||
33310505|NCT00958165|62685887|FG000|Overall Study|Not eligible|9|||
33310506|NCT00958009|62685891|FG000|Overall Study|Adverse Event|1|||
33310507|NCT00958009|62685891|FG000|Overall Study|Subject found device difficult to use|1|||
33310508|NCT00953407|62685900|FG000|Overall Study|Failed inclusion criteria|1|||
33310509|NCT00953407|62685901|FG001|Overall Study|Failed inclusion criteria|1|||
33310510|NCT00953407|62685902|FG002|Overall Study|Failed inclusion criteria|1|||
33310511|NCT00953407|62685903|FG003|Overall Study|Failed inclusion criteria|1|||
33310512|NCT00953407|62685904|FG004|Overall Study|Failed inclusion criteria|1|||
33310513|NCT00953407|62685900|FG000|Overall Study|Lost to Follow-up|0|||
33310514|NCT00953407|62685901|FG001|Overall Study|Lost to Follow-up|0|||
33310515|NCT00953407|62685902|FG002|Overall Study|Lost to Follow-up|0|||
33310516|NCT00953407|62685903|FG003|Overall Study|Lost to Follow-up|1|||
33310517|NCT00953407|62685904|FG004|Overall Study|Lost to Follow-up|0|||
33310518|NCT00953329|62685916|FG000|Overall Study|Lack of Efficacy|1|||
33310519|NCT00953017|62685924|FG000|Overall Study|DId not show up for colonoscopy|4|||
33310520|NCT00953017|62685925|FG001|Overall Study|DId not show up for colonoscopy|4|||
33310521|NCT00953017|62685926|FG002|Overall Study|DId not show up for colonoscopy|5|||
33310522|NCT00953017|62685927|FG003|Overall Study|DId not show up for colonoscopy|4|||
33310523|NCT00953017|62685924|FG000|Overall Study|Incomplete data|1|||
33310524|NCT00953017|62685925|FG001|Overall Study|Incomplete data|1|||
33310525|NCT00953017|62685926|FG002|Overall Study|Incomplete data|0|||
33310526|NCT00953017|62685927|FG003|Overall Study|Incomplete data|0|||
33464750|NCT00356915|62838244|FG002|Overall Study|Lost to Follow-up|14|||
33310527|NCT00953017|62685924|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
33310528|NCT00953017|62685925|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
33310529|NCT00953017|62685926|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
33310530|NCT00953017|62685927|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
33310531|NCT00953017|62685924|FG000|Overall Study|Brown stool prior to procedure|0|||
33310532|NCT00953017|62685925|FG001|Overall Study|Brown stool prior to procedure|0|||
33310533|NCT00953017|62685926|FG002|Overall Study|Brown stool prior to procedure|1|||
33310534|NCT00953017|62685927|FG003|Overall Study|Brown stool prior to procedure|0|||
33310535|NCT00952705|62685940|FG000|Overall Study|Lost to Follow-up|24|||
33310536|NCT00952705|62685941|FG001|Overall Study|Lost to Follow-up|8|||
33310537|NCT00952705|62685942|FG002|Overall Study|Lost to Follow-up|9|||
33310538|NCT00952705|62685940|FG000|Overall Study|Withdrawal by Subject|2|||
33310539|NCT00952705|62685941|FG001|Overall Study|Withdrawal by Subject|1|||
33310540|NCT00952705|62685942|FG002|Overall Study|Withdrawal by Subject|1|||
33310541|NCT00952705|62685940|FG000|Overall Study|Death|2|||
33310542|NCT00952705|62685941|FG001|Overall Study|Death|0|||
33310543|NCT00952705|62685942|FG002|Overall Study|Death|0|||
33310544|NCT00952705|62685940|FG000|Overall Study|Incarcerated post dose|5|||
33310545|NCT00952705|62685941|FG001|Overall Study|Incarcerated post dose|0|||
33310546|NCT00952705|62685942|FG002|Overall Study|Incarcerated post dose|0|||
33310547|NCT00952705|62685940|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
33310548|NCT00952705|62685941|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
33310549|NCT00952705|62685942|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
33310550|NCT00955357|62685956|FG000|Titration Phase|Adverse Event|9|||
33310551|NCT00955357|62685957|FG001|Titration Phase|Adverse Event|46|||
33310552|NCT00955357|62685956|FG000|Titration Phase|Lack of Efficacy|0|||
33310553|NCT00955357|62685957|FG001|Titration Phase|Lack of Efficacy|2|||
33310554|NCT00955357|62685956|FG000|Titration Phase|Protocol Violation|3|||
33310555|NCT00955357|62685957|FG001|Titration Phase|Protocol Violation|7|||
33310556|NCT00955357|62685956|FG000|Titration Phase|Lost to Follow-up|1|||
33310557|NCT00955357|62685957|FG001|Titration Phase|Lost to Follow-up|3|||
33310558|NCT00955357|62685956|FG000|Titration Phase|Withdrawal by Subject|3|||
33310559|NCT00955357|62685957|FG001|Titration Phase|Withdrawal by Subject|5|||
33310560|NCT00955357|62685956|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
33310561|NCT00955357|62685957|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
33310562|NCT00955357|62685956|FG000|Titration Phase|Study medication not tolerated|0|||
33310563|NCT00955357|62685957|FG001|Titration Phase|Study medication not tolerated|1|||
33310564|NCT00955357|62685956|FG000|Titration Phase|Non compliance to study procedures|0|||
33310565|NCT00955357|62685957|FG001|Titration Phase|Non compliance to study procedures|1|||
33310566|NCT00955357|62685956|FG000|Maintenance Phase|Adverse Event|3|||
33310567|NCT00955357|62685957|FG001|Maintenance Phase|Adverse Event|23|||
33310568|NCT00955357|62685956|FG000|Maintenance Phase|Lack of Efficacy|0|||
33310569|NCT00955357|62685957|FG001|Maintenance Phase|Lack of Efficacy|4|||
33310570|NCT00955357|62685956|FG000|Maintenance Phase|Protocol Violation|2|||
33310571|NCT00955357|62685957|FG001|Maintenance Phase|Protocol Violation|6|||
33310572|NCT00955357|62685956|FG000|Maintenance Phase|Lost to Follow-up|2|||
33310573|NCT00955357|62685957|FG001|Maintenance Phase|Lost to Follow-up|7|||
33310574|NCT00955357|62685956|FG000|Maintenance Phase|Withdrawal by Subject|4|||
33310575|NCT00955357|62685957|FG001|Maintenance Phase|Withdrawal by Subject|4|||
33310576|NCT00955357|62685956|FG000|Maintenance Phase|Patient moving out of area|0|||
33310577|NCT00955357|62685957|FG001|Maintenance Phase|Patient moving out of area|1|||
33310578|NCT00955357|62685956|FG000|Maintenance Phase|Non compliance to study procedures|1|||
33310579|NCT00955357|62685957|FG001|Maintenance Phase|Non compliance to study procedures|0|||
33310580|NCT00955279|62685966|FG000|Overall Study|Other|0|||
33310581|NCT00955279|62685967|FG001|Overall Study|Other|0|||
33310582|NCT00955279|62685968|FG002|Overall Study|Other|3|||
33310583|NCT00955279|62685966|FG000|Overall Study|Death|1|||
33310584|NCT00955279|62685967|FG001|Overall Study|Death|1|||
33310585|NCT00955279|62685968|FG002|Overall Study|Death|1|||
33310586|NCT00955279|62685966|FG000|Overall Study|Lost to Follow-up|0|||
33310587|NCT00955279|62685967|FG001|Overall Study|Lost to Follow-up|3|||
33310588|NCT00955279|62685968|FG002|Overall Study|Lost to Follow-up|1|||
33310589|NCT00955279|62685966|FG000|Overall Study|Withdrawal by Subject|2|||
33310590|NCT00955279|62685967|FG001|Overall Study|Withdrawal by Subject|0|||
33310591|NCT00955279|62685968|FG002|Overall Study|Withdrawal by Subject|3|||
33310592|NCT00954733|62685976|FG000|Overall Study|blood gas machine did not work|1|||
33491654|NCT01468922|62869585|FG002|Overall Study|Refused further treatment|0|||
33491655|NCT01468922|62869586|FG003|Overall Study|Refused further treatment|0|||
33310593|NCT00954421|62685980|FG000|Screening|screen failures|3|||
33310594|NCT00954421|62685980|FG000|6 Months of DBS|Withdrawal by Subject|1|||
33310595|NCT00954421|62685980|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
33310596|NCT01241448|62685990|FG000|Overall Study|Adverse Event|1|||
33310597|NCT01241448|62685991|FG001|Overall Study|Adverse Event|0|||
33310598|NCT01241448|62685992|FG002|Overall Study|Adverse Event|2|||
33310599|NCT01241448|62685993|FG003|Overall Study|Adverse Event|2|||
33491656|NCT01468922|62869587|FG004|Overall Study|Refused further treatment|0|||
33310600|NCT01241448|62685990|FG000|Overall Study|Lost to Follow-up|2|||
33310601|NCT01241448|62685991|FG001|Overall Study|Lost to Follow-up|1|||
33310602|NCT01241448|62685992|FG002|Overall Study|Lost to Follow-up|1|||
33310603|NCT01241448|62685993|FG003|Overall Study|Lost to Follow-up|1|||
33310604|NCT01241448|62685990|FG000|Overall Study|Physician Decision|0|||
33310605|NCT01241448|62685991|FG001|Overall Study|Physician Decision|2|||
33310606|NCT01241448|62685992|FG002|Overall Study|Physician Decision|0|||
33310607|NCT01241448|62685993|FG003|Overall Study|Physician Decision|0|||
33310608|NCT01241448|62685990|FG000|Overall Study|Protocol Violation|10|||
33310609|NCT01241448|62685991|FG001|Overall Study|Protocol Violation|5|||
33310610|NCT01241448|62685992|FG002|Overall Study|Protocol Violation|3|||
33310611|NCT01241448|62685993|FG003|Overall Study|Protocol Violation|6|||
33310612|NCT01241448|62685990|FG000|Overall Study|Sponsor Decision|17|||
33310613|NCT01241448|62685991|FG001|Overall Study|Sponsor Decision|14|||
33491657|NCT01468922|62869588|FG005|Overall Study|Refused further treatment|0|||
33491658|NCT01468922|62869589|FG006|Overall Study|Refused further treatment|0|||
33491659|NCT01468922|62869590|FG007|Overall Study|Refused further treatment|1|||
33491660|NCT01468922|62869591|FG008|Overall Study|Refused further treatment|0|||
33491661|NCT01381094|62869614|FG000|Overall Study|Adverse Event|1|||
33491662|NCT01381094|62869615|FG001|Overall Study|Adverse Event|2|||
33491663|NCT01381094|62869616|FG002|Overall Study|Adverse Event|0|||
33491664|NCT01381094|62869617|FG003|Overall Study|Adverse Event|1|||
33491665|NCT01381094|62869618|FG004|Overall Study|Adverse Event|0|||
33491666|NCT01381094|62869614|FG000|Overall Study|Lost to Follow-up|0|||
33491667|NCT01381094|62869615|FG001|Overall Study|Lost to Follow-up|0|||
33491668|NCT01381094|62869616|FG002|Overall Study|Lost to Follow-up|0|||
33491669|NCT01381094|62869617|FG003|Overall Study|Lost to Follow-up|0|||
33491670|NCT01381094|62869618|FG004|Overall Study|Lost to Follow-up|1|||
33491671|NCT01381094|62869614|FG000|Overall Study|Withdrawal of informed consent|0|||
33491672|NCT01381094|62869615|FG001|Overall Study|Withdrawal of informed consent|1|||
33491673|NCT01381094|62869616|FG002|Overall Study|Withdrawal of informed consent|0|||
33491674|NCT01381094|62869617|FG003|Overall Study|Withdrawal of informed consent|0|||
33491675|NCT01381094|62869618|FG004|Overall Study|Withdrawal of informed consent|0|||
33491676|NCT01381094|62869614|FG000|Overall Study|Participant given Aranesp injection|1|||
33491677|NCT01381094|62869615|FG001|Overall Study|Participant given Aranesp injection|0|||
33491678|NCT01381094|62869616|FG002|Overall Study|Participant given Aranesp injection|0|||
33491679|NCT01381094|62869617|FG003|Overall Study|Participant given Aranesp injection|0|||
33491680|NCT01381094|62869618|FG004|Overall Study|Participant given Aranesp injection|0|||
33491681|NCT03197558|62869630|FG000|Overall Study|Tubes not placed|1|||
33491682|NCT03197324|62869636|FG000|Overall Study|Adverse Event|0|||
33491683|NCT03197324|62869637|FG001|Overall Study|Adverse Event|1|||
33491684|NCT03162614|62869649|FG000|Overall Study|Lost to Follow-up|2|||
33491685|NCT03162614|62869650|FG001|Overall Study|Lost to Follow-up|1|||
33491686|NCT03162614|62869651|FG002|Overall Study|Lost to Follow-up|1|||
33491687|NCT03162614|62869652|FG003|Overall Study|Lost to Follow-up|1|||
33491688|NCT03162614|62869653|FG004|Overall Study|Lost to Follow-up|2|||
33491689|NCT03162614|62869654|FG005|Overall Study|Lost to Follow-up|0|||
33491690|NCT03162614|62869649|FG000|Overall Study|Protocol Violation|0|||
33491691|NCT03162614|62869650|FG001|Overall Study|Protocol Violation|1|||
33491692|NCT03162614|62869651|FG002|Overall Study|Protocol Violation|0|||
33491693|NCT03162614|62869652|FG003|Overall Study|Protocol Violation|1|||
33491694|NCT03162614|62869653|FG004|Overall Study|Protocol Violation|0|||
33491695|NCT03162614|62869654|FG005|Overall Study|Protocol Violation|0|||
33491696|NCT03162614|62869649|FG000|Overall Study|Withdrawal by Subject|2|||
33491697|NCT03162614|62869650|FG001|Overall Study|Withdrawal by Subject|1|||
33491698|NCT03162614|62869651|FG002|Overall Study|Withdrawal by Subject|1|||
33491699|NCT03162614|62869652|FG003|Overall Study|Withdrawal by Subject|1|||
33491700|NCT03162614|62869653|FG004|Overall Study|Withdrawal by Subject|0|||
33491701|NCT03162614|62869654|FG005|Overall Study|Withdrawal by Subject|0|||
33491702|NCT03162614|62869649|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
33491703|NCT03162614|62869650|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
33491704|NCT03162614|62869651|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
33491705|NCT03162614|62869652|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
33491706|NCT03162614|62869653|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
33310614|NCT01241448|62685992|FG002|Overall Study|Sponsor Decision|12|||
33310615|NCT01241448|62685993|FG003|Overall Study|Sponsor Decision|6|||
33491707|NCT03162614|62869654|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
33491708|NCT03160898|62869672|FG000|Overall Study|Adverse Event|4|||
33491709|NCT03160898|62869673|FG001|Overall Study|Adverse Event|8|||
33491710|NCT03160898|62869674|FG002|Overall Study|Adverse Event|7|||
33491711|NCT03160898|62869675|FG003|Overall Study|Adverse Event|10|||
33491712|NCT03160898|62869672|FG000|Overall Study|Death|1|||
33491713|NCT03160898|62869673|FG001|Overall Study|Death|0|||
33491714|NCT03160898|62869674|FG002|Overall Study|Death|0|||
33491715|NCT03160898|62869675|FG003|Overall Study|Death|1|||
33491716|NCT03160898|62869672|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
33491717|NCT03160898|62869673|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
33491718|NCT03160898|62869674|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
33491719|NCT03160898|62869675|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
33491720|NCT03160898|62869672|FG000|Overall Study|Lost to Follow-up|1|||
33491721|NCT03160898|62869673|FG001|Overall Study|Lost to Follow-up|1|||
33491722|NCT03160898|62869674|FG002|Overall Study|Lost to Follow-up|1|||
33491723|NCT03160898|62869675|FG003|Overall Study|Lost to Follow-up|2|||
33491724|NCT03160898|62869672|FG000|Overall Study|Physician Decision|1|||
33491725|NCT03160898|62869673|FG001|Overall Study|Physician Decision|0|||
33491726|NCT03160898|62869674|FG002|Overall Study|Physician Decision|0|||
33491727|NCT03160898|62869675|FG003|Overall Study|Physician Decision|1|||
33491728|NCT03160898|62869672|FG000|Overall Study|Progressive Disease|4|||
33491729|NCT03160898|62869673|FG001|Overall Study|Progressive Disease|1|||
33491730|NCT03160898|62869674|FG002|Overall Study|Progressive Disease|2|||
33491731|NCT03160898|62869675|FG003|Overall Study|Progressive Disease|1|||
33491732|NCT03160898|62869672|FG000|Overall Study|Protocol Violation|1|||
33491733|NCT03160898|62869673|FG001|Overall Study|Protocol Violation|0|||
33491734|NCT03160898|62869674|FG002|Overall Study|Protocol Violation|2|||
33491735|NCT03160898|62869675|FG003|Overall Study|Protocol Violation|0|||
33491736|NCT03160898|62869672|FG000|Overall Study|Sponsor Discretion|2|||
33491737|NCT03160898|62869673|FG001|Overall Study|Sponsor Discretion|0|||
33491738|NCT03160898|62869674|FG002|Overall Study|Sponsor Discretion|0|||
33491739|NCT03160898|62869675|FG003|Overall Study|Sponsor Discretion|0|||
33491740|NCT03160898|62869672|FG000|Overall Study|Withdrawal by Subject|1|||
33491741|NCT03160898|62869673|FG001|Overall Study|Withdrawal by Subject|3|||
33491742|NCT03160898|62869674|FG002|Overall Study|Withdrawal by Subject|2|||
33491743|NCT03160898|62869675|FG003|Overall Study|Withdrawal by Subject|1|||
33491744|NCT03160898|62869672|FG000|Overall Study|Other|2|||
33491745|NCT03160898|62869673|FG001|Overall Study|Other|0|||
33491746|NCT03160898|62869674|FG002|Overall Study|Other|2|||
33491747|NCT03160898|62869675|FG003|Overall Study|Other|2|||
33491748|NCT03193736|62869686|FG000|Overall Study|Death|2|||
33491749|NCT03193736|62869686|FG000|Overall Study|Withdrawal by Subject|1|||
33491750|NCT03193736|62869686|FG000|Overall Study|Lost to Follow-up|1|||
33491751|NCT03193736|62869686|FG000|Overall Study|implant not received|1|||
33491752|NCT03192488|62869703|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
33491753|NCT03192488|62869704|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
33491754|NCT03192488|62869705|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
33491755|NCT03192488|62869706|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
33491756|NCT03192488|62869707|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
33491757|NCT03192488|62869708|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
33491758|NCT03192488|62869703|FG000|Third Intervention (d1)|Adverse Event|0|||
33491759|NCT03192488|62869704|FG001|Third Intervention (d1)|Adverse Event|0|||
33491760|NCT03192488|62869705|FG002|Third Intervention (d1)|Adverse Event|0|||
33491761|NCT03192488|62869706|FG003|Third Intervention (d1)|Adverse Event|0|||
33491762|NCT03192488|62869707|FG004|Third Intervention (d1)|Adverse Event|1|||
33491763|NCT03192488|62869708|FG005|Third Intervention (d1)|Adverse Event|0|||
33491764|NCT01642004|62869724|FG000|Randomization|Adverse Event unrelated to study drug|1|||
33491765|NCT01642004|62869725|FG001|Randomization|Adverse Event unrelated to study drug|0|||
33491766|NCT01642004|62869724|FG000|Randomization|Participant withdrew consent|1|||
33491767|NCT01642004|62869725|FG001|Randomization|Participant withdrew consent|6|||
33491768|NCT01642004|62869724|FG000|Randomization|No longer meets study criteria|2|||
33491769|NCT01642004|62869725|FG001|Randomization|No longer meets study criteria|2|||
33491770|NCT01642004|62869724|FG000|Treatment|Disease progression|95|||
33491771|NCT01642004|62869725|FG001|Treatment|Disease progression|79|||
33491772|NCT01642004|62869724|FG000|Treatment|Study drug toxicity|10|||
33491773|NCT01642004|62869725|FG001|Treatment|Study drug toxicity|13|||
33491774|NCT01642004|62869724|FG000|Treatment|Death|1|||
33491775|NCT01642004|62869725|FG001|Treatment|Death|1|||
33491776|NCT01642004|62869724|FG000|Treatment|Adverse event unrelated to study drug|9|||
33491777|NCT01642004|62869725|FG001|Treatment|Adverse event unrelated to study drug|13|||
33491778|NCT01642004|62869724|FG000|Treatment|Maximum clinical benefit|1|||
33491779|NCT01642004|62869725|FG001|Treatment|Maximum clinical benefit|9|||
33491780|NCT01642004|62869724|FG000|Treatment|Poor/non-compliance|1|||
33491781|NCT01642004|62869725|FG001|Treatment|Poor/non-compliance|0|||
33491782|NCT01642004|62869724|FG000|Treatment|No longer meets study criteria|1|||
33491783|NCT01642004|62869725|FG001|Treatment|No longer meets study criteria|2|||
33491784|NCT01642004|62869724|FG000|Treatment|Other reasons|2|||
33491785|NCT01642004|62869725|FG001|Treatment|Other reasons|0|||
33491786|NCT01642004|62869724|FG000|Treatment|Not reported|0|||
33491787|NCT01642004|62869725|FG001|Treatment|Not reported|3|||
33491788|NCT01642004|62869724|FG000|Treatment|Participant request to discontinue study treatment|6|||
33491789|NCT01642004|62869725|FG001|Treatment|Participant request to discontinue study treatment|4|||
33491790|NCT01642004|62869724|FG000|Treatment|Participant withdrew consent|5|||
33491791|NCT01642004|62869725|FG001|Treatment|Participant withdrew consent|5|||
33491792|NCT00042289|62869781|FG000|Overall Study|Lost to Follow-up|3|||
33491793|NCT00042289|62869782|FG001|Overall Study|Lost to Follow-up|0|||
33491794|NCT00042289|62869783|FG002|Overall Study|Lost to Follow-up|0|||
33491795|NCT00042289|62869784|FG003|Overall Study|Lost to Follow-up|1|||
33491796|NCT00042289|62869785|FG004|Overall Study|Lost to Follow-up|3|||
33491797|NCT00042289|62869786|FG005|Overall Study|Lost to Follow-up|3|||
33491798|NCT00042289|62869787|FG006|Overall Study|Lost to Follow-up|6|||
33491799|NCT00042289|62869788|FG007|Overall Study|Lost to Follow-up|1|||
33491800|NCT00042289|62869789|FG008|Overall Study|Lost to Follow-up|1|||
33491801|NCT00042289|62869790|FG009|Overall Study|Lost to Follow-up|0|||
33491802|NCT00042289|62869791|FG010|Overall Study|Lost to Follow-up|0|||
33491803|NCT00042289|62869792|FG011|Overall Study|Lost to Follow-up|0|||
33491804|NCT00042289|62869793|FG012|Overall Study|Lost to Follow-up|0|||
33491805|NCT00042289|62869794|FG013|Overall Study|Lost to Follow-up|0|||
33491806|NCT00042289|62869795|FG014|Overall Study|Lost to Follow-up|0|||
33491807|NCT00042289|62869796|FG015|Overall Study|Lost to Follow-up|1|||
33491808|NCT00042289|62869797|FG016|Overall Study|Lost to Follow-up|1|||
33491809|NCT00042289|62869798|FG017|Overall Study|Lost to Follow-up|0|||
33491810|NCT00042289|62869799|FG018|Overall Study|Lost to Follow-up|3|||
33491811|NCT00042289|62869800|FG019|Overall Study|Lost to Follow-up|2|||
33491812|NCT00042289|62869801|FG020|Overall Study|Lost to Follow-up|0|||
33491813|NCT00042289|62869802|FG021|Overall Study|Lost to Follow-up|0|||
33491814|NCT00042289|62869803|FG022|Overall Study|Lost to Follow-up|0|||
33491815|NCT00042289|62869804|FG023|Overall Study|Lost to Follow-up|0|||
33491816|NCT00042289|62869805|FG024|Overall Study|Lost to Follow-up|0|||
33491817|NCT00042289|62869806|FG025|Overall Study|Lost to Follow-up|0|||
33491818|NCT00042289|62869807|FG026|Overall Study|Lost to Follow-up|2|||
33491819|NCT00042289|62869808|FG027|Overall Study|Lost to Follow-up|2|||
33491820|NCT00042289|62869809|FG028|Overall Study|Lost to Follow-up|2|||
33491821|NCT00042289|62869810|FG029|Overall Study|Lost to Follow-up|0|||
33491822|NCT00042289|62869811|FG030|Overall Study|Lost to Follow-up|0|||
33491823|NCT00042289|62869812|FG031|Overall Study|Lost to Follow-up|2|||
33491824|NCT00042289|62869813|FG032|Overall Study|Lost to Follow-up|1|||
33491825|NCT00042289|62869814|FG033|Overall Study|Lost to Follow-up|1|||
33491826|NCT00042289|62869815|FG034|Overall Study|Lost to Follow-up|1|||
33491827|NCT00042289|62869816|FG035|Overall Study|Lost to Follow-up|2|||
33491828|NCT00042289|62869817|FG036|Overall Study|Lost to Follow-up|1|||
33491829|NCT00042289|62869818|FG037|Overall Study|Lost to Follow-up|1|||
33491830|NCT00042289|62869819|FG038|Overall Study|Lost to Follow-up|0|||
33491831|NCT00042289|62869820|FG039|Overall Study|Lost to Follow-up|5|||
33491832|NCT00042289|62869821|FG040|Overall Study|Lost to Follow-up|0|||
33491833|NCT00042289|62869822|FG041|Overall Study|Lost to Follow-up|2|||
33491834|NCT00042289|62869823|FG042|Overall Study|Lost to Follow-up|2|||
33491835|NCT00042289|62869824|FG043|Overall Study|Lost to Follow-up|0|||
33491836|NCT00042289|62869825|FG044|Overall Study|Lost to Follow-up|0|||
33491837|NCT00042289|62869826|FG045|Overall Study|Lost to Follow-up|1|||
33491838|NCT00042289|62869827|FG046|Overall Study|Lost to Follow-up|0|||
33491839|NCT00042289|62869781|FG000|Overall Study|Other reason|0|||
33491840|NCT00042289|62869782|FG001|Overall Study|Other reason|0|||
33491841|NCT00042289|62869783|FG002|Overall Study|Other reason|0|||
33491842|NCT00042289|62869784|FG003|Overall Study|Other reason|2|||
33491843|NCT00042289|62869785|FG004|Overall Study|Other reason|0|||
33491844|NCT00042289|62869786|FG005|Overall Study|Other reason|0|||
33491845|NCT00042289|62869787|FG006|Overall Study|Other reason|0|||
33491846|NCT00042289|62869788|FG007|Overall Study|Other reason|0|||
33491847|NCT00042289|62869789|FG008|Overall Study|Other reason|0|||
33491848|NCT00042289|62869790|FG009|Overall Study|Other reason|0|||
33491849|NCT00042289|62869791|FG010|Overall Study|Other reason|0|||
33491850|NCT00042289|62869792|FG011|Overall Study|Other reason|0|||
33491851|NCT00042289|62869793|FG012|Overall Study|Other reason|0|||
33491852|NCT00042289|62869794|FG013|Overall Study|Other reason|0|||
33491853|NCT00042289|62869795|FG014|Overall Study|Other reason|0|||
33491854|NCT00042289|62869796|FG015|Overall Study|Other reason|0|||
33491855|NCT00042289|62869797|FG016|Overall Study|Other reason|0|||
33491856|NCT00042289|62869798|FG017|Overall Study|Other reason|0|||
33491857|NCT00042289|62869799|FG018|Overall Study|Other reason|1|||
33491858|NCT00042289|62869800|FG019|Overall Study|Other reason|0|||
33491859|NCT00042289|62869801|FG020|Overall Study|Other reason|0|||
33491860|NCT00042289|62869802|FG021|Overall Study|Other reason|0|||
33491861|NCT00042289|62869803|FG022|Overall Study|Other reason|0|||
33491862|NCT00042289|62869804|FG023|Overall Study|Other reason|1|||
33491863|NCT00042289|62869805|FG024|Overall Study|Other reason|0|||
33491864|NCT00042289|62869806|FG025|Overall Study|Other reason|0|||
33491865|NCT00042289|62869807|FG026|Overall Study|Other reason|1|||
33491866|NCT00042289|62869808|FG027|Overall Study|Other reason|0|||
33491867|NCT00042289|62869809|FG028|Overall Study|Other reason|3|||
33491868|NCT00042289|62869810|FG029|Overall Study|Other reason|0|||
33491869|NCT00042289|62869811|FG030|Overall Study|Other reason|0|||
33491870|NCT00042289|62869812|FG031|Overall Study|Other reason|1|||
33491871|NCT00042289|62869813|FG032|Overall Study|Other reason|0|||
33491872|NCT00042289|62869814|FG033|Overall Study|Other reason|1|||
33491873|NCT00042289|62869815|FG034|Overall Study|Other reason|0|||
33491874|NCT00042289|62869816|FG035|Overall Study|Other reason|2|||
33491875|NCT00042289|62869817|FG036|Overall Study|Other reason|0|||
33491876|NCT00042289|62869818|FG037|Overall Study|Other reason|0|||
33491877|NCT00042289|62869819|FG038|Overall Study|Other reason|0|||
33491878|NCT00042289|62869820|FG039|Overall Study|Other reason|0|||
33491879|NCT00042289|62869821|FG040|Overall Study|Other reason|0|||
33491880|NCT00042289|62869822|FG041|Overall Study|Other reason|0|||
33491881|NCT00042289|62869823|FG042|Overall Study|Other reason|0|||
33491882|NCT00042289|62869824|FG043|Overall Study|Other reason|1|||
33491883|NCT00042289|62869825|FG044|Overall Study|Other reason|0|||
33491884|NCT00042289|62869826|FG045|Overall Study|Other reason|0|||
33491885|NCT00042289|62869827|FG046|Overall Study|Other reason|0|||
33491886|NCT00042289|62869781|FG000|Overall Study|Severe debilitation, unable to continue|0|||
33491887|NCT00042289|62869782|FG001|Overall Study|Severe debilitation, unable to continue|0|||
33491888|NCT00042289|62869783|FG002|Overall Study|Severe debilitation, unable to continue|0|||
33491889|NCT00042289|62869784|FG003|Overall Study|Severe debilitation, unable to continue|0|||
33491890|NCT00042289|62869785|FG004|Overall Study|Severe debilitation, unable to continue|0|||
33491891|NCT00042289|62869786|FG005|Overall Study|Severe debilitation, unable to continue|0|||
33491892|NCT00042289|62869787|FG006|Overall Study|Severe debilitation, unable to continue|0|||
33491893|NCT00042289|62869788|FG007|Overall Study|Severe debilitation, unable to continue|0|||
33491894|NCT00042289|62869789|FG008|Overall Study|Severe debilitation, unable to continue|0|||
33491895|NCT00042289|62869790|FG009|Overall Study|Severe debilitation, unable to continue|0|||
33491896|NCT00042289|62869791|FG010|Overall Study|Severe debilitation, unable to continue|0|||
33491897|NCT00042289|62869792|FG011|Overall Study|Severe debilitation, unable to continue|0|||
33491898|NCT00042289|62869793|FG012|Overall Study|Severe debilitation, unable to continue|0|||
33491899|NCT00042289|62869794|FG013|Overall Study|Severe debilitation, unable to continue|0|||
33491900|NCT00042289|62869795|FG014|Overall Study|Severe debilitation, unable to continue|0|||
33491901|NCT00042289|62869796|FG015|Overall Study|Severe debilitation, unable to continue|0|||
33491902|NCT00042289|62869797|FG016|Overall Study|Severe debilitation, unable to continue|0|||
33491903|NCT00042289|62869798|FG017|Overall Study|Severe debilitation, unable to continue|0|||
33491904|NCT00042289|62869799|FG018|Overall Study|Severe debilitation, unable to continue|0|||
33491905|NCT00042289|62869800|FG019|Overall Study|Severe debilitation, unable to continue|0|||
33491906|NCT00042289|62869801|FG020|Overall Study|Severe debilitation, unable to continue|0|||
33491907|NCT00042289|62869802|FG021|Overall Study|Severe debilitation, unable to continue|1|||
33491908|NCT00042289|62869803|FG022|Overall Study|Severe debilitation, unable to continue|0|||
33491909|NCT00042289|62869804|FG023|Overall Study|Severe debilitation, unable to continue|1|||
33491910|NCT00042289|62869805|FG024|Overall Study|Severe debilitation, unable to continue|0|||
33491911|NCT00042289|62869806|FG025|Overall Study|Severe debilitation, unable to continue|0|||
33491912|NCT00042289|62869807|FG026|Overall Study|Severe debilitation, unable to continue|0|||
33491913|NCT00042289|62869808|FG027|Overall Study|Severe debilitation, unable to continue|1|||
33491914|NCT00042289|62869809|FG028|Overall Study|Severe debilitation, unable to continue|0|||
33491915|NCT00042289|62869810|FG029|Overall Study|Severe debilitation, unable to continue|0|||
33491916|NCT00042289|62869811|FG030|Overall Study|Severe debilitation, unable to continue|0|||
33491917|NCT00042289|62869812|FG031|Overall Study|Severe debilitation, unable to continue|1|||
33491918|NCT00042289|62869813|FG032|Overall Study|Severe debilitation, unable to continue|1|||
33491919|NCT00042289|62869814|FG033|Overall Study|Severe debilitation, unable to continue|0|||
33491920|NCT00042289|62869815|FG034|Overall Study|Severe debilitation, unable to continue|0|||
33491921|NCT00042289|62869816|FG035|Overall Study|Severe debilitation, unable to continue|0|||
33491922|NCT00042289|62869817|FG036|Overall Study|Severe debilitation, unable to continue|0|||
33491923|NCT00042289|62869818|FG037|Overall Study|Severe debilitation, unable to continue|0|||
33491924|NCT00042289|62869819|FG038|Overall Study|Severe debilitation, unable to continue|0|||
33491925|NCT00042289|62869820|FG039|Overall Study|Severe debilitation, unable to continue|0|||
33491926|NCT00042289|62869821|FG040|Overall Study|Severe debilitation, unable to continue|0|||
33491927|NCT00042289|62869822|FG041|Overall Study|Severe debilitation, unable to continue|0|||
33491928|NCT00042289|62869823|FG042|Overall Study|Severe debilitation, unable to continue|0|||
33491929|NCT00042289|62869824|FG043|Overall Study|Severe debilitation, unable to continue|0|||
33491930|NCT00042289|62869825|FG044|Overall Study|Severe debilitation, unable to continue|0|||
33491931|NCT00042289|62869826|FG045|Overall Study|Severe debilitation, unable to continue|0|||
33491932|NCT00042289|62869827|FG046|Overall Study|Severe debilitation, unable to continue|0|||
33491933|NCT00042289|62869781|FG000|Overall Study|Site closed|0|||
33491934|NCT00042289|62869782|FG001|Overall Study|Site closed|0|||
33491935|NCT00042289|62869783|FG002|Overall Study|Site closed|0|||
33491936|NCT00042289|62869784|FG003|Overall Study|Site closed|0|||
33491937|NCT00042289|62869785|FG004|Overall Study|Site closed|0|||
33491938|NCT00042289|62869786|FG005|Overall Study|Site closed|0|||
33491939|NCT00042289|62869787|FG006|Overall Study|Site closed|0|||
33491940|NCT00042289|62869788|FG007|Overall Study|Site closed|0|||
33491941|NCT00042289|62869789|FG008|Overall Study|Site closed|0|||
33491942|NCT00042289|62869790|FG009|Overall Study|Site closed|0|||
33491943|NCT00042289|62869791|FG010|Overall Study|Site closed|0|||
33491944|NCT00042289|62869792|FG011|Overall Study|Site closed|0|||
33491945|NCT00042289|62869793|FG012|Overall Study|Site closed|0|||
33491946|NCT00042289|62869794|FG013|Overall Study|Site closed|0|||
33491947|NCT00042289|62869795|FG014|Overall Study|Site closed|0|||
33491948|NCT00042289|62869796|FG015|Overall Study|Site closed|0|||
33491949|NCT00042289|62869797|FG016|Overall Study|Site closed|0|||
33491950|NCT00042289|62869798|FG017|Overall Study|Site closed|0|||
33491951|NCT00042289|62869799|FG018|Overall Study|Site closed|0|||
33491952|NCT00042289|62869800|FG019|Overall Study|Site closed|0|||
33491953|NCT00042289|62869801|FG020|Overall Study|Site closed|0|||
33491954|NCT00042289|62869802|FG021|Overall Study|Site closed|0|||
33491955|NCT00042289|62869803|FG022|Overall Study|Site closed|0|||
33491956|NCT00042289|62869804|FG023|Overall Study|Site closed|0|||
33491957|NCT00042289|62869805|FG024|Overall Study|Site closed|0|||
33491958|NCT00042289|62869806|FG025|Overall Study|Site closed|0|||
33491959|NCT00042289|62869807|FG026|Overall Study|Site closed|0|||
33491960|NCT00042289|62869808|FG027|Overall Study|Site closed|0|||
33491961|NCT00042289|62869809|FG028|Overall Study|Site closed|0|||
33491962|NCT00042289|62869810|FG029|Overall Study|Site closed|0|||
33491963|NCT00042289|62869811|FG030|Overall Study|Site closed|0|||
33491964|NCT00042289|62869812|FG031|Overall Study|Site closed|3|||
33491965|NCT00042289|62869813|FG032|Overall Study|Site closed|0|||
33491966|NCT00042289|62869814|FG033|Overall Study|Site closed|0|||
33491967|NCT00042289|62869815|FG034|Overall Study|Site closed|0|||
33491968|NCT00042289|62869816|FG035|Overall Study|Site closed|0|||
33491969|NCT00042289|62869817|FG036|Overall Study|Site closed|1|||
33491970|NCT00042289|62869818|FG037|Overall Study|Site closed|0|||
33491971|NCT00042289|62869819|FG038|Overall Study|Site closed|0|||
33491972|NCT00042289|62869820|FG039|Overall Study|Site closed|0|||
33491973|NCT00042289|62869821|FG040|Overall Study|Site closed|0|||
33491974|NCT00042289|62869822|FG041|Overall Study|Site closed|0|||
33491975|NCT00042289|62869823|FG042|Overall Study|Site closed|1|||
33491976|NCT00042289|62869824|FG043|Overall Study|Site closed|0|||
33491977|NCT00042289|62869825|FG044|Overall Study|Site closed|0|||
33491978|NCT00042289|62869826|FG045|Overall Study|Site closed|0|||
33491979|NCT00042289|62869827|FG046|Overall Study|Site closed|0|||
33491980|NCT00042289|62869781|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
33491981|NCT00042289|62869782|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
33491982|NCT00042289|62869783|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
33491983|NCT00042289|62869784|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
33491984|NCT00042289|62869785|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
33491985|NCT00042289|62869786|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
33491986|NCT00042289|62869787|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
33491987|NCT00042289|62869788|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
33491988|NCT00042289|62869789|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
33491989|NCT00042289|62869790|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
33491990|NCT00042289|62869791|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
33491991|NCT00042289|62869792|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
33491992|NCT00042289|62869793|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
33491993|NCT00042289|62869794|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
33491994|NCT00042289|62869795|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
33491995|NCT00042289|62869796|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
33491996|NCT00042289|62869797|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
33491997|NCT00042289|62869798|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
33491998|NCT00042289|62869799|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
33491999|NCT00042289|62869800|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
33492000|NCT00042289|62869801|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
33492001|NCT00042289|62869802|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
33492002|NCT00042289|62869803|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
33492003|NCT00042289|62869804|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
33492004|NCT00042289|62869805|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
33492005|NCT00042289|62869806|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
33492006|NCT00042289|62869807|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
33492007|NCT00042289|62869808|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
33492008|NCT00042289|62869809|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
33492009|NCT00042289|62869810|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
33492010|NCT00042289|62869811|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
33492011|NCT00042289|62869812|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
33492012|NCT00042289|62869813|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
33492013|NCT00042289|62869814|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
33492014|NCT00042289|62869815|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
33492015|NCT00042289|62869816|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
33492016|NCT00042289|62869817|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
33492017|NCT00042289|62869818|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
33492018|NCT00042289|62869819|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
33492019|NCT00042289|62869820|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
33492020|NCT00042289|62869821|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
33492021|NCT00042289|62869822|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
33492022|NCT00042289|62869823|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
33492023|NCT00042289|62869824|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
33492024|NCT00042289|62869825|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
33492025|NCT00042289|62869826|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
33492026|NCT00042289|62869827|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
33492027|NCT00042289|62869781|FG000|Overall Study|Protocol Violation|0|||
33492028|NCT00042289|62869782|FG001|Overall Study|Protocol Violation|0|||
33492029|NCT00042289|62869783|FG002|Overall Study|Protocol Violation|0|||
33492030|NCT00042289|62869784|FG003|Overall Study|Protocol Violation|0|||
33492031|NCT00042289|62869785|FG004|Overall Study|Protocol Violation|0|||
33492032|NCT00042289|62869786|FG005|Overall Study|Protocol Violation|1|||
33492033|NCT00042289|62869787|FG006|Overall Study|Protocol Violation|0|||
33492034|NCT00042289|62869788|FG007|Overall Study|Protocol Violation|1|||
33492035|NCT00042289|62869789|FG008|Overall Study|Protocol Violation|0|||
33492036|NCT00042289|62869790|FG009|Overall Study|Protocol Violation|0|||
33492037|NCT00042289|62869791|FG010|Overall Study|Protocol Violation|0|||
33492038|NCT00042289|62869792|FG011|Overall Study|Protocol Violation|0|||
33492039|NCT00042289|62869793|FG012|Overall Study|Protocol Violation|0|||
33492040|NCT00042289|62869794|FG013|Overall Study|Protocol Violation|0|||
33492041|NCT00042289|62869795|FG014|Overall Study|Protocol Violation|0|||
33492042|NCT00042289|62869796|FG015|Overall Study|Protocol Violation|0|||
33492043|NCT00042289|62869797|FG016|Overall Study|Protocol Violation|0|||
33492044|NCT00042289|62869798|FG017|Overall Study|Protocol Violation|0|||
33492045|NCT00042289|62869799|FG018|Overall Study|Protocol Violation|0|||
33492046|NCT00042289|62869800|FG019|Overall Study|Protocol Violation|0|||
33492047|NCT00042289|62869801|FG020|Overall Study|Protocol Violation|0|||
33492048|NCT00042289|62869802|FG021|Overall Study|Protocol Violation|0|||
33492049|NCT00042289|62869803|FG022|Overall Study|Protocol Violation|0|||
33492050|NCT00042289|62869804|FG023|Overall Study|Protocol Violation|1|||
33492051|NCT00042289|62869805|FG024|Overall Study|Protocol Violation|1|||
33492052|NCT00042289|62869806|FG025|Overall Study|Protocol Violation|0|||
33492053|NCT00042289|62869807|FG026|Overall Study|Protocol Violation|2|||
33492054|NCT00042289|62869808|FG027|Overall Study|Protocol Violation|0|||
33492055|NCT00042289|62869809|FG028|Overall Study|Protocol Violation|0|||
33492056|NCT00042289|62869810|FG029|Overall Study|Protocol Violation|0|||
33492057|NCT00042289|62869811|FG030|Overall Study|Protocol Violation|1|||
33492058|NCT00042289|62869812|FG031|Overall Study|Protocol Violation|0|||
33492059|NCT00042289|62869813|FG032|Overall Study|Protocol Violation|0|||
33492060|NCT00042289|62869814|FG033|Overall Study|Protocol Violation|0|||
33492061|NCT00042289|62869815|FG034|Overall Study|Protocol Violation|0|||
33492062|NCT00042289|62869816|FG035|Overall Study|Protocol Violation|0|||
33492063|NCT00042289|62869817|FG036|Overall Study|Protocol Violation|0|||
33492064|NCT00042289|62869818|FG037|Overall Study|Protocol Violation|0|||
33492065|NCT00042289|62869819|FG038|Overall Study|Protocol Violation|0|||
33492066|NCT00042289|62869820|FG039|Overall Study|Protocol Violation|0|||
33492067|NCT00042289|62869821|FG040|Overall Study|Protocol Violation|0|||
33492068|NCT00042289|62869822|FG041|Overall Study|Protocol Violation|1|||
33492069|NCT00042289|62869823|FG042|Overall Study|Protocol Violation|1|||
33492070|NCT00042289|62869824|FG043|Overall Study|Protocol Violation|1|||
33492071|NCT00042289|62869825|FG044|Overall Study|Protocol Violation|0|||
33492072|NCT00042289|62869826|FG045|Overall Study|Protocol Violation|0|||
33492073|NCT00042289|62869827|FG046|Overall Study|Protocol Violation|0|||
33492074|NCT00042289|62869781|FG000|Overall Study|Withdrawal by Subject|4|||
33492075|NCT00042289|62869782|FG001|Overall Study|Withdrawal by Subject|1|||
33492076|NCT00042289|62869783|FG002|Overall Study|Withdrawal by Subject|0|||
33492077|NCT00042289|62869784|FG003|Overall Study|Withdrawal by Subject|2|||
33492078|NCT00042289|62869785|FG004|Overall Study|Withdrawal by Subject|0|||
33492079|NCT00042289|62869786|FG005|Overall Study|Withdrawal by Subject|2|||
33492080|NCT00042289|62869787|FG006|Overall Study|Withdrawal by Subject|0|||
33492081|NCT00042289|62869788|FG007|Overall Study|Withdrawal by Subject|0|||
33492082|NCT00042289|62869789|FG008|Overall Study|Withdrawal by Subject|0|||
33492083|NCT00042289|62869790|FG009|Overall Study|Withdrawal by Subject|1|||
33492084|NCT00042289|62869791|FG010|Overall Study|Withdrawal by Subject|0|||
33492085|NCT00042289|62869792|FG011|Overall Study|Withdrawal by Subject|0|||
33492086|NCT00042289|62869793|FG012|Overall Study|Withdrawal by Subject|2|||
33492087|NCT00042289|62869794|FG013|Overall Study|Withdrawal by Subject|0|||
33492088|NCT00042289|62869795|FG014|Overall Study|Withdrawal by Subject|0|||
33492089|NCT00042289|62869796|FG015|Overall Study|Withdrawal by Subject|0|||
33492090|NCT00042289|62869797|FG016|Overall Study|Withdrawal by Subject|0|||
33492091|NCT00042289|62869798|FG017|Overall Study|Withdrawal by Subject|0|||
33492092|NCT00042289|62869799|FG018|Overall Study|Withdrawal by Subject|0|||
33492093|NCT00042289|62869800|FG019|Overall Study|Withdrawal by Subject|0|||
33492094|NCT00042289|62869801|FG020|Overall Study|Withdrawal by Subject|0|||
33492095|NCT00042289|62869802|FG021|Overall Study|Withdrawal by Subject|1|||
33492096|NCT00042289|62869803|FG022|Overall Study|Withdrawal by Subject|1|||
33492097|NCT00042289|62869804|FG023|Overall Study|Withdrawal by Subject|1|||
33492098|NCT00042289|62869805|FG024|Overall Study|Withdrawal by Subject|0|||
33492099|NCT00042289|62869806|FG025|Overall Study|Withdrawal by Subject|0|||
33492100|NCT00042289|62869807|FG026|Overall Study|Withdrawal by Subject|1|||
33492101|NCT00042289|62869808|FG027|Overall Study|Withdrawal by Subject|0|||
33492102|NCT00042289|62869809|FG028|Overall Study|Withdrawal by Subject|2|||
33492103|NCT00042289|62869810|FG029|Overall Study|Withdrawal by Subject|0|||
33492104|NCT00042289|62869811|FG030|Overall Study|Withdrawal by Subject|0|||
33492105|NCT00042289|62869812|FG031|Overall Study|Withdrawal by Subject|1|||
33492106|NCT00042289|62869813|FG032|Overall Study|Withdrawal by Subject|2|||
33492107|NCT00042289|62869814|FG033|Overall Study|Withdrawal by Subject|1|||
33492108|NCT00042289|62869815|FG034|Overall Study|Withdrawal by Subject|0|||
33492109|NCT00042289|62869816|FG035|Overall Study|Withdrawal by Subject|0|||
33492110|NCT00042289|62869817|FG036|Overall Study|Withdrawal by Subject|0|||
33492111|NCT00042289|62869818|FG037|Overall Study|Withdrawal by Subject|1|||
33492112|NCT00042289|62869819|FG038|Overall Study|Withdrawal by Subject|0|||
33492113|NCT00042289|62869820|FG039|Overall Study|Withdrawal by Subject|0|||
33492114|NCT00042289|62869821|FG040|Overall Study|Withdrawal by Subject|0|||
33492115|NCT00042289|62869822|FG041|Overall Study|Withdrawal by Subject|0|||
33492116|NCT00042289|62869823|FG042|Overall Study|Withdrawal by Subject|1|||
33492117|NCT00042289|62869824|FG043|Overall Study|Withdrawal by Subject|0|||
33492118|NCT00042289|62869825|FG044|Overall Study|Withdrawal by Subject|0|||
33492119|NCT00042289|62869826|FG045|Overall Study|Withdrawal by Subject|0|||
33492120|NCT00042289|62869827|FG046|Overall Study|Withdrawal by Subject|0|||
33492121|NCT02886728|62869999|FG000|Overall Study|Withdrew Consent|31|||
33492122|NCT02886728|62870000|FG001|Overall Study|Withdrew Consent|13|||
33492123|NCT02886728|62870001|FG002|Overall Study|Withdrew Consent|11|||
33492124|NCT02886728|62870002|FG003|Overall Study|Withdrew Consent|47|||
33492125|NCT02886728|62869999|FG000|Overall Study|Lost to Follow-up|12|||
33492126|NCT02886728|62870000|FG001|Overall Study|Lost to Follow-up|6|||
33492127|NCT02886728|62870001|FG002|Overall Study|Lost to Follow-up|13|||
33492128|NCT02886728|62870002|FG003|Overall Study|Lost to Follow-up|12|||
33492129|NCT02886728|62869999|FG000|Overall Study|Adverse Event|13|||
33492130|NCT02886728|62870000|FG001|Overall Study|Adverse Event|5|||
33492131|NCT02886728|62870001|FG002|Overall Study|Adverse Event|5|||
33492132|NCT02886728|62870002|FG003|Overall Study|Adverse Event|11|||
33492133|NCT02886728|62869999|FG000|Overall Study|Investigator's Discretion|11|||
33492134|NCT02886728|62870000|FG001|Overall Study|Investigator's Discretion|7|||
33492135|NCT02886728|62870001|FG002|Overall Study|Investigator's Discretion|5|||
33492136|NCT02886728|62870002|FG003|Overall Study|Investigator's Discretion|11|||
33492137|NCT02886728|62869999|FG000|Overall Study|Death|3|||
33492138|NCT02886728|62870000|FG001|Overall Study|Death|1|||
33492139|NCT02886728|62870001|FG002|Overall Study|Death|0|||
33492140|NCT02886728|62870002|FG003|Overall Study|Death|0|||
33492141|NCT02886728|62869999|FG000|Overall Study|Protocol Violation|0|||
33492142|NCT02886728|62870000|FG001|Overall Study|Protocol Violation|0|||
33492143|NCT02886728|62870001|FG002|Overall Study|Protocol Violation|0|||
33492144|NCT02886728|62870002|FG003|Overall Study|Protocol Violation|4|||
33492145|NCT02886728|62869999|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33492146|NCT02886728|62870000|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33492147|NCT02886728|62870001|FG002|Overall Study|Non-Compliance with Study Drug|1|||
33492148|NCT02886728|62870002|FG003|Overall Study|Non-Compliance with Study Drug|0|||
33492149|NCT02886728|62869999|FG000|Overall Study|Pregnancy|0|||
33492150|NCT02886728|62870000|FG001|Overall Study|Pregnancy|0|||
33492151|NCT02886728|62870001|FG002|Overall Study|Pregnancy|1|||
33492152|NCT02886728|62870002|FG003|Overall Study|Pregnancy|0|||
33492153|NCT02886728|62869999|FG000|Overall Study|Randomized but Not Dosed|1|||
33492154|NCT02886728|62870000|FG001|Overall Study|Randomized but Not Dosed|0|||
33492155|NCT02886728|62870001|FG002|Overall Study|Randomized but Not Dosed|0|||
33492156|NCT02886728|62870002|FG003|Overall Study|Randomized but Not Dosed|2|||
33492157|NCT00039871|62870012|FG000|Overall Study|Adverse Event|165|||
33492158|NCT00039871|62870012|FG000|Overall Study|Lost to Follow-up|18|||
33492159|NCT00039871|62870012|FG000|Overall Study|Protocol Violation|24|||
33492160|NCT00039871|62870012|FG000|Overall Study|Withdrawal by Subject|97|||
33492161|NCT00039871|62870012|FG000|Overall Study|Did not meet eligibility criteria|11|||
33492162|NCT00039871|62870012|FG000|Overall Study|Administrative|1|||
33492163|NCT00039871|62870012|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
33492164|NCT00039871|62870012|FG000|Overall Study|Never entered follow-up|7|||
33492165|NCT00015457|62870016|FG000|First Intervention|Adverse Event|0|||
33492166|NCT00015457|62870017|FG001|First Intervention|Adverse Event|2|||
33492167|NCT00015457|62870016|FG000|First Intervention|Lack of Efficacy|0|||
33492168|NCT00015457|62870017|FG001|First Intervention|Lack of Efficacy|1|||
33492169|NCT00015457|62870016|FG000|Second Intervention|Withdrawal by Subject|1|||
33492170|NCT00015457|62870017|FG001|Second Intervention|Withdrawal by Subject|0|||
33492171|NCT03191630|62870030|FG000|Overall Study|Lost to Follow-up|7|||
33492172|NCT03191630|62870031|FG001|Overall Study|Lost to Follow-up|7|||
33492173|NCT03191552|62870042|FG000|Overall Study|Lost to Follow-up|1|||
33492174|NCT03191552|62870043|FG001|Overall Study|Lost to Follow-up|0|||
33492175|NCT03191552|62870044|FG002|Overall Study|Lost to Follow-up|0|||
33492176|NCT03191552|62870042|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
33492177|NCT03191552|62870043|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
33492178|NCT03191552|62870044|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
33492179|NCT03191396|62870058|FG000|Overall Study|Lost to Follow-up|0|||
33492180|NCT03191396|62870059|FG001|Overall Study|Lost to Follow-up|3|||
33492181|NCT03191396|62870058|FG000|Overall Study|Withdrawal by Subject|3|||
33492182|NCT03191396|62870059|FG001|Overall Study|Withdrawal by Subject|2|||
33492183|NCT00007345|62870067|FG000|Overall Study|Refused further treatment|0|||
33492184|NCT00007345|62870068|FG001|Overall Study|Refused further treatment|7|||
33492185|NCT00007345|62870067|FG000|Overall Study|Switched to alternative treatment|0|||
33492186|NCT00007345|62870068|FG001|Overall Study|Switched to alternative treatment|3|||
33492187|NCT00007345|62870067|FG000|Overall Study|Intercurrent illness|1|||
33492188|NCT00007345|62870068|FG001|Overall Study|Intercurrent illness|0|||
33492189|NCT00007345|62870067|FG000|Overall Study|Death on study|1|||
33492190|NCT00007345|62870068|FG001|Overall Study|Death on study|1|||
33492191|NCT03405662|62870076|FG000|Overall Study|COVID-19 restriction|1|||
33492192|NCT03405662|62870077|FG001|Overall Study|COVID-19 restriction|0|||
33492193|NCT03405662|62870076|FG000|Overall Study|unblinding|0|||
33492194|NCT03405662|62870077|FG001|Overall Study|unblinding|1|||
33492195|NCT03405662|62870076|FG000|Overall Study|placement in memory care facility|0|||
33492196|NCT03405662|62870077|FG001|Overall Study|placement in memory care facility|2|||
33492197|NCT00031447|62870085|FG000|Overall Study|Lost to Follow-up|0|||
33492198|NCT00031447|62870086|FG001|Overall Study|Lost to Follow-up|1|||
33492199|NCT00031447|62870085|FG000|Overall Study|Non-compliant|1|||
33492200|NCT00031447|62870086|FG001|Overall Study|Non-compliant|1|||
33492201|NCT00031447|62870085|FG000|Overall Study|Re-activation of Disease|2|||
33492202|NCT00031447|62870086|FG001|Overall Study|Re-activation of Disease|1|||
33492203|NCT00031447|62870085|FG000|Overall Study|Disruption of blinded study drug supply|7|||
33492204|NCT00031447|62870086|FG001|Overall Study|Disruption of blinded study drug supply|4|||
33492205|NCT00006409|62870098|FG000|Baseline|Protocol Violation|48|||
33492206|NCT00006409|62870099|FG001|Baseline|Protocol Violation|70|||
33492207|NCT00006409|62870100|FG002|Baseline|Protocol Violation|0|||
33492208|NCT00006409|62870101|FG003|Baseline|Protocol Violation|0|||
33492209|NCT00006409|62870102|FG004|Baseline|Protocol Violation|0|||
33492210|NCT00006409|62870103|FG005|Baseline|Protocol Violation|0|||
33492211|NCT00006409|62870098|FG000|Post-2 Year Intervention|Protocol Violation|0|||
33492212|NCT00006409|62870099|FG001|Post-2 Year Intervention|Protocol Violation|0|||
33492213|NCT00006409|62870100|FG002|Post-2 Year Intervention|Protocol Violation|251|||
33492214|NCT00006409|62870101|FG003|Post-2 Year Intervention|Protocol Violation|168|||
33492215|NCT00006409|62870102|FG004|Post-2 Year Intervention|Protocol Violation|0|||
33492216|NCT00006409|62870103|FG005|Post-2 Year Intervention|Protocol Violation|0|||
33492217|NCT00006409|62870098|FG000|Post-3 Year Intervention|Protocol Violation|0|||
33492218|NCT00006409|62870099|FG001|Post-3 Year Intervention|Protocol Violation|0|||
33492219|NCT00006409|62870100|FG002|Post-3 Year Intervention|Protocol Violation|0|||
33492220|NCT00006409|62870101|FG003|Post-3 Year Intervention|Protocol Violation|0|||
33492221|NCT00006409|62870102|FG004|Post-3 Year Intervention|Protocol Violation|62|||
33492222|NCT00006409|62870103|FG005|Post-3 Year Intervention|Protocol Violation|62|||
33492223|NCT00006289|62870119|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
33492224|NCT00006289|62870120|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
33492225|NCT00006289|62870119|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
33492226|NCT00006289|62870120|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
33492227|NCT00005947|62870138|FG000|Overall Study|Death|54|||
33492228|NCT00005947|62870139|FG001|Overall Study|Death|40|||
33492229|NCT00005947|62870138|FG000|Overall Study|Patient Refused to Continue|2|||
33492230|NCT00005947|62870139|FG001|Overall Study|Patient Refused to Continue|1|||
33492231|NCT00005947|62870138|FG000|Overall Study|Site Closure|1|||
33492232|NCT00005947|62870139|FG001|Overall Study|Site Closure|0|||
33492233|NCT00005047|62870151|FG000|Overall Study|Withdrawal by Subject|12|||
33492234|NCT00005047|62870152|FG001|Overall Study|Withdrawal by Subject|0|||
33492235|NCT00005047|62870153|FG002|Overall Study|Withdrawal by Subject|0|||
33492236|NCT00005047|62870154|FG003|Overall Study|Withdrawal by Subject|0|||
33492237|NCT00005047|62870151|FG000|Overall Study|Adverse Event|5|||
33492238|NCT00005047|62870152|FG001|Overall Study|Adverse Event|0|||
33492239|NCT00005047|62870153|FG002|Overall Study|Adverse Event|0|||
33492240|NCT00005047|62870154|FG003|Overall Study|Adverse Event|0|||
33492241|NCT00005047|62870151|FG000|Overall Study|Lost to Follow-up|1|||
33492242|NCT00005047|62870152|FG001|Overall Study|Lost to Follow-up|0|||
33492243|NCT00005047|62870153|FG002|Overall Study|Lost to Follow-up|0|||
33492244|NCT00005047|62870154|FG003|Overall Study|Lost to Follow-up|0|||
33492245|NCT00005047|62870151|FG000|Overall Study|Lack of Efficacy|1|||
33492246|NCT00005047|62870152|FG001|Overall Study|Lack of Efficacy|0|||
33492247|NCT00005047|62870153|FG002|Overall Study|Lack of Efficacy|0|||
33492248|NCT00005047|62870154|FG003|Overall Study|Lack of Efficacy|0|||
33492249|NCT00003901|62870164|FG000|Overall Study|Adverse Event|1|||
33492250|NCT00003901|62870164|FG000|Overall Study|Withdrawal by Subject|1|||
33492251|NCT00003901|62870164|FG000|Overall Study|Ineligible|6|||
33492252|NCT00003901|62870164|FG000|Overall Study|CT Scan not within protocol requirement|2|||
33492253|NCT00003901|62870164|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
33492254|NCT00003901|62870164|FG000|Overall Study|Medical problems|6|||
33492255|NCT00003895|62870173|FG000|Overall Study|Adverse Event|4|||
33492256|NCT00003895|62870174|FG001|Overall Study|Adverse Event|0|||
33492257|NCT00003895|62870173|FG000|Overall Study|Lack of Efficacy|1|||
33492258|NCT00003895|62870174|FG001|Overall Study|Lack of Efficacy|1|||
33492259|NCT00003895|62870173|FG000|Overall Study|Patient Vacation|2|||
33492260|NCT00003895|62870174|FG001|Overall Study|Patient Vacation|0|||
33492261|NCT00003895|62870173|FG000|Overall Study|Withdrawal by Subject|0|||
33492262|NCT00003895|62870174|FG001|Overall Study|Withdrawal by Subject|3|||
33492263|NCT03800173|62870185|FG000|Overall Study|Lost to Follow-up|0|||
33492264|NCT03800173|62870186|FG001|Overall Study|Lost to Follow-up|0|||
33492265|NCT03800173|62870187|FG002|Overall Study|Lost to Follow-up|0|||
33492266|NCT03800173|62870188|FG003|Overall Study|Lost to Follow-up|0|||
33492267|NCT03800173|62870189|FG004|Overall Study|Lost to Follow-up|1|||
33492268|NCT00003631|62870208|FG000|Overall Study|Patient not treated|1|||
33492269|NCT00003631|62870209|FG001|Overall Study|Patient not treated|0|||
33492270|NCT00003631|62870210|FG002|Overall Study|Patient not treated|1|||
33492271|NCT00003631|62870208|FG000|Overall Study|Protocol Violation|1|||
33492272|NCT00003631|62870209|FG001|Overall Study|Protocol Violation|0|||
33492273|NCT00003631|62870210|FG002|Overall Study|Protocol Violation|0|||
33492274|NCT00003631|62870208|FG000|Overall Study|Adverse Event|1|||
33492275|NCT00003631|62870209|FG001|Overall Study|Adverse Event|1|||
33492276|NCT00003631|62870210|FG002|Overall Study|Adverse Event|5|||
33492277|NCT00003631|62870208|FG000|Overall Study|Death|0|||
33492278|NCT00003631|62870209|FG001|Overall Study|Death|0|||
33492279|NCT00003631|62870210|FG002|Overall Study|Death|1|||
33492280|NCT00003631|62870208|FG000|Overall Study|Evaluable for toxicity only|0|||
33492281|NCT00003631|62870209|FG001|Overall Study|Evaluable for toxicity only|0|||
33492282|NCT00003631|62870210|FG002|Overall Study|Evaluable for toxicity only|2|||
33492283|NCT00003535|62870218|FG000|Overall Study|Not evaluable|5|||
33492284|NCT00003511|62870222|FG000|Overall Study|Not evaluable|4|||
33492285|NCT00003499|62870226|FG000|Overall Study|Not evaluable|8|||
33492286|NCT00003487|62870230|FG000|Overall Study|Not evaluable|2|||
33492287|NCT00003475|62870234|FG000|Overall Study|Not evaluable|13|||
33492288|NCT00003457|62870239|FG000|Overall Study|Not evaluable|9|||
33492289|NCT00030901|62870245|FG000|Initial Registration|Ineligible|167|||
33492290|NCT00030901|62870246|FG001|Initial Registration|Ineligible|0|||
33492291|NCT00030901|62870247|FG002|Initial Registration|Ineligible|0|||
33492292|NCT00030901|62870245|FG000|Randomization|Adverse Event|0|||
33492293|NCT00030901|62870246|FG001|Randomization|Adverse Event|11|||
33492294|NCT00030901|62870247|FG002|Randomization|Adverse Event|7|||
33492295|NCT00030901|62870245|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
33492296|NCT00030901|62870246|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
33492297|NCT00030901|62870247|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
33492298|NCT00030901|62870245|FG000|Randomization|Progression/Relapse|0|||
33492299|NCT00030901|62870246|FG001|Randomization|Progression/Relapse|22|||
33492300|NCT00030901|62870247|FG002|Randomization|Progression/Relapse|21|||
33492301|NCT00030901|62870245|FG000|Randomization|Death|0|||
33492302|NCT00030901|62870246|FG001|Randomization|Death|1|||
33492303|NCT00030901|62870247|FG002|Randomization|Death|3|||
33492304|NCT00030901|62870245|FG000|Randomization|Other|0|||
33492305|NCT00030901|62870246|FG001|Randomization|Other|36|||
33492306|NCT00030901|62870247|FG002|Randomization|Other|33|||
33492307|NCT00030901|62870245|FG000|Randomization|Ineligible|0|||
33492308|NCT00030901|62870246|FG001|Randomization|Ineligible|15|||
33492309|NCT00030901|62870247|FG002|Randomization|Ineligible|14|||
33492310|NCT00003199|62870253|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
33492311|NCT00003199|62870253|FG000|Overall Study|Lack of insurance clearance|2|||
33492312|NCT00003199|62870253|FG000|Overall Study|Screen fail|15|||
33492313|NCT00030823|62870257|FG000|Overall Study|Withdrawal by Subject|1|||
33492314|NCT00001849|62870261|FG000|Overall Study|Death|4|||
33492315|NCT00001849|62870261|FG000|Overall Study|Lost to Follow-up|2|||
33492316|NCT00001849|62870261|FG000|Overall Study|Withdrawal by Subject|2|||
33492317|NCT00001849|62870261|FG000|Overall Study|tumor remained occult|6|||
33492318|NCT01342952|62870278|FG000|Overall Study|Adverse Event|0|||
33492319|NCT01342952|62870279|FG001|Overall Study|Adverse Event|5|||
33492320|NCT01342952|62870280|FG002|Overall Study|Adverse Event|1|||
33492321|NCT01342952|62870281|FG003|Overall Study|Adverse Event|0|||
33492322|NCT01342952|62870278|FG000|Overall Study|Lost to Follow-up|0|||
33492323|NCT01342952|62870279|FG001|Overall Study|Lost to Follow-up|2|||
33673549|NCT00244725|63110954|FG003|Overall Study|Headache|0|||
33492324|NCT01342952|62870280|FG002|Overall Study|Lost to Follow-up|0|||
33673550|NCT00244725|63110951|FG000|Overall Study|Received prohibited medication|0|||
33492325|NCT01342952|62870281|FG003|Overall Study|Lost to Follow-up|0|||
33492326|NCT01342952|62870278|FG000|Overall Study|Withdrawal by Subject|1|||
33492327|NCT01342952|62870279|FG001|Overall Study|Withdrawal by Subject|1|||
33492328|NCT01342952|62870280|FG002|Overall Study|Withdrawal by Subject|0|||
33492329|NCT01342952|62870281|FG003|Overall Study|Withdrawal by Subject|0|||
33492330|NCT01342952|62870278|FG000|Overall Study|Physician Decision|3|||
33492331|NCT01342952|62870279|FG001|Overall Study|Physician Decision|3|||
33492332|NCT01342952|62870280|FG002|Overall Study|Physician Decision|1|||
33492333|NCT01342952|62870281|FG003|Overall Study|Physician Decision|0|||
33492334|NCT02886884|62870308|FG000|Follow-up|Withdrawal by Subject|0|||
33492335|NCT02886884|62870309|FG001|Follow-up|Withdrawal by Subject|0|||
33492336|NCT02886884|62870310|FG002|Follow-up|Withdrawal by Subject|0|||
33492337|NCT02886884|62870311|FG003|Follow-up|Withdrawal by Subject|1|||
33492338|NCT01240694|62870330|FG000|Overall Study|Adverse Event|9|||
33492339|NCT01240694|62870330|FG000|Overall Study|Lack of Efficacy|6|||
33492340|NCT01240694|62870330|FG000|Overall Study|Withdrawal by Subject|6|||
33492341|NCT01240694|62870330|FG000|Overall Study|Protocol Violation|2|||
33492342|NCT01240694|62870330|FG000|Overall Study|Lost to Follow-up|2|||
33492343|NCT01240694|62870330|FG000|Overall Study|Other than specified|3|||
33492344|NCT01240694|62870330|FG000|Overall Study|Withdrawn due to early study termination|107|||
33492345|NCT03162224|62870337|FG000|Overall Study|Death|4|||
33492346|NCT03162224|62870338|FG001|Overall Study|Death|5|||
33492347|NCT03162224|62870339|FG002|Overall Study|Death|8|||
33492348|NCT03162224|62870337|FG000|Overall Study|Withdrawal by Subject|1|||
33492349|NCT03162224|62870338|FG001|Overall Study|Withdrawal by Subject|0|||
33492350|NCT03162224|62870339|FG002|Overall Study|Withdrawal by Subject|1|||
33492351|NCT03162224|62870337|FG000|Overall Study|Lost to Follow-up|0|||
33492352|NCT03162224|62870338|FG001|Overall Study|Lost to Follow-up|1|||
33492353|NCT03162224|62870339|FG002|Overall Study|Lost to Follow-up|0|||
33492354|NCT03162224|62870337|FG000|Overall Study|Other|6|||
33492355|NCT03162224|62870338|FG001|Overall Study|Other|2|||
33492356|NCT03162224|62870339|FG002|Overall Study|Other|1|||
33492357|NCT02886338|62870378|FG000|Overall Study|Withdrawal by Subject|1|||
33492358|NCT00004124|62870384|FG000|Overall Study|Received no protocol therapy|12|||
33492359|NCT00004124|62870385|FG001|Overall Study|Received no protocol therapy|20|||
33492360|NCT00383552|62870395|FG000|Overall Study|Adverse Event|7|||
33492361|NCT00383552|62870396|FG001|Overall Study|Adverse Event|6|||
33492362|NCT00383552|62870397|FG002|Overall Study|Adverse Event|9|||
33492363|NCT00383552|62870398|FG003|Overall Study|Adverse Event|6|||
33492364|NCT00383552|62870395|FG000|Overall Study|Lack of Efficacy|4|||
33492365|NCT00383552|62870396|FG001|Overall Study|Lack of Efficacy|13|||
33492366|NCT00383552|62870397|FG002|Overall Study|Lack of Efficacy|29|||
33492367|NCT00383552|62870398|FG003|Overall Study|Lack of Efficacy|42|||
33492368|NCT00383552|62870395|FG000|Overall Study|Lost to Follow-up|0|||
33492369|NCT00383552|62870396|FG001|Overall Study|Lost to Follow-up|1|||
33492370|NCT00383552|62870397|FG002|Overall Study|Lost to Follow-up|5|||
33492371|NCT00383552|62870398|FG003|Overall Study|Lost to Follow-up|1|||
33492372|NCT00383552|62870395|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
33492373|NCT00383552|62870396|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
33492374|NCT00383552|62870397|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
33492375|NCT00383552|62870398|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
33492376|NCT00383552|62870395|FG000|Overall Study|Did not wish to continue (related)|1|||
33492377|NCT00383552|62870396|FG001|Overall Study|Did not wish to continue (related)|0|||
33492378|NCT00383552|62870397|FG002|Overall Study|Did not wish to continue (related)|2|||
33492379|NCT00383552|62870398|FG003|Overall Study|Did not wish to continue (related)|3|||
33492380|NCT00383552|62870395|FG000|Overall Study|Noncompliance with the protocol|11|||
33492381|NCT00383552|62870396|FG001|Overall Study|Noncompliance with the protocol|6|||
33492382|NCT00383552|62870397|FG002|Overall Study|Noncompliance with the protocol|8|||
33492383|NCT00383552|62870398|FG003|Overall Study|Noncompliance with the protocol|10|||
33492384|NCT00383552|62870395|FG000|Overall Study|Did not meet protocol eligibility|8|||
33492385|NCT00383552|62870396|FG001|Overall Study|Did not meet protocol eligibility|6|||
33492386|NCT00383552|62870397|FG002|Overall Study|Did not meet protocol eligibility|2|||
33492387|NCT00383552|62870398|FG003|Overall Study|Did not meet protocol eligibility|3|||
33492388|NCT00383552|62870395|FG000|Overall Study|Administrative|1|||
33492389|NCT00383552|62870396|FG001|Overall Study|Administrative|0|||
33492390|NCT00383552|62870397|FG002|Overall Study|Administrative|1|||
33492391|NCT00383552|62870398|FG003|Overall Study|Administrative|1|||
33492392|NCT03158012|62870415|FG000|Overall Study|Withdrawal by Subject|0|||
33492393|NCT03158012|62870416|FG001|Overall Study|Withdrawal by Subject|1|||
33492394|NCT01776424|62870425|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
33492395|NCT01776424|62870426|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
33492396|NCT01776424|62870427|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
33492397|NCT01776424|62870425|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
33492398|NCT01776424|62870426|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
33492399|NCT01776424|62870427|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
33492400|NCT01776424|62870425|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
33492401|NCT01776424|62870426|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
33492402|NCT01776424|62870427|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
33492403|NCT01776424|62870425|FG000|LTOLE Part (Open Label)|Refused|5|||
33492404|NCT01776424|62870426|FG001|LTOLE Part (Open Label)|Refused|2|||
33492405|NCT01776424|62870427|FG002|LTOLE Part (Open Label)|Refused|11|||
33492406|NCT01776424|62870425|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
33492407|NCT01776424|62870426|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
33492408|NCT01776424|62870427|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
33492409|NCT03799627|62870453|FG000|Overall Study|Adverse Event|1|||
33492410|NCT03799627|62870454|FG001|Overall Study|Adverse Event|2|||
33492411|NCT03799627|62870455|FG002|Overall Study|Adverse Event|0|||
33492412|NCT03799627|62870456|FG003|Overall Study|Adverse Event|0|||
33492413|NCT03799627|62870457|FG004|Overall Study|Adverse Event|2|||
33492414|NCT03799627|62870458|FG005|Overall Study|Adverse Event|5|||
33492415|NCT03799627|62870459|FG006|Overall Study|Adverse Event|0|||
33492416|NCT03799627|62870460|FG007|Overall Study|Adverse Event|2|||
33492417|NCT03799627|62870461|FG008|Overall Study|Adverse Event|0|||
33492418|NCT03799627|62870453|FG000|Overall Study|Physician Decision|2|||
33492419|NCT03799627|62870454|FG001|Overall Study|Physician Decision|2|||
33492420|NCT03799627|62870455|FG002|Overall Study|Physician Decision|0|||
33492421|NCT03799627|62870456|FG003|Overall Study|Physician Decision|0|||
33492422|NCT03799627|62870457|FG004|Overall Study|Physician Decision|2|||
33492423|NCT03799627|62870458|FG005|Overall Study|Physician Decision|2|||
33492424|NCT03799627|62870459|FG006|Overall Study|Physician Decision|0|||
33492425|NCT03799627|62870460|FG007|Overall Study|Physician Decision|0|||
33492426|NCT03799627|62870461|FG008|Overall Study|Physician Decision|0|||
33492427|NCT03799627|62870453|FG000|Overall Study|Withdrawal by Subject|1|||
33492428|NCT03799627|62870454|FG001|Overall Study|Withdrawal by Subject|1|||
33492429|NCT03799627|62870455|FG002|Overall Study|Withdrawal by Subject|0|||
33492430|NCT03799627|62870456|FG003|Overall Study|Withdrawal by Subject|2|||
33492431|NCT03799627|62870457|FG004|Overall Study|Withdrawal by Subject|0|||
33492432|NCT03799627|62870458|FG005|Overall Study|Withdrawal by Subject|3|||
33492433|NCT03799627|62870459|FG006|Overall Study|Withdrawal by Subject|0|||
33492434|NCT03799627|62870460|FG007|Overall Study|Withdrawal by Subject|0|||
33492435|NCT03799627|62870461|FG008|Overall Study|Withdrawal by Subject|0|||
33492436|NCT03799627|62870453|FG000|Overall Study|Lack of Efficacy|0|||
33492437|NCT03799627|62870454|FG001|Overall Study|Lack of Efficacy|0|||
33492438|NCT03799627|62870455|FG002|Overall Study|Lack of Efficacy|0|||
33492439|NCT03799627|62870456|FG003|Overall Study|Lack of Efficacy|1|||
33492440|NCT03799627|62870457|FG004|Overall Study|Lack of Efficacy|0|||
33492441|NCT03799627|62870458|FG005|Overall Study|Lack of Efficacy|0|||
33492442|NCT03799627|62870459|FG006|Overall Study|Lack of Efficacy|0|||
33492443|NCT03799627|62870460|FG007|Overall Study|Lack of Efficacy|0|||
33492444|NCT03799627|62870461|FG008|Overall Study|Lack of Efficacy|0|||
33492445|NCT03799627|62870453|FG000|Overall Study|Lost to Follow-up|0|||
33492446|NCT03799627|62870454|FG001|Overall Study|Lost to Follow-up|0|||
33492447|NCT03799627|62870455|FG002|Overall Study|Lost to Follow-up|0|||
33492448|NCT03799627|62870456|FG003|Overall Study|Lost to Follow-up|0|||
33492449|NCT03799627|62870457|FG004|Overall Study|Lost to Follow-up|0|||
33492450|NCT03799627|62870458|FG005|Overall Study|Lost to Follow-up|0|||
33492451|NCT03799627|62870459|FG006|Overall Study|Lost to Follow-up|1|||
33492452|NCT03799627|62870460|FG007|Overall Study|Lost to Follow-up|0|||
33492453|NCT03799627|62870461|FG008|Overall Study|Lost to Follow-up|1|||
33492454|NCT03799627|62870453|FG000|Overall Study|Death|0|||
33492455|NCT03799627|62870454|FG001|Overall Study|Death|0|||
33492456|NCT03799627|62870455|FG002|Overall Study|Death|0|||
33492457|NCT03799627|62870456|FG003|Overall Study|Death|1|||
33492458|NCT03799627|62870457|FG004|Overall Study|Death|0|||
33492459|NCT03799627|62870458|FG005|Overall Study|Death|0|||
33492460|NCT03799627|62870459|FG006|Overall Study|Death|0|||
33492461|NCT03799627|62870460|FG007|Overall Study|Death|0|||
33492462|NCT03799627|62870461|FG008|Overall Study|Death|0|||
33492463|NCT03799627|62870453|FG000|Overall Study|Study Drug Put on Hold|1|||
33492464|NCT03799627|62870454|FG001|Overall Study|Study Drug Put on Hold|0|||
33492465|NCT03799627|62870455|FG002|Overall Study|Study Drug Put on Hold|0|||
33492466|NCT03799627|62870456|FG003|Overall Study|Study Drug Put on Hold|0|||
33492467|NCT03799627|62870457|FG004|Overall Study|Study Drug Put on Hold|0|||
33492468|NCT03799627|62870458|FG005|Overall Study|Study Drug Put on Hold|0|||
33492469|NCT03799627|62870459|FG006|Overall Study|Study Drug Put on Hold|0|||
33492470|NCT03799627|62870460|FG007|Overall Study|Study Drug Put on Hold|0|||
33492471|NCT03799627|62870461|FG008|Overall Study|Study Drug Put on Hold|0|||
33492472|NCT03799627|62870453|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
33492473|NCT03799627|62870454|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
33492474|NCT03799627|62870455|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
33492475|NCT03799627|62870456|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
33492476|NCT03799627|62870457|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
33492477|NCT03799627|62870458|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
33492478|NCT03799627|62870459|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
33492479|NCT03799627|62870460|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
33492480|NCT03799627|62870461|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
33492481|NCT03799627|62870453|FG000|Overall Study|Kidney Transplantation|1|||
33492482|NCT03799627|62870454|FG001|Overall Study|Kidney Transplantation|0|||
33492483|NCT03799627|62870455|FG002|Overall Study|Kidney Transplantation|0|||
33492484|NCT03799627|62870456|FG003|Overall Study|Kidney Transplantation|1|||
33492485|NCT03799627|62870457|FG004|Overall Study|Kidney Transplantation|1|||
33492486|NCT03799627|62870458|FG005|Overall Study|Kidney Transplantation|0|||
33492487|NCT03799627|62870459|FG006|Overall Study|Kidney Transplantation|0|||
33492488|NCT03799627|62870460|FG007|Overall Study|Kidney Transplantation|0|||
33492489|NCT03799627|62870461|FG008|Overall Study|Kidney Transplantation|0|||
33492490|NCT03799627|62870453|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
33492491|NCT03799627|62870454|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
33492492|NCT03799627|62870455|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
33492493|NCT03799627|62870456|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
33492494|NCT03799627|62870457|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
33492495|NCT03799627|62870458|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
33492496|NCT03799627|62870459|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
33492497|NCT03799627|62870460|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
33492498|NCT03799627|62870461|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
33492499|NCT03799627|62870453|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33492500|NCT03799627|62870454|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
33492501|NCT03799627|62870455|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33492502|NCT03799627|62870456|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33492503|NCT03799627|62870457|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33492504|NCT03799627|62870458|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33492505|NCT03799627|62870459|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33492506|NCT03799627|62870460|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33492507|NCT03799627|62870461|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33492508|NCT03799627|62870453|FG000|Overall Study|Met Exclusion Criteria|0|||
33492509|NCT03799627|62870454|FG001|Overall Study|Met Exclusion Criteria|0|||
33492510|NCT03799627|62870455|FG002|Overall Study|Met Exclusion Criteria|0|||
33492511|NCT03799627|62870456|FG003|Overall Study|Met Exclusion Criteria|1|||
33492512|NCT03799627|62870457|FG004|Overall Study|Met Exclusion Criteria|0|||
33492513|NCT03799627|62870458|FG005|Overall Study|Met Exclusion Criteria|0|||
33492514|NCT03799627|62870459|FG006|Overall Study|Met Exclusion Criteria|0|||
33492515|NCT03799627|62870460|FG007|Overall Study|Met Exclusion Criteria|0|||
33492516|NCT03799627|62870461|FG008|Overall Study|Met Exclusion Criteria|0|||
33492517|NCT03799627|62870453|FG000|Overall Study|Investigational Product Noncompliance|0|||
33492518|NCT03799627|62870454|FG001|Overall Study|Investigational Product Noncompliance|0|||
33492519|NCT03799627|62870455|FG002|Overall Study|Investigational Product Noncompliance|0|||
33492520|NCT03799627|62870456|FG003|Overall Study|Investigational Product Noncompliance|1|||
33492521|NCT03799627|62870457|FG004|Overall Study|Investigational Product Noncompliance|0|||
33492522|NCT03799627|62870458|FG005|Overall Study|Investigational Product Noncompliance|0|||
33492523|NCT03799627|62870459|FG006|Overall Study|Investigational Product Noncompliance|0|||
33492524|NCT03799627|62870460|FG007|Overall Study|Investigational Product Noncompliance|0|||
33492525|NCT03799627|62870461|FG008|Overall Study|Investigational Product Noncompliance|0|||
33492526|NCT03799627|62870453|FG000|Overall Study|Participant Relocation|0|||
33492527|NCT03799627|62870454|FG001|Overall Study|Participant Relocation|0|||
33492528|NCT03799627|62870455|FG002|Overall Study|Participant Relocation|0|||
33492529|NCT03799627|62870456|FG003|Overall Study|Participant Relocation|1|||
33492530|NCT03799627|62870457|FG004|Overall Study|Participant Relocation|0|||
33492531|NCT03799627|62870458|FG005|Overall Study|Participant Relocation|1|||
33492532|NCT03799627|62870459|FG006|Overall Study|Participant Relocation|0|||
33492533|NCT03799627|62870460|FG007|Overall Study|Participant Relocation|0|||
33492534|NCT03799627|62870461|FG008|Overall Study|Participant Relocation|0|||
33492535|NCT03799627|62870453|FG000|Overall Study|Eurofin Issue|0|||
33492536|NCT03799627|62870454|FG001|Overall Study|Eurofin Issue|0|||
33492537|NCT03799627|62870455|FG002|Overall Study|Eurofin Issue|0|||
33492538|NCT03799627|62870456|FG003|Overall Study|Eurofin Issue|0|||
33492539|NCT03799627|62870457|FG004|Overall Study|Eurofin Issue|1|||
33492540|NCT03799627|62870458|FG005|Overall Study|Eurofin Issue|0|||
33492541|NCT03799627|62870459|FG006|Overall Study|Eurofin Issue|0|||
33673551|NCT00244725|63110952|FG001|Overall Study|Received prohibited medication|1|||
33492542|NCT03799627|62870460|FG007|Overall Study|Eurofin Issue|0|||
33492543|NCT03799627|62870461|FG008|Overall Study|Eurofin Issue|0|||
33492544|NCT03799627|62870453|FG000|Overall Study|Noncompliance with Site Instructions|0|||
33492545|NCT03799627|62870454|FG001|Overall Study|Noncompliance with Site Instructions|0|||
33492546|NCT03799627|62870455|FG002|Overall Study|Noncompliance with Site Instructions|0|||
33492547|NCT03799627|62870456|FG003|Overall Study|Noncompliance with Site Instructions|0|||
33492548|NCT03799627|62870457|FG004|Overall Study|Noncompliance with Site Instructions|1|||
33492549|NCT03799627|62870458|FG005|Overall Study|Noncompliance with Site Instructions|0|||
33492550|NCT03799627|62870459|FG006|Overall Study|Noncompliance with Site Instructions|0|||
33492551|NCT03799627|62870460|FG007|Overall Study|Noncompliance with Site Instructions|0|||
33492552|NCT03799627|62870461|FG008|Overall Study|Noncompliance with Site Instructions|0|||
33492553|NCT03799627|62870453|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33492554|NCT03799627|62870454|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33492555|NCT03799627|62870455|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33492556|NCT03799627|62870456|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33492557|NCT03799627|62870457|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
33492558|NCT03799627|62870458|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33492559|NCT03799627|62870459|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33492560|NCT03799627|62870460|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33492561|NCT03799627|62870461|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33492562|NCT03799627|62870453|FG000|Overall Study|Changes In Hemoglobin Values|1|||
33492563|NCT03799627|62870454|FG001|Overall Study|Changes In Hemoglobin Values|2|||
33492564|NCT03799627|62870455|FG002|Overall Study|Changes In Hemoglobin Values|1|||
33492565|NCT03799627|62870456|FG003|Overall Study|Changes In Hemoglobin Values|0|||
33492566|NCT03799627|62870457|FG004|Overall Study|Changes In Hemoglobin Values|0|||
33492567|NCT03799627|62870458|FG005|Overall Study|Changes In Hemoglobin Values|2|||
33492568|NCT03799627|62870459|FG006|Overall Study|Changes In Hemoglobin Values|1|||
33492569|NCT03799627|62870460|FG007|Overall Study|Changes In Hemoglobin Values|0|||
33492570|NCT03799627|62870461|FG008|Overall Study|Changes In Hemoglobin Values|1|||
33492571|NCT00756574|62870502|FG000|Overall Study|Withdrawal by Subject|9|||
33492572|NCT00756574|62870503|FG001|Overall Study|Withdrawal by Subject|7|||
33492573|NCT00756574|62870502|FG000|Overall Study|Lost to Follow-up|4|||
33492574|NCT00756574|62870503|FG001|Overall Study|Lost to Follow-up|4|||
33492575|NCT02743780|62870512|FG000|Part 3 (7 Days)|Adverse Event|0|||
33492576|NCT02743780|62870513|FG001|Part 3 (7 Days)|Adverse Event|0|||
33492577|NCT02743780|62870514|FG002|Part 3 (7 Days)|Adverse Event|1|||
33492578|NCT02743780|62870515|FG003|Part 3 (7 Days)|Adverse Event|0|||
33492579|NCT02743780|62870516|FG004|Part 3 (7 Days)|Adverse Event|0|||
33492580|NCT02880956|62870540|FG000|Overall Study|Adverse Event|3|||
33492581|NCT02880956|62870541|FG001|Overall Study|Adverse Event|6|||
33492582|NCT02880956|62870542|FG002|Overall Study|Adverse Event|5|||
33492583|NCT02880956|62870543|FG003|Overall Study|Adverse Event|4|||
33492584|NCT02880956|62870540|FG000|Overall Study|Withdrawal by Subject|9|||
33492585|NCT02880956|62870541|FG001|Overall Study|Withdrawal by Subject|4|||
33492586|NCT02880956|62870542|FG002|Overall Study|Withdrawal by Subject|6|||
33492587|NCT02880956|62870543|FG003|Overall Study|Withdrawal by Subject|11|||
33492588|NCT02880956|62870540|FG000|Overall Study|Lost to Follow-up|0|||
33492589|NCT02880956|62870541|FG001|Overall Study|Lost to Follow-up|1|||
33492590|NCT02880956|62870542|FG002|Overall Study|Lost to Follow-up|0|||
33492591|NCT02880956|62870543|FG003|Overall Study|Lost to Follow-up|0|||
33492592|NCT02880956|62870540|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
33492593|NCT02880956|62870541|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
33492594|NCT02880956|62870542|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
33492595|NCT02880956|62870543|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
33492596|NCT02880956|62870540|FG000|Overall Study|Other, Not Specified|4|||
33492597|NCT02880956|62870541|FG001|Overall Study|Other, Not Specified|2|||
33492598|NCT02880956|62870542|FG002|Overall Study|Other, Not Specified|0|||
33492599|NCT02880956|62870543|FG003|Overall Study|Other, Not Specified|3|||
33492600|NCT01352416|62870560|FG000|Overall Study|Physician Decision|1|||
33492601|NCT01352416|62870561|FG001|Overall Study|Physician Decision|2|||
33492602|NCT01352416|62870562|FG002|Overall Study|Physician Decision|2|||
33492603|NCT01352416|62870563|FG003|Overall Study|Physician Decision|1|||
33492604|NCT00439738|62870575|FG000|Overall Study|Withdrawal by Subject|16|||
33492605|NCT00439738|62870576|FG001|Overall Study|Withdrawal by Subject|13|||
33492606|NCT00439738|62870575|FG000|Overall Study|Adverse Event|6|||
33492607|NCT00439738|62870576|FG001|Overall Study|Adverse Event|4|||
33492608|NCT00439738|62870575|FG000|Overall Study|Lost to Follow-up|5|||
33492609|NCT00439738|62870576|FG001|Overall Study|Lost to Follow-up|6|||
33492610|NCT00439738|62870575|FG000|Overall Study|Protocol Violation|6|||
33492611|NCT00439738|62870576|FG001|Overall Study|Protocol Violation|3|||
33492612|NCT00439738|62870575|FG000|Overall Study|Lack of Efficacy|2|||
33492613|NCT00439738|62870576|FG001|Overall Study|Lack of Efficacy|2|||
33492614|NCT00439738|62870575|FG000|Overall Study|Abnormal Lab Values|1|||
33492615|NCT00439738|62870576|FG001|Overall Study|Abnormal Lab Values|0|||
33492616|NCT00338104|62870583|FG000|Overall Study|Protocol Violation|2|||
33492617|NCT00338104|62870584|FG001|Overall Study|Protocol Violation|1|||
33492618|NCT00338104|62870585|FG002|Overall Study|Protocol Violation|3|||
33492619|NCT05091307|62870594|FG000|Overall Study|Death|0|||
33492620|NCT05091307|62870595|FG001|Overall Study|Death|0|||
33492621|NCT05091307|62870596|FG002|Overall Study|Death|1|||
33492622|NCT05091307|62870597|FG003|Overall Study|Death|0|||
33492623|NCT05091307|62870594|FG000|Overall Study|Lost to Follow-up|33|||
33492624|NCT05091307|62870595|FG001|Overall Study|Lost to Follow-up|33|||
33492625|NCT05091307|62870596|FG002|Overall Study|Lost to Follow-up|2|||
33492626|NCT05091307|62870597|FG003|Overall Study|Lost to Follow-up|0|||
33492627|NCT05091307|62870594|FG000|Overall Study|Physician Decision|1|||
33492628|NCT05091307|62870595|FG001|Overall Study|Physician Decision|0|||
33492629|NCT05091307|62870596|FG002|Overall Study|Physician Decision|0|||
33492630|NCT05091307|62870597|FG003|Overall Study|Physician Decision|0|||
33492631|NCT05091307|62870594|FG000|Overall Study|Protocol Violation|1|||
33492632|NCT05091307|62870595|FG001|Overall Study|Protocol Violation|0|||
33492633|NCT05091307|62870596|FG002|Overall Study|Protocol Violation|0|||
33492634|NCT05091307|62870597|FG003|Overall Study|Protocol Violation|0|||
33492635|NCT05091307|62870594|FG000|Overall Study|Withdrawal by Subject|16|||
33492636|NCT05091307|62870595|FG001|Overall Study|Withdrawal by Subject|16|||
33492637|NCT05091307|62870596|FG002|Overall Study|Withdrawal by Subject|0|||
33492638|NCT05091307|62870597|FG003|Overall Study|Withdrawal by Subject|1|||
33492639|NCT05091307|62870594|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
33492640|NCT05091307|62870595|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
33492641|NCT05091307|62870596|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
33492642|NCT05091307|62870597|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
33492643|NCT05091307|62870594|FG000|Overall Study|Initiated Prohibited Medication|1|||
33492644|NCT05091307|62870595|FG001|Overall Study|Initiated Prohibited Medication|0|||
33492645|NCT05091307|62870596|FG002|Overall Study|Initiated Prohibited Medication|0|||
33492646|NCT05091307|62870597|FG003|Overall Study|Initiated Prohibited Medication|0|||
33492647|NCT05091307|62870594|FG000|Overall Study|Other|4|||
33492648|NCT05091307|62870595|FG001|Overall Study|Other|4|||
33492649|NCT05091307|62870596|FG002|Overall Study|Other|0|||
33492650|NCT05091307|62870597|FG003|Overall Study|Other|0|||
33492651|NCT05091307|62870594|FG000|Overall Study|Randomized but not vaccinated|0|||
33492652|NCT05091307|62870595|FG001|Overall Study|Randomized but not vaccinated|2|||
33492653|NCT05091307|62870596|FG002|Overall Study|Randomized but not vaccinated|0|||
33492654|NCT05091307|62870597|FG003|Overall Study|Randomized but not vaccinated|0|||
33492655|NCT04446377|62870615|FG000|Overall Study|Withdrawal by Subject|6|||
33492656|NCT04446377|62870616|FG001|Overall Study|Withdrawal by Subject|1|||
33492657|NCT04446377|62870615|FG000|Overall Study|Physician Decision|1|||
33492658|NCT04446377|62870616|FG001|Overall Study|Physician Decision|1|||
33492659|NCT04446377|62870615|FG000|Overall Study|Lost to Follow-up|0|||
33492660|NCT04446377|62870616|FG001|Overall Study|Lost to Follow-up|2|||
33492661|NCT04446377|62870615|FG000|Overall Study|Not eligible|0|||
33492662|NCT04446377|62870616|FG001|Overall Study|Not eligible|1|||
33492663|NCT04398368|62870626|FG000|Overall Study|Withdrawal by Subject|2|||
33492664|NCT04275297|62870632|FG000|Overall Study|Lost to Follow-up|1|||
33492665|NCT04275297|62870633|FG001|Overall Study|Lost to Follow-up|1|||
33492666|NCT04247282|62870643|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
33492667|NCT04247282|62870644|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
33492668|NCT04247282|62870645|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
33492669|NCT04247282|62870646|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
33492670|NCT04247282|62870643|FG000|Overall Study|Refused further treatment|0|||
33492671|NCT04247282|62870644|FG001|Overall Study|Refused further treatment|1|||
33492672|NCT04247282|62870645|FG002|Overall Study|Refused further treatment|0|||
33492673|NCT04247282|62870646|FG003|Overall Study|Refused further treatment|0|||
33492674|NCT04224688|62870657|FG000|Overall Study|Withdrawal by Subject|1|||
33492675|NCT04224688|62870658|FG001|Overall Study|Withdrawal by Subject|3|||
33492676|NCT04224688|62870657|FG000|Overall Study|Lack of Efficacy|1|||
33492677|NCT04224688|62870658|FG001|Overall Study|Lack of Efficacy|1|||
33492678|NCT04224688|62870657|FG000|Overall Study|Adverse event, not fatal|0|||
33492679|NCT04224688|62870658|FG001|Overall Study|Adverse event, not fatal|2|||
33492680|NCT04224688|62870657|FG000|Overall Study|COVID-19|0|||
33492681|NCT04224688|62870658|FG001|Overall Study|COVID-19|1|||
33492682|NCT04200456|62870666|FG000|Overall Study|Physician Decision|0|||
33492683|NCT04200456|62870667|FG001|Overall Study|Physician Decision|1|||
33492684|NCT04200456|62870666|FG000|Overall Study|Withdrawal by Subject|2|||
33492685|NCT04200456|62870667|FG001|Overall Study|Withdrawal by Subject|2|||
33492686|NCT04200456|62870666|FG000|Overall Study|Lack of Efficacy|1|||
33492687|NCT04200456|62870667|FG001|Overall Study|Lack of Efficacy|1|||
33310616|NCT01241448|62685990|FG000|Overall Study|Withdrawal by Subject|4|||
33310617|NCT01241448|62685991|FG001|Overall Study|Withdrawal by Subject|5|||
33310618|NCT01241448|62685992|FG002|Overall Study|Withdrawal by Subject|3|||
33310619|NCT01241448|62685993|FG003|Overall Study|Withdrawal by Subject|6|||
33310620|NCT01241448|62685990|FG000|Overall Study|Excluded due to data integrity issues|3|||
33310621|NCT01241448|62685991|FG001|Overall Study|Excluded due to data integrity issues|2|||
33310622|NCT01241448|62685992|FG002|Overall Study|Excluded due to data integrity issues|2|||
33310623|NCT01241448|62685993|FG003|Overall Study|Excluded due to data integrity issues|2|||
33310624|NCT01240356|62686006|FG000|Overall Study|Withdrawal by Subject|2|||
33310625|NCT01240356|62686007|FG001|Overall Study|Withdrawal by Subject|0|||
33310626|NCT01240356|62686006|FG000|Overall Study|MRI contraindication|1|||
33492688|NCT04200456|62870666|FG000|Overall Study|Adverse event, non-fatal|0|||
33492689|NCT04200456|62870667|FG001|Overall Study|Adverse event, non-fatal|1|||
33492690|NCT04200456|62870666|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
33492691|NCT04200456|62870667|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
33492692|NCT03766685|62870677|FG000|Overall Study|Lost to Follow-up|1|||
33492693|NCT03766685|62870678|FG001|Overall Study|Lost to Follow-up|1|||
33492694|NCT03766685|62870679|FG002|Overall Study|Lost to Follow-up|0|||
33492695|NCT03766685|62870680|FG003|Overall Study|Lost to Follow-up|0|||
33492696|NCT03766685|62870677|FG000|Overall Study|Adverse Event, not fatal|0|||
33492697|NCT03766685|62870678|FG001|Overall Study|Adverse Event, not fatal|1|||
33492698|NCT03766685|62870679|FG002|Overall Study|Adverse Event, not fatal|0|||
33492699|NCT03766685|62870680|FG003|Overall Study|Adverse Event, not fatal|1|||
33492700|NCT03766685|62870677|FG000|Overall Study|Withdrawal by Subject|0|||
33492701|NCT03766685|62870678|FG001|Overall Study|Withdrawal by Subject|2|||
33492702|NCT03766685|62870679|FG002|Overall Study|Withdrawal by Subject|0|||
33492703|NCT03766685|62870680|FG003|Overall Study|Withdrawal by Subject|0|||
33492704|NCT03766685|62870677|FG000|Overall Study|Protocol Violation|0|||
33492705|NCT03766685|62870678|FG001|Overall Study|Protocol Violation|1|||
33492706|NCT03766685|62870679|FG002|Overall Study|Protocol Violation|0|||
33492707|NCT03766685|62870680|FG003|Overall Study|Protocol Violation|0|||
33492708|NCT03766685|62870677|FG000|Overall Study|Non-compliance|0|||
33492709|NCT03766685|62870678|FG001|Overall Study|Non-compliance|2|||
33492710|NCT03766685|62870679|FG002|Overall Study|Non-compliance|0|||
33492711|NCT03766685|62870680|FG003|Overall Study|Non-compliance|0|||
33492712|NCT03654274|62870694|FG000|Overall Study|Adverse Event|19|||
33492713|NCT03654274|62870695|FG001|Overall Study|Adverse Event|23|||
33492714|NCT03654274|62870696|FG002|Overall Study|Adverse Event|24|||
33492715|NCT03654274|62870694|FG000|Overall Study|Protocol Deviation|0|||
33492716|NCT03654274|62870695|FG001|Overall Study|Protocol Deviation|2|||
33492717|NCT03654274|62870696|FG002|Overall Study|Protocol Deviation|0|||
33492718|NCT03654274|62870694|FG000|Overall Study|Lost to Follow-up|8|||
33492719|NCT03654274|62870695|FG001|Overall Study|Lost to Follow-up|6|||
33492720|NCT03654274|62870696|FG002|Overall Study|Lost to Follow-up|5|||
33492721|NCT03654274|62870694|FG000|Overall Study|Withdrawal by Subject|46|||
33492722|NCT03654274|62870695|FG001|Overall Study|Withdrawal by Subject|25|||
33492723|NCT03654274|62870696|FG002|Overall Study|Withdrawal by Subject|33|||
33492724|NCT03654274|62870694|FG000|Overall Study|Lack of Efficacy|4|||
33492725|NCT03654274|62870695|FG001|Overall Study|Lack of Efficacy|5|||
33492726|NCT03654274|62870696|FG002|Overall Study|Lack of Efficacy|7|||
33492727|NCT03654274|62870694|FG000|Overall Study|Pregnancy|2|||
33492728|NCT03654274|62870695|FG001|Overall Study|Pregnancy|2|||
33492729|NCT03654274|62870696|FG002|Overall Study|Pregnancy|1|||
33492730|NCT03654274|62870694|FG000|Overall Study|Other|27|||
33492731|NCT03654274|62870695|FG001|Overall Study|Other|29|||
33492732|NCT03654274|62870696|FG002|Overall Study|Other|32|||
33492733|NCT03654274|62870694|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
33492734|NCT03654274|62870695|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
33492735|NCT03654274|62870696|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
33492736|NCT03592641|62870708|FG000|Overall Study|Withdrawal by Subject|1|||
33492737|NCT03533686|62870718|FG000|Overall Study|Withdrawal by Subject|1|||
33492738|NCT03533686|62870719|FG001|Overall Study|Withdrawal by Subject|0|||
33492739|NCT03533686|62870720|FG002|Overall Study|Withdrawal by Subject|0|||
33492740|NCT03533686|62870721|FG003|Overall Study|Withdrawal by Subject|3|||
33492741|NCT03533686|62870722|FG004|Overall Study|Withdrawal by Subject|5|||
33492742|NCT03533686|62870723|FG005|Overall Study|Withdrawal by Subject|1|||
33492743|NCT03533686|62870718|FG000|Overall Study|Lost to Follow-up|0|||
33492744|NCT03533686|62870719|FG001|Overall Study|Lost to Follow-up|1|||
33492745|NCT03533686|62870720|FG002|Overall Study|Lost to Follow-up|0|||
33492746|NCT03533686|62870721|FG003|Overall Study|Lost to Follow-up|0|||
33492747|NCT03533686|62870722|FG004|Overall Study|Lost to Follow-up|2|||
33492748|NCT03533686|62870723|FG005|Overall Study|Lost to Follow-up|0|||
33492749|NCT03533686|62870718|FG000|Overall Study|Screen Failure|0|||
33492750|NCT03533686|62870719|FG001|Overall Study|Screen Failure|0|||
33492751|NCT03533686|62870720|FG002|Overall Study|Screen Failure|0|||
33492752|NCT03533686|62870721|FG003|Overall Study|Screen Failure|2|||
33492753|NCT03533686|62870722|FG004|Overall Study|Screen Failure|0|||
33492754|NCT03533686|62870723|FG005|Overall Study|Screen Failure|0|||
33492755|NCT03154359|62870781|FG000|Overall Study|Adverse Event|1|||
33492756|NCT03154359|62870781|FG000|Overall Study|Lack of Efficacy|2|||
33492757|NCT03154359|62870781|FG000|Overall Study|Lost to Follow-up|3|||
33492758|NCT03154359|62870781|FG000|Overall Study|Physician Decision|3|||
33492759|NCT03154359|62870781|FG000|Overall Study|Protocol Violation|4|||
33492760|NCT03154359|62870781|FG000|Overall Study|Withdrawal by Subject|5|||
33492761|NCT03154359|62870781|FG000|Overall Study|Disruption of study due to COVID-19|4|||
33492762|NCT03135834|62870800|FG000|Stage 1|Adverse Event|1|||
33492763|NCT03135834|62870801|FG001|Stage 1|Adverse Event|2|||
33492764|NCT03135834|62870802|FG002|Stage 1|Adverse Event|2|||
33492765|NCT03135834|62870803|FG003|Stage 1|Adverse Event|1|||
33492766|NCT03135834|62870800|FG000|Stage 1|Death|1|||
33492767|NCT03135834|62870801|FG001|Stage 1|Death|0|||
33492768|NCT03135834|62870802|FG002|Stage 1|Death|0|||
33492769|NCT03135834|62870803|FG003|Stage 1|Death|0|||
33492770|NCT03135834|62870800|FG000|Stage 1|Lost to Follow-up|17|||
33492771|NCT03135834|62870801|FG001|Stage 1|Lost to Follow-up|24|||
33492772|NCT03135834|62870802|FG002|Stage 1|Lost to Follow-up|21|||
33492773|NCT03135834|62870803|FG003|Stage 1|Lost to Follow-up|38|||
33492774|NCT03135834|62870800|FG000|Stage 1|No longer met eligibility criteria|1|||
33492775|NCT03135834|62870801|FG001|Stage 1|No longer met eligibility criteria|6|||
33492776|NCT03135834|62870802|FG002|Stage 1|No longer met eligibility criteria|2|||
33492777|NCT03135834|62870803|FG003|Stage 1|No longer met eligibility criteria|5|||
33492778|NCT03135834|62870800|FG000|Stage 1|Other|0|||
33492779|NCT03135834|62870801|FG001|Stage 1|Other|2|||
33492780|NCT03135834|62870802|FG002|Stage 1|Other|1|||
33492781|NCT03135834|62870803|FG003|Stage 1|Other|0|||
33492782|NCT03135834|62870800|FG000|Stage 1|Physician Decision|0|||
33492783|NCT03135834|62870801|FG001|Stage 1|Physician Decision|1|||
33492784|NCT03135834|62870802|FG002|Stage 1|Physician Decision|0|||
33492785|NCT03135834|62870803|FG003|Stage 1|Physician Decision|0|||
33492786|NCT03135834|62870800|FG000|Stage 1|Pregnancy|0|||
33492787|NCT03135834|62870801|FG001|Stage 1|Pregnancy|4|||
33492788|NCT03135834|62870802|FG002|Stage 1|Pregnancy|2|||
33492789|NCT03135834|62870803|FG003|Stage 1|Pregnancy|4|||
33492790|NCT03135834|62870800|FG000|Stage 1|Protocol Violation|1|||
33492791|NCT03135834|62870801|FG001|Stage 1|Protocol Violation|1|||
33492792|NCT03135834|62870802|FG002|Stage 1|Protocol Violation|2|||
33492793|NCT03135834|62870803|FG003|Stage 1|Protocol Violation|1|||
33492794|NCT03135834|62870800|FG000|Stage 1|Withdrawal by parent/guardian|2|||
33492795|NCT03135834|62870801|FG001|Stage 1|Withdrawal by parent/guardian|10|||
33492796|NCT03135834|62870802|FG002|Stage 1|Withdrawal by parent/guardian|2|||
33492797|NCT03135834|62870803|FG003|Stage 1|Withdrawal by parent/guardian|1|||
33492798|NCT03135834|62870800|FG000|Stage 1|Withdrawal by Subject|16|||
33492799|NCT03135834|62870801|FG001|Stage 1|Withdrawal by Subject|22|||
33492800|NCT03135834|62870802|FG002|Stage 1|Withdrawal by Subject|7|||
33492801|NCT03135834|62870803|FG003|Stage 1|Withdrawal by Subject|10|||
33492802|NCT03135834|62870800|FG000|Stage 1|Randomized but not Vaccinated|0|||
33492803|NCT03135834|62870801|FG001|Stage 1|Randomized but not Vaccinated|3|||
33492804|NCT03135834|62870802|FG002|Stage 1|Randomized but not Vaccinated|1|||
33492805|NCT03135834|62870803|FG003|Stage 1|Randomized but not Vaccinated|6|||
33492806|NCT03135834|62870800|FG000|Stage 2|Lost to Follow-up|0|||
33492807|NCT03135834|62870801|FG001|Stage 2|Lost to Follow-up|1|||
33492808|NCT03135834|62870802|FG002|Stage 2|Lost to Follow-up|0|||
33492809|NCT03135834|62870803|FG003|Stage 2|Lost to Follow-up|0|||
33492810|NCT03135834|62870800|FG000|Stage 2|Withdrawal by Subject|0|||
33492811|NCT03135834|62870801|FG001|Stage 2|Withdrawal by Subject|1|||
33492812|NCT03135834|62870802|FG002|Stage 2|Withdrawal by Subject|0|||
33492813|NCT03135834|62870803|FG003|Stage 2|Withdrawal by Subject|0|||
33492814|NCT03135834|62870800|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
33492815|NCT03135834|62870801|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
33492816|NCT03135834|62870802|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
33492817|NCT03135834|62870803|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
33492818|NCT03135834|62870800|FG000|Stage 2|Did not receive Booster Vaccination|1|||
33492819|NCT03135834|62870801|FG001|Stage 2|Did not receive Booster Vaccination|1|||
33492820|NCT03135834|62870802|FG002|Stage 2|Did not receive Booster Vaccination|0|||
33492821|NCT03135834|62870803|FG003|Stage 2|Did not receive Booster Vaccination|0|||
33492822|NCT03130777|62870836|FG000|Overall Study|Death|0|||
33492823|NCT03130777|62870837|FG001|Overall Study|Death|1|||
33492824|NCT03130777|62870836|FG000|Overall Study|Did not meet eligibility criteria|1|||
33492825|NCT03130777|62870837|FG001|Overall Study|Did not meet eligibility criteria|0|||
33492826|NCT02207725|62870878|FG000|Overall Study|Did Not Receive Treatment|0|||
33492827|NCT02207725|62870879|FG001|Overall Study|Did Not Receive Treatment|1|||
33492828|NCT02207725|62870880|FG002|Overall Study|Did Not Receive Treatment|1|||
33492829|NCT02207725|62870881|FG003|Overall Study|Did Not Receive Treatment|1|||
33492830|NCT01802632|62870904|FG000|Overall Study|Death|28|||
33492831|NCT01802632|62870905|FG001|Overall Study|Death|1|||
33310627|NCT01240356|62686007|FG001|Overall Study|MRI contraindication|0|||
33492832|NCT01802632|62870906|FG002|Overall Study|Death|38|||
33492833|NCT01802632|62870907|FG003|Overall Study|Death|0|||
33492834|NCT01802632|62870908|FG004|Overall Study|Death|2|||
33492835|NCT01802632|62870909|FG005|Overall Study|Death|0|||
33492836|NCT01802632|62870904|FG000|Overall Study|Withdrawal by Subject|4|||
33492837|NCT01802632|62870905|FG001|Overall Study|Withdrawal by Subject|2|||
33492838|NCT01802632|62870906|FG002|Overall Study|Withdrawal by Subject|7|||
33492839|NCT01802632|62870907|FG003|Overall Study|Withdrawal by Subject|3|||
33492840|NCT01802632|62870908|FG004|Overall Study|Withdrawal by Subject|0|||
33492841|NCT01802632|62870909|FG005|Overall Study|Withdrawal by Subject|1|||
33492842|NCT01802632|62870904|FG000|Overall Study|Objective Disease Progression|1|||
33492843|NCT01802632|62870905|FG001|Overall Study|Objective Disease Progression|12|||
33492844|NCT01802632|62870906|FG002|Overall Study|Objective Disease Progression|104|||
33492845|NCT01802632|62870907|FG003|Overall Study|Objective Disease Progression|6|||
33492846|NCT01802632|62870908|FG004|Overall Study|Objective Disease Progression|4|||
33492847|NCT01802632|62870909|FG005|Overall Study|Objective Disease Progression|4|||
33492848|NCT01802632|62870904|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
33492849|NCT01802632|62870905|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
33492850|NCT01802632|62870906|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
33492851|NCT01802632|62870907|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
33492852|NCT01802632|62870908|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
33492853|NCT01802632|62870909|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
33492854|NCT01802632|62870904|FG000|Overall Study|Other (not specified)|0|||
33492855|NCT01802632|62870905|FG001|Overall Study|Other (not specified)|0|||
33492856|NCT01802632|62870906|FG002|Overall Study|Other (not specified)|7|||
33492857|NCT01802632|62870907|FG003|Overall Study|Other (not specified)|1|||
33492858|NCT01802632|62870908|FG004|Overall Study|Other (not specified)|0|||
33492859|NCT01802632|62870909|FG005|Overall Study|Other (not specified)|1|||
33492860|NCT00968799|62870938|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
33492861|NCT02883452|62870948|FG000|Overall Study|Withdrawal by Subject|1|||
33492862|NCT02883452|62870949|FG001|Overall Study|Withdrawal by Subject|1|||
33492863|NCT02883452|62870950|FG002|Overall Study|Withdrawal by Subject|3|||
33492864|NCT02883452|62870951|FG003|Overall Study|Withdrawal by Subject|0|||
33492865|NCT02883452|62870952|FG004|Overall Study|Withdrawal by Subject|2|||
33492866|NCT02883452|62870953|FG005|Overall Study|Withdrawal by Subject|5|||
33492867|NCT02883452|62870948|FG000|Overall Study|Disease progression|1|||
33492868|NCT02883452|62870949|FG001|Overall Study|Disease progression|0|||
33492869|NCT02883452|62870950|FG002|Overall Study|Disease progression|0|||
33492870|NCT02883452|62870951|FG003|Overall Study|Disease progression|1|||
33492871|NCT02883452|62870952|FG004|Overall Study|Disease progression|4|||
33492872|NCT02883452|62870953|FG005|Overall Study|Disease progression|5|||
33492873|NCT02883452|62870948|FG000|Overall Study|Adverse Event|2|||
33492874|NCT02883452|62870949|FG001|Overall Study|Adverse Event|1|||
33492875|NCT02883452|62870950|FG002|Overall Study|Adverse Event|1|||
33492876|NCT02883452|62870951|FG003|Overall Study|Adverse Event|1|||
33492877|NCT02883452|62870952|FG004|Overall Study|Adverse Event|1|||
33492878|NCT02883452|62870953|FG005|Overall Study|Adverse Event|3|||
33492879|NCT02883452|62870948|FG000|Overall Study|Physician Decision|0|||
33492880|NCT02883452|62870949|FG001|Overall Study|Physician Decision|0|||
33492881|NCT02883452|62870950|FG002|Overall Study|Physician Decision|0|||
33492882|NCT02883452|62870951|FG003|Overall Study|Physician Decision|0|||
33492883|NCT02883452|62870952|FG004|Overall Study|Physician Decision|4|||
33673552|NCT00244725|63110953|FG002|Overall Study|Received prohibited medication|0|||
33673553|NCT00244725|63110954|FG003|Overall Study|Received prohibited medication|1|||
33673554|NCT00244725|63110951|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
33673555|NCT00244725|63110952|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
33673556|NCT00244725|63110953|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
33673557|NCT00244725|63110954|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
33673558|NCT00244725|63110951|FG000|Overall Study|Administrative reason|0|||
33673559|NCT00244725|63110952|FG001|Overall Study|Administrative reason|0|||
33673560|NCT00244725|63110953|FG002|Overall Study|Administrative reason|1|||
33673561|NCT00244725|63110954|FG003|Overall Study|Administrative reason|0|||
33673562|NCT00244725|63110951|FG000|Overall Study|Vomit|0|||
33673563|NCT00244725|63110952|FG001|Overall Study|Vomit|0|||
33673564|NCT00244725|63110953|FG002|Overall Study|Vomit|1|||
33673565|NCT00244725|63110954|FG003|Overall Study|Vomit|0|||
33673566|NCT00244725|63110951|FG000|Overall Study|Failed to follow-up|0|||
33673567|NCT00244725|63110952|FG001|Overall Study|Failed to follow-up|0|||
33673568|NCT00244725|63110953|FG002|Overall Study|Failed to follow-up|1|||
33673569|NCT00244725|63110954|FG003|Overall Study|Failed to follow-up|1|||
33673570|NCT02649894|63110966|FG000|Overall Study|Adverse Event|1|||
33673571|NCT02649894|63110967|FG001|Overall Study|Adverse Event|0|||
33673572|NCT02649894|63110966|FG000|Overall Study|Physician Decision|0|||
33673573|NCT02649894|63110967|FG001|Overall Study|Physician Decision|1|||
33673574|NCT02649894|63110966|FG000|Overall Study|Withdrawal by Subject|5|||
33673575|NCT02649894|63110967|FG001|Overall Study|Withdrawal by Subject|2|||
33673576|NCT02649894|63110966|FG000|Overall Study|Lost to Follow-up|2|||
33673577|NCT02649894|63110967|FG001|Overall Study|Lost to Follow-up|1|||
33492884|NCT02883452|62870953|FG005|Overall Study|Physician Decision|1|||
33492885|NCT02883452|62870948|FG000|Overall Study|Death|1|||
33492886|NCT02883452|62870949|FG001|Overall Study|Death|0|||
33492887|NCT02883452|62870950|FG002|Overall Study|Death|1|||
33492888|NCT02883452|62870951|FG003|Overall Study|Death|0|||
33492889|NCT02883452|62870952|FG004|Overall Study|Death|0|||
33492890|NCT02883452|62870953|FG005|Overall Study|Death|0|||
33492891|NCT02883452|62870948|FG000|Overall Study|Other|0|||
33492892|NCT02883452|62870949|FG001|Overall Study|Other|0|||
33582468|NCT01659255|62980069|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33492893|NCT02883452|62870950|FG002|Overall Study|Other|0|||
33492894|NCT02883452|62870951|FG003|Overall Study|Other|0|||
33492895|NCT02883452|62870952|FG004|Overall Study|Other|0|||
33492896|NCT02883452|62870953|FG005|Overall Study|Other|1|||
33673578|NCT02649894|63110966|FG000|Overall Study|Death|30|||
33492897|NCT00151372|62870970|FG000|Overall Study|Death|12|||
33492898|NCT00151372|62870971|FG001|Overall Study|Death|11|||
33492899|NCT00151372|62870970|FG000|Overall Study|Lost to Follow-up|5|||
33492900|NCT00151372|62870971|FG001|Overall Study|Lost to Follow-up|5|||
33492901|NCT00151372|62870970|FG000|Overall Study|Too sick medically to continue|5|||
33492902|NCT00151372|62870971|FG001|Overall Study|Too sick medically to continue|6|||
33492903|NCT00151372|62870970|FG000|Overall Study|Withdrawal by Subject|7|||
33492904|NCT00151372|62870971|FG001|Overall Study|Withdrawal by Subject|7|||
33492905|NCT02603809|62870983|FG000|Overall Study|Withdrawal by Subject|4|||
33492906|NCT02603809|62870984|FG001|Overall Study|Withdrawal by Subject|1|||
33492907|NCT02603809|62870985|FG002|Overall Study|Withdrawal by Subject|2|||
33492908|NCT02603809|62870986|FG003|Overall Study|Withdrawal by Subject|3|||
33492909|NCT02603809|62870987|FG004|Overall Study|Withdrawal by Subject|3|||
33492910|NCT02603809|62870988|FG005|Overall Study|Withdrawal by Subject|4|||
33492911|NCT02603809|62870983|FG000|Overall Study|Lost to Follow-up|2|||
33492912|NCT02603809|62870984|FG001|Overall Study|Lost to Follow-up|3|||
33492913|NCT02603809|62870985|FG002|Overall Study|Lost to Follow-up|1|||
33492914|NCT02603809|62870986|FG003|Overall Study|Lost to Follow-up|4|||
33492915|NCT02603809|62870987|FG004|Overall Study|Lost to Follow-up|2|||
33492916|NCT02603809|62870988|FG005|Overall Study|Lost to Follow-up|2|||
33492917|NCT02603809|62870983|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
33492918|NCT02603809|62870984|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
33492919|NCT02603809|62870985|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
33492920|NCT02603809|62870986|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
33492921|NCT02603809|62870987|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
33492922|NCT02603809|62870988|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
33492923|NCT02603809|62870983|FG000|Overall Study|Physician Decision|0|||
33492924|NCT02603809|62870984|FG001|Overall Study|Physician Decision|0|||
33492925|NCT02603809|62870985|FG002|Overall Study|Physician Decision|0|||
33492926|NCT02603809|62870986|FG003|Overall Study|Physician Decision|1|||
33492927|NCT02603809|62870987|FG004|Overall Study|Physician Decision|2|||
33492928|NCT02603809|62870988|FG005|Overall Study|Physician Decision|1|||
33492929|NCT02603809|62870983|FG000|Overall Study|Adverse Event|3|||
33492930|NCT02603809|62870984|FG001|Overall Study|Adverse Event|0|||
33492931|NCT02603809|62870985|FG002|Overall Study|Adverse Event|2|||
33492932|NCT02603809|62870986|FG003|Overall Study|Adverse Event|2|||
33492933|NCT02603809|62870987|FG004|Overall Study|Adverse Event|1|||
33492934|NCT02603809|62870988|FG005|Overall Study|Adverse Event|1|||
33492935|NCT02603809|62870983|FG000|Overall Study|Lack of Efficacy|0|||
33492936|NCT02603809|62870984|FG001|Overall Study|Lack of Efficacy|1|||
33492937|NCT02603809|62870985|FG002|Overall Study|Lack of Efficacy|0|||
33492938|NCT02603809|62870986|FG003|Overall Study|Lack of Efficacy|0|||
33492939|NCT02603809|62870987|FG004|Overall Study|Lack of Efficacy|0|||
33492940|NCT02603809|62870988|FG005|Overall Study|Lack of Efficacy|1|||
33492941|NCT04269889|62871004|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|1|||
33492942|NCT04269889|62871004|FG000|Extended Phase (6 Months to Year 3)|Lack of Efficacy|13|||
33492943|NCT02741596|62871026|FG000|Overall Study|Adverse Event|1|||
33492944|NCT02741596|62871027|FG001|Overall Study|Adverse Event|5|||
33492945|NCT02741596|62871026|FG000|Overall Study|Lost to Follow-up|1|||
33492946|NCT02741596|62871027|FG001|Overall Study|Lost to Follow-up|1|||
33492947|NCT02741596|62871026|FG000|Overall Study|Physician Decision|2|||
33492948|NCT02741596|62871027|FG001|Overall Study|Physician Decision|1|||
33492949|NCT02741596|62871026|FG000|Overall Study|Pregnancy|3|||
33492950|NCT02741596|62871027|FG001|Overall Study|Pregnancy|1|||
33492951|NCT02741596|62871026|FG000|Overall Study|Other (Unspecified)|0|||
33492952|NCT02741596|62871027|FG001|Overall Study|Other (Unspecified)|3|||
33492953|NCT02741596|62871026|FG000|Overall Study|Subject withdrawn-Other|17|||
33492954|NCT02741596|62871027|FG001|Overall Study|Subject withdrawn-Other|4|||
33492955|NCT02741596|62871026|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
33492956|NCT02741596|62871027|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
33492957|NCT03147248|62871039|FG000|Overall Study|Adverse Event|0|||
33492958|NCT03147248|62871040|FG001|Overall Study|Adverse Event|2|||
33492959|NCT03147248|62871041|FG002|Overall Study|Adverse Event|2|||
33492960|NCT03147248|62871042|FG003|Overall Study|Adverse Event|2|||
33492961|NCT03147248|62871043|FG004|Overall Study|Adverse Event|6|||
33492962|NCT03147248|62871044|FG005|Overall Study|Adverse Event|11|||
33492963|NCT03147248|62871039|FG000|Overall Study|Disease progression|1|||
33492964|NCT03147248|62871040|FG001|Overall Study|Disease progression|0|||
33492965|NCT03147248|62871041|FG002|Overall Study|Disease progression|0|||
33492966|NCT03147248|62871042|FG003|Overall Study|Disease progression|0|||
33582469|NCT01659255|62980070|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33492967|NCT03147248|62871043|FG004|Overall Study|Disease progression|0|||
33582470|NCT01659255|62980071|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33582471|NCT01659255|62980072|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33582472|NCT01659255|62980073|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33492968|NCT03147248|62871044|FG005|Overall Study|Disease progression|2|||
33492969|NCT03147248|62871039|FG000|Overall Study|Withdrawal by Subject|0|||
33582473|NCT01659255|62980074|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
33582474|NCT01659255|62980075|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33582475|NCT01659255|62980059|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
33582476|NCT01659255|62980060|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
33582477|NCT01659255|62980061|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
33582478|NCT01659255|62980062|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
33582479|NCT01659255|62980063|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
33582480|NCT01659255|62980064|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
33582481|NCT01659255|62980065|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
33582482|NCT01659255|62980066|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
33582483|NCT01659255|62980067|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
33582484|NCT01659255|62980068|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
33582485|NCT01659255|62980069|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
33582486|NCT01659255|62980070|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
33582487|NCT01659255|62980071|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
33582488|NCT01659255|62980072|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
33582489|NCT01659255|62980073|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
33582490|NCT01659255|62980074|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
33582491|NCT01659255|62980075|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
33582492|NCT02637037|62980115|FG000|Overall Study|Positive drug screen at admission|1|||
33582493|NCT02637037|62980116|FG001|Overall Study|Positive drug screen at admission|0|||
33582494|NCT02637037|62980115|FG000|Overall Study|Withdrawal by Subject|2|||
33582495|NCT02637037|62980116|FG001|Overall Study|Withdrawal by Subject|1|||
33582496|NCT02637037|62980115|FG000|Overall Study|Adverse Event|1|||
33582497|NCT02637037|62980116|FG001|Overall Study|Adverse Event|0|||
33582498|NCT02637895|62980136|FG000|Overall Study|Lost to Follow-up|4|||
33582499|NCT02637895|62980137|FG001|Overall Study|Lost to Follow-up|0|||
33582500|NCT02637895|62980136|FG000|Overall Study|Protocol Violation|0|||
33582501|NCT02637895|62980137|FG001|Overall Study|Protocol Violation|1|||
33582502|NCT02637895|62980136|FG000|Overall Study|Lack of Efficacy|1|||
33582503|NCT02637895|62980137|FG001|Overall Study|Lack of Efficacy|0|||
33582504|NCT02637895|62980136|FG000|Overall Study|Withdrawal by Subject|1|||
33582505|NCT02637895|62980137|FG001|Overall Study|Withdrawal by Subject|1|||
33582506|NCT02637895|62980136|FG000|Overall Study|Abnormal baseline lab|0|||
33582507|NCT02637895|62980137|FG001|Overall Study|Abnormal baseline lab|1|||
33582508|NCT02522481|62980144|FG000|Overall Study|discontinued|1|||
33582509|NCT02522481|62980144|FG000|Overall Study|Not dosed|2|||
33582510|NCT02522403|62980157|FG000|Overall Study|Lost to Follow-up|2|||
33582511|NCT02522403|62980158|FG001|Overall Study|Lost to Follow-up|2|||
33582512|NCT02522403|62980157|FG000|Overall Study|Withdrawal by Subject|2|||
33582513|NCT02522403|62980158|FG001|Overall Study|Withdrawal by Subject|4|||
33582514|NCT02522325|62980164|FG000|Overall Study|Adverse Event|0|||
33582515|NCT02522325|62980165|FG001|Overall Study|Adverse Event|1|||
33582516|NCT01672879|62980174|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
33582517|NCT01672879|62980175|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
33582518|NCT01672879|62980176|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
33582519|NCT01672879|62980174|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
33582520|NCT01672879|62980175|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
33582521|NCT01672879|62980176|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
33582522|NCT01672879|62980174|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
33582523|NCT01672879|62980175|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
33582524|NCT01672879|62980176|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
33582525|NCT01672879|62980174|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
33582526|NCT01672879|62980175|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
33582527|NCT01672879|62980176|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
33582528|NCT01672879|62980174|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
33582529|NCT01672879|62980175|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
33582530|NCT01672879|62980176|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
33582531|NCT01672879|62980174|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
33582532|NCT01672879|62980175|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
33582533|NCT01672879|62980176|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
33582534|NCT01672879|62980174|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
33582535|NCT01672879|62980175|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
33582536|NCT01672879|62980176|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
33582537|NCT01672879|62980174|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
33582538|NCT01672879|62980175|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
33582539|NCT01672879|62980176|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
33582540|NCT01672879|62980174|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
33582541|NCT01672879|62980175|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
33673579|NCT02649894|63110967|FG001|Overall Study|Death|7|||
33582542|NCT01672879|62980176|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
33582543|NCT01672879|62980174|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
33582544|NCT01672879|62980175|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
33582545|NCT01672879|62980176|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
33582546|NCT01672879|62980174|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
33582547|NCT01672879|62980175|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
33582548|NCT01672879|62980176|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
33582549|NCT01672879|62980174|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
33582550|NCT01672879|62980175|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
33582551|NCT01672879|62980176|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
33582552|NCT01672879|62980174|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
33582553|NCT01672879|62980175|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
33582554|NCT01672879|62980176|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
33582555|NCT02601209|62980192|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
33582556|NCT02601209|62980193|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
33582557|NCT02601209|62980194|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
33582558|NCT02601209|62980195|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
33582559|NCT02601209|62980196|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
33582560|NCT02601209|62980197|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
33582561|NCT02601209|62980198|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
33582562|NCT02601209|62980199|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
33582563|NCT02601209|62980200|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
33582564|NCT02601209|62980192|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
33582565|NCT02601209|62980193|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
33582566|NCT02601209|62980194|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
33582567|NCT02601209|62980195|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
33582568|NCT02601209|62980196|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
33582569|NCT02601209|62980197|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
33582570|NCT02601209|62980198|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
33582571|NCT02601209|62980199|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
33582572|NCT02601209|62980200|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
33582573|NCT01659021|62980216|FG000|Main Study|Adverse Event|2|||
33582574|NCT01659021|62980217|FG001|Main Study|Adverse Event|3|||
33582575|NCT01659021|62980216|FG000|Main Study|Lost to Follow-up|1|||
33582576|NCT01659021|62980217|FG001|Main Study|Lost to Follow-up|0|||
33582577|NCT01659021|62980216|FG000|Main Study|Unknown Reasons|2|||
33582578|NCT01659021|62980217|FG001|Main Study|Unknown Reasons|1|||
33582579|NCT01659021|62980216|FG000|Main Study|Physician Decision|34|||
33582580|NCT01659021|62980217|FG001|Main Study|Physician Decision|16|||
33582581|NCT01659021|62980216|FG000|Main Study|Withdrawal by Subject|19|||
33582582|NCT01659021|62980217|FG001|Main Study|Withdrawal by Subject|16|||
33582583|NCT01659021|62980216|FG000|Main Study|Study Terminated by Sponsor|16|||
33582584|NCT01659021|62980217|FG001|Main Study|Study Terminated by Sponsor|1|||
33582585|NCT01659021|62980216|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
33582586|NCT01659021|62980217|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
33582587|NCT01659021|62980216|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
33582588|NCT01659021|62980217|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
33582589|NCT02524665|62980227|FG000|Overall Study|Lost to Follow-up|1|||
33582590|NCT02638129|62980234|FG000|Overall Study|Study terminated|28|||
33582591|NCT02638129|62980235|FG001|Overall Study|Study terminated|30|||
33582592|NCT01658943|62980243|FG000|Overall Study|Adverse Event|6|||
33582593|NCT01658943|62980244|FG001|Overall Study|Adverse Event|13|||
33582594|NCT01658943|62980243|FG000|Overall Study|Withdrawal by Subject|9|||
33582595|NCT01658943|62980244|FG001|Overall Study|Withdrawal by Subject|2|||
33582596|NCT01658943|62980243|FG000|Overall Study|Progression/Relapse|39|||
33582597|NCT01658943|62980244|FG001|Overall Study|Progression/Relapse|40|||
33582598|NCT01658943|62980243|FG000|Overall Study|Death|4|||
33582599|NCT01658943|62980244|FG001|Overall Study|Death|2|||
33582600|NCT01658943|62980243|FG000|Overall Study|not protocol specified|4|||
33582601|NCT01658943|62980244|FG001|Overall Study|not protocol specified|1|||
33582602|NCT01658943|62980243|FG000|Overall Study|Not eligible|7|||
33582603|NCT01658943|62980244|FG001|Overall Study|Not eligible|9|||
33582604|NCT01658943|62980243|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
33582605|NCT01658943|62980244|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
33582606|NCT02600819|62980250|FG000|GEN Phase|Adverse Event|2|||
33582607|NCT02600819|62980251|FG001|GEN Phase|Adverse Event|0|||
33582608|NCT02600819|62980250|FG000|GEN Phase|Death|2|||
33582609|NCT02600819|62980251|FG001|GEN Phase|Death|0|||
33582610|NCT02600819|62980250|FG000|GEN Phase|Investigator's Discretion|4|||
33582611|NCT02600819|62980251|FG001|GEN Phase|Investigator's Discretion|0|||
33582612|NCT02600819|62980250|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
33582613|NCT02600819|62980251|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
33582614|NCT02600819|62980250|FG000|GEN Phase|Withdrew Consent|5|||
33582615|NCT02600819|62980251|FG001|GEN Phase|Withdrew Consent|0|||
33582616|NCT02600819|62980250|FG000|GEN Phase|Lost to Follow-up|2|||
33582617|NCT02600819|62980251|FG001|GEN Phase|Lost to Follow-up|0|||
33582618|NCT02597933|62980259|FG000|Overall Study|Withdrawal by Subject|7|||
33582619|NCT02597933|62980260|FG001|Overall Study|Withdrawal by Subject|5|||
33582620|NCT02597933|62980259|FG000|Overall Study|Protocol Violation|2|||
33582621|NCT02597933|62980260|FG001|Overall Study|Protocol Violation|2|||
33582622|NCT02597933|62980259|FG000|Overall Study|Adverse Event|20|||
33582623|NCT02597933|62980260|FG001|Overall Study|Adverse Event|28|||
33582624|NCT02597933|62980259|FG000|Overall Study|Not treated|2|||
33582625|NCT02597933|62980260|FG001|Overall Study|Not treated|2|||
33582626|NCT02597933|62980259|FG000|Overall Study|Other than stated above|7|||
33582627|NCT02597933|62980260|FG001|Overall Study|Other than stated above|14|||
33582628|NCT02597855|62980268|FG000|Overall Study|Lost to Follow-up|2|||
33582629|NCT02597855|62980269|FG001|Overall Study|Lost to Follow-up|1|||
33582630|NCT02604407|62980278|FG000|Overall Study|Adverse Event|0|||
33582631|NCT02604407|62980279|FG001|Overall Study|Adverse Event|7|||
33582632|NCT02604407|62980280|FG002|Overall Study|Adverse Event|5|||
33582633|NCT02604407|62980278|FG000|Overall Study|Protocol Violation|2|||
33582634|NCT02604407|62980279|FG001|Overall Study|Protocol Violation|0|||
33582635|NCT02604407|62980280|FG002|Overall Study|Protocol Violation|0|||
33582636|NCT02604407|62980278|FG000|Overall Study|Withdrawal by Subject|3|||
33582637|NCT02604407|62980279|FG001|Overall Study|Withdrawal by Subject|3|||
33582638|NCT02604407|62980280|FG002|Overall Study|Withdrawal by Subject|5|||
33582639|NCT02604407|62980278|FG000|Overall Study|Lost to Follow-up|2|||
33582640|NCT02604407|62980279|FG001|Overall Study|Lost to Follow-up|1|||
33582641|NCT02604407|62980280|FG002|Overall Study|Lost to Follow-up|2|||
33582642|NCT02604407|62980278|FG000|Overall Study|Lack of Efficacy|1|||
33582643|NCT02604407|62980279|FG001|Overall Study|Lack of Efficacy|0|||
33582644|NCT02604407|62980280|FG002|Overall Study|Lack of Efficacy|0|||
33582645|NCT02604407|62980278|FG000|Overall Study|Other|3|||
33582646|NCT02604407|62980279|FG001|Overall Study|Other|1|||
33582647|NCT02604407|62980280|FG002|Overall Study|Other|4|||
33582648|NCT02593097|62980290|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
33582649|NCT02593097|62980291|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
33582650|NCT02593097|62980290|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
33582651|NCT02593097|62980291|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
33582652|NCT02593097|62980290|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
33582653|NCT02593097|62980291|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
33582654|NCT02593097|62980290|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
33582655|NCT02593097|62980291|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
33582656|NCT02593097|62980290|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
33582657|NCT02593097|62980291|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
33582658|NCT01657461|62980299|FG000|Overall Study|Death|9|||
33582659|NCT01657461|62980300|FG001|Overall Study|Death|12|||
33582660|NCT01657461|62980299|FG000|Overall Study|Lost to Follow-up|0|||
33582661|NCT01657461|62980300|FG001|Overall Study|Lost to Follow-up|3|||
33582662|NCT01657461|62980299|FG000|Overall Study|Physician Decision|0|||
33582663|NCT01657461|62980300|FG001|Overall Study|Physician Decision|2|||
33582664|NCT01657461|62980299|FG000|Overall Study|Withdrawal by Subject|1|||
33582665|NCT01657461|62980300|FG001|Overall Study|Withdrawal by Subject|3|||
33582666|NCT02592551|62980309|FG000|Overall Study|Not evaluable|1|||
33582667|NCT02592551|62980310|FG001|Overall Study|Not evaluable|3|||
33582668|NCT02592551|62980311|FG002|Overall Study|Not evaluable|0|||
33582669|NCT02595749|62980322|FG000|Overall Study|Withdrawal by Subject|12|||
33582670|NCT02595749|62980323|FG001|Overall Study|Withdrawal by Subject|7|||
33582671|NCT01657305|62980329|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
33582672|NCT01657305|62980329|FG000|Overall Study|Withdrawal by Subject|4|||
33582673|NCT01657305|62980329|FG000|Overall Study|Adverse Event|1|||
33582674|NCT01657305|62980329|FG000|Overall Study|Lost to Follow-up|1|||
33582675|NCT01657305|62980329|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
33582676|NCT02634307|62980372|FG000|Overall Study|Adverse Event|50|||
33582677|NCT02634307|62980373|FG001|Overall Study|Adverse Event|24|||
33582678|NCT02634307|62980374|FG002|Overall Study|Adverse Event|14|||
33582679|NCT02634307|62980372|FG000|Overall Study|Lost to Follow-up|21|||
33582680|NCT02634307|62980373|FG001|Overall Study|Lost to Follow-up|5|||
33582681|NCT02634307|62980374|FG002|Overall Study|Lost to Follow-up|6|||
33582682|NCT02634307|62980372|FG000|Overall Study|Pregnancy|5|||
33582683|NCT02634307|62980373|FG001|Overall Study|Pregnancy|1|||
33673580|NCT02649894|63110966|FG000|Overall Study|Other, not specified|6|||
33582684|NCT02634307|62980374|FG002|Overall Study|Pregnancy|3|||
33582685|NCT02634307|62980372|FG000|Overall Study|Withdrawal by Subject|38|||
33582686|NCT02634307|62980373|FG001|Overall Study|Withdrawal by Subject|24|||
33582687|NCT02634307|62980374|FG002|Overall Study|Withdrawal by Subject|18|||
33582688|NCT02634307|62980372|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33582689|NCT02634307|62980373|FG001|Overall Study|Non-Compliance with Study Drug|2|||
33582690|NCT02634307|62980374|FG002|Overall Study|Non-Compliance with Study Drug|2|||
33582691|NCT02634307|62980372|FG000|Overall Study|Lack of Efficacy|1|||
33582692|NCT02634307|62980373|FG001|Overall Study|Lack of Efficacy|5|||
33582693|NCT02634307|62980374|FG002|Overall Study|Lack of Efficacy|3|||
33582694|NCT02634307|62980372|FG000|Overall Study|Physician Decision|7|||
33582695|NCT02634307|62980373|FG001|Overall Study|Physician Decision|5|||
33582696|NCT02634307|62980374|FG002|Overall Study|Physician Decision|5|||
33582697|NCT02634307|62980372|FG000|Overall Study|Reason not Specified|3|||
33582698|NCT02634307|62980373|FG001|Overall Study|Reason not Specified|5|||
33582699|NCT02634307|62980374|FG002|Overall Study|Reason not Specified|10|||
33582700|NCT01365273|62980384|FG000|Overall Study|Lost to Follow-up|1|||
33582701|NCT01365273|62980385|FG001|Overall Study|Lost to Follow-up|0|||
33582702|NCT01365273|62980384|FG000|Overall Study|Protocol Violation|0|||
33582703|NCT01365273|62980385|FG001|Overall Study|Protocol Violation|1|||
33582704|NCT01365273|62980384|FG000|Overall Study|Physician Decision|1|||
33582705|NCT01365273|62980385|FG001|Overall Study|Physician Decision|0|||
33582706|NCT02595437|62980391|FG000|Triferic Via IV|Withdrawal by Subject|1|||
33582707|NCT02594735|62980412|FG000|Overall Study|Adverse Event|1|||
33582708|NCT02634151|62980420|FG000|Overall Study|Withdrawal by Subject|1|||
33582709|NCT02634151|62980421|FG001|Overall Study|Withdrawal by Subject|0|||
33582710|NCT02634151|62980420|FG000|Overall Study|Non-Compliance|0|||
33582711|NCT02634151|62980421|FG001|Overall Study|Non-Compliance|1|||
33582712|NCT02634151|62980420|FG000|Overall Study|Other|0|||
33582713|NCT02634151|62980421|FG001|Overall Study|Other|1|||
33582714|NCT01655823|62980432|FG000|Overall Study|Lost to Follow-up|0|||
33582715|NCT01655823|62980433|FG001|Overall Study|Lost to Follow-up|1|||
33582716|NCT01655823|62980434|FG002|Overall Study|Lost to Follow-up|0|||
33582717|NCT01655823|62980435|FG003|Overall Study|Lost to Follow-up|0|||
33582718|NCT01655823|62980436|FG004|Overall Study|Lost to Follow-up|1|||
33582719|NCT01655823|62980432|FG000|Overall Study|Withdrawal by Subject|0|||
33582720|NCT01655823|62980433|FG001|Overall Study|Withdrawal by Subject|1|||
33582721|NCT01655823|62980434|FG002|Overall Study|Withdrawal by Subject|0|||
33582722|NCT01655823|62980435|FG003|Overall Study|Withdrawal by Subject|1|||
33582723|NCT01655823|62980436|FG004|Overall Study|Withdrawal by Subject|0|||
33582724|NCT01360645|62980450|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
33582725|NCT01360645|62980451|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
33582726|NCT01360645|62980452|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
33582727|NCT01360645|62980453|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
33582728|NCT01360645|62980450|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
33582729|NCT01360645|62980451|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
33582730|NCT01360645|62980452|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
33582731|NCT01360645|62980453|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
33582732|NCT01360645|62980450|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
33582733|NCT01360645|62980451|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
33582734|NCT01360645|62980452|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
33582735|NCT01360645|62980453|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
33582736|NCT01360645|62980450|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
33582737|NCT01360645|62980451|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
33582738|NCT01360645|62980452|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
33582739|NCT01360645|62980453|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
33582740|NCT01360645|62980450|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
33582741|NCT01360645|62980451|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
33582742|NCT01360645|62980452|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
33582743|NCT01360645|62980453|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
33582744|NCT01360645|62980450|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
33582745|NCT01360645|62980451|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
33582746|NCT01360645|62980452|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
33582747|NCT01360645|62980453|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
33582748|NCT01360645|62980450|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
33582749|NCT01360645|62980451|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
33582750|NCT01360645|62980452|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
33582751|NCT01360645|62980453|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
33582752|NCT01360645|62980450|FG000|Phase B (6 Weeks)|Adverse Event|0|||
33582753|NCT01360645|62980451|FG001|Phase B (6 Weeks)|Adverse Event|6|||
33582754|NCT01360645|62980452|FG002|Phase B (6 Weeks)|Adverse Event|0|||
33582755|NCT01360645|62980453|FG003|Phase B (6 Weeks)|Adverse Event|0|||
33582756|NCT01360645|62980450|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
33582757|NCT01360645|62980451|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
33582758|NCT01360645|62980452|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
33582759|NCT01360645|62980453|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
33673581|NCT02649894|63110967|FG001|Overall Study|Other, not specified|0|||
33582760|NCT01360645|62980450|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
33582761|NCT01360645|62980451|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
33582762|NCT01360645|62980452|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
33582763|NCT01360645|62980453|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
33582764|NCT01360645|62980450|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
33582765|NCT01360645|62980451|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
33582766|NCT01360645|62980452|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
33582767|NCT01360645|62980453|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
33582768|NCT01360645|62980450|FG000|Phase A+|Lost to Follow-up|0|||
33582769|NCT01360645|62980451|FG001|Phase A+|Lost to Follow-up|0|||
33582770|NCT01360645|62980452|FG002|Phase A+|Lost to Follow-up|0|||
33582771|NCT01360645|62980453|FG003|Phase A+|Lost to Follow-up|7|||
33582772|NCT01360645|62980450|FG000|Phase A+|Adverse Event|0|||
33582773|NCT01360645|62980451|FG001|Phase A+|Adverse Event|0|||
33582774|NCT01360645|62980452|FG002|Phase A+|Adverse Event|0|||
33582775|NCT01360645|62980453|FG003|Phase A+|Adverse Event|2|||
33582776|NCT01360645|62980450|FG000|Phase A+|Met Withdrawal Criteria|0|||
33582777|NCT01360645|62980451|FG001|Phase A+|Met Withdrawal Criteria|0|||
33582778|NCT01360645|62980452|FG002|Phase A+|Met Withdrawal Criteria|0|||
33582779|NCT01360645|62980453|FG003|Phase A+|Met Withdrawal Criteria|4|||
33582780|NCT01360645|62980450|FG000|Phase A+|Physician Decision|0|||
33582781|NCT01360645|62980451|FG001|Phase A+|Physician Decision|0|||
33582782|NCT01360645|62980452|FG002|Phase A+|Physician Decision|0|||
33582783|NCT01360645|62980453|FG003|Phase A+|Physician Decision|2|||
33582784|NCT01360645|62980450|FG000|Phase A+|Withdrawal by Subject|0|||
33582785|NCT01360645|62980451|FG001|Phase A+|Withdrawal by Subject|0|||
33582786|NCT01360645|62980452|FG002|Phase A+|Withdrawal by Subject|0|||
33582787|NCT01360645|62980453|FG003|Phase A+|Withdrawal by Subject|5|||
33582788|NCT01360645|62980450|FG000|Phase A+|Protocol Deviation|0|||
33582789|NCT01360645|62980451|FG001|Phase A+|Protocol Deviation|0|||
33582790|NCT01360645|62980452|FG002|Phase A+|Protocol Deviation|0|||
33582791|NCT01360645|62980453|FG003|Phase A+|Protocol Deviation|4|||
33582792|NCT02633527|62980468|FG000|Overall Study|Failed to meet eligibility|0|||
33582793|NCT02633527|62980469|FG001|Overall Study|Failed to meet eligibility|1|||
33582794|NCT02633527|62980470|FG002|Overall Study|Failed to meet eligibility|1|||
33582795|NCT02633527|62980471|FG003|Overall Study|Failed to meet eligibility|0|||
33582796|NCT02633527|62980472|FG004|Overall Study|Failed to meet eligibility|1|||
33582797|NCT02633527|62980468|FG000|Overall Study|Adverse Event|0|||
33582798|NCT02633527|62980469|FG001|Overall Study|Adverse Event|4|||
33582799|NCT02633527|62980470|FG002|Overall Study|Adverse Event|3|||
33582800|NCT02633527|62980471|FG003|Overall Study|Adverse Event|1|||
33582801|NCT02633527|62980472|FG004|Overall Study|Adverse Event|5|||
33582802|NCT02633527|62980468|FG000|Overall Study|Lost to Follow-up|1|||
33582803|NCT02633527|62980469|FG001|Overall Study|Lost to Follow-up|2|||
33582804|NCT02633527|62980470|FG002|Overall Study|Lost to Follow-up|5|||
33582805|NCT02633527|62980471|FG003|Overall Study|Lost to Follow-up|5|||
33582806|NCT02633527|62980472|FG004|Overall Study|Lost to Follow-up|4|||
33582807|NCT02633527|62980468|FG000|Overall Study|Withdrawal by Subject|0|||
33582808|NCT02633527|62980469|FG001|Overall Study|Withdrawal by Subject|3|||
33582809|NCT02633527|62980470|FG002|Overall Study|Withdrawal by Subject|5|||
33582810|NCT02633527|62980471|FG003|Overall Study|Withdrawal by Subject|4|||
33582811|NCT02633527|62980472|FG004|Overall Study|Withdrawal by Subject|4|||
33582812|NCT02633527|62980468|FG000|Overall Study|Protocol Violation|0|||
33582813|NCT02633527|62980469|FG001|Overall Study|Protocol Violation|1|||
33582814|NCT02633527|62980470|FG002|Overall Study|Protocol Violation|1|||
33582815|NCT02633527|62980471|FG003|Overall Study|Protocol Violation|1|||
33582816|NCT02633527|62980472|FG004|Overall Study|Protocol Violation|1|||
33582817|NCT02633527|62980468|FG000|Overall Study|Physician Decision|0|||
33582818|NCT02633527|62980469|FG001|Overall Study|Physician Decision|0|||
33582819|NCT02633527|62980470|FG002|Overall Study|Physician Decision|0|||
33582820|NCT02633527|62980471|FG003|Overall Study|Physician Decision|0|||
33582821|NCT02633527|62980472|FG004|Overall Study|Physician Decision|1|||
33582822|NCT02633527|62980468|FG000|Overall Study|Administrative reason|1|||
33582823|NCT02633527|62980469|FG001|Overall Study|Administrative reason|0|||
33582824|NCT02633527|62980470|FG002|Overall Study|Administrative reason|0|||
33582825|NCT02633527|62980471|FG003|Overall Study|Administrative reason|1|||
33582826|NCT02633527|62980472|FG004|Overall Study|Administrative reason|0|||
33582827|NCT02633527|62980468|FG000|Overall Study|Multiple reasons|1|||
33582828|NCT02633527|62980469|FG001|Overall Study|Multiple reasons|0|||
33582829|NCT02633527|62980470|FG002|Overall Study|Multiple reasons|2|||
33582830|NCT02633527|62980471|FG003|Overall Study|Multiple reasons|2|||
33582831|NCT02633527|62980472|FG004|Overall Study|Multiple reasons|1|||
33582832|NCT01667549|62980489|FG000|Overall Study|Withdrawal by Subject|3|||
33582833|NCT01667549|62980490|FG001|Overall Study|Withdrawal by Subject|5|||
33582834|NCT01667549|62980491|FG002|Overall Study|Withdrawal by Subject|7|||
33582835|NCT01667549|62980492|FG003|Overall Study|Withdrawal by Subject|6|||
33582836|NCT01667549|62980493|FG004|Overall Study|Withdrawal by Subject|1|||
33673582|NCT01278615|63110973|FG000|Overall Study|Withdrawal by Subject|2|||
33582837|NCT01672801|62980532|FG000|Overall Study|Screen Failure|0|||
33582838|NCT01672801|62980533|FG001|Overall Study|Screen Failure|1|||
33582839|NCT01655901|62980539|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
33582840|NCT01655901|62980540|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
33582841|NCT01655901|62980541|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
33582842|NCT01655901|62980542|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
33582843|NCT01655901|62980543|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
33582844|NCT01655901|62980544|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
33582845|NCT01656759|62980555|FG000|Overall Study|Protocol Violation|2|||
33582846|NCT01656759|62980556|FG001|Overall Study|Protocol Violation|3|||
33582847|NCT02631577|62980564|FG000|Overall Study|Death|1|||
33582848|NCT02631577|62980565|FG001|Overall Study|Death|7|||
33582849|NCT02631577|62980564|FG000|Overall Study|Withdrawal by Subject|0|||
33582850|NCT02631577|62980565|FG001|Overall Study|Withdrawal by Subject|3|||
33582851|NCT01667081|62980573|FG000|Overall Study|Death|43|||
33582852|NCT01667081|62980574|FG001|Overall Study|Death|3|||
33582853|NCT01667081|62980573|FG000|Overall Study|Lost to Follow-up|99|||
33582854|NCT01667081|62980574|FG001|Overall Study|Lost to Follow-up|48|||
33582855|NCT01667081|62980573|FG000|Overall Study|Physician Decision|16|||
33582856|NCT01667081|62980574|FG001|Overall Study|Physician Decision|2|||
33582857|NCT01667081|62980573|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
33582858|NCT01667081|62980574|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
33582859|NCT01667081|62980573|FG000|Overall Study|Withdrawal by Subject|90|||
33582860|NCT01667081|62980574|FG001|Overall Study|Withdrawal by Subject|35|||
33582861|NCT04545619|62980591|FG000|Overall Study|due to equipment challenges|1|||
33582862|NCT02518971|62980597|FG000|Overall Study|Lost to Follow-up|0|||
33582863|NCT02518971|62980598|FG001|Overall Study|Lost to Follow-up|1|||
33582864|NCT02518971|62980597|FG000|Overall Study|Physician Decision|6|||
33582865|NCT02518971|62980598|FG001|Overall Study|Physician Decision|6|||
33582866|NCT02518971|62980597|FG000|Overall Study|Protocol Violation|6|||
33582867|NCT02518971|62980598|FG001|Overall Study|Protocol Violation|4|||
33582868|NCT02518971|62980597|FG000|Overall Study|Withdrawal by Subject|4|||
33582869|NCT02518971|62980598|FG001|Overall Study|Withdrawal by Subject|5|||
33582870|NCT02518971|62980597|FG000|Overall Study|Side effects|1|||
33582871|NCT02518971|62980598|FG001|Overall Study|Side effects|0|||
33582872|NCT02518971|62980597|FG000|Overall Study|medication lost in mail|0|||
33582873|NCT02518971|62980598|FG001|Overall Study|medication lost in mail|1|||
33582874|NCT02518971|62980597|FG000|Overall Study|eligibility criteria no longer met|6|||
33310628|NCT01239732|62686016|FG000|Overall Study|Termination of study per protocol|667|||
33310629|NCT01239732|62686016|FG000|Overall Study|Death|226|||
33310630|NCT01239732|62686016|FG000|Overall Study|Withdrawal by Subject|87|||
33310631|NCT01239732|62686016|FG000|Overall Study|Adverse Event|6|||
33310632|NCT01239732|62686016|FG000|Overall Study|Protocol Violation|3|||
33310633|NCT01239732|62686016|FG000|Overall Study|Participant non compliance|5|||
33310634|NCT01239732|62686016|FG000|Overall Study|Study termination by sponsor|2|||
33310635|NCT01239732|62686016|FG000|Overall Study|Investigator's decision|4|||
33310636|NCT01239732|62686016|FG000|Overall Study|Treatment failure|2|||
33310637|NCT01239732|62686016|FG000|Overall Study|Other|19|||
33310638|NCT02227147|62686022|FG000|Controlled Treatment Period|Adverse Event|4|||
33310639|NCT02227147|62686023|FG001|Controlled Treatment Period|Adverse Event|3|||
33310640|NCT02227147|62686022|FG000|Controlled Treatment Period|Other|2|||
33310641|NCT02227147|62686023|FG001|Controlled Treatment Period|Other|0|||
33310642|NCT02227147|62686022|FG000|Follow-up Period|Other|3|||
33310643|NCT02227147|62686023|FG001|Follow-up Period|Other|5|||
33310644|NCT00948025|62686035|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
33310645|NCT00948025|62686036|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
33310646|NCT00948025|62686035|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
33310647|NCT00948025|62686036|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
33310648|NCT00948025|62686035|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
33582875|NCT02518971|62980598|FG001|Overall Study|eligibility criteria no longer met|3|||
33582876|NCT01365039|62980607|FG000|Overall Study|Study related symptoms and complaints|1|||
33582877|NCT01365039|62980608|FG001|Overall Study|Study related symptoms and complaints|0|||
33582878|NCT01364727|62980615|FG000|Overall Study|Not Eligible|2|||
33582879|NCT02633215|62980623|FG000|Overall Study|Lost to Follow-up|2|||
33582880|NCT02633215|62980624|FG001|Overall Study|Lost to Follow-up|3|||
33582881|NCT01364649|62980632|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
33582882|NCT01364649|62980633|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
33582883|NCT01364649|62980632|FG000|Overall Study|Lack of Efficacy|6|||
33582884|NCT01364649|62980633|FG001|Overall Study|Lack of Efficacy|0|||
33582885|NCT01364649|62980632|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
33582886|NCT01364649|62980633|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
33582887|NCT01364649|62980632|FG000|Overall Study|Protocol Deviations|4|||
33582888|NCT01364649|62980633|FG001|Overall Study|Protocol Deviations|8|||
33582889|NCT01364649|62980632|FG000|Overall Study|Withdrawal of Consent|9|||
33582890|NCT01364649|62980633|FG001|Overall Study|Withdrawal of Consent|7|||
33582891|NCT01364649|62980632|FG000|Overall Study|Lost to Follow-up|12|||
33582892|NCT01364649|62980633|FG001|Overall Study|Lost to Follow-up|13|||
33582893|NCT01364649|62980632|FG000|Overall Study|Other|4|||
33582894|NCT01364649|62980633|FG001|Overall Study|Other|1|||
33582895|NCT02588261|62980641|FG000|Overall Study|Study Terminated by Sponsor|157|||
33582896|NCT02588261|62980642|FG001|Overall Study|Study Terminated by Sponsor|142|||
33582897|NCT02588261|62980641|FG000|Overall Study|Protocol Deviation|1|||
33582898|NCT02588261|62980642|FG001|Overall Study|Protocol Deviation|0|||
33582899|NCT02588261|62980641|FG000|Overall Study|Death|1|||
33582900|NCT02588261|62980642|FG001|Overall Study|Death|2|||
33582901|NCT02588261|62980641|FG000|Overall Study|Withdrawal by Subject|12|||
33582902|NCT02588261|62980642|FG001|Overall Study|Withdrawal by Subject|8|||
33582903|NCT02588261|62980641|FG000|Overall Study|Noncompliance with Study Drug|0|||
33582904|NCT02588261|62980642|FG001|Overall Study|Noncompliance with Study Drug|1|||
33582905|NCT02588261|62980641|FG000|Overall Study|Miscellaneous|5|||
33582906|NCT02588261|62980642|FG001|Overall Study|Miscellaneous|4|||
33582907|NCT02588261|62980641|FG000|Overall Study|Progressive Disease|61|||
33582908|NCT02588261|62980642|FG001|Overall Study|Progressive Disease|82|||
33582909|NCT02588261|62980641|FG000|Overall Study|Adverse Event|29|||
33582910|NCT02588261|62980642|FG001|Overall Study|Adverse Event|24|||
33582911|NCT02588261|62980641|FG000|Overall Study|Lost to Follow-up|1|||
33582912|NCT02588261|62980642|FG001|Overall Study|Lost to Follow-up|0|||
33582913|NCT01359449|62980650|FG000|Overall Study|Lost to Follow-up|1|||
33582914|NCT01359449|62980651|FG001|Overall Study|Lost to Follow-up|0|||
33582915|NCT01359449|62980650|FG000|Overall Study|Protocol Violation|0|||
33582916|NCT01359449|62980651|FG001|Overall Study|Protocol Violation|2|||
33582917|NCT01359449|62980650|FG000|Overall Study|Withdrawal by Subject|3|||
33582918|NCT01359449|62980651|FG001|Overall Study|Withdrawal by Subject|2|||
33582919|NCT01672723|62980657|FG000|First Intervention|Adverse Event|3|||
33582920|NCT01672723|62980658|FG001|First Intervention|Adverse Event|0|||
33582921|NCT02632747|62980666|FG000|Wash-out Period|Adverse Event|1|||
33582922|NCT02632747|62980667|FG001|Wash-out Period|Adverse Event|0|||
33582923|NCT02520531|62980686|FG000|Overall Study|Revision of study device components|2|||
33582924|NCT02520531|62980687|FG001|Overall Study|Revision of study device components|2|||
33582925|NCT02520531|62980686|FG000|Overall Study|Death|1|||
33582926|NCT02520531|62980687|FG001|Overall Study|Death|2|||
33582927|NCT02520531|62980686|FG000|Overall Study|Lost to Follow-up|1|||
33582928|NCT02520531|62980687|FG001|Overall Study|Lost to Follow-up|1|||
33582929|NCT02520531|62980686|FG000|Overall Study|Meet exclusion criterion|0|||
33582930|NCT02520531|62980687|FG001|Overall Study|Meet exclusion criterion|1|||
33582931|NCT02520531|62980686|FG000|Overall Study|Withdrawal by Subject|1|||
33582932|NCT02520531|62980687|FG001|Overall Study|Withdrawal by Subject|0|||
33582933|NCT02520531|62980686|FG000|Overall Study|Not study device|1|||
33582934|NCT02520531|62980687|FG001|Overall Study|Not study device|0|||
33582935|NCT01671319|62980693|FG000|Overall Study|Withdrawal by Subject|1|||
33582936|NCT01670539|62980697|FG000|Overall Study|Death|3|||
33582937|NCT01670539|62980698|FG001|Overall Study|Death|5|||
33582938|NCT01670539|62980697|FG000|Overall Study|Withdrawal by Subject|3|||
33582939|NCT01670539|62980698|FG001|Overall Study|Withdrawal by Subject|0|||
33582940|NCT02516163|62980705|FG000|Overall Study|Withdrawal by Subject|1|||
33582941|NCT02516163|62980705|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
33582942|NCT02516163|62980705|FG000|Overall Study|Unfit/delay in surgery|3|||
33582943|NCT02516163|62980705|FG000|Overall Study|Use of incorrect measurement technique|5|||
33582944|NCT02516163|62980705|FG000|Overall Study|Data not recorded|2|||
33582945|NCT02516163|62980705|FG000|Overall Study|MRI contraindication exclusion|6|||
33582946|NCT02589665|62980713|FG000|Induction Period|Did not receive drug|0|||
33582947|NCT02589665|62980714|FG001|Induction Period|Did not receive drug|0|||
33582948|NCT02589665|62980715|FG002|Induction Period|Did not receive drug|0|||
33582949|NCT02589665|62980716|FG003|Induction Period|Did not receive drug|1|||
33582950|NCT02589665|62980717|FG004|Induction Period|Did not receive drug|0|||
33582951|NCT02589665|62980718|FG005|Induction Period|Did not receive drug|0|||
33582952|NCT02589665|62980719|FG006|Induction Period|Did not receive drug|0|||
33582953|NCT02589665|62980720|FG007|Induction Period|Did not receive drug|0|||
33582954|NCT02589665|62980721|FG008|Induction Period|Did not receive drug|0|||
33673583|NCT01505114|63110999|FG000|Overall Study|Withdrawal by Subject|5|||
33582955|NCT02589665|62980722|FG009|Induction Period|Did not receive drug|0|||
33582956|NCT02589665|62980713|FG000|Induction Period|Adverse Event|3|||
33582957|NCT02589665|62980714|FG001|Induction Period|Adverse Event|0|||
33582958|NCT02589665|62980715|FG002|Induction Period|Adverse Event|2|||
33582959|NCT02589665|62980716|FG003|Induction Period|Adverse Event|2|||
33582960|NCT02589665|62980717|FG004|Induction Period|Adverse Event|0|||
33582961|NCT02589665|62980718|FG005|Induction Period|Adverse Event|0|||
33582962|NCT02589665|62980719|FG006|Induction Period|Adverse Event|0|||
33582963|NCT02589665|62980720|FG007|Induction Period|Adverse Event|0|||
33582964|NCT02589665|62980721|FG008|Induction Period|Adverse Event|0|||
33582965|NCT02589665|62980722|FG009|Induction Period|Adverse Event|0|||
33582966|NCT02589665|62980713|FG000|Induction Period|Withdrawal by Subject|0|||
33582967|NCT02589665|62980714|FG001|Induction Period|Withdrawal by Subject|1|||
33582968|NCT02589665|62980715|FG002|Induction Period|Withdrawal by Subject|0|||
33582969|NCT02589665|62980716|FG003|Induction Period|Withdrawal by Subject|1|||
33582970|NCT02589665|62980717|FG004|Induction Period|Withdrawal by Subject|0|||
33582971|NCT02589665|62980718|FG005|Induction Period|Withdrawal by Subject|0|||
33582972|NCT02589665|62980719|FG006|Induction Period|Withdrawal by Subject|0|||
33582973|NCT02589665|62980720|FG007|Induction Period|Withdrawal by Subject|0|||
33582974|NCT02589665|62980721|FG008|Induction Period|Withdrawal by Subject|0|||
33582975|NCT02589665|62980722|FG009|Induction Period|Withdrawal by Subject|0|||
33582976|NCT02589665|62980713|FG000|Induction Period|Protocol Violation|0|||
33582977|NCT02589665|62980714|FG001|Induction Period|Protocol Violation|1|||
33582978|NCT02589665|62980715|FG002|Induction Period|Protocol Violation|0|||
33582979|NCT02589665|62980716|FG003|Induction Period|Protocol Violation|0|||
33582980|NCT02589665|62980717|FG004|Induction Period|Protocol Violation|0|||
33582981|NCT02589665|62980718|FG005|Induction Period|Protocol Violation|0|||
33582982|NCT02589665|62980719|FG006|Induction Period|Protocol Violation|0|||
33582983|NCT02589665|62980720|FG007|Induction Period|Protocol Violation|0|||
33582984|NCT02589665|62980721|FG008|Induction Period|Protocol Violation|0|||
33582985|NCT02589665|62980722|FG009|Induction Period|Protocol Violation|0|||
33582986|NCT02589665|62980713|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33582987|NCT02589665|62980714|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33582988|NCT02589665|62980715|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33582989|NCT02589665|62980716|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33582990|NCT02589665|62980717|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
33582991|NCT02589665|62980718|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
33582992|NCT02589665|62980719|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
33582993|NCT02589665|62980720|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33582994|NCT02589665|62980721|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33582995|NCT02589665|62980722|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33582996|NCT02589665|62980713|FG000|Maintenance Period|Withdrawal by Subject|0|||
33582997|NCT02589665|62980714|FG001|Maintenance Period|Withdrawal by Subject|0|||
33582998|NCT02589665|62980715|FG002|Maintenance Period|Withdrawal by Subject|0|||
33582999|NCT02589665|62980716|FG003|Maintenance Period|Withdrawal by Subject|0|||
33583000|NCT02589665|62980717|FG004|Maintenance Period|Withdrawal by Subject|4|||
33583001|NCT02589665|62980718|FG005|Maintenance Period|Withdrawal by Subject|2|||
33583002|NCT02589665|62980719|FG006|Maintenance Period|Withdrawal by Subject|4|||
33583003|NCT02589665|62980720|FG007|Maintenance Period|Withdrawal by Subject|0|||
33583004|NCT02589665|62980721|FG008|Maintenance Period|Withdrawal by Subject|0|||
33583005|NCT02589665|62980722|FG009|Maintenance Period|Withdrawal by Subject|0|||
33583006|NCT02589665|62980713|FG000|Maintenance Period|Lack of Efficacy|0|||
33583007|NCT02589665|62980714|FG001|Maintenance Period|Lack of Efficacy|0|||
33583008|NCT02589665|62980715|FG002|Maintenance Period|Lack of Efficacy|0|||
33583009|NCT02589665|62980716|FG003|Maintenance Period|Lack of Efficacy|0|||
33583010|NCT02589665|62980717|FG004|Maintenance Period|Lack of Efficacy|2|||
33583011|NCT02589665|62980718|FG005|Maintenance Period|Lack of Efficacy|1|||
33583012|NCT02589665|62980719|FG006|Maintenance Period|Lack of Efficacy|0|||
33583013|NCT02589665|62980720|FG007|Maintenance Period|Lack of Efficacy|0|||
33583014|NCT02589665|62980721|FG008|Maintenance Period|Lack of Efficacy|0|||
33583015|NCT02589665|62980722|FG009|Maintenance Period|Lack of Efficacy|0|||
33583016|NCT02589665|62980713|FG000|Maintenance Period|Adverse Event|0|||
33583017|NCT02589665|62980714|FG001|Maintenance Period|Adverse Event|0|||
33583018|NCT02589665|62980715|FG002|Maintenance Period|Adverse Event|0|||
33583019|NCT02589665|62980716|FG003|Maintenance Period|Adverse Event|0|||
33583020|NCT02589665|62980717|FG004|Maintenance Period|Adverse Event|0|||
33583021|NCT02589665|62980718|FG005|Maintenance Period|Adverse Event|0|||
33583022|NCT02589665|62980719|FG006|Maintenance Period|Adverse Event|2|||
33583023|NCT02589665|62980720|FG007|Maintenance Period|Adverse Event|0|||
33583024|NCT02589665|62980721|FG008|Maintenance Period|Adverse Event|0|||
33583025|NCT02589665|62980722|FG009|Maintenance Period|Adverse Event|0|||
33583026|NCT02589665|62980713|FG000|Maintenance Period|Lost to Follow-up|0|||
33583027|NCT02589665|62980714|FG001|Maintenance Period|Lost to Follow-up|0|||
33583028|NCT02589665|62980715|FG002|Maintenance Period|Lost to Follow-up|0|||
33583029|NCT02589665|62980716|FG003|Maintenance Period|Lost to Follow-up|0|||
33583030|NCT02589665|62980717|FG004|Maintenance Period|Lost to Follow-up|0|||
33583031|NCT02589665|62980718|FG005|Maintenance Period|Lost to Follow-up|1|||
33583032|NCT02589665|62980719|FG006|Maintenance Period|Lost to Follow-up|0|||
33583033|NCT02589665|62980720|FG007|Maintenance Period|Lost to Follow-up|0|||
33583034|NCT02589665|62980721|FG008|Maintenance Period|Lost to Follow-up|0|||
33583035|NCT02589665|62980722|FG009|Maintenance Period|Lost to Follow-up|0|||
33583036|NCT02589665|62980713|FG000|Maintenance Period|Physician Decision|0|||
33583037|NCT02589665|62980714|FG001|Maintenance Period|Physician Decision|0|||
33583038|NCT02589665|62980715|FG002|Maintenance Period|Physician Decision|0|||
33583039|NCT02589665|62980716|FG003|Maintenance Period|Physician Decision|0|||
33583040|NCT02589665|62980717|FG004|Maintenance Period|Physician Decision|0|||
33583041|NCT02589665|62980718|FG005|Maintenance Period|Physician Decision|1|||
33583042|NCT02589665|62980719|FG006|Maintenance Period|Physician Decision|0|||
33583043|NCT02589665|62980720|FG007|Maintenance Period|Physician Decision|0|||
33583044|NCT02589665|62980721|FG008|Maintenance Period|Physician Decision|0|||
33583045|NCT02589665|62980722|FG009|Maintenance Period|Physician Decision|0|||
33583046|NCT02589665|62980713|FG000|Maintenance Period|Reason Not Collected|0|||
33583047|NCT02589665|62980714|FG001|Maintenance Period|Reason Not Collected|0|||
33583048|NCT02589665|62980715|FG002|Maintenance Period|Reason Not Collected|0|||
33583049|NCT02589665|62980716|FG003|Maintenance Period|Reason Not Collected|0|||
33583050|NCT02589665|62980717|FG004|Maintenance Period|Reason Not Collected|0|||
33583051|NCT02589665|62980718|FG005|Maintenance Period|Reason Not Collected|1|||
33583052|NCT02589665|62980719|FG006|Maintenance Period|Reason Not Collected|1|||
33583053|NCT02589665|62980720|FG007|Maintenance Period|Reason Not Collected|0|||
33583054|NCT02589665|62980721|FG008|Maintenance Period|Reason Not Collected|0|||
33583055|NCT02589665|62980722|FG009|Maintenance Period|Reason Not Collected|0|||
33583056|NCT02589665|62980713|FG000|Induction Extension Period|Adverse Event|0|||
33583057|NCT02589665|62980714|FG001|Induction Extension Period|Adverse Event|0|||
33583058|NCT02589665|62980715|FG002|Induction Extension Period|Adverse Event|0|||
33583059|NCT02589665|62980716|FG003|Induction Extension Period|Adverse Event|0|||
33583060|NCT02589665|62980717|FG004|Induction Extension Period|Adverse Event|0|||
33583061|NCT02589665|62980718|FG005|Induction Extension Period|Adverse Event|0|||
33583062|NCT02589665|62980719|FG006|Induction Extension Period|Adverse Event|0|||
33583063|NCT02589665|62980720|FG007|Induction Extension Period|Adverse Event|0|||
33583064|NCT02589665|62980721|FG008|Induction Extension Period|Adverse Event|4|||
33583065|NCT02589665|62980722|FG009|Induction Extension Period|Adverse Event|0|||
33583066|NCT02589665|62980713|FG000|Induction Extension Period|Lack of Efficacy|0|||
33583067|NCT02589665|62980714|FG001|Induction Extension Period|Lack of Efficacy|0|||
33583068|NCT02589665|62980715|FG002|Induction Extension Period|Lack of Efficacy|0|||
33583069|NCT02589665|62980716|FG003|Induction Extension Period|Lack of Efficacy|0|||
33583070|NCT02589665|62980717|FG004|Induction Extension Period|Lack of Efficacy|0|||
33583071|NCT02589665|62980718|FG005|Induction Extension Period|Lack of Efficacy|0|||
33583072|NCT02589665|62980719|FG006|Induction Extension Period|Lack of Efficacy|0|||
33583073|NCT02589665|62980720|FG007|Induction Extension Period|Lack of Efficacy|0|||
33583074|NCT02589665|62980721|FG008|Induction Extension Period|Lack of Efficacy|3|||
33583075|NCT02589665|62980722|FG009|Induction Extension Period|Lack of Efficacy|0|||
33583076|NCT02589665|62980713|FG000|Induction Extension Period|Withdrawal by Subject|0|||
33583077|NCT02589665|62980714|FG001|Induction Extension Period|Withdrawal by Subject|0|||
33583078|NCT02589665|62980715|FG002|Induction Extension Period|Withdrawal by Subject|0|||
33583079|NCT02589665|62980716|FG003|Induction Extension Period|Withdrawal by Subject|0|||
33310649|NCT00948025|62686036|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
33310650|NCT00947011|62686043|FG000|Overall Study|Study was terminated,PI left institution|12|||
33310651|NCT01239342|62686051|FG000|Overall Study|Adverse Event|1|||
33310652|NCT01239342|62686052|FG001|Overall Study|Adverse Event|0|||
33583080|NCT02589665|62980717|FG004|Induction Extension Period|Withdrawal by Subject|0|||
33583081|NCT02589665|62980718|FG005|Induction Extension Period|Withdrawal by Subject|0|||
33583082|NCT02589665|62980719|FG006|Induction Extension Period|Withdrawal by Subject|0|||
33583083|NCT02589665|62980720|FG007|Induction Extension Period|Withdrawal by Subject|2|||
33583084|NCT02589665|62980721|FG008|Induction Extension Period|Withdrawal by Subject|3|||
33583085|NCT02589665|62980722|FG009|Induction Extension Period|Withdrawal by Subject|0|||
33583086|NCT02589665|62980713|FG000|Induction Extension Period|Physician Decision|0|||
33583087|NCT02589665|62980714|FG001|Induction Extension Period|Physician Decision|0|||
33583088|NCT02589665|62980715|FG002|Induction Extension Period|Physician Decision|0|||
33583089|NCT02589665|62980716|FG003|Induction Extension Period|Physician Decision|0|||
33583090|NCT02589665|62980717|FG004|Induction Extension Period|Physician Decision|0|||
33583091|NCT02589665|62980718|FG005|Induction Extension Period|Physician Decision|0|||
33583092|NCT02589665|62980719|FG006|Induction Extension Period|Physician Decision|0|||
33583093|NCT02589665|62980720|FG007|Induction Extension Period|Physician Decision|0|||
33583094|NCT02589665|62980721|FG008|Induction Extension Period|Physician Decision|1|||
33583095|NCT02589665|62980722|FG009|Induction Extension Period|Physician Decision|0|||
33583096|NCT02589665|62980713|FG000|Induction Extension Period|Reason Not Collected|0|||
33583097|NCT02589665|62980714|FG001|Induction Extension Period|Reason Not Collected|0|||
33583098|NCT02589665|62980715|FG002|Induction Extension Period|Reason Not Collected|0|||
33583099|NCT02589665|62980716|FG003|Induction Extension Period|Reason Not Collected|0|||
33583100|NCT02589665|62980717|FG004|Induction Extension Period|Reason Not Collected|0|||
33583101|NCT02589665|62980718|FG005|Induction Extension Period|Reason Not Collected|0|||
33583102|NCT02589665|62980719|FG006|Induction Extension Period|Reason Not Collected|0|||
33583103|NCT02589665|62980720|FG007|Induction Extension Period|Reason Not Collected|0|||
33583104|NCT02589665|62980721|FG008|Induction Extension Period|Reason Not Collected|1|||
33583105|NCT02589665|62980722|FG009|Induction Extension Period|Reason Not Collected|0|||
33583106|NCT02589665|62980713|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33583107|NCT02589665|62980714|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33583108|NCT02589665|62980715|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33583109|NCT02589665|62980716|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33310653|NCT01239342|62686051|FG000|Overall Study|Withdrawal by Subject|1|||
33583110|NCT02589665|62980717|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33583111|NCT02589665|62980718|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33583112|NCT02589665|62980719|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33583113|NCT02589665|62980720|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33583114|NCT02589665|62980721|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33583115|NCT02589665|62980722|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
33583116|NCT02589665|62980713|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
33583117|NCT02589665|62980714|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
33583118|NCT02589665|62980715|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
33583119|NCT02589665|62980716|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
33583120|NCT02589665|62980717|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
33583121|NCT02589665|62980718|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
33583122|NCT02589665|62980719|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
33583123|NCT02589665|62980720|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
33583124|NCT02589665|62980721|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
33583125|NCT02589665|62980722|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
33583126|NCT02589665|62980713|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
33583127|NCT02589665|62980714|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
33583128|NCT02589665|62980715|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
33583129|NCT02589665|62980716|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
33583130|NCT02589665|62980717|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
33583131|NCT02589665|62980718|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
33583132|NCT02589665|62980719|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
33583133|NCT02589665|62980720|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
33583134|NCT02589665|62980721|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
33583135|NCT02589665|62980722|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
33583136|NCT02589665|62980713|FG000|Maintenance Extension Period|Adverse Event|0|||
33583137|NCT02589665|62980714|FG001|Maintenance Extension Period|Adverse Event|0|||
33583138|NCT02589665|62980715|FG002|Maintenance Extension Period|Adverse Event|0|||
33583139|NCT02589665|62980716|FG003|Maintenance Extension Period|Adverse Event|0|||
33583140|NCT02589665|62980717|FG004|Maintenance Extension Period|Adverse Event|0|||
33583141|NCT02589665|62980718|FG005|Maintenance Extension Period|Adverse Event|0|||
33583142|NCT02589665|62980719|FG006|Maintenance Extension Period|Adverse Event|0|||
33583143|NCT02589665|62980720|FG007|Maintenance Extension Period|Adverse Event|0|||
33583144|NCT02589665|62980721|FG008|Maintenance Extension Period|Adverse Event|0|||
33583145|NCT02589665|62980722|FG009|Maintenance Extension Period|Adverse Event|2|||
33583146|NCT02589665|62980713|FG000|Maintenance Extension Period|Non-responder|0|||
33583147|NCT02589665|62980714|FG001|Maintenance Extension Period|Non-responder|0|||
33583148|NCT02589665|62980715|FG002|Maintenance Extension Period|Non-responder|0|||
33583149|NCT02589665|62980716|FG003|Maintenance Extension Period|Non-responder|0|||
33583150|NCT02589665|62980717|FG004|Maintenance Extension Period|Non-responder|0|||
33583151|NCT02589665|62980718|FG005|Maintenance Extension Period|Non-responder|0|||
33583152|NCT02589665|62980719|FG006|Maintenance Extension Period|Non-responder|0|||
33583153|NCT02589665|62980720|FG007|Maintenance Extension Period|Non-responder|0|||
33583154|NCT02589665|62980721|FG008|Maintenance Extension Period|Non-responder|0|||
33583155|NCT02589665|62980722|FG009|Maintenance Extension Period|Non-responder|1|||
33583156|NCT01905397|62980748|FG000|Overall Study|Death|0|||
33583157|NCT01905397|62980749|FG001|Overall Study|Death|1|||
33583158|NCT01905397|62980748|FG000|Overall Study|Withdrawal by Subject|2|||
33583159|NCT01905397|62980749|FG001|Overall Study|Withdrawal by Subject|0|||
33583160|NCT01905397|62980748|FG000|Overall Study|Surgery canceled/aborted|9|||
33583161|NCT01905397|62980749|FG001|Overall Study|Surgery canceled/aborted|5|||
33583162|NCT01905397|62980748|FG000|Overall Study|Incision < 7 cm|2|||
33583163|NCT01905397|62980749|FG001|Overall Study|Incision < 7 cm|0|||
33583164|NCT01905397|62980748|FG000|Overall Study|Wrong treatment|1|||
33583165|NCT01905397|62980749|FG001|Overall Study|Wrong treatment|1|||
33583166|NCT01905397|62980748|FG000|Overall Study|Device not applied|3|||
33583167|NCT01905397|62980749|FG001|Overall Study|Device not applied|0|||
33583168|NCT01905397|62980748|FG000|Overall Study|Dressing not applied in operating room|1|||
33583169|NCT01905397|62980749|FG001|Overall Study|Dressing not applied in operating room|0|||
33583170|NCT01905397|62980748|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
33583171|NCT01905397|62980749|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
33583172|NCT01362595|62980755|FG000|Overall Study|Screen failure|10|||
33583173|NCT01362595|62980755|FG000|Overall Study|Withdrawal by Subject|2|||
33583174|NCT02519595|62980762|FG000|Overall Study|Protocol Violation|8|||
33583175|NCT02519595|62980763|FG001|Overall Study|Protocol Violation|22|||
33583176|NCT02519595|62980764|FG002|Overall Study|Protocol Violation|16|||
33583177|NCT00660673|62980776|FG000|Overall Study|Adverse Event|84|||
33583178|NCT00660673|62980776|FG000|Overall Study|Lack of Efficacy|7|||
33673584|NCT01505114|63111000|FG001|Overall Study|Withdrawal by Subject|4|||
33583179|NCT00660673|62980776|FG000|Overall Study|Withdrawal by Subject|22|||
33583180|NCT00660673|62980776|FG000|Overall Study|Administrative|2|||
33583181|NCT00660673|62980776|FG000|Overall Study|Protocol Violation|2|||
33583182|NCT02630563|62980791|FG000|Overall Study|Administrative|1|||
33583183|NCT02588339|62980805|FG000|Overall Study|Withdrawal by Subject|1|||
33583184|NCT02588339|62980805|FG000|Overall Study|GVHD Progression prior to treatment|2|||
33583185|NCT02629159|62980812|FG000|Overall Study|Adverse Event|17|||
33583186|NCT02629159|62980813|FG001|Overall Study|Adverse Event|20|||
33583187|NCT02629159|62980814|FG002|Overall Study|Adverse Event|22|||
33583188|NCT02629159|62980812|FG000|Overall Study|Withdrawal by Subject|22|||
33583189|NCT02629159|62980813|FG001|Overall Study|Withdrawal by Subject|11|||
33583190|NCT02629159|62980814|FG002|Overall Study|Withdrawal by Subject|15|||
33583191|NCT02629159|62980812|FG000|Overall Study|Lost to Follow-up|7|||
33583192|NCT02629159|62980813|FG001|Overall Study|Lost to Follow-up|4|||
33583193|NCT02629159|62980814|FG002|Overall Study|Lost to Follow-up|5|||
33583194|NCT02629159|62980812|FG000|Overall Study|Lack of Efficacy|4|||
33583195|NCT02629159|62980813|FG001|Overall Study|Lack of Efficacy|0|||
33583196|NCT02629159|62980814|FG002|Overall Study|Lack of Efficacy|1|||
33583197|NCT02629159|62980812|FG000|Overall Study|Other|6|||
33583198|NCT02629159|62980813|FG001|Overall Study|Other|4|||
33583199|NCT02629159|62980814|FG002|Overall Study|Other|8|||
33583200|NCT02628769|62980825|FG000|First Intervention|Adverse Event|1|||
33583201|NCT02628769|62980826|FG001|First Intervention|Adverse Event|0|||
33583202|NCT02628769|62980825|FG000|First Intervention|Withdrawal by Subject|0|||
33583203|NCT02628769|62980826|FG001|First Intervention|Withdrawal by Subject|1|||
33583204|NCT02628769|62980825|FG000|Second Intervention|Adverse Event|2|||
33583205|NCT02628769|62980826|FG001|Second Intervention|Adverse Event|0|||
33583206|NCT02628769|62980825|FG000|Second Intervention|Physician Decision|0|||
33583207|NCT02628769|62980826|FG001|Second Intervention|Physician Decision|1|||
33583208|NCT02626819|62980834|FG000|Overall Study|Lost to Follow-up|3|||
33583209|NCT02626819|62980835|FG001|Overall Study|Lost to Follow-up|2|||
33583210|NCT02626819|62980834|FG000|Overall Study|Withdrawal by Subject|1|||
33583211|NCT02626819|62980835|FG001|Overall Study|Withdrawal by Subject|0|||
33583212|NCT02626819|62980834|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
33583213|NCT02626819|62980835|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
33583214|NCT02630251|62980845|FG000|Overall Study|Physician Decision|0|||
33583215|NCT02630251|62980846|FG001|Overall Study|Physician Decision|0|||
33583216|NCT02630251|62980847|FG002|Overall Study|Physician Decision|1|||
33583217|NCT02630251|62980848|FG003|Overall Study|Physician Decision|0|||
33583218|NCT02518113|62980862|FG000|Overall Study|Adverse Event|1|||
33583219|NCT02518113|62980863|FG001|Overall Study|Adverse Event|0|||
33583220|NCT02518113|62980864|FG002|Overall Study|Adverse Event|1|||
33583221|NCT02518113|62980865|FG003|Overall Study|Adverse Event|0|||
33583222|NCT02518113|62980862|FG000|Overall Study|Death|1|||
33583223|NCT02518113|62980863|FG001|Overall Study|Death|2|||
33583224|NCT02518113|62980864|FG002|Overall Study|Death|0|||
33583225|NCT02518113|62980865|FG003|Overall Study|Death|0|||
33583226|NCT02518113|62980862|FG000|Overall Study|Physician Decision|0|||
33583227|NCT02518113|62980863|FG001|Overall Study|Physician Decision|1|||
33583228|NCT02518113|62980864|FG002|Overall Study|Physician Decision|0|||
33583229|NCT02518113|62980865|FG003|Overall Study|Physician Decision|0|||
33583230|NCT02518113|62980862|FG000|Overall Study|Progressive Disease|1|||
33583231|NCT02518113|62980863|FG001|Overall Study|Progressive Disease|2|||
33583232|NCT02518113|62980864|FG002|Overall Study|Progressive Disease|3|||
33583233|NCT02518113|62980865|FG003|Overall Study|Progressive Disease|0|||
33583234|NCT02629861|62980881|FG000|Overall Study|Adverse Event|7|||
33583235|NCT02629861|62980882|FG001|Overall Study|Adverse Event|5|||
33583236|NCT02629861|62980883|FG002|Overall Study|Adverse Event|4|||
33583237|NCT02629861|62980881|FG000|Overall Study|Withdrawal by Subject|5|||
33583238|NCT02629861|62980882|FG001|Overall Study|Withdrawal by Subject|8|||
33583239|NCT02629861|62980883|FG002|Overall Study|Withdrawal by Subject|13|||
33583240|NCT02629861|62980881|FG000|Overall Study|Protocol Violation|2|||
33583241|NCT02629861|62980882|FG001|Overall Study|Protocol Violation|3|||
33583242|NCT02629861|62980883|FG002|Overall Study|Protocol Violation|7|||
33583243|NCT02629861|62980881|FG000|Overall Study|Lost to Follow-up|12|||
33583244|NCT02629861|62980882|FG001|Overall Study|Lost to Follow-up|9|||
33583245|NCT02629861|62980883|FG002|Overall Study|Lost to Follow-up|4|||
33583246|NCT02629861|62980881|FG000|Overall Study|Other|1|||
33583247|NCT02629861|62980882|FG001|Overall Study|Other|1|||
33583248|NCT02629861|62980883|FG002|Overall Study|Other|0|||
33583249|NCT02629861|62980881|FG000|Overall Study|Pregnancy|2|||
33583250|NCT02629861|62980882|FG001|Overall Study|Pregnancy|1|||
33583251|NCT02629861|62980883|FG002|Overall Study|Pregnancy|0|||
33583252|NCT02482935|62980891|FG000|Period 1|Withdrawal by Subject|1|||
33583253|NCT02482935|62980892|FG001|Period 1|Withdrawal by Subject|0|||
33583254|NCT02513823|62980898|FG000|Overall Study|Lost to Follow-up|4|||
33583255|NCT02513823|62980898|FG000|Overall Study|Physician Decision|1|||
33583256|NCT02513745|62980904|FG000|Overall Study|Criteria at time of surgery not met.|3|||
33583257|NCT02513745|62980905|FG001|Overall Study|Criteria at time of surgery not met.|3|||
33583258|NCT02477553|62980913|FG000|Overall Study|Screening up-to-date|12|||
33583259|NCT02477553|62980914|FG001|Overall Study|Screening up-to-date|13|||
33583260|NCT02477553|62980913|FG000|Overall Study|No MD visit|1|||
33583261|NCT02477553|62980914|FG001|Overall Study|No MD visit|1|||
33583262|NCT02477553|62980913|FG000|Overall Study|Workup consistent w/CRC|1|||
33583263|NCT02477553|62980914|FG001|Overall Study|Workup consistent w/CRC|1|||
33583264|NCT02477553|62980913|FG000|Overall Study|Technical issues with intervention|2|||
33583265|NCT02477553|62980914|FG001|Overall Study|Technical issues with intervention|0|||
33583266|NCT02477553|62980913|FG000|Overall Study|Elevated risk for CRC|2|||
33583267|NCT02477553|62980914|FG001|Overall Study|Elevated risk for CRC|2|||
33583268|NCT02477553|62980913|FG000|Overall Study|MD advised against screening|1|||
33583269|NCT02477553|62980914|FG001|Overall Study|MD advised against screening|3|||
33583270|NCT02477553|62980913|FG000|Overall Study|patient deceased|1|||
33583271|NCT02477553|62980914|FG001|Overall Study|patient deceased|0|||
33583272|NCT01665911|62980920|FG000|Overall Study|Protocol Violation|4|||
33583273|NCT01665911|62980920|FG000|Overall Study|Withdrawal by Subject|1|||
33583274|NCT01665911|62980920|FG000|Overall Study|Adverse Event|1|||
33583275|NCT02452359|62980925|FG000|Overall Study|Adverse Event|1|||
33583276|NCT02452359|62980925|FG000|Overall Study|Lost to Follow-up|15|||
33583277|NCT02452359|62980925|FG000|Overall Study|Pregnancy|1|||
33583278|NCT02452359|62980925|FG000|Overall Study|Withdrawal by Subject|4|||
33583279|NCT02476617|62980929|FG000|Overall Study|Adverse Event|1|||
33583280|NCT02476617|62980929|FG000|Overall Study|Lost to Follow-up|1|||
33583281|NCT01665599|62980946|FG000|Overall Study|Adverse Event|1|||
33583282|NCT01665599|62980946|FG000|Overall Study|Consent Withdrawn|1|||
33583283|NCT01665599|62980946|FG000|Overall Study|Investigator/Sponsor decision|1|||
33583284|NCT01665599|62980946|FG000|Overall Study|Death|1|||
33583285|NCT01665599|62980946|FG000|Overall Study|Lost to Follow-up|2|||
33583286|NCT01665599|62980946|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
33583287|NCT01665599|62980946|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
33583288|NCT01671085|62980952|FG000|Overall Study|Withdrawal by Subject|1|||
33583289|NCT01671085|62980953|FG001|Overall Study|Withdrawal by Subject|0|||
33583290|NCT02510001|62980968|FG000|Overall Study|Early disease progression|0|||
33583291|NCT02510001|62980969|FG001|Overall Study|Early disease progression|0|||
33583292|NCT02510001|62980970|FG002|Overall Study|Early disease progression|0|||
33583293|NCT02510001|62980971|FG003|Overall Study|Early disease progression|1|||
33583294|NCT02510001|62980972|FG004|Overall Study|Early disease progression|1|||
33583295|NCT02510001|62980973|FG005|Overall Study|Early disease progression|1|||
33583296|NCT02510001|62980974|FG006|Overall Study|Early disease progression|0|||
33583297|NCT02510001|62980975|FG007|Overall Study|Early disease progression|0|||
33583298|NCT02510001|62980968|FG000|Overall Study|Adverse Event|0|||
33583299|NCT02510001|62980969|FG001|Overall Study|Adverse Event|0|||
33583300|NCT02510001|62980970|FG002|Overall Study|Adverse Event|0|||
33583301|NCT02510001|62980971|FG003|Overall Study|Adverse Event|1|||
33583302|NCT02510001|62980972|FG004|Overall Study|Adverse Event|2|||
33583303|NCT02510001|62980973|FG005|Overall Study|Adverse Event|1|||
33583304|NCT02510001|62980974|FG006|Overall Study|Adverse Event|2|||
33583305|NCT02510001|62980975|FG007|Overall Study|Adverse Event|5|||
33583306|NCT02510001|62980968|FG000|Overall Study|Physician Decision|0|||
33583307|NCT02510001|62980969|FG001|Overall Study|Physician Decision|0|||
33583308|NCT02510001|62980970|FG002|Overall Study|Physician Decision|0|||
33583309|NCT02510001|62980971|FG003|Overall Study|Physician Decision|0|||
33583310|NCT02510001|62980972|FG004|Overall Study|Physician Decision|1|||
33583311|NCT02510001|62980973|FG005|Overall Study|Physician Decision|0|||
33583312|NCT02510001|62980974|FG006|Overall Study|Physician Decision|0|||
33583313|NCT02510001|62980975|FG007|Overall Study|Physician Decision|0|||
33583314|NCT02510001|62980968|FG000|Overall Study|Withdrawal by Subject|0|||
33583315|NCT02510001|62980969|FG001|Overall Study|Withdrawal by Subject|0|||
33583316|NCT02510001|62980970|FG002|Overall Study|Withdrawal by Subject|0|||
33583317|NCT02510001|62980971|FG003|Overall Study|Withdrawal by Subject|0|||
33583318|NCT02510001|62980972|FG004|Overall Study|Withdrawal by Subject|0|||
33583319|NCT02510001|62980973|FG005|Overall Study|Withdrawal by Subject|0|||
33583320|NCT02510001|62980974|FG006|Overall Study|Withdrawal by Subject|0|||
33583321|NCT02510001|62980975|FG007|Overall Study|Withdrawal by Subject|2|||
33583322|NCT02452047|62981014|FG000|Overall Study|Adverse Event|0|||
33583323|NCT02452047|62981015|FG001|Overall Study|Adverse Event|1|||
33583324|NCT02452047|62981016|FG002|Overall Study|Adverse Event|1|||
33673585|NCT01505114|63111001|FG002|Overall Study|Withdrawal by Subject|4|||
33673586|NCT01505114|63111002|FG003|Overall Study|Withdrawal by Subject|7|||
33583325|NCT02452047|62981014|FG000|Overall Study|Death|1|||
33583326|NCT02452047|62981015|FG001|Overall Study|Death|3|||
33583327|NCT02452047|62981016|FG002|Overall Study|Death|1|||
33583328|NCT02452047|62981014|FG000|Overall Study|Physician Decision|1|||
33583329|NCT02452047|62981015|FG001|Overall Study|Physician Decision|0|||
33583330|NCT02452047|62981016|FG002|Overall Study|Physician Decision|0|||
33583331|NCT02452047|62981014|FG000|Overall Study|Lost to Follow-up|1|||
33583332|NCT02452047|62981015|FG001|Overall Study|Lost to Follow-up|1|||
33583333|NCT02452047|62981016|FG002|Overall Study|Lost to Follow-up|0|||
33583334|NCT02452047|62981014|FG000|Overall Study|Withdrawal by Subject|1|||
33583335|NCT02452047|62981015|FG001|Overall Study|Withdrawal by Subject|0|||
33583336|NCT02452047|62981016|FG002|Overall Study|Withdrawal by Subject|0|||
33583337|NCT02475369|62981024|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
33583338|NCT02475369|62981025|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
33583339|NCT02474589|62981038|FG000|Overall Study|Adverse Event|6|||
33583340|NCT02474589|62981039|FG001|Overall Study|Adverse Event|2|||
33583341|NCT02474589|62981038|FG000|Overall Study|Lost to Follow-up|6|||
33583342|NCT02474589|62981039|FG001|Overall Study|Lost to Follow-up|1|||
33583343|NCT02474589|62981038|FG000|Overall Study|Protocol Violation|4|||
33583344|NCT02474589|62981039|FG001|Overall Study|Protocol Violation|1|||
33583345|NCT02474589|62981038|FG000|Overall Study|Withdrawal by Subject|4|||
33583346|NCT02474589|62981039|FG001|Overall Study|Withdrawal by Subject|0|||
33583347|NCT02474589|62981038|FG000|Overall Study|Inability to complete study procedures|5|||
33583348|NCT02474589|62981039|FG001|Overall Study|Inability to complete study procedures|1|||
33583349|NCT02586233|62981052|FG000|Overall Study|Randomized but did not receive treatment|0|||
33583350|NCT02586233|62981053|FG001|Overall Study|Randomized but did not receive treatment|1|||
33583351|NCT02586233|62981054|FG002|Overall Study|Randomized but did not receive treatment|0|||
33583352|NCT02586233|62981055|FG003|Overall Study|Randomized but did not receive treatment|0|||
33583353|NCT02586233|62981056|FG004|Overall Study|Randomized but did not receive treatment|0|||
33583354|NCT02586233|62981057|FG005|Overall Study|Randomized but did not receive treatment|2|||
33583355|NCT02586233|62981058|FG006|Overall Study|Randomized but did not receive treatment|2|||
33583356|NCT02586233|62981052|FG000|Overall Study|Death|0|||
33583357|NCT02586233|62981053|FG001|Overall Study|Death|1|||
33583358|NCT02586233|62981054|FG002|Overall Study|Death|0|||
33583359|NCT02586233|62981055|FG003|Overall Study|Death|0|||
33583360|NCT02586233|62981056|FG004|Overall Study|Death|2|||
33583361|NCT02586233|62981057|FG005|Overall Study|Death|0|||
33583362|NCT02586233|62981058|FG006|Overall Study|Death|0|||
33583363|NCT02474355|62981078|FG000|Overall Study|Other|43|||
33583364|NCT02474355|62981078|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
33583365|NCT02474355|62981078|FG000|Overall Study|Lost to Follow-up|98|||
33583366|NCT02474355|62981078|FG000|Overall Study|Withdrawal by Subject|124|||
33583367|NCT02474355|62981078|FG000|Overall Study|Death|1361|||
33583368|NCT02474199|62981084|FG000|Overall Study|Lost to Follow-up|1|||
33583369|NCT02474199|62981085|FG001|Overall Study|Lost to Follow-up|0|||
33583370|NCT02474199|62981086|FG002|Overall Study|Lost to Follow-up|0|||
33583371|NCT02474199|62981087|FG003|Overall Study|Lost to Follow-up|0|||
33583372|NCT02474199|62981084|FG000|Overall Study|Withdrawal by Subject|1|||
33583373|NCT02474199|62981085|FG001|Overall Study|Withdrawal by Subject|2|||
33583374|NCT02474199|62981086|FG002|Overall Study|Withdrawal by Subject|0|||
33583375|NCT02474199|62981087|FG003|Overall Study|Withdrawal by Subject|1|||
33583376|NCT02474199|62981084|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
33583377|NCT02474199|62981085|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
33583378|NCT02474199|62981086|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
33583379|NCT02474199|62981087|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
33583380|NCT02474199|62981084|FG000|Overall Study|Did not meet eligibility criteria|0|||
33583381|NCT02474199|62981085|FG001|Overall Study|Did not meet eligibility criteria|0|||
33583382|NCT02474199|62981086|FG002|Overall Study|Did not meet eligibility criteria|2|||
33583383|NCT02474199|62981087|FG003|Overall Study|Did not meet eligibility criteria|2|||
33583384|NCT02450487|62981094|FG000|Overall Study|Lost to Follow-up|3|||
33583385|NCT02473965|62981101|FG000|Overall Study|Adverse Event|6|||
33583386|NCT02473965|62981102|FG001|Overall Study|Adverse Event|4|||
33583387|NCT02473965|62981101|FG000|Overall Study|MG worsening|4|||
33583388|NCT02473965|62981102|FG001|Overall Study|MG worsening|1|||
33583389|NCT02473965|62981101|FG000|Overall Study|Withdrawal by Subject|2|||
33583390|NCT02473965|62981102|FG001|Overall Study|Withdrawal by Subject|3|||
33583391|NCT02473965|62981101|FG000|Overall Study|Physician Decision|0|||
33583392|NCT02473965|62981102|FG001|Overall Study|Physician Decision|2|||
33583393|NCT02472795|62981113|FG000|Overall Study|Adverse Event|0|||
33583394|NCT02472795|62981114|FG001|Overall Study|Adverse Event|1|||
33583395|NCT02472795|62981115|FG002|Overall Study|Adverse Event|0|||
33583396|NCT02472795|62981116|FG003|Overall Study|Adverse Event|0|||
33583397|NCT02472795|62981117|FG004|Overall Study|Adverse Event|2|||
33583398|NCT02472795|62981113|FG000|Overall Study|Withdrawal by Subject|0|||
33583399|NCT02472795|62981114|FG001|Overall Study|Withdrawal by Subject|0|||
33583400|NCT02472795|62981115|FG002|Overall Study|Withdrawal by Subject|0|||
33583401|NCT02472795|62981116|FG003|Overall Study|Withdrawal by Subject|0|||
33583402|NCT02472795|62981117|FG004|Overall Study|Withdrawal by Subject|1|||
33583403|NCT02507349|62981131|FG000|Overall Study|Death|12|||
33583404|NCT02507349|62981132|FG001|Overall Study|Death|16|||
33583405|NCT02507349|62981131|FG000|Overall Study|Withdrawal by Subject|1|||
33583406|NCT02507349|62981132|FG001|Overall Study|Withdrawal by Subject|1|||
33583407|NCT02507349|62981131|FG000|Overall Study|Lost to Follow-up|174|||
33583408|NCT02507349|62981132|FG001|Overall Study|Lost to Follow-up|144|||
33583409|NCT02506881|62981142|FG000|First Intervention (Day 1)|Protocol Violation|0|||
33583410|NCT02506881|62981143|FG001|First Intervention (Day 1)|Protocol Violation|0|||
33583411|NCT02506881|62981144|FG002|First Intervention (Day 1)|Protocol Violation|1|||
33583412|NCT02506881|62981145|FG003|First Intervention (Day 1)|Protocol Violation|0|||
33583413|NCT02506881|62981142|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
33583414|NCT02506881|62981143|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
33583415|NCT02506881|62981144|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
33583416|NCT02506881|62981145|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
33583417|NCT02506881|62981142|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
33583418|NCT02506881|62981143|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
33583419|NCT02506881|62981144|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
33583420|NCT02506881|62981145|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
33583421|NCT02506257|62981169|FG000|Overall Study|Adverse Event|0|||
33583422|NCT02506257|62981170|FG001|Overall Study|Adverse Event|2|||
33583423|NCT02506257|62981171|FG002|Overall Study|Adverse Event|3|||
33583424|NCT02506257|62981172|FG003|Overall Study|Adverse Event|0|||
33583425|NCT02506257|62981169|FG000|Overall Study|Protocol Violation|0|||
33583426|NCT02506257|62981170|FG001|Overall Study|Protocol Violation|0|||
33583427|NCT02506257|62981171|FG002|Overall Study|Protocol Violation|1|||
33583428|NCT02506257|62981172|FG003|Overall Study|Protocol Violation|0|||
33583429|NCT02506101|62981184|FG000|Overall Study|Transportation issues|1|||
33583430|NCT02506101|62981185|FG001|Overall Study|Transportation issues|0|||
33583431|NCT02506101|62981184|FG000|Overall Study|No enrollment and staff unavailability|1|||
33583432|NCT02506101|62981185|FG001|Overall Study|No enrollment and staff unavailability|0|||
33583433|NCT01671007|62981200|FG000|Overall Study|Other reasons than listed|166|||
33583434|NCT01671007|62981201|FG001|Overall Study|Other reasons than listed|373|||
33583435|NCT01671007|62981202|FG002|Overall Study|Other reasons than listed|197|||
33583436|NCT01671007|62981203|FG003|Overall Study|Other reasons than listed|228|||
33583437|NCT01671007|62981204|FG004|Overall Study|Other reasons than listed|14|||
33583438|NCT01671007|62981205|FG005|Overall Study|Other reasons than listed|71|||
33583439|NCT01671007|62981206|FG006|Overall Study|Other reasons than listed|17|||
33583440|NCT01671007|62981207|FG007|Overall Study|Other reasons than listed|66|||
33583441|NCT01671007|62981208|FG008|Overall Study|Other reasons than listed|0|||
33583442|NCT01671007|62981200|FG000|Overall Study|Withdrawal by Subject|36|||
33583443|NCT01671007|62981201|FG001|Overall Study|Withdrawal by Subject|59|||
33583444|NCT01671007|62981202|FG002|Overall Study|Withdrawal by Subject|53|||
33583445|NCT01671007|62981203|FG003|Overall Study|Withdrawal by Subject|58|||
33583446|NCT01671007|62981204|FG004|Overall Study|Withdrawal by Subject|4|||
33583447|NCT01671007|62981205|FG005|Overall Study|Withdrawal by Subject|15|||
33583448|NCT01671007|62981206|FG006|Overall Study|Withdrawal by Subject|1|||
33583449|NCT01671007|62981207|FG007|Overall Study|Withdrawal by Subject|19|||
33583450|NCT01671007|62981208|FG008|Overall Study|Withdrawal by Subject|0|||
33583451|NCT01671007|62981200|FG000|Overall Study|Lost to Follow-up|93|||
33583452|NCT01671007|62981201|FG001|Overall Study|Lost to Follow-up|142|||
33583453|NCT01671007|62981202|FG002|Overall Study|Lost to Follow-up|91|||
33583454|NCT01671007|62981203|FG003|Overall Study|Lost to Follow-up|63|||
33583455|NCT01671007|62981204|FG004|Overall Study|Lost to Follow-up|7|||
33583456|NCT01671007|62981205|FG005|Overall Study|Lost to Follow-up|20|||
33583457|NCT01671007|62981206|FG006|Overall Study|Lost to Follow-up|2|||
33583458|NCT01671007|62981207|FG007|Overall Study|Lost to Follow-up|28|||
33583459|NCT01671007|62981208|FG008|Overall Study|Lost to Follow-up|0|||
33583460|NCT01671007|62981200|FG000|Overall Study|No end of study case report form|3|||
33583461|NCT01671007|62981201|FG001|Overall Study|No end of study case report form|1|||
33583462|NCT01671007|62981202|FG002|Overall Study|No end of study case report form|0|||
33583463|NCT01671007|62981203|FG003|Overall Study|No end of study case report form|2|||
33583464|NCT01671007|62981204|FG004|Overall Study|No end of study case report form|0|||
33583465|NCT01671007|62981205|FG005|Overall Study|No end of study case report form|0|||
33583466|NCT01671007|62981206|FG006|Overall Study|No end of study case report form|0|||
33583467|NCT01671007|62981207|FG007|Overall Study|No end of study case report form|0|||
33583468|NCT01671007|62981208|FG008|Overall Study|No end of study case report form|0|||
33583469|NCT01671007|62981200|FG000|Overall Study|Not eligible|23|||
33583470|NCT01671007|62981201|FG001|Overall Study|Not eligible|76|||
33583471|NCT01671007|62981202|FG002|Overall Study|Not eligible|25|||
33583472|NCT01671007|62981203|FG003|Overall Study|Not eligible|17|||
33583473|NCT01671007|62981204|FG004|Overall Study|Not eligible|0|||
33583474|NCT01671007|62981205|FG005|Overall Study|Not eligible|6|||
33583475|NCT01671007|62981206|FG006|Overall Study|Not eligible|1|||
33583476|NCT01671007|62981207|FG007|Overall Study|Not eligible|19|||
33583477|NCT01671007|62981208|FG008|Overall Study|Not eligible|0|||
33583478|NCT02505945|62981221|FG000|Overall Study|Withdrawal by Subject|13|||
33583479|NCT02505945|62981222|FG001|Overall Study|Withdrawal by Subject|2|||
33583480|NCT02505945|62981221|FG000|Overall Study|Adverse Event|1|||
33583481|NCT02505945|62981222|FG001|Overall Study|Adverse Event|0|||
33583482|NCT02505945|62981221|FG000|Overall Study|Physician Decision|2|||
33583483|NCT02505945|62981222|FG001|Overall Study|Physician Decision|1|||
33583484|NCT02505945|62981221|FG000|Overall Study|Lost to Follow-up|6|||
33583485|NCT02505945|62981222|FG001|Overall Study|Lost to Follow-up|1|||
33583486|NCT02505867|62981230|FG000|Overall Study|Lack of Efficacy|6|||
33583487|NCT02505867|62981231|FG001|Overall Study|Lack of Efficacy|6|||
33583488|NCT02472639|62981239|FG000|Overall Study|Physician Decision|4|||
33583489|NCT02472639|62981240|FG001|Overall Study|Physician Decision|3|||
33583490|NCT02472405|62981246|FG000|Overall Study|Lost to Follow-up|9|||
33583491|NCT02472405|62981246|FG000|Overall Study|Adverse Event|1|||
33583492|NCT02448771|62981252|FG000|Overall Study|Disease Progression|30|||
33583493|NCT02448771|62981252|FG000|Overall Study|Unacceptable Toxicity|1|||
33583494|NCT02448771|62981252|FG000|Overall Study|Physician Decision|3|||
33583495|NCT02448771|62981252|FG000|Overall Study|Started new therapy|2|||
33583496|NCT02504541|62981257|FG000|Overall Study|Adverse Event|4|||
33583497|NCT02504541|62981257|FG000|Overall Study|Withdrawal by Subject|4|||
33583498|NCT02504541|62981257|FG000|Overall Study|Lost to Follow-up|1|||
33583499|NCT02504541|62981257|FG000|Overall Study|Met Stopping Criteria|1|||
33583500|NCT02504541|62981257|FG000|Overall Study|Protocol Violation|2|||
33583501|NCT02504541|62981257|FG000|Overall Study|Termination by Sponsor|1|||
33583502|NCT02504541|62981257|FG000|Overall Study|Other|2|||
33673587|NCT01505114|63110999|FG000|Overall Study|Death|1|||
33673588|NCT01505114|63111000|FG001|Overall Study|Death|0|||
33673589|NCT01505114|63111001|FG002|Overall Study|Death|0|||
33583503|NCT02504541|62981257|FG000|Overall Study|Multiple|5|||
33583504|NCT02725177|62981261|FG000|Overall Study|Physician Decision|4|||
33583505|NCT02725177|62981261|FG000|Overall Study|Adverse Event|1|||
33583506|NCT02448537|62981268|FG000|Overall Study|Withdrawal by Subject|1|||
33583507|NCT02448537|62981269|FG001|Overall Study|Withdrawal by Subject|1|||
33583508|NCT02448537|62981270|FG002|Overall Study|Withdrawal by Subject|1|||
33583509|NCT02504151|62981280|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
33583510|NCT02504151|62981281|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
33583511|NCT02504151|62981280|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
33583512|NCT02504151|62981281|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
33583513|NCT02504151|62981280|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
33583514|NCT02504151|62981281|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
33583515|NCT02504151|62981280|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
33583516|NCT02504151|62981281|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
33583517|NCT02448381|62981289|FG000|Overall Study|Adverse Event|2|||
33583518|NCT02448381|62981290|FG001|Overall Study|Adverse Event|0|||
33583519|NCT02448381|62981289|FG000|Overall Study|Lost to Follow-up|16|||
33583520|NCT02448381|62981290|FG001|Overall Study|Lost to Follow-up|9|||
33583521|NCT02448381|62981289|FG000|Overall Study|Physician Decision|1|||
33583522|NCT02448381|62981290|FG001|Overall Study|Physician Decision|1|||
33583523|NCT02448381|62981289|FG000|Overall Study|Pregnancy|1|||
33583524|NCT02448381|62981290|FG001|Overall Study|Pregnancy|0|||
33583525|NCT02448381|62981289|FG000|Overall Study|Withdrawal by Subject|13|||
33583526|NCT02448381|62981290|FG001|Overall Study|Withdrawal by Subject|9|||
33583527|NCT02448381|62981289|FG000|Overall Study|Noncompliance with Study Procedures|2|||
33583528|NCT02448381|62981290|FG001|Overall Study|Noncompliance with Study Procedures|0|||
33583529|NCT02448225|62981302|FG000|Overall Study|Withdrawal by Subject|1|||
33583530|NCT02448225|62981302|FG000|Overall Study|Did not get FSPG scan|18|||
33583531|NCT02448225|62981302|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
33583532|NCT02503215|62981309|FG000|Overall Study|Unable to wear compression stockings|1|||
33583533|NCT02503215|62981309|FG000|Overall Study|Unable to use positive airway pressure|2|||
33583534|NCT02447991|62981315|FG000|Overall Study|Withdrawn by subject - no data|0|||
33583535|NCT02447991|62981316|FG001|Overall Study|Withdrawn by subject - no data|2|||
33583536|NCT02447991|62981315|FG000|Overall Study|Withdrawn by Subject - with data|4|||
33583537|NCT02447991|62981316|FG001|Overall Study|Withdrawn by Subject - with data|4|||
33673590|NCT01505114|63111002|FG003|Overall Study|Death|1|||
33673591|NCT01505114|63110999|FG000|Overall Study|unable to adhere to visit schedule|3|||
33673592|NCT01505114|63111000|FG001|Overall Study|unable to adhere to visit schedule|2|||
33673593|NCT01505114|63111001|FG002|Overall Study|unable to adhere to visit schedule|3|||
33673594|NCT01505114|63111002|FG003|Overall Study|unable to adhere to visit schedule|3|||
33673595|NCT01505114|63110999|FG000|Overall Study|Lost to Follow-up|11|||
33673596|NCT01505114|63111000|FG001|Overall Study|Lost to Follow-up|5|||
33310654|NCT01239342|62686052|FG001|Overall Study|Withdrawal by Subject|5|||
33583538|NCT02447991|62981315|FG000|Overall Study|Lost to Follow-up - no data|3|||
33583539|NCT02447991|62981316|FG001|Overall Study|Lost to Follow-up - no data|6|||
33583540|NCT02447991|62981315|FG000|Overall Study|Lost to follow-up - with data|0|||
33583541|NCT02447991|62981316|FG001|Overall Study|Lost to follow-up - with data|3|||
33583542|NCT02447991|62981315|FG000|Overall Study|End of study - no treatment results|3|||
33583543|NCT02447991|62981316|FG001|Overall Study|End of study - no treatment results|6|||
33583544|NCT02447991|62981315|FG000|Overall Study|End of study - partial treatment results|0|||
33673597|NCT01505114|63111001|FG002|Overall Study|Lost to Follow-up|8|||
33673598|NCT01505114|63111002|FG003|Overall Study|Lost to Follow-up|7|||
33583545|NCT02447991|62981316|FG001|Overall Study|End of study - partial treatment results|9|||
33583546|NCT02586155|62981328|FG000|Overall Study|Adverse Event|2|||
33583547|NCT02586155|62981329|FG001|Overall Study|Adverse Event|3|||
33583548|NCT02586155|62981328|FG000|Overall Study|Withdrawal by Subject|31|||
33583549|NCT02586155|62981329|FG001|Overall Study|Withdrawal by Subject|24|||
33583550|NCT02586155|62981328|FG000|Overall Study|Lost to Follow-up|7|||
33583551|NCT02586155|62981329|FG001|Overall Study|Lost to Follow-up|13|||
33583552|NCT02586155|62981328|FG000|Overall Study|Death|61|||
33583553|NCT02586155|62981329|FG001|Overall Study|Death|72|||
33583554|NCT02586155|62981328|FG000|Overall Study|Other reasons|26|||
33583555|NCT02586155|62981329|FG001|Overall Study|Other reasons|15|||
33583556|NCT02446743|62981337|FG000|Overall Study|Withdrawal by Subject|1|||
33583557|NCT02446743|62981338|FG001|Overall Study|Withdrawal by Subject|1|||
33583558|NCT02446743|62981337|FG000|Overall Study|Lost to Follow-up|1|||
33583559|NCT02446743|62981338|FG001|Overall Study|Lost to Follow-up|0|||
33583560|NCT02446743|62981337|FG000|Overall Study|Adverse Event|1|||
33583561|NCT02446743|62981338|FG001|Overall Study|Adverse Event|1|||
33583562|NCT02446743|62981337|FG000|Overall Study|Other|2|||
33583563|NCT02446743|62981338|FG001|Overall Study|Other|3|||
33583564|NCT02586077|62981353|FG000|Overall Study|Withdrawal by Subject|1|||
33583565|NCT02586077|62981353|FG000|Overall Study|Physician Decision|4|||
33583566|NCT02586077|62981353|FG000|Overall Study|Lost to Follow-up|3|||
33583567|NCT02583425|62981358|FG000|Screening|Did not meet entry criteria|12|||
33583568|NCT02583425|62981358|FG000|Baseline|Did not meet continued criteria|5|||
33583569|NCT02583425|62981358|FG000|Treatment Period|Adverse Event|1|||
33583570|NCT02581163|62981363|FG000|Overall Study|Failure to return|15|||
33583571|NCT02581163|62981363|FG000|Overall Study|Insufficient virological response|3|||
33583572|NCT02581163|62981363|FG000|Overall Study|Withdrew consent|1|||
33583573|NCT02581163|62981363|FG000|Overall Study|Death|1|||
33583574|NCT02581163|62981363|FG000|Overall Study|Other, not specified|9|||
33583575|NCT02627677|62981373|FG000|Overall Study|Adverse event (not progressive disease)|1|||
33583576|NCT02627677|62981374|FG001|Overall Study|Adverse event (not progressive disease)|4|||
33583577|NCT02627677|62981375|FG002|Overall Study|Adverse event (not progressive disease)|1|||
33583578|NCT02627677|62981373|FG000|Overall Study|Progressive disease|1|||
33583579|NCT02627677|62981374|FG001|Overall Study|Progressive disease|3|||
33583580|NCT02627677|62981375|FG002|Overall Study|Progressive disease|0|||
33583581|NCT02627677|62981373|FG000|Overall Study|Lack of Efficacy|1|||
33583582|NCT02627677|62981374|FG001|Overall Study|Lack of Efficacy|2|||
33583583|NCT02627677|62981375|FG002|Overall Study|Lack of Efficacy|0|||
33583584|NCT02627677|62981373|FG000|Overall Study|Lost to Follow-up|0|||
33583585|NCT02627677|62981374|FG001|Overall Study|Lost to Follow-up|0|||
33583586|NCT02627677|62981375|FG002|Overall Study|Lost to Follow-up|1|||
33583587|NCT02627677|62981373|FG000|Overall Study|Pregnancy|0|||
33583588|NCT02627677|62981374|FG001|Overall Study|Pregnancy|1|||
33583589|NCT02627677|62981375|FG002|Overall Study|Pregnancy|0|||
33583590|NCT02627677|62981373|FG000|Overall Study|Study Terminated by Sponsor|5|||
33583591|NCT02627677|62981374|FG001|Overall Study|Study Terminated by Sponsor|10|||
33583592|NCT02627677|62981375|FG002|Overall Study|Study Terminated by Sponsor|6|||
33583593|NCT02627677|62981373|FG000|Overall Study|Physician Decision|0|||
33583594|NCT02627677|62981374|FG001|Overall Study|Physician Decision|0|||
33583595|NCT02627677|62981375|FG002|Overall Study|Physician Decision|2|||
33583596|NCT02627677|62981373|FG000|Overall Study|Withdrawal by Subject|2|||
33583597|NCT02627677|62981374|FG001|Overall Study|Withdrawal by Subject|1|||
33583598|NCT02627677|62981375|FG002|Overall Study|Withdrawal by Subject|1|||
33583599|NCT02627677|62981373|FG000|Overall Study|Reason not Specified|0|||
33583600|NCT02627677|62981374|FG001|Overall Study|Reason not Specified|0|||
33583601|NCT02627677|62981375|FG002|Overall Study|Reason not Specified|1|||
33583602|NCT02627677|62981373|FG000|Overall Study|Randomized but not Treated|1|||
33583603|NCT02627677|62981374|FG001|Overall Study|Randomized but not Treated|0|||
33583604|NCT02627677|62981375|FG002|Overall Study|Randomized but not Treated|0|||
33583605|NCT02501811|62981388|FG000|Overall Study|Death|1|||
33583606|NCT02501811|62981389|FG001|Overall Study|Death|3|||
33583607|NCT02501811|62981390|FG002|Overall Study|Death|2|||
33583608|NCT02501811|62981391|FG003|Overall Study|Death|3|||
33583609|NCT02501811|62981388|FG000|Overall Study|Withdrawal by Subject|3|||
33583610|NCT02501811|62981389|FG001|Overall Study|Withdrawal by Subject|3|||
33583611|NCT02501811|62981390|FG002|Overall Study|Withdrawal by Subject|2|||
33583612|NCT02501811|62981391|FG003|Overall Study|Withdrawal by Subject|3|||
33583613|NCT02501811|62981388|FG000|Overall Study|Lost to Follow-up|0|||
33583614|NCT02501811|62981389|FG001|Overall Study|Lost to Follow-up|0|||
33583615|NCT02501811|62981390|FG002|Overall Study|Lost to Follow-up|2|||
33583616|NCT02501811|62981391|FG003|Overall Study|Lost to Follow-up|1|||
33583617|NCT02585999|62981401|FG000|Overall Study|Lost to Follow-up|1|||
33583618|NCT02585999|62981401|FG000|Overall Study|Protocol Violation|1|||
33583619|NCT02582255|62981408|FG000|Overall Study|Protocol Violation|0|||
33583620|NCT02582255|62981409|FG001|Overall Study|Protocol Violation|3|||
33583621|NCT02500719|62981418|FG000|Overall Study|Lost to Follow-up|2|||
33583622|NCT02500719|62981419|FG001|Overall Study|Lost to Follow-up|3|||
33583623|NCT02500719|62981418|FG000|Overall Study|Trauma history|1|||
33583624|NCT02500719|62981419|FG001|Overall Study|Trauma history|0|||
33583625|NCT02500719|62981418|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
33583626|NCT02500719|62981419|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
33583627|NCT02500719|62981418|FG000|Overall Study|Did not meet criteria for PTSD|0|||
33583628|NCT02500719|62981419|FG001|Overall Study|Did not meet criteria for PTSD|1|||
33583629|NCT02500719|62981418|FG000|Overall Study|Claustrophobia|0|||
33583630|NCT02500719|62981419|FG001|Overall Study|Claustrophobia|1|||
33583631|NCT02500719|62981418|FG000|Overall Study|History of head trauma|0|||
33583632|NCT02500719|62981419|FG001|Overall Study|History of head trauma|1|||
33583633|NCT02500641|62981427|FG000|Overall Study|Adverse Event|0|||
33583634|NCT02500641|62981428|FG001|Overall Study|Adverse Event|2|||
33583635|NCT02500641|62981427|FG000|Overall Study|Withdrawal by Subject|4|||
33583636|NCT02500641|62981428|FG001|Overall Study|Withdrawal by Subject|5|||
33583637|NCT02500641|62981427|FG000|Overall Study|Unable to follow study procedures|3|||
33583638|NCT02500641|62981428|FG001|Overall Study|Unable to follow study procedures|2|||
33583639|NCT02500641|62981427|FG000|Overall Study|Protocol Violation|1|||
33583640|NCT02500641|62981428|FG001|Overall Study|Protocol Violation|2|||
33583641|NCT02500641|62981427|FG000|Overall Study|Lost to Follow-up|1|||
33583642|NCT02500641|62981428|FG001|Overall Study|Lost to Follow-up|0|||
33583643|NCT02500641|62981427|FG000|Overall Study|Sponsor decision|1|||
33583644|NCT02500641|62981428|FG001|Overall Study|Sponsor decision|0|||
33583645|NCT02500641|62981427|FG000|Overall Study|Non compliance to study drug|0|||
33583646|NCT02500641|62981428|FG001|Overall Study|Non compliance to study drug|1|||
33583647|NCT02499783|62981436|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
33583648|NCT02499783|62981437|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
33583649|NCT02499783|62981438|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
33583650|NCT02499783|62981436|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
33583651|NCT02499783|62981437|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
33583652|NCT02499783|62981438|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
33583653|NCT02499783|62981436|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
33583654|NCT02499783|62981437|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
33583655|NCT02499783|62981438|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
33583656|NCT02499783|62981436|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
33583657|NCT02499783|62981437|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
33583658|NCT02499783|62981438|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
33583659|NCT02499783|62981436|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
33583660|NCT02499783|62981437|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
33583661|NCT02499783|62981438|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
33583662|NCT02499783|62981436|FG000|DB Period: Weeks 0-8|Other|1|||
33583663|NCT02499783|62981437|FG001|DB Period: Weeks 0-8|Other|1|||
33583664|NCT02499783|62981438|FG002|DB Period: Weeks 0-8|Other|0|||
33583665|NCT02499783|62981436|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
33583666|NCT02499783|62981437|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
33583667|NCT02499783|62981438|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
33583668|NCT02499783|62981436|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
33583669|NCT02499783|62981437|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
33583670|NCT02499783|62981438|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
33583671|NCT02499783|62981436|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
33583672|NCT02499783|62981437|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
33583673|NCT02499783|62981438|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
33583674|NCT02499783|62981436|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
33583675|NCT02499783|62981437|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
33583676|NCT02499783|62981438|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
33583677|NCT02468193|62981448|FG000|Overall Study|Adverse Event|4|||
33583678|NCT02468193|62981448|FG000|Overall Study|Subject/ Guardian decision|2|||
33583679|NCT02466555|62981468|FG000|Overall Study|Lost to Follow-up|2|||
33583680|NCT02466399|62981475|FG000|Overall Study|Adverse Event|1|||
33583681|NCT02466399|62981476|FG001|Overall Study|Adverse Event|0|||
33583682|NCT02466399|62981475|FG000|Overall Study|Early exit due to family emergency|1|||
33583683|NCT02466399|62981476|FG001|Overall Study|Early exit due to family emergency|0|||
33583684|NCT02465931|62981484|FG000|Overall Study|Lost to Follow-up|9|||
33583685|NCT02465931|62981485|FG001|Overall Study|Lost to Follow-up|11|||
33583686|NCT02465931|62981484|FG000|Overall Study|Protocol Violation|1|||
33583687|NCT02465931|62981485|FG001|Overall Study|Protocol Violation|0|||
33583688|NCT02465931|62981484|FG000|Overall Study|Withdrawal by Subject|1|||
33583689|NCT02465931|62981485|FG001|Overall Study|Withdrawal by Subject|0|||
33583690|NCT02465463|62981493|FG000|Overall Study|Lost to Follow-up|2|||
33583691|NCT02465463|62981494|FG001|Overall Study|Lost to Follow-up|1|||
33583692|NCT02465463|62981493|FG000|Overall Study|Death|1|||
33583693|NCT02465463|62981494|FG001|Overall Study|Death|0|||
33583694|NCT02465463|62981493|FG000|Overall Study|Protocol Violation|1|||
33583695|NCT02465463|62981494|FG001|Overall Study|Protocol Violation|0|||
33583696|NCT02464059|62981501|FG000|Overall Study|Lost to Follow-up|6|||
33583697|NCT02463357|62981510|FG000|Overall Study|Withdrawal by Subject|1|||
33583698|NCT02463357|62981511|FG001|Overall Study|Withdrawal by Subject|0|||
33583699|NCT02463357|62981512|FG002|Overall Study|Withdrawal by Subject|0|||
33583700|NCT02463357|62981513|FG003|Overall Study|Withdrawal by Subject|0|||
33583701|NCT02463357|62981514|FG004|Overall Study|Withdrawal by Subject|0|||
33583702|NCT02463357|62981510|FG000|Overall Study|Withdrawal by Subject|0|||
33583703|NCT02463357|62981511|FG001|Overall Study|Withdrawal by Subject|0|||
33583704|NCT02463357|62981512|FG002|Overall Study|Withdrawal by Subject|0|||
33583705|NCT02463357|62981513|FG003|Overall Study|Withdrawal by Subject|0|||
33583706|NCT02463357|62981514|FG004|Overall Study|Withdrawal by Subject|1|||
33583707|NCT02579759|62981529|FG000|Overall Study|Protocol Violation|2|||
33583708|NCT02579759|62981530|FG001|Overall Study|Protocol Violation|0|||
33583709|NCT02579759|62981531|FG002|Overall Study|Protocol Violation|0|||
33583710|NCT02579759|62981529|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
33583711|NCT02579759|62981530|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
33583712|NCT02579759|62981531|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
33583713|NCT02579759|62981529|FG000|Overall Study|BfArM hold|13|||
33583714|NCT02579759|62981530|FG001|Overall Study|BfArM hold|12|||
33583715|NCT02579759|62981531|FG002|Overall Study|BfArM hold|12|||
33583716|NCT02579759|62981529|FG000|Overall Study|Sponsor stopped Dose 2|0|||
33583717|NCT02579759|62981530|FG001|Overall Study|Sponsor stopped Dose 2|41|||
33583718|NCT02579759|62981531|FG002|Overall Study|Sponsor stopped Dose 2|0|||
33583719|NCT02579759|62981529|FG000|Overall Study|Non compliance|0|||
33583720|NCT02579759|62981530|FG001|Overall Study|Non compliance|1|||
33583721|NCT02579759|62981531|FG002|Overall Study|Non compliance|0|||
33583722|NCT02579759|62981529|FG000|Overall Study|Pregnancy|0|||
33583723|NCT02579759|62981530|FG001|Overall Study|Pregnancy|1|||
33583724|NCT02579759|62981531|FG002|Overall Study|Pregnancy|0|||
33583725|NCT02579759|62981529|FG000|Overall Study|Inclusion/exclusion criteria|0|||
33583726|NCT02579759|62981530|FG001|Overall Study|Inclusion/exclusion criteria|0|||
33583727|NCT02579759|62981531|FG002|Overall Study|Inclusion/exclusion criteria|1|||
33583728|NCT02579759|62981529|FG000|Overall Study|Adverse Event|4|||
33583729|NCT02579759|62981530|FG001|Overall Study|Adverse Event|3|||
33583730|NCT02579759|62981531|FG002|Overall Study|Adverse Event|1|||
33583731|NCT02579759|62981529|FG000|Overall Study|Withdrawal by Subject|3|||
33583732|NCT02579759|62981530|FG001|Overall Study|Withdrawal by Subject|3|||
33583733|NCT02579759|62981531|FG002|Overall Study|Withdrawal by Subject|5|||
33583734|NCT02579759|62981529|FG000|Overall Study|Lost to Follow-up|2|||
33583735|NCT02579759|62981530|FG001|Overall Study|Lost to Follow-up|2|||
33583736|NCT02579759|62981531|FG002|Overall Study|Lost to Follow-up|2|||
33583737|NCT02445963|62981545|FG000|Overall Study|Lost to Follow-up|1|||
33583738|NCT02445963|62981546|FG001|Overall Study|Lost to Follow-up|0|||
33583739|NCT02445963|62981547|FG002|Overall Study|Lost to Follow-up|0|||
33583740|NCT02445963|62981548|FG003|Overall Study|Lost to Follow-up|0|||
33583741|NCT02445963|62981545|FG000|Overall Study|Change in employment|1|||
33583742|NCT02445963|62981546|FG001|Overall Study|Change in employment|0|||
33583743|NCT02445963|62981547|FG002|Overall Study|Change in employment|0|||
33583744|NCT02445963|62981548|FG003|Overall Study|Change in employment|0|||
33583745|NCT02445963|62981545|FG000|Overall Study|Symptoms post-vaccination|0|||
33583746|NCT02445963|62981546|FG001|Overall Study|Symptoms post-vaccination|0|||
33583747|NCT02445963|62981547|FG002|Overall Study|Symptoms post-vaccination|1|||
33583748|NCT02445963|62981548|FG003|Overall Study|Symptoms post-vaccination|0|||
33583749|NCT02499159|62981562|FG000|Randomization|Protocol Violation|1|||
33583750|NCT02499159|62981563|FG001|Randomization|Protocol Violation|1|||
33583751|NCT02499159|62981562|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
33583752|NCT02499159|62981563|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
33583753|NCT02499159|62981562|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
33583754|NCT02499159|62981563|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
33583755|NCT02499159|62981562|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
33583756|NCT02499159|62981563|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
33583757|NCT02499159|62981562|FG000|30-Day Follow-Up Phone Call|Other|1|||
33583758|NCT02499159|62981563|FG001|30-Day Follow-Up Phone Call|Other|0|||
33583759|NCT01664039|62981571|FG000|Overall Study|Adverse Event|3|||
33583760|NCT01664039|62981572|FG001|Overall Study|Adverse Event|4|||
33583761|NCT01664039|62981571|FG000|Overall Study|Lost to Follow-up|1|||
33583762|NCT01664039|62981572|FG001|Overall Study|Lost to Follow-up|1|||
33583763|NCT01664039|62981571|FG000|Overall Study|Withdrawal by Subject|1|||
33583764|NCT01664039|62981572|FG001|Overall Study|Withdrawal by Subject|3|||
33583765|NCT01664039|62981571|FG000|Overall Study|Noncompliance|1|||
33583766|NCT01664039|62981572|FG001|Overall Study|Noncompliance|1|||
33583767|NCT02445573|62981580|FG000|Overall Study|Withdrawal by Subject|1|||
33583768|NCT02445573|62981581|FG001|Overall Study|Withdrawal by Subject|1|||
33583769|NCT02445573|62981580|FG000|Overall Study|Lost to Follow-up|0|||
33583770|NCT02445573|62981581|FG001|Overall Study|Lost to Follow-up|1|||
33583771|NCT02445339|62981589|FG000|Overall Study|Physician Decision|1|||
33583772|NCT02445339|62981590|FG001|Overall Study|Physician Decision|0|||
33583773|NCT02445339|62981589|FG000|Overall Study|Lost to Follow-up|11|||
33583774|NCT02445339|62981590|FG001|Overall Study|Lost to Follow-up|15|||
33583775|NCT02579603|62981598|FG000|Overall Study|Not treated|1|||
33583776|NCT02579603|62981599|FG001|Overall Study|Not treated|0|||
33583777|NCT02579603|62981598|FG000|Overall Study|Adverse Event|2|||
33583778|NCT02579603|62981599|FG001|Overall Study|Adverse Event|2|||
33583779|NCT02579603|62981598|FG000|Overall Study|Other than stated|1|||
33583780|NCT02579603|62981599|FG001|Overall Study|Other than stated|0|||
33583781|NCT02625259|62981611|FG000|First Intervention (Day 1)|Other|0|||
33583782|NCT02625259|62981612|FG001|First Intervention (Day 1)|Other|0|||
33583783|NCT02625259|62981613|FG002|First Intervention (Day 1)|Other|1|||
33583784|NCT02625259|62981614|FG003|First Intervention (Day 1)|Other|0|||
33583785|NCT02625259|62981615|FG004|First Intervention (Day 1)|Other|0|||
33583786|NCT02625259|62981611|FG000|First Intervention (Day 1)|Adverse Event|2|||
33583787|NCT02625259|62981612|FG001|First Intervention (Day 1)|Adverse Event|1|||
33583788|NCT02625259|62981613|FG002|First Intervention (Day 1)|Adverse Event|0|||
33583789|NCT02625259|62981614|FG003|First Intervention (Day 1)|Adverse Event|0|||
33583790|NCT02625259|62981615|FG004|First Intervention (Day 1)|Adverse Event|0|||
33583791|NCT02625259|62981611|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
33583792|NCT02625259|62981612|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
33583793|NCT02625259|62981613|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
33583794|NCT02625259|62981614|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
33583795|NCT02625259|62981615|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
33583796|NCT02577107|62981632|FG000|Overall Study|Protocol deviation|0|||
33583797|NCT02577107|62981633|FG001|Overall Study|Protocol deviation|1|||
33583798|NCT02444793|62981643|FG000|Overall Study|Lost to Follow-up|2|||
33583799|NCT02444793|62981644|FG001|Overall Study|Lost to Follow-up|2|||
33583800|NCT02444793|62981645|FG002|Overall Study|Lost to Follow-up|0|||
33583801|NCT02444793|62981646|FG003|Overall Study|Lost to Follow-up|0|||
33583802|NCT02444793|62981643|FG000|Overall Study|Death|0|||
33583803|NCT02444793|62981644|FG001|Overall Study|Death|3|||
33583804|NCT02444793|62981645|FG002|Overall Study|Death|0|||
33583805|NCT02444793|62981646|FG003|Overall Study|Death|0|||
33583806|NCT02444793|62981643|FG000|Overall Study|Other|0|||
33583807|NCT02444793|62981644|FG001|Overall Study|Other|0|||
33583808|NCT02444793|62981645|FG002|Overall Study|Other|2|||
33583809|NCT02444793|62981646|FG003|Overall Study|Other|0|||
33583810|NCT02444793|62981643|FG000|Overall Study|Objective progression or relapse|9|||
33583811|NCT02444793|62981644|FG001|Overall Study|Objective progression or relapse|1|||
33583812|NCT02444793|62981645|FG002|Overall Study|Objective progression or relapse|2|||
33583813|NCT02444793|62981646|FG003|Overall Study|Objective progression or relapse|3|||
33583814|NCT02624713|62981659|FG000|Overall Study|Lost to Follow-up|14|||
33583815|NCT02624713|62981660|FG001|Overall Study|Lost to Follow-up|0|||
33583816|NCT02624791|62981667|FG000|Overall Study|Withdrawal by Subject|2|||
33583817|NCT02624791|62981668|FG001|Overall Study|Withdrawal by Subject|0|||
33583818|NCT02624791|62981669|FG002|Overall Study|Withdrawal by Subject|0|||
33583819|NCT02624791|62981670|FG003|Overall Study|Withdrawal by Subject|0|||
33583820|NCT02624791|62981671|FG004|Overall Study|Withdrawal by Subject|0|||
33583821|NCT02624791|62981672|FG005|Overall Study|Withdrawal by Subject|0|||
33583822|NCT02577029|62981684|FG000|Overall Study|Adverse Event|1|||
33583823|NCT02577029|62981685|FG001|Overall Study|Adverse Event|0|||
33583824|NCT02577029|62981686|FG002|Overall Study|Adverse Event|2|||
33583825|NCT02577029|62981687|FG003|Overall Study|Adverse Event|0|||
33583826|NCT02577029|62981688|FG004|Overall Study|Adverse Event|1|||
33583827|NCT02577029|62981689|FG005|Overall Study|Adverse Event|0|||
33583828|NCT02577029|62981690|FG006|Overall Study|Adverse Event|0|||
33583829|NCT02577029|62981691|FG007|Overall Study|Adverse Event|0|||
33583830|NCT02577029|62981684|FG000|Overall Study|Withdrawal by Subject|0|||
33583831|NCT02577029|62981685|FG001|Overall Study|Withdrawal by Subject|0|||
33583832|NCT02577029|62981686|FG002|Overall Study|Withdrawal by Subject|0|||
33583833|NCT02577029|62981687|FG003|Overall Study|Withdrawal by Subject|0|||
33583834|NCT02577029|62981688|FG004|Overall Study|Withdrawal by Subject|0|||
33583835|NCT02577029|62981689|FG005|Overall Study|Withdrawal by Subject|1|||
33583836|NCT02577029|62981690|FG006|Overall Study|Withdrawal by Subject|0|||
33583837|NCT02577029|62981691|FG007|Overall Study|Withdrawal by Subject|0|||
33583838|NCT02577029|62981684|FG000|Overall Study|Sponsor Termination of the Study|9|||
33583839|NCT02577029|62981685|FG001|Overall Study|Sponsor Termination of the Study|2|||
33583840|NCT02577029|62981686|FG002|Overall Study|Sponsor Termination of the Study|5|||
33583841|NCT02577029|62981687|FG003|Overall Study|Sponsor Termination of the Study|12|||
33583842|NCT02577029|62981688|FG004|Overall Study|Sponsor Termination of the Study|10|||
33583843|NCT02577029|62981689|FG005|Overall Study|Sponsor Termination of the Study|12|||
33583844|NCT02577029|62981690|FG006|Overall Study|Sponsor Termination of the Study|12|||
33583845|NCT02577029|62981691|FG007|Overall Study|Sponsor Termination of the Study|12|||
33583846|NCT02577887|62981709|FG000|Overall Study|Death|93|||
33583847|NCT02577887|62981709|FG000|Overall Study|Protocol Violation|125|||
33583848|NCT02577887|62981709|FG000|Overall Study|Withdrawal by Subject|80|||
33583849|NCT03597347|62981716|FG000|Overall Study|Withdrawal by Subject|1|||
33583850|NCT03597347|62981717|FG001|Overall Study|Withdrawal by Subject|1|||
33583851|NCT03597347|62981718|FG002|Overall Study|Withdrawal by Subject|0|||
33583852|NCT03597347|62981716|FG000|Overall Study|Withdrawal due to Covid-19|3|||
33583853|NCT03597347|62981717|FG001|Overall Study|Withdrawal due to Covid-19|0|||
33583854|NCT03597347|62981718|FG002|Overall Study|Withdrawal due to Covid-19|0|||
33583855|NCT03597347|62981716|FG000|Overall Study|Sponsor decision to terminate study|3|||
33583856|NCT03597347|62981717|FG001|Overall Study|Sponsor decision to terminate study|2|||
33583857|NCT03597347|62981718|FG002|Overall Study|Sponsor decision to terminate study|4|||
33583858|NCT02576951|62981730|FG000|Overall Study|Lost to Follow-up|0|||
33583859|NCT02576951|62981731|FG001|Overall Study|Lost to Follow-up|0|||
33583860|NCT02576951|62981732|FG002|Overall Study|Lost to Follow-up|2|||
33583861|NCT02576951|62981733|FG003|Overall Study|Lost to Follow-up|2|||
33583862|NCT02576951|62981730|FG000|Overall Study|Withdrawal by Subject|1|||
33583863|NCT02576951|62981731|FG001|Overall Study|Withdrawal by Subject|0|||
33583864|NCT02576951|62981732|FG002|Overall Study|Withdrawal by Subject|0|||
33583865|NCT02576951|62981733|FG003|Overall Study|Withdrawal by Subject|2|||
33583866|NCT02576951|62981730|FG000|Overall Study|Protocol Violation|0|||
33583867|NCT02576951|62981731|FG001|Overall Study|Protocol Violation|0|||
33583868|NCT02576951|62981732|FG002|Overall Study|Protocol Violation|0|||
33583869|NCT02576951|62981733|FG003|Overall Study|Protocol Violation|1|||
33583870|NCT02621047|62981748|FG000|Overall Study|Adverse Event|0|||
33583871|NCT02621047|62981749|FG001|Overall Study|Adverse Event|0|||
33583872|NCT02621047|62981750|FG002|Overall Study|Adverse Event|1|||
33583873|NCT02443155|62981763|FG000|Overall Study|Adverse Event|3|||
33583874|NCT02443155|62981764|FG001|Overall Study|Adverse Event|4|||
33583875|NCT02443155|62981765|FG002|Overall Study|Adverse Event|1|||
33583876|NCT02443155|62981766|FG003|Overall Study|Adverse Event|2|||
33583877|NCT02443155|62981763|FG000|Overall Study|Unclassified|0|||
33583878|NCT02443155|62981764|FG001|Overall Study|Unclassified|0|||
33583879|NCT02443155|62981765|FG002|Overall Study|Unclassified|2|||
33583880|NCT02443155|62981766|FG003|Overall Study|Unclassified|1|||
33583881|NCT02443155|62981763|FG000|Overall Study|Withdrawal by Subject|4|||
33583882|NCT02443155|62981764|FG001|Overall Study|Withdrawal by Subject|7|||
33583883|NCT02443155|62981765|FG002|Overall Study|Withdrawal by Subject|3|||
33583884|NCT02443155|62981766|FG003|Overall Study|Withdrawal by Subject|9|||
33583885|NCT02443155|62981763|FG000|Overall Study|Pregnancy|3|||
33583886|NCT02443155|62981764|FG001|Overall Study|Pregnancy|1|||
33583887|NCT02443155|62981765|FG002|Overall Study|Pregnancy|1|||
33583888|NCT02443155|62981766|FG003|Overall Study|Pregnancy|2|||
33583889|NCT02443155|62981763|FG000|Overall Study|Lost to Follow-up|1|||
33583890|NCT02443155|62981764|FG001|Overall Study|Lost to Follow-up|2|||
33583891|NCT02443155|62981765|FG002|Overall Study|Lost to Follow-up|0|||
33583892|NCT02443155|62981766|FG003|Overall Study|Lost to Follow-up|1|||
33583893|NCT02443155|62981763|FG000|Overall Study|Protocol Violation|1|||
33583894|NCT02443155|62981764|FG001|Overall Study|Protocol Violation|0|||
33583895|NCT02443155|62981765|FG002|Overall Study|Protocol Violation|1|||
33583896|NCT02443155|62981766|FG003|Overall Study|Protocol Violation|1|||
33583897|NCT02443155|62981763|FG000|Overall Study|Death|0|||
33583898|NCT02443155|62981764|FG001|Overall Study|Death|0|||
33583899|NCT02443155|62981765|FG002|Overall Study|Death|1|||
33583900|NCT02443155|62981766|FG003|Overall Study|Death|0|||
33583901|NCT02460159|62981779|FG000|Overall Study|Adverse Event|4|||
33583902|NCT02460159|62981780|FG001|Overall Study|Adverse Event|1|||
33583903|NCT02460159|62981779|FG000|Overall Study|Withdrawal by Subject|2|||
33583904|NCT02460159|62981780|FG001|Overall Study|Withdrawal by Subject|0|||
33583905|NCT02498067|62981786|FG000|Overall Study|Lost to Follow-up|22|||
33583906|NCT02498067|62981786|FG000|Overall Study|Did not meet inclusion criteria|11|||
33583907|NCT02497755|62981794|FG000|Overall Study|Protocol Violation|1|||
33583908|NCT02497755|62981795|FG001|Overall Study|Protocol Violation|0|||
33583909|NCT02619175|62981804|FG000|Overall Study|Withdrawal by Subject|1|||
33583910|NCT02619175|62981805|FG001|Overall Study|Withdrawal by Subject|0|||
33583911|NCT02619175|62981804|FG000|Overall Study|foot pain|1|||
33583912|NCT02619175|62981805|FG001|Overall Study|foot pain|0|||
33583913|NCT01360021|62981822|FG000|Overall Study|Eligibility criteria + other|2|||
33583914|NCT01360021|62981823|FG001|Overall Study|Eligibility criteria + other|1|||
33583915|NCT01360021|62981824|FG002|Overall Study|Eligibility criteria + other|1|||
33583916|NCT01360021|62981822|FG000|Overall Study|Protocol Violation|0|||
33583917|NCT01360021|62981823|FG001|Overall Study|Protocol Violation|0|||
33583918|NCT01360021|62981824|FG002|Overall Study|Protocol Violation|1|||
33583919|NCT01360021|62981822|FG000|Overall Study|Withdrawal by Subject|4|||
33583920|NCT01360021|62981823|FG001|Overall Study|Withdrawal by Subject|0|||
33583921|NCT01360021|62981824|FG002|Overall Study|Withdrawal by Subject|2|||
33583922|NCT01360021|62981822|FG000|Overall Study|Adverse Event|2|||
33583923|NCT01360021|62981823|FG001|Overall Study|Adverse Event|3|||
33583924|NCT01360021|62981824|FG002|Overall Study|Adverse Event|3|||
33583925|NCT02497287|62981841|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
33583926|NCT02497287|62981841|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
33583927|NCT02497287|62981841|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
33583928|NCT02497287|62981841|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
33583929|NCT02497287|62981841|FG000|Induction Phase (4 Weeks)|Other|13|||
33583930|NCT02497287|62981841|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
33583931|NCT02497287|62981841|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
33583932|NCT02497287|62981841|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
33583933|NCT02497287|62981841|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
33583934|NCT02497287|62981841|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
33583935|NCT02497287|62981841|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
33583936|NCT02497287|62981841|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
33583937|NCT02497287|62981841|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
33583938|NCT02497287|62981841|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
33583939|NCT02497287|62981841|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
33583940|NCT02497287|62981841|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
33583941|NCT02497287|62981841|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
33583942|NCT02497287|62981841|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
33583943|NCT02497287|62981841|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
33583944|NCT02497287|62981841|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
33583945|NCT02497287|62981841|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
33583946|NCT02497287|62981841|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
33583947|NCT02497287|62981841|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
33583948|NCT02497287|62981841|FG000|Follow-up Phase (4 Week)|Other|1|||
33583949|NCT02458287|62981851|FG000|Overall Study|Adverse Event|0|||
33583950|NCT02458287|62981852|FG001|Overall Study|Adverse Event|0|||
33583951|NCT02458287|62981853|FG002|Overall Study|Adverse Event|0|||
33583952|NCT02458287|62981854|FG003|Overall Study|Adverse Event|1|||
33583953|NCT02458287|62981851|FG000|Overall Study|Lost to Follow-up|0|||
33583954|NCT02458287|62981852|FG001|Overall Study|Lost to Follow-up|1|||
33583955|NCT02458287|62981853|FG002|Overall Study|Lost to Follow-up|1|||
33583956|NCT02458287|62981854|FG003|Overall Study|Lost to Follow-up|0|||
33583957|NCT02458287|62981851|FG000|Overall Study|Protocol Violation|0|||
33583958|NCT02458287|62981852|FG001|Overall Study|Protocol Violation|1|||
33583959|NCT02458287|62981853|FG002|Overall Study|Protocol Violation|0|||
33583960|NCT02458287|62981854|FG003|Overall Study|Protocol Violation|0|||
33583961|NCT02458287|62981851|FG000|Overall Study|Withdrawal by Subject|0|||
33583962|NCT02458287|62981852|FG001|Overall Study|Withdrawal by Subject|2|||
33583963|NCT02458287|62981853|FG002|Overall Study|Withdrawal by Subject|2|||
33583964|NCT02458287|62981854|FG003|Overall Study|Withdrawal by Subject|1|||
33583965|NCT02458287|62981851|FG000|Overall Study|Relocated Out of State|0|||
33583966|NCT02458287|62981852|FG001|Overall Study|Relocated Out of State|0|||
33583967|NCT02458287|62981853|FG002|Overall Study|Relocated Out of State|0|||
33583968|NCT02458287|62981854|FG003|Overall Study|Relocated Out of State|1|||
33583969|NCT02441517|62981870|FG000|Overall Study|Lost to Follow-up|1|||
33583970|NCT02441517|62981870|FG000|Overall Study|Withdrawal by Subject|2|||
33583971|NCT02441517|62981870|FG000|Overall Study|Study Terminated by Sponsor|1|||
33583972|NCT02457819|62981874|FG000|Overall Study|reason not given|8|||
33583973|NCT02457819|62981874|FG000|Overall Study|Withdrawal by Subject|24|||
33583974|NCT02457819|62981874|FG000|Overall Study|Protocol Violation|1|||
33583975|NCT02457819|62981874|FG000|Overall Study|non compliance with study drug|4|||
33583976|NCT02457819|62981874|FG000|Overall Study|Lost to Follow-up|10|||
33583977|NCT02457819|62981874|FG000|Overall Study|Lack of Efficacy|19|||
33583978|NCT02457819|62981874|FG000|Overall Study|Adverse Event|33|||
33583979|NCT02496039|62981878|FG000|Overall Study|Adverse Event|3|||
33583980|NCT02496039|62981878|FG000|Overall Study|Protocol Violation|1|||
33583981|NCT02441283|62981882|FG000|Overall Study|Withdrew consent|15|||
33583982|NCT02441283|62981882|FG000|Overall Study|Lost to Follow-up|42|||
33583983|NCT02441283|62981882|FG000|Overall Study|Death|1|||
33583984|NCT02441283|62981882|FG000|Overall Study|Other, not specified|32|||
33583985|NCT02495883|62981888|FG000|Overall Study|Excessive head motion|1|||
33583986|NCT02495883|62981889|FG001|Overall Study|Excessive head motion|0|||
33583987|NCT02495025|62981896|FG000|Overall Study|Lost to Follow-up|21|||
33583988|NCT02495025|62981897|FG001|Overall Study|Lost to Follow-up|14|||
33583989|NCT02495025|62981896|FG000|Overall Study|Withdrawal by Subject|5|||
33583990|NCT02495025|62981897|FG001|Overall Study|Withdrawal by Subject|0|||
33583991|NCT02439957|62981905|FG000|Overall Study|Study Terminated|3|||
33583992|NCT02439957|62981906|FG001|Overall Study|Study Terminated|3|||
33583993|NCT02494401|62981914|FG000|Overall Study|Lost to Follow-up|22|||
33583994|NCT02494401|62981915|FG001|Overall Study|Lost to Follow-up|25|||
33583995|NCT02494401|62981914|FG000|Overall Study|Withdrawal by Subject|3|||
33583996|NCT02494401|62981915|FG001|Overall Study|Withdrawal by Subject|2|||
33583997|NCT02457195|62981921|FG000|Overall Study|Adverse Event|3|||
33583998|NCT02457195|62981921|FG000|Overall Study|Protocol Violation|2|||
33583999|NCT02457195|62981921|FG000|Overall Study|Withdrawal by Subject|4|||
33584000|NCT02456727|62981927|FG000|Overall Study|Lost to Follow-up|63|||
33584001|NCT02456727|62981928|FG001|Overall Study|Lost to Follow-up|65|||
33584002|NCT02456727|62981927|FG000|Overall Study|Death|2|||
33584003|NCT02456727|62981928|FG001|Overall Study|Death|1|||
33584004|NCT02456727|62981927|FG000|Overall Study|Withdrawal by Subject|1|||
33584005|NCT02456727|62981928|FG001|Overall Study|Withdrawal by Subject|10|||
33584006|NCT02456727|62981927|FG000|Overall Study|Never Initiated Treatment|43|||
33584007|NCT02456727|62981928|FG001|Overall Study|Never Initiated Treatment|30|||
33584008|NCT02456103|62981950|FG000|Overall Study|Study Closure|207|||
33584009|NCT02456103|62981950|FG000|Overall Study|Physician Decision|1|||
33584010|NCT02456103|62981950|FG000|Overall Study|Required prohibited medications|5|||
33584011|NCT02456103|62981950|FG000|Overall Study|Protocol Violation|1|||
33584012|NCT02456103|62981950|FG000|Overall Study|Adverse Event|5|||
33584013|NCT02456103|62981950|FG000|Overall Study|Abnormal Laboratory Value|2|||
33584014|NCT02456103|62981950|FG000|Overall Study|Lost to Follow-up|1|||
33584015|NCT02456103|62981950|FG000|Overall Study|Withdrawal by Subject|24|||
33584016|NCT01653327|62981954|FG000|Overall Study|Withdrawal by Subject|1|||
33584017|NCT02493855|62981963|FG000|Overall Study|Non-compliance|1|||
33584018|NCT02493855|62981964|FG001|Overall Study|Non-compliance|0|||
33584019|NCT02493855|62981965|FG002|Overall Study|Non-compliance|0|||
33584020|NCT02493855|62981963|FG000|Overall Study|Adverse Event|0|||
33584021|NCT02493855|62981964|FG001|Overall Study|Adverse Event|1|||
33584022|NCT02493855|62981965|FG002|Overall Study|Adverse Event|0|||
33584023|NCT02493855|62981963|FG000|Overall Study|Withdrawal by Subject|1|||
33584024|NCT02493855|62981964|FG001|Overall Study|Withdrawal by Subject|0|||
33584025|NCT02493855|62981965|FG002|Overall Study|Withdrawal by Subject|0|||
33584026|NCT02438787|62981976|FG000|Overall Study|Adverse Event|1|||
33584027|NCT02438787|62981977|FG001|Overall Study|Adverse Event|0|||
33584028|NCT02438787|62981978|FG002|Overall Study|Adverse Event|2|||
33584029|NCT02438787|62981976|FG000|Overall Study|Lack of Efficacy|1|||
33584030|NCT02438787|62981977|FG001|Overall Study|Lack of Efficacy|2|||
33584031|NCT02438787|62981978|FG002|Overall Study|Lack of Efficacy|0|||
33584032|NCT02438787|62981976|FG000|Overall Study|Lost to Follow-up|0|||
33584033|NCT02438787|62981977|FG001|Overall Study|Lost to Follow-up|1|||
33584034|NCT02438787|62981978|FG002|Overall Study|Lost to Follow-up|0|||
33584035|NCT02438787|62981976|FG000|Overall Study|Protocol Violation|0|||
33584036|NCT02438787|62981977|FG001|Overall Study|Protocol Violation|0|||
33584037|NCT02438787|62981978|FG002|Overall Study|Protocol Violation|1|||
33584038|NCT02438787|62981976|FG000|Overall Study|Withdrawal by Subject|15|||
33584039|NCT02438787|62981977|FG001|Overall Study|Withdrawal by Subject|7|||
33584040|NCT02438787|62981978|FG002|Overall Study|Withdrawal by Subject|10|||
33584041|NCT02438787|62981976|FG000|Overall Study|Study discontinued by sponsor|64|||
33584042|NCT02438787|62981977|FG001|Overall Study|Study discontinued by sponsor|72|||
33584043|NCT02438787|62981978|FG002|Overall Study|Study discontinued by sponsor|69|||
33584044|NCT02438787|62981976|FG000|Overall Study|Other|0|||
33584045|NCT02438787|62981977|FG001|Overall Study|Other|1|||
33584046|NCT02438787|62981978|FG002|Overall Study|Other|0|||
33584047|NCT02438787|62981976|FG000|Overall Study|Site terminated by sponsor|0|||
33584048|NCT02438787|62981977|FG001|Overall Study|Site terminated by sponsor|0|||
33584049|NCT02438787|62981978|FG002|Overall Study|Site terminated by sponsor|1|||
33584050|NCT02493777|62981993|FG000|Overall Study|Lost to Follow-up|0|||
33584051|NCT02493777|62981994|FG001|Overall Study|Lost to Follow-up|1|||
33584052|NCT02616601|62982003|FG000|Overall Study|Withdrawal by Subject|4|||
33584053|NCT02616601|62982004|FG001|Overall Study|Withdrawal by Subject|4|||
33584054|NCT02616601|62982005|FG002|Overall Study|Withdrawal by Subject|3|||
33584055|NCT02616601|62982003|FG000|Overall Study|Adverse Event|2|||
33584056|NCT02616601|62982004|FG001|Overall Study|Adverse Event|0|||
33584057|NCT02616601|62982005|FG002|Overall Study|Adverse Event|2|||
33584058|NCT02616601|62982003|FG000|Overall Study|Death|1|||
33584059|NCT02616601|62982004|FG001|Overall Study|Death|0|||
33584060|NCT02616601|62982005|FG002|Overall Study|Death|0|||
33584061|NCT02616601|62982003|FG000|Overall Study|Lost to Follow-up|1|||
33584062|NCT02616601|62982004|FG001|Overall Study|Lost to Follow-up|0|||
33584063|NCT02616601|62982005|FG002|Overall Study|Lost to Follow-up|1|||
33584064|NCT02616601|62982003|FG000|Overall Study|Non-Compliance with Test Article|1|||
33584065|NCT02616601|62982004|FG001|Overall Study|Non-Compliance with Test Article|0|||
33584066|NCT02616601|62982005|FG002|Overall Study|Non-Compliance with Test Article|1|||
33584067|NCT02492997|62982015|FG000|Overall Study|Withdrawal by Subject|1|||
33584068|NCT02492997|62982016|FG001|Overall Study|Withdrawal by Subject|0|||
33584069|NCT02492997|62982015|FG000|Overall Study|Gained Weight|1|||
33584070|NCT02492997|62982016|FG001|Overall Study|Gained Weight|0|||
33584071|NCT02492997|62982015|FG000|Overall Study|Lost to Follow-up|0|||
33584072|NCT02492997|62982016|FG001|Overall Study|Lost to Follow-up|1|||
33584073|NCT02437305|62982024|FG000|Overall Study|Lost to Follow-up|18|||
33673599|NCT01505114|63110999|FG000|Overall Study|relocated|4|||
33584074|NCT02437305|62982025|FG001|Overall Study|Lost to Follow-up|12|||
33584075|NCT02492841|62982034|FG000|Overall Study|Lost to Follow-up|34|||
33584076|NCT02492841|62982035|FG001|Overall Study|Lost to Follow-up|31|||
33584077|NCT02492841|62982036|FG002|Overall Study|Lost to Follow-up|35|||
33584078|NCT02436915|62982049|FG000|Overall Study|Withdrawal by Subject|0|||
33584079|NCT02436915|62982050|FG001|Overall Study|Withdrawal by Subject|1|||
33673600|NCT01505114|63111000|FG001|Overall Study|relocated|2|||
33584080|NCT02492763|62982062|FG000|Overall Study|Withdrawal by Subject|0|||
33584081|NCT02492763|62982063|FG001|Overall Study|Withdrawal by Subject|2|||
33584082|NCT02492763|62982064|FG002|Overall Study|Withdrawal by Subject|1|||
33584083|NCT02492763|62982065|FG003|Overall Study|Withdrawal by Subject|0|||
33584084|NCT02492763|62982062|FG000|Overall Study|Adverse Event|3|||
33584085|NCT02492763|62982063|FG001|Overall Study|Adverse Event|1|||
33584086|NCT02492763|62982064|FG002|Overall Study|Adverse Event|1|||
33584087|NCT02492763|62982065|FG003|Overall Study|Adverse Event|2|||
33584088|NCT02492763|62982062|FG000|Overall Study|Death|0|||
33584089|NCT02492763|62982063|FG001|Overall Study|Death|0|||
33584090|NCT02492763|62982064|FG002|Overall Study|Death|1|||
33584091|NCT02492763|62982065|FG003|Overall Study|Death|0|||
33584092|NCT02492763|62982062|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
33584093|NCT02492763|62982063|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
33584094|NCT02492763|62982064|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
33584095|NCT02492763|62982065|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
33584096|NCT02492763|62982062|FG000|Overall Study|Lost to Follow-up|0|||
33584097|NCT02492763|62982063|FG001|Overall Study|Lost to Follow-up|0|||
33584098|NCT02492763|62982064|FG002|Overall Study|Lost to Follow-up|1|||
33584099|NCT02492763|62982065|FG003|Overall Study|Lost to Follow-up|0|||
33584100|NCT02492763|62982062|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33584101|NCT02492763|62982063|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33584102|NCT02492763|62982064|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33584103|NCT02492763|62982065|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33584104|NCT02492763|62982062|FG000|Overall Study|Screen Failure|0|||
33584105|NCT02492763|62982063|FG001|Overall Study|Screen Failure|0|||
33584106|NCT02492763|62982064|FG002|Overall Study|Screen Failure|0|||
33584107|NCT02492763|62982065|FG003|Overall Study|Screen Failure|1|||
33584108|NCT02492763|62982062|FG000|Overall Study|Study Terminated by Sponsor|13|||
33584109|NCT02492763|62982063|FG001|Overall Study|Study Terminated by Sponsor|10|||
33584110|NCT02492763|62982064|FG002|Overall Study|Study Terminated by Sponsor|6|||
33584111|NCT02492763|62982065|FG003|Overall Study|Study Terminated by Sponsor|10|||
33584112|NCT02491671|62982077|FG000|Overall Study|Adverse Event|6|||
33584113|NCT02491671|62982078|FG001|Overall Study|Adverse Event|8|||
33584114|NCT02491671|62982077|FG000|Overall Study|Death|0|||
33584115|NCT02491671|62982078|FG001|Overall Study|Death|2|||
33584116|NCT02491671|62982077|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
33584117|NCT02491671|62982078|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
33584118|NCT02453841|62982084|FG000|Overall Study|Protocol Violation|1|||
33584119|NCT02453841|62982084|FG000|Overall Study|Unable to obtain blood samples|2|||
33584120|NCT02453685|62982090|FG000|Overall Study|Adverse Event|0|||
33584121|NCT02453685|62982091|FG001|Overall Study|Adverse Event|1|||
33584122|NCT02453685|62982090|FG000|Overall Study|Protocol Violation|7|||
33584123|NCT02453685|62982091|FG001|Overall Study|Protocol Violation|4|||
33584124|NCT02453685|62982090|FG000|Overall Study|Lost to Follow-up|0|||
33584125|NCT02453685|62982091|FG001|Overall Study|Lost to Follow-up|1|||
33584126|NCT02453685|62982090|FG000|Overall Study|Withdrawal by Subject|8|||
33584127|NCT02453685|62982091|FG001|Overall Study|Withdrawal by Subject|4|||
33584128|NCT02453685|62982090|FG000|Overall Study|Unclassified|4|||
33584129|NCT02453685|62982091|FG001|Overall Study|Unclassified|2|||
33584130|NCT02436759|62982099|FG000|Overall Study|Adverse Event|3|||
33584131|NCT02436759|62982100|FG001|Overall Study|Adverse Event|0|||
33584132|NCT02436759|62982099|FG000|Overall Study|Protocol Violation|1|||
33584133|NCT02436759|62982100|FG001|Overall Study|Protocol Violation|0|||
33584134|NCT02436759|62982099|FG000|Overall Study|Withdrawal by Subject|0|||
33584135|NCT02436759|62982100|FG001|Overall Study|Withdrawal by Subject|1|||
33584136|NCT02436681|62982106|FG000|Overall Study|Lost to Follow-up|10|||
33584137|NCT02436681|62982106|FG000|Overall Study|Withdrawal by Subject|2|||
33584138|NCT02436681|62982106|FG000|Overall Study|Death|2|||
33584139|NCT02436135|62982112|FG000|Overall Study|Progressive Disease|3|||
33584140|NCT02436135|62982113|FG001|Overall Study|Progressive Disease|1|||
33584141|NCT02436135|62982112|FG000|Overall Study|Investigator Discretion|1|||
33584142|NCT02436135|62982113|FG001|Overall Study|Investigator Discretion|2|||
33584143|NCT02436135|62982112|FG000|Overall Study|Adverse Event|1|||
33584144|NCT02436135|62982113|FG001|Overall Study|Adverse Event|0|||
33584145|NCT02436135|62982112|FG000|Overall Study|Withdrawal by Participant|1|||
33584146|NCT02436135|62982113|FG001|Overall Study|Withdrawal by Participant|0|||
33584147|NCT02436135|62982112|FG000|Overall Study|Study Terminated By Sponsor|0|||
33584148|NCT02436135|62982113|FG001|Overall Study|Study Terminated By Sponsor|1|||
33584149|NCT02489799|62982121|FG000|Overall Study|Lost to Follow-up|4|||
33584150|NCT02489799|62982122|FG001|Overall Study|Lost to Follow-up|1|||
33584151|NCT02489799|62982121|FG000|Overall Study|Failure to Maintain Eligibility|4|||
33584152|NCT02489799|62982122|FG001|Overall Study|Failure to Maintain Eligibility|6|||
33584153|NCT02489799|62982121|FG000|Overall Study|Withdrawal by Subject|1|||
33584154|NCT02489799|62982122|FG001|Overall Study|Withdrawal by Subject|1|||
33584155|NCT02489799|62982121|FG000|Overall Study|Death|0|||
33584156|NCT02489799|62982122|FG001|Overall Study|Death|1|||
33584157|NCT02435277|62982132|FG000|Overall Study|Adverse Event|1|||
33584158|NCT02435277|62982133|FG001|Overall Study|Adverse Event|1|||
33584159|NCT02435277|62982134|FG002|Overall Study|Adverse Event|0|||
33584160|NCT02435277|62982135|FG003|Overall Study|Adverse Event|0|||
33584161|NCT02435277|62982132|FG000|Overall Study|Withdrawal by Subject|1|||
33584162|NCT02435277|62982133|FG001|Overall Study|Withdrawal by Subject|0|||
33584163|NCT02435277|62982134|FG002|Overall Study|Withdrawal by Subject|0|||
33584164|NCT02435277|62982135|FG003|Overall Study|Withdrawal by Subject|0|||
33584165|NCT02420223|62982147|FG000|Overall Study|Adverse Event|1|||
33584166|NCT02420223|62982148|FG001|Overall Study|Adverse Event|0|||
33584167|NCT02420223|62982147|FG000|Overall Study|Physician Decision|0|||
33584168|NCT02420223|62982148|FG001|Overall Study|Physician Decision|2|||
33584169|NCT02433483|62982154|FG000|Overall Study|Unacceptable toxicity|1|||
33584170|NCT02433483|62982154|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
33584171|NCT02419755|62982160|FG000|Overall Study|Death|1|||
33584172|NCT02419755|62982161|FG001|Overall Study|Death|3|||
33584173|NCT02419755|62982160|FG000|Overall Study|Relapse|0|||
33584174|NCT02419755|62982161|FG001|Overall Study|Relapse|1|||
33584175|NCT02419755|62982160|FG000|Overall Study|Ineligible|1|||
33584176|NCT02419755|62982161|FG001|Overall Study|Ineligible|0|||
33584177|NCT02419755|62982160|FG000|Overall Study|Withdrawal by Subject|1|||
33584178|NCT02419755|62982161|FG001|Overall Study|Withdrawal by Subject|0|||
33584179|NCT02488551|62982171|FG000|Overall Study|Lost to Follow-up|4|||
33584180|NCT02488551|62982172|FG001|Overall Study|Lost to Follow-up|7|||
33584181|NCT02488551|62982173|FG002|Overall Study|Lost to Follow-up|0|||
33584182|NCT02488551|62982174|FG003|Overall Study|Lost to Follow-up|0|||
33584183|NCT02488551|62982171|FG000|Overall Study|Military Deployment|1|||
33584184|NCT02488551|62982172|FG001|Overall Study|Military Deployment|1|||
33584185|NCT02488551|62982173|FG002|Overall Study|Military Deployment|0|||
33584186|NCT02488551|62982174|FG003|Overall Study|Military Deployment|0|||
33584187|NCT02488239|62982184|FG000|Overall Study|Death|3|||
33673601|NCT01505114|63111001|FG002|Overall Study|relocated|2|||
33673602|NCT01505114|63111002|FG003|Overall Study|relocated|3|||
33673603|NCT01505114|63110999|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
33673604|NCT01505114|63111000|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
33673605|NCT01505114|63111001|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
33673606|NCT01505114|63111002|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
33673607|NCT01505114|63110999|FG000|Overall Study|staff safety concerns|0|||
33673608|NCT01505114|63111000|FG001|Overall Study|staff safety concerns|0|||
33673609|NCT01505114|63111001|FG002|Overall Study|staff safety concerns|0|||
33673610|NCT01505114|63111002|FG003|Overall Study|staff safety concerns|1|||
33673611|NCT01505114|63110999|FG000|Overall Study|investigator decision|1|||
33673612|NCT01505114|63111000|FG001|Overall Study|investigator decision|0|||
33673613|NCT01505114|63111001|FG002|Overall Study|investigator decision|1|||
33673614|NCT01505114|63111002|FG003|Overall Study|investigator decision|0|||
33673615|NCT02651922|63111034|FG000|Overall Study|due to exclusion criteria|2|||
33673616|NCT01277757|63111038|FG000|Overall Study|Disease Progression|1|||
33673617|NCT01277757|63111038|FG000|Overall Study|Withdrawal by Subject|1|||
33673618|NCT01276821|63111044|FG000|Overall Study|Protocol Violation|0|||
33673619|NCT01276821|63111045|FG001|Overall Study|Protocol Violation|1|||
33673620|NCT00245037|63111051|FG000|Overall Study|Death|17|||
33673621|NCT00241839|63111057|FG000|Overall Study|Withdrawal by Subject|18|||
33673622|NCT00241839|63111058|FG001|Overall Study|Withdrawal by Subject|17|||
33673623|NCT00241839|63111057|FG000|Overall Study|Adverse Event|1|||
33673624|NCT00241839|63111058|FG001|Overall Study|Adverse Event|1|||
33673625|NCT02651688|63111067|FG000|Overall Study|Non-compliance|0|||
33673626|NCT02651688|63111068|FG001|Overall Study|Non-compliance|0|||
33673627|NCT02651688|63111069|FG002|Overall Study|Non-compliance|1|||
33673628|NCT02651688|63111067|FG000|Overall Study|Principal Investigator (PI) decision|0|||
33673629|NCT02651688|63111068|FG001|Overall Study|Principal Investigator (PI) decision|2|||
33673630|NCT02651688|63111069|FG002|Overall Study|Principal Investigator (PI) decision|0|||
33673631|NCT02651688|63111067|FG000|Overall Study|Lost to Follow-up|1|||
33673632|NCT02651688|63111068|FG001|Overall Study|Lost to Follow-up|3|||
33673633|NCT02651688|63111069|FG002|Overall Study|Lost to Follow-up|0|||
33673634|NCT02651688|63111067|FG000|Overall Study|Withdrawal by Subject|1|||
33673635|NCT02651688|63111068|FG001|Overall Study|Withdrawal by Subject|0|||
33673636|NCT02651688|63111069|FG002|Overall Study|Withdrawal by Subject|2|||
33673637|NCT01276353|63111079|FG000|Double-blind|Adverse Event|2|||
33673638|NCT01276353|63111080|FG001|Double-blind|Adverse Event|0|||
33673639|NCT01276353|63111079|FG000|Double-blind|Withdrawal by Subject|1|||
33673640|NCT01276353|63111080|FG001|Double-blind|Withdrawal by Subject|0|||
33673641|NCT01276353|63111079|FG000|Extension|Adverse Event|2|||
33673642|NCT01276353|63111080|FG001|Extension|Adverse Event|5|||
33673643|NCT01276353|63111079|FG000|Extension|Withdrawal by Subject|1|||
33673644|NCT01276353|63111080|FG001|Extension|Withdrawal by Subject|2|||
33673645|NCT01276353|63111079|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
33673646|NCT01276353|63111080|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
33673647|NCT01276353|63111079|FG000|Extension|Physician Decision|1|||
33673648|NCT01276353|63111080|FG001|Extension|Physician Decision|0|||
33673649|NCT01276353|63111079|FG000|Extension|Prohibited concomitant medications|0|||
33673650|NCT01276353|63111080|FG001|Extension|Prohibited concomitant medications|1|||
33673651|NCT02536794|63111115|FG000|Reached 1st Response Assessment|Adverse Event|2|||
33584188|NCT02488239|62982184|FG000|Overall Study|Withdrawal by Subject|3|||
33673652|NCT02536794|63111115|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
33673653|NCT02536794|63111115|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
33673654|NCT02536794|63111115|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
33673655|NCT02536794|63111115|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
33673656|NCT02536794|63111115|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
33673657|NCT01480076|63111194|FG000|Overall Study|Run-in Failure|52|||
33673658|NCT01480076|63111194|FG000|Overall Study|Adverse Event|39|||
33673659|NCT01480076|63111194|FG000|Overall Study|Death|2|||
33673660|NCT01480076|63111194|FG000|Overall Study|Disease Progression|5|||
33673661|NCT01480076|63111194|FG000|Overall Study|Non-compliance With Study Protocol|15|||
33673662|NCT01480076|63111194|FG000|Overall Study|Withdrawal by Subject|105|||
33673663|NCT01480076|63111194|FG000|Overall Study|Lost to Follow-up|7|||
33673664|NCT01480076|63111194|FG000|Overall Study|Investigator Decision|13|||
33673665|NCT01480076|63111194|FG000|Overall Study|Other|52|||
33673666|NCT02650128|63111282|FG000|Overall Study|Death|2|||
33673667|NCT01362270|63111297|FG000|Overall Study|Withdrawal by Subject|1|||
33673668|NCT01362270|63111298|FG001|Overall Study|Withdrawal by Subject|0|||
33673669|NCT01362270|63111297|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
33673670|NCT01362270|63111298|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
33673671|NCT01362270|63111297|FG000|Overall Study|Met excl. criteria before 1st session|1|||
33673672|NCT01362270|63111298|FG001|Overall Study|Met excl. criteria before 1st session|1|||
33673673|NCT00089479|63111319|FG000|Overall Study|Death|108|||
33673674|NCT00089479|63111320|FG001|Overall Study|Death|75|||
33673675|NCT00089479|63111319|FG000|Overall Study|Withdrawal by Subject|86|||
33673676|NCT00089479|63111320|FG001|Overall Study|Withdrawal by Subject|107|||
33673677|NCT00089479|63111319|FG000|Overall Study|Lost to Follow-up|137|||
33673678|NCT00089479|63111320|FG001|Overall Study|Lost to Follow-up|107|||
33673679|NCT01463306|63111329|FG000|Overall Study|Adverse Event|6|||
33673680|NCT01463306|63111330|FG001|Overall Study|Adverse Event|9|||
33673681|NCT01463306|63111331|FG002|Overall Study|Adverse Event|3|||
33673682|NCT01463306|63111329|FG000|Overall Study|Death|3|||
33673683|NCT01463306|63111330|FG001|Overall Study|Death|3|||
33673684|NCT01463306|63111331|FG002|Overall Study|Death|0|||
33673685|NCT01463306|63111329|FG000|Overall Study|Lack of Efficacy|22|||
33673686|NCT01463306|63111330|FG001|Overall Study|Lack of Efficacy|16|||
33673687|NCT01463306|63111331|FG002|Overall Study|Lack of Efficacy|1|||
33673688|NCT01463306|63111329|FG000|Overall Study|Lost to Follow-up|5|||
33673689|NCT01463306|63111330|FG001|Overall Study|Lost to Follow-up|2|||
33673690|NCT01463306|63111331|FG002|Overall Study|Lost to Follow-up|0|||
33673691|NCT01463306|63111329|FG000|Overall Study|Protocol Violation|4|||
33673692|NCT01463306|63111330|FG001|Overall Study|Protocol Violation|0|||
33673693|NCT01463306|63111331|FG002|Overall Study|Protocol Violation|0|||
33673694|NCT01463306|63111329|FG000|Overall Study|Withdrawal by Subject|19|||
33673695|NCT01463306|63111330|FG001|Overall Study|Withdrawal by Subject|9|||
33673696|NCT01463306|63111331|FG002|Overall Study|Withdrawal by Subject|1|||
33673697|NCT01463306|63111329|FG000|Overall Study|Other|26|||
33673698|NCT01463306|63111330|FG001|Overall Study|Other|13|||
33673699|NCT01463306|63111331|FG002|Overall Study|Other|0|||
33673700|NCT01463306|63111329|FG000|Overall Study|Approval expiry at site|1|||
33673701|NCT01463306|63111330|FG001|Overall Study|Approval expiry at site|0|||
33673702|NCT01463306|63111331|FG002|Overall Study|Approval expiry at site|0|||
33673703|NCT01504412|63111360|FG000|Overall Study|Adverse Event|1|||
33673704|NCT01504412|63111361|FG001|Overall Study|Adverse Event|8|||
33673705|NCT01504412|63111362|FG002|Overall Study|Adverse Event|1|||
33673706|NCT01504412|63111363|FG003|Overall Study|Adverse Event|7|||
33673707|NCT01504412|63111364|FG004|Overall Study|Adverse Event|10|||
33673708|NCT01504412|63111360|FG000|Overall Study|Withdrawal by Subject|2|||
33673709|NCT01504412|63111361|FG001|Overall Study|Withdrawal by Subject|1|||
33673710|NCT01504412|63111362|FG002|Overall Study|Withdrawal by Subject|1|||
33673711|NCT01504412|63111363|FG003|Overall Study|Withdrawal by Subject|5|||
33673712|NCT01504412|63111364|FG004|Overall Study|Withdrawal by Subject|1|||
33673713|NCT01504412|63111360|FG000|Overall Study|Other|2|||
33673714|NCT01504412|63111361|FG001|Overall Study|Other|1|||
33673715|NCT01504412|63111362|FG002|Overall Study|Other|1|||
33673716|NCT01504412|63111363|FG003|Overall Study|Other|6|||
33673717|NCT01504412|63111364|FG004|Overall Study|Other|1|||
33673718|NCT01504412|63111360|FG000|Overall Study|Lost to Follow-up|0|||
33673719|NCT01504412|63111361|FG001|Overall Study|Lost to Follow-up|2|||
33673720|NCT01504412|63111362|FG002|Overall Study|Lost to Follow-up|0|||
33673721|NCT01504412|63111363|FG003|Overall Study|Lost to Follow-up|0|||
33673722|NCT01504412|63111364|FG004|Overall Study|Lost to Follow-up|0|||
33673723|NCT01504412|63111360|FG000|Overall Study|Lack of Efficacy|0|||
33673724|NCT01504412|63111361|FG001|Overall Study|Lack of Efficacy|0|||
33673725|NCT01504412|63111362|FG002|Overall Study|Lack of Efficacy|1|||
33673726|NCT01504412|63111363|FG003|Overall Study|Lack of Efficacy|0|||
33673727|NCT01504412|63111364|FG004|Overall Study|Lack of Efficacy|1|||
33673728|NCT01504412|63111360|FG000|Overall Study|Death|0|||
33673729|NCT01504412|63111361|FG001|Overall Study|Death|0|||
33673730|NCT01504412|63111362|FG002|Overall Study|Death|0|||
33673731|NCT01504412|63111363|FG003|Overall Study|Death|1|||
33673732|NCT01504412|63111364|FG004|Overall Study|Death|0|||
33673733|NCT01503164|63111394|FG000|Overall Study|Withdrawal by Subject|2|||
33673734|NCT01503164|63111395|FG001|Overall Study|Withdrawal by Subject|1|||
33673735|NCT00088465|63111401|FG000|Overall Study|Withdrawal by Subject|290|||
33673736|NCT00088465|63111401|FG000|Overall Study|Adverse Event|77|||
33673737|NCT00088465|63111401|FG000|Overall Study|Lost to Follow-up|57|||
33673738|NCT00088465|63111401|FG000|Overall Study|Physician Decision|45|||
33673739|NCT00088465|63111401|FG000|Overall Study|Sponsor Decision|37|||
33673740|NCT00088465|63111401|FG000|Overall Study|Lack of Efficacy|27|||
33673741|NCT00088465|63111401|FG000|Overall Study|Protocol Violation|17|||
33673742|NCT00088465|63111401|FG000|Overall Study|Death|11|||
33673743|NCT00088153|63111429|FG000|Overall Study|Physician Decision|3|||
33673744|NCT00088153|63111430|FG001|Overall Study|Physician Decision|3|||
33673745|NCT00088153|63111429|FG000|Overall Study|Withdrawal by Subject|10|||
33673746|NCT00088153|63111430|FG001|Overall Study|Withdrawal by Subject|10|||
33673747|NCT00088153|63111429|FG000|Overall Study|Lost to Follow-up|11|||
33673748|NCT00088153|63111430|FG001|Overall Study|Lost to Follow-up|12|||
33673749|NCT00087685|63111449|FG000|Overall Study|Adverse Event|5|||
33673750|NCT00087685|63111449|FG000|Overall Study|Non-Compliance|1|||
33673751|NCT00087685|63111449|FG000|Overall Study|Progressive Disease|5|||
33673752|NCT00087685|63111449|FG000|Overall Study|Withdrawal by Subject|3|||
33673753|NCT01502228|63111453|FG000|Overall Study|Death|1|||
33673754|NCT01502072|63111460|FG000|Overall Study|Withdrawal by Subject|1|||
33673755|NCT01502072|63111461|FG001|Overall Study|Withdrawal by Subject|0|||
33673756|NCT01502072|63111462|FG002|Overall Study|Withdrawal by Subject|0|||
33673757|NCT01502072|63111460|FG000|Overall Study|Death|0|||
33673758|NCT01502072|63111461|FG001|Overall Study|Death|1|||
33673759|NCT01502072|63111462|FG002|Overall Study|Death|0|||
33673760|NCT01462370|63111470|FG000|Overall Study|Lack of Qualifying Event|1|||
33673761|NCT01462370|63111471|FG001|Overall Study|Lack of Qualifying Event|1|||
33673762|NCT01462370|63111470|FG000|Overall Study|Physician Decision|0|||
33673763|NCT01462370|63111471|FG001|Overall Study|Physician Decision|1|||
33673764|NCT01462370|63111470|FG000|Overall Study|Withdrawal by Subject|0|||
33673765|NCT01462370|63111471|FG001|Overall Study|Withdrawal by Subject|3|||
33673766|NCT01479764|63111479|FG000|Randomized|Adverse Event|1|||
33673767|NCT01479764|63111480|FG001|Randomized|Adverse Event|1|||
33673768|NCT01479764|63111479|FG000|Randomized|Withdrawal by Subject|1|||
33673769|NCT01479764|63111480|FG001|Randomized|Withdrawal by Subject|0|||
33673770|NCT01479764|63111479|FG000|Treated|Lost to Follow-up|0|||
33673771|NCT01479764|63111480|FG001|Treated|Lost to Follow-up|2|||
33673772|NCT01479530|63111488|FG000|Overall Study|Adverse Event|5|||
33673773|NCT01479530|63111489|FG001|Overall Study|Adverse Event|6|||
33673774|NCT01479530|63111488|FG000|Overall Study|Lack of Efficacy|0|||
33673775|NCT01479530|63111489|FG001|Overall Study|Lack of Efficacy|1|||
33673776|NCT01479530|63111488|FG000|Overall Study|Protocol Violation|2|||
33673777|NCT01479530|63111489|FG001|Overall Study|Protocol Violation|3|||
33673778|NCT01479530|63111488|FG000|Overall Study|Withdrawal of Consent|3|||
33673779|NCT01479530|63111489|FG001|Overall Study|Withdrawal of Consent|2|||
33673780|NCT01479374|63111498|FG000|Overall Study|Adverse Event|2|||
33673781|NCT01479374|63111499|FG001|Overall Study|Adverse Event|1|||
33673782|NCT01479374|63111500|FG002|Overall Study|Adverse Event|0|||
33673783|NCT01479374|63111498|FG000|Overall Study|Lost to Follow-up|1|||
33673784|NCT01479374|63111499|FG001|Overall Study|Lost to Follow-up|2|||
33673785|NCT01479374|63111500|FG002|Overall Study|Lost to Follow-up|0|||
33673786|NCT01479374|63111498|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
33673787|NCT01479374|63111499|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
33673788|NCT01479374|63111500|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
33673789|NCT01479374|63111498|FG000|Overall Study|Other|0|||
33673790|NCT01479374|63111499|FG001|Overall Study|Other|4|||
33673791|NCT01479374|63111500|FG002|Overall Study|Other|5|||
33673792|NCT00087529|63111510|FG000|Overall Study|Death|1|||
33673793|NCT00087529|63111511|FG001|Overall Study|Death|0|||
33673794|NCT00087529|63111510|FG000|Overall Study|Adverse Event|0|||
33673795|NCT00087529|63111511|FG001|Overall Study|Adverse Event|8|||
33673796|NCT00087529|63111510|FG000|Overall Study|Pregnancy|0|||
33673797|NCT00087529|63111511|FG001|Overall Study|Pregnancy|1|||
33673798|NCT00087529|63111510|FG000|Overall Study|Lost to Follow-up|2|||
33673799|NCT00087529|63111511|FG001|Overall Study|Lost to Follow-up|3|||
33673800|NCT00087529|63111510|FG000|Overall Study|Participant Decision|14|||
33673801|NCT00087529|63111511|FG001|Overall Study|Participant Decision|37|||
33673802|NCT00087529|63111510|FG000|Overall Study|Physician Decision|4|||
33673803|NCT00087529|63111511|FG001|Overall Study|Physician Decision|8|||
33673804|NCT00087529|63111510|FG000|Overall Study|Initiation of Excluded Therapy|0|||
33673805|NCT00087529|63111511|FG001|Overall Study|Initiation of Excluded Therapy|1|||
33673806|NCT00087529|63111510|FG000|Overall Study|Participant Noncompliance|0|||
33673807|NCT00087529|63111511|FG001|Overall Study|Participant Noncompliance|1|||
33673808|NCT00087529|63111510|FG000|Overall Study|Disease Progression|5|||
33673809|NCT00087529|63111511|FG001|Overall Study|Disease Progression|4|||
33673810|NCT00087529|63111510|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
33673811|NCT00087529|63111511|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
33673812|NCT01500434|63111534|FG000|Overall Study|Death|1|||
33673813|NCT01500434|63111534|FG000|Overall Study|Withdrawal by Subject|1|||
33673814|NCT01500434|63111534|FG000|Overall Study|Missed 12-month follow-up|5|||
33673815|NCT00087139|63111541|FG000|Overall Study|Adverse Event|18|||
33673816|NCT00087139|63111542|FG001|Overall Study|Adverse Event|17|||
33673817|NCT00087139|63111543|FG002|Overall Study|Adverse Event|13|||
33673818|NCT00087139|63111541|FG000|Overall Study|Death|2|||
33673819|NCT00087139|63111542|FG001|Overall Study|Death|1|||
33673820|NCT00087139|63111543|FG002|Overall Study|Death|0|||
33673821|NCT00087139|63111541|FG000|Overall Study|Withdrawal by Subject|3|||
33673822|NCT00087139|63111542|FG001|Overall Study|Withdrawal by Subject|2|||
33673823|NCT00087139|63111543|FG002|Overall Study|Withdrawal by Subject|2|||
33673824|NCT00087139|63111541|FG000|Overall Study|Physician Decision|1|||
33673825|NCT00087139|63111542|FG001|Overall Study|Physician Decision|1|||
33673826|NCT00087139|63111543|FG002|Overall Study|Physician Decision|1|||
33673827|NCT00087139|63111541|FG000|Overall Study|Disease progression|9|||
33673828|NCT00087139|63111542|FG001|Overall Study|Disease progression|19|||
33673829|NCT00087139|63111543|FG002|Overall Study|Disease progression|12|||
33673830|NCT00087139|63111541|FG000|Overall Study|Ineligible|4|||
33673831|NCT00087139|63111542|FG001|Overall Study|Ineligible|7|||
33673832|NCT00087139|63111543|FG002|Overall Study|Ineligible|4|||
33673833|NCT00087139|63111541|FG000|Overall Study|Symptomatic deterioration|1|||
33673834|NCT00087139|63111542|FG001|Overall Study|Symptomatic deterioration|1|||
33673835|NCT00087139|63111543|FG002|Overall Study|Symptomatic deterioration|3|||
33673836|NCT00087139|63111541|FG000|Overall Study|Use of coumadin|1|||
33673837|NCT00087139|63111542|FG001|Overall Study|Use of coumadin|0|||
33673838|NCT00087139|63111543|FG002|Overall Study|Use of coumadin|0|||
33673839|NCT00087139|63111541|FG000|Overall Study|Response achieved|0|||
33673840|NCT00087139|63111542|FG001|Overall Study|Response achieved|1|||
33673841|NCT00087139|63111543|FG002|Overall Study|Response achieved|0|||
33673842|NCT00087139|63111541|FG000|Overall Study|Extradural disease|0|||
33673843|NCT00087139|63111542|FG001|Overall Study|Extradural disease|0|||
33673844|NCT00087139|63111543|FG002|Overall Study|Extradural disease|1|||
33673845|NCT01500278|63111595|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
33673846|NCT01500278|63111596|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
33673847|NCT01500278|63111595|FG000|Week 0 - Week 12|Protocol Violation|10|||
33673848|NCT01500278|63111596|FG001|Week 0 - Week 12|Protocol Violation|16|||
33673849|NCT01500278|63111595|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
33673850|NCT01500278|63111596|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
33673851|NCT01500278|63111595|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
33673852|NCT01500278|63111596|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
33673853|NCT01500278|63111595|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
33673854|NCT01500278|63111596|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
33673855|NCT01500278|63111595|FG000|Week 0 - Week 12|Patient decision|1|||
33673856|NCT01500278|63111596|FG001|Week 0 - Week 12|Patient decision|0|||
33673857|NCT01500278|63111595|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
33673858|NCT01500278|63111596|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
33673859|NCT01500278|63111595|FG000|Week 0 - Week 12|Investigator decision|1|||
33673860|NCT01500278|63111596|FG001|Week 0 - Week 12|Investigator decision|0|||
33673861|NCT01500278|63111595|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
33673862|NCT01500278|63111596|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
33673863|NCT01500278|63111595|FG000|Week 0 - Week 12|Sponsor decision|1|||
33673864|NCT01500278|63111596|FG001|Week 0 - Week 12|Sponsor decision|0|||
33673865|NCT01500278|63111595|FG000|Week 0 - Week 12|Personal reason|0|||
33673866|NCT01500278|63111596|FG001|Week 0 - Week 12|Personal reason|1|||
33673867|NCT01500278|63111595|FG000|Week 0 - Week 12|Other serious disease|0|||
33673868|NCT01500278|63111596|FG001|Week 0 - Week 12|Other serious disease|1|||
33673869|NCT01500278|63111595|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
33673870|NCT01500278|63111596|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
33673871|NCT01500278|63111595|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
33673872|NCT01500278|63111596|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
33673873|NCT01500278|63111595|FG000|Week 13 - Week 104|Protocol Violation|6|||
33673874|NCT01500278|63111596|FG001|Week 13 - Week 104|Protocol Violation|6|||
33673875|NCT01500278|63111595|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
33673876|NCT01500278|63111596|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
33673877|NCT01500278|63111595|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
33673878|NCT01500278|63111596|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
33673879|NCT01500278|63111595|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
33673880|NCT01500278|63111596|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
33673881|NCT01500278|63111595|FG000|Week 13 - Week 104|Non/bad compliance|7|||
33673882|NCT01500278|63111596|FG001|Week 13 - Week 104|Non/bad compliance|5|||
33673883|NCT01500278|63111595|FG000|Week 13 - Week 104|Recurrent infections|1|||
33673884|NCT01500278|63111596|FG001|Week 13 - Week 104|Recurrent infections|0|||
33673885|NCT01500278|63111595|FG000|Week 13 - Week 104|False positive test|1|||
33673886|NCT01500278|63111596|FG001|Week 13 - Week 104|False positive test|2|||
33673887|NCT01500278|63111595|FG000|Week 13 - Week 104|Sponsor request|4|||
33673888|NCT01500278|63111596|FG001|Week 13 - Week 104|Sponsor request|0|||
33673889|NCT01500278|63111595|FG000|Week 13 - Week 104|Withdrawn in error|1|||
33673890|NCT01500278|63111596|FG001|Week 13 - Week 104|Withdrawn in error|0|||
33673891|NCT01500278|63111595|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
33673892|NCT01500278|63111596|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
33673893|NCT01500278|63111595|FG000|Week 13 - Week 104|Protocol deviation|1|||
33673894|NCT01500278|63111596|FG001|Week 13 - Week 104|Protocol deviation|0|||
33673895|NCT01500278|63111595|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
33673896|NCT01500278|63111596|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
33673897|NCT01500278|63111595|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
33673898|NCT01500278|63111596|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
33673899|NCT01500278|63111595|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
33673900|NCT01500278|63111596|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
33673901|NCT01500278|63111595|FG000|Week 13 - Week 104|Relocation|0|||
33673902|NCT01500278|63111596|FG001|Week 13 - Week 104|Relocation|1|||
33673903|NCT01500278|63111595|FG000|Week 13 - Week 104|Sponsor decision|0|||
33673904|NCT01500278|63111596|FG001|Week 13 - Week 104|Sponsor decision|2|||
33673905|NCT01500278|63111595|FG000|Week 13 - Week 104|Medical monitor decision|0|||
33673906|NCT01500278|63111596|FG001|Week 13 - Week 104|Medical monitor decision|2|||
33673907|NCT01500278|63111595|FG000|Week 13 - Week 104|Personal reason|0|||
33673908|NCT01500278|63111596|FG001|Week 13 - Week 104|Personal reason|1|||
33673909|NCT01500278|63111595|FG000|Week 13 - Week 104|Not completed|0|||
33673910|NCT01500278|63111596|FG001|Week 13 - Week 104|Not completed|1|||
33673911|NCT01500278|63111595|FG000|Week 13 - Week 104|Death|2|||
33673912|NCT01500278|63111596|FG001|Week 13 - Week 104|Death|4|||
33673913|NCT01500278|63111595|FG000|Week 13 - Week 104|Adverse Event|54|||
33673914|NCT01500278|63111596|FG001|Week 13 - Week 104|Adverse Event|54|||
33673915|NCT00086281|63111619|FG000|Phase 1|Adverse Event|0|||
33673916|NCT00086281|63111620|FG001|Phase 1|Adverse Event|0|||
33673917|NCT00086281|63111621|FG002|Phase 1|Adverse Event|0|||
33673918|NCT00086281|63111622|FG003|Phase 1|Adverse Event|0|||
33673919|NCT00086281|63111623|FG004|Phase 1|Adverse Event|0|||
33673920|NCT00086281|63111624|FG005|Phase 1|Adverse Event|0|||
33673921|NCT00086281|63111625|FG006|Phase 1|Adverse Event|0|||
33673922|NCT00086281|63111626|FG007|Phase 1|Adverse Event|0|||
33673923|NCT00086281|63111627|FG008|Phase 1|Adverse Event|0|||
33673924|NCT00086281|63111628|FG009|Phase 1|Adverse Event|1|||
33673925|NCT00086281|63111629|FG010|Phase 1|Adverse Event|2|||
33673926|NCT00086281|63111630|FG011|Phase 1|Adverse Event|1|||
33673927|NCT00086281|63111631|FG012|Phase 1|Adverse Event|1|||
33673928|NCT00086281|63111632|FG013|Phase 1|Adverse Event|1|||
33673929|NCT00086281|63111633|FG014|Phase 1|Adverse Event|2|||
33673930|NCT00086281|63111619|FG000|Phase 1|Protocol Violation|0|||
33673931|NCT00086281|63111620|FG001|Phase 1|Protocol Violation|0|||
33673932|NCT00086281|63111621|FG002|Phase 1|Protocol Violation|0|||
33673933|NCT00086281|63111622|FG003|Phase 1|Protocol Violation|0|||
33673934|NCT00086281|63111623|FG004|Phase 1|Protocol Violation|0|||
33673935|NCT00086281|63111624|FG005|Phase 1|Protocol Violation|0|||
33673936|NCT00086281|63111625|FG006|Phase 1|Protocol Violation|0|||
33673937|NCT00086281|63111626|FG007|Phase 1|Protocol Violation|0|||
33673938|NCT00086281|63111627|FG008|Phase 1|Protocol Violation|0|||
33673939|NCT00086281|63111628|FG009|Phase 1|Protocol Violation|0|||
33673940|NCT00086281|63111629|FG010|Phase 1|Protocol Violation|1|||
33673941|NCT00086281|63111630|FG011|Phase 1|Protocol Violation|0|||
33673942|NCT00086281|63111631|FG012|Phase 1|Protocol Violation|0|||
33673943|NCT00086281|63111632|FG013|Phase 1|Protocol Violation|0|||
33673944|NCT00086281|63111633|FG014|Phase 1|Protocol Violation|0|||
33673945|NCT00086281|63111619|FG000|Phase 1|Serious Adverse Event|0|||
33673946|NCT00086281|63111620|FG001|Phase 1|Serious Adverse Event|0|||
33673947|NCT00086281|63111621|FG002|Phase 1|Serious Adverse Event|0|||
33673948|NCT00086281|63111622|FG003|Phase 1|Serious Adverse Event|0|||
33673949|NCT00086281|63111623|FG004|Phase 1|Serious Adverse Event|0|||
33673950|NCT00086281|63111624|FG005|Phase 1|Serious Adverse Event|0|||
33673951|NCT00086281|63111625|FG006|Phase 1|Serious Adverse Event|0|||
33673952|NCT00086281|63111626|FG007|Phase 1|Serious Adverse Event|0|||
33673953|NCT00086281|63111627|FG008|Phase 1|Serious Adverse Event|0|||
33673954|NCT00086281|63111628|FG009|Phase 1|Serious Adverse Event|0|||
33673955|NCT00086281|63111629|FG010|Phase 1|Serious Adverse Event|0|||
33673956|NCT00086281|63111630|FG011|Phase 1|Serious Adverse Event|0|||
33673957|NCT00086281|63111631|FG012|Phase 1|Serious Adverse Event|0|||
33673958|NCT00086281|63111632|FG013|Phase 1|Serious Adverse Event|0|||
33673959|NCT00086281|63111633|FG014|Phase 1|Serious Adverse Event|1|||
33673960|NCT00086281|63111619|FG000|Phase 2|Adverse Event|0|||
33673961|NCT00086281|63111620|FG001|Phase 2|Adverse Event|0|||
33673962|NCT00086281|63111621|FG002|Phase 2|Adverse Event|0|||
33673963|NCT00086281|63111622|FG003|Phase 2|Adverse Event|0|||
33673964|NCT00086281|63111623|FG004|Phase 2|Adverse Event|0|||
33673965|NCT00086281|63111624|FG005|Phase 2|Adverse Event|0|||
33673966|NCT00086281|63111625|FG006|Phase 2|Adverse Event|0|||
33673967|NCT00086281|63111626|FG007|Phase 2|Adverse Event|0|||
33673968|NCT00086281|63111627|FG008|Phase 2|Adverse Event|0|||
33673969|NCT00086281|63111628|FG009|Phase 2|Adverse Event|0|||
33673970|NCT00086281|63111629|FG010|Phase 2|Adverse Event|0|||
33673971|NCT00086281|63111630|FG011|Phase 2|Adverse Event|0|||
33673972|NCT00086281|63111631|FG012|Phase 2|Adverse Event|1|||
33673973|NCT00086281|63111632|FG013|Phase 2|Adverse Event|1|||
33673974|NCT00086281|63111633|FG014|Phase 2|Adverse Event|0|||
33673975|NCT00086047|63111645|FG000|Overall Study|Lost to Follow-up|7|||
33673976|NCT00086047|63111646|FG001|Overall Study|Lost to Follow-up|6|||
33673977|NCT00086047|63111645|FG000|Overall Study|Physician Decision|0|||
33673978|NCT00086047|63111646|FG001|Overall Study|Physician Decision|1|||
33673979|NCT01478828|63111658|FG000|Overall Study|Adverse Event|1|||
33673980|NCT00085423|63111663|FG000|Overall Study|Withdrawal by Subject|1|||
33673981|NCT00085423|63111663|FG000|Overall Study|screen failure|1|||
33673982|NCT00084487|63111667|FG000|Overall Study|Death|1|||
33673983|NCT01425281|63111707|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
33673984|NCT01425281|63111708|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
33673985|NCT01425281|63111707|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
33673986|NCT01425281|63111708|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
33673987|NCT01425281|63111707|FG000|At 180-day Clinical Follow-up|Death|0|||
33673988|NCT01425281|63111708|FG001|At 180-day Clinical Follow-up|Death|1|||
33673989|NCT01425281|63111707|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
33673990|NCT01425281|63111708|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
33673991|NCT01425281|63111707|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
33673992|NCT01425281|63111708|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
33673993|NCT01425281|63111707|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
33673994|NCT01425281|63111708|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
33673995|NCT01425281|63111707|FG000|At 2-year Clinical Follow-up|Death|2|||
33673996|NCT01425281|63111708|FG001|At 2-year Clinical Follow-up|Death|0|||
33673997|NCT01425281|63111707|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
33673998|NCT01425281|63111708|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
33673999|NCT01425281|63111707|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
33674000|NCT01425281|63111708|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
33674001|NCT01425281|63111707|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
33674002|NCT01425281|63111708|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
33674003|NCT01425281|63111707|FG000|At 3-year Clinical Follow-up|Death|2|||
33674004|NCT01425281|63111708|FG001|At 3-year Clinical Follow-up|Death|3|||
33674005|NCT01425281|63111707|FG000|At 4-year Clinical Follow-up|Death|7|||
33674006|NCT01425281|63111708|FG001|At 4-year Clinical Follow-up|Death|3|||
33674007|NCT01425281|63111707|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
33674008|NCT01425281|63111708|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
33674009|NCT01425281|63111707|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
33674010|NCT01425281|63111708|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
33674011|NCT01425281|63111707|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
33674012|NCT01425281|63111708|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
33674013|NCT01425281|63111707|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
33674014|NCT01425281|63111708|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
33674015|NCT01425281|63111707|FG000|At 5-year Clinical Follow-up|Death|2|||
33674016|NCT01425281|63111708|FG001|At 5-year Clinical Follow-up|Death|0|||
33674017|NCT01425281|63111707|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
33674018|NCT01425281|63111708|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
33674019|NCT01425281|63111707|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
33674020|NCT01425281|63111708|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
33674021|NCT01425281|63111707|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
33674022|NCT01425281|63111708|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
33674023|NCT02648724|63111736|FG000|Overall Study|Withdrawal by Subject|0|||
33674024|NCT02648724|63111737|FG001|Overall Study|Withdrawal by Subject|1|||
33674025|NCT02648724|63111738|FG002|Overall Study|Withdrawal by Subject|1|||
33674026|NCT02648724|63111739|FG003|Overall Study|Withdrawal by Subject|0|||
33674027|NCT02648724|63111740|FG004|Overall Study|Withdrawal by Subject|1|||
33674028|NCT02648724|63111741|FG005|Overall Study|Withdrawal by Subject|0|||
33674029|NCT02648724|63111742|FG006|Overall Study|Withdrawal by Subject|0|||
33674030|NCT02648724|63111736|FG000|Overall Study|Progressive disease|2|||
33674031|NCT02648724|63111737|FG001|Overall Study|Progressive disease|2|||
33674032|NCT02648724|63111738|FG002|Overall Study|Progressive disease|2|||
33674033|NCT02648724|63111739|FG003|Overall Study|Progressive disease|3|||
33674034|NCT02648724|63111740|FG004|Overall Study|Progressive disease|22|||
33674035|NCT02648724|63111741|FG005|Overall Study|Progressive disease|7|||
33674036|NCT02648724|63111742|FG006|Overall Study|Progressive disease|8|||
33674037|NCT02648724|63111736|FG000|Overall Study|Other reason (unknown)|1|||
33674038|NCT02648724|63111737|FG001|Overall Study|Other reason (unknown)|0|||
33674039|NCT02648724|63111738|FG002|Overall Study|Other reason (unknown)|0|||
33674040|NCT02648724|63111739|FG003|Overall Study|Other reason (unknown)|0|||
33674041|NCT02648724|63111740|FG004|Overall Study|Other reason (unknown)|0|||
33674042|NCT02648724|63111741|FG005|Overall Study|Other reason (unknown)|0|||
33674043|NCT02648724|63111742|FG006|Overall Study|Other reason (unknown)|0|||
33674044|NCT02648724|63111736|FG000|Overall Study|Protocol Violation|0|||
33674045|NCT02648724|63111737|FG001|Overall Study|Protocol Violation|0|||
33674046|NCT02648724|63111738|FG002|Overall Study|Protocol Violation|0|||
33674047|NCT02648724|63111739|FG003|Overall Study|Protocol Violation|0|||
33674048|NCT02648724|63111740|FG004|Overall Study|Protocol Violation|1|||
33674049|NCT02648724|63111741|FG005|Overall Study|Protocol Violation|0|||
33674050|NCT02648724|63111742|FG006|Overall Study|Protocol Violation|0|||
33674051|NCT02648724|63111736|FG000|Overall Study|Death|0|||
33674052|NCT02648724|63111737|FG001|Overall Study|Death|0|||
33674053|NCT02648724|63111738|FG002|Overall Study|Death|0|||
33674054|NCT02648724|63111739|FG003|Overall Study|Death|0|||
33674055|NCT02648724|63111740|FG004|Overall Study|Death|0|||
33674056|NCT02648724|63111741|FG005|Overall Study|Death|0|||
33674057|NCT02648724|63111742|FG006|Overall Study|Death|3|||
33674058|NCT02648724|63111736|FG000|Overall Study|Physician Decision|0|||
33674059|NCT02648724|63111737|FG001|Overall Study|Physician Decision|0|||
33674060|NCT02648724|63111738|FG002|Overall Study|Physician Decision|0|||
33674061|NCT02648724|63111739|FG003|Overall Study|Physician Decision|0|||
33674062|NCT02648724|63111740|FG004|Overall Study|Physician Decision|1|||
33674063|NCT02648724|63111741|FG005|Overall Study|Physician Decision|0|||
33674064|NCT02648724|63111742|FG006|Overall Study|Physician Decision|1|||
33674065|NCT02648724|63111736|FG000|Overall Study|Transferred to named patient program|0|||
33674066|NCT02648724|63111737|FG001|Overall Study|Transferred to named patient program|0|||
33674067|NCT02648724|63111738|FG002|Overall Study|Transferred to named patient program|0|||
33674068|NCT02648724|63111739|FG003|Overall Study|Transferred to named patient program|0|||
33674069|NCT02648724|63111740|FG004|Overall Study|Transferred to named patient program|0|||
33674070|NCT02648724|63111741|FG005|Overall Study|Transferred to named patient program|1|||
33674071|NCT02648724|63111742|FG006|Overall Study|Transferred to named patient program|0|||
33674072|NCT01402817|63111774|FG000|Overall Study|Withdrawal by Subject|3|||
33674073|NCT01402817|63111774|FG000|Overall Study|Study Suspended by FDA|8|||
33674074|NCT01425203|63111781|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
33674075|NCT01425203|63111782|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
33674076|NCT01425203|63111783|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
33674077|NCT01425203|63111781|FG000|Treatment Phase|Failure at futility timepoint|8|||
33674078|NCT01425203|63111782|FG001|Treatment Phase|Failure at futility timepoint|27|||
33674079|NCT01425203|63111783|FG002|Treatment Phase|Failure at futility timepoint|0|||
33674080|NCT01425203|63111781|FG000|Treatment Phase|Other virologic failure criteria|5|||
33674081|NCT01425203|63111782|FG001|Treatment Phase|Other virologic failure criteria|3|||
33674082|NCT01425203|63111783|FG002|Treatment Phase|Other virologic failure criteria|0|||
33674083|NCT01425203|63111781|FG000|Treatment Phase|Unidentified reasons|11|||
33674084|NCT01425203|63111782|FG001|Treatment Phase|Unidentified reasons|5|||
33674085|NCT01425203|63111783|FG002|Treatment Phase|Unidentified reasons|0|||
33674086|NCT01425203|63111781|FG000|Treatment Phase|Did not receive treatment|0|||
33674087|NCT01425203|63111782|FG001|Treatment Phase|Did not receive treatment|1|||
33674088|NCT01425203|63111783|FG002|Treatment Phase|Did not receive treatment|0|||
33674089|NCT01425203|63111781|FG000|Crossover Phase|Failure at futility timepoint|0|||
33674090|NCT01425203|63111782|FG001|Crossover Phase|Failure at futility timepoint|0|||
33674091|NCT01425203|63111783|FG002|Crossover Phase|Failure at futility timepoint|3|||
33674092|NCT01425203|63111781|FG000|Crossover Phase|Other virologic failure criteria|0|||
33674093|NCT01425203|63111782|FG001|Crossover Phase|Other virologic failure criteria|0|||
33674094|NCT01425203|63111783|FG002|Crossover Phase|Other virologic failure criteria|3|||
33674095|NCT00081289|63111793|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
33674096|NCT00081289|63111794|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
33674097|NCT00081289|63111793|FG000|Overall Study|Ineligible / no protocol treatment|3|||
33674098|NCT00081289|63111794|FG001|Overall Study|Ineligible / no protocol treatment|4|||
33674099|NCT01478594|63111803|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
33674100|NCT01478594|63111804|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
33674101|NCT01478594|63111803|FG000|Overall Study|Death|45|||
33674102|NCT01478594|63111804|FG001|Overall Study|Death|18|||
33674103|NCT01478594|63111803|FG000|Overall Study|Lost to Follow-up|3|||
33674104|NCT01478594|63111804|FG001|Overall Study|Lost to Follow-up|1|||
33674105|NCT01478594|63111803|FG000|Overall Study|Withdrawal by Subject|9|||
33674106|NCT01478594|63111804|FG001|Overall Study|Withdrawal by Subject|3|||
33674107|NCT01478594|63111803|FG000|Overall Study|Study Closed by Sponsor|8|||
33674108|NCT01478594|63111804|FG001|Overall Study|Study Closed by Sponsor|5|||
33674109|NCT01424813|63111865|FG000|Overall Study|Withdrawal by Subject|3|||
33674110|NCT01424813|63111866|FG001|Overall Study|Withdrawal by Subject|0|||
33674111|NCT01424813|63111865|FG000|Overall Study|Protocol Violation|1|||
33674112|NCT01424813|63111866|FG001|Overall Study|Protocol Violation|0|||
33674113|NCT01424813|63111865|FG000|Overall Study|Other|1|||
33674114|NCT01424813|63111866|FG001|Overall Study|Other|2|||
33674115|NCT00080899|63111872|FG000|Overall Study|Adverse Event|1|||
33674116|NCT00089635|63111876|FG000|Overall Study|Adverse Event|2|||
33674117|NCT00089635|63111876|FG000|Overall Study|Death|17|||
33674118|NCT00089635|63111876|FG000|Overall Study|Disease Progression|12|||
33674119|NCT00089635|63111876|FG000|Overall Study|Lost to Follow-up|3|||
33674120|NCT00089635|63111876|FG000|Overall Study|Withdrawal by Subject|6|||
33674121|NCT00089635|63111876|FG000|Overall Study|Ineligibility determined|1|||
33674122|NCT00089635|63111876|FG000|Overall Study|Other|2|||
33674123|NCT01500200|63111890|FG000|Stage 1|Adverse Event|1|||
33674124|NCT01500200|63111891|FG001|Stage 1|Adverse Event|4|||
33674125|NCT01500200|63111892|FG002|Stage 1|Adverse Event|5|||
33674126|NCT01500200|63111893|FG003|Stage 1|Adverse Event|0|||
33674127|NCT01500200|63111894|FG004|Stage 1|Adverse Event|0|||
33674128|NCT01500200|63111895|FG005|Stage 1|Adverse Event|0|||
33674129|NCT01500200|63111890|FG000|Stage 1|Lost to Follow-up|2|||
33674130|NCT01500200|63111891|FG001|Stage 1|Lost to Follow-up|2|||
33674131|NCT01500200|63111892|FG002|Stage 1|Lost to Follow-up|1|||
33674132|NCT01500200|63111893|FG003|Stage 1|Lost to Follow-up|0|||
33674133|NCT01500200|63111894|FG004|Stage 1|Lost to Follow-up|0|||
33674134|NCT01500200|63111895|FG005|Stage 1|Lost to Follow-up|0|||
33674135|NCT01500200|63111890|FG000|Stage 1|Withdrawal by Subject|3|||
33674136|NCT01500200|63111891|FG001|Stage 1|Withdrawal by Subject|0|||
33674137|NCT01500200|63111892|FG002|Stage 1|Withdrawal by Subject|0|||
33674138|NCT01500200|63111893|FG003|Stage 1|Withdrawal by Subject|0|||
33674139|NCT01500200|63111894|FG004|Stage 1|Withdrawal by Subject|0|||
33674140|NCT01500200|63111895|FG005|Stage 1|Withdrawal by Subject|0|||
33674141|NCT01500200|63111890|FG000|Stage 1|Noncompliance with Study Drug|1|||
33674142|NCT01500200|63111891|FG001|Stage 1|Noncompliance with Study Drug|0|||
33674143|NCT01500200|63111892|FG002|Stage 1|Noncompliance with Study Drug|0|||
33674144|NCT01500200|63111893|FG003|Stage 1|Noncompliance with Study Drug|0|||
33674145|NCT01500200|63111894|FG004|Stage 1|Noncompliance with Study Drug|0|||
33674146|NCT01500200|63111895|FG005|Stage 1|Noncompliance with Study Drug|0|||
33674147|NCT01500200|63111890|FG000|Stage 1|Physician Decision|1|||
33674148|NCT01500200|63111891|FG001|Stage 1|Physician Decision|0|||
33674149|NCT01500200|63111892|FG002|Stage 1|Physician Decision|0|||
33674150|NCT01500200|63111893|FG003|Stage 1|Physician Decision|0|||
33674151|NCT01500200|63111894|FG004|Stage 1|Physician Decision|0|||
33674152|NCT01500200|63111895|FG005|Stage 1|Physician Decision|0|||
33674153|NCT01500200|63111890|FG000|Stage 2|Adverse Event|0|||
33674154|NCT01500200|63111891|FG001|Stage 2|Adverse Event|0|||
33674155|NCT01500200|63111892|FG002|Stage 2|Adverse Event|0|||
33674156|NCT01500200|63111893|FG003|Stage 2|Adverse Event|0|||
33674157|NCT01500200|63111894|FG004|Stage 2|Adverse Event|5|||
33674158|NCT01500200|63111895|FG005|Stage 2|Adverse Event|4|||
33674159|NCT01478360|63111911|FG000|Overall Study|Lost to Follow-up|1|||
33674160|NCT01478360|63111912|FG001|Overall Study|Lost to Follow-up|0|||
33674161|NCT01478360|63111911|FG000|Overall Study|Adverse Event|0|||
33674162|NCT01478360|63111912|FG001|Overall Study|Adverse Event|1|||
33674163|NCT01478360|63111911|FG000|Overall Study|Administrative problems|1|||
33674164|NCT01478360|63111912|FG001|Overall Study|Administrative problems|2|||
33674165|NCT01461980|63111930|FG000|Overall Study|Other|9|||
33674166|NCT01461980|63111931|FG001|Overall Study|Other|8|||
33674167|NCT01461980|63111932|FG002|Overall Study|Other|6|||
33674168|NCT01461980|63111930|FG000|Overall Study|Medication error|7|||
33674169|NCT01461980|63111931|FG001|Overall Study|Medication error|5|||
33674170|NCT01461980|63111932|FG002|Overall Study|Medication error|6|||
33674171|NCT01461980|63111930|FG000|Overall Study|Adverse Event|12|||
33674172|NCT01461980|63111931|FG001|Overall Study|Adverse Event|5|||
33674173|NCT01461980|63111932|FG002|Overall Study|Adverse Event|6|||
33674174|NCT01461980|63111930|FG000|Overall Study|Protocol Violation|12|||
33674175|NCT01461980|63111931|FG001|Overall Study|Protocol Violation|19|||
33674176|NCT01461980|63111932|FG002|Overall Study|Protocol Violation|16|||
33674177|NCT01461980|63111930|FG000|Overall Study|No longer meets eligibility criteria|18|||
33674178|NCT01461980|63111931|FG001|Overall Study|No longer meets eligibility criteria|9|||
33674179|NCT01461980|63111932|FG002|Overall Study|No longer meets eligibility criteria|19|||
33674180|NCT01461980|63111930|FG000|Overall Study|Lost to Follow-up|52|||
33674181|NCT01461980|63111931|FG001|Overall Study|Lost to Follow-up|53|||
33674182|NCT01461980|63111932|FG002|Overall Study|Lost to Follow-up|51|||
33674183|NCT01461980|63111930|FG000|Overall Study|No longer willing to participate|52|||
33674184|NCT01461980|63111931|FG001|Overall Study|No longer willing to participate|38|||
33674185|NCT01461980|63111932|FG002|Overall Study|No longer willing to participate|54|||
33674186|NCT01461980|63111930|FG000|Overall Study|Randomized but not vaccinated|4|||
33674187|NCT01461980|63111931|FG001|Overall Study|Randomized but not vaccinated|8|||
33674188|NCT01461980|63111932|FG002|Overall Study|Randomized but not vaccinated|7|||
33674189|NCT01424501|63111947|FG000|Overall Study|Withdrawal by Subject|1|||
33674190|NCT01424501|63111948|FG001|Overall Study|Withdrawal by Subject|0|||
33674191|NCT01424501|63111949|FG002|Overall Study|Withdrawal by Subject|1|||
33674192|NCT01424501|63111950|FG003|Overall Study|Withdrawal by Subject|0|||
33674193|NCT01424501|63111951|FG004|Overall Study|Withdrawal by Subject|0|||
33674194|NCT01424501|63111952|FG005|Overall Study|Withdrawal by Subject|0|||
33674195|NCT01424501|63111947|FG000|Overall Study|Lost to Follow-up|0|||
33674196|NCT01424501|63111948|FG001|Overall Study|Lost to Follow-up|1|||
33674197|NCT01424501|63111949|FG002|Overall Study|Lost to Follow-up|1|||
33674198|NCT01424501|63111950|FG003|Overall Study|Lost to Follow-up|0|||
33674199|NCT01424501|63111951|FG004|Overall Study|Lost to Follow-up|0|||
33674200|NCT01424501|63111952|FG005|Overall Study|Lost to Follow-up|0|||
33674201|NCT01401959|63112033|FG000|Enrolled|Withdrawal by Subject|1|||
33674202|NCT01401959|63112034|FG001|Enrolled|Withdrawal by Subject|0|||
33674203|NCT01401959|63112035|FG002|Enrolled|Withdrawal by Subject|0|||
33674204|NCT01401959|63112033|FG000|Treated|Disease Progression|2|||
33674205|NCT01401959|63112034|FG001|Treated|Disease Progression|2|||
33674206|NCT01401959|63112035|FG002|Treated|Disease Progression|1|||
33674207|NCT01401959|63112033|FG000|Treated|Adverse Event|4|||
33674208|NCT01401959|63112034|FG001|Treated|Adverse Event|3|||
33674209|NCT01401959|63112035|FG002|Treated|Adverse Event|2|||
33674210|NCT01401959|63112033|FG000|Treated|Withdrawal by Subject|1|||
33674211|NCT01401959|63112034|FG001|Treated|Withdrawal by Subject|2|||
33674212|NCT01401959|63112035|FG002|Treated|Withdrawal by Subject|2|||
33674213|NCT01401959|63112033|FG000|Treated|Protocol Violation|0|||
33674214|NCT01401959|63112034|FG001|Treated|Protocol Violation|1|||
33674215|NCT01401959|63112035|FG002|Treated|Protocol Violation|0|||
33674216|NCT01478048|63112065|FG000|Overall Study|Disease Progression|52|||
33674217|NCT01478048|63112066|FG001|Overall Study|Disease Progression|35|||
33674218|NCT01478048|63112065|FG000|Overall Study|study drug toxicity|11|||
33674219|NCT01478048|63112066|FG001|Overall Study|study drug toxicity|14|||
33674220|NCT01478048|63112065|FG000|Overall Study|Adverse Event|2|||
33674221|NCT01478048|63112066|FG001|Overall Study|Adverse Event|11|||
33674222|NCT01478048|63112065|FG000|Overall Study|subject request to discontinue treatment|3|||
33674223|NCT01478048|63112066|FG001|Overall Study|subject request to discontinue treatment|5|||
33674224|NCT01478048|63112065|FG000|Overall Study|Withdrawal by Subject|2|||
33674225|NCT01478048|63112066|FG001|Overall Study|Withdrawal by Subject|5|||
33674226|NCT01478048|63112065|FG000|Overall Study|non-specified|6|||
33674227|NCT01478048|63112066|FG001|Overall Study|non-specified|4|||
33674228|NCT01478048|63112065|FG000|Overall Study|poor/non-compliance|0|||
33674229|NCT01478048|63112066|FG001|Overall Study|poor/non-compliance|1|||
33674230|NCT01478048|63112065|FG000|Overall Study|no longer meets study criteria|1|||
33674231|NCT01478048|63112066|FG001|Overall Study|no longer meets study criteria|0|||
33674232|NCT01424189|63112074|FG000|Overall Study|Adverse Event|1|||
33674233|NCT01424189|63112075|FG001|Overall Study|Adverse Event|0|||
33674234|NCT01424189|63112074|FG000|Overall Study|Lost to Follow-up|4|||
33674235|NCT01424189|63112075|FG001|Overall Study|Lost to Follow-up|1|||
33674236|NCT01424189|63112074|FG000|Overall Study|Withdrawal by Subject|4|||
33674237|NCT01424189|63112075|FG001|Overall Study|Withdrawal by Subject|4|||
33674238|NCT01424189|63112074|FG000|Overall Study|Subject moved|1|||
33674239|NCT01424189|63112075|FG001|Overall Study|Subject moved|0|||
33674240|NCT01424189|63112074|FG000|Overall Study|Death|3|||
33674241|NCT01424189|63112075|FG001|Overall Study|Death|1|||
33674242|NCT01401647|63112088|FG000|Overall Study|Withdrawal by Subject|1|||
33674243|NCT01401647|63112089|FG001|Overall Study|Withdrawal by Subject|5|||
33674244|NCT01401647|63112090|FG002|Overall Study|Withdrawal by Subject|2|||
33674245|NCT01401647|63112088|FG000|Overall Study|Lost to Follow-up|3|||
33674246|NCT01401647|63112089|FG001|Overall Study|Lost to Follow-up|3|||
33674247|NCT01401647|63112090|FG002|Overall Study|Lost to Follow-up|1|||
33674248|NCT01499810|63112098|FG000|Overall Study|Lost to Follow-up|10|||
33674249|NCT01499810|63112098|FG000|Overall Study|Protocol Violation|1|||
33674250|NCT01499810|63112098|FG000|Overall Study|Withdrawal by Subject|1|||
33674251|NCT01423253|63112103|FG000|Overall Study|Adverse Event|2|||
33674252|NCT01423253|63112103|FG000|Overall Study|Lack of Efficacy|2|||
33674253|NCT01423253|63112103|FG000|Overall Study|Lost to Follow-up|1|||
33674254|NCT01423253|63112103|FG000|Overall Study|Protocol Violation|2|||
33674255|NCT01423253|63112103|FG000|Overall Study|Withdrawal by Subject|2|||
33674256|NCT01477892|63112109|FG000|Overall Study|Withdrawal by Subject|0|||
33674257|NCT01477892|63112110|FG001|Overall Study|Withdrawal by Subject|2|||
33674258|NCT01422239|63112123|FG000|Overall Study|Lost to Follow-up|4|||
33674259|NCT01422239|63112124|FG001|Overall Study|Lost to Follow-up|3|||
33674260|NCT01499576|63112130|FG000|Overall Study|Physician Decision|12|||
33674261|NCT01499576|63112130|FG000|Overall Study|Withdrawal by Subject|9|||
33674262|NCT01476722|63112144|FG000|Overall Study|Adverse Event|1|||
33674263|NCT01476644|63112157|FG000|Overall Study|Death|5|||
33674264|NCT01476644|63112157|FG000|Overall Study|moved to another state|2|||
33674265|NCT01476644|63112157|FG000|Overall Study|Lost to Follow-up|19|||
33674266|NCT01476644|63112157|FG000|Overall Study|Withdrawal by Subject|13|||
33674267|NCT01421459|63112181|FG000|Overall Study|Adverse Event|6|||
33674268|NCT01421459|63112182|FG001|Overall Study|Adverse Event|10|||
33674269|NCT01421459|63112181|FG000|Overall Study|Death|1|||
33674270|NCT01421459|63112182|FG001|Overall Study|Death|1|||
33674271|NCT01421459|63112181|FG000|Overall Study|Lack of Efficacy|1|||
33674272|NCT01421459|63112182|FG001|Overall Study|Lack of Efficacy|2|||
33674273|NCT01421459|63112181|FG000|Overall Study|Lost to Follow-up|8|||
33674274|NCT01421459|63112182|FG001|Overall Study|Lost to Follow-up|9|||
33674275|NCT01421459|63112181|FG000|Overall Study|Physician Decision|9|||
33674276|NCT01421459|63112182|FG001|Overall Study|Physician Decision|9|||
33674277|NCT01421459|63112181|FG000|Overall Study|Protocol Violation|8|||
33674278|NCT01421459|63112182|FG001|Overall Study|Protocol Violation|5|||
33674279|NCT01421459|63112181|FG000|Overall Study|Withdrawal by Subject|12|||
33674280|NCT01421459|63112182|FG001|Overall Study|Withdrawal by Subject|16|||
33674281|NCT01498952|63112190|FG000|Overall Study|Death|2|||
33674282|NCT01498952|63112191|FG001|Overall Study|Death|2|||
33674283|NCT01498952|63112192|FG002|Overall Study|Death|0|||
33674284|NCT01498952|63112193|FG003|Overall Study|Death|0|||
33674285|NCT01498952|63112194|FG004|Overall Study|Death|0|||
33674286|NCT01461044|63112226|FG000|Overall Study|Death|58|||
33674287|NCT01461044|63112227|FG001|Overall Study|Death|35|||
33674288|NCT01461044|63112226|FG000|Overall Study|Lost to Follow-up|12|||
33674289|NCT01461044|63112227|FG001|Overall Study|Lost to Follow-up|5|||
33674290|NCT01421303|63112260|FG000|Overall Study|Lost to Follow-up|13|||
33674291|NCT01421303|63112260|FG000|Overall Study|Non compliance with study procedure|1|||
33674292|NCT01421303|63112260|FG000|Overall Study|Other|7|||
33674293|NCT01421303|63112260|FG000|Overall Study|Withdrawal by Subject|1|||
33674294|NCT01475474|63112264|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
33674295|NCT01475474|63112264|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
33674296|NCT01400243|63112271|FG000|Overall Study|Protocol Violation|8|||
33674297|NCT01400243|63112272|FG001|Overall Study|Protocol Violation|11|||
33674298|NCT01475162|63112289|FG000|Overall Study|Physician Decision|1|||
33674299|NCT01475162|63112289|FG000|Overall Study|Death|10|||
33674300|NCT01475162|63112289|FG000|Overall Study|Study closed for safety|3|||
33674301|NCT01421225|63112296|FG000|Overall Study|Withdrawal by Subject|0|||
33674302|NCT01421225|63112297|FG001|Overall Study|Withdrawal by Subject|1|||
33674303|NCT01498640|63112313|FG000|Overall Study|Lost to Follow-up|1|||
33674304|NCT01498640|63112313|FG000|Overall Study|Death|1|||
33674305|NCT01498640|63112313|FG000|Overall Study|Other|3|||
33674306|NCT01498484|63112325|FG000|Overall Study|Death|6|||
33674307|NCT01498484|63112326|FG001|Overall Study|Death|3|||
33674308|NCT01498484|63112327|FG002|Overall Study|Death|1|||
33674309|NCT01498484|63112328|FG003|Overall Study|Death|1|||
33674310|NCT01498484|63112329|FG004|Overall Study|Death|0|||
33674311|NCT01498484|63112330|FG005|Overall Study|Death|0|||
33674312|NCT01498484|63112331|FG006|Overall Study|Death|10|||
33674313|NCT01498484|63112332|FG007|Overall Study|Death|1|||
33674314|NCT01498484|63112333|FG008|Overall Study|Death|0|||
33674315|NCT01498484|63112325|FG000|Overall Study|Physician Decision|3|||
33674316|NCT01498484|63112326|FG001|Overall Study|Physician Decision|2|||
33674317|NCT01498484|63112327|FG002|Overall Study|Physician Decision|1|||
33674318|NCT01498484|63112328|FG003|Overall Study|Physician Decision|1|||
33674319|NCT01498484|63112329|FG004|Overall Study|Physician Decision|0|||
33674320|NCT01498484|63112330|FG005|Overall Study|Physician Decision|0|||
33674321|NCT01498484|63112331|FG006|Overall Study|Physician Decision|8|||
33674322|NCT01498484|63112332|FG007|Overall Study|Physician Decision|13|||
33674323|NCT01498484|63112333|FG008|Overall Study|Physician Decision|1|||
33674324|NCT01498484|63112325|FG000|Overall Study|Adverse Event|0|||
33674325|NCT01498484|63112326|FG001|Overall Study|Adverse Event|0|||
33674326|NCT01498484|63112327|FG002|Overall Study|Adverse Event|0|||
33674327|NCT01498484|63112328|FG003|Overall Study|Adverse Event|0|||
33674328|NCT01498484|63112329|FG004|Overall Study|Adverse Event|0|||
33674329|NCT01498484|63112330|FG005|Overall Study|Adverse Event|1|||
33674330|NCT01498484|63112331|FG006|Overall Study|Adverse Event|0|||
33674331|NCT01498484|63112332|FG007|Overall Study|Adverse Event|0|||
33674332|NCT01498484|63112333|FG008|Overall Study|Adverse Event|0|||
33674333|NCT01498484|63112325|FG000|Overall Study|Withdrawal by Subject|0|||
33674334|NCT01498484|63112326|FG001|Overall Study|Withdrawal by Subject|0|||
33674335|NCT01498484|63112327|FG002|Overall Study|Withdrawal by Subject|0|||
33674336|NCT01498484|63112328|FG003|Overall Study|Withdrawal by Subject|1|||
33674337|NCT01498484|63112329|FG004|Overall Study|Withdrawal by Subject|0|||
33674338|NCT01498484|63112330|FG005|Overall Study|Withdrawal by Subject|0|||
33674339|NCT01498484|63112331|FG006|Overall Study|Withdrawal by Subject|1|||
33674340|NCT01498484|63112332|FG007|Overall Study|Withdrawal by Subject|0|||
33674341|NCT01498484|63112333|FG008|Overall Study|Withdrawal by Subject|0|||
33674342|NCT01498484|63112325|FG000|Overall Study|Other|5|||
33674343|NCT01498484|63112326|FG001|Overall Study|Other|2|||
33674344|NCT01498484|63112327|FG002|Overall Study|Other|0|||
33674345|NCT01498484|63112328|FG003|Overall Study|Other|0|||
33674346|NCT01498484|63112329|FG004|Overall Study|Other|1|||
33674347|NCT01498484|63112330|FG005|Overall Study|Other|0|||
33674348|NCT01498484|63112331|FG006|Overall Study|Other|3|||
33674349|NCT01498484|63112332|FG007|Overall Study|Other|0|||
33674350|NCT01498484|63112333|FG008|Overall Study|Other|1|||
33674351|NCT01474772|63112342|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
33674352|NCT01474772|63112343|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
33674353|NCT01474772|63112342|FG000|Period 1|AE not Related to Study Drug|1|||
33674354|NCT01474772|63112343|FG001|Period 1|AE not Related to Study Drug|0|||
33674355|NCT01474772|63112342|FG000|Period 1|Withdrawal by Subject|3|||
33674356|NCT01474772|63112343|FG001|Period 1|Withdrawal by Subject|1|||
33674357|NCT01474772|63112342|FG000|Period 1|Lost to Follow-up|1|||
33674358|NCT01474772|63112343|FG001|Period 1|Lost to Follow-up|0|||
33674359|NCT01474772|63112342|FG000|Period 1|Reason not Specified|1|||
33674360|NCT01474772|63112343|FG001|Period 1|Reason not Specified|1|||
33674361|NCT01474772|63112342|FG000|Washout|AE not Related to Study Drug|2|||
33674362|NCT01474772|63112343|FG001|Washout|AE not Related to Study Drug|0|||
33674363|NCT01474772|63112342|FG000|Washout|Withdrawal by Subject|1|||
33674364|NCT01474772|63112343|FG001|Washout|Withdrawal by Subject|0|||
33674365|NCT01474772|63112342|FG000|Washout|Lost to Follow-up|0|||
33674366|NCT01474772|63112343|FG001|Washout|Lost to Follow-up|1|||
33674367|NCT01474772|63112342|FG000|Washout|Reason not Specified|0|||
33674368|NCT01474772|63112343|FG001|Washout|Reason not Specified|1|||
33674369|NCT01474772|63112342|FG000|Period 2|Death|0|||
33674370|NCT01474772|63112343|FG001|Period 2|Death|1|||
33674371|NCT01474772|63112342|FG000|Period 2|AE Related to Study Drug|0|||
33674372|NCT01474772|63112343|FG001|Period 2|AE Related to Study Drug|1|||
33674373|NCT01474772|63112342|FG000|Period 2|AE not Related to Study Drug|4|||
33674374|NCT01474772|63112343|FG001|Period 2|AE not Related to Study Drug|1|||
33674375|NCT01474772|63112342|FG000|Period 2|Lack of Efficacy|1|||
33674376|NCT01474772|63112343|FG001|Period 2|Lack of Efficacy|0|||
33674377|NCT01474772|63112342|FG000|Period 2|Withdrawal by Subject|3|||
33674378|NCT01474772|63112343|FG001|Period 2|Withdrawal by Subject|4|||
33674379|NCT01474772|63112342|FG000|Period 2|Lost to Follow-up|1|||
33674380|NCT01474772|63112343|FG001|Period 2|Lost to Follow-up|1|||
33674381|NCT01474772|63112342|FG000|Period 2|Reason not Specified|0|||
33674382|NCT01474772|63112343|FG001|Period 2|Reason not Specified|2|||
33674383|NCT01474772|63112342|FG000|Follow-up|AE not Related to Study Drug|0|||
33674384|NCT01474772|63112343|FG001|Follow-up|AE not Related to Study Drug|1|||
33674385|NCT01421147|63112351|FG000|Treatment Period|Adverse Event|2|||
33674386|NCT01421147|63112352|FG001|Treatment Period|Adverse Event|3|||
33674387|NCT01421147|63112351|FG000|Treatment Period|Lost to Follow-up|2|||
33674388|NCT01421147|63112352|FG001|Treatment Period|Lost to Follow-up|1|||
33674389|NCT01421147|63112351|FG000|Treatment Period|Physician Decision|2|||
33674390|NCT01421147|63112352|FG001|Treatment Period|Physician Decision|2|||
33674391|NCT01421147|63112351|FG000|Treatment Period|Withdrawal by Subject|10|||
33674392|NCT01421147|63112352|FG001|Treatment Period|Withdrawal by Subject|5|||
33674393|NCT01421147|63112351|FG000|Extension Period|Adverse Event|0|||
33674394|NCT01421147|63112352|FG001|Extension Period|Adverse Event|2|||
33674395|NCT01421147|63112351|FG000|Extension Period|Death|0|||
33674396|NCT01421147|63112352|FG001|Extension Period|Death|1|||
33674397|NCT01421147|63112351|FG000|Extension Period|Lost to Follow-up|2|||
33674398|NCT01421147|63112352|FG001|Extension Period|Lost to Follow-up|5|||
33674399|NCT01421147|63112351|FG000|Extension Period|Physician Decision|1|||
33674400|NCT01421147|63112352|FG001|Extension Period|Physician Decision|0|||
33674401|NCT01421147|63112351|FG000|Extension Period|Withdrawal by Subject|5|||
33674402|NCT01421147|63112352|FG001|Extension Period|Withdrawal by Subject|3|||
33674403|NCT01497938|63112369|FG000|Overall Study|Adverse Event|0|||
33674404|NCT01497938|63112370|FG001|Overall Study|Adverse Event|1|||
33674405|NCT01497938|63112369|FG000|Overall Study|Physician Decision|0|||
33674406|NCT01497938|63112370|FG001|Overall Study|Physician Decision|1|||
33674407|NCT01497938|63112369|FG000|Overall Study|Withdrawal by Subject|4|||
33674408|NCT01497938|63112370|FG001|Overall Study|Withdrawal by Subject|0|||
33674409|NCT01497938|63112369|FG000|Overall Study|Device Violation|1|||
33674410|NCT01497938|63112370|FG001|Overall Study|Device Violation|0|||
33674411|NCT01460342|63112420|FG000|Overall Study|Adverse Event|5|||
33674412|NCT01460342|63112421|FG001|Overall Study|Adverse Event|4|||
33674413|NCT01460342|63112420|FG000|Overall Study|Lost to Follow-up|1|||
33674414|NCT01460342|63112421|FG001|Overall Study|Lost to Follow-up|2|||
33674415|NCT01460342|63112420|FG000|Overall Study|Protocol Violation|0|||
33674416|NCT01460342|63112421|FG001|Overall Study|Protocol Violation|1|||
33674417|NCT01460342|63112420|FG000|Overall Study|Withdrawal by Subject|3|||
33674418|NCT01460342|63112421|FG001|Overall Study|Withdrawal by Subject|4|||
33674419|NCT01460342|63112420|FG000|Overall Study|Physician Decision|1|||
33674420|NCT01460342|63112421|FG001|Overall Study|Physician Decision|3|||
33674421|NCT01460342|63112420|FG000|Overall Study|Lack of Efficacy|1|||
33674422|NCT01460342|63112421|FG001|Overall Study|Lack of Efficacy|0|||
33674423|NCT01459796|63112453|FG000|Overall Study|Non compliance with protocol|2|||
33674424|NCT01459796|63112454|FG001|Overall Study|Non compliance with protocol|4|||
33674425|NCT01459796|63112453|FG000|Overall Study|Adverse Event|5|||
33674426|NCT01459796|63112454|FG001|Overall Study|Adverse Event|5|||
33674427|NCT01459796|63112453|FG000|Overall Study|Withdrawal by Subject|6|||
33674428|NCT01459796|63112454|FG001|Overall Study|Withdrawal by Subject|3|||
33674429|NCT01459796|63112453|FG000|Overall Study|Lost to Follow-up|5|||
33674430|NCT01459796|63112454|FG001|Overall Study|Lost to Follow-up|4|||
33674431|NCT01459796|63112453|FG000|Overall Study|Reason unspecified|1|||
33674432|NCT01459796|63112454|FG001|Overall Study|Reason unspecified|2|||
33674433|NCT01459796|63112453|FG000|Overall Study|Decision by the sponsor|75|||
33674434|NCT01459796|63112454|FG001|Overall Study|Decision by the sponsor|108|||
33674435|NCT01459718|63112464|FG000|Overall Study|Physician Decision|1|||
33674436|NCT01459718|63112464|FG000|Overall Study|Lost to Follow-up|1|||
33674437|NCT01459718|63112464|FG000|Overall Study|Adverse Event|1|||
33674438|NCT01474538|63112478|FG000|Treatment Period 1|Death|1|||
33674439|NCT01474538|63112479|FG001|Treatment Period 1|Death|0|||
33674440|NCT01474538|63112478|FG000|Treatment Period 1|Physician Decision|1|||
33674441|NCT01474538|63112479|FG001|Treatment Period 1|Physician Decision|0|||
33674442|NCT01474538|63112478|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33674443|NCT01474538|63112479|FG001|Treatment Period 1|Withdrawal by Subject|3|||
33674444|NCT01474538|63112478|FG000|Treatment Period 1|Protocol Violation|0|||
33674445|NCT01474538|63112479|FG001|Treatment Period 1|Protocol Violation|1|||
33674446|NCT01474538|63112478|FG000|Treatment Period 2|Death|1|||
33674447|NCT01474538|63112479|FG001|Treatment Period 2|Death|0|||
33674448|NCT01474538|63112478|FG000|Treatment Period 2|Adverse Event|1|||
33674449|NCT01474538|63112479|FG001|Treatment Period 2|Adverse Event|1|||
33674450|NCT01474538|63112478|FG000|Treatment Period 2|Withdrawal by Subject|2|||
33674451|NCT01474538|63112479|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33674452|NCT01474538|63112478|FG000|Treatment Period 2|Sponsor decision|1|||
33674453|NCT01474538|63112479|FG001|Treatment Period 2|Sponsor decision|0|||
33674454|NCT01474538|63112478|FG000|Treatment Period 2|Physician Decision|0|||
33674455|NCT01474538|63112479|FG001|Treatment Period 2|Physician Decision|1|||
33674456|NCT01474538|63112478|FG000|Treatment Period 2|Protocol Violation|1|||
33674457|NCT01474538|63112479|FG001|Treatment Period 2|Protocol Violation|0|||
33674458|NCT02647788|63112487|FG000|Overall Study|Lost to Follow-up|13|||
33674459|NCT02647788|63112488|FG001|Overall Study|Lost to Follow-up|11|||
33674460|NCT02647788|63112487|FG000|Overall Study|Did not want opiate|0|||
33674461|NCT02647788|63112488|FG001|Overall Study|Did not want opiate|1|||
33674462|NCT02647788|63112487|FG000|Overall Study|Withdrawal by Subject|1|||
33674463|NCT02647788|63112488|FG001|Overall Study|Withdrawal by Subject|0|||
33674464|NCT02647788|63112487|FG000|Overall Study|Felt itchy with assigned medication|1|||
33674465|NCT02647788|63112488|FG001|Overall Study|Felt itchy with assigned medication|0|||
33674466|NCT02647788|63112487|FG000|Overall Study|Felt nauseous with assigned medication|1|||
33674467|NCT02647788|63112488|FG001|Overall Study|Felt nauseous with assigned medication|1|||
33674468|NCT01459016|63112494|FG000|Overall Study|Withdrawal by Subject|11|||
33674469|NCT01459016|63112494|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
33674470|NCT01458392|63112536|FG000|Overall Study|Death|2|||
33674471|NCT01458392|63112537|FG001|Overall Study|Death|11|||
33674472|NCT01458392|63112538|FG002|Overall Study|Death|22|||
33674473|NCT01458392|63112536|FG000|Overall Study|At the discretion of the sponsor|0|||
33674474|NCT01458392|63112537|FG001|Overall Study|At the discretion of the sponsor|2|||
33674475|NCT01458392|63112538|FG002|Overall Study|At the discretion of the sponsor|7|||
33674476|NCT01458392|63112536|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
33674477|NCT01458392|63112537|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
33674478|NCT01458392|63112538|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
33674479|NCT01421069|63112550|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
33674480|NCT01421069|63112550|FG000|Parent Study|Failed to return|3|||
33674481|NCT01421069|63112550|FG000|Parent Study|Withdrawal by Subject|1|||
33674482|NCT01421069|63112550|FG000|Parent Study|Lost to Follow-up|2|||
33674483|NCT01421069|63112550|FG000|Parent Study|Lack of Efficacy|1|||
33674484|NCT01421069|63112550|FG000|Overall Period for Extension Study|Other|2|||
33674485|NCT01421069|63112550|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
33674486|NCT01421069|63112550|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
33674487|NCT01421069|63112550|FG000|Overall Period for Extension Study|Pregnancy|1|||
33674488|NCT01421069|63112550|FG000|Overall Period for Extension Study|Adverse Event|1|||
33674489|NCT01421069|63112550|FG000|Overall Period for Extension Study|Protocol Violation|1|||
33674490|NCT01421069|63112550|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
33674491|NCT01421069|63112550|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
33674492|NCT01421069|63112550|FG000|Active Treatment Period|Other|1|||
33674493|NCT01421069|63112550|FG000|Active Treatment Period|No longer willing to participate in study|8|||
33674494|NCT01421069|63112550|FG000|Active Treatment Period|Insufficient clinical response|1|||
33674495|NCT01421069|63112550|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
33674496|NCT01421069|63112550|FG000|Active Treatment Period|Pregnancy|1|||
33674497|NCT01421069|63112550|FG000|Active Treatment Period|Adverse Event|1|||
33674498|NCT01421069|63112550|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
33674499|NCT01421069|63112550|FG000|Active Treatment Period|Enrolled in observational period|29|||
33674500|NCT01421069|63112550|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
33674501|NCT01421069|63112550|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
33674502|NCT01421069|63112550|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
33674503|NCT01421069|63112550|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
33674504|NCT01421069|63112550|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
33674505|NCT01421069|63112550|FG000|2b. Retreatment Period|Protocol Violation|1|||
33674506|NCT01421069|63112550|FG000|Observational Period|Other|1|||
33674507|NCT01421069|63112550|FG000|Observational Period|No longer willing to participate in study|4|||
33674508|NCT01421069|63112550|FG000|Observational Period|Lost to Follow-up|3|||
33674509|NCT01473836|63112582|FG000|Overall Study|Adverse Event|4|||
33674510|NCT01473836|63112582|FG000|Overall Study|Lack of Efficacy|1|||
33674511|NCT01473836|63112582|FG000|Overall Study|Does not meet entrance criteria|1|||
33674512|NCT01473758|63112622|FG000|Cycle 1|Adverse Event|10|||
33674513|NCT01473758|63112623|FG001|Cycle 1|Adverse Event|2|||
33674514|NCT01473758|63112624|FG002|Cycle 1|Adverse Event|0|||
33674515|NCT01473758|63112625|FG003|Cycle 1|Adverse Event|0|||
33674516|NCT01473758|63112622|FG000|Cycle 1|Withdrawal by Subject|1|||
33674517|NCT01473758|63112623|FG001|Cycle 1|Withdrawal by Subject|1|||
33674518|NCT01473758|63112624|FG002|Cycle 1|Withdrawal by Subject|0|||
33674519|NCT01473758|63112625|FG003|Cycle 1|Withdrawal by Subject|0|||
33674520|NCT01473758|63112622|FG000|Cycle 2|Adverse Event|0|||
33674521|NCT01473758|63112623|FG001|Cycle 2|Adverse Event|0|||
33674522|NCT01473758|63112624|FG002|Cycle 2|Adverse Event|5|||
33674523|NCT01473758|63112625|FG003|Cycle 2|Adverse Event|0|||
33674524|NCT01420679|63112635|FG000|Overall Study|Disease Progression|3|||
33674525|NCT01420679|63112636|FG001|Overall Study|Disease Progression|2|||
33674526|NCT01420679|63112635|FG000|Overall Study|Adverse Event|4|||
33674527|NCT01420679|63112636|FG001|Overall Study|Adverse Event|0|||
33674528|NCT01420679|63112635|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
33674529|NCT01420679|63112636|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
33674530|NCT01420679|63112635|FG000|Overall Study|Patient Decision|1|||
33674531|NCT01420679|63112636|FG001|Overall Study|Patient Decision|0|||
33674532|NCT01420679|63112635|FG000|Overall Study|Investigator Decision|1|||
33674533|NCT01420679|63112636|FG001|Overall Study|Investigator Decision|2|||
33674534|NCT01420679|63112635|FG000|Overall Study|Sponsor Decision|3|||
33674535|NCT01420679|63112636|FG001|Overall Study|Sponsor Decision|3|||
33674536|NCT01420679|63112635|FG000|Overall Study|Other|1|||
33674537|NCT01420679|63112636|FG001|Overall Study|Other|0|||
33674538|NCT01496846|63112653|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
33674539|NCT01496846|63112654|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
33674540|NCT01496846|63112655|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
33674541|NCT01496846|63112656|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
33674542|NCT01496846|63112657|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
33674543|NCT01496846|63112658|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
33674544|NCT00964002|63112669|FG000|Overall Study|Protocol Violation|8|||
33674545|NCT01399697|63112681|FG000|Overall Study|Adverse Event|13|||
33674546|NCT01399697|63112682|FG001|Overall Study|Adverse Event|3|||
33674547|NCT01399697|63112683|FG002|Overall Study|Adverse Event|1|||
33674548|NCT01399697|63112681|FG000|Overall Study|Lost to Follow-up|2|||
33674549|NCT01399697|63112682|FG001|Overall Study|Lost to Follow-up|0|||
33674550|NCT01399697|63112683|FG002|Overall Study|Lost to Follow-up|0|||
33674551|NCT01399697|63112681|FG000|Overall Study|Withdrawal by Subject|8|||
33674552|NCT01399697|63112682|FG001|Overall Study|Withdrawal by Subject|0|||
33674553|NCT01399697|63112683|FG002|Overall Study|Withdrawal by Subject|0|||
33674554|NCT01399697|63112681|FG000|Overall Study|Investigator Decisión|1|||
33674555|NCT01399697|63112682|FG001|Overall Study|Investigator Decisión|0|||
33674556|NCT01399697|63112683|FG002|Overall Study|Investigator Decisión|2|||
33674557|NCT01399697|63112681|FG000|Overall Study|Lack of Efficacy|9|||
33674558|NCT01399697|63112682|FG001|Overall Study|Lack of Efficacy|0|||
33674559|NCT01399697|63112683|FG002|Overall Study|Lack of Efficacy|1|||
33674560|NCT01399697|63112681|FG000|Overall Study|Protocol Violation|2|||
33674561|NCT01399697|63112682|FG001|Overall Study|Protocol Violation|0|||
33674562|NCT01399697|63112683|FG002|Overall Study|Protocol Violation|0|||
33674563|NCT01399697|63112681|FG000|Overall Study|Non-Compliant|1|||
33674564|NCT01399697|63112682|FG001|Overall Study|Non-Compliant|0|||
33674565|NCT01399697|63112683|FG002|Overall Study|Non-Compliant|0|||
33674566|NCT01399697|63112681|FG000|Overall Study|Inclusion Error|2|||
33674567|NCT01399697|63112682|FG001|Overall Study|Inclusion Error|0|||
33674568|NCT01399697|63112683|FG002|Overall Study|Inclusion Error|0|||
33674569|NCT01399697|63112681|FG000|Overall Study|Positive result for hepatitis B|1|||
33674570|NCT01399697|63112682|FG001|Overall Study|Positive result for hepatitis B|0|||
33674571|NCT01399697|63112683|FG002|Overall Study|Positive result for hepatitis B|0|||
33674572|NCT01399697|63112681|FG000|Overall Study|Clinical RA remission|1|||
33674573|NCT01399697|63112682|FG001|Overall Study|Clinical RA remission|0|||
33674574|NCT01399697|63112683|FG002|Overall Study|Clinical RA remission|0|||
33674575|NCT01399697|63112681|FG000|Overall Study|Sponsor Decision|1|||
33674576|NCT01399697|63112682|FG001|Overall Study|Sponsor Decision|0|||
33674577|NCT01399697|63112683|FG002|Overall Study|Sponsor Decision|0|||
33674578|NCT01473602|63112717|FG000|Overall Study|Adverse Event|1|||
33674579|NCT01473602|63112718|FG001|Overall Study|Adverse Event|2|||
33674580|NCT01473602|63112717|FG000|Overall Study|Death|0|||
33674581|NCT01473602|63112718|FG001|Overall Study|Death|1|||
33674582|NCT01473602|63112717|FG000|Overall Study|Lost to Follow-up|1|||
33674583|NCT01473602|63112718|FG001|Overall Study|Lost to Follow-up|1|||
33674584|NCT01473602|63112717|FG000|Overall Study|Withdrawal by Subject|5|||
33674585|NCT01473602|63112718|FG001|Overall Study|Withdrawal by Subject|4|||
33674586|NCT01473602|63112717|FG000|Overall Study|Physician Decision|1|||
33674587|NCT01473602|63112718|FG001|Overall Study|Physician Decision|0|||
33674588|NCT01496612|63112726|FG000|1st Intervention|Adverse Event|1|||
33674589|NCT01496612|63112727|FG001|1st Intervention|Adverse Event|0|||
33674590|NCT01496612|63112726|FG000|1st Intervention|Withdrawal by Subject|1|||
33674591|NCT01496612|63112727|FG001|1st Intervention|Withdrawal by Subject|0|||
33674592|NCT00790218|63112744|FG000|Overall Study|Death|1|||
33674593|NCT00790218|63112745|FG001|Overall Study|Death|0|||
33674594|NCT00790218|63112746|FG002|Overall Study|Death|0|||
33674595|NCT01457924|63112772|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
33674596|NCT01457924|63112773|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
33674597|NCT01457924|63112774|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
33674598|NCT01457924|63112775|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
33674599|NCT01457924|63112776|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
33674600|NCT01457924|63112772|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
33674601|NCT01457924|63112773|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
33674602|NCT01457924|63112774|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
33674603|NCT01457924|63112775|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
33674604|NCT01457924|63112776|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
33674605|NCT01457924|63112772|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
33674606|NCT01457924|63112773|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
33674607|NCT01457924|63112774|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
33674608|NCT01457924|63112775|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
33674609|NCT01457924|63112776|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
33674610|NCT01457924|63112772|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
33674611|NCT01457924|63112773|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
33674612|NCT01457924|63112774|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
33674613|NCT01457924|63112775|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
33674614|NCT01457924|63112776|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
33674615|NCT01457924|63112772|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
33674616|NCT01457924|63112773|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
33674617|NCT01457924|63112774|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
33674618|NCT01457924|63112775|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
33674619|NCT01457924|63112776|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
33674620|NCT01457924|63112772|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
33674621|NCT01457924|63112773|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
33674622|NCT01457924|63112774|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
33674623|NCT01457924|63112775|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
33674624|NCT01457924|63112776|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
33674625|NCT01457924|63112772|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
33674626|NCT01457924|63112773|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
33674627|NCT01457924|63112774|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
33674628|NCT01457924|63112775|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
33674629|NCT01457924|63112776|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
33674630|NCT01457924|63112772|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
33674631|NCT01457924|63112773|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
33674632|NCT01457924|63112774|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
33674633|NCT01457924|63112775|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
33674634|NCT01457924|63112776|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
33674635|NCT01457924|63112772|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
33674636|NCT01457924|63112773|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
33674637|NCT01457924|63112774|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
33674638|NCT01457924|63112775|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
33674639|NCT01457924|63112776|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
33674640|NCT01457924|63112772|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
33674641|NCT01457924|63112773|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
33674642|NCT01457924|63112774|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
33674643|NCT01457924|63112775|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
33674644|NCT01457924|63112776|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
33674645|NCT01457924|63112772|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
33674646|NCT01457924|63112773|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
33674647|NCT01457924|63112774|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
33674648|NCT01457924|63112775|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
33674649|NCT01457924|63112776|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
33674650|NCT01457924|63112772|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
33674651|NCT01457924|63112773|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
33674652|NCT01457924|63112774|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
33674653|NCT01457924|63112775|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
33674654|NCT01457924|63112776|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
33674655|NCT01457924|63112772|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
33674656|NCT01457924|63112773|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
33674657|NCT01457924|63112774|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
33674658|NCT01457924|63112775|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
33674659|NCT01457924|63112776|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
33674660|NCT01399619|63112797|FG000|Overall Study|Adverse Event|10|||
33674661|NCT01399619|63112798|FG001|Overall Study|Adverse Event|0|||
33674662|NCT01399619|63112799|FG002|Overall Study|Adverse Event|4|||
33674663|NCT01399619|63112800|FG003|Overall Study|Adverse Event|10|||
33674664|NCT01399619|63112797|FG000|Overall Study|Lack of Efficacy|9|||
33674665|NCT01399619|63112798|FG001|Overall Study|Lack of Efficacy|0|||
33674666|NCT01399619|63112799|FG002|Overall Study|Lack of Efficacy|5|||
33674667|NCT01399619|63112800|FG003|Overall Study|Lack of Efficacy|0|||
33674668|NCT01399619|63112797|FG000|Overall Study|Withdrawal by Subject|6|||
33674669|NCT01399619|63112798|FG001|Overall Study|Withdrawal by Subject|0|||
33674670|NCT01399619|63112799|FG002|Overall Study|Withdrawal by Subject|3|||
33674671|NCT01399619|63112800|FG003|Overall Study|Withdrawal by Subject|4|||
33674672|NCT01399619|63112797|FG000|Overall Study|Protocol Violation|0|||
33674673|NCT01399619|63112798|FG001|Overall Study|Protocol Violation|0|||
33674674|NCT01399619|63112799|FG002|Overall Study|Protocol Violation|0|||
33674675|NCT01399619|63112800|FG003|Overall Study|Protocol Violation|1|||
33674676|NCT01399619|63112797|FG000|Overall Study|Not treated|0|||
33674677|NCT01399619|63112798|FG001|Overall Study|Not treated|0|||
33674678|NCT01399619|63112799|FG002|Overall Study|Not treated|0|||
33674679|NCT01399619|63112800|FG003|Overall Study|Not treated|2|||
33674680|NCT01496456|63112815|FG000|Overall Study|Protocol Violation|1|||
33674681|NCT01496456|63112815|FG000|Overall Study|Lost to Follow-up|7|||
33674682|NCT04999111|63112978|FG000|Overall Study|Lost to Follow-up|0|||
33674683|NCT04999111|63112979|FG001|Overall Study|Lost to Follow-up|3|||
33674684|NCT04999111|63112980|FG002|Overall Study|Lost to Follow-up|1|||
33674685|NCT04999111|63112981|FG003|Overall Study|Lost to Follow-up|1|||
33674686|NCT04999111|63112982|FG004|Overall Study|Lost to Follow-up|1|||
33674687|NCT04999111|63112983|FG005|Overall Study|Lost to Follow-up|1|||
33674688|NCT04999111|63112978|FG000|Overall Study|Physician Decision|0|||
33674689|NCT04999111|63112979|FG001|Overall Study|Physician Decision|0|||
33674690|NCT04999111|63112980|FG002|Overall Study|Physician Decision|0|||
33674691|NCT04999111|63112981|FG003|Overall Study|Physician Decision|1|||
33674692|NCT04999111|63112982|FG004|Overall Study|Physician Decision|0|||
33674693|NCT04999111|63112983|FG005|Overall Study|Physician Decision|0|||
33674694|NCT04999111|63112978|FG000|Overall Study|Withdrawal by Subject|3|||
33674695|NCT04999111|63112979|FG001|Overall Study|Withdrawal by Subject|3|||
33674696|NCT04999111|63112980|FG002|Overall Study|Withdrawal by Subject|2|||
33674697|NCT04999111|63112981|FG003|Overall Study|Withdrawal by Subject|1|||
33674698|NCT04999111|63112982|FG004|Overall Study|Withdrawal by Subject|3|||
33674699|NCT04999111|63112983|FG005|Overall Study|Withdrawal by Subject|0|||
33674700|NCT04999111|63112978|FG000|Overall Study|Other|1|||
33674701|NCT04999111|63112979|FG001|Overall Study|Other|1|||
33674702|NCT04999111|63112980|FG002|Overall Study|Other|1|||
33674703|NCT04999111|63112981|FG003|Overall Study|Other|0|||
33674704|NCT04999111|63112982|FG004|Overall Study|Other|0|||
33674705|NCT04999111|63112983|FG005|Overall Study|Other|0|||
33674706|NCT04999111|63112978|FG000|Overall Study|Ongoing|326|||
33674707|NCT04999111|63112979|FG001|Overall Study|Ongoing|321|||
33674708|NCT04999111|63112980|FG002|Overall Study|Ongoing|112|||
33674709|NCT04999111|63112981|FG003|Overall Study|Ongoing|323|||
33674710|NCT04999111|63112982|FG004|Overall Study|Ongoing|322|||
33674711|NCT04999111|63112983|FG005|Overall Study|Ongoing|105|||
33674712|NCT04999111|63112978|FG000|Overall Study|Randomized but not vaccinated|1|||
33674713|NCT04999111|63112979|FG001|Overall Study|Randomized but not vaccinated|2|||
33674714|NCT04999111|63112980|FG002|Overall Study|Randomized but not vaccinated|0|||
33674715|NCT04999111|63112981|FG003|Overall Study|Randomized but not vaccinated|3|||
33674716|NCT04999111|63112982|FG004|Overall Study|Randomized but not vaccinated|3|||
33674717|NCT04999111|63112983|FG005|Overall Study|Randomized but not vaccinated|0|||
33674718|NCT01673646|63113044|FG000|Overall Study|Adverse Event|2|||
33674719|NCT01673646|63113045|FG001|Overall Study|Adverse Event|1|||
33674720|NCT01673646|63113046|FG002|Overall Study|Adverse Event|1|||
33674721|NCT01673646|63113044|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33674722|NCT01673646|63113045|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33674723|NCT01673646|63113046|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33674724|NCT01673646|63113044|FG000|Overall Study|Condition no longer requires study drug|0|||
33674725|NCT01673646|63113045|FG001|Overall Study|Condition no longer requires study drug|1|||
33674726|NCT01673646|63113046|FG002|Overall Study|Condition no longer requires study drug|0|||
33674727|NCT01673646|63113044|FG000|Overall Study|Withdrawal by Subject|0|||
33674728|NCT01673646|63113045|FG001|Overall Study|Withdrawal by Subject|2|||
33674729|NCT01673646|63113046|FG002|Overall Study|Withdrawal by Subject|2|||
33674730|NCT01673646|63113044|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
33674731|NCT01673646|63113045|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
33674732|NCT01673646|63113046|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
33674733|NCT02647944|63113086|FG000|Overall Study|Withdrawal by Subject|0|||
33674734|NCT02647944|63113087|FG001|Overall Study|Withdrawal by Subject|3|||
33674735|NCT02647944|63113086|FG000|Overall Study|Adverse Event|2|||
33674736|NCT02647944|63113087|FG001|Overall Study|Adverse Event|0|||
33674737|NCT01397825|63113142|FG000|Overall Study|Progressive Disease|10|||
33674738|NCT01397825|63113143|FG001|Overall Study|Progressive Disease|3|||
33674739|NCT01397825|63113144|FG002|Overall Study|Progressive Disease|11|||
33674740|NCT01397825|63113145|FG003|Overall Study|Progressive Disease|1|||
33674741|NCT01397825|63113146|FG004|Overall Study|Progressive Disease|0|||
33674742|NCT01397825|63113142|FG000|Overall Study|Symptomatic Deterioration|2|||
33674743|NCT01397825|63113143|FG001|Overall Study|Symptomatic Deterioration|0|||
33674744|NCT01397825|63113144|FG002|Overall Study|Symptomatic Deterioration|4|||
33674745|NCT01397825|63113145|FG003|Overall Study|Symptomatic Deterioration|0|||
33674746|NCT01397825|63113146|FG004|Overall Study|Symptomatic Deterioration|0|||
33674747|NCT01397825|63113142|FG000|Overall Study|Adverse Event|0|||
33674748|NCT01397825|63113143|FG001|Overall Study|Adverse Event|1|||
33674749|NCT01397825|63113144|FG002|Overall Study|Adverse Event|5|||
33674750|NCT01397825|63113145|FG003|Overall Study|Adverse Event|1|||
33674751|NCT01397825|63113146|FG004|Overall Study|Adverse Event|0|||
33674752|NCT01397825|63113142|FG000|Overall Study|Withdrawal by Subject|1|||
33674753|NCT01397825|63113143|FG001|Overall Study|Withdrawal by Subject|0|||
33674754|NCT01397825|63113144|FG002|Overall Study|Withdrawal by Subject|5|||
33674755|NCT01397825|63113145|FG003|Overall Study|Withdrawal by Subject|1|||
33674756|NCT01397825|63113146|FG004|Overall Study|Withdrawal by Subject|0|||
33674757|NCT01397747|63113169|FG000|Overall Study|Multitarget DNA test excluded|689|||
33674758|NCT01397747|63113169|FG000|Overall Study|Colonoscopy excluded|304|||
33674759|NCT01397747|63113169|FG000|Overall Study|FIT excluded|34|||
33674760|NCT01397201|63113207|FG000|Overall Study|Not treated|0|||
33674761|NCT01397201|63113208|FG001|Overall Study|Not treated|0|||
33674762|NCT01397201|63113209|FG002|Overall Study|Not treated|1|||
33674763|NCT01397201|63113210|FG003|Overall Study|Not treated|0|||
33674764|NCT01397201|63113211|FG004|Overall Study|Not treated|0|||
33674765|NCT01397201|63113207|FG000|Overall Study|Not yet defined|3|||
33674766|NCT01397201|63113208|FG001|Overall Study|Not yet defined|6|||
33674767|NCT01397201|63113209|FG002|Overall Study|Not yet defined|5|||
33674768|NCT01397201|63113210|FG003|Overall Study|Not yet defined|5|||
33674769|NCT01397201|63113211|FG004|Overall Study|Not yet defined|4|||
33674770|NCT01397201|63113207|FG000|Overall Study|Adverse Event|2|||
33674771|NCT01397201|63113208|FG001|Overall Study|Adverse Event|0|||
33674772|NCT01397201|63113209|FG002|Overall Study|Adverse Event|0|||
33674773|NCT01397201|63113210|FG003|Overall Study|Adverse Event|0|||
33674774|NCT01397201|63113211|FG004|Overall Study|Adverse Event|0|||
33674775|NCT01393613|63113245|FG000|Overall Study|Adverse Event|11|||
33674776|NCT01393613|63113246|FG001|Overall Study|Adverse Event|11|||
33674777|NCT01393613|63113247|FG002|Overall Study|Adverse Event|13|||
33674778|NCT01393613|63113248|FG003|Overall Study|Adverse Event|22|||
33674779|NCT01393613|63113245|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
33674780|NCT01393613|63113246|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
33674781|NCT01393613|63113247|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
33674782|NCT01393613|63113248|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
33674783|NCT01393613|63113245|FG000|Overall Study|Physician Decision|2|||
33674784|NCT01393613|63113246|FG001|Overall Study|Physician Decision|0|||
33674785|NCT01393613|63113247|FG002|Overall Study|Physician Decision|0|||
33674786|NCT01393613|63113248|FG003|Overall Study|Physician Decision|1|||
33674787|NCT01393613|63113245|FG000|Overall Study|Withdrawal by Subject|15|||
33674788|NCT01393613|63113246|FG001|Overall Study|Withdrawal by Subject|25|||
33674789|NCT01393613|63113247|FG002|Overall Study|Withdrawal by Subject|23|||
33674790|NCT01393613|63113248|FG003|Overall Study|Withdrawal by Subject|21|||
33674791|NCT01393613|63113245|FG000|Overall Study|Protocol Deviation|2|||
33674792|NCT01393613|63113246|FG001|Overall Study|Protocol Deviation|1|||
33674793|NCT01393613|63113247|FG002|Overall Study|Protocol Deviation|0|||
33674794|NCT01393613|63113248|FG003|Overall Study|Protocol Deviation|0|||
33674795|NCT01393613|63113245|FG000|Overall Study|Lack of Efficacy|9|||
33674796|NCT01393613|63113246|FG001|Overall Study|Lack of Efficacy|20|||
33674797|NCT01393613|63113247|FG002|Overall Study|Lack of Efficacy|16|||
33674798|NCT01393613|63113248|FG003|Overall Study|Lack of Efficacy|21|||
33674799|NCT01396421|63113298|FG000|Overall Study|Lost to Follow-up|0|||
33674800|NCT01396421|63113299|FG001|Overall Study|Lost to Follow-up|0|||
33674801|NCT01396421|63113300|FG002|Overall Study|Lost to Follow-up|0|||
33674802|NCT01396421|63113301|FG003|Overall Study|Lost to Follow-up|1|||
33674803|NCT01396421|63113298|FG000|Overall Study|Adverse Event|17|||
33674804|NCT01396421|63113299|FG001|Overall Study|Adverse Event|15|||
33674805|NCT01396421|63113300|FG002|Overall Study|Adverse Event|12|||
33674806|NCT01396421|63113301|FG003|Overall Study|Adverse Event|32|||
33674807|NCT01396421|63113298|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
33674808|NCT01396421|63113299|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
33674809|NCT01396421|63113300|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
33674810|NCT01396421|63113301|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
33674811|NCT01396421|63113298|FG000|Overall Study|Physician Decision|1|||
33674812|NCT01396421|63113299|FG001|Overall Study|Physician Decision|1|||
33674813|NCT01396421|63113300|FG002|Overall Study|Physician Decision|0|||
33674814|NCT01396421|63113301|FG003|Overall Study|Physician Decision|3|||
33674815|NCT01396421|63113298|FG000|Overall Study|Withdrawal by Subject|31|||
33674816|NCT01396421|63113299|FG001|Overall Study|Withdrawal by Subject|24|||
33674817|NCT01396421|63113300|FG002|Overall Study|Withdrawal by Subject|13|||
33674818|NCT01396421|63113301|FG003|Overall Study|Withdrawal by Subject|21|||
33674819|NCT01396421|63113298|FG000|Overall Study|Protocol Deviation|2|||
33674820|NCT01396421|63113299|FG001|Overall Study|Protocol Deviation|1|||
33674821|NCT01396421|63113300|FG002|Overall Study|Protocol Deviation|1|||
33674822|NCT01396421|63113301|FG003|Overall Study|Protocol Deviation|0|||
33674823|NCT01396421|63113298|FG000|Overall Study|Lack of Efficacy|7|||
33674824|NCT01396421|63113299|FG001|Overall Study|Lack of Efficacy|17|||
33674825|NCT01396421|63113300|FG002|Overall Study|Lack of Efficacy|7|||
33674826|NCT01396421|63113301|FG003|Overall Study|Lack of Efficacy|18|||
33674827|NCT01396265|63113359|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
33674828|NCT02647866|63113404|FG000|Overall Study|Adverse Event|0|||
33674829|NCT02647866|63113405|FG001|Overall Study|Adverse Event|0|||
33674830|NCT02647866|63113406|FG002|Overall Study|Adverse Event|2|||
33674831|NCT02647866|63113407|FG003|Overall Study|Adverse Event|2|||
33674832|NCT02647866|63113408|FG004|Overall Study|Adverse Event|1|||
33674833|NCT02647866|63113404|FG000|Overall Study|Disease Worsening|3|||
33674834|NCT02647866|63113405|FG001|Overall Study|Disease Worsening|1|||
33674835|NCT02647866|63113406|FG002|Overall Study|Disease Worsening|0|||
33674836|NCT02647866|63113407|FG003|Overall Study|Disease Worsening|0|||
33674837|NCT02647866|63113408|FG004|Overall Study|Disease Worsening|1|||
33674838|NCT02647866|63113404|FG000|Overall Study|Withdrawal by Subject|1|||
33674839|NCT02647866|63113405|FG001|Overall Study|Withdrawal by Subject|1|||
33674840|NCT02647866|63113406|FG002|Overall Study|Withdrawal by Subject|2|||
33674841|NCT02647866|63113407|FG003|Overall Study|Withdrawal by Subject|4|||
33674842|NCT02647866|63113408|FG004|Overall Study|Withdrawal by Subject|4|||
33674843|NCT02647866|63113404|FG000|Overall Study|Physician Decision|0|||
33674844|NCT02647866|63113405|FG001|Overall Study|Physician Decision|1|||
33674845|NCT02647866|63113406|FG002|Overall Study|Physician Decision|1|||
33674846|NCT02647866|63113407|FG003|Overall Study|Physician Decision|0|||
33674847|NCT02647866|63113408|FG004|Overall Study|Physician Decision|2|||
33674848|NCT02647866|63113404|FG000|Overall Study|Death|0|||
33674849|NCT02647866|63113405|FG001|Overall Study|Death|1|||
33674850|NCT02647866|63113406|FG002|Overall Study|Death|0|||
33674851|NCT02647866|63113407|FG003|Overall Study|Death|0|||
33674852|NCT02647866|63113408|FG004|Overall Study|Death|0|||
33674853|NCT02647866|63113404|FG000|Overall Study|Subject moved to different country|1|||
33674854|NCT02647866|63113405|FG001|Overall Study|Subject moved to different country|0|||
33674855|NCT02647866|63113406|FG002|Overall Study|Subject moved to different country|0|||
33674856|NCT02647866|63113407|FG003|Overall Study|Subject moved to different country|0|||
33674857|NCT02647866|63113408|FG004|Overall Study|Subject moved to different country|0|||
33674858|NCT01396187|63113468|FG000|Overall Study|Adverse Event|0|||
33674859|NCT01396187|63113469|FG001|Overall Study|Adverse Event|1|||
33674860|NCT01396187|63113470|FG002|Overall Study|Adverse Event|0|||
33674861|NCT01396187|63113471|FG003|Overall Study|Adverse Event|0|||
33674862|NCT01396187|63113472|FG004|Overall Study|Adverse Event|0|||
33674863|NCT01396187|63113468|FG000|Overall Study|Withdrawal by Subject|0|||
33674864|NCT01396187|63113469|FG001|Overall Study|Withdrawal by Subject|1|||
33674865|NCT01396187|63113470|FG002|Overall Study|Withdrawal by Subject|1|||
33674866|NCT01396187|63113471|FG003|Overall Study|Withdrawal by Subject|0|||
33674867|NCT01396187|63113472|FG004|Overall Study|Withdrawal by Subject|0|||
33674868|NCT01396187|63113468|FG000|Overall Study|Other|1|||
33674869|NCT01396187|63113469|FG001|Overall Study|Other|1|||
33674870|NCT01396187|63113470|FG002|Overall Study|Other|0|||
33674871|NCT01396187|63113471|FG003|Overall Study|Other|0|||
33674872|NCT01396187|63113472|FG004|Overall Study|Other|1|||
33674873|NCT01392677|63113519|FG000|Overall Study|Adverse Event|3|||
33674874|NCT01392677|63113520|FG001|Overall Study|Adverse Event|1|||
33674875|NCT01392677|63113519|FG000|Overall Study|Withdrawal by Subject|0|||
33674876|NCT01392677|63113520|FG001|Overall Study|Withdrawal by Subject|2|||
33674877|NCT01392677|63113519|FG000|Overall Study|Incorrect enrollment|2|||
33674878|NCT01392677|63113520|FG001|Overall Study|Incorrect enrollment|3|||
33674879|NCT01392677|63113519|FG000|Overall Study|Other reason|3|||
33674880|NCT01392677|63113520|FG001|Overall Study|Other reason|2|||
33674881|NCT01392443|63113569|FG000|Overall Study|Disease progression|30|||
33674882|NCT01392443|63113569|FG000|Overall Study|Adverse Event|24|||
33674883|NCT01392443|63113569|FG000|Overall Study|Death|7|||
33674884|NCT01392443|63113569|FG000|Overall Study|Withdrawal by Subject|5|||
33674885|NCT01392443|63113569|FG000|Overall Study|Lost to Follow-up|1|||
33674886|NCT01392443|63113569|FG000|Overall Study|Protocol Violation|1|||
33674887|NCT01391819|63113573|FG000|Overall Study|Withdrawal by Subject|56|||
33674888|NCT01391819|63113573|FG000|Overall Study|Migrated/moved from study area|82|||
33674889|NCT01391819|63113573|FG000|Overall Study|Lost to Follow-up|252|||
33674890|NCT01391819|63113573|FG000|Overall Study|Death|3|||
33674891|NCT01391819|63113573|FG000|Overall Study|Other|9|||
33674892|NCT03845023|63113584|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
33674893|NCT03845023|63113585|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
33674894|NCT03845023|63113586|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
33674895|NCT03845023|63113587|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
33674896|NCT03845023|63113584|FG000|Follow-Up (14 Days)|Adverse Event|0|||
33674897|NCT03845023|63113585|FG001|Follow-Up (14 Days)|Adverse Event|0|||
33674898|NCT03845023|63113586|FG002|Follow-Up (14 Days)|Adverse Event|1|||
33674899|NCT03845023|63113587|FG003|Follow-Up (14 Days)|Adverse Event|1|||
33674900|NCT01395017|63113649|FG000|Overall Study|Lost to Follow-up|1|||
33674901|NCT01395017|63113650|FG001|Overall Study|Lost to Follow-up|0|||
33674902|NCT01395017|63113649|FG000|Overall Study|Adverse Event|26|||
33674903|NCT01395017|63113650|FG001|Overall Study|Adverse Event|12|||
33674904|NCT01395017|63113649|FG000|Overall Study|Physician Decision|11|||
33674905|NCT01395017|63113650|FG001|Overall Study|Physician Decision|15|||
33674906|NCT01395017|63113649|FG000|Overall Study|Withdrawal by Subject|14|||
33674907|NCT01395017|63113650|FG001|Overall Study|Withdrawal by Subject|8|||
33674908|NCT01395017|63113649|FG000|Overall Study|Protocol deviation|1|||
33674909|NCT01395017|63113650|FG001|Overall Study|Protocol deviation|2|||
33674910|NCT01395017|63113649|FG000|Overall Study|Death|4|||
33674911|NCT01395017|63113650|FG001|Overall Study|Death|3|||
33674912|NCT01395017|63113649|FG000|Overall Study|Disease progression|42|||
33674913|NCT01395017|63113650|FG001|Overall Study|Disease progression|58|||
33674914|NCT01395017|63113649|FG000|Overall Study|Sponsor discontinued study|1|||
33674915|NCT01395017|63113650|FG001|Overall Study|Sponsor discontinued study|4|||
33674916|NCT02647320|63113679|FG000|Overall Study|Adverse Event|0|||
33674917|NCT02647320|63113680|FG001|Overall Study|Adverse Event|1|||
33674918|NCT02647320|63113681|FG002|Overall Study|Adverse Event|3|||
33674919|NCT02647320|63113682|FG003|Overall Study|Adverse Event|2|||
33674920|NCT02647320|63113683|FG004|Overall Study|Adverse Event|1|||
33674921|NCT02647320|63113679|FG000|Overall Study|Protocol Violation|0|||
33674922|NCT02647320|63113680|FG001|Overall Study|Protocol Violation|0|||
33674923|NCT02647320|63113681|FG002|Overall Study|Protocol Violation|3|||
33674924|NCT02647320|63113682|FG003|Overall Study|Protocol Violation|0|||
33674925|NCT02647320|63113683|FG004|Overall Study|Protocol Violation|0|||
33674926|NCT02647320|63113679|FG000|Overall Study|Withdrawal by Subject|7|||
33674927|NCT02647320|63113680|FG001|Overall Study|Withdrawal by Subject|4|||
33674928|NCT02647320|63113681|FG002|Overall Study|Withdrawal by Subject|2|||
33674929|NCT02647320|63113682|FG003|Overall Study|Withdrawal by Subject|2|||
33674930|NCT02647320|63113683|FG004|Overall Study|Withdrawal by Subject|7|||
33674931|NCT02647320|63113679|FG000|Overall Study|Persistent hyperglycemia|0|||
33674932|NCT02647320|63113680|FG001|Overall Study|Persistent hyperglycemia|1|||
33674933|NCT02647320|63113681|FG002|Overall Study|Persistent hyperglycemia|1|||
33674934|NCT02647320|63113682|FG003|Overall Study|Persistent hyperglycemia|1|||
33674935|NCT02647320|63113683|FG004|Overall Study|Persistent hyperglycemia|1|||
33674936|NCT02647320|63113679|FG000|Overall Study|Study terminated by sponsor|1|||
33674937|NCT02647320|63113680|FG001|Overall Study|Study terminated by sponsor|1|||
33674938|NCT02647320|63113681|FG002|Overall Study|Study terminated by sponsor|1|||
33674939|NCT02647320|63113682|FG003|Overall Study|Study terminated by sponsor|1|||
33674940|NCT02647320|63113683|FG004|Overall Study|Study terminated by sponsor|2|||
33674941|NCT02647320|63113679|FG000|Overall Study|Reason not provided|0|||
33674942|NCT02647320|63113680|FG001|Overall Study|Reason not provided|0|||
33674943|NCT02647320|63113681|FG002|Overall Study|Reason not provided|1|||
33674944|NCT02647320|63113682|FG003|Overall Study|Reason not provided|0|||
33674945|NCT02647320|63113683|FG004|Overall Study|Reason not provided|2|||
33674946|NCT02647320|63113679|FG000|Overall Study|Lost to Follow-up|1|||
33674947|NCT02647320|63113680|FG001|Overall Study|Lost to Follow-up|1|||
33674948|NCT02647320|63113681|FG002|Overall Study|Lost to Follow-up|0|||
33674949|NCT02647320|63113682|FG003|Overall Study|Lost to Follow-up|0|||
33674950|NCT02647320|63113683|FG004|Overall Study|Lost to Follow-up|0|||
33674951|NCT02647320|63113679|FG000|Overall Study|Develop anemia|1|||
33674952|NCT02647320|63113680|FG001|Overall Study|Develop anemia|0|||
33674953|NCT02647320|63113681|FG002|Overall Study|Develop anemia|0|||
33674954|NCT02647320|63113682|FG003|Overall Study|Develop anemia|0|||
33674955|NCT02647320|63113683|FG004|Overall Study|Develop anemia|0|||
33674956|NCT02647320|63113679|FG000|Overall Study|Lack of Efficacy|0|||
33674957|NCT02647320|63113680|FG001|Overall Study|Lack of Efficacy|0|||
33674958|NCT02647320|63113681|FG002|Overall Study|Lack of Efficacy|0|||
33674959|NCT02647320|63113682|FG003|Overall Study|Lack of Efficacy|1|||
33674960|NCT02647320|63113683|FG004|Overall Study|Lack of Efficacy|0|||
33674961|NCT02647320|63113679|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
33674962|NCT02647320|63113680|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
33674963|NCT02647320|63113681|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
33674964|NCT02647320|63113682|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
33674965|NCT02647320|63113683|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
33674966|NCT03458325|63113706|FG000|Overall Study|Withdrawal by Subject|1|||
33674967|NCT02646618|63113715|FG000|Overall Study|Lost to Follow-up|10|||
33674968|NCT02646618|63113716|FG001|Overall Study|Lost to Follow-up|14|||
33674969|NCT02644122|63113752|FG000|Overall Study|Withdrawal by Subject|1|||
33674970|NCT01394939|63113778|FG000|Overall Study|Adverse Event|1|||
33674971|NCT01394939|63113779|FG001|Overall Study|Adverse Event|3|||
33674972|NCT01394939|63113780|FG002|Overall Study|Adverse Event|0|||
33674973|NCT01394939|63113781|FG003|Overall Study|Adverse Event|2|||
33674974|NCT01394939|63113778|FG000|Overall Study|Death|0|||
33674975|NCT01394939|63113779|FG001|Overall Study|Death|2|||
33674976|NCT01394939|63113780|FG002|Overall Study|Death|0|||
33674977|NCT01394939|63113781|FG003|Overall Study|Death|0|||
33674978|NCT01394939|63113778|FG000|Overall Study|Physician Decision|0|||
33674979|NCT01394939|63113779|FG001|Overall Study|Physician Decision|1|||
33674980|NCT01394939|63113780|FG002|Overall Study|Physician Decision|0|||
33674981|NCT01394939|63113781|FG003|Overall Study|Physician Decision|0|||
33674982|NCT01394939|63113778|FG000|Overall Study|Withdrawal by Subject|0|||
33674983|NCT01394939|63113779|FG001|Overall Study|Withdrawal by Subject|2|||
33674984|NCT01394939|63113780|FG002|Overall Study|Withdrawal by Subject|0|||
33674985|NCT01394939|63113781|FG003|Overall Study|Withdrawal by Subject|2|||
33674986|NCT01394939|63113778|FG000|Overall Study|Others|0|||
33674987|NCT01394939|63113779|FG001|Overall Study|Others|2|||
33674988|NCT01394939|63113780|FG002|Overall Study|Others|0|||
33674989|NCT01394939|63113781|FG003|Overall Study|Others|3|||
33674990|NCT01394627|63113799|FG000|First Intervention (1 Day)|poor intravenous access|0|||
33674991|NCT01394627|63113800|FG001|First Intervention (1 Day)|poor intravenous access|1|||
33674992|NCT01394627|63113799|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
33674993|NCT01394627|63113800|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
33674994|NCT01391663|63113819|FG000|Overall Study|Withdrawal by Subject|0|||
33674995|NCT01391663|63113820|FG001|Overall Study|Withdrawal by Subject|0|||
33674996|NCT01391663|63113821|FG002|Overall Study|Withdrawal by Subject|1|||
33674997|NCT01391663|63113822|FG003|Overall Study|Withdrawal by Subject|0|||
33674998|NCT02641392|63113843|FG000|Overall Study|Lost to Follow-up|0|||
33674999|NCT02641392|63113844|FG001|Overall Study|Lost to Follow-up|0|||
33675000|NCT02641392|63113845|FG002|Overall Study|Lost to Follow-up|2|||
33675001|NCT02641392|63113843|FG000|Overall Study|Withdrawal by Subject|0|||
33675002|NCT02641392|63113844|FG001|Overall Study|Withdrawal by Subject|0|||
33675003|NCT02641392|63113845|FG002|Overall Study|Withdrawal by Subject|17|||
33675004|NCT02641392|63113843|FG000|Overall Study|Adverse Event|0|||
33675005|NCT02641392|63113844|FG001|Overall Study|Adverse Event|1|||
33675006|NCT02641392|63113845|FG002|Overall Study|Adverse Event|25|||
33675007|NCT02641392|63113843|FG000|Overall Study|Study Terminated by Sponsor|4|||
33675008|NCT02641392|63113844|FG001|Overall Study|Study Terminated by Sponsor|12|||
33675009|NCT02641392|63113845|FG002|Overall Study|Study Terminated by Sponsor|144|||
33675010|NCT02641392|63113843|FG000|Overall Study|Lack of Efficacy|0|||
33675011|NCT02641392|63113844|FG001|Overall Study|Lack of Efficacy|0|||
33675012|NCT02641392|63113845|FG002|Overall Study|Lack of Efficacy|101|||
33675013|NCT02641392|63113843|FG000|Overall Study|Miscellaneous|0|||
33675014|NCT02641392|63113844|FG001|Overall Study|Miscellaneous|0|||
33675015|NCT02641392|63113845|FG002|Overall Study|Miscellaneous|3|||
33675016|NCT02641392|63113843|FG000|Overall Study|Death|0|||
33675017|NCT02641392|63113844|FG001|Overall Study|Death|0|||
33675018|NCT02641392|63113845|FG002|Overall Study|Death|1|||
33675019|NCT04440007|63113855|FG000|Overall Study|Adverse Event|0|||
33675020|NCT04440007|63113856|FG001|Overall Study|Adverse Event|1|||
33675021|NCT04440007|63113855|FG000|Overall Study|Lost to Follow-up|1|||
33675022|NCT04440007|63113856|FG001|Overall Study|Lost to Follow-up|3|||
33675023|NCT04440007|63113855|FG000|Overall Study|Death|7|||
33675024|NCT04440007|63113856|FG001|Overall Study|Death|2|||
33675025|NCT04440007|63113855|FG000|Overall Study|Physician Decision|1|||
33675026|NCT04440007|63113856|FG001|Overall Study|Physician Decision|1|||
33675027|NCT04440007|63113855|FG000|Overall Study|Withdrawal by Subject|2|||
33675028|NCT04440007|63113856|FG001|Overall Study|Withdrawal by Subject|1|||
33675029|NCT04440007|63113855|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
33675030|NCT04440007|63113856|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
33675031|NCT04440007|63113855|FG000|Overall Study|Discontinued prior to dosing|0|||
33675032|NCT04440007|63113856|FG001|Overall Study|Discontinued prior to dosing|2|||
33675033|NCT01391507|63113875|FG000|Overall Study|Death|0|||
33675034|NCT01391507|63113876|FG001|Overall Study|Death|0|||
33675035|NCT01391507|63113877|FG002|Overall Study|Death|0|||
33675036|NCT01391507|63113878|FG003|Overall Study|Death|1|||
33675037|NCT01391507|63113875|FG000|Overall Study|Adverse Event|1|||
33675038|NCT01391507|63113876|FG001|Overall Study|Adverse Event|1|||
33675039|NCT01391507|63113877|FG002|Overall Study|Adverse Event|2|||
33675040|NCT01391507|63113878|FG003|Overall Study|Adverse Event|2|||
33675041|NCT01391507|63113875|FG000|Overall Study|Withdrawal by Subject|1|||
33675042|NCT01391507|63113876|FG001|Overall Study|Withdrawal by Subject|2|||
33675043|NCT01391507|63113877|FG002|Overall Study|Withdrawal by Subject|1|||
33675044|NCT01391507|63113878|FG003|Overall Study|Withdrawal by Subject|1|||
33675045|NCT01391507|63113875|FG000|Overall Study|Lack of Efficacy|0|||
33675046|NCT01391507|63113876|FG001|Overall Study|Lack of Efficacy|0|||
33675047|NCT01391507|63113877|FG002|Overall Study|Lack of Efficacy|0|||
33675048|NCT01391507|63113878|FG003|Overall Study|Lack of Efficacy|1|||
33675049|NCT01391507|63113875|FG000|Overall Study|Protocol Violation|2|||
33675050|NCT01391507|63113876|FG001|Overall Study|Protocol Violation|1|||
33675051|NCT01391507|63113877|FG002|Overall Study|Protocol Violation|1|||
33675052|NCT01391507|63113878|FG003|Overall Study|Protocol Violation|2|||
33675053|NCT01473524|63113900|FG000|DB Phase|Adverse Event|4|||
33675054|NCT01473524|63113901|FG001|DB Phase|Adverse Event|8|||
33675055|NCT01473524|63113902|FG002|DB Phase|Adverse Event|2|||
33675056|NCT01473524|63113903|FG003|DB Phase|Adverse Event|0|||
33675057|NCT01473524|63113904|FG004|DB Phase|Adverse Event|0|||
33675058|NCT01473524|63113905|FG005|DB Phase|Adverse Event|0|||
33675059|NCT01473524|63113900|FG000|DB Phase|Death|1|||
33675060|NCT01473524|63113901|FG001|DB Phase|Death|0|||
33675061|NCT01473524|63113902|FG002|DB Phase|Death|0|||
33675062|NCT01473524|63113903|FG003|DB Phase|Death|0|||
33675063|NCT01473524|63113904|FG004|DB Phase|Death|0|||
33675064|NCT01473524|63113905|FG005|DB Phase|Death|0|||
33675065|NCT01473524|63113900|FG000|DB Phase|Withdrawal by Subject|2|||
33675066|NCT01473524|63113901|FG001|DB Phase|Withdrawal by Subject|1|||
33675067|NCT01473524|63113902|FG002|DB Phase|Withdrawal by Subject|1|||
33675068|NCT01473524|63113903|FG003|DB Phase|Withdrawal by Subject|0|||
33675069|NCT01473524|63113904|FG004|DB Phase|Withdrawal by Subject|0|||
33675070|NCT01473524|63113905|FG005|DB Phase|Withdrawal by Subject|0|||
33675071|NCT01473524|63113900|FG000|LTSE Phase|Withdrawal by Subject|0|||
33675072|NCT01473524|63113901|FG001|LTSE Phase|Withdrawal by Subject|0|||
33675073|NCT01473524|63113902|FG002|LTSE Phase|Withdrawal by Subject|0|||
33675074|NCT01473524|63113903|FG003|LTSE Phase|Withdrawal by Subject|3|||
33675075|NCT01473524|63113904|FG004|LTSE Phase|Withdrawal by Subject|3|||
33675076|NCT01473524|63113905|FG005|LTSE Phase|Withdrawal by Subject|6|||
33675077|NCT01473524|63113900|FG000|LTSE Phase|Death|0|||
33675078|NCT01473524|63113901|FG001|LTSE Phase|Death|0|||
33675079|NCT01473524|63113902|FG002|LTSE Phase|Death|0|||
33675080|NCT01473524|63113903|FG003|LTSE Phase|Death|0|||
33675081|NCT01473524|63113904|FG004|LTSE Phase|Death|1|||
33675082|NCT01473524|63113905|FG005|LTSE Phase|Death|0|||
33675083|NCT01473524|63113900|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
33675084|NCT01473524|63113901|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
33675085|NCT01473524|63113902|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
33675086|NCT01473524|63113903|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
33675087|NCT01473524|63113904|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
33675088|NCT01473524|63113905|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
33675089|NCT01473524|63113900|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
33675090|NCT01473524|63113901|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
33675091|NCT01473524|63113902|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
33675092|NCT01473524|63113903|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
33675093|NCT01473524|63113904|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
33675094|NCT01473524|63113905|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
33675095|NCT01473524|63113900|FG000|LTSE Phase|Lost to Follow-up|0|||
33675096|NCT01473524|63113901|FG001|LTSE Phase|Lost to Follow-up|0|||
33675097|NCT01473524|63113902|FG002|LTSE Phase|Lost to Follow-up|0|||
33675098|NCT01473524|63113903|FG003|LTSE Phase|Lost to Follow-up|1|||
33675099|NCT01473524|63113904|FG004|LTSE Phase|Lost to Follow-up|3|||
33675100|NCT01473524|63113905|FG005|LTSE Phase|Lost to Follow-up|2|||
33675101|NCT01473524|63113900|FG000|LTSE Phase|Principal Investigator Decision|0|||
33675102|NCT01473524|63113901|FG001|LTSE Phase|Principal Investigator Decision|0|||
33675103|NCT01473524|63113902|FG002|LTSE Phase|Principal Investigator Decision|0|||
33675104|NCT01473524|63113903|FG003|LTSE Phase|Principal Investigator Decision|1|||
33675105|NCT01473524|63113904|FG004|LTSE Phase|Principal Investigator Decision|1|||
33675106|NCT01473524|63113905|FG005|LTSE Phase|Principal Investigator Decision|3|||
33675107|NCT01473524|63113900|FG000|LTSE Phase|Liver Transplantation|0|||
33675108|NCT01473524|63113901|FG001|LTSE Phase|Liver Transplantation|0|||
33675109|NCT01473524|63113902|FG002|LTSE Phase|Liver Transplantation|0|||
33675110|NCT01473524|63113903|FG003|LTSE Phase|Liver Transplantation|0|||
33675111|NCT01473524|63113904|FG004|LTSE Phase|Liver Transplantation|0|||
33675112|NCT01473524|63113905|FG005|LTSE Phase|Liver Transplantation|1|||
33675113|NCT01473524|63113900|FG000|LTSE Phase|Pregnancy|0|||
33675114|NCT01473524|63113901|FG001|LTSE Phase|Pregnancy|0|||
33675115|NCT01473524|63113902|FG002|LTSE Phase|Pregnancy|0|||
33675116|NCT01473524|63113903|FG003|LTSE Phase|Pregnancy|1|||
33675117|NCT01473524|63113904|FG004|LTSE Phase|Pregnancy|0|||
33675118|NCT01473524|63113905|FG005|LTSE Phase|Pregnancy|0|||
33675119|NCT01473524|63113900|FG000|LTSE Phase|Protocol Violation|0|||
33675120|NCT01473524|63113901|FG001|LTSE Phase|Protocol Violation|0|||
33675121|NCT01473524|63113902|FG002|LTSE Phase|Protocol Violation|0|||
33675122|NCT01473524|63113903|FG003|LTSE Phase|Protocol Violation|0|||
33675123|NCT01473524|63113904|FG004|LTSE Phase|Protocol Violation|0|||
33675124|NCT01473524|63113905|FG005|LTSE Phase|Protocol Violation|1|||
33675125|NCT01390649|63113936|FG000|Overall Study|Physician Decision|1|||
33675126|NCT01390181|63113940|FG000|Overall Study|Lost to Follow-up|1|||
33675127|NCT01390181|63113940|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
33675128|NCT02641080|63113946|FG000|Overall Study|Physician Decision|2|||
33675129|NCT02641080|63113947|FG001|Overall Study|Physician Decision|0|||
33675130|NCT02641080|63113946|FG000|Overall Study|Withdrawal by Subject|0|||
33675131|NCT02641080|63113947|FG001|Overall Study|Withdrawal by Subject|1|||
33675132|NCT02641080|63113946|FG000|Overall Study|Rehab Center denied use of pumps|0|||
33675133|NCT02641080|63113947|FG001|Overall Study|Rehab Center denied use of pumps|3|||
33675134|NCT02641080|63113946|FG000|Overall Study|Lost to Follow-up|0|||
33675135|NCT02641080|63113947|FG001|Overall Study|Lost to Follow-up|3|||
33675136|NCT01457846|63113955|FG000|Overall Study|Death before treatment|1|||
33675137|NCT01457846|63113956|FG001|Overall Study|Death before treatment|2|||
33675138|NCT01457846|63113955|FG000|Overall Study|Did not receive treatment|0|||
33675139|NCT01457846|63113956|FG001|Overall Study|Did not receive treatment|1|||
33675140|NCT01457846|63113955|FG000|Overall Study|Death|27|||
33675141|NCT01457846|63113956|FG001|Overall Study|Death|16|||
33675142|NCT01457846|63113955|FG000|Overall Study|Unclassified reason for not completed|11|||
33675143|NCT01457846|63113956|FG001|Overall Study|Unclassified reason for not completed|10|||
33675144|NCT01457846|63113955|FG000|Overall Study|Withdrawal by Subject|1|||
33675145|NCT01457846|63113956|FG001|Overall Study|Withdrawal by Subject|1|||
33675146|NCT01457846|63113955|FG000|Overall Study|Lost to Follow-up|1|||
33675147|NCT01457846|63113956|FG001|Overall Study|Lost to Follow-up|0|||
33675148|NCT01496066|63113968|FG000|Overall Study|Lost to Follow-up|8|||
33675149|NCT01496066|63113969|FG001|Overall Study|Lost to Follow-up|5|||
33675150|NCT01496066|63113968|FG000|Overall Study|Explant|3|||
33675151|NCT01496066|63113969|FG001|Overall Study|Explant|0|||
33675152|NCT01496066|63113968|FG000|Overall Study|Death|1|||
33675153|NCT01496066|63113969|FG001|Overall Study|Death|4|||
33675154|NCT01389323|63113982|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
33675155|NCT01389323|63113982|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
33675156|NCT01389323|63113982|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
33675157|NCT01389323|63113982|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
33675158|NCT01389323|63113982|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
33675159|NCT01389323|63113982|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
33675160|NCT01389323|63113982|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
33675161|NCT01389323|63113982|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
33675162|NCT01389323|63113982|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
33675163|NCT01389323|63113982|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
33675164|NCT01389323|63113982|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
33675165|NCT01389245|63113993|FG000|Overall Study|Protocol Violation|10|||
33675166|NCT01389245|63113993|FG000|Overall Study|Lost to Follow-up|3|||
33675167|NCT01389245|63113993|FG000|Overall Study|Withdrawal by Subject|2|||
33675168|NCT01494818|63113999|FG000|Overall Study|Relocation|1|||
33675169|NCT01494818|63114000|FG001|Overall Study|Relocation|2|||
33675170|NCT01494818|63113999|FG000|Overall Study|Lost to Follow-up|1|||
33675171|NCT01494818|63114000|FG001|Overall Study|Lost to Follow-up|0|||
33675172|NCT01494584|63114006|FG000|Overall Study|Study Closed/Terminated|1|||
33675173|NCT01388543|63114031|FG000|Day 14|Adverse Event|1|||
33675174|NCT01388543|63114032|FG001|Day 14|Adverse Event|4|||
33675175|NCT00512317|63114051|FG000|Overall Study|Insufficient clinical response|36|||
33675176|NCT00512317|63114051|FG000|Overall Study|Withdrawal by Subject|23|||
33675177|NCT00512317|63114051|FG000|Overall Study|Sponsor closure of study|21|||
33675178|NCT00512317|63114051|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
33675179|NCT00512317|63114051|FG000|Overall Study|Adverse Event|13|||
33675180|NCT00512317|63114051|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
33675181|NCT00512317|63114051|FG000|Overall Study|Lost to Follow-up|2|||
33675182|NCT00512317|63114051|FG000|Overall Study|Other|2|||
33675183|NCT01494506|63114067|FG000|Overall Study|Lack of Efficacy|77|||
33675184|NCT01494506|63114068|FG001|Overall Study|Lack of Efficacy|83|||
33675185|NCT01494506|63114069|FG002|Overall Study|Lack of Efficacy|57|||
33584189|NCT02488239|62982184|FG000|Overall Study|Physician Decision|2|||
33584190|NCT02488239|62982184|FG000|Overall Study|Consent ineligible|1|||
33584191|NCT02488239|62982184|FG000|Overall Study|Did not undergo implant procedure|1|||
33584192|NCT02488005|62982189|FG000|Overall Study|Lost to Follow-up|2|||
33584193|NCT02487771|62982195|FG000|Overall Study|Lost to Follow-up|2|||
33584194|NCT02487771|62982196|FG001|Overall Study|Lost to Follow-up|3|||
33584195|NCT02487771|62982195|FG000|Overall Study|Moved out of area|5|||
33584196|NCT02487771|62982196|FG001|Overall Study|Moved out of area|6|||
33584197|NCT02487771|62982195|FG000|Overall Study|Withdrawal by Subject|3|||
33584198|NCT02487771|62982196|FG001|Overall Study|Withdrawal by Subject|5|||
33584199|NCT01359943|62982205|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
33584200|NCT01359943|62982206|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
33584201|NCT01359943|62982207|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
33584202|NCT01359943|62982205|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
33584203|NCT01359943|62982206|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
33584204|NCT01359943|62982207|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
33584205|NCT01359943|62982205|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
33584206|NCT01359943|62982206|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
33675186|NCT01494506|63114067|FG000|Overall Study|Adverse Event|17|||
33675187|NCT01494506|63114068|FG001|Overall Study|Adverse Event|10|||
33675188|NCT01494506|63114069|FG002|Overall Study|Adverse Event|11|||
33675189|NCT01494506|63114067|FG000|Overall Study|Death|9|||
33675190|NCT01494506|63114068|FG001|Overall Study|Death|5|||
33675191|NCT01494506|63114069|FG002|Overall Study|Death|2|||
33675192|NCT01494506|63114067|FG000|Overall Study|Physician Decision|7|||
33584207|NCT01359943|62982207|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
33584208|NCT01359943|62982205|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
33675193|NCT01494506|63114068|FG001|Overall Study|Physician Decision|5|||
33675194|NCT01494506|63114069|FG002|Overall Study|Physician Decision|4|||
33675195|NCT01494506|63114067|FG000|Overall Study|Withdrawal by Subject|17|||
33675196|NCT01494506|63114068|FG001|Overall Study|Withdrawal by Subject|20|||
33675197|NCT01494506|63114069|FG002|Overall Study|Withdrawal by Subject|14|||
33675198|NCT01494506|63114067|FG000|Overall Study|Clinical Deterioration|21|||
33675199|NCT01494506|63114068|FG001|Overall Study|Clinical Deterioration|17|||
33675200|NCT01494506|63114069|FG002|Overall Study|Clinical Deterioration|13|||
33675201|NCT01494506|63114067|FG000|Overall Study|Sponsor Decision|0|||
33675202|NCT01494506|63114068|FG001|Overall Study|Sponsor Decision|0|||
33675203|NCT01494506|63114069|FG002|Overall Study|Sponsor Decision|1|||
33675204|NCT01494506|63114067|FG000|Overall Study|Other|0|||
33675205|NCT01494506|63114068|FG001|Overall Study|Other|3|||
33675206|NCT01494506|63114069|FG002|Overall Study|Other|1|||
33675207|NCT02643420|63114081|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
33675208|NCT02643420|63114082|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
33675209|NCT02643420|63114081|FG000|Overall Study|Withdrawal by Subject|25|||
33675210|NCT02643420|63114082|FG001|Overall Study|Withdrawal by Subject|19|||
33675211|NCT02643420|63114081|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
33675212|NCT02643420|63114082|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
33675213|NCT02643420|63114081|FG000|Overall Study|Lost to Follow-up|6|||
33675214|NCT02643420|63114082|FG001|Overall Study|Lost to Follow-up|10|||
33675215|NCT02643420|63114081|FG000|Overall Study|Investigator Decision|2|||
33675216|NCT02643420|63114082|FG001|Overall Study|Investigator Decision|4|||
33675217|NCT02643420|63114081|FG000|Overall Study|Sponsor decision|1|||
33675218|NCT02643420|63114082|FG001|Overall Study|Sponsor decision|1|||
33675219|NCT02643420|63114081|FG000|Overall Study|Death|0|||
33675220|NCT02643420|63114082|FG001|Overall Study|Death|2|||
33675221|NCT02643420|63114081|FG000|Overall Study|Reason not Specified|8|||
33675222|NCT02643420|63114082|FG001|Overall Study|Reason not Specified|7|||
33675223|NCT01456130|63114105|FG000|Overall Study|Adverse Event|4|||
33675224|NCT01456130|63114105|FG000|Overall Study|Voluntary Withdrawal|1|||
33675225|NCT01456130|63114105|FG000|Overall Study|Lack of Efficacy|4|||
33675226|NCT01456130|63114105|FG000|Overall Study|Other|1|||
33675227|NCT01456052|63114112|FG000|Overall Study|Adverse Event|1|||
33675228|NCT01456052|63114113|FG001|Overall Study|Adverse Event|1|||
33675229|NCT01456052|63114114|FG002|Overall Study|Adverse Event|2|||
33675230|NCT01456052|63114112|FG000|Overall Study|Consent withdrawn|0|||
33675231|NCT01456052|63114113|FG001|Overall Study|Consent withdrawn|2|||
33675232|NCT01456052|63114114|FG002|Overall Study|Consent withdrawn|1|||
33675233|NCT01456052|63114112|FG000|Overall Study|Protocol Violation|0|||
33675234|NCT01456052|63114113|FG001|Overall Study|Protocol Violation|1|||
33675235|NCT01456052|63114114|FG002|Overall Study|Protocol Violation|0|||
33675236|NCT01456052|63114112|FG000|Overall Study|Physician Decision|1|||
33675237|NCT01456052|63114113|FG001|Overall Study|Physician Decision|0|||
33675238|NCT01456052|63114114|FG002|Overall Study|Physician Decision|1|||
33675239|NCT01456052|63114112|FG000|Overall Study|Treatment Failure|0|||
33675240|NCT01456052|63114113|FG001|Overall Study|Treatment Failure|1|||
33675241|NCT01456052|63114114|FG002|Overall Study|Treatment Failure|1|||
33675242|NCT01387607|63114125|FG000|Overall Study|Adverse Event|23|||
33675243|NCT01387607|63114126|FG001|Overall Study|Adverse Event|11|||
33675244|NCT01387607|63114125|FG000|Overall Study|Lack of Efficacy|8|||
33675245|NCT01387607|63114126|FG001|Overall Study|Lack of Efficacy|6|||
33675246|NCT01387607|63114125|FG000|Overall Study|Lost to Follow-up|2|||
33675247|NCT01387607|63114126|FG001|Overall Study|Lost to Follow-up|1|||
33675248|NCT01387607|63114125|FG000|Overall Study|No longer meets eligibility criteria|0|||
33675249|NCT01387607|63114126|FG001|Overall Study|No longer meets eligibility criteria|1|||
33675250|NCT01387607|63114125|FG000|Overall Study|Protocol Violation|1|||
33675251|NCT01387607|63114126|FG001|Overall Study|Protocol Violation|5|||
33675252|NCT01387607|63114125|FG000|Overall Study|Withdrawal by Subject|13|||
33675253|NCT01387607|63114126|FG001|Overall Study|Withdrawal by Subject|14|||
33675254|NCT01387607|63114125|FG000|Overall Study|Other|1|||
33675255|NCT01387607|63114126|FG001|Overall Study|Other|1|||
33675256|NCT01387607|63114125|FG000|Overall Study|Randomized, not treated|3|||
33675257|NCT01387607|63114126|FG001|Overall Study|Randomized, not treated|6|||
33675258|NCT03451045|63114135|FG000|Overall Study|Lack of Efficacy|3|||
33675259|NCT03451045|63114136|FG001|Overall Study|Lack of Efficacy|2|||
33675260|NCT03451045|63114137|FG002|Overall Study|Lack of Efficacy|2|||
33675261|NCT03451045|63114135|FG000|Overall Study|Physician Decision|1|||
33675262|NCT03451045|63114136|FG001|Overall Study|Physician Decision|1|||
33675263|NCT03451045|63114137|FG002|Overall Study|Physician Decision|1|||
33675264|NCT03451045|63114135|FG000|Overall Study|Withdrawal by Subject|4|||
33675265|NCT03451045|63114136|FG001|Overall Study|Withdrawal by Subject|0|||
33675266|NCT03451045|63114137|FG002|Overall Study|Withdrawal by Subject|5|||
33675267|NCT03451045|63114135|FG000|Overall Study|Pregnancy|0|||
33675268|NCT03451045|63114136|FG001|Overall Study|Pregnancy|0|||
33675269|NCT03451045|63114137|FG002|Overall Study|Pregnancy|2|||
33675270|NCT03451045|63114135|FG000|Overall Study|Adverse Event|7|||
33675271|NCT03451045|63114136|FG001|Overall Study|Adverse Event|1|||
33584209|NCT01359943|62982206|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
33584210|NCT01359943|62982207|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
33584211|NCT01359943|62982205|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
33584212|NCT01359943|62982206|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
33584213|NCT01359943|62982207|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
33584214|NCT01359943|62982205|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
33584215|NCT01359943|62982206|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
33584216|NCT01359943|62982207|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
33584217|NCT01359943|62982205|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
33584218|NCT01359943|62982206|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
33584219|NCT01359943|62982207|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
33584220|NCT01359943|62982205|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
33584221|NCT01359943|62982206|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
33584222|NCT01359943|62982207|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
33584223|NCT01359943|62982205|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
33584224|NCT01359943|62982206|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
33584225|NCT01359943|62982207|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
33584226|NCT01359943|62982205|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
33584227|NCT01359943|62982206|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
33584228|NCT01359943|62982207|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
33584229|NCT01359943|62982205|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
33584230|NCT01359943|62982206|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
33584231|NCT01359943|62982207|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
33584232|NCT01359943|62982205|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
33584233|NCT01359943|62982206|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
33584234|NCT01359943|62982207|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
33584235|NCT01359943|62982205|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
33584236|NCT01359943|62982206|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
33584237|NCT01359943|62982207|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
33584238|NCT01359943|62982205|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
33584239|NCT01359943|62982206|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
33584240|NCT01359943|62982207|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
33584241|NCT01359943|62982205|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
33584242|NCT01359943|62982206|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
33584243|NCT01359943|62982207|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
33584244|NCT02432703|62982219|FG000|Overall Study|Adverse Event|1|||
33584245|NCT02432703|62982220|FG001|Overall Study|Adverse Event|4|||
33584246|NCT02432703|62982219|FG000|Overall Study|Lack of Efficacy|1|||
33584247|NCT02432703|62982220|FG001|Overall Study|Lack of Efficacy|0|||
33584248|NCT02432703|62982219|FG000|Overall Study|Lost to Follow-up|5|||
33584249|NCT02432703|62982220|FG001|Overall Study|Lost to Follow-up|3|||
33584250|NCT02432703|62982219|FG000|Overall Study|Withdrawal by Subject|9|||
33584251|NCT02432703|62982220|FG001|Overall Study|Withdrawal by Subject|6|||
33584252|NCT02432703|62982219|FG000|Overall Study|Other|6|||
33584253|NCT02432703|62982220|FG001|Overall Study|Other|5|||
33584254|NCT02486757|62982226|FG000|Overall Study|Lost to Follow-up|1|||
33584255|NCT02418819|62982234|FG000|Overall Study|Adverse Event|0|||
33584256|NCT02418819|62982235|FG001|Overall Study|Adverse Event|0|||
33584257|NCT02418819|62982236|FG002|Overall Study|Adverse Event|1|||
33584258|NCT02418819|62982237|FG003|Overall Study|Adverse Event|0|||
33584259|NCT02418819|62982234|FG000|Overall Study|Lost to Follow-up|1|||
33584260|NCT02418819|62982235|FG001|Overall Study|Lost to Follow-up|0|||
33584261|NCT02418819|62982236|FG002|Overall Study|Lost to Follow-up|0|||
33584262|NCT02418819|62982237|FG003|Overall Study|Lost to Follow-up|0|||
33584263|NCT02418819|62982234|FG000|Overall Study|No longer meets eligibility criteria|0|||
33584264|NCT02418819|62982235|FG001|Overall Study|No longer meets eligibility criteria|0|||
33584265|NCT02418819|62982236|FG002|Overall Study|No longer meets eligibility criteria|1|||
33584266|NCT02418819|62982237|FG003|Overall Study|No longer meets eligibility criteria|0|||
33584267|NCT02418819|62982234|FG000|Overall Study|No longer willing to participate|0|||
33584268|NCT02418819|62982235|FG001|Overall Study|No longer willing to participate|0|||
33584269|NCT02418819|62982236|FG002|Overall Study|No longer willing to participate|2|||
33584270|NCT02418819|62982237|FG003|Overall Study|No longer willing to participate|1|||
33584271|NCT02576639|62982252|FG000|Overall Study|Withdrawal by Subject|1|||
33584272|NCT02576639|62982253|FG001|Overall Study|Withdrawal by Subject|2|||
33584273|NCT02576639|62982254|FG002|Overall Study|Withdrawal by Subject|1|||
33584274|NCT02576639|62982255|FG003|Overall Study|Withdrawal by Subject|0|||
33584275|NCT02576639|62982256|FG004|Overall Study|Withdrawal by Subject|1|||
33584276|NCT02576639|62982252|FG000|Overall Study|Adverse Event|1|||
33584277|NCT02576639|62982253|FG001|Overall Study|Adverse Event|0|||
33584278|NCT02576639|62982254|FG002|Overall Study|Adverse Event|1|||
33584279|NCT02576639|62982255|FG003|Overall Study|Adverse Event|1|||
33675272|NCT03451045|63114137|FG002|Overall Study|Adverse Event|3|||
33675273|NCT03451045|63114135|FG000|Overall Study|Non-compliance with study|2|||
33675274|NCT03451045|63114136|FG001|Overall Study|Non-compliance with study|0|||
33675275|NCT03451045|63114137|FG002|Overall Study|Non-compliance with study|1|||
33675276|NCT03451045|63114135|FG000|Overall Study|any other reason|10|||
33675277|NCT03451045|63114136|FG001|Overall Study|any other reason|2|||
33675278|NCT03451045|63114137|FG002|Overall Study|any other reason|13|||
33675279|NCT03219567|63114148|FG000|Overall Study|Withdrawal by Subject|0|||
33675280|NCT03219567|63114149|FG001|Overall Study|Withdrawal by Subject|1|||
33675281|NCT01386125|63114158|FG000|Overall Study|Lost to Follow-up|3|||
33675282|NCT01386125|63114159|FG001|Overall Study|Lost to Follow-up|9|||
33675283|NCT01386125|63114158|FG000|Overall Study|Physician Decision|0|||
33675284|NCT01386125|63114159|FG001|Overall Study|Physician Decision|1|||
33675285|NCT01386125|63114158|FG000|Overall Study|Protocol Violation|5|||
33675286|NCT01386125|63114159|FG001|Overall Study|Protocol Violation|7|||
33675287|NCT01386125|63114158|FG000|Overall Study|Disease Progress|1|||
33675288|NCT01386125|63114159|FG001|Overall Study|Disease Progress|2|||
33675289|NCT01386125|63114158|FG000|Overall Study|Withdrawal by Subject|13|||
33675290|NCT01386125|63114159|FG001|Overall Study|Withdrawal by Subject|12|||
33675291|NCT01386125|63114158|FG000|Overall Study|Adverse Event|2|||
33675292|NCT01386125|63114159|FG001|Overall Study|Adverse Event|5|||
33675293|NCT01386125|63114158|FG000|Overall Study|Lack of Efficacy|0|||
33675294|NCT01386125|63114159|FG001|Overall Study|Lack of Efficacy|1|||
33675295|NCT01386125|63114158|FG000|Overall Study|Participant Leaving Country|1|||
33675296|NCT01386125|63114159|FG001|Overall Study|Participant Leaving Country|0|||
33675297|NCT01384877|63114167|FG000|Treatment 2|Lost to Follow-up|2|||
33675298|NCT01384877|63114168|FG001|Treatment 2|Lost to Follow-up|2|||
33675299|NCT00114517|63114178|FG000|Overall Study|Adverse Event|6|||
33675300|NCT00114517|63114179|FG001|Overall Study|Adverse Event|1|||
33675301|NCT00114517|63114180|FG002|Overall Study|Adverse Event|6|||
33675302|NCT00114517|63114181|FG003|Overall Study|Adverse Event|3|||
33675303|NCT00114517|63114178|FG000|Overall Study|Lost to Follow-up|2|||
33675304|NCT00114517|63114179|FG001|Overall Study|Lost to Follow-up|2|||
33675305|NCT00114517|63114180|FG002|Overall Study|Lost to Follow-up|2|||
33675306|NCT00114517|63114181|FG003|Overall Study|Lost to Follow-up|1|||
33675307|NCT00114517|63114178|FG000|Overall Study|Too busy|3|||
33675308|NCT00114517|63114179|FG001|Overall Study|Too busy|1|||
33675309|NCT00114517|63114180|FG002|Overall Study|Too busy|1|||
33675310|NCT00114517|63114181|FG003|Overall Study|Too busy|2|||
33675311|NCT00114517|63114178|FG000|Overall Study|Moved from area|0|||
33675312|NCT00114517|63114179|FG001|Overall Study|Moved from area|3|||
33675313|NCT00114517|63114180|FG002|Overall Study|Moved from area|2|||
33675314|NCT00114517|63114181|FG003|Overall Study|Moved from area|1|||
33675315|NCT00114517|63114178|FG000|Overall Study|Did not want estradiol|1|||
33675316|NCT00114517|63114179|FG001|Overall Study|Did not want estradiol|1|||
33675317|NCT00114517|63114180|FG002|Overall Study|Did not want estradiol|0|||
33675318|NCT00114517|63114181|FG003|Overall Study|Did not want estradiol|0|||
33675319|NCT00114517|63114178|FG000|Overall Study|Armed-services duty|0|||
33675320|NCT00114517|63114179|FG001|Overall Study|Armed-services duty|1|||
33675321|NCT00114517|63114180|FG002|Overall Study|Armed-services duty|0|||
33675322|NCT00114517|63114181|FG003|Overall Study|Armed-services duty|1|||
33675323|NCT00114517|63114178|FG000|Overall Study|Competing family issue|0|||
33675324|NCT00114517|63114179|FG001|Overall Study|Competing family issue|1|||
33675325|NCT00114517|63114180|FG002|Overall Study|Competing family issue|0|||
33675326|NCT00114517|63114181|FG003|Overall Study|Competing family issue|1|||
33675327|NCT00114517|63114178|FG000|Overall Study|Physician Decision|0|||
33675328|NCT00114517|63114179|FG001|Overall Study|Physician Decision|1|||
33675329|NCT00114517|63114180|FG002|Overall Study|Physician Decision|0|||
33675330|NCT00114517|63114181|FG003|Overall Study|Physician Decision|0|||
33675331|NCT00114517|63114178|FG000|Overall Study|Lost interest|0|||
33675332|NCT00114517|63114179|FG001|Overall Study|Lost interest|0|||
33675333|NCT00114517|63114180|FG002|Overall Study|Lost interest|1|||
33675334|NCT00114517|63114181|FG003|Overall Study|Lost interest|0|||
33584280|NCT02576639|62982256|FG004|Overall Study|Adverse Event|2|||
33584281|NCT02576639|62982252|FG000|Overall Study|Physician Decision|0|||
33584282|NCT02576639|62982253|FG001|Overall Study|Physician Decision|0|||
33584283|NCT02576639|62982254|FG002|Overall Study|Physician Decision|0|||
33584284|NCT02576639|62982255|FG003|Overall Study|Physician Decision|0|||
33584285|NCT02576639|62982256|FG004|Overall Study|Physician Decision|1|||
33584286|NCT02418585|62982274|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
33584287|NCT02418585|62982275|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
33584288|NCT02418585|62982274|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
33584289|NCT02418585|62982275|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
33675335|NCT00114517|63114178|FG000|Overall Study|Weight increase|0|||
33675336|NCT00114517|63114179|FG001|Overall Study|Weight increase|0|||
33675337|NCT00114517|63114180|FG002|Overall Study|Weight increase|1|||
33675338|NCT00114517|63114181|FG003|Overall Study|Weight increase|0|||
33675339|NCT00114517|63114178|FG000|Overall Study|Concern about blood clots|0|||
33675340|NCT00114517|63114179|FG001|Overall Study|Concern about blood clots|0|||
33675341|NCT00114517|63114180|FG002|Overall Study|Concern about blood clots|1|||
33675342|NCT00114517|63114181|FG003|Overall Study|Concern about blood clots|0|||
33675343|NCT00114517|63114178|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
33675344|NCT00114517|63114179|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
33675345|NCT00114517|63114180|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
33675346|NCT00114517|63114181|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
33675347|NCT01384019|63114234|FG000|Overall Study|Withdrawal by Subject|3|||
33675348|NCT01384019|63114235|FG001|Overall Study|Withdrawal by Subject|0|||
33675349|NCT01384019|63114234|FG000|Overall Study|Death|1|||
33675350|NCT01384019|63114235|FG001|Overall Study|Death|0|||
33675351|NCT01384019|63114234|FG000|Overall Study|MRI refusal|6|||
33675352|NCT01384019|63114235|FG001|Overall Study|MRI refusal|6|||
33675353|NCT00033631|63114243|FG000|Overall Study|Protocol Violation|14|||
33675354|NCT00033631|63114244|FG001|Overall Study|Protocol Violation|11|||
33675355|NCT00033631|63114243|FG000|Overall Study|Withdrawal by Subject|4|||
33675356|NCT00033631|63114244|FG001|Overall Study|Withdrawal by Subject|4|||
33675357|NCT01471574|63114255|FG000|Treatment Period|Lack of Efficacy|12|||
33675358|NCT01471574|63114256|FG001|Treatment Period|Lack of Efficacy|4|||
33675359|NCT01471574|63114257|FG002|Treatment Period|Lack of Efficacy|14|||
33675360|NCT01471574|63114258|FG003|Treatment Period|Lack of Efficacy|1|||
33675361|NCT01471574|63114255|FG000|Treatment Period|Adverse Event|7|||
33675362|NCT01471574|63114256|FG001|Treatment Period|Adverse Event|3|||
33675363|NCT01471574|63114257|FG002|Treatment Period|Adverse Event|6|||
33675364|NCT01471574|63114258|FG003|Treatment Period|Adverse Event|1|||
33675365|NCT01471574|63114255|FG000|Treatment Period|Withdrawal by Subject|5|||
33675366|NCT01471574|63114256|FG001|Treatment Period|Withdrawal by Subject|1|||
33675367|NCT01471574|63114257|FG002|Treatment Period|Withdrawal by Subject|1|||
33675368|NCT01471574|63114258|FG003|Treatment Period|Withdrawal by Subject|0|||
33675369|NCT01471574|63114255|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
33675370|NCT01471574|63114256|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
33675371|NCT01471574|63114257|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
33675372|NCT01471574|63114258|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
33675373|NCT01471574|63114255|FG000|Treatment Period|Lost to Follow-up|1|||
33675374|NCT01471574|63114256|FG001|Treatment Period|Lost to Follow-up|2|||
33675375|NCT01471574|63114257|FG002|Treatment Period|Lost to Follow-up|2|||
33675376|NCT01471574|63114258|FG003|Treatment Period|Lost to Follow-up|0|||
33675377|NCT01471574|63114255|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
33675378|NCT01471574|63114256|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
33675379|NCT01471574|63114257|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
33675380|NCT01471574|63114258|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
33675381|NCT01471574|63114255|FG000|Treatment Period|Other|1|||
33675382|NCT01471574|63114256|FG001|Treatment Period|Other|0|||
33675383|NCT01471574|63114257|FG002|Treatment Period|Other|0|||
33675384|NCT01471574|63114258|FG003|Treatment Period|Other|0|||
33675385|NCT01471574|63114255|FG000|Follow-up Period|Withdrawal by Subject|3|||
33675386|NCT01471574|63114256|FG001|Follow-up Period|Withdrawal by Subject|0|||
33675387|NCT01471574|63114257|FG002|Follow-up Period|Withdrawal by Subject|3|||
33675388|NCT01471574|63114258|FG003|Follow-up Period|Withdrawal by Subject|1|||
33675389|NCT01471574|63114255|FG000|Follow-up Period|Lost to Follow-up|4|||
33675390|NCT01471574|63114256|FG001|Follow-up Period|Lost to Follow-up|1|||
33675391|NCT01471574|63114257|FG002|Follow-up Period|Lost to Follow-up|3|||
33675392|NCT01471574|63114258|FG003|Follow-up Period|Lost to Follow-up|2|||
33675393|NCT01471574|63114255|FG000|Follow-up Period|Death|0|||
33675394|NCT01471574|63114256|FG001|Follow-up Period|Death|0|||
33675395|NCT01471574|63114257|FG002|Follow-up Period|Death|1|||
33675396|NCT01471574|63114258|FG003|Follow-up Period|Death|0|||
33675397|NCT01471574|63114255|FG000|Follow-up Period|Follow-up no longer required|0|||
33675398|NCT01471574|63114256|FG001|Follow-up Period|Follow-up no longer required|1|||
33675399|NCT01471574|63114257|FG002|Follow-up Period|Follow-up no longer required|0|||
33675400|NCT01471574|63114258|FG003|Follow-up Period|Follow-up no longer required|0|||
33675401|NCT01383707|63114274|FG000|Overall Study|Consent withdrawal|6|||
33675402|NCT01383707|63114274|FG000|Overall Study|Death|19|||
33675403|NCT01383707|63114274|FG000|Overall Study|Other|8|||
33675404|NCT01383707|63114274|FG000|Overall Study|Sponsor's decision|2|||
33675405|NCT01383707|63114274|FG000|Overall Study|Adverse Event|14|||
33675406|NCT01383707|63114274|FG000|Overall Study|Progressive disease|23|||
33310655|NCT01239342|62686051|FG000|Overall Study|Reason Unknown|1|||
33675407|NCT01383317|63114280|FG000|Overall Study|Lost to Follow-up|2|||
33675408|NCT01383317|63114281|FG001|Overall Study|Lost to Follow-up|1|||
33675409|NCT01383317|63114280|FG000|Overall Study|Death|1|||
33675410|NCT01383317|63114281|FG001|Overall Study|Death|0|||
33675411|NCT01383317|63114280|FG000|Overall Study|Adverse Event|0|||
33675412|NCT01383317|63114281|FG001|Overall Study|Adverse Event|1|||
33675413|NCT01455428|63114289|FG000|Overall Study|Protocol Violation|2|||
33675414|NCT01455428|63114290|FG001|Overall Study|Protocol Violation|1|||
33675415|NCT01455428|63114289|FG000|Overall Study|Adverse Event|6|||
33675416|NCT01455428|63114290|FG001|Overall Study|Adverse Event|2|||
33675417|NCT01455428|63114289|FG000|Overall Study|Lost to Follow-up|1|||
33675418|NCT01455428|63114290|FG001|Overall Study|Lost to Follow-up|1|||
33675419|NCT01455428|63114289|FG000|Overall Study|Withdrawal by Subject|2|||
33675420|NCT01455428|63114290|FG001|Overall Study|Withdrawal by Subject|5|||
33675421|NCT01455428|63114289|FG000|Overall Study|Did not meet entrance criteria|0|||
33675422|NCT01455428|63114290|FG001|Overall Study|Did not meet entrance criteria|2|||
33675423|NCT01455428|63114289|FG000|Overall Study|Insufficient clinical response|0|||
33675424|NCT01455428|63114290|FG001|Overall Study|Insufficient clinical response|2|||
33675425|NCT01455428|63114289|FG000|Overall Study|Did not receive treatment|1|||
33675426|NCT01455428|63114290|FG001|Overall Study|Did not receive treatment|1|||
33675427|NCT01455428|63114289|FG000|Overall Study|Other|2|||
33675428|NCT01455428|63114290|FG001|Overall Study|Other|4|||
33675429|NCT01383161|63114298|FG000|Overall Study|Adverse Event|5|||
33675430|NCT01383161|63114299|FG001|Overall Study|Adverse Event|1|||
33675431|NCT01383161|63114298|FG000|Overall Study|Withdrawal by Subject|0|||
33675432|NCT01383161|63114299|FG001|Overall Study|Withdrawal by Subject|2|||
33675433|NCT01383161|63114298|FG000|Overall Study|Lack of Efficacy|0|||
33675434|NCT01383161|63114299|FG001|Overall Study|Lack of Efficacy|1|||
33675435|NCT01382225|63114325|FG000|Overall Study|Adverse Event|3|||
33675436|NCT01382225|63114326|FG001|Overall Study|Adverse Event|2|||
33675437|NCT01382225|63114325|FG000|Overall Study|Protocol Violation|2|||
33675438|NCT01382225|63114326|FG001|Overall Study|Protocol Violation|1|||
33675439|NCT01382225|63114325|FG000|Overall Study|Subject Withdrew Consent|5|||
33675440|NCT01382225|63114326|FG001|Overall Study|Subject Withdrew Consent|2|||
33675441|NCT01382225|63114325|FG000|Overall Study|Other|4|||
33675442|NCT01382225|63114326|FG001|Overall Study|Other|2|||
33675443|NCT01381679|63114332|FG000|Overall Study|Adverse Event|3|||
33675444|NCT01381679|63114332|FG000|Overall Study|Lost to Follow-up|885|||
33675445|NCT01455194|63114339|FG000|Overall Study|Screen Failure|20|||
33675446|NCT01455194|63114340|FG001|Overall Study|Screen Failure|0|||
33675447|NCT01455194|63114341|FG002|Overall Study|Screen Failure|0|||
33675448|NCT01455194|63114342|FG003|Overall Study|Screen Failure|0|||
33675449|NCT01455194|63114339|FG000|Overall Study|Randomisation Failure|90|||
33675450|NCT01455194|63114340|FG001|Overall Study|Randomisation Failure|0|||
33675451|NCT01455194|63114341|FG002|Overall Study|Randomisation Failure|0|||
33675452|NCT01455194|63114342|FG003|Overall Study|Randomisation Failure|0|||
33675453|NCT01455194|63114339|FG000|Overall Study|Deterioration in asthma|12|||
33675454|NCT01455194|63114340|FG001|Overall Study|Deterioration in asthma|6|||
33675455|NCT01455194|63114341|FG002|Overall Study|Deterioration in asthma|14|||
33675456|NCT01455194|63114342|FG003|Overall Study|Deterioration in asthma|9|||
33675457|NCT01455194|63114339|FG000|Overall Study|Adverse Event|1|||
33675458|NCT01455194|63114340|FG001|Overall Study|Adverse Event|1|||
33675459|NCT01455194|63114341|FG002|Overall Study|Adverse Event|1|||
33675460|NCT01455194|63114342|FG003|Overall Study|Adverse Event|3|||
33675461|NCT01455194|63114339|FG000|Overall Study|Withdrawal by Subject|21|||
33675462|NCT01455194|63114340|FG001|Overall Study|Withdrawal by Subject|16|||
33675463|NCT01455194|63114341|FG002|Overall Study|Withdrawal by Subject|12|||
33675464|NCT01455194|63114342|FG003|Overall Study|Withdrawal by Subject|9|||
33675465|NCT01455194|63114339|FG000|Overall Study|Lost to Follow-up|2|||
33675466|NCT01455194|63114340|FG001|Overall Study|Lost to Follow-up|0|||
33675467|NCT01455194|63114341|FG002|Overall Study|Lost to Follow-up|1|||
33675468|NCT01455194|63114342|FG003|Overall Study|Lost to Follow-up|1|||
33675469|NCT01455194|63114339|FG000|Overall Study|Pregnancy|0|||
33675470|NCT01455194|63114340|FG001|Overall Study|Pregnancy|1|||
33675471|NCT01455194|63114341|FG002|Overall Study|Pregnancy|1|||
33675472|NCT01455194|63114342|FG003|Overall Study|Pregnancy|0|||
33675473|NCT01455194|63114339|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
33675474|NCT01455194|63114340|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
33675475|NCT01455194|63114341|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
33675476|NCT01455194|63114342|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
33675477|NCT01455194|63114339|FG000|Overall Study|Miscellaneous|4|||
33675478|NCT01455194|63114340|FG001|Overall Study|Miscellaneous|5|||
33675479|NCT01455194|63114341|FG002|Overall Study|Miscellaneous|1|||
33675480|NCT01455194|63114342|FG003|Overall Study|Miscellaneous|4|||
33675481|NCT01454726|63114366|FG000|Overall Study|Withdrawal by Subject|0|||
33675482|NCT01454726|63114367|FG001|Overall Study|Withdrawal by Subject|1|||
33675483|NCT01361568|63114379|FG000|Overall Study|Adverse Event|0|||
33675484|NCT01361568|63114380|FG001|Overall Study|Adverse Event|0|||
33675485|NCT01361568|63114381|FG002|Overall Study|Adverse Event|0|||
33675486|NCT01361568|63114382|FG003|Overall Study|Adverse Event|0|||
33675487|NCT01361568|63114383|FG004|Overall Study|Adverse Event|1|||
33675488|NCT01361568|63114384|FG005|Overall Study|Adverse Event|0|||
33675489|NCT01361568|63114379|FG000|Overall Study|Physician Decision|0|||
33675490|NCT01361568|63114380|FG001|Overall Study|Physician Decision|0|||
33675491|NCT01361568|63114381|FG002|Overall Study|Physician Decision|0|||
33675492|NCT01361568|63114382|FG003|Overall Study|Physician Decision|0|||
33675493|NCT01361568|63114383|FG004|Overall Study|Physician Decision|0|||
33675494|NCT01361568|63114384|FG005|Overall Study|Physician Decision|1|||
33675495|NCT01361568|63114379|FG000|Overall Study|Withdrawal by Subject|2|||
33675496|NCT01361568|63114380|FG001|Overall Study|Withdrawal by Subject|1|||
33675497|NCT01361568|63114381|FG002|Overall Study|Withdrawal by Subject|0|||
33675498|NCT01361568|63114382|FG003|Overall Study|Withdrawal by Subject|0|||
33675499|NCT01361568|63114383|FG004|Overall Study|Withdrawal by Subject|0|||
33675500|NCT01361568|63114384|FG005|Overall Study|Withdrawal by Subject|1|||
33675501|NCT03084367|63114399|FG000|Overall Study|Lost to Follow-up|32|||
33675502|NCT03084367|63114399|FG000|Overall Study|Withdrawal by Subject|4|||
33675503|NCT03084367|63114399|FG000|Overall Study|Other|1|||
33675504|NCT01454570|63114412|FG000|Overall Study|Withdrawal by Subject|2|||
33675505|NCT01454570|63114412|FG000|Overall Study|Screen Failure|7|||
33675506|NCT01494350|63114425|FG000|Overall Study|Worsening of lesion|1|||
33675507|NCT03281629|63114435|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
33675508|NCT03281629|63114436|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
33675509|NCT03281629|63114435|FG000|Overall Study|Death|0|||
33675510|NCT03281629|63114436|FG001|Overall Study|Death|1|||
33675511|NCT03281629|63114435|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
33675512|NCT03281629|63114436|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
33675513|NCT00218543|63114442|FG000|Overall Study|Lost to Follow-up|8|||
33675514|NCT00218543|63114442|FG000|Overall Study|relocated|1|||
33675515|NCT00218543|63114442|FG000|Overall Study|Withdrawal by Subject|1|||
33675516|NCT00218543|63114442|FG000|Overall Study|Physician Decision|3|||
33675517|NCT00218543|63114442|FG000|Overall Study|Adverse Event|2|||
33675518|NCT00216671|63114457|FG000|Overall Study|Adverse Event|4|||
33675519|NCT00216671|63114458|FG001|Overall Study|Adverse Event|9|||
33675520|NCT00216671|63114457|FG000|Overall Study|Pregnancy|0|||
33675521|NCT00216671|63114458|FG001|Overall Study|Pregnancy|1|||
33675522|NCT00216671|63114457|FG000|Overall Study|Withdrawal by Subject|4|||
33675523|NCT00216671|63114458|FG001|Overall Study|Withdrawal by Subject|2|||
33675524|NCT00216671|63114457|FG000|Overall Study|Refused Injections|3|||
33675525|NCT00216671|63114458|FG001|Overall Study|Refused Injections|13|||
33675526|NCT00216671|63114457|FG000|Overall Study|No Need to Continue Medication|1|||
33675527|NCT00216671|63114458|FG001|Overall Study|No Need to Continue Medication|1|||
33675528|NCT00216671|63114457|FG000|Overall Study|Insufficient Response|9|||
33675529|NCT00216671|63114458|FG001|Overall Study|Insufficient Response|4|||
33675530|NCT00216671|63114457|FG000|Overall Study|Lost to Follow-up|3|||
33675531|NCT00216671|63114458|FG001|Overall Study|Lost to Follow-up|5|||
33675532|NCT00216671|63114457|FG000|Overall Study|Non compliant|2|||
33675533|NCT00216671|63114458|FG001|Overall Study|Non compliant|2|||
33675534|NCT00216671|63114457|FG000|Overall Study|Ineligible|0|||
33675535|NCT00216671|63114458|FG001|Overall Study|Ineligible|2|||
33675536|NCT00216671|63114457|FG000|Overall Study|Physician Decision|1|||
33675537|NCT00216671|63114458|FG001|Overall Study|Physician Decision|1|||
33675538|NCT00216671|63114457|FG000|Overall Study|Protocol Violation|3|||
33675539|NCT00216671|63114458|FG001|Overall Study|Protocol Violation|5|||
33675540|NCT00216671|63114457|FG000|Overall Study|Relapse|1|||
33675541|NCT00216671|63114458|FG001|Overall Study|Relapse|0|||
33675542|NCT00216671|63114457|FG000|Overall Study|Investigator Illness|0|||
33675543|NCT00216671|63114458|FG001|Overall Study|Investigator Illness|1|||
33675544|NCT00216671|63114457|FG000|Overall Study|Patient Moved|0|||
33675545|NCT00216671|63114458|FG001|Overall Study|Patient Moved|1|||
33675546|NCT00216671|63114457|FG000|Overall Study|Ineligible, no efficacy data|2|||
33675547|NCT00216671|63114458|FG001|Overall Study|Ineligible, no efficacy data|2|||
33675548|NCT00216671|63114457|FG000|Overall Study|Insufficient Response Adverse Event|2|||
33675549|NCT00216671|63114458|FG001|Overall Study|Insufficient Response Adverse Event|1|||
33675550|NCT00216203|63114464|FG000|Overall Study|Withdrawal by Subject|2|||
33675551|NCT02644668|63114499|FG000|Overall Study|Adverse Event|2|||
33675552|NCT02644668|63114500|FG001|Overall Study|Adverse Event|0|||
33675553|NCT02644668|63114501|FG002|Overall Study|Adverse Event|1|||
33675554|NCT02644668|63114499|FG000|Overall Study|Protocol Violation|0|||
33675555|NCT02644668|63114500|FG001|Overall Study|Protocol Violation|0|||
33675556|NCT02644668|63114501|FG002|Overall Study|Protocol Violation|1|||
33675557|NCT02644668|63114499|FG000|Overall Study|Withdrawal by Subject|0|||
33675558|NCT02644668|63114500|FG001|Overall Study|Withdrawal by Subject|0|||
33675559|NCT02644668|63114501|FG002|Overall Study|Withdrawal by Subject|1|||
33675560|NCT02644356|63114520|FG000|Overall Study|Withdrawal by Subject|2|||
33675561|NCT01494038|63114561|FG000|Overall Study|Protocol Violation|1|||
33675562|NCT01494038|63114562|FG001|Overall Study|Protocol Violation|1|||
33675563|NCT01494038|63114561|FG000|Overall Study|Lost to Follow-up|18|||
33675564|NCT01494038|63114562|FG001|Overall Study|Lost to Follow-up|20|||
33675565|NCT01494038|63114561|FG000|Overall Study|Withdrawal by Subject|44|||
33675566|NCT01494038|63114562|FG001|Overall Study|Withdrawal by Subject|34|||
33675567|NCT01494038|63114561|FG000|Overall Study|Not able to get to clinic|21|||
33675568|NCT01494038|63114562|FG001|Overall Study|Not able to get to clinic|15|||
33675569|NCT01494038|63114561|FG000|Overall Study|Not willing to adhere to reqs|2|||
33675570|NCT01494038|63114562|FG001|Overall Study|Not willing to adhere to reqs|9|||
33675571|NCT01494038|63114561|FG000|Overall Study|Death|2|||
33675572|NCT01494038|63114562|FG001|Overall Study|Death|4|||
33675573|NCT02640612|63114599|FG000|Overall Study|Adverse Event|6|||
33675574|NCT02640612|63114600|FG001|Overall Study|Adverse Event|7|||
33675575|NCT02640612|63114601|FG002|Overall Study|Adverse Event|2|||
33675576|NCT02640612|63114599|FG000|Overall Study|Death|1|||
33675577|NCT02640612|63114600|FG001|Overall Study|Death|0|||
33675578|NCT02640612|63114601|FG002|Overall Study|Death|0|||
33675579|NCT02640612|63114599|FG000|Overall Study|Withdrawal by Subject|10|||
33675580|NCT02640612|63114600|FG001|Overall Study|Withdrawal by Subject|3|||
33675581|NCT02640612|63114601|FG002|Overall Study|Withdrawal by Subject|3|||
33675582|NCT02640612|63114599|FG000|Overall Study|Lost to Follow-up|4|||
33675583|NCT02640612|63114600|FG001|Overall Study|Lost to Follow-up|1|||
33675584|NCT02640612|63114601|FG002|Overall Study|Lost to Follow-up|1|||
33675585|NCT02640612|63114599|FG000|Overall Study|Protocol Violation|0|||
33675586|NCT02640612|63114600|FG001|Overall Study|Protocol Violation|2|||
33584290|NCT02418585|62982274|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
33584291|NCT02418585|62982275|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
33584292|NCT02418585|62982274|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
33675587|NCT02640612|63114601|FG002|Overall Study|Protocol Violation|0|||
33675588|NCT02640612|63114599|FG000|Overall Study|Lack of Efficacy|1|||
33675589|NCT02640612|63114600|FG001|Overall Study|Lack of Efficacy|1|||
33675590|NCT02640612|63114601|FG002|Overall Study|Lack of Efficacy|0|||
33675591|NCT00639769|63114609|FG000|Overall Study|Death|2|||
33675592|NCT00639769|63114609|FG000|Overall Study|Adverse Event|7|||
33675593|NCT00639769|63114609|FG000|Overall Study|Lack of Efficacy|1|||
33675594|NCT00639769|63114609|FG000|Overall Study|Disease progression|26|||
33675595|NCT00639769|63114609|FG000|Overall Study|Withdrawal by Subject|4|||
33675596|NCT00639457|63114615|FG000|Overall Study|Withdrawal by Subject|2|||
33675597|NCT00639457|63114616|FG001|Overall Study|Withdrawal by Subject|3|||
33675598|NCT00639379|63114622|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
33675599|NCT00639379|63114623|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
33584293|NCT02418585|62982275|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
33584294|NCT02418585|62982274|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
33675600|NCT00639379|63114622|FG000|Period 1 - 2 Weeks|lens issue|3|||
33675601|NCT00639379|63114623|FG001|Period 1 - 2 Weeks|lens issue|0|||
33675602|NCT00639223|63114631|FG000|Overall Study|Lost to Follow-up|0|||
33675603|NCT00639223|63114632|FG001|Overall Study|Lost to Follow-up|2|||
33675604|NCT00638989|63114641|FG000|Overall Study|Lost to Follow-up|0|||
33675605|NCT00638989|63114642|FG001|Overall Study|Lost to Follow-up|0|||
33675606|NCT00638989|63114643|FG002|Overall Study|Lost to Follow-up|1|||
33675607|NCT00637273|63114664|FG000|Overall Study|Adverse Event|11|||
33675608|NCT00637273|63114665|FG001|Overall Study|Adverse Event|5|||
33584295|NCT02418585|62982275|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
33584296|NCT02418585|62982274|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
33584297|NCT02418585|62982275|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
33584298|NCT02418585|62982274|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
33584299|NCT02418585|62982275|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
33584300|NCT02418585|62982274|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
33584301|NCT02418585|62982275|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
33584302|NCT02418585|62982274|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
33584303|NCT02418585|62982275|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
33584304|NCT02418585|62982274|FG000|Follow-up Phase (24 Weeks)|Other|3|||
33584305|NCT02418585|62982275|FG001|Follow-up Phase (24 Weeks)|Other|2|||
33584306|NCT02417961|62982283|FG000|Overall Study|Adverse Event|1|||
33584307|NCT02417961|62982283|FG000|Overall Study|Lost to Follow-up|1|||
33584308|NCT02417961|62982283|FG000|Overall Study|Withdrawal by Subject|2|||
33584309|NCT01596127|62982287|FG000|Overall Study|Patient Ineligible|1|||
33584310|NCT01595581|62982293|FG000|Overall Study|Withdrawal by Subject|1|||
33584311|NCT01595581|62982294|FG001|Overall Study|Withdrawal by Subject|0|||
33584312|NCT01610687|62982302|FG000|Overall Study|Lack of Efficacy|26|||
33584313|NCT01610687|62982302|FG000|Overall Study|Adverse Event|18|||
33584314|NCT01610687|62982302|FG000|Overall Study|Moved out of area|6|||
33584315|NCT01610687|62982302|FG000|Overall Study|Withdrawal by Subject|7|||
33584316|NCT01610687|62982302|FG000|Overall Study|Lost to Follow-up|4|||
33584317|NCT01610687|62982302|FG000|Overall Study|Symptom control without study medication|2|||
33675609|NCT00637273|63114666|FG002|Overall Study|Adverse Event|7|||
33675610|NCT00637273|63114664|FG000|Overall Study|Lost to Follow-up|8|||
33675611|NCT00637273|63114665|FG001|Overall Study|Lost to Follow-up|9|||
33675612|NCT00637273|63114666|FG002|Overall Study|Lost to Follow-up|13|||
33675613|NCT00637273|63114664|FG000|Overall Study|Protocol Violation|2|||
33675614|NCT00637273|63114665|FG001|Overall Study|Protocol Violation|4|||
33675615|NCT00637273|63114666|FG002|Overall Study|Protocol Violation|1|||
33675616|NCT00637273|63114664|FG000|Overall Study|Withdrawal of Consent|18|||
33675617|NCT00637273|63114665|FG001|Overall Study|Withdrawal of Consent|6|||
33675618|NCT00637273|63114666|FG002|Overall Study|Withdrawal of Consent|18|||
33584318|NCT01610687|62982302|FG000|Overall Study|Unable to make journey|1|||
33584319|NCT01610687|62982302|FG000|Overall Study|Death|1|||
33675619|NCT00637273|63114664|FG000|Overall Study|Investigator Decision|1|||
33675620|NCT00637273|63114665|FG001|Overall Study|Investigator Decision|3|||
33675621|NCT00637273|63114666|FG002|Overall Study|Investigator Decision|1|||
33675622|NCT00637273|63114664|FG000|Overall Study|Administrative|2|||
33675623|NCT00637273|63114665|FG001|Overall Study|Administrative|0|||
33675624|NCT00637273|63114666|FG002|Overall Study|Administrative|0|||
33675625|NCT00637273|63114664|FG000|Overall Study|Loss of Glucose Control|1|||
33584320|NCT01610687|62982302|FG000|Overall Study|Cannabis affecting job|1|||
33584321|NCT01610687|62982302|FG000|Overall Study|Felt more alter without study medication|1|||
33675626|NCT00637273|63114665|FG001|Overall Study|Loss of Glucose Control|1|||
33584322|NCT02615509|62982306|FG000|Overall Study|Lost to Follow-up|134|||
33584323|NCT02615509|62982306|FG000|Overall Study|Death|4|||
33584324|NCT02615509|62982306|FG000|Overall Study|Withdrawal by Subject|8|||
33584325|NCT02575079|62982312|FG000|Overall Study|Death|3|||
33584326|NCT02575079|62982313|FG001|Overall Study|Death|0|||
33584327|NCT02575079|62982312|FG000|Overall Study|Withdrawal by Subject|3|||
33584328|NCT02575079|62982313|FG001|Overall Study|Withdrawal by Subject|0|||
33675627|NCT00637273|63114666|FG002|Overall Study|Loss of Glucose Control|1|||
33675628|NCT00988351|63114676|FG000|Overall Study|Withdrawal by Subject|8|||
33675629|NCT00988351|63114677|FG001|Overall Study|Withdrawal by Subject|0|||
33675630|NCT00988351|63114676|FG000|Overall Study|Lost to Follow-up|6|||
33675631|NCT00988351|63114677|FG001|Overall Study|Lost to Follow-up|9|||
33675632|NCT00988351|63114676|FG000|Overall Study|not using CPAP|5|||
33675633|NCT00988351|63114677|FG001|Overall Study|not using CPAP|3|||
33675634|NCT00988117|63114683|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
33675635|NCT00988117|63114683|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
33675636|NCT00637195|63114690|FG000|Overall Study|Lost to Follow-up|1|||
33675637|NCT00637195|63114691|FG001|Overall Study|Lost to Follow-up|0|||
33675638|NCT00637195|63114690|FG000|Overall Study|Other|2|||
33675639|NCT00637195|63114691|FG001|Overall Study|Other|0|||
33675640|NCT00637195|63114690|FG000|Overall Study|Withdrawal by Subject|0|||
33675641|NCT00637195|63114691|FG001|Overall Study|Withdrawal by Subject|1|||
33675642|NCT00636961|63114709|FG000|Period 1|Administrative problems|1|||
33675643|NCT00636961|63114710|FG001|Period 1|Administrative problems|1|||
33675644|NCT00636961|63114709|FG000|Period 2|Adverse Event|1|||
33675645|NCT00636961|63114710|FG001|Period 2|Adverse Event|0|||
33675646|NCT00635089|63114725|FG000|Overall Study|Adverse Event|7|||
33675647|NCT00635089|63114725|FG000|Overall Study|Lack of Efficacy|28|||
33675648|NCT00635089|63114725|FG000|Overall Study|Protocol Deviation|4|||
33675649|NCT00635089|63114725|FG000|Overall Study|Lost to Follow-up|8|||
33675650|NCT00635089|63114725|FG000|Overall Study|Other|31|||
33675651|NCT01493414|63114742|FG000|Overall Study|Adverse Event|405|||
33675652|NCT01493414|63114742|FG000|Overall Study|Disease progression|204|||
33675653|NCT01493414|63114742|FG000|Overall Study|Death|101|||
33675654|NCT01493414|63114742|FG000|Overall Study|Physician Decision|93|||
33675655|NCT01493414|63114742|FG000|Overall Study|Withdrawal by Subject|79|||
33675656|NCT01493414|63114742|FG000|Overall Study|Protocol deviation|27|||
33675657|NCT01493414|63114742|FG000|Overall Study|Administrative problems|25|||
33675658|NCT01493414|63114742|FG000|Overall Study|Lost to Follow-up|16|||
33675659|NCT00634543|63114752|FG000|Overall Study|Other|1|||
33675660|NCT00634543|63114753|FG001|Overall Study|Other|2|||
33675661|NCT00634543|63114752|FG000|Overall Study|Protocol Violation|3|||
33675662|NCT00634543|63114753|FG001|Overall Study|Protocol Violation|3|||
33675663|NCT00634543|63114752|FG000|Overall Study|Adverse Event|11|||
33675664|NCT00634543|63114753|FG001|Overall Study|Adverse Event|11|||
33675665|NCT00634543|63114752|FG000|Overall Study|Withdrawal by Subject|4|||
33675666|NCT00634543|63114753|FG001|Overall Study|Withdrawal by Subject|4|||
33675667|NCT00634543|63114752|FG000|Overall Study|Lost to Follow-up|0|||
33675668|NCT00634543|63114753|FG001|Overall Study|Lost to Follow-up|1|||
33675669|NCT00985465|63114761|FG000|Overall Study|Withdrawal by Subject|1|||
33675670|NCT00985465|63114762|FG001|Overall Study|Withdrawal by Subject|2|||
33675671|NCT00985465|63114761|FG000|Overall Study|Considered to be part of the other group|0|||
33675672|NCT00985465|63114762|FG001|Overall Study|Considered to be part of the other group|1|||
33675673|NCT01049919|63114771|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
33675674|NCT01049919|63114772|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
33675675|NCT01049919|63114771|FG000|Overall Study|Withdrawal by Subject|5|||
33675676|NCT01049919|63114772|FG001|Overall Study|Withdrawal by Subject|0|||
33675677|NCT01049919|63114771|FG000|Overall Study|Lost to Follow-up|6|||
33675678|NCT01049919|63114772|FG001|Overall Study|Lost to Follow-up|1|||
33675679|NCT01049919|63114771|FG000|Overall Study|Physician Decision|2|||
33584329|NCT02574845|62982324|FG000|Overall Study|Consent withdrawn further participation|0|||
33584330|NCT02574845|62982325|FG001|Overall Study|Consent withdrawn further participation|0|||
33584331|NCT02574845|62982326|FG002|Overall Study|Consent withdrawn further participation|0|||
33584332|NCT02574845|62982327|FG003|Overall Study|Consent withdrawn further participation|0|||
33584333|NCT02574845|62982328|FG004|Overall Study|Consent withdrawn further participation|1|||
33675680|NCT01049919|63114772|FG001|Overall Study|Physician Decision|0|||
33675681|NCT01049919|63114771|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
33675682|NCT01049919|63114772|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
33675683|NCT01049919|63114771|FG000|Overall Study|Early study termination by sponsor.|2|||
33584334|NCT02574845|62982329|FG005|Overall Study|Consent withdrawn further participation|0|||
33584335|NCT02574845|62982324|FG000|Overall Study|Adverse Event|0|||
33584336|NCT02574845|62982325|FG001|Overall Study|Adverse Event|1|||
33584337|NCT02574845|62982326|FG002|Overall Study|Adverse Event|0|||
33584338|NCT02574845|62982327|FG003|Overall Study|Adverse Event|0|||
33584339|NCT02574845|62982328|FG004|Overall Study|Adverse Event|0|||
33584340|NCT02574845|62982329|FG005|Overall Study|Adverse Event|1|||
33584341|NCT02614183|62982346|FG000|Double Blind Treatment Phase|Adverse Event|10|||
33584342|NCT02614183|62982347|FG001|Double Blind Treatment Phase|Adverse Event|9|||
33584343|NCT02614183|62982348|FG002|Double Blind Treatment Phase|Adverse Event|7|||
33584344|NCT02614183|62982346|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
33584345|NCT02614183|62982347|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
33584346|NCT02614183|62982348|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
33584347|NCT02614183|62982346|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
33584348|NCT02614183|62982347|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
33584349|NCT02614183|62982348|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
33584350|NCT02614183|62982346|FG000|Double Blind Treatment Phase|Physician Decision|7|||
33584351|NCT02614183|62982347|FG001|Double Blind Treatment Phase|Physician Decision|3|||
33584352|NCT02614183|62982348|FG002|Double Blind Treatment Phase|Physician Decision|2|||
33584353|NCT02614183|62982346|FG000|Double Blind Treatment Phase|Pregnancy|2|||
33584354|NCT02614183|62982347|FG001|Double Blind Treatment Phase|Pregnancy|1|||
33584355|NCT02614183|62982348|FG002|Double Blind Treatment Phase|Pregnancy|3|||
33584356|NCT02614183|62982346|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
33584357|NCT02614183|62982347|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
33584358|NCT02614183|62982348|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
33584359|NCT02614183|62982346|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
33584360|NCT02614183|62982347|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
33584361|NCT02614183|62982348|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
33584362|NCT02614183|62982346|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
33584363|NCT02614183|62982347|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
33584364|NCT02614183|62982348|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
33584365|NCT02614183|62982346|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
33584366|NCT02614183|62982347|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
33584367|NCT02614183|62982348|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
33584368|NCT02614183|62982346|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
33584369|NCT02614183|62982347|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
33584370|NCT02614183|62982348|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
33584371|NCT02614183|62982346|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
33584372|NCT02614183|62982347|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
33584373|NCT02614183|62982348|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
33584374|NCT02614183|62982346|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
33584375|NCT02614183|62982347|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
33584376|NCT02614183|62982348|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
33584377|NCT02612155|62982373|FG000|Overall Study|Death|1|||
33584378|NCT02612155|62982374|FG001|Overall Study|Death|1|||
33584379|NCT02612155|62982373|FG000|Overall Study|Lost to Follow-up|2|||
33584380|NCT02612155|62982374|FG001|Overall Study|Lost to Follow-up|2|||
33584381|NCT02614729|62982382|FG000|Overall Study|Withdrawal by Subject|1|||
33584382|NCT02614729|62982383|FG001|Overall Study|Withdrawal by Subject|0|||
33584383|NCT02613871|62982391|FG000|Overall Study|Death|2|||
33584384|NCT02613871|62982391|FG000|Overall Study|Withdrew Consent|1|||
33584385|NCT05021081|62982397|FG000|Phase 2|Subject enrolled in error|1|||
33584386|NCT05021081|62982398|FG001|Phase 2|Subject enrolled in error|1|||
33584387|NCT05021081|62982399|FG002|Phase 2|Subject enrolled in error|0|||
33584388|NCT02612077|62982415|FG000|Overall Study|Adverse Event|3|||
33584389|NCT02612077|62982415|FG000|Overall Study|Withdrawal by Subject|9|||
33584390|NCT02612077|62982415|FG000|Overall Study|Protocol Violation|28|||
33584391|NCT02612077|62982415|FG000|Overall Study|Lost to Follow-up|20|||
33584392|NCT02612077|62982415|FG000|Overall Study|Death|377|||
33584393|NCT02612077|62982415|FG000|Overall Study|Moved or Changed Medical Team|23|||
33584394|NCT02612077|62982415|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
33584395|NCT02612077|62982415|FG000|Overall Study|Disease Progression|3|||
33584396|NCT02612077|62982415|FG000|Overall Study|Unknown reason|2|||
33584397|NCT02613481|62982422|FG000|Overall Study|Lost to Follow-up|7|||
33584398|NCT02613481|62982422|FG000|Overall Study|Withdrawal by Subject|2|||
33584399|NCT02613403|62982430|FG000|Overall Study|Lost to Follow-up|0|||
33584400|NCT02613403|62982431|FG001|Overall Study|Lost to Follow-up|1|||
33584401|NCT02613403|62982432|FG002|Overall Study|Lost to Follow-up|0|||
33584402|NCT02613403|62982433|FG003|Overall Study|Lost to Follow-up|0|||
33584403|NCT02613403|62982434|FG004|Overall Study|Lost to Follow-up|0|||
33584404|NCT02613403|62982430|FG000|Overall Study|Withdrawal by Subject|2|||
33584405|NCT02613403|62982431|FG001|Overall Study|Withdrawal by Subject|0|||
33584406|NCT02613403|62982432|FG002|Overall Study|Withdrawal by Subject|0|||
33584407|NCT02613403|62982433|FG003|Overall Study|Withdrawal by Subject|0|||
33675684|NCT01049919|63114772|FG001|Overall Study|Early study termination by sponsor.|0|||
33675685|NCT01049373|63114780|FG000|Overall Study|Protocol Violation|9|||
33675686|NCT01049373|63114781|FG001|Overall Study|Protocol Violation|9|||
33675687|NCT01049373|63114780|FG000|Overall Study|Withdrawal by Subject|8|||
33675688|NCT01049373|63114781|FG001|Overall Study|Withdrawal by Subject|5|||
33675689|NCT01049373|63114780|FG000|Overall Study|Adverse Event|3|||
33675690|NCT01049373|63114781|FG001|Overall Study|Adverse Event|3|||
33675691|NCT01049373|63114780|FG000|Overall Study|Lost to Follow-up|9|||
33675692|NCT01049373|63114781|FG001|Overall Study|Lost to Follow-up|4|||
33675693|NCT01049373|63114780|FG000|Overall Study|no evaluable study values|9|||
33675694|NCT01049373|63114781|FG001|Overall Study|no evaluable study values|21|||
33675695|NCT01049373|63114780|FG000|Overall Study|Other|1|||
33675696|NCT01049373|63114781|FG001|Overall Study|Other|1|||
33675697|NCT01049373|63114780|FG000|Overall Study|Non-cooperation|0|||
33675698|NCT01049373|63114781|FG001|Overall Study|Non-cooperation|1|||
33675699|NCT00985231|63114791|FG000|Overall Study|ineligible|1|||
33675700|NCT00985231|63114792|FG001|Overall Study|ineligible|0|||
33675701|NCT00985231|63114791|FG000|Overall Study|Protocol Violation|1|||
33675702|NCT00985231|63114792|FG001|Overall Study|Protocol Violation|0|||
33675703|NCT00985231|63114791|FG000|Overall Study|Withdrawal by Subject|1|||
33675704|NCT00985231|63114792|FG001|Overall Study|Withdrawal by Subject|0|||
33675705|NCT00985231|63114791|FG000|Overall Study|Lost to Follow-up|0|||
33675706|NCT00985231|63114792|FG001|Overall Study|Lost to Follow-up|1|||
33675707|NCT00985231|63114791|FG000|Overall Study|Study related symptoms & complaints|0|||
33675708|NCT00985231|63114792|FG001|Overall Study|Study related symptoms & complaints|2|||
33675709|NCT01048671|63114812|FG000|Overall Study|Protocol Violation|0|||
33675710|NCT01048671|63114813|FG001|Overall Study|Protocol Violation|1|||
33675711|NCT01048671|63114814|FG002|Overall Study|Protocol Violation|1|||
33675712|NCT01360866|63114826|FG000|Overall Study|Lost to Follow-up|11|||
33675713|NCT01360866|63114827|FG001|Overall Study|Lost to Follow-up|28|||
33675714|NCT01360866|63114828|FG002|Overall Study|Lost to Follow-up|41|||
33675715|NCT01360866|63114829|FG003|Overall Study|Lost to Follow-up|0|||
33675716|NCT01360866|63114826|FG000|Overall Study|Adverse Event|56|||
33675717|NCT01360866|63114827|FG001|Overall Study|Adverse Event|61|||
33675718|NCT01360866|63114828|FG002|Overall Study|Adverse Event|134|||
33675719|NCT01360866|63114829|FG003|Overall Study|Adverse Event|6|||
33675720|NCT01360866|63114826|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
33675721|NCT01360866|63114827|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
33675722|NCT01360866|63114828|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
33675723|NCT01360866|63114829|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
33675724|NCT01360866|63114826|FG000|Overall Study|Withdrawn by Investigator|9|||
33675725|NCT01360866|63114827|FG001|Overall Study|Withdrawn by Investigator|8|||
33675726|NCT01360866|63114828|FG002|Overall Study|Withdrawn by Investigator|31|||
33675727|NCT01360866|63114829|FG003|Overall Study|Withdrawn by Investigator|2|||
33675728|NCT01360866|63114826|FG000|Overall Study|Withdrawal by participant|79|||
33675729|NCT01360866|63114827|FG001|Overall Study|Withdrawal by participant|89|||
33675730|NCT01360866|63114828|FG002|Overall Study|Withdrawal by participant|168|||
33675731|NCT01360866|63114829|FG003|Overall Study|Withdrawal by participant|8|||
33675732|NCT01360866|63114826|FG000|Overall Study|Protocol Deviation|25|||
33675733|NCT01360866|63114827|FG001|Overall Study|Protocol Deviation|33|||
33675734|NCT01360866|63114828|FG002|Overall Study|Protocol Deviation|61|||
33675735|NCT01360866|63114829|FG003|Overall Study|Protocol Deviation|2|||
33675736|NCT01360866|63114826|FG000|Overall Study|Lack of Efficacy|30|||
33675737|NCT01360866|63114827|FG001|Overall Study|Lack of Efficacy|40|||
33675738|NCT01360866|63114828|FG002|Overall Study|Lack of Efficacy|30|||
33675739|NCT01360866|63114829|FG003|Overall Study|Lack of Efficacy|4|||
33675740|NCT00985153|63114843|FG000|Overall Study|Lost to Follow-up|16|||
33675741|NCT00985153|63114844|FG001|Overall Study|Lost to Follow-up|19|||
33675742|NCT00985153|63114845|FG002|Overall Study|Lost to Follow-up|17|||
33675743|NCT00985153|63114846|FG003|Overall Study|Lost to Follow-up|20|||
33675744|NCT00985153|63114843|FG000|Overall Study|Protocol Violation|3|||
33675745|NCT00985153|63114844|FG001|Overall Study|Protocol Violation|2|||
33675746|NCT00985153|63114845|FG002|Overall Study|Protocol Violation|4|||
33675747|NCT00985153|63114846|FG003|Overall Study|Protocol Violation|3|||
33675748|NCT00985153|63114843|FG000|Overall Study|Withdrawal by Subject|6|||
33675749|NCT00985153|63114844|FG001|Overall Study|Withdrawal by Subject|11|||
33675750|NCT00985153|63114845|FG002|Overall Study|Withdrawal by Subject|11|||
33675751|NCT00985153|63114846|FG003|Overall Study|Withdrawal by Subject|10|||
33675752|NCT00985153|63114843|FG000|Overall Study|Missed One or More Bleeds|7|||
33675753|NCT00985153|63114844|FG001|Overall Study|Missed One or More Bleeds|7|||
33675754|NCT00985153|63114845|FG002|Overall Study|Missed One or More Bleeds|8|||
33675755|NCT00985153|63114846|FG003|Overall Study|Missed One or More Bleeds|10|||
33675756|NCT00985153|63114843|FG000|Overall Study|Incomplete Safety Follow-up|3|||
33675757|NCT00985153|63114844|FG001|Overall Study|Incomplete Safety Follow-up|5|||
33675758|NCT00985153|63114845|FG002|Overall Study|Incomplete Safety Follow-up|4|||
33675759|NCT00985153|63114846|FG003|Overall Study|Incomplete Safety Follow-up|4|||
33675760|NCT01047345|63114858|FG000|Base Study|Adverse Event|3|||
33675761|NCT01047345|63114859|FG001|Base Study|Adverse Event|0|||
33675762|NCT01047345|63114860|FG002|Base Study|Adverse Event|0|||
33675763|NCT01047345|63114858|FG000|Base Study|Lost to Follow-up|4|||
33675764|NCT01047345|63114859|FG001|Base Study|Lost to Follow-up|1|||
33675765|NCT01047345|63114860|FG002|Base Study|Lost to Follow-up|0|||
33675766|NCT01047345|63114858|FG000|Base Study|Protocol Violation|3|||
33675767|NCT01047345|63114859|FG001|Base Study|Protocol Violation|1|||
33675768|NCT01047345|63114860|FG002|Base Study|Protocol Violation|0|||
33675769|NCT01047345|63114858|FG000|Base Study|Withdrawal by Subject|12|||
33675770|NCT01047345|63114859|FG001|Base Study|Withdrawal by Subject|4|||
33675771|NCT01047345|63114860|FG002|Base Study|Withdrawal by Subject|0|||
33675772|NCT01047345|63114858|FG000|Extension|Withdrawal by Subject|0|||
33675773|NCT01047345|63114859|FG001|Extension|Withdrawal by Subject|0|||
33675774|NCT01047345|63114860|FG002|Extension|Withdrawal by Subject|1|||
33675775|NCT01047345|63114858|FG000|Extension|Lost to Follow-up|0|||
33675776|NCT01047345|63114859|FG001|Extension|Lost to Follow-up|0|||
33675777|NCT01047345|63114860|FG002|Extension|Lost to Follow-up|5|||
33675778|NCT01046877|63114868|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
33675779|NCT01046877|63114868|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
33675780|NCT00984061|63114872|FG000|Clarithromycin Alone|Protocol Violation|1|||
33675781|NCT01046643|63114881|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
33675782|NCT01046643|63114882|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
33675783|NCT01046643|63114883|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
33675784|NCT01046643|63114884|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
33675785|NCT00983905|63114894|FG000|Theophylline Alone|Adverse Event|1|||
33675786|NCT00983905|63114894|FG000|Colchicine Alone|Adverse Event|2|||
33675787|NCT01046565|63114901|FG000|Overall Study|Adverse Event|2|||
33675788|NCT01046565|63114901|FG000|Overall Study|Withdrawal by Subject|7|||
33675789|NCT00983827|63114910|FG000|Overall Study|Withdrawal by Subject|1|||
33675790|NCT00983749|63114916|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
33675791|NCT00983749|63114917|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
33675792|NCT01046253|63114925|FG000|Second Intervention|Adverse Event|0|||
33675793|NCT01046253|63114926|FG001|Second Intervention|Adverse Event|1|||
33675794|NCT01046253|63114925|FG000|Second Intervention|Protocol Violation|0|||
33675795|NCT01046253|63114926|FG001|Second Intervention|Protocol Violation|1|||
33675796|NCT00983515|63114932|FG000|Ritonavir Alone|liver panel out of range|6|||
33675797|NCT00983515|63114932|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
33675798|NCT00982735|63114939|FG000|Overall Study|Lost to Follow-up|6|||
33675799|NCT00982735|63114939|FG000|Overall Study|Patient ineligible for trial|224|||
33675800|NCT01361178|63114945|FG000|Overall Study|Death|13|||
33675801|NCT01361178|63114946|FG001|Overall Study|Death|0|||
33675802|NCT00981799|63114956|FG000|Overall Study|Adverse Event|1|||
33675803|NCT00981799|63114957|FG001|Overall Study|Adverse Event|1|||
33675804|NCT00981799|63114958|FG002|Overall Study|Adverse Event|0|||
33675805|NCT00981799|63114959|FG003|Overall Study|Adverse Event|0|||
33675806|NCT00981175|63114973|FG000|Primary Dose Vaccination|Adverse Event|1|||
33675807|NCT00981175|63114974|FG001|Primary Dose Vaccination|Adverse Event|0|||
33675808|NCT00981175|63114973|FG000|Primary Dose Vaccination|Protocol Violation|0|||
33675809|NCT00981175|63114974|FG001|Primary Dose Vaccination|Protocol Violation|1|||
33675810|NCT00981175|63114973|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
33675811|NCT00981175|63114974|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
33675812|NCT00981175|63114973|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
33675813|NCT00981175|63114974|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
33675814|NCT00981019|63114987|FG000|Overall Study|Did not respond|65|||
33675815|NCT00981019|63114987|FG000|Overall Study|Did not match target population|94|||
33675816|NCT00981019|63114987|FG000|Overall Study|Inadvertent exclusion|239|||
33675817|NCT00981019|63114987|FG000|Overall Study|Hit the survey after closure|79|||
33675818|NCT01045161|63114994|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
33675819|NCT01045161|63114995|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
33675820|NCT01045161|63114996|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
33675821|NCT01045161|63114994|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
33675822|NCT01045161|63114995|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
33675823|NCT01045161|63114996|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
33675824|NCT01045161|63114994|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
33675825|NCT01045161|63114995|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
33675826|NCT01045161|63114996|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
33675827|NCT01045161|63114994|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
33675828|NCT01045161|63114995|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
33401424|NCT00737477|62780462|FG000|Overall Study|Withdrawal by Subject|1|||
33675829|NCT01045161|63114996|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
33675830|NCT01045161|63114994|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
33675831|NCT01045161|63114995|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
33675832|NCT01045161|63114996|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
33675833|NCT01045161|63114994|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
33675834|NCT01045161|63114995|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
33675835|NCT01045161|63114996|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
33675836|NCT01045161|63114994|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
33675837|NCT01045161|63114995|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
33675838|NCT01045161|63114996|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
33675839|NCT01045161|63114994|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
33675840|NCT01045161|63114995|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
33675841|NCT01045161|63114996|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
33675842|NCT01045161|63114994|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
33675843|NCT01045161|63114995|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
33675844|NCT01045161|63114996|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
33675845|NCT01045161|63114994|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
33675846|NCT01045161|63114995|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
33675847|NCT01045161|63114996|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
33675848|NCT01045161|63114994|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
33675849|NCT01045161|63114995|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
33675850|NCT01045161|63114996|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
33675851|NCT01045161|63114994|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
33675852|NCT01045161|63114995|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
33675853|NCT01045161|63114996|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
33675854|NCT01045161|63114994|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
33584408|NCT02613403|62982434|FG004|Overall Study|Withdrawal by Subject|0|||
33675855|NCT01045161|63114995|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
33675856|NCT01045161|63114996|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
33675857|NCT01045161|63114994|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
33675858|NCT01045161|63114995|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
33675859|NCT01045161|63114996|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
33675860|NCT00633217|63115015|FG000|Overall Study|Adverse Event|5|||
33675861|NCT00633217|63115016|FG001|Overall Study|Adverse Event|9|||
33675862|NCT00633217|63115015|FG000|Overall Study|Lack of Efficacy|0|||
33675863|NCT00633217|63115016|FG001|Overall Study|Lack of Efficacy|2|||
33675864|NCT00633217|63115015|FG000|Overall Study|Protocol Violation|3|||
33675865|NCT00633217|63115016|FG001|Overall Study|Protocol Violation|7|||
33675866|NCT00633217|63115015|FG000|Overall Study|Lost to Follow-up|2|||
33675867|NCT00633217|63115016|FG001|Overall Study|Lost to Follow-up|2|||
33675868|NCT00633217|63115015|FG000|Overall Study|Investigator Discretion|2|||
33675869|NCT00633217|63115016|FG001|Overall Study|Investigator Discretion|0|||
33675870|NCT00633217|63115015|FG000|Overall Study|Withdrew Consent|3|||
33675871|NCT00633217|63115016|FG001|Overall Study|Withdrew Consent|3|||
33675872|NCT01673490|63115022|FG000|Overall Study|Lost to Follow-up|1|||
33675873|NCT01673490|63115022|FG000|Overall Study|Adverse Event|3|||
33675874|NCT01673490|63115022|FG000|Overall Study|Withdrawal by Subject|3|||
33675875|NCT00215657|63115034|FG000|Overall Study|Adverse Event|5|||
33675876|NCT00215657|63115035|FG001|Overall Study|Adverse Event|1|||
33675877|NCT00215657|63115036|FG002|Overall Study|Adverse Event|3|||
33675878|NCT00215657|63115037|FG003|Overall Study|Adverse Event|0|||
33675879|NCT00215657|63115038|FG004|Overall Study|Adverse Event|3|||
33675880|NCT00215657|63115039|FG005|Overall Study|Adverse Event|1|||
33675881|NCT00215657|63115040|FG006|Overall Study|Adverse Event|0|||
33675882|NCT00215657|63115041|FG007|Overall Study|Adverse Event|3|||
33675883|NCT00215657|63115034|FG000|Overall Study|Withdrawal by Subject|6|||
33675884|NCT00215657|63115035|FG001|Overall Study|Withdrawal by Subject|3|||
33675885|NCT00215657|63115036|FG002|Overall Study|Withdrawal by Subject|3|||
33675886|NCT00215657|63115037|FG003|Overall Study|Withdrawal by Subject|1|||
33675887|NCT00215657|63115038|FG004|Overall Study|Withdrawal by Subject|6|||
33675888|NCT00215657|63115039|FG005|Overall Study|Withdrawal by Subject|1|||
33675889|NCT00215657|63115040|FG006|Overall Study|Withdrawal by Subject|10|||
33584409|NCT02572817|62982446|FG000|Overall Study|Death|6|||
33584410|NCT02572817|62982447|FG001|Overall Study|Death|3|||
33584411|NCT02572817|62982446|FG000|Overall Study|Lost to Follow-up|3|||
33584412|NCT02572817|62982447|FG001|Overall Study|Lost to Follow-up|3|||
33584413|NCT02566109|62982453|FG000|Overall Study|Withdrawal by Subject|1|||
33584414|NCT02566031|62982459|FG000|Overall Study|Patient/guardian decision|14|||
33584415|NCT02566031|62982460|FG001|Overall Study|Patient/guardian decision|7|||
33584416|NCT02566031|62982459|FG000|Overall Study|Protocol deviation|2|||
33584417|NCT02566031|62982460|FG001|Overall Study|Protocol deviation|3|||
33584418|NCT02566031|62982459|FG000|Overall Study|Adverse Event|3|||
33584419|NCT02566031|62982460|FG001|Overall Study|Adverse Event|1|||
33584420|NCT02566031|62982459|FG000|Overall Study|Lost to Follow-up|1|||
33584421|NCT02566031|62982460|FG001|Overall Study|Lost to Follow-up|1|||
33584422|NCT02569853|62982469|FG000|Overall Study|Adverse Event|2|||
33584423|NCT02569853|62982470|FG001|Overall Study|Adverse Event|0|||
33584424|NCT02569853|62982469|FG000|Overall Study|Withdrawal by Subject|3|||
33675890|NCT00215657|63115041|FG007|Overall Study|Withdrawal by Subject|3|||
33675891|NCT00215657|63115034|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
33675892|NCT00215657|63115035|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
33675893|NCT00215657|63115036|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
33675894|NCT00215657|63115037|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
33675895|NCT00215657|63115038|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
33675896|NCT00215657|63115039|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
33675897|NCT00215657|63115040|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
33675898|NCT00215657|63115041|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
33675899|NCT00215657|63115034|FG000|Overall Study|Insufficient testosterone response|5|||
33675900|NCT00215657|63115035|FG001|Overall Study|Insufficient testosterone response|4|||
33675901|NCT00215657|63115036|FG002|Overall Study|Insufficient testosterone response|1|||
33675902|NCT00215657|63115037|FG003|Overall Study|Insufficient testosterone response|12|||
33675903|NCT00215657|63115038|FG004|Overall Study|Insufficient testosterone response|8|||
33675904|NCT00215657|63115039|FG005|Overall Study|Insufficient testosterone response|12|||
33675905|NCT00215657|63115040|FG006|Overall Study|Insufficient testosterone response|4|||
33675906|NCT00215657|63115041|FG007|Overall Study|Insufficient testosterone response|7|||
33675907|NCT00215657|63115034|FG000|Overall Study|Other|3|||
33675908|NCT00215657|63115035|FG001|Overall Study|Other|1|||
33675909|NCT00215657|63115036|FG002|Overall Study|Other|2|||
33675910|NCT00215657|63115037|FG003|Overall Study|Other|3|||
33675911|NCT00215657|63115038|FG004|Overall Study|Other|5|||
33675912|NCT00215657|63115039|FG005|Overall Study|Other|4|||
33675913|NCT00215657|63115040|FG006|Overall Study|Other|6|||
33675914|NCT00215657|63115041|FG007|Overall Study|Other|1|||
33675915|NCT00633061|63115061|FG000|Overall Study|Study closed|86|||
33675916|NCT00633061|63115062|FG001|Overall Study|Study closed|0|||
33675917|NCT00632827|63115070|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
33675918|NCT00632827|63115070|FG000|Overall Study|Death|2|||
33675919|NCT00632827|63115070|FG000|Overall Study|Adverse Event|5|||
33675920|NCT00632827|63115070|FG000|Overall Study|Lost to Follow-up|1|||
33675921|NCT00214019|63115075|FG000|Overall Study|Lost to Follow-up|11|||
33675922|NCT00214019|63115075|FG000|Overall Study|Withdrawal by Subject|2|||
33675923|NCT00214019|63115075|FG000|Overall Study|Screen Failed prior to randomization|17|||
33675924|NCT00210119|63115082|FG000|Overall Study|Protocol Violation|1|||
33675925|NCT00210119|63115082|FG000|Overall Study|Withdrawal by Subject|1|||
33675926|NCT01044459|63115088|FG000|Overall Study|Withdrawal by Subject|21|||
33675927|NCT01044459|63115089|FG001|Overall Study|Withdrawal by Subject|28|||
33675928|NCT01044459|63115088|FG000|Overall Study|Terminated by Sponsor|22|||
33675929|NCT01044459|63115089|FG001|Overall Study|Terminated by Sponsor|21|||
33675930|NCT01044459|63115088|FG000|Overall Study|Adverse Event|22|||
33675931|NCT01044459|63115089|FG001|Overall Study|Adverse Event|20|||
33675932|NCT01044459|63115088|FG000|Overall Study|Lack of Efficacy|23|||
33675933|NCT01044459|63115089|FG001|Overall Study|Lack of Efficacy|12|||
33675934|NCT01044459|63115088|FG000|Overall Study|Protocol Violation|11|||
33675935|NCT01044459|63115089|FG001|Overall Study|Protocol Violation|16|||
33675936|NCT01044459|63115088|FG000|Overall Study|Other Reason|7|||
33310656|NCT01239342|62686052|FG001|Overall Study|Reason Unknown|1|||
33310657|NCT00946309|62686060|FG000|Overall Study|Protocol Violation|1|||
33310658|NCT00946309|62686061|FG001|Overall Study|Protocol Violation|0|||
33675937|NCT01044459|63115089|FG001|Overall Study|Other Reason|14|||
33675938|NCT01044459|63115088|FG000|Overall Study|COPD exacerbation|9|||
33675939|NCT01044459|63115089|FG001|Overall Study|COPD exacerbation|8|||
33675940|NCT01044459|63115088|FG000|Overall Study|Lost to Follow-up|18|||
33675941|NCT01044459|63115089|FG001|Overall Study|Lost to Follow-up|12|||
33675942|NCT00980005|63115097|FG000|Overall Study|Withdrawal by Subject|6|||
33675943|NCT00980005|63115098|FG001|Overall Study|Withdrawal by Subject|17|||
33675944|NCT00980005|63115097|FG000|Overall Study|Lost to Follow-up|37|||
33675945|NCT00980005|63115098|FG001|Overall Study|Lost to Follow-up|43|||
33675946|NCT00980005|63115097|FG000|Overall Study|Other|4|||
33675947|NCT00980005|63115098|FG001|Overall Study|Other|3|||
33675948|NCT01044303|63115108|FG000|Overall Study|Lost to Follow-up|2|||
33675949|NCT00983437|63115115|FG000|Overall Study|Adverse Event|9|||
33675950|NCT00983437|63115115|FG000|Overall Study|Lack of Efficacy|1|||
33675951|NCT00983437|63115115|FG000|Overall Study|Withdrawal by Subject|8|||
33675952|NCT00983437|63115115|FG000|Overall Study|Noncompliance to Study Procedures|1|||
33675953|NCT00983437|63115115|FG000|Overall Study|Lost to Follow-up|2|||
33675954|NCT00983437|63115115|FG000|Overall Study|Other Reason|26|||
33675955|NCT01042977|63115121|FG000|Overall Study|Adverse Event|4|||
33675956|NCT01042977|63115122|FG001|Overall Study|Adverse Event|12|||
33675957|NCT01042977|63115121|FG000|Overall Study|Death|2|||
33675958|NCT01042977|63115122|FG001|Overall Study|Death|1|||
33492970|NCT03147248|62871040|FG001|Overall Study|Withdrawal by Subject|0|||
33675959|NCT01042977|63115121|FG000|Overall Study|Withdrawal by Subject|8|||
33675960|NCT01042977|63115122|FG001|Overall Study|Withdrawal by Subject|16|||
33675961|NCT01042977|63115121|FG000|Overall Study|Lost to Follow-up|0|||
33675962|NCT01042977|63115122|FG001|Overall Study|Lost to Follow-up|2|||
33675963|NCT01042977|63115121|FG000|Overall Study|Poor/non-compliance|3|||
33675964|NCT01042977|63115122|FG001|Overall Study|Poor/non-compliance|4|||
33675965|NCT01042977|63115121|FG000|Overall Study|Subject no longer meets study criteria|15|||
33675966|NCT01042977|63115122|FG001|Overall Study|Subject no longer meets study criteria|13|||
33675967|NCT01042977|63115121|FG000|Overall Study|Incorrect enrollment|6|||
33675968|NCT01042977|63115122|FG001|Overall Study|Incorrect enrollment|4|||
33675969|NCT01042977|63115121|FG000|Overall Study|Safety|0|||
33675970|NCT01042977|63115122|FG001|Overall Study|Safety|2|||
33675971|NCT01042977|63115121|FG000|Overall Study|Administrative reason by sponsor|0|||
33675972|NCT01042977|63115122|FG001|Overall Study|Administrative reason by sponsor|1|||
33675973|NCT01042977|63115121|FG000|Overall Study|Various|3|||
33675974|NCT01042977|63115122|FG001|Overall Study|Various|0|||
33675975|NCT01041573|63115132|FG000|Overall Study|Withdrawal by Subject|2|||
33675976|NCT01041573|63115133|FG001|Overall Study|Withdrawal by Subject|5|||
33675977|NCT01041573|63115134|FG002|Overall Study|Withdrawal by Subject|2|||
33675978|NCT01041573|63115135|FG003|Overall Study|Withdrawal by Subject|0|||
33675979|NCT01041573|63115132|FG000|Overall Study|Death|1|||
33675980|NCT01041573|63115133|FG001|Overall Study|Death|0|||
33675981|NCT01041573|63115134|FG002|Overall Study|Death|0|||
33675982|NCT01041573|63115135|FG003|Overall Study|Death|0|||
33675983|NCT01041573|63115132|FG000|Overall Study|Lost to Follow-up|0|||
33675984|NCT01041573|63115133|FG001|Overall Study|Lost to Follow-up|1|||
33675985|NCT01041573|63115134|FG002|Overall Study|Lost to Follow-up|2|||
33675986|NCT01041573|63115135|FG003|Overall Study|Lost to Follow-up|1|||
33675987|NCT01041573|63115132|FG000|Overall Study|Adverse Event|0|||
33675988|NCT01041573|63115133|FG001|Overall Study|Adverse Event|2|||
33675989|NCT01041573|63115134|FG002|Overall Study|Adverse Event|0|||
33675990|NCT01041573|63115135|FG003|Overall Study|Adverse Event|0|||
33675991|NCT01041573|63115132|FG000|Overall Study|relocation|1|||
33675992|NCT01041573|63115133|FG001|Overall Study|relocation|4|||
33675993|NCT01041573|63115134|FG002|Overall Study|relocation|3|||
33675994|NCT01041573|63115135|FG003|Overall Study|relocation|1|||
33675995|NCT01041573|63115132|FG000|Overall Study|further blood extraction|0|||
33675996|NCT01041573|63115133|FG001|Overall Study|further blood extraction|1|||
33675997|NCT01041573|63115134|FG002|Overall Study|further blood extraction|0|||
33675998|NCT01041573|63115135|FG003|Overall Study|further blood extraction|0|||
33675999|NCT01041573|63115132|FG000|Overall Study|positive to anti-HCV|1|||
33676000|NCT01041573|63115133|FG001|Overall Study|positive to anti-HCV|0|||
33676001|NCT01041573|63115134|FG002|Overall Study|positive to anti-HCV|0|||
33676002|NCT01041573|63115135|FG003|Overall Study|positive to anti-HCV|0|||
33676003|NCT01041495|63115162|FG000|Overall Study|Withdrawal by Subject|2|||
33676004|NCT01041495|63115163|FG001|Overall Study|Withdrawal by Subject|5|||
33676005|NCT01041495|63115162|FG000|Overall Study|Adverse Event|2|||
33676006|NCT01041495|63115163|FG001|Overall Study|Adverse Event|1|||
33676007|NCT01041495|63115162|FG000|Overall Study|Lost to Follow-up|0|||
33676008|NCT01041495|63115163|FG001|Overall Study|Lost to Follow-up|1|||
33676009|NCT01041417|63115171|FG000|Overall Study|Adverse Event|5|||
33676010|NCT01041417|63115172|FG001|Overall Study|Adverse Event|2|||
33676011|NCT01041417|63115171|FG000|Overall Study|Lost to Follow-up|1|||
33676012|NCT01041417|63115172|FG001|Overall Study|Lost to Follow-up|1|||
33676013|NCT01041417|63115171|FG000|Overall Study|Death|1|||
33676014|NCT01041417|63115172|FG001|Overall Study|Death|0|||
33676015|NCT01040871|63115182|FG000|Overall Study|Adverse Event|6|||
33676016|NCT01040871|63115183|FG001|Overall Study|Adverse Event|2|||
33676017|NCT01040871|63115182|FG000|Overall Study|Withdrawal by Subject|2|||
33676018|NCT01040871|63115183|FG001|Overall Study|Withdrawal by Subject|0|||
33676019|NCT01040871|63115182|FG000|Overall Study|Death|1|||
33676020|NCT01040871|63115183|FG001|Overall Study|Death|3|||
33676021|NCT01040871|63115182|FG000|Overall Study|Lack of Efficacy|1|||
33676022|NCT01040871|63115183|FG001|Overall Study|Lack of Efficacy|1|||
33676023|NCT01040871|63115182|FG000|Overall Study|drug supply issue|1|||
33676024|NCT01040871|63115183|FG001|Overall Study|drug supply issue|0|||
33676025|NCT01040871|63115182|FG000|Overall Study|Randomized and Not Treated|2|||
33676026|NCT01040871|63115183|FG001|Overall Study|Randomized and Not Treated|1|||
33676027|NCT01040169|63115191|FG000|Overall Study|Lost to Follow-up|3|||
33676028|NCT01040169|63115192|FG001|Overall Study|Lost to Follow-up|8|||
33676029|NCT01673178|63115212|FG000|Overall Study|Lost to Follow-up|0|||
33676030|NCT01673178|63115213|FG001|Overall Study|Lost to Follow-up|1|||
33676031|NCT01673178|63115214|FG002|Overall Study|Lost to Follow-up|0|||
33676032|NCT01673178|63115215|FG003|Overall Study|Lost to Follow-up|0|||
33676033|NCT01673178|63115216|FG004|Overall Study|Lost to Follow-up|0|||
33676034|NCT01673178|63115212|FG000|Overall Study|Withdrawal by Subject|0|||
33676035|NCT01673178|63115213|FG001|Overall Study|Withdrawal by Subject|0|||
33676036|NCT01673178|63115214|FG002|Overall Study|Withdrawal by Subject|1|||
33676037|NCT01673178|63115215|FG003|Overall Study|Withdrawal by Subject|4|||
33676038|NCT01673178|63115216|FG004|Overall Study|Withdrawal by Subject|2|||
33676039|NCT01673178|63115212|FG000|Overall Study|Protocol Violation|1|||
33676040|NCT01673178|63115213|FG001|Overall Study|Protocol Violation|1|||
33676041|NCT01673178|63115214|FG002|Overall Study|Protocol Violation|0|||
33676042|NCT01673178|63115215|FG003|Overall Study|Protocol Violation|1|||
33676043|NCT01673178|63115216|FG004|Overall Study|Protocol Violation|0|||
33676044|NCT01673178|63115212|FG000|Overall Study|Adverse Event|1|||
33676045|NCT01673178|63115213|FG001|Overall Study|Adverse Event|0|||
33676046|NCT01673178|63115214|FG002|Overall Study|Adverse Event|0|||
33676047|NCT01673178|63115215|FG003|Overall Study|Adverse Event|2|||
33676048|NCT01673178|63115216|FG004|Overall Study|Adverse Event|0|||
33676049|NCT01673178|63115212|FG000|Overall Study|Other|1|||
33676050|NCT01673178|63115213|FG001|Overall Study|Other|0|||
33676051|NCT01673178|63115214|FG002|Overall Study|Other|2|||
33676052|NCT01673178|63115215|FG003|Overall Study|Other|1|||
33676053|NCT01673178|63115216|FG004|Overall Study|Other|0|||
33676054|NCT03593213|63115245|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
33676055|NCT03593213|63115246|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
33676056|NCT03593213|63115247|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
33676057|NCT03593213|63115248|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
33676058|NCT03593213|63115245|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
33676059|NCT03593213|63115246|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
33676060|NCT03593213|63115247|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
33676061|NCT03593213|63115248|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
33676062|NCT03593213|63115245|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
33676063|NCT03593213|63115246|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
33676064|NCT03593213|63115247|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
33676065|NCT03593213|63115248|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
33676066|NCT03593213|63115245|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
33676067|NCT03593213|63115246|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
33676068|NCT03593213|63115247|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
33676069|NCT03593213|63115248|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
33676070|NCT03593213|63115245|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
33676071|NCT03593213|63115246|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
33676072|NCT03593213|63115247|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
33676073|NCT03593213|63115248|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
33676074|NCT03593213|63115245|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
33676075|NCT03593213|63115246|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
33676076|NCT03593213|63115247|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
33676077|NCT03593213|63115248|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
33676078|NCT03593213|63115245|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
33676079|NCT03593213|63115246|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
33676080|NCT03593213|63115247|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
33676081|NCT03593213|63115248|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
33676082|NCT03593213|63115245|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
33676083|NCT03593213|63115246|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
33676084|NCT03593213|63115247|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
33676085|NCT03593213|63115248|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
33676086|NCT03593213|63115245|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
33676087|NCT03593213|63115246|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
33676088|NCT03593213|63115247|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
33676089|NCT03593213|63115248|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
33676090|NCT03593213|63115245|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
33676091|NCT03593213|63115246|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
33676092|NCT03593213|63115247|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
33676093|NCT03593213|63115248|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
33676094|NCT03593213|63115245|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
33676095|NCT03593213|63115246|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
33676096|NCT03593213|63115247|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
33676097|NCT03593213|63115248|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
33676098|NCT03593213|63115245|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
33676099|NCT03593213|63115246|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
33676100|NCT03593213|63115247|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
33676101|NCT03593213|63115248|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
33676102|NCT03593213|63115245|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
33676103|NCT03593213|63115246|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
33676104|NCT03593213|63115247|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
33676105|NCT03593213|63115248|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
33676106|NCT03593213|63115245|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
33676107|NCT03593213|63115246|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
33676108|NCT03593213|63115247|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
33676109|NCT03593213|63115248|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
33676110|NCT03593213|63115245|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
33676111|NCT03593213|63115246|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
33676112|NCT03593213|63115247|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
33676113|NCT03593213|63115248|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
33676114|NCT03593213|63115245|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
33676115|NCT03593213|63115246|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
33676116|NCT03593213|63115247|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
33676117|NCT03593213|63115248|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
33676118|NCT03593213|63115245|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
33676119|NCT03593213|63115246|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
33676120|NCT03593213|63115247|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
33676121|NCT03593213|63115248|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
33676122|NCT03593213|63115245|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
33676123|NCT03593213|63115246|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
33676124|NCT03593213|63115247|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
33676125|NCT03593213|63115248|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
33676126|NCT03593213|63115245|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
33676127|NCT03593213|63115246|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
33676128|NCT03593213|63115247|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
33676129|NCT03593213|63115248|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
33676130|NCT00013611|63115292|FG000|Overall Study|Lost to Follow-up|91|||
33676131|NCT00013611|63115293|FG001|Overall Study|Lost to Follow-up|100|||
33676132|NCT00010257|63115301|FG000|Overall Study|Withdrawal by Subject|1|||
33584425|NCT02569853|62982470|FG001|Overall Study|Withdrawal by Subject|2|||
33584426|NCT02569853|62982469|FG000|Overall Study|Lost to Follow-up|3|||
33584427|NCT02569853|62982470|FG001|Overall Study|Lost to Follow-up|3|||
33584428|NCT02569853|62982469|FG000|Overall Study|Protocol Violation|1|||
33584429|NCT02569853|62982470|FG001|Overall Study|Protocol Violation|1|||
33584430|NCT02569853|62982469|FG000|Overall Study|Did not experience migraine attack|10|||
33584431|NCT02569853|62982470|FG001|Overall Study|Did not experience migraine attack|7|||
33584432|NCT02569853|62982469|FG000|Overall Study|Physician Decision|1|||
33584433|NCT02569853|62982470|FG001|Overall Study|Physician Decision|1|||
33584434|NCT02570711|62982480|FG000|Overall Study|Death|1|||
33584435|NCT02570711|62982481|FG001|Overall Study|Death|0|||
33584436|NCT02570711|62982480|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
33584437|NCT02570711|62982481|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
33584438|NCT02570165|62982494|FG000|Overall Study|Adverse Event|1|||
33584439|NCT02570165|62982495|FG001|Overall Study|Adverse Event|0|||
33584440|NCT02570165|62982496|FG002|Overall Study|Adverse Event|2|||
33584441|NCT02570165|62982497|FG003|Overall Study|Adverse Event|0|||
33584442|NCT02570165|62982498|FG004|Overall Study|Adverse Event|0|||
33584443|NCT02570165|62982499|FG005|Overall Study|Adverse Event|0|||
33584444|NCT02570165|62982500|FG006|Overall Study|Adverse Event|0|||
33584445|NCT02570165|62982494|FG000|Overall Study|Lack of Efficacy|0|||
33584446|NCT02570165|62982495|FG001|Overall Study|Lack of Efficacy|1|||
33584447|NCT02570165|62982496|FG002|Overall Study|Lack of Efficacy|0|||
33584448|NCT02570165|62982497|FG003|Overall Study|Lack of Efficacy|0|||
33584449|NCT02570165|62982498|FG004|Overall Study|Lack of Efficacy|4|||
33584450|NCT02570165|62982499|FG005|Overall Study|Lack of Efficacy|0|||
33584451|NCT02570165|62982500|FG006|Overall Study|Lack of Efficacy|0|||
33584452|NCT02570165|62982494|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
33584453|NCT02570165|62982495|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
33584454|NCT02570165|62982496|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
33584455|NCT02570165|62982497|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
33584456|NCT02570165|62982498|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
33584457|NCT02570165|62982499|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
33584458|NCT02570165|62982500|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
33584459|NCT02570165|62982494|FG000|Overall Study|Lost to Follow-up|0|||
33584460|NCT02570165|62982495|FG001|Overall Study|Lost to Follow-up|0|||
33584461|NCT02570165|62982496|FG002|Overall Study|Lost to Follow-up|1|||
33584462|NCT02570165|62982497|FG003|Overall Study|Lost to Follow-up|1|||
33584463|NCT02570165|62982498|FG004|Overall Study|Lost to Follow-up|0|||
33584464|NCT02570165|62982499|FG005|Overall Study|Lost to Follow-up|0|||
33584465|NCT02570165|62982500|FG006|Overall Study|Lost to Follow-up|0|||
33584466|NCT02570165|62982494|FG000|Overall Study|Physician Decision|0|||
33584467|NCT02570165|62982495|FG001|Overall Study|Physician Decision|1|||
33584468|NCT02570165|62982496|FG002|Overall Study|Physician Decision|0|||
33584469|NCT02570165|62982497|FG003|Overall Study|Physician Decision|0|||
33676133|NCT00010257|63115302|FG001|Overall Study|Withdrawal by Subject|0|||
33676134|NCT00211757|63115340|FG000|Overall Study|Withdrawal by Subject|1|||
33676135|NCT00211757|63115341|FG001|Overall Study|Withdrawal by Subject|1|||
33676136|NCT00211757|63115340|FG000|Overall Study|Lack of Efficacy|0|||
33676137|NCT00211757|63115341|FG001|Overall Study|Lack of Efficacy|1|||
33676138|NCT02639052|63115358|FG000|Overall Study|Lost to Follow-up|1|||
33676139|NCT02635776|63115465|FG000|Overall Study|Physician Decision|1|||
33676140|NCT02635776|63115466|FG001|Overall Study|Physician Decision|0|||
33676141|NCT02635776|63115465|FG000|Overall Study|Adverse Event|51|||
33676142|NCT02635776|63115466|FG001|Overall Study|Adverse Event|3|||
33676143|NCT02635776|63115465|FG000|Overall Study|Withdrawal by Subject|41|||
33676144|NCT02635776|63115466|FG001|Overall Study|Withdrawal by Subject|7|||
33676145|NCT02635776|63115465|FG000|Overall Study|Lost to Follow-up|4|||
33676146|NCT02635776|63115466|FG001|Overall Study|Lost to Follow-up|0|||
33676147|NCT02635776|63115465|FG000|Overall Study|Other reasons|5|||
33676148|NCT02635776|63115466|FG001|Overall Study|Other reasons|1|||
33676149|NCT02704403|63115480|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
33676150|NCT02704403|63115481|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
33676151|NCT02704403|63115480|FG000|Overall Study|Administrative reasons by sponsor|1251|||
33676152|NCT02704403|63115481|FG001|Overall Study|Administrative reasons by sponsor|616|||
33676153|NCT02704403|63115480|FG000|Overall Study|Death|4|||
33676154|NCT02704403|63115481|FG001|Overall Study|Death|3|||
33676155|NCT02704403|63115480|FG000|Overall Study|Endpoint event|52|||
33676156|NCT02704403|63115481|FG001|Overall Study|Endpoint event|24|||
33676157|NCT02704403|63115480|FG000|Overall Study|Lost to Follow-up|22|||
33676158|NCT02704403|63115481|FG001|Overall Study|Lost to Follow-up|11|||
33676159|NCT02704403|63115480|FG000|Overall Study|Protocol Violation|15|||
33676160|NCT02704403|63115481|FG001|Overall Study|Protocol Violation|15|||
33676161|NCT02704403|63115480|FG000|Overall Study|Adverse Event|2|||
33676162|NCT02704403|63115481|FG001|Overall Study|Adverse Event|0|||
33676163|NCT02704403|63115480|FG000|Overall Study|Withdrawal by Subject|85|||
33676164|NCT02704403|63115481|FG001|Overall Study|Withdrawal by Subject|45|||
33676165|NCT02704403|63115480|FG000|Overall Study|Investigator decision|1|||
33676166|NCT02704403|63115481|FG001|Overall Study|Investigator decision|1|||
33676167|NCT02704403|63115480|FG000|Overall Study|Follow-up not possible|1|||
33676168|NCT02704403|63115481|FG001|Overall Study|Follow-up not possible|2|||
33676169|NCT02636868|63115516|FG000|Overall Study|Death|0|||
33676170|NCT02636868|63115517|FG001|Overall Study|Death|1|||
33676171|NCT02636868|63115518|FG002|Overall Study|Death|2|||
33676172|NCT02635386|63115599|FG000|Overall Study|Pregnancy|2|||
33676173|NCT02635386|63115600|FG001|Overall Study|Pregnancy|0|||
33676174|NCT02635386|63115601|FG002|Overall Study|Pregnancy|0|||
33676175|NCT02635386|63115602|FG003|Overall Study|Pregnancy|0|||
33676176|NCT02635386|63115603|FG004|Overall Study|Pregnancy|2|||
33676177|NCT02635386|63115599|FG000|Overall Study|Withdrawal by Subject|1|||
33676178|NCT02635386|63115600|FG001|Overall Study|Withdrawal by Subject|1|||
33676179|NCT02635386|63115601|FG002|Overall Study|Withdrawal by Subject|0|||
33676180|NCT02635386|63115602|FG003|Overall Study|Withdrawal by Subject|1|||
33676181|NCT02635386|63115603|FG004|Overall Study|Withdrawal by Subject|0|||
33676182|NCT02635386|63115599|FG000|Overall Study|Physician Decision|0|||
33676183|NCT02635386|63115600|FG001|Overall Study|Physician Decision|1|||
33676184|NCT02635386|63115601|FG002|Overall Study|Physician Decision|0|||
33676185|NCT02635386|63115602|FG003|Overall Study|Physician Decision|0|||
33676186|NCT02635386|63115603|FG004|Overall Study|Physician Decision|0|||
33676187|NCT02635386|63115599|FG000|Overall Study|Moved Out of State|0|||
33676188|NCT02635386|63115600|FG001|Overall Study|Moved Out of State|1|||
33584470|NCT02570165|62982498|FG004|Overall Study|Physician Decision|0|||
33584471|NCT02570165|62982499|FG005|Overall Study|Physician Decision|0|||
33584472|NCT02570165|62982500|FG006|Overall Study|Physician Decision|0|||
33584473|NCT02570165|62982494|FG000|Overall Study|Withdrawal by Subject|0|||
33584474|NCT02570165|62982495|FG001|Overall Study|Withdrawal by Subject|0|||
33584475|NCT02570165|62982496|FG002|Overall Study|Withdrawal by Subject|0|||
33584476|NCT02570165|62982497|FG003|Overall Study|Withdrawal by Subject|2|||
33584477|NCT02570165|62982498|FG004|Overall Study|Withdrawal by Subject|1|||
33584478|NCT02570165|62982499|FG005|Overall Study|Withdrawal by Subject|0|||
33584479|NCT02570165|62982500|FG006|Overall Study|Withdrawal by Subject|0|||
33676189|NCT02635386|63115601|FG002|Overall Study|Moved Out of State|0|||
33676190|NCT02635386|63115602|FG003|Overall Study|Moved Out of State|0|||
33676191|NCT02635386|63115603|FG004|Overall Study|Moved Out of State|0|||
33676192|NCT02635386|63115599|FG000|Overall Study|Noncompliant|0|||
33584480|NCT02570165|62982494|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
33584481|NCT02570165|62982495|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
33676193|NCT02635386|63115600|FG001|Overall Study|Noncompliant|2|||
33676194|NCT02635386|63115601|FG002|Overall Study|Noncompliant|1|||
33676195|NCT02635386|63115602|FG003|Overall Study|Noncompliant|1|||
33676196|NCT02635386|63115603|FG004|Overall Study|Noncompliant|1|||
33676197|NCT02635386|63115599|FG000|Overall Study|side effects|0|||
33676198|NCT02635386|63115600|FG001|Overall Study|side effects|0|||
33676199|NCT02635386|63115601|FG002|Overall Study|side effects|1|||
33676200|NCT02635386|63115602|FG003|Overall Study|side effects|4|||
33676201|NCT02635386|63115603|FG004|Overall Study|side effects|6|||
33676202|NCT02635386|63115599|FG000|Overall Study|needed other major surgery|0|||
33676203|NCT02635386|63115600|FG001|Overall Study|needed other major surgery|1|||
33676204|NCT02635386|63115601|FG002|Overall Study|needed other major surgery|0|||
33676205|NCT02635386|63115602|FG003|Overall Study|needed other major surgery|0|||
33676206|NCT02635386|63115603|FG004|Overall Study|needed other major surgery|0|||
33676207|NCT02635386|63115599|FG000|Overall Study|Other medical problems not drug related|0|||
33676208|NCT02635386|63115600|FG001|Overall Study|Other medical problems not drug related|0|||
33676209|NCT02635386|63115601|FG002|Overall Study|Other medical problems not drug related|0|||
33676210|NCT02635386|63115602|FG003|Overall Study|Other medical problems not drug related|1|||
33676211|NCT02635386|63115603|FG004|Overall Study|Other medical problems not drug related|0|||
33676212|NCT02634606|63115701|FG000|Overall Study|unable to obtain the drug at start|13|||
33676213|NCT01672866|63115747|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
33676214|NCT01672866|63115748|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
33676215|NCT01672866|63115749|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
33676216|NCT01672866|63115747|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
33676217|NCT01672866|63115748|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
33676218|NCT01672866|63115749|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
33676219|NCT01672866|63115747|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
33676220|NCT01672866|63115748|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
33676221|NCT01672866|63115749|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
33676222|NCT01672866|63115747|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
33676223|NCT01672866|63115748|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
33676224|NCT01672866|63115749|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
33676225|NCT01672866|63115747|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
33676226|NCT01672866|63115748|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
33676227|NCT01672866|63115749|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
33676228|NCT01672866|63115747|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
33676229|NCT01672866|63115748|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
33676230|NCT01672866|63115749|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
33676231|NCT01672866|63115747|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
33676232|NCT01672866|63115748|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
33676233|NCT01672866|63115749|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
33676234|NCT01672866|63115747|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
33676235|NCT01672866|63115748|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
33676236|NCT01672866|63115749|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
33676237|NCT01672866|63115747|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
33676238|NCT01672866|63115748|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
33676239|NCT01672866|63115749|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
33676240|NCT01672866|63115747|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
33676241|NCT01672866|63115748|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
33676242|NCT01672866|63115749|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
33676243|NCT01672866|63115747|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
33676244|NCT01672866|63115748|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
33676245|NCT01672866|63115749|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
33676246|NCT01672866|63115747|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
33676247|NCT01672866|63115748|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
33676248|NCT01672866|63115749|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
33676249|NCT01672866|63115747|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
33676250|NCT01672866|63115748|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
33676251|NCT01672866|63115749|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
33676252|NCT04465877|63115975|FG000|Overall Study|Noncompliant with study requirements|0|||
33676253|NCT04465877|63115976|FG001|Overall Study|Noncompliant with study requirements|0|||
33676254|NCT04465877|63115977|FG002|Overall Study|Noncompliant with study requirements|1|||
33676255|NCT04465877|63115978|FG003|Overall Study|Noncompliant with study requirements|0|||
33676256|NCT04267133|63116035|FG000|Overall Study|Withdrawal by Subject|1|||
33676257|NCT04267133|63116035|FG000|Overall Study|Adverse Event|4|||
33676258|NCT02631876|63116166|FG000|Overall Study|Death|96|||
33676259|NCT02631876|63116167|FG001|Overall Study|Death|50|||
33676260|NCT02631876|63116166|FG000|Overall Study|Investigator's discretion|1|||
33676261|NCT02631876|63116167|FG001|Overall Study|Investigator's discretion|0|||
33676262|NCT02631876|63116166|FG000|Overall Study|Lost to Follow-up|2|||
33676263|NCT02631876|63116167|FG001|Overall Study|Lost to Follow-up|0|||
33676264|NCT02631876|63116166|FG000|Overall Study|Withdrawal by Subject|16|||
33676265|NCT02631876|63116167|FG001|Overall Study|Withdrawal by Subject|9|||
33676266|NCT02631876|63116166|FG000|Overall Study|Other than specified|4|||
33310659|NCT00946309|62686060|FG000|Overall Study|Lost to Follow-up|0|||
33676267|NCT02631876|63116167|FG001|Overall Study|Other than specified|4|||
33676268|NCT02633046|63116196|FG000|Overall Study|Adverse Event|8|||
33676269|NCT02633046|63116196|FG000|Overall Study|Physician Decision|7|||
33676270|NCT02633046|63116196|FG000|Overall Study|Withdrawal by Subject|8|||
33676271|NCT02633046|63116196|FG000|Overall Study|Increased proteinuria|2|||
33676272|NCT02633046|63116196|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
33676273|NCT02633046|63116196|FG000|Overall Study|Mutual decision patient and physician|1|||
33676274|NCT01672788|63116255|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
33676275|NCT01672788|63116256|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
33676276|NCT01672788|63116257|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
33676277|NCT01672788|63116258|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
33676278|NCT02632110|63116273|FG000|Overall Study|Withdrawal by Subject|1|||
33676279|NCT02632110|63116274|FG001|Overall Study|Withdrawal by Subject|1|||
33676280|NCT02632110|63116275|FG002|Overall Study|Withdrawal by Subject|0|||
33676281|NCT02632110|63116276|FG003|Overall Study|Withdrawal by Subject|0|||
33676282|NCT02632110|63116277|FG004|Overall Study|Withdrawal by Subject|1|||
33676283|NCT02632110|63116278|FG005|Overall Study|Withdrawal by Subject|1|||
33676284|NCT02632110|63116279|FG006|Overall Study|Withdrawal by Subject|3|||
33676285|NCT02632110|63116280|FG007|Overall Study|Withdrawal by Subject|3|||
33676286|NCT02632110|63116281|FG008|Overall Study|Withdrawal by Subject|1|||
33676287|NCT02632110|63116282|FG009|Overall Study|Withdrawal by Subject|1|||
33676288|NCT01672710|63116524|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
33676289|NCT01672710|63116525|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
33676290|NCT01672710|63116524|FG000|3 Month Follow up|Lost to Follow-up|2|||
33676291|NCT01672710|63116525|FG001|3 Month Follow up|Lost to Follow-up|3|||
33676292|NCT01672710|63116524|FG000|3 Month Follow up|follow up due after termination date|4|||
33676293|NCT01672710|63116525|FG001|3 Month Follow up|follow up due after termination date|1|||
33676294|NCT02630472|63116560|FG000|Overall Study|Physician Decision|10|||
33676295|NCT02630472|63116561|FG001|Overall Study|Physician Decision|0|||
33676296|NCT01670526|63116597|FG000|Overall Study|Withdrawal by Subject|3|||
33676297|NCT01670526|63116598|FG001|Overall Study|Withdrawal by Subject|1|||
33676298|NCT01670526|63116597|FG000|Overall Study|Lost to Follow-up|9|||
33676299|NCT01670526|63116598|FG001|Overall Study|Lost to Follow-up|5|||
33676300|NCT02630706|63116642|FG000|Overall Study|Adverse Event|2|||
33676301|NCT02630706|63116643|FG001|Overall Study|Adverse Event|1|||
33676302|NCT02630706|63116644|FG002|Overall Study|Adverse Event|1|||
33676303|NCT02630706|63116642|FG000|Overall Study|Lost to Follow-up|0|||
33676304|NCT02630706|63116643|FG001|Overall Study|Lost to Follow-up|1|||
33676305|NCT02630706|63116644|FG002|Overall Study|Lost to Follow-up|2|||
33676306|NCT02630706|63116642|FG000|Overall Study|Physician Decision|1|||
33676307|NCT02630706|63116643|FG001|Overall Study|Physician Decision|1|||
33676308|NCT02630706|63116644|FG002|Overall Study|Physician Decision|0|||
33676309|NCT02630706|63116642|FG000|Overall Study|Pregnancy|0|||
33676310|NCT02630706|63116643|FG001|Overall Study|Pregnancy|1|||
33676311|NCT02630706|63116644|FG002|Overall Study|Pregnancy|0|||
33676312|NCT02630706|63116642|FG000|Overall Study|Withdrawal by Subject|4|||
33676313|NCT02630706|63116643|FG001|Overall Study|Withdrawal by Subject|5|||
33676314|NCT02630706|63116644|FG002|Overall Study|Withdrawal by Subject|7|||
33676315|NCT02089997|63116821|FG000|Overall Study|Case report forms uncollected|99|||
33676316|NCT02089997|63116821|FG000|Overall Study|Protocol Violation|147|||
33676317|NCT01363661|63116827|FG000|Overall Study|Adverse Event|9|||
33676318|NCT01363661|63116828|FG001|Overall Study|Adverse Event|2|||
33676319|NCT01363661|63116827|FG000|Overall Study|Withdrawal by Subject|1|||
33676320|NCT01363661|63116828|FG001|Overall Study|Withdrawal by Subject|1|||
33676321|NCT01363661|63116827|FG000|Overall Study|Protocol Violation|1|||
33676322|NCT01363661|63116828|FG001|Overall Study|Protocol Violation|0|||
33676323|NCT01363661|63116827|FG000|Overall Study|Lost to Follow-up|3|||
33676324|NCT01363661|63116828|FG001|Overall Study|Lost to Follow-up|1|||
33676325|NCT02628600|63116836|FG000|Overall Study|Death|2|||
33676326|NCT02628600|63116837|FG001|Overall Study|Death|1|||
33676327|NCT02628600|63116836|FG000|Overall Study|Adverse Event|3|||
33676328|NCT02628600|63116837|FG001|Overall Study|Adverse Event|20|||
33676329|NCT02628600|63116836|FG000|Overall Study|Protocol Violation|0|||
33676330|NCT02628600|63116837|FG001|Overall Study|Protocol Violation|1|||
33676331|NCT02628600|63116836|FG000|Overall Study|Lack of Efficacy|2|||
33676332|NCT02628600|63116837|FG001|Overall Study|Lack of Efficacy|0|||
33676333|NCT02628600|63116836|FG000|Overall Study|Withdrawal by Subject|13|||
33676334|NCT02628600|63116837|FG001|Overall Study|Withdrawal by Subject|8|||
33676335|NCT02628600|63116836|FG000|Overall Study|Lost to Follow-up|1|||
33676336|NCT02628600|63116837|FG001|Overall Study|Lost to Follow-up|0|||
33676337|NCT02628600|63116836|FG000|Overall Study|Physician Decision|2|||
33676338|NCT02628600|63116837|FG001|Overall Study|Physician Decision|2|||
33676339|NCT02628600|63116836|FG000|Overall Study|Other not specified|1|||
33676340|NCT02628600|63116837|FG001|Overall Study|Other not specified|0|||
33676341|NCT00591318|63116854|FG000|Overall Study|Lack of Efficacy|2|||
33676342|NCT00591318|63116855|FG001|Overall Study|Lack of Efficacy|0|||
33676343|NCT00591318|63116854|FG000|Overall Study|Adverse Event|2|||
33676344|NCT00591318|63116855|FG001|Overall Study|Adverse Event|0|||
33676345|NCT01360632|63116868|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
33676346|NCT01360632|63116869|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
33676347|NCT01360632|63116870|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
33676348|NCT01360632|63116871|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
33676349|NCT01360632|63116872|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
33676350|NCT01360632|63116868|FG000|Phase A (8 Weeks)|Adverse Event|60|||
33676351|NCT01360632|63116869|FG001|Phase A (8 Weeks)|Adverse Event|0|||
33676352|NCT01360632|63116870|FG002|Phase A (8 Weeks)|Adverse Event|0|||
33676353|NCT01360632|63116871|FG003|Phase A (8 Weeks)|Adverse Event|0|||
33676354|NCT01360632|63116872|FG004|Phase A (8 Weeks)|Adverse Event|0|||
33676355|NCT01360632|63116868|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
33676356|NCT01360632|63116869|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
33676357|NCT01360632|63116870|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
33676358|NCT01360632|63116871|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
33676359|NCT01360632|63116872|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
33676360|NCT01360632|63116868|FG000|Phase A (8 Weeks)|Physician Decision|10|||
33676361|NCT01360632|63116869|FG001|Phase A (8 Weeks)|Physician Decision|0|||
33676362|NCT01360632|63116870|FG002|Phase A (8 Weeks)|Physician Decision|0|||
33676363|NCT01360632|63116871|FG003|Phase A (8 Weeks)|Physician Decision|0|||
33676364|NCT01360632|63116872|FG004|Phase A (8 Weeks)|Physician Decision|0|||
33676365|NCT01360632|63116868|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
33676366|NCT01360632|63116869|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
33676367|NCT01360632|63116870|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
33676368|NCT01360632|63116871|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
33676369|NCT01360632|63116872|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
33676370|NCT01360632|63116868|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
33676371|NCT01360632|63116869|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
33676372|NCT01360632|63116870|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
33676373|NCT01360632|63116871|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
33676374|NCT01360632|63116872|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
33676375|NCT01360632|63116868|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
33676376|NCT01360632|63116869|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
33676377|NCT01360632|63116870|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
33676378|NCT01360632|63116871|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
33676379|NCT01360632|63116872|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
33676380|NCT01360632|63116868|FG000|Phase B (6 Weeks)|Adverse Event|0|||
33676381|NCT01360632|63116869|FG001|Phase B (6 Weeks)|Adverse Event|3|||
33676382|NCT01360632|63116870|FG002|Phase B (6 Weeks)|Adverse Event|9|||
33676383|NCT01360632|63116871|FG003|Phase B (6 Weeks)|Adverse Event|3|||
33676384|NCT01360632|63116872|FG004|Phase B (6 Weeks)|Adverse Event|0|||
33676385|NCT01360632|63116868|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
33676386|NCT01360632|63116869|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
33676387|NCT01360632|63116870|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
33676388|NCT01360632|63116871|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
33676389|NCT01360632|63116872|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
33676390|NCT01360632|63116868|FG000|Phase B (6 Weeks)|Physician Decision|0|||
33676391|NCT01360632|63116869|FG001|Phase B (6 Weeks)|Physician Decision|0|||
33676392|NCT01360632|63116870|FG002|Phase B (6 Weeks)|Physician Decision|0|||
33676393|NCT01360632|63116871|FG003|Phase B (6 Weeks)|Physician Decision|1|||
33676394|NCT01360632|63116872|FG004|Phase B (6 Weeks)|Physician Decision|0|||
33676395|NCT01360632|63116868|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
33676396|NCT01360632|63116869|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
33676397|NCT01360632|63116870|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
33676398|NCT01360632|63116871|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
33676399|NCT01360632|63116872|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
33676400|NCT01360632|63116868|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
33676401|NCT01360632|63116869|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
33676402|NCT01360632|63116870|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
33676403|NCT01360632|63116871|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
33676404|NCT01360632|63116872|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
33676405|NCT01360632|63116868|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
33676406|NCT01360632|63116869|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
33676407|NCT01360632|63116870|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
33676408|NCT01360632|63116871|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
33676409|NCT01360632|63116872|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
33676410|NCT01360632|63116868|FG000|Phase A+|Lost to Follow-up|0|||
33676411|NCT01360632|63116869|FG001|Phase A+|Lost to Follow-up|0|||
33676412|NCT01360632|63116870|FG002|Phase A+|Lost to Follow-up|0|||
33676413|NCT01360632|63116871|FG003|Phase A+|Lost to Follow-up|0|||
33676414|NCT01360632|63116872|FG004|Phase A+|Lost to Follow-up|2|||
33676415|NCT01360632|63116868|FG000|Phase A+|Adverse Event|0|||
33676416|NCT01360632|63116869|FG001|Phase A+|Adverse Event|0|||
33676417|NCT01360632|63116870|FG002|Phase A+|Adverse Event|0|||
33676418|NCT01360632|63116871|FG003|Phase A+|Adverse Event|0|||
33676419|NCT01360632|63116872|FG004|Phase A+|Adverse Event|2|||
33676420|NCT01360632|63116868|FG000|Phase A+|Met Withdrawal Criteria|0|||
33676421|NCT01360632|63116869|FG001|Phase A+|Met Withdrawal Criteria|0|||
33676422|NCT01360632|63116870|FG002|Phase A+|Met Withdrawal Criteria|0|||
33676423|NCT01360632|63116871|FG003|Phase A+|Met Withdrawal Criteria|0|||
33676424|NCT01360632|63116872|FG004|Phase A+|Met Withdrawal Criteria|7|||
33676425|NCT01360632|63116868|FG000|Phase A+|Physician Decision|0|||
33676426|NCT01360632|63116869|FG001|Phase A+|Physician Decision|0|||
33676427|NCT01360632|63116870|FG002|Phase A+|Physician Decision|0|||
33676428|NCT01360632|63116871|FG003|Phase A+|Physician Decision|0|||
33676429|NCT01360632|63116872|FG004|Phase A+|Physician Decision|3|||
33676430|NCT01360632|63116868|FG000|Phase A+|Withdrawal by Subject|0|||
33676431|NCT01360632|63116869|FG001|Phase A+|Withdrawal by Subject|0|||
33676432|NCT01360632|63116870|FG002|Phase A+|Withdrawal by Subject|0|||
33676433|NCT01360632|63116871|FG003|Phase A+|Withdrawal by Subject|0|||
33676434|NCT01360632|63116872|FG004|Phase A+|Withdrawal by Subject|8|||
33676435|NCT01360632|63116868|FG000|Phase A+|Protocol Deviation|0|||
33676436|NCT01360632|63116869|FG001|Phase A+|Protocol Deviation|0|||
33676437|NCT01360632|63116870|FG002|Phase A+|Protocol Deviation|0|||
33676438|NCT01360632|63116871|FG003|Phase A+|Protocol Deviation|0|||
33676439|NCT01360632|63116872|FG004|Phase A+|Protocol Deviation|3|||
33676440|NCT04157400|63116918|FG000|Overall Study|Withdrawal by Subject|1|||
33676441|NCT04157400|63116918|FG000|Overall Study|Lost to Follow-up|3|||
33676442|NCT02626182|63116992|FG000|Overall Study|Adverse Event|2|||
33676443|NCT02626182|63116993|FG001|Overall Study|Adverse Event|0|||
33676444|NCT01669902|63117100|FG000|Overall Study|Adverse Event|11|||
33676445|NCT01669902|63117100|FG000|Overall Study|Lack of Efficacy|10|||
33676446|NCT01669902|63117100|FG000|Overall Study|Other|8|||
33676447|NCT01670292|63117133|FG000|Overall Study|Lost to Follow-up|14|||
33676448|NCT01360554|63117370|FG000|Overall Study|Death|359|||
33676449|NCT01360554|63117371|FG001|Overall Study|Death|371|||
33676450|NCT01360554|63117370|FG000|Overall Study|Lost to Follow-up|4|||
33676451|NCT01360554|63117371|FG001|Overall Study|Lost to Follow-up|4|||
33676452|NCT01360554|63117370|FG000|Overall Study|Withdrawal by Subject|23|||
33676453|NCT01360554|63117371|FG001|Overall Study|Withdrawal by Subject|24|||
33676454|NCT01360554|63117370|FG000|Overall Study|Study terminated by sponsor|49|||
33676455|NCT01360554|63117371|FG001|Overall Study|Study terminated by sponsor|37|||
33676456|NCT01360554|63117370|FG000|Overall Study|Other, not specified|1|||
33676457|NCT01360554|63117371|FG001|Overall Study|Other, not specified|0|||
33676458|NCT01360554|63117370|FG000|Overall Study|Randomized but not treated.|3|||
33676459|NCT01360554|63117371|FG001|Overall Study|Randomized but not treated.|3|||
33676460|NCT01360398|63117393|FG000|Overall Study|Withdrawal by Subject|14|||
33676461|NCT01360398|63117393|FG000|Overall Study|Other|7|||
33676462|NCT01360398|63117393|FG000|Overall Study|Migrated/moved from study area|1|||
33676463|NCT02626026|63117403|FG000|Overall Study|Randomized but Never Treated|0|||
33676464|NCT02626026|63117404|FG001|Overall Study|Randomized but Never Treated|0|||
33676465|NCT02626026|63117405|FG002|Overall Study|Randomized but Never Treated|0|||
33676466|NCT02626026|63117406|FG003|Overall Study|Randomized but Never Treated|0|||
33676467|NCT02626026|63117407|FG004|Overall Study|Randomized but Never Treated|1|||
33676468|NCT02626026|63117408|FG005|Overall Study|Randomized but Never Treated|0|||
33676469|NCT01765296|63117668|FG000|Overall Study|Protocol Violation|0|||
33676470|NCT01765296|63117669|FG001|Overall Study|Protocol Violation|5|||
33676471|NCT01765296|63117670|FG002|Overall Study|Protocol Violation|4|||
33676472|NCT01765296|63117668|FG000|Overall Study|Withdrawal by Subject|4|||
33676473|NCT01765296|63117669|FG001|Overall Study|Withdrawal by Subject|2|||
33676474|NCT01765296|63117670|FG002|Overall Study|Withdrawal by Subject|2|||
33676475|NCT01765296|63117668|FG000|Overall Study|Adverse Event|1|||
33676476|NCT01765296|63117669|FG001|Overall Study|Adverse Event|13|||
33676477|NCT01765296|63117670|FG002|Overall Study|Adverse Event|5|||
33676478|NCT01765296|63117668|FG000|Overall Study|Lack of Efficacy|0|||
33676479|NCT01765296|63117669|FG001|Overall Study|Lack of Efficacy|0|||
33676480|NCT01765296|63117670|FG002|Overall Study|Lack of Efficacy|2|||
33676481|NCT02089685|63117744|FG000|Overall Study|Adverse Event|1|||
33676482|NCT02089685|63117745|FG001|Overall Study|Adverse Event|0|||
33584482|NCT02570165|62982496|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
33584483|NCT02570165|62982497|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
33584484|NCT02570165|62982498|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
33584485|NCT02570165|62982499|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
33584486|NCT02570165|62982500|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
33584487|NCT02570165|62982494|FG000|Overall Study|Withdrawal Request by GSK|0|||
33584488|NCT02570165|62982495|FG001|Overall Study|Withdrawal Request by GSK|0|||
33584489|NCT02570165|62982496|FG002|Overall Study|Withdrawal Request by GSK|2|||
33584490|NCT02570165|62982497|FG003|Overall Study|Withdrawal Request by GSK|0|||
33584491|NCT02570165|62982498|FG004|Overall Study|Withdrawal Request by GSK|0|||
33584492|NCT02570165|62982499|FG005|Overall Study|Withdrawal Request by GSK|0|||
33676483|NCT02089685|63117746|FG002|Overall Study|Adverse Event|0|||
33676484|NCT02089685|63117747|FG003|Overall Study|Adverse Event|0|||
33676485|NCT02089685|63117748|FG004|Overall Study|Adverse Event|1|||
33676486|NCT02089685|63117749|FG005|Overall Study|Adverse Event|0|||
33676487|NCT02089685|63117744|FG000|Overall Study|Clinical Progression|4|||
33676488|NCT02089685|63117745|FG001|Overall Study|Clinical Progression|0|||
33676489|NCT02089685|63117746|FG002|Overall Study|Clinical Progression|0|||
33676490|NCT02089685|63117747|FG003|Overall Study|Clinical Progression|5|||
33676491|NCT02089685|63117748|FG004|Overall Study|Clinical Progression|1|||
33676492|NCT02089685|63117749|FG005|Overall Study|Clinical Progression|2|||
33676493|NCT02089685|63117744|FG000|Overall Study|Excluded Medication|1|||
33676494|NCT02089685|63117745|FG001|Overall Study|Excluded Medication|0|||
33676495|NCT02089685|63117746|FG002|Overall Study|Excluded Medication|0|||
33676496|NCT02089685|63117747|FG003|Overall Study|Excluded Medication|11|||
33676497|NCT02089685|63117748|FG004|Overall Study|Excluded Medication|2|||
33676498|NCT02089685|63117749|FG005|Overall Study|Excluded Medication|1|||
33676499|NCT02089685|63117744|FG000|Overall Study|Progressive disease|13|||
33676500|NCT02089685|63117745|FG001|Overall Study|Progressive disease|10|||
33676501|NCT02089685|63117746|FG002|Overall Study|Progressive disease|3|||
33676502|NCT02089685|63117747|FG003|Overall Study|Progressive disease|51|||
33676503|NCT02089685|63117748|FG004|Overall Study|Progressive disease|17|||
33676504|NCT02089685|63117749|FG005|Overall Study|Progressive disease|12|||
33676505|NCT02089685|63117744|FG000|Overall Study|Follow up ended by sponsor|2|||
33676506|NCT02089685|63117745|FG001|Overall Study|Follow up ended by sponsor|2|||
33676507|NCT02089685|63117746|FG002|Overall Study|Follow up ended by sponsor|0|||
33676508|NCT02089685|63117747|FG003|Overall Study|Follow up ended by sponsor|70|||
33676509|NCT02089685|63117748|FG004|Overall Study|Follow up ended by sponsor|26|||
33676510|NCT02089685|63117749|FG005|Overall Study|Follow up ended by sponsor|26|||
33676511|NCT02089685|63117744|FG000|Overall Study|Withdrawal by Subject|0|||
33676512|NCT02089685|63117745|FG001|Overall Study|Withdrawal by Subject|2|||
33676513|NCT02089685|63117746|FG002|Overall Study|Withdrawal by Subject|0|||
33676514|NCT02089685|63117747|FG003|Overall Study|Withdrawal by Subject|8|||
33676515|NCT02089685|63117748|FG004|Overall Study|Withdrawal by Subject|1|||
33676516|NCT02089685|63117749|FG005|Overall Study|Withdrawal by Subject|1|||
33676517|NCT02089685|63117744|FG000|Overall Study|Status not recorded|1|||
33676518|NCT02089685|63117745|FG001|Overall Study|Status not recorded|0|||
33676519|NCT02089685|63117746|FG002|Overall Study|Status not recorded|0|||
33676520|NCT02089685|63117747|FG003|Overall Study|Status not recorded|0|||
33676521|NCT02089685|63117748|FG004|Overall Study|Status not recorded|1|||
33676522|NCT02089685|63117749|FG005|Overall Study|Status not recorded|0|||
33676523|NCT02089685|63117744|FG000|Overall Study|Death|0|||
33676524|NCT02089685|63117745|FG001|Overall Study|Death|0|||
33676525|NCT02089685|63117746|FG002|Overall Study|Death|0|||
33676526|NCT02089685|63117747|FG003|Overall Study|Death|7|||
33676527|NCT02089685|63117748|FG004|Overall Study|Death|2|||
33676528|NCT02089685|63117749|FG005|Overall Study|Death|5|||
33676529|NCT02089685|63117744|FG000|Overall Study|Lost to Follow-up|0|||
33676530|NCT02089685|63117745|FG001|Overall Study|Lost to Follow-up|0|||
33676531|NCT02089685|63117746|FG002|Overall Study|Lost to Follow-up|0|||
33676532|NCT02089685|63117747|FG003|Overall Study|Lost to Follow-up|1|||
33676533|NCT02089685|63117748|FG004|Overall Study|Lost to Follow-up|0|||
33676534|NCT02089685|63117749|FG005|Overall Study|Lost to Follow-up|0|||
33676535|NCT02089685|63117744|FG000|Overall Study|Physician Decision|0|||
33676536|NCT02089685|63117745|FG001|Overall Study|Physician Decision|0|||
33676537|NCT02089685|63117746|FG002|Overall Study|Physician Decision|0|||
33676538|NCT02089685|63117747|FG003|Overall Study|Physician Decision|0|||
33676539|NCT02089685|63117748|FG004|Overall Study|Physician Decision|0|||
33676540|NCT02089685|63117749|FG005|Overall Study|Physician Decision|4|||
33676541|NCT02089685|63117744|FG000|Overall Study|Screen failure|1|||
33676542|NCT02089685|63117745|FG001|Overall Study|Screen failure|0|||
33676543|NCT02089685|63117746|FG002|Overall Study|Screen failure|0|||
33676544|NCT02089685|63117747|FG003|Overall Study|Screen failure|0|||
33676545|NCT02089685|63117748|FG004|Overall Study|Screen failure|0|||
33676546|NCT02089685|63117749|FG005|Overall Study|Screen failure|0|||
33676547|NCT05282004|63117807|FG000|Overall Study|Adverse Event|2|||
33676548|NCT05004649|63117811|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
33676549|NCT05004649|63117811|FG000|Overall Study|Lost to Follow-up|1|||
33676550|NCT05004649|63117811|FG000|Overall Study|Withdrawal by Subject|2|||
33676551|NCT05004649|63117811|FG000|Overall Study|COVID-19|1|||
33676552|NCT04666298|63117821|FG000|Overall Study|Subject decision|1|||
33676553|NCT04666298|63117822|FG001|Overall Study|Subject decision|0|||
33676554|NCT04666298|63117823|FG002|Overall Study|Subject decision|0|||
33676555|NCT04666298|63117824|FG003|Overall Study|Subject decision|2|||
33676556|NCT04666298|63117821|FG000|Overall Study|Death|1|||
33676557|NCT04666298|63117822|FG001|Overall Study|Death|0|||
33676558|NCT04666298|63117823|FG002|Overall Study|Death|0|||
33676559|NCT04666298|63117824|FG003|Overall Study|Death|0|||
33676560|NCT04666298|63117821|FG000|Overall Study|Lost to Follow-up|0|||
33676561|NCT04666298|63117822|FG001|Overall Study|Lost to Follow-up|0|||
33676562|NCT04666298|63117823|FG002|Overall Study|Lost to Follow-up|0|||
33676563|NCT04666298|63117824|FG003|Overall Study|Lost to Follow-up|1|||
33676564|NCT04666298|63117821|FG000|Overall Study|Physician Decision|0|||
33676565|NCT04666298|63117822|FG001|Overall Study|Physician Decision|0|||
33676566|NCT04666298|63117823|FG002|Overall Study|Physician Decision|0|||
33676567|NCT04666298|63117824|FG003|Overall Study|Physician Decision|1|||
33676568|NCT04666298|63117821|FG000|Overall Study|Protocol deviation|0|||
33676569|NCT04666298|63117822|FG001|Overall Study|Protocol deviation|0|||
33676570|NCT04666298|63117823|FG002|Overall Study|Protocol deviation|1|||
33676571|NCT04666298|63117824|FG003|Overall Study|Protocol deviation|0|||
33676572|NCT04581200|63117836|FG000|Overall Study|Lost to Follow-up|6|||
33676573|NCT04581200|63117837|FG001|Overall Study|Lost to Follow-up|5|||
33676574|NCT04303780|63117872|FG000|Overall Study|Death|104|||
33676575|NCT04303780|63117873|FG001|Overall Study|Death|85|||
33676576|NCT04303780|63117872|FG000|Overall Study|Lost to Follow-up|5|||
33676577|NCT04303780|63117873|FG001|Overall Study|Lost to Follow-up|2|||
33676578|NCT04303780|63117872|FG000|Overall Study|Withdrawal by Subject|12|||
33676579|NCT04303780|63117873|FG001|Overall Study|Withdrawal by Subject|39|||
33676580|NCT04303780|63117872|FG000|Overall Study|Ongoing in study|50|||
33676581|NCT04303780|63117873|FG001|Overall Study|Ongoing in study|45|||
33676582|NCT04188301|63117883|FG000|Month 3|Lost to Follow-up|0|||
33676583|NCT04188301|63117884|FG001|Month 3|Lost to Follow-up|0|||
33676584|NCT04188301|63117885|FG002|Month 3|Lost to Follow-up|1|||
33676585|NCT04188301|63117883|FG000|Month 12|Lost to Follow-up|0|||
33676586|NCT04188301|63117884|FG001|Month 12|Lost to Follow-up|0|||
33676587|NCT04188301|63117885|FG002|Month 12|Lost to Follow-up|2|||
33676588|NCT04188301|63117883|FG000|Month 12|Death|1|||
33676589|NCT04188301|63117884|FG001|Month 12|Death|1|||
33676590|NCT04188301|63117885|FG002|Month 12|Death|0|||
33676591|NCT04188301|63117883|FG000|Month 18|Lost to Follow-up|6|||
33676592|NCT04188301|63117884|FG001|Month 18|Lost to Follow-up|0|||
33676593|NCT04188301|63117885|FG002|Month 18|Lost to Follow-up|0|||
33676594|NCT04006925|63117895|FG000|Overall Study|Side effects|2|||
33676595|NCT04006925|63117896|FG001|Overall Study|Side effects|0|||
33676596|NCT03599713|63117908|FG000|Overall Study|Death|26|||
33676597|NCT03599713|63117909|FG001|Overall Study|Death|3|||
33676598|NCT03599713|63117908|FG000|Overall Study|Withdrawal by Subject|6|||
33676599|NCT03599713|63117909|FG001|Overall Study|Withdrawal by Subject|0|||
33676600|NCT03599713|63117908|FG000|Overall Study|Ongoing|69|||
33676601|NCT03599713|63117909|FG001|Overall Study|Ongoing|3|||
33676602|NCT03597061|63117919|FG000|Overall Study|Lost to Follow-up|1|||
33676603|NCT03597061|63117920|FG001|Overall Study|Lost to Follow-up|0|||
33676604|NCT03597061|63117919|FG000|Overall Study|Protocol Violation|0|||
33676605|NCT03597061|63117920|FG001|Overall Study|Protocol Violation|1|||
33676606|NCT03148795|63117948|FG000|Overall Study|Death|6|||
33676607|NCT03148795|63117948|FG000|Overall Study|Adverse Event|5|||
33676608|NCT03148795|63117948|FG000|Overall Study|Other|15|||
33676609|NCT03148795|63117948|FG000|Overall Study|No Longer Clinically Benefitting|2|||
33676610|NCT03148795|63117948|FG000|Overall Study|Global Deterioration Of Health Status|6|||
33676611|NCT03148795|63117948|FG000|Overall Study|Withdrawal by Subject|2|||
33676612|NCT03148795|63117948|FG000|Overall Study|Progressive Disease|62|||
33676613|NCT03148795|63117948|FG000|Overall Study|Ongoing|30|||
33676614|NCT03146845|63117954|FG000|Overall Study|Reference ulcer healed|1|||
33676615|NCT03146845|63117955|FG001|Overall Study|Reference ulcer healed|0|||
33676616|NCT03146845|63117954|FG000|Overall Study|Physician Decision|1|||
33676617|NCT03146845|63117955|FG001|Overall Study|Physician Decision|0|||
33676618|NCT03146845|63117954|FG000|Overall Study|Adverse Event|1|||
33676619|NCT03146845|63117955|FG001|Overall Study|Adverse Event|0|||
33676620|NCT03146845|63117954|FG000|Overall Study|Withdrawal by Subject|2|||
33676621|NCT03146845|63117955|FG001|Overall Study|Withdrawal by Subject|0|||
33676622|NCT03146845|63117954|FG000|Overall Study|Noncompliance|0|||
33676623|NCT03146845|63117955|FG001|Overall Study|Noncompliance|1|||
33676624|NCT03146845|63117954|FG000|Overall Study|Protocol Violation|0|||
33676625|NCT03146845|63117955|FG001|Overall Study|Protocol Violation|2|||
33676626|NCT03146845|63117954|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
33676627|NCT03146845|63117955|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
33676628|NCT02975700|63117961|FG000|Overall Study|Adverse Event|1|||
33676629|NCT02975700|63117961|FG000|Overall Study|Progressive disease|3|||
33676630|NCT02975700|63117961|FG000|Overall Study|Failed screening criteria|2|||
33676631|NCT02895360|63117971|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
33676632|NCT02895360|63117972|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
33676633|NCT02895360|63117973|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
33676634|NCT02895360|63117974|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
33676635|NCT02895360|63117975|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
33676636|NCT02895360|63117976|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
33676637|NCT02895360|63117971|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
33676638|NCT02895360|63117972|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
33676639|NCT02895360|63117973|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
33676640|NCT02895360|63117974|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
33676641|NCT02895360|63117975|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
33676642|NCT02895360|63117976|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
33676643|NCT02895360|63117971|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
33676644|NCT02895360|63117972|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
33676645|NCT02895360|63117973|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
33676646|NCT02895360|63117974|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
33676647|NCT02895360|63117975|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
33676648|NCT02895360|63117976|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
33676649|NCT02895360|63117971|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
33676650|NCT02895360|63117972|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
33676651|NCT02895360|63117973|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
33676652|NCT02895360|63117974|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
33676653|NCT02895360|63117975|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
33676654|NCT02895360|63117976|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
33676655|NCT02895360|63117971|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
33676656|NCT02895360|63117972|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
33676657|NCT02895360|63117973|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
33676658|NCT02895360|63117974|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
33676659|NCT02895360|63117975|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
33676660|NCT02895360|63117976|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
33676661|NCT02895360|63117971|FG000|Phase 2a|Adverse Event|0|||
33676662|NCT02895360|63117972|FG001|Phase 2a|Adverse Event|0|||
33676663|NCT02895360|63117973|FG002|Phase 2a|Adverse Event|0|||
33676664|NCT02895360|63117974|FG003|Phase 2a|Adverse Event|0|||
33676665|NCT02895360|63117975|FG004|Phase 2a|Adverse Event|0|||
33676666|NCT02895360|63117976|FG005|Phase 2a|Adverse Event|1|||
33676667|NCT02895360|63117971|FG000|Phase 2a|Progressive disease|0|||
33676668|NCT02895360|63117972|FG001|Phase 2a|Progressive disease|0|||
33676669|NCT02895360|63117973|FG002|Phase 2a|Progressive disease|0|||
33676670|NCT02895360|63117974|FG003|Phase 2a|Progressive disease|0|||
33676671|NCT02895360|63117975|FG004|Phase 2a|Progressive disease|11|||
33676672|NCT02895360|63117976|FG005|Phase 2a|Progressive disease|11|||
33676673|NCT02863809|63118010|FG000|Overall Study|Adverse Event|8|||
33676674|NCT02863809|63118011|FG001|Overall Study|Adverse Event|8|||
33676675|NCT02863809|63118010|FG000|Overall Study|Withdrawal by Subject|0|||
33676676|NCT02863809|63118011|FG001|Overall Study|Withdrawal by Subject|1|||
33676677|NCT02863809|63118010|FG000|Overall Study|Lost to Follow-up|1|||
33676678|NCT02863809|63118011|FG001|Overall Study|Lost to Follow-up|1|||
33676679|NCT02863809|63118010|FG000|Overall Study|Death|1|||
33676680|NCT02863809|63118011|FG001|Overall Study|Death|0|||
33676681|NCT02829957|63118019|FG000|Overall Study|Lost to Follow-up|2|||
33676682|NCT02829957|63118020|FG001|Overall Study|Lost to Follow-up|1|||
33676683|NCT02753530|63118044|FG000|Overall Study|Adverse Event|7|||
33676684|NCT02753530|63118045|FG001|Overall Study|Adverse Event|1|||
33676685|NCT02753530|63118044|FG000|Overall Study|Death|0|||
33676686|NCT02753530|63118045|FG001|Overall Study|Death|1|||
33676687|NCT02753530|63118044|FG000|Overall Study|Physician Decision|0|||
33676688|NCT02753530|63118045|FG001|Overall Study|Physician Decision|1|||
33676689|NCT02753530|63118044|FG000|Overall Study|Protocol Violation|1|||
33676690|NCT02753530|63118045|FG001|Overall Study|Protocol Violation|0|||
33676691|NCT02753530|63118044|FG000|Overall Study|Withdrawal by Subject|4|||
33676692|NCT02753530|63118045|FG001|Overall Study|Withdrawal by Subject|3|||
33676693|NCT02289079|63118057|FG000|Overall Study|Physician Decision|2|||
33676694|NCT02289079|63118058|FG001|Overall Study|Physician Decision|0|||
33676695|NCT02289079|63118057|FG000|Overall Study|Lost to Follow-up|0|||
33676696|NCT02289079|63118058|FG001|Overall Study|Lost to Follow-up|1|||
33676697|NCT00602667|63118141|FG000|Overall Study|Still on Therapy|0|||
33676698|NCT00602667|63118142|FG001|Overall Study|Still on Therapy|2|||
33676699|NCT00602667|63118143|FG002|Overall Study|Still on Therapy|2|||
33676700|NCT00602667|63118141|FG000|Overall Study|Death|0|||
33676701|NCT00602667|63118142|FG001|Overall Study|Death|1|||
33676702|NCT00602667|63118143|FG002|Overall Study|Death|1|||
33584493|NCT02570165|62982500|FG006|Overall Study|Withdrawal Request by GSK|0|||
33584494|NCT02564471|62982520|FG000|Overall Study|Adverse Event|1|||
33584495|NCT02564471|62982521|FG001|Overall Study|Adverse Event|0|||
33584496|NCT02564471|62982522|FG002|Overall Study|Adverse Event|0|||
33584497|NCT02564471|62982523|FG003|Overall Study|Adverse Event|0|||
33584498|NCT02564471|62982520|FG000|Overall Study|Withdrawal by Subject|2|||
33584499|NCT02564471|62982521|FG001|Overall Study|Withdrawal by Subject|1|||
33584500|NCT02564471|62982522|FG002|Overall Study|Withdrawal by Subject|3|||
33584501|NCT02564471|62982523|FG003|Overall Study|Withdrawal by Subject|0|||
33584502|NCT02564471|62982520|FG000|Overall Study|Lost to Follow-up|0|||
33584503|NCT02564471|62982521|FG001|Overall Study|Lost to Follow-up|2|||
33584504|NCT02564471|62982522|FG002|Overall Study|Lost to Follow-up|0|||
33584505|NCT02564471|62982523|FG003|Overall Study|Lost to Follow-up|0|||
33584506|NCT02563067|62982536|FG000|Overall Study|Subject/guardian decision|14|||
33584507|NCT02563067|62982537|FG001|Overall Study|Subject/guardian decision|20|||
33584508|NCT02563067|62982538|FG002|Overall Study|Subject/guardian decision|16|||
33584509|NCT02563067|62982536|FG000|Overall Study|Physician Decision|0|||
33676703|NCT00602667|63118141|FG000|Overall Study|Family request|3|||
33676704|NCT00602667|63118142|FG001|Overall Study|Family request|25|||
33676705|NCT00602667|63118143|FG002|Overall Study|Family request|6|||
33676706|NCT00602667|63118141|FG000|Overall Study|Excessive toxicity|1|||
33676707|NCT00602667|63118142|FG001|Overall Study|Excessive toxicity|1|||
33676708|NCT00602667|63118143|FG002|Overall Study|Excessive toxicity|0|||
33676709|NCT00602667|63118141|FG000|Overall Study|Second malignancy|0|||
33676710|NCT00602667|63118142|FG001|Overall Study|Second malignancy|1|||
33676711|NCT00602667|63118143|FG002|Overall Study|Second malignancy|0|||
33676712|NCT00602667|63118141|FG000|Overall Study|Physician Decision|2|||
33676713|NCT00602667|63118142|FG001|Overall Study|Physician Decision|3|||
33676714|NCT00602667|63118143|FG002|Overall Study|Physician Decision|8|||
33676715|NCT00602667|63118141|FG000|Overall Study|Progressive disease|13|||
33676716|NCT00602667|63118142|FG001|Overall Study|Progressive disease|48|||
33676717|NCT00602667|63118143|FG002|Overall Study|Progressive disease|45|||
33676718|NCT00602667|63118141|FG000|Overall Study|Progressive disease prior to therapy|0|||
33676719|NCT00602667|63118142|FG001|Overall Study|Progressive disease prior to therapy|0|||
33676720|NCT00602667|63118143|FG002|Overall Study|Progressive disease prior to therapy|1|||
33676721|NCT02088905|63118186|FG000|Overall Study|Withdrawal by Subject|5|||
33676722|NCT02088905|63118187|FG001|Overall Study|Withdrawal by Subject|1|||
33676723|NCT02088047|63118195|FG000|Overall Study|Withdrawal by Subject|1|||
33676724|NCT02088047|63118196|FG001|Overall Study|Withdrawal by Subject|0|||
33676725|NCT02086565|63118222|FG000|Overall Study|Lost to Follow-up|9|||
33676726|NCT02086565|63118223|FG001|Overall Study|Lost to Follow-up|7|||
33676727|NCT02086565|63118222|FG000|Overall Study|Withdrawal by Subject|2|||
33676728|NCT02086565|63118223|FG001|Overall Study|Withdrawal by Subject|1|||
33676729|NCT02086565|63118222|FG000|Overall Study|Death|3|||
33676730|NCT02086565|63118223|FG001|Overall Study|Death|2|||
33676731|NCT02086565|63118222|FG000|Overall Study|withdrawn by research team|2|||
33676732|NCT02086565|63118223|FG001|Overall Study|withdrawn by research team|2|||
33676733|NCT02085941|63118231|FG000|Overall Study|Lack of Efficacy|1|||
33676734|NCT02085941|63118232|FG001|Overall Study|Lack of Efficacy|0|||
33676735|NCT02085941|63118231|FG000|Overall Study|Death|6|||
33676736|NCT02085941|63118232|FG001|Overall Study|Death|1|||
33676737|NCT02085941|63118231|FG000|Overall Study|Lost to Follow-up|1|||
33676738|NCT02085941|63118232|FG001|Overall Study|Lost to Follow-up|0|||
33676739|NCT02085941|63118231|FG000|Overall Study|Physician Decision|0|||
33676740|NCT02085941|63118232|FG001|Overall Study|Physician Decision|2|||
33676741|NCT02085785|63118240|FG000|Overall Study|Withdrawal by Subject|2|||
33676742|NCT02085785|63118241|FG001|Overall Study|Withdrawal by Subject|1|||
33676743|NCT02085785|63118240|FG000|Overall Study|Lost to Follow-up|0|||
33676744|NCT02085785|63118241|FG001|Overall Study|Lost to Follow-up|1|||
33676745|NCT02085161|63118269|FG000|Overall Study|Not Treated|1|||
33676746|NCT02085161|63118270|FG001|Overall Study|Not Treated|0|||
33676747|NCT02085161|63118271|FG002|Overall Study|Not Treated|0|||
33676748|NCT02085161|63118272|FG003|Overall Study|Not Treated|0|||
33676749|NCT02085161|63118269|FG000|Overall Study|Adverse Event|8|||
33676750|NCT02085161|63118270|FG001|Overall Study|Adverse Event|5|||
33676751|NCT02085161|63118271|FG002|Overall Study|Adverse Event|4|||
33676752|NCT02085161|63118272|FG003|Overall Study|Adverse Event|5|||
33676753|NCT02085161|63118269|FG000|Overall Study|Protocol Violation|0|||
33676754|NCT02085161|63118270|FG001|Overall Study|Protocol Violation|1|||
33676755|NCT02085161|63118271|FG002|Overall Study|Protocol Violation|0|||
33676756|NCT02085161|63118272|FG003|Overall Study|Protocol Violation|1|||
33676757|NCT02085161|63118269|FG000|Overall Study|Withdrawal by Subject|2|||
33676758|NCT02085161|63118270|FG001|Overall Study|Withdrawal by Subject|4|||
33676759|NCT02085161|63118271|FG002|Overall Study|Withdrawal by Subject|0|||
33676760|NCT02085161|63118272|FG003|Overall Study|Withdrawal by Subject|3|||
33676761|NCT02085161|63118269|FG000|Overall Study|Other Reason|1|||
33676762|NCT02085161|63118270|FG001|Overall Study|Other Reason|0|||
33676763|NCT02085161|63118271|FG002|Overall Study|Other Reason|1|||
33676764|NCT02085161|63118272|FG003|Overall Study|Other Reason|1|||
33676765|NCT02082977|63119155|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
33676766|NCT02082977|63119156|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
33676767|NCT02082977|63119157|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
33676768|NCT02082977|63119158|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
33676769|NCT02082977|63119159|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
33676770|NCT02082977|63119160|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
33676771|NCT02082977|63119161|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
33676772|NCT02082977|63119162|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
33676773|NCT02082977|63119163|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
33676774|NCT02082977|63119164|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
33676775|NCT02082977|63119155|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33676776|NCT02082977|63119156|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33676777|NCT02082977|63119157|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33676778|NCT02082977|63119158|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33676779|NCT02082977|63119159|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33676780|NCT02082977|63119160|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33676781|NCT02082977|63119161|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33676782|NCT02082977|63119162|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
33676783|NCT02082977|63119163|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33676784|NCT02082977|63119164|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33676785|NCT02082977|63119155|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33676786|NCT02082977|63119156|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33676787|NCT02082977|63119157|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33676788|NCT02082977|63119158|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33676789|NCT02082977|63119159|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33676790|NCT02082977|63119160|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
33676791|NCT02082977|63119161|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33676792|NCT02082977|63119162|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33676793|NCT02082977|63119163|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33676794|NCT02082977|63119164|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33676795|NCT02082977|63119155|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
33676796|NCT02082977|63119156|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
33676797|NCT02082977|63119157|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
33676798|NCT02082977|63119158|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
33676799|NCT02082977|63119159|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
33676800|NCT02082977|63119160|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
33676801|NCT02082977|63119161|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
33676802|NCT02082977|63119162|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
33676803|NCT02082977|63119163|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
33676804|NCT02082977|63119164|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
33676805|NCT02082977|63119155|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33676806|NCT02082977|63119156|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33676807|NCT02082977|63119157|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33676808|NCT02082977|63119158|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33676809|NCT02082977|63119159|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33676810|NCT02082977|63119160|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33676811|NCT02082977|63119161|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33676812|NCT02082977|63119162|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
33676813|NCT02082977|63119163|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33676814|NCT02082977|63119164|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33676815|NCT01624259|63119198|FG000|Overall Study|Adverse Event|18|||
33676816|NCT01624259|63119199|FG001|Overall Study|Adverse Event|18|||
33676817|NCT01624259|63119198|FG000|Overall Study|Protocol Violation|1|||
33676818|NCT01624259|63119199|FG001|Overall Study|Protocol Violation|2|||
33676819|NCT01624259|63119198|FG000|Overall Study|Withdrawal by Subject|5|||
33676820|NCT01624259|63119199|FG001|Overall Study|Withdrawal by Subject|7|||
33676821|NCT01624259|63119198|FG000|Overall Study|Physician Decision|1|||
33676822|NCT01624259|63119199|FG001|Overall Study|Physician Decision|1|||
33676823|NCT01624259|63119198|FG000|Overall Study|Lost to Follow-up|2|||
33676824|NCT01624259|63119199|FG001|Overall Study|Lost to Follow-up|3|||
33676825|NCT01624259|63119198|FG000|Overall Study|Abnormal laboratory measure|3|||
33676826|NCT01624259|63119199|FG001|Overall Study|Abnormal laboratory measure|0|||
33676827|NCT02081417|63119209|FG000|Overall Study|Lost to Follow-up|26|||
33676828|NCT02081417|63119210|FG001|Overall Study|Lost to Follow-up|23|||
33676829|NCT02081417|63119209|FG000|Overall Study|Moved Away|1|||
33676830|NCT02081417|63119210|FG001|Overall Study|Moved Away|2|||
33676831|NCT02081417|63119209|FG000|Overall Study|Incarcerated|2|||
33676832|NCT02081417|63119210|FG001|Overall Study|Incarcerated|2|||
33676833|NCT02081417|63119209|FG000|Overall Study|Death|4|||
33676834|NCT02081417|63119210|FG001|Overall Study|Death|3|||
33676835|NCT02081417|63119209|FG000|Overall Study|Withdrawal by Subject|4|||
33676836|NCT02081417|63119210|FG001|Overall Study|Withdrawal by Subject|0|||
33676837|NCT02081417|63119209|FG000|Overall Study|Admitted to Residential Treatment|2|||
33676838|NCT02081417|63119210|FG001|Overall Study|Admitted to Residential Treatment|0|||
33676839|NCT02081417|63119209|FG000|Overall Study|Did not start treatment|17|||
33676840|NCT02081417|63119210|FG001|Overall Study|Did not start treatment|21|||
33676841|NCT02081183|63119218|FG000|Overall Study|Lost to Follow-up|0|||
33676842|NCT02081183|63119219|FG001|Overall Study|Lost to Follow-up|1|||
33676843|NCT02081183|63119218|FG000|Overall Study|Protocol Violation|1|||
33676844|NCT02081183|63119219|FG001|Overall Study|Protocol Violation|0|||
33676845|NCT02081183|63119218|FG000|Overall Study|Other|3|||
33676846|NCT02081183|63119219|FG001|Overall Study|Other|3|||
33676847|NCT02080871|63119225|FG000|Overall Study|Death|1|||
33676848|NCT02080871|63119225|FG000|Overall Study|Lost to Follow-up|1|||
33676849|NCT02080481|63119231|FG000|Overall Study|Never received a block.|1|||
33676850|NCT02080481|63119232|FG001|Overall Study|Never received a block.|0|||
33676851|NCT02080403|63119240|FG000|Overall Study|Adverse Event|5|||
33676852|NCT02080403|63119241|FG001|Overall Study|Adverse Event|1|||
33676853|NCT02080403|63119240|FG000|Overall Study|Death|0|||
33676854|NCT02080403|63119241|FG001|Overall Study|Death|2|||
33676855|NCT02080403|63119240|FG000|Overall Study|Lost to Follow-up|2|||
33676856|NCT02080403|63119241|FG001|Overall Study|Lost to Follow-up|0|||
33676857|NCT02080403|63119240|FG000|Overall Study|Pregnancy|0|||
33676858|NCT02080403|63119241|FG001|Overall Study|Pregnancy|1|||
33676859|NCT02080403|63119240|FG000|Overall Study|Protocol Violation|3|||
33676860|NCT02080403|63119241|FG001|Overall Study|Protocol Violation|7|||
33676861|NCT02080403|63119240|FG000|Overall Study|Withdrawal by Subject|5|||
33676862|NCT02080403|63119241|FG001|Overall Study|Withdrawal by Subject|1|||
33676863|NCT02080091|63119247|FG000|Overall Study|Study Terminated|22|||
33676864|NCT02080091|63119247|FG000|Overall Study|Death|1|||
33676865|NCT02080091|63119247|FG000|Overall Study|Withdrawal by Subject|1|||
33676866|NCT02080091|63119247|FG000|Overall Study|Other|1|||
33676867|NCT02079077|63119253|FG000|Overall Study|Lost to Follow-up|5|||
33676868|NCT02079077|63119254|FG001|Overall Study|Lost to Follow-up|7|||
33676869|NCT02079077|63119253|FG000|Overall Study|Became STIs Positive|1|||
33676870|NCT02079077|63119254|FG001|Overall Study|Became STIs Positive|2|||
33676871|NCT02078219|63119282|FG000|Overall Study|Other|2|||
33676872|NCT02078219|63119283|FG001|Overall Study|Other|2|||
33676873|NCT02078219|63119284|FG002|Overall Study|Other|3|||
33676874|NCT02078219|63119285|FG003|Overall Study|Other|0|||
33676875|NCT02078219|63119286|FG004|Overall Study|Other|1|||
33676876|NCT02078219|63119282|FG000|Overall Study|Withdrawal by Subject|0|||
33676877|NCT02078219|63119283|FG001|Overall Study|Withdrawal by Subject|1|||
33676878|NCT02078219|63119284|FG002|Overall Study|Withdrawal by Subject|0|||
33676879|NCT02078219|63119285|FG003|Overall Study|Withdrawal by Subject|1|||
33676880|NCT02078219|63119286|FG004|Overall Study|Withdrawal by Subject|1|||
33676881|NCT02078219|63119282|FG000|Overall Study|Protocol Violation|0|||
33676882|NCT02078219|63119283|FG001|Overall Study|Protocol Violation|0|||
33676883|NCT02078219|63119284|FG002|Overall Study|Protocol Violation|0|||
33676884|NCT02078219|63119285|FG003|Overall Study|Protocol Violation|1|||
33676885|NCT02078219|63119286|FG004|Overall Study|Protocol Violation|0|||
33676886|NCT02078219|63119282|FG000|Overall Study|Death|0|||
33676887|NCT02078219|63119283|FG001|Overall Study|Death|0|||
33676888|NCT02078219|63119284|FG002|Overall Study|Death|0|||
33676889|NCT02078219|63119285|FG003|Overall Study|Death|1|||
33676890|NCT02078219|63119286|FG004|Overall Study|Death|0|||
33676891|NCT02078219|63119282|FG000|Overall Study|Adverse Event|1|||
33676892|NCT02078219|63119283|FG001|Overall Study|Adverse Event|1|||
33676893|NCT02078219|63119284|FG002|Overall Study|Adverse Event|3|||
33676894|NCT02078219|63119285|FG003|Overall Study|Adverse Event|1|||
33676895|NCT02078219|63119286|FG004|Overall Study|Adverse Event|0|||
33676896|NCT02076113|63119300|FG000|Overall Study|Lost to Follow-up|4|||
33676897|NCT02076113|63119301|FG001|Overall Study|Lost to Follow-up|1|||
33676898|NCT02076113|63119300|FG000|Overall Study|Withdrawal by Subject|2|||
33676899|NCT02076113|63119301|FG001|Overall Study|Withdrawal by Subject|3|||
33676900|NCT02076113|63119300|FG000|Overall Study|Death|1|||
33676901|NCT02076113|63119301|FG001|Overall Study|Death|3|||
33676902|NCT02075255|63119313|FG000|Overall Study|Study specific withdrawal criteria|0|||
33676903|NCT02075255|63119314|FG001|Overall Study|Study specific withdrawal criteria|1|||
33676904|NCT02075255|63119315|FG002|Overall Study|Study specific withdrawal criteria|1|||
33676905|NCT02075255|63119313|FG000|Overall Study|Withdrawal by Subject|4|||
33676906|NCT02075255|63119314|FG001|Overall Study|Withdrawal by Subject|1|||
33676907|NCT02075255|63119315|FG002|Overall Study|Withdrawal by Subject|0|||
33676908|NCT02075255|63119313|FG000|Overall Study|Lost to Follow-up|0|||
33676909|NCT02075255|63119314|FG001|Overall Study|Lost to Follow-up|0|||
33676910|NCT02075255|63119315|FG002|Overall Study|Lost to Follow-up|1|||
33676911|NCT02075255|63119313|FG000|Overall Study|Adverse Event|0|||
33676912|NCT02075255|63119314|FG001|Overall Study|Adverse Event|0|||
33676913|NCT02075255|63119315|FG002|Overall Study|Adverse Event|1|||
33676914|NCT02075255|63119313|FG000|Overall Study|Death|0|||
33676915|NCT02075255|63119314|FG001|Overall Study|Death|2|||
33676916|NCT02075255|63119315|FG002|Overall Study|Death|0|||
33584510|NCT02563067|62982537|FG001|Overall Study|Physician Decision|1|||
33584511|NCT02563067|62982538|FG002|Overall Study|Physician Decision|3|||
33584512|NCT02563067|62982536|FG000|Overall Study|Lost to Follow-up|1|||
33584513|NCT02563067|62982537|FG001|Overall Study|Lost to Follow-up|2|||
33584514|NCT02563067|62982538|FG002|Overall Study|Lost to Follow-up|0|||
33584515|NCT02563067|62982536|FG000|Overall Study|Technical problems|0|||
33584516|NCT02563067|62982537|FG001|Overall Study|Technical problems|1|||
33676917|NCT02400671|63119486|FG000|Overall Study|Death|5|||
33676918|NCT02400671|63119487|FG001|Overall Study|Death|3|||
33676919|NCT02400671|63119488|FG002|Overall Study|Death|4|||
33676920|NCT02400671|63119486|FG000|Overall Study|Lost to Follow-up|20|||
33676921|NCT02400671|63119487|FG001|Overall Study|Lost to Follow-up|27|||
33676922|NCT02400671|63119488|FG002|Overall Study|Lost to Follow-up|24|||
33676923|NCT02400671|63119486|FG000|Overall Study|Withdrawal by Subject|2|||
33676924|NCT02400671|63119487|FG001|Overall Study|Withdrawal by Subject|2|||
33676925|NCT02400671|63119488|FG002|Overall Study|Withdrawal by Subject|0|||
33584517|NCT02563067|62982538|FG002|Overall Study|Technical problems|0|||
33584518|NCT02563067|62982536|FG000|Overall Study|Lack of Efficacy|1|||
33676926|NCT00089999|63119498|FG000|Overall Study|Adverse Event|4|||
33676927|NCT00089999|63119499|FG001|Overall Study|Adverse Event|7|||
33676928|NCT00089999|63119498|FG000|Overall Study|Withdrawal by Subject|0|||
33584519|NCT02563067|62982537|FG001|Overall Study|Lack of Efficacy|0|||
33676929|NCT00089999|63119499|FG001|Overall Study|Withdrawal by Subject|4|||
33676930|NCT00089999|63119498|FG000|Overall Study|Lost to Follow-up|2|||
33676931|NCT00089999|63119499|FG001|Overall Study|Lost to Follow-up|1|||
33676932|NCT00089999|63119498|FG000|Overall Study|Radiological Progression of Cancer|52|||
33676933|NCT00089999|63119499|FG001|Overall Study|Radiological Progression of Cancer|44|||
33676934|NCT00089999|63119498|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
33676935|NCT00089999|63119499|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
33676936|NCT00089999|63119498|FG000|Overall Study|Death|3|||
33676937|NCT00089999|63119499|FG001|Overall Study|Death|3|||
33676938|NCT00089999|63119498|FG000|Overall Study|Poor General Condition|1|||
33676939|NCT00089999|63119499|FG001|Overall Study|Poor General Condition|0|||
33676940|NCT00089999|63119498|FG000|Overall Study|Clinical Progression|1|||
33676941|NCT00089999|63119499|FG001|Overall Study|Clinical Progression|2|||
33676942|NCT00089999|63119498|FG000|Overall Study|Physician Decision|2|||
33676943|NCT00089999|63119499|FG001|Overall Study|Physician Decision|2|||
33676944|NCT00089999|63119498|FG000|Overall Study|Patient Underwent Surgery|2|||
33676945|NCT00089999|63119499|FG001|Overall Study|Patient Underwent Surgery|0|||
33676946|NCT00089999|63119498|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
33676947|NCT00089999|63119499|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
33676948|NCT00089843|63119510|FG000|Overall Study|Withdrawal by Subject|1|||
33676949|NCT00089843|63119511|FG001|Overall Study|Withdrawal by Subject|4|||
33676950|NCT00089843|63119512|FG002|Overall Study|Withdrawal by Subject|5|||
33676951|NCT00089843|63119513|FG003|Overall Study|Withdrawal by Subject|6|||
33676952|NCT00089843|63119510|FG000|Overall Study|Physician Decision|1|||
33676953|NCT00089843|63119511|FG001|Overall Study|Physician Decision|0|||
33676954|NCT00089843|63119512|FG002|Overall Study|Physician Decision|0|||
33676955|NCT00089843|63119513|FG003|Overall Study|Physician Decision|1|||
33676956|NCT00089297|63119523|FG000|Overall Study|Adverse Event|9|||
33676957|NCT00089297|63119523|FG000|Overall Study|Death|1|||
33676958|NCT00089297|63119523|FG000|Overall Study|Withdrawal by Subject|12|||
33676959|NCT00089297|63119523|FG000|Overall Study|Disease progression|2|||
33676960|NCT00089297|63119523|FG000|Overall Study|Ineligible|11|||
33676961|NCT00089297|63119523|FG000|Overall Study|Secondary malignancy|1|||
33676962|NCT00089297|63119523|FG000|Overall Study|IRB approval not ready|1|||
33676963|NCT00089297|63119523|FG000|Overall Study|Non-compliance|1|||
33676964|NCT00088907|63119565|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
33676965|NCT00088907|63119566|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
33676966|NCT00088907|63119565|FG000|Randomized Study (Step 1)|Adverse Event|14|||
33676967|NCT00088907|63119566|FG001|Randomized Study (Step 1)|Adverse Event|19|||
33676968|NCT00088907|63119565|FG000|Randomized Study (Step 1)|Death|11|||
33676969|NCT00088907|63119566|FG001|Randomized Study (Step 1)|Death|12|||
33676970|NCT00088907|63119565|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
33676971|NCT00088907|63119566|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
33676972|NCT00088907|63119565|FG000|Randomized Study (Step 1)|complicating disease|3|||
33676973|NCT00088907|63119566|FG001|Randomized Study (Step 1)|complicating disease|1|||
33676974|NCT00088907|63119565|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
33676975|NCT00088907|63119566|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
33676976|NCT00088907|63119565|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
33676977|NCT00088907|63119566|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
33676978|NCT00088907|63119565|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
33676979|NCT00088907|63119566|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
33676980|NCT00088907|63119565|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
33676981|NCT00088907|63119566|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
33676982|NCT00088907|63119565|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
33676983|NCT00088907|63119566|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
33676984|NCT00088907|63119565|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
33676985|NCT00088907|63119566|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
33676986|NCT00088829|63119573|FG000|Overall Study|PI left institution and study was close|22|||
33676987|NCT00088595|63119577|FG000|Overall Study|Adverse Event|11|||
33676988|NCT00088595|63119577|FG000|Overall Study|Withdrawal by Subject|8|||
33676989|NCT00088595|63119577|FG000|Overall Study|Ongoing (After Core)|7|||
33676990|NCT00088595|63119577|FG000|Overall Study|New Cancer Therapy|2|||
33676991|NCT00088205|63119591|FG000|Overall Study|Adverse Event|4|||
33676992|NCT00088205|63119591|FG000|Overall Study|Progressive Disease|51|||
33676993|NCT00088205|63119591|FG000|Overall Study|Physician Decision|1|||
33676994|NCT00088205|63119591|FG000|Overall Study|Death Due to Study Disease|4|||
33676995|NCT00085709|63119685|FG000|Overall Study|Adverse Event|8|||
33676996|NCT00085709|63119686|FG001|Overall Study|Adverse Event|0|||
33676997|NCT00085709|63119685|FG000|Overall Study|Death|8|||
33676998|NCT00085709|63119686|FG001|Overall Study|Death|2|||
33676999|NCT00085709|63119685|FG000|Overall Study|Refusal unrelated to adverse events|1|||
33677000|NCT00085709|63119686|FG001|Overall Study|Refusal unrelated to adverse events|2|||
33677001|NCT00085709|63119685|FG000|Overall Study|Progression|3|||
33677002|NCT00085709|63119686|FG001|Overall Study|Progression|4|||
33677003|NCT00085709|63119685|FG000|Overall Study|Not protocol specified|12|||
33677004|NCT00085709|63119686|FG001|Overall Study|Not protocol specified|22|||
33677005|NCT00085709|63119685|FG000|Overall Study|Not eligible|19|||
33677006|NCT00085709|63119686|FG001|Overall Study|Not eligible|19|||
33677007|NCT00085709|63119685|FG000|Overall Study|Withdrawal by Subject|2|||
33677008|NCT00085709|63119686|FG001|Overall Study|Withdrawal by Subject|1|||
33677009|NCT00085631|63119721|FG000|Overall Study|Missing Data|4|||
33677010|NCT00085631|63119722|FG001|Overall Study|Missing Data|11|||
33677011|NCT00085631|63119723|FG002|Overall Study|Missing Data|7|||
33677012|NCT00084929|63119739|FG000|Overall Study|ineligible - medical contraindication|1|||
33677013|NCT00084929|63119739|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
33677014|NCT00084929|63119739|FG000|Overall Study|Ineligible - Medical history|6|||
33677015|NCT00084929|63119739|FG000|Overall Study|Withdrawal by Subject|10|||
33677016|NCT00084929|63119739|FG000|Overall Study|Missing/incomplete CTC exam|9|||
33677017|NCT00084929|63119739|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
33677018|NCT00084617|63119797|FG000|Overall Study|Withdrawal by Subject|7|||
33677019|NCT00084617|63119797|FG000|Overall Study|Lack of Efficacy|1|||
33677020|NCT00084617|63119797|FG000|Overall Study|Protocol Violation|1|||
33677021|NCT00083915|63119911|FG000|Overall Study|Death|6|||
33677022|NCT00083915|63119912|FG001|Overall Study|Death|3|||
33677023|NCT00083915|63119911|FG000|Overall Study|Physician Decision|11|||
33677024|NCT00083915|63119912|FG001|Overall Study|Physician Decision|6|||
33677025|NCT00083915|63119911|FG000|Overall Study|Withdrawal by Subject|8|||
33677026|NCT00083915|63119912|FG001|Overall Study|Withdrawal by Subject|3|||
33677027|NCT00083915|63119911|FG000|Overall Study|disease progression|18|||
33677028|NCT00083915|63119912|FG001|Overall Study|disease progression|23|||
33677029|NCT00083915|63119911|FG000|Overall Study|Failure to collect|3|||
33677030|NCT00083915|63119912|FG001|Overall Study|Failure to collect|0|||
33677031|NCT00083915|63119911|FG000|Overall Study|No response|3|||
33677032|NCT00083915|63119912|FG001|Overall Study|No response|1|||
33677033|NCT00083915|63119911|FG000|Overall Study|Insurance issues|1|||
33677034|NCT00083915|63119912|FG001|Overall Study|Insurance issues|1|||
33677035|NCT04362761|63120574|FG000|Part A (48 Weeks)|Adverse Event|2|||
33677036|NCT04362761|63120574|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
33677037|NCT04362761|63120574|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
33677038|NCT04362761|63120574|FG000|Part A (48 Weeks)|Other|5|||
33677039|NCT04362761|63120574|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
33677040|NCT04362761|63120574|FG000|Part B (86 Weeks)|Other|4|||
33677041|NCT00632749|63120770|FG000|Overall Study|Progressive disease|3|||
33677042|NCT00632749|63120771|FG001|Overall Study|Progressive disease|2|||
33677043|NCT00632749|63120772|FG002|Overall Study|Progressive disease|2|||
33677044|NCT00632749|63120773|FG003|Overall Study|Progressive disease|2|||
33677045|NCT00632749|63120774|FG004|Overall Study|Progressive disease|4|||
33677046|NCT00632749|63120775|FG005|Overall Study|Progressive disease|4|||
33677047|NCT00632749|63120776|FG006|Overall Study|Progressive disease|3|||
33677048|NCT00632749|63120777|FG007|Overall Study|Progressive disease|2|||
33677049|NCT00632749|63120778|FG008|Overall Study|Progressive disease|3|||
33677050|NCT00632749|63120779|FG009|Overall Study|Progressive disease|2|||
33677051|NCT00632749|63120780|FG010|Overall Study|Progressive disease|4|||
33677052|NCT00632749|63120781|FG011|Overall Study|Progressive disease|3|||
33677053|NCT00632749|63120782|FG012|Overall Study|Progressive disease|2|||
33677054|NCT00632749|63120783|FG013|Overall Study|Progressive disease|4|||
33677055|NCT00632749|63120770|FG000|Overall Study|Other Adverse event|1|||
33677056|NCT00632749|63120771|FG001|Overall Study|Other Adverse event|1|||
33677057|NCT00632749|63120772|FG002|Overall Study|Other Adverse event|1|||
33677058|NCT00632749|63120773|FG003|Overall Study|Other Adverse event|1|||
33677059|NCT00632749|63120774|FG004|Overall Study|Other Adverse event|2|||
33677060|NCT00632749|63120775|FG005|Overall Study|Other Adverse event|4|||
33677061|NCT00632749|63120776|FG006|Overall Study|Other Adverse event|1|||
33677062|NCT00632749|63120777|FG007|Overall Study|Other Adverse event|2|||
33677063|NCT00632749|63120778|FG008|Overall Study|Other Adverse event|2|||
33677064|NCT00632749|63120779|FG009|Overall Study|Other Adverse event|0|||
33677065|NCT00632749|63120780|FG010|Overall Study|Other Adverse event|1|||
33677066|NCT00632749|63120781|FG011|Overall Study|Other Adverse event|0|||
33677067|NCT00632749|63120782|FG012|Overall Study|Other Adverse event|1|||
33677068|NCT00632749|63120783|FG013|Overall Study|Other Adverse event|0|||
33677069|NCT00632749|63120770|FG000|Overall Study|Refuse to continue medication|0|||
33677070|NCT00632749|63120771|FG001|Overall Study|Refuse to continue medication|0|||
33677071|NCT00632749|63120772|FG002|Overall Study|Refuse to continue medication|0|||
33677072|NCT00632749|63120773|FG003|Overall Study|Refuse to continue medication|1|||
33677073|NCT00632749|63120774|FG004|Overall Study|Refuse to continue medication|0|||
33677074|NCT00632749|63120775|FG005|Overall Study|Refuse to continue medication|0|||
33677075|NCT00632749|63120776|FG006|Overall Study|Refuse to continue medication|0|||
33677076|NCT00632749|63120777|FG007|Overall Study|Refuse to continue medication|0|||
33677077|NCT00632749|63120778|FG008|Overall Study|Refuse to continue medication|0|||
33677078|NCT00632749|63120779|FG009|Overall Study|Refuse to continue medication|1|||
33677079|NCT00632749|63120780|FG010|Overall Study|Refuse to continue medication|0|||
33677080|NCT00632749|63120781|FG011|Overall Study|Refuse to continue medication|0|||
33677081|NCT00632749|63120782|FG012|Overall Study|Refuse to continue medication|0|||
33677082|NCT00632749|63120783|FG013|Overall Study|Refuse to continue medication|0|||
33677083|NCT00632749|63120770|FG000|Overall Study|Reason other than those specified above|0|||
33677084|NCT00632749|63120771|FG001|Overall Study|Reason other than those specified above|2|||
33677085|NCT00632749|63120772|FG002|Overall Study|Reason other than those specified above|0|||
33677086|NCT00632749|63120773|FG003|Overall Study|Reason other than those specified above|0|||
33677087|NCT00632749|63120774|FG004|Overall Study|Reason other than those specified above|1|||
33677088|NCT00632749|63120775|FG005|Overall Study|Reason other than those specified above|0|||
33677089|NCT00632749|63120776|FG006|Overall Study|Reason other than those specified above|1|||
33677090|NCT00632749|63120777|FG007|Overall Study|Reason other than those specified above|0|||
33677091|NCT00632749|63120778|FG008|Overall Study|Reason other than those specified above|0|||
33677092|NCT00632749|63120779|FG009|Overall Study|Reason other than those specified above|0|||
33677093|NCT00632749|63120780|FG010|Overall Study|Reason other than those specified above|2|||
33677094|NCT00632749|63120781|FG011|Overall Study|Reason other than those specified above|1|||
33677095|NCT00632749|63120782|FG012|Overall Study|Reason other than those specified above|0|||
33677096|NCT00632749|63120783|FG013|Overall Study|Reason other than those specified above|2|||
33677097|NCT00632359|63120844|FG000|Overall Study|Withdrawal by Subject|2|||
33677098|NCT00632203|63120851|FG000|Overall Study|Did not start study treatment|1|||
33677099|NCT00632203|63120852|FG001|Overall Study|Did not start study treatment|0|||
33677100|NCT03830333|63120873|FG000|Overall Study|Death|0|||
33677101|NCT03830333|63120874|FG001|Overall Study|Death|1|||
33677102|NCT03830333|63120873|FG000|Overall Study|Withdrawal by Subject|5|||
33677103|NCT03830333|63120874|FG001|Overall Study|Withdrawal by Subject|1|||
33677104|NCT03830333|63120873|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
33677105|NCT03830333|63120874|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
33677106|NCT00631969|63120960|FG000|Overall Study|Adverse Event|3|||
33677107|NCT00631969|63120961|FG001|Overall Study|Adverse Event|1|||
33677108|NCT00631969|63120960|FG000|Overall Study|Lack of Efficacy|2|||
33677109|NCT00631969|63120961|FG001|Overall Study|Lack of Efficacy|8|||
33677110|NCT00631969|63120960|FG000|Overall Study|Lost to Follow-up|2|||
33677111|NCT00631969|63120961|FG001|Overall Study|Lost to Follow-up|1|||
33677112|NCT00631969|63120960|FG000|Overall Study|Protocol Violation|1|||
33677113|NCT00631969|63120961|FG001|Overall Study|Protocol Violation|1|||
33677114|NCT00631969|63120960|FG000|Overall Study|Consent Withdrawn|5|||
33677115|NCT00631969|63120961|FG001|Overall Study|Consent Withdrawn|7|||
33677116|NCT00631969|63120960|FG000|Overall Study|Noncompliant With Study Medication|0|||
33677117|NCT00631969|63120961|FG001|Overall Study|Noncompliant With Study Medication|1|||
33677118|NCT00631969|63120960|FG000|Overall Study|No Drug Exposure|2|||
33677119|NCT00631969|63120961|FG001|Overall Study|No Drug Exposure|2|||
33677120|NCT00631657|63120997|FG000|6-Month Treatment Period|Adverse Event|47|||
33677121|NCT00631657|63120998|FG001|6-Month Treatment Period|Adverse Event|0|||
33677122|NCT00631657|63120999|FG002|6-Month Treatment Period|Adverse Event|7|||
33677123|NCT00631657|63120997|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
33677124|NCT00631657|63120998|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
33677125|NCT00631657|63120999|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
33677126|NCT00631657|63120997|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
33677127|NCT00631657|63120998|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
33677128|NCT00631657|63120999|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
33677129|NCT00631657|63120997|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
33677130|NCT00631657|63120998|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
33677131|NCT00631657|63120999|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
33677132|NCT00631657|63120997|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
33677133|NCT00631657|63120998|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
33677134|NCT00631657|63120999|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
33677135|NCT00631657|63120997|FG000|6-Month Treatment Period|Other|16|||
33677136|NCT00631657|63120998|FG001|6-Month Treatment Period|Other|0|||
33677137|NCT00631657|63120999|FG002|6-Month Treatment Period|Other|4|||
33677138|NCT00631657|63120997|FG000|6-Month Treatment Period|Not Treated|2|||
33677139|NCT00631657|63120998|FG001|6-Month Treatment Period|Not Treated|0|||
33677140|NCT00631657|63120999|FG002|6-Month Treatment Period|Not Treated|1|||
33677141|NCT00631657|63120997|FG000|7-Day Discontinuation Period|Not Treated|1|||
33677142|NCT00631657|63120998|FG001|7-Day Discontinuation Period|Not Treated|1|||
33677143|NCT00631657|63120999|FG002|7-Day Discontinuation Period|Not Treated|1|||
33677144|NCT00631657|63120997|FG000|7-Day Discontinuation Period|Other|1|||
33677145|NCT00631657|63120998|FG001|7-Day Discontinuation Period|Other|0|||
33677146|NCT00631657|63120999|FG002|7-Day Discontinuation Period|Other|0|||
33677147|NCT00631189|63121037|FG000|Initial Phase|Protocol Violation|347|||
33677148|NCT00631189|63121038|FG001|Initial Phase|Protocol Violation|0|||
33677149|NCT00631189|63121039|FG002|Initial Phase|Protocol Violation|0|||
33677150|NCT00631189|63121040|FG003|Initial Phase|Protocol Violation|0|||
33677151|NCT00631189|63121037|FG000|Initial Phase|Withdrawal by Subject|4|||
33677152|NCT00631189|63121038|FG001|Initial Phase|Withdrawal by Subject|0|||
33677153|NCT00631189|63121039|FG002|Initial Phase|Withdrawal by Subject|0|||
33677154|NCT00631189|63121040|FG003|Initial Phase|Withdrawal by Subject|0|||
33677155|NCT00631189|63121037|FG000|Treatment Phase|Withdrawal by Subject|0|||
33677156|NCT00631189|63121038|FG001|Treatment Phase|Withdrawal by Subject|2|||
33677157|NCT00631189|63121039|FG002|Treatment Phase|Withdrawal by Subject|1|||
33677158|NCT00631189|63121040|FG003|Treatment Phase|Withdrawal by Subject|1|||
33677159|NCT00631189|63121037|FG000|Treatment Phase|Protocol Violation|0|||
33677160|NCT00631189|63121038|FG001|Treatment Phase|Protocol Violation|1|||
33677161|NCT00631189|63121039|FG002|Treatment Phase|Protocol Violation|6|||
33677162|NCT00631189|63121040|FG003|Treatment Phase|Protocol Violation|2|||
33677163|NCT00631189|63121037|FG000|Treatment Phase|Adverse Event|0|||
33677164|NCT00631189|63121038|FG001|Treatment Phase|Adverse Event|3|||
33677165|NCT00631189|63121039|FG002|Treatment Phase|Adverse Event|2|||
33677166|NCT00631189|63121040|FG003|Treatment Phase|Adverse Event|4|||
33677167|NCT00631189|63121037|FG000|Treatment Phase|Lost to Follow-up|0|||
33677168|NCT00631189|63121038|FG001|Treatment Phase|Lost to Follow-up|1|||
33677169|NCT00631189|63121039|FG002|Treatment Phase|Lost to Follow-up|0|||
33677170|NCT00631189|63121040|FG003|Treatment Phase|Lost to Follow-up|0|||
33677171|NCT00631189|63121037|FG000|Treatment Phase|Pregnancy|0|||
33677172|NCT00631189|63121038|FG001|Treatment Phase|Pregnancy|0|||
33677173|NCT00631189|63121039|FG002|Treatment Phase|Pregnancy|1|||
33677174|NCT00631189|63121040|FG003|Treatment Phase|Pregnancy|0|||
33677175|NCT00631189|63121037|FG000|Treatment Phase|patient did not take pravastatin|0|||
33677176|NCT00631189|63121038|FG001|Treatment Phase|patient did not take pravastatin|0|||
33677177|NCT00631189|63121039|FG002|Treatment Phase|patient did not take pravastatin|1|||
33677178|NCT00631189|63121040|FG003|Treatment Phase|patient did not take pravastatin|0|||
33677179|NCT00630877|63121053|FG000|Overall Study|Adverse Event|11|||
33677180|NCT00630877|63121054|FG001|Overall Study|Adverse Event|8|||
33677181|NCT00630877|63121055|FG002|Overall Study|Adverse Event|7|||
33677182|NCT00630877|63121053|FG000|Overall Study|Withdrawal by Subject|3|||
33677183|NCT00630877|63121054|FG001|Overall Study|Withdrawal by Subject|4|||
33677184|NCT00630877|63121055|FG002|Overall Study|Withdrawal by Subject|0|||
33677185|NCT00630877|63121053|FG000|Overall Study|Lost to Follow-up|2|||
33677186|NCT00630877|63121054|FG001|Overall Study|Lost to Follow-up|0|||
33677187|NCT00630877|63121055|FG002|Overall Study|Lost to Follow-up|0|||
33677188|NCT00630877|63121053|FG000|Overall Study|Noncompliance|2|||
33677189|NCT00630877|63121054|FG001|Overall Study|Noncompliance|3|||
33677190|NCT00630877|63121055|FG002|Overall Study|Noncompliance|1|||
33677191|NCT00630877|63121053|FG000|Overall Study|Protocol violation|1|||
33677192|NCT00630877|63121054|FG001|Overall Study|Protocol violation|0|||
33677193|NCT00630877|63121055|FG002|Overall Study|Protocol violation|1|||
33677194|NCT00630877|63121053|FG000|Overall Study|Personal reasons|0|||
33677195|NCT00630877|63121054|FG001|Overall Study|Personal reasons|0|||
33677196|NCT00630877|63121055|FG002|Overall Study|Personal reasons|1|||
33677197|NCT02915783|63121067|FG000|Overall Study|Death|21|||
33677198|NCT02915783|63121067|FG000|Overall Study|Lost to Follow-up|1|||
33677199|NCT02915783|63121067|FG000|Overall Study|Withdrawal by Subject|2|||
33677200|NCT00630331|63121082|FG000|Overall Study|Death|2|||
33677201|NCT00630331|63121083|FG001|Overall Study|Death|1|||
33677202|NCT00630331|63121084|FG002|Overall Study|Death|1|||
33677203|NCT00630331|63121082|FG000|Overall Study|Adverse Event|1|||
33677204|NCT00630331|63121083|FG001|Overall Study|Adverse Event|0|||
33677205|NCT00630331|63121084|FG002|Overall Study|Adverse Event|0|||
33677206|NCT00630331|63121082|FG000|Overall Study|Withdrawal by Subject|12|||
33677207|NCT00630331|63121083|FG001|Overall Study|Withdrawal by Subject|7|||
33677208|NCT00630331|63121084|FG002|Overall Study|Withdrawal by Subject|5|||
33677209|NCT00630331|63121082|FG000|Overall Study|Lost to Follow-up|175|||
33677210|NCT00630331|63121083|FG001|Overall Study|Lost to Follow-up|143|||
33677211|NCT00630331|63121084|FG002|Overall Study|Lost to Follow-up|170|||
33677212|NCT00630331|63121082|FG000|Overall Study|Inappropriate enrollment|3|||
33677213|NCT00630331|63121083|FG001|Overall Study|Inappropriate enrollment|6|||
33677214|NCT00630331|63121084|FG002|Overall Study|Inappropriate enrollment|3|||
33677215|NCT00630331|63121082|FG000|Overall Study|Unable to classify|9|||
33677216|NCT00630331|63121083|FG001|Overall Study|Unable to classify|4|||
33677217|NCT00630331|63121084|FG002|Overall Study|Unable to classify|3|||
33677218|NCT00630331|63121082|FG000|Overall Study|Protocol Violation|4|||
33677219|NCT00630331|63121083|FG001|Overall Study|Protocol Violation|5|||
33677220|NCT00630331|63121084|FG002|Overall Study|Protocol Violation|6|||
33677221|NCT00639509|63121136|FG000|Overall Study|Death|1|||
33677222|NCT00638963|63121142|FG000|Overall Study|Withdrawal by Subject|1|||
33677223|NCT00638963|63121143|FG001|Overall Study|Withdrawal by Subject|0|||
33677224|NCT00638183|63121149|FG000|Overall Study|Adverse Event|23|||
33677225|NCT00638183|63121149|FG000|Overall Study|Lack of Efficacy|14|||
33677226|NCT00638183|63121149|FG000|Overall Study|Physician Decision|9|||
33677227|NCT00638183|63121149|FG000|Overall Study|Lost to Follow-up|46|||
33677228|NCT00638183|63121149|FG000|Overall Study|Other reason not defined above|27|||
33677229|NCT00638027|63121155|FG000|Overall Study|Adverse Event|0|||
33677230|NCT00638027|63121156|FG001|Overall Study|Adverse Event|2|||
33677231|NCT00636155|63121162|FG000|Overall Study|Adverse Event|8|||
33677232|NCT00636155|63121162|FG000|Overall Study|Lack of Efficacy|1|||
33677233|NCT00636155|63121162|FG000|Overall Study|Withdrawal by Subject|3|||
33677234|NCT00636155|63121162|FG000|Overall Study|Stem cell transplant|1|||
33677235|NCT00636155|63121162|FG000|Overall Study|Physician Decision|5|||
33677236|NCT00634907|63121168|FG000|Overall Study|Withdrawal by Subject|3|||
33677237|NCT00634907|63121169|FG001|Overall Study|Withdrawal by Subject|0|||
33677238|NCT00634907|63121168|FG000|Overall Study|Physician Decision|3|||
33677239|NCT00634907|63121169|FG001|Overall Study|Physician Decision|9|||
33677240|NCT00634907|63121168|FG000|Overall Study|Withdrawal by Subject|11|||
33677241|NCT00634907|63121169|FG001|Overall Study|Withdrawal by Subject|8|||
33677242|NCT00634751|63121183|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
33677243|NCT00634751|63121184|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
33677244|NCT00634751|63121185|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
33677245|NCT00634751|63121186|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
33677246|NCT00634751|63121183|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
33677247|NCT00634751|63121184|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
33677248|NCT00634751|63121185|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
33677249|NCT00634751|63121186|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
33677250|NCT00634751|63121183|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
33677251|NCT00634751|63121184|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
33677252|NCT00634751|63121185|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
33677253|NCT00634751|63121186|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
33677254|NCT00634049|63121221|FG000|Overall Study|Never received study drug|1|||
33677255|NCT00634049|63121221|FG000|Overall Study|Died prior to receiving study drug|1|||
33677256|NCT00634049|63121221|FG000|Overall Study|Screening failure|1|||
33677257|NCT00632099|63121260|FG000|Overall Study|Lost to Follow-up|3|||
33677258|NCT00632099|63121261|FG001|Overall Study|Lost to Follow-up|3|||
33677259|NCT00632021|63121269|FG000|Overall Study|Withdrawal/death|4|||
33677260|NCT00632021|63121270|FG001|Overall Study|Withdrawal/death|7|||
33677261|NCT00631475|63121277|FG000|Overall Study|Death|18|||
33677262|NCT00631475|63121277|FG000|Overall Study|Adverse Event|14|||
33677263|NCT00631475|63121277|FG000|Overall Study|Withdrew consent|5|||
33677264|NCT00631475|63121277|FG000|Overall Study|Preparation for lung transplant|8|||
33677265|NCT00631163|63121298|FG000|Number of Participants in Year 1|Adverse Event|12|||
33677266|NCT00631163|63121298|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
33677267|NCT00631163|63121298|FG000|Number of Participants in Year 1|Death|6|||
33677268|NCT00631163|63121298|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
33677269|NCT00631163|63121298|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
33677270|NCT00631163|63121298|FG000|Number of Participants in Year 1|Administrative problems|6|||
33677271|NCT00631163|63121298|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
33677272|NCT00631163|63121298|FG000|Number of Participants in Year 2|Adverse Event|1|||
33677273|NCT00631163|63121298|FG000|Number of Participants in Year 2|Protocol Violation|1|||
33677274|NCT00631163|63121298|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
33677275|NCT00631007|63121315|FG000|Overall Study|Adverse Event|0|||
33677276|NCT00631007|63121316|FG001|Overall Study|Adverse Event|2|||
33677277|NCT00631007|63121317|FG002|Overall Study|Adverse Event|0|||
33677278|NCT00631007|63121318|FG003|Overall Study|Adverse Event|2|||
33677279|NCT00631007|63121319|FG004|Overall Study|Adverse Event|3|||
33677280|NCT00631007|63121320|FG005|Overall Study|Adverse Event|2|||
33677281|NCT00631007|63121315|FG000|Overall Study|Lost to Follow-up|2|||
33677282|NCT00631007|63121316|FG001|Overall Study|Lost to Follow-up|1|||
33677283|NCT00631007|63121317|FG002|Overall Study|Lost to Follow-up|2|||
33677284|NCT00631007|63121318|FG003|Overall Study|Lost to Follow-up|4|||
33677285|NCT00631007|63121319|FG004|Overall Study|Lost to Follow-up|5|||
33677286|NCT00631007|63121320|FG005|Overall Study|Lost to Follow-up|3|||
33677287|NCT00631007|63121315|FG000|Overall Study|Physician Decision|1|||
33677288|NCT00631007|63121316|FG001|Overall Study|Physician Decision|0|||
33677289|NCT00631007|63121317|FG002|Overall Study|Physician Decision|1|||
33677290|NCT00631007|63121318|FG003|Overall Study|Physician Decision|0|||
33677291|NCT00631007|63121319|FG004|Overall Study|Physician Decision|0|||
33677292|NCT00631007|63121320|FG005|Overall Study|Physician Decision|2|||
33677293|NCT00631007|63121315|FG000|Overall Study|Persistent Hyperglycemia|2|||
33584520|NCT02563067|62982538|FG002|Overall Study|Lack of Efficacy|0|||
33584521|NCT02563067|62982536|FG000|Overall Study|Death|0|||
33584522|NCT02563067|62982537|FG001|Overall Study|Death|1|||
33584523|NCT02563067|62982538|FG002|Overall Study|Death|1|||
33677294|NCT00631007|63121316|FG001|Overall Study|Persistent Hyperglycemia|2|||
33677295|NCT00631007|63121317|FG002|Overall Study|Persistent Hyperglycemia|5|||
33677296|NCT00631007|63121318|FG003|Overall Study|Persistent Hyperglycemia|1|||
33677297|NCT00631007|63121319|FG004|Overall Study|Persistent Hyperglycemia|2|||
33677298|NCT00631007|63121320|FG005|Overall Study|Persistent Hyperglycemia|5|||
33677299|NCT00631007|63121315|FG000|Overall Study|Withdrawal by Subject|4|||
33584524|NCT02563067|62982536|FG000|Overall Study|Adverse Event|2|||
33584525|NCT02563067|62982537|FG001|Overall Study|Adverse Event|1|||
33584526|NCT02563067|62982538|FG002|Overall Study|Adverse Event|0|||
33584527|NCT02563067|62982536|FG000|Overall Study|Death post Treatment/safety period|1|||
33677300|NCT00631007|63121316|FG001|Overall Study|Withdrawal by Subject|5|||
33677301|NCT00631007|63121317|FG002|Overall Study|Withdrawal by Subject|2|||
33677302|NCT00631007|63121318|FG003|Overall Study|Withdrawal by Subject|2|||
33310660|NCT00946309|62686061|FG001|Overall Study|Lost to Follow-up|1|||
33677303|NCT00631007|63121319|FG004|Overall Study|Withdrawal by Subject|1|||
33584528|NCT02563067|62982537|FG001|Overall Study|Death post Treatment/safety period|0|||
33584529|NCT02563067|62982538|FG002|Overall Study|Death post Treatment/safety period|0|||
33584530|NCT02568683|62982548|FG000|Overall Study|Death|0|||
33584531|NCT02568683|62982549|FG001|Overall Study|Death|2|||
33584532|NCT02568683|62982548|FG000|Overall Study|Withdrew Consent|1|||
33584533|NCT02568683|62982549|FG001|Overall Study|Withdrew Consent|0|||
33584534|NCT02568683|62982548|FG000|Overall Study|Study Terminated By Sponsor|5|||
33584535|NCT02568683|62982549|FG001|Overall Study|Study Terminated By Sponsor|2|||
33584536|NCT02563925|62982555|FG000|Overall Study|Withdrawal by Subject|2|||
33584537|NCT01663727|62982562|FG000|Overall Study|Death|161|||
33584538|NCT01663727|62982563|FG001|Overall Study|Death|155|||
33584539|NCT01663727|62982562|FG000|Overall Study|Lost to Follow-up|10|||
33584540|NCT01663727|62982563|FG001|Overall Study|Lost to Follow-up|8|||
33584541|NCT01663727|62982562|FG000|Overall Study|Withdrawal by Subject|18|||
33584542|NCT01663727|62982563|FG001|Overall Study|Withdrawal by Subject|25|||
33584543|NCT01663727|62982562|FG000|Overall Study|Study Terminated|51|||
33677304|NCT00631007|63121320|FG005|Overall Study|Withdrawal by Subject|3|||
33677305|NCT00631007|63121315|FG000|Overall Study|Other|2|||
33677306|NCT00631007|63121316|FG001|Overall Study|Other|1|||
33677307|NCT00631007|63121317|FG002|Overall Study|Other|0|||
33677308|NCT00631007|63121318|FG003|Overall Study|Other|0|||
33677309|NCT00631007|63121319|FG004|Overall Study|Other|1|||
33677310|NCT00631007|63121320|FG005|Overall Study|Other|0|||
33677311|NCT00630539|63121347|FG000|Overall Study|Adverse Event|1|||
33677312|NCT00630539|63121348|FG001|Overall Study|Adverse Event|3|||
33677313|NCT00630539|63121349|FG002|Overall Study|Adverse Event|1|||
33677314|NCT00630539|63121350|FG003|Overall Study|Adverse Event|2|||
33677315|NCT00630539|63121347|FG000|Overall Study|Withdrawal by Subject|0|||
33677316|NCT00630539|63121348|FG001|Overall Study|Withdrawal by Subject|1|||
33677317|NCT00630539|63121349|FG002|Overall Study|Withdrawal by Subject|0|||
33677318|NCT00630539|63121350|FG003|Overall Study|Withdrawal by Subject|1|||
33677319|NCT00630305|63121428|FG000|Overall Study|Withdrawal by Subject|1|||
33677320|NCT00630305|63121428|FG000|Overall Study|Inability to insert contact lens|1|||
33677321|NCT01926197|63121654|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
33677322|NCT01926197|63121655|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
33677323|NCT01926197|63121654|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
33677324|NCT01926197|63121655|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
33677325|NCT00989963|63121680|FG000|Overall Study|Adverse Event|1|||
33677326|NCT00989963|63121681|FG001|Overall Study|Adverse Event|1|||
33677327|NCT00989963|63121682|FG002|Overall Study|Adverse Event|1|||
33677328|NCT00989573|63121720|FG000|Overall Study|Adverse Event|8|||
33677329|NCT00989573|63121721|FG001|Overall Study|Adverse Event|12|||
33677330|NCT00989573|63121722|FG002|Overall Study|Adverse Event|4|||
33677331|NCT00989573|63121720|FG000|Overall Study|Physician Decision|0|||
33677332|NCT00989573|63121721|FG001|Overall Study|Physician Decision|2|||
33677333|NCT00989573|63121722|FG002|Overall Study|Physician Decision|0|||
33677334|NCT00989573|63121720|FG000|Overall Study|Protocol Violation|1|||
33677335|NCT00989573|63121721|FG001|Overall Study|Protocol Violation|1|||
33677336|NCT00989573|63121722|FG002|Overall Study|Protocol Violation|1|||
33677337|NCT00989573|63121720|FG000|Overall Study|Withdrawal by Subject|4|||
33677338|NCT00989573|63121721|FG001|Overall Study|Withdrawal by Subject|7|||
33677339|NCT00989573|63121722|FG002|Overall Study|Withdrawal by Subject|3|||
33677340|NCT04126213|63121796|FG000|Overall Study|Lost to Follow-up|9|||
33677341|NCT04126213|63121797|FG001|Overall Study|Lost to Follow-up|1|||
33677342|NCT04126213|63121798|FG002|Overall Study|Lost to Follow-up|5|||
33677343|NCT04126213|63121799|FG003|Overall Study|Lost to Follow-up|10|||
33677344|NCT04126213|63121800|FG004|Overall Study|Lost to Follow-up|4|||
33677345|NCT04126213|63121801|FG005|Overall Study|Lost to Follow-up|7|||
33677346|NCT04126213|63121796|FG000|Overall Study|Withdrawal by Subject|3|||
33677347|NCT04126213|63121797|FG001|Overall Study|Withdrawal by Subject|2|||
33677348|NCT04126213|63121798|FG002|Overall Study|Withdrawal by Subject|1|||
33677349|NCT04126213|63121799|FG003|Overall Study|Withdrawal by Subject|1|||
33677350|NCT04126213|63121800|FG004|Overall Study|Withdrawal by Subject|1|||
33677351|NCT04126213|63121801|FG005|Overall Study|Withdrawal by Subject|1|||
33584544|NCT01663727|62982563|FG001|Overall Study|Study Terminated|50|||
33677352|NCT04126213|63121796|FG000|Overall Study|Other|0|||
33677353|NCT04126213|63121797|FG001|Overall Study|Other|0|||
33677354|NCT04126213|63121798|FG002|Overall Study|Other|2|||
33677355|NCT04126213|63121799|FG003|Overall Study|Other|2|||
33677356|NCT04126213|63121800|FG004|Overall Study|Other|0|||
33677357|NCT04126213|63121801|FG005|Overall Study|Other|1|||
33584545|NCT01663727|62982562|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
33584546|NCT01663727|62982563|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
33584547|NCT01663727|62982562|FG000|Overall Study|Withdrawal prior to dosing.|1|||
33584548|NCT01663727|62982563|FG001|Overall Study|Withdrawal prior to dosing.|0|||
33677358|NCT04126213|63121796|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33677359|NCT04126213|63121797|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
33677360|NCT04126213|63121798|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33677361|NCT04126213|63121799|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33677362|NCT04126213|63121800|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33677363|NCT04126213|63121801|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
33677364|NCT04128319|63121818|FG000|Overall Study|Death|3|||
33677365|NCT05038293|63121864|FG000|Overall Study|device was not operating properly for one subject.|1|||
33677366|NCT05038293|63121865|FG001|Overall Study|device was not operating properly for one subject.|0|||
33677367|NCT05038293|63121864|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
33677368|NCT05038293|63121865|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
33677369|NCT04753164|63121882|FG000|Overall Study|Adverse Event|0|||
33677370|NCT04753164|63121883|FG001|Overall Study|Adverse Event|2|||
33677371|NCT04753164|63121882|FG000|Overall Study|Withdrawal by Subject|9|||
33677372|NCT04753164|63121883|FG001|Overall Study|Withdrawal by Subject|7|||
33677373|NCT04753164|63121882|FG000|Overall Study|Lost to Follow-up|6|||
33677374|NCT04753164|63121883|FG001|Overall Study|Lost to Follow-up|6|||
33677375|NCT04753164|63121882|FG000|Overall Study|Other|12|||
33677376|NCT04753164|63121883|FG001|Overall Study|Other|5|||
33677377|NCT04729101|63121891|FG000|Overall Study|Adverse Event|1|||
33677378|NCT04729101|63121892|FG001|Overall Study|Adverse Event|0|||
33677379|NCT04729101|63121891|FG000|Overall Study|Physician Decision|1|||
33677380|NCT04729101|63121892|FG001|Overall Study|Physician Decision|0|||
33677381|NCT04729101|63121891|FG000|Overall Study|Withdrawal by Subject|1|||
33677382|NCT04729101|63121892|FG001|Overall Study|Withdrawal by Subject|0|||
33677383|NCT04569968|63121918|FG000|Overall Study|Lost to Follow-up|2|||
33677384|NCT04569968|63121919|FG001|Overall Study|Lost to Follow-up|5|||
33677385|NCT04569968|63121918|FG000|Overall Study|Story of head and/or neck surgery|2|||
33677386|NCT04569968|63121919|FG001|Overall Study|Story of head and/or neck surgery|2|||
33677387|NCT04569968|63121918|FG000|Overall Study|Time of stroke onset|8|||
33677388|NCT04569968|63121919|FG001|Overall Study|Time of stroke onset|7|||
33677389|NCT04569968|63121918|FG000|Overall Study|Type of strokr|12|||
33677390|NCT04569968|63121919|FG001|Overall Study|Type of strokr|8|||
33677391|NCT04569968|63121918|FG000|Overall Study|Cooperation|8|||
33677392|NCT04569968|63121919|FG001|Overall Study|Cooperation|8|||
33677393|NCT04569968|63121918|FG000|Overall Study|Age interval|17|||
33677394|NCT04569968|63121919|FG001|Overall Study|Age interval|6|||
33677395|NCT04569968|63121918|FG000|Overall Study|Denial of participation to the study|0|||
33677396|NCT04569968|63121919|FG001|Overall Study|Denial of participation to the study|3|||
33677397|NCT04569968|63121918|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
33677398|NCT04569968|63121919|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
33677399|NCT04569968|63121918|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
33677400|NCT04569968|63121919|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
33677401|NCT04569968|63121918|FG000|Overall Study|Quarantine|1|||
33677402|NCT04569968|63121919|FG001|Overall Study|Quarantine|0|||
33677403|NCT04569968|63121918|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
33677404|NCT04569968|63121919|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
33677405|NCT04569968|63121918|FG000|Overall Study|Repetitive stroke|8|||
33677406|NCT04569968|63121919|FG001|Overall Study|Repetitive stroke|0|||
33677407|NCT04569968|63121918|FG000|Overall Study|Insufficient mastication|1|||
33677408|NCT04569968|63121919|FG001|Overall Study|Insufficient mastication|0|||
33677409|NCT04569968|63121918|FG000|Overall Study|Infection|1|||
33677410|NCT04569968|63121919|FG001|Overall Study|Infection|0|||
33677411|NCT03385304|63121927|FG000|Overall Study|Death|19|||
33677412|NCT03385304|63121928|FG001|Overall Study|Death|7|||
33677413|NCT03385304|63121927|FG000|Overall Study|Lost to Follow-up|17|||
33677414|NCT03385304|63121928|FG001|Overall Study|Lost to Follow-up|14|||
33677415|NCT03385304|63121927|FG000|Overall Study|Withdrawal by Subject|3|||
33677416|NCT03385304|63121928|FG001|Overall Study|Withdrawal by Subject|2|||
33677417|NCT03385304|63121927|FG000|Overall Study|Incarceration|2|||
33677418|NCT03385304|63121928|FG001|Overall Study|Incarceration|3|||
33677419|NCT03325608|63121938|FG000|Overall Study|Lost to Follow-up|47|||
33677420|NCT03325608|63121939|FG001|Overall Study|Lost to Follow-up|47|||
33677421|NCT03325608|63121940|FG002|Overall Study|Lost to Follow-up|41|||
33677422|NCT03325608|63121941|FG003|Overall Study|Lost to Follow-up|41|||
33677423|NCT03325608|63121938|FG000|Overall Study|Death|44|||
33677424|NCT03325608|63121939|FG001|Overall Study|Death|0|||
33677425|NCT03325608|63121940|FG002|Overall Study|Death|41|||
33677426|NCT03325608|63121941|FG003|Overall Study|Death|0|||
33677427|NCT03325608|63121938|FG000|Overall Study|Death of Care Recipient|0|||
33677428|NCT03325608|63121939|FG001|Overall Study|Death of Care Recipient|44|||
33677429|NCT03325608|63121940|FG002|Overall Study|Death of Care Recipient|0|||
33677430|NCT03325608|63121941|FG003|Overall Study|Death of Care Recipient|41|||
33677431|NCT03325608|63121938|FG000|Overall Study|Withdrawal by Subject|44|||
33677432|NCT03325608|63121939|FG001|Overall Study|Withdrawal by Subject|44|||
33677433|NCT03325608|63121940|FG002|Overall Study|Withdrawal by Subject|30|||
33677434|NCT03325608|63121941|FG003|Overall Study|Withdrawal by Subject|30|||
33677435|NCT03183141|63121951|FG000|Overall Study|Withdrawal by Subject|2|||
33677436|NCT03183141|63121952|FG001|Overall Study|Withdrawal by Subject|4|||
33677437|NCT03183141|63121951|FG000|Overall Study|Death|0|||
33677438|NCT03183141|63121952|FG001|Overall Study|Death|8|||
33677439|NCT02957539|63121961|FG000|Baseline to Week 16|Lost to Follow-up|8|||
33677440|NCT02957539|63121962|FG001|Baseline to Week 16|Lost to Follow-up|10|||
33677441|NCT02957539|63121963|FG002|Baseline to Week 16|Lost to Follow-up|16|||
33677442|NCT02957539|63121961|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
33677443|NCT02957539|63121962|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
33677444|NCT02957539|63121963|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
33677445|NCT02957539|63121961|FG000|Week 16 to 32|Withdrawal by Subject|3|||
33677446|NCT02957539|63121962|FG001|Week 16 to 32|Withdrawal by Subject|3|||
33677447|NCT02957539|63121963|FG002|Week 16 to 32|Withdrawal by Subject|1|||
33677448|NCT02957539|63121961|FG000|Week 16 to 32|Lost to Follow-up|8|||
33677449|NCT02957539|63121962|FG001|Week 16 to 32|Lost to Follow-up|7|||
33677450|NCT02957539|63121963|FG002|Week 16 to 32|Lost to Follow-up|5|||
33677451|NCT02957539|63121961|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
33677452|NCT02957539|63121962|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
33677453|NCT02957539|63121963|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
33677454|NCT02957539|63121961|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
33677455|NCT02957539|63121962|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
33677456|NCT02957539|63121963|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
33677457|NCT02690077|63121976|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
33677458|NCT02690077|63121977|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
33677459|NCT02690077|63121976|FG000|Overall Study|Withdrawal by Subject|0|||
33677460|NCT02690077|63121977|FG001|Overall Study|Withdrawal by Subject|5|||
33677461|NCT02690077|63121976|FG000|Overall Study|Excluded by IRB|0|||
33677462|NCT02690077|63121977|FG001|Overall Study|Excluded by IRB|2|||
33677463|NCT02275780|63121985|FG000|Base Study: 96 Weeks|Adverse Event|6|||
33677464|NCT02275780|63121986|FG001|Base Study: 96 Weeks|Adverse Event|14|||
33677465|NCT02275780|63121985|FG000|Base Study: 96 Weeks|Death|3|||
33677466|NCT02275780|63121986|FG001|Base Study: 96 Weeks|Death|1|||
33677467|NCT02275780|63121985|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
33677468|NCT02275780|63121986|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
33677469|NCT02275780|63121985|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
33677470|NCT02275780|63121986|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
33677471|NCT02275780|63121985|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
33677472|NCT02275780|63121986|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
33677473|NCT02275780|63121985|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
33677474|NCT02275780|63121986|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
33677475|NCT02275780|63121985|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
33677476|NCT02275780|63121986|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
33677477|NCT02275780|63121985|FG000|Base Study: 96 Weeks|Physician Decision|2|||
33677478|NCT02275780|63121986|FG001|Base Study: 96 Weeks|Physician Decision|4|||
33677479|NCT02275780|63121985|FG000|Base Study: 96 Weeks|Pregnancy|2|||
33677480|NCT02275780|63121986|FG001|Base Study: 96 Weeks|Pregnancy|1|||
33677481|NCT02275780|63121985|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
33677482|NCT02275780|63121986|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
33677483|NCT02275780|63121985|FG000|Extension Study: up to 192 Weeks|Ongoing|260|||
33677484|NCT02275780|63121986|FG001|Extension Study: up to 192 Weeks|Ongoing|233|||
33677485|NCT02158091|63121995|FG000|Overall Study|DLT|2|||
33677486|NCT02158091|63121996|FG001|Overall Study|DLT|1|||
33677487|NCT02158091|63121997|FG002|Overall Study|DLT|0|||
33677488|NCT00545077|63122007|FG000|Overall Study|Treatment not received|5|||
33677489|NCT00545077|63122008|FG001|Overall Study|Treatment not received|1|||
33677490|NCT00545077|63122007|FG000|Overall Study|Disease Progression|131|||
33677491|NCT00545077|63122008|FG001|Overall Study|Disease Progression|98|||
33677492|NCT00545077|63122007|FG000|Overall Study|Withdrawal by Subject|3|||
33677493|NCT00545077|63122008|FG001|Overall Study|Withdrawal by Subject|14|||
33677494|NCT00545077|63122007|FG000|Overall Study|Physician Decision|6|||
33677495|NCT00545077|63122008|FG001|Overall Study|Physician Decision|3|||
33677496|NCT00545077|63122007|FG000|Overall Study|Lost to Follow-up|2|||
33677497|NCT00545077|63122008|FG001|Overall Study|Lost to Follow-up|0|||
33677498|NCT00545077|63122007|FG000|Overall Study|Protocol Violation|1|||
33677499|NCT00545077|63122008|FG001|Overall Study|Protocol Violation|0|||
33677500|NCT00545077|63122007|FG000|Overall Study|Adverse Event|0|||
33677501|NCT00545077|63122008|FG001|Overall Study|Adverse Event|31|||
33677502|NCT00545077|63122007|FG000|Overall Study|Death|0|||
33677503|NCT00545077|63122008|FG001|Overall Study|Death|8|||
33677504|NCT00130533|63122016|FG000|Overall Study|Withdrawal by Subject|33|||
33677505|NCT00130533|63122017|FG001|Overall Study|Withdrawal by Subject|6|||
33677506|NCT00130533|63122016|FG000|Overall Study|Adverse Event|34|||
33677507|NCT00130533|63122017|FG001|Overall Study|Adverse Event|1|||
33677508|NCT00130533|63122016|FG000|Overall Study|Disease relapse|9|||
33677509|NCT00130533|63122017|FG001|Overall Study|Disease relapse|13|||
33677510|NCT00130533|63122016|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
33677511|NCT00130533|63122017|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
33677512|NCT00130533|63122016|FG000|Overall Study|Death|4|||
33677513|NCT00130533|63122017|FG001|Overall Study|Death|2|||
33677514|NCT00130533|63122016|FG000|Overall Study|Protocol Violation|5|||
33677515|NCT00130533|63122017|FG001|Overall Study|Protocol Violation|1|||
33677516|NCT00130533|63122016|FG000|Overall Study|Lost to Follow-up|1|||
33677517|NCT00130533|63122017|FG001|Overall Study|Lost to Follow-up|1|||
33677518|NCT00130533|63122016|FG000|Overall Study|Sponsor´s decision|2|||
33677519|NCT00130533|63122017|FG001|Overall Study|Sponsor´s decision|0|||
33677520|NCT00130533|63122016|FG000|Overall Study|Second Primary Malignancy|0|||
33677521|NCT00130533|63122017|FG001|Overall Study|Second Primary Malignancy|1|||
33677522|NCT00130533|63122016|FG000|Overall Study|Other|12|||
33677523|NCT00130533|63122017|FG001|Overall Study|Other|5|||
33677524|NCT00129935|63122025|FG000|Overall Study|Adverse Event|18|||
33677525|NCT00129935|63122026|FG001|Overall Study|Adverse Event|56|||
33677526|NCT00129935|63122025|FG000|Overall Study|Death|1|||
33677527|NCT00129935|63122026|FG001|Overall Study|Death|1|||
33677528|NCT00129935|63122025|FG000|Overall Study|Withdrawal by Subject|7|||
33677529|NCT00129935|63122026|FG001|Overall Study|Withdrawal by Subject|20|||
33677530|NCT00129935|63122025|FG000|Overall Study|Protocol Violation|0|||
33677531|NCT00129935|63122026|FG001|Overall Study|Protocol Violation|4|||
33677532|NCT00129935|63122025|FG000|Overall Study|Physician Decision|3|||
33677533|NCT00129935|63122026|FG001|Overall Study|Physician Decision|4|||
33677534|NCT00129935|63122025|FG000|Overall Study|Recurrence|1|||
33677535|NCT00129935|63122026|FG001|Overall Study|Recurrence|3|||
33677536|NCT00129935|63122025|FG000|Overall Study|Second primary|0|||
33677537|NCT00129935|63122026|FG001|Overall Study|Second primary|1|||
33677538|NCT00129935|63122025|FG000|Overall Study|Other|3|||
33677539|NCT00129935|63122026|FG001|Overall Study|Other|2|||
33677540|NCT00129935|63122025|FG000|Overall Study|Crossed to the other arm|2|||
33677541|NCT00129935|63122026|FG001|Overall Study|Crossed to the other arm|1|||
33677542|NCT00129935|63122025|FG000|Overall Study|Incorrect study treatment|1|||
33677543|NCT00129935|63122026|FG001|Overall Study|Incorrect study treatment|0|||
33677544|NCT01647828|63122041|FG000|Overall Study|Death|3|||
33677545|NCT01647828|63122042|FG001|Overall Study|Death|4|||
33677546|NCT01647828|63122043|FG002|Overall Study|Death|4|||
33677547|NCT01647828|63122044|FG003|Overall Study|Death|5|||
33677548|NCT01647828|63122045|FG004|Overall Study|Death|6|||
33677549|NCT01647828|63122046|FG005|Overall Study|Death|3|||
33677550|NCT01647828|63122047|FG006|Overall Study|Death|10|||
33677551|NCT01647828|63122048|FG007|Overall Study|Death|60|||
33677552|NCT01647828|63122049|FG008|Overall Study|Death|71|||
33677553|NCT01647828|63122041|FG000|Overall Study|Withdrawal by Subject|2|||
33677554|NCT01647828|63122042|FG001|Overall Study|Withdrawal by Subject|0|||
33677555|NCT01647828|63122043|FG002|Overall Study|Withdrawal by Subject|0|||
33677556|NCT01647828|63122044|FG003|Overall Study|Withdrawal by Subject|1|||
33677557|NCT01647828|63122045|FG004|Overall Study|Withdrawal by Subject|0|||
33677558|NCT01647828|63122046|FG005|Overall Study|Withdrawal by Subject|0|||
33677559|NCT01647828|63122047|FG006|Overall Study|Withdrawal by Subject|1|||
33677560|NCT01647828|63122048|FG007|Overall Study|Withdrawal by Subject|0|||
33677561|NCT01647828|63122049|FG008|Overall Study|Withdrawal by Subject|2|||
33677562|NCT01647828|63122041|FG000|Overall Study|Study terminated by Sponsor|0|||
33677563|NCT01647828|63122042|FG001|Overall Study|Study terminated by Sponsor|0|||
33677564|NCT01647828|63122043|FG002|Overall Study|Study terminated by Sponsor|0|||
33677565|NCT01647828|63122044|FG003|Overall Study|Study terminated by Sponsor|0|||
33677566|NCT01647828|63122045|FG004|Overall Study|Study terminated by Sponsor|0|||
33677567|NCT01647828|63122046|FG005|Overall Study|Study terminated by Sponsor|0|||
33677568|NCT01647828|63122047|FG006|Overall Study|Study terminated by Sponsor|1|||
33677569|NCT01647828|63122048|FG007|Overall Study|Study terminated by Sponsor|26|||
33677570|NCT01647828|63122049|FG008|Overall Study|Study terminated by Sponsor|16|||
33677571|NCT01647828|63122041|FG000|Overall Study|Lost to Follow-up|0|||
33677572|NCT01647828|63122042|FG001|Overall Study|Lost to Follow-up|0|||
33677573|NCT01647828|63122043|FG002|Overall Study|Lost to Follow-up|0|||
33677574|NCT01647828|63122044|FG003|Overall Study|Lost to Follow-up|0|||
33677575|NCT01647828|63122045|FG004|Overall Study|Lost to Follow-up|0|||
33677576|NCT01647828|63122046|FG005|Overall Study|Lost to Follow-up|0|||
33677577|NCT01647828|63122047|FG006|Overall Study|Lost to Follow-up|0|||
33677578|NCT01647828|63122048|FG007|Overall Study|Lost to Follow-up|2|||
33677579|NCT01647828|63122049|FG008|Overall Study|Lost to Follow-up|0|||
33677580|NCT00989261|63122071|FG000|Overall Study|Still in follow up|12|||
33677581|NCT00989261|63122072|FG001|Overall Study|Still in follow up|21|||
33677582|NCT00989261|63122071|FG000|Overall Study|Withdrawal by Subject|0|||
33677583|NCT00989261|63122072|FG001|Overall Study|Withdrawal by Subject|1|||
33677584|NCT00989261|63122071|FG000|Overall Study|Lost to Follow-up|3|||
33677585|NCT00989261|63122072|FG001|Overall Study|Lost to Follow-up|0|||
33677586|NCT00988559|63122091|FG000|Overall Study|Withdrawal by Subject|1|||
33677587|NCT00988559|63122092|FG001|Overall Study|Withdrawal by Subject|1|||
33677588|NCT00988559|63122093|FG002|Overall Study|Withdrawal by Subject|0|||
33677589|NCT00988559|63122094|FG003|Overall Study|Withdrawal by Subject|1|||
33677590|NCT00988559|63122091|FG000|Overall Study|Pregnancy|0|||
33677591|NCT00988559|63122092|FG001|Overall Study|Pregnancy|1|||
33677592|NCT00988559|63122093|FG002|Overall Study|Pregnancy|1|||
33677593|NCT00988559|63122094|FG003|Overall Study|Pregnancy|0|||
33677594|NCT00988559|63122091|FG000|Overall Study|Lost to Follow-up|0|||
33677595|NCT00988559|63122092|FG001|Overall Study|Lost to Follow-up|0|||
33677596|NCT00988559|63122093|FG002|Overall Study|Lost to Follow-up|1|||
33677597|NCT00988559|63122094|FG003|Overall Study|Lost to Follow-up|0|||
33677598|NCT00988169|63122104|FG000|Overall Study|Withdrawal by Subject|1|||
33677599|NCT00988091|63122131|FG000|Double-blind Period|Withdrawal by Subject|15|||
33677600|NCT00988091|63122132|FG001|Double-blind Period|Withdrawal by Subject|13|||
33677601|NCT00988091|63122131|FG000|Double-blind Period|Lost to Follow-up|12|||
33677602|NCT00988091|63122132|FG001|Double-blind Period|Lost to Follow-up|14|||
33677603|NCT00988091|63122131|FG000|Double-blind Period|Other|8|||
33677604|NCT00988091|63122132|FG001|Double-blind Period|Other|8|||
33677605|NCT00988091|63122131|FG000|Double-blind Period|Adverse Event|6|||
33677606|NCT00988091|63122132|FG001|Double-blind Period|Adverse Event|9|||
33677607|NCT00988091|63122131|FG000|Double-blind Period|Use of exclusionary medication|2|||
33677608|NCT00988091|63122132|FG001|Double-blind Period|Use of exclusionary medication|3|||
33677609|NCT00988091|63122131|FG000|Open-label Period|Adverse Event|4|||
33677610|NCT00988091|63122132|FG001|Open-label Period|Adverse Event|7|||
33677611|NCT00988091|63122131|FG000|Open-label Period|Use of exclusionary medication|1|||
33677612|NCT00988091|63122132|FG001|Open-label Period|Use of exclusionary medication|1|||
33677613|NCT00988091|63122131|FG000|Open-label Period|Protocol Violation|1|||
33677614|NCT00988091|63122132|FG001|Open-label Period|Protocol Violation|1|||
33677615|NCT00988091|63122131|FG000|Open-label Period|Withdrawal by Subject|10|||
33677616|NCT00988091|63122132|FG001|Open-label Period|Withdrawal by Subject|16|||
33677617|NCT00988091|63122131|FG000|Open-label Period|Lost to Follow-up|3|||
33677618|NCT00988091|63122132|FG001|Open-label Period|Lost to Follow-up|5|||
33677619|NCT00988091|63122131|FG000|Open-label Period|Other|2|||
33677620|NCT00988091|63122132|FG001|Open-label Period|Other|3|||
33677621|NCT02623218|63122422|FG000|Overall Study|Lost to Follow-up|0|||
33677622|NCT02623218|63122423|FG001|Overall Study|Lost to Follow-up|1|||
33677623|NCT02623218|63122424|FG002|Overall Study|Lost to Follow-up|0|||
33677624|NCT02623218|63122425|FG003|Overall Study|Lost to Follow-up|0|||
33677625|NCT02623218|63122426|FG004|Overall Study|Lost to Follow-up|0|||
33677626|NCT02622828|63122460|FG000|Overall Study|participant withdrew|3|||
33677627|NCT02621424|63122576|FG000|Overall Study|Withdrawal by Subject|1|||
33677628|NCT02621424|63122577|FG001|Overall Study|Withdrawal by Subject|2|||
33677629|NCT02621034|63122605|FG000|Overall Study|Lost to Follow-up|3|||
33677630|NCT02621034|63122606|FG001|Overall Study|Lost to Follow-up|2|||
33677631|NCT02621034|63122607|FG002|Overall Study|Lost to Follow-up|5|||
33677632|NCT02620020|63122680|FG000|Overall Study|Adverse Event|8|||
33677633|NCT02620020|63122681|FG001|Overall Study|Adverse Event|4|||
33677634|NCT02620020|63122682|FG002|Overall Study|Adverse Event|3|||
33677635|NCT02620020|63122683|FG003|Overall Study|Adverse Event|5|||
33677636|NCT02620020|63122680|FG000|Overall Study|Lost to Follow-up|4|||
33677637|NCT02620020|63122681|FG001|Overall Study|Lost to Follow-up|8|||
33677638|NCT02620020|63122682|FG002|Overall Study|Lost to Follow-up|1|||
33677639|NCT02620020|63122683|FG003|Overall Study|Lost to Follow-up|4|||
33677640|NCT02620020|63122680|FG000|Overall Study|Physician Decision|7|||
33677641|NCT02620020|63122681|FG001|Overall Study|Physician Decision|4|||
33677642|NCT02620020|63122682|FG002|Overall Study|Physician Decision|3|||
33677643|NCT02620020|63122683|FG003|Overall Study|Physician Decision|4|||
33677644|NCT02620020|63122680|FG000|Overall Study|Protocol Violation|5|||
33677645|NCT02620020|63122681|FG001|Overall Study|Protocol Violation|2|||
33677646|NCT02620020|63122682|FG002|Overall Study|Protocol Violation|1|||
33677647|NCT02620020|63122683|FG003|Overall Study|Protocol Violation|1|||
33677648|NCT02620020|63122680|FG000|Overall Study|Withdrawal by Subject|20|||
33677649|NCT02620020|63122681|FG001|Overall Study|Withdrawal by Subject|16|||
33677650|NCT02620020|63122682|FG002|Overall Study|Withdrawal by Subject|17|||
33677651|NCT02620020|63122683|FG003|Overall Study|Withdrawal by Subject|12|||
33677652|NCT02620020|63122680|FG000|Overall Study|Death|0|||
33677653|NCT02620020|63122681|FG001|Overall Study|Death|1|||
33677654|NCT02620020|63122682|FG002|Overall Study|Death|0|||
33677655|NCT02620020|63122683|FG003|Overall Study|Death|0|||
33677656|NCT02549989|63122693|FG000|Overall Study|Adverse Event|4|||
33677657|NCT02549989|63122693|FG000|Overall Study|Death|1|||
33677658|NCT02549989|63122693|FG000|Overall Study|Lack of Efficacy|19|||
33677659|NCT02549989|63122693|FG000|Overall Study|Withdrawal by Subject|3|||
33677660|NCT00987935|63122852|FG000|Overall Study|Progressive disease|3|||
33677661|NCT00987935|63122853|FG001|Overall Study|Progressive disease|2|||
33677662|NCT00987935|63122854|FG002|Overall Study|Progressive disease|3|||
33677663|NCT00987935|63122855|FG003|Overall Study|Progressive disease|2|||
33677664|NCT00987935|63122856|FG004|Overall Study|Progressive disease|5|||
33677665|NCT00987935|63122857|FG005|Overall Study|Progressive disease|3|||
33677666|NCT00987935|63122858|FG006|Overall Study|Progressive disease|9|||
33677667|NCT00987935|63122859|FG007|Overall Study|Progressive disease|48|||
33677668|NCT00987935|63122860|FG008|Overall Study|Progressive disease|23|||
33677669|NCT00987935|63122852|FG000|Overall Study|Adverse Event|0|||
33677670|NCT00987935|63122853|FG001|Overall Study|Adverse Event|1|||
33677671|NCT00987935|63122854|FG002|Overall Study|Adverse Event|0|||
33677672|NCT00987935|63122855|FG003|Overall Study|Adverse Event|1|||
33677673|NCT00987935|63122856|FG004|Overall Study|Adverse Event|1|||
33677674|NCT00987935|63122857|FG005|Overall Study|Adverse Event|0|||
33677675|NCT00987935|63122858|FG006|Overall Study|Adverse Event|2|||
33677676|NCT00987935|63122859|FG007|Overall Study|Adverse Event|10|||
33677677|NCT00987935|63122860|FG008|Overall Study|Adverse Event|6|||
33677678|NCT00987935|63122852|FG000|Overall Study|Refused to continue taking trial med.|1|||
33677679|NCT00987935|63122853|FG001|Overall Study|Refused to continue taking trial med.|0|||
33677680|NCT00987935|63122854|FG002|Overall Study|Refused to continue taking trial med.|0|||
33677681|NCT00987935|63122855|FG003|Overall Study|Refused to continue taking trial med.|0|||
33677682|NCT00987935|63122856|FG004|Overall Study|Refused to continue taking trial med.|1|||
33677683|NCT00987935|63122857|FG005|Overall Study|Refused to continue taking trial med.|0|||
33677684|NCT00987935|63122858|FG006|Overall Study|Refused to continue taking trial med.|4|||
33677685|NCT00987935|63122859|FG007|Overall Study|Refused to continue taking trial med.|4|||
33677686|NCT00987935|63122860|FG008|Overall Study|Refused to continue taking trial med.|2|||
33677687|NCT00987935|63122852|FG000|Overall Study|Reason other than those specified above|0|||
33677688|NCT00987935|63122853|FG001|Overall Study|Reason other than those specified above|0|||
33677689|NCT00987935|63122854|FG002|Overall Study|Reason other than those specified above|0|||
33677690|NCT00987935|63122855|FG003|Overall Study|Reason other than those specified above|0|||
33677691|NCT00987935|63122856|FG004|Overall Study|Reason other than those specified above|0|||
33677692|NCT00987935|63122857|FG005|Overall Study|Reason other than those specified above|0|||
33677693|NCT00987935|63122858|FG006|Overall Study|Reason other than those specified above|0|||
33677694|NCT00987935|63122859|FG007|Overall Study|Reason other than those specified above|0|||
33677695|NCT00987935|63122860|FG008|Overall Study|Reason other than those specified above|1|||
33677696|NCT01597050|63122888|FG000|Overall Study|Withdrawal by Subject|1|||
33677697|NCT01597050|63122889|FG001|Overall Study|Withdrawal by Subject|0|||
33677698|NCT00987623|63122906|FG000|Overall Study|Lost to Follow-up|2|||
33677699|NCT00987623|63122907|FG001|Overall Study|Lost to Follow-up|1|||
33677700|NCT00987623|63122906|FG000|Overall Study|Time/job conflict|2|||
33677701|NCT00987623|63122907|FG001|Overall Study|Time/job conflict|0|||
33677702|NCT00987623|63122906|FG000|Overall Study|Discomfort|1|||
33677703|NCT00987623|63122907|FG001|Overall Study|Discomfort|0|||
33677704|NCT00987623|63122906|FG000|Overall Study|Biomicroscopy|0|||
33677705|NCT00987623|63122907|FG001|Overall Study|Biomicroscopy|1|||
33677706|NCT00987623|63122906|FG000|Overall Study|Influenza|0|||
33677707|NCT00987623|63122907|FG001|Overall Study|Influenza|1|||
33677708|NCT00987467|63122913|FG000|Overall Study|Lost to Follow-up|2|||
33677709|NCT04990440|63122921|FG000|Overall Study|Sponsor's Decision|0|||
33677710|NCT04990440|63122922|FG001|Overall Study|Sponsor's Decision|0|||
33677711|NCT04990440|63122923|FG002|Overall Study|Sponsor's Decision|1|||
33677712|NCT04829747|63122931|FG000|Overall Study|Protocol Violation|1|||
33677713|NCT04408924|63122957|FG000|Overall Study|On Study Treatment|3|||
33677714|NCT04408924|63122957|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|14|||
33677715|NCT04408924|63122957|FG000|Overall Study|Lost to Follow-up|1|||
33677716|NCT04408924|63122957|FG000|Overall Study|Withdrawal by Subject|7|||
33677717|NCT04258423|63122973|FG000|Overall Study|Study Closure|2|||
33677718|NCT04258423|63122974|FG001|Overall Study|Study Closure|2|||
33677719|NCT04178967|63122982|FG000|Induction Period|Adverse Event|4|||
33677720|NCT04178967|63122983|FG001|Induction Period|Adverse Event|6|||
33677721|NCT04178967|63122984|FG002|Induction Period|Adverse Event|0|||
33677722|NCT04178967|63122985|FG003|Induction Period|Adverse Event|0|||
33677723|NCT04178967|63122986|FG004|Induction Period|Adverse Event|0|||
33677724|NCT04178967|63122987|FG005|Induction Period|Adverse Event|0|||
33677725|NCT04178967|63122988|FG006|Induction Period|Adverse Event|0|||
33677726|NCT04178967|63122989|FG007|Induction Period|Adverse Event|0|||
33677727|NCT04178967|63122990|FG008|Induction Period|Adverse Event|0|||
33677728|NCT04178967|63122991|FG009|Induction Period|Adverse Event|0|||
33677729|NCT04178967|63122992|FG010|Induction Period|Adverse Event|0|||
33677730|NCT04178967|63122982|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
33677731|NCT04178967|63122983|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
33677732|NCT04178967|63122984|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
33677733|NCT04178967|63122985|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
33677734|NCT04178967|63122986|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
33677735|NCT04178967|63122987|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
33677736|NCT04178967|63122988|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
33677737|NCT04178967|63122989|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
33677738|NCT04178967|63122990|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
33677739|NCT04178967|63122991|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
33677740|NCT04178967|63122992|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
33677741|NCT04178967|63122982|FG000|Induction Period|Lack of Efficacy|4|||
33677742|NCT04178967|63122983|FG001|Induction Period|Lack of Efficacy|1|||
33677743|NCT04178967|63122984|FG002|Induction Period|Lack of Efficacy|0|||
33677744|NCT04178967|63122985|FG003|Induction Period|Lack of Efficacy|0|||
33677745|NCT04178967|63122986|FG004|Induction Period|Lack of Efficacy|0|||
33677746|NCT04178967|63122987|FG005|Induction Period|Lack of Efficacy|0|||
33677747|NCT04178967|63122988|FG006|Induction Period|Lack of Efficacy|0|||
33677748|NCT04178967|63122989|FG007|Induction Period|Lack of Efficacy|0|||
33677749|NCT04178967|63122990|FG008|Induction Period|Lack of Efficacy|0|||
33677750|NCT04178967|63122991|FG009|Induction Period|Lack of Efficacy|0|||
33677751|NCT04178967|63122992|FG010|Induction Period|Lack of Efficacy|0|||
33677752|NCT04178967|63122982|FG000|Induction Period|Protocol Violation|0|||
33677753|NCT04178967|63122983|FG001|Induction Period|Protocol Violation|6|||
33677754|NCT04178967|63122984|FG002|Induction Period|Protocol Violation|0|||
33677755|NCT04178967|63122985|FG003|Induction Period|Protocol Violation|0|||
33677756|NCT04178967|63122986|FG004|Induction Period|Protocol Violation|0|||
33677757|NCT04178967|63122987|FG005|Induction Period|Protocol Violation|0|||
33677758|NCT04178967|63122988|FG006|Induction Period|Protocol Violation|0|||
33677759|NCT04178967|63122989|FG007|Induction Period|Protocol Violation|0|||
33677760|NCT04178967|63122990|FG008|Induction Period|Protocol Violation|0|||
33677761|NCT04178967|63122991|FG009|Induction Period|Protocol Violation|0|||
33677762|NCT04178967|63122992|FG010|Induction Period|Protocol Violation|0|||
33677763|NCT04178967|63122982|FG000|Induction Period|Withdrawal by Subject|6|||
33677764|NCT04178967|63122983|FG001|Induction Period|Withdrawal by Subject|4|||
33677765|NCT04178967|63122984|FG002|Induction Period|Withdrawal by Subject|0|||
33677766|NCT04178967|63122985|FG003|Induction Period|Withdrawal by Subject|0|||
33677767|NCT04178967|63122986|FG004|Induction Period|Withdrawal by Subject|0|||
33677768|NCT04178967|63122987|FG005|Induction Period|Withdrawal by Subject|0|||
33677769|NCT04178967|63122988|FG006|Induction Period|Withdrawal by Subject|0|||
33677770|NCT04178967|63122989|FG007|Induction Period|Withdrawal by Subject|0|||
33677771|NCT04178967|63122990|FG008|Induction Period|Withdrawal by Subject|0|||
33677772|NCT04178967|63122991|FG009|Induction Period|Withdrawal by Subject|0|||
33677773|NCT04178967|63122992|FG010|Induction Period|Withdrawal by Subject|0|||
33677774|NCT04178967|63122982|FG000|Induction Period|Lost to Follow-up|2|||
33677775|NCT04178967|63122983|FG001|Induction Period|Lost to Follow-up|0|||
33677776|NCT04178967|63122984|FG002|Induction Period|Lost to Follow-up|0|||
33677777|NCT04178967|63122985|FG003|Induction Period|Lost to Follow-up|0|||
33677778|NCT04178967|63122986|FG004|Induction Period|Lost to Follow-up|0|||
33677779|NCT04178967|63122987|FG005|Induction Period|Lost to Follow-up|0|||
33677780|NCT04178967|63122988|FG006|Induction Period|Lost to Follow-up|0|||
33677781|NCT04178967|63122989|FG007|Induction Period|Lost to Follow-up|0|||
33677782|NCT04178967|63122990|FG008|Induction Period|Lost to Follow-up|0|||
33677783|NCT04178967|63122991|FG009|Induction Period|Lost to Follow-up|0|||
33677784|NCT04178967|63122992|FG010|Induction Period|Lost to Follow-up|0|||
33677785|NCT04178967|63122982|FG000|Induction Period|Participant Missed Study Visits|0|||
33677786|NCT04178967|63122983|FG001|Induction Period|Participant Missed Study Visits|1|||
33677787|NCT04178967|63122984|FG002|Induction Period|Participant Missed Study Visits|0|||
33677788|NCT04178967|63122985|FG003|Induction Period|Participant Missed Study Visits|0|||
33677789|NCT04178967|63122986|FG004|Induction Period|Participant Missed Study Visits|0|||
33677790|NCT04178967|63122987|FG005|Induction Period|Participant Missed Study Visits|0|||
33677791|NCT04178967|63122988|FG006|Induction Period|Participant Missed Study Visits|0|||
33677792|NCT04178967|63122989|FG007|Induction Period|Participant Missed Study Visits|0|||
33677793|NCT04178967|63122990|FG008|Induction Period|Participant Missed Study Visits|0|||
33677794|NCT04178967|63122991|FG009|Induction Period|Participant Missed Study Visits|0|||
33677795|NCT04178967|63122992|FG010|Induction Period|Participant Missed Study Visits|0|||
33677796|NCT04178967|63122982|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
33677797|NCT04178967|63122983|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
33677798|NCT04178967|63122984|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
33677799|NCT04178967|63122985|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
33677800|NCT04178967|63122986|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
33677801|NCT04178967|63122987|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
33677802|NCT04178967|63122988|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
33677803|NCT04178967|63122989|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
33677804|NCT04178967|63122990|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
33677805|NCT04178967|63122991|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
33677806|NCT04178967|63122992|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
33677807|NCT04178967|63122982|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33677808|NCT04178967|63122983|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33677809|NCT04178967|63122984|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33677810|NCT04178967|63122985|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33677811|NCT04178967|63122986|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33677812|NCT04178967|63122987|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
33677813|NCT04178967|63122988|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33677814|NCT04178967|63122989|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33677815|NCT04178967|63122990|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33677816|NCT04178967|63122991|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33677817|NCT04178967|63122992|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33677818|NCT04178967|63122982|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33677819|NCT04178967|63122983|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33677820|NCT04178967|63122984|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33677821|NCT04178967|63122985|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
33677822|NCT04178967|63122986|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33677823|NCT04178967|63122987|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33677824|NCT04178967|63122988|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33677825|NCT04178967|63122989|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33677826|NCT04178967|63122990|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33677827|NCT04178967|63122991|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33677828|NCT04178967|63122992|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33677829|NCT04178967|63122982|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
33677830|NCT04178967|63122983|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
33677831|NCT04178967|63122984|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
33677832|NCT04178967|63122985|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
33677833|NCT04178967|63122986|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
33677834|NCT04178967|63122987|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
33677835|NCT04178967|63122988|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
33677836|NCT04178967|63122989|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
33677837|NCT04178967|63122990|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
33677838|NCT04178967|63122991|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
33677839|NCT04178967|63122992|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
33677840|NCT04178967|63122982|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33677841|NCT04178967|63122983|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33677842|NCT04178967|63122984|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33677843|NCT04178967|63122985|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33677844|NCT04178967|63122986|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
33677845|NCT04178967|63122987|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
33677846|NCT04178967|63122988|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33677847|NCT04178967|63122989|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
33677848|NCT04178967|63122990|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33677849|NCT04178967|63122991|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33677850|NCT04178967|63122992|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33677851|NCT04178967|63122982|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
33677852|NCT04178967|63122983|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
33677853|NCT04178967|63122984|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
33677854|NCT04178967|63122985|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
33677855|NCT04178967|63122986|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
33677856|NCT04178967|63122987|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
33677857|NCT04178967|63122988|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
33677858|NCT04178967|63122989|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
33677859|NCT04178967|63122990|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
33677860|NCT04178967|63122991|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
33677861|NCT04178967|63122992|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
33677862|NCT04178967|63122982|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33677863|NCT04178967|63122983|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33677864|NCT04178967|63122984|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33677865|NCT04178967|63122985|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
33677866|NCT04178967|63122986|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33677867|NCT04178967|63122987|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
33677868|NCT04178967|63122988|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
33677869|NCT04178967|63122989|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
33677870|NCT04178967|63122990|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33677871|NCT04178967|63122991|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33677872|NCT04178967|63122992|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33677873|NCT04178967|63122982|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
33677874|NCT04178967|63122983|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
33677875|NCT04178967|63122984|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
33677876|NCT04178967|63122985|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
33677877|NCT04178967|63122986|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
33677878|NCT04178967|63122987|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
33677879|NCT04178967|63122988|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
33677880|NCT04178967|63122989|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
33677881|NCT04178967|63122990|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
33677882|NCT04178967|63122991|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
33677883|NCT04178967|63122992|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
33677884|NCT04178967|63122982|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33677885|NCT04178967|63122983|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33677886|NCT04178967|63122984|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33677887|NCT04178967|63122985|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33677888|NCT04178967|63122986|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33677889|NCT04178967|63122987|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33677890|NCT04178967|63122988|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33677891|NCT04178967|63122989|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33677892|NCT04178967|63122990|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
33677893|NCT04178967|63122991|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
33677894|NCT04178967|63122992|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
33677895|NCT04178967|63122982|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33677896|NCT04178967|63122983|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33677897|NCT04178967|63122984|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33677898|NCT04178967|63122985|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33677899|NCT04178967|63122986|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33677900|NCT04178967|63122987|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33677901|NCT04178967|63122988|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33677902|NCT04178967|63122989|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33677903|NCT04178967|63122990|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33677904|NCT04178967|63122991|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
33677905|NCT04178967|63122992|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33677906|NCT04178967|63122982|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33677907|NCT04178967|63122983|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33677908|NCT04178967|63122984|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33677909|NCT04178967|63122985|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33677910|NCT04178967|63122986|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33677911|NCT04178967|63122987|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33677912|NCT04178967|63122988|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33677913|NCT04178967|63122989|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33677914|NCT04178967|63122990|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
33677915|NCT04178967|63122991|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
33677916|NCT04178967|63122992|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
33677917|NCT04178967|63122982|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33677918|NCT04178967|63122983|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33677919|NCT04178967|63122984|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33677920|NCT04178967|63122985|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33677921|NCT04178967|63122986|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33677922|NCT04178967|63122987|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33677923|NCT04178967|63122988|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33677924|NCT04178967|63122989|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33677925|NCT04178967|63122990|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33677926|NCT04178967|63122991|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
33677927|NCT04178967|63122992|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33677928|NCT04178967|63122982|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33677929|NCT04178967|63122983|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33677930|NCT04178967|63122984|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33677931|NCT04178967|63122985|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33677932|NCT04178967|63122986|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33677933|NCT04178967|63122987|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33677934|NCT04178967|63122988|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33677935|NCT04178967|63122989|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33677936|NCT04178967|63122990|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33677937|NCT04178967|63122991|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
33677938|NCT04178967|63122992|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33677939|NCT04163900|63123014|FG000|Overall Study|Radiological disease progression|112|||
33677940|NCT04163900|63123015|FG001|Overall Study|Radiological disease progression|127|||
33677941|NCT04163900|63123014|FG000|Overall Study|Study closure|98|||
33677942|NCT04163900|63123015|FG001|Overall Study|Study closure|133|||
33677943|NCT04163900|63123014|FG000|Overall Study|Adverse Event|78|||
33677944|NCT04163900|63123015|FG001|Overall Study|Adverse Event|32|||
33677945|NCT04163900|63123014|FG000|Overall Study|Withdrawal by Subject|37|||
33677946|NCT04163900|63123015|FG001|Overall Study|Withdrawal by Subject|34|||
33677947|NCT04163900|63123014|FG000|Overall Study|Death|29|||
33677948|NCT04163900|63123015|FG001|Overall Study|Death|16|||
33677949|NCT04163900|63123014|FG000|Overall Study|Physician Decision|17|||
33677950|NCT04163900|63123015|FG001|Overall Study|Physician Decision|25|||
33677951|NCT04163900|63123014|FG000|Overall Study|Clinical disease progression|14|||
33677952|NCT04163900|63123015|FG001|Overall Study|Clinical disease progression|13|||
33677953|NCT04163900|63123014|FG000|Overall Study|Protocol Violation|3|||
33677954|NCT04163900|63123015|FG001|Overall Study|Protocol Violation|4|||
33677955|NCT04163900|63123014|FG000|Overall Study|Lost to Follow-up|0|||
33677956|NCT04163900|63123015|FG001|Overall Study|Lost to Follow-up|1|||
33677957|NCT04161495|63123023|FG000|Overall Study|Withdrawal by Subject|3|||
33677958|NCT04161495|63123024|FG001|Overall Study|Withdrawal by Subject|0|||
33677959|NCT04161495|63123023|FG000|Overall Study|Protocol Violation|1|||
33677960|NCT04161495|63123024|FG001|Overall Study|Protocol Violation|0|||
33677961|NCT04161495|63123023|FG000|Overall Study|Prohibited concomitant medication|3|||
33677962|NCT04161495|63123024|FG001|Overall Study|Prohibited concomitant medication|0|||
33677963|NCT04161495|63123023|FG000|Overall Study|Adverse Event|1|||
33677964|NCT04161495|63123024|FG001|Overall Study|Adverse Event|0|||
33677965|NCT04161495|63123023|FG000|Overall Study|Other - Unspecified|1|||
33677966|NCT04161495|63123024|FG001|Overall Study|Other - Unspecified|0|||
33677967|NCT04161495|63123023|FG000|Overall Study|Death|0|||
33677968|NCT04161495|63123024|FG001|Overall Study|Death|1|||
33677969|NCT04108000|63123053|FG000|Overall Study|Death of patient|1|||
33677970|NCT04108000|63123054|FG001|Overall Study|Death of patient|0|||
33677971|NCT04108000|63123055|FG002|Overall Study|Death of patient|1|||
33677972|NCT04108000|63123056|FG003|Overall Study|Death of patient|0|||
33677973|NCT04108000|63123053|FG000|Overall Study|Withdrawal by Subject|2|||
33677974|NCT04108000|63123054|FG001|Overall Study|Withdrawal by Subject|2|||
33677975|NCT04108000|63123055|FG002|Overall Study|Withdrawal by Subject|0|||
33677976|NCT04108000|63123056|FG003|Overall Study|Withdrawal by Subject|0|||
33677977|NCT04108000|63123053|FG000|Overall Study|Death of surrogate partner|0|||
33677978|NCT04108000|63123054|FG001|Overall Study|Death of surrogate partner|1|||
33677979|NCT04108000|63123055|FG002|Overall Study|Death of surrogate partner|0|||
33677980|NCT04108000|63123056|FG003|Overall Study|Death of surrogate partner|1|||
33677981|NCT03945266|63123072|FG000|Overall Study|Withdrawal by Subject|1|||
33677982|NCT03945266|63123073|FG001|Overall Study|Withdrawal by Subject|0|||
33677983|NCT03945266|63123072|FG000|Overall Study|Miscarriage|0|||
33677984|NCT03945266|63123073|FG001|Overall Study|Miscarriage|2|||
33677985|NCT03945266|63123072|FG000|Overall Study|Lost to Follow-up|1|||
33677986|NCT03945266|63123073|FG001|Overall Study|Lost to Follow-up|0|||
33677987|NCT03916484|63123087|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
33677988|NCT03916484|63123088|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
33677989|NCT03916484|63123089|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
33677990|NCT03916484|63123090|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
33677991|NCT03916484|63123087|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
33677992|NCT03916484|63123088|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
33677993|NCT03916484|63123089|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
33677994|NCT03916484|63123090|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
33677995|NCT03769311|63123105|FG000|Overall Study|Withdrawal by Subject|1|||
33677996|NCT03738566|63123113|FG000|Initial Study Phase|Withdrawal by Subject|1|||
33677997|NCT03738566|63123114|FG001|Initial Study Phase|Withdrawal by Subject|1|||
33677998|NCT03738566|63123115|FG002|Initial Study Phase|Withdrawal by Subject|2|||
33677999|NCT03738566|63123116|FG003|Initial Study Phase|Withdrawal by Subject|0|||
33678000|NCT03738566|63123113|FG000|Initial Study Phase|Death|0|||
33678001|NCT03738566|63123114|FG001|Initial Study Phase|Death|1|||
33678002|NCT03738566|63123115|FG002|Initial Study Phase|Death|0|||
33678003|NCT03738566|63123116|FG003|Initial Study Phase|Death|0|||
33678004|NCT03738566|63123113|FG000|Initial Study Phase|Treatment failure|5|||
33678005|NCT03738566|63123114|FG001|Initial Study Phase|Treatment failure|0|||
33678006|NCT03738566|63123115|FG002|Initial Study Phase|Treatment failure|0|||
33678007|NCT03738566|63123116|FG003|Initial Study Phase|Treatment failure|0|||
33678008|NCT03738566|63123113|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
33678009|NCT03738566|63123114|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
33678010|NCT03738566|63123115|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
33678011|NCT03738566|63123116|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
33678012|NCT03533751|63123151|FG000|Overall Study|Withdrawal by Subject|12|||
33678013|NCT03533751|63123152|FG001|Overall Study|Withdrawal by Subject|6|||
33678014|NCT03533751|63123153|FG002|Overall Study|Withdrawal by Subject|11|||
33678015|NCT03533751|63123154|FG003|Overall Study|Withdrawal by Subject|9|||
33678016|NCT03533751|63123155|FG004|Overall Study|Withdrawal by Subject|10|||
33678017|NCT03533751|63123151|FG000|Overall Study|Adverse Event|4|||
33678018|NCT03533751|63123152|FG001|Overall Study|Adverse Event|7|||
33678019|NCT03533751|63123153|FG002|Overall Study|Adverse Event|2|||
33678020|NCT03533751|63123154|FG003|Overall Study|Adverse Event|4|||
33678021|NCT03533751|63123155|FG004|Overall Study|Adverse Event|5|||
33678022|NCT03533751|63123151|FG000|Overall Study|Physician Decision|0|||
33678023|NCT03533751|63123152|FG001|Overall Study|Physician Decision|2|||
33678024|NCT03533751|63123153|FG002|Overall Study|Physician Decision|1|||
33678025|NCT03533751|63123154|FG003|Overall Study|Physician Decision|2|||
33678026|NCT03533751|63123155|FG004|Overall Study|Physician Decision|1|||
33678027|NCT03533751|63123151|FG000|Overall Study|Sponsor Decision|0|||
33678028|NCT03533751|63123152|FG001|Overall Study|Sponsor Decision|0|||
33678029|NCT03533751|63123153|FG002|Overall Study|Sponsor Decision|1|||
33678030|NCT03533751|63123154|FG003|Overall Study|Sponsor Decision|1|||
33678031|NCT03533751|63123155|FG004|Overall Study|Sponsor Decision|0|||
33678032|NCT03533751|63123151|FG000|Overall Study|Lost to Follow-up|3|||
33678033|NCT03533751|63123152|FG001|Overall Study|Lost to Follow-up|7|||
33678034|NCT03533751|63123153|FG002|Overall Study|Lost to Follow-up|6|||
33678035|NCT03533751|63123154|FG003|Overall Study|Lost to Follow-up|4|||
33678036|NCT03533751|63123155|FG004|Overall Study|Lost to Follow-up|3|||
33678037|NCT03533751|63123151|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
33678038|NCT03533751|63123152|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
33678039|NCT03533751|63123153|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
33678040|NCT03533751|63123154|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
33678041|NCT03533751|63123155|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
33678042|NCT03533751|63123151|FG000|Overall Study|Other|0|||
33678043|NCT03533751|63123152|FG001|Overall Study|Other|2|||
33678044|NCT03533751|63123153|FG002|Overall Study|Other|1|||
33678045|NCT03533751|63123154|FG003|Overall Study|Other|0|||
33678046|NCT03533751|63123155|FG004|Overall Study|Other|3|||
33678047|NCT04856917|63123174|FG000|Overall Study|Withdrawal by Subject|4|||
33678048|NCT04856917|63123175|FG001|Overall Study|Withdrawal by Subject|3|||
33678049|NCT04856917|63123176|FG002|Overall Study|Withdrawal by Subject|1|||
33678050|NCT04856917|63123174|FG000|Overall Study|Lost to Follow-up|3|||
33678051|NCT04856917|63123175|FG001|Overall Study|Lost to Follow-up|1|||
33678052|NCT04856917|63123176|FG002|Overall Study|Lost to Follow-up|1|||
33678053|NCT04856917|63123174|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
33678054|NCT04856917|63123175|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
33678055|NCT04856917|63123176|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
33678056|NCT04856917|63123174|FG000|Overall Study|Other|1|||
33678057|NCT04856917|63123175|FG001|Overall Study|Other|1|||
33678058|NCT04856917|63123176|FG002|Overall Study|Other|0|||
33678059|NCT04615247|63123214|FG000|Overall Study|Adverse Event|0|||
33678060|NCT04615247|63123215|FG001|Overall Study|Adverse Event|2|||
33678061|NCT04615247|63123214|FG000|Overall Study|Withdrawal by Subject|1|||
33678062|NCT04615247|63123215|FG001|Overall Study|Withdrawal by Subject|1|||
33678063|NCT04552132|63123236|FG000|Overall Study|Lost to Follow-up|4|||
33678064|NCT04552132|63123237|FG001|Overall Study|Lost to Follow-up|3|||
33678065|NCT04552132|63123236|FG000|Overall Study|Protocol Violation|1|||
33678066|NCT04552132|63123237|FG001|Overall Study|Protocol Violation|0|||
33678067|NCT04421456|63123246|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
33678068|NCT04421456|63123247|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
33678069|NCT04421456|63123248|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
33678070|NCT04421456|63123246|FG000|Randomized Treatment Period|Adverse Event|0|||
33678071|NCT04421456|63123247|FG001|Randomized Treatment Period|Adverse Event|1|||
33678072|NCT04421456|63123248|FG002|Randomized Treatment Period|Adverse Event|0|||
33678073|NCT04421456|63123246|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
33678074|NCT04421456|63123247|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
33678075|NCT04421456|63123248|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
33678076|NCT04421456|63123246|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
33678077|NCT04421456|63123247|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
33678078|NCT04421456|63123248|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
33678079|NCT04421456|63123246|FG000|Randomized Treatment Period|Participant non-compliance|1|||
33678080|NCT04421456|63123247|FG001|Randomized Treatment Period|Participant non-compliance|1|||
33678081|NCT04421456|63123248|FG002|Randomized Treatment Period|Participant non-compliance|2|||
33678082|NCT04421456|63123246|FG000|Randomized Treatment Period|Other|0|||
33678083|NCT04421456|63123247|FG001|Randomized Treatment Period|Other|1|||
33678084|NCT04421456|63123248|FG002|Randomized Treatment Period|Other|3|||
33678085|NCT04341363|63123257|FG000|Overall Study|Adverse Event|1|||
33678086|NCT04341363|63123257|FG000|Overall Study|Withdrawal by Subject|1|||
33678087|NCT04268303|63123268|FG000|Overall Study|Lost to Follow-up|1|||
33678088|NCT04268303|63123269|FG001|Overall Study|Lost to Follow-up|1|||
33678089|NCT04268303|63123270|FG002|Overall Study|Lost to Follow-up|2|||
33678090|NCT04268303|63123268|FG000|Overall Study|Withdrawal by Subject|0|||
33678091|NCT04268303|63123269|FG001|Overall Study|Withdrawal by Subject|1|||
33678092|NCT04268303|63123270|FG002|Overall Study|Withdrawal by Subject|1|||
33678093|NCT04268303|63123268|FG000|Overall Study|Adverse Event|2|||
33678094|NCT04268303|63123269|FG001|Overall Study|Adverse Event|0|||
33678095|NCT04268303|63123270|FG002|Overall Study|Adverse Event|0|||
33678096|NCT04092452|63123314|FG000|Overall Study|Adverse Event|1|||
33678097|NCT04092452|63123315|FG001|Overall Study|Adverse Event|3|||
33678098|NCT04092452|63123316|FG002|Overall Study|Adverse Event|3|||
33678099|NCT04092452|63123317|FG003|Overall Study|Adverse Event|7|||
33678100|NCT04092452|63123314|FG000|Overall Study|Lack of Efficacy|1|||
33678101|NCT04092452|63123315|FG001|Overall Study|Lack of Efficacy|1|||
33678102|NCT04092452|63123316|FG002|Overall Study|Lack of Efficacy|1|||
33678103|NCT04092452|63123317|FG003|Overall Study|Lack of Efficacy|0|||
33678104|NCT04092452|63123314|FG000|Overall Study|Lost to Follow-up|4|||
33678105|NCT04092452|63123315|FG001|Overall Study|Lost to Follow-up|3|||
33678106|NCT04092452|63123316|FG002|Overall Study|Lost to Follow-up|5|||
33678107|NCT04092452|63123317|FG003|Overall Study|Lost to Follow-up|1|||
33678108|NCT04092452|63123314|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33678109|NCT04092452|63123315|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33678110|NCT04092452|63123316|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33678111|NCT04092452|63123317|FG003|Overall Study|Non-Compliance With Study Drug|1|||
33678112|NCT04092452|63123314|FG000|Overall Study|Physician Decision|1|||
33678113|NCT04092452|63123315|FG001|Overall Study|Physician Decision|0|||
33678114|NCT04092452|63123316|FG002|Overall Study|Physician Decision|1|||
33678115|NCT04092452|63123317|FG003|Overall Study|Physician Decision|0|||
33678116|NCT04092452|63123314|FG000|Overall Study|Pregnancy|2|||
33678117|NCT04092452|63123315|FG001|Overall Study|Pregnancy|0|||
33678118|NCT04092452|63123316|FG002|Overall Study|Pregnancy|0|||
33678119|NCT04092452|63123317|FG003|Overall Study|Pregnancy|0|||
33678120|NCT04092452|63123314|FG000|Overall Study|Protocol Deviation|1|||
33678121|NCT04092452|63123315|FG001|Overall Study|Protocol Deviation|0|||
33678122|NCT04092452|63123316|FG002|Overall Study|Protocol Deviation|0|||
33678123|NCT04092452|63123317|FG003|Overall Study|Protocol Deviation|0|||
33678124|NCT04092452|63123314|FG000|Overall Study|Withdrawal by Subject|3|||
33678125|NCT04092452|63123315|FG001|Overall Study|Withdrawal by Subject|10|||
33678126|NCT04092452|63123316|FG002|Overall Study|Withdrawal by Subject|3|||
33678127|NCT04092452|63123317|FG003|Overall Study|Withdrawal by Subject|5|||
33678128|NCT04092452|63123314|FG000|Overall Study|Other|0|||
33678129|NCT04092452|63123315|FG001|Overall Study|Other|0|||
33678130|NCT04092452|63123316|FG002|Overall Study|Other|1|||
33678131|NCT04092452|63123317|FG003|Overall Study|Other|2|||
33678132|NCT04029116|63123332|FG000|Overall Study|Adverse Event|0|||
33678133|NCT04029116|63123333|FG001|Overall Study|Adverse Event|2|||
33678134|NCT04029116|63123332|FG000|Overall Study|Lost to Follow-up|3|||
33678135|NCT04029116|63123333|FG001|Overall Study|Lost to Follow-up|5|||
33678136|NCT04029116|63123332|FG000|Overall Study|Physician Decision|2|||
33678137|NCT04029116|63123333|FG001|Overall Study|Physician Decision|0|||
33678138|NCT04029116|63123332|FG000|Overall Study|Pregnancy|1|||
33678139|NCT04029116|63123333|FG001|Overall Study|Pregnancy|2|||
33678140|NCT04029116|63123332|FG000|Overall Study|Withdrawal by Subject|4|||
33678141|NCT04029116|63123333|FG001|Overall Study|Withdrawal by Subject|6|||
33678142|NCT04029116|63123332|FG000|Overall Study|Other|2|||
33678143|NCT04029116|63123333|FG001|Overall Study|Other|1|||
33678144|NCT03734029|63123364|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
33678145|NCT03734029|63123365|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
33678146|NCT03734029|63123364|FG000|Overall Study|Adverse Event|60|||
33678147|NCT03734029|63123365|FG001|Overall Study|Adverse Event|14|||
33678148|NCT03734029|63123364|FG000|Overall Study|Withdrawal by Subject|12|||
33678149|NCT03734029|63123365|FG001|Overall Study|Withdrawal by Subject|11|||
33678150|NCT03734029|63123364|FG000|Overall Study|Clinical progression by investigator|10|||
33678151|NCT03734029|63123365|FG001|Overall Study|Clinical progression by investigator|8|||
33678152|NCT03734029|63123364|FG000|Overall Study|Death|5|||
33678153|NCT03734029|63123365|FG001|Overall Study|Death|2|||
33678154|NCT03734029|63123364|FG000|Overall Study|Physician Decision|4|||
33678155|NCT03734029|63123365|FG001|Overall Study|Physician Decision|3|||
33678156|NCT03734029|63123364|FG000|Overall Study|Other|2|||
33678157|NCT03734029|63123365|FG001|Overall Study|Other|0|||
33678158|NCT03734029|63123364|FG000|Overall Study|Lost to Follow-up|0|||
33678159|NCT03734029|63123365|FG001|Overall Study|Lost to Follow-up|1|||
33678160|NCT03734029|63123364|FG000|Overall Study|Randomized, but not treated|2|||
33678161|NCT03734029|63123365|FG001|Overall Study|Randomized, but not treated|12|||
33678162|NCT03732820|63123373|FG000|Overall Study|Death|143|||
33678163|NCT03732820|63123374|FG001|Overall Study|Death|169|||
33678164|NCT03732820|63123373|FG000|Overall Study|Screen failure|0|||
33678165|NCT03732820|63123374|FG001|Overall Study|Screen failure|1|||
33678166|NCT03732820|63123373|FG000|Overall Study|Ongoing study at data cut off|239|||
33678167|NCT03732820|63123374|FG001|Overall Study|Ongoing study at data cut off|216|||
33678168|NCT03732820|63123373|FG000|Overall Study|Failure to meet randomisation criteria|1|||
33678169|NCT03732820|63123374|FG001|Overall Study|Failure to meet randomisation criteria|1|||
33678170|NCT03732820|63123373|FG000|Overall Study|Lost to Follow-up|1|||
33678171|NCT03732820|63123374|FG001|Overall Study|Lost to Follow-up|0|||
33678172|NCT03732820|63123373|FG000|Overall Study|Patient decision|13|||
33678173|NCT03732820|63123374|FG001|Overall Study|Patient decision|8|||
33678174|NCT03732820|63123373|FG000|Overall Study|Other|2|||
33678175|NCT03732820|63123374|FG001|Overall Study|Other|2|||
33678176|NCT03724032|63123383|FG000|Overall Study|Physician Decision|1|||
33678177|NCT03724032|63123384|FG001|Overall Study|Physician Decision|0|||
33678178|NCT03724032|63123385|FG002|Overall Study|Physician Decision|0|||
33678179|NCT03724032|63123383|FG000|Overall Study|Protocol Violation|2|||
33678180|NCT03724032|63123384|FG001|Overall Study|Protocol Violation|2|||
33678181|NCT03724032|63123385|FG002|Overall Study|Protocol Violation|1|||
33678182|NCT03657797|63123406|FG000|Overall Study|Lost to Follow-up|0|||
33678183|NCT03657797|63123407|FG001|Overall Study|Lost to Follow-up|1|||
33678184|NCT03657797|63123408|FG002|Overall Study|Lost to Follow-up|1|||
33678185|NCT03657797|63123409|FG003|Overall Study|Lost to Follow-up|0|||
33678186|NCT03657797|63123406|FG000|Overall Study|Physician Decision|0|||
33678187|NCT03657797|63123407|FG001|Overall Study|Physician Decision|1|||
33678188|NCT03657797|63123408|FG002|Overall Study|Physician Decision|0|||
33678189|NCT03657797|63123409|FG003|Overall Study|Physician Decision|0|||
33678190|NCT03657797|63123406|FG000|Overall Study|Withdrawal by Subject|0|||
33678191|NCT03657797|63123407|FG001|Overall Study|Withdrawal by Subject|1|||
33678192|NCT03657797|63123408|FG002|Overall Study|Withdrawal by Subject|2|||
33678193|NCT03657797|63123409|FG003|Overall Study|Withdrawal by Subject|0|||
33678194|NCT03657797|63123406|FG000|Overall Study|Adverse Event|0|||
33678195|NCT03657797|63123407|FG001|Overall Study|Adverse Event|0|||
33678196|NCT03657797|63123408|FG002|Overall Study|Adverse Event|2|||
33678197|NCT03657797|63123409|FG003|Overall Study|Adverse Event|0|||
33678198|NCT03551938|63123425|FG000|3-Month Follow Up|Lost to Follow-up|39|||
33678199|NCT03551938|63123426|FG001|3-Month Follow Up|Lost to Follow-up|38|||
33678200|NCT03551938|63123425|FG000|6-Month Follow Up|Lost to Follow-up|46|||
33678201|NCT03551938|63123426|FG001|6-Month Follow Up|Lost to Follow-up|42|||
33678202|NCT03551938|63123425|FG000|9-Month Follow Up|Lost to Follow-up|44|||
33678203|NCT03551938|63123426|FG001|9-Month Follow Up|Lost to Follow-up|43|||
33678204|NCT03525600|63123435|FG000|Overall Study|Adverse Event|9|||
33678205|NCT03525600|63123436|FG001|Overall Study|Adverse Event|6|||
33678206|NCT03525600|63123437|FG002|Overall Study|Adverse Event|5|||
33678207|NCT03525600|63123438|FG003|Overall Study|Adverse Event|3|||
33678208|NCT03525600|63123435|FG000|Overall Study|Lost to Follow-up|2|||
33678209|NCT03525600|63123436|FG001|Overall Study|Lost to Follow-up|4|||
33678210|NCT03525600|63123437|FG002|Overall Study|Lost to Follow-up|4|||
33678211|NCT03525600|63123438|FG003|Overall Study|Lost to Follow-up|0|||
33678212|NCT03525600|63123435|FG000|Overall Study|Physician Decision|1|||
33678213|NCT03525600|63123436|FG001|Overall Study|Physician Decision|0|||
33678214|NCT03525600|63123437|FG002|Overall Study|Physician Decision|2|||
33678215|NCT03525600|63123438|FG003|Overall Study|Physician Decision|0|||
33678216|NCT03525600|63123435|FG000|Overall Study|Consent withdrawal|36|||
33678217|NCT03525600|63123436|FG001|Overall Study|Consent withdrawal|20|||
33678218|NCT03525600|63123437|FG002|Overall Study|Consent withdrawal|6|||
33678219|NCT03525600|63123438|FG003|Overall Study|Consent withdrawal|13|||
33678220|NCT03525600|63123435|FG000|Overall Study|Death|7|||
33678221|NCT03525600|63123436|FG001|Overall Study|Death|6|||
33678222|NCT03525600|63123437|FG002|Overall Study|Death|4|||
33678223|NCT03525600|63123438|FG003|Overall Study|Death|3|||
33678224|NCT03525600|63123435|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
33678225|NCT03525600|63123436|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
33678226|NCT03525600|63123437|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
33678227|NCT03525600|63123438|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
33678228|NCT03525600|63123435|FG000|Overall Study|Other|0|||
33678229|NCT03525600|63123436|FG001|Overall Study|Other|1|||
33678230|NCT03525600|63123437|FG002|Overall Study|Other|0|||
33678231|NCT03525600|63123438|FG003|Overall Study|Other|0|||
33678232|NCT03472040|63123455|FG000|Overall Study|Physician Decision|0|||
33678233|NCT03472040|63123456|FG001|Overall Study|Physician Decision|3|||
33678234|NCT03472040|63123455|FG000|Overall Study|Withdrawal by Subject|10|||
33678235|NCT03472040|63123456|FG001|Overall Study|Withdrawal by Subject|23|||
33678236|NCT03472040|63123455|FG000|Overall Study|Perceived Lack of Efficacy|29|||
33678237|NCT03472040|63123456|FG001|Overall Study|Perceived Lack of Efficacy|30|||
33678238|NCT03472040|63123455|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
33678239|NCT03472040|63123456|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
33678240|NCT03472040|63123455|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
33678241|NCT03472040|63123456|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
33678242|NCT03472040|63123455|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
33678243|NCT03472040|63123456|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
33678244|NCT03472040|63123455|FG000|Overall Study|Subject Non-compliance|2|||
33678245|NCT03472040|63123456|FG001|Overall Study|Subject Non-compliance|5|||
33678246|NCT03472040|63123455|FG000|Overall Study|Discontinuation due to Rash|0|||
33678247|NCT03472040|63123456|FG001|Overall Study|Discontinuation due to Rash|1|||
33678248|NCT03472040|63123455|FG000|Overall Study|Subsequent Ineligibility|0|||
33678249|NCT03472040|63123456|FG001|Overall Study|Subsequent Ineligibility|2|||
33678250|NCT03472040|63123455|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
33678251|NCT03472040|63123456|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
33678252|NCT03323385|63123474|FG000|Overall Study|Withdrawal by Subject|1|||
33678253|NCT03323385|63123475|FG001|Overall Study|Withdrawal by Subject|2|||
33678254|NCT03323385|63123474|FG000|Overall Study|Noncompliance|0|||
33678255|NCT03323385|63123475|FG001|Overall Study|Noncompliance|1|||
33678256|NCT03298451|63123485|FG000|Overall Study|Death|275|||
33678257|NCT03298451|63123486|FG001|Overall Study|Death|260|||
33678258|NCT03298451|63123487|FG002|Overall Study|Death|122|||
33678259|NCT03298451|63123488|FG003|Overall Study|Death|280|||
33678260|NCT03298451|63123485|FG000|Overall Study|Lost to Follow-up|1|||
33678261|NCT03298451|63123486|FG001|Overall Study|Lost to Follow-up|1|||
33678262|NCT03298451|63123487|FG002|Overall Study|Lost to Follow-up|0|||
33678263|NCT03298451|63123488|FG003|Overall Study|Lost to Follow-up|7|||
33678264|NCT03298451|63123485|FG000|Overall Study|Withdrawal by Subject|9|||
33678265|NCT03298451|63123486|FG001|Overall Study|Withdrawal by Subject|7|||
33678266|NCT03298451|63123487|FG002|Overall Study|Withdrawal by Subject|1|||
33678267|NCT03298451|63123488|FG003|Overall Study|Withdrawal by Subject|20|||
33678268|NCT03161483|63123502|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
33678269|NCT03161483|63123503|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
33678270|NCT03161483|63123504|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
33678271|NCT03161483|63123505|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
33678272|NCT03161483|63123502|FG000|Treatment Period|Death|1|||
33678273|NCT03161483|63123503|FG001|Treatment Period|Death|0|||
33678274|NCT03161483|63123504|FG002|Treatment Period|Death|0|||
33678275|NCT03161483|63123505|FG003|Treatment Period|Death|0|||
33678276|NCT03161483|63123502|FG000|Treatment Period|Adverse Event|5|||
33678277|NCT03161483|63123503|FG001|Treatment Period|Adverse Event|2|||
33678278|NCT03161483|63123504|FG002|Treatment Period|Adverse Event|1|||
33678279|NCT03161483|63123505|FG003|Treatment Period|Adverse Event|11|||
33678280|NCT03161483|63123502|FG000|Treatment Period|Pregnancy|1|||
33678281|NCT03161483|63123503|FG001|Treatment Period|Pregnancy|0|||
33678282|NCT03161483|63123504|FG002|Treatment Period|Pregnancy|0|||
33678283|NCT03161483|63123505|FG003|Treatment Period|Pregnancy|0|||
33678284|NCT03161483|63123502|FG000|Treatment Period|Lack of Efficacy|0|||
33678285|NCT03161483|63123503|FG001|Treatment Period|Lack of Efficacy|0|||
33678286|NCT03161483|63123504|FG002|Treatment Period|Lack of Efficacy|0|||
33678287|NCT03161483|63123505|FG003|Treatment Period|Lack of Efficacy|1|||
33678288|NCT03161483|63123502|FG000|Treatment Period|Withdrawal by Subject|2|||
33678289|NCT03161483|63123503|FG001|Treatment Period|Withdrawal by Subject|5|||
33678290|NCT03161483|63123504|FG002|Treatment Period|Withdrawal by Subject|2|||
33678291|NCT03161483|63123505|FG003|Treatment Period|Withdrawal by Subject|6|||
33678292|NCT03161483|63123502|FG000|Treatment Period|Lost to Follow-up|0|||
33678293|NCT03161483|63123503|FG001|Treatment Period|Lost to Follow-up|0|||
33678294|NCT03161483|63123504|FG002|Treatment Period|Lost to Follow-up|0|||
33678295|NCT03161483|63123505|FG003|Treatment Period|Lost to Follow-up|1|||
33678296|NCT03161483|63123502|FG000|Treatment Period|Protocol Violation|0|||
33678297|NCT03161483|63123503|FG001|Treatment Period|Protocol Violation|0|||
33678298|NCT03161483|63123504|FG002|Treatment Period|Protocol Violation|0|||
33678299|NCT03161483|63123505|FG003|Treatment Period|Protocol Violation|1|||
33678300|NCT03161483|63123502|FG000|Treatment Period|Other reasons|1|||
33678301|NCT03161483|63123503|FG001|Treatment Period|Other reasons|1|||
33678302|NCT03161483|63123504|FG002|Treatment Period|Other reasons|0|||
33678303|NCT03161483|63123505|FG003|Treatment Period|Other reasons|0|||
33678304|NCT03132636|63123519|FG000|Overall Study|Adverse Event|1|||
33678305|NCT03132636|63123520|FG001|Overall Study|Adverse Event|2|||
33678306|NCT03132636|63123519|FG000|Overall Study|Death|4|||
33678307|NCT03132636|63123520|FG001|Overall Study|Death|7|||
33678308|NCT03132636|63123519|FG000|Overall Study|Lost to Follow-up|2|||
33678309|NCT03132636|63123520|FG001|Overall Study|Lost to Follow-up|2|||
33678310|NCT03132636|63123519|FG000|Overall Study|Protocol Violation|1|||
33678311|NCT03132636|63123520|FG001|Overall Study|Protocol Violation|1|||
33678312|NCT03132636|63123519|FG000|Overall Study|Participant Decision|1|||
33678313|NCT03132636|63123520|FG001|Overall Study|Participant Decision|9|||
33678314|NCT03132636|63123519|FG000|Overall Study|Sponsor Decision|0|||
33678315|NCT03132636|63123520|FG001|Overall Study|Sponsor Decision|1|||
33678316|NCT03132636|63123519|FG000|Overall Study|Progressive disease|32|||
33678317|NCT03132636|63123520|FG001|Overall Study|Progressive disease|36|||
33678318|NCT03132636|63123519|FG000|Overall Study|Withdrawal of consent|2|||
33678319|NCT03132636|63123520|FG001|Overall Study|Withdrawal of consent|5|||
33678320|NCT03132636|63123519|FG000|Overall Study|Study ongoing|9|||
33678321|NCT03132636|63123520|FG001|Overall Study|Study ongoing|10|||
33678322|NCT03132636|63123519|FG000|Overall Study|Other|1|||
33678323|NCT03132636|63123520|FG001|Overall Study|Other|2|||
33678324|NCT02906202|63123526|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
33678325|NCT02869789|63123534|FG000|Overall Study|Disease progression|184|||
33678326|NCT02869789|63123535|FG001|Overall Study|Disease progression|109|||
33678327|NCT02869789|63123536|FG002|Overall Study|Disease progression|260|||
33678328|NCT02869789|63123537|FG003|Overall Study|Disease progression|19|||
33678329|NCT02869789|63123534|FG000|Overall Study|Study drug toxicity|90|||
33678330|NCT02869789|63123535|FG001|Overall Study|Study drug toxicity|32|||
33678331|NCT02869789|63123536|FG002|Overall Study|Study drug toxicity|55|||
33678332|NCT02869789|63123537|FG003|Overall Study|Study drug toxicity|14|||
33678333|NCT02869789|63123534|FG000|Overall Study|Death|7|||
33678334|NCT02869789|63123535|FG001|Overall Study|Death|3|||
33678335|NCT02869789|63123536|FG002|Overall Study|Death|5|||
33678336|NCT02869789|63123537|FG003|Overall Study|Death|1|||
33678337|NCT02869789|63123534|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
33678338|NCT02869789|63123535|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
33678339|NCT02869789|63123536|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
33678340|NCT02869789|63123537|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
33678341|NCT02869789|63123534|FG000|Overall Study|Participant request to discontinue study treatment|10|||
33678342|NCT02869789|63123535|FG001|Overall Study|Participant request to discontinue study treatment|5|||
33678343|NCT02869789|63123536|FG002|Overall Study|Participant request to discontinue study treatment|5|||
33678344|NCT02869789|63123537|FG003|Overall Study|Participant request to discontinue study treatment|3|||
33678345|NCT02869789|63123534|FG000|Overall Study|Withdrawal by Subject|5|||
33678346|NCT02869789|63123535|FG001|Overall Study|Withdrawal by Subject|2|||
33678347|NCT02869789|63123536|FG002|Overall Study|Withdrawal by Subject|7|||
33678348|NCT02869789|63123537|FG003|Overall Study|Withdrawal by Subject|2|||
33678349|NCT02869789|63123534|FG000|Overall Study|Lost to Follow-up|0|||
33678350|NCT02869789|63123535|FG001|Overall Study|Lost to Follow-up|0|||
33678351|NCT02869789|63123536|FG002|Overall Study|Lost to Follow-up|2|||
33678352|NCT02869789|63123537|FG003|Overall Study|Lost to Follow-up|0|||
33678353|NCT02869789|63123534|FG000|Overall Study|Maximum clinical benefit|5|||
33678354|NCT02869789|63123535|FG001|Overall Study|Maximum clinical benefit|2|||
33678355|NCT02869789|63123536|FG002|Overall Study|Maximum clinical benefit|1|||
33678356|NCT02869789|63123537|FG003|Overall Study|Maximum clinical benefit|0|||
33678357|NCT02869789|63123534|FG000|Overall Study|Poor/Non-compliance|0|||
33678358|NCT02869789|63123535|FG001|Overall Study|Poor/Non-compliance|2|||
33678359|NCT02869789|63123536|FG002|Overall Study|Poor/Non-compliance|1|||
33678360|NCT02869789|63123537|FG003|Overall Study|Poor/Non-compliance|0|||
33678361|NCT02869789|63123534|FG000|Overall Study|Participant no longer meets study criteria|0|||
33678362|NCT02869789|63123535|FG001|Overall Study|Participant no longer meets study criteria|1|||
33678363|NCT02869789|63123536|FG002|Overall Study|Participant no longer meets study criteria|1|||
33678364|NCT02869789|63123537|FG003|Overall Study|Participant no longer meets study criteria|0|||
33678365|NCT02869789|63123534|FG000|Overall Study|Administrative reason by sponsor|0|||
33678366|NCT02869789|63123535|FG001|Overall Study|Administrative reason by sponsor|0|||
33678367|NCT02869789|63123536|FG002|Overall Study|Administrative reason by sponsor|1|||
33678368|NCT02869789|63123537|FG003|Overall Study|Administrative reason by sponsor|0|||
33678369|NCT02869789|63123534|FG000|Overall Study|Other reasons|4|||
33678370|NCT02869789|63123535|FG001|Overall Study|Other reasons|8|||
33678371|NCT02869789|63123536|FG002|Overall Study|Other reasons|6|||
33678372|NCT02869789|63123537|FG003|Overall Study|Other reasons|0|||
33678373|NCT02760485|63123558|FG000|Phase 1|Death|3|||
33678374|NCT02760485|63123559|FG001|Phase 1|Death|6|||
33678375|NCT02760485|63123560|FG002|Phase 1|Death|0|||
33678376|NCT02760485|63123558|FG000|Phase 1|Withdrawal by Subject|2|||
33678377|NCT02760485|63123559|FG001|Phase 1|Withdrawal by Subject|0|||
33678378|NCT02760485|63123560|FG002|Phase 1|Withdrawal by Subject|0|||
33678379|NCT02760485|63123558|FG000|Phase 1|Progressive Disease|1|||
33678380|NCT02760485|63123559|FG001|Phase 1|Progressive Disease|0|||
33678381|NCT02760485|63123560|FG002|Phase 1|Progressive Disease|0|||
33678382|NCT02760485|63123558|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
33678383|NCT02760485|63123559|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
33678384|NCT02760485|63123560|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
33678385|NCT02760485|63123558|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
33678386|NCT02760485|63123559|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
33678387|NCT02760485|63123560|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
33678388|NCT02760485|63123558|FG000|Phase 2|Death|0|||
33678389|NCT02760485|63123559|FG001|Phase 2|Death|0|||
33678390|NCT02760485|63123560|FG002|Phase 2|Death|12|||
33678391|NCT02760485|63123558|FG000|Phase 2|Withdrawal by Subject|0|||
33678392|NCT02760485|63123559|FG001|Phase 2|Withdrawal by Subject|0|||
33678393|NCT02760485|63123560|FG002|Phase 2|Withdrawal by Subject|3|||
33678394|NCT02760485|63123558|FG000|Phase 2|Progressive Disease|0|||
33678395|NCT02760485|63123559|FG001|Phase 2|Progressive Disease|0|||
33678396|NCT02760485|63123560|FG002|Phase 2|Progressive Disease|1|||
33678397|NCT02760485|63123558|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
33678398|NCT02760485|63123559|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
33678399|NCT02760485|63123560|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
33678400|NCT02634333|63123595|FG000|Overall Study|Completed out of Window|3|||
33678401|NCT02634333|63123596|FG001|Overall Study|Completed out of Window|2|||
33678402|NCT02634333|63123595|FG000|Overall Study|Missed Visit|5|||
33678403|NCT02634333|63123596|FG001|Overall Study|Missed Visit|2|||
33678404|NCT02634333|63123595|FG000|Overall Study|Lost to Follow-up|12|||
33678405|NCT02634333|63123596|FG001|Overall Study|Lost to Follow-up|7|||
33678406|NCT02634333|63123595|FG000|Overall Study|Withdrawal by Subject|9|||
33678407|NCT02634333|63123596|FG001|Overall Study|Withdrawal by Subject|13|||
33678408|NCT02634333|63123595|FG000|Overall Study|Death|11|||
33678409|NCT02634333|63123596|FG001|Overall Study|Death|8|||
33678410|NCT02515630|63123614|FG000|Overall Study|Withdrawal by Subject|5|||
33678411|NCT02515630|63123614|FG000|Overall Study|Adverse Event|4|||
33678412|NCT02515630|63123614|FG000|Overall Study|Physician Decision|4|||
33678413|NCT02515630|63123614|FG000|Overall Study|Death|2|||
33678414|NCT02515630|63123614|FG000|Overall Study|Disease Progression|1|||
33678415|NCT02450331|63123623|FG000|Overall Study|Death|162|||
33678416|NCT02450331|63123624|FG001|Overall Study|Death|171|||
33678417|NCT02450331|63123623|FG000|Overall Study|Lost to Follow-up|14|||
33678418|NCT02450331|63123624|FG001|Overall Study|Lost to Follow-up|12|||
33678419|NCT02450331|63123623|FG000|Overall Study|Withdrawal by Subject|55|||
33678420|NCT02450331|63123624|FG001|Overall Study|Withdrawal by Subject|44|||
33678421|NCT02450331|63123623|FG000|Overall Study|Non-specified other|1|||
33678422|NCT02450331|63123624|FG001|Overall Study|Non-specified other|1|||
33678423|NCT02335944|63123641|FG000|Treatment Phase|Progressive Disease|2|||
33678424|NCT02335944|63123642|FG001|Treatment Phase|Progressive Disease|5|||
33678425|NCT02335944|63123643|FG002|Treatment Phase|Progressive Disease|2|||
33678426|NCT02335944|63123644|FG003|Treatment Phase|Progressive Disease|11|||
33678427|NCT02335944|63123645|FG004|Treatment Phase|Progressive Disease|4|||
33678428|NCT02335944|63123646|FG005|Treatment Phase|Progressive Disease|25|||
33678429|NCT02335944|63123647|FG006|Treatment Phase|Progressive Disease|2|||
33678430|NCT02335944|63123648|FG007|Treatment Phase|Progressive Disease|30|||
33678431|NCT02335944|63123649|FG008|Treatment Phase|Progressive Disease|27|||
33678432|NCT02335944|63123650|FG009|Treatment Phase|Progressive Disease|0|||
33678433|NCT02335944|63123641|FG000|Treatment Phase|Adverse Event|2|||
33678434|NCT02335944|63123642|FG001|Treatment Phase|Adverse Event|0|||
33678435|NCT02335944|63123643|FG002|Treatment Phase|Adverse Event|0|||
33678436|NCT02335944|63123644|FG003|Treatment Phase|Adverse Event|2|||
33678437|NCT02335944|63123645|FG004|Treatment Phase|Adverse Event|1|||
33678438|NCT02335944|63123646|FG005|Treatment Phase|Adverse Event|15|||
33678439|NCT02335944|63123647|FG006|Treatment Phase|Adverse Event|0|||
33678440|NCT02335944|63123648|FG007|Treatment Phase|Adverse Event|5|||
33678441|NCT02335944|63123649|FG008|Treatment Phase|Adverse Event|7|||
33678442|NCT02335944|63123650|FG009|Treatment Phase|Adverse Event|0|||
33678443|NCT02335944|63123641|FG000|Treatment Phase|Physician Decision|0|||
33678444|NCT02335944|63123642|FG001|Treatment Phase|Physician Decision|0|||
33678445|NCT02335944|63123643|FG002|Treatment Phase|Physician Decision|0|||
33678446|NCT02335944|63123644|FG003|Treatment Phase|Physician Decision|1|||
33678447|NCT02335944|63123645|FG004|Treatment Phase|Physician Decision|0|||
33678448|NCT02335944|63123646|FG005|Treatment Phase|Physician Decision|6|||
33678449|NCT02335944|63123647|FG006|Treatment Phase|Physician Decision|1|||
33678450|NCT02335944|63123648|FG007|Treatment Phase|Physician Decision|2|||
33678451|NCT02335944|63123649|FG008|Treatment Phase|Physician Decision|1|||
33678452|NCT02335944|63123650|FG009|Treatment Phase|Physician Decision|0|||
33678453|NCT02335944|63123641|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
33678454|NCT02335944|63123642|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
33678455|NCT02335944|63123643|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
33678456|NCT02335944|63123644|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
33678457|NCT02335944|63123645|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
33678458|NCT02335944|63123646|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
33678459|NCT02335944|63123647|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
33678460|NCT02335944|63123648|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
33678461|NCT02335944|63123649|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
33678462|NCT02335944|63123650|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
33678463|NCT02335944|63123641|FG000|Treatment Phase|Subject/Guardian Decision|0|||
33678464|NCT02335944|63123642|FG001|Treatment Phase|Subject/Guardian Decision|0|||
33678465|NCT02335944|63123643|FG002|Treatment Phase|Subject/Guardian Decision|1|||
33678466|NCT02335944|63123644|FG003|Treatment Phase|Subject/Guardian Decision|0|||
33678467|NCT02335944|63123645|FG004|Treatment Phase|Subject/Guardian Decision|0|||
33678468|NCT02335944|63123646|FG005|Treatment Phase|Subject/Guardian Decision|1|||
33678469|NCT02335944|63123647|FG006|Treatment Phase|Subject/Guardian Decision|0|||
33678470|NCT02335944|63123648|FG007|Treatment Phase|Subject/Guardian Decision|4|||
33678471|NCT02335944|63123649|FG008|Treatment Phase|Subject/Guardian Decision|0|||
33584549|NCT02614261|62982572|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
33584550|NCT02614261|62982573|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
33678472|NCT02335944|63123650|FG009|Treatment Phase|Subject/Guardian Decision|0|||
33678473|NCT02335944|63123641|FG000|Post-treatment Follow-up|Progressive Disease|0|||
33678474|NCT02335944|63123642|FG001|Post-treatment Follow-up|Progressive Disease|0|||
33678475|NCT02335944|63123643|FG002|Post-treatment Follow-up|Progressive Disease|0|||
33678476|NCT02335944|63123644|FG003|Post-treatment Follow-up|Progressive Disease|1|||
33678477|NCT02335944|63123645|FG004|Post-treatment Follow-up|Progressive Disease|0|||
33678478|NCT02335944|63123646|FG005|Post-treatment Follow-up|Progressive Disease|9|||
33492971|NCT03147248|62871041|FG002|Overall Study|Withdrawal by Subject|0|||
33584551|NCT02614261|62982574|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
33678479|NCT02335944|63123647|FG006|Post-treatment Follow-up|Progressive Disease|0|||
33678480|NCT02335944|63123648|FG007|Post-treatment Follow-up|Progressive Disease|2|||
33678481|NCT02335944|63123649|FG008|Post-treatment Follow-up|Progressive Disease|3|||
33678482|NCT02335944|63123650|FG009|Post-treatment Follow-up|Progressive Disease|0|||
33678483|NCT02335944|63123641|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33678484|NCT02335944|63123642|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33678485|NCT02335944|63123643|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33678486|NCT02335944|63123644|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33678487|NCT02335944|63123645|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33678488|NCT02335944|63123646|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
33678489|NCT02335944|63123647|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33678490|NCT02335944|63123648|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33678491|NCT02335944|63123649|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33678492|NCT02335944|63123650|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33678493|NCT02335944|63123641|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
33678494|NCT02335944|63123642|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
33678495|NCT02335944|63123643|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
33678496|NCT02335944|63123644|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
33678497|NCT02335944|63123645|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
33678498|NCT02335944|63123646|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
33678499|NCT02335944|63123647|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
33678500|NCT02335944|63123648|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
33678501|NCT02335944|63123649|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
33678502|NCT02335944|63123650|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
33678503|NCT02335944|63123641|FG000|Post-treatment Follow-up|Adverse Event|0|||
33678504|NCT02335944|63123642|FG001|Post-treatment Follow-up|Adverse Event|0|||
33678505|NCT02335944|63123643|FG002|Post-treatment Follow-up|Adverse Event|0|||
33678506|NCT02335944|63123644|FG003|Post-treatment Follow-up|Adverse Event|0|||
33678507|NCT02335944|63123645|FG004|Post-treatment Follow-up|Adverse Event|0|||
33678508|NCT02335944|63123646|FG005|Post-treatment Follow-up|Adverse Event|1|||
33678509|NCT02335944|63123647|FG006|Post-treatment Follow-up|Adverse Event|0|||
33678510|NCT02335944|63123648|FG007|Post-treatment Follow-up|Adverse Event|0|||
33678511|NCT02335944|63123649|FG008|Post-treatment Follow-up|Adverse Event|0|||
33678512|NCT02335944|63123650|FG009|Post-treatment Follow-up|Adverse Event|0|||
33678513|NCT02335944|63123641|FG000|Post-treatment Follow-up|Death|0|||
33678514|NCT02335944|63123642|FG001|Post-treatment Follow-up|Death|0|||
33678515|NCT02335944|63123643|FG002|Post-treatment Follow-up|Death|0|||
33678516|NCT02335944|63123644|FG003|Post-treatment Follow-up|Death|1|||
33678517|NCT02335944|63123645|FG004|Post-treatment Follow-up|Death|0|||
33678518|NCT02335944|63123646|FG005|Post-treatment Follow-up|Death|1|||
33678519|NCT02335944|63123647|FG006|Post-treatment Follow-up|Death|0|||
33678520|NCT02335944|63123648|FG007|Post-treatment Follow-up|Death|0|||
33678521|NCT02335944|63123649|FG008|Post-treatment Follow-up|Death|0|||
33678522|NCT02335944|63123650|FG009|Post-treatment Follow-up|Death|0|||
33678523|NCT02335944|63123641|FG000|Post-treatment Follow-up|Physician Decision|1|||
33678524|NCT02335944|63123642|FG001|Post-treatment Follow-up|Physician Decision|0|||
33678525|NCT02335944|63123643|FG002|Post-treatment Follow-up|Physician Decision|0|||
33678526|NCT02335944|63123644|FG003|Post-treatment Follow-up|Physician Decision|0|||
33678527|NCT02335944|63123645|FG004|Post-treatment Follow-up|Physician Decision|0|||
33678528|NCT02335944|63123646|FG005|Post-treatment Follow-up|Physician Decision|0|||
33678529|NCT02335944|63123647|FG006|Post-treatment Follow-up|Physician Decision|0|||
33678530|NCT02335944|63123648|FG007|Post-treatment Follow-up|Physician Decision|1|||
33678531|NCT02335944|63123649|FG008|Post-treatment Follow-up|Physician Decision|0|||
33678532|NCT02335944|63123650|FG009|Post-treatment Follow-up|Physician Decision|0|||
33678533|NCT02326974|63123688|FG000|Overall Study|Withdrawal by Subject|2|||
33678534|NCT02326974|63123688|FG000|Overall Study|failed heterogenity evaluation|5|||
33678535|NCT02246621|63123716|FG000|Overall Study|Withdrawal by Subject|28|||
33678536|NCT02246621|63123717|FG001|Overall Study|Withdrawal by Subject|16|||
33678537|NCT02246621|63123716|FG000|Overall Study|Lost to Follow-up|1|||
33678538|NCT02246621|63123717|FG001|Overall Study|Lost to Follow-up|0|||
33678539|NCT02246621|63123716|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
33678540|NCT02246621|63123717|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
33678541|NCT02200445|63123763|FG000|Overall Study|Lack of Efficacy|1|||
33678542|NCT02200445|63123764|FG001|Overall Study|Lack of Efficacy|2|||
33678543|NCT02200445|63123765|FG002|Overall Study|Lack of Efficacy|2|||
33678544|NCT02200445|63123763|FG000|Overall Study|Adverse Event|0|||
33678545|NCT02200445|63123764|FG001|Overall Study|Adverse Event|2|||
33678546|NCT02200445|63123765|FG002|Overall Study|Adverse Event|0|||
33678547|NCT02120352|63123773|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
33678548|NCT02120352|63123774|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
33678549|NCT02120352|63123775|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
33678550|NCT02120352|63123776|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
33678551|NCT02120352|63123773|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
33678552|NCT02120352|63123774|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
33678553|NCT02120352|63123775|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
33678554|NCT02120352|63123776|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
33678555|NCT02120352|63123773|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
33678556|NCT02120352|63123774|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
33678557|NCT02120352|63123775|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
33678558|NCT02120352|63123776|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
33678559|NCT02120352|63123773|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
33678560|NCT02120352|63123774|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
33678561|NCT02120352|63123775|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
33678562|NCT02120352|63123776|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
33678563|NCT02120352|63123773|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
33678564|NCT02120352|63123774|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
33678565|NCT02120352|63123775|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
33678566|NCT02120352|63123776|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
33678567|NCT02120352|63123773|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
33678568|NCT02120352|63123774|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
33678569|NCT02120352|63123775|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
33678570|NCT02120352|63123776|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
33678571|NCT02120352|63123773|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
33678572|NCT02120352|63123774|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
33678573|NCT02120352|63123775|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
33678574|NCT02120352|63123776|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
33678575|NCT02120352|63123773|FG000|Maintenance Period (32 Weeks)|Adverse Event|0|||
33678576|NCT02120352|63123774|FG001|Maintenance Period (32 Weeks)|Adverse Event|0|||
33678577|NCT02120352|63123775|FG002|Maintenance Period (32 Weeks)|Adverse Event|6|||
33678578|NCT02120352|63123776|FG003|Maintenance Period (32 Weeks)|Adverse Event|1|||
33678579|NCT02120352|63123773|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
33678580|NCT02120352|63123774|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
33678581|NCT02120352|63123775|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
33678582|NCT02120352|63123776|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
33678583|NCT02120352|63123773|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0|||
33678584|NCT02120352|63123774|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0|||
33678585|NCT02120352|63123775|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2|||
33678586|NCT02120352|63123776|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0|||
33678587|NCT02120352|63123773|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
33678588|NCT02120352|63123774|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
33678589|NCT02120352|63123775|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
33678590|NCT02120352|63123776|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
33678591|NCT02120352|63123773|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
33678592|NCT02120352|63123774|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
33678593|NCT02120352|63123775|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
33678594|NCT02120352|63123776|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1|||
33678595|NCT02120352|63123773|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0|||
33678596|NCT02120352|63123774|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
33678597|NCT02120352|63123775|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1|||
33678598|NCT02120352|63123776|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
33678599|NCT02120352|63123773|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0|||
33678600|NCT02120352|63123774|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112|||
33678601|NCT02120352|63123775|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105|||
33678602|NCT02120352|63123776|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50|||
33678603|NCT02058693|63123792|FG000|Phase 1|Withdrawal by Subject|3|||
33678604|NCT02058693|63123793|FG001|Phase 1|Withdrawal by Subject|2|||
33678605|NCT02058693|63123792|FG000|Phase 1|Adverse Event|0|||
33678606|NCT02058693|63123793|FG001|Phase 1|Adverse Event|1|||
33678607|NCT02058693|63123792|FG000|Phase 1|Lack of Efficacy|1|||
33678608|NCT02058693|63123793|FG001|Phase 1|Lack of Efficacy|0|||
33678609|NCT02058693|63123792|FG000|Phase 1|Physician Decision|1|||
33678610|NCT02058693|63123793|FG001|Phase 1|Physician Decision|1|||
33678611|NCT02058693|63123792|FG000|Phase 2|Withdrawal by Subject|0|||
33678612|NCT02058693|63123793|FG001|Phase 2|Withdrawal by Subject|2|||
33678613|NCT02039856|63123803|FG000|Overall Study|Death|5|||
33678614|NCT02039856|63123804|FG001|Overall Study|Death|3|||
33678615|NCT02039856|63123803|FG000|Overall Study|Partial survey completion|61|||
33678616|NCT02039856|63123804|FG001|Overall Study|Partial survey completion|26|||
33678617|NCT02039856|63123803|FG000|Overall Study|Lost to Follow-up|388|||
33678618|NCT02039856|63123804|FG001|Overall Study|Lost to Follow-up|206|||
33678619|NCT02039856|63123803|FG000|Overall Study|Withdrawal by Subject|1573|||
33678620|NCT02039856|63123804|FG001|Overall Study|Withdrawal by Subject|618|||
33678621|NCT01796392|63123814|FG000|Overall Study|Withdrawal by Subject|2|||
33678622|NCT01796392|63123815|FG001|Overall Study|Withdrawal by Subject|0|||
33678623|NCT01796392|63123814|FG000|Overall Study|Death|5|||
33678624|NCT01796392|63123815|FG001|Overall Study|Death|1|||
33678625|NCT01796392|63123814|FG000|Overall Study|Excluded for medical reasons|1|||
33678626|NCT01796392|63123815|FG001|Overall Study|Excluded for medical reasons|2|||
33678627|NCT01796392|63123814|FG000|Overall Study|Lost to Follow-up|1|||
33678628|NCT01796392|63123815|FG001|Overall Study|Lost to Follow-up|0|||
33678629|NCT01571635|63123826|FG000|Overall Study|Adverse Event|3|||
33678630|NCT01571635|63123827|FG001|Overall Study|Adverse Event|0|||
33678631|NCT01571635|63123828|FG002|Overall Study|Adverse Event|2|||
33678632|NCT01571635|63123829|FG003|Overall Study|Adverse Event|3|||
33678633|NCT01571635|63123830|FG004|Overall Study|Adverse Event|5|||
33678634|NCT01571635|63123826|FG000|Overall Study|Other reasons|2|||
33678635|NCT01571635|63123827|FG001|Overall Study|Other reasons|1|||
33678636|NCT01571635|63123828|FG002|Overall Study|Other reasons|2|||
33678637|NCT01571635|63123829|FG003|Overall Study|Other reasons|2|||
33678638|NCT01571635|63123830|FG004|Overall Study|Other reasons|1|||
33678639|NCT01571635|63123826|FG000|Overall Study|Study terminated by sponsor|0|||
33678640|NCT01571635|63123827|FG001|Overall Study|Study terminated by sponsor|4|||
33678641|NCT01571635|63123828|FG002|Overall Study|Study terminated by sponsor|1|||
33678642|NCT01571635|63123829|FG003|Overall Study|Study terminated by sponsor|3|||
33678643|NCT01571635|63123830|FG004|Overall Study|Study terminated by sponsor|1|||
33678644|NCT01571635|63123826|FG000|Overall Study|Withdrew consent|1|||
33678645|NCT01571635|63123827|FG001|Overall Study|Withdrew consent|1|||
33678646|NCT01571635|63123828|FG002|Overall Study|Withdrew consent|2|||
33678647|NCT01571635|63123829|FG003|Overall Study|Withdrew consent|3|||
33678648|NCT01571635|63123830|FG004|Overall Study|Withdrew consent|0|||
33678649|NCT01571635|63123826|FG000|Overall Study|Lack of Efficacy|0|||
33678650|NCT01571635|63123827|FG001|Overall Study|Lack of Efficacy|2|||
33678651|NCT01571635|63123828|FG002|Overall Study|Lack of Efficacy|0|||
33678652|NCT01571635|63123829|FG003|Overall Study|Lack of Efficacy|1|||
33678653|NCT01571635|63123830|FG004|Overall Study|Lack of Efficacy|2|||
33678654|NCT01248715|63123848|FG000|Overall Study|Not influenza positive|501|||
33678655|NCT01248715|63123849|FG001|Overall Study|Not influenza positive|510|||
33678656|NCT00937937|63123872|FG000|Overall Study|Adverse Event|6|||
33678657|NCT00937937|63123872|FG000|Overall Study|Withdrawal by Subject|2|||
33678658|NCT00937937|63123872|FG000|Overall Study|Progression/relapse|61|||
33678659|NCT00937937|63123872|FG000|Overall Study|Death|1|||
33678660|NCT00937937|63123872|FG000|Overall Study|Other|2|||
33678661|NCT00812214|63123906|FG000|Overall Study|Lost to Follow-up|3|||
33678662|NCT00812214|63123907|FG001|Overall Study|Lost to Follow-up|1|||
33678663|NCT00658814|63123916|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
33678664|NCT00658814|63123917|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
33678665|NCT00658814|63123916|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
33678666|NCT00658814|63123917|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
33678667|NCT00658814|63123916|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
33678668|NCT00658814|63123917|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
33678669|NCT00658814|63123916|FG000|Remission Induction Chemotherapy|Death|1|||
33678670|NCT00658814|63123917|FG001|Remission Induction Chemotherapy|Death|4|||
33678671|NCT00658814|63123916|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
33678672|NCT00658814|63123917|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
33678673|NCT00658814|63123916|FG000|Remission Induction Chemotherapy|Not eligible|1|||
33678674|NCT00658814|63123917|FG001|Remission Induction Chemotherapy|Not eligible|2|||
33678675|NCT00658814|63123916|FG000|Consolidation Therapy|Not protocol specified|0|||
33678676|NCT00658814|63123917|FG001|Consolidation Therapy|Not protocol specified|1|||
33678677|NCT00658814|63123916|FG000|Consolidation Therapy|Not eligible|2|||
33678678|NCT00658814|63123917|FG001|Consolidation Therapy|Not eligible|2|||
33678679|NCT00658814|63123916|FG000|Maintenance Therapy|Adverse Event|1|||
33678680|NCT00658814|63123917|FG001|Maintenance Therapy|Adverse Event|1|||
33678681|NCT00658814|63123916|FG000|Maintenance Therapy|Not protocol specified|1|||
33678682|NCT00658814|63123917|FG001|Maintenance Therapy|Not protocol specified|0|||
33678683|NCT00658814|63123916|FG000|Maintenance Therapy|Not eligible|1|||
33678684|NCT00658814|63123917|FG001|Maintenance Therapy|Not eligible|0|||
33678685|NCT00217425|63123927|FG000|Overall Study|Never started treatment|2|||
33678686|NCT00217425|63123927|FG000|Overall Study|Patient ineligible|5|||
33678687|NCT00217425|63123927|FG000|Overall Study|Lack of Efficacy|13|||
33678688|NCT00217425|63123927|FG000|Overall Study|Adverse Event|8|||
33678689|NCT00217425|63123927|FG000|Overall Study|Withdrawal by Subject|4|||
33678690|NCT00217425|63123927|FG000|Overall Study|Other complicating disease|1|||
33678691|NCT00217425|63123927|FG000|Overall Study|Other|4|||
33678692|NCT03208231|63123946|FG000|Overall Study|Death|1|||
33678693|NCT03208231|63123947|FG001|Overall Study|Death|2|||
33678694|NCT03208231|63123946|FG000|Overall Study|Moved and unable to get to clinic|1|||
33678695|NCT03208231|63123947|FG001|Overall Study|Moved and unable to get to clinic|0|||
33678696|NCT03208231|63123946|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
33678697|NCT03208231|63123947|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
33678698|NCT03102242|63123970|FG000|Overall Study|Adverse Event|2|||
33678699|NCT03097328|63123974|FG000|Overall Study|Still on Therapy|2|||
33678700|NCT03097328|63123974|FG000|Overall Study|Progressive Disease|29|||
33678701|NCT03097328|63123974|FG000|Overall Study|Adverse Event|4|||
33678702|NCT03097328|63123974|FG000|Overall Study|Withdrawal by Subject|1|||
33678703|NCT03097328|63123974|FG000|Overall Study|Physician Decision|1|||
33678704|NCT03097328|63123974|FG000|Overall Study|Patient Decision|1|||
33678705|NCT03097328|63123974|FG000|Overall Study|Ineligible for Study Drug|1|||
33678706|NCT03033602|63123980|FG000|Overall Study|Withdrawal by Subject|11|||
33678707|NCT03033602|63123981|FG001|Overall Study|Withdrawal by Subject|21|||
33678708|NCT03033602|63123980|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
33678709|NCT03033602|63123981|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
33678710|NCT02994784|63123992|FG000|6 Months Follow-up|Lost to Follow-up|3|||
33678711|NCT02948829|63123996|FG000|Overall Study|Lost to Follow-up|2|||
33678712|NCT02948829|63123996|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
33678713|NCT02948829|63123996|FG000|Overall Study|Pregnancy|1|||
33678714|NCT02948829|63123996|FG000|Overall Study|Other: Reason not Specified|8|||
33678715|NCT02617446|63124027|FG000|Overall Study|Withdrawal by Subject|0|||
33678716|NCT02617446|63124028|FG001|Overall Study|Withdrawal by Subject|2|||
33678717|NCT02617446|63124029|FG002|Overall Study|Withdrawal by Subject|0|||
33678718|NCT02617446|63124027|FG000|Overall Study|Adverse Event|1|||
33678719|NCT02617446|63124028|FG001|Overall Study|Adverse Event|0|||
33678720|NCT02617446|63124029|FG002|Overall Study|Adverse Event|5|||
33678721|NCT02617446|63124027|FG000|Overall Study|Lost to Follow-up|3|||
33678722|NCT02617446|63124028|FG001|Overall Study|Lost to Follow-up|0|||
33678723|NCT02617446|63124029|FG002|Overall Study|Lost to Follow-up|0|||
33678724|NCT02617446|63124027|FG000|Overall Study|Death|0|||
33678725|NCT02617446|63124028|FG001|Overall Study|Death|0|||
33678726|NCT02617446|63124029|FG002|Overall Study|Death|2|||
33678727|NCT02549170|63124043|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
33678728|NCT02549170|63124044|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
33678729|NCT02549170|63124045|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
33678730|NCT02549170|63124046|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
33678731|NCT02549170|63124047|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
33678732|NCT02549170|63124043|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
33678733|NCT02549170|63124044|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
33678734|NCT02549170|63124045|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
33678735|NCT02549170|63124046|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
33678736|NCT02549170|63124047|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
33678737|NCT02549170|63124043|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
33678738|NCT02549170|63124044|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
33678739|NCT02549170|63124045|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
33678740|NCT02549170|63124046|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
33678741|NCT02549170|63124047|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
33678742|NCT02410902|63124064|FG000|Overall Study|Adverse Event|2|||
33678743|NCT02410902|63124065|FG001|Overall Study|Adverse Event|3|||
33678744|NCT02410902|63124064|FG000|Overall Study|Lost to Follow-up|4|||
33678745|NCT02410902|63124065|FG001|Overall Study|Lost to Follow-up|1|||
33678746|NCT02410902|63124064|FG000|Overall Study|Protocol Violation|1|||
33678747|NCT02410902|63124065|FG001|Overall Study|Protocol Violation|4|||
33678748|NCT02410902|63124064|FG000|Overall Study|Withdrawal by Subject|6|||
33678749|NCT02410902|63124065|FG001|Overall Study|Withdrawal by Subject|8|||
33678750|NCT02410902|63124064|FG000|Overall Study|Non-Compliance|8|||
33584552|NCT02614261|62982575|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
33584553|NCT02614261|62982572|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
33678751|NCT02410902|63124065|FG001|Overall Study|Non-Compliance|2|||
33678752|NCT02101736|63124075|FG000|Overall Study|Protocol Violation|3|||
33678753|NCT02101736|63124076|FG001|Overall Study|Protocol Violation|0|||
33678754|NCT02101736|63124075|FG000|Overall Study|Withdrawal by Subject|1|||
33678755|NCT02101736|63124076|FG001|Overall Study|Withdrawal by Subject|1|||
33678756|NCT01918397|63124088|FG000|Overall Study|Never started treatment|2|||
33678757|NCT01918397|63124089|FG001|Overall Study|Never started treatment|1|||
33678758|NCT01918397|63124090|FG002|Overall Study|Never started treatment|0|||
33678759|NCT01918397|63124091|FG003|Overall Study|Never started treatment|0|||
33678760|NCT01918397|63124088|FG000|Overall Study|Adverse Event|1|||
33678761|NCT01918397|63124089|FG001|Overall Study|Adverse Event|1|||
33678762|NCT01918397|63124090|FG002|Overall Study|Adverse Event|1|||
33678763|NCT01918397|63124091|FG003|Overall Study|Adverse Event|0|||
33678764|NCT01918397|63124088|FG000|Overall Study|Lack of compliance|2|||
33678765|NCT01918397|63124089|FG001|Overall Study|Lack of compliance|2|||
33678766|NCT01918397|63124090|FG002|Overall Study|Lack of compliance|3|||
33678767|NCT01918397|63124091|FG003|Overall Study|Lack of compliance|0|||
33678768|NCT01918397|63124088|FG000|Overall Study|Pregnancy|0|||
33678769|NCT01918397|63124089|FG001|Overall Study|Pregnancy|1|||
33584554|NCT02614261|62982573|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
33678770|NCT01918397|63124090|FG002|Overall Study|Pregnancy|0|||
33678771|NCT01918397|63124091|FG003|Overall Study|Pregnancy|0|||
33678772|NCT01918397|63124088|FG000|Overall Study|Rifampin susceptible|0|||
33678773|NCT01918397|63124089|FG001|Overall Study|Rifampin susceptible|0|||
33678774|NCT01918397|63124090|FG002|Overall Study|Rifampin susceptible|0|||
33678775|NCT01918397|63124091|FG003|Overall Study|Rifampin susceptible|2|||
33678776|NCT01918397|63124088|FG000|Overall Study|Treatment failure|0|||
33678777|NCT01918397|63124089|FG001|Overall Study|Treatment failure|0|||
33678778|NCT01918397|63124090|FG002|Overall Study|Treatment failure|0|||
33678779|NCT01918397|63124091|FG003|Overall Study|Treatment failure|1|||
33678780|NCT01918397|63124088|FG000|Overall Study|Withdrawal by Subject|3|||
33678781|NCT01918397|63124089|FG001|Overall Study|Withdrawal by Subject|2|||
33678782|NCT01918397|63124090|FG002|Overall Study|Withdrawal by Subject|1|||
33678783|NCT01918397|63124091|FG003|Overall Study|Withdrawal by Subject|1|||
33678784|NCT01918397|63124088|FG000|Overall Study|XDR at baseline|0|||
33678785|NCT01918397|63124089|FG001|Overall Study|XDR at baseline|0|||
33678786|NCT01918397|63124090|FG002|Overall Study|XDR at baseline|1|||
33678787|NCT01918397|63124091|FG003|Overall Study|XDR at baseline|0|||
33678788|NCT01918397|63124088|FG000|Overall Study|Lost to Follow-up|2|||
33678789|NCT01918397|63124089|FG001|Overall Study|Lost to Follow-up|1|||
33678790|NCT01918397|63124090|FG002|Overall Study|Lost to Follow-up|1|||
33678791|NCT01918397|63124091|FG003|Overall Study|Lost to Follow-up|1|||
33678792|NCT01918397|63124088|FG000|Overall Study|Increased QTc|1|||
33678793|NCT01918397|63124089|FG001|Overall Study|Increased QTc|0|||
33678794|NCT01918397|63124090|FG002|Overall Study|Increased QTc|0|||
33678795|NCT01918397|63124091|FG003|Overall Study|Increased QTc|1|||
33678796|NCT01918397|63124088|FG000|Overall Study|Death|0|||
33678797|NCT01918397|63124089|FG001|Overall Study|Death|0|||
33678798|NCT01918397|63124090|FG002|Overall Study|Death|1|||
33678799|NCT01918397|63124091|FG003|Overall Study|Death|0|||
33678800|NCT01918397|63124088|FG000|Overall Study|Involved in another investigative trial|0|||
33678801|NCT01918397|63124089|FG001|Overall Study|Involved in another investigative trial|0|||
33678802|NCT01918397|63124090|FG002|Overall Study|Involved in another investigative trial|0|||
33678803|NCT01918397|63124091|FG003|Overall Study|Involved in another investigative trial|1|||
33678804|NCT00986921|63124125|FG000|Overall Study|Physician Decision|1|||
33678805|NCT00986921|63124126|FG001|Overall Study|Physician Decision|0|||
33678806|NCT01596972|63124137|FG000|Overall Study|Physician Decision|1|||
33678807|NCT01596972|63124138|FG001|Overall Study|Physician Decision|9|||
33678808|NCT01596972|63124137|FG000|Overall Study|Lost to Follow-up|0|||
33678809|NCT01596972|63124138|FG001|Overall Study|Lost to Follow-up|4|||
33678810|NCT01596972|63124137|FG000|Overall Study|Withdrawal by Subject|0|||
33678811|NCT01596972|63124138|FG001|Overall Study|Withdrawal by Subject|1|||
33678812|NCT00985751|63124239|FG000|Overall Study|Adverse Event|0|||
33678813|NCT00985751|63124240|FG001|Overall Study|Adverse Event|0|||
33678814|NCT00985751|63124241|FG002|Overall Study|Adverse Event|0|||
33678815|NCT00985751|63124242|FG003|Overall Study|Adverse Event|0|||
33678816|NCT00985751|63124243|FG004|Overall Study|Adverse Event|1|||
33678817|NCT01596582|63124288|FG000|Overall Study|Deemed ineligible after study visit|3|||
33678818|NCT01596582|63124289|FG001|Overall Study|Deemed ineligible after study visit|6|||
33678819|NCT01596582|63124288|FG000|Overall Study|Missing all outcome data|1|||
33678820|NCT01596582|63124289|FG001|Overall Study|Missing all outcome data|1|||
33678821|NCT01596504|63124305|FG000|Overall Study|Participant's Private Reason|0|||
33678822|NCT01596504|63124306|FG001|Overall Study|Participant's Private Reason|1|||
33678823|NCT01596504|63124307|FG002|Overall Study|Participant's Private Reason|0|||
33678824|NCT01596504|63124305|FG000|Overall Study|Adverse Event|1|||
33678825|NCT01596504|63124306|FG001|Overall Study|Adverse Event|2|||
33678826|NCT01596504|63124307|FG002|Overall Study|Adverse Event|1|||
33678827|NCT01596504|63124305|FG000|Overall Study|Withdrawal by Subject|1|||
33678828|NCT01596504|63124306|FG001|Overall Study|Withdrawal by Subject|0|||
33678829|NCT01596504|63124307|FG002|Overall Study|Withdrawal by Subject|0|||
33678830|NCT02616900|63124362|FG000|Overall Study|Lack of Efficacy|7|||
33678831|NCT02616900|63124362|FG000|Overall Study|Lost to Follow-up|2|||
33678832|NCT02616900|63124362|FG000|Overall Study|Protocol Violation|5|||
33678833|NCT02616900|63124362|FG000|Overall Study|Withdrawal by Subject|3|||
33678834|NCT02616900|63124362|FG000|Overall Study|Incomplete data|6|||
33678835|NCT00985673|63124474|FG000|Overall Study|Lost to Follow-up|6|||
33678836|NCT00985673|63124475|FG001|Overall Study|Lost to Follow-up|7|||
33678837|NCT00985673|63124476|FG002|Overall Study|Lost to Follow-up|6|||
33678838|NCT00985673|63124477|FG003|Overall Study|Lost to Follow-up|10|||
33678839|NCT00985673|63124478|FG004|Overall Study|Lost to Follow-up|5|||
33678840|NCT00985673|63124479|FG005|Overall Study|Lost to Follow-up|3|||
33678841|NCT00985673|63124474|FG000|Overall Study|Withdrawal by Subject|0|||
33678842|NCT00985673|63124475|FG001|Overall Study|Withdrawal by Subject|4|||
33678843|NCT00985673|63124476|FG002|Overall Study|Withdrawal by Subject|5|||
33678844|NCT00985673|63124477|FG003|Overall Study|Withdrawal by Subject|2|||
33678845|NCT00985673|63124478|FG004|Overall Study|Withdrawal by Subject|2|||
33678846|NCT00985673|63124479|FG005|Overall Study|Withdrawal by Subject|3|||
33678847|NCT00985673|63124474|FG000|Overall Study|Other|1|||
33678848|NCT00985673|63124475|FG001|Overall Study|Other|0|||
33678849|NCT00985673|63124476|FG002|Overall Study|Other|1|||
33678850|NCT00985673|63124477|FG003|Overall Study|Other|0|||
33678851|NCT00985673|63124478|FG004|Overall Study|Other|1|||
33678852|NCT00985673|63124479|FG005|Overall Study|Other|0|||
33678853|NCT00985439|63124525|FG000|Overall Study|Adverse Event|0|||
33678854|NCT00985439|63124526|FG001|Overall Study|Adverse Event|0|||
33678855|NCT00985439|63124527|FG002|Overall Study|Adverse Event|1|||
33678856|NCT00985439|63124528|FG003|Overall Study|Adverse Event|0|||
33678857|NCT02618928|63124538|FG000|Overall Study|Failure to Return|28|||
33678858|NCT02618928|63124538|FG000|Overall Study|Insufficient Virological Response|1|||
33678859|NCT02618928|63124538|FG000|Overall Study|Withdrawal by Subject|2|||
33678860|NCT02618928|63124538|FG000|Overall Study|Death|3|||
33678861|NCT02618928|63124538|FG000|Overall Study|Other|11|||
33678862|NCT02618928|63124538|FG000|Overall Study|Missing|6|||
33678863|NCT02618928|63124538|FG000|Overall Study|Treatment Never Started|7|||
33678864|NCT00983957|63124549|FG000|Overall Study|Adverse Event|1|||
33678865|NCT00983957|63124549|FG000|Overall Study|Personal Reasons|1|||
33678866|NCT00981149|63124603|FG000|Overall Study|Lost to Follow-up|1|||
33678867|NCT00981149|63124604|FG001|Overall Study|Lost to Follow-up|2|||
33678868|NCT00981149|63124603|FG000|Overall Study|Withdrawal by Subject|1|||
33678869|NCT00981149|63124604|FG001|Overall Study|Withdrawal by Subject|1|||
33678870|NCT01595646|63124662|FG000|Overall Study|Withdrawal by Subject|1|||
33678871|NCT01595646|63124663|FG001|Overall Study|Withdrawal by Subject|0|||
33678872|NCT01595646|63124664|FG002|Overall Study|Withdrawal by Subject|0|||
33678873|NCT00981461|63124692|FG000|Overall Study|Lost to Follow-up|5|||
33678874|NCT00981461|63124693|FG001|Overall Study|Lost to Follow-up|2|||
33678875|NCT02618616|63124710|FG000|Overall Study|Lack of Efficacy|4|||
33678876|NCT02618616|63124711|FG001|Overall Study|Lack of Efficacy|0|||
33678877|NCT02618616|63124710|FG000|Overall Study|Pregnancy|0|||
33678878|NCT02618616|63124711|FG001|Overall Study|Pregnancy|1|||
33678879|NCT02618616|63124710|FG000|Overall Study|Adverse Event|8|||
33678880|NCT02618616|63124711|FG001|Overall Study|Adverse Event|0|||
33678881|NCT02618616|63124710|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
33678882|NCT02618616|63124711|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
33310661|NCT00946309|62686060|FG000|Overall Study|Procedure cancelled/discontinued|0|||
33310662|NCT00946309|62686061|FG001|Overall Study|Procedure cancelled/discontinued|3|||
33310663|NCT01236534|62686070|FG000|Overall Study|Adverse Event|3|||
33310664|NCT01236534|62686071|FG001|Overall Study|Adverse Event|0|||
33678883|NCT02618616|63124710|FG000|Overall Study|Consent withdrawn by subject|8|||
33678884|NCT02618616|63124711|FG001|Overall Study|Consent withdrawn by subject|5|||
33678885|NCT02618616|63124710|FG000|Overall Study|Lost to Follow-up|0|||
33678886|NCT02618616|63124711|FG001|Overall Study|Lost to Follow-up|1|||
33678887|NCT02618382|63124790|FG000|Overall Study|Physician Decision|1|||
33678888|NCT02618382|63124790|FG000|Overall Study|Withdrawal by Subject|1|||
33678889|NCT02618382|63124790|FG000|Overall Study|Protocol Violation|1|||
33678890|NCT00980057|63124834|FG000|Overall Study|Death|13|||
33678891|NCT00980057|63124835|FG001|Overall Study|Death|3|||
33678892|NCT00980057|63124834|FG000|Overall Study|Adverse Event|0|||
33678893|NCT00980057|63124835|FG001|Overall Study|Adverse Event|1|||
33678894|NCT00980057|63124834|FG000|Overall Study|Physician Decision|4|||
33678895|NCT00980057|63124835|FG001|Overall Study|Physician Decision|0|||
33678896|NCT00980057|63124834|FG000|Overall Study|Lost to Follow-up|1|||
33678897|NCT00980057|63124835|FG001|Overall Study|Lost to Follow-up|0|||
33678898|NCT00980057|63124834|FG000|Overall Study|Withdrawal by Subject|1|||
33678899|NCT00980057|63124835|FG001|Overall Study|Withdrawal by Subject|1|||
33678900|NCT04126733|63124947|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
33678901|NCT04126733|63124947|FG000|Treatment Period|Adverse Event|8|||
33678902|NCT04126733|63124947|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
33678903|NCT04126733|63124947|FG000|Treatment Period|Physician Decision|5|||
33678904|NCT04126733|63124947|FG000|Treatment Period|Death|1|||
33678905|NCT04126733|63124947|FG000|Treatment Period|Other Reasons|2|||
33678906|NCT04126733|63124947|FG000|Active Follow-up Period|Death|13|||
33678907|NCT04126733|63124947|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
33678908|NCT04126733|63124947|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
33678909|NCT04126733|63124947|FG000|Active Follow-up Period|Other Reasons|1|||
33678910|NCT04126733|63124947|FG000|Long-term Follow-up Period|Death|22|||
33678911|NCT04126733|63124947|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
33678912|NCT04126733|63124947|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
33678913|NCT00988247|63124982|FG000|Overall Study|Adverse Event|17|||
33678914|NCT00988247|63124983|FG001|Overall Study|Adverse Event|3|||
33678915|NCT00988247|63124982|FG000|Overall Study|Withdrawal by Subject|44|||
33678916|NCT00988247|63124983|FG001|Overall Study|Withdrawal by Subject|13|||
33678917|NCT00988247|63124982|FG000|Overall Study|Pregnancy|1|||
33678918|NCT00988247|63124983|FG001|Overall Study|Pregnancy|2|||
33678919|NCT00988247|63124982|FG000|Overall Study|Lost to Follow-up|11|||
33678920|NCT00988247|63124983|FG001|Overall Study|Lost to Follow-up|2|||
33678921|NCT00988247|63124982|FG000|Overall Study|Protocol Violation|4|||
33678922|NCT00988247|63124983|FG001|Overall Study|Protocol Violation|5|||
33310665|NCT01235598|62686079|FG000|Overall Study|Adverse Event|0|||
33678923|NCT00988247|63124982|FG000|Overall Study|Sponsor requested withdrawal|3|||
33678924|NCT00988247|63124983|FG001|Overall Study|Sponsor requested withdrawal|1|||
33678925|NCT00988247|63124982|FG000|Overall Study|Other|3|||
33678926|NCT00988247|63124983|FG001|Overall Study|Other|0|||
33678927|NCT00984659|63124993|FG000|2-week Run-in Period|Adverse Event|8|||
33678928|NCT00984659|63124994|FG001|2-week Run-in Period|Adverse Event|0|||
33678929|NCT00984659|63124995|FG002|2-week Run-in Period|Adverse Event|0|||
33678930|NCT00984659|63124996|FG003|2-week Run-in Period|Adverse Event|0|||
33678931|NCT00984659|63124993|FG000|2-week Run-in Period|Protocol Violation|5|||
33678932|NCT00984659|63124994|FG001|2-week Run-in Period|Protocol Violation|0|||
33678933|NCT00984659|63124995|FG002|2-week Run-in Period|Protocol Violation|0|||
33678934|NCT00984659|63124996|FG003|2-week Run-in Period|Protocol Violation|0|||
33678935|NCT00984659|63124993|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
33678936|NCT00984659|63124994|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
33678937|NCT00984659|63124995|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
33678938|NCT00984659|63124996|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
33678939|NCT00984659|63124993|FG000|2-week Run-in Period|Lost to Follow-up|3|||
33678940|NCT00984659|63124994|FG001|2-week Run-in Period|Lost to Follow-up|0|||
33678941|NCT00984659|63124995|FG002|2-week Run-in Period|Lost to Follow-up|0|||
33678942|NCT00984659|63124996|FG003|2-week Run-in Period|Lost to Follow-up|0|||
33678943|NCT00984659|63124993|FG000|2-week Run-in Period|Physician Decision|10|||
33678944|NCT00984659|63124994|FG001|2-week Run-in Period|Physician Decision|0|||
33678945|NCT00984659|63124995|FG002|2-week Run-in Period|Physician Decision|0|||
33678946|NCT00984659|63124996|FG003|2-week Run-in Period|Physician Decision|0|||
33678947|NCT00984659|63124993|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
33678948|NCT00984659|63124994|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
33678949|NCT00984659|63124995|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
33678950|NCT00984659|63124996|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
33678951|NCT00984659|63124993|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
33678952|NCT00984659|63124994|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
33678953|NCT00984659|63124995|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
33678954|NCT00984659|63124996|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
33678955|NCT00984659|63124993|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
33678956|NCT00984659|63124994|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
33678957|NCT00984659|63124995|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
33678958|NCT00984659|63124996|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
33678959|NCT00984659|63124993|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
33678960|NCT00984659|63124994|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
33678961|NCT00984659|63124995|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
33678962|NCT00984659|63124996|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
33678963|NCT00984659|63124993|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
33678964|NCT00984659|63124994|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
33678965|NCT00984659|63124995|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
33678966|NCT00984659|63124996|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
33678967|NCT00984659|63124993|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
33678968|NCT00984659|63124994|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
33678969|NCT00984659|63124995|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
33678970|NCT00984659|63124996|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
33678971|NCT00984659|63124993|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33678972|NCT00984659|63124994|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
33678973|NCT00984659|63124995|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
33678974|NCT00984659|63124996|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
33678975|NCT00982319|63125005|FG000|Overall Study|Surgery date change|1|||
33678976|NCT00982319|63125006|FG001|Overall Study|Surgery date change|0|||
33678977|NCT00982319|63125005|FG000|Overall Study|Preop values out of acceptable range|1|||
33678978|NCT00982319|63125006|FG001|Overall Study|Preop values out of acceptable range|1|||
33678979|NCT00982319|63125005|FG000|Overall Study|Pregnancy|0|||
33678980|NCT00982319|63125006|FG001|Overall Study|Pregnancy|1|||
33678981|NCT02612064|63125018|FG000|Overall Study|Withdrawal by Subject|1|||
33678982|NCT02612064|63125019|FG001|Overall Study|Withdrawal by Subject|1|||
33678983|NCT02612064|63125018|FG000|Overall Study|Other|0|||
33678984|NCT02612064|63125019|FG001|Overall Study|Other|2|||
33678985|NCT02614560|63125038|FG000|Overall Study|Death|6|||
33678986|NCT02614560|63125039|FG001|Overall Study|Death|2|||
33678987|NCT01669122|63125056|FG000|Period I|Lost to Follow-up|1|||
33678988|NCT01669122|63125056|FG000|Washout Period II|Protocol Violation|2|||
33678989|NCT02611752|63125089|FG000|Overall Study|Adverse Event|0|||
33678990|NCT02611752|63125090|FG001|Overall Study|Adverse Event|1|||
33678991|NCT02611362|63125111|FG000|Overall Study|Withdrawal by Subject|7|||
33678992|NCT02611362|63125112|FG001|Overall Study|Withdrawal by Subject|2|||
33678993|NCT02611362|63125111|FG000|Overall Study|Lost to Follow-up|2|||
33678994|NCT02611362|63125112|FG001|Overall Study|Lost to Follow-up|4|||
33678995|NCT01594476|63125132|FG000|Overall Study|Protocol Violation|1|||
33678996|NCT01594476|63125133|FG001|Overall Study|Protocol Violation|3|||
33678997|NCT01668966|63125147|FG000|Overall Study|Withdrawal by Subject|1|||
33678998|NCT01668966|63125147|FG000|Overall Study|Death|1|||
33678999|NCT01668966|63125147|FG000|Overall Study|Not treated|2|||
33679000|NCT02609724|63125154|FG000|Overall Study|Death|2|||
33679001|NCT02609724|63125155|FG001|Overall Study|Death|0|||
33679002|NCT02609724|63125156|FG002|Overall Study|Death|1|||
33679003|NCT02609724|63125154|FG000|Overall Study|Withdrawal by Subject|1|||
33679004|NCT02609724|63125155|FG001|Overall Study|Withdrawal by Subject|2|||
33679005|NCT02609724|63125156|FG002|Overall Study|Withdrawal by Subject|3|||
33679006|NCT02609724|63125154|FG000|Overall Study|Illness|2|||
33679007|NCT02609724|63125155|FG001|Overall Study|Illness|1|||
33679008|NCT02609724|63125156|FG002|Overall Study|Illness|0|||
33679009|NCT02610816|63125185|FG000|Phase 1|Withdrawal by Subject|2|||
33679010|NCT02610816|63125186|FG001|Phase 1|Withdrawal by Subject|6|||
33679011|NCT02610816|63125187|FG002|Phase 1|Withdrawal by Subject|0|||
33679012|NCT02610816|63125188|FG003|Phase 1|Withdrawal by Subject|0|||
33679013|NCT02610816|63125185|FG000|Phase 1|Lost to Follow-up|2|||
33679014|NCT02610816|63125186|FG001|Phase 1|Lost to Follow-up|1|||
33679015|NCT02610816|63125187|FG002|Phase 1|Lost to Follow-up|0|||
33679016|NCT02610816|63125188|FG003|Phase 1|Lost to Follow-up|0|||
33679017|NCT02610816|63125185|FG000|Phase 1|Physician Decision|0|||
33679018|NCT02610816|63125186|FG001|Phase 1|Physician Decision|1|||
33679019|NCT02610816|63125187|FG002|Phase 1|Physician Decision|0|||
33679020|NCT02610816|63125188|FG003|Phase 1|Physician Decision|0|||
33679021|NCT02610816|63125185|FG000|Phase 2|Withdrawal by Subject|0|||
33679022|NCT02610816|63125186|FG001|Phase 2|Withdrawal by Subject|0|||
33679023|NCT02610816|63125187|FG002|Phase 2|Withdrawal by Subject|9|||
33679024|NCT02610816|63125188|FG003|Phase 2|Withdrawal by Subject|3|||
33679025|NCT02610816|63125185|FG000|Phase 2|Lost to Follow-up|0|||
33679026|NCT02610816|63125186|FG001|Phase 2|Lost to Follow-up|0|||
33679027|NCT02610816|63125187|FG002|Phase 2|Lost to Follow-up|2|||
33679028|NCT02610816|63125188|FG003|Phase 2|Lost to Follow-up|0|||
33679029|NCT02610816|63125185|FG000|Phase 2|Physician Decision|0|||
33679030|NCT02610816|63125186|FG001|Phase 2|Physician Decision|0|||
33679031|NCT02610816|63125187|FG002|Phase 2|Physician Decision|0|||
33679032|NCT02610816|63125188|FG003|Phase 2|Physician Decision|2|||
33679033|NCT02610816|63125185|FG000|Phase 2|Pregnancy|0|||
33679034|NCT02610816|63125186|FG001|Phase 2|Pregnancy|0|||
33679035|NCT02610816|63125187|FG002|Phase 2|Pregnancy|0|||
33679036|NCT02610816|63125188|FG003|Phase 2|Pregnancy|1|||
33679037|NCT02612610|63125284|FG000|Overall Study|Withdrawal by Subject|1|||
33679038|NCT02612610|63125285|FG001|Overall Study|Withdrawal by Subject|1|||
33679039|NCT02612610|63125286|FG002|Overall Study|Withdrawal by Subject|0|||
33679040|NCT02612610|63125287|FG003|Overall Study|Withdrawal by Subject|2|||
33679041|NCT02612610|63125284|FG000|Overall Study|Adverse Event|2|||
33679042|NCT02612610|63125285|FG001|Overall Study|Adverse Event|2|||
33679043|NCT02612610|63125286|FG002|Overall Study|Adverse Event|3|||
33679044|NCT02612610|63125287|FG003|Overall Study|Adverse Event|10|||
33679045|NCT02612610|63125284|FG000|Overall Study|Lost to Follow-up|0|||
33679046|NCT02612610|63125285|FG001|Overall Study|Lost to Follow-up|1|||
33679047|NCT02612610|63125286|FG002|Overall Study|Lost to Follow-up|0|||
33679048|NCT02612610|63125287|FG003|Overall Study|Lost to Follow-up|0|||
33679049|NCT02612610|63125284|FG000|Overall Study|Protocol Violation|0|||
33679050|NCT02612610|63125285|FG001|Overall Study|Protocol Violation|1|||
33679051|NCT02612610|63125286|FG002|Overall Study|Protocol Violation|1|||
33679052|NCT02612610|63125287|FG003|Overall Study|Protocol Violation|0|||
33679053|NCT02612610|63125284|FG000|Overall Study|Lack of Efficacy|1|||
33679054|NCT02612610|63125285|FG001|Overall Study|Lack of Efficacy|2|||
33679055|NCT02612610|63125286|FG002|Overall Study|Lack of Efficacy|0|||
33679056|NCT02612610|63125287|FG003|Overall Study|Lack of Efficacy|1|||
33679057|NCT02612610|63125284|FG000|Overall Study|Physician Decision|0|||
33679058|NCT02612610|63125285|FG001|Overall Study|Physician Decision|1|||
33679059|NCT02612610|63125286|FG002|Overall Study|Physician Decision|0|||
33679060|NCT02612610|63125287|FG003|Overall Study|Physician Decision|0|||
33679061|NCT02612610|63125284|FG000|Overall Study|Noncompliance|1|||
33679062|NCT02612610|63125285|FG001|Overall Study|Noncompliance|0|||
33679063|NCT02612610|63125286|FG002|Overall Study|Noncompliance|0|||
33679064|NCT02612610|63125287|FG003|Overall Study|Noncompliance|0|||
33679065|NCT02612610|63125284|FG000|Overall Study|Cough Improvement|0|||
33679066|NCT02612610|63125285|FG001|Overall Study|Cough Improvement|0|||
33679067|NCT02612610|63125286|FG002|Overall Study|Cough Improvement|1|||
33679068|NCT02612610|63125287|FG003|Overall Study|Cough Improvement|0|||
33679069|NCT02610192|63125500|FG000|Overall Study|Received other treatment|8|||
33679070|NCT02610192|63125500|FG000|Overall Study|Physician Decision|1|||
33679071|NCT02609178|63125644|FG000|First Crown|Withdrawal by Subject|0|||
33679072|NCT02609178|63125645|FG001|First Crown|Withdrawal by Subject|0|||
33679073|NCT02609178|63125646|FG002|First Crown|Withdrawal by Subject|1|||
33679074|NCT02609178|63125647|FG003|First Crown|Withdrawal by Subject|1|||
33679075|NCT02609178|63125648|FG004|First Crown|Withdrawal by Subject|0|||
33679076|NCT02609178|63125649|FG005|First Crown|Withdrawal by Subject|0|||
33679077|NCT02607228|63125873|FG000|Overall Study|Progressive Disease|4|||
33679078|NCT02607228|63125874|FG001|Overall Study|Progressive Disease|3|||
33679079|NCT02607228|63125875|FG002|Overall Study|Progressive Disease|1|||
33679080|NCT02607228|63125876|FG003|Overall Study|Progressive Disease|5|||
33679081|NCT02607228|63125877|FG004|Overall Study|Progressive Disease|4|||
33679082|NCT02607228|63125878|FG005|Overall Study|Progressive Disease|3|||
33679083|NCT02607228|63125879|FG006|Overall Study|Progressive Disease|1|||
33679084|NCT02607228|63125873|FG000|Overall Study|Adverse Event|1|||
33679085|NCT02607228|63125874|FG001|Overall Study|Adverse Event|0|||
33679086|NCT02607228|63125875|FG002|Overall Study|Adverse Event|1|||
33679087|NCT02607228|63125876|FG003|Overall Study|Adverse Event|0|||
33679088|NCT02607228|63125877|FG004|Overall Study|Adverse Event|1|||
33679089|NCT02607228|63125878|FG005|Overall Study|Adverse Event|1|||
33679090|NCT02607228|63125879|FG006|Overall Study|Adverse Event|1|||
33584555|NCT02614261|62982574|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
33584556|NCT02614261|62982575|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
33584557|NCT02614261|62982572|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
33679091|NCT02607228|63125873|FG000|Overall Study|Investigator's Discretion|0|||
33679092|NCT02607228|63125874|FG001|Overall Study|Investigator's Discretion|0|||
33679093|NCT02607228|63125875|FG002|Overall Study|Investigator's Discretion|1|||
33679094|NCT02607228|63125876|FG003|Overall Study|Investigator's Discretion|0|||
33679095|NCT02607228|63125877|FG004|Overall Study|Investigator's Discretion|0|||
33679096|NCT02607228|63125878|FG005|Overall Study|Investigator's Discretion|1|||
33679097|NCT02607228|63125879|FG006|Overall Study|Investigator's Discretion|0|||
33679098|NCT02607228|63125873|FG000|Overall Study|Withdrew Consent|0|||
33679099|NCT02607228|63125874|FG001|Overall Study|Withdrew Consent|1|||
33679100|NCT02607228|63125875|FG002|Overall Study|Withdrew Consent|0|||
33679101|NCT02607228|63125876|FG003|Overall Study|Withdrew Consent|0|||
33679102|NCT02607228|63125877|FG004|Overall Study|Withdrew Consent|0|||
33679103|NCT02607228|63125878|FG005|Overall Study|Withdrew Consent|1|||
33679104|NCT02607228|63125879|FG006|Overall Study|Withdrew Consent|0|||
33679105|NCT02607228|63125873|FG000|Overall Study|Study Terminated by Sponsor|0|||
33679106|NCT02607228|63125874|FG001|Overall Study|Study Terminated by Sponsor|0|||
33679107|NCT02607228|63125875|FG002|Overall Study|Study Terminated by Sponsor|0|||
33679108|NCT02607228|63125876|FG003|Overall Study|Study Terminated by Sponsor|1|||
33679109|NCT02607228|63125877|FG004|Overall Study|Study Terminated by Sponsor|0|||
33679110|NCT02607228|63125878|FG005|Overall Study|Study Terminated by Sponsor|0|||
33679111|NCT02607228|63125879|FG006|Overall Study|Study Terminated by Sponsor|0|||
33679112|NCT01668654|63125921|FG000|Overall Study|Study Closed/Terminated|3|||
33679113|NCT01668654|63125921|FG000|Overall Study|Withdrawal by Subject|1|||
33679114|NCT02608476|63126015|FG000|Overall Study|Withdrawal by Subject|30|||
33679115|NCT02608476|63126016|FG001|Overall Study|Withdrawal by Subject|37|||
33679116|NCT02608476|63126015|FG000|Overall Study|Lost to Follow-up|24|||
33679117|NCT02608476|63126016|FG001|Overall Study|Lost to Follow-up|24|||
33679118|NCT02608476|63126015|FG000|Overall Study|Adverse Event|2|||
33679119|NCT02608476|63126016|FG001|Overall Study|Adverse Event|8|||
33679120|NCT02608476|63126015|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
33679121|NCT02608476|63126016|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
33679122|NCT02608476|63126015|FG000|Overall Study|Noncompliance with treatment|1|||
33679123|NCT02608476|63126016|FG001|Overall Study|Noncompliance with treatment|5|||
33679124|NCT02608476|63126015|FG000|Overall Study|Lack of Efficacy|3|||
33679125|NCT02608476|63126016|FG001|Overall Study|Lack of Efficacy|1|||
33679126|NCT02608476|63126015|FG000|Overall Study|Other|0|||
33679127|NCT02608476|63126016|FG001|Overall Study|Other|1|||
33679128|NCT02608476|63126015|FG000|Overall Study|Physician Decision|1|||
33679129|NCT02608476|63126016|FG001|Overall Study|Physician Decision|0|||
33679130|NCT02608476|63126015|FG000|Overall Study|Pregnancy|0|||
33679131|NCT02608476|63126016|FG001|Overall Study|Pregnancy|1|||
33679132|NCT02608476|63126015|FG000|Overall Study|Progressive disease|1|||
33679133|NCT02608476|63126016|FG001|Overall Study|Progressive disease|0|||
33679134|NCT02607306|63126154|FG000|Overall Study|Adverse Event|8|||
33679135|NCT02607306|63126155|FG001|Overall Study|Adverse Event|6|||
33679136|NCT02607306|63126156|FG002|Overall Study|Adverse Event|6|||
33679137|NCT02607306|63126154|FG000|Overall Study|Unclassified|1|||
33679138|NCT02607306|63126155|FG001|Overall Study|Unclassified|4|||
33679139|NCT02607306|63126156|FG002|Overall Study|Unclassified|0|||
33679140|NCT02607306|63126154|FG000|Overall Study|Withdrawal by Subject|8|||
33679141|NCT02607306|63126155|FG001|Overall Study|Withdrawal by Subject|10|||
33679142|NCT02607306|63126156|FG002|Overall Study|Withdrawal by Subject|2|||
33679143|NCT02607306|63126154|FG000|Overall Study|Lack of Efficacy|0|||
33679144|NCT02607306|63126155|FG001|Overall Study|Lack of Efficacy|1|||
33679145|NCT02607306|63126156|FG002|Overall Study|Lack of Efficacy|1|||
33679146|NCT02607306|63126154|FG000|Overall Study|Protocol Violation|4|||
33679147|NCT02607306|63126155|FG001|Overall Study|Protocol Violation|2|||
33679148|NCT02607306|63126156|FG002|Overall Study|Protocol Violation|1|||
33679149|NCT02603952|63126479|FG000|Overall Study|Withdrawal by Subject|1|||
33679150|NCT02603952|63126480|FG001|Overall Study|Withdrawal by Subject|0|||
33679151|NCT02603952|63126481|FG002|Overall Study|Withdrawal by Subject|0|||
33584558|NCT02614261|62982573|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
33679152|NCT02603952|63126482|FG003|Overall Study|Withdrawal by Subject|0|||
33679153|NCT02603952|63126479|FG000|Overall Study|Received oseltamivir by error|0|||
33679154|NCT02603952|63126480|FG001|Overall Study|Received oseltamivir by error|0|||
33679155|NCT02603952|63126481|FG002|Overall Study|Received oseltamivir by error|0|||
33679156|NCT02603952|63126482|FG003|Overall Study|Received oseltamivir by error|1|||
33679157|NCT02603172|63126996|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
33679158|NCT02603172|63126997|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
33679159|NCT02603172|63126998|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
33679160|NCT02603172|63126999|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
33679161|NCT02603172|63127000|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
33679162|NCT02603172|63127001|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
33679163|NCT02603172|63127002|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
33679164|NCT02603172|63127003|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
33679165|NCT02605824|63127124|FG000|Overall Study|Physician Decision|1|||
33679166|NCT02605824|63127125|FG001|Overall Study|Physician Decision|0|||
33679167|NCT02605122|63127255|FG000|Overall Study|Withdrawal by Subject|4|||
33679168|NCT02605122|63127256|FG001|Overall Study|Withdrawal by Subject|1|||
33679169|NCT02605122|63127255|FG000|Overall Study|Lost to Follow-up|1|||
33679170|NCT02605122|63127256|FG001|Overall Study|Lost to Follow-up|1|||
33679171|NCT01454102|63127307|FG000|Overall Study|Continuing in the treatment period|0|||
33679172|NCT01454102|63127308|FG001|Overall Study|Continuing in the treatment period|0|||
33679173|NCT01454102|63127309|FG002|Overall Study|Continuing in the treatment period|0|||
33679174|NCT01454102|63127310|FG003|Overall Study|Continuing in the treatment period|0|||
33679175|NCT01454102|63127311|FG004|Overall Study|Continuing in the treatment period|3|||
33679176|NCT01454102|63127312|FG005|Overall Study|Continuing in the treatment period|3|||
33679177|NCT01454102|63127313|FG006|Overall Study|Continuing in the treatment period|2|||
33679178|NCT01454102|63127314|FG007|Overall Study|Continuing in the treatment period|0|||
33679179|NCT01454102|63127315|FG008|Overall Study|Continuing in the treatment period|1|||
33679180|NCT01454102|63127316|FG009|Overall Study|Continuing in the treatment period|0|||
33679181|NCT01454102|63127317|FG010|Overall Study|Continuing in the treatment period|0|||
33679182|NCT01454102|63127318|FG011|Overall Study|Continuing in the treatment period|4|||
33679183|NCT01454102|63127319|FG012|Overall Study|Continuing in the treatment period|7|||
33679184|NCT01454102|63127320|FG013|Overall Study|Continuing in the treatment period|4|||
33679185|NCT01454102|63127321|FG014|Overall Study|Continuing in the treatment period|3|||
33679186|NCT01454102|63127322|FG015|Overall Study|Continuing in the treatment period|1|||
33679187|NCT02602080|63127416|FG000|Overall Study|Protocol Violation|6|||
33679188|NCT02602080|63127417|FG001|Overall Study|Protocol Violation|1|||
33679189|NCT02602080|63127418|FG002|Overall Study|Protocol Violation|3|||
33679190|NCT02604342|63127502|FG000|Overall Study|Death|32|||
33679191|NCT02604342|63127503|FG001|Overall Study|Death|16|||
33679192|NCT02604342|63127502|FG000|Overall Study|Progression of disease|1|||
33679193|NCT02604342|63127503|FG001|Overall Study|Progression of disease|0|||
33679194|NCT02604342|63127502|FG000|Overall Study|Withdrawal by Subject|5|||
33679195|NCT02604342|63127503|FG001|Overall Study|Withdrawal by Subject|6|||
33679196|NCT02604342|63127502|FG000|Overall Study|Other|1|||
33679197|NCT02604342|63127503|FG001|Overall Study|Other|0|||
33679198|NCT02604342|63127502|FG000|Overall Study|Study Termination by Sponsor|1|||
33679199|NCT02604342|63127503|FG001|Overall Study|Study Termination by Sponsor|0|||
33679200|NCT02604342|63127502|FG000|Overall Study|Lost to Follow-up|1|||
33679201|NCT02604342|63127503|FG001|Overall Study|Lost to Follow-up|1|||
33679202|NCT02604342|63127502|FG000|Overall Study|Physician Decision|2|||
33679203|NCT02604342|63127503|FG001|Overall Study|Physician Decision|0|||
33679204|NCT02604264|63127532|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
33679205|NCT02604264|63127533|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
33679206|NCT02601300|63127570|FG000|Induction Phase|Lack of Efficacy|2|||
33679207|NCT02601300|63127570|FG000|Induction Phase|Protocol Violation|1|||
33679208|NCT02601300|63127570|FG000|Extension Phase|Withdrawal by Subject|3|||
33679209|NCT02601300|63127570|FG000|Extension Phase|Adverse Event|4|||
33679210|NCT02601300|63127570|FG000|Extension Phase|Lack of Efficacy|10|||
33679211|NCT01471340|63127609|FG000|Overall Study|Death|5|||
33679212|NCT01471340|63127610|FG001|Overall Study|Death|4|||
33679213|NCT01471340|63127609|FG000|Overall Study|Lost to Follow-up|0|||
33679214|NCT01471340|63127610|FG001|Overall Study|Lost to Follow-up|1|||
33679215|NCT01471340|63127609|FG000|Overall Study|Investigational site closure|0|||
33679216|NCT01471340|63127610|FG001|Overall Study|Investigational site closure|1|||
33679217|NCT01471340|63127609|FG000|Overall Study|Invalid informed consent|1|||
33679218|NCT01471340|63127610|FG001|Overall Study|Invalid informed consent|0|||
33310666|NCT01235598|62686080|FG001|Overall Study|Adverse Event|3|||
33679219|NCT01492400|63127632|FG000|Overall Study|Miscellaneous Reasons|2|||
33679220|NCT01492400|63127633|FG001|Overall Study|Miscellaneous Reasons|3|||
33679221|NCT01492400|63127632|FG000|Overall Study|Personal Reasons|0|||
33679222|NCT01492400|63127633|FG001|Overall Study|Personal Reasons|5|||
33679223|NCT01492400|63127632|FG000|Overall Study|Lost to Follow-up|3|||
33679224|NCT01492400|63127633|FG001|Overall Study|Lost to Follow-up|1|||
33679225|NCT01492400|63127632|FG000|Overall Study|Pregnancy|0|||
33679226|NCT01492400|63127633|FG001|Overall Study|Pregnancy|1|||
33679227|NCT01492400|63127632|FG000|Overall Study|Lack of Efficacy|1|||
33679228|NCT01492400|63127633|FG001|Overall Study|Lack of Efficacy|1|||
33679229|NCT01492400|63127632|FG000|Overall Study|Adverse Event|10|||
33679230|NCT01492400|63127633|FG001|Overall Study|Adverse Event|5|||
33679231|NCT02596854|63127758|FG000|Overall Study|Withdrawn|8|||
33679232|NCT02592876|63127895|FG000|Overall Study|Withdrawal by Subject|3|||
33679233|NCT02592876|63127896|FG001|Overall Study|Withdrawal by Subject|3|||
33679234|NCT02592876|63127895|FG000|Overall Study|Study Termination by Sponsor|32|||
33679235|NCT02592876|63127896|FG001|Overall Study|Study Termination by Sponsor|27|||
33679236|NCT02592876|63127895|FG000|Overall Study|Lost to Follow-up|0|||
33679237|NCT02592876|63127896|FG001|Overall Study|Lost to Follow-up|1|||
33679238|NCT02592876|63127895|FG000|Overall Study|Death|6|||
33679239|NCT02592876|63127896|FG001|Overall Study|Death|9|||
33679240|NCT01492088|63127913|FG000|Overall Study|Withdrawal by Patient|0|||
33679241|NCT01492088|63127914|FG001|Overall Study|Withdrawal by Patient|2|||
33679242|NCT01492088|63127915|FG002|Overall Study|Withdrawal by Patient|0|||
33679243|NCT01492088|63127913|FG000|Overall Study|Death|1|||
33679244|NCT01492088|63127914|FG001|Overall Study|Death|6|||
33679245|NCT01492088|63127915|FG002|Overall Study|Death|2|||
33679246|NCT01492088|63127913|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
33679247|NCT01492088|63127914|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
33679248|NCT01492088|63127915|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
33679249|NCT01492088|63127913|FG000|Overall Study|Alive at Last Follow-up|0|||
33584559|NCT02614261|62982574|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
33584560|NCT02614261|62982575|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33584561|NCT02614261|62982572|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
33584562|NCT02614261|62982573|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
33584563|NCT02614261|62982574|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
33584564|NCT02614261|62982575|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
33584565|NCT02614261|62982572|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
33679250|NCT01492088|63127914|FG001|Overall Study|Alive at Last Follow-up|6|||
33679251|NCT01492088|63127915|FG002|Overall Study|Alive at Last Follow-up|11|||
33679252|NCT02592798|63128157|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
33679253|NCT02592798|63128158|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
33679254|NCT02592798|63128157|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
33679255|NCT02592798|63128158|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
33679256|NCT02592798|63128157|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
33679257|NCT02592798|63128158|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
33679258|NCT02592798|63128157|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
33679259|NCT02592798|63128158|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
33679260|NCT02592798|63128157|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
33679261|NCT02592798|63128158|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
33679262|NCT02592798|63128157|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
33679263|NCT02592798|63128158|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
33679264|NCT02592798|63128157|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
33679265|NCT02592798|63128158|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
33679266|NCT02592798|63128157|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
33679267|NCT02592798|63128158|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
33679268|NCT02592798|63128157|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
33679269|NCT02592798|63128158|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
33679270|NCT02592798|63128157|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
33679271|NCT02592798|63128158|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
33679272|NCT02592798|63128157|FG000|Transition From DB2 to OLE|Other reasons|1|||
33679273|NCT02592798|63128158|FG001|Transition From DB2 to OLE|Other reasons|0|||
33679274|NCT02592798|63128157|FG000|Open Label Period (OLE)|Other reasons|0|||
33679275|NCT02592798|63128158|FG001|Open Label Period (OLE)|Other reasons|2|||
33679276|NCT02592798|63128157|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
33584566|NCT02614261|62982573|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
33584567|NCT02614261|62982574|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
33584568|NCT02614261|62982575|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
33584569|NCT02614261|62982572|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
33584570|NCT02614261|62982573|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
33584571|NCT02614261|62982574|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
33584572|NCT02614261|62982575|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
33584573|NCT02614261|62982572|FG000|Double-Blind Treatment Phase|Screen failure|0|||
33584574|NCT02614261|62982573|FG001|Double-Blind Treatment Phase|Screen failure|1|||
33584575|NCT02614261|62982574|FG002|Double-Blind Treatment Phase|Screen failure|2|||
33584576|NCT02614261|62982575|FG003|Double-Blind Treatment Phase|Screen failure|0|||
33584577|NCT02614261|62982572|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
33679277|NCT02592798|63128158|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
33679278|NCT02592798|63128157|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
33679279|NCT02592798|63128158|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
33679280|NCT02592798|63128157|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
33310667|NCT01235598|62686079|FG000|Overall Study|Lack of Efficacy|0|||
33679281|NCT02592798|63128158|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
33679282|NCT02592798|63128157|FG000|Open Label Period (OLE)|Adverse Event|0|||
33679283|NCT02592798|63128158|FG001|Open Label Period (OLE)|Adverse Event|1|||
33679284|NCT00081653|63128198|FG000|Overall Study|Adverse Event|23|||
33679285|NCT00081653|63128199|FG001|Overall Study|Adverse Event|17|||
33679286|NCT00081653|63128198|FG000|Overall Study|Lost to Follow-up|2|||
33679287|NCT00081653|63128199|FG001|Overall Study|Lost to Follow-up|4|||
33679288|NCT00081653|63128198|FG000|Overall Study|Refused Treatment|18|||
33679289|NCT00081653|63128199|FG001|Overall Study|Refused Treatment|14|||
33679290|NCT00081653|63128198|FG000|Overall Study|Low bone mineral density|1|||
33679291|NCT00081653|63128199|FG001|Overall Study|Low bone mineral density|0|||
33679292|NCT00081653|63128198|FG000|Overall Study|Bone loss|2|||
33679293|NCT00081653|63128199|FG001|Overall Study|Bone loss|0|||
33679294|NCT00081653|63128198|FG000|Overall Study|Participant leaving country|1|||
33679295|NCT00081653|63128199|FG001|Overall Study|Participant leaving country|0|||
33679296|NCT00081653|63128198|FG000|Overall Study|Loss of bone mass|0|||
33679297|NCT00081653|63128199|FG001|Overall Study|Loss of bone mass|2|||
33679298|NCT02596620|63128269|FG000|Overall Study|Lost to Follow-up|1|||
33679299|NCT02596620|63128270|FG001|Overall Study|Lost to Follow-up|1|||
33679300|NCT02596230|63128426|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
33679301|NCT02596230|63128427|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
33679302|NCT02596230|63128428|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
33679303|NCT02596230|63128429|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
33679304|NCT02596230|63128430|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
33679305|NCT02596230|63128426|FG000|Objective 2, One Year|Lost to Follow-up|0|||
33679306|NCT02596230|63128427|FG001|Objective 2, One Year|Lost to Follow-up|41|||
33679307|NCT02596230|63128428|FG002|Objective 2, One Year|Lost to Follow-up|41|||
33679308|NCT02596230|63128429|FG003|Objective 2, One Year|Lost to Follow-up|32|||
33679309|NCT02596230|63128430|FG004|Objective 2, One Year|Lost to Follow-up|46|||
33679310|NCT02596230|63128426|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
33679311|NCT02596230|63128427|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
33679312|NCT02596230|63128428|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
33679313|NCT02596230|63128429|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
33679314|NCT02596230|63128430|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
33679315|NCT02596230|63128426|FG000|Objective 2, One Year|Adverse drug reaction|0|||
33679316|NCT02596230|63128427|FG001|Objective 2, One Year|Adverse drug reaction|1|||
33679317|NCT02596230|63128428|FG002|Objective 2, One Year|Adverse drug reaction|0|||
33679318|NCT02596230|63128429|FG003|Objective 2, One Year|Adverse drug reaction|0|||
33679319|NCT02596230|63128430|FG004|Objective 2, One Year|Adverse drug reaction|0|||
33679320|NCT02596230|63128426|FG000|Objective 2, One Year|Death|0|||
33679321|NCT02596230|63128427|FG001|Objective 2, One Year|Death|12|||
33679322|NCT02596230|63128428|FG002|Objective 2, One Year|Death|41|||
33679323|NCT02596230|63128429|FG003|Objective 2, One Year|Death|21|||
33679324|NCT02596230|63128430|FG004|Objective 2, One Year|Death|30|||
33679325|NCT02596230|63128426|FG000|Objective 2, One Year|Other|0|||
33679326|NCT02596230|63128427|FG001|Objective 2, One Year|Other|3|||
33679327|NCT02596230|63128428|FG002|Objective 2, One Year|Other|2|||
33679328|NCT02596230|63128429|FG003|Objective 2, One Year|Other|0|||
33679329|NCT02596230|63128430|FG004|Objective 2, One Year|Other|0|||
33679330|NCT01667562|63128479|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
33679331|NCT01667562|63128480|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
33679332|NCT01667562|63128479|FG000|Erlotinib Phase|Lost to Follow-up|0|||
33679333|NCT01667562|63128480|FG001|Erlotinib Phase|Lost to Follow-up|1|||
33679334|NCT01667562|63128479|FG000|Erlotinib Phase|Adverse Event|0|||
33679335|NCT01667562|63128480|FG001|Erlotinib Phase|Adverse Event|1|||
33679336|NCT01667562|63128479|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
33679337|NCT01667562|63128480|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
33679338|NCT02595528|63128517|FG000|Overall Study|Withdrawal by Subject|1|||
33679339|NCT02595528|63128518|FG001|Overall Study|Withdrawal by Subject|2|||
33679340|NCT02595528|63128519|FG002|Overall Study|Withdrawal by Subject|1|||
33679341|NCT02595528|63128520|FG003|Overall Study|Withdrawal by Subject|3|||
33679342|NCT02595528|63128517|FG000|Overall Study|Lost to Follow-up|1|||
33679343|NCT02595528|63128518|FG001|Overall Study|Lost to Follow-up|1|||
33679344|NCT02595528|63128519|FG002|Overall Study|Lost to Follow-up|0|||
33679345|NCT02595528|63128520|FG003|Overall Study|Lost to Follow-up|1|||
33584578|NCT02614261|62982573|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
33584579|NCT02614261|62982574|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
33679346|NCT02595450|63128548|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
33679347|NCT02595450|63128548|FG000|Overall Study|Enrolled, but not treated|8|||
33679348|NCT02592018|63128552|FG000|Overall Study|Adverse Event|1|||
33679349|NCT02592018|63128552|FG000|Overall Study|Lost to Follow-up|1|||
33679350|NCT02591238|63128560|FG000|Overall Study|Pregnancy|1|||
33679351|NCT02591238|63128561|FG001|Overall Study|Pregnancy|0|||
33679352|NCT02591238|63128562|FG002|Overall Study|Pregnancy|0|||
33679353|NCT02591238|63128563|FG003|Overall Study|Pregnancy|0|||
33679354|NCT02591238|63128560|FG000|Overall Study|Withdrawal by Subject|0|||
33679355|NCT02591238|63128561|FG001|Overall Study|Withdrawal by Subject|0|||
33679356|NCT02591238|63128562|FG002|Overall Study|Withdrawal by Subject|0|||
33679357|NCT02591238|63128563|FG003|Overall Study|Withdrawal by Subject|1|||
33679358|NCT02591238|63128560|FG000|Overall Study|influenza|0|||
33679359|NCT02591238|63128561|FG001|Overall Study|influenza|0|||
33679360|NCT02591238|63128562|FG002|Overall Study|influenza|0|||
33679361|NCT02591238|63128563|FG003|Overall Study|influenza|1|||
33679362|NCT02591238|63128560|FG000|Overall Study|personal circumstances|0|||
33679363|NCT02591238|63128561|FG001|Overall Study|personal circumstances|0|||
33679364|NCT02591238|63128562|FG002|Overall Study|personal circumstances|0|||
33679365|NCT02591238|63128563|FG003|Overall Study|personal circumstances|1|||
33679366|NCT02591238|63128560|FG000|Overall Study|personal circumstances|0|||
33679367|NCT02591238|63128561|FG001|Overall Study|personal circumstances|1|||
33679368|NCT02591238|63128562|FG002|Overall Study|personal circumstances|0|||
33679369|NCT02591238|63128563|FG003|Overall Study|personal circumstances|0|||
33679370|NCT02597946|63128645|FG000|Overall Study|Withdrawal by Subject|1|||
33679371|NCT02597946|63128645|FG000|Overall Study|Progressive disease|16|||
33679372|NCT02597946|63128645|FG000|Overall Study|Other than above|1|||
33679373|NCT02597712|63128651|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
33679374|NCT02597712|63128652|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
33679375|NCT02597712|63128651|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
33679376|NCT02597712|63128652|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
33679377|NCT02597712|63128651|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
33679378|NCT02597712|63128652|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
33679379|NCT02597478|63128660|FG000|Overall Study|Withdrawal by Subject|2|||
33679380|NCT02597478|63128661|FG001|Overall Study|Withdrawal by Subject|0|||
33679381|NCT02597478|63128660|FG000|Overall Study|Change of opioid dose|1|||
33679382|NCT02597478|63128661|FG001|Overall Study|Change of opioid dose|0|||
33679383|NCT02597478|63128660|FG000|Overall Study|Insufficient exertional dyspnea|0|||
33679384|NCT02597478|63128661|FG001|Overall Study|Insufficient exertional dyspnea|1|||
33679385|NCT01471028|63128756|FG000|VTI-208|Adverse Event|39|||
33679386|NCT01471028|63128757|FG001|VTI-208|Adverse Event|41|||
33679387|NCT01471028|63128756|FG000|VTI-208|Withdrawal by Subject|0|||
33679388|NCT01471028|63128757|FG001|VTI-208|Withdrawal by Subject|2|||
33679389|NCT01471028|63128756|FG000|VTI-208|Lost to Follow-up|1|||
33679390|NCT01471028|63128757|FG001|VTI-208|Lost to Follow-up|1|||
33679391|NCT01471028|63128756|FG000|VTI-208E|Death|7|||
33679392|NCT01471028|63128757|FG001|VTI-208E|Death|10|||
33679393|NCT01471028|63128756|FG000|VTI-208E|Withdrawal by Subject|1|||
33679394|NCT01471028|63128757|FG001|VTI-208E|Withdrawal by Subject|0|||
33679395|NCT01471028|63128756|FG000|VTI-208E|Lost to Follow-up|0|||
33679396|NCT01471028|63128757|FG001|VTI-208E|Lost to Follow-up|2|||
33679397|NCT01491854|63128771|FG000|Overall Study|mainly due to premature termination|93|||
33679398|NCT01491854|63128771|FG000|Overall Study|Death|1|||
33679399|NCT01491854|63128771|FG000|Overall Study|Withdrawal by Subject|3|||
33679400|NCT01491854|63128771|FG000|Overall Study|Lost to Follow-up|33|||
33679401|NCT01470248|63128779|FG000|Overall Study|Withdrawal by Subject|1|||
33679402|NCT01490918|63128799|FG000|Overall Study|Lost to Follow-up|2|||
33679403|NCT01490918|63128800|FG001|Overall Study|Lost to Follow-up|1|||
33679404|NCT01490918|63128801|FG002|Overall Study|Lost to Follow-up|0|||
33679405|NCT01490918|63128799|FG000|Overall Study|Withdrawal by Subject|7|||
33679406|NCT01490918|63128800|FG001|Overall Study|Withdrawal by Subject|8|||
33679407|NCT01490918|63128801|FG002|Overall Study|Withdrawal by Subject|3|||
33679408|NCT01490918|63128799|FG000|Overall Study|Adverse Event|0|||
33679409|NCT01490918|63128800|FG001|Overall Study|Adverse Event|0|||
33679410|NCT01490918|63128801|FG002|Overall Study|Adverse Event|1|||
33679411|NCT01490918|63128799|FG000|Overall Study|other cause|4|||
33679412|NCT01490918|63128800|FG001|Overall Study|other cause|5|||
33679413|NCT01490918|63128801|FG002|Overall Study|other cause|8|||
33679414|NCT01490840|63128833|FG000|Phase 1|Lost to Follow-up|1|||
33679415|NCT01490840|63128834|FG001|Phase 1|Lost to Follow-up|0|||
33679416|NCT01490840|63128833|FG000|Phase 1|Adverse Event|2|||
33679417|NCT01490840|63128834|FG001|Phase 1|Adverse Event|1|||
33679418|NCT01490840|63128833|FG000|Phase 1|Withdrawal by Subject|6|||
33679419|NCT01490840|63128834|FG001|Phase 1|Withdrawal by Subject|5|||
33679420|NCT01490840|63128833|FG000|Phase 1|Visit 6a omitted|1|||
33679421|NCT01490840|63128834|FG001|Phase 1|Visit 6a omitted|0|||
33679422|NCT01490840|63128833|FG000|Phase 2|Withdrawal by Subject|4|||
33679423|NCT01490840|63128834|FG001|Phase 2|Withdrawal by Subject|3|||
33679424|NCT01490840|63128833|FG000|Phase 2|Permanent interruption of fingolimod|0|||
33679425|NCT01490840|63128834|FG001|Phase 2|Permanent interruption of fingolimod|1|||
33679426|NCT01490840|63128833|FG000|Phase 2|Lost to Follow-up|1|||
33679427|NCT01490840|63128834|FG001|Phase 2|Lost to Follow-up|1|||
33679428|NCT01490840|63128833|FG000|Phase 2|Adverse Event|1|||
33679429|NCT01490840|63128834|FG001|Phase 2|Adverse Event|1|||
33679430|NCT01490450|63128866|FG000|Period 1|Lack of Efficacy|2|||
33679431|NCT01490450|63128867|FG001|Period 1|Lack of Efficacy|0|||
33679432|NCT01490450|63128868|FG002|Period 1|Lack of Efficacy|3|||
33679433|NCT01490450|63128869|FG003|Period 1|Lack of Efficacy|0|||
33679434|NCT01490450|63128866|FG000|Period 1|Adverse Event|0|||
33679435|NCT01490450|63128867|FG001|Period 1|Adverse Event|0|||
33679436|NCT01490450|63128868|FG002|Period 1|Adverse Event|0|||
33679437|NCT01490450|63128869|FG003|Period 1|Adverse Event|5|||
33679438|NCT01490450|63128866|FG000|Period 1|Request to discontinue treatment|1|||
33679439|NCT01490450|63128867|FG001|Period 1|Request to discontinue treatment|0|||
33679440|NCT01490450|63128868|FG002|Period 1|Request to discontinue treatment|0|||
33679441|NCT01490450|63128869|FG003|Period 1|Request to discontinue treatment|0|||
33679442|NCT01490450|63128866|FG000|Period 1|Withdrawal by Subject|0|||
33679443|NCT01490450|63128867|FG001|Period 1|Withdrawal by Subject|0|||
33679444|NCT01490450|63128868|FG002|Period 1|Withdrawal by Subject|0|||
33679445|NCT01490450|63128869|FG003|Period 1|Withdrawal by Subject|3|||
33679446|NCT01490450|63128866|FG000|Period 1|No longer met study criteria|0|||
33679447|NCT01490450|63128867|FG001|Period 1|No longer met study criteria|1|||
33679448|NCT01490450|63128868|FG002|Period 1|No longer met study criteria|1|||
33679449|NCT01490450|63128869|FG003|Period 1|No longer met study criteria|0|||
33679450|NCT01490450|63128866|FG000|Period 2|Lack of Efficacy|0|||
33679451|NCT01490450|63128867|FG001|Period 2|Lack of Efficacy|0|||
33679452|NCT01490450|63128868|FG002|Period 2|Lack of Efficacy|0|||
33679453|NCT01490450|63128869|FG003|Period 2|Lack of Efficacy|1|||
33679454|NCT01490450|63128866|FG000|Period 2|Adverse Event|1|||
33679455|NCT01490450|63128867|FG001|Period 2|Adverse Event|1|||
33679456|NCT01490450|63128868|FG002|Period 2|Adverse Event|0|||
33679457|NCT01490450|63128869|FG003|Period 2|Adverse Event|1|||
33679458|NCT01490450|63128866|FG000|Period 2|Withdrawal by Subject|1|||
33679459|NCT01490450|63128867|FG001|Period 2|Withdrawal by Subject|0|||
33679460|NCT01490450|63128868|FG002|Period 2|Withdrawal by Subject|0|||
33679461|NCT01490450|63128869|FG003|Period 2|Withdrawal by Subject|0|||
33679462|NCT01490450|63128866|FG000|Period 2|Lost to Follow-up|0|||
33679463|NCT01490450|63128867|FG001|Period 2|Lost to Follow-up|0|||
33679464|NCT01490450|63128868|FG002|Period 2|Lost to Follow-up|0|||
33679465|NCT01490450|63128869|FG003|Period 2|Lost to Follow-up|2|||
33679466|NCT01469546|63128913|FG000|Received 5 mg Dose|Adverse Event|13|||
33679467|NCT01469546|63128913|FG000|Received 5 mg Dose|Death|2|||
33679468|NCT01469546|63128913|FG000|Received 5 mg Dose|Protocol Violation|2|||
33679469|NCT01469546|63128913|FG000|Received 5 mg Dose|Progressive Disease|3|||
33679470|NCT01469546|63128913|FG000|Received 5 mg Dose|Physician Decision|3|||
33679471|NCT00081497|63128919|FG000|Overall Study|Adverse Event|2|||
33679472|NCT00081497|63128920|FG001|Overall Study|Adverse Event|0|||
33679473|NCT00081497|63128919|FG000|Overall Study|Death|0|||
33679474|NCT00081497|63128920|FG001|Overall Study|Death|1|||
33679475|NCT00081497|63128919|FG000|Overall Study|Withdrawal by Subject|1|||
33679476|NCT00081497|63128920|FG001|Overall Study|Withdrawal by Subject|0|||
33584580|NCT02614261|62982575|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
33584581|NCT02614261|62982572|FG000|Open-Label Extension Phase|Adverse Event|23|||
33584582|NCT02614261|62982573|FG001|Open-Label Extension Phase|Adverse Event|12|||
33584583|NCT02614261|62982574|FG002|Open-Label Extension Phase|Adverse Event|11|||
33584584|NCT02614261|62982575|FG003|Open-Label Extension Phase|Adverse Event|0|||
33584585|NCT02614261|62982572|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
33584586|NCT02614261|62982573|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
33584587|NCT02614261|62982574|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
33584588|NCT02614261|62982575|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
33584589|NCT02614261|62982572|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
33584590|NCT02614261|62982573|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
33584591|NCT02614261|62982574|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
33584592|NCT02614261|62982575|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
33584593|NCT02614261|62982572|FG000|Open-Label Extension Phase|Physician Decision|2|||
33584594|NCT02614261|62982573|FG001|Open-Label Extension Phase|Physician Decision|0|||
33584595|NCT02614261|62982574|FG002|Open-Label Extension Phase|Physician Decision|0|||
33679477|NCT00081497|63128919|FG000|Overall Study|Non-compliance|0|||
33679478|NCT00081497|63128920|FG001|Overall Study|Non-compliance|1|||
33679479|NCT00081263|63128934|FG000|Overall Study|clerical error|1|||
33679480|NCT00081263|63128935|FG001|Overall Study|clerical error|0|||
33679481|NCT00081263|63128934|FG000|Overall Study|wrong cell type|7|||
33679482|NCT00081263|63128935|FG001|Overall Study|wrong cell type|5|||
33679483|NCT00081263|63128934|FG000|Overall Study|improper pre-protocol therapy|0|||
33679484|NCT00081263|63128935|FG001|Overall Study|improper pre-protocol therapy|1|||
33679485|NCT00081263|63128934|FG000|Overall Study|Inadequate pathology|0|||
33679486|NCT00081263|63128935|FG001|Overall Study|Inadequate pathology|1|||
33679487|NCT00081263|63128934|FG000|Overall Study|Never treated|4|||
33584596|NCT02614261|62982575|FG003|Open-Label Extension Phase|Physician Decision|0|||
33584597|NCT02614261|62982572|FG000|Open-Label Extension Phase|Pregnancy|1|||
33584598|NCT02614261|62982573|FG001|Open-Label Extension Phase|Pregnancy|2|||
33679488|NCT00081263|63128935|FG001|Overall Study|Never treated|5|||
33679489|NCT00081263|63128934|FG000|Overall Study|Inadequate data|5|||
33679490|NCT00081263|63128935|FG001|Overall Study|Inadequate data|10|||
33679491|NCT01490294|63128945|FG000|Overall Study|Prematurely discontinuation|4|||
33584599|NCT02614261|62982574|FG002|Open-Label Extension Phase|Pregnancy|1|||
33584600|NCT02614261|62982575|FG003|Open-Label Extension Phase|Pregnancy|0|||
33584601|NCT02614261|62982572|FG000|Open-Label Extension Phase|Protocol Violation|3|||
33584602|NCT02614261|62982573|FG001|Open-Label Extension Phase|Protocol Violation|4|||
33584603|NCT02614261|62982574|FG002|Open-Label Extension Phase|Protocol Violation|1|||
33584604|NCT02614261|62982575|FG003|Open-Label Extension Phase|Protocol Violation|0|||
33584605|NCT02614261|62982572|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
33584606|NCT02614261|62982573|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
33584607|NCT02614261|62982574|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
33584608|NCT02614261|62982575|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
33584609|NCT02614261|62982572|FG000|Follow-up Phase|Adverse Event|2|||
33584610|NCT02614261|62982573|FG001|Follow-up Phase|Adverse Event|0|||
33584611|NCT02614261|62982574|FG002|Follow-up Phase|Adverse Event|1|||
33584612|NCT02614261|62982575|FG003|Follow-up Phase|Adverse Event|0|||
33584613|NCT02614261|62982572|FG000|Follow-up Phase|Lost to Follow-up|12|||
33584614|NCT02614261|62982573|FG001|Follow-up Phase|Lost to Follow-up|5|||
33584615|NCT02614261|62982574|FG002|Follow-up Phase|Lost to Follow-up|2|||
33679492|NCT01490294|63128946|FG001|Overall Study|Prematurely discontinuation|0|||
33679493|NCT01490294|63128947|FG002|Overall Study|Prematurely discontinuation|1|||
33679494|NCT01490294|63128948|FG003|Overall Study|Prematurely discontinuation|1|||
33679495|NCT01490294|63128945|FG000|Overall Study|Adverse Event|1|||
33679496|NCT01490294|63128946|FG001|Overall Study|Adverse Event|0|||
33679497|NCT01490294|63128947|FG002|Overall Study|Adverse Event|0|||
33679498|NCT01490294|63128948|FG003|Overall Study|Adverse Event|0|||
33679499|NCT00080483|63128975|FG000|Overall Study|Lost to Follow-up|1|||
33679500|NCT00080483|63128976|FG001|Overall Study|Lost to Follow-up|1|||
33679501|NCT00080483|63128975|FG000|Overall Study|Physician Decision|1|||
33679502|NCT00080483|63128976|FG001|Overall Study|Physician Decision|1|||
33679503|NCT00089141|63128997|FG000|Overall Study|Termination of trial|18|||
33679504|NCT00089141|63128998|FG001|Overall Study|Termination of trial|24|||
33679505|NCT02588664|63129044|FG000|Overall Study|Death|56|||
33679506|NCT02588664|63129045|FG001|Overall Study|Death|55|||
33679507|NCT02588664|63129044|FG000|Overall Study|Lost to Follow-up|1305|||
33679508|NCT02588664|63129045|FG001|Overall Study|Lost to Follow-up|990|||
33679509|NCT00083759|63129108|FG000|Overall Study|Adverse Event|5|||
33679510|NCT00083759|63129109|FG001|Overall Study|Adverse Event|3|||
33679511|NCT00083759|63129108|FG000|Overall Study|Lost to Follow-up|1|||
33679512|NCT00083759|63129109|FG001|Overall Study|Lost to Follow-up|0|||
33679513|NCT00083759|63129108|FG000|Overall Study|Death|1|||
33679514|NCT00083759|63129109|FG001|Overall Study|Death|1|||
33679515|NCT00083759|63129108|FG000|Overall Study|Inadequate Therapeutic Response|32|||
33679516|NCT00083759|63129109|FG001|Overall Study|Inadequate Therapeutic Response|35|||
33679517|NCT00083759|63129108|FG000|Overall Study|Subject Withdrew Consent|2|||
33679518|NCT00083759|63129109|FG001|Overall Study|Subject Withdrew Consent|2|||
33679519|NCT00083759|63129108|FG000|Overall Study|Non-Compliance|1|||
33679520|NCT00083759|63129109|FG001|Overall Study|Non-Compliance|0|||
33679521|NCT00083759|63129108|FG000|Overall Study|Sponsor's Discretion|28|||
33679522|NCT00083759|63129109|FG001|Overall Study|Sponsor's Discretion|29|||
33679523|NCT00083759|63129108|FG000|Overall Study|Other|14|||
33679524|NCT00083759|63129109|FG001|Overall Study|Other|13|||
33679525|NCT00089609|63129235|FG000|Overall Study|Withdrawal by Subject|3|||
33679526|NCT00089609|63129236|FG001|Overall Study|Withdrawal by Subject|1|||
33679527|NCT02440581|63129377|FG000|Overall Study|Death|0|||
33679528|NCT02440581|63129378|FG001|Overall Study|Death|0|||
33679529|NCT02440581|63129379|FG002|Overall Study|Death|7|||
33679530|NCT02440581|63129380|FG003|Overall Study|Death|5|||
33679531|NCT02440581|63129377|FG000|Overall Study|Transplanted|1|||
33679532|NCT02440581|63129378|FG001|Overall Study|Transplanted|0|||
33679533|NCT02440581|63129379|FG002|Overall Study|Transplanted|3|||
33679534|NCT02440581|63129380|FG003|Overall Study|Transplanted|2|||
33584616|NCT02614261|62982575|FG003|Follow-up Phase|Lost to Follow-up|0|||
33584617|NCT02614261|62982572|FG000|Follow-up Phase|Physician Decision|5|||
33584618|NCT02614261|62982573|FG001|Follow-up Phase|Physician Decision|1|||
33584619|NCT02614261|62982574|FG002|Follow-up Phase|Physician Decision|0|||
33584620|NCT02614261|62982575|FG003|Follow-up Phase|Physician Decision|0|||
33584621|NCT02614261|62982572|FG000|Follow-up Phase|Pregnancy|0|||
33584622|NCT02614261|62982573|FG001|Follow-up Phase|Pregnancy|1|||
33584623|NCT02614261|62982574|FG002|Follow-up Phase|Pregnancy|0|||
33584624|NCT02614261|62982575|FG003|Follow-up Phase|Pregnancy|0|||
33679535|NCT02440581|63129377|FG000|Overall Study|Withdrawal by Subject|4|||
33679536|NCT02440581|63129378|FG001|Overall Study|Withdrawal by Subject|11|||
33679537|NCT02440581|63129379|FG002|Overall Study|Withdrawal by Subject|3|||
33679538|NCT02440581|63129380|FG003|Overall Study|Withdrawal by Subject|7|||
33679539|NCT01359150|63129392|FG000|Overall Study|Lack of Efficacy|1|||
33679540|NCT01359150|63129393|FG001|Overall Study|Lack of Efficacy|1|||
33679541|NCT01359150|63129392|FG000|Overall Study|Withdrawal by Subject|1|||
33679542|NCT01359150|63129393|FG001|Overall Study|Withdrawal by Subject|1|||
33584625|NCT02614261|62982572|FG000|Follow-up Phase|Protocol Violation|1|||
33584626|NCT02614261|62982573|FG001|Follow-up Phase|Protocol Violation|0|||
33584627|NCT02614261|62982574|FG002|Follow-up Phase|Protocol Violation|0|||
33584628|NCT02614261|62982575|FG003|Follow-up Phase|Protocol Violation|0|||
33584629|NCT02614261|62982572|FG000|Follow-up Phase|Withdrawal by Subject|12|||
33584630|NCT02614261|62982573|FG001|Follow-up Phase|Withdrawal by Subject|4|||
33584631|NCT02614261|62982574|FG002|Follow-up Phase|Withdrawal by Subject|11|||
33584632|NCT02614261|62982575|FG003|Follow-up Phase|Withdrawal by Subject|0|||
33584633|NCT02614261|62982572|FG000|Israel Addendum|Withdrawal by Subject|0|||
33584634|NCT02614261|62982573|FG001|Israel Addendum|Withdrawal by Subject|0|||
33584635|NCT02614261|62982574|FG002|Israel Addendum|Withdrawal by Subject|0|||
33584636|NCT02614261|62982575|FG003|Israel Addendum|Withdrawal by Subject|4|||
33584637|NCT01594411|62982601|FG000|Overall Study|Lost to Follow-up|2|||
33584638|NCT01594333|62982610|FG000|Overall Study|Death|96|||
33584639|NCT01594333|62982611|FG001|Overall Study|Death|83|||
33584640|NCT01594333|62982610|FG000|Overall Study|Lost to Follow-up|5|||
33584641|NCT01594333|62982611|FG001|Overall Study|Lost to Follow-up|5|||
33584642|NCT01594333|62982610|FG000|Overall Study|Withdrawal by Subject|60|||
33584643|NCT01594333|62982611|FG001|Overall Study|Withdrawal by Subject|63|||
33584644|NCT02609659|62982617|FG000|Overall Study|Adverse Event|1|||
33584645|NCT02609659|62982617|FG000|Overall Study|Lost to Follow-up|6|||
33584646|NCT02609659|62982617|FG000|Overall Study|Other|1|||
33584647|NCT02612779|62982623|FG000|Overall Study|Administrative reason by sponsor|4|||
33584648|NCT02612779|62982624|FG001|Overall Study|Administrative reason by sponsor|1|||
33584649|NCT02612779|62982623|FG000|Overall Study|No longer meet study criteria|0|||
33584650|NCT02612779|62982624|FG001|Overall Study|No longer meet study criteria|1|||
33584651|NCT02612779|62982623|FG000|Overall Study|Disease progression|29|||
33584652|NCT02612779|62982624|FG001|Overall Study|Disease progression|2|||
33584653|NCT02612779|62982623|FG000|Overall Study|Study drug toxicity|10|||
33584654|NCT02612779|62982624|FG001|Overall Study|Study drug toxicity|1|||
33584655|NCT02612779|62982623|FG000|Overall Study|Death|1|||
33584656|NCT02612779|62982624|FG001|Overall Study|Death|0|||
33584657|NCT02612779|62982623|FG000|Overall Study|Adverse event unrelated to study drug|5|||
33584658|NCT02612779|62982624|FG001|Overall Study|Adverse event unrelated to study drug|0|||
33584659|NCT02612779|62982623|FG000|Overall Study|Participant withdrew consent|4|||
33584660|NCT02612779|62982624|FG001|Overall Study|Participant withdrew consent|0|||
33584661|NCT02612779|62982623|FG000|Overall Study|Lost to Follow-up|1|||
33584662|NCT02612779|62982624|FG001|Overall Study|Lost to Follow-up|0|||
33584663|NCT02612779|62982623|FG000|Overall Study|Maximum clinical benefit|10|||
33584664|NCT02612779|62982624|FG001|Overall Study|Maximum clinical benefit|1|||
33584665|NCT02612779|62982623|FG000|Overall Study|Other reasons|4|||
33584666|NCT02612779|62982624|FG001|Overall Study|Other reasons|0|||
33584667|NCT02612623|62982635|FG000|Overall Study|Withdrawal by Subject|0|||
33584668|NCT02612623|62982636|FG001|Overall Study|Withdrawal by Subject|1|||
33584669|NCT02612623|62982637|FG002|Overall Study|Withdrawal by Subject|0|||
33584670|NCT02612623|62982638|FG003|Overall Study|Withdrawal by Subject|0|||
33584671|NCT02612623|62982635|FG000|Overall Study|Adverse Event|1|||
33584672|NCT02612623|62982636|FG001|Overall Study|Adverse Event|0|||
33584673|NCT02612623|62982637|FG002|Overall Study|Adverse Event|1|||
33584674|NCT02612623|62982638|FG003|Overall Study|Adverse Event|0|||
33584675|NCT02607865|62982652|FG000|Overall Study|Lost to Follow-up|9|||
33584676|NCT02607865|62982653|FG001|Overall Study|Lost to Follow-up|7|||
33584677|NCT02607865|62982654|FG002|Overall Study|Lost to Follow-up|7|||
33584678|NCT02607865|62982655|FG003|Overall Study|Lost to Follow-up|5|||
33584679|NCT02607865|62982652|FG000|Overall Study|Withdrawal by Subject|18|||
33584680|NCT02607865|62982653|FG001|Overall Study|Withdrawal by Subject|18|||
33584681|NCT02607865|62982654|FG002|Overall Study|Withdrawal by Subject|17|||
33584682|NCT02607865|62982655|FG003|Overall Study|Withdrawal by Subject|8|||
33584683|NCT02607865|62982652|FG000|Overall Study|Death|5|||
33584684|NCT02607865|62982653|FG001|Overall Study|Death|4|||
33584685|NCT02607865|62982654|FG002|Overall Study|Death|1|||
33584686|NCT02607865|62982655|FG003|Overall Study|Death|3|||
33584687|NCT02607865|62982652|FG000|Overall Study|Unclassified|1|||
33584688|NCT02607865|62982653|FG001|Overall Study|Unclassified|1|||
33584689|NCT02607865|62982654|FG002|Overall Study|Unclassified|2|||
33584690|NCT02607865|62982655|FG003|Overall Study|Unclassified|0|||
33584691|NCT01668667|62982669|FG000|Overall Study|Adverse Event|3|||
33584692|NCT01668667|62982670|FG001|Overall Study|Adverse Event|6|||
33584693|NCT01668667|62982671|FG002|Overall Study|Adverse Event|4|||
33584694|NCT01668667|62982672|FG003|Overall Study|Adverse Event|4|||
33584695|NCT01668667|62982669|FG000|Overall Study|Lack of Efficacy|3|||
33584696|NCT01668667|62982670|FG001|Overall Study|Lack of Efficacy|2|||
33584697|NCT01668667|62982671|FG002|Overall Study|Lack of Efficacy|2|||
33584698|NCT01668667|62982672|FG003|Overall Study|Lack of Efficacy|3|||
33584699|NCT01668667|62982669|FG000|Overall Study|Protocol Violation|6|||
33584700|NCT01668667|62982670|FG001|Overall Study|Protocol Violation|10|||
33584701|NCT01668667|62982671|FG002|Overall Study|Protocol Violation|12|||
33584702|NCT01668667|62982672|FG003|Overall Study|Protocol Violation|5|||
33584703|NCT01668667|62982669|FG000|Overall Study|Lost to Follow-up|9|||
33584704|NCT01668667|62982670|FG001|Overall Study|Lost to Follow-up|4|||
33584705|NCT01668667|62982671|FG002|Overall Study|Lost to Follow-up|7|||
33584706|NCT01668667|62982672|FG003|Overall Study|Lost to Follow-up|6|||
33584707|NCT01668667|62982669|FG000|Overall Study|Physician Decision|3|||
33584708|NCT01668667|62982670|FG001|Overall Study|Physician Decision|0|||
33584709|NCT01668667|62982671|FG002|Overall Study|Physician Decision|1|||
33679543|NCT01359150|63129392|FG000|Overall Study|Adverse Event|4|||
33584710|NCT01668667|62982672|FG003|Overall Study|Physician Decision|0|||
33584711|NCT01668667|62982669|FG000|Overall Study|Withdrawal by Subject|7|||
33584712|NCT01668667|62982670|FG001|Overall Study|Withdrawal by Subject|4|||
33584713|NCT01668667|62982671|FG002|Overall Study|Withdrawal by Subject|5|||
33584714|NCT01668667|62982672|FG003|Overall Study|Withdrawal by Subject|5|||
33584715|NCT02608879|62982685|FG000|Overall Study|Lost to Follow-up|1|||
33584716|NCT02608879|62982686|FG001|Overall Study|Lost to Follow-up|0|||
33584717|NCT02608879|62982687|FG002|Overall Study|Lost to Follow-up|0|||
33679544|NCT01359150|63129393|FG001|Overall Study|Adverse Event|3|||
33679545|NCT01359150|63129392|FG000|Overall Study|Other|1|||
33679546|NCT01359150|63129393|FG001|Overall Study|Other|0|||
33679547|NCT01469000|63129454|FG000|Overall Study|Withdrawal by Subject|16|||
33679548|NCT01469000|63129455|FG001|Overall Study|Withdrawal by Subject|3|||
33679549|NCT01469000|63129454|FG000|Overall Study|Sponsor Decision|4|||
33584718|NCT02608879|62982685|FG000|Overall Study|Did not meet continuation criteria|0|||
33584719|NCT02608879|62982686|FG001|Overall Study|Did not meet continuation criteria|0|||
33584720|NCT02608879|62982687|FG002|Overall Study|Did not meet continuation criteria|3|||
33584721|NCT02608099|62982697|FG000|Overall Study|Ablation procedure not initiated|3|||
33584722|NCT02608099|62982698|FG001|Overall Study|Ablation procedure not initiated|2|||
33584723|NCT01668589|62982708|FG000|Overall Study|Lost to Follow-up|29|||
33584724|NCT01668589|62982709|FG001|Overall Study|Lost to Follow-up|37|||
33584725|NCT01668589|62982710|FG002|Overall Study|Lost to Follow-up|15|||
33584726|NCT01668589|62982711|FG003|Overall Study|Lost to Follow-up|5|||
33584727|NCT01668589|62982708|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
33584728|NCT01668589|62982709|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
33584729|NCT01668589|62982710|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
33584730|NCT01668589|62982711|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
33584731|NCT01668589|62982708|FG000|Overall Study|Death|12|||
33584732|NCT01668589|62982709|FG001|Overall Study|Death|3|||
33584733|NCT01668589|62982710|FG002|Overall Study|Death|2|||
33584734|NCT01668589|62982711|FG003|Overall Study|Death|11|||
33584735|NCT01668589|62982708|FG000|Overall Study|Other|44|||
33584736|NCT01668589|62982709|FG001|Overall Study|Other|10|||
33584737|NCT01668589|62982710|FG002|Overall Study|Other|7|||
33584738|NCT01668589|62982711|FG003|Overall Study|Other|15|||
33584739|NCT02432235|62982733|FG000|Overall Study|Death|1|||
33584740|NCT02432235|62982734|FG001|Overall Study|Death|1|||
33584741|NCT02432235|62982735|FG002|Overall Study|Death|2|||
33584742|NCT02432235|62982736|FG003|Overall Study|Death|2|||
33584743|NCT02432235|62982737|FG004|Overall Study|Death|1|||
33584744|NCT02432235|62982738|FG005|Overall Study|Death|3|||
33584745|NCT02432235|62982739|FG006|Overall Study|Death|11|||
33584746|NCT02432235|62982740|FG007|Overall Study|Death|15|||
33584747|NCT02432235|62982741|FG008|Overall Study|Death|15|||
33584748|NCT02432235|62982742|FG009|Overall Study|Death|3|||
33584749|NCT02432235|62982743|FG010|Overall Study|Death|1|||
33584750|NCT02432235|62982744|FG011|Overall Study|Death|0|||
33584751|NCT02432235|62982733|FG000|Overall Study|Withdrawal by Subject|0|||
33584752|NCT02432235|62982734|FG001|Overall Study|Withdrawal by Subject|1|||
33584753|NCT02432235|62982735|FG002|Overall Study|Withdrawal by Subject|0|||
33584754|NCT02432235|62982736|FG003|Overall Study|Withdrawal by Subject|0|||
33584755|NCT02432235|62982737|FG004|Overall Study|Withdrawal by Subject|0|||
33584756|NCT02432235|62982738|FG005|Overall Study|Withdrawal by Subject|2|||
33584757|NCT02432235|62982739|FG006|Overall Study|Withdrawal by Subject|5|||
33584758|NCT02432235|62982740|FG007|Overall Study|Withdrawal by Subject|3|||
33584759|NCT02432235|62982741|FG008|Overall Study|Withdrawal by Subject|1|||
33679550|NCT01469000|63129455|FG001|Overall Study|Sponsor Decision|1|||
33679551|NCT01490060|63129468|FG000|Cycle 1|Change of Treatment|0|||
33679552|NCT01490060|63129469|FG001|Cycle 1|Change of Treatment|1|||
33679553|NCT01490060|63129470|FG002|Cycle 1|Change of Treatment|1|||
33310668|NCT01235598|62686080|FG001|Overall Study|Lack of Efficacy|1|||
33584760|NCT02432235|62982742|FG009|Overall Study|Withdrawal by Subject|0|||
33584761|NCT02432235|62982743|FG010|Overall Study|Withdrawal by Subject|0|||
33584762|NCT02432235|62982744|FG011|Overall Study|Withdrawal by Subject|0|||
33584763|NCT02432235|62982733|FG000|Overall Study|Lost to Follow-up|0|||
33584764|NCT02432235|62982734|FG001|Overall Study|Lost to Follow-up|0|||
33584765|NCT02432235|62982735|FG002|Overall Study|Lost to Follow-up|0|||
33584766|NCT02432235|62982736|FG003|Overall Study|Lost to Follow-up|0|||
33584767|NCT02432235|62982737|FG004|Overall Study|Lost to Follow-up|0|||
33679554|NCT01490060|63129471|FG003|Cycle 1|Change of Treatment|1|||
33584768|NCT02432235|62982738|FG005|Overall Study|Lost to Follow-up|1|||
33584769|NCT02432235|62982739|FG006|Overall Study|Lost to Follow-up|0|||
33584770|NCT02432235|62982740|FG007|Overall Study|Lost to Follow-up|0|||
33584771|NCT02432235|62982741|FG008|Overall Study|Lost to Follow-up|1|||
33584772|NCT02432235|62982742|FG009|Overall Study|Lost to Follow-up|0|||
33584773|NCT02432235|62982743|FG010|Overall Study|Lost to Follow-up|0|||
33584774|NCT02432235|62982744|FG011|Overall Study|Lost to Follow-up|0|||
33584775|NCT02432235|62982733|FG000|Overall Study|Miscellaneous|0|||
33584776|NCT02432235|62982734|FG001|Overall Study|Miscellaneous|0|||
33584777|NCT02432235|62982735|FG002|Overall Study|Miscellaneous|0|||
33584778|NCT02432235|62982736|FG003|Overall Study|Miscellaneous|0|||
33584779|NCT02432235|62982737|FG004|Overall Study|Miscellaneous|1|||
33584780|NCT02432235|62982738|FG005|Overall Study|Miscellaneous|6|||
33584781|NCT02432235|62982739|FG006|Overall Study|Miscellaneous|2|||
33584782|NCT02432235|62982740|FG007|Overall Study|Miscellaneous|2|||
33584783|NCT02432235|62982741|FG008|Overall Study|Miscellaneous|4|||
33584784|NCT02432235|62982742|FG009|Overall Study|Miscellaneous|0|||
33584785|NCT02432235|62982743|FG010|Overall Study|Miscellaneous|0|||
33584786|NCT02432235|62982744|FG011|Overall Study|Miscellaneous|1|||
33584787|NCT02431533|62982774|FG000|Overall Study|Withdrawal by Subject|1|||
33584788|NCT02431533|62982775|FG001|Overall Study|Withdrawal by Subject|3|||
33584789|NCT02431533|62982774|FG000|Overall Study|Developed Exclusionary criteria|1|||
33584790|NCT02431533|62982775|FG001|Overall Study|Developed Exclusionary criteria|0|||
33584791|NCT02416791|62982784|FG000|6 Months|Lost to Follow-up|0|||
33584792|NCT02416791|62982785|FG001|6 Months|Lost to Follow-up|0|||
33584793|NCT02416791|62982786|FG002|6 Months|Lost to Follow-up|1|||
33584794|NCT02414841|62982796|FG000|Overall Study|Withdrawal by Subject|7|||
33584795|NCT02414841|62982797|FG001|Overall Study|Withdrawal by Subject|5|||
33584796|NCT02414841|62982796|FG000|Overall Study|Lost to Follow-up|13|||
33584797|NCT02414841|62982797|FG001|Overall Study|Lost to Follow-up|6|||
33584798|NCT02414841|62982796|FG000|Overall Study|Death|17|||
33584799|NCT02414841|62982797|FG001|Overall Study|Death|14|||
33584800|NCT02414841|62982796|FG000|Overall Study|Received a Kidney Transplant|13|||
33584801|NCT02414841|62982797|FG001|Overall Study|Received a Kidney Transplant|4|||
33584802|NCT02414841|62982796|FG000|Overall Study|Randomized But Not Treated|6|||
33584803|NCT02414841|62982797|FG001|Overall Study|Randomized But Not Treated|4|||
33584804|NCT02413593|62982805|FG000|Overall Study|Lost to Follow-up|3|||
33584805|NCT02413593|62982805|FG000|Overall Study|Adverse Event|1|||
33584806|NCT01652703|62982815|FG000|Overall Study|Withdrawal by Subject|0|||
33584807|NCT01652703|62982816|FG001|Overall Study|Withdrawal by Subject|1|||
33584808|NCT01652703|62982817|FG002|Overall Study|Withdrawal by Subject|3|||
33584809|NCT01652703|62982818|FG003|Overall Study|Withdrawal by Subject|1|||
33584810|NCT01652703|62982819|FG004|Overall Study|Withdrawal by Subject|0|||
33584811|NCT01652703|62982820|FG005|Overall Study|Withdrawal by Subject|1|||
33584812|NCT01652703|62982815|FG000|Overall Study|Other|0|||
33584813|NCT01652703|62982816|FG001|Overall Study|Other|0|||
33584814|NCT01652703|62982817|FG002|Overall Study|Other|0|||
33584815|NCT01652703|62982818|FG003|Overall Study|Other|1|||
33584816|NCT01652703|62982819|FG004|Overall Study|Other|1|||
33584817|NCT01652703|62982820|FG005|Overall Study|Other|1|||
33584818|NCT01652469|62982836|FG000|Overall Study|Withdrawal by Subject|1|||
33584819|NCT01652469|62982837|FG001|Overall Study|Withdrawal by Subject|4|||
33584820|NCT01652469|62982836|FG000|Overall Study|Lost to Follow-up|0|||
33584821|NCT01652469|62982837|FG001|Overall Study|Lost to Follow-up|2|||
33584822|NCT02429427|62982845|FG000|Overall Study|Adverse Event|220|||
33584823|NCT02429427|62982846|FG001|Overall Study|Adverse Event|92|||
33679555|NCT01490060|63129468|FG000|Cycle 1|Insurance Denied|0|||
33679556|NCT01490060|63129469|FG001|Cycle 1|Insurance Denied|0|||
33679557|NCT01490060|63129470|FG002|Cycle 1|Insurance Denied|2|||
33679558|NCT01490060|63129471|FG003|Cycle 1|Insurance Denied|0|||
33584824|NCT02429427|62982845|FG000|Overall Study|Protocol Violation|10|||
33584825|NCT02429427|62982846|FG001|Overall Study|Protocol Violation|6|||
33584826|NCT02429427|62982845|FG000|Overall Study|Lost to Follow-up|15|||
33584827|NCT02429427|62982846|FG001|Overall Study|Lost to Follow-up|6|||
33584828|NCT02429427|62982845|FG000|Overall Study|Withdrawal by Subject|64|||
33584829|NCT02429427|62982846|FG001|Overall Study|Withdrawal by Subject|34|||
33584830|NCT02429427|62982845|FG000|Overall Study|Other|62|||
33584831|NCT02429427|62982846|FG001|Overall Study|Other|41|||
33584832|NCT02412735|62982855|FG000|Overall Study|Adverse Event|0|||
33584833|NCT02412735|62982856|FG001|Overall Study|Adverse Event|1|||
33584834|NCT02412735|62982857|FG002|Overall Study|Adverse Event|2|||
33584835|NCT02412735|62982855|FG000|Overall Study|Withdrawal by Subject|23|||
33584836|NCT02412735|62982856|FG001|Overall Study|Withdrawal by Subject|27|||
33584837|NCT02412735|62982857|FG002|Overall Study|Withdrawal by Subject|22|||
33584838|NCT02412735|62982855|FG000|Overall Study|Investigator Decision|3|||
33584839|NCT02412735|62982856|FG001|Overall Study|Investigator Decision|3|||
33584840|NCT02412735|62982857|FG002|Overall Study|Investigator Decision|2|||
33679559|NCT01490060|63129468|FG000|Cycle 1|Withdrawal by Subject|0|||
33679560|NCT01490060|63129469|FG001|Cycle 1|Withdrawal by Subject|0|||
33584841|NCT02412735|62982855|FG000|Overall Study|Lost to Follow-up|17|||
33584842|NCT02412735|62982856|FG001|Overall Study|Lost to Follow-up|11|||
33584843|NCT02412735|62982857|FG002|Overall Study|Lost to Follow-up|18|||
33584844|NCT02412735|62982855|FG000|Overall Study|Reason not Specified|3|||
33584845|NCT02412735|62982856|FG001|Overall Study|Reason not Specified|2|||
33679561|NCT01490060|63129470|FG002|Cycle 1|Withdrawal by Subject|0|||
33584846|NCT02412735|62982857|FG002|Overall Study|Reason not Specified|2|||
33584847|NCT02412657|62982868|FG000|Overall Study|Lost to Follow-up|1|||
33584848|NCT02412657|62982869|FG001|Overall Study|Lost to Follow-up|0|||
33584849|NCT02412657|62982870|FG002|Overall Study|Lost to Follow-up|0|||
33584850|NCT02412657|62982868|FG000|Overall Study|Protocol Violation|0|||
33584851|NCT02412657|62982869|FG001|Overall Study|Protocol Violation|2|||
33584852|NCT02412657|62982870|FG002|Overall Study|Protocol Violation|3|||
33584853|NCT02428413|62982880|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
33584854|NCT02428413|62982881|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
33584855|NCT02428413|62982880|FG000|Overall Study|Protocol Violation|1|||
33584856|NCT02428413|62982881|FG001|Overall Study|Protocol Violation|2|||
33584857|NCT02428413|62982880|FG000|Overall Study|Case Cancelled|2|||
33584858|NCT02428413|62982881|FG001|Overall Study|Case Cancelled|0|||
33584859|NCT02428413|62982880|FG000|Overall Study|Missed Cases|1|||
33584860|NCT02428413|62982881|FG001|Overall Study|Missed Cases|2|||
33584861|NCT02428413|62982880|FG000|Overall Study|Nurse Refusal|1|||
33584862|NCT02428413|62982881|FG001|Overall Study|Nurse Refusal|0|||
33584863|NCT02412111|62982889|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
33584864|NCT02412111|62982890|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
33584865|NCT02412111|62982891|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
33584866|NCT02412111|62982889|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
33679562|NCT01490060|63129471|FG003|Cycle 1|Withdrawal by Subject|1|||
33679563|NCT01490060|63129468|FG000|Cycle 1|Treatment at Another Facility|0|||
33679564|NCT01490060|63129469|FG001|Cycle 1|Treatment at Another Facility|0|||
33679565|NCT01490060|63129470|FG002|Cycle 1|Treatment at Another Facility|0|||
33679566|NCT01490060|63129471|FG003|Cycle 1|Treatment at Another Facility|1|||
33584867|NCT02412111|62982890|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
33679567|NCT01490060|63129468|FG000|Cycle 2|Change of Treatment|1|||
33679568|NCT01490060|63129469|FG001|Cycle 2|Change of Treatment|1|||
33679569|NCT01490060|63129470|FG002|Cycle 2|Change of Treatment|0|||
33679570|NCT01490060|63129471|FG003|Cycle 2|Change of Treatment|0|||
33679571|NCT01490060|63129468|FG000|Cycle 2|Non-Compliance|0|||
33679572|NCT01490060|63129469|FG001|Cycle 2|Non-Compliance|0|||
33679573|NCT01490060|63129470|FG002|Cycle 2|Non-Compliance|1|||
33679574|NCT01490060|63129471|FG003|Cycle 2|Non-Compliance|0|||
33679575|NCT01490060|63129468|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
33679576|NCT01490060|63129469|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
33679577|NCT01490060|63129470|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
33679578|NCT01490060|63129471|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
33679579|NCT01452152|63129523|FG000|Overall Study|Study termination by sponsor|5|||
33679580|NCT01452152|63129524|FG001|Overall Study|Study termination by sponsor|0|||
33679581|NCT01452152|63129525|FG002|Overall Study|Study termination by sponsor|4|||
33679582|NCT01451762|63129536|FG000|Overall Study|Lost to Follow-up|3|||
33679583|NCT01451762|63129537|FG001|Overall Study|Lost to Follow-up|6|||
33679584|NCT01451762|63129538|FG002|Overall Study|Lost to Follow-up|6|||
33679585|NCT01468844|63129573|FG000|Overall Study|Adverse Event|1|||
33679586|NCT01468844|63129574|FG001|Overall Study|Adverse Event|0|||
33679587|NCT01468844|63129573|FG000|Overall Study|Withdrawal by Subject|1|||
33679588|NCT01468844|63129574|FG001|Overall Study|Withdrawal by Subject|0|||
33679589|NCT01451606|63129598|FG000|Overall Study|Withdrawal by Subject|4|||
33679590|NCT01451606|63129599|FG001|Overall Study|Withdrawal by Subject|3|||
33679591|NCT00473343|63129654|FG000|Overall Study|Adverse Event|9|||
33584868|NCT02412111|62982891|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
33584869|NCT02412111|62982889|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
33584870|NCT02412111|62982890|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
33679592|NCT00473343|63129654|FG000|Overall Study|Lost to Follow-up|8|||
33679593|NCT00473343|63129654|FG000|Overall Study|Treatment failure|27|||
33584871|NCT02412111|62982891|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
33584872|NCT02412111|62982889|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
33584873|NCT02412111|62982890|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
33584874|NCT02412111|62982891|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
33584875|NCT02412111|62982889|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
33584876|NCT02412111|62982890|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
33584877|NCT02412111|62982891|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
33584878|NCT02412111|62982889|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
33584879|NCT02412111|62982890|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
33679594|NCT00473343|63129654|FG000|Overall Study|Withdrew consent|3|||
33584880|NCT02412111|62982891|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
33584881|NCT02412111|62982889|FG000|Active Comparator Period (8 Weeks)|Other|0|||
33679595|NCT00473343|63129654|FG000|Overall Study|Other un-specified reason|3|||
33679596|NCT02587962|63130111|FG000|Overall Study|Adverse Event|0|||
33679597|NCT02587962|63130112|FG001|Overall Study|Adverse Event|0|||
33679598|NCT02587962|63130113|FG002|Overall Study|Adverse Event|1|||
33679599|NCT02587962|63130114|FG003|Overall Study|Adverse Event|0|||
33584882|NCT02412111|62982890|FG001|Active Comparator Period (8 Weeks)|Other|0|||
33584883|NCT02412111|62982891|FG002|Active Comparator Period (8 Weeks)|Other|2|||
33584884|NCT02427477|62982903|FG000|Period 1|Adverse Event|1|||
33584885|NCT02427477|62982904|FG001|Period 1|Adverse Event|0|||
33584886|NCT02427399|62982915|FG000|Overall Study|Protocol Violation|14|||
33584887|NCT02427399|62982916|FG001|Overall Study|Protocol Violation|16|||
33584888|NCT02427399|62982917|FG002|Overall Study|Protocol Violation|12|||
33584889|NCT02427399|62982918|FG003|Overall Study|Protocol Violation|18|||
33584890|NCT02427399|62982919|FG004|Overall Study|Protocol Violation|15|||
33584891|NCT02426541|62982933|FG000|Overall Study|Protocol Violation|1|||
33584892|NCT02426541|62982934|FG001|Overall Study|Protocol Violation|0|||
33584893|NCT02484651|62982942|FG000|Overall Study|Patients' data files were corrupted.|1|||
33584894|NCT02484651|62982943|FG001|Overall Study|Patients' data files were corrupted.|1|||
33584895|NCT02484651|62982942|FG000|Overall Study|BIS monitoring failed.|1|||
33584896|NCT02484651|62982943|FG001|Overall Study|BIS monitoring failed.|1|||
33584897|NCT02484651|62982942|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
33584898|NCT02484651|62982943|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
33584899|NCT02410551|62982950|FG000|Overall Study|Adverse Event|1|||
33584900|NCT02410551|62982950|FG000|Overall Study|Withdrawal by Subject|1|||
33584901|NCT02410551|62982950|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
33584902|NCT02424591|62982957|FG000|Overall Study|Protocol Violation|2|||
33584903|NCT02424591|62982958|FG001|Overall Study|Protocol Violation|3|||
33584904|NCT02408523|62982966|FG000|Overall Study|Adverse Event|4|||
33584905|NCT02408523|62982967|FG001|Overall Study|Adverse Event|10|||
33584906|NCT02408523|62982966|FG000|Overall Study|Lack of Efficacy|0|||
33584907|NCT02408523|62982967|FG001|Overall Study|Lack of Efficacy|1|||
33584908|NCT02408523|62982966|FG000|Overall Study|Protocol Violation|1|||
33584909|NCT02408523|62982967|FG001|Overall Study|Protocol Violation|2|||
33584910|NCT02408523|62982966|FG000|Overall Study|Lost to Follow-up|2|||
33584911|NCT02408523|62982967|FG001|Overall Study|Lost to Follow-up|3|||
33584912|NCT02408523|62982966|FG000|Overall Study|Withdrawal by Subject|3|||
33584913|NCT02408523|62982967|FG001|Overall Study|Withdrawal by Subject|1|||
33584914|NCT02408523|62982966|FG000|Overall Study|Sponsor request|1|||
33584915|NCT02408523|62982967|FG001|Overall Study|Sponsor request|0|||
33584916|NCT02408523|62982966|FG000|Overall Study|Did not satisfy extension conditions|0|||
33584917|NCT02408523|62982967|FG001|Overall Study|Did not satisfy extension conditions|1|||
33584918|NCT02603419|62982987|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
33584919|NCT02603419|62982988|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
33584920|NCT02603419|62982989|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
33584921|NCT02603419|62982990|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
33584922|NCT02603419|62982991|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
33584923|NCT02603419|62982992|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
33584924|NCT02603419|62982987|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
33584925|NCT02603419|62982988|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
33584926|NCT02603419|62982989|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
33584927|NCT02603419|62982990|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
33584928|NCT02603419|62982991|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
33584929|NCT02603419|62982992|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
33584930|NCT02603419|62982987|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
33584931|NCT02603419|62982988|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
33584932|NCT02603419|62982989|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
33584933|NCT02603419|62982990|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
33584934|NCT02603419|62982991|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
33584935|NCT02603419|62982992|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
33584936|NCT02603419|62982987|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
33584937|NCT02603419|62982988|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
33584938|NCT02603419|62982989|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
33584939|NCT02603419|62982990|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
33584940|NCT02603419|62982991|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
33584941|NCT02603419|62982992|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
33584942|NCT02603419|62982987|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
33584943|NCT02603419|62982988|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
33584944|NCT02603419|62982989|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
33584945|NCT02603419|62982990|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
33679600|NCT02587962|63130115|FG004|Overall Study|Adverse Event|0|||
33679601|NCT02587962|63130111|FG000|Overall Study|Withdrawal by Subject|0|||
33584946|NCT02603419|62982991|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
33584947|NCT02603419|62982992|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
33584948|NCT02603419|62982987|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
33679602|NCT02587962|63130112|FG001|Overall Study|Withdrawal by Subject|0|||
33679603|NCT02587962|63130113|FG002|Overall Study|Withdrawal by Subject|1|||
33679604|NCT02587962|63130114|FG003|Overall Study|Withdrawal by Subject|1|||
33679605|NCT02587962|63130115|FG004|Overall Study|Withdrawal by Subject|4|||
33679606|NCT02587962|63130111|FG000|Overall Study|Radiological progression|2|||
33679607|NCT02587962|63130112|FG001|Overall Study|Radiological progression|2|||
33679608|NCT02587962|63130113|FG002|Overall Study|Radiological progression|2|||
33679609|NCT02587962|63130114|FG003|Overall Study|Radiological progression|5|||
33679610|NCT02587962|63130115|FG004|Overall Study|Radiological progression|10|||
33679611|NCT02587962|63130111|FG000|Overall Study|Clinical progression|0|||
33679612|NCT02587962|63130112|FG001|Overall Study|Clinical progression|1|||
33679613|NCT02587962|63130113|FG002|Overall Study|Clinical progression|2|||
33679614|NCT02587962|63130114|FG003|Overall Study|Clinical progression|0|||
33679615|NCT02587962|63130115|FG004|Overall Study|Clinical progression|1|||
33679616|NCT01440374|63130269|FG000|Part 1: Open-label Phase|Adverse Event|5|||
33679617|NCT01440374|63130270|FG001|Part 1: Open-label Phase|Adverse Event|0|||
33679618|NCT01440374|63130271|FG002|Part 1: Open-label Phase|Adverse Event|0|||
33679619|NCT01440374|63130272|FG003|Part 1: Open-label Phase|Adverse Event|0|||
33679620|NCT01440374|63130269|FG000|Part 1: Open-label Phase|Physician Decision|1|||
33679621|NCT01440374|63130270|FG001|Part 1: Open-label Phase|Physician Decision|0|||
33679622|NCT01440374|63130271|FG002|Part 1: Open-label Phase|Physician Decision|0|||
33679623|NCT01440374|63130272|FG003|Part 1: Open-label Phase|Physician Decision|0|||
33679624|NCT01440374|63130269|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
33679625|NCT01440374|63130270|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
33679626|NCT01440374|63130271|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
33584949|NCT02603419|62982988|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
33584950|NCT02603419|62982989|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
33584951|NCT02603419|62982990|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
33584952|NCT02603419|62982991|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
33584953|NCT02603419|62982992|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
33584954|NCT02603419|62982987|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
33584955|NCT02603419|62982988|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
33584956|NCT02603419|62982989|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
33584957|NCT02603419|62982990|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
33584958|NCT02603419|62982991|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
33584959|NCT02603419|62982992|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
33584960|NCT02603419|62982987|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
33584961|NCT02603419|62982988|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
33584962|NCT02603419|62982989|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
33584963|NCT02603419|62982990|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
33584964|NCT02603419|62982991|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
33584965|NCT02603419|62982992|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
33584966|NCT02603419|62982987|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
33584967|NCT02603419|62982988|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
33584968|NCT02603419|62982989|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
33584969|NCT02603419|62982990|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
33679627|NCT01440374|63130272|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
33679628|NCT01440374|63130269|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
33679629|NCT01440374|63130270|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
33679630|NCT01440374|63130271|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
33679631|NCT01440374|63130272|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
33679632|NCT01440374|63130269|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
33679633|NCT01440374|63130270|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
33679634|NCT01440374|63130271|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
33679635|NCT01440374|63130272|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
33679636|NCT01440374|63130269|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
33679637|NCT01440374|63130270|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
33679638|NCT01440374|63130271|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
33679639|NCT01440374|63130272|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
33679640|NCT01440374|63130269|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
33584970|NCT02603419|62982991|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
33584971|NCT02603419|62982992|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
33679641|NCT01440374|63130270|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
33679642|NCT01440374|63130271|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
33679643|NCT01440374|63130272|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
33679644|NCT01440374|63130269|FG000|Part 2; Double-blind Phase|Not treated|0|||
33584972|NCT02603419|62982987|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
33679645|NCT01440374|63130270|FG001|Part 2; Double-blind Phase|Not treated|0|||
33679646|NCT01440374|63130271|FG002|Part 2; Double-blind Phase|Not treated|1|||
33679647|NCT01440374|63130272|FG003|Part 2; Double-blind Phase|Not treated|0|||
33679648|NCT01440374|63130269|FG000|Part 3: Extension|Withdrawal by Subject|0|||
33679649|NCT01440374|63130270|FG001|Part 3: Extension|Withdrawal by Subject|0|||
33679650|NCT01440374|63130271|FG002|Part 3: Extension|Withdrawal by Subject|0|||
33679651|NCT01440374|63130272|FG003|Part 3: Extension|Withdrawal by Subject|5|||
33679652|NCT01440374|63130269|FG000|Part 3: Extension|Adverse Event|0|||
33679653|NCT01440374|63130270|FG001|Part 3: Extension|Adverse Event|0|||
33679654|NCT01440374|63130271|FG002|Part 3: Extension|Adverse Event|0|||
33679655|NCT01440374|63130272|FG003|Part 3: Extension|Adverse Event|13|||
33679656|NCT01440374|63130269|FG000|Part 3: Extension|Physician Decision|0|||
33679657|NCT01440374|63130270|FG001|Part 3: Extension|Physician Decision|0|||
33679658|NCT01440374|63130271|FG002|Part 3: Extension|Physician Decision|0|||
33679659|NCT01440374|63130272|FG003|Part 3: Extension|Physician Decision|14|||
33679660|NCT01666782|63130420|FG000|Overall Study|Received 2 doses of vaccine|0|||
33679661|NCT01666782|63130421|FG001|Overall Study|Received 2 doses of vaccine|1|||
33679662|NCT01666782|63130420|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
33679663|NCT01666782|63130421|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
33679664|NCT01439360|63130437|FG000|Overall Study|Adverse Event|4|||
33584973|NCT02603419|62982988|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
33584974|NCT02603419|62982989|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
33584975|NCT02603419|62982990|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
33584976|NCT02603419|62982991|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
33584977|NCT02603419|62982992|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
33584978|NCT01668355|62983009|FG000|Overall Study|Death|3|||
33584979|NCT01668355|62983010|FG001|Overall Study|Death|1|||
33584980|NCT01668355|62983009|FG000|Overall Study|Withdrawal by Subject|6|||
33584981|NCT01668355|62983010|FG001|Overall Study|Withdrawal by Subject|1|||
33584982|NCT01667731|62983022|FG000|Overall Study|Enrolled but not treated|0|||
33584983|NCT01667731|62983023|FG001|Overall Study|Enrolled but not treated|0|||
33584984|NCT01667731|62983024|FG002|Overall Study|Enrolled but not treated|0|||
33584985|NCT01667731|62983025|FG003|Overall Study|Enrolled but not treated|0|||
33584986|NCT01667731|62983026|FG004|Overall Study|Enrolled but not treated|1|||
33584987|NCT01667731|62983022|FG000|Overall Study|Efficacy Failure|1|||
33584988|NCT01667731|62983023|FG001|Overall Study|Efficacy Failure|12|||
33584989|NCT01667731|62983024|FG002|Overall Study|Efficacy Failure|0|||
33584990|NCT01667731|62983025|FG003|Overall Study|Efficacy Failure|1|||
33584991|NCT01667731|62983026|FG004|Overall Study|Efficacy Failure|24|||
33584992|NCT01667731|62983022|FG000|Overall Study|Lost to Follow-up|2|||
33584993|NCT01667731|62983023|FG001|Overall Study|Lost to Follow-up|3|||
33584994|NCT01667731|62983024|FG002|Overall Study|Lost to Follow-up|1|||
33584995|NCT01667731|62983025|FG003|Overall Study|Lost to Follow-up|1|||
33584996|NCT01667731|62983026|FG004|Overall Study|Lost to Follow-up|2|||
33584997|NCT01667731|62983022|FG000|Overall Study|Subject Withdrew Consent|2|||
33584998|NCT01667731|62983023|FG001|Overall Study|Subject Withdrew Consent|0|||
33584999|NCT01667731|62983024|FG002|Overall Study|Subject Withdrew Consent|1|||
33585000|NCT01667731|62983025|FG003|Overall Study|Subject Withdrew Consent|0|||
33585001|NCT01667731|62983026|FG004|Overall Study|Subject Withdrew Consent|1|||
33585002|NCT01667731|62983022|FG000|Overall Study|Death|0|||
33585003|NCT01667731|62983023|FG001|Overall Study|Death|1|||
33585004|NCT01667731|62983024|FG002|Overall Study|Death|0|||
33585005|NCT01667731|62983025|FG003|Overall Study|Death|0|||
33585006|NCT01667731|62983026|FG004|Overall Study|Death|0|||
33679665|NCT01439360|63130438|FG001|Overall Study|Adverse Event|16|||
33679666|NCT01439360|63130437|FG000|Overall Study|Lost to Follow-up|43|||
33679667|NCT01439360|63130438|FG001|Overall Study|Lost to Follow-up|58|||
33679668|NCT01439360|63130437|FG000|Overall Study|Others|10|||
33679669|NCT01439360|63130438|FG001|Overall Study|Others|5|||
33679670|NCT01439360|63130437|FG000|Overall Study|Protocol Violation|1|||
33679671|NCT01439360|63130438|FG001|Overall Study|Protocol Violation|0|||
33679672|NCT01439360|63130437|FG000|Overall Study|Withdrawal by Subject|140|||
33679673|NCT01439360|63130438|FG001|Overall Study|Withdrawal by Subject|129|||
33679674|NCT01439204|63130615|FG000|Overall Study|Withdrawal by Subject|0|||
33679675|NCT01439204|63130616|FG001|Overall Study|Withdrawal by Subject|1|||
33679676|NCT01439204|63130615|FG000|Overall Study|Lost to Follow-up|0|||
33679677|NCT01439204|63130616|FG001|Overall Study|Lost to Follow-up|2|||
33679678|NCT01439204|63130615|FG000|Overall Study|No longer meets study criteria|1|||
33679679|NCT01439204|63130616|FG001|Overall Study|No longer meets study criteria|0|||
33679680|NCT01439204|63130615|FG000|Overall Study|poor/non-compliance|3|||
33585007|NCT02605837|62983041|FG000|Overall Study|Adverse Event|3|||
33585008|NCT02605837|62983042|FG001|Overall Study|Adverse Event|1|||
33679681|NCT01439204|63130616|FG001|Overall Study|poor/non-compliance|0|||
33585009|NCT02605837|62983041|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33585010|NCT02605837|62983042|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33679682|NCT01439126|63130662|FG000|Overall Study|Adverse Event|2|||
33679683|NCT01439126|63130663|FG001|Overall Study|Adverse Event|0|||
33585011|NCT02605837|62983041|FG000|Overall Study|Withdrawal by Subject|8|||
33679684|NCT01439126|63130662|FG000|Overall Study|Withdrawal by Subject|5|||
33679685|NCT01439126|63130663|FG001|Overall Study|Withdrawal by Subject|21|||
33679686|NCT01439126|63130662|FG000|Overall Study|Protocol Violation|6|||
33585012|NCT02605837|62983042|FG001|Overall Study|Withdrawal by Subject|8|||
33585013|NCT02605837|62983041|FG000|Overall Study|Physician Decision|0|||
33585014|NCT02605837|62983042|FG001|Overall Study|Physician Decision|1|||
33585015|NCT02423343|62983055|FG000|Overall Study|Withdrawal by Subject|0|||
33585016|NCT02423343|62983056|FG001|Overall Study|Withdrawal by Subject|1|||
33585017|NCT02423343|62983057|FG002|Overall Study|Withdrawal by Subject|0|||
33585018|NCT02423343|62983058|FG003|Overall Study|Withdrawal by Subject|0|||
33585019|NCT02423343|62983059|FG004|Overall Study|Withdrawal by Subject|0|||
33585020|NCT02423343|62983060|FG005|Overall Study|Withdrawal by Subject|0|||
33585021|NCT02423343|62983055|FG000|Overall Study|Progressive Disease|0|||
33679687|NCT01439126|63130663|FG001|Overall Study|Protocol Violation|4|||
33679688|NCT01439126|63130662|FG000|Overall Study|Lost to Follow-up|6|||
33679689|NCT01439126|63130663|FG001|Overall Study|Lost to Follow-up|3|||
33679690|NCT01439126|63130662|FG000|Overall Study|Other-Use of prohibited treatment|0|||
33679691|NCT01439126|63130663|FG001|Overall Study|Other-Use of prohibited treatment|2|||
33679692|NCT01439126|63130662|FG000|Overall Study|Other-Miscellaneous|12|||
33679693|NCT01439126|63130663|FG001|Overall Study|Other-Miscellaneous|12|||
33679694|NCT01449812|63130689|FG000|Overall Study|Migrated/moved from study area|1|||
33679695|NCT01449812|63130690|FG001|Overall Study|Migrated/moved from study area|0|||
33679696|NCT01449812|63130691|FG002|Overall Study|Migrated/moved from study area|0|||
33679697|NCT01449812|63130689|FG000|Overall Study|Withdrawal by Subject|0|||
33679698|NCT01449812|63130690|FG001|Overall Study|Withdrawal by Subject|0|||
33679699|NCT01449812|63130691|FG002|Overall Study|Withdrawal by Subject|1|||
33679700|NCT01449812|63130689|FG000|Overall Study|Lost to Follow-up|1|||
33679701|NCT01449812|63130690|FG001|Overall Study|Lost to Follow-up|0|||
33679702|NCT01449812|63130691|FG002|Overall Study|Lost to Follow-up|0|||
33679703|NCT01665144|63130744|FG000|Overall Study|New therapy for study indication|2|||
33679704|NCT01665144|63130745|FG001|Overall Study|New therapy for study indication|1|||
33679705|NCT01665144|63130744|FG000|Overall Study|Technical problems|2|||
33679706|NCT01665144|63130745|FG001|Overall Study|Technical problems|0|||
33679707|NCT01665144|63130744|FG000|Overall Study|Death|3|||
33679708|NCT01665144|63130745|FG001|Overall Study|Death|1|||
33679709|NCT01665144|63130744|FG000|Overall Study|Protocol deviation|3|||
33679710|NCT01665144|63130745|FG001|Overall Study|Protocol deviation|1|||
33679711|NCT01665144|63130744|FG000|Overall Study|Non-compliance w/study treatment|5|||
33679712|NCT01665144|63130745|FG001|Overall Study|Non-compliance w/study treatment|0|||
33679713|NCT01665144|63130744|FG000|Overall Study|Progressive disease|8|||
33679714|NCT01665144|63130745|FG001|Overall Study|Progressive disease|4|||
33679715|NCT01665144|63130744|FG000|Overall Study|Lost to Follow-up|9|||
33679716|NCT01665144|63130745|FG001|Overall Study|Lost to Follow-up|8|||
33679717|NCT01665144|63130744|FG000|Overall Study|Physician Decision|13|||
33679718|NCT01665144|63130745|FG001|Overall Study|Physician Decision|1|||
33679719|NCT01665144|63130744|FG000|Overall Study|Lack of Efficacy|16|||
33679720|NCT01665144|63130745|FG001|Overall Study|Lack of Efficacy|11|||
33679721|NCT01665144|63130744|FG000|Overall Study|Adverse Event|45|||
33679722|NCT01665144|63130745|FG001|Overall Study|Adverse Event|18|||
33679723|NCT01665144|63130744|FG000|Overall Study|Withdrawal by Subject|96|||
33679724|NCT01665144|63130745|FG001|Overall Study|Withdrawal by Subject|77|||
33679725|NCT01466660|63130880|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
33679726|NCT01466660|63130881|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
33679727|NCT01466660|63130880|FG000|Overall Study|Worsening of underlying cancer disease|5|||
33679728|NCT01466660|63130881|FG001|Overall Study|Worsening of underlying cancer disease|2|||
33679729|NCT01466660|63130880|FG000|Overall Study|Other adverse event|19|||
33679730|NCT01466660|63130881|FG001|Overall Study|Other adverse event|18|||
33679731|NCT01466660|63130880|FG000|Overall Study|Protocol Violation|2|||
33679732|NCT01466660|63130881|FG001|Overall Study|Protocol Violation|1|||
33679733|NCT01466660|63130880|FG000|Overall Study|Refused continuation of trial medication|4|||
33679734|NCT01466660|63130881|FG001|Overall Study|Refused continuation of trial medication|3|||
33679735|NCT01466660|63130880|FG000|Overall Study|Other reason not defined above|10|||
33679736|NCT01466660|63130881|FG001|Overall Study|Other reason not defined above|8|||
33679737|NCT01466348|63130906|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
33679738|NCT01466348|63130907|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
33679739|NCT01466270|63130930|FG000|Overall Study|Withdrawal by Subject|4|||
33679740|NCT01466270|63130931|FG001|Overall Study|Withdrawal by Subject|1|||
33679741|NCT01466270|63130930|FG000|Overall Study|Physician Decision|1|||
33679742|NCT01466270|63130931|FG001|Overall Study|Physician Decision|0|||
33585022|NCT02423343|62983056|FG001|Overall Study|Progressive Disease|0|||
33679743|NCT01466270|63130930|FG000|Overall Study|Lost to Follow-up|1|||
33679744|NCT01466270|63130931|FG001|Overall Study|Lost to Follow-up|3|||
33679745|NCT01466270|63130930|FG000|Overall Study|Progression|1|||
33679746|NCT01466270|63130931|FG001|Overall Study|Progression|0|||
33679747|NCT01466270|63130930|FG000|Overall Study|Toxicity|4|||
33679748|NCT01466270|63130931|FG001|Overall Study|Toxicity|1|||
33679749|NCT01466270|63130930|FG000|Overall Study|Multiple|1|||
33679750|NCT01466270|63130931|FG001|Overall Study|Multiple|1|||
33679751|NCT01466192|63130964|FG000|Overall Study|Physician Decision|1|||
33679752|NCT01466192|63130964|FG000|Overall Study|Withdrawal by Subject|3|||
33585023|NCT02423343|62983057|FG002|Overall Study|Progressive Disease|0|||
33585024|NCT02423343|62983058|FG003|Overall Study|Progressive Disease|0|||
33585025|NCT02423343|62983059|FG004|Overall Study|Progressive Disease|2|||
33585026|NCT02423343|62983060|FG005|Overall Study|Progressive Disease|0|||
33585027|NCT02423343|62983055|FG000|Overall Study|Adverse Event|0|||
33585028|NCT02423343|62983056|FG001|Overall Study|Adverse Event|0|||
33585029|NCT02423343|62983057|FG002|Overall Study|Adverse Event|0|||
33585030|NCT02423343|62983058|FG003|Overall Study|Adverse Event|0|||
33585031|NCT02423343|62983059|FG004|Overall Study|Adverse Event|2|||
33585032|NCT02423343|62983060|FG005|Overall Study|Adverse Event|0|||
33585033|NCT02423343|62983055|FG000|Overall Study|Death|0|||
33585034|NCT02423343|62983056|FG001|Overall Study|Death|0|||
33585035|NCT02423343|62983057|FG002|Overall Study|Death|0|||
33585036|NCT02423343|62983058|FG003|Overall Study|Death|0|||
33585037|NCT02423343|62983059|FG004|Overall Study|Death|1|||
33585038|NCT02423343|62983060|FG005|Overall Study|Death|0|||
33585039|NCT02605447|62983088|FG000|Overall Study|Death|66|||
33585040|NCT02605447|62983088|FG000|Overall Study|Physician Decision|1|||
33585041|NCT02605447|62983088|FG000|Overall Study|Lost to Follow-up|24|||
33585042|NCT02605447|62983088|FG000|Overall Study|Withdrawal by Subject|10|||
33585043|NCT02605447|62983088|FG000|Overall Study|Not disclosed|1|||
33585044|NCT02485899|62983095|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
33585045|NCT02485899|62983096|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33585046|NCT02485899|62983095|FG000|Overall Study|Withdrawal by Subject|1|||
33585047|NCT02485899|62983096|FG001|Overall Study|Withdrawal by Subject|0|||
33679753|NCT01438814|63130984|FG000|Overall Study|Adverse Event|3|||
33679754|NCT01438814|63130985|FG001|Overall Study|Adverse Event|3|||
33679755|NCT01438814|63130984|FG000|Overall Study|Protocol Violation|1|||
33679756|NCT01438814|63130985|FG001|Overall Study|Protocol Violation|2|||
33679757|NCT01438814|63130984|FG000|Overall Study|Lost to Follow-up|4|||
33679758|NCT01438814|63130985|FG001|Overall Study|Lost to Follow-up|3|||
33679759|NCT01438814|63130984|FG000|Overall Study|Withdrawal by Subject|4|||
33679760|NCT01438814|63130985|FG001|Overall Study|Withdrawal by Subject|2|||
33679761|NCT01438814|63130984|FG000|Overall Study|Other|2|||
33679762|NCT01438814|63130985|FG001|Overall Study|Other|4|||
33679763|NCT02926833|63131566|FG000|Overall Study|Full Consent Withdrawal|0|||
33679764|NCT02926833|63131567|FG001|Overall Study|Full Consent Withdrawal|0|||
33679765|NCT02926833|63131568|FG002|Overall Study|Full Consent Withdrawal|0|||
33679766|NCT02926833|63131569|FG003|Overall Study|Full Consent Withdrawal|2|||
33679767|NCT02926833|63131566|FG000|Overall Study|Death|1|||
33679768|NCT02926833|63131567|FG001|Overall Study|Death|1|||
33679769|NCT02926833|63131568|FG002|Overall Study|Death|1|||
33679770|NCT02926833|63131569|FG003|Overall Study|Death|7|||
33679771|NCT02926833|63131566|FG000|Overall Study|Still on study|2|||
33679772|NCT02926833|63131567|FG001|Overall Study|Still on study|3|||
33679773|NCT02926833|63131568|FG002|Overall Study|Still on study|5|||
33679774|NCT02926833|63131569|FG003|Overall Study|Still on study|14|||
33679775|NCT02926833|63131566|FG000|Overall Study|Adverse Event|0|||
33679776|NCT02926833|63131567|FG001|Overall Study|Adverse Event|0|||
33679777|NCT02926833|63131568|FG002|Overall Study|Adverse Event|1|||
33679778|NCT02926833|63131569|FG003|Overall Study|Adverse Event|0|||
33679779|NCT02851797|63131616|FG000|Overall Study|Withdrawal by Subject|4|||
33585048|NCT02485899|62983095|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
33585049|NCT02485899|62983096|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
33585050|NCT02423109|62983102|FG000|Lens 1|Adverse Event|1|||
33585051|NCT02423109|62983103|FG001|Lens 1|Adverse Event|0|||
33585052|NCT02420691|62983111|FG000|Overall Study|Adverse Event|3|||
33585053|NCT02420691|62983111|FG000|Overall Study|Withdrawal by Subject|3|||
33585054|NCT02406651|62983115|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
33585055|NCT02406261|62983122|FG000|Period 1|Lost to Follow-up|2|||
33585056|NCT02406261|62983123|FG001|Period 1|Lost to Follow-up|0|||
33585057|NCT02406261|62983122|FG000|Period 1|Adverse Event|1|||
33585058|NCT02406261|62983123|FG001|Period 1|Adverse Event|0|||
33679780|NCT02851797|63131617|FG001|Overall Study|Withdrawal by Subject|2|||
33679781|NCT02851797|63131616|FG000|Overall Study|Adverse Event|3|||
33679782|NCT02851797|63131617|FG001|Overall Study|Adverse Event|0|||
33679783|NCT01666314|63131841|FG000|Overall Study|Adverse Event|3|||
33310669|NCT01235598|62686079|FG000|Overall Study|Withdrawal by Subject|1|||
33585059|NCT02406261|62983122|FG000|Period 2|Physician Decision|0|||
33585060|NCT02406261|62983123|FG001|Period 2|Physician Decision|1|||
33585061|NCT02406261|62983122|FG000|Period 2|Protocol Violation|0|||
33585062|NCT02406261|62983123|FG001|Period 2|Protocol Violation|1|||
33585063|NCT02406261|62983122|FG000|Period 2|Withdrawal by Subject|0|||
33679784|NCT01666314|63131842|FG001|Overall Study|Adverse Event|13|||
33679785|NCT01666314|63131843|FG002|Overall Study|Adverse Event|7|||
33679786|NCT01666314|63131844|FG003|Overall Study|Adverse Event|7|||
33585064|NCT02406261|62983123|FG001|Period 2|Withdrawal by Subject|1|||
33585065|NCT02405091|62983133|FG000|Overall Study|Adverse Event|16|||
33585066|NCT02405091|62983134|FG001|Overall Study|Adverse Event|10|||
33585067|NCT02405091|62983135|FG002|Overall Study|Adverse Event|0|||
33585068|NCT02405091|62983133|FG000|Overall Study|Protocol Violation|1|||
33585069|NCT02405091|62983134|FG001|Overall Study|Protocol Violation|0|||
33585070|NCT02405091|62983135|FG002|Overall Study|Protocol Violation|0|||
33585071|NCT02405091|62983133|FG000|Overall Study|Noncompliance|1|||
33585072|NCT02405091|62983134|FG001|Overall Study|Noncompliance|6|||
33585073|NCT02405091|62983135|FG002|Overall Study|Noncompliance|2|||
33585074|NCT02405091|62983133|FG000|Overall Study|Withdrawal by Subject|4|||
33585075|NCT02405091|62983134|FG001|Overall Study|Withdrawal by Subject|8|||
33585076|NCT02405091|62983135|FG002|Overall Study|Withdrawal by Subject|0|||
33585077|NCT02405091|62983133|FG000|Overall Study|Death|0|||
33585078|NCT02405091|62983134|FG001|Overall Study|Death|1|||
33585079|NCT02405091|62983135|FG002|Overall Study|Death|0|||
33585080|NCT02405091|62983133|FG000|Overall Study|Lost to Follow-up|5|||
33585081|NCT02405091|62983134|FG001|Overall Study|Lost to Follow-up|6|||
33585082|NCT02405091|62983135|FG002|Overall Study|Lost to Follow-up|0|||
33585083|NCT02405091|62983133|FG000|Overall Study|Physician Decision|2|||
33585084|NCT02405091|62983134|FG001|Overall Study|Physician Decision|2|||
33585085|NCT02405091|62983135|FG002|Overall Study|Physician Decision|0|||
33585086|NCT02485353|62983146|FG000|Overall Study|Death|1|||
33585087|NCT02485353|62983146|FG000|Overall Study|Disease Progression|1|||
33585088|NCT02603107|62983152|FG000|Randomized Phase|Withdrew consent|8|||
33585089|NCT02603107|62983153|FG001|Randomized Phase|Withdrew consent|15|||
33585090|NCT02603107|62983152|FG000|Randomized Phase|Lost to Follow-up|1|||
33585091|NCT02603107|62983153|FG001|Randomized Phase|Lost to Follow-up|3|||
33585092|NCT02603107|62983152|FG000|Randomized Phase|Adverse Event|2|||
33585093|NCT02603107|62983153|FG001|Randomized Phase|Adverse Event|0|||
33585094|NCT02603107|62983152|FG000|Randomized Phase|Death|1|||
33585095|NCT02603107|62983153|FG001|Randomized Phase|Death|1|||
33585096|NCT02603107|62983152|FG000|Randomized Phase|Non-compliance with study drug|1|||
33585097|NCT02603107|62983153|FG001|Randomized Phase|Non-compliance with study drug|1|||
33585098|NCT02603107|62983152|FG000|Randomized Phase|Investigator's discretion|0|||
33585099|NCT02603107|62983153|FG001|Randomized Phase|Investigator's discretion|1|||
33585100|NCT02603107|62983152|FG000|Randomized Phase|Lack of Efficacy|1|||
33585101|NCT02603107|62983153|FG001|Randomized Phase|Lack of Efficacy|0|||
33585102|NCT02603107|62983152|FG000|Randomized Phase|Protocol Violation|1|||
33585103|NCT02603107|62983153|FG001|Randomized Phase|Protocol Violation|0|||
33585104|NCT02603107|62983152|FG000|Optional Extension Phase|Lost to Follow-up|3|||
33585105|NCT02603107|62983153|FG001|Optional Extension Phase|Lost to Follow-up|3|||
33585106|NCT02603107|62983152|FG000|Optional Extension Phase|Withdrew consent|3|||
33585107|NCT02603107|62983153|FG001|Optional Extension Phase|Withdrew consent|2|||
33585108|NCT02603107|62983152|FG000|Optional Extension Phase|Investigator's discretion|2|||
33585109|NCT02603107|62983153|FG001|Optional Extension Phase|Investigator's discretion|2|||
33585110|NCT02603107|62983152|FG000|Optional Extension Phase|Pregnancy|0|||
33585111|NCT02603107|62983153|FG001|Optional Extension Phase|Pregnancy|3|||
33585112|NCT02603107|62983152|FG000|Optional Extension Phase|Adverse Event|0|||
33585113|NCT02603107|62983153|FG001|Optional Extension Phase|Adverse Event|2|||
33585114|NCT02603107|62983152|FG000|Optional Extension Phase|Not treated in extension phase|0|||
33585115|NCT02603107|62983153|FG001|Optional Extension Phase|Not treated in extension phase|1|||
33585116|NCT02603107|62983152|FG000|Optional Extension Phase|Protocol Violation|1|||
33585117|NCT02603107|62983153|FG001|Optional Extension Phase|Protocol Violation|0|||
33585118|NCT02484729|62983171|FG000|Overall Study|Failure of IntelliCap Error|0|||
33585119|NCT02484729|62983172|FG001|Overall Study|Failure of IntelliCap Error|0|||
33585120|NCT02484729|62983173|FG002|Overall Study|Failure of IntelliCap Error|0|||
33585121|NCT02484729|62983174|FG003|Overall Study|Failure of IntelliCap Error|0|||
33585122|NCT02484729|62983175|FG004|Overall Study|Failure of IntelliCap Error|0|||
33585123|NCT02484729|62983176|FG005|Overall Study|Failure of IntelliCap Error|0|||
33585124|NCT02484729|62983177|FG006|Overall Study|Failure of IntelliCap Error|0|||
33585125|NCT02484729|62983178|FG007|Overall Study|Failure of IntelliCap Error|0|||
33585126|NCT02484729|62983179|FG008|Overall Study|Failure of IntelliCap Error|0|||
33585127|NCT02484729|62983180|FG009|Overall Study|Failure of IntelliCap Error|1|||
33585128|NCT02601625|62983218|FG000|Overall Study|Lost to Follow-up|0|||
33585129|NCT02601625|62983219|FG001|Overall Study|Lost to Follow-up|0|||
33585130|NCT02601625|62983220|FG002|Overall Study|Lost to Follow-up|1|||
33585131|NCT02601625|62983221|FG003|Overall Study|Lost to Follow-up|1|||
33585132|NCT02601469|62983247|FG000|Overall Study|Enrolled in Error|1|||
33585133|NCT02601469|62983248|FG001|Overall Study|Enrolled in Error|0|||
33585134|NCT02604589|62983257|FG000|Overall Study|catheter dislodgement|0|||
33585135|NCT02604589|62983258|FG001|Overall Study|catheter dislodgement|0|||
33585136|NCT02604589|62983259|FG002|Overall Study|catheter dislodgement|1|||
33585137|NCT02601001|62983270|FG000|Dosing Period 2|Adverse Event|0|||
33585138|NCT02601001|62983271|FG001|Dosing Period 2|Adverse Event|0|||
33585139|NCT02601001|62983272|FG002|Dosing Period 2|Adverse Event|0|||
33585140|NCT02601001|62983273|FG003|Dosing Period 2|Adverse Event|0|||
33585141|NCT02601001|62983274|FG004|Dosing Period 2|Adverse Event|0|||
33585142|NCT02601001|62983275|FG005|Dosing Period 2|Adverse Event|0|||
33585143|NCT02601001|62983276|FG006|Dosing Period 2|Adverse Event|1|||
33585144|NCT02604199|62983301|FG000|Overall Study|Pregnancy|0|||
33585145|NCT02604199|62983302|FG001|Overall Study|Pregnancy|0|||
33585146|NCT02604199|62983303|FG002|Overall Study|Pregnancy|0|||
33585147|NCT02604199|62983304|FG003|Overall Study|Pregnancy|1|||
33585148|NCT02604199|62983301|FG000|Overall Study|Study terminated by sponsor|0|||
33585149|NCT02604199|62983302|FG001|Overall Study|Study terminated by sponsor|2|||
33585150|NCT02604199|62983303|FG002|Overall Study|Study terminated by sponsor|0|||
33585151|NCT02604199|62983304|FG003|Overall Study|Study terminated by sponsor|2|||
33585152|NCT02604199|62983301|FG000|Overall Study|Withdrawal by Subject|0|||
33585153|NCT02604199|62983302|FG001|Overall Study|Withdrawal by Subject|1|||
33585154|NCT02604199|62983303|FG002|Overall Study|Withdrawal by Subject|0|||
33585155|NCT02604199|62983304|FG003|Overall Study|Withdrawal by Subject|0|||
33585156|NCT02600845|62983317|FG000|Overall Study|Reason Not Specified|3|||
33585157|NCT02600845|62983317|FG000|Overall Study|Non-compliance with Study Procedures|10|||
33585158|NCT02600845|62983317|FG000|Overall Study|Consent Withdrawal|5|||
33585159|NCT02599129|62983323|FG000|Overall Study|Lack of Efficacy|2|||
33585160|NCT02599129|62983324|FG001|Overall Study|Lack of Efficacy|2|||
33585161|NCT02599129|62983323|FG000|Overall Study|Lost to Follow-up|1|||
33585162|NCT02599129|62983324|FG001|Overall Study|Lost to Follow-up|0|||
33585163|NCT02599129|62983323|FG000|Overall Study|Withdrawal by Subject|2|||
33585164|NCT02599129|62983324|FG001|Overall Study|Withdrawal by Subject|1|||
33585165|NCT02596711|62983333|FG000|Overall Study|Lost to Follow-up|1|||
33585166|NCT02596711|62983334|FG001|Overall Study|Lost to Follow-up|2|||
33585167|NCT02596711|62983335|FG002|Overall Study|Lost to Follow-up|3|||
33585168|NCT02596009|62983343|FG000|Overall Study|Administrative problems|0|||
33585169|NCT02596009|62983344|FG001|Overall Study|Administrative problems|1|||
33585170|NCT02596009|62983345|FG002|Overall Study|Administrative problems|0|||
33585171|NCT02596009|62983346|FG003|Overall Study|Administrative problems|0|||
33585172|NCT02596009|62983347|FG004|Overall Study|Administrative problems|0|||
33585173|NCT02596009|62983348|FG005|Overall Study|Administrative problems|0|||
33585174|NCT02590939|62983356|FG000|Overall Study|Withdrawal by Subject|3|||
33585175|NCT02590939|62983357|FG001|Overall Study|Withdrawal by Subject|1|||
33585176|NCT02590939|62983356|FG000|Overall Study|Failed the nociceptive test|2|||
33585177|NCT02590939|62983357|FG001|Overall Study|Failed the nociceptive test|1|||
33585178|NCT04351087|62983365|FG000|Overall Study|Lost to Follow-up|7|||
33585179|NCT04351087|62983366|FG001|Overall Study|Lost to Follow-up|3|||
33585180|NCT04351087|62983365|FG000|Overall Study|Withdrawal by Subject|3|||
33585181|NCT04351087|62983366|FG001|Overall Study|Withdrawal by Subject|4|||
33585182|NCT04351087|62983365|FG000|Overall Study|Lack of Efficacy|3|||
33585183|NCT04351087|62983366|FG001|Overall Study|Lack of Efficacy|2|||
33585184|NCT02598193|62983372|FG000|Overall Study|Adverse Event|13|||
33585185|NCT02598193|62983372|FG000|Overall Study|Withdrawal by Subject|1|||
33585186|NCT02598193|62983372|FG000|Overall Study|Listed in active lung transplant list|1|||
33585187|NCT02598193|62983372|FG000|Overall Study|Does not want to take Nintedanib|1|||
33585188|NCT02595073|62983378|FG000|Overall Study|Progressive Disease|0|||
33585189|NCT02595073|62983379|FG001|Overall Study|Progressive Disease|1|||
33585190|NCT02595073|62983378|FG000|Overall Study|Protocol Violation|2|||
33585191|NCT02595073|62983379|FG001|Overall Study|Protocol Violation|0|||
33585192|NCT02593825|62983387|FG000|Intervention|Lost to Follow-up|10|||
33585193|NCT02593825|62983388|FG001|Intervention|Lost to Follow-up|12|||
33585194|NCT02388165|62983398|FG000|Overall Study|Study terminated by sponsor|5|||
33585195|NCT02388165|62983399|FG001|Overall Study|Study terminated by sponsor|5|||
33585196|NCT02388165|62983398|FG000|Overall Study|Other|11|||
33585197|NCT02388165|62983399|FG001|Overall Study|Other|13|||
33585198|NCT02388165|62983398|FG000|Overall Study|No longer meet eligibility criteria|40|||
33585199|NCT02388165|62983399|FG001|Overall Study|No longer meet eligibility criteria|43|||
33585200|NCT02388165|62983398|FG000|Overall Study|Withdrawal of consent|31|||
33585201|NCT02388165|62983399|FG001|Overall Study|Withdrawal of consent|32|||
33585202|NCT02388165|62983398|FG000|Overall Study|Lost to Follow-up|19|||
33585203|NCT02388165|62983399|FG001|Overall Study|Lost to Follow-up|20|||
33585204|NCT02388165|62983398|FG000|Overall Study|Death|13|||
33585205|NCT02388165|62983399|FG001|Overall Study|Death|10|||
33585206|NCT02388165|62983398|FG000|Overall Study|Adverse Event|3|||
33585207|NCT02388165|62983399|FG001|Overall Study|Adverse Event|5|||
33585208|NCT02388165|62983398|FG000|Overall Study|Did not meet entrance criteria|5|||
33585209|NCT02388165|62983399|FG001|Overall Study|Did not meet entrance criteria|2|||
33585210|NCT02404545|62983407|FG000|Overall Study|Sponsor Termination|6|||
33585211|NCT02404545|62983408|FG001|Overall Study|Sponsor Termination|6|||
33585212|NCT02420379|62983417|FG000|Overall Study|Withdrawal by Subject|0|||
33585213|NCT02420379|62983418|FG001|Overall Study|Withdrawal by Subject|3|||
33585214|NCT02420379|62983417|FG000|Overall Study|Unable to complete due to schooling|0|||
33585215|NCT02420379|62983418|FG001|Overall Study|Unable to complete due to schooling|1|||
33585216|NCT02420379|62983417|FG000|Overall Study|Transitioned to commercial drug|1|||
33585217|NCT02420379|62983418|FG001|Overall Study|Transitioned to commercial drug|0|||
33585218|NCT02347761|62983427|FG000|All Collected|Death|1|||
33585219|NCT02347761|62983428|FG001|All Collected|Death|0|||
33585220|NCT02347761|62983429|FG002|All Collected|Death|0|||
33585221|NCT02347761|62983427|FG000|All Collected|Lost to Follow-up|3|||
33585222|NCT02347761|62983428|FG001|All Collected|Lost to Follow-up|2|||
33585223|NCT02347761|62983429|FG002|All Collected|Lost to Follow-up|3|||
33585224|NCT02347761|62983427|FG000|All Collected|Withdrawal by Subject|11|||
33585225|NCT02347761|62983428|FG001|All Collected|Withdrawal by Subject|11|||
33585226|NCT02347761|62983429|FG002|All Collected|Withdrawal by Subject|22|||
33585227|NCT02347761|62983427|FG000|All Collected|invetigator disretion|2|||
33585228|NCT02347761|62983428|FG001|All Collected|invetigator disretion|0|||
33585229|NCT02347761|62983429|FG002|All Collected|invetigator disretion|0|||
33585230|NCT02347761|62983427|FG000|All Collected|instillation site pain|0|||
33585231|NCT02347761|62983428|FG001|All Collected|instillation site pain|0|||
33585232|NCT02347761|62983429|FG002|All Collected|instillation site pain|1|||
33585233|NCT02347761|62983427|FG000|All Collected|exacerbation of COPD|0|||
33585234|NCT02347761|62983428|FG001|All Collected|exacerbation of COPD|0|||
33585235|NCT02347761|62983429|FG002|All Collected|exacerbation of COPD|1|||
33585236|NCT02347761|62983427|FG000|All Collected|moved/travel|0|||
33585237|NCT02347761|62983428|FG001|All Collected|moved/travel|1|||
33585238|NCT02347761|62983429|FG002|All Collected|moved/travel|0|||
33585239|NCT02347761|62983427|FG000|On Study Treatment|Lack of Efficacy|2|||
33585240|NCT02347761|62983428|FG001|On Study Treatment|Lack of Efficacy|3|||
33585241|NCT02347761|62983429|FG002|On Study Treatment|Lack of Efficacy|4|||
33585242|NCT02347761|62983427|FG000|On Study Treatment|non-compliance with study medication|0|||
33585243|NCT02347761|62983428|FG001|On Study Treatment|non-compliance with study medication|0|||
33585244|NCT02347761|62983429|FG002|On Study Treatment|non-compliance with study medication|2|||
33585245|NCT02347761|62983427|FG000|On Study Treatment|Withdrawal by Subject|7|||
33585246|NCT02347761|62983428|FG001|On Study Treatment|Withdrawal by Subject|3|||
33585247|NCT02347761|62983429|FG002|On Study Treatment|Withdrawal by Subject|5|||
33585248|NCT02347761|62983427|FG000|On Study Treatment|move/travel|2|||
33585249|NCT02347761|62983428|FG001|On Study Treatment|move/travel|6|||
33585250|NCT02347761|62983429|FG002|On Study Treatment|move/travel|5|||
33585251|NCT02347761|62983427|FG000|On Study Treatment|dissastisfaction with device|2|||
33585252|NCT02347761|62983428|FG001|On Study Treatment|dissastisfaction with device|1|||
33585253|NCT02347761|62983429|FG002|On Study Treatment|dissastisfaction with device|4|||
33585254|NCT02347761|62983427|FG000|On Study Treatment|Lost to Follow-up|2|||
33585255|NCT02347761|62983428|FG001|On Study Treatment|Lost to Follow-up|1|||
33585256|NCT02347761|62983429|FG002|On Study Treatment|Lost to Follow-up|1|||
33585257|NCT02347761|62983427|FG000|On Study Treatment|investigator discretion|2|||
33585258|NCT02347761|62983428|FG001|On Study Treatment|investigator discretion|0|||
33585259|NCT02347761|62983429|FG002|On Study Treatment|investigator discretion|0|||
33585260|NCT02347761|62983427|FG000|On Study Treatment|durg not working|0|||
33585261|NCT02347761|62983428|FG001|On Study Treatment|durg not working|1|||
33585262|NCT02347761|62983429|FG002|On Study Treatment|durg not working|1|||
33585263|NCT02347761|62983427|FG000|On Study Treatment|Adverse Event|10|||
33585264|NCT02347761|62983428|FG001|On Study Treatment|Adverse Event|8|||
33585265|NCT02347761|62983429|FG002|On Study Treatment|Adverse Event|20|||
33585266|NCT02596945|62983437|FG000|Overall Study|No documentation of study drug dosing|3|||
33585267|NCT02596945|62983437|FG000|Overall Study|Other|32|||
33585268|NCT02596945|62983437|FG000|Overall Study|Change to hemodialysis|15|||
33585269|NCT02596945|62983437|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
33585270|NCT02596945|62983437|FG000|Overall Study|Withdrawal by Subject|1|||
33585271|NCT02596945|62983437|FG000|Overall Study|Missing|1|||
33585272|NCT02404389|62983455|FG000|Overall Study|Adverse Event|1|||
33585273|NCT02404389|62983456|FG001|Overall Study|Adverse Event|0|||
33585274|NCT02404389|62983457|FG002|Overall Study|Adverse Event|1|||
33585275|NCT02404389|62983458|FG003|Overall Study|Adverse Event|0|||
33585276|NCT02404389|62983459|FG004|Overall Study|Adverse Event|2|||
33585277|NCT02404389|62983455|FG000|Overall Study|Subject/guardian decision|1|||
33585278|NCT02404389|62983456|FG001|Overall Study|Subject/guardian decision|0|||
33585279|NCT02404389|62983457|FG002|Overall Study|Subject/guardian decision|0|||
33585280|NCT02404389|62983458|FG003|Overall Study|Subject/guardian decision|1|||
33585281|NCT02404389|62983459|FG004|Overall Study|Subject/guardian decision|1|||
33585282|NCT01667419|62983477|FG000|Overall Study|Reason Not Specified|1|||
33585283|NCT01667419|62983478|FG001|Overall Study|Reason Not Specified|0|||
33585284|NCT01667419|62983479|FG002|Overall Study|Reason Not Specified|0|||
33585285|NCT01667419|62983480|FG003|Overall Study|Reason Not Specified|0|||
33585286|NCT01667419|62983477|FG000|Overall Study|Withdrawal by Subject|16|||
33585287|NCT01667419|62983478|FG001|Overall Study|Withdrawal by Subject|8|||
33585288|NCT01667419|62983479|FG002|Overall Study|Withdrawal by Subject|9|||
33585289|NCT01667419|62983480|FG003|Overall Study|Withdrawal by Subject|8|||
33585290|NCT01667419|62983477|FG000|Overall Study|Non-compliance|0|||
33585291|NCT01667419|62983478|FG001|Overall Study|Non-compliance|0|||
33585292|NCT01667419|62983479|FG002|Overall Study|Non-compliance|0|||
33585293|NCT01667419|62983480|FG003|Overall Study|Non-compliance|1|||
33585294|NCT01667419|62983477|FG000|Overall Study|Protocol Violation|1|||
33585295|NCT01667419|62983478|FG001|Overall Study|Protocol Violation|0|||
33585296|NCT01667419|62983479|FG002|Overall Study|Protocol Violation|0|||
33585297|NCT01667419|62983480|FG003|Overall Study|Protocol Violation|0|||
33585298|NCT01667419|62983477|FG000|Overall Study|Lost to Follow-up|7|||
33585299|NCT01667419|62983478|FG001|Overall Study|Lost to Follow-up|6|||
33585300|NCT01667419|62983479|FG002|Overall Study|Lost to Follow-up|2|||
33585301|NCT01667419|62983480|FG003|Overall Study|Lost to Follow-up|4|||
33585302|NCT01667419|62983477|FG000|Overall Study|Death|18|||
33585303|NCT01667419|62983478|FG001|Overall Study|Death|33|||
33585304|NCT01667419|62983479|FG002|Overall Study|Death|25|||
33585305|NCT01667419|62983480|FG003|Overall Study|Death|26|||
33585306|NCT02588833|62983497|FG000|Part 1|Withdrawal by Subject|1|||
33585307|NCT02588833|62983498|FG001|Part 1|Withdrawal by Subject|0|||
33585308|NCT02588833|62983497|FG000|Part 2A|Physician Decision|0|||
33585309|NCT02588833|62983498|FG001|Part 2A|Physician Decision|1|||
33585310|NCT02588833|62983497|FG000|Part 2A|Withdrawal by Subject|0|||
33585311|NCT02588833|62983498|FG001|Part 2A|Withdrawal by Subject|1|||
33585312|NCT02588833|62983497|FG000|Part 2B|Adverse Event|0|||
33585313|NCT02588833|62983498|FG001|Part 2B|Adverse Event|1|||
33585314|NCT02588833|62983497|FG000|Part 2C|Adverse Event|0|||
33585315|NCT02588833|62983498|FG001|Part 2C|Adverse Event|1|||
33585316|NCT02588833|62983497|FG000|Part 2C|Withdrawal by Subject|0|||
33585317|NCT02588833|62983498|FG001|Part 2C|Withdrawal by Subject|1|||
33585318|NCT02588833|62983497|FG000|Part 3 (Safety Follow-up)|Other|0|||
33585319|NCT02588833|62983498|FG001|Part 3 (Safety Follow-up)|Other|2|||
33585320|NCT01667107|62983507|FG000|Overall Study|Adverse Event|4|||
33585321|NCT01667107|62983508|FG001|Overall Study|Adverse Event|3|||
33585322|NCT01667107|62983507|FG000|Overall Study|Tolerability issues|0|||
33585323|NCT01667107|62983508|FG001|Overall Study|Tolerability issues|2|||
33585324|NCT01667107|62983507|FG000|Overall Study|Protocol Violation|0|||
33585325|NCT01667107|62983508|FG001|Overall Study|Protocol Violation|1|||
33585326|NCT01667107|62983507|FG000|Overall Study|Lack of Efficacy|0|||
33585327|NCT01667107|62983508|FG001|Overall Study|Lack of Efficacy|1|||
33585328|NCT02590003|62983532|FG000|Overall Study|Death|1|||
33585329|NCT02590003|62983533|FG001|Overall Study|Death|2|||
33585330|NCT02404311|62983562|FG000|Part A: Month 0-18|Death|2|||
33585331|NCT02404311|62983563|FG001|Part A: Month 0-18|Death|0|||
33585332|NCT02404311|62983564|FG002|Part A: Month 0-18|Death|0|||
33585333|NCT02404311|62983565|FG003|Part A: Month 0-18|Death|0|||
33585334|NCT02404311|62983566|FG004|Part A: Month 0-18|Death|0|||
33585335|NCT02404311|62983562|FG000|Part A: Month 0-18|Physician Decision|1|||
33585336|NCT02404311|62983563|FG001|Part A: Month 0-18|Physician Decision|0|||
33585337|NCT02404311|62983564|FG002|Part A: Month 0-18|Physician Decision|0|||
33585338|NCT02404311|62983565|FG003|Part A: Month 0-18|Physician Decision|0|||
33585339|NCT02404311|62983566|FG004|Part A: Month 0-18|Physician Decision|0|||
33585340|NCT02404311|62983562|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
33585341|NCT02404311|62983563|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
33585342|NCT02404311|62983564|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
33585343|NCT02404311|62983565|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
33585344|NCT02404311|62983566|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
33585345|NCT02404311|62983562|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
33585346|NCT02404311|62983563|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
33585347|NCT02404311|62983564|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
33585348|NCT02404311|62983565|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
33585349|NCT02404311|62983566|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
33585350|NCT02404311|62983562|FG000|Part A: Month 0-18|HIV Infection|6|||
33585351|NCT02404311|62983563|FG001|Part A: Month 0-18|HIV Infection|2|||
33585352|NCT02404311|62983564|FG002|Part A: Month 0-18|HIV Infection|0|||
33585353|NCT02404311|62983565|FG003|Part A: Month 0-18|HIV Infection|0|||
33585354|NCT02404311|62983566|FG004|Part A: Month 0-18|HIV Infection|0|||
33585355|NCT02404311|62983562|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
33585356|NCT02404311|62983563|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
33585357|NCT02404311|62983564|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
33585358|NCT02404311|62983565|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
33310670|NCT01235598|62686080|FG001|Overall Study|Withdrawal by Subject|0|||
33310671|NCT01235442|62686089|FG000|Overall Study|Lost to Follow-up|12|||
33310672|NCT01235442|62686090|FG001|Overall Study|Lost to Follow-up|10|||
33585359|NCT02404311|62983566|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
33585360|NCT01650519|62983580|FG000|Overall Study|Withdrawal by Subject|1|||
33585361|NCT01650519|62983581|FG001|Overall Study|Withdrawal by Subject|0|||
33585362|NCT01650285|62983587|FG000|Overall Study|Adverse Event|1|||
33585363|NCT02347527|62983595|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
33585364|NCT02347527|62983596|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
33585365|NCT02347527|62983597|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
33585366|NCT02347527|62983598|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
33585367|NCT02347527|62983595|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
33585368|NCT02347527|62983596|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
33585369|NCT02347527|62983597|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
33585370|NCT02347527|62983598|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
33585371|NCT02347527|62983595|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
33585372|NCT02347527|62983596|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
33651238|NCT01972841|63062640|FG004|Overall Study|Withdrawal by participants|33|||
33585373|NCT02347527|62983597|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
33585374|NCT02347527|62983598|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
33585375|NCT02347527|62983595|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
33585376|NCT02347527|62983596|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
33585377|NCT02347527|62983597|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
33585378|NCT02347527|62983598|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
33585379|NCT02347527|62983595|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
33585380|NCT02347527|62983596|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
33585381|NCT02347527|62983597|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
33585382|NCT02347527|62983598|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
33585383|NCT02386839|62983612|FG000|Overall Study|Death|1|||
33585384|NCT02386839|62983613|FG001|Overall Study|Death|0|||
33585385|NCT02386839|62983612|FG000|Overall Study|Withdrawal by Subject|9|||
33585386|NCT02386839|62983613|FG001|Overall Study|Withdrawal by Subject|10|||
33585387|NCT02386839|62983612|FG000|Overall Study|Lost to Follow-up|4|||
33585388|NCT02386839|62983613|FG001|Overall Study|Lost to Follow-up|4|||
33585389|NCT02386839|62983612|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
33585390|NCT02386839|62983613|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
33585391|NCT02386839|62983612|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
33585392|NCT02386839|62983613|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
33585393|NCT02386839|62983612|FG000|Overall Study|Other (unspecified)|1|||
33585394|NCT02386839|62983613|FG001|Overall Study|Other (unspecified)|0|||
33585395|NCT01649271|62983625|FG000|Overall Study|Progressive disease|4|||
33585396|NCT01649271|62983626|FG001|Overall Study|Progressive disease|5|||
33585397|NCT01649271|62983625|FG000|Overall Study|Other Adverse Event|0|||
33585398|NCT01649271|62983626|FG001|Overall Study|Other Adverse Event|2|||
33585399|NCT01649271|62983625|FG000|Overall Study|Withdrawal by Subject|1|||
33585400|NCT01649271|62983626|FG001|Overall Study|Withdrawal by Subject|0|||
33585401|NCT01649271|62983625|FG000|Overall Study|Other than stated above|1|||
33585402|NCT01649271|62983626|FG001|Overall Study|Other than stated above|0|||
33585403|NCT02385669|62983633|FG000|Overall Study|Adverse Event|2|||
33585404|NCT02402907|62983639|FG000|Overall Study|Delivered vaginally|9|||
33585405|NCT02402907|62983640|FG001|Overall Study|Delivered vaginally|3|||
33585406|NCT02402907|62983639|FG000|Overall Study|Delivered outside of Sinai|1|||
33585407|NCT02402907|62983640|FG001|Overall Study|Delivered outside of Sinai|1|||
33585408|NCT02402907|62983639|FG000|Overall Study|Lost to follow up after C-Section|10|||
33585409|NCT02402907|62983640|FG001|Overall Study|Lost to follow up after C-Section|23|||
33585410|NCT02345889|62983650|FG000|Overall Study|Inadequate Bowel Prep|17|||
33585411|NCT02345889|62983651|FG001|Overall Study|Inadequate Bowel Prep|16|||
33585412|NCT02345889|62983652|FG002|Overall Study|Inadequate Bowel Prep|18|||
33585413|NCT02345889|62983653|FG003|Overall Study|Inadequate Bowel Prep|14|||
33585414|NCT02345889|62983650|FG000|Overall Study|Polyposis identified during procedure|1|||
33585415|NCT02345889|62983651|FG001|Overall Study|Polyposis identified during procedure|1|||
33585416|NCT02345889|62983652|FG002|Overall Study|Polyposis identified during procedure|0|||
33585417|NCT02345889|62983653|FG003|Overall Study|Polyposis identified during procedure|1|||
33585418|NCT02345889|62983650|FG000|Overall Study|Recognized ineligible post-randomization|1|||
33585419|NCT02345889|62983651|FG001|Overall Study|Recognized ineligible post-randomization|0|||
33585420|NCT02345889|62983652|FG002|Overall Study|Recognized ineligible post-randomization|2|||
33585421|NCT02345889|62983653|FG003|Overall Study|Recognized ineligible post-randomization|1|||
33585422|NCT02345889|62983650|FG000|Overall Study|Ulcerative Colitis identified|1|||
33585423|NCT02345889|62983651|FG001|Overall Study|Ulcerative Colitis identified|0|||
33585424|NCT02345889|62983652|FG002|Overall Study|Ulcerative Colitis identified|0|||
33585425|NCT02345889|62983653|FG003|Overall Study|Ulcerative Colitis identified|0|||
33585426|NCT02345889|62983650|FG000|Overall Study|Cecum not intubated|1|||
33585427|NCT02345889|62983651|FG001|Overall Study|Cecum not intubated|0|||
33585428|NCT02345889|62983652|FG002|Overall Study|Cecum not intubated|0|||
33585429|NCT02345889|62983653|FG003|Overall Study|Cecum not intubated|0|||
33585430|NCT02345811|62983663|FG000|First Intervention|Withdrawal by Subject|1|||
33585431|NCT02345811|62983664|FG001|First Intervention|Withdrawal by Subject|1|||
33585432|NCT02344173|62983672|FG000|Procedure|Ablation Procedure Not Performed|7|||
33585433|NCT02344173|62983672|FG000|12-month Visit|Death|8|||
33585434|NCT02344173|62983672|FG000|12-month Visit|Withdrawal by Subject|30|||
33585435|NCT02344173|62983672|FG000|12-month Visit|Lost to Follow-up|58|||
33585436|NCT02586493|62983678|FG000|Overall Study|Adverse Event|4|||
33585437|NCT02586493|62983678|FG000|Overall Study|Protocol Violation|6|||
33585438|NCT02586493|62983678|FG000|Overall Study|Lost to Follow-up|1|||
33585439|NCT02586493|62983678|FG000|Overall Study|Withdrawal by Subject|1|||
33585440|NCT02400333|62983686|FG000|Overall Study|Withdrawal by Subject|0|||
33585441|NCT02400333|62983687|FG001|Overall Study|Withdrawal by Subject|1|||
33585442|NCT02400333|62983688|FG002|Overall Study|Withdrawal by Subject|0|||
33585443|NCT02400333|62983689|FG003|Overall Study|Withdrawal by Subject|1|||
33585444|NCT02400333|62983686|FG000|Overall Study|Protocol Violation|1|||
33585445|NCT02400333|62983687|FG001|Overall Study|Protocol Violation|0|||
33585446|NCT02400333|62983688|FG002|Overall Study|Protocol Violation|2|||
33585447|NCT02400333|62983689|FG003|Overall Study|Protocol Violation|1|||
33585448|NCT02399475|62983702|FG000|Overall Study|Physician Decision|1|||
33585449|NCT02399475|62983703|FG001|Overall Study|Physician Decision|0|||
33585450|NCT02399163|62983709|FG000|Overall Study|Adverse Event|2|||
33585451|NCT02399163|62983709|FG000|Overall Study|Protocol Deviation|2|||
33585452|NCT02399163|62983709|FG000|Overall Study|Withdrawal by Participant|5|||
33585453|NCT02398227|62983723|FG000|Overall Study|Lost to Follow-up|21|||
33585454|NCT02398227|62983724|FG001|Overall Study|Lost to Follow-up|12|||
33585455|NCT02398227|62983723|FG000|Overall Study|Withdrawal by Subject|5|||
33585456|NCT02398227|62983724|FG001|Overall Study|Withdrawal by Subject|6|||
33585457|NCT02398227|62983723|FG000|Overall Study|Removed from treatment and dropped out|1|||
33585458|NCT02398227|62983724|FG001|Overall Study|Removed from treatment and dropped out|0|||
33585459|NCT02397915|62983730|FG000|Period 1|Protocol Violation|0|||
33585460|NCT02397915|62983731|FG001|Period 1|Protocol Violation|1|||
33585461|NCT02397915|62983732|FG002|Period 1|Protocol Violation|0|||
33585462|NCT02397915|62983733|FG003|Period 1|Protocol Violation|0|||
33585463|NCT02397915|62983730|FG000|Period 1|Physician Decision|1|||
33585464|NCT02397915|62983731|FG001|Period 1|Physician Decision|0|||
33585465|NCT02397915|62983732|FG002|Period 1|Physician Decision|0|||
33585466|NCT02397915|62983733|FG003|Period 1|Physician Decision|0|||
33585467|NCT02397837|62983743|FG000|Overall Study|Withdrawal by Subject|6|||
33585468|NCT02397837|62983744|FG001|Overall Study|Withdrawal by Subject|5|||
33585469|NCT02397837|62983743|FG000|Overall Study|Physician Decision|1|||
33585470|NCT02397837|62983744|FG001|Overall Study|Physician Decision|1|||
33585471|NCT02586415|62983752|FG000|Overall Study|Death|13|||
33585472|NCT02586415|62983753|FG001|Overall Study|Death|23|||
33585473|NCT02586415|62983752|FG000|Overall Study|Lost to Follow-up|1|||
33585474|NCT02586415|62983753|FG001|Overall Study|Lost to Follow-up|2|||
33585475|NCT02383017|62983762|FG000|Overall Study|Injury Sustained Outside Study|1|||
33585476|NCT02383017|62983763|FG001|Overall Study|Injury Sustained Outside Study|0|||
33585477|NCT02383017|62983762|FG000|Overall Study|Compliance|3|||
33585478|NCT02383017|62983763|FG001|Overall Study|Compliance|2|||
33585479|NCT02383017|62983762|FG000|Overall Study|Found to be Hypogonadal|1|||
33585480|NCT02383017|62983763|FG001|Overall Study|Found to be Hypogonadal|0|||
33585481|NCT02382939|62983771|FG000|Overall Study|Adverse Event|1|||
33585482|NCT02382939|62983772|FG001|Overall Study|Adverse Event|1|||
33585483|NCT02382939|62983771|FG000|Overall Study|Withdrawal by Subject|2|||
33585484|NCT02382939|62983772|FG001|Overall Study|Withdrawal by Subject|2|||
33585485|NCT02587819|62983779|FG000|Overall Study|Adverse Event|1|||
33585486|NCT02587819|62983779|FG000|Overall Study|Lost to Follow-up|1|||
33585487|NCT01666951|62983786|FG000|Overall Study|Not dosed|1|||
33585488|NCT01666951|62983787|FG001|Overall Study|Not dosed|1|||
33585489|NCT02586805|62983797|FG000|Overall Study|Withdrawal by Subject|3|||
33585490|NCT02586805|62983798|FG001|Overall Study|Withdrawal by Subject|1|||
33585491|NCT02586805|62983799|FG002|Overall Study|Withdrawal by Subject|1|||
33585492|NCT02586805|62983800|FG003|Overall Study|Withdrawal by Subject|2|||
33585493|NCT02586805|62983797|FG000|Overall Study|Adverse Event|2|||
33585494|NCT02586805|62983798|FG001|Overall Study|Adverse Event|0|||
33585495|NCT02586805|62983799|FG002|Overall Study|Adverse Event|1|||
33585496|NCT02586805|62983800|FG003|Overall Study|Adverse Event|0|||
33585497|NCT02586805|62983797|FG000|Overall Study|Lost to Follow-up|0|||
33585498|NCT02586805|62983798|FG001|Overall Study|Lost to Follow-up|0|||
33585499|NCT02586805|62983799|FG002|Overall Study|Lost to Follow-up|1|||
33585500|NCT02586805|62983800|FG003|Overall Study|Lost to Follow-up|0|||
33585501|NCT02586805|62983797|FG000|Overall Study|Physician Decision|1|||
33585502|NCT02586805|62983798|FG001|Overall Study|Physician Decision|0|||
33585503|NCT02586805|62983799|FG002|Overall Study|Physician Decision|0|||
33585504|NCT02586805|62983800|FG003|Overall Study|Physician Decision|0|||
33585505|NCT02586727|62983812|FG000|Overall Study|Lost to Follow-up|1|||
33585506|NCT02586727|62983813|FG001|Overall Study|Lost to Follow-up|0|||
33679787|NCT01666314|63131841|FG000|Overall Study|Progressive Disease|11|||
33585507|NCT02580877|62983821|FG000|Overall Study|Withdrawal by Subject|1|||
33585508|NCT02580877|62983822|FG001|Overall Study|Withdrawal by Subject|3|||
33585509|NCT02580877|62983821|FG000|Overall Study|Adverse Event|0|||
33585510|NCT02580877|62983822|FG001|Overall Study|Adverse Event|1|||
33585511|NCT02582983|62983838|FG000|Overall Study|Death|3|||
33585512|NCT02582983|62983838|FG000|Overall Study|Withdrawal by Subject|2|||
33585513|NCT02582983|62983838|FG000|Overall Study|Adverse Event|1|||
33585514|NCT02582749|62983844|FG000|Overall Study|Study terminated by funder|5|||
33585515|NCT02582749|62983845|FG001|Overall Study|Study terminated by funder|10|||
33679788|NCT01666314|63131842|FG001|Overall Study|Progressive Disease|9|||
33585516|NCT02582749|62983844|FG000|Overall Study|Withdrawal by Subject|0|||
33585517|NCT02582749|62983845|FG001|Overall Study|Withdrawal by Subject|1|||
33585518|NCT02582671|62983851|FG000|Overall Study|Failure to return|1|||
33585519|NCT02582671|62983851|FG000|Overall Study|Other, not specified|1|||
33585520|NCT02585713|62983858|FG000|Overall Study|Withdrew prior to treatment|2|||
33585521|NCT02585713|62983859|FG001|Overall Study|Withdrew prior to treatment|7|||
33585522|NCT02585713|62983858|FG000|Overall Study|Other|3|||
33585523|NCT02585713|62983859|FG001|Overall Study|Other|1|||
33585524|NCT02579863|62983867|FG000|Overall Study|Final Disposition Unknown|2|||
33585525|NCT02579863|62983868|FG001|Overall Study|Final Disposition Unknown|1|||
33585526|NCT02579863|62983867|FG000|Overall Study|Adverse Event|18|||
33585527|NCT02579863|62983868|FG001|Overall Study|Adverse Event|11|||
33585528|NCT02579863|62983867|FG000|Overall Study|Death|31|||
33585529|NCT02579863|62983868|FG001|Overall Study|Death|29|||
33585530|NCT02579863|62983867|FG000|Overall Study|Lost to Follow-up|2|||
33585531|NCT02579863|62983868|FG001|Overall Study|Lost to Follow-up|1|||
33585532|NCT02579863|62983867|FG000|Overall Study|Physician Decision|1|||
33585533|NCT02579863|62983868|FG001|Overall Study|Physician Decision|2|||
33585534|NCT02579863|62983867|FG000|Overall Study|Screen Failure|0|||
33585535|NCT02579863|62983868|FG001|Overall Study|Screen Failure|2|||
33585536|NCT02579863|62983867|FG000|Overall Study|Study Terminated at Selected Sites|82|||
33585537|NCT02579863|62983868|FG001|Overall Study|Study Terminated at Selected Sites|88|||
33585538|NCT02579863|62983867|FG000|Overall Study|Withdrawal by Subject|20|||
33585539|NCT02579863|62983868|FG001|Overall Study|Withdrawal by Subject|20|||
33585540|NCT02582515|62983876|FG000|Overall Study|Withdrawal by Subject|0|||
33585541|NCT02582515|62983877|FG001|Overall Study|Withdrawal by Subject|1|||
33585542|NCT02579629|62983886|FG000|Overall Study|Withdrawal by Subject|0|||
33585543|NCT02579629|62983887|FG001|Overall Study|Withdrawal by Subject|1|||
33585544|NCT02579629|62983888|FG002|Overall Study|Withdrawal by Subject|0|||
33585545|NCT02579629|62983886|FG000|Overall Study|Screen Failure|2|||
33585546|NCT02579629|62983887|FG001|Overall Study|Screen Failure|0|||
33585547|NCT02579629|62983888|FG002|Overall Study|Screen Failure|2|||
33585548|NCT02343939|62983905|FG000|Overall Study|Death|0|||
33585549|NCT02343939|62983906|FG001|Overall Study|Death|15|||
33585550|NCT02343939|62983907|FG002|Overall Study|Death|4|||
33585551|NCT02343939|62983908|FG003|Overall Study|Death|2|||
33585552|NCT02343939|62983909|FG004|Overall Study|Death|5|||
33585553|NCT02343939|62983910|FG005|Overall Study|Death|11|||
33585554|NCT02343939|62983911|FG006|Overall Study|Death|8|||
33585555|NCT02343939|62983912|FG007|Overall Study|Death|22|||
33585556|NCT02343939|62983913|FG008|Overall Study|Death|1|||
33585557|NCT02343939|62983905|FG000|Overall Study|Study terminated by sponsor|0|||
33585558|NCT02343939|62983906|FG001|Overall Study|Study terminated by sponsor|27|||
33585559|NCT02343939|62983907|FG002|Overall Study|Study terminated by sponsor|0|||
33585560|NCT02343939|62983908|FG003|Overall Study|Study terminated by sponsor|1|||
33585561|NCT02343939|62983909|FG004|Overall Study|Study terminated by sponsor|1|||
33585562|NCT02343939|62983910|FG005|Overall Study|Study terminated by sponsor|5|||
33585563|NCT02343939|62983911|FG006|Overall Study|Study terminated by sponsor|3|||
33585564|NCT02343939|62983912|FG007|Overall Study|Study terminated by sponsor|4|||
33585565|NCT02343939|62983913|FG008|Overall Study|Study terminated by sponsor|0|||
33585566|NCT02343939|62983905|FG000|Overall Study|Withdrew consent|3|||
33585567|NCT02343939|62983906|FG001|Overall Study|Withdrew consent|6|||
33585568|NCT02343939|62983907|FG002|Overall Study|Withdrew consent|1|||
33585569|NCT02343939|62983908|FG003|Overall Study|Withdrew consent|2|||
33585570|NCT02343939|62983909|FG004|Overall Study|Withdrew consent|2|||
33585571|NCT02343939|62983910|FG005|Overall Study|Withdrew consent|0|||
33585572|NCT02343939|62983911|FG006|Overall Study|Withdrew consent|0|||
33585573|NCT02343939|62983912|FG007|Overall Study|Withdrew consent|8|||
33585574|NCT02343939|62983913|FG008|Overall Study|Withdrew consent|6|||
33585575|NCT02343939|62983905|FG000|Overall Study|Treatment failure|0|||
33585576|NCT02343939|62983906|FG001|Overall Study|Treatment failure|0|||
33585577|NCT02343939|62983907|FG002|Overall Study|Treatment failure|0|||
33585578|NCT02343939|62983908|FG003|Overall Study|Treatment failure|0|||
33585579|NCT02343939|62983909|FG004|Overall Study|Treatment failure|0|||
33585580|NCT02343939|62983910|FG005|Overall Study|Treatment failure|0|||
33585581|NCT02343939|62983911|FG006|Overall Study|Treatment failure|2|||
33585582|NCT02343939|62983912|FG007|Overall Study|Treatment failure|1|||
33585583|NCT02343939|62983913|FG008|Overall Study|Treatment failure|0|||
33585584|NCT02343939|62983905|FG000|Overall Study|Investigator's discretion|0|||
33585585|NCT02343939|62983906|FG001|Overall Study|Investigator's discretion|0|||
33585586|NCT02343939|62983907|FG002|Overall Study|Investigator's discretion|0|||
33585587|NCT02343939|62983908|FG003|Overall Study|Investigator's discretion|1|||
33585588|NCT02343939|62983909|FG004|Overall Study|Investigator's discretion|0|||
33585589|NCT02343939|62983910|FG005|Overall Study|Investigator's discretion|0|||
33585590|NCT02343939|62983911|FG006|Overall Study|Investigator's discretion|1|||
33585591|NCT02343939|62983912|FG007|Overall Study|Investigator's discretion|0|||
33585592|NCT02343939|62983913|FG008|Overall Study|Investigator's discretion|0|||
33585593|NCT02343939|62983905|FG000|Overall Study|Adverse Event|0|||
33585594|NCT02343939|62983906|FG001|Overall Study|Adverse Event|0|||
33585595|NCT02343939|62983907|FG002|Overall Study|Adverse Event|0|||
33585596|NCT02343939|62983908|FG003|Overall Study|Adverse Event|0|||
33585597|NCT02343939|62983909|FG004|Overall Study|Adverse Event|0|||
33585598|NCT02343939|62983910|FG005|Overall Study|Adverse Event|1|||
33585599|NCT02343939|62983911|FG006|Overall Study|Adverse Event|0|||
33585600|NCT02343939|62983912|FG007|Overall Study|Adverse Event|0|||
33585601|NCT02343939|62983913|FG008|Overall Study|Adverse Event|0|||
33585602|NCT02343939|62983905|FG000|Overall Study|Never Treated With ENTO|0|||
33585603|NCT02343939|62983906|FG001|Overall Study|Never Treated With ENTO|0|||
33585604|NCT02343939|62983907|FG002|Overall Study|Never Treated With ENTO|0|||
33585605|NCT02343939|62983908|FG003|Overall Study|Never Treated With ENTO|0|||
33585606|NCT02343939|62983909|FG004|Overall Study|Never Treated With ENTO|0|||
33585607|NCT02343939|62983910|FG005|Overall Study|Never Treated With ENTO|0|||
33585608|NCT02343939|62983911|FG006|Overall Study|Never Treated With ENTO|1|||
33585609|NCT02343939|62983912|FG007|Overall Study|Never Treated With ENTO|2|||
33585610|NCT02343939|62983913|FG008|Overall Study|Never Treated With ENTO|0|||
33585611|NCT02397447|62983949|FG000|Overall Study|Lost to Follow-up|2|||
33585612|NCT02397447|62983950|FG001|Overall Study|Lost to Follow-up|2|||
33585613|NCT02397057|62983958|FG000|Overall Study|Withdrawal by Subject|6|||
33585614|NCT02397057|62983959|FG001|Overall Study|Withdrawal by Subject|7|||
33585615|NCT02397057|62983958|FG000|Overall Study|Lost to Follow-up|4|||
33585616|NCT02397057|62983959|FG001|Overall Study|Lost to Follow-up|3|||
33585617|NCT02397057|62983958|FG000|Overall Study|Death|1|||
33585618|NCT02397057|62983959|FG001|Overall Study|Death|0|||
33585619|NCT02397057|62983958|FG000|Overall Study|Adverse Event|0|||
33585620|NCT02397057|62983959|FG001|Overall Study|Adverse Event|1|||
33585621|NCT02397057|62983958|FG000|Overall Study|Physician Decision|0|||
33585622|NCT02397057|62983959|FG001|Overall Study|Physician Decision|1|||
33585623|NCT02397057|62983958|FG000|Overall Study|Subject did not receive study drug|0|||
33585624|NCT02397057|62983959|FG001|Overall Study|Subject did not receive study drug|1|||
33585625|NCT02343549|62983965|FG000|Overall Study|Death|11|||
33585626|NCT02343549|62983965|FG000|Overall Study|Withdrawal by Subject|2|||
33585627|NCT02343159|62983972|FG000|Overall Study|Early Study Termination|16|||
33585628|NCT02343159|62983973|FG001|Overall Study|Early Study Termination|19|||
33585629|NCT02343159|62983974|FG002|Overall Study|Early Study Termination|23|||
33585630|NCT02343159|62983972|FG000|Overall Study|Physician Decision|2|||
33585631|NCT02343159|62983973|FG001|Overall Study|Physician Decision|0|||
33585632|NCT02343159|62983974|FG002|Overall Study|Physician Decision|1|||
33585633|NCT02343159|62983972|FG000|Overall Study|Withdrawal by Subject|3|||
33585634|NCT02343159|62983973|FG001|Overall Study|Withdrawal by Subject|0|||
33585635|NCT02343159|62983974|FG002|Overall Study|Withdrawal by Subject|2|||
33679789|NCT01666314|63131843|FG002|Overall Study|Progressive Disease|19|||
33679790|NCT01666314|63131844|FG003|Overall Study|Progressive Disease|20|||
33679791|NCT01666314|63131841|FG000|Overall Study|Symptomatic Deterioration|1|||
33679792|NCT01666314|63131842|FG001|Overall Study|Symptomatic Deterioration|0|||
33679793|NCT01666314|63131843|FG002|Overall Study|Symptomatic Deterioration|2|||
33679794|NCT01666314|63131844|FG003|Overall Study|Symptomatic Deterioration|0|||
33679795|NCT01666314|63131841|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
33679796|NCT01666314|63131842|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
33310673|NCT01235442|62686089|FG000|Overall Study|Death|0|||
33585636|NCT02343159|62983972|FG000|Overall Study|Lost to Follow-up|0|||
33585637|NCT02343159|62983973|FG001|Overall Study|Lost to Follow-up|2|||
33585638|NCT02343159|62983974|FG002|Overall Study|Lost to Follow-up|2|||
33585639|NCT02343159|62983972|FG000|Overall Study|Adverse Event|4|||
33585640|NCT02343159|62983973|FG001|Overall Study|Adverse Event|4|||
33585641|NCT02343159|62983974|FG002|Overall Study|Adverse Event|2|||
33585642|NCT02343159|62983972|FG000|Overall Study|Sponsor Decision|0|||
33585643|NCT02343159|62983973|FG001|Overall Study|Sponsor Decision|1|||
33585644|NCT02343159|62983974|FG002|Overall Study|Sponsor Decision|0|||
33585645|NCT02343159|62983972|FG000|Overall Study|Enrollment Error|1|||
33585646|NCT02343159|62983973|FG001|Overall Study|Enrollment Error|0|||
33585647|NCT02343159|62983974|FG002|Overall Study|Enrollment Error|0|||
33585648|NCT02395653|62983983|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
33585649|NCT02395653|62983983|FG000|Overall Study|Consent Withdrawn at Screening|1|||
33585650|NCT02395653|62983983|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
33585651|NCT02395653|62983983|FG000|Overall Study|Investigator Decision at Screening|1|||
33585652|NCT02395653|62983983|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
33585653|NCT02395653|62983983|FG000|Overall Study|Withdrawal by Subject|1|||
33585654|NCT02395653|62983983|FG000|Overall Study|Lost to Follow-up|1|||
33585655|NCT01664923|62983989|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
33585656|NCT01664923|62983990|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
33585657|NCT01664923|62983989|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
33679797|NCT01666314|63131843|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
33585658|NCT01664923|62983990|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
33585659|NCT01664923|62983989|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
33585660|NCT01664923|62983990|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
33585661|NCT01664923|62983989|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
33585662|NCT01664923|62983990|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
33585663|NCT01664923|62983989|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
33585664|NCT01664923|62983990|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
33585665|NCT01664923|62983989|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
33585666|NCT01664923|62983990|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
33585667|NCT01664923|62983989|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
33585668|NCT01664923|62983990|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
33585669|NCT01664923|62983989|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
33585670|NCT01664923|62983990|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
33585671|NCT01664923|62983989|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
33585672|NCT01664923|62983990|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
33585673|NCT01664923|62983989|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
33585674|NCT01664923|62983990|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
33585675|NCT01664923|62983989|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
33585676|NCT01664923|62983990|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
33585677|NCT01664923|62983989|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
33585678|NCT01664923|62983990|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
33585679|NCT01664923|62983989|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
33585680|NCT01664923|62983990|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
33585681|NCT01664923|62983989|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
33585682|NCT01664923|62983990|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
33585683|NCT01664533|62984000|FG000|Overall Study|Death|42|||
33585684|NCT01664533|62984000|FG000|Overall Study|Lost to Follow-up|3|||
33585685|NCT01664533|62984000|FG000|Overall Study|Study termination|9|||
33585686|NCT01664533|62984000|FG000|Overall Study|Protocol Violation|3|||
33585687|NCT02584855|62984005|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
33585688|NCT02584855|62984006|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
33585689|NCT02584855|62984007|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
33585690|NCT02584855|62984008|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
33585691|NCT02584855|62984009|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
33585692|NCT02584855|62984010|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
33585693|NCT02584855|62984005|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
33585694|NCT02584855|62984006|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
33585695|NCT02584855|62984007|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
33585696|NCT02584855|62984008|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
33585697|NCT02584855|62984009|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
33585698|NCT02584855|62984010|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
33585699|NCT02584855|62984005|FG000|Open-Label Treatment Period|Adverse Event|14|||
33585700|NCT02584855|62984006|FG001|Open-Label Treatment Period|Adverse Event|0|||
33585701|NCT02584855|62984007|FG002|Open-Label Treatment Period|Adverse Event|0|||
33585702|NCT02584855|62984008|FG003|Open-Label Treatment Period|Adverse Event|0|||
33585703|NCT02584855|62984009|FG004|Open-Label Treatment Period|Adverse Event|0|||
33585704|NCT02584855|62984010|FG005|Open-Label Treatment Period|Adverse Event|0|||
33585705|NCT02584855|62984005|FG000|Open-Label Treatment Period|Death|2|||
33585706|NCT02584855|62984006|FG001|Open-Label Treatment Period|Death|0|||
33585707|NCT02584855|62984007|FG002|Open-Label Treatment Period|Death|0|||
33585708|NCT02584855|62984008|FG003|Open-Label Treatment Period|Death|0|||
33585709|NCT02584855|62984009|FG004|Open-Label Treatment Period|Death|0|||
33585710|NCT02584855|62984010|FG005|Open-Label Treatment Period|Death|0|||
33585711|NCT02584855|62984005|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
33585712|NCT02584855|62984006|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
33585713|NCT02584855|62984007|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
33585714|NCT02584855|62984008|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
33585715|NCT02584855|62984009|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
33585716|NCT02584855|62984010|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
33585717|NCT02584855|62984005|FG000|Open-Label Treatment Period|Protocol Violation|1|||
33585718|NCT02584855|62984006|FG001|Open-Label Treatment Period|Protocol Violation|0|||
33585719|NCT02584855|62984007|FG002|Open-Label Treatment Period|Protocol Violation|0|||
33585720|NCT02584855|62984008|FG003|Open-Label Treatment Period|Protocol Violation|0|||
33585721|NCT02584855|62984009|FG004|Open-Label Treatment Period|Protocol Violation|0|||
33585722|NCT02584855|62984010|FG005|Open-Label Treatment Period|Protocol Violation|0|||
33585723|NCT02584855|62984005|FG000|Open-Label Treatment Period|No PI Available|2|||
33585724|NCT02584855|62984006|FG001|Open-Label Treatment Period|No PI Available|0|||
33585725|NCT02584855|62984007|FG002|Open-Label Treatment Period|No PI Available|0|||
33585726|NCT02584855|62984008|FG003|Open-Label Treatment Period|No PI Available|0|||
33585727|NCT02584855|62984009|FG004|Open-Label Treatment Period|No PI Available|0|||
33585728|NCT02584855|62984010|FG005|Open-Label Treatment Period|No PI Available|0|||
33585729|NCT02584855|62984005|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
33585730|NCT02584855|62984006|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
33585731|NCT02584855|62984007|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
33585732|NCT02584855|62984008|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
33585733|NCT02584855|62984009|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
33585734|NCT02584855|62984010|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
33585735|NCT02584855|62984005|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
33585736|NCT02584855|62984006|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
33585737|NCT02584855|62984007|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
33585738|NCT02584855|62984008|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
33585739|NCT02584855|62984009|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
33585740|NCT02584855|62984010|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
33585741|NCT02584855|62984005|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
33585742|NCT02584855|62984006|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
33585743|NCT02584855|62984007|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
33585744|NCT02584855|62984008|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
33585745|NCT02584855|62984009|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
33585746|NCT02584855|62984010|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
33585747|NCT02584855|62984005|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
33585748|NCT02584855|62984006|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
33585749|NCT02584855|62984007|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
33585750|NCT02584855|62984008|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
33585751|NCT02584855|62984009|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
33585752|NCT02584855|62984010|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
33585753|NCT02584855|62984005|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
33585754|NCT02584855|62984006|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
33585755|NCT02584855|62984007|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
33585756|NCT02584855|62984008|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
33585757|NCT02584855|62984009|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
33585758|NCT02584855|62984010|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
33585759|NCT02584855|62984005|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33585760|NCT02584855|62984006|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33585761|NCT02584855|62984007|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33585762|NCT02584855|62984008|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33585763|NCT02584855|62984009|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
33585764|NCT02584855|62984010|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33585765|NCT02584855|62984005|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
33585766|NCT02584855|62984006|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
33585767|NCT02584855|62984007|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
33585768|NCT02584855|62984008|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
33585769|NCT02584855|62984009|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
33585770|NCT02584855|62984010|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
33585771|NCT02581891|62984025|FG000|Overall Study|Adverse Event|4|||
33585772|NCT02581891|62984026|FG001|Overall Study|Adverse Event|6|||
33585773|NCT02581891|62984025|FG000|Overall Study|Death|3|||
33585774|NCT02581891|62984026|FG001|Overall Study|Death|4|||
33585775|NCT02581891|62984025|FG000|Overall Study|Lost to Follow-up|1|||
33585776|NCT02581891|62984026|FG001|Overall Study|Lost to Follow-up|2|||
33585777|NCT02581891|62984025|FG000|Overall Study|Physician Decision|0|||
33585778|NCT02581891|62984026|FG001|Overall Study|Physician Decision|1|||
33585779|NCT02581891|62984025|FG000|Overall Study|Withdrawal by Subject|4|||
33585780|NCT02581891|62984026|FG001|Overall Study|Withdrawal by Subject|5|||
33585781|NCT02581891|62984025|FG000|Overall Study|Other Reasons|3|||
33585782|NCT02581891|62984026|FG001|Overall Study|Other Reasons|1|||
33585783|NCT02581891|62984025|FG000|Overall Study|Discontinued during followup|1|||
33585784|NCT02581891|62984026|FG001|Overall Study|Discontinued during followup|0|||
33585785|NCT02581345|62984035|FG000|Part 1: up to Week 16|Adverse Event|3|||
33585786|NCT02581345|62984036|FG001|Part 1: up to Week 16|Adverse Event|8|||
33585787|NCT02581345|62984037|FG002|Part 1: up to Week 16|Adverse Event|0|||
33585788|NCT02581345|62984038|FG003|Part 1: up to Week 16|Adverse Event|0|||
33585789|NCT02581345|62984035|FG000|Part 1: up to Week 16|Physician Decision|2|||
33585790|NCT02581345|62984036|FG001|Part 1: up to Week 16|Physician Decision|4|||
33585791|NCT02581345|62984037|FG002|Part 1: up to Week 16|Physician Decision|0|||
33585792|NCT02581345|62984038|FG003|Part 1: up to Week 16|Physician Decision|0|||
33585793|NCT02581345|62984035|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
33585794|NCT02581345|62984036|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
33585795|NCT02581345|62984037|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
33585796|NCT02581345|62984038|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
33585797|NCT02581345|62984035|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
33585798|NCT02581345|62984036|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
33585799|NCT02581345|62984037|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
33585800|NCT02581345|62984038|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
33585801|NCT02581345|62984035|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
33585802|NCT02581345|62984036|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
33585803|NCT02581345|62984037|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
33585804|NCT02581345|62984038|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
33585805|NCT02581345|62984035|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
33585806|NCT02581345|62984036|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
33585807|NCT02581345|62984037|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
33585808|NCT02581345|62984038|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
33585809|NCT02581345|62984035|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
33585810|NCT02581345|62984036|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
33585811|NCT02581345|62984037|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
33585812|NCT02581345|62984038|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
33585813|NCT02581345|62984035|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
33585814|NCT02581345|62984036|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
33585815|NCT02581345|62984037|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
33585816|NCT02581345|62984038|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
33585817|NCT02581345|62984035|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
33585818|NCT02581345|62984036|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
33585819|NCT02581345|62984037|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
33585820|NCT02581345|62984038|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
33585821|NCT02581345|62984035|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
33585822|NCT02581345|62984036|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
33585823|NCT02581345|62984037|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
33585824|NCT02581345|62984038|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
33585825|NCT02581345|62984035|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
33585826|NCT02581345|62984036|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
33585827|NCT02581345|62984037|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
33585828|NCT02581345|62984038|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
33585829|NCT02581345|62984035|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
33585830|NCT02581345|62984036|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
33585831|NCT02581345|62984037|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
33585832|NCT02581345|62984038|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
33585833|NCT02581189|62984056|FG000|Overall Study|Failure to return|36|||
33585834|NCT02581189|62984056|FG000|Overall Study|Withdrew consent|5|||
33585835|NCT02581189|62984056|FG000|Overall Study|Death|3|||
33585836|NCT02581189|62984056|FG000|Overall Study|Insufficient virological response|2|||
33585837|NCT02581189|62984056|FG000|Overall Study|Other, not specified|7|||
33585838|NCT02576977|62984065|FG000|Overall Study|Adverse Event|13|||
33585839|NCT02576977|62984066|FG001|Overall Study|Adverse Event|2|||
33585840|NCT02576977|62984065|FG000|Overall Study|Death|73|||
33585841|NCT02576977|62984066|FG001|Overall Study|Death|60|||
33585842|NCT02576977|62984065|FG000|Overall Study|Screen failure|1|||
33585843|NCT02576977|62984066|FG001|Overall Study|Screen failure|0|||
33585844|NCT02576977|62984065|FG000|Overall Study|Study Terminated at Selected Sites|27|||
33585845|NCT02576977|62984066|FG001|Overall Study|Study Terminated at Selected Sites|50|||
33585846|NCT02576977|62984065|FG000|Overall Study|Withdrawal by Subject|11|||
33585847|NCT02576977|62984066|FG001|Overall Study|Withdrawal by Subject|11|||
33585848|NCT02576977|62984065|FG000|Overall Study|Final Disposition Unknown|0|||
33585849|NCT02576977|62984066|FG001|Overall Study|Final Disposition Unknown|1|||
33585850|NCT02576977|62984065|FG000|Overall Study|Lost to Follow-up|1|||
33585851|NCT02576977|62984066|FG001|Overall Study|Lost to Follow-up|0|||
33585852|NCT02576977|62984065|FG000|Overall Study|Progressive Disease|0|||
33585853|NCT02576977|62984066|FG001|Overall Study|Progressive Disease|1|||
33585854|NCT05150964|62984072|FG000|Overall Study|Lost to Follow-up|2|||
33585855|NCT04952402|62984080|FG000|Overall Study|Lost to Follow-up|1|||
33585856|NCT04952402|62984081|FG001|Overall Study|Lost to Follow-up|3|||
33585857|NCT04952402|62984080|FG000|Overall Study|Lack Of Venous Access|0|||
33585858|NCT04952402|62984081|FG001|Overall Study|Lack Of Venous Access|1|||
33585859|NCT04378010|62984120|FG000|Overall Study|Adverse Event|8|||
33585860|NCT04378010|62984121|FG001|Overall Study|Adverse Event|14|||
33585861|NCT04378010|62984122|FG002|Overall Study|Adverse Event|4|||
33585862|NCT04378010|62984120|FG000|Overall Study|Withdrawal by Subject|0|||
33585863|NCT04378010|62984121|FG001|Overall Study|Withdrawal by Subject|2|||
33585864|NCT04378010|62984122|FG002|Overall Study|Withdrawal by Subject|1|||
33585865|NCT04378010|62984120|FG000|Overall Study|Protocol Violation|2|||
33585866|NCT04378010|62984121|FG001|Overall Study|Protocol Violation|1|||
33585867|NCT04378010|62984122|FG002|Overall Study|Protocol Violation|4|||
33585868|NCT04378010|62984120|FG000|Overall Study|Study terminated by Sponsor|22|||
33585869|NCT04378010|62984121|FG001|Overall Study|Study terminated by Sponsor|16|||
33585870|NCT04378010|62984122|FG002|Overall Study|Study terminated by Sponsor|22|||
33585871|NCT04378010|62984120|FG000|Overall Study|Subject inability to complete study visit|0|||
33585872|NCT04378010|62984121|FG001|Overall Study|Subject inability to complete study visit|0|||
33585873|NCT04378010|62984122|FG002|Overall Study|Subject inability to complete study visit|1|||
33585874|NCT04378010|62984120|FG000|Overall Study|Subject never dosed|0|||
33585875|NCT04378010|62984121|FG001|Overall Study|Subject never dosed|1|||
33585876|NCT04378010|62984122|FG002|Overall Study|Subject never dosed|0|||
33585877|NCT04349072|62984133|FG000|Randomization Period|Found ineligible post enrollment|0|||
33585878|NCT04349072|62984134|FG001|Randomization Period|Found ineligible post enrollment|1|||
33585879|NCT04349072|62984133|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
33585880|NCT04349072|62984134|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
33585881|NCT04349072|62984133|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
33585882|NCT04349072|62984134|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
33585883|NCT04349072|62984133|FG000|Treatment Period|Physician Decision|0|||
33585884|NCT04349072|62984134|FG001|Treatment Period|Physician Decision|1|||
33585885|NCT04349072|62984133|FG000|Treatment Period|Protocol Violation|0|||
33585886|NCT04349072|62984134|FG001|Treatment Period|Protocol Violation|1|||
33585887|NCT04349072|62984133|FG000|Treatment Period|Withdrawal by Subject|1|||
33585888|NCT04349072|62984134|FG001|Treatment Period|Withdrawal by Subject|1|||
33585889|NCT04240886|62984140|FG000|Treatment Phase|Death|4|||
33585890|NCT04240886|62984140|FG000|Treatment Phase|Discontinuation by Subject|1|||
33585891|NCT04240886|62984140|FG000|Treatment Phase|Adverse Event|5|||
33585892|NCT04240886|62984140|FG000|Follow-up Phase|Withdrawal by Subject|1|||
33585893|NCT04240886|62984140|FG000|Follow-up Phase|Discontinuation by Subject|1|||
33585894|NCT04240886|62984140|FG000|Follow-up Phase|Death|2|||
33585895|NCT04074161|62984156|FG000|Overall Study|Withdrawal by Subject|2|||
33585896|NCT04074161|62984157|FG001|Overall Study|Withdrawal by Subject|4|||
33585897|NCT04074161|62984158|FG002|Overall Study|Withdrawal by Subject|1|||
33585898|NCT04074161|62984156|FG000|Overall Study|Lost to Follow-up|4|||
33585899|NCT04074161|62984157|FG001|Overall Study|Lost to Follow-up|5|||
33585900|NCT04074161|62984158|FG002|Overall Study|Lost to Follow-up|3|||
33585901|NCT03966157|62984168|FG000|Overall Study|Physician Decision|1|||
33585902|NCT03966157|62984169|FG001|Overall Study|Physician Decision|0|||
33585903|NCT03733210|62984177|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
33585904|NCT03733210|62984178|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
33585905|NCT03698994|62984184|FG000|Overall Study|Adverse Event|2|||
33585906|NCT03698994|62984184|FG000|Overall Study|Death|1|||
33585907|NCT03698994|62984184|FG000|Overall Study|Physician Decision|1|||
33585908|NCT03698994|62984184|FG000|Overall Study|Withdrawal by Subject|3|||
33585909|NCT03698994|62984184|FG000|Overall Study|Progressive Disease|12|||
33585910|NCT03627468|62984190|FG000|Overall Study|Adverse Event|5|||
33585911|NCT03627468|62984191|FG001|Overall Study|Adverse Event|33|||
33585912|NCT03627468|62984190|FG000|Overall Study|Withdrawal by Subject|13|||
33585913|NCT03627468|62984191|FG001|Overall Study|Withdrawal by Subject|23|||
33585914|NCT03627468|62984190|FG000|Overall Study|Physician Decision|1|||
33585915|NCT03627468|62984191|FG001|Overall Study|Physician Decision|0|||
33585916|NCT03627468|62984190|FG000|Overall Study|Protocol Violation|0|||
33585917|NCT03627468|62984191|FG001|Overall Study|Protocol Violation|2|||
33585918|NCT03627468|62984190|FG000|Overall Study|Lost to Follow-up|10|||
33585919|NCT03627468|62984191|FG001|Overall Study|Lost to Follow-up|16|||
33585920|NCT03627468|62984190|FG000|Overall Study|Death|1|||
33585921|NCT03627468|62984191|FG001|Overall Study|Death|0|||
33585922|NCT03627468|62984190|FG000|Overall Study|Pregnancy|1|||
33585923|NCT03627468|62984191|FG001|Overall Study|Pregnancy|1|||
33585924|NCT03627468|62984190|FG000|Overall Study|Lack of Efficacy|0|||
33585925|NCT03627468|62984191|FG001|Overall Study|Lack of Efficacy|2|||
33585926|NCT03627468|62984190|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
33585927|NCT03627468|62984191|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
33585928|NCT03595176|62984199|FG000|Overall Study|Death|0|||
33585929|NCT03595176|62984200|FG001|Overall Study|Death|2|||
33585930|NCT03595176|62984199|FG000|Overall Study|Lost to Follow-up|0|||
33585931|NCT03595176|62984200|FG001|Overall Study|Lost to Follow-up|1|||
33585932|NCT03052816|62984209|FG000|Overall Study|Withdrawal by Subject|1|||
33585933|NCT03052816|62984210|FG001|Overall Study|Withdrawal by Subject|0|||
33585934|NCT03052816|62984209|FG000|Overall Study|Desired opioids|2|||
33585935|NCT03052816|62984210|FG001|Overall Study|Desired opioids|0|||
33585936|NCT02684058|62984230|FG000|Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|61|||
33585937|NCT02684058|62984231|FG001|Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|8|||
33585938|NCT02684058|62984232|FG002|Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|21|||
33585939|NCT02684058|62984230|FG000|Treatment Period|Progressive disease|5|||
33585940|NCT02684058|62984231|FG001|Treatment Period|Progressive disease|9|||
33585941|NCT02684058|62984232|FG002|Treatment Period|Progressive disease|16|||
33585942|NCT02684058|62984230|FG000|Treatment Period|Adverse Event|3|||
33585943|NCT02684058|62984231|FG001|Treatment Period|Adverse Event|6|||
33585944|NCT02684058|62984232|FG002|Treatment Period|Adverse Event|1|||
33585945|NCT02684058|62984230|FG000|Treatment Period|Physician Decision|2|||
33585946|NCT02684058|62984231|FG001|Treatment Period|Physician Decision|1|||
33585947|NCT02684058|62984232|FG002|Treatment Period|Physician Decision|1|||
33585948|NCT02684058|62984230|FG000|Treatment Period|New therapy for study indication|1|||
33585949|NCT02684058|62984231|FG001|Treatment Period|New therapy for study indication|0|||
33585950|NCT02684058|62984232|FG002|Treatment Period|New therapy for study indication|0|||
33585951|NCT02684058|62984230|FG000|Treatment Period|Protocol deviation|0|||
33585952|NCT02684058|62984231|FG001|Treatment Period|Protocol deviation|1|||
33585953|NCT02684058|62984232|FG002|Treatment Period|Protocol deviation|0|||
33585954|NCT02684058|62984230|FG000|Treatment Period|Patient/guardian decision|1|||
33585955|NCT02684058|62984231|FG001|Treatment Period|Patient/guardian decision|3|||
33585956|NCT02684058|62984232|FG002|Treatment Period|Patient/guardian decision|0|||
33585957|NCT02684058|62984230|FG000|Treatment Period|Death|0|||
33585958|NCT02684058|62984231|FG001|Treatment Period|Death|0|||
33585959|NCT02684058|62984232|FG002|Treatment Period|Death|2|||
33585960|NCT02684058|62984230|FG000|Post-treatment Efficacy Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|5|||
33585961|NCT02684058|62984231|FG001|Post-treatment Efficacy Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|13|||
33585962|NCT02684058|62984232|FG002|Post-treatment Efficacy Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|2|||
33585963|NCT02684058|62984230|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
33585964|NCT02684058|62984231|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
33585965|NCT02684058|62984232|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
33585966|NCT02684058|62984230|FG000|Post-treatment Efficacy Follow-up|Progressive disease|0|||
33585967|NCT02684058|62984231|FG001|Post-treatment Efficacy Follow-up|Progressive disease|1|||
33585968|NCT02684058|62984232|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
33585969|NCT02684058|62984230|FG000|Post-treatment Efficacy Follow-up|Patient/guardian decision|1|||
33585970|NCT02684058|62984231|FG001|Post-treatment Efficacy Follow-up|Patient/guardian decision|0|||
33585971|NCT02684058|62984232|FG002|Post-treatment Efficacy Follow-up|Patient/guardian decision|0|||
33585972|NCT02684058|62984230|FG000|Post-treatment Efficacy Follow-up|Death|0|||
33585973|NCT02684058|62984231|FG001|Post-treatment Efficacy Follow-up|Death|0|||
33585974|NCT02684058|62984232|FG002|Post-treatment Efficacy Follow-up|Death|3|||
33585975|NCT02684058|62984230|FG000|Survival Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|4|||
33585976|NCT02684058|62984231|FG001|Survival Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|0|||
33585977|NCT02684058|62984232|FG002|Survival Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|2|||
33585978|NCT02684058|62984230|FG000|Survival Follow-up|Other|2|||
33585979|NCT02684058|62984231|FG001|Survival Follow-up|Other|1|||
33585980|NCT02684058|62984232|FG002|Survival Follow-up|Other|0|||
33585981|NCT02684058|62984230|FG000|Survival Follow-up|Death|0|||
33585982|NCT02684058|62984231|FG001|Survival Follow-up|Death|0|||
33585983|NCT02684058|62984232|FG002|Survival Follow-up|Death|6|||
33585984|NCT02684058|62984230|FG000|Crossover Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|0|||
33585985|NCT02684058|62984231|FG001|Crossover Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|8|||
33585986|NCT02684058|62984232|FG002|Crossover Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|0|||
33585987|NCT02684058|62984230|FG000|Crossover Treatment Period|Progressive disease|0|||
33585988|NCT02684058|62984231|FG001|Crossover Treatment Period|Progressive disease|1|||
33585989|NCT02684058|62984232|FG002|Crossover Treatment Period|Progressive disease|0|||
33585990|NCT02684058|62984230|FG000|Crossover Survival Follow-up|Death|0|||
33585991|NCT02684058|62984231|FG001|Crossover Survival Follow-up|Death|1|||
33585992|NCT02684058|62984232|FG002|Crossover Survival Follow-up|Death|0|||
33585993|NCT02682238|62984248|FG000|Overall Study|Lost to Follow-up|0|||
33585994|NCT02682238|62984249|FG001|Overall Study|Lost to Follow-up|2|||
33585995|NCT02682238|62984248|FG000|Overall Study|Withdrawal by Subject|1|||
33585996|NCT02682238|62984249|FG001|Overall Study|Withdrawal by Subject|0|||
33585997|NCT02682238|62984248|FG000|Overall Study|Adverse Event|1|||
33585998|NCT02682238|62984249|FG001|Overall Study|Adverse Event|0|||
33585999|NCT02682238|62984248|FG000|Overall Study|Non-compliance with Study Drug|1|||
33586000|NCT02682238|62984249|FG001|Overall Study|Non-compliance with Study Drug|0|||
33586001|NCT02682238|62984248|FG000|Overall Study|Non-compliance with Protocol|0|||
33586002|NCT02682238|62984249|FG001|Overall Study|Non-compliance with Protocol|2|||
33586003|NCT02657356|62984273|FG000|Overall Study|Death|1|||
33586004|NCT02657356|62984274|FG001|Overall Study|Death|0|||
33586005|NCT02657356|62984273|FG000|Overall Study|Withdrawal by Subject|5|||
33586006|NCT02657356|62984274|FG001|Overall Study|Withdrawal by Subject|6|||
33586007|NCT02657356|62984273|FG000|Overall Study|Terminated by Sponsor|8|||
33586008|NCT02657356|62984274|FG001|Overall Study|Terminated by Sponsor|5|||
33586009|NCT02657356|62984273|FG000|Overall Study|Rolled over to EAP study|6|||
33586010|NCT02657356|62984274|FG001|Overall Study|Rolled over to EAP study|4|||
33586011|NCT01719562|62984300|FG000|Overall Study|Lost to Follow-up|1|||
33586012|NCT01719562|62984301|FG001|Overall Study|Lost to Follow-up|0|||
33586013|NCT01719562|62984300|FG000|Overall Study|Death|1|||
33586014|NCT01719562|62984301|FG001|Overall Study|Death|0|||
33586015|NCT01719562|62984300|FG000|Overall Study|New cancer diagnosis|1|||
33586016|NCT01719562|62984301|FG001|Overall Study|New cancer diagnosis|0|||
33586017|NCT01700439|62984307|FG000|Overall Study|Lost to Follow-up|47|||
33586018|NCT01700439|62984307|FG000|Overall Study|Withdrawal by Subject|183|||
33586019|NCT01700439|62984307|FG000|Overall Study|Death|186|||
33679798|NCT01666314|63131844|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
33679799|NCT01666314|63131841|FG000|Overall Study|Withdrawal by Subject|1|||
33679800|NCT01666314|63131842|FG001|Overall Study|Withdrawal by Subject|1|||
33586020|NCT01433289|62984329|FG000|Overall Study|Pregnancy|0|||
33586021|NCT01433289|62984330|FG001|Overall Study|Pregnancy|1|||
33586022|NCT01433289|62984331|FG002|Overall Study|Pregnancy|0|||
33586023|NCT01433289|62984332|FG003|Overall Study|Pregnancy|0|||
33586024|NCT02576587|62984376|FG000|Baseline|Equipment failure|0|||
33679801|NCT01666314|63131843|FG002|Overall Study|Withdrawal by Subject|2|||
33586025|NCT02576587|62984377|FG001|Baseline|Equipment failure|1|||
33586026|NCT02576587|62984376|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
33586027|NCT02576587|62984377|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
33586028|NCT02576587|62984376|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
33586029|NCT02576587|62984377|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
33586030|NCT02576587|62984376|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
33586031|NCT02576587|62984377|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
33586032|NCT03016975|62984401|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
33586033|NCT03016975|62984402|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
33586034|NCT03016975|62984403|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
33586035|NCT03016975|62984401|FG000|At 6 Months Follow-up|Death|2|||
33586036|NCT03016975|62984402|FG001|At 6 Months Follow-up|Death|0|||
33586037|NCT03016975|62984403|FG002|At 6 Months Follow-up|Death|0|||
33586038|NCT03016975|62984401|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
33586039|NCT03016975|62984402|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
33586040|NCT03016975|62984403|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
33586041|NCT03016975|62984401|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
33586042|NCT03016975|62984402|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
33586043|NCT03016975|62984403|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
33586044|NCT03016975|62984401|FG000|At 6 Months Follow-up|Aborted implant|1|||
33586045|NCT03016975|62984402|FG001|At 6 Months Follow-up|Aborted implant|0|||
33586046|NCT03016975|62984403|FG002|At 6 Months Follow-up|Aborted implant|0|||
33586047|NCT03016975|62984401|FG000|At 2 Year Follow-up|Death|1|||
33586048|NCT03016975|62984402|FG001|At 2 Year Follow-up|Death|0|||
33586049|NCT03016975|62984403|FG002|At 2 Year Follow-up|Death|0|||
33586050|NCT03016975|62984401|FG000|At 3 Year Follow-up|Death|1|||
33586051|NCT03016975|62984402|FG001|At 3 Year Follow-up|Death|0|||
33586052|NCT03016975|62984403|FG002|At 3 Year Follow-up|Death|0|||
33586053|NCT03016975|62984401|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
33586054|NCT03016975|62984402|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
33586055|NCT03016975|62984403|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
33586056|NCT05340751|62984457|FG000|Overall Study|Physician Decision|3|||
33586057|NCT02575807|62984466|FG000|Overall Study|Death|8|||
33586058|NCT02575807|62984467|FG001|Overall Study|Death|3|||
33586059|NCT02575807|62984468|FG002|Overall Study|Death|7|||
33586060|NCT02575807|62984469|FG003|Overall Study|Death|0|||
33586061|NCT02575807|62984470|FG004|Overall Study|Death|1|||
33586062|NCT02575807|62984466|FG000|Overall Study|Study terminated by Sponsor|0|||
33586063|NCT02575807|62984467|FG001|Overall Study|Study terminated by Sponsor|1|||
33586064|NCT02575807|62984468|FG002|Overall Study|Study terminated by Sponsor|7|||
33586065|NCT02575807|62984469|FG003|Overall Study|Study terminated by Sponsor|0|||
33586066|NCT02575807|62984470|FG004|Overall Study|Study terminated by Sponsor|1|||
33586067|NCT02575807|62984466|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
33586068|NCT02575807|62984467|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
33586069|NCT02575807|62984468|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
33586070|NCT02575807|62984469|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
33586071|NCT02575807|62984470|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
33586072|NCT02575807|62984466|FG000|Overall Study|Terminated due to physician decision|0|||
33586073|NCT02575807|62984467|FG001|Overall Study|Terminated due to physician decision|0|||
33586074|NCT02575807|62984468|FG002|Overall Study|Terminated due to physician decision|1|||
33586075|NCT02575807|62984469|FG003|Overall Study|Terminated due to physician decision|0|||
33586076|NCT02575807|62984470|FG004|Overall Study|Terminated due to physician decision|0|||
33586077|NCT02575807|62984466|FG000|Overall Study|Subject ineligible - medical implant|0|||
33586078|NCT02575807|62984467|FG001|Overall Study|Subject ineligible - medical implant|0|||
33586079|NCT02575807|62984468|FG002|Overall Study|Subject ineligible - medical implant|0|||
33586080|NCT02575807|62984469|FG003|Overall Study|Subject ineligible - medical implant|1|||
33586081|NCT02575807|62984470|FG004|Overall Study|Subject ineligible - medical implant|0|||
33586082|NCT02575807|62984466|FG000|Overall Study|Withdrawal by Subject|0|||
33586083|NCT02575807|62984467|FG001|Overall Study|Withdrawal by Subject|0|||
33586084|NCT02575807|62984468|FG002|Overall Study|Withdrawal by Subject|1|||
33586085|NCT02575807|62984469|FG003|Overall Study|Withdrawal by Subject|1|||
33586086|NCT02575807|62984470|FG004|Overall Study|Withdrawal by Subject|2|||
33586087|NCT02575339|62984496|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
33586088|NCT02575339|62984497|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
33586089|NCT02575339|62984498|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
33586090|NCT02575339|62984496|FG000|Study Treatment|Disease Progression|5|||
33586091|NCT02575339|62984497|FG001|Study Treatment|Disease Progression|2|||
33586092|NCT02575339|62984498|FG002|Study Treatment|Disease Progression|0|||
33586093|NCT02575339|62984496|FG000|Study Treatment|Adverse Event|1|||
33586094|NCT02575339|62984497|FG001|Study Treatment|Adverse Event|2|||
33586095|NCT02575339|62984498|FG002|Study Treatment|Adverse Event|0|||
33586096|NCT02575339|62984496|FG000|Follow up|Death|6|||
33586097|NCT02575339|62984497|FG001|Follow up|Death|2|||
33586098|NCT02575339|62984498|FG002|Follow up|Death|0|||
33586099|NCT02575339|62984496|FG000|Follow up|Study Terminated|0|||
33586100|NCT02575339|62984497|FG001|Follow up|Study Terminated|2|||
33586101|NCT02575339|62984498|FG002|Follow up|Study Terminated|0|||
33586102|NCT02575339|62984496|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
33586103|NCT02575339|62984497|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
33586104|NCT02575339|62984498|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
33586105|NCT01712659|62984511|FG000|Dose Escalation|Physician Decision|0|||
33586106|NCT01712659|62984512|FG001|Dose Escalation|Physician Decision|1|||
33586107|NCT01712659|62984513|FG002|Dose Escalation|Physician Decision|0|||
33586108|NCT01712659|62984514|FG003|Dose Escalation|Physician Decision|0|||
33586109|NCT01712659|62984515|FG004|Dose Escalation|Physician Decision|0|||
33586110|NCT01712659|62984511|FG000|Dose Escalation|Unable to take study drug|0|||
33586111|NCT01712659|62984512|FG001|Dose Escalation|Unable to take study drug|1|||
33586112|NCT01712659|62984513|FG002|Dose Escalation|Unable to take study drug|0|||
33586113|NCT01712659|62984514|FG003|Dose Escalation|Unable to take study drug|0|||
33586114|NCT01712659|62984515|FG004|Dose Escalation|Unable to take study drug|0|||
33586115|NCT01712659|62984511|FG000|Dose Expansion|Early disease progression|1|||
33586116|NCT01712659|62984512|FG001|Dose Expansion|Early disease progression|0|||
33586117|NCT01712659|62984513|FG002|Dose Expansion|Early disease progression|0|||
33586118|NCT01712659|62984514|FG003|Dose Expansion|Early disease progression|0|||
33586119|NCT01712659|62984515|FG004|Dose Expansion|Early disease progression|0|||
33586120|NCT01712659|62984511|FG000|Dose Expansion|Physician Decision|1|||
33586121|NCT01712659|62984512|FG001|Dose Expansion|Physician Decision|0|||
33586122|NCT01712659|62984513|FG002|Dose Expansion|Physician Decision|0|||
33586123|NCT01712659|62984514|FG003|Dose Expansion|Physician Decision|0|||
33586124|NCT01712659|62984515|FG004|Dose Expansion|Physician Decision|0|||
33586125|NCT01610713|62984541|FG000|Overall Study|Adverse Event|3|||
33586126|NCT01610713|62984542|FG001|Overall Study|Adverse Event|0|||
33586127|NCT01610713|62984541|FG000|Overall Study|Lack of Efficacy|1|||
33586128|NCT01610713|62984542|FG001|Overall Study|Lack of Efficacy|0|||
33586129|NCT01610713|62984541|FG000|Overall Study|low mood and poor motivation|1|||
33586130|NCT01610713|62984542|FG001|Overall Study|low mood and poor motivation|0|||
33586131|NCT01610713|62984541|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
33586132|NCT01610713|62984542|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
33586133|NCT01610713|62984541|FG000|Overall Study|Lost to Follow-up|0|||
33586134|NCT01610713|62984542|FG001|Overall Study|Lost to Follow-up|1|||
33586135|NCT01606189|62984548|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
33586136|NCT01606189|62984549|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
33586137|NCT01606189|62984550|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
33586138|NCT01606189|62984551|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
33586139|NCT01606189|62984552|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
33586140|NCT01606189|62984553|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
33586141|NCT01606189|62984548|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
33586142|NCT01606189|62984549|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
33586143|NCT01606189|62984550|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
33586144|NCT01606189|62984551|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
33586145|NCT01606189|62984552|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
33586146|NCT01606189|62984553|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
33586147|NCT01663987|62984563|FG000|Overall Study|Adverse Event|7|||
33586148|NCT01663987|62984564|FG001|Overall Study|Adverse Event|2|||
33586149|NCT01663987|62984563|FG000|Overall Study|Lost to Follow-up|1|||
33586150|NCT01663987|62984564|FG001|Overall Study|Lost to Follow-up|1|||
33586151|NCT01663987|62984563|FG000|Overall Study|Withdrawal by Subject|2|||
33586152|NCT01663987|62984564|FG001|Overall Study|Withdrawal by Subject|3|||
33586153|NCT01663987|62984563|FG000|Overall Study|Other reason not defined above|3|||
33586154|NCT01663987|62984564|FG001|Overall Study|Other reason not defined above|0|||
33586155|NCT02380677|62984582|FG000|Overall Study|Adverse Event|0|||
33586156|NCT02380677|62984583|FG001|Overall Study|Adverse Event|0|||
33586157|NCT02380677|62984584|FG002|Overall Study|Adverse Event|0|||
33586158|NCT02380677|62984585|FG003|Overall Study|Adverse Event|1|||
33586159|NCT02380677|62984586|FG004|Overall Study|Adverse Event|1|||
33586160|NCT02380677|62984587|FG005|Overall Study|Adverse Event|4|||
33586161|NCT02380677|62984588|FG006|Overall Study|Adverse Event|2|||
33586162|NCT02380677|62984589|FG007|Overall Study|Adverse Event|2|||
33679802|NCT01666314|63131844|FG003|Overall Study|Withdrawal by Subject|3|||
33679803|NCT01666314|63131841|FG000|Overall Study|Reason not Specified|10|||
33586163|NCT02380677|62984590|FG008|Overall Study|Adverse Event|2|||
33586164|NCT02380677|62984591|FG009|Overall Study|Adverse Event|1|||
33586165|NCT02380677|62984592|FG010|Overall Study|Adverse Event|2|||
33586166|NCT02380677|62984593|FG011|Overall Study|Adverse Event|1|||
33586167|NCT02380677|62984582|FG000|Overall Study|Physician Decision|1|||
33586168|NCT02380677|62984583|FG001|Overall Study|Physician Decision|0|||
33679804|NCT01666314|63131842|FG001|Overall Study|Reason not Specified|7|||
33586169|NCT02380677|62984584|FG002|Overall Study|Physician Decision|1|||
33679805|NCT01666314|63131843|FG002|Overall Study|Reason not Specified|5|||
33586170|NCT02380677|62984585|FG003|Overall Study|Physician Decision|1|||
33586171|NCT02380677|62984586|FG004|Overall Study|Physician Decision|0|||
33586172|NCT02380677|62984587|FG005|Overall Study|Physician Decision|0|||
33586173|NCT02380677|62984588|FG006|Overall Study|Physician Decision|0|||
33586174|NCT02380677|62984589|FG007|Overall Study|Physician Decision|0|||
33586175|NCT02380677|62984590|FG008|Overall Study|Physician Decision|0|||
33586176|NCT02380677|62984591|FG009|Overall Study|Physician Decision|0|||
33586177|NCT02380677|62984592|FG010|Overall Study|Physician Decision|0|||
33586178|NCT02380677|62984593|FG011|Overall Study|Physician Decision|0|||
33586179|NCT02380677|62984582|FG000|Overall Study|Lack of Efficacy|0|||
33586180|NCT02380677|62984583|FG001|Overall Study|Lack of Efficacy|1|||
33586181|NCT02380677|62984584|FG002|Overall Study|Lack of Efficacy|2|||
33586182|NCT02380677|62984585|FG003|Overall Study|Lack of Efficacy|0|||
33586183|NCT02380677|62984586|FG004|Overall Study|Lack of Efficacy|4|||
33586184|NCT02380677|62984587|FG005|Overall Study|Lack of Efficacy|1|||
33586185|NCT02380677|62984588|FG006|Overall Study|Lack of Efficacy|1|||
33586186|NCT02380677|62984589|FG007|Overall Study|Lack of Efficacy|2|||
33586187|NCT02380677|62984590|FG008|Overall Study|Lack of Efficacy|2|||
33586188|NCT02380677|62984591|FG009|Overall Study|Lack of Efficacy|0|||
33586189|NCT02380677|62984592|FG010|Overall Study|Lack of Efficacy|2|||
33586190|NCT02380677|62984593|FG011|Overall Study|Lack of Efficacy|1|||
33586191|NCT02380677|62984582|FG000|Overall Study|Withdrawal by Subject|0|||
33586192|NCT02380677|62984583|FG001|Overall Study|Withdrawal by Subject|0|||
33586193|NCT02380677|62984584|FG002|Overall Study|Withdrawal by Subject|0|||
33586194|NCT02380677|62984585|FG003|Overall Study|Withdrawal by Subject|0|||
33586195|NCT02380677|62984586|FG004|Overall Study|Withdrawal by Subject|0|||
33586196|NCT02380677|62984587|FG005|Overall Study|Withdrawal by Subject|0|||
33586197|NCT02380677|62984588|FG006|Overall Study|Withdrawal by Subject|0|||
33586198|NCT02380677|62984589|FG007|Overall Study|Withdrawal by Subject|0|||
33586199|NCT02380677|62984590|FG008|Overall Study|Withdrawal by Subject|0|||
33586200|NCT02380677|62984591|FG009|Overall Study|Withdrawal by Subject|1|||
33586201|NCT02380677|62984592|FG010|Overall Study|Withdrawal by Subject|0|||
33586202|NCT02380677|62984593|FG011|Overall Study|Withdrawal by Subject|3|||
33586203|NCT02380677|62984582|FG000|Overall Study|Other|0|||
33586204|NCT02380677|62984583|FG001|Overall Study|Other|0|||
33586205|NCT02380677|62984584|FG002|Overall Study|Other|0|||
33586206|NCT02380677|62984585|FG003|Overall Study|Other|1|||
33586207|NCT02380677|62984586|FG004|Overall Study|Other|1|||
33586208|NCT02380677|62984587|FG005|Overall Study|Other|1|||
33586209|NCT02380677|62984588|FG006|Overall Study|Other|0|||
33586210|NCT02380677|62984589|FG007|Overall Study|Other|0|||
33586211|NCT02380677|62984590|FG008|Overall Study|Other|0|||
33586212|NCT02380677|62984591|FG009|Overall Study|Other|0|||
33586213|NCT02380677|62984592|FG010|Overall Study|Other|0|||
33586214|NCT02380677|62984593|FG011|Overall Study|Other|0|||
33586215|NCT02380287|62984629|FG000|Overall Study|Adverse Event|0|||
33586216|NCT02380287|62984630|FG001|Overall Study|Adverse Event|0|||
33586217|NCT02380287|62984631|FG002|Overall Study|Adverse Event|1|||
33586218|NCT02380287|62984632|FG003|Overall Study|Adverse Event|0|||
33586219|NCT02380287|62984633|FG004|Overall Study|Adverse Event|0|||
33586220|NCT02380287|62984634|FG005|Overall Study|Adverse Event|0|||
33586221|NCT02380287|62984635|FG006|Overall Study|Adverse Event|0|||
33586222|NCT02380287|62984636|FG007|Overall Study|Adverse Event|0|||
33586223|NCT02343003|62984663|FG000|Overall Study|Withdrawal by Subject|9|||
33586224|NCT02343003|62984664|FG001|Overall Study|Withdrawal by Subject|4|||
33586225|NCT02343003|62984663|FG000|Overall Study|Lost to Follow-up|5|||
33586226|NCT02343003|62984664|FG001|Overall Study|Lost to Follow-up|1|||
33586227|NCT02343003|62984663|FG000|Overall Study|Protocol Violation|1|||
33586228|NCT02343003|62984664|FG001|Overall Study|Protocol Violation|0|||
33586229|NCT02343003|62984663|FG000|Overall Study|Death|0|||
33586230|NCT02343003|62984664|FG001|Overall Study|Death|1|||
33586231|NCT02343003|62984663|FG000|Overall Study|exclusion criteria met|1|||
33586232|NCT02343003|62984664|FG001|Overall Study|exclusion criteria met|1|||
33586233|NCT02343003|62984663|FG000|Overall Study|terminated by sponsor|2|||
33586234|NCT02343003|62984664|FG001|Overall Study|terminated by sponsor|0|||
33586235|NCT02394561|62984672|FG000|CORE Phase|Adverse Event|7|||
33586236|NCT02394561|62984673|FG001|CORE Phase|Adverse Event|9|||
33586237|NCT02394561|62984672|FG000|CORE Phase|Death|0|||
33586238|NCT02394561|62984673|FG001|CORE Phase|Death|1|||
33586239|NCT02394561|62984672|FG000|CORE Phase|Pregnancy|1|||
33586240|NCT02394561|62984673|FG001|CORE Phase|Pregnancy|0|||
33586241|NCT02394561|62984672|FG000|CORE Phase|Lost to Follow-up|1|||
33586242|NCT02394561|62984673|FG001|CORE Phase|Lost to Follow-up|0|||
33586243|NCT02394561|62984672|FG000|CORE Phase|Physician Decision|1|||
33586244|NCT02394561|62984673|FG001|CORE Phase|Physician Decision|1|||
33586245|NCT02394561|62984672|FG000|CORE Phase|Withdrawal by Subject|2|||
33586246|NCT02394561|62984673|FG001|CORE Phase|Withdrawal by Subject|2|||
33586247|NCT02394561|62984672|FG000|CORE Phase|Lack of Efficacy|1|||
33586248|NCT02394561|62984673|FG001|CORE Phase|Lack of Efficacy|6|||
33586249|NCT02394561|62984672|FG000|Extension Phase|Adverse Event|6|||
33586250|NCT02394561|62984673|FG001|Extension Phase|Adverse Event|1|||
33586251|NCT02394561|62984672|FG000|Extension Phase|Death|0|||
33586252|NCT02394561|62984673|FG001|Extension Phase|Death|1|||
33586253|NCT02394561|62984672|FG000|Extension Phase|Protocol Violation|1|||
33586254|NCT02394561|62984673|FG001|Extension Phase|Protocol Violation|0|||
33586255|NCT02394561|62984672|FG000|Extension Phase|Lost to Follow-up|1|||
33586256|NCT02394561|62984673|FG001|Extension Phase|Lost to Follow-up|0|||
33586257|NCT02394561|62984672|FG000|Extension Phase|Physician Decision|0|||
33586258|NCT02394561|62984673|FG001|Extension Phase|Physician Decision|2|||
33586259|NCT02394561|62984672|FG000|Extension Phase|Withdrawal by Subject|0|||
33586260|NCT02394561|62984673|FG001|Extension Phase|Withdrawal by Subject|5|||
33586261|NCT02394561|62984672|FG000|Extension Phase|Lack of Efficacy|3|||
33586262|NCT02394561|62984673|FG001|Extension Phase|Lack of Efficacy|3|||
33586263|NCT02342223|62984682|FG000|Overall Study|Lost to Follow-up|1|||
33586264|NCT02393547|62984686|FG000|Overall Study|Adverse Event|2|||
33586265|NCT02393547|62984686|FG000|Overall Study|Withdrawal by Subject|3|||
33586266|NCT02393547|62984686|FG000|Overall Study|Lost to Follow-up|1|||
33586267|NCT02574637|62984695|FG000|Double-blind Period|Adverse Event|1|||
33586268|NCT02574637|62984696|FG001|Double-blind Period|Adverse Event|0|||
33586269|NCT02574637|62984697|FG002|Double-blind Period|Adverse Event|0|||
33586270|NCT02574637|62984698|FG003|Double-blind Period|Adverse Event|0|||
33586271|NCT02574637|62984699|FG004|Double-blind Period|Adverse Event|0|||
33586272|NCT02574637|62984700|FG005|Double-blind Period|Adverse Event|0|||
33586273|NCT02574637|62984701|FG006|Double-blind Period|Adverse Event|0|||
33586274|NCT02574637|62984702|FG007|Double-blind Period|Adverse Event|0|||
33586275|NCT02574637|62984703|FG008|Double-blind Period|Adverse Event|0|||
33586276|NCT02574637|62984704|FG009|Double-blind Period|Adverse Event|0|||
33586277|NCT02574637|62984695|FG000|Double-blind Period|Lack of Efficacy|0|||
33586278|NCT02574637|62984696|FG001|Double-blind Period|Lack of Efficacy|0|||
33586279|NCT02574637|62984697|FG002|Double-blind Period|Lack of Efficacy|2|||
33586280|NCT02574637|62984698|FG003|Double-blind Period|Lack of Efficacy|0|||
33586281|NCT02574637|62984699|FG004|Double-blind Period|Lack of Efficacy|0|||
33586282|NCT02574637|62984700|FG005|Double-blind Period|Lack of Efficacy|0|||
33586283|NCT02574637|62984701|FG006|Double-blind Period|Lack of Efficacy|0|||
33586284|NCT02574637|62984702|FG007|Double-blind Period|Lack of Efficacy|0|||
33586285|NCT02574637|62984703|FG008|Double-blind Period|Lack of Efficacy|0|||
33586286|NCT02574637|62984704|FG009|Double-blind Period|Lack of Efficacy|0|||
33586287|NCT02574637|62984695|FG000|Double-blind Period|Protocol Deviation|1|||
33586288|NCT02574637|62984696|FG001|Double-blind Period|Protocol Deviation|0|||
33586289|NCT02574637|62984697|FG002|Double-blind Period|Protocol Deviation|0|||
33586290|NCT02574637|62984698|FG003|Double-blind Period|Protocol Deviation|0|||
33586291|NCT02574637|62984699|FG004|Double-blind Period|Protocol Deviation|0|||
33586292|NCT02574637|62984700|FG005|Double-blind Period|Protocol Deviation|0|||
33586293|NCT02574637|62984701|FG006|Double-blind Period|Protocol Deviation|0|||
33586294|NCT02574637|62984702|FG007|Double-blind Period|Protocol Deviation|0|||
33586295|NCT02574637|62984703|FG008|Double-blind Period|Protocol Deviation|0|||
33586296|NCT02574637|62984704|FG009|Double-blind Period|Protocol Deviation|0|||
33586297|NCT02574637|62984695|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
33586298|NCT02574637|62984696|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
33586299|NCT02574637|62984697|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
33586300|NCT02574637|62984698|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
33586301|NCT02574637|62984699|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
33586302|NCT02574637|62984700|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
33586303|NCT02574637|62984701|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
33586304|NCT02574637|62984702|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
33586305|NCT02574637|62984703|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
33586306|NCT02574637|62984704|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
33586307|NCT02574637|62984695|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
33586308|NCT02574637|62984696|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
33586309|NCT02574637|62984697|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
33586310|NCT02574637|62984698|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
33586311|NCT02574637|62984699|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
33586312|NCT02574637|62984700|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
33586313|NCT02574637|62984701|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
33586314|NCT02574637|62984702|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
33586315|NCT02574637|62984703|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
33586316|NCT02574637|62984704|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
33586317|NCT02574637|62984695|FG000|Double-blind Period|Reason Not Specified|0|||
33586318|NCT02574637|62984696|FG001|Double-blind Period|Reason Not Specified|0|||
33586319|NCT02574637|62984697|FG002|Double-blind Period|Reason Not Specified|0|||
33586320|NCT02574637|62984698|FG003|Double-blind Period|Reason Not Specified|1|||
33586321|NCT02574637|62984699|FG004|Double-blind Period|Reason Not Specified|0|||
33586322|NCT02574637|62984700|FG005|Double-blind Period|Reason Not Specified|0|||
33586323|NCT02574637|62984701|FG006|Double-blind Period|Reason Not Specified|0|||
33586324|NCT02574637|62984702|FG007|Double-blind Period|Reason Not Specified|0|||
33586325|NCT02574637|62984703|FG008|Double-blind Period|Reason Not Specified|0|||
33586326|NCT02574637|62984704|FG009|Double-blind Period|Reason Not Specified|0|||
33586327|NCT02574637|62984695|FG000|Open-label (OL) Period|Adverse Event|0|||
33586328|NCT02574637|62984696|FG001|Open-label (OL) Period|Adverse Event|0|||
33586329|NCT02574637|62984697|FG002|Open-label (OL) Period|Adverse Event|0|||
33586330|NCT02574637|62984698|FG003|Open-label (OL) Period|Adverse Event|0|||
33586331|NCT02574637|62984699|FG004|Open-label (OL) Period|Adverse Event|0|||
33586332|NCT02574637|62984700|FG005|Open-label (OL) Period|Adverse Event|0|||
33586333|NCT02574637|62984701|FG006|Open-label (OL) Period|Adverse Event|0|||
33586334|NCT02574637|62984702|FG007|Open-label (OL) Period|Adverse Event|0|||
33586335|NCT02574637|62984703|FG008|Open-label (OL) Period|Adverse Event|1|||
33586336|NCT02574637|62984704|FG009|Open-label (OL) Period|Adverse Event|0|||
33586337|NCT02574637|62984695|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
33586338|NCT02574637|62984696|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
33586339|NCT02574637|62984697|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
33586340|NCT02574637|62984698|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
33586341|NCT02574637|62984699|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
33586342|NCT02574637|62984700|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
33586343|NCT02574637|62984701|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
33586344|NCT02574637|62984702|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
33586345|NCT02574637|62984703|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
33586346|NCT02574637|62984704|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
33586347|NCT02574637|62984695|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
33586348|NCT02574637|62984696|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
33586349|NCT02574637|62984697|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
33586350|NCT02574637|62984698|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
33586351|NCT02574637|62984699|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
33586352|NCT02574637|62984700|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
33586353|NCT02574637|62984701|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
33679806|NCT01666314|63131844|FG003|Overall Study|Reason not Specified|5|||
33679807|NCT01666002|63131875|FG000|Overall Study|Lost to Follow-up|5|||
33679808|NCT01666002|63131876|FG001|Overall Study|Lost to Follow-up|0|||
33679809|NCT01665768|63131948|FG000|Overall Study|Adverse Event|3|||
33679810|NCT01665768|63131948|FG000|Overall Study|Lack of Efficacy|19|||
33679811|NCT01665768|63131948|FG000|Overall Study|Withdrawal by Subject|1|||
33679812|NCT02584452|63132156|FG000|Overall Study|Physician Decision|1|||
33586354|NCT02574637|62984702|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
33679813|NCT02584452|63132157|FG001|Overall Study|Physician Decision|1|||
33586355|NCT02574637|62984703|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
33679814|NCT02584452|63132156|FG000|Overall Study|Lost to Follow-up|1|||
33679815|NCT02584452|63132157|FG001|Overall Study|Lost to Follow-up|1|||
33679816|NCT02586012|63132204|FG000|Overall Study|Withdrawal by Subject|1|||
33679817|NCT02586012|63132205|FG001|Overall Study|Withdrawal by Subject|1|||
33679818|NCT02586012|63132206|FG002|Overall Study|Withdrawal by Subject|0|||
33679819|NCT02586012|63132207|FG003|Overall Study|Withdrawal by Subject|1|||
33679820|NCT02586012|63132208|FG004|Overall Study|Withdrawal by Subject|0|||
33679821|NCT02586012|63132209|FG005|Overall Study|Withdrawal by Subject|2|||
33679822|NCT02586012|63132204|FG000|Overall Study|Protocol Violation|0|||
33679823|NCT02586012|63132205|FG001|Overall Study|Protocol Violation|0|||
33679824|NCT02586012|63132206|FG002|Overall Study|Protocol Violation|0|||
33679825|NCT02586012|63132207|FG003|Overall Study|Protocol Violation|0|||
33679826|NCT02586012|63132208|FG004|Overall Study|Protocol Violation|0|||
33679827|NCT02586012|63132209|FG005|Overall Study|Protocol Violation|1|||
33679828|NCT02586012|63132204|FG000|Overall Study|study terminated|0|||
33679829|NCT02586012|63132205|FG001|Overall Study|study terminated|2|||
33679830|NCT02586012|63132206|FG002|Overall Study|study terminated|1|||
33679831|NCT02586012|63132207|FG003|Overall Study|study terminated|1|||
33679832|NCT02586012|63132208|FG004|Overall Study|study terminated|1|||
33679833|NCT02586012|63132209|FG005|Overall Study|study terminated|0|||
33586356|NCT02574637|62984704|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
33586357|NCT02392611|62984734|FG000|Overall Study|Adverse Event|0|||
33679834|NCT02582814|63132220|FG000|Overall Study|Study-specific withdrawal criteria|1|||
33679835|NCT02582814|63132221|FG001|Overall Study|Study-specific withdrawal criteria|0|||
33492972|NCT03147248|62871042|FG003|Overall Study|Withdrawal by Subject|0|||
33492973|NCT03147248|62871043|FG004|Overall Study|Withdrawal by Subject|12|||
33586358|NCT02392611|62984735|FG001|Overall Study|Adverse Event|0|||
33586359|NCT02392611|62984736|FG002|Overall Study|Adverse Event|0|||
33586360|NCT02392611|62984737|FG003|Overall Study|Adverse Event|1|||
33586361|NCT02392611|62984738|FG004|Overall Study|Adverse Event|0|||
33586362|NCT02392611|62984739|FG005|Overall Study|Adverse Event|0|||
33586363|NCT02392611|62984740|FG006|Overall Study|Adverse Event|0|||
33679836|NCT02582814|63132220|FG000|Overall Study|Withdrawal by Subject|4|||
33679837|NCT02582814|63132221|FG001|Overall Study|Withdrawal by Subject|3|||
33679838|NCT02582814|63132220|FG000|Overall Study|Adverse Event|4|||
33679839|NCT02582814|63132221|FG001|Overall Study|Adverse Event|4|||
33679840|NCT02585934|63132369|FG000|Overall Study|Lost to Follow-up|2|||
33586364|NCT02392611|62984741|FG007|Overall Study|Adverse Event|0|||
33586365|NCT02392611|62984742|FG008|Overall Study|Adverse Event|0|||
33586366|NCT02392611|62984734|FG000|Overall Study|Progressive disease|0|||
33586367|NCT02392611|62984735|FG001|Overall Study|Progressive disease|0|||
33586368|NCT02392611|62984736|FG002|Overall Study|Progressive disease|0|||
33586369|NCT02392611|62984737|FG003|Overall Study|Progressive disease|2|||
33586370|NCT02392611|62984738|FG004|Overall Study|Progressive disease|1|||
33586371|NCT02392611|62984739|FG005|Overall Study|Progressive disease|0|||
33586372|NCT02392611|62984740|FG006|Overall Study|Progressive disease|0|||
33586373|NCT02392611|62984741|FG007|Overall Study|Progressive disease|0|||
33586374|NCT02392611|62984742|FG008|Overall Study|Progressive disease|0|||
33586375|NCT02392611|62984734|FG000|Overall Study|Death|1|||
33586376|NCT02392611|62984735|FG001|Overall Study|Death|0|||
33586377|NCT02392611|62984736|FG002|Overall Study|Death|0|||
33586378|NCT02392611|62984737|FG003|Overall Study|Death|0|||
33586379|NCT02392611|62984738|FG004|Overall Study|Death|0|||
33586380|NCT02392611|62984739|FG005|Overall Study|Death|1|||
33586381|NCT02392611|62984740|FG006|Overall Study|Death|0|||
33586382|NCT02392611|62984741|FG007|Overall Study|Death|0|||
33586383|NCT02392611|62984742|FG008|Overall Study|Death|0|||
33586384|NCT02392611|62984734|FG000|Overall Study|Withdrawal by Subject|0|||
33586385|NCT02392611|62984735|FG001|Overall Study|Withdrawal by Subject|0|||
33586386|NCT02392611|62984736|FG002|Overall Study|Withdrawal by Subject|0|||
33586387|NCT02392611|62984737|FG003|Overall Study|Withdrawal by Subject|1|||
33586388|NCT02392611|62984738|FG004|Overall Study|Withdrawal by Subject|0|||
33586389|NCT02392611|62984739|FG005|Overall Study|Withdrawal by Subject|0|||
33586390|NCT02392611|62984740|FG006|Overall Study|Withdrawal by Subject|0|||
33586391|NCT02392611|62984741|FG007|Overall Study|Withdrawal by Subject|0|||
33586392|NCT02392611|62984742|FG008|Overall Study|Withdrawal by Subject|0|||
33586393|NCT02392611|62984734|FG000|Overall Study|Lost to Follow-up|0|||
33586394|NCT02392611|62984735|FG001|Overall Study|Lost to Follow-up|0|||
33586395|NCT02392611|62984736|FG002|Overall Study|Lost to Follow-up|0|||
33586396|NCT02392611|62984737|FG003|Overall Study|Lost to Follow-up|0|||
33586397|NCT02392611|62984738|FG004|Overall Study|Lost to Follow-up|0|||
33586398|NCT02392611|62984739|FG005|Overall Study|Lost to Follow-up|0|||
33586399|NCT02392611|62984740|FG006|Overall Study|Lost to Follow-up|1|||
33586400|NCT02392611|62984741|FG007|Overall Study|Lost to Follow-up|0|||
33586401|NCT02392611|62984742|FG008|Overall Study|Lost to Follow-up|0|||
33586402|NCT02392611|62984734|FG000|Overall Study|Enrolled, not treated|0|||
33586403|NCT02392611|62984735|FG001|Overall Study|Enrolled, not treated|0|||
33586404|NCT02392611|62984736|FG002|Overall Study|Enrolled, not treated|0|||
33586405|NCT02392611|62984737|FG003|Overall Study|Enrolled, not treated|2|||
33586406|NCT02392611|62984738|FG004|Overall Study|Enrolled, not treated|0|||
33586407|NCT02392611|62984739|FG005|Overall Study|Enrolled, not treated|0|||
33586408|NCT02392611|62984740|FG006|Overall Study|Enrolled, not treated|0|||
33586409|NCT02392611|62984741|FG007|Overall Study|Enrolled, not treated|0|||
33586410|NCT02392611|62984742|FG008|Overall Study|Enrolled, not treated|0|||
33586411|NCT02378961|62984766|FG000|Overall Study|Lack of Efficacy|4|||
33586412|NCT02378961|62984767|FG001|Overall Study|Lack of Efficacy|2|||
33586413|NCT02378961|62984768|FG002|Overall Study|Lack of Efficacy|0|||
33586414|NCT02378961|62984769|FG003|Overall Study|Lack of Efficacy|1|||
33586415|NCT02378961|62984766|FG000|Overall Study|Death|0|||
33586416|NCT02378961|62984767|FG001|Overall Study|Death|0|||
33679841|NCT02585934|63132370|FG001|Overall Study|Lost to Follow-up|2|||
33679842|NCT02585934|63132369|FG000|Overall Study|Protocol Violation|14|||
33679843|NCT02585934|63132370|FG001|Overall Study|Protocol Violation|11|||
33679844|NCT02585934|63132369|FG000|Overall Study|Adverse Event|21|||
33679845|NCT02585934|63132370|FG001|Overall Study|Adverse Event|22|||
33679846|NCT02585934|63132369|FG000|Overall Study|Physician Decision|3|||
33679847|NCT02585934|63132370|FG001|Overall Study|Physician Decision|2|||
33586417|NCT02378961|62984768|FG002|Overall Study|Death|1|||
33586418|NCT02378961|62984769|FG003|Overall Study|Death|0|||
33586419|NCT02378883|62984779|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
33586420|NCT02378883|62984779|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
33586421|NCT02378883|62984779|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
33586422|NCT02378883|62984779|FG000|30 Day Follow-Up|Physician Decision|2|||
33586423|NCT02378883|62984779|FG000|30 Day Follow-Up|Missed Visit|2|||
33586424|NCT02378883|62984779|FG000|30 Day Follow-Up|Death|1|||
33586425|NCT02378883|62984779|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
33586426|NCT02378883|62984779|FG000|12 Months Follow-Up|Death|2|||
33586427|NCT02340975|62984790|FG000|Overall Study|Death|6|||
33586428|NCT02340975|62984791|FG001|Overall Study|Death|23|||
33586429|NCT02340975|62984792|FG002|Overall Study|Death|21|||
33586430|NCT02340975|62984793|FG003|Overall Study|Death|7|||
33586431|NCT02340975|62984794|FG004|Overall Study|Death|21|||
33586432|NCT02340975|62984795|FG005|Overall Study|Death|13|||
33586433|NCT02340975|62984790|FG000|Overall Study|Lost to Follow-up|0|||
33586434|NCT02340975|62984791|FG001|Overall Study|Lost to Follow-up|0|||
33586435|NCT02340975|62984792|FG002|Overall Study|Lost to Follow-up|0|||
33679848|NCT02585934|63132369|FG000|Overall Study|Withdrawal by Subject|7|||
33679849|NCT02585934|63132370|FG001|Overall Study|Withdrawal by Subject|21|||
33586436|NCT02340975|62984793|FG003|Overall Study|Lost to Follow-up|0|||
33586437|NCT02340975|62984794|FG004|Overall Study|Lost to Follow-up|2|||
33586438|NCT02340975|62984795|FG005|Overall Study|Lost to Follow-up|0|||
33586439|NCT02340975|62984790|FG000|Overall Study|Withdrawal by Subject|0|||
33586440|NCT02340975|62984791|FG001|Overall Study|Withdrawal by Subject|0|||
33586441|NCT02340975|62984792|FG002|Overall Study|Withdrawal by Subject|3|||
33586442|NCT02340975|62984793|FG003|Overall Study|Withdrawal by Subject|3|||
33586443|NCT02340975|62984794|FG004|Overall Study|Withdrawal by Subject|2|||
33586444|NCT02340975|62984795|FG005|Overall Study|Withdrawal by Subject|0|||
33586445|NCT02340975|62984790|FG000|Overall Study|Other|0|||
33586446|NCT02340975|62984791|FG001|Overall Study|Other|4|||
33586447|NCT02340975|62984792|FG002|Overall Study|Other|0|||
33586448|NCT02340975|62984793|FG003|Overall Study|Other|2|||
33586449|NCT02340975|62984794|FG004|Overall Study|Other|0|||
33586450|NCT02340975|62984795|FG005|Overall Study|Other|6|||
33586451|NCT02392377|62984812|FG000|Overall Study|Withdrawal by Subject|0|||
33586452|NCT02392377|62984813|FG001|Overall Study|Withdrawal by Subject|1|||
33586453|NCT02340819|62984821|FG000|Overall Study|Adverse Event|1|||
33586454|NCT02340819|62984821|FG000|Overall Study|Withdrawal by Subject|2|||
33586455|NCT02340819|62984821|FG000|Overall Study|Discontinued with other reason|1|||
33586456|NCT02340663|62984827|FG000|Overall Study|Lost to Follow-up|1|||
33586457|NCT02340663|62984828|FG001|Overall Study|Lost to Follow-up|0|||
33586458|NCT02340663|62984827|FG000|Overall Study|Protocol Violation|1|||
33586459|NCT02340663|62984828|FG001|Overall Study|Protocol Violation|0|||
33586460|NCT02340663|62984827|FG000|Overall Study|Withdrawal by Subject|3|||
33586461|NCT02340663|62984828|FG001|Overall Study|Withdrawal by Subject|1|||
33586462|NCT02573467|62984838|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
33586463|NCT02573467|62984839|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
33586464|NCT02573467|62984840|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
33586465|NCT02573467|62984841|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
33586466|NCT02573467|62984838|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
33586467|NCT02573467|62984839|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
33586468|NCT02573467|62984840|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
33586469|NCT02573467|62984841|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
33586470|NCT02573467|62984838|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
33586471|NCT02573467|62984839|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
33586472|NCT02573467|62984840|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
33586473|NCT02573467|62984841|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
33586474|NCT02573467|62984838|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
33586475|NCT02573467|62984839|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
33586476|NCT02573467|62984840|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
33586477|NCT02573467|62984841|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
33586478|NCT02573467|62984838|FG000|Post-treatment Follow up Epoch|Death|1|||
33586479|NCT02573467|62984839|FG001|Post-treatment Follow up Epoch|Death|1|||
33586480|NCT02573467|62984840|FG002|Post-treatment Follow up Epoch|Death|0|||
33586481|NCT02573467|62984841|FG003|Post-treatment Follow up Epoch|Death|1|||
33586482|NCT02573467|62984838|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
33586483|NCT02573467|62984839|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
33586484|NCT02573467|62984840|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
33586485|NCT02573467|62984841|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
33586486|NCT02573467|62984838|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
33586487|NCT02573467|62984839|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
33586488|NCT02573467|62984840|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
33586489|NCT02573467|62984841|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
33492974|NCT03147248|62871044|FG005|Overall Study|Withdrawal by Subject|9|||
33492975|NCT03147248|62871039|FG000|Overall Study|Protocol Violation|0|||
33492976|NCT03147248|62871040|FG001|Overall Study|Protocol Violation|0|||
33492977|NCT03147248|62871041|FG002|Overall Study|Protocol Violation|0|||
33492978|NCT03147248|62871042|FG003|Overall Study|Protocol Violation|0|||
33492979|NCT03147248|62871043|FG004|Overall Study|Protocol Violation|2|||
33492980|NCT03147248|62871044|FG005|Overall Study|Protocol Violation|0|||
33492981|NCT03147248|62871039|FG000|Overall Study|Lost to Follow-up|0|||
33492982|NCT03147248|62871040|FG001|Overall Study|Lost to Follow-up|0|||
33492983|NCT03147248|62871041|FG002|Overall Study|Lost to Follow-up|0|||
33492984|NCT03147248|62871042|FG003|Overall Study|Lost to Follow-up|0|||
33586490|NCT02337387|62984856|FG000|Overall Study|Adverse Event|0|||
33586491|NCT02337387|62984857|FG001|Overall Study|Adverse Event|1|||
33586492|NCT02337387|62984858|FG002|Overall Study|Adverse Event|0|||
33586493|NCT02337387|62984859|FG003|Overall Study|Adverse Event|0|||
33586494|NCT02337387|62984856|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
33586495|NCT02337387|62984857|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
33586496|NCT02337387|62984858|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
33586497|NCT02337387|62984859|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
33492985|NCT03147248|62871043|FG004|Overall Study|Lost to Follow-up|2|||
33492986|NCT03147248|62871044|FG005|Overall Study|Lost to Follow-up|0|||
33586498|NCT02574247|62984872|FG000|Overall Study|Withdrawal by Subject|1|||
33586499|NCT02574247|62984873|FG001|Overall Study|Withdrawal by Subject|0|||
33586500|NCT02574247|62984874|FG002|Overall Study|Withdrawal by Subject|0|||
33586501|NCT02574247|62984872|FG000|Overall Study|Did not meet inclusion criteria|4|||
33586502|NCT02574247|62984873|FG001|Overall Study|Did not meet inclusion criteria|3|||
33586503|NCT02574247|62984874|FG002|Overall Study|Did not meet inclusion criteria|5|||
33586504|NCT02391363|62984886|FG000|Overall Study|Lost to Follow-up|5|||
33586505|NCT02391363|62984887|FG001|Overall Study|Lost to Follow-up|5|||
33586506|NCT02391363|62984886|FG000|Overall Study|Withdrawal by Subject|6|||
33586507|NCT02391363|62984887|FG001|Overall Study|Withdrawal by Subject|3|||
33586508|NCT02569957|62984895|FG000|Overall Study|Withdrawal by Subject|0|||
33586509|NCT02569957|62984896|FG001|Overall Study|Withdrawal by Subject|1|||
33586510|NCT01649427|62984904|FG000|Overall Study|Adverse Event|1|||
33586511|NCT01649427|62984905|FG001|Overall Study|Adverse Event|1|||
33586512|NCT01649427|62984904|FG000|Overall Study|Withdrawal by Subject|8|||
33586513|NCT01649427|62984905|FG001|Overall Study|Withdrawal by Subject|7|||
33586514|NCT01649427|62984904|FG000|Overall Study|Lost to Follow-up|0|||
33586515|NCT01649427|62984905|FG001|Overall Study|Lost to Follow-up|1|||
33586516|NCT01649427|62984904|FG000|Overall Study|Graft loss|0|||
33586517|NCT01649427|62984905|FG001|Overall Study|Graft loss|1|||
33586518|NCT01649427|62984904|FG000|Overall Study|Surgical problems during nephrectomy|2|||
33586519|NCT01649427|62984905|FG001|Overall Study|Surgical problems during nephrectomy|2|||
33586520|NCT02375373|62984911|FG000|Overall Study|Withdrawal by Subject|11|||
33586521|NCT02336607|62984919|FG000|Overall Study|Physician Decision|1|||
33586522|NCT02336607|62984920|FG001|Overall Study|Physician Decision|4|||
33586523|NCT02336607|62984921|FG002|Overall Study|Physician Decision|3|||
33586524|NCT02336607|62984922|FG003|Overall Study|Physician Decision|15|||
33586525|NCT02336607|62984919|FG000|Overall Study|Lack of Efficacy|1|||
33586526|NCT02336607|62984920|FG001|Overall Study|Lack of Efficacy|0|||
33679850|NCT02585934|63132369|FG000|Overall Study|Lack of Efficacy|2|||
33310674|NCT01235442|62686090|FG001|Overall Study|Death|2|||
33310675|NCT01235442|62686089|FG000|Overall Study|Pregnancy|1|||
33492987|NCT03147248|62871039|FG000|Overall Study|Pregnancy|0|||
33492988|NCT03147248|62871040|FG001|Overall Study|Pregnancy|0|||
33492989|NCT03147248|62871041|FG002|Overall Study|Pregnancy|0|||
33492990|NCT03147248|62871042|FG003|Overall Study|Pregnancy|0|||
33492991|NCT03147248|62871043|FG004|Overall Study|Pregnancy|1|||
33492992|NCT03147248|62871044|FG005|Overall Study|Pregnancy|0|||
33492993|NCT03147248|62871039|FG000|Overall Study|Death|0|||
33492994|NCT03147248|62871040|FG001|Overall Study|Death|0|||
33492995|NCT03147248|62871041|FG002|Overall Study|Death|0|||
33492996|NCT03147248|62871042|FG003|Overall Study|Death|0|||
33586527|NCT02336607|62984921|FG002|Overall Study|Lack of Efficacy|0|||
33586528|NCT02336607|62984922|FG003|Overall Study|Lack of Efficacy|2|||
33586529|NCT02336607|62984919|FG000|Overall Study|Lost to Follow-up|2|||
33586530|NCT02336607|62984920|FG001|Overall Study|Lost to Follow-up|1|||
33586531|NCT02336607|62984921|FG002|Overall Study|Lost to Follow-up|0|||
33586532|NCT02336607|62984922|FG003|Overall Study|Lost to Follow-up|21|||
33586533|NCT02336607|62984919|FG000|Overall Study|Protocol Violation|0|||
33586534|NCT02336607|62984920|FG001|Overall Study|Protocol Violation|1|||
33310676|NCT01235442|62686090|FG001|Overall Study|Pregnancy|1|||
33310677|NCT01235442|62686089|FG000|Overall Study|Ineligibility determined|5|||
33310678|NCT01235442|62686090|FG001|Overall Study|Ineligibility determined|4|||
33310679|NCT01235442|62686089|FG000|Overall Study|Protocol Violation|3|||
33310680|NCT01235442|62686090|FG001|Overall Study|Protocol Violation|3|||
33310681|NCT01235442|62686089|FG000|Overall Study|Adverse Event|4|||
33310682|NCT01235442|62686090|FG001|Overall Study|Adverse Event|6|||
33310683|NCT01235442|62686089|FG000|Overall Study|Withdrawal by Subject|15|||
33310684|NCT01235442|62686090|FG001|Overall Study|Withdrawal by Subject|9|||
33310685|NCT01235442|62686089|FG000|Overall Study|Lack of Efficacy|1|||
33310686|NCT01235442|62686090|FG001|Overall Study|Lack of Efficacy|3|||
33310687|NCT01235442|62686089|FG000|Overall Study|Noncompliance|1|||
33310688|NCT01235442|62686090|FG001|Overall Study|Noncompliance|2|||
33310689|NCT01235442|62686089|FG000|Overall Study|Administrative decision|1|||
33310690|NCT01235442|62686090|FG001|Overall Study|Administrative decision|2|||
33310691|NCT01235442|62686089|FG000|Overall Study|Other unspecified|1|||
33310692|NCT01235442|62686090|FG001|Overall Study|Other unspecified|2|||
33310693|NCT01163253|62686098|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
33310694|NCT01163253|62686099|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
33310695|NCT01163253|62686098|FG000|Overall Study|Study Terminated by Sponsor|978|||
33310696|NCT01163253|62686099|FG001|Overall Study|Study Terminated by Sponsor|349|||
33310697|NCT01163253|62686098|FG000|Overall Study|Protocol Violation|43|||
33310698|NCT01163253|62686099|FG001|Overall Study|Protocol Violation|12|||
33310699|NCT01163253|62686098|FG000|Overall Study|Withdrawal by Subject|199|||
33310700|NCT01163253|62686099|FG001|Overall Study|Withdrawal by Subject|50|||
33310701|NCT01163253|62686098|FG000|Overall Study|Medication Error|1|||
33310702|NCT01163253|62686099|FG001|Overall Study|Medication Error|0|||
33310703|NCT01163253|62686098|FG000|Overall Study|Lost to Follow-up|125|||
33492997|NCT03147248|62871043|FG004|Overall Study|Death|0|||
33492998|NCT03147248|62871044|FG005|Overall Study|Death|4|||
33492999|NCT03147248|62871039|FG000|Overall Study|Physician Decision|0|||
33493000|NCT03147248|62871040|FG001|Overall Study|Physician Decision|0|||
33493001|NCT03147248|62871041|FG002|Overall Study|Physician Decision|0|||
33493002|NCT03147248|62871042|FG003|Overall Study|Physician Decision|0|||
33493003|NCT03147248|62871043|FG004|Overall Study|Physician Decision|2|||
33493004|NCT03147248|62871044|FG005|Overall Study|Physician Decision|4|||
33493005|NCT03147248|62871039|FG000|Overall Study|Prolonged Dosing Interval|0|||
33493006|NCT03147248|62871040|FG001|Overall Study|Prolonged Dosing Interval|0|||
33493007|NCT03147248|62871041|FG002|Overall Study|Prolonged Dosing Interval|0|||
33493008|NCT03147248|62871042|FG003|Overall Study|Prolonged Dosing Interval|0|||
33493009|NCT03147248|62871043|FG004|Overall Study|Prolonged Dosing Interval|1|||
33493010|NCT03147248|62871044|FG005|Overall Study|Prolonged Dosing Interval|1|||
33493011|NCT03796039|62871060|FG000|Overall Study|Death|2|||
33493012|NCT03796039|62871061|FG001|Overall Study|Death|1|||
33493013|NCT03796039|62871060|FG000|Overall Study|Withdrawal by Subject|7|||
33493014|NCT03796039|62871061|FG001|Overall Study|Withdrawal by Subject|4|||
33493015|NCT03151304|62871067|FG000|Overall Study|Termination of study by Sponsor|23|||
33493016|NCT03151304|62871067|FG000|Overall Study|missing|3|||
33493017|NCT03151304|62871067|FG000|Overall Study|Withdrawal by Subject|8|||
33493018|NCT03151304|62871067|FG000|Overall Study|multiple reasons|30|||
33493019|NCT03152552|62871076|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
33493020|NCT03152552|62871077|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
33679851|NCT02585934|63132370|FG001|Overall Study|Lack of Efficacy|1|||
33679852|NCT02585934|63132369|FG000|Overall Study|Death|2|||
33679853|NCT02585934|63132370|FG001|Overall Study|Death|0|||
33679854|NCT02585934|63132369|FG000|Overall Study|Caregiver Withdrew Consent|7|||
33679855|NCT02585934|63132370|FG001|Overall Study|Caregiver Withdrew Consent|7|||
33679856|NCT02585934|63132369|FG000|Overall Study|Sponsor Termination|1|||
33679857|NCT02585934|63132370|FG001|Overall Study|Sponsor Termination|2|||
33679858|NCT02585934|63132369|FG000|Overall Study|Another Reason|10|||
33679859|NCT02585934|63132370|FG001|Overall Study|Another Reason|5|||
33679860|NCT02582658|63132399|FG000|Overall Study|Failure to Return|10|||
33679861|NCT02582658|63132399|FG000|Overall Study|Insufficient Virological Response|2|||
33679862|NCT02582658|63132399|FG000|Overall Study|Withdrawn Consent|1|||
33679863|NCT02582658|63132399|FG000|Overall Study|Death|1|||
33679864|NCT02582658|63132399|FG000|Overall Study|Not further specified|11|||
33679865|NCT02585778|63132501|FG000|Overall Study|Adverse Event|17|||
33679866|NCT02585778|63132502|FG001|Overall Study|Adverse Event|4|||
33679867|NCT02585778|63132501|FG000|Overall Study|Participant did not wish to continue|9|||
33679868|NCT02585778|63132502|FG001|Overall Study|Participant did not wish to continue|4|||
33679869|NCT02585778|63132501|FG000|Overall Study|Poor compliance to study protocol|0|||
33679870|NCT02585778|63132502|FG001|Overall Study|Poor compliance to study protocol|2|||
33679871|NCT02585778|63132501|FG000|Overall Study|Death|0|||
33679872|NCT02585778|63132502|FG001|Overall Study|Death|1|||
33679873|NCT02585778|63132501|FG000|Overall Study|Randomized but not treated|1|||
33679874|NCT02585778|63132502|FG001|Overall Study|Randomized but not treated|2|||
33679875|NCT02585778|63132501|FG000|Overall Study|Other than specified above|6|||
33679876|NCT02585778|63132502|FG001|Overall Study|Other than specified above|2|||
33679877|NCT01438424|63132525|FG000|Overall Study|Continuing treatment|29|||
33679878|NCT01438424|63132525|FG000|Overall Study|Minimal virologic response|95|||
33679879|NCT01438424|63132525|FG000|Overall Study|Not identified|55|||
33679880|NCT01438424|63132525|FG000|Overall Study|Withdrawal by Subject|104|||
33679881|NCT01438424|63132525|FG000|Overall Study|Progression of chronic hepatitis B|22|||
33679882|NCT01438424|63132525|FG000|Overall Study|Death|22|||
33679883|NCT01438424|63132525|FG000|Overall Study|Adverse Event|17|||
33493021|NCT03152552|62871078|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
33493022|NCT03152552|62871079|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
33493023|NCT03152552|62871080|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
33493024|NCT03152552|62871076|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
33493025|NCT03152552|62871077|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
33493026|NCT03152552|62871078|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
33493027|NCT03152552|62871079|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
33493028|NCT03152552|62871080|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
33493029|NCT03152552|62871076|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
33493030|NCT03152552|62871077|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
33493031|NCT03152552|62871078|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
33493032|NCT03152552|62871079|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
33493033|NCT03152552|62871080|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
33493034|NCT03152552|62871076|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33493035|NCT03152552|62871077|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33679884|NCT01438424|63132525|FG000|Overall Study|Lost to Follow-up|17|||
33679885|NCT01438424|63132525|FG000|Overall Study|Abnormal laboratory test result|14|||
33679886|NCT01438424|63132525|FG000|Overall Study|Need for drug prohibited by protocol|14|||
33679887|NCT01438424|63132525|FG000|Overall Study|Pregnancy|7|||
33679888|NCT01438424|63132525|FG000|Overall Study|No longer met inclusion criteria|1|||
33679889|NCT01438424|63132525|FG000|Overall Study|Participant noncompliance|20|||
33493036|NCT03152552|62871078|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
33493037|NCT03152552|62871079|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33493038|NCT03152552|62871080|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33493039|NCT03152552|62871076|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
33493040|NCT03152552|62871077|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
33493041|NCT03152552|62871078|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
33493042|NCT03152552|62871079|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
33493043|NCT03152552|62871080|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
33493044|NCT03152552|62871076|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
33493045|NCT03152552|62871077|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
33493046|NCT03152552|62871078|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
33493047|NCT03152552|62871079|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
33493048|NCT03152552|62871080|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
33493049|NCT03152552|62871076|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
33493050|NCT03152552|62871077|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
33493051|NCT03152552|62871078|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
33493052|NCT03152552|62871079|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
33493053|NCT03152552|62871080|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
33493054|NCT03151226|62871093|FG000|Overall Study|Withdrawal by Subject|2|||
33493055|NCT03151226|62871093|FG000|Overall Study|not wear device correctly|1|||
33493056|NCT03151148|62871099|FG000|Overall Study|Lost to Follow-up|1|||
33493057|NCT03151148|62871100|FG001|Overall Study|Lost to Follow-up|0|||
33493058|NCT03151148|62871099|FG000|Overall Study|Withdrawal by Subject|1|||
33493059|NCT03151148|62871100|FG001|Overall Study|Withdrawal by Subject|0|||
33493060|NCT02741518|62871109|FG000|Overall Study|Withdrawal by Subject|1|||
33493061|NCT02741518|62871110|FG001|Overall Study|Withdrawal by Subject|1|||
33493062|NCT03145766|62871121|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
33493063|NCT03145766|62871122|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
33586535|NCT02336607|62984921|FG002|Overall Study|Protocol Violation|1|||
33586536|NCT02336607|62984922|FG003|Overall Study|Protocol Violation|3|||
33586537|NCT02336607|62984919|FG000|Overall Study|Adverse Event|0|||
33586538|NCT02336607|62984920|FG001|Overall Study|Adverse Event|2|||
33586539|NCT02336607|62984921|FG002|Overall Study|Adverse Event|2|||
33586540|NCT02336607|62984922|FG003|Overall Study|Adverse Event|26|||
33586541|NCT02336607|62984919|FG000|Overall Study|Withdrawal by Subject|0|||
33586542|NCT02336607|62984920|FG001|Overall Study|Withdrawal by Subject|2|||
33586543|NCT02336607|62984921|FG002|Overall Study|Withdrawal by Subject|0|||
33586544|NCT02336607|62984922|FG003|Overall Study|Withdrawal by Subject|20|||
33586545|NCT02374671|62984935|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
33586546|NCT02374671|62984936|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
33586547|NCT02374671|62984937|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
33586548|NCT02374671|62984935|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
33586549|NCT02374671|62984936|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
33586550|NCT02374671|62984937|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
33586551|NCT02374671|62984935|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
33586552|NCT02374671|62984936|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
33586553|NCT02374671|62984937|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
33586554|NCT02374671|62984935|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
33586555|NCT02374671|62984936|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
33586556|NCT02374671|62984937|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
33586557|NCT02374671|62984935|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
33586558|NCT02374671|62984936|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
33586559|NCT02374671|62984937|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
33586560|NCT02569801|62984945|FG000|Overall Study|Withdrawal by Subject|9|||
33586561|NCT02569801|62984946|FG001|Overall Study|Withdrawal by Subject|9|||
33586562|NCT02569801|62984945|FG000|Overall Study|Sponsor Decision|13|||
33586563|NCT02569801|62984946|FG001|Overall Study|Sponsor Decision|14|||
33586564|NCT02569801|62984945|FG000|Overall Study|Progressive Disease|2|||
33586565|NCT02569801|62984946|FG001|Overall Study|Progressive Disease|7|||
33586566|NCT02569801|62984945|FG000|Overall Study|Lost to Follow-up|0|||
33586567|NCT02569801|62984946|FG001|Overall Study|Lost to Follow-up|1|||
33586568|NCT02569801|62984945|FG000|Overall Study|Death|12|||
33586569|NCT02569801|62984946|FG001|Overall Study|Death|4|||
33586570|NCT02573311|62984954|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
33586571|NCT02573311|62984955|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
33586572|NCT02573311|62984954|FG000|Disposition for Part 2|Physician Decision|25|||
33679890|NCT02580240|63132541|FG000|Overall Study|Physician Decision|2|||
33679891|NCT02580240|63132542|FG001|Overall Study|Physician Decision|0|||
33310704|NCT01163253|62686099|FG001|Overall Study|Lost to Follow-up|23|||
33493064|NCT03145766|62871123|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
33679892|NCT01465958|63132548|FG000|Run-in Phase|Protocol Violation|1|||
33679893|NCT01465958|63132549|FG001|Run-in Phase|Protocol Violation|0|||
33586573|NCT02573311|62984955|FG001|Disposition for Part 2|Physician Decision|7|||
33586574|NCT02573311|62984954|FG000|Disposition for Part 2|Adverse Event|36|||
33586575|NCT02573311|62984955|FG001|Disposition for Part 2|Adverse Event|5|||
33586576|NCT02573311|62984954|FG000|Disposition for Part 2|Lost to Follow-up|76|||
33586577|NCT02573311|62984955|FG001|Disposition for Part 2|Lost to Follow-up|7|||
33586578|NCT02573311|62984954|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
33586579|NCT02573311|62984955|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
33586580|NCT02573311|62984954|FG000|Disposition for Part 2|Investigator decision|0|||
33586581|NCT02573311|62984955|FG001|Disposition for Part 2|Investigator decision|1|||
33586582|NCT02573311|62984954|FG000|Disposition for Part 2|Other than specified above|13|||
33586583|NCT02573311|62984955|FG001|Disposition for Part 2|Other than specified above|3|||
33586584|NCT02571049|62984961|FG000|Screening|Did not meet entry criteria|2|||
33586585|NCT02571049|62984962|FG001|Screening|Did not meet entry criteria|2|||
33586586|NCT02571049|62984961|FG000|Randomization|No migraine attack|0|||
33586587|NCT02571049|62984962|FG001|Randomization|No migraine attack|1|||
33586588|NCT02571049|62984961|FG000|Randomization|Adverse Event|0|||
33586589|NCT02571049|62984962|FG001|Randomization|Adverse Event|1|||
33586590|NCT02573155|62984970|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
33586591|NCT02573155|62984971|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
33586592|NCT02573155|62984970|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
33586593|NCT02573155|62984971|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
33586594|NCT02573155|62984970|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
33586595|NCT02573155|62984971|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
33586596|NCT02573155|62984970|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
33586597|NCT02573155|62984971|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
33586598|NCT02573155|62984970|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
33586599|NCT02573155|62984971|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
33586600|NCT02573155|62984970|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
33586601|NCT02573155|62984971|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
33586602|NCT02573155|62984970|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
33586603|NCT02573155|62984971|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
33586604|NCT02573155|62984970|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
33586605|NCT02573155|62984971|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
33586606|NCT02568475|62984999|FG000|Overall Study|Lost to Follow-up|40|||
33586607|NCT02568475|62985000|FG001|Overall Study|Lost to Follow-up|39|||
33586608|NCT02568475|62984999|FG000|Overall Study|Withdrawal by Subject|2|||
33586609|NCT02568475|62985000|FG001|Overall Study|Withdrawal by Subject|0|||
33586610|NCT02568475|62984999|FG000|Overall Study|Discharged home|4|||
33586611|NCT02568475|62985000|FG001|Overall Study|Discharged home|4|||
33586612|NCT02568475|62984999|FG000|Overall Study|Short-term: Discharge location unknown|4|||
33586613|NCT02568475|62985000|FG001|Overall Study|Short-term: Discharge location unknown|0|||
33586614|NCT02568475|62984999|FG000|Overall Study|Transferred to another facility|1|||
33586615|NCT02568475|62985000|FG001|Overall Study|Transferred to another facility|0|||
33586616|NCT02568397|62985006|FG000|Period 2|Withdrawal by Subject|0|||
33586617|NCT02568397|62985007|FG001|Period 2|Withdrawal by Subject|1|||
33586618|NCT02568397|62985006|FG000|Period 2|Physician Decision|0|||
33586619|NCT02568397|62985007|FG001|Period 2|Physician Decision|1|||
33586620|NCT02566525|62985024|FG000|Overall Study|Protocol Violation|3|||
33586621|NCT02566525|62985025|FG001|Overall Study|Protocol Violation|5|||
33586622|NCT02567227|62985035|FG000|9 Weeks|Adverse Event|5|||
33586623|NCT02567227|62985036|FG001|9 Weeks|Adverse Event|5|||
33586624|NCT02567227|62985035|FG000|9 Weeks|Withdrawal by Subject|18|||
33586625|NCT02567227|62985036|FG001|9 Weeks|Withdrawal by Subject|8|||
33586626|NCT02567227|62985035|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
33586627|NCT02567227|62985036|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
33586628|NCT02567227|62985035|FG000|6 Month|Death|2|||
33586629|NCT02567227|62985036|FG001|6 Month|Death|0|||
33586630|NCT02567227|62985035|FG000|6 Month|Lost to Follow-up|43|||
33586631|NCT02567227|62985036|FG001|6 Month|Lost to Follow-up|40|||
33586632|NCT02567227|62985035|FG000|12 Months|Lost to Follow-up|31|||
33586633|NCT02567227|62985036|FG001|12 Months|Lost to Follow-up|32|||
33586634|NCT02567227|62985035|FG000|12 Months|Death|0|||
33586635|NCT02567227|62985036|FG001|12 Months|Death|2|||
33586636|NCT02336451|62985047|FG000|Overall Study|Adverse Event|1|||
33586637|NCT02336451|62985048|FG001|Overall Study|Adverse Event|2|||
33586638|NCT02336451|62985049|FG002|Overall Study|Adverse Event|0|||
33586639|NCT02336451|62985050|FG003|Overall Study|Adverse Event|6|||
33586640|NCT02336451|62985051|FG004|Overall Study|Adverse Event|4|||
33586641|NCT02336451|62985047|FG000|Overall Study|Death|6|||
33586642|NCT02336451|62985048|FG001|Overall Study|Death|2|||
33586643|NCT02336451|62985049|FG002|Overall Study|Death|3|||
33586644|NCT02336451|62985050|FG003|Overall Study|Death|6|||
33586645|NCT02336451|62985051|FG004|Overall Study|Death|6|||
33586646|NCT02336451|62985047|FG000|Overall Study|Physician Decision|9|||
33586647|NCT02336451|62985048|FG001|Overall Study|Physician Decision|6|||
33586648|NCT02336451|62985049|FG002|Overall Study|Physician Decision|7|||
33586649|NCT02336451|62985050|FG003|Overall Study|Physician Decision|16|||
33586650|NCT02336451|62985051|FG004|Overall Study|Physician Decision|3|||
33586651|NCT02336451|62985047|FG000|Overall Study|Progressive disease|23|||
33586652|NCT02336451|62985048|FG001|Overall Study|Progressive disease|26|||
33586653|NCT02336451|62985049|FG002|Overall Study|Progressive disease|2|||
33586654|NCT02336451|62985050|FG003|Overall Study|Progressive disease|14|||
33586655|NCT02336451|62985051|FG004|Overall Study|Progressive disease|4|||
33586656|NCT02336451|62985047|FG000|Overall Study|Protocol Violation|1|||
33586657|NCT02336451|62985048|FG001|Overall Study|Protocol Violation|0|||
33586658|NCT02336451|62985049|FG002|Overall Study|Protocol Violation|0|||
33586659|NCT02336451|62985050|FG003|Overall Study|Protocol Violation|0|||
33586660|NCT02336451|62985051|FG004|Overall Study|Protocol Violation|0|||
33586661|NCT02336451|62985047|FG000|Overall Study|Patient/guardian decision|2|||
33586662|NCT02336451|62985048|FG001|Overall Study|Patient/guardian decision|4|||
33586663|NCT02336451|62985049|FG002|Overall Study|Patient/guardian decision|0|||
33586664|NCT02336451|62985050|FG003|Overall Study|Patient/guardian decision|2|||
33586665|NCT02336451|62985051|FG004|Overall Study|Patient/guardian decision|1|||
33586666|NCT02374593|62985067|FG000|Overall Study|non-compliant|2|||
33586667|NCT02374593|62985068|FG001|Overall Study|non-compliant|0|||
33586668|NCT01648101|62985081|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
33586669|NCT01648101|62985082|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
33586670|NCT01648101|62985083|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
33586671|NCT01648101|62985081|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
33586672|NCT01648101|62985082|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
33586673|NCT01648101|62985083|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
33586674|NCT01648101|62985081|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
33586675|NCT01648101|62985082|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
33586676|NCT01648101|62985083|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
33586677|NCT01648101|62985081|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
33586678|NCT01648101|62985082|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
33586679|NCT01648101|62985083|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
33586680|NCT01648101|62985081|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
33586681|NCT01648101|62985082|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
33586682|NCT01648101|62985083|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
33586683|NCT01648101|62985081|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
33586684|NCT01648101|62985082|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
33586685|NCT01648101|62985083|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
33586686|NCT01648101|62985081|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
33586687|NCT01648101|62985082|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
33586688|NCT01648101|62985083|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
33586689|NCT01648101|62985081|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
33586690|NCT01648101|62985082|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
33586691|NCT01648101|62985083|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
33586692|NCT01648101|62985081|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
33586693|NCT01648101|62985082|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
33586694|NCT01648101|62985083|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
33586695|NCT01648101|62985081|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
33586696|NCT01648101|62985082|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
33586697|NCT01648101|62985083|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
33586698|NCT01648101|62985081|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
33586699|NCT01648101|62985082|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
33586700|NCT01648101|62985083|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
33586701|NCT02336373|62985095|FG000|Overall Study|Protocol closed early|4|||
33586702|NCT02336373|62985095|FG000|Overall Study|Physician Decision|14|||
33586703|NCT02372799|62985104|FG000|Treatment Period|Adverse Event|3|||
33586704|NCT02372799|62985105|FG001|Treatment Period|Adverse Event|10|||
33586705|NCT02372799|62985106|FG002|Treatment Period|Adverse Event|6|||
33586706|NCT02372799|62985104|FG000|Treatment Period|Insufficient therapeutic response|2|||
33586707|NCT02372799|62985105|FG001|Treatment Period|Insufficient therapeutic response|2|||
33586708|NCT02372799|62985106|FG002|Treatment Period|Insufficient therapeutic response|0|||
33679894|NCT01465958|63132548|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
33586709|NCT02372799|62985104|FG000|Treatment Period|Withdrawal by Subject|10|||
33586710|NCT02372799|62985105|FG001|Treatment Period|Withdrawal by Subject|10|||
33586711|NCT02372799|62985106|FG002|Treatment Period|Withdrawal by Subject|2|||
33586712|NCT02372799|62985104|FG000|Treatment Period|Lost to Follow-up|11|||
33586713|NCT02372799|62985105|FG001|Treatment Period|Lost to Follow-up|5|||
33586714|NCT02372799|62985106|FG002|Treatment Period|Lost to Follow-up|3|||
33586715|NCT02372799|62985104|FG000|Treatment Period|Protocol Violation|3|||
33586716|NCT02372799|62985105|FG001|Treatment Period|Protocol Violation|0|||
33586717|NCT02372799|62985106|FG002|Treatment Period|Protocol Violation|0|||
33586718|NCT02372799|62985104|FG000|Treatment Period|Non-compliance with study drug|4|||
33586719|NCT02372799|62985105|FG001|Treatment Period|Non-compliance with study drug|4|||
33679895|NCT01465958|63132549|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
33586720|NCT02372799|62985106|FG002|Treatment Period|Non-compliance with study drug|4|||
33586721|NCT02372799|62985104|FG000|Treatment Period|Miscellaneous Reasons|1|||
33586722|NCT02372799|62985105|FG001|Treatment Period|Miscellaneous Reasons|1|||
33586723|NCT02372799|62985106|FG002|Treatment Period|Miscellaneous Reasons|0|||
33586724|NCT02372799|62985104|FG000|Down-taper Period|Lost to Follow-up|1|||
33586725|NCT02372799|62985105|FG001|Down-taper Period|Lost to Follow-up|2|||
33586726|NCT02372799|62985106|FG002|Down-taper Period|Lost to Follow-up|2|||
33586727|NCT02566993|62985116|FG000|Overall Study|Randomized but not treated|5|||
33586728|NCT02566993|62985117|FG001|Overall Study|Randomized but not treated|16|||
33586729|NCT02566993|62985116|FG000|Overall Study|Progressive disease|213|||
33586730|NCT02566993|62985117|FG001|Overall Study|Progressive disease|152|||
33586731|NCT02566993|62985116|FG000|Overall Study|Withdrawal by Subject|12|||
33586732|NCT02566993|62985117|FG001|Overall Study|Withdrawal by Subject|28|||
33586733|NCT02566993|62985116|FG000|Overall Study|Death|17|||
33586734|NCT02566993|62985117|FG001|Overall Study|Death|23|||
33586735|NCT02566993|62985116|FG000|Overall Study|Physician Decision|10|||
33586736|NCT02566993|62985117|FG001|Overall Study|Physician Decision|17|||
33586737|NCT02566993|62985116|FG000|Overall Study|Study drug-related adverse event|20|||
33586738|NCT02566993|62985117|FG001|Overall Study|Study drug-related adverse event|41|||
33586739|NCT02566993|62985116|FG000|Overall Study|Non study drug-related adverse event|9|||
33586740|NCT02566993|62985117|FG001|Overall Study|Non study drug-related adverse event|9|||
33586741|NCT02566993|62985116|FG000|Overall Study|Symptomatic deterioration|9|||
33586742|NCT02566993|62985117|FG001|Overall Study|Symptomatic deterioration|16|||
33586743|NCT02566993|62985116|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
33586744|NCT02566993|62985117|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
33586745|NCT02566993|62985116|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
33586746|NCT02566993|62985117|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
33586747|NCT02566993|62985116|FG000|Overall Study|Screening failure|2|||
33586748|NCT02566993|62985117|FG001|Overall Study|Screening failure|0|||
33586749|NCT02566993|62985116|FG000|Overall Study|Lost to Follow-up|0|||
33586750|NCT02566993|62985117|FG001|Overall Study|Lost to Follow-up|1|||
33586751|NCT02566993|62985116|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
33586752|NCT02566993|62985117|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
33586753|NCT02311881|62985128|FG000|Overall Study|Did not meet the study criteria|2|||
33586754|NCT02311881|62985129|FG001|Overall Study|Did not meet the study criteria|2|||
33586755|NCT02311881|62985130|FG002|Overall Study|Did not meet the study criteria|0|||
33586756|NCT02311881|62985128|FG000|Overall Study|Adverse Event|7|||
33586757|NCT02311881|62985129|FG001|Overall Study|Adverse Event|15|||
33586758|NCT02311881|62985130|FG002|Overall Study|Adverse Event|8|||
33586759|NCT02311881|62985128|FG000|Overall Study|Lost to Follow-up|3|||
33586760|NCT02311881|62985129|FG001|Overall Study|Lost to Follow-up|3|||
33586761|NCT02311881|62985130|FG002|Overall Study|Lost to Follow-up|2|||
33586762|NCT02311881|62985128|FG000|Overall Study|Protocol Violation|1|||
33586763|NCT02311881|62985129|FG001|Overall Study|Protocol Violation|2|||
33586764|NCT02311881|62985130|FG002|Overall Study|Protocol Violation|3|||
33586765|NCT02311881|62985128|FG000|Overall Study|Withdrawal of consent|14|||
33586766|NCT02311881|62985129|FG001|Overall Study|Withdrawal of consent|16|||
33586767|NCT02311881|62985130|FG002|Overall Study|Withdrawal of consent|17|||
33586768|NCT02311881|62985128|FG000|Overall Study|Other|0|||
33586769|NCT02311881|62985129|FG001|Overall Study|Other|0|||
33586770|NCT02311881|62985130|FG002|Overall Study|Other|1|||
33586771|NCT02311881|62985128|FG000|Overall Study|Lack of Efficacy|1|||
33586772|NCT02311881|62985129|FG001|Overall Study|Lack of Efficacy|2|||
33586773|NCT02311881|62985130|FG002|Overall Study|Lack of Efficacy|0|||
33586774|NCT02311881|62985128|FG000|Overall Study|Subject has border line pregnancy test|1|||
33586775|NCT02311881|62985129|FG001|Overall Study|Subject has border line pregnancy test|0|||
33586776|NCT02311881|62985130|FG002|Overall Study|Subject has border line pregnancy test|0|||
33586777|NCT02311881|62985128|FG000|Overall Study|Withdrawal by Subject|3|||
33586778|NCT02311881|62985129|FG001|Overall Study|Withdrawal by Subject|1|||
33586779|NCT02311881|62985130|FG002|Overall Study|Withdrawal by Subject|4|||
33586780|NCT02311881|62985128|FG000|Overall Study|Sponsor Decision|1|||
33586781|NCT02311881|62985129|FG001|Overall Study|Sponsor Decision|1|||
33586782|NCT02311881|62985130|FG002|Overall Study|Sponsor Decision|1|||
33586783|NCT02311881|62985128|FG000|Overall Study|Protocol Deviation|1|||
33586784|NCT02311881|62985129|FG001|Overall Study|Protocol Deviation|0|||
33586785|NCT02311881|62985130|FG002|Overall Study|Protocol Deviation|0|||
33679896|NCT02581488|63132762|FG000|Overall Study|Adverse Event|6|||
33679897|NCT02581488|63132763|FG001|Overall Study|Adverse Event|7|||
33586786|NCT02311881|62985128|FG000|Overall Study|Non-Compliance|1|||
33586787|NCT02311881|62985129|FG001|Overall Study|Non-Compliance|0|||
33586788|NCT02311881|62985130|FG002|Overall Study|Non-Compliance|2|||
33586789|NCT02311881|62985128|FG000|Overall Study|Physician Decision|0|||
33586790|NCT02311881|62985129|FG001|Overall Study|Physician Decision|0|||
33586791|NCT02311881|62985130|FG002|Overall Study|Physician Decision|1|||
33586792|NCT02311881|62985128|FG000|Overall Study|Medical Monitor Discretion|0|||
33586793|NCT02311881|62985129|FG001|Overall Study|Medical Monitor Discretion|0|||
33586794|NCT02311881|62985130|FG002|Overall Study|Medical Monitor Discretion|1|||
33586795|NCT02311881|62985128|FG000|Overall Study|Participant taking another medication|0|||
33586796|NCT02311881|62985129|FG001|Overall Study|Participant taking another medication|0|||
33586797|NCT02311881|62985130|FG002|Overall Study|Participant taking another medication|1|||
33586798|NCT02311881|62985128|FG000|Overall Study|Serious Adverse Event|0|||
33586799|NCT02311881|62985129|FG001|Overall Study|Serious Adverse Event|1|||
33586800|NCT02311881|62985130|FG002|Overall Study|Serious Adverse Event|0|||
33586801|NCT02565511|62985145|FG000|Overall Study|Study terminated by Sponsor|35|||
33586802|NCT02565511|62985146|FG001|Overall Study|Study terminated by Sponsor|22|||
33586803|NCT02565511|62985147|FG002|Overall Study|Study terminated by Sponsor|235|||
33586804|NCT02565511|62985148|FG003|Overall Study|Study terminated by Sponsor|156|||
33586805|NCT02565511|62985145|FG000|Overall Study|Withdrawal by Subject|3|||
33586806|NCT02565511|62985146|FG001|Overall Study|Withdrawal by Subject|0|||
33586807|NCT02565511|62985147|FG002|Overall Study|Withdrawal by Subject|12|||
33586808|NCT02565511|62985148|FG003|Overall Study|Withdrawal by Subject|5|||
33586809|NCT02565511|62985145|FG000|Overall Study|Adverse Event|0|||
33586810|NCT02565511|62985146|FG001|Overall Study|Adverse Event|0|||
33586811|NCT02565511|62985147|FG002|Overall Study|Adverse Event|1|||
33586812|NCT02565511|62985148|FG003|Overall Study|Adverse Event|1|||
33586813|NCT02565511|62985145|FG000|Overall Study|Lost to Follow-up|4|||
33586814|NCT02565511|62985146|FG001|Overall Study|Lost to Follow-up|1|||
33586815|NCT02565511|62985147|FG002|Overall Study|Lost to Follow-up|0|||
33586816|NCT02565511|62985148|FG003|Overall Study|Lost to Follow-up|1|||
33586817|NCT02565511|62985145|FG000|Overall Study|Physician Decision|0|||
33586818|NCT02565511|62985146|FG001|Overall Study|Physician Decision|0|||
33586819|NCT02565511|62985147|FG002|Overall Study|Physician Decision|0|||
33586820|NCT02565511|62985148|FG003|Overall Study|Physician Decision|1|||
33586821|NCT02565511|62985145|FG000|Overall Study|Protocol deviation|0|||
33586822|NCT02565511|62985146|FG001|Overall Study|Protocol deviation|0|||
33586823|NCT02565511|62985147|FG002|Overall Study|Protocol deviation|3|||
33586824|NCT02565511|62985148|FG003|Overall Study|Protocol deviation|0|||
33586825|NCT02561455|62985162|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
33586826|NCT02561455|62985163|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
33586827|NCT02561455|62985164|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
33586828|NCT02561455|62985165|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
33586829|NCT02561455|62985162|FG000|Overall Study|Withdrawal by Subject|1|||
33586830|NCT02561455|62985163|FG001|Overall Study|Withdrawal by Subject|0|||
33586831|NCT02561455|62985164|FG002|Overall Study|Withdrawal by Subject|1|||
33586832|NCT02561455|62985165|FG003|Overall Study|Withdrawal by Subject|0|||
33586833|NCT02561455|62985162|FG000|Overall Study|Disease Progression|0|||
33586834|NCT02561455|62985163|FG001|Overall Study|Disease Progression|1|||
33586835|NCT02561455|62985164|FG002|Overall Study|Disease Progression|0|||
33586836|NCT02561455|62985165|FG003|Overall Study|Disease Progression|0|||
33586837|NCT02561299|62985177|FG000|Overall Study|Death|2|||
33586838|NCT02561299|62985178|FG001|Overall Study|Death|4|||
33586839|NCT02561299|62985177|FG000|Overall Study|Lost to Follow-up|1|||
33586840|NCT02561299|62985178|FG001|Overall Study|Lost to Follow-up|0|||
33586841|NCT02561299|62985177|FG000|Overall Study|Withdrawal by Subject|2|||
33586842|NCT02561299|62985178|FG001|Overall Study|Withdrawal by Subject|2|||
33586843|NCT02566759|62985201|FG000|All Parts|Withdrawal by Subject|0|||
33586844|NCT02566759|62985202|FG001|All Parts|Withdrawal by Subject|1|||
33586845|NCT02566759|62985203|FG002|All Parts|Withdrawal by Subject|0|||
33586846|NCT02566759|62985204|FG003|All Parts|Withdrawal by Subject|0|||
33586847|NCT02566759|62985205|FG004|All Parts|Withdrawal by Subject|0|||
33586848|NCT02566759|62985206|FG005|All Parts|Withdrawal by Subject|0|||
33586849|NCT02566759|62985207|FG006|All Parts|Withdrawal by Subject|0|||
33586850|NCT02566759|62985208|FG007|All Parts|Withdrawal by Subject|0|||
33586851|NCT02566759|62985209|FG008|All Parts|Withdrawal by Subject|0|||
33586852|NCT02566759|62985210|FG009|All Parts|Withdrawal by Subject|0|||
33586853|NCT02566759|62985211|FG010|All Parts|Withdrawal by Subject|0|||
33586854|NCT02566759|62985212|FG011|All Parts|Withdrawal by Subject|0|||
33586855|NCT02566759|62985213|FG012|All Parts|Withdrawal by Subject|0|||
33586856|NCT02566759|62985214|FG013|All Parts|Withdrawal by Subject|0|||
33679898|NCT02581488|63132762|FG000|Overall Study|Lost to Follow-up|1|||
33586857|NCT02566759|62985215|FG014|All Parts|Withdrawal by Subject|0|||
33586858|NCT02566759|62985216|FG015|All Parts|Withdrawal by Subject|0|||
33586859|NCT02566759|62985217|FG016|All Parts|Withdrawal by Subject|0|||
33586860|NCT02566759|62985201|FG000|All Parts|Adverse Event|0|||
33586861|NCT02566759|62985202|FG001|All Parts|Adverse Event|0|||
33586862|NCT02566759|62985203|FG002|All Parts|Adverse Event|0|||
33586863|NCT02566759|62985204|FG003|All Parts|Adverse Event|0|||
33586864|NCT02566759|62985205|FG004|All Parts|Adverse Event|0|||
33586865|NCT02566759|62985206|FG005|All Parts|Adverse Event|0|||
33586866|NCT02566759|62985207|FG006|All Parts|Adverse Event|0|||
33586867|NCT02566759|62985208|FG007|All Parts|Adverse Event|0|||
33586868|NCT02566759|62985209|FG008|All Parts|Adverse Event|0|||
33679899|NCT02581488|63132763|FG001|Overall Study|Lost to Follow-up|0|||
33586869|NCT02566759|62985210|FG009|All Parts|Adverse Event|0|||
33586870|NCT02566759|62985211|FG010|All Parts|Adverse Event|0|||
33586871|NCT02566759|62985212|FG011|All Parts|Adverse Event|0|||
33586872|NCT02566759|62985213|FG012|All Parts|Adverse Event|1|||
33586873|NCT02566759|62985214|FG013|All Parts|Adverse Event|3|||
33586874|NCT02566759|62985215|FG014|All Parts|Adverse Event|0|||
33586875|NCT02566759|62985216|FG015|All Parts|Adverse Event|0|||
33586876|NCT02566759|62985217|FG016|All Parts|Adverse Event|0|||
33586877|NCT02566759|62985201|FG000|All Parts|Other|0|||
33586878|NCT02566759|62985202|FG001|All Parts|Other|0|||
33586879|NCT02566759|62985203|FG002|All Parts|Other|0|||
33586880|NCT02566759|62985204|FG003|All Parts|Other|0|||
33586881|NCT02566759|62985205|FG004|All Parts|Other|0|||
33586882|NCT02566759|62985206|FG005|All Parts|Other|0|||
33586883|NCT02566759|62985207|FG006|All Parts|Other|0|||
33586884|NCT02566759|62985208|FG007|All Parts|Other|0|||
33586885|NCT02566759|62985209|FG008|All Parts|Other|0|||
33586886|NCT02566759|62985210|FG009|All Parts|Other|0|||
33586887|NCT02566759|62985211|FG010|All Parts|Other|0|||
33586888|NCT02566759|62985212|FG011|All Parts|Other|0|||
33586889|NCT02566759|62985213|FG012|All Parts|Other|0|||
33586890|NCT02566759|62985214|FG013|All Parts|Other|2|||
33586891|NCT02566759|62985215|FG014|All Parts|Other|0|||
33586892|NCT02566759|62985216|FG015|All Parts|Other|0|||
33586893|NCT02566759|62985217|FG016|All Parts|Other|0|||
33586894|NCT02566759|62985201|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586895|NCT02566759|62985202|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586896|NCT02566759|62985203|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586897|NCT02566759|62985204|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586898|NCT02566759|62985205|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586899|NCT02566759|62985206|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586900|NCT02566759|62985207|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586901|NCT02566759|62985208|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586902|NCT02566759|62985209|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586903|NCT02566759|62985210|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586904|NCT02566759|62985211|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586905|NCT02566759|62985212|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586906|NCT02566759|62985213|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586907|NCT02566759|62985214|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586908|NCT02566759|62985215|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586909|NCT02566759|62985216|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33586910|NCT02566759|62985217|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
33586911|NCT02335983|62985282|FG000|Overall Study|Sponsor Decision|0|||
33586912|NCT02335983|62985283|FG001|Overall Study|Sponsor Decision|0|||
33586913|NCT02335983|62985284|FG002|Overall Study|Sponsor Decision|1|||
33586914|NCT02335983|62985285|FG003|Overall Study|Sponsor Decision|1|||
33586915|NCT02335983|62985286|FG004|Overall Study|Sponsor Decision|0|||
33586916|NCT02335983|62985287|FG005|Overall Study|Sponsor Decision|1|||
33586917|NCT02335983|62985282|FG000|Overall Study|Withdrawal by Subject|3|||
33586918|NCT02335983|62985283|FG001|Overall Study|Withdrawal by Subject|2|||
33586919|NCT02335983|62985284|FG002|Overall Study|Withdrawal by Subject|2|||
33679900|NCT02581488|63132762|FG000|Overall Study|Withdrawal by Subject|1|||
33679901|NCT02581488|63132763|FG001|Overall Study|Withdrawal by Subject|0|||
33679902|NCT02581488|63132762|FG000|Overall Study|Non-Compliance|1|||
33679903|NCT02581488|63132763|FG001|Overall Study|Non-Compliance|0|||
33679904|NCT02581488|63132762|FG000|Overall Study|Protocol Violation|0|||
33679905|NCT02581488|63132763|FG001|Overall Study|Protocol Violation|4|||
33679906|NCT02581410|63132806|FG000|Vaccination Phase|Adverse Event|2|||
33679907|NCT02581410|63132807|FG001|Vaccination Phase|Adverse Event|1|||
33679908|NCT02581410|63132806|FG000|Vaccination Phase|Withdrawal by Subject|0|||
33679909|NCT02581410|63132807|FG001|Vaccination Phase|Withdrawal by Subject|1|||
33679910|NCT02581410|63132806|FG000|Vaccination Phase|Migrated/moved from study area|0|||
33679911|NCT02581410|63132807|FG001|Vaccination Phase|Migrated/moved from study area|1|||
33679912|NCT02581410|63132806|FG000|End of Study Phase|Adverse Event|4|||
33586920|NCT02335983|62985285|FG003|Overall Study|Withdrawal by Subject|1|||
33586921|NCT02335983|62985286|FG004|Overall Study|Withdrawal by Subject|3|||
33586922|NCT02335983|62985287|FG005|Overall Study|Withdrawal by Subject|9|||
33586923|NCT02335983|62985282|FG000|Overall Study|Death|0|||
33586924|NCT02335983|62985283|FG001|Overall Study|Death|0|||
33586925|NCT02335983|62985284|FG002|Overall Study|Death|2|||
33586926|NCT02335983|62985285|FG003|Overall Study|Death|0|||
33586927|NCT02335983|62985286|FG004|Overall Study|Death|0|||
33586928|NCT02335983|62985287|FG005|Overall Study|Death|0|||
33586929|NCT02335983|62985282|FG000|Overall Study|Lost to Follow-up|0|||
33586930|NCT02335983|62985283|FG001|Overall Study|Lost to Follow-up|0|||
33586931|NCT02335983|62985284|FG002|Overall Study|Lost to Follow-up|0|||
33679913|NCT02581410|63132807|FG001|End of Study Phase|Adverse Event|3|||
33679914|NCT02581410|63132806|FG000|End of Study Phase|Withdrawal by Subject|1|||
33679915|NCT02581410|63132807|FG001|End of Study Phase|Withdrawal by Subject|2|||
33679916|NCT02581410|63132806|FG000|End of Study Phase|Migrated/moved from study area|0|||
33586932|NCT02335983|62985285|FG003|Overall Study|Lost to Follow-up|0|||
33586933|NCT02335983|62985286|FG004|Overall Study|Lost to Follow-up|0|||
33586934|NCT02335983|62985287|FG005|Overall Study|Lost to Follow-up|1|||
33586935|NCT02335983|62985282|FG000|Overall Study|Protocol Specified Criteria|5|||
33586936|NCT02335983|62985283|FG001|Overall Study|Protocol Specified Criteria|7|||
33586937|NCT02335983|62985284|FG002|Overall Study|Protocol Specified Criteria|27|||
33586938|NCT02335983|62985285|FG003|Overall Study|Protocol Specified Criteria|7|||
33586939|NCT02335983|62985286|FG004|Overall Study|Protocol Specified Criteria|5|||
33586940|NCT02335983|62985287|FG005|Overall Study|Protocol Specified Criteria|21|||
33586941|NCT04640311|62985323|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
33586942|NCT04640311|62985324|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33586943|NCT04640311|62985325|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33586944|NCT04640311|62985326|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33586945|NCT04640311|62985327|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33586946|NCT04640311|62985328|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33586947|NCT04640311|62985329|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33586948|NCT04640311|62985330|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33586949|NCT04640311|62985331|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33586950|NCT04640311|62985332|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33586951|NCT04640311|62985333|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33586952|NCT04640311|62985334|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33586953|NCT04640311|62985335|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33586954|NCT04640311|62985323|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33586955|NCT04640311|62985324|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
33586956|NCT04640311|62985325|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33586957|NCT04640311|62985326|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33586958|NCT04640311|62985327|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33586959|NCT04640311|62985328|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33586960|NCT04640311|62985329|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33586961|NCT04640311|62985330|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33586962|NCT04640311|62985331|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33586963|NCT04640311|62985332|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33679917|NCT02581410|63132807|FG001|End of Study Phase|Migrated/moved from study area|3|||
33679918|NCT02581410|63132806|FG000|End of Study Phase|Lost to Follow-up|0|||
33679919|NCT02581410|63132807|FG001|End of Study Phase|Lost to Follow-up|2|||
33679920|NCT02581410|63132806|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
33679921|NCT02581410|63132807|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
33679922|NCT01664130|63132866|FG000|Overall Study|competing secondary disease|2|||
33679923|NCT02579928|63132897|FG000|Overall Study|Withdrawal by Subject|1|||
33679924|NCT02579928|63132898|FG001|Overall Study|Withdrawal by Subject|0|||
33679925|NCT00551460|63132992|FG000|Overall Study|Adverse Event|1|||
33679926|NCT00551460|63132992|FG000|Overall Study|Withdrawal by Subject|1|||
33679927|NCT00551460|63132992|FG000|Overall Study|Physician Decision|1|||
33679928|NCT00551460|63132992|FG000|Overall Study|Death|7|||
33679929|NCT00551460|63132992|FG000|Overall Study|Ineligible|4|||
33679930|NCT00551460|63132992|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
33679931|NCT02579772|63133053|FG000|Overall Study|Withdrawal by Subject|0|||
33679932|NCT02579772|63133054|FG001|Overall Study|Withdrawal by Subject|1|||
33586964|NCT04640311|62985333|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33586965|NCT04640311|62985334|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33586966|NCT04640311|62985335|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33586967|NCT04640311|62985323|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586968|NCT04640311|62985324|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
33586969|NCT04640311|62985325|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586970|NCT04640311|62985326|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586971|NCT04640311|62985327|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586972|NCT04640311|62985328|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586973|NCT04640311|62985329|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586974|NCT04640311|62985330|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586975|NCT04640311|62985331|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33679933|NCT02579772|63133053|FG000|Overall Study|Usage of additional antioxidants|1|||
33679934|NCT02579772|63133054|FG001|Overall Study|Usage of additional antioxidants|0|||
33493065|NCT03145766|62871124|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
33586976|NCT04640311|62985332|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586977|NCT04640311|62985333|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586978|NCT04640311|62985334|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586979|NCT04640311|62985335|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586980|NCT04640311|62985323|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
33586981|NCT04640311|62985324|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
33586982|NCT04640311|62985325|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
33586983|NCT04640311|62985326|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586984|NCT04640311|62985327|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586985|NCT04640311|62985328|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586986|NCT04640311|62985329|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586987|NCT04640311|62985330|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586988|NCT04640311|62985331|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586989|NCT04640311|62985332|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586990|NCT04640311|62985333|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586991|NCT04640311|62985334|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586992|NCT04640311|62985335|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33586993|NCT04640311|62985323|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33586994|NCT04640311|62985324|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33586995|NCT04640311|62985325|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
33586996|NCT04640311|62985326|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33586997|NCT04640311|62985327|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33586998|NCT04640311|62985328|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33586999|NCT04640311|62985329|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33587000|NCT04640311|62985330|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33587001|NCT04640311|62985331|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33587002|NCT04640311|62985332|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33587003|NCT04640311|62985333|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33587004|NCT04640311|62985334|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33587005|NCT04640311|62985335|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33587006|NCT04640311|62985323|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33587007|NCT04640311|62985324|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33587008|NCT04640311|62985325|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33587009|NCT04640311|62985326|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
33587010|NCT04640311|62985327|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33587011|NCT04640311|62985328|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33587012|NCT04640311|62985329|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
33587013|NCT04640311|62985330|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33587014|NCT04640311|62985331|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33587015|NCT04640311|62985332|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33587016|NCT04640311|62985333|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33587017|NCT04640311|62985334|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33587018|NCT04640311|62985335|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33587019|NCT04640311|62985323|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33587020|NCT04640311|62985324|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33587021|NCT04640311|62985325|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33587022|NCT04640311|62985326|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33587023|NCT04640311|62985327|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33587024|NCT04640311|62985328|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
33587025|NCT04640311|62985329|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33587026|NCT04640311|62985330|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33587027|NCT04640311|62985331|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
33587028|NCT04640311|62985332|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33679935|NCT02579772|63133053|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
33679936|NCT02579772|63133054|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
33679937|NCT02579616|63133127|FG000|Overall Study|Participants did not receive treatment|3|||
33679938|NCT04027608|63133204|FG000|Overall Study|Withdrawal by Subject|13|||
33679939|NCT04027608|63133205|FG001|Overall Study|Withdrawal by Subject|2|||
33587029|NCT04640311|62985333|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33587030|NCT04640311|62985334|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33587031|NCT04640311|62985335|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33587032|NCT04640311|62985323|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33587033|NCT04640311|62985324|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33587034|NCT04640311|62985325|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33587035|NCT04640311|62985326|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33587036|NCT04640311|62985327|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33587037|NCT04640311|62985328|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33587038|NCT04640311|62985329|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
33587039|NCT04640311|62985330|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33587040|NCT04640311|62985331|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33587041|NCT04640311|62985332|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33587042|NCT04640311|62985333|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
33587043|NCT04640311|62985334|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33587044|NCT04640311|62985335|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33587045|NCT04640311|62985323|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33587046|NCT04640311|62985324|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33587047|NCT04640311|62985325|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33587048|NCT04640311|62985326|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33587049|NCT04640311|62985327|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33587050|NCT04640311|62985328|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33587051|NCT04640311|62985329|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33587052|NCT04640311|62985330|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33587053|NCT04640311|62985331|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33587054|NCT04640311|62985332|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33587055|NCT04640311|62985333|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33587056|NCT04640311|62985334|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
33587057|NCT04640311|62985335|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33587058|NCT02334423|62985366|FG000|Overall Study|Protocol Violation|10|||
33587059|NCT02334423|62985367|FG001|Overall Study|Protocol Violation|3|||
33587060|NCT02310789|62985373|FG000|Overall Study|Adverse Event|1|||
33587061|NCT02372253|62985379|FG000|Overall Study|Non Compliance|2|||
33587062|NCT02372253|62985380|FG001|Overall Study|Non Compliance|0|||
33587063|NCT02559895|62985392|FG000|Overall Study|Adverse Event|3|||
33587064|NCT02559895|62985393|FG001|Overall Study|Adverse Event|3|||
33587065|NCT02559895|62985394|FG002|Overall Study|Adverse Event|2|||
33587066|NCT02559895|62985395|FG003|Overall Study|Adverse Event|1|||
33587067|NCT02559895|62985392|FG000|Overall Study|Lack of Efficacy|2|||
33587068|NCT02559895|62985393|FG001|Overall Study|Lack of Efficacy|3|||
33587069|NCT02559895|62985394|FG002|Overall Study|Lack of Efficacy|2|||
33587070|NCT02559895|62985395|FG003|Overall Study|Lack of Efficacy|8|||
33587071|NCT02559895|62985392|FG000|Overall Study|Lost to Follow-up|22|||
33587072|NCT02559895|62985393|FG001|Overall Study|Lost to Follow-up|16|||
33587073|NCT02559895|62985394|FG002|Overall Study|Lost to Follow-up|12|||
33587074|NCT02559895|62985395|FG003|Overall Study|Lost to Follow-up|17|||
33587075|NCT02559895|62985392|FG000|Overall Study|Physician Decision|1|||
33587076|NCT02559895|62985393|FG001|Overall Study|Physician Decision|1|||
33587077|NCT02559895|62985394|FG002|Overall Study|Physician Decision|3|||
33587078|NCT02559895|62985395|FG003|Overall Study|Physician Decision|0|||
33587079|NCT02559895|62985392|FG000|Overall Study|Withdrawal by Subject|16|||
33587080|NCT02559895|62985393|FG001|Overall Study|Withdrawal by Subject|9|||
33587081|NCT02559895|62985394|FG002|Overall Study|Withdrawal by Subject|20|||
33587082|NCT02559895|62985395|FG003|Overall Study|Withdrawal by Subject|9|||
33587083|NCT02559895|62985392|FG000|Overall Study|Study Burden|10|||
33587084|NCT02559895|62985393|FG001|Overall Study|Study Burden|16|||
33587085|NCT02559895|62985394|FG002|Overall Study|Study Burden|12|||
33587086|NCT02559895|62985395|FG003|Overall Study|Study Burden|22|||
33587087|NCT02559895|62985392|FG000|Overall Study|Other|1|||
33587088|NCT02559895|62985393|FG001|Overall Study|Other|5|||
33587089|NCT02559895|62985394|FG002|Overall Study|Other|3|||
33587090|NCT02559895|62985395|FG003|Overall Study|Other|3|||
33587091|NCT02371629|62985407|FG000|Overall Study|Patient decision|14|||
33587092|NCT02371629|62985408|FG001|Overall Study|Patient decision|10|||
33587093|NCT02371629|62985407|FG000|Overall Study|Adverse Event|8|||
33587094|NCT02371629|62985408|FG001|Overall Study|Adverse Event|8|||
33587095|NCT02371629|62985407|FG000|Overall Study|Physician Decision|2|||
33587096|NCT02371629|62985408|FG001|Overall Study|Physician Decision|3|||
33587097|NCT02371629|62985407|FG000|Overall Study|Death|1|||
33587098|NCT02371629|62985408|FG001|Overall Study|Death|1|||
33587099|NCT02371629|62985407|FG000|Overall Study|Noncompliance with study treatment|1|||
33587100|NCT02371629|62985408|FG001|Overall Study|Noncompliance with study treatment|0|||
33587101|NCT02371629|62985407|FG000|Overall Study|Lack of Efficacy|0|||
33587102|NCT02371629|62985408|FG001|Overall Study|Lack of Efficacy|2|||
33587103|NCT02371629|62985407|FG000|Overall Study|Protocol deviation|0|||
33587104|NCT02371629|62985408|FG001|Overall Study|Protocol deviation|1|||
33587105|NCT02559817|62985419|FG000|Treatment Period|Adverse Event|1|||
33587106|NCT02559817|62985420|FG001|Treatment Period|Adverse Event|0|||
33587107|NCT02559817|62985421|FG002|Treatment Period|Adverse Event|1|||
33587108|NCT02559817|62985422|FG003|Treatment Period|Adverse Event|0|||
33587109|NCT02559817|62985423|FG004|Treatment Period|Adverse Event|0|||
33587110|NCT02559817|62985419|FG000|Treatment Period|Lack of Efficacy|0|||
33587111|NCT02559817|62985420|FG001|Treatment Period|Lack of Efficacy|1|||
33587112|NCT02559817|62985421|FG002|Treatment Period|Lack of Efficacy|0|||
33587113|NCT02559817|62985422|FG003|Treatment Period|Lack of Efficacy|0|||
33587114|NCT02559817|62985423|FG004|Treatment Period|Lack of Efficacy|0|||
33587115|NCT02559817|62985419|FG000|Treatment Period|Lost to Follow-up|0|||
33587116|NCT02559817|62985420|FG001|Treatment Period|Lost to Follow-up|1|||
33587117|NCT02559817|62985421|FG002|Treatment Period|Lost to Follow-up|0|||
33587118|NCT02559817|62985422|FG003|Treatment Period|Lost to Follow-up|1|||
33587119|NCT02559817|62985423|FG004|Treatment Period|Lost to Follow-up|0|||
33587120|NCT02559817|62985419|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
33587121|NCT02559817|62985420|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
33587122|NCT02559817|62985421|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
33587123|NCT02559817|62985422|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
33587124|NCT02559817|62985423|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
33587125|NCT02559817|62985419|FG000|Treatment Period|Protocol Violation|0|||
33587126|NCT02559817|62985420|FG001|Treatment Period|Protocol Violation|0|||
33587127|NCT02559817|62985421|FG002|Treatment Period|Protocol Violation|0|||
33587128|NCT02559817|62985422|FG003|Treatment Period|Protocol Violation|1|||
33587129|NCT02559817|62985423|FG004|Treatment Period|Protocol Violation|0|||
33587130|NCT02564887|62985437|FG000|Overall Study|Lost to Follow-up|6|||
33587131|NCT02564887|62985438|FG001|Overall Study|Lost to Follow-up|0|||
33587132|NCT02333487|62985449|FG000|Overall Study|Adverse Event|0|||
33587133|NCT02333487|62985450|FG001|Overall Study|Adverse Event|2|||
33587134|NCT02333487|62985451|FG002|Overall Study|Adverse Event|0|||
33587135|NCT02333331|62985464|FG000|Overall Study|Adverse Event|1|||
33587136|NCT02333331|62985465|FG001|Overall Study|Adverse Event|0|||
33587137|NCT02333331|62985466|FG002|Overall Study|Adverse Event|4|||
33587138|NCT02333331|62985467|FG003|Overall Study|Adverse Event|1|||
33587139|NCT02333331|62985464|FG000|Overall Study|Death|0|||
33587140|NCT02333331|62985465|FG001|Overall Study|Death|0|||
33587141|NCT02333331|62985466|FG002|Overall Study|Death|2|||
33587142|NCT02333331|62985467|FG003|Overall Study|Death|0|||
33587143|NCT02333331|62985464|FG000|Overall Study|Lost to Follow-up|0|||
33587144|NCT02333331|62985465|FG001|Overall Study|Lost to Follow-up|0|||
33587145|NCT02333331|62985466|FG002|Overall Study|Lost to Follow-up|1|||
33587146|NCT02333331|62985467|FG003|Overall Study|Lost to Follow-up|0|||
33587147|NCT02333331|62985464|FG000|Overall Study|Physician Decision|0|||
33587148|NCT02333331|62985465|FG001|Overall Study|Physician Decision|1|||
33587149|NCT02333331|62985466|FG002|Overall Study|Physician Decision|0|||
33587150|NCT02333331|62985467|FG003|Overall Study|Physician Decision|0|||
33587151|NCT02333331|62985464|FG000|Overall Study|Protocol Deviation|0|||
33587152|NCT02333331|62985465|FG001|Overall Study|Protocol Deviation|3|||
33587153|NCT02333331|62985466|FG002|Overall Study|Protocol Deviation|2|||
33587154|NCT02333331|62985467|FG003|Overall Study|Protocol Deviation|1|||
33587155|NCT02333331|62985464|FG000|Overall Study|Patient/Guardian Decision|1|||
33587156|NCT02333331|62985465|FG001|Overall Study|Patient/Guardian Decision|2|||
33587157|NCT02333331|62985466|FG002|Overall Study|Patient/Guardian Decision|9|||
33587158|NCT02333331|62985467|FG003|Overall Study|Patient/Guardian Decision|1|||
33587159|NCT02563561|62985480|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
33587160|NCT02563561|62985481|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
33587161|NCT02563561|62985482|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
33587162|NCT02563561|62985480|FG000|Overall Study|Withdrew of Consent|1|||
33587163|NCT02563561|62985481|FG001|Overall Study|Withdrew of Consent|1|||
33587164|NCT02563561|62985482|FG002|Overall Study|Withdrew of Consent|2|||
33587165|NCT02563561|62985480|FG000|Overall Study|Lost to Follow-up|1|||
33587166|NCT02563561|62985481|FG001|Overall Study|Lost to Follow-up|1|||
33587167|NCT02563561|62985482|FG002|Overall Study|Lost to Follow-up|0|||
33587168|NCT02563561|62985480|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
33587169|NCT02563561|62985481|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
33587170|NCT02563561|62985482|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
33587171|NCT02563561|62985480|FG000|Overall Study|Investigator Decision|3|||
33587172|NCT02563561|62985481|FG001|Overall Study|Investigator Decision|4|||
33587173|NCT02563561|62985482|FG002|Overall Study|Investigator Decision|2|||
33587174|NCT02563561|62985480|FG000|Overall Study|Sponsor Decision|5|||
33587175|NCT02563561|62985481|FG001|Overall Study|Sponsor Decision|2|||
33587176|NCT02563561|62985482|FG002|Overall Study|Sponsor Decision|4|||
33587177|NCT02563561|62985480|FG000|Overall Study|Other|1|||
33587178|NCT02563561|62985481|FG001|Overall Study|Other|5|||
33587179|NCT02563561|62985482|FG002|Overall Study|Other|2|||
33587180|NCT02559505|62985498|FG000|Overall Study|Lost to Follow-up|23|||
33587181|NCT02559505|62985499|FG001|Overall Study|Lost to Follow-up|20|||
33587182|NCT02559505|62985498|FG000|Overall Study|Withdrawal by Subject|4|||
33587183|NCT02559505|62985499|FG001|Overall Study|Withdrawal by Subject|2|||
33587184|NCT04191967|62985521|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
33587185|NCT04191967|62985521|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
33587186|NCT02556307|62985527|FG000|Overall Study|Premature treatment interruption|11|||
33587187|NCT02556307|62985527|FG000|Overall Study|Lost to Follow-up|36|||
33587188|NCT02556307|62985527|FG000|Overall Study|Change to triple therapy|4|||
33587189|NCT02556307|62985527|FG000|Overall Study|Enrolled but not treated|2|||
33587190|NCT04364737|62985533|FG000|Overall Study|Withdrawal by Subject|4|||
33587191|NCT04364737|62985534|FG001|Overall Study|Withdrawal by Subject|9|||
33587192|NCT04364737|62985533|FG000|Overall Study|Lost to Follow-up|1|||
33587193|NCT04364737|62985534|FG001|Overall Study|Lost to Follow-up|1|||
33587194|NCT02559115|62985540|FG000|Overall Study|Withdrawal by Subject|3|||
33587195|NCT01662895|62985558|FG000|Overall Study|Lost to Follow-up|0|||
33587196|NCT01662895|62985559|FG001|Overall Study|Lost to Follow-up|1|||
33587197|NCT02557399|62985567|FG000|Overall Study|Adverse Event|6|||
33587198|NCT02557399|62985568|FG001|Overall Study|Adverse Event|5|||
33587199|NCT02557399|62985567|FG000|Overall Study|Protocol Violation|0|||
33587200|NCT02557399|62985568|FG001|Overall Study|Protocol Violation|1|||
33587201|NCT02557399|62985567|FG000|Overall Study|Protocol-defined stopping criteria|0|||
33587202|NCT02557399|62985568|FG001|Overall Study|Protocol-defined stopping criteria|1|||
33587203|NCT02557399|62985567|FG000|Overall Study|Withdrawal by Subject|1|||
33587204|NCT02557399|62985568|FG001|Overall Study|Withdrawal by Subject|1|||
33587205|NCT02555371|62985577|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
33587206|NCT02555371|62985578|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
33587207|NCT02555371|62985579|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
33587208|NCT02555371|62985580|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
33587209|NCT02555371|62985581|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
33587210|NCT02555371|62985577|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
33587211|NCT02555371|62985578|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
33587212|NCT02555371|62985579|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
33587213|NCT02555371|62985580|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
33587214|NCT02555371|62985581|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
33587215|NCT02555371|62985577|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
33587216|NCT02555371|62985578|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
33587217|NCT02555371|62985579|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
33587218|NCT02555371|62985580|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
33587219|NCT02555371|62985581|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
33587220|NCT02555371|62985577|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
33587221|NCT02555371|62985578|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
33587222|NCT02555371|62985579|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
33587223|NCT02555371|62985580|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
33587224|NCT02555371|62985581|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
33587225|NCT02555371|62985577|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
33587226|NCT02555371|62985578|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
33587227|NCT02555371|62985579|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
33587228|NCT02555371|62985580|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
33587229|NCT02555371|62985581|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
33587230|NCT02555371|62985577|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
33587231|NCT02555371|62985578|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
33587232|NCT02555371|62985579|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
33587233|NCT02555371|62985580|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
33587234|NCT02555371|62985581|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
33587235|NCT02555371|62985577|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
33587236|NCT02555371|62985578|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
33587237|NCT02555371|62985579|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
33587238|NCT02555371|62985580|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
33587239|NCT02555371|62985581|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
33679940|NCT04027608|63133204|FG000|Overall Study|Protocol Violation|2|||
33587240|NCT02555371|62985577|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
33587241|NCT02555371|62985578|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
33587242|NCT02555371|62985579|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
33587243|NCT02555371|62985580|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
33587244|NCT02555371|62985581|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
33587245|NCT02555371|62985577|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
33679941|NCT04027608|63133205|FG001|Overall Study|Protocol Violation|1|||
33679942|NCT04027608|63133204|FG000|Overall Study|Physician Decision|1|||
33587246|NCT02555371|62985578|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
33587247|NCT02555371|62985579|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
33587248|NCT02555371|62985580|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
33587249|NCT02555371|62985581|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
33587250|NCT02555371|62985577|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
33587251|NCT02555371|62985578|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
33587252|NCT02555371|62985579|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
33587253|NCT02555371|62985580|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
33587254|NCT02555371|62985581|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
33587255|NCT02555371|62985577|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
33587256|NCT02555371|62985578|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
33587257|NCT02555371|62985579|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
33587258|NCT02555371|62985580|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
33587259|NCT02555371|62985581|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
33587260|NCT02555371|62985577|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
33587261|NCT02555371|62985578|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
33587262|NCT02555371|62985579|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
33587263|NCT02555371|62985580|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
33587264|NCT02555371|62985581|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
33587265|NCT02555371|62985577|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
33587266|NCT02555371|62985578|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
33587267|NCT02555371|62985579|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
33587268|NCT02555371|62985580|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
33587269|NCT02555371|62985581|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
33587270|NCT02555371|62985577|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
33587271|NCT02555371|62985578|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
33587272|NCT02555371|62985579|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
33587273|NCT02555371|62985580|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
33587274|NCT02555371|62985581|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
33587275|NCT02555215|62985590|FG000|Overall Study|Other|1|||
33587276|NCT02555215|62985590|FG000|Overall Study|Investigator Decision|2|||
33587277|NCT02555683|62985597|FG000|Overall Study|Physician Decision|1|||
33587278|NCT02555683|62985598|FG001|Overall Study|Physician Decision|0|||
33587279|NCT02555683|62985599|FG002|Overall Study|Physician Decision|2|||
33587280|NCT02555683|62985597|FG000|Overall Study|Lost to Follow-up|2|||
33587281|NCT02555683|62985598|FG001|Overall Study|Lost to Follow-up|1|||
33587282|NCT02555683|62985599|FG002|Overall Study|Lost to Follow-up|2|||
33587283|NCT02555683|62985597|FG000|Overall Study|Technical Problems|1|||
33587284|NCT02555683|62985598|FG001|Overall Study|Technical Problems|1|||
33587285|NCT02555683|62985599|FG002|Overall Study|Technical Problems|0|||
33587286|NCT02555683|62985597|FG000|Overall Study|Protocol deviation|0|||
33587287|NCT02555683|62985598|FG001|Overall Study|Protocol deviation|1|||
33587288|NCT02555683|62985599|FG002|Overall Study|Protocol deviation|0|||
33587289|NCT02555683|62985597|FG000|Overall Study|Lack of Efficacy|2|||
33587290|NCT02555683|62985598|FG001|Overall Study|Lack of Efficacy|0|||
33587291|NCT02555683|62985599|FG002|Overall Study|Lack of Efficacy|0|||
33587292|NCT02555683|62985597|FG000|Overall Study|Death|0|||
33587293|NCT02555683|62985598|FG001|Overall Study|Death|1|||
33587294|NCT02555683|62985599|FG002|Overall Study|Death|2|||
33587295|NCT02555683|62985597|FG000|Overall Study|Adverse Event|1|||
33587296|NCT02555683|62985598|FG001|Overall Study|Adverse Event|0|||
33587297|NCT02555683|62985599|FG002|Overall Study|Adverse Event|1|||
33587298|NCT02555683|62985597|FG000|Overall Study|Subject/guardian decision|12|||
33587299|NCT02555683|62985598|FG001|Overall Study|Subject/guardian decision|12|||
33587300|NCT02555683|62985599|FG002|Overall Study|Subject/guardian decision|22|||
33587301|NCT02555683|62985597|FG000|Overall Study|Death post Treatment/safety period|0|||
33587302|NCT02555683|62985598|FG001|Overall Study|Death post Treatment/safety period|1|||
33587303|NCT02555683|62985599|FG002|Overall Study|Death post Treatment/safety period|0|||
33587304|NCT02554981|62985607|FG000|Overall Study|Adverse Event|1|||
33587305|NCT02554981|62985607|FG000|Overall Study|Administrative Reasons|1|||
33587306|NCT02554981|62985607|FG000|Overall Study|Other Miscellaneous Reasons|3|||
33587307|NCT02556775|62985615|FG000|Overall Study|Withdrawal by Subject|1|||
33587308|NCT02556775|62985616|FG001|Overall Study|Withdrawal by Subject|0|||
33587309|NCT02556775|62985617|FG002|Overall Study|Withdrawal by Subject|1|||
33587310|NCT02556775|62985618|FG003|Overall Study|Withdrawal by Subject|0|||
33587311|NCT02556775|62985615|FG000|Overall Study|Lost to Follow-up|1|||
33587312|NCT02556775|62985616|FG001|Overall Study|Lost to Follow-up|0|||
33310705|NCT01163253|62686098|FG000|Overall Study|Insufficient Clinical Response|423|||
33587313|NCT02556775|62985617|FG002|Overall Study|Lost to Follow-up|0|||
33587314|NCT02556775|62985618|FG003|Overall Study|Lost to Follow-up|0|||
33587315|NCT01662505|62985633|FG000|Overall Study|Progressive disease|6|||
33587316|NCT01662505|62985634|FG001|Overall Study|Progressive disease|1|||
33587317|NCT01662505|62985635|FG002|Overall Study|Progressive disease|5|||
33587318|NCT01662505|62985633|FG000|Overall Study|Refused cont. medication|0|||
33587319|NCT01662505|62985634|FG001|Overall Study|Refused cont. medication|0|||
33587320|NCT01662505|62985635|FG002|Overall Study|Refused cont. medication|1|||
33587321|NCT01662505|62985633|FG000|Overall Study|Not specified above|1|||
33587322|NCT01662505|62985634|FG001|Overall Study|Not specified above|3|||
33587323|NCT01662505|62985635|FG002|Overall Study|Not specified above|2|||
33587324|NCT03796195|62985644|FG000|Overall Study|Study closed early|1|||
33587325|NCT02554513|62985648|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
33587326|NCT02554513|62985649|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
33587327|NCT02554903|62985663|FG000|Overall Study|Death|1|||
33587328|NCT02554903|62985664|FG001|Overall Study|Death|1|||
33587329|NCT02554903|62985663|FG000|Overall Study|Physician Decision|2|||
33587330|NCT02554903|62985664|FG001|Overall Study|Physician Decision|2|||
33587331|NCT02554903|62985663|FG000|Overall Study|Heart Transplant|1|||
33587332|NCT02554903|62985664|FG001|Overall Study|Heart Transplant|2|||
33587333|NCT02332707|62985689|FG000|Overall Study|Adverse Event|0|||
33587334|NCT02332707|62985690|FG001|Overall Study|Adverse Event|0|||
33587335|NCT02332707|62985691|FG002|Overall Study|Adverse Event|0|||
33587336|NCT02332707|62985692|FG003|Overall Study|Adverse Event|0|||
33587337|NCT02332707|62985693|FG004|Overall Study|Adverse Event|0|||
33587338|NCT02332707|62985694|FG005|Overall Study|Adverse Event|0|||
33587339|NCT02332707|62985695|FG006|Overall Study|Adverse Event|0|||
33587340|NCT02332707|62985696|FG007|Overall Study|Adverse Event|0|||
33587341|NCT02332707|62985697|FG008|Overall Study|Adverse Event|0|||
33587342|NCT02332707|62985698|FG009|Overall Study|Adverse Event|0|||
33587343|NCT02332707|62985699|FG010|Overall Study|Adverse Event|0|||
33587344|NCT02332707|62985700|FG011|Overall Study|Adverse Event|0|||
33587345|NCT02332707|62985701|FG012|Overall Study|Adverse Event|1|||
33587346|NCT02332707|62985702|FG013|Overall Study|Adverse Event|0|||
33587347|NCT02332707|62985703|FG014|Overall Study|Adverse Event|0|||
33587348|NCT02332707|62985704|FG015|Overall Study|Adverse Event|0|||
33587349|NCT02332707|62985705|FG016|Overall Study|Adverse Event|0|||
33587350|NCT02332707|62985706|FG017|Overall Study|Adverse Event|0|||
33587351|NCT02332707|62985689|FG000|Overall Study|Lost to Follow-up|0|||
33587352|NCT02332707|62985690|FG001|Overall Study|Lost to Follow-up|0|||
33587353|NCT02332707|62985691|FG002|Overall Study|Lost to Follow-up|0|||
33587354|NCT02332707|62985692|FG003|Overall Study|Lost to Follow-up|0|||
33587355|NCT02332707|62985693|FG004|Overall Study|Lost to Follow-up|0|||
33587356|NCT02332707|62985694|FG005|Overall Study|Lost to Follow-up|1|||
33587357|NCT02332707|62985695|FG006|Overall Study|Lost to Follow-up|0|||
33587358|NCT02332707|62985696|FG007|Overall Study|Lost to Follow-up|0|||
33587359|NCT02332707|62985697|FG008|Overall Study|Lost to Follow-up|0|||
33587360|NCT02332707|62985698|FG009|Overall Study|Lost to Follow-up|0|||
33587361|NCT02332707|62985699|FG010|Overall Study|Lost to Follow-up|2|||
33587362|NCT02332707|62985700|FG011|Overall Study|Lost to Follow-up|0|||
33587363|NCT02332707|62985701|FG012|Overall Study|Lost to Follow-up|3|||
33587364|NCT02332707|62985702|FG013|Overall Study|Lost to Follow-up|0|||
33587365|NCT02332707|62985703|FG014|Overall Study|Lost to Follow-up|0|||
33587366|NCT02332707|62985704|FG015|Overall Study|Lost to Follow-up|0|||
33587367|NCT02332707|62985705|FG016|Overall Study|Lost to Follow-up|0|||
33587368|NCT02332707|62985706|FG017|Overall Study|Lost to Follow-up|0|||
33587369|NCT02332707|62985689|FG000|Overall Study|Physician Decision|0|||
33587370|NCT02332707|62985690|FG001|Overall Study|Physician Decision|0|||
33587371|NCT02332707|62985691|FG002|Overall Study|Physician Decision|0|||
33587372|NCT02332707|62985692|FG003|Overall Study|Physician Decision|1|||
33587373|NCT02332707|62985693|FG004|Overall Study|Physician Decision|0|||
33587374|NCT02332707|62985694|FG005|Overall Study|Physician Decision|0|||
33587375|NCT02332707|62985695|FG006|Overall Study|Physician Decision|0|||
33587376|NCT02332707|62985696|FG007|Overall Study|Physician Decision|0|||
33587377|NCT02332707|62985697|FG008|Overall Study|Physician Decision|0|||
33587378|NCT02332707|62985698|FG009|Overall Study|Physician Decision|0|||
33587379|NCT02332707|62985699|FG010|Overall Study|Physician Decision|0|||
33587380|NCT02332707|62985700|FG011|Overall Study|Physician Decision|0|||
33679943|NCT04027608|63133205|FG001|Overall Study|Physician Decision|0|||
33679944|NCT04027608|63133204|FG000|Overall Study|Lost to Follow-up|20|||
33587381|NCT02332707|62985701|FG012|Overall Study|Physician Decision|1|||
33587382|NCT02332707|62985702|FG013|Overall Study|Physician Decision|0|||
33587383|NCT02332707|62985703|FG014|Overall Study|Physician Decision|0|||
33587384|NCT02332707|62985704|FG015|Overall Study|Physician Decision|0|||
33587385|NCT02332707|62985705|FG016|Overall Study|Physician Decision|0|||
33587386|NCT02332707|62985706|FG017|Overall Study|Physician Decision|0|||
33587387|NCT02332707|62985689|FG000|Overall Study|Withdrawal by Subject|0|||
33587388|NCT02332707|62985690|FG001|Overall Study|Withdrawal by Subject|0|||
33587389|NCT02332707|62985691|FG002|Overall Study|Withdrawal by Subject|1|||
33587390|NCT02332707|62985692|FG003|Overall Study|Withdrawal by Subject|0|||
33587391|NCT02332707|62985693|FG004|Overall Study|Withdrawal by Subject|0|||
33587392|NCT02332707|62985694|FG005|Overall Study|Withdrawal by Subject|0|||
33679945|NCT04027608|63133205|FG001|Overall Study|Lost to Follow-up|4|||
33587393|NCT02332707|62985695|FG006|Overall Study|Withdrawal by Subject|0|||
33587394|NCT02332707|62985696|FG007|Overall Study|Withdrawal by Subject|0|||
33587395|NCT02332707|62985697|FG008|Overall Study|Withdrawal by Subject|0|||
33587396|NCT02332707|62985698|FG009|Overall Study|Withdrawal by Subject|3|||
33587397|NCT02332707|62985699|FG010|Overall Study|Withdrawal by Subject|0|||
33587398|NCT02332707|62985700|FG011|Overall Study|Withdrawal by Subject|0|||
33587399|NCT02332707|62985701|FG012|Overall Study|Withdrawal by Subject|0|||
33587400|NCT02332707|62985702|FG013|Overall Study|Withdrawal by Subject|0|||
33587401|NCT02332707|62985703|FG014|Overall Study|Withdrawal by Subject|0|||
33587402|NCT02332707|62985704|FG015|Overall Study|Withdrawal by Subject|0|||
33587403|NCT02332707|62985705|FG016|Overall Study|Withdrawal by Subject|0|||
33587404|NCT02332707|62985706|FG017|Overall Study|Withdrawal by Subject|0|||
33587405|NCT02370615|62985746|FG000|Overall Study|Adverse Event|1|||
33587406|NCT02370615|62985747|FG001|Overall Study|Adverse Event|0|||
33587407|NCT02307513|62985762|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
33587408|NCT02307513|62985763|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
33587409|NCT02307513|62985762|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
33587410|NCT02307513|62985763|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
33587411|NCT02307513|62985762|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
33587412|NCT02307513|62985763|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
33587413|NCT02307513|62985762|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
33587414|NCT02307513|62985763|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
33587415|NCT02307513|62985762|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
33587416|NCT02307513|62985763|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
33587417|NCT02307513|62985762|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
33587418|NCT02307513|62985763|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
33587419|NCT02307513|62985762|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
33587420|NCT02307513|62985763|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
33587421|NCT02307513|62985762|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
33587422|NCT02307513|62985763|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
33587423|NCT02307513|62985762|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
33587424|NCT02307513|62985763|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
33587425|NCT02307513|62985762|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
33587426|NCT02307513|62985763|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
33587427|NCT02307513|62985762|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
33587428|NCT02307513|62985763|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
33587429|NCT02307513|62985762|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
33587430|NCT02307513|62985763|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
33587431|NCT02307513|62985762|FG000|Long-term Extension|Physician Decision|1|||
33587432|NCT02307513|62985763|FG001|Long-term Extension|Physician Decision|0|||
33587433|NCT02332239|62985775|FG000|Overall Study|Lost to Follow-up|4|||
33587434|NCT02332239|62985776|FG001|Overall Study|Lost to Follow-up|6|||
33587435|NCT02370537|62985787|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
33587436|NCT02370537|62985788|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
33587437|NCT02370537|62985789|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
33587438|NCT02370537|62985787|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
33587439|NCT02370537|62985788|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
33587440|NCT02370537|62985789|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
33587441|NCT02370537|62985787|FG000|Part B|Not randomised to receive treatment|1|||
33587442|NCT02370537|62985788|FG001|Part B|Not randomised to receive treatment|2|||
33587443|NCT02370537|62985789|FG002|Part B|Not randomised to receive treatment|259|||
33587444|NCT02370537|62985787|FG000|Part B|Withdrawal by Subject|0|||
33587445|NCT02370537|62985788|FG001|Part B|Withdrawal by Subject|1|||
33587446|NCT02370537|62985789|FG002|Part B|Withdrawal by Subject|0|||
33587447|NCT02330055|62985808|FG000|Overall Study|technical issues|2|||
33587448|NCT02330055|62985809|FG001|Overall Study|technical issues|0|||
33587449|NCT02330055|62985808|FG000|Overall Study|participant forgot to wear device|5|||
33587450|NCT02330055|62985809|FG001|Overall Study|participant forgot to wear device|5|||
33587451|NCT02330055|62985808|FG000|Overall Study|data for less than 60 minutes|3|||
33587452|NCT02330055|62985809|FG001|Overall Study|data for less than 60 minutes|3|||
33587453|NCT02330055|62985808|FG000|Overall Study|participant did not sleep|0|||
33587454|NCT02330055|62985809|FG001|Overall Study|participant did not sleep|1|||
33587455|NCT02306265|62985815|FG000|Overall Study|Withdrawal by Subject|1|||
33587456|NCT02329743|62985823|FG000|Overall Study|Adverse Event|1|||
33587457|NCT02329743|62985824|FG001|Overall Study|Adverse Event|1|||
33587458|NCT02329743|62985825|FG002|Overall Study|Adverse Event|3|||
33587459|NCT02329743|62985823|FG000|Overall Study|Lost to Follow-up|1|||
33587460|NCT02329743|62985824|FG001|Overall Study|Lost to Follow-up|0|||
33587461|NCT02329743|62985825|FG002|Overall Study|Lost to Follow-up|1|||
33587462|NCT02329743|62985823|FG000|Overall Study|Withdrawal by Subject|4|||
33587463|NCT02329743|62985824|FG001|Overall Study|Withdrawal by Subject|4|||
33587464|NCT02329743|62985825|FG002|Overall Study|Withdrawal by Subject|1|||
33587465|NCT02329743|62985823|FG000|Overall Study|Other|0|||
33587466|NCT02329743|62985824|FG001|Overall Study|Other|2|||
33587467|NCT02329743|62985825|FG002|Overall Study|Other|3|||
33587468|NCT02329431|62985835|FG000|Overall Study|Lost to Follow-up|20|||
33587469|NCT02329431|62985836|FG001|Overall Study|Lost to Follow-up|13|||
33587470|NCT02328105|62985842|FG000|Overall Study|Death|6|||
33587471|NCT02328105|62985842|FG000|Overall Study|Withdrawal by Subject|1|||
33587472|NCT02328105|62985842|FG000|Overall Study|Still On Study in Follow-Up|4|||
33587473|NCT02305797|62985848|FG000|Overall Study|Adverse Event|11|||
33587474|NCT02305797|62985849|FG001|Overall Study|Adverse Event|2|||
33587475|NCT02305797|62985848|FG000|Overall Study|Withdrawal by Subject|9|||
33587476|NCT02305797|62985849|FG001|Overall Study|Withdrawal by Subject|10|||
33587477|NCT02305797|62985848|FG000|Overall Study|Lack of Efficacy|6|||
33587478|NCT02305797|62985849|FG001|Overall Study|Lack of Efficacy|0|||
33587479|NCT02305797|62985848|FG000|Overall Study|Lost to Follow-up|5|||
33587480|NCT02305797|62985849|FG001|Overall Study|Lost to Follow-up|11|||
33587481|NCT02305797|62985848|FG000|Overall Study|Pregnancy|0|||
33587482|NCT02305797|62985849|FG001|Overall Study|Pregnancy|2|||
33587483|NCT02305797|62985848|FG000|Overall Study|Noncompliance|14|||
33587484|NCT02305797|62985849|FG001|Overall Study|Noncompliance|12|||
33587485|NCT02305797|62985848|FG000|Overall Study|Reason not collected|0|||
33587486|NCT02305797|62985849|FG001|Overall Study|Reason not collected|1|||
33587487|NCT01646073|62985857|FG000|Period A (12 Weeks)|Adverse Event|0|||
33587488|NCT01646073|62985858|FG001|Period A (12 Weeks)|Adverse Event|2|||
33587489|NCT01646073|62985857|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
33587490|NCT01646073|62985858|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
33587491|NCT01646073|62985857|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
33587492|NCT01646073|62985858|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
33587493|NCT01646073|62985857|FG000|Period A (12 Weeks)|Protocol Violation|0|||
33587494|NCT01646073|62985858|FG001|Period A (12 Weeks)|Protocol Violation|1|||
33587495|NCT01646073|62985857|FG000|Period A (12 Weeks)|Other|0|||
33587496|NCT01646073|62985858|FG001|Period A (12 Weeks)|Other|1|||
33587497|NCT01646073|62985857|FG000|Period B (12 Weeks)|Adverse Event|0|||
33587498|NCT01646073|62985858|FG001|Period B (12 Weeks)|Adverse Event|7|||
33587499|NCT01646073|62985857|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
33587500|NCT01646073|62985858|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
33587501|NCT01646073|62985857|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
33587502|NCT01646073|62985858|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
33587503|NCT02328027|62985869|FG000|Overall Study|Withdrawal by Subject|0|||
33587504|NCT02328027|62985870|FG001|Overall Study|Withdrawal by Subject|1|||
33587505|NCT02551159|62985880|FG000|Overall Study|Death|352|||
33587506|NCT02551159|62985881|FG001|Overall Study|Death|174|||
33587507|NCT02551159|62985882|FG002|Overall Study|Death|161|||
33587508|NCT02551159|62985880|FG000|Overall Study|Withdrawal by Subject|8|||
33587509|NCT02551159|62985881|FG001|Overall Study|Withdrawal by Subject|5|||
33587510|NCT02551159|62985882|FG002|Overall Study|Withdrawal by Subject|16|||
33587511|NCT02551159|62985880|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
33587512|NCT02551159|62985881|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
33587513|NCT02551159|62985882|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
33587514|NCT02305563|62985895|FG000|Treatment Period|Disease progression|0|||
33587515|NCT02305563|62985896|FG001|Treatment Period|Disease progression|0|||
33587516|NCT02305563|62985897|FG002|Treatment Period|Disease progression|15|||
33587517|NCT02305563|62985898|FG003|Treatment Period|Disease progression|6|||
33587518|NCT02305563|62985899|FG004|Treatment Period|Disease progression|6|||
33587519|NCT02305563|62985895|FG000|Treatment Period|Study drug toxicity|0|||
33587520|NCT02305563|62985896|FG001|Treatment Period|Study drug toxicity|0|||
33587521|NCT02305563|62985897|FG002|Treatment Period|Study drug toxicity|0|||
33587522|NCT02305563|62985898|FG003|Treatment Period|Study drug toxicity|1|||
33587523|NCT02305563|62985899|FG004|Treatment Period|Study drug toxicity|2|||
33587524|NCT02305563|62985895|FG000|Treatment Period|Death|0|||
33587525|NCT02305563|62985896|FG001|Treatment Period|Death|0|||
33587526|NCT02305563|62985897|FG002|Treatment Period|Death|1|||
33587527|NCT02305563|62985898|FG003|Treatment Period|Death|2|||
33587528|NCT02305563|62985899|FG004|Treatment Period|Death|1|||
33587529|NCT02305563|62985895|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
33587530|NCT02305563|62985896|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
33587531|NCT02305563|62985897|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
33587532|NCT02305563|62985898|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
33587533|NCT02305563|62985899|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
33587534|NCT02305563|62985895|FG000|Treatment Period|Participant request to stop therapy|0|||
33587535|NCT02305563|62985896|FG001|Treatment Period|Participant request to stop therapy|2|||
33587536|NCT02305563|62985897|FG002|Treatment Period|Participant request to stop therapy|0|||
33587537|NCT02305563|62985898|FG003|Treatment Period|Participant request to stop therapy|1|||
33587538|NCT02305563|62985899|FG004|Treatment Period|Participant request to stop therapy|0|||
33587539|NCT02305563|62985895|FG000|Treatment Period|Participant withdrew consent|0|||
33587540|NCT02305563|62985896|FG001|Treatment Period|Participant withdrew consent|0|||
33587541|NCT02305563|62985897|FG002|Treatment Period|Participant withdrew consent|1|||
33587542|NCT02305563|62985898|FG003|Treatment Period|Participant withdrew consent|1|||
33587543|NCT02305563|62985899|FG004|Treatment Period|Participant withdrew consent|1|||
33587544|NCT02305563|62985895|FG000|Treatment Period|Maximum clinical benefit|0|||
33587545|NCT02305563|62985896|FG001|Treatment Period|Maximum clinical benefit|0|||
33587546|NCT02305563|62985897|FG002|Treatment Period|Maximum clinical benefit|0|||
33587547|NCT02305563|62985898|FG003|Treatment Period|Maximum clinical benefit|0|||
33587548|NCT02305563|62985899|FG004|Treatment Period|Maximum clinical benefit|1|||
33587549|NCT02305563|62985895|FG000|Treatment Period|Poor/non-compliance|0|||
33587550|NCT02305563|62985896|FG001|Treatment Period|Poor/non-compliance|0|||
33587551|NCT02305563|62985897|FG002|Treatment Period|Poor/non-compliance|0|||
33587552|NCT02305563|62985898|FG003|Treatment Period|Poor/non-compliance|0|||
33587553|NCT02305563|62985899|FG004|Treatment Period|Poor/non-compliance|1|||
33587554|NCT02305563|62985895|FG000|Treatment Period|Administrative reason by Sponsor|0|||
33587555|NCT02305563|62985896|FG001|Treatment Period|Administrative reason by Sponsor|0|||
33587556|NCT02305563|62985897|FG002|Treatment Period|Administrative reason by Sponsor|0|||
33587557|NCT02305563|62985898|FG003|Treatment Period|Administrative reason by Sponsor|0|||
33587558|NCT02305563|62985899|FG004|Treatment Period|Administrative reason by Sponsor|1|||
33587559|NCT02305563|62985895|FG000|Treatment Period|other reason|2|||
33587560|NCT02305563|62985896|FG001|Treatment Period|other reason|0|||
33587561|NCT02305563|62985897|FG002|Treatment Period|other reason|2|||
33587562|NCT02305563|62985898|FG003|Treatment Period|other reason|2|||
33587563|NCT02305563|62985899|FG004|Treatment Period|other reason|1|||
33587564|NCT02305563|62985895|FG000|Treatment Period|Randomized but not treated|0|||
33587565|NCT02305563|62985896|FG001|Treatment Period|Randomized but not treated|0|||
33587566|NCT02305563|62985897|FG002|Treatment Period|Randomized but not treated|0|||
33587567|NCT02305563|62985898|FG003|Treatment Period|Randomized but not treated|0|||
33587568|NCT02305563|62985899|FG004|Treatment Period|Randomized but not treated|2|||
33587569|NCT02305563|62985895|FG000|Treatment Period|added ULO, then disease progression|0|||
33587570|NCT02305563|62985896|FG001|Treatment Period|added ULO, then disease progression|0|||
33587571|NCT02305563|62985897|FG002|Treatment Period|added ULO, then disease progression|0|||
33587572|NCT02305563|62985898|FG003|Treatment Period|added ULO, then disease progression|0|||
33587573|NCT02305563|62985899|FG004|Treatment Period|added ULO, then disease progression|4|||
33587574|NCT02305563|62985895|FG000|Treatment Period|added ULO; then other reason|0|||
33587575|NCT02305563|62985896|FG001|Treatment Period|added ULO; then other reason|0|||
33587576|NCT02305563|62985897|FG002|Treatment Period|added ULO; then other reason|0|||
33587577|NCT02305563|62985898|FG003|Treatment Period|added ULO; then other reason|0|||
33587578|NCT02305563|62985899|FG004|Treatment Period|added ULO; then other reason|1|||
33587579|NCT02305563|62985895|FG000|Treatment Period|added ULO, then request to stop|0|||
33587580|NCT02305563|62985896|FG001|Treatment Period|added ULO, then request to stop|0|||
33587581|NCT02305563|62985897|FG002|Treatment Period|added ULO, then request to stop|0|||
33587582|NCT02305563|62985898|FG003|Treatment Period|added ULO, then request to stop|0|||
33587583|NCT02305563|62985899|FG004|Treatment Period|added ULO, then request to stop|1|||
33587584|NCT02305563|62985895|FG000|Follow-up Period|Death|0|||
33587585|NCT02305563|62985896|FG001|Follow-up Period|Death|0|||
33587586|NCT02305563|62985897|FG002|Follow-up Period|Death|5|||
33587587|NCT02305563|62985898|FG003|Follow-up Period|Death|4|||
33587588|NCT02305563|62985899|FG004|Follow-up Period|Death|7|||
33587589|NCT02305563|62985895|FG000|Follow-up Period|Participant withdrew consent|0|||
33587590|NCT02305563|62985896|FG001|Follow-up Period|Participant withdrew consent|0|||
33587591|NCT02305563|62985897|FG002|Follow-up Period|Participant withdrew consent|2|||
33587592|NCT02305563|62985898|FG003|Follow-up Period|Participant withdrew consent|1|||
33587593|NCT02305563|62985899|FG004|Follow-up Period|Participant withdrew consent|0|||
33587594|NCT02305563|62985895|FG000|Follow-up Period|other reason|0|||
33587595|NCT02305563|62985896|FG001|Follow-up Period|other reason|0|||
33587596|NCT02305563|62985897|FG002|Follow-up Period|other reason|0|||
33587597|NCT02305563|62985898|FG003|Follow-up Period|other reason|0|||
33587598|NCT02305563|62985899|FG004|Follow-up Period|other reason|1|||
33587599|NCT02305563|62985895|FG000|Follow-up Period|Followup no longer required per protocol|3|||
33587600|NCT02305563|62985896|FG001|Follow-up Period|Followup no longer required per protocol|3|||
33587601|NCT02305563|62985897|FG002|Follow-up Period|Followup no longer required per protocol|4|||
33587602|NCT02305563|62985898|FG003|Follow-up Period|Followup no longer required per protocol|1|||
33587603|NCT02305563|62985899|FG004|Follow-up Period|Followup no longer required per protocol|4|||
33587604|NCT02327325|62985918|FG000|Overall Study|Withdrawal by Subject|1|||
33587605|NCT02327325|62985919|FG001|Overall Study|Withdrawal by Subject|4|||
33587606|NCT02327325|62985920|FG002|Overall Study|Withdrawal by Subject|4|||
33587607|NCT02327325|62985918|FG000|Overall Study|Excluded by Study Team|0|||
33310706|NCT01163253|62686099|FG001|Overall Study|Insufficient Clinical Response|29|||
33587608|NCT02327325|62985919|FG001|Overall Study|Excluded by Study Team|0|||
33587609|NCT02327325|62985920|FG002|Overall Study|Excluded by Study Team|1|||
33587610|NCT02304705|62985930|FG000|Overall Study|Withdrawal by Subject|2|||
33587611|NCT02304705|62985931|FG001|Overall Study|Withdrawal by Subject|0|||
33587612|NCT02304705|62985930|FG000|Overall Study|Physician Decision|2|||
33587613|NCT02304705|62985931|FG001|Overall Study|Physician Decision|4|||
33587614|NCT02304705|62985930|FG000|Overall Study|Death|0|||
33587615|NCT02304705|62985931|FG001|Overall Study|Death|1|||
33587616|NCT02304705|62985930|FG000|Overall Study|Lost to Follow-up|0|||
33587617|NCT02304705|62985931|FG001|Overall Study|Lost to Follow-up|2|||
33587618|NCT02553499|62985951|FG000|Overall Study|Adverse Event|0|||
33587619|NCT02553499|62985952|FG001|Overall Study|Adverse Event|0|||
33587620|NCT02553499|62985953|FG002|Overall Study|Adverse Event|0|||
33587621|NCT02553499|62985954|FG003|Overall Study|Adverse Event|0|||
33587622|NCT02553499|62985955|FG004|Overall Study|Adverse Event|0|||
33587623|NCT02553499|62985956|FG005|Overall Study|Adverse Event|0|||
33587624|NCT02553499|62985957|FG006|Overall Study|Adverse Event|1|||
33587625|NCT02553499|62985958|FG007|Overall Study|Adverse Event|1|||
33587626|NCT02553499|62985959|FG008|Overall Study|Adverse Event|0|||
33587627|NCT02553499|62985960|FG009|Overall Study|Adverse Event|0|||
33587628|NCT02553499|62985961|FG010|Overall Study|Adverse Event|0|||
33587629|NCT02553499|62985962|FG011|Overall Study|Adverse Event|0|||
33587630|NCT02553499|62985963|FG012|Overall Study|Adverse Event|0|||
33587631|NCT02553499|62985964|FG013|Overall Study|Adverse Event|1|||
33587632|NCT02553499|62985951|FG000|Overall Study|Death|0|||
33587633|NCT02553499|62985952|FG001|Overall Study|Death|1|||
33587634|NCT02553499|62985953|FG002|Overall Study|Death|1|||
33587635|NCT02553499|62985954|FG003|Overall Study|Death|0|||
33587636|NCT02553499|62985955|FG004|Overall Study|Death|1|||
33587637|NCT02553499|62985956|FG005|Overall Study|Death|2|||
33587638|NCT02553499|62985957|FG006|Overall Study|Death|0|||
33587639|NCT02553499|62985958|FG007|Overall Study|Death|0|||
33587640|NCT02553499|62985959|FG008|Overall Study|Death|0|||
33587641|NCT02553499|62985960|FG009|Overall Study|Death|0|||
33587642|NCT02553499|62985961|FG010|Overall Study|Death|1|||
33587643|NCT02553499|62985962|FG011|Overall Study|Death|0|||
33587644|NCT02553499|62985963|FG012|Overall Study|Death|0|||
33587645|NCT02553499|62985964|FG013|Overall Study|Death|0|||
33587646|NCT02553499|62985951|FG000|Overall Study|Lost to Follow-up|0|||
33587647|NCT02553499|62985952|FG001|Overall Study|Lost to Follow-up|0|||
33587648|NCT02553499|62985953|FG002|Overall Study|Lost to Follow-up|0|||
33587649|NCT02553499|62985954|FG003|Overall Study|Lost to Follow-up|0|||
33587650|NCT02553499|62985955|FG004|Overall Study|Lost to Follow-up|0|||
33587651|NCT02553499|62985956|FG005|Overall Study|Lost to Follow-up|0|||
33587652|NCT02553499|62985957|FG006|Overall Study|Lost to Follow-up|1|||
33587653|NCT02553499|62985958|FG007|Overall Study|Lost to Follow-up|0|||
33587654|NCT02553499|62985959|FG008|Overall Study|Lost to Follow-up|0|||
33587655|NCT02553499|62985960|FG009|Overall Study|Lost to Follow-up|0|||
33587656|NCT02553499|62985961|FG010|Overall Study|Lost to Follow-up|0|||
33587657|NCT02553499|62985962|FG011|Overall Study|Lost to Follow-up|0|||
33587658|NCT02553499|62985963|FG012|Overall Study|Lost to Follow-up|0|||
33587659|NCT02553499|62985964|FG013|Overall Study|Lost to Follow-up|0|||
33587660|NCT02553499|62985951|FG000|Overall Study|Physician Decision|0|||
33587661|NCT02553499|62985952|FG001|Overall Study|Physician Decision|1|||
33587662|NCT02553499|62985953|FG002|Overall Study|Physician Decision|1|||
33587663|NCT02553499|62985954|FG003|Overall Study|Physician Decision|0|||
33587664|NCT02553499|62985955|FG004|Overall Study|Physician Decision|1|||
33587665|NCT02553499|62985956|FG005|Overall Study|Physician Decision|0|||
33587666|NCT02553499|62985957|FG006|Overall Study|Physician Decision|0|||
33587667|NCT02553499|62985958|FG007|Overall Study|Physician Decision|1|||
33587668|NCT02553499|62985959|FG008|Overall Study|Physician Decision|1|||
33587669|NCT02553499|62985960|FG009|Overall Study|Physician Decision|2|||
33587670|NCT02553499|62985961|FG010|Overall Study|Physician Decision|1|||
33587671|NCT02553499|62985962|FG011|Overall Study|Physician Decision|3|||
33587672|NCT02553499|62985963|FG012|Overall Study|Physician Decision|1|||
33587673|NCT02553499|62985964|FG013|Overall Study|Physician Decision|0|||
33587674|NCT02553499|62985951|FG000|Overall Study|Progressive Disease|0|||
33587675|NCT02553499|62985952|FG001|Overall Study|Progressive Disease|0|||
33587676|NCT02553499|62985953|FG002|Overall Study|Progressive Disease|0|||
33587677|NCT02553499|62985954|FG003|Overall Study|Progressive Disease|2|||
33310707|NCT01163253|62686098|FG000|Overall Study|Adverse Event|300|||
33587678|NCT02553499|62985955|FG004|Overall Study|Progressive Disease|1|||
33587679|NCT02553499|62985956|FG005|Overall Study|Progressive Disease|1|||
33587680|NCT02553499|62985957|FG006|Overall Study|Progressive Disease|1|||
33587681|NCT02553499|62985958|FG007|Overall Study|Progressive Disease|0|||
33587682|NCT02553499|62985959|FG008|Overall Study|Progressive Disease|0|||
33587683|NCT02553499|62985960|FG009|Overall Study|Progressive Disease|1|||
33587684|NCT02553499|62985961|FG010|Overall Study|Progressive Disease|0|||
33587685|NCT02553499|62985962|FG011|Overall Study|Progressive Disease|0|||
33587686|NCT02553499|62985963|FG012|Overall Study|Progressive Disease|2|||
33587687|NCT02553499|62985964|FG013|Overall Study|Progressive Disease|1|||
33587688|NCT02553499|62985951|FG000|Overall Study|Study Terminated by Sponsor|0|||
33587689|NCT02553499|62985952|FG001|Overall Study|Study Terminated by Sponsor|0|||
33587690|NCT02553499|62985953|FG002|Overall Study|Study Terminated by Sponsor|0|||
33587691|NCT02553499|62985954|FG003|Overall Study|Study Terminated by Sponsor|0|||
33587692|NCT02553499|62985955|FG004|Overall Study|Study Terminated by Sponsor|0|||
33587693|NCT02553499|62985956|FG005|Overall Study|Study Terminated by Sponsor|0|||
33587694|NCT02553499|62985957|FG006|Overall Study|Study Terminated by Sponsor|0|||
33587695|NCT02553499|62985958|FG007|Overall Study|Study Terminated by Sponsor|0|||
33587696|NCT02553499|62985959|FG008|Overall Study|Study Terminated by Sponsor|1|||
33587697|NCT02553499|62985960|FG009|Overall Study|Study Terminated by Sponsor|0|||
33587698|NCT02553499|62985961|FG010|Overall Study|Study Terminated by Sponsor|0|||
33587699|NCT02553499|62985962|FG011|Overall Study|Study Terminated by Sponsor|0|||
33587700|NCT02553499|62985963|FG012|Overall Study|Study Terminated by Sponsor|0|||
33587701|NCT02553499|62985964|FG013|Overall Study|Study Terminated by Sponsor|0|||
33587702|NCT02553499|62985951|FG000|Overall Study|Withdrawal by Subject|2|||
33587703|NCT02553499|62985952|FG001|Overall Study|Withdrawal by Subject|0|||
33587704|NCT02553499|62985953|FG002|Overall Study|Withdrawal by Subject|0|||
33587705|NCT02553499|62985954|FG003|Overall Study|Withdrawal by Subject|0|||
33587706|NCT02553499|62985955|FG004|Overall Study|Withdrawal by Subject|0|||
33587707|NCT02553499|62985956|FG005|Overall Study|Withdrawal by Subject|0|||
33587708|NCT02553499|62985957|FG006|Overall Study|Withdrawal by Subject|0|||
33587709|NCT02553499|62985958|FG007|Overall Study|Withdrawal by Subject|1|||
33587710|NCT02553499|62985959|FG008|Overall Study|Withdrawal by Subject|1|||
33587711|NCT02553499|62985960|FG009|Overall Study|Withdrawal by Subject|0|||
33587712|NCT02553499|62985961|FG010|Overall Study|Withdrawal by Subject|1|||
33587713|NCT02553499|62985962|FG011|Overall Study|Withdrawal by Subject|0|||
33587714|NCT02553499|62985963|FG012|Overall Study|Withdrawal by Subject|0|||
33587715|NCT02553499|62985964|FG013|Overall Study|Withdrawal by Subject|0|||
33587716|NCT02553421|62985997|FG000|Overall Study|Lost to Follow-up|21|||
33587717|NCT02553421|62985998|FG001|Overall Study|Lost to Follow-up|1|||
33587718|NCT02553421|62985997|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
33587719|NCT02553421|62985998|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
33587720|NCT02553421|62985997|FG000|Overall Study|Improper Device Placement|3|||
33587721|NCT02553421|62985998|FG001|Overall Study|Improper Device Placement|0|||
33587722|NCT02549287|62986007|FG000|Overall Study|Lost to Follow-up|65|||
33587723|NCT02549287|62986008|FG001|Overall Study|Lost to Follow-up|26|||
33587724|NCT02549287|62986007|FG000|Overall Study|Withdrawal by Subject|15|||
33587725|NCT02549287|62986008|FG001|Overall Study|Withdrawal by Subject|6|||
33587726|NCT02553265|62986014|FG000|Enrollment|Death|0|||
33587727|NCT02553265|62986015|FG001|Enrollment|Death|0|||
33587728|NCT02553265|62986016|FG002|Enrollment|Death|1|||
33587729|NCT02553265|62986014|FG000|First Intervention (28 Days)|Adverse Event|1|||
33587730|NCT02553265|62986015|FG001|First Intervention (28 Days)|Adverse Event|0|||
33587731|NCT02553265|62986016|FG002|First Intervention (28 Days)|Adverse Event|0|||
33587732|NCT02553265|62986014|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
33587733|NCT02553265|62986015|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
33587734|NCT02553265|62986016|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
33587735|NCT02553265|62986014|FG000|Second Intervention (28 Days)|Adverse Event|1|||
33587736|NCT02553265|62986015|FG001|Second Intervention (28 Days)|Adverse Event|0|||
33587737|NCT02553265|62986016|FG002|Second Intervention (28 Days)|Adverse Event|0|||
33587738|NCT02553265|62986014|FG000|Third Intervention (28 Days)|Adverse Event|1|||
33587739|NCT02553265|62986015|FG001|Third Intervention (28 Days)|Adverse Event|0|||
33587740|NCT02553265|62986016|FG002|Third Intervention (28 Days)|Adverse Event|0|||
33587741|NCT02553265|62986014|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
33587742|NCT02553265|62986015|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
33587743|NCT02553265|62986016|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
33587744|NCT02561195|62986033|FG000|Vaccination 1 to 3|Adverse Event|4|||
33587745|NCT02561195|62986034|FG001|Vaccination 1 to 3|Adverse Event|5|||
33587746|NCT02561195|62986035|FG002|Vaccination 1 to 3|Adverse Event|0|||
33587747|NCT02561195|62986036|FG003|Vaccination 1 to 3|Adverse Event|3|||
33587748|NCT02561195|62986037|FG004|Vaccination 1 to 3|Adverse Event|4|||
33587749|NCT02561195|62986038|FG005|Vaccination 1 to 3|Adverse Event|0|||
33587750|NCT02561195|62986039|FG006|Vaccination 1 to 3|Adverse Event|0|||
33587751|NCT02561195|62986040|FG007|Vaccination 1 to 3|Adverse Event|0|||
33587752|NCT02561195|62986041|FG008|Vaccination 1 to 3|Adverse Event|0|||
33587753|NCT02561195|62986042|FG009|Vaccination 1 to 3|Adverse Event|0|||
33587754|NCT02561195|62986043|FG010|Vaccination 1 to 3|Adverse Event|0|||
33587755|NCT02561195|62986044|FG011|Vaccination 1 to 3|Adverse Event|0|||
33587756|NCT02561195|62986045|FG012|Vaccination 1 to 3|Adverse Event|0|||
33587757|NCT02561195|62986046|FG013|Vaccination 1 to 3|Adverse Event|0|||
33587758|NCT02561195|62986033|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
33587759|NCT02561195|62986034|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
33587760|NCT02561195|62986035|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
33587761|NCT02561195|62986036|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
33587762|NCT02561195|62986037|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
33587763|NCT02561195|62986038|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
33587764|NCT02561195|62986039|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
33587765|NCT02561195|62986040|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
33587766|NCT02561195|62986041|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
33587767|NCT02561195|62986042|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
33587768|NCT02561195|62986043|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
33587769|NCT02561195|62986044|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
33587770|NCT02561195|62986045|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
33587771|NCT02561195|62986046|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
33587772|NCT02561195|62986033|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33587773|NCT02561195|62986034|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
33587774|NCT02561195|62986035|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33587775|NCT02561195|62986036|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
33587776|NCT02561195|62986037|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
33587777|NCT02561195|62986038|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
33587778|NCT02561195|62986039|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33587779|NCT02561195|62986040|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33679946|NCT01664052|63133296|FG000|Phase 1|No device placement|6|||
33679947|NCT01664052|63133297|FG001|Phase 1|No device placement|0|||
33679948|NCT01664052|63133296|FG000|Phase 1|No HSG 1 hr post placement|1|||
33679949|NCT01664052|63133297|FG001|Phase 1|No HSG 1 hr post placement|0|||
33587780|NCT02561195|62986041|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33587781|NCT02561195|62986042|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33587782|NCT02561195|62986043|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33587783|NCT02561195|62986044|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33587784|NCT02561195|62986045|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33587785|NCT02561195|62986046|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33587786|NCT02561195|62986033|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
33587787|NCT02561195|62986034|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
33587788|NCT02561195|62986035|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
33587789|NCT02561195|62986036|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
33587790|NCT02561195|62986037|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
33587791|NCT02561195|62986038|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
33587792|NCT02561195|62986039|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
33587793|NCT02561195|62986040|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
33587794|NCT02561195|62986041|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
33587795|NCT02561195|62986042|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
33587796|NCT02561195|62986043|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
33587797|NCT02561195|62986044|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
33587798|NCT02561195|62986045|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
33587799|NCT02561195|62986046|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
33587800|NCT02561195|62986033|FG000|Vaccination 1 to 3|Other|7|||
33679950|NCT01664052|63133296|FG000|Phase 2|No device placement|0|||
33679951|NCT01664052|63133297|FG001|Phase 2|No device placement|4|||
33679952|NCT01465802|63133344|FG000|Overall Study|Study terminated by sponsor|1|||
33587801|NCT02561195|62986034|FG001|Vaccination 1 to 3|Other|3|||
33587802|NCT02561195|62986035|FG002|Vaccination 1 to 3|Other|1|||
33587803|NCT02561195|62986036|FG003|Vaccination 1 to 3|Other|7|||
33587804|NCT02561195|62986037|FG004|Vaccination 1 to 3|Other|5|||
33587805|NCT02561195|62986038|FG005|Vaccination 1 to 3|Other|1|||
33587806|NCT02561195|62986039|FG006|Vaccination 1 to 3|Other|0|||
33679953|NCT01465802|63133345|FG001|Overall Study|Study terminated by sponsor|0|||
33679954|NCT01465802|63133346|FG002|Overall Study|Study terminated by sponsor|0|||
33679955|NCT01465802|63133347|FG003|Overall Study|Study terminated by sponsor|1|||
33679956|NCT01465802|63133348|FG004|Overall Study|Study terminated by sponsor|7|||
33679957|NCT01465802|63133344|FG000|Overall Study|Withdrawal by Subject|7|||
33679958|NCT01465802|63133345|FG001|Overall Study|Withdrawal by Subject|7|||
33679959|NCT01465802|63133346|FG002|Overall Study|Withdrawal by Subject|0|||
33679960|NCT01465802|63133347|FG003|Overall Study|Withdrawal by Subject|8|||
33587807|NCT02561195|62986040|FG007|Vaccination 1 to 3|Other|0|||
33679961|NCT01465802|63133348|FG004|Overall Study|Withdrawal by Subject|1|||
33679962|NCT01465802|63133344|FG000|Overall Study|Lost to Follow-up|1|||
33679963|NCT01465802|63133345|FG001|Overall Study|Lost to Follow-up|1|||
33679964|NCT01465802|63133346|FG002|Overall Study|Lost to Follow-up|0|||
33679965|NCT01465802|63133347|FG003|Overall Study|Lost to Follow-up|0|||
33679966|NCT01465802|63133348|FG004|Overall Study|Lost to Follow-up|0|||
33679967|NCT01465802|63133344|FG000|Overall Study|Reason not specified|9|||
33679968|NCT01465802|63133345|FG001|Overall Study|Reason not specified|4|||
33679969|NCT01465802|63133346|FG002|Overall Study|Reason not specified|0|||
33679970|NCT01465802|63133347|FG003|Overall Study|Reason not specified|10|||
33679971|NCT01465802|63133348|FG004|Overall Study|Reason not specified|2|||
33679972|NCT01465802|63133344|FG000|Overall Study|Death|15|||
33679973|NCT01465802|63133345|FG001|Overall Study|Death|12|||
33679974|NCT01465802|63133346|FG002|Overall Study|Death|0|||
33679975|NCT01465802|63133347|FG003|Overall Study|Death|10|||
33679976|NCT01465802|63133348|FG004|Overall Study|Death|2|||
33679977|NCT01437878|63133393|FG000|Overall Study|Withdrawal by Subject|1|||
33587808|NCT02561195|62986041|FG008|Vaccination 1 to 3|Other|0|||
33310708|NCT01163253|62686099|FG001|Overall Study|Adverse Event|78|||
33679978|NCT01437878|63133394|FG001|Overall Study|Withdrawal by Subject|0|||
33679979|NCT01465178|63133420|FG000|Overall Study|Withdrawal by Subject|1|||
33679980|NCT01465178|63133421|FG001|Overall Study|Withdrawal by Subject|0|||
33679981|NCT01445678|63133527|FG000|Overall Study|Adverse Event|12|||
33679982|NCT01445678|63133528|FG001|Overall Study|Adverse Event|8|||
33679983|NCT01445678|63133527|FG000|Overall Study|Lack of Efficacy|0|||
33679984|NCT01445678|63133528|FG001|Overall Study|Lack of Efficacy|2|||
33679985|NCT01445678|63133527|FG000|Overall Study|Lost to Follow-up|8|||
33679986|NCT01445678|63133528|FG001|Overall Study|Lost to Follow-up|5|||
33679987|NCT01445678|63133527|FG000|Overall Study|Protocol Violation|1|||
33679988|NCT01445678|63133528|FG001|Overall Study|Protocol Violation|1|||
33679989|NCT01445678|63133527|FG000|Overall Study|Withdrawal by Subject|9|||
33679990|NCT01445678|63133528|FG001|Overall Study|Withdrawal by Subject|5|||
33679991|NCT03769194|63133547|FG000|Overall Study|Withdrawal by Subject|0|||
33679992|NCT03769194|63133548|FG001|Overall Study|Withdrawal by Subject|7|||
33679993|NCT03769194|63133549|FG002|Overall Study|Withdrawal by Subject|4|||
33679994|NCT03769194|63133550|FG003|Overall Study|Withdrawal by Subject|1|||
33679995|NCT03769194|63133547|FG000|Overall Study|moved from study area|0|||
33679996|NCT03769194|63133548|FG001|Overall Study|moved from study area|2|||
33679997|NCT03769194|63133549|FG002|Overall Study|moved from study area|1|||
33679998|NCT03769194|63133550|FG003|Overall Study|moved from study area|1|||
33679999|NCT03769194|63133547|FG000|Overall Study|Lost to Follow-up|3|||
33680000|NCT03769194|63133548|FG001|Overall Study|Lost to Follow-up|6|||
33680001|NCT03769194|63133549|FG002|Overall Study|Lost to Follow-up|3|||
33680002|NCT03769194|63133550|FG003|Overall Study|Lost to Follow-up|6|||
33680003|NCT03769194|63133547|FG000|Overall Study|other|1|||
33680004|NCT03769194|63133548|FG001|Overall Study|other|3|||
33310709|NCT01163253|62686098|FG000|Overall Study|Death|17|||
33310710|NCT01163253|62686099|FG001|Overall Study|Death|5|||
33587809|NCT02561195|62986042|FG009|Vaccination 1 to 3|Other|0|||
33587810|NCT02561195|62986043|FG010|Vaccination 1 to 3|Other|0|||
33587811|NCT02561195|62986044|FG011|Vaccination 1 to 3|Other|0|||
33587812|NCT02561195|62986045|FG012|Vaccination 1 to 3|Other|0|||
33587813|NCT02561195|62986046|FG013|Vaccination 1 to 3|Other|0|||
33587814|NCT02561195|62986033|FG000|Vaccination 1 to 3|Protocol Violation|1|||
33587815|NCT02561195|62986034|FG001|Vaccination 1 to 3|Protocol Violation|0|||
33587816|NCT02561195|62986035|FG002|Vaccination 1 to 3|Protocol Violation|1|||
33587817|NCT02561195|62986036|FG003|Vaccination 1 to 3|Protocol Violation|2|||
33587818|NCT02561195|62986037|FG004|Vaccination 1 to 3|Protocol Violation|5|||
33587819|NCT02561195|62986038|FG005|Vaccination 1 to 3|Protocol Violation|2|||
33587820|NCT02561195|62986039|FG006|Vaccination 1 to 3|Protocol Violation|0|||
33587821|NCT02561195|62986040|FG007|Vaccination 1 to 3|Protocol Violation|0|||
33587822|NCT02561195|62986041|FG008|Vaccination 1 to 3|Protocol Violation|0|||
33587823|NCT02561195|62986042|FG009|Vaccination 1 to 3|Protocol Violation|0|||
33587824|NCT02561195|62986043|FG010|Vaccination 1 to 3|Protocol Violation|0|||
33587825|NCT02561195|62986044|FG011|Vaccination 1 to 3|Protocol Violation|0|||
33587826|NCT02561195|62986045|FG012|Vaccination 1 to 3|Protocol Violation|0|||
33587827|NCT02561195|62986046|FG013|Vaccination 1 to 3|Protocol Violation|0|||
33587828|NCT02561195|62986033|FG000|Vaccination 1 to 3|Death|2|||
33587829|NCT02561195|62986034|FG001|Vaccination 1 to 3|Death|1|||
33587830|NCT02561195|62986035|FG002|Vaccination 1 to 3|Death|0|||
33587831|NCT02561195|62986036|FG003|Vaccination 1 to 3|Death|2|||
33587832|NCT02561195|62986037|FG004|Vaccination 1 to 3|Death|0|||
33587833|NCT02561195|62986038|FG005|Vaccination 1 to 3|Death|0|||
33587834|NCT02561195|62986039|FG006|Vaccination 1 to 3|Death|0|||
33587835|NCT02561195|62986040|FG007|Vaccination 1 to 3|Death|0|||
33587836|NCT02561195|62986041|FG008|Vaccination 1 to 3|Death|0|||
33587837|NCT02561195|62986042|FG009|Vaccination 1 to 3|Death|0|||
33587838|NCT02561195|62986043|FG010|Vaccination 1 to 3|Death|0|||
33587839|NCT02561195|62986044|FG011|Vaccination 1 to 3|Death|0|||
33587840|NCT02561195|62986045|FG012|Vaccination 1 to 3|Death|0|||
33587841|NCT02561195|62986046|FG013|Vaccination 1 to 3|Death|0|||
33587842|NCT02561195|62986033|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
33587843|NCT02561195|62986034|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
33587844|NCT02561195|62986035|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
33587845|NCT02561195|62986036|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
33587846|NCT02561195|62986037|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
33587847|NCT02561195|62986038|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
33587848|NCT02561195|62986039|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
33587849|NCT02561195|62986040|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
33587850|NCT02561195|62986041|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
33680005|NCT03769194|63133549|FG002|Overall Study|other|0|||
33680006|NCT03769194|63133550|FG003|Overall Study|other|1|||
33587851|NCT02561195|62986042|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
33587852|NCT02561195|62986043|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
33587853|NCT02561195|62986044|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
33587854|NCT02561195|62986045|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
33587855|NCT02561195|62986046|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
33587856|NCT02561195|62986033|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
33587857|NCT02561195|62986034|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
33587858|NCT02561195|62986035|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
33587859|NCT02561195|62986036|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
33680007|NCT01465022|63133576|FG000|Overall Study|Lost to Follow-up|15|||
33587860|NCT02561195|62986037|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
33587861|NCT02561195|62986038|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
33587862|NCT02561195|62986039|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
33587863|NCT02561195|62986040|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
33587864|NCT02561195|62986041|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
33587865|NCT02561195|62986042|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
33587866|NCT02561195|62986043|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
33587867|NCT02561195|62986044|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
33587868|NCT02561195|62986045|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
33587869|NCT02561195|62986046|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
33587870|NCT02561195|62986033|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33587871|NCT02561195|62986034|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33587872|NCT02561195|62986035|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33587873|NCT02561195|62986036|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33587874|NCT02561195|62986037|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33587875|NCT02561195|62986038|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33587876|NCT02561195|62986039|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33587877|NCT02561195|62986040|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33587878|NCT02561195|62986041|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
33587879|NCT02561195|62986042|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
33587880|NCT02561195|62986043|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
33587881|NCT02561195|62986044|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
33587882|NCT02561195|62986045|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
33587883|NCT02561195|62986046|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33587884|NCT02561195|62986033|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
33587885|NCT02561195|62986034|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
33587886|NCT02561195|62986035|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
33587887|NCT02561195|62986036|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
33587888|NCT02561195|62986037|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
33587889|NCT02561195|62986038|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
33587890|NCT02561195|62986039|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
33587891|NCT02561195|62986040|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
33587892|NCT02561195|62986041|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
33587893|NCT02561195|62986042|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
33587894|NCT02561195|62986043|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
33587895|NCT02561195|62986044|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
33587896|NCT02561195|62986045|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
33587897|NCT02561195|62986046|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
33587898|NCT02561195|62986033|FG000|Extension Stage (Vaccination 4)|Death|0|||
33587899|NCT02561195|62986034|FG001|Extension Stage (Vaccination 4)|Death|0|||
33587900|NCT02561195|62986035|FG002|Extension Stage (Vaccination 4)|Death|0|||
33587901|NCT02561195|62986036|FG003|Extension Stage (Vaccination 4)|Death|0|||
33587902|NCT02561195|62986037|FG004|Extension Stage (Vaccination 4)|Death|0|||
33587903|NCT02561195|62986038|FG005|Extension Stage (Vaccination 4)|Death|0|||
33680008|NCT01465022|63133577|FG001|Overall Study|Lost to Follow-up|14|||
33680009|NCT01465022|63133578|FG002|Overall Study|Lost to Follow-up|0|||
33680010|NCT01465022|63133576|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
33680011|NCT01465022|63133577|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
33680012|NCT01465022|63133578|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
33680013|NCT01465022|63133576|FG000|Overall Study|Not Randomized|0|||
33680014|NCT01465022|63133577|FG001|Overall Study|Not Randomized|0|||
33680015|NCT01465022|63133578|FG002|Overall Study|Not Randomized|70|||
33680016|NCT01464788|63133622|FG000|Overall Study|Lost to Follow-up|0|||
33680017|NCT01464788|63133623|FG001|Overall Study|Lost to Follow-up|1|||
33680018|NCT01464788|63133624|FG002|Overall Study|Lost to Follow-up|0|||
33680019|NCT01464788|63133622|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
33680020|NCT01464788|63133623|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
33680021|NCT01464788|63133624|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
33680022|NCT01444898|63133634|FG000|Overall Study|Withdrawal by Subject|1|||
33680023|NCT01419626|63133656|FG000|Overall Study|Protocol Violation|3|||
33680024|NCT01419626|63133657|FG001|Overall Study|Protocol Violation|2|||
33680025|NCT01419626|63133658|FG002|Overall Study|Protocol Violation|2|||
33680026|NCT01419626|63133656|FG000|Overall Study|Withdrawal by Subject|1|||
33680027|NCT01419626|63133657|FG001|Overall Study|Withdrawal by Subject|0|||
33680028|NCT01419626|63133658|FG002|Overall Study|Withdrawal by Subject|0|||
33680029|NCT01419626|63133656|FG000|Overall Study|Lost to Follow-up|0|||
33680030|NCT01419626|63133657|FG001|Overall Study|Lost to Follow-up|1|||
33680031|NCT01419626|63133658|FG002|Overall Study|Lost to Follow-up|1|||
33680032|NCT01444742|63133697|FG000|Overall Study|Death|1|||
33587904|NCT02561195|62986039|FG006|Extension Stage (Vaccination 4)|Death|0|||
33587905|NCT02561195|62986040|FG007|Extension Stage (Vaccination 4)|Death|0|||
33587906|NCT02561195|62986041|FG008|Extension Stage (Vaccination 4)|Death|0|||
33587907|NCT02561195|62986042|FG009|Extension Stage (Vaccination 4)|Death|1|||
33587908|NCT02561195|62986043|FG010|Extension Stage (Vaccination 4)|Death|0|||
33587909|NCT02561195|62986044|FG011|Extension Stage (Vaccination 4)|Death|0|||
33587910|NCT02561195|62986045|FG012|Extension Stage (Vaccination 4)|Death|0|||
33587911|NCT02561195|62986046|FG013|Extension Stage (Vaccination 4)|Death|0|||
33587912|NCT02561195|62986033|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33587913|NCT02561195|62986034|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33587914|NCT02561195|62986035|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33587915|NCT02561195|62986036|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33587916|NCT02561195|62986037|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33587917|NCT02561195|62986038|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33587918|NCT02561195|62986039|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
33587919|NCT02561195|62986040|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
33587920|NCT02561195|62986041|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33587921|NCT02561195|62986042|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33587922|NCT02561195|62986043|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
33587923|NCT02561195|62986044|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
33587924|NCT02561195|62986045|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
33587925|NCT02561195|62986046|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
33587926|NCT02561195|62986033|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33587927|NCT02561195|62986034|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33587928|NCT02561195|62986035|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33587929|NCT02561195|62986036|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33587930|NCT02561195|62986037|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33587931|NCT02561195|62986038|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33587932|NCT02561195|62986039|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33587933|NCT02561195|62986040|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33587934|NCT02561195|62986041|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33587935|NCT02561195|62986042|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33587936|NCT02561195|62986043|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33587937|NCT02561195|62986044|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
33587938|NCT02561195|62986045|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
33587939|NCT02561195|62986046|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
33587940|NCT02561195|62986033|FG000|Extension Stage (Vaccination 4)|Other|0|||
33587941|NCT02561195|62986034|FG001|Extension Stage (Vaccination 4)|Other|0|||
33587942|NCT02561195|62986035|FG002|Extension Stage (Vaccination 4)|Other|0|||
33587943|NCT02561195|62986036|FG003|Extension Stage (Vaccination 4)|Other|0|||
33587944|NCT02561195|62986037|FG004|Extension Stage (Vaccination 4)|Other|0|||
33587945|NCT02561195|62986038|FG005|Extension Stage (Vaccination 4)|Other|0|||
33587946|NCT02561195|62986039|FG006|Extension Stage (Vaccination 4)|Other|0|||
33587947|NCT02561195|62986040|FG007|Extension Stage (Vaccination 4)|Other|0|||
33587948|NCT02561195|62986041|FG008|Extension Stage (Vaccination 4)|Other|0|||
33587949|NCT02561195|62986042|FG009|Extension Stage (Vaccination 4)|Other|0|||
33587950|NCT02561195|62986043|FG010|Extension Stage (Vaccination 4)|Other|2|||
33587951|NCT02561195|62986044|FG011|Extension Stage (Vaccination 4)|Other|2|||
33587952|NCT02561195|62986045|FG012|Extension Stage (Vaccination 4)|Other|1|||
33587953|NCT02561195|62986046|FG013|Extension Stage (Vaccination 4)|Other|0|||
33587954|NCT02561195|62986033|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33587955|NCT02561195|62986034|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33587956|NCT02561195|62986035|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33587957|NCT02561195|62986036|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33587958|NCT02561195|62986037|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33587959|NCT02561195|62986038|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33587960|NCT02561195|62986039|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
33587961|NCT02561195|62986040|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33587962|NCT02561195|62986041|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33587963|NCT02561195|62986042|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33587964|NCT02561195|62986043|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
33587965|NCT02561195|62986044|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
33587966|NCT02561195|62986045|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33587967|NCT02561195|62986046|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
33587968|NCT01663103|62986080|FG000|Overall Study|Withdrawal by Subject|1|||
33587969|NCT01663103|62986081|FG001|Overall Study|Withdrawal by Subject|2|||
33587970|NCT01663103|62986080|FG000|Overall Study|Adverse Event|1|||
33587971|NCT01663103|62986081|FG001|Overall Study|Adverse Event|0|||
33680033|NCT01444430|63133897|FG000|Overall Study|Withdrawal by Subject|53|||
33680034|NCT01444430|63133898|FG001|Overall Study|Withdrawal by Subject|72|||
33680035|NCT01444430|63133897|FG000|Overall Study|Death|6|||
33680036|NCT01444430|63133898|FG001|Overall Study|Death|8|||
33587972|NCT01663103|62986080|FG000|Overall Study|dog bite|1|||
33587973|NCT01663103|62986081|FG001|Overall Study|dog bite|0|||
33587974|NCT02560025|62986100|FG000|Overall Study|Ineligible after consent/ registration|3|||
33587975|NCT02566889|62986115|FG000|Overall Study|Withdrawal by Subject|3|||
33587976|NCT02566889|62986116|FG001|Overall Study|Withdrawal by Subject|1|||
33587977|NCT02566889|62986115|FG000|Overall Study|Adverse Event|4|||
33587978|NCT02566889|62986116|FG001|Overall Study|Adverse Event|2|||
33587979|NCT02566889|62986115|FG000|Overall Study|Other|6|||
33587980|NCT02566889|62986116|FG001|Overall Study|Other|2|||
33587981|NCT02566577|62986123|FG000|Overall Study|Withdrawal by Subject|1|||
33587982|NCT02566577|62986124|FG001|Overall Study|Withdrawal by Subject|1|||
33587983|NCT02566577|62986123|FG000|Overall Study|Equipment failure|1|||
33587984|NCT02566577|62986124|FG001|Overall Study|Equipment failure|1|||
33587985|NCT02566577|62986123|FG000|Overall Study|Physical limitation|1|||
33587986|NCT02566577|62986124|FG001|Overall Study|Physical limitation|0|||
33587987|NCT02717507|62986134|FG000|Overall Study|Lost to Follow-up|5|||
33587988|NCT02717507|62986135|FG001|Overall Study|Lost to Follow-up|8|||
33587989|NCT02717507|62986134|FG000|Overall Study|Pregnancy|1|||
33587990|NCT02717507|62986135|FG001|Overall Study|Pregnancy|1|||
33587991|NCT02717507|62986134|FG000|Overall Study|Protocol Violation|2|||
33587992|NCT02717507|62986135|FG001|Overall Study|Protocol Violation|2|||
33587993|NCT02717507|62986134|FG000|Overall Study|Withdrawal by Subject|20|||
33587994|NCT02717507|62986135|FG001|Overall Study|Withdrawal by Subject|20|||
33587995|NCT02717507|62986134|FG000|Overall Study|Relapse|1|||
33587996|NCT02717507|62986135|FG001|Overall Study|Relapse|1|||
33587997|NCT02717507|62986134|FG000|Overall Study|Cardiac Event|2|||
33587998|NCT02717507|62986135|FG001|Overall Study|Cardiac Event|6|||
33587999|NCT02559713|62986142|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
33588000|NCT01358981|62986153|FG000|Period 1|Withdrawal by Subject|0|||
33588001|NCT01358981|62986154|FG001|Period 1|Withdrawal by Subject|0|||
33588002|NCT01358981|62986155|FG002|Period 1|Withdrawal by Subject|0|||
33588003|NCT01358981|62986156|FG003|Period 1|Withdrawal by Subject|1|||
33588004|NCT01358981|62986157|FG004|Period 1|Withdrawal by Subject|0|||
33588005|NCT01358981|62986158|FG005|Period 1|Withdrawal by Subject|0|||
33588006|NCT01358981|62986159|FG006|Period 1|Withdrawal by Subject|0|||
33588007|NCT02548585|62986191|FG000|Overall Study|Withdrawal by Subject|0|||
33588008|NCT02548585|62986192|FG001|Overall Study|Withdrawal by Subject|0|||
33588009|NCT02548585|62986193|FG002|Overall Study|Withdrawal by Subject|0|||
33588010|NCT02548585|62986194|FG003|Overall Study|Withdrawal by Subject|0|||
33588011|NCT02548585|62986195|FG004|Overall Study|Withdrawal by Subject|0|||
33588012|NCT02548585|62986196|FG005|Overall Study|Withdrawal by Subject|1|||
33588013|NCT02548585|62986197|FG006|Overall Study|Withdrawal by Subject|0|||
33588014|NCT02548585|62986191|FG000|Overall Study|Lost to Follow-up|1|||
33588015|NCT02548585|62986192|FG001|Overall Study|Lost to Follow-up|0|||
33588016|NCT02548585|62986193|FG002|Overall Study|Lost to Follow-up|0|||
33588017|NCT02548585|62986194|FG003|Overall Study|Lost to Follow-up|0|||
33588018|NCT02548585|62986195|FG004|Overall Study|Lost to Follow-up|0|||
33588019|NCT02548585|62986196|FG005|Overall Study|Lost to Follow-up|0|||
33588020|NCT02548585|62986197|FG006|Overall Study|Lost to Follow-up|0|||
33588021|NCT02548585|62986191|FG000|Overall Study|Other|1|||
33588022|NCT02548585|62986192|FG001|Overall Study|Other|0|||
33588023|NCT02548585|62986193|FG002|Overall Study|Other|0|||
33588024|NCT02548585|62986194|FG003|Overall Study|Other|2|||
33588025|NCT02548585|62986195|FG004|Overall Study|Other|3|||
33588026|NCT02548585|62986196|FG005|Overall Study|Other|0|||
33588027|NCT02548585|62986197|FG006|Overall Study|Other|1|||
33588028|NCT02548585|62986191|FG000|Overall Study|Randomized but not treated|0|||
33588029|NCT02548585|62986192|FG001|Overall Study|Randomized but not treated|0|||
33588030|NCT02548585|62986193|FG002|Overall Study|Randomized but not treated|0|||
33588031|NCT02548585|62986194|FG003|Overall Study|Randomized but not treated|0|||
33588032|NCT02548585|62986195|FG004|Overall Study|Randomized but not treated|0|||
33588033|NCT02548585|62986196|FG005|Overall Study|Randomized but not treated|1|||
33588034|NCT02548585|62986197|FG006|Overall Study|Randomized but not treated|0|||
33588035|NCT02547649|62986241|FG000|Overall Study|Lost to Follow-up|3|||
33588036|NCT02547649|62986242|FG001|Overall Study|Lost to Follow-up|1|||
33588037|NCT02547649|62986243|FG002|Overall Study|Lost to Follow-up|1|||
33588038|NCT02547649|62986241|FG000|Overall Study|Not vaccinated|0|||
33588039|NCT02547649|62986242|FG001|Overall Study|Not vaccinated|0|||
33588040|NCT02547649|62986243|FG002|Overall Study|Not vaccinated|1|||
33588041|NCT02547649|62986241|FG000|Overall Study|Withdrawal by Subject|0|||
33680037|NCT01444430|63133897|FG000|Overall Study|Lost to Follow-up|2|||
33310711|NCT01163253|62686098|FG000|Overall Study|Ongoing|13|||
33588042|NCT02547649|62986242|FG001|Overall Study|Withdrawal by Subject|4|||
33588043|NCT02547649|62986243|FG002|Overall Study|Withdrawal by Subject|2|||
33588044|NCT02535715|62986263|FG000|Overall Study|Withdrawal by Subject|0|||
33588045|NCT02535715|62986264|FG001|Overall Study|Withdrawal by Subject|0|||
33588046|NCT02535715|62986265|FG002|Overall Study|Withdrawal by Subject|1|||
33588047|NCT02336815|62986278|FG000|Overall Study|Disease Progression|45|||
33588048|NCT02336815|62986279|FG001|Overall Study|Disease Progression|70|||
33588049|NCT02336815|62986278|FG000|Overall Study|Adverse Event|18|||
33588050|NCT02336815|62986279|FG001|Overall Study|Adverse Event|39|||
33588051|NCT02336815|62986278|FG000|Overall Study|Physician Decision|11|||
33588052|NCT02336815|62986279|FG001|Overall Study|Physician Decision|4|||
33588053|NCT02336815|62986278|FG000|Overall Study|Withdrawal by Subject|3|||
33588054|NCT02336815|62986279|FG001|Overall Study|Withdrawal by Subject|2|||
33588055|NCT02336815|62986278|FG000|Overall Study|Lost to Follow-up|1|||
33588056|NCT02336815|62986279|FG001|Overall Study|Lost to Follow-up|3|||
33588057|NCT02336815|62986278|FG000|Overall Study|Other|1|||
33588058|NCT02336815|62986279|FG001|Overall Study|Other|5|||
33588059|NCT02543203|62986289|FG000|Overall Study|Unpalatable Fragrance|2|||
33588060|NCT02543203|62986290|FG001|Overall Study|Unpalatable Fragrance|2|||
33588061|NCT02543203|62986289|FG000|Overall Study|Lost to Follow-up|1|||
33588062|NCT02543203|62986290|FG001|Overall Study|Lost to Follow-up|0|||
33588063|NCT02543203|62986289|FG000|Overall Study|Increased Irritability|1|||
33588064|NCT02543203|62986290|FG001|Overall Study|Increased Irritability|0|||
33588065|NCT02543203|62986289|FG000|Overall Study|Family|1|||
33588066|NCT02543203|62986290|FG001|Overall Study|Family|2|||
33588067|NCT02543203|62986289|FG000|Overall Study|Negative Behavior|1|||
33588068|NCT02543203|62986290|FG001|Overall Study|Negative Behavior|0|||
33588069|NCT02543203|62986289|FG000|Overall Study|Withdrawal by Subject|0|||
33588070|NCT02543203|62986290|FG001|Overall Study|Withdrawal by Subject|1|||
33588071|NCT02546323|62986306|FG000|Overall Study|Withdrawal by Subject|36|||
33588072|NCT02546323|62986307|FG001|Overall Study|Withdrawal by Subject|33|||
33588073|NCT02546323|62986306|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
33588074|NCT02546323|62986307|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
33588075|NCT02546323|62986306|FG000|Overall Study|Adverse Event|17|||
33588076|NCT02546323|62986307|FG001|Overall Study|Adverse Event|11|||
33680038|NCT01444430|63133898|FG001|Overall Study|Lost to Follow-up|0|||
33680039|NCT01444430|63133897|FG000|Overall Study|CRF termination module not completed.|0|||
33588077|NCT02546323|62986306|FG000|Overall Study|Patient Specific Reasons|1|||
33588078|NCT02546323|62986307|FG001|Overall Study|Patient Specific Reasons|2|||
33588079|NCT02546323|62986306|FG000|Overall Study|Lost to Follow-up|2|||
33588080|NCT02546323|62986307|FG001|Overall Study|Lost to Follow-up|3|||
33588081|NCT02546323|62986306|FG000|Overall Study|Non-compliance with Study Drug|2|||
33588082|NCT02546323|62986307|FG001|Overall Study|Non-compliance with Study Drug|2|||
33588083|NCT02546323|62986306|FG000|Overall Study|Met Withdrawal Criteria|2|||
33588084|NCT02546323|62986307|FG001|Overall Study|Met Withdrawal Criteria|14|||
33588085|NCT02545933|62986316|FG000|Overall Study|Adverse Event|3|||
33588086|NCT02545933|62986317|FG001|Overall Study|Adverse Event|0|||
33588087|NCT02545933|62986318|FG002|Overall Study|Adverse Event|0|||
33588088|NCT02545933|62986316|FG000|Overall Study|Withdrawal by Subject|2|||
33588089|NCT02545933|62986317|FG001|Overall Study|Withdrawal by Subject|3|||
33588090|NCT02545933|62986318|FG002|Overall Study|Withdrawal by Subject|3|||
33588091|NCT02545933|62986316|FG000|Overall Study|Protocol Violation|1|||
33588092|NCT02545933|62986317|FG001|Overall Study|Protocol Violation|0|||
33588093|NCT02545933|62986318|FG002|Overall Study|Protocol Violation|1|||
33588094|NCT01661179|62986326|FG000|Overall Study|Death|1|||
33588095|NCT01661179|62986326|FG000|Overall Study|Withdrawal by Subject|1|||
33588096|NCT01661179|62986326|FG000|Overall Study|Other Eligibility criteria|4|||
33588097|NCT02545543|62986332|FG000|Overall Study|Lost to Follow-up|67|||
33588098|NCT02545543|62986333|FG001|Overall Study|Lost to Follow-up|25|||
33588099|NCT02545543|62986332|FG000|Overall Study|Physician Decision|3|||
33588100|NCT02545543|62986333|FG001|Overall Study|Physician Decision|0|||
33588101|NCT02545543|62986332|FG000|Overall Study|Withdrawal by Subject|9|||
33588102|NCT02545543|62986333|FG001|Overall Study|Withdrawal by Subject|8|||
33588103|NCT02545543|62986332|FG000|Overall Study|Noncomplaince|1|||
33680040|NCT01444430|63133898|FG001|Overall Study|CRF termination module not completed.|1|||
33680041|NCT01436162|63133974|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
33680042|NCT01436162|63133975|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
33680043|NCT01436162|63133976|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
33680044|NCT01436162|63133974|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
33588104|NCT02545543|62986333|FG001|Overall Study|Noncomplaince|0|||
33588105|NCT02545543|62986332|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
33588106|NCT02545543|62986333|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
33588107|NCT02542267|62986341|FG000|Overall Study|Withdrawal by Subject|10|||
33588108|NCT02542267|62986341|FG000|Overall Study|Physician Decision|6|||
33588109|NCT02542267|62986341|FG000|Overall Study|Lost to Follow-up|4|||
33588110|NCT02542267|62986341|FG000|Overall Study|Death|13|||
33588111|NCT02542267|62986341|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
33588112|NCT02542267|62986341|FG000|Overall Study|Other|9|||
33588113|NCT02545075|62986347|FG000|Randomization|Lost to Follow-up|0|||
33588114|NCT02545075|62986348|FG001|Randomization|Lost to Follow-up|1|||
33588115|NCT02545075|62986347|FG000|Randomization|Withdrawal by Subject|0|||
33588116|NCT02545075|62986348|FG001|Randomization|Withdrawal by Subject|6|||
33588117|NCT02545075|62986347|FG000|Treatment|Disease progression|71|||
33588118|NCT02545075|62986348|FG001|Treatment|Disease progression|32|||
33588119|NCT02545075|62986347|FG000|Treatment|Participant dicontinued study treatment|7|||
33588120|NCT02545075|62986348|FG001|Treatment|Participant dicontinued study treatment|9|||
33588121|NCT02545075|62986347|FG000|Treatment|Withdrawal by Subject|1|||
33588122|NCT02545075|62986348|FG001|Treatment|Withdrawal by Subject|0|||
33310712|NCT01163253|62686099|FG001|Overall Study|Ongoing|4|||
33310713|NCT01163253|62686098|FG000|Overall Study|Other Unspecified|170|||
33310714|NCT01163253|62686099|FG001|Overall Study|Other Unspecified|34|||
33310715|NCT01162863|62686108|FG000|Overall Study|Lack of Efficacy|1|||
33310716|NCT01162863|62686109|FG001|Overall Study|Lack of Efficacy|0|||
33310717|NCT01162863|62686110|FG002|Overall Study|Lack of Efficacy|0|||
33310718|NCT01162863|62686108|FG000|Overall Study|Adverse Event|0|||
33310719|NCT01162863|62686109|FG001|Overall Study|Adverse Event|1|||
33310720|NCT01162863|62686110|FG002|Overall Study|Adverse Event|0|||
33588123|NCT02545075|62986347|FG000|Treatment|Adverse event not related to study drug|1|||
33588124|NCT02545075|62986348|FG001|Treatment|Adverse event not related to study drug|0|||
33680045|NCT01436162|63133975|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
33680046|NCT01436162|63133976|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
33588125|NCT02545075|62986347|FG000|Treatment|Death|1|||
33588126|NCT02545075|62986348|FG001|Treatment|Death|0|||
33588127|NCT02545075|62986347|FG000|Treatment|Participant drug toxicity|1|||
33588128|NCT02545075|62986348|FG001|Treatment|Participant drug toxicity|0|||
33588129|NCT02545075|62986347|FG000|Treatment|Completed treatment|40|||
33588130|NCT02545075|62986348|FG001|Treatment|Completed treatment|12|||
33588131|NCT03004183|62986363|FG000|Overall Study|Adverse Event|7|||
33588132|NCT03004183|62986363|FG000|Overall Study|Lost to Follow-up|1|||
33588133|NCT03004183|62986363|FG000|Overall Study|Physician Decision|40|||
33588134|NCT03004183|62986363|FG000|Overall Study|Withdrawal by Subject|1|||
33588135|NCT03004183|62986363|FG000|Overall Study|COVID-19|1|||
33588136|NCT02544763|62986370|FG000|Overall Study|Adverse Event|8|||
33588137|NCT02544763|62986371|FG001|Overall Study|Adverse Event|8|||
33588138|NCT02544763|62986372|FG002|Overall Study|Adverse Event|0|||
33588139|NCT02544763|62986370|FG000|Overall Study|Withdrawn by parent/guardian|1|||
33588140|NCT02544763|62986371|FG001|Overall Study|Withdrawn by parent/guardian|1|||
33588141|NCT02544763|62986372|FG002|Overall Study|Withdrawn by parent/guardian|1|||
33588142|NCT02544763|62986370|FG000|Overall Study|Met withdrawal criteria|0|||
33588143|NCT02544763|62986371|FG001|Overall Study|Met withdrawal criteria|2|||
33588144|NCT02544763|62986372|FG002|Overall Study|Met withdrawal criteria|0|||
33588145|NCT02544763|62986370|FG000|Overall Study|Physician Decision|0|||
33588146|NCT02544763|62986371|FG001|Overall Study|Physician Decision|1|||
33588147|NCT02544763|62986372|FG002|Overall Study|Physician Decision|0|||
33588148|NCT02544763|62986370|FG000|Overall Study|Difficulties taking IMP|1|||
33588149|NCT02544763|62986371|FG001|Overall Study|Difficulties taking IMP|0|||
33588150|NCT02544763|62986372|FG002|Overall Study|Difficulties taking IMP|0|||
33588151|NCT02556203|62986382|FG000|Overall Study|Withdrawal by Subject|21|||
33588152|NCT02556203|62986383|FG001|Overall Study|Withdrawal by Subject|21|||
33588153|NCT02556203|62986382|FG000|Overall Study|Lost to Follow-up|5|||
33588154|NCT02556203|62986383|FG001|Overall Study|Lost to Follow-up|5|||
33588155|NCT02556203|62986382|FG000|Overall Study|Adverse Event|1|||
33588156|NCT02556203|62986383|FG001|Overall Study|Adverse Event|0|||
33588157|NCT02558231|62986400|FG000|Overall Study|Death|4|||
33588158|NCT02558231|62986401|FG001|Overall Study|Death|12|||
33588159|NCT02558231|62986400|FG000|Overall Study|Lost to Follow-up|7|||
33588160|NCT02558231|62986401|FG001|Overall Study|Lost to Follow-up|4|||
33588161|NCT02558231|62986400|FG000|Overall Study|Withdrawal by Subject|7|||
33588162|NCT02558231|62986401|FG001|Overall Study|Withdrawal by Subject|4|||
33588163|NCT02558231|62986400|FG000|Overall Study|Physician Decision|7|||
33588164|NCT02558231|62986401|FG001|Overall Study|Physician Decision|5|||
33588165|NCT02558231|62986400|FG000|Overall Study|Sponsor Decision|0|||
33588166|NCT02558231|62986401|FG001|Overall Study|Sponsor Decision|1|||
33588167|NCT02554877|62986411|FG000|Overall Study|Adverse Event|2|||
33588168|NCT02554877|62986412|FG001|Overall Study|Adverse Event|0|||
33588169|NCT02554877|62986413|FG002|Overall Study|Adverse Event|0|||
33588170|NCT02554877|62986414|FG003|Overall Study|Adverse Event|1|||
33588171|NCT02554877|62986411|FG000|Overall Study|Lost to Follow-up|1|||
33588172|NCT02554877|62986412|FG001|Overall Study|Lost to Follow-up|1|||
33588173|NCT02554877|62986413|FG002|Overall Study|Lost to Follow-up|1|||
33680047|NCT01436162|63133974|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
33588174|NCT02554877|62986414|FG003|Overall Study|Lost to Follow-up|2|||
33588175|NCT02554877|62986411|FG000|Overall Study|Did not meet entrance criteria|0|||
33588176|NCT02554877|62986412|FG001|Overall Study|Did not meet entrance criteria|0|||
33588177|NCT02554877|62986413|FG002|Overall Study|Did not meet entrance criteria|1|||
33588178|NCT02554877|62986414|FG003|Overall Study|Did not meet entrance criteria|0|||
33588179|NCT02554877|62986411|FG000|Overall Study|No longer met eligibility criteria|1|||
33588180|NCT02554877|62986412|FG001|Overall Study|No longer met eligibility criteria|0|||
33588181|NCT02554877|62986413|FG002|Overall Study|No longer met eligibility criteria|1|||
33680048|NCT01436162|63133975|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
33680049|NCT01436162|63133976|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
33588182|NCT02554877|62986414|FG003|Overall Study|No longer met eligibility criteria|1|||
33588183|NCT02554877|62986411|FG000|Overall Study|Protocol Violation|3|||
33588184|NCT02554877|62986412|FG001|Overall Study|Protocol Violation|1|||
33588185|NCT02554877|62986413|FG002|Overall Study|Protocol Violation|1|||
33588186|NCT02554877|62986414|FG003|Overall Study|Protocol Violation|0|||
33588187|NCT02554877|62986411|FG000|Overall Study|Other|1|||
33588188|NCT02554877|62986412|FG001|Overall Study|Other|3|||
33588189|NCT02554877|62986413|FG002|Overall Study|Other|0|||
33588190|NCT02554877|62986414|FG003|Overall Study|Other|3|||
33588191|NCT02554877|62986411|FG000|Overall Study|Insufficient clinical response|4|||
33588192|NCT02554877|62986412|FG001|Overall Study|Insufficient clinical response|0|||
33588193|NCT02554877|62986413|FG002|Overall Study|Insufficient clinical response|0|||
33588194|NCT02554877|62986414|FG003|Overall Study|Insufficient clinical response|0|||
33588195|NCT02554877|62986411|FG000|Overall Study|No longer willing to participate|0|||
33588196|NCT02554877|62986412|FG001|Overall Study|No longer willing to participate|2|||
33588197|NCT02554877|62986413|FG002|Overall Study|No longer willing to participate|2|||
33588198|NCT02554877|62986414|FG003|Overall Study|No longer willing to participate|0|||
33588199|NCT02554721|62986429|FG000|Overall Study|Adverse Event|1|||
33588200|NCT02554721|62986430|FG001|Overall Study|Adverse Event|0|||
33588201|NCT02554721|62986431|FG002|Overall Study|Adverse Event|0|||
33588202|NCT02554721|62986432|FG003|Overall Study|Adverse Event|0|||
33588203|NCT02554721|62986433|FG004|Overall Study|Adverse Event|1|||
33588204|NCT02554721|62986429|FG000|Overall Study|Noncompliance|0|||
33588205|NCT02554721|62986430|FG001|Overall Study|Noncompliance|0|||
33588206|NCT02554721|62986431|FG002|Overall Study|Noncompliance|0|||
33588207|NCT02554721|62986432|FG003|Overall Study|Noncompliance|0|||
33588208|NCT02554721|62986433|FG004|Overall Study|Noncompliance|1|||
33588209|NCT02552225|62986444|FG000|Overall Study|Withdrawal by Subject|1|||
33588210|NCT02552225|62986445|FG001|Overall Study|Withdrawal by Subject|0|||
33588211|NCT02552147|62986451|FG000|First Intervention (7 Days)|Protocol Violation|1|||
33588212|NCT02552147|62986452|FG001|First Intervention (7 Days)|Protocol Violation|0|||
33588213|NCT02552147|62986451|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
33588214|NCT02552147|62986452|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
33588215|NCT01662635|62986458|FG000|Overall Study|scarce samples for evaluation|30|||
33588216|NCT02534935|62986467|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
33588217|NCT02534935|62986468|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
33588218|NCT02534935|62986469|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
33588219|NCT02534935|62986467|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
33588220|NCT02534935|62986468|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
33588221|NCT02534935|62986469|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
33680050|NCT01436162|63133974|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
33680051|NCT01436162|63133975|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
33680052|NCT01436162|63133976|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
33680053|NCT01436162|63133974|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
33680054|NCT01436162|63133975|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
33680055|NCT01436162|63133976|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
33680056|NCT01436162|63133974|FG000|Single-blind Lead-in Phase|Other|107|||
33680057|NCT01436162|63133975|FG001|Single-blind Lead-in Phase|Other|0|||
33680058|NCT01436162|63133976|FG002|Single-blind Lead-in Phase|Other|0|||
33680059|NCT01436162|63133974|FG000|Randomized Phase|Adverse Event|1|||
33680060|NCT01436162|63133975|FG001|Randomized Phase|Adverse Event|5|||
33680061|NCT01436162|63133976|FG002|Randomized Phase|Adverse Event|6|||
33680062|NCT01436162|63133974|FG000|Randomized Phase|Protocol Violation|4|||
33680063|NCT01436162|63133975|FG001|Randomized Phase|Protocol Violation|4|||
33680064|NCT01436162|63133976|FG002|Randomized Phase|Protocol Violation|2|||
33680065|NCT01436162|63133974|FG000|Randomized Phase|Withdrawal by Subject|16|||
33493066|NCT03145766|62871125|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
33493067|NCT03145766|62871121|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
33493068|NCT03145766|62871122|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
33493069|NCT03145766|62871123|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
33493070|NCT03145766|62871124|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
33493071|NCT03145766|62871125|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
33493072|NCT03145766|62871121|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
33493073|NCT03145766|62871122|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
33680066|NCT01436162|63133975|FG001|Randomized Phase|Withdrawal by Subject|9|||
33680067|NCT01436162|63133976|FG002|Randomized Phase|Withdrawal by Subject|8|||
33680068|NCT01436162|63133974|FG000|Randomized Phase|Lost to Follow-up|17|||
33680069|NCT01436162|63133975|FG001|Randomized Phase|Lost to Follow-up|5|||
33680070|NCT01436162|63133976|FG002|Randomized Phase|Lost to Follow-up|4|||
33680071|NCT01436162|63133974|FG000|Randomized Phase|Lack of Efficacy|0|||
33680072|NCT01436162|63133975|FG001|Randomized Phase|Lack of Efficacy|1|||
33493074|NCT03145766|62871123|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
33588222|NCT02534935|62986467|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
33680073|NCT01436162|63133976|FG002|Randomized Phase|Lack of Efficacy|1|||
33680074|NCT01436162|63133974|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
33588223|NCT02534935|62986468|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
33588224|NCT02534935|62986469|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
33588225|NCT02534935|62986467|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
33588226|NCT02534935|62986468|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
33588227|NCT02534935|62986469|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
33588228|NCT02534935|62986467|FG000|Stage 1: 24 Months|Adverse Event|0|||
33588229|NCT02534935|62986468|FG001|Stage 1: 24 Months|Adverse Event|2|||
33588230|NCT02534935|62986469|FG002|Stage 1: 24 Months|Adverse Event|0|||
33588231|NCT02534935|62986467|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
33588232|NCT02534935|62986468|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
33588233|NCT02534935|62986469|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
33588234|NCT02534935|62986467|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
33588235|NCT02534935|62986468|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
33588236|NCT02534935|62986469|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
33588237|NCT02544451|62986498|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
33588238|NCT02544451|62986499|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
33588239|NCT02544451|62986500|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
33588240|NCT02544451|62986501|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
33588241|NCT02544451|62986498|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
33588242|NCT02544451|62986499|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
33588243|NCT02544451|62986500|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
33588244|NCT02544451|62986501|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
33588245|NCT02544451|62986498|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
33588246|NCT02544451|62986499|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
33588247|NCT02544451|62986500|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
33588248|NCT02544451|62986501|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
33588249|NCT02544451|62986498|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
33588250|NCT02544451|62986499|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
33588251|NCT02544451|62986500|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
33588252|NCT02544451|62986501|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
33588253|NCT02544451|62986498|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
33588254|NCT02544451|62986499|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
33588255|NCT02544451|62986500|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
33588256|NCT02544451|62986501|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
33588257|NCT02544451|62986498|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
33588258|NCT02544451|62986499|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
33588259|NCT02544451|62986500|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
33588260|NCT02544451|62986501|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
33588261|NCT02544373|62986521|FG000|Overall Study|Lost to Follow-up|5|||
33588262|NCT02544373|62986522|FG001|Overall Study|Lost to Follow-up|3|||
33588263|NCT02544373|62986521|FG000|Overall Study|Withdrawal by Subject|8|||
33588264|NCT02544373|62986522|FG001|Overall Study|Withdrawal by Subject|2|||
33588265|NCT02551991|62986534|FG000|Overall Study|Death|5|||
33588266|NCT02551991|62986535|FG001|Overall Study|Death|7|||
33588267|NCT02551991|62986536|FG002|Overall Study|Death|8|||
33588268|NCT02551991|62986537|FG003|Overall Study|Death|7|||
33588269|NCT02551991|62986538|FG004|Overall Study|Death|17|||
33588270|NCT02551991|62986534|FG000|Overall Study|Withdrawal by Subject|1|||
33588271|NCT02551991|62986535|FG001|Overall Study|Withdrawal by Subject|0|||
33588272|NCT02551991|62986536|FG002|Overall Study|Withdrawal by Subject|0|||
33588273|NCT02551991|62986537|FG003|Overall Study|Withdrawal by Subject|0|||
33588274|NCT02551991|62986538|FG004|Overall Study|Withdrawal by Subject|2|||
33588275|NCT02551991|62986534|FG000|Overall Study|Lost to Follow-up|0|||
33588276|NCT02551991|62986535|FG001|Overall Study|Lost to Follow-up|0|||
33588277|NCT02551991|62986536|FG002|Overall Study|Lost to Follow-up|1|||
33588278|NCT02551991|62986537|FG003|Overall Study|Lost to Follow-up|0|||
33588279|NCT02551991|62986538|FG004|Overall Study|Lost to Follow-up|0|||
33588280|NCT02551991|62986534|FG000|Overall Study|Sponsor Decision|1|||
33588281|NCT02551991|62986535|FG001|Overall Study|Sponsor Decision|0|||
33588282|NCT02551991|62986536|FG002|Overall Study|Sponsor Decision|1|||
33588283|NCT02551991|62986537|FG003|Overall Study|Sponsor Decision|0|||
33588284|NCT02551991|62986538|FG004|Overall Study|Sponsor Decision|5|||
33588285|NCT02551991|62986534|FG000|Overall Study|Other|0|||
33588286|NCT02551991|62986535|FG001|Overall Study|Other|0|||
33588287|NCT02551991|62986536|FG002|Overall Study|Other|0|||
33588288|NCT02551991|62986537|FG003|Overall Study|Other|0|||
33588289|NCT02551991|62986538|FG004|Overall Study|Other|1|||
33588290|NCT01661933|62986551|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
33588291|NCT01661933|62986551|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
33588292|NCT02544217|62986563|FG000|Overall Study|Withdrawal by Subject|1|||
33588293|NCT02544217|62986564|FG001|Overall Study|Withdrawal by Subject|1|||
33588294|NCT02544217|62986565|FG002|Overall Study|Withdrawal by Subject|0|||
33588295|NCT02544217|62986566|FG003|Overall Study|Withdrawal by Subject|0|||
33588296|NCT02544217|62986567|FG004|Overall Study|Withdrawal by Subject|0|||
33588297|NCT02544217|62986568|FG005|Overall Study|Withdrawal by Subject|0|||
33588298|NCT02533999|62986637|FG000|Overall Study|Lost to Follow-up|3|||
33588299|NCT02533999|62986638|FG001|Overall Study|Lost to Follow-up|5|||
33588300|NCT02533999|62986637|FG000|Overall Study|Protocol Violation|3|||
33588301|NCT02533999|62986638|FG001|Overall Study|Protocol Violation|0|||
33588302|NCT02533999|62986637|FG000|Overall Study|Adverse Event|0|||
33680075|NCT01436162|63133975|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
33680076|NCT01436162|63133976|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
33680077|NCT01436162|63133974|FG000|Randomized Phase|Other|2|||
33680078|NCT01436162|63133975|FG001|Randomized Phase|Other|5|||
33680079|NCT01436162|63133976|FG002|Randomized Phase|Other|4|||
33680080|NCT02579382|63133988|FG000|Main Study Phase|Lost to Follow-up|0|||
33680081|NCT02579382|63133989|FG001|Main Study Phase|Lost to Follow-up|0|||
33680082|NCT02579382|63133990|FG002|Main Study Phase|Lost to Follow-up|2|||
33680083|NCT02579382|63133991|FG003|Main Study Phase|Lost to Follow-up|0|||
33680084|NCT02579382|63133988|FG000|Main Study Phase|Withdrew Consent|0|||
33680085|NCT02579382|63133989|FG001|Main Study Phase|Withdrew Consent|0|||
33680086|NCT02579382|63133990|FG002|Main Study Phase|Withdrew Consent|0|||
33680087|NCT02579382|63133991|FG003|Main Study Phase|Withdrew Consent|2|||
33680088|NCT02579382|63133988|FG000|Main Study Phase|Lack of Efficacy|0|||
33680089|NCT02579382|63133989|FG001|Main Study Phase|Lack of Efficacy|0|||
33680090|NCT02579382|63133990|FG002|Main Study Phase|Lack of Efficacy|0|||
33680091|NCT02579382|63133991|FG003|Main Study Phase|Lack of Efficacy|1|||
33680092|NCT02579382|63133988|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
33680093|NCT02579382|63133989|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
33680094|NCT02579382|63133990|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
33680095|NCT02579382|63133991|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
33680096|NCT02579382|63133988|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
33680097|NCT02579382|63133989|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
33680098|NCT02579382|63133990|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
33680099|NCT02579382|63133991|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
33680100|NCT02579382|63133988|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
33588303|NCT02533999|62986638|FG001|Overall Study|Adverse Event|1|||
33680101|NCT02579382|63133989|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
33680102|NCT02579382|63133990|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
33680103|NCT02579382|63133991|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
33680104|NCT02579382|63133988|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
33680105|NCT02579382|63133989|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
33680106|NCT02579382|63133990|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
33680107|NCT02579382|63133991|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
33680108|NCT02579382|63133988|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
33680109|NCT02579382|63133989|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
33680110|NCT02579382|63133990|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
33680111|NCT02579382|63133991|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
33680112|NCT02579382|63133988|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
33680113|NCT02579382|63133989|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
33680114|NCT02579382|63133990|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
33680115|NCT02579382|63133991|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
33588304|NCT02533999|62986637|FG000|Overall Study|Randomized but intervention not received|0|||
33588305|NCT02533999|62986638|FG001|Overall Study|Randomized but intervention not received|1|||
33588306|NCT02533531|62986644|FG000|Overall Study|Device did not turn on|1|||
33588307|NCT02533453|62986648|FG000|Overall Study|Adverse Event|6|||
33588308|NCT02533453|62986648|FG000|Overall Study|Protocol Violation|1|||
33588309|NCT02533453|62986648|FG000|Overall Study|Withdrawal by Subject|2|||
33588310|NCT02533375|62986652|FG000|Overall Study|Lack of Efficacy|3|||
33588311|NCT02533375|62986652|FG000|Overall Study|Adverse Event|2|||
33588312|NCT01553149|62986658|FG000|Overall Study|Adverse Event|0|||
33588313|NCT01553149|62986659|FG001|Overall Study|Adverse Event|9|||
33588314|NCT01553149|62986658|FG000|Overall Study|Physician Decision|5|||
33588315|NCT01553149|62986659|FG001|Overall Study|Physician Decision|10|||
33588316|NCT01553149|62986658|FG000|Overall Study|Ineligible|0|||
33588317|NCT01553149|62986659|FG001|Overall Study|Ineligible|1|||
33588318|NCT02551055|62986672|FG000|Overall Study|Death|2|||
33588319|NCT02551055|62986673|FG001|Overall Study|Death|4|||
33588320|NCT02551055|62986674|FG002|Overall Study|Death|2|||
33588321|NCT02551055|62986675|FG003|Overall Study|Death|2|||
33588322|NCT02551055|62986676|FG004|Overall Study|Death|2|||
33588323|NCT02551055|62986677|FG005|Overall Study|Death|1|||
33588324|NCT02551055|62986678|FG006|Overall Study|Death|2|||
33588325|NCT02551055|62986679|FG007|Overall Study|Death|0|||
33588326|NCT02551055|62986672|FG000|Overall Study|Study Terminated by Sponsor|1|||
33588327|NCT02551055|62986673|FG001|Overall Study|Study Terminated by Sponsor|1|||
33588328|NCT02551055|62986674|FG002|Overall Study|Study Terminated by Sponsor|0|||
33588329|NCT02551055|62986675|FG003|Overall Study|Study Terminated by Sponsor|2|||
33588330|NCT02551055|62986676|FG004|Overall Study|Study Terminated by Sponsor|2|||
33588331|NCT02551055|62986677|FG005|Overall Study|Study Terminated by Sponsor|0|||
33588332|NCT02551055|62986678|FG006|Overall Study|Study Terminated by Sponsor|0|||
33588333|NCT02551055|62986679|FG007|Overall Study|Study Terminated by Sponsor|0|||
33588334|NCT02551055|62986672|FG000|Overall Study|Withdrawal by Subject|1|||
33588335|NCT02551055|62986673|FG001|Overall Study|Withdrawal by Subject|1|||
33588336|NCT02551055|62986674|FG002|Overall Study|Withdrawal by Subject|0|||
33588337|NCT02551055|62986675|FG003|Overall Study|Withdrawal by Subject|1|||
33588338|NCT02551055|62986676|FG004|Overall Study|Withdrawal by Subject|2|||
33588339|NCT02551055|62986677|FG005|Overall Study|Withdrawal by Subject|0|||
33588340|NCT02551055|62986678|FG006|Overall Study|Withdrawal by Subject|0|||
33588341|NCT02551055|62986679|FG007|Overall Study|Withdrawal by Subject|0|||
33588342|NCT02551055|62986672|FG000|Overall Study|Reason not specified|0|||
33588343|NCT02551055|62986673|FG001|Overall Study|Reason not specified|0|||
33680116|NCT01436084|63134018|FG000|Overall Study|Disease Progression|2|||
33680117|NCT01436084|63134018|FG000|Overall Study|Withdrawal by Subject|1|||
33588344|NCT02551055|62986674|FG002|Overall Study|Reason not specified|0|||
33588345|NCT02551055|62986675|FG003|Overall Study|Reason not specified|0|||
33588346|NCT02551055|62986676|FG004|Overall Study|Reason not specified|1|||
33588347|NCT02551055|62986677|FG005|Overall Study|Reason not specified|0|||
33588348|NCT02551055|62986678|FG006|Overall Study|Reason not specified|1|||
33588349|NCT02551055|62986679|FG007|Overall Study|Reason not specified|0|||
33588350|NCT02542943|62986700|FG000|Overall Study|Lost to Follow-up|1|||
33588351|NCT02542943|62986701|FG001|Overall Study|Lost to Follow-up|0|||
33588352|NCT02542943|62986702|FG002|Overall Study|Lost to Follow-up|0|||
33588353|NCT02542943|62986700|FG000|Overall Study|Withdrawal by Subject|0|||
33588354|NCT02542943|62986701|FG001|Overall Study|Withdrawal by Subject|1|||
33588355|NCT02542943|62986702|FG002|Overall Study|Withdrawal by Subject|0|||
33588356|NCT02542865|62986713|FG000|Overall Study|Identified as screen failure|1|||
33588357|NCT02542865|62986714|FG001|Overall Study|Identified as screen failure|0|||
33588358|NCT02542865|62986713|FG000|Overall Study|Withdrawal by Subject|16|||
33588359|NCT02542865|62986714|FG001|Overall Study|Withdrawal by Subject|0|||
33588360|NCT03644927|62986720|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
33588361|NCT03644927|62986721|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
33680118|NCT01436084|63134018|FG000|Overall Study|Early Closure of Study|1|||
33588362|NCT02542631|62986728|FG000|Overall Study|Adverse Event|1|||
33588363|NCT02542631|62986729|FG001|Overall Study|Adverse Event|1|||
33588364|NCT02542631|62986728|FG000|Overall Study|Sponsor Termination|1|||
33588365|NCT02542631|62986729|FG001|Overall Study|Sponsor Termination|0|||
33588366|NCT02542631|62986728|FG000|Overall Study|Withdrawal by Subject|11|||
33588367|NCT02542631|62986729|FG001|Overall Study|Withdrawal by Subject|16|||
33588368|NCT02542631|62986728|FG000|Overall Study|Protocol Violation|1|||
33588369|NCT02542631|62986729|FG001|Overall Study|Protocol Violation|1|||
33588370|NCT02542631|62986728|FG000|Overall Study|Physician Decision|6|||
33588371|NCT02542631|62986729|FG001|Overall Study|Physician Decision|4|||
33588372|NCT02542631|62986728|FG000|Overall Study|Lost to Follow-up|6|||
33588373|NCT02542631|62986729|FG001|Overall Study|Lost to Follow-up|5|||
33588374|NCT02542631|62986728|FG000|Overall Study|Death|1|||
33588375|NCT02542631|62986729|FG001|Overall Study|Death|2|||
33588376|NCT02542631|62986728|FG000|Overall Study|Other|2|||
33588377|NCT02542631|62986729|FG001|Overall Study|Other|1|||
33588378|NCT02542631|62986728|FG000|Overall Study|Used Prohibited Medication|2|||
33588379|NCT02542631|62986729|FG001|Overall Study|Used Prohibited Medication|1|||
33588380|NCT02542397|62986735|FG000|Overall Study|Death|2|||
33588381|NCT02542397|62986735|FG000|Overall Study|Physician Decision|6|||
33588382|NCT02542397|62986735|FG000|Overall Study|Withdrawal by Subject|6|||
33588383|NCT02542397|62986735|FG000|Overall Study|Lost to Follow-up|2|||
33588384|NCT02549339|62986742|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
33588385|NCT02549339|62986743|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
33588386|NCT02549339|62986742|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
33588387|NCT02549339|62986743|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
33588388|NCT02549339|62986742|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
33588389|NCT02549339|62986743|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
33588390|NCT02549339|62986742|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
33588391|NCT02549339|62986743|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
33588392|NCT02549339|62986742|FG000|12-month Follow-up|Lack of Efficacy|0|||
33588393|NCT02549339|62986743|FG001|12-month Follow-up|Lack of Efficacy|2|||
33588394|NCT02549339|62986742|FG000|12-month Follow-up|Withdrawal by Subject|8|||
33588395|NCT02549339|62986743|FG001|12-month Follow-up|Withdrawal by Subject|3|||
33588396|NCT02549339|62986742|FG000|12-month Follow-up|Lost to Follow-up|1|||
33588397|NCT02549339|62986743|FG001|12-month Follow-up|Lost to Follow-up|3|||
33588398|NCT02549339|62986742|FG000|12-month Follow-up|Other|0|||
33588399|NCT02549339|62986743|FG001|12-month Follow-up|Other|3|||
33588400|NCT02549027|62986751|FG000|Washout After Period 4|Withdrawal by Subject|0|||
33588401|NCT02549027|62986752|FG001|Washout After Period 4|Withdrawal by Subject|1|||
33588402|NCT02549027|62986753|FG002|Washout After Period 4|Withdrawal by Subject|1|||
33588403|NCT02549027|62986754|FG003|Washout After Period 4|Withdrawal by Subject|1|||
33588404|NCT02549027|62986755|FG004|Washout After Period 4|Withdrawal by Subject|0|||
33588405|NCT02549027|62986756|FG005|Washout After Period 4|Withdrawal by Subject|0|||
33588406|NCT02549027|62986751|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
33588407|NCT02549027|62986752|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
33588408|NCT02549027|62986753|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
33588409|NCT02549027|62986754|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
33588410|NCT02549027|62986755|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
33588411|NCT02549027|62986756|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
33588412|NCT02529553|62986784|FG000|Overall Study|Progressive Disease|1|||
33588413|NCT02529553|62986785|FG001|Overall Study|Progressive Disease|0|||
33588414|NCT02529553|62986786|FG002|Overall Study|Progressive Disease|1|||
33588415|NCT02529553|62986787|FG003|Overall Study|Progressive Disease|3|||
33588416|NCT02529553|62986788|FG004|Overall Study|Progressive Disease|2|||
33588417|NCT02529553|62986789|FG005|Overall Study|Progressive Disease|3|||
33588418|NCT02529553|62986790|FG006|Overall Study|Progressive Disease|3|||
33588419|NCT02529553|62986791|FG007|Overall Study|Progressive Disease|5|||
33588420|NCT02529553|62986792|FG008|Overall Study|Progressive Disease|3|||
33588421|NCT02529553|62986784|FG000|Overall Study|Physician Decision|0|||
33588422|NCT02529553|62986785|FG001|Overall Study|Physician Decision|1|||
33588423|NCT02529553|62986786|FG002|Overall Study|Physician Decision|0|||
33588424|NCT02529553|62986787|FG003|Overall Study|Physician Decision|0|||
33588425|NCT02529553|62986788|FG004|Overall Study|Physician Decision|1|||
33588426|NCT02529553|62986789|FG005|Overall Study|Physician Decision|0|||
33588427|NCT02529553|62986790|FG006|Overall Study|Physician Decision|0|||
33588428|NCT02529553|62986791|FG007|Overall Study|Physician Decision|0|||
33588429|NCT02529553|62986792|FG008|Overall Study|Physician Decision|0|||
33680119|NCT01419314|63134033|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
33680120|NCT01419314|63134034|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
33680121|NCT01419314|63134033|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
33680122|NCT01419314|63134034|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
33588430|NCT02529553|62986784|FG000|Overall Study|Withdrawal by Subject|0|||
33588431|NCT02529553|62986785|FG001|Overall Study|Withdrawal by Subject|0|||
33588432|NCT02529553|62986786|FG002|Overall Study|Withdrawal by Subject|0|||
33588433|NCT02529553|62986787|FG003|Overall Study|Withdrawal by Subject|0|||
33588434|NCT02529553|62986788|FG004|Overall Study|Withdrawal by Subject|0|||
33588435|NCT02529553|62986789|FG005|Overall Study|Withdrawal by Subject|1|||
33588436|NCT02529553|62986790|FG006|Overall Study|Withdrawal by Subject|0|||
33588437|NCT02529553|62986791|FG007|Overall Study|Withdrawal by Subject|1|||
33588438|NCT02529553|62986792|FG008|Overall Study|Withdrawal by Subject|0|||
33588439|NCT02547935|62986816|FG000|Overall Study|Other|0|||
33588440|NCT02547935|62986817|FG001|Overall Study|Other|1|||
33588441|NCT02547935|62986818|FG002|Overall Study|Other|0|||
33588442|NCT02547935|62986816|FG000|Overall Study|Withdrawal by Subject|2|||
33588443|NCT02547935|62986817|FG001|Overall Study|Withdrawal by Subject|3|||
33588444|NCT02547935|62986818|FG002|Overall Study|Withdrawal by Subject|4|||
33588445|NCT02547935|62986816|FG000|Overall Study|Screen Failure|2|||
33588446|NCT02547935|62986817|FG001|Overall Study|Screen Failure|0|||
33588447|NCT02547935|62986818|FG002|Overall Study|Screen Failure|0|||
33588448|NCT02547935|62986816|FG000|Overall Study|Physician Decision|0|||
33588449|NCT02547935|62986817|FG001|Overall Study|Physician Decision|1|||
33588450|NCT02547935|62986818|FG002|Overall Study|Physician Decision|0|||
33588451|NCT02547935|62986816|FG000|Overall Study|Lost to Follow-up|0|||
33588452|NCT02547935|62986817|FG001|Overall Study|Lost to Follow-up|2|||
33588453|NCT02547935|62986818|FG002|Overall Study|Lost to Follow-up|1|||
33588454|NCT02547935|62986816|FG000|Overall Study|Death|1|||
33588455|NCT02547935|62986817|FG001|Overall Study|Death|1|||
33588456|NCT02547935|62986818|FG002|Overall Study|Death|0|||
33588457|NCT02554019|62986831|FG000|Overall Study|Withdrawal by Subject|1|||
33588458|NCT02554019|62986832|FG001|Overall Study|Withdrawal by Subject|0|||
33588459|NCT02554019|62986833|FG002|Overall Study|Withdrawal by Subject|2|||
33588460|NCT02554019|62986831|FG000|Overall Study|Adverse Event|1|||
33588461|NCT02554019|62986832|FG001|Overall Study|Adverse Event|0|||
33588462|NCT02554019|62986833|FG002|Overall Study|Adverse Event|0|||
33588463|NCT02327169|62986856|FG000|Overall Study|Progressive Disease|1|||
33588464|NCT02327169|62986857|FG001|Overall Study|Progressive Disease|3|||
33588465|NCT02327169|62986858|FG002|Overall Study|Progressive Disease|4|||
33588466|NCT02327169|62986859|FG003|Overall Study|Progressive Disease|3|||
33588467|NCT02327169|62986860|FG004|Overall Study|Progressive Disease|4|||
33588468|NCT02327169|62986861|FG005|Overall Study|Progressive Disease|3|||
33588469|NCT02327169|62986862|FG006|Overall Study|Progressive Disease|3|||
33588470|NCT02327169|62986863|FG007|Overall Study|Progressive Disease|3|||
33588471|NCT02327169|62986864|FG008|Overall Study|Progressive Disease|4|||
33588472|NCT02327169|62986865|FG009|Overall Study|Progressive Disease|4|||
33588473|NCT02327169|62986866|FG010|Overall Study|Progressive Disease|4|||
33588474|NCT02327169|62986867|FG011|Overall Study|Progressive Disease|3|||
33588475|NCT02327169|62986868|FG012|Overall Study|Progressive Disease|1|||
33588476|NCT02327169|62986869|FG013|Overall Study|Progressive Disease|3|||
33588477|NCT02327169|62986870|FG014|Overall Study|Progressive Disease|3|||
33588478|NCT02327169|62986856|FG000|Overall Study|Adverse Event|2|||
33588479|NCT02327169|62986857|FG001|Overall Study|Adverse Event|0|||
33588480|NCT02327169|62986858|FG002|Overall Study|Adverse Event|1|||
33588481|NCT02327169|62986859|FG003|Overall Study|Adverse Event|0|||
33588482|NCT02327169|62986860|FG004|Overall Study|Adverse Event|1|||
33588483|NCT02327169|62986861|FG005|Overall Study|Adverse Event|0|||
33680123|NCT01419314|63134033|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
33680124|NCT01419314|63134034|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
33680125|NCT01419236|63134091|FG000|Overall Study|Adverse Event|1|||
33680126|NCT01419236|63134092|FG001|Overall Study|Adverse Event|0|||
33680127|NCT01419236|63134091|FG000|Overall Study|Lack of Efficacy|0|||
33680128|NCT01419236|63134092|FG001|Overall Study|Lack of Efficacy|1|||
33680129|NCT01419236|63134091|FG000|Overall Study|Lost to Follow-up|1|||
33680130|NCT01419236|63134092|FG001|Overall Study|Lost to Follow-up|0|||
33680131|NCT01419236|63134091|FG000|Overall Study|Physician Decision|1|||
33680132|NCT01419236|63134092|FG001|Overall Study|Physician Decision|0|||
33680133|NCT01419236|63134091|FG000|Overall Study|Withdrawal by Subject|1|||
33680134|NCT01419236|63134092|FG001|Overall Study|Withdrawal by Subject|4|||
33680135|NCT01419236|63134091|FG000|Overall Study|Entry Criteria Not Met|1|||
33680136|NCT01419236|63134092|FG001|Overall Study|Entry Criteria Not Met|0|||
33680137|NCT03323658|63134105|FG000|Overall Study|Adverse Event|0|||
33680138|NCT03323658|63134106|FG001|Overall Study|Adverse Event|1|||
33680139|NCT03323658|63134107|FG002|Overall Study|Adverse Event|0|||
33680140|NCT01443026|63134132|FG000|Overall Study|Physician Decision|1|||
33680141|NCT01443026|63134133|FG001|Overall Study|Physician Decision|0|||
33680142|NCT01443026|63134132|FG000|Overall Study|Death|0|||
33588484|NCT02327169|62986862|FG006|Overall Study|Adverse Event|0|||
33588485|NCT02327169|62986863|FG007|Overall Study|Adverse Event|0|||
33588486|NCT02327169|62986864|FG008|Overall Study|Adverse Event|0|||
33588487|NCT02327169|62986865|FG009|Overall Study|Adverse Event|2|||
33588488|NCT02327169|62986866|FG010|Overall Study|Adverse Event|0|||
33588489|NCT02327169|62986867|FG011|Overall Study|Adverse Event|3|||
33588490|NCT02327169|62986868|FG012|Overall Study|Adverse Event|0|||
33588491|NCT02327169|62986869|FG013|Overall Study|Adverse Event|2|||
33588492|NCT02327169|62986870|FG014|Overall Study|Adverse Event|1|||
33588493|NCT02327169|62986856|FG000|Overall Study|Symptomatic Deterioration|0|||
33680143|NCT01443026|63134133|FG001|Overall Study|Death|1|||
33588494|NCT02327169|62986857|FG001|Overall Study|Symptomatic Deterioration|0|||
33588495|NCT02327169|62986858|FG002|Overall Study|Symptomatic Deterioration|1|||
33588496|NCT02327169|62986859|FG003|Overall Study|Symptomatic Deterioration|0|||
33588497|NCT02327169|62986860|FG004|Overall Study|Symptomatic Deterioration|1|||
33588498|NCT02327169|62986861|FG005|Overall Study|Symptomatic Deterioration|1|||
33680144|NCT01443026|63134132|FG000|Overall Study|Withdrawal by Subject|0|||
33680145|NCT01443026|63134133|FG001|Overall Study|Withdrawal by Subject|3|||
33680146|NCT01443026|63134132|FG000|Overall Study|Lost to Follow-up|2|||
33680147|NCT01443026|63134133|FG001|Overall Study|Lost to Follow-up|1|||
33680148|NCT01442714|63134167|FG000|Overall Study|Death|11|||
33680149|NCT01442714|63134167|FG000|Overall Study|Withdrawal by Subject|1|||
33680150|NCT01418378|63134180|FG000|Overall Study|Death|1|||
33680151|NCT01418378|63134181|FG001|Overall Study|Death|2|||
33680152|NCT01418378|63134180|FG000|Overall Study|Physician Decision|0|||
33588499|NCT02327169|62986862|FG006|Overall Study|Symptomatic Deterioration|0|||
33588500|NCT02327169|62986863|FG007|Overall Study|Symptomatic Deterioration|0|||
33588501|NCT02327169|62986864|FG008|Overall Study|Symptomatic Deterioration|2|||
33588502|NCT02327169|62986865|FG009|Overall Study|Symptomatic Deterioration|1|||
33588503|NCT02327169|62986866|FG010|Overall Study|Symptomatic Deterioration|0|||
33588504|NCT02327169|62986867|FG011|Overall Study|Symptomatic Deterioration|0|||
33588505|NCT02327169|62986868|FG012|Overall Study|Symptomatic Deterioration|0|||
33588506|NCT02327169|62986869|FG013|Overall Study|Symptomatic Deterioration|2|||
33588507|NCT02327169|62986870|FG014|Overall Study|Symptomatic Deterioration|1|||
33588508|NCT02327169|62986856|FG000|Overall Study|Reason Not Specified|0|||
33588509|NCT02327169|62986857|FG001|Overall Study|Reason Not Specified|0|||
33588510|NCT02327169|62986858|FG002|Overall Study|Reason Not Specified|1|||
33588511|NCT02327169|62986859|FG003|Overall Study|Reason Not Specified|0|||
33588512|NCT02327169|62986860|FG004|Overall Study|Reason Not Specified|0|||
33588513|NCT02327169|62986861|FG005|Overall Study|Reason Not Specified|0|||
33588514|NCT02327169|62986862|FG006|Overall Study|Reason Not Specified|0|||
33588515|NCT02327169|62986863|FG007|Overall Study|Reason Not Specified|0|||
33588516|NCT02327169|62986864|FG008|Overall Study|Reason Not Specified|0|||
33588517|NCT02327169|62986865|FG009|Overall Study|Reason Not Specified|1|||
33588518|NCT02327169|62986866|FG010|Overall Study|Reason Not Specified|2|||
33588519|NCT02327169|62986867|FG011|Overall Study|Reason Not Specified|1|||
33588520|NCT02327169|62986868|FG012|Overall Study|Reason Not Specified|0|||
33588521|NCT02327169|62986869|FG013|Overall Study|Reason Not Specified|0|||
33588522|NCT02327169|62986870|FG014|Overall Study|Reason Not Specified|2|||
33588523|NCT02327169|62986856|FG000|Overall Study|Withdrawal by Subject|1|||
33680153|NCT01418378|63134181|FG001|Overall Study|Physician Decision|1|||
33588524|NCT02327169|62986857|FG001|Overall Study|Withdrawal by Subject|0|||
33588525|NCT02327169|62986858|FG002|Overall Study|Withdrawal by Subject|0|||
33588526|NCT02327169|62986859|FG003|Overall Study|Withdrawal by Subject|0|||
33588527|NCT02327169|62986860|FG004|Overall Study|Withdrawal by Subject|1|||
33588528|NCT02327169|62986861|FG005|Overall Study|Withdrawal by Subject|0|||
33588529|NCT02327169|62986862|FG006|Overall Study|Withdrawal by Subject|0|||
33588530|NCT02327169|62986863|FG007|Overall Study|Withdrawal by Subject|1|||
33588531|NCT02327169|62986864|FG008|Overall Study|Withdrawal by Subject|0|||
33588532|NCT02327169|62986865|FG009|Overall Study|Withdrawal by Subject|0|||
33588533|NCT02327169|62986866|FG010|Overall Study|Withdrawal by Subject|0|||
33588534|NCT02327169|62986867|FG011|Overall Study|Withdrawal by Subject|0|||
33588535|NCT02327169|62986868|FG012|Overall Study|Withdrawal by Subject|0|||
33588536|NCT02327169|62986869|FG013|Overall Study|Withdrawal by Subject|0|||
33588537|NCT02327169|62986870|FG014|Overall Study|Withdrawal by Subject|3|||
33588538|NCT02327169|62986856|FG000|Overall Study|Lost to Follow-up|0|||
33588539|NCT02327169|62986857|FG001|Overall Study|Lost to Follow-up|0|||
33588540|NCT02327169|62986858|FG002|Overall Study|Lost to Follow-up|0|||
33588541|NCT02327169|62986859|FG003|Overall Study|Lost to Follow-up|0|||
33588542|NCT02327169|62986860|FG004|Overall Study|Lost to Follow-up|1|||
33588543|NCT02327169|62986861|FG005|Overall Study|Lost to Follow-up|0|||
33588544|NCT02327169|62986862|FG006|Overall Study|Lost to Follow-up|0|||
33588545|NCT02327169|62986863|FG007|Overall Study|Lost to Follow-up|0|||
33588546|NCT02327169|62986864|FG008|Overall Study|Lost to Follow-up|0|||
33588547|NCT02327169|62986865|FG009|Overall Study|Lost to Follow-up|0|||
33588548|NCT02327169|62986866|FG010|Overall Study|Lost to Follow-up|0|||
33588549|NCT02327169|62986867|FG011|Overall Study|Lost to Follow-up|0|||
33588550|NCT02327169|62986868|FG012|Overall Study|Lost to Follow-up|0|||
33588551|NCT02327169|62986869|FG013|Overall Study|Lost to Follow-up|0|||
33588552|NCT02327169|62986870|FG014|Overall Study|Lost to Follow-up|0|||
33588553|NCT02327013|62986915|FG000|Overall Study|Adverse Event|4|||
33588554|NCT02327013|62986916|FG001|Overall Study|Adverse Event|4|||
33588555|NCT02327013|62986917|FG002|Overall Study|Adverse Event|3|||
33588556|NCT02327013|62986918|FG003|Overall Study|Adverse Event|0|||
33588557|NCT02327013|62986919|FG004|Overall Study|Adverse Event|1|||
33588558|NCT02327013|62986915|FG000|Overall Study|Lack of Efficacy|2|||
33588559|NCT02327013|62986916|FG001|Overall Study|Lack of Efficacy|0|||
33588560|NCT02327013|62986917|FG002|Overall Study|Lack of Efficacy|5|||
33588561|NCT02327013|62986918|FG003|Overall Study|Lack of Efficacy|0|||
33588562|NCT02327013|62986919|FG004|Overall Study|Lack of Efficacy|1|||
33588563|NCT02327013|62986915|FG000|Overall Study|Non-compliance with IMP|1|||
33588564|NCT02327013|62986916|FG001|Overall Study|Non-compliance with IMP|2|||
33588565|NCT02327013|62986917|FG002|Overall Study|Non-compliance with IMP|7|||
33588566|NCT02327013|62986918|FG003|Overall Study|Non-compliance with IMP|0|||
33588567|NCT02327013|62986919|FG004|Overall Study|Non-compliance with IMP|0|||
33680154|NCT01418378|63134180|FG000|Overall Study|ligament imbalance|0|||
33680155|NCT01418378|63134181|FG001|Overall Study|ligament imbalance|1|||
33588568|NCT02327013|62986915|FG000|Overall Study|Withdrawal of Consent|1|||
33588569|NCT02327013|62986916|FG001|Overall Study|Withdrawal of Consent|0|||
33588570|NCT02327013|62986917|FG002|Overall Study|Withdrawal of Consent|3|||
33588571|NCT02327013|62986918|FG003|Overall Study|Withdrawal of Consent|0|||
33588572|NCT02327013|62986919|FG004|Overall Study|Withdrawal of Consent|0|||
33588573|NCT02327013|62986915|FG000|Overall Study|Lost to Follow-up|2|||
33588574|NCT02327013|62986916|FG001|Overall Study|Lost to Follow-up|4|||
33588575|NCT02327013|62986917|FG002|Overall Study|Lost to Follow-up|5|||
33588576|NCT02327013|62986918|FG003|Overall Study|Lost to Follow-up|0|||
33588577|NCT02327013|62986919|FG004|Overall Study|Lost to Follow-up|0|||
33588578|NCT02327013|62986915|FG000|Overall Study|Administrative or other reason(s)|1|||
33588579|NCT02327013|62986916|FG001|Overall Study|Administrative or other reason(s)|5|||
33588580|NCT02327013|62986917|FG002|Overall Study|Administrative or other reason(s)|11|||
33588581|NCT02327013|62986918|FG003|Overall Study|Administrative or other reason(s)|1|||
33588582|NCT02327013|62986919|FG004|Overall Study|Administrative or other reason(s)|1|||
33588583|NCT02327013|62986915|FG000|Overall Study|Protocol Violation|0|||
33588584|NCT02327013|62986916|FG001|Overall Study|Protocol Violation|0|||
33588585|NCT02327013|62986917|FG002|Overall Study|Protocol Violation|3|||
33588586|NCT02327013|62986918|FG003|Overall Study|Protocol Violation|0|||
33588587|NCT02327013|62986919|FG004|Overall Study|Protocol Violation|1|||
33588588|NCT02327013|62986915|FG000|Overall Study|Withdrawal before treatment|2|||
33588589|NCT02327013|62986916|FG001|Overall Study|Withdrawal before treatment|1|||
33588590|NCT02327013|62986917|FG002|Overall Study|Withdrawal before treatment|5|||
33588591|NCT02327013|62986918|FG003|Overall Study|Withdrawal before treatment|0|||
33588592|NCT02327013|62986919|FG004|Overall Study|Withdrawal before treatment|0|||
33588593|NCT02301975|62986942|FG000|Overall Study|Adverse Event|8|||
33588594|NCT02301975|62986943|FG001|Overall Study|Adverse Event|3|||
33588595|NCT02301975|62986944|FG002|Overall Study|Adverse Event|2|||
33588596|NCT02301975|62986942|FG000|Overall Study|Lack of Efficacy|1|||
33588597|NCT02301975|62986943|FG001|Overall Study|Lack of Efficacy|1|||
33588598|NCT02301975|62986944|FG002|Overall Study|Lack of Efficacy|1|||
33588599|NCT02301975|62986942|FG000|Overall Study|Protocol Violation|3|||
33588600|NCT02301975|62986943|FG001|Overall Study|Protocol Violation|5|||
33588601|NCT02301975|62986944|FG002|Overall Study|Protocol Violation|3|||
33588602|NCT02301975|62986942|FG000|Overall Study|Lost to Follow-up|0|||
33588603|NCT02301975|62986943|FG001|Overall Study|Lost to Follow-up|2|||
33588604|NCT02301975|62986944|FG002|Overall Study|Lost to Follow-up|2|||
33588605|NCT02301975|62986942|FG000|Overall Study|Physician Decision|4|||
33588606|NCT02301975|62986943|FG001|Overall Study|Physician Decision|2|||
33588607|NCT02301975|62986944|FG002|Overall Study|Physician Decision|3|||
33588608|NCT02301975|62986942|FG000|Overall Study|Withdrawal by Subject|15|||
33588609|NCT02301975|62986943|FG001|Overall Study|Withdrawal by Subject|12|||
33588610|NCT02301975|62986944|FG002|Overall Study|Withdrawal by Subject|11|||
33588611|NCT02301897|62986955|FG000|Treatment Course 1|Non-Compliance|0|||
33588612|NCT02301897|62986956|FG001|Treatment Course 1|Non-Compliance|0|||
33588613|NCT02301897|62986957|FG002|Treatment Course 1|Non-Compliance|1|||
33588614|NCT02301897|62986955|FG000|Treatment Course 1|Adverse Event|1|||
33588615|NCT02301897|62986956|FG001|Treatment Course 1|Adverse Event|1|||
33588616|NCT02301897|62986957|FG002|Treatment Course 1|Adverse Event|0|||
33588617|NCT02301897|62986955|FG000|Treatment Course 1|Lost to Follow-up|1|||
33588618|NCT02301897|62986956|FG001|Treatment Course 1|Lost to Follow-up|2|||
33588619|NCT02301897|62986957|FG002|Treatment Course 1|Lost to Follow-up|1|||
33588620|NCT02301897|62986955|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
33588621|NCT02301897|62986956|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
33588622|NCT02301897|62986957|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
33588623|NCT02301897|62986955|FG000|Treatment Course 1|Withdrawal by Subject|0|||
33588624|NCT02301897|62986956|FG001|Treatment Course 1|Withdrawal by Subject|0|||
33588625|NCT02301897|62986957|FG002|Treatment Course 1|Withdrawal by Subject|2|||
33588626|NCT02301897|62986955|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
33588627|NCT02301897|62986956|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
33588628|NCT02301897|62986957|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
33588629|NCT02301897|62986955|FG000|Treatment Course 2|Lost to Follow-up|0|||
33588630|NCT02301897|62986956|FG001|Treatment Course 2|Lost to Follow-up|2|||
33588631|NCT02301897|62986957|FG002|Treatment Course 2|Lost to Follow-up|0|||
33588632|NCT02301897|62986955|FG000|Treatment Course 2|Pregnancy|0|||
33588633|NCT02301897|62986956|FG001|Treatment Course 2|Pregnancy|1|||
33588634|NCT02301897|62986957|FG002|Treatment Course 2|Pregnancy|1|||
33588635|NCT02301897|62986955|FG000|Treatment Course 2|Withdrawal by Subject|0|||
33588636|NCT02301897|62986956|FG001|Treatment Course 2|Withdrawal by Subject|2|||
33588637|NCT02301897|62986957|FG002|Treatment Course 2|Withdrawal by Subject|0|||
33588638|NCT02301897|62986955|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
33588639|NCT02301897|62986956|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
33588640|NCT02301897|62986957|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
33588641|NCT02301429|62986965|FG000|Overall Study|not acceptable vascular anatomy|3|||
33588642|NCT02300259|62986972|FG000|Period 1|Adverse Event|0|||
33588643|NCT02300259|62986973|FG001|Period 1|Adverse Event|0|||
33588644|NCT02300259|62986974|FG002|Period 1|Adverse Event|1|||
33588645|NCT02300259|62986972|FG000|Period 1|Withdrawal by Subject|0|||
33588646|NCT02300259|62986973|FG001|Period 1|Withdrawal by Subject|0|||
33588647|NCT02300259|62986974|FG002|Period 1|Withdrawal by Subject|1|||
33588648|NCT02300259|62986972|FG000|Period 2|Adverse Event|1|||
33588649|NCT02300259|62986973|FG001|Period 2|Adverse Event|0|||
33588650|NCT02300259|62986974|FG002|Period 2|Adverse Event|0|||
33588651|NCT02300259|62986972|FG000|Period 2|Withdrawal by Subject|0|||
33588652|NCT02300259|62986973|FG001|Period 2|Withdrawal by Subject|0|||
33588653|NCT02300259|62986974|FG002|Period 2|Withdrawal by Subject|1|||
33588654|NCT02367885|62986996|FG000|Overall Study|Lost to Follow-up|1|||
33588655|NCT02367885|62986997|FG001|Overall Study|Lost to Follow-up|0|||
33588656|NCT02367885|62986998|FG002|Overall Study|Lost to Follow-up|0|||
33588657|NCT02367885|62986996|FG000|Overall Study|Withdrawal by Subject|1|||
33588658|NCT02367885|62986997|FG001|Overall Study|Withdrawal by Subject|0|||
33588659|NCT02367885|62986998|FG002|Overall Study|Withdrawal by Subject|0|||
33588660|NCT02367729|62987011|FG000|Overall Study|Organic disorder diagnosed|2|||
33588661|NCT02367729|62987012|FG001|Overall Study|Organic disorder diagnosed|1|||
33588662|NCT02367729|62987011|FG000|Overall Study|Adverse Event|1|||
33588663|NCT02367729|62987012|FG001|Overall Study|Adverse Event|2|||
33588664|NCT02367729|62987011|FG000|Overall Study|Withdrawal by Subject|0|||
33588665|NCT02367729|62987012|FG001|Overall Study|Withdrawal by Subject|5|||
33588666|NCT02366637|62987019|FG000|First Intervention Period|Adverse Event|0|||
33588667|NCT02366637|62987020|FG001|First Intervention Period|Adverse Event|1|||
33588668|NCT02366637|62987019|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
33588669|NCT02366637|62987020|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
33588670|NCT02366637|62987019|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
33588671|NCT02366637|62987020|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
33588672|NCT02300103|62987026|FG000|Overall Study|Lack of Efficacy|3|||
33588673|NCT02300103|62987026|FG000|Overall Study|Protocol Violation|1|||
33588674|NCT02300103|62987026|FG000|Overall Study|Withdrew Consent|2|||
33588675|NCT02326467|62987030|FG000|Overall Study|Withdrawal by Subject|1|||
33588676|NCT02299635|62987035|FG000|Overall Study|Adverse Event|2|||
33588677|NCT02299635|62987035|FG000|Overall Study|Death|1|||
33588678|NCT02299635|62987035|FG000|Overall Study|Global deterioration of health status|1|||
33588679|NCT02299635|62987035|FG000|Overall Study|Objective progression or relapse|10|||
33588680|NCT02299635|62987035|FG000|Overall Study|Withdrawal by Subject|2|||
33588681|NCT02299635|62987035|FG000|Overall Study|Other|3|||
33588682|NCT02366091|62987043|FG000|Overall Study|Withdrawal by Subject|3|||
33588683|NCT02366091|62987044|FG001|Overall Study|Withdrawal by Subject|7|||
33588684|NCT02366091|62987045|FG002|Overall Study|Withdrawal by Subject|3|||
33588685|NCT02366091|62987046|FG003|Overall Study|Withdrawal by Subject|1|||
33588686|NCT02326155|62987058|FG000|Overall Study|Adverse Event|21|||
33588687|NCT02326155|62987059|FG001|Overall Study|Adverse Event|5|||
33588688|NCT02326155|62987058|FG000|Overall Study|Death|3|||
33588689|NCT02326155|62987059|FG001|Overall Study|Death|0|||
33588690|NCT02326155|62987058|FG000|Overall Study|Lack of Efficacy|49|||
33588691|NCT02326155|62987059|FG001|Overall Study|Lack of Efficacy|5|||
33588692|NCT02326155|62987058|FG000|Overall Study|Lost to Follow-up|14|||
33588693|NCT02326155|62987059|FG001|Overall Study|Lost to Follow-up|3|||
33588694|NCT02326155|62987058|FG000|Overall Study|Protocol Violation|2|||
33588695|NCT02326155|62987059|FG001|Overall Study|Protocol Violation|0|||
33588696|NCT02326155|62987058|FG000|Overall Study|Withdrawal by Subject|34|||
33588697|NCT02326155|62987059|FG001|Overall Study|Withdrawal by Subject|11|||
33588698|NCT02326155|62987058|FG000|Overall Study|Disease progression|37|||
33588699|NCT02326155|62987059|FG001|Overall Study|Disease progression|4|||
33588700|NCT02326155|62987058|FG000|Overall Study|Study close|188|||
33588701|NCT02326155|62987059|FG001|Overall Study|Study close|21|||
33588702|NCT02326155|62987058|FG000|Overall Study|except for study close|46|||
33588703|NCT02326155|62987059|FG001|Overall Study|except for study close|13|||
33588704|NCT02299167|62987065|FG000|Overall Study|patients were excluded from the study|11|||
33588705|NCT01647711|62987074|FG000|Overall Study|Progressive disease|6|||
33588706|NCT01647711|62987075|FG001|Overall Study|Progressive disease|2|||
33588707|NCT01647711|62987076|FG002|Overall Study|Progressive disease|6|||
33588708|NCT01647711|62987077|FG003|Overall Study|Progressive disease|8|||
33588709|NCT01647711|62987078|FG004|Overall Study|Progressive disease|2|||
33588710|NCT01647711|62987074|FG000|Overall Study|Other adverse event|0|||
33588711|NCT01647711|62987075|FG001|Overall Study|Other adverse event|0|||
33588712|NCT01647711|62987076|FG002|Overall Study|Other adverse event|2|||
33588713|NCT01647711|62987077|FG003|Overall Study|Other adverse event|0|||
33588714|NCT01647711|62987078|FG004|Overall Study|Other adverse event|2|||
33588715|NCT01647711|62987074|FG000|Overall Study|Protocol Violation|0|||
33588716|NCT01647711|62987075|FG001|Overall Study|Protocol Violation|0|||
33588717|NCT01647711|62987076|FG002|Overall Study|Protocol Violation|0|||
33588718|NCT01647711|62987077|FG003|Overall Study|Protocol Violation|0|||
33588719|NCT01647711|62987078|FG004|Overall Study|Protocol Violation|1|||
33588720|NCT01647711|62987074|FG000|Overall Study|Refused to continue taking medication|0|||
33588721|NCT01647711|62987075|FG001|Overall Study|Refused to continue taking medication|0|||
33588722|NCT01647711|62987076|FG002|Overall Study|Refused to continue taking medication|0|||
33588723|NCT01647711|62987077|FG003|Overall Study|Refused to continue taking medication|2|||
33588724|NCT01647711|62987078|FG004|Overall Study|Refused to continue taking medication|1|||
33588725|NCT01647711|62987074|FG000|Overall Study|Other reason not defined|0|||
33588726|NCT01647711|62987075|FG001|Overall Study|Other reason not defined|1|||
33588727|NCT01647711|62987076|FG002|Overall Study|Other reason not defined|1|||
33588728|NCT01647711|62987077|FG003|Overall Study|Other reason not defined|1|||
33588729|NCT01647711|62987078|FG004|Overall Study|Other reason not defined|0|||
33588730|NCT02547233|62987094|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
33588731|NCT02547233|62987095|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
33588732|NCT02547233|62987094|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
33588733|NCT02547233|62987095|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
33588734|NCT02547233|62987094|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
33588735|NCT02547233|62987095|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
33588736|NCT02547233|62987094|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
33588737|NCT02547233|62987095|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
33588738|NCT02547233|62987094|FG000|12-month Follow-up|Withdrawal by Subject|10|||
33588739|NCT02547233|62987095|FG001|12-month Follow-up|Withdrawal by Subject|10|||
33588740|NCT02547233|62987094|FG000|12-month Follow-up|Lost to Follow-up|3|||
33588741|NCT02547233|62987095|FG001|12-month Follow-up|Lost to Follow-up|3|||
33588742|NCT02547233|62987094|FG000|12-month Follow-up|Lack of Efficacy|1|||
33588743|NCT02547233|62987095|FG001|12-month Follow-up|Lack of Efficacy|2|||
33588744|NCT02547233|62987094|FG000|12-month Follow-up|Protocol Violation|0|||
33588745|NCT02547233|62987095|FG001|12-month Follow-up|Protocol Violation|1|||
33588746|NCT02547233|62987094|FG000|12-month Follow-up|Other|0|||
33588747|NCT02547233|62987095|FG001|12-month Follow-up|Other|1|||
33588748|NCT02546765|62987107|FG000|Overall Study|Withdrawal by Subject|0|||
33588749|NCT02546765|62987108|FG001|Overall Study|Withdrawal by Subject|1|||
33588750|NCT02546765|62987109|FG002|Overall Study|Withdrawal by Subject|0|||
33588751|NCT02546765|62987110|FG003|Overall Study|Withdrawal by Subject|0|||
33588752|NCT02553629|62987133|FG000|Overall Study|Logistic reasons|3|||
33588753|NCT02553629|62987134|FG001|Overall Study|Logistic reasons|6|||
33588754|NCT02546609|62987143|FG000|Overall Study|Withdrawal by Subject|0|||
33588755|NCT02546609|62987144|FG001|Overall Study|Withdrawal by Subject|1|||
33588756|NCT02546609|62987145|FG002|Overall Study|Withdrawal by Subject|2|||
33588757|NCT02546609|62987143|FG000|Overall Study|Adverse Event|0|||
33588758|NCT02546609|62987144|FG001|Overall Study|Adverse Event|6|||
33588759|NCT02546609|62987145|FG002|Overall Study|Adverse Event|1|||
33680156|NCT01418378|63134180|FG000|Overall Study|developed chronic myopathy|0|||
33680157|NCT01418378|63134181|FG001|Overall Study|developed chronic myopathy|1|||
33680158|NCT01435928|63134202|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
33680159|NCT01435928|63134203|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
33588760|NCT02546609|62987143|FG000|Overall Study|Protocol Violation|0|||
33588761|NCT02546609|62987144|FG001|Overall Study|Protocol Violation|1|||
33588762|NCT02546609|62987145|FG002|Overall Study|Protocol Violation|1|||
33588763|NCT02546609|62987143|FG000|Overall Study|Lost to Follow-up|2|||
33588764|NCT02546609|62987144|FG001|Overall Study|Lost to Follow-up|3|||
33588765|NCT02546609|62987145|FG002|Overall Study|Lost to Follow-up|1|||
33588766|NCT02546609|62987143|FG000|Overall Study|travel or work schedule restriction|0|||
33588767|NCT02546609|62987144|FG001|Overall Study|travel or work schedule restriction|0|||
33588768|NCT02546609|62987145|FG002|Overall Study|travel or work schedule restriction|2|||
33588769|NCT02553317|62987155|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
33588770|NCT02553317|62987156|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
33588771|NCT02553317|62987155|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
33588772|NCT02553317|62987156|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
33588773|NCT02553317|62987155|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
33588774|NCT02553317|62987156|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
33588775|NCT02553317|62987155|FG000|Overall Treatment Period + Follow-up|Death|1|||
33588776|NCT02553317|62987156|FG001|Overall Treatment Period + Follow-up|Death|3|||
33588777|NCT02553317|62987155|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
33588778|NCT02553317|62987156|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
33588779|NCT02553317|62987155|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
33588780|NCT02553317|62987156|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
33588781|NCT02553317|62987155|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
33588782|NCT02553317|62987156|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
33588783|NCT02553317|62987155|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
33588784|NCT02553317|62987156|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
33588785|NCT02553317|62987155|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
33588786|NCT02553317|62987156|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
33588787|NCT02553317|62987155|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
33588788|NCT02553317|62987156|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
33588789|NCT02325219|62987166|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
33588790|NCT02325219|62987167|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
33588791|NCT02325219|62987168|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
33588792|NCT02325219|62987169|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
33588793|NCT02325219|62987170|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
33588794|NCT02325219|62987166|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
33588795|NCT02325219|62987167|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
33588796|NCT02325219|62987168|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33588797|NCT02325219|62987169|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33588798|NCT02325219|62987170|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33588799|NCT02325219|62987166|FG000|Controlled Period (Week 0 - 16)|Other|0|||
33588800|NCT02325219|62987167|FG001|Controlled Period (Week 0 - 16)|Other|0|||
33588801|NCT02325219|62987168|FG002|Controlled Period (Week 0 - 16)|Other|1|||
33588802|NCT02325219|62987169|FG003|Controlled Period (Week 0 - 16)|Other|0|||
33588803|NCT02325219|62987170|FG004|Controlled Period (Week 0 - 16)|Other|0|||
33588804|NCT02325219|62987166|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
33588805|NCT02325219|62987167|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
33588806|NCT02325219|62987168|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
33588807|NCT02325219|62987169|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
33588808|NCT02325219|62987170|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
33588809|NCT02325219|62987166|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
33588810|NCT02325219|62987167|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
33588811|NCT02325219|62987168|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
33588812|NCT02325219|62987169|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
33588813|NCT02325219|62987170|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
33588814|NCT02325219|62987166|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
33588815|NCT02325219|62987167|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
33588816|NCT02325219|62987168|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
33588817|NCT02325219|62987169|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
33588818|NCT02325219|62987170|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
33588819|NCT02297841|62987186|FG000|Overall Study|Withdrawal by Subject|1|||
33588820|NCT02297841|62987186|FG000|Overall Study|Protocol Violation|7|||
33588821|NCT02324361|62987192|FG000|Overall Study|Lost to Follow-up|5|||
33588822|NCT02324361|62987193|FG001|Overall Study|Lost to Follow-up|2|||
33588823|NCT02365233|62987202|FG000|Overall Study|IRB withheld the data|1|||
33588824|NCT02365233|62987203|FG001|Overall Study|IRB withheld the data|2|||
33588825|NCT02365233|62987204|FG002|Overall Study|IRB withheld the data|2|||
33588826|NCT02324205|62987212|FG000|Overall Study|Withdrawal by Subject|37|||
33588827|NCT02324049|62987216|FG000|Part C|Study terminated|11|||
33588828|NCT02364999|62987222|FG000|Overall Study|Death|136|||
33588829|NCT02364999|62987223|FG001|Overall Study|Death|138|||
33588830|NCT02364999|62987222|FG000|Overall Study|Lost to Follow-up|10|||
33588831|NCT02364999|62987223|FG001|Overall Study|Lost to Follow-up|15|||
33588832|NCT02364999|62987222|FG000|Overall Study|Protocol Violation|3|||
33588833|NCT02364999|62987223|FG001|Overall Study|Protocol Violation|2|||
33588834|NCT02364999|62987222|FG000|Overall Study|Withdrawal by Subject|14|||
33588835|NCT02364999|62987223|FG001|Overall Study|Withdrawal by Subject|14|||
33588836|NCT02364999|62987222|FG000|Overall Study|Other|0|||
33588837|NCT02364999|62987223|FG001|Overall Study|Other|1|||
33588838|NCT02364999|62987222|FG000|Overall Study|Randomized but did not receive treatment|2|||
33588839|NCT02364999|62987223|FG001|Overall Study|Randomized but did not receive treatment|3|||
33588840|NCT02322879|62987232|FG000|First Intervention|Physician Decision|1|||
33588841|NCT02322879|62987233|FG001|First Intervention|Physician Decision|0|||
33588842|NCT02322411|62987241|FG000|Overall Study|Lost to Follow-up|4|||
33588843|NCT02322411|62987242|FG001|Overall Study|Lost to Follow-up|7|||
33588844|NCT02322411|62987241|FG000|Overall Study|Withdrawal by Subject|1|||
33588845|NCT02322411|62987242|FG001|Overall Study|Withdrawal by Subject|0|||
33588846|NCT02322021|62987252|FG000|Core Phase|Adverse Event|1|||
33588847|NCT02322021|62987253|FG001|Core Phase|Adverse Event|3|||
33588848|NCT02322021|62987254|FG002|Core Phase|Adverse Event|4|||
33588849|NCT02322021|62987255|FG003|Core Phase|Adverse Event|2|||
33588850|NCT02322021|62987256|FG004|Core Phase|Adverse Event|0|||
33588851|NCT02322021|62987252|FG000|Core Phase|Participant Choice|4|||
33588852|NCT02322021|62987253|FG001|Core Phase|Participant Choice|5|||
33588853|NCT02322021|62987254|FG002|Core Phase|Participant Choice|4|||
33588854|NCT02322021|62987255|FG003|Core Phase|Participant Choice|2|||
33588855|NCT02322021|62987256|FG004|Core Phase|Participant Choice|0|||
33588856|NCT02322021|62987252|FG000|Core Phase|Lost to Follow-up|0|||
33588857|NCT02322021|62987253|FG001|Core Phase|Lost to Follow-up|0|||
33588858|NCT02322021|62987254|FG002|Core Phase|Lost to Follow-up|0|||
33588859|NCT02322021|62987255|FG003|Core Phase|Lost to Follow-up|1|||
33588860|NCT02322021|62987256|FG004|Core Phase|Lost to Follow-up|0|||
33588861|NCT02322021|62987252|FG000|Core Phase|Other|0|||
33588862|NCT02322021|62987253|FG001|Core Phase|Other|0|||
33588863|NCT02322021|62987254|FG002|Core Phase|Other|1|||
33588864|NCT02322021|62987255|FG003|Core Phase|Other|0|||
33588865|NCT02322021|62987256|FG004|Core Phase|Other|0|||
33588866|NCT02322021|62987252|FG000|Extension Phase|Adverse Event|0|||
33588867|NCT02322021|62987253|FG001|Extension Phase|Adverse Event|0|||
33588868|NCT02322021|62987254|FG002|Extension Phase|Adverse Event|0|||
33588869|NCT02322021|62987255|FG003|Extension Phase|Adverse Event|0|||
33588870|NCT02322021|62987256|FG004|Extension Phase|Adverse Event|3|||
33588871|NCT02322021|62987252|FG000|Extension Phase|Participant Choice|0|||
33588872|NCT02322021|62987253|FG001|Extension Phase|Participant Choice|0|||
33588873|NCT02322021|62987254|FG002|Extension Phase|Participant Choice|0|||
33588874|NCT02322021|62987255|FG003|Extension Phase|Participant Choice|0|||
33588875|NCT02322021|62987256|FG004|Extension Phase|Participant Choice|6|||
33588876|NCT02322021|62987252|FG000|Extension Phase|Other|0|||
33588877|NCT02322021|62987253|FG001|Extension Phase|Other|0|||
33588878|NCT02322021|62987254|FG002|Extension Phase|Other|0|||
33588879|NCT02322021|62987255|FG003|Extension Phase|Other|0|||
33588880|NCT02322021|62987256|FG004|Extension Phase|Other|3|||
33588881|NCT02322021|62987252|FG000|Extension Phase|Lost to Follow-up|0|||
33588882|NCT02322021|62987253|FG001|Extension Phase|Lost to Follow-up|0|||
33588883|NCT02322021|62987254|FG002|Extension Phase|Lost to Follow-up|0|||
33588884|NCT02322021|62987255|FG003|Extension Phase|Lost to Follow-up|0|||
33588885|NCT02322021|62987256|FG004|Extension Phase|Lost to Follow-up|1|||
33588886|NCT02322021|62987252|FG000|Extension Phase|Study terminated by sponsor|0|||
33588887|NCT02322021|62987253|FG001|Extension Phase|Study terminated by sponsor|0|||
33588888|NCT02322021|62987254|FG002|Extension Phase|Study terminated by sponsor|0|||
33588889|NCT02322021|62987255|FG003|Extension Phase|Study terminated by sponsor|0|||
33588890|NCT02322021|62987256|FG004|Extension Phase|Study terminated by sponsor|28|||
33588891|NCT02363439|62987271|FG000|Overall Study|Lack of Efficacy|4|||
33588892|NCT02363283|62987275|FG000|Overall Study|Withdrawal by Subject|1|||
33588893|NCT02363283|62987275|FG000|Overall Study|Not eligible due to transaminitis|1|||
33588894|NCT02321319|62987279|FG000|Overall Study|Product discontinued|5|||
33588895|NCT02294175|62987285|FG000|Overall Study|Withdrawal by Subject|1|||
33588896|NCT02294175|62987286|FG001|Overall Study|Withdrawal by Subject|2|||
33588897|NCT02294175|62987285|FG000|Overall Study|pt taking excluded medication|3|||
33588898|NCT02294175|62987286|FG001|Overall Study|pt taking excluded medication|1|||
33588899|NCT02294175|62987285|FG000|Overall Study|Protocol Violation|1|||
33588900|NCT02294175|62987286|FG001|Overall Study|Protocol Violation|0|||
33588901|NCT02294175|62987285|FG000|Overall Study|Lost to Follow-up|0|||
33588902|NCT02294175|62987286|FG001|Overall Study|Lost to Follow-up|1|||
33588903|NCT02294175|62987285|FG000|Overall Study|wound healed|0|||
33588904|NCT02294175|62987286|FG001|Overall Study|wound healed|2|||
33588905|NCT02088541|62987297|FG000|Overall Study|Adverse Event|3|||
33588906|NCT02088541|62987298|FG001|Overall Study|Adverse Event|0|||
33680160|NCT01435928|63134204|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
33680161|NCT01435928|63134202|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
33680162|NCT01435928|63134203|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
33680163|NCT01435928|63134204|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
33588907|NCT02088541|62987299|FG002|Overall Study|Adverse Event|3|||
33588908|NCT02088541|62987300|FG003|Overall Study|Adverse Event|3|||
33588909|NCT02088541|62987301|FG004|Overall Study|Adverse Event|0|||
33680164|NCT01435928|63134202|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
33680165|NCT01435928|63134203|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
33680166|NCT01435928|63134204|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
33680167|NCT01435928|63134202|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
33680168|NCT01435928|63134203|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
33680169|NCT01435928|63134204|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
33680170|NCT01435928|63134202|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
33588910|NCT02088541|62987297|FG000|Overall Study|Death|51|||
33588911|NCT02088541|62987298|FG001|Overall Study|Death|21|||
33588912|NCT02088541|62987299|FG002|Overall Study|Death|85|||
33680171|NCT01435928|63134203|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
33588913|NCT02088541|62987300|FG003|Overall Study|Death|28|||
33588914|NCT02088541|62987301|FG004|Overall Study|Death|38|||
33588915|NCT02088541|62987297|FG000|Overall Study|Lost to Follow-up|2|||
33588916|NCT02088541|62987298|FG001|Overall Study|Lost to Follow-up|0|||
33588917|NCT02088541|62987299|FG002|Overall Study|Lost to Follow-up|1|||
33588918|NCT02088541|62987300|FG003|Overall Study|Lost to Follow-up|0|||
33588919|NCT02088541|62987301|FG004|Overall Study|Lost to Follow-up|0|||
33588920|NCT02088541|62987297|FG000|Overall Study|Physician Decision|2|||
33588921|NCT02088541|62987298|FG001|Overall Study|Physician Decision|1|||
33588922|NCT02088541|62987299|FG002|Overall Study|Physician Decision|2|||
33588923|NCT02088541|62987300|FG003|Overall Study|Physician Decision|0|||
33588924|NCT02088541|62987301|FG004|Overall Study|Physician Decision|2|||
33588925|NCT02088541|62987297|FG000|Overall Study|Disease progression|7|||
33588926|NCT02088541|62987298|FG001|Overall Study|Disease progression|1|||
33588927|NCT02088541|62987299|FG002|Overall Study|Disease progression|2|||
33588928|NCT02088541|62987300|FG003|Overall Study|Disease progression|3|||
33588929|NCT02088541|62987301|FG004|Overall Study|Disease progression|1|||
33588930|NCT02088541|62987297|FG000|Overall Study|Study terminated by sponsor|1|||
33588931|NCT02088541|62987298|FG001|Overall Study|Study terminated by sponsor|1|||
33588932|NCT02088541|62987299|FG002|Overall Study|Study terminated by sponsor|12|||
33588933|NCT02088541|62987300|FG003|Overall Study|Study terminated by sponsor|2|||
33588934|NCT02088541|62987301|FG004|Overall Study|Study terminated by sponsor|6|||
33588935|NCT02088541|62987297|FG000|Overall Study|Withdrawal by Subject|3|||
33588936|NCT02088541|62987298|FG001|Overall Study|Withdrawal by Subject|2|||
33588937|NCT02088541|62987299|FG002|Overall Study|Withdrawal by Subject|9|||
33588938|NCT02088541|62987300|FG003|Overall Study|Withdrawal by Subject|7|||
33588939|NCT02088541|62987301|FG004|Overall Study|Withdrawal by Subject|10|||
33588940|NCT02088541|62987297|FG000|Overall Study|Other|2|||
33588941|NCT02088541|62987298|FG001|Overall Study|Other|1|||
33588942|NCT02088541|62987299|FG002|Overall Study|Other|3|||
33680172|NCT01435928|63134204|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
33680173|NCT01435928|63134202|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
33680174|NCT01435928|63134203|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
33680175|NCT01435928|63134204|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
33680176|NCT01435928|63134202|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
33680177|NCT01435928|63134203|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
33680178|NCT01435928|63134204|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
33680179|NCT01435928|63134202|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
33680180|NCT01435928|63134203|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
33680181|NCT01435928|63134204|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
33680182|NCT01435928|63134202|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
33680183|NCT01435928|63134203|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
33680184|NCT01435928|63134204|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
33680185|NCT01435928|63134202|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
33680186|NCT01435928|63134203|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
33680187|NCT01435928|63134204|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
33680188|NCT01435928|63134202|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
33680189|NCT01435928|63134203|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
33680190|NCT01435928|63134204|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
33680191|NCT01435928|63134202|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
33680192|NCT01435928|63134203|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
33680193|NCT01435928|63134204|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
33680194|NCT01435928|63134202|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
33680195|NCT01435928|63134203|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
33680196|NCT01435928|63134204|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
33680197|NCT01435928|63134202|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
33680198|NCT01435928|63134203|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
33680199|NCT01435928|63134204|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
33680200|NCT01435928|63134202|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
33680201|NCT01435928|63134203|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
33680202|NCT01435928|63134204|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
33680203|NCT01435928|63134202|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
33680204|NCT01435928|63134203|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
33680205|NCT01435928|63134204|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
33588943|NCT02088541|62987300|FG003|Overall Study|Other|1|||
33588944|NCT02088541|62987301|FG004|Overall Study|Other|1|||
33588945|NCT02294019|62987311|FG000|Overall Study|Adverse Event|2|||
33588946|NCT02294019|62987311|FG000|Overall Study|Protocol Violation|68|||
33588947|NCT02294019|62987311|FG000|Overall Study|Lost to Follow-up|31|||
33588948|NCT02294019|62987311|FG000|Overall Study|Other|1|||
33588949|NCT02294019|62987311|FG000|Overall Study|Withdrawal by Subject|1|||
33588950|NCT02320149|62987317|FG000|Overall Study|Adverse Event|3|||
33588951|NCT02320149|62987318|FG001|Overall Study|Adverse Event|7|||
33588952|NCT02320149|62987317|FG000|Overall Study|Withdrawal of Consent|28|||
33588953|NCT02320149|62987318|FG001|Overall Study|Withdrawal of Consent|32|||
33588954|NCT02320149|62987317|FG000|Overall Study|Lost to Follow-up|21|||
33588955|NCT02320149|62987318|FG001|Overall Study|Lost to Follow-up|34|||
33588956|NCT02320149|62987317|FG000|Overall Study|Protocol Violation|2|||
33588957|NCT02320149|62987318|FG001|Overall Study|Protocol Violation|1|||
33588958|NCT02320149|62987317|FG000|Overall Study|Noncompliance with Study Treatment|7|||
33588959|NCT02320149|62987318|FG001|Overall Study|Noncompliance with Study Treatment|2|||
33588960|NCT02320149|62987317|FG000|Overall Study|Lack of Efficacy|0|||
33588961|NCT02320149|62987318|FG001|Overall Study|Lack of Efficacy|1|||
33588962|NCT02320149|62987317|FG000|Overall Study|Other Miscellaneous Reasons|2|||
33588963|NCT02320149|62987318|FG001|Overall Study|Other Miscellaneous Reasons|3|||
33588964|NCT02540083|62987324|FG000|Overall Study|Withdrawal by Subject|16|||
33588965|NCT02293863|62987331|FG000|Overall Study|Death|4|||
33588966|NCT02293863|62987332|FG001|Overall Study|Death|6|||
33588967|NCT02293863|62987333|FG002|Overall Study|Death|4|||
33588968|NCT02293863|62987331|FG000|Overall Study|Lost to Follow-up|2|||
33588969|NCT02293863|62987332|FG001|Overall Study|Lost to Follow-up|2|||
33588970|NCT02293863|62987333|FG002|Overall Study|Lost to Follow-up|2|||
33588971|NCT02293863|62987331|FG000|Overall Study|Withdrawal by Subject|3|||
33588972|NCT02293863|62987332|FG001|Overall Study|Withdrawal by Subject|3|||
33588973|NCT02293863|62987333|FG002|Overall Study|Withdrawal by Subject|1|||
33588974|NCT02293863|62987331|FG000|Overall Study|Reason Not Specified|0|||
33588975|NCT02293863|62987332|FG001|Overall Study|Reason Not Specified|2|||
33588976|NCT02293863|62987333|FG002|Overall Study|Reason Not Specified|2|||
33588977|NCT02293395|62987345|FG000|Overall Study|Lost to Follow-up|1|||
33588978|NCT02293395|62987346|FG001|Overall Study|Lost to Follow-up|0|||
33588979|NCT02293395|62987345|FG000|Overall Study|Withdrawal by Subject|8|||
33588980|NCT02293395|62987346|FG001|Overall Study|Withdrawal by Subject|7|||
33588981|NCT02025985|62987357|FG000|Overall Study|Consent withdrawn|0|||
33588982|NCT02025985|62987358|FG001|Overall Study|Consent withdrawn|0|||
33588983|NCT02025985|62987359|FG002|Overall Study|Consent withdrawn|1|||
33588984|NCT02025985|62987360|FG003|Overall Study|Consent withdrawn|0|||
33588985|NCT02025985|62987361|FG004|Overall Study|Consent withdrawn|0|||
33588986|NCT02025985|62987357|FG000|Overall Study|Termination of study by Sponsor|4|||
33588987|NCT02025985|62987358|FG001|Overall Study|Termination of study by Sponsor|3|||
33588988|NCT02025985|62987359|FG002|Overall Study|Termination of study by Sponsor|1|||
33588989|NCT02025985|62987360|FG003|Overall Study|Termination of study by Sponsor|1|||
33588990|NCT02025985|62987361|FG004|Overall Study|Termination of study by Sponsor|3|||
33588991|NCT02025985|62987357|FG000|Overall Study|Death|21|||
33588992|NCT02025985|62987358|FG001|Overall Study|Death|20|||
33588993|NCT02025985|62987359|FG002|Overall Study|Death|23|||
33588994|NCT02025985|62987360|FG003|Overall Study|Death|20|||
33588995|NCT02025985|62987361|FG004|Overall Study|Death|17|||
33588996|NCT02528305|62987375|FG000|Overall Study|Withdrawal by Subject|1|||
33588997|NCT02528305|62987375|FG000|Overall Study|Adverse Event|1|||
33588998|NCT02528305|62987375|FG000|Overall Study|Physician Decision|1|||
33588999|NCT02532517|62987381|FG000|Overall Study|Did not complete 24-Month visit|4|||
33589000|NCT02532517|62987381|FG000|Overall Study|Failed Angiographic eligibility|1|||
33589001|NCT02532517|62987381|FG000|Overall Study|Lost to Follow-up|4|||
33589002|NCT02532517|62987381|FG000|Overall Study|Withdrawal by Subject|4|||
33589003|NCT02532517|62987381|FG000|Overall Study|Death|4|||
33589004|NCT02545049|62987387|FG000|Overall Study|Withdrawal by Subject|1|||
33589005|NCT02545049|62987388|FG001|Overall Study|Withdrawal by Subject|7|||
33589006|NCT02545049|62987387|FG000|Overall Study|Lost to Follow-up|4|||
33589007|NCT02545049|62987388|FG001|Overall Study|Lost to Follow-up|6|||
33589008|NCT02545049|62987387|FG000|Overall Study|GCP violations|37|||
33589009|NCT02545049|62987388|FG001|Overall Study|GCP violations|48|||
33589010|NCT02532283|62987396|FG000|Overall Study|Adverse Event|0|||
33589011|NCT02532283|62987397|FG001|Overall Study|Adverse Event|1|||
33589012|NCT02532283|62987396|FG000|Overall Study|Death|1|||
33589013|NCT02532283|62987397|FG001|Overall Study|Death|0|||
33589014|NCT02532283|62987396|FG000|Overall Study|Lost to Follow-up|0|||
33589015|NCT02532283|62987397|FG001|Overall Study|Lost to Follow-up|1|||
33589016|NCT02532283|62987396|FG000|Overall Study|Withdrawal by Subject|8|||
33589017|NCT02532283|62987397|FG001|Overall Study|Withdrawal by Subject|3|||
33589018|NCT01349959|62987418|FG000|Overall Study|Adverse Event|7|||
33589019|NCT01295125|62987422|FG000|Overall Study|Study stopped prematurely|9|||
33589020|NCT02540291|62987430|FG000|Overall Study|Death|7|||
33589021|NCT02540291|62987431|FG001|Overall Study|Death|7|||
33589022|NCT02540291|62987432|FG002|Overall Study|Death|5|||
33310721|NCT01162473|62686120|FG000|Overall Study|Adverse Event|2|||
33589023|NCT02540291|62987433|FG003|Overall Study|Death|7|||
33589024|NCT02540291|62987430|FG000|Overall Study|Lost to Follow-up|0|||
33589025|NCT02540291|62987431|FG001|Overall Study|Lost to Follow-up|0|||
33589026|NCT02540291|62987432|FG002|Overall Study|Lost to Follow-up|1|||
33589027|NCT02540291|62987433|FG003|Overall Study|Lost to Follow-up|0|||
33589028|NCT02540291|62987430|FG000|Overall Study|Withdrawal Of Consent|0|||
33589029|NCT02540291|62987431|FG001|Overall Study|Withdrawal Of Consent|1|||
33589030|NCT02540291|62987432|FG002|Overall Study|Withdrawal Of Consent|0|||
33589031|NCT02540291|62987433|FG003|Overall Study|Withdrawal Of Consent|0|||
33589032|NCT02540291|62987430|FG000|Overall Study|Study Terminated By Sponsor|1|||
33589033|NCT02540291|62987431|FG001|Overall Study|Study Terminated By Sponsor|0|||
33589034|NCT02540291|62987432|FG002|Overall Study|Study Terminated By Sponsor|0|||
33589035|NCT02540291|62987433|FG003|Overall Study|Study Terminated By Sponsor|0|||
33589036|NCT02540291|62987430|FG000|Overall Study|Other|0|||
33589037|NCT02540291|62987431|FG001|Overall Study|Other|0|||
33589038|NCT02540291|62987432|FG002|Overall Study|Other|1|||
33589039|NCT02540291|62987433|FG003|Overall Study|Other|0|||
33589040|NCT02540213|62987445|FG000|Overall Study|Death/adverse event|18|||
33589041|NCT02540213|62987445|FG000|Overall Study|Administrative reasons|3|||
33589042|NCT02540213|62987445|FG000|Overall Study|Kidney transplant|3|||
33589043|NCT02540213|62987445|FG000|Overall Study|Lack of Efficacy|6|||
33589044|NCT02540213|62987445|FG000|Overall Study|Consent withdrawn|7|||
33589045|NCT02540213|62987445|FG000|Overall Study|Enrolled but not treated|2|||
33589046|NCT02552303|62987453|FG000|Allocation|Withdrawal by Subject|2|||
33589047|NCT02552303|62987454|FG001|Allocation|Withdrawal by Subject|1|||
33589048|NCT02552303|62987455|FG002|Allocation|Withdrawal by Subject|1|||
33589049|NCT02552303|62987456|FG003|Allocation|Withdrawal by Subject|1|||
33589050|NCT02552303|62987453|FG000|Allocation|ineligible|1|||
33589051|NCT02552303|62987454|FG001|Allocation|ineligible|1|||
33589052|NCT02552303|62987455|FG002|Allocation|ineligible|0|||
33589053|NCT02552303|62987456|FG003|Allocation|ineligible|0|||
33589054|NCT02552303|62987453|FG000|Follow-Up|Lost to Follow-up|0|||
33589055|NCT02552303|62987454|FG001|Follow-Up|Lost to Follow-up|0|||
33589056|NCT02552303|62987455|FG002|Follow-Up|Lost to Follow-up|1|||
33589057|NCT02552303|62987456|FG003|Follow-Up|Lost to Follow-up|0|||
33589058|NCT02552303|62987453|FG000|Follow-Up|ineligible|0|||
33589059|NCT02552303|62987454|FG001|Follow-Up|ineligible|2|||
33589060|NCT02552303|62987455|FG002|Follow-Up|ineligible|0|||
33589061|NCT02552303|62987456|FG003|Follow-Up|ineligible|0|||
33589062|NCT01660711|62987466|FG000|Overall Study|Adverse Event|7|||
33589063|NCT01660711|62987466|FG000|Overall Study|Withdrawal by Subject|1|||
33589064|NCT02544113|62987472|FG000|Overall Study|Death|3|||
33589065|NCT02544113|62987473|FG001|Overall Study|Death|4|||
33589066|NCT02538965|62987479|FG000|Treatment Period|Other = Death due to disease progression|1|||
33589067|NCT02538965|62987479|FG000|Treatment Period|Adverse Event|2|||
33589068|NCT02538965|62987479|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
33589069|NCT02538965|62987479|FG000|Treatment Period|Treatment Failure|9|||
33589070|NCT02538965|62987479|FG000|Treatment Period|Disease Progression|1|||
33589071|NCT02538965|62987479|FG000|Treatment Period|Physician Decision|2|||
33589072|NCT02538965|62987479|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
33589073|NCT02538965|62987479|FG000|Follow-Up Period|Withdrawal by Parent|4|||
33589074|NCT02543801|62987487|FG000|Overall Study|Protocol Violation|1|||
33589075|NCT02543801|62987488|FG001|Overall Study|Protocol Violation|2|||
33589076|NCT02543801|62987489|FG002|Overall Study|Protocol Violation|0|||
33589077|NCT02543801|62987490|FG003|Overall Study|Protocol Violation|0|||
33589078|NCT02470091|62987502|FG000|Overall Study|Withdrawal by Subject|1|||
33589079|NCT02470091|62987503|FG001|Overall Study|Withdrawal by Subject|0|||
33589080|NCT02470091|62987502|FG000|Overall Study|Ineligible|0|||
33589081|NCT02470091|62987503|FG001|Overall Study|Ineligible|2|||
33589082|NCT02362503|62987514|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
33589083|NCT02362503|62987515|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
33589084|NCT02362503|62987516|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
33589085|NCT02362503|62987514|FG000|Double-blind Period-Up to 8 Days|Death|1|||
33589086|NCT02362503|62987515|FG001|Double-blind Period-Up to 8 Days|Death|0|||
33589087|NCT02362503|62987516|FG002|Double-blind Period-Up to 8 Days|Death|0|||
33589088|NCT02362503|62987514|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
33589089|NCT02362503|62987515|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
33589090|NCT02362503|62987516|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
33589091|NCT02362503|62987514|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
33589092|NCT02362503|62987515|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
33589093|NCT02362503|62987516|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
33589094|NCT02362503|62987514|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
33589095|NCT02362503|62987515|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
33589096|NCT02362503|62987516|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
33589097|NCT02362503|62987514|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
33589098|NCT02362503|62987515|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
33589099|NCT02362503|62987516|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
33589100|NCT02362503|62987514|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
33589101|NCT02362503|62987515|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
33589102|NCT02362503|62987516|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
33589103|NCT02362503|62987514|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
33589104|NCT02362503|62987515|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
33589105|NCT02362503|62987516|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
33589106|NCT02362503|62987514|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
33589107|NCT02362503|62987515|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
33589108|NCT02362503|62987516|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
33589109|NCT02362503|62987514|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
33589110|NCT02362503|62987515|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
33589111|NCT02362503|62987516|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
33589112|NCT02362503|62987514|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
33589113|NCT02362503|62987515|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
33589114|NCT02362503|62987516|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
33589115|NCT02362503|62987514|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
33589116|NCT02362503|62987515|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
33589117|NCT02362503|62987516|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
33589118|NCT02362503|62987514|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
33589119|NCT02362503|62987515|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
33589120|NCT02362503|62987516|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
33589121|NCT02362503|62987514|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
33589122|NCT02362503|62987515|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
33589123|NCT02362503|62987516|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
33589124|NCT02535065|62987527|FG000|Overall Study|Death|13|||
33589125|NCT02535065|62987527|FG000|Overall Study|Lost to Follow-up|1|||
33589126|NCT02535065|62987527|FG000|Overall Study|Withdrawal by Subject|6|||
33589127|NCT02530619|62987531|FG000|Registered for Study|Withdrawal by Subject|2|||
33589128|NCT02530619|62987531|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
33589129|NCT02530619|62987531|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
33589130|NCT02530619|62987531|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
33589131|NCT02530619|62987531|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
33589132|NCT02530619|62987531|FG000|Follow-up Period (6 Months)|Death|4|||
33589133|NCT02530619|62987531|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
33589134|NCT02530619|62987531|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
33589135|NCT02530385|62987537|FG000|Overall Study|Withdrawal by Subject|0|||
33589136|NCT02530385|62987538|FG001|Overall Study|Withdrawal by Subject|1|||
33589137|NCT02362425|62987548|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
33589138|NCT02362425|62987549|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
33589139|NCT02362425|62987550|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
33589140|NCT02362425|62987551|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
33589141|NCT02362425|62987548|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
33589142|NCT02362425|62987549|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
33589143|NCT02362425|62987550|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
33589144|NCT02362425|62987551|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
33589145|NCT02362425|62987548|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
33589146|NCT02362425|62987549|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
33589147|NCT02362425|62987550|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
33589148|NCT02362425|62987551|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
33589149|NCT02362425|62987548|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
33589150|NCT02362425|62987549|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
33589151|NCT02362425|62987550|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
33589152|NCT02362425|62987551|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
33589153|NCT02362425|62987548|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
33589154|NCT02362425|62987549|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
33589155|NCT02362425|62987550|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
33589156|NCT02362425|62987551|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
33589157|NCT02362425|62987548|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
33589158|NCT02362425|62987549|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
33589159|NCT02362425|62987550|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
33589160|NCT02362425|62987551|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
33589161|NCT02362425|62987548|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
33589162|NCT02362425|62987549|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
33589163|NCT02362425|62987550|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
33589164|NCT02362425|62987551|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
33589165|NCT02362425|62987548|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
33589166|NCT02362425|62987549|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
33589167|NCT02362425|62987550|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
33589168|NCT02362425|62987551|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
33589169|NCT02362269|62987564|FG000|Overall Study|Moved|1|||
33589170|NCT02362269|62987565|FG001|Overall Study|Moved|0|||
33589171|NCT02362269|62987564|FG000|Overall Study|Lost to Follow-up|0|||
33589172|NCT02362269|62987565|FG001|Overall Study|Lost to Follow-up|6|||
33589173|NCT02529995|62987573|FG000|Part A|Ongoing Study at Data Cut-off|14|||
33589174|NCT02529995|62987574|FG001|Part A|Ongoing Study at Data Cut-off|16|||
33589175|NCT02529995|62987573|FG000|Part A|Discontinued Study|1|||
33589176|NCT02529995|62987574|FG001|Part A|Discontinued Study|0|||
33589177|NCT02529995|62987573|FG000|Part B|Ongoing Study at Data Cut-off|0|||
33589178|NCT02529995|62987574|FG001|Part B|Ongoing Study at Data Cut-off|7|||
33589179|NCT02529995|62987573|FG000|Part B|Discontinued Study|6|||
33589180|NCT02529995|62987574|FG001|Part B|Discontinued Study|5|||
33589181|NCT02529137|62987580|FG000|Overall Study|Discontinuation for different reasons|8|||
33589182|NCT02319759|62987587|FG000|Week 0 - 16|Lack of Efficacy|1|||
33589183|NCT02319759|62987588|FG001|Week 0 - 16|Lack of Efficacy|0|||
33589184|NCT02319759|62987589|FG002|Week 0 - 16|Lack of Efficacy|0|||
33589185|NCT02319759|62987590|FG003|Week 0 - 16|Lack of Efficacy|0|||
33589186|NCT02319759|62987591|FG004|Week 0 - 16|Lack of Efficacy|0|||
33589187|NCT02319759|62987587|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
33589188|NCT02319759|62987588|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
33589189|NCT02319759|62987589|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
33589190|NCT02319759|62987590|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
33589191|NCT02319759|62987591|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
33589192|NCT02319759|62987587|FG000|Week 16 - 24|Lack of Efficacy|1|||
33589193|NCT02319759|62987588|FG001|Week 16 - 24|Lack of Efficacy|0|||
33589194|NCT02319759|62987589|FG002|Week 16 - 24|Lack of Efficacy|1|||
33589195|NCT02319759|62987590|FG003|Week 16 - 24|Lack of Efficacy|0|||
33589196|NCT02319759|62987591|FG004|Week 16 - 24|Lack of Efficacy|0|||
33589197|NCT02319759|62987587|FG000|Week 16 - 24|Lost to Follow-up|1|||
33589198|NCT02319759|62987588|FG001|Week 16 - 24|Lost to Follow-up|0|||
33589199|NCT02319759|62987589|FG002|Week 16 - 24|Lost to Follow-up|0|||
33589200|NCT02319759|62987590|FG003|Week 16 - 24|Lost to Follow-up|0|||
33589201|NCT02319759|62987591|FG004|Week 16 - 24|Lost to Follow-up|0|||
33589202|NCT02319759|62987587|FG000|Week 16 - 24|Withdrawal by Subject|0|||
33589203|NCT02319759|62987588|FG001|Week 16 - 24|Withdrawal by Subject|0|||
33589204|NCT02319759|62987589|FG002|Week 16 - 24|Withdrawal by Subject|2|||
33589205|NCT02319759|62987590|FG003|Week 16 - 24|Withdrawal by Subject|0|||
33589206|NCT02319759|62987591|FG004|Week 16 - 24|Withdrawal by Subject|0|||
33589207|NCT02319759|62987587|FG000|Week 24 - 56|Adverse Event|0|||
33589208|NCT02319759|62987588|FG001|Week 24 - 56|Adverse Event|0|||
33589209|NCT02319759|62987589|FG002|Week 24 - 56|Adverse Event|2|||
33589210|NCT02319759|62987590|FG003|Week 24 - 56|Adverse Event|0|||
33589211|NCT02319759|62987591|FG004|Week 24 - 56|Adverse Event|0|||
33589212|NCT02319759|62987587|FG000|Week 24 - 56|Lack of Efficacy|0|||
33589213|NCT02319759|62987588|FG001|Week 24 - 56|Lack of Efficacy|0|||
33589214|NCT02319759|62987589|FG002|Week 24 - 56|Lack of Efficacy|0|||
33589215|NCT02319759|62987590|FG003|Week 24 - 56|Lack of Efficacy|2|||
33589216|NCT02319759|62987591|FG004|Week 24 - 56|Lack of Efficacy|1|||
33589217|NCT02319759|62987587|FG000|Week 24 - 56|Withdrawal by Subject|0|||
33589218|NCT02319759|62987588|FG001|Week 24 - 56|Withdrawal by Subject|1|||
33589219|NCT02319759|62987589|FG002|Week 24 - 56|Withdrawal by Subject|0|||
33589220|NCT02319759|62987590|FG003|Week 24 - 56|Withdrawal by Subject|0|||
33589221|NCT02319759|62987591|FG004|Week 24 - 56|Withdrawal by Subject|0|||
33589222|NCT02319759|62987587|FG000|Week 24 - 56|Lost to Follow-up|0|||
33589223|NCT02319759|62987588|FG001|Week 24 - 56|Lost to Follow-up|0|||
33589224|NCT02319759|62987589|FG002|Week 24 - 56|Lost to Follow-up|0|||
33589225|NCT02319759|62987590|FG003|Week 24 - 56|Lost to Follow-up|0|||
33589226|NCT02319759|62987591|FG004|Week 24 - 56|Lost to Follow-up|1|||
33589227|NCT02293005|62987604|FG000|Overall Study|Adverse Event|2|||
33589228|NCT02293005|62987604|FG000|Overall Study|Death|4|||
33589229|NCT02293005|62987604|FG000|Overall Study|Lost to Follow-up|1|||
33589230|NCT02293005|62987604|FG000|Overall Study|Withdrawal by Subject|2|||
33589231|NCT02293005|62987604|FG000|Overall Study|Progression|17|||
33589232|NCT02319525|62987610|FG000|Overall Study|Withdrawal by Subject|2|||
33589233|NCT02319525|62987611|FG001|Overall Study|Withdrawal by Subject|1|||
33589234|NCT02292927|62987619|FG000|Overall Study|Protocol Violation|13|||
33589235|NCT02292927|62987620|FG001|Overall Study|Protocol Violation|7|||
33589236|NCT02292849|62987632|FG000|Overall Study|Lost to Follow-up|0|||
33589237|NCT02292849|62987633|FG001|Overall Study|Lost to Follow-up|2|||
33680206|NCT01416272|63134216|FG000|Overall Study|Unacceptable distance visual acuity|2|||
33680207|NCT01416272|63134216|FG000|Overall Study|Lost to Follow-up|1|||
33680208|NCT01416272|63134216|FG000|Overall Study|Study related complaints|1|||
33401425|NCT00737477|62780462|FG000|Overall Study|Renal Transplantation|10|||
33589238|NCT02292849|62987634|FG002|Overall Study|Lost to Follow-up|2|||
33589239|NCT02292849|62987632|FG000|Overall Study|Physician Decision|4|||
33589240|NCT02292849|62987633|FG001|Overall Study|Physician Decision|0|||
33589241|NCT02292849|62987634|FG002|Overall Study|Physician Decision|0|||
33589242|NCT02318667|62987642|FG000|Overall Study|Adverse Event|1|||
33589243|NCT02318667|62987642|FG000|Overall Study|Lack of Efficacy|6|||
33589244|NCT02318667|62987642|FG000|Overall Study|Protocol Violation|2|||
33589245|NCT02292771|62987652|FG000|Overall Study|Withdrawal by Subject|2|||
33589246|NCT02292771|62987653|FG001|Overall Study|Withdrawal by Subject|1|||
33589247|NCT02292771|62987652|FG000|Overall Study|Lost to Follow-up|2|||
33589248|NCT02292771|62987653|FG001|Overall Study|Lost to Follow-up|1|||
33589249|NCT02291913|62987663|FG000|Overall Study|Progressive Disease|32|||
33589250|NCT02291913|62987663|FG000|Overall Study|Adverse Event|11|||
33589251|NCT02291913|62987663|FG000|Overall Study|Death|2|||
33589252|NCT02291913|62987663|FG000|Overall Study|Physician Decision|1|||
33589253|NCT02291913|62987663|FG000|Overall Study|Withdrawal by Subject|1|||
33589254|NCT02291913|62987663|FG000|Overall Study|Protocol Violation|1|||
33589255|NCT02291679|62987670|FG000|Overall Study|Adverse Event|2|||
33589256|NCT02291679|62987671|FG001|Overall Study|Adverse Event|12|||
33589257|NCT02291679|62987672|FG002|Overall Study|Adverse Event|19|||
33589258|NCT02291679|62987670|FG000|Overall Study|Protocol Violation|5|||
33589259|NCT02291679|62987671|FG001|Overall Study|Protocol Violation|1|||
33589260|NCT02291679|62987672|FG002|Overall Study|Protocol Violation|7|||
33589261|NCT02291679|62987670|FG000|Overall Study|Withdrew Consent|18|||
33589262|NCT02291679|62987671|FG001|Overall Study|Withdrew Consent|10|||
33589263|NCT02291679|62987672|FG002|Overall Study|Withdrew Consent|15|||
33589264|NCT02291679|62987670|FG000|Overall Study|Lost to Follow-up|12|||
33589265|NCT02291679|62987671|FG001|Overall Study|Lost to Follow-up|10|||
33589266|NCT02291679|62987672|FG002|Overall Study|Lost to Follow-up|9|||
33589267|NCT02291679|62987670|FG000|Overall Study|Insufficient Therapeutic Response|5|||
33589268|NCT02291679|62987671|FG001|Overall Study|Insufficient Therapeutic Response|5|||
33589269|NCT02291679|62987672|FG002|Overall Study|Insufficient Therapeutic Response|7|||
33589270|NCT02291679|62987670|FG000|Overall Study|Other|2|||
33589271|NCT02291679|62987671|FG001|Overall Study|Other|4|||
33589272|NCT02291679|62987672|FG002|Overall Study|Other|2|||
33589273|NCT02291601|62987679|FG000|Abdomen|Did not qualify|333|||
33589274|NCT02291601|62987680|FG001|Abdomen|Did not qualify|54|||
33589275|NCT02291601|62987681|FG002|Abdomen|Did not qualify|339|||
33589276|NCT02291601|62987679|FG000|Groin|Did not qualify|183|||
33589277|NCT02291601|62987680|FG001|Groin|Did not qualify|30|||
33589278|NCT02291601|62987681|FG002|Groin|Did not qualify|177|||
33589279|NCT02360475|62987696|FG000|Overall Study|Lost to Follow-up|4|||
33589280|NCT02360475|62987697|FG001|Overall Study|Lost to Follow-up|12|||
33589281|NCT02360475|62987698|FG002|Overall Study|Lost to Follow-up|6|||
33589282|NCT02360475|62987699|FG003|Overall Study|Lost to Follow-up|4|||
33589283|NCT02360475|62987696|FG000|Overall Study|Withdrawal by Subject|0|||
33589284|NCT02360475|62987697|FG001|Overall Study|Withdrawal by Subject|1|||
33589285|NCT02360475|62987698|FG002|Overall Study|Withdrawal by Subject|2|||
33589286|NCT02360475|62987699|FG003|Overall Study|Withdrawal by Subject|0|||
33589287|NCT02360475|62987696|FG000|Overall Study|Migrated/moved from study area|0|||
33589288|NCT02360475|62987697|FG001|Overall Study|Migrated/moved from study area|0|||
33589289|NCT02360475|62987698|FG002|Overall Study|Migrated/moved from study area|0|||
33589290|NCT02360475|62987699|FG003|Overall Study|Migrated/moved from study area|1|||
33589291|NCT02360397|62987709|FG000|Overall Study|Incomplete screening|3|||
33589292|NCT02360397|62987709|FG000|Overall Study|Adverse Event|1|||
33589293|NCT02317809|62987714|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
33589294|NCT02317809|62987715|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
33589295|NCT02317809|62987714|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
33589296|NCT02317809|62987715|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
33589297|NCT02359851|62987724|FG000|Overall Study|Death|1|||
33589298|NCT02359851|62987724|FG000|Overall Study|Disease progression|1|||
33589299|NCT01607905|62987735|FG000|Overall Study|Withdrawal by participant|7|||
33589300|NCT01607905|62987736|FG001|Overall Study|Withdrawal by participant|2|||
33589301|NCT01607905|62987737|FG002|Overall Study|Withdrawal by participant|4|||
33589302|NCT01607905|62987738|FG003|Overall Study|Withdrawal by participant|6|||
33589303|NCT01607905|62987739|FG004|Overall Study|Withdrawal by participant|0|||
33589304|NCT01607905|62987740|FG005|Overall Study|Withdrawal by participant|4|||
33589305|NCT01607905|62987741|FG006|Overall Study|Withdrawal by participant|12|||
33589306|NCT01607905|62987735|FG000|Overall Study|Incidence or severity of AEs|5|||
33589307|NCT01607905|62987736|FG001|Overall Study|Incidence or severity of AEs|1|||
33589308|NCT01607905|62987737|FG002|Overall Study|Incidence or severity of AEs|1|||
33589309|NCT01607905|62987738|FG003|Overall Study|Incidence or severity of AEs|3|||
33589310|NCT01607905|62987739|FG004|Overall Study|Incidence or severity of AEs|0|||
33589311|NCT01607905|62987740|FG005|Overall Study|Incidence or severity of AEs|2|||
33589312|NCT01607905|62987741|FG006|Overall Study|Incidence or severity of AEs|8|||
33589313|NCT01607905|62987735|FG000|Overall Study|Disease progression|44|||
33589314|NCT01607905|62987736|FG001|Overall Study|Disease progression|16|||
33589315|NCT01607905|62987737|FG002|Overall Study|Disease progression|15|||
33589316|NCT01607905|62987738|FG003|Overall Study|Disease progression|11|||
33589317|NCT01607905|62987739|FG004|Overall Study|Disease progression|6|||
33589318|NCT01607905|62987740|FG005|Overall Study|Disease progression|7|||
33589319|NCT01607905|62987741|FG006|Overall Study|Disease progression|21|||
33589320|NCT01607905|62987735|FG000|Overall Study|Non-compliance with study procedures|0|||
33589321|NCT01607905|62987736|FG001|Overall Study|Non-compliance with study procedures|0|||
33589322|NCT01607905|62987737|FG002|Overall Study|Non-compliance with study procedures|0|||
33589323|NCT01607905|62987738|FG003|Overall Study|Non-compliance with study procedures|0|||
33589324|NCT01607905|62987739|FG004|Overall Study|Non-compliance with study procedures|0|||
33589325|NCT01607905|62987740|FG005|Overall Study|Non-compliance with study procedures|0|||
33589326|NCT01607905|62987741|FG006|Overall Study|Non-compliance with study procedures|1|||
33589327|NCT01607905|62987735|FG000|Overall Study|Death|1|||
33589328|NCT01607905|62987736|FG001|Overall Study|Death|1|||
33589329|NCT01607905|62987737|FG002|Overall Study|Death|1|||
33589330|NCT01607905|62987738|FG003|Overall Study|Death|1|||
33589331|NCT01607905|62987739|FG004|Overall Study|Death|0|||
33589332|NCT01607905|62987740|FG005|Overall Study|Death|0|||
33589333|NCT01607905|62987741|FG006|Overall Study|Death|3|||
33589334|NCT01607905|62987735|FG000|Overall Study|Other treatments become available|1|||
33589335|NCT01607905|62987736|FG001|Overall Study|Other treatments become available|0|||
33589336|NCT01607905|62987737|FG002|Overall Study|Other treatments become available|0|||
33589337|NCT01607905|62987738|FG003|Overall Study|Other treatments become available|0|||
33589338|NCT01607905|62987739|FG004|Overall Study|Other treatments become available|0|||
33589339|NCT01607905|62987740|FG005|Overall Study|Other treatments become available|0|||
33589340|NCT01607905|62987741|FG006|Overall Study|Other treatments become available|1|||
33589341|NCT01607905|62987735|FG000|Overall Study|Investigator discretion|0|||
33589342|NCT01607905|62987736|FG001|Overall Study|Investigator discretion|0|||
33589343|NCT01607905|62987737|FG002|Overall Study|Investigator discretion|0|||
33589344|NCT01607905|62987738|FG003|Overall Study|Investigator discretion|0|||
33589345|NCT01607905|62987739|FG004|Overall Study|Investigator discretion|0|||
33589346|NCT01607905|62987740|FG005|Overall Study|Investigator discretion|1|||
33589347|NCT01607905|62987741|FG006|Overall Study|Investigator discretion|0|||
33589348|NCT01607905|62987735|FG000|Overall Study|Other|1|||
33589349|NCT01607905|62987736|FG001|Overall Study|Other|0|||
33589350|NCT01607905|62987737|FG002|Overall Study|Other|0|||
33589351|NCT01607905|62987738|FG003|Overall Study|Other|0|||
33589352|NCT01607905|62987739|FG004|Overall Study|Other|0|||
33589353|NCT01607905|62987740|FG005|Overall Study|Other|0|||
33589354|NCT01607905|62987741|FG006|Overall Study|Other|1|||
33589355|NCT01607905|62987735|FG000|Overall Study|Randomized but not treated|1|||
33589356|NCT01607905|62987736|FG001|Overall Study|Randomized but not treated|0|||
33589357|NCT01607905|62987737|FG002|Overall Study|Randomized but not treated|0|||
33589358|NCT01607905|62987738|FG003|Overall Study|Randomized but not treated|0|||
33589359|NCT01607905|62987739|FG004|Overall Study|Randomized but not treated|1|||
33589360|NCT01607905|62987740|FG005|Overall Study|Randomized but not treated|1|||
33589361|NCT01607905|62987741|FG006|Overall Study|Randomized but not treated|0|||
33589362|NCT02536963|62987799|FG000|Overall Study|Withdrawal by Subject|18|||
33589363|NCT02531035|62987805|FG000|Overall Study|Death|0|||
33589364|NCT02531035|62987806|FG001|Overall Study|Death|1|||
33589365|NCT02531035|62987805|FG000|Overall Study|Protocol Violation|1|||
33589366|NCT02531035|62987806|FG001|Overall Study|Protocol Violation|1|||
33589367|NCT02531035|62987805|FG000|Overall Study|Noncompliance with study drug|8|||
33589368|NCT02531035|62987806|FG001|Overall Study|Noncompliance with study drug|3|||
33589369|NCT02531035|62987805|FG000|Overall Study|Physician Decision|1|||
33589370|NCT02531035|62987806|FG001|Overall Study|Physician Decision|0|||
33589371|NCT02531035|62987805|FG000|Overall Study|Adverse Event|16|||
33589372|NCT02531035|62987806|FG001|Overall Study|Adverse Event|45|||
33589373|NCT02531035|62987805|FG000|Overall Study|Other|3|||
33589374|NCT02531035|62987806|FG001|Overall Study|Other|2|||
33589375|NCT02531035|62987805|FG000|Overall Study|Withdrawal by Subject|42|||
33589376|NCT02531035|62987806|FG001|Overall Study|Withdrawal by Subject|32|||
33589377|NCT02531035|62987805|FG000|Overall Study|Lost to Follow-up|8|||
33589378|NCT02531035|62987806|FG001|Overall Study|Lost to Follow-up|10|||
33589379|NCT02531035|62987805|FG000|Overall Study|Randomized, not treated|2|||
33589380|NCT02531035|62987806|FG001|Overall Study|Randomized, not treated|1|||
33589381|NCT01659853|62987822|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
33589382|NCT01659853|62987823|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
33589383|NCT01659853|62987822|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
33589384|NCT01659853|62987823|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
33589385|NCT01660243|62987835|FG000|Overall Study|Adverse Event|1|||
33589386|NCT01660243|62987836|FG001|Overall Study|Adverse Event|0|||
33589387|NCT01660243|62987837|FG002|Overall Study|Adverse Event|1|||
33589388|NCT01660243|62987838|FG003|Overall Study|Adverse Event|0|||
33589389|NCT01660243|62987835|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
33589390|NCT01660243|62987836|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
33589391|NCT01660243|62987837|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
33589392|NCT01660243|62987838|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
33589393|NCT01660243|62987835|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
33589394|NCT01660243|62987836|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
33589395|NCT01660243|62987837|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
33651239|NCT01972841|63062641|FG005|Overall Study|Withdrawal by participants|34|||
33651240|NCT01972841|63062636|FG000|Overall Study|Miscellaneous|0|||
33651241|NCT01972841|63062637|FG001|Overall Study|Miscellaneous|0|||
33651242|NCT01972841|63062638|FG002|Overall Study|Miscellaneous|4|||
33651243|NCT01972841|63062639|FG003|Overall Study|Miscellaneous|1|||
33651244|NCT01972841|63062640|FG004|Overall Study|Miscellaneous|0|||
33651245|NCT01972841|63062641|FG005|Overall Study|Miscellaneous|4|||
33651246|NCT01972841|63062636|FG000|Overall Study|Did not have end of treatment page|0|||
33589396|NCT01660243|62987838|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
33589397|NCT01660243|62987835|FG000|Overall Study|Randomization error|0|||
33589398|NCT01660243|62987836|FG001|Overall Study|Randomization error|0|||
33589399|NCT01660243|62987837|FG002|Overall Study|Randomization error|0|||
33589400|NCT01660243|62987838|FG003|Overall Study|Randomization error|1|||
33589401|NCT02531113|62987848|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
33589402|NCT02531113|62987848|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
33589403|NCT02531113|62987848|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
33589404|NCT02531113|62987848|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
33589405|NCT02531113|62987848|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
33589406|NCT02531113|62987848|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
33589407|NCT02531113|62987848|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
33589408|NCT02531113|62987848|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
33589409|NCT02522767|62987858|FG000|Double-blind|Withdrawal by Subject|8|||
33589410|NCT02522767|62987859|FG001|Double-blind|Withdrawal by Subject|11|||
33589411|NCT02522767|62987858|FG000|Double-blind|Lost to Follow-up|1|||
33589412|NCT02522767|62987859|FG001|Double-blind|Lost to Follow-up|0|||
33589413|NCT02522767|62987858|FG000|Double-blind|Adverse Event|1|||
33589414|NCT02522767|62987859|FG001|Double-blind|Adverse Event|10|||
33589415|NCT02522767|62987858|FG000|Double-blind|Protocol Violation|0|||
33589416|NCT02522767|62987859|FG001|Double-blind|Protocol Violation|1|||
33589417|NCT02522767|62987858|FG000|Double-blind|Lack of Efficacy|0|||
33589418|NCT02522767|62987859|FG001|Double-blind|Lack of Efficacy|2|||
33589419|NCT02522767|62987858|FG000|Double-blind|Protocol Deviation|1|||
33589420|NCT02522767|62987859|FG001|Double-blind|Protocol Deviation|0|||
33589421|NCT02522767|62987858|FG000|Open-label|Withdrawal by Subject|2|||
33589422|NCT02522767|62987859|FG001|Open-label|Withdrawal by Subject|3|||
33589423|NCT02522767|62987858|FG000|Open-label|Lost to Follow-up|0|||
33589424|NCT02522767|62987859|FG001|Open-label|Lost to Follow-up|1|||
33589425|NCT02522767|62987858|FG000|Open-label|Adverse Event|2|||
33589426|NCT02522767|62987859|FG001|Open-label|Adverse Event|1|||
33589427|NCT02522767|62987858|FG000|Open-label|Lack of Efficacy|1|||
33589428|NCT02522767|62987859|FG001|Open-label|Lack of Efficacy|1|||
33589429|NCT02522767|62987858|FG000|Open-label|Protocol Violation|0|||
33589430|NCT02522767|62987859|FG001|Open-label|Protocol Violation|1|||
33589431|NCT02522377|62987869|FG000|Overall Study|Withdrawal by Subject|1|||
33589432|NCT02522377|62987870|FG001|Overall Study|Withdrawal by Subject|0|||
33589433|NCT02522377|62987869|FG000|Overall Study|Remission Achieved|3|||
33589434|NCT02522377|62987870|FG001|Overall Study|Remission Achieved|0|||
33589435|NCT01657903|62987876|FG000|Overall Study|Lost to Follow-up|1|||
33589436|NCT01657903|62987876|FG000|Overall Study|Withdrawal by Subject|1|||
33589437|NCT01656733|62987889|FG000|Overall Study|No permission to collect birth outcomes|0|||
33589438|NCT01656733|62987890|FG001|Overall Study|No permission to collect birth outcomes|1|||
33589439|NCT01656733|62987889|FG000|Overall Study|Delivery at another hospital|0|||
33589440|NCT01656733|62987890|FG001|Overall Study|Delivery at another hospital|2|||
33589441|NCT01656733|62987889|FG000|Overall Study|Spontaneous abortion|0|||
33589442|NCT01656733|62987890|FG001|Overall Study|Spontaneous abortion|1|||
33680209|NCT01435772|63134706|FG000|Overall Study|Adverse Event|1|||
33680210|NCT01435772|63134707|FG001|Overall Study|Adverse Event|0|||
33680211|NCT01435772|63134708|FG002|Overall Study|Adverse Event|2|||
33680212|NCT01435772|63134706|FG000|Overall Study|Withdrawal by Subject|0|||
33680213|NCT01435772|63134707|FG001|Overall Study|Withdrawal by Subject|1|||
33680214|NCT01435772|63134708|FG002|Overall Study|Withdrawal by Subject|3|||
33680215|NCT01435772|63134706|FG000|Overall Study|Other - study termination|2|||
33680216|NCT01435772|63134707|FG001|Overall Study|Other - study termination|2|||
33680217|NCT01435772|63134708|FG002|Overall Study|Other - study termination|10|||
33680218|NCT01435616|63134927|FG000|Overall Study|Adverse Event|39|||
33680219|NCT01435616|63134928|FG001|Overall Study|Adverse Event|21|||
33680220|NCT01435616|63134927|FG000|Overall Study|Death|7|||
33680221|NCT01435616|63134928|FG001|Overall Study|Death|2|||
33680222|NCT01435616|63134927|FG000|Overall Study|Lost to Follow-up|22|||
33680223|NCT01435616|63134928|FG001|Overall Study|Lost to Follow-up|13|||
33680224|NCT01435616|63134927|FG000|Overall Study|Protocol Violation|16|||
33589443|NCT01656967|62987898|FG000|Overall Study|faulty monitor|1|||
33589444|NCT01656967|62987899|FG001|Overall Study|faulty monitor|0|||
33589445|NCT01656967|62987898|FG000|Overall Study|unsuccessful ETT insertion|3|||
33589446|NCT01656967|62987899|FG001|Overall Study|unsuccessful ETT insertion|2|||
33589447|NCT01656889|62987911|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
33589448|NCT01656889|62987912|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
33589449|NCT01656889|62987911|FG000|Treatment Period, 12 Weeks|Death|0|||
33589450|NCT01656889|62987912|FG001|Treatment Period, 12 Weeks|Death|1|||
33589451|NCT01656889|62987911|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
33589452|NCT01656889|62987912|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
33589453|NCT01656889|62987911|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
33589454|NCT01656889|62987912|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
33680225|NCT01435616|63134928|FG001|Overall Study|Protocol Violation|13|||
33589455|NCT01656889|62987911|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
33589456|NCT01656889|62987912|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
33589457|NCT01656889|62987911|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
33589458|NCT01656889|62987912|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
33589459|NCT01656889|62987911|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
33589460|NCT01656889|62987912|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
33589461|NCT01656889|62987911|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
33589462|NCT01656889|62987912|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
33589463|NCT01656889|62987911|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
33589464|NCT01656889|62987912|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
33589465|NCT01656889|62987911|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
33589466|NCT01656889|62987912|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
33589467|NCT02522299|62987920|FG000|Overall Study|Adverse Event|2|||
33589468|NCT02522299|62987921|FG001|Overall Study|Adverse Event|0|||
33589469|NCT02522299|62987920|FG000|Overall Study|Physician Decision|0|||
33589470|NCT02522299|62987921|FG001|Overall Study|Physician Decision|1|||
33589471|NCT02522299|62987920|FG000|Overall Study|Withdrawal by Subject|2|||
33589472|NCT02522299|62987921|FG001|Overall Study|Withdrawal by Subject|0|||
33589473|NCT01365091|62987945|FG000|Period 1|Adverse Event|1|||
33589474|NCT01365091|62987946|FG001|Period 1|Adverse Event|0|||
33589475|NCT01365091|62987947|FG002|Period 1|Adverse Event|2|||
33589476|NCT01365091|62987948|FG003|Period 1|Adverse Event|3|||
33589477|NCT01365091|62987945|FG000|Period 1|Positive test result for drugs of abuse|1|||
33589478|NCT01365091|62987946|FG001|Period 1|Positive test result for drugs of abuse|0|||
33589479|NCT01365091|62987947|FG002|Period 1|Positive test result for drugs of abuse|0|||
33589480|NCT01365091|62987948|FG003|Period 1|Positive test result for drugs of abuse|0|||
33589481|NCT01365091|62987945|FG000|Period 1|No longer met study criteria|0|||
33589482|NCT01365091|62987946|FG001|Period 1|No longer met study criteria|1|||
33589483|NCT01365091|62987947|FG002|Period 1|No longer met study criteria|0|||
33589484|NCT01365091|62987948|FG003|Period 1|No longer met study criteria|0|||
33589485|NCT01365091|62987945|FG000|Period 1|Withdrawal by Subject|0|||
33589486|NCT01365091|62987946|FG001|Period 1|Withdrawal by Subject|1|||
33589487|NCT01365091|62987947|FG002|Period 1|Withdrawal by Subject|0|||
33589488|NCT01365091|62987948|FG003|Period 1|Withdrawal by Subject|0|||
33589489|NCT01365091|62987945|FG000|Period 1|Personal reasons|0|||
33589490|NCT01365091|62987946|FG001|Period 1|Personal reasons|0|||
33589491|NCT01365091|62987947|FG002|Period 1|Personal reasons|1|||
33589492|NCT01365091|62987948|FG003|Period 1|Personal reasons|0|||
33589493|NCT01365091|62987945|FG000|Period 2|Withdrawal by Subject|1|||
33589494|NCT01365091|62987946|FG001|Period 2|Withdrawal by Subject|0|||
33680226|NCT01435616|63134927|FG000|Overall Study|Withdrawal by Subject|66|||
33680227|NCT01435616|63134928|FG001|Overall Study|Withdrawal by Subject|24|||
33680228|NCT01435616|63134927|FG000|Overall Study|Physician Decision|20|||
33680229|NCT01435616|63134928|FG001|Overall Study|Physician Decision|7|||
33680230|NCT01435616|63134927|FG000|Overall Study|Sponsor Decision|1|||
33680231|NCT01435616|63134928|FG001|Overall Study|Sponsor Decision|0|||
33589495|NCT01365091|62987947|FG002|Period 2|Withdrawal by Subject|0|||
33589496|NCT01365091|62987948|FG003|Period 2|Withdrawal by Subject|0|||
33589497|NCT01365091|62987945|FG000|Period 2|Adverse Event|0|||
33589498|NCT01365091|62987946|FG001|Period 2|Adverse Event|0|||
33589499|NCT01365091|62987947|FG002|Period 2|Adverse Event|1|||
33589500|NCT01365091|62987948|FG003|Period 2|Adverse Event|0|||
33589501|NCT01364467|62987974|FG000|Overall Study|Lost to Follow-up|1|||
33589502|NCT01364467|62987975|FG001|Overall Study|Lost to Follow-up|2|||
33589503|NCT02520661|62987983|FG000|Overall Study|Lost to Follow-up|7|||
33589504|NCT02520661|62987984|FG001|Overall Study|Lost to Follow-up|3|||
33589505|NCT02520661|62987983|FG000|Overall Study|Admitted from ED|49|||
33680232|NCT01435460|63134978|FG000|Overall Study|Adverse Event|2|||
33680233|NCT01435460|63134979|FG001|Overall Study|Adverse Event|1|||
33680234|NCT01435460|63134978|FG000|Overall Study|Lost to Follow-up|6|||
33680235|NCT01435460|63134979|FG001|Overall Study|Lost to Follow-up|1|||
33680236|NCT01435460|63134978|FG000|Overall Study|Withdrawal by Subject|1|||
33680237|NCT01435460|63134979|FG001|Overall Study|Withdrawal by Subject|3|||
33680238|NCT01435460|63134978|FG000|Overall Study|Protocol Violation|0|||
33589506|NCT02520661|62987984|FG001|Overall Study|Admitted from ED|48|||
33589507|NCT02520661|62987983|FG000|Overall Study|ED greater than 24 hours|29|||
33589508|NCT02520661|62987984|FG001|Overall Study|ED greater than 24 hours|38|||
33589509|NCT02520661|62987983|FG000|Overall Study|other ineligibility|14|||
33589510|NCT02520661|62987984|FG001|Overall Study|other ineligibility|22|||
33589511|NCT02520661|62987983|FG000|Overall Study|Withdrawal by Subject|7|||
33589512|NCT02520661|62987984|FG001|Overall Study|Withdrawal by Subject|16|||
33589513|NCT01364389|62987997|FG000|Overall Study|Withdrawal by Subject|0|||
33680239|NCT01435460|63134979|FG001|Overall Study|Protocol Violation|1|||
33680240|NCT01435460|63134978|FG000|Overall Study|Did not meet eligibility criteria|2|||
33589514|NCT01364389|62987998|FG001|Overall Study|Withdrawal by Subject|1|||
33589515|NCT01364389|62987999|FG002|Overall Study|Withdrawal by Subject|0|||
33589516|NCT01364389|62987997|FG000|Overall Study|Protocol deviation|0|||
33680241|NCT01435460|63134979|FG001|Overall Study|Did not meet eligibility criteria|0|||
33589517|NCT01364389|62987998|FG001|Overall Study|Protocol deviation|0|||
33589518|NCT01364389|62987999|FG002|Overall Study|Protocol deviation|1|||
33589519|NCT01364389|62987997|FG000|Overall Study|Administrative problems|1|||
33589520|NCT01364389|62987998|FG001|Overall Study|Administrative problems|0|||
33589521|NCT01364389|62987999|FG002|Overall Study|Administrative problems|0|||
33589522|NCT01364389|62987997|FG000|Overall Study|Adverse Event|1|||
33589523|NCT01364389|62987998|FG001|Overall Study|Adverse Event|0|||
33589524|NCT01364389|62987999|FG002|Overall Study|Adverse Event|0|||
33589525|NCT01364233|62988007|FG000|Overall Study|Lost to Follow-up|1|||
33589526|NCT02291289|62988015|FG000|Induction Treatment|Not Dosed|2|||
33589527|NCT02291289|62988016|FG001|Induction Treatment|Not Dosed|0|||
33589528|NCT02291289|62988017|FG002|Induction Treatment|Not Dosed|0|||
33589529|NCT02291289|62988018|FG003|Induction Treatment|Not Dosed|9|||
33589530|NCT02291289|62988019|FG004|Induction Treatment|Not Dosed|0|||
33589531|NCT02291289|62988020|FG005|Induction Treatment|Not Dosed|0|||
33589532|NCT02291289|62988021|FG006|Induction Treatment|Not Dosed|0|||
33589533|NCT02291289|62988022|FG007|Induction Treatment|Not Dosed|0|||
33589534|NCT02291289|62988023|FG008|Induction Treatment|Not Dosed|0|||
33589535|NCT02291289|62988024|FG009|Induction Treatment|Not Dosed|1|||
33589536|NCT02291289|62988025|FG010|Induction Treatment|Not Dosed|0|||
33589537|NCT02291289|62988026|FG011|Induction Treatment|Not Dosed|0|||
33589538|NCT02291289|62988015|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33589539|NCT02291289|62988016|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33589540|NCT02291289|62988017|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33589541|NCT02291289|62988018|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33589542|NCT02291289|62988019|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13|||
33589543|NCT02291289|62988020|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11|||
33589544|NCT02291289|62988021|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33589545|NCT02291289|62988022|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33589546|NCT02291289|62988023|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33589547|NCT02291289|62988024|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33589548|NCT02291289|62988025|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
33589549|NCT02291289|62988026|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
33589550|NCT02291289|62988015|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
33589551|NCT02291289|62988016|FG001|Maintenance Treatment Phase|Protocol Violation|1|||
33589552|NCT02291289|62988017|FG002|Maintenance Treatment Phase|Protocol Violation|0|||
33589553|NCT02291289|62988018|FG003|Maintenance Treatment Phase|Protocol Violation|0|||
33589554|NCT02291289|62988019|FG004|Maintenance Treatment Phase|Protocol Violation|2|||
33589555|NCT02291289|62988020|FG005|Maintenance Treatment Phase|Protocol Violation|1|||
33589556|NCT02291289|62988021|FG006|Maintenance Treatment Phase|Protocol Violation|0|||
33589557|NCT02291289|62988022|FG007|Maintenance Treatment Phase|Protocol Violation|0|||
33589558|NCT02291289|62988023|FG008|Maintenance Treatment Phase|Protocol Violation|0|||
33589559|NCT02291289|62988024|FG009|Maintenance Treatment Phase|Protocol Violation|0|||
33589560|NCT02291289|62988025|FG010|Maintenance Treatment Phase|Protocol Violation|0|||
33589561|NCT02291289|62988026|FG011|Maintenance Treatment Phase|Protocol Violation|0|||
33589562|NCT02291289|62988015|FG000|Maintenance Treatment Phase|Death|0|||
33589563|NCT02291289|62988016|FG001|Maintenance Treatment Phase|Death|23|||
33589564|NCT02291289|62988017|FG002|Maintenance Treatment Phase|Death|13|||
33589565|NCT02291289|62988018|FG003|Maintenance Treatment Phase|Death|0|||
33589566|NCT02291289|62988019|FG004|Maintenance Treatment Phase|Death|185|||
33589567|NCT02291289|62988020|FG005|Maintenance Treatment Phase|Death|100|||
33589568|NCT02291289|62988021|FG006|Maintenance Treatment Phase|Death|0|||
33680242|NCT01435382|63135065|FG000|Overall Study|Lost to Follow-up|1|||
33589569|NCT02291289|62988022|FG007|Maintenance Treatment Phase|Death|1|||
33589570|NCT02291289|62988023|FG008|Maintenance Treatment Phase|Death|1|||
33589571|NCT02291289|62988024|FG009|Maintenance Treatment Phase|Death|0|||
33589572|NCT02291289|62988025|FG010|Maintenance Treatment Phase|Death|26|||
33589573|NCT02291289|62988026|FG011|Maintenance Treatment Phase|Death|11|||
33589574|NCT02291289|62988015|FG000|Maintenance Treatment Phase|Adverse Event|0|||
33589575|NCT02291289|62988016|FG001|Maintenance Treatment Phase|Adverse Event|0|||
33589576|NCT02291289|62988017|FG002|Maintenance Treatment Phase|Adverse Event|0|||
33589577|NCT02291289|62988018|FG003|Maintenance Treatment Phase|Adverse Event|0|||
33589578|NCT02291289|62988019|FG004|Maintenance Treatment Phase|Adverse Event|1|||
33589579|NCT02291289|62988020|FG005|Maintenance Treatment Phase|Adverse Event|0|||
33589580|NCT02291289|62988021|FG006|Maintenance Treatment Phase|Adverse Event|0|||
33589581|NCT02291289|62988022|FG007|Maintenance Treatment Phase|Adverse Event|0|||
33589582|NCT02291289|62988023|FG008|Maintenance Treatment Phase|Adverse Event|0|||
33589583|NCT02291289|62988024|FG009|Maintenance Treatment Phase|Adverse Event|0|||
33589584|NCT02291289|62988025|FG010|Maintenance Treatment Phase|Adverse Event|0|||
33589585|NCT02291289|62988026|FG011|Maintenance Treatment Phase|Adverse Event|0|||
33589586|NCT02291289|62988015|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
33589587|NCT02291289|62988016|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
33589588|NCT02291289|62988017|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
33589589|NCT02291289|62988018|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
33680243|NCT01435382|63135066|FG001|Overall Study|Lost to Follow-up|0|||
33680244|NCT01435382|63135067|FG002|Overall Study|Lost to Follow-up|1|||
33589590|NCT02291289|62988019|FG004|Maintenance Treatment Phase|Lost to Follow-up|12|||
33589591|NCT02291289|62988020|FG005|Maintenance Treatment Phase|Lost to Follow-up|3|||
33589592|NCT02291289|62988021|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
33589593|NCT02291289|62988022|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
33589594|NCT02291289|62988023|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
33589595|NCT02291289|62988024|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
33589596|NCT02291289|62988025|FG010|Maintenance Treatment Phase|Lost to Follow-up|2|||
33589597|NCT02291289|62988026|FG011|Maintenance Treatment Phase|Lost to Follow-up|1|||
33589598|NCT02291289|62988015|FG000|Maintenance Treatment Phase|Other|0|||
33589599|NCT02291289|62988016|FG001|Maintenance Treatment Phase|Other|0|||
33589600|NCT02291289|62988017|FG002|Maintenance Treatment Phase|Other|1|||
33589601|NCT02291289|62988018|FG003|Maintenance Treatment Phase|Other|0|||
33589602|NCT02291289|62988019|FG004|Maintenance Treatment Phase|Other|29|||
33589603|NCT02291289|62988020|FG005|Maintenance Treatment Phase|Other|8|||
33589604|NCT02291289|62988021|FG006|Maintenance Treatment Phase|Other|0|||
33589605|NCT02291289|62988022|FG007|Maintenance Treatment Phase|Other|0|||
33589606|NCT02291289|62988023|FG008|Maintenance Treatment Phase|Other|1|||
33589607|NCT02291289|62988024|FG009|Maintenance Treatment Phase|Other|0|||
33589608|NCT02291289|62988025|FG010|Maintenance Treatment Phase|Other|0|||
33589609|NCT02291289|62988026|FG011|Maintenance Treatment Phase|Other|0|||
33589610|NCT02291289|62988015|FG000|Maintenance Treatment Phase|Physician Decision|0|||
33589611|NCT02291289|62988016|FG001|Maintenance Treatment Phase|Physician Decision|0|||
33589612|NCT02291289|62988017|FG002|Maintenance Treatment Phase|Physician Decision|0|||
33589613|NCT02291289|62988018|FG003|Maintenance Treatment Phase|Physician Decision|0|||
33589614|NCT02291289|62988019|FG004|Maintenance Treatment Phase|Physician Decision|2|||
33589615|NCT02291289|62988020|FG005|Maintenance Treatment Phase|Physician Decision|0|||
33589616|NCT02291289|62988021|FG006|Maintenance Treatment Phase|Physician Decision|0|||
33589617|NCT02291289|62988022|FG007|Maintenance Treatment Phase|Physician Decision|0|||
33589618|NCT02291289|62988023|FG008|Maintenance Treatment Phase|Physician Decision|0|||
33589619|NCT02291289|62988024|FG009|Maintenance Treatment Phase|Physician Decision|0|||
33589620|NCT02291289|62988025|FG010|Maintenance Treatment Phase|Physician Decision|0|||
33589621|NCT02291289|62988026|FG011|Maintenance Treatment Phase|Physician Decision|1|||
33589622|NCT02291289|62988015|FG000|Maintenance Treatment Phase|Multiple Reasons|0|||
33589623|NCT02291289|62988016|FG001|Maintenance Treatment Phase|Multiple Reasons|0|||
33589624|NCT02291289|62988017|FG002|Maintenance Treatment Phase|Multiple Reasons|0|||
33589625|NCT02291289|62988018|FG003|Maintenance Treatment Phase|Multiple Reasons|0|||
33589626|NCT02291289|62988019|FG004|Maintenance Treatment Phase|Multiple Reasons|4|||
33589627|NCT02291289|62988020|FG005|Maintenance Treatment Phase|Multiple Reasons|1|||
33589628|NCT02291289|62988021|FG006|Maintenance Treatment Phase|Multiple Reasons|0|||
33589629|NCT02291289|62988022|FG007|Maintenance Treatment Phase|Multiple Reasons|0|||
33589630|NCT02291289|62988023|FG008|Maintenance Treatment Phase|Multiple Reasons|0|||
33589631|NCT02291289|62988024|FG009|Maintenance Treatment Phase|Multiple Reasons|0|||
33589632|NCT02291289|62988025|FG010|Maintenance Treatment Phase|Multiple Reasons|0|||
33589633|NCT02291289|62988026|FG011|Maintenance Treatment Phase|Multiple Reasons|0|||
33589634|NCT02291289|62988015|FG000|Maintenance Treatment Phase|No Treatment Received|0|||
33589635|NCT02291289|62988016|FG001|Maintenance Treatment Phase|No Treatment Received|0|||
33589636|NCT02291289|62988017|FG002|Maintenance Treatment Phase|No Treatment Received|2|||
33589637|NCT02291289|62988018|FG003|Maintenance Treatment Phase|No Treatment Received|0|||
33589638|NCT02291289|62988019|FG004|Maintenance Treatment Phase|No Treatment Received|4|||
33589639|NCT02291289|62988020|FG005|Maintenance Treatment Phase|No Treatment Received|5|||
33589640|NCT02291289|62988021|FG006|Maintenance Treatment Phase|No Treatment Received|0|||
33589641|NCT02291289|62988022|FG007|Maintenance Treatment Phase|No Treatment Received|0|||
33589642|NCT02291289|62988023|FG008|Maintenance Treatment Phase|No Treatment Received|0|||
33589643|NCT02291289|62988024|FG009|Maintenance Treatment Phase|No Treatment Received|0|||
33589644|NCT02291289|62988025|FG010|Maintenance Treatment Phase|No Treatment Received|1|||
33589645|NCT02291289|62988026|FG011|Maintenance Treatment Phase|No Treatment Received|0|||
33589646|NCT02317575|62988051|FG000|Period 1|Difficulty with venous cannulation|0|||
33589647|NCT02317575|62988052|FG001|Period 1|Difficulty with venous cannulation|1|||
33589648|NCT02317575|62988053|FG002|Period 1|Difficulty with venous cannulation|0|||
33589649|NCT02317575|62988054|FG003|Period 1|Difficulty with venous cannulation|0|||
33589650|NCT02317575|62988055|FG004|Period 1|Difficulty with venous cannulation|0|||
33589651|NCT02317575|62988051|FG000|Period 1|Withdrawal by Subject|1|||
33589652|NCT02317575|62988052|FG001|Period 1|Withdrawal by Subject|0|||
33589653|NCT02317575|62988053|FG002|Period 1|Withdrawal by Subject|0|||
33589654|NCT02317575|62988054|FG003|Period 1|Withdrawal by Subject|0|||
33589655|NCT02317575|62988055|FG004|Period 1|Withdrawal by Subject|0|||
33589656|NCT02316717|62988076|FG000|Overall Study|Adverse Event|2|||
33589657|NCT02316717|62988077|FG001|Overall Study|Adverse Event|2|||
33589658|NCT02316717|62988078|FG002|Overall Study|Adverse Event|0|||
33589659|NCT02316717|62988076|FG000|Overall Study|Lost to Follow-up|1|||
33589660|NCT02316717|62988077|FG001|Overall Study|Lost to Follow-up|2|||
33589661|NCT02316717|62988078|FG002|Overall Study|Lost to Follow-up|1|||
33589662|NCT02316717|62988076|FG000|Overall Study|Non compliance|3|||
33589663|NCT02316717|62988077|FG001|Overall Study|Non compliance|1|||
33589664|NCT02316717|62988078|FG002|Overall Study|Non compliance|0|||
33589665|NCT02316717|62988076|FG000|Overall Study|Protocol Violation|2|||
33589666|NCT02316717|62988077|FG001|Overall Study|Protocol Violation|0|||
33589667|NCT02316717|62988078|FG002|Overall Study|Protocol Violation|0|||
33589668|NCT02316717|62988076|FG000|Overall Study|Withdrawal by Subject|2|||
33589669|NCT02316717|62988077|FG001|Overall Study|Withdrawal by Subject|1|||
33589670|NCT02316717|62988078|FG002|Overall Study|Withdrawal by Subject|1|||
33589671|NCT02316717|62988076|FG000|Overall Study|Death|0|||
33589672|NCT02316717|62988077|FG001|Overall Study|Death|0|||
33589673|NCT02316717|62988078|FG002|Overall Study|Death|1|||
33589674|NCT02316717|62988076|FG000|Overall Study|Physician Decision|0|||
33589675|NCT02316717|62988077|FG001|Overall Study|Physician Decision|1|||
33589676|NCT02316717|62988078|FG002|Overall Study|Physician Decision|0|||
33589677|NCT02316717|62988076|FG000|Overall Study|TBC|1|||
33589678|NCT02316717|62988077|FG001|Overall Study|TBC|0|||
33589679|NCT02316717|62988078|FG002|Overall Study|TBC|0|||
33589680|NCT02290821|62988091|FG000|Overall Study|Withdrawal by Subject|1|||
33589681|NCT02290821|62988092|FG001|Overall Study|Withdrawal by Subject|1|||
33589682|NCT02290821|62988091|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
33589683|NCT02290821|62988092|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
33589684|NCT02290821|62988091|FG000|Overall Study|Lost to Follow-up|3|||
33589685|NCT02290821|62988092|FG001|Overall Study|Lost to Follow-up|2|||
33589686|NCT02289963|62988100|FG000|Overall Study|Adverse Event|1|||
33589687|NCT02289963|62988101|FG001|Overall Study|Adverse Event|2|||
33589688|NCT02289963|62988100|FG000|Overall Study|Poor compliance to protocol|1|||
33589689|NCT02289963|62988101|FG001|Overall Study|Poor compliance to protocol|0|||
33589690|NCT02289963|62988100|FG000|Overall Study|Withdrawal by Subject|1|||
33589691|NCT02289963|62988101|FG001|Overall Study|Withdrawal by Subject|0|||
33589692|NCT02289963|62988100|FG000|Overall Study|Last injection missed|2|||
33589693|NCT02289963|62988101|FG001|Overall Study|Last injection missed|2|||
33589694|NCT02289963|62988100|FG000|Overall Study|End treatment visit outside visit window|0|||
33589695|NCT02289963|62988101|FG001|Overall Study|End treatment visit outside visit window|4|||
33589696|NCT02289963|62988100|FG000|Overall Study|Other than specified above|0|||
33589697|NCT02289963|62988101|FG001|Overall Study|Other than specified above|2|||
33589698|NCT02358369|62988110|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
33589699|NCT02358369|62988111|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
33589700|NCT02358369|62988112|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
33589701|NCT02358369|62988113|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
33589702|NCT02358369|62988114|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
33589703|NCT02358369|62988110|FG000|Treatment Period A/B|Adverse Event|0|||
33589704|NCT02358369|62988111|FG001|Treatment Period A/B|Adverse Event|0|||
33589705|NCT02358369|62988112|FG002|Treatment Period A/B|Adverse Event|1|||
33589706|NCT02358369|62988113|FG003|Treatment Period A/B|Adverse Event|2|||
33589707|NCT02358369|62988114|FG004|Treatment Period A/B|Adverse Event|0|||
33589708|NCT02358369|62988110|FG000|Treatment Period A/B|Death|0|||
33589709|NCT02358369|62988111|FG001|Treatment Period A/B|Death|0|||
33589710|NCT02358369|62988112|FG002|Treatment Period A/B|Death|1|||
33589711|NCT02358369|62988113|FG003|Treatment Period A/B|Death|0|||
33589712|NCT02358369|62988114|FG004|Treatment Period A/B|Death|0|||
33589713|NCT02358369|62988110|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
33589714|NCT02358369|62988111|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
33589715|NCT02358369|62988112|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
33589716|NCT02358369|62988113|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
33589717|NCT02358369|62988114|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
33589718|NCT02358369|62988110|FG000|Treatment Period C|Adverse Event|0|||
33589719|NCT02358369|62988111|FG001|Treatment Period C|Adverse Event|0|||
33589720|NCT02358369|62988112|FG002|Treatment Period C|Adverse Event|0|||
33589721|NCT02358369|62988113|FG003|Treatment Period C|Adverse Event|0|||
33589722|NCT02358369|62988114|FG004|Treatment Period C|Adverse Event|7|||
33589723|NCT02316171|62988126|FG000|Overall Study|difficulties with urinary catheter|1|||
33589724|NCT02316171|62988127|FG001|Overall Study|difficulties with urinary catheter|0|||
33589725|NCT02316171|62988128|FG002|Overall Study|difficulties with urinary catheter|0|||
33589726|NCT02316171|62988129|FG003|Overall Study|difficulties with urinary catheter|0|||
33589727|NCT02289729|62988135|FG000|Overall Study|Lack of Efficacy|3|||
33589728|NCT02289729|62988135|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
33589729|NCT02289729|62988135|FG000|Overall Study|Withdrawal by Subject|1|||
33589730|NCT02289729|62988135|FG000|Overall Study|Death|1|||
33589731|NCT02315625|62988141|FG000|First Intervention|Disease Progression|1|||
33589732|NCT02315625|62988142|FG001|First Intervention|Disease Progression|0|||
33589733|NCT02315625|62988141|FG000|Second Intervention|Physician Decision|2|||
33589734|NCT02315625|62988142|FG001|Second Intervention|Physician Decision|1|||
33589735|NCT02315625|62988141|FG000|Second Intervention|Study closure|1|||
33589736|NCT02315625|62988142|FG001|Second Intervention|Study closure|0|||
33589737|NCT02315625|62988141|FG000|Second Intervention|Disease Progression|1|||
33589738|NCT02315625|62988142|FG001|Second Intervention|Disease Progression|0|||
33589739|NCT02357979|62988152|FG000|Overall Study|Lost to Follow-up|5|||
33589740|NCT02357979|62988153|FG001|Overall Study|Lost to Follow-up|5|||
33589741|NCT02357901|62988162|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
33589742|NCT02357901|62988163|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
33589743|NCT02357901|62988164|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
33589744|NCT02357901|62988165|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
33589745|NCT02357901|62988162|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
33589746|NCT02357901|62988163|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
33589747|NCT02357901|62988164|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
33589748|NCT02357901|62988165|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
33589749|NCT02357901|62988162|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
33589750|NCT02357901|62988163|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
33589751|NCT02357901|62988164|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
33589752|NCT02357901|62988165|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
33589753|NCT02357901|62988162|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
33589754|NCT02357901|62988163|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
33589755|NCT02357901|62988164|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
33589756|NCT02357901|62988165|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
33589757|NCT02357901|62988162|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
33589758|NCT02357901|62988163|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
33589759|NCT02357901|62988164|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
33589760|NCT02357901|62988165|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
33589761|NCT02357901|62988162|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
33589762|NCT02357901|62988163|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
33589763|NCT02357901|62988164|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
33589764|NCT02357901|62988165|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
33589765|NCT02357901|62988162|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
33589766|NCT02357901|62988163|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
33589767|NCT02357901|62988164|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
33589768|NCT02357901|62988165|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
33589769|NCT02357901|62988162|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
33589770|NCT02357901|62988163|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
33589771|NCT02357901|62988164|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
33589772|NCT02357901|62988165|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
33589773|NCT02357901|62988162|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
33589774|NCT02357901|62988163|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
33589775|NCT02357901|62988164|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
33589776|NCT02357901|62988165|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
33589777|NCT02357901|62988162|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
33589778|NCT02357901|62988163|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
33589779|NCT02357901|62988164|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
33589780|NCT02357901|62988165|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
33589781|NCT02357901|62988162|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
33589782|NCT02357901|62988163|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
33589783|NCT02357901|62988164|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
33589784|NCT02357901|62988165|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
33589785|NCT01601847|62988175|FG000|Overall Study|Death|1|||
33589786|NCT01601847|62988176|FG001|Overall Study|Death|0|||
33589787|NCT01601847|62988175|FG000|Overall Study|Withdrawal by Subject|11|||
33589788|NCT01601847|62988176|FG001|Overall Study|Withdrawal by Subject|7|||
33589789|NCT01601847|62988175|FG000|Overall Study|Lost to Follow-up|1|||
33589790|NCT01601847|62988176|FG001|Overall Study|Lost to Follow-up|3|||
33589791|NCT02515669|62988186|FG000|228 Week Open-Label Phase|Other|0|||
33589792|NCT02515669|62988187|FG001|228 Week Open-Label Phase|Other|0|||
33589793|NCT02515669|62988188|FG002|228 Week Open-Label Phase|Other|1|||
33589794|NCT02515669|62988189|FG003|228 Week Open-Label Phase|Other|4|||
33589795|NCT02515669|62988186|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
33589796|NCT02515669|62988187|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
33589797|NCT02515669|62988188|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
33589798|NCT02515669|62988189|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
33589799|NCT02515669|62988186|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
33589800|NCT02515669|62988187|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
33589801|NCT02515669|62988188|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
33589802|NCT02515669|62988189|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
33589803|NCT02515669|62988186|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
33589804|NCT02515669|62988187|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
33589805|NCT02515669|62988188|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
33589806|NCT02515669|62988189|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
33589807|NCT02515669|62988186|FG000|228 Week Open-Label Phase|Missing|0|||
33589808|NCT02515669|62988187|FG001|228 Week Open-Label Phase|Missing|2|||
33589809|NCT02515669|62988188|FG002|228 Week Open-Label Phase|Missing|2|||
33589810|NCT02515669|62988189|FG003|228 Week Open-Label Phase|Missing|2|||
33589811|NCT02515279|62988219|FG000|Overall Study|Adverse Event|7|||
33589812|NCT02515279|62988219|FG000|Overall Study|Lack of Efficacy|31|||
33589813|NCT02515279|62988219|FG000|Overall Study|Lost to Follow-up|9|||
33589814|NCT02515279|62988219|FG000|Overall Study|Withdrawal by Subject|18|||
33589815|NCT02515279|62988219|FG000|Overall Study|End-of-treatment visit not attended|17|||
33589816|NCT02515279|62988219|FG000|Overall Study|Other|22|||
33589817|NCT02515045|62988225|FG000|Overall Study|Adverse Event|0|||
33589818|NCT02515045|62988226|FG001|Overall Study|Adverse Event|3|||
33589819|NCT02515045|62988227|FG002|Overall Study|Adverse Event|3|||
33589820|NCT02515045|62988225|FG000|Overall Study|Lost to Follow-up|0|||
33589821|NCT02515045|62988226|FG001|Overall Study|Lost to Follow-up|1|||
33589822|NCT02515045|62988227|FG002|Overall Study|Lost to Follow-up|1|||
33589823|NCT02514577|62988237|FG000|Overall Study|Lost to Follow-up|6|||
33589824|NCT02514577|62988238|FG001|Overall Study|Lost to Follow-up|6|||
33589825|NCT02514577|62988237|FG000|Overall Study|Protocol Violation|1|||
33589826|NCT02514577|62988238|FG001|Overall Study|Protocol Violation|0|||
33589827|NCT02514577|62988237|FG000|Overall Study|Withdrawal by Subject|6|||
33589828|NCT02514577|62988238|FG001|Overall Study|Withdrawal by Subject|6|||
33589829|NCT02514577|62988237|FG000|Overall Study|Adverse Event|1|||
33589830|NCT02514577|62988238|FG001|Overall Study|Adverse Event|1|||
33589831|NCT02513485|62988246|FG000|Overall Study|Adverse Event|1|||
33589832|NCT02513485|62988247|FG001|Overall Study|Adverse Event|0|||
33589833|NCT02289417|62988256|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
33589834|NCT02289417|62988257|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
33589835|NCT02289417|62988258|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
33589836|NCT02289417|62988259|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
33589837|NCT02289417|62988260|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
33589838|NCT02289417|62988261|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
33589839|NCT02289417|62988262|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
33589840|NCT02289417|62988263|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
33589841|NCT02289417|62988264|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
33589842|NCT02289417|62988256|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
33589843|NCT02289417|62988257|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
33589844|NCT02289417|62988258|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
33589845|NCT02289417|62988259|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
33589846|NCT02289417|62988260|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
33589847|NCT02289417|62988261|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
33589848|NCT02289417|62988262|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
33589849|NCT02289417|62988263|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
33589850|NCT02289417|62988264|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
33589851|NCT02289417|62988256|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33589852|NCT02289417|62988257|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
33589853|NCT02289417|62988258|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33589854|NCT02289417|62988259|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33589855|NCT02289417|62988260|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33589856|NCT02289417|62988261|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33589857|NCT02289417|62988262|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33589858|NCT02289417|62988263|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33589859|NCT02289417|62988264|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33589860|NCT02289417|62988256|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
33589861|NCT02289417|62988257|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33589862|NCT02289417|62988258|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33589863|NCT02289417|62988259|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33589864|NCT02289417|62988260|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33589865|NCT02289417|62988261|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33589866|NCT02289417|62988262|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33589867|NCT02289417|62988263|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33589868|NCT02289417|62988264|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33589869|NCT02289417|62988256|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
33589870|NCT02289417|62988257|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
33589871|NCT02289417|62988258|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
33589872|NCT02289417|62988259|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
33589873|NCT02289417|62988260|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
33589874|NCT02289417|62988261|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
33589875|NCT02289417|62988262|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
33589876|NCT02289417|62988263|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
33589877|NCT02289417|62988264|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
33589878|NCT02289417|62988256|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33589879|NCT02289417|62988257|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33589880|NCT02289417|62988258|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
33589881|NCT02289417|62988259|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33589882|NCT02289417|62988260|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33589883|NCT02289417|62988261|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33589884|NCT02289417|62988262|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33589885|NCT02289417|62988263|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33589886|NCT02289417|62988264|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33589887|NCT02289417|62988256|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
33589888|NCT02289417|62988257|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
33589889|NCT02289417|62988258|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
33589890|NCT02289417|62988259|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
33589891|NCT02289417|62988260|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
33589892|NCT02289417|62988261|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
33589893|NCT02289417|62988262|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
33589894|NCT02289417|62988263|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
33589895|NCT02289417|62988264|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
33589896|NCT02289417|62988256|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
33589897|NCT02289417|62988257|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
33589898|NCT02289417|62988258|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
33589899|NCT02289417|62988259|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
33589900|NCT02289417|62988260|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
33589901|NCT02289417|62988261|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
33589902|NCT02289417|62988262|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
33589903|NCT02289417|62988263|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
33589904|NCT02289417|62988264|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
33589905|NCT02289417|62988256|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33589906|NCT02289417|62988257|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33589907|NCT02289417|62988258|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33589908|NCT02289417|62988259|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33589909|NCT02289417|62988260|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33589910|NCT02289417|62988261|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33589911|NCT02289417|62988262|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
33589912|NCT02289417|62988263|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33589913|NCT02289417|62988264|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33589914|NCT02289417|62988256|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
33589915|NCT02289417|62988257|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
33589916|NCT02289417|62988258|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
33589917|NCT02289417|62988259|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
33589918|NCT02289417|62988260|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
33589919|NCT02289417|62988261|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
33589920|NCT02289417|62988262|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
33589921|NCT02289417|62988263|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
33589922|NCT02289417|62988264|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
33589923|NCT02289417|62988256|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
33589924|NCT02289417|62988257|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
33589925|NCT02289417|62988258|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
33589926|NCT02289417|62988259|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
33589927|NCT02289417|62988260|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
33589928|NCT02289417|62988261|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
33589929|NCT02289417|62988262|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
33680245|NCT01435382|63135068|FG003|Overall Study|Lost to Follow-up|0|||
33680246|NCT01435382|63135065|FG000|Overall Study|Withdrawal by Subject|0|||
33680247|NCT01435382|63135066|FG001|Overall Study|Withdrawal by Subject|2|||
33680248|NCT01435382|63135067|FG002|Overall Study|Withdrawal by Subject|0|||
33680249|NCT01435382|63135068|FG003|Overall Study|Withdrawal by Subject|1|||
33680250|NCT01414166|63135133|FG000|Overall Study|Adverse Event|10|||
33680251|NCT01414166|63135134|FG001|Overall Study|Adverse Event|2|||
33589930|NCT02289417|62988263|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
33589931|NCT02289417|62988264|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
33589932|NCT02289417|62988256|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
33589933|NCT02289417|62988257|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
33680252|NCT01414166|63135133|FG000|Overall Study|Lost to Follow-up|4|||
33680253|NCT01414166|63135134|FG001|Overall Study|Lost to Follow-up|1|||
33680254|NCT01414166|63135133|FG000|Overall Study|Non-compliance with study drug|2|||
33680255|NCT01414166|63135134|FG001|Overall Study|Non-compliance with study drug|0|||
33680256|NCT01414166|63135133|FG000|Overall Study|Physician Decision|2|||
33680257|NCT01414166|63135134|FG001|Overall Study|Physician Decision|0|||
33589934|NCT02289417|62988258|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
33589935|NCT02289417|62988259|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
33589936|NCT02289417|62988260|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
33589937|NCT02289417|62988261|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
33589938|NCT02289417|62988262|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
33589939|NCT02289417|62988263|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
33589940|NCT02289417|62988264|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
33589941|NCT02289417|62988256|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
33589942|NCT02289417|62988257|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
33589943|NCT02289417|62988258|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
33589944|NCT02289417|62988259|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
33589945|NCT02289417|62988260|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
33589946|NCT02289417|62988261|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
33589947|NCT02289417|62988262|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
33589948|NCT02289417|62988263|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
33589949|NCT02289417|62988264|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
33589950|NCT02289417|62988256|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
33589951|NCT02289417|62988257|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
33589952|NCT02289417|62988258|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
33589953|NCT02289417|62988259|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
33589954|NCT02289417|62988260|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
33589955|NCT02289417|62988261|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
33589956|NCT02289417|62988262|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
33589957|NCT02289417|62988263|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
33589958|NCT02289417|62988264|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
33589959|NCT02512861|62988282|FG000|Overall Study|Protocol Violation|3|||
33589960|NCT02512861|62988283|FG001|Overall Study|Protocol Violation|7|||
33589961|NCT02512861|62988282|FG000|Overall Study|Physician Decision|3|||
33589962|NCT02512861|62988283|FG001|Overall Study|Physician Decision|1|||
33589963|NCT02512861|62988282|FG000|Overall Study|Withdrawal by Subject|0|||
33589964|NCT02512861|62988283|FG001|Overall Study|Withdrawal by Subject|1|||
33589965|NCT02288559|62988293|FG000|Overall Study|Adverse Event|1|||
33589966|NCT02288559|62988294|FG001|Overall Study|Adverse Event|1|||
33589967|NCT02288559|62988295|FG002|Overall Study|Adverse Event|5|||
33589968|NCT02288559|62988296|FG003|Overall Study|Adverse Event|0|||
33589969|NCT02288559|62988293|FG000|Overall Study|Death|0|||
33589970|NCT02288559|62988294|FG001|Overall Study|Death|0|||
33589971|NCT02288559|62988295|FG002|Overall Study|Death|1|||
33589972|NCT02288559|62988296|FG003|Overall Study|Death|0|||
33589973|NCT02288559|62988293|FG000|Overall Study|Lost to Follow-up|0|||
33589974|NCT02288559|62988294|FG001|Overall Study|Lost to Follow-up|0|||
33589975|NCT02288559|62988295|FG002|Overall Study|Lost to Follow-up|0|||
33589976|NCT02288559|62988296|FG003|Overall Study|Lost to Follow-up|1|||
33589977|NCT02288559|62988293|FG000|Overall Study|Withdrawal by Subject|0|||
33589978|NCT02288559|62988294|FG001|Overall Study|Withdrawal by Subject|0|||
33589979|NCT02288559|62988295|FG002|Overall Study|Withdrawal by Subject|2|||
33589980|NCT02288559|62988296|FG003|Overall Study|Withdrawal by Subject|1|||
33589981|NCT02288559|62988293|FG000|Overall Study|Reason Not Specified|0|||
33589982|NCT02288559|62988294|FG001|Overall Study|Reason Not Specified|0|||
33589983|NCT02288559|62988295|FG002|Overall Study|Reason Not Specified|3|||
33589984|NCT02288559|62988296|FG003|Overall Study|Reason Not Specified|0|||
33589985|NCT02288325|62988308|FG000|Run-in Period|Adverse Event|48|||
33589986|NCT02288325|62988309|FG001|Run-in Period|Adverse Event|0|||
33589987|NCT02288325|62988310|FG002|Run-in Period|Adverse Event|0|||
33589988|NCT02288325|62988308|FG000|Run-in Period|Lack of Efficacy|16|||
33589989|NCT02288325|62988309|FG001|Run-in Period|Lack of Efficacy|0|||
33589990|NCT02288325|62988310|FG002|Run-in Period|Lack of Efficacy|0|||
33589991|NCT02288325|62988308|FG000|Run-in Period|Withdrawal of Consent|28|||
33589992|NCT02288325|62988309|FG001|Run-in Period|Withdrawal of Consent|0|||
33589993|NCT02288325|62988310|FG002|Run-in Period|Withdrawal of Consent|0|||
33680258|NCT01414166|63135133|FG000|Overall Study|Protocol Violation|2|||
33680259|NCT01414166|63135134|FG001|Overall Study|Protocol Violation|0|||
33680260|NCT01414166|63135133|FG000|Overall Study|Study terminated by Sponsor|68|||
33589994|NCT02288325|62988308|FG000|Run-in Period|Lost to Follow-up|25|||
33589995|NCT02288325|62988309|FG001|Run-in Period|Lost to Follow-up|0|||
33589996|NCT02288325|62988310|FG002|Run-in Period|Lost to Follow-up|0|||
33589997|NCT02288325|62988308|FG000|Run-in Period|Protocol Violation|17|||
33589998|NCT02288325|62988309|FG001|Run-in Period|Protocol Violation|0|||
33589999|NCT02288325|62988310|FG002|Run-in Period|Protocol Violation|0|||
33590000|NCT02288325|62988308|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
33680261|NCT01414166|63135134|FG001|Overall Study|Study terminated by Sponsor|75|||
33680262|NCT01414166|63135133|FG000|Overall Study|Withdrawal by Subject|3|||
33590001|NCT02288325|62988309|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
33590002|NCT02288325|62988310|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
33590003|NCT02288325|62988308|FG000|Run-in Period|Reason not Specified|8|||
33590004|NCT02288325|62988309|FG001|Run-in Period|Reason not Specified|0|||
33590005|NCT02288325|62988310|FG002|Run-in Period|Reason not Specified|0|||
33590006|NCT02288325|62988308|FG000|Stabilization Period|Adverse Event|13|||
33590007|NCT02288325|62988309|FG001|Stabilization Period|Adverse Event|0|||
33590008|NCT02288325|62988310|FG002|Stabilization Period|Adverse Event|0|||
33590009|NCT02288325|62988308|FG000|Stabilization Period|Lack of Efficacy|22|||
33590010|NCT02288325|62988309|FG001|Stabilization Period|Lack of Efficacy|0|||
33590011|NCT02288325|62988310|FG002|Stabilization Period|Lack of Efficacy|0|||
33590012|NCT02288325|62988308|FG000|Stabilization Period|Withdrawal of Consent|23|||
33590013|NCT02288325|62988309|FG001|Stabilization Period|Withdrawal of Consent|0|||
33590014|NCT02288325|62988310|FG002|Stabilization Period|Withdrawal of Consent|0|||
33590015|NCT02288325|62988308|FG000|Stabilization Period|Lost to Follow-up|12|||
33590016|NCT02288325|62988309|FG001|Stabilization Period|Lost to Follow-up|0|||
33590017|NCT02288325|62988310|FG002|Stabilization Period|Lost to Follow-up|0|||
33590018|NCT02288325|62988308|FG000|Stabilization Period|Protocol Violation|8|||
33590019|NCT02288325|62988309|FG001|Stabilization Period|Protocol Violation|0|||
33590020|NCT02288325|62988310|FG002|Stabilization Period|Protocol Violation|0|||
33590021|NCT02288325|62988308|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
33590022|NCT02288325|62988309|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
33590023|NCT02288325|62988310|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
33590024|NCT02288325|62988308|FG000|Stabilization Period|Reason not Specified|15|||
33590025|NCT02288325|62988309|FG001|Stabilization Period|Reason not Specified|0|||
33590026|NCT02288325|62988310|FG002|Stabilization Period|Reason not Specified|0|||
33590027|NCT02288325|62988308|FG000|Double-blind Treatment Period|Adverse Event|0|||
33590028|NCT02288325|62988309|FG001|Double-blind Treatment Period|Adverse Event|2|||
33590029|NCT02288325|62988310|FG002|Double-blind Treatment Period|Adverse Event|5|||
33590030|NCT02288325|62988308|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
33590031|NCT02288325|62988309|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
33590032|NCT02288325|62988310|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
33590033|NCT02288325|62988308|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
33590034|NCT02288325|62988309|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
33590035|NCT02288325|62988310|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
33590036|NCT02288325|62988308|FG000|Double-blind Treatment Period|Protocol Violation|0|||
33590037|NCT02288325|62988309|FG001|Double-blind Treatment Period|Protocol Violation|1|||
33590038|NCT02288325|62988310|FG002|Double-blind Treatment Period|Protocol Violation|2|||
33590039|NCT02288325|62988308|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
33590040|NCT02288325|62988309|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
33590041|NCT02288325|62988310|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
33590042|NCT02288325|62988308|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
33590043|NCT02288325|62988309|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
33590044|NCT02288325|62988310|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
33590045|NCT02509117|62988327|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33590046|NCT02509117|62988328|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
33590047|NCT02509117|62988329|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33590048|NCT02509117|62988330|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33590049|NCT02509117|62988331|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33590050|NCT02509117|62988332|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33590051|NCT02509117|62988333|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33590052|NCT02509117|62988334|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33590053|NCT02509117|62988335|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33590054|NCT02509117|62988336|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33590055|NCT02509117|62988327|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33590056|NCT02509117|62988328|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33590057|NCT02509117|62988329|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33590058|NCT02509117|62988330|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33590059|NCT02509117|62988331|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33590060|NCT02509117|62988332|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33590061|NCT02509117|62988333|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33590062|NCT02509117|62988334|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33590063|NCT02509117|62988335|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33590064|NCT02509117|62988336|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
33590065|NCT02509117|62988327|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33590066|NCT02509117|62988328|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33590067|NCT02509117|62988329|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33590068|NCT02509117|62988330|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33590069|NCT02509117|62988331|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33590070|NCT02509117|62988332|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33590071|NCT02509117|62988333|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33590072|NCT02509117|62988334|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33590073|NCT02509117|62988335|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33590074|NCT02509117|62988336|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
33590075|NCT01654549|62988376|FG000|Overall Study|H.pylori eradication not successful|0|||
33590076|NCT01654549|62988377|FG001|Overall Study|H.pylori eradication not successful|1|||
33590077|NCT02508649|62988391|FG000|Overall Study|Withdrawal by Subject|4|||
33590078|NCT02508649|62988392|FG001|Overall Study|Withdrawal by Subject|6|||
33590079|NCT02508649|62988393|FG002|Overall Study|Withdrawal by Subject|5|||
33590080|NCT02508649|62988394|FG003|Overall Study|Withdrawal by Subject|6|||
33590081|NCT02508649|62988391|FG000|Overall Study|Investigator withdrew the subject|1|||
33590082|NCT02508649|62988392|FG001|Overall Study|Investigator withdrew the subject|2|||
33590083|NCT02508649|62988393|FG002|Overall Study|Investigator withdrew the subject|1|||
33590084|NCT02508649|62988394|FG003|Overall Study|Investigator withdrew the subject|0|||
33590085|NCT02508649|62988391|FG000|Overall Study|Post randomization screening failure|12|||
33590086|NCT02508649|62988392|FG001|Overall Study|Post randomization screening failure|4|||
33590087|NCT02508649|62988393|FG002|Overall Study|Post randomization screening failure|9|||
33590088|NCT02508649|62988394|FG003|Overall Study|Post randomization screening failure|3|||
33590089|NCT02508649|62988391|FG000|Overall Study|Lost to Follow-up|1|||
33590090|NCT02508649|62988392|FG001|Overall Study|Lost to Follow-up|1|||
33590091|NCT02508649|62988393|FG002|Overall Study|Lost to Follow-up|0|||
33590092|NCT02508649|62988394|FG003|Overall Study|Lost to Follow-up|1|||
33590093|NCT02505217|62988409|FG000|Overall Study|Withdrawal by Subject|1|||
33590094|NCT02505217|62988410|FG001|Overall Study|Withdrawal by Subject|2|||
33590095|NCT02504827|62988416|FG000|Overall Study|Could not produce sputum|1|||
33590096|NCT02504671|62988426|FG000|Overall Study|Withdrawal by Subject|1|||
33590097|NCT02504671|62988427|FG001|Overall Study|Withdrawal by Subject|5|||
33590098|NCT02504671|62988428|FG002|Overall Study|Withdrawal by Subject|4|||
33590099|NCT02504671|62988429|FG003|Overall Study|Withdrawal by Subject|4|||
33590100|NCT02504671|62988430|FG004|Overall Study|Withdrawal by Subject|5|||
33590101|NCT02504671|62988431|FG005|Overall Study|Withdrawal by Subject|3|||
33590102|NCT02504671|62988426|FG000|Overall Study|Lack of Efficacy|1|||
33590103|NCT02504671|62988427|FG001|Overall Study|Lack of Efficacy|3|||
33590104|NCT02504671|62988428|FG002|Overall Study|Lack of Efficacy|1|||
33590105|NCT02504671|62988429|FG003|Overall Study|Lack of Efficacy|0|||
33590106|NCT02504671|62988430|FG004|Overall Study|Lack of Efficacy|4|||
33590107|NCT02504671|62988431|FG005|Overall Study|Lack of Efficacy|4|||
33590108|NCT02504671|62988426|FG000|Overall Study|Adverse Event|1|||
33590109|NCT02504671|62988427|FG001|Overall Study|Adverse Event|1|||
33590110|NCT02504671|62988428|FG002|Overall Study|Adverse Event|0|||
33590111|NCT02504671|62988429|FG003|Overall Study|Adverse Event|1|||
33590112|NCT02504671|62988430|FG004|Overall Study|Adverse Event|0|||
33590113|NCT02504671|62988431|FG005|Overall Study|Adverse Event|2|||
33590114|NCT02504671|62988426|FG000|Overall Study|Protocol Violation|2|||
33590115|NCT02504671|62988427|FG001|Overall Study|Protocol Violation|1|||
33590116|NCT02504671|62988428|FG002|Overall Study|Protocol Violation|0|||
33590117|NCT02504671|62988429|FG003|Overall Study|Protocol Violation|0|||
33590118|NCT02504671|62988430|FG004|Overall Study|Protocol Violation|0|||
33590119|NCT02504671|62988431|FG005|Overall Study|Protocol Violation|1|||
33590120|NCT02504671|62988426|FG000|Overall Study|Lost to Follow-up|0|||
33590121|NCT02504671|62988427|FG001|Overall Study|Lost to Follow-up|0|||
33590122|NCT02504671|62988428|FG002|Overall Study|Lost to Follow-up|2|||
33590123|NCT02504671|62988429|FG003|Overall Study|Lost to Follow-up|0|||
33590124|NCT02504671|62988430|FG004|Overall Study|Lost to Follow-up|0|||
33590125|NCT02504671|62988431|FG005|Overall Study|Lost to Follow-up|1|||
33590126|NCT02504671|62988426|FG000|Overall Study|Protocol defined stopping criteria|7|||
33590127|NCT02504671|62988427|FG001|Overall Study|Protocol defined stopping criteria|4|||
33590128|NCT02504671|62988428|FG002|Overall Study|Protocol defined stopping criteria|3|||
33590129|NCT02504671|62988429|FG003|Overall Study|Protocol defined stopping criteria|5|||
33590130|NCT02504671|62988430|FG004|Overall Study|Protocol defined stopping criteria|3|||
33590131|NCT02504671|62988431|FG005|Overall Study|Protocol defined stopping criteria|3|||
33680263|NCT01414166|63135134|FG001|Overall Study|Withdrawal by Subject|5|||
33680264|NCT01434680|63135144|FG000|Overall Study|Withdrawal by Subject|1|||
33680265|NCT01434680|63135145|FG001|Overall Study|Withdrawal by Subject|0|||
33590132|NCT02314143|62988448|FG000|Overall Study|Adverse Event|0|||
33590133|NCT02314143|62988449|FG001|Overall Study|Adverse Event|6|||
33590134|NCT02314143|62988450|FG002|Overall Study|Adverse Event|4|||
33590135|NCT02314143|62988448|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
33590136|NCT02314143|62988449|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
33590137|NCT02314143|62988450|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
33590138|NCT02314143|62988448|FG000|Overall Study|Physician Decision|2|||
33590139|NCT02314143|62988449|FG001|Overall Study|Physician Decision|1|||
33590140|NCT02314143|62988450|FG002|Overall Study|Physician Decision|0|||
33590141|NCT02314143|62988448|FG000|Overall Study|Withdrawal by Subject|1|||
33590142|NCT02314143|62988449|FG001|Overall Study|Withdrawal by Subject|0|||
33590143|NCT02314143|62988450|FG002|Overall Study|Withdrawal by Subject|1|||
33590144|NCT02288091|62988459|FG000|Overall Study|Lost to Follow-up|1|||
33590145|NCT02288091|62988459|FG000|Overall Study|Screen fail|7|||
33590146|NCT02503501|62988465|FG000|Overall Study|Physician Decision|1|||
33590147|NCT02503501|62988466|FG001|Overall Study|Physician Decision|0|||
33590148|NCT02503501|62988465|FG000|Overall Study|Protocol Violation|0|||
33590149|NCT02503501|62988466|FG001|Overall Study|Protocol Violation|1|||
33590150|NCT02503501|62988465|FG000|Overall Study|Withdrawal by Subject|0|||
33590151|NCT02503501|62988466|FG001|Overall Study|Withdrawal by Subject|2|||
33590152|NCT02502097|62988476|FG000|Period 1|Adverse Event|0|||
33590153|NCT02502097|62988477|FG001|Period 1|Adverse Event|0|||
33590154|NCT02502097|62988478|FG002|Period 1|Adverse Event|1|||
33590155|NCT02502097|62988479|FG003|Period 1|Adverse Event|0|||
33590156|NCT02502097|62988476|FG000|Wash Out Period|Adverse Event|0|||
33590157|NCT02502097|62988477|FG001|Wash Out Period|Adverse Event|1|||
33590158|NCT02502097|62988478|FG002|Wash Out Period|Adverse Event|1|||
33590159|NCT02502097|62988479|FG003|Wash Out Period|Adverse Event|1|||
33590160|NCT02502097|62988476|FG000|Period 2|Adverse Event|0|||
33590161|NCT02502097|62988477|FG001|Period 2|Adverse Event|0|||
33590162|NCT02502097|62988478|FG002|Period 2|Adverse Event|1|||
33590163|NCT02502097|62988479|FG003|Period 2|Adverse Event|0|||
33590164|NCT02501629|62988488|FG000|Overall Study|Death|0|||
33590165|NCT02501629|62988489|FG001|Overall Study|Death|1|||
33590166|NCT02501629|62988488|FG000|Overall Study|Withdrawn from study by sponsor|1|||
33590167|NCT02501629|62988489|FG001|Overall Study|Withdrawn from study by sponsor|0|||
33590168|NCT02501629|62988488|FG000|Overall Study|Early termination by sponsor|1|||
33590169|NCT02501629|62988489|FG001|Overall Study|Early termination by sponsor|0|||
33590170|NCT02501629|62988488|FG000|Overall Study|Withdrawal by Subject|3|||
33590171|NCT02501629|62988489|FG001|Overall Study|Withdrawal by Subject|5|||
33590172|NCT02501629|62988488|FG000|Overall Study|Subject did not return to site|0|||
33590173|NCT02501629|62988489|FG001|Overall Study|Subject did not return to site|1|||
33590174|NCT02501473|62988502|FG000|Overall Study|Study Terminated|2|||
33590175|NCT02501473|62988503|FG001|Overall Study|Study Terminated|3|||
33590176|NCT02501473|62988504|FG002|Overall Study|Study Terminated|7|||
33590177|NCT02501473|62988505|FG003|Overall Study|Study Terminated|9|||
33590178|NCT02501473|62988506|FG004|Overall Study|Study Terminated|2|||
33590179|NCT02501473|62988507|FG005|Overall Study|Study Terminated|10|||
33590180|NCT02501473|62988508|FG006|Overall Study|Study Terminated|1|||
33590181|NCT02501473|62988509|FG007|Overall Study|Study Terminated|0|||
33590182|NCT02501473|62988502|FG000|Overall Study|Withdrawal by Subject|0|||
33590183|NCT02501473|62988503|FG001|Overall Study|Withdrawal by Subject|0|||
33590184|NCT02501473|62988504|FG002|Overall Study|Withdrawal by Subject|3|||
33590185|NCT02501473|62988505|FG003|Overall Study|Withdrawal by Subject|3|||
33590186|NCT02501473|62988506|FG004|Overall Study|Withdrawal by Subject|2|||
33590187|NCT02501473|62988507|FG005|Overall Study|Withdrawal by Subject|2|||
33590188|NCT02501473|62988508|FG006|Overall Study|Withdrawal by Subject|0|||
33590189|NCT02501473|62988509|FG007|Overall Study|Withdrawal by Subject|0|||
33590190|NCT02501473|62988502|FG000|Overall Study|Death|0|||
33590191|NCT02501473|62988503|FG001|Overall Study|Death|0|||
33590192|NCT02501473|62988504|FG002|Overall Study|Death|1|||
33590193|NCT02501473|62988505|FG003|Overall Study|Death|1|||
33590194|NCT02501473|62988506|FG004|Overall Study|Death|0|||
33590195|NCT02501473|62988507|FG005|Overall Study|Death|1|||
33590196|NCT02501473|62988508|FG006|Overall Study|Death|0|||
33590197|NCT02501473|62988509|FG007|Overall Study|Death|0|||
33590198|NCT02501473|62988502|FG000|Overall Study|Lost to Follow-up|1|||
33590199|NCT02501473|62988503|FG001|Overall Study|Lost to Follow-up|0|||
33590200|NCT02501473|62988504|FG002|Overall Study|Lost to Follow-up|1|||
33590201|NCT02501473|62988505|FG003|Overall Study|Lost to Follow-up|0|||
33590202|NCT02501473|62988506|FG004|Overall Study|Lost to Follow-up|0|||
33590203|NCT02501473|62988507|FG005|Overall Study|Lost to Follow-up|1|||
33590204|NCT02501473|62988508|FG006|Overall Study|Lost to Follow-up|0|||
33590205|NCT02501473|62988509|FG007|Overall Study|Lost to Follow-up|0|||
33590206|NCT02501473|62988502|FG000|Overall Study|Reason not specified|0|||
33590207|NCT02501473|62988503|FG001|Overall Study|Reason not specified|0|||
33590208|NCT02501473|62988504|FG002|Overall Study|Reason not specified|1|||
33590209|NCT02501473|62988505|FG003|Overall Study|Reason not specified|1|||
33590210|NCT02501473|62988506|FG004|Overall Study|Reason not specified|0|||
33590211|NCT02501473|62988507|FG005|Overall Study|Reason not specified|0|||
33590212|NCT02501473|62988508|FG006|Overall Study|Reason not specified|0|||
33590213|NCT02501473|62988509|FG007|Overall Study|Reason not specified|0|||
33590214|NCT02501161|62988527|FG000|Overall Study|Adverse Event|2|||
33590215|NCT02501161|62988528|FG001|Overall Study|Adverse Event|6|||
33590216|NCT02501161|62988527|FG000|Overall Study|Lost to Follow-up|7|||
33590217|NCT02501161|62988528|FG001|Overall Study|Lost to Follow-up|4|||
33590218|NCT02501161|62988527|FG000|Overall Study|Withdrawal by Subject|10|||
33590219|NCT02501161|62988528|FG001|Overall Study|Withdrawal by Subject|15|||
33590220|NCT02501161|62988527|FG000|Overall Study|Other|3|||
33590221|NCT02501161|62988528|FG001|Overall Study|Other|0|||
33590222|NCT02500537|62988536|FG000|Overall Study|Death|2|||
33590223|NCT02500537|62988537|FG001|Overall Study|Death|0|||
33590224|NCT02500537|62988536|FG000|Overall Study|Lost to Follow-up|0|||
33590225|NCT02500537|62988537|FG001|Overall Study|Lost to Follow-up|1|||
33590226|NCT02500537|62988536|FG000|Overall Study|Withdrawal by Subject|1|||
33590227|NCT02500537|62988537|FG001|Overall Study|Withdrawal by Subject|0|||
33590228|NCT02498821|62988546|FG000|Overall Study|Screen failure|3|||
33590229|NCT02498821|62988547|FG001|Overall Study|Screen failure|5|||
33590230|NCT02313909|62988555|FG000|Overall Study|Consent withdrawn by participant|33|||
33590231|NCT02313909|62988556|FG001|Overall Study|Consent withdrawn by participant|33|||
33590232|NCT02313909|62988555|FG000|Overall Study|Lost to Follow-up|24|||
33590233|NCT02313909|62988556|FG001|Overall Study|Lost to Follow-up|17|||
33590234|NCT02287467|62988564|FG000|Overall Study|Protocol Violation|12|||
33590235|NCT02287467|62988565|FG001|Overall Study|Protocol Violation|9|||
33590236|NCT02287233|62988577|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
33590237|NCT02287233|62988578|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
33590238|NCT02287233|62988579|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
33590239|NCT02287233|62988577|FG000|Overall Study|Adverse Event Related to Progression|0|||
33590240|NCT02287233|62988578|FG001|Overall Study|Adverse Event Related to Progression|2|||
33590241|NCT02287233|62988579|FG002|Overall Study|Adverse Event Related to Progression|8|||
33590242|NCT02287233|62988577|FG000|Overall Study|Physician Decision|1|||
33590243|NCT02287233|62988578|FG001|Overall Study|Physician Decision|2|||
33590244|NCT02287233|62988579|FG002|Overall Study|Physician Decision|4|||
33590245|NCT02287233|62988577|FG000|Overall Study|Progressive Disease with Death|0|||
33590246|NCT02287233|62988578|FG001|Overall Study|Progressive Disease with Death|0|||
33590247|NCT02287233|62988579|FG002|Overall Study|Progressive Disease with Death|10|||
33590248|NCT02287233|62988577|FG000|Overall Study|Progressive Disease Without Death|2|||
33590249|NCT02287233|62988578|FG001|Overall Study|Progressive Disease Without Death|3|||
33590250|NCT02287233|62988579|FG002|Overall Study|Progressive Disease Without Death|20|||
33590251|NCT02287233|62988577|FG000|Overall Study|Withdrawal by Subject|1|||
33590252|NCT02287233|62988578|FG001|Overall Study|Withdrawal by Subject|1|||
33590253|NCT02287233|62988579|FG002|Overall Study|Withdrawal by Subject|7|||
33590254|NCT02287233|62988577|FG000|Overall Study|Other|3|||
33590255|NCT02287233|62988578|FG001|Overall Study|Other|0|||
33590256|NCT02287233|62988579|FG002|Overall Study|Other|15|||
33590257|NCT02287233|62988577|FG000|Overall Study|Did Not Receive Treatment|0|||
33590258|NCT02287233|62988578|FG001|Overall Study|Did Not Receive Treatment|0|||
33590259|NCT02287233|62988579|FG002|Overall Study|Did Not Receive Treatment|2|||
33590260|NCT01646385|62988592|FG000|Overall Study|Death|202|||
33590261|NCT01646385|62988593|FG001|Overall Study|Death|222|||
33590262|NCT01646385|62988592|FG000|Overall Study|Switched to alternate biologic|636|||
33590263|NCT01646385|62988593|FG001|Overall Study|Switched to alternate biologic|649|||
33590264|NCT02286843|62988599|FG000|Overall Study|Not Treated|4|||
33590265|NCT02286843|62988599|FG000|Overall Study|Protocol Violation|1|||
33590266|NCT02286843|62988599|FG000|Overall Study|Withdrawal by Subject|1|||
33590267|NCT02282163|62988603|FG000|Overall Study|Protocol Violation|1|||
33590268|NCT02281773|62988621|FG000|Overall Study|Adverse Event|6|||
33590269|NCT02281773|62988622|FG001|Overall Study|Adverse Event|1|||
33590270|NCT02281773|62988623|FG002|Overall Study|Adverse Event|4|||
33590271|NCT02281773|62988624|FG003|Overall Study|Adverse Event|8|||
33590272|NCT02281773|62988625|FG004|Overall Study|Adverse Event|9|||
33590273|NCT02281773|62988621|FG000|Overall Study|Protocol Violation|1|||
33590274|NCT02281773|62988622|FG001|Overall Study|Protocol Violation|0|||
33590275|NCT02281773|62988623|FG002|Overall Study|Protocol Violation|0|||
33590276|NCT02281773|62988624|FG003|Overall Study|Protocol Violation|2|||
33590277|NCT02281773|62988625|FG004|Overall Study|Protocol Violation|2|||
33680266|NCT01434680|63135146|FG002|Overall Study|Withdrawal by Subject|2|||
33680267|NCT01434680|63135147|FG003|Overall Study|Withdrawal by Subject|0|||
33680268|NCT01434680|63135144|FG000|Overall Study|Lost to Follow-up|1|||
33680269|NCT01434680|63135145|FG001|Overall Study|Lost to Follow-up|1|||
33401426|NCT00737477|62780462|FG000|Overall Study|Other|4|||
33590278|NCT02281773|62988621|FG000|Overall Study|Lost to Follow-up|2|||
33590279|NCT02281773|62988622|FG001|Overall Study|Lost to Follow-up|2|||
33590280|NCT02281773|62988623|FG002|Overall Study|Lost to Follow-up|6|||
33590281|NCT02281773|62988624|FG003|Overall Study|Lost to Follow-up|2|||
33590282|NCT02281773|62988625|FG004|Overall Study|Lost to Follow-up|10|||
33590283|NCT02281773|62988621|FG000|Overall Study|Withdrawal by Subject|2|||
33590284|NCT02281773|62988622|FG001|Overall Study|Withdrawal by Subject|8|||
33590285|NCT02281773|62988623|FG002|Overall Study|Withdrawal by Subject|6|||
33590286|NCT02281773|62988624|FG003|Overall Study|Withdrawal by Subject|6|||
33590287|NCT02281773|62988625|FG004|Overall Study|Withdrawal by Subject|8|||
33590288|NCT02281773|62988621|FG000|Overall Study|Other Reason|0|||
33590289|NCT02281773|62988622|FG001|Overall Study|Other Reason|4|||
33680270|NCT01434680|63135146|FG002|Overall Study|Lost to Follow-up|0|||
33590290|NCT02281773|62988623|FG002|Overall Study|Other Reason|2|||
33590291|NCT02281773|62988624|FG003|Overall Study|Other Reason|3|||
33590292|NCT02281773|62988625|FG004|Overall Study|Other Reason|1|||
33590293|NCT02285361|62988637|FG000|Overall Study|Protocol Violation|43|||
33590294|NCT02285361|62988637|FG000|Overall Study|Lost to Follow-up|5|||
33590295|NCT02285361|62988637|FG000|Overall Study|Not taken GIOTRIF|2|||
33590296|NCT02285361|62988637|FG000|Overall Study|Consented prior to the contract date|1|||
33590297|NCT02354235|62988643|FG000|Overall Study|Adverse Event|2|||
33590298|NCT02354235|62988644|FG001|Overall Study|Adverse Event|2|||
33590299|NCT02354235|62988643|FG000|Overall Study|Physician Decision|0|||
33590300|NCT02354235|62988644|FG001|Overall Study|Physician Decision|1|||
33590301|NCT02354235|62988643|FG000|Overall Study|Withdrawal by Subject|1|||
33590302|NCT02354235|62988644|FG001|Overall Study|Withdrawal by Subject|3|||
33590303|NCT02354235|62988643|FG000|Overall Study|Conflict with the stopping criteria|0|||
33590304|NCT02354235|62988644|FG001|Overall Study|Conflict with the stopping criteria|1|||
33590305|NCT02280291|62988654|FG000|Overall Study|Lost to Follow-up|2|||
33590306|NCT02280291|62988655|FG001|Overall Study|Lost to Follow-up|1|||
33590307|NCT02280291|62988656|FG002|Overall Study|Lost to Follow-up|3|||
33590308|NCT02280291|62988657|FG003|Overall Study|Lost to Follow-up|8|||
33590309|NCT02280291|62988654|FG000|Overall Study|Protocol Violation|1|||
33590310|NCT02280291|62988655|FG001|Overall Study|Protocol Violation|0|||
33590311|NCT02280291|62988656|FG002|Overall Study|Protocol Violation|0|||
33590312|NCT02280291|62988657|FG003|Overall Study|Protocol Violation|0|||
33590313|NCT02280291|62988654|FG000|Overall Study|Other|1|||
33590314|NCT02280291|62988655|FG001|Overall Study|Other|1|||
33590315|NCT02280291|62988656|FG002|Overall Study|Other|0|||
33590316|NCT02280291|62988657|FG003|Overall Study|Other|0|||
33590317|NCT02284893|62988671|FG000|26 Week (Short Term)|Adverse Event|1|||
33590318|NCT02284893|62988672|FG001|26 Week (Short Term)|Adverse Event|9|||
33590319|NCT02284893|62988671|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
33590320|NCT02284893|62988672|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
33590321|NCT02284893|62988671|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
33590322|NCT02284893|62988672|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
33590323|NCT02284893|62988671|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
33590324|NCT02284893|62988672|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
33590325|NCT02284893|62988671|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
33590326|NCT02284893|62988672|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
33590327|NCT02284893|62988671|FG000|26 Week (Short Term)|Other|1|||
33590328|NCT02284893|62988672|FG001|26 Week (Short Term)|Other|1|||
33590329|NCT02284893|62988671|FG000|52 Week (Long Term)|Adverse Event|3|||
33590330|NCT02284893|62988672|FG001|52 Week (Long Term)|Adverse Event|1|||
33590331|NCT02284893|62988671|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
33590332|NCT02284893|62988672|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
33590333|NCT02284893|62988671|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
33590334|NCT02284893|62988672|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
33590335|NCT02284893|62988671|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
33590336|NCT02284893|62988672|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
33590337|NCT02284893|62988671|FG000|52 Week (Long Term)|Non-Compliance|2|||
33590338|NCT02284893|62988672|FG001|52 Week (Long Term)|Non-Compliance|3|||
33590339|NCT02284347|62988678|FG000|Overall Study|Lost to Follow-up|2|||
33590340|NCT02284347|62988678|FG000|Overall Study|Withdrawn prior to treatment|1|||
33590341|NCT02279043|62988685|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
33590342|NCT02279043|62988686|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
33590343|NCT02279043|62988687|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
33590344|NCT02279043|62988685|FG000|Overall Study|Lost to Follow-up|46|||
33590345|NCT02279043|62988686|FG001|Overall Study|Lost to Follow-up|88|||
33590346|NCT02279043|62988687|FG002|Overall Study|Lost to Follow-up|0|||
33590347|NCT02283411|62988693|FG000|Overall Study|Withdrawal by Subject|3|||
33590348|NCT02283411|62988693|FG000|Overall Study|Screen Failed|28|||
33590349|NCT02351817|62988697|FG000|Period 1|Adverse Event|1|||
33590350|NCT02351817|62988698|FG001|Period 1|Adverse Event|2|||
33590351|NCT02351817|62988697|FG000|Period 1|Lack of Efficacy|0|||
33590352|NCT02351817|62988698|FG001|Period 1|Lack of Efficacy|1|||
33590353|NCT02351817|62988697|FG000|Period 2|Adverse Event|0|||
33590354|NCT02351817|62988698|FG001|Period 2|Adverse Event|2|||
33590355|NCT02351817|62988697|FG000|Period 2|Protocol Violation|1|||
33590356|NCT02351817|62988698|FG001|Period 2|Protocol Violation|0|||
33680271|NCT01434680|63135147|FG003|Overall Study|Lost to Follow-up|0|||
33680272|NCT01434680|63135144|FG000|Overall Study|Protocol Violation|1|||
33590357|NCT02351349|62988707|FG000|Overall Study|Withdrawal by Subject|2|||
33590358|NCT02351349|62988708|FG001|Overall Study|Withdrawal by Subject|3|||
33590359|NCT02484547|62988722|FG000|Placebo-Controlled Period|Adverse Event|10|||
33590360|NCT02484547|62988723|FG001|Placebo-Controlled Period|Adverse Event|13|||
33590361|NCT02484547|62988724|FG002|Placebo-Controlled Period|Adverse Event|20|||
33590362|NCT02484547|62988725|FG003|Placebo-Controlled Period|Adverse Event|0|||
33590363|NCT02484547|62988726|FG004|Placebo-Controlled Period|Adverse Event|0|||
33590364|NCT02484547|62988727|FG005|Placebo-Controlled Period|Adverse Event|0|||
33590365|NCT02484547|62988728|FG006|Placebo-Controlled Period|Adverse Event|0|||
33590366|NCT02484547|62988722|FG000|Placebo-Controlled Period|Change of Treatment|0|||
33590367|NCT02484547|62988723|FG001|Placebo-Controlled Period|Change of Treatment|0|||
33590368|NCT02484547|62988724|FG002|Placebo-Controlled Period|Change of Treatment|1|||
33590369|NCT02484547|62988725|FG003|Placebo-Controlled Period|Change of Treatment|0|||
33590370|NCT02484547|62988726|FG004|Placebo-Controlled Period|Change of Treatment|0|||
33590371|NCT02484547|62988727|FG005|Placebo-Controlled Period|Change of Treatment|0|||
33590372|NCT02484547|62988728|FG006|Placebo-Controlled Period|Change of Treatment|0|||
33590373|NCT02484547|62988722|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
33590374|NCT02484547|62988723|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
33590375|NCT02484547|62988724|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
33590376|NCT02484547|62988725|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
33590377|NCT02484547|62988726|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
33590378|NCT02484547|62988727|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
33590379|NCT02484547|62988728|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
33590380|NCT02484547|62988722|FG000|Placebo-Controlled Period|Death|5|||
33590381|NCT02484547|62988723|FG001|Placebo-Controlled Period|Death|0|||
33590382|NCT02484547|62988724|FG002|Placebo-Controlled Period|Death|6|||
33590383|NCT02484547|62988725|FG003|Placebo-Controlled Period|Death|0|||
33590384|NCT02484547|62988726|FG004|Placebo-Controlled Period|Death|0|||
33590385|NCT02484547|62988727|FG005|Placebo-Controlled Period|Death|0|||
33590386|NCT02484547|62988728|FG006|Placebo-Controlled Period|Death|0|||
33590387|NCT02484547|62988722|FG000|Placebo-Controlled Period|Disease Progression|2|||
33590388|NCT02484547|62988723|FG001|Placebo-Controlled Period|Disease Progression|0|||
33590389|NCT02484547|62988724|FG002|Placebo-Controlled Period|Disease Progression|1|||
33680273|NCT01434680|63135145|FG001|Overall Study|Protocol Violation|1|||
33680274|NCT01434680|63135146|FG002|Overall Study|Protocol Violation|0|||
33680275|NCT01434680|63135147|FG003|Overall Study|Protocol Violation|0|||
33680276|NCT01433978|63135280|FG000|Core Study|Adverse Event, Non-Fatal|0|||
33680277|NCT01433978|63135281|FG001|Core Study|Adverse Event, Non-Fatal|1|||
33680278|NCT01433978|63135282|FG002|Core Study|Adverse Event, Non-Fatal|0|||
33680279|NCT01433978|63135280|FG000|Core Study|Lack of Efficacy|5|||
33680280|NCT01433978|63135281|FG001|Core Study|Lack of Efficacy|1|||
33680281|NCT01433978|63135282|FG002|Core Study|Lack of Efficacy|0|||
33680282|NCT01433978|63135280|FG000|Core Study|Study Terminated by Sponsor|6|||
33680283|NCT01433978|63135281|FG001|Core Study|Study Terminated by Sponsor|9|||
33680284|NCT01433978|63135282|FG002|Core Study|Study Terminated by Sponsor|0|||
33680285|NCT01433978|63135280|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
33680286|NCT01433978|63135281|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
33680287|NCT01433978|63135282|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
33680288|NCT01433978|63135280|FG000|Extension Phase|Lack of Efficacy|0|||
33680289|NCT01433978|63135281|FG001|Extension Phase|Lack of Efficacy|0|||
33680290|NCT01433978|63135282|FG002|Extension Phase|Lack of Efficacy|1|||
33680291|NCT01433978|63135280|FG000|Extension Phase|Study Terminated by Sponsor|0|||
33680292|NCT01433978|63135281|FG001|Extension Phase|Study Terminated by Sponsor|0|||
33680293|NCT01433978|63135282|FG002|Extension Phase|Study Terminated by Sponsor|4|||
33680294|NCT01433354|63135331|FG000|Overall Study|Adverse Event|6|||
33680295|NCT01433354|63135331|FG000|Overall Study|Lost to Follow-up|1|||
33680296|NCT01433354|63135331|FG000|Overall Study|Administrative problems|90|||
33680297|NCT01433354|63135331|FG000|Overall Study|Protocol Violation|2|||
33680298|NCT01433354|63135331|FG000|Overall Study|Lack of Efficacy|17|||
33680299|NCT01433354|63135331|FG000|Overall Study|Subject Withdrew Consent|3|||
33680300|NCT04508023|63135842|FG000|Overall Study|Withdrawal by Subject|1|||
33590390|NCT02484547|62988725|FG003|Placebo-Controlled Period|Disease Progression|0|||
33590391|NCT02484547|62988726|FG004|Placebo-Controlled Period|Disease Progression|0|||
33590392|NCT02484547|62988727|FG005|Placebo-Controlled Period|Disease Progression|0|||
33590393|NCT02484547|62988728|FG006|Placebo-Controlled Period|Disease Progression|0|||
33590394|NCT02484547|62988722|FG000|Placebo-Controlled Period|Investigator Decision|2|||
33590395|NCT02484547|62988723|FG001|Placebo-Controlled Period|Investigator Decision|2|||
33590396|NCT02484547|62988724|FG002|Placebo-Controlled Period|Investigator Decision|5|||
33590397|NCT02484547|62988725|FG003|Placebo-Controlled Period|Investigator Decision|0|||
33680301|NCT04508023|63135843|FG001|Overall Study|Withdrawal by Subject|2|||
33680302|NCT04187144|63135851|FG000|Overall Study|Lost to Follow-up|12|||
33680303|NCT04187144|63135852|FG001|Overall Study|Lost to Follow-up|11|||
33590398|NCT02484547|62988726|FG004|Placebo-Controlled Period|Investigator Decision|0|||
33590399|NCT02484547|62988727|FG005|Placebo-Controlled Period|Investigator Decision|0|||
33590400|NCT02484547|62988728|FG006|Placebo-Controlled Period|Investigator Decision|0|||
33590401|NCT02484547|62988722|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
33680304|NCT04187144|63135851|FG000|Overall Study|Withdrawal by Subject|20|||
33680305|NCT04187144|63135852|FG001|Overall Study|Withdrawal by Subject|18|||
33680306|NCT04187144|63135851|FG000|Overall Study|Adverse Event|19|||
33680307|NCT04187144|63135852|FG001|Overall Study|Adverse Event|4|||
33680308|NCT04187144|63135851|FG000|Overall Study|Physician Decision|5|||
33680309|NCT04187144|63135852|FG001|Overall Study|Physician Decision|3|||
33590402|NCT02484547|62988723|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
33590403|NCT02484547|62988724|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
33590404|NCT02484547|62988725|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
33590405|NCT02484547|62988726|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
33590406|NCT02484547|62988727|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
33590407|NCT02484547|62988728|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
33590408|NCT02484547|62988722|FG000|Placebo-Controlled Period|Relocation|1|||
33590409|NCT02484547|62988723|FG001|Placebo-Controlled Period|Relocation|1|||
33590410|NCT02484547|62988724|FG002|Placebo-Controlled Period|Relocation|1|||
33590411|NCT02484547|62988725|FG003|Placebo-Controlled Period|Relocation|0|||
33590412|NCT02484547|62988726|FG004|Placebo-Controlled Period|Relocation|0|||
33590413|NCT02484547|62988727|FG005|Placebo-Controlled Period|Relocation|0|||
33590414|NCT02484547|62988728|FG006|Placebo-Controlled Period|Relocation|0|||
33590415|NCT02484547|62988722|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
33590416|NCT02484547|62988723|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
33590417|NCT02484547|62988724|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
33590418|NCT02484547|62988725|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
33590419|NCT02484547|62988726|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
33590420|NCT02484547|62988727|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
33590421|NCT02484547|62988728|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
33590422|NCT02484547|62988722|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
33590423|NCT02484547|62988723|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
33590424|NCT02484547|62988724|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
33590425|NCT02484547|62988725|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33590426|NCT02484547|62988726|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33590427|NCT02484547|62988727|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33590428|NCT02484547|62988728|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33590429|NCT02484547|62988722|FG000|Placebo-Controlled Period|Reason not Specified|216|||
33590430|NCT02484547|62988723|FG001|Placebo-Controlled Period|Reason not Specified|194|||
33590431|NCT02484547|62988724|FG002|Placebo-Controlled Period|Reason not Specified|183|||
33590432|NCT02484547|62988725|FG003|Placebo-Controlled Period|Reason not Specified|0|||
33590433|NCT02484547|62988726|FG004|Placebo-Controlled Period|Reason not Specified|0|||
33590434|NCT02484547|62988727|FG005|Placebo-Controlled Period|Reason not Specified|0|||
33590435|NCT02484547|62988728|FG006|Placebo-Controlled Period|Reason not Specified|0|||
33590436|NCT02484547|62988722|FG000|Long-Term Extension Period|Adverse Event|0|||
33590437|NCT02484547|62988723|FG001|Long-Term Extension Period|Adverse Event|0|||
33590438|NCT02484547|62988724|FG002|Long-Term Extension Period|Adverse Event|0|||
33590439|NCT02484547|62988725|FG003|Long-Term Extension Period|Adverse Event|0|||
33590440|NCT02484547|62988726|FG004|Long-Term Extension Period|Adverse Event|1|||
33590441|NCT02484547|62988727|FG005|Long-Term Extension Period|Adverse Event|3|||
33590442|NCT02484547|62988728|FG006|Long-Term Extension Period|Adverse Event|2|||
33590443|NCT02484547|62988722|FG000|Long-Term Extension Period|Death|0|||
33590444|NCT02484547|62988723|FG001|Long-Term Extension Period|Death|0|||
33590445|NCT02484547|62988724|FG002|Long-Term Extension Period|Death|0|||
33590446|NCT02484547|62988725|FG003|Long-Term Extension Period|Death|0|||
33590447|NCT02484547|62988726|FG004|Long-Term Extension Period|Death|0|||
33590448|NCT02484547|62988727|FG005|Long-Term Extension Period|Death|3|||
33590449|NCT02484547|62988728|FG006|Long-Term Extension Period|Death|0|||
33590450|NCT02484547|62988722|FG000|Long-Term Extension Period|Disease Progression|0|||
33590451|NCT02484547|62988723|FG001|Long-Term Extension Period|Disease Progression|0|||
33590452|NCT02484547|62988724|FG002|Long-Term Extension Period|Disease Progression|0|||
33590453|NCT02484547|62988725|FG003|Long-Term Extension Period|Disease Progression|0|||
33590454|NCT02484547|62988726|FG004|Long-Term Extension Period|Disease Progression|2|||
33590455|NCT02484547|62988727|FG005|Long-Term Extension Period|Disease Progression|4|||
33590456|NCT02484547|62988728|FG006|Long-Term Extension Period|Disease Progression|0|||
33590457|NCT02484547|62988722|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
33590458|NCT02484547|62988723|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
33590459|NCT02484547|62988724|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
33590460|NCT02484547|62988725|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
33590461|NCT02484547|62988726|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
33590462|NCT02484547|62988727|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
33590463|NCT02484547|62988728|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
33590464|NCT02484547|62988722|FG000|Long-Term Extension Period|Loss of Capacity|0|||
33590465|NCT02484547|62988723|FG001|Long-Term Extension Period|Loss of Capacity|0|||
33590466|NCT02484547|62988724|FG002|Long-Term Extension Period|Loss of Capacity|0|||
33590467|NCT02484547|62988725|FG003|Long-Term Extension Period|Loss of Capacity|0|||
33590468|NCT02484547|62988726|FG004|Long-Term Extension Period|Loss of Capacity|1|||
33590469|NCT02484547|62988727|FG005|Long-Term Extension Period|Loss of Capacity|0|||
33590470|NCT02484547|62988728|FG006|Long-Term Extension Period|Loss of Capacity|0|||
33590471|NCT02484547|62988722|FG000|Long-Term Extension Period|Change of Treatment|0|||
33590472|NCT02484547|62988723|FG001|Long-Term Extension Period|Change of Treatment|0|||
33590473|NCT02484547|62988724|FG002|Long-Term Extension Period|Change of Treatment|0|||
33590474|NCT02484547|62988725|FG003|Long-Term Extension Period|Change of Treatment|0|||
33590475|NCT02484547|62988726|FG004|Long-Term Extension Period|Change of Treatment|0|||
33590476|NCT02484547|62988727|FG005|Long-Term Extension Period|Change of Treatment|0|||
33590477|NCT02484547|62988728|FG006|Long-Term Extension Period|Change of Treatment|1|||
33590478|NCT02484547|62988722|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
33590479|NCT02484547|62988723|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
33590480|NCT02484547|62988724|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
33590481|NCT02484547|62988725|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
33590482|NCT02484547|62988726|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
33590483|NCT02484547|62988727|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
33590484|NCT02484547|62988728|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
33590485|NCT02484547|62988722|FG000|Long-Term Extension Period|Investigator Decision|0|||
33590486|NCT02484547|62988723|FG001|Long-Term Extension Period|Investigator Decision|0|||
33590487|NCT02484547|62988724|FG002|Long-Term Extension Period|Investigator Decision|0|||
33590488|NCT02484547|62988725|FG003|Long-Term Extension Period|Investigator Decision|2|||
33590489|NCT02484547|62988726|FG004|Long-Term Extension Period|Investigator Decision|1|||
33590490|NCT02484547|62988727|FG005|Long-Term Extension Period|Investigator Decision|0|||
33590491|NCT02484547|62988728|FG006|Long-Term Extension Period|Investigator Decision|1|||
33590492|NCT02484547|62988722|FG000|Long-Term Extension Period|Relocation|0|||
33590493|NCT02484547|62988723|FG001|Long-Term Extension Period|Relocation|0|||
33590494|NCT02484547|62988724|FG002|Long-Term Extension Period|Relocation|0|||
33590495|NCT02484547|62988725|FG003|Long-Term Extension Period|Relocation|1|||
33590496|NCT02484547|62988726|FG004|Long-Term Extension Period|Relocation|1|||
33590497|NCT02484547|62988727|FG005|Long-Term Extension Period|Relocation|0|||
33590498|NCT02484547|62988728|FG006|Long-Term Extension Period|Relocation|0|||
33590499|NCT02484547|62988722|FG000|Long-Term Extension Period|Study Visit Burden|0|||
33590500|NCT02484547|62988723|FG001|Long-Term Extension Period|Study Visit Burden|0|||
33590501|NCT02484547|62988724|FG002|Long-Term Extension Period|Study Visit Burden|0|||
33590502|NCT02484547|62988725|FG003|Long-Term Extension Period|Study Visit Burden|2|||
33590503|NCT02484547|62988726|FG004|Long-Term Extension Period|Study Visit Burden|0|||
33590504|NCT02484547|62988727|FG005|Long-Term Extension Period|Study Visit Burden|0|||
33590505|NCT02484547|62988728|FG006|Long-Term Extension Period|Study Visit Burden|3|||
33590506|NCT02484547|62988722|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
33590507|NCT02484547|62988723|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
33590508|NCT02484547|62988724|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
33590509|NCT02484547|62988725|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
33590510|NCT02484547|62988726|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
33590511|NCT02484547|62988727|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
33590512|NCT02484547|62988728|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
33590513|NCT02484547|62988722|FG000|Long-Term Extension Period|Reason not Specified|0|||
33590514|NCT02484547|62988723|FG001|Long-Term Extension Period|Reason not Specified|0|||
33590515|NCT02484547|62988724|FG002|Long-Term Extension Period|Reason not Specified|0|||
33590516|NCT02484547|62988725|FG003|Long-Term Extension Period|Reason not Specified|119|||
33590517|NCT02484547|62988726|FG004|Long-Term Extension Period|Reason not Specified|117|||
33590518|NCT02484547|62988727|FG005|Long-Term Extension Period|Reason not Specified|223|||
33590519|NCT02484547|62988728|FG006|Long-Term Extension Period|Reason not Specified|231|||
33590520|NCT02517541|62988740|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
33590521|NCT02517541|62988740|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
33590522|NCT02517541|62988740|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
33590523|NCT02517541|62988740|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
33590524|NCT02517541|62988740|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
33590525|NCT02517541|62988740|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
33590526|NCT02496091|62988746|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33590527|NCT02483611|62988754|FG000|Overall Study|Protocol Violation|0|||
33590528|NCT02483611|62988755|FG001|Overall Study|Protocol Violation|0|||
33590529|NCT02483611|62988756|FG002|Overall Study|Protocol Violation|1|||
33590530|NCT02483533|62988766|FG000|Overall Study|Lack of Efficacy|50|||
33590531|NCT02483533|62988767|FG001|Overall Study|Lack of Efficacy|50|||
33590532|NCT02482129|62988775|FG000|Overall Study|Adverse Event-prior to treatment|0|||
33590533|NCT02482129|62988776|FG001|Overall Study|Adverse Event-prior to treatment|1|||
33590534|NCT02482129|62988775|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
33590535|NCT02482129|62988776|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
33590536|NCT02482129|62988775|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
33590537|NCT02482129|62988776|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
33590538|NCT02482129|62988775|FG000|Overall Study|Criteria not met-prior to treatment|1|||
33590539|NCT02482129|62988776|FG001|Overall Study|Criteria not met-prior to treatment|0|||
33590540|NCT02482129|62988775|FG000|Overall Study|Adverse Event|1|||
33590541|NCT02482129|62988776|FG001|Overall Study|Adverse Event|0|||
33590542|NCT02482129|62988775|FG000|Overall Study|Withdrawal by Subject|2|||
33590543|NCT02482129|62988776|FG001|Overall Study|Withdrawal by Subject|0|||
33590544|NCT02482129|62988775|FG000|Overall Study|Criteria not met|1|||
33590545|NCT02482129|62988776|FG001|Overall Study|Criteria not met|0|||
33590546|NCT02495857|62988787|FG000|Overall Study|Adverse Event|5|||
33590547|NCT02495857|62988788|FG001|Overall Study|Adverse Event|0|||
33590548|NCT02495857|62988789|FG002|Overall Study|Adverse Event|1|||
33590549|NCT02495857|62988787|FG000|Overall Study|Withdrawal by Subject|9|||
33590550|NCT02495857|62988788|FG001|Overall Study|Withdrawal by Subject|6|||
33590551|NCT02495857|62988789|FG002|Overall Study|Withdrawal by Subject|10|||
33590552|NCT02495857|62988787|FG000|Overall Study|Physician Decision|0|||
33590553|NCT02495857|62988788|FG001|Overall Study|Physician Decision|1|||
33590554|NCT02495857|62988789|FG002|Overall Study|Physician Decision|0|||
33590555|NCT02495857|62988787|FG000|Overall Study|Protocol Violation|1|||
33590556|NCT02495857|62988788|FG001|Overall Study|Protocol Violation|1|||
33590557|NCT02495857|62988789|FG002|Overall Study|Protocol Violation|2|||
33590558|NCT02495857|62988787|FG000|Overall Study|Lost to Follow-up|4|||
33590559|NCT02495857|62988788|FG001|Overall Study|Lost to Follow-up|5|||
33590560|NCT02495857|62988789|FG002|Overall Study|Lost to Follow-up|3|||
33590561|NCT02495857|62988787|FG000|Overall Study|Other|3|||
33590562|NCT02495857|62988788|FG001|Overall Study|Other|3|||
33590563|NCT02495857|62988789|FG002|Overall Study|Other|2|||
33590564|NCT02495389|62988797|FG000|Overall Study|Withdrawal by Subject|40|||
33590565|NCT02495233|62988803|FG000|Overall Study|Miscellaneous|0|||
33590566|NCT02495233|62988804|FG001|Overall Study|Miscellaneous|1|||
33590567|NCT02495077|62988812|FG000|Overall Study|Adverse Event|0|||
33590568|NCT02495077|62988813|FG001|Overall Study|Adverse Event|1|||
33590569|NCT02495077|62988814|FG002|Overall Study|Adverse Event|1|||
33590570|NCT02495077|62988815|FG003|Overall Study|Adverse Event|0|||
33590571|NCT02495077|62988812|FG000|Overall Study|Death|3|||
33590572|NCT02495077|62988813|FG001|Overall Study|Death|5|||
33590573|NCT02495077|62988814|FG002|Overall Study|Death|0|||
33590574|NCT02495077|62988815|FG003|Overall Study|Death|0|||
33590575|NCT02495077|62988812|FG000|Overall Study|Lost to Follow-up|6|||
33590576|NCT02495077|62988813|FG001|Overall Study|Lost to Follow-up|4|||
33590577|NCT02495077|62988814|FG002|Overall Study|Lost to Follow-up|0|||
33590578|NCT02495077|62988815|FG003|Overall Study|Lost to Follow-up|0|||
33590579|NCT02495077|62988812|FG000|Overall Study|Physician Decision|2|||
33590580|NCT02495077|62988813|FG001|Overall Study|Physician Decision|1|||
33590581|NCT02495077|62988814|FG002|Overall Study|Physician Decision|4|||
33590582|NCT02495077|62988815|FG003|Overall Study|Physician Decision|0|||
33590583|NCT02495077|62988812|FG000|Overall Study|Protocol Violation|0|||
33590584|NCT02495077|62988813|FG001|Overall Study|Protocol Violation|1|||
33590585|NCT02495077|62988814|FG002|Overall Study|Protocol Violation|0|||
33590586|NCT02495077|62988815|FG003|Overall Study|Protocol Violation|0|||
33590587|NCT02495077|62988812|FG000|Overall Study|Screen Failure|0|||
33590588|NCT02495077|62988813|FG001|Overall Study|Screen Failure|0|||
33590589|NCT02495077|62988814|FG002|Overall Study|Screen Failure|0|||
33590590|NCT02495077|62988815|FG003|Overall Study|Screen Failure|48|||
33590591|NCT02495077|62988812|FG000|Overall Study|Withdrawal by Subject|7|||
33590592|NCT02495077|62988813|FG001|Overall Study|Withdrawal by Subject|7|||
33590593|NCT02495077|62988814|FG002|Overall Study|Withdrawal by Subject|7|||
33590594|NCT02495077|62988815|FG003|Overall Study|Withdrawal by Subject|0|||
33590595|NCT02495077|62988812|FG000|Overall Study|Covid-19 research restrictions|1|||
33590596|NCT02495077|62988813|FG001|Overall Study|Covid-19 research restrictions|0|||
33590597|NCT02495077|62988814|FG002|Overall Study|Covid-19 research restrictions|0|||
33590598|NCT02495077|62988815|FG003|Overall Study|Covid-19 research restrictions|0|||
33590599|NCT02495077|62988812|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
33590600|NCT02495077|62988813|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
33590601|NCT02495077|62988814|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
33590602|NCT02495077|62988815|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
33590603|NCT02495077|62988812|FG000|Overall Study|Incarcerated|0|||
33680310|NCT04187144|63135851|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
33590604|NCT02495077|62988813|FG001|Overall Study|Incarcerated|1|||
33590605|NCT02495077|62988814|FG002|Overall Study|Incarcerated|0|||
33590606|NCT02495077|62988815|FG003|Overall Study|Incarcerated|0|||
33590607|NCT02495077|62988812|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
33590608|NCT02495077|62988813|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
33590609|NCT02495077|62988814|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
33590610|NCT02495077|62988815|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
33590611|NCT02495077|62988812|FG000|Overall Study|Timing of transplant and randomization|0|||
33590612|NCT02495077|62988813|FG001|Overall Study|Timing of transplant and randomization|0|||
33590613|NCT02495077|62988814|FG002|Overall Study|Timing of transplant and randomization|5|||
33590614|NCT02495077|62988815|FG003|Overall Study|Timing of transplant and randomization|0|||
33590615|NCT02278341|62988823|FG000|Overall Study|Randomized but never received study drug|1|||
33590616|NCT02278341|62988824|FG001|Overall Study|Randomized but never received study drug|1|||
33590617|NCT02278341|62988823|FG000|Overall Study|Adverse Event|3|||
33590618|NCT02278341|62988824|FG001|Overall Study|Adverse Event|0|||
33590619|NCT02278341|62988823|FG000|Overall Study|Death|68|||
33590620|NCT02278341|62988824|FG001|Overall Study|Death|56|||
33590621|NCT02278341|62988823|FG000|Overall Study|Withdrawal by Subject|30|||
33590622|NCT02278341|62988824|FG001|Overall Study|Withdrawal by Subject|19|||
33590623|NCT02278341|62988823|FG000|Overall Study|Lost to Follow-up|0|||
33590624|NCT02278341|62988824|FG001|Overall Study|Lost to Follow-up|1|||
33590625|NCT02278341|62988823|FG000|Overall Study|Physician Decision|1|||
33590626|NCT02278341|62988824|FG001|Overall Study|Physician Decision|1|||
33590627|NCT02278341|62988823|FG000|Overall Study|Miscellaneous|15|||
33590628|NCT02278341|62988824|FG001|Overall Study|Miscellaneous|14|||
33590629|NCT02282631|62988833|FG000|Overall Study|Lost to Follow-up|2|||
33590630|NCT02282631|62988834|FG001|Overall Study|Lost to Follow-up|0|||
33590631|NCT02278263|62988849|FG000|Overall Study|Protocol Violation|7|||
33590632|NCT02278263|62988850|FG001|Overall Study|Protocol Violation|0|||
33590633|NCT02278263|62988851|FG002|Overall Study|Protocol Violation|9|||
33590634|NCT02349789|62988862|FG000|Overall Study|Withdrawal by Subject|2|||
33590635|NCT02349711|62988868|FG000|Overall Study|Withdrawal by Subject|2|||
33590636|NCT02349711|62988869|FG001|Overall Study|Withdrawal by Subject|1|||
33590637|NCT02349711|62988868|FG000|Overall Study|Lost to Follow-up|1|||
33590638|NCT02349711|62988869|FG001|Overall Study|Lost to Follow-up|1|||
33590639|NCT02494921|62988880|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
33590640|NCT02494921|62988881|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
33590641|NCT02494921|62988882|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
33590642|NCT02494921|62988883|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
33590643|NCT02494921|62988884|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
33590644|NCT02494921|62988880|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
33590645|NCT02494921|62988881|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
33590646|NCT02494921|62988882|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
33590647|NCT02494921|62988883|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
33590648|NCT02494921|62988884|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
33590649|NCT02494921|62988880|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
33590650|NCT02494921|62988881|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
33590651|NCT02494921|62988882|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
33590652|NCT02494921|62988883|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
33590653|NCT02494921|62988884|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
33590654|NCT01653847|62988904|FG000|Overall Study|Withdrawal by Subject|1|||
33590655|NCT01653847|62988905|FG001|Overall Study|Withdrawal by Subject|0|||
33590656|NCT02493751|62988913|FG000|Overall Study|Withdrawal by Subject|2|||
33590657|NCT02493751|62988914|FG001|Overall Study|Withdrawal by Subject|8|||
33590658|NCT02493751|62988913|FG000|Overall Study|Death|6|||
33590659|NCT02493751|62988914|FG001|Overall Study|Death|13|||
33590660|NCT02493751|62988913|FG000|Overall Study|Lost to Follow-up|2|||
33590661|NCT02493751|62988914|FG001|Overall Study|Lost to Follow-up|3|||
33590662|NCT02493751|62988913|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
33590663|NCT02493751|62988914|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
33590664|NCT02493517|62988923|FG000|Overall Study|Protocol Violation|1|||
33590665|NCT02493517|62988924|FG001|Overall Study|Protocol Violation|2|||
33590666|NCT02493517|62988923|FG000|Overall Study|Withdrawal by Subject|1|||
33590667|NCT02493517|62988924|FG001|Overall Study|Withdrawal by Subject|2|||
33590668|NCT02493517|62988923|FG000|Overall Study|Adverse Event|0|||
33590669|NCT02493517|62988924|FG001|Overall Study|Adverse Event|2|||
33590670|NCT02493517|62988923|FG000|Overall Study|Missed study visit|0|||
33590671|NCT02493517|62988924|FG001|Overall Study|Missed study visit|1|||
33590672|NCT02493361|62988932|FG000|Overall Study|Withdrawal by Subject|3|||
33590673|NCT02493127|62988938|FG000|Overall Study|Lost to Follow-up|1|||
33590674|NCT02493127|62988939|FG001|Overall Study|Lost to Follow-up|1|||
33590675|NCT02478463|62988947|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
33590676|NCT02478463|62988947|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
33590677|NCT02478463|62988947|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
33590678|NCT02491411|62988953|FG000|Overall Study|Physician Decision|4|||
33590679|NCT02517463|62988959|FG000|Overall Study|Lost to Follow-up|5|||
33590680|NCT02517463|62988960|FG001|Overall Study|Lost to Follow-up|2|||
33590681|NCT02516605|62988971|FG000|Overall Study|Protocol Violation|0|||
33590682|NCT02516605|62988972|FG001|Overall Study|Protocol Violation|0|||
33590683|NCT02516605|62988973|FG002|Overall Study|Protocol Violation|0|||
33590684|NCT02516605|62988974|FG003|Overall Study|Protocol Violation|0|||
33590685|NCT02516605|62988975|FG004|Overall Study|Protocol Violation|1|||
33590686|NCT02516605|62988971|FG000|Overall Study|Withdrawal by Subject|0|||
33680311|NCT04187144|63135852|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
33310722|NCT01162473|62686121|FG001|Overall Study|Adverse Event|1|||
33590687|NCT02516605|62988972|FG001|Overall Study|Withdrawal by Subject|0|||
33590688|NCT02516605|62988973|FG002|Overall Study|Withdrawal by Subject|0|||
33590689|NCT02516605|62988974|FG003|Overall Study|Withdrawal by Subject|1|||
33590690|NCT02516605|62988975|FG004|Overall Study|Withdrawal by Subject|0|||
33590691|NCT02490475|62988995|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
33590692|NCT02490475|62988996|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
33590693|NCT02490475|62988997|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
33590694|NCT02490475|62988998|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
33590695|NCT02490475|62988995|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
33590696|NCT02490475|62988996|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
33590697|NCT02490475|62988997|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
33590698|NCT02490475|62988998|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
33590699|NCT02490475|62988995|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
33590700|NCT02490475|62988996|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
33590701|NCT02490475|62988997|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
33590702|NCT02490475|62988998|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
33590703|NCT02490475|62988995|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
33590704|NCT02490475|62988996|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
33590705|NCT02490475|62988997|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
33590706|NCT02490475|62988998|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
33590707|NCT02490475|62988995|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
33590708|NCT02490475|62988996|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
33590709|NCT02490475|62988997|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
33590710|NCT02490475|62988998|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
33590711|NCT02490475|62988995|FG000|Period 2: Extension Phase|Refused Treatment|0|||
33590712|NCT02490475|62988996|FG001|Period 2: Extension Phase|Refused Treatment|0|||
33590713|NCT02490475|62988997|FG002|Period 2: Extension Phase|Refused Treatment|0|||
33590714|NCT02490475|62988998|FG003|Period 2: Extension Phase|Refused Treatment|1|||
33590715|NCT02490475|62988995|FG000|Period 2: Extension Phase|Adverse Event|0|||
33590716|NCT02490475|62988996|FG001|Period 2: Extension Phase|Adverse Event|0|||
33590717|NCT02490475|62988997|FG002|Period 2: Extension Phase|Adverse Event|1|||
33590718|NCT02490475|62988998|FG003|Period 2: Extension Phase|Adverse Event|0|||
33590719|NCT02477839|62989021|FG000|Overall Study|Adverse Event|0|||
33590720|NCT02477839|62989022|FG001|Overall Study|Adverse Event|1|||
33590721|NCT02477839|62989021|FG000|Overall Study|Protocol Violation|0|||
33590722|NCT02477839|62989022|FG001|Overall Study|Protocol Violation|2|||
33590723|NCT02477839|62989021|FG000|Overall Study|Withdrawal by Subject|3|||
33590724|NCT02477839|62989022|FG001|Overall Study|Withdrawal by Subject|3|||
33590725|NCT02477839|62989021|FG000|Overall Study|Participant had PGS during V6|0|||
33590726|NCT02477839|62989022|FG001|Overall Study|Participant had PGS during V6|1|||
33590727|NCT02477839|62989021|FG000|Overall Study|Parents decided to stop medication|0|||
33590728|NCT02477839|62989022|FG001|Overall Study|Parents decided to stop medication|1|||
33590729|NCT02477839|62989021|FG000|Overall Study|Lack of tolerability|0|||
33590730|NCT02477839|62989022|FG001|Overall Study|Lack of tolerability|1|||
33590731|NCT02477839|62989021|FG000|Overall Study|Exclusion criterion|0|||
33590732|NCT02477839|62989022|FG001|Overall Study|Exclusion criterion|1|||
33590733|NCT02489773|62989032|FG000|Overall Study|Lost to Follow-up|4|||
33590734|NCT02489773|62989033|FG001|Overall Study|Lost to Follow-up|1|||
33590735|NCT02489773|62989032|FG000|Overall Study|Physician Decision|1|||
33590736|NCT02489773|62989033|FG001|Overall Study|Physician Decision|0|||
33590737|NCT02489773|62989032|FG000|Overall Study|Withdrawal by Subject|1|||
33590738|NCT02489773|62989033|FG001|Overall Study|Withdrawal by Subject|0|||
33590739|NCT02489773|62989032|FG000|Overall Study|Leave the country or the state|1|||
33590740|NCT02489773|62989033|FG001|Overall Study|Leave the country or the state|1|||
33590741|NCT02488915|62989039|FG000|Overall Study|Death|21|||
33590742|NCT02488915|62989039|FG000|Overall Study|Lost to Follow-up|4|||
33590743|NCT02488915|62989039|FG000|Overall Study|Withdrawal by Subject|1|||
33590744|NCT02488681|62989043|FG000|Overall Study|Implant unsuccessful|7|||
33590745|NCT02477605|62989049|FG000|Overall Study|Discontinued prior to treatment|1|||
33590746|NCT02477605|62989050|FG001|Overall Study|Discontinued prior to treatment|0|||
33590747|NCT02477605|62989049|FG000|Overall Study|Lost to Follow-up|0|||
33590748|NCT02477605|62989050|FG001|Overall Study|Lost to Follow-up|2|||
33590749|NCT02477605|62989049|FG000|Overall Study|Withdrawal by Subject|0|||
33590750|NCT02477605|62989050|FG001|Overall Study|Withdrawal by Subject|1|||
33590751|NCT02477605|62989049|FG000|Overall Study|Administered gas during surgery|0|||
33590752|NCT02477605|62989050|FG001|Overall Study|Administered gas during surgery|1|||
33590753|NCT02477527|62989060|FG000|Overall Study|Lost to Follow-up|2|||
33590754|NCT02477527|62989060|FG000|Overall Study|Withdrawal by Subject|1|||
33590755|NCT02477527|62989060|FG000|Overall Study|Screen Failure|3|||
33590756|NCT02477215|62989068|FG000|Dose Escalation Phase|Physician Decision|1|||
33590757|NCT02477215|62989069|FG001|Dose Escalation Phase|Physician Decision|2|||
33590758|NCT02477215|62989070|FG002|Dose Escalation Phase|Physician Decision|0|||
33590759|NCT02477215|62989068|FG000|Fixed Dose Phase|Physician Decision|0|||
33680312|NCT04187144|63135851|FG000|Overall Study|Protocol Deviation|1|||
33590760|NCT02477215|62989069|FG001|Fixed Dose Phase|Physician Decision|7|||
33590761|NCT02477215|62989070|FG002|Fixed Dose Phase|Physician Decision|0|||
33590762|NCT02487199|62989083|FG000|Overall Study|Withdrew Consent|0|||
33590763|NCT02487199|62989084|FG001|Overall Study|Withdrew Consent|1|||
33590764|NCT02475733|62989092|FG000|Overall Study|Withdrawal by Subject|1|||
33590765|NCT02475733|62989093|FG001|Overall Study|Withdrawal by Subject|0|||
33590766|NCT02475733|62989092|FG000|Overall Study|Physician Decision|1|||
33590767|NCT02475733|62989093|FG001|Overall Study|Physician Decision|0|||
33590768|NCT02486653|62989101|FG000|Overall Study|Withdrawal by Subject|1|||
33590769|NCT02486653|62989102|FG001|Overall Study|Withdrawal by Subject|3|||
33590770|NCT02486653|62989101|FG000|Overall Study|Protocol Violation|1|||
33590771|NCT02486653|62989102|FG001|Overall Study|Protocol Violation|0|||
33590772|NCT02486653|62989101|FG000|Overall Study|surgery cancelled|4|||
33590773|NCT02486653|62989102|FG001|Overall Study|surgery cancelled|1|||
33590774|NCT02475655|62989110|FG000|Overall Study|Lost to Follow-up|0|||
33590775|NCT02475655|62989111|FG001|Overall Study|Lost to Follow-up|1|||
33590776|NCT02475265|62989117|FG000|Overall Study|Physician Decision|1|||
33590777|NCT02475265|62989117|FG000|Overall Study|Withdrawal by Subject|2|||
33590778|NCT02485717|62989124|FG000|Overall Study|Lost to Follow-up|6|||
33590779|NCT02485717|62989125|FG001|Overall Study|Lost to Follow-up|0|||
33590780|NCT02485717|62989126|FG002|Overall Study|Lost to Follow-up|0|||
33590781|NCT02485717|62989124|FG000|Overall Study|Withdrawal by Subject|0|||
33590782|NCT02485717|62989125|FG001|Overall Study|Withdrawal by Subject|0|||
33590783|NCT02485717|62989126|FG002|Overall Study|Withdrawal by Subject|1|||
33590784|NCT02485717|62989124|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
33590785|NCT02485717|62989125|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
33590786|NCT02485717|62989126|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
33590787|NCT02485717|62989124|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
33590788|NCT02485717|62989125|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
33590789|NCT02485717|62989126|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
33590790|NCT02451007|62989134|FG000|Overall Study|Withdrawal by Subject|4|||
33590791|NCT02451007|62989134|FG000|Overall Study|Adverse Event|1|||
33590792|NCT02451007|62989134|FG000|Overall Study|Disease Progression|2|||
33590793|NCT02485483|62989140|FG000|Overall Study|Depression at baseline|15|||
33590794|NCT02485483|62989141|FG001|Overall Study|Depression at baseline|0|||
33590795|NCT02485483|62989140|FG000|Overall Study|Discontinued after baseline|39|||
33590796|NCT02485483|62989141|FG001|Overall Study|Discontinued after baseline|0|||
33590797|NCT02473471|62989147|FG000|Overall Study|poor oral hygiene|2|||
33590798|NCT02473471|62989147|FG000|Overall Study|Lost to Follow-up|1|||
33590799|NCT02450539|62989159|FG000|Overall Study|Withdrawal by Subject|12|||
33590800|NCT02450539|62989160|FG001|Overall Study|Withdrawal by Subject|6|||
33590801|NCT02450539|62989159|FG000|Overall Study|Lost to Follow-up|4|||
33590802|NCT02450539|62989160|FG001|Overall Study|Lost to Follow-up|1|||
33590803|NCT02449915|62989171|FG000|Overall Study|Exclusion criteria - drug use|1|||
33590804|NCT02449915|62989172|FG001|Overall Study|Exclusion criteria - drug use|0|||
33590805|NCT02449915|62989171|FG000|Overall Study|Withdrawal by Subject|0|||
33590806|NCT02449915|62989172|FG001|Overall Study|Withdrawal by Subject|2|||
33590807|NCT02449915|62989171|FG000|Overall Study|Intraoperative surgical findings|1|||
33590808|NCT02449915|62989172|FG001|Overall Study|Intraoperative surgical findings|1|||
33590809|NCT02449915|62989171|FG000|Overall Study|Abnormal preop lab|0|||
33590810|NCT02449915|62989172|FG001|Overall Study|Abnormal preop lab|1|||
33590811|NCT02420119|62989178|FG000|Overall Study|insufficient laboratory data|5|||
33590812|NCT02473393|62989186|FG000|Overall Study|Adverse Event|0|||
33590813|NCT02473393|62989187|FG001|Overall Study|Adverse Event|0|||
33590814|NCT02473393|62989188|FG002|Overall Study|Adverse Event|1|||
33590815|NCT02473393|62989189|FG003|Overall Study|Adverse Event|0|||
33590816|NCT02473393|62989186|FG000|Overall Study|Withdrawal by Subject|0|||
33590817|NCT02473393|62989187|FG001|Overall Study|Withdrawal by Subject|0|||
33590818|NCT02473393|62989188|FG002|Overall Study|Withdrawal by Subject|1|||
33590819|NCT02473393|62989189|FG003|Overall Study|Withdrawal by Subject|1|||
33590820|NCT02419573|62989201|FG000|Overall Study|Lost to Follow-up|3|||
33590821|NCT02419573|62989202|FG001|Overall Study|Lost to Follow-up|0|||
33590822|NCT02419573|62989201|FG000|Overall Study|Withdrawal by Subject|1|||
33590823|NCT02419573|62989202|FG001|Overall Study|Withdrawal by Subject|0|||
33590824|NCT02472847|62989210|FG000|Overall Study|Withdrawal by Subject|1|||
33590825|NCT02472847|62989211|FG001|Overall Study|Withdrawal by Subject|5|||
33590826|NCT02472145|62989220|FG000|Overall Study|Death|10|||
33590827|NCT02472145|62989221|FG001|Overall Study|Death|101|||
33680313|NCT04187144|63135852|FG001|Overall Study|Protocol Deviation|4|||
33590828|NCT02472145|62989222|FG002|Overall Study|Death|99|||
33590829|NCT02472145|62989220|FG000|Overall Study|Lost to Follow-up|0|||
33590830|NCT02472145|62989221|FG001|Overall Study|Lost to Follow-up|1|||
33590831|NCT02472145|62989222|FG002|Overall Study|Lost to Follow-up|0|||
33590832|NCT02472145|62989220|FG000|Overall Study|Withdrawal by Subject|0|||
33590833|NCT02472145|62989221|FG001|Overall Study|Withdrawal by Subject|9|||
33590834|NCT02472145|62989222|FG002|Overall Study|Withdrawal by Subject|13|||
33590835|NCT02472145|62989220|FG000|Overall Study|Sponsor decision|0|||
33590836|NCT02472145|62989221|FG001|Overall Study|Sponsor decision|3|||
33590837|NCT02472145|62989222|FG002|Overall Study|Sponsor decision|2|||
33590838|NCT02472145|62989220|FG000|Overall Study|Other|0|||
33590839|NCT02472145|62989221|FG001|Overall Study|Other|45|||
33680314|NCT04027946|63135858|FG000|Overall Study|Screen failures|3|||
33590840|NCT02472145|62989222|FG002|Overall Study|Other|43|||
33590841|NCT02418949|62989233|FG000|Overall Study|Withdrawal by Subject|1|||
33590842|NCT02418949|62989234|FG001|Overall Study|Withdrawal by Subject|0|||
33590843|NCT02418949|62989235|FG002|Overall Study|Withdrawal by Subject|1|||
33590844|NCT02418949|62989236|FG003|Overall Study|Withdrawal by Subject|1|||
33590845|NCT02418949|62989233|FG000|Overall Study|Lost to Follow-up|1|||
33590846|NCT02418949|62989234|FG001|Overall Study|Lost to Follow-up|0|||
33590847|NCT02418949|62989235|FG002|Overall Study|Lost to Follow-up|1|||
33590848|NCT02418949|62989236|FG003|Overall Study|Lost to Follow-up|0|||
33590849|NCT02418949|62989233|FG000|Overall Study|Physician Decision|1|||
33590850|NCT02418949|62989234|FG001|Overall Study|Physician Decision|1|||
33590851|NCT02418949|62989235|FG002|Overall Study|Physician Decision|1|||
33590852|NCT02418949|62989236|FG003|Overall Study|Physician Decision|0|||
33590853|NCT02448043|62989248|FG000|Overall Study|Withdrawal by Subject|2|||
33590854|NCT02448043|62989249|FG001|Overall Study|Withdrawal by Subject|2|||
33590855|NCT02448043|62989248|FG000|Overall Study|Protocol Violation|1|||
33590856|NCT02448043|62989249|FG001|Overall Study|Protocol Violation|2|||
33590857|NCT02447887|62989258|FG000|Overall Study|Study was terminated|3|||
33590858|NCT02471755|62989264|FG000|Overall Study|Withdrawal by Subject|1|||
33590859|NCT02471755|62989265|FG001|Overall Study|Withdrawal by Subject|0|||
33590860|NCT02471755|62989264|FG000|Overall Study|Lost to Follow-up|0|||
33590861|NCT02471755|62989265|FG001|Overall Study|Lost to Follow-up|1|||
33590862|NCT02470429|62989273|FG000|Overall Study|Adverse Event|1|||
33590863|NCT02470429|62989274|FG001|Overall Study|Adverse Event|0|||
33590864|NCT02470429|62989273|FG000|Overall Study|Withdrawal by Subject|1|||
33590865|NCT02470429|62989274|FG001|Overall Study|Withdrawal by Subject|0|||
33590866|NCT02447497|62989285|FG000|Overall Study|Did not meet treatment day baseline.|6|||
33590867|NCT02447497|62989286|FG001|Overall Study|Did not meet treatment day baseline.|5|||
33590868|NCT02447497|62989287|FG002|Overall Study|Did not meet treatment day baseline.|2|||
33590869|NCT02447497|62989288|FG003|Overall Study|Did not meet treatment day baseline.|2|||
33590870|NCT02447497|62989285|FG000|Overall Study|Dressing was compromised|0|||
33590871|NCT02447497|62989286|FG001|Overall Study|Dressing was compromised|1|||
33590872|NCT02447497|62989287|FG002|Overall Study|Dressing was compromised|0|||
33590873|NCT02447497|62989288|FG003|Overall Study|Dressing was compromised|0|||
33590874|NCT02417935|62989308|FG000|Treatment Period|Adverse Event|12|||
33590875|NCT02417935|62989309|FG001|Treatment Period|Adverse Event|10|||
33590876|NCT02417935|62989308|FG000|Treatment Period|Lost to Follow-up|1|||
33590877|NCT02417935|62989309|FG001|Treatment Period|Lost to Follow-up|0|||
33680315|NCT03856047|63135879|FG000|Overall Study|Withdrawal by Subject|0|||
33680316|NCT03856047|63135880|FG001|Overall Study|Withdrawal by Subject|1|||
33680317|NCT03856047|63135881|FG002|Overall Study|Withdrawal by Subject|1|||
33680318|NCT03856047|63135882|FG003|Overall Study|Withdrawal by Subject|0|||
33680319|NCT03856047|63135883|FG004|Overall Study|Withdrawal by Subject|3|||
33680320|NCT03856047|63135884|FG005|Overall Study|Withdrawal by Subject|0|||
33590878|NCT02417935|62989308|FG000|Treatment Period|Entry Criteria not met|0|||
33590879|NCT02417935|62989309|FG001|Treatment Period|Entry Criteria not met|1|||
33590880|NCT02417935|62989308|FG000|Treatment Period|Protocol Violation|2|||
33590881|NCT02417935|62989309|FG001|Treatment Period|Protocol Violation|1|||
33590882|NCT02417935|62989308|FG000|Treatment Period|Withdrawal by Subject|3|||
33590883|NCT02417935|62989309|FG001|Treatment Period|Withdrawal by Subject|3|||
33590884|NCT02417935|62989308|FG000|Treatment Period|Physician Decision|3|||
33590885|NCT02417935|62989309|FG001|Treatment Period|Physician Decision|1|||
33590886|NCT02417233|62989318|FG000|Overall Study|Death|4|||
33590887|NCT02417233|62989319|FG001|Overall Study|Death|10|||
33590888|NCT02417233|62989320|FG002|Overall Study|Death|14|||
33590889|NCT02417233|62989318|FG000|Overall Study|Lost to Follow-up|27|||
33590890|NCT02417233|62989319|FG001|Overall Study|Lost to Follow-up|39|||
33590891|NCT02417233|62989320|FG002|Overall Study|Lost to Follow-up|34|||
33590892|NCT02417233|62989318|FG000|Overall Study|Protocol Violation|2|||
33590893|NCT02417233|62989319|FG001|Overall Study|Protocol Violation|0|||
33680321|NCT03856047|63135885|FG006|Overall Study|Withdrawal by Subject|2|||
33590894|NCT02417233|62989320|FG002|Overall Study|Protocol Violation|2|||
33590895|NCT02417233|62989318|FG000|Overall Study|Withdrawal by Subject|2|||
33590896|NCT02417233|62989319|FG001|Overall Study|Withdrawal by Subject|1|||
33590897|NCT02417233|62989320|FG002|Overall Study|Withdrawal by Subject|8|||
33590898|NCT02417233|62989318|FG000|Overall Study|Relocation out of study area|1|||
33590899|NCT02417233|62989319|FG001|Overall Study|Relocation out of study area|0|||
33590900|NCT02417233|62989320|FG002|Overall Study|Relocation out of study area|1|||
33590901|NCT02417233|62989318|FG000|Overall Study|Mentally unstable|0|||
33680322|NCT03856047|63135879|FG000|Overall Study|Lost to Follow-up|4|||
33590902|NCT02417233|62989319|FG001|Overall Study|Mentally unstable|1|||
33590903|NCT02417233|62989320|FG002|Overall Study|Mentally unstable|0|||
33590904|NCT02447029|62989331|FG000|Overall Study|Withdrawal by Subject|3|||
33401427|NCT00256867|62780474|FG000|Overall Study|Adverse Event|0|||
33590905|NCT02447029|62989332|FG001|Overall Study|Withdrawal by Subject|2|||
33590906|NCT02416453|62989349|FG000|Overall Study|Adverse Event|0|||
33590907|NCT02416453|62989350|FG001|Overall Study|Adverse Event|0|||
33590908|NCT02416453|62989351|FG002|Overall Study|Adverse Event|0|||
33590909|NCT02416453|62989352|FG003|Overall Study|Adverse Event|2|||
33590910|NCT02416453|62989353|FG004|Overall Study|Adverse Event|0|||
33590911|NCT02416453|62989354|FG005|Overall Study|Adverse Event|1|||
33590912|NCT02416453|62989355|FG006|Overall Study|Adverse Event|0|||
33590913|NCT02416453|62989356|FG007|Overall Study|Adverse Event|0|||
33590914|NCT02416453|62989357|FG008|Overall Study|Adverse Event|0|||
33590915|NCT02416453|62989358|FG009|Overall Study|Adverse Event|0|||
33590916|NCT02416453|62989359|FG010|Overall Study|Adverse Event|0|||
33590917|NCT02416453|62989349|FG000|Overall Study|Lost to Follow-up|1|||
33590918|NCT02416453|62989350|FG001|Overall Study|Lost to Follow-up|3|||
33590919|NCT02416453|62989351|FG002|Overall Study|Lost to Follow-up|0|||
33590920|NCT02416453|62989352|FG003|Overall Study|Lost to Follow-up|8|||
33590921|NCT02416453|62989353|FG004|Overall Study|Lost to Follow-up|0|||
33590922|NCT02416453|62989354|FG005|Overall Study|Lost to Follow-up|5|||
33590923|NCT02416453|62989355|FG006|Overall Study|Lost to Follow-up|1|||
33590924|NCT02416453|62989356|FG007|Overall Study|Lost to Follow-up|3|||
33590925|NCT02416453|62989357|FG008|Overall Study|Lost to Follow-up|1|||
33590926|NCT02416453|62989358|FG009|Overall Study|Lost to Follow-up|0|||
33590927|NCT02416453|62989359|FG010|Overall Study|Lost to Follow-up|0|||
33590928|NCT02416453|62989349|FG000|Overall Study|Physician Decision|0|||
33590929|NCT02416453|62989350|FG001|Overall Study|Physician Decision|0|||
33590930|NCT02416453|62989351|FG002|Overall Study|Physician Decision|0|||
33680323|NCT03856047|63135880|FG001|Overall Study|Lost to Follow-up|2|||
33680324|NCT03856047|63135881|FG002|Overall Study|Lost to Follow-up|3|||
33680325|NCT03856047|63135882|FG003|Overall Study|Lost to Follow-up|1|||
33680326|NCT03856047|63135883|FG004|Overall Study|Lost to Follow-up|4|||
33680327|NCT03856047|63135884|FG005|Overall Study|Lost to Follow-up|4|||
33680328|NCT03856047|63135885|FG006|Overall Study|Lost to Follow-up|4|||
33680329|NCT03797014|63135902|FG000|Overall Study|Withdrawal by Subject|1|||
33680330|NCT03797014|63135902|FG000|Overall Study|Lost to Follow-up|1|||
33680331|NCT03797014|63135902|FG000|Overall Study|Protocol Violation|1|||
33680332|NCT03112603|63135940|FG000|End of Randomization Period|Lost to Follow-up|3|||
33680333|NCT03112603|63135941|FG001|End of Randomization Period|Lost to Follow-up|0|||
33680334|NCT03112603|63135942|FG002|End of Randomization Period|Lost to Follow-up|0|||
33680335|NCT03112603|63135940|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
33680336|NCT03112603|63135941|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
33680337|NCT03112603|63135942|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
33680338|NCT03112603|63135940|FG000|End of Randomization Period|Physician Decision|43|||
33680339|NCT03112603|63135941|FG001|End of Randomization Period|Physician Decision|18|||
33680340|NCT03112603|63135942|FG002|End of Randomization Period|Physician Decision|0|||
33680341|NCT03112603|63135940|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
33680342|NCT03112603|63135941|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
33680343|NCT03112603|63135942|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
33680344|NCT03112603|63135940|FG000|End of Randomization Period|Death|10|||
33680345|NCT03112603|63135941|FG001|End of Randomization Period|Death|7|||
33680346|NCT03112603|63135942|FG002|End of Randomization Period|Death|0|||
33680347|NCT03112603|63135940|FG000|End of Randomization Period|Disease Relapse|12|||
33680348|NCT03112603|63135941|FG001|End of Randomization Period|Disease Relapse|7|||
33680349|NCT03112603|63135942|FG002|End of Randomization Period|Disease Relapse|0|||
33680350|NCT03112603|63135940|FG000|End of Randomization Period|Lack of Efficacy|25|||
33680351|NCT03112603|63135941|FG001|End of Randomization Period|Lack of Efficacy|77|||
33680352|NCT03112603|63135942|FG002|End of Randomization Period|Lack of Efficacy|0|||
33680353|NCT03112603|63135940|FG000|End of Randomization Period|Adverse Event|32|||
33680354|NCT03112603|63135941|FG001|End of Randomization Period|Adverse Event|12|||
33680355|NCT03112603|63135942|FG002|End of Randomization Period|Adverse Event|0|||
33680356|NCT03112603|63135940|FG000|End of Cross Over Period|Death|0|||
33680357|NCT03112603|63135941|FG001|End of Cross Over Period|Death|0|||
33680358|NCT03112603|63135942|FG002|End of Cross Over Period|Death|2|||
33680359|NCT03112603|63135940|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
33680360|NCT03112603|63135941|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
33680361|NCT03112603|63135942|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
33680362|NCT03112603|63135940|FG000|End of Cross Over Period|Physician Decision|0|||
33680363|NCT03112603|63135941|FG001|End of Cross Over Period|Physician Decision|0|||
33680364|NCT03112603|63135942|FG002|End of Cross Over Period|Physician Decision|29|||
33680365|NCT03112603|63135940|FG000|End of Cross Over Period|Lack of Efficacy|0|||
33590931|NCT02416453|62989352|FG003|Overall Study|Physician Decision|0|||
33590932|NCT02416453|62989353|FG004|Overall Study|Physician Decision|0|||
33590933|NCT02416453|62989354|FG005|Overall Study|Physician Decision|1|||
33590934|NCT02416453|62989355|FG006|Overall Study|Physician Decision|1|||
33680366|NCT03112603|63135941|FG001|End of Cross Over Period|Lack of Efficacy|0|||
33590935|NCT02416453|62989356|FG007|Overall Study|Physician Decision|1|||
33590936|NCT02416453|62989357|FG008|Overall Study|Physician Decision|0|||
33590937|NCT02416453|62989358|FG009|Overall Study|Physician Decision|0|||
33590938|NCT02416453|62989359|FG010|Overall Study|Physician Decision|0|||
33680367|NCT03112603|63135942|FG002|End of Cross Over Period|Lack of Efficacy|8|||
33680368|NCT03112603|63135940|FG000|End of Cross Over Period|Adverse Event|0|||
33680369|NCT03112603|63135941|FG001|End of Cross Over Period|Adverse Event|0|||
33680370|NCT03112603|63135942|FG002|End of Cross Over Period|Adverse Event|6|||
33680371|NCT03112603|63135940|FG000|End of Cross Over Period|Disease Relapse|0|||
33680372|NCT03112603|63135941|FG001|End of Cross Over Period|Disease Relapse|0|||
33680373|NCT03112603|63135942|FG002|End of Cross Over Period|Disease Relapse|2|||
33680374|NCT03056001|63135951|FG000|Overall Study|Death|24|||
33680375|NCT03056001|63135951|FG000|Overall Study|Still On Study (in follow up)|1|||
33680376|NCT02725528|63135961|FG000|Overall Study|Lost to Follow-up|1|||
33680377|NCT02725528|63135962|FG001|Overall Study|Lost to Follow-up|4|||
33680378|NCT02725528|63135961|FG000|Overall Study|Withdrawal by Subject|0|||
33680379|NCT02725528|63135962|FG001|Overall Study|Withdrawal by Subject|1|||
33680380|NCT02627963|63135979|FG000|Overall Study|Randomized but not treated|2|||
33680381|NCT02627963|63135980|FG001|Overall Study|Randomized but not treated|6|||
33680382|NCT02585258|63135988|FG000|Overall Study|Adverse Event|28|||
33680383|NCT02585258|63135989|FG001|Overall Study|Adverse Event|29|||
33680384|NCT02585258|63135988|FG000|Overall Study|Death|3|||
33680385|NCT02585258|63135989|FG001|Overall Study|Death|2|||
33680386|NCT02585258|63135988|FG000|Overall Study|Lack of Efficacy|7|||
33680387|NCT02585258|63135989|FG001|Overall Study|Lack of Efficacy|9|||
33680388|NCT02585258|63135988|FG000|Overall Study|includes covid-related access problems|42|||
33680389|NCT02585258|63135989|FG001|Overall Study|includes covid-related access problems|46|||
33590939|NCT02416453|62989349|FG000|Overall Study|Withdrawal by Subject|2|||
33590940|NCT02416453|62989350|FG001|Overall Study|Withdrawal by Subject|0|||
33590941|NCT02416453|62989351|FG002|Overall Study|Withdrawal by Subject|0|||
33590942|NCT02416453|62989352|FG003|Overall Study|Withdrawal by Subject|5|||
33590943|NCT02416453|62989353|FG004|Overall Study|Withdrawal by Subject|1|||
33590944|NCT02416453|62989354|FG005|Overall Study|Withdrawal by Subject|8|||
33590945|NCT02416453|62989355|FG006|Overall Study|Withdrawal by Subject|0|||
33590946|NCT02416453|62989356|FG007|Overall Study|Withdrawal by Subject|8|||
33590947|NCT02416453|62989357|FG008|Overall Study|Withdrawal by Subject|4|||
33590948|NCT02416453|62989358|FG009|Overall Study|Withdrawal by Subject|0|||
33590949|NCT02416453|62989359|FG010|Overall Study|Withdrawal by Subject|0|||
33590950|NCT02416453|62989349|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33590951|NCT02416453|62989350|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33590952|NCT02416453|62989351|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
33590953|NCT02416453|62989352|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33590954|NCT02416453|62989353|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33590955|NCT02416453|62989354|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33590956|NCT02416453|62989355|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33590957|NCT02416453|62989356|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33590958|NCT02416453|62989357|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33590959|NCT02416453|62989358|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33590960|NCT02416453|62989359|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33590961|NCT02416453|62989349|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33590962|NCT02416453|62989350|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33590963|NCT02416453|62989351|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33590964|NCT02416453|62989352|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33590965|NCT02416453|62989353|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33590966|NCT02416453|62989354|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
33590967|NCT02416453|62989355|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33590968|NCT02416453|62989356|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33590969|NCT02416453|62989357|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33590970|NCT02416453|62989358|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33590971|NCT02416453|62989359|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33590972|NCT02469961|62989391|FG000|Overall Study|Physician Decision|4|||
33590973|NCT02469961|62989392|FG001|Overall Study|Physician Decision|1|||
33590974|NCT02415595|62989407|FG000|Overall Study|Administrative reason by sponsor|39|||
33590975|NCT02415595|62989408|FG001|Overall Study|Administrative reason by sponsor|40|||
33590976|NCT02415595|62989409|FG002|Overall Study|Administrative reason by sponsor|41|||
33680390|NCT02585258|63135988|FG000|Overall Study|Lost to Follow-up|5|||
33680391|NCT02585258|63135989|FG001|Overall Study|Lost to Follow-up|2|||
33680392|NCT02132611|63136015|FG000|Overall Study|Death|2|||
33680393|NCT01941030|63136021|FG000|Overall Study|Death|3|||
33590977|NCT02415595|62989410|FG003|Overall Study|Administrative reason by sponsor|39|||
33590978|NCT02415595|62989407|FG000|Overall Study|Adverse Event|1|||
33680394|NCT01941030|63136022|FG001|Overall Study|Death|2|||
33680395|NCT01941030|63136021|FG000|Overall Study|Lost to Follow-up|6|||
33401428|NCT00256867|62780475|FG001|Overall Study|Adverse Event|1|||
33680396|NCT01941030|63136022|FG001|Overall Study|Lost to Follow-up|5|||
33680397|NCT01941030|63136021|FG000|Overall Study|Withdrawal by Subject|4|||
33680398|NCT01941030|63136022|FG001|Overall Study|Withdrawal by Subject|6|||
33680399|NCT01874353|63136030|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
33590979|NCT02415595|62989408|FG001|Overall Study|Adverse Event|3|||
33590980|NCT02415595|62989409|FG002|Overall Study|Adverse Event|5|||
33590981|NCT02415595|62989410|FG003|Overall Study|Adverse Event|10|||
33590982|NCT02415595|62989407|FG000|Overall Study|Lack of Efficacy|4|||
33590983|NCT02415595|62989408|FG001|Overall Study|Lack of Efficacy|4|||
33590984|NCT02415595|62989409|FG002|Overall Study|Lack of Efficacy|0|||
33590985|NCT02415595|62989410|FG003|Overall Study|Lack of Efficacy|0|||
33590986|NCT02415595|62989407|FG000|Overall Study|Lost to Follow-up|1|||
33590987|NCT02415595|62989408|FG001|Overall Study|Lost to Follow-up|3|||
33590988|NCT02415595|62989409|FG002|Overall Study|Lost to Follow-up|1|||
33590989|NCT02415595|62989410|FG003|Overall Study|Lost to Follow-up|1|||
33590990|NCT02415595|62989407|FG000|Overall Study|Poor/Non-compliance|1|||
33590991|NCT02415595|62989408|FG001|Overall Study|Poor/Non-compliance|0|||
33590992|NCT02415595|62989409|FG002|Overall Study|Poor/Non-compliance|1|||
33590993|NCT02415595|62989410|FG003|Overall Study|Poor/Non-compliance|0|||
33590994|NCT02415595|62989407|FG000|Overall Study|Reached stopping criteria|0|||
33590995|NCT02415595|62989408|FG001|Overall Study|Reached stopping criteria|1|||
33590996|NCT02415595|62989409|FG002|Overall Study|Reached stopping criteria|1|||
33590997|NCT02415595|62989410|FG003|Overall Study|Reached stopping criteria|0|||
33590998|NCT02415595|62989407|FG000|Overall Study|Withdrawal by Subject|4|||
33590999|NCT02415595|62989408|FG001|Overall Study|Withdrawal by Subject|0|||
33591000|NCT02415595|62989409|FG002|Overall Study|Withdrawal by Subject|1|||
33591001|NCT02415595|62989410|FG003|Overall Study|Withdrawal by Subject|3|||
33591002|NCT02415595|62989407|FG000|Overall Study|Other|0|||
33591003|NCT02415595|62989408|FG001|Overall Study|Other|1|||
33591004|NCT02415595|62989409|FG002|Overall Study|Other|1|||
33591005|NCT02415595|62989410|FG003|Overall Study|Other|0|||
33591006|NCT02446717|62989426|FG000|Overall Study|Adverse Event|0|||
33591007|NCT02446717|62989427|FG001|Overall Study|Adverse Event|0|||
33591008|NCT02446717|62989428|FG002|Overall Study|Adverse Event|1|||
33591009|NCT02446717|62989429|FG003|Overall Study|Adverse Event|0|||
33591010|NCT02446717|62989430|FG004|Overall Study|Adverse Event|0|||
33591011|NCT02446717|62989426|FG000|Overall Study|Lost to Follow-up|0|||
33591012|NCT02446717|62989427|FG001|Overall Study|Lost to Follow-up|1|||
33591013|NCT02446717|62989428|FG002|Overall Study|Lost to Follow-up|1|||
33591014|NCT02446717|62989429|FG003|Overall Study|Lost to Follow-up|0|||
33591015|NCT02446717|62989430|FG004|Overall Study|Lost to Follow-up|1|||
33591016|NCT02446717|62989426|FG000|Overall Study|Withdrew consent|0|||
33591017|NCT02446717|62989427|FG001|Overall Study|Withdrew consent|0|||
33591018|NCT02446717|62989428|FG002|Overall Study|Withdrew consent|0|||
33591019|NCT02446717|62989429|FG003|Overall Study|Withdrew consent|1|||
33591020|NCT02446717|62989430|FG004|Overall Study|Withdrew consent|0|||
33591021|NCT02469415|62989442|FG000|Overall Study|Withdrawal by Subject|1|||
33591022|NCT02469415|62989442|FG000|Overall Study|Investigational agent placed on hold|2|||
33591023|NCT02446171|62989450|FG000|Overall Study|Withdrawal by Subject|0|||
33591024|NCT02446171|62989451|FG001|Overall Study|Withdrawal by Subject|0|||
33591025|NCT02446171|62989452|FG002|Overall Study|Withdrawal by Subject|2|||
33591026|NCT02446171|62989453|FG003|Overall Study|Withdrawal by Subject|0|||
33591027|NCT02446015|62989467|FG000|Overall Study|Adverse Event|0|||
33591028|NCT02446015|62989468|FG001|Overall Study|Adverse Event|1|||
33591029|NCT02446015|62989467|FG000|Overall Study|Withdrawal by Subject|1|||
33591030|NCT02446015|62989468|FG001|Overall Study|Withdrawal by Subject|0|||
33591031|NCT02415127|62989477|FG000|Overall Study|Adverse Event|1|||
33591032|NCT02415127|62989478|FG001|Overall Study|Adverse Event|0|||
33591033|NCT02468557|62989484|FG000|Overall Study|Adverse Event|1|||
33591034|NCT02468557|62989484|FG000|Overall Study|Death|1|||
33591035|NCT02468557|62989484|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
33591036|NCT02468557|62989484|FG000|Overall Study|All Enrolled but Never Dosed|4|||
33591037|NCT02413489|62989495|FG000|Overall Study|Death|11|||
33591038|NCT02413489|62989496|FG001|Overall Study|Death|3|||
33591039|NCT02413489|62989497|FG002|Overall Study|Death|4|||
33591040|NCT02413489|62989495|FG000|Overall Study|Withdrawal by Subject|2|||
33591041|NCT02413489|62989496|FG001|Overall Study|Withdrawal by Subject|0|||
33591042|NCT02413489|62989497|FG002|Overall Study|Withdrawal by Subject|0|||
33591043|NCT02413489|62989495|FG000|Overall Study|Study Terminated By Sponsor|2|||
33591044|NCT02413489|62989496|FG001|Overall Study|Study Terminated By Sponsor|13|||
33591045|NCT02413489|62989497|FG002|Overall Study|Study Terminated By Sponsor|1|||
33591046|NCT02413333|62989509|FG000|Period 1|Adverse Event|1|||
33591047|NCT02413333|62989510|FG001|Period 1|Adverse Event|0|||
33591048|NCT02413333|62989509|FG000|Period 1|Reason Not Specified|0|||
33591049|NCT02413333|62989510|FG001|Period 1|Reason Not Specified|1|||
33591050|NCT02413333|62989509|FG000|Period 2|Protocol Deviation|1|||
33591051|NCT02413333|62989510|FG001|Period 2|Protocol Deviation|0|||
33591052|NCT02413255|62989533|FG000|Overall Study|Voluntary Withdrawal|0|||
33591053|NCT02413255|62989534|FG001|Overall Study|Voluntary Withdrawal|0|||
33591054|NCT02413255|62989535|FG002|Overall Study|Voluntary Withdrawal|0|||
33591055|NCT02413255|62989536|FG003|Overall Study|Voluntary Withdrawal|0|||
33591056|NCT02413255|62989537|FG004|Overall Study|Voluntary Withdrawal|0|||
33591057|NCT02413255|62989538|FG005|Overall Study|Voluntary Withdrawal|0|||
33591058|NCT02413255|62989539|FG006|Overall Study|Voluntary Withdrawal|0|||
33591059|NCT02413255|62989540|FG007|Overall Study|Voluntary Withdrawal|0|||
33591060|NCT02413255|62989541|FG008|Overall Study|Voluntary Withdrawal|0|||
33591061|NCT02413255|62989542|FG009|Overall Study|Voluntary Withdrawal|0|||
33591062|NCT02413255|62989543|FG010|Overall Study|Voluntary Withdrawal|0|||
33591063|NCT02413255|62989544|FG011|Overall Study|Voluntary Withdrawal|0|||
33591064|NCT02413255|62989545|FG012|Overall Study|Voluntary Withdrawal|0|||
33591065|NCT02413255|62989546|FG013|Overall Study|Voluntary Withdrawal|0|||
33591066|NCT02413255|62989547|FG014|Overall Study|Voluntary Withdrawal|1|||
33591067|NCT02413255|62989548|FG015|Overall Study|Voluntary Withdrawal|0|||
33591068|NCT02413255|62989549|FG016|Overall Study|Voluntary Withdrawal|0|||
33591069|NCT02444533|62989602|FG000|Overall Study|Not able to complete forms|0|||
33591070|NCT02444533|62989603|FG001|Overall Study|Not able to complete forms|2|||
33591071|NCT02444533|62989602|FG000|Overall Study|Only gave post-procedure complications|2|||
33591072|NCT02444533|62989603|FG001|Overall Study|Only gave post-procedure complications|2|||
33591073|NCT01651039|62989609|FG000|Overall Study|Non-evaluables|5|||
33591074|NCT01651039|62989609|FG000|Overall Study|Physician Decision|2|||
33591075|NCT01651039|62989609|FG000|Overall Study|Withdrawal by Subject|1|||
33591076|NCT01651039|62989609|FG000|Overall Study|Progressive Disease|22|||
33591077|NCT02349633|62989627|FG000|Overall Study|Death|0|||
33591078|NCT02349633|62989628|FG001|Overall Study|Death|1|||
33591079|NCT02349633|62989629|FG002|Overall Study|Death|0|||
33591080|NCT02349633|62989630|FG003|Overall Study|Death|0|||
33591081|NCT02349633|62989631|FG004|Overall Study|Death|0|||
33591082|NCT02349633|62989632|FG005|Overall Study|Death|1|||
33591083|NCT02349633|62989633|FG006|Overall Study|Death|1|||
33591084|NCT02349633|62989634|FG007|Overall Study|Death|1|||
33591085|NCT02349633|62989635|FG008|Overall Study|Death|0|||
33591086|NCT02349633|62989636|FG009|Overall Study|Death|1|||
33591087|NCT02349633|62989637|FG010|Overall Study|Death|0|||
33591088|NCT02349633|62989638|FG011|Overall Study|Death|0|||
33591089|NCT02349633|62989639|FG012|Overall Study|Death|0|||
33591090|NCT02349633|62989640|FG013|Overall Study|Death|0|||
33591091|NCT02349633|62989627|FG000|Overall Study|Withdrawal by Subject|0|||
33591092|NCT02349633|62989628|FG001|Overall Study|Withdrawal by Subject|0|||
33591093|NCT02349633|62989629|FG002|Overall Study|Withdrawal by Subject|0|||
33591094|NCT02349633|62989630|FG003|Overall Study|Withdrawal by Subject|1|||
33591095|NCT02349633|62989631|FG004|Overall Study|Withdrawal by Subject|0|||
33591096|NCT02349633|62989632|FG005|Overall Study|Withdrawal by Subject|0|||
33591097|NCT02349633|62989633|FG006|Overall Study|Withdrawal by Subject|0|||
33591098|NCT02349633|62989634|FG007|Overall Study|Withdrawal by Subject|2|||
33591099|NCT02349633|62989635|FG008|Overall Study|Withdrawal by Subject|2|||
33591100|NCT02349633|62989636|FG009|Overall Study|Withdrawal by Subject|1|||
33591101|NCT02349633|62989637|FG010|Overall Study|Withdrawal by Subject|0|||
33591102|NCT02349633|62989638|FG011|Overall Study|Withdrawal by Subject|0|||
33591103|NCT02349633|62989639|FG012|Overall Study|Withdrawal by Subject|0|||
33591104|NCT02349633|62989640|FG013|Overall Study|Withdrawal by Subject|0|||
33591105|NCT02349633|62989627|FG000|Overall Study|Withdrawal of informed consent|0|||
33591106|NCT02349633|62989628|FG001|Overall Study|Withdrawal of informed consent|0|||
33591107|NCT02349633|62989629|FG002|Overall Study|Withdrawal of informed consent|0|||
33591108|NCT02349633|62989630|FG003|Overall Study|Withdrawal of informed consent|1|||
33591109|NCT02349633|62989631|FG004|Overall Study|Withdrawal of informed consent|1|||
33591110|NCT02349633|62989632|FG005|Overall Study|Withdrawal of informed consent|0|||
33591111|NCT02349633|62989633|FG006|Overall Study|Withdrawal of informed consent|0|||
33591112|NCT02349633|62989634|FG007|Overall Study|Withdrawal of informed consent|3|||
33591113|NCT02349633|62989635|FG008|Overall Study|Withdrawal of informed consent|0|||
33591114|NCT02349633|62989636|FG009|Overall Study|Withdrawal of informed consent|0|||
33591115|NCT02349633|62989637|FG010|Overall Study|Withdrawal of informed consent|0|||
33591116|NCT02349633|62989638|FG011|Overall Study|Withdrawal of informed consent|0|||
33591117|NCT02349633|62989639|FG012|Overall Study|Withdrawal of informed consent|0|||
33591118|NCT02349633|62989640|FG013|Overall Study|Withdrawal of informed consent|0|||
33591119|NCT02349633|62989627|FG000|Overall Study|Transition to compassionate use|0|||
33680400|NCT01874353|63136031|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
33591120|NCT02349633|62989628|FG001|Overall Study|Transition to compassionate use|0|||
33591121|NCT02349633|62989629|FG002|Overall Study|Transition to compassionate use|0|||
33591122|NCT02349633|62989630|FG003|Overall Study|Transition to compassionate use|0|||
33591123|NCT02349633|62989631|FG004|Overall Study|Transition to compassionate use|1|||
33591124|NCT02349633|62989632|FG005|Overall Study|Transition to compassionate use|0|||
33591125|NCT02349633|62989633|FG006|Overall Study|Transition to compassionate use|0|||
33591126|NCT02349633|62989634|FG007|Overall Study|Transition to compassionate use|3|||
33591127|NCT02349633|62989635|FG008|Overall Study|Transition to compassionate use|0|||
33591128|NCT02349633|62989636|FG009|Overall Study|Transition to compassionate use|1|||
33591129|NCT02349633|62989637|FG010|Overall Study|Transition to compassionate use|0|||
33591130|NCT02349633|62989638|FG011|Overall Study|Transition to compassionate use|0|||
33591131|NCT02349633|62989639|FG012|Overall Study|Transition to compassionate use|0|||
33591132|NCT02349633|62989640|FG013|Overall Study|Transition to compassionate use|0|||
33591133|NCT02349633|62989627|FG000|Overall Study|Early termination of survival follow-up|0|||
33591134|NCT02349633|62989628|FG001|Overall Study|Early termination of survival follow-up|0|||
33591135|NCT02349633|62989629|FG002|Overall Study|Early termination of survival follow-up|0|||
33591136|NCT02349633|62989630|FG003|Overall Study|Early termination of survival follow-up|0|||
33591137|NCT02349633|62989631|FG004|Overall Study|Early termination of survival follow-up|0|||
33591138|NCT02349633|62989632|FG005|Overall Study|Early termination of survival follow-up|0|||
33591139|NCT02349633|62989633|FG006|Overall Study|Early termination of survival follow-up|0|||
33591140|NCT02349633|62989634|FG007|Overall Study|Early termination of survival follow-up|4|||
33591141|NCT02349633|62989635|FG008|Overall Study|Early termination of survival follow-up|0|||
33591142|NCT02349633|62989636|FG009|Overall Study|Early termination of survival follow-up|0|||
33591143|NCT02349633|62989637|FG010|Overall Study|Early termination of survival follow-up|0|||
33591144|NCT02349633|62989638|FG011|Overall Study|Early termination of survival follow-up|0|||
33591145|NCT02349633|62989639|FG012|Overall Study|Early termination of survival follow-up|0|||
33591146|NCT02349633|62989640|FG013|Overall Study|Early termination of survival follow-up|0|||
33591147|NCT02349633|62989627|FG000|Overall Study|Termination by sponsor|0|||
33591148|NCT02349633|62989628|FG001|Overall Study|Termination by sponsor|0|||
33591149|NCT02349633|62989629|FG002|Overall Study|Termination by sponsor|0|||
33591150|NCT02349633|62989630|FG003|Overall Study|Termination by sponsor|0|||
33591151|NCT02349633|62989631|FG004|Overall Study|Termination by sponsor|0|||
33591152|NCT02349633|62989632|FG005|Overall Study|Termination by sponsor|0|||
33591153|NCT02349633|62989633|FG006|Overall Study|Termination by sponsor|0|||
33591154|NCT02349633|62989634|FG007|Overall Study|Termination by sponsor|1|||
33591155|NCT02349633|62989635|FG008|Overall Study|Termination by sponsor|0|||
33591156|NCT02349633|62989636|FG009|Overall Study|Termination by sponsor|2|||
33591157|NCT02349633|62989637|FG010|Overall Study|Termination by sponsor|0|||
33591158|NCT02349633|62989638|FG011|Overall Study|Termination by sponsor|0|||
33591159|NCT02349633|62989639|FG012|Overall Study|Termination by sponsor|0|||
33591160|NCT02349633|62989640|FG013|Overall Study|Termination by sponsor|0|||
33591161|NCT02349633|62989627|FG000|Overall Study|Other|0|||
33591162|NCT02349633|62989628|FG001|Overall Study|Other|0|||
33591163|NCT02349633|62989629|FG002|Overall Study|Other|0|||
33591164|NCT02349633|62989630|FG003|Overall Study|Other|0|||
33591165|NCT02349633|62989631|FG004|Overall Study|Other|0|||
33591166|NCT02349633|62989632|FG005|Overall Study|Other|0|||
33591167|NCT02349633|62989633|FG006|Overall Study|Other|0|||
33591168|NCT02349633|62989634|FG007|Overall Study|Other|2|||
33591169|NCT02349633|62989635|FG008|Overall Study|Other|0|||
33591170|NCT02349633|62989636|FG009|Overall Study|Other|0|||
33591171|NCT02349633|62989637|FG010|Overall Study|Other|0|||
33591172|NCT02349633|62989638|FG011|Overall Study|Other|0|||
33591173|NCT02349633|62989639|FG012|Overall Study|Other|0|||
33591174|NCT02349633|62989640|FG013|Overall Study|Other|0|||
33591175|NCT02275611|62989705|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
33591176|NCT02275611|62989706|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
33591177|NCT02275611|62989707|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
33591178|NCT02275611|62989708|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
33591179|NCT02275065|62989725|FG000|Overall Study|Randomized but not treated|1|||
33591180|NCT02275065|62989726|FG001|Overall Study|Randomized but not treated|0|||
33591181|NCT02275065|62989727|FG002|Overall Study|Randomized but not treated|1|||
33591182|NCT02275065|62989728|FG003|Overall Study|Randomized but not treated|1|||
33591183|NCT02275065|62989729|FG004|Overall Study|Randomized but not treated|0|||
33591184|NCT02273973|62989743|FG000|Overall Study|Adverse Event|4|||
33591185|NCT02273973|62989744|FG001|Overall Study|Adverse Event|0|||
33591186|NCT02273973|62989743|FG000|Overall Study|Withdrawal by Subject|2|||
33591187|NCT02273973|62989744|FG001|Overall Study|Withdrawal by Subject|3|||
33591188|NCT02273973|62989743|FG000|Overall Study|Death|1|||
33591189|NCT02273973|62989744|FG001|Overall Study|Death|0|||
33591190|NCT02273973|62989743|FG000|Overall Study|Non-compliance|1|||
33591191|NCT02273973|62989744|FG001|Overall Study|Non-compliance|0|||
33591192|NCT02273973|62989743|FG000|Overall Study|Protocol Violation|1|||
33591193|NCT02273973|62989744|FG001|Overall Study|Protocol Violation|0|||
33591194|NCT02273973|62989743|FG000|Overall Study|Progression of disease|0|||
33591195|NCT02273973|62989744|FG001|Overall Study|Progression of disease|2|||
33591196|NCT02273973|62989743|FG000|Overall Study|Lost to Follow-up|0|||
33591197|NCT02273973|62989744|FG001|Overall Study|Lost to Follow-up|1|||
33591198|NCT02273973|62989743|FG000|Overall Study|Physician Decision|0|||
33591199|NCT02273973|62989744|FG001|Overall Study|Physician Decision|1|||
33591200|NCT02273973|62989743|FG000|Overall Study|Reason not specified|0|||
33591201|NCT02273973|62989744|FG001|Overall Study|Reason not specified|1|||
33591202|NCT02273739|62989754|FG000|Overall Study|Progression of Disease|3|||
33591203|NCT02273739|62989755|FG001|Overall Study|Progression of Disease|4|||
33591204|NCT02273739|62989756|FG002|Overall Study|Progression of Disease|5|||
33591205|NCT02273739|62989757|FG003|Overall Study|Progression of Disease|2|||
33591206|NCT02273739|62989754|FG000|Overall Study|Death|0|||
33591207|NCT02273739|62989755|FG001|Overall Study|Death|0|||
33591208|NCT02273739|62989756|FG002|Overall Study|Death|0|||
33591209|NCT02273739|62989757|FG003|Overall Study|Death|2|||
33591210|NCT02273739|62989754|FG000|Overall Study|Adverse Event|0|||
33591211|NCT02273739|62989755|FG001|Overall Study|Adverse Event|0|||
33591212|NCT02273739|62989756|FG002|Overall Study|Adverse Event|0|||
33591213|NCT02273739|62989757|FG003|Overall Study|Adverse Event|1|||
33591214|NCT02273739|62989754|FG000|Overall Study|Withdrawal by Subject|0|||
33591215|NCT02273739|62989755|FG001|Overall Study|Withdrawal by Subject|0|||
33591216|NCT02273739|62989756|FG002|Overall Study|Withdrawal by Subject|2|||
33591217|NCT02273739|62989757|FG003|Overall Study|Withdrawal by Subject|1|||
33591218|NCT02273739|62989754|FG000|Overall Study|Physician Decision|0|||
33591219|NCT02273739|62989755|FG001|Overall Study|Physician Decision|0|||
33591220|NCT02273739|62989756|FG002|Overall Study|Physician Decision|0|||
33591221|NCT02273739|62989757|FG003|Overall Study|Physician Decision|1|||
33591222|NCT02273037|62989774|FG000|Overall Study|Lost to Follow-up|1|||
33591223|NCT02273037|62989775|FG001|Overall Study|Lost to Follow-up|0|||
33591224|NCT02273037|62989774|FG000|Overall Study|Delivered before monitoring initiated|1|||
33591225|NCT02273037|62989775|FG001|Overall Study|Delivered before monitoring initiated|3|||
33591226|NCT02273037|62989774|FG000|Overall Study|Breech delivery|2|||
33591227|NCT02273037|62989775|FG001|Overall Study|Breech delivery|3|||
33591228|NCT02273037|62989774|FG000|Overall Study|Multiple delivery|2|||
33591229|NCT02273037|62989775|FG001|Overall Study|Multiple delivery|2|||
33591230|NCT02273037|62989774|FG000|Overall Study|Other complication|2|||
33591231|NCT02273037|62989775|FG001|Overall Study|Other complication|0|||
33591232|NCT02465515|62989785|FG000|Overall Study|Investigator site closed|4|||
33591233|NCT02465515|62989786|FG001|Overall Study|Investigator site closed|5|||
33591234|NCT02465515|62989785|FG000|Overall Study|Withdrawal by Subject|74|||
33591235|NCT02465515|62989786|FG001|Overall Study|Withdrawal by Subject|43|||
33591236|NCT02465515|62989785|FG000|Overall Study|Physician Decision|8|||
33591237|NCT02465515|62989786|FG001|Overall Study|Physician Decision|12|||
33591238|NCT02465515|62989785|FG000|Overall Study|Lost to Follow-up|68|||
33591239|NCT02465515|62989786|FG001|Overall Study|Lost to Follow-up|51|||
33591240|NCT02412631|62989794|FG000|Overall Study|Adverse Event|1|||
33591241|NCT02412631|62989795|FG001|Overall Study|Adverse Event|2|||
33591242|NCT02412631|62989794|FG000|Overall Study|Lost to Follow-up|5|||
33591243|NCT02412631|62989795|FG001|Overall Study|Lost to Follow-up|9|||
33591244|NCT02412631|62989794|FG000|Overall Study|Withdrawal by Subject|9|||
33591245|NCT02412631|62989795|FG001|Overall Study|Withdrawal by Subject|3|||
33591246|NCT02412631|62989794|FG000|Overall Study|Early stop by FDA|5|||
33591247|NCT02412631|62989795|FG001|Overall Study|Early stop by FDA|2|||
33591248|NCT02412631|62989794|FG000|Overall Study|Unspecified reason|6|||
33591249|NCT02412631|62989795|FG001|Overall Study|Unspecified reason|8|||
33591250|NCT02272803|62989803|FG000|Overall Study|Disease progression|16|||
33591251|NCT02272803|62989804|FG001|Overall Study|Disease progression|8|||
33591252|NCT02272803|62989803|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
33591253|NCT02272803|62989804|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
33591254|NCT02272803|62989803|FG000|Overall Study|Study drug toxicity|4|||
33591255|NCT02272803|62989804|FG001|Overall Study|Study drug toxicity|9|||
33591256|NCT02272803|62989803|FG000|Overall Study|Participant request to discontinue study treatment|3|||
33591257|NCT02272803|62989804|FG001|Overall Study|Participant request to discontinue study treatment|7|||
33591258|NCT02272803|62989803|FG000|Overall Study|Maximum clinical benefit|4|||
33591259|NCT02272803|62989804|FG001|Overall Study|Maximum clinical benefit|2|||
33591260|NCT02272803|62989803|FG000|Overall Study|Poor/non-compliance|2|||
33591261|NCT02272803|62989804|FG001|Overall Study|Poor/non-compliance|2|||
33591262|NCT02272803|62989803|FG000|Overall Study|Withdrawal by Subject|2|||
33591263|NCT02272803|62989804|FG001|Overall Study|Withdrawal by Subject|1|||
33591264|NCT02272803|62989803|FG000|Overall Study|Death|0|||
33591265|NCT02272803|62989804|FG001|Overall Study|Death|1|||
33591266|NCT02272803|62989803|FG000|Overall Study|Other reasons|1|||
33591267|NCT02272803|62989804|FG001|Overall Study|Other reasons|3|||
33591268|NCT02272803|62989803|FG000|Overall Study|Administrative reason by sponsor|5|||
33680401|NCT01874353|63136032|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
33680402|NCT01874353|63136033|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
33591269|NCT02272803|62989804|FG001|Overall Study|Administrative reason by sponsor|4|||
33591270|NCT02272725|62989812|FG000|Overall Study|equipment malfunction|2|||
33591271|NCT02272725|62989813|FG001|Overall Study|equipment malfunction|0|||
33591272|NCT01650805|62989821|FG000|Overall Study|Withdrawal by Subject|1|||
33591273|NCT01650805|62989822|FG001|Overall Study|Withdrawal by Subject|0|||
33591274|NCT02442349|62989828|FG000|Overall Study|Death|14|||
33680403|NCT01874353|63136030|FG000|Overall Study|Lost to Follow-up|2|||
33680404|NCT01874353|63136031|FG001|Overall Study|Lost to Follow-up|2|||
33591275|NCT02442349|62989828|FG000|Overall Study|Withdrawal by Subject|8|||
33591276|NCT02442349|62989828|FG000|Overall Study|On-going Study at Data Cut-off|149|||
33591277|NCT02411539|62989834|FG000|Overall Study|Lost to Follow-up|2|||
33591278|NCT02411539|62989835|FG001|Overall Study|Lost to Follow-up|0|||
33591279|NCT02411539|62989834|FG000|Overall Study|Confounding medical condition|0|||
33591280|NCT02411539|62989835|FG001|Overall Study|Confounding medical condition|1|||
33591281|NCT02465437|62989848|FG000|Overall Study|Physician Decision|0|||
33591282|NCT02465437|62989849|FG001|Overall Study|Physician Decision|0|||
33591283|NCT02465437|62989850|FG002|Overall Study|Physician Decision|1|||
33591284|NCT02465437|62989851|FG003|Overall Study|Physician Decision|0|||
33591285|NCT02465437|62989848|FG000|Overall Study|Withdrawal by Subject|1|||
33591286|NCT02465437|62989849|FG001|Overall Study|Withdrawal by Subject|0|||
33591287|NCT02465437|62989850|FG002|Overall Study|Withdrawal by Subject|0|||
33591288|NCT02465437|62989851|FG003|Overall Study|Withdrawal by Subject|1|||
33591289|NCT02465437|62989848|FG000|Overall Study|Adverse Event|0|||
33591290|NCT02465437|62989849|FG001|Overall Study|Adverse Event|1|||
33591291|NCT02465437|62989850|FG002|Overall Study|Adverse Event|0|||
33591292|NCT02465437|62989851|FG003|Overall Study|Adverse Event|0|||
33591293|NCT02442271|62989859|FG000|Overall Study|Adverse Event|1|||
33591294|NCT02442271|62989859|FG000|Overall Study|Withdrew Consent|1|||
33591295|NCT02442271|62989859|FG000|Overall Study|Lost to Follow-up|1|||
33591296|NCT02442271|62989859|FG000|Overall Study|Other|1|||
33591297|NCT02465203|62989880|FG000|Overall Study|Protocol Violation|1|||
33591298|NCT02465203|62989881|FG001|Overall Study|Protocol Violation|1|||
33591299|NCT02465203|62989882|FG002|Overall Study|Protocol Violation|1|||
33591300|NCT02465203|62989880|FG000|Overall Study|Study terminated by sponsor|50|||
33591301|NCT02465203|62989881|FG001|Overall Study|Study terminated by sponsor|34|||
33591302|NCT02465203|62989882|FG002|Overall Study|Study terminated by sponsor|11|||
33591303|NCT02465203|62989880|FG000|Overall Study|New therapy for study indication|4|||
33591304|NCT02465203|62989881|FG001|Overall Study|New therapy for study indication|0|||
33591305|NCT02465203|62989882|FG002|Overall Study|New therapy for study indication|0|||
33591306|NCT02465203|62989880|FG000|Overall Study|Patient/guardian decision|1|||
33591307|NCT02465203|62989881|FG001|Overall Study|Patient/guardian decision|1|||
33591308|NCT02465203|62989882|FG002|Overall Study|Patient/guardian decision|1|||
33591309|NCT02463409|62989889|FG000|Overall Study|Withdrawal by Subject|1|||
33591310|NCT02463409|62989889|FG000|Overall Study|Screen failure|1|||
33591311|NCT02528357|62989912|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591312|NCT02528357|62989913|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
33591313|NCT02528357|62989914|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591314|NCT02528357|62989915|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591315|NCT02528357|62989916|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591316|NCT02528357|62989917|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591317|NCT02528357|62989918|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591318|NCT02528357|62989919|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591319|NCT02528357|62989920|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591320|NCT02528357|62989921|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591321|NCT02528357|62989922|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591322|NCT02528357|62989923|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591323|NCT02528357|62989924|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591324|NCT02528357|62989925|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591325|NCT02528357|62989926|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591326|NCT02528357|62989927|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591327|NCT02528357|62989928|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591328|NCT02528357|62989929|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591329|NCT02528357|62989930|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33591330|NCT02528357|62989912|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33680405|NCT01874353|63136032|FG002|Overall Study|Lost to Follow-up|2|||
33680406|NCT01874353|63136033|FG003|Overall Study|Lost to Follow-up|0|||
33680407|NCT01874353|63136030|FG000|Overall Study|Death|110|||
33680408|NCT01874353|63136031|FG001|Overall Study|Death|60|||
33680409|NCT01874353|63136032|FG002|Overall Study|Death|13|||
33680410|NCT01874353|63136033|FG003|Overall Study|Death|7|||
33680411|NCT01874353|63136030|FG000|Overall Study|Withdrawal by Subject|13|||
33680412|NCT01874353|63136031|FG001|Overall Study|Withdrawal by Subject|11|||
33680413|NCT01874353|63136032|FG002|Overall Study|Withdrawal by Subject|0|||
33680414|NCT01874353|63136033|FG003|Overall Study|Withdrawal by Subject|0|||
33680415|NCT01092416|63136050|FG000|Enrollment|Atherectomy device not inserted|3|||
33680416|NCT01092416|63136050|FG000|30-Day Follow-up|Death|2|||
33591331|NCT02528357|62989913|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33591332|NCT02528357|62989914|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33680417|NCT01092416|63136050|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
33591333|NCT02528357|62989915|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
33680418|NCT01092416|63136050|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
33680419|NCT01092416|63136050|FG000|12-Month Follow-up|Death|16|||
33680420|NCT01092416|63136050|FG000|12-Month Follow-up|Lost to Follow-up|4|||
33680421|NCT01092416|63136050|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
33591334|NCT02528357|62989916|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33591335|NCT02528357|62989917|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
33591336|NCT02528357|62989918|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33591337|NCT02528357|62989919|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
33591338|NCT02528357|62989920|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33591339|NCT02528357|62989921|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33591340|NCT02528357|62989922|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33591341|NCT02528357|62989923|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33591342|NCT02528357|62989924|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33591343|NCT02528357|62989925|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33591344|NCT02528357|62989926|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33591345|NCT02528357|62989927|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33591346|NCT02528357|62989928|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33591347|NCT02528357|62989929|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33591348|NCT02528357|62989930|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33591349|NCT02528357|62989912|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33591350|NCT02528357|62989913|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33591351|NCT02528357|62989914|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
33591352|NCT02528357|62989915|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33591353|NCT02528357|62989916|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
33591354|NCT02528357|62989917|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33591355|NCT02528357|62989918|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
33591356|NCT02528357|62989919|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
33591357|NCT02528357|62989920|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33591358|NCT02528357|62989921|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33591359|NCT02528357|62989922|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33591360|NCT02528357|62989923|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33591361|NCT02528357|62989924|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33591362|NCT02528357|62989925|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33591363|NCT02528357|62989926|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33591364|NCT02528357|62989927|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33591365|NCT02528357|62989928|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33591366|NCT02528357|62989929|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33591367|NCT02528357|62989930|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33591368|NCT02528357|62989912|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591369|NCT02528357|62989913|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591370|NCT02528357|62989914|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591371|NCT02528357|62989915|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591372|NCT02528357|62989916|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
33591373|NCT02528357|62989917|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591374|NCT02528357|62989918|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591375|NCT02528357|62989919|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591376|NCT02528357|62989920|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591377|NCT02528357|62989921|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591378|NCT02528357|62989922|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591379|NCT02528357|62989923|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591380|NCT02528357|62989924|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33651247|NCT01972841|63062637|FG001|Overall Study|Did not have end of treatment page|0|||
33651248|NCT01972841|63062638|FG002|Overall Study|Did not have end of treatment page|0|||
33651249|NCT01972841|63062639|FG003|Overall Study|Did not have end of treatment page|0|||
33651250|NCT01972841|63062640|FG004|Overall Study|Did not have end of treatment page|1|||
33651251|NCT01972841|63062641|FG005|Overall Study|Did not have end of treatment page|0|||
33651252|NCT01774903|63062655|FG000|Overall Study|Adverse Event|7|||
33651253|NCT01774903|63062655|FG000|Overall Study|Withdrawal by Subject|2|||
33651254|NCT01774903|63062655|FG000|Overall Study|Lack of Efficacy|1|||
33651255|NCT01774903|63062655|FG000|Overall Study|Ineligible to continue the trial|1|||
33651256|NCT01774591|63062662|FG000|Overall Study|Physician Decision|1|||
33651257|NCT01774591|63062663|FG001|Overall Study|Physician Decision|1|||
33651258|NCT01774591|63062662|FG000|Overall Study|Withdrawal by Subject|0|||
33651259|NCT01774591|63062663|FG001|Overall Study|Withdrawal by Subject|1|||
33591381|NCT02528357|62989925|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591382|NCT02528357|62989926|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591383|NCT02528357|62989927|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591384|NCT02528357|62989928|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591385|NCT02528357|62989929|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591386|NCT02528357|62989930|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591387|NCT02528357|62989912|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591388|NCT02528357|62989913|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591389|NCT02528357|62989914|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591390|NCT02528357|62989915|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591391|NCT02528357|62989916|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591392|NCT02528357|62989917|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591393|NCT02528357|62989918|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591394|NCT02528357|62989919|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591395|NCT02528357|62989920|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591396|NCT02528357|62989921|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591397|NCT02528357|62989922|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591398|NCT02528357|62989923|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591399|NCT02528357|62989924|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591400|NCT02528357|62989925|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
33591401|NCT02528357|62989926|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
33591402|NCT02528357|62989927|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591403|NCT02528357|62989928|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591404|NCT02528357|62989929|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591405|NCT02528357|62989930|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33591406|NCT02528357|62989912|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591407|NCT02528357|62989913|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591408|NCT02528357|62989914|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591409|NCT02528357|62989915|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591410|NCT02528357|62989916|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591411|NCT02528357|62989917|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591412|NCT02528357|62989918|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591413|NCT02528357|62989919|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591414|NCT02528357|62989920|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591415|NCT02528357|62989921|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591416|NCT02528357|62989922|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591417|NCT02528357|62989923|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591418|NCT02528357|62989924|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591419|NCT02528357|62989925|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
33591420|NCT02528357|62989926|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591421|NCT02528357|62989927|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591422|NCT02528357|62989928|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591423|NCT02528357|62989929|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591424|NCT02528357|62989930|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33591425|NCT02528357|62989912|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33591426|NCT02528357|62989913|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33591427|NCT02528357|62989914|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33591428|NCT02528357|62989915|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33591429|NCT02528357|62989916|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33591430|NCT02528357|62989917|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33591431|NCT02528357|62989918|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33591432|NCT02528357|62989919|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33591433|NCT02528357|62989920|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33591434|NCT02528357|62989921|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33651260|NCT01774591|63062662|FG000|Overall Study|Adverse Event|0|||
33651261|NCT01774591|63062663|FG001|Overall Study|Adverse Event|2|||
33651262|NCT01708915|63062673|FG000|Overall Study|Adverse Event|1|||
33651263|NCT01708915|63062674|FG001|Overall Study|Adverse Event|0|||
33651264|NCT01708915|63062675|FG002|Overall Study|Adverse Event|9|||
33651265|NCT01708915|63062676|FG003|Overall Study|Adverse Event|13|||
33651266|NCT01708915|63062673|FG000|Overall Study|Lack of Efficacy|84|||
33651267|NCT01708915|63062674|FG001|Overall Study|Lack of Efficacy|60|||
33591435|NCT02528357|62989922|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
33591436|NCT02528357|62989923|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33591437|NCT02528357|62989924|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
33591438|NCT02528357|62989925|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
33591439|NCT02528357|62989926|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
33591440|NCT02528357|62989927|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33591441|NCT02528357|62989928|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33591442|NCT02528357|62989929|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33591443|NCT02528357|62989930|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33591444|NCT02528357|62989912|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591445|NCT02528357|62989913|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591446|NCT02528357|62989914|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591447|NCT02528357|62989915|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591448|NCT02528357|62989916|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591449|NCT02528357|62989917|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591450|NCT02528357|62989918|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591451|NCT02528357|62989919|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591452|NCT02528357|62989920|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
33591453|NCT02528357|62989921|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
33591454|NCT02528357|62989922|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591455|NCT02528357|62989923|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
33591456|NCT02528357|62989924|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
33591457|NCT02528357|62989925|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
33591458|NCT02528357|62989926|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
33591459|NCT02528357|62989927|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591460|NCT02528357|62989928|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591461|NCT02528357|62989929|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591462|NCT02528357|62989930|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591463|NCT02528357|62989912|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591464|NCT02528357|62989913|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591465|NCT02528357|62989914|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591466|NCT02528357|62989915|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591467|NCT02528357|62989916|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591468|NCT02528357|62989917|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591469|NCT02528357|62989918|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591470|NCT02528357|62989919|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591471|NCT02528357|62989920|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591472|NCT02528357|62989921|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591473|NCT02528357|62989922|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591474|NCT02528357|62989923|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591475|NCT02528357|62989924|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591476|NCT02528357|62989925|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591477|NCT02528357|62989926|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591478|NCT02528357|62989927|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591479|NCT02528357|62989928|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
33591480|NCT02528357|62989929|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591481|NCT02528357|62989930|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33591482|NCT02528357|62989912|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591483|NCT02528357|62989913|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591484|NCT02528357|62989914|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591485|NCT02528357|62989915|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591486|NCT02528357|62989916|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591487|NCT02528357|62989917|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591488|NCT02528357|62989918|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591489|NCT02528357|62989919|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591490|NCT02528357|62989920|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591491|NCT02528357|62989921|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591492|NCT02528357|62989922|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591493|NCT02528357|62989923|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591494|NCT02528357|62989924|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591495|NCT02528357|62989925|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591496|NCT02528357|62989926|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591497|NCT02528357|62989927|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33591498|NCT02528357|62989928|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
33591499|NCT02528357|62989929|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
33591500|NCT02528357|62989930|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
33591501|NCT02463331|62989972|FG000|Overall Study|Adverse Event|4|||
33591502|NCT02463331|62989973|FG001|Overall Study|Adverse Event|2|||
33591503|NCT02463331|62989972|FG000|Overall Study|Lost to Follow-up|1|||
33591504|NCT02463331|62989973|FG001|Overall Study|Lost to Follow-up|1|||
33591505|NCT02463331|62989972|FG000|Overall Study|Pregnancy|2|||
33591506|NCT02463331|62989973|FG001|Overall Study|Pregnancy|3|||
33591507|NCT02463331|62989972|FG000|Overall Study|Lack of Efficacy|6|||
33591508|NCT02463331|62989973|FG001|Overall Study|Lack of Efficacy|0|||
33591509|NCT02463331|62989972|FG000|Overall Study|Physician Decision|3|||
33591510|NCT02463331|62989973|FG001|Overall Study|Physician Decision|0|||
33591511|NCT02410837|62989979|FG000|Overall Study|Death|387|||
33591512|NCT02410837|62989979|FG000|Overall Study|Lost to Follow-up|50|||
33591513|NCT02410837|62989979|FG000|Overall Study|Withdrawal by Subject|44|||
33591514|NCT02410837|62989979|FG000|Overall Study|Physician Decision|6|||
33591515|NCT02410837|62989979|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
33591516|NCT02314247|62989985|FG000|Overall Study|Adverse Event|2|||
33591517|NCT02314247|62989986|FG001|Overall Study|Adverse Event|1|||
33591518|NCT02314247|62989987|FG002|Overall Study|Adverse Event|0|||
33591519|NCT02314247|62989985|FG000|Overall Study|Withdrawal by Subject|1|||
33591520|NCT02314247|62989986|FG001|Overall Study|Withdrawal by Subject|3|||
33591521|NCT02314247|62989987|FG002|Overall Study|Withdrawal by Subject|1|||
33591522|NCT02314247|62989985|FG000|Overall Study|Progression of Disease|6|||
33591523|NCT02314247|62989986|FG001|Overall Study|Progression of Disease|2|||
33591524|NCT02314247|62989987|FG002|Overall Study|Progression of Disease|0|||
33591525|NCT02463097|62989997|FG000|Overall Study|Withdrawal by Subject|1|||
33591526|NCT02441179|62990003|FG000|Overall Study|Withdrawal by Subject|1|||
33591527|NCT02441179|62990004|FG001|Overall Study|Withdrawal by Subject|1|||
33591528|NCT02462473|62990011|FG000|Overall Study|Death|1|||
33591529|NCT02462473|62990011|FG000|Overall Study|Other|3|||
33591530|NCT02440789|62990024|FG000|Overall Study|Withdrawal by Subject|3|||
33591531|NCT02440789|62990024|FG000|Overall Study|Not willing to adhere to reqs|1|||
33591532|NCT02462083|62990028|FG000|Overall Study|Sponsor request|39|||
33591533|NCT02462083|62990028|FG000|Overall Study|Withdrawal by Subject|87|||
33591534|NCT02462083|62990028|FG000|Overall Study|Lost to Follow-up|41|||
33591535|NCT02462083|62990028|FG000|Overall Study|Lack of Efficacy|151|||
33591536|NCT02462083|62990028|FG000|Overall Study|Pregnancy|1|||
33591537|NCT02462083|62990028|FG000|Overall Study|Protocol Violation|6|||
33591538|NCT02462083|62990028|FG000|Overall Study|Adverse Event|33|||
33591539|NCT02462083|62990028|FG000|Overall Study|Worsening condition|16|||
33591540|NCT02462083|62990028|FG000|Overall Study|Other than specified|45|||
33591541|NCT02538341|62990034|FG000|Overall Study|Lost to Follow-up|51|||
33591542|NCT02538341|62990035|FG001|Overall Study|Lost to Follow-up|46|||
33591543|NCT02538341|62990034|FG000|Overall Study|Withdrawal by Subject|3|||
33591544|NCT02538341|62990035|FG001|Overall Study|Withdrawal by Subject|1|||
33591545|NCT02538341|62990034|FG000|Overall Study|Death|2|||
33591546|NCT02538341|62990035|FG001|Overall Study|Death|0|||
33591547|NCT02538107|62990041|FG000|Overall Study|Did not receive any Mircera dose|11|||
33591548|NCT02538107|62990041|FG000|Overall Study|Missing|5|||
33591549|NCT02538107|62990041|FG000|Overall Study|Necessity of dialysis|20|||
33591550|NCT02538107|62990041|FG000|Overall Study|Administration of other ESA|11|||
33591551|NCT02538107|62990041|FG000|Overall Study|No further treatment necessary|18|||
33591552|NCT02538107|62990041|FG000|Overall Study|Withdrawal by Subject|17|||
33591553|NCT02538107|62990041|FG000|Overall Study|Death|4|||
33591554|NCT02538107|62990041|FG000|Overall Study|Administrative reason|5|||
33591555|NCT02538107|62990041|FG000|Overall Study|Adverse Event|4|||
33591556|NCT02538107|62990041|FG000|Overall Study|Surgery|1|||
33591557|NCT02538107|62990041|FG000|Overall Study|Other|7|||
33591558|NCT02538107|62990041|FG000|Overall Study|Not recorded|7|||
33591559|NCT02538029|62990058|FG000|Overall Study|unable to complete cognitive assessments|1|||
33591560|NCT02538029|62990059|FG001|Overall Study|unable to complete cognitive assessments|0|||
33591561|NCT02538029|62990060|FG002|Overall Study|unable to complete cognitive assessments|1|||
33591562|NCT02272413|62990072|FG000|Randomized Through Treatment Start|Not treated|3|||
33591563|NCT02272413|62990073|FG001|Randomized Through Treatment Start|Not treated|5|||
33591564|NCT02272413|62990072|FG000|Pre-switch Period|Adverse Event|38|||
33591565|NCT02272413|62990073|FG001|Pre-switch Period|Adverse Event|37|||
33591566|NCT02272413|62990072|FG000|Pre-switch Period|Death|26|||
33591567|NCT02272413|62990073|FG001|Pre-switch Period|Death|26|||
33591568|NCT02272413|62990072|FG000|Pre-switch Period|Withdrawal by Subject|27|||
33591569|NCT02272413|62990073|FG001|Pre-switch Period|Withdrawal by Subject|15|||
33591570|NCT02272413|62990072|FG000|Pre-switch Period|Physician Decision|6|||
33591571|NCT02272413|62990073|FG001|Pre-switch Period|Physician Decision|18|||
33591572|NCT02272413|62990072|FG000|Pre-switch Period|Progressive disease|185|||
33591573|NCT02272413|62990073|FG001|Pre-switch Period|Progressive disease|173|||
33591574|NCT02272413|62990072|FG000|Pre-switch Period|Lost to Follow-up|0|||
33591575|NCT02272413|62990073|FG001|Pre-switch Period|Lost to Follow-up|2|||
33591576|NCT02272413|62990072|FG000|Pre-switch Period|Protocol Violation|1|||
33680422|NCT01092416|63136050|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
33591577|NCT02272413|62990073|FG001|Pre-switch Period|Protocol Violation|0|||
33591578|NCT02272413|62990072|FG000|Pre-switch Period|Other than listed|10|||
33591579|NCT02272413|62990073|FG001|Pre-switch Period|Other than listed|11|||
33591580|NCT02272413|62990072|FG000|Post-switch Period|Adverse Event|4|||
33591581|NCT02272413|62990073|FG001|Post-switch Period|Adverse Event|4|||
33591582|NCT02272413|62990072|FG000|Post-switch Period|Death|3|||
33591583|NCT02272413|62990073|FG001|Post-switch Period|Death|2|||
33591584|NCT02272413|62990072|FG000|Post-switch Period|Withdrawal by Subject|1|||
33591585|NCT02272413|62990073|FG001|Post-switch Period|Withdrawal by Subject|2|||
33591586|NCT02272413|62990072|FG000|Post-switch Period|Physician Decision|1|||
33591587|NCT02272413|62990073|FG001|Post-switch Period|Physician Decision|1|||
33591588|NCT02272413|62990072|FG000|Post-switch Period|Progressive disease|21|||
33591589|NCT02272413|62990073|FG001|Post-switch Period|Progressive disease|21|||
33591590|NCT02272413|62990072|FG000|Post-switch Period|Study terminated by sponsor|8|||
33591591|NCT02272413|62990073|FG001|Post-switch Period|Study terminated by sponsor|11|||
33591592|NCT02272413|62990072|FG000|Post-switch Period|Other than listed|4|||
33591593|NCT02272413|62990073|FG001|Post-switch Period|Other than listed|5|||
33591594|NCT02396381|62990085|FG000|Overall Study|Adverse Event|3|||
33591595|NCT02396381|62990086|FG001|Overall Study|Adverse Event|2|||
33591596|NCT02396381|62990085|FG000|Overall Study|Withdrawal by Subject|33|||
33591597|NCT02396381|62990086|FG001|Overall Study|Withdrawal by Subject|24|||
33591598|NCT02396381|62990085|FG000|Overall Study|Lost to Follow-up|49|||
33591599|NCT02396381|62990086|FG001|Overall Study|Lost to Follow-up|31|||
33591600|NCT02396381|62990085|FG000|Overall Study|Protocol Violation|1|||
33591601|NCT02396381|62990086|FG001|Overall Study|Protocol Violation|0|||
33591602|NCT02396381|62990085|FG000|Overall Study|Site terminated by sponsor|7|||
33591603|NCT02396381|62990086|FG001|Overall Study|Site terminated by sponsor|8|||
33591604|NCT02396381|62990085|FG000|Overall Study|Physician Decision|5|||
33591605|NCT02396381|62990086|FG001|Overall Study|Physician Decision|5|||
33591606|NCT02396381|62990085|FG000|Overall Study|Pregnancy|2|||
33591607|NCT02396381|62990086|FG001|Overall Study|Pregnancy|0|||
33591608|NCT02396381|62990085|FG000|Overall Study|Non-compliance with study procedures|1|||
33591609|NCT02396381|62990086|FG001|Overall Study|Non-compliance with study procedures|0|||
33591610|NCT02396381|62990085|FG000|Overall Study|Moved out of town/state|1|||
33591611|NCT02396381|62990086|FG001|Overall Study|Moved out of town/state|3|||
33591612|NCT02396381|62990085|FG000|Overall Study|Could not complete visit|1|||
33591613|NCT02396381|62990086|FG001|Overall Study|Could not complete visit|0|||
33591614|NCT02396381|62990085|FG000|Overall Study|Possible conflict of interest|1|||
33591615|NCT02396381|62990086|FG001|Overall Study|Possible conflict of interest|0|||
33591616|NCT02396381|62990085|FG000|Overall Study|Randomization/Screening Error|3|||
33591617|NCT02396381|62990086|FG001|Overall Study|Randomization/Screening Error|1|||
33591618|NCT02532647|62990098|FG000|Overall Study|Did not receive trial medication|1|||
33591619|NCT02532647|62990099|FG001|Overall Study|Did not receive trial medication|0|||
33591620|NCT02532647|62990100|FG002|Overall Study|Did not receive trial medication|1|||
33591621|NCT02537015|62990108|FG000|Overall Study|Adverse Event|3|||
33591622|NCT02537015|62990108|FG000|Overall Study|Withdrawal by Subject|2|||
33680423|NCT01092416|63136050|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
33680424|NCT00701220|63136059|FG000|Overall Study|Withdrawal by Subject|0|||
33680425|NCT00701220|63136060|FG001|Overall Study|Withdrawal by Subject|2|||
33591623|NCT02537015|62990108|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33591624|NCT02271945|62990114|FG000|Overall Study|Death|3|||
33680426|NCT00701220|63136059|FG000|Overall Study|Protocol Violation|2|||
33680427|NCT00701220|63136060|FG001|Overall Study|Protocol Violation|0|||
33680428|NCT00559845|63136134|FG000|Overall Study|Withdrew Consent|1|||
33401429|NCT00256867|62780476|FG002|Overall Study|Adverse Event|1|||
33401430|NCT00256867|62780477|FG003|Overall Study|Adverse Event|1|||
33591625|NCT02271945|62990115|FG001|Overall Study|Death|3|||
33591626|NCT02271945|62990114|FG000|Overall Study|Withdrawal by Subject|1|||
33591627|NCT02271945|62990115|FG001|Overall Study|Withdrawal by Subject|1|||
33591628|NCT02271945|62990114|FG000|Overall Study|Other|1|||
33591629|NCT02271945|62990115|FG001|Overall Study|Other|1|||
33591630|NCT01660763|62990123|FG000|Overall Study|Lack of Efficacy|45|||
33591631|NCT01660763|62990124|FG001|Overall Study|Lack of Efficacy|50|||
33591632|NCT01660763|62990123|FG000|Overall Study|Adverse Event|22|||
33591633|NCT01660763|62990124|FG001|Overall Study|Adverse Event|7|||
33591634|NCT01660763|62990123|FG000|Overall Study|Protocol Violation|1|||
33591635|NCT01660763|62990124|FG001|Overall Study|Protocol Violation|0|||
33591636|NCT01660763|62990123|FG000|Overall Study|Withdrawal by Subject|4|||
33591637|NCT01660763|62990124|FG001|Overall Study|Withdrawal by Subject|0|||
33591638|NCT01660763|62990123|FG000|Overall Study|Patient ready for early discharge|28|||
33591639|NCT01660763|62990124|FG001|Overall Study|Patient ready for early discharge|4|||
33591640|NCT01937117|62990130|FG000|Overall Study|Disease Progression|7|||
33591641|NCT01937117|62990130|FG000|Overall Study|Physician Decision|4|||
33591642|NCT01937117|62990130|FG000|Overall Study|Adverse Event|2|||
33591643|NCT02268045|62990136|FG000|Overall Study|Death|4|||
33591644|NCT02268045|62990137|FG001|Overall Study|Death|4|||
33591645|NCT02268045|62990136|FG000|Overall Study|Disease Progression|2|||
33591646|NCT02268045|62990137|FG001|Overall Study|Disease Progression|1|||
33591647|NCT02268045|62990136|FG000|Overall Study|Adverse Event|7|||
33591648|NCT02268045|62990137|FG001|Overall Study|Adverse Event|7|||
33591649|NCT02268045|62990136|FG000|Overall Study|Withdrawal by Subject|2|||
33591650|NCT02268045|62990137|FG001|Overall Study|Withdrawal by Subject|6|||
33591651|NCT02268045|62990136|FG000|Overall Study|Physician Decision|0|||
33591652|NCT02268045|62990137|FG001|Overall Study|Physician Decision|1|||
33591653|NCT02268045|62990136|FG000|Overall Study|Protocol Violation|1|||
33591654|NCT02268045|62990137|FG001|Overall Study|Protocol Violation|1|||
33591655|NCT02536781|62990147|FG000|Overall Study|Lost to Follow-up|2|||
33591656|NCT02536781|62990148|FG001|Overall Study|Lost to Follow-up|0|||
33591657|NCT02267187|62990154|FG000|Overall Study|Physician Decision|2|||
33591658|NCT02267187|62990154|FG000|Overall Study|Screen fail|3|||
33591659|NCT02532179|62990158|FG000|Overall Study|Lost to Follow-up|1|||
33591660|NCT02532179|62990158|FG000|Overall Study|Pregnancy|1|||
33591661|NCT02532179|62990158|FG000|Overall Study|Subject received depot steroid injection|1|||
33591662|NCT02409667|62990162|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
33591663|NCT02409667|62990163|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
33591664|NCT02409667|62990164|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
33591665|NCT02409667|62990165|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
33591666|NCT02409667|62990166|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
33591667|NCT02409667|62990162|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
33591668|NCT02409667|62990163|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
33591669|NCT02409667|62990164|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
33591670|NCT02409667|62990165|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
33591671|NCT02409667|62990166|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
33591672|NCT02409667|62990162|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
33591673|NCT02409667|62990163|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
33591674|NCT02409667|62990164|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
33591675|NCT02409667|62990165|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
33591676|NCT02409667|62990166|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
33591677|NCT02409667|62990162|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
33591678|NCT02409667|62990163|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
33591679|NCT02409667|62990164|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
33591680|NCT02409667|62990165|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
33591681|NCT02409667|62990166|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
33591682|NCT02409667|62990162|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
33591683|NCT02409667|62990163|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
33591684|NCT02409667|62990164|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
33591685|NCT02409667|62990165|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
33591686|NCT02409667|62990166|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
33591687|NCT02409667|62990162|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
33591688|NCT02409667|62990163|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
33591689|NCT02409667|62990164|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
33591690|NCT02409667|62990165|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
33591691|NCT02409667|62990166|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
33591692|NCT02409667|62990162|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
33591693|NCT02409667|62990163|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
33591694|NCT02409667|62990164|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
33591695|NCT02409667|62990165|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
33591696|NCT02409667|62990166|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
33591697|NCT02409667|62990162|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
33591698|NCT02409667|62990163|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
33591699|NCT02409667|62990164|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
33591700|NCT02409667|62990165|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
33591701|NCT02409667|62990166|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
33591702|NCT02409667|62990162|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
33591703|NCT02409667|62990163|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
33591704|NCT02409667|62990164|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
33591705|NCT02409667|62990165|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
33591706|NCT02409667|62990166|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
33591707|NCT02409667|62990162|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
33591708|NCT02409667|62990163|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
33591709|NCT02409667|62990164|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
33591710|NCT02409667|62990165|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
33591711|NCT02409667|62990166|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
33591712|NCT02409667|62990162|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
33591713|NCT02409667|62990163|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
33591714|NCT02409667|62990164|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
33591715|NCT02409667|62990165|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
33591716|NCT02409667|62990166|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
33591717|NCT02409667|62990162|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
33591718|NCT02409667|62990163|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
33591719|NCT02409667|62990164|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
33591720|NCT02409667|62990165|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
33591721|NCT02409667|62990166|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
33591722|NCT02409667|62990162|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
33591723|NCT02409667|62990163|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
33591724|NCT02409667|62990164|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
33591725|NCT02409667|62990165|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
33591726|NCT02409667|62990166|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
33591727|NCT02409667|62990162|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
33591728|NCT02409667|62990163|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
33591729|NCT02409667|62990164|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
33591730|NCT02409667|62990165|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
33591731|NCT02409667|62990166|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
33591732|NCT02409667|62990162|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
33591733|NCT02409667|62990163|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
33591734|NCT02409667|62990164|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
33591735|NCT02409667|62990165|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
33591736|NCT02409667|62990166|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
33591737|NCT02409667|62990162|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
33591738|NCT02409667|62990163|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
33591739|NCT02409667|62990164|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
33591740|NCT02409667|62990165|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
33591741|NCT02409667|62990166|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
33591742|NCT01641939|62990180|FG000|Overall Study|Death|90|||
33591743|NCT01641939|62990181|FG001|Overall Study|Death|187|||
33591744|NCT01641939|62990182|FG002|Overall Study|Death|61|||
33591745|NCT01641939|62990180|FG000|Overall Study|Lost to Follow-up|3|||
33591746|NCT01641939|62990181|FG001|Overall Study|Lost to Follow-up|2|||
33591747|NCT01641939|62990182|FG002|Overall Study|Lost to Follow-up|1|||
33591748|NCT01641939|62990180|FG000|Overall Study|Withdrawal by Subject|14|||
33591749|NCT01641939|62990181|FG001|Overall Study|Withdrawal by Subject|11|||
33591750|NCT01641939|62990182|FG002|Overall Study|Withdrawal by Subject|5|||
33591751|NCT01641939|62990180|FG000|Overall Study|Study Terminated by Sponsor|10|||
33591752|NCT01641939|62990181|FG001|Overall Study|Study Terminated by Sponsor|28|||
33591753|NCT01641939|62990182|FG002|Overall Study|Study Terminated by Sponsor|3|||
33591754|NCT01641861|62990194|FG000|Overall Study|Lost to Follow-up|21|||
33591755|NCT01641861|62990195|FG001|Overall Study|Lost to Follow-up|16|||
33591756|NCT01641861|62990194|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
33591757|NCT01641861|62990195|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
33591758|NCT01641861|62990194|FG000|Overall Study|Died due to drowning|0|||
33591759|NCT01641861|62990195|FG001|Overall Study|Died due to drowning|1|||
33591760|NCT02409355|62990203|FG000|Overall Study|Withdrawal by Subject|1|||
33591761|NCT02409355|62990204|FG001|Overall Study|Withdrawal by Subject|0|||
33591762|NCT02409355|62990203|FG000|Overall Study|Death|1|||
33591763|NCT02409355|62990204|FG001|Overall Study|Death|1|||
33591764|NCT02409355|62990203|FG000|Overall Study|Study terminated by Sponsor|2|||
33591765|NCT02409355|62990204|FG001|Overall Study|Study terminated by Sponsor|3|||
33591766|NCT02408887|62990212|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
33591767|NCT02408887|62990213|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
33591768|NCT02408887|62990212|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
33591769|NCT02408887|62990213|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
33591770|NCT02266875|62990221|FG000|Overall Study|Withdrawal by Subject|9|||
33591771|NCT02266875|62990222|FG001|Overall Study|Withdrawal by Subject|0|||
33591772|NCT02266875|62990221|FG000|Overall Study|Lost to Follow-up|2|||
33591773|NCT02266875|62990222|FG001|Overall Study|Lost to Follow-up|0|||
33591774|NCT02438371|62990230|FG000|Overall Study|Lost to Follow-up|3|||
33591775|NCT02438371|62990231|FG001|Overall Study|Lost to Follow-up|2|||
33591776|NCT02438371|62990230|FG000|Overall Study|Withdrawal by Subject|1|||
33591777|NCT02438371|62990231|FG001|Overall Study|Withdrawal by Subject|1|||
33591778|NCT02438137|62990239|FG000|Overall Study|Lost to Follow-up|3|||
33591779|NCT02438137|62990240|FG001|Overall Study|Lost to Follow-up|2|||
33591780|NCT02438137|62990239|FG000|Overall Study|Adverse Event|1|||
33591781|NCT02438137|62990240|FG001|Overall Study|Adverse Event|0|||
33591782|NCT02438137|62990239|FG000|Overall Study|Withdrawal by Subject|4|||
33591783|NCT02438137|62990240|FG001|Overall Study|Withdrawal by Subject|3|||
33591784|NCT02438137|62990239|FG000|Overall Study|Physician Decision|0|||
33591785|NCT02438137|62990240|FG001|Overall Study|Physician Decision|1|||
33591786|NCT02437903|62990248|FG000|Overall Study|Adverse Event|1|||
33591787|NCT02437903|62990248|FG000|Overall Study|Withdrawal by Subject|1|||
33591788|NCT02437903|62990248|FG000|Overall Study|Lost to Follow-up|3|||
33591789|NCT02437513|62990253|FG000|Overall Study|Withdrawal by Subject|2|||
33591790|NCT02460991|62990259|FG000|Overall Study|Withdrawal by Subject|0|||
33591791|NCT02460991|62990260|FG001|Overall Study|Withdrawal by Subject|2|||
33591792|NCT02407249|62990271|FG000|Overall Study|Did not complete 12-month follow-up|13|||
33591793|NCT02407249|62990271|FG000|Overall Study|Not treated|13|||
33591794|NCT02460679|62990275|FG000|Overall Study|Investigator Decision|1|||
33591795|NCT02460679|62990275|FG000|Overall Study|Withdrawal by Subject|4|||
33591796|NCT02459899|62990283|FG000|Overall Study|Adverse Event|1|||
33591797|NCT02459899|62990284|FG001|Overall Study|Adverse Event|1|||
33591798|NCT02459899|62990285|FG002|Overall Study|Adverse Event|0|||
33591799|NCT02459899|62990286|FG003|Overall Study|Adverse Event|0|||
33591800|NCT02459899|62990283|FG000|Overall Study|Lost to Follow-up|1|||
33591801|NCT02459899|62990284|FG001|Overall Study|Lost to Follow-up|2|||
33591802|NCT02459899|62990285|FG002|Overall Study|Lost to Follow-up|0|||
33591803|NCT02459899|62990286|FG003|Overall Study|Lost to Follow-up|1|||
33591804|NCT02459899|62990283|FG000|Overall Study|Non-compliance with the treatment|0|||
33591805|NCT02459899|62990284|FG001|Overall Study|Non-compliance with the treatment|0|||
33591806|NCT02459899|62990285|FG002|Overall Study|Non-compliance with the treatment|0|||
33591807|NCT02459899|62990286|FG003|Overall Study|Non-compliance with the treatment|1|||
33591808|NCT02459899|62990283|FG000|Overall Study|Withdrawal by Subject|1|||
33591809|NCT02459899|62990284|FG001|Overall Study|Withdrawal by Subject|3|||
33591810|NCT02459899|62990285|FG002|Overall Study|Withdrawal by Subject|0|||
33591811|NCT02459899|62990286|FG003|Overall Study|Withdrawal by Subject|0|||
33591812|NCT02436889|62990298|FG000|Overall Study|No improvement in symptoms|1|||
33591813|NCT02436889|62990299|FG001|Overall Study|No improvement in symptoms|0|||
33591814|NCT02436889|62990298|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
33591815|NCT02436889|62990299|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
33591816|NCT02436811|62990308|FG000|Overall Study|Lost to Follow-up|2|||
33591817|NCT02436811|62990309|FG001|Overall Study|Lost to Follow-up|9|||
33591818|NCT02436811|62990310|FG002|Overall Study|Lost to Follow-up|7|||
33591819|NCT02436577|62990324|FG000|Overall Study|Protocol Deviation|0|||
33591820|NCT02436577|62990325|FG001|Overall Study|Protocol Deviation|1|||
33591821|NCT02436577|62990326|FG002|Overall Study|Protocol Deviation|0|||
33591822|NCT02436577|62990327|FG003|Overall Study|Protocol Deviation|0|||
33591823|NCT02436577|62990328|FG004|Overall Study|Protocol Deviation|0|||
33591824|NCT02436577|62990329|FG005|Overall Study|Protocol Deviation|0|||
33591825|NCT02265705|62990339|FG000|Treatment Period Week 0-24|Adverse Event|3|||
33591826|NCT02265705|62990340|FG001|Treatment Period Week 0-24|Adverse Event|2|||
33591827|NCT02265705|62990341|FG002|Treatment Period Week 0-24|Adverse Event|0|||
33591828|NCT02265705|62990342|FG003|Treatment Period Week 0-24|Adverse Event|0|||
33591829|NCT02265705|62990343|FG004|Treatment Period Week 0-24|Adverse Event|0|||
33591830|NCT02265705|62990344|FG005|Treatment Period Week 0-24|Adverse Event|0|||
33591831|NCT02265705|62990345|FG006|Treatment Period Week 0-24|Adverse Event|0|||
33591832|NCT02265705|62990339|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
33591833|NCT02265705|62990340|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
33591834|NCT02265705|62990341|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
33591835|NCT02265705|62990342|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
33591836|NCT02265705|62990343|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
33591837|NCT02265705|62990344|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
33591838|NCT02265705|62990345|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
33591839|NCT02265705|62990339|FG000|Treatment Period Week 0-24|Physician Decision|1|||
33591840|NCT02265705|62990340|FG001|Treatment Period Week 0-24|Physician Decision|0|||
33591841|NCT02265705|62990341|FG002|Treatment Period Week 0-24|Physician Decision|0|||
33591842|NCT02265705|62990342|FG003|Treatment Period Week 0-24|Physician Decision|0|||
33591843|NCT02265705|62990343|FG004|Treatment Period Week 0-24|Physician Decision|0|||
33591844|NCT02265705|62990344|FG005|Treatment Period Week 0-24|Physician Decision|0|||
33591845|NCT02265705|62990345|FG006|Treatment Period Week 0-24|Physician Decision|0|||
33591846|NCT02265705|62990339|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
33591847|NCT02265705|62990340|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
33591848|NCT02265705|62990341|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
33591849|NCT02265705|62990342|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
33591850|NCT02265705|62990343|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
33591851|NCT02265705|62990344|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
33591852|NCT02265705|62990345|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
33591853|NCT02265705|62990339|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
33591854|NCT02265705|62990340|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
33591855|NCT02265705|62990341|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
33591856|NCT02265705|62990342|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
33591857|NCT02265705|62990343|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
33591858|NCT02265705|62990344|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
33591859|NCT02265705|62990345|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
33591860|NCT02265705|62990339|FG000|Rescue Period|Withdrawal by Subject|0|||
33591861|NCT02265705|62990340|FG001|Rescue Period|Withdrawal by Subject|0|||
33591862|NCT02265705|62990341|FG002|Rescue Period|Withdrawal by Subject|1|||
33591863|NCT02265705|62990342|FG003|Rescue Period|Withdrawal by Subject|0|||
33591864|NCT02265705|62990343|FG004|Rescue Period|Withdrawal by Subject|0|||
33591865|NCT02265705|62990344|FG005|Rescue Period|Withdrawal by Subject|0|||
33591866|NCT02265705|62990345|FG006|Rescue Period|Withdrawal by Subject|0|||
33591867|NCT02265705|62990339|FG000|Rescue Period|Death|0|||
33591868|NCT02265705|62990340|FG001|Rescue Period|Death|0|||
33591869|NCT02265705|62990341|FG002|Rescue Period|Death|1|||
33591870|NCT02265705|62990342|FG003|Rescue Period|Death|0|||
33591871|NCT02265705|62990343|FG004|Rescue Period|Death|0|||
33591872|NCT02265705|62990344|FG005|Rescue Period|Death|0|||
33591873|NCT02265705|62990345|FG006|Rescue Period|Death|0|||
33591874|NCT02265705|62990339|FG000|Rescue Period|Lack of Efficacy|0|||
33591875|NCT02265705|62990340|FG001|Rescue Period|Lack of Efficacy|0|||
33591876|NCT02265705|62990341|FG002|Rescue Period|Lack of Efficacy|1|||
33591877|NCT02265705|62990342|FG003|Rescue Period|Lack of Efficacy|0|||
33591878|NCT02265705|62990343|FG004|Rescue Period|Lack of Efficacy|0|||
33591879|NCT02265705|62990344|FG005|Rescue Period|Lack of Efficacy|0|||
33591880|NCT02265705|62990345|FG006|Rescue Period|Lack of Efficacy|0|||
33591881|NCT02265705|62990339|FG000|Open Label Period|Adverse Event|0|||
33591882|NCT02265705|62990340|FG001|Open Label Period|Adverse Event|0|||
33591883|NCT02265705|62990341|FG002|Open Label Period|Adverse Event|0|||
33591884|NCT02265705|62990342|FG003|Open Label Period|Adverse Event|2|||
33591885|NCT02265705|62990343|FG004|Open Label Period|Adverse Event|2|||
33591886|NCT02265705|62990344|FG005|Open Label Period|Adverse Event|0|||
33591887|NCT02265705|62990345|FG006|Open Label Period|Adverse Event|0|||
33591888|NCT02265705|62990339|FG000|Open Label Period|Physician Decision|0|||
33591889|NCT02265705|62990340|FG001|Open Label Period|Physician Decision|0|||
33591890|NCT02265705|62990341|FG002|Open Label Period|Physician Decision|0|||
33591891|NCT02265705|62990342|FG003|Open Label Period|Physician Decision|0|||
33591892|NCT02265705|62990343|FG004|Open Label Period|Physician Decision|1|||
33591893|NCT02265705|62990344|FG005|Open Label Period|Physician Decision|0|||
33591894|NCT02265705|62990345|FG006|Open Label Period|Physician Decision|0|||
33591895|NCT02265705|62990339|FG000|Open Label Period|Withdrawal by Subject|0|||
33591896|NCT02265705|62990340|FG001|Open Label Period|Withdrawal by Subject|0|||
33591897|NCT02265705|62990341|FG002|Open Label Period|Withdrawal by Subject|0|||
33591898|NCT02265705|62990342|FG003|Open Label Period|Withdrawal by Subject|0|||
33591899|NCT02265705|62990343|FG004|Open Label Period|Withdrawal by Subject|2|||
33591900|NCT02265705|62990344|FG005|Open Label Period|Withdrawal by Subject|0|||
33591901|NCT02265705|62990345|FG006|Open Label Period|Withdrawal by Subject|0|||
33591902|NCT02265705|62990339|FG000|Follow-up Period|Sponsor Decision|0|||
33591903|NCT02265705|62990340|FG001|Follow-up Period|Sponsor Decision|0|||
33591904|NCT02265705|62990341|FG002|Follow-up Period|Sponsor Decision|0|||
33591905|NCT02265705|62990342|FG003|Follow-up Period|Sponsor Decision|0|||
33591906|NCT02265705|62990343|FG004|Follow-up Period|Sponsor Decision|0|||
33591907|NCT02265705|62990344|FG005|Follow-up Period|Sponsor Decision|1|||
33591908|NCT02265705|62990345|FG006|Follow-up Period|Sponsor Decision|6|||
33591909|NCT02265705|62990339|FG000|Follow-up Period|Adverse Event|0|||
33591910|NCT02265705|62990340|FG001|Follow-up Period|Adverse Event|0|||
33591911|NCT02265705|62990341|FG002|Follow-up Period|Adverse Event|0|||
33591912|NCT02265705|62990342|FG003|Follow-up Period|Adverse Event|0|||
33591913|NCT02265705|62990343|FG004|Follow-up Period|Adverse Event|0|||
33591914|NCT02265705|62990344|FG005|Follow-up Period|Adverse Event|0|||
33591915|NCT02265705|62990345|FG006|Follow-up Period|Adverse Event|3|||
33591916|NCT02265705|62990339|FG000|Follow-up Period|Physician Decision|0|||
33591917|NCT02265705|62990340|FG001|Follow-up Period|Physician Decision|0|||
33591918|NCT02265705|62990341|FG002|Follow-up Period|Physician Decision|0|||
33591919|NCT02265705|62990342|FG003|Follow-up Period|Physician Decision|0|||
33591920|NCT02265705|62990343|FG004|Follow-up Period|Physician Decision|0|||
33591921|NCT02265705|62990344|FG005|Follow-up Period|Physician Decision|0|||
33591922|NCT02265705|62990345|FG006|Follow-up Period|Physician Decision|1|||
33591923|NCT02265705|62990339|FG000|Follow-up Period|Withdrawal by Subject|0|||
33591924|NCT02265705|62990340|FG001|Follow-up Period|Withdrawal by Subject|0|||
33591925|NCT02265705|62990341|FG002|Follow-up Period|Withdrawal by Subject|0|||
33591926|NCT02265705|62990342|FG003|Follow-up Period|Withdrawal by Subject|0|||
33591927|NCT02265705|62990343|FG004|Follow-up Period|Withdrawal by Subject|0|||
33591928|NCT02265705|62990344|FG005|Follow-up Period|Withdrawal by Subject|0|||
33591929|NCT02265705|62990345|FG006|Follow-up Period|Withdrawal by Subject|1|||
33591930|NCT02459665|62990360|FG000|Overall Study|Withdrawal by Subject|0|||
33591931|NCT02459665|62990361|FG001|Overall Study|Withdrawal by Subject|1|||
33680429|NCT00559845|63136134|FG000|Overall Study|Disease Progression|1|||
33680430|NCT00559845|63136134|FG000|Overall Study|Adverse Event|3|||
33680431|NCT00559845|63136134|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
33680432|NCT00559845|63136134|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
33680433|NCT01393964|63136237|FG000|Overall Study|Disease Progression|4|||
33680434|NCT01393964|63136238|FG001|Overall Study|Disease Progression|3|||
33680435|NCT01393964|63136239|FG002|Overall Study|Disease Progression|5|||
33680436|NCT01393964|63136237|FG000|Overall Study|Study drug toxicity|1|||
33680437|NCT01393964|63136238|FG001|Overall Study|Study drug toxicity|0|||
33680438|NCT01393964|63136239|FG002|Overall Study|Study drug toxicity|0|||
33680439|NCT01393964|63136237|FG000|Overall Study|Withdrawal by Subject|0|||
33680440|NCT01393964|63136238|FG001|Overall Study|Withdrawal by Subject|0|||
33680441|NCT01393964|63136239|FG002|Overall Study|Withdrawal by Subject|1|||
33680442|NCT01393964|63136237|FG000|Overall Study|Adverse event unrelated to study drug|0|||
33680443|NCT01393964|63136238|FG001|Overall Study|Adverse event unrelated to study drug|3|||
33680444|NCT01393964|63136239|FG002|Overall Study|Adverse event unrelated to study drug|0|||
33680445|NCT01393964|63136237|FG000|Overall Study|Subject request stop study treatment|0|||
33680446|NCT01393964|63136238|FG001|Overall Study|Subject request stop study treatment|1|||
33680447|NCT01393964|63136239|FG002|Overall Study|Subject request stop study treatment|0|||
33680448|NCT01393964|63136237|FG000|Overall Study|Subject decided to move to transplant|1|||
33680449|NCT01393964|63136238|FG001|Overall Study|Subject decided to move to transplant|0|||
33680450|NCT01393964|63136239|FG002|Overall Study|Subject decided to move to transplant|0|||
33680451|NCT01393964|63136237|FG000|Overall Study|Subject switched to commercial supply|1|||
33591932|NCT02459665|62990362|FG002|Overall Study|Withdrawal by Subject|1|||
33591933|NCT02459665|62990363|FG003|Overall Study|Withdrawal by Subject|2|||
33591934|NCT02265237|62990384|FG000|As Treated (Overall Study)|Adverse Event|1|||
33680452|NCT01393964|63136238|FG001|Overall Study|Subject switched to commercial supply|0|||
33680453|NCT01393964|63136239|FG002|Overall Study|Subject switched to commercial supply|2|||
33680454|NCT01393964|63136237|FG000|Overall Study|Subject plateaued in terms of effect|1|||
33680455|NCT01393964|63136238|FG001|Overall Study|Subject plateaued in terms of effect|0|||
33680456|NCT01393964|63136239|FG002|Overall Study|Subject plateaued in terms of effect|0|||
33680457|NCT01393964|63136237|FG000|Overall Study|Investigator removed subject from study|0|||
33680458|NCT01393964|63136238|FG001|Overall Study|Investigator removed subject from study|1|||
33680459|NCT01393964|63136239|FG002|Overall Study|Investigator removed subject from study|0|||
33680460|NCT01393964|63136237|FG000|Overall Study|Subject converted to roll-over study|0|||
33680461|NCT01393964|63136238|FG001|Overall Study|Subject converted to roll-over study|1|||
33680462|NCT01393964|63136239|FG002|Overall Study|Subject converted to roll-over study|0|||
33680463|NCT01393964|63136237|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
33680464|NCT01393964|63136238|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
33680465|NCT01393964|63136239|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
33680466|NCT01393730|63136327|FG000|Overall Study|Withdrawal by Subject|3|||
33680467|NCT01393730|63136327|FG000|Overall Study|Other|2|||
33680468|NCT01393730|63136327|FG000|Overall Study|Adverse Event|1|||
33680469|NCT01393106|63136346|FG000|Overall Study|Adverse Event|3|||
33680470|NCT01393106|63136346|FG000|Overall Study|Withdrawal by Subject|1|||
33680471|NCT01393106|63136346|FG000|Overall Study|Lack of Efficacy|1|||
33680472|NCT00553059|63136352|FG000|Overall Study|Deemed ineligible|1|||
33680473|NCT00553059|63136353|FG001|Overall Study|Deemed ineligible|1|||
33680474|NCT00553059|63136352|FG000|Overall Study|Drug supply not available|0|||
33680475|NCT00553059|63136353|FG001|Overall Study|Drug supply not available|1|||
33680476|NCT01413542|63136386|FG000|Overall Study|Physician Decision|1|||
33680477|NCT01413542|63136387|FG001|Overall Study|Physician Decision|0|||
33680478|NCT01413542|63136388|FG002|Overall Study|Physician Decision|3|||
33680479|NCT01413542|63136389|FG003|Overall Study|Physician Decision|0|||
33680480|NCT01413542|63136386|FG000|Overall Study|Adverse Event|0|||
33680481|NCT01413542|63136387|FG001|Overall Study|Adverse Event|0|||
33680482|NCT01413542|63136388|FG002|Overall Study|Adverse Event|0|||
33680483|NCT01413542|63136389|FG003|Overall Study|Adverse Event|1|||
33680484|NCT01432730|63136421|FG000|Period 1|Adverse Event|2|||
33680485|NCT01432730|63136422|FG001|Period 1|Adverse Event|0|||
33680486|NCT01432730|63136421|FG000|Period 2|Adverse Event|0|||
33680487|NCT01432730|63136422|FG001|Period 2|Adverse Event|4|||
33680488|NCT01432574|63136437|FG000|Overall Study|Moved|2|||
33680489|NCT01432574|63136437|FG000|Overall Study|Not interested|1|||
33591935|NCT02265237|62990385|FG001|As Treated (Overall Study)|Adverse Event|1|||
33591936|NCT02265237|62990386|FG002|As Treated (Overall Study)|Adverse Event|0|||
33591937|NCT02265237|62990387|FG003|As Treated (Overall Study)|Adverse Event|0|||
33591938|NCT02265237|62990384|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
33591939|NCT02265237|62990385|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
33591940|NCT02265237|62990386|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
33591941|NCT02265237|62990387|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
33591942|NCT02265237|62990384|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
33591943|NCT02265237|62990385|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
33591944|NCT02265237|62990386|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
33591945|NCT02265237|62990387|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
33591946|NCT02265237|62990384|FG000|As Treated (Overall Study)|Other|2|||
33591947|NCT02265237|62990385|FG001|As Treated (Overall Study)|Other|0|||
33591948|NCT02265237|62990386|FG002|As Treated (Overall Study)|Other|3|||
33591949|NCT02265237|62990387|FG003|As Treated (Overall Study)|Other|1|||
33591950|NCT02263365|62990400|FG000|Overall Study|Physician Decision|22|||
33591951|NCT02263365|62990401|FG001|Overall Study|Physician Decision|18|||
33591952|NCT02261493|62990411|FG000|Overall Study|Noncompliance|0|||
33591953|NCT02261493|62990412|FG001|Overall Study|Noncompliance|0|||
33591954|NCT02261493|62990413|FG002|Overall Study|Noncompliance|2|||
33591955|NCT02261493|62990411|FG000|Overall Study|Physician Decision|0|||
33591956|NCT02261493|62990412|FG001|Overall Study|Physician Decision|1|||
33591957|NCT02261493|62990413|FG002|Overall Study|Physician Decision|0|||
33591958|NCT02261493|62990411|FG000|Overall Study|Undisclosed alcohol abuse|0|||
33680490|NCT01392560|63136470|FG000|Overall Study|Adverse Event|2|||
33680491|NCT01392560|63136470|FG000|Overall Study|not entered|8|||
33680492|NCT01392560|63136470|FG000|Overall Study|discontinued during placebo run-in|2|||
33680493|NCT00552279|63136531|FG000|Overall Study|Adverse Event|0|||
33680494|NCT00552279|63136532|FG001|Overall Study|Adverse Event|1|||
33680495|NCT00552279|63136531|FG000|Overall Study|Withdrawal by Subject|12|||
33680496|NCT00552279|63136532|FG001|Overall Study|Withdrawal by Subject|1|||
33680497|NCT00552279|63136531|FG000|Overall Study|Lost to Follow-up|1|||
33680498|NCT00552279|63136532|FG001|Overall Study|Lost to Follow-up|0|||
33680499|NCT00552279|63136531|FG000|Overall Study|Other|1|||
33680500|NCT00552279|63136532|FG001|Overall Study|Other|1|||
33680501|NCT00559377|63136573|FG000|Overall Study|Withdrawal by Subject|9|||
33680502|NCT01412060|63136580|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
33680503|NCT01412060|63136581|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
33680504|NCT01412060|63136582|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
33591959|NCT02261493|62990412|FG001|Overall Study|Undisclosed alcohol abuse|1|||
33591960|NCT02261493|62990413|FG002|Overall Study|Undisclosed alcohol abuse|0|||
33591961|NCT02261493|62990411|FG000|Overall Study|Protocol Violation|1|||
33591962|NCT02261493|62990412|FG001|Overall Study|Protocol Violation|0|||
33591963|NCT02261493|62990413|FG002|Overall Study|Protocol Violation|0|||
33591964|NCT02261493|62990411|FG000|Overall Study|Personal Reasons|14|||
33591965|NCT02261493|62990412|FG001|Overall Study|Personal Reasons|14|||
33591966|NCT02261493|62990413|FG002|Overall Study|Personal Reasons|16|||
33591967|NCT02261493|62990411|FG000|Overall Study|Lost to Follow-up|14|||
33591968|NCT02261493|62990412|FG001|Overall Study|Lost to Follow-up|27|||
33591969|NCT02261493|62990413|FG002|Overall Study|Lost to Follow-up|8|||
33591970|NCT02261493|62990411|FG000|Overall Study|Pregnancy|1|||
33591971|NCT02261493|62990412|FG001|Overall Study|Pregnancy|2|||
33591972|NCT02261493|62990413|FG002|Overall Study|Pregnancy|0|||
33591973|NCT02261493|62990411|FG000|Overall Study|Lack of Efficacy|0|||
33591974|NCT02261493|62990412|FG001|Overall Study|Lack of Efficacy|1|||
33591975|NCT02261493|62990413|FG002|Overall Study|Lack of Efficacy|0|||
33591976|NCT02261493|62990411|FG000|Overall Study|Adverse Event|0|||
33591977|NCT02261493|62990412|FG001|Overall Study|Adverse Event|1|||
33591978|NCT02261493|62990413|FG002|Overall Study|Adverse Event|0|||
33591979|NCT02260791|62990423|FG000|Overall Study|Lost to Follow-up|4|||
33591980|NCT02260791|62990424|FG001|Overall Study|Lost to Follow-up|4|||
33591981|NCT02260791|62990423|FG000|Overall Study|Lack of Efficacy|2|||
33591982|NCT02260791|62990424|FG001|Overall Study|Lack of Efficacy|1|||
33591983|NCT02260791|62990423|FG000|Overall Study|Adverse Event|13|||
33591984|NCT02260791|62990424|FG001|Overall Study|Adverse Event|9|||
33591985|NCT02260791|62990423|FG000|Overall Study|Death|1|||
33591986|NCT02260791|62990424|FG001|Overall Study|Death|0|||
33591987|NCT02260791|62990423|FG000|Overall Study|Withdrawal by Subject|11|||
33591988|NCT02260791|62990424|FG001|Overall Study|Withdrawal by Subject|16|||
33591989|NCT02260791|62990423|FG000|Overall Study|Screen failure|0|||
33591990|NCT02260791|62990424|FG001|Overall Study|Screen failure|1|||
33591991|NCT02260791|62990423|FG000|Overall Study|Protocol deviation|2|||
33591992|NCT02260791|62990424|FG001|Overall Study|Protocol deviation|3|||
33591993|NCT02260635|62990432|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
33591994|NCT02260635|62990433|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
33591995|NCT02260635|62990432|FG000|Open-Label Extension|Study Termination|25|||
33591996|NCT02260635|62990433|FG001|Open-Label Extension|Study Termination|25|||
33591997|NCT02260635|62990432|FG000|Open-Label Extension|Withdrawal by Subject|1|||
33591998|NCT02260635|62990433|FG001|Open-Label Extension|Withdrawal by Subject|0|||
33591999|NCT02259231|62990448|FG000|Overall Study|Adverse Event|1|||
33592000|NCT02259231|62990449|FG001|Overall Study|Adverse Event|1|||
33592001|NCT02259231|62990450|FG002|Overall Study|Adverse Event|2|||
33592002|NCT02259231|62990451|FG003|Overall Study|Adverse Event|0|||
33592003|NCT02259231|62990452|FG004|Overall Study|Adverse Event|0|||
33592004|NCT02259231|62990453|FG005|Overall Study|Adverse Event|0|||
33592005|NCT02259231|62990454|FG006|Overall Study|Adverse Event|0|||
33592006|NCT02259231|62990448|FG000|Overall Study|Progressive Disease|4|||
33592007|NCT02259231|62990449|FG001|Overall Study|Progressive Disease|5|||
33592008|NCT02259231|62990450|FG002|Overall Study|Progressive Disease|4|||
33592009|NCT02259231|62990451|FG003|Overall Study|Progressive Disease|5|||
33592010|NCT02259231|62990452|FG004|Overall Study|Progressive Disease|4|||
33592011|NCT02259231|62990453|FG005|Overall Study|Progressive Disease|5|||
33592012|NCT02259231|62990454|FG006|Overall Study|Progressive Disease|4|||
33592013|NCT02259231|62990448|FG000|Overall Study|Sponsor termination of study|1|||
33592014|NCT02259231|62990449|FG001|Overall Study|Sponsor termination of study|0|||
33592015|NCT02259231|62990450|FG002|Overall Study|Sponsor termination of study|0|||
33592016|NCT02259231|62990451|FG003|Overall Study|Sponsor termination of study|1|||
33592017|NCT02259231|62990452|FG004|Overall Study|Sponsor termination of study|2|||
33680505|NCT01412060|63136580|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
33680506|NCT01412060|63136581|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
33592018|NCT02259231|62990453|FG005|Overall Study|Sponsor termination of study|1|||
33592019|NCT02259231|62990454|FG006|Overall Study|Sponsor termination of study|1|||
33680507|NCT01412060|63136582|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
33680508|NCT01412060|63136580|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
33680509|NCT01412060|63136581|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
33680510|NCT01412060|63136582|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
33680511|NCT01412060|63136580|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
33592020|NCT02258529|62990470|FG000|Overall Study|Study Terminated by Sponsor|9|||
33592021|NCT02258529|62990470|FG000|Overall Study|Adverse Event|1|||
33592022|NCT02256969|62990477|FG000|Overall Study|Screenfailed or withdrew|2|||
33592023|NCT02256969|62990478|FG001|Overall Study|Screenfailed or withdrew|1|||
33592024|NCT02256969|62990479|FG002|Overall Study|Screenfailed or withdrew|1|||
33592025|NCT02256891|62990489|FG000|Overall Study|Death|0|||
33592026|NCT02256891|62990490|FG001|Overall Study|Death|2|||
33592027|NCT02256891|62990489|FG000|Overall Study|Lost to Follow-up|0|||
33680512|NCT01412060|63136581|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
33680513|NCT01412060|63136582|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
33680514|NCT01412060|63136580|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
33680515|NCT01412060|63136581|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
33680516|NCT01412060|63136582|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
33680517|NCT01412060|63136580|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
33680518|NCT01412060|63136581|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
33680519|NCT01412060|63136582|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
33680520|NCT01412060|63136580|FG000|Period Between RIP and SP|Adverse Event|4|||
33680521|NCT01412060|63136581|FG001|Period Between RIP and SP|Adverse Event|0|||
33680522|NCT01412060|63136582|FG002|Period Between RIP and SP|Adverse Event|0|||
33680523|NCT01412060|63136580|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
33680524|NCT01412060|63136581|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
33680525|NCT01412060|63136582|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
33680526|NCT01412060|63136580|FG000|Period Between RIP and SP|Protocol Violation|2|||
33680527|NCT01412060|63136581|FG001|Period Between RIP and SP|Protocol Violation|0|||
33680528|NCT01412060|63136582|FG002|Period Between RIP and SP|Protocol Violation|0|||
33680529|NCT01412060|63136580|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
33680530|NCT01412060|63136581|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
33680531|NCT01412060|63136582|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
33680532|NCT01412060|63136580|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
33592028|NCT02256891|62990490|FG001|Overall Study|Lost to Follow-up|3|||
33592029|NCT02256891|62990489|FG000|Overall Study|Physician Decision|7|||
33592030|NCT02256891|62990490|FG001|Overall Study|Physician Decision|3|||
33592031|NCT02256891|62990489|FG000|Overall Study|Screen Fail|5|||
33592032|NCT02256891|62990490|FG001|Overall Study|Screen Fail|4|||
33592033|NCT02256891|62990489|FG000|Overall Study|Equipment Malfunction|0|||
33592034|NCT02256891|62990490|FG001|Overall Study|Equipment Malfunction|1|||
33592035|NCT02256267|62990498|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
33592036|NCT02256267|62990498|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
33592037|NCT01641471|62990507|FG000|Overall Study|Withdrawal by Subject|19|||
33592038|NCT01641471|62990508|FG001|Overall Study|Withdrawal by Subject|19|||
33592039|NCT01641471|62990507|FG000|Overall Study|Lost to Follow-up|2|||
33592040|NCT01641471|62990508|FG001|Overall Study|Lost to Follow-up|4|||
33592041|NCT01641471|62990507|FG000|Overall Study|Protocol Violation|2|||
33592042|NCT01641471|62990508|FG001|Overall Study|Protocol Violation|4|||
33592043|NCT02255565|62990517|FG000|Overall Study|Withdrawal by Subject|0|||
33592044|NCT02255565|62990518|FG001|Overall Study|Withdrawal by Subject|1|||
33592045|NCT02255565|62990519|FG002|Overall Study|Withdrawal by Subject|0|||
33592046|NCT01640301|62990562|FG000|Overall Study|Death|0|||
33592047|NCT01640301|62990563|FG001|Overall Study|Death|8|||
33592048|NCT01642407|62990571|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
33592049|NCT01642407|62990571|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
33592050|NCT01642407|62990571|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
33592051|NCT02255097|62990575|FG000|Overall Study|Death|151|||
33592052|NCT02255097|62990575|FG000|Overall Study|Lost to Follow-up|5|||
33592053|NCT02255097|62990575|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
33592054|NCT02255097|62990575|FG000|Overall Study|Withdrawal by Subject|7|||
33592055|NCT02255097|62990575|FG000|Overall Study|Allocated but not treated|1|||
33592056|NCT02254551|62990580|FG000|Dose Escalation|Physician Decision|1|||
33592057|NCT02254551|62990580|FG000|Dose Escalation|Dose-limiting toxicity|2|||
33592058|NCT01641237|62990587|FG000|Period II|Withdrawal by Subject|1|||
33592059|NCT01641237|62990588|FG001|Period II|Withdrawal by Subject|0|||
33592060|NCT01641237|62990589|FG002|Period II|Withdrawal by Subject|0|||
33592061|NCT01641237|62990590|FG003|Period II|Withdrawal by Subject|0|||
33592062|NCT01641237|62990587|FG000|Period III|Lost to Follow-up|1|||
33592063|NCT01641237|62990588|FG001|Period III|Lost to Follow-up|0|||
33592064|NCT01641237|62990589|FG002|Period III|Lost to Follow-up|0|||
33592065|NCT01641237|62990590|FG003|Period III|Lost to Follow-up|0|||
33680533|NCT01412060|63136581|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
33680534|NCT01412060|63136582|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
33680535|NCT01412060|63136580|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
33592066|NCT01639833|62990602|FG000|Overall Study|Death|4|||
33592067|NCT01639833|62990603|FG001|Overall Study|Death|2|||
33592068|NCT01639833|62990602|FG000|Overall Study|Withdrawal by Subject|2|||
33592069|NCT01639833|62990603|FG001|Overall Study|Withdrawal by Subject|2|||
33592070|NCT01639131|62990609|FG000|Overall Study|Disease Progression|6|||
33592071|NCT01641159|62990615|FG000|Overall Study|Lost to Follow-up|2|||
33680536|NCT01412060|63136581|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
33592072|NCT01641159|62990616|FG001|Overall Study|Lost to Follow-up|1|||
33592073|NCT01641159|62990615|FG000|Overall Study|Withdrawal by Subject|0|||
33592074|NCT01641159|62990616|FG001|Overall Study|Withdrawal by Subject|1|||
33592075|NCT01641081|62990622|FG000|Period 1|Sponsor request (potential unblinding)|0|||
33592076|NCT01641081|62990623|FG001|Period 1|Sponsor request (potential unblinding)|0|||
33592077|NCT01641081|62990624|FG002|Period 1|Sponsor request (potential unblinding)|0|||
33592078|NCT01641081|62990625|FG003|Period 1|Sponsor request (potential unblinding)|0|||
33592079|NCT01641081|62990626|FG004|Period 1|Sponsor request (potential unblinding)|0|||
33592080|NCT01641081|62990627|FG005|Period 1|Sponsor request (potential unblinding)|0|||
33592081|NCT01641081|62990628|FG006|Period 1|Sponsor request (potential unblinding)|1|||
33592082|NCT01641081|62990629|FG007|Period 1|Sponsor request (potential unblinding)|0|||
33592083|NCT01641081|62990630|FG008|Period 1|Sponsor request (potential unblinding)|0|||
33592084|NCT01641081|62990631|FG009|Period 1|Sponsor request (potential unblinding)|0|||
33592085|NCT01641081|62990622|FG000|Period 1|Protocol Violation|0|||
33592086|NCT01641081|62990623|FG001|Period 1|Protocol Violation|0|||
33592087|NCT01641081|62990624|FG002|Period 1|Protocol Violation|0|||
33592088|NCT01641081|62990625|FG003|Period 1|Protocol Violation|0|||
33592089|NCT01641081|62990626|FG004|Period 1|Protocol Violation|1|||
33592090|NCT01641081|62990627|FG005|Period 1|Protocol Violation|0|||
33592091|NCT01641081|62990628|FG006|Period 1|Protocol Violation|0|||
33592092|NCT01641081|62990629|FG007|Period 1|Protocol Violation|1|||
33592093|NCT01641081|62990630|FG008|Period 1|Protocol Violation|0|||
33592094|NCT01641081|62990631|FG009|Period 1|Protocol Violation|0|||
33592095|NCT01641081|62990622|FG000|Period 1|Adverse Event|1|||
33592096|NCT01641081|62990623|FG001|Period 1|Adverse Event|0|||
33592097|NCT01641081|62990624|FG002|Period 1|Adverse Event|0|||
33592098|NCT01641081|62990625|FG003|Period 1|Adverse Event|0|||
33592099|NCT01641081|62990626|FG004|Period 1|Adverse Event|0|||
33592100|NCT01641081|62990627|FG005|Period 1|Adverse Event|0|||
33592101|NCT01641081|62990628|FG006|Period 1|Adverse Event|0|||
33592102|NCT01641081|62990629|FG007|Period 1|Adverse Event|2|||
33592103|NCT01641081|62990630|FG008|Period 1|Adverse Event|0|||
33592104|NCT01641081|62990631|FG009|Period 1|Adverse Event|0|||
33592105|NCT01641081|62990622|FG000|Period 2|Adverse Event|0|||
33592106|NCT01641081|62990623|FG001|Period 2|Adverse Event|0|||
33592107|NCT01641081|62990624|FG002|Period 2|Adverse Event|0|||
33592108|NCT01641081|62990625|FG003|Period 2|Adverse Event|0|||
33592109|NCT01641081|62990626|FG004|Period 2|Adverse Event|0|||
33592110|NCT01641081|62990627|FG005|Period 2|Adverse Event|1|||
33592111|NCT01641081|62990628|FG006|Period 2|Adverse Event|0|||
33592112|NCT01641081|62990629|FG007|Period 2|Adverse Event|0|||
33592113|NCT01641081|62990630|FG008|Period 2|Adverse Event|0|||
33592114|NCT01641081|62990631|FG009|Period 2|Adverse Event|0|||
33592115|NCT01641081|62990622|FG000|Period 2|Withdrawal by Subject|0|||
33592116|NCT01641081|62990623|FG001|Period 2|Withdrawal by Subject|0|||
33592117|NCT01641081|62990624|FG002|Period 2|Withdrawal by Subject|0|||
33592118|NCT01641081|62990625|FG003|Period 2|Withdrawal by Subject|1|||
33592119|NCT01641081|62990626|FG004|Period 2|Withdrawal by Subject|0|||
33592120|NCT01641081|62990627|FG005|Period 2|Withdrawal by Subject|0|||
33592121|NCT01641081|62990628|FG006|Period 2|Withdrawal by Subject|2|||
33592122|NCT01641081|62990629|FG007|Period 2|Withdrawal by Subject|0|||
33592123|NCT01641081|62990630|FG008|Period 2|Withdrawal by Subject|0|||
33592124|NCT01641081|62990631|FG009|Period 2|Withdrawal by Subject|0|||
33592125|NCT01641081|62990622|FG000|Period 2|Protocol Violation|1|||
33592126|NCT01641081|62990623|FG001|Period 2|Protocol Violation|0|||
33592127|NCT01641081|62990624|FG002|Period 2|Protocol Violation|0|||
33592128|NCT01641081|62990625|FG003|Period 2|Protocol Violation|0|||
33592129|NCT01641081|62990626|FG004|Period 2|Protocol Violation|0|||
33592130|NCT01641081|62990627|FG005|Period 2|Protocol Violation|0|||
33592131|NCT01641081|62990628|FG006|Period 2|Protocol Violation|0|||
33592132|NCT01641081|62990629|FG007|Period 2|Protocol Violation|0|||
33592133|NCT01641081|62990630|FG008|Period 2|Protocol Violation|0|||
33592134|NCT01641081|62990631|FG009|Period 2|Protocol Violation|0|||
33592135|NCT01641081|62990622|FG000|Period 3|Adverse Event|0|||
33592136|NCT01641081|62990623|FG001|Period 3|Adverse Event|0|||
33592137|NCT01641081|62990624|FG002|Period 3|Adverse Event|1|||
33592138|NCT01641081|62990625|FG003|Period 3|Adverse Event|0|||
33592139|NCT01641081|62990626|FG004|Period 3|Adverse Event|0|||
33592140|NCT01641081|62990627|FG005|Period 3|Adverse Event|0|||
33592141|NCT01641081|62990628|FG006|Period 3|Adverse Event|0|||
33592142|NCT01641081|62990629|FG007|Period 3|Adverse Event|0|||
33592143|NCT01641081|62990630|FG008|Period 3|Adverse Event|0|||
33592144|NCT01641081|62990631|FG009|Period 3|Adverse Event|0|||
33592145|NCT01641081|62990622|FG000|Period 3|Withdrawal by Subject|0|||
33592146|NCT01641081|62990623|FG001|Period 3|Withdrawal by Subject|0|||
33592147|NCT01641081|62990624|FG002|Period 3|Withdrawal by Subject|0|||
33592148|NCT01641081|62990625|FG003|Period 3|Withdrawal by Subject|0|||
33592149|NCT01641081|62990626|FG004|Period 3|Withdrawal by Subject|0|||
33592150|NCT01641081|62990627|FG005|Period 3|Withdrawal by Subject|0|||
33592151|NCT01641081|62990628|FG006|Period 3|Withdrawal by Subject|0|||
33592152|NCT01641081|62990629|FG007|Period 3|Withdrawal by Subject|0|||
33592153|NCT01641081|62990630|FG008|Period 3|Withdrawal by Subject|1|||
33592154|NCT01641081|62990631|FG009|Period 3|Withdrawal by Subject|0|||
33592155|NCT01641081|62990622|FG000|Period 4|Adverse Event|0|||
33592156|NCT01641081|62990623|FG001|Period 4|Adverse Event|1|||
33592157|NCT01641081|62990624|FG002|Period 4|Adverse Event|0|||
33592158|NCT01641081|62990625|FG003|Period 4|Adverse Event|1|||
33592159|NCT01641081|62990626|FG004|Period 4|Adverse Event|0|||
33592160|NCT01641081|62990627|FG005|Period 4|Adverse Event|0|||
33592161|NCT01641081|62990628|FG006|Period 4|Adverse Event|0|||
33592162|NCT01641081|62990629|FG007|Period 4|Adverse Event|0|||
33592163|NCT01641081|62990630|FG008|Period 4|Adverse Event|0|||
33592164|NCT01641081|62990631|FG009|Period 4|Adverse Event|0|||
33592165|NCT01641081|62990622|FG000|Period 5|Adverse Event|0|||
33592166|NCT01641081|62990623|FG001|Period 5|Adverse Event|0|||
33592167|NCT01641081|62990624|FG002|Period 5|Adverse Event|2|||
33592168|NCT01641081|62990625|FG003|Period 5|Adverse Event|0|||
33592169|NCT01641081|62990626|FG004|Period 5|Adverse Event|0|||
33592170|NCT01641081|62990627|FG005|Period 5|Adverse Event|0|||
33592171|NCT01641081|62990628|FG006|Period 5|Adverse Event|0|||
33592172|NCT01641081|62990629|FG007|Period 5|Adverse Event|0|||
33592173|NCT01641081|62990630|FG008|Period 5|Adverse Event|0|||
33592174|NCT01641081|62990631|FG009|Period 5|Adverse Event|0|||
33592175|NCT01640925|62990645|FG000|Overall Study|Withdrawal by Subject|1|||
33592176|NCT01640925|62990646|FG001|Overall Study|Withdrawal by Subject|0|||
33592177|NCT01640925|62990645|FG000|Overall Study|Previously enrolled in this trial|13|||
33592178|NCT01640925|62990646|FG001|Overall Study|Previously enrolled in this trial|11|||
33592179|NCT01638429|62990652|FG000|Overall Study|Withdrawal by Subject|1|||
33592180|NCT01639755|62990660|FG000|Overall Study|Study Ongoing|15|||
33592181|NCT01639755|62990660|FG000|Overall Study|Patient had device explantation|4|||
33592182|NCT01601535|62990670|FG000|Phase 1|Adverse Event|1|||
33592183|NCT01601535|62990671|FG001|Phase 1|Adverse Event|0|||
33592184|NCT01601535|62990672|FG002|Phase 1|Adverse Event|2|||
33592185|NCT01601535|62990673|FG003|Phase 1|Adverse Event|1|||
33592186|NCT01601535|62990674|FG004|Phase 1|Adverse Event|0|||
33592187|NCT01601535|62990675|FG005|Phase 1|Adverse Event|0|||
33592188|NCT01601535|62990670|FG000|Phase 1|Withdrawal by Subject|2|||
33592189|NCT01601535|62990671|FG001|Phase 1|Withdrawal by Subject|1|||
33592190|NCT01601535|62990672|FG002|Phase 1|Withdrawal by Subject|1|||
33592191|NCT01601535|62990673|FG003|Phase 1|Withdrawal by Subject|2|||
33592192|NCT01601535|62990674|FG004|Phase 1|Withdrawal by Subject|0|||
33592193|NCT01601535|62990675|FG005|Phase 1|Withdrawal by Subject|0|||
33592194|NCT01601535|62990670|FG000|Phase 1|Progressive Disease|2|||
33592195|NCT01601535|62990671|FG001|Phase 1|Progressive Disease|3|||
33592196|NCT01601535|62990672|FG002|Phase 1|Progressive Disease|2|||
33592197|NCT01601535|62990673|FG003|Phase 1|Progressive Disease|1|||
33592198|NCT01601535|62990674|FG004|Phase 1|Progressive Disease|0|||
33592199|NCT01601535|62990675|FG005|Phase 1|Progressive Disease|0|||
33592200|NCT01601535|62990670|FG000|Phase 1|Started Another Treatment|1|||
33592201|NCT01601535|62990671|FG001|Phase 1|Started Another Treatment|2|||
33592202|NCT01601535|62990672|FG002|Phase 1|Started Another Treatment|0|||
33592203|NCT01601535|62990673|FG003|Phase 1|Started Another Treatment|0|||
33592204|NCT01601535|62990674|FG004|Phase 1|Started Another Treatment|0|||
33592205|NCT01601535|62990675|FG005|Phase 1|Started Another Treatment|0|||
33592206|NCT01601535|62990670|FG000|Phase 2|Adverse Event|0|||
33592207|NCT01601535|62990671|FG001|Phase 2|Adverse Event|0|||
33592208|NCT01601535|62990672|FG002|Phase 2|Adverse Event|0|||
33592209|NCT01601535|62990673|FG003|Phase 2|Adverse Event|0|||
33592210|NCT01601535|62990674|FG004|Phase 2|Adverse Event|5|||
33592211|NCT01601535|62990675|FG005|Phase 2|Adverse Event|1|||
33592212|NCT01601535|62990670|FG000|Phase 2|Withdrawal by Subject|0|||
33592213|NCT01601535|62990671|FG001|Phase 2|Withdrawal by Subject|0|||
33592214|NCT01601535|62990672|FG002|Phase 2|Withdrawal by Subject|0|||
33592215|NCT01601535|62990673|FG003|Phase 2|Withdrawal by Subject|0|||
33592216|NCT01601535|62990674|FG004|Phase 2|Withdrawal by Subject|8|||
33592217|NCT01601535|62990675|FG005|Phase 2|Withdrawal by Subject|2|||
33592218|NCT01601535|62990670|FG000|Phase 2|Progressive Disease|0|||
33592219|NCT01601535|62990671|FG001|Phase 2|Progressive Disease|0|||
33592220|NCT01601535|62990672|FG002|Phase 2|Progressive Disease|0|||
33592221|NCT01601535|62990673|FG003|Phase 2|Progressive Disease|0|||
33592222|NCT01601535|62990674|FG004|Phase 2|Progressive Disease|5|||
33592223|NCT01601535|62990675|FG005|Phase 2|Progressive Disease|7|||
33592224|NCT01601535|62990670|FG000|Phase 2|Started Another Treatment|0|||
33592225|NCT01601535|62990671|FG001|Phase 2|Started Another Treatment|0|||
33592226|NCT01601535|62990672|FG002|Phase 2|Started Another Treatment|0|||
33592227|NCT01601535|62990673|FG003|Phase 2|Started Another Treatment|0|||
33592228|NCT01601535|62990674|FG004|Phase 2|Started Another Treatment|1|||
33592229|NCT01601535|62990675|FG005|Phase 2|Started Another Treatment|2|||
33592230|NCT01638819|62990700|FG000|Overall Study|Lost to Follow-up|1|||
33592231|NCT01638819|62990701|FG001|Overall Study|Lost to Follow-up|0|||
33592232|NCT01363713|62990706|FG000|Overall Study|Adverse Event|1|||
33592233|NCT01363713|62990706|FG000|Overall Study|Protocol Violation|3|||
33592234|NCT01363713|62990706|FG000|Overall Study|Withdrawal by Subject|2|||
33592235|NCT01637961|62990710|FG000|Overall Study|Ineligible: wrong primary|1|||
33592236|NCT01637961|62990710|FG000|Overall Study|Ineligible: inadequate pathology|1|||
33592237|NCT04183335|62990722|FG000|Overall Study|Adverse Event|1|||
33592238|NCT04183335|62990723|FG001|Overall Study|Adverse Event|0|||
33592239|NCT04183335|62990722|FG000|Overall Study|Withdrawal by Subject|12|||
33592240|NCT04183335|62990723|FG001|Overall Study|Withdrawal by Subject|3|||
33592241|NCT04199793|62990731|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
33592242|NCT04199793|62990732|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
33592243|NCT04199793|62990731|FG000|Overall Study|Withdrawal by Subject|1|||
33592244|NCT04199793|62990732|FG001|Overall Study|Withdrawal by Subject|1|||
33592245|NCT01636947|62990740|FG000|Overall Study|Not Treated|2|||
33592246|NCT01636947|62990741|FG001|Overall Study|Not Treated|2|||
33592247|NCT01636947|62990740|FG000|Overall Study|Lost to Follow-up|4|||
33592248|NCT01636947|62990741|FG001|Overall Study|Lost to Follow-up|0|||
33592249|NCT01636947|62990740|FG000|Overall Study|Protocol Violation|1|||
33592250|NCT01636947|62990741|FG001|Overall Study|Protocol Violation|1|||
33592251|NCT01636947|62990740|FG000|Overall Study|Withdrawal by Subject|3|||
33592252|NCT01636947|62990741|FG001|Overall Study|Withdrawal by Subject|3|||
33592253|NCT01636947|62990740|FG000|Overall Study|Adverse Event|1|||
33592254|NCT01636947|62990741|FG001|Overall Study|Adverse Event|1|||
33592255|NCT01636947|62990740|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
33592256|NCT01636947|62990741|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
33592257|NCT01635933|62990749|FG000|Overall Study|Adverse Event|1|||
33592258|NCT01635933|62990750|FG001|Overall Study|Adverse Event|0|||
33592259|NCT01635933|62990749|FG000|Overall Study|Lost to Follow-up|0|||
33592260|NCT01635933|62990750|FG001|Overall Study|Lost to Follow-up|5|||
33592261|NCT01635933|62990749|FG000|Overall Study|Subject decision|1|||
33592262|NCT01635933|62990750|FG001|Overall Study|Subject decision|1|||
33592263|NCT01635933|62990749|FG000|Overall Study|Noncompliance|0|||
33592264|NCT01635933|62990750|FG001|Overall Study|Noncompliance|1|||
33592265|NCT01635933|62990749|FG000|Overall Study|No longer had transportation|0|||
33592266|NCT01635933|62990750|FG001|Overall Study|No longer had transportation|1|||
33592267|NCT01635855|62990756|FG000|Overall Study|Withdrawal by Subject|4|||
33592268|NCT03052725|62990762|FG000|Overall Study|Adverse Event|2|||
33592269|NCT03052725|62990763|FG001|Overall Study|Adverse Event|0|||
33592270|NCT03052725|62990762|FG000|Overall Study|Withdrawal by Subject|3|||
33592271|NCT03052725|62990763|FG001|Overall Study|Withdrawal by Subject|4|||
33592272|NCT03052725|62990762|FG000|Overall Study|Pregnancy|0|||
33592273|NCT03052725|62990763|FG001|Overall Study|Pregnancy|1|||
33592274|NCT03052725|62990762|FG000|Overall Study|Site closure|0|||
33592275|NCT03052725|62990763|FG001|Overall Study|Site closure|1|||
33592276|NCT03052725|62990762|FG000|Overall Study|Study terminated by sponsor|143|||
33592277|NCT03052725|62990763|FG001|Overall Study|Study terminated by sponsor|144|||
33592278|NCT02775435|62990770|FG000|Overall Study|Adverse Event|48|||
33592279|NCT02775435|62990771|FG001|Overall Study|Adverse Event|25|||
33592280|NCT02775435|62990770|FG000|Overall Study|Lost to Follow-up|0|||
33592281|NCT02775435|62990771|FG001|Overall Study|Lost to Follow-up|2|||
33592282|NCT02775435|62990770|FG000|Overall Study|Physician Decision|5|||
33592283|NCT02775435|62990771|FG001|Overall Study|Physician Decision|6|||
33592284|NCT02775435|62990770|FG000|Overall Study|Withdrawal by Subject|5|||
33592285|NCT02775435|62990771|FG001|Overall Study|Withdrawal by Subject|9|||
33592286|NCT02775435|62990770|FG000|Overall Study|Progressive Disease|86|||
33592287|NCT02775435|62990771|FG001|Overall Study|Progressive Disease|140|||
33592288|NCT02775435|62990770|FG000|Overall Study|Clinical Progression|13|||
33592289|NCT02775435|62990771|FG001|Overall Study|Clinical Progression|26|||
33592290|NCT02775435|62990770|FG000|Overall Study|Ongoing in Study|121|||
33592291|NCT02775435|62990771|FG001|Overall Study|Ongoing in Study|72|||
33592292|NCT02775435|62990770|FG000|Overall Study|Not Treated|0|||
33592293|NCT02775435|62990771|FG001|Overall Study|Not Treated|1|||
33592294|NCT01635153|62990796|FG000|Overall Study|Lost to Follow-up|40|||
33592295|NCT01635153|62990797|FG001|Overall Study|Lost to Follow-up|43|||
33592296|NCT01636713|62990806|FG000|Overall Study|Adverse Event|16|||
33592297|NCT01636713|62990807|FG001|Overall Study|Adverse Event|16|||
33592298|NCT01636713|62990808|FG002|Overall Study|Adverse Event|7|||
33592299|NCT01636713|62990806|FG000|Overall Study|Lack of Efficacy|6|||
33592300|NCT01636713|62990807|FG001|Overall Study|Lack of Efficacy|6|||
33592301|NCT01636713|62990808|FG002|Overall Study|Lack of Efficacy|2|||
33592302|NCT01636713|62990806|FG000|Overall Study|Protocol Violation|3|||
33592303|NCT01636713|62990807|FG001|Overall Study|Protocol Violation|0|||
33592304|NCT01636713|62990808|FG002|Overall Study|Protocol Violation|1|||
33592305|NCT01636713|62990806|FG000|Overall Study|Lost to Follow-up|0|||
33592306|NCT01636713|62990807|FG001|Overall Study|Lost to Follow-up|0|||
33592307|NCT01636713|62990808|FG002|Overall Study|Lost to Follow-up|1|||
33592308|NCT01636713|62990806|FG000|Overall Study|Withdrawal by Subject|5|||
33592309|NCT01636713|62990807|FG001|Overall Study|Withdrawal by Subject|4|||
33592310|NCT01636713|62990808|FG002|Overall Study|Withdrawal by Subject|8|||
33592311|NCT01636713|62990806|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
33592312|NCT01636713|62990807|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
33592313|NCT01636713|62990808|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
33592314|NCT01600053|62990816|FG000|Overall Study|Adverse Event|2|||
33592315|NCT01600053|62990816|FG000|Overall Study|trial will not meet the interim endpoint|9|||
33592316|NCT01068249|62990820|FG000|Overall Study|Death|1|||
33592317|NCT01068249|62990820|FG000|Overall Study|Withdrawal by Subject|3|||
33592318|NCT02246673|62990839|FG000|Overall Study|Sponsor Decision|1|||
33592319|NCT02246673|62990840|FG001|Overall Study|Sponsor Decision|0|||
33592320|NCT02246673|62990841|FG002|Overall Study|Sponsor Decision|0|||
33592321|NCT02246673|62990842|FG003|Overall Study|Sponsor Decision|0|||
33592322|NCT02246673|62990843|FG004|Overall Study|Sponsor Decision|0|||
33592323|NCT02246673|62990839|FG000|Overall Study|Withdrawal by Subject|0|||
33592324|NCT02246673|62990840|FG001|Overall Study|Withdrawal by Subject|0|||
33592325|NCT02246673|62990841|FG002|Overall Study|Withdrawal by Subject|0|||
33592326|NCT02246673|62990842|FG003|Overall Study|Withdrawal by Subject|0|||
33592327|NCT02246673|62990843|FG004|Overall Study|Withdrawal by Subject|1|||
33592328|NCT02246673|62990839|FG000|Overall Study|Lost to Follow-up|0|||
33592329|NCT02246673|62990840|FG001|Overall Study|Lost to Follow-up|0|||
33592330|NCT02246673|62990841|FG002|Overall Study|Lost to Follow-up|0|||
33592331|NCT02246673|62990842|FG003|Overall Study|Lost to Follow-up|1|||
33592332|NCT02246673|62990843|FG004|Overall Study|Lost to Follow-up|0|||
33592333|NCT02246673|62990839|FG000|Overall Study|Protocol Violation|0|||
33592334|NCT02246673|62990840|FG001|Overall Study|Protocol Violation|0|||
33592335|NCT02246673|62990841|FG002|Overall Study|Protocol Violation|0|||
33592336|NCT02246673|62990842|FG003|Overall Study|Protocol Violation|1|||
33592337|NCT02246673|62990843|FG004|Overall Study|Protocol Violation|0|||
33592338|NCT02246439|62990905|FG000|Overall Study|Adverse Event|3|||
33592339|NCT02246439|62990906|FG001|Overall Study|Adverse Event|0|||
33592340|NCT02246439|62990905|FG000|Overall Study|Lost to Follow-up|7|||
33592341|NCT02246439|62990906|FG001|Overall Study|Lost to Follow-up|5|||
33592342|NCT02246439|62990905|FG000|Overall Study|Protocol Violation|0|||
33592343|NCT02246439|62990906|FG001|Overall Study|Protocol Violation|2|||
33592344|NCT02246439|62990905|FG000|Overall Study|Physician Decision|0|||
33592345|NCT02246439|62990906|FG001|Overall Study|Physician Decision|1|||
33592346|NCT02246439|62990905|FG000|Overall Study|Unkonwn|1|||
33592347|NCT02246439|62990906|FG001|Overall Study|Unkonwn|3|||
33592348|NCT02246439|62990905|FG000|Overall Study|Withdrawal by Subject|1|||
33592349|NCT02246439|62990906|FG001|Overall Study|Withdrawal by Subject|0|||
33592350|NCT02245737|62990915|FG000|Overall Study|Adverse Event|23|||
33592351|NCT02245737|62990916|FG001|Overall Study|Adverse Event|26|||
33592352|NCT02245737|62990917|FG002|Overall Study|Adverse Event|33|||
33592353|NCT02245737|62990915|FG000|Overall Study|Condition Worsened|9|||
33592354|NCT02245737|62990916|FG001|Overall Study|Condition Worsened|10|||
33592355|NCT02245737|62990917|FG002|Overall Study|Condition Worsened|9|||
33592356|NCT02245737|62990915|FG000|Overall Study|Death|2|||
33592357|NCT02245737|62990916|FG001|Overall Study|Death|4|||
33592358|NCT02245737|62990917|FG002|Overall Study|Death|4|||
33592359|NCT02245737|62990915|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
33592360|NCT02245737|62990916|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
33592361|NCT02245737|62990917|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
33592362|NCT02245737|62990915|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
33592363|NCT02245737|62990916|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
33592364|NCT02245737|62990917|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
33592365|NCT02245737|62990915|FG000|Overall Study|Lost to Follow-up|2|||
33592366|NCT02245737|62990916|FG001|Overall Study|Lost to Follow-up|5|||
33592367|NCT02245737|62990917|FG002|Overall Study|Lost to Follow-up|4|||
33592368|NCT02245737|62990915|FG000|Overall Study|Other-determined by Investigator|9|||
33592369|NCT02245737|62990916|FG001|Overall Study|Other-determined by Investigator|10|||
33592370|NCT02245737|62990917|FG002|Overall Study|Other-determined by Investigator|10|||
33592371|NCT02245737|62990915|FG000|Overall Study|Physician Decision|6|||
33592372|NCT02245737|62990916|FG001|Overall Study|Physician Decision|3|||
33592373|NCT02245737|62990917|FG002|Overall Study|Physician Decision|6|||
33592374|NCT02245737|62990915|FG000|Overall Study|Protocol Violation|3|||
33592375|NCT02245737|62990916|FG001|Overall Study|Protocol Violation|2|||
33592376|NCT02245737|62990917|FG002|Overall Study|Protocol Violation|3|||
33592377|NCT02245737|62990915|FG000|Overall Study|Withdrawal by Subject|40|||
33592378|NCT02245737|62990916|FG001|Overall Study|Withdrawal by Subject|41|||
33592379|NCT02245737|62990917|FG002|Overall Study|Withdrawal by Subject|44|||
33592380|NCT02245737|62990915|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
33592381|NCT02245737|62990916|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
33592382|NCT02245737|62990917|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
33680537|NCT01412060|63136582|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
33680538|NCT01412060|63136580|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
33680539|NCT01412060|63136581|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
33592383|NCT02245737|62990915|FG000|Overall Study|Sponsor Decision|445|||
33592384|NCT02245737|62990916|FG001|Overall Study|Sponsor Decision|430|||
33592385|NCT02245737|62990917|FG002|Overall Study|Sponsor Decision|432|||
33592386|NCT02244957|62990929|FG000|Overall Study|Lack of Efficacy|1|||
33592387|NCT02244957|62990930|FG001|Overall Study|Lack of Efficacy|0|||
33592388|NCT02243865|62990940|FG000|Overall Study|Protocol Violation|1|||
33592389|NCT02243865|62990941|FG001|Overall Study|Protocol Violation|3|||
33592390|NCT02243865|62990940|FG000|Overall Study|Lost to Follow-up|1|||
33592391|NCT02243865|62990941|FG001|Overall Study|Lost to Follow-up|1|||
33592392|NCT02243865|62990940|FG000|Overall Study|Withdrawal by Subject|1|||
33592393|NCT02243865|62990941|FG001|Overall Study|Withdrawal by Subject|0|||
33592394|NCT02243865|62990940|FG000|Overall Study|Adverse Event|1|||
33592395|NCT02243865|62990941|FG001|Overall Study|Adverse Event|1|||
33592396|NCT02243631|62990951|FG000|Overall Study|no synovial fluid on second aspirate|0|||
33592397|NCT02243631|62990952|FG001|Overall Study|no synovial fluid on second aspirate|1|||
33592398|NCT02242305|62990960|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
33592399|NCT02242305|62990961|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
33592400|NCT02242305|62990960|FG000|Overall Study|Adverse Event|1|||
33592401|NCT02242305|62990961|FG001|Overall Study|Adverse Event|0|||
33592402|NCT02242305|62990960|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
33592403|NCT02242305|62990961|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
33592404|NCT02242305|62990960|FG000|Overall Study|Subject withdraws inform consent|0|||
33592405|NCT02242305|62990961|FG001|Overall Study|Subject withdraws inform consent|4|||
33592406|NCT02242305|62990960|FG000|Overall Study|Lost to Follow-up|2|||
33592407|NCT02242305|62990961|FG001|Overall Study|Lost to Follow-up|0|||
33592408|NCT02240121|62990969|FG000|Overall Study|Protocol Violation|1|||
33592409|NCT02240121|62990970|FG001|Overall Study|Protocol Violation|2|||
33592410|NCT02240121|62990969|FG000|Overall Study|Physician Decision|0|||
33592411|NCT02240121|62990970|FG001|Overall Study|Physician Decision|1|||
33592412|NCT02240121|62990969|FG000|Overall Study|Change in protocol interpretation|1|||
33592413|NCT02240121|62990970|FG001|Overall Study|Change in protocol interpretation|0|||
33592414|NCT02240121|62990969|FG000|Overall Study|Lack of Efficacy|2|||
33592415|NCT02240121|62990970|FG001|Overall Study|Lack of Efficacy|3|||
33592416|NCT02240121|62990969|FG000|Overall Study|Site closed|1|||
33592417|NCT02240121|62990970|FG001|Overall Study|Site closed|1|||
33592418|NCT02240121|62990969|FG000|Overall Study|Pregnancy|1|||
33592419|NCT02240121|62990970|FG001|Overall Study|Pregnancy|0|||
33592420|NCT02240121|62990969|FG000|Overall Study|Adverse Event|2|||
33592421|NCT02240121|62990970|FG001|Overall Study|Adverse Event|4|||
33592422|NCT02240121|62990969|FG000|Overall Study|Withdrawal by Subject|6|||
33592423|NCT02240121|62990970|FG001|Overall Study|Withdrawal by Subject|2|||
33592424|NCT02240121|62990969|FG000|Overall Study|Lost to Follow-up|3|||
33592425|NCT02240121|62990970|FG001|Overall Study|Lost to Follow-up|4|||
33592426|NCT02240121|62990969|FG000|Overall Study|Other than specified|1|||
33592427|NCT02240121|62990970|FG001|Overall Study|Other than specified|3|||
33592428|NCT02239263|62990976|FG000|Overall Study|Protocol Violation|6|||
33592429|NCT02238483|62990984|FG000|Overall Study|Withdrawal by Subject|2|||
33592430|NCT02238483|62990985|FG001|Overall Study|Withdrawal by Subject|7|||
33592431|NCT02238483|62990984|FG000|Overall Study|Lost to Follow-up|1|||
33592432|NCT02238483|62990985|FG001|Overall Study|Lost to Follow-up|1|||
33592433|NCT02238483|62990984|FG000|Overall Study|Protocol Violation|1|||
33592434|NCT02238483|62990985|FG001|Overall Study|Protocol Violation|2|||
33592435|NCT02238483|62990984|FG000|Overall Study|Death|1|||
33592436|NCT02238483|62990985|FG001|Overall Study|Death|0|||
33592437|NCT02238483|62990984|FG000|Overall Study|Adverse Event|7|||
33592438|NCT02238483|62990985|FG001|Overall Study|Adverse Event|3|||
33592439|NCT02238483|62990984|FG000|Overall Study|Withdrawn due to physician decision|1|||
33592440|NCT02238483|62990985|FG001|Overall Study|Withdrawn due to physician decision|0|||
33592441|NCT02238483|62990984|FG000|Overall Study|Completion status not recorded|1|||
33592442|NCT02238483|62990985|FG001|Overall Study|Completion status not recorded|1|||
33592443|NCT02238483|62990984|FG000|Overall Study|Illness in family member|1|||
33592444|NCT02238483|62990985|FG001|Overall Study|Illness in family member|0|||
33592445|NCT01632891|62990993|FG000|Overall Study|Lost to Follow-up|0|||
33592446|NCT01632891|62990994|FG001|Overall Study|Lost to Follow-up|1|||
33592447|NCT01632891|62990993|FG000|Overall Study|Withdrawal by Subject|1|||
33592448|NCT01632891|62990994|FG001|Overall Study|Withdrawal by Subject|0|||
33592449|NCT02208999|62991006|FG000|Overall Study|Lost to Follow-up|1|||
33592450|NCT02208843|62991025|FG000|Overall Study|Clinical symptoms of progression|2|||
33592451|NCT02208843|62991025|FG000|Overall Study|Progression disease according to RECIST|24|||
33592452|NCT02208843|62991025|FG000|Overall Study|Adverse Event|12|||
33592453|NCT02208843|62991025|FG000|Overall Study|Protocol Violation|1|||
33592454|NCT02208843|62991025|FG000|Overall Study|Withdrawal by Subject|1|||
33592455|NCT02208843|62991025|FG000|Overall Study|Switched to commercial afatinib|20|||
33592456|NCT02208063|62991031|FG000|Overall Study|Death|3|||
33592457|NCT02208063|62991032|FG001|Overall Study|Death|5|||
33592458|NCT02208063|62991031|FG000|Overall Study|Not Specified in report|3|||
33680540|NCT01412060|63136582|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
33592459|NCT02208063|62991032|FG001|Overall Study|Not Specified in report|4|||
33592460|NCT02208063|62991031|FG000|Overall Study|Withdrawal by Subject|5|||
33592461|NCT02208063|62991032|FG001|Overall Study|Withdrawal by Subject|2|||
33592462|NCT02208063|62991031|FG000|Overall Study|Lost to Follow-up|1|||
33592463|NCT02208063|62991032|FG001|Overall Study|Lost to Follow-up|0|||
33592464|NCT02207907|62991040|FG000|Overall Study|Lost to Follow-up|3|||
33592465|NCT02207907|62991041|FG001|Overall Study|Lost to Follow-up|1|||
33592466|NCT02207907|62991040|FG000|Overall Study|Withdrawal by Subject|5|||
33592467|NCT02207907|62991041|FG001|Overall Study|Withdrawal by Subject|6|||
33592468|NCT02207907|62991040|FG000|Overall Study|Did not meet study criteria|3|||
33592469|NCT02207907|62991041|FG001|Overall Study|Did not meet study criteria|0|||
33592470|NCT02207907|62991040|FG000|Overall Study|Pregnancy|0|||
33592471|NCT02207907|62991041|FG001|Overall Study|Pregnancy|1|||
33592472|NCT02207829|62991050|FG000|Overall Study|Adverse Event|10|||
33592473|NCT02207829|62991051|FG001|Overall Study|Adverse Event|9|||
33592474|NCT02207829|62991050|FG000|Overall Study|Lack of Efficacy|7|||
33592475|NCT02207829|62991051|FG001|Overall Study|Lack of Efficacy|5|||
33592476|NCT02207829|62991050|FG000|Overall Study|Lost to Follow-up|2|||
33592477|NCT02207829|62991051|FG001|Overall Study|Lost to Follow-up|2|||
33592478|NCT02207829|62991050|FG000|Overall Study|Protocol deviation|5|||
33592479|NCT02207829|62991051|FG001|Overall Study|Protocol deviation|4|||
33592480|NCT02207829|62991050|FG000|Overall Study|Withdrew consent|18|||
33680541|NCT01412060|63136580|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
33680542|NCT01412060|63136581|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
33680543|NCT01412060|63136582|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
33680544|NCT01412060|63136580|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
33592481|NCT02207829|62991051|FG001|Overall Study|Withdrew consent|14|||
33592482|NCT02237157|62991057|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
33592483|NCT02237157|62991058|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
33592484|NCT02237157|62991059|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
33592485|NCT02237157|62991060|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
33592486|NCT02237157|62991057|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
33592487|NCT02237157|62991058|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
33592488|NCT02237157|62991059|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
33592489|NCT02237157|62991060|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
33592490|NCT02237001|62991067|FG000|Overall Study|Lost to Follow-up|2|||
33592491|NCT02237001|62991067|FG000|Overall Study|Withdrawal by Subject|1|||
33592492|NCT02237001|62991067|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
33592493|NCT02237001|62991067|FG000|Overall Study|Re-operation|4|||
33592494|NCT02237001|62991067|FG000|Overall Study|Incarceration|1|||
33592495|NCT02236611|62991073|FG000|Overall Study|Adverse Event|10|||
33592496|NCT02236611|62991074|FG001|Overall Study|Adverse Event|16|||
33592497|NCT02236611|62991073|FG000|Overall Study|Lack of Efficacy|4|||
33592498|NCT02236611|62991074|FG001|Overall Study|Lack of Efficacy|7|||
33592499|NCT02236611|62991073|FG000|Overall Study|Lost to Follow-up|0|||
33592500|NCT02236611|62991074|FG001|Overall Study|Lost to Follow-up|2|||
33592501|NCT02236611|62991073|FG000|Overall Study|Protocol deviation|3|||
33592502|NCT02236611|62991074|FG001|Overall Study|Protocol deviation|5|||
33592503|NCT02236611|62991073|FG000|Overall Study|Withdrew consent|9|||
33592504|NCT02236611|62991074|FG001|Overall Study|Withdrew consent|4|||
33592505|NCT02234583|62991082|FG000|Overall Study|Adverse Event|172|||
33592506|NCT02234583|62991083|FG001|Overall Study|Adverse Event|156|||
33592507|NCT02234583|62991082|FG000|Overall Study|Withdrawal by Subject|109|||
33592508|NCT02234583|62991083|FG001|Overall Study|Withdrawal by Subject|157|||
33592509|NCT02234583|62991082|FG000|Overall Study|Lost to Follow-up|0|||
33592510|NCT02234583|62991083|FG001|Overall Study|Lost to Follow-up|1|||
33592511|NCT02234583|62991082|FG000|Overall Study|Lack of Efficacy|58|||
33592512|NCT02234583|62991083|FG001|Overall Study|Lack of Efficacy|103|||
33592513|NCT02234583|62991082|FG000|Overall Study|Protocol Violation|35|||
33592514|NCT02234583|62991083|FG001|Overall Study|Protocol Violation|42|||
33592515|NCT02234583|62991082|FG000|Overall Study|Other|39|||
33592516|NCT02234583|62991083|FG001|Overall Study|Other|97|||
33592517|NCT03686397|62991097|FG000|Overall Study|Lack of Efficacy|3|||
33592518|NCT03686397|62991098|FG001|Overall Study|Lack of Efficacy|5|||
33592519|NCT03686397|62991097|FG000|Overall Study|Adverse Event|0|||
33592520|NCT03686397|62991098|FG001|Overall Study|Adverse Event|1|||
33592521|NCT03686397|62991097|FG000|Overall Study|Protocol Violation|0|||
33592522|NCT03686397|62991098|FG001|Overall Study|Protocol Violation|1|||
33592523|NCT03686397|62991097|FG000|Overall Study|Withdrawal by Subject|0|||
33592524|NCT03686397|62991098|FG001|Overall Study|Withdrawal by Subject|1|||
33592525|NCT03686397|62991097|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
33592526|NCT03686397|62991098|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
33592527|NCT02233803|62991104|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
33592528|NCT02233803|62991105|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
33592529|NCT02233803|62991104|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
33592530|NCT02233803|62991105|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
33592531|NCT02233803|62991104|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
33592532|NCT02233803|62991105|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
33592533|NCT02233803|62991104|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
33592534|NCT02233803|62991105|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
33592535|NCT02233803|62991104|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
33592536|NCT02233803|62991105|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
33592537|NCT02233803|62991104|FG000|Washout Period (4-Wks)|Physician Decision|1|||
33592538|NCT02233803|62991105|FG001|Washout Period (4-Wks)|Physician Decision|0|||
33592539|NCT02233803|62991104|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
33592540|NCT02233803|62991105|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
33592541|NCT02233803|62991104|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
33592542|NCT02233803|62991105|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
33592543|NCT02233803|62991104|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
33592544|NCT02233803|62991105|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
33592545|NCT02233647|62991113|FG000|Overall Study|Adverse Event|1|||
33592546|NCT02233413|62991119|FG000|Overall Study|Lost to Follow-up|7|||
33592547|NCT02233413|62991120|FG001|Overall Study|Lost to Follow-up|9|||
33592548|NCT02233413|62991119|FG000|Overall Study|Withdrawal by Subject|4|||
33592549|NCT02233413|62991120|FG001|Overall Study|Withdrawal by Subject|5|||
33592550|NCT01632579|62991126|FG000|Washout Period|Adverse Event|1|||
33592551|NCT01632579|62991127|FG001|Washout Period|Adverse Event|0|||
33592552|NCT01632579|62991128|FG002|Washout Period|Adverse Event|0|||
33592553|NCT01632579|62991129|FG003|Washout Period|Adverse Event|0|||
33592554|NCT01632579|62991130|FG004|Washout Period|Adverse Event|0|||
33592555|NCT01632579|62991131|FG005|Washout Period|Adverse Event|0|||
33592556|NCT01632579|62991132|FG006|Washout Period|Adverse Event|0|||
33592557|NCT01632579|62991133|FG007|Washout Period|Adverse Event|0|||
33592558|NCT01632579|62991134|FG008|Washout Period|Adverse Event|0|||
33592559|NCT01632579|62991126|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
33592560|NCT01632579|62991127|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
33592561|NCT01632579|62991128|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
33592562|NCT01632579|62991129|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
33592563|NCT01632579|62991130|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
33592564|NCT01632579|62991131|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
33592565|NCT01632579|62991132|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
33592566|NCT01632579|62991133|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
33592567|NCT01632579|62991134|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
33592568|NCT01632345|62991163|FG000|Treatment: Part I|Adverse Event|1|||
33592569|NCT01632345|62991164|FG001|Treatment: Part I|Adverse Event|4|||
33592570|NCT01632345|62991165|FG002|Treatment: Part I|Adverse Event|2|||
33592571|NCT01632345|62991166|FG003|Treatment: Part I|Adverse Event|1|||
33592572|NCT01632345|62991167|FG004|Treatment: Part I|Adverse Event|3|||
33592573|NCT01632345|62991168|FG005|Treatment: Part I|Adverse Event|0|||
33592574|NCT01632345|62991169|FG006|Treatment: Part I|Adverse Event|0|||
33592575|NCT01632345|62991163|FG000|Treatment: Part I|Lack of Efficacy|0|||
33592576|NCT01632345|62991164|FG001|Treatment: Part I|Lack of Efficacy|1|||
33592577|NCT01632345|62991165|FG002|Treatment: Part I|Lack of Efficacy|0|||
33592578|NCT01632345|62991166|FG003|Treatment: Part I|Lack of Efficacy|1|||
33592579|NCT01632345|62991167|FG004|Treatment: Part I|Lack of Efficacy|1|||
33592580|NCT01632345|62991168|FG005|Treatment: Part I|Lack of Efficacy|0|||
33592581|NCT01632345|62991169|FG006|Treatment: Part I|Lack of Efficacy|0|||
33592582|NCT01632345|62991163|FG000|Treatment: Part I|Lost to Follow-up|3|||
33592583|NCT01632345|62991164|FG001|Treatment: Part I|Lost to Follow-up|2|||
33592584|NCT01632345|62991165|FG002|Treatment: Part I|Lost to Follow-up|1|||
33592585|NCT01632345|62991166|FG003|Treatment: Part I|Lost to Follow-up|3|||
33592586|NCT01632345|62991167|FG004|Treatment: Part I|Lost to Follow-up|4|||
33592587|NCT01632345|62991168|FG005|Treatment: Part I|Lost to Follow-up|0|||
33592588|NCT01632345|62991169|FG006|Treatment: Part I|Lost to Follow-up|0|||
33592589|NCT01632345|62991163|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
33592590|NCT01632345|62991164|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
33592591|NCT01632345|62991165|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
33592592|NCT01632345|62991166|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
33592593|NCT01632345|62991167|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
33592594|NCT01632345|62991168|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
33592595|NCT01632345|62991169|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
33592596|NCT01632345|62991163|FG000|Treatment: Part I|Physician Decision|2|||
33592597|NCT01632345|62991164|FG001|Treatment: Part I|Physician Decision|1|||
33592598|NCT01632345|62991165|FG002|Treatment: Part I|Physician Decision|0|||
33592599|NCT01632345|62991166|FG003|Treatment: Part I|Physician Decision|0|||
33592600|NCT01632345|62991167|FG004|Treatment: Part I|Physician Decision|1|||
33592601|NCT01632345|62991168|FG005|Treatment: Part I|Physician Decision|0|||
33592602|NCT01632345|62991169|FG006|Treatment: Part I|Physician Decision|0|||
33592603|NCT01632345|62991163|FG000|Treatment: Part I|Pregnancy|0|||
33592604|NCT01632345|62991164|FG001|Treatment: Part I|Pregnancy|1|||
33592605|NCT01632345|62991165|FG002|Treatment: Part I|Pregnancy|0|||
33592606|NCT01632345|62991166|FG003|Treatment: Part I|Pregnancy|0|||
33592607|NCT01632345|62991167|FG004|Treatment: Part I|Pregnancy|0|||
33592608|NCT01632345|62991168|FG005|Treatment: Part I|Pregnancy|0|||
33592609|NCT01632345|62991169|FG006|Treatment: Part I|Pregnancy|0|||
33592610|NCT01632345|62991163|FG000|Treatment: Part I|Protocol Deviation|0|||
33592611|NCT01632345|62991164|FG001|Treatment: Part I|Protocol Deviation|0|||
33592612|NCT01632345|62991165|FG002|Treatment: Part I|Protocol Deviation|1|||
33592613|NCT01632345|62991166|FG003|Treatment: Part I|Protocol Deviation|1|||
33651268|NCT01708915|63062675|FG002|Overall Study|Lack of Efficacy|35|||
33592614|NCT01632345|62991167|FG004|Treatment: Part I|Protocol Deviation|0|||
33592615|NCT01632345|62991168|FG005|Treatment: Part I|Protocol Deviation|0|||
33592616|NCT01632345|62991169|FG006|Treatment: Part I|Protocol Deviation|0|||
33592617|NCT01632345|62991163|FG000|Treatment: Part I|Withdrawal by Subject|3|||
33592618|NCT01632345|62991164|FG001|Treatment: Part I|Withdrawal by Subject|4|||
33592619|NCT01632345|62991165|FG002|Treatment: Part I|Withdrawal by Subject|4|||
33592620|NCT01632345|62991166|FG003|Treatment: Part I|Withdrawal by Subject|1|||
33592621|NCT01632345|62991167|FG004|Treatment: Part I|Withdrawal by Subject|4|||
33592622|NCT01632345|62991168|FG005|Treatment: Part I|Withdrawal by Subject|0|||
33592623|NCT01632345|62991169|FG006|Treatment: Part I|Withdrawal by Subject|0|||
33592624|NCT01632345|62991163|FG000|Treatment: Part II|Adverse Event|0|||
33592625|NCT01632345|62991164|FG001|Treatment: Part II|Adverse Event|0|||
33592626|NCT01632345|62991165|FG002|Treatment: Part II|Adverse Event|0|||
33592627|NCT01632345|62991166|FG003|Treatment: Part II|Adverse Event|0|||
33592628|NCT01632345|62991167|FG004|Treatment: Part II|Adverse Event|0|||
33592629|NCT01632345|62991168|FG005|Treatment: Part II|Adverse Event|3|||
33592630|NCT01632345|62991169|FG006|Treatment: Part II|Adverse Event|8|||
33592631|NCT01632345|62991163|FG000|Treatment: Part II|Lost to Follow-up|0|||
33592632|NCT01632345|62991164|FG001|Treatment: Part II|Lost to Follow-up|0|||
33592633|NCT01632345|62991165|FG002|Treatment: Part II|Lost to Follow-up|0|||
33592634|NCT01632345|62991166|FG003|Treatment: Part II|Lost to Follow-up|0|||
33592635|NCT01632345|62991167|FG004|Treatment: Part II|Lost to Follow-up|0|||
33592636|NCT01632345|62991168|FG005|Treatment: Part II|Lost to Follow-up|3|||
33592637|NCT01632345|62991169|FG006|Treatment: Part II|Lost to Follow-up|1|||
33592638|NCT01632345|62991163|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
33592639|NCT01632345|62991164|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
33592640|NCT01632345|62991165|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
33592641|NCT01632345|62991166|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
33592642|NCT01632345|62991167|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
33592643|NCT01632345|62991168|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
33592644|NCT01632345|62991169|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
33592645|NCT01632345|62991163|FG000|Treatment: Part II|Withdrawal by Subject|0|||
33592646|NCT01632345|62991164|FG001|Treatment: Part II|Withdrawal by Subject|0|||
33592647|NCT01632345|62991165|FG002|Treatment: Part II|Withdrawal by Subject|0|||
33592648|NCT01632345|62991166|FG003|Treatment: Part II|Withdrawal by Subject|0|||
33592649|NCT01632345|62991167|FG004|Treatment: Part II|Withdrawal by Subject|0|||
33592650|NCT01632345|62991168|FG005|Treatment: Part II|Withdrawal by Subject|2|||
33592651|NCT01632345|62991169|FG006|Treatment: Part II|Withdrawal by Subject|2|||
33592652|NCT02232243|62991187|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
33592653|NCT02232243|62991188|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
33592654|NCT02232243|62991189|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
33592655|NCT02205333|62991207|FG000|Overall Study|Death|5|||
33592656|NCT02205333|62991208|FG001|Overall Study|Death|6|||
33592657|NCT02205333|62991209|FG002|Overall Study|Death|2|||
33592658|NCT02205333|62991210|FG003|Overall Study|Death|6|||
33592659|NCT02205333|62991211|FG004|Overall Study|Death|5|||
33592660|NCT02205333|62991212|FG005|Overall Study|Death|3|||
33592661|NCT02205333|62991213|FG006|Overall Study|Death|3|||
33592662|NCT02205333|62991214|FG007|Overall Study|Death|2|||
33592663|NCT02205333|62991215|FG008|Overall Study|Death|0|||
33592664|NCT02205333|62991207|FG000|Overall Study|Withdrawal by Subject|1|||
33592665|NCT02205333|62991208|FG001|Overall Study|Withdrawal by Subject|0|||
33592666|NCT02205333|62991209|FG002|Overall Study|Withdrawal by Subject|0|||
33592667|NCT02205333|62991210|FG003|Overall Study|Withdrawal by Subject|1|||
33592668|NCT02205333|62991211|FG004|Overall Study|Withdrawal by Subject|0|||
33592669|NCT02205333|62991212|FG005|Overall Study|Withdrawal by Subject|0|||
33592670|NCT02205333|62991213|FG006|Overall Study|Withdrawal by Subject|2|||
33592671|NCT02205333|62991214|FG007|Overall Study|Withdrawal by Subject|0|||
33592672|NCT02205333|62991215|FG008|Overall Study|Withdrawal by Subject|0|||
33592673|NCT02230683|62991235|FG000|Overall Study|Adverse Event|1|||
33592674|NCT02230527|62991247|FG000|Overall Study|Withdrawal by Subject|1|||
33592675|NCT02230527|62991248|FG001|Overall Study|Withdrawal by Subject|1|||
33592676|NCT02230527|62991247|FG000|Overall Study|Death|1|||
33592677|NCT02230527|62991248|FG001|Overall Study|Death|0|||
33592678|NCT02230527|62991247|FG000|Overall Study|Lost to Follow-up|2|||
33680545|NCT01412060|63136581|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
33592679|NCT02230527|62991248|FG001|Overall Study|Lost to Follow-up|1|||
33592680|NCT02230527|62991247|FG000|Overall Study|Other|1|||
33680546|NCT01412060|63136582|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
33592681|NCT02230527|62991248|FG001|Overall Study|Other|0|||
33592682|NCT02204319|62991254|FG000|Overall Study|Pregnancy|1|||
33592683|NCT02204319|62991254|FG000|Overall Study|Withdrawal by Subject|2|||
33592684|NCT02204007|62991261|FG000|Overall Study|Surgery Canceled|1|||
33592685|NCT02204007|62991262|FG001|Overall Study|Surgery Canceled|1|||
33592686|NCT02203851|62991268|FG000|Overall Study|Lost to Follow-up|4|||
33592687|NCT02203851|62991268|FG000|Overall Study|Withdrawal by Subject|6|||
33592688|NCT02203851|62991268|FG000|Overall Study|Other|1|||
33592689|NCT02228967|62991281|FG000|Overall Study|Lost to Follow-up|146|||
33592690|NCT02228967|62991282|FG001|Overall Study|Lost to Follow-up|142|||
33592691|NCT02228967|62991281|FG000|Overall Study|Withdrawal by Subject|13|||
33592692|NCT02228967|62991282|FG001|Overall Study|Withdrawal by Subject|18|||
33592693|NCT02227875|62991290|FG000|Overall Study|Protocol Violation|10|||
33592694|NCT02227875|62991291|FG001|Overall Study|Protocol Violation|7|||
33592695|NCT02227875|62991290|FG000|Overall Study|Other|1|||
33592696|NCT02227875|62991291|FG001|Overall Study|Other|3|||
33592697|NCT02227875|62991290|FG000|Overall Study|Physician Decision|1|||
33592698|NCT02227875|62991291|FG001|Overall Study|Physician Decision|0|||
33592699|NCT02227875|62991290|FG000|Overall Study|Adverse Event|3|||
33592700|NCT02227875|62991291|FG001|Overall Study|Adverse Event|0|||
33592701|NCT02227875|62991290|FG000|Overall Study|Withdrawal by Subject|12|||
33592702|NCT02227875|62991291|FG001|Overall Study|Withdrawal by Subject|13|||
33592703|NCT02227875|62991290|FG000|Overall Study|Lost to Follow-up|10|||
33592704|NCT02227875|62991291|FG001|Overall Study|Lost to Follow-up|10|||
33592705|NCT02203149|62991302|FG000|Part 1|Adverse Event|0|||
33592706|NCT02203149|62991303|FG001|Part 1|Adverse Event|1|||
33592707|NCT02203149|62991304|FG002|Part 1|Adverse Event|0|||
33592708|NCT02203149|62991305|FG003|Part 1|Adverse Event|0|||
33592709|NCT02203149|62991306|FG004|Part 1|Adverse Event|0|||
33592710|NCT02203149|62991302|FG000|Part 2|Death|0|||
33592711|NCT02203149|62991303|FG001|Part 2|Death|0|||
33592712|NCT02203149|62991304|FG002|Part 2|Death|1|||
33592713|NCT02203149|62991305|FG003|Part 2|Death|1|||
33592714|NCT02203149|62991306|FG004|Part 2|Death|0|||
33592715|NCT02203149|62991302|FG000|Part 2|Withdrawal by Subject|0|||
33592716|NCT02203149|62991303|FG001|Part 2|Withdrawal by Subject|0|||
33592717|NCT02203149|62991304|FG002|Part 2|Withdrawal by Subject|0|||
33592718|NCT02203149|62991305|FG003|Part 2|Withdrawal by Subject|1|||
33592719|NCT02203149|62991306|FG004|Part 2|Withdrawal by Subject|0|||
33680547|NCT01412060|63136580|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
33680548|NCT01412060|63136581|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
33592720|NCT02203149|62991302|FG000|Part 2|Adverse Event|0|||
33592721|NCT02203149|62991303|FG001|Part 2|Adverse Event|0|||
33592722|NCT02203149|62991304|FG002|Part 2|Adverse Event|0|||
33592723|NCT02203149|62991305|FG003|Part 2|Adverse Event|1|||
33592724|NCT02203149|62991306|FG004|Part 2|Adverse Event|1|||
33592725|NCT02203071|62991330|FG000|Overall Study|Lost to Follow-up|3|||
33592726|NCT02203071|62991331|FG001|Overall Study|Lost to Follow-up|1|||
33592727|NCT02202837|62991339|FG000|Overall Study|Enbrel treatment discontinued|36|||
33592728|NCT02202837|62991340|FG001|Overall Study|Enbrel treatment discontinued|4|||
33592729|NCT02202837|62991339|FG000|Overall Study|Other|10|||
33592730|NCT02202837|62991340|FG001|Overall Study|Other|0|||
33592731|NCT02202837|62991339|FG000|Overall Study|Lost to Follow-up|7|||
33592732|NCT02202837|62991340|FG001|Overall Study|Lost to Follow-up|1|||
33592733|NCT02202759|62991349|FG000|Overall Study|Study Terminated by Sponsor|3|||
33592734|NCT02202759|62991350|FG001|Overall Study|Study Terminated by Sponsor|3|||
33592735|NCT02202759|62991351|FG002|Overall Study|Study Terminated by Sponsor|3|||
33592736|NCT02202759|62991349|FG000|Overall Study|Withdrawal by Subject|2|||
33592737|NCT02202759|62991350|FG001|Overall Study|Withdrawal by Subject|1|||
33592738|NCT02202759|62991351|FG002|Overall Study|Withdrawal by Subject|1|||
33592739|NCT02202759|62991349|FG000|Overall Study|Reason not Specified|4|||
33592740|NCT02202759|62991350|FG001|Overall Study|Reason not Specified|11|||
33680549|NCT01412060|63136582|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
33680550|NCT01412060|63136580|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
33680551|NCT01412060|63136581|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
33680552|NCT01412060|63136582|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
33680553|NCT01412060|63136580|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
33680554|NCT01412060|63136581|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
33680555|NCT01412060|63136582|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
33680556|NCT01412060|63136580|FG000|Period Between SP and DBP|Protocol Violation|2|||
33592741|NCT02202759|62991351|FG002|Overall Study|Reason not Specified|10|||
33592742|NCT02226549|62991360|FG000|Overall Study|Randomized but Never Treated|1|||
33592743|NCT02226549|62991361|FG001|Overall Study|Randomized but Never Treated|0|||
33592744|NCT02226549|62991360|FG000|Overall Study|Lost to Follow-up|0|||
33592745|NCT02226549|62991361|FG001|Overall Study|Lost to Follow-up|1|||
33592746|NCT02226003|62991370|FG000|Overall Study|Lost to Follow-up|2|||
33680557|NCT01412060|63136581|FG001|Period Between SP and DBP|Protocol Violation|0|||
33592747|NCT02226003|62991371|FG001|Overall Study|Lost to Follow-up|1|||
33592748|NCT02226003|62991372|FG002|Overall Study|Lost to Follow-up|3|||
33592749|NCT02226003|62991370|FG000|Overall Study|Withdrawal by Subject|0|||
33592750|NCT02226003|62991371|FG001|Overall Study|Withdrawal by Subject|0|||
33592751|NCT02226003|62991372|FG002|Overall Study|Withdrawal by Subject|3|||
33592752|NCT02225223|62991382|FG000|Overall Study|Death|10|||
33592753|NCT02225223|62991383|FG001|Overall Study|Death|1|||
33592754|NCT02225223|62991382|FG000|Overall Study|Lost to Follow-up|5|||
33592755|NCT02225223|62991383|FG001|Overall Study|Lost to Follow-up|0|||
33592756|NCT02225223|62991382|FG000|Overall Study|Other|1|||
33592757|NCT02225223|62991383|FG001|Overall Study|Other|2|||
33592758|NCT02225223|62991382|FG000|Overall Study|Physician Decision|1|||
33592759|NCT02225223|62991383|FG001|Overall Study|Physician Decision|0|||
33592760|NCT02225223|62991382|FG000|Overall Study|Withdrawal by Subject|2|||
33592761|NCT02225223|62991383|FG001|Overall Study|Withdrawal by Subject|2|||
33592762|NCT01634139|62991392|FG000|Overall Study|Non compliant with protocol|1|||
33592763|NCT01634139|62991393|FG001|Overall Study|Non compliant with protocol|0|||
33592764|NCT01634139|62991394|FG002|Overall Study|Non compliant with protocol|0|||
33592765|NCT01634139|62991392|FG000|Overall Study|Consent withdrawn not due to AE|4|||
33592766|NCT01634139|62991393|FG001|Overall Study|Consent withdrawn not due to AE|3|||
33592767|NCT01634139|62991394|FG002|Overall Study|Consent withdrawn not due to AE|2|||
33592768|NCT01634139|62991392|FG000|Overall Study|Other|4|||
33592769|NCT01634139|62991393|FG001|Overall Study|Other|0|||
33592770|NCT01634139|62991394|FG002|Overall Study|Other|3|||
33592771|NCT01634139|62991392|FG000|Overall Study|Lost to Follow-up|0|||
33592772|NCT01634139|62991393|FG001|Overall Study|Lost to Follow-up|2|||
33592773|NCT01634139|62991394|FG002|Overall Study|Lost to Follow-up|0|||
33592774|NCT01634139|62991392|FG000|Overall Study|Not treated|1|||
33592775|NCT01634139|62991393|FG001|Overall Study|Not treated|1|||
33592776|NCT01634139|62991394|FG002|Overall Study|Not treated|0|||
33592777|NCT02224755|62991404|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
33592778|NCT02224755|62991405|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
33592779|NCT02224755|62991404|FG000|Two Year Follow up Post-implant|Death|103|||
33592780|NCT02224755|62991405|FG001|Two Year Follow up Post-implant|Death|98|||
33592781|NCT02224755|62991404|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
33592782|NCT02224755|62991405|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
33592783|NCT02224755|62991404|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
33592784|NCT02224755|62991405|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
33592785|NCT02224755|62991404|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
33592786|NCT02224755|62991405|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
33592787|NCT02404441|62991425|FG000|Phase 1 Part|Adverse Event|1|||
33592788|NCT02404441|62991426|FG001|Phase 1 Part|Adverse Event|0|||
33592789|NCT02404441|62991427|FG002|Phase 1 Part|Adverse Event|0|||
33592790|NCT02404441|62991428|FG003|Phase 1 Part|Adverse Event|0|||
33592791|NCT02404441|62991429|FG004|Phase 1 Part|Adverse Event|0|||
33592792|NCT02404441|62991430|FG005|Phase 1 Part|Adverse Event|0|||
33592793|NCT02404441|62991431|FG006|Phase 1 Part|Adverse Event|0|||
33592794|NCT02404441|62991432|FG007|Phase 1 Part|Adverse Event|0|||
33592795|NCT02404441|62991433|FG008|Phase 1 Part|Adverse Event|0|||
33592796|NCT02404441|62991434|FG009|Phase 1 Part|Adverse Event|0|||
33592797|NCT02404441|62991425|FG000|Phase 1 Part|Physician Decision|0|||
33592798|NCT02404441|62991426|FG001|Phase 1 Part|Physician Decision|1|||
33592799|NCT02404441|62991427|FG002|Phase 1 Part|Physician Decision|0|||
33592800|NCT02404441|62991428|FG003|Phase 1 Part|Physician Decision|0|||
33592801|NCT02404441|62991429|FG004|Phase 1 Part|Physician Decision|0|||
33680558|NCT01412060|63136582|FG002|Period Between SP and DBP|Protocol Violation|0|||
33680559|NCT01412060|63136580|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
33680560|NCT01412060|63136581|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
33680561|NCT01412060|63136582|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
33680562|NCT01412060|63136580|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
33592802|NCT02404441|62991430|FG005|Phase 1 Part|Physician Decision|0|||
33592803|NCT02404441|62991431|FG006|Phase 1 Part|Physician Decision|0|||
33592804|NCT02404441|62991432|FG007|Phase 1 Part|Physician Decision|0|||
33592805|NCT02404441|62991433|FG008|Phase 1 Part|Physician Decision|0|||
33592806|NCT02404441|62991434|FG009|Phase 1 Part|Physician Decision|0|||
33592807|NCT02404441|62991425|FG000|Phase 1 Part|Progressive Disease|14|||
33592808|NCT02404441|62991426|FG001|Phase 1 Part|Progressive Disease|11|||
33592809|NCT02404441|62991427|FG002|Phase 1 Part|Progressive Disease|7|||
33592810|NCT02404441|62991428|FG003|Phase 1 Part|Progressive Disease|6|||
33592811|NCT02404441|62991429|FG004|Phase 1 Part|Progressive Disease|9|||
33592812|NCT02404441|62991430|FG005|Phase 1 Part|Progressive Disease|0|||
33592813|NCT02404441|62991431|FG006|Phase 1 Part|Progressive Disease|0|||
33592814|NCT02404441|62991432|FG007|Phase 1 Part|Progressive Disease|0|||
33592815|NCT02404441|62991433|FG008|Phase 1 Part|Progressive Disease|0|||
33592816|NCT02404441|62991434|FG009|Phase 1 Part|Progressive Disease|0|||
33592817|NCT02404441|62991425|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
33592818|NCT02404441|62991426|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
33592819|NCT02404441|62991427|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
33592820|NCT02404441|62991428|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
33592821|NCT02404441|62991429|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
33592822|NCT02404441|62991430|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
33592823|NCT02404441|62991431|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
33592824|NCT02404441|62991432|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
33592825|NCT02404441|62991433|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
33592826|NCT02404441|62991434|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
33493075|NCT03145766|62871124|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
33493076|NCT03145766|62871125|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
33493077|NCT03145766|62871121|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
33592827|NCT02404441|62991425|FG000|Phase 1 Part|Death|1|||
33592828|NCT02404441|62991426|FG001|Phase 1 Part|Death|1|||
33592829|NCT02404441|62991427|FG002|Phase 1 Part|Death|1|||
33592830|NCT02404441|62991428|FG003|Phase 1 Part|Death|0|||
33592831|NCT02404441|62991429|FG004|Phase 1 Part|Death|1|||
33592832|NCT02404441|62991430|FG005|Phase 1 Part|Death|0|||
33592833|NCT02404441|62991431|FG006|Phase 1 Part|Death|0|||
33592834|NCT02404441|62991432|FG007|Phase 1 Part|Death|0|||
33592835|NCT02404441|62991433|FG008|Phase 1 Part|Death|0|||
33592836|NCT02404441|62991434|FG009|Phase 1 Part|Death|0|||
33592837|NCT02404441|62991425|FG000|Phase 2 Part|Adverse Event|0|||
33592838|NCT02404441|62991426|FG001|Phase 2 Part|Adverse Event|0|||
33592839|NCT02404441|62991427|FG002|Phase 2 Part|Adverse Event|0|||
33592840|NCT02404441|62991428|FG003|Phase 2 Part|Adverse Event|0|||
33592841|NCT02404441|62991429|FG004|Phase 2 Part|Adverse Event|0|||
33592842|NCT02404441|62991430|FG005|Phase 2 Part|Adverse Event|2|||
33592843|NCT02404441|62991431|FG006|Phase 2 Part|Adverse Event|3|||
33592844|NCT02404441|62991432|FG007|Phase 2 Part|Adverse Event|3|||
33592845|NCT02404441|62991433|FG008|Phase 2 Part|Adverse Event|6|||
33592846|NCT02404441|62991434|FG009|Phase 2 Part|Adverse Event|1|||
33592847|NCT02404441|62991425|FG000|Phase 2 Part|Physician Decision|0|||
33592848|NCT02404441|62991426|FG001|Phase 2 Part|Physician Decision|0|||
33592849|NCT02404441|62991427|FG002|Phase 2 Part|Physician Decision|0|||
33592850|NCT02404441|62991428|FG003|Phase 2 Part|Physician Decision|0|||
33592851|NCT02404441|62991429|FG004|Phase 2 Part|Physician Decision|0|||
33592852|NCT02404441|62991430|FG005|Phase 2 Part|Physician Decision|7|||
33592853|NCT02404441|62991431|FG006|Phase 2 Part|Physician Decision|9|||
33592854|NCT02404441|62991432|FG007|Phase 2 Part|Physician Decision|2|||
33592855|NCT02404441|62991433|FG008|Phase 2 Part|Physician Decision|1|||
33592856|NCT02404441|62991434|FG009|Phase 2 Part|Physician Decision|3|||
33592857|NCT02404441|62991425|FG000|Phase 2 Part|Progressive disease|0|||
33592858|NCT02404441|62991426|FG001|Phase 2 Part|Progressive disease|0|||
33592859|NCT02404441|62991427|FG002|Phase 2 Part|Progressive disease|0|||
33592860|NCT02404441|62991428|FG003|Phase 2 Part|Progressive disease|0|||
33592861|NCT02404441|62991429|FG004|Phase 2 Part|Progressive disease|0|||
33592862|NCT02404441|62991430|FG005|Phase 2 Part|Progressive disease|43|||
33592863|NCT02404441|62991431|FG006|Phase 2 Part|Progressive disease|32|||
33592864|NCT02404441|62991432|FG007|Phase 2 Part|Progressive disease|31|||
33592865|NCT02404441|62991433|FG008|Phase 2 Part|Progressive disease|39|||
33592866|NCT02404441|62991434|FG009|Phase 2 Part|Progressive disease|27|||
33592867|NCT02404441|62991425|FG000|Phase 2 Part|Subject/guardian decision|0|||
33592868|NCT02404441|62991426|FG001|Phase 2 Part|Subject/guardian decision|0|||
33592869|NCT02404441|62991427|FG002|Phase 2 Part|Subject/guardian decision|0|||
33592870|NCT02404441|62991428|FG003|Phase 2 Part|Subject/guardian decision|0|||
33680563|NCT01412060|63136581|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
33680564|NCT01412060|63136582|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
33493078|NCT03145766|62871122|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
33493079|NCT03145766|62871123|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
33493080|NCT03145766|62871124|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
33493081|NCT03145766|62871125|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
33592871|NCT02404441|62991429|FG004|Phase 2 Part|Subject/guardian decision|0|||
33592872|NCT02404441|62991430|FG005|Phase 2 Part|Subject/guardian decision|3|||
33592873|NCT02404441|62991431|FG006|Phase 2 Part|Subject/guardian decision|9|||
33592874|NCT02404441|62991432|FG007|Phase 2 Part|Subject/guardian decision|0|||
33592875|NCT02404441|62991433|FG008|Phase 2 Part|Subject/guardian decision|3|||
33592876|NCT02404441|62991434|FG009|Phase 2 Part|Subject/guardian decision|2|||
33592877|NCT02404441|62991425|FG000|Phase 2 Part|Death|0|||
33592878|NCT02404441|62991426|FG001|Phase 2 Part|Death|0|||
33592879|NCT02404441|62991427|FG002|Phase 2 Part|Death|0|||
33592880|NCT02404441|62991428|FG003|Phase 2 Part|Death|0|||
33592881|NCT02404441|62991429|FG004|Phase 2 Part|Death|0|||
33592882|NCT02404441|62991430|FG005|Phase 2 Part|Death|4|||
33592883|NCT02404441|62991431|FG006|Phase 2 Part|Death|8|||
33592884|NCT02404441|62991432|FG007|Phase 2 Part|Death|4|||
33592885|NCT02404441|62991433|FG008|Phase 2 Part|Death|10|||
33592886|NCT02404441|62991434|FG009|Phase 2 Part|Death|9|||
33592887|NCT02101281|62991480|FG000|Overall Study|Adverse Event|0|||
33592888|NCT02101281|62991481|FG001|Overall Study|Adverse Event|1|||
33592889|NCT02224599|62991493|FG000|Overall Study|Physician Decision|1|||
33592890|NCT02224599|62991493|FG000|Overall Study|Progression of Disease|1|||
33592891|NCT02201901|62991500|FG000|Overall Study|Randomized but never treated|0|||
33592892|NCT02201901|62991501|FG001|Overall Study|Randomized but never treated|1|||
33592893|NCT02201901|62991502|FG002|Overall Study|Randomized but never treated|0|||
33592894|NCT02201901|62991500|FG000|Overall Study|Lack of Efficacy|7|||
33592895|NCT02201901|62991501|FG001|Overall Study|Lack of Efficacy|1|||
33592896|NCT02201901|62991502|FG002|Overall Study|Lack of Efficacy|6|||
33592897|NCT02201901|62991500|FG000|Overall Study|Death|3|||
33592898|NCT02201901|62991501|FG001|Overall Study|Death|3|||
33592899|NCT02201901|62991502|FG002|Overall Study|Death|3|||
33592900|NCT02201901|62991500|FG000|Overall Study|Lost to Follow-up|2|||
33592901|NCT02201901|62991501|FG001|Overall Study|Lost to Follow-up|3|||
33592902|NCT02201901|62991502|FG002|Overall Study|Lost to Follow-up|2|||
33592903|NCT02201901|62991500|FG000|Overall Study|Withdrew Consent|2|||
33592904|NCT02201901|62991501|FG001|Overall Study|Withdrew Consent|0|||
33592905|NCT02201901|62991502|FG002|Overall Study|Withdrew Consent|2|||
33592906|NCT02201901|62991500|FG000|Overall Study|Adverse Event|1|||
33592907|NCT02201901|62991501|FG001|Overall Study|Adverse Event|1|||
33592908|NCT02201901|62991502|FG002|Overall Study|Adverse Event|0|||
33592909|NCT02201277|62991513|FG000|Overall Study|Death|3|||
33592910|NCT02201277|62991514|FG001|Overall Study|Death|4|||
33592911|NCT02201277|62991513|FG000|Overall Study|Lost to Follow-up|2|||
33592912|NCT02201277|62991514|FG001|Overall Study|Lost to Follow-up|1|||
33592913|NCT02201277|62991513|FG000|Overall Study|Failed retrieval|1|||
33592914|NCT02201277|62991514|FG001|Overall Study|Failed retrieval|0|||
33592915|NCT02201277|62991513|FG000|Overall Study|Physician Decision|1|||
33592916|NCT02201277|62991514|FG001|Overall Study|Physician Decision|0|||
33592917|NCT02224053|62991524|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
33592918|NCT02224053|62991524|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
33592919|NCT02224053|62991524|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
33592920|NCT02224053|62991524|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
33592921|NCT02224053|62991524|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
33592922|NCT02457793|62991536|FG000|Overall Study|Reason not specified|0|||
33592923|NCT02457793|62991537|FG001|Overall Study|Reason not specified|0|||
33592924|NCT02457793|62991538|FG002|Overall Study|Reason not specified|0|||
33592925|NCT02457793|62991539|FG003|Overall Study|Reason not specified|1|||
33592926|NCT02457793|62991540|FG004|Overall Study|Reason not specified|1|||
33592927|NCT02457793|62991541|FG005|Overall Study|Reason not specified|1|||
33592928|NCT02457793|62991536|FG000|Overall Study|Withdrawal by Subject|0|||
33592929|NCT02457793|62991537|FG001|Overall Study|Withdrawal by Subject|4|||
33592930|NCT02457793|62991538|FG002|Overall Study|Withdrawal by Subject|2|||
33592931|NCT02457793|62991539|FG003|Overall Study|Withdrawal by Subject|2|||
33592932|NCT02457793|62991540|FG004|Overall Study|Withdrawal by Subject|2|||
33592933|NCT02457793|62991541|FG005|Overall Study|Withdrawal by Subject|2|||
33592934|NCT02457793|62991536|FG000|Overall Study|Adverse Event|0|||
33592935|NCT02457793|62991537|FG001|Overall Study|Adverse Event|0|||
33592936|NCT02457793|62991538|FG002|Overall Study|Adverse Event|0|||
33592937|NCT02457793|62991539|FG003|Overall Study|Adverse Event|1|||
33592938|NCT02457793|62991540|FG004|Overall Study|Adverse Event|0|||
33592939|NCT02457793|62991541|FG005|Overall Study|Adverse Event|0|||
33592940|NCT02457793|62991536|FG000|Overall Study|Physician Decision|1|||
33592941|NCT02457793|62991537|FG001|Overall Study|Physician Decision|0|||
33592942|NCT02457793|62991538|FG002|Overall Study|Physician Decision|1|||
33592943|NCT02457793|62991539|FG003|Overall Study|Physician Decision|1|||
33592944|NCT02457793|62991540|FG004|Overall Study|Physician Decision|1|||
33592945|NCT02457793|62991541|FG005|Overall Study|Physician Decision|3|||
33592946|NCT01650259|62991558|FG000|Overall Study|Improvement|105|||
33680565|NCT01412060|63136580|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
33592947|NCT01650259|62991559|FG001|Overall Study|Improvement|0|||
33592948|NCT01650259|62991558|FG000|Overall Study|Adverse Event|127|||
33592949|NCT01650259|62991559|FG001|Overall Study|Adverse Event|0|||
33592950|NCT01650259|62991558|FG000|Overall Study|Lack of Efficacy|143|||
33592951|NCT01650259|62991559|FG001|Overall Study|Lack of Efficacy|0|||
33592952|NCT01650259|62991558|FG000|Overall Study|Lost to Follow-up|435|||
33592953|NCT01650259|62991559|FG001|Overall Study|Lost to Follow-up|0|||
33592954|NCT01650259|62991558|FG000|Overall Study|Patients had no visit after entry|70|||
33401431|NCT00256867|62780478|FG004|Overall Study|Adverse Event|2|||
33592955|NCT01650259|62991559|FG001|Overall Study|Patients had no visit after entry|0|||
33592956|NCT01650259|62991558|FG000|Overall Study|CRF not collected|98|||
33592957|NCT01650259|62991559|FG001|Overall Study|CRF not collected|82|||
33592958|NCT01650259|62991558|FG000|Overall Study|Not treated|1|||
33592959|NCT01650259|62991559|FG001|Overall Study|Not treated|7|||
33592960|NCT01650259|62991558|FG000|Overall Study|Other than listed|64|||
33592961|NCT01650259|62991559|FG001|Overall Study|Other than listed|146|||
33592962|NCT02434939|62991565|FG000|Overall Study|Lack of Efficacy|34|||
33592963|NCT02434939|62991566|FG001|Overall Study|Lack of Efficacy|48|||
33592964|NCT02434939|62991565|FG000|Overall Study|Withdrawal by Subject|3|||
33592965|NCT02434939|62991566|FG001|Overall Study|Withdrawal by Subject|0|||
33592966|NCT02434939|62991565|FG000|Overall Study|Adverse Event|0|||
33592967|NCT02434939|62991566|FG001|Overall Study|Adverse Event|1|||
33592968|NCT02434471|62991573|FG000|Overall Study|Physician Decision|9|||
33592969|NCT02457637|62991578|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
33592970|NCT02457325|62991585|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
33592971|NCT02457325|62991586|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
33592972|NCT02434081|62991592|FG000|Overall Study|Death (never started treatment)|2|||
33592973|NCT02434081|62991592|FG000|Overall Study|Death|2|||
33592974|NCT02434081|62991592|FG000|Overall Study|Progression|20|||
33592975|NCT02434081|62991592|FG000|Overall Study|Adverse Event|20|||
33592976|NCT02434081|62991592|FG000|Overall Study|Physician Decision|2|||
33592977|NCT02434081|62991592|FG000|Overall Study|Withdrawal by Subject|1|||
33592978|NCT02434081|62991592|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
33592979|NCT02222493|62991598|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
33592980|NCT02222493|62991599|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
33592981|NCT02222493|62991598|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
33592982|NCT02222493|62991599|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
33592983|NCT02222493|62991598|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
33592984|NCT02222493|62991599|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
33592985|NCT02222493|62991598|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
33592986|NCT02222493|62991599|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
33592987|NCT02222493|62991598|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
33592988|NCT02222493|62991599|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
33592989|NCT02222493|62991598|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
33592990|NCT02222493|62991599|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
33592991|NCT02222493|62991598|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
33592992|NCT02222493|62991599|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
33592993|NCT02222493|62991598|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
33592994|NCT02222493|62991599|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
33592995|NCT02222493|62991598|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
33592996|NCT02222493|62991599|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
33592997|NCT02222493|62991598|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
33592998|NCT02222493|62991599|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
33592999|NCT02222493|62991598|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
33593000|NCT02222493|62991599|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
33593001|NCT02222493|62991598|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
33593002|NCT02222493|62991599|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
33593003|NCT02222493|62991598|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
33593004|NCT02222493|62991599|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
33593005|NCT02222493|62991598|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
33593006|NCT02222493|62991599|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
33593007|NCT02222493|62991598|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
33593008|NCT02222493|62991599|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
33593009|NCT02222493|62991598|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
33593010|NCT02222493|62991599|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
33593011|NCT02222493|62991598|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
33593012|NCT02222493|62991599|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
33593013|NCT02222493|62991598|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
33593014|NCT02222493|62991599|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
33593015|NCT02222493|62991598|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
33593016|NCT02222493|62991599|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
33593017|NCT02222493|62991598|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
33593018|NCT02222493|62991599|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
33593019|NCT02222493|62991598|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
33593020|NCT02222493|62991599|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
33593021|NCT02222493|62991598|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
33593022|NCT02222493|62991599|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
33593023|NCT02433379|62991618|FG000|Overall Study|Screen Failures|55|||
33593024|NCT02433379|62991618|FG000|Overall Study|Death|57|||
33593025|NCT02433379|62991618|FG000|Overall Study|Total Withdrawals|209|||
33593026|NCT02199795|62991626|FG000|Overall Study|no longer met inclusion criteria|1|||
33593027|NCT02199795|62991627|FG001|Overall Study|no longer met inclusion criteria|0|||
33593028|NCT02199795|62991626|FG000|Overall Study|withdrew due to shoulder pain|1|||
33593029|NCT02199795|62991627|FG001|Overall Study|withdrew due to shoulder pain|0|||
33593030|NCT02403817|62991635|FG000|Overall Study|Withdrawal by Subject|5|||
33593031|NCT02403817|62991636|FG001|Overall Study|Withdrawal by Subject|0|||
33593032|NCT02403271|62991642|FG000|Period 1|Other varied reasons|1|||
33593033|NCT02403271|62991643|FG001|Period 1|Other varied reasons|0|||
33593034|NCT02403271|62991642|FG000|Period 2|Withdrawal by Subject|0|||
33593035|NCT02403271|62991643|FG001|Period 2|Withdrawal by Subject|14|||
33593036|NCT02403271|62991642|FG000|Period 2|Death|0|||
33593037|NCT02403271|62991643|FG001|Period 2|Death|84|||
33593038|NCT02403271|62991642|FG000|Period 2|Lost to Follow-up|0|||
33593039|NCT02403271|62991643|FG001|Period 2|Lost to Follow-up|2|||
33593040|NCT02403271|62991642|FG000|Period 2|Study Terminated by Sponsor|0|||
33593041|NCT02403271|62991643|FG001|Period 2|Study Terminated by Sponsor|14|||
33593042|NCT02403271|62991642|FG000|Period 2|Other varied reasons|0|||
33593043|NCT02403271|62991643|FG001|Period 2|Other varied reasons|10|||
33593044|NCT02219685|62991651|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
33593045|NCT02219685|62991652|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
33593046|NCT02219685|62991651|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
33593047|NCT02219685|62991652|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
33593048|NCT02457247|62991664|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
33593049|NCT02457247|62991665|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
33593050|NCT02457247|62991666|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
33593051|NCT02457247|62991667|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
33593052|NCT02457247|62991664|FG000|Period 1|Significant Protocol Deviation|1|||
33593053|NCT02457247|62991665|FG001|Period 1|Significant Protocol Deviation|1|||
33593054|NCT02457247|62991666|FG002|Period 1|Significant Protocol Deviation|0|||
33593055|NCT02457247|62991667|FG003|Period 1|Significant Protocol Deviation|0|||
33593056|NCT02457247|62991664|FG000|Period 1|Voluntary Withdrawal|1|||
33593057|NCT02457247|62991665|FG001|Period 1|Voluntary Withdrawal|0|||
33593058|NCT02457247|62991666|FG002|Period 1|Voluntary Withdrawal|0|||
33593059|NCT02457247|62991667|FG003|Period 1|Voluntary Withdrawal|0|||
33593060|NCT02457247|62991664|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
33593061|NCT02457247|62991665|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
33593062|NCT02457247|62991666|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
33593063|NCT02457247|62991667|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
33593064|NCT02457247|62991664|FG000|Period 2|Significant Protocol Deviation|1|||
33593065|NCT02457247|62991665|FG001|Period 2|Significant Protocol Deviation|0|||
33593066|NCT02457247|62991666|FG002|Period 2|Significant Protocol Deviation|0|||
33593067|NCT02457247|62991667|FG003|Period 2|Significant Protocol Deviation|0|||
33593068|NCT02457247|62991664|FG000|Period 2|Lost to Follow-up|0|||
33593069|NCT02457247|62991665|FG001|Period 2|Lost to Follow-up|1|||
33593070|NCT02457247|62991666|FG002|Period 2|Lost to Follow-up|0|||
33593071|NCT02457247|62991667|FG003|Period 2|Lost to Follow-up|0|||
33593072|NCT02457247|62991664|FG000|Period 2|Voluntary Withdrawal|1|||
33593073|NCT02457247|62991665|FG001|Period 2|Voluntary Withdrawal|1|||
33593074|NCT02457247|62991666|FG002|Period 2|Voluntary Withdrawal|0|||
33593075|NCT02457247|62991667|FG003|Period 2|Voluntary Withdrawal|0|||
33593076|NCT02401867|62991683|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
33593077|NCT02401867|62991683|FG000|Analysis|Cervical assay could not be conducted|9|||
33593078|NCT02198235|62991691|FG000|Overall Study|Lost to Follow-up|3|||
33593079|NCT02198235|62991692|FG001|Overall Study|Lost to Follow-up|2|||
33593080|NCT02198235|62991693|FG002|Overall Study|Lost to Follow-up|2|||
33593081|NCT02253147|62991701|FG000|Overall Study|Protocol Violation|30|||
33593082|NCT02253147|62991701|FG000|Overall Study|Did not consent to study extension|9|||
33593083|NCT02253147|62991701|FG000|Overall Study|Conditional re-treatment at W52|5|||
33593084|NCT02253147|62991701|FG000|Overall Study|Lost to Follow-up|2|||
33593085|NCT02253147|62991701|FG000|Overall Study|Withdrawal by Subject|1|||
33593086|NCT02217501|62991709|FG000|Overall Study|Death|3|||
33593087|NCT02217501|62991710|FG001|Overall Study|Death|4|||
33593088|NCT01649869|62991718|FG000|Overall Study|Family member illness|1|||
33593089|NCT01649869|62991719|FG001|Overall Study|Family member illness|0|||
33593090|NCT01649869|62991718|FG000|Overall Study|Required treatment outside protocol|1|||
33593091|NCT01649869|62991719|FG001|Overall Study|Required treatment outside protocol|0|||
33593092|NCT01649869|62991718|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
33593093|NCT01649869|62991719|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
33593094|NCT02197377|62991729|FG000|Overall Study|Insertion Failure|0|||
33593095|NCT02197377|62991730|FG001|Overall Study|Insertion Failure|3|||
33593096|NCT02400307|62991738|FG000|Overall Study|Enrolled and Never Dosed|1|||
33593097|NCT02400307|62991739|FG001|Overall Study|Enrolled and Never Dosed|0|||
33593098|NCT02196675|62991748|FG000|Overall Study|Withdrawal by Subject|1|||
33593099|NCT02196675|62991749|FG001|Overall Study|Withdrawal by Subject|0|||
33593100|NCT02196675|62991750|FG002|Overall Study|Withdrawal by Subject|0|||
33593101|NCT02196675|62991748|FG000|Overall Study|Intra-operative surgical exclusion|1|||
33593102|NCT02196675|62991749|FG001|Overall Study|Intra-operative surgical exclusion|1|||
33593103|NCT02196675|62991750|FG002|Overall Study|Intra-operative surgical exclusion|0|||
33593104|NCT02196675|62991748|FG000|Overall Study|Protocol Violation|0|||
33593105|NCT02196675|62991749|FG001|Overall Study|Protocol Violation|1|||
33593106|NCT02196675|62991750|FG002|Overall Study|Protocol Violation|0|||
33593107|NCT02196675|62991748|FG000|Overall Study|Death|0|||
33593108|NCT02196675|62991749|FG001|Overall Study|Death|0|||
33593109|NCT02196675|62991750|FG002|Overall Study|Death|1|||
33593110|NCT02399449|62991760|FG000|Overall Study|Withdrawal by Subject|3|||
33593111|NCT02399449|62991761|FG001|Overall Study|Withdrawal by Subject|9|||
33593112|NCT02399449|62991760|FG000|Overall Study|Physician Decision|0|||
33593113|NCT02399449|62991761|FG001|Overall Study|Physician Decision|1|||
33593114|NCT02217345|62991769|FG000|Overall Study|Lost to Follow-up|2|||
33593115|NCT02217345|62991770|FG001|Overall Study|Lost to Follow-up|1|||
33593116|NCT02217345|62991769|FG000|Overall Study|Withdrawal by Subject|3|||
33593117|NCT02217345|62991770|FG001|Overall Study|Withdrawal by Subject|2|||
33593118|NCT02217345|62991769|FG000|Overall Study|Adverse Event|2|||
33593119|NCT02217345|62991770|FG001|Overall Study|Adverse Event|1|||
33593120|NCT02217345|62991769|FG000|Overall Study|Physician Decision|0|||
33593121|NCT02217345|62991770|FG001|Overall Study|Physician Decision|1|||
33593122|NCT01652287|62991778|FG000|Overall Study|Withdrawal by Subject|2|||
33593123|NCT01652287|62991779|FG001|Overall Study|Withdrawal by Subject|0|||
33593124|NCT02251743|62991787|FG000|Overall Study|Withdrawal by Subject|1|||
33593125|NCT02251743|62991788|FG001|Overall Study|Withdrawal by Subject|1|||
33593126|NCT02428855|62991794|FG000|Overall Study|Withdrawal by Subject|2|||
33593127|NCT02428699|62991798|FG000|Washout Period 1|Screen Failure|1|||
33593128|NCT02428699|62991799|FG001|Washout Period 1|Screen Failure|2|||
33593129|NCT02428231|62991812|FG000|Overall Study|Other|10|||
33593130|NCT02428231|62991813|FG001|Overall Study|Other|16|||
33593131|NCT02428231|62991812|FG000|Overall Study|Required Symptomatic Therapy|0|||
33593132|NCT02428231|62991813|FG001|Overall Study|Required Symptomatic Therapy|1|||
33593133|NCT02428231|62991812|FG000|Overall Study|Adverse Event|3|||
33593134|NCT02428231|62991813|FG001|Overall Study|Adverse Event|0|||
33593135|NCT02397889|62991821|FG000|Overall Study|Physician Decision|1|||
33593136|NCT02397889|62991822|FG001|Overall Study|Physician Decision|0|||
33593137|NCT02397655|62991828|FG000|Overall Study|data not completed|1301|||
33593138|NCT02396953|62991835|FG000|Overall Study|Withdrawal by Subject|0|||
33593139|NCT02396953|62991836|FG001|Overall Study|Withdrawal by Subject|0|||
33593140|NCT02396953|62991837|FG002|Overall Study|Withdrawal by Subject|1|||
33593141|NCT02396953|62991835|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
33593142|NCT02396953|62991836|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
33593143|NCT02396953|62991837|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
33593144|NCT02396953|62991835|FG000|Overall Study|Personal Reasons|1|||
33593145|NCT02396953|62991836|FG001|Overall Study|Personal Reasons|1|||
33593146|NCT02396953|62991837|FG002|Overall Study|Personal Reasons|0|||
33593147|NCT02387983|62991852|FG000|Overall Study|Adverse Event|4|||
33593148|NCT02387983|62991852|FG000|Overall Study|Protocol Violation|1|||
33593149|NCT02387983|62991852|FG000|Overall Study|Withdrawal by Subject|2|||
33593150|NCT02395627|62991859|FG000|Overall Study|Withdrawal by Subject|0|||
33593151|NCT02395627|62991860|FG001|Overall Study|Withdrawal by Subject|2|||
33593152|NCT02395627|62991861|FG002|Overall Study|Withdrawal by Subject|0|||
33593153|NCT02395627|62991859|FG000|Overall Study|Did not receive pembrolizumab|3|||
33593154|NCT02395627|62991860|FG001|Overall Study|Did not receive pembrolizumab|1|||
33593155|NCT02395627|62991861|FG002|Overall Study|Did not receive pembrolizumab|0|||
33593156|NCT02395471|62991873|FG000|Overall Study|Lost to Follow-up|2|||
33593157|NCT02395471|62991874|FG001|Overall Study|Lost to Follow-up|0|||
33593158|NCT02395471|62991873|FG000|Overall Study|Withdrawal by Subject|2|||
33593159|NCT02395471|62991874|FG001|Overall Study|Withdrawal by Subject|1|||
33593160|NCT02395471|62991873|FG000|Overall Study|Physician Decision|1|||
33593161|NCT02395471|62991874|FG001|Overall Study|Physician Decision|0|||
33593162|NCT02395471|62991873|FG000|Overall Study|Protocol Violation|0|||
33593163|NCT02395471|62991874|FG001|Overall Study|Protocol Violation|1|||
33593164|NCT02395471|62991873|FG000|Overall Study|Failure to swollow sponge twice|1|||
33593165|NCT02395471|62991874|FG001|Overall Study|Failure to swollow sponge twice|0|||
33593166|NCT02395471|62991873|FG000|Overall Study|Patient did not return for procedure|0|||
33593167|NCT02395471|62991874|FG001|Overall Study|Patient did not return for procedure|1|||
33593168|NCT02395471|62991873|FG000|Overall Study|Subject not eligible|1|||
33593169|NCT02395471|62991874|FG001|Overall Study|Subject not eligible|0|||
33593170|NCT02395081|62991892|FG000|Overall Study|Withdrawal by Subject|1|||
33593171|NCT02395081|62991893|FG001|Overall Study|Withdrawal by Subject|1|||
33593172|NCT02395081|62991894|FG002|Overall Study|Withdrawal by Subject|0|||
33651269|NCT01708915|63062676|FG003|Overall Study|Lack of Efficacy|15|||
33593173|NCT02395081|62991892|FG000|Overall Study|Moved where blood couldn't be collected|4|||
33593174|NCT02395081|62991893|FG001|Overall Study|Moved where blood couldn't be collected|1|||
33593175|NCT02395081|62991894|FG002|Overall Study|Moved where blood couldn't be collected|3|||
33593176|NCT02395081|62991892|FG000|Overall Study|Fetal Loss|2|||
33593177|NCT02395081|62991893|FG001|Overall Study|Fetal Loss|3|||
33593178|NCT02395081|62991894|FG002|Overall Study|Fetal Loss|1|||
33593179|NCT02394925|62991905|FG000|Overall Study|Adverse Event|1|||
33593180|NCT02394925|62991905|FG000|Overall Study|Lens Discomfort|3|||
33593181|NCT02394925|62991905|FG000|Overall Study|Lens handling difficulities|5|||
33593182|NCT02394925|62991905|FG000|Overall Study|Lost to Follow-up|9|||
33593183|NCT02394925|62991905|FG000|Overall Study|Protocol Violation|5|||
33593184|NCT02394925|62991905|FG000|Overall Study|No longer meet eligibility criteria|1|||
33593185|NCT02394925|62991905|FG000|Overall Study|Unsatisfactory Visual Response|5|||
33593186|NCT02427607|62991909|FG000|Overall Study|Withdrawal by Subject|1|||
33593187|NCT02425111|62991913|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
33593188|NCT02425111|62991913|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
33593189|NCT02425111|62991913|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
33593190|NCT02425111|62991913|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
33593191|NCT02425111|62991913|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
33593192|NCT02425111|62991913|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
33593193|NCT02424565|62991918|FG000|Period 1 (D0)|Protocol Violation|0|||
33593194|NCT02424565|62991919|FG001|Period 1 (D0)|Protocol Violation|1|||
33593195|NCT02424253|62991927|FG000|Overall Study|Other, unspecified|1|||
33593196|NCT02424253|62991928|FG001|Overall Study|Other, unspecified|0|||
33593197|NCT02424253|62991927|FG000|Overall Study|Compliance problems|1|||
33593198|NCT02424253|62991928|FG001|Overall Study|Compliance problems|0|||
33593199|NCT02424253|62991927|FG000|Overall Study|Physician Decision|2|||
33593200|NCT02424253|62991928|FG001|Overall Study|Physician Decision|0|||
33593201|NCT02424253|62991927|FG000|Overall Study|Lack of Efficacy|0|||
33593202|NCT02424253|62991928|FG001|Overall Study|Lack of Efficacy|7|||
33593203|NCT02424253|62991927|FG000|Overall Study|Adverse Event|2|||
33593204|NCT02424253|62991928|FG001|Overall Study|Adverse Event|0|||
33593205|NCT02424253|62991927|FG000|Overall Study|Consent withdrawn by subject|4|||
33593206|NCT02424253|62991928|FG001|Overall Study|Consent withdrawn by subject|1|||
33593207|NCT02424253|62991927|FG000|Overall Study|Lost to Follow-up|1|||
33593208|NCT02424253|62991928|FG001|Overall Study|Lost to Follow-up|1|||
33593209|NCT02393755|62991936|FG000|Overall Study|Withdrawal by Subject|0|||
33593210|NCT02393755|62991937|FG001|Overall Study|Withdrawal by Subject|3|||
33593211|NCT02393755|62991936|FG000|Overall Study|Adverse Event|0|||
33593212|NCT02393755|62991937|FG001|Overall Study|Adverse Event|2|||
33593213|NCT02393755|62991936|FG000|Overall Study|Physician Decision|0|||
33593214|NCT02393755|62991937|FG001|Overall Study|Physician Decision|2|||
33593215|NCT02393209|62991944|FG000|Overall Study|Study Terminated by Sponsor|1|||
33593216|NCT02393209|62991945|FG001|Overall Study|Study Terminated by Sponsor|1|||
33593217|NCT02393209|62991946|FG002|Overall Study|Study Terminated by Sponsor|0|||
33593218|NCT02393209|62991947|FG003|Overall Study|Study Terminated by Sponsor|0|||
33593219|NCT02393209|62991944|FG000|Overall Study|Withdrawal by Patient|1|||
33593220|NCT02393209|62991945|FG001|Overall Study|Withdrawal by Patient|0|||
33593221|NCT02393209|62991946|FG002|Overall Study|Withdrawal by Patient|0|||
33593222|NCT02393209|62991947|FG003|Overall Study|Withdrawal by Patient|0|||
33593223|NCT02393209|62991944|FG000|Overall Study|Death|2|||
33593224|NCT02393209|62991945|FG001|Overall Study|Death|2|||
33593225|NCT02393209|62991946|FG002|Overall Study|Death|0|||
33593226|NCT02393209|62991947|FG003|Overall Study|Death|0|||
33593227|NCT02393209|62991944|FG000|Overall Study|Death due to Disease Progression|2|||
33593228|NCT02393209|62991945|FG001|Overall Study|Death due to Disease Progression|2|||
33593229|NCT02393209|62991946|FG002|Overall Study|Death due to Disease Progression|0|||
33593230|NCT02393209|62991947|FG003|Overall Study|Death due to Disease Progression|0|||
33593231|NCT02393209|62991944|FG000|Overall Study|Death from Legionella Infection|0|||
33593232|NCT02393209|62991945|FG001|Overall Study|Death from Legionella Infection|1|||
33593233|NCT02393209|62991946|FG002|Overall Study|Death from Legionella Infection|0|||
33593234|NCT02393209|62991947|FG003|Overall Study|Death from Legionella Infection|0|||
33593235|NCT02393209|62991944|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
33593236|NCT02393209|62991945|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
33493082|NCT03145766|62871121|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
33593237|NCT02393209|62991946|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
33593238|NCT02393209|62991947|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
33593239|NCT02393209|62991944|FG000|Overall Study|Lost to Follow-up|0|||
33493083|NCT03145766|62871122|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
33593240|NCT02393209|62991945|FG001|Overall Study|Lost to Follow-up|1|||
33593241|NCT02393209|62991946|FG002|Overall Study|Lost to Follow-up|0|||
33593242|NCT02393209|62991947|FG003|Overall Study|Lost to Follow-up|0|||
33593243|NCT02424097|62991958|FG000|Overall Study|Lost to Follow-up|1|||
33593244|NCT02424097|62991959|FG001|Overall Study|Lost to Follow-up|2|||
33593245|NCT02392507|62991965|FG000|Induction Regimen|Death|3|||
33651270|NCT01708915|63062673|FG000|Overall Study|Protocol Violation|0|||
33593246|NCT02392507|62991965|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
33593247|NCT02392507|62991965|FG000|Induction Regimen|Physician Decision|1|||
33593248|NCT02392507|62991965|FG000|Induction Regimen|Withdrawal by Subject|2|||
33593249|NCT02392507|62991965|FG000|Maintenance Regimen|Death|1|||
33593250|NCT02392507|62991965|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
33593251|NCT02386345|62991974|FG000|Overall Study|Not treated|14|||
33593252|NCT02386345|62991974|FG000|Overall Study|Lost to Follow-up|1|||
33593253|NCT02386345|62991974|FG000|Overall Study|Adverse Event|5|||
33593254|NCT02386345|62991974|FG000|Overall Study|Repeat Procedure|10|||
33593255|NCT02386345|62991974|FG000|Overall Study|Did not complete 12-month follow-up|72|||
33593256|NCT01651117|62991982|FG000|Overall Study|Death|2|||
33593257|NCT01651117|62991983|FG001|Overall Study|Death|3|||
33593258|NCT01651117|62991984|FG002|Overall Study|Death|2|||
33593259|NCT01651117|62991985|FG003|Overall Study|Death|2|||
33593260|NCT02386189|62992000|FG000|Overall Study|Lost to Follow-up|2|||
33593261|NCT02386189|62992001|FG001|Overall Study|Lost to Follow-up|3|||
33593262|NCT02386189|62992000|FG000|Overall Study|Withdrawal by Subject|1|||
33593263|NCT02386189|62992001|FG001|Overall Study|Withdrawal by Subject|0|||
33593264|NCT02386189|62992000|FG000|Overall Study|Death|1|||
33593265|NCT02386189|62992001|FG001|Overall Study|Death|0|||
33593266|NCT02385799|62992009|FG000|Overall Study|Lost to Follow-up|1|||
33593267|NCT02385799|62992010|FG001|Overall Study|Lost to Follow-up|2|||
33593268|NCT02385799|62992009|FG000|Overall Study|Adverse Event|4|||
33593269|NCT02385799|62992010|FG001|Overall Study|Adverse Event|2|||
33593270|NCT02385799|62992009|FG000|Overall Study|Withdrawal by Subject|0|||
33593271|NCT02385799|62992010|FG001|Overall Study|Withdrawal by Subject|4|||
33593272|NCT02422303|62992018|FG000|Overall Study|Lost to Follow-up|1|||
33593273|NCT02422303|62992019|FG001|Overall Study|Lost to Follow-up|1|||
33593274|NCT02392195|62992025|FG000|Overall Study|Lost to Follow-up|4|||
33593275|NCT02392195|62992025|FG000|Overall Study|Withdrawal by Subject|4|||
33593276|NCT02391961|62992031|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
33593277|NCT02391961|62992032|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
33593278|NCT02391961|62992031|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
33593279|NCT02391961|62992032|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
33593280|NCT02391961|62992031|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
33593281|NCT02391961|62992032|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
33593282|NCT02384941|62992041|FG000|Overall Study|Adverse Event|11|||
33593283|NCT02384941|62992042|FG001|Overall Study|Adverse Event|13|||
33593284|NCT02384941|62992043|FG002|Overall Study|Adverse Event|17|||
33593285|NCT02384941|62992041|FG000|Overall Study|Lost to Follow-up|3|||
33593286|NCT02384941|62992042|FG001|Overall Study|Lost to Follow-up|2|||
33593287|NCT02384941|62992043|FG002|Overall Study|Lost to Follow-up|1|||
33593288|NCT02384941|62992041|FG000|Overall Study|Non-Compliance With Study Drug|2|||
33593289|NCT02384941|62992042|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33593290|NCT02384941|62992043|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33593291|NCT02384941|62992041|FG000|Overall Study|Physician Decision|1|||
33593292|NCT02384941|62992042|FG001|Overall Study|Physician Decision|1|||
33593293|NCT02384941|62992043|FG002|Overall Study|Physician Decision|0|||
33593294|NCT02384941|62992041|FG000|Overall Study|Protocol Violation|3|||
33593295|NCT02384941|62992042|FG001|Overall Study|Protocol Violation|0|||
33593296|NCT02384941|62992043|FG002|Overall Study|Protocol Violation|0|||
33593297|NCT02384941|62992041|FG000|Overall Study|Withdrawal by Subject|26|||
33593298|NCT02384941|62992042|FG001|Overall Study|Withdrawal by Subject|19|||
33593299|NCT02384941|62992043|FG002|Overall Study|Withdrawal by Subject|20|||
33593300|NCT02384941|62992041|FG000|Overall Study|Pregnancy|0|||
33593301|NCT02384941|62992042|FG001|Overall Study|Pregnancy|0|||
33593302|NCT02384941|62992043|FG002|Overall Study|Pregnancy|1|||
33593303|NCT02384941|62992041|FG000|Overall Study|Other than specified above|4|||
33593304|NCT02384941|62992042|FG001|Overall Study|Other than specified above|0|||
33593305|NCT02384941|62992043|FG002|Overall Study|Other than specified above|1|||
33593306|NCT02384395|62992052|FG000|Overall Study|Physician Decision|4|||
33593307|NCT02384395|62992052|FG000|Overall Study|Withdrawal by Subject|3|||
33593308|NCT02384395|62992052|FG000|Overall Study|Lost to Follow-up|3|||
33593309|NCT02420353|62992058|FG000|Overall Study|Withdrawal by Subject|0|||
33593310|NCT02420353|62992059|FG001|Overall Study|Withdrawal by Subject|1|||
33593311|NCT02391337|62992067|FG000|6 Months Follow-up|Death|5|||
33593312|NCT02391337|62992068|FG001|6 Months Follow-up|Death|4|||
33593313|NCT02391337|62992067|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
33593314|NCT02391337|62992068|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
33593315|NCT02391337|62992067|FG000|12 Months Follow-up|Death|2|||
33593316|NCT02391337|62992068|FG001|12 Months Follow-up|Death|0|||
33680566|NCT01412060|63136581|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
33593317|NCT02391337|62992067|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
33593318|NCT02391337|62992068|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
33593319|NCT02391337|62992067|FG000|12 Months Follow-up|Lost to Follow-up|0|||
33593320|NCT02391337|62992068|FG001|12 Months Follow-up|Lost to Follow-up|2|||
33593321|NCT02382991|62992076|FG000|Overall Study|Adverse Event|1|||
33593322|NCT02382991|62992077|FG001|Overall Study|Adverse Event|2|||
33593323|NCT02382991|62992076|FG000|Overall Study|Lost to Follow-up|1|||
33593324|NCT02382991|62992077|FG001|Overall Study|Lost to Follow-up|0|||
33593325|NCT02382991|62992076|FG000|Overall Study|Withdrawal by Subject|0|||
33593326|NCT02382991|62992077|FG001|Overall Study|Withdrawal by Subject|1|||
33593327|NCT02390557|62992085|FG000|Wave 2|Survey non-respondent|72|||
33593328|NCT02390557|62992086|FG001|Wave 2|Survey non-respondent|41|||
33593329|NCT02390557|62992087|FG002|Wave 2|Survey non-respondent|23|||
33593330|NCT01649791|62992095|FG000|Overall Study|Disease Progression|2|||
33593331|NCT01649791|62992095|FG000|Overall Study|Adverse Event|1|||
33593332|NCT01649557|62992102|FG000|Overall Study|Lost to Follow-up|5|||
33593333|NCT01649557|62992103|FG001|Overall Study|Lost to Follow-up|0|||
33593334|NCT01649557|62992104|FG002|Overall Study|Lost to Follow-up|3|||
33593335|NCT01649557|62992102|FG000|Overall Study|Adverse Event|7|||
33593336|NCT01649557|62992103|FG001|Overall Study|Adverse Event|5|||
33593337|NCT01649557|62992104|FG002|Overall Study|Adverse Event|1|||
33593338|NCT01649557|62992102|FG000|Overall Study|Met withdrawal criteria|4|||
33593339|NCT01649557|62992103|FG001|Overall Study|Met withdrawal criteria|0|||
33593340|NCT01649557|62992104|FG002|Overall Study|Met withdrawal criteria|0|||
33593341|NCT01649557|62992102|FG000|Overall Study|Physician Decision|8|||
33593342|NCT01649557|62992103|FG001|Overall Study|Physician Decision|2|||
33593343|NCT01649557|62992104|FG002|Overall Study|Physician Decision|1|||
33593344|NCT01649557|62992102|FG000|Overall Study|Withdrawal by Subject|15|||
33593345|NCT01649557|62992103|FG001|Overall Study|Withdrawal by Subject|5|||
33593346|NCT01649557|62992104|FG002|Overall Study|Withdrawal by Subject|4|||
33593347|NCT01649557|62992102|FG000|Overall Study|Protocol deviation|0|||
33593348|NCT01649557|62992103|FG001|Overall Study|Protocol deviation|2|||
33593349|NCT01649557|62992104|FG002|Overall Study|Protocol deviation|0|||
33593350|NCT01649557|62992102|FG000|Overall Study|Lack of Efficacy|5|||
33593351|NCT01649557|62992103|FG001|Overall Study|Lack of Efficacy|0|||
33593352|NCT01649557|62992104|FG002|Overall Study|Lack of Efficacy|0|||
33593353|NCT02390245|62992112|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
33593354|NCT02390245|62992113|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
33593355|NCT02390245|62992114|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
33593356|NCT02390245|62992112|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
33593357|NCT02390245|62992113|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
33593358|NCT02390245|62992114|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
33593359|NCT02390167|62992123|FG000|Overall Study|Lost to Follow-up|1|||
33593360|NCT02347657|62992133|FG000|Overall Study|Physician Decision|0|||
33593361|NCT02347657|62992134|FG001|Overall Study|Physician Decision|1|||
33593362|NCT02347657|62992133|FG000|Overall Study|Adverse Event|8|||
33593363|NCT02347657|62992134|FG001|Overall Study|Adverse Event|4|||
33593364|NCT02347657|62992133|FG000|Overall Study|Withdrawal by Subject|6|||
33593365|NCT02347657|62992134|FG001|Overall Study|Withdrawal by Subject|7|||
33593366|NCT02347657|62992133|FG000|Overall Study|Randomized but not treated|1|||
33593367|NCT02347657|62992134|FG001|Overall Study|Randomized but not treated|0|||
33593368|NCT02347657|62992133|FG000|Overall Study|Other|3|||
33593369|NCT02347657|62992134|FG001|Overall Study|Other|3|||
33593370|NCT02347189|62992141|FG000|Overall Study|No implant attempted of study device|9|||
33593371|NCT02347189|62992141|FG000|Overall Study|No primary outcome data available|2|||
33593372|NCT02382133|62992156|FG000|Overall Study|Death|22|||
33593373|NCT02382133|62992156|FG000|Overall Study|transfer out of ICU|4|||
33593374|NCT02382133|62992156|FG000|Overall Study|Physician Decision|2|||
33593375|NCT02382133|62992156|FG000|Overall Study|arterial catheter loss|4|||
33593376|NCT02382133|62992156|FG000|Overall Study|pressure injury both sites|1|||
33593377|NCT02346877|62992162|FG000|Overall Study|Adverse Event|1|||
33680567|NCT01412060|63136582|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
33493084|NCT03145766|62871123|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
33593378|NCT02346877|62992163|FG001|Overall Study|Adverse Event|0|||
33593379|NCT02346877|62992162|FG000|Overall Study|Administrative Decision|1|||
33593380|NCT02346877|62992163|FG001|Overall Study|Administrative Decision|0|||
33593381|NCT02346877|62992162|FG000|Overall Study|Sponsor Decision|12|||
33593382|NCT02346877|62992163|FG001|Overall Study|Sponsor Decision|0|||
33593383|NCT02346877|62992162|FG000|Overall Study|Missing|5|||
33593384|NCT02346877|62992163|FG001|Overall Study|Missing|0|||
33593385|NCT02346721|62992169|FG000|Overall Study|Withdrew Consent|3|||
33680568|NCT01412060|63136580|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
33680569|NCT01412060|63136581|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
33680570|NCT01412060|63136582|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
33593386|NCT02346721|62992169|FG000|Overall Study|Lack of Efficacy|1|||
33593387|NCT02389621|62992177|FG000|Treatment Period|Withdrawal by Subject|1|||
33593388|NCT02389621|62992178|FG001|Treatment Period|Withdrawal by Subject|1|||
33593389|NCT02389621|62992177|FG000|Posttreatment Period|Adverse Event|3|||
33593390|NCT02389621|62992178|FG001|Posttreatment Period|Adverse Event|1|||
33593391|NCT02389621|62992177|FG000|Posttreatment Period|Withdrawal by Subject|3|||
33593392|NCT02389621|62992178|FG001|Posttreatment Period|Withdrawal by Subject|2|||
33593393|NCT02389621|62992177|FG000|Posttreatment Period|Lost to Follow-up|1|||
33593394|NCT02389621|62992178|FG001|Posttreatment Period|Lost to Follow-up|1|||
33593395|NCT02389621|62992177|FG000|Posttreatment Period|Other - Miscellaneous|2|||
33593396|NCT02389621|62992178|FG001|Posttreatment Period|Other - Miscellaneous|0|||
33593397|NCT02388997|62992190|FG000|Overall Study|Adverse Event|1|||
33593398|NCT02388997|62992191|FG001|Overall Study|Adverse Event|2|||
33593399|NCT02388997|62992190|FG000|Overall Study|Withdrawal by Subject|2|||
33593400|NCT02388997|62992191|FG001|Overall Study|Withdrawal by Subject|1|||
33593401|NCT02388997|62992190|FG000|Overall Study|Lung function exclusion criteria|0|||
33593402|NCT02388997|62992191|FG001|Overall Study|Lung function exclusion criteria|2|||
33593403|NCT02388997|62992190|FG000|Overall Study|Tested positive for virus during run-in|0|||
33593404|NCT02388997|62992191|FG001|Overall Study|Tested positive for virus during run-in|1|||
33593405|NCT02388763|62992197|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
33593406|NCT02388763|62992198|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
33593407|NCT02388763|62992197|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
33593408|NCT02388763|62992198|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
33593409|NCT02388295|62992210|FG000|Dose Escalation Week 1|Adverse Event|1|||
33593410|NCT02388295|62992211|FG001|Dose Escalation Week 1|Adverse Event|2|||
33593411|NCT02388295|62992212|FG002|Dose Escalation Week 1|Adverse Event|1|||
33593412|NCT02388295|62992210|FG000|Dose Escalation Week 1|Determined not eligible|1|||
33593413|NCT02388295|62992211|FG001|Dose Escalation Week 1|Determined not eligible|1|||
33593414|NCT02388295|62992212|FG002|Dose Escalation Week 1|Determined not eligible|1|||
33593415|NCT02388295|62992210|FG000|Dose Escalation Week 2|Protocol Violation|0|||
33593416|NCT02388295|62992211|FG001|Dose Escalation Week 2|Protocol Violation|1|||
33593417|NCT02388295|62992212|FG002|Dose Escalation Week 2|Protocol Violation|0|||
33593418|NCT02388295|62992210|FG000|Dose Escalation Week 2|Determined not eligible|1|||
33593419|NCT02388295|62992211|FG001|Dose Escalation Week 2|Determined not eligible|1|||
33593420|NCT02388295|62992212|FG002|Dose Escalation Week 2|Determined not eligible|1|||
33593421|NCT02388295|62992210|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
33593422|NCT02388295|62992211|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
33593423|NCT02388295|62992212|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
33593424|NCT02345161|62992222|FG000|Overall Study|Withdrawal by Subject|25|||
33593425|NCT02345161|62992223|FG001|Overall Study|Withdrawal by Subject|33|||
33593426|NCT02345161|62992222|FG000|Overall Study|Adverse Event|16|||
33593427|NCT02345161|62992223|FG001|Overall Study|Adverse Event|19|||
33593428|NCT02345161|62992222|FG000|Overall Study|Physician Decision|4|||
33593429|NCT02345161|62992223|FG001|Overall Study|Physician Decision|4|||
33593430|NCT02345161|62992222|FG000|Overall Study|Lost to Follow-up|0|||
33593431|NCT02345161|62992223|FG001|Overall Study|Lost to Follow-up|1|||
33593432|NCT02251275|62992239|FG000|Overall Study|Adverse Event|23|||
33593433|NCT02251275|62992240|FG001|Overall Study|Adverse Event|60|||
33593434|NCT02251275|62992241|FG002|Overall Study|Adverse Event|28|||
33593435|NCT02251275|62992242|FG003|Overall Study|Adverse Event|0|||
33593436|NCT02251275|62992243|FG004|Overall Study|Adverse Event|0|||
33593437|NCT02251275|62992239|FG000|Overall Study|Lost to Follow-up|5|||
33593438|NCT02251275|62992240|FG001|Overall Study|Lost to Follow-up|6|||
33593439|NCT02251275|62992241|FG002|Overall Study|Lost to Follow-up|4|||
33593440|NCT02251275|62992242|FG003|Overall Study|Lost to Follow-up|0|||
33593441|NCT02251275|62992243|FG004|Overall Study|Lost to Follow-up|0|||
33593442|NCT02251275|62992239|FG000|Overall Study|Physician Decision|19|||
33593443|NCT02251275|62992240|FG001|Overall Study|Physician Decision|30|||
33593444|NCT02251275|62992241|FG002|Overall Study|Physician Decision|26|||
33593445|NCT02251275|62992242|FG003|Overall Study|Physician Decision|0|||
33593446|NCT02251275|62992243|FG004|Overall Study|Physician Decision|1|||
33593447|NCT02251275|62992239|FG000|Overall Study|Protocol Deviation|0|||
33593448|NCT02251275|62992240|FG001|Overall Study|Protocol Deviation|0|||
33593449|NCT02251275|62992241|FG002|Overall Study|Protocol Deviation|1|||
33593450|NCT02251275|62992242|FG003|Overall Study|Protocol Deviation|0|||
33593451|NCT02251275|62992243|FG004|Overall Study|Protocol Deviation|0|||
33593452|NCT02251275|62992239|FG000|Overall Study|Withdrawal by Subject|25|||
33593453|NCT02251275|62992240|FG001|Overall Study|Withdrawal by Subject|51|||
33593454|NCT02251275|62992241|FG002|Overall Study|Withdrawal by Subject|35|||
33593455|NCT02251275|62992242|FG003|Overall Study|Withdrawal by Subject|1|||
33593456|NCT02251275|62992243|FG004|Overall Study|Withdrawal by Subject|0|||
33593457|NCT02379637|62992257|FG000|Overall Study|Protocol Violation|0|||
33593458|NCT02379637|62992258|FG001|Overall Study|Protocol Violation|1|||
33593459|NCT02379637|62992257|FG000|Overall Study|Adverse Event|1|||
33593460|NCT02379637|62992258|FG001|Overall Study|Adverse Event|0|||
33593461|NCT02379637|62992257|FG000|Overall Study|Withdrawal by Subject|1|||
33593462|NCT02379637|62992258|FG001|Overall Study|Withdrawal by Subject|0|||
33401432|NCT00256867|62780479|FG005|Overall Study|Adverse Event|2|||
33593463|NCT02195583|62992264|FG000|Overall Study|Lost to Follow-up|1|||
33593464|NCT02195583|62992264|FG000|Overall Study|Withdrawal by Subject|4|||
33593465|NCT02195583|62992264|FG000|Overall Study|Adverse Event|2|||
33593466|NCT02195583|62992264|FG000|Overall Study|Other Reason|2|||
33593467|NCT02379091|62992283|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33593468|NCT02379091|62992284|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
33593469|NCT02379091|62992285|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
33593470|NCT02379091|62992286|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
33593471|NCT02379091|62992283|FG000|Overall Study|Principal Investigator Discretion|0|||
33593472|NCT02379091|62992284|FG001|Overall Study|Principal Investigator Discretion|1|||
33593473|NCT02379091|62992285|FG002|Overall Study|Principal Investigator Discretion|0|||
33310723|NCT01162473|62686120|FG000|Overall Study|Withdrawal by Subject|0|||
33310724|NCT01162473|62686121|FG001|Overall Study|Withdrawal by Subject|4|||
33310725|NCT01162239|62686131|FG000|Treatment Phase|Withdrawal by Subject|1|||
33310726|NCT01162239|62686132|FG001|Treatment Phase|Withdrawal by Subject|3|||
33310727|NCT01162239|62686133|FG002|Treatment Phase|Withdrawal by Subject|2|||
33310728|NCT01162239|62686134|FG003|Treatment Phase|Withdrawal by Subject|3|||
33310729|NCT01162239|62686131|FG000|Treatment Phase|Death|0|||
33310730|NCT01162239|62686132|FG001|Treatment Phase|Death|0|||
33310731|NCT01162239|62686133|FG002|Treatment Phase|Death|0|||
33310732|NCT01162239|62686134|FG003|Treatment Phase|Death|1|||
33310733|NCT01162239|62686131|FG000|Treatment Phase|Lost to Follow-up|5|||
33310734|NCT01162239|62686132|FG001|Treatment Phase|Lost to Follow-up|4|||
33310735|NCT01162239|62686133|FG002|Treatment Phase|Lost to Follow-up|2|||
33310736|NCT01162239|62686134|FG003|Treatment Phase|Lost to Follow-up|1|||
33310737|NCT01162239|62686131|FG000|Extended Follow-up|Lost to Follow-up|8|||
33593474|NCT02379091|62992286|FG003|Overall Study|Principal Investigator Discretion|0|||
33593475|NCT02379091|62992283|FG000|Overall Study|Lost to Follow-up|0|||
33593476|NCT02379091|62992284|FG001|Overall Study|Lost to Follow-up|0|||
33593477|NCT02379091|62992285|FG002|Overall Study|Lost to Follow-up|0|||
33593478|NCT02379091|62992286|FG003|Overall Study|Lost to Follow-up|1|||
33593479|NCT02379091|62992283|FG000|Overall Study|Voluntary Withdrawal|2|||
33593480|NCT02379091|62992284|FG001|Overall Study|Voluntary Withdrawal|5|||
33593481|NCT02379091|62992285|FG002|Overall Study|Voluntary Withdrawal|2|||
33593482|NCT02379091|62992286|FG003|Overall Study|Voluntary Withdrawal|4|||
33593483|NCT02379091|62992283|FG000|Overall Study|Study Termination|7|||
33593484|NCT02379091|62992284|FG001|Overall Study|Study Termination|2|||
33593485|NCT02379091|62992285|FG002|Overall Study|Study Termination|5|||
33593486|NCT02379091|62992286|FG003|Overall Study|Study Termination|8|||
33593487|NCT02379091|62992283|FG000|Overall Study|Lack of Efficacy|3|||
33593488|NCT02379091|62992284|FG001|Overall Study|Lack of Efficacy|0|||
33593489|NCT02379091|62992285|FG002|Overall Study|Lack of Efficacy|0|||
33593490|NCT02379091|62992286|FG003|Overall Study|Lack of Efficacy|0|||
33593491|NCT02378935|62992305|FG000|Overall Study|Lack of Efficacy|10|||
33593492|NCT02378935|62992306|FG001|Overall Study|Lack of Efficacy|0|||
33593493|NCT02378935|62992307|FG002|Overall Study|Lack of Efficacy|2|||
33593494|NCT02378935|62992308|FG003|Overall Study|Lack of Efficacy|6|||
33593495|NCT02378935|62992309|FG004|Overall Study|Lack of Efficacy|0|||
33593496|NCT02378935|62992310|FG005|Overall Study|Lack of Efficacy|0|||
33593497|NCT02378935|62992311|FG006|Overall Study|Lack of Efficacy|0|||
33593498|NCT02378935|62992305|FG000|Overall Study|Death|0|||
33593499|NCT02378935|62992306|FG001|Overall Study|Death|0|||
33593500|NCT02378935|62992307|FG002|Overall Study|Death|1|||
33593501|NCT02378935|62992308|FG003|Overall Study|Death|0|||
33593502|NCT02378935|62992309|FG004|Overall Study|Death|0|||
33593503|NCT02378935|62992310|FG005|Overall Study|Death|0|||
33593504|NCT02378935|62992311|FG006|Overall Study|Death|0|||
33593505|NCT02250651|62992330|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
33593506|NCT02250651|62992331|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
33593507|NCT02250651|62992332|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
33593508|NCT02250651|62992330|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
33593509|NCT02250651|62992331|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
33593510|NCT02250651|62992332|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
33593511|NCT02250651|62992330|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
33593512|NCT02250651|62992331|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
33593513|NCT02250651|62992332|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
33593514|NCT02250651|62992330|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
33593515|NCT02250651|62992331|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
33593516|NCT02250651|62992332|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
33593517|NCT02250651|62992330|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
33593518|NCT02250651|62992331|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
33593519|NCT02250651|62992332|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
33593520|NCT02250651|62992330|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
33593521|NCT02250651|62992331|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
33593522|NCT02250651|62992332|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
33593523|NCT02250651|62992330|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
33593524|NCT02250651|62992331|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
33593525|NCT02250651|62992332|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
33593526|NCT02250651|62992330|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
33593527|NCT02250651|62992331|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
33593528|NCT02250651|62992332|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
33593529|NCT02250651|62992330|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
33593530|NCT02250651|62992331|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
33593531|NCT02250651|62992332|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
33593532|NCT02250651|62992330|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
33593533|NCT02250651|62992331|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
33593534|NCT02250651|62992332|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
33593535|NCT02250651|62992330|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
33593536|NCT02250651|62992331|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
33593537|NCT02250651|62992332|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
33593538|NCT02250651|62992330|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
33593539|NCT02250651|62992331|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
33593540|NCT02250651|62992332|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
33593541|NCT02250651|62992330|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
33593542|NCT02250651|62992331|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
33593543|NCT02250651|62992332|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
33593544|NCT02250651|62992330|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
33593545|NCT02250651|62992331|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
33593546|NCT02250651|62992332|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
33593547|NCT02250651|62992330|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
33593548|NCT02250651|62992331|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
33593549|NCT02250651|62992332|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
33593550|NCT02377921|62992342|FG000|Overall Study|Subject non-compliance|1|||
33593551|NCT02377921|62992343|FG001|Overall Study|Subject non-compliance|1|||
33593552|NCT02311153|62992351|FG000|Overall Study|Lost to Follow-up|5|||
33593553|NCT02311153|62992352|FG001|Overall Study|Lost to Follow-up|7|||
33593554|NCT02195427|62992360|FG000|Overall Study|Did not consent to study extension|13|||
33593555|NCT02195427|62992361|FG001|Overall Study|Did not consent to study extension|9|||
33593556|NCT02195427|62992360|FG000|Overall Study|Withdrawal by Subject|4|||
33593557|NCT02195427|62992361|FG001|Overall Study|Withdrawal by Subject|2|||
33593558|NCT02195427|62992360|FG000|Overall Study|Lost to Follow-up|0|||
33593559|NCT02195427|62992361|FG001|Overall Study|Lost to Follow-up|1|||
33593560|NCT02195427|62992360|FG000|Overall Study|Protocol Violation|7|||
33593561|NCT02195427|62992361|FG001|Overall Study|Protocol Violation|14|||
33593562|NCT02195427|62992360|FG000|Overall Study|Conditional re-treatment at W52|2|||
33680571|NCT01412060|63136580|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
33680572|NCT01412060|63136581|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
33680573|NCT01412060|63136582|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
33680574|NCT01412060|63136580|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
33680575|NCT01412060|63136581|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
33680576|NCT01412060|63136582|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
33680577|NCT01412060|63136580|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
33680578|NCT01412060|63136581|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
33680579|NCT01412060|63136582|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
33680580|NCT01412060|63136580|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
33680581|NCT01412060|63136581|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
33680582|NCT01412060|63136582|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
33680583|NCT01412060|63136580|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
33680584|NCT01412060|63136581|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
33680585|NCT01412060|63136582|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
33680586|NCT01412060|63136580|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
33680587|NCT01412060|63136581|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
33680588|NCT01412060|63136582|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
33593563|NCT02195427|62992361|FG001|Overall Study|Conditional re-treatment at W52|1|||
33593564|NCT02214225|62992374|FG000|Overall Study|Lost to Follow-up|46|||
33593565|NCT02214225|62992375|FG001|Overall Study|Lost to Follow-up|18|||
33593566|NCT02214225|62992376|FG002|Overall Study|Lost to Follow-up|18|||
33593567|NCT02214225|62992374|FG000|Overall Study|Withdrawal by Subject|2|||
33593568|NCT02214225|62992375|FG001|Overall Study|Withdrawal by Subject|0|||
33593569|NCT02214225|62992376|FG002|Overall Study|Withdrawal by Subject|2|||
33593570|NCT02214225|62992374|FG000|Overall Study|Death|5|||
33593571|NCT02214225|62992375|FG001|Overall Study|Death|0|||
33593572|NCT02214225|62992376|FG002|Overall Study|Death|1|||
33593573|NCT02214225|62992374|FG000|Overall Study|randomized in error, not vaccinated|2|||
33593574|NCT02214225|62992375|FG001|Overall Study|randomized in error, not vaccinated|1|||
33593575|NCT02214225|62992376|FG002|Overall Study|randomized in error, not vaccinated|1|||
33593576|NCT02250183|62992407|FG000|Overall Study|Withdrawal by Subject|2|||
33593577|NCT02250183|62992407|FG000|Overall Study|Adverse Event|5|||
33593578|NCT02250183|62992407|FG000|Overall Study|Lost to Follow-up|1|||
33593579|NCT02249949|62992414|FG000|Overall Study|Cancelled prior to treatment|2|||
33593580|NCT02249091|62992420|FG000|Overall Study|Lack of Efficacy|8|||
33593581|NCT02249091|62992421|FG001|Overall Study|Lack of Efficacy|3|||
33593582|NCT02249091|62992420|FG000|Overall Study|Physician Decision|4|||
33593583|NCT02249091|62992421|FG001|Overall Study|Physician Decision|1|||
33593584|NCT02249091|62992420|FG000|Overall Study|Withdrawal by Subject|2|||
33593585|NCT02249091|62992421|FG001|Overall Study|Withdrawal by Subject|2|||
33593586|NCT02249091|62992420|FG000|Overall Study|Death|3|||
33593587|NCT02249091|62992421|FG001|Overall Study|Death|4|||
33593588|NCT02249091|62992420|FG000|Overall Study|Adverse Event|1|||
33593589|NCT02249091|62992421|FG001|Overall Study|Adverse Event|0|||
33593590|NCT02249091|62992420|FG000|Overall Study|Stable disease with following SCT|0|||
33593591|NCT02249091|62992421|FG001|Overall Study|Stable disease with following SCT|1|||
33593592|NCT02249091|62992420|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
33593593|NCT02249091|62992421|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
33593594|NCT02249091|62992420|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
33593595|NCT02249091|62992421|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
33593596|NCT02249091|62992420|FG000|Overall Study|Refractory AML|1|||
33593597|NCT02249091|62992421|FG001|Overall Study|Refractory AML|1|||
33593598|NCT02248857|62992430|FG000|3 Month|Withdrawal by Subject|9|||
33593599|NCT02248857|62992431|FG001|3 Month|Withdrawal by Subject|3|||
33593600|NCT02248857|62992432|FG002|3 Month|Withdrawal by Subject|4|||
33593601|NCT02248857|62992430|FG000|3 Month|Unable to reach for 3 month|35|||
33593602|NCT02248857|62992431|FG001|3 Month|Unable to reach for 3 month|29|||
33593603|NCT02248857|62992432|FG002|3 Month|Unable to reach for 3 month|26|||
33593604|NCT02248857|62992430|FG000|3 Month|Partially completed, unable to finish|2|||
33593605|NCT02248857|62992431|FG001|3 Month|Partially completed, unable to finish|2|||
33593606|NCT02248857|62992432|FG002|3 Month|Partially completed, unable to finish|1|||
33593607|NCT02248857|62992430|FG000|6 Month|Lost to Follow-up|27|||
33593608|NCT02248857|62992431|FG001|6 Month|Lost to Follow-up|26|||
33593609|NCT02248857|62992432|FG002|6 Month|Lost to Follow-up|15|||
33593610|NCT02248857|62992430|FG000|6 Month|Partially completed, unable to finish|0|||
33593611|NCT02248857|62992431|FG001|6 Month|Partially completed, unable to finish|1|||
33593612|NCT02248857|62992432|FG002|6 Month|Partially completed, unable to finish|0|||
33593613|NCT02248857|62992430|FG000|6 Month|Withdrawal by Subject|0|||
33593614|NCT02248857|62992431|FG001|6 Month|Withdrawal by Subject|2|||
33593615|NCT02248857|62992432|FG002|6 Month|Withdrawal by Subject|2|||
33593616|NCT02248857|62992430|FG000|6 Month|Death|1|||
33593617|NCT02248857|62992431|FG001|6 Month|Death|0|||
33593618|NCT02248857|62992432|FG002|6 Month|Death|0|||
33593619|NCT02213055|62992442|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
33593620|NCT02213055|62992443|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
33593621|NCT02213055|62992442|FG000|Overall Study|Protocol was not Followed during Study|1|||
33593622|NCT02213055|62992443|FG001|Overall Study|Protocol was not Followed during Study|0|||
33593623|NCT02213055|62992442|FG000|Overall Study|Documentation Issue at Enrollment|1|||
33593624|NCT02213055|62992443|FG001|Overall Study|Documentation Issue at Enrollment|0|||
33593625|NCT02213055|62992442|FG000|Overall Study|Documentation Issue during Study|10|||
33593626|NCT02213055|62992443|FG001|Overall Study|Documentation Issue during Study|0|||
33593627|NCT02213055|62992442|FG000|Overall Study|Did not have Live Lice|8|||
33593628|NCT02213055|62992443|FG001|Overall Study|Did not have Live Lice|0|||
33593629|NCT02213055|62992442|FG000|Overall Study|Had another Treatment during the Study|3|||
33593630|NCT02213055|62992443|FG001|Overall Study|Had another Treatment during the Study|0|||
33593631|NCT02213055|62992442|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
33593632|NCT02213055|62992443|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
33593633|NCT02213055|62992442|FG000|Overall Study|Did not Return to School|5|||
33593634|NCT02213055|62992443|FG001|Overall Study|Did not Return to School|0|||
33593635|NCT02310763|62992452|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
33593636|NCT02310763|62992453|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
33593637|NCT02310763|62992454|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
33593638|NCT02310763|62992452|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
33593639|NCT02310763|62992453|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
33593640|NCT02310763|62992454|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
33593641|NCT02310763|62992452|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
33593642|NCT02310763|62992453|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
33593643|NCT02310763|62992454|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
33593644|NCT02310763|62992452|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
33593645|NCT02310763|62992453|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
33593646|NCT02310763|62992454|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
33593647|NCT02310763|62992452|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
33593648|NCT02310763|62992453|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
33593649|NCT02310763|62992454|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
33593650|NCT02342743|62992480|FG000|Baseline Period|Withdrawal by Subject|3|||
33593651|NCT02342743|62992480|FG000|Baseline Period|Lost to Follow-up|2|||
33593652|NCT02342743|62992480|FG000|Baseline Period|Change in prophylactic medication|3|||
33593653|NCT02342743|62992480|FG000|Baseline Period|Screening failure regarding baseline|7|||
33593654|NCT02342743|62992480|FG000|Treatment Period|Withdrawal by Subject|2|||
33593655|NCT02342743|62992480|FG000|Treatment Period|Lost to Follow-up|8|||
33593656|NCT02342743|62992480|FG000|Treatment Period|Change in prophylactic medication|1|||
33593657|NCT02377063|62992484|FG000|Overall Study|Non-compliance|5|||
33593658|NCT02309515|62992490|FG000|Overall Study|Withdrawal by Subject|0|||
33593659|NCT02309515|62992491|FG001|Overall Study|Withdrawal by Subject|1|||
33593660|NCT02309359|62992502|FG000|Overall Study|Adverse Event|4|||
33593661|NCT02309359|62992503|FG001|Overall Study|Adverse Event|5|||
33593662|NCT02309359|62992504|FG002|Overall Study|Adverse Event|5|||
33593663|NCT02309359|62992505|FG003|Overall Study|Adverse Event|4|||
33593664|NCT02309359|62992506|FG004|Overall Study|Adverse Event|4|||
33593665|NCT02309359|62992502|FG000|Overall Study|Death|1|||
33593666|NCT02309359|62992503|FG001|Overall Study|Death|0|||
33593667|NCT02309359|62992504|FG002|Overall Study|Death|0|||
33593668|NCT02309359|62992505|FG003|Overall Study|Death|0|||
33593669|NCT02309359|62992506|FG004|Overall Study|Death|0|||
33593670|NCT02309359|62992502|FG000|Overall Study|Withdrawal by Subject|2|||
33593671|NCT02309359|62992503|FG001|Overall Study|Withdrawal by Subject|2|||
33593672|NCT02309359|62992504|FG002|Overall Study|Withdrawal by Subject|4|||
33593673|NCT02309359|62992505|FG003|Overall Study|Withdrawal by Subject|4|||
33593674|NCT02309359|62992506|FG004|Overall Study|Withdrawal by Subject|0|||
33593675|NCT02309359|62992502|FG000|Overall Study|Lack of Efficacy|3|||
33593676|NCT02309359|62992503|FG001|Overall Study|Lack of Efficacy|1|||
33593677|NCT02309359|62992504|FG002|Overall Study|Lack of Efficacy|0|||
33593678|NCT02309359|62992505|FG003|Overall Study|Lack of Efficacy|0|||
33593679|NCT02309359|62992506|FG004|Overall Study|Lack of Efficacy|3|||
33593680|NCT02309359|62992502|FG000|Overall Study|Lost to Follow-up|0|||
33593681|NCT02309359|62992503|FG001|Overall Study|Lost to Follow-up|0|||
33593682|NCT02309359|62992504|FG002|Overall Study|Lost to Follow-up|0|||
33593683|NCT02309359|62992505|FG003|Overall Study|Lost to Follow-up|1|||
33593684|NCT02309359|62992506|FG004|Overall Study|Lost to Follow-up|0|||
33593685|NCT02309359|62992502|FG000|Overall Study|Other|2|||
33593686|NCT02309359|62992503|FG001|Overall Study|Other|0|||
33593687|NCT02309359|62992504|FG002|Overall Study|Other|2|||
33593688|NCT02309359|62992505|FG003|Overall Study|Other|3|||
33593689|NCT02309359|62992506|FG004|Overall Study|Other|2|||
33593690|NCT02247531|62992522|FG000|Overall Study|Adverse Event|3|||
33593691|NCT02247531|62992523|FG001|Overall Study|Adverse Event|4|||
33593692|NCT02247531|62992524|FG002|Overall Study|Adverse Event|9|||
33593693|NCT02247531|62992522|FG000|Overall Study|Death|8|||
33593694|NCT02247531|62992523|FG001|Overall Study|Death|9|||
33593695|NCT02247531|62992524|FG002|Overall Study|Death|5|||
33593696|NCT02247531|62992522|FG000|Overall Study|Lost to Follow-up|1|||
33593697|NCT02247531|62992523|FG001|Overall Study|Lost to Follow-up|8|||
33593698|NCT02247531|62992524|FG002|Overall Study|Lost to Follow-up|3|||
33401433|NCT00256867|62780480|FG006|Overall Study|Adverse Event|1|||
33593699|NCT02247531|62992522|FG000|Overall Study|Non-compliance|2|||
33593700|NCT02247531|62992523|FG001|Overall Study|Non-compliance|2|||
33593701|NCT02247531|62992524|FG002|Overall Study|Non-compliance|0|||
33593702|NCT02247531|62992522|FG000|Overall Study|Withdrawal by Subject|26|||
33593703|NCT02247531|62992523|FG001|Overall Study|Withdrawal by Subject|31|||
33593704|NCT02247531|62992524|FG002|Overall Study|Withdrawal by Subject|25|||
33593705|NCT02247531|62992522|FG000|Overall Study|Study Terminated by Sponsor|64|||
33593706|NCT02247531|62992523|FG001|Overall Study|Study Terminated by Sponsor|66|||
33593707|NCT02247531|62992524|FG002|Overall Study|Study Terminated by Sponsor|62|||
33593708|NCT02247531|62992522|FG000|Overall Study|Physician Decision|0|||
33593709|NCT02247531|62992523|FG001|Overall Study|Physician Decision|2|||
33593710|NCT02247531|62992524|FG002|Overall Study|Physician Decision|2|||
33593711|NCT02247531|62992522|FG000|Overall Study|Unspecified Reason|2|||
33593712|NCT02247531|62992523|FG001|Overall Study|Unspecified Reason|3|||
33593713|NCT02247531|62992524|FG002|Overall Study|Unspecified Reason|4|||
33593714|NCT02375971|62992535|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
33593715|NCT02375971|62992536|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
33593716|NCT02375971|62992537|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
33593717|NCT02375971|62992535|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
33593718|NCT02375971|62992536|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
33593719|NCT02375971|62992537|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
33593720|NCT02375971|62992535|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
33593721|NCT02375971|62992536|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
33593722|NCT02375971|62992537|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
33593723|NCT02375971|62992535|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
33593724|NCT02375971|62992536|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
33593725|NCT02375971|62992537|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
33593726|NCT02375971|62992535|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
33593727|NCT02375971|62992536|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
33593728|NCT02375971|62992537|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
33593729|NCT02375971|62992535|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
33593730|NCT02375971|62992536|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
33593731|NCT02375971|62992537|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
33593732|NCT02375971|62992535|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
33593733|NCT02375971|62992536|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
33593734|NCT02375971|62992537|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
33593735|NCT02375971|62992535|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
33593736|NCT02375971|62992536|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
33593737|NCT02375971|62992537|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
33593738|NCT02308735|62992549|FG000|Overall Study|Physician Decision|2|||
33593739|NCT02308735|62992550|FG001|Overall Study|Physician Decision|0|||
33593740|NCT02308735|62992551|FG002|Overall Study|Physician Decision|0|||
33593741|NCT02308735|62992552|FG003|Overall Study|Physician Decision|2|||
33593742|NCT02212197|62992565|FG000|Overall Study|Need for radiotherapy|1|||
33593743|NCT02212197|62992566|FG001|Overall Study|Need for radiotherapy|0|||
33593744|NCT02212197|62992567|FG002|Overall Study|Need for radiotherapy|0|||
33593745|NCT02193165|62992578|FG000|4 Week Product Use|Lost to Follow-up|1|||
33593746|NCT02193165|62992579|FG001|4 Week Product Use|Lost to Follow-up|1|||
33593747|NCT02193165|62992580|FG002|4 Week Product Use|Lost to Follow-up|1|||
33593748|NCT02193165|62992578|FG000|6 Week Product Use|Lost to Follow-up|0|||
33593749|NCT02193165|62992579|FG001|6 Week Product Use|Lost to Follow-up|1|||
33593750|NCT02193165|62992580|FG002|6 Week Product Use|Lost to Follow-up|0|||
33593751|NCT01617460|62992588|FG000|Overall Study|Adverse Event|10|||
33593752|NCT01617460|62992588|FG000|Overall Study|Physician Decision|16|||
33593753|NCT01617460|62992588|FG000|Overall Study|Protocol Violation|5|||
33593754|NCT01617460|62992588|FG000|Overall Study|Withdrawal by Subject|9|||
33593755|NCT01890148|62992592|FG000|Overall Study|Adverse Event|1|||
33593756|NCT01889602|62992599|FG000|First Intervention|Adverse Event|1|||
33593757|NCT01889602|62992600|FG001|First Intervention|Adverse Event|1|||
33593758|NCT01889602|62992601|FG002|First Intervention|Adverse Event|1|||
33593759|NCT01889602|62992599|FG000|First Intervention|Protocol Violation|0|||
33593760|NCT01889602|62992600|FG001|First Intervention|Protocol Violation|1|||
33593761|NCT01889602|62992601|FG002|First Intervention|Protocol Violation|1|||
33593762|NCT01889602|62992599|FG000|First Intervention|Study ending|0|||
33593763|NCT01889602|62992600|FG001|First Intervention|Study ending|1|||
33593764|NCT01889602|62992601|FG002|First Intervention|Study ending|0|||
33593765|NCT01889602|62992599|FG000|Second Intervention|Adverse Event|0|||
33593766|NCT01889602|62992600|FG001|Second Intervention|Adverse Event|0|||
33593767|NCT01889602|62992601|FG002|Second Intervention|Adverse Event|1|||
33593768|NCT01889602|62992599|FG000|Second Intervention|Study ending|1|||
33593769|NCT01889602|62992600|FG001|Second Intervention|Study ending|0|||
33593770|NCT01889602|62992601|FG002|Second Intervention|Study ending|0|||
33593771|NCT01889602|62992599|FG000|Second Intervention|Withdrawal by Subject|0|||
33593772|NCT01889602|62992600|FG001|Second Intervention|Withdrawal by Subject|0|||
33593773|NCT01889602|62992601|FG002|Second Intervention|Withdrawal by Subject|1|||
33493085|NCT03145766|62871124|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
33493086|NCT03145766|62871125|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
33593774|NCT01889602|62992599|FG000|Third Intervention|Protocol Violation|1|||
33593775|NCT01889602|62992600|FG001|Third Intervention|Protocol Violation|0|||
33593776|NCT01889602|62992601|FG002|Third Intervention|Protocol Violation|0|||
33593777|NCT01889602|62992599|FG000|Third Intervention|Withdrawal by Subject|2|||
33593778|NCT01889602|62992600|FG001|Third Intervention|Withdrawal by Subject|2|||
33593779|NCT01889602|62992601|FG002|Third Intervention|Withdrawal by Subject|0|||
33593780|NCT01935700|62992619|FG000|Overall Study|Withdrawal by Subject|1|||
33593781|NCT01935700|62992620|FG001|Overall Study|Withdrawal by Subject|0|||
33593782|NCT01935700|62992619|FG000|Overall Study|Physician Decision|4|||
33593783|NCT01935700|62992620|FG001|Overall Study|Physician Decision|0|||
33593784|NCT01618162|62992630|FG000|Overall Study|Protocol Violation|13|||
33593785|NCT01618162|62992631|FG001|Overall Study|Protocol Violation|10|||
33593786|NCT01618162|62992630|FG000|Overall Study|Adverse Event|9|||
33593787|NCT01618162|62992631|FG001|Overall Study|Adverse Event|2|||
33593788|NCT01618162|62992630|FG000|Overall Study|Withdrawal Criteria|2|||
33593789|NCT01618162|62992631|FG001|Overall Study|Withdrawal Criteria|10|||
33593790|NCT01618162|62992630|FG000|Overall Study|Unclassified|14|||
33593791|NCT01618162|62992631|FG001|Overall Study|Unclassified|13|||
33593792|NCT02193087|62992641|FG000|Overall Study|Adverse Event|2|||
33593793|NCT02193087|62992642|FG001|Overall Study|Adverse Event|0|||
33593794|NCT02193087|62992643|FG002|Overall Study|Adverse Event|0|||
33593795|NCT02193087|62992644|FG003|Overall Study|Adverse Event|11|||
33593796|NCT02193087|62992641|FG000|Overall Study|Lost to Follow-up|14|||
33593797|NCT02193087|62992642|FG001|Overall Study|Lost to Follow-up|6|||
33593798|NCT02193087|62992643|FG002|Overall Study|Lost to Follow-up|4|||
33593799|NCT02193087|62992644|FG003|Overall Study|Lost to Follow-up|37|||
33593800|NCT02193087|62992641|FG000|Overall Study|Protocol Violation|2|||
33593801|NCT02193087|62992642|FG001|Overall Study|Protocol Violation|0|||
33593802|NCT02193087|62992643|FG002|Overall Study|Protocol Violation|1|||
33593803|NCT02193087|62992644|FG003|Overall Study|Protocol Violation|2|||
33593804|NCT02193087|62992641|FG000|Overall Study|Withdrawal by Subject|10|||
33593805|NCT02193087|62992642|FG001|Overall Study|Withdrawal by Subject|3|||
33593806|NCT02193087|62992643|FG002|Overall Study|Withdrawal by Subject|1|||
33593807|NCT02193087|62992644|FG003|Overall Study|Withdrawal by Subject|19|||
33593808|NCT02193087|62992641|FG000|Overall Study|Other Reason Not Specified|7|||
33593809|NCT02193087|62992642|FG001|Overall Study|Other Reason Not Specified|2|||
33593810|NCT02193087|62992643|FG002|Overall Study|Other Reason Not Specified|1|||
33593811|NCT02193087|62992644|FG003|Overall Study|Other Reason Not Specified|9|||
33593812|NCT02193087|62992641|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
33593813|NCT02193087|62992642|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
33593814|NCT02193087|62992643|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
33593815|NCT02193087|62992644|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
33593816|NCT01617070|62992661|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
33593817|NCT02341417|62992674|FG000|Overall Study|Withdrawal by Subject|0|||
33593818|NCT02341417|62992675|FG001|Overall Study|Withdrawal by Subject|2|||
33593819|NCT02341417|62992676|FG002|Overall Study|Withdrawal by Subject|0|||
33593820|NCT02341417|62992674|FG000|Overall Study|Decision by sponsor|2|||
33593821|NCT02341417|62992675|FG001|Overall Study|Decision by sponsor|0|||
33593822|NCT02341417|62992676|FG002|Overall Study|Decision by sponsor|0|||
33593823|NCT02341417|62992674|FG000|Overall Study|Death|0|||
33593824|NCT02341417|62992675|FG001|Overall Study|Death|0|||
33593825|NCT02341417|62992676|FG002|Overall Study|Death|1|||
33593826|NCT01888900|62992687|FG000|Overall Study|failed treatment|0|||
33593827|NCT01888900|62992688|FG001|Overall Study|failed treatment|2|||
33593828|NCT02340949|62992698|FG000|Overall Study|Adverse Event|4|||
33593829|NCT02340949|62992699|FG001|Overall Study|Adverse Event|2|||
33593830|NCT02340949|62992698|FG000|Overall Study|Withdrawal by Subject|2|||
33593831|NCT02340949|62992699|FG001|Overall Study|Withdrawal by Subject|0|||
33593832|NCT02340949|62992698|FG000|Overall Study|Progression disease|6|||
33593833|NCT02340949|62992699|FG001|Overall Study|Progression disease|2|||
33593834|NCT02340949|62992698|FG000|Overall Study|Death|3|||
33593835|NCT02340949|62992699|FG001|Overall Study|Death|0|||
33593836|NCT02340949|62992698|FG000|Overall Study|Physician Decision|1|||
33593837|NCT02340949|62992699|FG001|Overall Study|Physician Decision|0|||
33593838|NCT01646203|62992708|FG000|Overall Study|Adverse Event|2|||
33593839|NCT01646203|62992709|FG001|Overall Study|Adverse Event|0|||
33593840|NCT01646203|62992710|FG002|Overall Study|Adverse Event|1|||
33593841|NCT01646203|62992708|FG000|Overall Study|Withdrawal by Subject|0|||
33593842|NCT01646203|62992709|FG001|Overall Study|Withdrawal by Subject|1|||
33593843|NCT01646203|62992710|FG002|Overall Study|Withdrawal by Subject|0|||
33593844|NCT01646203|62992708|FG000|Overall Study|Physician's Decision|0|||
33593845|NCT01646203|62992709|FG001|Overall Study|Physician's Decision|1|||
33593846|NCT01646203|62992710|FG002|Overall Study|Physician's Decision|0|||
33593847|NCT02375347|62992723|FG000|Overall Study|Protocol Violation|1|||
33593848|NCT02374957|62992729|FG000|Overall Study|Patient did not complete forms correctly|1|||
33593849|NCT02374957|62992730|FG001|Overall Study|Patient did not complete forms correctly|0|||
33593850|NCT02374255|62992740|FG000|Overall Study|Withdrawal by Subject|2|||
33593851|NCT02374255|62992741|FG001|Overall Study|Withdrawal by Subject|0|||
33593852|NCT02374255|62992742|FG002|Overall Study|Withdrawal by Subject|0|||
33593853|NCT02374255|62992743|FG003|Overall Study|Withdrawal by Subject|0|||
33593854|NCT02308033|62992761|FG000|Overall Study|Normal Gram stain at Baseline|13|||
33593855|NCT02308033|62992762|FG001|Overall Study|Normal Gram stain at Baseline|10|||
33593856|NCT02308033|62992761|FG000|Overall Study|Positive for STD at Baseline|7|||
33593857|NCT02308033|62992762|FG001|Overall Study|Positive for STD at Baseline|4|||
33593858|NCT02308033|62992761|FG000|Overall Study|Lost to Follow-up|6|||
33593859|NCT02308033|62992762|FG001|Overall Study|Lost to Follow-up|5|||
33593860|NCT02339155|62992770|FG000|Overall Study|Adverse Event|0|||
33593861|NCT02339155|62992771|FG001|Overall Study|Adverse Event|6|||
33593862|NCT02339155|62992770|FG000|Overall Study|Death|1|||
33593863|NCT02339155|62992771|FG001|Overall Study|Death|1|||
33593864|NCT02339155|62992770|FG000|Overall Study|Lost to Follow-up|8|||
33593865|NCT02339155|62992771|FG001|Overall Study|Lost to Follow-up|9|||
33593866|NCT02339155|62992770|FG000|Overall Study|Physician Decision|2|||
33593867|NCT02339155|62992771|FG001|Overall Study|Physician Decision|1|||
33593868|NCT02339155|62992770|FG000|Overall Study|Withdrawal by Subject|4|||
33593869|NCT02339155|62992771|FG001|Overall Study|Withdrawal by Subject|4|||
33593870|NCT02211261|62992790|FG000|Overall Study|Withdrawal by Subject|0|||
33593871|NCT02211261|62992791|FG001|Overall Study|Withdrawal by Subject|0|||
33593872|NCT02211261|62992792|FG002|Overall Study|Withdrawal by Subject|1|||
33593873|NCT02211261|62992793|FG003|Overall Study|Withdrawal by Subject|0|||
33593874|NCT02211261|62992794|FG004|Overall Study|Withdrawal by Subject|2|||
33593875|NCT02211261|62992795|FG005|Overall Study|Withdrawal by Subject|0|||
33593876|NCT02211261|62992796|FG006|Overall Study|Withdrawal by Subject|0|||
33593877|NCT02211261|62992797|FG007|Overall Study|Withdrawal by Subject|0|||
33593878|NCT02211261|62992798|FG008|Overall Study|Withdrawal by Subject|0|||
33593879|NCT02211261|62992799|FG009|Overall Study|Withdrawal by Subject|0|||
33593880|NCT02211261|62992800|FG010|Overall Study|Withdrawal by Subject|0|||
33593881|NCT02211261|62992790|FG000|Overall Study|Other|0|||
33593882|NCT02211261|62992791|FG001|Overall Study|Other|0|||
33593883|NCT02211261|62992792|FG002|Overall Study|Other|0|||
33593884|NCT02211261|62992793|FG003|Overall Study|Other|0|||
33593885|NCT02211261|62992794|FG004|Overall Study|Other|0|||
33593886|NCT02211261|62992795|FG005|Overall Study|Other|1|||
33593887|NCT02211261|62992796|FG006|Overall Study|Other|0|||
33593888|NCT02211261|62992797|FG007|Overall Study|Other|0|||
33593889|NCT02211261|62992798|FG008|Overall Study|Other|0|||
33593890|NCT02211261|62992799|FG009|Overall Study|Other|2|||
33593891|NCT02211261|62992800|FG010|Overall Study|Other|0|||
33593892|NCT02211261|62992790|FG000|Overall Study|Lost to Follow-up|0|||
33593893|NCT02211261|62992791|FG001|Overall Study|Lost to Follow-up|0|||
33593894|NCT02211261|62992792|FG002|Overall Study|Lost to Follow-up|0|||
33593895|NCT02211261|62992793|FG003|Overall Study|Lost to Follow-up|0|||
33593896|NCT02211261|62992794|FG004|Overall Study|Lost to Follow-up|0|||
33593897|NCT02211261|62992795|FG005|Overall Study|Lost to Follow-up|0|||
33593898|NCT02211261|62992796|FG006|Overall Study|Lost to Follow-up|0|||
33593899|NCT02211261|62992797|FG007|Overall Study|Lost to Follow-up|1|||
33593900|NCT02211261|62992798|FG008|Overall Study|Lost to Follow-up|0|||
33593901|NCT02211261|62992799|FG009|Overall Study|Lost to Follow-up|0|||
33593902|NCT02211261|62992800|FG010|Overall Study|Lost to Follow-up|0|||
33593903|NCT02170077|62992836|FG000|Overall Study|Withdrawal by Subject|3|||
33593904|NCT02170077|62992837|FG001|Overall Study|Withdrawal by Subject|4|||
33593905|NCT02170077|62992838|FG002|Overall Study|Withdrawal by Subject|2|||
33593906|NCT02170077|62992836|FG000|Overall Study|Adverse Event|4|||
33593907|NCT02170077|62992837|FG001|Overall Study|Adverse Event|4|||
33593908|NCT02170077|62992838|FG002|Overall Study|Adverse Event|4|||
33593909|NCT02170077|62992836|FG000|Overall Study|Lost to Follow-up|0|||
33593910|NCT02170077|62992837|FG001|Overall Study|Lost to Follow-up|1|||
33593911|NCT02170077|62992838|FG002|Overall Study|Lost to Follow-up|0|||
33593912|NCT02170077|62992836|FG000|Overall Study|Exclusion criteria|2|||
33593913|NCT02170077|62992837|FG001|Overall Study|Exclusion criteria|2|||
33593914|NCT02170077|62992838|FG002|Overall Study|Exclusion criteria|5|||
33593915|NCT02170077|62992836|FG000|Overall Study|Exacerbation of seizures|0|||
33593916|NCT02170077|62992837|FG001|Overall Study|Exacerbation of seizures|2|||
33593917|NCT02170077|62992838|FG002|Overall Study|Exacerbation of seizures|1|||
33593918|NCT02210091|62992848|FG000|Overall Study|Physician Decision|0|||
33593919|NCT02210091|62992849|FG001|Overall Study|Physician Decision|1|||
33593920|NCT02210091|62992848|FG000|Overall Study|Withdrawal by Sponsor|0|||
33593921|NCT02210091|62992849|FG001|Overall Study|Withdrawal by Sponsor|1|||
33593922|NCT02338999|62992873|FG000|First Intervention|Withdrawal by Subject|3|||
33593923|NCT02338999|62992874|FG001|First Intervention|Withdrawal by Subject|1|||
33593924|NCT02338999|62992873|FG000|Washout Period|Withdrawal by Subject|0|||
33593925|NCT02338999|62992874|FG001|Washout Period|Withdrawal by Subject|2|||
33593926|NCT02338999|62992873|FG000|Second Intervention|Withdrawal by Subject|0|||
33593927|NCT02338999|62992874|FG001|Second Intervention|Withdrawal by Subject|2|||
33593928|NCT02169219|62992880|FG000|Overall Study|Lack of Efficacy|6|||
33593929|NCT02191605|62992894|FG000|Overall Study|Lost to Follow-up|9|||
33593930|NCT02191605|62992895|FG001|Overall Study|Lost to Follow-up|4|||
33593931|NCT02191605|62992896|FG002|Overall Study|Lost to Follow-up|7|||
33593932|NCT02191605|62992897|FG003|Overall Study|Lost to Follow-up|3|||
33593933|NCT02191605|62992898|FG004|Overall Study|Lost to Follow-up|4|||
33593934|NCT02191137|62992910|FG000|Treatment|Death|4|||
33593935|NCT02191137|62992910|FG000|Treatment|Withdrawal by Subject|3|||
33593936|NCT02191137|62992910|FG000|Treatment|Adverse Event|2|||
33593937|NCT02191137|62992910|FG000|Treatment|Other|1|||
33593938|NCT02191137|62992910|FG000|Follow-up|Lost to Follow-up|2|||
33593939|NCT02191137|62992910|FG000|Follow-up|Ongoing/unknown|2|||
33593940|NCT02191137|62992910|FG000|Follow-up|Adverse Event|1|||
33593941|NCT02168439|62992916|FG000|Overall Study|Protocol Violation|0|||
33593942|NCT02168439|62992917|FG001|Overall Study|Protocol Violation|2|||
33593943|NCT02190591|62992925|FG000|Overall Study|Withdrawal by Subject|1|||
33593944|NCT02190591|62992926|FG001|Overall Study|Withdrawal by Subject|8|||
33593945|NCT02190591|62992925|FG000|Overall Study|Protocol Violation|1|||
33593946|NCT02190591|62992926|FG001|Overall Study|Protocol Violation|0|||
33593947|NCT02190591|62992925|FG000|Overall Study|did not use peanut ball as instructed|0|||
33593948|NCT02190591|62992926|FG001|Overall Study|did not use peanut ball as instructed|2|||
33593949|NCT02190591|62992925|FG000|Overall Study|face presentation so she was ineligible|0|||
33593950|NCT02190591|62992926|FG001|Overall Study|face presentation so she was ineligible|1|||
33593951|NCT02190435|62992934|FG000|Overall Study|First 12 patients were lead-ins|12|||
33593952|NCT02190435|62992935|FG001|Overall Study|First 12 patients were lead-ins|0|||
33593953|NCT02190435|62992934|FG000|Overall Study|3 consented screen fails|3|||
33593954|NCT02190435|62992935|FG001|Overall Study|3 consented screen fails|0|||
33593955|NCT02338843|62992943|FG000|Overall Study|Adverse Event|2|||
33593956|NCT02338843|62992944|FG001|Overall Study|Adverse Event|1|||
33593957|NCT02338843|62992943|FG000|Overall Study|Death|40|||
33593958|NCT02338843|62992944|FG001|Overall Study|Death|53|||
33593959|NCT02338843|62992943|FG000|Overall Study|Physician Decision|1|||
33593960|NCT02338843|62992944|FG001|Overall Study|Physician Decision|0|||
33593961|NCT02338843|62992943|FG000|Overall Study|Withdrawal by Subject|0|||
33593962|NCT02338843|62992944|FG001|Overall Study|Withdrawal by Subject|2|||
33593963|NCT02338843|62992943|FG000|Overall Study|Subject Recovered|0|||
33593964|NCT02338843|62992944|FG001|Overall Study|Subject Recovered|2|||
33593965|NCT02338843|62992943|FG000|Overall Study|Discontinued prior to randomizat|1|||
33593966|NCT02338843|62992944|FG001|Overall Study|Discontinued prior to randomizat|0|||
33593967|NCT02190279|62992953|FG000|Overall Study|Withdrawal consent|1|||
33593968|NCT02190279|62992954|FG001|Overall Study|Withdrawal consent|0|||
33593969|NCT02190279|62992955|FG002|Overall Study|Withdrawal consent|1|||
33593970|NCT02190279|62992953|FG000|Overall Study|Lost to Follow-up|2|||
33593971|NCT02190279|62992954|FG001|Overall Study|Lost to Follow-up|0|||
33593972|NCT02190279|62992955|FG002|Overall Study|Lost to Follow-up|0|||
33593973|NCT02190279|62992953|FG000|Overall Study|Refused further treatment|0|||
33593974|NCT02190279|62992954|FG001|Overall Study|Refused further treatment|0|||
33593975|NCT02190279|62992955|FG002|Overall Study|Refused further treatment|1|||
33593976|NCT02190279|62992953|FG000|Overall Study|Screening failure|0|||
33593977|NCT02190279|62992954|FG001|Overall Study|Screening failure|0|||
33593978|NCT02190279|62992955|FG002|Overall Study|Screening failure|1|||
33593979|NCT02135445|62992967|FG000|Overall Study|Lost to Follow-up|1|||
33593980|NCT02135445|62992968|FG001|Overall Study|Lost to Follow-up|0|||
33593981|NCT02135445|62992967|FG000|Overall Study|Withdrawal by Subject|1|||
33593982|NCT02135445|62992968|FG001|Overall Study|Withdrawal by Subject|0|||
33593983|NCT02374099|62992976|FG000|Overall Study|Adverse Event|1|||
33593984|NCT02374099|62992977|FG001|Overall Study|Adverse Event|0|||
33593985|NCT02374099|62992976|FG000|Overall Study|Progressive Disease|35|||
33593986|NCT02374099|62992977|FG001|Overall Study|Progressive Disease|40|||
33593987|NCT02374099|62992976|FG000|Overall Study|Withdrawal by Subject|5|||
33593988|NCT02374099|62992977|FG001|Overall Study|Withdrawal by Subject|1|||
33593989|NCT02374099|62992976|FG000|Overall Study|Miscellaneous|2|||
33593990|NCT02374099|62992977|FG001|Overall Study|Miscellaneous|3|||
33593991|NCT02374099|62992976|FG000|Overall Study|Randomized, but not treated|2|||
33593992|NCT02374099|62992977|FG001|Overall Study|Randomized, but not treated|1|||
33593993|NCT02374099|62992976|FG000|Overall Study|Study Terminated by Sponsor|3|||
33593994|NCT02374099|62992977|FG001|Overall Study|Study Terminated by Sponsor|4|||
33593995|NCT02134977|62992983|FG000|Overall Study|Protocol Deviation|102|||
33593996|NCT02374021|62992989|FG000|Overall Study|Adverse Event|1|||
33593997|NCT02374021|62992990|FG001|Overall Study|Adverse Event|0|||
33593998|NCT02374021|62992989|FG000|Overall Study|Lost to Follow-up|3|||
33593999|NCT02374021|62992990|FG001|Overall Study|Lost to Follow-up|2|||
33594000|NCT02374021|62992989|FG000|Overall Study|Physician Decision|0|||
33594001|NCT02374021|62992990|FG001|Overall Study|Physician Decision|3|||
33594002|NCT02374021|62992989|FG000|Overall Study|Withdrawal by Subject|6|||
33594003|NCT02374021|62992990|FG001|Overall Study|Withdrawal by Subject|5|||
33594004|NCT02374021|62992989|FG000|Overall Study|Poor Adherence|0|||
33594005|NCT02374021|62992990|FG001|Overall Study|Poor Adherence|1|||
33594006|NCT02374021|62992989|FG000|Overall Study|Scan protocol not followed|0|||
33594007|NCT02374021|62992990|FG001|Overall Study|Scan protocol not followed|1|||
33594008|NCT02374021|62992989|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
33594009|NCT02374021|62992990|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
33594010|NCT02372383|62992998|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
33594011|NCT02372383|62992999|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
33594012|NCT02372383|62993000|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
33594013|NCT01648699|62993010|FG000|Overall Study|Death|1|||
33594014|NCT01648699|62993010|FG000|Overall Study|Lost to Follow-up|2|||
33594015|NCT01648699|62993010|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
33594016|NCT02134353|62993025|FG000|Overall Study|Adverse Event|10|||
33594017|NCT02134353|62993026|FG001|Overall Study|Adverse Event|6|||
33594018|NCT02134353|62993025|FG000|Overall Study|Lost to Follow-up|1|||
33594019|NCT02134353|62993026|FG001|Overall Study|Lost to Follow-up|1|||
33594020|NCT02134353|62993025|FG000|Overall Study|Lack of Efficacy|2|||
33594021|NCT02134353|62993026|FG001|Overall Study|Lack of Efficacy|1|||
33594022|NCT02134353|62993025|FG000|Overall Study|Withdrawal by Subject|12|||
33594023|NCT02134353|62993026|FG001|Overall Study|Withdrawal by Subject|13|||
33594024|NCT02134353|62993025|FG000|Overall Study|Death|0|||
33594025|NCT02134353|62993026|FG001|Overall Study|Death|1|||
33594026|NCT02134353|62993025|FG000|Overall Study|Pregnancy|0|||
33594027|NCT02134353|62993026|FG001|Overall Study|Pregnancy|1|||
33594028|NCT02134353|62993025|FG000|Overall Study|Relocation|1|||
33594029|NCT02134353|62993026|FG001|Overall Study|Relocation|0|||
33594030|NCT02134353|62993025|FG000|Overall Study|Other - Patient's Choice|0|||
33594031|NCT02134353|62993026|FG001|Overall Study|Other - Patient's Choice|1|||
33594032|NCT01646125|62993034|FG000|Overall Study|Untreated|2|||
33594033|NCT01646125|62993035|FG001|Overall Study|Untreated|5|||
33594034|NCT01646125|62993034|FG000|Overall Study|Adverse Event|2|||
33594035|NCT01646125|62993035|FG001|Overall Study|Adverse Event|1|||
33594036|NCT01646125|62993034|FG000|Overall Study|Death|1|||
33594037|NCT01646125|62993035|FG001|Overall Study|Death|1|||
33594038|NCT01646125|62993034|FG000|Overall Study|Physician Decision|1|||
33594039|NCT01646125|62993035|FG001|Overall Study|Physician Decision|3|||
33594040|NCT01646125|62993034|FG000|Overall Study|Progressive disease|22|||
33594041|NCT01646125|62993035|FG001|Overall Study|Progressive disease|16|||
33594042|NCT01646125|62993034|FG000|Overall Study|Study terminated by sponsor|2|||
33594043|NCT01646125|62993035|FG001|Overall Study|Study terminated by sponsor|1|||
33594044|NCT01646125|62993034|FG000|Overall Study|Subject/Guardian decision|1|||
33594045|NCT01646125|62993035|FG001|Overall Study|Subject/Guardian decision|1|||
33594046|NCT01362790|62993048|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
33594047|NCT01362790|62993049|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
33594048|NCT01362790|62993050|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
33594049|NCT01362790|62993051|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
33594050|NCT01362790|62993052|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
33594051|NCT01362790|62993053|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
33594052|NCT01362790|62993054|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
33594053|NCT01362790|62993048|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
33594054|NCT01362790|62993049|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
33594055|NCT01362790|62993050|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
33594056|NCT01362790|62993051|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
33594057|NCT01362790|62993052|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
33594058|NCT01362790|62993053|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
33594059|NCT01362790|62993054|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
33594060|NCT01362790|62993048|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
33594061|NCT01362790|62993049|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
33594062|NCT01362790|62993050|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
33594063|NCT01362790|62993051|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
33594064|NCT01362790|62993052|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
33594065|NCT01362790|62993053|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
33594066|NCT01362790|62993054|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
33594067|NCT01362790|62993048|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
33594068|NCT01362790|62993049|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
33594069|NCT01362790|62993050|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
33594070|NCT01362790|62993051|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
33594071|NCT01362790|62993052|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
33594072|NCT01362790|62993053|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
33594073|NCT01362790|62993054|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
33594074|NCT01362790|62993048|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
33594075|NCT01362790|62993049|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
33594076|NCT01362790|62993050|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
33594077|NCT01362790|62993051|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
33594078|NCT01362790|62993052|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
33594079|NCT01362790|62993053|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
33594080|NCT01362790|62993054|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
33594081|NCT01362790|62993048|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
33594082|NCT01362790|62993049|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
33594083|NCT01362790|62993050|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
33594084|NCT01362790|62993051|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
33594085|NCT01362790|62993052|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
33594086|NCT01362790|62993053|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
33594087|NCT01362790|62993054|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
33594088|NCT01362790|62993048|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
33594089|NCT01362790|62993049|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
33594090|NCT01362790|62993050|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
33594091|NCT01362790|62993051|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
33594092|NCT01362790|62993052|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
33594093|NCT01362790|62993053|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
33594094|NCT01362790|62993054|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
33594095|NCT01362790|62993048|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
33594096|NCT01362790|62993049|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
33594097|NCT01362790|62993050|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
33594098|NCT01362790|62993051|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
33594099|NCT01362790|62993052|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
33594100|NCT01362790|62993053|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
33594101|NCT01362790|62993054|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
33594102|NCT01362790|62993048|FG000|Pilot Phase & Phase 2|Death on study|0|||
33594103|NCT01362790|62993049|FG001|Pilot Phase & Phase 2|Death on study|0|||
33594104|NCT01362790|62993050|FG002|Pilot Phase & Phase 2|Death on study|0|||
33594105|NCT01362790|62993051|FG003|Pilot Phase & Phase 2|Death on study|1|||
33594106|NCT01362790|62993052|FG004|Pilot Phase & Phase 2|Death on study|0|||
33594107|NCT01362790|62993053|FG005|Pilot Phase & Phase 2|Death on study|0|||
33594108|NCT01362790|62993054|FG006|Pilot Phase & Phase 2|Death on study|0|||
33594109|NCT01362790|62993048|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
33594110|NCT01362790|62993049|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
33680589|NCT00551421|63136613|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
33680590|NCT01891643|63136633|FG000|Overall Study|Adverse event unrelated to study drug|2|||
33680591|NCT01891643|63136634|FG001|Overall Study|Adverse event unrelated to study drug|5|||
33680592|NCT01891643|63136633|FG000|Overall Study|Disease Progression|4|||
33680593|NCT01891643|63136634|FG001|Overall Study|Disease Progression|3|||
33680594|NCT01891643|63136633|FG000|Overall Study|Study Drug Toxicity|3|||
33680595|NCT01891643|63136634|FG001|Overall Study|Study Drug Toxicity|0|||
33680596|NCT01891643|63136633|FG000|Overall Study|Maximum Clinical Benefit|0|||
33680597|NCT01891643|63136634|FG001|Overall Study|Maximum Clinical Benefit|1|||
33680598|NCT01891643|63136633|FG000|Overall Study|Poor/Non-compliance|0|||
33680599|NCT01891643|63136634|FG001|Overall Study|Poor/Non-compliance|1|||
33680600|NCT01891643|63136633|FG000|Overall Study|Participant request to discontinue|1|||
33680601|NCT01891643|63136634|FG001|Overall Study|Participant request to discontinue|0|||
33680602|NCT01392326|63136768|FG000|Overall Study|Death|2|||
33680603|NCT01392326|63136769|FG001|Overall Study|Death|0|||
33680604|NCT01392326|63136770|FG002|Overall Study|Death|0|||
33680605|NCT01392326|63136768|FG000|Overall Study|Withdrawal by Subject|12|||
33680606|NCT01392326|63136769|FG001|Overall Study|Withdrawal by Subject|11|||
33680607|NCT01392326|63136770|FG002|Overall Study|Withdrawal by Subject|15|||
33680608|NCT01392326|63136768|FG000|Overall Study|Protocol Violation|2|||
33680609|NCT01392326|63136769|FG001|Overall Study|Protocol Violation|0|||
33680610|NCT01392326|63136770|FG002|Overall Study|Protocol Violation|0|||
33680611|NCT01392326|63136768|FG000|Overall Study|Pregnancy|0|||
33680612|NCT01392326|63136769|FG001|Overall Study|Pregnancy|0|||
33680613|NCT01392326|63136770|FG002|Overall Study|Pregnancy|1|||
33680614|NCT01392326|63136768|FG000|Overall Study|Physician Decision|7|||
33680615|NCT01392326|63136769|FG001|Overall Study|Physician Decision|5|||
33680616|NCT01392326|63136770|FG002|Overall Study|Physician Decision|2|||
33680617|NCT01392326|63136768|FG000|Overall Study|Lost to Follow-up|1|||
33594111|NCT01362790|62993050|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
33594112|NCT01362790|62993051|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
33594113|NCT01362790|62993052|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
33594114|NCT01362790|62993053|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
33594115|NCT01362790|62993054|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
33680618|NCT01392326|63136769|FG001|Overall Study|Lost to Follow-up|3|||
33680619|NCT01392326|63136770|FG002|Overall Study|Lost to Follow-up|4|||
33680620|NCT01392326|63136768|FG000|Overall Study|Lack of Efficacy|14|||
33680621|NCT01392326|63136769|FG001|Overall Study|Lack of Efficacy|10|||
33680622|NCT01392326|63136770|FG002|Overall Study|Lack of Efficacy|15|||
33680623|NCT01392326|63136768|FG000|Overall Study|Adverse Event|9|||
33680624|NCT01392326|63136769|FG001|Overall Study|Adverse Event|6|||
33680625|NCT01392326|63136770|FG002|Overall Study|Adverse Event|11|||
33680626|NCT01432262|63136813|FG000|Overall Study|Withdrawal by Subject|2|||
33594116|NCT01362790|62993048|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
33594117|NCT01362790|62993049|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
33594118|NCT01362790|62993050|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
33594119|NCT01362790|62993051|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
33594120|NCT01362790|62993052|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
33594121|NCT01362790|62993053|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
33594122|NCT01362790|62993054|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
33594123|NCT01362790|62993048|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
33594124|NCT01362790|62993049|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
33594125|NCT01362790|62993050|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
33594126|NCT01362790|62993051|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
33594127|NCT01362790|62993052|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
33594128|NCT01362790|62993053|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
33594129|NCT01362790|62993054|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
33594130|NCT02167893|62993074|FG000|Overall Study|Investigator transferred|85|||
33594131|NCT02167893|62993074|FG000|Overall Study|Investigator health reasons|10|||
33594132|NCT02167893|62993074|FG000|Overall Study|Case report forms not collected|68|||
33594133|NCT02167035|62993080|FG000|Overall Study|Adverse Event|2|||
33594134|NCT02167035|62993081|FG001|Overall Study|Adverse Event|2|||
33594135|NCT02167035|62993080|FG000|Overall Study|Lost to Follow-up|3|||
33594136|NCT02167035|62993081|FG001|Overall Study|Lost to Follow-up|3|||
33594137|NCT02167035|62993080|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
33594138|NCT02167035|62993081|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
33594139|NCT01615198|62993091|FG000|Overall Study|Withdrawal by Subject|5|||
33594140|NCT01615198|62993092|FG001|Overall Study|Withdrawal by Subject|5|||
33594141|NCT01615198|62993091|FG000|Overall Study|Protocol deviation|1|||
33594142|NCT01615198|62993092|FG001|Overall Study|Protocol deviation|1|||
33594143|NCT01615198|62993091|FG000|Overall Study|Physician Decision|5|||
33594144|NCT01615198|62993092|FG001|Overall Study|Physician Decision|1|||
33594145|NCT01615198|62993091|FG000|Overall Study|Lost to Follow-up|1|||
33594146|NCT01615198|62993092|FG001|Overall Study|Lost to Follow-up|1|||
33594147|NCT01615198|62993091|FG000|Overall Study|Lack of Efficacy|1|||
33594148|NCT01615198|62993092|FG001|Overall Study|Lack of Efficacy|6|||
33594149|NCT01615198|62993091|FG000|Overall Study|Adverse Event|11|||
33594150|NCT01615198|62993092|FG001|Overall Study|Adverse Event|5|||
33594151|NCT02337907|62993104|FG000|Overall Study|Other than listed|1|||
33594152|NCT02337907|62993105|FG001|Overall Study|Other than listed|0|||
33594153|NCT02337907|62993106|FG002|Overall Study|Other than listed|0|||
33594154|NCT02337907|62993107|FG003|Overall Study|Other than listed|1|||
33594155|NCT02337907|62993108|FG004|Overall Study|Other than listed|1|||
33594156|NCT02337907|62993109|FG005|Overall Study|Other than listed|0|||
33594157|NCT02337907|62993104|FG000|Overall Study|Withdrawal by Subject|2|||
33594158|NCT02337907|62993105|FG001|Overall Study|Withdrawal by Subject|3|||
33594159|NCT02337907|62993106|FG002|Overall Study|Withdrawal by Subject|0|||
33594160|NCT02337907|62993107|FG003|Overall Study|Withdrawal by Subject|2|||
33594161|NCT02337907|62993108|FG004|Overall Study|Withdrawal by Subject|5|||
33594162|NCT02337907|62993109|FG005|Overall Study|Withdrawal by Subject|0|||
33594163|NCT02337907|62993104|FG000|Overall Study|Lost to Follow-up|0|||
33594164|NCT02337907|62993105|FG001|Overall Study|Lost to Follow-up|0|||
33594165|NCT02337907|62993106|FG002|Overall Study|Lost to Follow-up|0|||
33594166|NCT02337907|62993107|FG003|Overall Study|Lost to Follow-up|0|||
33594167|NCT02337907|62993108|FG004|Overall Study|Lost to Follow-up|0|||
33594168|NCT02337907|62993109|FG005|Overall Study|Lost to Follow-up|1|||
33594169|NCT02337907|62993104|FG000|Overall Study|Adverse Event|1|||
33594170|NCT02337907|62993105|FG001|Overall Study|Adverse Event|1|||
33594171|NCT02337907|62993106|FG002|Overall Study|Adverse Event|1|||
33594172|NCT02337907|62993107|FG003|Overall Study|Adverse Event|1|||
33680627|NCT01432262|63136814|FG001|Overall Study|Withdrawal by Subject|1|||
33680628|NCT01410890|63136834|FG000|Overall Study|Withdrawal by Subject|0|||
33680629|NCT01410890|63136835|FG001|Overall Study|Withdrawal by Subject|1|||
33680630|NCT01431950|63136845|FG000|Overall Study|Study Site Closed/Terminated|7|||
33680631|NCT01431950|63136846|FG001|Overall Study|Study Site Closed/Terminated|3|||
33680632|NCT01431950|63136845|FG000|Overall Study|Withdrawal by Subject|4|||
33594173|NCT02337907|62993108|FG004|Overall Study|Adverse Event|4|||
33594174|NCT02337907|62993109|FG005|Overall Study|Adverse Event|0|||
33594175|NCT01913470|62993126|FG000|Overall Study|Lost to Follow-up|0|||
33594176|NCT01913470|62993127|FG001|Overall Study|Lost to Follow-up|1|||
33594177|NCT01913470|62993126|FG000|Overall Study|Physician Decision|0|||
33680633|NCT01431950|63136846|FG001|Overall Study|Withdrawal by Subject|3|||
33680634|NCT01431950|63136845|FG000|Overall Study|Protocol Violation|2|||
33594178|NCT01913470|62993127|FG001|Overall Study|Physician Decision|1|||
33594179|NCT01913470|62993126|FG000|Overall Study|Withdrawal by Subject|0|||
33680635|NCT01431950|63136846|FG001|Overall Study|Protocol Violation|3|||
33594180|NCT01913470|62993127|FG001|Overall Study|Withdrawal by Subject|1|||
33594181|NCT02372071|62993134|FG000|Overall Study|Protocol Violation|18|||
33594182|NCT02337751|62993141|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
33594183|NCT02337751|62993142|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
33594184|NCT02337751|62993141|FG000|Overall Study|Voluntary Withdrawal|6|||
33594185|NCT02337751|62993142|FG001|Overall Study|Voluntary Withdrawal|8|||
33594186|NCT02337751|62993141|FG000|Overall Study|Lack of Efficacy|2|||
33594187|NCT02337751|62993142|FG001|Overall Study|Lack of Efficacy|5|||
33594188|NCT02337751|62993141|FG000|Overall Study|Investigator's Judgement|1|||
33594189|NCT02337751|62993142|FG001|Overall Study|Investigator's Judgement|0|||
33594190|NCT02166333|62993153|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
33594191|NCT02166333|62993154|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
33594192|NCT02166333|62993155|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
33594193|NCT02166333|62993156|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
33594194|NCT02166333|62993157|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
33594195|NCT02166333|62993158|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
33594196|NCT02166333|62993153|FG000|Stage 1|Death|4|||
33594197|NCT02166333|62993154|FG001|Stage 1|Death|0|||
33594198|NCT02166333|62993155|FG002|Stage 1|Death|2|||
33594199|NCT02166333|62993156|FG003|Stage 1|Death|0|||
33594200|NCT02166333|62993157|FG004|Stage 1|Death|3|||
33594201|NCT02166333|62993158|FG005|Stage 1|Death|2|||
33594202|NCT02166333|62993153|FG000|Stage 1|Lost to Follow-up|12|||
33594203|NCT02166333|62993154|FG001|Stage 1|Lost to Follow-up|0|||
33594204|NCT02166333|62993155|FG002|Stage 1|Lost to Follow-up|6|||
33594205|NCT02166333|62993156|FG003|Stage 1|Lost to Follow-up|0|||
33594206|NCT02166333|62993157|FG004|Stage 1|Lost to Follow-up|3|||
33594207|NCT02166333|62993158|FG005|Stage 1|Lost to Follow-up|3|||
33594208|NCT02166333|62993153|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
33594209|NCT02166333|62993154|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
33594210|NCT02166333|62993155|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
33594211|NCT02166333|62993156|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
33594212|NCT02166333|62993157|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
33594213|NCT02166333|62993158|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
33594214|NCT02166333|62993153|FG000|Stage 2|Death|4|||
33594215|NCT02166333|62993154|FG001|Stage 2|Death|2|||
33594216|NCT02166333|62993155|FG002|Stage 2|Death|1|||
33594217|NCT02166333|62993156|FG003|Stage 2|Death|0|||
33594218|NCT02166333|62993157|FG004|Stage 2|Death|0|||
33594219|NCT02166333|62993158|FG005|Stage 2|Death|1|||
33594220|NCT02166333|62993153|FG000|Stage 2|Lost to Follow-up|23|||
33594221|NCT02166333|62993154|FG001|Stage 2|Lost to Follow-up|4|||
33594222|NCT02166333|62993155|FG002|Stage 2|Lost to Follow-up|11|||
33594223|NCT02166333|62993156|FG003|Stage 2|Lost to Follow-up|9|||
33594224|NCT02166333|62993157|FG004|Stage 2|Lost to Follow-up|3|||
33594225|NCT02166333|62993158|FG005|Stage 2|Lost to Follow-up|6|||
33594226|NCT02132949|62993172|FG000|Overall Study|Death|7|||
33310738|NCT01162239|62686132|FG001|Extended Follow-up|Lost to Follow-up|13|||
33401434|NCT00256867|62780481|FG007|Overall Study|Adverse Event|4|||
33594227|NCT02132949|62993173|FG001|Overall Study|Death|13|||
33594228|NCT02132949|62993172|FG000|Overall Study|Lost to Follow-up|14|||
33594229|NCT02132949|62993173|FG001|Overall Study|Lost to Follow-up|4|||
33493087|NCT03145766|62871121|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
33493088|NCT03145766|62871122|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
33493089|NCT03145766|62871123|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
33493090|NCT03145766|62871124|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
33493091|NCT03145766|62871125|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
33493092|NCT03145766|62871121|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
33493093|NCT03145766|62871122|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
33493094|NCT03145766|62871123|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
33493095|NCT03145766|62871124|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
33493096|NCT03145766|62871125|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
33493097|NCT03145064|62871138|FG000|Overall Study|Death|24|||
33594230|NCT02132949|62993172|FG000|Overall Study|Withdrawal by Subject|6|||
33594231|NCT02132949|62993173|FG001|Overall Study|Withdrawal by Subject|5|||
33594232|NCT02132949|62993172|FG000|Overall Study|Noncompliance|5|||
33594233|NCT02132949|62993173|FG001|Overall Study|Noncompliance|1|||
33594234|NCT02132949|62993172|FG000|Overall Study|Physician Decision|3|||
33594235|NCT02132949|62993173|FG001|Overall Study|Physician Decision|1|||
33594236|NCT02132949|62993172|FG000|Overall Study|Disease Progression|3|||
33594237|NCT02132949|62993173|FG001|Overall Study|Disease Progression|0|||
33594238|NCT02132949|62993172|FG000|Overall Study|Adverse Event|2|||
33594239|NCT02132949|62993173|FG001|Overall Study|Adverse Event|1|||
33594240|NCT02132949|62993172|FG000|Overall Study|Withdrew Prior to Treatment|1|||
33594241|NCT02132949|62993173|FG001|Overall Study|Withdrew Prior to Treatment|2|||
33594242|NCT02132949|62993172|FG000|Overall Study|Reason Unspecified|0|||
33594243|NCT02132949|62993173|FG001|Overall Study|Reason Unspecified|1|||
33594244|NCT02165397|62993182|FG000|Overall Study|Death|7|||
33594245|NCT02165397|62993183|FG001|Overall Study|Death|10|||
33594246|NCT02165397|62993184|FG002|Overall Study|Death|8|||
33594247|NCT02165397|62993182|FG000|Overall Study|Lost to Follow-up|1|||
33594248|NCT02165397|62993183|FG001|Overall Study|Lost to Follow-up|3|||
33594249|NCT02165397|62993184|FG002|Overall Study|Lost to Follow-up|0|||
33594250|NCT02165397|62993182|FG000|Overall Study|Withdrawal by Subject|6|||
33594251|NCT02165397|62993183|FG001|Overall Study|Withdrawal by Subject|6|||
33594252|NCT02165397|62993184|FG002|Overall Study|Withdrawal by Subject|1|||
33594253|NCT02165397|62993182|FG000|Overall Study|Other, Not Specified|0|||
33594254|NCT02165397|62993183|FG001|Overall Study|Other, Not Specified|0|||
33594255|NCT02165397|62993184|FG002|Overall Study|Other, Not Specified|1|||
33594256|NCT02132637|62993196|FG000|Study Period 1|Withdrawal by Subject|0|||
33594257|NCT02132637|62993197|FG001|Study Period 1|Withdrawal by Subject|4|||
33594258|NCT02132637|62993196|FG000|Study Period 1|Physician Decision|1|||
33594259|NCT02132637|62993197|FG001|Study Period 1|Physician Decision|0|||
33594260|NCT02132637|62993196|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
33594261|NCT02132637|62993197|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
33594262|NCT02132637|62993196|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
33594263|NCT02132637|62993197|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
33594264|NCT02164929|62993207|FG000|Overall Study|Converted to open procedure|1|||
33594265|NCT02164929|62993208|FG001|Overall Study|Converted to open procedure|0|||
33594266|NCT02164929|62993209|FG002|Overall Study|Converted to open procedure|0|||
33594267|NCT02164929|62993210|FG003|Overall Study|Converted to open procedure|2|||
33594268|NCT02164929|62993207|FG000|Overall Study|Failed regional block|0|||
33594269|NCT02164929|62993208|FG001|Overall Study|Failed regional block|0|||
33594270|NCT02164929|62993209|FG002|Overall Study|Failed regional block|1|||
33594271|NCT02164929|62993210|FG003|Overall Study|Failed regional block|0|||
33594272|NCT01888432|62993222|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
33594273|NCT01888432|62993223|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
33594274|NCT01888432|62993222|FG000|12-month Analysis (FAS)|Physician Decision|1|||
33594275|NCT01888432|62993223|FG001|12-month Analysis (FAS)|Physician Decision|1|||
33594276|NCT01888432|62993222|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
33594277|NCT01888432|62993223|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
33594278|NCT01888432|62993222|FG000|12-month Analysis (FAS)|Death|4|||
33594279|NCT01888432|62993223|FG001|12-month Analysis (FAS)|Death|3|||
33594280|NCT01888432|62993222|FG000|24-month Analysis (FAS)|Graft loss|0|||
33594281|NCT01888432|62993223|FG001|24-month Analysis (FAS)|Graft loss|1|||
33594282|NCT01888432|62993222|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
33594283|NCT01888432|62993223|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
33594284|NCT01888432|62993222|FG000|24-month Analysis (FAS)|Physician Decision|2|||
33594285|NCT01888432|62993223|FG001|24-month Analysis (FAS)|Physician Decision|4|||
33594286|NCT01888432|62993222|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
33594287|NCT01888432|62993223|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
33594288|NCT01888432|62993222|FG000|24-month Analysis (FAS)|Death|8|||
33594289|NCT01888432|62993223|FG001|24-month Analysis (FAS)|Death|4|||
33594290|NCT01888432|62993222|FG000|36-month Analysis (Extension)|Death|1|||
33594291|NCT01888432|62993223|FG001|36-month Analysis (Extension)|Death|0|||
33594292|NCT02188719|62993235|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
33594293|NCT02188719|62993236|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
33594294|NCT02188719|62993237|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
33594295|NCT02188719|62993238|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
33594296|NCT01934140|62993248|FG000|Persistence Phase (Year 6-10)|Other|24|||
33594297|NCT01934140|62993249|FG001|Persistence Phase (Year 6-10)|Other|6|||
33594298|NCT01934140|62993248|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
33594299|NCT01934140|62993249|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
33594300|NCT01934140|62993248|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
33594301|NCT01934140|62993249|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
33594302|NCT01934140|62993248|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
33594303|NCT01934140|62993249|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
33594304|NCT01934140|62993248|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
33594305|NCT01934140|62993249|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
33594306|NCT01934140|62993248|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
33594307|NCT01934140|62993249|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
33594308|NCT01934140|62993248|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
33594309|NCT01934140|62993249|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
33594310|NCT01934140|62993248|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
33594311|NCT01934140|62993249|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
33594312|NCT01933672|62993257|FG000|Metformin Run-in Period|Adverse Event|1|||
33594313|NCT01933672|62993258|FG001|Metformin Run-in Period|Adverse Event|0|||
33594314|NCT01933672|62993259|FG002|Metformin Run-in Period|Adverse Event|0|||
33594315|NCT01933672|62993260|FG003|Metformin Run-in Period|Adverse Event|0|||
33594316|NCT01933672|62993261|FG004|Metformin Run-in Period|Adverse Event|0|||
33594317|NCT01933672|62993262|FG005|Metformin Run-in Period|Adverse Event|0|||
33594318|NCT01933672|62993263|FG006|Metformin Run-in Period|Adverse Event|0|||
33594319|NCT01933672|62993257|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
33594320|NCT01933672|62993258|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
33594321|NCT01933672|62993259|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
33594322|NCT01933672|62993260|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
33594323|NCT01933672|62993261|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
33594324|NCT01933672|62993262|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
33594325|NCT01933672|62993263|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
33594326|NCT01933672|62993257|FG000|Metformin Run-in Period|Other|5|||
33594327|NCT01933672|62993258|FG001|Metformin Run-in Period|Other|0|||
33594328|NCT01933672|62993259|FG002|Metformin Run-in Period|Other|0|||
33594329|NCT01933672|62993260|FG003|Metformin Run-in Period|Other|0|||
33594330|NCT01933672|62993261|FG004|Metformin Run-in Period|Other|0|||
33594331|NCT01933672|62993262|FG005|Metformin Run-in Period|Other|0|||
33594332|NCT01933672|62993263|FG006|Metformin Run-in Period|Other|0|||
33594333|NCT01933672|62993257|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33594334|NCT01933672|62993258|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33594335|NCT01933672|62993259|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33594336|NCT01933672|62993260|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33594337|NCT01933672|62993261|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
33594338|NCT01933672|62993262|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33594339|NCT01933672|62993263|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33594340|NCT01933672|62993257|FG000|First Intervention Period (12-16 Days)|Other|0|||
33594341|NCT01933672|62993258|FG001|First Intervention Period (12-16 Days)|Other|0|||
33594342|NCT01933672|62993259|FG002|First Intervention Period (12-16 Days)|Other|1|||
33594343|NCT01933672|62993260|FG003|First Intervention Period (12-16 Days)|Other|0|||
33594344|NCT01933672|62993261|FG004|First Intervention Period (12-16 Days)|Other|0|||
33594345|NCT01933672|62993262|FG005|First Intervention Period (12-16 Days)|Other|1|||
33594346|NCT01933672|62993263|FG006|First Intervention Period (12-16 Days)|Other|0|||
33594347|NCT01933672|62993257|FG000|Second Intervention Period (12-16 Days)|Other|0|||
33594348|NCT01933672|62993258|FG001|Second Intervention Period (12-16 Days)|Other|1|||
33594349|NCT01933672|62993259|FG002|Second Intervention Period (12-16 Days)|Other|1|||
33594350|NCT01933672|62993260|FG003|Second Intervention Period (12-16 Days)|Other|0|||
33594351|NCT01933672|62993261|FG004|Second Intervention Period (12-16 Days)|Other|0|||
33594352|NCT01933672|62993262|FG005|Second Intervention Period (12-16 Days)|Other|0|||
33594353|NCT01933672|62993263|FG006|Second Intervention Period (12-16 Days)|Other|0|||
33594354|NCT01933672|62993257|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33594355|NCT01933672|62993258|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33594356|NCT01933672|62993259|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33594357|NCT01933672|62993260|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
33594358|NCT01933672|62993261|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33594359|NCT01933672|62993262|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33594360|NCT01933672|62993263|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33594361|NCT01933672|62993257|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
33594362|NCT01933672|62993258|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
33594363|NCT01933672|62993259|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
33594364|NCT01933672|62993260|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
33594365|NCT01933672|62993261|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
33594366|NCT01933672|62993262|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
33594367|NCT01933672|62993263|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
33594368|NCT02164539|62993282|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
33594369|NCT02164539|62993283|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
33594370|NCT02164539|62993284|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
33594371|NCT02164539|62993285|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
33594372|NCT02164539|62993286|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
33594373|NCT02164539|62993287|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
33594374|NCT02164539|62993288|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
33594375|NCT02164539|62993282|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
33594376|NCT02164539|62993283|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
33594377|NCT02164539|62993284|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
33594378|NCT02164539|62993285|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
33594379|NCT02164539|62993286|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
33594380|NCT02164539|62993287|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
33594381|NCT02164539|62993288|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
33594382|NCT02164539|62993282|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
33594383|NCT02164539|62993283|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
33594384|NCT02164539|62993284|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
33594385|NCT02164539|62993285|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
33594386|NCT02164539|62993286|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
33594387|NCT02164539|62993287|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
33594388|NCT02164539|62993288|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
33594389|NCT02164539|62993282|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
33594390|NCT02164539|62993283|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
33594391|NCT02164539|62993284|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
33594392|NCT02164539|62993285|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
33594393|NCT02164539|62993286|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
33594394|NCT02164539|62993287|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
33594395|NCT02164539|62993288|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
33594396|NCT02164539|62993282|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
33594397|NCT02164539|62993283|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
33594398|NCT02164539|62993284|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
33594399|NCT02164539|62993285|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
33594400|NCT02164539|62993286|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
33594401|NCT02164539|62993287|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
33594402|NCT02164539|62993288|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
33594403|NCT02164539|62993282|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
33594404|NCT02164539|62993283|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
33594405|NCT02164539|62993284|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
33594406|NCT02164539|62993285|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
33594407|NCT02164539|62993286|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
33594408|NCT02164539|62993287|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
33594409|NCT02164539|62993288|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
33594410|NCT02188485|62993305|FG000|Overall Study|Withdrawal by Subject|2|||
33594411|NCT02188485|62993306|FG001|Overall Study|Withdrawal by Subject|1|||
33594412|NCT02188485|62993305|FG000|Overall Study|PI withdrew, lack of capacity|0|||
33594413|NCT02188485|62993306|FG001|Overall Study|PI withdrew, lack of capacity|2|||
33594414|NCT02132247|62993314|FG000|Overall Study|Protocol Violation|1|||
33594415|NCT02132247|62993315|FG001|Overall Study|Protocol Violation|0|||
33594416|NCT01629381|62993323|FG000|Overall Study|Withdrawal by Subject|2|||
33594417|NCT01629381|62993324|FG001|Overall Study|Withdrawal by Subject|5|||
33594418|NCT02131311|62993334|FG000|Overall Study|Adverse Event|2|||
33594419|NCT02131311|62993334|FG000|Overall Study|Protocol Violation|1|||
33594420|NCT02131311|62993334|FG000|Overall Study|Lost to Follow-up|1|||
33594421|NCT01628913|62993341|FG000|Overall Study|Adverse Event|12|||
33594422|NCT01628913|62993342|FG001|Overall Study|Adverse Event|5|||
33594423|NCT01628913|62993341|FG000|Overall Study|Disease Progression|11|||
33594424|NCT01628913|62993342|FG001|Overall Study|Disease Progression|14|||
33594425|NCT01628913|62993341|FG000|Overall Study|Protocol Violation|1|||
33594426|NCT01628913|62993342|FG001|Overall Study|Protocol Violation|0|||
33594427|NCT01628913|62993341|FG000|Overall Study|Death|1|||
33594428|NCT01628913|62993342|FG001|Overall Study|Death|0|||
33594429|NCT01628913|62993341|FG000|Overall Study|study terminated by Sponsor|4|||
33594430|NCT01628913|62993342|FG001|Overall Study|study terminated by Sponsor|9|||
33594431|NCT01628913|62993341|FG000|Overall Study|Withdrawal by Subject|1|||
33594432|NCT01628913|62993342|FG001|Overall Study|Withdrawal by Subject|0|||
33594433|NCT01628913|62993341|FG000|Overall Study|Physician Decision|1|||
33594434|NCT01628913|62993342|FG001|Overall Study|Physician Decision|3|||
33594435|NCT02164383|62993350|FG000|Overall Study|Lost to Follow-up|1|||
33594436|NCT02164383|62993351|FG001|Overall Study|Lost to Follow-up|0|||
33594437|NCT02131233|62993359|FG000|Overall Study|Not Treated|2|||
33594438|NCT02131233|62993360|FG001|Overall Study|Not Treated|3|||
33594439|NCT02131233|62993359|FG000|Overall Study|Adverse Event|7|||
33594440|NCT02131233|62993360|FG001|Overall Study|Adverse Event|6|||
33594441|NCT02131233|62993359|FG000|Overall Study|Death|0|||
33594442|NCT02131233|62993360|FG001|Overall Study|Death|1|||
33594443|NCT02131233|62993359|FG000|Overall Study|Lack of Efficacy|6|||
33594444|NCT02131233|62993360|FG001|Overall Study|Lack of Efficacy|3|||
33594445|NCT02131233|62993359|FG000|Overall Study|Lost to Follow-up|14|||
33594446|NCT02131233|62993360|FG001|Overall Study|Lost to Follow-up|13|||
33594447|NCT02131233|62993359|FG000|Overall Study|Non-Compliance With Study Drug|8|||
33594448|NCT02131233|62993360|FG001|Overall Study|Non-Compliance With Study Drug|5|||
33594449|NCT02131233|62993359|FG000|Overall Study|Physician Decision|7|||
33594450|NCT02131233|62993360|FG001|Overall Study|Physician Decision|0|||
33594451|NCT02131233|62993359|FG000|Overall Study|Pregnancy|4|||
33594452|NCT02131233|62993360|FG001|Overall Study|Pregnancy|0|||
33594453|NCT02131233|62993359|FG000|Overall Study|Withdrawal by Subject|18|||
33594454|NCT02131233|62993360|FG001|Overall Study|Withdrawal by Subject|11|||
33594455|NCT02131155|62993368|FG000|Overall Study|Adverse Event|1|||
33594456|NCT02131155|62993369|FG001|Overall Study|Adverse Event|0|||
33594457|NCT02131155|62993368|FG000|Overall Study|Treatment completed|1|||
33594458|NCT02131155|62993369|FG001|Overall Study|Treatment completed|0|||
33594459|NCT02131155|62993368|FG000|Overall Study|Primary tumour recurrence|2|||
33594460|NCT02131155|62993369|FG001|Overall Study|Primary tumour recurrence|1|||
33594461|NCT02131155|62993368|FG000|Overall Study|Refused to continue study medication|1|||
33594462|NCT02131155|62993369|FG001|Overall Study|Refused to continue study medication|0|||
33594463|NCT02131155|62993368|FG000|Overall Study|Study early termination|20|||
33594464|NCT02131155|62993369|FG001|Overall Study|Study early termination|10|||
33594465|NCT01933594|62993381|FG000|Overall Study|Lost to Follow-up|1|||
33594466|NCT01933594|62993382|FG001|Overall Study|Lost to Follow-up|0|||
33594467|NCT01933594|62993383|FG002|Overall Study|Lost to Follow-up|0|||
33594468|NCT01933594|62993384|FG003|Overall Study|Lost to Follow-up|0|||
33594469|NCT01933594|62993385|FG004|Overall Study|Lost to Follow-up|1|||
33594470|NCT01933594|62993386|FG005|Overall Study|Lost to Follow-up|0|||
33594471|NCT01933594|62993381|FG000|Overall Study|Ineligible for subsequent study step|0|||
33594472|NCT01933594|62993382|FG001|Overall Study|Ineligible for subsequent study step|0|||
33594473|NCT01933594|62993383|FG002|Overall Study|Ineligible for subsequent study step|0|||
33594474|NCT01933594|62993384|FG003|Overall Study|Ineligible for subsequent study step|0|||
33594475|NCT01933594|62993385|FG004|Overall Study|Ineligible for subsequent study step|1|||
33594476|NCT01933594|62993386|FG005|Overall Study|Ineligible for subsequent study step|0|||
33594477|NCT01932970|62993404|FG000|Overall Study|Withdrawal by Subject|5|||
33594478|NCT01932970|62993404|FG000|Overall Study|Death|1|||
33594479|NCT01932970|62993404|FG000|Overall Study|Lost to Follow-up|2|||
33594480|NCT01932970|62993404|FG000|Overall Study|Protocol Specified Criteria|10|||
33594481|NCT01912768|62993410|FG000|Overall Study|Adverse Event|2|||
33594482|NCT01912768|62993411|FG001|Overall Study|Adverse Event|0|||
33594483|NCT01912768|62993410|FG000|Overall Study|Lost to Follow-up|2|||
33594484|NCT01912768|62993411|FG001|Overall Study|Lost to Follow-up|1|||
33594485|NCT01912768|62993410|FG000|Overall Study|Withdrawal by Subject|5|||
33594486|NCT01912768|62993411|FG001|Overall Study|Withdrawal by Subject|3|||
33594487|NCT01912768|62993410|FG000|Overall Study|Randomized in error|1|||
33594488|NCT01912768|62993411|FG001|Overall Study|Randomized in error|0|||
33594489|NCT02305849|62993421|FG000|Overall Study|Adverse Event|10|||
33594490|NCT02305849|62993422|FG001|Overall Study|Adverse Event|12|||
33594491|NCT02305849|62993423|FG002|Overall Study|Adverse Event|7|||
33594492|NCT02305849|62993424|FG003|Overall Study|Adverse Event|3|||
33594493|NCT02305849|62993421|FG000|Overall Study|Lack of Efficacy|10|||
33594494|NCT02305849|62993422|FG001|Overall Study|Lack of Efficacy|6|||
33594495|NCT02305849|62993423|FG002|Overall Study|Lack of Efficacy|3|||
33594496|NCT02305849|62993424|FG003|Overall Study|Lack of Efficacy|9|||
33594497|NCT02305849|62993421|FG000|Overall Study|Withdrawal by Subject|2|||
33594498|NCT02305849|62993422|FG001|Overall Study|Withdrawal by Subject|2|||
33594499|NCT02305849|62993423|FG002|Overall Study|Withdrawal by Subject|1|||
33594500|NCT02305849|62993424|FG003|Overall Study|Withdrawal by Subject|4|||
33594501|NCT02305849|62993421|FG000|Overall Study|Lost to Follow-up|0|||
33594502|NCT02305849|62993422|FG001|Overall Study|Lost to Follow-up|2|||
33594503|NCT02305849|62993423|FG002|Overall Study|Lost to Follow-up|0|||
33594504|NCT02305849|62993424|FG003|Overall Study|Lost to Follow-up|0|||
33594505|NCT02305849|62993421|FG000|Overall Study|Protocol Violation|3|||
33594506|NCT02305849|62993422|FG001|Overall Study|Protocol Violation|2|||
33594507|NCT02305849|62993423|FG002|Overall Study|Protocol Violation|1|||
33594508|NCT02305849|62993424|FG003|Overall Study|Protocol Violation|1|||
33594509|NCT02305849|62993421|FG000|Overall Study|Lab data met discontinuation criteria|0|||
33594510|NCT02305849|62993422|FG001|Overall Study|Lab data met discontinuation criteria|1|||
33594511|NCT02305849|62993423|FG002|Overall Study|Lab data met discontinuation criteria|2|||
33594512|NCT02305849|62993424|FG003|Overall Study|Lab data met discontinuation criteria|1|||
33594513|NCT02305849|62993421|FG000|Overall Study|Miscellaneous|1|||
33594514|NCT02305849|62993422|FG001|Overall Study|Miscellaneous|2|||
33680636|NCT01431950|63136845|FG000|Overall Study|Adverse Event|2|||
33594515|NCT02305849|62993423|FG002|Overall Study|Miscellaneous|4|||
33594516|NCT02305849|62993424|FG003|Overall Study|Miscellaneous|1|||
33594517|NCT02305849|62993421|FG000|Overall Study|Not fulfill eligibility criteria|1|||
33594518|NCT02305849|62993422|FG001|Overall Study|Not fulfill eligibility criteria|1|||
33594519|NCT02305849|62993423|FG002|Overall Study|Not fulfill eligibility criteria|0|||
33594520|NCT02305849|62993424|FG003|Overall Study|Not fulfill eligibility criteria|0|||
33680637|NCT01431950|63136846|FG001|Overall Study|Adverse Event|2|||
33594521|NCT02371759|62993463|FG000|Overall Study|Protocol Violation|3|||
33680638|NCT01431950|63136845|FG000|Overall Study|Physician Decision|2|||
33594522|NCT02371759|62993464|FG001|Overall Study|Protocol Violation|1|||
33594523|NCT02371759|62993465|FG002|Overall Study|Protocol Violation|1|||
33594524|NCT02371759|62993466|FG003|Overall Study|Protocol Violation|0|||
33594525|NCT02371759|62993467|FG004|Overall Study|Protocol Violation|3|||
33594526|NCT02371759|62993468|FG005|Overall Study|Protocol Violation|1|||
33594527|NCT02371759|62993469|FG006|Overall Study|Protocol Violation|0|||
33594528|NCT02371759|62993470|FG007|Overall Study|Protocol Violation|3|||
33594529|NCT02371759|62993463|FG000|Overall Study|Withdrawal by Subject|0|||
33594530|NCT02371759|62993464|FG001|Overall Study|Withdrawal by Subject|0|||
33594531|NCT02371759|62993465|FG002|Overall Study|Withdrawal by Subject|0|||
33594532|NCT02371759|62993466|FG003|Overall Study|Withdrawal by Subject|0|||
33594533|NCT02371759|62993467|FG004|Overall Study|Withdrawal by Subject|0|||
33594534|NCT02371759|62993468|FG005|Overall Study|Withdrawal by Subject|0|||
33594535|NCT02371759|62993469|FG006|Overall Study|Withdrawal by Subject|0|||
33594536|NCT02371759|62993470|FG007|Overall Study|Withdrawal by Subject|1|||
33594537|NCT02531633|62993493|FG000|Part A (52 Weeks)|Sponsor request|24|||
33594538|NCT02531633|62993494|FG001|Part A (52 Weeks)|Sponsor request|24|||
33594539|NCT02531633|62993495|FG002|Part A (52 Weeks)|Sponsor request|18|||
33594540|NCT02531633|62993496|FG003|Part A (52 Weeks)|Sponsor request|18|||
33594541|NCT02531633|62993497|FG004|Part A (52 Weeks)|Sponsor request|19|||
33594542|NCT02531633|62993498|FG005|Part A (52 Weeks)|Sponsor request|0|||
33594543|NCT02531633|62993499|FG006|Part A (52 Weeks)|Sponsor request|0|||
33594544|NCT02531633|62993500|FG007|Part A (52 Weeks)|Sponsor request|0|||
33594545|NCT02531633|62993501|FG008|Part A (52 Weeks)|Sponsor request|0|||
33594546|NCT02531633|62993502|FG009|Part A (52 Weeks)|Sponsor request|0|||
33594547|NCT02531633|62993493|FG000|Part A (52 Weeks)|Protocol Violation|1|||
33594548|NCT02531633|62993494|FG001|Part A (52 Weeks)|Protocol Violation|0|||
33594549|NCT02531633|62993495|FG002|Part A (52 Weeks)|Protocol Violation|0|||
33594550|NCT02531633|62993496|FG003|Part A (52 Weeks)|Protocol Violation|0|||
33594551|NCT02531633|62993497|FG004|Part A (52 Weeks)|Protocol Violation|0|||
33594552|NCT02531633|62993498|FG005|Part A (52 Weeks)|Protocol Violation|0|||
33594553|NCT02531633|62993499|FG006|Part A (52 Weeks)|Protocol Violation|0|||
33594554|NCT02531633|62993500|FG007|Part A (52 Weeks)|Protocol Violation|0|||
33594555|NCT02531633|62993501|FG008|Part A (52 Weeks)|Protocol Violation|0|||
33594556|NCT02531633|62993502|FG009|Part A (52 Weeks)|Protocol Violation|0|||
33594557|NCT02531633|62993493|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
33594558|NCT02531633|62993494|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
33594559|NCT02531633|62993495|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
33594560|NCT02531633|62993496|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
33594561|NCT02531633|62993497|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
33594562|NCT02531633|62993498|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
33594563|NCT02531633|62993499|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
33594564|NCT02531633|62993500|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
33594565|NCT02531633|62993501|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
33594566|NCT02531633|62993502|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
33594567|NCT02531633|62993493|FG000|Part A (52 Weeks)|Physician Decision|1|||
33594568|NCT02531633|62993494|FG001|Part A (52 Weeks)|Physician Decision|4|||
33594569|NCT02531633|62993495|FG002|Part A (52 Weeks)|Physician Decision|3|||
33594570|NCT02531633|62993496|FG003|Part A (52 Weeks)|Physician Decision|1|||
33594571|NCT02531633|62993497|FG004|Part A (52 Weeks)|Physician Decision|0|||
33594572|NCT02531633|62993498|FG005|Part A (52 Weeks)|Physician Decision|0|||
33594573|NCT02531633|62993499|FG006|Part A (52 Weeks)|Physician Decision|0|||
33594574|NCT02531633|62993500|FG007|Part A (52 Weeks)|Physician Decision|0|||
33594575|NCT02531633|62993501|FG008|Part A (52 Weeks)|Physician Decision|0|||
33594576|NCT02531633|62993502|FG009|Part A (52 Weeks)|Physician Decision|0|||
33594577|NCT02531633|62993493|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
33594578|NCT02531633|62993494|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
33594579|NCT02531633|62993495|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
33594580|NCT02531633|62993496|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
33594581|NCT02531633|62993497|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
33594582|NCT02531633|62993498|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
33594583|NCT02531633|62993499|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
33594584|NCT02531633|62993500|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
33594585|NCT02531633|62993501|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
33594586|NCT02531633|62993502|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
33594587|NCT02531633|62993493|FG000|Part A (52 Weeks)|Other|2|||
33594588|NCT02531633|62993494|FG001|Part A (52 Weeks)|Other|0|||
33594589|NCT02531633|62993495|FG002|Part A (52 Weeks)|Other|0|||
33594590|NCT02531633|62993496|FG003|Part A (52 Weeks)|Other|0|||
33594591|NCT02531633|62993497|FG004|Part A (52 Weeks)|Other|0|||
33680639|NCT01431950|63136846|FG001|Overall Study|Physician Decision|1|||
33594592|NCT02531633|62993498|FG005|Part A (52 Weeks)|Other|0|||
33594593|NCT02531633|62993499|FG006|Part A (52 Weeks)|Other|0|||
33594594|NCT02531633|62993500|FG007|Part A (52 Weeks)|Other|0|||
33594595|NCT02531633|62993501|FG008|Part A (52 Weeks)|Other|0|||
33594596|NCT02531633|62993502|FG009|Part A (52 Weeks)|Other|0|||
33594597|NCT02531633|62993493|FG000|Part B (104 Weeks)|Sponsor request|0|||
33594598|NCT02531633|62993494|FG001|Part B (104 Weeks)|Sponsor request|0|||
33594599|NCT02531633|62993495|FG002|Part B (104 Weeks)|Sponsor request|0|||
33594600|NCT02531633|62993496|FG003|Part B (104 Weeks)|Sponsor request|0|||
33594601|NCT02531633|62993497|FG004|Part B (104 Weeks)|Sponsor request|0|||
33594602|NCT02531633|62993498|FG005|Part B (104 Weeks)|Sponsor request|8|||
33594603|NCT02531633|62993499|FG006|Part B (104 Weeks)|Sponsor request|5|||
33594604|NCT02531633|62993500|FG007|Part B (104 Weeks)|Sponsor request|3|||
33594605|NCT02531633|62993501|FG008|Part B (104 Weeks)|Sponsor request|5|||
33594606|NCT02531633|62993502|FG009|Part B (104 Weeks)|Sponsor request|4|||
33594607|NCT02531633|62993493|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
33594608|NCT02531633|62993494|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
33594609|NCT02531633|62993495|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
33594610|NCT02531633|62993496|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
33594611|NCT02531633|62993497|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
33594612|NCT02531633|62993498|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
33594613|NCT02531633|62993499|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
33594614|NCT02531633|62993500|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
33594615|NCT02531633|62993501|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
33594616|NCT02531633|62993502|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
33594617|NCT02536313|62993544|FG000|Overall Study|Lack of Efficacy|0|||
33594618|NCT02536313|62993545|FG001|Overall Study|Lack of Efficacy|1|||
33680640|NCT01431950|63136845|FG000|Overall Study|Lack of Efficacy|2|||
33680641|NCT01431950|63136846|FG001|Overall Study|Lack of Efficacy|1|||
33680642|NCT01431950|63136845|FG000|Overall Study|Lost to Follow-up|0|||
33680643|NCT01431950|63136846|FG001|Overall Study|Lost to Follow-up|1|||
33680644|NCT01431950|63136845|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
33680645|NCT01431950|63136846|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33680646|NCT00551031|63136857|FG000|Overall Study|Adverse Event|0|||
33680647|NCT00551031|63136858|FG001|Overall Study|Adverse Event|1|||
33680648|NCT00551031|63136859|FG002|Overall Study|Adverse Event|0|||
33680649|NCT00551031|63136860|FG003|Overall Study|Adverse Event|0|||
33680650|NCT00551031|63136861|FG004|Overall Study|Adverse Event|0|||
33680651|NCT00551031|63136857|FG000|Overall Study|Protocol Violation|1|||
33680652|NCT00551031|63136858|FG001|Overall Study|Protocol Violation|1|||
33680653|NCT00551031|63136859|FG002|Overall Study|Protocol Violation|0|||
33680654|NCT00551031|63136860|FG003|Overall Study|Protocol Violation|0|||
33680655|NCT00551031|63136861|FG004|Overall Study|Protocol Violation|0|||
33680656|NCT00551031|63136857|FG000|Overall Study|Lost to Follow-up|0|||
33680657|NCT00551031|63136858|FG001|Overall Study|Lost to Follow-up|1|||
33680658|NCT00551031|63136859|FG002|Overall Study|Lost to Follow-up|0|||
33680659|NCT00551031|63136860|FG003|Overall Study|Lost to Follow-up|1|||
33680660|NCT00551031|63136861|FG004|Overall Study|Lost to Follow-up|1|||
33680661|NCT00551031|63136857|FG000|Overall Study|Withdrawal by Subject|0|||
33680662|NCT00551031|63136858|FG001|Overall Study|Withdrawal by Subject|4|||
33680663|NCT00551031|63136859|FG002|Overall Study|Withdrawal by Subject|1|||
33680664|NCT00551031|63136860|FG003|Overall Study|Withdrawal by Subject|2|||
33680665|NCT00551031|63136861|FG004|Overall Study|Withdrawal by Subject|0|||
33680666|NCT00551031|63136857|FG000|Overall Study|Serious Adverse Event|0|||
33680667|NCT00551031|63136858|FG001|Overall Study|Serious Adverse Event|2|||
33680668|NCT00551031|63136859|FG002|Overall Study|Serious Adverse Event|1|||
33680669|NCT00551031|63136860|FG003|Overall Study|Serious Adverse Event|0|||
33680670|NCT00551031|63136861|FG004|Overall Study|Serious Adverse Event|0|||
33680671|NCT00551031|63136857|FG000|Overall Study|Did not receive vaccine|1|||
33680672|NCT00551031|63136858|FG001|Overall Study|Did not receive vaccine|2|||
33680673|NCT00551031|63136859|FG002|Overall Study|Did not receive vaccine|0|||
33680674|NCT00551031|63136860|FG003|Overall Study|Did not receive vaccine|0|||
33680675|NCT00551031|63136861|FG004|Overall Study|Did not receive vaccine|0|||
33680676|NCT01431716|63136873|FG000|Overall Study|Withdrawal of consent|1|||
33680677|NCT00550953|63136879|FG000|Overall Study|Adverse Event|4|||
33680678|NCT00550953|63136880|FG001|Overall Study|Adverse Event|3|||
33680679|NCT00550953|63136879|FG000|Overall Study|Not able to visit the site|2|||
33680680|NCT00550953|63136880|FG001|Overall Study|Not able to visit the site|3|||
33680681|NCT00558831|63136915|FG000|Overall Study|Lost to Follow-up|1|||
33680682|NCT01431638|63136924|FG000|Overall Study|Adverse Event|1|||
33680683|NCT01431638|63136925|FG001|Overall Study|Adverse Event|3|||
33680684|NCT01431638|63136926|FG002|Overall Study|Adverse Event|1|||
33594619|NCT02187861|62993557|FG000|Overall Study|Adverse Event|2|||
33594620|NCT02187861|62993558|FG001|Overall Study|Adverse Event|1|||
33594621|NCT02187861|62993559|FG002|Overall Study|Adverse Event|2|||
33594622|NCT02187861|62993560|FG003|Overall Study|Adverse Event|1|||
33680685|NCT01431638|63136924|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33680686|NCT01431638|63136925|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33680687|NCT01431638|63136926|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
33680688|NCT01431638|63136924|FG000|Overall Study|Participants condition no longer requires study drug|0|||
33680689|NCT01431638|63136925|FG001|Overall Study|Participants condition no longer requires study drug|1|||
33680690|NCT01431638|63136926|FG002|Overall Study|Participants condition no longer requires study drug|0|||
33680691|NCT01431638|63136924|FG000|Overall Study|Participant withdrew consent|14|||
33680692|NCT01431638|63136925|FG001|Overall Study|Participant withdrew consent|5|||
33680693|NCT01431638|63136926|FG002|Overall Study|Participant withdrew consent|8|||
33680694|NCT01431638|63136924|FG000|Overall Study|Lost to Follow-up|7|||
33680695|NCT01431638|63136925|FG001|Overall Study|Lost to Follow-up|9|||
33680696|NCT01431638|63136926|FG002|Overall Study|Lost to Follow-up|7|||
33680697|NCT01431638|63136924|FG000|Overall Study|Administrative problems|1|||
33680698|NCT01431638|63136925|FG001|Overall Study|Administrative problems|4|||
33680699|NCT01431638|63136926|FG002|Overall Study|Administrative problems|6|||
33680700|NCT01431638|63136924|FG000|Overall Study|Death|1|||
33680701|NCT01431638|63136925|FG001|Overall Study|Death|0|||
33680702|NCT01431638|63136926|FG002|Overall Study|Death|0|||
33680703|NCT01431638|63136924|FG000|Overall Study|Protocol deviation|1|||
33680704|NCT01431638|63136925|FG001|Overall Study|Protocol deviation|1|||
33680705|NCT01431638|63136926|FG002|Overall Study|Protocol deviation|4|||
33680706|NCT01431638|63136924|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
33680707|NCT01431638|63136925|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
33680708|NCT01431638|63136926|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
33680709|NCT01392170|63136934|FG000|Overall Study|Withdrawal by Subject|1|||
33680710|NCT01392170|63136934|FG000|Overall Study|Ineligible|1|||
33680711|NCT00558753|63136940|FG000|Overall Study|Lost to Follow-up|5|||
33680712|NCT00558753|63136941|FG001|Overall Study|Lost to Follow-up|7|||
33680713|NCT01391546|63136949|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
33680714|NCT01391546|63136950|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
33680715|NCT01410110|63136959|FG000|Overall Study|Withdrawal by Subject|4|||
33680716|NCT01410110|63136960|FG001|Overall Study|Withdrawal by Subject|2|||
33680717|NCT01391000|63136968|FG000|Overall Study|Lost to Follow-up|2|||
33680718|NCT01391000|63136969|FG001|Overall Study|Lost to Follow-up|0|||
33680719|NCT01390844|63137044|FG000|Treatment Phase|Adverse Event|12|||
33680720|NCT01390844|63137045|FG001|Treatment Phase|Adverse Event|2|||
33680721|NCT01390844|63137046|FG002|Treatment Phase|Adverse Event|3|||
33680722|NCT01390844|63137047|FG003|Treatment Phase|Adverse Event|2|||
33680723|NCT01390844|63137044|FG000|Treatment Phase|Treatment Failure|23|||
33680724|NCT01390844|63137045|FG001|Treatment Phase|Treatment Failure|25|||
33680725|NCT01390844|63137046|FG002|Treatment Phase|Treatment Failure|10|||
33680726|NCT01390844|63137047|FG003|Treatment Phase|Treatment Failure|13|||
33680727|NCT01390844|63137044|FG000|Treatment Phase|Non-Medical Reasons|5|||
33680728|NCT01390844|63137045|FG001|Treatment Phase|Non-Medical Reasons|1|||
33680729|NCT01390844|63137046|FG002|Treatment Phase|Non-Medical Reasons|8|||
33680730|NCT01390844|63137047|FG003|Treatment Phase|Non-Medical Reasons|1|||
33680731|NCT01390844|63137044|FG000|Treatment Phase|Non-GCP Compliant|0|||
33680732|NCT01390844|63137045|FG001|Treatment Phase|Non-GCP Compliant|0|||
33680733|NCT01390844|63137046|FG002|Treatment Phase|Non-GCP Compliant|10|||
33680734|NCT01390844|63137047|FG003|Treatment Phase|Non-GCP Compliant|3|||
33680735|NCT01390844|63137044|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
33680736|NCT01390844|63137045|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
33680737|NCT01390844|63137046|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
33680738|NCT01390844|63137047|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
33680739|NCT01430624|63137060|FG000|Overall Study|Lost to Follow-up|23|||
33680740|NCT01430624|63137061|FG001|Overall Study|Lost to Follow-up|29|||
33680741|NCT01430624|63137062|FG002|Overall Study|Lost to Follow-up|27|||
33680742|NCT01430624|63137060|FG000|Overall Study|technical or eligibility|5|||
33680743|NCT01430624|63137061|FG001|Overall Study|technical or eligibility|5|||
33594623|NCT02187861|62993557|FG000|Overall Study|Death|0|||
33594624|NCT02187861|62993558|FG001|Overall Study|Death|3|||
33594625|NCT02187861|62993559|FG002|Overall Study|Death|1|||
33594626|NCT02187861|62993560|FG003|Overall Study|Death|2|||
33594627|NCT02187861|62993557|FG000|Overall Study|Physician Decision|0|||
33594628|NCT02187861|62993558|FG001|Overall Study|Physician Decision|1|||
33594629|NCT02187861|62993559|FG002|Overall Study|Physician Decision|0|||
33594630|NCT02187861|62993560|FG003|Overall Study|Physician Decision|3|||
33594631|NCT02187861|62993557|FG000|Overall Study|Progressive Disease|4|||
33594632|NCT02187861|62993558|FG001|Overall Study|Progressive Disease|42|||
33594633|NCT02187861|62993559|FG002|Overall Study|Progressive Disease|19|||
33594634|NCT02187861|62993560|FG003|Overall Study|Progressive Disease|22|||
33680744|NCT01430624|63137062|FG002|Overall Study|technical or eligibility|2|||
33680745|NCT01430468|63137087|FG000|Overall Study|Physician Decision|2|||
33680746|NCT01430468|63137088|FG001|Overall Study|Physician Decision|1|||
33680747|NCT01430468|63137087|FG000|Overall Study|Withdrawal by Subject|5|||
33680748|NCT01430468|63137088|FG001|Overall Study|Withdrawal by Subject|5|||
33680749|NCT01409564|63137109|FG000|Overall Study|low medication compliance|4|||
33680750|NCT01409564|63137110|FG001|Overall Study|low medication compliance|3|||
33680751|NCT01409564|63137109|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
33680752|NCT01409564|63137110|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
33680753|NCT01390298|63137120|FG000|Overall Study|Death|1|||
33680754|NCT01390298|63137120|FG000|Overall Study|long term ICU admission|1|||
33594635|NCT02187861|62993557|FG000|Overall Study|Withdrawal by Subject|0|||
33594636|NCT02187861|62993558|FG001|Overall Study|Withdrawal by Subject|0|||
33594637|NCT02187861|62993559|FG002|Overall Study|Withdrawal by Subject|3|||
33680755|NCT01390298|63137120|FG000|Overall Study|Withdrawal by Subject|14|||
33680756|NCT01390298|63137120|FG000|Overall Study|Lost to Follow-up|7|||
33680757|NCT01390298|63137120|FG000|Overall Study|Surgery cancelled|1|||
33680758|NCT01390220|63137138|FG000|Test Dose Phase|Adverse Event|17|||
33680759|NCT01390220|63137139|FG001|Test Dose Phase|Adverse Event|0|||
33680760|NCT01390220|63137140|FG002|Test Dose Phase|Adverse Event|0|||
33680761|NCT01390220|63137138|FG000|Test Dose Phase|Withdrawal by Subject|8|||
33680762|NCT01390220|63137139|FG001|Test Dose Phase|Withdrawal by Subject|0|||
33680763|NCT01390220|63137140|FG002|Test Dose Phase|Withdrawal by Subject|0|||
33680764|NCT01390220|63137138|FG000|Test Dose Phase|Lost to Follow-up|2|||
33680765|NCT01390220|63137139|FG001|Test Dose Phase|Lost to Follow-up|0|||
33680766|NCT01390220|63137140|FG002|Test Dose Phase|Lost to Follow-up|0|||
33680767|NCT01390220|63137138|FG000|Test Dose Phase|Protocol Violation|8|||
33680768|NCT01390220|63137139|FG001|Test Dose Phase|Protocol Violation|0|||
33680769|NCT01390220|63137140|FG002|Test Dose Phase|Protocol Violation|0|||
33680770|NCT01390220|63137138|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
33680771|NCT01390220|63137139|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
33680772|NCT01390220|63137140|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
33680773|NCT01390220|63137138|FG000|Test Dose Phase|Study/Site closure|6|||
33680774|NCT01390220|63137139|FG001|Test Dose Phase|Study/Site closure|0|||
33680775|NCT01390220|63137140|FG002|Test Dose Phase|Study/Site closure|0|||
33680776|NCT01390220|63137138|FG000|Test Dose Phase|Caregiver no longer available|5|||
33680777|NCT01390220|63137139|FG001|Test Dose Phase|Caregiver no longer available|0|||
33680778|NCT01390220|63137140|FG002|Test Dose Phase|Caregiver no longer available|0|||
33680779|NCT01390220|63137138|FG000|Test Dose Phase|Noncompliance|2|||
33680780|NCT01390220|63137139|FG001|Test Dose Phase|Noncompliance|0|||
33680781|NCT01390220|63137140|FG002|Test Dose Phase|Noncompliance|0|||
33680782|NCT01390220|63137138|FG000|Test Dose Phase|Logistical|6|||
33680783|NCT01390220|63137139|FG001|Test Dose Phase|Logistical|0|||
33680784|NCT01390220|63137140|FG002|Test Dose Phase|Logistical|0|||
33680785|NCT01390220|63137138|FG000|Comparative Phase|Withdrawal by Subject|0|||
33680786|NCT01390220|63137139|FG001|Comparative Phase|Withdrawal by Subject|1|||
33680787|NCT01390220|63137140|FG002|Comparative Phase|Withdrawal by Subject|0|||
33680788|NCT00550173|63137170|FG000|Overall Study|Death|45|||
33680789|NCT00550173|63137171|FG001|Overall Study|Death|38|||
33680790|NCT00550173|63137172|FG002|Overall Study|Death|50|||
33680791|NCT00550173|63137170|FG000|Overall Study|Physician Decision|1|||
33680792|NCT00550173|63137171|FG001|Overall Study|Physician Decision|2|||
33680793|NCT00550173|63137172|FG002|Overall Study|Physician Decision|2|||
33680794|NCT00550173|63137170|FG000|Overall Study|Withdrawal by Subject|9|||
33680795|NCT00550173|63137171|FG001|Overall Study|Withdrawal by Subject|12|||
33680796|NCT00550173|63137172|FG002|Overall Study|Withdrawal by Subject|17|||
33680797|NCT00550173|63137170|FG000|Overall Study|Sponsor Decision|13|||
33680798|NCT00550173|63137171|FG001|Overall Study|Sponsor Decision|7|||
33680799|NCT00550173|63137172|FG002|Overall Study|Sponsor Decision|1|||
33680800|NCT00550173|63137170|FG000|Overall Study|Lost to Follow-up|4|||
33680801|NCT00550173|63137171|FG001|Overall Study|Lost to Follow-up|4|||
33680802|NCT00550173|63137172|FG002|Overall Study|Lost to Follow-up|3|||
33680803|NCT01429298|63137183|FG000|Overall Study|Protocol Violation|4|||
33680804|NCT01429298|63137184|FG001|Overall Study|Protocol Violation|6|||
33680805|NCT01408706|63137196|FG000|Overall Study|Physician Decision|1|||
33680806|NCT01408706|63137197|FG001|Overall Study|Physician Decision|0|||
33680807|NCT01408628|63137205|FG000|Consented|Withdrawal by Subject|12|||
33680808|NCT01408628|63137205|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
33680809|NCT01408628|63137205|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
33680810|NCT01408628|63137205|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
33680811|NCT01389752|63137210|FG000|Study Period 1|Sponsor decision|0|||
33680812|NCT01389752|63137211|FG001|Study Period 1|Sponsor decision|2|||
33680813|NCT01389752|63137210|FG000|Study Period 2|Sponsor decision|1|||
33680814|NCT01389752|63137211|FG001|Study Period 2|Sponsor decision|0|||
33493098|NCT03145064|62871138|FG000|Overall Study|Lost to Follow-up|3|||
33680815|NCT01428128|63137218|FG000|Overall Study|Withdrawal by Subject|4|||
33680816|NCT01428128|63137218|FG000|Overall Study|Screen failure by p53|10|||
33680817|NCT01428128|63137218|FG000|Overall Study|Received Neulasta in one cycle|2|||
33680818|NCT01428128|63137218|FG000|Overall Study|Adverse Event|1|||
33680819|NCT01407926|63137223|FG000|Overall Study|Lost to Follow-up|55|||
33680820|NCT01427972|63137250|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33680821|NCT01427972|63137251|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33680822|NCT01427972|63137252|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33680823|NCT01427972|63137253|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33680824|NCT01427972|63137254|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33680825|NCT01427972|63137255|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33680826|NCT01427972|63137256|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33680827|NCT01427972|63137257|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
33493099|NCT03145064|62871138|FG000|Overall Study|Withdrawal by Subject|6|||
33680828|NCT01427972|63137258|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33680829|NCT01427972|63137259|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33680830|NCT01427972|63137260|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33680831|NCT01427972|63137261|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33680832|NCT01427972|63137250|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33680833|NCT01427972|63137251|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33680834|NCT01427972|63137252|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33680835|NCT01427972|63137253|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33680836|NCT01427972|63137254|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33680837|NCT01427972|63137255|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
33680838|NCT01427972|63137256|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33680839|NCT01427972|63137257|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33680840|NCT01427972|63137258|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33680841|NCT01427972|63137259|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33680842|NCT01427972|63137260|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33680843|NCT01427972|63137261|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33680844|NCT01427972|63137250|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33680845|NCT01427972|63137251|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
33680846|NCT01427972|63137252|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33680847|NCT01427972|63137253|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33680848|NCT01427972|63137254|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33680849|NCT01427972|63137255|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33680850|NCT01427972|63137256|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33680851|NCT01427972|63137257|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33680852|NCT01427972|63137258|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33680853|NCT01427972|63137259|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33680854|NCT01427972|63137260|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33680855|NCT01427972|63137261|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33680856|NCT01427738|63137298|FG000|Overall Study|Death|12|||
33680857|NCT01427738|63137299|FG001|Overall Study|Death|9|||
33680858|NCT01427738|63137298|FG000|Overall Study|Severe debilitation, unable to continue|0|||
33680859|NCT01427738|63137299|FG001|Overall Study|Severe debilitation, unable to continue|1|||
33680860|NCT01427738|63137298|FG000|Overall Study|Subject unable to get to clinic|5|||
33680861|NCT01427738|63137299|FG001|Overall Study|Subject unable to get to clinic|2|||
33680862|NCT01427738|63137298|FG000|Overall Study|Withdrawal by Subject|0|||
33680863|NCT01427738|63137299|FG001|Overall Study|Withdrawal by Subject|2|||
33680864|NCT01427738|63137298|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
33680865|NCT01427738|63137299|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
33680866|NCT01427738|63137298|FG000|Overall Study|Lost to Follow-up|1|||
33680867|NCT01427738|63137299|FG001|Overall Study|Lost to Follow-up|5|||
33680868|NCT01426958|63137305|FG000|Overall Study|Adverse Event|2|||
33680869|NCT02578992|63137483|FG000|Overall Study|equipment not available or malfunction|3|||
33680870|NCT02578992|63137484|FG001|Overall Study|equipment not available or malfunction|3|||
33680871|NCT00558519|63137548|FG000|Overall Study|Ph+|20|||
33680872|NCT00558519|63137548|FG000|Overall Study|Ineligible|1|||
33680873|NCT00558519|63137548|FG000|Overall Study|Insufficient data|1|||
33680874|NCT00558519|63137548|FG000|Overall Study|Never received treatment|1|||
33680875|NCT00558285|63137592|FG000|Overall Study|Adverse Event|1|||
33680876|NCT00558285|63137593|FG001|Overall Study|Adverse Event|1|||
33680877|NCT00558285|63137594|FG002|Overall Study|Adverse Event|4|||
33680878|NCT00558285|63137595|FG003|Overall Study|Adverse Event|1|||
33680879|NCT00558285|63137596|FG004|Overall Study|Adverse Event|2|||
33680880|NCT00558285|63137592|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33680881|NCT00558285|63137593|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33680882|NCT00558285|63137594|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33680883|NCT00558285|63137595|FG003|Overall Study|Abnormal test procedure result(s)|0|||
33680884|NCT00558285|63137596|FG004|Overall Study|Abnormal test procedure result(s)|0|||
33680885|NCT00558285|63137592|FG000|Overall Study|Subject withdrew consent|2|||
33680886|NCT00558285|63137593|FG001|Overall Study|Subject withdrew consent|0|||
33680887|NCT00558285|63137594|FG002|Overall Study|Subject withdrew consent|1|||
33680888|NCT00558285|63137595|FG003|Overall Study|Subject withdrew consent|1|||
33680889|NCT00558285|63137596|FG004|Overall Study|Subject withdrew consent|1|||
33680890|NCT00558285|63137592|FG000|Overall Study|Lost to Follow-up|1|||
33680891|NCT00558285|63137593|FG001|Overall Study|Lost to Follow-up|1|||
33680892|NCT00558285|63137594|FG002|Overall Study|Lost to Follow-up|0|||
33680893|NCT00558285|63137595|FG003|Overall Study|Lost to Follow-up|0|||
33680894|NCT00558285|63137596|FG004|Overall Study|Lost to Follow-up|0|||
33680895|NCT00558285|63137592|FG000|Overall Study|Administrative problems|0|||
33680896|NCT00558285|63137593|FG001|Overall Study|Administrative problems|0|||
33680897|NCT00558285|63137594|FG002|Overall Study|Administrative problems|0|||
33680898|NCT00558285|63137595|FG003|Overall Study|Administrative problems|1|||
33680899|NCT00558285|63137596|FG004|Overall Study|Administrative problems|1|||
33680900|NCT00558285|63137592|FG000|Overall Study|Protocol deviation|1|||
33680901|NCT00558285|63137593|FG001|Overall Study|Protocol deviation|1|||
33680902|NCT00558285|63137594|FG002|Overall Study|Protocol deviation|0|||
33680903|NCT00558285|63137595|FG003|Overall Study|Protocol deviation|1|||
33680904|NCT00558285|63137596|FG004|Overall Study|Protocol deviation|0|||
33680905|NCT01389596|63137611|FG000|Overall Study|Protocol Violation|3|||
33680906|NCT01389596|63137612|FG001|Overall Study|Protocol Violation|4|||
33680907|NCT01389596|63137613|FG002|Overall Study|Protocol Violation|3|||
33680908|NCT01389596|63137611|FG000|Overall Study|Withdrawal by Subject|1|||
33680909|NCT01389596|63137612|FG001|Overall Study|Withdrawal by Subject|2|||
33680910|NCT01389596|63137613|FG002|Overall Study|Withdrawal by Subject|2|||
33680911|NCT01389596|63137611|FG000|Overall Study|Insufficient Clinical Response|3|||
33680912|NCT01389596|63137612|FG001|Overall Study|Insufficient Clinical Response|4|||
33680913|NCT01389596|63137613|FG002|Overall Study|Insufficient Clinical Response|5|||
33680914|NCT01389596|63137611|FG000|Overall Study|Adverse Event|1|||
33680915|NCT01389596|63137612|FG001|Overall Study|Adverse Event|4|||
33680916|NCT01389596|63137613|FG002|Overall Study|Adverse Event|0|||
33680917|NCT01389596|63137611|FG000|Overall Study|Death|0|||
33680918|NCT01389596|63137612|FG001|Overall Study|Death|1|||
33680919|NCT01389596|63137613|FG002|Overall Study|Death|0|||
33680920|NCT01389596|63137611|FG000|Overall Study|Other Unspecified|2|||
33680921|NCT01389596|63137612|FG001|Overall Study|Other Unspecified|1|||
33680922|NCT01389596|63137613|FG002|Overall Study|Other Unspecified|0|||
33680923|NCT01405898|63137649|FG000|Overall Study|Withdrawal by Subject|2|||
33680924|NCT01405898|63137650|FG001|Overall Study|Withdrawal by Subject|2|||
33680925|NCT01389128|63137676|FG000|Overall Study|Fetal distress|1|||
33680926|NCT01389128|63137677|FG001|Overall Study|Fetal distress|0|||
33680927|NCT01389128|63137676|FG000|Overall Study|Cervix dilation stop|1|||
33680928|NCT01389128|63137677|FG001|Overall Study|Cervix dilation stop|2|||
33680929|NCT01389128|63137676|FG000|Overall Study|Rapid labor evolution|3|||
33680930|NCT01389128|63137677|FG001|Overall Study|Rapid labor evolution|2|||
33680931|NCT01389128|63137676|FG000|Overall Study|Intolerance to procedure|0|||
33680932|NCT01389128|63137677|FG001|Overall Study|Intolerance to procedure|2|||
33680933|NCT01388816|63137708|FG000|Overall Study|Adverse Event|0|||
33680934|NCT01388816|63137709|FG001|Overall Study|Adverse Event|2|||
33680935|NCT01388816|63137710|FG002|Overall Study|Adverse Event|0|||
33680936|NCT01388816|63137711|FG003|Overall Study|Adverse Event|0|||
33680937|NCT01388816|63137708|FG000|Overall Study|Lost to Follow-up|0|||
33680938|NCT01388816|63137709|FG001|Overall Study|Lost to Follow-up|1|||
33680939|NCT01388816|63137710|FG002|Overall Study|Lost to Follow-up|0|||
33680940|NCT01388816|63137711|FG003|Overall Study|Lost to Follow-up|0|||
33680941|NCT01388816|63137708|FG000|Overall Study|Withdrawal by Subject|2|||
33680942|NCT01388816|63137709|FG001|Overall Study|Withdrawal by Subject|1|||
33680943|NCT01388816|63137710|FG002|Overall Study|Withdrawal by Subject|1|||
33680944|NCT01388816|63137711|FG003|Overall Study|Withdrawal by Subject|0|||
33680945|NCT01388816|63137708|FG000|Overall Study|Protocol Violation|0|||
33680946|NCT01388816|63137709|FG001|Overall Study|Protocol Violation|0|||
33594638|NCT02187861|62993560|FG003|Overall Study|Withdrawal by Subject|3|||
33594639|NCT02187861|62993557|FG000|Overall Study|Other|0|||
33594640|NCT02187861|62993558|FG001|Overall Study|Other|1|||
33594641|NCT02187861|62993559|FG002|Overall Study|Other|7|||
33594642|NCT02187861|62993560|FG003|Overall Study|Other|1|||
33594643|NCT02163993|62993575|FG000|Treatment Period|Adverse Event|0|||
33594644|NCT02163993|62993576|FG001|Treatment Period|Adverse Event|1|||
33594645|NCT02163993|62993577|FG002|Treatment Period|Adverse Event|0|||
33594646|NCT02163993|62993578|FG003|Treatment Period|Adverse Event|0|||
33594647|NCT02163993|62993579|FG004|Treatment Period|Adverse Event|1|||
33680947|NCT01388816|63137710|FG002|Overall Study|Protocol Violation|2|||
33680948|NCT01388816|63137711|FG003|Overall Study|Protocol Violation|0|||
33680949|NCT00555477|63137865|FG000|Overall Study|Adverse Event|0|||
33594648|NCT02163993|62993575|FG000|Treatment Period|Lost to Follow-up|2|||
33594649|NCT02163993|62993576|FG001|Treatment Period|Lost to Follow-up|3|||
33594650|NCT02163993|62993577|FG002|Treatment Period|Lost to Follow-up|1|||
33680950|NCT00555477|63137866|FG001|Overall Study|Adverse Event|9|||
33680951|NCT00555477|63137865|FG000|Overall Study|Withdrawal by Subject|1|||
33680952|NCT00555477|63137866|FG001|Overall Study|Withdrawal by Subject|2|||
33680953|NCT00555477|63137865|FG000|Overall Study|Physician Decision|1|||
33680954|NCT00555477|63137866|FG001|Overall Study|Physician Decision|2|||
33680955|NCT00554619|63137883|FG000|Overall Study|Adverse Event|1|||
33680956|NCT00554619|63137883|FG000|Overall Study|Physician Decision|1|||
33680957|NCT00554619|63137883|FG000|Overall Study|Liver Function Test Abnormality|1|||
33680958|NCT01426412|63137943|FG000|Overall Study|Withdrawal by Subject|1|||
33680959|NCT01426412|63137944|FG001|Overall Study|Withdrawal by Subject|0|||
33680960|NCT01426412|63137945|FG002|Overall Study|Withdrawal by Subject|0|||
33680961|NCT01426412|63137946|FG003|Overall Study|Withdrawal by Subject|0|||
33680962|NCT01426412|63137947|FG004|Overall Study|Withdrawal by Subject|1|||
33680963|NCT01426412|63137948|FG005|Overall Study|Withdrawal by Subject|0|||
33680964|NCT01426412|63137949|FG006|Overall Study|Withdrawal by Subject|0|||
33680965|NCT01426412|63137950|FG007|Overall Study|Withdrawal by Subject|3|||
33680966|NCT01426412|63137951|FG008|Overall Study|Withdrawal by Subject|1|||
33680967|NCT00554229|63138155|FG000|Overall Study|Lost to Follow-up|3|||
33680968|NCT00554229|63138156|FG001|Overall Study|Lost to Follow-up|6|||
33680969|NCT00554229|63138155|FG000|Overall Study|Withdrawal by Subject|29|||
33680970|NCT00554229|63138156|FG001|Overall Study|Withdrawal by Subject|37|||
33680971|NCT00554229|63138155|FG000|Overall Study|Adverse Event|71|||
33680972|NCT00554229|63138156|FG001|Overall Study|Adverse Event|39|||
33680973|NCT00554229|63138155|FG000|Overall Study|Protocol Violation|3|||
33680974|NCT00554229|63138156|FG001|Overall Study|Protocol Violation|3|||
33680975|NCT00554229|63138155|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
33680976|NCT00554229|63138156|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
33680977|NCT00554229|63138155|FG000|Overall Study|Randomised but no treatment received|1|||
33680978|NCT00554229|63138156|FG001|Overall Study|Randomised but no treatment received|0|||
33680979|NCT01405820|63138266|FG000|Randomized Treatment Period|Adverse Event|3|||
33680980|NCT01405820|63138267|FG001|Randomized Treatment Period|Adverse Event|3|||
33680981|NCT01405820|63138268|FG002|Randomized Treatment Period|Adverse Event|3|||
33680982|NCT01405820|63138269|FG003|Randomized Treatment Period|Adverse Event|0|||
33680983|NCT01405820|63138270|FG004|Randomized Treatment Period|Adverse Event|2|||
33680984|NCT01405820|63138271|FG005|Randomized Treatment Period|Adverse Event|1|||
33680985|NCT01405820|63138266|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
33680986|NCT01405820|63138267|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
33680987|NCT01405820|63138268|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
33680988|NCT01405820|63138269|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
33680989|NCT01405820|63138270|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
33680990|NCT01405820|63138271|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
33680991|NCT01405820|63138266|FG000|Randomized Treatment Period|Other|2|||
33680992|NCT01405820|63138267|FG001|Randomized Treatment Period|Other|2|||
33680993|NCT01405820|63138268|FG002|Randomized Treatment Period|Other|1|||
33680994|NCT01405820|63138269|FG003|Randomized Treatment Period|Other|1|||
33680995|NCT01405820|63138270|FG004|Randomized Treatment Period|Other|0|||
33680996|NCT01405820|63138271|FG005|Randomized Treatment Period|Other|0|||
33680997|NCT01405820|63138266|FG000|Randomized Treatment Period|Physician Decision|0|||
33680998|NCT01405820|63138267|FG001|Randomized Treatment Period|Physician Decision|2|||
33680999|NCT01405820|63138268|FG002|Randomized Treatment Period|Physician Decision|1|||
33681000|NCT01405820|63138269|FG003|Randomized Treatment Period|Physician Decision|0|||
33681001|NCT01405820|63138270|FG004|Randomized Treatment Period|Physician Decision|0|||
33681002|NCT01405820|63138271|FG005|Randomized Treatment Period|Physician Decision|0|||
33681003|NCT01405820|63138266|FG000|Randomized Treatment Period|Rescue|0|||
33681004|NCT01405820|63138267|FG001|Randomized Treatment Period|Rescue|1|||
33681005|NCT01405820|63138268|FG002|Randomized Treatment Period|Rescue|13|||
33681006|NCT01405820|63138269|FG003|Randomized Treatment Period|Rescue|10|||
33681007|NCT01405820|63138270|FG004|Randomized Treatment Period|Rescue|8|||
33681008|NCT01405820|63138271|FG005|Randomized Treatment Period|Rescue|8|||
33681009|NCT01405820|63138266|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
33681010|NCT01405820|63138267|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
33681011|NCT01405820|63138268|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
33681012|NCT01405820|63138269|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
33681013|NCT01405820|63138270|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
33681014|NCT01405820|63138271|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
33681015|NCT01405820|63138266|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
33681016|NCT01405820|63138267|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
33681017|NCT01405820|63138268|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
33681018|NCT01405820|63138269|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
33681019|NCT01405820|63138270|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
33681020|NCT01405820|63138271|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
33681021|NCT01405820|63138266|FG000|Randomized Treatment Period|Death|0|||
33681022|NCT01405820|63138267|FG001|Randomized Treatment Period|Death|0|||
33681023|NCT01405820|63138268|FG002|Randomized Treatment Period|Death|0|||
33681024|NCT01405820|63138269|FG003|Randomized Treatment Period|Death|1|||
33681025|NCT01405820|63138270|FG004|Randomized Treatment Period|Death|0|||
33681026|NCT01405820|63138271|FG005|Randomized Treatment Period|Death|0|||
33681027|NCT01405820|63138266|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
33681028|NCT01405820|63138267|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
33681029|NCT01405820|63138268|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
33681030|NCT01405820|63138269|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
33681031|NCT01405820|63138270|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
33681032|NCT01405820|63138271|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
33681033|NCT01405820|63138266|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
33681034|NCT01405820|63138267|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
33681035|NCT01405820|63138268|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
33681036|NCT01405820|63138269|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
33681037|NCT01405820|63138270|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
33681038|NCT01405820|63138271|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
33681039|NCT01405820|63138266|FG000|Open-Label Treatment Period|Other|1|||
33681040|NCT01405820|63138267|FG001|Open-Label Treatment Period|Other|1|||
33681041|NCT01405820|63138268|FG002|Open-Label Treatment Period|Other|1|||
33681042|NCT01405820|63138269|FG003|Open-Label Treatment Period|Other|1|||
33681043|NCT01405820|63138270|FG004|Open-Label Treatment Period|Other|1|||
33681044|NCT01405820|63138271|FG005|Open-Label Treatment Period|Other|1|||
33681045|NCT01405820|63138266|FG000|Open-Label Treatment Period|Physician Decision|0|||
33681046|NCT01405820|63138267|FG001|Open-Label Treatment Period|Physician Decision|0|||
33681047|NCT01405820|63138268|FG002|Open-Label Treatment Period|Physician Decision|1|||
33681048|NCT01405820|63138269|FG003|Open-Label Treatment Period|Physician Decision|2|||
33681049|NCT01405820|63138270|FG004|Open-Label Treatment Period|Physician Decision|1|||
33681050|NCT01405820|63138271|FG005|Open-Label Treatment Period|Physician Decision|0|||
33681051|NCT01405820|63138266|FG000|Open-Label Treatment Period|Adverse Event|0|||
33681052|NCT01405820|63138267|FG001|Open-Label Treatment Period|Adverse Event|0|||
33681053|NCT01405820|63138268|FG002|Open-Label Treatment Period|Adverse Event|0|||
33681054|NCT01405820|63138269|FG003|Open-Label Treatment Period|Adverse Event|1|||
33681055|NCT01405820|63138270|FG004|Open-Label Treatment Period|Adverse Event|0|||
33681056|NCT01405820|63138271|FG005|Open-Label Treatment Period|Adverse Event|0|||
33681057|NCT01405742|63138300|FG000|Overall Study|Lost to Follow-up|1|||
33681058|NCT01405742|63138301|FG001|Overall Study|Lost to Follow-up|0|||
33681059|NCT01425632|63138330|FG000|Overall Study|Adverse Event|0|||
33681060|NCT01425632|63138331|FG001|Overall Study|Adverse Event|1|||
33681061|NCT01425632|63138332|FG002|Overall Study|Adverse Event|1|||
33681062|NCT01425632|63138330|FG000|Overall Study|Physician Decision|1|||
33681063|NCT01425632|63138331|FG001|Overall Study|Physician Decision|0|||
33681064|NCT01425632|63138332|FG002|Overall Study|Physician Decision|0|||
33681065|NCT01425632|63138330|FG000|Overall Study|Protocol Violation|0|||
33681066|NCT01425632|63138331|FG001|Overall Study|Protocol Violation|0|||
33681067|NCT01425632|63138332|FG002|Overall Study|Protocol Violation|2|||
33681068|NCT01425632|63138330|FG000|Overall Study|Withdrawal by Subject|0|||
33681069|NCT01425632|63138331|FG001|Overall Study|Withdrawal by Subject|0|||
33681070|NCT01425632|63138332|FG002|Overall Study|Withdrawal by Subject|1|||
33681071|NCT01405508|63138369|FG000|Overall Study|AE, non-serious non-fatal|1|||
33681072|NCT01405508|63138370|FG001|Overall Study|AE, non-serious non-fatal|1|||
33681073|NCT01405508|63138371|FG002|Overall Study|AE, non-serious non-fatal|0|||
33681074|NCT01405508|63138372|FG003|Overall Study|AE, non-serious non-fatal|0|||
33681075|NCT01405196|63138508|FG000|Overall Study|Study Terminated by Sponsor|0|||
33681076|NCT01405196|63138509|FG001|Overall Study|Study Terminated by Sponsor|0|||
33681077|NCT01405196|63138510|FG002|Overall Study|Study Terminated by Sponsor|9|||
33681078|NCT01405196|63138511|FG003|Overall Study|Study Terminated by Sponsor|0|||
33681079|NCT01405196|63138508|FG000|Overall Study|Other|2|||
33681080|NCT01405196|63138509|FG001|Overall Study|Other|2|||
33681081|NCT01405196|63138510|FG002|Overall Study|Other|5|||
33681082|NCT01405196|63138511|FG003|Overall Study|Other|0|||
33681083|NCT01405196|63138508|FG000|Overall Study|Withdrawal by Subject|4|||
33681084|NCT01405196|63138509|FG001|Overall Study|Withdrawal by Subject|6|||
33681085|NCT01405196|63138510|FG002|Overall Study|Withdrawal by Subject|3|||
33681086|NCT01405196|63138511|FG003|Overall Study|Withdrawal by Subject|6|||
33681087|NCT01405196|63138508|FG000|Overall Study|Adverse Event|2|||
33681088|NCT01405196|63138509|FG001|Overall Study|Adverse Event|2|||
33681089|NCT01405196|63138510|FG002|Overall Study|Adverse Event|0|||
33681090|NCT01405196|63138511|FG003|Overall Study|Adverse Event|2|||
33681091|NCT01405196|63138508|FG000|Overall Study|Death|1|||
33681092|NCT01405196|63138509|FG001|Overall Study|Death|0|||
33681093|NCT01405196|63138510|FG002|Overall Study|Death|3|||
33681094|NCT01405196|63138511|FG003|Overall Study|Death|0|||
33681095|NCT01405196|63138508|FG000|Overall Study|Lost to Follow-up|2|||
33681096|NCT01405196|63138509|FG001|Overall Study|Lost to Follow-up|2|||
33681097|NCT01405196|63138510|FG002|Overall Study|Lost to Follow-up|3|||
33681098|NCT01405196|63138511|FG003|Overall Study|Lost to Follow-up|1|||
33681099|NCT01402700|63138561|FG000|Overall Study|Death|3|||
33681100|NCT01402700|63138561|FG000|Overall Study|Withdrawal by Subject|3|||
33681101|NCT01402700|63138561|FG000|Overall Study|Missed Visit|1|||
33681102|NCT01424930|63138683|FG000|Overall Study|Adverse Event|0|||
33681103|NCT01424930|63138684|FG001|Overall Study|Adverse Event|1|||
33681104|NCT01424930|63138683|FG000|Overall Study|Death|1|||
33681105|NCT01424930|63138684|FG001|Overall Study|Death|0|||
33681106|NCT01424930|63138683|FG000|Overall Study|Progressive Disease|3|||
33681107|NCT01424930|63138684|FG001|Overall Study|Progressive Disease|6|||
33681108|NCT01424930|63138683|FG000|Overall Study|Screen Failure|0|||
33681109|NCT01424930|63138684|FG001|Overall Study|Screen Failure|1|||
33681110|NCT01424930|63138683|FG000|Overall Study|Reason not specified|0|||
33681111|NCT01424930|63138684|FG001|Overall Study|Reason not specified|6|||
33681112|NCT01424306|63138699|FG000|Overall Study|Protocol Violation|0|||
33681113|NCT01424306|63138700|FG001|Overall Study|Protocol Violation|0|||
33681114|NCT01424306|63138701|FG002|Overall Study|Protocol Violation|0|||
33681115|NCT01424306|63138702|FG003|Overall Study|Protocol Violation|0|||
33681116|NCT01424306|63138703|FG004|Overall Study|Protocol Violation|1|||
33681117|NCT01424306|63138704|FG005|Overall Study|Protocol Violation|0|||
33681118|NCT01424228|63138748|FG000|Overall Study|Withdrawal by Subject|27|||
33681119|NCT01424228|63138749|FG001|Overall Study|Withdrawal by Subject|11|||
33681120|NCT01424228|63138748|FG000|Overall Study|Adverse Event|10|||
33681121|NCT01424228|63138749|FG001|Overall Study|Adverse Event|14|||
33681122|NCT01424228|63138748|FG000|Overall Study|Sponsor's decision|9|||
33681123|NCT01424228|63138749|FG001|Overall Study|Sponsor's decision|12|||
33681124|NCT01424228|63138748|FG000|Overall Study|Lack of Efficacy|5|||
33681125|NCT01424228|63138749|FG001|Overall Study|Lack of Efficacy|7|||
33681126|NCT01424228|63138748|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
33681127|NCT01424228|63138749|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
33681128|NCT01424228|63138748|FG000|Overall Study|Non-compliance|2|||
33681129|NCT01424228|63138749|FG001|Overall Study|Non-compliance|0|||
33681130|NCT01424228|63138748|FG000|Overall Study|Worsening of symptoms|1|||
33681131|NCT01424228|63138749|FG001|Overall Study|Worsening of symptoms|0|||
33681132|NCT01424228|63138748|FG000|Overall Study|Unplanned journey|0|||
33681133|NCT01424228|63138749|FG001|Overall Study|Unplanned journey|1|||
33681134|NCT01423916|63138758|FG000|Overall Study|Adverse Event|5|||
33681135|NCT01423916|63138759|FG001|Overall Study|Adverse Event|9|||
33681136|NCT01423916|63138760|FG002|Overall Study|Adverse Event|2|||
33681137|NCT01423916|63138758|FG000|Overall Study|Met Withdrawal Criteria|1|||
33681138|NCT01423916|63138759|FG001|Overall Study|Met Withdrawal Criteria|1|||
33681139|NCT01423916|63138760|FG002|Overall Study|Met Withdrawal Criteria|1|||
33681140|NCT01423916|63138758|FG000|Overall Study|Physician Decision|1|||
33681141|NCT01423916|63138759|FG001|Overall Study|Physician Decision|0|||
33681142|NCT01423916|63138760|FG002|Overall Study|Physician Decision|1|||
33681143|NCT01423916|63138758|FG000|Overall Study|Withdrawal by Subject|3|||
33681144|NCT01423916|63138759|FG001|Overall Study|Withdrawal by Subject|10|||
33681145|NCT01423916|63138760|FG002|Overall Study|Withdrawal by Subject|3|||
33681146|NCT01423916|63138758|FG000|Overall Study|Protocol Deviation|1|||
33681147|NCT01423916|63138759|FG001|Overall Study|Protocol Deviation|0|||
33681148|NCT01423916|63138760|FG002|Overall Study|Protocol Deviation|0|||
33681149|NCT01423604|63138879|FG000|Safety Run-In|Adverse Event|3|||
33681150|NCT01423604|63138880|FG001|Safety Run-In|Adverse Event|0|||
33681151|NCT01423604|63138879|FG000|Safety Run-In|Death|1|||
33681152|NCT01423604|63138880|FG001|Safety Run-In|Death|0|||
33681153|NCT01423604|63138879|FG000|Safety Run-In|Physician Decision|1|||
33681154|NCT01423604|63138880|FG001|Safety Run-In|Physician Decision|0|||
33681155|NCT01423604|63138879|FG000|Safety Run-In|Disease progression|3|||
33681156|NCT01423604|63138880|FG001|Safety Run-In|Disease progression|0|||
33681157|NCT01423604|63138879|FG000|Safety Run-In|Patient decision|1|||
33681158|NCT01423604|63138880|FG001|Safety Run-In|Patient decision|0|||
33681159|NCT01423604|63138879|FG000|Randomized|Adverse Event|4|||
33681160|NCT01423604|63138880|FG001|Randomized|Adverse Event|10|||
33681161|NCT01423604|63138879|FG000|Randomized|Death|1|||
33681162|NCT01423604|63138880|FG001|Randomized|Death|0|||
33681163|NCT01423604|63138879|FG000|Randomized|Physician Decision|16|||
33681164|NCT01423604|63138880|FG001|Randomized|Physician Decision|13|||
33681165|NCT01423604|63138879|FG000|Randomized|Other - unspecified|37|||
33681166|NCT01423604|63138880|FG001|Randomized|Other - unspecified|31|||
33681167|NCT01423604|63138879|FG000|Randomized|Patient decision|5|||
33681168|NCT01423604|63138880|FG001|Randomized|Patient decision|9|||
33681169|NCT01402544|63138896|FG000|Overall Study|Withdrawal by Subject|6|||
33681170|NCT01401842|63138902|FG000|Overall Study|Withdrawal by Subject|3|||
33681171|NCT01401842|63138903|FG001|Overall Study|Withdrawal by Subject|2|||
33681172|NCT01401842|63138902|FG000|Overall Study|academic reason|4|||
33681173|NCT01401842|63138903|FG001|Overall Study|academic reason|1|||
33681174|NCT01401842|63138902|FG000|Overall Study|changed companies|20|||
33681175|NCT01401842|63138903|FG001|Overall Study|changed companies|34|||
33681176|NCT01401842|63138902|FG000|Overall Study|discharged from US Army|3|||
33681177|NCT01401842|63138903|FG001|Overall Study|discharged from US Army|4|||
33681178|NCT01401842|63138902|FG000|Overall Study|invalid follow-up strength data|1|||
33681179|NCT01401842|63138903|FG001|Overall Study|invalid follow-up strength data|4|||
33681180|NCT01401842|63138902|FG000|Overall Study|on profile|9|||
33681181|NCT01401842|63138903|FG001|Overall Study|on profile|5|||
33681182|NCT01401842|63138902|FG000|Overall Study|other/unknown|28|||
33681183|NCT01401842|63138903|FG001|Overall Study|other/unknown|17|||
33681184|NCT01422824|63138909|FG000|Overall Study|Case record form not evaluated|1|||
33681185|NCT01422824|63138909|FG000|Overall Study|Lost to Follow-up|37|||
33681186|NCT01401530|63138972|FG000|Overall Study|Disease Progression|1|||
33681187|NCT01401530|63138973|FG001|Overall Study|Disease Progression|2|||
33681188|NCT01401530|63138974|FG002|Overall Study|Disease Progression|1|||
33681189|NCT01401530|63138972|FG000|Overall Study|Adverse Event|1|||
33681190|NCT01401530|63138973|FG001|Overall Study|Adverse Event|1|||
33681191|NCT01401530|63138974|FG002|Overall Study|Adverse Event|1|||
33681192|NCT01401530|63138972|FG000|Overall Study|Participant Choice|1|||
33681193|NCT01401530|63138973|FG001|Overall Study|Participant Choice|2|||
33681194|NCT01401530|63138974|FG002|Overall Study|Participant Choice|1|||
33681195|NCT01401530|63138972|FG000|Overall Study|Physician Decision|0|||
33681196|NCT01401530|63138973|FG001|Overall Study|Physician Decision|1|||
33681197|NCT01401530|63138974|FG002|Overall Study|Physician Decision|0|||
33681198|NCT01387022|63138986|FG000|Overall Study|Death|1|||
33681199|NCT01387022|63138987|FG001|Overall Study|Death|1|||
33681200|NCT01387022|63138986|FG000|Overall Study|Lost to Follow-up|0|||
33681201|NCT01387022|63138987|FG001|Overall Study|Lost to Follow-up|3|||
33681202|NCT01386944|63139013|FG000|Overall Study|Adverse Event|26|||
33681203|NCT01386944|63139013|FG000|Overall Study|Lack of Efficacy|14|||
33681204|NCT01386944|63139013|FG000|Overall Study|Lost to Follow-up|8|||
33681205|NCT01386944|63139013|FG000|Overall Study|Unspecified reason|8|||
33681206|NCT01386788|63139024|FG000|Overall Study|Lost to Follow-up|2|||
33681207|NCT01386554|63139089|FG000|Overall Study|Lost to Follow-up|0|||
33681208|NCT01386554|63139090|FG001|Overall Study|Lost to Follow-up|0|||
33681209|NCT01386554|63139091|FG002|Overall Study|Lost to Follow-up|1|||
33681210|NCT01386554|63139089|FG000|Overall Study|Adverse Event|2|||
33681211|NCT01386554|63139090|FG001|Overall Study|Adverse Event|5|||
33681212|NCT01386554|63139091|FG002|Overall Study|Adverse Event|2|||
33681213|NCT01386554|63139089|FG000|Overall Study|Progressive disease|1|||
33681214|NCT01386554|63139090|FG001|Overall Study|Progressive disease|2|||
33681215|NCT01386554|63139091|FG002|Overall Study|Progressive disease|2|||
33681216|NCT01386554|63139089|FG000|Overall Study|Administration of live vaccines|0|||
33681217|NCT01386554|63139090|FG001|Overall Study|Administration of live vaccines|1|||
33681218|NCT01386554|63139091|FG002|Overall Study|Administration of live vaccines|0|||
33681219|NCT01386554|63139089|FG000|Overall Study|Investigator discretion|0|||
33681220|NCT01386554|63139090|FG001|Overall Study|Investigator discretion|0|||
33681221|NCT01386554|63139091|FG002|Overall Study|Investigator discretion|1|||
33681222|NCT01386554|63139089|FG000|Overall Study|Reason not collected|0|||
33681223|NCT01386554|63139090|FG001|Overall Study|Reason not collected|1|||
33681224|NCT01386554|63139091|FG002|Overall Study|Reason not collected|0|||
33681225|NCT01386008|63139116|FG000|Overall Study|exited w/o incident /study discontinued|17|||
33681226|NCT01386008|63139116|FG000|Overall Study|Adverse Event|3|||
33681227|NCT01421342|63139264|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
33681228|NCT01421342|63139265|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
33681229|NCT01421342|63139266|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
33681230|NCT01421342|63139264|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
33594651|NCT02163993|62993578|FG003|Treatment Period|Lost to Follow-up|3|||
33594652|NCT02163993|62993579|FG004|Treatment Period|Lost to Follow-up|1|||
33594653|NCT02163993|62993575|FG000|Treatment Period|Physician Decision|1|||
33594654|NCT02163993|62993576|FG001|Treatment Period|Physician Decision|0|||
33594655|NCT02163993|62993577|FG002|Treatment Period|Physician Decision|0|||
33594656|NCT02163993|62993578|FG003|Treatment Period|Physician Decision|0|||
33594657|NCT02163993|62993579|FG004|Treatment Period|Physician Decision|0|||
33594658|NCT02163993|62993575|FG000|Treatment Period|Protocol Violation|2|||
33594659|NCT02163993|62993576|FG001|Treatment Period|Protocol Violation|1|||
33594660|NCT02163993|62993577|FG002|Treatment Period|Protocol Violation|0|||
33594661|NCT02163993|62993578|FG003|Treatment Period|Protocol Violation|1|||
33681231|NCT01421342|63139265|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
33681232|NCT01421342|63139266|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
33681233|NCT01421342|63139264|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
33681234|NCT01421342|63139265|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
33681235|NCT01421342|63139266|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
33681236|NCT01421342|63139264|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
33681237|NCT01421342|63139265|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
33681238|NCT01421342|63139266|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
33594662|NCT02163993|62993579|FG004|Treatment Period|Protocol Violation|2|||
33681239|NCT01421342|63139264|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
33681240|NCT01421342|63139265|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
33681241|NCT01421342|63139266|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
33681242|NCT01421342|63139264|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
33681243|NCT01421342|63139265|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
33681244|NCT01421342|63139266|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
33681245|NCT01421342|63139264|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
33681246|NCT01421342|63139265|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
33681247|NCT01421342|63139266|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
33681248|NCT01421342|63139264|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
33681249|NCT01421342|63139265|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
33681250|NCT01421342|63139266|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
33681251|NCT01421342|63139264|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
33681252|NCT01421342|63139265|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
33681253|NCT01421342|63139266|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
33681254|NCT01421342|63139264|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
33681255|NCT01421342|63139265|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
33681256|NCT01421342|63139266|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
33681257|NCT01421342|63139264|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
33681258|NCT01421342|63139265|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
33681259|NCT01421342|63139266|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
33681260|NCT01421342|63139264|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
33681261|NCT01421342|63139265|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
33681262|NCT01421342|63139266|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
33681263|NCT01421342|63139264|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
33681264|NCT01421342|63139265|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
33681265|NCT01421342|63139266|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
33681266|NCT01421342|63139264|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
33681267|NCT01421342|63139265|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
33681268|NCT01421342|63139266|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
33681269|NCT01421342|63139264|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
33681270|NCT01421342|63139265|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
33681271|NCT01421342|63139266|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
33681272|NCT01421342|63139264|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
33681273|NCT01421342|63139265|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
33681274|NCT01421342|63139266|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
33681275|NCT01421342|63139264|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
33681276|NCT01421342|63139265|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
33681277|NCT01421342|63139266|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
33681278|NCT01421342|63139264|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
33681279|NCT01421342|63139265|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
33681280|NCT01421342|63139266|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
33681281|NCT01421342|63139264|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
33681282|NCT01421342|63139265|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
33681283|NCT01421342|63139266|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
33681284|NCT01421342|63139264|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
33681285|NCT01421342|63139265|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
33681286|NCT01421342|63139266|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
33681287|NCT01421342|63139264|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
33681288|NCT01421342|63139265|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
33681289|NCT01421342|63139266|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
33681290|NCT01421342|63139264|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
33681291|NCT01421342|63139265|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
33681292|NCT01421342|63139266|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
33681293|NCT01421342|63139264|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
33681294|NCT01421342|63139265|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
33681295|NCT01421342|63139266|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
33681296|NCT01421342|63139264|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
33681297|NCT01421342|63139265|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
33681298|NCT01421342|63139266|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
33681299|NCT01421342|63139264|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
33401435|NCT00256867|62780474|FG000|Overall Study|Lost to Follow-up|2|||
33681300|NCT01421342|63139265|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
33681301|NCT01421342|63139266|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
33681302|NCT01421342|63139264|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
33681303|NCT01421342|63139265|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
33681304|NCT01421342|63139266|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
33681305|NCT01421342|63139264|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
33681306|NCT01421342|63139265|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
33681307|NCT01421342|63139266|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
33681308|NCT01421342|63139264|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
33681309|NCT01421342|63139265|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
33681310|NCT01421342|63139266|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
33681311|NCT01384760|63139289|FG000|Overall Study|Lost to Follow-up|0|||
33681312|NCT01384760|63139290|FG001|Overall Study|Lost to Follow-up|6|||
33681313|NCT01384760|63139289|FG000|Overall Study|Protocol Violation|16|||
33681314|NCT01384760|63139290|FG001|Overall Study|Protocol Violation|0|||
33681315|NCT01384292|63139330|FG000|Part B|Severe non-compliance to protocol|1|||
33681316|NCT01384292|63139331|FG001|Part B|Severe non-compliance to protocol|0|||
33681317|NCT01384292|63139332|FG002|Part B|Severe non-compliance to protocol|0|||
33681318|NCT01401452|63139342|FG000|Overall Study|Adverse reaction|9|||
33681319|NCT01401452|63139342|FG000|Overall Study|Lost to Follow-up|12|||
33681320|NCT01401452|63139342|FG000|Overall Study|Lack of Efficacy|30|||
33681321|NCT01401452|63139342|FG000|Overall Study|Participant developed breast cancer|1|||
33681322|NCT01401452|63139342|FG000|Overall Study|Tx stopped due to financial reasons|1|||
33681323|NCT01401452|63139342|FG000|Overall Study|Tx stopped by psychiatrist|1|||
33681324|NCT01401452|63139342|FG000|Overall Study|No more visits within the 36 wk followup|4|||
33681325|NCT01401452|63139342|FG000|Overall Study|Subject did not come to follow up visits|2|||
33681326|NCT01401452|63139342|FG000|Overall Study|Subject didn't return for routine visits|1|||
33681327|NCT01401452|63139342|FG000|Overall Study|Subject moved to another city|1|||
33681328|NCT01401452|63139342|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
33681329|NCT01401452|63139342|FG000|Overall Study|Psoriatic arthritis|1|||
33681330|NCT01401452|63139342|FG000|Overall Study|Participant stopped Tx|2|||
33681331|NCT01401452|63139342|FG000|Overall Study|Discontinuation for personal reasons|1|||
33681332|NCT01401452|63139342|FG000|Overall Study|Treatment failure|1|||
33681333|NCT01401452|63139342|FG000|Overall Study|Unsatisfactory output|1|||
33681334|NCT01401452|63139342|FG000|Overall Study|Subject withdrew because of Tx success|1|||
33681335|NCT01401452|63139342|FG000|Overall Study|Subject chose to discontinue treatment|1|||
33681336|NCT01401452|63139342|FG000|Overall Study|Participant withdrew consent|1|||
33681337|NCT01401062|63139377|FG000|Overall Study|Death|9|||
33681338|NCT01401062|63139378|FG001|Overall Study|Death|7|||
33681339|NCT01401062|63139377|FG000|Overall Study|Physician Decision|1|||
33681340|NCT01401062|63139378|FG001|Overall Study|Physician Decision|0|||
33681341|NCT01401062|63139377|FG000|Overall Study|Withdrawal by Subject|1|||
33681342|NCT01401062|63139378|FG001|Overall Study|Withdrawal by Subject|1|||
33681343|NCT01400516|63139411|FG000|Primary Trial|Withdrawal by Subject|0|||
33681344|NCT01400516|63139412|FG001|Primary Trial|Withdrawal by Subject|2|||
33681345|NCT01383356|63139418|FG000|Period 1|Adverse Event|5|||
33681346|NCT01383356|63139419|FG001|Period 1|Adverse Event|3|||
33681347|NCT01383356|63139418|FG000|Period 1|Non-compliance|3|||
33681348|NCT01383356|63139419|FG001|Period 1|Non-compliance|0|||
33681349|NCT01383356|63139418|FG000|Period 1|Out of Range Mid-study-Test|0|||
33681350|NCT01383356|63139419|FG001|Period 1|Out of Range Mid-study-Test|1|||
33681351|NCT01383356|63139418|FG000|Period 1|Personal|0|||
33681352|NCT01383356|63139419|FG001|Period 1|Personal|2|||
33681353|NCT05740098|63139445|FG000|Overall Study|Lost to Follow-up|26|||
33681354|NCT05740098|63139446|FG001|Overall Study|Lost to Follow-up|17|||
33681355|NCT05740098|63139447|FG002|Overall Study|Lost to Follow-up|21|||
33681356|NCT05299359|63139458|FG000|Overall Study|Ongoing in Study|149|||
33681357|NCT05299359|63139458|FG000|Overall Study|Other|1|||
33681358|NCT05059080|63139464|FG000|Overall Study|Withdrawal by Subject|3|||
33681359|NCT05059080|63139464|FG000|Overall Study|Study Terminated by Sponsor|64|||
33681360|NCT05012163|63139472|FG000|Overall Study|Protocol Violation|0|||
33681361|NCT05012163|63139473|FG001|Overall Study|Protocol Violation|0|||
33681362|NCT05012163|63139474|FG002|Overall Study|Protocol Violation|1|||
33681363|NCT05012163|63139475|FG003|Overall Study|Protocol Violation|1|||
33681364|NCT05009251|63139490|FG000|Overall Study|Protocol Violation|100|||
33681365|NCT05009251|63139491|FG001|Overall Study|Protocol Violation|105|||
33681366|NCT05009251|63139492|FG002|Overall Study|Protocol Violation|119|||
33681367|NCT05009251|63139493|FG003|Overall Study|Protocol Violation|120|||
33681368|NCT05009251|63139494|FG004|Overall Study|Protocol Violation|119|||
33681369|NCT05009251|63139490|FG000|Overall Study|Death|25|||
33681370|NCT05009251|63139491|FG001|Overall Study|Death|22|||
33681371|NCT05009251|63139492|FG002|Overall Study|Death|24|||
33681372|NCT05009251|63139493|FG003|Overall Study|Death|19|||
33681373|NCT05009251|63139494|FG004|Overall Study|Death|15|||
33681374|NCT04839692|63139508|FG000|Overall Study|Withdrawal by Subject|0|||
33681375|NCT04839692|63139509|FG001|Overall Study|Withdrawal by Subject|3|||
33681376|NCT04839692|63139508|FG000|Overall Study|Physician Decision|1|||
33681377|NCT04839692|63139509|FG001|Overall Study|Physician Decision|0|||
33681378|NCT04476017|63139537|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
33681379|NCT04476017|63139538|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
33681380|NCT04422639|63139547|FG000|Overall Study|Death|1|||
33681381|NCT04422639|63139548|FG001|Overall Study|Death|0|||
33681382|NCT04422639|63139547|FG000|Overall Study|study closed prior to completion of FU visits|0|||
33681383|NCT04422639|63139548|FG001|Overall Study|study closed prior to completion of FU visits|2|||
33681384|NCT04384107|63139556|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
33681385|NCT04384107|63139557|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
33681386|NCT04384107|63139556|FG000|Overall Study|Lost to Follow-up|1|||
33681387|NCT04384107|63139557|FG001|Overall Study|Lost to Follow-up|0|||
33681388|NCT04275089|63139563|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
33681389|NCT04096326|63139598|FG000|Overall Study|Withdrawal by Subject|0|||
33681390|NCT04096326|63139599|FG001|Overall Study|Withdrawal by Subject|0|||
33681391|NCT04096326|63139600|FG002|Overall Study|Withdrawal by Subject|0|||
33681392|NCT04096326|63139601|FG003|Overall Study|Withdrawal by Subject|0|||
33681393|NCT04096326|63139602|FG004|Overall Study|Withdrawal by Subject|0|||
33681394|NCT04096326|63139603|FG005|Overall Study|Withdrawal by Subject|0|||
33681395|NCT04096326|63139604|FG006|Overall Study|Withdrawal by Subject|1|||
33681396|NCT04096326|63139605|FG007|Overall Study|Withdrawal by Subject|0|||
33681397|NCT04096326|63139606|FG008|Overall Study|Withdrawal by Subject|0|||
33681398|NCT04096326|63139607|FG009|Overall Study|Withdrawal by Subject|0|||
33681399|NCT04096326|63139598|FG000|Overall Study|Lost to Follow-up|0|||
33681400|NCT04096326|63139599|FG001|Overall Study|Lost to Follow-up|1|||
33681401|NCT04096326|63139600|FG002|Overall Study|Lost to Follow-up|0|||
33681402|NCT04096326|63139601|FG003|Overall Study|Lost to Follow-up|0|||
33681403|NCT04096326|63139602|FG004|Overall Study|Lost to Follow-up|0|||
33681404|NCT04096326|63139603|FG005|Overall Study|Lost to Follow-up|0|||
33681405|NCT04096326|63139604|FG006|Overall Study|Lost to Follow-up|0|||
33681406|NCT04096326|63139605|FG007|Overall Study|Lost to Follow-up|0|||
33681407|NCT04096326|63139606|FG008|Overall Study|Lost to Follow-up|0|||
33681408|NCT04096326|63139607|FG009|Overall Study|Lost to Follow-up|0|||
33681409|NCT04096326|63139598|FG000|Overall Study|COVID-19-related reasons|0|||
33681410|NCT04096326|63139599|FG001|Overall Study|COVID-19-related reasons|0|||
33681411|NCT04096326|63139600|FG002|Overall Study|COVID-19-related reasons|0|||
33594663|NCT02163993|62993575|FG000|Treatment Period|Withdrawal by Subject|6|||
33594664|NCT02163993|62993576|FG001|Treatment Period|Withdrawal by Subject|4|||
33594665|NCT02163993|62993577|FG002|Treatment Period|Withdrawal by Subject|1|||
33594666|NCT02163993|62993578|FG003|Treatment Period|Withdrawal by Subject|4|||
33594667|NCT02163993|62993579|FG004|Treatment Period|Withdrawal by Subject|1|||
33594668|NCT02163993|62993575|FG000|Treatment Period|Not treated|1|||
33594669|NCT02163993|62993576|FG001|Treatment Period|Not treated|0|||
33594670|NCT02163993|62993577|FG002|Treatment Period|Not treated|0|||
33594671|NCT02163993|62993578|FG003|Treatment Period|Not treated|1|||
33594672|NCT02163993|62993579|FG004|Treatment Period|Not treated|2|||
33594673|NCT02163993|62993575|FG000|Post-treatment Period|Adverse Event|0|||
33594674|NCT02163993|62993576|FG001|Post-treatment Period|Adverse Event|0|||
33594675|NCT02163993|62993577|FG002|Post-treatment Period|Adverse Event|1|||
33594676|NCT02163993|62993578|FG003|Post-treatment Period|Adverse Event|0|||
33594677|NCT02163993|62993579|FG004|Post-treatment Period|Adverse Event|0|||
33594678|NCT02163993|62993575|FG000|Post-treatment Period|Lost to Follow-up|2|||
33594679|NCT02163993|62993576|FG001|Post-treatment Period|Lost to Follow-up|2|||
33594680|NCT02163993|62993577|FG002|Post-treatment Period|Lost to Follow-up|3|||
33594681|NCT02163993|62993578|FG003|Post-treatment Period|Lost to Follow-up|1|||
33594682|NCT02163993|62993579|FG004|Post-treatment Period|Lost to Follow-up|0|||
33594683|NCT02163993|62993575|FG000|Post-treatment Period|Protocol Violation|0|||
33594684|NCT02163993|62993576|FG001|Post-treatment Period|Protocol Violation|0|||
33681412|NCT04096326|63139601|FG003|Overall Study|COVID-19-related reasons|0|||
33681413|NCT04096326|63139602|FG004|Overall Study|COVID-19-related reasons|1|||
33681414|NCT04096326|63139603|FG005|Overall Study|COVID-19-related reasons|5|||
33681415|NCT04096326|63139604|FG006|Overall Study|COVID-19-related reasons|0|||
33681416|NCT04096326|63139605|FG007|Overall Study|COVID-19-related reasons|0|||
33681417|NCT04096326|63139606|FG008|Overall Study|COVID-19-related reasons|0|||
33681418|NCT04096326|63139607|FG009|Overall Study|COVID-19-related reasons|0|||
33681419|NCT04072822|63139631|FG000|Treatment|Adverse Event|9|||
33681420|NCT04072822|63139632|FG001|Treatment|Adverse Event|5|||
33681421|NCT04072822|63139631|FG000|Treatment|Met Stopping Criteria|13|||
33681422|NCT04072822|63139632|FG001|Treatment|Met Stopping Criteria|24|||
33594685|NCT02163993|62993577|FG002|Post-treatment Period|Protocol Violation|0|||
33681423|NCT04072822|63139631|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
33681424|NCT04072822|63139632|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
33681425|NCT04072822|63139631|FG000|Treatment|Withdrawal by Subject|0|||
33681426|NCT04072822|63139632|FG001|Treatment|Withdrawal by Subject|2|||
33681427|NCT04072822|63139631|FG000|Treatment|Death|0|||
33681428|NCT04072822|63139632|FG001|Treatment|Death|2|||
33681429|NCT04072822|63139631|FG000|Treatment|Lost to Follow-up|11|||
33681430|NCT04072822|63139632|FG001|Treatment|Lost to Follow-up|3|||
33681431|NCT04072822|63139631|FG000|Treatment|Physician Decision|1|||
33681432|NCT04072822|63139632|FG001|Treatment|Physician Decision|0|||
33681433|NCT04072822|63139631|FG000|Treatment|Other|7|||
33681434|NCT04072822|63139632|FG001|Treatment|Other|9|||
33681435|NCT04072822|63139631|FG000|Follow-up|Withdrawal by Subject|1|||
33681436|NCT04072822|63139632|FG001|Follow-up|Withdrawal by Subject|0|||
33681437|NCT04072822|63139631|FG000|Follow-up|Lost to Follow-up|5|||
33681438|NCT04072822|63139632|FG001|Follow-up|Lost to Follow-up|4|||
33681439|NCT04031846|63139640|FG000|Overall Study|Lost to Follow-up|4|||
33681440|NCT04031846|63139641|FG001|Overall Study|Lost to Follow-up|4|||
33681441|NCT04031846|63139640|FG000|Overall Study|Physician Decision|0|||
33681442|NCT04031846|63139641|FG001|Overall Study|Physician Decision|1|||
33681443|NCT04031846|63139640|FG000|Overall Study|Protocol Violation|1|||
33681444|NCT04031846|63139641|FG001|Overall Study|Protocol Violation|1|||
33681445|NCT04031846|63139640|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
33681446|NCT04031846|63139641|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
33681447|NCT03893448|63139650|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
33681448|NCT03893448|63139651|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
33681449|NCT03893448|63139650|FG000|Overall Study|Physician Decision|8|||
33681450|NCT03893448|63139651|FG001|Overall Study|Physician Decision|14|||
33681451|NCT03893448|63139650|FG000|Overall Study|Lost to Follow-up|34|||
33681452|NCT03893448|63139651|FG001|Overall Study|Lost to Follow-up|27|||
33681453|NCT03893448|63139650|FG000|Overall Study|Death|1|||
33681454|NCT03893448|63139651|FG001|Overall Study|Death|0|||
33681455|NCT03692871|63139674|FG000|Overall Study|Death|1|||
33681456|NCT03692871|63139675|FG001|Overall Study|Death|1|||
33681457|NCT03692871|63139674|FG000|Overall Study|Lost to Follow-up|24|||
33681458|NCT03692871|63139675|FG001|Overall Study|Lost to Follow-up|9|||
33681459|NCT03692871|63139674|FG000|Overall Study|Physician Decision|22|||
33681460|NCT03692871|63139675|FG001|Overall Study|Physician Decision|7|||
33681461|NCT03692871|63139674|FG000|Overall Study|Protocol Deviation|1|||
33681462|NCT03692871|63139675|FG001|Overall Study|Protocol Deviation|0|||
33681463|NCT03692871|63139674|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
33681464|NCT03692871|63139675|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
33681465|NCT03565900|63139683|FG000|Overall Study|Disposition Unknown|4|||
33681466|NCT03565900|63139684|FG001|Overall Study|Disposition Unknown|1|||
33681467|NCT03565900|63139683|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
33681468|NCT03565900|63139684|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
33681469|NCT03565900|63139683|FG000|Overall Study|Withdrawal by Subject|4|||
33681470|NCT03565900|63139684|FG001|Overall Study|Withdrawal by Subject|5|||
33681471|NCT03565900|63139683|FG000|Overall Study|Randomized By Mistake|0|||
33681472|NCT03565900|63139684|FG001|Overall Study|Randomized By Mistake|2|||
33681473|NCT03565900|63139683|FG000|Overall Study|Physician Decision|7|||
33681474|NCT03565900|63139684|FG001|Overall Study|Physician Decision|11|||
33681475|NCT03565900|63139683|FG000|Overall Study|Death|9|||
33681476|NCT03565900|63139684|FG001|Overall Study|Death|7|||
33681477|NCT03443869|63139723|FG000|Overall Study|Death|3|||
33681478|NCT03443869|63139724|FG001|Overall Study|Death|3|||
33681479|NCT03443869|63139723|FG000|Overall Study|Withdrawal by Subject|34|||
33681480|NCT03443869|63139724|FG001|Overall Study|Withdrawal by Subject|22|||
33681481|NCT03443869|63139723|FG000|Overall Study|Lost to Follow-up|1|||
33681482|NCT03443869|63139724|FG001|Overall Study|Lost to Follow-up|2|||
33681483|NCT03443869|63139723|FG000|Overall Study|Physician Decision|3|||
33681484|NCT03443869|63139724|FG001|Overall Study|Physician Decision|3|||
33681485|NCT03443869|63139723|FG000|Overall Study|Other|4|||
33681486|NCT03443869|63139724|FG001|Overall Study|Other|4|||
33681487|NCT03260140|63139732|FG000|Overall Study|Death|4|||
33681488|NCT03260140|63139733|FG001|Overall Study|Death|1|||
33681489|NCT03260140|63139732|FG000|Overall Study|Withdrawal by Subject|1|||
33681490|NCT03260140|63139733|FG001|Overall Study|Withdrawal by Subject|4|||
33681491|NCT03253796|63139744|FG000|Period 1: Run-In|Adverse Event|4|||
33681492|NCT03253796|63139745|FG001|Period 1: Run-In|Adverse Event|0|||
33681493|NCT03253796|63139746|FG002|Period 1: Run-In|Adverse Event|0|||
33681494|NCT03253796|63139747|FG003|Period 1: Run-In|Adverse Event|0|||
33681495|NCT03253796|63139748|FG004|Period 1: Run-In|Adverse Event|0|||
33681496|NCT03253796|63139744|FG000|Period 1: Run-In|Lack of Efficacy|1|||
33681497|NCT03253796|63139745|FG001|Period 1: Run-In|Lack of Efficacy|0|||
33681498|NCT03253796|63139746|FG002|Period 1: Run-In|Lack of Efficacy|0|||
33681499|NCT03253796|63139747|FG003|Period 1: Run-In|Lack of Efficacy|0|||
33681500|NCT03253796|63139748|FG004|Period 1: Run-In|Lack of Efficacy|0|||
33681501|NCT03253796|63139744|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
33681502|NCT03253796|63139745|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
33681503|NCT03253796|63139746|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
33681504|NCT03253796|63139747|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
33681505|NCT03253796|63139748|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
33681506|NCT03253796|63139744|FG000|Period 1: Run-In|Protocol Violation|5|||
33681507|NCT03253796|63139745|FG001|Period 1: Run-In|Protocol Violation|0|||
33681508|NCT03253796|63139746|FG002|Period 1: Run-In|Protocol Violation|0|||
33681509|NCT03253796|63139747|FG003|Period 1: Run-In|Protocol Violation|0|||
33681510|NCT03253796|63139748|FG004|Period 1: Run-In|Protocol Violation|0|||
33681511|NCT03253796|63139744|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
33681512|NCT03253796|63139745|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
33681513|NCT03253796|63139746|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
33681514|NCT03253796|63139747|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
33681515|NCT03253796|63139748|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
33681516|NCT03253796|63139744|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
33681517|NCT03253796|63139745|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
33681518|NCT03253796|63139746|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
33681519|NCT03253796|63139747|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
33681520|NCT03253796|63139748|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
33681521|NCT03253796|63139744|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
33681522|NCT03253796|63139745|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
33681523|NCT03253796|63139746|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
33681524|NCT03253796|63139747|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
33681525|NCT03253796|63139748|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
33681526|NCT03253796|63139744|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
33681527|NCT03253796|63139745|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
33681528|NCT03253796|63139746|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
33681529|NCT03253796|63139747|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
33681530|NCT03253796|63139748|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
33681531|NCT03253796|63139744|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
33681532|NCT03253796|63139745|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
33681533|NCT03253796|63139746|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
33681534|NCT03253796|63139747|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
33681535|NCT03253796|63139748|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
33681536|NCT03253796|63139744|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
33681537|NCT03253796|63139745|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
33681538|NCT03253796|63139746|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
33681539|NCT03253796|63139747|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
33681540|NCT03253796|63139748|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
33681541|NCT03253796|63139744|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
33681542|NCT03253796|63139745|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
33681543|NCT03253796|63139746|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
33681544|NCT03253796|63139747|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
33681545|NCT03253796|63139748|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
33681546|NCT03073733|63139766|FG000|Overall Study|Lost to Follow-up|1|||
33681547|NCT03073733|63139767|FG001|Overall Study|Lost to Follow-up|0|||
33681548|NCT03073733|63139768|FG002|Overall Study|Lost to Follow-up|0|||
33681549|NCT03073733|63139766|FG000|Overall Study|Physician Decision|0|||
33681550|NCT03073733|63139767|FG001|Overall Study|Physician Decision|1|||
33681551|NCT03073733|63139768|FG002|Overall Study|Physician Decision|0|||
33681552|NCT03073733|63139766|FG000|Overall Study|Withdrawal by Subject|0|||
33681553|NCT03073733|63139767|FG001|Overall Study|Withdrawal by Subject|0|||
33681554|NCT03073733|63139768|FG002|Overall Study|Withdrawal by Subject|1|||
33681555|NCT03029143|63139778|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
33681556|NCT03029143|63139779|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
33681557|NCT03029143|63139780|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
33681558|NCT03029143|63139778|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
33681559|NCT03029143|63139779|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
33681560|NCT03029143|63139780|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
33681561|NCT03029143|63139778|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
33681562|NCT03029143|63139779|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
33681563|NCT03029143|63139780|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
33681564|NCT03029143|63139778|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
33681565|NCT03029143|63139779|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
33681566|NCT03029143|63139780|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
33681567|NCT03029143|63139778|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
33681568|NCT03029143|63139779|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
33681569|NCT03029143|63139780|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
33681570|NCT03029143|63139778|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
33681571|NCT03029143|63139779|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
33681572|NCT03029143|63139780|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
33681573|NCT03029143|63139778|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
33681574|NCT03029143|63139779|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
33681575|NCT03029143|63139780|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
33681576|NCT03029143|63139778|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33681577|NCT03029143|63139779|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
33681578|NCT03029143|63139780|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
33681579|NCT03029143|63139778|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
33681580|NCT03029143|63139779|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
33681581|NCT03029143|63139780|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
33681582|NCT03029143|63139778|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
33681583|NCT03029143|63139779|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
33681584|NCT03029143|63139780|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
33681585|NCT03029143|63139778|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
33681586|NCT03029143|63139779|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
33681587|NCT03029143|63139780|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
33681588|NCT02971137|63139791|FG000|Overall Study|Lost to Follow-up|44|||
33681589|NCT02971137|63139792|FG001|Overall Study|Lost to Follow-up|56|||
33681590|NCT02953262|63139802|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
33681591|NCT02953262|63139803|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
33681592|NCT02953262|63139804|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
33681593|NCT02953262|63139805|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
33594686|NCT02163993|62993578|FG003|Post-treatment Period|Protocol Violation|0|||
33594687|NCT02163993|62993579|FG004|Post-treatment Period|Protocol Violation|1|||
33594688|NCT02163993|62993575|FG000|Post-treatment Period|Withdrawal by Subject|2|||
33594689|NCT02163993|62993576|FG001|Post-treatment Period|Withdrawal by Subject|4|||
33594690|NCT02163993|62993577|FG002|Post-treatment Period|Withdrawal by Subject|0|||
33594691|NCT02163993|62993578|FG003|Post-treatment Period|Withdrawal by Subject|1|||
33594692|NCT02163993|62993579|FG004|Post-treatment Period|Withdrawal by Subject|2|||
33594693|NCT02527421|62993602|FG000|Overall Study|Withdrawal by Subject|1|||
33594694|NCT02527421|62993603|FG001|Overall Study|Withdrawal by Subject|0|||
33594695|NCT02163915|62993614|FG000|Overall Study|Withdrawal by Subject|2|||
33594696|NCT02163915|62993615|FG001|Overall Study|Withdrawal by Subject|0|||
33594697|NCT02163915|62993616|FG002|Overall Study|Withdrawal by Subject|2|||
33681594|NCT02763579|63139821|FG000|Global Period|Death|167|||
33681595|NCT02763579|63139822|FG001|Global Period|Death|151|||
33681596|NCT02763579|63139823|FG002|Global Period|Death|0|||
33681597|NCT02763579|63139824|FG003|Global Period|Death|0|||
33681598|NCT02763579|63139821|FG000|Global Period|Lost to Follow-up|2|||
33681599|NCT02763579|63139822|FG001|Global Period|Lost to Follow-up|4|||
33681600|NCT02763579|63139823|FG002|Global Period|Lost to Follow-up|0|||
33681601|NCT02763579|63139824|FG003|Global Period|Lost to Follow-up|0|||
33681602|NCT02763579|63139821|FG000|Global Period|Physician Decision|0|||
33681603|NCT02763579|63139822|FG001|Global Period|Physician Decision|2|||
33681604|NCT02763579|63139823|FG002|Global Period|Physician Decision|0|||
33681605|NCT02763579|63139824|FG003|Global Period|Physician Decision|0|||
33681606|NCT02763579|63139821|FG000|Global Period|Study Terminated By Sponsor|21|||
33681607|NCT02763579|63139822|FG001|Global Period|Study Terminated By Sponsor|26|||
33681608|NCT02763579|63139823|FG002|Global Period|Study Terminated By Sponsor|0|||
33681609|NCT02763579|63139824|FG003|Global Period|Study Terminated By Sponsor|0|||
33681610|NCT02763579|63139821|FG000|Global Period|Withdrawal by Subject|12|||
33681611|NCT02763579|63139822|FG001|Global Period|Withdrawal by Subject|18|||
33681612|NCT02763579|63139823|FG002|Global Period|Withdrawal by Subject|0|||
33681613|NCT02763579|63139824|FG003|Global Period|Withdrawal by Subject|0|||
33681614|NCT02763579|63139821|FG000|China Period|Death|0|||
33681615|NCT02763579|63139822|FG001|China Period|Death|0|||
33681616|NCT02763579|63139823|FG002|China Period|Death|46|||
33681617|NCT02763579|63139824|FG003|China Period|Death|48|||
33681618|NCT02763579|63139821|FG000|China Period|Lost to Follow-up|0|||
33681619|NCT02763579|63139822|FG001|China Period|Lost to Follow-up|0|||
33681620|NCT02763579|63139823|FG002|China Period|Lost to Follow-up|1|||
33681621|NCT02763579|63139824|FG003|China Period|Lost to Follow-up|1|||
33681622|NCT02763579|63139821|FG000|China Period|Physician Decision|0|||
33681623|NCT02763579|63139822|FG001|China Period|Physician Decision|0|||
33681624|NCT02763579|63139823|FG002|China Period|Physician Decision|0|||
33681625|NCT02763579|63139824|FG003|China Period|Physician Decision|1|||
33681626|NCT02763579|63139821|FG000|China Period|Study Terminated By Sponsor|0|||
33681627|NCT02763579|63139822|FG001|China Period|Study Terminated By Sponsor|0|||
33681628|NCT02763579|63139823|FG002|China Period|Study Terminated By Sponsor|3|||
33681629|NCT02763579|63139824|FG003|China Period|Study Terminated By Sponsor|4|||
33681630|NCT02763579|63139821|FG000|China Period|Withdrawal by Subject|0|||
33681631|NCT02763579|63139822|FG001|China Period|Withdrawal by Subject|0|||
33681632|NCT02763579|63139823|FG002|China Period|Withdrawal by Subject|3|||
33681633|NCT02763579|63139824|FG003|China Period|Withdrawal by Subject|3|||
33681634|NCT02623699|63139868|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33681635|NCT02623699|63139869|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
33681636|NCT02623699|63139870|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33681637|NCT02623699|63139871|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33681638|NCT02623699|63139872|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33681639|NCT02623699|63139873|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33681640|NCT02623699|63139874|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33681641|NCT02623699|63139875|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33681642|NCT02623699|63139876|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33681643|NCT02623699|63139877|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33681644|NCT02623699|63139878|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33681645|NCT02623699|63139879|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33681646|NCT02623699|63139868|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33681647|NCT02623699|63139869|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33681648|NCT02623699|63139870|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33681649|NCT02623699|63139871|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33681650|NCT02623699|63139872|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33681651|NCT02623699|63139873|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33681652|NCT02623699|63139874|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
33681653|NCT02623699|63139875|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33681654|NCT02623699|63139876|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33681655|NCT02623699|63139877|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33681656|NCT02623699|63139878|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33681657|NCT02623699|63139879|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33681658|NCT02623699|63139868|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33681659|NCT02623699|63139869|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33681660|NCT02623699|63139870|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33681661|NCT02623699|63139871|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33681662|NCT02623699|63139872|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33681663|NCT02623699|63139873|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
33681664|NCT02623699|63139874|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33681665|NCT02623699|63139875|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33681666|NCT02623699|63139876|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33681667|NCT02623699|63139877|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33681668|NCT02623699|63139878|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33681669|NCT02623699|63139879|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33681670|NCT02623699|63139868|FG000|Part B (Up to 289 Days)|Death|0|||
33681671|NCT02623699|63139869|FG001|Part B (Up to 289 Days)|Death|0|||
33681672|NCT02623699|63139870|FG002|Part B (Up to 289 Days)|Death|0|||
33681673|NCT02623699|63139871|FG003|Part B (Up to 289 Days)|Death|0|||
33681674|NCT02623699|63139872|FG004|Part B (Up to 289 Days)|Death|0|||
33681675|NCT02623699|63139873|FG005|Part B (Up to 289 Days)|Death|1|||
33681676|NCT02623699|63139874|FG006|Part B (Up to 289 Days)|Death|1|||
33681677|NCT02623699|63139875|FG007|Part B (Up to 289 Days)|Death|0|||
33681678|NCT02623699|63139876|FG008|Part B (Up to 289 Days)|Death|1|||
33681679|NCT02623699|63139877|FG009|Part B (Up to 289 Days)|Death|0|||
33681680|NCT02623699|63139878|FG010|Part B (Up to 289 Days)|Death|0|||
33681681|NCT02623699|63139879|FG011|Part B (Up to 289 Days)|Death|0|||
33681682|NCT02623699|63139868|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
33681683|NCT02623699|63139869|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
33681684|NCT02623699|63139870|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
33681685|NCT02623699|63139871|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
33681686|NCT02623699|63139872|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
33681687|NCT02623699|63139873|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
33681688|NCT02623699|63139874|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
33681689|NCT02623699|63139875|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
33681690|NCT02623699|63139876|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
33681691|NCT02623699|63139877|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
33681692|NCT02623699|63139878|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
33681693|NCT02623699|63139879|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
33681694|NCT02623699|63139868|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33681695|NCT02623699|63139869|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33681696|NCT02623699|63139870|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33681697|NCT02623699|63139871|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33681698|NCT02623699|63139872|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33681699|NCT02623699|63139873|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33681700|NCT02623699|63139874|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33681701|NCT02623699|63139875|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33681702|NCT02623699|63139876|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33681703|NCT02623699|63139877|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33681704|NCT02623699|63139878|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
33681705|NCT02623699|63139879|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
33681706|NCT02623699|63139868|FG000|Part C (Up to 236 Days)|Death|0|||
33681707|NCT02623699|63139869|FG001|Part C (Up to 236 Days)|Death|0|||
33681708|NCT02623699|63139870|FG002|Part C (Up to 236 Days)|Death|0|||
33681709|NCT02623699|63139871|FG003|Part C (Up to 236 Days)|Death|0|||
33401436|NCT00256867|62780475|FG001|Overall Study|Lost to Follow-up|2|||
33594698|NCT02163915|62993617|FG003|Overall Study|Withdrawal by Subject|2|||
33594699|NCT02163915|62993618|FG004|Overall Study|Withdrawal by Subject|2|||
33594700|NCT02163915|62993614|FG000|Overall Study|Study termination|1|||
33594701|NCT02163915|62993615|FG001|Overall Study|Study termination|0|||
33594702|NCT02163915|62993616|FG002|Overall Study|Study termination|0|||
33594703|NCT02163915|62993617|FG003|Overall Study|Study termination|0|||
33594704|NCT02163915|62993618|FG004|Overall Study|Study termination|2|||
33594705|NCT02163915|62993614|FG000|Overall Study|Physician Decision|0|||
33594706|NCT02163915|62993615|FG001|Overall Study|Physician Decision|0|||
33594707|NCT02163915|62993616|FG002|Overall Study|Physician Decision|0|||
33594708|NCT02163915|62993617|FG003|Overall Study|Physician Decision|1|||
33594709|NCT02163915|62993618|FG004|Overall Study|Physician Decision|0|||
33594710|NCT02163759|62993637|FG000|Overall Study|Withdrawal by Subject|1|||
33594711|NCT02163759|62993638|FG001|Overall Study|Withdrawal by Subject|5|||
33594712|NCT02163759|62993639|FG002|Overall Study|Withdrawal by Subject|1|||
33681710|NCT02623699|63139872|FG004|Part C (Up to 236 Days)|Death|0|||
33681711|NCT02623699|63139873|FG005|Part C (Up to 236 Days)|Death|0|||
33681712|NCT02623699|63139874|FG006|Part C (Up to 236 Days)|Death|0|||
33681713|NCT02623699|63139875|FG007|Part C (Up to 236 Days)|Death|0|||
33681714|NCT02623699|63139876|FG008|Part C (Up to 236 Days)|Death|0|||
33681715|NCT02623699|63139877|FG009|Part C (Up to 236 Days)|Death|0|||
33681716|NCT02623699|63139878|FG010|Part C (Up to 236 Days)|Death|0|||
33681717|NCT02623699|63139879|FG011|Part C (Up to 236 Days)|Death|1|||
33681718|NCT02623699|63139868|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
33681719|NCT02623699|63139869|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
33681720|NCT02623699|63139870|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
33681721|NCT02623699|63139871|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
33681722|NCT02623699|63139872|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
33681723|NCT02623699|63139873|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
33681724|NCT02623699|63139874|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
33681725|NCT02623699|63139875|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
33681726|NCT02623699|63139876|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
33681727|NCT02623699|63139877|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
33681728|NCT02623699|63139878|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
33681729|NCT02623699|63139879|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
33681730|NCT02550652|63139920|FG000|Overall Study|Death|1|||
33681731|NCT02550652|63139921|FG001|Overall Study|Death|4|||
33681732|NCT02550652|63139920|FG000|Overall Study|Lack of Efficacy|1|||
33681733|NCT02550652|63139921|FG001|Overall Study|Lack of Efficacy|0|||
33681734|NCT02550652|63139920|FG000|Overall Study|Withdrawal by Subject|3|||
33681735|NCT02550652|63139921|FG001|Overall Study|Withdrawal by Subject|7|||
33681736|NCT02550652|63139920|FG000|Overall Study|Post Trial Access|1|||
33681737|NCT02550652|63139921|FG001|Overall Study|Post Trial Access|0|||
33681738|NCT02550652|63139920|FG000|Overall Study|Lost to Follow-up|1|||
33681739|NCT02550652|63139921|FG001|Overall Study|Lost to Follow-up|3|||
33681740|NCT02550652|63139920|FG000|Overall Study|Physician Decision|0|||
33681741|NCT02550652|63139921|FG001|Overall Study|Physician Decision|2|||
33681742|NCT02550652|63139920|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14|||
33681743|NCT02550652|63139921|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5|||
33681744|NCT02501642|63139929|FG000|Overall Study|Lost to Follow-up|7|||
33681745|NCT02501642|63139930|FG001|Overall Study|Lost to Follow-up|11|||
33681746|NCT02475954|63139938|FG000|Overall Study|Withdrawal by Subject|2|||
33594713|NCT02163759|62993637|FG000|Overall Study|Adverse Event|0|||
33681747|NCT02475954|63139939|FG001|Overall Study|Withdrawal by Subject|2|||
33681748|NCT02475954|63139938|FG000|Overall Study|Lost to Follow-up|11|||
33681749|NCT02475954|63139939|FG001|Overall Study|Lost to Follow-up|9|||
33681750|NCT02475954|63139938|FG000|Overall Study|Death|1|||
33681751|NCT02475954|63139939|FG001|Overall Study|Death|1|||
33681752|NCT02459587|63139948|FG000|3-Month Follow-up Assessment|Death|0|||
33681753|NCT02459587|63139949|FG001|3-Month Follow-up Assessment|Death|2|||
33681754|NCT02459587|63139948|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
33681755|NCT02459587|63139949|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
33681756|NCT02459587|63139948|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
33681757|NCT02459587|63139949|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
33681758|NCT02459587|63139948|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
33681759|NCT02459587|63139949|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
33681760|NCT02459587|63139948|FG000|6-month Follow-up Assessment|Death|2|||
33681761|NCT02459587|63139949|FG001|6-month Follow-up Assessment|Death|1|||
33681762|NCT02459587|63139948|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
33681763|NCT02459587|63139949|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
33681764|NCT02459587|63139948|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
33681765|NCT02459587|63139949|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
33681766|NCT02459587|63139948|FG000|12-month Follow-up Assessment|Death|2|||
33681767|NCT02459587|63139949|FG001|12-month Follow-up Assessment|Death|0|||
33594714|NCT02163759|62993638|FG001|Overall Study|Adverse Event|0|||
33594715|NCT02163759|62993639|FG002|Overall Study|Adverse Event|1|||
33594716|NCT02163759|62993637|FG000|Overall Study|Death|0|||
33594717|NCT02163759|62993638|FG001|Overall Study|Death|0|||
33594718|NCT02163759|62993639|FG002|Overall Study|Death|1|||
33594719|NCT02371369|62993652|FG000|Part 1|Physician Decision|0|||
33594720|NCT02371369|62993653|FG001|Part 1|Physician Decision|3|||
33594721|NCT02371369|62993652|FG000|Part 1|Adverse Event|8|||
33594722|NCT02371369|62993653|FG001|Part 1|Adverse Event|0|||
33594723|NCT02371369|62993652|FG000|Part 1|Withdrawal by Subject|1|||
33594724|NCT02371369|62993653|FG001|Part 1|Withdrawal by Subject|6|||
33594725|NCT02371369|62993652|FG000|Part 1|Disease progression|0|||
33594726|NCT02371369|62993653|FG001|Part 1|Disease progression|1|||
33594727|NCT02371369|62993652|FG000|Part 1|Protocol Violation|0|||
33594728|NCT02371369|62993653|FG001|Part 1|Protocol Violation|1|||
33594729|NCT02371369|62993652|FG000|Part 2|Adverse Event|6|||
33594730|NCT02371369|62993653|FG001|Part 2|Adverse Event|5|||
33594731|NCT02371369|62993652|FG000|Part 2|Withdrawal by Subject|16|||
33594732|NCT02371369|62993653|FG001|Part 2|Withdrawal by Subject|6|||
33594733|NCT02371369|62993652|FG000|Part 2|Investigator decision|1|||
33594734|NCT02371369|62993653|FG001|Part 2|Investigator decision|2|||
33594735|NCT02371369|62993652|FG000|Part 2|Death|0|||
33594736|NCT02371369|62993653|FG001|Part 2|Death|1|||
33594737|NCT02371369|62993652|FG000|Part 2|Disease progression|1|||
33594738|NCT02371369|62993653|FG001|Part 2|Disease progression|0|||
33681768|NCT02459587|63139948|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
33681769|NCT02459587|63139949|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
33681770|NCT02459587|63139948|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
33681771|NCT02459587|63139949|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
33681772|NCT02459587|63139948|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
33681773|NCT02459587|63139949|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
33681774|NCT02281084|63139960|FG000|Overall Study|Adverse Event|1|||
33681775|NCT02281084|63139961|FG001|Overall Study|Adverse Event|0|||
33681776|NCT02281084|63139962|FG002|Overall Study|Adverse Event|0|||
33681777|NCT02281084|63139963|FG003|Overall Study|Adverse Event|0|||
33681778|NCT02281084|63139960|FG000|Overall Study|Withdrawal by Subject|1|||
33681779|NCT02281084|63139961|FG001|Overall Study|Withdrawal by Subject|2|||
33681780|NCT02281084|63139962|FG002|Overall Study|Withdrawal by Subject|0|||
33681781|NCT02281084|63139963|FG003|Overall Study|Withdrawal by Subject|0|||
33681782|NCT02281084|63139960|FG000|Overall Study|Death|20|||
33681783|NCT02281084|63139961|FG001|Overall Study|Death|16|||
33681784|NCT02281084|63139962|FG002|Overall Study|Death|3|||
33681785|NCT02281084|63139963|FG003|Overall Study|Death|5|||
33681786|NCT02281084|63139960|FG000|Overall Study|Physician Decision|0|||
33681787|NCT02281084|63139961|FG001|Overall Study|Physician Decision|0|||
33681788|NCT02281084|63139962|FG002|Overall Study|Physician Decision|1|||
33681789|NCT02281084|63139963|FG003|Overall Study|Physician Decision|0|||
33681790|NCT01966120|63139984|FG000|Overall Study|Withdrawal by Subject|0|||
33681791|NCT01966120|63139985|FG001|Overall Study|Withdrawal by Subject|5|||
33681792|NCT01966120|63139984|FG000|Overall Study|Lost to Follow-up|1|||
33681793|NCT01966120|63139985|FG001|Overall Study|Lost to Follow-up|1|||
33681794|NCT01399736|63140028|FG000|Overall Study|Withdrawal by Subject|4|||
33681795|NCT01399736|63140029|FG001|Overall Study|Withdrawal by Subject|2|||
33681796|NCT01399736|63140028|FG000|Overall Study|Lost to Follow-up|0|||
33681797|NCT01399736|63140029|FG001|Overall Study|Lost to Follow-up|2|||
33681798|NCT04372927|63140159|FG000|Overall Study|Death|1|||
33681799|NCT01381874|63140166|FG000|Overall Study|Lost to Follow-up|1|||
33681800|NCT01381874|63140167|FG001|Overall Study|Lost to Follow-up|1|||
33681801|NCT01381874|63140168|FG002|Overall Study|Lost to Follow-up|0|||
33681802|NCT01381874|63140166|FG000|Overall Study|Withdrawal by Subject|9|||
33681803|NCT01381874|63140167|FG001|Overall Study|Withdrawal by Subject|10|||
33681804|NCT01381874|63140168|FG002|Overall Study|Withdrawal by Subject|9|||
33681805|NCT01381874|63140166|FG000|Overall Study|Other|67|||
33681806|NCT01381874|63140167|FG001|Overall Study|Other|52|||
33681807|NCT01381874|63140168|FG002|Overall Study|Other|67|||
33681808|NCT01399190|63140176|FG000|Overall Study|Not Eligible for Final Analysis|5|||
33681809|NCT01399190|63140176|FG000|Overall Study|Adverse Event|8|||
33681810|NCT01399190|63140176|FG000|Overall Study|Participant's Request|5|||
33681811|NCT01399190|63140176|FG000|Overall Study|Physician Decision|2|||
33681812|NCT01381718|63140194|FG000|Overall Study|Withdrawal by Subject|2|||
33681813|NCT01381718|63140195|FG001|Overall Study|Withdrawal by Subject|5|||
33681814|NCT01381718|63140194|FG000|Overall Study|Lost to Follow-up|3|||
33681815|NCT01381718|63140195|FG001|Overall Study|Lost to Follow-up|5|||
33681816|NCT01381718|63140194|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
33681817|NCT01381718|63140195|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
33681818|NCT01398956|63140214|FG000|Overall Study|Withdrawal by Subject|4|||
33681819|NCT01398956|63140214|FG000|Overall Study|AE, non-serious non-fatal|4|||
33681820|NCT01398956|63140214|FG000|Overall Study|Withdrawal Criteria No.3|1|||
33681821|NCT01398956|63140214|FG000|Overall Study|Subject moved a long distance|1|||
33681822|NCT01381562|63140240|FG000|Overall Study|Adverse Event|0|||
33681823|NCT01381562|63140241|FG001|Overall Study|Adverse Event|1|||
33681824|NCT01381562|63140242|FG002|Overall Study|Adverse Event|0|||
33681825|NCT01381016|63140265|FG000|Overall Study|Lost to Follow-up|1|||
33681826|NCT01381016|63140266|FG001|Overall Study|Lost to Follow-up|1|||
33681827|NCT01381016|63140265|FG000|Overall Study|Screen Failure|2|||
33681828|NCT01381016|63140266|FG001|Overall Study|Screen Failure|2|||
33681829|NCT01381016|63140265|FG000|Overall Study|Withdrawal by Subject|0|||
33681830|NCT01381016|63140266|FG001|Overall Study|Withdrawal by Subject|1|||
33681831|NCT01381016|63140265|FG000|Overall Study|Physician Decision|0|||
33681832|NCT01381016|63140266|FG001|Overall Study|Physician Decision|2|||
33681833|NCT01398410|63140293|FG000|Overall Study|Adverse Event|12|||
33681834|NCT01398410|63140294|FG001|Overall Study|Adverse Event|16|||
33681835|NCT01398410|63140293|FG000|Overall Study|Participants Choice|8|||
33681836|NCT01398410|63140294|FG001|Overall Study|Participants Choice|11|||
33681837|NCT01398410|63140293|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
33681838|NCT01398410|63140294|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
33681839|NCT01398410|63140293|FG000|Overall Study|Other|36|||
33681840|NCT01398410|63140294|FG001|Overall Study|Other|29|||
33681841|NCT01380782|63140360|FG000|Overall Study|Adverse Event|0|||
33681842|NCT01380782|63140361|FG001|Overall Study|Adverse Event|1|||
33681843|NCT01380782|63140362|FG002|Overall Study|Adverse Event|0|||
33681844|NCT01380782|63140363|FG003|Overall Study|Adverse Event|0|||
33681845|NCT01380782|63140360|FG000|Overall Study|Death|1|||
33681846|NCT01380782|63140361|FG001|Overall Study|Death|0|||
33681847|NCT01380782|63140362|FG002|Overall Study|Death|0|||
33681848|NCT01380782|63140363|FG003|Overall Study|Death|0|||
33681849|NCT01380782|63140360|FG000|Overall Study|Lack of Efficacy|10|||
33681850|NCT01380782|63140361|FG001|Overall Study|Lack of Efficacy|9|||
33681851|NCT01380782|63140362|FG002|Overall Study|Lack of Efficacy|10|||
33681852|NCT01380782|63140363|FG003|Overall Study|Lack of Efficacy|3|||
33681853|NCT01380782|63140360|FG000|Overall Study|Physician Decision|1|||
33681854|NCT01380782|63140361|FG001|Overall Study|Physician Decision|0|||
33681855|NCT01380782|63140362|FG002|Overall Study|Physician Decision|0|||
33681856|NCT01380782|63140363|FG003|Overall Study|Physician Decision|0|||
33681857|NCT01380782|63140360|FG000|Overall Study|Withdrawal by Subject|0|||
33681858|NCT01380782|63140361|FG001|Overall Study|Withdrawal by Subject|0|||
33681859|NCT01380782|63140362|FG002|Overall Study|Withdrawal by Subject|1|||
33681860|NCT01380782|63140363|FG003|Overall Study|Withdrawal by Subject|1|||
33681861|NCT01398176|63140377|FG000|Overall Study|Lost to Follow-up|1|||
33681862|NCT01398176|63140378|FG001|Overall Study|Lost to Follow-up|3|||
33681863|NCT01398176|63140377|FG000|Overall Study|Physician Decision|2|||
33681864|NCT01398176|63140378|FG001|Overall Study|Physician Decision|3|||
33681865|NCT01397786|63140431|FG000|Phase A|Lost to Follow-up|0|||
33681866|NCT01397786|63140432|FG001|Phase A|Lost to Follow-up|0|||
33681867|NCT01397786|63140433|FG002|Phase A|Lost to Follow-up|6|||
33681868|NCT01397786|63140431|FG000|Phase A|Adverse Event|0|||
33681869|NCT01397786|63140432|FG001|Phase A|Adverse Event|0|||
33681870|NCT01397786|63140433|FG002|Phase A|Adverse Event|8|||
33681871|NCT01397786|63140431|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
33681872|NCT01397786|63140432|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
33681873|NCT01397786|63140433|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
33681874|NCT01397786|63140431|FG000|Phase A|Physician Decision|0|||
33681875|NCT01397786|63140432|FG001|Phase A|Physician Decision|0|||
33681876|NCT01397786|63140433|FG002|Phase A|Physician Decision|1|||
33681877|NCT01397786|63140431|FG000|Phase A|Withdrawal by Subject|0|||
33681878|NCT01397786|63140432|FG001|Phase A|Withdrawal by Subject|0|||
33681879|NCT01397786|63140433|FG002|Phase A|Withdrawal by Subject|5|||
33681880|NCT01397786|63140431|FG000|Phase A|Lack of Efficacy|0|||
33681881|NCT01397786|63140432|FG001|Phase A|Lack of Efficacy|0|||
33681882|NCT01397786|63140433|FG002|Phase A|Lack of Efficacy|1|||
33681883|NCT01397786|63140431|FG000|Phase B|Lost to Follow-up|22|||
33681884|NCT01397786|63140432|FG001|Phase B|Lost to Follow-up|12|||
33681885|NCT01397786|63140433|FG002|Phase B|Lost to Follow-up|22|||
33594739|NCT02371369|62993652|FG000|Part 2|Subject Noncompliance|1|||
33594740|NCT02371369|62993653|FG001|Part 2|Subject Noncompliance|0|||
33594741|NCT02371369|62993652|FG000|Part 2|Lost to Follow-up|1|||
33594742|NCT02371369|62993653|FG001|Part 2|Lost to Follow-up|1|||
33594743|NCT02371369|62993652|FG000|Part 2|Subject transitioned to commercial supply|6|||
33594744|NCT02371369|62993653|FG001|Part 2|Subject transitioned to commercial supply|4|||
33594745|NCT02371369|62993652|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
33594746|NCT02371369|62993653|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
33594747|NCT02371369|62993652|FG000|Part 2|Surgical resection of tumor|1|||
33594748|NCT02371369|62993653|FG001|Part 2|Surgical resection of tumor|1|||
33594749|NCT02371369|62993652|FG000|Part 2|Other|0|||
33594750|NCT02371369|62993653|FG001|Part 2|Other|1|||
33594751|NCT02187783|62993675|FG000|Overall Study|Adverse Event|8|||
33594752|NCT02187783|62993675|FG000|Overall Study|Death|3|||
33594753|NCT02187783|62993675|FG000|Overall Study|Progressive disease|80|||
33594754|NCT02187783|62993675|FG000|Overall Study|Protocol Violation|3|||
33594755|NCT02187783|62993675|FG000|Overall Study|Physician Decision|2|||
33594756|NCT02187783|62993675|FG000|Overall Study|Withdrawal by Subject|9|||
33681886|NCT01397786|63140431|FG000|Phase B|Adverse Event|109|||
33681887|NCT01397786|63140432|FG001|Phase B|Adverse Event|23|||
33681888|NCT01397786|63140433|FG002|Phase B|Adverse Event|27|||
33681889|NCT01397786|63140431|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
33681890|NCT01397786|63140432|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
33681891|NCT01397786|63140433|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
33681892|NCT01397786|63140431|FG000|Phase B|Physician Decision|9|||
33681893|NCT01397786|63140432|FG001|Phase B|Physician Decision|1|||
33681894|NCT01397786|63140433|FG002|Phase B|Physician Decision|3|||
33681895|NCT01397786|63140431|FG000|Phase B|Withdrawal by Subject|102|||
33681896|NCT01397786|63140432|FG001|Phase B|Withdrawal by Subject|45|||
33681897|NCT01397786|63140433|FG002|Phase B|Withdrawal by Subject|30|||
33681898|NCT01397786|63140431|FG000|Phase B|Protocol Deviation|1|||
33681899|NCT01397786|63140432|FG001|Phase B|Protocol Deviation|2|||
33681900|NCT01397786|63140433|FG002|Phase B|Protocol Deviation|4|||
33681901|NCT01397786|63140431|FG000|Phase B|Lack of Efficacy|22|||
33681902|NCT01397786|63140432|FG001|Phase B|Lack of Efficacy|7|||
33681903|NCT01397786|63140433|FG002|Phase B|Lack of Efficacy|14|||
33681904|NCT01397552|63140483|FG000|Overall Study|Adverse Event|1|||
33681905|NCT01397552|63140484|FG001|Overall Study|Adverse Event|0|||
33681906|NCT01397552|63140483|FG000|Overall Study|Withdrawal by Subject|2|||
33681907|NCT01397552|63140484|FG001|Overall Study|Withdrawal by Subject|1|||
33681908|NCT01397162|63140504|FG000|Overall Study|Adverse Event|4|||
33681909|NCT01397162|63140505|FG001|Overall Study|Adverse Event|0|||
33681910|NCT01397162|63140506|FG002|Overall Study|Adverse Event|0|||
33681911|NCT01397162|63140507|FG003|Overall Study|Adverse Event|0|||
33681912|NCT01397162|63140508|FG004|Overall Study|Adverse Event|0|||
33681913|NCT01397162|63140504|FG000|Overall Study|Not yet defined|3|||
33681914|NCT01397162|63140505|FG001|Overall Study|Not yet defined|4|||
33681915|NCT01397162|63140506|FG002|Overall Study|Not yet defined|3|||
33681916|NCT01397162|63140507|FG003|Overall Study|Not yet defined|5|||
33681917|NCT01397162|63140508|FG004|Overall Study|Not yet defined|3|||
33681918|NCT01397084|63140541|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
33681919|NCT01397084|63140541|FG000|Overall Study|Protocol Violation|2|||
33681920|NCT01397084|63140541|FG000|Overall Study|Adverse Event|2|||
33594757|NCT02187783|62993675|FG000|Overall Study|Study terminated by sponsor|1|||
33594758|NCT02337361|62993681|FG000|3-month Follow-up|Lost to Follow-up|19|||
33594759|NCT02337361|62993682|FG001|3-month Follow-up|Lost to Follow-up|14|||
33594760|NCT02337361|62993681|FG000|6-month Follow-up|Lost to Follow-up|2|||
33594761|NCT02337361|62993682|FG001|6-month Follow-up|Lost to Follow-up|4|||
33594762|NCT02336737|62993689|FG000|Overall Study|Withdrawal by Subject|5|||
33594763|NCT02336737|62993689|FG000|Overall Study|Physician Decision|8|||
33594764|NCT02130765|62993698|FG000|Overall Study|Did not receive treatment|4|||
33594765|NCT02130765|62993699|FG001|Overall Study|Did not receive treatment|0|||
33594766|NCT02130765|62993700|FG002|Overall Study|Did not receive treatment|0|||
33594767|NCT02130765|62993701|FG003|Overall Study|Did not receive treatment|0|||
33594768|NCT02305381|62993716|FG000|Overall Study|Unclassified|5|||
33594769|NCT02305381|62993717|FG001|Overall Study|Unclassified|5|||
33594770|NCT02305381|62993718|FG002|Overall Study|Unclassified|7|||
33594771|NCT02336425|62993730|FG000|Overall Study|Study terminated.|2|||
33594772|NCT02336425|62993731|FG001|Overall Study|Study terminated.|2|||
33594773|NCT02336425|62993732|FG002|Overall Study|Study terminated.|3|||
33594774|NCT02336425|62993733|FG003|Overall Study|Study terminated.|3|||
33594775|NCT02163447|62993746|FG000|Overall Study|Withdrawal by Subject|2|||
33594776|NCT02163447|62993747|FG001|Overall Study|Withdrawal by Subject|0|||
33594777|NCT02163447|62993748|FG002|Overall Study|Withdrawal by Subject|1|||
33594778|NCT02163447|62993746|FG000|Overall Study|Lost to Follow-up|1|||
33594779|NCT02163447|62993747|FG001|Overall Study|Lost to Follow-up|3|||
33594780|NCT02163447|62993748|FG002|Overall Study|Lost to Follow-up|0|||
33594781|NCT02163447|62993746|FG000|Overall Study|Moved out of study area|2|||
33594782|NCT02163447|62993747|FG001|Overall Study|Moved out of study area|3|||
33594783|NCT02163447|62993748|FG002|Overall Study|Moved out of study area|2|||
33594784|NCT02163447|62993746|FG000|Overall Study|Became HIV infected at time of delivery|1|||
33594785|NCT02163447|62993747|FG001|Overall Study|Became HIV infected at time of delivery|0|||
33594786|NCT02163447|62993748|FG002|Overall Study|Became HIV infected at time of delivery|0|||
33594787|NCT02370667|62993769|FG000|Overall Study|Lost to Follow-up|0|||
33594788|NCT02370667|62993770|FG001|Overall Study|Lost to Follow-up|1|||
33594789|NCT02370667|62993771|FG002|Overall Study|Lost to Follow-up|0|||
33594790|NCT02130297|62993779|FG000|Overall Study|Lost to Follow-up|4|||
33594791|NCT01931956|62993787|FG000|Overall Study|Death|42|||
33594792|NCT01931956|62993788|FG001|Overall Study|Death|7|||
33594793|NCT01931956|62993789|FG002|Overall Study|Death|379|||
33594794|NCT01931956|62993790|FG003|Overall Study|Death|96|||
33594795|NCT01931956|62993787|FG000|Overall Study|Withdrawal by Subject|5|||
33594796|NCT01931956|62993788|FG001|Overall Study|Withdrawal by Subject|0|||
33594797|NCT01931956|62993789|FG002|Overall Study|Withdrawal by Subject|70|||
33594798|NCT01931956|62993790|FG003|Overall Study|Withdrawal by Subject|30|||
33594799|NCT01931956|62993787|FG000|Overall Study|Lost to Follow-up|2|||
33594800|NCT01931956|62993788|FG001|Overall Study|Lost to Follow-up|0|||
33594801|NCT01931956|62993789|FG002|Overall Study|Lost to Follow-up|11|||
33594802|NCT01931956|62993790|FG003|Overall Study|Lost to Follow-up|7|||
33594803|NCT01931956|62993787|FG000|Overall Study|Expected|2|||
33594804|NCT01931956|62993788|FG001|Overall Study|Expected|0|||
33594805|NCT01931956|62993789|FG002|Overall Study|Expected|6|||
33594806|NCT01931956|62993790|FG003|Overall Study|Expected|0|||
33594807|NCT01931956|62993787|FG000|Overall Study|Not due|0|||
33594808|NCT01931956|62993788|FG001|Overall Study|Not due|0|||
33594809|NCT01931956|62993789|FG002|Overall Study|Not due|21|||
33594810|NCT01931956|62993790|FG003|Overall Study|Not due|0|||
33594811|NCT01887418|62993816|FG000|Overall Study|Travelling difficulties|0|||
33594812|NCT01887418|62993817|FG001|Overall Study|Travelling difficulties|0|||
33594813|NCT01887418|62993818|FG002|Overall Study|Travelling difficulties|1|||
33594814|NCT01886716|62993830|FG000|Week 1|Lost to Follow-up|0|||
33681921|NCT01397084|63140541|FG000|Overall Study|Withdrawal by Subject|1|||
33681922|NCT01397084|63140541|FG000|Overall Study|Lost to Follow-up|1|||
33681923|NCT01397084|63140541|FG000|Overall Study|Used other proton pump inhibitor|1|||
33681924|NCT01396148|63140581|FG000|Overall Study|Patient Decision|1|||
33681925|NCT01396070|63140614|FG000|Overall Study|Withdrawal by Subject|2|||
33681926|NCT01396070|63140614|FG000|Overall Study|Death|2|||
33681927|NCT01396070|63140614|FG000|Overall Study|Adverse Event|8|||
33681928|NCT01396070|63140614|FG000|Overall Study|Physician Decision|3|||
33681929|NCT01396070|63140614|FG000|Overall Study|Lack of Efficacy|4|||
33681930|NCT01395914|63140631|FG000|Overall Study|Unrelated to study drug AE|6|||
33681931|NCT01395914|63140632|FG001|Overall Study|Unrelated to study drug AE|1|||
33681932|NCT01395914|63140631|FG000|Overall Study|Death|23|||
33681933|NCT01395914|63140632|FG001|Overall Study|Death|17|||
33681934|NCT01395914|63140631|FG000|Overall Study|Other|9|||
33681935|NCT01395914|63140632|FG001|Overall Study|Other|3|||
33681936|NCT01395914|63140631|FG000|Overall Study|Withdrawal by patient|27|||
33681937|NCT01395914|63140632|FG001|Overall Study|Withdrawal by patient|14|||
33681938|NCT01395914|63140631|FG000|Overall Study|Study drug-related AE|1|||
33681939|NCT01395914|63140632|FG001|Overall Study|Study drug-related AE|0|||
33681940|NCT01395914|63140631|FG000|Overall Study|Lost to Follow-up|6|||
33681941|NCT01395914|63140632|FG001|Overall Study|Lost to Follow-up|2|||
33681942|NCT01395758|63140890|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
33681943|NCT01395758|63140891|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
33681944|NCT01395758|63140892|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
33681945|NCT01395524|63140950|FG000|Overall Study|Non-compliance with study schedule|1|||
33681946|NCT01395524|63140951|FG001|Overall Study|Non-compliance with study schedule|0|||
33681947|NCT01395524|63140952|FG002|Overall Study|Non-compliance with study schedule|1|||
33681948|NCT01395524|63140950|FG000|Overall Study|Lost to Follow-up|3|||
33681949|NCT01395524|63140951|FG001|Overall Study|Lost to Follow-up|1|||
33681950|NCT01395524|63140952|FG002|Overall Study|Lost to Follow-up|1|||
33681951|NCT01395524|63140950|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
33681952|NCT01395524|63140951|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
33681953|NCT01395524|63140952|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
33681954|NCT01395524|63140950|FG000|Overall Study|Severe noncompliance with protocol|1|||
33681955|NCT01395524|63140951|FG001|Overall Study|Severe noncompliance with protocol|0|||
33681956|NCT01395524|63140952|FG002|Overall Study|Severe noncompliance with protocol|0|||
33681957|NCT01395524|63140950|FG000|Overall Study|Adverse Event|4|||
33681958|NCT01395524|63140951|FG001|Overall Study|Adverse Event|4|||
33681959|NCT01395524|63140952|FG002|Overall Study|Adverse Event|3|||
33681960|NCT01395524|63140950|FG000|Overall Study|Death|1|||
33681961|NCT01395524|63140951|FG001|Overall Study|Death|0|||
33681962|NCT01395524|63140952|FG002|Overall Study|Death|0|||
33681963|NCT01395524|63140950|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
33681964|NCT01395524|63140951|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
33681965|NCT01395524|63140952|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
33681966|NCT01395524|63140950|FG000|Overall Study|Withdrawal by Subject|4|||
33681967|NCT01395524|63140951|FG001|Overall Study|Withdrawal by Subject|8|||
33681968|NCT01395524|63140952|FG002|Overall Study|Withdrawal by Subject|8|||
33681969|NCT01395524|63140950|FG000|Overall Study|Did not receive treatment|1|||
33681970|NCT01395524|63140951|FG001|Overall Study|Did not receive treatment|1|||
33681971|NCT01395524|63140952|FG002|Overall Study|Did not receive treatment|3|||
33681972|NCT01395524|63140950|FG000|Overall Study|Subject had spinal surgery|0|||
33681973|NCT01395524|63140951|FG001|Overall Study|Subject had spinal surgery|0|||
33681974|NCT01395524|63140952|FG002|Overall Study|Subject had spinal surgery|1|||
33681975|NCT01395368|63140960|FG000|Overall Study|Physician Decision|14|||
33681976|NCT01395368|63140960|FG000|Overall Study|Withdrawal by Subject|2|||
33681977|NCT01394978|63140967|FG000|Overall Study|Withdrawal by Subject|2|||
33681978|NCT01394978|63140968|FG001|Overall Study|Withdrawal by Subject|4|||
33681979|NCT01394978|63140967|FG000|Overall Study|Lost to Follow-up|13|||
33681980|NCT01394978|63140968|FG001|Overall Study|Lost to Follow-up|20|||
33543976|NCT03034967|62934794|FG000|Overall Study|Liver function test abnormality|0|||
33681981|NCT01394978|63140967|FG000|Overall Study|Death|6|||
33681982|NCT01394978|63140968|FG001|Overall Study|Death|7|||
33681983|NCT01394276|63140975|FG000|Overall Study|Related Adverse event (AEs)|15|||
33681984|NCT01394276|63140975|FG000|Overall Study|Not related AEs|9|||
33681985|NCT01394276|63140975|FG000|Overall Study|Remission of disease|2|||
33681986|NCT01394276|63140975|FG000|Overall Study|Insufficient therapeutic effect|17|||
33681987|NCT01394276|63140975|FG000|Overall Study|Insufficient compliance|9|||
33681988|NCT01394276|63140975|FG000|Overall Study|Lost to Follow-up|5|||
33681989|NCT01394276|63140975|FG000|Overall Study|Participant moved to another site|1|||
33681990|NCT01394276|63140975|FG000|Overall Study|Pregnancy|1|||
33681991|NCT01394276|63140975|FG000|Overall Study|unavailability of drug at the Hospital|2|||
33681992|NCT01394276|63140975|FG000|Overall Study|Symptoms of concurrent diseases|1|||
33681993|NCT00211172|63141075|FG000|Overall Study|Died or lost health plan eligibility|39|||
33681994|NCT00211172|63141076|FG001|Overall Study|Died or lost health plan eligibility|32|||
33681995|NCT00210626|63141127|FG000|Overall Study|Adverse Event|1|||
33681996|NCT00210626|63141128|FG001|Overall Study|Adverse Event|2|||
33681997|NCT00210626|63141127|FG000|Overall Study|Protocol Violation|1|||
33681998|NCT00210626|63141128|FG001|Overall Study|Protocol Violation|5|||
33681999|NCT00210626|63141127|FG000|Overall Study|Lost to Follow-up|11|||
33682000|NCT00210626|63141128|FG001|Overall Study|Lost to Follow-up|11|||
33682001|NCT00210626|63141127|FG000|Overall Study|Death|1|||
33682002|NCT00210626|63141128|FG001|Overall Study|Death|0|||
33682003|NCT00210626|63141127|FG000|Overall Study|Withdrawal by Subject|29|||
33682004|NCT00210626|63141128|FG001|Overall Study|Withdrawal by Subject|20|||
33682005|NCT00210626|63141127|FG000|Overall Study|Physician Decision|0|||
33682006|NCT00210626|63141128|FG001|Overall Study|Physician Decision|2|||
33682007|NCT00210626|63141127|FG000|Overall Study|Sponser Request|1|||
33682008|NCT00210626|63141128|FG001|Overall Study|Sponser Request|0|||
33682009|NCT00210626|63141127|FG000|Overall Study|Other|4|||
33682010|NCT00210626|63141128|FG001|Overall Study|Other|5|||
33682011|NCT00217022|63141150|FG000|Overall Study|Withdrawal by Subject|1|||
33682012|NCT00217022|63141151|FG001|Overall Study|Withdrawal by Subject|1|||
33682013|NCT00219284|63141498|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
33682014|NCT00219284|63141499|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
33682015|NCT00219284|63141498|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
33682016|NCT00219284|63141499|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
33682017|NCT00219284|63141498|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
33682018|NCT00219284|63141499|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
33682019|NCT00219284|63141498|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
33682020|NCT00219284|63141499|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
33682021|NCT00219284|63141498|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
33682022|NCT00219284|63141499|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
33682023|NCT00219284|63141498|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
33682024|NCT00219284|63141499|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
33682025|NCT00219284|63141498|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
33682026|NCT00219284|63141499|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
33682027|NCT00219284|63141498|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
33682028|NCT00219284|63141499|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
33682029|NCT00219284|63141498|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
33682030|NCT00219284|63141499|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
33682031|NCT00216476|63141638|FG000|Overall Study|Withdrawal by Subject|59|||
33682032|NCT00216476|63141639|FG001|Overall Study|Withdrawal by Subject|72|||
33682033|NCT00216476|63141640|FG002|Overall Study|Withdrawal by Subject|9|||
33682034|NCT00216476|63141638|FG000|Overall Study|Lost to Follow-up|10|||
33682035|NCT00216476|63141639|FG001|Overall Study|Lost to Follow-up|9|||
33682036|NCT00216476|63141640|FG002|Overall Study|Lost to Follow-up|1|||
33682037|NCT00216476|63141638|FG000|Overall Study|Adverse Event|6|||
33682038|NCT00216476|63141639|FG001|Overall Study|Adverse Event|10|||
33682039|NCT00216476|63141640|FG002|Overall Study|Adverse Event|1|||
33682040|NCT00216476|63141638|FG000|Overall Study|Lack of Efficacy|4|||
33682041|NCT00216476|63141639|FG001|Overall Study|Lack of Efficacy|3|||
33682042|NCT00216476|63141640|FG002|Overall Study|Lack of Efficacy|0|||
33682043|NCT00216476|63141638|FG000|Overall Study|Death|2|||
33682044|NCT00216476|63141639|FG001|Overall Study|Death|0|||
33682045|NCT00216476|63141640|FG002|Overall Study|Death|0|||
33682046|NCT00216476|63141638|FG000|Overall Study|Pregnancy|0|||
33682047|NCT00216476|63141639|FG001|Overall Study|Pregnancy|1|||
33682048|NCT00216476|63141640|FG002|Overall Study|Pregnancy|1|||
33682049|NCT00216476|63141638|FG000|Overall Study|Other|0|||
33682050|NCT00216476|63141639|FG001|Overall Study|Other|0|||
33682051|NCT00216476|63141640|FG002|Overall Study|Other|1|||
33682052|NCT00216476|63141638|FG000|Overall Study|Refuses Injection|11|||
33682053|NCT00216476|63141639|FG001|Overall Study|Refuses Injection|0|||
33682054|NCT00216476|63141640|FG002|Overall Study|Refuses Injection|0|||
33682055|NCT00216476|63141638|FG000|Overall Study|No Further Need for Treatment|3|||
33682056|NCT00216476|63141639|FG001|Overall Study|No Further Need for Treatment|4|||
33682057|NCT00216476|63141640|FG002|Overall Study|No Further Need for Treatment|1|||
33682058|NCT00216476|63141638|FG000|Overall Study|Non-compliance|0|||
33682059|NCT00216476|63141639|FG001|Overall Study|Non-compliance|4|||
33682060|NCT00216476|63141640|FG002|Overall Study|Non-compliance|1|||
33682061|NCT00216476|63141638|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
33682062|NCT00216476|63141639|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
33682063|NCT00216476|63141640|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
33682064|NCT00216476|63141638|FG000|Overall Study|Administrative Reasons|1|||
33682065|NCT00216476|63141639|FG001|Overall Study|Administrative Reasons|1|||
33682066|NCT00216476|63141640|FG002|Overall Study|Administrative Reasons|0|||
33682067|NCT00216476|63141638|FG000|Overall Study|Protocol Deviation|5|||
33682068|NCT00216476|63141639|FG001|Overall Study|Protocol Deviation|1|||
33682069|NCT00216476|63141640|FG002|Overall Study|Protocol Deviation|0|||
33682070|NCT00216476|63141638|FG000|Overall Study|Patient Moved|2|||
33682071|NCT00216476|63141639|FG001|Overall Study|Patient Moved|2|||
33682072|NCT00216476|63141640|FG002|Overall Study|Patient Moved|0|||
33682073|NCT00216086|63141691|FG000|Overall Study|Protocol Violation|1|||
33682074|NCT00216086|63141691|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
33682075|NCT00216086|63141691|FG000|Overall Study|Social Reasons|2|||
33682076|NCT00215150|63141722|FG000|Open Label Phase|Lost to Follow-up|7|||
33682077|NCT00215150|63141722|FG000|Open Label Phase|Withdrawal by Subject|1|||
33682078|NCT00215150|63141722|FG000|Open Label Phase|Did not complete a post base visit|13|||
33682079|NCT00215150|63141722|FG000|Open Label Phase|Did not meet randomization criteria|9|||
33682080|NCT00215150|63141722|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
33682081|NCT00215150|63141722|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
33682082|NCT00215150|63141722|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
33682083|NCT00214136|63141730|FG000|Overall Study|Death|5|||
33682084|NCT00213980|63141736|FG000|Overall Study|Withdrawal by Subject|3|||
33682085|NCT00213980|63141737|FG001|Overall Study|Withdrawal by Subject|1|||
33594815|NCT01886716|62993831|FG001|Week 1|Lost to Follow-up|0|||
33594816|NCT01886716|62993832|FG002|Week 1|Lost to Follow-up|2|||
33594817|NCT01886716|62993833|FG003|Week 1|Lost to Follow-up|2|||
33594818|NCT01886716|62993830|FG000|Week 2|Lost to Follow-up|3|||
33594819|NCT01886716|62993831|FG001|Week 2|Lost to Follow-up|2|||
33594820|NCT01886716|62993832|FG002|Week 2|Lost to Follow-up|1|||
33594821|NCT01886716|62993833|FG003|Week 2|Lost to Follow-up|3|||
33594822|NCT01886716|62993830|FG000|Week 3|Lost to Follow-up|1|||
33594823|NCT01886716|62993831|FG001|Week 3|Lost to Follow-up|1|||
33594824|NCT01886716|62993832|FG002|Week 3|Lost to Follow-up|0|||
33594825|NCT01886716|62993833|FG003|Week 3|Lost to Follow-up|1|||
33594826|NCT01912612|62993845|FG000|Overall Study|Adverse Event|4|||
33594827|NCT01912612|62993846|FG001|Overall Study|Adverse Event|0|||
33594828|NCT01912612|62993847|FG002|Overall Study|Adverse Event|0|||
33594829|NCT01912612|62993845|FG000|Overall Study|Withdrew consent|1|||
33594830|NCT01912612|62993846|FG001|Overall Study|Withdrew consent|0|||
33594831|NCT01912612|62993847|FG002|Overall Study|Withdrew consent|0|||
33594832|NCT01912612|62993845|FG000|Overall Study|Study design change|0|||
33594833|NCT01912612|62993846|FG001|Overall Study|Study design change|0|||
33594834|NCT01912612|62993847|FG002|Overall Study|Study design change|3|||
33594835|NCT02370511|62993856|FG000|Overall Study|Death|10|||
33594836|NCT02370511|62993857|FG001|Overall Study|Death|7|||
33594837|NCT02370511|62993858|FG002|Overall Study|Death|1|||
33594838|NCT02370511|62993856|FG000|Overall Study|Withdrawal by Subject|2|||
33594839|NCT02370511|62993857|FG001|Overall Study|Withdrawal by Subject|0|||
33594840|NCT02370511|62993858|FG002|Overall Study|Withdrawal by Subject|0|||
33594841|NCT02370511|62993856|FG000|Overall Study|Lost to Follow-up|0|||
33594842|NCT02370511|62993857|FG001|Overall Study|Lost to Follow-up|4|||
33594843|NCT02370511|62993858|FG002|Overall Study|Lost to Follow-up|0|||
33594844|NCT02303041|62993868|FG000|Overall Study|Adverse Event|1|||
33594845|NCT02303041|62993869|FG001|Overall Study|Adverse Event|2|||
33594846|NCT02302807|62993877|FG000|Overall Study|Withdrawal by Subject|28|||
33594847|NCT02302807|62993878|FG001|Overall Study|Withdrawal by Subject|11|||
33594848|NCT02302807|62993877|FG000|Overall Study|Lost to Follow-up|4|||
33594849|NCT02302807|62993878|FG001|Overall Study|Lost to Follow-up|6|||
33594850|NCT02302807|62993877|FG000|Overall Study|Death|397|||
33594851|NCT02302807|62993878|FG001|Overall Study|Death|385|||
33594852|NCT02302807|62993877|FG000|Overall Study|Study Terminated By Sponsor|35|||
33594853|NCT02302807|62993878|FG001|Overall Study|Study Terminated By Sponsor|64|||
33594854|NCT02302807|62993877|FG000|Overall Study|Physician Decision|0|||
33594855|NCT02302807|62993878|FG001|Overall Study|Physician Decision|1|||
33594856|NCT02335489|62993897|FG000|Overall Study|Sponsor terminated study|4|||
33594857|NCT02335489|62993897|FG000|Overall Study|Lost to Follow-up|1|||
33594858|NCT02335489|62993897|FG000|Overall Study|Withdrawal by Subject|2|||
33594859|NCT02335489|62993897|FG000|Overall Study|Physician Decision|2|||
33594860|NCT02335489|62993897|FG000|Overall Study|Lack of Efficacy|1|||
33594861|NCT02527343|62993903|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
33594862|NCT02527343|62993904|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
33594863|NCT02527343|62993905|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
33594864|NCT02527343|62993906|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
33594865|NCT02527343|62993907|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
33594866|NCT02527343|62993908|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
33594867|NCT02527343|62993903|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
33594868|NCT02527343|62993904|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
33594869|NCT02527343|62993905|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
33594870|NCT02527343|62993906|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
33682086|NCT00213980|63141736|FG000|Overall Study|Adverse Event|1|||
33682087|NCT00213980|63141737|FG001|Overall Study|Adverse Event|1|||
33682088|NCT00213980|63141736|FG000|Overall Study|Disease progression|0|||
33594871|NCT02527343|62993907|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
33594872|NCT02527343|62993908|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
33594873|NCT02527343|62993903|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
33682089|NCT00213980|63141737|FG001|Overall Study|Disease progression|2|||
33594874|NCT02527343|62993904|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
33594875|NCT02527343|62993905|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
33594876|NCT02527343|62993906|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
33682090|NCT00213980|63141736|FG000|Overall Study|Developed ovarian cancer|1|||
33682091|NCT00213980|63141737|FG001|Overall Study|Developed ovarian cancer|0|||
33682092|NCT00213980|63141736|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
33682093|NCT00213980|63141737|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
33682094|NCT04388527|63142177|FG000|Overall Study|Death|14|||
33682095|NCT04388527|63142177|FG000|Overall Study|Withdrawal by Subject|2|||
33682096|NCT04388527|63142177|FG000|Overall Study|Lost to Follow-up|1|||
33682097|NCT04149002|63142429|FG000|Overall Study|Lost to Follow-up|1|||
33682098|NCT04149002|63142430|FG001|Overall Study|Lost to Follow-up|0|||
33682099|NCT04149002|63142429|FG000|Overall Study|Withdrawal by Subject|1|||
33682100|NCT04149002|63142430|FG001|Overall Study|Withdrawal by Subject|0|||
33682101|NCT00555321|63142504|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
33682102|NCT00555321|63142505|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
33682103|NCT00555321|63142506|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
33682104|NCT00555321|63142507|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
33682105|NCT00555321|63142508|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
33682106|NCT00555321|63142504|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
33682107|NCT00555321|63142505|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
33682108|NCT00555321|63142506|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
33682109|NCT00555321|63142507|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
33682110|NCT00555321|63142508|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
33682111|NCT00555321|63142504|FG000|Treatment Phase up to 12-months|Death|2|||
33682112|NCT00555321|63142505|FG001|Treatment Phase up to 12-months|Death|1|||
33682113|NCT00555321|63142506|FG002|Treatment Phase up to 12-months|Death|4|||
33682114|NCT00555321|63142507|FG003|Treatment Phase up to 12-months|Death|0|||
33682115|NCT00555321|63142508|FG004|Treatment Phase up to 12-months|Death|0|||
33682116|NCT00555321|63142504|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
33682117|NCT00555321|63142505|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
33682118|NCT00555321|63142506|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
33682119|NCT00555321|63142507|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
33682120|NCT00555321|63142508|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
33682121|NCT00555321|63142504|FG000|Treatment Phase up to 12-months|Other Reason|1|||
33682122|NCT00555321|63142505|FG001|Treatment Phase up to 12-months|Other Reason|3|||
33682123|NCT00555321|63142506|FG002|Treatment Phase up to 12-months|Other Reason|2|||
33682124|NCT00555321|63142507|FG003|Treatment Phase up to 12-months|Other Reason|0|||
33682125|NCT00555321|63142508|FG004|Treatment Phase up to 12-months|Other Reason|0|||
33682126|NCT00555321|63142504|FG000|Treatment Phase up to 12-months|Never treated|2|||
33682127|NCT00555321|63142505|FG001|Treatment Phase up to 12-months|Never treated|3|||
33682128|NCT00555321|63142506|FG002|Treatment Phase up to 12-months|Never treated|1|||
33682129|NCT00555321|63142507|FG003|Treatment Phase up to 12-months|Never treated|0|||
33682130|NCT00555321|63142508|FG004|Treatment Phase up to 12-months|Never treated|4|||
33682131|NCT00555321|63142504|FG000|Long-term Extension Phase|Adverse Event|2|||
33682132|NCT00555321|63142505|FG001|Long-term Extension Phase|Adverse Event|5|||
33682133|NCT00555321|63142506|FG002|Long-term Extension Phase|Adverse Event|2|||
33682134|NCT00555321|63142507|FG003|Long-term Extension Phase|Adverse Event|1|||
33682135|NCT00555321|63142508|FG004|Long-term Extension Phase|Adverse Event|0|||
33682136|NCT00555321|63142504|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
33682137|NCT00555321|63142505|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
33682138|NCT00555321|63142506|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
33682139|NCT00555321|63142507|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
33682140|NCT00555321|63142508|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
33682141|NCT00555321|63142504|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
33682142|NCT00555321|63142505|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
33682143|NCT00555321|63142506|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
33682144|NCT00555321|63142507|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
33682145|NCT00555321|63142508|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
33682146|NCT00555321|63142504|FG000|Long-term Extension Phase|Death|2|||
33682147|NCT00555321|63142505|FG001|Long-term Extension Phase|Death|0|||
33682148|NCT00555321|63142506|FG002|Long-term Extension Phase|Death|0|||
33682149|NCT00555321|63142507|FG003|Long-term Extension Phase|Death|3|||
33682150|NCT00555321|63142508|FG004|Long-term Extension Phase|Death|0|||
33682151|NCT00555321|63142504|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
33682152|NCT00555321|63142505|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
33682153|NCT00555321|63142506|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
33682154|NCT00555321|63142507|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
33682155|NCT00555321|63142508|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
33682156|NCT00555321|63142504|FG000|Long-term Extension Phase|Other Reason|1|||
33682157|NCT00555321|63142505|FG001|Long-term Extension Phase|Other Reason|0|||
33682158|NCT00555321|63142506|FG002|Long-term Extension Phase|Other Reason|2|||
33682159|NCT00555321|63142507|FG003|Long-term Extension Phase|Other Reason|0|||
33682160|NCT00555321|63142508|FG004|Long-term Extension Phase|Other Reason|0|||
33682161|NCT03589976|63143020|FG000|Overall Study|Death|5|||
33682162|NCT03589976|63143021|FG001|Overall Study|Death|1|||
33682163|NCT03589976|63143020|FG000|Overall Study|Adverse Event|5|||
33682164|NCT03589976|63143021|FG001|Overall Study|Adverse Event|1|||
33682165|NCT03589976|63143020|FG000|Overall Study|Withdrawal by Subject|4|||
33682166|NCT03589976|63143021|FG001|Overall Study|Withdrawal by Subject|1|||
33682167|NCT03589976|63143020|FG000|Overall Study|Lost to Follow-up|1|||
33682168|NCT03589976|63143021|FG001|Overall Study|Lost to Follow-up|0|||
33682169|NCT03589976|63143020|FG000|Overall Study|Other|4|||
33682170|NCT03589976|63143021|FG001|Overall Study|Other|3|||
33682171|NCT03029780|63143177|FG000|Overall Study|Disease Progression|20|||
33682172|NCT03029780|63143178|FG001|Overall Study|Disease Progression|22|||
33682173|NCT03029780|63143177|FG000|Overall Study|Study Drug Toxicity|15|||
33682174|NCT03029780|63143178|FG001|Overall Study|Study Drug Toxicity|11|||
33682175|NCT03029780|63143177|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
33682176|NCT03029780|63143178|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
33682177|NCT03029780|63143177|FG000|Overall Study|Participant request to discontinue study treatment|4|||
33682178|NCT03029780|63143178|FG001|Overall Study|Participant request to discontinue study treatment|1|||
33682179|NCT03029780|63143177|FG000|Overall Study|Maximum clinical benefit|1|||
33682180|NCT03029780|63143178|FG001|Overall Study|Maximum clinical benefit|0|||
33682181|NCT03029780|63143177|FG000|Overall Study|Participant no longer meets study criteria|0|||
33682182|NCT03029780|63143178|FG001|Overall Study|Participant no longer meets study criteria|1|||
33682183|NCT03029780|63143177|FG000|Overall Study|Other reasons|6|||
33682184|NCT03029780|63143178|FG001|Overall Study|Other reasons|6|||
33682185|NCT03029780|63143177|FG000|Overall Study|Not reported|1|||
33682186|NCT03029780|63143178|FG001|Overall Study|Not reported|1|||
33682187|NCT03029780|63143177|FG000|Overall Study|Death|2|||
33682188|NCT03029780|63143178|FG001|Overall Study|Death|6|||
33682189|NCT03029234|63143238|FG000|Overall Study|Sponsor Decision|1|||
33682190|NCT03029234|63143238|FG000|Overall Study|Withdrawal by Subject|5|||
33682191|NCT03029234|63143238|FG000|Overall Study|Death|91|||
33682192|NCT03029234|63143238|FG000|Overall Study|Lost to Follow-up|2|||
33682193|NCT03991299|63143913|FG000|Overall Study|Study closed, sponsor decision|3|||
33682194|NCT03991299|63143913|FG000|Overall Study|Withdrawal by Subject|1|||
33682195|NCT03155373|63143931|FG000|Overall Study|No longer required surgery|1|||
33682196|NCT03155373|63143931|FG000|Overall Study|Protocol Violation|1|||
33682197|NCT03155373|63143931|FG000|Overall Study|Death|2|||
33682198|NCT03155373|63143931|FG000|Overall Study|Withdrawal by Subject|3|||
33682199|NCT02775903|63144635|FG000|Overall Study|Death|7|||
33682200|NCT02775903|63144636|FG001|Overall Study|Death|11|||
33682201|NCT02775903|63144637|FG002|Overall Study|Death|12|||
33682202|NCT02775903|63144638|FG003|Overall Study|Death|11|||
33682203|NCT02775903|63144635|FG000|Overall Study|Adverse Event|0|||
33594877|NCT02527343|62993907|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
33682204|NCT02775903|63144636|FG001|Overall Study|Adverse Event|1|||
33682205|NCT02775903|63144637|FG002|Overall Study|Adverse Event|12|||
33682206|NCT02775903|63144638|FG003|Overall Study|Adverse Event|3|||
33682207|NCT02775903|63144635|FG000|Overall Study|Progressive disease|15|||
33682208|NCT02775903|63144636|FG001|Overall Study|Progressive disease|14|||
33682209|NCT02775903|63144637|FG002|Overall Study|Progressive disease|30|||
33682210|NCT02775903|63144638|FG003|Overall Study|Progressive disease|20|||
33682211|NCT02775903|63144635|FG000|Overall Study|Lack of Efficacy|2|||
33682212|NCT02775903|63144636|FG001|Overall Study|Lack of Efficacy|2|||
33594878|NCT02527343|62993908|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
33594879|NCT02527343|62993903|FG000|RT Period: Weeks 1 to 52|Other|4|||
33594880|NCT02527343|62993904|FG001|RT Period: Weeks 1 to 52|Other|3|||
33594881|NCT02527343|62993905|FG002|RT Period: Weeks 1 to 52|Other|0|||
33594882|NCT02527343|62993906|FG003|RT Period: Weeks 1 to 52|Other|0|||
33594883|NCT02527343|62993907|FG004|RT Period: Weeks 1 to 52|Other|0|||
33594884|NCT02527343|62993908|FG005|RT Period: Weeks 1 to 52|Other|0|||
33594885|NCT02527343|62993903|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
33682213|NCT02775903|63144637|FG002|Overall Study|Lack of Efficacy|2|||
33682214|NCT02775903|63144638|FG003|Overall Study|Lack of Efficacy|6|||
33682215|NCT02775903|63144635|FG000|Overall Study|Withdrawal by Subject|7|||
33682216|NCT02775903|63144636|FG001|Overall Study|Withdrawal by Subject|5|||
33682217|NCT02775903|63144637|FG002|Overall Study|Withdrawal by Subject|5|||
33682218|NCT02775903|63144638|FG003|Overall Study|Withdrawal by Subject|8|||
33682219|NCT02775903|63144635|FG000|Overall Study|Other reasons|7|||
33682220|NCT02775903|63144636|FG001|Overall Study|Other reasons|8|||
33682221|NCT02775903|63144637|FG002|Overall Study|Other reasons|2|||
33682222|NCT02775903|63144638|FG003|Overall Study|Other reasons|12|||
33594886|NCT02527343|62993904|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
33682223|NCT02723019|63144707|FG000|Overall Study|Death|17|||
33682224|NCT02723019|63144708|FG001|Overall Study|Death|13|||
33682225|NCT02723019|63144707|FG000|Overall Study|Withdrawal by Subject|11|||
33682226|NCT02723019|63144708|FG001|Overall Study|Withdrawal by Subject|7|||
33682227|NCT02723019|63144707|FG000|Overall Study|Lost to Follow-up|57|||
33682228|NCT02723019|63144708|FG001|Overall Study|Lost to Follow-up|70|||
33682229|NCT00088166|63144958|FG000|Overall Study|Adverse Event|11|||
33682230|NCT00088166|63144959|FG001|Overall Study|Adverse Event|9|||
33682231|NCT00088166|63144958|FG000|Overall Study|Death|3|||
33682232|NCT00088166|63144959|FG001|Overall Study|Death|1|||
33682233|NCT00088166|63144958|FG000|Overall Study|Lost to Follow-up|0|||
33682234|NCT00088166|63144959|FG001|Overall Study|Lost to Follow-up|1|||
33682235|NCT00088166|63144958|FG000|Overall Study|Physician Decision|4|||
33682236|NCT00088166|63144959|FG001|Overall Study|Physician Decision|1|||
33682237|NCT00088166|63144958|FG000|Overall Study|Protocol Violation|1|||
33682238|NCT00088166|63144959|FG001|Overall Study|Protocol Violation|5|||
33682239|NCT00088166|63144958|FG000|Overall Study|Patient deterioration|29|||
33682240|NCT00088166|63144959|FG001|Overall Study|Patient deterioration|39|||
33682241|NCT00088166|63144958|FG000|Overall Study|Withdrawal by Subject|5|||
33682242|NCT00088166|63144959|FG001|Overall Study|Withdrawal by Subject|5|||
33682243|NCT00087698|63145003|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
33682244|NCT00087698|63145003|FG000|Overall Study|Death from Other Causes|3|||
33682245|NCT00087698|63145003|FG000|Overall Study|Adverse Event|4|||
33682246|NCT00087698|63145003|FG000|Overall Study|Withdrawal by Subject|4|||
33682247|NCT00087698|63145003|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
33682248|NCT00087698|63145003|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
33682249|NCT00087698|63145003|FG000|Overall Study|Clinical Relapse|1|||
33682250|NCT00087698|63145003|FG000|Overall Study|Death from Study Disease|2|||
33682251|NCT00087698|63145003|FG000|Overall Study|Death from Study Drug Toxicity|2|||
33682252|NCT00087698|63145003|FG000|Overall Study|Protocol Violation|1|||
33682253|NCT00087152|63145021|FG000|Overall Study|Ineligible|6|||
33682254|NCT00086996|63145073|FG000|Overall Study|Adverse Event|29|||
33682255|NCT00086996|63145073|FG000|Overall Study|Death|4|||
33682256|NCT00086996|63145073|FG000|Overall Study|progression/relapse|7|||
33682257|NCT00086996|63145073|FG000|Overall Study|Withdrawal by Subject|13|||
33682258|NCT00086996|63145073|FG000|Overall Study|Other|6|||
33682259|NCT00086996|63145073|FG000|Overall Study|not eligible|5|||
33682260|NCT00086684|63145375|FG000|Overall Study|Adverse Event|12|||
33682261|NCT00086684|63145376|FG001|Overall Study|Adverse Event|17|||
33682262|NCT00086684|63145377|FG002|Overall Study|Adverse Event|14|||
33682263|NCT00086684|63145375|FG000|Overall Study|Lack of Efficacy|6|||
33682264|NCT00086684|63145376|FG001|Overall Study|Lack of Efficacy|6|||
33682265|NCT00086684|63145377|FG002|Overall Study|Lack of Efficacy|5|||
33682266|NCT00086684|63145375|FG000|Overall Study|Lost to Follow-up|15|||
33682267|NCT00086684|63145376|FG001|Overall Study|Lost to Follow-up|8|||
33682268|NCT00086684|63145377|FG002|Overall Study|Lost to Follow-up|10|||
33682269|NCT00086684|63145375|FG000|Overall Study|Protocol Violation|8|||
33682270|NCT00086684|63145376|FG001|Overall Study|Protocol Violation|3|||
33682271|NCT00086684|63145377|FG002|Overall Study|Protocol Violation|0|||
33682272|NCT00086684|63145375|FG000|Overall Study|Withdrawal by Subject|0|||
33682273|NCT00086684|63145376|FG001|Overall Study|Withdrawal by Subject|4|||
33682274|NCT00086684|63145377|FG002|Overall Study|Withdrawal by Subject|10|||
33682275|NCT00086684|63145375|FG000|Overall Study|NONCOMPLIANCE|5|||
33682276|NCT00086684|63145376|FG001|Overall Study|NONCOMPLIANCE|7|||
33682277|NCT00086684|63145377|FG002|Overall Study|NONCOMPLIANCE|6|||
33682278|NCT00086684|63145375|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
33682279|NCT00086684|63145376|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
33682280|NCT00086684|63145377|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
33682281|NCT00086684|63145375|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
33682282|NCT00086684|63145376|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
33682283|NCT00086684|63145377|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
33682284|NCT00086684|63145375|FG000|Overall Study|Other|4|||
33682285|NCT00086684|63145376|FG001|Overall Study|Other|2|||
33543977|NCT03034967|62934795|FG001|Overall Study|Liver function test abnormality|0|||
33682286|NCT00086684|63145377|FG002|Overall Study|Other|3|||
33682287|NCT00082628|63145441|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
33682288|NCT00082628|63145442|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
33682289|NCT00082628|63145443|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
33682290|NCT00082628|63145444|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
33682291|NCT00082628|63145445|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
33682292|NCT00082628|63145441|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
33682293|NCT00082628|63145442|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
33682294|NCT00082628|63145443|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
33682295|NCT00082628|63145444|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
33682296|NCT00082628|63145445|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
33682297|NCT00082628|63145441|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
33682298|NCT00082628|63145442|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
33682299|NCT00082628|63145443|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
33682300|NCT00082628|63145444|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
33682301|NCT00082628|63145445|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
33682302|NCT00082628|63145441|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
33682303|NCT00082628|63145442|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
33682304|NCT00082628|63145443|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
33682305|NCT00082628|63145444|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
33682306|NCT00082628|63145445|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
33682307|NCT00082628|63145441|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
33682308|NCT00082628|63145442|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
33682309|NCT00082628|63145443|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
33682310|NCT00082628|63145444|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
33682311|NCT00082628|63145445|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
33682312|NCT00082628|63145441|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
33682313|NCT00082628|63145442|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
33682314|NCT00082628|63145443|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
33682315|NCT00082628|63145444|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
33682316|NCT00082628|63145445|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
33682317|NCT00082628|63145441|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
33682318|NCT00082628|63145442|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
33682319|NCT00082628|63145443|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
33682320|NCT00082628|63145444|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
33682321|NCT00082628|63145445|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
33682322|NCT02993263|63145787|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
33682323|NCT01274533|63145815|FG000|Overall Study|Withdrawal by Subject|1|||
33682324|NCT01274533|63145815|FG000|Overall Study|Non-compliance|1|||
33682325|NCT01274533|63145815|FG000|Overall Study|Disease progression|2|||
33682326|NCT01273597|63145819|FG000|Overall Study|Adverse Event|5|||
33682327|NCT01273597|63145819|FG000|Overall Study|Underwent Kidney Transplantation|2|||
33682328|NCT01273597|63145819|FG000|Overall Study|Reason Not Reported|1|||
33682329|NCT01273519|63145826|FG000|Overall Study|Adverse Event|3|||
33682330|NCT01273519|63145827|FG001|Overall Study|Adverse Event|0|||
33682331|NCT01273519|63145828|FG002|Overall Study|Adverse Event|0|||
33682332|NCT01273519|63145826|FG000|Overall Study|Lost to Follow-up|2|||
33682333|NCT01273519|63145827|FG001|Overall Study|Lost to Follow-up|1|||
33682334|NCT01273519|63145828|FG002|Overall Study|Lost to Follow-up|3|||
33682335|NCT01273519|63145826|FG000|Overall Study|Lack of Efficacy|8|||
33682336|NCT01273519|63145827|FG001|Overall Study|Lack of Efficacy|3|||
33682337|NCT01273519|63145828|FG002|Overall Study|Lack of Efficacy|4|||
33682338|NCT01273519|63145826|FG000|Overall Study|Other|6|||
33682339|NCT01273519|63145827|FG001|Overall Study|Other|1|||
33682340|NCT01273519|63145828|FG002|Overall Study|Other|1|||
33682341|NCT01272661|63145885|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
33682342|NCT01272661|63145886|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
33682343|NCT01272661|63145887|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
33682344|NCT04276051|63146053|FG000|Overall Study|Lost to Follow-up|0|||
33682345|NCT04276051|63146054|FG001|Overall Study|Lost to Follow-up|1|||
33682346|NCT04276051|63146053|FG000|Overall Study|Physician Decision|0|||
33682347|NCT04276051|63146054|FG001|Overall Study|Physician Decision|1|||
33682348|NCT04276051|63146053|FG000|Overall Study|Withdrawal by Subject|1|||
33682349|NCT04276051|63146054|FG001|Overall Study|Withdrawal by Subject|1|||
33682350|NCT00081770|63146314|FG000|Overall Study|Adverse Event|130|||
33682351|NCT00081770|63146315|FG001|Overall Study|Adverse Event|98|||
33682352|NCT00081770|63146316|FG002|Overall Study|Adverse Event|136|||
33682353|NCT00081770|63146314|FG000|Overall Study|Lack of Efficacy|262|||
33682354|NCT00081770|63146315|FG001|Overall Study|Lack of Efficacy|357|||
33682355|NCT00081770|63146316|FG002|Overall Study|Lack of Efficacy|211|||
33682356|NCT00081770|63146314|FG000|Overall Study|Lost to Follow-up|45|||
33682357|NCT00081770|63146315|FG001|Overall Study|Lost to Follow-up|34|||
33682358|NCT00081770|63146316|FG002|Overall Study|Lost to Follow-up|45|||
33682359|NCT00081770|63146314|FG000|Overall Study|Protocol Violation|15|||
33682360|NCT00081770|63146315|FG001|Overall Study|Protocol Violation|10|||
33682361|NCT00081770|63146316|FG002|Overall Study|Protocol Violation|10|||
33682362|NCT00081770|63146314|FG000|Overall Study|Withdrawal by Subject|45|||
33682363|NCT00081770|63146315|FG001|Overall Study|Withdrawal by Subject|40|||
33682364|NCT00081770|63146316|FG002|Overall Study|Withdrawal by Subject|42|||
33682365|NCT00081770|63146314|FG000|Overall Study|Did not meet protocol eligibility|2|||
33682366|NCT00081770|63146315|FG001|Overall Study|Did not meet protocol eligibility|0|||
33682367|NCT00081770|63146316|FG002|Overall Study|Did not meet protocol eligibility|3|||
33543978|NCT03034967|62934796|FG002|Overall Study|Liver function test abnormality|1|||
33682368|NCT00081770|63146314|FG000|Overall Study|Administrative|1|||
33682369|NCT00081770|63146315|FG001|Overall Study|Administrative|0|||
33682370|NCT00081770|63146316|FG002|Overall Study|Administrative|1|||
33682371|NCT00081770|63146314|FG000|Overall Study|Other|2|||
33682372|NCT00081770|63146315|FG001|Overall Study|Other|7|||
33682373|NCT00081770|63146316|FG002|Overall Study|Other|8|||
33682374|NCT00081458|63146416|FG000|Overall Study|Adverse Event|1|||
33682375|NCT00081458|63146417|FG001|Overall Study|Adverse Event|5|||
33682376|NCT00081458|63146418|FG002|Overall Study|Adverse Event|2|||
33682377|NCT00081458|63146416|FG000|Overall Study|Withdrawal by Subject|0|||
33682378|NCT00081458|63146417|FG001|Overall Study|Withdrawal by Subject|3|||
33682379|NCT00081458|63146418|FG002|Overall Study|Withdrawal by Subject|1|||
33682380|NCT00081458|63146416|FG000|Overall Study|Randomized but not dosed|0|||
33682381|NCT00081458|63146417|FG001|Overall Study|Randomized but not dosed|0|||
33682382|NCT00081458|63146418|FG002|Overall Study|Randomized but not dosed|1|||
33682383|NCT01271803|63146495|FG000|Overall Study|Progressive disease|0|||
33682384|NCT01271803|63146496|FG001|Overall Study|Progressive disease|0|||
33682385|NCT01271803|63146497|FG002|Overall Study|Progressive disease|2|||
33682386|NCT01271803|63146495|FG000|Overall Study|Death|53|||
33682387|NCT01271803|63146496|FG001|Overall Study|Death|34|||
33682388|NCT01271803|63146497|FG002|Overall Study|Death|0|||
33682389|NCT01271803|63146495|FG000|Overall Study|Withdrawal by Subject|1|||
33682390|NCT01271803|63146496|FG001|Overall Study|Withdrawal by Subject|5|||
33682391|NCT01271803|63146497|FG002|Overall Study|Withdrawal by Subject|0|||
33682392|NCT01271803|63146495|FG000|Overall Study|Lost to Follow-up|1|||
33682393|NCT01271803|63146496|FG001|Overall Study|Lost to Follow-up|0|||
33682394|NCT01271803|63146497|FG002|Overall Study|Lost to Follow-up|0|||
33682395|NCT00080288|63146548|FG000|Overall Study|Adverse Event|7|||
33682396|NCT00080288|63146549|FG001|Overall Study|Adverse Event|4|||
33682397|NCT00080288|63146548|FG000|Overall Study|Lost to Follow-up|3|||
33682398|NCT00080288|63146549|FG001|Overall Study|Lost to Follow-up|5|||
33682399|NCT00080288|63146548|FG000|Overall Study|Physician Decision|6|||
33682400|NCT00080288|63146549|FG001|Overall Study|Physician Decision|2|||
33682401|NCT00080288|63146548|FG000|Overall Study|Withdrawal by Subject|3|||
33682402|NCT00080288|63146549|FG001|Overall Study|Withdrawal by Subject|16|||
33682403|NCT00080288|63146548|FG000|Overall Study|Miscellaneous|11|||
33682404|NCT00080288|63146549|FG001|Overall Study|Miscellaneous|11|||
33682405|NCT01271725|63146619|FG000|Part A|Progressive disease according to RECIST|8|||
33682406|NCT01271725|63146620|FG001|Part A|Progressive disease according to RECIST|0|||
33682407|NCT01271725|63146619|FG000|Part A|Clinical signs/symptoms of progression|2|||
33682408|NCT01271725|63146620|FG001|Part A|Clinical signs/symptoms of progression|0|||
33682409|NCT01271725|63146619|FG000|Part A|Other Adverse Event|8|||
33682410|NCT01271725|63146620|FG001|Part A|Other Adverse Event|0|||
33682411|NCT01271725|63146619|FG000|Part A|Lost to Follow-up|1|||
33682412|NCT01271725|63146620|FG001|Part A|Lost to Follow-up|0|||
33682413|NCT01271725|63146619|FG000|Part A|Withdrawal by Subject|12|||
33682414|NCT01271725|63146620|FG001|Part A|Withdrawal by Subject|0|||
33682415|NCT01271725|63146619|FG000|Part A|Other than specified|3|||
33682416|NCT01271725|63146620|FG001|Part A|Other than specified|0|||
33682417|NCT01271725|63146619|FG000|Part A|Protocol Violation|1|||
33682418|NCT01271725|63146620|FG001|Part A|Protocol Violation|0|||
33682419|NCT01271725|63146619|FG000|Part B|Other than specified|0|||
33682420|NCT01271725|63146620|FG001|Part B|Other than specified|2|||
33682421|NCT01271725|63146619|FG000|Part B|Clinical signs/symptoms of progression|0|||
33682422|NCT01271725|63146620|FG001|Part B|Clinical signs/symptoms of progression|2|||
33682423|NCT01271725|63146619|FG000|Part B|Other Adverse Event|0|||
33682424|NCT01271725|63146620|FG001|Part B|Other Adverse Event|1|||
33682425|NCT01271725|63146619|FG000|Part B|Protocol Violation|0|||
33682426|NCT01271725|63146620|FG001|Part B|Protocol Violation|1|||
33682427|NCT01271725|63146619|FG000|Part B|Withdrawal by Subject|0|||
33682428|NCT01271725|63146620|FG001|Part B|Withdrawal by Subject|6|||
33682429|NCT01270321|63146645|FG000|Overall Study|Death|3|||
33682430|NCT01270321|63146646|FG001|Overall Study|Death|1|||
33682431|NCT01270321|63146647|FG002|Overall Study|Death|4|||
33682432|NCT01270321|63146645|FG000|Overall Study|Adverse Event|7|||
33682433|NCT01270321|63146646|FG001|Overall Study|Adverse Event|9|||
33682434|NCT01270321|63146647|FG002|Overall Study|Adverse Event|5|||
33682435|NCT00249769|63146741|FG000|Overall Study|Withdrawal by Subject|1|||
33682436|NCT00249769|63146742|FG001|Overall Study|Withdrawal by Subject|10|||
33682437|NCT00249769|63146743|FG002|Overall Study|Withdrawal by Subject|6|||
33682438|NCT00249769|63146741|FG000|Overall Study|Migration from Study Area|1|||
33682439|NCT00249769|63146742|FG001|Overall Study|Migration from Study Area|3|||
33682440|NCT00249769|63146743|FG002|Overall Study|Migration from Study Area|14|||
33682441|NCT00249769|63146741|FG000|Overall Study|Miscellaneous|0|||
33682442|NCT00249769|63146742|FG001|Overall Study|Miscellaneous|2|||
33682443|NCT00249769|63146743|FG002|Overall Study|Miscellaneous|2|||
33682444|NCT00249769|63146741|FG000|Overall Study|Adverse Event|0|||
33682445|NCT00249769|63146742|FG001|Overall Study|Adverse Event|0|||
33682446|NCT00249769|63146743|FG002|Overall Study|Adverse Event|1|||
33682447|NCT00249769|63146741|FG000|Overall Study|Physician Decision|0|||
33682448|NCT00249769|63146742|FG001|Overall Study|Physician Decision|0|||
33682449|NCT00249769|63146743|FG002|Overall Study|Physician Decision|2|||
33682450|NCT00249769|63146741|FG000|Overall Study|Lost to Follow-up|0|||
33682451|NCT00249769|63146742|FG001|Overall Study|Lost to Follow-up|0|||
33682452|NCT00249769|63146743|FG002|Overall Study|Lost to Follow-up|3|||
33682453|NCT00249613|63146753|FG000|12 Month Follow-up|Death|1|||
33682454|NCT00249613|63146754|FG001|12 Month Follow-up|Death|1|||
33682455|NCT00249613|63146753|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
33682456|NCT00249613|63146754|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
33682457|NCT00249613|63146753|FG000|12 Month Follow-up|Lost to Follow-up|10|||
33682458|NCT00249613|63146754|FG001|12 Month Follow-up|Lost to Follow-up|8|||
33682459|NCT00248833|63146790|FG000|Overall Study|Adverse Event|2|||
33682460|NCT00248833|63146791|FG001|Overall Study|Adverse Event|0|||
33682461|NCT00248833|63146792|FG002|Overall Study|Adverse Event|0|||
33682462|NCT00248833|63146790|FG000|Overall Study|Withdrawal by Subject|0|||
33682463|NCT00248833|63146791|FG001|Overall Study|Withdrawal by Subject|1|||
33682464|NCT00248833|63146792|FG002|Overall Study|Withdrawal by Subject|1|||
33682465|NCT00248833|63146790|FG000|Overall Study|Lost to Follow-up|1|||
33682466|NCT00248833|63146791|FG001|Overall Study|Lost to Follow-up|1|||
33682467|NCT00248833|63146792|FG002|Overall Study|Lost to Follow-up|1|||
33682468|NCT00248833|63146790|FG000|Overall Study|Other|0|||
33682469|NCT00248833|63146791|FG001|Overall Study|Other|1|||
33682470|NCT00248833|63146792|FG002|Overall Study|Other|0|||
33682471|NCT00247273|63146972|FG000|Overall Study|Adverse Event|85|||
33682472|NCT00247273|63146973|FG001|Overall Study|Adverse Event|80|||
33682473|NCT00247273|63146972|FG000|Overall Study|Physician Decision|6|||
33682474|NCT00247273|63146973|FG001|Overall Study|Physician Decision|3|||
33682475|NCT00247273|63146972|FG000|Overall Study|Lost to Follow-up|7|||
33682476|NCT00247273|63146973|FG001|Overall Study|Lost to Follow-up|7|||
33682477|NCT00247273|63146972|FG000|Overall Study|Withdrawal by Subject|46|||
33682478|NCT00247273|63146973|FG001|Overall Study|Withdrawal by Subject|47|||
33682479|NCT00247273|63146972|FG000|Overall Study|Did not take any study drug|2|||
33682480|NCT00247273|63146973|FG001|Overall Study|Did not take any study drug|0|||
33682481|NCT00246259|63147061|FG000|Overall Study|Other|3|||
33682482|NCT00246259|63147062|FG001|Overall Study|Other|3|||
33682483|NCT00246259|63147061|FG000|Overall Study|Not stable by Week 18|2|||
33682484|NCT00246259|63147062|FG001|Overall Study|Not stable by Week 18|1|||
33682485|NCT00246259|63147061|FG000|Overall Study|Participant non-compliant|4|||
33682486|NCT00246259|63147062|FG001|Overall Study|Participant non-compliant|9|||
33682487|NCT00246259|63147061|FG000|Overall Study|Lack of Efficacy|2|||
33682488|NCT00246259|63147062|FG001|Overall Study|Lack of Efficacy|2|||
33682489|NCT00246259|63147061|FG000|Overall Study|Investigator withdrew participant|2|||
33682490|NCT00246259|63147062|FG001|Overall Study|Investigator withdrew participant|0|||
33682491|NCT00246259|63147061|FG000|Overall Study|Adverse Event|5|||
33682492|NCT00246259|63147062|FG001|Overall Study|Adverse Event|0|||
33682493|NCT00246259|63147061|FG000|Overall Study|Lost to Follow-up|3|||
33682494|NCT00246259|63147062|FG001|Overall Study|Lost to Follow-up|4|||
33682495|NCT00246259|63147061|FG000|Overall Study|Withdrawal by Subject|5|||
33682496|NCT00246259|63147062|FG001|Overall Study|Withdrawal by Subject|1|||
33682497|NCT00246259|63147061|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
33682498|NCT00246259|63147062|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
33682499|NCT00246025|63147114|FG000|Overall Study|Adverse Event|7|||
33594887|NCT02527343|62993905|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
33594888|NCT02527343|62993906|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
33594889|NCT02527343|62993907|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
33594890|NCT02527343|62993908|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
33594891|NCT02527343|62993903|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
33594892|NCT02527343|62993904|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
33594893|NCT02527343|62993905|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
33594894|NCT02527343|62993906|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
33594895|NCT02527343|62993907|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
33594896|NCT02527343|62993908|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
33594897|NCT02527343|62993903|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
33682500|NCT00246025|63147115|FG001|Overall Study|Adverse Event|9|||
33682501|NCT00246025|63147116|FG002|Overall Study|Adverse Event|9|||
33682502|NCT00246025|63147117|FG003|Overall Study|Adverse Event|10|||
33682503|NCT00246025|63147114|FG000|Overall Study|Withdrawal by Subject|3|||
33682504|NCT00246025|63147115|FG001|Overall Study|Withdrawal by Subject|0|||
33682505|NCT00246025|63147116|FG002|Overall Study|Withdrawal by Subject|1|||
33682506|NCT00246025|63147117|FG003|Overall Study|Withdrawal by Subject|2|||
33682507|NCT00246025|63147114|FG000|Overall Study|unsuitable medical history was found|0|||
33682508|NCT00246025|63147115|FG001|Overall Study|unsuitable medical history was found|0|||
33682509|NCT00246025|63147116|FG002|Overall Study|unsuitable medical history was found|0|||
33682510|NCT00246025|63147117|FG003|Overall Study|unsuitable medical history was found|1|||
33682511|NCT00245011|63147247|FG000|Overall Study|Lack of Efficacy|1|||
33682512|NCT00244855|63147266|FG000|Overall Study|Withdrawal by Subject|0|||
33682513|NCT00244855|63147267|FG001|Overall Study|Withdrawal by Subject|1|||
33682514|NCT00244621|63147297|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
33682515|NCT00244621|63147298|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
33682516|NCT00244621|63147299|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
33682517|NCT00244621|63147297|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
33682518|NCT00244621|63147298|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
33682519|NCT00244621|63147299|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33682520|NCT00244621|63147297|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
33682521|NCT00244621|63147298|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
33682522|NCT00244621|63147299|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
33682523|NCT00244621|63147297|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
33682524|NCT00244621|63147298|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
33682525|NCT00244621|63147299|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
33682526|NCT00244621|63147297|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
33682527|NCT00244621|63147298|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
33682528|NCT00244621|63147299|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
33682529|NCT00244621|63147297|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
33682530|NCT00244621|63147298|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
33682531|NCT00244621|63147299|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
33682532|NCT00244621|63147297|FG000|Open-label Treatment Period|Adverse Event|0|||
33682533|NCT00244621|63147298|FG001|Open-label Treatment Period|Adverse Event|0|||
33682534|NCT00244621|63147299|FG002|Open-label Treatment Period|Adverse Event|1|||
33682535|NCT00244621|63147297|FG000|Open-label Treatment Period|Moved abroad|0|||
33682536|NCT00244621|63147298|FG001|Open-label Treatment Period|Moved abroad|0|||
33682537|NCT00244621|63147299|FG002|Open-label Treatment Period|Moved abroad|1|||
33682538|NCT00243841|63147382|FG000|Overall Study|Physician Decision|0|||
33682539|NCT00243841|63147383|FG001|Overall Study|Physician Decision|0|||
33682540|NCT00243841|63147384|FG002|Overall Study|Physician Decision|1|||
33682541|NCT00243841|63147385|FG003|Overall Study|Physician Decision|0|||
33682542|NCT00243841|63147386|FG004|Overall Study|Physician Decision|0|||
33682543|NCT00243841|63147387|FG005|Overall Study|Physician Decision|2|||
33682544|NCT02980731|63147580|FG000|Overall Study|Death|63|||
33682545|NCT02980731|63147580|FG000|Overall Study|Withdrawal by Subject|6|||
33682546|NCT02980731|63147580|FG000|Overall Study|Lost to Follow-up|5|||
33682547|NCT02980731|63147580|FG000|Overall Study|Study terminated by Sponsor|4|||
33682548|NCT02980731|63147580|FG000|Overall Study|Completed survival follow-up period|65|||
33682549|NCT02980731|63147580|FG000|Overall Study|COVID-19 infection|1|||
33682550|NCT02980731|63147580|FG000|Overall Study|Other, not specified|66|||
33682551|NCT02641587|63147620|FG000|Confinement Period|Adverse Event|1|||
33682552|NCT02641587|63147621|FG001|Confinement Period|Adverse Event|0|||
33682553|NCT02641587|63147620|FG000|Confinement Period|Withdrawal by Subject|2|||
33682554|NCT02641587|63147621|FG001|Confinement Period|Withdrawal by Subject|1|||
33682555|NCT02641587|63147620|FG000|Ambulatory Period|Withdrawal by Subject|1|||
33682556|NCT02641587|63147621|FG001|Ambulatory Period|Withdrawal by Subject|0|||
33682557|NCT04672083|63147728|FG000|Overall Study|Lost to Follow-up|1|||
33682558|NCT04672083|63147729|FG001|Overall Study|Lost to Follow-up|0|||
33682559|NCT04672083|63147730|FG002|Overall Study|Lost to Follow-up|0|||
33682560|NCT04672083|63147731|FG003|Overall Study|Lost to Follow-up|0|||
33682561|NCT04672083|63147732|FG004|Overall Study|Lost to Follow-up|0|||
33682562|NCT01781637|63147835|FG000|Overall Study|Adverse Event|1|||
33651271|NCT01708915|63062674|FG001|Overall Study|Protocol Violation|0|||
33651272|NCT01708915|63062675|FG002|Overall Study|Protocol Violation|0|||
33651273|NCT01708915|63062676|FG003|Overall Study|Protocol Violation|1|||
33651274|NCT01708915|63062673|FG000|Overall Study|Withdrawal by Subject|0|||
33651275|NCT01708915|63062674|FG001|Overall Study|Withdrawal by Subject|1|||
33651276|NCT01708915|63062675|FG002|Overall Study|Withdrawal by Subject|2|||
33651277|NCT01708915|63062676|FG003|Overall Study|Withdrawal by Subject|2|||
33651278|NCT01708915|63062673|FG000|Overall Study|Other reasons than stated above|1|||
33651279|NCT01708915|63062674|FG001|Overall Study|Other reasons than stated above|1|||
33651280|NCT01708915|63062675|FG002|Overall Study|Other reasons than stated above|0|||
33651281|NCT01708915|63062676|FG003|Overall Study|Other reasons than stated above|2|||
33651282|NCT01708291|63062688|FG000|Overall Study|fighting|2|||
33651283|NCT01708291|63062689|FG001|Overall Study|fighting|1|||
33651284|NCT01708057|63062695|FG000|Overall Study|Withdrawal due to study termination.|1|||
33651285|NCT01708057|63062696|FG001|Overall Study|Withdrawal due to study termination.|1|||
33651286|NCT01708057|63062697|FG002|Overall Study|Withdrawal due to study termination.|1|||
33651287|NCT01748071|63062714|FG000|Overall Study|Adverse Event|2|||
33651288|NCT01748071|63062715|FG001|Overall Study|Adverse Event|2|||
33651289|NCT01748071|63062716|FG002|Overall Study|Adverse Event|0|||
33651290|NCT01972529|63062728|FG000|Overall Study|Adverse Event|0|||
33682563|NCT01781637|63147836|FG001|Overall Study|Adverse Event|0|||
33682564|NCT01781637|63147835|FG000|Overall Study|Lack of Efficacy|2|||
33682565|NCT01781637|63147836|FG001|Overall Study|Lack of Efficacy|6|||
33682566|NCT01781637|63147835|FG000|Overall Study|Withdrawal by Subject|1|||
33682567|NCT01781637|63147836|FG001|Overall Study|Withdrawal by Subject|0|||
33682568|NCT01459497|63147884|FG000|Overall Study|Inability to meet trial constraints.|1|||
33682569|NCT01459497|63147885|FG001|Overall Study|Inability to meet trial constraints.|0|||
33682570|NCT01459497|63147884|FG000|Overall Study|Physician Decision|1|||
33682571|NCT01459497|63147885|FG001|Overall Study|Physician Decision|1|||
33682572|NCT01459497|63147884|FG000|Overall Study|Hospitalization.|0|||
33682573|NCT01459497|63147885|FG001|Overall Study|Hospitalization.|3|||
33682574|NCT01459497|63147884|FG000|Overall Study|Disease progression.|0|||
33682575|NCT01459497|63147885|FG001|Overall Study|Disease progression.|1|||
33682576|NCT04575584|63148234|FG000|Overall Study|Death|6|||
33682577|NCT04575584|63148235|FG001|Overall Study|Death|4|||
33682578|NCT04575584|63148236|FG002|Overall Study|Death|6|||
33682579|NCT04575584|63148237|FG003|Overall Study|Death|2|||
33682580|NCT04575584|63148238|FG004|Overall Study|Death|0|||
33682581|NCT04575584|63148239|FG005|Overall Study|Death|0|||
33682582|NCT04575584|63148234|FG000|Overall Study|Lost to Follow-up|1|||
33682583|NCT04575584|63148235|FG001|Overall Study|Lost to Follow-up|1|||
33682584|NCT04575584|63148236|FG002|Overall Study|Lost to Follow-up|1|||
33682585|NCT04575584|63148237|FG003|Overall Study|Lost to Follow-up|1|||
33682586|NCT04575584|63148238|FG004|Overall Study|Lost to Follow-up|0|||
33682587|NCT04575584|63148239|FG005|Overall Study|Lost to Follow-up|0|||
33682588|NCT04575584|63148234|FG000|Overall Study|Physician Decision|0|||
33682589|NCT04575584|63148235|FG001|Overall Study|Physician Decision|1|||
33682590|NCT04575584|63148236|FG002|Overall Study|Physician Decision|1|||
33682591|NCT04575584|63148237|FG003|Overall Study|Physician Decision|1|||
33682592|NCT04575584|63148238|FG004|Overall Study|Physician Decision|0|||
33682593|NCT04575584|63148239|FG005|Overall Study|Physician Decision|0|||
33682594|NCT04575584|63148234|FG000|Overall Study|Withdrawal by Subject|7|||
33682595|NCT04575584|63148235|FG001|Overall Study|Withdrawal by Subject|9|||
33682596|NCT04575584|63148236|FG002|Overall Study|Withdrawal by Subject|5|||
33682597|NCT04575584|63148237|FG003|Overall Study|Withdrawal by Subject|3|||
33682598|NCT04575584|63148238|FG004|Overall Study|Withdrawal by Subject|0|||
33682599|NCT04575584|63148239|FG005|Overall Study|Withdrawal by Subject|0|||
33682600|NCT04575584|63148234|FG000|Overall Study|Not recorded|0|||
33682601|NCT04575584|63148235|FG001|Overall Study|Not recorded|0|||
33682602|NCT04575584|63148236|FG002|Overall Study|Not recorded|0|||
33682603|NCT04575584|63148237|FG003|Overall Study|Not recorded|1|||
33682604|NCT04575584|63148238|FG004|Overall Study|Not recorded|0|||
33682605|NCT04575584|63148239|FG005|Overall Study|Not recorded|0|||
33682606|NCT03721965|63148278|FG000|Overall Study|Death|1|||
33682607|NCT03721965|63148278|FG000|Overall Study|Study Terminated by Sponsor|1|||
33682608|NCT03873116|63148334|FG000|Overall Study|Study drug discontinuation due to rash|0|||
33682609|NCT03873116|63148335|FG001|Overall Study|Study drug discontinuation due to rash|0|||
33682610|NCT03873116|63148336|FG002|Overall Study|Study drug discontinuation due to rash|1|||
33682611|NCT03686384|63148784|FG000|Overall Study|Lack of Efficacy|4|||
33682612|NCT03686384|63148785|FG001|Overall Study|Lack of Efficacy|13|||
33682613|NCT03686384|63148784|FG000|Overall Study|Lost to Follow-up|3|||
33682614|NCT03686384|63148785|FG001|Overall Study|Lost to Follow-up|0|||
33682615|NCT03686384|63148784|FG000|Overall Study|Physician Decision|0|||
33682616|NCT03686384|63148785|FG001|Overall Study|Physician Decision|1|||
33682617|NCT03686384|63148784|FG000|Overall Study|Took prohibited medication|0|||
33682618|NCT03686384|63148785|FG001|Overall Study|Took prohibited medication|1|||
33682619|NCT00240331|63148857|FG000|Overall Study|Withdrawal by Subject|125|||
33682620|NCT00240331|63148858|FG001|Overall Study|Withdrawal by Subject|132|||
33682621|NCT00240331|63148857|FG000|Overall Study|Option selected by investigator|1|||
33682622|NCT00240331|63148858|FG001|Overall Study|Option selected by investigator|2|||
33682623|NCT00240097|63148864|FG000|Part I|Adverse Event|1|||
33682624|NCT00240097|63148864|FG000|Part I|Death|1|||
33682625|NCT00240097|63148864|FG000|Part I|histology|1|||
33682626|NCT00240097|63148864|FG000|Part I|unevaluable|1|||
33682627|NCT00240097|63148864|FG000|Part II|did not continue from Part I|23|||
33682628|NCT03620162|63148955|FG000|Overall Study|Physician Decision|4|||
33682629|NCT03620162|63148956|FG001|Overall Study|Physician Decision|0|||
33682630|NCT03620162|63148957|FG002|Overall Study|Physician Decision|1|||
33682631|NCT03620162|63148958|FG003|Overall Study|Physician Decision|0|||
33682632|NCT03620162|63148959|FG004|Overall Study|Physician Decision|2|||
33682633|NCT03620162|63148955|FG000|Overall Study|Lost to Follow-up|2|||
33682634|NCT03620162|63148956|FG001|Overall Study|Lost to Follow-up|6|||
33682635|NCT03620162|63148957|FG002|Overall Study|Lost to Follow-up|7|||
33682636|NCT03620162|63148958|FG003|Overall Study|Lost to Follow-up|3|||
33682637|NCT03620162|63148959|FG004|Overall Study|Lost to Follow-up|2|||
33682638|NCT03620162|63148955|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
33682639|NCT03620162|63148956|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
33682640|NCT03620162|63148957|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
33682641|NCT03620162|63148958|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
33682642|NCT03620162|63148959|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
33682643|NCT03084302|63149100|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
33682644|NCT03084302|63149100|FG000|Overall Study|No valid objective monitor data|6|||
33682645|NCT01279681|63149242|FG000|Overall Study|Disease Progression|9|||
33682646|NCT01279681|63149243|FG001|Overall Study|Disease Progression|6|||
33682647|NCT01279681|63149242|FG000|Overall Study|Withdrawal by Subject|3|||
33682648|NCT01279681|63149243|FG001|Overall Study|Withdrawal by Subject|4|||
33682649|NCT01279681|63149242|FG000|Overall Study|Adverse Event|2|||
33682650|NCT01279681|63149243|FG001|Overall Study|Adverse Event|3|||
33682651|NCT01279681|63149242|FG000|Overall Study|Death|0|||
33682652|NCT01279681|63149243|FG001|Overall Study|Death|1|||
33682653|NCT01279681|63149242|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
33682654|NCT01279681|63149243|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
33682655|NCT01279681|63149242|FG000|Overall Study|Physician Decision|1|||
33682656|NCT01279681|63149243|FG001|Overall Study|Physician Decision|0|||
33682657|NCT01279681|63149242|FG000|Overall Study|Other Reason|0|||
33682658|NCT01279681|63149243|FG001|Overall Study|Other Reason|2|||
33682659|NCT01279057|63149261|FG000|Overall Study|Adverse Event|1|||
33682660|NCT01279057|63149262|FG001|Overall Study|Adverse Event|0|||
33682661|NCT01279057|63149263|FG002|Overall Study|Adverse Event|1|||
33682662|NCT01279057|63149261|FG000|Overall Study|Insufficient therapeutic response|0|||
33682663|NCT01279057|63149262|FG001|Overall Study|Insufficient therapeutic response|0|||
33682664|NCT01279057|63149263|FG002|Overall Study|Insufficient therapeutic response|1|||
33682665|NCT01279057|63149261|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
33682666|NCT01279057|63149262|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
33682667|NCT01279057|63149263|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
33682668|NCT01279057|63149261|FG000|Overall Study|Withdrew consent|2|||
33682669|NCT01279057|63149262|FG001|Overall Study|Withdrew consent|0|||
33682670|NCT01279057|63149263|FG002|Overall Study|Withdrew consent|1|||
33682671|NCT01279057|63149261|FG000|Overall Study|Pregnancy|0|||
33682672|NCT01279057|63149262|FG001|Overall Study|Pregnancy|1|||
33682673|NCT01279057|63149263|FG002|Overall Study|Pregnancy|0|||
33682674|NCT01279057|63149261|FG000|Overall Study|Other|3|||
33682675|NCT01279057|63149262|FG001|Overall Study|Other|3|||
33682676|NCT01279057|63149263|FG002|Overall Study|Other|0|||
33682677|NCT02999633|63149271|FG000|Overall Study|Adverse Event|2|||
33682678|NCT02999633|63149271|FG000|Overall Study|Progressive disease|12|||
33682679|NCT01278745|63149373|FG000|Overall Study|Death|2|||
33682680|NCT01278745|63149374|FG001|Overall Study|Death|5|||
33682681|NCT01278745|63149375|FG002|Overall Study|Death|7|||
33682682|NCT01278745|63149376|FG003|Overall Study|Death|0|||
33682683|NCT01278745|63149373|FG000|Overall Study|Physician Decision|1|||
33682684|NCT01278745|63149374|FG001|Overall Study|Physician Decision|0|||
33682685|NCT01278745|63149375|FG002|Overall Study|Physician Decision|0|||
33682686|NCT01278745|63149376|FG003|Overall Study|Physician Decision|9|||
33682687|NCT01278745|63149373|FG000|Overall Study|Withdrawal by Subject|1|||
33682688|NCT01278745|63149374|FG001|Overall Study|Withdrawal by Subject|1|||
33682689|NCT01278745|63149375|FG002|Overall Study|Withdrawal by Subject|5|||
33682690|NCT01278745|63149376|FG003|Overall Study|Withdrawal by Subject|1|||
33682691|NCT01278745|63149373|FG000|Overall Study|Sponsor Decision|1|||
33682692|NCT01278745|63149374|FG001|Overall Study|Sponsor Decision|0|||
33682693|NCT01278745|63149375|FG002|Overall Study|Sponsor Decision|62|||
33682694|NCT01278745|63149376|FG003|Overall Study|Sponsor Decision|6|||
33682695|NCT01278745|63149373|FG000|Overall Study|Ineligible|0|||
33682696|NCT01278745|63149374|FG001|Overall Study|Ineligible|0|||
33682697|NCT01278745|63149375|FG002|Overall Study|Ineligible|42|||
33682698|NCT01278745|63149376|FG003|Overall Study|Ineligible|61|||
33682699|NCT01278745|63149373|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
33682700|NCT01278745|63149374|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
33682701|NCT01278745|63149375|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
33682702|NCT01278745|63149376|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
33682703|NCT03006926|63149386|FG000|Overall Study|Death|0|||
33682704|NCT03006926|63149387|FG001|Overall Study|Death|33|||
33682705|NCT03006926|63149386|FG000|Overall Study|Ongoing Survival Follow-up|0|||
33682706|NCT03006926|63149387|FG001|Overall Study|Ongoing Survival Follow-up|26|||
33682707|NCT03006926|63149386|FG000|Overall Study|Ongoing-on Treatment|0|||
33682708|NCT03006926|63149387|FG001|Overall Study|Ongoing-on Treatment|36|||
33682709|NCT03006926|63149386|FG000|Overall Study|Lost to Follow-up|0|||
33682710|NCT03006926|63149387|FG001|Overall Study|Lost to Follow-up|1|||
33682711|NCT03006926|63149386|FG000|Overall Study|Withdrawal by Subject|0|||
33682712|NCT03006926|63149387|FG001|Overall Study|Withdrawal by Subject|2|||
33682713|NCT01277887|63149449|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
33682714|NCT01277887|63149450|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
33682715|NCT01277887|63149449|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
33682716|NCT01277887|63149450|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
33682717|NCT01277887|63149449|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
33682718|NCT01277887|63149450|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
33682719|NCT01276327|63149464|FG000|Overall Study|Adverse Event|1|||
33682720|NCT01276327|63149465|FG001|Overall Study|Adverse Event|3|||
33682721|NCT01276327|63149464|FG000|Overall Study|Withdrawal by Subject|1|||
33682722|NCT01276327|63149465|FG001|Overall Study|Withdrawal by Subject|0|||
33682723|NCT00639002|63149587|FG000|Overall Study|Death|1|||
33682724|NCT00639002|63149587|FG000|Overall Study|Adverse Event|1|||
33682725|NCT00639002|63149587|FG000|Overall Study|Protocol Violation|1|||
33682726|NCT00639002|63149587|FG000|Overall Study|Disease progression|3|||
33682727|NCT00639002|63149587|FG000|Overall Study|Physician Decision|6|||
33682728|NCT00639002|63149587|FG000|Overall Study|Lack of Efficacy|1|||
33682729|NCT00638846|63149623|FG000|Overall Study|Adverse Event|0|||
33682730|NCT00638846|63149624|FG001|Overall Study|Adverse Event|1|||
33682731|NCT00638846|63149623|FG000|Overall Study|Lost to Follow-up|3|||
33682732|NCT00638846|63149624|FG001|Overall Study|Lost to Follow-up|2|||
33682733|NCT00638846|63149623|FG000|Overall Study|lens issue|1|||
33682734|NCT00638846|63149624|FG001|Overall Study|lens issue|3|||
33682735|NCT00638456|63149632|FG000|Overall Study|Withdrawal by Subject|6|||
33682736|NCT00638456|63149633|FG001|Overall Study|Withdrawal by Subject|2|||
33682737|NCT00638378|63149662|FG000|Overall Study|Death|2|||
33682738|NCT00638378|63149662|FG000|Overall Study|Adverse Event|1|||
33682739|NCT00638378|63149662|FG000|Overall Study|Disease progression|15|||
33682740|NCT00638378|63149662|FG000|Overall Study|Physician Decision|4|||
33682741|NCT03807349|63149839|FG000|Overall Study|Early Study Termination|9|||
33682742|NCT03802825|63149849|FG000|Overall Study|Lost to follow-up for intervention|12|||
33682743|NCT03802825|63149850|FG001|Overall Study|Lost to follow-up for intervention|3|||
33682744|NCT03802825|63149849|FG000|Overall Study|Received only 1 component of intervention|0|||
33682745|NCT03802825|63149850|FG001|Overall Study|Received only 1 component of intervention|13|||
33682746|NCT03808909|63149869|FG000|Overall Study|Lost to Follow-up|3|||
33594898|NCT02527343|62993904|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
33594899|NCT02527343|62993905|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
33594900|NCT02527343|62993906|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
33594901|NCT02527343|62993907|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
33594902|NCT02527343|62993908|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
33594903|NCT02527343|62993903|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
33594904|NCT02527343|62993904|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
33594905|NCT02527343|62993905|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
33594906|NCT02527343|62993906|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
33594907|NCT02527343|62993907|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
33594908|NCT02527343|62993908|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
33594909|NCT02527343|62993903|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
33594910|NCT02527343|62993904|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
33682747|NCT03808909|63149870|FG001|Overall Study|Lost to Follow-up|0|||
33682748|NCT03802513|63149891|FG000|Overall Study|Lost to Follow-up|1|||
33682749|NCT01276223|63150082|FG000|Overall Study|Adverse Event|7|||
33682750|NCT01276223|63150083|FG001|Overall Study|Adverse Event|4|||
33682751|NCT01276223|63150084|FG002|Overall Study|Adverse Event|1|||
33682752|NCT01276223|63150082|FG000|Overall Study|Lost to Follow-up|0|||
33493100|NCT03145064|62871138|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
33493101|NCT03145064|62871138|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
33493102|NCT03787615|62871163|FG000|Overall Study|Withdrawal by Subject|2|||
33493103|NCT03787615|62871163|FG000|Overall Study|Lost to Follow-up|2|||
33493104|NCT03784963|62871172|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
33493105|NCT03784963|62871173|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
33493106|NCT03784963|62871174|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
33493107|NCT03784963|62871175|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
33493108|NCT03787303|62871185|FG000|Overall Study|Death|1|||
33493109|NCT03787303|62871185|FG000|Overall Study|Premature Termination of Study|1|||
33493110|NCT04170296|62871191|FG000|Overall Study|Adverse Event|1|||
33493111|NCT04170296|62871192|FG001|Overall Study|Adverse Event|0|||
33493112|NCT04170296|62871191|FG000|Overall Study|Withdrawal by Subject|3|||
33493113|NCT04170296|62871192|FG001|Overall Study|Withdrawal by Subject|2|||
33493114|NCT04170296|62871191|FG000|Overall Study|Lost to Follow-up|4|||
33493115|NCT04170296|62871192|FG001|Overall Study|Lost to Follow-up|2|||
33493116|NCT03141788|62871219|FG000|Overall Study|Lost to Follow-up|1|||
33493117|NCT03141788|62871219|FG000|Overall Study|Protocol Violation|3|||
33493118|NCT03141788|62871219|FG000|Overall Study|Withdrawal by Subject|4|||
33493119|NCT03781375|62871228|FG000|Double-blind Phase|Adverse Event|0|||
33682753|NCT01276223|63150083|FG001|Overall Study|Lost to Follow-up|0|||
33682754|NCT01276223|63150084|FG002|Overall Study|Lost to Follow-up|1|||
33682755|NCT01276223|63150082|FG000|Overall Study|Other|0|||
33682756|NCT01276223|63150083|FG001|Overall Study|Other|0|||
33682757|NCT01276223|63150084|FG002|Overall Study|Other|1|||
33682758|NCT01276223|63150082|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
33682759|NCT01276223|63150083|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
33682760|NCT01276223|63150084|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
33682761|NCT01276223|63150082|FG000|Overall Study|Protocol Violation|1|||
33682762|NCT01276223|63150083|FG001|Overall Study|Protocol Violation|0|||
33682763|NCT01276223|63150084|FG002|Overall Study|Protocol Violation|0|||
33682764|NCT01275833|63150093|FG000|Overall Study|Study terminated|1|||
33682765|NCT01275833|63150094|FG001|Overall Study|Study terminated|1|||
33682766|NCT01275755|63150102|FG000|Double-blind Treatment Period|Adverse Event|0|||
33682767|NCT01275755|63150103|FG001|Double-blind Treatment Period|Adverse Event|2|||
33682768|NCT01275755|63150102|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
33682769|NCT01275755|63150103|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
33682770|NCT01275755|63150102|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
33682771|NCT01275755|63150103|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
33682772|NCT01275755|63150102|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
33682773|NCT01275755|63150103|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
33682774|NCT01275131|63150134|FG000|Period 1|Withdrawal by Subject|1|||
33682775|NCT01275131|63150135|FG001|Period 1|Withdrawal by Subject|0|||
33682776|NCT01275131|63150136|FG002|Period 1|Withdrawal by Subject|3|||
33682777|NCT01275131|63150137|FG003|Period 1|Withdrawal by Subject|2|||
33682778|NCT01275131|63150134|FG000|Period 1|Physician Decision|1|||
33682779|NCT01275131|63150135|FG001|Period 1|Physician Decision|0|||
33682780|NCT01275131|63150136|FG002|Period 1|Physician Decision|0|||
33682781|NCT01275131|63150137|FG003|Period 1|Physician Decision|0|||
33682782|NCT01275131|63150134|FG000|Period 2 (Crossover)|Adverse Event|0|||
33682783|NCT01275131|63150135|FG001|Period 2 (Crossover)|Adverse Event|1|||
33682784|NCT01275131|63150136|FG002|Period 2 (Crossover)|Adverse Event|0|||
33682785|NCT01275131|63150137|FG003|Period 2 (Crossover)|Adverse Event|0|||
33682786|NCT01275131|63150134|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
33682787|NCT01275131|63150135|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
33682788|NCT01275131|63150136|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
33682789|NCT01275131|63150137|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
33682790|NCT01274429|63150166|FG000|Overall Study|Study closed do to lack of funding|5|||
33682791|NCT01273883|63150170|FG000|First Intervention|Adverse Event|2|||
33682792|NCT01273883|63150171|FG001|First Intervention|Adverse Event|1|||
33682793|NCT01273883|63150170|FG000|Second Intervention|Lost to Follow-up|1|||
33682794|NCT01273883|63150171|FG001|Second Intervention|Lost to Follow-up|1|||
33682795|NCT01273883|63150170|FG000|Second Intervention|Lack of Efficacy|1|||
33682796|NCT01273883|63150171|FG001|Second Intervention|Lack of Efficacy|0|||
33682797|NCT01273805|63150179|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
33682798|NCT01273805|63150180|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
33682799|NCT01273181|63150190|FG000|Phase I, Dose 1|Study termination|1|||
33682800|NCT01273181|63150191|FG001|Phase I, Dose 1|Study termination|0|||
33682801|NCT01273181|63150192|FG002|Phase I, Dose 1|Study termination|0|||
33682802|NCT01273181|63150193|FG003|Phase I, Dose 1|Study termination|0|||
33682803|NCT01273181|63150190|FG000|Phase I, Dose 2|Death during treatment|0|||
33682804|NCT01273181|63150191|FG001|Phase I, Dose 2|Death during treatment|1|||
33682805|NCT01273181|63150192|FG002|Phase I, Dose 2|Death during treatment|0|||
33682806|NCT01273181|63150193|FG003|Phase I, Dose 2|Death during treatment|0|||
33682807|NCT01273181|63150190|FG000|Phase 2, Dose 1|Study termination|0|||
33682808|NCT01273181|63150191|FG001|Phase 2, Dose 1|Study termination|0|||
33682809|NCT01273181|63150192|FG002|Phase 2, Dose 1|Study termination|1|||
33682810|NCT01273181|63150193|FG003|Phase 2, Dose 1|Study termination|0|||
33682811|NCT01273181|63150190|FG000|Phase 2, Dose 2|Death during treatment|0|||
33682812|NCT01273181|63150191|FG001|Phase 2, Dose 2|Death during treatment|0|||
33682813|NCT01273181|63150192|FG002|Phase 2, Dose 2|Death during treatment|0|||
33682814|NCT01273181|63150193|FG003|Phase 2, Dose 2|Death during treatment|1|||
33682815|NCT01272947|63150209|FG000|Overall Study|Abnormal Laboratory Value|2|||
33682816|NCT01272947|63150210|FG001|Overall Study|Abnormal Laboratory Value|2|||
33682817|NCT01279343|63150218|FG000|Overall Study|Did not receive treatment|2|||
33682818|NCT01279343|63150219|FG001|Overall Study|Did not receive treatment|6|||
33682819|NCT01278797|63150225|FG000|Period 1|Adverse Event|0|||
33682820|NCT01278797|63150226|FG001|Period 1|Adverse Event|1|||
33682821|NCT01278797|63150225|FG000|Period 1|Protocol Violation|1|||
33682822|NCT01278797|63150226|FG001|Period 1|Protocol Violation|0|||
33682823|NCT01272869|63150234|FG000|Period 2 (14 Days)|Adverse Event|1|||
33682824|NCT01272869|63150235|FG001|Period 2 (14 Days)|Adverse Event|0|||
33682825|NCT01272635|63150243|FG000|Overall Study|Lost to Follow-up|31|||
33682826|NCT01272635|63150244|FG001|Overall Study|Lost to Follow-up|20|||
33682827|NCT01272635|63150245|FG002|Overall Study|Lost to Follow-up|31|||
33682828|NCT01272635|63150246|FG003|Overall Study|Lost to Follow-up|23|||
33682829|NCT01272011|63150257|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
33682830|NCT01272011|63150258|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
33682831|NCT01272011|63150259|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
33682832|NCT01270841|63150280|FG000|Overall Study|Adverse Event|0|||
33682833|NCT01270841|63150281|FG001|Overall Study|Adverse Event|1|||
33682834|NCT01270841|63150282|FG002|Overall Study|Adverse Event|0|||
33682835|NCT01270841|63150283|FG003|Overall Study|Adverse Event|3|||
33682836|NCT01270841|63150280|FG000|Overall Study|Withdrawal by Subject|3|||
33682837|NCT01270841|63150281|FG001|Overall Study|Withdrawal by Subject|2|||
33682838|NCT01270841|63150282|FG002|Overall Study|Withdrawal by Subject|3|||
33682839|NCT01270841|63150283|FG003|Overall Study|Withdrawal by Subject|3|||
33682840|NCT01270841|63150280|FG000|Overall Study|Lost to Follow-up|3|||
33682841|NCT01270841|63150281|FG001|Overall Study|Lost to Follow-up|1|||
33682842|NCT01270841|63150282|FG002|Overall Study|Lost to Follow-up|4|||
33682843|NCT01270841|63150283|FG003|Overall Study|Lost to Follow-up|2|||
33682844|NCT01270841|63150280|FG000|Overall Study|Physician Decision|0|||
33682845|NCT01270841|63150281|FG001|Overall Study|Physician Decision|1|||
33682846|NCT01270841|63150282|FG002|Overall Study|Physician Decision|0|||
33682847|NCT01270841|63150283|FG003|Overall Study|Physician Decision|0|||
33682848|NCT01270841|63150280|FG000|Overall Study|Did not qualify|6|||
33682849|NCT01270841|63150281|FG001|Overall Study|Did not qualify|3|||
33682850|NCT01270841|63150282|FG002|Overall Study|Did not qualify|4|||
33682851|NCT01270841|63150283|FG003|Overall Study|Did not qualify|5|||
33682852|NCT01270841|63150280|FG000|Overall Study|Protocol Violation|1|||
33682853|NCT01270841|63150281|FG001|Overall Study|Protocol Violation|5|||
33682854|NCT01270841|63150282|FG002|Overall Study|Protocol Violation|0|||
33682855|NCT01270841|63150283|FG003|Overall Study|Protocol Violation|0|||
33682856|NCT01270841|63150280|FG000|Overall Study|Enrolled in error|0|||
33682857|NCT01270841|63150281|FG001|Overall Study|Enrolled in error|1|||
33682858|NCT01270841|63150282|FG002|Overall Study|Enrolled in error|0|||
33682859|NCT01270841|63150283|FG003|Overall Study|Enrolled in error|0|||
33682860|NCT01270139|63150296|FG000|Overall Study|Adverse Event|8|||
33682861|NCT01270139|63150297|FG001|Overall Study|Adverse Event|17|||
33682862|NCT01270139|63150298|FG002|Overall Study|Adverse Event|18|||
33682863|NCT01270139|63150296|FG000|Overall Study|Lost to Follow-up|10|||
33682864|NCT01270139|63150297|FG001|Overall Study|Lost to Follow-up|9|||
33682865|NCT01270139|63150298|FG002|Overall Study|Lost to Follow-up|2|||
33682866|NCT01278407|63150316|FG000|Confirmatory Phase|Adverse Event|5|||
33682867|NCT01278407|63150317|FG001|Confirmatory Phase|Adverse Event|10|||
33682868|NCT01278407|63150318|FG002|Confirmatory Phase|Adverse Event|1|||
33682869|NCT01278407|63150319|FG003|Confirmatory Phase|Adverse Event|0|||
33682870|NCT01278407|63150320|FG004|Confirmatory Phase|Adverse Event|0|||
33682871|NCT01278407|63150316|FG000|Confirmatory Phase|Participant's Choice|3|||
33682872|NCT01278407|63150317|FG001|Confirmatory Phase|Participant's Choice|5|||
33682873|NCT01278407|63150318|FG002|Confirmatory Phase|Participant's Choice|3|||
33682874|NCT01278407|63150319|FG003|Confirmatory Phase|Participant's Choice|0|||
33682875|NCT01278407|63150320|FG004|Confirmatory Phase|Participant's Choice|0|||
33682876|NCT01278407|63150316|FG000|Confirmatory Phase|Other|1|||
33682877|NCT01278407|63150317|FG001|Confirmatory Phase|Other|1|||
33682878|NCT01278407|63150318|FG002|Confirmatory Phase|Other|2|||
33682879|NCT01278407|63150319|FG003|Confirmatory Phase|Other|0|||
33682880|NCT01278407|63150320|FG004|Confirmatory Phase|Other|0|||
33682881|NCT01278407|63150316|FG000|Extension Phase|Adverse Event|0|||
33682882|NCT01278407|63150317|FG001|Extension Phase|Adverse Event|0|||
33682883|NCT01278407|63150318|FG002|Extension Phase|Adverse Event|0|||
33682884|NCT01278407|63150319|FG003|Extension Phase|Adverse Event|7|||
33682885|NCT01278407|63150320|FG004|Extension Phase|Adverse Event|16|||
33682886|NCT01278407|63150316|FG000|Extension Phase|Participant's Choice|0|||
33682887|NCT01278407|63150317|FG001|Extension Phase|Participant's Choice|0|||
33682888|NCT01278407|63150318|FG002|Extension Phase|Participant's Choice|0|||
33682889|NCT01278407|63150319|FG003|Extension Phase|Participant's Choice|4|||
33682890|NCT01278407|63150320|FG004|Extension Phase|Participant's Choice|11|||
33682891|NCT01278407|63150316|FG000|Extension Phase|Other|0|||
33682892|NCT01278407|63150317|FG001|Extension Phase|Other|0|||
33682893|NCT01278407|63150318|FG002|Extension Phase|Other|0|||
33682894|NCT01278407|63150319|FG003|Extension Phase|Other|1|||
33682895|NCT01278407|63150320|FG004|Extension Phase|Other|3|||
33682896|NCT01278173|63150330|FG000|Overall Study|Lack of Efficacy|13|||
33682897|NCT01278173|63150330|FG000|Overall Study|Adverse Event|8|||
33682898|NCT01278173|63150330|FG000|Overall Study|Administrative or other reason|4|||
33682899|NCT01278173|63150330|FG000|Overall Study|Protocol Violation|1|||
33682900|NCT01278173|63150330|FG000|Overall Study|Withdrawal by Subject|1|||
33682901|NCT01277861|63150363|FG000|Overall Study|Physician Decision|2|||
33682902|NCT01277861|63150364|FG001|Overall Study|Physician Decision|2|||
33682903|NCT01277549|63150391|FG000|Overall Study|Failed to meet eligibility criteria|13|||
33682904|NCT01277549|63150392|FG001|Overall Study|Failed to meet eligibility criteria|9|||
33682905|NCT01277549|63150391|FG000|Overall Study|Withdrawal by Subject|1|||
33682906|NCT01277549|63150392|FG001|Overall Study|Withdrawal by Subject|3|||
33682907|NCT01277549|63150391|FG000|Overall Study|Protocol Violation|10|||
33594911|NCT02527343|62993905|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
33594912|NCT02527343|62993906|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
33594913|NCT02527343|62993907|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
33594914|NCT02527343|62993908|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
33594915|NCT02527343|62993903|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
33594916|NCT02527343|62993904|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
33594917|NCT02527343|62993905|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
33594918|NCT02527343|62993906|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
33594919|NCT02527343|62993907|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
33594920|NCT02527343|62993908|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
33594921|NCT02527343|62993903|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
33594922|NCT02527343|62993904|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
33594923|NCT02527343|62993905|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
33594924|NCT02527343|62993906|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
33594925|NCT02527343|62993907|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
33594926|NCT02527343|62993908|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
33594927|NCT02527343|62993903|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
33594928|NCT02527343|62993904|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
33594929|NCT02527343|62993905|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
33594930|NCT02527343|62993906|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
33594931|NCT02527343|62993907|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
33594932|NCT02527343|62993908|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
33594933|NCT02527343|62993903|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
33594934|NCT02527343|62993904|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
33594935|NCT02527343|62993905|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
33594936|NCT02527343|62993906|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
33594937|NCT02527343|62993907|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
33594938|NCT02527343|62993908|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
33594939|NCT01931566|62993926|FG000|Overall Study|Randomized But Not Treated|6|||
33594940|NCT01931566|62993927|FG001|Overall Study|Randomized But Not Treated|9|||
33594941|NCT01931566|62993928|FG002|Overall Study|Randomized But Not Treated|14|||
33594942|NCT01931566|62993926|FG000|Overall Study|Adverse Event|37|||
33594943|NCT01931566|62993927|FG001|Overall Study|Adverse Event|167|||
33594944|NCT01931566|62993928|FG002|Overall Study|Adverse Event|132|||
33594945|NCT01931566|62993926|FG000|Overall Study|Major Protocol Deviation|5|||
33594946|NCT01931566|62993927|FG001|Overall Study|Major Protocol Deviation|14|||
33594947|NCT01931566|62993928|FG002|Overall Study|Major Protocol Deviation|21|||
33594948|NCT01931566|62993926|FG000|Overall Study|Lost to Follow-up|3|||
33594949|NCT01931566|62993927|FG001|Overall Study|Lost to Follow-up|26|||
33594950|NCT01931566|62993928|FG002|Overall Study|Lost to Follow-up|23|||
33594951|NCT01931566|62993926|FG000|Overall Study|Voluntary Withdrawal|78|||
33594952|NCT01931566|62993927|FG001|Overall Study|Voluntary Withdrawal|245|||
33594953|NCT01931566|62993928|FG002|Overall Study|Voluntary Withdrawal|225|||
33594954|NCT01931566|62993926|FG000|Overall Study|Study Termination|289|||
33594955|NCT01931566|62993927|FG001|Overall Study|Study Termination|968|||
33594956|NCT01931566|62993928|FG002|Overall Study|Study Termination|1037|||
33594957|NCT01931566|62993926|FG000|Overall Study|Reason Not Specified|11|||
33594958|NCT01931566|62993927|FG001|Overall Study|Reason Not Specified|47|||
33594959|NCT01931566|62993928|FG002|Overall Study|Reason Not Specified|53|||
33594960|NCT01931566|62993926|FG000|Overall Study|Missing|0|||
33594961|NCT01931566|62993927|FG001|Overall Study|Missing|0|||
33594962|NCT01931566|62993928|FG002|Overall Study|Missing|1|||
33594963|NCT01912456|62993939|FG000|Period 1|Physician Decision|0|||
33594964|NCT01912456|62993940|FG001|Period 1|Physician Decision|0|||
33594965|NCT01912456|62993941|FG002|Period 1|Physician Decision|1|||
33594966|NCT01912456|62993942|FG003|Period 1|Physician Decision|0|||
33594967|NCT01912456|62993939|FG000|Period 1|non-compliance|1|||
33594968|NCT01912456|62993940|FG001|Period 1|non-compliance|0|||
33594969|NCT01912456|62993941|FG002|Period 1|non-compliance|0|||
33594970|NCT01912456|62993942|FG003|Period 1|non-compliance|1|||
33594971|NCT01912456|62993939|FG000|Period 1|Adverse Event|1|||
33594972|NCT01912456|62993940|FG001|Period 1|Adverse Event|0|||
33594973|NCT01912456|62993941|FG002|Period 1|Adverse Event|0|||
33594974|NCT01912456|62993942|FG003|Period 1|Adverse Event|1|||
33594975|NCT01912456|62993939|FG000|Period 1|Withdrawal by Subject|0|||
33594976|NCT01912456|62993940|FG001|Period 1|Withdrawal by Subject|1|||
33594977|NCT01912456|62993941|FG002|Period 1|Withdrawal by Subject|1|||
33594978|NCT01912456|62993942|FG003|Period 1|Withdrawal by Subject|1|||
33594979|NCT01912456|62993939|FG000|Period 2|Lack of Efficacy|0|||
33594980|NCT01912456|62993940|FG001|Period 2|Lack of Efficacy|2|||
33594981|NCT01912456|62993941|FG002|Period 2|Lack of Efficacy|0|||
33594982|NCT01912456|62993942|FG003|Period 2|Lack of Efficacy|0|||
33594983|NCT01912456|62993939|FG000|Period 2|Adverse Event|0|||
33594984|NCT01912456|62993940|FG001|Period 2|Adverse Event|0|||
33594985|NCT01912456|62993941|FG002|Period 2|Adverse Event|0|||
33594986|NCT01912456|62993942|FG003|Period 2|Adverse Event|1|||
33594987|NCT01885936|62993954|FG000|Overall Study|Withdrawal by Subject|1|||
33594988|NCT01885936|62993955|FG001|Overall Study|Withdrawal by Subject|0|||
33682908|NCT01277549|63150392|FG001|Overall Study|Protocol Violation|1|||
33682909|NCT01277549|63150391|FG000|Overall Study|Physician Decision|2|||
33594989|NCT01912222|62993964|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
33594990|NCT01912222|62993965|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
33594991|NCT01912222|62993966|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
33594992|NCT01912222|62993964|FG000|Part B: Treatment Period|Progressive disease|10|||
33594993|NCT01912222|62993965|FG001|Part B: Treatment Period|Progressive disease|12|||
33594994|NCT01912222|62993966|FG002|Part B: Treatment Period|Progressive disease|15|||
33594995|NCT01912222|62993964|FG000|Part B: Treatment Period|Adverse Event|1|||
33594996|NCT01912222|62993965|FG001|Part B: Treatment Period|Adverse Event|2|||
33594997|NCT01912222|62993966|FG002|Part B: Treatment Period|Adverse Event|3|||
33594998|NCT01912222|62993964|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
33594999|NCT01912222|62993965|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
33595000|NCT01912222|62993966|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
33595001|NCT02525861|62993977|FG000|Overall Study|Adverse Event|1|||
33595002|NCT02525861|62993978|FG001|Overall Study|Adverse Event|0|||
33595003|NCT02525861|62993977|FG000|Overall Study|Withdrawal by Subject|0|||
33595004|NCT02525861|62993978|FG001|Overall Study|Withdrawal by Subject|1|||
33595005|NCT02525861|62993977|FG000|Overall Study|Physician Decision|0|||
33595006|NCT02525861|62993978|FG001|Overall Study|Physician Decision|1|||
33595007|NCT02524847|62993986|FG000|Overall Study|Adverse Event|4|||
33595008|NCT02524847|62993986|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
33595009|NCT02524847|62993986|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
33595010|NCT02524847|62993986|FG000|Overall Study|Death|1|||
33595011|NCT02524847|62993986|FG000|Overall Study|Reason not Specified|1|||
33595012|NCT02525627|62993993|FG000|Overall Study|Revision|1|||
33595013|NCT02525627|62993994|FG001|Overall Study|Revision|1|||
33595014|NCT02525627|62993993|FG000|Overall Study|Withdrawal by Subject|1|||
33595015|NCT02525627|62993994|FG001|Overall Study|Withdrawal by Subject|2|||
33595016|NCT02525627|62993993|FG000|Overall Study|Death|1|||
33595017|NCT02525627|62993994|FG001|Overall Study|Death|0|||
33595018|NCT02525627|62993993|FG000|Overall Study|Site terminated|11|||
33595019|NCT02525627|62993994|FG001|Overall Study|Site terminated|10|||
33595020|NCT02129205|62994010|FG000|Overall Study|Withdrawal by Subject|0|||
33595021|NCT02129205|62994011|FG001|Overall Study|Withdrawal by Subject|0|||
33595022|NCT02129205|62994012|FG002|Overall Study|Withdrawal by Subject|0|||
33595023|NCT02129205|62994013|FG003|Overall Study|Withdrawal by Subject|0|||
33595024|NCT02129205|62994014|FG004|Overall Study|Withdrawal by Subject|1|||
33595025|NCT02129205|62994015|FG005|Overall Study|Withdrawal by Subject|1|||
33595026|NCT02129205|62994016|FG006|Overall Study|Withdrawal by Subject|1|||
33595027|NCT02129205|62994017|FG007|Overall Study|Withdrawal by Subject|0|||
33595028|NCT02129205|62994018|FG008|Overall Study|Withdrawal by Subject|1|||
33595029|NCT02129205|62994019|FG009|Overall Study|Withdrawal by Subject|0|||
33595030|NCT02129205|62994010|FG000|Overall Study|Other|1|||
33595031|NCT02129205|62994011|FG001|Overall Study|Other|0|||
33595032|NCT02129205|62994012|FG002|Overall Study|Other|0|||
33595033|NCT02129205|62994013|FG003|Overall Study|Other|0|||
33595034|NCT02129205|62994014|FG004|Overall Study|Other|2|||
33595035|NCT02129205|62994015|FG005|Overall Study|Other|3|||
33595036|NCT02129205|62994016|FG006|Overall Study|Other|3|||
33595037|NCT02129205|62994017|FG007|Overall Study|Other|2|||
33595038|NCT02129205|62994018|FG008|Overall Study|Other|1|||
33595039|NCT02129205|62994019|FG009|Overall Study|Other|0|||
33595040|NCT02128269|62994043|FG000|Treatment Period|Adverse Event|1|||
33595041|NCT02128269|62994043|FG000|Treatment Period|Physician Decision|1|||
33595042|NCT01626885|62994047|FG000|Overall Study|Adverse Event|8|||
33595043|NCT01626885|62994047|FG000|Overall Study|Withdrawal by Subject|4|||
33595044|NCT02524379|62994051|FG000|Overall Study|Death|1|||
33595045|NCT02524145|62994058|FG000|Overall Study|Withdrawal by Subject|2|||
33595046|NCT02524145|62994059|FG001|Overall Study|Withdrawal by Subject|2|||
33595047|NCT02524145|62994060|FG002|Overall Study|Withdrawal by Subject|3|||
33595048|NCT01658813|62994068|FG000|Overall Study|Disease progression|3|||
33595049|NCT02187471|62994080|FG000|Overall Study|Protocol Violation|4|||
33595050|NCT02187471|62994081|FG001|Overall Study|Protocol Violation|5|||
33595051|NCT02187471|62994082|FG002|Overall Study|Protocol Violation|4|||
33595052|NCT02187471|62994083|FG003|Overall Study|Protocol Violation|4|||
33595053|NCT02187471|62994080|FG000|Overall Study|Missing|0|||
33595054|NCT02187471|62994081|FG001|Overall Study|Missing|0|||
33682910|NCT01277549|63150392|FG001|Overall Study|Physician Decision|1|||
33595055|NCT02187471|62994082|FG002|Overall Study|Missing|0|||
33595056|NCT02187471|62994083|FG003|Overall Study|Missing|1|||
33595057|NCT02187471|62994080|FG000|Overall Study|Lack of Efficacy|18|||
33595058|NCT02187471|62994081|FG001|Overall Study|Lack of Efficacy|9|||
33595059|NCT02187471|62994082|FG002|Overall Study|Lack of Efficacy|13|||
33595060|NCT02187471|62994083|FG003|Overall Study|Lack of Efficacy|11|||
33595061|NCT02187471|62994080|FG000|Overall Study|Adverse Event|24|||
33595062|NCT02187471|62994081|FG001|Overall Study|Adverse Event|34|||
33682911|NCT01276847|63150404|FG000|Overall Study|Withdrawal by Subject|1|||
33595063|NCT02187471|62994082|FG002|Overall Study|Adverse Event|44|||
33682912|NCT01276847|63150405|FG001|Overall Study|Withdrawal by Subject|0|||
33682913|NCT01276847|63150406|FG002|Overall Study|Withdrawal by Subject|0|||
33682914|NCT01276457|63150438|FG000|Core Study|Adverse Event|6|||
33682915|NCT01276457|63150439|FG001|Core Study|Adverse Event|3|||
33682916|NCT01276457|63150438|FG000|Core Study|Lost to Follow-up|1|||
33682917|NCT01276457|63150439|FG001|Core Study|Lost to Follow-up|2|||
33682918|NCT01276457|63150438|FG000|Core Study|Administrative problems|1|||
33682919|NCT01276457|63150439|FG001|Core Study|Administrative problems|1|||
33682920|NCT01276457|63150438|FG000|Core Study|Death|2|||
33682921|NCT01276457|63150439|FG001|Core Study|Death|2|||
33682922|NCT01276457|63150438|FG000|Core Study|Lack of Efficacy|3|||
33682923|NCT01276457|63150439|FG001|Core Study|Lack of Efficacy|12|||
33682924|NCT01276457|63150438|FG000|Extension Study|Lost to Follow-up|3|||
33682925|NCT01276457|63150439|FG001|Extension Study|Lost to Follow-up|0|||
33682926|NCT01276457|63150438|FG000|Extension Study|Death|0|||
33682927|NCT01276457|63150439|FG001|Extension Study|Death|1|||
33682928|NCT01276457|63150438|FG000|Extension Study|Lack of Efficacy|3|||
33682929|NCT01276457|63150439|FG001|Extension Study|Lack of Efficacy|1|||
33682930|NCT01276379|63150529|FG000|Overall Study|Screening failure|40|||
33682931|NCT03809663|63150825|FG000|Overall Study|Decision by sponsor|24|||
33682932|NCT03809663|63150826|FG001|Overall Study|Decision by sponsor|18|||
33682933|NCT03809663|63150827|FG002|Overall Study|Decision by sponsor|20|||
33682934|NCT03809663|63150828|FG003|Overall Study|Decision by sponsor|20|||
33682935|NCT03809663|63150829|FG004|Overall Study|Decision by sponsor|0|||
33682936|NCT03809663|63150830|FG005|Overall Study|Decision by sponsor|0|||
33682937|NCT03809663|63150825|FG000|Overall Study|Withdrawal by Subject|26|||
33682938|NCT03809663|63150826|FG001|Overall Study|Withdrawal by Subject|22|||
33682939|NCT03809663|63150827|FG002|Overall Study|Withdrawal by Subject|27|||
33682940|NCT03809663|63150828|FG003|Overall Study|Withdrawal by Subject|26|||
33682941|NCT03809663|63150829|FG004|Overall Study|Withdrawal by Subject|0|||
33682942|NCT03809663|63150830|FG005|Overall Study|Withdrawal by Subject|0|||
33682943|NCT03809663|63150825|FG000|Overall Study|Lost to Follow-up|1|||
33682944|NCT03809663|63150826|FG001|Overall Study|Lost to Follow-up|4|||
33682945|NCT03809663|63150827|FG002|Overall Study|Lost to Follow-up|1|||
33682946|NCT03809663|63150828|FG003|Overall Study|Lost to Follow-up|1|||
33682947|NCT03809663|63150829|FG004|Overall Study|Lost to Follow-up|0|||
33682948|NCT03809663|63150830|FG005|Overall Study|Lost to Follow-up|0|||
33682949|NCT00249821|63150892|FG000|Overall Study|Technical problem|0|||
33682950|NCT00249821|63150893|FG001|Overall Study|Technical problem|1|||
33682951|NCT00248651|63150968|FG000|Overall Study|Withdrawal by Subject|28|||
33682952|NCT00248651|63150969|FG001|Overall Study|Withdrawal by Subject|40|||
33682953|NCT00248651|63150970|FG002|Overall Study|Withdrawal by Subject|32|||
33682954|NCT00248495|63151007|FG000|Overall Study|Withdrawal by Subject|1|||
33682955|NCT03802565|63151104|FG000|Overall Study|Adverse Event|0|||
33682956|NCT03802565|63151105|FG001|Overall Study|Adverse Event|1|||
33682957|NCT03802565|63151106|FG002|Overall Study|Adverse Event|2|||
33682958|NCT03802565|63151107|FG003|Overall Study|Adverse Event|1|||
33682959|NCT03802565|63151108|FG004|Overall Study|Adverse Event|1|||
33595064|NCT02187471|62994083|FG003|Overall Study|Adverse Event|36|||
33595065|NCT02187471|62994080|FG000|Overall Study|Withdrawal by Subject|23|||
33595066|NCT02187471|62994081|FG001|Overall Study|Withdrawal by Subject|29|||
33595067|NCT02187471|62994082|FG002|Overall Study|Withdrawal by Subject|22|||
33595068|NCT02187471|62994083|FG003|Overall Study|Withdrawal by Subject|24|||
33595069|NCT02187471|62994080|FG000|Overall Study|Other|7|||
33595070|NCT02187471|62994081|FG001|Overall Study|Other|5|||
33595071|NCT02187471|62994082|FG002|Overall Study|Other|3|||
33595072|NCT02187471|62994083|FG003|Overall Study|Other|4|||
33595073|NCT02525471|62994094|FG000|Overall Study|Screen Failure|6|||
33595074|NCT02525471|62994094|FG000|Overall Study|Withdrawal by Subject|4|||
33595075|NCT02525471|62994094|FG000|Overall Study|Death|1|||
33595076|NCT01658735|62994102|FG000|Overall Study|Lack of Efficacy|1|||
33595077|NCT01658735|62994103|FG001|Overall Study|Lack of Efficacy|0|||
33595078|NCT01658735|62994104|FG002|Overall Study|Lack of Efficacy|1|||
33595079|NCT01658735|62994102|FG000|Overall Study|Lost to Follow-up|1|||
33595080|NCT01658735|62994103|FG001|Overall Study|Lost to Follow-up|1|||
33595081|NCT01658735|62994104|FG002|Overall Study|Lost to Follow-up|0|||
33595082|NCT01658735|62994102|FG000|Overall Study|Protocol Violation|0|||
33595083|NCT01658735|62994103|FG001|Overall Study|Protocol Violation|1|||
33595084|NCT01658735|62994104|FG002|Overall Study|Protocol Violation|0|||
33682960|NCT03802565|63151104|FG000|Overall Study|Withdrawal by Subject|2|||
33682961|NCT03802565|63151105|FG001|Overall Study|Withdrawal by Subject|2|||
33595085|NCT01658735|62994102|FG000|Overall Study|Withdrawal by Subject|3|||
33595086|NCT01658735|62994103|FG001|Overall Study|Withdrawal by Subject|5|||
33682962|NCT03802565|63151106|FG002|Overall Study|Withdrawal by Subject|2|||
33682963|NCT03802565|63151107|FG003|Overall Study|Withdrawal by Subject|0|||
33682964|NCT03802565|63151108|FG004|Overall Study|Withdrawal by Subject|1|||
33682965|NCT03802565|63151104|FG000|Overall Study|Protocol Violation|2|||
33595087|NCT01658735|62994104|FG002|Overall Study|Withdrawal by Subject|3|||
33682966|NCT03802565|63151105|FG001|Overall Study|Protocol Violation|1|||
33682967|NCT03802565|63151106|FG002|Overall Study|Protocol Violation|4|||
33682968|NCT03802565|63151107|FG003|Overall Study|Protocol Violation|5|||
33682969|NCT03802565|63151108|FG004|Overall Study|Protocol Violation|1|||
33682970|NCT03802565|63151104|FG000|Overall Study|Lost to Follow-up|0|||
33682971|NCT03802565|63151105|FG001|Overall Study|Lost to Follow-up|0|||
33682972|NCT03802565|63151106|FG002|Overall Study|Lost to Follow-up|1|||
33682973|NCT03802565|63151107|FG003|Overall Study|Lost to Follow-up|0|||
33682974|NCT03802565|63151108|FG004|Overall Study|Lost to Follow-up|0|||
33682975|NCT03802565|63151104|FG000|Overall Study|Subjects Related to Each Other|1|||
33682976|NCT03802565|63151105|FG001|Overall Study|Subjects Related to Each Other|0|||
33682977|NCT03802565|63151106|FG002|Overall Study|Subjects Related to Each Other|0|||
33682978|NCT03802565|63151107|FG003|Overall Study|Subjects Related to Each Other|2|||
33682979|NCT03802565|63151108|FG004|Overall Study|Subjects Related to Each Other|1|||
33682980|NCT03802565|63151104|FG000|Overall Study|Elevated Enzymes|0|||
33682981|NCT03802565|63151105|FG001|Overall Study|Elevated Enzymes|0|||
33682982|NCT03802565|63151106|FG002|Overall Study|Elevated Enzymes|0|||
33682983|NCT03802565|63151107|FG003|Overall Study|Elevated Enzymes|0|||
33682984|NCT03802565|63151108|FG004|Overall Study|Elevated Enzymes|2|||
33682985|NCT00245765|63151152|FG000|Overall Study|Adverse Event|1|||
33682986|NCT00245765|63151153|FG001|Overall Study|Adverse Event|1|||
33682987|NCT00245765|63151154|FG002|Overall Study|Adverse Event|0|||
33682988|NCT00245765|63151152|FG000|Overall Study|Lack of Efficacy|14|||
33682989|NCT00245765|63151153|FG001|Overall Study|Lack of Efficacy|7|||
33682990|NCT00245765|63151154|FG002|Overall Study|Lack of Efficacy|0|||
33682991|NCT00245765|63151152|FG000|Overall Study|Lost to Follow-up|1|||
33682992|NCT00245765|63151153|FG001|Overall Study|Lost to Follow-up|2|||
33682993|NCT00245765|63151154|FG002|Overall Study|Lost to Follow-up|0|||
33682994|NCT00245765|63151152|FG000|Overall Study|Withdrawal by Subject|1|||
33682995|NCT00245765|63151153|FG001|Overall Study|Withdrawal by Subject|0|||
33682996|NCT00245765|63151154|FG002|Overall Study|Withdrawal by Subject|3|||
33682997|NCT00245765|63151152|FG000|Overall Study|Other reason|2|||
33682998|NCT00245765|63151153|FG001|Overall Study|Other reason|0|||
33682999|NCT00245765|63151154|FG002|Overall Study|Other reason|1|||
33683000|NCT00245765|63151152|FG000|Overall Study|Other|13|||
33683001|NCT00245765|63151153|FG001|Overall Study|Other|4|||
33683002|NCT00245765|63151154|FG002|Overall Study|Other|4|||
33683003|NCT00245063|63151226|FG000|Overall Study|Adverse Event|6|||
33683004|NCT00245063|63151227|FG001|Overall Study|Adverse Event|5|||
33683005|NCT00245063|63151226|FG000|Overall Study|Death|1|||
33683006|NCT00245063|63151227|FG001|Overall Study|Death|0|||
33683007|NCT04329091|63151292|FG000|Overall Study|Physician Decision|5|||
33683008|NCT00244751|63151299|FG000|Overall Study|Adverse Event|7|||
33683009|NCT00244751|63151300|FG001|Overall Study|Adverse Event|7|||
33683010|NCT00244751|63151301|FG002|Overall Study|Adverse Event|5|||
33683011|NCT00244751|63151299|FG000|Overall Study|Lost to Follow-up|0|||
33683012|NCT00244751|63151300|FG001|Overall Study|Lost to Follow-up|1|||
33683013|NCT00244751|63151301|FG002|Overall Study|Lost to Follow-up|0|||
33683014|NCT00244751|63151299|FG000|Overall Study|Protocol Violation|1|||
33683015|NCT00244751|63151300|FG001|Overall Study|Protocol Violation|0|||
33683016|NCT00244751|63151301|FG002|Overall Study|Protocol Violation|1|||
33683017|NCT00244751|63151299|FG000|Overall Study|Withdrawal by Subject|7|||
33683018|NCT00244751|63151300|FG001|Overall Study|Withdrawal by Subject|5|||
33683019|NCT00244751|63151301|FG002|Overall Study|Withdrawal by Subject|3|||
33683020|NCT00244751|63151299|FG000|Overall Study|Elevated liver enzymes|1|||
33683021|NCT00244751|63151300|FG001|Overall Study|Elevated liver enzymes|0|||
33683022|NCT00244751|63151301|FG002|Overall Study|Elevated liver enzymes|0|||
33683023|NCT00244751|63151299|FG000|Overall Study|Lack of compliance with protocol|0|||
33683024|NCT00244751|63151300|FG001|Overall Study|Lack of compliance with protocol|1|||
33683025|NCT00244751|63151301|FG002|Overall Study|Lack of compliance with protocol|0|||
33683026|NCT00244751|63151299|FG000|Overall Study|Safety reasons|0|||
33683027|NCT00244751|63151300|FG001|Overall Study|Safety reasons|1|||
33683028|NCT00244751|63151301|FG002|Overall Study|Safety reasons|0|||
33683029|NCT00244751|63151299|FG000|Overall Study|Participant randomized by mistake|0|||
33683030|NCT00244751|63151300|FG001|Overall Study|Participant randomized by mistake|0|||
33683031|NCT00244751|63151301|FG002|Overall Study|Participant randomized by mistake|1|||
33683032|NCT00243659|63151343|FG000|Overall Study|Withdrawal by Subject|1|||
33683033|NCT00243659|63151344|FG001|Overall Study|Withdrawal by Subject|1|||
33683034|NCT00243659|63151343|FG000|Overall Study|Protocol Violation|1|||
33683035|NCT00243659|63151344|FG001|Overall Study|Protocol Violation|2|||
33683036|NCT00243347|63151359|FG000|Overall Study|Lack of Efficacy|4|||
33683037|NCT00243347|63151359|FG000|Overall Study|Adverse Event|2|||
33683038|NCT00243347|63151359|FG000|Overall Study|Death|1|||
33683039|NCT00243347|63151359|FG000|Overall Study|Withdrawal by Subject|5|||
33683040|NCT00243347|63151359|FG000|Overall Study|Condition worsened|7|||
33683041|NCT00243269|63151367|FG000|Overall Study|Protocol Violation|2|||
33683042|NCT00243269|63151368|FG001|Overall Study|Protocol Violation|1|||
33683043|NCT00243269|63151369|FG002|Overall Study|Protocol Violation|0|||
33683044|NCT00243269|63151370|FG003|Overall Study|Protocol Violation|1|||
33683045|NCT00243269|63151367|FG000|Overall Study|Lost to Follow-up|1|||
33683046|NCT00243269|63151368|FG001|Overall Study|Lost to Follow-up|0|||
33683047|NCT00243269|63151369|FG002|Overall Study|Lost to Follow-up|1|||
33683048|NCT00243269|63151370|FG003|Overall Study|Lost to Follow-up|3|||
33683049|NCT00242567|63152594|FG000|Overall Study|Adverse Event|70|||
33683050|NCT00242567|63152595|FG001|Overall Study|Adverse Event|43|||
33683051|NCT00242567|63152594|FG000|Overall Study|Disease Progression|17|||
33683052|NCT00242567|63152595|FG001|Overall Study|Disease Progression|22|||
33683053|NCT00242567|63152594|FG000|Overall Study|Symptomatic deterioration|9|||
33683054|NCT00242567|63152595|FG001|Overall Study|Symptomatic deterioration|3|||
33683055|NCT00242567|63152594|FG000|Overall Study|Lack of Efficacy|2|||
33683056|NCT00242567|63152595|FG001|Overall Study|Lack of Efficacy|2|||
33683057|NCT00242567|63152594|FG000|Overall Study|Lost to Follow-up|9|||
33683058|NCT00242567|63152595|FG001|Overall Study|Lost to Follow-up|19|||
33683059|NCT00242567|63152594|FG000|Overall Study|Withdrawal by Subject|33|||
33683060|NCT00242567|63152595|FG001|Overall Study|Withdrawal by Subject|28|||
33683061|NCT00242567|63152594|FG000|Overall Study|Protocol Violation|12|||
33683062|NCT00242567|63152595|FG001|Overall Study|Protocol Violation|12|||
33683063|NCT00242567|63152594|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
33683064|NCT00242567|63152595|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
33683065|NCT00242567|63152594|FG000|Overall Study|Other|14|||
33683066|NCT00242567|63152595|FG001|Overall Study|Other|9|||
33683067|NCT00241631|63152605|FG000|Run in (2 Weeks)|Physician Decision|3|||
33683068|NCT00241631|63152606|FG001|Run in (2 Weeks)|Physician Decision|3|||
33683069|NCT00241631|63152605|FG000|Phase 1 (4 Weeks)|sore throat|1|||
33683070|NCT00241631|63152606|FG001|Phase 1 (4 Weeks)|sore throat|0|||
33683071|NCT00241631|63152605|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
33683072|NCT00241631|63152606|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
33683073|NCT00241631|63152605|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
33683074|NCT00241631|63152606|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
33683075|NCT00241631|63152605|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
33683076|NCT00241631|63152606|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
33683077|NCT00240071|63152621|FG000|Overall Study|Withdrawal by Subject|3|||
33683078|NCT03761277|63153618|FG000|Enrollment to Implant|Screen Failure|17|||
33683079|NCT03761277|63153618|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
33683080|NCT03761277|63153618|FG000|Enrollment to Implant|Physician Decision|2|||
33683081|NCT03761277|63153618|FG000|Enrollment to Implant|Site Closure|3|||
33683082|NCT03761277|63153618|FG000|Enrollment to Implant|Sponsor Request|2|||
33683083|NCT03761277|63153618|FG000|Post-Implant to 6 Months|Adverse Event|2|||
33683084|NCT03761277|63153618|FG000|Post-Implant to 6 Months|Death|1|||
33683085|NCT03761277|63153618|FG000|Post-Implant to 6 Months|Site Closure|2|||
33683086|NCT03761277|63153618|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
33683087|NCT03761277|63153618|FG000|6 Months to 12 Months|Physician Decision|2|||
33683088|NCT03761277|63153618|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
33683089|NCT04099641|63153669|FG000|Overall Study|Death|46|||
33683090|NCT04099641|63153670|FG001|Overall Study|Death|12|||
33683091|NCT04099641|63153669|FG000|Overall Study|Lost to Follow-up|1|||
33683092|NCT04099641|63153670|FG001|Overall Study|Lost to Follow-up|0|||
33683093|NCT04099641|63153669|FG000|Overall Study|Withdrawal by Subject|2|||
33683094|NCT04099641|63153670|FG001|Overall Study|Withdrawal by Subject|0|||
33683095|NCT03123393|63153796|FG000|Overall Study|Study Terminated by Sponsor|6|||
33683096|NCT03123393|63153797|FG001|Overall Study|Study Terminated by Sponsor|9|||
33683097|NCT03123393|63153796|FG000|Overall Study|Withdrawal by Subject|2|||
33683098|NCT03123393|63153797|FG001|Overall Study|Withdrawal by Subject|1|||
33683099|NCT03123393|63153796|FG000|Overall Study|Reason not Specified|13|||
33683100|NCT03123393|63153797|FG001|Overall Study|Reason not Specified|13|||
33683101|NCT02834247|63154419|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
33683102|NCT02834247|63154420|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
33683103|NCT02834247|63154421|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
33683104|NCT02834247|63154422|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
33683105|NCT02834247|63154419|FG000|Dose Escalation Phase|Death|5|||
33683106|NCT02834247|63154420|FG001|Dose Escalation Phase|Death|6|||
33683107|NCT02834247|63154421|FG002|Dose Escalation Phase|Death|5|||
33683108|NCT02834247|63154422|FG003|Dose Escalation Phase|Death|0|||
33683109|NCT02834247|63154419|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
33683110|NCT02834247|63154420|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
33683111|NCT02834247|63154421|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
33683112|NCT02834247|63154422|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
33683113|NCT02834247|63154419|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
33683114|NCT02834247|63154420|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
33683115|NCT02834247|63154421|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
33683116|NCT02834247|63154422|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
33683117|NCT02834247|63154419|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
33683118|NCT02834247|63154420|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
33683119|NCT02834247|63154421|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
33683120|NCT02834247|63154422|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
33683121|NCT02834247|63154419|FG000|Dose Expansion Phase|Death|0|||
33683122|NCT02834247|63154420|FG001|Dose Expansion Phase|Death|0|||
33683123|NCT02834247|63154421|FG002|Dose Expansion Phase|Death|0|||
33683124|NCT02834247|63154422|FG003|Dose Expansion Phase|Death|8|||
33683125|NCT02834247|63154419|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
33683126|NCT02834247|63154420|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
33683127|NCT02834247|63154421|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
33683128|NCT02834247|63154422|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
33683129|NCT02834247|63154419|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
33683130|NCT02834247|63154420|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
33683131|NCT02834247|63154421|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
33683132|NCT02834247|63154422|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
33683133|NCT01839331|63155706|FG000|Overall Study|Early Termination|3|||
33683134|NCT01839331|63155707|FG001|Overall Study|Early Termination|0|||
33683135|NCT01839331|63155708|FG002|Overall Study|Early Termination|1|||
33683136|NCT01839331|63155709|FG003|Overall Study|Early Termination|2|||
33683137|NCT01839331|63155706|FG000|Overall Study|Protocol Violation|1|||
33683138|NCT01839331|63155707|FG001|Overall Study|Protocol Violation|6|||
33683139|NCT01839331|63155708|FG002|Overall Study|Protocol Violation|4|||
33683140|NCT01839331|63155709|FG003|Overall Study|Protocol Violation|3|||
33683141|NCT02733042|63155855|FG000|Treatment Period|Adverse Event|1|||
33683142|NCT02733042|63155856|FG001|Treatment Period|Adverse Event|0|||
33683143|NCT02733042|63155857|FG002|Treatment Period|Adverse Event|1|||
33683144|NCT02733042|63155858|FG003|Treatment Period|Adverse Event|1|||
33683145|NCT02733042|63155859|FG004|Treatment Period|Adverse Event|0|||
33683146|NCT02733042|63155860|FG005|Treatment Period|Adverse Event|0|||
33683147|NCT02733042|63155861|FG006|Treatment Period|Adverse Event|0|||
33683148|NCT02733042|63155862|FG007|Treatment Period|Adverse Event|0|||
33683149|NCT02733042|63155863|FG008|Treatment Period|Adverse Event|0|||
33683150|NCT02733042|63155864|FG009|Treatment Period|Adverse Event|0|||
33683151|NCT02733042|63155865|FG010|Treatment Period|Adverse Event|2|||
33683152|NCT02733042|63155866|FG011|Treatment Period|Adverse Event|2|||
33683153|NCT02733042|63155867|FG012|Treatment Period|Adverse Event|0|||
33683154|NCT02733042|63155868|FG013|Treatment Period|Adverse Event|2|||
33683155|NCT02733042|63155869|FG014|Treatment Period|Adverse Event|0|||
33683156|NCT02733042|63155870|FG015|Treatment Period|Adverse Event|0|||
33683157|NCT02733042|63155871|FG016|Treatment Period|Adverse Event|0|||
33683158|NCT02733042|63155872|FG017|Treatment Period|Adverse Event|1|||
33683159|NCT02733042|63155873|FG018|Treatment Period|Adverse Event|0|||
33683160|NCT02733042|63155855|FG000|Treatment Period|Progressive Disease|2|||
33683161|NCT02733042|63155856|FG001|Treatment Period|Progressive Disease|1|||
33683162|NCT02733042|63155857|FG002|Treatment Period|Progressive Disease|3|||
33683163|NCT02733042|63155858|FG003|Treatment Period|Progressive Disease|1|||
33683164|NCT02733042|63155859|FG004|Treatment Period|Progressive Disease|1|||
33683165|NCT02733042|63155860|FG005|Treatment Period|Progressive Disease|3|||
33683166|NCT02733042|63155861|FG006|Treatment Period|Progressive Disease|0|||
33683167|NCT02733042|63155862|FG007|Treatment Period|Progressive Disease|3|||
33683168|NCT02733042|63155863|FG008|Treatment Period|Progressive Disease|3|||
33683169|NCT02733042|63155864|FG009|Treatment Period|Progressive Disease|0|||
33683170|NCT02733042|63155865|FG010|Treatment Period|Progressive Disease|2|||
33683171|NCT02733042|63155866|FG011|Treatment Period|Progressive Disease|2|||
33683172|NCT02733042|63155867|FG012|Treatment Period|Progressive Disease|8|||
33683173|NCT02733042|63155868|FG013|Treatment Period|Progressive Disease|1|||
33683174|NCT02733042|63155869|FG014|Treatment Period|Progressive Disease|4|||
33683175|NCT02733042|63155870|FG015|Treatment Period|Progressive Disease|7|||
33683176|NCT02733042|63155871|FG016|Treatment Period|Progressive Disease|2|||
33683177|NCT02733042|63155872|FG017|Treatment Period|Progressive Disease|3|||
33683178|NCT02733042|63155873|FG018|Treatment Period|Progressive Disease|4|||
33683179|NCT02733042|63155855|FG000|Treatment Period|Withdrawal by Subject|0|||
33683180|NCT02733042|63155856|FG001|Treatment Period|Withdrawal by Subject|1|||
33683181|NCT02733042|63155857|FG002|Treatment Period|Withdrawal by Subject|2|||
33683182|NCT02733042|63155858|FG003|Treatment Period|Withdrawal by Subject|1|||
33683183|NCT02733042|63155859|FG004|Treatment Period|Withdrawal by Subject|0|||
33683184|NCT02733042|63155860|FG005|Treatment Period|Withdrawal by Subject|0|||
33683185|NCT02733042|63155861|FG006|Treatment Period|Withdrawal by Subject|0|||
33683186|NCT02733042|63155862|FG007|Treatment Period|Withdrawal by Subject|0|||
33683187|NCT02733042|63155863|FG008|Treatment Period|Withdrawal by Subject|1|||
33683188|NCT02733042|63155864|FG009|Treatment Period|Withdrawal by Subject|1|||
33683189|NCT02733042|63155865|FG010|Treatment Period|Withdrawal by Subject|0|||
33683190|NCT02733042|63155866|FG011|Treatment Period|Withdrawal by Subject|2|||
33683191|NCT02733042|63155867|FG012|Treatment Period|Withdrawal by Subject|1|||
33683192|NCT02733042|63155868|FG013|Treatment Period|Withdrawal by Subject|1|||
33683193|NCT02733042|63155869|FG014|Treatment Period|Withdrawal by Subject|0|||
33683194|NCT02733042|63155870|FG015|Treatment Period|Withdrawal by Subject|0|||
33683195|NCT02733042|63155871|FG016|Treatment Period|Withdrawal by Subject|0|||
33683196|NCT02733042|63155872|FG017|Treatment Period|Withdrawal by Subject|0|||
33683197|NCT02733042|63155873|FG018|Treatment Period|Withdrawal by Subject|0|||
33683198|NCT02733042|63155855|FG000|Treatment Period|Other|0|||
33683199|NCT02733042|63155856|FG001|Treatment Period|Other|0|||
33683200|NCT02733042|63155857|FG002|Treatment Period|Other|1|||
33683201|NCT02733042|63155858|FG003|Treatment Period|Other|0|||
33683202|NCT02733042|63155859|FG004|Treatment Period|Other|0|||
33683203|NCT02733042|63155860|FG005|Treatment Period|Other|0|||
33683204|NCT02733042|63155861|FG006|Treatment Period|Other|0|||
33683205|NCT02733042|63155862|FG007|Treatment Period|Other|0|||
33683206|NCT02733042|63155863|FG008|Treatment Period|Other|0|||
33683207|NCT02733042|63155864|FG009|Treatment Period|Other|1|||
33683208|NCT02733042|63155865|FG010|Treatment Period|Other|1|||
33683209|NCT02733042|63155866|FG011|Treatment Period|Other|0|||
33683210|NCT02733042|63155867|FG012|Treatment Period|Other|0|||
33683211|NCT02733042|63155868|FG013|Treatment Period|Other|0|||
33683212|NCT02733042|63155869|FG014|Treatment Period|Other|0|||
33683213|NCT02733042|63155870|FG015|Treatment Period|Other|1|||
33683214|NCT02733042|63155871|FG016|Treatment Period|Other|0|||
33683215|NCT02733042|63155872|FG017|Treatment Period|Other|1|||
33683216|NCT02733042|63155873|FG018|Treatment Period|Other|0|||
33683217|NCT02733042|63155855|FG000|Treatment Period|Ongoing on Assigned Treatment|0|||
33683218|NCT02733042|63155856|FG001|Treatment Period|Ongoing on Assigned Treatment|0|||
33683219|NCT02733042|63155857|FG002|Treatment Period|Ongoing on Assigned Treatment|0|||
33683220|NCT02733042|63155858|FG003|Treatment Period|Ongoing on Assigned Treatment|0|||
33683221|NCT02733042|63155859|FG004|Treatment Period|Ongoing on Assigned Treatment|3|||
33683222|NCT02733042|63155860|FG005|Treatment Period|Ongoing on Assigned Treatment|0|||
33683223|NCT02733042|63155861|FG006|Treatment Period|Ongoing on Assigned Treatment|0|||
33683224|NCT02733042|63155862|FG007|Treatment Period|Ongoing on Assigned Treatment|0|||
33683225|NCT02733042|63155863|FG008|Treatment Period|Ongoing on Assigned Treatment|0|||
33683226|NCT02733042|63155864|FG009|Treatment Period|Ongoing on Assigned Treatment|8|||
33683227|NCT02733042|63155865|FG010|Treatment Period|Ongoing on Assigned Treatment|4|||
33683228|NCT02733042|63155866|FG011|Treatment Period|Ongoing on Assigned Treatment|0|||
33683229|NCT02733042|63155867|FG012|Treatment Period|Ongoing on Assigned Treatment|0|||
33683230|NCT02733042|63155868|FG013|Treatment Period|Ongoing on Assigned Treatment|0|||
33683231|NCT02733042|63155869|FG014|Treatment Period|Ongoing on Assigned Treatment|0|||
33683232|NCT02733042|63155870|FG015|Treatment Period|Ongoing on Assigned Treatment|0|||
33683233|NCT02733042|63155871|FG016|Treatment Period|Ongoing on Assigned Treatment|0|||
33683234|NCT02733042|63155872|FG017|Treatment Period|Ongoing on Assigned Treatment|0|||
33683235|NCT02733042|63155873|FG018|Treatment Period|Ongoing on Assigned Treatment|1|||
33683236|NCT02733042|63155855|FG000|Treatment Period|Death|0|||
33683237|NCT02733042|63155856|FG001|Treatment Period|Death|0|||
33683238|NCT02733042|63155857|FG002|Treatment Period|Death|0|||
33683239|NCT02733042|63155858|FG003|Treatment Period|Death|0|||
33683240|NCT02733042|63155859|FG004|Treatment Period|Death|0|||
33683241|NCT02733042|63155860|FG005|Treatment Period|Death|0|||
33683242|NCT02733042|63155861|FG006|Treatment Period|Death|1|||
33683243|NCT02733042|63155862|FG007|Treatment Period|Death|0|||
33683244|NCT02733042|63155863|FG008|Treatment Period|Death|1|||
33683245|NCT02733042|63155864|FG009|Treatment Period|Death|0|||
33683246|NCT02733042|63155865|FG010|Treatment Period|Death|1|||
33683247|NCT02733042|63155866|FG011|Treatment Period|Death|0|||
33683248|NCT02733042|63155867|FG012|Treatment Period|Death|0|||
33683249|NCT02733042|63155868|FG013|Treatment Period|Death|0|||
33683250|NCT02733042|63155869|FG014|Treatment Period|Death|1|||
33683251|NCT02733042|63155870|FG015|Treatment Period|Death|2|||
33683252|NCT02733042|63155871|FG016|Treatment Period|Death|0|||
33683253|NCT02733042|63155872|FG017|Treatment Period|Death|0|||
33683254|NCT02733042|63155873|FG018|Treatment Period|Death|0|||
33683255|NCT02733042|63155855|FG000|Follow-up Period|Ongoing on Follow-up|2|||
33683256|NCT02733042|63155856|FG001|Follow-up Period|Ongoing on Follow-up|2|||
33683257|NCT02733042|63155857|FG002|Follow-up Period|Ongoing on Follow-up|4|||
33683258|NCT02733042|63155858|FG003|Follow-up Period|Ongoing on Follow-up|2|||
33683259|NCT02733042|63155859|FG004|Follow-up Period|Ongoing on Follow-up|0|||
33683260|NCT02733042|63155860|FG005|Follow-up Period|Ongoing on Follow-up|0|||
33683261|NCT02733042|63155861|FG006|Follow-up Period|Ongoing on Follow-up|0|||
33683262|NCT02733042|63155862|FG007|Follow-up Period|Ongoing on Follow-up|1|||
33683263|NCT02733042|63155863|FG008|Follow-up Period|Ongoing on Follow-up|0|||
33683264|NCT02733042|63155864|FG009|Follow-up Period|Ongoing on Follow-up|2|||
33683265|NCT02733042|63155865|FG010|Follow-up Period|Ongoing on Follow-up|4|||
33683266|NCT02733042|63155866|FG011|Follow-up Period|Ongoing on Follow-up|9|||
33683267|NCT02733042|63155867|FG012|Follow-up Period|Ongoing on Follow-up|1|||
33683268|NCT02733042|63155868|FG013|Follow-up Period|Ongoing on Follow-up|3|||
33683269|NCT02733042|63155869|FG014|Follow-up Period|Ongoing on Follow-up|0|||
33683270|NCT02733042|63155870|FG015|Follow-up Period|Ongoing on Follow-up|0|||
33683271|NCT02733042|63155871|FG016|Follow-up Period|Ongoing on Follow-up|0|||
33683272|NCT02733042|63155872|FG017|Follow-up Period|Ongoing on Follow-up|1|||
33683273|NCT02733042|63155873|FG018|Follow-up Period|Ongoing on Follow-up|0|||
33683274|NCT02733042|63155855|FG000|Follow-up Period|Death|1|||
33683275|NCT02733042|63155856|FG001|Follow-up Period|Death|1|||
33683276|NCT02733042|63155857|FG002|Follow-up Period|Death|2|||
33683277|NCT02733042|63155858|FG003|Follow-up Period|Death|0|||
33683278|NCT02733042|63155859|FG004|Follow-up Period|Death|1|||
33683279|NCT02733042|63155860|FG005|Follow-up Period|Death|2|||
33683280|NCT02733042|63155861|FG006|Follow-up Period|Death|0|||
33683281|NCT02733042|63155862|FG007|Follow-up Period|Death|3|||
33683282|NCT02733042|63155863|FG008|Follow-up Period|Death|3|||
33683283|NCT02733042|63155864|FG009|Follow-up Period|Death|0|||
33683284|NCT02733042|63155865|FG010|Follow-up Period|Death|0|||
33683285|NCT02733042|63155866|FG011|Follow-up Period|Death|0|||
33683286|NCT02733042|63155867|FG012|Follow-up Period|Death|8|||
33683287|NCT02733042|63155868|FG013|Follow-up Period|Death|1|||
33683288|NCT02733042|63155869|FG014|Follow-up Period|Death|1|||
33683289|NCT02733042|63155870|FG015|Follow-up Period|Death|4|||
33683290|NCT02733042|63155871|FG016|Follow-up Period|Death|0|||
33683291|NCT02733042|63155872|FG017|Follow-up Period|Death|1|||
33683292|NCT02733042|63155873|FG018|Follow-up Period|Death|2|||
33683293|NCT02733042|63155855|FG000|Follow-up Period|Other|0|||
33683294|NCT02733042|63155856|FG001|Follow-up Period|Other|0|||
33683295|NCT02733042|63155857|FG002|Follow-up Period|Other|0|||
33683296|NCT02733042|63155858|FG003|Follow-up Period|Other|1|||
33683297|NCT02733042|63155859|FG004|Follow-up Period|Other|0|||
33683298|NCT02733042|63155860|FG005|Follow-up Period|Other|0|||
33683299|NCT02733042|63155861|FG006|Follow-up Period|Other|0|||
33683300|NCT02733042|63155862|FG007|Follow-up Period|Other|0|||
33683301|NCT02733042|63155863|FG008|Follow-up Period|Other|0|||
33683302|NCT02733042|63155864|FG009|Follow-up Period|Other|0|||
33683303|NCT02733042|63155865|FG010|Follow-up Period|Other|0|||
33683304|NCT02733042|63155866|FG011|Follow-up Period|Other|0|||
33683305|NCT02733042|63155867|FG012|Follow-up Period|Other|0|||
33683306|NCT02733042|63155868|FG013|Follow-up Period|Other|0|||
33683307|NCT02733042|63155869|FG014|Follow-up Period|Other|0|||
33683308|NCT02733042|63155870|FG015|Follow-up Period|Other|0|||
33683309|NCT02733042|63155871|FG016|Follow-up Period|Other|0|||
33683310|NCT02733042|63155872|FG017|Follow-up Period|Other|0|||
33683311|NCT02733042|63155873|FG018|Follow-up Period|Other|0|||
33683312|NCT02733042|63155855|FG000|Follow-up Period|Withdrawal by Subject|0|||
33683313|NCT02733042|63155856|FG001|Follow-up Period|Withdrawal by Subject|0|||
33683314|NCT02733042|63155857|FG002|Follow-up Period|Withdrawal by Subject|0|||
33683315|NCT02733042|63155858|FG003|Follow-up Period|Withdrawal by Subject|0|||
33683316|NCT02733042|63155859|FG004|Follow-up Period|Withdrawal by Subject|0|||
33683317|NCT02733042|63155860|FG005|Follow-up Period|Withdrawal by Subject|0|||
33683318|NCT02733042|63155861|FG006|Follow-up Period|Withdrawal by Subject|0|||
33683319|NCT02733042|63155862|FG007|Follow-up Period|Withdrawal by Subject|0|||
33683320|NCT02733042|63155863|FG008|Follow-up Period|Withdrawal by Subject|1|||
33683321|NCT02733042|63155864|FG009|Follow-up Period|Withdrawal by Subject|0|||
33683322|NCT02733042|63155865|FG010|Follow-up Period|Withdrawal by Subject|1|||
33683323|NCT02733042|63155866|FG011|Follow-up Period|Withdrawal by Subject|0|||
33683324|NCT02733042|63155867|FG012|Follow-up Period|Withdrawal by Subject|0|||
33683325|NCT02733042|63155868|FG013|Follow-up Period|Withdrawal by Subject|0|||
33683326|NCT02733042|63155869|FG014|Follow-up Period|Withdrawal by Subject|0|||
33683327|NCT02733042|63155870|FG015|Follow-up Period|Withdrawal by Subject|1|||
33683328|NCT02733042|63155871|FG016|Follow-up Period|Withdrawal by Subject|0|||
33683329|NCT02733042|63155872|FG017|Follow-up Period|Withdrawal by Subject|0|||
33683330|NCT02733042|63155873|FG018|Follow-up Period|Withdrawal by Subject|0|||
33683331|NCT02859064|63156099|FG000|Overall Study|Progressive Disease|3|||
33683332|NCT02859064|63156099|FG000|Overall Study|Physician Decision|1|||
33683333|NCT02859064|63156099|FG000|Overall Study|Withdrawal by Subject|1|||
33683334|NCT02859064|63156099|FG000|Overall Study|Death|1|||
33683335|NCT01606176|63156138|FG000|Overall Study|Adverse Event|2|||
33683336|NCT01606176|63156139|FG001|Overall Study|Adverse Event|3|||
33683337|NCT01606176|63156138|FG000|Overall Study|Disease progression|1|||
33683338|NCT01606176|63156139|FG001|Overall Study|Disease progression|0|||
33683339|NCT01606176|63156138|FG000|Overall Study|Withdrawal by Subject|1|||
33683340|NCT01606176|63156139|FG001|Overall Study|Withdrawal by Subject|0|||
33683341|NCT01663896|63156205|FG000|Overall Study|Various reasons|43|||
33683342|NCT02576652|63156258|FG000|Overall Study|Withdrawal by Subject|2|||
33683343|NCT02575950|63156342|FG000|Overall Study|Withdrawal by Subject|0|||
33683344|NCT02575950|63156343|FG001|Overall Study|Withdrawal by Subject|0|||
33683345|NCT02575950|63156344|FG002|Overall Study|Withdrawal by Subject|0|||
33683346|NCT02575950|63156345|FG003|Overall Study|Withdrawal by Subject|2|||
33683347|NCT02575950|63156342|FG000|Overall Study|Lost to Follow-up|0|||
33683348|NCT02575950|63156343|FG001|Overall Study|Lost to Follow-up|1|||
33683349|NCT02575950|63156344|FG002|Overall Study|Lost to Follow-up|0|||
33683350|NCT02575950|63156345|FG003|Overall Study|Lost to Follow-up|3|||
33683351|NCT01049581|63156444|FG000|Overall Study|Lost to Follow-up|2|||
33683352|NCT01049581|63156445|FG001|Overall Study|Lost to Follow-up|1|||
33683353|NCT02571972|63156463|FG000|Overall Study|Protocol Violation|2|||
33683354|NCT02571972|63156463|FG000|Overall Study|Withdrawal by Subject|2|||
33683355|NCT02166905|63156561|FG000|Overall Study|Withdrawal by Subject|1|||
33683356|NCT02166905|63156562|FG001|Overall Study|Withdrawal by Subject|0|||
33683357|NCT02166905|63156563|FG002|Overall Study|Withdrawal by Subject|0|||
33683358|NCT02166905|63156564|FG003|Overall Study|Withdrawal by Subject|0|||
33683359|NCT01501955|63156611|FG000|Overall Study|Withdrawal by Subject|1|||
33683360|NCT01501955|63156612|FG001|Overall Study|Withdrawal by Subject|0|||
33683361|NCT01501955|63156611|FG000|Overall Study|Adverse Event|1|||
33683362|NCT01501955|63156612|FG001|Overall Study|Adverse Event|3|||
33683363|NCT02574312|63156740|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
33683364|NCT02574312|63156741|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
33683365|NCT01049035|63156763|FG000|Overall Study|Serious adverse event|0|||
33683366|NCT01049035|63156764|FG001|Overall Study|Serious adverse event|1|||
33683367|NCT01049035|63156765|FG002|Overall Study|Serious adverse event|1|||
33683368|NCT01049035|63156766|FG003|Overall Study|Serious adverse event|2|||
33683369|NCT01049035|63156767|FG004|Overall Study|Serious adverse event|0|||
33683370|NCT01049035|63156768|FG005|Overall Study|Serious adverse event|0|||
33683371|NCT01049035|63156769|FG006|Overall Study|Serious adverse event|0|||
33683372|NCT01049035|63156763|FG000|Overall Study|Other adverse event (AE)|0|||
33683373|NCT01049035|63156764|FG001|Overall Study|Other adverse event (AE)|0|||
33683374|NCT01049035|63156765|FG002|Overall Study|Other adverse event (AE)|0|||
33683375|NCT01049035|63156766|FG003|Overall Study|Other adverse event (AE)|1|||
33683376|NCT01049035|63156767|FG004|Overall Study|Other adverse event (AE)|0|||
33683377|NCT01049035|63156768|FG005|Overall Study|Other adverse event (AE)|0|||
33683378|NCT01049035|63156769|FG006|Overall Study|Other adverse event (AE)|0|||
33683379|NCT01049035|63156763|FG000|Overall Study|Non-compliance with the protocol|12|||
33683380|NCT01049035|63156764|FG001|Overall Study|Non-compliance with the protocol|6|||
33683381|NCT01049035|63156765|FG002|Overall Study|Non-compliance with the protocol|14|||
33683382|NCT01049035|63156766|FG003|Overall Study|Non-compliance with the protocol|5|||
33683383|NCT01049035|63156767|FG004|Overall Study|Non-compliance with the protocol|3|||
33683384|NCT01049035|63156768|FG005|Overall Study|Non-compliance with the protocol|4|||
33683385|NCT01049035|63156769|FG006|Overall Study|Non-compliance with the protocol|10|||
33683386|NCT01049035|63156763|FG000|Overall Study|Lost to Follow-up|5|||
33683387|NCT01049035|63156764|FG001|Overall Study|Lost to Follow-up|4|||
33683388|NCT01049035|63156765|FG002|Overall Study|Lost to Follow-up|4|||
33683389|NCT01049035|63156766|FG003|Overall Study|Lost to Follow-up|1|||
33683390|NCT01049035|63156767|FG004|Overall Study|Lost to Follow-up|0|||
33493120|NCT03781375|62871229|FG001|Double-blind Phase|Adverse Event|1|||
33683391|NCT01049035|63156768|FG005|Overall Study|Lost to Follow-up|3|||
33683392|NCT01049035|63156769|FG006|Overall Study|Lost to Follow-up|3|||
33683393|NCT01049035|63156763|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
33493121|NCT03781375|62871228|FG000|Double-blind Phase|Lack of Response|6|||
33683394|NCT01049035|63156764|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
33683395|NCT01049035|63156765|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
33683396|NCT01049035|63156766|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
33683397|NCT01049035|63156767|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
33683398|NCT01049035|63156768|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
33683399|NCT01049035|63156769|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
33683400|NCT01048333|63156795|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
33683401|NCT01048333|63156796|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
33683402|NCT01048333|63156797|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
33683403|NCT01048333|63156798|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
33683404|NCT01048333|63156799|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
33683405|NCT01048333|63156800|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
33683406|NCT02323113|63156815|FG000|Overall Study|Adverse Event|3|||
33683407|NCT02323113|63156816|FG001|Overall Study|Adverse Event|3|||
33683408|NCT02323113|63156817|FG002|Overall Study|Adverse Event|2|||
33683409|NCT02323113|63156818|FG003|Overall Study|Adverse Event|5|||
33683410|NCT02323113|63156819|FG004|Overall Study|Adverse Event|8|||
33683411|NCT02323113|63156820|FG005|Overall Study|Adverse Event|3|||
33683412|NCT02323113|63156821|FG006|Overall Study|Adverse Event|6|||
33683413|NCT02323113|63156822|FG007|Overall Study|Adverse Event|0|||
33683414|NCT02323113|63156815|FG000|Overall Study|Progressive Disease|0|||
33683415|NCT02323113|63156816|FG001|Overall Study|Progressive Disease|1|||
33683416|NCT02323113|63156817|FG002|Overall Study|Progressive Disease|1|||
33683417|NCT02323113|63156818|FG003|Overall Study|Progressive Disease|0|||
33683418|NCT02323113|63156819|FG004|Overall Study|Progressive Disease|0|||
33683419|NCT02323113|63156820|FG005|Overall Study|Progressive Disease|3|||
33683420|NCT02323113|63156821|FG006|Overall Study|Progressive Disease|0|||
33683421|NCT02323113|63156822|FG007|Overall Study|Progressive Disease|0|||
33683422|NCT02323113|63156815|FG000|Overall Study|Symptomatic Deterioration|0|||
33683423|NCT02323113|63156816|FG001|Overall Study|Symptomatic Deterioration|0|||
33683424|NCT02323113|63156817|FG002|Overall Study|Symptomatic Deterioration|1|||
33683425|NCT02323113|63156818|FG003|Overall Study|Symptomatic Deterioration|0|||
33683426|NCT02323113|63156819|FG004|Overall Study|Symptomatic Deterioration|1|||
33683427|NCT02323113|63156820|FG005|Overall Study|Symptomatic Deterioration|0|||
33683428|NCT02323113|63156821|FG006|Overall Study|Symptomatic Deterioration|0|||
33683429|NCT02323113|63156822|FG007|Overall Study|Symptomatic Deterioration|0|||
33683430|NCT02323113|63156815|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
33683431|NCT02323113|63156816|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
33683432|NCT02323113|63156817|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
33683433|NCT02323113|63156818|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
33683434|NCT02323113|63156819|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
33683435|NCT02323113|63156820|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
33683436|NCT02323113|63156821|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
33683437|NCT02323113|63156822|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
33683438|NCT02323113|63156815|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
33683439|NCT02323113|63156816|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
33683440|NCT02323113|63156817|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
33683441|NCT02323113|63156818|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
33683442|NCT02323113|63156819|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
33683443|NCT02323113|63156820|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
33683444|NCT02323113|63156821|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
33683445|NCT02323113|63156822|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
33683446|NCT02281383|63156869|FG000|Overall Study|Progressive Disease|1|||
33683447|NCT02281383|63156869|FG000|Overall Study|Withdrawal by Subject|6|||
33683448|NCT02281383|63156869|FG000|Overall Study|Protocol Violation|2|||
33683449|NCT02281383|63156869|FG000|Overall Study|Death|1|||
33683450|NCT02281383|63156869|FG000|Overall Study|Adverse Event|2|||
33683451|NCT01047553|63156875|FG000|Overall Study|Adverse Event|10|||
33683452|NCT01047553|63156876|FG001|Overall Study|Adverse Event|5|||
33683453|NCT01047553|63156875|FG000|Overall Study|Withdrawal by Subject|4|||
33683454|NCT01047553|63156876|FG001|Overall Study|Withdrawal by Subject|2|||
33683455|NCT01047553|63156875|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
33683456|NCT01047553|63156876|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
33683457|NCT01047553|63156875|FG000|Overall Study|Lost to Follow-up|1|||
33683458|NCT01047553|63156876|FG001|Overall Study|Lost to Follow-up|0|||
33683459|NCT01047553|63156875|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
33683460|NCT01047553|63156876|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
33683461|NCT01047553|63156875|FG000|Overall Study|PI's decision|0|||
33683462|NCT01047553|63156876|FG001|Overall Study|PI's decision|1|||
33683463|NCT01046695|63156908|FG000|Overall Study|Subject had a pacemaker|0|||
33683464|NCT01046695|63156909|FG001|Overall Study|Subject had a pacemaker|1|||
33683465|NCT01046695|63156908|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
33683466|NCT01046695|63156909|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
33683467|NCT03304379|63156924|FG000|Overall Study|Protocol Violation|8|||
33683468|NCT03304379|63156925|FG001|Overall Study|Protocol Violation|10|||
33683469|NCT03304379|63156926|FG002|Overall Study|Protocol Violation|5|||
33683470|NCT03304379|63156927|FG003|Overall Study|Protocol Violation|0|||
33595088|NCT02523599|62994114|FG000|Overall Study|Adverse Event|1|||
33595089|NCT02523599|62994115|FG001|Overall Study|Adverse Event|0|||
33595090|NCT02523599|62994114|FG000|Overall Study|Physician Decision|1|||
33595091|NCT02523599|62994115|FG001|Overall Study|Physician Decision|0|||
33595092|NCT02523599|62994114|FG000|Overall Study|Lost to Follow-up|4|||
33595093|NCT02523599|62994115|FG001|Overall Study|Lost to Follow-up|1|||
33595094|NCT02523599|62994114|FG000|Overall Study|Did not return for Day 30 visit|2|||
33595095|NCT02523599|62994115|FG001|Overall Study|Did not return for Day 30 visit|0|||
33595096|NCT02187159|62994125|FG000|Overall Study|Protocol Violation|4|||
33595097|NCT02187159|62994126|FG001|Overall Study|Protocol Violation|6|||
33595098|NCT02187159|62994127|FG002|Overall Study|Protocol Violation|3|||
33595099|NCT02187159|62994128|FG003|Overall Study|Protocol Violation|4|||
33595100|NCT02187159|62994125|FG000|Overall Study|Lack of Efficacy|10|||
33595101|NCT02187159|62994126|FG001|Overall Study|Lack of Efficacy|5|||
33595102|NCT02187159|62994127|FG002|Overall Study|Lack of Efficacy|4|||
33595103|NCT02187159|62994128|FG003|Overall Study|Lack of Efficacy|7|||
33683471|NCT03304379|63156928|FG004|Overall Study|Protocol Violation|2|||
33683472|NCT03304379|63156924|FG000|Overall Study|Adverse Event|4|||
33683473|NCT03304379|63156925|FG001|Overall Study|Adverse Event|20|||
33683474|NCT03304379|63156926|FG002|Overall Study|Adverse Event|17|||
33683475|NCT03304379|63156927|FG003|Overall Study|Adverse Event|1|||
33683476|NCT03304379|63156928|FG004|Overall Study|Adverse Event|0|||
33683477|NCT03304379|63156924|FG000|Overall Study|Lack of Efficacy|17|||
33683478|NCT03304379|63156925|FG001|Overall Study|Lack of Efficacy|16|||
33683479|NCT03304379|63156926|FG002|Overall Study|Lack of Efficacy|20|||
33683480|NCT03304379|63156927|FG003|Overall Study|Lack of Efficacy|0|||
33683481|NCT03304379|63156928|FG004|Overall Study|Lack of Efficacy|0|||
33683482|NCT03304379|63156924|FG000|Overall Study|Physician Decision|6|||
33683483|NCT03304379|63156925|FG001|Overall Study|Physician Decision|10|||
33683484|NCT03304379|63156926|FG002|Overall Study|Physician Decision|6|||
33683485|NCT03304379|63156927|FG003|Overall Study|Physician Decision|9|||
33683486|NCT03304379|63156928|FG004|Overall Study|Physician Decision|10|||
33683487|NCT03304379|63156924|FG000|Overall Study|Withdrawal by Subject|26|||
33683488|NCT03304379|63156925|FG001|Overall Study|Withdrawal by Subject|58|||
33683489|NCT03304379|63156926|FG002|Overall Study|Withdrawal by Subject|66|||
33683490|NCT03304379|63156927|FG003|Overall Study|Withdrawal by Subject|3|||
33683491|NCT03304379|63156928|FG004|Overall Study|Withdrawal by Subject|5|||
33683492|NCT03304379|63156924|FG000|Overall Study|Lost to Follow-up|8|||
33683493|NCT03304379|63156925|FG001|Overall Study|Lost to Follow-up|24|||
33683494|NCT03304379|63156926|FG002|Overall Study|Lost to Follow-up|35|||
33683495|NCT03304379|63156927|FG003|Overall Study|Lost to Follow-up|4|||
33683496|NCT03304379|63156928|FG004|Overall Study|Lost to Follow-up|0|||
33683497|NCT03304379|63156924|FG000|Overall Study|Death|1|||
33683498|NCT03304379|63156925|FG001|Overall Study|Death|2|||
33683499|NCT03304379|63156926|FG002|Overall Study|Death|0|||
33683500|NCT03304379|63156927|FG003|Overall Study|Death|0|||
33683501|NCT03304379|63156928|FG004|Overall Study|Death|0|||
33683502|NCT03304379|63156924|FG000|Overall Study|Other|0|||
33683503|NCT03304379|63156925|FG001|Overall Study|Other|1|||
33683504|NCT03304379|63156926|FG002|Overall Study|Other|0|||
33683505|NCT03304379|63156927|FG003|Overall Study|Other|0|||
33683506|NCT03304379|63156928|FG004|Overall Study|Other|0|||
33683507|NCT01044433|63157001|FG000|Overall Study|Lost to Follow-up|3|||
33683508|NCT01044433|63157001|FG000|Overall Study|Withdrawal by Subject|3|||
33683509|NCT01043185|63157010|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
33683510|NCT01043185|63157011|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
33683511|NCT01043185|63157012|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
33683512|NCT01043185|63157013|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
33683513|NCT01043185|63157014|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
33683514|NCT01043185|63157015|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
33683515|NCT01043185|63157016|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
33683516|NCT01043185|63157017|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
33683517|NCT01043185|63157018|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
33683518|NCT01043185|63157019|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
33683519|NCT01042093|63157044|FG000|Overall Study|Protocol Violation|2|||
33683520|NCT01042093|63157045|FG001|Overall Study|Protocol Violation|2|||
33683521|NCT01042093|63157046|FG002|Overall Study|Protocol Violation|2|||
33683522|NCT01042093|63157047|FG003|Overall Study|Protocol Violation|3|||
33683523|NCT01042093|63157044|FG000|Overall Study|Withdrawal by Subject|0|||
33683524|NCT01042093|63157045|FG001|Overall Study|Withdrawal by Subject|0|||
33683525|NCT01042093|63157046|FG002|Overall Study|Withdrawal by Subject|0|||
33683526|NCT01042093|63157047|FG003|Overall Study|Withdrawal by Subject|1|||
33683527|NCT01041859|63157077|FG000|Open-Label Titration|Adverse Event|69|||
33683528|NCT01041859|63157078|FG001|Open-Label Titration|Adverse Event|0|||
33683529|NCT01041859|63157079|FG002|Open-Label Titration|Adverse Event|0|||
33683530|NCT01041859|63157077|FG000|Open-Label Titration|Lack of Efficacy|3|||
33683531|NCT01041859|63157078|FG001|Open-Label Titration|Lack of Efficacy|0|||
33683532|NCT01041859|63157079|FG002|Open-Label Titration|Lack of Efficacy|0|||
33683533|NCT01041859|63157077|FG000|Open-Label Titration|Lost to Follow-up|1|||
33683534|NCT01041859|63157078|FG001|Open-Label Titration|Lost to Follow-up|0|||
33683535|NCT01041859|63157079|FG002|Open-Label Titration|Lost to Follow-up|0|||
33683536|NCT01041859|63157077|FG000|Open-Label Titration|Physician Decision|1|||
33683537|NCT01041859|63157078|FG001|Open-Label Titration|Physician Decision|0|||
33683538|NCT01041859|63157079|FG002|Open-Label Titration|Physician Decision|0|||
33683539|NCT01041859|63157077|FG000|Open-Label Titration|Protocol Violation|1|||
33683540|NCT01041859|63157078|FG001|Open-Label Titration|Protocol Violation|0|||
33683541|NCT01041859|63157079|FG002|Open-Label Titration|Protocol Violation|0|||
33683542|NCT01041859|63157077|FG000|Open-Label Titration|Other|7|||
33683543|NCT01041859|63157078|FG001|Open-Label Titration|Other|0|||
33683544|NCT01041859|63157079|FG002|Open-Label Titration|Other|0|||
33683545|NCT01041859|63157077|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
33683546|NCT01041859|63157078|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
33683547|NCT01041859|63157079|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
33683548|NCT01041859|63157077|FG000|Open-Label Titration|Withdrawal by Subject|11|||
33683549|NCT01041859|63157078|FG001|Open-Label Titration|Withdrawal by Subject|0|||
33683550|NCT01041859|63157079|FG002|Open-Label Titration|Withdrawal by Subject|0|||
33683551|NCT01041859|63157077|FG000|Double-Blind Maintenance|Adverse Event|0|||
33683552|NCT01041859|63157078|FG001|Double-Blind Maintenance|Adverse Event|23|||
33683553|NCT01041859|63157079|FG002|Double-Blind Maintenance|Adverse Event|13|||
33683554|NCT01041859|63157077|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
33683555|NCT01041859|63157078|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
33683556|NCT01041859|63157079|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
33683557|NCT01041859|63157077|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
33683558|NCT01041859|63157078|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
33683559|NCT01041859|63157079|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
33683560|NCT01041859|63157077|FG000|Double-Blind Maintenance|Physician Decision|0|||
33683561|NCT01041859|63157078|FG001|Double-Blind Maintenance|Physician Decision|2|||
33683562|NCT01041859|63157079|FG002|Double-Blind Maintenance|Physician Decision|1|||
33683563|NCT01041859|63157077|FG000|Double-Blind Maintenance|Protocol Violation|0|||
33683564|NCT01041859|63157078|FG001|Double-Blind Maintenance|Protocol Violation|1|||
33683565|NCT01041859|63157079|FG002|Double-Blind Maintenance|Protocol Violation|3|||
33683566|NCT01041859|63157077|FG000|Double-Blind Maintenance|Other|0|||
33683567|NCT01041859|63157078|FG001|Double-Blind Maintenance|Other|6|||
33683568|NCT01041859|63157079|FG002|Double-Blind Maintenance|Other|2|||
33683569|NCT01041859|63157077|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
33683570|NCT01041859|63157078|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
33683571|NCT01041859|63157079|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
33683572|NCT01041859|63157077|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
33683573|NCT01041859|63157078|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
33683574|NCT01041859|63157079|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
33683575|NCT01040845|63157088|FG000|Overall Study|Withdrawal by Subject|1|||
33683576|NCT01040845|63157089|FG001|Overall Study|Withdrawal by Subject|1|||
33683577|NCT01040845|63157088|FG000|Overall Study|Physician Decision|1|||
33683578|NCT01040845|63157089|FG001|Overall Study|Physician Decision|0|||
33683579|NCT01040689|63157097|FG000|Overall Study|Adverse Event|0|||
33683580|NCT01040689|63157098|FG001|Overall Study|Adverse Event|0|||
33683581|NCT01040689|63157099|FG002|Overall Study|Adverse Event|2|||
33683582|NCT01040689|63157100|FG003|Overall Study|Adverse Event|4|||
33683583|NCT01040689|63157097|FG000|Overall Study|Lack of Efficacy|0|||
33683584|NCT01040689|63157098|FG001|Overall Study|Lack of Efficacy|0|||
33683585|NCT01040689|63157099|FG002|Overall Study|Lack of Efficacy|1|||
33683586|NCT01040689|63157100|FG003|Overall Study|Lack of Efficacy|0|||
33683587|NCT01040689|63157097|FG000|Overall Study|Lost to Follow-up|1|||
33683588|NCT01040689|63157098|FG001|Overall Study|Lost to Follow-up|0|||
33683589|NCT01040689|63157099|FG002|Overall Study|Lost to Follow-up|0|||
33683590|NCT01040689|63157100|FG003|Overall Study|Lost to Follow-up|0|||
33683591|NCT01040689|63157097|FG000|Overall Study|Withdrawal by Subject|2|||
33401437|NCT00256867|62780476|FG002|Overall Study|Lost to Follow-up|2|||
33683592|NCT01040689|63157098|FG001|Overall Study|Withdrawal by Subject|1|||
33683593|NCT01040689|63157099|FG002|Overall Study|Withdrawal by Subject|1|||
33683594|NCT01040689|63157100|FG003|Overall Study|Withdrawal by Subject|0|||
33683595|NCT01040689|63157097|FG000|Overall Study|Other reasons not listed above|0|||
33683596|NCT01040689|63157098|FG001|Overall Study|Other reasons not listed above|1|||
33683597|NCT01040689|63157099|FG002|Overall Study|Other reasons not listed above|0|||
33683598|NCT01040689|63157100|FG003|Overall Study|Other reasons not listed above|0|||
33683599|NCT01047319|63157149|FG000|Overall Study|Teva requested participant withdrawal|3|||
33683600|NCT01047319|63157150|FG001|Overall Study|Teva requested participant withdrawal|0|||
33683601|NCT01047319|63157151|FG002|Overall Study|Teva requested participant withdrawal|1|||
33683602|NCT01047319|63157149|FG000|Overall Study|Protocol Violation|3|||
33683603|NCT01047319|63157150|FG001|Overall Study|Protocol Violation|2|||
33683604|NCT01047319|63157151|FG002|Overall Study|Protocol Violation|4|||
33683605|NCT01047319|63157149|FG000|Overall Study|Lack of Efficacy|4|||
33683606|NCT01047319|63157150|FG001|Overall Study|Lack of Efficacy|3|||
33683607|NCT01047319|63157151|FG002|Overall Study|Lack of Efficacy|3|||
33683608|NCT01047319|63157149|FG000|Overall Study|Death|5|||
33683609|NCT01047319|63157150|FG001|Overall Study|Death|1|||
33683610|NCT01047319|63157151|FG002|Overall Study|Death|5|||
33683611|NCT01047319|63157149|FG000|Overall Study|Pregnancy|13|||
33683612|NCT01047319|63157150|FG001|Overall Study|Pregnancy|8|||
33683613|NCT01047319|63157151|FG002|Overall Study|Pregnancy|8|||
33683614|NCT01047319|63157149|FG000|Overall Study|Physician Decision|12|||
33683615|NCT01047319|63157150|FG001|Overall Study|Physician Decision|9|||
33683616|NCT01047319|63157151|FG002|Overall Study|Physician Decision|10|||
33683617|NCT01047319|63157149|FG000|Overall Study|Lost to Follow-up|14|||
33683618|NCT01047319|63157150|FG001|Overall Study|Lost to Follow-up|10|||
33683619|NCT01047319|63157151|FG002|Overall Study|Lost to Follow-up|10|||
33683620|NCT01047319|63157149|FG000|Overall Study|Adverse Event|16|||
33683621|NCT01047319|63157150|FG001|Overall Study|Adverse Event|27|||
33683622|NCT01047319|63157151|FG002|Overall Study|Adverse Event|21|||
33683623|NCT01047319|63157149|FG000|Overall Study|Withdrawal by Subject|77|||
33683624|NCT01047319|63157150|FG001|Overall Study|Withdrawal by Subject|75|||
33683625|NCT01047319|63157151|FG002|Overall Study|Withdrawal by Subject|87|||
33683626|NCT01047319|63157149|FG000|Overall Study|Study terminated by Sponsor|198|||
33683627|NCT01047319|63157150|FG001|Overall Study|Study terminated by Sponsor|215|||
33683628|NCT01047319|63157151|FG002|Overall Study|Study terminated by Sponsor|203|||
33683629|NCT00014911|63157468|FG000|Overall Study|Adverse Event|1|||
33683630|NCT00014911|63157468|FG000|Overall Study|Lost to Follow-up|1|||
33683631|NCT00014911|63157468|FG000|Overall Study|Withdrawal by Subject|6|||
33683632|NCT00014911|63157468|FG000|Overall Study|Unknown Reasons|2|||
33683633|NCT00014911|63157468|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
33683634|NCT01049009|63158001|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
33683635|NCT01049009|63158002|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
33683636|NCT01049009|63158001|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33683637|NCT01049009|63158002|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
33683638|NCT01049009|63158001|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
33683639|NCT01049009|63158002|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
33683640|NCT01049009|63158001|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
33683641|NCT01049009|63158002|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
33683642|NCT01047683|63158024|FG000|Overall Study|Adverse Event|3|||
33683643|NCT01047683|63158025|FG001|Overall Study|Adverse Event|1|||
33683644|NCT01047683|63158026|FG002|Overall Study|Adverse Event|0|||
33683645|NCT01047683|63158024|FG000|Overall Study|Withdrew Consent|1|||
33683646|NCT01047683|63158025|FG001|Overall Study|Withdrew Consent|4|||
33683647|NCT01047683|63158026|FG002|Overall Study|Withdrew Consent|2|||
33310739|NCT01162239|62686133|FG002|Extended Follow-up|Lost to Follow-up|8|||
33683648|NCT01047683|63158024|FG000|Overall Study|Lost to Follow-up|0|||
33683649|NCT01047683|63158025|FG001|Overall Study|Lost to Follow-up|1|||
33683650|NCT01047683|63158026|FG002|Overall Study|Lost to Follow-up|0|||
33683651|NCT01047683|63158024|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
33310740|NCT01162239|62686134|FG003|Extended Follow-up|Lost to Follow-up|6|||
33683652|NCT01047683|63158025|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
33683653|NCT01047683|63158026|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
33683654|NCT01047293|63158114|FG000|Overall Study|DLT criteria not fulfilled|1|||
33683655|NCT01047293|63158115|FG001|Overall Study|DLT criteria not fulfilled|1|||
33683656|NCT01047293|63158116|FG002|Overall Study|DLT criteria not fulfilled|0|||
33683657|NCT01047293|63158117|FG003|Overall Study|DLT criteria not fulfilled|0|||
33683658|NCT01045967|63158126|FG000|Second Intervention|Protocol Violation|0|||
33683659|NCT01045967|63158127|FG001|Second Intervention|Protocol Violation|1|||
33683660|NCT01045421|63158713|FG000|Phase 1|Progressive Disease|0|||
33683661|NCT01045421|63158714|FG001|Phase 1|Progressive Disease|0|||
33683662|NCT01045421|63158715|FG002|Phase 1|Progressive Disease|0|||
33683663|NCT01045421|63158716|FG003|Phase 1|Progressive Disease|0|||
33683664|NCT01045421|63158717|FG004|Phase 1|Progressive Disease|1|||
33683665|NCT01045421|63158718|FG005|Phase 1|Progressive Disease|0|||
33683666|NCT01045421|63158719|FG006|Phase 1|Progressive Disease|0|||
33683667|NCT01045421|63158720|FG007|Phase 1|Progressive Disease|0|||
33683668|NCT01045421|63158721|FG008|Phase 1|Progressive Disease|0|||
33683669|NCT01045421|63158722|FG009|Phase 1|Progressive Disease|0|||
33683670|NCT01045421|63158723|FG010|Phase 1|Progressive Disease|0|||
33683671|NCT01045421|63158713|FG000|Phase 1|Withdrawal by Subject|0|||
33683672|NCT01045421|63158714|FG001|Phase 1|Withdrawal by Subject|0|||
33683673|NCT01045421|63158715|FG002|Phase 1|Withdrawal by Subject|0|||
33683674|NCT01045421|63158716|FG003|Phase 1|Withdrawal by Subject|1|||
33683675|NCT01045421|63158717|FG004|Phase 1|Withdrawal by Subject|0|||
33683676|NCT01045421|63158718|FG005|Phase 1|Withdrawal by Subject|0|||
33683677|NCT01045421|63158719|FG006|Phase 1|Withdrawal by Subject|0|||
33683678|NCT01045421|63158720|FG007|Phase 1|Withdrawal by Subject|0|||
33683679|NCT01045421|63158721|FG008|Phase 1|Withdrawal by Subject|0|||
33683680|NCT01045421|63158722|FG009|Phase 1|Withdrawal by Subject|0|||
33683681|NCT01045421|63158723|FG010|Phase 1|Withdrawal by Subject|0|||
33683682|NCT01045421|63158713|FG000|Phase 2|Progressive Disease|0|||
33683683|NCT01045421|63158714|FG001|Phase 2|Progressive Disease|0|||
33683684|NCT01045421|63158715|FG002|Phase 2|Progressive Disease|0|||
33683685|NCT01045421|63158716|FG003|Phase 2|Progressive Disease|0|||
33683686|NCT01045421|63158717|FG004|Phase 2|Progressive Disease|0|||
33683687|NCT01045421|63158718|FG005|Phase 2|Progressive Disease|0|||
33683688|NCT01045421|63158719|FG006|Phase 2|Progressive Disease|0|||
33683689|NCT01045421|63158720|FG007|Phase 2|Progressive Disease|1|||
33683690|NCT01045421|63158721|FG008|Phase 2|Progressive Disease|1|||
33683691|NCT01045421|63158722|FG009|Phase 2|Progressive Disease|1|||
33683692|NCT01045421|63158723|FG010|Phase 2|Progressive Disease|1|||
33683693|NCT01045421|63158713|FG000|Phase 2|Death|0|||
33683694|NCT01045421|63158714|FG001|Phase 2|Death|0|||
33683695|NCT01045421|63158715|FG002|Phase 2|Death|0|||
33683696|NCT01045421|63158716|FG003|Phase 2|Death|0|||
33683697|NCT01045421|63158717|FG004|Phase 2|Death|0|||
33683698|NCT01045421|63158718|FG005|Phase 2|Death|0|||
33683699|NCT01045421|63158719|FG006|Phase 2|Death|0|||
33683700|NCT01045421|63158720|FG007|Phase 2|Death|1|||
33683701|NCT01045421|63158721|FG008|Phase 2|Death|1|||
33683702|NCT01045421|63158722|FG009|Phase 2|Death|2|||
33683703|NCT01045421|63158723|FG010|Phase 2|Death|0|||
33683704|NCT01045421|63158713|FG000|Phase 2|Other|0|||
33683705|NCT01045421|63158714|FG001|Phase 2|Other|0|||
33683706|NCT01045421|63158715|FG002|Phase 2|Other|0|||
33683707|NCT01045421|63158716|FG003|Phase 2|Other|0|||
33683708|NCT01045421|63158717|FG004|Phase 2|Other|0|||
33683709|NCT01045421|63158718|FG005|Phase 2|Other|0|||
33683710|NCT01045421|63158719|FG006|Phase 2|Other|0|||
33683711|NCT01045421|63158720|FG007|Phase 2|Other|3|||
33683712|NCT01045421|63158721|FG008|Phase 2|Other|0|||
33683713|NCT01045421|63158722|FG009|Phase 2|Other|0|||
33683714|NCT01045421|63158723|FG010|Phase 2|Other|1|||
33683715|NCT01042535|63158771|FG000|Overall Study|disease progression prior to treatment|3|||
33683716|NCT01042535|63158771|FG000|Overall Study|disease progression during treatment|3|||
33683717|NCT01042535|63158771|FG000|Overall Study|complications from other disease|2|||
33683718|NCT01041287|63158777|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
33683719|NCT01041287|63158778|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
33683720|NCT01041287|63158777|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
33683721|NCT01041287|63158778|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
33683722|NCT01040351|63158799|FG000|Overall Study|poor ovarian response|1|||
33683723|NCT01040351|63158800|FG001|Overall Study|poor ovarian response|2|||
33683724|NCT02049957|63158820|FG000|Overall Study|Progressive Disease|5|||
33683725|NCT02049957|63158821|FG001|Overall Study|Progressive Disease|4|||
33683726|NCT02049957|63158822|FG002|Overall Study|Progressive Disease|2|||
33683727|NCT02049957|63158823|FG003|Overall Study|Progressive Disease|2|||
33683728|NCT02049957|63158824|FG004|Overall Study|Progressive Disease|6|||
33683729|NCT02049957|63158825|FG005|Overall Study|Progressive Disease|35|||
33683730|NCT02049957|63158826|FG006|Overall Study|Progressive Disease|7|||
33683731|NCT02049957|63158827|FG007|Overall Study|Progressive Disease|26|||
33683732|NCT02049957|63158828|FG008|Overall Study|Progressive Disease|6|||
33683733|NCT02049957|63158820|FG000|Overall Study|Adverse Event|1|||
33683734|NCT02049957|63158821|FG001|Overall Study|Adverse Event|1|||
33683735|NCT02049957|63158822|FG002|Overall Study|Adverse Event|1|||
33683736|NCT02049957|63158823|FG003|Overall Study|Adverse Event|0|||
33683737|NCT02049957|63158824|FG004|Overall Study|Adverse Event|0|||
33683738|NCT02049957|63158825|FG005|Overall Study|Adverse Event|5|||
33683739|NCT02049957|63158826|FG006|Overall Study|Adverse Event|0|||
33683740|NCT02049957|63158827|FG007|Overall Study|Adverse Event|6|||
33683741|NCT02049957|63158828|FG008|Overall Study|Adverse Event|1|||
33683742|NCT02049957|63158820|FG000|Overall Study|Study Terminated by Sponsor|0|||
33683743|NCT02049957|63158821|FG001|Overall Study|Study Terminated by Sponsor|1|||
33683744|NCT02049957|63158822|FG002|Overall Study|Study Terminated by Sponsor|0|||
33683745|NCT02049957|63158823|FG003|Overall Study|Study Terminated by Sponsor|0|||
33683746|NCT02049957|63158824|FG004|Overall Study|Study Terminated by Sponsor|0|||
33683747|NCT02049957|63158825|FG005|Overall Study|Study Terminated by Sponsor|0|||
33683748|NCT02049957|63158826|FG006|Overall Study|Study Terminated by Sponsor|1|||
33683749|NCT02049957|63158827|FG007|Overall Study|Study Terminated by Sponsor|0|||
33683750|NCT02049957|63158828|FG008|Overall Study|Study Terminated by Sponsor|0|||
33683751|NCT02049957|63158820|FG000|Overall Study|Withdrawal by Subject|0|||
33683752|NCT02049957|63158821|FG001|Overall Study|Withdrawal by Subject|0|||
33683753|NCT02049957|63158822|FG002|Overall Study|Withdrawal by Subject|0|||
33683754|NCT02049957|63158823|FG003|Overall Study|Withdrawal by Subject|1|||
33683755|NCT02049957|63158824|FG004|Overall Study|Withdrawal by Subject|0|||
33683756|NCT02049957|63158825|FG005|Overall Study|Withdrawal by Subject|2|||
33683757|NCT02049957|63158826|FG006|Overall Study|Withdrawal by Subject|0|||
33683758|NCT02049957|63158827|FG007|Overall Study|Withdrawal by Subject|3|||
33683759|NCT02049957|63158828|FG008|Overall Study|Withdrawal by Subject|1|||
33683760|NCT02049957|63158820|FG000|Overall Study|Physician Decision|0|||
33683761|NCT02049957|63158821|FG001|Overall Study|Physician Decision|0|||
33683762|NCT02049957|63158822|FG002|Overall Study|Physician Decision|0|||
33683763|NCT02049957|63158823|FG003|Overall Study|Physician Decision|0|||
33683764|NCT02049957|63158824|FG004|Overall Study|Physician Decision|0|||
33683765|NCT02049957|63158825|FG005|Overall Study|Physician Decision|1|||
33683766|NCT02049957|63158826|FG006|Overall Study|Physician Decision|0|||
33683767|NCT02049957|63158827|FG007|Overall Study|Physician Decision|0|||
33683768|NCT02049957|63158828|FG008|Overall Study|Physician Decision|0|||
33683769|NCT00014495|63159091|FG000|Overall Study|Death|0|||
33683770|NCT00014495|63159092|FG001|Overall Study|Death|0|||
33683771|NCT00014495|63159093|FG002|Overall Study|Death|1|||
33683772|NCT00014495|63159094|FG003|Overall Study|Death|0|||
33683773|NCT00014495|63159091|FG000|Overall Study|Clinical deterioration|0|||
33683774|NCT00014495|63159092|FG001|Overall Study|Clinical deterioration|0|||
33683775|NCT00014495|63159093|FG002|Overall Study|Clinical deterioration|0|||
33683776|NCT00014495|63159094|FG003|Overall Study|Clinical deterioration|1|||
33683777|NCT01351623|63161129|FG000|Overall Study|Protocol Violation|2|||
33683778|NCT01351623|63161129|FG000|Overall Study|Adverse Event|4|||
33683779|NCT01351623|63161129|FG000|Overall Study|Withdrawal by Subject|1|||
33683780|NCT01351623|63161129|FG000|Overall Study|Death|2|||
33683781|NCT03670953|63161266|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
33683782|NCT03670953|63161267|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
33683783|NCT03670953|63161268|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
33683784|NCT03670953|63161269|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
33683785|NCT03670953|63161266|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
33683786|NCT03670953|63161267|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
33683787|NCT03670953|63161268|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
33683788|NCT03670953|63161269|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
33683789|NCT03670953|63161266|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
33683790|NCT03670953|63161267|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
33683791|NCT03670953|63161268|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
33683792|NCT03670953|63161269|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
33683793|NCT03670953|63161266|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
33683794|NCT03670953|63161267|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
33683795|NCT03670953|63161268|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
33683796|NCT03670953|63161269|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
33683797|NCT03670953|63161266|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
33683798|NCT03670953|63161267|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
33683799|NCT03670953|63161268|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
33683800|NCT03670953|63161269|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
33683801|NCT03670953|63161266|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
33683802|NCT03670953|63161267|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
33683803|NCT03670953|63161268|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
33683804|NCT03670953|63161269|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
33683805|NCT03670953|63161266|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
33683806|NCT03670953|63161267|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
33683807|NCT03670953|63161268|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
33683808|NCT03670953|63161269|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
33683809|NCT03670953|63161266|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
33683810|NCT03670953|63161267|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
33683811|NCT03670953|63161268|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
33683812|NCT03670953|63161269|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
33683813|NCT03670953|63161266|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
33683814|NCT03670953|63161267|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
33683815|NCT03670953|63161268|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
33683816|NCT03670953|63161269|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
33683817|NCT03670953|63161266|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
33683818|NCT03670953|63161267|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
33683819|NCT03670953|63161268|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
33683820|NCT03670953|63161269|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
33683821|NCT03670953|63161266|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
33683822|NCT03670953|63161267|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
33683823|NCT03670953|63161268|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
33683824|NCT03670953|63161269|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
33683825|NCT03670953|63161266|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
33683826|NCT03670953|63161267|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
33683827|NCT03670953|63161268|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
33683828|NCT03670953|63161269|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
33683829|NCT03670953|63161266|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
33683830|NCT03670953|63161267|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
33683831|NCT03670953|63161268|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
33683832|NCT03670953|63161269|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
33683833|NCT03670953|63161266|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
33683834|NCT03670953|63161267|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
33683835|NCT03670953|63161268|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
33683836|NCT03670953|63161269|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
33683837|NCT03670953|63161266|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
33683838|NCT03670953|63161267|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
33683839|NCT03670953|63161268|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
33683840|NCT03670953|63161269|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
33683841|NCT03670953|63161266|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
33683842|NCT03670953|63161267|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
33683843|NCT03670953|63161268|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
33683844|NCT03670953|63161269|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
33595104|NCT02187159|62994125|FG000|Overall Study|Adverse Event|28|||
33595105|NCT02187159|62994126|FG001|Overall Study|Adverse Event|33|||
33595106|NCT02187159|62994127|FG002|Overall Study|Adverse Event|42|||
33595107|NCT02187159|62994128|FG003|Overall Study|Adverse Event|50|||
33595108|NCT02187159|62994125|FG000|Overall Study|Withdrawal by Subject|24|||
33595109|NCT02187159|62994126|FG001|Overall Study|Withdrawal by Subject|28|||
33595110|NCT02187159|62994127|FG002|Overall Study|Withdrawal by Subject|25|||
33595111|NCT02187159|62994128|FG003|Overall Study|Withdrawal by Subject|26|||
33595112|NCT02187159|62994125|FG000|Overall Study|Other|3|||
33595113|NCT02187159|62994126|FG001|Overall Study|Other|7|||
33595114|NCT02187159|62994127|FG002|Overall Study|Other|3|||
33595115|NCT02187159|62994128|FG003|Overall Study|Other|9|||
33595116|NCT02335411|62994141|FG000|Overall Study|Death|223|||
33595117|NCT02335411|62994142|FG001|Overall Study|Death|22|||
33595118|NCT02335411|62994143|FG002|Overall Study|Death|26|||
33595119|NCT02335411|62994141|FG000|Overall Study|Physician Decision|3|||
33595120|NCT02335411|62994142|FG001|Overall Study|Physician Decision|0|||
33683845|NCT03670953|63161266|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
33683846|NCT03670953|63161267|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
33683847|NCT03670953|63161268|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
33310741|NCT01161537|62686145|FG000|Part B|Withdrawal by Subject|2|||
33595121|NCT02335411|62994143|FG002|Overall Study|Physician Decision|0|||
33595122|NCT02335411|62994141|FG000|Overall Study|Protocol Violation|1|||
33595123|NCT02335411|62994142|FG001|Overall Study|Protocol Violation|0|||
33595124|NCT02335411|62994143|FG002|Overall Study|Protocol Violation|0|||
33595125|NCT02335411|62994141|FG000|Overall Study|Withdrawal by Subject|11|||
33683848|NCT03670953|63161269|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
33683849|NCT03670953|63161266|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
33683850|NCT03670953|63161267|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
33683851|NCT03670953|63161268|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
33683852|NCT03670953|63161269|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
33683853|NCT02519348|63161304|FG000|Overall Study|Death|31|||
33683854|NCT02519348|63161305|FG001|Overall Study|Death|74|||
33683855|NCT02519348|63161306|FG002|Overall Study|Death|47|||
33683856|NCT02519348|63161307|FG003|Overall Study|Death|54|||
33683857|NCT02519348|63161308|FG004|Overall Study|Death|63|||
33683858|NCT02519348|63161309|FG005|Overall Study|Death|18|||
33683859|NCT02519348|63161310|FG006|Overall Study|Death|2|||
33683860|NCT02519348|63161311|FG007|Overall Study|Death|5|||
33683861|NCT02519348|63161312|FG008|Overall Study|Death|5|||
33683862|NCT02519348|63161304|FG000|Overall Study|Withdrawal by Subject|4|||
33683863|NCT02519348|63161305|FG001|Overall Study|Withdrawal by Subject|7|||
33683864|NCT02519348|63161306|FG002|Overall Study|Withdrawal by Subject|4|||
33683865|NCT02519348|63161307|FG003|Overall Study|Withdrawal by Subject|3|||
33683866|NCT02519348|63161308|FG004|Overall Study|Withdrawal by Subject|3|||
33683867|NCT02519348|63161309|FG005|Overall Study|Withdrawal by Subject|2|||
33683868|NCT02519348|63161310|FG006|Overall Study|Withdrawal by Subject|0|||
33683869|NCT02519348|63161311|FG007|Overall Study|Withdrawal by Subject|0|||
33683870|NCT02519348|63161312|FG008|Overall Study|Withdrawal by Subject|1|||
33683871|NCT02519348|63161304|FG000|Overall Study|Lost to Follow-up|0|||
33683872|NCT02519348|63161305|FG001|Overall Study|Lost to Follow-up|0|||
33683873|NCT02519348|63161306|FG002|Overall Study|Lost to Follow-up|1|||
33683874|NCT02519348|63161307|FG003|Overall Study|Lost to Follow-up|0|||
33683875|NCT02519348|63161308|FG004|Overall Study|Lost to Follow-up|2|||
33683876|NCT02519348|63161309|FG005|Overall Study|Lost to Follow-up|1|||
33683877|NCT02519348|63161310|FG006|Overall Study|Lost to Follow-up|1|||
33683878|NCT02519348|63161311|FG007|Overall Study|Lost to Follow-up|0|||
33683879|NCT02519348|63161312|FG008|Overall Study|Lost to Follow-up|0|||
33683880|NCT02519348|63161304|FG000|Overall Study|Other|0|||
33683881|NCT02519348|63161305|FG001|Overall Study|Other|3|||
33683882|NCT02519348|63161306|FG002|Overall Study|Other|0|||
33683883|NCT02519348|63161307|FG003|Overall Study|Other|0|||
33683884|NCT02519348|63161308|FG004|Overall Study|Other|1|||
33683885|NCT02519348|63161309|FG005|Overall Study|Other|0|||
33683886|NCT02519348|63161310|FG006|Overall Study|Other|0|||
33683887|NCT02519348|63161311|FG007|Overall Study|Other|0|||
33683888|NCT02519348|63161312|FG008|Overall Study|Other|0|||
33683889|NCT02519348|63161304|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
33683890|NCT02519348|63161305|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
33683891|NCT02519348|63161306|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
33683892|NCT02519348|63161307|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
33683893|NCT02519348|63161308|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
33683894|NCT02519348|63161309|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
33683895|NCT02519348|63161310|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
33683896|NCT02519348|63161311|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
33683897|NCT02519348|63161312|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
33683898|NCT00636818|63161333|FG000|Overall Study|Adverse Event|1|||
33683899|NCT00636818|63161333|FG000|Overall Study|Lost to Follow-up|2|||
33683900|NCT00636818|63161333|FG000|Overall Study|Entry Criteria Exclusion|3|||
33683901|NCT00636818|63161333|FG000|Overall Study|Protocol Violation|1|||
33683902|NCT00636818|63161333|FG000|Overall Study|Withdrawal by Subject|4|||
33683903|NCT03127137|63161339|FG000|Overall Study|Requested sedation after consent|1|||
33683904|NCT03127137|63161340|FG001|Overall Study|Requested sedation after consent|0|||
33683905|NCT03127137|63161339|FG000|Overall Study|Malfunction in electronic data collection|1|||
33683906|NCT03127137|63161340|FG001|Overall Study|Malfunction in electronic data collection|0|||
33683907|NCT03127137|63161339|FG000|Overall Study|Post procedure testing could not be obtained|0|||
33683908|NCT03127137|63161340|FG001|Overall Study|Post procedure testing could not be obtained|1|||
33683909|NCT00636506|63161348|FG000|Overall Study|Lost to Follow-up|8|||
33683910|NCT00636506|63161348|FG000|Overall Study|Explanted|1|||
33683911|NCT00636506|63161348|FG000|Overall Study|Withdrawal by Subject|6|||
33683912|NCT00636506|63161348|FG000|Overall Study|Procedure aborted|1|||
33683913|NCT00636194|63161372|FG000|Overall Study|Study related symptoms and complaints|1|||
33683914|NCT00636194|63161373|FG001|Overall Study|Study related symptoms and complaints|0|||
33683915|NCT00636194|63161372|FG000|Overall Study|Protocol Violation|2|||
33683916|NCT00636194|63161373|FG001|Overall Study|Protocol Violation|0|||
33683917|NCT00635804|63161439|FG000|Overall Study|Adverse Event|0|||
33683918|NCT00635804|63161440|FG001|Overall Study|Adverse Event|0|||
33683919|NCT00635804|63161441|FG002|Overall Study|Adverse Event|0|||
33683920|NCT00635804|63161442|FG003|Overall Study|Adverse Event|0|||
33683921|NCT00635804|63161443|FG004|Overall Study|Adverse Event|0|||
33683922|NCT00635804|63161444|FG005|Overall Study|Adverse Event|1|||
33683923|NCT00635804|63161445|FG006|Overall Study|Adverse Event|0|||
33683924|NCT00635804|63161446|FG007|Overall Study|Adverse Event|0|||
33683925|NCT00635804|63161439|FG000|Overall Study|Withdrawal by Subject|1|||
33683926|NCT00635804|63161440|FG001|Overall Study|Withdrawal by Subject|0|||
33683927|NCT00635804|63161441|FG002|Overall Study|Withdrawal by Subject|0|||
33683928|NCT00635804|63161442|FG003|Overall Study|Withdrawal by Subject|0|||
33683929|NCT00635804|63161443|FG004|Overall Study|Withdrawal by Subject|0|||
33683930|NCT00635804|63161444|FG005|Overall Study|Withdrawal by Subject|0|||
33683931|NCT00635804|63161445|FG006|Overall Study|Withdrawal by Subject|0|||
33683932|NCT00635804|63161446|FG007|Overall Study|Withdrawal by Subject|0|||
33683933|NCT00635648|63161476|FG000|Overall Study|Adverse Event|12|||
33683934|NCT00635648|63161476|FG000|Overall Study|Withdrawal by Subject|9|||
33683935|NCT00635648|63161476|FG000|Overall Study|Physician Decision|4|||
33683936|NCT00635648|63161476|FG000|Overall Study|Rapid progression of baseline disease|4|||
33683937|NCT00635648|63161476|FG000|Overall Study|Use of other antifungal agent needed|1|||
33683938|NCT00635648|63161476|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
33683939|NCT00635648|63161476|FG000|Overall Study|Noncompliance with protocol|1|||
33683940|NCT00635648|63161476|FG000|Overall Study|Other reason|2|||
33683941|NCT00635102|63161501|FG000|Overall Study|Withdrawal by Subject|7|||
33683942|NCT00635102|63161502|FG001|Overall Study|Withdrawal by Subject|8|||
33683943|NCT00635024|63161517|FG000|Overall Study|Adverse Event|1|||
33683944|NCT00634244|63161566|FG000|Overall Study|Never started treatment|0|||
33683945|NCT00634244|63161567|FG001|Overall Study|Never started treatment|1|||
33683946|NCT00634244|63161568|FG002|Overall Study|Never started treatment|0|||
33683947|NCT00634244|63161566|FG000|Overall Study|Death|1|||
33683948|NCT00634244|63161567|FG001|Overall Study|Death|6|||
33683949|NCT00634244|63161568|FG002|Overall Study|Death|0|||
33683950|NCT00634244|63161566|FG000|Overall Study|Adverse Event|0|||
33683951|NCT00634244|63161567|FG001|Overall Study|Adverse Event|2|||
33683952|NCT00634244|63161568|FG002|Overall Study|Adverse Event|0|||
33683953|NCT00634244|63161566|FG000|Overall Study|Withdrawal by Subject|0|||
33683954|NCT00634244|63161567|FG001|Overall Study|Withdrawal by Subject|1|||
33683955|NCT00634244|63161568|FG002|Overall Study|Withdrawal by Subject|0|||
33683956|NCT00634244|63161566|FG000|Overall Study|Physician Decision|0|||
33683957|NCT00634244|63161567|FG001|Overall Study|Physician Decision|1|||
33683958|NCT00634244|63161568|FG002|Overall Study|Physician Decision|0|||
33683959|NCT00634244|63161566|FG000|Overall Study|Disease progression/relapse|0|||
33683960|NCT00634244|63161567|FG001|Overall Study|Disease progression/relapse|1|||
33683961|NCT00634244|63161568|FG002|Overall Study|Disease progression/relapse|0|||
33683962|NCT00634244|63161566|FG000|Overall Study|Other complicating disease|0|||
33683963|NCT00634244|63161567|FG001|Overall Study|Other complicating disease|1|||
33683964|NCT00634244|63161568|FG002|Overall Study|Other complicating disease|0|||
33683965|NCT00634088|63161752|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
33683966|NCT00634088|63161753|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
33683967|NCT00634088|63161754|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
33683968|NCT00634088|63161755|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
33683969|NCT00634088|63161752|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
33683970|NCT00634088|63161753|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
33683971|NCT00634088|63161754|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
33683972|NCT00634088|63161755|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
33683973|NCT00634088|63161752|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
33683974|NCT00634088|63161753|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
33683975|NCT00634088|63161754|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
33683976|NCT00634088|63161755|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
33683977|NCT00634088|63161752|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
33683978|NCT00634088|63161753|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
33683979|NCT00634088|63161754|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
33683980|NCT00634088|63161755|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
33683981|NCT00634088|63161752|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
33683982|NCT00634088|63161753|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
33683983|NCT00634088|63161754|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
33683984|NCT00634088|63161755|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
33683985|NCT00634088|63161752|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
33683986|NCT00634088|63161753|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
33683987|NCT00634088|63161754|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
33683988|NCT00634088|63161755|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
33683989|NCT00634010|63161855|FG000|Overall Study|Adverse Event|2|||
33683990|NCT00634010|63161856|FG001|Overall Study|Adverse Event|5|||
33683991|NCT00634010|63161855|FG000|Overall Study|Withdrawal by Subject|5|||
33683992|NCT00634010|63161856|FG001|Overall Study|Withdrawal by Subject|6|||
33683993|NCT00634010|63161855|FG000|Overall Study|Physician Decision|1|||
33683994|NCT00634010|63161856|FG001|Overall Study|Physician Decision|1|||
33683995|NCT00634010|63161855|FG000|Overall Study|Disease Progression|1|||
33683996|NCT00634010|63161856|FG001|Overall Study|Disease Progression|1|||
33683997|NCT00634010|63161855|FG000|Overall Study|Non-Compliant|1|||
33683998|NCT00634010|63161856|FG001|Overall Study|Non-Compliant|1|||
33683999|NCT00633932|63161869|FG000|Overall Study|Adverse Event|1|||
33684000|NCT00633932|63161870|FG001|Overall Study|Adverse Event|3|||
33684001|NCT00633932|63161871|FG002|Overall Study|Adverse Event|4|||
33684002|NCT00633932|63161869|FG000|Overall Study|Withdrawal by Subject|3|||
33684003|NCT00633932|63161870|FG001|Overall Study|Withdrawal by Subject|9|||
33684004|NCT00633932|63161871|FG002|Overall Study|Withdrawal by Subject|1|||
33684005|NCT00633932|63161869|FG000|Overall Study|Lost to Follow-up|1|||
33684006|NCT00633932|63161870|FG001|Overall Study|Lost to Follow-up|0|||
33684007|NCT00633932|63161871|FG002|Overall Study|Lost to Follow-up|2|||
33684008|NCT00633932|63161869|FG000|Overall Study|Protocol Violation|5|||
33684009|NCT00633932|63161870|FG001|Overall Study|Protocol Violation|2|||
33684010|NCT00633932|63161871|FG002|Overall Study|Protocol Violation|3|||
33684011|NCT00633932|63161869|FG000|Overall Study|Physician Decision|0|||
33684012|NCT00633932|63161870|FG001|Overall Study|Physician Decision|0|||
33684013|NCT00633932|63161871|FG002|Overall Study|Physician Decision|1|||
33684014|NCT00633932|63161869|FG000|Overall Study|Doctor's judgement|1|||
33684015|NCT00633932|63161870|FG001|Overall Study|Doctor's judgement|0|||
33684016|NCT00633932|63161871|FG002|Overall Study|Doctor's judgement|0|||
33684017|NCT00633932|63161869|FG000|Overall Study|Moved Away|1|||
33684018|NCT00633932|63161870|FG001|Overall Study|Moved Away|0|||
33684019|NCT00633932|63161871|FG002|Overall Study|Moved Away|0|||
33684020|NCT00633464|63162001|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
33684021|NCT00633464|63162002|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
33684022|NCT00633464|63162001|FG000|Overall Study|Never Treated (Randomized in error)|0|||
33684023|NCT00633464|63162002|FG001|Overall Study|Never Treated (Randomized in error)|1|||
33684024|NCT00633152|63162043|FG000|Overall Study|Adverse Event|1|||
33684025|NCT00633152|63162044|FG001|Overall Study|Adverse Event|0|||
33684026|NCT00633152|63162043|FG000|Overall Study|Randomized, did not receive study drug|5|||
33684027|NCT00633152|63162044|FG001|Overall Study|Randomized, did not receive study drug|2|||
33684028|NCT00633152|63162043|FG000|Overall Study|Withdrawal by Subject|1|||
33684029|NCT00633152|63162044|FG001|Overall Study|Withdrawal by Subject|1|||
33684030|NCT00633152|63162043|FG000|Overall Study|Lost to Follow-up|4|||
33684031|NCT00633152|63162044|FG001|Overall Study|Lost to Follow-up|1|||
33684032|NCT00633152|63162043|FG000|Overall Study|Miscellaneous Other|3|||
33684033|NCT00633152|63162044|FG001|Overall Study|Miscellaneous Other|2|||
33684034|NCT00633074|63162063|FG000|Overall Study|Adverse Event|1|||
33684035|NCT00633074|63162064|FG001|Overall Study|Adverse Event|0|||
33684036|NCT00630344|63162251|FG000|Overall Study|Adverse Event|5|||
33684037|NCT00630344|63162251|FG000|Overall Study|Progressive Disease|19|||
33684038|NCT00630344|63162251|FG000|Overall Study|Physician Decision|9|||
33684039|NCT00630344|63162251|FG000|Overall Study|Withdrawal by Subject|1|||
33684040|NCT00630344|63162251|FG000|Overall Study|Intercurrent Illness|1|||
33684041|NCT00630344|63162251|FG000|Overall Study|Other|1|||
33684042|NCT02913261|63162277|FG000|Overall Study|Technical problems|0|||
33684043|NCT02913261|63162278|FG001|Overall Study|Technical problems|1|||
33684044|NCT02913261|63162277|FG000|Overall Study|Lack of Efficacy|32|||
33684045|NCT02913261|63162278|FG001|Overall Study|Lack of Efficacy|69|||
33684046|NCT02913261|63162277|FG000|Overall Study|Adverse Event|27|||
33684047|NCT02913261|63162278|FG001|Overall Study|Adverse Event|5|||
33684048|NCT02913261|63162277|FG000|Overall Study|Death|25|||
33684049|NCT02913261|63162278|FG001|Overall Study|Death|22|||
33684050|NCT02913261|63162277|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
33684051|NCT02913261|63162278|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
33684052|NCT02913261|63162277|FG000|Overall Study|Disease relapse|8|||
33684053|NCT02913261|63162278|FG001|Overall Study|Disease relapse|13|||
33684054|NCT02913261|63162277|FG000|Overall Study|Physician Decision|8|||
33684055|NCT02913261|63162278|FG001|Overall Study|Physician Decision|9|||
33684056|NCT02913261|63162277|FG000|Overall Study|Subject/guardian decision|4|||
33684057|NCT02913261|63162278|FG001|Overall Study|Subject/guardian decision|6|||
33684058|NCT02913261|63162277|FG000|Overall Study|Graft loss|2|||
33684059|NCT02913261|63162278|FG001|Overall Study|Graft loss|0|||
33684060|NCT00635882|63162342|FG000|Overall Study|Protocol Violation|1|||
33684061|NCT00635882|63162343|FG001|Overall Study|Protocol Violation|0|||
33684062|NCT00635882|63162344|FG002|Overall Study|Protocol Violation|0|||
33684063|NCT00635882|63162345|FG003|Overall Study|Protocol Violation|0|||
33595126|NCT02335411|62994142|FG001|Overall Study|Withdrawal by Subject|0|||
33595127|NCT02335411|62994143|FG002|Overall Study|Withdrawal by Subject|3|||
33595128|NCT02335411|62994141|FG000|Overall Study|Sponsor Decision|12|||
33595129|NCT02335411|62994142|FG001|Overall Study|Sponsor Decision|3|||
33595130|NCT02335411|62994143|FG002|Overall Study|Sponsor Decision|2|||
33595131|NCT02335411|62994141|FG000|Overall Study|Adverse Event|9|||
33595132|NCT02335411|62994142|FG001|Overall Study|Adverse Event|0|||
33595133|NCT02335411|62994143|FG002|Overall Study|Adverse Event|0|||
33595134|NCT02186301|62994157|FG000|Overall Study|Progressive Disease|7|||
33595135|NCT02186301|62994158|FG001|Overall Study|Progressive Disease|22|||
33595136|NCT02186301|62994159|FG002|Overall Study|Progressive Disease|27|||
33595137|NCT02186301|62994157|FG000|Overall Study|Adverse Event|5|||
33595138|NCT02186301|62994158|FG001|Overall Study|Adverse Event|5|||
33595139|NCT02186301|62994159|FG002|Overall Study|Adverse Event|5|||
33595140|NCT02186301|62994157|FG000|Overall Study|Death|1|||
33595141|NCT02186301|62994158|FG001|Overall Study|Death|0|||
33595142|NCT02186301|62994159|FG002|Overall Study|Death|0|||
33595143|NCT02186301|62994157|FG000|Overall Study|Withdrawal by Subject|5|||
33595144|NCT02186301|62994158|FG001|Overall Study|Withdrawal by Subject|1|||
33595145|NCT02186301|62994159|FG002|Overall Study|Withdrawal by Subject|3|||
33595146|NCT02186301|62994157|FG000|Overall Study|Physician Decision|1|||
33595147|NCT02186301|62994158|FG001|Overall Study|Physician Decision|0|||
33595148|NCT02186301|62994159|FG002|Overall Study|Physician Decision|1|||
33595149|NCT02186301|62994157|FG000|Overall Study|Study Terminated by Sponsor|1|||
33595150|NCT02186301|62994158|FG001|Overall Study|Study Terminated by Sponsor|0|||
33595151|NCT02186301|62994159|FG002|Overall Study|Study Terminated by Sponsor|11|||
33595152|NCT02186301|62994157|FG000|Overall Study|Protocol Deviation|0|||
33595153|NCT02186301|62994158|FG001|Overall Study|Protocol Deviation|2|||
33595154|NCT02186301|62994159|FG002|Overall Study|Protocol Deviation|0|||
33595155|NCT02186301|62994157|FG000|Overall Study|Missing|0|||
33595156|NCT02186301|62994158|FG001|Overall Study|Missing|0|||
33595157|NCT02186301|62994159|FG002|Overall Study|Missing|2|||
33595158|NCT02186301|62994157|FG000|Overall Study|Other|0|||
33595159|NCT02186301|62994158|FG001|Overall Study|Other|0|||
33595160|NCT02186301|62994159|FG002|Overall Study|Other|1|||
33595161|NCT02186223|62994169|FG000|Overall Study|Not eligible for device placement|6|||
33595162|NCT02186223|62994169|FG000|Overall Study|Unable to obtain femoral access|3|||
33595163|NCT02186223|62994169|FG000|Overall Study|Death|3|||
33595164|NCT02186223|62994169|FG000|Overall Study|Device in place less than 48 hours|9|||
33595165|NCT02163057|62994176|FG000|Overall Study|Participant Refusal to Continue|2|||
33595166|NCT02163057|62994177|FG001|Overall Study|Participant Refusal to Continue|2|||
33595167|NCT02163057|62994176|FG000|Overall Study|Participant Significant Noncompliance|0|||
33595168|NCT02163057|62994177|FG001|Overall Study|Participant Significant Noncompliance|1|||
33595169|NCT02163057|62994176|FG000|Overall Study|Progression of Disease|1|||
33595170|NCT02163057|62994177|FG001|Overall Study|Progression of Disease|2|||
33595171|NCT02185521|62994185|FG000|Overall Study|Withdrawal by Subject|1|||
33595172|NCT02185521|62994185|FG000|Overall Study|Protocol Violation|1|||
33595173|NCT01599585|62994192|FG000|Overall Study|Withdrawal by Subject|16|||
33595174|NCT01599585|62994193|FG001|Overall Study|Withdrawal by Subject|9|||
33595175|NCT01599585|62994192|FG000|Overall Study|Lost to Follow-up|3|||
33595176|NCT01599585|62994193|FG001|Overall Study|Lost to Follow-up|5|||
33595177|NCT01599585|62994192|FG000|Overall Study|randomized did not start treatment|3|||
33595178|NCT01599585|62994193|FG001|Overall Study|randomized did not start treatment|3|||
33595179|NCT02185053|62994199|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
33595180|NCT02185053|62994200|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
33595181|NCT02185053|62994201|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
33595182|NCT02185053|62994199|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
33595183|NCT02185053|62994200|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
33595184|NCT02185053|62994201|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
33595185|NCT02185053|62994199|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
33595186|NCT02185053|62994200|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
33595187|NCT02185053|62994201|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
33595188|NCT02185053|62994199|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
33595189|NCT02185053|62994200|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
33595190|NCT02185053|62994201|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
33595191|NCT02185053|62994199|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
33595192|NCT02185053|62994200|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
33684064|NCT00635882|63162346|FG004|Overall Study|Protocol Violation|0|||
33684065|NCT00635882|63162347|FG005|Overall Study|Protocol Violation|0|||
33684066|NCT00986570|63162598|FG000|Overall Study|Lost to Follow-up|6|||
33684067|NCT00986570|63162598|FG000|Overall Study|Potential bias for objective assessment|1|||
33684068|NCT00986258|63162602|FG000|Observation Period|Not eligible to be dosed|11|||
33684069|NCT00986258|63162602|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
33684070|NCT00986258|63162602|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
33684071|NCT00986258|63162602|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
33684072|NCT00986258|63162602|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
33684073|NCT00986258|63162602|FG000|Titration and Optimal Dose Period|Other|1|||
33684074|NCT00986258|63162602|FG000|Maintenance Period|Adverse Event|5|||
33684075|NCT00986258|63162602|FG000|Maintenance Period|Lack of Efficacy|2|||
33684076|NCT00986258|63162602|FG000|Maintenance Period|Withdrawal by Subject|2|||
33684077|NCT00986180|63162618|FG000|Overall Study|Adverse Event|21|||
33684078|NCT00986180|63162619|FG001|Overall Study|Adverse Event|23|||
33684079|NCT00986180|63162618|FG000|Overall Study|Lack of Efficacy|4|||
33684080|NCT00986180|63162619|FG001|Overall Study|Lack of Efficacy|3|||
33684081|NCT00986180|63162618|FG000|Overall Study|Lost to Follow-up|5|||
33684082|NCT00986180|63162619|FG001|Overall Study|Lost to Follow-up|7|||
33684083|NCT00986180|63162618|FG000|Overall Study|Physician Decision|1|||
33684084|NCT00986180|63162619|FG001|Overall Study|Physician Decision|3|||
33684085|NCT00986180|63162618|FG000|Overall Study|Protocol Violation|2|||
33684086|NCT00986180|63162619|FG001|Overall Study|Protocol Violation|0|||
33684087|NCT00986180|63162618|FG000|Overall Study|Withdrawal by Subject|1|||
33684088|NCT00986180|63162619|FG001|Overall Study|Withdrawal by Subject|9|||
33684089|NCT00986180|63162618|FG000|Overall Study|Miscellanies|10|||
33684090|NCT00986180|63162619|FG001|Overall Study|Miscellanies|11|||
33684091|NCT00986102|63162801|FG000|Overall Study|Lost to Follow-up|0|||
33684092|NCT00986102|63162802|FG001|Overall Study|Lost to Follow-up|1|||
33684093|NCT00986102|63162803|FG002|Overall Study|Lost to Follow-up|0|||
33684094|NCT00986102|63162804|FG003|Overall Study|Lost to Follow-up|1|||
33684095|NCT00986102|63162801|FG000|Overall Study|Withdrawal by Subject|1|||
33684096|NCT00986102|63162802|FG001|Overall Study|Withdrawal by Subject|1|||
33684097|NCT00986102|63162803|FG002|Overall Study|Withdrawal by Subject|0|||
33684098|NCT00986102|63162804|FG003|Overall Study|Withdrawal by Subject|0|||
33684099|NCT00985946|63162827|FG000|Overall Study|Lost to Follow-up|6|||
33684100|NCT00985946|63162827|FG000|Overall Study|Withdrawal by Subject|1|||
33684101|NCT00985790|63162842|FG000|Overall Study|Withdrawal by Subject|1|||
33684102|NCT00985790|63162843|FG001|Overall Study|Withdrawal by Subject|1|||
33684103|NCT00985790|63162842|FG000|Overall Study|Lost to Follow-up|6|||
33684104|NCT00985790|63162843|FG001|Overall Study|Lost to Follow-up|7|||
33684105|NCT00985712|63162870|FG000|Overall Study|Adverse Event|0|||
33684106|NCT00985712|63162871|FG001|Overall Study|Adverse Event|1|||
33684107|NCT00985712|63162870|FG000|Overall Study|Lost to Follow-up|2|||
33684108|NCT00985712|63162871|FG001|Overall Study|Lost to Follow-up|2|||
33684109|NCT00985712|63162870|FG000|Overall Study|Protocol Violation|0|||
33684110|NCT00985712|63162871|FG001|Overall Study|Protocol Violation|1|||
33684111|NCT00985712|63162870|FG000|Overall Study|Withdrawal by Subject|4|||
33684112|NCT00985712|63162871|FG001|Overall Study|Withdrawal by Subject|1|||
33684113|NCT00985712|63162870|FG000|Overall Study|Sponsor decision|0|||
33684114|NCT00985712|63162871|FG001|Overall Study|Sponsor decision|2|||
33684115|NCT00985166|63162978|FG000|Overall Study|Lost to Follow-up|3|||
33684116|NCT00985166|63162979|FG001|Overall Study|Lost to Follow-up|2|||
33684117|NCT00985166|63162980|FG002|Overall Study|Lost to Follow-up|2|||
33684118|NCT00985166|63162978|FG000|Overall Study|Withdrawal by Subject|3|||
33684119|NCT00985166|63162979|FG001|Overall Study|Withdrawal by Subject|2|||
33684120|NCT00985166|63162980|FG002|Overall Study|Withdrawal by Subject|0|||
33684121|NCT00985166|63162978|FG000|Overall Study|Test not done|2|||
33684122|NCT00985166|63162979|FG001|Overall Study|Test not done|0|||
33684123|NCT00985166|63162980|FG002|Overall Study|Test not done|4|||
33684124|NCT00985166|63162978|FG000|Overall Study|Other|1|||
33684125|NCT00985166|63162979|FG001|Overall Study|Other|0|||
33684126|NCT00985166|63162980|FG002|Overall Study|Other|1|||
33684127|NCT01341405|63163226|FG000|Overall Study|Adverse Event|0|||
33684128|NCT01341405|63163227|FG001|Overall Study|Adverse Event|1|||
33684129|NCT01341405|63163228|FG002|Overall Study|Adverse Event|1|||
33684130|NCT01341405|63163226|FG000|Overall Study|Withdrawal by Subject|3|||
33684131|NCT01341405|63163227|FG001|Overall Study|Withdrawal by Subject|2|||
33684132|NCT01341405|63163228|FG002|Overall Study|Withdrawal by Subject|1|||
33684133|NCT00633945|63164475|FG000|Overall Study|Physician Decision|2|||
33684134|NCT02574078|63164739|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33684135|NCT02574078|63164740|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33684136|NCT02574078|63164741|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33684137|NCT02574078|63164742|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33684138|NCT02574078|63164743|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33684139|NCT02574078|63164744|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
33684140|NCT02574078|63164745|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
33684141|NCT02574078|63164746|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33595193|NCT02185053|62994201|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
33595194|NCT02185053|62994199|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
33595195|NCT02185053|62994200|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
33595196|NCT02185053|62994201|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
33595197|NCT02185053|62994199|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
33595198|NCT02185053|62994200|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
33595199|NCT02185053|62994201|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
33595200|NCT02185053|62994199|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
33595201|NCT02185053|62994200|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
33595202|NCT02185053|62994201|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
33595203|NCT02161731|62994210|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
33595204|NCT02161731|62994211|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
33595205|NCT02161731|62994210|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
33595206|NCT02161731|62994211|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
33595207|NCT02124759|62994221|FG000|Overall Study|Withdrawal by Subject|3|||
33595208|NCT02124759|62994222|FG001|Overall Study|Withdrawal by Subject|1|||
33595209|NCT02124759|62994223|FG002|Overall Study|Withdrawal by Subject|1|||
33595210|NCT02124759|62994221|FG000|Overall Study|Screen Fail|2|||
33595211|NCT02124759|62994222|FG001|Overall Study|Screen Fail|2|||
33595212|NCT02124759|62994223|FG002|Overall Study|Screen Fail|3|||
33595213|NCT02302339|62994240|FG000|Overall Study|Lost to Follow-up|1|||
33595214|NCT02302339|62994241|FG001|Overall Study|Lost to Follow-up|0|||
33595215|NCT02302339|62994242|FG002|Overall Study|Lost to Follow-up|0|||
33595216|NCT02302339|62994243|FG003|Overall Study|Lost to Follow-up|0|||
33595217|NCT02302339|62994240|FG000|Overall Study|Withdrawal by Subject|0|||
33595218|NCT02302339|62994241|FG001|Overall Study|Withdrawal by Subject|2|||
33595219|NCT02302339|62994242|FG002|Overall Study|Withdrawal by Subject|1|||
33595220|NCT02302339|62994243|FG003|Overall Study|Withdrawal by Subject|0|||
33595221|NCT02161575|62994254|FG000|Overall Study|Protocol Violation|8|||
33595222|NCT02161575|62994254|FG000|Overall Study|Lack of Efficacy|1|||
33595223|NCT02161575|62994254|FG000|Overall Study|Adverse Event|2|||
33595224|NCT02370121|62994260|FG000|Overall Study|Lost to Follow-up|1|||
33595225|NCT02370121|62994261|FG001|Overall Study|Lost to Follow-up|1|||
33595226|NCT02161185|62994267|FG000|Treatment Phase|Administrative/Other|7|||
33595227|NCT02159469|62994271|FG000|Overall Study|Missing Completion status|1|||
33595228|NCT02159469|62994271|FG000|Overall Study|Adverse Event|5|||
33595229|NCT02159469|62994271|FG000|Overall Study|Non-compliance|2|||
33595230|NCT02159469|62994271|FG000|Overall Study|Withdrawal by Subject|9|||
33595231|NCT02159469|62994271|FG000|Overall Study|Lost to Follow-up|1|||
33595232|NCT02159469|62994271|FG000|Overall Study|Sponsor's request|2|||
33595233|NCT02159469|62994271|FG000|Overall Study|Met Stopping Criteria|3|||
33595234|NCT02159469|62994271|FG000|Overall Study|Other|1|||
33595235|NCT02159469|62994271|FG000|Overall Study|Multiple|29|||
33595236|NCT02123511|62994278|FG000|Overall Study|Cancelled treatment|1|||
33595237|NCT02123511|62994279|FG001|Overall Study|Cancelled treatment|0|||
33595238|NCT02123511|62994278|FG000|Overall Study|Incomplete data|1|||
33595239|NCT02123511|62994279|FG001|Overall Study|Incomplete data|3|||
33595240|NCT02123511|62994278|FG000|Overall Study|Ineligible|0|||
33595241|NCT02123511|62994279|FG001|Overall Study|Ineligible|1|||
33595242|NCT02122887|62994287|FG000|Overall Study|Withdrawal by Subject|20|||
33595243|NCT02122887|62994288|FG001|Overall Study|Withdrawal by Subject|2|||
33595244|NCT02182947|62994294|FG000|Overall Study|Withdrawal by Subject|7|||
33595245|NCT02182947|62994294|FG000|Overall Study|Lost to Follow-up|3|||
33595246|NCT02182947|62994294|FG000|Overall Study|Failed screening activities|8|||
33595247|NCT02370043|62994298|FG000|Overall Study|Withdrawal by Subject|0|||
33595248|NCT02370043|62994299|FG001|Overall Study|Withdrawal by Subject|0|||
33595249|NCT02370043|62994300|FG002|Overall Study|Withdrawal by Subject|0|||
33595250|NCT02370043|62994301|FG003|Overall Study|Withdrawal by Subject|0|||
33595251|NCT02370043|62994302|FG004|Overall Study|Withdrawal by Subject|1|||
33595252|NCT02370043|62994303|FG005|Overall Study|Withdrawal by Subject|1|||
33595253|NCT02301403|62994333|FG000|Overall Study|Withdrawal by Subject|28|||
33595254|NCT02301403|62994334|FG001|Overall Study|Withdrawal by Subject|41|||
33595255|NCT02301169|62994342|FG000|Overall Study|Adverse Event|1|||
33595256|NCT02301169|62994343|FG001|Overall Study|Adverse Event|0|||
33595257|NCT02333383|62994349|FG000|Overall Study|Adalimumab discontinuation|21|||
33595258|NCT02333383|62994349|FG000|Overall Study|Lost to Follow-up|15|||
33595259|NCT02333383|62994349|FG000|Overall Study|Withdrawal by Subject|3|||
33595260|NCT02333383|62994349|FG000|Overall Study|Transfer to another hospital|2|||
33595261|NCT02332915|62994355|FG000|Overall Study|Moved out of region|3|||
33595262|NCT02332915|62994356|FG001|Overall Study|Moved out of region|0|||
33595263|NCT02332915|62994355|FG000|Overall Study|Unrelated illness|1|||
33595264|NCT02332915|62994356|FG001|Overall Study|Unrelated illness|1|||
33595265|NCT02332915|62994355|FG000|Overall Study|Travel distance prohibitive|0|||
33595266|NCT02332915|62994356|FG001|Overall Study|Travel distance prohibitive|1|||
33595267|NCT02332915|62994355|FG000|Overall Study|did not meet inclusion criteria|2|||
33684142|NCT02574078|63164747|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
33684143|NCT02574078|63164748|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33684144|NCT02574078|63164749|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33684145|NCT02574078|63164750|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33684146|NCT02574078|63164751|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33684147|NCT02574078|63164739|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
33684148|NCT02574078|63164740|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
33684149|NCT02574078|63164741|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
33684150|NCT02574078|63164742|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
33684151|NCT02574078|63164743|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
33684152|NCT02574078|63164744|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
33684153|NCT02574078|63164745|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
33684154|NCT02574078|63164746|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
33684155|NCT02574078|63164747|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
33684156|NCT02574078|63164748|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
33684157|NCT02574078|63164749|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
33684158|NCT02574078|63164750|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
33684159|NCT02574078|63164751|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
33684160|NCT02574078|63164739|FG000|Pre-Treatment Period|Other reasons|0|||
33684161|NCT02574078|63164740|FG001|Pre-Treatment Period|Other reasons|0|||
33684162|NCT02574078|63164741|FG002|Pre-Treatment Period|Other reasons|0|||
33684163|NCT02574078|63164742|FG003|Pre-Treatment Period|Other reasons|0|||
33684164|NCT02574078|63164743|FG004|Pre-Treatment Period|Other reasons|0|||
33684165|NCT02574078|63164744|FG005|Pre-Treatment Period|Other reasons|0|||
33684166|NCT02574078|63164745|FG006|Pre-Treatment Period|Other reasons|2|||
33684167|NCT02574078|63164746|FG007|Pre-Treatment Period|Other reasons|0|||
33684168|NCT02574078|63164747|FG008|Pre-Treatment Period|Other reasons|0|||
33684169|NCT02574078|63164748|FG009|Pre-Treatment Period|Other reasons|0|||
33684170|NCT02574078|63164749|FG010|Pre-Treatment Period|Other reasons|2|||
33684171|NCT02574078|63164750|FG011|Pre-Treatment Period|Other reasons|0|||
33684172|NCT02574078|63164751|FG012|Pre-Treatment Period|Other reasons|0|||
33684173|NCT02574078|63164739|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
33684174|NCT02574078|63164740|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
33684175|NCT02574078|63164741|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
33684176|NCT02574078|63164742|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
33684177|NCT02574078|63164743|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
33684178|NCT02574078|63164744|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
33684179|NCT02574078|63164745|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
33684180|NCT02574078|63164746|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
33684181|NCT02574078|63164747|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
33684182|NCT02574078|63164748|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
33684183|NCT02574078|63164749|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
33684184|NCT02574078|63164750|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
33684185|NCT02574078|63164751|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
33684186|NCT02574078|63164739|FG000|Treatment Period|Disease progression|6|||
33684187|NCT02574078|63164740|FG001|Treatment Period|Disease progression|4|||
33684188|NCT02574078|63164741|FG002|Treatment Period|Disease progression|7|||
33684189|NCT02574078|63164742|FG003|Treatment Period|Disease progression|18|||
33684190|NCT02574078|63164743|FG004|Treatment Period|Disease progression|16|||
33684191|NCT02574078|63164744|FG005|Treatment Period|Disease progression|26|||
33684192|NCT02574078|63164745|FG006|Treatment Period|Disease progression|5|||
33684193|NCT02574078|63164746|FG007|Treatment Period|Disease progression|9|||
33684194|NCT02574078|63164747|FG008|Treatment Period|Disease progression|8|||
33595268|NCT02332915|62994356|FG001|Overall Study|did not meet inclusion criteria|4|||
33595269|NCT02369341|62994369|FG000|Overall Study|Migrated/moved from study area|1|||
33595270|NCT02369341|62994370|FG001|Overall Study|Migrated/moved from study area|0|||
33595271|NCT02121795|62994382|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
33595272|NCT02121795|62994383|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
33595273|NCT02121795|62994382|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
33595274|NCT02121795|62994383|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
33595275|NCT02121795|62994382|FG000|Double-Blind Phase|Lost to Follow-up|7|||
33595276|NCT02121795|62994383|FG001|Double-Blind Phase|Lost to Follow-up|4|||
33595277|NCT02121795|62994382|FG000|Double-Blind Phase|Physician Decision|2|||
33595278|NCT02121795|62994383|FG001|Double-Blind Phase|Physician Decision|5|||
33595279|NCT02121795|62994382|FG000|Double-Blind Phase|Adverse Event|5|||
33595280|NCT02121795|62994383|FG001|Double-Blind Phase|Adverse Event|0|||
33684195|NCT02574078|63164748|FG009|Treatment Period|Disease progression|5|||
33684196|NCT02574078|63164749|FG010|Treatment Period|Disease progression|20|||
33684197|NCT02574078|63164750|FG011|Treatment Period|Disease progression|29|||
33684198|NCT02574078|63164751|FG012|Treatment Period|Disease progression|2|||
33595281|NCT02121795|62994382|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
33595282|NCT02121795|62994383|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
33595283|NCT02121795|62994382|FG000|Double-Blind Phase|Protocol Violation|0|||
33684199|NCT02574078|63164739|FG000|Treatment Period|Study drug toxicity|1|||
33684200|NCT02574078|63164740|FG001|Treatment Period|Study drug toxicity|1|||
33684201|NCT02574078|63164741|FG002|Treatment Period|Study drug toxicity|0|||
33684202|NCT02574078|63164742|FG003|Treatment Period|Study drug toxicity|5|||
33684203|NCT02574078|63164743|FG004|Treatment Period|Study drug toxicity|3|||
33684204|NCT02574078|63164744|FG005|Treatment Period|Study drug toxicity|1|||
33684205|NCT02574078|63164745|FG006|Treatment Period|Study drug toxicity|2|||
33684206|NCT02574078|63164746|FG007|Treatment Period|Study drug toxicity|0|||
33684207|NCT02574078|63164747|FG008|Treatment Period|Study drug toxicity|2|||
33684208|NCT02574078|63164748|FG009|Treatment Period|Study drug toxicity|1|||
33684209|NCT02574078|63164749|FG010|Treatment Period|Study drug toxicity|16|||
33684210|NCT02574078|63164750|FG011|Treatment Period|Study drug toxicity|2|||
33684211|NCT02574078|63164751|FG012|Treatment Period|Study drug toxicity|4|||
33684212|NCT02574078|63164739|FG000|Treatment Period|Death|2|||
33684213|NCT02574078|63164740|FG001|Treatment Period|Death|0|||
33684214|NCT02574078|63164741|FG002|Treatment Period|Death|0|||
33684215|NCT02574078|63164742|FG003|Treatment Period|Death|0|||
33684216|NCT02574078|63164743|FG004|Treatment Period|Death|1|||
33684217|NCT02574078|63164744|FG005|Treatment Period|Death|1|||
33684218|NCT02574078|63164745|FG006|Treatment Period|Death|1|||
33684219|NCT02574078|63164746|FG007|Treatment Period|Death|1|||
33684220|NCT02574078|63164747|FG008|Treatment Period|Death|7|||
33684221|NCT02574078|63164748|FG009|Treatment Period|Death|1|||
33684222|NCT02574078|63164749|FG010|Treatment Period|Death|0|||
33684223|NCT02574078|63164750|FG011|Treatment Period|Death|2|||
33684224|NCT02574078|63164751|FG012|Treatment Period|Death|1|||
33684225|NCT02574078|63164739|FG000|Treatment Period|Adverse event unrelated to drug|0|||
33684226|NCT02574078|63164740|FG001|Treatment Period|Adverse event unrelated to drug|0|||
33684227|NCT02574078|63164741|FG002|Treatment Period|Adverse event unrelated to drug|1|||
33684228|NCT02574078|63164742|FG003|Treatment Period|Adverse event unrelated to drug|0|||
33684229|NCT02574078|63164743|FG004|Treatment Period|Adverse event unrelated to drug|2|||
33684230|NCT02574078|63164744|FG005|Treatment Period|Adverse event unrelated to drug|3|||
33684231|NCT02574078|63164745|FG006|Treatment Period|Adverse event unrelated to drug|0|||
33684232|NCT02574078|63164746|FG007|Treatment Period|Adverse event unrelated to drug|0|||
33684233|NCT02574078|63164747|FG008|Treatment Period|Adverse event unrelated to drug|1|||
33684234|NCT02574078|63164748|FG009|Treatment Period|Adverse event unrelated to drug|2|||
33684235|NCT02574078|63164749|FG010|Treatment Period|Adverse event unrelated to drug|4|||
33684236|NCT02574078|63164750|FG011|Treatment Period|Adverse event unrelated to drug|1|||
33684237|NCT02574078|63164751|FG012|Treatment Period|Adverse event unrelated to drug|0|||
33684238|NCT02574078|63164739|FG000|Treatment Period|Administrative reason by Sponsor|0|||
33684239|NCT02574078|63164740|FG001|Treatment Period|Administrative reason by Sponsor|1|||
33684240|NCT02574078|63164741|FG002|Treatment Period|Administrative reason by Sponsor|0|||
33684241|NCT02574078|63164742|FG003|Treatment Period|Administrative reason by Sponsor|0|||
33684242|NCT02574078|63164743|FG004|Treatment Period|Administrative reason by Sponsor|0|||
33684243|NCT02574078|63164744|FG005|Treatment Period|Administrative reason by Sponsor|0|||
33684244|NCT02574078|63164745|FG006|Treatment Period|Administrative reason by Sponsor|1|||
33684245|NCT02574078|63164746|FG007|Treatment Period|Administrative reason by Sponsor|0|||
33684246|NCT02574078|63164747|FG008|Treatment Period|Administrative reason by Sponsor|0|||
33684247|NCT02574078|63164748|FG009|Treatment Period|Administrative reason by Sponsor|0|||
33684248|NCT02574078|63164749|FG010|Treatment Period|Administrative reason by Sponsor|0|||
33684249|NCT02574078|63164750|FG011|Treatment Period|Administrative reason by Sponsor|0|||
33684250|NCT02574078|63164751|FG012|Treatment Period|Administrative reason by Sponsor|3|||
33684251|NCT02574078|63164739|FG000|Treatment Period|Other reasons|1|||
33684252|NCT02574078|63164740|FG001|Treatment Period|Other reasons|0|||
33684253|NCT02574078|63164741|FG002|Treatment Period|Other reasons|1|||
33684254|NCT02574078|63164742|FG003|Treatment Period|Other reasons|3|||
33684255|NCT02574078|63164743|FG004|Treatment Period|Other reasons|3|||
33684256|NCT02574078|63164744|FG005|Treatment Period|Other reasons|1|||
33684257|NCT02574078|63164745|FG006|Treatment Period|Other reasons|2|||
33684258|NCT02574078|63164746|FG007|Treatment Period|Other reasons|1|||
33684259|NCT02574078|63164747|FG008|Treatment Period|Other reasons|3|||
33684260|NCT02574078|63164748|FG009|Treatment Period|Other reasons|1|||
33684261|NCT02574078|63164749|FG010|Treatment Period|Other reasons|1|||
33684262|NCT02574078|63164750|FG011|Treatment Period|Other reasons|3|||
33493122|NCT03781375|62871229|FG001|Double-blind Phase|Lack of Response|2|||
33493123|NCT03781375|62871228|FG000|Double-blind Phase|Other|1|||
33684263|NCT02574078|63164751|FG012|Treatment Period|Other reasons|1|||
33684264|NCT02574078|63164739|FG000|Treatment Period|Participant request to stop drug|0|||
33684265|NCT02574078|63164740|FG001|Treatment Period|Participant request to stop drug|0|||
33684266|NCT02574078|63164741|FG002|Treatment Period|Participant request to stop drug|0|||
33684267|NCT02574078|63164742|FG003|Treatment Period|Participant request to stop drug|2|||
33684268|NCT02574078|63164743|FG004|Treatment Period|Participant request to stop drug|4|||
33684269|NCT02574078|63164744|FG005|Treatment Period|Participant request to stop drug|0|||
33684270|NCT02574078|63164745|FG006|Treatment Period|Participant request to stop drug|1|||
33493124|NCT03781375|62871229|FG001|Double-blind Phase|Other|3|||
33493125|NCT03781375|62871228|FG000|Open-label Phase|Protocol Issues|0|||
33684271|NCT02574078|63164746|FG007|Treatment Period|Participant request to stop drug|0|||
33684272|NCT02574078|63164747|FG008|Treatment Period|Participant request to stop drug|3|||
33684273|NCT02574078|63164748|FG009|Treatment Period|Participant request to stop drug|2|||
33684274|NCT02574078|63164749|FG010|Treatment Period|Participant request to stop drug|2|||
33684275|NCT02574078|63164750|FG011|Treatment Period|Participant request to stop drug|4|||
33684276|NCT02574078|63164751|FG012|Treatment Period|Participant request to stop drug|1|||
33684277|NCT02574078|63164739|FG000|Treatment Period|Participant withdrew consent|0|||
33684278|NCT02574078|63164740|FG001|Treatment Period|Participant withdrew consent|0|||
33684279|NCT02574078|63164741|FG002|Treatment Period|Participant withdrew consent|0|||
33684280|NCT02574078|63164742|FG003|Treatment Period|Participant withdrew consent|0|||
33684281|NCT02574078|63164743|FG004|Treatment Period|Participant withdrew consent|1|||
33684282|NCT02574078|63164744|FG005|Treatment Period|Participant withdrew consent|1|||
33684283|NCT02574078|63164745|FG006|Treatment Period|Participant withdrew consent|0|||
33684284|NCT02574078|63164746|FG007|Treatment Period|Participant withdrew consent|1|||
33684285|NCT02574078|63164747|FG008|Treatment Period|Participant withdrew consent|0|||
33684286|NCT02574078|63164748|FG009|Treatment Period|Participant withdrew consent|2|||
33684287|NCT02574078|63164749|FG010|Treatment Period|Participant withdrew consent|1|||
33684288|NCT02574078|63164750|FG011|Treatment Period|Participant withdrew consent|4|||
33684289|NCT02574078|63164751|FG012|Treatment Period|Participant withdrew consent|1|||
33684290|NCT02574078|63164739|FG000|Treatment Period|Participant no longer meets criteria|0|||
33684291|NCT02574078|63164740|FG001|Treatment Period|Participant no longer meets criteria|0|||
33684292|NCT02574078|63164741|FG002|Treatment Period|Participant no longer meets criteria|0|||
33684293|NCT02574078|63164742|FG003|Treatment Period|Participant no longer meets criteria|0|||
33684294|NCT02574078|63164743|FG004|Treatment Period|Participant no longer meets criteria|1|||
33684295|NCT02574078|63164744|FG005|Treatment Period|Participant no longer meets criteria|0|||
33684296|NCT02574078|63164745|FG006|Treatment Period|Participant no longer meets criteria|0|||
33684297|NCT02574078|63164746|FG007|Treatment Period|Participant no longer meets criteria|0|||
33684298|NCT02574078|63164747|FG008|Treatment Period|Participant no longer meets criteria|0|||
33684299|NCT02574078|63164748|FG009|Treatment Period|Participant no longer meets criteria|1|||
33684300|NCT02574078|63164749|FG010|Treatment Period|Participant no longer meets criteria|1|||
33684301|NCT02574078|63164750|FG011|Treatment Period|Participant no longer meets criteria|1|||
33684302|NCT02574078|63164751|FG012|Treatment Period|Participant no longer meets criteria|0|||
33684303|NCT02574078|63164739|FG000|Treatment Period|Lost to Follow-up|0|||
33684304|NCT02574078|63164740|FG001|Treatment Period|Lost to Follow-up|0|||
33684305|NCT02574078|63164741|FG002|Treatment Period|Lost to Follow-up|0|||
33684306|NCT02574078|63164742|FG003|Treatment Period|Lost to Follow-up|0|||
33684307|NCT02574078|63164743|FG004|Treatment Period|Lost to Follow-up|0|||
33684308|NCT02574078|63164744|FG005|Treatment Period|Lost to Follow-up|0|||
33684309|NCT02574078|63164745|FG006|Treatment Period|Lost to Follow-up|0|||
33684310|NCT02574078|63164746|FG007|Treatment Period|Lost to Follow-up|0|||
33684311|NCT02574078|63164747|FG008|Treatment Period|Lost to Follow-up|0|||
33684312|NCT02574078|63164748|FG009|Treatment Period|Lost to Follow-up|1|||
33684313|NCT02574078|63164749|FG010|Treatment Period|Lost to Follow-up|0|||
33684314|NCT02574078|63164750|FG011|Treatment Period|Lost to Follow-up|1|||
33684315|NCT02574078|63164751|FG012|Treatment Period|Lost to Follow-up|0|||
33684316|NCT02574078|63164739|FG000|Treatment Period|Maximum clinical benefit|0|||
33684317|NCT02574078|63164740|FG001|Treatment Period|Maximum clinical benefit|0|||
33684318|NCT02574078|63164741|FG002|Treatment Period|Maximum clinical benefit|0|||
33684319|NCT02574078|63164742|FG003|Treatment Period|Maximum clinical benefit|0|||
33684320|NCT02574078|63164743|FG004|Treatment Period|Maximum clinical benefit|0|||
33684321|NCT02574078|63164744|FG005|Treatment Period|Maximum clinical benefit|0|||
33684322|NCT02574078|63164745|FG006|Treatment Period|Maximum clinical benefit|0|||
33684323|NCT02574078|63164746|FG007|Treatment Period|Maximum clinical benefit|0|||
33684324|NCT02574078|63164747|FG008|Treatment Period|Maximum clinical benefit|0|||
33684325|NCT02574078|63164748|FG009|Treatment Period|Maximum clinical benefit|1|||
33684326|NCT02574078|63164749|FG010|Treatment Period|Maximum clinical benefit|0|||
33684327|NCT02574078|63164750|FG011|Treatment Period|Maximum clinical benefit|0|||
33684328|NCT02574078|63164751|FG012|Treatment Period|Maximum clinical benefit|0|||
33684329|NCT02565810|63164869|FG000|Overall Study|Withdrawal by Subject|1|||
33684330|NCT02561832|63165034|FG000|Overall Study|Withdrawal by Subject|1|||
33684331|NCT02561832|63165035|FG001|Overall Study|Withdrawal by Subject|1|||
33684332|NCT02561832|63165034|FG000|Overall Study|Adverse Event|3|||
33684333|NCT02561832|63165035|FG001|Overall Study|Adverse Event|0|||
33684334|NCT02561832|63165034|FG000|Overall Study|Disease progression|3|||
33684335|NCT02561832|63165035|FG001|Overall Study|Disease progression|3|||
33684336|NCT00985088|63166679|FG000|Overall Study|Serious Adverse Event|1|||
33684337|NCT00985088|63166680|FG001|Overall Study|Serious Adverse Event|1|||
33684338|NCT00985088|63166681|FG002|Overall Study|Serious Adverse Event|0|||
33684339|NCT00985088|63166682|FG003|Overall Study|Serious Adverse Event|0|||
33684340|NCT00985088|63166683|FG004|Overall Study|Serious Adverse Event|0|||
33684341|NCT00985088|63166684|FG005|Overall Study|Serious Adverse Event|0|||
33684342|NCT00985088|63166685|FG006|Overall Study|Serious Adverse Event|0|||
33684343|NCT00985088|63166686|FG007|Overall Study|Serious Adverse Event|1|||
33684344|NCT00985088|63166679|FG000|Overall Study|Adverse Event|0|||
33684345|NCT00985088|63166680|FG001|Overall Study|Adverse Event|0|||
33684346|NCT00985088|63166681|FG002|Overall Study|Adverse Event|1|||
33684347|NCT00985088|63166682|FG003|Overall Study|Adverse Event|0|||
33684348|NCT00985088|63166683|FG004|Overall Study|Adverse Event|0|||
33684349|NCT00985088|63166684|FG005|Overall Study|Adverse Event|0|||
33684350|NCT00985088|63166685|FG006|Overall Study|Adverse Event|0|||
33684351|NCT00985088|63166686|FG007|Overall Study|Adverse Event|0|||
33684352|NCT00985088|63166679|FG000|Overall Study|Withdrawal by Subject|4|||
33684353|NCT00985088|63166680|FG001|Overall Study|Withdrawal by Subject|0|||
33684354|NCT00985088|63166681|FG002|Overall Study|Withdrawal by Subject|0|||
33684355|NCT00985088|63166682|FG003|Overall Study|Withdrawal by Subject|1|||
33684356|NCT00985088|63166683|FG004|Overall Study|Withdrawal by Subject|3|||
33684357|NCT00985088|63166684|FG005|Overall Study|Withdrawal by Subject|2|||
33684358|NCT00985088|63166685|FG006|Overall Study|Withdrawal by Subject|1|||
33684359|NCT00985088|63166686|FG007|Overall Study|Withdrawal by Subject|2|||
33684360|NCT00985088|63166679|FG000|Overall Study|Migrated/moved from study area|0|||
33684361|NCT00985088|63166680|FG001|Overall Study|Migrated/moved from study area|0|||
33684362|NCT00985088|63166681|FG002|Overall Study|Migrated/moved from study area|1|||
33684363|NCT00985088|63166682|FG003|Overall Study|Migrated/moved from study area|0|||
33684364|NCT00985088|63166683|FG004|Overall Study|Migrated/moved from study area|0|||
33684365|NCT00985088|63166684|FG005|Overall Study|Migrated/moved from study area|0|||
33684366|NCT00985088|63166685|FG006|Overall Study|Migrated/moved from study area|0|||
33684367|NCT00985088|63166686|FG007|Overall Study|Migrated/moved from study area|1|||
33684368|NCT00985088|63166679|FG000|Overall Study|Lost to Follow-up|6|||
33684369|NCT00985088|63166680|FG001|Overall Study|Lost to Follow-up|1|||
33684370|NCT00985088|63166681|FG002|Overall Study|Lost to Follow-up|2|||
33684371|NCT00985088|63166682|FG003|Overall Study|Lost to Follow-up|6|||
33684372|NCT00985088|63166683|FG004|Overall Study|Lost to Follow-up|6|||
33684373|NCT00985088|63166684|FG005|Overall Study|Lost to Follow-up|5|||
33684374|NCT00985088|63166685|FG006|Overall Study|Lost to Follow-up|3|||
33684375|NCT00985088|63166686|FG007|Overall Study|Lost to Follow-up|2|||
33684376|NCT00984542|63166732|FG000|Overall Study|disease progression|19|||
33684377|NCT00984542|63166732|FG000|Overall Study|toxicity|7|||
33684378|NCT00984542|63166732|FG000|Overall Study|Death|7|||
33684379|NCT00984542|63166732|FG000|Overall Study|complicating disease|3|||
33684380|NCT00984542|63166732|FG000|Overall Study|Withdrawal by Subject|3|||
33684381|NCT00984542|63166732|FG000|Overall Study|clinical deterioration|2|||
33684382|NCT00983918|63166741|FG000|Overall Study|conversion to open cholecystectomy|0|||
33684383|NCT00983918|63166742|FG001|Overall Study|conversion to open cholecystectomy|2|||
33684384|NCT00983918|63166743|FG002|Overall Study|conversion to open cholecystectomy|2|||
33684385|NCT00983918|63166744|FG003|Overall Study|conversion to open cholecystectomy|2|||
33684386|NCT00983528|63166754|FG000|Overall Study|Death|4|||
33684387|NCT00983528|63166754|FG000|Overall Study|Lost to Follow-up|1|||
33684388|NCT00983528|63166754|FG000|Overall Study|Study Terminated|1|||
33684389|NCT00983372|63166758|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
33684390|NCT00983372|63166758|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
33684391|NCT00983372|63166758|FG000|Diltiazem ER Alone|Adverse Event|1|||
33684392|NCT00983294|63166790|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
33684393|NCT00983294|63166790|FG000|Colchicine With Azithromycin|Adverse Event|1|||
33684394|NCT00982280|63166806|FG000|Observation Period|Not eligible to be dosed|19|||
33684395|NCT00982280|63166806|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
33684396|NCT00982280|63166806|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
33684397|NCT00982280|63166806|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
33684398|NCT00982280|63166806|FG000|Maintenance Period|Adverse Event|1|||
33684399|NCT00981578|63166824|FG000|Overall Study|Death|1|||
33684400|NCT00981578|63166824|FG000|Overall Study|Withdrawal by Subject|2|||
33684401|NCT00980798|63166847|FG000|Overall Study|Adverse Event|7|||
33684402|NCT00980798|63166848|FG001|Overall Study|Adverse Event|36|||
33684403|NCT00980798|63166847|FG000|Overall Study|Lack of Efficacy|16|||
33684404|NCT00980798|63166848|FG001|Overall Study|Lack of Efficacy|5|||
33684405|NCT00980798|63166847|FG000|Overall Study|Lost to Follow-up|0|||
33684406|NCT00980798|63166848|FG001|Overall Study|Lost to Follow-up|1|||
33684407|NCT00980798|63166847|FG000|Overall Study|Physician Decision|2|||
33684408|NCT00980798|63166848|FG001|Overall Study|Physician Decision|1|||
33684409|NCT00980798|63166847|FG000|Overall Study|Withdrawal by Subject|8|||
33684410|NCT00980798|63166848|FG001|Overall Study|Withdrawal by Subject|11|||
33684411|NCT00980798|63166847|FG000|Overall Study|Other|0|||
33684412|NCT00980798|63166848|FG001|Overall Study|Other|1|||
33684413|NCT00980330|63166993|FG000|Overall Study|Adverse Event|0|||
33684414|NCT00980330|63166994|FG001|Overall Study|Adverse Event|0|||
33684415|NCT00980330|63166995|FG002|Overall Study|Adverse Event|0|||
33684416|NCT00980330|63166996|FG003|Overall Study|Adverse Event|1|||
33684417|NCT00980330|63166997|FG004|Overall Study|Adverse Event|0|||
33684418|NCT00980330|63166998|FG005|Overall Study|Adverse Event|0|||
33684419|NCT00980330|63166999|FG006|Overall Study|Adverse Event|0|||
33684420|NCT00980330|63166993|FG000|Overall Study|Lost to Follow-up|1|||
33684421|NCT00980330|63166994|FG001|Overall Study|Lost to Follow-up|1|||
33684422|NCT00980330|63166995|FG002|Overall Study|Lost to Follow-up|4|||
33684423|NCT00980330|63166996|FG003|Overall Study|Lost to Follow-up|2|||
33684424|NCT00980330|63166997|FG004|Overall Study|Lost to Follow-up|1|||
33684425|NCT00980330|63166998|FG005|Overall Study|Lost to Follow-up|1|||
33684426|NCT00980330|63166999|FG006|Overall Study|Lost to Follow-up|2|||
33684427|NCT00980330|63166993|FG000|Overall Study|Withdrawal by Subject|2|||
33684428|NCT00980330|63166994|FG001|Overall Study|Withdrawal by Subject|4|||
33684429|NCT00980330|63166995|FG002|Overall Study|Withdrawal by Subject|4|||
33684430|NCT00980330|63166996|FG003|Overall Study|Withdrawal by Subject|1|||
33684431|NCT00980330|63166997|FG004|Overall Study|Withdrawal by Subject|3|||
33684432|NCT00980330|63166998|FG005|Overall Study|Withdrawal by Subject|2|||
33684433|NCT00980330|63166999|FG006|Overall Study|Withdrawal by Subject|5|||
33684434|NCT00980330|63166993|FG000|Overall Study|(not specified)|2|||
33684435|NCT00980330|63166994|FG001|Overall Study|(not specified)|0|||
33684436|NCT00980330|63166995|FG002|Overall Study|(not specified)|0|||
33684437|NCT00980330|63166996|FG003|Overall Study|(not specified)|1|||
33684438|NCT00980330|63166997|FG004|Overall Study|(not specified)|1|||
33684439|NCT00980330|63166998|FG005|Overall Study|(not specified)|1|||
33684440|NCT00980330|63166999|FG006|Overall Study|(not specified)|0|||
33684441|NCT00980174|63167043|FG000|Overall Study|Withdrawal by Subject|1|||
33684442|NCT00980174|63167044|FG001|Overall Study|Withdrawal by Subject|4|||
33684443|NCT00980174|63167043|FG000|Overall Study|Adverse Event|0|||
33684444|NCT00980174|63167044|FG001|Overall Study|Adverse Event|3|||
33684445|NCT00980174|63167043|FG000|Overall Study|Ineligibility determined|2|||
33684446|NCT00980174|63167044|FG001|Overall Study|Ineligibility determined|1|||
33684447|NCT00980174|63167043|FG000|Overall Study|Death|1|||
33684448|NCT00980174|63167044|FG001|Overall Study|Death|1|||
33684449|NCT00980174|63167043|FG000|Overall Study|Other|0|||
33684450|NCT00980174|63167044|FG001|Overall Study|Other|1|||
33684451|NCT00980018|63167072|FG000|Overall Study|Adverse Event|8|||
33684452|NCT00980018|63167072|FG000|Overall Study|Patient withdrew consent|3|||
33684453|NCT00980018|63167072|FG000|Overall Study|Lost to Follow-up|1|||
33684454|NCT00988052|63167095|FG000|Overall Study|Missing|1|||
33684455|NCT00988052|63167096|FG001|Overall Study|Missing|0|||
33684456|NCT00988052|63167095|FG000|Overall Study|Teva requested subject withdrawal|3|||
33684457|NCT00988052|63167096|FG001|Overall Study|Teva requested subject withdrawal|1|||
33684458|NCT00988052|63167095|FG000|Overall Study|Death|1|||
33684459|NCT00988052|63167096|FG001|Overall Study|Death|3|||
33684460|NCT00988052|63167095|FG000|Overall Study|Protocol Violation|6|||
33684461|NCT00988052|63167096|FG001|Overall Study|Protocol Violation|5|||
33684462|NCT00988052|63167095|FG000|Overall Study|Pregnancy|6|||
33684463|NCT00988052|63167096|FG001|Overall Study|Pregnancy|6|||
33684464|NCT00988052|63167095|FG000|Overall Study|Lack of Efficacy|8|||
33684465|NCT00988052|63167096|FG001|Overall Study|Lack of Efficacy|7|||
33684466|NCT00988052|63167095|FG000|Overall Study|Lost to Follow-up|6|||
33684467|NCT00988052|63167096|FG001|Overall Study|Lost to Follow-up|11|||
33684468|NCT00988052|63167095|FG000|Overall Study|Physician Decision|27|||
33684469|NCT00988052|63167096|FG001|Overall Study|Physician Decision|28|||
33684470|NCT00988052|63167095|FG000|Overall Study|Adverse Event|35|||
33684471|NCT00988052|63167096|FG001|Overall Study|Adverse Event|28|||
33684472|NCT00988052|63167095|FG000|Overall Study|Withdrawal by Subject|90|||
33684473|NCT00988052|63167096|FG001|Overall Study|Withdrawal by Subject|91|||
33684474|NCT00988052|63167095|FG000|Overall Study|Study terminated by sponsor|240|||
33684475|NCT00988052|63167096|FG001|Overall Study|Study terminated by sponsor|236|||
33684476|NCT02569710|63167197|FG000|Overall Study|Adverse Event|1|||
33684477|NCT02569710|63167198|FG001|Overall Study|Adverse Event|0|||
33684478|NCT02569710|63167199|FG002|Overall Study|Adverse Event|0|||
33684479|NCT02569710|63167200|FG003|Overall Study|Adverse Event|0|||
33684480|NCT02569710|63167201|FG004|Overall Study|Adverse Event|0|||
33684481|NCT02569710|63167202|FG005|Overall Study|Adverse Event|0|||
33684482|NCT02569710|63167203|FG006|Overall Study|Adverse Event|0|||
33684483|NCT02569710|63167204|FG007|Overall Study|Adverse Event|0|||
33595284|NCT02121795|62994383|FG001|Double-Blind Phase|Protocol Violation|3|||
33595285|NCT02121795|62994382|FG000|Double-Blind Phase|Death|1|||
33595286|NCT02121795|62994383|FG001|Double-Blind Phase|Death|1|||
33595287|NCT02121795|62994382|FG000|Open-Label Phase|Physician Decision|8|||
33595288|NCT02121795|62994383|FG001|Open-Label Phase|Physician Decision|8|||
33595289|NCT02121795|62994382|FG000|Open-Label Phase|Withdrawal by Subject|3|||
33595290|NCT02121795|62994383|FG001|Open-Label Phase|Withdrawal by Subject|2|||
33595291|NCT02121795|62994382|FG000|Open-Label Phase|Lost to Follow-up|1|||
33684484|NCT02569710|63167205|FG008|Overall Study|Adverse Event|0|||
33684485|NCT02569710|63167206|FG009|Overall Study|Adverse Event|0|||
33684486|NCT02569710|63167197|FG000|Overall Study|Lost to Follow-up|0|||
33684487|NCT02569710|63167198|FG001|Overall Study|Lost to Follow-up|0|||
33684488|NCT02569710|63167199|FG002|Overall Study|Lost to Follow-up|0|||
33595292|NCT02121795|62994383|FG001|Open-Label Phase|Lost to Follow-up|0|||
33684489|NCT02569710|63167200|FG003|Overall Study|Lost to Follow-up|0|||
33684490|NCT02569710|63167201|FG004|Overall Study|Lost to Follow-up|0|||
33684491|NCT02569710|63167202|FG005|Overall Study|Lost to Follow-up|0|||
33684492|NCT02569710|63167203|FG006|Overall Study|Lost to Follow-up|1|||
33684493|NCT02569710|63167204|FG007|Overall Study|Lost to Follow-up|0|||
33684494|NCT02569710|63167205|FG008|Overall Study|Lost to Follow-up|1|||
33684495|NCT02569710|63167206|FG009|Overall Study|Lost to Follow-up|0|||
33684496|NCT02569710|63167197|FG000|Overall Study|Virologic failure|0|||
33684497|NCT02569710|63167198|FG001|Overall Study|Virologic failure|0|||
33684498|NCT02569710|63167199|FG002|Overall Study|Virologic failure|0|||
33684499|NCT02569710|63167200|FG003|Overall Study|Virologic failure|0|||
33684500|NCT02569710|63167201|FG004|Overall Study|Virologic failure|1|||
33684501|NCT02569710|63167202|FG005|Overall Study|Virologic failure|0|||
33684502|NCT02569710|63167203|FG006|Overall Study|Virologic failure|1|||
33684503|NCT02569710|63167204|FG007|Overall Study|Virologic failure|0|||
33684504|NCT02569710|63167205|FG008|Overall Study|Virologic failure|0|||
33684505|NCT02569710|63167206|FG009|Overall Study|Virologic failure|0|||
33684506|NCT02569710|63167197|FG000|Overall Study|Withdrawal by Subject|0|||
33684507|NCT02569710|63167198|FG001|Overall Study|Withdrawal by Subject|0|||
33684508|NCT02569710|63167199|FG002|Overall Study|Withdrawal by Subject|0|||
33684509|NCT02569710|63167200|FG003|Overall Study|Withdrawal by Subject|0|||
33684510|NCT02569710|63167201|FG004|Overall Study|Withdrawal by Subject|0|||
33684511|NCT02569710|63167202|FG005|Overall Study|Withdrawal by Subject|1|||
33684512|NCT02569710|63167203|FG006|Overall Study|Withdrawal by Subject|0|||
33684513|NCT02569710|63167204|FG007|Overall Study|Withdrawal by Subject|0|||
33684514|NCT02569710|63167205|FG008|Overall Study|Withdrawal by Subject|0|||
33684515|NCT02569710|63167206|FG009|Overall Study|Withdrawal by Subject|0|||
33684516|NCT02569476|63167308|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
33684517|NCT02569476|63167308|FG000|Overall Study|Death|33|||
33684518|NCT02569476|63167308|FG000|Overall Study|Withdrawal by Subject|9|||
33684519|NCT02569476|63167308|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
33684520|NCT02569476|63167308|FG000|Overall Study|Palliative care|1|||
33684521|NCT02569476|63167308|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
33684522|NCT02569476|63167308|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
33684523|NCT02565576|63167380|FG000|Overall Study|abnormal lab value|2|||
33684524|NCT02565576|63167381|FG001|Overall Study|abnormal lab value|0|||
33684525|NCT02565576|63167380|FG000|Overall Study|subject / guardian decision|1|||
33684526|NCT02565576|63167381|FG001|Overall Study|subject / guardian decision|3|||
33684527|NCT02565576|63167380|FG000|Overall Study|Lost to Follow-up|1|||
33684528|NCT02565576|63167381|FG001|Overall Study|Lost to Follow-up|0|||
33684529|NCT02565576|63167380|FG000|Overall Study|Death|0|||
33684530|NCT02565576|63167381|FG001|Overall Study|Death|2|||
33684531|NCT02565576|63167380|FG000|Overall Study|Adverse Event|1|||
33684532|NCT02565576|63167381|FG001|Overall Study|Adverse Event|0|||
33684533|NCT02569398|63167412|FG000|Overall Study|Adverse Event|0|||
33684534|NCT02569398|63167413|FG001|Overall Study|Adverse Event|1|||
33684535|NCT02569398|63167414|FG002|Overall Study|Adverse Event|6|||
33684536|NCT02569398|63167412|FG000|Overall Study|Withdrawal by Subject|43|||
33684537|NCT02569398|63167413|FG001|Overall Study|Withdrawal by Subject|43|||
33684538|NCT02569398|63167414|FG002|Overall Study|Withdrawal by Subject|30|||
33684539|NCT02569398|63167412|FG000|Overall Study|Study terminated by sponsor|130|||
33684540|NCT02569398|63167413|FG001|Overall Study|Study terminated by sponsor|131|||
33684541|NCT02569398|63167414|FG002|Overall Study|Study terminated by sponsor|134|||
33684542|NCT02569398|63167412|FG000|Overall Study|Other|12|||
33684543|NCT02569398|63167413|FG001|Overall Study|Other|14|||
33684544|NCT02569398|63167414|FG002|Overall Study|Other|13|||
33684545|NCT02569242|63167458|FG000|Overall Study|Death|1|||
33684546|NCT02569242|63167459|FG001|Overall Study|Death|0|||
33684547|NCT02569242|63167458|FG000|Overall Study|Withdrawal by Subject|0|||
33684548|NCT02569242|63167459|FG001|Overall Study|Withdrawal by Subject|1|||
33684549|NCT01663740|63167527|FG000|Overall Study|Lost to Follow-up|1|||
33684550|NCT01663740|63167528|FG001|Overall Study|Lost to Follow-up|4|||
33684551|NCT01663740|63167527|FG000|Overall Study|Other|9|||
33684552|NCT01663740|63167528|FG001|Overall Study|Other|2|||
33684553|NCT01663740|63167527|FG000|Overall Study|Inclusion/Exclusion not met|1|||
33684554|NCT01663740|63167528|FG001|Overall Study|Inclusion/Exclusion not met|0|||
33684555|NCT01663740|63167527|FG000|Overall Study|Death|0|||
33684556|NCT01663740|63167528|FG001|Overall Study|Death|1|||
33684557|NCT01663740|63167527|FG000|Overall Study|Withdrawal by Subject|2|||
33684558|NCT01663740|63167528|FG001|Overall Study|Withdrawal by Subject|1|||
33684559|NCT01663740|63167527|FG000|Overall Study|No end of study status|3|||
33684560|NCT01663740|63167528|FG001|Overall Study|No end of study status|0|||
33684561|NCT01663506|63167644|FG000|Overall Study|Lack of Efficacy|3|||
33684562|NCT01663506|63167644|FG000|Overall Study|Consent Withdrawal by Subject|1|||
33684563|NCT01663506|63167644|FG000|Overall Study|Lost to Follow-up|1|||
33684564|NCT01663506|63167644|FG000|Overall Study|Adverse Event|1|||
33684565|NCT01663506|63167644|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
33684566|NCT02568384|63167648|FG000|Overall Study|Mobile devices incompatible with App|2|||
33684567|NCT02965976|63167744|FG000|Overall Study|Withdrawal by Subject|2|||
33684568|NCT02965976|63167745|FG001|Overall Study|Withdrawal by Subject|0|||
33493126|NCT03781375|62871229|FG001|Open-label Phase|Protocol Issues|1|||
33493127|NCT03781375|62871228|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
33493128|NCT03781375|62871229|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
33493129|NCT03781375|62871228|FG000|Open-label Phase|Other|2|||
33493130|NCT03781375|62871229|FG001|Open-label Phase|Other|2|||
33493131|NCT03779503|62871236|FG000|First Intervention|Adverse Event|0|||
33493132|NCT03779503|62871237|FG001|First Intervention|Adverse Event|1|||
33493133|NCT03779503|62871236|FG000|First Intervention|Withdrawal by Subject|1|||
33493134|NCT03779503|62871237|FG001|First Intervention|Withdrawal by Subject|0|||
33493135|NCT03150056|62871249|FG000|Overall Study|Withdrawal by Subject|0|||
33595293|NCT02158533|62994394|FG000|Stage 1|Adverse Event|6|||
33595294|NCT02158533|62994395|FG001|Stage 1|Adverse Event|4|||
33595295|NCT02158533|62994396|FG002|Stage 1|Adverse Event|7|||
33595296|NCT02158533|62994397|FG003|Stage 1|Adverse Event|0|||
33595297|NCT02158533|62994398|FG004|Stage 1|Adverse Event|0|||
33595298|NCT02158533|62994399|FG005|Stage 1|Adverse Event|0|||
33595299|NCT02158533|62994394|FG000|Stage 1|Withdrawal by Subject|3|||
33595300|NCT02158533|62994395|FG001|Stage 1|Withdrawal by Subject|2|||
33595301|NCT02158533|62994396|FG002|Stage 1|Withdrawal by Subject|1|||
33595302|NCT02158533|62994397|FG003|Stage 1|Withdrawal by Subject|0|||
33595303|NCT02158533|62994398|FG004|Stage 1|Withdrawal by Subject|0|||
33595304|NCT02158533|62994399|FG005|Stage 1|Withdrawal by Subject|0|||
33595305|NCT02158533|62994394|FG000|Stage 1|Lack of Efficacy|1|||
33595306|NCT02158533|62994395|FG001|Stage 1|Lack of Efficacy|0|||
33595307|NCT02158533|62994396|FG002|Stage 1|Lack of Efficacy|0|||
33595308|NCT02158533|62994397|FG003|Stage 1|Lack of Efficacy|0|||
33595309|NCT02158533|62994398|FG004|Stage 1|Lack of Efficacy|0|||
33595310|NCT02158533|62994399|FG005|Stage 1|Lack of Efficacy|0|||
33595311|NCT02158533|62994394|FG000|Stage 1|Lost to Follow-up|3|||
33595312|NCT02158533|62994395|FG001|Stage 1|Lost to Follow-up|1|||
33595313|NCT02158533|62994396|FG002|Stage 1|Lost to Follow-up|0|||
33595314|NCT02158533|62994397|FG003|Stage 1|Lost to Follow-up|0|||
33595315|NCT02158533|62994398|FG004|Stage 1|Lost to Follow-up|0|||
33595316|NCT02158533|62994399|FG005|Stage 1|Lost to Follow-up|0|||
33595317|NCT02158533|62994394|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
33595318|NCT02158533|62994395|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
33595319|NCT02158533|62994396|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
33595320|NCT02158533|62994397|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
33595321|NCT02158533|62994398|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
33595322|NCT02158533|62994399|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
33595323|NCT02158533|62994394|FG000|Stage 1|Non-compliance with study visits|1|||
33595324|NCT02158533|62994395|FG001|Stage 1|Non-compliance with study visits|0|||
33595325|NCT02158533|62994396|FG002|Stage 1|Non-compliance with study visits|0|||
33595326|NCT02158533|62994397|FG003|Stage 1|Non-compliance with study visits|0|||
33595327|NCT02158533|62994398|FG004|Stage 1|Non-compliance with study visits|0|||
33595328|NCT02158533|62994399|FG005|Stage 1|Non-compliance with study visits|0|||
33595329|NCT02158533|62994394|FG000|Stage 2|Adverse Event|0|||
33595330|NCT02158533|62994395|FG001|Stage 2|Adverse Event|0|||
33595331|NCT02158533|62994396|FG002|Stage 2|Adverse Event|0|||
33595332|NCT02158533|62994397|FG003|Stage 2|Adverse Event|0|||
33595333|NCT02158533|62994398|FG004|Stage 2|Adverse Event|0|||
33595334|NCT02158533|62994399|FG005|Stage 2|Adverse Event|1|||
33595335|NCT02158533|62994394|FG000|Stage 2|Lack of Efficacy|0|||
33595336|NCT02158533|62994395|FG001|Stage 2|Lack of Efficacy|0|||
33595337|NCT02158533|62994396|FG002|Stage 2|Lack of Efficacy|0|||
33595338|NCT02158533|62994397|FG003|Stage 2|Lack of Efficacy|0|||
33595339|NCT02158533|62994398|FG004|Stage 2|Lack of Efficacy|1|||
33595340|NCT02158533|62994399|FG005|Stage 2|Lack of Efficacy|0|||
33595341|NCT02158533|62994394|FG000|Stage 2|Lost to Follow-up|0|||
33595342|NCT02158533|62994395|FG001|Stage 2|Lost to Follow-up|0|||
33595343|NCT02158533|62994396|FG002|Stage 2|Lost to Follow-up|0|||
33595344|NCT02158533|62994397|FG003|Stage 2|Lost to Follow-up|1|||
33595345|NCT02158533|62994398|FG004|Stage 2|Lost to Follow-up|1|||
33595346|NCT02158533|62994399|FG005|Stage 2|Lost to Follow-up|2|||
33595347|NCT02158533|62994394|FG000|Stage 2|Withdrawal by Subject|0|||
33595348|NCT02158533|62994395|FG001|Stage 2|Withdrawal by Subject|0|||
33595349|NCT02158533|62994396|FG002|Stage 2|Withdrawal by Subject|0|||
33595350|NCT02158533|62994397|FG003|Stage 2|Withdrawal by Subject|0|||
33595351|NCT02158533|62994398|FG004|Stage 2|Withdrawal by Subject|1|||
33595352|NCT02158533|62994399|FG005|Stage 2|Withdrawal by Subject|2|||
33595353|NCT02158533|62994394|FG000|Stage 2|Physician Decision|0|||
33595354|NCT02158533|62994395|FG001|Stage 2|Physician Decision|0|||
33493136|NCT03150056|62871250|FG001|Overall Study|Withdrawal by Subject|0|||
33595355|NCT02158533|62994396|FG002|Stage 2|Physician Decision|0|||
33595356|NCT02158533|62994397|FG003|Stage 2|Physician Decision|0|||
33595357|NCT02158533|62994398|FG004|Stage 2|Physician Decision|1|||
33595358|NCT02158533|62994399|FG005|Stage 2|Physician Decision|0|||
33595359|NCT02158533|62994394|FG000|Stage 2|Pregnancy|0|||
33595360|NCT02158533|62994395|FG001|Stage 2|Pregnancy|0|||
33595361|NCT02158533|62994396|FG002|Stage 2|Pregnancy|0|||
33595362|NCT02158533|62994397|FG003|Stage 2|Pregnancy|1|||
33595363|NCT02158533|62994398|FG004|Stage 2|Pregnancy|0|||
33595364|NCT02158533|62994399|FG005|Stage 2|Pregnancy|0|||
33684569|NCT04125680|63167763|FG000|Overall Study|Lost to Follow-up|15|||
33684570|NCT02565186|63167787|FG000|Overall Study|Adverse Event|113|||
33684571|NCT02565186|63167788|FG001|Overall Study|Adverse Event|148|||
33684572|NCT02565186|63167787|FG000|Overall Study|Lost to Follow-up|102|||
33684573|NCT02565186|63167788|FG001|Overall Study|Lost to Follow-up|93|||
33684574|NCT02565186|63167787|FG000|Overall Study|Non-Compliance|57|||
33684575|NCT02565186|63167788|FG001|Overall Study|Non-Compliance|55|||
33684576|NCT02565186|63167787|FG000|Overall Study|Withdrawal by Subject|229|||
33684577|NCT02565186|63167788|FG001|Overall Study|Withdrawal by Subject|214|||
33684578|NCT02565186|63167787|FG000|Overall Study|Physician Decision|18|||
33684579|NCT02565186|63167788|FG001|Overall Study|Physician Decision|16|||
33684580|NCT02565186|63167787|FG000|Overall Study|Sponsor Request|5|||
33684581|NCT02565186|63167788|FG001|Overall Study|Sponsor Request|9|||
33684582|NCT02565186|63167787|FG000|Overall Study|Missing|1|||
33684583|NCT02565186|63167788|FG001|Overall Study|Missing|0|||
33684584|NCT02565186|63167787|FG000|Overall Study|Did Not Receive Study Drug|55|||
33684585|NCT02565186|63167788|FG001|Overall Study|Did Not Receive Study Drug|86|||
33684586|NCT02568072|63167794|FG000|Overall Study|Unavailable for appointment|23|||
33684587|NCT02568072|63167794|FG000|Overall Study|Unable to contact|3|||
33684588|NCT02568072|63167794|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
33684589|NCT02568072|63167794|FG000|Overall Study|Withdrawal by Subject|1|||
33684590|NCT02568072|63167794|FG000|Overall Study|Sustained injury, marathon not run|24|||
33684591|NCT02565108|63167801|FG000|Overall Study|Adverse Event|1|||
33684592|NCT02565108|63167802|FG001|Overall Study|Adverse Event|0|||
33684593|NCT02565108|63167801|FG000|Overall Study|Withdrew Consent|1|||
33684594|NCT02565108|63167802|FG001|Overall Study|Withdrew Consent|0|||
33684595|NCT02564952|63167808|FG000|Overall Study|Adverse Event|6|||
33684596|NCT02564952|63167808|FG000|Overall Study|Lost to Follow-up|1|||
33684597|NCT02564952|63167808|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
33684598|NCT02564952|63167808|FG000|Overall Study|Withdrawal by Subject|1|||
33684599|NCT02564952|63167808|FG000|Overall Study|Low Efficacy|1|||
33684600|NCT02564952|63167808|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
33684601|NCT02566902|63167814|FG000|Overall Study|Protocol Violation|2|||
33684602|NCT02566902|63167815|FG001|Overall Study|Protocol Violation|1|||
33684603|NCT02564796|63167823|FG000|Overall Study|Physician Decision|2|||
33684604|NCT02564796|63167824|FG001|Overall Study|Physician Decision|2|||
33684605|NCT02564718|63167832|FG000|Overall Study|Withdrew from treatment|0|||
33684606|NCT02564718|63167833|FG001|Overall Study|Withdrew from treatment|1|||
33684607|NCT01453946|63167839|FG000|Overall Study|Did not receive drug for the taper phase|1|||
33684608|NCT01453946|63167839|FG000|Overall Study|Protocol Violation|2|||
33684609|NCT01453946|63167839|FG000|Overall Study|Lack of Efficacy|3|||
33684610|NCT01453946|63167839|FG000|Overall Study|Adverse Event|3|||
33684611|NCT02563548|63167961|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
33684612|NCT02563548|63167962|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
33684613|NCT02563548|63167963|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
33684614|NCT02563548|63167964|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
33684615|NCT02563548|63167965|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
33684616|NCT02563548|63167966|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
33684617|NCT02563548|63167961|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
33684618|NCT02563548|63167962|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
33684619|NCT02563548|63167963|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
33493137|NCT03150056|62871251|FG002|Overall Study|Withdrawal by Subject|0|||
33684620|NCT02563548|63167964|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
33684621|NCT02563548|63167965|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
33684622|NCT02563548|63167966|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
33684623|NCT02563548|63167961|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
33684624|NCT02563548|63167962|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
33684625|NCT02563548|63167963|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
33684626|NCT02563548|63167964|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
33684627|NCT02563548|63167965|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
33684628|NCT02563548|63167966|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
33684629|NCT02563548|63167961|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
33684630|NCT02563548|63167962|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
33595365|NCT02158533|62994394|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
33595366|NCT02158533|62994395|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
33595367|NCT02158533|62994396|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
33595368|NCT02158533|62994397|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
33595369|NCT02158533|62994398|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
33595370|NCT02158533|62994399|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
33684631|NCT02563548|63167963|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
33684632|NCT02563548|63167964|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
33684633|NCT02563548|63167965|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
33684634|NCT02563548|63167966|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
33684635|NCT02563548|63167961|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
33684636|NCT02563548|63167962|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
33684637|NCT02563548|63167963|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
33684638|NCT02563548|63167964|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
33684639|NCT02563548|63167965|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
33684640|NCT02563548|63167966|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
33684641|NCT02563548|63167961|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
33684642|NCT02563548|63167962|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
33684643|NCT02563548|63167963|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
33684644|NCT02563548|63167964|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
33684645|NCT02563548|63167965|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
33684646|NCT02563548|63167966|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
33684647|NCT02563548|63167961|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
33684648|NCT02563548|63167962|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
33684649|NCT02563548|63167963|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
33684650|NCT02563548|63167964|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
33684651|NCT02563548|63167965|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
33684652|NCT02563548|63167966|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
33684653|NCT02563548|63167961|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
33684654|NCT02563548|63167962|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
33684655|NCT02563548|63167963|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
33684656|NCT02563548|63167964|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
33684657|NCT02563548|63167965|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
33684658|NCT02563548|63167966|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
33684659|NCT02563548|63167961|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
33684660|NCT02563548|63167962|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
33684661|NCT02563548|63167963|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
33684662|NCT02563548|63167964|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
33684663|NCT02563548|63167965|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
33595371|NCT02158533|62994394|FG000|Stage 2|Non-adherence with study visits|0|||
33595372|NCT02158533|62994395|FG001|Stage 2|Non-adherence with study visits|0|||
33684664|NCT02563548|63167966|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
33684665|NCT02563548|63167961|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
33684666|NCT02563548|63167962|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
33684667|NCT02563548|63167963|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
33595373|NCT02158533|62994396|FG002|Stage 2|Non-adherence with study visits|0|||
33595374|NCT02158533|62994397|FG003|Stage 2|Non-adherence with study visits|0|||
33595375|NCT02158533|62994398|FG004|Stage 2|Non-adherence with study visits|0|||
33595376|NCT02158533|62994399|FG005|Stage 2|Non-adherence with study visits|1|||
33310742|NCT01234350|62686156|FG000|Overall Study|Adverse Event|277|||
33595377|NCT02120781|62994415|FG000|Overall Study|Physician Decision|2|||
33595378|NCT02120781|62994416|FG001|Overall Study|Physician Decision|0|||
33595379|NCT02120781|62994415|FG000|Overall Study|Completion not documented|2|||
33684668|NCT02563548|63167964|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
33684669|NCT02563548|63167965|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
33684670|NCT02563548|63167966|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
33684671|NCT02563548|63167961|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
33684672|NCT02563548|63167962|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
33684673|NCT02563548|63167963|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
33684674|NCT02563548|63167964|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
33684675|NCT02563548|63167965|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
33684676|NCT02563548|63167966|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
33684677|NCT02563548|63167961|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
33684678|NCT02563548|63167962|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
33684679|NCT02563548|63167963|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
33684680|NCT02563548|63167964|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
33684681|NCT02563548|63167965|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
33684682|NCT02563548|63167966|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
33684683|NCT02559570|63168047|FG000|Overall Study|Adverse Event|0|||
33684684|NCT02559570|63168048|FG001|Overall Study|Adverse Event|2|||
33684685|NCT02559570|63168049|FG002|Overall Study|Adverse Event|0|||
33684686|NCT02559570|63168050|FG003|Overall Study|Adverse Event|1|||
33684687|NCT02559570|63168051|FG004|Overall Study|Adverse Event|0|||
33684688|NCT02559570|63168047|FG000|Overall Study|Withdrawal of Consent|0|||
33684689|NCT02559570|63168048|FG001|Overall Study|Withdrawal of Consent|0|||
33684690|NCT02559570|63168049|FG002|Overall Study|Withdrawal of Consent|1|||
33684691|NCT02559570|63168050|FG003|Overall Study|Withdrawal of Consent|2|||
33684692|NCT02559570|63168051|FG004|Overall Study|Withdrawal of Consent|1|||
33684693|NCT02559570|63168047|FG000|Overall Study|Lost to Follow-up|1|||
33684694|NCT02559570|63168048|FG001|Overall Study|Lost to Follow-up|0|||
33684695|NCT02559570|63168049|FG002|Overall Study|Lost to Follow-up|0|||
33684696|NCT02559570|63168050|FG003|Overall Study|Lost to Follow-up|0|||
33684697|NCT02559570|63168051|FG004|Overall Study|Lost to Follow-up|0|||
33684698|NCT02559570|63168047|FG000|Overall Study|Protocol Violation|1|||
33684699|NCT02559570|63168048|FG001|Overall Study|Protocol Violation|0|||
33684700|NCT02559570|63168049|FG002|Overall Study|Protocol Violation|0|||
33684701|NCT02559570|63168050|FG003|Overall Study|Protocol Violation|0|||
33684702|NCT02559570|63168051|FG004|Overall Study|Protocol Violation|1|||
33684703|NCT02559570|63168047|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33684704|NCT02559570|63168048|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33684705|NCT02559570|63168049|FG002|Overall Study|Other Miscellaneous Reasons|1|||
33684706|NCT02559570|63168050|FG003|Overall Study|Other Miscellaneous Reasons|0|||
33684707|NCT02559570|63168051|FG004|Overall Study|Other Miscellaneous Reasons|0|||
33684708|NCT02559414|63168406|FG000|Overall Study|Lost to Follow-up|0|||
33684709|NCT02559414|63168407|FG001|Overall Study|Lost to Follow-up|1|||
33684710|NCT02559414|63168408|FG002|Overall Study|Lost to Follow-up|0|||
33684711|NCT02559414|63168406|FG000|Overall Study|Withdrawal by Subject|1|||
33684712|NCT02559414|63168407|FG001|Overall Study|Withdrawal by Subject|0|||
33684713|NCT02559414|63168408|FG002|Overall Study|Withdrawal by Subject|1|||
33684714|NCT02559414|63168406|FG000|Overall Study|Other|0|||
33684715|NCT02559414|63168407|FG001|Overall Study|Other|1|||
33684716|NCT02559414|63168408|FG002|Overall Study|Other|1|||
33684717|NCT02558790|63168483|FG000|Overall Study|Lost to Follow-up|2|||
33684718|NCT02558790|63168483|FG000|Overall Study|Physician Decision|1|||
33684719|NCT02558790|63168483|FG000|Overall Study|Withdrawal by Subject|1|||
33684720|NCT02558790|63168483|FG000|Overall Study|Screen Fail|3|||
33684721|NCT02556138|63168509|FG000|Overall Study|Withdrawal by Subject|1|||
33684722|NCT02558400|63168592|FG000|Overall Study|Adverse Event|47|||
33684723|NCT02558400|63168593|FG001|Overall Study|Adverse Event|53|||
33684724|NCT02558400|63168594|FG002|Overall Study|Adverse Event|4|||
33684725|NCT02558400|63168592|FG000|Overall Study|Withdrawal by Subject|13|||
33684726|NCT02558400|63168593|FG001|Overall Study|Withdrawal by Subject|9|||
33684727|NCT02558400|63168594|FG002|Overall Study|Withdrawal by Subject|8|||
33684728|NCT02558400|63168592|FG000|Overall Study|Non-Compliant|0|||
33684729|NCT02558400|63168593|FG001|Overall Study|Non-Compliant|1|||
33684730|NCT02558400|63168594|FG002|Overall Study|Non-Compliant|3|||
33684731|NCT02558400|63168592|FG000|Overall Study|Lost to Follow-up|5|||
33684732|NCT02558400|63168593|FG001|Overall Study|Lost to Follow-up|5|||
33684733|NCT02558400|63168594|FG002|Overall Study|Lost to Follow-up|4|||
33684734|NCT02558400|63168592|FG000|Overall Study|Lack of Efficacy|0|||
33684735|NCT02558400|63168593|FG001|Overall Study|Lack of Efficacy|13|||
33684736|NCT02558400|63168594|FG002|Overall Study|Lack of Efficacy|1|||
33684737|NCT02558400|63168592|FG000|Overall Study|Disallowed Concurrent Medication|6|||
33684738|NCT02558400|63168593|FG001|Overall Study|Disallowed Concurrent Medication|7|||
33684739|NCT02558400|63168594|FG002|Overall Study|Disallowed Concurrent Medication|5|||
33684740|NCT02558400|63168592|FG000|Overall Study|Physician Decision|2|||
33684741|NCT02558400|63168593|FG001|Overall Study|Physician Decision|2|||
33684742|NCT02558400|63168594|FG002|Overall Study|Physician Decision|0|||
33595380|NCT02120781|62994416|FG001|Overall Study|Completion not documented|1|||
33595381|NCT02120625|62994422|FG000|Overall Study|Physician Decision|2|||
33595382|NCT02120469|62994429|FG000|Overall Study|HER-2/neu-amplified|1|||
33595383|NCT02120469|62994430|FG001|Overall Study|HER-2/neu-amplified|0|||
33595384|NCT02120469|62994431|FG002|Overall Study|HER-2/neu-amplified|1|||
33595385|NCT02157519|62994444|FG000|Overall Study|Death|3|||
33595386|NCT02157519|62994445|FG001|Overall Study|Death|1|||
33595387|NCT02157519|62994444|FG000|Overall Study|Withdrawal by Subject|7|||
33595388|NCT02157519|62994445|FG001|Overall Study|Withdrawal by Subject|0|||
33595389|NCT02157519|62994444|FG000|Overall Study|Lost to Follow-up|1|||
33595390|NCT02157519|62994445|FG001|Overall Study|Lost to Follow-up|0|||
33595391|NCT02180061|62994453|FG000|Overall Study|Adverse Event|4|||
33595392|NCT02180061|62994454|FG001|Overall Study|Adverse Event|2|||
33595393|NCT02180061|62994453|FG000|Overall Study|Clinical Progression|5|||
33595394|NCT02180061|62994454|FG001|Overall Study|Clinical Progression|1|||
33595395|NCT02180061|62994453|FG000|Overall Study|Progressive Disease|15|||
33595396|NCT02180061|62994454|FG001|Overall Study|Progressive Disease|5|||
33595397|NCT02180061|62994453|FG000|Overall Study|Physician Decision|1|||
33595398|NCT02180061|62994454|FG001|Overall Study|Physician Decision|0|||
33595399|NCT02179515|62994463|FG000|Overall Study|switched to alternative treatment|0|||
33595400|NCT02179515|62994464|FG001|Overall Study|switched to alternative treatment|1|||
33595401|NCT02179515|62994465|FG002|Overall Study|switched to alternative treatment|1|||
33595402|NCT02179515|62994463|FG000|Overall Study|Death|0|||
33595403|NCT02179515|62994464|FG001|Overall Study|Death|1|||
33595404|NCT02179515|62994465|FG002|Overall Study|Death|1|||
33595405|NCT02179515|62994463|FG000|Overall Study|refused further treatment|0|||
33595406|NCT02179515|62994464|FG001|Overall Study|refused further treatment|3|||
33595407|NCT02179515|62994465|FG002|Overall Study|refused further treatment|4|||
33595408|NCT02179515|62994463|FG000|Overall Study|Disease progression on study|2|||
33595409|NCT02179515|62994464|FG001|Overall Study|Disease progression on study|11|||
33595410|NCT02179515|62994465|FG002|Overall Study|Disease progression on study|8|||
33595411|NCT02120157|62994477|FG000|Overall Study|Death|8|||
33595412|NCT02119299|62994483|FG000|Overall Study|Withdrawal by Subject|7|||
33595413|NCT02119299|62994483|FG000|Overall Study|Lack of Efficacy|1|||
33595414|NCT02119299|62994483|FG000|Overall Study|Pregnancy|1|||
33595415|NCT02156271|62994489|FG000|Overall Study|Physician Decision|4|||
33595416|NCT02156271|62994490|FG001|Overall Study|Physician Decision|3|||
33595417|NCT01365455|62994499|FG000|Induction Period|Adverse Event|5|||
33595418|NCT01365455|62994500|FG001|Induction Period|Adverse Event|3|||
33595419|NCT01365455|62994501|FG002|Induction Period|Adverse Event|4|||
33595420|NCT01365455|62994502|FG003|Induction Period|Adverse Event|0|||
33595421|NCT01365455|62994503|FG004|Induction Period|Adverse Event|0|||
33595422|NCT01365455|62994499|FG000|Induction Period|Lack of Efficacy|1|||
33595423|NCT01365455|62994500|FG001|Induction Period|Lack of Efficacy|1|||
33595424|NCT01365455|62994501|FG002|Induction Period|Lack of Efficacy|0|||
33595425|NCT01365455|62994502|FG003|Induction Period|Lack of Efficacy|0|||
33595426|NCT01365455|62994503|FG004|Induction Period|Lack of Efficacy|0|||
33595427|NCT01365455|62994499|FG000|Induction Period|Pregnancy|0|||
33595428|NCT01365455|62994500|FG001|Induction Period|Pregnancy|1|||
33595429|NCT01365455|62994501|FG002|Induction Period|Pregnancy|0|||
33595430|NCT01365455|62994502|FG003|Induction Period|Pregnancy|0|||
33595431|NCT01365455|62994503|FG004|Induction Period|Pregnancy|0|||
33595432|NCT01365455|62994499|FG000|Induction Period|Protocol deviation|0|||
33595433|NCT01365455|62994500|FG001|Induction Period|Protocol deviation|1|||
33595434|NCT01365455|62994501|FG002|Induction Period|Protocol deviation|1|||
33595435|NCT01365455|62994502|FG003|Induction Period|Protocol deviation|0|||
33595436|NCT01365455|62994503|FG004|Induction Period|Protocol deviation|0|||
33595437|NCT01365455|62994499|FG000|Induction Period|Subject/guardian decision|9|||
33595438|NCT01365455|62994500|FG001|Induction Period|Subject/guardian decision|1|||
33595439|NCT01365455|62994501|FG002|Induction Period|Subject/guardian decision|8|||
33595440|NCT01365455|62994502|FG003|Induction Period|Subject/guardian decision|0|||
33595441|NCT01365455|62994503|FG004|Induction Period|Subject/guardian decision|0|||
33595442|NCT01365455|62994499|FG000|Induction Period|Lost to Follow-up|0|||
33595443|NCT01365455|62994500|FG001|Induction Period|Lost to Follow-up|0|||
33595444|NCT01365455|62994501|FG002|Induction Period|Lost to Follow-up|3|||
33595445|NCT01365455|62994502|FG003|Induction Period|Lost to Follow-up|0|||
33595446|NCT01365455|62994503|FG004|Induction Period|Lost to Follow-up|0|||
33595447|NCT01365455|62994499|FG000|Maintenance Period|Adverse Event|12|||
33595448|NCT01365455|62994500|FG001|Maintenance Period|Adverse Event|5|||
33595449|NCT01365455|62994501|FG002|Maintenance Period|Adverse Event|1|||
33595450|NCT01365455|62994502|FG003|Maintenance Period|Adverse Event|2|||
33595451|NCT01365455|62994503|FG004|Maintenance Period|Adverse Event|4|||
33595452|NCT01365455|62994499|FG000|Maintenance Period|Lack of Efficacy|10|||
33595453|NCT01365455|62994500|FG001|Maintenance Period|Lack of Efficacy|2|||
33595454|NCT01365455|62994501|FG002|Maintenance Period|Lack of Efficacy|0|||
33595455|NCT01365455|62994502|FG003|Maintenance Period|Lack of Efficacy|2|||
33595456|NCT01365455|62994503|FG004|Maintenance Period|Lack of Efficacy|2|||
33595457|NCT01365455|62994499|FG000|Maintenance Period|Lost to Follow-up|2|||
33684743|NCT02558400|63168592|FG000|Overall Study|Protocol Violation|6|||
33684744|NCT02558400|63168593|FG001|Overall Study|Protocol Violation|3|||
33684745|NCT02558400|63168594|FG002|Overall Study|Protocol Violation|8|||
33684746|NCT02558400|63168592|FG000|Overall Study|Death|0|||
33684747|NCT02558400|63168593|FG001|Overall Study|Death|1|||
33684748|NCT02558400|63168594|FG002|Overall Study|Death|0|||
33684749|NCT02558400|63168592|FG000|Overall Study|Ineligible for the study|0|||
33684750|NCT02558400|63168593|FG001|Overall Study|Ineligible for the study|2|||
33684751|NCT02558400|63168594|FG002|Overall Study|Ineligible for the study|0|||
33684752|NCT01662648|63168726|FG000|Overall Study|Death|1|||
33684753|NCT01662648|63168727|FG001|Overall Study|Death|3|||
33684754|NCT01662648|63168726|FG000|Overall Study|Adverse Event|40|||
33684755|NCT01662648|63168727|FG001|Overall Study|Adverse Event|37|||
33684756|NCT01662648|63168726|FG000|Overall Study|Lack of Efficacy|17|||
33684757|NCT01662648|63168727|FG001|Overall Study|Lack of Efficacy|16|||
33684758|NCT01662648|63168726|FG000|Overall Study|Participant ineligible to continue trial|1|||
33684759|NCT01662648|63168727|FG001|Overall Study|Participant ineligible to continue trial|1|||
33684760|NCT01662648|63168726|FG000|Overall Study|Lost to Follow-up|24|||
33684761|NCT01662648|63168727|FG001|Overall Study|Lost to Follow-up|36|||
33684762|NCT01662648|63168726|FG000|Overall Study|Withdrawal by Subject|36|||
33684763|NCT01662648|63168727|FG001|Overall Study|Withdrawal by Subject|53|||
33684764|NCT01662648|63168726|FG000|Overall Study|Participant non-compliant|16|||
33684765|NCT01662648|63168727|FG001|Overall Study|Participant non-compliant|20|||
33684766|NCT01662648|63168726|FG000|Overall Study|Other|8|||
33684767|NCT01662648|63168727|FG001|Overall Study|Other|11|||
33684768|NCT01662648|63168726|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
33684769|NCT01662648|63168727|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
33684770|NCT01662648|63168726|FG000|Overall Study|LOE and other reason unspecified|1|||
33684771|NCT01662648|63168727|FG001|Overall Study|LOE and other reason unspecified|0|||
33684772|NCT01662648|63168726|FG000|Overall Study|LOE and Participant non-compliant|0|||
33684773|NCT01662648|63168727|FG001|Overall Study|LOE and Participant non-compliant|1|||
33684774|NCT02556918|63168792|FG000|Overall Study|Protocol Violation|5|||
33684775|NCT02556918|63168793|FG001|Overall Study|Protocol Violation|6|||
33684776|NCT02556918|63168792|FG000|Overall Study|Withdrawal by Subject|4|||
33684777|NCT02556918|63168793|FG001|Overall Study|Withdrawal by Subject|4|||
33684778|NCT01662492|63168909|FG000|Overall Study|Other miscellaneous reasons.|1|||
33684779|NCT01662492|63168910|FG001|Overall Study|Other miscellaneous reasons.|0|||
33684780|NCT01662492|63168911|FG002|Overall Study|Other miscellaneous reasons.|1|||
33684781|NCT01662492|63168909|FG000|Overall Study|Withdrawal by Subject|0|||
33684782|NCT01662492|63168910|FG001|Overall Study|Withdrawal by Subject|0|||
33684783|NCT01662492|63168911|FG002|Overall Study|Withdrawal by Subject|1|||
33684784|NCT01662492|63168909|FG000|Overall Study|Protocol Violation|1|||
33684785|NCT01662492|63168910|FG001|Overall Study|Protocol Violation|0|||
33684786|NCT01662492|63168911|FG002|Overall Study|Protocol Violation|0|||
33684787|NCT01662492|63168909|FG000|Overall Study|Lost to Follow-up|0|||
33684788|NCT01662492|63168910|FG001|Overall Study|Lost to Follow-up|0|||
33684789|NCT01662492|63168911|FG002|Overall Study|Lost to Follow-up|2|||
33684790|NCT01662492|63168909|FG000|Overall Study|Lack of Efficacy|1|||
33684791|NCT01662492|63168910|FG001|Overall Study|Lack of Efficacy|1|||
33684792|NCT01662492|63168911|FG002|Overall Study|Lack of Efficacy|2|||
33684793|NCT02552238|63169081|FG000|Overall Study|Withdrawal by Subject|2|||
33684794|NCT02552238|63169081|FG000|Overall Study|Adverse Event|2|||
33684795|NCT01662102|63169299|FG000|Overall Study|Sponsor's decision|1|||
33684796|NCT01662102|63169300|FG001|Overall Study|Sponsor's decision|0|||
33684797|NCT02554656|63169340|FG000|Overall Study|Protocol Violation|3|||
33684798|NCT04053868|63169388|FG000|Overall Study|Withdrawal by Subject|1|||
33684799|NCT04053868|63169389|FG001|Overall Study|Withdrawal by Subject|0|||
33684800|NCT03414684|63169504|FG000|First-course Treatment|Complete response|0|||
33684801|NCT03414684|63169505|FG001|First-course Treatment|Complete response|1|||
33684802|NCT03414684|63169504|FG000|First-course Treatment|Intercurrent illness|1|||
33684803|NCT03414684|63169505|FG001|First-course Treatment|Intercurrent illness|0|||
33684804|NCT03414684|63169504|FG000|First-course Treatment|Progressive Disease|31|||
33595458|NCT01365455|62994500|FG001|Maintenance Period|Lost to Follow-up|4|||
33595459|NCT01365455|62994501|FG002|Maintenance Period|Lost to Follow-up|0|||
33595460|NCT01365455|62994502|FG003|Maintenance Period|Lost to Follow-up|0|||
33595461|NCT01365455|62994503|FG004|Maintenance Period|Lost to Follow-up|3|||
33595462|NCT01365455|62994499|FG000|Maintenance Period|Non-compliance with study treatment|0|||
33595463|NCT01365455|62994500|FG001|Maintenance Period|Non-compliance with study treatment|0|||
33595464|NCT01365455|62994501|FG002|Maintenance Period|Non-compliance with study treatment|0|||
33595465|NCT01365455|62994502|FG003|Maintenance Period|Non-compliance with study treatment|1|||
33595466|NCT01365455|62994503|FG004|Maintenance Period|Non-compliance with study treatment|0|||
33595467|NCT01365455|62994499|FG000|Maintenance Period|Physician Decision|0|||
33684805|NCT03414684|63169505|FG001|First-course Treatment|Progressive Disease|32|||
33684806|NCT03414684|63169504|FG000|First-course Treatment|Adverse Event|1|||
33684807|NCT03414684|63169505|FG001|First-course Treatment|Adverse Event|2|||
33684808|NCT03414684|63169504|FG000|First-course Treatment|Physician Decision|0|||
33684809|NCT03414684|63169505|FG001|First-course Treatment|Physician Decision|1|||
33684810|NCT03414684|63169504|FG000|First-course Treatment|Withdrawal by Subject|0|||
33684811|NCT03414684|63169505|FG001|First-course Treatment|Withdrawal by Subject|1|||
33684812|NCT03414684|63169504|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
33684813|NCT03414684|63169505|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
33684814|NCT03414684|63169504|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
33684815|NCT03414684|63169505|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
33684816|NCT03414684|63169504|FG000|First-course Treatment|Still on treatment|3|||
33684817|NCT03414684|63169505|FG001|First-course Treatment|Still on treatment|0|||
33684818|NCT03414684|63169504|FG000|First-course Treatment|Never started protocol therapy|2|||
33684819|NCT03414684|63169505|FG001|First-course Treatment|Never started protocol therapy|1|||
33684820|NCT03414684|63169504|FG000|Crossover Treatment|Progressive disease|0|||
33684821|NCT03414684|63169505|FG001|Crossover Treatment|Progressive disease|12|||
33684822|NCT03414684|63169504|FG000|Crossover Treatment|Adverse Event|0|||
33684823|NCT03414684|63169505|FG001|Crossover Treatment|Adverse Event|3|||
33684824|NCT03414684|63169504|FG000|Crossover Treatment|Physician Decision|0|||
33684825|NCT03414684|63169505|FG001|Crossover Treatment|Physician Decision|1|||
33684826|NCT03414684|63169504|FG000|Crossover Treatment|Still on treatment|0|||
33684827|NCT03414684|63169505|FG001|Crossover Treatment|Still on treatment|2|||
33684828|NCT02551692|63169584|FG000|Overall Study|Lost to Follow-up|0|||
33684829|NCT02551692|63169585|FG001|Overall Study|Lost to Follow-up|1|||
33684830|NCT02551692|63169586|FG002|Overall Study|Lost to Follow-up|4|||
33684831|NCT02551692|63169584|FG000|Overall Study|Withdrawal by Subject|1|||
33684832|NCT02551692|63169585|FG001|Overall Study|Withdrawal by Subject|0|||
33684833|NCT02551692|63169586|FG002|Overall Study|Withdrawal by Subject|1|||
33684834|NCT02553330|63169673|FG000|Overall Study|Study Terminated by Sponsor|2|||
33684835|NCT02553330|63169674|FG001|Overall Study|Study Terminated by Sponsor|13|||
33684836|NCT02553330|63169675|FG002|Overall Study|Study Terminated by Sponsor|12|||
33684837|NCT02553330|63169673|FG000|Overall Study|Withdrawal by Subject|3|||
33684838|NCT02553330|63169674|FG001|Overall Study|Withdrawal by Subject|19|||
33684839|NCT02553330|63169675|FG002|Overall Study|Withdrawal by Subject|21|||
33684840|NCT02553330|63169673|FG000|Overall Study|Other|0|||
33684841|NCT02553330|63169674|FG001|Overall Study|Other|1|||
33684842|NCT02553330|63169675|FG002|Overall Study|Other|0|||
33684843|NCT02553330|63169673|FG000|Overall Study|Non compliance to study treatment|0|||
33684844|NCT02553330|63169674|FG001|Overall Study|Non compliance to study treatment|1|||
33684845|NCT02553330|63169675|FG002|Overall Study|Non compliance to study treatment|0|||
33684846|NCT02553330|63169673|FG000|Overall Study|Adverse Event|0|||
33684847|NCT02553330|63169674|FG001|Overall Study|Adverse Event|1|||
33684848|NCT02553330|63169675|FG002|Overall Study|Adverse Event|0|||
33684849|NCT02553330|63169673|FG000|Overall Study|Lost to Follow-up|0|||
33684850|NCT02553330|63169674|FG001|Overall Study|Lost to Follow-up|4|||
33684851|NCT02553330|63169675|FG002|Overall Study|Lost to Follow-up|4|||
33684852|NCT02550288|63169717|FG000|Overall Study|Adverse Event|0|||
33684853|NCT02550288|63169718|FG001|Overall Study|Adverse Event|1|||
33684854|NCT02550288|63169719|FG002|Overall Study|Adverse Event|0|||
33684855|NCT02550288|63169720|FG003|Overall Study|Adverse Event|0|||
33684856|NCT02550288|63169721|FG004|Overall Study|Adverse Event|0|||
33684857|NCT02550288|63169717|FG000|Overall Study|Physician Decision|0|||
33684858|NCT02550288|63169718|FG001|Overall Study|Physician Decision|0|||
33684859|NCT02550288|63169719|FG002|Overall Study|Physician Decision|0|||
33684860|NCT02550288|63169720|FG003|Overall Study|Physician Decision|1|||
33684861|NCT02550288|63169721|FG004|Overall Study|Physician Decision|0|||
33684862|NCT02550288|63169717|FG000|Overall Study|Protocol Violation|2|||
33684863|NCT02550288|63169718|FG001|Overall Study|Protocol Violation|2|||
33684864|NCT02550288|63169719|FG002|Overall Study|Protocol Violation|1|||
33684865|NCT02550288|63169720|FG003|Overall Study|Protocol Violation|0|||
33684866|NCT02550288|63169721|FG004|Overall Study|Protocol Violation|3|||
33684867|NCT02550288|63169717|FG000|Overall Study|Participant moved|0|||
33684868|NCT02550288|63169718|FG001|Overall Study|Participant moved|0|||
33684869|NCT02550288|63169719|FG002|Overall Study|Participant moved|0|||
33684870|NCT02550288|63169720|FG003|Overall Study|Participant moved|1|||
33684871|NCT02550288|63169721|FG004|Overall Study|Participant moved|0|||
33684872|NCT02550288|63169717|FG000|Overall Study|Withdrawal by Subject|0|||
33684873|NCT02550288|63169718|FG001|Overall Study|Withdrawal by Subject|0|||
33684874|NCT02550288|63169719|FG002|Overall Study|Withdrawal by Subject|0|||
33684875|NCT02550288|63169720|FG003|Overall Study|Withdrawal by Subject|1|||
33684876|NCT02550288|63169721|FG004|Overall Study|Withdrawal by Subject|0|||
33684877|NCT01662336|63169782|FG000|Overall Study|Adverse Event|1|||
33684878|NCT01662336|63169782|FG000|Overall Study|No longer on LPV/r|30|||
33684879|NCT01662336|63169782|FG000|Overall Study|Other|29|||
33684880|NCT01662336|63169782|FG000|Overall Study|Withdrawal by Subject|6|||
33684881|NCT02549352|63169801|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
33684882|NCT02549352|63169802|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
33684883|NCT02549352|63169801|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
33684884|NCT02549352|63169802|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
33684885|NCT02549352|63169801|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
33684886|NCT02549352|63169802|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
33684887|NCT02549352|63169801|FG000|12-month Follow-up|Withdrawal by Subject|4|||
33684888|NCT02549352|63169802|FG001|12-month Follow-up|Withdrawal by Subject|5|||
33684889|NCT02549352|63169801|FG000|12-month Follow-up|Lost to Follow-up|3|||
33684890|NCT02549352|63169802|FG001|12-month Follow-up|Lost to Follow-up|2|||
33684891|NCT02549352|63169801|FG000|12-month Follow-up|Death|0|||
33684892|NCT02549352|63169802|FG001|12-month Follow-up|Death|1|||
33684893|NCT02549352|63169801|FG000|12-month Follow-up|Protocol Violation|0|||
33684894|NCT02549352|63169802|FG001|12-month Follow-up|Protocol Violation|1|||
33684895|NCT02549352|63169801|FG000|12-month Follow-up|Other|1|||
33684896|NCT02549352|63169802|FG001|12-month Follow-up|Other|3|||
33684897|NCT02554890|63169979|FG000|Double-blind|Adverse Event|45|||
33684898|NCT02554890|63169980|FG001|Double-blind|Adverse Event|51|||
33684899|NCT02554890|63169979|FG000|Double-blind|Death|6|||
33684900|NCT02554890|63169980|FG001|Double-blind|Death|4|||
33684901|NCT02554890|63169979|FG000|Double-blind|Protocol Violation|1|||
33684902|NCT02554890|63169980|FG001|Double-blind|Protocol Violation|1|||
33684903|NCT02554890|63169979|FG000|Double-blind|Physician Decision|4|||
33684904|NCT02554890|63169980|FG001|Double-blind|Physician Decision|3|||
33684905|NCT02554890|63169979|FG000|Double-blind|Subject/Guardian decision|21|||
33684906|NCT02554890|63169980|FG001|Double-blind|Subject/Guardian decision|16|||
33684907|NCT02554890|63169979|FG000|Double-blind|Lost to Follow-up|7|||
33684908|NCT02554890|63169980|FG001|Double-blind|Lost to Follow-up|5|||
33684909|NCT02554890|63169979|FG000|Double-blind|Technical problems|1|||
33684910|NCT02554890|63169980|FG001|Double-blind|Technical problems|0|||
33684911|NCT02554890|63169979|FG000|Double-blind|Withdrawal by Subject|5|||
33684912|NCT02554890|63169980|FG001|Double-blind|Withdrawal by Subject|6|||
33684913|NCT02554890|63169979|FG000|Double-blind|Noncompliance with study treatment|6|||
33684914|NCT02554890|63169980|FG001|Double-blind|Noncompliance with study treatment|5|||
33684915|NCT02554890|63169979|FG000|Open-label|Adverse Event|0|||
33684916|NCT02554890|63169980|FG001|Open-label|Adverse Event|30|||
33684917|NCT02554890|63169979|FG000|Open-label|Death|0|||
33684918|NCT02554890|63169980|FG001|Open-label|Death|1|||
33684919|NCT02554890|63169979|FG000|Open-label|Physician Decision|0|||
33684920|NCT02554890|63169980|FG001|Open-label|Physician Decision|1|||
33684921|NCT02554890|63169979|FG000|Open-label|Subject/Guardian decision|0|||
33684922|NCT02554890|63169980|FG001|Open-label|Subject/Guardian decision|11|||
33684923|NCT02554890|63169979|FG000|Open-label|Lost to Follow-up|0|||
33684924|NCT02554890|63169980|FG001|Open-label|Lost to Follow-up|7|||
33684925|NCT02554890|63169979|FG000|Open-label|Technical problems|0|||
33684926|NCT02554890|63169980|FG001|Open-label|Technical problems|1|||
33684927|NCT02554890|63169979|FG000|Open-label|Withdrawal by Subject|0|||
33684928|NCT02554890|63169980|FG001|Open-label|Withdrawal by Subject|1|||
33684929|NCT02552316|63169997|FG000|Overall Study|Withdrawal by Subject|1|||
33684930|NCT02552316|63169997|FG000|Overall Study|Withdrawal due to non-compliance|1|||
33684931|NCT02543346|63170045|FG000|Second Priming Visit|Withdrawal by Subject|0|||
33684932|NCT02543346|63170046|FG001|Second Priming Visit|Withdrawal by Subject|2|||
33684933|NCT02543346|63170047|FG002|Second Priming Visit|Withdrawal by Subject|2|||
33684934|NCT02543346|63170048|FG003|Second Priming Visit|Withdrawal by Subject|2|||
33684935|NCT02543346|63170045|FG000|Second Priming Visit|Adverse Event|1|||
33684936|NCT02543346|63170046|FG001|Second Priming Visit|Adverse Event|0|||
33684937|NCT02543346|63170047|FG002|Second Priming Visit|Adverse Event|0|||
33684938|NCT02543346|63170048|FG003|Second Priming Visit|Adverse Event|0|||
33684939|NCT02549196|63170062|FG000|Overall Study|Protocol Violation|0|||
33684940|NCT02549196|63170063|FG001|Overall Study|Protocol Violation|0|||
33684941|NCT02549196|63170064|FG002|Overall Study|Protocol Violation|0|||
33684942|NCT02549196|63170065|FG003|Overall Study|Protocol Violation|1|||
33684943|NCT02549196|63170062|FG000|Overall Study|Withdrawal by Subject|1|||
33684944|NCT02549196|63170063|FG001|Overall Study|Withdrawal by Subject|0|||
33684945|NCT02549196|63170064|FG002|Overall Study|Withdrawal by Subject|1|||
33684946|NCT02549196|63170065|FG003|Overall Study|Withdrawal by Subject|0|||
33684947|NCT02904954|63170077|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
33684948|NCT02904954|63170078|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
33684949|NCT02904954|63170077|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
33684950|NCT02904954|63170078|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
33684951|NCT02904954|63170077|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
33684952|NCT02904954|63170078|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
33595468|NCT01365455|62994500|FG001|Maintenance Period|Physician Decision|1|||
33595469|NCT01365455|62994501|FG002|Maintenance Period|Physician Decision|0|||
33595470|NCT01365455|62994502|FG003|Maintenance Period|Physician Decision|0|||
33595471|NCT01365455|62994503|FG004|Maintenance Period|Physician Decision|1|||
33595472|NCT01365455|62994499|FG000|Maintenance Period|Pregnancy|0|||
33595473|NCT01365455|62994500|FG001|Maintenance Period|Pregnancy|4|||
33595474|NCT01365455|62994501|FG002|Maintenance Period|Pregnancy|0|||
33595475|NCT01365455|62994502|FG003|Maintenance Period|Pregnancy|0|||
33595476|NCT01365455|62994503|FG004|Maintenance Period|Pregnancy|2|||
33595477|NCT01365455|62994499|FG000|Maintenance Period|Protocol deviation|1|||
33595478|NCT01365455|62994500|FG001|Maintenance Period|Protocol deviation|1|||
33595479|NCT01365455|62994501|FG002|Maintenance Period|Protocol deviation|0|||
33595480|NCT01365455|62994502|FG003|Maintenance Period|Protocol deviation|0|||
33595481|NCT01365455|62994503|FG004|Maintenance Period|Protocol deviation|0|||
33595482|NCT01365455|62994499|FG000|Maintenance Period|Subject/guardian decision|4|||
33595483|NCT01365455|62994500|FG001|Maintenance Period|Subject/guardian decision|6|||
33595484|NCT01365455|62994501|FG002|Maintenance Period|Subject/guardian decision|2|||
33595485|NCT01365455|62994502|FG003|Maintenance Period|Subject/guardian decision|4|||
33595486|NCT01365455|62994503|FG004|Maintenance Period|Subject/guardian decision|1|||
33595487|NCT02155881|62994523|FG000|Overall Study|Withdrawal by Subject|0|||
33595488|NCT02155881|62994524|FG001|Overall Study|Withdrawal by Subject|2|||
33595489|NCT02155881|62994523|FG000|Overall Study|Inappropriately randomized|2|||
33595490|NCT02155881|62994524|FG001|Overall Study|Inappropriately randomized|2|||
33595491|NCT01658579|62994534|FG000|Treatment Period A|Other|0|||
33595492|NCT01658579|62994535|FG001|Treatment Period A|Other|0|||
33595493|NCT01658579|62994536|FG002|Treatment Period A|Other|1|||
33595494|NCT01658579|62994537|FG003|Treatment Period A|Other|1|||
33595495|NCT01658579|62994534|FG000|Treatment Period A|Adverse Event|1|||
33595496|NCT01658579|62994535|FG001|Treatment Period A|Adverse Event|0|||
33595497|NCT01658579|62994536|FG002|Treatment Period A|Adverse Event|0|||
33595498|NCT01658579|62994537|FG003|Treatment Period A|Adverse Event|0|||
33595499|NCT01658579|62994534|FG000|Treatment Period B|Other|0|||
33595500|NCT01658579|62994535|FG001|Treatment Period B|Other|0|||
33595501|NCT01658579|62994536|FG002|Treatment Period B|Other|0|||
33595502|NCT01658579|62994537|FG003|Treatment Period B|Other|1|||
33595503|NCT02154087|62994543|FG000|Overall Study|Study Termination|1|||
33595504|NCT02118597|62994547|FG000|Overall Study|Sponsor terminated the study|14|||
33595505|NCT02118597|62994547|FG000|Overall Study|Serious Adverse Event|1|||
33595506|NCT02118597|62994547|FG000|Overall Study|Investigator's decision|1|||
33595507|NCT01659125|62994551|FG000|Overall Study|Withdrawal by Subject|2|||
33595508|NCT01659125|62994551|FG000|Overall Study|Lost to Follow-up|7|||
33595509|NCT01659125|62994551|FG000|Overall Study|Technical Problem|1|||
33595510|NCT01659125|62994551|FG000|Overall Study|Time Constraints|2|||
33595511|NCT01659125|62994551|FG000|Overall Study|Failed to Start Treatment|2|||
33595512|NCT01657253|62994557|FG000|Overall Study|Lost to Follow-up|6|||
33595513|NCT01657253|62994558|FG001|Overall Study|Lost to Follow-up|5|||
33595514|NCT01657253|62994557|FG000|Overall Study|Withdrawal by Subject|11|||
33595515|NCT01657253|62994558|FG001|Overall Study|Withdrawal by Subject|12|||
33595516|NCT01657253|62994557|FG000|Overall Study|Adverse Event|0|||
33595517|NCT01657253|62994558|FG001|Overall Study|Adverse Event|1|||
33595518|NCT02117427|62994567|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
33595519|NCT02117427|62994568|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
33595520|NCT02117427|62994569|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
33595521|NCT02117427|62994567|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
33595522|NCT02117427|62994568|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
33595523|NCT02117427|62994569|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
33595524|NCT02117427|62994567|FG000|Overall Study|Physician Decision|0|||
33595525|NCT02117427|62994568|FG001|Overall Study|Physician Decision|2|||
33595526|NCT02117427|62994569|FG002|Overall Study|Physician Decision|0|||
33595527|NCT02117427|62994567|FG000|Overall Study|No longer meets inclusion criteria|0|||
33595528|NCT02117427|62994568|FG001|Overall Study|No longer meets inclusion criteria|1|||
33595529|NCT02117427|62994569|FG002|Overall Study|No longer meets inclusion criteria|0|||
33684953|NCT02904954|63170077|FG000|Adjuvant Durvalumab|Recurrence|2|||
33684954|NCT02904954|63170078|FG001|Adjuvant Durvalumab|Recurrence|0|||
33595530|NCT02117427|62994567|FG000|Overall Study|Death|0|||
33595531|NCT02117427|62994568|FG001|Overall Study|Death|1|||
33595532|NCT02117427|62994569|FG002|Overall Study|Death|0|||
33595533|NCT02117349|62994577|FG000|Overall Study|Withdrawal by Subject|1|||
33595534|NCT02117349|62994578|FG001|Overall Study|Withdrawal by Subject|0|||
33595535|NCT02117349|62994577|FG000|Overall Study|Lost to Follow-up|1|||
33595536|NCT02117349|62994578|FG001|Overall Study|Lost to Follow-up|1|||
33595537|NCT02117349|62994577|FG000|Overall Study|Death|1|||
33595538|NCT02117349|62994578|FG001|Overall Study|Death|0|||
33595539|NCT01626495|62994584|FG000|Overall Study|Adverse Event|3|||
33595540|NCT01626495|62994584|FG000|Overall Study|Disease progression|27|||
33595541|NCT01626495|62994584|FG000|Overall Study|Withdrawal by Subject|1|||
33684955|NCT02904954|63170077|FG000|Adjuvant Durvalumab|Adverse Event|2|||
33684956|NCT02904954|63170078|FG001|Adjuvant Durvalumab|Adverse Event|6|||
33684957|NCT02904954|63170077|FG000|Adjuvant Durvalumab|Participant wishes|12|||
33684958|NCT02904954|63170078|FG001|Adjuvant Durvalumab|Participant wishes|7|||
33684959|NCT02904954|63170077|FG000|Adjuvant Durvalumab|Physician Decision|2|||
33684960|NCT02904954|63170078|FG001|Adjuvant Durvalumab|Physician Decision|1|||
33684961|NCT02904954|63170077|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
33684962|NCT02904954|63170078|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
33684963|NCT02904954|63170077|FG000|Adjuvant Durvalumab|Death|0|||
33684964|NCT02904954|63170078|FG001|Adjuvant Durvalumab|Death|1|||
33684965|NCT02904954|63170077|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
33684966|NCT02904954|63170078|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
33684967|NCT02548962|63170194|FG000|Overall Study|Withdrawal by Subject|1|||
33684968|NCT02548962|63170195|FG001|Overall Study|Withdrawal by Subject|0|||
33684969|NCT02548650|63170222|FG000|Triple Therapy|Adverse Event|1|||
33684970|NCT02548650|63170223|FG001|Triple Therapy|Adverse Event|0|||
33684971|NCT02548650|63170222|FG000|Triple Therapy|Withdrawal by Subject|0|||
33684972|NCT02548650|63170223|FG001|Triple Therapy|Withdrawal by Subject|4|||
33684973|NCT02548650|63170222|FG000|Double Therapy|Adverse Event|1|||
33684974|NCT02548650|63170223|FG001|Double Therapy|Adverse Event|1|||
33684975|NCT02548650|63170222|FG000|Double Therapy|Withdrawal by Subject|0|||
33684976|NCT02548650|63170223|FG001|Double Therapy|Withdrawal by Subject|1|||
33684977|NCT02535000|63170318|FG000|Overall Study|Cancellation of surgery.|1|||
33684978|NCT02535000|63170319|FG001|Overall Study|Cancellation of surgery.|2|||
33684979|NCT03110562|63170448|FG000|Overall Study|Withdrawal by Subject|37|||
33684980|NCT03110562|63170449|FG001|Overall Study|Withdrawal by Subject|35|||
33684981|NCT03110562|63170448|FG000|Overall Study|Death|47|||
33684982|NCT03110562|63170449|FG001|Overall Study|Death|61|||
33684983|NCT03110562|63170448|FG000|Overall Study|Lost to Follow-up|7|||
33684984|NCT03110562|63170449|FG001|Overall Study|Lost to Follow-up|6|||
33684985|NCT03110562|63170448|FG000|Overall Study|Other|2|||
33684986|NCT03110562|63170449|FG001|Overall Study|Other|1|||
33684987|NCT03110562|63170448|FG000|Overall Study|Randomized but never treated|0|||
33684988|NCT03110562|63170449|FG001|Overall Study|Randomized but never treated|3|||
33684989|NCT03110562|63170448|FG000|Overall Study|Ongoing|102|||
33684990|NCT03110562|63170449|FG001|Overall Study|Ongoing|101|||
33684991|NCT02546856|63170492|FG000|4 Months Evaluation|Death|2|||
33684992|NCT02546856|63170493|FG001|4 Months Evaluation|Death|3|||
33684993|NCT02546856|63170492|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
33684994|NCT02546856|63170493|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
33684995|NCT02546856|63170492|FG000|4 Months Evaluation|Lost to Follow-up|3|||
33684996|NCT02546856|63170493|FG001|4 Months Evaluation|Lost to Follow-up|3|||
33684997|NCT02546856|63170492|FG000|4 Months Evaluation|Physician Decision|3|||
33684998|NCT02546856|63170493|FG001|4 Months Evaluation|Physician Decision|0|||
33684999|NCT02546856|63170492|FG000|4 Months Evaluation|Working or living abroad|5|||
33685000|NCT02546856|63170493|FG001|4 Months Evaluation|Working or living abroad|1|||
33685001|NCT02546856|63170492|FG000|4 Months Evaluation|reasons not due to titration|4|||
33685002|NCT02546856|63170493|FG001|4 Months Evaluation|reasons not due to titration|1|||
33685003|NCT02546856|63170492|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
33685004|NCT02546856|63170493|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
33685005|NCT02546856|63170492|FG000|6 Months Evaluation|Death|1|||
33685006|NCT02546856|63170493|FG001|6 Months Evaluation|Death|1|||
33685007|NCT02546856|63170492|FG000|6 Months Evaluation|Lost to Follow-up|1|||
33685008|NCT02546856|63170493|FG001|6 Months Evaluation|Lost to Follow-up|1|||
33685009|NCT02546856|63170492|FG000|6 Months Evaluation|Working or living abroad|6|||
33685010|NCT02546856|63170493|FG001|6 Months Evaluation|Working or living abroad|4|||
33685011|NCT02546856|63170492|FG000|6 Months Evaluation|reasons not due to titration|0|||
33685012|NCT02546856|63170493|FG001|6 Months Evaluation|reasons not due to titration|1|||
33685013|NCT02696616|63170618|FG000|Overall Study|Adverse Event|0|||
33685014|NCT02696616|63170619|FG001|Overall Study|Adverse Event|1|||
33685015|NCT02696616|63170620|FG002|Overall Study|Adverse Event|0|||
33685016|NCT02696616|63170621|FG003|Overall Study|Adverse Event|0|||
33685017|NCT02696616|63170622|FG004|Overall Study|Adverse Event|0|||
33685018|NCT02696616|63170623|FG005|Overall Study|Adverse Event|0|||
33685019|NCT02696616|63170624|FG006|Overall Study|Adverse Event|0|||
33685020|NCT01661790|63170667|FG000|Overall Study|Lost to Follow-up|0|||
33685021|NCT01661790|63170668|FG001|Overall Study|Lost to Follow-up|2|||
33685022|NCT02546544|63170688|FG000|Overall Study|Disease Progression|14|||
33685023|NCT02546544|63170688|FG000|Overall Study|Adverse Event|1|||
33685024|NCT02546544|63170688|FG000|Overall Study|Withdrawal by Subject|1|||
33685025|NCT05593211|63170983|FG000|Overall Study|Withdrawal by Subject|1|||
33595542|NCT01626495|62994584|FG000|Overall Study|Administrative problem|1|||
33595543|NCT01626495|62994584|FG000|Overall Study|Death|2|||
33595544|NCT01626495|62994584|FG000|Overall Study|Physician Decision|1|||
33595545|NCT01626495|62994584|FG000|Overall Study|New cancer therapy|16|||
33595546|NCT01626495|62994584|FG000|Overall Study|Manufacturing failure|1|||
33595547|NCT02177175|62994590|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
33595548|NCT02177175|62994591|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
33595549|NCT02153073|62994597|FG000|Overall Study|Case Report Forms Uncollected|230|||
33595550|NCT02153073|62994597|FG000|Overall Study|Protocol Deviation|68|||
33595551|NCT01657877|62994601|FG000|Overall Study|Withdrawal by Subject|4|||
33595552|NCT01657877|62994601|FG000|Overall Study|Protocol Violation|6|||
33595553|NCT01657877|62994601|FG000|Overall Study|Adverse Event|2|||
33595554|NCT01657877|62994601|FG000|Overall Study|Other Reason|2|||
33595555|NCT02175771|62994626|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
33595556|NCT02175771|62994627|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33595557|NCT02175771|62994628|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33595558|NCT02175771|62994629|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33595559|NCT02175771|62994630|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33595560|NCT02175771|62994631|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33595561|NCT02175771|62994632|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33595562|NCT02175771|62994633|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33595563|NCT02175771|62994634|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33595564|NCT02175771|62994626|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
33595565|NCT02175771|62994627|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33595566|NCT02175771|62994628|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33595567|NCT02175771|62994629|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33595568|NCT02175771|62994630|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33595569|NCT02175771|62994631|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33595570|NCT02175771|62994632|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33595571|NCT02175771|62994633|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33595572|NCT02175771|62994634|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33595573|NCT02175771|62994626|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
33595574|NCT02175771|62994627|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33595575|NCT02175771|62994628|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33595576|NCT02175771|62994629|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33595577|NCT02175771|62994630|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33595578|NCT02175771|62994631|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33595579|NCT02175771|62994632|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33595580|NCT02175771|62994633|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33595581|NCT02175771|62994634|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33595582|NCT02175771|62994626|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
33595583|NCT02175771|62994627|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
33595584|NCT02175771|62994628|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
33595585|NCT02175771|62994629|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
33595586|NCT02175771|62994630|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
33595587|NCT02175771|62994631|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
33595588|NCT02175771|62994632|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
33595589|NCT02175771|62994633|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
33595590|NCT02175771|62994634|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
33595591|NCT02175771|62994626|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
33595592|NCT02175771|62994627|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33595593|NCT02175771|62994628|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33595594|NCT02175771|62994629|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33595595|NCT02175771|62994630|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33595596|NCT02175771|62994631|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33595597|NCT02175771|62994632|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33595598|NCT02175771|62994633|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33595599|NCT02175771|62994634|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33595600|NCT02175771|62994626|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
33595601|NCT02175771|62994627|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33595602|NCT02175771|62994628|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33595603|NCT02175771|62994629|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33595604|NCT02175771|62994630|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33595605|NCT02175771|62994631|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33595606|NCT02175771|62994632|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33595607|NCT02175771|62994633|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33595608|NCT02175771|62994634|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33595609|NCT02175771|62994626|FG000|Run-In Period (Pre-assignment)|Other|8|||
33685026|NCT02533674|63171322|FG000|Dose Level I|Progressive disease|1|||
33685027|NCT02533674|63171323|FG001|Dose Level I|Progressive disease|0|||
33685028|NCT02533674|63171324|FG002|Dose Level I|Progressive disease|0|||
33685029|NCT02533674|63171325|FG003|Dose Level I|Progressive disease|0|||
33685030|NCT02533674|63171326|FG004|Dose Level I|Progressive disease|0|||
33685031|NCT02533674|63171327|FG005|Dose Level I|Progressive disease|0|||
33685032|NCT02533674|63171328|FG006|Dose Level I|Progressive disease|0|||
33685033|NCT02533674|63171329|FG007|Dose Level I|Progressive disease|0|||
33685034|NCT02533674|63171322|FG000|Dose Level I|Withdrawal by Subject|1|||
33685035|NCT02533674|63171323|FG001|Dose Level I|Withdrawal by Subject|0|||
33685036|NCT02533674|63171324|FG002|Dose Level I|Withdrawal by Subject|0|||
33685037|NCT02533674|63171325|FG003|Dose Level I|Withdrawal by Subject|0|||
33685038|NCT02533674|63171326|FG004|Dose Level I|Withdrawal by Subject|0|||
33685039|NCT02533674|63171327|FG005|Dose Level I|Withdrawal by Subject|0|||
33685040|NCT02533674|63171328|FG006|Dose Level I|Withdrawal by Subject|0|||
33685041|NCT02533674|63171329|FG007|Dose Level I|Withdrawal by Subject|0|||
33685042|NCT02533674|63171322|FG000|Dose Level I|Physician Decision|1|||
33685043|NCT02533674|63171323|FG001|Dose Level I|Physician Decision|0|||
33685044|NCT02533674|63171324|FG002|Dose Level I|Physician Decision|0|||
33685045|NCT02533674|63171325|FG003|Dose Level I|Physician Decision|0|||
33685046|NCT02533674|63171326|FG004|Dose Level I|Physician Decision|0|||
33685047|NCT02533674|63171327|FG005|Dose Level I|Physician Decision|0|||
33685048|NCT02533674|63171328|FG006|Dose Level I|Physician Decision|0|||
33685049|NCT02533674|63171329|FG007|Dose Level I|Physician Decision|0|||
33685050|NCT02533674|63171322|FG000|Dose Level I|Death|1|||
33685051|NCT02533674|63171323|FG001|Dose Level I|Death|0|||
33685052|NCT02533674|63171324|FG002|Dose Level I|Death|0|||
33685053|NCT02533674|63171325|FG003|Dose Level I|Death|0|||
33685054|NCT02533674|63171326|FG004|Dose Level I|Death|0|||
33685055|NCT02533674|63171327|FG005|Dose Level I|Death|0|||
33685056|NCT02533674|63171328|FG006|Dose Level I|Death|0|||
33685057|NCT02533674|63171329|FG007|Dose Level I|Death|0|||
33685058|NCT02533674|63171322|FG000|Dose Level I|Never Treated|1|||
33685059|NCT02533674|63171323|FG001|Dose Level I|Never Treated|0|||
33685060|NCT02533674|63171324|FG002|Dose Level I|Never Treated|0|||
33685061|NCT02533674|63171325|FG003|Dose Level I|Never Treated|0|||
33685062|NCT02533674|63171326|FG004|Dose Level I|Never Treated|0|||
33685063|NCT02533674|63171327|FG005|Dose Level I|Never Treated|0|||
33685064|NCT02533674|63171328|FG006|Dose Level I|Never Treated|0|||
33685065|NCT02533674|63171329|FG007|Dose Level I|Never Treated|0|||
33685066|NCT02533674|63171322|FG000|Dose Level II|Progressive disease|0|||
33685067|NCT02533674|63171323|FG001|Dose Level II|Progressive disease|3|||
33685068|NCT02533674|63171324|FG002|Dose Level II|Progressive disease|0|||
33685069|NCT02533674|63171325|FG003|Dose Level II|Progressive disease|0|||
33685070|NCT02533674|63171326|FG004|Dose Level II|Progressive disease|0|||
33685071|NCT02533674|63171327|FG005|Dose Level II|Progressive disease|0|||
33685072|NCT02533674|63171328|FG006|Dose Level II|Progressive disease|0|||
33685073|NCT02533674|63171329|FG007|Dose Level II|Progressive disease|0|||
33685074|NCT02533674|63171322|FG000|Dose Level II|Withdrawal by Subject|0|||
33685075|NCT02533674|63171323|FG001|Dose Level II|Withdrawal by Subject|1|||
33685076|NCT02533674|63171324|FG002|Dose Level II|Withdrawal by Subject|0|||
33685077|NCT02533674|63171325|FG003|Dose Level II|Withdrawal by Subject|0|||
33685078|NCT02533674|63171326|FG004|Dose Level II|Withdrawal by Subject|0|||
33685079|NCT02533674|63171327|FG005|Dose Level II|Withdrawal by Subject|0|||
33685080|NCT02533674|63171328|FG006|Dose Level II|Withdrawal by Subject|0|||
33685081|NCT02533674|63171329|FG007|Dose Level II|Withdrawal by Subject|0|||
33685082|NCT02533674|63171322|FG000|Dose Level II|Treatment-related AE|0|||
33685083|NCT02533674|63171323|FG001|Dose Level II|Treatment-related AE|1|||
33685084|NCT02533674|63171324|FG002|Dose Level II|Treatment-related AE|0|||
33685085|NCT02533674|63171325|FG003|Dose Level II|Treatment-related AE|0|||
33685086|NCT02533674|63171326|FG004|Dose Level II|Treatment-related AE|0|||
33685087|NCT02533674|63171327|FG005|Dose Level II|Treatment-related AE|0|||
33685088|NCT02533674|63171328|FG006|Dose Level II|Treatment-related AE|0|||
33685089|NCT02533674|63171329|FG007|Dose Level II|Treatment-related AE|0|||
33685090|NCT02533674|63171322|FG000|Dose Level II|Physician Decision|0|||
33685091|NCT02533674|63171323|FG001|Dose Level II|Physician Decision|1|||
33685092|NCT02533674|63171324|FG002|Dose Level II|Physician Decision|0|||
33685093|NCT02533674|63171325|FG003|Dose Level II|Physician Decision|0|||
33685094|NCT02533674|63171326|FG004|Dose Level II|Physician Decision|0|||
33685095|NCT02533674|63171327|FG005|Dose Level II|Physician Decision|0|||
33685096|NCT02533674|63171328|FG006|Dose Level II|Physician Decision|0|||
33685097|NCT02533674|63171329|FG007|Dose Level II|Physician Decision|0|||
33685098|NCT02533674|63171322|FG000|Dose Level II|Non-treatment-related AE|0|||
33685099|NCT02533674|63171323|FG001|Dose Level II|Non-treatment-related AE|1|||
33685100|NCT02533674|63171324|FG002|Dose Level II|Non-treatment-related AE|0|||
33685101|NCT02533674|63171325|FG003|Dose Level II|Non-treatment-related AE|0|||
33685102|NCT02533674|63171326|FG004|Dose Level II|Non-treatment-related AE|0|||
33685103|NCT02533674|63171327|FG005|Dose Level II|Non-treatment-related AE|0|||
33685104|NCT02533674|63171328|FG006|Dose Level II|Non-treatment-related AE|0|||
33685105|NCT02533674|63171329|FG007|Dose Level II|Non-treatment-related AE|0|||
33685106|NCT02533674|63171322|FG000|Dose Level III|Progressive disease|0|||
33685107|NCT02533674|63171323|FG001|Dose Level III|Progressive disease|0|||
33685108|NCT02533674|63171324|FG002|Dose Level III|Progressive disease|2|||
33685109|NCT02533674|63171325|FG003|Dose Level III|Progressive disease|0|||
33685110|NCT02533674|63171326|FG004|Dose Level III|Progressive disease|0|||
33685111|NCT02533674|63171327|FG005|Dose Level III|Progressive disease|0|||
33685112|NCT02533674|63171328|FG006|Dose Level III|Progressive disease|0|||
33685113|NCT02533674|63171329|FG007|Dose Level III|Progressive disease|0|||
33685114|NCT02533674|63171322|FG000|Dose Level III|Withdrawal by Subject|0|||
33685115|NCT02533674|63171323|FG001|Dose Level III|Withdrawal by Subject|0|||
33685116|NCT02533674|63171324|FG002|Dose Level III|Withdrawal by Subject|1|||
33685117|NCT02533674|63171325|FG003|Dose Level III|Withdrawal by Subject|0|||
33685118|NCT02533674|63171326|FG004|Dose Level III|Withdrawal by Subject|0|||
33685119|NCT02533674|63171327|FG005|Dose Level III|Withdrawal by Subject|0|||
33685120|NCT02533674|63171328|FG006|Dose Level III|Withdrawal by Subject|0|||
33685121|NCT02533674|63171329|FG007|Dose Level III|Withdrawal by Subject|0|||
33685122|NCT02533674|63171322|FG000|Dose Level III|Treatment-related AE|0|||
33685123|NCT02533674|63171323|FG001|Dose Level III|Treatment-related AE|0|||
33685124|NCT02533674|63171324|FG002|Dose Level III|Treatment-related AE|1|||
33685125|NCT02533674|63171325|FG003|Dose Level III|Treatment-related AE|0|||
33685126|NCT02533674|63171326|FG004|Dose Level III|Treatment-related AE|0|||
33685127|NCT02533674|63171327|FG005|Dose Level III|Treatment-related AE|0|||
33685128|NCT02533674|63171328|FG006|Dose Level III|Treatment-related AE|0|||
33685129|NCT02533674|63171329|FG007|Dose Level III|Treatment-related AE|0|||
33685130|NCT02533674|63171322|FG000|Dose Level IV|Progressive disease|0|||
33685131|NCT02533674|63171323|FG001|Dose Level IV|Progressive disease|0|||
33685132|NCT02533674|63171324|FG002|Dose Level IV|Progressive disease|0|||
33685133|NCT02533674|63171325|FG003|Dose Level IV|Progressive disease|3|||
33685134|NCT02533674|63171326|FG004|Dose Level IV|Progressive disease|0|||
33685135|NCT02533674|63171327|FG005|Dose Level IV|Progressive disease|0|||
33685136|NCT02533674|63171328|FG006|Dose Level IV|Progressive disease|0|||
33685137|NCT02533674|63171329|FG007|Dose Level IV|Progressive disease|0|||
33685138|NCT02533674|63171322|FG000|Dose Level IV|Withdrawal by Subject|0|||
33685139|NCT02533674|63171323|FG001|Dose Level IV|Withdrawal by Subject|0|||
33685140|NCT02533674|63171324|FG002|Dose Level IV|Withdrawal by Subject|0|||
33685141|NCT02533674|63171325|FG003|Dose Level IV|Withdrawal by Subject|1|||
33685142|NCT02533674|63171326|FG004|Dose Level IV|Withdrawal by Subject|0|||
33685143|NCT02533674|63171327|FG005|Dose Level IV|Withdrawal by Subject|0|||
33685144|NCT02533674|63171328|FG006|Dose Level IV|Withdrawal by Subject|0|||
33685145|NCT02533674|63171329|FG007|Dose Level IV|Withdrawal by Subject|0|||
33685146|NCT02533674|63171322|FG000|Dose Level IV|Physician Decision|0|||
33685147|NCT02533674|63171323|FG001|Dose Level IV|Physician Decision|0|||
33685148|NCT02533674|63171324|FG002|Dose Level IV|Physician Decision|0|||
33685149|NCT02533674|63171325|FG003|Dose Level IV|Physician Decision|1|||
33685150|NCT02533674|63171326|FG004|Dose Level IV|Physician Decision|0|||
33685151|NCT02533674|63171327|FG005|Dose Level IV|Physician Decision|0|||
33685152|NCT02533674|63171328|FG006|Dose Level IV|Physician Decision|0|||
33685153|NCT02533674|63171329|FG007|Dose Level IV|Physician Decision|0|||
33685154|NCT02533674|63171322|FG000|Dose Level V|Progressive disease|0|||
33685155|NCT02533674|63171323|FG001|Dose Level V|Progressive disease|0|||
33685156|NCT02533674|63171324|FG002|Dose Level V|Progressive disease|0|||
33685157|NCT02533674|63171325|FG003|Dose Level V|Progressive disease|0|||
33685158|NCT02533674|63171326|FG004|Dose Level V|Progressive disease|3|||
33685159|NCT02533674|63171327|FG005|Dose Level V|Progressive disease|0|||
33685160|NCT02533674|63171328|FG006|Dose Level V|Progressive disease|0|||
33685161|NCT02533674|63171329|FG007|Dose Level V|Progressive disease|0|||
33685162|NCT02533674|63171322|FG000|Dose Level V|Withdrawal by Subject|0|||
33685163|NCT02533674|63171323|FG001|Dose Level V|Withdrawal by Subject|0|||
33685164|NCT02533674|63171324|FG002|Dose Level V|Withdrawal by Subject|0|||
33685165|NCT02533674|63171325|FG003|Dose Level V|Withdrawal by Subject|0|||
33685166|NCT02533674|63171326|FG004|Dose Level V|Withdrawal by Subject|1|||
33685167|NCT02533674|63171327|FG005|Dose Level V|Withdrawal by Subject|0|||
33685168|NCT02533674|63171328|FG006|Dose Level V|Withdrawal by Subject|0|||
33685169|NCT02533674|63171329|FG007|Dose Level V|Withdrawal by Subject|0|||
33685170|NCT02533674|63171322|FG000|Dose Level V|Physician Decision|0|||
33685171|NCT02533674|63171323|FG001|Dose Level V|Physician Decision|0|||
33685172|NCT02533674|63171324|FG002|Dose Level V|Physician Decision|0|||
33685173|NCT02533674|63171325|FG003|Dose Level V|Physician Decision|0|||
33685174|NCT02533674|63171326|FG004|Dose Level V|Physician Decision|1|||
33685175|NCT02533674|63171327|FG005|Dose Level V|Physician Decision|0|||
33685176|NCT02533674|63171328|FG006|Dose Level V|Physician Decision|0|||
33685177|NCT02533674|63171329|FG007|Dose Level V|Physician Decision|0|||
33685178|NCT02533674|63171322|FG000|Dose Level VI|Progressive disease|0|||
33685179|NCT02533674|63171323|FG001|Dose Level VI|Progressive disease|0|||
33685180|NCT02533674|63171324|FG002|Dose Level VI|Progressive disease|0|||
33685181|NCT02533674|63171325|FG003|Dose Level VI|Progressive disease|0|||
33685182|NCT02533674|63171326|FG004|Dose Level VI|Progressive disease|0|||
33685183|NCT02533674|63171327|FG005|Dose Level VI|Progressive disease|7|||
33685184|NCT02533674|63171328|FG006|Dose Level VI|Progressive disease|0|||
33685185|NCT02533674|63171329|FG007|Dose Level VI|Progressive disease|0|||
33685186|NCT02533674|63171322|FG000|Dose Level VI|Withdrawal by Subject|0|||
33685187|NCT02533674|63171323|FG001|Dose Level VI|Withdrawal by Subject|0|||
33685188|NCT02533674|63171324|FG002|Dose Level VI|Withdrawal by Subject|0|||
33685189|NCT02533674|63171325|FG003|Dose Level VI|Withdrawal by Subject|0|||
33685190|NCT02533674|63171326|FG004|Dose Level VI|Withdrawal by Subject|0|||
33685191|NCT02533674|63171327|FG005|Dose Level VI|Withdrawal by Subject|1|||
33685192|NCT02533674|63171328|FG006|Dose Level VI|Withdrawal by Subject|0|||
33685193|NCT02533674|63171329|FG007|Dose Level VI|Withdrawal by Subject|0|||
33685194|NCT02533674|63171322|FG000|Dose Level VI|Treatment-related AE|0|||
33685195|NCT02533674|63171323|FG001|Dose Level VI|Treatment-related AE|0|||
33685196|NCT02533674|63171324|FG002|Dose Level VI|Treatment-related AE|0|||
33685197|NCT02533674|63171325|FG003|Dose Level VI|Treatment-related AE|0|||
33685198|NCT02533674|63171326|FG004|Dose Level VI|Treatment-related AE|0|||
33685199|NCT02533674|63171327|FG005|Dose Level VI|Treatment-related AE|1|||
33685200|NCT02533674|63171328|FG006|Dose Level VI|Treatment-related AE|0|||
33685201|NCT02533674|63171329|FG007|Dose Level VI|Treatment-related AE|0|||
33685202|NCT02533674|63171322|FG000|Dose Level VII|Progressive disease|0|||
33685203|NCT02533674|63171323|FG001|Dose Level VII|Progressive disease|0|||
33685204|NCT02533674|63171324|FG002|Dose Level VII|Progressive disease|0|||
33685205|NCT02533674|63171325|FG003|Dose Level VII|Progressive disease|0|||
33685206|NCT02533674|63171326|FG004|Dose Level VII|Progressive disease|0|||
33685207|NCT02533674|63171327|FG005|Dose Level VII|Progressive disease|0|||
33685208|NCT02533674|63171328|FG006|Dose Level VII|Progressive disease|10|||
33685209|NCT02533674|63171329|FG007|Dose Level VII|Progressive disease|0|||
33685210|NCT02533674|63171322|FG000|Dose Level VII|Withdrawal by Subject|0|||
33685211|NCT02533674|63171323|FG001|Dose Level VII|Withdrawal by Subject|0|||
33685212|NCT02533674|63171324|FG002|Dose Level VII|Withdrawal by Subject|0|||
33685213|NCT02533674|63171325|FG003|Dose Level VII|Withdrawal by Subject|0|||
33685214|NCT02533674|63171326|FG004|Dose Level VII|Withdrawal by Subject|0|||
33685215|NCT02533674|63171327|FG005|Dose Level VII|Withdrawal by Subject|0|||
33685216|NCT02533674|63171328|FG006|Dose Level VII|Withdrawal by Subject|3|||
33685217|NCT02533674|63171329|FG007|Dose Level VII|Withdrawal by Subject|0|||
33685218|NCT02533674|63171322|FG000|Dose Level VII|Treatment-related AE|0|||
33685219|NCT02533674|63171323|FG001|Dose Level VII|Treatment-related AE|0|||
33685220|NCT02533674|63171324|FG002|Dose Level VII|Treatment-related AE|0|||
33685221|NCT02533674|63171325|FG003|Dose Level VII|Treatment-related AE|0|||
33685222|NCT02533674|63171326|FG004|Dose Level VII|Treatment-related AE|0|||
33685223|NCT02533674|63171327|FG005|Dose Level VII|Treatment-related AE|0|||
33685224|NCT02533674|63171328|FG006|Dose Level VII|Treatment-related AE|1|||
33685225|NCT02533674|63171329|FG007|Dose Level VII|Treatment-related AE|0|||
33685226|NCT02533674|63171322|FG000|Dose Level VII|Death|0|||
33685227|NCT02533674|63171323|FG001|Dose Level VII|Death|0|||
33685228|NCT02533674|63171324|FG002|Dose Level VII|Death|0|||
33685229|NCT02533674|63171325|FG003|Dose Level VII|Death|0|||
33685230|NCT02533674|63171326|FG004|Dose Level VII|Death|0|||
33685231|NCT02533674|63171327|FG005|Dose Level VII|Death|0|||
33685232|NCT02533674|63171328|FG006|Dose Level VII|Death|2|||
33685233|NCT02533674|63171329|FG007|Dose Level VII|Death|0|||
33685234|NCT02533674|63171322|FG000|Dose Level VIII|Progressive disease|0|||
33685235|NCT02533674|63171323|FG001|Dose Level VIII|Progressive disease|0|||
33685236|NCT02533674|63171324|FG002|Dose Level VIII|Progressive disease|0|||
33685237|NCT02533674|63171325|FG003|Dose Level VIII|Progressive disease|0|||
33685238|NCT02533674|63171326|FG004|Dose Level VIII|Progressive disease|0|||
33685239|NCT02533674|63171327|FG005|Dose Level VIII|Progressive disease|0|||
33685240|NCT02533674|63171328|FG006|Dose Level VIII|Progressive disease|0|||
33685241|NCT02533674|63171329|FG007|Dose Level VIII|Progressive disease|3|||
33685242|NCT02533674|63171322|FG000|Dose Level VIII|Withdrawal by Subject|0|||
33685243|NCT02533674|63171323|FG001|Dose Level VIII|Withdrawal by Subject|0|||
33685244|NCT02533674|63171324|FG002|Dose Level VIII|Withdrawal by Subject|0|||
33685245|NCT02533674|63171325|FG003|Dose Level VIII|Withdrawal by Subject|0|||
33685246|NCT02533674|63171326|FG004|Dose Level VIII|Withdrawal by Subject|0|||
33685247|NCT02533674|63171327|FG005|Dose Level VIII|Withdrawal by Subject|0|||
33685248|NCT02533674|63171328|FG006|Dose Level VIII|Withdrawal by Subject|0|||
33685249|NCT02533674|63171329|FG007|Dose Level VIII|Withdrawal by Subject|1|||
33685250|NCT02533674|63171322|FG000|Dose Level VIII|Treatment-related AE|0|||
33685251|NCT02533674|63171323|FG001|Dose Level VIII|Treatment-related AE|0|||
33685252|NCT02533674|63171324|FG002|Dose Level VIII|Treatment-related AE|0|||
33685253|NCT02533674|63171325|FG003|Dose Level VIII|Treatment-related AE|0|||
33685254|NCT02533674|63171326|FG004|Dose Level VIII|Treatment-related AE|0|||
33685255|NCT02533674|63171327|FG005|Dose Level VIII|Treatment-related AE|0|||
33685256|NCT02533674|63171328|FG006|Dose Level VIII|Treatment-related AE|0|||
33685257|NCT02533674|63171329|FG007|Dose Level VIII|Treatment-related AE|1|||
33685258|NCT02533674|63171322|FG000|Dose Level VIII|Never treated|0|||
33685259|NCT02533674|63171323|FG001|Dose Level VIII|Never treated|0|||
33685260|NCT02533674|63171324|FG002|Dose Level VIII|Never treated|0|||
33685261|NCT02533674|63171325|FG003|Dose Level VIII|Never treated|0|||
33685262|NCT02533674|63171326|FG004|Dose Level VIII|Never treated|0|||
33685263|NCT02533674|63171327|FG005|Dose Level VIII|Never treated|0|||
33685264|NCT02533674|63171328|FG006|Dose Level VIII|Never treated|0|||
33685265|NCT02533674|63171329|FG007|Dose Level VIII|Never treated|1|||
33685266|NCT02540850|63171350|FG000|Overall Study|Lost to Follow-up|69|||
33685267|NCT02540850|63171351|FG001|Overall Study|Lost to Follow-up|66|||
33685268|NCT02540850|63171352|FG002|Overall Study|Lost to Follow-up|34|||
33685269|NCT01662024|63171360|FG000|Overall Study|Pregnancy|2|||
33685270|NCT01662024|63171360|FG000|Overall Study|Withdrawal by Subject|3|||
33685271|NCT02544750|63171429|FG000|Overall Study|Physician Decision|3|||
33685272|NCT02544750|63171430|FG001|Overall Study|Physician Decision|1|||
33685273|NCT02544750|63171429|FG000|Overall Study|Other reasons|69|||
33685274|NCT02544750|63171430|FG001|Overall Study|Other reasons|39|||
33685275|NCT02544750|63171429|FG000|Overall Study|Met withdrawal criteria|2|||
33685276|NCT02544750|63171430|FG001|Overall Study|Met withdrawal criteria|2|||
33685277|NCT02544750|63171429|FG000|Overall Study|Transition To Commercial Product|1|||
33685278|NCT02544750|63171430|FG001|Overall Study|Transition To Commercial Product|0|||
33685279|NCT02544750|63171429|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
33685280|NCT02544750|63171430|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
33685281|NCT02544750|63171429|FG000|Overall Study|Adverse Event|8|||
33685282|NCT02544750|63171430|FG001|Overall Study|Adverse Event|10|||
33685283|NCT02544750|63171429|FG000|Overall Study|Withdrawal by Subject|10|||
33685284|NCT02544750|63171430|FG001|Overall Study|Withdrawal by Subject|4|||
33685285|NCT02544750|63171429|FG000|Overall Study|Lost to Follow-up|1|||
33685286|NCT02544750|63171430|FG001|Overall Study|Lost to Follow-up|0|||
33685287|NCT02540538|63171476|FG000|Overall Study|Pregnancy|0|||
33685288|NCT02540538|63171477|FG001|Overall Study|Pregnancy|1|||
33685289|NCT02540538|63171478|FG002|Overall Study|Pregnancy|0|||
33685290|NCT04697056|63171511|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
33685291|NCT04697056|63171512|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
33685292|NCT02181738|63171636|FG000|Overall Study|Death|1|||
33685293|NCT02181738|63171637|FG001|Overall Study|Death|1|||
33685294|NCT02181738|63171638|FG002|Overall Study|Death|6|||
33685295|NCT02181738|63171639|FG003|Overall Study|Death|1|||
33685296|NCT02181738|63171636|FG000|Overall Study|Subject Withdrew Consent|1|||
33685297|NCT02181738|63171637|FG001|Overall Study|Subject Withdrew Consent|3|||
33685298|NCT02181738|63171638|FG002|Overall Study|Subject Withdrew Consent|2|||
33685299|NCT02181738|63171639|FG003|Overall Study|Subject Withdrew Consent|1|||
33685300|NCT02181738|63171636|FG000|Overall Study|Lost to Follow-up|0|||
33685301|NCT02181738|63171637|FG001|Overall Study|Lost to Follow-up|4|||
33685302|NCT02181738|63171638|FG002|Overall Study|Lost to Follow-up|2|||
33685303|NCT02181738|63171639|FG003|Overall Study|Lost to Follow-up|0|||
33685304|NCT02181738|63171636|FG000|Overall Study|Patient Return to Home Country|0|||
33685305|NCT02181738|63171637|FG001|Overall Study|Patient Return to Home Country|1|||
33685306|NCT02181738|63171638|FG002|Overall Study|Patient Return to Home Country|0|||
33685307|NCT02181738|63171639|FG003|Overall Study|Patient Return to Home Country|0|||
33685308|NCT02532972|63171667|FG000|Overall Study|Withdrawal by Subject|1|||
33685309|NCT03187834|63171720|FG000|Overall Study|Lost to Follow-up|0|||
33685310|NCT03187834|63171721|FG001|Overall Study|Lost to Follow-up|1|||
33685311|NCT03187834|63171722|FG002|Overall Study|Lost to Follow-up|2|||
33685312|NCT03187834|63171723|FG003|Overall Study|Lost to Follow-up|2|||
33685313|NCT03187834|63171720|FG000|Overall Study|Had invalid anthropometric measurements|5|||
33685314|NCT03187834|63171721|FG001|Overall Study|Had invalid anthropometric measurements|3|||
33685315|NCT03187834|63171722|FG002|Overall Study|Had invalid anthropometric measurements|4|||
33685316|NCT03187834|63171723|FG003|Overall Study|Had invalid anthropometric measurements|2|||
33685317|NCT03713944|63171876|FG000|Study Treatment|Patient non-compliance|1|||
33685318|NCT03713944|63171876|FG000|Study Treatment|Alternative Cancer Therapy|3|||
33685319|NCT03713944|63171876|FG000|Study Treatment|Disease Progression|18|||
33685320|NCT03713944|63171876|FG000|Study Treatment|AE/Side Effects/Complications|2|||
33685321|NCT03713944|63171876|FG000|Study Treatment|Death|2|||
33685322|NCT03713944|63171876|FG000|Study Treatment|Withdrawal by Subject|1|||
33685323|NCT03713944|63171876|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
33685324|NCT03713944|63171876|FG000|Study Treatment|Symptomatic Deterioration|2|||
33685325|NCT03713944|63171876|FG000|Follow up|Withdrawal by Subject|2|||
33685326|NCT03713944|63171876|FG000|Follow up|Death|11|||
33685327|NCT03713944|63171876|FG000|Follow up|Study Terminated|3|||
33685328|NCT01572662|63171954|FG000|Overall Study|Withdrawal by Subject|1|||
33685329|NCT01572662|63171955|FG001|Overall Study|Withdrawal by Subject|0|||
33685330|NCT01572662|63171954|FG000|Overall Study|Physician Decision|0|||
33685331|NCT01572662|63171955|FG001|Overall Study|Physician Decision|1|||
33685332|NCT02325154|63171985|FG000|Overall Study|Physician Decision|1|||
33685333|NCT00493870|63172112|FG000|Overall Study|Lost to Follow-up|12|||
33685334|NCT00493870|63172113|FG001|Overall Study|Lost to Follow-up|15|||
33685335|NCT04439344|63172366|FG000|Overall Study|Never started threapy|3|||
33685336|NCT04439344|63172366|FG000|Overall Study|Ineligible|3|||
33685337|NCT04439344|63172366|FG000|Overall Study|Adverse Event|13|||
33685338|NCT04439344|63172366|FG000|Overall Study|Death|2|||
33685339|NCT04439344|63172366|FG000|Overall Study|Disease progression|29|||
33685340|NCT04439344|63172366|FG000|Overall Study|Withdrawal by Subject|2|||
33685341|NCT04439344|63172366|FG000|Overall Study|Alternative therapy|1|||
33685342|NCT04439279|63172370|FG000|Overall Study|Adverse Event|7|||
33685343|NCT04439279|63172370|FG000|Overall Study|Death|4|||
33685344|NCT04439279|63172370|FG000|Overall Study|Disease progression|17|||
33685345|NCT04439279|63172370|FG000|Overall Study|Complicating disease|3|||
33685346|NCT04439279|63172370|FG000|Overall Study|Withdrawal by Subject|2|||
33685347|NCT04439279|63172370|FG000|Overall Study|Ineligible|1|||
33685348|NCT04439279|63172370|FG000|Overall Study|Treatment still ongoing|1|||
33685349|NCT04439175|63172374|FG000|Overall Study|Never started treatment|4|||
33685350|NCT04439175|63172374|FG000|Overall Study|Ineligible|5|||
33685351|NCT04439175|63172374|FG000|Overall Study|Adverse Event|6|||
33685352|NCT04439175|63172374|FG000|Overall Study|Death|4|||
33685353|NCT04439175|63172374|FG000|Overall Study|Disease progression|44|||
33685354|NCT04439175|63172374|FG000|Overall Study|Withdrawal by Subject|4|||
33685355|NCT04439175|63172374|FG000|Overall Study|Alternative Therapy|1|||
33685356|NCT04439175|63172374|FG000|Overall Study|Other|2|||
33685357|NCT03951753|63172394|FG000|Overall Study|Adverse Event|1|||
33685358|NCT03951753|63172395|FG001|Overall Study|Adverse Event|0|||
33685359|NCT03951753|63172396|FG002|Overall Study|Adverse Event|3|||
33685360|NCT03951753|63172394|FG000|Overall Study|Withdrawal by Subject|3|||
33685361|NCT03951753|63172395|FG001|Overall Study|Withdrawal by Subject|1|||
33685362|NCT03951753|63172396|FG002|Overall Study|Withdrawal by Subject|0|||
33685363|NCT03951753|63172394|FG000|Overall Study|Lost to Follow-up|0|||
33685364|NCT03951753|63172395|FG001|Overall Study|Lost to Follow-up|0|||
33685365|NCT03951753|63172396|FG002|Overall Study|Lost to Follow-up|1|||
33685366|NCT03941964|63172406|FG000|Overall Study|Adverse Event|1|||
33685367|NCT03941964|63172407|FG001|Overall Study|Adverse Event|8|||
33685368|NCT03941964|63172406|FG000|Overall Study|Progressive disease|7|||
33685369|NCT03941964|63172407|FG001|Overall Study|Progressive disease|3|||
33685370|NCT03941964|63172406|FG000|Overall Study|Lack of Efficacy|0|||
33685371|NCT03941964|63172407|FG001|Overall Study|Lack of Efficacy|1|||
33685372|NCT03941964|63172406|FG000|Overall Study|Death|3|||
33685373|NCT03941964|63172407|FG001|Overall Study|Death|1|||
33685374|NCT03941964|63172406|FG000|Overall Study|Withdrew consent|1|||
33685375|NCT03941964|63172407|FG001|Overall Study|Withdrew consent|3|||
33685376|NCT03941964|63172406|FG000|Overall Study|Physician Decision|9|||
33685377|NCT03941964|63172407|FG001|Overall Study|Physician Decision|2|||
33685378|NCT03941964|63172406|FG000|Overall Study|Other, not specified|2|||
33685379|NCT03941964|63172407|FG001|Overall Study|Other, not specified|1|||
33685380|NCT03837509|63172437|FG000|Phase 1|Death|5|||
33685381|NCT03837509|63172438|FG001|Phase 1|Death|2|||
33595610|NCT02175771|62994627|FG001|Run-In Period (Pre-assignment)|Other|0|||
33595611|NCT02175771|62994628|FG002|Run-In Period (Pre-assignment)|Other|0|||
33595612|NCT02175771|62994629|FG003|Run-In Period (Pre-assignment)|Other|0|||
33595613|NCT02175771|62994630|FG004|Run-In Period (Pre-assignment)|Other|0|||
33595614|NCT02175771|62994631|FG005|Run-In Period (Pre-assignment)|Other|0|||
33595615|NCT02175771|62994632|FG006|Run-In Period (Pre-assignment)|Other|0|||
33595616|NCT02175771|62994633|FG007|Run-In Period (Pre-assignment)|Other|0|||
33595617|NCT02175771|62994634|FG008|Run-In Period (Pre-assignment)|Other|0|||
33595618|NCT02175771|62994626|FG000|Treatment Period|Adverse Event|0|||
33595619|NCT02175771|62994627|FG001|Treatment Period|Adverse Event|2|||
33595620|NCT02175771|62994628|FG002|Treatment Period|Adverse Event|1|||
33595621|NCT02175771|62994629|FG003|Treatment Period|Adverse Event|1|||
33685382|NCT03837509|63172439|FG002|Phase 1|Death|0|||
33685383|NCT03837509|63172440|FG003|Phase 1|Death|0|||
33685384|NCT03837509|63172441|FG004|Phase 1|Death|0|||
33685385|NCT03837509|63172437|FG000|Phase 2|Death|0|||
33685386|NCT03837509|63172438|FG001|Phase 2|Death|0|||
33685387|NCT03837509|63172439|FG002|Phase 2|Death|0|||
33310743|NCT01234350|62686157|FG001|Overall Study|Adverse Event|92|||
33595622|NCT02175771|62994630|FG004|Treatment Period|Adverse Event|1|||
33685388|NCT03837509|63172440|FG003|Phase 2|Death|1|||
33685389|NCT03837509|63172441|FG004|Phase 2|Death|1|||
33685390|NCT03822117|63172461|FG000|Overall Study|Death|18|||
33685391|NCT03822117|63172462|FG001|Overall Study|Death|17|||
33685392|NCT03822117|63172463|FG002|Overall Study|Death|12|||
33685393|NCT03822117|63172464|FG003|Overall Study|Death|4|||
33685394|NCT03822117|63172461|FG000|Overall Study|Lost to Follow-up|1|||
33685395|NCT03822117|63172462|FG001|Overall Study|Lost to Follow-up|2|||
33685396|NCT03822117|63172463|FG002|Overall Study|Lost to Follow-up|3|||
33685397|NCT03822117|63172464|FG003|Overall Study|Lost to Follow-up|0|||
33685398|NCT03822117|63172461|FG000|Overall Study|Study Terminated by Sponsor|25|||
33685399|NCT03822117|63172462|FG001|Overall Study|Study Terminated by Sponsor|11|||
33685400|NCT03822117|63172463|FG002|Overall Study|Study Terminated by Sponsor|6|||
33685401|NCT03822117|63172464|FG003|Overall Study|Study Terminated by Sponsor|0|||
33685402|NCT03822117|63172461|FG000|Overall Study|Withdrawal by Subject|4|||
33685403|NCT03822117|63172462|FG001|Overall Study|Withdrawal by Subject|0|||
33685404|NCT03822117|63172463|FG002|Overall Study|Withdrawal by Subject|3|||
33685405|NCT03822117|63172464|FG003|Overall Study|Withdrawal by Subject|0|||
33685406|NCT03822117|63172461|FG000|Overall Study|Disease Progression|1|||
33685407|NCT03822117|63172462|FG001|Overall Study|Disease Progression|2|||
33685408|NCT03822117|63172463|FG002|Overall Study|Disease Progression|1|||
33685409|NCT03822117|63172464|FG003|Overall Study|Disease Progression|0|||
33685410|NCT03822117|63172461|FG000|Overall Study|Never Returned to Hospital|0|||
33685411|NCT03822117|63172462|FG001|Overall Study|Never Returned to Hospital|0|||
33685412|NCT03822117|63172463|FG002|Overall Study|Never Returned to Hospital|1|||
33685413|NCT03822117|63172464|FG003|Overall Study|Never Returned to Hospital|0|||
33685414|NCT03497897|63172478|FG000|Overall Study|Adverse Event|1|||
33685415|NCT03497897|63172479|FG001|Overall Study|Adverse Event|1|||
33685416|NCT03497897|63172480|FG002|Overall Study|Adverse Event|1|||
33685417|NCT03497897|63172478|FG000|Overall Study|Lost to Follow-up|2|||
33685418|NCT03497897|63172479|FG001|Overall Study|Lost to Follow-up|0|||
33685419|NCT03497897|63172480|FG002|Overall Study|Lost to Follow-up|2|||
33685420|NCT03497897|63172478|FG000|Overall Study|Physician Decision|1|||
33685421|NCT03497897|63172479|FG001|Overall Study|Physician Decision|0|||
33685422|NCT03497897|63172480|FG002|Overall Study|Physician Decision|0|||
33685423|NCT03497897|63172478|FG000|Overall Study|Subject/Guardian Decision|2|||
33685424|NCT03497897|63172479|FG001|Overall Study|Subject/Guardian Decision|1|||
33685425|NCT03497897|63172480|FG002|Overall Study|Subject/Guardian Decision|3|||
33685426|NCT03428217|63172491|FG000|Overall Study|Death|89|||
33685427|NCT03428217|63172492|FG001|Overall Study|Death|93|||
33685428|NCT03428217|63172491|FG000|Overall Study|Withdrawal by Subject|8|||
33685429|NCT03428217|63172492|FG001|Overall Study|Withdrawal by Subject|7|||
33685430|NCT03428217|63172491|FG000|Overall Study|Lost to Follow-up|1|||
33685431|NCT03428217|63172492|FG001|Overall Study|Lost to Follow-up|3|||
33685432|NCT03428217|63172491|FG000|Overall Study|Study terminated by sponsor|124|||
33685433|NCT03428217|63172492|FG001|Overall Study|Study terminated by sponsor|118|||
33685434|NCT03428217|63172491|FG000|Overall Study|Other, Not Specified|1|||
33685435|NCT03428217|63172492|FG001|Overall Study|Other, Not Specified|0|||
33685436|NCT03189719|63172502|FG000|Overall Study|Death|260|||
33685437|NCT03189719|63172503|FG001|Overall Study|Death|308|||
33685438|NCT03189719|63172502|FG000|Overall Study|Withdrawal by Subject|5|||
33685439|NCT03189719|63172503|FG001|Overall Study|Withdrawal by Subject|3|||
33685440|NCT03189719|63172502|FG000|Overall Study|Ongoing in Study|108|||
33685441|NCT03189719|63172503|FG001|Overall Study|Ongoing in Study|65|||
33685442|NCT02969525|63172514|FG000|Double-Blind Period|Adverse Event|0|||
33685443|NCT02969525|63172515|FG001|Double-Blind Period|Adverse Event|0|||
33685444|NCT02969525|63172516|FG002|Double-Blind Period|Adverse Event|1|||
33685445|NCT02969525|63172517|FG003|Double-Blind Period|Adverse Event|1|||
33685446|NCT02969525|63172518|FG004|Double-Blind Period|Adverse Event|0|||
33685447|NCT02969525|63172519|FG005|Double-Blind Period|Adverse Event|0|||
33685448|NCT02969525|63172520|FG006|Double-Blind Period|Adverse Event|0|||
33685449|NCT02969525|63172521|FG007|Double-Blind Period|Adverse Event|0|||
33685450|NCT02969525|63172522|FG008|Double-Blind Period|Adverse Event|0|||
33685451|NCT02969525|63172523|FG009|Double-Blind Period|Adverse Event|0|||
33685452|NCT02969525|63172524|FG010|Double-Blind Period|Adverse Event|0|||
33685453|NCT02969525|63172525|FG011|Double-Blind Period|Adverse Event|0|||
33685454|NCT02969525|63172514|FG000|Double-Blind Period|LOW EGFR|0|||
33685455|NCT02969525|63172515|FG001|Double-Blind Period|LOW EGFR|0|||
33685456|NCT02969525|63172516|FG002|Double-Blind Period|LOW EGFR|0|||
33685457|NCT02969525|63172517|FG003|Double-Blind Period|LOW EGFR|1|||
33685458|NCT02969525|63172518|FG004|Double-Blind Period|LOW EGFR|0|||
33685459|NCT02969525|63172519|FG005|Double-Blind Period|LOW EGFR|0|||
33685460|NCT02969525|63172520|FG006|Double-Blind Period|LOW EGFR|0|||
33685461|NCT02969525|63172521|FG007|Double-Blind Period|LOW EGFR|0|||
33685462|NCT02969525|63172522|FG008|Double-Blind Period|LOW EGFR|0|||
33685463|NCT02969525|63172523|FG009|Double-Blind Period|LOW EGFR|0|||
33685464|NCT02969525|63172524|FG010|Double-Blind Period|LOW EGFR|0|||
33685465|NCT02969525|63172525|FG011|Double-Blind Period|LOW EGFR|0|||
33685466|NCT02969525|63172514|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
33685467|NCT02969525|63172515|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33685468|NCT02969525|63172516|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33685469|NCT02969525|63172517|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
33685470|NCT02969525|63172518|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33685471|NCT02969525|63172519|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33685472|NCT02969525|63172520|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33685473|NCT02969525|63172521|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33685474|NCT02969525|63172522|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33685475|NCT02969525|63172523|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33685476|NCT02969525|63172524|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33685477|NCT02969525|63172525|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33685478|NCT02969525|63172514|FG000|Dose-Blind Period|Adverse Event|0|||
33685479|NCT02969525|63172515|FG001|Dose-Blind Period|Adverse Event|0|||
33685480|NCT02969525|63172516|FG002|Dose-Blind Period|Adverse Event|0|||
33685481|NCT02969525|63172517|FG003|Dose-Blind Period|Adverse Event|0|||
33685482|NCT02969525|63172518|FG004|Dose-Blind Period|Adverse Event|0|||
33685483|NCT02969525|63172519|FG005|Dose-Blind Period|Adverse Event|0|||
33685484|NCT02969525|63172520|FG006|Dose-Blind Period|Adverse Event|0|||
33685485|NCT02969525|63172521|FG007|Dose-Blind Period|Adverse Event|0|||
33685486|NCT02969525|63172522|FG008|Dose-Blind Period|Adverse Event|0|||
33685487|NCT02969525|63172523|FG009|Dose-Blind Period|Adverse Event|1|||
33685488|NCT02969525|63172524|FG010|Dose-Blind Period|Adverse Event|1|||
33685489|NCT02969525|63172525|FG011|Dose-Blind Period|Adverse Event|1|||
33685490|NCT02969525|63172514|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
33685491|NCT02969525|63172515|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
33685492|NCT02969525|63172516|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
33685493|NCT02969525|63172517|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
33685494|NCT02969525|63172518|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
33685495|NCT02969525|63172519|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
33685496|NCT02969525|63172520|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
33685497|NCT02969525|63172521|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
33685498|NCT02969525|63172522|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
33685499|NCT02969525|63172523|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
33685500|NCT02969525|63172524|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
33685501|NCT02969525|63172525|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
33685502|NCT02969525|63172514|FG000|Dose-Blind Period|Non-cooperating patient|0|||
33685503|NCT02969525|63172515|FG001|Dose-Blind Period|Non-cooperating patient|0|||
33685504|NCT02969525|63172516|FG002|Dose-Blind Period|Non-cooperating patient|0|||
33685505|NCT02969525|63172517|FG003|Dose-Blind Period|Non-cooperating patient|0|||
33685506|NCT02969525|63172518|FG004|Dose-Blind Period|Non-cooperating patient|0|||
33685507|NCT02969525|63172519|FG005|Dose-Blind Period|Non-cooperating patient|0|||
33685508|NCT02969525|63172520|FG006|Dose-Blind Period|Non-cooperating patient|0|||
33685509|NCT02969525|63172521|FG007|Dose-Blind Period|Non-cooperating patient|0|||
33685510|NCT02969525|63172522|FG008|Dose-Blind Period|Non-cooperating patient|0|||
33685511|NCT02969525|63172523|FG009|Dose-Blind Period|Non-cooperating patient|0|||
33685512|NCT02969525|63172524|FG010|Dose-Blind Period|Non-cooperating patient|0|||
33685513|NCT02969525|63172525|FG011|Dose-Blind Period|Non-cooperating patient|1|||
33685514|NCT02969525|63172514|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33685515|NCT02969525|63172515|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33685516|NCT02969525|63172516|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33685517|NCT02969525|63172517|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33685518|NCT02969525|63172518|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33685519|NCT02969525|63172519|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33685520|NCT02969525|63172520|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33685521|NCT02969525|63172521|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33685522|NCT02969525|63172522|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33685523|NCT02969525|63172523|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33685524|NCT02969525|63172524|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
33685525|NCT02969525|63172525|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33685526|NCT04232215|63172556|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
33685527|NCT04232215|63172557|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
33685528|NCT02399813|63172572|FG000|Overall Study|Progressive Disease-Radiographic|2|||
33685529|NCT02399813|63172572|FG000|Overall Study|Death|20|||
33685530|NCT02399813|63172572|FG000|Overall Study|Withdrawal by Subject|3|||
33685531|NCT02399813|63172572|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
33685532|NCT02399813|63172572|FG000|Overall Study|Lost to Follow-up|2|||
33685533|NCT02399813|63172572|FG000|Overall Study|Other than specified|5|||
33685534|NCT02291055|63172581|FG000|Overall Study|Death|2|||
33685535|NCT02291055|63172582|FG001|Overall Study|Death|2|||
33685536|NCT02291055|63172583|FG002|Overall Study|Death|5|||
33685537|NCT02291055|63172584|FG003|Overall Study|Death|8|||
33685538|NCT02291055|63172585|FG004|Overall Study|Death|12|||
33685539|NCT02291055|63172581|FG000|Overall Study|Lost to Follow-up|0|||
33685540|NCT02291055|63172582|FG001|Overall Study|Lost to Follow-up|0|||
33685541|NCT02291055|63172583|FG002|Overall Study|Lost to Follow-up|0|||
33685542|NCT02291055|63172584|FG003|Overall Study|Lost to Follow-up|1|||
33685543|NCT02291055|63172585|FG004|Overall Study|Lost to Follow-up|2|||
33685544|NCT02291055|63172581|FG000|Overall Study|Withdrawal by Subject|3|||
33685545|NCT02291055|63172582|FG001|Overall Study|Withdrawal by Subject|1|||
33685546|NCT02291055|63172583|FG002|Overall Study|Withdrawal by Subject|1|||
33685547|NCT02291055|63172584|FG003|Overall Study|Withdrawal by Subject|5|||
33685548|NCT02291055|63172585|FG004|Overall Study|Withdrawal by Subject|10|||
33685549|NCT02291055|63172581|FG000|Overall Study|Progressive Disease|0|||
33685550|NCT02291055|63172582|FG001|Overall Study|Progressive Disease|0|||
33685551|NCT02291055|63172583|FG002|Overall Study|Progressive Disease|1|||
33685552|NCT02291055|63172584|FG003|Overall Study|Progressive Disease|4|||
33685553|NCT02291055|63172585|FG004|Overall Study|Progressive Disease|2|||
33685554|NCT02291055|63172581|FG000|Overall Study|Study Terminated by Sponsor|0|||
33685555|NCT02291055|63172582|FG001|Overall Study|Study Terminated by Sponsor|0|||
33685556|NCT02291055|63172583|FG002|Overall Study|Study Terminated by Sponsor|0|||
33685557|NCT02291055|63172584|FG003|Overall Study|Study Terminated by Sponsor|5|||
33685558|NCT02291055|63172585|FG004|Overall Study|Study Terminated by Sponsor|1|||
33685559|NCT02291055|63172581|FG000|Overall Study|Other|0|||
33685560|NCT02291055|63172582|FG001|Overall Study|Other|2|||
33685561|NCT02291055|63172583|FG002|Overall Study|Other|1|||
33685562|NCT02291055|63172584|FG003|Overall Study|Other|4|||
33685563|NCT02291055|63172585|FG004|Overall Study|Other|0|||
33685564|NCT00723697|63172601|FG000|Overall Study|Physician questionnaires not received|2|||
33685565|NCT00723697|63172601|FG000|Overall Study|Missing Informed Consent Form|10|||
33685566|NCT00723697|63172601|FG000|Overall Study|Other exclusion criteria applied|6|||
33685567|NCT00684073|63172608|FG000|Selection|Selection/non-selection criteria|3|||
33685568|NCT00684073|63172608|FG000|Selection|Death|1|||
33685569|NCT00684073|63172608|FG000|Selection|noncompliance|1|||
33685570|NCT00684073|63172608|FG000|Selection|Lost to Follow-up|1|||
33685571|NCT00684073|63172608|FG000|Selection|request of the sponsor|1|||
33685572|NCT00684073|63172608|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
33685573|NCT02539368|63174549|FG000|Overall Study|Death|4|||
33685574|NCT02539368|63174550|FG001|Overall Study|Death|2|||
33685575|NCT02539368|63174551|FG002|Overall Study|Death|1|||
33685576|NCT02539368|63174552|FG003|Overall Study|Death|0|||
33685577|NCT02539368|63174553|FG004|Overall Study|Death|0|||
33595623|NCT02175771|62994631|FG005|Treatment Period|Adverse Event|3|||
33595624|NCT02175771|62994632|FG006|Treatment Period|Adverse Event|2|||
33595625|NCT02175771|62994633|FG007|Treatment Period|Adverse Event|0|||
33595626|NCT02175771|62994634|FG008|Treatment Period|Adverse Event|1|||
33595627|NCT02175771|62994626|FG000|Treatment Period|Withdrawal by Subject|0|||
33595628|NCT02175771|62994627|FG001|Treatment Period|Withdrawal by Subject|9|||
33595629|NCT02175771|62994628|FG002|Treatment Period|Withdrawal by Subject|3|||
33595630|NCT02175771|62994629|FG003|Treatment Period|Withdrawal by Subject|6|||
33595631|NCT02175771|62994630|FG004|Treatment Period|Withdrawal by Subject|2|||
33595632|NCT02175771|62994631|FG005|Treatment Period|Withdrawal by Subject|4|||
33685578|NCT02539368|63174549|FG000|Overall Study|Withdrawal by Subject|44|||
33685579|NCT02539368|63174550|FG001|Overall Study|Withdrawal by Subject|35|||
33685580|NCT02539368|63174551|FG002|Overall Study|Withdrawal by Subject|9|||
33685581|NCT02539368|63174552|FG003|Overall Study|Withdrawal by Subject|1|||
33685582|NCT02539368|63174553|FG004|Overall Study|Withdrawal by Subject|3|||
33685583|NCT02539368|63174549|FG000|Overall Study|Physician Decision|49|||
33685584|NCT02539368|63174550|FG001|Overall Study|Physician Decision|15|||
33685585|NCT02539368|63174551|FG002|Overall Study|Physician Decision|7|||
33685586|NCT02539368|63174552|FG003|Overall Study|Physician Decision|0|||
33685587|NCT02539368|63174553|FG004|Overall Study|Physician Decision|2|||
33685588|NCT02539368|63174549|FG000|Overall Study|Lost to Follow-up|96|||
33685589|NCT02539368|63174550|FG001|Overall Study|Lost to Follow-up|21|||
33685590|NCT02539368|63174551|FG002|Overall Study|Lost to Follow-up|16|||
33685591|NCT02539368|63174552|FG003|Overall Study|Lost to Follow-up|4|||
33685592|NCT02539368|63174553|FG004|Overall Study|Lost to Follow-up|3|||
33685593|NCT02539368|63174549|FG000|Overall Study|Adverse Event|44|||
33685594|NCT02539368|63174550|FG001|Overall Study|Adverse Event|5|||
33685595|NCT02539368|63174551|FG002|Overall Study|Adverse Event|9|||
33685596|NCT02539368|63174552|FG003|Overall Study|Adverse Event|0|||
33685597|NCT02539368|63174553|FG004|Overall Study|Adverse Event|3|||
33685598|NCT02539368|63174549|FG000|Overall Study|Participant Non-compliant|13|||
33685599|NCT02539368|63174550|FG001|Overall Study|Participant Non-compliant|2|||
33685600|NCT02539368|63174551|FG002|Overall Study|Participant Non-compliant|1|||
33685601|NCT02539368|63174552|FG003|Overall Study|Participant Non-compliant|1|||
33685602|NCT02539368|63174553|FG004|Overall Study|Participant Non-compliant|0|||
33685603|NCT02539368|63174549|FG000|Overall Study|Other|145|||
33685604|NCT02539368|63174550|FG001|Overall Study|Other|18|||
33685605|NCT02539368|63174551|FG002|Overall Study|Other|24|||
33685606|NCT02539368|63174552|FG003|Overall Study|Other|1|||
33685607|NCT02539368|63174553|FG004|Overall Study|Other|3|||
33685608|NCT02539368|63174549|FG000|Overall Study|Missing|10|||
33685609|NCT02539368|63174550|FG001|Overall Study|Missing|3|||
33685610|NCT02539368|63174551|FG002|Overall Study|Missing|0|||
33685611|NCT02539368|63174552|FG003|Overall Study|Missing|0|||
33685612|NCT02539368|63174553|FG004|Overall Study|Missing|0|||
33685613|NCT02539134|63174706|FG000|Overall Study|Lost to Follow-up|1|||
33685614|NCT02539134|63174707|FG001|Overall Study|Lost to Follow-up|0|||
33685615|NCT02539134|63174708|FG002|Overall Study|Lost to Follow-up|0|||
33685616|NCT02539134|63174709|FG003|Overall Study|Lost to Follow-up|0|||
33685617|NCT02539134|63174710|FG004|Overall Study|Lost to Follow-up|0|||
33685618|NCT02539134|63174711|FG005|Overall Study|Lost to Follow-up|0|||
33685619|NCT02538900|63174815|FG000|Overall Study|Death|2|||
33685620|NCT02538900|63174816|FG001|Overall Study|Death|2|||
33685621|NCT02538900|63174817|FG002|Overall Study|Death|2|||
33685622|NCT02538900|63174815|FG000|Overall Study|Withdrawal by Subject|18|||
33685623|NCT02538900|63174816|FG001|Overall Study|Withdrawal by Subject|16|||
33685624|NCT02538900|63174817|FG002|Overall Study|Withdrawal by Subject|15|||
33685625|NCT01986348|63175297|FG000|Overall Study|Death|8|||
33685626|NCT01986348|63175298|FG001|Overall Study|Death|22|||
33685627|NCT01986348|63175299|FG002|Overall Study|Death|10|||
33685628|NCT01986348|63175300|FG003|Overall Study|Death|21|||
33685629|NCT01986348|63175297|FG000|Overall Study|Lost to Follow-up|0|||
33685630|NCT01986348|63175298|FG001|Overall Study|Lost to Follow-up|0|||
33685631|NCT01986348|63175299|FG002|Overall Study|Lost to Follow-up|0|||
33685632|NCT01986348|63175300|FG003|Overall Study|Lost to Follow-up|2|||
33685633|NCT01986348|63175297|FG000|Overall Study|Physician Decision|0|||
33685634|NCT01986348|63175298|FG001|Overall Study|Physician Decision|0|||
33685635|NCT01986348|63175299|FG002|Overall Study|Physician Decision|0|||
33685636|NCT01986348|63175300|FG003|Overall Study|Physician Decision|1|||
33685637|NCT01986348|63175297|FG000|Overall Study|Progressive Disease|0|||
33685638|NCT01986348|63175298|FG001|Overall Study|Progressive Disease|0|||
33685639|NCT01986348|63175299|FG002|Overall Study|Progressive Disease|2|||
33685640|NCT01986348|63175300|FG003|Overall Study|Progressive Disease|0|||
33685641|NCT01986348|63175297|FG000|Overall Study|Withdrawal by Participant|0|||
33685642|NCT01986348|63175298|FG001|Overall Study|Withdrawal by Participant|1|||
33685643|NCT01986348|63175299|FG002|Overall Study|Withdrawal by Participant|2|||
33685644|NCT01986348|63175300|FG003|Overall Study|Withdrawal by Participant|1|||
33685645|NCT01986348|63175297|FG000|Overall Study|Study Terminated by Sponsor|0|||
33685646|NCT01986348|63175298|FG001|Overall Study|Study Terminated by Sponsor|0|||
33685647|NCT01986348|63175299|FG002|Overall Study|Study Terminated by Sponsor|0|||
33685648|NCT01986348|63175300|FG003|Overall Study|Study Terminated by Sponsor|3|||
33685649|NCT01986348|63175297|FG000|Overall Study|Other-unspecified|0|||
33685650|NCT01986348|63175298|FG001|Overall Study|Other-unspecified|1|||
33685651|NCT01986348|63175299|FG002|Overall Study|Other-unspecified|0|||
33685652|NCT01986348|63175300|FG003|Overall Study|Other-unspecified|2|||
33685653|NCT02543892|63175873|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
33685654|NCT02543892|63175874|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
33685655|NCT02543892|63175875|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
33685656|NCT02543892|63175876|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
33685657|NCT02543892|63175877|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
33685658|NCT02543892|63175878|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
33685659|NCT02543892|63175879|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
33685660|NCT02543892|63175880|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
33685661|NCT02543892|63175873|FG000|Received Vaccination 2|Physician Decision|0|||
33685662|NCT02543892|63175874|FG001|Received Vaccination 2|Physician Decision|0|||
33685663|NCT02543892|63175875|FG002|Received Vaccination 2|Physician Decision|0|||
33685664|NCT02543892|63175876|FG003|Received Vaccination 2|Physician Decision|0|||
33685665|NCT02543892|63175877|FG004|Received Vaccination 2|Physician Decision|0|||
33685666|NCT02543892|63175878|FG005|Received Vaccination 2|Physician Decision|1|||
33685667|NCT02543892|63175879|FG006|Received Vaccination 2|Physician Decision|0|||
33685668|NCT02543892|63175880|FG007|Received Vaccination 2|Physician Decision|0|||
33685669|NCT02543892|63175873|FG000|Received Vaccination 2|Adverse Event|0|||
33685670|NCT02543892|63175874|FG001|Received Vaccination 2|Adverse Event|1|||
33685671|NCT02543892|63175875|FG002|Received Vaccination 2|Adverse Event|0|||
33685672|NCT02543892|63175876|FG003|Received Vaccination 2|Adverse Event|0|||
33685673|NCT02543892|63175877|FG004|Received Vaccination 2|Adverse Event|0|||
33685674|NCT02543892|63175878|FG005|Received Vaccination 2|Adverse Event|0|||
33685675|NCT02543892|63175879|FG006|Received Vaccination 2|Adverse Event|0|||
33685676|NCT02543892|63175880|FG007|Received Vaccination 2|Adverse Event|0|||
33685677|NCT02543892|63175873|FG000|Had Immunology Data|Withdrawal by Subject|0|||
33685678|NCT02543892|63175874|FG001|Had Immunology Data|Withdrawal by Subject|0|||
33685679|NCT02543892|63175875|FG002|Had Immunology Data|Withdrawal by Subject|0|||
33685680|NCT02543892|63175876|FG003|Had Immunology Data|Withdrawal by Subject|0|||
33685681|NCT02543892|63175877|FG004|Had Immunology Data|Withdrawal by Subject|0|||
33685682|NCT02543892|63175878|FG005|Had Immunology Data|Withdrawal by Subject|0|||
33685683|NCT02543892|63175879|FG006|Had Immunology Data|Withdrawal by Subject|1|||
33685684|NCT02543892|63175880|FG007|Had Immunology Data|Withdrawal by Subject|0|||
33685685|NCT02543658|63175961|FG000|Overall Study|Lack of Efficacy|0|||
33685686|NCT02543658|63175962|FG001|Overall Study|Lack of Efficacy|4|||
33685687|NCT01607892|63176717|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
33685688|NCT01607892|63176718|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
33685689|NCT01607892|63176719|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
33685690|NCT01607892|63176720|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
33685691|NCT01607892|63176721|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
33685692|NCT01607892|63176717|FG000|Overall Study|Death|4|||
33685693|NCT01607892|63176718|FG001|Overall Study|Death|2|||
33685694|NCT01607892|63176719|FG002|Overall Study|Death|8|||
33685695|NCT01607892|63176720|FG003|Overall Study|Death|10|||
33685696|NCT01607892|63176721|FG004|Overall Study|Death|3|||
33685697|NCT01607892|63176717|FG000|Overall Study|Investigator discretion|2|||
33685698|NCT01607892|63176718|FG001|Overall Study|Investigator discretion|4|||
33685699|NCT01607892|63176719|FG002|Overall Study|Investigator discretion|4|||
33685700|NCT01607892|63176720|FG003|Overall Study|Investigator discretion|8|||
33685701|NCT01607892|63176721|FG004|Overall Study|Investigator discretion|0|||
33685702|NCT01607892|63176717|FG000|Overall Study|Other treatments became available|1|||
33685703|NCT01607892|63176718|FG001|Overall Study|Other treatments became available|1|||
33685704|NCT01607892|63176719|FG002|Overall Study|Other treatments became available|0|||
33685705|NCT01607892|63176720|FG003|Overall Study|Other treatments became available|0|||
33685706|NCT01607892|63176721|FG004|Overall Study|Other treatments became available|2|||
33685707|NCT01607892|63176717|FG000|Overall Study|Intercurrent illness|1|||
33685708|NCT01607892|63176718|FG001|Overall Study|Intercurrent illness|0|||
33685709|NCT01607892|63176719|FG002|Overall Study|Intercurrent illness|0|||
33685710|NCT01607892|63176720|FG003|Overall Study|Intercurrent illness|3|||
33685711|NCT01607892|63176721|FG004|Overall Study|Intercurrent illness|0|||
33685712|NCT01607892|63176717|FG000|Overall Study|Non-Compliance with study procedures|0|||
33685713|NCT01607892|63176718|FG001|Overall Study|Non-Compliance with study procedures|0|||
33685714|NCT01607892|63176719|FG002|Overall Study|Non-Compliance with study procedures|1|||
33685715|NCT01607892|63176720|FG003|Overall Study|Non-Compliance with study procedures|0|||
33685716|NCT01607892|63176721|FG004|Overall Study|Non-Compliance with study procedures|0|||
33685717|NCT01607892|63176717|FG000|Overall Study|Consent withdrawn by participant|9|||
33685718|NCT01607892|63176718|FG001|Overall Study|Consent withdrawn by participant|4|||
33685719|NCT01607892|63176719|FG002|Overall Study|Consent withdrawn by participant|24|||
33685720|NCT01607892|63176720|FG003|Overall Study|Consent withdrawn by participant|14|||
33685721|NCT01607892|63176721|FG004|Overall Study|Consent withdrawn by participant|4|||
33685722|NCT01607892|63176717|FG000|Overall Study|Disease progression|38|||
33685723|NCT01607892|63176718|FG001|Overall Study|Disease progression|13|||
33685724|NCT01607892|63176719|FG002|Overall Study|Disease progression|37|||
33685725|NCT01607892|63176720|FG003|Overall Study|Disease progression|57|||
33685726|NCT01607892|63176721|FG004|Overall Study|Disease progression|9|||
33685727|NCT01607892|63176717|FG000|Overall Study|Incidence or severity of Adverse events|3|||
33685728|NCT01607892|63176718|FG001|Overall Study|Incidence or severity of Adverse events|3|||
33685729|NCT01607892|63176719|FG002|Overall Study|Incidence or severity of Adverse events|7|||
33685730|NCT01607892|63176720|FG003|Overall Study|Incidence or severity of Adverse events|2|||
33685731|NCT01607892|63176721|FG004|Overall Study|Incidence or severity of Adverse events|6|||
33685732|NCT02530242|63176767|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
33685733|NCT02530242|63176768|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
33685734|NCT02537574|63176792|FG000|Overall Study|Adverse Event|1|||
33685735|NCT02537574|63176793|FG001|Overall Study|Adverse Event|3|||
33685736|NCT02537574|63176794|FG002|Overall Study|Adverse Event|2|||
33685737|NCT02537574|63176792|FG000|Overall Study|Lost to Follow-up|40|||
33685738|NCT02537574|63176793|FG001|Overall Study|Lost to Follow-up|51|||
33685739|NCT02537574|63176794|FG002|Overall Study|Lost to Follow-up|55|||
33685740|NCT02537574|63176792|FG000|Overall Study|Noncompliance with study drug|0|||
33685741|NCT02537574|63176793|FG001|Overall Study|Noncompliance with study drug|1|||
33685742|NCT02537574|63176794|FG002|Overall Study|Noncompliance with study drug|1|||
33685743|NCT02537574|63176792|FG000|Overall Study|Physician Decision|2|||
33685744|NCT02537574|63176793|FG001|Overall Study|Physician Decision|0|||
33685745|NCT02537574|63176794|FG002|Overall Study|Physician Decision|0|||
33685746|NCT02537574|63176792|FG000|Overall Study|Protocol Violation|4|||
33685747|NCT02537574|63176793|FG001|Overall Study|Protocol Violation|2|||
33685748|NCT02537574|63176794|FG002|Overall Study|Protocol Violation|3|||
33685749|NCT02537574|63176792|FG000|Overall Study|Withdrawal by Subject|37|||
33685750|NCT02537574|63176793|FG001|Overall Study|Withdrawal by Subject|27|||
33685751|NCT02537574|63176794|FG002|Overall Study|Withdrawal by Subject|29|||
33685752|NCT02537574|63176792|FG000|Overall Study|Lack of Efficacy|14|||
33685753|NCT02537574|63176793|FG001|Overall Study|Lack of Efficacy|16|||
33685754|NCT02537574|63176794|FG002|Overall Study|Lack of Efficacy|15|||
33685755|NCT02537574|63176792|FG000|Overall Study|Duplicate Patient|1|||
33685756|NCT02537574|63176793|FG001|Overall Study|Duplicate Patient|0|||
33685757|NCT02537574|63176794|FG002|Overall Study|Duplicate Patient|0|||
33685758|NCT02537574|63176792|FG000|Overall Study|Patient not Stable|0|||
33685759|NCT02537574|63176793|FG001|Overall Study|Patient not Stable|1|||
33685760|NCT02537574|63176794|FG002|Overall Study|Patient not Stable|0|||
33685761|NCT02537574|63176792|FG000|Overall Study|Incarceration|0|||
33685762|NCT02537574|63176793|FG001|Overall Study|Incarceration|1|||
33685763|NCT02537574|63176794|FG002|Overall Study|Incarceration|0|||
33685764|NCT02537574|63176792|FG000|Overall Study|Failed Naloxone Challenge|0|||
33685765|NCT02537574|63176793|FG001|Overall Study|Failed Naloxone Challenge|1|||
33685766|NCT02537574|63176794|FG002|Overall Study|Failed Naloxone Challenge|0|||
33685767|NCT02537574|63176792|FG000|Overall Study|Transportation Issues|0|||
33685768|NCT02537574|63176793|FG001|Overall Study|Transportation Issues|0|||
33685769|NCT02537574|63176794|FG002|Overall Study|Transportation Issues|1|||
33685770|NCT02537574|63176792|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
33685771|NCT02537574|63176793|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
33685772|NCT02537574|63176794|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
33685773|NCT02537574|63176792|FG000|Overall Study|Noncompliance with Protocol|0|||
33685774|NCT02537574|63176793|FG001|Overall Study|Noncompliance with Protocol|0|||
33685775|NCT02537574|63176794|FG002|Overall Study|Noncompliance with Protocol|1|||
33685776|NCT02531802|63177459|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
33685777|NCT02531802|63177460|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
33685778|NCT02531802|63177461|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
33685779|NCT02531802|63177462|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
33685780|NCT02531802|63177463|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
33685781|NCT02531802|63177464|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
33685782|NCT02531802|63177465|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
33685783|NCT02531802|63177466|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
33685784|NCT02531802|63177467|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
33685785|NCT02531802|63177468|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
33685786|NCT02531802|63177469|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
33685787|NCT02531802|63177470|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
33685788|NCT02531802|63177471|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
33685789|NCT02531802|63177472|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
33685790|NCT02531802|63177473|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
33685791|NCT02531802|63177474|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
33685792|NCT02531802|63177475|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
33685793|NCT02531802|63177476|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
33685794|NCT02531802|63177477|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
33685795|NCT02531802|63177478|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
33685796|NCT02531802|63177479|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
33685797|NCT02531802|63177459|FG000|Received Vaccination 2|Physician Decision|0|||
33685798|NCT02531802|63177460|FG001|Received Vaccination 2|Physician Decision|0|||
33685799|NCT02531802|63177461|FG002|Received Vaccination 2|Physician Decision|0|||
33685800|NCT02531802|63177462|FG003|Received Vaccination 2|Physician Decision|0|||
33685801|NCT02531802|63177463|FG004|Received Vaccination 2|Physician Decision|0|||
33685802|NCT02531802|63177464|FG005|Received Vaccination 2|Physician Decision|1|||
33685803|NCT02531802|63177465|FG006|Received Vaccination 2|Physician Decision|0|||
33685804|NCT02531802|63177466|FG007|Received Vaccination 2|Physician Decision|0|||
33685805|NCT02531802|63177467|FG008|Received Vaccination 2|Physician Decision|0|||
33685806|NCT02531802|63177468|FG009|Received Vaccination 2|Physician Decision|2|||
33685807|NCT02531802|63177469|FG010|Received Vaccination 2|Physician Decision|0|||
33685808|NCT02531802|63177470|FG011|Received Vaccination 2|Physician Decision|0|||
33685809|NCT02531802|63177471|FG012|Received Vaccination 2|Physician Decision|0|||
33685810|NCT02531802|63177472|FG013|Received Vaccination 2|Physician Decision|1|||
33685811|NCT02531802|63177473|FG014|Received Vaccination 2|Physician Decision|0|||
33685812|NCT02531802|63177474|FG015|Received Vaccination 2|Physician Decision|0|||
33685813|NCT02531802|63177475|FG016|Received Vaccination 2|Physician Decision|0|||
33685814|NCT02531802|63177476|FG017|Received Vaccination 2|Physician Decision|1|||
33685815|NCT02531802|63177477|FG018|Received Vaccination 2|Physician Decision|0|||
33685816|NCT02531802|63177478|FG019|Received Vaccination 2|Physician Decision|0|||
33685817|NCT02531802|63177479|FG020|Received Vaccination 2|Physician Decision|0|||
33685818|NCT02531802|63177459|FG000|Received Vaccination 2|Adverse Event|0|||
33685819|NCT02531802|63177460|FG001|Received Vaccination 2|Adverse Event|0|||
33685820|NCT02531802|63177461|FG002|Received Vaccination 2|Adverse Event|0|||
33685821|NCT02531802|63177462|FG003|Received Vaccination 2|Adverse Event|0|||
33685822|NCT02531802|63177463|FG004|Received Vaccination 2|Adverse Event|0|||
33685823|NCT02531802|63177464|FG005|Received Vaccination 2|Adverse Event|2|||
33685824|NCT02531802|63177465|FG006|Received Vaccination 2|Adverse Event|0|||
33685825|NCT02531802|63177466|FG007|Received Vaccination 2|Adverse Event|0|||
33685826|NCT02531802|63177467|FG008|Received Vaccination 2|Adverse Event|0|||
33685827|NCT02531802|63177468|FG009|Received Vaccination 2|Adverse Event|0|||
33595633|NCT02175771|62994632|FG006|Treatment Period|Withdrawal by Subject|2|||
33595634|NCT02175771|62994633|FG007|Treatment Period|Withdrawal by Subject|9|||
33595635|NCT02175771|62994634|FG008|Treatment Period|Withdrawal by Subject|2|||
33595636|NCT02175771|62994626|FG000|Treatment Period|Noncompliance|0|||
33595637|NCT02175771|62994627|FG001|Treatment Period|Noncompliance|1|||
33595638|NCT02175771|62994628|FG002|Treatment Period|Noncompliance|2|||
33595639|NCT02175771|62994629|FG003|Treatment Period|Noncompliance|0|||
33595640|NCT02175771|62994630|FG004|Treatment Period|Noncompliance|0|||
33595641|NCT02175771|62994631|FG005|Treatment Period|Noncompliance|0|||
33595642|NCT02175771|62994632|FG006|Treatment Period|Noncompliance|0|||
33595643|NCT02175771|62994633|FG007|Treatment Period|Noncompliance|0|||
33595644|NCT02175771|62994634|FG008|Treatment Period|Noncompliance|1|||
33595645|NCT02175771|62994626|FG000|Treatment Period|Protocol Violation|0|||
33595646|NCT02175771|62994627|FG001|Treatment Period|Protocol Violation|0|||
33595647|NCT02175771|62994628|FG002|Treatment Period|Protocol Violation|0|||
33595648|NCT02175771|62994629|FG003|Treatment Period|Protocol Violation|0|||
33595649|NCT02175771|62994630|FG004|Treatment Period|Protocol Violation|0|||
33595650|NCT02175771|62994631|FG005|Treatment Period|Protocol Violation|0|||
33595651|NCT02175771|62994632|FG006|Treatment Period|Protocol Violation|0|||
33685828|NCT02531802|63177469|FG010|Received Vaccination 2|Adverse Event|0|||
33685829|NCT02531802|63177470|FG011|Received Vaccination 2|Adverse Event|0|||
33685830|NCT02531802|63177471|FG012|Received Vaccination 2|Adverse Event|0|||
33685831|NCT02531802|63177472|FG013|Received Vaccination 2|Adverse Event|0|||
33595652|NCT02175771|62994633|FG007|Treatment Period|Protocol Violation|1|||
33595653|NCT02175771|62994634|FG008|Treatment Period|Protocol Violation|0|||
33595654|NCT02175771|62994626|FG000|Treatment Period|Disease progression|0|||
33595655|NCT02175771|62994627|FG001|Treatment Period|Disease progression|0|||
33685832|NCT02531802|63177473|FG014|Received Vaccination 2|Adverse Event|0|||
33685833|NCT02531802|63177474|FG015|Received Vaccination 2|Adverse Event|0|||
33685834|NCT02531802|63177475|FG016|Received Vaccination 2|Adverse Event|0|||
33685835|NCT02531802|63177476|FG017|Received Vaccination 2|Adverse Event|2|||
33685836|NCT02531802|63177477|FG018|Received Vaccination 2|Adverse Event|1|||
33685837|NCT02531802|63177478|FG019|Received Vaccination 2|Adverse Event|0|||
33685838|NCT02531802|63177479|FG020|Received Vaccination 2|Adverse Event|1|||
33685839|NCT02531802|63177459|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
33685840|NCT02531802|63177460|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
33685841|NCT02531802|63177461|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
33685842|NCT02531802|63177462|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
33685843|NCT02531802|63177463|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
33685844|NCT02531802|63177464|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
33685845|NCT02531802|63177465|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
33685846|NCT02531802|63177466|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
33685847|NCT02531802|63177467|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
33685848|NCT02531802|63177468|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
33685849|NCT02531802|63177469|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
33685850|NCT02531802|63177470|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
33685851|NCT02531802|63177471|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
33685852|NCT02531802|63177472|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
33685853|NCT02531802|63177473|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
33685854|NCT02531802|63177474|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
33685855|NCT02531802|63177475|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
33685856|NCT02531802|63177476|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
33685857|NCT02531802|63177477|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
33685858|NCT02531802|63177478|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
33685859|NCT02531802|63177479|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
33685860|NCT01602666|63177582|FG000|Induction Chemotherapy|Death|2|||
33685861|NCT01602666|63177583|FG001|Induction Chemotherapy|Death|1|||
33685862|NCT01602666|63177582|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
33685863|NCT01602666|63177583|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
33685864|NCT01602666|63177582|FG000|Induction Chemotherapy|Physician Decision|12|||
33685865|NCT01602666|63177583|FG001|Induction Chemotherapy|Physician Decision|5|||
33685866|NCT01602666|63177582|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
33685867|NCT01602666|63177583|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
33685868|NCT01602666|63177582|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
33685869|NCT01602666|63177583|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
33685870|NCT01602666|63177582|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
33685871|NCT01602666|63177583|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
33685872|NCT01602666|63177582|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
33685873|NCT01602666|63177583|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
33685874|NCT01602666|63177582|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
33685875|NCT01602666|63177583|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
33685876|NCT01602666|63177582|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
33685877|NCT01602666|63177583|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
33685878|NCT01602666|63177582|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
33685879|NCT01602666|63177583|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
33685880|NCT01602666|63177582|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
33685881|NCT01602666|63177583|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
33685882|NCT02531646|63177594|FG000|Overall Study|equip. image processing issue|5|||
33685883|NCT02531646|63177595|FG001|Overall Study|equip. image processing issue|1|||
33685884|NCT02531646|63177596|FG002|Overall Study|equip. image processing issue|0|||
33685885|NCT02536404|63177661|FG000|Overall Study|Adverse Event|5|||
33685886|NCT02536404|63177662|FG001|Overall Study|Adverse Event|0|||
33685887|NCT02536404|63177661|FG000|Overall Study|Withdrawal by Subject|4|||
33685888|NCT02536404|63177662|FG001|Overall Study|Withdrawal by Subject|1|||
33685889|NCT02536404|63177661|FG000|Overall Study|Physician Decision|10|||
33685890|NCT02536404|63177662|FG001|Overall Study|Physician Decision|0|||
33685891|NCT02536404|63177661|FG000|Overall Study|Sponsor decision|1|||
33685892|NCT02536404|63177662|FG001|Overall Study|Sponsor decision|0|||
33685893|NCT01659996|63178622|FG000|Overall Study|Protocol Violation|3|||
33685894|NCT01659996|63178623|FG001|Overall Study|Protocol Violation|3|||
33685895|NCT01659996|63178624|FG002|Overall Study|Protocol Violation|3|||
33685896|NCT01659996|63178622|FG000|Overall Study|Lost to Follow-up|1|||
33685897|NCT01659996|63178623|FG001|Overall Study|Lost to Follow-up|3|||
33685898|NCT01659996|63178624|FG002|Overall Study|Lost to Follow-up|2|||
33685899|NCT01659996|63178622|FG000|Overall Study|Adverse Event|0|||
33685900|NCT01659996|63178623|FG001|Overall Study|Adverse Event|0|||
33685901|NCT01659996|63178624|FG002|Overall Study|Adverse Event|1|||
33685902|NCT01659996|63178622|FG000|Overall Study|Withdrawal by Subject|4|||
33685903|NCT01659996|63178623|FG001|Overall Study|Withdrawal by Subject|1|||
33685904|NCT01659996|63178624|FG002|Overall Study|Withdrawal by Subject|5|||
33685905|NCT02525874|63178988|FG000|Overall Study|Other|1|||
33685906|NCT02525874|63178988|FG000|Overall Study|Investigator Decision|1|||
33685907|NCT02525874|63178988|FG000|Overall Study|Consent withdrawn|22|||
33685908|NCT02525874|63178988|FG000|Overall Study|Non-compliance with study drug|3|||
33685909|NCT02525874|63178988|FG000|Overall Study|Adverse Event|17|||
33685910|NCT02525874|63178988|FG000|Overall Study|Lost to Follow-up|7|||
33685911|NCT02525874|63178988|FG000|Overall Study|Disease progression, defined by protocol|2|||
33685912|NCT02525874|63178988|FG000|Overall Study|Disease relapse|4|||
33685913|NCT02525874|63178988|FG000|Overall Study|Alternative Treatment for MS|2|||
33685914|NCT02525874|63178988|FG000|Overall Study|New lesions in Brain|1|||
33685915|NCT02528214|63178998|FG000|Overall Study|Protocol Violation|0|||
33685916|NCT02528214|63178999|FG001|Overall Study|Protocol Violation|1|||
33685917|NCT02528214|63178998|FG000|Overall Study|Adverse Event|0|||
33685918|NCT02528214|63178999|FG001|Overall Study|Adverse Event|1|||
33685919|NCT02528214|63178998|FG000|Overall Study|Other than specified above|0|||
33685920|NCT02528214|63178999|FG001|Overall Study|Other than specified above|1|||
33685921|NCT05348681|63179043|FG000|Overall Study|Study terminated by Sponsor|8|||
33685922|NCT05348681|63179044|FG001|Overall Study|Study terminated by Sponsor|3|||
33685923|NCT05348681|63179043|FG000|Overall Study|Withdrawal by Subject|1|||
33685924|NCT05348681|63179044|FG001|Overall Study|Withdrawal by Subject|1|||
33685925|NCT05348681|63179043|FG000|Overall Study|Lost to Follow-up|1|||
33685926|NCT05348681|63179044|FG001|Overall Study|Lost to Follow-up|1|||
33685927|NCT05348681|63179043|FG000|Overall Study|Adverse Event|1|||
33685928|NCT05348681|63179044|FG001|Overall Study|Adverse Event|0|||
33685929|NCT05348681|63179043|FG000|Overall Study|Other|2|||
33685930|NCT05348681|63179044|FG001|Overall Study|Other|1|||
33685931|NCT04423757|63179070|FG000|Overall Study|Adverse Event|2|||
33685932|NCT04423757|63179071|FG001|Overall Study|Adverse Event|0|||
33685933|NCT04423757|63179070|FG000|Overall Study|Not treated|1|||
33685934|NCT04423757|63179071|FG001|Overall Study|Not treated|1|||
33685935|NCT04379713|63179079|FG000|Overall Study|Adverse Event|2|||
33685936|NCT04379713|63179080|FG001|Overall Study|Adverse Event|0|||
33685937|NCT04379713|63179079|FG000|Overall Study|Physician Decision|2|||
33685938|NCT04379713|63179080|FG001|Overall Study|Physician Decision|1|||
33685939|NCT04379713|63179079|FG000|Overall Study|Protocol Violation|11|||
33685940|NCT04379713|63179080|FG001|Overall Study|Protocol Violation|6|||
33685941|NCT04379713|63179079|FG000|Overall Study|No longer met eligibility criteria|14|||
33685942|NCT04379713|63179080|FG001|Overall Study|No longer met eligibility criteria|11|||
33685943|NCT04379713|63179079|FG000|Overall Study|Withdrawal by parent/guardian|36|||
33685944|NCT04379713|63179080|FG001|Overall Study|Withdrawal by parent/guardian|15|||
33685945|NCT04379713|63179079|FG000|Overall Study|Lost to Follow-up|31|||
33685946|NCT04379713|63179080|FG001|Overall Study|Lost to Follow-up|21|||
33685947|NCT04085328|63179088|FG000|Overall Study|Witihdrew Consent|16|||
33685948|NCT04085328|63179089|FG001|Overall Study|Witihdrew Consent|16|||
33685949|NCT04085328|63179088|FG000|Overall Study|Adverse Event|8|||
33685950|NCT04085328|63179089|FG001|Overall Study|Adverse Event|7|||
33685951|NCT04085328|63179088|FG000|Overall Study|Lost to Follow-up|7|||
33685952|NCT04085328|63179089|FG001|Overall Study|Lost to Follow-up|2|||
33685953|NCT04085328|63179088|FG000|Overall Study|Physician Decision|0|||
33685954|NCT04085328|63179089|FG001|Overall Study|Physician Decision|1|||
33685955|NCT04085328|63179088|FG000|Overall Study|Pregnancy|0|||
33685956|NCT04085328|63179089|FG001|Overall Study|Pregnancy|1|||
33685957|NCT04085328|63179088|FG000|Overall Study|Reasons Related to COVID-19|5|||
33685958|NCT04085328|63179089|FG001|Overall Study|Reasons Related to COVID-19|8|||
33685959|NCT04085328|63179088|FG000|Overall Study|Did not meet inclusion criteria|1|||
33685960|NCT04085328|63179089|FG001|Overall Study|Did not meet inclusion criteria|1|||
33685961|NCT04085328|63179088|FG000|Overall Study|Early termination|1|||
33685962|NCT04085328|63179089|FG001|Overall Study|Early termination|0|||
33685963|NCT03789110|63179102|FG000|Overall Study|Adverse Event|2|||
33685964|NCT03789110|63179102|FG000|Overall Study|Physician Decision|1|||
33685965|NCT03789110|63179102|FG000|Overall Study|Withdrawal by Subject|2|||
33685966|NCT03789110|63179102|FG000|Overall Study|Lack of Efficacy|22|||
33685967|NCT03789110|63179102|FG000|Overall Study|still on treatment|3|||
33685968|NCT03074474|63179124|FG000|Overall Study|Lost to Follow-up|10|||
33685969|NCT03074474|63179124|FG000|Overall Study|Withdrawal by Subject|10|||
33685970|NCT03074474|63179124|FG000|Overall Study|Death|4|||
33685971|NCT03074474|63179124|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
33685972|NCT03043313|63179132|FG000|Overall Study|Withdrawal by Subject|4|||
33685973|NCT03043313|63179133|FG001|Overall Study|Withdrawal by Subject|1|||
33685974|NCT03043313|63179134|FG002|Overall Study|Withdrawal by Subject|1|||
33685975|NCT03043313|63179132|FG000|Overall Study|Lost to Follow-up|1|||
33685976|NCT03043313|63179133|FG001|Overall Study|Lost to Follow-up|0|||
33685977|NCT03043313|63179134|FG002|Overall Study|Lost to Follow-up|0|||
33685978|NCT03043313|63179132|FG000|Overall Study|Death|26|||
33685979|NCT03043313|63179133|FG001|Overall Study|Death|13|||
33685980|NCT03043313|63179134|FG002|Overall Study|Death|8|||
33685981|NCT03043313|63179132|FG000|Overall Study|On Treatment|7|||
33685982|NCT03043313|63179133|FG001|Overall Study|On Treatment|12|||
33685983|NCT03043313|63179134|FG002|Overall Study|On Treatment|11|||
33685984|NCT03043313|63179132|FG000|Overall Study|In follow up|7|||
33685985|NCT03043313|63179133|FG001|Overall Study|In follow up|15|||
33685986|NCT03043313|63179134|FG002|Overall Study|In follow up|11|||
33685987|NCT02744391|63179145|FG000|Overall Study|Lost to Follow-up|9|||
33685988|NCT02744391|63179145|FG000|Overall Study|Physician Decision|2|||
33685989|NCT02744391|63179145|FG000|Overall Study|Withdrawal by Subject|3|||
33685990|NCT02462837|63179151|FG000|Overall Study|pt developed hives|1|||
33685991|NCT02462837|63179152|FG001|Overall Study|pt developed hives|0|||
33685992|NCT02462837|63179151|FG000|Overall Study|Withdrawal by Subject|1|||
33685993|NCT02462837|63179152|FG001|Overall Study|Withdrawal by Subject|0|||
33685994|NCT02346201|63179160|FG000|Overall Study|Adverse Event|3|||
33685995|NCT02346201|63179161|FG001|Overall Study|Adverse Event|2|||
33685996|NCT02346201|63179160|FG000|Overall Study|Lost to Follow-up|1|||
33685997|NCT02346201|63179161|FG001|Overall Study|Lost to Follow-up|0|||
33685998|NCT02346201|63179160|FG000|Overall Study|Withdrawal by Subject|6|||
33685999|NCT02346201|63179161|FG001|Overall Study|Withdrawal by Subject|3|||
33686000|NCT02346201|63179160|FG000|Overall Study|Unavailable for future follow-up|0|||
33686001|NCT02346201|63179161|FG001|Overall Study|Unavailable for future follow-up|1|||
33686002|NCT02346201|63179160|FG000|Overall Study|Physician Decision|0|||
33686003|NCT02346201|63179161|FG001|Overall Study|Physician Decision|1|||
33686004|NCT02346201|63179160|FG000|Overall Study|Missed final visit|0|||
33686005|NCT02346201|63179161|FG001|Overall Study|Missed final visit|2|||
33686006|NCT01866930|63179181|FG000|Treatment Period|Other|1|||
33686007|NCT01866930|63179182|FG001|Treatment Period|Other|0|||
33686008|NCT01866930|63179181|FG000|Treatment Period|Death|0|||
33686009|NCT01866930|63179182|FG001|Treatment Period|Death|2|||
33686010|NCT01866930|63179181|FG000|Treatment Period|Poor/non compliance|0|||
33686011|NCT01866930|63179182|FG001|Treatment Period|Poor/non compliance|2|||
33686012|NCT01866930|63179181|FG000|Treatment Period|No longer meets study criteria|0|||
33686013|NCT01866930|63179182|FG001|Treatment Period|No longer meets study criteria|1|||
33686014|NCT01866930|63179181|FG000|Treatment Period|Withdrawal by Subject|2|||
33686015|NCT01866930|63179182|FG001|Treatment Period|Withdrawal by Subject|8|||
33686016|NCT01866930|63179181|FG000|Treatment Period|Lack of Efficacy|1|||
33686017|NCT01866930|63179182|FG001|Treatment Period|Lack of Efficacy|9|||
33686018|NCT01866930|63179181|FG000|Treatment Period|Adverse Event|4|||
33686019|NCT01866930|63179182|FG001|Treatment Period|Adverse Event|12|||
33686020|NCT01866930|63179181|FG000|Treatment Period|Lost to Follow-up|1|||
33686021|NCT01866930|63179182|FG001|Treatment Period|Lost to Follow-up|1|||
33686022|NCT01866930|63179181|FG000|Follow-up Period|Lost to Follow-up|1|||
33686023|NCT01866930|63179182|FG001|Follow-up Period|Lost to Follow-up|1|||
33686024|NCT01866930|63179181|FG000|Follow-up Period|Other|1|||
33686025|NCT01866930|63179182|FG001|Follow-up Period|Other|5|||
33686026|NCT01866930|63179181|FG000|Follow-up Period|No longer required per protocol|1|||
33686027|NCT01866930|63179182|FG001|Follow-up Period|No longer required per protocol|0|||
33686028|NCT01866930|63179181|FG000|Follow-up Period|Withdrawal by Subject|3|||
33686029|NCT01866930|63179182|FG001|Follow-up Period|Withdrawal by Subject|3|||
33686030|NCT01621568|63179190|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
33686031|NCT01621568|63179191|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
33686032|NCT01621568|63179190|FG000|Week 5-6 No Treatment|Death|1|||
33686033|NCT01621568|63179191|FG001|Week 5-6 No Treatment|Death|0|||
33686034|NCT00813293|63179211|FG000|Overall Study|Intercurrent illness|1|||
33686035|NCT00813293|63179212|FG001|Overall Study|Intercurrent illness|0|||
33686036|NCT00813293|63179211|FG000|Overall Study|Adverse Event|0|||
33686037|NCT00813293|63179212|FG001|Overall Study|Adverse Event|1|||
33686038|NCT00481091|63179228|FG000|Overall Study|Withdrawal by Subject|0|||
33686039|NCT00481091|63179229|FG001|Overall Study|Withdrawal by Subject|1|||
33686040|NCT00481091|63179230|FG002|Overall Study|Withdrawal by Subject|1|||
33686041|NCT00481091|63179231|FG003|Overall Study|Withdrawal by Subject|0|||
33686042|NCT00481091|63179232|FG004|Overall Study|Withdrawal by Subject|0|||
33686043|NCT00481091|63179233|FG005|Overall Study|Withdrawal by Subject|0|||
33686044|NCT00481091|63179234|FG006|Overall Study|Withdrawal by Subject|0|||
33686045|NCT00481091|63179235|FG007|Overall Study|Withdrawal by Subject|0|||
33686046|NCT00481091|63179236|FG008|Overall Study|Withdrawal by Subject|1|||
33686047|NCT00481091|63179237|FG009|Overall Study|Withdrawal by Subject|6|||
33686048|NCT00481091|63179228|FG000|Overall Study|Other, Not Specified|0|||
33686049|NCT00481091|63179229|FG001|Overall Study|Other, Not Specified|1|||
33686050|NCT00481091|63179230|FG002|Overall Study|Other, Not Specified|1|||
33686051|NCT00481091|63179231|FG003|Overall Study|Other, Not Specified|0|||
33686052|NCT00481091|63179232|FG004|Overall Study|Other, Not Specified|0|||
33686053|NCT00481091|63179233|FG005|Overall Study|Other, Not Specified|1|||
33686054|NCT00481091|63179234|FG006|Overall Study|Other, Not Specified|0|||
33686055|NCT00481091|63179235|FG007|Overall Study|Other, Not Specified|0|||
33686056|NCT00481091|63179236|FG008|Overall Study|Other, Not Specified|0|||
33686057|NCT00481091|63179237|FG009|Overall Study|Other, Not Specified|4|||
33686058|NCT00481091|63179228|FG000|Overall Study|Adverse Event|1|||
33686059|NCT00481091|63179229|FG001|Overall Study|Adverse Event|2|||
33686060|NCT00481091|63179230|FG002|Overall Study|Adverse Event|0|||
33686061|NCT00481091|63179231|FG003|Overall Study|Adverse Event|1|||
33686062|NCT00481091|63179232|FG004|Overall Study|Adverse Event|1|||
33686063|NCT00481091|63179233|FG005|Overall Study|Adverse Event|1|||
33686064|NCT00481091|63179234|FG006|Overall Study|Adverse Event|2|||
33686065|NCT00481091|63179235|FG007|Overall Study|Adverse Event|1|||
33686066|NCT00481091|63179236|FG008|Overall Study|Adverse Event|1|||
33686067|NCT00481091|63179237|FG009|Overall Study|Adverse Event|6|||
33686068|NCT00481091|63179228|FG000|Overall Study|Progressive disease clinical|0|||
33686069|NCT00481091|63179229|FG001|Overall Study|Progressive disease clinical|0|||
33686070|NCT00481091|63179230|FG002|Overall Study|Progressive disease clinical|0|||
33686071|NCT00481091|63179231|FG003|Overall Study|Progressive disease clinical|0|||
33686072|NCT00481091|63179232|FG004|Overall Study|Progressive disease clinical|0|||
33686073|NCT00481091|63179233|FG005|Overall Study|Progressive disease clinical|0|||
33686074|NCT00481091|63179234|FG006|Overall Study|Progressive disease clinical|0|||
33686075|NCT00481091|63179235|FG007|Overall Study|Progressive disease clinical|0|||
33686076|NCT00481091|63179236|FG008|Overall Study|Progressive disease clinical|1|||
33686077|NCT00481091|63179237|FG009|Overall Study|Progressive disease clinical|7|||
33686078|NCT00481091|63179228|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
33686079|NCT00481091|63179229|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
33686080|NCT00481091|63179230|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
33686081|NCT00481091|63179231|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
33686082|NCT00481091|63179232|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
33686083|NCT00481091|63179233|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
33686084|NCT00481091|63179234|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
33686085|NCT00481091|63179235|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
33686086|NCT00481091|63179236|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
33686087|NCT00481091|63179237|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
33686088|NCT00481091|63179228|FG000|Overall Study|Progressive disease other|1|||
33686089|NCT00481091|63179229|FG001|Overall Study|Progressive disease other|1|||
33686090|NCT00481091|63179230|FG002|Overall Study|Progressive disease other|0|||
33686091|NCT00481091|63179231|FG003|Overall Study|Progressive disease other|1|||
33686092|NCT00481091|63179232|FG004|Overall Study|Progressive disease other|1|||
33686093|NCT00481091|63179233|FG005|Overall Study|Progressive disease other|1|||
33686094|NCT00481091|63179234|FG006|Overall Study|Progressive disease other|0|||
33686095|NCT00481091|63179235|FG007|Overall Study|Progressive disease other|2|||
33686096|NCT00481091|63179236|FG008|Overall Study|Progressive disease other|0|||
33686097|NCT00481091|63179237|FG009|Overall Study|Progressive disease other|0|||
33686098|NCT00481091|63179228|FG000|Overall Study|No reason given|0|||
33686099|NCT00481091|63179229|FG001|Overall Study|No reason given|0|||
33686100|NCT00481091|63179230|FG002|Overall Study|No reason given|1|||
33686101|NCT00481091|63179231|FG003|Overall Study|No reason given|1|||
33686102|NCT00481091|63179232|FG004|Overall Study|No reason given|1|||
33686103|NCT00481091|63179233|FG005|Overall Study|No reason given|0|||
33686104|NCT00481091|63179234|FG006|Overall Study|No reason given|1|||
33686105|NCT00481091|63179235|FG007|Overall Study|No reason given|1|||
33686106|NCT00481091|63179236|FG008|Overall Study|No reason given|1|||
33686107|NCT00481091|63179237|FG009|Overall Study|No reason given|4|||
33686108|NCT00003641|63179268|FG000|Overall Study|Withdrawal by Subject|0|||
33686109|NCT00003641|63179269|FG001|Overall Study|Withdrawal by Subject|100|||
33686110|NCT00003641|63179268|FG000|Overall Study|Adverse Event|0|||
33686111|NCT00003641|63179269|FG001|Overall Study|Adverse Event|38|||
33686112|NCT00003641|63179268|FG000|Overall Study|Disease progression|0|||
33686113|NCT00003641|63179269|FG001|Overall Study|Disease progression|2|||
33686114|NCT00003641|63179268|FG000|Overall Study|Unknown/missing|0|||
33686115|NCT00003641|63179269|FG001|Overall Study|Unknown/missing|22|||
33686116|NCT00003641|63179268|FG000|Overall Study|Should not receive interferon therapy|2|||
33686117|NCT00003641|63179269|FG001|Overall Study|Should not receive interferon therapy|0|||
33686118|NCT00003641|63179268|FG000|Overall Study|Never started interferon|567|||
33686119|NCT00003641|63179269|FG001|Overall Study|Never started interferon|12|||
33686120|NCT02524158|63179299|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
33686121|NCT02524158|63179300|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
33686122|NCT02524158|63179299|FG000|12-weeks Assessment|Lost to Follow-up|18|||
33686123|NCT02524158|63179300|FG001|12-weeks Assessment|Lost to Follow-up|12|||
33686124|NCT02524158|63179299|FG000|6-month Assessment|Withdrawal by Subject|1|||
33686125|NCT02524158|63179300|FG001|6-month Assessment|Withdrawal by Subject|1|||
33686126|NCT02524158|63179299|FG000|6-month Assessment|Lost to Follow-up|21|||
33686127|NCT02524158|63179300|FG001|6-month Assessment|Lost to Follow-up|20|||
33686128|NCT02525094|63179320|FG000|Overall Study|Lost to Follow-up|2|||
33686129|NCT02525094|63179321|FG001|Overall Study|Lost to Follow-up|1|||
33686130|NCT02525094|63179320|FG000|Overall Study|Withdrawal by Subject|5|||
33686131|NCT02525094|63179321|FG001|Overall Study|Withdrawal by Subject|6|||
33686132|NCT02525094|63179320|FG000|Overall Study|Not Treated|1|||
33686133|NCT02525094|63179321|FG001|Overall Study|Not Treated|1|||
33686134|NCT01657266|63179478|FG000|Overall Study|Lost to Follow-up|2|||
33686135|NCT01657266|63179479|FG001|Overall Study|Lost to Follow-up|2|||
33686136|NCT01657266|63179478|FG000|Overall Study|Adverse Event|2|||
33686137|NCT01657266|63179479|FG001|Overall Study|Adverse Event|3|||
33686138|NCT01657032|63179558|FG000|Overall Study|Lost to Follow-up|0|||
33686139|NCT01657032|63179559|FG001|Overall Study|Lost to Follow-up|7|||
33686140|NCT01657500|63179687|FG000|Overall Study|set impropperly matched|3|||
33686141|NCT01657500|63179688|FG001|Overall Study|set impropperly matched|3|||
33686142|NCT01657500|63179687|FG000|Overall Study|Lost to Follow-up|2|||
33686143|NCT01657500|63179688|FG001|Overall Study|Lost to Follow-up|2|||
33686144|NCT01658904|63179701|FG000|Overall Study|Principal Investigator discretion|2|||
33686145|NCT01658904|63179702|FG001|Overall Study|Principal Investigator discretion|0|||
33686146|NCT01658904|63179703|FG002|Overall Study|Principal Investigator discretion|0|||
33686147|NCT01658514|63179887|FG000|Overall Study|Protocol Violation|1|||
33686148|NCT01658514|63179888|FG001|Overall Study|Protocol Violation|0|||
33686149|NCT01658514|63179889|FG002|Overall Study|Protocol Violation|2|||
33686150|NCT01658436|63179910|FG000|Overall Study|Adverse Event|6|||
33686151|NCT01658436|63179911|FG001|Overall Study|Adverse Event|5|||
33686152|NCT01658436|63179910|FG000|Overall Study|Physician Decision|1|||
33686153|NCT01658436|63179911|FG001|Overall Study|Physician Decision|0|||
33686154|NCT01658436|63179910|FG000|Overall Study|Progressive disease|12|||
33686155|NCT01658436|63179911|FG001|Overall Study|Progressive disease|4|||
33686156|NCT01658436|63179910|FG000|Overall Study|Study terminated by sponsor|0|||
33686157|NCT01658436|63179911|FG001|Overall Study|Study terminated by sponsor|1|||
33686158|NCT01658436|63179910|FG000|Overall Study|Subject/guardian decision|0|||
33686159|NCT01658436|63179911|FG001|Overall Study|Subject/guardian decision|1|||
33686160|NCT01658436|63179910|FG000|Overall Study|Death|1|||
33686161|NCT01658436|63179911|FG001|Overall Study|Death|0|||
33686162|NCT01656408|63180462|FG000|Overall Study|Adverse Event|0|||
33686163|NCT01656408|63180463|FG001|Overall Study|Adverse Event|0|||
33686164|NCT01656408|63180464|FG002|Overall Study|Adverse Event|1|||
33686165|NCT01656408|63180465|FG003|Overall Study|Adverse Event|0|||
33686166|NCT01656408|63180466|FG004|Overall Study|Adverse Event|0|||
33686167|NCT01656408|63180467|FG005|Overall Study|Adverse Event|1|||
33686168|NCT01656408|63180468|FG006|Overall Study|Adverse Event|1|||
33686169|NCT01656408|63180469|FG007|Overall Study|Adverse Event|0|||
33686170|NCT01656408|63180470|FG008|Overall Study|Adverse Event|1|||
33686171|NCT01656408|63180471|FG009|Overall Study|Adverse Event|0|||
33686172|NCT01656408|63180462|FG000|Overall Study|Physician Decision|1|||
33686173|NCT01656408|63180463|FG001|Overall Study|Physician Decision|0|||
33686174|NCT01656408|63180464|FG002|Overall Study|Physician Decision|1|||
33686175|NCT01656408|63180465|FG003|Overall Study|Physician Decision|0|||
33686176|NCT01656408|63180466|FG004|Overall Study|Physician Decision|1|||
33686177|NCT01656408|63180467|FG005|Overall Study|Physician Decision|1|||
33686178|NCT01656408|63180468|FG006|Overall Study|Physician Decision|0|||
33686179|NCT01656408|63180469|FG007|Overall Study|Physician Decision|1|||
33595656|NCT02175771|62994628|FG002|Treatment Period|Disease progression|0|||
33595657|NCT02175771|62994629|FG003|Treatment Period|Disease progression|0|||
33595658|NCT02175771|62994630|FG004|Treatment Period|Disease progression|0|||
33595659|NCT02175771|62994631|FG005|Treatment Period|Disease progression|0|||
33595660|NCT02175771|62994632|FG006|Treatment Period|Disease progression|0|||
33595661|NCT02175771|62994633|FG007|Treatment Period|Disease progression|2|||
33595662|NCT02175771|62994634|FG008|Treatment Period|Disease progression|0|||
33595663|NCT02175771|62994626|FG000|Treatment Period|Lost to Follow-up|0|||
33595664|NCT02175771|62994627|FG001|Treatment Period|Lost to Follow-up|3|||
33595665|NCT02175771|62994628|FG002|Treatment Period|Lost to Follow-up|1|||
33595666|NCT02175771|62994629|FG003|Treatment Period|Lost to Follow-up|3|||
33595667|NCT02175771|62994630|FG004|Treatment Period|Lost to Follow-up|1|||
33595668|NCT02175771|62994631|FG005|Treatment Period|Lost to Follow-up|2|||
33686180|NCT01656408|63180470|FG008|Overall Study|Physician Decision|1|||
33686181|NCT01656408|63180471|FG009|Overall Study|Physician Decision|3|||
33686182|NCT01364298|63180914|FG000|Overall Study|Adverse Event|3|||
33686183|NCT01364298|63180915|FG001|Overall Study|Adverse Event|4|||
33686184|NCT01364298|63180914|FG000|Overall Study|Lack of adherence to treatment|1|||
33686185|NCT01364298|63180915|FG001|Overall Study|Lack of adherence to treatment|3|||
33686186|NCT01364298|63180914|FG000|Overall Study|Lack of Efficacy|1|||
33686187|NCT01364298|63180915|FG001|Overall Study|Lack of Efficacy|0|||
33595669|NCT02175771|62994632|FG006|Treatment Period|Lost to Follow-up|1|||
33595670|NCT02175771|62994633|FG007|Treatment Period|Lost to Follow-up|2|||
33595671|NCT02175771|62994634|FG008|Treatment Period|Lost to Follow-up|2|||
33686188|NCT01364298|63180914|FG000|Overall Study|Lost to Follow-up|5|||
33686189|NCT01364298|63180915|FG001|Overall Study|Lost to Follow-up|10|||
33686190|NCT01364298|63180914|FG000|Overall Study|Withdrawal by Subject|3|||
33686191|NCT01364298|63180915|FG001|Overall Study|Withdrawal by Subject|3|||
33686192|NCT01364298|63180914|FG000|Overall Study|Other|1|||
33686193|NCT01364298|63180915|FG001|Overall Study|Other|3|||
33686194|NCT01364922|63180974|FG000|Open-label (OL) Period|Adverse Event|7|||
33686195|NCT01364922|63180975|FG001|Open-label (OL) Period|Adverse Event|0|||
33686196|NCT01364922|63180976|FG002|Open-label (OL) Period|Adverse Event|0|||
33686197|NCT01364922|63180974|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
33686198|NCT01364922|63180975|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
33686199|NCT01364922|63180976|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
33686200|NCT01364922|63180974|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
33686201|NCT01364922|63180975|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
33686202|NCT01364922|63180976|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
33686203|NCT01364922|63180974|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
33686204|NCT01364922|63180975|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
33686205|NCT01364922|63180976|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
33686206|NCT01364922|63180974|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
33686207|NCT01364922|63180975|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
33686208|NCT01364922|63180976|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
33686209|NCT01364922|63180974|FG000|Open-label (OL) Period|Other, Unspecified|1|||
33686210|NCT01364922|63180975|FG001|Open-label (OL) Period|Other, Unspecified|0|||
33686211|NCT01364922|63180976|FG002|Open-label (OL) Period|Other, Unspecified|0|||
33686212|NCT01364922|63180974|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
33686213|NCT01364922|63180975|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
33686214|NCT01364922|63180976|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
33686215|NCT01364922|63180974|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
33686216|NCT01364922|63180975|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
33686217|NCT01364922|63180976|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
33686218|NCT01364922|63180974|FG000|Double-Blind (DB) Period|Adverse Event|0|||
33686219|NCT01364922|63180975|FG001|Double-Blind (DB) Period|Adverse Event|0|||
33686220|NCT01364922|63180976|FG002|Double-Blind (DB) Period|Adverse Event|1|||
33686221|NCT01364922|63180974|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
33686222|NCT01364922|63180975|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
33686223|NCT01364922|63180976|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
33686224|NCT02522286|63181150|FG000|Overall Study|Withdrawal by Subject|3|||
33686225|NCT02522286|63181151|FG001|Overall Study|Withdrawal by Subject|0|||
33686226|NCT02522286|63181152|FG002|Overall Study|Withdrawal by Subject|0|||
33686227|NCT02522286|63181153|FG003|Overall Study|Withdrawal by Subject|3|||
33686228|NCT02520726|63181174|FG000|Overall Study|Lost to Follow-up|3|||
33686229|NCT02520726|63181175|FG001|Overall Study|Lost to Follow-up|2|||
33686230|NCT02519712|63181198|FG000|Overall Study|Disease Relapse|1|||
33686231|NCT02519712|63181198|FG000|Overall Study|Disease Progression|1|||
33686232|NCT02519712|63181198|FG000|Overall Study|Accruals are donors|2|||
33686233|NCT02516202|63181441|FG000|Overall Study|Withdrawal by Subject|1|||
33686234|NCT02516202|63181442|FG001|Overall Study|Withdrawal by Subject|0|||
33686235|NCT02516202|63181443|FG002|Overall Study|Withdrawal by Subject|1|||
33686236|NCT02516202|63181441|FG000|Overall Study|Lost to Follow-up|1|||
33686237|NCT02516202|63181442|FG001|Overall Study|Lost to Follow-up|1|||
33686238|NCT02516202|63181443|FG002|Overall Study|Lost to Follow-up|1|||
33686239|NCT02516202|63181441|FG000|Overall Study|Stopped Follow-up|0|||
33686240|NCT02516202|63181442|FG001|Overall Study|Stopped Follow-up|0|||
33686241|NCT02516202|63181443|FG002|Overall Study|Stopped Follow-up|1|||
33686242|NCT02518620|63181649|FG000|Overall Study|Adverse Event|23|||
33686243|NCT02518620|63181650|FG001|Overall Study|Adverse Event|11|||
33686244|NCT02518620|63181649|FG000|Overall Study|Lack of Efficacy|2|||
33686245|NCT02518620|63181650|FG001|Overall Study|Lack of Efficacy|0|||
33686246|NCT02518620|63181649|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33686247|NCT02518620|63181650|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33686248|NCT02518620|63181649|FG000|Overall Study|Physician Decision|1|||
33686249|NCT02518620|63181650|FG001|Overall Study|Physician Decision|1|||
33686250|NCT02518620|63181649|FG000|Overall Study|Sponsor's Decision|0|||
33686251|NCT02518620|63181650|FG001|Overall Study|Sponsor's Decision|3|||
33686252|NCT02518620|63181649|FG000|Overall Study|Lost to Follow-up|1|||
33686253|NCT02518620|63181650|FG001|Overall Study|Lost to Follow-up|1|||
33686254|NCT02518620|63181649|FG000|Overall Study|Withdrawal by Subject|17|||
33686255|NCT02518620|63181650|FG001|Overall Study|Withdrawal by Subject|9|||
33686256|NCT02518620|63181649|FG000|Overall Study|Death|1|||
33686257|NCT02518620|63181650|FG001|Overall Study|Death|0|||
33686258|NCT02518620|63181649|FG000|Overall Study|Pregnancy Wish|3|||
33686259|NCT02518620|63181650|FG001|Overall Study|Pregnancy Wish|0|||
33686260|NCT02518620|63181649|FG000|Overall Study|Pregnancy|1|||
33686261|NCT02518620|63181650|FG001|Overall Study|Pregnancy|0|||
33686262|NCT02518620|63181649|FG000|Overall Study|Relocation|2|||
33686263|NCT02518620|63181650|FG001|Overall Study|Relocation|1|||
33686264|NCT01653912|63181829|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
33686265|NCT01653912|63181830|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
33686266|NCT01653912|63181831|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
33686267|NCT01653912|63181832|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
33686268|NCT01653912|63181833|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
33686269|NCT01653912|63181834|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
33686270|NCT01653912|63181829|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
33686271|NCT01653912|63181830|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
33686272|NCT01653912|63181831|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
33686273|NCT01653912|63181832|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
33686274|NCT01653912|63181833|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
33686275|NCT01653912|63181834|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
33686276|NCT01653912|63181829|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
33686277|NCT01653912|63181830|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
33686278|NCT01653912|63181831|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
33686279|NCT01653912|63181832|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
33686280|NCT01653912|63181833|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
33686281|NCT01653912|63181834|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
33686282|NCT01653912|63181829|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
33686283|NCT01653912|63181830|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
33686284|NCT01653912|63181831|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
33686285|NCT01653912|63181832|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
33686286|NCT01653912|63181833|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
33686287|NCT01653912|63181834|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
33686288|NCT01653912|63181829|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
33686289|NCT01653912|63181830|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
33686290|NCT01653912|63181831|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
33686291|NCT01653912|63181832|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
33686292|NCT01653912|63181833|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
33686293|NCT01653912|63181834|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
33686294|NCT01653912|63181829|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
33686295|NCT01653912|63181830|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
33686296|NCT01653912|63181831|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
33686297|NCT01653912|63181832|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
33686298|NCT01653912|63181833|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
33686299|NCT01653912|63181834|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
33686300|NCT01653912|63181829|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
33686301|NCT01653912|63181830|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
33686302|NCT01653912|63181831|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
33686303|NCT01653912|63181832|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
33686304|NCT01653912|63181833|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
33686305|NCT01653912|63181834|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
33686306|NCT02483520|63181860|FG000|Overall Study|Lost to Follow-up|3|||
33686307|NCT02483520|63181861|FG001|Overall Study|Lost to Follow-up|4|||
33686308|NCT02483520|63181860|FG000|Overall Study|Withdrawal by Subject|4|||
33686309|NCT02483520|63181861|FG001|Overall Study|Withdrawal by Subject|14|||
33686310|NCT02483520|63181860|FG000|Overall Study|Hospitalized|2|||
33686311|NCT02483520|63181861|FG001|Overall Study|Hospitalized|3|||
33686312|NCT02483520|63181860|FG000|Overall Study|Moved to LTC|2|||
33686313|NCT02483520|63181861|FG001|Overall Study|Moved to LTC|3|||
33686314|NCT02514174|63181867|FG000|Overall Study|Patient refused to continue medication|1|||
33686315|NCT02514174|63181867|FG000|Overall Study|Adverse Event|2|||
33686316|NCT02514174|63181867|FG000|Overall Study|Study closed by sponsor|9|||
33686317|NCT02514174|63181867|FG000|Overall Study|Progressive disease|11|||
33686318|NCT02514174|63181867|FG000|Overall Study|Treatment change|1|||
33686319|NCT02514174|63181867|FG000|Overall Study|Treated off study with Afatinib.|1|||
33686320|NCT02482428|63181927|FG000|Overall Study|Lost to Follow-up|4|||
33686321|NCT02482428|63181928|FG001|Overall Study|Lost to Follow-up|9|||
33686322|NCT02482428|63181929|FG002|Overall Study|Lost to Follow-up|1|||
33686323|NCT02482428|63181930|FG003|Overall Study|Lost to Follow-up|2|||
33686324|NCT02482428|63181931|FG004|Overall Study|Lost to Follow-up|4|||
33686325|NCT02482428|63181927|FG000|Overall Study|Physician Decision|0|||
33686326|NCT02482428|63181928|FG001|Overall Study|Physician Decision|0|||
33686327|NCT02482428|63181929|FG002|Overall Study|Physician Decision|0|||
33686328|NCT02482428|63181930|FG003|Overall Study|Physician Decision|0|||
33686329|NCT02482428|63181931|FG004|Overall Study|Physician Decision|1|||
33686330|NCT02482428|63181927|FG000|Overall Study|protocol deviation|1|||
33686331|NCT02482428|63181928|FG001|Overall Study|protocol deviation|1|||
33686332|NCT02482428|63181929|FG002|Overall Study|protocol deviation|0|||
33686333|NCT02482428|63181930|FG003|Overall Study|protocol deviation|0|||
33686334|NCT02482428|63181931|FG004|Overall Study|protocol deviation|0|||
33686335|NCT02482428|63181927|FG000|Overall Study|subject/guardian decision|4|||
33686336|NCT02482428|63181928|FG001|Overall Study|subject/guardian decision|2|||
33686337|NCT02482428|63181929|FG002|Overall Study|subject/guardian decision|0|||
33686338|NCT02482428|63181930|FG003|Overall Study|subject/guardian decision|0|||
33686339|NCT02482428|63181931|FG004|Overall Study|subject/guardian decision|2|||
33686340|NCT02480712|63181990|FG000|Overall Study|Enrolled but Never Treated|1|||
33686341|NCT02480712|63181990|FG000|Overall Study|Lost to Follow-up|5|||
33686342|NCT02480712|63181990|FG000|Overall Study|Withdrew Consent|3|||
33686343|NCT02480712|63181990|FG000|Overall Study|Death|1|||
33686344|NCT02480712|63181990|FG000|Overall Study|Lack of Efficacy|1|||
33686345|NCT02513550|63183299|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
33686346|NCT02513550|63183300|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
33686347|NCT02513550|63183301|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
33686348|NCT02513550|63183302|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
33686349|NCT02513550|63183303|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
33686350|NCT02513550|63183304|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
33686351|NCT02513550|63183299|FG000|Double Blind Treatment Period|Adverse Event|5|||
33686352|NCT02513550|63183300|FG001|Double Blind Treatment Period|Adverse Event|13|||
33686353|NCT02513550|63183301|FG002|Double Blind Treatment Period|Adverse Event|17|||
33686354|NCT02513550|63183302|FG003|Double Blind Treatment Period|Adverse Event|0|||
33686355|NCT02513550|63183303|FG004|Double Blind Treatment Period|Adverse Event|1|||
33686356|NCT02513550|63183304|FG005|Double Blind Treatment Period|Adverse Event|0|||
33686357|NCT02513550|63183299|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
33686358|NCT02513550|63183300|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
33686359|NCT02513550|63183301|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
33686360|NCT02513550|63183302|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
33686361|NCT02513550|63183303|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
33686362|NCT02513550|63183304|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
33686363|NCT02513550|63183299|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
33686364|NCT02513550|63183300|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
33686365|NCT02513550|63183301|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
33686366|NCT02513550|63183302|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
33686367|NCT02513550|63183303|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
33686368|NCT02513550|63183304|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
33686369|NCT02513550|63183299|FG000|Double Blind Treatment Period|Protocol Violation|1|||
33686370|NCT02513550|63183300|FG001|Double Blind Treatment Period|Protocol Violation|1|||
33686371|NCT02513550|63183301|FG002|Double Blind Treatment Period|Protocol Violation|4|||
33686372|NCT02513550|63183302|FG003|Double Blind Treatment Period|Protocol Violation|0|||
33686373|NCT02513550|63183303|FG004|Double Blind Treatment Period|Protocol Violation|0|||
33686374|NCT02513550|63183304|FG005|Double Blind Treatment Period|Protocol Violation|0|||
33686375|NCT02513550|63183299|FG000|Double Blind Treatment Period|Physician Decision|2|||
33686376|NCT02513550|63183300|FG001|Double Blind Treatment Period|Physician Decision|0|||
33686377|NCT02513550|63183301|FG002|Double Blind Treatment Period|Physician Decision|4|||
33686378|NCT02513550|63183302|FG003|Double Blind Treatment Period|Physician Decision|0|||
33686379|NCT02513550|63183303|FG004|Double Blind Treatment Period|Physician Decision|0|||
33686380|NCT02513550|63183304|FG005|Double Blind Treatment Period|Physician Decision|0|||
33686381|NCT02513550|63183299|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
33686382|NCT02513550|63183300|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
33686383|NCT02513550|63183301|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
33686384|NCT02513550|63183302|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
33686385|NCT02513550|63183303|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
33686386|NCT02513550|63183304|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
33686387|NCT02513550|63183299|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
33686388|NCT02513550|63183300|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
33686389|NCT02513550|63183301|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
33686390|NCT02513550|63183302|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
33686391|NCT02513550|63183303|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
33686392|NCT02513550|63183304|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
33686393|NCT02513550|63183299|FG000|Double Blind Treatment Period|Due to personal business|2|||
33686394|NCT02513550|63183300|FG001|Double Blind Treatment Period|Due to personal business|0|||
33686395|NCT02513550|63183301|FG002|Double Blind Treatment Period|Due to personal business|1|||
33686396|NCT02513550|63183302|FG003|Double Blind Treatment Period|Due to personal business|0|||
33686397|NCT02513550|63183303|FG004|Double Blind Treatment Period|Due to personal business|0|||
33686398|NCT02513550|63183304|FG005|Double Blind Treatment Period|Due to personal business|0|||
33686399|NCT02513550|63183299|FG000|Double Blind Treatment Period|Death|1|||
33686400|NCT02513550|63183300|FG001|Double Blind Treatment Period|Death|0|||
33686401|NCT02513550|63183301|FG002|Double Blind Treatment Period|Death|2|||
33686402|NCT02513550|63183302|FG003|Double Blind Treatment Period|Death|0|||
33686403|NCT02513550|63183303|FG004|Double Blind Treatment Period|Death|0|||
33686404|NCT02513550|63183304|FG005|Double Blind Treatment Period|Death|0|||
33686405|NCT02513550|63183299|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
33686406|NCT02513550|63183300|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
33686407|NCT02513550|63183301|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
33686408|NCT02513550|63183302|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33686409|NCT02513550|63183303|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33686410|NCT02513550|63183304|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33686411|NCT02513550|63183299|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
33686412|NCT02513550|63183300|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
33686413|NCT02513550|63183301|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
33686414|NCT02513550|63183302|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
33686415|NCT02513550|63183303|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
33686416|NCT02513550|63183304|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
33686417|NCT02513550|63183299|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
33686418|NCT02513550|63183300|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
33686419|NCT02513550|63183301|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
33686420|NCT02513550|63183302|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33686421|NCT02513550|63183303|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33686422|NCT02513550|63183304|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33686423|NCT02513550|63183299|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
33686424|NCT02513550|63183300|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
33686425|NCT02513550|63183301|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
33686426|NCT02513550|63183302|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
33686427|NCT02513550|63183303|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
33686428|NCT02513550|63183304|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
33686429|NCT02513550|63183299|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
33686430|NCT02513550|63183300|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
33686431|NCT02513550|63183301|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
33686432|NCT02513550|63183302|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
33686433|NCT02513550|63183303|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
33686434|NCT02513550|63183304|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
33686435|NCT02513550|63183299|FG000|Post-Treatment Follow-up Period|Death|0|||
33686436|NCT02513550|63183300|FG001|Post-Treatment Follow-up Period|Death|0|||
33686437|NCT02513550|63183301|FG002|Post-Treatment Follow-up Period|Death|1|||
33686438|NCT02513550|63183302|FG003|Post-Treatment Follow-up Period|Death|0|||
33686439|NCT02513550|63183303|FG004|Post-Treatment Follow-up Period|Death|0|||
33686440|NCT02513550|63183304|FG005|Post-Treatment Follow-up Period|Death|0|||
33686441|NCT02513550|63183299|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
33686442|NCT02513550|63183300|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
33686443|NCT02513550|63183301|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
33686444|NCT02513550|63183302|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
33686445|NCT02513550|63183303|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
33686446|NCT02513550|63183304|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
33686447|NCT02513550|63183299|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
33686448|NCT02513550|63183300|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
33686449|NCT02513550|63183301|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
33686450|NCT02513550|63183302|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
33686451|NCT02513550|63183303|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
33686452|NCT02513550|63183304|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
33686453|NCT02513550|63183299|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
33686454|NCT02513550|63183300|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
33686455|NCT02513550|63183301|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
33686456|NCT02513550|63183302|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
33686457|NCT02513550|63183303|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
33686458|NCT02513550|63183304|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
33686459|NCT02513472|63183621|FG000|Overall Study|Radiological Disease Progression|45|||
33686460|NCT02513472|63183622|FG001|Overall Study|Radiological Disease Progression|57|||
33686461|NCT02513472|63183621|FG000|Overall Study|Clinical Disease Progression|5|||
33686462|NCT02513472|63183622|FG001|Overall Study|Clinical Disease Progression|13|||
33686463|NCT02513472|63183621|FG000|Overall Study|Adverse Event|8|||
33686464|NCT02513472|63183622|FG001|Overall Study|Adverse Event|11|||
33686465|NCT02513472|63183621|FG000|Overall Study|Withdrawal by Subject|0|||
33686466|NCT02513472|63183622|FG001|Overall Study|Withdrawal by Subject|4|||
33686467|NCT02513472|63183621|FG000|Overall Study|Subject Choice|2|||
33686468|NCT02513472|63183622|FG001|Overall Study|Subject Choice|7|||
33686469|NCT02513472|63183621|FG000|Overall Study|Treatment Completed as per Protocol|3|||
33686470|NCT02513472|63183622|FG001|Overall Study|Treatment Completed as per Protocol|3|||
33686471|NCT02513472|63183621|FG000|Overall Study|Other|3|||
33686472|NCT02513472|63183622|FG001|Overall Study|Other|6|||
33686473|NCT04490395|63183842|FG000|Overall Study|Lost to Follow-up|0|||
33686474|NCT04490395|63183843|FG001|Overall Study|Lost to Follow-up|1|||
33686475|NCT03843541|63184286|FG000|Overall Study|Adverse Event|4|||
33686476|NCT03843541|63184287|FG001|Overall Study|Adverse Event|2|||
33686477|NCT03843541|63184288|FG002|Overall Study|Adverse Event|3|||
33686478|NCT03843541|63184286|FG000|Overall Study|Death|1|||
33686479|NCT03843541|63184287|FG001|Overall Study|Death|0|||
33686480|NCT03843541|63184288|FG002|Overall Study|Death|0|||
33686481|NCT03843541|63184286|FG000|Overall Study|Lack of adherence to study medication|0|||
33686482|NCT03843541|63184287|FG001|Overall Study|Lack of adherence to study medication|0|||
33686483|NCT03843541|63184288|FG002|Overall Study|Lack of adherence to study medication|1|||
33686484|NCT03843541|63184286|FG000|Overall Study|Physician Decision|1|||
33686485|NCT03843541|63184287|FG001|Overall Study|Physician Decision|2|||
33686486|NCT03843541|63184288|FG002|Overall Study|Physician Decision|2|||
33686487|NCT03843541|63184286|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
33686488|NCT03843541|63184287|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
33686489|NCT03843541|63184288|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
33686490|NCT03843541|63184286|FG000|Overall Study|Withdrawal by Subject|6|||
33686491|NCT03843541|63184287|FG001|Overall Study|Withdrawal by Subject|9|||
33686492|NCT03843541|63184288|FG002|Overall Study|Withdrawal by Subject|7|||
33686493|NCT03843541|63184286|FG000|Overall Study|Administration of rescue mucolytic|0|||
33686494|NCT03843541|63184287|FG001|Overall Study|Administration of rescue mucolytic|0|||
33686495|NCT03843541|63184288|FG002|Overall Study|Administration of rescue mucolytic|1|||
33686496|NCT03843541|63184286|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
33686497|NCT03843541|63184287|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
33686498|NCT03843541|63184288|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
33686499|NCT02992418|63185551|FG000|Overall Study|Withdrawal by Subject|11|||
33686500|NCT02992418|63185552|FG001|Overall Study|Withdrawal by Subject|12|||
33686501|NCT02992418|63185551|FG000|Overall Study|Non-compliance with the protocol|308|||
33686502|NCT02992418|63185552|FG001|Overall Study|Non-compliance with the protocol|308|||
33686503|NCT02992418|63185551|FG000|Overall Study|Lost to Follow-up|27|||
33686504|NCT02992418|63185552|FG001|Overall Study|Lost to Follow-up|22|||
33686505|NCT01276106|63185794|FG000|Overall Study|Adverse Event|3|||
33686506|NCT01276106|63185795|FG001|Overall Study|Adverse Event|3|||
33686507|NCT01276106|63185796|FG002|Overall Study|Adverse Event|11|||
33686508|NCT01276106|63185797|FG003|Overall Study|Adverse Event|3|||
33686509|NCT01276106|63185794|FG000|Overall Study|Withdrawal by Subject|6|||
33686510|NCT01276106|63185795|FG001|Overall Study|Withdrawal by Subject|3|||
33686511|NCT01276106|63185796|FG002|Overall Study|Withdrawal by Subject|1|||
33686512|NCT01276106|63185797|FG003|Overall Study|Withdrawal by Subject|6|||
33686513|NCT01276106|63185794|FG000|Overall Study|Lack of Efficacy|0|||
33595672|NCT02175771|62994626|FG000|Treatment Period|Lack of Efficacy|0|||
33595673|NCT02175771|62994627|FG001|Treatment Period|Lack of Efficacy|0|||
33595674|NCT02175771|62994628|FG002|Treatment Period|Lack of Efficacy|0|||
33595675|NCT02175771|62994629|FG003|Treatment Period|Lack of Efficacy|0|||
33595676|NCT02175771|62994630|FG004|Treatment Period|Lack of Efficacy|0|||
33595677|NCT02175771|62994631|FG005|Treatment Period|Lack of Efficacy|1|||
33595678|NCT02175771|62994632|FG006|Treatment Period|Lack of Efficacy|0|||
33595679|NCT02175771|62994633|FG007|Treatment Period|Lack of Efficacy|1|||
33595680|NCT02175771|62994634|FG008|Treatment Period|Lack of Efficacy|0|||
33595681|NCT02175771|62994626|FG000|Treatment Period|Other|0|||
33595682|NCT02175771|62994627|FG001|Treatment Period|Other|1|||
33686514|NCT01276106|63185795|FG001|Overall Study|Lack of Efficacy|1|||
33686515|NCT01276106|63185796|FG002|Overall Study|Lack of Efficacy|0|||
33493138|NCT03150056|62871252|FG003|Overall Study|Withdrawal by Subject|0|||
33493139|NCT03150056|62871253|FG004|Overall Study|Withdrawal by Subject|0|||
33493140|NCT03150056|62871254|FG005|Overall Study|Withdrawal by Subject|2|||
33493141|NCT03150056|62871249|FG000|Overall Study|Study terminated by Sponsor|1|||
33493142|NCT03150056|62871250|FG001|Overall Study|Study terminated by Sponsor|3|||
33493143|NCT03150056|62871251|FG002|Overall Study|Study terminated by Sponsor|1|||
33493144|NCT03150056|62871252|FG003|Overall Study|Study terminated by Sponsor|1|||
33493145|NCT03150056|62871253|FG004|Overall Study|Study terminated by Sponsor|5|||
33493146|NCT03150056|62871254|FG005|Overall Study|Study terminated by Sponsor|6|||
33493147|NCT03150056|62871249|FG000|Overall Study|Death|9|||
33493148|NCT03150056|62871250|FG001|Overall Study|Death|2|||
33493149|NCT03150056|62871251|FG002|Overall Study|Death|2|||
33493150|NCT03150056|62871252|FG003|Overall Study|Death|7|||
33493151|NCT03150056|62871253|FG004|Overall Study|Death|8|||
33493152|NCT03150056|62871254|FG005|Overall Study|Death|10|||
33493153|NCT02640664|62871274|FG000|Epoch 1|Withdrawal of informed consent|1|||
33493154|NCT02640664|62871275|FG001|Epoch 1|Withdrawal of informed consent|0|||
33595683|NCT02175771|62994628|FG002|Treatment Period|Other|0|||
33493155|NCT02640664|62871276|FG002|Epoch 1|Withdrawal of informed consent|0|||
33595684|NCT02175771|62994629|FG003|Treatment Period|Other|3|||
33686516|NCT01276106|63185797|FG003|Overall Study|Lack of Efficacy|1|||
33686517|NCT01276106|63185794|FG000|Overall Study|Lost to Follow-up|2|||
33686518|NCT01276106|63185795|FG001|Overall Study|Lost to Follow-up|1|||
33686519|NCT01276106|63185796|FG002|Overall Study|Lost to Follow-up|1|||
33686520|NCT01276106|63185797|FG003|Overall Study|Lost to Follow-up|0|||
33686521|NCT01276106|63185794|FG000|Overall Study|Physician Decision|0|||
33686522|NCT01276106|63185795|FG001|Overall Study|Physician Decision|0|||
33686523|NCT01276106|63185796|FG002|Overall Study|Physician Decision|1|||
33686524|NCT01276106|63185797|FG003|Overall Study|Physician Decision|1|||
33686525|NCT01276106|63185794|FG000|Overall Study|Protocol Violation|1|||
33686526|NCT01276106|63185795|FG001|Overall Study|Protocol Violation|1|||
33686527|NCT01276106|63185796|FG002|Overall Study|Protocol Violation|0|||
33686528|NCT01276106|63185797|FG003|Overall Study|Protocol Violation|2|||
33686529|NCT01276106|63185794|FG000|Overall Study|Insufficient therapeutic effects|0|||
33686530|NCT01276106|63185795|FG001|Overall Study|Insufficient therapeutic effects|0|||
33686531|NCT01276106|63185796|FG002|Overall Study|Insufficient therapeutic effects|2|||
33686532|NCT01276106|63185797|FG003|Overall Study|Insufficient therapeutic effects|0|||
33686533|NCT01275170|63185815|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
33686534|NCT01275170|63185816|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
33686535|NCT01275170|63185817|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
33686536|NCT01275170|63185818|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
33686537|NCT01275170|63185819|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
33686538|NCT01275170|63185820|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
33686539|NCT01275170|63185821|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
33686540|NCT01275170|63185822|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
33686541|NCT01273064|63185869|FG000|Overall Study|Adverse Event|5|||
33686542|NCT01273064|63185870|FG001|Overall Study|Adverse Event|1|||
33686543|NCT01273064|63185871|FG002|Overall Study|Adverse Event|3|||
33686544|NCT01273064|63185872|FG003|Overall Study|Adverse Event|2|||
33686545|NCT01273064|63185873|FG004|Overall Study|Adverse Event|1|||
33686546|NCT01273064|63185869|FG000|Overall Study|Withdrawal by Subject|4|||
33686547|NCT01273064|63185870|FG001|Overall Study|Withdrawal by Subject|2|||
33686548|NCT01273064|63185871|FG002|Overall Study|Withdrawal by Subject|2|||
33686549|NCT01273064|63185872|FG003|Overall Study|Withdrawal by Subject|2|||
33686550|NCT01273064|63185873|FG004|Overall Study|Withdrawal by Subject|0|||
33686551|NCT01273064|63185869|FG000|Overall Study|Study Termination|13|||
33686552|NCT01273064|63185870|FG001|Overall Study|Study Termination|27|||
33686553|NCT01273064|63185871|FG002|Overall Study|Study Termination|26|||
33686554|NCT01273064|63185872|FG003|Overall Study|Study Termination|16|||
33686555|NCT01273064|63185873|FG004|Overall Study|Study Termination|8|||
33686556|NCT01273064|63185869|FG000|Overall Study|Lost to Follow-up|1|||
33686557|NCT01273064|63185870|FG001|Overall Study|Lost to Follow-up|0|||
33686558|NCT01273064|63185871|FG002|Overall Study|Lost to Follow-up|0|||
33686559|NCT01273064|63185872|FG003|Overall Study|Lost to Follow-up|0|||
33686560|NCT01273064|63185873|FG004|Overall Study|Lost to Follow-up|0|||
33686561|NCT01273064|63185869|FG000|Overall Study|Physician Decision|0|||
33686562|NCT01273064|63185870|FG001|Overall Study|Physician Decision|0|||
33686563|NCT01273064|63185871|FG002|Overall Study|Physician Decision|0|||
33686564|NCT01273064|63185872|FG003|Overall Study|Physician Decision|0|||
33686565|NCT01273064|63185873|FG004|Overall Study|Physician Decision|1|||
33686566|NCT01272908|63185885|FG000|Initial Treatment Period|Adverse Event|1|||
33686567|NCT01272908|63185885|FG000|Initial Treatment Period|Lack of Efficacy|5|||
33686568|NCT01272908|63185885|FG000|Initial Treatment Period|Protocol Violation|1|||
33686569|NCT01272908|63185885|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
33686570|NCT01272908|63185885|FG000|Re-Treatment Period|Adverse Event|2|||
33686571|NCT01272908|63185885|FG000|Re-Treatment Period|Lack of Efficacy|3|||
33686572|NCT01272908|63185885|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
33686573|NCT01271504|63185895|FG000|Overall Study|Death|7|||
33686574|NCT01271504|63185896|FG001|Overall Study|Death|6|||
33686575|NCT01271504|63185897|FG002|Overall Study|Death|32|||
33686576|NCT01271504|63185898|FG003|Overall Study|Death|32|||
33686577|NCT01271504|63185895|FG000|Overall Study|Lost to Follow-up|0|||
33686578|NCT01271504|63185896|FG001|Overall Study|Lost to Follow-up|1|||
33686579|NCT01271504|63185897|FG002|Overall Study|Lost to Follow-up|3|||
33686580|NCT01271504|63185898|FG003|Overall Study|Lost to Follow-up|1|||
33686581|NCT01271504|63185895|FG000|Overall Study|Protocol Violation|0|||
33686582|NCT01271504|63185896|FG001|Overall Study|Protocol Violation|0|||
33686583|NCT01271504|63185897|FG002|Overall Study|Protocol Violation|0|||
33686584|NCT01271504|63185898|FG003|Overall Study|Protocol Violation|2|||
33686585|NCT01271504|63185895|FG000|Overall Study|Administrative Reasons|0|||
33686586|NCT01271504|63185896|FG001|Overall Study|Administrative Reasons|0|||
33686587|NCT01271504|63185897|FG002|Overall Study|Administrative Reasons|6|||
33686588|NCT01271504|63185898|FG003|Overall Study|Administrative Reasons|5|||
33686589|NCT01271504|63185895|FG000|Overall Study|Withdrawal by Subject|0|||
33686590|NCT01271504|63185896|FG001|Overall Study|Withdrawal by Subject|0|||
33686591|NCT01271504|63185897|FG002|Overall Study|Withdrawal by Subject|1|||
33686592|NCT01271504|63185898|FG003|Overall Study|Withdrawal by Subject|3|||
33686593|NCT01271504|63185895|FG000|Overall Study|Other|0|||
33686594|NCT01271504|63185896|FG001|Overall Study|Other|1|||
33686595|NCT01271504|63185897|FG002|Overall Study|Other|2|||
33686596|NCT01271504|63185898|FG003|Overall Study|Other|0|||
33686597|NCT01270958|63185941|FG000|Overall Study|Lost to Follow-up|2|||
33686598|NCT01270958|63185941|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
33686599|NCT01270880|63185945|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
33686600|NCT01270802|63185951|FG000|Overall Study|Withdrawal by Subject|1|||
33686601|NCT01270802|63185952|FG001|Overall Study|Withdrawal by Subject|0|||
33686602|NCT01270802|63185951|FG000|Overall Study|Adverse Event|1|||
33686603|NCT01270802|63185952|FG001|Overall Study|Adverse Event|0|||
33686604|NCT01270802|63185951|FG000|Overall Study|Lost to Follow-up|0|||
33686605|NCT01270802|63185952|FG001|Overall Study|Lost to Follow-up|1|||
33686606|NCT01270256|63185961|FG000|Overall Study|Withdrawal by Subject|1|||
33686607|NCT01270256|63185962|FG001|Overall Study|Withdrawal by Subject|0|||
33686608|NCT01279616|63186032|FG000|Overall Study|donor could not be located|5|||
33686609|NCT01279616|63186032|FG000|Overall Study|no signs of sickle cell disease|2|||
33686610|NCT01279070|63186043|FG000|Overall Study|Withdrawal by Subject|2|||
33686611|NCT01279070|63186044|FG001|Overall Study|Withdrawal by Subject|3|||
33686612|NCT01279070|63186043|FG000|Overall Study|Acute exacerbation|3|||
33686613|NCT01279070|63186044|FG001|Overall Study|Acute exacerbation|1|||
33686614|NCT01277744|63186054|FG000|Overall Study|Physician Decision|2|||
33686615|NCT01277822|63186060|FG000|Overall Study|Adverse Event|2|||
33686616|NCT01277822|63186061|FG001|Overall Study|Adverse Event|1|||
33686617|NCT01277822|63186060|FG000|Overall Study|Withdrawal by Subject|6|||
33686618|NCT01277822|63186061|FG001|Overall Study|Withdrawal by Subject|7|||
33686619|NCT01277822|63186060|FG000|Overall Study|Physician Decision|1|||
33686620|NCT01277822|63186061|FG001|Overall Study|Physician Decision|1|||
33686621|NCT01277822|63186060|FG000|Overall Study|Protocol Violation|1|||
33686622|NCT01277822|63186061|FG001|Overall Study|Protocol Violation|0|||
33686623|NCT01277822|63186060|FG000|Overall Study|Lost to Follow-up|2|||
33686624|NCT01277822|63186061|FG001|Overall Study|Lost to Follow-up|1|||
33686625|NCT01277822|63186060|FG000|Overall Study|Contraindicated medication used|2|||
33686626|NCT01277822|63186061|FG001|Overall Study|Contraindicated medication used|1|||
33686627|NCT01277822|63186060|FG000|Overall Study|Participant moved|1|||
33595685|NCT02175771|62994630|FG004|Treatment Period|Other|1|||
33595686|NCT02175771|62994631|FG005|Treatment Period|Other|0|||
33595687|NCT02175771|62994632|FG006|Treatment Period|Other|0|||
33595688|NCT02175771|62994633|FG007|Treatment Period|Other|2|||
33595689|NCT02175771|62994634|FG008|Treatment Period|Other|0|||
33595690|NCT01657799|62994655|FG000|Overall Study|Adverse Event Related to progression|6|||
33595691|NCT01657799|62994656|FG001|Overall Study|Adverse Event Related to progression|8|||
33595692|NCT01657799|62994657|FG002|Overall Study|Adverse Event Related to progression|12|||
33595693|NCT01657799|62994655|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
33595694|NCT01657799|62994656|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
33595695|NCT01657799|62994657|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
33595696|NCT01657799|62994655|FG000|Overall Study|Withdrawal by Subject|13|||
33595697|NCT01657799|62994656|FG001|Overall Study|Withdrawal by Subject|10|||
33595698|NCT01657799|62994657|FG002|Overall Study|Withdrawal by Subject|10|||
33595699|NCT01657799|62994655|FG000|Overall Study|Lost to Follow-up|1|||
33595700|NCT01657799|62994656|FG001|Overall Study|Lost to Follow-up|0|||
33595701|NCT01657799|62994657|FG002|Overall Study|Lost to Follow-up|1|||
33595702|NCT01657799|62994655|FG000|Overall Study|Disease Progression|2|||
33595703|NCT01657799|62994656|FG001|Overall Study|Disease Progression|4|||
33595704|NCT01657799|62994657|FG002|Overall Study|Disease Progression|4|||
33595705|NCT01657799|62994655|FG000|Overall Study|Progressive Disease Clinical|7|||
33595706|NCT01657799|62994656|FG001|Overall Study|Progressive Disease Clinical|4|||
33595707|NCT01657799|62994657|FG002|Overall Study|Progressive Disease Clinical|7|||
33595708|NCT01657799|62994655|FG000|Overall Study|Radiographic & Clinical Progression|16|||
33595709|NCT01657799|62994656|FG001|Overall Study|Radiographic & Clinical Progression|11|||
33595710|NCT01657799|62994657|FG002|Overall Study|Radiographic & Clinical Progression|15|||
33595711|NCT01657799|62994655|FG000|Overall Study|Other|52|||
33595712|NCT01657799|62994656|FG001|Overall Study|Other|62|||
33595713|NCT01657799|62994657|FG002|Overall Study|Other|49|||
33595714|NCT02116803|62994667|FG000|Overall Study|Adverse Event|2|||
33595715|NCT02116803|62994668|FG001|Overall Study|Adverse Event|1|||
33595716|NCT02116803|62994667|FG000|Overall Study|Physician Decision|1|||
33595717|NCT02116803|62994668|FG001|Overall Study|Physician Decision|0|||
33595718|NCT02116803|62994667|FG000|Overall Study|Progressive disease|4|||
33686628|NCT01277822|63186061|FG001|Overall Study|Participant moved|0|||
33686629|NCT01277666|63186070|FG000|Overall Study|Adverse Event|26|||
33686630|NCT01277666|63186071|FG001|Overall Study|Adverse Event|25|||
33686631|NCT01277666|63186072|FG002|Overall Study|Adverse Event|20|||
33595719|NCT02116803|62994668|FG001|Overall Study|Progressive disease|0|||
33595720|NCT02116803|62994667|FG000|Overall Study|Study terminated by sponsor|2|||
33595721|NCT02116803|62994668|FG001|Overall Study|Study terminated by sponsor|1|||
33686632|NCT01277666|63186070|FG000|Overall Study|Lack of Efficacy|8|||
33686633|NCT01277666|63186071|FG001|Overall Study|Lack of Efficacy|20|||
33686634|NCT01277666|63186072|FG002|Overall Study|Lack of Efficacy|12|||
33686635|NCT01277666|63186070|FG000|Overall Study|Protocol Violation|2|||
33686636|NCT01277666|63186071|FG001|Overall Study|Protocol Violation|3|||
33686637|NCT01277666|63186072|FG002|Overall Study|Protocol Violation|2|||
33686638|NCT01277666|63186070|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
33686639|NCT01277666|63186071|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
33686640|NCT01277666|63186072|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
33686641|NCT01277666|63186070|FG000|Overall Study|Lost to Follow-up|1|||
33686642|NCT01277666|63186071|FG001|Overall Study|Lost to Follow-up|1|||
33686643|NCT01277666|63186072|FG002|Overall Study|Lost to Follow-up|2|||
33686644|NCT01277666|63186070|FG000|Overall Study|Withdrawal by Subject|7|||
33686645|NCT01277666|63186071|FG001|Overall Study|Withdrawal by Subject|8|||
33686646|NCT01277666|63186072|FG002|Overall Study|Withdrawal by Subject|6|||
33686647|NCT01277666|63186070|FG000|Overall Study|Death|0|||
33686648|NCT01277666|63186071|FG001|Overall Study|Death|0|||
33686649|NCT01277666|63186072|FG002|Overall Study|Death|1|||
33686650|NCT00249002|63186080|FG000|Overall Study|Adverse Event|2|||
33686651|NCT00249002|63186080|FG000|Overall Study|Study cancellation|3|||
33686652|NCT00249002|63186080|FG000|Overall Study|Other|2|||
33686653|NCT01277042|63186086|FG000|Overall Study|Adverse Event|4|||
33686654|NCT01277042|63186087|FG001|Overall Study|Adverse Event|3|||
33686655|NCT01277042|63186086|FG000|Overall Study|Lost to Follow-up|2|||
33686656|NCT01277042|63186087|FG001|Overall Study|Lost to Follow-up|2|||
33686657|NCT01277042|63186086|FG000|Overall Study|Withdrawal by Subject|2|||
33686658|NCT01277042|63186087|FG001|Overall Study|Withdrawal by Subject|0|||
33686659|NCT00246740|63186127|FG000|Initial Enrollment|Death|1|||
33686660|NCT00246740|63186128|FG001|Initial Enrollment|Death|0|||
33686661|NCT00246740|63186127|FG000|Initial Enrollment|Additional surgery scheduled|0|||
33686662|NCT00246740|63186128|FG001|Initial Enrollment|Additional surgery scheduled|2|||
33686663|NCT00246740|63186127|FG000|Initial Enrollment|Surgery schedule change|4|||
33686664|NCT00246740|63186128|FG001|Initial Enrollment|Surgery schedule change|4|||
33686665|NCT00246740|63186127|FG000|Initial Enrollment|Other|1|||
33686666|NCT00246740|63186128|FG001|Initial Enrollment|Other|2|||
33686667|NCT00245102|63186173|FG000|Overall Study|Not Treated|1|||
33686668|NCT00245102|63186174|FG001|Overall Study|Not Treated|0|||
33686669|NCT00245102|63186175|FG002|Overall Study|Not Treated|1|||
33686670|NCT00245102|63186176|FG003|Overall Study|Not Treated|0|||
33686671|NCT00245102|63186177|FG004|Overall Study|Not Treated|0|||
33686672|NCT00245102|63186178|FG005|Overall Study|Not Treated|0|||
33686673|NCT00245102|63186173|FG000|Overall Study|Protocol Violation|1|||
33686674|NCT00245102|63186174|FG001|Overall Study|Protocol Violation|0|||
33686675|NCT00245102|63186175|FG002|Overall Study|Protocol Violation|0|||
33686676|NCT00245102|63186176|FG003|Overall Study|Protocol Violation|0|||
33686677|NCT00245102|63186177|FG004|Overall Study|Protocol Violation|0|||
33686678|NCT00245102|63186178|FG005|Overall Study|Protocol Violation|0|||
33686679|NCT00245102|63186173|FG000|Overall Study|Death|0|||
33686680|NCT00245102|63186174|FG001|Overall Study|Death|0|||
33686681|NCT00245102|63186175|FG002|Overall Study|Death|0|||
33686682|NCT00245102|63186176|FG003|Overall Study|Death|1|||
33686683|NCT00245102|63186177|FG004|Overall Study|Death|0|||
33686684|NCT00245102|63186178|FG005|Overall Study|Death|0|||
33686685|NCT00245102|63186173|FG000|Overall Study|Adverse Event|4|||
33686686|NCT00245102|63186174|FG001|Overall Study|Adverse Event|2|||
33686687|NCT00245102|63186175|FG002|Overall Study|Adverse Event|5|||
33686688|NCT00245102|63186176|FG003|Overall Study|Adverse Event|1|||
33686689|NCT00245102|63186177|FG004|Overall Study|Adverse Event|0|||
33686690|NCT00245102|63186178|FG005|Overall Study|Adverse Event|2|||
33686691|NCT00245102|63186173|FG000|Overall Study|Decline in performance|0|||
33686692|NCT00245102|63186174|FG001|Overall Study|Decline in performance|2|||
33686693|NCT00245102|63186175|FG002|Overall Study|Decline in performance|0|||
33686694|NCT00245102|63186176|FG003|Overall Study|Decline in performance|1|||
33595722|NCT02116803|62994667|FG000|Overall Study|Death|1|||
33595723|NCT02116803|62994668|FG001|Overall Study|Death|0|||
33595724|NCT02115321|62994676|FG000|Overall Study|Death|1|||
33595725|NCT02115321|62994677|FG001|Overall Study|Death|0|||
33595726|NCT02367781|62994685|FG000|Overall Study|Withdrawal by Subject|20|||
33595727|NCT02367781|62994686|FG001|Overall Study|Withdrawal by Subject|13|||
33595728|NCT02367781|62994685|FG000|Overall Study|Protocol Violation|0|||
33595729|NCT02367781|62994686|FG001|Overall Study|Protocol Violation|1|||
33595730|NCT02367781|62994685|FG000|Overall Study|Physician Decision|7|||
33595731|NCT02367781|62994686|FG001|Overall Study|Physician Decision|0|||
33686695|NCT00245102|63186177|FG004|Overall Study|Decline in performance|0|||
33686696|NCT00245102|63186178|FG005|Overall Study|Decline in performance|2|||
33595732|NCT02367781|62994685|FG000|Overall Study|Randomized in Error|5|||
33686697|NCT00245102|63186173|FG000|Overall Study|Participant needed surgery|0|||
33686698|NCT00245102|63186174|FG001|Overall Study|Participant needed surgery|0|||
33686699|NCT00245102|63186175|FG002|Overall Study|Participant needed surgery|1|||
33686700|NCT00245102|63186176|FG003|Overall Study|Participant needed surgery|0|||
33686701|NCT00245102|63186177|FG004|Overall Study|Participant needed surgery|0|||
33686702|NCT00245102|63186178|FG005|Overall Study|Participant needed surgery|0|||
33686703|NCT00245102|63186173|FG000|Overall Study|Clinical progression|1|||
33686704|NCT00245102|63186174|FG001|Overall Study|Clinical progression|0|||
33686705|NCT00245102|63186175|FG002|Overall Study|Clinical progression|0|||
33686706|NCT00245102|63186176|FG003|Overall Study|Clinical progression|0|||
33686707|NCT00245102|63186177|FG004|Overall Study|Clinical progression|0|||
33686708|NCT00245102|63186178|FG005|Overall Study|Clinical progression|0|||
33686709|NCT00244712|63186223|FG000|Overall Study|Adverse Event|20|||
33686710|NCT00244712|63186224|FG001|Overall Study|Adverse Event|21|||
33686711|NCT00244712|63186223|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
33686712|NCT00244712|63186224|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
33686713|NCT00244712|63186223|FG000|Overall Study|Lack of Compliance|10|||
33686714|NCT00244712|63186224|FG001|Overall Study|Lack of Compliance|11|||
33686715|NCT00244712|63186223|FG000|Overall Study|Lost to Follow-up|45|||
33686716|NCT00244712|63186224|FG001|Overall Study|Lost to Follow-up|52|||
33686717|NCT00244712|63186223|FG000|Overall Study|Withdrawal by Subject|13|||
33686718|NCT00244712|63186224|FG001|Overall Study|Withdrawal by Subject|23|||
33686719|NCT00244712|63186223|FG000|Overall Study|Protocol Violation, disease progression|13|||
33686720|NCT00244712|63186224|FG001|Overall Study|Protocol Violation, disease progression|11|||
33686721|NCT00243932|63186242|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
33686722|NCT00243932|63186243|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
33686723|NCT00243932|63186244|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
33686724|NCT00243386|63186252|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
33686725|NCT00243386|63186253|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
33686726|NCT00243386|63186254|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
33686727|NCT00243386|63186252|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
33686728|NCT00243386|63186253|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
33686729|NCT00243386|63186254|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
33686730|NCT00243386|63186252|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
33686731|NCT00243386|63186253|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
33686732|NCT00243386|63186254|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
33686733|NCT00243386|63186252|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
33686734|NCT00243386|63186253|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
33686735|NCT00243386|63186254|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
33686736|NCT00243386|63186252|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
33686737|NCT00243386|63186253|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
33686738|NCT00243386|63186254|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
33686739|NCT00243386|63186252|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
33686740|NCT00243386|63186253|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
33686741|NCT00243386|63186254|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
33686742|NCT00243386|63186252|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
33686743|NCT00243386|63186253|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
33686744|NCT00243386|63186254|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
33686745|NCT00243386|63186252|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
33686746|NCT00243386|63186253|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
33686747|NCT00243386|63186254|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
33686748|NCT00243230|63186313|FG000|Double-Blind Period|Adverse Event|0|||
33686749|NCT00243230|63186314|FG001|Double-Blind Period|Adverse Event|2|||
33686750|NCT00243230|63186315|FG002|Double-Blind Period|Adverse Event|2|||
33686751|NCT00243230|63186316|FG003|Double-Blind Period|Adverse Event|0|||
33686752|NCT00243230|63186313|FG000|Double-Blind Period|Withdrawal by Subject|1|||
33686753|NCT00243230|63186314|FG001|Double-Blind Period|Withdrawal by Subject|0|||
33686754|NCT00243230|63186315|FG002|Double-Blind Period|Withdrawal by Subject|0|||
33686755|NCT00243230|63186316|FG003|Double-Blind Period|Withdrawal by Subject|0|||
33686756|NCT00243230|63186313|FG000|Double-Blind Period|Protocol Violation|0|||
33686757|NCT00243230|63186314|FG001|Double-Blind Period|Protocol Violation|0|||
33686758|NCT00243230|63186315|FG002|Double-Blind Period|Protocol Violation|1|||
33686759|NCT00243230|63186316|FG003|Double-Blind Period|Protocol Violation|0|||
33686760|NCT00243230|63186313|FG000|Double-Blind Period|Randomized but Not Treated|0|||
33686761|NCT00243230|63186314|FG001|Double-Blind Period|Randomized but Not Treated|0|||
33686762|NCT00243230|63186315|FG002|Double-Blind Period|Randomized but Not Treated|2|||
33686763|NCT00243230|63186316|FG003|Double-Blind Period|Randomized but Not Treated|0|||
33686764|NCT00243230|63186313|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
33686765|NCT00243230|63186314|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
33686766|NCT00243230|63186315|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
33686767|NCT00243230|63186316|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
33686768|NCT00243230|63186313|FG000|Open Label Period|Adverse Event|0|||
33686769|NCT00243230|63186314|FG001|Open Label Period|Adverse Event|0|||
33686770|NCT00243230|63186315|FG002|Open Label Period|Adverse Event|0|||
33686771|NCT00243230|63186316|FG003|Open Label Period|Adverse Event|2|||
33686772|NCT00243230|63186313|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
33686773|NCT00243230|63186314|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
33686774|NCT00243230|63186315|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
33686775|NCT00243230|63186316|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
33686776|NCT00243230|63186313|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
33686777|NCT00243230|63186314|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
33686778|NCT00243230|63186315|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
33686779|NCT00243230|63186316|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
33686780|NCT00243230|63186313|FG000|Open Label Period|Lost to Follow-up|0|||
33686781|NCT00243230|63186314|FG001|Open Label Period|Lost to Follow-up|0|||
33686782|NCT00243230|63186315|FG002|Open Label Period|Lost to Follow-up|0|||
33686783|NCT00243230|63186316|FG003|Open Label Period|Lost to Follow-up|2|||
33686784|NCT00243230|63186313|FG000|Open Label Period|Withdrawal by Subject|0|||
33686785|NCT00243230|63186314|FG001|Open Label Period|Withdrawal by Subject|0|||
33686786|NCT00243230|63186315|FG002|Open Label Period|Withdrawal by Subject|0|||
33686787|NCT00243230|63186316|FG003|Open Label Period|Withdrawal by Subject|2|||
33686788|NCT00243230|63186313|FG000|Open Label Period|Protocol Violation|0|||
33686789|NCT00243230|63186314|FG001|Open Label Period|Protocol Violation|0|||
33686790|NCT00243230|63186315|FG002|Open Label Period|Protocol Violation|0|||
33686791|NCT00243230|63186316|FG003|Open Label Period|Protocol Violation|2|||
33686792|NCT00243230|63186313|FG000|Open Label Period|Administrative Reason|0|||
33686793|NCT00243230|63186314|FG001|Open Label Period|Administrative Reason|0|||
33686794|NCT00243230|63186315|FG002|Open Label Period|Administrative Reason|0|||
33686795|NCT00243230|63186316|FG003|Open Label Period|Administrative Reason|63|||
33686796|NCT00243074|63186326|FG000|Overall Study|Ineligible|6|||
33686797|NCT00243074|63186326|FG000|Overall Study|Adverse Event|6|||
33686798|NCT00243074|63186326|FG000|Overall Study|Withdrawal by Subject|2|||
33686799|NCT00243074|63186326|FG000|Overall Study|Lack of Efficacy|36|||
33686800|NCT00243074|63186326|FG000|Overall Study|Death|2|||
33686801|NCT00243074|63186326|FG000|Overall Study|not protocol specified|1|||
33686802|NCT00243074|63186326|FG000|Overall Study|Did not receive any treatment|1|||
33686803|NCT00241358|63186334|FG000|Overall Study|Determined to be not ineligible|0|||
33595733|NCT02367781|62994686|FG001|Overall Study|Randomized in Error|4|||
33595734|NCT02367781|62994685|FG000|Overall Study|Non-Compliance|1|||
33595735|NCT02367781|62994686|FG001|Overall Study|Non-Compliance|0|||
33595736|NCT02367781|62994685|FG000|Overall Study|Lost to Follow-up|1|||
33595737|NCT02367781|62994686|FG001|Overall Study|Lost to Follow-up|2|||
33595738|NCT02367781|62994685|FG000|Overall Study|Death|330|||
33595739|NCT02367781|62994686|FG001|Overall Study|Death|176|||
33595740|NCT02367781|62994685|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
33595741|NCT02367781|62994686|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
33595742|NCT02367781|62994685|FG000|Overall Study|Prolonged Hospitalization|1|||
33595743|NCT02367781|62994686|FG001|Overall Study|Prolonged Hospitalization|0|||
33595744|NCT02367781|62994685|FG000|Overall Study|Death Prior First Dose|1|||
33595745|NCT02367781|62994686|FG001|Overall Study|Death Prior First Dose|0|||
33595746|NCT02367781|62994685|FG000|Overall Study|Administrative-Change Facility|1|||
33595747|NCT02367781|62994686|FG001|Overall Study|Administrative-Change Facility|0|||
33595748|NCT02367781|62994685|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
33595749|NCT02367781|62994686|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
33595750|NCT02367781|62994685|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
33595751|NCT02367781|62994686|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
33595752|NCT02367781|62994685|FG000|Overall Study|Study Terminated by Sponsor|3|||
33595753|NCT02367781|62994686|FG001|Overall Study|Study Terminated by Sponsor|1|||
33595754|NCT02367781|62994685|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
33595755|NCT02367781|62994686|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
33595756|NCT02367781|62994685|FG000|Overall Study|Sponsor Decision|2|||
33595757|NCT02367781|62994686|FG001|Overall Study|Sponsor Decision|0|||
33595758|NCT02367781|62994685|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
33595759|NCT02367781|62994686|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
33595760|NCT02152761|62994698|FG000|Epoch: Treatment Epoch|Technical problems|0|||
33595761|NCT02152761|62994699|FG001|Epoch: Treatment Epoch|Technical problems|0|||
33595762|NCT02152761|62994700|FG002|Epoch: Treatment Epoch|Technical problems|0|||
33595763|NCT02152761|62994701|FG003|Epoch: Treatment Epoch|Technical problems|1|||
33595764|NCT02152761|62994698|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
33595765|NCT02152761|62994699|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
33595766|NCT02152761|62994700|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
33595767|NCT02152761|62994701|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
33595768|NCT02152761|62994698|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
33595769|NCT02152761|62994699|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
33595770|NCT02152761|62994700|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
33595771|NCT02152761|62994701|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
33595772|NCT02152761|62994698|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
33595773|NCT02152761|62994699|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
33595774|NCT02152761|62994700|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
33595775|NCT02152761|62994701|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
33595776|NCT02152761|62994698|FG000|Epoch: Treatment Epoch|Death|0|||
33595777|NCT02152761|62994699|FG001|Epoch: Treatment Epoch|Death|3|||
33595778|NCT02152761|62994700|FG002|Epoch: Treatment Epoch|Death|1|||
33595779|NCT02152761|62994701|FG003|Epoch: Treatment Epoch|Death|0|||
33595780|NCT02152761|62994698|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
33595781|NCT02152761|62994699|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
33595782|NCT02152761|62994700|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
33595783|NCT02152761|62994701|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
33595784|NCT02152761|62994698|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
33595785|NCT02152761|62994699|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
33595786|NCT02152761|62994700|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
33595787|NCT02152761|62994701|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
33595788|NCT02152761|62994698|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
33595789|NCT02152761|62994699|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
33595790|NCT02152761|62994700|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
33595791|NCT02152761|62994701|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
33595792|NCT02152761|62994698|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
33595793|NCT02152761|62994699|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
33595794|NCT02152761|62994700|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
33595795|NCT02152761|62994701|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
33595796|NCT02152761|62994698|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
33595797|NCT02152761|62994699|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
33595798|NCT02152761|62994700|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
33595799|NCT02152761|62994701|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
33595800|NCT02152605|62994723|FG000|Overall Study|Adverse Event|6|||
33595801|NCT02152605|62994724|FG001|Overall Study|Adverse Event|8|||
33595802|NCT02152605|62994723|FG000|Overall Study|Lack of Efficacy|7|||
33595803|NCT02152605|62994724|FG001|Overall Study|Lack of Efficacy|4|||
33595804|NCT02152605|62994723|FG000|Overall Study|Protocol deviation|1|||
33595805|NCT02152605|62994724|FG001|Overall Study|Protocol deviation|4|||
33595806|NCT02152605|62994723|FG000|Overall Study|Lost to Follow-up|1|||
33595807|NCT02152605|62994724|FG001|Overall Study|Lost to Follow-up|0|||
33595808|NCT02152605|62994723|FG000|Overall Study|Withdrew consent|4|||
33595809|NCT02152605|62994724|FG001|Overall Study|Withdrew consent|2|||
33595810|NCT02152371|62994733|FG000|Overall Study|Adverse Event|6|||
33595811|NCT02152371|62994734|FG001|Overall Study|Adverse Event|2|||
33595812|NCT02152371|62994733|FG000|Overall Study|Withdrawal by Subject|3|||
33595813|NCT02152371|62994734|FG001|Overall Study|Withdrawal by Subject|7|||
33595814|NCT02152371|62994733|FG000|Overall Study|Protocol Violation|2|||
33595815|NCT02152371|62994734|FG001|Overall Study|Protocol Violation|3|||
33595816|NCT02152371|62994733|FG000|Overall Study|Lost to Follow-up|1|||
33595817|NCT02152371|62994734|FG001|Overall Study|Lost to Follow-up|0|||
33595818|NCT02152371|62994733|FG000|Overall Study|Lack of Efficacy|0|||
33595819|NCT02152371|62994734|FG001|Overall Study|Lack of Efficacy|1|||
33595820|NCT02152371|62994733|FG000|Overall Study|Physician Decision|0|||
33595821|NCT02152371|62994734|FG001|Overall Study|Physician Decision|2|||
33595822|NCT02152371|62994733|FG000|Overall Study|Reason Not Given|0|||
33595823|NCT02152371|62994734|FG001|Overall Study|Reason Not Given|1|||
33686804|NCT00241358|63186335|FG001|Overall Study|Determined to be not ineligible|1|||
33686805|NCT00241358|63186336|FG002|Overall Study|Determined to be not ineligible|1|||
33686806|NCT00241280|63186345|FG000|Overall Study|Adverse Event|2|||
33686807|NCT00241280|63186346|FG001|Overall Study|Adverse Event|6|||
33686808|NCT00241280|63186345|FG000|Overall Study|Discomfort|11|||
33686809|NCT00241280|63186346|FG001|Overall Study|Discomfort|16|||
33686810|NCT00241280|63186345|FG000|Overall Study|Pregnancy|1|||
33686811|NCT00241280|63186346|FG001|Overall Study|Pregnancy|5|||
33686812|NCT00241280|63186345|FG000|Overall Study|Lost to Follow-up|5|||
33686813|NCT00241280|63186346|FG001|Overall Study|Lost to Follow-up|8|||
33686814|NCT00241280|63186345|FG000|Overall Study|Withdrawal by Subject|7|||
33686815|NCT00241280|63186346|FG001|Overall Study|Withdrawal by Subject|4|||
33686816|NCT00241280|63186345|FG000|Overall Study|Protocol Violation|4|||
33686817|NCT00241280|63186346|FG001|Overall Study|Protocol Violation|10|||
33686818|NCT00241280|63186345|FG000|Overall Study|Relocation|4|||
33686819|NCT00241280|63186346|FG001|Overall Study|Relocation|4|||
33686820|NCT00241280|63186345|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
33686821|NCT00241280|63186346|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
33686822|NCT00241280|63186345|FG000|Overall Study|Unsatisfactory Visual Response|1|||
33686823|NCT00241280|63186346|FG001|Overall Study|Unsatisfactory Visual Response|1|||
33686824|NCT00241280|63186345|FG000|Overall Study|Diabetic|1|||
33686825|NCT00241280|63186346|FG001|Overall Study|Diabetic|0|||
33686826|NCT00241280|63186345|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
33686827|NCT00241280|63186346|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
33686828|NCT00241280|63186345|FG000|Overall Study|Dispensed incorrect test article|1|||
33686829|NCT00241280|63186346|FG001|Overall Study|Dispensed incorrect test article|2|||
33686830|NCT00241280|63186345|FG000|Overall Study|Unacceptable Fit|0|||
33686831|NCT00241280|63186346|FG001|Overall Study|Unacceptable Fit|1|||
33686832|NCT00241280|63186345|FG000|Overall Study|Scheduling Conflict|0|||
33686833|NCT00241280|63186346|FG001|Overall Study|Scheduling Conflict|2|||
33686834|NCT00241280|63186345|FG000|Overall Study|History of Ocular Surgery|0|||
33686835|NCT00241280|63186346|FG001|Overall Study|History of Ocular Surgery|1|||
33686836|NCT00241280|63186345|FG000|Overall Study|Coating on Lens|1|||
33686837|NCT00241280|63186346|FG001|Overall Study|Coating on Lens|0|||
33686838|NCT00241280|63186345|FG000|Overall Study|Excessive Dryness|0|||
33686839|NCT00241280|63186346|FG001|Overall Study|Excessive Dryness|1|||
33686840|NCT04278872|63186923|FG000|Overall Study|Adverse Event|1|||
33686841|NCT04278872|63186924|FG001|Overall Study|Adverse Event|0|||
33686842|NCT04278872|63186923|FG000|Overall Study|Protocol Violation|0|||
33686843|NCT04278872|63186924|FG001|Overall Study|Protocol Violation|1|||
33686844|NCT04278872|63186923|FG000|Overall Study|Study Termination|2|||
33686845|NCT04278872|63186924|FG001|Overall Study|Study Termination|0|||
33686846|NCT02513160|63189404|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
33686847|NCT02513160|63189405|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
33686848|NCT02513160|63189406|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
33686849|NCT02513160|63189407|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
33686850|NCT02513160|63189404|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
33686851|NCT02513160|63189405|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
33686852|NCT02513160|63189406|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
33686853|NCT02513160|63189407|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
33686854|NCT02513160|63189404|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
33686855|NCT02513160|63189405|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
33686856|NCT02513160|63189406|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
33686857|NCT02513160|63189407|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
33686858|NCT02513160|63189404|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
33686859|NCT02513160|63189405|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
33686860|NCT02513160|63189406|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
33686861|NCT02513160|63189407|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
33686862|NCT02513160|63189404|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
33686863|NCT02513160|63189405|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
33686864|NCT02513160|63189406|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
33686865|NCT02513160|63189407|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
33686866|NCT02513160|63189404|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
33686867|NCT02513160|63189405|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
33686868|NCT02513160|63189406|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
33686869|NCT02513160|63189407|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
33686870|NCT02513160|63189404|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
33686871|NCT02513160|63189405|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
33686872|NCT02513160|63189406|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
33686873|NCT02513160|63189407|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
33686874|NCT02513160|63189404|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
33686875|NCT02513160|63189405|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
33686876|NCT02513160|63189406|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
33686877|NCT02513160|63189407|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
33686878|NCT02513160|63189404|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
33686879|NCT02513160|63189405|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
33686880|NCT02513160|63189406|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
33686881|NCT02513160|63189407|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
33686882|NCT02513160|63189404|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
33686883|NCT02513160|63189405|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
33686884|NCT02513160|63189406|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
33686885|NCT02513160|63189407|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
33686886|NCT02513160|63189404|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
33686887|NCT02513160|63189405|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
33686888|NCT02513160|63189406|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
33686889|NCT02513160|63189407|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
33686890|NCT02513160|63189404|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
33686891|NCT02513160|63189405|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
33686892|NCT02513160|63189406|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
33686893|NCT02513160|63189407|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
33686894|NCT02480010|63189442|FG000|Overall Study|Adverse Event|3|||
33686895|NCT02480010|63189443|FG001|Overall Study|Adverse Event|1|||
33686896|NCT02480010|63189442|FG000|Overall Study|Death|1|||
33686897|NCT02480010|63189443|FG001|Overall Study|Death|0|||
33686898|NCT02480010|63189442|FG000|Overall Study|Insufficient therapeutic response|31|||
33686899|NCT02480010|63189443|FG001|Overall Study|Insufficient therapeutic response|29|||
33686900|NCT02480010|63189442|FG000|Overall Study|Refused Treatment|0|||
33686901|NCT02480010|63189443|FG001|Overall Study|Refused Treatment|3|||
33686902|NCT02512302|63189471|FG000|Period 1|Adverse Event|0|||
33686903|NCT02512302|63189472|FG001|Period 1|Adverse Event|1|||
33686904|NCT02512302|63189473|FG002|Period 1|Adverse Event|0|||
33686905|NCT02512302|63189474|FG003|Period 1|Adverse Event|0|||
33686906|NCT02512302|63189475|FG004|Period 1|Adverse Event|0|||
33686907|NCT02512302|63189476|FG005|Period 1|Adverse Event|0|||
33686908|NCT02512302|63189477|FG006|Period 1|Adverse Event|0|||
33686909|NCT02512302|63189478|FG007|Period 1|Adverse Event|0|||
33686910|NCT02512302|63189479|FG008|Period 1|Adverse Event|0|||
33686911|NCT02512302|63189480|FG009|Period 1|Adverse Event|0|||
33686912|NCT02512302|63189471|FG000|Period 2|Adverse Event|0|||
33686913|NCT02512302|63189472|FG001|Period 2|Adverse Event|0|||
33686914|NCT02512302|63189473|FG002|Period 2|Adverse Event|0|||
33686915|NCT02512302|63189474|FG003|Period 2|Adverse Event|0|||
33686916|NCT02512302|63189475|FG004|Period 2|Adverse Event|0|||
33686917|NCT02512302|63189476|FG005|Period 2|Adverse Event|0|||
33686918|NCT02512302|63189477|FG006|Period 2|Adverse Event|0|||
33686919|NCT02512302|63189478|FG007|Period 2|Adverse Event|0|||
33686920|NCT02512302|63189479|FG008|Period 2|Adverse Event|0|||
33686921|NCT02512302|63189480|FG009|Period 2|Adverse Event|1|||
33686922|NCT02512302|63189471|FG000|Period 3|Lost to Follow-up|0|||
33686923|NCT02512302|63189472|FG001|Period 3|Lost to Follow-up|0|||
33686924|NCT02512302|63189473|FG002|Period 3|Lost to Follow-up|1|||
33686925|NCT02512302|63189474|FG003|Period 3|Lost to Follow-up|0|||
33686926|NCT02512302|63189475|FG004|Period 3|Lost to Follow-up|0|||
33686927|NCT02512302|63189476|FG005|Period 3|Lost to Follow-up|0|||
33686928|NCT02512302|63189477|FG006|Period 3|Lost to Follow-up|0|||
33686929|NCT02512302|63189478|FG007|Period 3|Lost to Follow-up|0|||
33686930|NCT02512302|63189479|FG008|Period 3|Lost to Follow-up|0|||
33686931|NCT02512302|63189480|FG009|Period 3|Lost to Follow-up|0|||
33686932|NCT02512302|63189471|FG000|Period 4|Adverse Event|0|||
33686933|NCT02512302|63189472|FG001|Period 4|Adverse Event|0|||
33686934|NCT02512302|63189473|FG002|Period 4|Adverse Event|0|||
33686935|NCT02512302|63189474|FG003|Period 4|Adverse Event|0|||
33686936|NCT02512302|63189475|FG004|Period 4|Adverse Event|0|||
33686937|NCT02512302|63189476|FG005|Period 4|Adverse Event|0|||
33686938|NCT02512302|63189477|FG006|Period 4|Adverse Event|1|||
33595824|NCT02332291|62994742|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
33595825|NCT02332291|62994743|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
33595826|NCT02332291|62994742|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
33595827|NCT02332291|62994743|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
33595828|NCT02332291|62994742|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
33595829|NCT02332291|62994743|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
33595830|NCT02332291|62994742|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
33595831|NCT02332291|62994743|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
33595832|NCT02332291|62994742|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
33595833|NCT02332291|62994743|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
33595834|NCT02332291|62994742|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
33595835|NCT02332291|62994743|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
33595836|NCT01656395|62994759|FG000|Overall Study|Adverse Event|1|||
33686939|NCT02512302|63189478|FG007|Period 4|Adverse Event|0|||
33686940|NCT02512302|63189479|FG008|Period 4|Adverse Event|0|||
33686941|NCT02512302|63189480|FG009|Period 4|Adverse Event|0|||
33686942|NCT02512068|63189588|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
33595837|NCT01656395|62994760|FG001|Overall Study|Adverse Event|14|||
33686943|NCT02512068|63189589|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
33686944|NCT02512068|63189588|FG000|Overall Study|Major Protocol Deviation|1|||
33686945|NCT02512068|63189589|FG001|Overall Study|Major Protocol Deviation|0|||
33686946|NCT02512068|63189588|FG000|Overall Study|Voluntary Withdrawal|0|||
33686947|NCT02512068|63189589|FG001|Overall Study|Voluntary Withdrawal|1|||
33686948|NCT02512068|63189588|FG000|Overall Study|Lack of Efficacy|0|||
33686949|NCT02512068|63189589|FG001|Overall Study|Lack of Efficacy|1|||
33686950|NCT02512068|63189588|FG000|Overall Study|Reason Not Specified|3|||
33686951|NCT02512068|63189589|FG001|Overall Study|Reason Not Specified|5|||
33686952|NCT02511678|63189604|FG000|Overall Study|Withdrawal by Subject|2|||
33686953|NCT02511678|63189604|FG000|Overall Study|Lost to Follow-up|4|||
33686954|NCT02511678|63189604|FG000|Overall Study|Death|19|||
33686955|NCT02511678|63189604|FG000|Overall Study|Adverse Event|1|||
33686956|NCT02511678|63189604|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
33686957|NCT02511678|63189604|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
33686958|NCT02511678|63189604|FG000|Overall Study|Required Radiofrequency Ablation|1|||
33686959|NCT02511678|63189604|FG000|Overall Study|Biopsy was Negative|1|||
33686960|NCT02511678|63189604|FG000|Overall Study|Protocol Violation|1|||
33686961|NCT02511678|63189604|FG000|Overall Study|Received Radiation Treatment|1|||
33686962|NCT02518464|63189631|FG000|Overall Study|Adverse Event|2|||
33686963|NCT02510820|63189635|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
33686964|NCT02510820|63189636|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
33686965|NCT02510820|63189635|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
33686966|NCT02510820|63189636|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
33686967|NCT02510664|63189646|FG000|Overall Study|Transferred Care|9|||
33686968|NCT02510664|63189647|FG001|Overall Study|Transferred Care|9|||
33686969|NCT02510664|63189648|FG002|Overall Study|Transferred Care|0|||
33686970|NCT02510664|63189646|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
33686971|NCT02510664|63189647|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
33686972|NCT02510664|63189648|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
33686973|NCT02510664|63189646|FG000|Overall Study|Time Constraints|1|||
33686974|NCT02510664|63189647|FG001|Overall Study|Time Constraints|1|||
33686975|NCT02510664|63189648|FG002|Overall Study|Time Constraints|0|||
33686976|NCT01363986|63189679|FG000|Overall Study|Disease progression|1|||
33686977|NCT02478372|63189713|FG000|Overall Study|Protocol Violation|12|||
33686978|NCT02478372|63189714|FG001|Overall Study|Protocol Violation|8|||
33686979|NCT02478372|63189713|FG000|Overall Study|Lost to Follow-up|1|||
33686980|NCT02478372|63189714|FG001|Overall Study|Lost to Follow-up|4|||
33686981|NCT02478372|63189713|FG000|Overall Study|Death|0|||
33686982|NCT02478372|63189714|FG001|Overall Study|Death|2|||
33686983|NCT01654536|63189726|FG000|Overall Study|Lost to Follow-up|5|||
33686984|NCT01654536|63189727|FG001|Overall Study|Lost to Follow-up|5|||
33686985|NCT01654536|63189726|FG000|Overall Study|Physician Decision|12|||
33686986|NCT01654536|63189727|FG001|Overall Study|Physician Decision|8|||
33686987|NCT01654536|63189726|FG000|Overall Study|Withdrawal by Subject|27|||
33686988|NCT01654536|63189727|FG001|Overall Study|Withdrawal by Subject|25|||
33686989|NCT01654380|63189736|FG000|Part B, Period 1|Physician Decision|0|||
33686990|NCT01654380|63189737|FG001|Part B, Period 1|Physician Decision|0|||
33686991|NCT01654380|63189738|FG002|Part B, Period 1|Physician Decision|1|||
33686992|NCT01654380|63189739|FG003|Part B, Period 1|Physician Decision|0|||
33686993|NCT02477670|63189758|FG000|Stage 1|Adverse Event|2|||
33686994|NCT02477670|63189759|FG001|Stage 1|Adverse Event|7|||
33686995|NCT02477670|63189760|FG002|Stage 1|Adverse Event|0|||
33686996|NCT02477670|63189761|FG003|Stage 1|Adverse Event|0|||
33686997|NCT02477670|63189762|FG004|Stage 1|Adverse Event|0|||
33686998|NCT02477670|63189763|FG005|Stage 1|Adverse Event|0|||
33686999|NCT02477670|63189764|FG006|Stage 1|Adverse Event|0|||
33687000|NCT02477670|63189758|FG000|Stage 1|Lost to Follow-up|0|||
33687001|NCT02477670|63189759|FG001|Stage 1|Lost to Follow-up|2|||
33687002|NCT02477670|63189760|FG002|Stage 1|Lost to Follow-up|0|||
33687003|NCT02477670|63189761|FG003|Stage 1|Lost to Follow-up|0|||
33687004|NCT02477670|63189762|FG004|Stage 1|Lost to Follow-up|0|||
33687005|NCT02477670|63189763|FG005|Stage 1|Lost to Follow-up|0|||
33687006|NCT02477670|63189764|FG006|Stage 1|Lost to Follow-up|0|||
33687007|NCT02477670|63189758|FG000|Stage 1|Withdrawal by Subject|1|||
33687008|NCT02477670|63189759|FG001|Stage 1|Withdrawal by Subject|2|||
33687009|NCT02477670|63189760|FG002|Stage 1|Withdrawal by Subject|0|||
33687010|NCT02477670|63189761|FG003|Stage 1|Withdrawal by Subject|0|||
33687011|NCT02477670|63189762|FG004|Stage 1|Withdrawal by Subject|0|||
33687012|NCT02477670|63189763|FG005|Stage 1|Withdrawal by Subject|0|||
33687013|NCT02477670|63189764|FG006|Stage 1|Withdrawal by Subject|0|||
33687014|NCT02477670|63189758|FG000|Stage 1|Non-compliance with Study Drug|1|||
33687015|NCT02477670|63189759|FG001|Stage 1|Non-compliance with Study Drug|2|||
33687016|NCT02477670|63189760|FG002|Stage 1|Non-compliance with Study Drug|0|||
33687017|NCT02477670|63189761|FG003|Stage 1|Non-compliance with Study Drug|0|||
33687018|NCT02477670|63189762|FG004|Stage 1|Non-compliance with Study Drug|0|||
33687019|NCT02477670|63189763|FG005|Stage 1|Non-compliance with Study Drug|0|||
33687020|NCT02477670|63189764|FG006|Stage 1|Non-compliance with Study Drug|0|||
33687021|NCT02477670|63189758|FG000|Stage 2|Adverse Event|0|||
33687022|NCT02477670|63189759|FG001|Stage 2|Adverse Event|0|||
33687023|NCT02477670|63189760|FG002|Stage 2|Adverse Event|1|||
33687024|NCT02477670|63189761|FG003|Stage 2|Adverse Event|0|||
33687025|NCT02477670|63189762|FG004|Stage 2|Adverse Event|0|||
33687026|NCT02477670|63189763|FG005|Stage 2|Adverse Event|0|||
33687027|NCT02477670|63189764|FG006|Stage 2|Adverse Event|0|||
33687028|NCT02477670|63189758|FG000|Stage 2|Antipsychotic Medication Changed|0|||
33687029|NCT02477670|63189759|FG001|Stage 2|Antipsychotic Medication Changed|0|||
33687030|NCT02477670|63189760|FG002|Stage 2|Antipsychotic Medication Changed|1|||
33687031|NCT02477670|63189761|FG003|Stage 2|Antipsychotic Medication Changed|0|||
33687032|NCT02477670|63189762|FG004|Stage 2|Antipsychotic Medication Changed|0|||
33687033|NCT02477670|63189763|FG005|Stage 2|Antipsychotic Medication Changed|0|||
33687034|NCT02477670|63189764|FG006|Stage 2|Antipsychotic Medication Changed|0|||
33687035|NCT02477670|63189758|FG000|Stage 2|Withdrawal by Subject|0|||
33687036|NCT02477670|63189759|FG001|Stage 2|Withdrawal by Subject|0|||
33687037|NCT02477670|63189760|FG002|Stage 2|Withdrawal by Subject|0|||
33687038|NCT02477670|63189761|FG003|Stage 2|Withdrawal by Subject|1|||
33687039|NCT02477670|63189762|FG004|Stage 2|Withdrawal by Subject|0|||
33687040|NCT02477670|63189763|FG005|Stage 2|Withdrawal by Subject|0|||
33687041|NCT02477670|63189764|FG006|Stage 2|Withdrawal by Subject|0|||
33687042|NCT02509026|63189775|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
33687043|NCT02509026|63189775|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
33687044|NCT02509026|63189775|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
33687045|NCT02509026|63189775|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
33687046|NCT02509026|63189775|FG000|Induction Period (24 Weeks)|Other|2|||
33687047|NCT02509026|63189775|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
33687048|NCT02509026|63189775|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
33687049|NCT02509026|63189775|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
33687050|NCT02509026|63189775|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
33687051|NCT02509026|63189775|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
33687052|NCT02509026|63189775|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
33687053|NCT02509026|63189775|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
33687054|NCT02509026|63189775|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
33687055|NCT02476968|63190158|FG000|Overall Study|Other|0|||
33687056|NCT02476968|63190159|FG001|Overall Study|Other|2|||
33687057|NCT02476968|63190160|FG002|Overall Study|Other|0|||
33687058|NCT02476968|63190158|FG000|Overall Study|Lost to Follow-up|10|||
33687059|NCT02476968|63190159|FG001|Overall Study|Lost to Follow-up|0|||
33687060|NCT02476968|63190160|FG002|Overall Study|Lost to Follow-up|1|||
33687061|NCT02476968|63190158|FG000|Overall Study|Death|48|||
33687062|NCT02476968|63190159|FG001|Overall Study|Death|8|||
33687063|NCT02476968|63190160|FG002|Overall Study|Death|1|||
33687064|NCT02476968|63190158|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33687065|NCT02476968|63190159|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33687066|NCT02476968|63190160|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
33687067|NCT02476968|63190158|FG000|Overall Study|Patient decision|37|||
33687068|NCT02476968|63190159|FG001|Overall Study|Patient decision|8|||
33687069|NCT02476968|63190160|FG002|Overall Study|Patient decision|0|||
33687070|NCT02476578|63190181|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
33687071|NCT02476578|63190182|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
33687072|NCT02476578|63190181|FG000|Overall Study|Lost to Follow-up|6|||
33687073|NCT02476578|63190182|FG001|Overall Study|Lost to Follow-up|13|||
33687074|NCT02504892|63190200|FG000|Overall Study|Adverse event-pneumonitis|2|||
33687075|NCT02504502|63190206|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
33687076|NCT02504502|63190207|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
33687077|NCT02504502|63190206|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
33687078|NCT02504502|63190207|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
33687079|NCT04184622|63190230|FG000|Overall Study|Adverse Event|7|||
33687080|NCT04184622|63190231|FG001|Overall Study|Adverse Event|7|||
33687081|NCT04184622|63190232|FG002|Overall Study|Adverse Event|11|||
33687082|NCT04184622|63190233|FG003|Overall Study|Adverse Event|8|||
33687083|NCT04184622|63190230|FG000|Overall Study|Death|4|||
33687084|NCT04184622|63190231|FG001|Overall Study|Death|4|||
33687085|NCT04184622|63190232|FG002|Overall Study|Death|2|||
33687086|NCT04184622|63190233|FG003|Overall Study|Death|1|||
33687087|NCT04184622|63190230|FG000|Overall Study|Lost to Follow-up|41|||
33687088|NCT04184622|63190231|FG001|Overall Study|Lost to Follow-up|19|||
33687089|NCT04184622|63190232|FG002|Overall Study|Lost to Follow-up|20|||
33687090|NCT04184622|63190233|FG003|Overall Study|Lost to Follow-up|15|||
33687091|NCT04184622|63190230|FG000|Overall Study|Missing Weight at Week 72|1|||
33687092|NCT04184622|63190231|FG001|Overall Study|Missing Weight at Week 72|0|||
33687093|NCT04184622|63190232|FG002|Overall Study|Missing Weight at Week 72|1|||
33687094|NCT04184622|63190233|FG003|Overall Study|Missing Weight at Week 72|0|||
33687095|NCT04184622|63190230|FG000|Overall Study|Other - as reported by the investigator|22|||
33687096|NCT04184622|63190231|FG001|Overall Study|Other - as reported by the investigator|7|||
33687097|NCT04184622|63190232|FG002|Overall Study|Other - as reported by the investigator|5|||
33687098|NCT04184622|63190233|FG003|Overall Study|Other - as reported by the investigator|12|||
33687099|NCT04184622|63190230|FG000|Overall Study|Physician Decision|0|||
33687100|NCT04184622|63190231|FG001|Overall Study|Physician Decision|0|||
33687101|NCT04184622|63190232|FG002|Overall Study|Physician Decision|3|||
33687102|NCT04184622|63190233|FG003|Overall Study|Physician Decision|1|||
33687103|NCT04184622|63190230|FG000|Overall Study|Pregnancy|4|||
33687104|NCT04184622|63190231|FG001|Overall Study|Pregnancy|4|||
33687105|NCT04184622|63190232|FG002|Overall Study|Pregnancy|3|||
33687106|NCT04184622|63190233|FG003|Overall Study|Pregnancy|5|||
33687107|NCT04184622|63190230|FG000|Overall Study|Protocol Deviation|1|||
33687108|NCT04184622|63190231|FG001|Overall Study|Protocol Deviation|0|||
33687109|NCT04184622|63190232|FG002|Overall Study|Protocol Deviation|0|||
33687110|NCT04184622|63190233|FG003|Overall Study|Protocol Deviation|0|||
33687111|NCT04184622|63190230|FG000|Overall Study|Withdrawal by Subject|68|||
33687112|NCT04184622|63190231|FG001|Overall Study|Withdrawal by Subject|28|||
33687113|NCT04184622|63190232|FG002|Overall Study|Withdrawal by Subject|29|||
33687114|NCT04184622|63190233|FG003|Overall Study|Withdrawal by Subject|22|||
33687115|NCT03772717|63190266|FG000|Overall Study|Withdrawal by Subject|2|||
33687116|NCT03770403|63190270|FG000|Overall Study|Adverse Event|8|||
33687117|NCT03770403|63190270|FG000|Overall Study|Death|5|||
33687118|NCT03770403|63190270|FG000|Overall Study|Physician Decision|1|||
33687119|NCT03770403|63190270|FG000|Overall Study|Sponsor decision|1|||
33687120|NCT03770403|63190270|FG000|Overall Study|Study terminated by Sponsor|1|||
33687121|NCT03770403|63190270|FG000|Overall Study|Withdrawal by Subject|13|||
33687122|NCT03770403|63190270|FG000|Overall Study|Other|88|||
33687123|NCT03740100|63190274|FG000|Overall Study|Adverse Event|1|||
33687124|NCT03740100|63190274|FG000|Overall Study|Death|1|||
33687125|NCT03499795|63190278|FG000|Overall Study|Adverse Event|1|||
33687126|NCT03499795|63190278|FG000|Overall Study|Lost to Follow-up|1|||
33687127|NCT03456700|63190295|FG000|Overall Study|Withdrawal by Subject|1|||
33687128|NCT03401450|63190301|FG000|Overall Study|Lost to Follow-up|4|||
33687129|NCT03401450|63190302|FG001|Overall Study|Lost to Follow-up|6|||
33687130|NCT03401450|63190301|FG000|Overall Study|Anesthesia plan changed|2|||
33687131|NCT03401450|63190302|FG001|Overall Study|Anesthesia plan changed|2|||
33687132|NCT03401450|63190301|FG000|Overall Study|Did not complete medication diary|4|||
33687133|NCT03401450|63190302|FG001|Overall Study|Did not complete medication diary|2|||
33687134|NCT03401450|63190301|FG000|Overall Study|post surgery medication change|2|||
33687135|NCT03401450|63190302|FG001|Overall Study|post surgery medication change|1|||
33687136|NCT03401450|63190301|FG000|Overall Study|Cancelled surgery|0|||
33687137|NCT03401450|63190302|FG001|Overall Study|Cancelled surgery|2|||
33595838|NCT01656395|62994761|FG002|Overall Study|Adverse Event|5|||
33595839|NCT01656395|62994762|FG003|Overall Study|Adverse Event|4|||
33595840|NCT01656395|62994763|FG004|Overall Study|Adverse Event|5|||
33595841|NCT01656395|62994764|FG005|Overall Study|Adverse Event|7|||
33595842|NCT01656395|62994765|FG006|Overall Study|Adverse Event|0|||
33595843|NCT01656395|62994766|FG007|Overall Study|Adverse Event|0|||
33595844|NCT01656395|62994759|FG000|Overall Study|Lack of Efficacy|1|||
33595845|NCT01656395|62994760|FG001|Overall Study|Lack of Efficacy|8|||
33595846|NCT01656395|62994761|FG002|Overall Study|Lack of Efficacy|6|||
33595847|NCT01656395|62994762|FG003|Overall Study|Lack of Efficacy|1|||
33595848|NCT01656395|62994763|FG004|Overall Study|Lack of Efficacy|1|||
33595849|NCT01656395|62994764|FG005|Overall Study|Lack of Efficacy|6|||
33687138|NCT03326063|63190310|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
33687139|NCT03326063|63190311|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
33687140|NCT03155997|63190332|FG000|Overall Study|Withdrawal by Subject|119|||
33687141|NCT03155997|63190333|FG001|Overall Study|Withdrawal by Subject|134|||
33687142|NCT03155997|63190332|FG000|Overall Study|Lost to Follow-up|12|||
33687143|NCT03155997|63190333|FG001|Overall Study|Lost to Follow-up|13|||
33687144|NCT03155997|63190332|FG000|Overall Study|Missing disposition data|0|||
33687145|NCT03155997|63190333|FG001|Overall Study|Missing disposition data|1|||
33687146|NCT03155997|63190332|FG000|Overall Study|On study treatment|2027|||
33687147|NCT03155997|63190333|FG001|Overall Study|On study treatment|2074|||
33687148|NCT02764762|63190350|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
33687149|NCT02764762|63190350|FG000|Overall Study|Lost to Follow-up|4|||
33687150|NCT02764762|63190350|FG000|Overall Study|Voluntary Withdrawal|8|||
33687151|NCT02764762|63190350|FG000|Overall Study|Site Termination|1|||
33687152|NCT02764762|63190350|FG000|Overall Study|Lack of Efficacy|16|||
33687153|NCT02764762|63190350|FG000|Overall Study|Reason not Specified|1|||
33687154|NCT02340962|63190360|FG000|Overall Study|Lost to Follow-up|1|||
33687155|NCT02340962|63190361|FG001|Overall Study|Lost to Follow-up|0|||
33687156|NCT02272634|63190381|FG000|Overall Study|Adverse Event|1|||
33687157|NCT02272634|63190382|FG001|Overall Study|Adverse Event|0|||
33687158|NCT02272634|63190383|FG002|Overall Study|Adverse Event|0|||
33687159|NCT02272634|63190381|FG000|Overall Study|Protocol Violation|0|||
33687160|NCT02272634|63190382|FG001|Overall Study|Protocol Violation|0|||
33687161|NCT02272634|63190383|FG002|Overall Study|Protocol Violation|1|||
33687162|NCT02272634|63190381|FG000|Overall Study|Withdrawal by Subject|0|||
33687163|NCT02272634|63190382|FG001|Overall Study|Withdrawal by Subject|1|||
33687164|NCT02272634|63190383|FG002|Overall Study|Withdrawal by Subject|0|||
33687165|NCT00788125|63190394|FG000|Overall Study|Death|6|||
33687166|NCT00676715|63190402|FG000|Overall Study|Withdrawal by Subject|7|||
33595850|NCT01656395|62994765|FG006|Overall Study|Lack of Efficacy|0|||
33687167|NCT00676715|63190403|FG001|Overall Study|Withdrawal by Subject|9|||
33687168|NCT00676715|63190404|FG002|Overall Study|Withdrawal by Subject|10|||
33687169|NCT00676715|63190405|FG003|Overall Study|Withdrawal by Subject|10|||
33687170|NCT00676715|63190402|FG000|Overall Study|Other|2|||
33687171|NCT00676715|63190403|FG001|Overall Study|Other|6|||
33687172|NCT00676715|63190404|FG002|Overall Study|Other|4|||
33687173|NCT00676715|63190405|FG003|Overall Study|Other|3|||
33687174|NCT00676715|63190402|FG000|Overall Study|Lost to Follow-up|1|||
33687175|NCT00676715|63190403|FG001|Overall Study|Lost to Follow-up|1|||
33687176|NCT00676715|63190404|FG002|Overall Study|Lost to Follow-up|7|||
33687177|NCT00676715|63190405|FG003|Overall Study|Lost to Follow-up|3|||
33687178|NCT00676715|63190402|FG000|Overall Study|Death|1|||
33687179|NCT00676715|63190403|FG001|Overall Study|Death|1|||
33687180|NCT00676715|63190404|FG002|Overall Study|Death|1|||
33687181|NCT00676715|63190405|FG003|Overall Study|Death|0|||
33687182|NCT00676715|63190402|FG000|Overall Study|Adverse Event|0|||
33687183|NCT00676715|63190403|FG001|Overall Study|Adverse Event|1|||
33687184|NCT00676715|63190404|FG002|Overall Study|Adverse Event|2|||
33687185|NCT00676715|63190405|FG003|Overall Study|Adverse Event|0|||
33687186|NCT00676715|63190402|FG000|Overall Study|Participants Ongoing|29|||
33687187|NCT00676715|63190403|FG001|Overall Study|Participants Ongoing|29|||
33687188|NCT00676715|63190404|FG002|Overall Study|Participants Ongoing|17|||
33687189|NCT00676715|63190405|FG003|Overall Study|Participants Ongoing|24|||
33687190|NCT02504424|63190424|FG000|Overall Study|Withdrawal by Subject|2|||
33687191|NCT02548832|63190754|FG000|Overall Study|Lost to Follow-up|2|||
33687192|NCT02548832|63190755|FG001|Overall Study|Lost to Follow-up|2|||
33687193|NCT02548832|63190756|FG002|Overall Study|Lost to Follow-up|2|||
33687194|NCT02504268|63191007|FG000|Overall Study|Adverse Event|18|||
33687195|NCT02504268|63191008|FG001|Overall Study|Adverse Event|8|||
33687196|NCT02504268|63191009|FG002|Overall Study|Adverse Event|14|||
33687197|NCT02504268|63191010|FG003|Overall Study|Adverse Event|0|||
33687198|NCT02504268|63191011|FG004|Overall Study|Adverse Event|0|||
33687199|NCT02504268|63191012|FG005|Overall Study|Adverse Event|0|||
33687200|NCT02504268|63191013|FG006|Overall Study|Adverse Event|0|||
33687201|NCT02504268|63191014|FG007|Overall Study|Adverse Event|0|||
33687202|NCT02504268|63191015|FG008|Overall Study|Adverse Event|0|||
33687203|NCT02504268|63191007|FG000|Overall Study|Withdrawal of Consent|11|||
33687204|NCT02504268|63191008|FG001|Overall Study|Withdrawal of Consent|10|||
33687205|NCT02504268|63191009|FG002|Overall Study|Withdrawal of Consent|3|||
33687206|NCT02504268|63191010|FG003|Overall Study|Withdrawal of Consent|0|||
33687207|NCT02504268|63191011|FG004|Overall Study|Withdrawal of Consent|0|||
33687208|NCT02504268|63191012|FG005|Overall Study|Withdrawal of Consent|0|||
33687209|NCT02504268|63191013|FG006|Overall Study|Withdrawal of Consent|0|||
33687210|NCT02504268|63191014|FG007|Overall Study|Withdrawal of Consent|0|||
33687211|NCT02504268|63191015|FG008|Overall Study|Withdrawal of Consent|0|||
33687212|NCT02504268|63191007|FG000|Overall Study|Pregnancy|2|||
33687213|NCT02504268|63191008|FG001|Overall Study|Pregnancy|0|||
33687214|NCT02504268|63191009|FG002|Overall Study|Pregnancy|0|||
33687215|NCT02504268|63191010|FG003|Overall Study|Pregnancy|0|||
33687216|NCT02504268|63191011|FG004|Overall Study|Pregnancy|0|||
33687217|NCT02504268|63191012|FG005|Overall Study|Pregnancy|0|||
33687218|NCT02504268|63191013|FG006|Overall Study|Pregnancy|0|||
33687219|NCT02504268|63191014|FG007|Overall Study|Pregnancy|0|||
33687220|NCT02504268|63191015|FG008|Overall Study|Pregnancy|0|||
33687221|NCT02504268|63191007|FG000|Overall Study|Lost to Follow-up|3|||
33595851|NCT01656395|62994766|FG007|Overall Study|Lack of Efficacy|0|||
33595852|NCT01656395|62994759|FG000|Overall Study|Lost to Follow-up|1|||
33595853|NCT01656395|62994760|FG001|Overall Study|Lost to Follow-up|0|||
33595854|NCT01656395|62994761|FG002|Overall Study|Lost to Follow-up|0|||
33595855|NCT01656395|62994762|FG003|Overall Study|Lost to Follow-up|0|||
33595856|NCT01656395|62994763|FG004|Overall Study|Lost to Follow-up|0|||
33595857|NCT01656395|62994764|FG005|Overall Study|Lost to Follow-up|0|||
33595858|NCT01656395|62994765|FG006|Overall Study|Lost to Follow-up|0|||
33595859|NCT01656395|62994766|FG007|Overall Study|Lost to Follow-up|0|||
33595860|NCT01656395|62994759|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33651291|NCT01972529|63062729|FG001|Overall Study|Adverse Event|1|||
33687222|NCT02504268|63191008|FG001|Overall Study|Lost to Follow-up|6|||
33687223|NCT02504268|63191009|FG002|Overall Study|Lost to Follow-up|4|||
33687224|NCT02504268|63191010|FG003|Overall Study|Lost to Follow-up|0|||
33687225|NCT02504268|63191011|FG004|Overall Study|Lost to Follow-up|0|||
33687226|NCT02504268|63191012|FG005|Overall Study|Lost to Follow-up|0|||
33687227|NCT02504268|63191013|FG006|Overall Study|Lost to Follow-up|0|||
33651292|NCT01972529|63062730|FG002|Overall Study|Adverse Event|0|||
33651293|NCT01972529|63062731|FG003|Overall Study|Adverse Event|0|||
33651294|NCT01972529|63062728|FG000|Overall Study|Lost to Follow-up|1|||
33651295|NCT01972529|63062729|FG001|Overall Study|Lost to Follow-up|0|||
33651296|NCT01972529|63062730|FG002|Overall Study|Lost to Follow-up|0|||
33651297|NCT01972529|63062731|FG003|Overall Study|Lost to Follow-up|0|||
33651298|NCT01972529|63062728|FG000|Overall Study|Participant Choice|0|||
33687228|NCT02504268|63191014|FG007|Overall Study|Lost to Follow-up|0|||
33687229|NCT02504268|63191015|FG008|Overall Study|Lost to Follow-up|0|||
33687230|NCT02504268|63191007|FG000|Overall Study|Death|1|||
33687231|NCT02504268|63191008|FG001|Overall Study|Death|1|||
33687232|NCT02504268|63191009|FG002|Overall Study|Death|0|||
33687233|NCT02504268|63191010|FG003|Overall Study|Death|0|||
33687234|NCT02504268|63191011|FG004|Overall Study|Death|0|||
33687235|NCT02504268|63191012|FG005|Overall Study|Death|0|||
33687236|NCT02504268|63191013|FG006|Overall Study|Death|0|||
33687237|NCT02504268|63191014|FG007|Overall Study|Death|0|||
33687238|NCT02504268|63191015|FG008|Overall Study|Death|0|||
33687239|NCT02504268|63191007|FG000|Overall Study|Subject Request to Discontinue|11|||
33687240|NCT02504268|63191008|FG001|Overall Study|Subject Request to Discontinue|3|||
33687241|NCT02504268|63191009|FG002|Overall Study|Subject Request to Discontinue|6|||
33687242|NCT02504268|63191010|FG003|Overall Study|Subject Request to Discontinue|0|||
33687243|NCT02504268|63191011|FG004|Overall Study|Subject Request to Discontinue|0|||
33687244|NCT02504268|63191012|FG005|Overall Study|Subject Request to Discontinue|0|||
33687245|NCT02504268|63191013|FG006|Overall Study|Subject Request to Discontinue|0|||
33687246|NCT02504268|63191014|FG007|Overall Study|Subject Request to Discontinue|0|||
33687247|NCT02504268|63191015|FG008|Overall Study|Subject Request to Discontinue|0|||
33687248|NCT02504268|63191007|FG000|Overall Study|No Longer Meets Study Criteria|2|||
33687249|NCT02504268|63191008|FG001|Overall Study|No Longer Meets Study Criteria|3|||
33687250|NCT02504268|63191009|FG002|Overall Study|No Longer Meets Study Criteria|0|||
33687251|NCT02504268|63191010|FG003|Overall Study|No Longer Meets Study Criteria|0|||
33687252|NCT02504268|63191011|FG004|Overall Study|No Longer Meets Study Criteria|0|||
33687253|NCT02504268|63191012|FG005|Overall Study|No Longer Meets Study Criteria|0|||
33687254|NCT02504268|63191013|FG006|Overall Study|No Longer Meets Study Criteria|0|||
33687255|NCT02504268|63191014|FG007|Overall Study|No Longer Meets Study Criteria|0|||
33687256|NCT02504268|63191015|FG008|Overall Study|No Longer Meets Study Criteria|0|||
33687257|NCT02504268|63191007|FG000|Overall Study|Lack of Efficacy|11|||
33687258|NCT02504268|63191008|FG001|Overall Study|Lack of Efficacy|35|||
33687259|NCT02504268|63191009|FG002|Overall Study|Lack of Efficacy|9|||
33687260|NCT02504268|63191010|FG003|Overall Study|Lack of Efficacy|0|||
33687261|NCT02504268|63191011|FG004|Overall Study|Lack of Efficacy|0|||
33687262|NCT02504268|63191012|FG005|Overall Study|Lack of Efficacy|0|||
33687263|NCT02504268|63191013|FG006|Overall Study|Lack of Efficacy|0|||
33687264|NCT02504268|63191014|FG007|Overall Study|Lack of Efficacy|0|||
33687265|NCT02504268|63191015|FG008|Overall Study|Lack of Efficacy|0|||
33687266|NCT02504268|63191007|FG000|Overall Study|Poor/Non-Compliance|3|||
33687267|NCT02504268|63191008|FG001|Overall Study|Poor/Non-Compliance|2|||
33687268|NCT02504268|63191009|FG002|Overall Study|Poor/Non-Compliance|3|||
33687269|NCT02504268|63191010|FG003|Overall Study|Poor/Non-Compliance|0|||
33687270|NCT02504268|63191011|FG004|Overall Study|Poor/Non-Compliance|0|||
33687271|NCT02504268|63191012|FG005|Overall Study|Poor/Non-Compliance|0|||
33687272|NCT02504268|63191013|FG006|Overall Study|Poor/Non-Compliance|0|||
33687273|NCT02504268|63191014|FG007|Overall Study|Poor/Non-Compliance|0|||
33687274|NCT02504268|63191015|FG008|Overall Study|Poor/Non-Compliance|0|||
33687275|NCT02504268|63191007|FG000|Overall Study|Not Disclosed|1|||
33687276|NCT02504268|63191008|FG001|Overall Study|Not Disclosed|0|||
33687277|NCT02504268|63191009|FG002|Overall Study|Not Disclosed|2|||
33687278|NCT02504268|63191010|FG003|Overall Study|Not Disclosed|0|||
33687279|NCT02504268|63191011|FG004|Overall Study|Not Disclosed|0|||
33687280|NCT02504268|63191012|FG005|Overall Study|Not Disclosed|0|||
33687281|NCT02504268|63191013|FG006|Overall Study|Not Disclosed|0|||
33687282|NCT02504268|63191014|FG007|Overall Study|Not Disclosed|0|||
33687283|NCT02504268|63191015|FG008|Overall Study|Not Disclosed|0|||
33687284|NCT01654302|63191059|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
33687285|NCT01654302|63191060|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
33687286|NCT02476422|63191076|FG000|Overall Study|Subject/guardian decision|0|||
33687287|NCT02476422|63191077|FG001|Overall Study|Subject/guardian decision|1|||
33687288|NCT02475564|63191107|FG000|Overall Study|Withdrawal by Subject|1|||
33687289|NCT02475564|63191108|FG001|Overall Study|Withdrawal by Subject|0|||
33687290|NCT02475564|63191107|FG000|Overall Study|Lost to Follow-up|2|||
33687291|NCT02475564|63191108|FG001|Overall Study|Lost to Follow-up|1|||
33687292|NCT02475564|63191107|FG000|Overall Study|Intense Menstrual bleeding|1|||
33687293|NCT02475564|63191108|FG001|Overall Study|Intense Menstrual bleeding|0|||
33687294|NCT02503332|63191396|FG000|Overall Study|Adverse Event|17|||
33687295|NCT02503332|63191397|FG001|Overall Study|Adverse Event|5|||
33687296|NCT02503332|63191398|FG002|Overall Study|Adverse Event|3|||
33687297|NCT02503332|63191399|FG003|Overall Study|Adverse Event|1|||
33687298|NCT02503332|63191396|FG000|Overall Study|Investigator's Decision|5|||
33687299|NCT02503332|63191397|FG001|Overall Study|Investigator's Decision|1|||
33687300|NCT02503332|63191398|FG002|Overall Study|Investigator's Decision|0|||
33687301|NCT02503332|63191399|FG003|Overall Study|Investigator's Decision|0|||
33687302|NCT02503332|63191396|FG000|Overall Study|Sponsor's Decision|1|||
33687303|NCT02503332|63191397|FG001|Overall Study|Sponsor's Decision|0|||
33687304|NCT02503332|63191398|FG002|Overall Study|Sponsor's Decision|0|||
33687305|NCT02503332|63191399|FG003|Overall Study|Sponsor's Decision|1|||
33687306|NCT02503332|63191396|FG000|Overall Study|Subject Request|6|||
33687307|NCT02503332|63191397|FG001|Overall Study|Subject Request|5|||
33687308|NCT02503332|63191398|FG002|Overall Study|Subject Request|2|||
33687309|NCT02503332|63191399|FG003|Overall Study|Subject Request|1|||
33687310|NCT02503332|63191396|FG000|Overall Study|Death|0|||
33687311|NCT02503332|63191397|FG001|Overall Study|Death|2|||
33687312|NCT02503332|63191398|FG002|Overall Study|Death|2|||
33687313|NCT02503332|63191399|FG003|Overall Study|Death|0|||
33687314|NCT02503332|63191396|FG000|Overall Study|Other|5|||
33687315|NCT02503332|63191397|FG001|Overall Study|Other|6|||
33687316|NCT02503332|63191398|FG002|Overall Study|Other|1|||
33687317|NCT02503332|63191399|FG003|Overall Study|Other|1|||
33687318|NCT02502864|63191417|FG000|Overall Study|Withdrawal by Subject|1|||
33687319|NCT02474082|63191451|FG000|Overall Study|Adverse Event|2|||
33687320|NCT02474082|63191452|FG001|Overall Study|Adverse Event|32|||
33687321|NCT02474082|63191451|FG000|Overall Study|Withdrawal of informed consent|1|||
33687322|NCT02474082|63191452|FG001|Overall Study|Withdrawal of informed consent|11|||
33687323|NCT02474082|63191451|FG000|Overall Study|Lost to Follow-up|2|||
33687324|NCT02474082|63191452|FG001|Overall Study|Lost to Follow-up|2|||
33687325|NCT02474082|63191451|FG000|Overall Study|Dose tapering not achieved|0|||
33687326|NCT02474082|63191452|FG001|Overall Study|Dose tapering not achieved|4|||
33687327|NCT02474082|63191451|FG000|Overall Study|Participant/guardian decision|1|||
33687328|NCT02474082|63191452|FG001|Overall Study|Participant/guardian decision|2|||
33687329|NCT02474082|63191451|FG000|Overall Study|Non-compliance with study treatment|0|||
33687330|NCT02474082|63191452|FG001|Overall Study|Non-compliance with study treatment|2|||
33687331|NCT02474082|63191451|FG000|Overall Study|Protocol deviation|0|||
33687332|NCT02474082|63191452|FG001|Overall Study|Protocol deviation|1|||
33687333|NCT02501928|63191562|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
33687334|NCT02501928|63191563|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
33687335|NCT02501928|63191564|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
33687336|NCT02501928|63191565|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
33687337|NCT02501928|63191566|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
33687338|NCT02501928|63191567|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
33687339|NCT02473614|63191631|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
33687340|NCT02473614|63191632|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
33687341|NCT02500758|63191654|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
33687342|NCT02500758|63191655|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
33687343|NCT02500758|63191654|FG000|Washout (1 Week)|Lost to Follow-up|2|||
33687344|NCT02500758|63191655|FG001|Washout (1 Week)|Lost to Follow-up|2|||
33687345|NCT02500758|63191654|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
33687346|NCT02500758|63191655|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
33687347|NCT02500758|63191654|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
33687348|NCT02500758|63191655|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
33687349|NCT02500758|63191654|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
33687350|NCT02500758|63191655|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
33687351|NCT02500056|63191669|FG000|Overall Study|Lost to Follow-up|3|||
33687352|NCT02500056|63191670|FG001|Overall Study|Lost to Follow-up|7|||
33687353|NCT02500056|63191669|FG000|Overall Study|Recurrence|1|||
33595861|NCT01656395|62994760|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33595862|NCT01656395|62994761|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33595863|NCT01656395|62994762|FG003|Overall Study|Non-Compliance with Study Drug|0|||
33595864|NCT01656395|62994763|FG004|Overall Study|Non-Compliance with Study Drug|1|||
33595865|NCT01656395|62994764|FG005|Overall Study|Non-Compliance with Study Drug|1|||
33595866|NCT01656395|62994765|FG006|Overall Study|Non-Compliance with Study Drug|0|||
33595867|NCT01656395|62994766|FG007|Overall Study|Non-Compliance with Study Drug|0|||
33687354|NCT02500056|63191670|FG001|Overall Study|Recurrence|0|||
33687355|NCT02500056|63191669|FG000|Overall Study|Death|3|||
33687356|NCT02500056|63191670|FG001|Overall Study|Death|1|||
33687357|NCT02472756|63191719|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
33687358|NCT02472756|63191719|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
33687359|NCT02472756|63191719|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
33687360|NCT02472756|63191719|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
33595868|NCT01656395|62994759|FG000|Overall Study|Other|0|||
33595869|NCT01656395|62994760|FG001|Overall Study|Other|0|||
33595870|NCT01656395|62994761|FG002|Overall Study|Other|1|||
33595871|NCT01656395|62994762|FG003|Overall Study|Other|0|||
33595872|NCT01656395|62994763|FG004|Overall Study|Other|0|||
33595873|NCT01656395|62994764|FG005|Overall Study|Other|1|||
33595874|NCT01656395|62994765|FG006|Overall Study|Other|0|||
33687361|NCT02472756|63191719|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
33687362|NCT02498652|63191729|FG000|Overall Study|Protocol Violation|0|||
33687363|NCT02498652|63191730|FG001|Overall Study|Protocol Violation|1|||
33687364|NCT03213158|63191754|FG000|Overall Study|Withdrawal by Subject|1|||
33687365|NCT03213158|63191754|FG000|Overall Study|Physician Decision|2|||
33687366|NCT02498418|63191761|FG000|Overall Study|Lack of Efficacy|0|||
33687367|NCT02498418|63191762|FG001|Overall Study|Lack of Efficacy|0|||
33687368|NCT02498418|63191763|FG002|Overall Study|Lack of Efficacy|1|||
33687369|NCT02498418|63191761|FG000|Overall Study|Withdrawal by Subject|2|||
33687370|NCT02498418|63191762|FG001|Overall Study|Withdrawal by Subject|0|||
33687371|NCT02498418|63191763|FG002|Overall Study|Withdrawal by Subject|3|||
33687372|NCT02498418|63191761|FG000|Overall Study|Lost to Follow-up|0|||
33687373|NCT02498418|63191762|FG001|Overall Study|Lost to Follow-up|1|||
33687374|NCT02498418|63191763|FG002|Overall Study|Lost to Follow-up|1|||
33687375|NCT02498418|63191761|FG000|Overall Study|Participant taken prohibited medication|0|||
33687376|NCT02498418|63191762|FG001|Overall Study|Participant taken prohibited medication|1|||
33687377|NCT02498418|63191763|FG002|Overall Study|Participant taken prohibited medication|1|||
33687378|NCT02472366|63191781|FG000|Overall Study|Lost to Follow-up|1|||
33687379|NCT02472366|63191782|FG001|Overall Study|Lost to Follow-up|0|||
33687380|NCT03219164|63191790|FG000|Overall Study|Study Terminated by Sponsor|16|||
33687381|NCT03219164|63191791|FG001|Overall Study|Study Terminated by Sponsor|12|||
33687382|NCT03219164|63191790|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
33687383|NCT03219164|63191791|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
33687384|NCT03219164|63191790|FG000|Overall Study|Lost to Follow-up|1|||
33687385|NCT03219164|63191791|FG001|Overall Study|Lost to Follow-up|1|||
33687386|NCT03219164|63191790|FG000|Overall Study|Adverse Event|1|||
33687387|NCT03219164|63191791|FG001|Overall Study|Adverse Event|0|||
33687388|NCT03219164|63191790|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33687389|NCT03219164|63191791|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33687390|NCT03219164|63191790|FG000|Overall Study|Protocol Violation|0|||
33687391|NCT03219164|63191791|FG001|Overall Study|Protocol Violation|1|||
33687392|NCT03219164|63191790|FG000|Overall Study|Withdrew Assent|1|||
33687393|NCT03219164|63191791|FG001|Overall Study|Withdrew Assent|0|||
33687394|NCT02471586|63191809|FG000|Overall Study|Lost to Follow-up|3|||
33687395|NCT02471586|63191810|FG001|Overall Study|Lost to Follow-up|8|||
33687396|NCT02471586|63191811|FG002|Overall Study|Lost to Follow-up|4|||
33687397|NCT02471586|63191809|FG000|Overall Study|Death|2|||
33687398|NCT02471586|63191810|FG001|Overall Study|Death|2|||
33687399|NCT02471586|63191811|FG002|Overall Study|Death|0|||
33687400|NCT02470806|63191962|FG000|Overall Study|Lost to Follow-up|1|||
33687401|NCT02470806|63191963|FG001|Overall Study|Lost to Follow-up|1|||
33687402|NCT02470806|63191962|FG000|Overall Study|Adverse Event|5|||
33687403|NCT02470806|63191963|FG001|Overall Study|Adverse Event|2|||
33687404|NCT02470806|63191962|FG000|Overall Study|Protocol Violation|4|||
33687405|NCT02470806|63191963|FG001|Overall Study|Protocol Violation|11|||
33687406|NCT02470806|63191962|FG000|Overall Study|Physician Decision|0|||
33687407|NCT02470806|63191963|FG001|Overall Study|Physician Decision|3|||
33687408|NCT02470806|63191962|FG000|Overall Study|Withdrawal by Subject|3|||
33687409|NCT02470806|63191963|FG001|Overall Study|Withdrawal by Subject|10|||
33687410|NCT02470806|63191962|FG000|Overall Study|Lack of Efficacy|5|||
33687411|NCT02470806|63191963|FG001|Overall Study|Lack of Efficacy|15|||
33687412|NCT01363908|63192005|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
33687413|NCT01363908|63192006|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
33687414|NCT01363908|63192005|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
33687415|NCT01363908|63192006|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
33687416|NCT01363908|63192005|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
33687417|NCT01363908|63192006|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
33687418|NCT01363908|63192005|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
33687419|NCT01363908|63192006|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
33687420|NCT02497404|63192044|FG000|Overall Study|Adverse Event|1|||
33687421|NCT02496702|63192077|FG000|Overall Study|Lost to Follow-up|8|||
33687422|NCT02496702|63192078|FG001|Overall Study|Lost to Follow-up|6|||
33687423|NCT02496702|63192077|FG000|Overall Study|Only partially tested|0|||
33687424|NCT02496702|63192078|FG001|Overall Study|Only partially tested|2|||
33595875|NCT01656395|62994766|FG007|Overall Study|Other|0|||
33595876|NCT01656395|62994759|FG000|Overall Study|Physician Decision|2|||
33595877|NCT01656395|62994760|FG001|Overall Study|Physician Decision|3|||
33687425|NCT02469246|63192154|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
33687426|NCT02469246|63192155|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
33687427|NCT02469246|63192154|FG000|Double-Blind Phase|Adverse Event|12|||
33401438|NCT00256867|62780477|FG003|Overall Study|Lost to Follow-up|3|||
33687428|NCT02469246|63192155|FG001|Double-Blind Phase|Adverse Event|9|||
33687429|NCT02469246|63192154|FG000|Double-Blind Phase|Death|2|||
33595878|NCT01656395|62994761|FG002|Overall Study|Physician Decision|3|||
33595879|NCT01656395|62994762|FG003|Overall Study|Physician Decision|2|||
33595880|NCT01656395|62994763|FG004|Overall Study|Physician Decision|3|||
33595881|NCT01656395|62994764|FG005|Overall Study|Physician Decision|3|||
33595882|NCT01656395|62994765|FG006|Overall Study|Physician Decision|0|||
33595883|NCT01656395|62994766|FG007|Overall Study|Physician Decision|0|||
33595884|NCT01656395|62994759|FG000|Overall Study|Pregnancy|0|||
33595885|NCT01656395|62994760|FG001|Overall Study|Pregnancy|0|||
33687430|NCT02469246|63192155|FG001|Double-Blind Phase|Death|0|||
33687431|NCT02469246|63192154|FG000|Double-Blind Phase|Lack of Efficacy|2|||
33687432|NCT02469246|63192155|FG001|Double-Blind Phase|Lack of Efficacy|1|||
33687433|NCT02469246|63192154|FG000|Double-Blind Phase|Investigator's Discretion|8|||
33687434|NCT02469246|63192155|FG001|Double-Blind Phase|Investigator's Discretion|8|||
33687435|NCT02469246|63192154|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
33687436|NCT02469246|63192155|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
33687437|NCT02469246|63192154|FG000|Double-Blind Phase|Protocol Violation|1|||
33687438|NCT02469246|63192155|FG001|Double-Blind Phase|Protocol Violation|1|||
33687439|NCT02469246|63192154|FG000|Double-Blind Phase|Withdrew Consent|25|||
33687440|NCT02469246|63192155|FG001|Double-Blind Phase|Withdrew Consent|25|||
33687441|NCT02469246|63192154|FG000|Double-Blind Phase|Lost to Follow-up|9|||
33687442|NCT02469246|63192155|FG001|Double-Blind Phase|Lost to Follow-up|5|||
33687443|NCT02469168|63192174|FG000|Overall Study|Trial closed|1|||
33687444|NCT02469168|63192175|FG001|Overall Study|Trial closed|0|||
33687445|NCT02469090|63192183|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
33687446|NCT02469090|63192184|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
33687447|NCT02469090|63192185|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
33687448|NCT02469090|63192183|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
33687449|NCT02469090|63192184|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
33687450|NCT02469090|63192185|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
33687451|NCT02469090|63192183|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
33687452|NCT02469090|63192184|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
33687453|NCT02469090|63192185|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
33687454|NCT02469090|63192183|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
33687455|NCT02469090|63192184|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
33687456|NCT02469090|63192185|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
33687457|NCT02469090|63192183|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
33687458|NCT02469090|63192184|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
33687459|NCT02469090|63192185|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
33687460|NCT02469090|63192183|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
33687461|NCT02469090|63192184|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
33687462|NCT02469090|63192185|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
33687463|NCT02469090|63192183|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
33687464|NCT02469090|63192184|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
33687465|NCT02469090|63192185|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
33687466|NCT02469090|63192183|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
33687467|NCT02469090|63192184|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
33687468|NCT02469090|63192185|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
33687469|NCT02496000|63192195|FG000|Overall Study|Withdrawal by Subject|1|||
33687470|NCT02496000|63192196|FG001|Overall Study|Withdrawal by Subject|2|||
33687471|NCT02496000|63192197|FG002|Overall Study|Withdrawal by Subject|0|||
33687472|NCT02496000|63192195|FG000|Overall Study|Lost to Follow-up|1|||
33687473|NCT02496000|63192196|FG001|Overall Study|Lost to Follow-up|0|||
33687474|NCT02496000|63192197|FG002|Overall Study|Lost to Follow-up|1|||
33687475|NCT02496000|63192195|FG000|Overall Study|Protocol Violation|0|||
33687476|NCT02496000|63192196|FG001|Overall Study|Protocol Violation|0|||
33687477|NCT02496000|63192197|FG002|Overall Study|Protocol Violation|1|||
33687478|NCT02496000|63192195|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
33687479|NCT02496000|63192196|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
33687480|NCT02496000|63192197|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
33687481|NCT02496000|63192195|FG000|Overall Study|undetermined|0|||
33687482|NCT02496000|63192196|FG001|Overall Study|undetermined|1|||
33687483|NCT02496000|63192197|FG002|Overall Study|undetermined|0|||
33595886|NCT01656395|62994761|FG002|Overall Study|Pregnancy|1|||
33595887|NCT01656395|62994762|FG003|Overall Study|Pregnancy|0|||
33595888|NCT01656395|62994763|FG004|Overall Study|Pregnancy|0|||
33595889|NCT01656395|62994764|FG005|Overall Study|Pregnancy|0|||
33595890|NCT01656395|62994765|FG006|Overall Study|Pregnancy|0|||
33595891|NCT01656395|62994766|FG007|Overall Study|Pregnancy|0|||
33595892|NCT01656395|62994759|FG000|Overall Study|Progressive Disease|0|||
33595893|NCT01656395|62994760|FG001|Overall Study|Progressive Disease|0|||
33595894|NCT01656395|62994761|FG002|Overall Study|Progressive Disease|0|||
33595895|NCT01656395|62994762|FG003|Overall Study|Progressive Disease|0|||
33595896|NCT01656395|62994763|FG004|Overall Study|Progressive Disease|0|||
33595897|NCT01656395|62994764|FG005|Overall Study|Progressive Disease|1|||
33595898|NCT01656395|62994765|FG006|Overall Study|Progressive Disease|0|||
33595899|NCT01656395|62994766|FG007|Overall Study|Progressive Disease|0|||
33595900|NCT01656395|62994759|FG000|Overall Study|Protocol Violation|6|||
33595901|NCT01656395|62994760|FG001|Overall Study|Protocol Violation|6|||
33595902|NCT01656395|62994761|FG002|Overall Study|Protocol Violation|9|||
33595903|NCT01656395|62994762|FG003|Overall Study|Protocol Violation|2|||
33595904|NCT01656395|62994763|FG004|Overall Study|Protocol Violation|4|||
33595905|NCT01656395|62994764|FG005|Overall Study|Protocol Violation|10|||
33687484|NCT02468934|63192206|FG000|Overall Study|Withdrawal by Subject|4|||
33687485|NCT02468934|63192206|FG000|Overall Study|Screen Failure|3|||
33687486|NCT02517528|63192212|FG000|Overall Study|Withdrawal by Subject|1|||
33687487|NCT02495844|63192218|FG000|Overall Study|Lack of Efficacy|1|||
33687488|NCT02495844|63192219|FG001|Overall Study|Lack of Efficacy|2|||
33687489|NCT02495844|63192218|FG000|Overall Study|AE, non-fatal|0|||
33687490|NCT02495844|63192219|FG001|Overall Study|AE, non-fatal|1|||
33687491|NCT02495844|63192218|FG000|Overall Study|Hepatitis Positivity|0|||
33687492|NCT02495844|63192219|FG001|Overall Study|Hepatitis Positivity|1|||
33687493|NCT02468778|63192230|FG000|Overall Study|Death|2|||
33687494|NCT02468778|63192231|FG001|Overall Study|Death|1|||
33687495|NCT02468778|63192232|FG002|Overall Study|Death|0|||
33687496|NCT02468778|63192230|FG000|Overall Study|Lost to Follow-up|1|||
33687497|NCT02468778|63192231|FG001|Overall Study|Lost to Follow-up|2|||
33687498|NCT02468778|63192232|FG002|Overall Study|Lost to Follow-up|2|||
33687499|NCT02468778|63192230|FG000|Overall Study|Withdrawal by Subject|0|||
33687500|NCT02468778|63192231|FG001|Overall Study|Withdrawal by Subject|1|||
33687501|NCT02468778|63192232|FG002|Overall Study|Withdrawal by Subject|1|||
33687502|NCT01727336|63192246|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
33687503|NCT01727336|63192247|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
33687504|NCT01727336|63192248|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
33687505|NCT01727336|63192249|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
33687506|NCT01727336|63192250|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
33687507|NCT01727336|63192251|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
33687508|NCT01727336|63192246|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
33687509|NCT01727336|63192247|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
33687510|NCT01727336|63192248|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
33687511|NCT01727336|63192249|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
33687512|NCT01727336|63192250|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
33687513|NCT01727336|63192251|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
33687514|NCT01727336|63192246|FG000|Part 2 Blinded|Death|0|||
33687515|NCT01727336|63192247|FG001|Part 2 Blinded|Death|0|||
33687516|NCT01727336|63192248|FG002|Part 2 Blinded|Death|0|||
33687517|NCT01727336|63192249|FG003|Part 2 Blinded|Death|0|||
33687518|NCT01727336|63192250|FG004|Part 2 Blinded|Death|20|||
33687519|NCT01727336|63192251|FG005|Part 2 Blinded|Death|16|||
33687520|NCT01727336|63192246|FG000|Part 2 Blinded|Lack of Efficacy|0|||
33687521|NCT01727336|63192247|FG001|Part 2 Blinded|Lack of Efficacy|0|||
33687522|NCT01727336|63192248|FG002|Part 2 Blinded|Lack of Efficacy|0|||
33687523|NCT01727336|63192249|FG003|Part 2 Blinded|Lack of Efficacy|0|||
33687524|NCT01727336|63192250|FG004|Part 2 Blinded|Lack of Efficacy|42|||
33687525|NCT01727336|63192251|FG005|Part 2 Blinded|Lack of Efficacy|44|||
33687526|NCT01727336|63192246|FG000|Part 2 Blinded|Lost to Follow-up|0|||
33687527|NCT01727336|63192247|FG001|Part 2 Blinded|Lost to Follow-up|0|||
33687528|NCT01727336|63192248|FG002|Part 2 Blinded|Lost to Follow-up|0|||
33687529|NCT01727336|63192249|FG003|Part 2 Blinded|Lost to Follow-up|0|||
33687530|NCT01727336|63192250|FG004|Part 2 Blinded|Lost to Follow-up|0|||
33687531|NCT01727336|63192251|FG005|Part 2 Blinded|Lost to Follow-up|1|||
33687532|NCT01727336|63192246|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
33687533|NCT01727336|63192247|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
33687534|NCT01727336|63192248|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
33687535|NCT01727336|63192249|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
33687536|NCT01727336|63192250|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
33687537|NCT01727336|63192251|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
33687538|NCT01727336|63192246|FG000|Part 2 Blinded|use of prohibited medications|0|||
33687539|NCT01727336|63192247|FG001|Part 2 Blinded|use of prohibited medications|0|||
33687540|NCT01727336|63192248|FG002|Part 2 Blinded|use of prohibited medications|0|||
33687541|NCT01727336|63192249|FG003|Part 2 Blinded|use of prohibited medications|0|||
33687542|NCT01727336|63192250|FG004|Part 2 Blinded|use of prohibited medications|1|||
33687543|NCT01727336|63192251|FG005|Part 2 Blinded|use of prohibited medications|3|||
33687544|NCT02466516|63192285|FG000|Overall Study|Adverse Event|1|||
33687545|NCT02466516|63192286|FG001|Overall Study|Adverse Event|1|||
33687546|NCT02466516|63192287|FG002|Overall Study|Adverse Event|0|||
33687547|NCT02466516|63192288|FG003|Overall Study|Adverse Event|0|||
33687548|NCT02466516|63192289|FG004|Overall Study|Adverse Event|0|||
33687549|NCT02466516|63192285|FG000|Overall Study|Withdrew Consent|1|||
33687550|NCT02466516|63192286|FG001|Overall Study|Withdrew Consent|0|||
33687551|NCT02466516|63192287|FG002|Overall Study|Withdrew Consent|0|||
33687552|NCT02466516|63192288|FG003|Overall Study|Withdrew Consent|0|||
33687553|NCT02466516|63192289|FG004|Overall Study|Withdrew Consent|0|||
33687554|NCT02466516|63192285|FG000|Overall Study|Lost to Follow-up|2|||
33687555|NCT02466516|63192286|FG001|Overall Study|Lost to Follow-up|0|||
33687556|NCT02466516|63192287|FG002|Overall Study|Lost to Follow-up|1|||
33687557|NCT02466516|63192288|FG003|Overall Study|Lost to Follow-up|0|||
33687558|NCT02466516|63192289|FG004|Overall Study|Lost to Follow-up|0|||
33687559|NCT01725152|63192303|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
33687560|NCT01725152|63192304|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
33687561|NCT01725152|63192303|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
33687562|NCT01725152|63192304|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
33687563|NCT01725152|63192303|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
33687564|NCT01725152|63192304|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
33687565|NCT01725152|63192303|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
33687566|NCT01725152|63192304|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
33687567|NCT01049984|63192320|FG000|Overall Study|Withdrawal by Subject|1|||
33687568|NCT01049984|63192321|FG001|Overall Study|Withdrawal by Subject|5|||
33687569|NCT01049984|63192320|FG000|Overall Study|Protocol Violation|3|||
33687570|NCT01049984|63192321|FG001|Overall Study|Protocol Violation|4|||
33687571|NCT01049984|63192320|FG000|Overall Study|Lost to Follow-up|2|||
33687572|NCT01049984|63192321|FG001|Overall Study|Lost to Follow-up|1|||
33687573|NCT01049984|63192320|FG000|Overall Study|Adverse Event|13|||
33687574|NCT01049984|63192321|FG001|Overall Study|Adverse Event|7|||
33687575|NCT01049984|63192320|FG000|Overall Study|Treatment failure|0|||
33687576|NCT01049984|63192321|FG001|Overall Study|Treatment failure|2|||
33687577|NCT01049360|63192327|FG000|Period 1|Adverse Event|0|||
33687578|NCT01049360|63192328|FG001|Period 1|Adverse Event|1|||
33687579|NCT01049360|63192329|FG002|Period 1|Adverse Event|0|||
33687580|NCT01049360|63192330|FG003|Period 1|Adverse Event|1|||
33687581|NCT01049360|63192331|FG004|Period 1|Adverse Event|0|||
33687582|NCT01049360|63192332|FG005|Period 1|Adverse Event|0|||
33687583|NCT01049360|63192333|FG006|Period 1|Adverse Event|0|||
33687584|NCT01049360|63192334|FG007|Period 1|Adverse Event|1|||
33687585|NCT01049360|63192335|FG008|Period 1|Adverse Event|0|||
33687586|NCT01049360|63192336|FG009|Period 1|Adverse Event|0|||
33687587|NCT01049360|63192337|FG010|Period 1|Adverse Event|0|||
33687588|NCT01049360|63192338|FG011|Period 1|Adverse Event|0|||
33687589|NCT01049360|63192339|FG012|Period 1|Adverse Event|1|||
33687590|NCT01049360|63192340|FG013|Period 1|Adverse Event|1|||
33687591|NCT01049360|63192341|FG014|Period 1|Adverse Event|0|||
33687592|NCT01049360|63192342|FG015|Period 1|Adverse Event|0|||
33687593|NCT01049360|63192343|FG016|Period 1|Adverse Event|1|||
33687594|NCT01049360|63192344|FG017|Period 1|Adverse Event|0|||
33687595|NCT01049360|63192345|FG018|Period 1|Adverse Event|1|||
33687596|NCT01049360|63192346|FG019|Period 1|Adverse Event|0|||
33687597|NCT01049360|63192327|FG000|Period 1|Did not meet inc/exc criteria|0|||
33687598|NCT01049360|63192328|FG001|Period 1|Did not meet inc/exc criteria|0|||
33687599|NCT01049360|63192329|FG002|Period 1|Did not meet inc/exc criteria|0|||
33687600|NCT01049360|63192330|FG003|Period 1|Did not meet inc/exc criteria|0|||
33687601|NCT01049360|63192331|FG004|Period 1|Did not meet inc/exc criteria|0|||
33687602|NCT01049360|63192332|FG005|Period 1|Did not meet inc/exc criteria|0|||
33687603|NCT01049360|63192333|FG006|Period 1|Did not meet inc/exc criteria|0|||
33687604|NCT01049360|63192334|FG007|Period 1|Did not meet inc/exc criteria|1|||
33687605|NCT01049360|63192335|FG008|Period 1|Did not meet inc/exc criteria|1|||
33687606|NCT01049360|63192336|FG009|Period 1|Did not meet inc/exc criteria|0|||
33687607|NCT01049360|63192337|FG010|Period 1|Did not meet inc/exc criteria|0|||
33687608|NCT01049360|63192338|FG011|Period 1|Did not meet inc/exc criteria|0|||
33687609|NCT01049360|63192339|FG012|Period 1|Did not meet inc/exc criteria|0|||
33687610|NCT01049360|63192340|FG013|Period 1|Did not meet inc/exc criteria|0|||
33687611|NCT01049360|63192341|FG014|Period 1|Did not meet inc/exc criteria|0|||
33687612|NCT01049360|63192342|FG015|Period 1|Did not meet inc/exc criteria|0|||
33687613|NCT01049360|63192343|FG016|Period 1|Did not meet inc/exc criteria|0|||
33687614|NCT01049360|63192344|FG017|Period 1|Did not meet inc/exc criteria|0|||
33687615|NCT01049360|63192345|FG018|Period 1|Did not meet inc/exc criteria|0|||
33687616|NCT01049360|63192346|FG019|Period 1|Did not meet inc/exc criteria|0|||
33687617|NCT01049360|63192327|FG000|Period 1|Withdrawal by Subject|0|||
33687618|NCT01049360|63192328|FG001|Period 1|Withdrawal by Subject|0|||
33687619|NCT01049360|63192329|FG002|Period 1|Withdrawal by Subject|0|||
33687620|NCT01049360|63192330|FG003|Period 1|Withdrawal by Subject|0|||
33687621|NCT01049360|63192331|FG004|Period 1|Withdrawal by Subject|0|||
33687622|NCT01049360|63192332|FG005|Period 1|Withdrawal by Subject|0|||
33687623|NCT01049360|63192333|FG006|Period 1|Withdrawal by Subject|0|||
33687624|NCT01049360|63192334|FG007|Period 1|Withdrawal by Subject|0|||
33687625|NCT01049360|63192335|FG008|Period 1|Withdrawal by Subject|1|||
33687626|NCT01049360|63192336|FG009|Period 1|Withdrawal by Subject|0|||
33687627|NCT01049360|63192337|FG010|Period 1|Withdrawal by Subject|1|||
33687628|NCT01049360|63192338|FG011|Period 1|Withdrawal by Subject|0|||
33687629|NCT01049360|63192339|FG012|Period 1|Withdrawal by Subject|1|||
33687630|NCT01049360|63192340|FG013|Period 1|Withdrawal by Subject|0|||
33687631|NCT01049360|63192341|FG014|Period 1|Withdrawal by Subject|0|||
33595906|NCT01656395|62994765|FG006|Overall Study|Protocol Violation|0|||
33687632|NCT01049360|63192342|FG015|Period 1|Withdrawal by Subject|0|||
33687633|NCT01049360|63192343|FG016|Period 1|Withdrawal by Subject|0|||
33687634|NCT01049360|63192344|FG017|Period 1|Withdrawal by Subject|0|||
33687635|NCT01049360|63192345|FG018|Period 1|Withdrawal by Subject|0|||
33687636|NCT01049360|63192346|FG019|Period 1|Withdrawal by Subject|0|||
33687637|NCT01049360|63192327|FG000|Period 2|Protocol Violation|0|||
33687638|NCT01049360|63192328|FG001|Period 2|Protocol Violation|0|||
33687639|NCT01049360|63192329|FG002|Period 2|Protocol Violation|0|||
33687640|NCT01049360|63192330|FG003|Period 2|Protocol Violation|1|||
33687641|NCT01049360|63192331|FG004|Period 2|Protocol Violation|0|||
33687642|NCT01049360|63192332|FG005|Period 2|Protocol Violation|0|||
33687643|NCT01049360|63192333|FG006|Period 2|Protocol Violation|0|||
33687644|NCT01049360|63192334|FG007|Period 2|Protocol Violation|0|||
33687645|NCT01049360|63192335|FG008|Period 2|Protocol Violation|0|||
33687646|NCT01049360|63192336|FG009|Period 2|Protocol Violation|0|||
33687647|NCT01049360|63192337|FG010|Period 2|Protocol Violation|0|||
33687648|NCT01049360|63192338|FG011|Period 2|Protocol Violation|0|||
33687649|NCT01049360|63192339|FG012|Period 2|Protocol Violation|0|||
33687650|NCT01049360|63192340|FG013|Period 2|Protocol Violation|0|||
33687651|NCT01049360|63192341|FG014|Period 2|Protocol Violation|1|||
33687652|NCT01049360|63192342|FG015|Period 2|Protocol Violation|1|||
33687653|NCT01049360|63192343|FG016|Period 2|Protocol Violation|0|||
33687654|NCT01049360|63192344|FG017|Period 2|Protocol Violation|0|||
33687655|NCT01049360|63192345|FG018|Period 2|Protocol Violation|0|||
33687656|NCT01049360|63192346|FG019|Period 2|Protocol Violation|0|||
33687657|NCT01049360|63192327|FG000|Period 2|Adverse Event|0|||
33687658|NCT01049360|63192328|FG001|Period 2|Adverse Event|1|||
33687659|NCT01049360|63192329|FG002|Period 2|Adverse Event|0|||
33687660|NCT01049360|63192330|FG003|Period 2|Adverse Event|0|||
33687661|NCT01049360|63192331|FG004|Period 2|Adverse Event|0|||
33687662|NCT01049360|63192332|FG005|Period 2|Adverse Event|0|||
33687663|NCT01049360|63192333|FG006|Period 2|Adverse Event|0|||
33687664|NCT01049360|63192334|FG007|Period 2|Adverse Event|0|||
33687665|NCT01049360|63192335|FG008|Period 2|Adverse Event|1|||
33687666|NCT01049360|63192336|FG009|Period 2|Adverse Event|0|||
33687667|NCT01049360|63192337|FG010|Period 2|Adverse Event|0|||
33687668|NCT01049360|63192338|FG011|Period 2|Adverse Event|0|||
33687669|NCT01049360|63192339|FG012|Period 2|Adverse Event|0|||
33687670|NCT01049360|63192340|FG013|Period 2|Adverse Event|0|||
33687671|NCT01049360|63192341|FG014|Period 2|Adverse Event|0|||
33687672|NCT01049360|63192342|FG015|Period 2|Adverse Event|0|||
33687673|NCT01049360|63192343|FG016|Period 2|Adverse Event|0|||
33687674|NCT01049360|63192344|FG017|Period 2|Adverse Event|0|||
33687675|NCT01049360|63192345|FG018|Period 2|Adverse Event|0|||
33687676|NCT01049360|63192346|FG019|Period 2|Adverse Event|1|||
33687677|NCT01049360|63192327|FG000|Period 2|Withdrawal by Subject|0|||
33687678|NCT01049360|63192328|FG001|Period 2|Withdrawal by Subject|0|||
33687679|NCT01049360|63192329|FG002|Period 2|Withdrawal by Subject|0|||
33687680|NCT01049360|63192330|FG003|Period 2|Withdrawal by Subject|1|||
33687681|NCT01049360|63192331|FG004|Period 2|Withdrawal by Subject|0|||
33687682|NCT01049360|63192332|FG005|Period 2|Withdrawal by Subject|0|||
33687683|NCT01049360|63192333|FG006|Period 2|Withdrawal by Subject|0|||
33687684|NCT01049360|63192334|FG007|Period 2|Withdrawal by Subject|0|||
33687685|NCT01049360|63192335|FG008|Period 2|Withdrawal by Subject|0|||
33687686|NCT01049360|63192336|FG009|Period 2|Withdrawal by Subject|0|||
33687687|NCT01049360|63192337|FG010|Period 2|Withdrawal by Subject|0|||
33687688|NCT01049360|63192338|FG011|Period 2|Withdrawal by Subject|0|||
33687689|NCT01049360|63192339|FG012|Period 2|Withdrawal by Subject|0|||
33687690|NCT01049360|63192340|FG013|Period 2|Withdrawal by Subject|0|||
33687691|NCT01049360|63192341|FG014|Period 2|Withdrawal by Subject|1|||
33687692|NCT01049360|63192342|FG015|Period 2|Withdrawal by Subject|0|||
33687693|NCT01049360|63192343|FG016|Period 2|Withdrawal by Subject|0|||
33687694|NCT01049360|63192344|FG017|Period 2|Withdrawal by Subject|0|||
33687695|NCT01049360|63192345|FG018|Period 2|Withdrawal by Subject|0|||
33687696|NCT01049360|63192346|FG019|Period 2|Withdrawal by Subject|1|||
33687697|NCT01049360|63192327|FG000|Period 2|Lack of Efficacy|0|||
33687698|NCT01049360|63192328|FG001|Period 2|Lack of Efficacy|0|||
33687699|NCT01049360|63192329|FG002|Period 2|Lack of Efficacy|0|||
33687700|NCT01049360|63192330|FG003|Period 2|Lack of Efficacy|0|||
33687701|NCT01049360|63192331|FG004|Period 2|Lack of Efficacy|0|||
33595907|NCT01656395|62994766|FG007|Overall Study|Protocol Violation|0|||
33595908|NCT01656395|62994759|FG000|Overall Study|Screen Failure|2|||
33595909|NCT01656395|62994760|FG001|Overall Study|Screen Failure|1|||
33595910|NCT01656395|62994761|FG002|Overall Study|Screen Failure|7|||
33595911|NCT01656395|62994762|FG003|Overall Study|Screen Failure|1|||
33595912|NCT01656395|62994763|FG004|Overall Study|Screen Failure|0|||
33595913|NCT01656395|62994764|FG005|Overall Study|Screen Failure|8|||
33595914|NCT01656395|62994765|FG006|Overall Study|Screen Failure|0|||
33687702|NCT01049360|63192332|FG005|Period 2|Lack of Efficacy|1|||
33687703|NCT01049360|63192333|FG006|Period 2|Lack of Efficacy|0|||
33687704|NCT01049360|63192334|FG007|Period 2|Lack of Efficacy|0|||
33687705|NCT01049360|63192335|FG008|Period 2|Lack of Efficacy|0|||
33687706|NCT01049360|63192336|FG009|Period 2|Lack of Efficacy|0|||
33687707|NCT01049360|63192337|FG010|Period 2|Lack of Efficacy|0|||
33687708|NCT01049360|63192338|FG011|Period 2|Lack of Efficacy|0|||
33687709|NCT01049360|63192339|FG012|Period 2|Lack of Efficacy|0|||
33687710|NCT01049360|63192340|FG013|Period 2|Lack of Efficacy|0|||
33687711|NCT01049360|63192341|FG014|Period 2|Lack of Efficacy|0|||
33687712|NCT01049360|63192342|FG015|Period 2|Lack of Efficacy|0|||
33687713|NCT01049360|63192343|FG016|Period 2|Lack of Efficacy|0|||
33687714|NCT01049360|63192344|FG017|Period 2|Lack of Efficacy|0|||
33687715|NCT01049360|63192345|FG018|Period 2|Lack of Efficacy|0|||
33687716|NCT01049360|63192346|FG019|Period 2|Lack of Efficacy|0|||
33687717|NCT01049360|63192327|FG000|Period 4|Protocol Violation|0|||
33687718|NCT01049360|63192328|FG001|Period 4|Protocol Violation|0|||
33687719|NCT01049360|63192329|FG002|Period 4|Protocol Violation|0|||
33687720|NCT01049360|63192330|FG003|Period 4|Protocol Violation|0|||
33687721|NCT01049360|63192331|FG004|Period 4|Protocol Violation|0|||
33687722|NCT01049360|63192332|FG005|Period 4|Protocol Violation|0|||
33687723|NCT01049360|63192333|FG006|Period 4|Protocol Violation|0|||
33687724|NCT01049360|63192334|FG007|Period 4|Protocol Violation|0|||
33687725|NCT01049360|63192335|FG008|Period 4|Protocol Violation|0|||
33687726|NCT01049360|63192336|FG009|Period 4|Protocol Violation|0|||
33687727|NCT01049360|63192337|FG010|Period 4|Protocol Violation|0|||
33687728|NCT01049360|63192338|FG011|Period 4|Protocol Violation|0|||
33687729|NCT01049360|63192339|FG012|Period 4|Protocol Violation|0|||
33687730|NCT01049360|63192340|FG013|Period 4|Protocol Violation|0|||
33687731|NCT01049360|63192341|FG014|Period 4|Protocol Violation|0|||
33687732|NCT01049360|63192342|FG015|Period 4|Protocol Violation|0|||
33687733|NCT01049360|63192343|FG016|Period 4|Protocol Violation|0|||
33687734|NCT01049360|63192344|FG017|Period 4|Protocol Violation|1|||
33687735|NCT01049360|63192345|FG018|Period 4|Protocol Violation|0|||
33687736|NCT01049360|63192346|FG019|Period 4|Protocol Violation|0|||
33687737|NCT01049360|63192327|FG000|Period 4|Withdrawal by Subject|0|||
33687738|NCT01049360|63192328|FG001|Period 4|Withdrawal by Subject|0|||
33687739|NCT01049360|63192329|FG002|Period 4|Withdrawal by Subject|0|||
33687740|NCT01049360|63192330|FG003|Period 4|Withdrawal by Subject|1|||
33687741|NCT01049360|63192331|FG004|Period 4|Withdrawal by Subject|0|||
33687742|NCT01049360|63192332|FG005|Period 4|Withdrawal by Subject|0|||
33687743|NCT01049360|63192333|FG006|Period 4|Withdrawal by Subject|0|||
33687744|NCT01049360|63192334|FG007|Period 4|Withdrawal by Subject|0|||
33687745|NCT01049360|63192335|FG008|Period 4|Withdrawal by Subject|0|||
33687746|NCT01049360|63192336|FG009|Period 4|Withdrawal by Subject|0|||
33687747|NCT01049360|63192337|FG010|Period 4|Withdrawal by Subject|0|||
33687748|NCT01049360|63192338|FG011|Period 4|Withdrawal by Subject|0|||
33687749|NCT01049360|63192339|FG012|Period 4|Withdrawal by Subject|0|||
33687750|NCT01049360|63192340|FG013|Period 4|Withdrawal by Subject|0|||
33687751|NCT01049360|63192341|FG014|Period 4|Withdrawal by Subject|0|||
33687752|NCT01049360|63192342|FG015|Period 4|Withdrawal by Subject|0|||
33687753|NCT01049360|63192343|FG016|Period 4|Withdrawal by Subject|0|||
33687754|NCT01049360|63192344|FG017|Period 4|Withdrawal by Subject|0|||
33687755|NCT01049360|63192345|FG018|Period 4|Withdrawal by Subject|0|||
33687756|NCT01049360|63192346|FG019|Period 4|Withdrawal by Subject|0|||
33687757|NCT02494596|63192358|FG000|Overall Study|Insufficient Therapeutic Response|3|||
33687758|NCT02494596|63192359|FG001|Overall Study|Insufficient Therapeutic Response|3|||
33687759|NCT02494596|63192360|FG002|Overall Study|Insufficient Therapeutic Response|1|||
33687760|NCT02494596|63192358|FG000|Overall Study|Adverse Event|0|||
33687761|NCT02494596|63192359|FG001|Overall Study|Adverse Event|1|||
33687762|NCT02494596|63192360|FG002|Overall Study|Adverse Event|0|||
33687763|NCT02494596|63192358|FG000|Overall Study|Refused Treatment|0|||
33687764|NCT02494596|63192359|FG001|Overall Study|Refused Treatment|1|||
33687765|NCT02494596|63192360|FG002|Overall Study|Refused Treatment|0|||
33687766|NCT02494206|63192379|FG000|Overall Study|Adverse Event|1|||
33687767|NCT02494206|63192379|FG000|Overall Study|Disease Progression|1|||
33687768|NCT01048502|63192396|FG000|Overall Study|Lost to Follow-up|2|||
33687769|NCT01048502|63192397|FG001|Overall Study|Lost to Follow-up|0|||
33595915|NCT01656395|62994766|FG007|Overall Study|Screen Failure|0|||
33595916|NCT01656395|62994759|FG000|Overall Study|Withdrawal by Subject|3|||
33595917|NCT01656395|62994760|FG001|Overall Study|Withdrawal by Subject|1|||
33595918|NCT01656395|62994761|FG002|Overall Study|Withdrawal by Subject|4|||
33595919|NCT01656395|62994762|FG003|Overall Study|Withdrawal by Subject|2|||
33595920|NCT01656395|62994763|FG004|Overall Study|Withdrawal by Subject|0|||
33595921|NCT01656395|62994764|FG005|Overall Study|Withdrawal by Subject|3|||
33595922|NCT01656395|62994765|FG006|Overall Study|Withdrawal by Subject|0|||
33595923|NCT01656395|62994766|FG007|Overall Study|Withdrawal by Subject|0|||
33595924|NCT02114931|62994782|FG000|Overall Study|Withdrawal by Subject|15|||
33595925|NCT02114931|62994783|FG001|Overall Study|Withdrawal by Subject|18|||
33595926|NCT02114931|62994782|FG000|Overall Study|Adverse Event|4|||
33595927|NCT02114931|62994783|FG001|Overall Study|Adverse Event|6|||
33687770|NCT01048502|63192398|FG002|Overall Study|Lost to Follow-up|0|||
33687771|NCT01048502|63192399|FG003|Overall Study|Lost to Follow-up|0|||
33687772|NCT01048502|63192396|FG000|Overall Study|Adverse Event|1|||
33687773|NCT01048502|63192397|FG001|Overall Study|Adverse Event|0|||
33687774|NCT01048502|63192398|FG002|Overall Study|Adverse Event|0|||
33687775|NCT01048502|63192399|FG003|Overall Study|Adverse Event|0|||
33687776|NCT01048502|63192396|FG000|Overall Study|Withdrawal by Subject|1|||
33687777|NCT01048502|63192397|FG001|Overall Study|Withdrawal by Subject|4|||
33687778|NCT01048502|63192398|FG002|Overall Study|Withdrawal by Subject|5|||
33687779|NCT01048502|63192399|FG003|Overall Study|Withdrawal by Subject|3|||
33687780|NCT01048502|63192396|FG000|Overall Study|Physician Decision|0|||
33687781|NCT01048502|63192397|FG001|Overall Study|Physician Decision|3|||
33687782|NCT01048502|63192398|FG002|Overall Study|Physician Decision|0|||
33687783|NCT01048502|63192399|FG003|Overall Study|Physician Decision|1|||
33687784|NCT02465034|63192412|FG000|Overall Study|Withdrawal by Subject|1|||
33687785|NCT02465034|63192413|FG001|Overall Study|Withdrawal by Subject|1|||
33687786|NCT02465034|63192412|FG000|Overall Study|Screen fail|2|||
33687787|NCT02465034|63192413|FG001|Overall Study|Screen fail|0|||
33687788|NCT02465034|63192412|FG000|Overall Study|Could not be scheduled for study visit|0|||
33687789|NCT02465034|63192413|FG001|Overall Study|Could not be scheduled for study visit|5|||
33687790|NCT02516982|63192440|FG000|Overall Study|Called in to antenatal appointment|32|||
33687791|NCT02516982|63192441|FG001|Overall Study|Called in to antenatal appointment|35|||
33687792|NCT02516982|63192442|FG002|Overall Study|Called in to antenatal appointment|0|||
33687793|NCT02516982|63192443|FG003|Overall Study|Called in to antenatal appointment|0|||
33687794|NCT02516982|63192440|FG000|Overall Study|Withdrawal by Subject|0|||
33687795|NCT02516982|63192441|FG001|Overall Study|Withdrawal by Subject|0|||
33687796|NCT02516982|63192442|FG002|Overall Study|Withdrawal by Subject|1|||
33687797|NCT02516982|63192443|FG003|Overall Study|Withdrawal by Subject|2|||
33687798|NCT02516982|63192440|FG000|Overall Study|Protocol Violation|0|||
33687799|NCT02516982|63192441|FG001|Overall Study|Protocol Violation|0|||
33687800|NCT02516982|63192442|FG002|Overall Study|Protocol Violation|1|||
33687801|NCT02516982|63192443|FG003|Overall Study|Protocol Violation|1|||
33687802|NCT02516982|63192440|FG000|Overall Study|Did not install the app|0|||
33687803|NCT02516982|63192441|FG001|Overall Study|Did not install the app|0|||
33687804|NCT02516982|63192442|FG002|Overall Study|Did not install the app|46|||
33687805|NCT02516982|63192443|FG003|Overall Study|Did not install the app|47|||
33687806|NCT02464410|63192488|FG000|Overall Study|Death|3|||
33687807|NCT02464410|63192489|FG001|Overall Study|Death|4|||
33687808|NCT02464410|63192488|FG000|Overall Study|Lost to Follow-up|7|||
33687809|NCT02464410|63192489|FG001|Overall Study|Lost to Follow-up|9|||
33687810|NCT02464410|63192488|FG000|Overall Study|Withdrawal by Subject|12|||
33687811|NCT02464410|63192489|FG001|Overall Study|Withdrawal by Subject|3|||
33687812|NCT01047332|63192497|FG000|Overall Study|SEMS Obstruction|11|||
33687813|NCT01047332|63192498|FG001|Overall Study|SEMS Obstruction|20|||
33687814|NCT01047332|63192497|FG000|Overall Study|Died Unobstructed|38|||
33687815|NCT01047332|63192498|FG001|Overall Study|Died Unobstructed|41|||
33687816|NCT01047332|63192497|FG000|Overall Study|Lost to Follow-up|8|||
33687817|NCT01047332|63192498|FG001|Overall Study|Lost to Follow-up|3|||
33687818|NCT01046396|63192504|FG000|Overall Study|Withdrawal by Subject|5|||
33687819|NCT01046084|63192530|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
33687820|NCT01046084|63192531|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
33687821|NCT01045694|63192550|FG000|Overall Study|Withdrawal by Subject|2|||
33687822|NCT01044290|63192610|FG000|Follow-up 1|Death|3|||
33687823|NCT01044290|63192611|FG001|Follow-up 1|Death|3|||
33687824|NCT01044290|63192612|FG002|Follow-up 1|Death|1|||
33687825|NCT01044290|63192610|FG000|Follow-up 1|Withdrawal by Subject|2|||
33687826|NCT01044290|63192611|FG001|Follow-up 1|Withdrawal by Subject|2|||
33687827|NCT01044290|63192612|FG002|Follow-up 1|Withdrawal by Subject|0|||
33687828|NCT01044290|63192610|FG000|Follow-Up 2|Death|0|||
33687829|NCT01044290|63192611|FG001|Follow-Up 2|Death|1|||
33687830|NCT01044290|63192612|FG002|Follow-Up 2|Death|1|||
33687831|NCT01044290|63192610|FG000|Follow-Up 2|Withdrawal by Subject|0|||
33687832|NCT01044290|63192611|FG001|Follow-Up 2|Withdrawal by Subject|1|||
33687833|NCT01044290|63192612|FG002|Follow-Up 2|Withdrawal by Subject|1|||
33687834|NCT01041638|63192693|FG000|Overall Study|Adverse Event|4|||
33687835|NCT01041638|63192693|FG000|Overall Study|Death|1|||
33687836|NCT01041638|63192693|FG000|Overall Study|Lack of Efficacy|7|||
33687837|NCT01041638|63192693|FG000|Overall Study|Physician Decision|4|||
33687838|NCT01041638|63192693|FG000|Overall Study|Withdrawal by Subject|11|||
33687839|NCT01045460|63192717|FG000|Overall Study|Physician Decision|3|||
33687840|NCT01045460|63192718|FG001|Overall Study|Physician Decision|2|||
33687841|NCT01045460|63192717|FG000|Overall Study|Lost to Follow-up|0|||
33595928|NCT02114931|62994782|FG000|Overall Study|Lost to Follow-up|3|||
33595929|NCT02114931|62994783|FG001|Overall Study|Lost to Follow-up|3|||
33595930|NCT02114931|62994782|FG000|Overall Study|Physician Decision|1|||
33595931|NCT02114931|62994783|FG001|Overall Study|Physician Decision|2|||
33595932|NCT02114931|62994782|FG000|Overall Study|Other|2|||
33595933|NCT02114931|62994783|FG001|Overall Study|Other|1|||
33595934|NCT01657019|62994789|FG000|Overall Study|Withdrawal by Subject|65|||
33595935|NCT01657019|62994789|FG000|Overall Study|Adverse Event|55|||
33595936|NCT01657019|62994789|FG000|Overall Study|Lost to Follow-up|48|||
33595937|NCT01657019|62994789|FG000|Overall Study|Protocol Violation|6|||
33595938|NCT01657019|62994789|FG000|Overall Study|Lack of Efficacy|3|||
33595939|NCT01657019|62994789|FG000|Overall Study|Other|58|||
33595940|NCT02329327|62994795|FG000|Overall Study|Death|78|||
33595941|NCT02329327|62994796|FG001|Overall Study|Death|0|||
33595942|NCT02329327|62994795|FG000|Overall Study|Withdrawal by Subject|3|||
33595943|NCT02329327|62994796|FG001|Overall Study|Withdrawal by Subject|0|||
33595944|NCT02329327|62994795|FG000|Overall Study|Lost to Follow-up|4|||
33595945|NCT02329327|62994796|FG001|Overall Study|Lost to Follow-up|0|||
33595946|NCT02328937|62994815|FG000|Period 1|Lost to Follow-up|0|||
33595947|NCT02328937|62994816|FG001|Period 1|Lost to Follow-up|0|||
33595948|NCT02328937|62994817|FG002|Period 1|Lost to Follow-up|0|||
33595949|NCT02328937|62994818|FG003|Period 1|Lost to Follow-up|1|||
33595950|NCT02328937|62994819|FG004|Period 1|Lost to Follow-up|0|||
33595951|NCT02328937|62994820|FG005|Period 1|Lost to Follow-up|0|||
33595952|NCT02328937|62994815|FG000|Period 2|Adverse Event|0|||
33595953|NCT02328937|62994816|FG001|Period 2|Adverse Event|0|||
33687842|NCT01045460|63192718|FG001|Overall Study|Lost to Follow-up|1|||
33687843|NCT01045460|63192717|FG000|Overall Study|Lack of Efficacy|3|||
33687844|NCT01045460|63192718|FG001|Overall Study|Lack of Efficacy|0|||
33687845|NCT05014919|63192729|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
33687846|NCT05014919|63192730|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
33687847|NCT05014919|63192731|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
33687848|NCT05014919|63192729|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
33687849|NCT05014919|63192730|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
33687850|NCT05014919|63192731|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
33687851|NCT05014919|63192729|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
33687852|NCT05014919|63192730|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
33687853|NCT05014919|63192731|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
33687854|NCT05014919|63192729|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
33687855|NCT05014919|63192730|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
33687856|NCT05014919|63192731|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
33687857|NCT05014919|63192729|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
33687858|NCT05014919|63192730|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
33687859|NCT05014919|63192731|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
33687860|NCT05014919|63192729|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
33687861|NCT05014919|63192730|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
33687862|NCT05014919|63192731|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
33687863|NCT05014919|63192729|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
33687864|NCT05014919|63192730|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
33687865|NCT05014919|63192731|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
33687866|NCT05014919|63192729|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
33687867|NCT05014919|63192730|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
33687868|NCT05014919|63192731|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
33687869|NCT03409796|63192774|FG000|Overall Study|Adverse Event|2|||
33687870|NCT03409796|63192775|FG001|Overall Study|Adverse Event|0|||
33687871|NCT03409796|63192774|FG000|Overall Study|Other|0|||
33687872|NCT03409796|63192775|FG001|Overall Study|Other|1|||
33687873|NCT02462928|63192784|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
33687874|NCT02462928|63192785|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
33687875|NCT02462928|63192786|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
33687876|NCT02462928|63192784|FG000|Overall Study|Adverse Event|47|||
33687877|NCT02462928|63192785|FG001|Overall Study|Adverse Event|51|||
33687878|NCT02462928|63192786|FG002|Overall Study|Adverse Event|25|||
33687879|NCT02462928|63192784|FG000|Overall Study|Lack of Efficacy|3|||
33687880|NCT02462928|63192785|FG001|Overall Study|Lack of Efficacy|8|||
33687881|NCT02462928|63192786|FG002|Overall Study|Lack of Efficacy|3|||
33687882|NCT02462928|63192784|FG000|Overall Study|Lost to Follow-up|4|||
33687883|NCT02462928|63192785|FG001|Overall Study|Lost to Follow-up|4|||
33687884|NCT02462928|63192786|FG002|Overall Study|Lost to Follow-up|1|||
33687885|NCT02462928|63192784|FG000|Overall Study|Withdrawal by Patient|31|||
33687886|NCT02462928|63192785|FG001|Overall Study|Withdrawal by Patient|21|||
33687887|NCT02462928|63192786|FG002|Overall Study|Withdrawal by Patient|21|||
33687888|NCT02462928|63192784|FG000|Overall Study|Protocol Violation|0|||
33687889|NCT02462928|63192785|FG001|Overall Study|Protocol Violation|1|||
33687890|NCT02462928|63192786|FG002|Overall Study|Protocol Violation|0|||
33687891|NCT02462928|63192784|FG000|Overall Study|Reason not Specified|4|||
33595954|NCT02328937|62994817|FG002|Period 2|Adverse Event|1|||
33595955|NCT02328937|62994818|FG003|Period 2|Adverse Event|0|||
33595956|NCT02328937|62994819|FG004|Period 2|Adverse Event|0|||
33595957|NCT02328937|62994820|FG005|Period 2|Adverse Event|0|||
33595958|NCT02328547|62994830|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
33595959|NCT02328547|62994831|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
33595960|NCT02328547|62994830|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
33595961|NCT02328547|62994831|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
33595962|NCT02300311|62994845|FG000|Overall Study|Other than the reason specified|1|||
33595963|NCT02300311|62994846|FG001|Overall Study|Other than the reason specified|0|||
33595964|NCT02300311|62994845|FG000|Overall Study|Refused to continue taking medication|18|||
33595965|NCT02300311|62994846|FG001|Overall Study|Refused to continue taking medication|0|||
33595966|NCT02300233|62994855|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
33595967|NCT02300233|62994856|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
33595968|NCT02300233|62994857|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
33595969|NCT02300233|62994855|FG000|Overall Study|Withdrawal by Subject|1|||
33595970|NCT02300233|62994856|FG001|Overall Study|Withdrawal by Subject|0|||
33595971|NCT02300233|62994857|FG002|Overall Study|Withdrawal by Subject|3|||
33595972|NCT02300233|62994855|FG000|Overall Study|Investigator Judgement|0|||
33595973|NCT02300233|62994856|FG001|Overall Study|Investigator Judgement|0|||
33687892|NCT02462928|63192785|FG001|Overall Study|Reason not Specified|6|||
33595974|NCT02300233|62994857|FG002|Overall Study|Investigator Judgement|1|||
33595975|NCT02300233|62994855|FG000|Overall Study|Reason Not Specified|0|||
33595976|NCT02300233|62994856|FG001|Overall Study|Reason Not Specified|0|||
33595977|NCT02300233|62994857|FG002|Overall Study|Reason Not Specified|5|||
33687893|NCT02462928|63192786|FG002|Overall Study|Reason not Specified|5|||
33687894|NCT00019604|63192803|FG000|Overall Study|Death|1|||
33687895|NCT00019604|63192803|FG000|Overall Study|Progressive disease|23|||
33687896|NCT00019604|63192803|FG000|Overall Study|Refused treatment|1|||
33687897|NCT00019604|63192803|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
33687898|NCT00019604|63192803|FG000|Overall Study|Going to have liver transplant|1|||
33687899|NCT00019604|63192803|FG000|Overall Study|Move to a different study|1|||
33687900|NCT00019604|63192803|FG000|Overall Study|Non compliant on systemic CH|1|||
33687901|NCT00019604|63192803|FG000|Overall Study|Non compliant|1|||
33687902|NCT00019604|63192803|FG000|Overall Study|Resectable disease|1|||
33687903|NCT00019604|63192803|FG000|Overall Study|Started new chemo regimen|1|||
33687904|NCT00019604|63192803|FG000|Overall Study|Pt going to immunotherapy study|1|||
33687905|NCT00019604|63192803|FG000|Overall Study|Too much disease|1|||
33687906|NCT00019604|63192803|FG000|Overall Study|Unable to evaluate|1|||
33687907|NCT00019604|63192803|FG000|Overall Study|Details for other not available|4|||
33687908|NCT02492958|63192819|FG000|Overall Study|Withdrawal by Subject|0|||
33687909|NCT02492958|63192820|FG001|Overall Study|Withdrawal by Subject|0|||
33687910|NCT02492958|63192821|FG002|Overall Study|Withdrawal by Subject|1|||
33687911|NCT02492958|63192822|FG003|Overall Study|Withdrawal by Subject|0|||
33687912|NCT02492958|63192819|FG000|Overall Study|Adverse Event|1|||
33687913|NCT02492958|63192820|FG001|Overall Study|Adverse Event|0|||
33687914|NCT02492958|63192821|FG002|Overall Study|Adverse Event|1|||
33687915|NCT02492958|63192822|FG003|Overall Study|Adverse Event|0|||
33687916|NCT02492880|63192832|FG000|Overall Study|Lost to Follow-up|1|||
33687917|NCT02492880|63192832|FG000|Overall Study|Protocol Violation|1|||
33687918|NCT02516592|63192838|FG000|Overall Study|Patient withdrew consent|5|||
33687919|NCT02516592|63192839|FG001|Overall Study|Patient withdrew consent|2|||
33687920|NCT02516592|63192838|FG000|Overall Study|Protocol deviation|4|||
33687921|NCT02516592|63192839|FG001|Overall Study|Protocol deviation|4|||
33687922|NCT02516592|63192838|FG000|Overall Study|Lost to Follow-up|2|||
33687923|NCT02516592|63192839|FG001|Overall Study|Lost to Follow-up|3|||
33687924|NCT02516592|63192838|FG000|Overall Study|Patient/guardian decision|2|||
33687925|NCT02516592|63192839|FG001|Overall Study|Patient/guardian decision|1|||
33687926|NCT02516592|63192838|FG000|Overall Study|Adverse Event|1|||
33687927|NCT02516592|63192839|FG001|Overall Study|Adverse Event|2|||
33687928|NCT02516592|63192838|FG000|Overall Study|Abnormal test procedure result|1|||
33687929|NCT02516592|63192839|FG001|Overall Study|Abnormal test procedure result|0|||
33687930|NCT02516592|63192838|FG000|Overall Study|Death|1|||
33687931|NCT02516592|63192839|FG001|Overall Study|Death|1|||
33687932|NCT02492100|63192867|FG000|Overall Study|Death|1|||
33687933|NCT02461758|63192890|FG000|Overall Study|Lost to Follow-up|0|||
33687934|NCT02461758|63192891|FG001|Overall Study|Lost to Follow-up|1|||
33687935|NCT02461758|63192892|FG002|Overall Study|Lost to Follow-up|1|||
33687936|NCT02461758|63192893|FG003|Overall Study|Lost to Follow-up|0|||
33687937|NCT02461290|63192915|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
33687938|NCT02461290|63192915|FG000|Overall Study|Lost to Follow-up|3|||
33687939|NCT02461134|63192919|FG000|Overall Study|Adverse Event|1|||
33687940|NCT02460978|63192948|FG000|Overall Study|Adverse Event|17|||
33687941|NCT02460978|63192949|FG001|Overall Study|Adverse Event|11|||
33687942|NCT02460978|63192950|FG002|Overall Study|Adverse Event|11|||
33687943|NCT02460978|63192948|FG000|Overall Study|Withdrawal by Subject|5|||
33687944|NCT02460978|63192949|FG001|Overall Study|Withdrawal by Subject|5|||
33687945|NCT02460978|63192950|FG002|Overall Study|Withdrawal by Subject|14|||
33687946|NCT02460978|63192948|FG000|Overall Study|Lost to Follow-up|2|||
33687947|NCT02460978|63192949|FG001|Overall Study|Lost to Follow-up|3|||
33687948|NCT02460978|63192950|FG002|Overall Study|Lost to Follow-up|1|||
33687949|NCT02460978|63192948|FG000|Overall Study|Protocol Violation|1|||
33687950|NCT02460978|63192949|FG001|Overall Study|Protocol Violation|1|||
33687951|NCT02460978|63192950|FG002|Overall Study|Protocol Violation|1|||
33687952|NCT02460978|63192948|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
33687953|NCT02460978|63192949|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
33687954|NCT02460978|63192950|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
33687955|NCT02460978|63192948|FG000|Overall Study|Pregnancy|0|||
33687956|NCT02460978|63192949|FG001|Overall Study|Pregnancy|0|||
33687957|NCT02460978|63192950|FG002|Overall Study|Pregnancy|2|||
33595978|NCT02175225|62994868|FG000|Overall Study|Withdrawal by Subject|1|||
33595979|NCT02175225|62994869|FG001|Overall Study|Withdrawal by Subject|2|||
33595980|NCT02175225|62994868|FG000|Overall Study|Lost to Follow-up|6|||
33595981|NCT02175225|62994869|FG001|Overall Study|Lost to Follow-up|7|||
33595982|NCT02175225|62994868|FG000|Overall Study|Study drug not administered|1|||
33595983|NCT02175225|62994869|FG001|Overall Study|Study drug not administered|2|||
33595984|NCT02299375|62994877|FG000|Overall Study|Adverse Event, serious fatal|1|||
33595985|NCT02299375|62994878|FG001|Overall Study|Adverse Event, serious fatal|3|||
33595986|NCT02299375|62994877|FG000|Overall Study|Adverse Event, non-fatal|8|||
33595987|NCT02299375|62994878|FG001|Overall Study|Adverse Event, non-fatal|9|||
33595988|NCT02299375|62994877|FG000|Overall Study|Lack of Efficacy|1|||
33595989|NCT02299375|62994878|FG001|Overall Study|Lack of Efficacy|3|||
33687958|NCT02489448|63192965|FG000|Overall Study|Death|3|||
33687959|NCT02489448|63192965|FG000|Overall Study|Withdrawal by Subject|2|||
33687960|NCT02488980|63192986|FG000|Overall Study|Protocol Violation|2|||
33687961|NCT02488980|63192987|FG001|Overall Study|Protocol Violation|2|||
33687962|NCT02488980|63192988|FG002|Overall Study|Protocol Violation|2|||
33687963|NCT02460822|63193000|FG000|Overall Study|Withdrawal by Subject|1|||
33687964|NCT02488824|63193006|FG000|Overall Study|Adverse Event|1|||
33687965|NCT02488824|63193007|FG001|Overall Study|Adverse Event|1|||
33687966|NCT02308241|63193119|FG000|Overall Study|Withdrawal by Subject|3|||
33687967|NCT02460198|63193158|FG000|Overall Study|Adverse Event|1|||
33687968|NCT02460198|63193159|FG001|Overall Study|Adverse Event|3|||
33687969|NCT02460198|63193158|FG000|Overall Study|Death|36|||
33687970|NCT02460198|63193159|FG001|Overall Study|Death|28|||
33687971|NCT02460198|63193158|FG000|Overall Study|Lost to Follow-up|1|||
33687972|NCT02460198|63193159|FG001|Overall Study|Lost to Follow-up|1|||
33687973|NCT02460198|63193158|FG000|Overall Study|Transferred to Extension Study|15|||
33687974|NCT02460198|63193159|FG001|Overall Study|Transferred to Extension Study|15|||
33687975|NCT02460198|63193158|FG000|Overall Study|Withdrawal by Subject|2|||
33687976|NCT02460198|63193159|FG001|Overall Study|Withdrawal by Subject|4|||
33687977|NCT02460198|63193158|FG000|Overall Study|Site Terminated By Sponsor|0|||
33687978|NCT02460198|63193159|FG001|Overall Study|Site Terminated By Sponsor|1|||
33687979|NCT02460198|63193158|FG000|Overall Study|Did Not Continue on Extension Study|6|||
33687980|NCT02460198|63193159|FG001|Overall Study|Did Not Continue on Extension Study|11|||
33687981|NCT02487810|63193179|FG000|Overall Study|Withdrawal by Subject|1|||
33687982|NCT02487810|63193180|FG001|Overall Study|Withdrawal by Subject|0|||
33687983|NCT02452320|63193188|FG000|Overall Study|Adverse Event|0|||
33687984|NCT02452320|63193189|FG001|Overall Study|Adverse Event|1|||
33687985|NCT02459964|63193198|FG000|Overall Study|Withdrawal by Subject|0|||
33687986|NCT02459964|63193199|FG001|Overall Study|Withdrawal by Subject|0|||
33687987|NCT02459964|63193200|FG002|Overall Study|Withdrawal by Subject|1|||
33687988|NCT02459964|63193198|FG000|Overall Study|Abnormal EKG changes|0|||
33687989|NCT02459964|63193199|FG001|Overall Study|Abnormal EKG changes|0|||
33687990|NCT02459964|63193200|FG002|Overall Study|Abnormal EKG changes|1|||
33687991|NCT02451930|63193277|FG000|Overall Study|Death|0|||
33687992|NCT02451930|63193278|FG001|Overall Study|Death|15|||
33687993|NCT02451930|63193277|FG000|Overall Study|Lost to Follow-up|0|||
33687994|NCT02451930|63193278|FG001|Overall Study|Lost to Follow-up|3|||
33687995|NCT02451930|63193277|FG000|Overall Study|Sponsor Decision|2|||
33687996|NCT02451930|63193278|FG001|Overall Study|Sponsor Decision|10|||
33687997|NCT02451930|63193277|FG000|Overall Study|Withdrawal by Subject|0|||
33687998|NCT02451930|63193278|FG001|Overall Study|Withdrawal by Subject|1|||
33687999|NCT02451930|63193277|FG000|Overall Study|Other|0|||
33688000|NCT02451930|63193278|FG001|Overall Study|Other|1|||
33688001|NCT02451696|63193314|FG000|Overall Study|Surgery postponed|1|||
33688002|NCT02451696|63193315|FG001|Overall Study|Surgery postponed|0|||
33688003|NCT02459418|63193338|FG000|Overall Study|Exclusion Criteria|4|||
33688004|NCT02459418|63193339|FG001|Overall Study|Exclusion Criteria|0|||
33688005|NCT02459418|63193338|FG000|Overall Study|Protocol Violation|0|||
33688006|NCT02459418|63193339|FG001|Overall Study|Protocol Violation|2|||
33688007|NCT02459418|63193338|FG000|Overall Study|Physician Decision|0|||
33688008|NCT02459418|63193339|FG001|Overall Study|Physician Decision|2|||
33688009|NCT02459418|63193338|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
33688010|NCT02459418|63193339|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
33688011|NCT02459418|63193338|FG000|Overall Study|Adverse Event|0|||
33688012|NCT02459418|63193339|FG001|Overall Study|Adverse Event|1|||
33688013|NCT02459418|63193338|FG000|Overall Study|Withdrawal by Subject|1|||
33688014|NCT02459418|63193339|FG001|Overall Study|Withdrawal by Subject|1|||
33688015|NCT02459418|63193338|FG000|Overall Study|Elevated Creatine Kinase|1|||
33688016|NCT02459418|63193339|FG001|Overall Study|Elevated Creatine Kinase|0|||
33688017|NCT02459418|63193338|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
33688018|NCT02459418|63193339|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
33688019|NCT02487498|63193369|FG000|Period: Period 1|Adverse Event|2|||
33688020|NCT02487498|63193370|FG001|Period: Period 1|Adverse Event|4|||
33688021|NCT02487498|63193369|FG000|Period: Period 1|Subject/guardian decision|2|||
33493156|NCT02640664|62871274|FG000|Epoch 1|Death|0|||
33493157|NCT02640664|62871275|FG001|Epoch 1|Death|0|||
33688022|NCT02487498|63193370|FG001|Period: Period 1|Subject/guardian decision|4|||
33688023|NCT02487498|63193369|FG000|Period: Period 1|Lost to Follow-up|0|||
33688024|NCT02487498|63193370|FG001|Period: Period 1|Lost to Follow-up|2|||
33688025|NCT02487498|63193369|FG000|Period: Period 1|Lack of Efficacy|1|||
33688026|NCT02487498|63193370|FG001|Period: Period 1|Lack of Efficacy|0|||
33688027|NCT02487498|63193369|FG000|Period: Period 1|Physician Decision|0|||
33688028|NCT02487498|63193370|FG001|Period: Period 1|Physician Decision|1|||
33688029|NCT02487498|63193369|FG000|Period: Period 1|Protocol deviation|1|||
33688030|NCT02487498|63193370|FG001|Period: Period 1|Protocol deviation|0|||
33688031|NCT02487498|63193369|FG000|Period: Washout|Subject/guardian decision|0|||
33401439|NCT00256867|62780478|FG004|Overall Study|Lost to Follow-up|2|||
33688032|NCT02487498|63193370|FG001|Period: Washout|Subject/guardian decision|5|||
33688033|NCT02487498|63193369|FG000|Period: Washout|Lack of Efficacy|1|||
33688034|NCT02487498|63193370|FG001|Period: Washout|Lack of Efficacy|1|||
33688035|NCT02487498|63193369|FG000|Period: Washout|Physician Decision|1|||
33688036|NCT02487498|63193370|FG001|Period: Washout|Physician Decision|0|||
33688037|NCT02487498|63193369|FG000|Period: Washout|Non-compliance with study treatment|0|||
33688038|NCT02487498|63193370|FG001|Period: Washout|Non-compliance with study treatment|1|||
33688039|NCT02487498|63193369|FG000|Period: Period 2|Adverse Event|2|||
33688040|NCT02487498|63193370|FG001|Period: Period 2|Adverse Event|2|||
33688041|NCT02487498|63193369|FG000|Period: Period 2|Subject/guardian decision|2|||
33688042|NCT02487498|63193370|FG001|Period: Period 2|Subject/guardian decision|1|||
33688043|NCT02487498|63193369|FG000|Period: Period 2|Lost to Follow-up|1|||
33688044|NCT02487498|63193370|FG001|Period: Period 2|Lost to Follow-up|1|||
33688045|NCT02487498|63193369|FG000|Period: Period 2|Death|0|||
33688046|NCT02487498|63193370|FG001|Period: Period 2|Death|1|||
33688047|NCT02487498|63193369|FG000|Period: Period 2|Physician Decision|1|||
33688048|NCT02487498|63193370|FG001|Period: Period 2|Physician Decision|0|||
33688049|NCT02487108|63193381|FG000|Overall Study|Adverse Event|1|||
33688050|NCT02487108|63193382|FG001|Overall Study|Adverse Event|6|||
33688051|NCT02487108|63193383|FG002|Overall Study|Adverse Event|12|||
33688052|NCT02487108|63193384|FG003|Overall Study|Adverse Event|6|||
33688053|NCT02487108|63193381|FG000|Overall Study|Withdrawal by Subject|8|||
33688054|NCT02487108|63193382|FG001|Overall Study|Withdrawal by Subject|5|||
33688055|NCT02487108|63193383|FG002|Overall Study|Withdrawal by Subject|5|||
33688056|NCT02487108|63193384|FG003|Overall Study|Withdrawal by Subject|0|||
33688057|NCT02487108|63193381|FG000|Overall Study|Non-compliance to study medication|3|||
33688058|NCT02487108|63193382|FG001|Overall Study|Non-compliance to study medication|2|||
33688059|NCT02487108|63193383|FG002|Overall Study|Non-compliance to study medication|5|||
33688060|NCT02487108|63193384|FG003|Overall Study|Non-compliance to study medication|4|||
33688061|NCT02487108|63193381|FG000|Overall Study|Protocol Violation|1|||
33688062|NCT02487108|63193382|FG001|Overall Study|Protocol Violation|1|||
33688063|NCT02487108|63193383|FG002|Overall Study|Protocol Violation|2|||
33688064|NCT02487108|63193384|FG003|Overall Study|Protocol Violation|0|||
33688065|NCT02487108|63193381|FG000|Overall Study|Non-compliance to study procedures|0|||
33688066|NCT02487108|63193382|FG001|Overall Study|Non-compliance to study procedures|0|||
33688067|NCT02487108|63193383|FG002|Overall Study|Non-compliance to study procedures|0|||
33688068|NCT02487108|63193384|FG003|Overall Study|Non-compliance to study procedures|1|||
33688069|NCT02487108|63193381|FG000|Overall Study|Other than specified|3|||
33688070|NCT02487108|63193382|FG001|Overall Study|Other than specified|2|||
33688071|NCT02487108|63193383|FG002|Overall Study|Other than specified|2|||
33688072|NCT02487108|63193384|FG003|Overall Study|Other than specified|0|||
33688073|NCT02487030|63193401|FG000|Overall Study|Lack of Efficacy|2|||
33688074|NCT02487030|63193402|FG001|Overall Study|Lack of Efficacy|4|||
33688075|NCT02487030|63193403|FG002|Overall Study|Lack of Efficacy|1|||
33688076|NCT02487030|63193404|FG003|Overall Study|Lack of Efficacy|0|||
33688077|NCT02487030|63193405|FG004|Overall Study|Lack of Efficacy|1|||
33688078|NCT02487030|63193406|FG005|Overall Study|Lack of Efficacy|0|||
33688079|NCT02487030|63193407|FG006|Overall Study|Lack of Efficacy|0|||
33688080|NCT02487030|63193401|FG000|Overall Study|Lost to Follow-up|0|||
33688081|NCT02487030|63193402|FG001|Overall Study|Lost to Follow-up|0|||
33688082|NCT02487030|63193403|FG002|Overall Study|Lost to Follow-up|1|||
33688083|NCT02487030|63193404|FG003|Overall Study|Lost to Follow-up|1|||
33688084|NCT02487030|63193405|FG004|Overall Study|Lost to Follow-up|0|||
33688085|NCT02487030|63193406|FG005|Overall Study|Lost to Follow-up|1|||
33688086|NCT02487030|63193407|FG006|Overall Study|Lost to Follow-up|0|||
33688087|NCT02487030|63193401|FG000|Overall Study|Adverse Event|0|||
33688088|NCT02487030|63193402|FG001|Overall Study|Adverse Event|0|||
33688089|NCT02487030|63193403|FG002|Overall Study|Adverse Event|0|||
33688090|NCT02487030|63193404|FG003|Overall Study|Adverse Event|1|||
33688091|NCT02487030|63193405|FG004|Overall Study|Adverse Event|0|||
33688092|NCT02487030|63193406|FG005|Overall Study|Adverse Event|0|||
33688093|NCT02487030|63193407|FG006|Overall Study|Adverse Event|0|||
33688094|NCT02487030|63193401|FG000|Overall Study|Death|0|||
33688095|NCT02487030|63193402|FG001|Overall Study|Death|0|||
33688096|NCT02487030|63193403|FG002|Overall Study|Death|0|||
33688097|NCT02487030|63193404|FG003|Overall Study|Death|0|||
33688098|NCT02487030|63193405|FG004|Overall Study|Death|1|||
33688099|NCT02487030|63193406|FG005|Overall Study|Death|0|||
33595990|NCT02299375|62994877|FG000|Overall Study|Protocol Violation|1|||
33688100|NCT02487030|63193407|FG006|Overall Study|Death|0|||
33688101|NCT02486952|63193424|FG000|Overall Study|Not Started Induction Therapy|3|||
33688102|NCT02486952|63193424|FG000|Overall Study|Adverse Event|1|||
33688103|NCT02486952|63193424|FG000|Overall Study|Death|15|||
33688104|NCT02486952|63193424|FG000|Overall Study|Lack of Efficacy|3|||
33688105|NCT02486952|63193424|FG000|Overall Study|Lost to Follow-up|26|||
33688106|NCT02486952|63193424|FG000|Overall Study|Other|2|||
33688107|NCT02486796|63193430|FG000|Overall Study|Withdrawal by Subject|1|||
33688108|NCT02486796|63193431|FG001|Overall Study|Withdrawal by Subject|1|||
33688109|NCT02486796|63193430|FG000|Overall Study|Physician Decision|1|||
33688110|NCT02486796|63193431|FG001|Overall Study|Physician Decision|0|||
33688111|NCT02459262|63193448|FG000|Overall Study|Withdrawal by Subject|0|||
33688112|NCT02459262|63193449|FG001|Overall Study|Withdrawal by Subject|0|||
33688113|NCT02459262|63193450|FG002|Overall Study|Withdrawal by Subject|0|||
33688114|NCT02459262|63193451|FG003|Overall Study|Withdrawal by Subject|0|||
33688115|NCT02459262|63193452|FG004|Overall Study|Withdrawal by Subject|0|||
33688116|NCT02459262|63193453|FG005|Overall Study|Withdrawal by Subject|0|||
33688117|NCT02459262|63193454|FG006|Overall Study|Withdrawal by Subject|0|||
33688118|NCT02459262|63193455|FG007|Overall Study|Withdrawal by Subject|0|||
33688119|NCT02459262|63193456|FG008|Overall Study|Withdrawal by Subject|0|||
33688120|NCT02459262|63193457|FG009|Overall Study|Withdrawal by Subject|1|||
33688121|NCT02459262|63193458|FG010|Overall Study|Withdrawal by Subject|0|||
33688122|NCT02450526|63193542|FG000|DB Period (Cycle 1)|Adverse Event|0|||
33688123|NCT02450526|63193543|FG001|DB Period (Cycle 1)|Adverse Event|0|||
33688124|NCT02450526|63193544|FG002|DB Period (Cycle 1)|Adverse Event|2|||
33688125|NCT02450526|63193545|FG003|DB Period (Cycle 1)|Adverse Event|0|||
33688126|NCT02450526|63193546|FG004|DB Period (Cycle 1)|Adverse Event|0|||
33688127|NCT02450526|63193542|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
33688128|NCT02450526|63193543|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
33688129|NCT02450526|63193544|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
33688130|NCT02450526|63193545|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
33688131|NCT02450526|63193546|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
33688132|NCT02450526|63193542|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
33688133|NCT02450526|63193543|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
33688134|NCT02450526|63193544|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
33688135|NCT02450526|63193545|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
33688136|NCT02450526|63193546|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
33688137|NCT02450526|63193542|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
33688138|NCT02450526|63193543|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
33688139|NCT02450526|63193544|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
33688140|NCT02450526|63193545|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
33688141|NCT02450526|63193546|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
33688142|NCT02450526|63193542|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
33688143|NCT02450526|63193543|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
33688144|NCT02450526|63193544|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
33688145|NCT02450526|63193545|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
33688146|NCT02450526|63193546|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
33688147|NCT02450526|63193542|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
33688148|NCT02450526|63193543|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
33688149|NCT02450526|63193544|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
33688150|NCT02450526|63193545|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
33688151|NCT02450526|63193546|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
33688152|NCT02450526|63193542|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
33688153|NCT02450526|63193543|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
33688154|NCT02450526|63193544|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
33688155|NCT02450526|63193545|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
33688156|NCT02450526|63193546|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
33688157|NCT02450526|63193542|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
33688158|NCT02450526|63193543|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
33688159|NCT02450526|63193544|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
33688160|NCT02450526|63193545|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
33688161|NCT02450526|63193546|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
33688162|NCT02458638|63193613|FG000|Overall Study|Death|309|||
33688163|NCT02458638|63193613|FG000|Overall Study|End of Cohort/End of Study|67|||
33688164|NCT02458638|63193613|FG000|Overall Study|Lost to Follow-up|31|||
33688165|NCT02458638|63193613|FG000|Overall Study|Other Reasons|4|||
33688166|NCT02458638|63193613|FG000|Overall Study|Physician Decision|1|||
33688167|NCT02458638|63193613|FG000|Overall Study|Withdrawal by Subject|47|||
33688168|NCT02458092|63193751|FG000|Overall Study|Withdrawal by Subject|1|||
33688169|NCT02458092|63193752|FG001|Overall Study|Withdrawal by Subject|0|||
33688170|NCT02449902|63193775|FG000|Overall Study|Adverse Event|0|||
33688171|NCT02449902|63193776|FG001|Overall Study|Adverse Event|1|||
33688172|NCT02449902|63193775|FG000|Overall Study|Withdrawal by Subject|0|||
33688173|NCT02449902|63193776|FG001|Overall Study|Withdrawal by Subject|1|||
33688174|NCT02449044|63193784|FG000|Overall Study|Lost to Follow-up|2|||
33688175|NCT02449044|63193784|FG000|Overall Study|Withdrawal by Subject|13|||
33688176|NCT02449044|63193784|FG000|Overall Study|Adverse Event|30|||
33688177|NCT02449044|63193784|FG000|Overall Study|Met Withdrawal Criteria|7|||
33688178|NCT02449044|63193784|FG000|Overall Study|Physician Decision|9|||
33688179|NCT02449044|63193784|FG000|Overall Study|Sponsor Discontinued Trial|3|||
33688180|NCT02448810|63194655|FG000|Overall Study|Adverse Event|0|||
33688181|NCT02448810|63194656|FG001|Overall Study|Adverse Event|0|||
33688182|NCT02448810|63194657|FG002|Overall Study|Adverse Event|1|||
33688183|NCT02448810|63194658|FG003|Overall Study|Adverse Event|0|||
33688184|NCT02448810|63194659|FG004|Overall Study|Adverse Event|0|||
33595991|NCT02299375|62994878|FG001|Overall Study|Protocol Violation|3|||
33401440|NCT00256867|62780479|FG005|Overall Study|Lost to Follow-up|0|||
33688185|NCT02448810|63194660|FG005|Overall Study|Adverse Event|0|||
33688186|NCT02448810|63194661|FG006|Overall Study|Adverse Event|0|||
33688187|NCT02448810|63194662|FG007|Overall Study|Adverse Event|0|||
33688188|NCT02448810|63194655|FG000|Overall Study|Withdrawal by Subject|0|||
33688189|NCT02448810|63194656|FG001|Overall Study|Withdrawal by Subject|0|||
33688190|NCT02448810|63194657|FG002|Overall Study|Withdrawal by Subject|1|||
33688191|NCT02448810|63194658|FG003|Overall Study|Withdrawal by Subject|0|||
33688192|NCT02448810|63194659|FG004|Overall Study|Withdrawal by Subject|3|||
33688193|NCT02448810|63194660|FG005|Overall Study|Withdrawal by Subject|5|||
33688194|NCT02448810|63194661|FG006|Overall Study|Withdrawal by Subject|0|||
33688195|NCT02448810|63194662|FG007|Overall Study|Withdrawal by Subject|2|||
33688196|NCT02448810|63194655|FG000|Overall Study|Other (study terminated by sponsor)|0|||
33688197|NCT02448810|63194656|FG001|Overall Study|Other (study terminated by sponsor)|0|||
33688198|NCT02448810|63194657|FG002|Overall Study|Other (study terminated by sponsor)|0|||
33688199|NCT02448810|63194658|FG003|Overall Study|Other (study terminated by sponsor)|0|||
33688200|NCT02448810|63194659|FG004|Overall Study|Other (study terminated by sponsor)|4|||
33688201|NCT02448810|63194660|FG005|Overall Study|Other (study terminated by sponsor)|2|||
33688202|NCT02448810|63194661|FG006|Overall Study|Other (study terminated by sponsor)|2|||
33688203|NCT02448810|63194662|FG007|Overall Study|Other (study terminated by sponsor)|1|||
33688204|NCT02448810|63194655|FG000|Overall Study|Death|1|||
33688205|NCT02448810|63194656|FG001|Overall Study|Death|0|||
33688206|NCT02448810|63194657|FG002|Overall Study|Death|1|||
33688207|NCT02448810|63194658|FG003|Overall Study|Death|0|||
33688208|NCT02448810|63194659|FG004|Overall Study|Death|1|||
33688209|NCT02448810|63194660|FG005|Overall Study|Death|0|||
33688210|NCT02448810|63194661|FG006|Overall Study|Death|0|||
33688211|NCT02448810|63194662|FG007|Overall Study|Death|0|||
33688212|NCT02448810|63194655|FG000|Overall Study|Other (Progressive disease)|2|||
33688213|NCT02448810|63194656|FG001|Overall Study|Other (Progressive disease)|2|||
33688214|NCT02448810|63194657|FG002|Overall Study|Other (Progressive disease)|0|||
33688215|NCT02448810|63194658|FG003|Overall Study|Other (Progressive disease)|3|||
33688216|NCT02448810|63194659|FG004|Overall Study|Other (Progressive disease)|23|||
33688217|NCT02448810|63194660|FG005|Overall Study|Other (Progressive disease)|9|||
33595992|NCT02299375|62994877|FG000|Overall Study|Other: Met stopping criteria|1|||
33595993|NCT02299375|62994878|FG001|Overall Study|Other: Met stopping criteria|0|||
33595994|NCT02299375|62994877|FG000|Overall Study|Other: Study closed/terminated|66|||
33595995|NCT02299375|62994878|FG001|Overall Study|Other: Study closed/terminated|55|||
33595996|NCT02299375|62994877|FG000|Overall Study|Lost to Follow-up|0|||
33595997|NCT02299375|62994878|FG001|Overall Study|Lost to Follow-up|2|||
33595998|NCT02299375|62994877|FG000|Overall Study|Physician Decision|1|||
33595999|NCT02299375|62994878|FG001|Overall Study|Physician Decision|1|||
33596000|NCT02299375|62994877|FG000|Overall Study|Withdrawal by Subject|1|||
33596001|NCT02299375|62994878|FG001|Overall Study|Withdrawal by Subject|4|||
33651299|NCT01972529|63062729|FG001|Overall Study|Participant Choice|1|||
33651300|NCT01972529|63062730|FG002|Overall Study|Participant Choice|0|||
33651301|NCT01972529|63062731|FG003|Overall Study|Participant Choice|0|||
33651302|NCT01972529|63062728|FG000|Overall Study|Withdrawl of Consent|1|||
33651303|NCT01972529|63062729|FG001|Overall Study|Withdrawl of Consent|2|||
33651304|NCT01972529|63062730|FG002|Overall Study|Withdrawl of Consent|0|||
33651305|NCT01972529|63062731|FG003|Overall Study|Withdrawl of Consent|1|||
33651306|NCT01972529|63062728|FG000|Overall Study|Other|0|||
33651307|NCT01972529|63062729|FG001|Overall Study|Other|0|||
33651308|NCT01972529|63062730|FG002|Overall Study|Other|0|||
33651309|NCT01972529|63062731|FG003|Overall Study|Other|2|||
33651310|NCT01972529|63062728|FG000|Overall Study|Not treated|0|||
33651311|NCT01972529|63062729|FG001|Overall Study|Not treated|1|||
33651312|NCT01972529|63062730|FG002|Overall Study|Not treated|2|||
33651313|NCT01972529|63062731|FG003|Overall Study|Not treated|1|||
33651314|NCT01747915|63062745|FG000|Overall Study|Other|1|||
33651315|NCT01747915|63062746|FG001|Overall Study|Other|1|||
33651316|NCT01747915|63062747|FG002|Overall Study|Other|1|||
33651317|NCT01747915|63062745|FG000|Overall Study|Adverse Event|8|||
33651318|NCT01747915|63062746|FG001|Overall Study|Adverse Event|5|||
33651319|NCT01747915|63062747|FG002|Overall Study|Adverse Event|2|||
33651320|NCT01747915|63062745|FG000|Overall Study|Death|0|||
33651321|NCT01747915|63062746|FG001|Overall Study|Death|0|||
33651322|NCT01747915|63062747|FG002|Overall Study|Death|1|||
33651323|NCT01747915|63062745|FG000|Overall Study|Lack of Efficacy|0|||
33651324|NCT01747915|63062746|FG001|Overall Study|Lack of Efficacy|1|||
33651325|NCT01747915|63062747|FG002|Overall Study|Lack of Efficacy|0|||
33651326|NCT01747915|63062745|FG000|Overall Study|Lost to Follow-up|1|||
33651327|NCT01747915|63062746|FG001|Overall Study|Lost to Follow-up|0|||
33651328|NCT01747915|63062747|FG002|Overall Study|Lost to Follow-up|0|||
33651329|NCT01747915|63062745|FG000|Overall Study|Withdrawal by Subject|4|||
33651330|NCT01747915|63062746|FG001|Overall Study|Withdrawal by Subject|4|||
33651331|NCT01747915|63062747|FG002|Overall Study|Withdrawal by Subject|1|||
33651332|NCT01747915|63062745|FG000|Overall Study|Protocol Violation|1|||
33651333|NCT01747915|63062746|FG001|Overall Study|Protocol Violation|0|||
33688218|NCT02448810|63194661|FG006|Overall Study|Other (Progressive disease)|14|||
33688219|NCT02448810|63194662|FG007|Overall Study|Other (Progressive disease)|5|||
33688220|NCT02448810|63194655|FG000|Overall Study|Lost to Follow-up|0|||
33688221|NCT02448810|63194656|FG001|Overall Study|Lost to Follow-up|1|||
33688222|NCT02448810|63194657|FG002|Overall Study|Lost to Follow-up|0|||
33688223|NCT02448810|63194658|FG003|Overall Study|Lost to Follow-up|0|||
33688224|NCT02448810|63194659|FG004|Overall Study|Lost to Follow-up|0|||
33688225|NCT02448810|63194660|FG005|Overall Study|Lost to Follow-up|0|||
33688226|NCT02448810|63194661|FG006|Overall Study|Lost to Follow-up|0|||
33688227|NCT02448810|63194662|FG007|Overall Study|Lost to Follow-up|0|||
33688228|NCT02448810|63194655|FG000|Overall Study|Other (unspecified)|0|||
33688229|NCT02448810|63194656|FG001|Overall Study|Other (unspecified)|0|||
33688230|NCT02448810|63194657|FG002|Overall Study|Other (unspecified)|0|||
33688231|NCT02448810|63194658|FG003|Overall Study|Other (unspecified)|0|||
33688232|NCT02448810|63194659|FG004|Overall Study|Other (unspecified)|0|||
33688233|NCT02448810|63194660|FG005|Overall Study|Other (unspecified)|0|||
33688234|NCT02448810|63194661|FG006|Overall Study|Other (unspecified)|2|||
33688235|NCT02448810|63194662|FG007|Overall Study|Other (unspecified)|0|||
33688236|NCT02457546|63194735|FG000|Overall Study|Other reasons|4|||
33688237|NCT02457546|63194736|FG001|Overall Study|Other reasons|1|||
33688238|NCT02457546|63194735|FG000|Overall Study|Refused to complete study/procedures|1|||
33688239|NCT02457546|63194736|FG001|Overall Study|Refused to complete study/procedures|1|||
33688240|NCT02457546|63194735|FG000|Overall Study|Lost to Follow-up|4|||
33688241|NCT02457546|63194736|FG001|Overall Study|Lost to Follow-up|1|||
33688242|NCT02457546|63194735|FG000|Overall Study|Adverse Event|0|||
33688243|NCT02457546|63194736|FG001|Overall Study|Adverse Event|1|||
33688244|NCT02447952|63194757|FG000|Overall Study|Adverse Event|2|||
33688245|NCT02447952|63194757|FG000|Overall Study|Physician Decision|1|||
33688246|NCT02447952|63194757|FG000|Overall Study|Withdrawal by Subject|4|||
33688247|NCT02447718|63194791|FG000|Overall Study|Lost to Follow-up|8|||
33688248|NCT02447718|63194792|FG001|Overall Study|Lost to Follow-up|0|||
33688249|NCT02447718|63194791|FG000|Overall Study|Withdrawal by Subject|3|||
33688250|NCT02447718|63194792|FG001|Overall Study|Withdrawal by Subject|0|||
33688251|NCT02447718|63194791|FG000|Overall Study|Screen Failure|1|||
33688252|NCT02447718|63194792|FG001|Overall Study|Screen Failure|0|||
33688253|NCT02486406|63194969|FG000|Overall Study|Withdrew consent|1|||
33688254|NCT02486406|63194970|FG001|Overall Study|Withdrew consent|0|||
33688255|NCT02486406|63194971|FG002|Overall Study|Withdrew consent|0|||
33688256|NCT02486406|63194972|FG003|Overall Study|Withdrew consent|1|||
33688257|NCT02486406|63194969|FG000|Overall Study|Lost to Follow-up|1|||
33688258|NCT02486406|63194970|FG001|Overall Study|Lost to Follow-up|3|||
33688259|NCT02486406|63194971|FG002|Overall Study|Lost to Follow-up|1|||
33688260|NCT02486406|63194972|FG003|Overall Study|Lost to Follow-up|3|||
33688261|NCT02486406|63194969|FG000|Overall Study|Other, not specified|0|||
33688262|NCT02486406|63194970|FG001|Overall Study|Other, not specified|0|||
33688263|NCT02486406|63194971|FG002|Overall Study|Other, not specified|1|||
33688264|NCT02486406|63194972|FG003|Overall Study|Other, not specified|0|||
33688265|NCT02485704|63195044|FG000|Overall Study|Lost to Follow-up|4|||
33688266|NCT02485704|63195045|FG001|Overall Study|Lost to Follow-up|5|||
33688267|NCT02485704|63195044|FG000|Overall Study|Withdrawal by Subject|0|||
33688268|NCT02485704|63195045|FG001|Overall Study|Withdrawal by Subject|3|||
33688269|NCT02485704|63195044|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
33688270|NCT02485704|63195045|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
33688271|NCT02485158|63195055|FG000|Overall Study|Withdrawal by Subject|3|||
33688272|NCT02485158|63195055|FG000|Overall Study|expected drug side effect|1|||
33688273|NCT02455518|63195074|FG000|Overall Study|Protocol Violation|0|||
33688274|NCT02455518|63195075|FG001|Overall Study|Protocol Violation|1|||
33688275|NCT02455518|63195076|FG002|Overall Study|Protocol Violation|1|||
33688276|NCT02455518|63195077|FG003|Overall Study|Protocol Violation|3|||
33688277|NCT02240069|63195295|FG000|Overall Study|Withdrawal by Subject|5|||
33688278|NCT02240069|63195296|FG001|Overall Study|Withdrawal by Subject|5|||
33688279|NCT02240069|63195297|FG002|Overall Study|Withdrawal by Subject|2|||
33688280|NCT02484690|63195383|FG000|Overall Study|Adverse Event|1|||
33688281|NCT02484690|63195384|FG001|Overall Study|Adverse Event|3|||
33688282|NCT02484690|63195385|FG002|Overall Study|Adverse Event|0|||
33688283|NCT02484690|63195386|FG003|Overall Study|Adverse Event|0|||
33596002|NCT02151903|62994887|FG000|Overall Study|Withdrawal by Subject|1|||
33688284|NCT02484690|63195387|FG004|Overall Study|Adverse Event|5|||
33688285|NCT02484690|63195383|FG000|Overall Study|Death|0|||
33688286|NCT02484690|63195384|FG001|Overall Study|Death|0|||
33688287|NCT02484690|63195385|FG002|Overall Study|Death|0|||
33688288|NCT02484690|63195386|FG003|Overall Study|Death|0|||
33688289|NCT02484690|63195387|FG004|Overall Study|Death|1|||
33688290|NCT02484690|63195383|FG000|Overall Study|Withdrawal by Subject|1|||
33688291|NCT02484690|63195384|FG001|Overall Study|Withdrawal by Subject|3|||
33688292|NCT02484690|63195385|FG002|Overall Study|Withdrawal by Subject|1|||
33688293|NCT02484690|63195386|FG003|Overall Study|Withdrawal by Subject|2|||
33688294|NCT02484690|63195387|FG004|Overall Study|Withdrawal by Subject|0|||
33688295|NCT02484690|63195383|FG000|Overall Study|Physician Decision|2|||
33688296|NCT02484690|63195384|FG001|Overall Study|Physician Decision|0|||
33688297|NCT02484690|63195385|FG002|Overall Study|Physician Decision|1|||
33688298|NCT02484690|63195386|FG003|Overall Study|Physician Decision|0|||
33688299|NCT02484690|63195387|FG004|Overall Study|Physician Decision|0|||
33688300|NCT02484690|63195383|FG000|Overall Study|Lost to Follow-up|0|||
33688301|NCT02484690|63195384|FG001|Overall Study|Lost to Follow-up|0|||
33688302|NCT02484690|63195385|FG002|Overall Study|Lost to Follow-up|1|||
33688303|NCT02484690|63195386|FG003|Overall Study|Lost to Follow-up|0|||
33688304|NCT02484690|63195387|FG004|Overall Study|Lost to Follow-up|0|||
33688305|NCT01654224|63195411|FG000|Overall Study|Lost to Follow-up|2|||
33688306|NCT01654224|63195412|FG001|Overall Study|Lost to Follow-up|2|||
33688307|NCT01654224|63195411|FG000|Overall Study|Did not receive allocation|1|||
33688308|NCT01654224|63195412|FG001|Overall Study|Did not receive allocation|8|||
33688309|NCT01654224|63195411|FG000|Overall Study|Insufficient blood sample|3|||
33688310|NCT01654224|63195412|FG001|Overall Study|Insufficient blood sample|2|||
33688311|NCT02447328|63195418|FG000|Overall Study|Withdrawal by Subject|1|||
33688312|NCT02447250|63195422|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
33688313|NCT02447250|63195422|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
33688314|NCT02447250|63195422|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
33688315|NCT02447172|63195526|FG000|Overall Study|Adverse Event|11|||
33688316|NCT02447172|63195527|FG001|Overall Study|Adverse Event|8|||
33688317|NCT02447172|63195528|FG002|Overall Study|Adverse Event|7|||
33688318|NCT02447172|63195526|FG000|Overall Study|Death|3|||
33688319|NCT02447172|63195527|FG001|Overall Study|Death|1|||
33688320|NCT02447172|63195528|FG002|Overall Study|Death|0|||
33688321|NCT02447172|63195526|FG000|Overall Study|Protocol Violation|2|||
33688322|NCT02447172|63195527|FG001|Overall Study|Protocol Violation|1|||
33688323|NCT02447172|63195528|FG002|Overall Study|Protocol Violation|2|||
33688324|NCT02447172|63195526|FG000|Overall Study|Lost to Follow-up|7|||
33688325|NCT02447172|63195527|FG001|Overall Study|Lost to Follow-up|4|||
33688326|NCT02447172|63195528|FG002|Overall Study|Lost to Follow-up|4|||
33688327|NCT02447172|63195526|FG000|Overall Study|Withdrawal by Subject|5|||
33688328|NCT02447172|63195527|FG001|Overall Study|Withdrawal by Subject|1|||
33688329|NCT02447172|63195528|FG002|Overall Study|Withdrawal by Subject|3|||
33688330|NCT02447172|63195526|FG000|Overall Study|protocol specific treatment unrelated|3|||
33688331|NCT02447172|63195527|FG001|Overall Study|protocol specific treatment unrelated|0|||
33688332|NCT02447172|63195528|FG002|Overall Study|protocol specific treatment unrelated|2|||
33688333|NCT02455050|63195561|FG000|Treatment Period 1|Lost to Follow-up|1|||
33688334|NCT02455050|63195562|FG001|Treatment Period 1|Lost to Follow-up|1|||
33688335|NCT02455050|63195563|FG002|Treatment Period 1|Lost to Follow-up|1|||
33688336|NCT02455050|63195564|FG003|Treatment Period 1|Lost to Follow-up|2|||
33688337|NCT02455050|63195561|FG000|Treatment Period 2|Lost to Follow-up|1|||
33688338|NCT02455050|63195562|FG001|Treatment Period 2|Lost to Follow-up|0|||
33688339|NCT02455050|63195563|FG002|Treatment Period 2|Lost to Follow-up|2|||
33688340|NCT02455050|63195564|FG003|Treatment Period 2|Lost to Follow-up|1|||
33688341|NCT02418468|63195604|FG000|Overall Study|Adverse Event|1|||
33688342|NCT02418468|63195605|FG001|Overall Study|Adverse Event|0|||
33688343|NCT02418468|63195604|FG000|Overall Study|Withdrawal of informed consent|1|||
33688344|NCT02418468|63195605|FG001|Overall Study|Withdrawal of informed consent|1|||
33688345|NCT02418000|63195736|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
33688346|NCT02418000|63195737|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
33688347|NCT02418000|63195738|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
33688348|NCT02418000|63195739|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
33688349|NCT02418000|63195740|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
33596003|NCT02151903|62994888|FG001|Overall Study|Withdrawal by Subject|0|||
33688350|NCT02418000|63195736|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
33688351|NCT02418000|63195737|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
33688352|NCT02418000|63195738|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
33688353|NCT02418000|63195739|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
33688354|NCT02418000|63195740|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
33688355|NCT02418000|63195736|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
33688356|NCT02418000|63195737|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
33688357|NCT02418000|63195738|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
33688358|NCT02418000|63195739|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
33688359|NCT02418000|63195740|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
33688360|NCT02418000|63195736|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
33688361|NCT02418000|63195737|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
33688362|NCT02418000|63195738|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
33688363|NCT02418000|63195739|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
33688364|NCT02418000|63195740|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
33688365|NCT02418000|63195736|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
33688366|NCT02418000|63195737|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
33688367|NCT02418000|63195738|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
33688368|NCT02418000|63195739|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
33688369|NCT02418000|63195740|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
33688370|NCT02418000|63195736|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33688371|NCT02418000|63195737|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33688372|NCT02418000|63195738|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
33688373|NCT02418000|63195739|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33688374|NCT02418000|63195740|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33688375|NCT02418000|63195736|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33688376|NCT02418000|63195737|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33688377|NCT02418000|63195738|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33688378|NCT02418000|63195739|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
33688379|NCT02418000|63195740|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33688380|NCT02418000|63195736|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
33688381|NCT02418000|63195737|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
33688382|NCT02418000|63195738|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
33688383|NCT02418000|63195739|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
33688384|NCT02418000|63195740|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
33688385|NCT02418000|63195736|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33688386|NCT02418000|63195737|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33688387|NCT02418000|63195738|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33688388|NCT02418000|63195739|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33688389|NCT02418000|63195740|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
33688390|NCT02417064|63195844|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
33688391|NCT02417064|63195845|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
33688392|NCT02417064|63195846|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
33688393|NCT02417064|63195844|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
33688394|NCT02417064|63195845|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
33688395|NCT02417064|63195846|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
33688396|NCT02417064|63195844|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
33688397|NCT02417064|63195845|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
33688398|NCT02417064|63195846|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
33688399|NCT02417064|63195844|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
33688400|NCT02417064|63195845|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
33688401|NCT02417064|63195846|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
33688402|NCT02417064|63195844|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
33688403|NCT02417064|63195845|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
33688404|NCT02417064|63195846|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
33688405|NCT02417064|63195844|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
33688406|NCT02417064|63195845|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
33688407|NCT02417064|63195846|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
33688408|NCT02417064|63195844|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
33688409|NCT02417064|63195845|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
33688410|NCT02417064|63195846|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
33688411|NCT02417064|63195844|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
33688412|NCT02417064|63195845|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
33688413|NCT02417064|63195846|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
33688414|NCT02417064|63195844|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
33688415|NCT02417064|63195845|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
33688416|NCT02417064|63195846|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
33688417|NCT02417064|63195844|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
33688418|NCT02417064|63195845|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
33688419|NCT02417064|63195846|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
33688420|NCT02417064|63195844|FG000|Follow-up Phase (24 Weeks)|Other|2|||
33688421|NCT02417064|63195845|FG001|Follow-up Phase (24 Weeks)|Other|2|||
33688422|NCT02417064|63195846|FG002|Follow-up Phase (24 Weeks)|Other|3|||
33688423|NCT01653132|63195861|FG000|First Intervention|Protocol Violation|1|||
33688424|NCT01653132|63195862|FG001|First Intervention|Protocol Violation|0|||
33688425|NCT02453334|63195887|FG000|Overall Study|Death|15|||
33688426|NCT02453334|63195888|FG001|Overall Study|Death|13|||
33688427|NCT02453334|63195887|FG000|Overall Study|Adverse Event|2|||
33688428|NCT02453334|63195888|FG001|Overall Study|Adverse Event|1|||
33688429|NCT02453334|63195887|FG000|Overall Study|Lost to Follow-up|5|||
33688430|NCT02453334|63195888|FG001|Overall Study|Lost to Follow-up|9|||
33596004|NCT02151903|62994887|FG000|Overall Study|Progressive disease|2|||
33596005|NCT02151903|62994888|FG001|Overall Study|Progressive disease|1|||
33688431|NCT02453334|63195887|FG000|Overall Study|Physician Decision|1|||
33688432|NCT02453334|63195888|FG001|Overall Study|Physician Decision|0|||
33688433|NCT02453334|63195887|FG000|Overall Study|Withdrawal by Subject|17|||
33688434|NCT02453334|63195888|FG001|Overall Study|Withdrawal by Subject|13|||
33688435|NCT02453334|63195887|FG000|Overall Study|Other reason|1|||
33688436|NCT02453334|63195888|FG001|Overall Study|Other reason|4|||
33688437|NCT02443740|63195974|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
33688438|NCT02443740|63195975|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
33688439|NCT02443740|63195976|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
33688440|NCT02443740|63195977|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
33688441|NCT02443740|63195978|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
33688442|NCT02443740|63195979|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
33688443|NCT02443740|63195980|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
33688444|NCT02443740|63195981|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
33688445|NCT02443740|63195982|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
33688446|NCT02443740|63195983|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
33688447|NCT02443740|63195984|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
33688448|NCT02443740|63195974|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
33688449|NCT02443740|63195975|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33688450|NCT02443740|63195976|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33688451|NCT02443740|63195977|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33688452|NCT02443740|63195978|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33688453|NCT02443740|63195979|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33688454|NCT02443740|63195980|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
33688455|NCT02443740|63195981|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33688456|NCT02443740|63195982|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33688457|NCT02443740|63195983|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33688458|NCT02443740|63195984|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33688459|NCT02443740|63195974|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33688460|NCT02443740|63195975|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33688461|NCT02443740|63195976|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33688462|NCT02443740|63195977|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33688463|NCT02443740|63195978|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33688464|NCT02443740|63195979|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
33688465|NCT02443740|63195980|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33688466|NCT02443740|63195981|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33688467|NCT02443740|63195982|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33688468|NCT02443740|63195983|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33688469|NCT02443740|63195984|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33688470|NCT02416908|63196215|FG000|Dose Escalation Phase|Adverse Event|0|||
33688471|NCT02416908|63196216|FG001|Dose Escalation Phase|Adverse Event|0|||
33688472|NCT02416908|63196217|FG002|Dose Escalation Phase|Adverse Event|3|||
33688473|NCT02416908|63196218|FG003|Dose Escalation Phase|Adverse Event|0|||
33688474|NCT02416908|63196215|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
33688475|NCT02416908|63196216|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
33688476|NCT02416908|63196217|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
33688477|NCT02416908|63196218|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
33688478|NCT02453256|63196308|FG000|Double Blind Period|Death|1|||
33688479|NCT02453256|63196309|FG001|Double Blind Period|Death|1|||
33688480|NCT02453256|63196308|FG000|Double Blind Period|Adverse Event|3|||
33688481|NCT02453256|63196309|FG001|Double Blind Period|Adverse Event|2|||
33688482|NCT02453256|63196308|FG000|Double Blind Period|Withdrawal by Subject|9|||
33688483|NCT02453256|63196309|FG001|Double Blind Period|Withdrawal by Subject|5|||
33688484|NCT02453256|63196308|FG000|Double Blind Period|Other|0|||
33688485|NCT02453256|63196309|FG001|Double Blind Period|Other|1|||
33688486|NCT02453256|63196308|FG000|Open Label Period|Adverse Event|1|||
33688487|NCT02453256|63196309|FG001|Open Label Period|Adverse Event|3|||
33688488|NCT02453256|63196308|FG000|Open Label Period|Death|0|||
33688489|NCT02453256|63196309|FG001|Open Label Period|Death|1|||
33688490|NCT02453256|63196308|FG000|Open Label Period|Lost to Follow-up|1|||
33688491|NCT02453256|63196309|FG001|Open Label Period|Lost to Follow-up|0|||
33688492|NCT02453256|63196308|FG000|Open Label Period|Other|0|||
33688493|NCT02453256|63196309|FG001|Open Label Period|Other|2|||
33688494|NCT02453256|63196308|FG000|Open Label Period|Withdrawal by Subject|5|||
33688495|NCT02453256|63196309|FG001|Open Label Period|Withdrawal by Subject|1|||
33688496|NCT02442804|63196324|FG000|Overall Study|Withdrawal by Subject|0|||
33688497|NCT02442804|63196325|FG001|Overall Study|Withdrawal by Subject|1|||
33688498|NCT02442804|63196324|FG000|Overall Study|Adverse Event|1|||
33401441|NCT00256867|62780480|FG006|Overall Study|Lost to Follow-up|1|||
33688499|NCT02442804|63196325|FG001|Overall Study|Adverse Event|0|||
33688500|NCT02414958|63196414|FG000|Overall Study|Adverse Event|6|||
33688501|NCT02414958|63196415|FG001|Overall Study|Adverse Event|6|||
33688502|NCT02414958|63196416|FG002|Overall Study|Adverse Event|3|||
33688503|NCT02414958|63196414|FG000|Overall Study|Protocol Violation|10|||
33688504|NCT02414958|63196415|FG001|Overall Study|Protocol Violation|3|||
33688505|NCT02414958|63196416|FG002|Overall Study|Protocol Violation|1|||
33688506|NCT02414958|63196414|FG000|Overall Study|Lost to Follow-up|7|||
33688507|NCT02414958|63196415|FG001|Overall Study|Lost to Follow-up|4|||
33688508|NCT02414958|63196416|FG002|Overall Study|Lost to Follow-up|0|||
33688509|NCT02414958|63196414|FG000|Overall Study|Withdrawal by Subject|5|||
33688510|NCT02414958|63196415|FG001|Overall Study|Withdrawal by Subject|3|||
33688511|NCT02414958|63196416|FG002|Overall Study|Withdrawal by Subject|5|||
33688512|NCT02414958|63196414|FG000|Overall Study|Other than specified|4|||
33688513|NCT02414958|63196415|FG001|Overall Study|Other than specified|4|||
33688514|NCT02414958|63196416|FG002|Overall Study|Other than specified|5|||
33688515|NCT02452476|63196489|FG000|Overall Study|Death|4|||
33688516|NCT02452476|63196490|FG001|Overall Study|Death|7|||
33688517|NCT02452476|63196489|FG000|Overall Study|Lost to Follow-up|1|||
33688518|NCT02452476|63196490|FG001|Overall Study|Lost to Follow-up|1|||
33688519|NCT02452476|63196489|FG000|Overall Study|Physician Decision|1|||
33688520|NCT02452476|63196490|FG001|Overall Study|Physician Decision|1|||
33688521|NCT02452476|63196489|FG000|Overall Study|Not treated|5|||
33688522|NCT02452476|63196490|FG001|Overall Study|Not treated|1|||
33688523|NCT02442336|63196505|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
33688524|NCT02442336|63196505|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
33688525|NCT02442336|63196505|FG000|Overall Study|Lost to Follow-up|11|||
33688526|NCT02452398|63196509|FG000|Overall Study|Adverse Event|1|||
33688527|NCT02452398|63196509|FG000|Overall Study|Lost to Follow-up|28|||
33688528|NCT02452398|63196509|FG000|Overall Study|Physician Decision|2|||
33688529|NCT02452398|63196509|FG000|Overall Study|Withdrawal by Subject|6|||
33688530|NCT02452398|63196509|FG000|Overall Study|Moved away|4|||
33688531|NCT02413398|63196515|FG000|Overall Study|Lost to Follow-up|2|||
33688532|NCT02413398|63196516|FG001|Overall Study|Lost to Follow-up|4|||
33688533|NCT02413398|63196515|FG000|Overall Study|Withdrawal by Subject|1|||
33688534|NCT02413398|63196516|FG001|Overall Study|Withdrawal by Subject|1|||
33688535|NCT02413398|63196515|FG000|Overall Study|Other Eligibility criteria|1|||
33688536|NCT02413398|63196516|FG001|Overall Study|Other Eligibility criteria|2|||
33688537|NCT02441946|63196525|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
33688538|NCT02441946|63196526|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
33688539|NCT02441946|63196527|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
33688540|NCT02441946|63196525|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
33688541|NCT02441946|63196526|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
33688542|NCT02441946|63196527|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
33688543|NCT02441946|63196525|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
33688544|NCT02441946|63196526|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
33688545|NCT02441946|63196527|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
33688546|NCT02441946|63196525|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
33688547|NCT02441946|63196526|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
33688548|NCT02441946|63196527|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
33688549|NCT02441946|63196525|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
33688550|NCT02441946|63196526|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
33688551|NCT02441946|63196527|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
33688552|NCT02441946|63196525|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
33688553|NCT02441946|63196526|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
33688554|NCT02441946|63196527|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
33688555|NCT02441946|63196525|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
33688556|NCT02441946|63196526|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
33688557|NCT02441946|63196527|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
33688558|NCT02441946|63196525|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
33688559|NCT02441946|63196526|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
33688560|NCT02441946|63196527|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
33688561|NCT02441946|63196525|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
33688562|NCT02441946|63196526|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
33688563|NCT02441946|63196527|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
33688564|NCT02441946|63196525|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
33688565|NCT02441946|63196526|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
33688566|NCT02441946|63196527|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
33688567|NCT02441946|63196525|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
33688568|NCT02441946|63196526|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
33688569|NCT02441946|63196527|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
33688570|NCT02387580|63196561|FG000|Overall Study|Withdrawal by Subject|0|||
33688571|NCT02387580|63196562|FG001|Overall Study|Withdrawal by Subject|0|||
33688572|NCT02387580|63196563|FG002|Overall Study|Withdrawal by Subject|0|||
33688573|NCT02387580|63196564|FG003|Overall Study|Withdrawal by Subject|1|||
33688574|NCT02387580|63196565|FG004|Overall Study|Withdrawal by Subject|0|||
33688575|NCT02387580|63196566|FG005|Overall Study|Withdrawal by Subject|0|||
33688576|NCT02440854|63196582|FG000|Overall Study|Relocation of patient|1|||
33688577|NCT02440854|63196582|FG000|Overall Study|Death|6|||
33688578|NCT02440854|63196582|FG000|Overall Study|Lost to Follow-up|10|||
33688579|NCT02440854|63196582|FG000|Overall Study|Afatinib discontinuation|46|||
33688580|NCT02440854|63196582|FG000|Overall Study|stopped study at earlier timepoint|14|||
33688581|NCT02440854|63196582|FG000|Overall Study|Study medication not received|1|||
33688582|NCT02440854|63196582|FG000|Overall Study|Violation of inclusion criteria|2|||
33688583|NCT02412852|63196637|FG000|Overall Study|Withdrawal by Subject|0|||
33688584|NCT02412852|63196638|FG001|Overall Study|Withdrawal by Subject|1|||
33688585|NCT02412852|63196639|FG002|Overall Study|Withdrawal by Subject|0|||
33688586|NCT02412852|63196640|FG003|Overall Study|Withdrawal by Subject|0|||
33688587|NCT02412852|63196637|FG000|Overall Study|Physician Decision|0|||
33688588|NCT02412852|63196638|FG001|Overall Study|Physician Decision|0|||
33688589|NCT02412852|63196639|FG002|Overall Study|Physician Decision|0|||
33688590|NCT02412852|63196640|FG003|Overall Study|Physician Decision|1|||
33688591|NCT02386098|63196696|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
33688592|NCT02386098|63196697|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
33688593|NCT02386098|63196698|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
33688594|NCT02386098|63196699|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
33688595|NCT02386098|63196700|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
33688596|NCT02386098|63196696|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
33688597|NCT02386098|63196697|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
33688598|NCT02386098|63196698|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
33688599|NCT02386098|63196699|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
33688600|NCT02386098|63196700|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
33688601|NCT02386098|63196696|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
33688602|NCT02386098|63196697|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
33688603|NCT02386098|63196698|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
33688604|NCT02386098|63196699|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
33688605|NCT02386098|63196700|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
33688606|NCT02386098|63196696|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
33688607|NCT02386098|63196697|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
33688608|NCT02386098|63196698|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
33688609|NCT02386098|63196699|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
33688610|NCT02386098|63196700|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
33688611|NCT02386098|63196696|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
33688612|NCT02386098|63196697|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
33688613|NCT02386098|63196698|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
33688614|NCT02386098|63196699|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
33688615|NCT02386098|63196700|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
33688616|NCT02386098|63196696|FG000|Stage 1 (96 Weeks)|Other|1|||
33688617|NCT02386098|63196697|FG001|Stage 1 (96 Weeks)|Other|0|||
33688618|NCT02386098|63196698|FG002|Stage 1 (96 Weeks)|Other|0|||
33688619|NCT02386098|63196699|FG003|Stage 1 (96 Weeks)|Other|0|||
33688620|NCT02386098|63196700|FG004|Stage 1 (96 Weeks)|Other|0|||
33688621|NCT02386098|63196696|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
33688622|NCT02386098|63196697|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
33688623|NCT02386098|63196698|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
33688624|NCT02386098|63196699|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
33688625|NCT02386098|63196700|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
33688626|NCT02412618|63196743|FG000|Overall Study|Withdrawal by Subject|1|||
33688627|NCT02412618|63196744|FG001|Overall Study|Withdrawal by Subject|1|||
33688628|NCT02412618|63196743|FG000|Overall Study|Expulsion|1|||
33688629|NCT02412618|63196744|FG001|Overall Study|Expulsion|1|||
33688630|NCT00585195|63196941|FG000|Overall Study|Adverse Event|0|||
33688631|NCT00585195|63196942|FG001|Overall Study|Adverse Event|0|||
33688632|NCT00585195|63196943|FG002|Overall Study|Adverse Event|0|||
33688633|NCT00585195|63196944|FG003|Overall Study|Adverse Event|0|||
33688634|NCT00585195|63196945|FG004|Overall Study|Adverse Event|2|||
33688635|NCT00585195|63196946|FG005|Overall Study|Adverse Event|1|||
33688636|NCT00585195|63196947|FG006|Overall Study|Adverse Event|0|||
33688637|NCT00585195|63196948|FG007|Overall Study|Adverse Event|1|||
33688638|NCT00585195|63196949|FG008|Overall Study|Adverse Event|0|||
33688639|NCT00585195|63196950|FG009|Overall Study|Adverse Event|0|||
33688640|NCT00585195|63196951|FG010|Overall Study|Adverse Event|3|||
33688641|NCT00585195|63196952|FG011|Overall Study|Adverse Event|0|||
33688642|NCT00585195|63196953|FG012|Overall Study|Adverse Event|8|||
33688643|NCT00585195|63196954|FG013|Overall Study|Adverse Event|6|||
33688644|NCT00585195|63196955|FG014|Overall Study|Adverse Event|4|||
33688645|NCT00585195|63196956|FG015|Overall Study|Adverse Event|1|||
33688646|NCT00585195|63196957|FG016|Overall Study|Adverse Event|14|||
33596006|NCT02151591|62994896|FG000|Overall Study|Lost to Follow-up|6|||
33596007|NCT02151591|62994897|FG001|Overall Study|Lost to Follow-up|3|||
33688647|NCT00585195|63196958|FG017|Overall Study|Adverse Event|9|||
33688648|NCT00585195|63196959|FG018|Overall Study|Adverse Event|2|||
33688649|NCT00585195|63196960|FG019|Overall Study|Adverse Event|3|||
33688650|NCT00585195|63196961|FG020|Overall Study|Adverse Event|1|||
33688651|NCT00585195|63196941|FG000|Overall Study|Progressive Disease|2|||
33688652|NCT00585195|63196942|FG001|Overall Study|Progressive Disease|2|||
33688653|NCT00585195|63196943|FG002|Overall Study|Progressive Disease|5|||
33688654|NCT00585195|63196944|FG003|Overall Study|Progressive Disease|4|||
33688655|NCT00585195|63196945|FG004|Overall Study|Progressive Disease|6|||
33688656|NCT00585195|63196946|FG005|Overall Study|Progressive Disease|4|||
33688657|NCT00585195|63196947|FG006|Overall Study|Progressive Disease|6|||
33688658|NCT00585195|63196948|FG007|Overall Study|Progressive Disease|3|||
33688659|NCT00585195|63196949|FG008|Overall Study|Progressive Disease|0|||
33688660|NCT00585195|63196950|FG009|Overall Study|Progressive Disease|5|||
33688661|NCT00585195|63196951|FG010|Overall Study|Progressive Disease|2|||
33688662|NCT00585195|63196952|FG011|Overall Study|Progressive Disease|25|||
33688663|NCT00585195|63196953|FG012|Overall Study|Progressive Disease|29|||
33688664|NCT00585195|63196954|FG013|Overall Study|Progressive Disease|26|||
33688665|NCT00585195|63196955|FG014|Overall Study|Progressive Disease|21|||
33688666|NCT00585195|63196956|FG015|Overall Study|Progressive Disease|12|||
33688667|NCT00585195|63196957|FG016|Overall Study|Progressive Disease|94|||
33688668|NCT00585195|63196958|FG017|Overall Study|Progressive Disease|42|||
33688669|NCT00585195|63196959|FG018|Overall Study|Progressive Disease|4|||
33688670|NCT00585195|63196960|FG019|Overall Study|Progressive Disease|9|||
33688671|NCT00585195|63196961|FG020|Overall Study|Progressive Disease|8|||
33688672|NCT00585195|63196941|FG000|Overall Study|Withdrawal by Subject|1|||
33688673|NCT00585195|63196942|FG001|Overall Study|Withdrawal by Subject|1|||
33688674|NCT00585195|63196943|FG002|Overall Study|Withdrawal by Subject|2|||
33688675|NCT00585195|63196944|FG003|Overall Study|Withdrawal by Subject|2|||
33688676|NCT00585195|63196945|FG004|Overall Study|Withdrawal by Subject|0|||
33688677|NCT00585195|63196946|FG005|Overall Study|Withdrawal by Subject|0|||
33688678|NCT00585195|63196947|FG006|Overall Study|Withdrawal by Subject|0|||
33688679|NCT00585195|63196948|FG007|Overall Study|Withdrawal by Subject|1|||
33688680|NCT00585195|63196949|FG008|Overall Study|Withdrawal by Subject|0|||
33688681|NCT00585195|63196950|FG009|Overall Study|Withdrawal by Subject|0|||
33688682|NCT00585195|63196951|FG010|Overall Study|Withdrawal by Subject|3|||
33688683|NCT00585195|63196952|FG011|Overall Study|Withdrawal by Subject|8|||
33688684|NCT00585195|63196953|FG012|Overall Study|Withdrawal by Subject|15|||
33688685|NCT00585195|63196954|FG013|Overall Study|Withdrawal by Subject|0|||
33688686|NCT00585195|63196955|FG014|Overall Study|Withdrawal by Subject|3|||
33688687|NCT00585195|63196956|FG015|Overall Study|Withdrawal by Subject|0|||
33688688|NCT00585195|63196957|FG016|Overall Study|Withdrawal by Subject|7|||
33688689|NCT00585195|63196958|FG017|Overall Study|Withdrawal by Subject|1|||
33688690|NCT00585195|63196959|FG018|Overall Study|Withdrawal by Subject|2|||
33688691|NCT00585195|63196960|FG019|Overall Study|Withdrawal by Subject|2|||
33688692|NCT00585195|63196961|FG020|Overall Study|Withdrawal by Subject|0|||
33688693|NCT00585195|63196941|FG000|Overall Study|Other|0|||
33688694|NCT00585195|63196942|FG001|Overall Study|Other|1|||
33688695|NCT00585195|63196943|FG002|Overall Study|Other|1|||
33688696|NCT00585195|63196944|FG003|Overall Study|Other|1|||
33688697|NCT00585195|63196945|FG004|Overall Study|Other|0|||
33688698|NCT00585195|63196946|FG005|Overall Study|Other|1|||
33688699|NCT00585195|63196947|FG006|Overall Study|Other|0|||
33688700|NCT00585195|63196948|FG007|Overall Study|Other|0|||
33688701|NCT00585195|63196949|FG008|Overall Study|Other|2|||
33688702|NCT00585195|63196950|FG009|Overall Study|Other|1|||
33688703|NCT00585195|63196951|FG010|Overall Study|Other|0|||
33688704|NCT00585195|63196952|FG011|Overall Study|Other|19|||
33688705|NCT00585195|63196953|FG012|Overall Study|Other|24|||
33688706|NCT00585195|63196954|FG013|Overall Study|Other|7|||
33688707|NCT00585195|63196955|FG014|Overall Study|Other|11|||
33688708|NCT00585195|63196956|FG015|Overall Study|Other|3|||
33688709|NCT00585195|63196957|FG016|Overall Study|Other|28|||
33688710|NCT00585195|63196958|FG017|Overall Study|Other|12|||
33688711|NCT00585195|63196959|FG018|Overall Study|Other|10|||
33688712|NCT00585195|63196960|FG019|Overall Study|Other|4|||
33688713|NCT00585195|63196961|FG020|Overall Study|Other|2|||
33688714|NCT00585195|63196941|FG000|Overall Study|Randomized not treated|0|||
33688715|NCT00585195|63196942|FG001|Overall Study|Randomized not treated|0|||
33688716|NCT00585195|63196943|FG002|Overall Study|Randomized not treated|1|||
33688717|NCT00585195|63196944|FG003|Overall Study|Randomized not treated|0|||
33688718|NCT00585195|63196945|FG004|Overall Study|Randomized not treated|1|||
33688719|NCT00585195|63196946|FG005|Overall Study|Randomized not treated|0|||
33688720|NCT00585195|63196947|FG006|Overall Study|Randomized not treated|1|||
33688721|NCT00585195|63196948|FG007|Overall Study|Randomized not treated|0|||
33688722|NCT00585195|63196949|FG008|Overall Study|Randomized not treated|0|||
33688723|NCT00585195|63196950|FG009|Overall Study|Randomized not treated|0|||
33688724|NCT00585195|63196951|FG010|Overall Study|Randomized not treated|2|||
33688725|NCT00585195|63196952|FG011|Overall Study|Randomized not treated|0|||
33688726|NCT00585195|63196953|FG012|Overall Study|Randomized not treated|0|||
33688727|NCT00585195|63196954|FG013|Overall Study|Randomized not treated|0|||
33688728|NCT00585195|63196955|FG014|Overall Study|Randomized not treated|0|||
33688729|NCT00585195|63196956|FG015|Overall Study|Randomized not treated|1|||
33688730|NCT00585195|63196957|FG016|Overall Study|Randomized not treated|0|||
33688731|NCT00585195|63196958|FG017|Overall Study|Randomized not treated|1|||
33688732|NCT00585195|63196959|FG018|Overall Study|Randomized not treated|3|||
33688733|NCT00585195|63196960|FG019|Overall Study|Randomized not treated|0|||
33688734|NCT00585195|63196961|FG020|Overall Study|Randomized not treated|2|||
33688735|NCT00585195|63196941|FG000|Overall Study|Death|0|||
33688736|NCT00585195|63196942|FG001|Overall Study|Death|0|||
33688737|NCT00585195|63196943|FG002|Overall Study|Death|0|||
33688738|NCT00585195|63196944|FG003|Overall Study|Death|0|||
33688739|NCT00585195|63196945|FG004|Overall Study|Death|0|||
33688740|NCT00585195|63196946|FG005|Overall Study|Death|0|||
33688741|NCT00585195|63196947|FG006|Overall Study|Death|0|||
33688742|NCT00585195|63196948|FG007|Overall Study|Death|0|||
33688743|NCT00585195|63196949|FG008|Overall Study|Death|1|||
33688744|NCT00585195|63196950|FG009|Overall Study|Death|0|||
33688745|NCT00585195|63196951|FG010|Overall Study|Death|1|||
33688746|NCT00585195|63196952|FG011|Overall Study|Death|1|||
33688747|NCT00585195|63196953|FG012|Overall Study|Death|7|||
33688748|NCT00585195|63196954|FG013|Overall Study|Death|2|||
33688749|NCT00585195|63196955|FG014|Overall Study|Death|8|||
33688750|NCT00585195|63196956|FG015|Overall Study|Death|2|||
33688751|NCT00585195|63196957|FG016|Overall Study|Death|11|||
33688752|NCT00585195|63196958|FG017|Overall Study|Death|0|||
33688753|NCT00585195|63196959|FG018|Overall Study|Death|0|||
33688754|NCT00585195|63196960|FG019|Overall Study|Death|0|||
33688755|NCT00585195|63196961|FG020|Overall Study|Death|1|||
33688756|NCT00585195|63196941|FG000|Overall Study|Lost to Follow-up|0|||
33688757|NCT00585195|63196942|FG001|Overall Study|Lost to Follow-up|0|||
33688758|NCT00585195|63196943|FG002|Overall Study|Lost to Follow-up|0|||
33688759|NCT00585195|63196944|FG003|Overall Study|Lost to Follow-up|0|||
33688760|NCT00585195|63196945|FG004|Overall Study|Lost to Follow-up|0|||
33688761|NCT00585195|63196946|FG005|Overall Study|Lost to Follow-up|0|||
33688762|NCT00585195|63196947|FG006|Overall Study|Lost to Follow-up|0|||
33688763|NCT00585195|63196948|FG007|Overall Study|Lost to Follow-up|0|||
33688764|NCT00585195|63196949|FG008|Overall Study|Lost to Follow-up|0|||
33688765|NCT00585195|63196950|FG009|Overall Study|Lost to Follow-up|0|||
33596008|NCT02174523|62994905|FG000|Overall Study|Withdrawal by Subject|1|||
33688766|NCT00585195|63196951|FG010|Overall Study|Lost to Follow-up|0|||
33688767|NCT00585195|63196952|FG011|Overall Study|Lost to Follow-up|0|||
33688768|NCT00585195|63196953|FG012|Overall Study|Lost to Follow-up|1|||
33688769|NCT00585195|63196954|FG013|Overall Study|Lost to Follow-up|0|||
33688770|NCT00585195|63196955|FG014|Overall Study|Lost to Follow-up|0|||
33688771|NCT00585195|63196956|FG015|Overall Study|Lost to Follow-up|0|||
33688772|NCT00585195|63196957|FG016|Overall Study|Lost to Follow-up|0|||
33688773|NCT00585195|63196958|FG017|Overall Study|Lost to Follow-up|2|||
33688774|NCT00585195|63196959|FG018|Overall Study|Lost to Follow-up|0|||
33688775|NCT00585195|63196960|FG019|Overall Study|Lost to Follow-up|0|||
33688776|NCT00585195|63196961|FG020|Overall Study|Lost to Follow-up|0|||
33688777|NCT00585195|63196941|FG000|Overall Study|Site Terminated by Sponsor|0|||
33688778|NCT00585195|63196942|FG001|Overall Study|Site Terminated by Sponsor|0|||
33688779|NCT00585195|63196943|FG002|Overall Study|Site Terminated by Sponsor|0|||
33688780|NCT00585195|63196944|FG003|Overall Study|Site Terminated by Sponsor|0|||
33688781|NCT00585195|63196945|FG004|Overall Study|Site Terminated by Sponsor|0|||
33688782|NCT00585195|63196946|FG005|Overall Study|Site Terminated by Sponsor|0|||
33688783|NCT00585195|63196947|FG006|Overall Study|Site Terminated by Sponsor|0|||
33688784|NCT00585195|63196948|FG007|Overall Study|Site Terminated by Sponsor|0|||
33688785|NCT00585195|63196949|FG008|Overall Study|Site Terminated by Sponsor|0|||
33688786|NCT00585195|63196950|FG009|Overall Study|Site Terminated by Sponsor|0|||
33688787|NCT00585195|63196951|FG010|Overall Study|Site Terminated by Sponsor|0|||
33688788|NCT00585195|63196952|FG011|Overall Study|Site Terminated by Sponsor|0|||
33688789|NCT00585195|63196953|FG012|Overall Study|Site Terminated by Sponsor|1|||
33688790|NCT00585195|63196954|FG013|Overall Study|Site Terminated by Sponsor|0|||
33688791|NCT00585195|63196955|FG014|Overall Study|Site Terminated by Sponsor|0|||
33688792|NCT00585195|63196956|FG015|Overall Study|Site Terminated by Sponsor|0|||
33688793|NCT00585195|63196957|FG016|Overall Study|Site Terminated by Sponsor|0|||
33688794|NCT00585195|63196958|FG017|Overall Study|Site Terminated by Sponsor|0|||
33688795|NCT00585195|63196959|FG018|Overall Study|Site Terminated by Sponsor|0|||
33688796|NCT00585195|63196960|FG019|Overall Study|Site Terminated by Sponsor|0|||
33688797|NCT00585195|63196961|FG020|Overall Study|Site Terminated by Sponsor|0|||
33688798|NCT00585195|63196941|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
33688799|NCT00585195|63196942|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
33596009|NCT02174523|62994906|FG001|Overall Study|Withdrawal by Subject|0|||
33688800|NCT00585195|63196943|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
33688801|NCT00585195|63196944|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
33688802|NCT00585195|63196945|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
33688803|NCT00585195|63196946|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
33688804|NCT00585195|63196947|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
33688805|NCT00585195|63196948|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
33688806|NCT00585195|63196949|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
33688807|NCT00585195|63196950|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
33688808|NCT00585195|63196951|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
33688809|NCT00585195|63196952|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
33688810|NCT00585195|63196953|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
33688811|NCT00585195|63196954|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
33688812|NCT00585195|63196955|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
33688813|NCT00585195|63196956|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
33688814|NCT00585195|63196957|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
33688815|NCT00585195|63196958|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
33688816|NCT00585195|63196959|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
33688817|NCT00585195|63196960|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
33688818|NCT00585195|63196961|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
33688819|NCT02439216|63197133|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
33688820|NCT02439216|63197134|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33688821|NCT02439216|63197135|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33688822|NCT02439216|63197136|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33688823|NCT02439216|63197137|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33688824|NCT02439216|63197138|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33688825|NCT02439216|63197139|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33688826|NCT02439216|63197140|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33688827|NCT02439216|63197141|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33688828|NCT02439216|63197133|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33688829|NCT02439216|63197134|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33688830|NCT02439216|63197135|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33688831|NCT02439216|63197136|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33688832|NCT02439216|63197137|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33688833|NCT02439216|63197138|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33688834|NCT02439216|63197139|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33688835|NCT02439216|63197140|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
33688836|NCT02439216|63197141|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33688837|NCT02439216|63197133|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
33688838|NCT02439216|63197134|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
33688839|NCT02439216|63197135|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
33688840|NCT02439216|63197136|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
33688841|NCT02439216|63197137|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
33688842|NCT02439216|63197138|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
33688843|NCT02439216|63197139|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
33688844|NCT02439216|63197140|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
33688845|NCT02439216|63197141|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
33688846|NCT02439216|63197133|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33688847|NCT02439216|63197134|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33688848|NCT02439216|63197135|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33688849|NCT02439216|63197136|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33688850|NCT02439216|63197137|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33688851|NCT02439216|63197138|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33688852|NCT02439216|63197139|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33688853|NCT02439216|63197140|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33688854|NCT02439216|63197141|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
33688855|NCT02439216|63197133|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
33688856|NCT02439216|63197134|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
33688857|NCT02439216|63197135|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
33688858|NCT02439216|63197136|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
33688859|NCT02439216|63197137|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
33688860|NCT02439216|63197138|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
33688861|NCT02439216|63197139|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
33688862|NCT02439216|63197140|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
33688863|NCT02439216|63197141|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
33688864|NCT02439138|63197169|FG000|Overall Study|Adverse Event|1|||
33688865|NCT02439138|63197169|FG000|Overall Study|PI decision to terminate the study|2|||
33688866|NCT02438826|63197545|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
33688867|NCT02438826|63197546|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
33688868|NCT02438826|63197547|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
33688869|NCT02438826|63197548|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
33688870|NCT02438826|63197545|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
33688871|NCT02438826|63197546|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
33688872|NCT02438826|63197547|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
33688873|NCT02438826|63197548|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
33688874|NCT02438826|63197545|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
33688875|NCT02438826|63197546|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
33688876|NCT02438826|63197547|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
33688877|NCT02438826|63197548|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
33688878|NCT02438826|63197545|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
33688879|NCT02438826|63197546|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
33688880|NCT02438826|63197547|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
33688881|NCT02438826|63197548|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
33688882|NCT02438826|63197545|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
33688883|NCT02438826|63197546|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
33688884|NCT02438826|63197547|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
33688885|NCT02438826|63197548|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
33688886|NCT02438826|63197545|FG000|Open-Label Treatment Phase|Adverse Event|11|||
33688887|NCT02438826|63197546|FG001|Open-Label Treatment Phase|Adverse Event|6|||
33688888|NCT02438826|63197547|FG002|Open-Label Treatment Phase|Adverse Event|0|||
33688889|NCT02438826|63197548|FG003|Open-Label Treatment Phase|Adverse Event|0|||
33688890|NCT02438826|63197545|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
33688891|NCT02438826|63197546|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
33688892|NCT02438826|63197547|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
33688893|NCT02438826|63197548|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
33688894|NCT02438826|63197545|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
33688895|NCT02438826|63197546|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
33688896|NCT02438826|63197547|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
33688897|NCT02438826|63197548|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
33688898|NCT02438826|63197545|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
33688899|NCT02438826|63197546|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
33688900|NCT02438826|63197547|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
33688901|NCT02438826|63197548|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
33688902|NCT02438826|63197545|FG000|Post-Treatment Phase|Adverse Event|3|||
33688903|NCT02438826|63197546|FG001|Post-Treatment Phase|Adverse Event|0|||
33688904|NCT02438826|63197547|FG002|Post-Treatment Phase|Adverse Event|0|||
33688905|NCT02438826|63197548|FG003|Post-Treatment Phase|Adverse Event|0|||
33688906|NCT02438826|63197545|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
33688907|NCT02438826|63197546|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
33688908|NCT02438826|63197547|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
33688909|NCT02438826|63197548|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
33688910|NCT02438826|63197545|FG000|Post-Treatment Phase|Physician Decision|1|||
33688911|NCT02438826|63197546|FG001|Post-Treatment Phase|Physician Decision|0|||
33688912|NCT02438826|63197547|FG002|Post-Treatment Phase|Physician Decision|0|||
33688913|NCT02438826|63197548|FG003|Post-Treatment Phase|Physician Decision|0|||
33688914|NCT02438826|63197545|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
33688915|NCT02438826|63197546|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
33688916|NCT02438826|63197547|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
33688917|NCT02438826|63197548|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
33688918|NCT02438280|63197565|FG000|Overall Study|Physician Decision|1|||
33688919|NCT02438280|63197566|FG001|Overall Study|Physician Decision|0|||
33688920|NCT02385708|63197584|FG000|Overall Study|Withdrawal by Subject|0|||
33688921|NCT02385708|63197585|FG001|Overall Study|Withdrawal by Subject|2|||
33688922|NCT02385708|63197584|FG000|Overall Study|Withdrawn - surgery canceled|2|||
33688923|NCT02385708|63197585|FG001|Overall Study|Withdrawn - surgery canceled|5|||
33688924|NCT02385708|63197584|FG000|Overall Study|Investigator decision|5|||
33688925|NCT02385708|63197585|FG001|Overall Study|Investigator decision|7|||
33688926|NCT02385708|63197584|FG000|Overall Study|Protocol Violation|1|||
33688927|NCT02385708|63197585|FG001|Overall Study|Protocol Violation|1|||
33688928|NCT02385084|63198324|FG000|Period 2|Protocol Violation|0|||
33688929|NCT02385084|63198325|FG001|Period 2|Protocol Violation|0|||
33688930|NCT02385084|63198326|FG002|Period 2|Protocol Violation|1|||
33688931|NCT02385084|63198327|FG003|Period 2|Protocol Violation|0|||
33688932|NCT02385084|63198328|FG004|Period 2|Protocol Violation|0|||
33688933|NCT02385084|63198329|FG005|Period 2|Protocol Violation|0|||
33688934|NCT02411292|63198338|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
33688935|NCT02411292|63198338|FG000|Overall Study|Death|2|||
33688936|NCT02411292|63198338|FG000|Overall Study|Lost to Follow-up|3|||
33688937|NCT02384850|63198401|FG000|Overall Study|Withdrawal by Subject|2|||
33688938|NCT02384850|63198402|FG001|Overall Study|Withdrawal by Subject|2|||
33688939|NCT02437890|63198624|FG000|Overall Study|Non-compliance to study drug|0|||
33688940|NCT02437890|63198625|FG001|Overall Study|Non-compliance to study drug|1|||
33688941|NCT02437890|63198626|FG002|Overall Study|Non-compliance to study drug|0|||
33688942|NCT02437890|63198627|FG003|Overall Study|Non-compliance to study drug|0|||
33688943|NCT02437890|63198628|FG004|Overall Study|Non-compliance to study drug|1|||
33688944|NCT02437890|63198624|FG000|Overall Study|Sponsor's decision|1|||
33688945|NCT02437890|63198625|FG001|Overall Study|Sponsor's decision|1|||
33688946|NCT02437890|63198626|FG002|Overall Study|Sponsor's decision|4|||
33688947|NCT02437890|63198627|FG003|Overall Study|Sponsor's decision|0|||
33688948|NCT02437890|63198628|FG004|Overall Study|Sponsor's decision|2|||
33688949|NCT02437890|63198624|FG000|Overall Study|Physician Decision|0|||
33688950|NCT02437890|63198625|FG001|Overall Study|Physician Decision|0|||
33688951|NCT02437890|63198626|FG002|Overall Study|Physician Decision|0|||
33688952|NCT02437890|63198627|FG003|Overall Study|Physician Decision|1|||
33688953|NCT02437890|63198628|FG004|Overall Study|Physician Decision|0|||
33688954|NCT02437890|63198624|FG000|Overall Study|Unable to attend visit(s)|1|||
33688955|NCT02437890|63198625|FG001|Overall Study|Unable to attend visit(s)|0|||
33688956|NCT02437890|63198626|FG002|Overall Study|Unable to attend visit(s)|0|||
33688957|NCT02437890|63198627|FG003|Overall Study|Unable to attend visit(s)|0|||
33688958|NCT02437890|63198628|FG004|Overall Study|Unable to attend visit(s)|0|||
33688959|NCT02437890|63198624|FG000|Overall Study|Lack of Efficacy|1|||
33688960|NCT02437890|63198625|FG001|Overall Study|Lack of Efficacy|3|||
33688961|NCT02437890|63198626|FG002|Overall Study|Lack of Efficacy|0|||
33688962|NCT02437890|63198627|FG003|Overall Study|Lack of Efficacy|3|||
33688963|NCT02437890|63198628|FG004|Overall Study|Lack of Efficacy|1|||
33688964|NCT02437890|63198624|FG000|Overall Study|Adverse Event|4|||
33688965|NCT02437890|63198625|FG001|Overall Study|Adverse Event|9|||
33688966|NCT02437890|63198626|FG002|Overall Study|Adverse Event|5|||
33688967|NCT02437890|63198627|FG003|Overall Study|Adverse Event|11|||
33493158|NCT02640664|62871276|FG002|Epoch 1|Death|1|||
33493159|NCT02640664|62871274|FG000|Epoch 2|Withdrawal of informed consent|3|||
33596010|NCT02297815|62994913|FG000|Overall Study|Lost to Follow-up|236|||
33688968|NCT02437890|63198628|FG004|Overall Study|Adverse Event|7|||
33688969|NCT02437890|63198624|FG000|Overall Study|Withdrawal by Subject|1|||
33688970|NCT02437890|63198625|FG001|Overall Study|Withdrawal by Subject|2|||
33688971|NCT02437890|63198626|FG002|Overall Study|Withdrawal by Subject|6|||
33688972|NCT02437890|63198627|FG003|Overall Study|Withdrawal by Subject|5|||
33688973|NCT02437890|63198628|FG004|Overall Study|Withdrawal by Subject|5|||
33688974|NCT02437890|63198624|FG000|Overall Study|Death|0|||
33688975|NCT02437890|63198625|FG001|Overall Study|Death|0|||
33688976|NCT02437890|63198626|FG002|Overall Study|Death|0|||
33688977|NCT02437890|63198627|FG003|Overall Study|Death|2|||
33688978|NCT02437890|63198628|FG004|Overall Study|Death|0|||
33688979|NCT02384538|63198689|FG000|Overall Study|Adverse Event|1|||
33688980|NCT02384538|63198690|FG001|Overall Study|Adverse Event|4|||
33688981|NCT02384538|63198689|FG000|Overall Study|Lack of Efficacy|4|||
33688982|NCT02384538|63198690|FG001|Overall Study|Lack of Efficacy|4|||
33688983|NCT02384538|63198689|FG000|Overall Study|Withdrew Consent|0|||
33688984|NCT02384538|63198690|FG001|Overall Study|Withdrew Consent|4|||
33688985|NCT02384538|63198689|FG000|Overall Study|Other|1|||
33688986|NCT02384538|63198690|FG001|Overall Study|Other|3|||
33688987|NCT02410824|63198714|FG000|First Intervention (One Week)|Headache|0|||
33688988|NCT02410824|63198715|FG001|First Intervention (One Week)|Headache|1|||
33688989|NCT02384460|63198745|FG000|Overall Study|Protocol Violation|0|||
33688990|NCT02384460|63198746|FG001|Overall Study|Protocol Violation|1|||
33688991|NCT02384460|63198745|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
33688992|NCT02384460|63198746|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
33688993|NCT02384460|63198745|FG000|Overall Study|Adverse Event|5|||
33688994|NCT02384460|63198746|FG001|Overall Study|Adverse Event|2|||
33688995|NCT02384460|63198745|FG000|Overall Study|Withdrawal by Subject|0|||
33688996|NCT02384460|63198746|FG001|Overall Study|Withdrawal by Subject|3|||
33688997|NCT02384460|63198745|FG000|Overall Study|Elective medical treatment|1|||
33688998|NCT02384460|63198746|FG001|Overall Study|Elective medical treatment|0|||
33688999|NCT02384460|63198745|FG000|Overall Study|Non-compliance|1|||
33689000|NCT02384460|63198746|FG001|Overall Study|Non-compliance|0|||
33689001|NCT02384382|63198769|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
33689002|NCT02384382|63198769|FG000|Overall Study|Death|1|||
33689003|NCT02384382|63198769|FG000|Overall Study|Adverse Event|1|||
33689004|NCT02384382|63198769|FG000|Overall Study|Disease progression|16|||
33689005|NCT02437188|63198789|FG000|Overall Study|Randomized but did not receive surgery|4|||
33689006|NCT02437188|63198790|FG001|Overall Study|Randomized but did not receive surgery|8|||
33689007|NCT02437188|63198789|FG000|Overall Study|Adverse Event|0|||
33689008|NCT02437188|63198790|FG001|Overall Study|Adverse Event|1|||
33689009|NCT02383758|63198812|FG000|Overall Study|Withdrawal by Subject|0|||
33689010|NCT02383758|63198813|FG001|Overall Study|Withdrawal by Subject|2|||
33689011|NCT02410278|63198863|FG000|Run-in Period|Adverse Event|5|||
33689012|NCT02410278|63198864|FG001|Run-in Period|Adverse Event|0|||
33689013|NCT02410278|63198865|FG002|Run-in Period|Adverse Event|0|||
33689014|NCT02410278|63198863|FG000|Run-in Period|GSRS Threshold Not Met|30|||
33689015|NCT02410278|63198864|FG001|Run-in Period|GSRS Threshold Not Met|0|||
33689016|NCT02410278|63198865|FG002|Run-in Period|GSRS Threshold Not Met|0|||
33689017|NCT02410278|63198863|FG000|Run-in Period|Lost to Follow-up|1|||
33689018|NCT02410278|63198864|FG001|Run-in Period|Lost to Follow-up|0|||
33689019|NCT02410278|63198865|FG002|Run-in Period|Lost to Follow-up|0|||
33689020|NCT02410278|63198863|FG000|Run-in Period|Withdrawal by Subject|1|||
33493160|NCT02640664|62871275|FG001|Epoch 2|Withdrawal of informed consent|4|||
33689021|NCT02410278|63198864|FG001|Run-in Period|Withdrawal by Subject|0|||
33689022|NCT02410278|63198865|FG002|Run-in Period|Withdrawal by Subject|0|||
33689023|NCT02410278|63198863|FG000|Run-in Period|Pregnancy|1|||
33689024|NCT02410278|63198864|FG001|Run-in Period|Pregnancy|0|||
33689025|NCT02410278|63198865|FG002|Run-in Period|Pregnancy|0|||
33689026|NCT02410278|63198863|FG000|Study Treatment Period|Adverse Event|0|||
33689027|NCT02410278|63198864|FG001|Study Treatment Period|Adverse Event|6|||
33689028|NCT02410278|63198865|FG002|Study Treatment Period|Adverse Event|3|||
33689029|NCT02410278|63198863|FG000|Study Treatment Period|Physician Decision|0|||
33689030|NCT02410278|63198864|FG001|Study Treatment Period|Physician Decision|0|||
33689031|NCT02410278|63198865|FG002|Study Treatment Period|Physician Decision|1|||
33689032|NCT02410278|63198863|FG000|Study Treatment Period|Withdrawal by Subject|0|||
33689033|NCT02410278|63198864|FG001|Study Treatment Period|Withdrawal by Subject|1|||
33689034|NCT02410278|63198865|FG002|Study Treatment Period|Withdrawal by Subject|0|||
33689035|NCT02410278|63198863|FG000|Study Treatment Period|Other|0|||
33689036|NCT02410278|63198864|FG001|Study Treatment Period|Other|3|||
33689037|NCT02410278|63198865|FG002|Study Treatment Period|Other|0|||
33689038|NCT02410278|63198863|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
33689039|NCT02410278|63198864|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
33689040|NCT02410278|63198865|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
33689041|NCT02410200|63198898|FG000|Overall Study|Adverse Event|2|||
33689042|NCT02383056|63198917|FG000|Overall Study|Adverse Event|1|||
33689043|NCT02383056|63198918|FG001|Overall Study|Adverse Event|0|||
33689044|NCT02383056|63198917|FG000|Overall Study|Lost to Follow-up|0|||
33689045|NCT02383056|63198918|FG001|Overall Study|Lost to Follow-up|2|||
33689046|NCT02409732|63198924|FG000|Overall Study|Withdrawal by Subject|4|||
33689047|NCT02409732|63198924|FG000|Overall Study|Lost to Follow-up|2|||
33689048|NCT01650636|63198935|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
33689049|NCT01650636|63198936|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
33689050|NCT01650636|63198935|FG000|Washout up to 5 Months|Physician Decision|2|||
33689051|NCT01650636|63198936|FG001|Washout up to 5 Months|Physician Decision|2|||
33689052|NCT01650636|63198935|FG000|Washout up to 5 Months|Death|1|||
33689053|NCT01650636|63198936|FG001|Washout up to 5 Months|Death|0|||
33689054|NCT01650636|63198935|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
33689055|NCT01650636|63198936|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
33689056|NCT01650636|63198935|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
33689057|NCT01650636|63198936|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
33689058|NCT01650636|63198935|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
33689059|NCT01650636|63198936|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
33689060|NCT02436876|63198946|FG000|Overall Study|Lost to Follow-up|0|||
33689061|NCT02436876|63198947|FG001|Overall Study|Lost to Follow-up|1|||
33689062|NCT02436876|63198948|FG002|Overall Study|Lost to Follow-up|1|||
33689063|NCT02436876|63198949|FG003|Overall Study|Lost to Follow-up|1|||
33689064|NCT02436876|63198946|FG000|Overall Study|Withdrawal by Subject|1|||
33689065|NCT02436876|63198947|FG001|Overall Study|Withdrawal by Subject|0|||
33689066|NCT02436876|63198948|FG002|Overall Study|Withdrawal by Subject|0|||
33689067|NCT02436876|63198949|FG003|Overall Study|Withdrawal by Subject|1|||
33689068|NCT02436876|63198946|FG000|Overall Study|Physician Decision|0|||
33689069|NCT02436876|63198947|FG001|Overall Study|Physician Decision|2|||
33689070|NCT02436876|63198948|FG002|Overall Study|Physician Decision|1|||
33689071|NCT02436876|63198949|FG003|Overall Study|Physician Decision|0|||
33689072|NCT02436876|63198946|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
33689073|NCT02436876|63198947|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
33689074|NCT02436876|63198948|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
33689075|NCT02436876|63198949|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
33689076|NCT02382276|63198978|FG000|Overall Study|Withdrawal by Subject|4|||
33689077|NCT02382276|63198979|FG001|Overall Study|Withdrawal by Subject|8|||
33689078|NCT02382276|63198980|FG002|Overall Study|Withdrawal by Subject|5|||
33689079|NCT02382276|63198978|FG000|Overall Study|Adverse Event|7|||
33689080|NCT02382276|63198979|FG001|Overall Study|Adverse Event|2|||
33689081|NCT02382276|63198980|FG002|Overall Study|Adverse Event|32|||
33689082|NCT02382276|63198978|FG000|Overall Study|Physician Decision|0|||
33689083|NCT02382276|63198979|FG001|Overall Study|Physician Decision|0|||
33689084|NCT02382276|63198980|FG002|Overall Study|Physician Decision|2|||
33689085|NCT02436408|63199021|FG000|Overall Study|Death|1|||
33689086|NCT02436330|63199044|FG000|Cohort 1|Lost to Follow-up|5|||
33689087|NCT02436330|63199045|FG001|Cohort 1|Lost to Follow-up|2|||
33689088|NCT02436330|63199044|FG000|Cohort 1|Withdrawal by Subject|0|||
33689089|NCT02436330|63199045|FG001|Cohort 1|Withdrawal by Subject|1|||
33689090|NCT02436330|63199044|FG000|Cohort 2|Lost to Follow-up|2|||
33493161|NCT02640664|62871276|FG002|Epoch 2|Withdrawal of informed consent|2|||
33493162|NCT02640664|62871274|FG000|Epoch 2|Subject/guardian decision|0|||
33689091|NCT02436330|63199045|FG001|Cohort 2|Lost to Follow-up|0|||
33689092|NCT02436330|63199044|FG000|Cohort 2|Withdrawal by Subject|2|||
33689093|NCT02436330|63199045|FG001|Cohort 2|Withdrawal by Subject|3|||
33689094|NCT02436330|63199044|FG000|Cohort 3|Lost to Follow-up|1|||
33689095|NCT02436330|63199045|FG001|Cohort 3|Lost to Follow-up|0|||
33689096|NCT02436330|63199044|FG000|Cohort 3|Withdrawal by Subject|4|||
33689097|NCT02436330|63199045|FG001|Cohort 3|Withdrawal by Subject|0|||
33493163|NCT02640664|62871275|FG001|Epoch 2|Subject/guardian decision|2|||
33689098|NCT02436330|63199044|FG000|Cohort 4|Lost to Follow-up|1|||
33689099|NCT02436330|63199045|FG001|Cohort 4|Lost to Follow-up|0|||
33689100|NCT02436330|63199044|FG000|Cohort 4|Withdrawal by Subject|1|||
33689101|NCT02436330|63199045|FG001|Cohort 4|Withdrawal by Subject|0|||
33689102|NCT02436330|63199044|FG000|Cohort 5|Lost to Follow-up|3|||
33689103|NCT02436330|63199045|FG001|Cohort 5|Lost to Follow-up|2|||
33689104|NCT02436330|63199044|FG000|Cohort 5|Withdrawal by Subject|3|||
33689105|NCT02436330|63199045|FG001|Cohort 5|Withdrawal by Subject|2|||
33689106|NCT02436330|63199044|FG000|Cohort 6|Lost to Follow-up|2|||
33689107|NCT02436330|63199045|FG001|Cohort 6|Lost to Follow-up|0|||
33689108|NCT02436330|63199044|FG000|Cohort 6|Withdrawal by Subject|1|||
33689109|NCT02436330|63199045|FG001|Cohort 6|Withdrawal by Subject|1|||
33689110|NCT01650558|63199082|FG000|Overall Study|Migration out of study area|61|||
33689111|NCT01650558|63199083|FG001|Overall Study|Migration out of study area|71|||
33689112|NCT01650558|63199084|FG002|Overall Study|Migration out of study area|56|||
33689113|NCT01650558|63199082|FG000|Overall Study|Lost to Follow-up|10|||
33689114|NCT01650558|63199083|FG001|Overall Study|Lost to Follow-up|13|||
33689115|NCT01650558|63199084|FG002|Overall Study|Lost to Follow-up|6|||
33689116|NCT01650558|63199082|FG000|Overall Study|Death|10|||
33689117|NCT01650558|63199083|FG001|Overall Study|Death|6|||
33689118|NCT01650558|63199084|FG002|Overall Study|Death|8|||
33689119|NCT01650558|63199082|FG000|Overall Study|Withdrawal by Subject|1|||
33689120|NCT01650558|63199083|FG001|Overall Study|Withdrawal by Subject|1|||
33689121|NCT01650558|63199084|FG002|Overall Study|Withdrawal by Subject|3|||
33689122|NCT01650558|63199082|FG000|Overall Study|Non-compliant participant|1|||
33689123|NCT01650558|63199083|FG001|Overall Study|Non-compliant participant|0|||
33689124|NCT01650558|63199084|FG002|Overall Study|Non-compliant participant|2|||
33689125|NCT01650558|63199082|FG000|Overall Study|Physician Decision|0|||
33689126|NCT01650558|63199083|FG001|Overall Study|Physician Decision|1|||
33689127|NCT01650558|63199084|FG002|Overall Study|Physician Decision|0|||
33689128|NCT02408484|63199123|FG000|Overall Study|Withdrawal by Subject|3|||
33689129|NCT02408484|63199123|FG000|Overall Study|Not treated during study period|1|||
33689130|NCT02380248|63199151|FG000|Overall Study|Lost to Follow-up|11|||
33689131|NCT02380248|63199151|FG000|Overall Study|Withdrawal by Subject|3|||
33689132|NCT02408016|63199198|FG000|Overall Study|Death|6|||
33689133|NCT02408016|63199199|FG001|Overall Study|Death|1|||
33689134|NCT02408016|63199200|FG002|Overall Study|Death|0|||
33689135|NCT02408016|63199198|FG000|Overall Study|Physician Decision|0|||
33689136|NCT02408016|63199199|FG001|Overall Study|Physician Decision|2|||
33689137|NCT02408016|63199200|FG002|Overall Study|Physician Decision|0|||
33689138|NCT02407704|63199264|FG000|Overall Study|Lost to Follow-up|0|||
33689139|NCT02407704|63199265|FG001|Overall Study|Lost to Follow-up|0|||
33689140|NCT02407704|63199266|FG002|Overall Study|Lost to Follow-up|0|||
33493164|NCT02640664|62871276|FG002|Epoch 2|Subject/guardian decision|2|||
33493165|NCT02640664|62871274|FG000|Epoch 2|Lost to Follow-up|3|||
33689141|NCT02407704|63199267|FG003|Overall Study|Lost to Follow-up|2|||
33689142|NCT02407704|63199264|FG000|Overall Study|Protocol Violation|0|||
33689143|NCT02407704|63199265|FG001|Overall Study|Protocol Violation|0|||
33689144|NCT02407704|63199266|FG002|Overall Study|Protocol Violation|0|||
33689145|NCT02407704|63199267|FG003|Overall Study|Protocol Violation|1|||
33689146|NCT02407704|63199264|FG000|Overall Study|Withdrawal by Subject|0|||
33689147|NCT02407704|63199265|FG001|Overall Study|Withdrawal by Subject|0|||
33689148|NCT02407704|63199266|FG002|Overall Study|Withdrawal by Subject|1|||
33689149|NCT02407704|63199267|FG003|Overall Study|Withdrawal by Subject|0|||
33689150|NCT02406612|63199288|FG000|Overall Study|Screening Failure|3|||
33689151|NCT02406612|63199289|FG001|Overall Study|Screening Failure|0|||
33689152|NCT02406612|63199288|FG000|Overall Study|Intra-procedural Exclusion|1|||
33689153|NCT02406612|63199289|FG001|Overall Study|Intra-procedural Exclusion|3|||
33689154|NCT02406612|63199288|FG000|Overall Study|Guidewire Failure|0|||
33689155|NCT02406612|63199289|FG001|Overall Study|Guidewire Failure|1|||
33689156|NCT02405442|63199433|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
33596011|NCT02297815|62994914|FG001|Overall Study|Lost to Follow-up|140|||
33596012|NCT02114385|62994924|FG000|Overall Study|Withdrawal by Subject|3|||
33596013|NCT02114385|62994925|FG001|Overall Study|Withdrawal by Subject|2|||
33596014|NCT02114385|62994924|FG000|Overall Study|Lost to Follow-up|0|||
33596015|NCT02114385|62994925|FG001|Overall Study|Lost to Follow-up|6|||
33596016|NCT02114151|62994931|FG000|Overall Study|Death|1|||
33689157|NCT02405442|63199434|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
33689158|NCT02405442|63199435|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
33493166|NCT02640664|62871275|FG001|Epoch 2|Lost to Follow-up|4|||
33596017|NCT02114151|62994931|FG000|Overall Study|Lost to Follow-up|1|||
33596018|NCT02114151|62994931|FG000|Overall Study|Withdrawal by Subject|5|||
33596019|NCT02297503|62994937|FG000|Overall Study|Withdrawal by Subject|1|||
33689159|NCT02405442|63199436|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
33689160|NCT02405442|63199433|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
33689161|NCT02405442|63199434|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
33689162|NCT02405442|63199435|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
33689163|NCT02405442|63199436|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
33689164|NCT02405442|63199433|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
33689165|NCT02405442|63199434|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
33689166|NCT02405442|63199435|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
33689167|NCT02405442|63199436|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
33689168|NCT02405442|63199433|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
33689169|NCT02405442|63199434|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
33689170|NCT02405442|63199435|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
33689171|NCT02405442|63199436|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
33689172|NCT02405442|63199433|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
33689173|NCT02405442|63199434|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
33689174|NCT02405442|63199435|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
33689175|NCT02405442|63199436|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
33689176|NCT02405442|63199433|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
33689177|NCT02405442|63199434|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
33689178|NCT02405442|63199435|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
33689179|NCT02405442|63199436|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
33689180|NCT02405442|63199433|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
33689181|NCT02405442|63199434|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
33689182|NCT02405442|63199435|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
33689183|NCT02405442|63199436|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
33689184|NCT02405442|63199433|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
33689185|NCT02405442|63199434|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
33689186|NCT02405442|63199435|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
33689187|NCT02405442|63199436|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
33689188|NCT02405442|63199433|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
33689189|NCT02405442|63199434|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
33689190|NCT02405442|63199435|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
33689191|NCT02405442|63199436|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
33689192|NCT02405442|63199433|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
33689193|NCT02405442|63199434|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
33689194|NCT02405442|63199435|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
33689195|NCT02405442|63199436|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
33689196|NCT02405442|63199433|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
33689197|NCT02405442|63199434|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
33689198|NCT02405442|63199435|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
33689199|NCT02405442|63199436|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
33689200|NCT02405442|63199433|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
33689201|NCT02405442|63199434|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
33689202|NCT02405442|63199435|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
33689203|NCT02405442|63199436|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
33689204|NCT02405442|63199433|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
33689205|NCT02405442|63199434|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
33689206|NCT02405442|63199435|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
33689207|NCT02405442|63199436|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
33689208|NCT02405442|63199433|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
33689209|NCT02405442|63199434|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
33689210|NCT02405442|63199435|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
33689211|NCT02405442|63199436|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
33689212|NCT02404350|63199552|FG000|Overall Study|Adverse Event|2|||
33689213|NCT02404350|63199553|FG001|Overall Study|Adverse Event|2|||
33689214|NCT02404350|63199554|FG002|Overall Study|Adverse Event|3|||
33689215|NCT02404350|63199555|FG003|Overall Study|Adverse Event|9|||
33689216|NCT02404350|63199552|FG000|Overall Study|Lack of Efficacy|3|||
33689217|NCT02404350|63199553|FG001|Overall Study|Lack of Efficacy|1|||
33689218|NCT02404350|63199554|FG002|Overall Study|Lack of Efficacy|0|||
33689219|NCT02404350|63199555|FG003|Overall Study|Lack of Efficacy|3|||
33689220|NCT02404350|63199552|FG000|Overall Study|Lost to Follow-up|2|||
33401442|NCT00256867|62780481|FG007|Overall Study|Lost to Follow-up|2|||
33596020|NCT02297503|62994938|FG001|Overall Study|Withdrawal by Subject|1|||
33689221|NCT02404350|63199553|FG001|Overall Study|Lost to Follow-up|0|||
33689222|NCT02404350|63199554|FG002|Overall Study|Lost to Follow-up|0|||
33689223|NCT02404350|63199555|FG003|Overall Study|Lost to Follow-up|1|||
33689224|NCT02404350|63199552|FG000|Overall Study|Physician Decision|1|||
33689225|NCT02404350|63199553|FG001|Overall Study|Physician Decision|0|||
33689226|NCT02404350|63199554|FG002|Overall Study|Physician Decision|0|||
33689227|NCT02404350|63199555|FG003|Overall Study|Physician Decision|2|||
33689228|NCT02404350|63199552|FG000|Overall Study|Pregnancy|0|||
33689229|NCT02404350|63199553|FG001|Overall Study|Pregnancy|0|||
33689230|NCT02404350|63199554|FG002|Overall Study|Pregnancy|0|||
33689231|NCT02404350|63199555|FG003|Overall Study|Pregnancy|1|||
33689232|NCT02404350|63199552|FG000|Overall Study|Withdrawal by Subject|7|||
33689233|NCT02404350|63199553|FG001|Overall Study|Withdrawal by Subject|3|||
33689234|NCT02404350|63199554|FG002|Overall Study|Withdrawal by Subject|3|||
33689235|NCT02404350|63199555|FG003|Overall Study|Withdrawal by Subject|19|||
33689236|NCT02404350|63199552|FG000|Overall Study|Due to Non-compliance with treatment|0|||
33689237|NCT02404350|63199553|FG001|Overall Study|Due to Non-compliance with treatment|0|||
33689238|NCT02404350|63199554|FG002|Overall Study|Due to Non-compliance with treatment|0|||
33689239|NCT02404350|63199555|FG003|Overall Study|Due to Non-compliance with treatment|1|||
33689240|NCT02404350|63199552|FG000|Overall Study|Due to Technical problems|0|||
33689241|NCT02404350|63199553|FG001|Overall Study|Due to Technical problems|0|||
33689242|NCT02404350|63199554|FG002|Overall Study|Due to Technical problems|0|||
33689243|NCT02404350|63199555|FG003|Overall Study|Due to Technical problems|1|||
33689244|NCT02434770|63199854|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
33689245|NCT02434770|63199855|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
33689246|NCT02434770|63199856|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
33689247|NCT02434770|63199854|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
33689248|NCT02434770|63199855|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
33689249|NCT02434770|63199856|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
33689250|NCT02434770|63199854|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
33689251|NCT02434770|63199855|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
33689252|NCT02434770|63199856|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
33689253|NCT02434770|63199854|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
33689254|NCT02434770|63199855|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
33689255|NCT02434770|63199856|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
33689256|NCT02434770|63199854|FG000|Week 1 to Week 18|Death|1|||
33689257|NCT02434770|63199855|FG001|Week 1 to Week 18|Death|0|||
33689258|NCT02434770|63199856|FG002|Week 1 to Week 18|Death|0|||
33689259|NCT02434770|63199854|FG000|Week 18 to Week|Lost to Follow-up|2|||
33689260|NCT02434770|63199855|FG001|Week 18 to Week|Lost to Follow-up|2|||
33689261|NCT02434770|63199856|FG002|Week 18 to Week|Lost to Follow-up|1|||
33689262|NCT02434770|63199854|FG000|Week 18 to Week|Withdrawal by Subject|0|||
33310744|NCT01234350|62686156|FG000|Overall Study|Withdrawal by Subject|61|||
33310745|NCT01234350|62686157|FG001|Overall Study|Withdrawal by Subject|36|||
33310746|NCT01234350|62686156|FG000|Overall Study|Lost to Follow-up|115|||
33310747|NCT01234350|62686157|FG001|Overall Study|Lost to Follow-up|47|||
33310748|NCT01234350|62686156|FG000|Overall Study|Covers a diverse set of reasons|234|||
33689263|NCT02434770|63199855|FG001|Week 18 to Week|Withdrawal by Subject|0|||
33689264|NCT02434770|63199856|FG002|Week 18 to Week|Withdrawal by Subject|2|||
33689265|NCT02434770|63199854|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
33689266|NCT02434770|63199855|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
33689267|NCT02434770|63199856|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
33689268|NCT02433834|63199887|FG000|Overall Study|Protocol-specified criteria|7|||
33689269|NCT02433834|63199887|FG000|Overall Study|Protocol Violation|3|||
33689270|NCT02433834|63199887|FG000|Overall Study|Lost to Follow-up|6|||
33689271|NCT02433834|63199887|FG000|Overall Study|Withdrawal by Subject|14|||
33689272|NCT02433834|63199887|FG000|Overall Study|Adverse Event|6|||
33689273|NCT02433834|63199887|FG000|Overall Study|Physician Decision|1|||
33689274|NCT02433678|63199931|FG000|Overall Study|Lost to Follow-up|1|||
33689275|NCT02433678|63199932|FG001|Overall Study|Lost to Follow-up|2|||
33689276|NCT02433288|63199945|FG000|Overall Study|Severe non-compliance to protocol|13|||
33689277|NCT02433288|63199946|FG001|Overall Study|Severe non-compliance to protocol|7|||
33689278|NCT02433288|63199945|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
33689279|NCT02433288|63199946|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
33689280|NCT02433288|63199945|FG000|Overall Study|Withdrawal by Subject|101|||
33689281|NCT02433288|63199946|FG001|Overall Study|Withdrawal by Subject|99|||
33689282|NCT02433288|63199945|FG000|Overall Study|Lost to Follow-up|2|||
33689283|NCT02433288|63199946|FG001|Overall Study|Lost to Follow-up|14|||
33689284|NCT02433288|63199945|FG000|Overall Study|Death|0|||
33689285|NCT02433288|63199946|FG001|Overall Study|Death|3|||
33689286|NCT02433210|63199966|FG000|Overall Study|Physician Decision|1|||
33689287|NCT02433210|63199967|FG001|Overall Study|Physician Decision|0|||
33689288|NCT02433210|63199968|FG002|Overall Study|Physician Decision|0|||
33689289|NCT02432040|63200103|FG000|Overall Study|Lack of Efficacy|3|||
33689290|NCT02432040|63200104|FG001|Overall Study|Lack of Efficacy|0|||
33310749|NCT01234350|62686157|FG001|Overall Study|Covers a diverse set of reasons|92|||
33689291|NCT02432040|63200103|FG000|Overall Study|Lost to Follow-up|4|||
33689292|NCT02432040|63200104|FG001|Overall Study|Lost to Follow-up|5|||
33689293|NCT02432040|63200103|FG000|Overall Study|Physician Decision|1|||
33689294|NCT02432040|63200104|FG001|Overall Study|Physician Decision|1|||
33689295|NCT04418076|63200150|FG000|Overall Study|Death|1|||
33689296|NCT04418076|63200151|FG001|Overall Study|Death|0|||
33689297|NCT04418076|63200152|FG002|Overall Study|Death|0|||
33689298|NCT04418076|63200153|FG003|Overall Study|Death|0|||
33689299|NCT04418076|63200150|FG000|Overall Study|Lost to Follow-up|2|||
33596021|NCT02297503|62994937|FG000|Overall Study|Protocol Violation|1|||
33596022|NCT02297503|62994938|FG001|Overall Study|Protocol Violation|0|||
33596023|NCT02297503|62994937|FG000|Overall Study|Pregnancy|0|||
33596024|NCT02297503|62994938|FG001|Overall Study|Pregnancy|1|||
33596025|NCT02297503|62994937|FG000|Overall Study|Lost to Follow-up|0|||
33596026|NCT02297503|62994938|FG001|Overall Study|Lost to Follow-up|1|||
33596027|NCT02297503|62994937|FG000|Overall Study|Medical reason|0|||
33596028|NCT02297503|62994938|FG001|Overall Study|Medical reason|1|||
33596029|NCT02113449|62994953|FG000|Overall Study|Adverse Event|4|||
33596030|NCT02366923|62994961|FG000|Overall Study|Withdrawal by Subject|1|||
33689300|NCT04418076|63200151|FG001|Overall Study|Lost to Follow-up|5|||
33689301|NCT04418076|63200152|FG002|Overall Study|Lost to Follow-up|1|||
33689302|NCT04418076|63200153|FG003|Overall Study|Lost to Follow-up|2|||
33689303|NCT04418076|63200150|FG000|Overall Study|Withdrawal by Subject|1|||
33689304|NCT04418076|63200151|FG001|Overall Study|Withdrawal by Subject|0|||
33689305|NCT04418076|63200152|FG002|Overall Study|Withdrawal by Subject|1|||
33689306|NCT04418076|63200153|FG003|Overall Study|Withdrawal by Subject|1|||
33689307|NCT04418076|63200150|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
33689308|NCT04418076|63200151|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
33689309|NCT04418076|63200152|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
33689310|NCT04418076|63200153|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
33689311|NCT04165824|63200163|FG000|Overall Study|Adverse Event|23|||
33689312|NCT04165824|63200163|FG000|Overall Study|Physician Decision|1|||
33689313|NCT04165824|63200163|FG000|Overall Study|Withdrawal by Subject|17|||
33689314|NCT04165824|63200163|FG000|Overall Study|Other|5|||
33689315|NCT03809039|63200176|FG000|Part 1|Withdrawal by Subject|1|||
33689316|NCT03809039|63200177|FG001|Part 1|Withdrawal by Subject|0|||
33689317|NCT03809039|63200178|FG002|Part 1|Withdrawal by Subject|0|||
33689318|NCT03809039|63200179|FG003|Part 1|Withdrawal by Subject|1|||
33689319|NCT03809039|63200180|FG004|Part 1|Withdrawal by Subject|0|||
33689320|NCT03809039|63200181|FG005|Part 1|Withdrawal by Subject|0|||
33689321|NCT03809039|63200182|FG006|Part 1|Withdrawal by Subject|0|||
33689322|NCT03809039|63200183|FG007|Part 1|Withdrawal by Subject|0|||
33689323|NCT03809039|63200184|FG008|Part 1|Withdrawal by Subject|0|||
33689324|NCT03809039|63200176|FG000|Part 3|Withdrawn by study termination|0|||
33689325|NCT03809039|63200177|FG001|Part 3|Withdrawn by study termination|0|||
33689326|NCT03809039|63200178|FG002|Part 3|Withdrawn by study termination|0|||
33689327|NCT03809039|63200179|FG003|Part 3|Withdrawn by study termination|0|||
33689328|NCT03809039|63200180|FG004|Part 3|Withdrawn by study termination|0|||
33689329|NCT03809039|63200181|FG005|Part 3|Withdrawn by study termination|0|||
33689330|NCT03809039|63200182|FG006|Part 3|Withdrawn by study termination|0|||
33689331|NCT03809039|63200183|FG007|Part 3|Withdrawn by study termination|2|||
33689332|NCT03809039|63200184|FG008|Part 3|Withdrawn by study termination|6|||
33689333|NCT03541200|63200252|FG000|Overall Study|Adverse Event|19|||
33689334|NCT03541200|63200252|FG000|Overall Study|Death|1|||
33689335|NCT03541200|63200252|FG000|Overall Study|Lost to Follow-up|10|||
33689336|NCT03541200|63200252|FG000|Overall Study|Physician Decision|1|||
33689337|NCT03541200|63200252|FG000|Overall Study|Protocol Violation|51|||
33689338|NCT03541200|63200252|FG000|Overall Study|Withdrawal by Subject|23|||
33689339|NCT03541200|63200252|FG000|Overall Study|other|8|||
33689340|NCT03520036|63200259|FG000|Overall Study|Adverse Event|1|||
33689341|NCT03520036|63200260|FG001|Overall Study|Adverse Event|2|||
33689342|NCT03520036|63200261|FG002|Overall Study|Adverse Event|0|||
33689343|NCT03520036|63200259|FG000|Overall Study|Protocol Violation|1|||
33689344|NCT03520036|63200260|FG001|Overall Study|Protocol Violation|0|||
33689345|NCT03520036|63200261|FG002|Overall Study|Protocol Violation|0|||
33689346|NCT03520036|63200259|FG000|Overall Study|Withdrawal by Subject|0|||
33689347|NCT03520036|63200260|FG001|Overall Study|Withdrawal by Subject|1|||
33689348|NCT03520036|63200261|FG002|Overall Study|Withdrawal by Subject|4|||
33689349|NCT03520036|63200259|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
33689350|NCT03520036|63200260|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
33689351|NCT03520036|63200261|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
33689352|NCT03505710|63200272|FG000|Overall Study|Progressive Disease|22|||
33689353|NCT03505710|63200273|FG001|Overall Study|Progressive Disease|9|||
33689354|NCT03505710|63200274|FG002|Overall Study|Progressive Disease|34|||
33596031|NCT02366923|62994961|FG000|Overall Study|Positive Slit Lamp Findings|2|||
33689355|NCT03505710|63200272|FG000|Overall Study|Clinical Progression|6|||
33689356|NCT03505710|63200273|FG001|Overall Study|Clinical Progression|6|||
33689357|NCT03505710|63200274|FG002|Overall Study|Clinical Progression|3|||
33689358|NCT03505710|63200272|FG000|Overall Study|Adverse Event|12|||
33689359|NCT03505710|63200273|FG001|Overall Study|Adverse Event|5|||
33689360|NCT03505710|63200274|FG002|Overall Study|Adverse Event|27|||
33689361|NCT03505710|63200272|FG000|Overall Study|Withdrawal by Subject|1|||
33689362|NCT03505710|63200273|FG001|Overall Study|Withdrawal by Subject|3|||
33689363|NCT03505710|63200274|FG002|Overall Study|Withdrawal by Subject|3|||
33689364|NCT03505710|63200272|FG000|Overall Study|Physician Decision|1|||
33596032|NCT02366923|62994961|FG000|Overall Study|High Astigmatism|3|||
33689365|NCT03505710|63200273|FG001|Overall Study|Physician Decision|0|||
33689366|NCT03505710|63200274|FG002|Overall Study|Physician Decision|2|||
33689367|NCT03505710|63200272|FG000|Overall Study|Death|4|||
33689368|NCT03505710|63200273|FG001|Overall Study|Death|3|||
33689369|NCT03505710|63200274|FG002|Overall Study|Death|6|||
33689370|NCT03505710|63200272|FG000|Overall Study|Other Reasons|1|||
33689371|NCT03505710|63200273|FG001|Overall Study|Other Reasons|1|||
33689372|NCT03505710|63200274|FG002|Overall Study|Other Reasons|1|||
33689373|NCT03459729|63200282|FG000|Overall Study|Physician Decision|2|||
33689374|NCT03291067|63200290|FG000|Overall Study|Adverse Event|0|||
33689375|NCT03291067|63200291|FG001|Overall Study|Adverse Event|2|||
33689376|NCT03291067|63200292|FG002|Overall Study|Adverse Event|17|||
33689377|NCT03291067|63200293|FG003|Overall Study|Adverse Event|3|||
33689378|NCT03291067|63200290|FG000|Overall Study|Lost to Follow-up|2|||
33689379|NCT03291067|63200291|FG001|Overall Study|Lost to Follow-up|1|||
33689380|NCT03291067|63200292|FG002|Overall Study|Lost to Follow-up|0|||
33689381|NCT03291067|63200293|FG003|Overall Study|Lost to Follow-up|1|||
33689382|NCT03291067|63200290|FG000|Overall Study|Physician Decision|0|||
33689383|NCT03291067|63200291|FG001|Overall Study|Physician Decision|0|||
33689384|NCT03291067|63200292|FG002|Overall Study|Physician Decision|1|||
33689385|NCT03291067|63200293|FG003|Overall Study|Physician Decision|0|||
33689386|NCT03291067|63200290|FG000|Overall Study|Protocol Violation|5|||
33689387|NCT03291067|63200291|FG001|Overall Study|Protocol Violation|3|||
33689388|NCT03291067|63200292|FG002|Overall Study|Protocol Violation|4|||
33689389|NCT03291067|63200293|FG003|Overall Study|Protocol Violation|2|||
33689390|NCT03291067|63200290|FG000|Overall Study|Withdrawal by Subject|3|||
33689391|NCT03291067|63200291|FG001|Overall Study|Withdrawal by Subject|4|||
33689392|NCT03291067|63200292|FG002|Overall Study|Withdrawal by Subject|7|||
33689393|NCT03291067|63200293|FG003|Overall Study|Withdrawal by Subject|5|||
33689394|NCT03291067|63200290|FG000|Overall Study|Other|0|||
33689395|NCT03291067|63200291|FG001|Overall Study|Other|4|||
33689396|NCT03291067|63200292|FG002|Overall Study|Other|4|||
33689397|NCT03291067|63200293|FG003|Overall Study|Other|6|||
33689398|NCT03035409|63200303|FG000|Overall Study|Adverse Event|5|||
33689399|NCT03035409|63200303|FG000|Overall Study|Death|2|||
33689400|NCT03035409|63200303|FG000|Overall Study|Withdrawal by Subject|2|||
33689401|NCT03035409|63200303|FG000|Overall Study|Non compliance|4|||
33689402|NCT03035409|63200303|FG000|Overall Study|Patient was jittery|1|||
33689403|NCT03035409|63200303|FG000|Overall Study|Did not like Questionnaire|1|||
33689404|NCT03035409|63200303|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
33689405|NCT03035409|63200303|FG000|Overall Study|Did not like taking drugs|1|||
33689406|NCT02847598|63200315|FG000|Overall Study|Adverse Event|0|||
33689407|NCT02847598|63200316|FG001|Overall Study|Adverse Event|0|||
33689408|NCT02847598|63200317|FG002|Overall Study|Adverse Event|0|||
33689409|NCT02847598|63200318|FG003|Overall Study|Adverse Event|0|||
33689410|NCT02847598|63200319|FG004|Overall Study|Adverse Event|0|||
33689411|NCT02847598|63200320|FG005|Overall Study|Adverse Event|0|||
33689412|NCT02847598|63200321|FG006|Overall Study|Adverse Event|0|||
33689413|NCT02847598|63200322|FG007|Overall Study|Adverse Event|1|||
33689414|NCT02847598|63200315|FG000|Overall Study|Consent withdrawn|2|||
33689415|NCT02847598|63200316|FG001|Overall Study|Consent withdrawn|0|||
33689416|NCT02847598|63200317|FG002|Overall Study|Consent withdrawn|0|||
33689417|NCT02847598|63200318|FG003|Overall Study|Consent withdrawn|4|||
33689418|NCT02847598|63200319|FG004|Overall Study|Consent withdrawn|3|||
33689419|NCT02847598|63200320|FG005|Overall Study|Consent withdrawn|2|||
33689420|NCT02847598|63200321|FG006|Overall Study|Consent withdrawn|1|||
33689421|NCT02847598|63200322|FG007|Overall Study|Consent withdrawn|3|||
33689422|NCT02847598|63200315|FG000|Overall Study|Death|3|||
33689423|NCT02847598|63200316|FG001|Overall Study|Death|0|||
33689424|NCT02847598|63200317|FG002|Overall Study|Death|0|||
33689425|NCT02847598|63200318|FG003|Overall Study|Death|0|||
33689426|NCT02847598|63200319|FG004|Overall Study|Death|0|||
33689427|NCT02847598|63200320|FG005|Overall Study|Death|0|||
33689428|NCT02847598|63200321|FG006|Overall Study|Death|0|||
33689429|NCT02847598|63200322|FG007|Overall Study|Death|0|||
33689430|NCT02847598|63200315|FG000|Overall Study|Lost to Follow-up|0|||
33689431|NCT02847598|63200316|FG001|Overall Study|Lost to Follow-up|0|||
33689432|NCT02847598|63200317|FG002|Overall Study|Lost to Follow-up|0|||
33689433|NCT02847598|63200318|FG003|Overall Study|Lost to Follow-up|0|||
33689434|NCT02847598|63200319|FG004|Overall Study|Lost to Follow-up|0|||
33689435|NCT02847598|63200320|FG005|Overall Study|Lost to Follow-up|1|||
33689436|NCT02847598|63200321|FG006|Overall Study|Lost to Follow-up|1|||
33689437|NCT02847598|63200322|FG007|Overall Study|Lost to Follow-up|0|||
33689438|NCT02841280|63200348|FG000|Overall Study|Adverse Event|2|||
33689439|NCT02841280|63200349|FG001|Overall Study|Adverse Event|1|||
33689440|NCT02841280|63200348|FG000|Overall Study|Death|1|||
33689441|NCT02841280|63200349|FG001|Overall Study|Death|0|||
33689442|NCT02841280|63200348|FG000|Overall Study|Lost to Follow-up|2|||
33689443|NCT02841280|63200349|FG001|Overall Study|Lost to Follow-up|2|||
33689444|NCT02841280|63200348|FG000|Overall Study|Withdrawal by Subject|7|||
33689445|NCT02841280|63200349|FG001|Overall Study|Withdrawal by Subject|3|||
33689446|NCT02841280|63200348|FG000|Overall Study|Stop Point: BP above threshold|2|||
33689447|NCT02841280|63200349|FG001|Overall Study|Stop Point: BP above threshold|0|||
33689448|NCT02345330|63200363|FG000|Overall Study|Death|1|||
33689449|NCT02345330|63200363|FG000|Overall Study|Progressive Disease|2|||
33689450|NCT01513343|63200378|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
33689451|NCT01513343|63200379|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
33689452|NCT01513343|63200378|FG000|Post Data Collection|Dropped/withdrew from study|7|||
33689453|NCT01513343|63200379|FG001|Post Data Collection|Dropped/withdrew from study|1|||
33689454|NCT01513343|63200378|FG000|Post Data Collection|Lost to Follow-up|10|||
33689455|NCT01513343|63200379|FG001|Post Data Collection|Lost to Follow-up|23|||
33689456|NCT01513343|63200378|FG000|6-month Follow-up|Lost to Follow-up|28|||
33689457|NCT01513343|63200379|FG001|6-month Follow-up|Lost to Follow-up|17|||
33689458|NCT01513343|63200378|FG000|12-month Follow-up|Lost to Follow-up|10|||
33689459|NCT01513343|63200379|FG001|12-month Follow-up|Lost to Follow-up|3|||
33689460|NCT01440816|63200406|FG000|Overall Study|Disease Progression|0|||
33689461|NCT01440816|63200407|FG001|Overall Study|Disease Progression|9|||
33689462|NCT01440816|63200406|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
33689463|NCT01440816|63200407|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
33689464|NCT01348919|63200418|FG000|Overall Study|Adverse Event|3|||
33689465|NCT01348919|63200419|FG001|Overall Study|Adverse Event|1|||
33689466|NCT01348919|63200420|FG002|Overall Study|Adverse Event|0|||
33689467|NCT01348919|63200418|FG000|Overall Study|Withdrawal by Subject|0|||
33689468|NCT01348919|63200419|FG001|Overall Study|Withdrawal by Subject|1|||
33689469|NCT01348919|63200420|FG002|Overall Study|Withdrawal by Subject|0|||
33689470|NCT01348919|63200418|FG000|Overall Study|Disease progression|0|||
33689471|NCT01348919|63200419|FG001|Overall Study|Disease progression|1|||
33689472|NCT01348919|63200420|FG002|Overall Study|Disease progression|1|||
33689473|NCT00966381|63200432|FG000|Overall Study|Withdrawal by Subject|2|||
33689474|NCT00966381|63200433|FG001|Overall Study|Withdrawal by Subject|2|||
33689475|NCT02431806|63200445|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
33689476|NCT02431806|63200446|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
33689477|NCT02431806|63200447|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
33689478|NCT02431806|63200448|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
33689479|NCT02431806|63200445|FG000|Double-blind Treatment Period|Adverse Event|4|||
33689480|NCT02431806|63200446|FG001|Double-blind Treatment Period|Adverse Event|7|||
33689481|NCT02431806|63200447|FG002|Double-blind Treatment Period|Adverse Event|11|||
33689482|NCT02431806|63200448|FG003|Double-blind Treatment Period|Adverse Event|7|||
33689483|NCT02431806|63200445|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
33689484|NCT02431806|63200446|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
33689485|NCT02431806|63200447|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
33689486|NCT02431806|63200448|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
33689487|NCT02431806|63200445|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
33689488|NCT02431806|63200446|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
33689489|NCT02431806|63200447|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
33689490|NCT02431806|63200448|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
33689491|NCT02431806|63200445|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
33689492|NCT02431806|63200446|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
33689493|NCT02431806|63200447|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
33689494|NCT02431806|63200448|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
33689495|NCT02431806|63200445|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
33689496|NCT02431806|63200446|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
33689497|NCT02431806|63200447|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
33689498|NCT02431806|63200448|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
33689499|NCT02431806|63200445|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
33689500|NCT02431806|63200446|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
33689501|NCT02431806|63200447|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
33689502|NCT02431806|63200448|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
33689503|NCT01650246|63200489|FG000|Overall Study|Adverse Event|23|||
33689504|NCT01650246|63200489|FG000|Overall Study|Protocol Violation|5|||
33689505|NCT01650246|63200489|FG000|Overall Study|Sponsor terminated study|53|||
33689506|NCT01650246|63200489|FG000|Overall Study|Lost to Follow-up|5|||
33689507|NCT01650246|63200489|FG000|Overall Study|Withdrawal by Subject|26|||
33689508|NCT01650246|63200489|FG000|Overall Study|Death|1|||
33689509|NCT01650246|63200489|FG000|Overall Study|Lack of Efficacy|30|||
33689510|NCT01652664|63200508|FG000|Overall Study|Treatment Failure|5|||
33689511|NCT01652664|63200509|FG001|Overall Study|Treatment Failure|1|||
33689512|NCT01652664|63200508|FG000|Overall Study|Inadequate IOP control|1|||
33689513|NCT01652664|63200509|FG001|Overall Study|Inadequate IOP control|0|||
33689514|NCT02379390|63200549|FG000|Overall Study|Adverse Event|1|||
33689515|NCT02379390|63200550|FG001|Overall Study|Adverse Event|1|||
33689516|NCT02379390|63200549|FG000|Overall Study|Investigator's decision|1|||
33689517|NCT02379390|63200550|FG001|Overall Study|Investigator's decision|0|||
33689518|NCT02379390|63200549|FG000|Overall Study|Study Termination|0|||
33689519|NCT02379390|63200550|FG001|Overall Study|Study Termination|1|||
33689520|NCT02379078|63200561|FG000|Overall Study|Lost to Follow-up|33|||
33689521|NCT02379078|63200562|FG001|Overall Study|Lost to Follow-up|30|||
33689522|NCT02379078|63200561|FG000|Overall Study|Withdrawal by Subject|6|||
33689523|NCT02379078|63200562|FG001|Overall Study|Withdrawal by Subject|5|||
33689524|NCT01714739|63200655|FG000|Overall Study|Disease progression|3|||
33689525|NCT01714739|63200656|FG001|Overall Study|Disease progression|5|||
33689526|NCT01714739|63200657|FG002|Overall Study|Disease progression|5|||
33689527|NCT01714739|63200658|FG003|Overall Study|Disease progression|204|||
33689528|NCT01714739|63200659|FG004|Overall Study|Disease progression|1|||
33689529|NCT01714739|63200660|FG005|Overall Study|Disease progression|3|||
33689530|NCT01714739|63200661|FG006|Overall Study|Disease progression|5|||
33689531|NCT01714739|63200655|FG000|Overall Study|Study drug toxicity|1|||
33689532|NCT01714739|63200656|FG001|Overall Study|Study drug toxicity|1|||
33689533|NCT01714739|63200657|FG002|Overall Study|Study drug toxicity|1|||
33689534|NCT01714739|63200658|FG003|Overall Study|Study drug toxicity|15|||
33689535|NCT01714739|63200659|FG004|Overall Study|Study drug toxicity|0|||
33689536|NCT01714739|63200660|FG005|Overall Study|Study drug toxicity|0|||
33689537|NCT01714739|63200661|FG006|Overall Study|Study drug toxicity|5|||
33689538|NCT01714739|63200655|FG000|Overall Study|Death|0|||
33689539|NCT01714739|63200656|FG001|Overall Study|Death|0|||
33689540|NCT01714739|63200657|FG002|Overall Study|Death|0|||
33689541|NCT01714739|63200658|FG003|Overall Study|Death|1|||
33689542|NCT01714739|63200659|FG004|Overall Study|Death|0|||
33689543|NCT01714739|63200660|FG005|Overall Study|Death|0|||
33689544|NCT01714739|63200661|FG006|Overall Study|Death|0|||
33689545|NCT01714739|63200655|FG000|Overall Study|Adverse Event unrelated to drug|0|||
33689546|NCT01714739|63200656|FG001|Overall Study|Adverse Event unrelated to drug|0|||
33689547|NCT01714739|63200657|FG002|Overall Study|Adverse Event unrelated to drug|3|||
33689548|NCT01714739|63200658|FG003|Overall Study|Adverse Event unrelated to drug|21|||
33689549|NCT01714739|63200659|FG004|Overall Study|Adverse Event unrelated to drug|0|||
33689550|NCT01714739|63200660|FG005|Overall Study|Adverse Event unrelated to drug|0|||
33689551|NCT01714739|63200661|FG006|Overall Study|Adverse Event unrelated to drug|0|||
33689552|NCT01714739|63200655|FG000|Overall Study|Participant request to stop therapy|0|||
33689553|NCT01714739|63200656|FG001|Overall Study|Participant request to stop therapy|1|||
33689554|NCT01714739|63200657|FG002|Overall Study|Participant request to stop therapy|0|||
33689555|NCT01714739|63200658|FG003|Overall Study|Participant request to stop therapy|6|||
33689556|NCT01714739|63200659|FG004|Overall Study|Participant request to stop therapy|0|||
33689557|NCT01714739|63200660|FG005|Overall Study|Participant request to stop therapy|0|||
33689558|NCT01714739|63200661|FG006|Overall Study|Participant request to stop therapy|0|||
33689559|NCT01714739|63200655|FG000|Overall Study|Participant withdrew consent|0|||
33689560|NCT01714739|63200656|FG001|Overall Study|Participant withdrew consent|1|||
33689561|NCT01714739|63200657|FG002|Overall Study|Participant withdrew consent|0|||
33689562|NCT01714739|63200658|FG003|Overall Study|Participant withdrew consent|8|||
33689563|NCT01714739|63200659|FG004|Overall Study|Participant withdrew consent|0|||
33689564|NCT01714739|63200660|FG005|Overall Study|Participant withdrew consent|0|||
33689565|NCT01714739|63200661|FG006|Overall Study|Participant withdrew consent|0|||
33689566|NCT01714739|63200655|FG000|Overall Study|Lost to Follow-up|0|||
33689567|NCT01714739|63200656|FG001|Overall Study|Lost to Follow-up|0|||
33689568|NCT01714739|63200657|FG002|Overall Study|Lost to Follow-up|0|||
33689569|NCT01714739|63200658|FG003|Overall Study|Lost to Follow-up|1|||
33689570|NCT01714739|63200659|FG004|Overall Study|Lost to Follow-up|0|||
33689571|NCT01714739|63200660|FG005|Overall Study|Lost to Follow-up|0|||
33689572|NCT01714739|63200661|FG006|Overall Study|Lost to Follow-up|0|||
33689573|NCT01714739|63200655|FG000|Overall Study|Maximum clinical benefit|0|||
33689574|NCT01714739|63200656|FG001|Overall Study|Maximum clinical benefit|1|||
33689575|NCT01714739|63200657|FG002|Overall Study|Maximum clinical benefit|1|||
33689576|NCT01714739|63200658|FG003|Overall Study|Maximum clinical benefit|3|||
33689577|NCT01714739|63200659|FG004|Overall Study|Maximum clinical benefit|0|||
33689578|NCT01714739|63200660|FG005|Overall Study|Maximum clinical benefit|0|||
33689579|NCT01714739|63200661|FG006|Overall Study|Maximum clinical benefit|0|||
33689580|NCT01714739|63200655|FG000|Overall Study|Poor/non-comliance|0|||
33689581|NCT01714739|63200656|FG001|Overall Study|Poor/non-comliance|1|||
33689582|NCT01714739|63200657|FG002|Overall Study|Poor/non-comliance|0|||
33689583|NCT01714739|63200658|FG003|Overall Study|Poor/non-comliance|1|||
33689584|NCT01714739|63200659|FG004|Overall Study|Poor/non-comliance|0|||
33689585|NCT01714739|63200660|FG005|Overall Study|Poor/non-comliance|0|||
33689586|NCT01714739|63200661|FG006|Overall Study|Poor/non-comliance|0|||
33689587|NCT01714739|63200655|FG000|Overall Study|No longer meets study criteria|0|||
33689588|NCT01714739|63200656|FG001|Overall Study|No longer meets study criteria|0|||
33689589|NCT01714739|63200657|FG002|Overall Study|No longer meets study criteria|0|||
33689590|NCT01714739|63200658|FG003|Overall Study|No longer meets study criteria|1|||
33689591|NCT01714739|63200659|FG004|Overall Study|No longer meets study criteria|0|||
33689592|NCT01714739|63200660|FG005|Overall Study|No longer meets study criteria|0|||
33689593|NCT01714739|63200661|FG006|Overall Study|No longer meets study criteria|0|||
33689594|NCT01714739|63200655|FG000|Overall Study|Other reason|0|||
33689595|NCT01714739|63200656|FG001|Overall Study|Other reason|0|||
33493167|NCT02640664|62871276|FG002|Epoch 2|Lost to Follow-up|1|||
33689596|NCT01714739|63200657|FG002|Overall Study|Other reason|0|||
33689597|NCT01714739|63200658|FG003|Overall Study|Other reason|3|||
33689598|NCT01714739|63200659|FG004|Overall Study|Other reason|1|||
33689599|NCT01714739|63200660|FG005|Overall Study|Other reason|0|||
33689600|NCT01714739|63200661|FG006|Overall Study|Other reason|0|||
33689601|NCT03823287|63202661|FG000|Overall Study|Withdrawal by Subject|25|||
33689602|NCT03823287|63202662|FG001|Overall Study|Withdrawal by Subject|17|||
33689603|NCT03823287|63202661|FG000|Overall Study|Death|13|||
33493168|NCT02640664|62871274|FG000|Epoch 2|Death|0|||
33493169|NCT02640664|62871275|FG001|Epoch 2|Death|0|||
33689604|NCT03823287|63202662|FG001|Overall Study|Death|7|||
33689605|NCT03823287|63202661|FG000|Overall Study|Lost to Follow-up|7|||
33689606|NCT03823287|63202662|FG001|Overall Study|Lost to Follow-up|8|||
33689607|NCT03823287|63202661|FG000|Overall Study|Adverse Event|6|||
33689608|NCT03823287|63202662|FG001|Overall Study|Adverse Event|8|||
33689609|NCT03823287|63202661|FG000|Overall Study|Physician Decision|5|||
33689610|NCT03823287|63202662|FG001|Overall Study|Physician Decision|2|||
33689611|NCT03823287|63202661|FG000|Overall Study|Lack of Efficacy|2|||
33689612|NCT03823287|63202662|FG001|Overall Study|Lack of Efficacy|0|||
33689613|NCT03823287|63202661|FG000|Overall Study|Other|2|||
33689614|NCT03823287|63202662|FG001|Overall Study|Other|4|||
33689615|NCT03707925|63202823|FG000|Overall Study|Inevaluable|1|||
33689616|NCT03461757|63202883|FG000|Overall Study|Adverse Event|1|||
33689617|NCT03461757|63202884|FG001|Overall Study|Adverse Event|0|||
33689618|NCT03461757|63202883|FG000|Overall Study|Lost to Follow-up|13|||
33689619|NCT03461757|63202884|FG001|Overall Study|Lost to Follow-up|7|||
33689620|NCT03461757|63202883|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
33689621|NCT03461757|63202884|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
33689622|NCT03461757|63202883|FG000|Overall Study|Non-compliance with study treatment|0|||
33689623|NCT03461757|63202884|FG001|Overall Study|Non-compliance with study treatment|1|||
33689624|NCT03461757|63202883|FG000|Overall Study|Pregnancy|2|||
33689625|NCT03461757|63202884|FG001|Overall Study|Pregnancy|0|||
33689626|NCT03461757|63202883|FG000|Overall Study|Protocol Violation|1|||
33689627|NCT03461757|63202884|FG001|Overall Study|Protocol Violation|1|||
33689628|NCT03461757|63202883|FG000|Overall Study|Withdrawal by Subject|7|||
33689629|NCT03461757|63202884|FG001|Overall Study|Withdrawal by Subject|7|||
33689630|NCT03461757|63202883|FG000|Overall Study|Other Reasons|1|||
33689631|NCT03461757|63202884|FG001|Overall Study|Other Reasons|4|||
33689632|NCT03235479|63203372|FG000|Overall Study|Lost to Follow-up|8|||
33689633|NCT03235479|63203373|FG001|Overall Study|Lost to Follow-up|11|||
33689634|NCT03235479|63203372|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
33689635|NCT03235479|63203373|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
33689636|NCT03235479|63203372|FG000|Overall Study|Pregnancy|1|||
33689637|NCT03235479|63203373|FG001|Overall Study|Pregnancy|0|||
33689638|NCT03235479|63203372|FG000|Overall Study|Protocol Deviation|1|||
33689639|NCT03235479|63203373|FG001|Overall Study|Protocol Deviation|3|||
33689640|NCT03235479|63203372|FG000|Overall Study|Technical Problems|3|||
33689641|NCT03235479|63203373|FG001|Overall Study|Technical Problems|2|||
33689642|NCT03235479|63203372|FG000|Overall Study|Withdrawal by Subject|2|||
33689643|NCT03235479|63203373|FG001|Overall Study|Withdrawal by Subject|2|||
33493170|NCT02640664|62871276|FG002|Epoch 2|Death|1|||
33689644|NCT03235479|63203372|FG000|Overall Study|Other Reasons|3|||
33689645|NCT03235479|63203373|FG001|Overall Study|Other Reasons|5|||
33493171|NCT00812006|62871288|FG000|Overall Study|Lost to Follow-up|0|||
33493172|NCT00812006|62871289|FG001|Overall Study|Lost to Follow-up|0|||
33689646|NCT03193437|63203429|FG000|Overall Study|Adverse Event|4|||
33689647|NCT03193437|63203429|FG000|Overall Study|Withdrawal by Subject|2|||
33689648|NCT03193437|63203429|FG000|Overall Study|Disease Progression|2|||
33689649|NCT02906787|63203471|FG000|Overall Study|Withdrawal by Subject|12|||
33689650|NCT02906787|63203472|FG001|Overall Study|Withdrawal by Subject|10|||
33689651|NCT02906787|63203471|FG000|Overall Study|Missed|24|||
33689652|NCT02906787|63203472|FG001|Overall Study|Missed|22|||
33689653|NCT02107443|63204058|FG000|Overall Study|Death|42|||
33689654|NCT02107443|63204059|FG001|Overall Study|Death|30|||
33689655|NCT02107443|63204058|FG000|Overall Study|Study Protocol Violation|3|||
33689656|NCT02107443|63204059|FG001|Overall Study|Study Protocol Violation|1|||
33689657|NCT02107443|63204058|FG000|Overall Study|Registered but Not Eligible|0|||
33689658|NCT02107443|63204059|FG001|Overall Study|Registered but Not Eligible|1|||
33689659|NCT02107443|63204058|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
33689660|NCT02107443|63204059|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
33689661|NCT02107443|63204058|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
33689662|NCT02107443|63204059|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
33689663|NCT02107443|63204058|FG000|Overall Study|Withdrawal: Changed Mind|2|||
33689664|NCT02107443|63204059|FG001|Overall Study|Withdrawal: Changed Mind|0|||
33689665|NCT02107443|63204058|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
33689666|NCT02107443|63204059|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
33689667|NCT02107443|63204058|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
33689668|NCT02107443|63204059|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
33689669|NCT02107443|63204058|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
33689670|NCT02107443|63204059|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
33689671|NCT02107443|63204058|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
33689672|NCT02107443|63204059|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
33689673|NCT02107443|63204058|FG000|Overall Study|Withdrawal: Other Medical|9|||
33689674|NCT02107443|63204059|FG001|Overall Study|Withdrawal: Other Medical|5|||
33689675|NCT02107443|63204058|FG000|Overall Study|Withdrawal: Disease Progression|4|||
33689676|NCT02107443|63204059|FG001|Overall Study|Withdrawal: Disease Progression|2|||
33689677|NCT02107443|63204058|FG000|Overall Study|Withdrawal: Personal Issues|0|||
33689678|NCT02107443|63204059|FG001|Overall Study|Withdrawal: Personal Issues|3|||
33689679|NCT00559949|63204976|FG000|Overall Study|Progressive Disease during cycle 1|1|||
33689680|NCT00559949|63204976|FG000|Overall Study|Adverse Event|1|||
33689681|NCT00559949|63204976|FG000|Overall Study|Withdrawal by Subject|4|||
33689682|NCT00559949|63204976|FG000|Overall Study|No disease evaluation per protocol|1|||
33689683|NCT00559637|63205028|FG000|Overall Study|Adverse Event|22|||
33689684|NCT00559637|63205028|FG000|Overall Study|Withdrawal by Subject|4|||
33689685|NCT00559637|63205028|FG000|Overall Study|Protocol Violation|6|||
33689686|NCT00559637|63205028|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
33689687|NCT00559637|63205028|FG000|Overall Study|Failure to return|6|||
33689688|NCT00559637|63205028|FG000|Overall Study|Insufficient response|3|||
33689689|NCT00559637|63205028|FG000|Overall Study|Started requiring dialysis after month 7|2|||
33689690|NCT00559637|63205028|FG000|Overall Study|Suspected lung cancer|1|||
33689691|NCT00559637|63205028|FG000|Overall Study|Participation in another study|1|||
33689692|NCT00559637|63205028|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
33689693|NCT00559637|63205028|FG000|Overall Study|Change of center|1|||
33689694|NCT00559637|63205028|FG000|Overall Study|Change of home|1|||
33689695|NCT00559637|63205028|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
33689696|NCT02578641|63205101|FG000|Overall Study|Adverse Event|5|||
33689697|NCT02578641|63205102|FG001|Overall Study|Adverse Event|15|||
33689698|NCT02578641|63205101|FG000|Overall Study|Death|16|||
33689699|NCT02578641|63205102|FG001|Overall Study|Death|8|||
33689700|NCT02578641|63205101|FG000|Overall Study|Lost to Follow-up|0|||
33689701|NCT02578641|63205102|FG001|Overall Study|Lost to Follow-up|1|||
33689702|NCT02578641|63205101|FG000|Overall Study|Withdrawal by Subject|14|||
33689703|NCT02578641|63205102|FG001|Overall Study|Withdrawal by Subject|7|||
33689704|NCT02578641|63205101|FG000|Overall Study|Progressive Disease|69|||
33689705|NCT02578641|63205102|FG001|Overall Study|Progressive Disease|21|||
33689706|NCT02578641|63205101|FG000|Overall Study|No Study Drug|2|||
33689707|NCT02578641|63205102|FG001|Overall Study|No Study Drug|0|||
33689708|NCT02578641|63205101|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
33689709|NCT02578641|63205102|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
33689710|NCT02578641|63205101|FG000|Overall Study|Non-compliance with Study Schedule|1|||
33689711|NCT02578641|63205102|FG001|Overall Study|Non-compliance with Study Schedule|0|||
33689712|NCT02578641|63205101|FG000|Overall Study|Other|1|||
33689713|NCT02578641|63205102|FG001|Overall Study|Other|10|||
33689714|NCT02578641|63205101|FG000|Overall Study|Not treated|1|||
33689715|NCT02578641|63205102|FG001|Overall Study|Not treated|4|||
33689716|NCT02431260|63205130|FG000|Overall Study|Subject Decision|0|||
33689717|NCT02431260|63205131|FG001|Overall Study|Subject Decision|1|||
33689718|NCT02431260|63205132|FG002|Overall Study|Subject Decision|1|||
33689719|NCT02431260|63205133|FG003|Overall Study|Subject Decision|0|||
33689720|NCT02431260|63205134|FG004|Overall Study|Subject Decision|0|||
33689721|NCT02431260|63205135|FG005|Overall Study|Subject Decision|0|||
33689722|NCT02431260|63205136|FG006|Overall Study|Subject Decision|0|||
33689723|NCT02431260|63205137|FG007|Overall Study|Subject Decision|0|||
33689724|NCT02431260|63205138|FG008|Overall Study|Subject Decision|1|||
33689725|NCT02431260|63205139|FG009|Overall Study|Subject Decision|1|||
33689726|NCT02431260|63205140|FG010|Overall Study|Subject Decision|0|||
33689727|NCT02431260|63205141|FG011|Overall Study|Subject Decision|1|||
33689728|NCT02431260|63205142|FG012|Overall Study|Subject Decision|0|||
33689729|NCT02431260|63205143|FG013|Overall Study|Subject Decision|0|||
33689730|NCT02431260|63205130|FG000|Overall Study|Death|4|||
33689731|NCT02431260|63205131|FG001|Overall Study|Death|4|||
33689732|NCT02431260|63205132|FG002|Overall Study|Death|3|||
33689733|NCT02431260|63205133|FG003|Overall Study|Death|4|||
33689734|NCT02431260|63205134|FG004|Overall Study|Death|2|||
33689735|NCT02431260|63205135|FG005|Overall Study|Death|2|||
33689736|NCT02431260|63205136|FG006|Overall Study|Death|3|||
33689737|NCT02431260|63205137|FG007|Overall Study|Death|1|||
33689738|NCT02431260|63205138|FG008|Overall Study|Death|6|||
33689739|NCT02431260|63205139|FG009|Overall Study|Death|6|||
33689740|NCT02431260|63205140|FG010|Overall Study|Death|3|||
33689741|NCT02431260|63205141|FG011|Overall Study|Death|2|||
33689742|NCT02431260|63205142|FG012|Overall Study|Death|5|||
33689743|NCT02431260|63205143|FG013|Overall Study|Death|1|||
33689744|NCT02431260|63205130|FG000|Overall Study|Lost to Follow-up|0|||
33689745|NCT02431260|63205131|FG001|Overall Study|Lost to Follow-up|0|||
33689746|NCT02431260|63205132|FG002|Overall Study|Lost to Follow-up|0|||
33689747|NCT02431260|63205133|FG003|Overall Study|Lost to Follow-up|0|||
33689748|NCT02431260|63205134|FG004|Overall Study|Lost to Follow-up|0|||
33689749|NCT02431260|63205135|FG005|Overall Study|Lost to Follow-up|1|||
33689750|NCT02431260|63205136|FG006|Overall Study|Lost to Follow-up|0|||
33689751|NCT02431260|63205137|FG007|Overall Study|Lost to Follow-up|0|||
33689752|NCT02431260|63205138|FG008|Overall Study|Lost to Follow-up|0|||
33689753|NCT02431260|63205139|FG009|Overall Study|Lost to Follow-up|0|||
33689754|NCT02431260|63205140|FG010|Overall Study|Lost to Follow-up|0|||
33689755|NCT02431260|63205141|FG011|Overall Study|Lost to Follow-up|0|||
33689756|NCT02431260|63205142|FG012|Overall Study|Lost to Follow-up|0|||
33689757|NCT02431260|63205143|FG013|Overall Study|Lost to Follow-up|0|||
33689758|NCT02431260|63205130|FG000|Overall Study|Study Terminated by the Sponsor|0|||
33689759|NCT02431260|63205131|FG001|Overall Study|Study Terminated by the Sponsor|0|||
33689760|NCT02431260|63205132|FG002|Overall Study|Study Terminated by the Sponsor|2|||
33689761|NCT02431260|63205133|FG003|Overall Study|Study Terminated by the Sponsor|1|||
33689762|NCT02431260|63205134|FG004|Overall Study|Study Terminated by the Sponsor|1|||
33689763|NCT02431260|63205135|FG005|Overall Study|Study Terminated by the Sponsor|0|||
33689764|NCT02431260|63205136|FG006|Overall Study|Study Terminated by the Sponsor|1|||
33689765|NCT02431260|63205137|FG007|Overall Study|Study Terminated by the Sponsor|2|||
33689766|NCT02431260|63205138|FG008|Overall Study|Study Terminated by the Sponsor|1|||
33689767|NCT02431260|63205139|FG009|Overall Study|Study Terminated by the Sponsor|1|||
33689768|NCT02431260|63205140|FG010|Overall Study|Study Terminated by the Sponsor|1|||
33689769|NCT02431260|63205141|FG011|Overall Study|Study Terminated by the Sponsor|0|||
33689770|NCT02431260|63205142|FG012|Overall Study|Study Terminated by the Sponsor|4|||
33689771|NCT02431260|63205143|FG013|Overall Study|Study Terminated by the Sponsor|0|||
33689772|NCT02431260|63205130|FG000|Overall Study|Physician Decision|0|||
33689773|NCT02431260|63205131|FG001|Overall Study|Physician Decision|0|||
33689774|NCT02431260|63205132|FG002|Overall Study|Physician Decision|0|||
33689775|NCT02431260|63205133|FG003|Overall Study|Physician Decision|0|||
33689776|NCT02431260|63205134|FG004|Overall Study|Physician Decision|0|||
33689777|NCT02431260|63205135|FG005|Overall Study|Physician Decision|1|||
33689778|NCT02431260|63205136|FG006|Overall Study|Physician Decision|0|||
33689779|NCT02431260|63205137|FG007|Overall Study|Physician Decision|0|||
33689780|NCT02431260|63205138|FG008|Overall Study|Physician Decision|0|||
33689781|NCT02431260|63205139|FG009|Overall Study|Physician Decision|0|||
33689782|NCT02431260|63205140|FG010|Overall Study|Physician Decision|0|||
33689783|NCT02431260|63205141|FG011|Overall Study|Physician Decision|0|||
33689784|NCT02431260|63205142|FG012|Overall Study|Physician Decision|0|||
33689785|NCT02431260|63205143|FG013|Overall Study|Physician Decision|0|||
33689786|NCT02431260|63205130|FG000|Overall Study|Other Unspecified|0|||
33689787|NCT02431260|63205131|FG001|Overall Study|Other Unspecified|0|||
33689788|NCT02431260|63205132|FG002|Overall Study|Other Unspecified|0|||
33689789|NCT02431260|63205133|FG003|Overall Study|Other Unspecified|0|||
33689790|NCT02431260|63205134|FG004|Overall Study|Other Unspecified|0|||
33689791|NCT02431260|63205135|FG005|Overall Study|Other Unspecified|0|||
33689792|NCT02431260|63205136|FG006|Overall Study|Other Unspecified|0|||
33689793|NCT02431260|63205137|FG007|Overall Study|Other Unspecified|0|||
33689794|NCT02431260|63205138|FG008|Overall Study|Other Unspecified|0|||
33689795|NCT02431260|63205139|FG009|Overall Study|Other Unspecified|0|||
33689796|NCT02431260|63205140|FG010|Overall Study|Other Unspecified|0|||
33493173|NCT00812006|62871290|FG002|Overall Study|Lost to Follow-up|2|||
33689797|NCT02431260|63205141|FG011|Overall Study|Other Unspecified|1|||
33689798|NCT02431260|63205142|FG012|Overall Study|Other Unspecified|1|||
33689799|NCT02431260|63205143|FG013|Overall Study|Other Unspecified|0|||
33689800|NCT02430870|63205338|FG000|Part 2|Voluntary Withdrawal|0|||
33689801|NCT02430870|63205339|FG001|Part 2|Voluntary Withdrawal|0|||
33689802|NCT02430870|63205340|FG002|Part 2|Voluntary Withdrawal|0|||
33689803|NCT02430870|63205341|FG003|Part 2|Voluntary Withdrawal|0|||
33689804|NCT02430870|63205342|FG004|Part 2|Voluntary Withdrawal|0|||
33689805|NCT02430870|63205343|FG005|Part 2|Voluntary Withdrawal|0|||
33689806|NCT02430870|63205344|FG006|Part 2|Voluntary Withdrawal|1|||
33689807|NCT02430870|63205345|FG007|Part 2|Voluntary Withdrawal|0|||
33689808|NCT02430870|63205338|FG000|Part 2|Other Reason Not Specified|0|||
33689809|NCT02430870|63205339|FG001|Part 2|Other Reason Not Specified|0|||
33689810|NCT02430870|63205340|FG002|Part 2|Other Reason Not Specified|0|||
33689811|NCT02430870|63205341|FG003|Part 2|Other Reason Not Specified|0|||
33689812|NCT02430870|63205342|FG004|Part 2|Other Reason Not Specified|0|||
33689813|NCT02430870|63205343|FG005|Part 2|Other Reason Not Specified|0|||
33689814|NCT02430870|63205344|FG006|Part 2|Other Reason Not Specified|0|||
33689815|NCT02430870|63205345|FG007|Part 2|Other Reason Not Specified|1|||
33689816|NCT02429934|63205411|FG000|Overall Study|Withdrawal by Subject|0|||
33689817|NCT02429934|63205412|FG001|Overall Study|Withdrawal by Subject|2|||
33689818|NCT02429934|63205411|FG000|Overall Study|Adverse Event|2|||
33689819|NCT02429934|63205412|FG001|Overall Study|Adverse Event|0|||
33689820|NCT02429934|63205411|FG000|Overall Study|Lost to Follow-up|1|||
33689821|NCT02429934|63205412|FG001|Overall Study|Lost to Follow-up|1|||
33689822|NCT02429934|63205411|FG000|Overall Study|Physician Decision|1|||
33689823|NCT02429934|63205412|FG001|Overall Study|Physician Decision|0|||
33689824|NCT02429856|63205426|FG000|Overall Study|Death|12|||
33689825|NCT02429856|63205427|FG001|Overall Study|Death|13|||
33689826|NCT02429856|63205426|FG000|Overall Study|Lost to Follow-up|6|||
33689827|NCT02429856|63205427|FG001|Overall Study|Lost to Follow-up|5|||
33689828|NCT02429856|63205426|FG000|Overall Study|Withdrawal by Subject|1|||
33689829|NCT02429856|63205427|FG001|Overall Study|Withdrawal by Subject|1|||
33689830|NCT02429778|63205437|FG000|Overall Study|Lost to Follow-up|2|||
33689831|NCT02429778|63205438|FG001|Overall Study|Lost to Follow-up|0|||
33689832|NCT02429778|63205437|FG000|Overall Study|Withdrawal by Subject|5|||
33689833|NCT02429778|63205438|FG001|Overall Study|Withdrawal by Subject|0|||
33689834|NCT02403180|63205446|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
33689835|NCT02403180|63205447|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
33689836|NCT02403180|63205446|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
33689837|NCT02403180|63205447|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
33689838|NCT00558467|63205481|FG000|Overall Study|Adverse Event|1|||
33689839|NCT00558467|63205482|FG001|Overall Study|Adverse Event|2|||
33689840|NCT00558467|63205481|FG000|Overall Study|Lack of Efficacy|0|||
33689841|NCT00558467|63205482|FG001|Overall Study|Lack of Efficacy|1|||
33689842|NCT00558467|63205481|FG000|Overall Study|Patient moving out of state|0|||
33689843|NCT00558467|63205482|FG001|Overall Study|Patient moving out of state|1|||
33689844|NCT02402166|63205488|FG000|Overall Study|Adverse Event|2|||
33689845|NCT02402166|63205488|FG000|Overall Study|Withdrawal by Subject|2|||
33689846|NCT02402166|63205488|FG000|Overall Study|Lost to Follow-up|1|||
33596033|NCT02326597|62994968|FG000|Overall Study|Lost to Follow-up|42|||
33689847|NCT02378220|63205508|FG000|Overall Study|Death|6|||
33689848|NCT02378220|63205509|FG001|Overall Study|Death|1|||
33689849|NCT04226495|63205518|FG000|Overall Study|Withdrawal by Subject|3|||
33689850|NCT04226495|63205519|FG001|Overall Study|Withdrawal by Subject|3|||
33689851|NCT04226495|63205518|FG000|Overall Study|PI discretion|2|||
33689852|NCT04226495|63205519|FG001|Overall Study|PI discretion|4|||
33689853|NCT02401308|63205527|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
33689854|NCT02401308|63205528|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
33689855|NCT02401230|63205537|FG000|Overall Study|Adverse Event|3|||
33689856|NCT02401230|63205538|FG001|Overall Study|Adverse Event|2|||
33689857|NCT02401230|63205539|FG002|Overall Study|Adverse Event|0|||
33689858|NCT02401230|63205537|FG000|Overall Study|Withdrawal by Subject|2|||
33689859|NCT02401230|63205538|FG001|Overall Study|Withdrawal by Subject|1|||
33689860|NCT02401230|63205539|FG002|Overall Study|Withdrawal by Subject|1|||
33689861|NCT02401230|63205537|FG000|Overall Study|Lost to Follow-up|1|||
33689862|NCT02401230|63205538|FG001|Overall Study|Lost to Follow-up|3|||
33689863|NCT02401230|63205539|FG002|Overall Study|Lost to Follow-up|3|||
33689864|NCT02429310|63205580|FG000|Overall Study|Lost to Follow-up|1|||
33689865|NCT02429310|63205581|FG001|Overall Study|Lost to Follow-up|2|||
33689866|NCT02429310|63205580|FG000|Overall Study|Protocol Violation|1|||
33689867|NCT02429310|63205581|FG001|Overall Study|Protocol Violation|1|||
33689868|NCT02428608|63205607|FG000|Overall Study|Pregnancy|2|||
33689869|NCT02428608|63205607|FG000|Overall Study|Lost to Follow-up|37|||
33689870|NCT02428608|63205607|FG000|Overall Study|Withdrawal by Subject|2|||
33689871|NCT02428608|63205607|FG000|Overall Study|scheduling conflicts|15|||
33689872|NCT02428608|63205607|FG000|Overall Study|moved away|10|||
33689873|NCT02428608|63205607|FG000|Overall Study|Death|1|||
33689874|NCT02428608|63205607|FG000|Overall Study|various|16|||
33689875|NCT02428296|63205627|FG000|Overall Study|Adverse Event|7|||
33689876|NCT02428296|63205627|FG000|Overall Study|Withdrawal by Subject|2|||
33689877|NCT02427984|63205641|FG000|Overall Study|Lost to Follow-up|13|||
33689878|NCT02427984|63205642|FG001|Overall Study|Lost to Follow-up|5|||
33689879|NCT02427984|63205643|FG002|Overall Study|Lost to Follow-up|18|||
33689880|NCT00556673|63205861|FG000|Overall Study|Protocol deviation|3|||
33689881|NCT00556673|63205862|FG001|Overall Study|Protocol deviation|2|||
33689882|NCT02402322|63205886|FG000|Pretreatment|Withdrawal by Subject|3|||
33689883|NCT02402322|63205887|FG001|Pretreatment|Withdrawal by Subject|1|||
33689884|NCT02402322|63205888|FG002|Pretreatment|Withdrawal by Subject|1|||
33689885|NCT02402322|63205886|FG000|Follow-up|Withdrawal by Subject|6|||
33689886|NCT02402322|63205887|FG001|Follow-up|Withdrawal by Subject|3|||
33689887|NCT02402322|63205888|FG002|Follow-up|Withdrawal by Subject|24|||
33689888|NCT00555425|63206004|FG000|Overall Study|Missed Medication > 1 wk|34|||
33689889|NCT00555425|63206005|FG001|Overall Study|Missed Medication > 1 wk|15|||
33689890|NCT00555425|63206004|FG000|Overall Study|Missed 3 physician management visits|1|||
33689891|NCT00555425|63206005|FG001|Overall Study|Missed 3 physician management visits|0|||
33689892|NCT00555425|63206004|FG000|Overall Study|Met criteria for protective transfer|16|||
33689893|NCT00555425|63206005|FG001|Overall Study|Met criteria for protective transfer|3|||
33689894|NCT00555425|63206004|FG000|Overall Study|Became pregnant and transferred care|0|||
33689895|NCT00555425|63206005|FG001|Overall Study|Became pregnant and transferred care|1|||
33689896|NCT00554099|63206186|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
33689897|NCT00554099|63206187|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
33689898|NCT00554099|63206188|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
33689899|NCT00554099|63206186|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
33689900|NCT00554099|63206187|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
33689901|NCT00554099|63206188|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
33689902|NCT00554099|63206186|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
33689903|NCT00554099|63206187|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
33689904|NCT00554099|63206188|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
33689905|NCT00554099|63206186|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
33689906|NCT00554099|63206187|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
33689907|NCT00554099|63206188|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
33689908|NCT00554099|63206186|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
33689909|NCT00554099|63206187|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
33689910|NCT00554099|63206188|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
33689911|NCT00554099|63206186|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
33689912|NCT00554099|63206187|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
33689913|NCT00554099|63206188|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
33689914|NCT00554099|63206186|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
33689915|NCT00554099|63206187|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
33689916|NCT00554099|63206188|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
33689917|NCT00554099|63206186|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
33689918|NCT00554099|63206187|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
33689919|NCT00554099|63206188|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
33689920|NCT00554099|63206186|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
33689921|NCT00554099|63206187|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
33689922|NCT00554099|63206188|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
33689923|NCT02377362|63206222|FG000|Part A Second Treatment|Protocol Violation|0|||
33689924|NCT02377362|63206223|FG001|Part A Second Treatment|Protocol Violation|0|||
33689925|NCT02377362|63206224|FG002|Part A Second Treatment|Protocol Violation|0|||
33689926|NCT02377362|63206225|FG003|Part A Second Treatment|Protocol Violation|0|||
33689927|NCT02377362|63206226|FG004|Part A Second Treatment|Protocol Violation|1|||
33689928|NCT02377362|63206227|FG005|Part A Second Treatment|Protocol Violation|0|||
33689929|NCT02377362|63206228|FG006|Part A Second Treatment|Protocol Violation|0|||
33689930|NCT02377362|63206229|FG007|Part A Second Treatment|Protocol Violation|0|||
33689931|NCT02377362|63206230|FG008|Part A Second Treatment|Protocol Violation|0|||
33689932|NCT02377362|63206231|FG009|Part A Second Treatment|Protocol Violation|0|||
33689933|NCT02377362|63206232|FG010|Part A Second Treatment|Protocol Violation|0|||
33689934|NCT02377362|63206233|FG011|Part A Second Treatment|Protocol Violation|0|||
33689935|NCT02377362|63206234|FG012|Part A Second Treatment|Protocol Violation|0|||
33689936|NCT02377362|63206222|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
33689937|NCT02377362|63206223|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
33689938|NCT02377362|63206224|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
33689939|NCT02377362|63206225|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
33689940|NCT02377362|63206226|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
33689941|NCT02377362|63206227|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
33689942|NCT02377362|63206228|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
33689943|NCT02377362|63206229|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
33689944|NCT02377362|63206230|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
33689945|NCT02377362|63206231|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
33689946|NCT02377362|63206232|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
33689947|NCT02377362|63206233|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
33689948|NCT02377362|63206234|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
33689949|NCT02377362|63206222|FG000|Part B Overall|Protocol Violation|0|||
33689950|NCT02377362|63206223|FG001|Part B Overall|Protocol Violation|0|||
33689951|NCT02377362|63206224|FG002|Part B Overall|Protocol Violation|0|||
33689952|NCT02377362|63206225|FG003|Part B Overall|Protocol Violation|0|||
33689953|NCT02377362|63206226|FG004|Part B Overall|Protocol Violation|0|||
33689954|NCT02377362|63206227|FG005|Part B Overall|Protocol Violation|0|||
33689955|NCT02377362|63206228|FG006|Part B Overall|Protocol Violation|0|||
33689956|NCT02377362|63206229|FG007|Part B Overall|Protocol Violation|0|||
33689957|NCT02377362|63206230|FG008|Part B Overall|Protocol Violation|0|||
33689958|NCT02377362|63206231|FG009|Part B Overall|Protocol Violation|1|||
33689959|NCT02377362|63206232|FG010|Part B Overall|Protocol Violation|0|||
33689960|NCT02377362|63206233|FG011|Part B Overall|Protocol Violation|0|||
33689961|NCT02377362|63206234|FG012|Part B Overall|Protocol Violation|0|||
33689962|NCT02377362|63206222|FG000|Part B Overall|Adverse Event|0|||
33689963|NCT02377362|63206223|FG001|Part B Overall|Adverse Event|0|||
33689964|NCT02377362|63206224|FG002|Part B Overall|Adverse Event|0|||
33689965|NCT02377362|63206225|FG003|Part B Overall|Adverse Event|0|||
33689966|NCT02377362|63206226|FG004|Part B Overall|Adverse Event|0|||
33689967|NCT02377362|63206227|FG005|Part B Overall|Adverse Event|0|||
33689968|NCT02377362|63206228|FG006|Part B Overall|Adverse Event|1|||
33689969|NCT02377362|63206229|FG007|Part B Overall|Adverse Event|1|||
33689970|NCT02377362|63206230|FG008|Part B Overall|Adverse Event|0|||
33689971|NCT02377362|63206231|FG009|Part B Overall|Adverse Event|0|||
33689972|NCT02377362|63206232|FG010|Part B Overall|Adverse Event|0|||
33689973|NCT02377362|63206233|FG011|Part B Overall|Adverse Event|0|||
33689974|NCT02377362|63206234|FG012|Part B Overall|Adverse Event|0|||
33689975|NCT02377362|63206222|FG000|Part B Overall|Withdrawal by Subject|0|||
33689976|NCT02377362|63206223|FG001|Part B Overall|Withdrawal by Subject|0|||
33689977|NCT02377362|63206224|FG002|Part B Overall|Withdrawal by Subject|0|||
33689978|NCT02377362|63206225|FG003|Part B Overall|Withdrawal by Subject|0|||
33689979|NCT02377362|63206226|FG004|Part B Overall|Withdrawal by Subject|0|||
33689980|NCT02377362|63206227|FG005|Part B Overall|Withdrawal by Subject|0|||
33689981|NCT02377362|63206228|FG006|Part B Overall|Withdrawal by Subject|1|||
33689982|NCT02377362|63206229|FG007|Part B Overall|Withdrawal by Subject|0|||
33689983|NCT02377362|63206230|FG008|Part B Overall|Withdrawal by Subject|0|||
33689984|NCT02377362|63206231|FG009|Part B Overall|Withdrawal by Subject|0|||
33689985|NCT02377362|63206232|FG010|Part B Overall|Withdrawal by Subject|0|||
33689986|NCT02377362|63206233|FG011|Part B Overall|Withdrawal by Subject|1|||
33689987|NCT02377362|63206234|FG012|Part B Overall|Withdrawal by Subject|0|||
33689988|NCT00553631|63206274|FG000|Overall Study|Withdrawal by Subject|0|||
33689989|NCT00553631|63206275|FG001|Overall Study|Withdrawal by Subject|1|||
33689990|NCT00553631|63206274|FG000|Overall Study|Lost to Follow-up|1|||
33689991|NCT00553631|63206275|FG001|Overall Study|Lost to Follow-up|0|||
33689992|NCT00553319|63206284|FG000|Overall Study|Lost to Follow-up|10|||
33689993|NCT00553319|63206285|FG001|Overall Study|Lost to Follow-up|9|||
33689994|NCT00553319|63206286|FG002|Overall Study|Lost to Follow-up|5|||
33689995|NCT00553319|63206284|FG000|Overall Study|wanted treatment elsewhere|2|||
33689996|NCT00553319|63206285|FG001|Overall Study|wanted treatment elsewhere|1|||
33689997|NCT00553319|63206286|FG002|Overall Study|wanted treatment elsewhere|1|||
33689998|NCT00553319|63206284|FG000|Overall Study|non-compliance|0|||
33689999|NCT00553319|63206285|FG001|Overall Study|non-compliance|0|||
33690000|NCT00553319|63206286|FG002|Overall Study|non-compliance|2|||
33690001|NCT00553319|63206284|FG000|Overall Study|incarceration|1|||
33690002|NCT00553319|63206285|FG001|Overall Study|incarceration|0|||
33690003|NCT00553319|63206286|FG002|Overall Study|incarceration|0|||
33690004|NCT00553319|63206284|FG000|Overall Study|moved|1|||
33690005|NCT00553319|63206285|FG001|Overall Study|moved|0|||
33690006|NCT00553319|63206286|FG002|Overall Study|moved|1|||
33690007|NCT01649856|63206472|FG000|Overall Study|Withdrawal by Subject|14|||
33690008|NCT01649856|63206473|FG001|Overall Study|Withdrawal by Subject|14|||
33690009|NCT01649856|63206472|FG000|Overall Study|Protocol Violation|4|||
33690010|NCT01649856|63206473|FG001|Overall Study|Protocol Violation|4|||
33690011|NCT01649856|63206472|FG000|Overall Study|Treatment Failure|1|||
33690012|NCT01649856|63206473|FG001|Overall Study|Treatment Failure|1|||
33690013|NCT01649856|63206472|FG000|Overall Study|Death|69|||
33690014|NCT01649856|63206473|FG001|Overall Study|Death|34|||
33690015|NCT01649856|63206472|FG000|Overall Study|Stable or Progressed Disease|5|||
33690016|NCT01649856|63206473|FG001|Overall Study|Stable or Progressed Disease|3|||
33690017|NCT01649856|63206472|FG000|Overall Study|Lost to Follow-up|20|||
33690018|NCT01649856|63206473|FG001|Overall Study|Lost to Follow-up|16|||
33690019|NCT01649856|63206472|FG000|Overall Study|Lack of Compliance|6|||
33690020|NCT01649856|63206473|FG001|Overall Study|Lack of Compliance|1|||
33690021|NCT01649856|63206472|FG000|Overall Study|Other|20|||
33690022|NCT01649856|63206473|FG001|Overall Study|Other|5|||
33690023|NCT02375724|63206494|FG000|Overall Study|Lack of Efficacy|1|||
33690024|NCT02375724|63206495|FG001|Overall Study|Lack of Efficacy|1|||
33690025|NCT02375724|63206494|FG000|Overall Study|Withdrawal by Subject|1|||
33690026|NCT02375724|63206495|FG001|Overall Study|Withdrawal by Subject|1|||
33690027|NCT02375724|63206494|FG000|Overall Study|Lost to Follow-up|1|||
33690028|NCT02375724|63206495|FG001|Overall Study|Lost to Follow-up|0|||
33690029|NCT02375724|63206494|FG000|Overall Study|Protocol Violation|1|||
33690030|NCT02375724|63206495|FG001|Overall Study|Protocol Violation|0|||
33690031|NCT02375724|63206494|FG000|Overall Study|Adverse Event|2|||
33690032|NCT02375724|63206495|FG001|Overall Study|Adverse Event|4|||
33690033|NCT02398188|63206503|FG000|Overall Study|Adverse Event|2|||
33690034|NCT02398188|63206504|FG001|Overall Study|Adverse Event|3|||
33690035|NCT02398188|63206503|FG000|Overall Study|Lost to Follow-up|5|||
33690036|NCT02398188|63206504|FG001|Overall Study|Lost to Follow-up|0|||
33690037|NCT02398188|63206503|FG000|Overall Study|Non-compliance|4|||
33690038|NCT02398188|63206504|FG001|Overall Study|Non-compliance|4|||
33690039|NCT02398188|63206503|FG000|Overall Study|Protocol Violation|6|||
33690040|NCT02398188|63206504|FG001|Overall Study|Protocol Violation|10|||
33690041|NCT02398188|63206503|FG000|Overall Study|Sponsor Decision|2|||
33690042|NCT02398188|63206504|FG001|Overall Study|Sponsor Decision|1|||
33690043|NCT02398188|63206503|FG000|Overall Study|Pregnancy|1|||
33690044|NCT02398188|63206504|FG001|Overall Study|Pregnancy|0|||
33690045|NCT02398188|63206503|FG000|Overall Study|Withdrawal by Subject|7|||
33690046|NCT02398188|63206504|FG001|Overall Study|Withdrawal by Subject|16|||
33690047|NCT02426580|63206512|FG000|Overall Study|Death|2|||
33690048|NCT02426580|63206513|FG001|Overall Study|Death|2|||
33690049|NCT02426580|63206512|FG000|Overall Study|Lost to Follow-up|0|||
33690050|NCT02426580|63206513|FG001|Overall Study|Lost to Follow-up|9|||
33690051|NCT02426580|63206512|FG000|Overall Study|transfer to hemodialysis|5|||
33690052|NCT02426580|63206513|FG001|Overall Study|transfer to hemodialysis|5|||
33690053|NCT02426580|63206512|FG000|Overall Study|Kidney transplant|3|||
33690054|NCT02426580|63206513|FG001|Overall Study|Kidney transplant|0|||
33690055|NCT02426580|63206512|FG000|Overall Study|Allergic to egg white|1|||
33690056|NCT02426580|63206513|FG001|Overall Study|Allergic to egg white|0|||
33690057|NCT01651260|63206519|FG000|Overall Study|unable to apply product|3|||
33690058|NCT02425098|63206539|FG000|Overall Study|Lost to Follow-up|7|||
33690059|NCT02425098|63206540|FG001|Overall Study|Lost to Follow-up|7|||
33690060|NCT02425098|63206539|FG000|Overall Study|Withdrawal by Subject|4|||
33690061|NCT02425098|63206540|FG001|Overall Study|Withdrawal by Subject|8|||
33690062|NCT02425098|63206539|FG000|Overall Study|Pregnancy|2|||
33690063|NCT02425098|63206540|FG001|Overall Study|Pregnancy|0|||
33690064|NCT02425098|63206539|FG000|Overall Study|Reason not Specified|0|||
33690065|NCT02425098|63206540|FG001|Overall Study|Reason not Specified|1|||
33690066|NCT02424630|63206548|FG000|Overall Study|No rotator cuff tear|1|||
33690067|NCT02424630|63206549|FG001|Overall Study|No rotator cuff tear|2|||
33690068|NCT02424630|63206548|FG000|Overall Study|Open procedure|0|||
33690069|NCT02424630|63206549|FG001|Overall Study|Open procedure|1|||
33690070|NCT02397408|63206555|FG000|Overall Study|Physician Decision|4|||
33690071|NCT02397408|63206555|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
33690072|NCT02397096|63206561|FG000|Day 1 to Week 24|Adverse Event|7|||
33690073|NCT02397096|63206562|FG001|Day 1 to Week 24|Adverse Event|1|||
33596034|NCT02326597|62994969|FG001|Overall Study|Lost to Follow-up|32|||
33651334|NCT01747915|63062747|FG002|Overall Study|Protocol Violation|0|||
33651335|NCT01747915|63062745|FG000|Overall Study|Pregnancy|0|||
33651336|NCT01747915|63062746|FG001|Overall Study|Pregnancy|0|||
33651337|NCT01747915|63062747|FG002|Overall Study|Pregnancy|1|||
33651338|NCT01961297|63062757|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
33651339|NCT01961297|63062758|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
33651340|NCT01960907|63062766|FG000|Overall Study|Death|4|||
33651341|NCT01960907|63062767|FG001|Overall Study|Death|3|||
33651342|NCT01960907|63062766|FG000|Overall Study|Withdrawal by Subject|32|||
33651343|NCT01960907|63062767|FG001|Overall Study|Withdrawal by Subject|42|||
33651344|NCT01747837|63062778|FG000|Overall Study|Lost to Follow-up|5|||
33651345|NCT01747837|63062779|FG001|Overall Study|Lost to Follow-up|2|||
33651346|NCT01747837|63062778|FG000|Overall Study|Death|4|||
33651347|NCT01747837|63062779|FG001|Overall Study|Death|4|||
33651348|NCT01971203|63062787|FG000|Overall Study|Protocol Violation|3|||
33651349|NCT01971203|63062788|FG001|Overall Study|Protocol Violation|2|||
33690074|NCT02397096|63206561|FG000|Day 1 to Week 24|Death|1|||
33690075|NCT02397096|63206562|FG001|Day 1 to Week 24|Death|0|||
33690076|NCT02397096|63206561|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
33690077|NCT02397096|63206562|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
33690078|NCT02397096|63206561|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
33690079|NCT02397096|63206562|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
33690080|NCT02397096|63206561|FG000|Day 1 to Week 24|Physician Decision|2|||
33690081|NCT02397096|63206562|FG001|Day 1 to Week 24|Physician Decision|3|||
33690082|NCT02397096|63206561|FG000|Day 1 to Week 24|Protocol Violation|1|||
33690083|NCT02397096|63206562|FG001|Day 1 to Week 24|Protocol Violation|4|||
33690084|NCT02397096|63206561|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
33690085|NCT02397096|63206562|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
33690086|NCT02397096|63206561|FG000|Week 24 to Week 48|Adverse Event|6|||
33690087|NCT02397096|63206562|FG001|Week 24 to Week 48|Adverse Event|2|||
33690088|NCT02397096|63206561|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
33690089|NCT02397096|63206562|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
33690090|NCT02397096|63206561|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
33690091|NCT02397096|63206562|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
33690092|NCT02397096|63206561|FG000|Week 24 to Week 48|Physician Decision|2|||
33690093|NCT02397096|63206562|FG001|Week 24 to Week 48|Physician Decision|1|||
33690094|NCT02397096|63206561|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
33690095|NCT02397096|63206562|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
33690096|NCT02397096|63206561|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
33690097|NCT02397096|63206562|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
33690098|NCT02397096|63206561|FG000|Study Extensions|Ongoing|399|||
33690099|NCT02397096|63206562|FG001|Study Extensions|Ongoing|202|||
33690100|NCT02372058|63206572|FG000|Overall Study|Withdrawal by Subject|3|||
33690101|NCT02396316|63206580|FG000|Overall Study|Physician Decision|1|||
33690102|NCT02396316|63206581|FG001|Overall Study|Physician Decision|0|||
33690103|NCT02396316|63206580|FG000|Overall Study|Progressive disease|6|||
33690104|NCT02396316|63206581|FG001|Overall Study|Progressive disease|3|||
33690105|NCT02396316|63206580|FG000|Overall Study|Protocol Violation|0|||
33690106|NCT02396316|63206581|FG001|Overall Study|Protocol Violation|1|||
33690107|NCT02396316|63206580|FG000|Overall Study|Treatment unblinded|0|||
33690108|NCT02396316|63206581|FG001|Overall Study|Treatment unblinded|1|||
33690109|NCT02395536|63206591|FG000|Overall Study|Lost to Follow-up|4|||
33690110|NCT02395536|63206592|FG001|Overall Study|Lost to Follow-up|4|||
33690111|NCT02395536|63206591|FG000|Overall Study|Death|2|||
33690112|NCT02395536|63206592|FG001|Overall Study|Death|0|||
33690113|NCT02395536|63206591|FG000|Overall Study|Physician Decision|4|||
33690114|NCT02395536|63206592|FG001|Overall Study|Physician Decision|6|||
33690115|NCT02395536|63206591|FG000|Overall Study|Withdrawal by Subject|9|||
33690116|NCT02395536|63206592|FG001|Overall Study|Withdrawal by Subject|17|||
33690117|NCT02395536|63206591|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
33690118|NCT02395536|63206592|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
33690119|NCT02395536|63206591|FG000|Overall Study|Insurance issue|0|||
33690120|NCT02395536|63206592|FG001|Overall Study|Insurance issue|1|||
33690121|NCT00552929|63206608|FG000|Overall Study|Lost to Follow-up|0|||
33690122|NCT00552929|63206609|FG001|Overall Study|Lost to Follow-up|0|||
33690123|NCT00552929|63206610|FG002|Overall Study|Lost to Follow-up|0|||
33690124|NCT00552929|63206611|FG003|Overall Study|Lost to Follow-up|0|||
33690125|NCT00552929|63206612|FG004|Overall Study|Lost to Follow-up|0|||
33690126|NCT00552929|63206613|FG005|Overall Study|Lost to Follow-up|0|||
33690127|NCT00552929|63206614|FG006|Overall Study|Lost to Follow-up|0|||
33690128|NCT00552929|63206615|FG007|Overall Study|Lost to Follow-up|0|||
33690129|NCT00552929|63206616|FG008|Overall Study|Lost to Follow-up|1|||
33690130|NCT00552929|63206617|FG009|Overall Study|Lost to Follow-up|0|||
33690131|NCT00552929|63206608|FG000|Overall Study|Not Eligible|0|||
33690132|NCT00552929|63206609|FG001|Overall Study|Not Eligible|0|||
33690133|NCT00552929|63206610|FG002|Overall Study|Not Eligible|0|||
33690134|NCT00552929|63206611|FG003|Overall Study|Not Eligible|0|||
33690135|NCT00552929|63206612|FG004|Overall Study|Not Eligible|0|||
33690136|NCT00552929|63206613|FG005|Overall Study|Not Eligible|1|||
33690137|NCT00552929|63206614|FG006|Overall Study|Not Eligible|0|||
33690138|NCT00552929|63206615|FG007|Overall Study|Not Eligible|0|||
33690139|NCT00552929|63206616|FG008|Overall Study|Not Eligible|0|||
33690140|NCT00552929|63206617|FG009|Overall Study|Not Eligible|0|||
33690141|NCT02395302|63206639|FG000|Overall Study|Screen Failure|3|||
33690142|NCT02395302|63206639|FG000|Overall Study|Run In Failure|7|||
33690143|NCT02395302|63206639|FG000|Overall Study|Withdrawal by Subject|2|||
33690144|NCT02395302|63206639|FG000|Overall Study|Physician Decision|2|||
33690145|NCT02371980|63206673|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
33690146|NCT02371980|63206674|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
33690147|NCT02371980|63206675|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
33690148|NCT02371980|63206676|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
33690149|NCT02371980|63206677|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
33690150|NCT02371980|63206673|FG000|Open-label Period|Significant Protocol Deviation|19|||
33690151|NCT02371980|63206674|FG001|Open-label Period|Significant Protocol Deviation|0|||
33690152|NCT02371980|63206675|FG002|Open-label Period|Significant Protocol Deviation|0|||
33690153|NCT02371980|63206676|FG003|Open-label Period|Significant Protocol Deviation|0|||
33690154|NCT02371980|63206677|FG004|Open-label Period|Significant Protocol Deviation|0|||
33690155|NCT02371980|63206673|FG000|Open-label Period|Noncompliance with Study Drug|10|||
33690156|NCT02371980|63206674|FG001|Open-label Period|Noncompliance with Study Drug|0|||
33690157|NCT02371980|63206675|FG002|Open-label Period|Noncompliance with Study Drug|0|||
33690158|NCT02371980|63206676|FG003|Open-label Period|Noncompliance with Study Drug|0|||
33690159|NCT02371980|63206677|FG004|Open-label Period|Noncompliance with Study Drug|0|||
33690160|NCT02371980|63206673|FG000|Open-label Period|Lost to Follow-up|55|||
33690161|NCT02371980|63206674|FG001|Open-label Period|Lost to Follow-up|0|||
33690162|NCT02371980|63206675|FG002|Open-label Period|Lost to Follow-up|0|||
33690163|NCT02371980|63206676|FG003|Open-label Period|Lost to Follow-up|0|||
33690164|NCT02371980|63206677|FG004|Open-label Period|Lost to Follow-up|0|||
33690165|NCT02371980|63206673|FG000|Open-label Period|Voluntary Withdrawal|91|||
33690166|NCT02371980|63206674|FG001|Open-label Period|Voluntary Withdrawal|0|||
33690167|NCT02371980|63206675|FG002|Open-label Period|Voluntary Withdrawal|0|||
33690168|NCT02371980|63206676|FG003|Open-label Period|Voluntary Withdrawal|0|||
33690169|NCT02371980|63206677|FG004|Open-label Period|Voluntary Withdrawal|0|||
33690170|NCT02371980|63206673|FG000|Open-label Period|Pregnancy|1|||
33690171|NCT02371980|63206674|FG001|Open-label Period|Pregnancy|0|||
33690172|NCT02371980|63206675|FG002|Open-label Period|Pregnancy|0|||
33690173|NCT02371980|63206676|FG003|Open-label Period|Pregnancy|0|||
33690174|NCT02371980|63206677|FG004|Open-label Period|Pregnancy|0|||
33690175|NCT02371980|63206673|FG000|Open-label Period|Lack of Efficacy|116|||
33690176|NCT02371980|63206674|FG001|Open-label Period|Lack of Efficacy|0|||
33690177|NCT02371980|63206675|FG002|Open-label Period|Lack of Efficacy|0|||
33690178|NCT02371980|63206676|FG003|Open-label Period|Lack of Efficacy|0|||
33690179|NCT02371980|63206677|FG004|Open-label Period|Lack of Efficacy|0|||
33690180|NCT02371980|63206673|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
33690181|NCT02371980|63206674|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
33690182|NCT02371980|63206675|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
33690183|NCT02371980|63206676|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
33690184|NCT02371980|63206677|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
33690185|NCT02371980|63206673|FG000|Open-label Period|Reason not Specified|9|||
33690186|NCT02371980|63206674|FG001|Open-label Period|Reason not Specified|0|||
33690187|NCT02371980|63206675|FG002|Open-label Period|Reason not Specified|0|||
33690188|NCT02371980|63206676|FG003|Open-label Period|Reason not Specified|0|||
33690189|NCT02371980|63206677|FG004|Open-label Period|Reason not Specified|0|||
33690190|NCT02371980|63206673|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
33690191|NCT02371980|63206674|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
33690192|NCT02371980|63206675|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
33690193|NCT02371980|63206676|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
33690194|NCT02371980|63206677|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
33690195|NCT02371980|63206673|FG000|Double-blind Period|Significant Protocol Deviation|0|||
33690196|NCT02371980|63206674|FG001|Double-blind Period|Significant Protocol Deviation|2|||
33690197|NCT02371980|63206675|FG002|Double-blind Period|Significant Protocol Deviation|7|||
33690198|NCT02371980|63206676|FG003|Double-blind Period|Significant Protocol Deviation|3|||
33690199|NCT02371980|63206677|FG004|Double-blind Period|Significant Protocol Deviation|3|||
33690200|NCT02371980|63206673|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
33690201|NCT02371980|63206674|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
33690202|NCT02371980|63206675|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
33690203|NCT02371980|63206676|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
33690204|NCT02371980|63206677|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
33690205|NCT02371980|63206673|FG000|Double-blind Period|Lost to Follow-up|0|||
33690206|NCT02371980|63206674|FG001|Double-blind Period|Lost to Follow-up|8|||
33690207|NCT02371980|63206675|FG002|Double-blind Period|Lost to Follow-up|8|||
33690208|NCT02371980|63206676|FG003|Double-blind Period|Lost to Follow-up|6|||
33690209|NCT02371980|63206677|FG004|Double-blind Period|Lost to Follow-up|5|||
33690210|NCT02371980|63206673|FG000|Double-blind Period|Voluntary Withdrawal|0|||
33690211|NCT02371980|63206674|FG001|Double-blind Period|Voluntary Withdrawal|12|||
33690212|NCT02371980|63206675|FG002|Double-blind Period|Voluntary Withdrawal|8|||
33690213|NCT02371980|63206676|FG003|Double-blind Period|Voluntary Withdrawal|9|||
33690214|NCT02371980|63206677|FG004|Double-blind Period|Voluntary Withdrawal|11|||
33690215|NCT02371980|63206673|FG000|Double-blind Period|Relapse|0|||
33690216|NCT02371980|63206674|FG001|Double-blind Period|Relapse|50|||
33690217|NCT02371980|63206675|FG002|Double-blind Period|Relapse|25|||
33493174|NCT00812006|62871288|FG000|Overall Study|Physician Decision|0|||
33596035|NCT02366767|62994979|FG000|Overall Study|left for home after 1 day at camp|1|||
33690218|NCT02371980|63206676|FG003|Double-blind Period|Relapse|25|||
33690219|NCT02371980|63206677|FG004|Double-blind Period|Relapse|26|||
33690220|NCT02371980|63206673|FG000|Double-blind Period|Reason not Specified|0|||
33690221|NCT02371980|63206674|FG001|Double-blind Period|Reason not Specified|3|||
33690222|NCT02371980|63206675|FG002|Double-blind Period|Reason not Specified|3|||
33690223|NCT02371980|63206676|FG003|Double-blind Period|Reason not Specified|2|||
33690224|NCT02371980|63206677|FG004|Double-blind Period|Reason not Specified|1|||
33690225|NCT02371980|63206673|FG000|Double-blind Period|Missing|0|||
33690226|NCT02371980|63206674|FG001|Double-blind Period|Missing|1|||
33690227|NCT02371980|63206675|FG002|Double-blind Period|Missing|0|||
33690228|NCT02371980|63206676|FG003|Double-blind Period|Missing|0|||
33690229|NCT02371980|63206677|FG004|Double-blind Period|Missing|0|||
33690230|NCT02371746|63206817|FG000|Overall Study|Consent withdrawn|0|||
33690231|NCT02371746|63206818|FG001|Overall Study|Consent withdrawn|0|||
33690232|NCT02371746|63206819|FG002|Overall Study|Consent withdrawn|0|||
33690233|NCT02371746|63206820|FG003|Overall Study|Consent withdrawn|0|||
33690234|NCT02371746|63206821|FG004|Overall Study|Consent withdrawn|0|||
33690235|NCT02371746|63206822|FG005|Overall Study|Consent withdrawn|0|||
33690236|NCT02371746|63206823|FG006|Overall Study|Consent withdrawn|1|||
33690237|NCT02421666|63206871|FG000|6-month Follow-up|Lost to Follow-up|8|||
33690238|NCT02421666|63206872|FG001|6-month Follow-up|Lost to Follow-up|7|||
33690239|NCT02421666|63206871|FG000|6-month Follow-up|Withdrawal by Subject|5|||
33690240|NCT02421666|63206872|FG001|6-month Follow-up|Withdrawal by Subject|6|||
33690241|NCT02421666|63206871|FG000|12-month Follow-up|Lost to Follow-up|5|||
33690242|NCT02421666|63206872|FG001|12-month Follow-up|Lost to Follow-up|5|||
33690243|NCT02421666|63206871|FG000|12-month Follow-up|Withdrawal by Subject|6|||
33690244|NCT02421666|63206872|FG001|12-month Follow-up|Withdrawal by Subject|11|||
33690245|NCT02394756|63206882|FG000|Period 1|Lens Discomfort|0|||
33690246|NCT02394756|63206883|FG001|Period 1|Lens Discomfort|0|||
33690247|NCT02394756|63206884|FG002|Period 1|Lens Discomfort|0|||
33690248|NCT02394756|63206885|FG003|Period 1|Lens Discomfort|0|||
33690249|NCT02394756|63206886|FG004|Period 1|Lens Discomfort|0|||
33690250|NCT02394756|63206887|FG005|Period 1|Lens Discomfort|1|||
33690251|NCT02394756|63206882|FG000|Period 1|Withdrawal by Subject|0|||
33690252|NCT02394756|63206883|FG001|Period 1|Withdrawal by Subject|1|||
33690253|NCT02394756|63206884|FG002|Period 1|Withdrawal by Subject|1|||
33690254|NCT02394756|63206885|FG003|Period 1|Withdrawal by Subject|1|||
33596036|NCT02366767|62994980|FG001|Overall Study|left for home after 1 day at camp|0|||
33596037|NCT02150343|62994990|FG000|Overall Study|Adverse Event|2|||
33596038|NCT02150343|62994991|FG001|Overall Study|Adverse Event|0|||
33596039|NCT02150343|62994992|FG002|Overall Study|Adverse Event|1|||
33596040|NCT02150343|62994993|FG003|Overall Study|Adverse Event|1|||
33596041|NCT02150343|62994990|FG000|Overall Study|Withdrawal by Subject|13|||
33596042|NCT02150343|62994991|FG001|Overall Study|Withdrawal by Subject|10|||
33596043|NCT02150343|62994992|FG002|Overall Study|Withdrawal by Subject|9|||
33596044|NCT02150343|62994993|FG003|Overall Study|Withdrawal by Subject|4|||
33596045|NCT02150343|62994990|FG000|Overall Study|Lost to Follow-up|4|||
33596046|NCT02150343|62994991|FG001|Overall Study|Lost to Follow-up|4|||
33596047|NCT02150343|62994992|FG002|Overall Study|Lost to Follow-up|2|||
33596048|NCT02150343|62994993|FG003|Overall Study|Lost to Follow-up|3|||
33596049|NCT02150343|62994990|FG000|Overall Study|Other|2|||
33596050|NCT02150343|62994991|FG001|Overall Study|Other|6|||
33596051|NCT02150343|62994992|FG002|Overall Study|Other|0|||
33596052|NCT02150343|62994993|FG003|Overall Study|Other|2|||
33596053|NCT02149875|62995006|FG000|Overall Study|Lost to Follow-up|3|||
33596054|NCT02149875|62995007|FG001|Overall Study|Lost to Follow-up|4|||
33596055|NCT02149875|62995008|FG002|Overall Study|Lost to Follow-up|5|||
33596056|NCT02149875|62995006|FG000|Overall Study|Withdrawal by Subject|3|||
33596057|NCT02149875|62995007|FG001|Overall Study|Withdrawal by Subject|2|||
33596058|NCT02149875|62995008|FG002|Overall Study|Withdrawal by Subject|2|||
33596059|NCT02149875|62995006|FG000|Overall Study|Physician Decision|1|||
33596060|NCT02149875|62995007|FG001|Overall Study|Physician Decision|2|||
33596061|NCT02149875|62995008|FG002|Overall Study|Physician Decision|2|||
33596062|NCT02112045|62995018|FG000|Overall Study|Withdrawal by Subject|1|||
33596063|NCT02112045|62995019|FG001|Overall Study|Withdrawal by Subject|0|||
33690255|NCT02394756|63206886|FG004|Period 1|Withdrawal by Subject|0|||
33690256|NCT02394756|63206887|FG005|Period 1|Withdrawal by Subject|0|||
33596064|NCT01629693|62995027|FG000|Overall Study|Lost to Follow-up|2|||
33596065|NCT01629693|62995028|FG001|Overall Study|Lost to Follow-up|4|||
33596066|NCT01629693|62995027|FG000|Overall Study|Withdrawal by Subject|2|||
33596067|NCT01629693|62995028|FG001|Overall Study|Withdrawal by Subject|2|||
33596068|NCT01629693|62995027|FG000|Overall Study|Adverse Event|1|||
33690257|NCT02394756|63206882|FG000|Period 2|Unsatisfactory Visual Response|0|||
33690258|NCT02394756|63206883|FG001|Period 2|Unsatisfactory Visual Response|0|||
33690259|NCT02394756|63206884|FG002|Period 2|Unsatisfactory Visual Response|0|||
33690260|NCT02394756|63206885|FG003|Period 2|Unsatisfactory Visual Response|0|||
33690261|NCT02394756|63206886|FG004|Period 2|Unsatisfactory Visual Response|1|||
33690262|NCT02394756|63206887|FG005|Period 2|Unsatisfactory Visual Response|0|||
33596069|NCT01629693|62995028|FG001|Overall Study|Adverse Event|0|||
33596070|NCT01629693|62995027|FG000|Overall Study|Investigator decision|0|||
33690263|NCT02370888|63206908|FG000|Overall Study|disease progression|2|||
33596071|NCT01629693|62995028|FG001|Overall Study|Investigator decision|1|||
33596072|NCT01629693|62995027|FG000|Overall Study|Poor comfort of study lenses|0|||
33596073|NCT01629693|62995028|FG001|Overall Study|Poor comfort of study lenses|2|||
33596074|NCT01629693|62995027|FG000|Overall Study|Subject decision unrelated to AE|0|||
33596075|NCT01629693|62995028|FG001|Overall Study|Subject decision unrelated to AE|1|||
33596076|NCT02147691|62995036|FG000|Overall Study|Withdrawal by Subject|2|||
33596077|NCT02147691|62995037|FG001|Overall Study|Withdrawal by Subject|0|||
33596078|NCT02147691|62995036|FG000|Overall Study|Adverse Event|2|||
33596079|NCT02147691|62995037|FG001|Overall Study|Adverse Event|0|||
33596080|NCT02147691|62995036|FG000|Overall Study|Lost to Follow-up|0|||
33596081|NCT02147691|62995037|FG001|Overall Study|Lost to Follow-up|1|||
33596082|NCT02111811|62995045|FG000|Treatment Phase|Lost to Follow-up|22|||
33596083|NCT02111811|62995046|FG001|Treatment Phase|Lost to Follow-up|18|||
33596084|NCT02111811|62995045|FG000|Treatment Phase|Death|2|||
33596085|NCT02111811|62995046|FG001|Treatment Phase|Death|0|||
33596086|NCT02111811|62995045|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
33596087|NCT02111811|62995046|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
33596088|NCT02111811|62995045|FG000|Follow up Period (Aim 2)|Death|2|||
33596089|NCT02111811|62995046|FG001|Follow up Period (Aim 2)|Death|0|||
33596090|NCT01655693|62995055|FG000|Overall Study|Progression of Disease|92|||
33596091|NCT01655693|62995056|FG001|Overall Study|Progression of Disease|76|||
33596092|NCT01655693|62995057|FG002|Overall Study|Progression of Disease|58|||
33596093|NCT01655693|62995055|FG000|Overall Study|Death|8|||
33596094|NCT01655693|62995056|FG001|Overall Study|Death|9|||
33596095|NCT01655693|62995057|FG002|Overall Study|Death|12|||
33596096|NCT01655693|62995055|FG000|Overall Study|Serious Adverse Event|3|||
33596097|NCT01655693|62995056|FG001|Overall Study|Serious Adverse Event|15|||
33596098|NCT01655693|62995057|FG002|Overall Study|Serious Adverse Event|11|||
33596099|NCT01655693|62995055|FG000|Overall Study|Withdrawal by Subject|3|||
33596100|NCT01655693|62995056|FG001|Overall Study|Withdrawal by Subject|2|||
33596101|NCT01655693|62995057|FG002|Overall Study|Withdrawal by Subject|20|||
33596102|NCT01655693|62995055|FG000|Overall Study|Adverse Event|3|||
33596103|NCT01655693|62995056|FG001|Overall Study|Adverse Event|11|||
33596104|NCT01655693|62995057|FG002|Overall Study|Adverse Event|3|||
33596105|NCT01655693|62995055|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
33596106|NCT01655693|62995056|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
33596107|NCT01655693|62995057|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
33596108|NCT01655693|62995055|FG000|Overall Study|Non-Compliance|0|||
33596109|NCT01655693|62995056|FG001|Overall Study|Non-Compliance|0|||
33596110|NCT01655693|62995057|FG002|Overall Study|Non-Compliance|7|||
33596111|NCT01655693|62995055|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
33596112|NCT01655693|62995056|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
33596113|NCT01655693|62995057|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
33596114|NCT01655693|62995055|FG000|Overall Study|Protocol Violation|1|||
33596115|NCT01655693|62995056|FG001|Overall Study|Protocol Violation|0|||
33596116|NCT01655693|62995057|FG002|Overall Study|Protocol Violation|3|||
33596117|NCT01655693|62995055|FG000|Overall Study|Lost to Follow-up|1|||
33596118|NCT01655693|62995056|FG001|Overall Study|Lost to Follow-up|0|||
33596119|NCT01655693|62995057|FG002|Overall Study|Lost to Follow-up|1|||
33596120|NCT01655693|62995055|FG000|Overall Study|Screening Failure|1|||
33690264|NCT02370888|63206908|FG000|Overall Study|did not meet chimerism criteria|6|||
33690265|NCT02394600|63206932|FG000|Overall Study|Adverse Event|3|||
33690266|NCT02394600|63206933|FG001|Overall Study|Adverse Event|0|||
33690267|NCT02394600|63206932|FG000|Overall Study|Lost to Follow-up|0|||
33690268|NCT02394600|63206933|FG001|Overall Study|Lost to Follow-up|1|||
33690269|NCT02394600|63206932|FG000|Overall Study|Withdrawal by Subject|0|||
33690270|NCT02394600|63206933|FG001|Overall Study|Withdrawal by Subject|1|||
33690271|NCT02394600|63206932|FG000|Overall Study|Protocol Violation|1|||
33690272|NCT02394600|63206933|FG001|Overall Study|Protocol Violation|0|||
33690273|NCT04685499|63206949|FG000|Overall Study|Study Terminated Early|1|||
33690274|NCT02421588|63207025|FG000|Overall Study|Non-treatment-related AE|8|||
33596121|NCT01655693|62995056|FG001|Overall Study|Screening Failure|0|||
33596122|NCT01655693|62995057|FG002|Overall Study|Screening Failure|0|||
33596123|NCT01655693|62995055|FG000|Overall Study|Other|8|||
33596124|NCT01655693|62995056|FG001|Overall Study|Other|6|||
33596125|NCT01655693|62995057|FG002|Overall Study|Other|15|||
33596126|NCT01655381|62995075|FG000|Overall Study|Investigator Decision|1|||
33596127|NCT01655381|62995075|FG000|Overall Study|Moved to Another City|1|||
33596128|NCT01655381|62995075|FG000|Overall Study|Insufficient Treatment Response|1|||
33596129|NCT01656161|62995080|FG000|Overall Study|Death|3|||
33596130|NCT01656161|62995080|FG000|Overall Study|Adverse Event|2|||
33596131|NCT01656161|62995080|FG000|Overall Study|Protocol Violation|1|||
33596132|NCT01656161|62995080|FG000|Overall Study|Withdrawal by Subject|1|||
33596133|NCT02111577|62995089|FG000|Overall Study|Protocol Violation|2|||
33596134|NCT02111577|62995090|FG001|Overall Study|Protocol Violation|0|||
33596135|NCT02111577|62995089|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
33596136|NCT02111577|62995090|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
33401443|NCT00256867|62780474|FG000|Overall Study|Protocol Violation|0|||
33596137|NCT02111577|62995089|FG000|Overall Study|Failure to produce study treatment|6|||
33596138|NCT02111577|62995090|FG001|Overall Study|Failure to produce study treatment|0|||
33596139|NCT02111577|62995089|FG000|Overall Study|Death|518|||
33596140|NCT02111577|62995090|FG001|Overall Study|Death|254|||
33596141|NCT02111577|62995089|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
33596142|NCT02111577|62995090|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
33596143|NCT02111577|62995089|FG000|Overall Study|Adverse Event|1|||
33596144|NCT02111577|62995090|FG001|Overall Study|Adverse Event|1|||
33596145|NCT02111577|62995089|FG000|Overall Study|Withdrawal by Subject|51|||
33596146|NCT02111577|62995090|FG001|Overall Study|Withdrawal by Subject|23|||
33596147|NCT02111577|62995089|FG000|Overall Study|Disease progression|0|||
33596148|NCT02111577|62995090|FG001|Overall Study|Disease progression|1|||
33596149|NCT02111577|62995089|FG000|Overall Study|Lost to Follow-up|19|||
33596150|NCT02111577|62995090|FG001|Overall Study|Lost to Follow-up|10|||
33690275|NCT02421588|63207026|FG001|Overall Study|Non-treatment-related AE|8|||
33690276|NCT02421588|63207025|FG000|Overall Study|Progressive disease|152|||
33690277|NCT02421588|63207026|FG001|Overall Study|Progressive disease|135|||
33690278|NCT02421588|63207025|FG000|Overall Study|Death|11|||
33690279|NCT02421588|63207026|FG001|Overall Study|Death|3|||
33690280|NCT02421588|63207025|FG000|Overall Study|Physician Decision|8|||
33690281|NCT02421588|63207026|FG001|Overall Study|Physician Decision|17|||
33690282|NCT02421588|63207025|FG000|Overall Study|Other reason not specified|3|||
33690283|NCT02421588|63207026|FG001|Overall Study|Other reason not specified|1|||
33690284|NCT02421588|63207025|FG000|Overall Study|Symptomatic deterioration|13|||
33690285|NCT02421588|63207026|FG001|Overall Study|Symptomatic deterioration|19|||
33690286|NCT02421588|63207025|FG000|Overall Study|Treatment-related AE|10|||
33690287|NCT02421588|63207026|FG001|Overall Study|Treatment-related AE|14|||
33690288|NCT02421588|63207025|FG000|Overall Study|Withdrawal by Subject|14|||
33690289|NCT02421588|63207026|FG001|Overall Study|Withdrawal by Subject|16|||
33690290|NCT02421588|63207025|FG000|Overall Study|Not treated|2|||
33690291|NCT02421588|63207026|FG001|Overall Study|Not treated|8|||
33690292|NCT02421510|63207035|FG000|Overall Study|Other|4|||
33690293|NCT02421510|63207036|FG001|Overall Study|Other|2|||
33690294|NCT02421510|63207037|FG002|Overall Study|Other|3|||
33690295|NCT02421510|63207035|FG000|Overall Study|Protocol Violation|1|||
33690296|NCT02421510|63207036|FG001|Overall Study|Protocol Violation|2|||
33690297|NCT02421510|63207037|FG002|Overall Study|Protocol Violation|0|||
33690298|NCT02421510|63207035|FG000|Overall Study|Death|1|||
33690299|NCT02421510|63207036|FG001|Overall Study|Death|0|||
33690300|NCT02421510|63207037|FG002|Overall Study|Death|0|||
33690301|NCT02421510|63207035|FG000|Overall Study|Noncompliance with study drug|1|||
33690302|NCT02421510|63207036|FG001|Overall Study|Noncompliance with study drug|0|||
33690303|NCT02421510|63207037|FG002|Overall Study|Noncompliance with study drug|0|||
33690304|NCT02421510|63207035|FG000|Overall Study|Physician Decision|1|||
33690305|NCT02421510|63207036|FG001|Overall Study|Physician Decision|1|||
33690306|NCT02421510|63207037|FG002|Overall Study|Physician Decision|3|||
33690307|NCT02421510|63207035|FG000|Overall Study|Adverse Event|9|||
33690308|NCT02421510|63207036|FG001|Overall Study|Adverse Event|10|||
33690309|NCT02421510|63207037|FG002|Overall Study|Adverse Event|18|||
33690310|NCT02421510|63207035|FG000|Overall Study|Pregnancy|1|||
33690311|NCT02421510|63207036|FG001|Overall Study|Pregnancy|1|||
33690312|NCT02421510|63207037|FG002|Overall Study|Pregnancy|0|||
33690313|NCT02421510|63207035|FG000|Overall Study|Withdrawal by Subject|14|||
33690314|NCT02421510|63207036|FG001|Overall Study|Withdrawal by Subject|18|||
33690315|NCT02421510|63207037|FG002|Overall Study|Withdrawal by Subject|12|||
33690316|NCT02421510|63207035|FG000|Overall Study|Lost to Follow-up|1|||
33690317|NCT02421510|63207036|FG001|Overall Study|Lost to Follow-up|1|||
33690318|NCT02421510|63207037|FG002|Overall Study|Lost to Follow-up|0|||
33690319|NCT00552617|63207055|FG000|Overall Study|Not Treated|0|||
33690320|NCT00552617|63207056|FG001|Overall Study|Not Treated|0|||
33690321|NCT00552617|63207057|FG002|Overall Study|Not Treated|1|||
33690322|NCT00552617|63207058|FG003|Overall Study|Not Treated|0|||
33690323|NCT00552617|63207059|FG004|Overall Study|Not Treated|0|||
33690324|NCT00552617|63207060|FG005|Overall Study|Not Treated|0|||
33690325|NCT00552617|63207061|FG006|Overall Study|Not Treated|0|||
33690326|NCT00552617|63207062|FG007|Overall Study|Not Treated|0|||
33690327|NCT00552617|63207063|FG008|Overall Study|Not Treated|0|||
33596151|NCT02170779|62995100|FG000|Overall Study|Withdrawal by Subject|1|||
33596152|NCT02170779|62995101|FG001|Overall Study|Withdrawal by Subject|0|||
33596153|NCT02170779|62995100|FG000|Overall Study|Lost to Follow-up|0|||
33690328|NCT00552617|63207064|FG009|Overall Study|Not Treated|1|||
33690329|NCT00552617|63207055|FG000|Overall Study|Lost to Follow-up|0|||
33690330|NCT00552617|63207056|FG001|Overall Study|Lost to Follow-up|0|||
33690331|NCT00552617|63207057|FG002|Overall Study|Lost to Follow-up|0|||
33690332|NCT00552617|63207058|FG003|Overall Study|Lost to Follow-up|1|||
33690333|NCT00552617|63207059|FG004|Overall Study|Lost to Follow-up|0|||
33690334|NCT00552617|63207060|FG005|Overall Study|Lost to Follow-up|2|||
33690335|NCT00552617|63207061|FG006|Overall Study|Lost to Follow-up|0|||
33690336|NCT00552617|63207062|FG007|Overall Study|Lost to Follow-up|0|||
33690337|NCT00552617|63207063|FG008|Overall Study|Lost to Follow-up|2|||
33690338|NCT00552617|63207064|FG009|Overall Study|Lost to Follow-up|0|||
33690339|NCT02421120|63207086|FG000|Overall Study|Adverse Event|1|||
33690340|NCT02420262|63207092|FG000|Overall Study|Adverse Event|1|||
33690341|NCT02420262|63207093|FG001|Overall Study|Adverse Event|0|||
33690342|NCT02420262|63207092|FG000|Overall Study|Withdrawal by Subject|1|||
33690343|NCT02420262|63207093|FG001|Overall Study|Withdrawal by Subject|4|||
33690344|NCT02420262|63207092|FG000|Overall Study|Unclassified|0|||
33690345|NCT02420262|63207093|FG001|Overall Study|Unclassified|1|||
33690346|NCT00552305|63207099|FG000|Overall Study|Adverse Event|43|||
33690347|NCT00552305|63207099|FG000|Overall Study|Lack of Efficacy|120|||
33690348|NCT00552305|63207099|FG000|Overall Study|Lost to Follow-up|4|||
33690349|NCT00552305|63207099|FG000|Overall Study|Protocol Violation|3|||
33690350|NCT00552305|63207099|FG000|Overall Study|Withdrawal by Subject|44|||
33690351|NCT00552305|63207099|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
33690352|NCT00552305|63207099|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
33690353|NCT00552305|63207099|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
33690354|NCT00552305|63207099|FG000|Overall Study|Unsatisfactory compliance|11|||
33690355|NCT00552305|63207099|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
33690356|NCT00552305|63207099|FG000|Overall Study|AE/Other: prohibited drug required|1|||
33690357|NCT00552305|63207099|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
33690358|NCT00552305|63207099|FG000|Overall Study|Other: Site closed|4|||
33690359|NCT00552305|63207099|FG000|Overall Study|Other: Personal problems|1|||
33690360|NCT00552305|63207099|FG000|Overall Study|Other: Unable to attend visits|1|||
33690361|NCT00552305|63207099|FG000|Overall Study|Other: Subject underwent surgery|4|||
33690362|NCT00552305|63207099|FG000|Overall Study|Other: Subject became pregnant|1|||
33690363|NCT00552305|63207099|FG000|Overall Study|Other: Health problems, not drug related|1|||
33690364|NCT00552305|63207099|FG000|Overall Study|Other: Subject moved from area|2|||
33690365|NCT00552305|63207099|FG000|Overall Study|Other: Subject incarcerated|1|||
33690366|NCT00552305|63207099|FG000|Overall Study|Other: Subject went to rehab|1|||
33690367|NCT00552071|63207125|FG000|Overall Study|Adverse Event|1|||
33690368|NCT00552071|63207126|FG001|Overall Study|Adverse Event|0|||
33690369|NCT00552071|63207125|FG000|Overall Study|Lack of Efficacy|1|||
33690370|NCT00552071|63207126|FG001|Overall Study|Lack of Efficacy|0|||
33690371|NCT00552071|63207125|FG000|Overall Study|Physician Decision|1|||
33690372|NCT00552071|63207126|FG001|Overall Study|Physician Decision|0|||
33690373|NCT00552071|63207125|FG000|Overall Study|Pregnancy|1|||
33690374|NCT00552071|63207126|FG001|Overall Study|Pregnancy|0|||
33690375|NCT00552071|63207125|FG000|Overall Study|Death|0|||
33690376|NCT00552071|63207126|FG001|Overall Study|Death|1|||
33690377|NCT00552071|63207125|FG000|Overall Study|Withdrawal by Subject|0|||
33690378|NCT00552071|63207126|FG001|Overall Study|Withdrawal by Subject|1|||
33690379|NCT00551525|63207134|FG000|Overall Study|Protocol Violation|5|||
33690380|NCT02370498|63207161|FG000|Overall Study|Adverse Event|10|||
33690381|NCT02370498|63207162|FG001|Overall Study|Adverse Event|8|||
33690382|NCT02370498|63207161|FG000|Overall Study|Death|263|||
33690383|NCT02370498|63207162|FG001|Overall Study|Death|265|||
33690384|NCT02370498|63207161|FG000|Overall Study|Protocol Violation|1|||
33690385|NCT02370498|63207162|FG001|Overall Study|Protocol Violation|2|||
33690386|NCT02370498|63207161|FG000|Overall Study|Withdrawal by Subject|7|||
33690387|NCT02370498|63207162|FG001|Overall Study|Withdrawal by Subject|12|||
33690388|NCT02370498|63207161|FG000|Overall Study|Sponsor's decision|15|||
33690389|NCT02370498|63207162|FG001|Overall Study|Sponsor's decision|9|||
33690390|NCT02347332|63207187|FG000|Overall Study|Not treated|5|||
33690391|NCT02347332|63207188|FG001|Overall Study|Not treated|2|||
33690392|NCT02347332|63207187|FG000|Overall Study|Progressive disease|141|||
33690393|NCT02347332|63207188|FG001|Overall Study|Progressive disease|159|||
33690394|NCT02347332|63207187|FG000|Overall Study|Adverse Event|50|||
33690395|NCT02347332|63207188|FG001|Overall Study|Adverse Event|41|||
33690396|NCT02347332|63207187|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
33690397|NCT02347332|63207188|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
33690398|NCT02347332|63207187|FG000|Overall Study|Protocol Violation|1|||
33690399|NCT02347332|63207188|FG001|Overall Study|Protocol Violation|1|||
33493175|NCT00812006|62871289|FG001|Overall Study|Physician Decision|0|||
33690400|NCT02347332|63207187|FG000|Overall Study|Lost to Follow-up|2|||
33690401|NCT02347332|63207188|FG001|Overall Study|Lost to Follow-up|1|||
33690402|NCT02347332|63207187|FG000|Overall Study|Physician Decision|4|||
33690403|NCT02347332|63207188|FG001|Overall Study|Physician Decision|3|||
33690404|NCT02347332|63207187|FG000|Overall Study|Withdrawal by Subject|20|||
33690405|NCT02347332|63207188|FG001|Overall Study|Withdrawal by Subject|14|||
33690406|NCT02347332|63207187|FG000|Overall Study|Protocol requirement|1|||
33690407|NCT02347332|63207188|FG001|Overall Study|Protocol requirement|1|||
33690408|NCT02347332|63207187|FG000|Overall Study|Switch Post-Trial program|0|||
33690409|NCT02347332|63207188|FG001|Overall Study|Switch Post-Trial program|1|||
33690410|NCT02347176|63207211|FG000|Overall Study|Lost to Follow-up|2|||
33690411|NCT02347176|63207212|FG001|Overall Study|Lost to Follow-up|3|||
33690412|NCT02347176|63207213|FG002|Overall Study|Lost to Follow-up|1|||
33690413|NCT02347176|63207214|FG003|Overall Study|Lost to Follow-up|1|||
33690414|NCT02347176|63207211|FG000|Overall Study|Withdrawal by Subject|9|||
33690415|NCT02347176|63207212|FG001|Overall Study|Withdrawal by Subject|5|||
33690416|NCT02347176|63207213|FG002|Overall Study|Withdrawal by Subject|5|||
33690417|NCT02347176|63207214|FG003|Overall Study|Withdrawal by Subject|3|||
33690418|NCT02347176|63207211|FG000|Overall Study|Other|1|||
33690419|NCT02347176|63207212|FG001|Overall Study|Other|2|||
33690420|NCT02347176|63207213|FG002|Overall Study|Other|2|||
33690421|NCT02347176|63207214|FG003|Overall Study|Other|0|||
33690422|NCT02370420|63207226|FG000|Overall Study|Physician Decision|3|||
33690423|NCT02370420|63207227|FG001|Overall Study|Physician Decision|3|||
33690424|NCT02370420|63207226|FG000|Overall Study|Lost to Follow-up|11|||
33690425|NCT02370420|63207227|FG001|Overall Study|Lost to Follow-up|9|||
33690426|NCT02347098|63207249|FG000|Overall Study|Death|1|||
33690427|NCT02347098|63207250|FG001|Overall Study|Death|0|||
33690428|NCT02347098|63207249|FG000|Overall Study|Withdrawal by Subject|1|||
33690429|NCT02347098|63207250|FG001|Overall Study|Withdrawal by Subject|0|||
33690430|NCT02347098|63207249|FG000|Overall Study|Lost to Follow-up|2|||
33690431|NCT02347098|63207250|FG001|Overall Study|Lost to Follow-up|2|||
33690432|NCT02347098|63207249|FG000|Overall Study|Refuse Follow-up Visit|1|||
33690433|NCT02347098|63207250|FG001|Overall Study|Refuse Follow-up Visit|5|||
33690434|NCT02347098|63207249|FG000|Overall Study|no visit due to illness|2|||
33690435|NCT02347098|63207250|FG001|Overall Study|no visit due to illness|1|||
33690436|NCT02346708|63207267|FG000|Overall Study|Adverse Event|2|||
33690437|NCT02346708|63207268|FG001|Overall Study|Adverse Event|0|||
33690438|NCT02346708|63207267|FG000|Overall Study|Protocol Violation|0|||
33690439|NCT02346708|63207268|FG001|Overall Study|Protocol Violation|1|||
33690440|NCT02346240|63207758|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690441|NCT02346240|63207759|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
33690442|NCT02346240|63207760|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
33690443|NCT02346240|63207761|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
33690444|NCT02346240|63207762|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690445|NCT02346240|63207763|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690446|NCT02346240|63207764|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690447|NCT02346240|63207765|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690448|NCT02346240|63207766|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690449|NCT02346240|63207767|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690450|NCT02346240|63207768|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690451|NCT02346240|63207769|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690452|NCT02346240|63207770|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690453|NCT02346240|63207771|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690454|NCT02346240|63207772|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690455|NCT02346240|63207773|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690456|NCT02346240|63207774|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690457|NCT02346240|63207775|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690458|NCT02346240|63207776|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690459|NCT02346240|63207777|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690460|NCT02346240|63207778|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690461|NCT02346240|63207779|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690462|NCT02346240|63207780|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690463|NCT02346240|63207781|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33690464|NCT02346240|63207758|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690465|NCT02346240|63207759|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
33690466|NCT02346240|63207760|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690467|NCT02346240|63207761|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690468|NCT02346240|63207762|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690469|NCT02346240|63207763|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690470|NCT02346240|63207764|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690471|NCT02346240|63207765|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690472|NCT02346240|63207766|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690473|NCT02346240|63207767|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690474|NCT02346240|63207768|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690475|NCT02346240|63207769|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690476|NCT02346240|63207770|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690477|NCT02346240|63207771|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690478|NCT02346240|63207772|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690479|NCT02346240|63207773|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690480|NCT02346240|63207774|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690481|NCT02346240|63207775|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33596154|NCT02170779|62995101|FG001|Overall Study|Lost to Follow-up|1|||
33690482|NCT02346240|63207776|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690483|NCT02346240|63207777|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690484|NCT02346240|63207778|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690485|NCT02346240|63207779|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690486|NCT02346240|63207780|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690487|NCT02346240|63207781|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33690488|NCT02346240|63207758|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690489|NCT02346240|63207759|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
33690490|NCT02346240|63207760|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690491|NCT02346240|63207761|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690492|NCT02346240|63207762|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690493|NCT02346240|63207763|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690494|NCT02346240|63207764|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690495|NCT02346240|63207765|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690496|NCT02346240|63207766|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690497|NCT02346240|63207767|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690498|NCT02346240|63207768|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690499|NCT02346240|63207769|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690500|NCT02346240|63207770|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690501|NCT02346240|63207771|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690502|NCT02346240|63207772|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690503|NCT02346240|63207773|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690504|NCT02346240|63207774|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690505|NCT02346240|63207775|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690506|NCT02346240|63207776|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690507|NCT02346240|63207777|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690508|NCT02346240|63207778|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33596155|NCT02147067|62995109|FG000|Overall Study|Withdrawal by Subject|2|||
33596156|NCT02147067|62995110|FG001|Overall Study|Withdrawal by Subject|2|||
33596157|NCT02170389|62995116|FG000|Overall Study|Study terminated prior to start of treat|1|||
33596158|NCT02146599|62995120|FG000|Overall Study|Failed to meet inclusion criteria|5|||
33596159|NCT02146365|62995130|FG000|Overall Study|Lost to Follow-up|2|||
33596160|NCT02146365|62995131|FG001|Overall Study|Lost to Follow-up|1|||
33596161|NCT02146365|62995132|FG002|Overall Study|Lost to Follow-up|3|||
33596162|NCT02146365|62995133|FG003|Overall Study|Lost to Follow-up|3|||
33596163|NCT02146365|62995134|FG004|Overall Study|Lost to Follow-up|1|||
33596164|NCT02146365|62995135|FG005|Overall Study|Lost to Follow-up|1|||
33690509|NCT02346240|63207779|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690510|NCT02346240|63207780|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690511|NCT02346240|63207781|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33690512|NCT02346240|63207758|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
33690513|NCT02346240|63207759|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
33690514|NCT02346240|63207760|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
33690515|NCT02346240|63207761|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
33690516|NCT02346240|63207762|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690517|NCT02346240|63207763|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690518|NCT02346240|63207764|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690519|NCT02346240|63207765|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690520|NCT02346240|63207766|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690521|NCT02346240|63207767|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690522|NCT02346240|63207768|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690523|NCT02346240|63207769|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690524|NCT02346240|63207770|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690525|NCT02346240|63207771|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690526|NCT02346240|63207772|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690527|NCT02346240|63207773|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690528|NCT02346240|63207774|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690529|NCT02346240|63207775|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690530|NCT02346240|63207776|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690531|NCT02346240|63207777|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690532|NCT02346240|63207778|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690533|NCT02346240|63207779|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33596165|NCT02146365|62995136|FG006|Overall Study|Lost to Follow-up|0|||
33596166|NCT02146365|62995137|FG007|Overall Study|Lost to Follow-up|1|||
33596167|NCT02146365|62995130|FG000|Overall Study|Withdrawal by Subject|1|||
33596168|NCT02146365|62995131|FG001|Overall Study|Withdrawal by Subject|2|||
33596169|NCT02146365|62995132|FG002|Overall Study|Withdrawal by Subject|1|||
33690534|NCT02346240|63207780|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690535|NCT02346240|63207781|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33690536|NCT02346240|63207758|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
33690537|NCT02346240|63207759|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
33690538|NCT02346240|63207760|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
33690539|NCT02346240|63207761|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
33690540|NCT02346240|63207762|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690541|NCT02346240|63207763|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690542|NCT02346240|63207764|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690543|NCT02346240|63207765|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690544|NCT02346240|63207766|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690545|NCT02346240|63207767|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690546|NCT02346240|63207768|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690547|NCT02346240|63207769|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690548|NCT02346240|63207770|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690549|NCT02346240|63207771|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690550|NCT02346240|63207772|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690551|NCT02346240|63207773|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690552|NCT02346240|63207774|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690553|NCT02346240|63207775|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690554|NCT02346240|63207776|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690555|NCT02346240|63207777|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690556|NCT02346240|63207778|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690557|NCT02346240|63207779|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690558|NCT02346240|63207780|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690559|NCT02346240|63207781|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33690560|NCT02346240|63207758|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690561|NCT02346240|63207759|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
33690562|NCT02346240|63207760|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690563|NCT02346240|63207761|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
33690564|NCT02346240|63207762|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690565|NCT02346240|63207763|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690566|NCT02346240|63207764|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690567|NCT02346240|63207765|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690568|NCT02346240|63207766|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690569|NCT02346240|63207767|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690570|NCT02346240|63207768|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690571|NCT02346240|63207769|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690572|NCT02346240|63207770|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690573|NCT02346240|63207771|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690574|NCT02346240|63207772|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690575|NCT02346240|63207773|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690576|NCT02346240|63207774|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690577|NCT02346240|63207775|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690578|NCT02346240|63207776|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690579|NCT02346240|63207777|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690580|NCT02346240|63207778|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690581|NCT02346240|63207779|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690582|NCT02346240|63207780|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690583|NCT02346240|63207781|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33690584|NCT02346240|63207758|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690585|NCT02346240|63207759|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690586|NCT02346240|63207760|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
33690587|NCT02346240|63207761|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690588|NCT02346240|63207762|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690589|NCT02346240|63207763|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690590|NCT02346240|63207764|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690591|NCT02346240|63207765|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690592|NCT02346240|63207766|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690593|NCT02346240|63207767|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690594|NCT02346240|63207768|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690595|NCT02346240|63207769|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690596|NCT02346240|63207770|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690597|NCT02346240|63207771|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690598|NCT02346240|63207772|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690599|NCT02346240|63207773|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690600|NCT02346240|63207774|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690601|NCT02346240|63207775|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690602|NCT02346240|63207776|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690603|NCT02346240|63207777|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690604|NCT02346240|63207778|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690605|NCT02346240|63207779|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690606|NCT02346240|63207780|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690607|NCT02346240|63207781|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33690608|NCT02346240|63207758|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690609|NCT02346240|63207759|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690610|NCT02346240|63207760|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690611|NCT02346240|63207761|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690612|NCT02346240|63207762|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690613|NCT02346240|63207763|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690614|NCT02346240|63207764|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690615|NCT02346240|63207765|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
33690616|NCT02346240|63207766|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
33690617|NCT02346240|63207767|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690618|NCT02346240|63207768|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690619|NCT02346240|63207769|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690620|NCT02346240|63207770|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690621|NCT02346240|63207771|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
33690622|NCT02346240|63207772|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
33690623|NCT02346240|63207773|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
33690624|NCT02346240|63207774|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
33690625|NCT02346240|63207775|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690626|NCT02346240|63207776|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690627|NCT02346240|63207777|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690628|NCT02346240|63207778|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690629|NCT02346240|63207779|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690630|NCT02346240|63207780|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690631|NCT02346240|63207781|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33690632|NCT02346240|63207758|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690633|NCT02346240|63207759|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690634|NCT02346240|63207760|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690635|NCT02346240|63207761|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690636|NCT02346240|63207762|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690637|NCT02346240|63207763|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690638|NCT02346240|63207764|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690639|NCT02346240|63207765|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690640|NCT02346240|63207766|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690641|NCT02346240|63207767|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690642|NCT02346240|63207768|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690643|NCT02346240|63207769|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690644|NCT02346240|63207770|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690645|NCT02346240|63207771|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
33690646|NCT02346240|63207772|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690647|NCT02346240|63207773|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
33690648|NCT02346240|63207774|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690649|NCT02346240|63207775|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690650|NCT02346240|63207776|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690651|NCT02346240|63207777|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690652|NCT02346240|63207778|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690653|NCT02346240|63207779|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690654|NCT02346240|63207780|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690655|NCT02346240|63207781|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33690656|NCT02346240|63207758|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690657|NCT02346240|63207759|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690658|NCT02346240|63207760|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690659|NCT02346240|63207761|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690660|NCT02346240|63207762|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690661|NCT02346240|63207763|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690662|NCT02346240|63207764|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690663|NCT02346240|63207765|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690664|NCT02346240|63207766|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690665|NCT02346240|63207767|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690666|NCT02346240|63207768|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690667|NCT02346240|63207769|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690668|NCT02346240|63207770|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690669|NCT02346240|63207771|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690670|NCT02346240|63207772|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
33690671|NCT02346240|63207773|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690672|NCT02346240|63207774|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690673|NCT02346240|63207775|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690674|NCT02346240|63207776|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690675|NCT02346240|63207777|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690676|NCT02346240|63207778|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690677|NCT02346240|63207779|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690678|NCT02346240|63207780|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690679|NCT02346240|63207781|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33690680|NCT02346240|63207758|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33690681|NCT02346240|63207759|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33690682|NCT02346240|63207760|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33690683|NCT02346240|63207761|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33690684|NCT02346240|63207762|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33690685|NCT02346240|63207763|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33690686|NCT02346240|63207764|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33690687|NCT02346240|63207765|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33690688|NCT02346240|63207766|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33690689|NCT02346240|63207767|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33690690|NCT02346240|63207768|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33690691|NCT02346240|63207769|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
33690692|NCT02346240|63207770|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33690693|NCT02346240|63207771|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
33690694|NCT02346240|63207772|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
33690695|NCT02346240|63207773|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
33690696|NCT02346240|63207774|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33690697|NCT02346240|63207775|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33690698|NCT02346240|63207776|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33690699|NCT02346240|63207777|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33690700|NCT02346240|63207778|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33690701|NCT02346240|63207779|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33690702|NCT02346240|63207780|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33690703|NCT02346240|63207781|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33690704|NCT02346240|63207758|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690705|NCT02346240|63207759|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690706|NCT02346240|63207760|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690707|NCT02346240|63207761|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690708|NCT02346240|63207762|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690709|NCT02346240|63207763|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690710|NCT02346240|63207764|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690711|NCT02346240|63207765|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690712|NCT02346240|63207766|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690713|NCT02346240|63207767|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690714|NCT02346240|63207768|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690715|NCT02346240|63207769|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690716|NCT02346240|63207770|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690717|NCT02346240|63207771|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
33690718|NCT02346240|63207772|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
33690719|NCT02346240|63207773|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
33493176|NCT00812006|62871290|FG002|Overall Study|Physician Decision|1|||
33493177|NCT00812006|62871288|FG000|Overall Study|Withdrawal by Subject|2|||
33690720|NCT02346240|63207774|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
33690721|NCT02346240|63207775|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690722|NCT02346240|63207776|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690723|NCT02346240|63207777|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690724|NCT02346240|63207778|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690725|NCT02346240|63207779|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690726|NCT02346240|63207780|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690727|NCT02346240|63207781|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33690728|NCT02346240|63207758|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690729|NCT02346240|63207759|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690730|NCT02346240|63207760|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690731|NCT02346240|63207761|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690732|NCT02346240|63207762|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690733|NCT02346240|63207763|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690734|NCT02346240|63207764|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
33690735|NCT02346240|63207765|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690736|NCT02346240|63207766|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690737|NCT02346240|63207767|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690738|NCT02346240|63207768|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690739|NCT02346240|63207769|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690740|NCT02346240|63207770|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690741|NCT02346240|63207771|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690742|NCT02346240|63207772|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690743|NCT02346240|63207773|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690744|NCT02346240|63207774|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690745|NCT02346240|63207775|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690746|NCT02346240|63207776|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690747|NCT02346240|63207777|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690748|NCT02346240|63207778|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690749|NCT02346240|63207779|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690750|NCT02346240|63207780|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690751|NCT02346240|63207781|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33690752|NCT02346240|63207758|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690753|NCT02346240|63207759|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690754|NCT02346240|63207760|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690755|NCT02346240|63207761|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690756|NCT02346240|63207762|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690757|NCT02346240|63207763|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690758|NCT02346240|63207764|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690759|NCT02346240|63207765|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690760|NCT02346240|63207766|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
33690761|NCT02346240|63207767|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690762|NCT02346240|63207768|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690763|NCT02346240|63207769|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
33690764|NCT02346240|63207770|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690765|NCT02346240|63207771|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
33690766|NCT02346240|63207772|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
33690767|NCT02346240|63207773|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690768|NCT02346240|63207774|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690769|NCT02346240|63207775|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690770|NCT02346240|63207776|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690771|NCT02346240|63207777|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690772|NCT02346240|63207778|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690773|NCT02346240|63207779|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690774|NCT02346240|63207780|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690775|NCT02346240|63207781|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33690776|NCT02346240|63207758|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690777|NCT02346240|63207759|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690778|NCT02346240|63207760|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690779|NCT02346240|63207761|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690780|NCT02346240|63207762|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690781|NCT02346240|63207763|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690782|NCT02346240|63207764|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690783|NCT02346240|63207765|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690784|NCT02346240|63207766|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690785|NCT02346240|63207767|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
33690786|NCT02346240|63207768|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690787|NCT02346240|63207769|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690788|NCT02346240|63207770|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690789|NCT02346240|63207771|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690790|NCT02346240|63207772|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690791|NCT02346240|63207773|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690792|NCT02346240|63207774|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690793|NCT02346240|63207775|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690794|NCT02346240|63207776|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690795|NCT02346240|63207777|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690796|NCT02346240|63207778|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690797|NCT02346240|63207779|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690798|NCT02346240|63207780|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690799|NCT02346240|63207781|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33690800|NCT02346240|63207758|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690801|NCT02346240|63207759|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690802|NCT02346240|63207760|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690803|NCT02346240|63207761|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690804|NCT02346240|63207762|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690805|NCT02346240|63207763|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690806|NCT02346240|63207764|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690807|NCT02346240|63207765|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690808|NCT02346240|63207766|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690809|NCT02346240|63207767|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690810|NCT02346240|63207768|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
33690811|NCT02346240|63207769|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690812|NCT02346240|63207770|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690813|NCT02346240|63207771|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690814|NCT02346240|63207772|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690815|NCT02346240|63207773|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690816|NCT02346240|63207774|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690817|NCT02346240|63207775|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690818|NCT02346240|63207776|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690819|NCT02346240|63207777|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690820|NCT02346240|63207778|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690821|NCT02346240|63207779|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690822|NCT02346240|63207780|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690823|NCT02346240|63207781|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33690824|NCT02346240|63207758|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690825|NCT02346240|63207759|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690826|NCT02346240|63207760|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690827|NCT02346240|63207761|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690828|NCT02346240|63207762|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690829|NCT02346240|63207763|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690830|NCT02346240|63207764|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690831|NCT02346240|63207765|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690832|NCT02346240|63207766|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690833|NCT02346240|63207767|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690834|NCT02346240|63207768|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690835|NCT02346240|63207769|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690836|NCT02346240|63207770|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690837|NCT02346240|63207771|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690838|NCT02346240|63207772|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
33690839|NCT02346240|63207773|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690840|NCT02346240|63207774|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690841|NCT02346240|63207775|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690842|NCT02346240|63207776|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690843|NCT02346240|63207777|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690844|NCT02346240|63207778|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690845|NCT02346240|63207779|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690846|NCT02346240|63207780|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690847|NCT02346240|63207781|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33690848|NCT02346240|63207758|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690849|NCT02346240|63207759|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690850|NCT02346240|63207760|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690851|NCT02346240|63207761|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690852|NCT02346240|63207762|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690853|NCT02346240|63207763|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690854|NCT02346240|63207764|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690855|NCT02346240|63207765|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690856|NCT02346240|63207766|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690857|NCT02346240|63207767|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690858|NCT02346240|63207768|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690859|NCT02346240|63207769|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690860|NCT02346240|63207770|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690861|NCT02346240|63207771|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690862|NCT02346240|63207772|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
33690863|NCT02346240|63207773|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690864|NCT02346240|63207774|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690865|NCT02346240|63207775|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690866|NCT02346240|63207776|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690867|NCT02346240|63207777|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690868|NCT02346240|63207778|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690869|NCT02346240|63207779|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690870|NCT02346240|63207780|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690871|NCT02346240|63207781|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33690872|NCT02346240|63207758|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690873|NCT02346240|63207759|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690874|NCT02346240|63207760|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690875|NCT02346240|63207761|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690876|NCT02346240|63207762|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690877|NCT02346240|63207763|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690878|NCT02346240|63207764|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690879|NCT02346240|63207765|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690880|NCT02346240|63207766|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690881|NCT02346240|63207767|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690882|NCT02346240|63207768|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33596170|NCT02146365|62995133|FG003|Overall Study|Withdrawal by Subject|5|||
33596171|NCT02146365|62995134|FG004|Overall Study|Withdrawal by Subject|1|||
33596172|NCT02146365|62995135|FG005|Overall Study|Withdrawal by Subject|0|||
33690883|NCT02346240|63207769|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690884|NCT02346240|63207770|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690885|NCT02346240|63207771|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690886|NCT02346240|63207772|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
33690887|NCT02346240|63207773|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690888|NCT02346240|63207774|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690889|NCT02346240|63207775|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690890|NCT02346240|63207776|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690891|NCT02346240|63207777|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690892|NCT02346240|63207778|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690893|NCT02346240|63207779|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690894|NCT02346240|63207780|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690895|NCT02346240|63207781|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33690896|NCT02346240|63207758|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690897|NCT02346240|63207759|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690898|NCT02346240|63207760|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690899|NCT02346240|63207761|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690900|NCT02346240|63207762|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690901|NCT02346240|63207763|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690902|NCT02346240|63207764|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690903|NCT02346240|63207765|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690904|NCT02346240|63207766|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690905|NCT02346240|63207767|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690906|NCT02346240|63207768|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690907|NCT02346240|63207769|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690908|NCT02346240|63207770|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690909|NCT02346240|63207771|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690910|NCT02346240|63207772|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690911|NCT02346240|63207773|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690912|NCT02346240|63207774|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33690913|NCT02346240|63207775|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
33690914|NCT02346240|63207776|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
33690915|NCT02346240|63207777|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
33690916|NCT02346240|63207778|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
33690917|NCT02346240|63207779|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
33690918|NCT02346240|63207780|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
33690919|NCT02346240|63207781|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
33690920|NCT02346240|63207758|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690921|NCT02346240|63207759|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690922|NCT02346240|63207760|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690923|NCT02346240|63207761|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690924|NCT02346240|63207762|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690925|NCT02346240|63207763|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690926|NCT02346240|63207764|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690927|NCT02346240|63207765|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690928|NCT02346240|63207766|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690929|NCT02346240|63207767|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690930|NCT02346240|63207768|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690931|NCT02346240|63207769|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690932|NCT02346240|63207770|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690933|NCT02346240|63207771|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690934|NCT02346240|63207772|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690935|NCT02346240|63207773|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690936|NCT02346240|63207774|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690937|NCT02346240|63207775|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690938|NCT02346240|63207776|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
33690939|NCT02346240|63207777|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
33690940|NCT02346240|63207778|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690941|NCT02346240|63207779|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
33690942|NCT02346240|63207780|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
33596173|NCT02146365|62995136|FG006|Overall Study|Withdrawal by Subject|0|||
33596174|NCT02146365|62995137|FG007|Overall Study|Withdrawal by Subject|0|||
33690943|NCT02346240|63207781|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
33690944|NCT02346240|63207758|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690945|NCT02346240|63207759|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690946|NCT02346240|63207760|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690947|NCT02346240|63207761|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690948|NCT02346240|63207762|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690949|NCT02346240|63207763|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690950|NCT02346240|63207764|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690951|NCT02346240|63207765|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690952|NCT02346240|63207766|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690953|NCT02346240|63207767|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690954|NCT02346240|63207768|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690955|NCT02346240|63207769|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690956|NCT02346240|63207770|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690957|NCT02346240|63207771|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690958|NCT02346240|63207772|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690959|NCT02346240|63207773|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690960|NCT02346240|63207774|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690961|NCT02346240|63207775|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690962|NCT02346240|63207776|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
33690963|NCT02346240|63207777|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690964|NCT02346240|63207778|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690965|NCT02346240|63207779|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
33690966|NCT02346240|63207780|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690967|NCT02346240|63207781|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33690968|NCT02346240|63207758|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690969|NCT02346240|63207759|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690970|NCT02346240|63207760|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690971|NCT02346240|63207761|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690972|NCT02346240|63207762|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690973|NCT02346240|63207763|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690974|NCT02346240|63207764|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690975|NCT02346240|63207765|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690976|NCT02346240|63207766|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690977|NCT02346240|63207767|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690978|NCT02346240|63207768|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690979|NCT02346240|63207769|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690980|NCT02346240|63207770|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690981|NCT02346240|63207771|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690982|NCT02346240|63207772|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690983|NCT02346240|63207773|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690984|NCT02346240|63207774|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690985|NCT02346240|63207775|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690986|NCT02346240|63207776|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690987|NCT02346240|63207777|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690988|NCT02346240|63207778|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690989|NCT02346240|63207779|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
33690990|NCT02346240|63207780|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690991|NCT02346240|63207781|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33690992|NCT02346240|63207758|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33690993|NCT02346240|63207759|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33690994|NCT02346240|63207760|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33690995|NCT02346240|63207761|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33690996|NCT02346240|63207762|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33690997|NCT02346240|63207763|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33690998|NCT02346240|63207764|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33690999|NCT02346240|63207765|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33691000|NCT02346240|63207766|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33691001|NCT02346240|63207767|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33691002|NCT02346240|63207768|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33691003|NCT02346240|63207769|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33691004|NCT02346240|63207770|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33691005|NCT02346240|63207771|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33691006|NCT02346240|63207772|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33691007|NCT02346240|63207773|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33691008|NCT02346240|63207774|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33691009|NCT02346240|63207775|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
33691010|NCT02346240|63207776|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
33691011|NCT02346240|63207777|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
33691012|NCT02346240|63207778|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33691013|NCT02346240|63207779|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
33691014|NCT02346240|63207780|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
33691015|NCT02346240|63207781|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
33691016|NCT02346240|63207758|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691017|NCT02346240|63207759|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691018|NCT02346240|63207760|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691019|NCT02346240|63207761|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691020|NCT02346240|63207762|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691021|NCT02346240|63207763|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691022|NCT02346240|63207764|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691023|NCT02346240|63207765|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691024|NCT02346240|63207766|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691025|NCT02346240|63207767|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691026|NCT02346240|63207768|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691027|NCT02346240|63207769|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691028|NCT02346240|63207770|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691029|NCT02346240|63207771|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691030|NCT02346240|63207772|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691031|NCT02346240|63207773|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691032|NCT02346240|63207774|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691033|NCT02346240|63207775|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691034|NCT02346240|63207776|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
33691035|NCT02346240|63207777|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
33691036|NCT02346240|63207778|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33691037|NCT02346240|63207779|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
33691038|NCT02346240|63207780|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
33691039|NCT02346240|63207781|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
33691040|NCT02346240|63207758|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691041|NCT02346240|63207759|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691042|NCT02346240|63207760|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691043|NCT02346240|63207761|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691044|NCT02346240|63207762|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691045|NCT02346240|63207763|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691046|NCT02346240|63207764|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691047|NCT02346240|63207765|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691048|NCT02346240|63207766|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691049|NCT02346240|63207767|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691050|NCT02346240|63207768|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691051|NCT02346240|63207769|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691052|NCT02346240|63207770|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691053|NCT02346240|63207771|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691054|NCT02346240|63207772|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691055|NCT02346240|63207773|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691056|NCT02346240|63207774|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691057|NCT02346240|63207775|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691058|NCT02346240|63207776|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
33691059|NCT02346240|63207777|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691060|NCT02346240|63207778|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33691061|NCT02346240|63207779|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
33691062|NCT02346240|63207780|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
33691063|NCT02346240|63207781|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
33691064|NCT02346240|63207758|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691065|NCT02346240|63207759|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691066|NCT02346240|63207760|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691067|NCT02346240|63207761|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691068|NCT02346240|63207762|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691069|NCT02346240|63207763|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691070|NCT02346240|63207764|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691071|NCT02346240|63207765|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691072|NCT02346240|63207766|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691073|NCT02346240|63207767|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691074|NCT02346240|63207768|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691075|NCT02346240|63207769|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691076|NCT02346240|63207770|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691077|NCT02346240|63207771|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691078|NCT02346240|63207772|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691079|NCT02346240|63207773|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691080|NCT02346240|63207774|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691081|NCT02346240|63207775|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691082|NCT02346240|63207776|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
33691083|NCT02346240|63207777|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691084|NCT02346240|63207778|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691085|NCT02346240|63207779|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691086|NCT02346240|63207780|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691087|NCT02346240|63207781|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33691088|NCT02392104|63207832|FG000|Overall Study|discontinuation of warfarin|3|||
33691089|NCT02392104|63207832|FG000|Overall Study|bleeding event|1|||
33691090|NCT02392104|63207832|FG000|Overall Study|transferred care to another doctor|2|||
33691091|NCT02392104|63207832|FG000|Overall Study|INR goal range changed|1|||
33691092|NCT02392104|63207832|FG000|Overall Study|admitted to skilled nursing facility|3|||
33691093|NCT02392104|63207832|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
33691094|NCT02391948|63207850|FG000|6-month Assessment|Death|0|||
33691095|NCT02391948|63207851|FG001|6-month Assessment|Death|0|||
33691096|NCT02391948|63207852|FG002|6-month Assessment|Death|0|||
33691097|NCT02391948|63207853|FG003|6-month Assessment|Death|0|||
33691098|NCT02391948|63207854|FG004|6-month Assessment|Death|1|||
33691099|NCT02391948|63207850|FG000|6-month Assessment|Withdrawal by Subject|0|||
33691100|NCT02391948|63207851|FG001|6-month Assessment|Withdrawal by Subject|0|||
33691101|NCT02391948|63207852|FG002|6-month Assessment|Withdrawal by Subject|1|||
33691102|NCT02391948|63207853|FG003|6-month Assessment|Withdrawal by Subject|2|||
33691103|NCT02391948|63207854|FG004|6-month Assessment|Withdrawal by Subject|0|||
33691104|NCT02391948|63207850|FG000|6-month Assessment|Lost to Follow-up|4|||
33691105|NCT02391948|63207851|FG001|6-month Assessment|Lost to Follow-up|5|||
33691106|NCT02391948|63207852|FG002|6-month Assessment|Lost to Follow-up|2|||
33691107|NCT02391948|63207853|FG003|6-month Assessment|Lost to Follow-up|3|||
33691108|NCT02391948|63207854|FG004|6-month Assessment|Lost to Follow-up|1|||
33691109|NCT02391948|63207850|FG000|6-month Assessment|Medical issue/illness|1|||
33691110|NCT02391948|63207851|FG001|6-month Assessment|Medical issue/illness|1|||
33691111|NCT02391948|63207852|FG002|6-month Assessment|Medical issue/illness|0|||
33691112|NCT02391948|63207853|FG003|6-month Assessment|Medical issue/illness|0|||
33691113|NCT02391948|63207854|FG004|6-month Assessment|Medical issue/illness|0|||
33691114|NCT02391948|63207850|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
33691115|NCT02391948|63207851|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
33691116|NCT02391948|63207852|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
33691117|NCT02391948|63207853|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
33691118|NCT02391948|63207854|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
33596175|NCT02146365|62995130|FG000|Overall Study|Unable to Comply with Protocol|0|||
33596176|NCT02146365|62995131|FG001|Overall Study|Unable to Comply with Protocol|1|||
33596177|NCT02146365|62995132|FG002|Overall Study|Unable to Comply with Protocol|1|||
33493178|NCT00812006|62871289|FG001|Overall Study|Withdrawal by Subject|1|||
33596178|NCT02146365|62995133|FG003|Overall Study|Unable to Comply with Protocol|0|||
33691119|NCT02391948|63207850|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
33691120|NCT02391948|63207851|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
33691121|NCT02391948|63207852|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
33493179|NCT00812006|62871290|FG002|Overall Study|Withdrawal by Subject|1|||
33493180|NCT00812006|62871288|FG000|Overall Study|Lack of Qualifying Event|4|||
33401444|NCT00256867|62780475|FG001|Overall Study|Protocol Violation|0|||
33596179|NCT02146365|62995134|FG004|Overall Study|Unable to Comply with Protocol|0|||
33596180|NCT02146365|62995135|FG005|Overall Study|Unable to Comply with Protocol|0|||
33596181|NCT02146365|62995136|FG006|Overall Study|Unable to Comply with Protocol|0|||
33596182|NCT02146365|62995137|FG007|Overall Study|Unable to Comply with Protocol|0|||
33596183|NCT02146365|62995130|FG000|Overall Study|Other|1|||
33493181|NCT00812006|62871289|FG001|Overall Study|Lack of Qualifying Event|2|||
33493182|NCT00812006|62871290|FG002|Overall Study|Lack of Qualifying Event|2|||
33493183|NCT03772327|62871305|FG000|Overall Study|Lost to Follow-up|3|||
33493184|NCT03772327|62871306|FG001|Overall Study|Lost to Follow-up|4|||
33493185|NCT03772327|62871305|FG000|Overall Study|Withdrawal by Subject|2|||
33493186|NCT03772327|62871306|FG001|Overall Study|Withdrawal by Subject|3|||
33596184|NCT02146365|62995131|FG001|Overall Study|Other|0|||
33596185|NCT02146365|62995132|FG002|Overall Study|Other|2|||
33691122|NCT02391948|63207853|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
33691123|NCT02391948|63207854|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
33691124|NCT02391948|63207850|FG000|12-month Assessment|Death|0|||
33691125|NCT02391948|63207851|FG001|12-month Assessment|Death|0|||
33691126|NCT02391948|63207852|FG002|12-month Assessment|Death|0|||
33691127|NCT02391948|63207853|FG003|12-month Assessment|Death|1|||
33691128|NCT02391948|63207854|FG004|12-month Assessment|Death|0|||
33691129|NCT02391948|63207850|FG000|12-month Assessment|Withdrawal by Subject|1|||
33691130|NCT02391948|63207851|FG001|12-month Assessment|Withdrawal by Subject|0|||
33691131|NCT02391948|63207852|FG002|12-month Assessment|Withdrawal by Subject|0|||
33691132|NCT02391948|63207853|FG003|12-month Assessment|Withdrawal by Subject|1|||
33691133|NCT02391948|63207854|FG004|12-month Assessment|Withdrawal by Subject|0|||
33691134|NCT02391948|63207850|FG000|12-month Assessment|Lost to Follow-up|5|||
33691135|NCT02391948|63207851|FG001|12-month Assessment|Lost to Follow-up|4|||
33691136|NCT02391948|63207852|FG002|12-month Assessment|Lost to Follow-up|4|||
33691137|NCT02391948|63207853|FG003|12-month Assessment|Lost to Follow-up|4|||
33691138|NCT02391948|63207854|FG004|12-month Assessment|Lost to Follow-up|5|||
33691139|NCT02391948|63207850|FG000|12-month Assessment|Medical issue/illness|0|||
33691140|NCT02391948|63207851|FG001|12-month Assessment|Medical issue/illness|1|||
33691141|NCT02391948|63207852|FG002|12-month Assessment|Medical issue/illness|0|||
33691142|NCT02391948|63207853|FG003|12-month Assessment|Medical issue/illness|1|||
33691143|NCT02391948|63207854|FG004|12-month Assessment|Medical issue/illness|0|||
33691144|NCT02391948|63207850|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
33691145|NCT02391948|63207851|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
33691146|NCT02391948|63207852|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
33691147|NCT02391948|63207853|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
33691148|NCT02391948|63207854|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
33691149|NCT02391948|63207850|FG000|18-month Assessment|Death|0|||
33691150|NCT02391948|63207851|FG001|18-month Assessment|Death|0|||
33691151|NCT02391948|63207852|FG002|18-month Assessment|Death|0|||
33691152|NCT02391948|63207853|FG003|18-month Assessment|Death|1|||
33691153|NCT02391948|63207854|FG004|18-month Assessment|Death|1|||
33691154|NCT02391948|63207850|FG000|18-month Assessment|Withdrawal by Subject|1|||
33691155|NCT02391948|63207851|FG001|18-month Assessment|Withdrawal by Subject|0|||
33691156|NCT02391948|63207852|FG002|18-month Assessment|Withdrawal by Subject|0|||
33691157|NCT02391948|63207853|FG003|18-month Assessment|Withdrawal by Subject|1|||
33691158|NCT02391948|63207854|FG004|18-month Assessment|Withdrawal by Subject|0|||
33691159|NCT02391948|63207850|FG000|18-month Assessment|Lost to Follow-up|2|||
33691160|NCT02391948|63207851|FG001|18-month Assessment|Lost to Follow-up|6|||
33691161|NCT02391948|63207852|FG002|18-month Assessment|Lost to Follow-up|2|||
33691162|NCT02391948|63207853|FG003|18-month Assessment|Lost to Follow-up|2|||
33691163|NCT02391948|63207854|FG004|18-month Assessment|Lost to Follow-up|3|||
33691164|NCT02391948|63207850|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
33691165|NCT02391948|63207851|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
33691166|NCT02391948|63207852|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
33691167|NCT02391948|63207853|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
33691168|NCT02391948|63207854|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
33691169|NCT02391948|63207850|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
33691170|NCT02391948|63207851|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
33691171|NCT02391948|63207852|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
33691172|NCT02391948|63207853|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
33691173|NCT02391948|63207854|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
33691174|NCT02391948|63207850|FG000|24-month Assessment|Death|0|||
33691175|NCT02391948|63207851|FG001|24-month Assessment|Death|0|||
33691176|NCT02391948|63207852|FG002|24-month Assessment|Death|0|||
33691177|NCT02391948|63207853|FG003|24-month Assessment|Death|0|||
33691178|NCT02391948|63207854|FG004|24-month Assessment|Death|1|||
33691179|NCT02391948|63207850|FG000|24-month Assessment|Withdrawal by Subject|1|||
33691180|NCT02391948|63207851|FG001|24-month Assessment|Withdrawal by Subject|1|||
33691181|NCT02391948|63207852|FG002|24-month Assessment|Withdrawal by Subject|0|||
33691182|NCT02391948|63207853|FG003|24-month Assessment|Withdrawal by Subject|0|||
33691183|NCT02391948|63207854|FG004|24-month Assessment|Withdrawal by Subject|1|||
33691184|NCT02391948|63207850|FG000|24-month Assessment|Lost to Follow-up|5|||
33691185|NCT02391948|63207851|FG001|24-month Assessment|Lost to Follow-up|4|||
33691186|NCT02391948|63207852|FG002|24-month Assessment|Lost to Follow-up|0|||
33691187|NCT02391948|63207853|FG003|24-month Assessment|Lost to Follow-up|0|||
33691188|NCT02391948|63207854|FG004|24-month Assessment|Lost to Follow-up|0|||
33691189|NCT02391948|63207850|FG000|24-month Assessment|Medical issue/illness|0|||
33691190|NCT02391948|63207851|FG001|24-month Assessment|Medical issue/illness|0|||
33691191|NCT02391948|63207852|FG002|24-month Assessment|Medical issue/illness|1|||
33691192|NCT02391948|63207853|FG003|24-month Assessment|Medical issue/illness|0|||
33691193|NCT02391948|63207854|FG004|24-month Assessment|Medical issue/illness|0|||
33691194|NCT02391948|63207850|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
33691195|NCT02391948|63207851|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
33691196|NCT02391948|63207852|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
33691197|NCT02391948|63207853|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
33691198|NCT02391948|63207854|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
33691199|NCT02369874|63208097|FG000|Overall Study|Lost to Follow-up|2|||
33691200|NCT02369874|63208098|FG001|Overall Study|Lost to Follow-up|2|||
33691201|NCT02369874|63208099|FG002|Overall Study|Lost to Follow-up|2|||
33691202|NCT02369874|63208097|FG000|Overall Study|Withdrawal by Subject|7|||
33691203|NCT02369874|63208098|FG001|Overall Study|Withdrawal by Subject|9|||
33691204|NCT02369874|63208099|FG002|Overall Study|Withdrawal by Subject|27|||
33691205|NCT02369874|63208097|FG000|Overall Study|Miscellaneous|1|||
33691206|NCT02369874|63208098|FG001|Overall Study|Miscellaneous|1|||
33691207|NCT02369874|63208099|FG002|Overall Study|Miscellaneous|0|||
33691208|NCT02369874|63208097|FG000|Overall Study|On Treatment/Off Study|34|||
33691209|NCT02369874|63208098|FG001|Overall Study|On Treatment/Off Study|45|||
33691210|NCT02369874|63208099|FG002|Overall Study|On Treatment/Off Study|32|||
33691211|NCT02368314|63208242|FG000|Overall Study|Withdrawal by Subject|2|||
33691212|NCT02368314|63208243|FG001|Overall Study|Withdrawal by Subject|1|||
33691213|NCT02368314|63208242|FG000|Overall Study|Adverse Event|1|||
33691214|NCT02368314|63208243|FG001|Overall Study|Adverse Event|2|||
33691215|NCT02366910|63208253|FG000|Overall Study|Withdrawal by Subject|2|||
33691216|NCT02366910|63208253|FG000|Overall Study|Screen Failure|3|||
33691217|NCT02345226|63208557|FG000|Double-Blind Phase|Adverse Event|5|||
33691218|NCT02345226|63208558|FG001|Double-Blind Phase|Adverse Event|6|||
33691219|NCT02345226|63208557|FG000|Double-Blind Phase|Death|3|||
33691220|NCT02345226|63208558|FG001|Double-Blind Phase|Death|0|||
33691221|NCT02345226|63208557|FG000|Double-Blind Phase|Pregnancy|0|||
33691222|NCT02345226|63208558|FG001|Double-Blind Phase|Pregnancy|1|||
33691223|NCT02345226|63208557|FG000|Double-Blind Phase|Lack of Efficacy|1|||
33691224|NCT02345226|63208558|FG001|Double-Blind Phase|Lack of Efficacy|0|||
33691225|NCT02345226|63208557|FG000|Double-Blind Phase|Investigator's Discretion|4|||
33691226|NCT02345226|63208558|FG001|Double-Blind Phase|Investigator's Discretion|3|||
33691227|NCT02345226|63208557|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
33691228|NCT02345226|63208558|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
33691229|NCT02345226|63208557|FG000|Double-Blind Phase|Withdrew Consent|41|||
33691230|NCT02345226|63208558|FG001|Double-Blind Phase|Withdrew Consent|39|||
33691231|NCT02345226|63208557|FG000|Double-Blind Phase|Lost to Follow-up|12|||
33691232|NCT02345226|63208558|FG001|Double-Blind Phase|Lost to Follow-up|16|||
33691233|NCT02345226|63208557|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
33691234|NCT02345226|63208558|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
33691235|NCT02345226|63208557|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
33691236|NCT02345226|63208558|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
33691237|NCT00551369|63209129|FG000|Overall Study|Protocol Violation|5|||
33691238|NCT00551369|63209129|FG000|Overall Study|Withdrawal by Subject|1|||
33691239|NCT00551369|63209129|FG000|Overall Study|Not treated per protocol and re|1|||
33691240|NCT00551291|63209142|FG000|Overall Study|Physician Decision|1|||
33691241|NCT00551213|63209248|FG000|Overall Study|Adverse Event|6|||
33691242|NCT00551213|63209249|FG001|Overall Study|Adverse Event|3|||
33691243|NCT00551213|63209248|FG000|Overall Study|Progressive Disease|41|||
33691244|NCT00551213|63209249|FG001|Overall Study|Progressive Disease|12|||
33691245|NCT00551213|63209248|FG000|Overall Study|Withdrawal by Subject|2|||
33691246|NCT00551213|63209249|FG001|Overall Study|Withdrawal by Subject|0|||
33691247|NCT00551213|63209248|FG000|Overall Study|Not Treated|1|||
33691248|NCT00551213|63209249|FG001|Overall Study|Not Treated|2|||
33691249|NCT00550043|63209386|FG000|Overall Study|Adverse Event|0|||
33691250|NCT00550043|63209387|FG001|Overall Study|Adverse Event|0|||
33691251|NCT00550043|63209388|FG002|Overall Study|Adverse Event|0|||
33691252|NCT00550043|63209389|FG003|Overall Study|Adverse Event|1|||
33691253|NCT00550043|63209390|FG004|Overall Study|Adverse Event|1|||
33691254|NCT00550043|63209386|FG000|Overall Study|Subject Withdrew Consent|0|||
33691255|NCT00550043|63209387|FG001|Overall Study|Subject Withdrew Consent|2|||
33691256|NCT00550043|63209388|FG002|Overall Study|Subject Withdrew Consent|1|||
33691257|NCT00550043|63209389|FG003|Overall Study|Subject Withdrew Consent|0|||
33691258|NCT00550043|63209390|FG004|Overall Study|Subject Withdrew Consent|0|||
33691259|NCT00550043|63209386|FG000|Overall Study|Other Reasons- Unspecified|0|||
33691260|NCT00550043|63209387|FG001|Overall Study|Other Reasons- Unspecified|1|||
33691261|NCT00550043|63209388|FG002|Overall Study|Other Reasons- Unspecified|0|||
33691262|NCT00550043|63209389|FG003|Overall Study|Other Reasons- Unspecified|1|||
33691263|NCT00550043|63209390|FG004|Overall Study|Other Reasons- Unspecified|0|||
33691264|NCT03188822|63210118|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
33691265|NCT03188822|63210118|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
33691266|NCT04976777|63210261|FG000|Overall Study|COVID-19 Infection|1|||
33691267|NCT04976777|63210262|FG001|Overall Study|COVID-19 Infection|0|||
33691268|NCT00555971|63210436|FG000|Overall Study|Adverse Event|1|||
33691269|NCT00555971|63210437|FG001|Overall Study|Adverse Event|1|||
33691270|NCT02343120|63211313|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
33691271|NCT02343120|63211314|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
33691272|NCT02343120|63211315|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
33691273|NCT02343120|63211316|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
33691274|NCT02343120|63211317|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
33691275|NCT02343120|63211313|FG000|Part 1: Dose Escalation|Death|1|||
33691276|NCT02343120|63211314|FG001|Part 1: Dose Escalation|Death|2|||
33691277|NCT02343120|63211315|FG002|Part 1: Dose Escalation|Death|2|||
33691278|NCT02343120|63211316|FG003|Part 1: Dose Escalation|Death|2|||
33691279|NCT02343120|63211317|FG004|Part 1: Dose Escalation|Death|1|||
33691280|NCT02343120|63211313|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
33691281|NCT02343120|63211314|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
33691282|NCT02343120|63211315|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
33691283|NCT02343120|63211316|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
33691284|NCT02343120|63211317|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
33691285|NCT02343120|63211313|FG000|Part 2: Expansion|Sponsor decision|0|||
33691286|NCT02343120|63211314|FG001|Part 2: Expansion|Sponsor decision|0|||
33691287|NCT02343120|63211315|FG002|Part 2: Expansion|Sponsor decision|0|||
33691288|NCT02343120|63211316|FG003|Part 2: Expansion|Sponsor decision|165|||
33691289|NCT02343120|63211317|FG004|Part 2: Expansion|Sponsor decision|67|||
33691290|NCT02343120|63211313|FG000|Part 2: Expansion|Death|0|||
33691291|NCT02343120|63211314|FG001|Part 2: Expansion|Death|0|||
33691292|NCT02343120|63211315|FG002|Part 2: Expansion|Death|0|||
33691293|NCT02343120|63211316|FG003|Part 2: Expansion|Death|74|||
33691294|NCT02343120|63211317|FG004|Part 2: Expansion|Death|17|||
33691295|NCT02343120|63211313|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
33691296|NCT02343120|63211314|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
33691297|NCT02343120|63211315|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
33691298|NCT02343120|63211316|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
33691299|NCT02343120|63211317|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
33691300|NCT02343120|63211313|FG000|Part 2: Expansion|Lost to Follow-up|0|||
33691301|NCT02343120|63211314|FG001|Part 2: Expansion|Lost to Follow-up|0|||
33691302|NCT02343120|63211315|FG002|Part 2: Expansion|Lost to Follow-up|0|||
33691303|NCT02343120|63211316|FG003|Part 2: Expansion|Lost to Follow-up|5|||
33691304|NCT02343120|63211317|FG004|Part 2: Expansion|Lost to Follow-up|2|||
33691305|NCT02343120|63211313|FG000|Part 2: Expansion|Other|0|||
33691306|NCT02343120|63211314|FG001|Part 2: Expansion|Other|0|||
33691307|NCT02343120|63211315|FG002|Part 2: Expansion|Other|0|||
33691308|NCT02343120|63211316|FG003|Part 2: Expansion|Other|1|||
33691309|NCT02343120|63211317|FG004|Part 2: Expansion|Other|5|||
33691310|NCT02343120|63211313|FG000|Part 2: Expansion|Adverse Event|0|||
33691311|NCT02343120|63211314|FG001|Part 2: Expansion|Adverse Event|0|||
33691312|NCT02343120|63211315|FG002|Part 2: Expansion|Adverse Event|0|||
33691313|NCT02343120|63211316|FG003|Part 2: Expansion|Adverse Event|1|||
33691314|NCT02343120|63211317|FG004|Part 2: Expansion|Adverse Event|1|||
33691315|NCT02342886|63211574|FG000|Overall Study|Treatment non-compliance|1|||
33691316|NCT02342886|63211575|FG001|Overall Study|Treatment non-compliance|0|||
33691317|NCT02342886|63211576|FG002|Overall Study|Treatment non-compliance|0|||
33691318|NCT02342886|63211577|FG003|Overall Study|Treatment non-compliance|1|||
33691319|NCT02342886|63211578|FG004|Overall Study|Treatment non-compliance|0|||
33691320|NCT02342886|63211574|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
33691321|NCT02342886|63211575|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
33691322|NCT02342886|63211576|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
33691323|NCT02342886|63211577|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
33691324|NCT02342886|63211578|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
33691325|NCT02342886|63211574|FG000|Overall Study|Adverse event/specific toxicity|4|||
33401445|NCT00256867|62780476|FG002|Overall Study|Protocol Violation|0|||
33691326|NCT02342886|63211575|FG001|Overall Study|Adverse event/specific toxicity|3|||
33691327|NCT02342886|63211576|FG002|Overall Study|Adverse event/specific toxicity|11|||
33691328|NCT02342886|63211577|FG003|Overall Study|Adverse event/specific toxicity|2|||
33691329|NCT02342886|63211578|FG004|Overall Study|Adverse event/specific toxicity|1|||
33691330|NCT02342886|63211574|FG000|Overall Study|Lost to Follow-up|1|||
33691331|NCT02342886|63211575|FG001|Overall Study|Lost to Follow-up|0|||
33691332|NCT02342886|63211576|FG002|Overall Study|Lost to Follow-up|0|||
33691333|NCT02342886|63211577|FG003|Overall Study|Lost to Follow-up|0|||
33691334|NCT02342886|63211578|FG004|Overall Study|Lost to Follow-up|0|||
33691335|NCT02342886|63211574|FG000|Overall Study|Death|1|||
33691336|NCT02342886|63211575|FG001|Overall Study|Death|2|||
33691337|NCT02342886|63211576|FG002|Overall Study|Death|1|||
33691338|NCT02342886|63211577|FG003|Overall Study|Death|0|||
33691339|NCT02342886|63211578|FG004|Overall Study|Death|1|||
33691340|NCT02342886|63211574|FG000|Overall Study|Withdrawal by Subject|0|||
33691341|NCT02342886|63211575|FG001|Overall Study|Withdrawal by Subject|1|||
33691342|NCT02342886|63211576|FG002|Overall Study|Withdrawal by Subject|0|||
33691343|NCT02342886|63211577|FG003|Overall Study|Withdrawal by Subject|1|||
33691344|NCT02342886|63211578|FG004|Overall Study|Withdrawal by Subject|0|||
33691345|NCT02342886|63211574|FG000|Overall Study|Investigator/sponsor decision|0|||
33691346|NCT02342886|63211575|FG001|Overall Study|Investigator/sponsor decision|2|||
33691347|NCT02342886|63211576|FG002|Overall Study|Investigator/sponsor decision|0|||
33691348|NCT02342886|63211577|FG003|Overall Study|Investigator/sponsor decision|3|||
33691349|NCT02342886|63211578|FG004|Overall Study|Investigator/sponsor decision|1|||
33691350|NCT02342886|63211574|FG000|Overall Study|Pregnancy|0|||
33691351|NCT02342886|63211575|FG001|Overall Study|Pregnancy|0|||
33691352|NCT02342886|63211576|FG002|Overall Study|Pregnancy|2|||
33691353|NCT02342886|63211577|FG003|Overall Study|Pregnancy|0|||
33691354|NCT02342886|63211578|FG004|Overall Study|Pregnancy|0|||
33691355|NCT02342886|63211574|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
33691356|NCT02342886|63211575|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
33691357|NCT02342886|63211576|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
33691358|NCT02342886|63211577|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
33691359|NCT02342886|63211578|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
33691360|NCT02342886|63211574|FG000|Overall Study|Protocol Violation|0|||
33691361|NCT02342886|63211575|FG001|Overall Study|Protocol Violation|0|||
33691362|NCT02342886|63211576|FG002|Overall Study|Protocol Violation|0|||
33691363|NCT02342886|63211577|FG003|Overall Study|Protocol Violation|2|||
33691364|NCT02342886|63211578|FG004|Overall Study|Protocol Violation|0|||
33691365|NCT02390076|63211614|FG000|Overall Study|Lost to Follow-up|2|||
33691366|NCT02390076|63211615|FG001|Overall Study|Lost to Follow-up|1|||
33691367|NCT02390076|63211616|FG002|Overall Study|Lost to Follow-up|4|||
33691368|NCT02389998|63211635|FG000|Overall Study|car accident|1|||
33691369|NCT02389998|63211636|FG001|Overall Study|car accident|0|||
33691370|NCT02389764|63211662|FG000|Overall Study|Lack of Efficacy|9|||
33691371|NCT02366130|63211733|FG000|Overall Study|Withdrawal by Subject|3|||
33691372|NCT02366130|63211733|FG000|Overall Study|Ineligible|6|||
33691373|NCT02389452|63211795|FG000|Overall Study|Lost to Follow-up|13|||
33691374|NCT02389452|63211795|FG000|Overall Study|Adverse Event|1|||
33691375|NCT02389452|63211795|FG000|Overall Study|Withdrawal by Subject|5|||
33691376|NCT02389452|63211795|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
33691377|NCT02365584|63211833|FG000|Overall Study|Adverse Event|2|||
33691378|NCT02365584|63211834|FG001|Overall Study|Adverse Event|2|||
33691379|NCT02365584|63211833|FG000|Overall Study|Withdrawal by Subject|1|||
33691380|NCT02365584|63211834|FG001|Overall Study|Withdrawal by Subject|0|||
33691381|NCT02365584|63211833|FG000|Overall Study|Disease Progression|9|||
33691382|NCT02365584|63211834|FG001|Overall Study|Disease Progression|12|||
33691383|NCT02342418|63211846|FG000|Overall Study|Adverse Event|0|||
33691384|NCT02342418|63211847|FG001|Overall Study|Adverse Event|1|||
33691385|NCT02365506|63211888|FG000|Overall Study|Investigator's Discretion|0|||
33691386|NCT02365506|63211889|FG001|Overall Study|Investigator's Discretion|0|||
33691387|NCT02365506|63211890|FG002|Overall Study|Investigator's Discretion|1|||
33691388|NCT02312934|63211927|FG000|Overall Study|Lost to Follow-up|1|||
33691389|NCT02312934|63211928|FG001|Overall Study|Lost to Follow-up|0|||
33691390|NCT02312934|63211927|FG000|Overall Study|Physician Decision|1|||
33691391|NCT02312934|63211928|FG001|Overall Study|Physician Decision|0|||
33691392|NCT02341482|63211962|FG000|Overall Study|Adverse Event|1|||
33691393|NCT02312856|63212002|FG000|Overall Study|Death|1|||
33691394|NCT02312856|63212002|FG000|Overall Study|Lost to Follow-up|3|||
33691395|NCT01602120|63212467|FG000|Overall Study|Adverse Event|3|||
33691396|NCT01602120|63212468|FG001|Overall Study|Adverse Event|6|||
33691397|NCT01602120|63212469|FG002|Overall Study|Adverse Event|0|||
33691398|NCT01602120|63212470|FG003|Overall Study|Adverse Event|2|||
33691399|NCT01602120|63212467|FG000|Overall Study|Death|0|||
33691400|NCT01602120|63212468|FG001|Overall Study|Death|4|||
33691401|NCT01602120|63212469|FG002|Overall Study|Death|0|||
33691402|NCT01602120|63212470|FG003|Overall Study|Death|0|||
33691403|NCT01602120|63212467|FG000|Overall Study|Lost to Follow-up|0|||
33691404|NCT01602120|63212468|FG001|Overall Study|Lost to Follow-up|1|||
33691405|NCT01602120|63212469|FG002|Overall Study|Lost to Follow-up|0|||
33691406|NCT01602120|63212470|FG003|Overall Study|Lost to Follow-up|1|||
33691407|NCT01602120|63212467|FG000|Overall Study|Protocol Violation|1|||
33691408|NCT01602120|63212468|FG001|Overall Study|Protocol Violation|1|||
33691409|NCT01602120|63212469|FG002|Overall Study|Protocol Violation|0|||
33691410|NCT01602120|63212470|FG003|Overall Study|Protocol Violation|0|||
33691411|NCT01602120|63212467|FG000|Overall Study|Non-compliance|0|||
33691412|NCT01602120|63212468|FG001|Overall Study|Non-compliance|3|||
33691413|NCT01602120|63212469|FG002|Overall Study|Non-compliance|0|||
33691414|NCT01602120|63212470|FG003|Overall Study|Non-compliance|1|||
33691415|NCT01602120|63212467|FG000|Overall Study|Withdrawal by Subject|8|||
33691416|NCT01602120|63212468|FG001|Overall Study|Withdrawal by Subject|17|||
33691417|NCT01602120|63212469|FG002|Overall Study|Withdrawal by Subject|0|||
33691418|NCT01602120|63212470|FG003|Overall Study|Withdrawal by Subject|3|||
33691419|NCT01602120|63212467|FG000|Overall Study|Study Terminated by Sponsor|12|||
33691420|NCT01602120|63212468|FG001|Overall Study|Study Terminated by Sponsor|24|||
33691421|NCT01602120|63212469|FG002|Overall Study|Study Terminated by Sponsor|17|||
33691422|NCT01602120|63212470|FG003|Overall Study|Study Terminated by Sponsor|44|||
33691423|NCT01602120|63212467|FG000|Overall Study|Physician Decision|2|||
33691424|NCT01602120|63212468|FG001|Overall Study|Physician Decision|3|||
33691425|NCT01602120|63212469|FG002|Overall Study|Physician Decision|0|||
33691426|NCT01602120|63212470|FG003|Overall Study|Physician Decision|0|||
33691427|NCT01602120|63212467|FG000|Overall Study|Unspecified Reason|3|||
33691428|NCT01602120|63212468|FG001|Overall Study|Unspecified Reason|1|||
33691429|NCT01602120|63212469|FG002|Overall Study|Unspecified Reason|0|||
33691430|NCT01602120|63212470|FG003|Overall Study|Unspecified Reason|2|||
33691431|NCT04543955|63213277|FG000|Overall Study|Company cancelled study|1|||
33691432|NCT04543955|63213278|FG001|Overall Study|Company cancelled study|0|||
33691433|NCT04436744|63213828|FG000|Overall Study|Adverse Event|1|||
33691434|NCT04436744|63213829|FG001|Overall Study|Adverse Event|1|||
33691435|NCT04436744|63213828|FG000|Overall Study|Death|1|||
33691436|NCT04436744|63213829|FG001|Overall Study|Death|0|||
33691437|NCT04436744|63213828|FG000|Overall Study|Lost to Follow-up|0|||
33691438|NCT04436744|63213829|FG001|Overall Study|Lost to Follow-up|2|||
33691439|NCT04436744|63213828|FG000|Overall Study|Physician Decision|0|||
33691440|NCT04436744|63213829|FG001|Overall Study|Physician Decision|1|||
33691441|NCT04436744|63213828|FG000|Overall Study|Progressive Disease|0|||
33691442|NCT04436744|63213829|FG001|Overall Study|Progressive Disease|4|||
33691443|NCT04436744|63213828|FG000|Overall Study|Protocol Deviation|1|||
33691444|NCT04436744|63213829|FG001|Overall Study|Protocol Deviation|1|||
33691445|NCT04436744|63213828|FG000|Overall Study|Withdrawal by Subject|1|||
33691446|NCT04436744|63213829|FG001|Overall Study|Withdrawal by Subject|2|||
33691447|NCT02243306|63213976|FG000|Overall Study|Adverse Event|0|||
33691448|NCT02243306|63213977|FG001|Overall Study|Adverse Event|1|||
33691449|NCT02243306|63213976|FG000|Overall Study|Other: Reached stopping criteria|0|||
33691450|NCT02243306|63213977|FG001|Overall Study|Other: Reached stopping criteria|1|||
33691451|NCT02243306|63213976|FG000|Overall Study|Physician Decision|0|||
33691452|NCT02243306|63213977|FG001|Overall Study|Physician Decision|1|||
33691453|NCT03214679|63214133|FG000|Overall Study|Lost to Follow-up|12|||
33691454|NCT03214679|63214134|FG001|Overall Study|Lost to Follow-up|14|||
33691455|NCT03214679|63214133|FG000|Overall Study|not eligible|2|||
33691456|NCT03214679|63214134|FG001|Overall Study|not eligible|0|||
33691457|NCT01602380|63214481|FG000|Overall Study|Death|63|||
33691458|NCT01602380|63214482|FG001|Overall Study|Death|68|||
33691459|NCT01602380|63214481|FG000|Overall Study|Withdrawal by Subject|22|||
33691460|NCT01602380|63214482|FG001|Overall Study|Withdrawal by Subject|29|||
33691461|NCT01602380|63214481|FG000|Overall Study|Lost to Follow-up|6|||
33691462|NCT01602380|63214482|FG001|Overall Study|Lost to Follow-up|1|||
33691463|NCT01602380|63214481|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33691464|NCT01602380|63214482|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
33691465|NCT01349465|63215425|FG000|Overall Study|Adverse Event|1|||
33691466|NCT01349465|63215426|FG001|Overall Study|Adverse Event|0|||
33691467|NCT01349465|63215425|FG000|Overall Study|Death|3|||
33691468|NCT01349465|63215426|FG001|Overall Study|Death|0|||
33691469|NCT01349465|63215425|FG000|Overall Study|Lost to Follow-up|10|||
33691470|NCT01349465|63215426|FG001|Overall Study|Lost to Follow-up|1|||
33691471|NCT01349465|63215425|FG000|Overall Study|Withdrawal by Subject|4|||
33691472|NCT01349465|63215426|FG001|Overall Study|Withdrawal by Subject|2|||
33691473|NCT01349465|63215425|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
33691474|NCT01349465|63215426|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
33691475|NCT01648764|63216545|FG000|Overall Study|Progressive Disease|0|||
33691476|NCT01648764|63216546|FG001|Overall Study|Progressive Disease|1|||
33691477|NCT01648764|63216547|FG002|Overall Study|Progressive Disease|0|||
33691478|NCT01648764|63216548|FG003|Overall Study|Progressive Disease|0|||
33691479|NCT01648764|63216549|FG004|Overall Study|Progressive Disease|0|||
33691480|NCT01648764|63216550|FG005|Overall Study|Progressive Disease|1|||
33691481|NCT01648764|63216551|FG006|Overall Study|Progressive Disease|1|||
33691482|NCT01648764|63216552|FG007|Overall Study|Progressive Disease|0|||
33596186|NCT02146365|62995133|FG003|Overall Study|Other|1|||
33596187|NCT02146365|62995134|FG004|Overall Study|Other|0|||
33596188|NCT02146365|62995135|FG005|Overall Study|Other|0|||
33596189|NCT02146365|62995136|FG006|Overall Study|Other|0|||
33596190|NCT02146365|62995137|FG007|Overall Study|Other|0|||
33596191|NCT02146131|62995157|FG000|Overall Study|Physician Decision|61|||
33596192|NCT02146131|62995158|FG001|Overall Study|Physician Decision|56|||
33691483|NCT01648764|63216553|FG008|Overall Study|Progressive Disease|0|||
33691484|NCT01648764|63216554|FG009|Overall Study|Progressive Disease|2|||
33691485|NCT01648764|63216555|FG010|Overall Study|Progressive Disease|0|||
33691486|NCT01648764|63216556|FG011|Overall Study|Progressive Disease|1|||
33691487|NCT01648764|63216557|FG012|Overall Study|Progressive Disease|2|||
33691488|NCT01648764|63216558|FG013|Overall Study|Progressive Disease|1|||
33691489|NCT01648764|63216545|FG000|Overall Study|Adverse Event|0|||
33691490|NCT01648764|63216546|FG001|Overall Study|Adverse Event|0|||
33691491|NCT01648764|63216547|FG002|Overall Study|Adverse Event|0|||
33691492|NCT01648764|63216548|FG003|Overall Study|Adverse Event|0|||
33691493|NCT01648764|63216549|FG004|Overall Study|Adverse Event|0|||
33691494|NCT01648764|63216550|FG005|Overall Study|Adverse Event|1|||
33691495|NCT01648764|63216551|FG006|Overall Study|Adverse Event|0|||
33691496|NCT01648764|63216552|FG007|Overall Study|Adverse Event|0|||
33691497|NCT01648764|63216553|FG008|Overall Study|Adverse Event|0|||
33691498|NCT01648764|63216554|FG009|Overall Study|Adverse Event|1|||
33691499|NCT01648764|63216555|FG010|Overall Study|Adverse Event|0|||
33691500|NCT01648764|63216556|FG011|Overall Study|Adverse Event|3|||
33691501|NCT01648764|63216557|FG012|Overall Study|Adverse Event|1|||
33691502|NCT01648764|63216558|FG013|Overall Study|Adverse Event|1|||
33691503|NCT01648764|63216545|FG000|Overall Study|Death|0|||
33691504|NCT01648764|63216546|FG001|Overall Study|Death|0|||
33691505|NCT01648764|63216547|FG002|Overall Study|Death|0|||
33691506|NCT01648764|63216548|FG003|Overall Study|Death|0|||
33691507|NCT01648764|63216549|FG004|Overall Study|Death|0|||
33691508|NCT01648764|63216550|FG005|Overall Study|Death|0|||
33691509|NCT01648764|63216551|FG006|Overall Study|Death|1|||
33691510|NCT01648764|63216552|FG007|Overall Study|Death|0|||
33691511|NCT01648764|63216553|FG008|Overall Study|Death|0|||
33691512|NCT01648764|63216554|FG009|Overall Study|Death|0|||
33691513|NCT01648764|63216555|FG010|Overall Study|Death|0|||
33691514|NCT01648764|63216556|FG011|Overall Study|Death|0|||
33691515|NCT01648764|63216557|FG012|Overall Study|Death|0|||
33691516|NCT01648764|63216558|FG013|Overall Study|Death|1|||
33691517|NCT01648764|63216545|FG000|Overall Study|Withdrawal by Subject|0|||
33691518|NCT01648764|63216546|FG001|Overall Study|Withdrawal by Subject|0|||
33691519|NCT01648764|63216547|FG002|Overall Study|Withdrawal by Subject|0|||
33691520|NCT01648764|63216548|FG003|Overall Study|Withdrawal by Subject|0|||
33691521|NCT01648764|63216549|FG004|Overall Study|Withdrawal by Subject|0|||
33691522|NCT01648764|63216550|FG005|Overall Study|Withdrawal by Subject|0|||
33691523|NCT01648764|63216551|FG006|Overall Study|Withdrawal by Subject|2|||
33691524|NCT01648764|63216552|FG007|Overall Study|Withdrawal by Subject|0|||
33691525|NCT01648764|63216553|FG008|Overall Study|Withdrawal by Subject|0|||
33691526|NCT01648764|63216554|FG009|Overall Study|Withdrawal by Subject|0|||
33691527|NCT01648764|63216555|FG010|Overall Study|Withdrawal by Subject|0|||
33691528|NCT01648764|63216556|FG011|Overall Study|Withdrawal by Subject|0|||
33691529|NCT01648764|63216557|FG012|Overall Study|Withdrawal by Subject|1|||
33691530|NCT01648764|63216558|FG013|Overall Study|Withdrawal by Subject|0|||
33691531|NCT01648764|63216545|FG000|Overall Study|Investigator Decision|0|||
33691532|NCT01648764|63216546|FG001|Overall Study|Investigator Decision|0|||
33691533|NCT01648764|63216547|FG002|Overall Study|Investigator Decision|0|||
33691534|NCT01648764|63216548|FG003|Overall Study|Investigator Decision|0|||
33691535|NCT01648764|63216549|FG004|Overall Study|Investigator Decision|0|||
33691536|NCT01648764|63216550|FG005|Overall Study|Investigator Decision|0|||
33691537|NCT01648764|63216551|FG006|Overall Study|Investigator Decision|1|||
33691538|NCT01648764|63216552|FG007|Overall Study|Investigator Decision|0|||
33691539|NCT01648764|63216553|FG008|Overall Study|Investigator Decision|0|||
33691540|NCT01648764|63216554|FG009|Overall Study|Investigator Decision|0|||
33691541|NCT01648764|63216555|FG010|Overall Study|Investigator Decision|0|||
33691542|NCT01648764|63216556|FG011|Overall Study|Investigator Decision|1|||
33691543|NCT01648764|63216557|FG012|Overall Study|Investigator Decision|0|||
33691544|NCT01648764|63216558|FG013|Overall Study|Investigator Decision|0|||
33691545|NCT02364336|63216594|FG000|Overall Study|Adverse Event|0|||
33691546|NCT02364336|63216595|FG001|Overall Study|Adverse Event|1|||
33691547|NCT02810951|63216826|FG000|Overall Study|Adverse Event|1|||
33691548|NCT02310906|63216922|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
33691549|NCT02310906|63216923|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
33691550|NCT02310906|63216924|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
33691551|NCT02310906|63216925|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
33691552|NCT02310906|63216922|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
33691553|NCT02310906|63216923|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
33691554|NCT02310906|63216924|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
33691555|NCT02310906|63216925|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
33691556|NCT02310906|63216922|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
33691557|NCT02310906|63216923|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
33691558|NCT02310906|63216924|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
33691559|NCT02310906|63216925|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
33691560|NCT02310906|63216922|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
33691561|NCT02310906|63216923|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
33691562|NCT02310906|63216924|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
33691563|NCT02310906|63216925|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
33691564|NCT02340078|63216975|FG000|Overall Study|Protocol Violation|1|||
33691565|NCT02340000|63216991|FG000|Time Period 1|Withdrawal by Subject|6|||
33691566|NCT02340000|63216992|FG001|Time Period 1|Withdrawal by Subject|8|||
33691567|NCT02340000|63216991|FG000|Time Period 1|Lost to Follow-up|6|||
33691568|NCT02340000|63216992|FG001|Time Period 1|Lost to Follow-up|7|||
33691569|NCT02340000|63216991|FG000|Time Period 2|Withdrawal by Subject|9|||
33691570|NCT02340000|63216992|FG001|Time Period 2|Withdrawal by Subject|7|||
33691571|NCT02340000|63216991|FG000|Time Period 2|Lost to Follow-up|10|||
33691572|NCT02340000|63216992|FG001|Time Period 2|Lost to Follow-up|8|||
33691573|NCT02364180|63217023|FG000|Overall Study|Screen Fail|1|||
33691574|NCT02310750|63217661|FG000|HP Period 1|Lost to Follow-up|0|||
33691575|NCT02310750|63217662|FG001|HP Period 1|Lost to Follow-up|0|||
33691576|NCT02310750|63217663|FG002|HP Period 1|Lost to Follow-up|0|||
33691577|NCT02310750|63217664|FG003|HP Period 1|Lost to Follow-up|0|||
33691578|NCT02310750|63217665|FG004|HP Period 1|Lost to Follow-up|0|||
33691579|NCT02310750|63217666|FG005|HP Period 1|Lost to Follow-up|0|||
33691580|NCT02310750|63217667|FG006|HP Period 1|Lost to Follow-up|1|||
33691581|NCT02310750|63217668|FG007|HP Period 1|Lost to Follow-up|0|||
33691582|NCT02310750|63217669|FG008|HP Period 1|Lost to Follow-up|0|||
33691583|NCT02310750|63217670|FG009|HP Period 1|Lost to Follow-up|0|||
33691584|NCT02310750|63217671|FG010|HP Period 1|Lost to Follow-up|0|||
33691585|NCT02310750|63217672|FG011|HP Period 1|Lost to Follow-up|0|||
33691586|NCT02310750|63217673|FG012|HP Period 1|Lost to Follow-up|0|||
33691587|NCT02310750|63217674|FG013|HP Period 1|Lost to Follow-up|0|||
33691588|NCT02310750|63217675|FG014|HP Period 1|Lost to Follow-up|0|||
33691589|NCT02310750|63217676|FG015|HP Period 1|Lost to Follow-up|0|||
33691590|NCT02310750|63217661|FG000|HP Period 1|Withdrawal by Subject|1|||
33691591|NCT02310750|63217662|FG001|HP Period 1|Withdrawal by Subject|0|||
33691592|NCT02310750|63217663|FG002|HP Period 1|Withdrawal by Subject|0|||
33691593|NCT02310750|63217664|FG003|HP Period 1|Withdrawal by Subject|1|||
33691594|NCT02310750|63217665|FG004|HP Period 1|Withdrawal by Subject|0|||
33691595|NCT02310750|63217666|FG005|HP Period 1|Withdrawal by Subject|0|||
33691596|NCT02310750|63217667|FG006|HP Period 1|Withdrawal by Subject|0|||
33691597|NCT02310750|63217668|FG007|HP Period 1|Withdrawal by Subject|0|||
33691598|NCT02310750|63217669|FG008|HP Period 1|Withdrawal by Subject|0|||
33691599|NCT02310750|63217670|FG009|HP Period 1|Withdrawal by Subject|0|||
33691600|NCT02310750|63217671|FG010|HP Period 1|Withdrawal by Subject|0|||
33691601|NCT02310750|63217672|FG011|HP Period 1|Withdrawal by Subject|0|||
33691602|NCT02310750|63217673|FG012|HP Period 1|Withdrawal by Subject|0|||
33691603|NCT02310750|63217674|FG013|HP Period 1|Withdrawal by Subject|0|||
33691604|NCT02310750|63217675|FG014|HP Period 1|Withdrawal by Subject|0|||
33691605|NCT02310750|63217676|FG015|HP Period 1|Withdrawal by Subject|0|||
33691606|NCT02310750|63217661|FG000|HP Washout 1|Lost to Follow-up|0|||
33691607|NCT02310750|63217662|FG001|HP Washout 1|Lost to Follow-up|0|||
33691608|NCT02310750|63217663|FG002|HP Washout 1|Lost to Follow-up|1|||
33691609|NCT02310750|63217664|FG003|HP Washout 1|Lost to Follow-up|1|||
33691610|NCT02310750|63217665|FG004|HP Washout 1|Lost to Follow-up|2|||
33691611|NCT02310750|63217666|FG005|HP Washout 1|Lost to Follow-up|2|||
33691612|NCT02310750|63217667|FG006|HP Washout 1|Lost to Follow-up|3|||
33691613|NCT02310750|63217668|FG007|HP Washout 1|Lost to Follow-up|0|||
33691614|NCT02310750|63217669|FG008|HP Washout 1|Lost to Follow-up|0|||
33691615|NCT02310750|63217670|FG009|HP Washout 1|Lost to Follow-up|0|||
33691616|NCT02310750|63217671|FG010|HP Washout 1|Lost to Follow-up|0|||
33691617|NCT02310750|63217672|FG011|HP Washout 1|Lost to Follow-up|0|||
33691618|NCT02310750|63217673|FG012|HP Washout 1|Lost to Follow-up|0|||
33691619|NCT02310750|63217674|FG013|HP Washout 1|Lost to Follow-up|0|||
33691620|NCT02310750|63217675|FG014|HP Washout 1|Lost to Follow-up|0|||
33691621|NCT02310750|63217676|FG015|HP Washout 1|Lost to Follow-up|0|||
33691622|NCT02310750|63217661|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33691623|NCT02310750|63217662|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33691624|NCT02310750|63217663|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33691625|NCT02310750|63217664|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
33691626|NCT02310750|63217665|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33691627|NCT02310750|63217666|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
33691628|NCT02310750|63217667|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33691629|NCT02310750|63217668|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33691630|NCT02310750|63217669|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
33691631|NCT02310750|63217670|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
33691632|NCT02310750|63217671|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33691633|NCT02310750|63217672|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33691634|NCT02310750|63217673|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33691635|NCT02310750|63217674|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33691636|NCT02310750|63217675|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33691637|NCT02310750|63217676|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33691638|NCT02310750|63217661|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33691639|NCT02310750|63217662|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33691640|NCT02310750|63217663|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33691641|NCT02310750|63217664|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33691642|NCT02310750|63217665|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33691643|NCT02310750|63217666|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33691644|NCT02310750|63217667|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33691645|NCT02310750|63217668|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33691646|NCT02310750|63217669|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33691647|NCT02310750|63217670|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
33691648|NCT02310750|63217671|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33691649|NCT02310750|63217672|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33691650|NCT02310750|63217673|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33691651|NCT02310750|63217674|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33691652|NCT02310750|63217675|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33691653|NCT02310750|63217676|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33691654|NCT02310750|63217661|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33691655|NCT02310750|63217662|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33691656|NCT02310750|63217663|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33691657|NCT02310750|63217664|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33691658|NCT02310750|63217665|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33691659|NCT02310750|63217666|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33691660|NCT02310750|63217667|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33691661|NCT02310750|63217668|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
33691662|NCT02310750|63217669|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
33691663|NCT02310750|63217670|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
33691664|NCT02310750|63217671|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33691665|NCT02310750|63217672|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33691666|NCT02310750|63217673|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33691667|NCT02310750|63217674|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33691668|NCT02310750|63217675|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33691669|NCT02310750|63217676|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33691670|NCT02310750|63217661|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33691671|NCT02310750|63217662|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33691672|NCT02310750|63217663|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33691673|NCT02310750|63217664|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33691674|NCT02310750|63217665|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33691675|NCT02310750|63217666|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33691676|NCT02310750|63217667|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33691677|NCT02310750|63217668|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
33691678|NCT02310750|63217669|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
33691679|NCT02310750|63217670|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33691680|NCT02310750|63217671|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33691681|NCT02310750|63217672|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33691682|NCT02310750|63217673|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33691683|NCT02310750|63217674|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33691684|NCT02310750|63217675|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33691685|NCT02310750|63217676|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33691686|NCT02310750|63217661|FG000|HP Washout 2|Lost to Follow-up|0|||
33691687|NCT02310750|63217662|FG001|HP Washout 2|Lost to Follow-up|0|||
33691688|NCT02310750|63217663|FG002|HP Washout 2|Lost to Follow-up|0|||
33691689|NCT02310750|63217664|FG003|HP Washout 2|Lost to Follow-up|0|||
33691690|NCT02310750|63217665|FG004|HP Washout 2|Lost to Follow-up|1|||
33691691|NCT02310750|63217666|FG005|HP Washout 2|Lost to Follow-up|0|||
33691692|NCT02310750|63217667|FG006|HP Washout 2|Lost to Follow-up|7|||
33691693|NCT02310750|63217668|FG007|HP Washout 2|Lost to Follow-up|0|||
33691694|NCT02310750|63217669|FG008|HP Washout 2|Lost to Follow-up|0|||
33691695|NCT02310750|63217670|FG009|HP Washout 2|Lost to Follow-up|0|||
33691696|NCT02310750|63217671|FG010|HP Washout 2|Lost to Follow-up|0|||
33691697|NCT02310750|63217672|FG011|HP Washout 2|Lost to Follow-up|0|||
33691698|NCT02310750|63217673|FG012|HP Washout 2|Lost to Follow-up|0|||
33691699|NCT02310750|63217674|FG013|HP Washout 2|Lost to Follow-up|0|||
33691700|NCT02310750|63217675|FG014|HP Washout 2|Lost to Follow-up|0|||
33691701|NCT02310750|63217676|FG015|HP Washout 2|Lost to Follow-up|0|||
33691702|NCT02310672|63217781|FG000|Overall Study|Death|1|||
33691703|NCT02310672|63217781|FG000|Overall Study|Lost to Follow-up|1|||
33691704|NCT02310672|63217781|FG000|Overall Study|Withdrawal by Subject|1|||
33691705|NCT02310672|63217781|FG000|Overall Study|Sponsor's decision|12|||
33691706|NCT02363946|63217927|FG000|Overall Study|Lost to Follow-up|0|||
33691707|NCT02363946|63217928|FG001|Overall Study|Lost to Follow-up|0|||
33691708|NCT02363946|63217929|FG002|Overall Study|Lost to Follow-up|0|||
33691709|NCT02363946|63217930|FG003|Overall Study|Lost to Follow-up|0|||
33691710|NCT02363946|63217931|FG004|Overall Study|Lost to Follow-up|0|||
33691711|NCT02363946|63217932|FG005|Overall Study|Lost to Follow-up|0|||
33691712|NCT02363946|63217933|FG006|Overall Study|Lost to Follow-up|0|||
33691713|NCT02363946|63217934|FG007|Overall Study|Lost to Follow-up|1|||
33691714|NCT02363946|63217935|FG008|Overall Study|Lost to Follow-up|0|||
33691715|NCT02363946|63217936|FG009|Overall Study|Lost to Follow-up|0|||
33691716|NCT02363946|63217937|FG010|Overall Study|Lost to Follow-up|0|||
33691717|NCT02363946|63217938|FG011|Overall Study|Lost to Follow-up|0|||
33691718|NCT02363946|63217939|FG012|Overall Study|Lost to Follow-up|0|||
33691719|NCT02363478|63217967|FG000|Overall Study|Lost to Follow-up|4|||
33691720|NCT02363478|63217967|FG000|Overall Study|Adverse Event|4|||
33691721|NCT02310126|63217974|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
33691722|NCT02310126|63217975|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
33691723|NCT02310126|63217974|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
33691724|NCT02310126|63217975|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
33691725|NCT02338362|63217983|FG000|Overall Study|Withdrawal by Subject|1|||
33691726|NCT02338362|63217984|FG001|Overall Study|Withdrawal by Subject|1|||
33691727|NCT02363322|63217992|FG000|Overall Study|Lost to Follow-up|1|||
33691728|NCT02363322|63217993|FG001|Overall Study|Lost to Follow-up|0|||
33691729|NCT02361762|63218001|FG000|Overall Study|Withdrawal by Subject|0|||
33691730|NCT02361762|63218002|FG001|Overall Study|Withdrawal by Subject|1|||
33691731|NCT02361762|63218001|FG000|Overall Study|Lost to Follow-up|0|||
33691732|NCT02361762|63218002|FG001|Overall Study|Lost to Follow-up|1|||
33691733|NCT02337738|63218011|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
33691734|NCT02337738|63218012|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
33691735|NCT02337738|63218013|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
33691736|NCT02337738|63218011|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
33691737|NCT02337738|63218012|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
33691738|NCT02337738|63218013|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
33691739|NCT02337738|63218011|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
33691740|NCT02337738|63218012|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
33691741|NCT02337738|63218013|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
33691742|NCT02337738|63218011|FG000|Overall Study|Voluntary Withdrawal|10|||
33691743|NCT02337738|63218012|FG001|Overall Study|Voluntary Withdrawal|5|||
33691744|NCT02337738|63218013|FG002|Overall Study|Voluntary Withdrawal|2|||
33691745|NCT02337738|63218011|FG000|Overall Study|Lack of Efficacy|2|||
33691746|NCT02337738|63218012|FG001|Overall Study|Lack of Efficacy|4|||
33691747|NCT02337738|63218013|FG002|Overall Study|Lack of Efficacy|0|||
33691748|NCT02337738|63218011|FG000|Overall Study|Investigator's Judgment|1|||
33691749|NCT02337738|63218012|FG001|Overall Study|Investigator's Judgment|1|||
33691750|NCT02337738|63218013|FG002|Overall Study|Investigator's Judgment|3|||
33691751|NCT02309112|63218024|FG000|Overall Study|Withdrawal by Subject|1|||
33691752|NCT02309112|63218025|FG001|Overall Study|Withdrawal by Subject|0|||
33691753|NCT02309112|63218026|FG002|Overall Study|Withdrawal by Subject|1|||
33691754|NCT02309112|63218024|FG000|Overall Study|Lost to Follow-up|0|||
33691755|NCT02309112|63218025|FG001|Overall Study|Lost to Follow-up|1|||
33691756|NCT02309112|63218026|FG002|Overall Study|Lost to Follow-up|0|||
33691757|NCT02361216|63218038|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
33691758|NCT02361216|63218039|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
33691759|NCT02361216|63218038|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
33691760|NCT02361216|63218039|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
33691761|NCT02361216|63218038|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
33691762|NCT02361216|63218039|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
33691763|NCT02361216|63218038|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
33691764|NCT02361216|63218039|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
33691765|NCT02361216|63218038|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
33691766|NCT02361216|63218039|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
33691767|NCT02361216|63218038|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
33691768|NCT02361216|63218039|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
33691769|NCT00559988|63218472|FG000|Overall Study|Death|147|||
33691770|NCT00559988|63218473|FG001|Overall Study|Death|140|||
33691771|NCT00559988|63218472|FG000|Overall Study|Withdrawal by Subject|152|||
33691772|NCT00559988|63218473|FG001|Overall Study|Withdrawal by Subject|139|||
33691773|NCT00559988|63218472|FG000|Overall Study|Lost to Follow-up|42|||
33691774|NCT00559988|63218473|FG001|Overall Study|Lost to Follow-up|56|||
33691775|NCT00559988|63218472|FG000|Overall Study|ICD device explanted|10|||
33691776|NCT00559988|63218473|FG001|Overall Study|ICD device explanted|17|||
33691777|NCT00559754|63218535|FG000|Overall Study|Disease progression|1|||
33691778|NCT00559754|63218535|FG000|Overall Study|Adverse Event|5|||
33691779|NCT00559754|63218535|FG000|Overall Study|Protocol Violation|1|||
33691780|NCT00559754|63218535|FG000|Overall Study|Investigator criteria|2|||
33691781|NCT00559754|63218535|FG000|Overall Study|Withdrawal by Subject|2|||
33691782|NCT00559364|63218649|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
33691783|NCT00559364|63218650|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
33691784|NCT02308020|63218713|FG000|Overall Study|Lost to Follow-up|1|||
33691785|NCT02308020|63218714|FG001|Overall Study|Lost to Follow-up|7|||
33691786|NCT02308020|63218715|FG002|Overall Study|Lost to Follow-up|0|||
33596193|NCT02107131|62995166|FG000|Overall Study|Lost to Follow-up|4|||
33596194|NCT02107131|62995167|FG001|Overall Study|Lost to Follow-up|4|||
33691787|NCT02308020|63218716|FG003|Overall Study|Lost to Follow-up|0|||
33691788|NCT02308020|63218717|FG004|Overall Study|Lost to Follow-up|1|||
33596195|NCT02107131|62995166|FG000|Overall Study|Physician Decision|1|||
33596196|NCT02107131|62995167|FG001|Overall Study|Physician Decision|0|||
33691789|NCT02308020|63218718|FG005|Overall Study|Lost to Follow-up|2|||
33691790|NCT02308020|63218713|FG000|Overall Study|Sponsor Decision|0|||
33691791|NCT02308020|63218714|FG001|Overall Study|Sponsor Decision|8|||
33691792|NCT02308020|63218715|FG002|Overall Study|Sponsor Decision|0|||
33691793|NCT02308020|63218716|FG003|Overall Study|Sponsor Decision|2|||
33691794|NCT02308020|63218717|FG004|Overall Study|Sponsor Decision|2|||
33691795|NCT02308020|63218718|FG005|Overall Study|Sponsor Decision|1|||
33691796|NCT02308020|63218713|FG000|Overall Study|Withdrawal by Subject|3|||
33691797|NCT02308020|63218714|FG001|Overall Study|Withdrawal by Subject|5|||
33691798|NCT02308020|63218715|FG002|Overall Study|Withdrawal by Subject|3|||
33691799|NCT02308020|63218716|FG003|Overall Study|Withdrawal by Subject|2|||
33691800|NCT02308020|63218717|FG004|Overall Study|Withdrawal by Subject|1|||
33691801|NCT02308020|63218718|FG005|Overall Study|Withdrawal by Subject|2|||
33691802|NCT02359890|63218738|FG000|Overall Study|Not meeting eligibility|4|||
33691803|NCT02359890|63218738|FG000|Overall Study|Never treated with study catheter|6|||
33691804|NCT02306850|63218742|FG000|Overall Study|Lack of Efficacy|2|||
33691805|NCT02306694|63218747|FG000|Overall Study|Withdrawal by Subject|3|||
33691806|NCT02306694|63218747|FG000|Overall Study|Lost to Follow-up|1|||
33691807|NCT01648140|63218759|FG000|Overall Study|Physician Decision|1|||
33691808|NCT01648140|63218760|FG001|Overall Study|Physician Decision|0|||
33691809|NCT01648140|63218761|FG002|Overall Study|Physician Decision|0|||
33691810|NCT01648140|63218762|FG003|Overall Study|Physician Decision|0|||
33691811|NCT01648140|63218759|FG000|Overall Study|Lack of Efficacy|4|||
33691812|NCT01648140|63218760|FG001|Overall Study|Lack of Efficacy|7|||
33691813|NCT01648140|63218761|FG002|Overall Study|Lack of Efficacy|1|||
33691814|NCT01648140|63218762|FG003|Overall Study|Lack of Efficacy|0|||
33691815|NCT01648140|63218759|FG000|Overall Study|Adverse Event|3|||
33691816|NCT01648140|63218760|FG001|Overall Study|Adverse Event|1|||
33691817|NCT01648140|63218761|FG002|Overall Study|Adverse Event|2|||
33691818|NCT01648140|63218762|FG003|Overall Study|Adverse Event|0|||
33691819|NCT01648140|63218759|FG000|Overall Study|Withdrawal by Subject|2|||
33691820|NCT01648140|63218760|FG001|Overall Study|Withdrawal by Subject|3|||
33691821|NCT01648140|63218761|FG002|Overall Study|Withdrawal by Subject|3|||
33691822|NCT01648140|63218762|FG003|Overall Study|Withdrawal by Subject|2|||
33691823|NCT01648140|63218759|FG000|Overall Study|Lost to Follow-up|2|||
33691824|NCT01648140|63218760|FG001|Overall Study|Lost to Follow-up|1|||
33691825|NCT01648140|63218761|FG002|Overall Study|Lost to Follow-up|2|||
33691826|NCT01648140|63218762|FG003|Overall Study|Lost to Follow-up|0|||
33691827|NCT02336178|63218781|FG000|Overall Study|Lost to Follow-up|1|||
33691828|NCT02336178|63218781|FG000|Overall Study|Protocol Violation|1|||
33691829|NCT02336178|63218781|FG000|Overall Study|Withdrawal by Subject|1|||
33691830|NCT02336178|63218781|FG000|Overall Study|Other|1|||
33691831|NCT02357940|63218795|FG000|Overall Study|Adverse Event|0|||
33691832|NCT02357940|63218796|FG001|Overall Study|Adverse Event|1|||
33691833|NCT02357940|63218795|FG000|Overall Study|Investigator's judgement|0|||
33691834|NCT02357940|63218796|FG001|Overall Study|Investigator's judgement|1|||
33691835|NCT02335242|63218804|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
33691836|NCT02335242|63218805|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
33691837|NCT02335242|63218804|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
33691838|NCT02335242|63218805|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33691839|NCT02335242|63218804|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
33691840|NCT02335242|63218805|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
33691841|NCT02334384|63218817|FG000|Overall Study|Lost to Follow-up|1|||
33691842|NCT02334384|63218818|FG001|Overall Study|Lost to Follow-up|1|||
33691843|NCT02334306|63218826|FG000|Double-blind Period|Adverse Event|0|||
33691844|NCT02334306|63218827|FG001|Double-blind Period|Adverse Event|1|||
33691845|NCT02334306|63218826|FG000|Double-blind Period|Withdrawal by Subject|1|||
33691846|NCT02334306|63218827|FG001|Double-blind Period|Withdrawal by Subject|1|||
33691847|NCT02305758|63218836|FG000|Overall Study|Death|27|||
33691848|NCT02305758|63218837|FG001|Overall Study|Death|27|||
33691849|NCT02305758|63218836|FG000|Overall Study|Withdrew consent|9|||
33691850|NCT02305758|63218837|FG001|Overall Study|Withdrew consent|2|||
33691851|NCT02305758|63218836|FG000|Overall Study|Lost to Follow-up|6|||
33691852|NCT02305758|63218837|FG001|Overall Study|Lost to Follow-up|1|||
33691853|NCT02305758|63218836|FG000|Overall Study|Study Terminated by Sponsor|21|||
33691854|NCT02305758|63218837|FG001|Overall Study|Study Terminated by Sponsor|34|||
33691855|NCT02305758|63218836|FG000|Overall Study|Other, not specified|2|||
33691856|NCT02305758|63218837|FG001|Overall Study|Other, not specified|1|||
33691857|NCT02305446|63218843|FG000|Overall Study|Adverse Event|1|||
33691858|NCT02303574|63218980|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33691859|NCT02303574|63218981|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33691860|NCT02303574|63218982|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
33691861|NCT02303574|63218983|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33691862|NCT02303574|63218984|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33691863|NCT02303574|63218985|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33691864|NCT02303574|63218986|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33691865|NCT02303574|63218987|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33691866|NCT02303574|63218988|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33691867|NCT02303574|63218989|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33691868|NCT02303574|63218980|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33691869|NCT02303574|63218981|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33691870|NCT02303574|63218982|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33691871|NCT02303574|63218983|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33691872|NCT02303574|63218984|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33691873|NCT02303574|63218985|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33691874|NCT02303574|63218986|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33691875|NCT02303574|63218987|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
33691876|NCT02303574|63218988|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33691877|NCT02303574|63218989|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33691878|NCT02354976|63219025|FG000|Overall Study|Other - reason not specified|1|||
33691879|NCT02354976|63219026|FG001|Overall Study|Other - reason not specified|0|||
33691880|NCT02354976|63219027|FG002|Overall Study|Other - reason not specified|1|||
33691881|NCT02354976|63219025|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
33691882|NCT02354976|63219026|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
33691883|NCT02354976|63219027|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
33691884|NCT02354976|63219025|FG000|Overall Study|Adverse Event|1|||
33691885|NCT02354976|63219026|FG001|Overall Study|Adverse Event|0|||
33691886|NCT02354976|63219027|FG002|Overall Study|Adverse Event|2|||
33691887|NCT02303262|63219035|FG000|Overall Study|Withdrawal by Subject|2|||
33691888|NCT00558896|63219046|FG000|Overall Study|Adverse Event|1|||
33691889|NCT00558896|63219047|FG001|Overall Study|Adverse Event|1|||
33691890|NCT00558896|63219048|FG002|Overall Study|Adverse Event|1|||
33691891|NCT00558896|63219049|FG003|Overall Study|Adverse Event|3|||
33691892|NCT00558896|63219050|FG004|Overall Study|Adverse Event|4|||
33691893|NCT00558896|63219051|FG005|Overall Study|Adverse Event|10|||
33691894|NCT00558896|63219052|FG006|Overall Study|Adverse Event|3|||
33691895|NCT00558896|63219046|FG000|Overall Study|Death|3|||
33691896|NCT00558896|63219047|FG001|Overall Study|Death|0|||
33691897|NCT00558896|63219048|FG002|Overall Study|Death|2|||
33691898|NCT00558896|63219049|FG003|Overall Study|Death|3|||
33691899|NCT00558896|63219050|FG004|Overall Study|Death|2|||
33691900|NCT00558896|63219051|FG005|Overall Study|Death|2|||
33691901|NCT00558896|63219052|FG006|Overall Study|Death|6|||
33691902|NCT00558896|63219046|FG000|Overall Study|Withdrawal by Subject|2|||
33691903|NCT00558896|63219047|FG001|Overall Study|Withdrawal by Subject|1|||
33691904|NCT00558896|63219048|FG002|Overall Study|Withdrawal by Subject|1|||
33691905|NCT00558896|63219049|FG003|Overall Study|Withdrawal by Subject|1|||
33691906|NCT00558896|63219050|FG004|Overall Study|Withdrawal by Subject|1|||
33691907|NCT00558896|63219051|FG005|Overall Study|Withdrawal by Subject|5|||
33691908|NCT00558896|63219052|FG006|Overall Study|Withdrawal by Subject|5|||
33691909|NCT00558896|63219046|FG000|Overall Study|Alternative Treatment|2|||
33691910|NCT00558896|63219047|FG001|Overall Study|Alternative Treatment|2|||
33691911|NCT00558896|63219048|FG002|Overall Study|Alternative Treatment|0|||
33691912|NCT00558896|63219049|FG003|Overall Study|Alternative Treatment|2|||
33691913|NCT00558896|63219050|FG004|Overall Study|Alternative Treatment|6|||
33691914|NCT00558896|63219051|FG005|Overall Study|Alternative Treatment|7|||
33691915|NCT00558896|63219052|FG006|Overall Study|Alternative Treatment|1|||
33691916|NCT00558896|63219046|FG000|Overall Study|Physician discretion|3|||
33691917|NCT00558896|63219047|FG001|Overall Study|Physician discretion|2|||
33691918|NCT00558896|63219048|FG002|Overall Study|Physician discretion|1|||
33691919|NCT00558896|63219049|FG003|Overall Study|Physician discretion|2|||
33691920|NCT00558896|63219050|FG004|Overall Study|Physician discretion|1|||
33691921|NCT00558896|63219051|FG005|Overall Study|Physician discretion|3|||
33691922|NCT00558896|63219052|FG006|Overall Study|Physician discretion|3|||
33691923|NCT00558896|63219046|FG000|Overall Study|Continues on treatment|10|||
33691924|NCT00558896|63219047|FG001|Overall Study|Continues on treatment|1|||
33691925|NCT00558896|63219048|FG002|Overall Study|Continues on treatment|0|||
33691926|NCT00558896|63219049|FG003|Overall Study|Continues on treatment|1|||
33691927|NCT00558896|63219050|FG004|Overall Study|Continues on treatment|9|||
33691928|NCT00558896|63219051|FG005|Overall Study|Continues on treatment|25|||
33691929|NCT00558896|63219052|FG006|Overall Study|Continues on treatment|6|||
33691930|NCT00558428|63219186|FG000|Overall Study|Adverse Event|6|||
33691931|NCT00558428|63219187|FG001|Overall Study|Adverse Event|22|||
33691932|NCT00558428|63219188|FG002|Overall Study|Adverse Event|3|||
33691933|NCT00558428|63219189|FG003|Overall Study|Adverse Event|4|||
33691934|NCT00558428|63219186|FG000|Overall Study|Lost to Follow-up|0|||
33691935|NCT00558428|63219187|FG001|Overall Study|Lost to Follow-up|1|||
33691936|NCT00558428|63219188|FG002|Overall Study|Lost to Follow-up|0|||
33691937|NCT00558428|63219189|FG003|Overall Study|Lost to Follow-up|0|||
33691938|NCT00558428|63219186|FG000|Overall Study|Lack of Efficacy|0|||
33691939|NCT00558428|63219187|FG001|Overall Study|Lack of Efficacy|0|||
33691940|NCT00558428|63219188|FG002|Overall Study|Lack of Efficacy|1|||
33691941|NCT00558428|63219189|FG003|Overall Study|Lack of Efficacy|2|||
33691942|NCT00558428|63219186|FG000|Overall Study|Non compliant with protocol|1|||
33691943|NCT00558428|63219187|FG001|Overall Study|Non compliant with protocol|0|||
33691944|NCT00558428|63219188|FG002|Overall Study|Non compliant with protocol|0|||
33691945|NCT00558428|63219189|FG003|Overall Study|Non compliant with protocol|3|||
33691946|NCT00558428|63219186|FG000|Overall Study|Consent withdrawn|2|||
33691947|NCT00558428|63219187|FG001|Overall Study|Consent withdrawn|1|||
33691948|NCT00558428|63219188|FG002|Overall Study|Consent withdrawn|0|||
33691949|NCT00558428|63219189|FG003|Overall Study|Consent withdrawn|1|||
33691950|NCT00558428|63219186|FG000|Overall Study|Other|3|||
33691951|NCT00558428|63219187|FG001|Overall Study|Other|0|||
33691952|NCT00558428|63219188|FG002|Overall Study|Other|0|||
33691953|NCT00558428|63219189|FG003|Overall Study|Other|1|||
33691954|NCT00558272|63219228|FG000|Overall Study|Adverse Event|10|||
33691955|NCT00558272|63219229|FG001|Overall Study|Adverse Event|0|||
33691956|NCT00558272|63219228|FG000|Overall Study|Death|1|||
33691957|NCT00558272|63219229|FG001|Overall Study|Death|0|||
33691958|NCT00558272|63219228|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
33691959|NCT00558272|63219229|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
33691960|NCT00558272|63219228|FG000|Overall Study|AZ study team decision|0|||
33691961|NCT00558272|63219229|FG001|Overall Study|AZ study team decision|1|||
33691962|NCT00558272|63219228|FG000|Overall Study|Incorrectly enrolled|1|||
33691963|NCT00558272|63219229|FG001|Overall Study|Incorrectly enrolled|0|||
33691964|NCT00558272|63219228|FG000|Overall Study|Withdrawal by Subject|0|||
33691965|NCT00558272|63219229|FG001|Overall Study|Withdrawal by Subject|1|||
33691966|NCT00557492|63219379|FG000|Overall Study|Change in health insurance|1|||
33691967|NCT02354586|63219482|FG000|Overall Study|Death|230|||
33691968|NCT02354586|63219482|FG000|Overall Study|Withdrawal by Subject|59|||
33691969|NCT02354586|63219482|FG000|Overall Study|Lost to Follow-up|11|||
33691970|NCT02354586|63219482|FG000|Overall Study|Sponsor decision|51|||
33691971|NCT02354586|63219482|FG000|Overall Study|Site closure|2|||
33691972|NCT02354586|63219482|FG000|Overall Study|Intercurrent illness|1|||
33691973|NCT02354586|63219482|FG000|Overall Study|Protocol Violation|3|||
33691974|NCT02354586|63219482|FG000|Overall Study|Physician Decision|13|||
33691975|NCT02354586|63219482|FG000|Overall Study|Lack of Efficacy|86|||
33691976|NCT02354586|63219482|FG000|Overall Study|Adverse Event|7|||
33691977|NCT02332824|63219507|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
33691978|NCT02332824|63219508|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
33691979|NCT02332824|63219509|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
33691980|NCT02332824|63219510|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
33691981|NCT02332824|63219511|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
33691982|NCT02332824|63219512|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
33691983|NCT02332824|63219507|FG000|Overall Study|Voluntary Withdrawal|1|||
33691984|NCT02332824|63219508|FG001|Overall Study|Voluntary Withdrawal|0|||
33691985|NCT02332824|63219509|FG002|Overall Study|Voluntary Withdrawal|0|||
33691986|NCT02332824|63219510|FG003|Overall Study|Voluntary Withdrawal|0|||
33691987|NCT02332824|63219511|FG004|Overall Study|Voluntary Withdrawal|0|||
33691988|NCT02332824|63219512|FG005|Overall Study|Voluntary Withdrawal|0|||
33691989|NCT02332824|63219507|FG000|Overall Study|Inconvenient schedule|1|||
33691990|NCT02332824|63219508|FG001|Overall Study|Inconvenient schedule|1|||
33691991|NCT02332824|63219509|FG002|Overall Study|Inconvenient schedule|0|||
33691992|NCT02332824|63219510|FG003|Overall Study|Inconvenient schedule|0|||
33691993|NCT02332824|63219511|FG004|Overall Study|Inconvenient schedule|0|||
33691994|NCT02332824|63219512|FG005|Overall Study|Inconvenient schedule|0|||
33691995|NCT02332824|63219507|FG000|Overall Study|Transfer|0|||
33691996|NCT02332824|63219508|FG001|Overall Study|Transfer|0|||
33691997|NCT02332824|63219509|FG002|Overall Study|Transfer|1|||
33691998|NCT02332824|63219510|FG003|Overall Study|Transfer|1|||
33691999|NCT02332824|63219511|FG004|Overall Study|Transfer|0|||
33692000|NCT02332824|63219512|FG005|Overall Study|Transfer|0|||
33692001|NCT00556712|63219659|FG000|Overall Study|Adverse Event|7|||
33692002|NCT00556712|63219660|FG001|Overall Study|Adverse Event|19|||
33692003|NCT00556712|63219659|FG000|Overall Study|Death|5|||
33692004|NCT00556712|63219660|FG001|Overall Study|Death|10|||
33692005|NCT00556712|63219659|FG000|Overall Study|Progressive Disease|383|||
33692006|NCT00556712|63219660|FG001|Overall Study|Progressive Disease|320|||
33692007|NCT00556712|63219659|FG000|Overall Study|Protocol Violation|3|||
33692008|NCT00556712|63219660|FG001|Overall Study|Protocol Violation|2|||
33692009|NCT00556712|63219659|FG000|Overall Study|Refused Treatment|17|||
33692010|NCT00556712|63219660|FG001|Overall Study|Refused Treatment|16|||
33692011|NCT00556712|63219659|FG000|Overall Study|Failure to Return|2|||
33692012|NCT00556712|63219660|FG001|Overall Study|Failure to Return|3|||
33692013|NCT00556712|63219659|FG000|Overall Study|Other|2|||
33692014|NCT00556712|63219660|FG001|Overall Study|Other|2|||
33692015|NCT00556712|63219659|FG000|Overall Study|Ongoing at Data Cutoff|32|||
33692016|NCT00556712|63219660|FG001|Overall Study|Ongoing at Data Cutoff|66|||
33692017|NCT00556322|63219734|FG000|Overall Study|Insufficient therapeutic response|158|||
33692018|NCT00556322|63219735|FG001|Overall Study|Insufficient therapeutic response|168|||
33692019|NCT00556322|63219734|FG000|Overall Study|Adverse Event|7|||
33692020|NCT00556322|63219735|FG001|Overall Study|Adverse Event|4|||
33692021|NCT00556322|63219734|FG000|Overall Study|Other|4|||
33692022|NCT00556322|63219735|FG001|Overall Study|Other|1|||
33692023|NCT00556322|63219734|FG000|Overall Study|Lost to Follow-up|5|||
33692024|NCT00556322|63219735|FG001|Overall Study|Lost to Follow-up|3|||
33692025|NCT00556322|63219734|FG000|Overall Study|Withdrawal by Subject|19|||
33692026|NCT00556322|63219735|FG001|Overall Study|Withdrawal by Subject|7|||
33692027|NCT00556322|63219734|FG000|Overall Study|Protocol Violation|5|||
33692028|NCT00556322|63219735|FG001|Overall Study|Protocol Violation|1|||
33692029|NCT00556322|63219734|FG000|Overall Study|Ongoing at data cutoff|3|||
33692030|NCT00556322|63219735|FG001|Overall Study|Ongoing at data cutoff|5|||
33692031|NCT00556322|63219734|FG000|Overall Study|Death|20|||
33692032|NCT00556322|63219735|FG001|Overall Study|Death|14|||
33692033|NCT00556166|63219753|FG000|Overall Study|Withdrawal by Subject|1|||
33692034|NCT02332590|63219913|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
33692035|NCT02332590|63219914|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
33692036|NCT02332590|63219913|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
33692037|NCT02332590|63219914|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
33692038|NCT02332590|63219913|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
33692039|NCT02332590|63219914|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
33692040|NCT02332590|63219913|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
33692041|NCT02332590|63219914|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
33692042|NCT02332590|63219913|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
33692043|NCT02332590|63219914|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
33692044|NCT02332590|63219913|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
33692045|NCT02332590|63219914|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
33692046|NCT02332590|63219913|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
33692047|NCT02332590|63219914|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
33692048|NCT02332590|63219913|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
33692049|NCT02332590|63219914|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
33692050|NCT02332590|63219913|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
33692051|NCT02332590|63219914|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
33692052|NCT00554840|63219985|FG000|Overall Study|Physician Decision|0|||
33692053|NCT00554840|63219986|FG001|Overall Study|Physician Decision|1|||
33692054|NCT02302716|63220011|FG000|Overall Study|Adverse Event|1|||
33692055|NCT02302716|63220012|FG001|Overall Study|Adverse Event|1|||
33692056|NCT02302716|63220011|FG000|Overall Study|Death|0|||
33692057|NCT02302716|63220012|FG001|Overall Study|Death|1|||
33692058|NCT02302716|63220011|FG000|Overall Study|Lack of Efficacy|0|||
33692059|NCT02302716|63220012|FG001|Overall Study|Lack of Efficacy|1|||
33692060|NCT02302716|63220011|FG000|Overall Study|Lost to Follow-up|2|||
33692061|NCT02302716|63220012|FG001|Overall Study|Lost to Follow-up|4|||
33692062|NCT02302716|63220011|FG000|Overall Study|Physician Decision|3|||
33692063|NCT02302716|63220012|FG001|Overall Study|Physician Decision|4|||
33692064|NCT02302716|63220011|FG000|Overall Study|Withdrawal by Subject|13|||
33692065|NCT02302716|63220012|FG001|Overall Study|Withdrawal by Subject|7|||
33692066|NCT02302716|63220011|FG000|Overall Study|Protocol Violation|0|||
33692067|NCT02302716|63220012|FG001|Overall Study|Protocol Violation|1|||
33692068|NCT00554606|63220041|FG000|Overall Study|Adverse Event|3|||
33692069|NCT00554606|63220041|FG000|Overall Study|Abnormal laboratory values|1|||
33692070|NCT00554606|63220041|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
33692071|NCT00554606|63220041|FG000|Overall Study|Subject withdrew consent|2|||
33692072|NCT00554606|63220041|FG000|Overall Study|Lost to Follow-up|2|||
33692073|NCT00554606|63220041|FG000|Overall Study|Administrative problems|60|||
33692074|NCT00554606|63220041|FG000|Overall Study|Death|1|||
33692075|NCT00554606|63220041|FG000|Overall Study|Protocol deviation|2|||
33692076|NCT02354508|63220077|FG000|Period 1: Core Phase|Adverse Event|1|||
33692077|NCT02354508|63220078|FG001|Period 1: Core Phase|Adverse Event|1|||
33692078|NCT02354508|63220079|FG002|Period 1: Core Phase|Adverse Event|2|||
33692079|NCT02354508|63220077|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
33692080|NCT02354508|63220078|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
33692081|NCT02354508|63220079|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
33692082|NCT02354508|63220077|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
33692083|NCT02354508|63220078|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
33692084|NCT02354508|63220079|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
33692085|NCT02354508|63220077|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
33692086|NCT02354508|63220078|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
33692087|NCT02354508|63220079|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
33692088|NCT02354508|63220077|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
33692089|NCT02354508|63220078|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
33692090|NCT02354508|63220079|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
33692091|NCT02354508|63220077|FG000|Period 2: Extension Phase|Physician Decision|5|||
33692092|NCT02354508|63220078|FG001|Period 2: Extension Phase|Physician Decision|0|||
33692093|NCT02354508|63220079|FG002|Period 2: Extension Phase|Physician Decision|1|||
33692094|NCT02354508|63220077|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
33692095|NCT02354508|63220078|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
33692096|NCT02354508|63220079|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
33692097|NCT02354508|63220077|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
33692098|NCT02354508|63220078|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
33692099|NCT02354508|63220079|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
33692100|NCT02354508|63220077|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
33692101|NCT02354508|63220078|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
33692102|NCT02354508|63220079|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
33692103|NCT00554216|63220131|FG000|Overall Study|Lost to Follow-up|92|||
33692104|NCT00554216|63220132|FG001|Overall Study|Lost to Follow-up|31|||
33692105|NCT00554216|63220133|FG002|Overall Study|Lost to Follow-up|63|||
33692106|NCT00554216|63220131|FG000|Overall Study|Adverse Event|16|||
33692107|NCT00554216|63220132|FG001|Overall Study|Adverse Event|16|||
33692108|NCT00554216|63220133|FG002|Overall Study|Adverse Event|36|||
33692109|NCT00554216|63220131|FG000|Overall Study|Withdrawal by Subject|92|||
33692110|NCT00554216|63220132|FG001|Overall Study|Withdrawal by Subject|31|||
33692111|NCT00554216|63220133|FG002|Overall Study|Withdrawal by Subject|43|||
33692112|NCT00554216|63220131|FG000|Overall Study|Non compliance|10|||
33692113|NCT00554216|63220132|FG001|Overall Study|Non compliance|4|||
33692114|NCT00554216|63220133|FG002|Overall Study|Non compliance|5|||
33692115|NCT00554216|63220131|FG000|Overall Study|Pregnancy|2|||
33692116|NCT00554216|63220132|FG001|Overall Study|Pregnancy|1|||
33692117|NCT00554216|63220133|FG002|Overall Study|Pregnancy|14|||
33692118|NCT00554216|63220131|FG000|Overall Study|Restricted med|3|||
33692119|NCT00554216|63220132|FG001|Overall Study|Restricted med|1|||
33692120|NCT00554216|63220133|FG002|Overall Study|Restricted med|1|||
33596197|NCT02107131|62995166|FG000|Overall Study|Withdrawal by Subject|2|||
33596198|NCT02107131|62995167|FG001|Overall Study|Withdrawal by Subject|0|||
33596199|NCT02107131|62995166|FG000|Overall Study|mental instability|1|||
33596200|NCT02107131|62995167|FG001|Overall Study|mental instability|0|||
33692121|NCT00554216|63220131|FG000|Overall Study|Other|12|||
33692122|NCT00554216|63220132|FG001|Overall Study|Other|7|||
33692123|NCT00554216|63220133|FG002|Overall Study|Other|10|||
33692124|NCT00554216|63220131|FG000|Overall Study|Lack of Efficacy|15|||
33692125|NCT00554216|63220132|FG001|Overall Study|Lack of Efficacy|3|||
33692126|NCT00554216|63220133|FG002|Overall Study|Lack of Efficacy|0|||
33692127|NCT02353572|63220158|FG000|Overall Study|Withdrawal by Subject|1|||
33692128|NCT02353572|63220158|FG000|Overall Study|Study terminated|2|||
33692129|NCT00552578|63220170|FG000|Overall Study|Lost to Follow-up|1|||
33692130|NCT00552578|63220171|FG001|Overall Study|Lost to Follow-up|1|||
33692131|NCT02301936|63220179|FG000|Overall Study|Lost to Follow-up|1|||
33692132|NCT02301936|63220180|FG001|Overall Study|Lost to Follow-up|0|||
33692133|NCT00552344|63220219|FG000|Overall Study|Lack of Efficacy|55|||
33692134|NCT00552344|63220219|FG000|Overall Study|Loss of efficacy|75|||
33692135|NCT00552344|63220219|FG000|Overall Study|Lost to Follow-up|8|||
33692136|NCT00552344|63220219|FG000|Overall Study|Withdrawal by Subject|48|||
33692137|NCT00552344|63220219|FG000|Overall Study|SAE, non-fatal|6|||
33692138|NCT00552344|63220219|FG000|Overall Study|AE, non-serious non-fatal|38|||
33692139|NCT00552344|63220219|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
33692140|NCT00552344|63220219|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
33692141|NCT00552344|63220219|FG000|Overall Study|Other Reason|22|||
33692142|NCT00553514|63220256|FG000|Overall Study|Protocol deviation|0|||
33692143|NCT00553514|63220257|FG001|Overall Study|Protocol deviation|0|||
33692144|NCT00553514|63220258|FG002|Overall Study|Protocol deviation|0|||
33692145|NCT00553514|63220259|FG003|Overall Study|Protocol deviation|1|||
33692146|NCT00553514|63220260|FG004|Overall Study|Protocol deviation|0|||
33692147|NCT00553514|63220256|FG000|Overall Study|Lack of ovarian response|4|||
33692148|NCT00553514|63220257|FG001|Overall Study|Lack of ovarian response|5|||
33692149|NCT00553514|63220258|FG002|Overall Study|Lack of ovarian response|5|||
33692150|NCT00553514|63220259|FG003|Overall Study|Lack of ovarian response|5|||
33692151|NCT00553514|63220260|FG004|Overall Study|Lack of ovarian response|6|||
33596201|NCT02107131|62995166|FG000|Overall Study|Death|0|||
33596202|NCT02107131|62995167|FG001|Overall Study|Death|1|||
33692152|NCT00553514|63220256|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
33692153|NCT00553514|63220257|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
33692154|NCT00553514|63220258|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
33692155|NCT00553514|63220259|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
33692156|NCT00553514|63220260|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
33692157|NCT00553514|63220256|FG000|Overall Study|Risk of multiple pregnancy|0|||
33692158|NCT00553514|63220257|FG001|Overall Study|Risk of multiple pregnancy|2|||
33692159|NCT00553514|63220258|FG002|Overall Study|Risk of multiple pregnancy|0|||
33692160|NCT00553514|63220259|FG003|Overall Study|Risk of multiple pregnancy|1|||
33692161|NCT00553514|63220260|FG004|Overall Study|Risk of multiple pregnancy|0|||
33692162|NCT00553514|63220256|FG000|Overall Study|Other|1|||
33692163|NCT00553514|63220257|FG001|Overall Study|Other|1|||
33692164|NCT00553514|63220258|FG002|Overall Study|Other|0|||
33692165|NCT00553514|63220259|FG003|Overall Study|Other|0|||
33692166|NCT00553514|63220260|FG004|Overall Study|Other|1|||
33692167|NCT00553436|63220284|FG000|Overall Study|Conversion to another procedure|1|||
33692168|NCT00553202|63220315|FG000|Overall Study|Death|16|||
33692169|NCT00553202|63220315|FG000|Overall Study|Lost to Follow-up|1|||
33692170|NCT00553202|63220315|FG000|Overall Study|Physician Decision|28|||
33692171|NCT00553202|63220315|FG000|Overall Study|Withdrawal by Subject|1|||
33692172|NCT00553202|63220315|FG000|Overall Study|No donor identified|16|||
33692173|NCT00553202|63220315|FG000|Overall Study|Fails to meet organ function|6|||
33692174|NCT00552188|63220339|FG000|Overall Study|Adverse Event|0|||
33692175|NCT00552188|63220340|FG001|Overall Study|Adverse Event|2|||
33692176|NCT00552188|63220339|FG000|Overall Study|Lost to Follow-up|2|||
33692177|NCT00552188|63220340|FG001|Overall Study|Lost to Follow-up|1|||
33692178|NCT00552188|63220339|FG000|Overall Study|Withdrawal of consent|0|||
33692179|NCT00552188|63220340|FG001|Overall Study|Withdrawal of consent|1|||
33692180|NCT00552188|63220339|FG000|Overall Study|Subject returned to home country|0|||
33692181|NCT00552188|63220340|FG001|Overall Study|Subject returned to home country|1|||
33692182|NCT00552110|63220360|FG000|Overall Study|Serious or Life-Threatening AE|0|||
33692183|NCT00552110|63220361|FG001|Overall Study|Serious or Life-Threatening AE|0|||
33692184|NCT00552110|63220362|FG002|Overall Study|Serious or Life-Threatening AE|1|||
33692185|NCT00552110|63220363|FG003|Overall Study|Serious or Life-Threatening AE|0|||
33692186|NCT00552110|63220364|FG004|Overall Study|Serious or Life-Threatening AE|0|||
33692187|NCT00552110|63220360|FG000|Overall Study|Lack of Efficacy|1|||
33692188|NCT00552110|63220361|FG001|Overall Study|Lack of Efficacy|0|||
33692189|NCT00552110|63220362|FG002|Overall Study|Lack of Efficacy|0|||
33692190|NCT00552110|63220363|FG003|Overall Study|Lack of Efficacy|1|||
33692191|NCT00552110|63220364|FG004|Overall Study|Lack of Efficacy|4|||
33692192|NCT00552110|63220360|FG000|Overall Study|Withdrawal by Subject|0|||
33692193|NCT00552110|63220361|FG001|Overall Study|Withdrawal by Subject|2|||
33692194|NCT00552110|63220362|FG002|Overall Study|Withdrawal by Subject|0|||
33692195|NCT00552110|63220363|FG003|Overall Study|Withdrawal by Subject|3|||
33692196|NCT00552110|63220364|FG004|Overall Study|Withdrawal by Subject|2|||
33692197|NCT00552110|63220360|FG000|Overall Study|Lost to Follow-up|0|||
33692198|NCT00552110|63220361|FG001|Overall Study|Lost to Follow-up|0|||
33692199|NCT00552110|63220362|FG002|Overall Study|Lost to Follow-up|0|||
33692200|NCT00552110|63220363|FG003|Overall Study|Lost to Follow-up|1|||
33692201|NCT00552110|63220364|FG004|Overall Study|Lost to Follow-up|1|||
33692202|NCT00552110|63220360|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
33692203|NCT00552110|63220361|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
33692204|NCT00552110|63220362|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
33692205|NCT00552110|63220363|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
33692206|NCT00552110|63220364|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
33692207|NCT00552110|63220360|FG000|Overall Study|Withdrawn per Sponsor|0|||
33692208|NCT00552110|63220361|FG001|Overall Study|Withdrawn per Sponsor|1|||
33692209|NCT00552110|63220362|FG002|Overall Study|Withdrawn per Sponsor|0|||
33692210|NCT00552110|63220363|FG003|Overall Study|Withdrawn per Sponsor|0|||
33692211|NCT00552110|63220364|FG004|Overall Study|Withdrawn per Sponsor|1|||
33692212|NCT00552110|63220360|FG000|Overall Study|Use of Prohibited Medication|1|||
33692213|NCT00552110|63220361|FG001|Overall Study|Use of Prohibited Medication|1|||
33692214|NCT00552110|63220362|FG002|Overall Study|Use of Prohibited Medication|0|||
33692215|NCT00552110|63220363|FG003|Overall Study|Use of Prohibited Medication|0|||
33692216|NCT00552110|63220364|FG004|Overall Study|Use of Prohibited Medication|0|||
33692217|NCT00552110|63220360|FG000|Overall Study|Delay of Study due to Relabeling|0|||
33692218|NCT00552110|63220361|FG001|Overall Study|Delay of Study due to Relabeling|0|||
33692219|NCT00552110|63220362|FG002|Overall Study|Delay of Study due to Relabeling|0|||
33692220|NCT00552110|63220363|FG003|Overall Study|Delay of Study due to Relabeling|1|||
33692221|NCT00552110|63220364|FG004|Overall Study|Delay of Study due to Relabeling|0|||
33692222|NCT00552110|63220360|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
33692223|NCT00552110|63220361|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
33692224|NCT00552110|63220362|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
33692225|NCT00552110|63220363|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
33692226|NCT00552110|63220364|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
33692227|NCT00552110|63220360|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
33692228|NCT00552110|63220361|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
33692229|NCT00552110|63220362|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
33692230|NCT00552110|63220363|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
33692231|NCT00552110|63220364|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
33692232|NCT02301624|63220387|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
33692233|NCT02301624|63220388|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
33692234|NCT02301624|63220387|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
33692235|NCT02301624|63220388|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
33692236|NCT02301624|63220387|FG000|Open-label Maintenance Phase|Adverse Event|2|||
33692237|NCT02301624|63220388|FG001|Open-label Maintenance Phase|Adverse Event|5|||
33692238|NCT02301624|63220387|FG000|Open-label Maintenance Phase|Physician Decision|3|||
33692239|NCT02301624|63220388|FG001|Open-label Maintenance Phase|Physician Decision|3|||
33692240|NCT02301624|63220387|FG000|Open-label Maintenance Phase|Death|2|||
33692241|NCT02301624|63220388|FG001|Open-label Maintenance Phase|Death|1|||
33692242|NCT02301624|63220387|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
33692243|NCT02301624|63220388|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
33692244|NCT02301546|63220429|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
33692245|NCT02301546|63220430|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
33692246|NCT02301546|63220429|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
33692247|NCT02301546|63220430|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
33692248|NCT02301546|63220429|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
33692249|NCT02301546|63220430|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
33692250|NCT02301546|63220429|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
33692251|NCT02301546|63220430|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
33692252|NCT02301546|63220429|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
33692253|NCT02301546|63220430|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
33692254|NCT02301546|63220429|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
33692255|NCT02301546|63220430|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
33692256|NCT02301546|63220429|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
33692257|NCT02301546|63220430|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
33692258|NCT02351934|63220454|FG000|Allocation|POD weight<pre-op weight|3|||
33692259|NCT02351934|63220455|FG001|Allocation|POD weight<pre-op weight|0|||
33692260|NCT02351934|63220454|FG000|Allocation|Hypotension preventing administration|2|||
33692261|NCT02351934|63220455|FG001|Allocation|Hypotension preventing administration|0|||
33692262|NCT02351934|63220454|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
33692263|NCT02351934|63220455|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
33692264|NCT02351934|63220454|FG000|Follow-Up|POD weight<pre-op weight|3|||
33692265|NCT02351934|63220455|FG001|Follow-Up|POD weight<pre-op weight|0|||
33692266|NCT02351934|63220454|FG000|Follow-Up|Acute Kidney Injury|1|||
33692267|NCT02351934|63220455|FG001|Follow-Up|Acute Kidney Injury|0|||
33692268|NCT02351934|63220454|FG000|Follow-Up|Early dismissal|3|||
33692269|NCT02351934|63220455|FG001|Follow-Up|Early dismissal|0|||
33692270|NCT02351934|63220454|FG000|Follow-Up|Hypotension|3|||
33692271|NCT02351934|63220455|FG001|Follow-Up|Hypotension|0|||
33692272|NCT02351934|63220454|FG000|Follow-Up|No documentation|2|||
33692273|NCT02351934|63220455|FG001|Follow-Up|No documentation|0|||
33692274|NCT02351934|63220454|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
33692275|NCT02351934|63220455|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
33692276|NCT02351934|63220454|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
33692277|NCT02351934|63220455|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
33692278|NCT02351856|63220495|FG000|Overall Study|Adverse Event|2|||
33692279|NCT02351856|63220495|FG000|Overall Study|Physician Decision|5|||
33692280|NCT02351856|63220495|FG000|Overall Study|Study terminated by sponsor|1|||
33692281|NCT02349360|63220535|FG000|Overall Study|Withdrawal by Subject|0|||
33692282|NCT02349360|63220536|FG001|Overall Study|Withdrawal by Subject|1|||
33692283|NCT00551642|63220561|FG000|Treatment Period|Protocol Deviation|6|||
33692284|NCT00551642|63220562|FG001|Treatment Period|Protocol Deviation|11|||
33692285|NCT00551642|63220561|FG000|Treatment Period|Delivery device failure|1|||
33692286|NCT00551642|63220562|FG001|Treatment Period|Delivery device failure|3|||
33692287|NCT00551642|63220561|FG000|Treatment Period|Physician Decision|0|||
33692288|NCT00551642|63220562|FG001|Treatment Period|Physician Decision|1|||
33692289|NCT00551642|63220561|FG000|Treatment Period|Death|33|||
33692290|NCT00551642|63220562|FG001|Treatment Period|Death|31|||
33692291|NCT00551642|63220561|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
33692292|NCT00551642|63220562|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
33692293|NCT00551642|63220561|FG000|Treatment Period|Adverse Event|15|||
33692294|NCT00551642|63220562|FG001|Treatment Period|Adverse Event|12|||
33692295|NCT00551642|63220561|FG000|Treatment Period|Withdrawal by Subject|2|||
33692296|NCT00551642|63220562|FG001|Treatment Period|Withdrawal by Subject|1|||
33692297|NCT00550550|63220656|FG000|Overall Study|Adverse Event|13|||
33692298|NCT00550550|63220657|FG001|Overall Study|Adverse Event|5|||
33692299|NCT00550550|63220656|FG000|Overall Study|Treatment Failure|0|||
33692300|NCT00550550|63220657|FG001|Overall Study|Treatment Failure|1|||
33692301|NCT00550550|63220656|FG000|Overall Study|Lost to Follow-up|4|||
33692302|NCT00550550|63220657|FG001|Overall Study|Lost to Follow-up|0|||
33692303|NCT00550550|63220656|FG000|Overall Study|Withdrawal by Subject|10|||
33692304|NCT00550550|63220657|FG001|Overall Study|Withdrawal by Subject|8|||
33692305|NCT00550550|63220656|FG000|Overall Study|Protocol Violation|5|||
33692306|NCT00550550|63220657|FG001|Overall Study|Protocol Violation|14|||
33692307|NCT00550550|63220656|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
33692308|NCT00550550|63220657|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
33692309|NCT00550550|63220656|FG000|Overall Study|Randomized But Not Treated|1|||
33692310|NCT00550550|63220657|FG001|Overall Study|Randomized But Not Treated|0|||
33692311|NCT02301156|63220708|FG000|Overall Study|Adverse Event|13|||
33692312|NCT02301156|63220709|FG001|Overall Study|Adverse Event|14|||
33692313|NCT02301156|63220708|FG000|Overall Study|Death|1|||
33692314|NCT02301156|63220709|FG001|Overall Study|Death|5|||
33692315|NCT02301156|63220708|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
33692316|NCT02301156|63220709|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
33692317|NCT02301156|63220708|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
33692318|NCT02301156|63220709|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
33692319|NCT02301156|63220708|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
33692320|NCT02301156|63220709|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
33692321|NCT02301156|63220708|FG000|Overall Study|Reason not Specified|6|||
33692322|NCT02301156|63220709|FG001|Overall Study|Reason not Specified|3|||
33692323|NCT02301390|63220790|FG000|Overall Study|Withdrawal by Subject|3|||
33692324|NCT02301390|63220791|FG001|Overall Study|Withdrawal by Subject|5|||
33692325|NCT02301390|63220790|FG000|Overall Study|Protocol Violation|1|||
33692326|NCT02301390|63220791|FG001|Overall Study|Protocol Violation|0|||
33692327|NCT02301390|63220790|FG000|Overall Study|Physician Decision|1|||
33692328|NCT02301390|63220791|FG001|Overall Study|Physician Decision|0|||
33692329|NCT02301390|63220790|FG000|Overall Study|Lost to Follow-up|0|||
33692330|NCT02301390|63220791|FG001|Overall Study|Lost to Follow-up|1|||
33692331|NCT02301390|63220790|FG000|Overall Study|Death|2|||
33692332|NCT02301390|63220791|FG001|Overall Study|Death|2|||
33692333|NCT02301390|63220790|FG000|Overall Study|Procedure not completed|0|||
33692334|NCT02301390|63220791|FG001|Overall Study|Procedure not completed|4|||
33692335|NCT02301390|63220790|FG000|Overall Study|Missed multiple visits|1|||
33692336|NCT02301390|63220791|FG001|Overall Study|Missed multiple visits|1|||
33692337|NCT02301390|63220790|FG000|Overall Study|study terminated|2|||
33692338|NCT02301390|63220791|FG001|Overall Study|study terminated|0|||
33692339|NCT02300610|63220908|FG000|Overall Study|Withdrawal by Subject|1|||
33692340|NCT02300610|63220909|FG001|Overall Study|Withdrawal by Subject|0|||
33692341|NCT02300610|63220910|FG002|Overall Study|Withdrawal by Subject|1|||
33692342|NCT02300298|63220955|FG000|Disposition for Nintedanib|Progressive disease|10|||
33692343|NCT02300298|63220956|FG001|Disposition for Nintedanib|Progressive disease|0|||
33692344|NCT02300298|63220955|FG000|Disposition for Docetaxel|Progressive disease|0|||
33692345|NCT02300298|63220956|FG001|Disposition for Docetaxel|Progressive disease|6|||
33692346|NCT02300298|63220955|FG000|Disposition for Docetaxel|other adverse event|0|||
33692347|NCT02300298|63220956|FG001|Disposition for Docetaxel|other adverse event|4|||
33692348|NCT02300220|63220962|FG000|Overall Study|Lost to Follow-up|1|||
33692349|NCT02300220|63220963|FG001|Overall Study|Lost to Follow-up|2|||
33692350|NCT02300220|63220962|FG000|Overall Study|Death|1|||
33692351|NCT02300220|63220963|FG001|Overall Study|Death|1|||
33692352|NCT02300220|63220962|FG000|Overall Study|Adverse Event|1|||
33692353|NCT02300220|63220963|FG001|Overall Study|Adverse Event|1|||
33692354|NCT02300220|63220962|FG000|Overall Study|Protocol Violation|1|||
33692355|NCT02300220|63220963|FG001|Overall Study|Protocol Violation|0|||
33692356|NCT02300220|63220962|FG000|Overall Study|Withdrawal by Subject|0|||
33692357|NCT02300220|63220963|FG001|Overall Study|Withdrawal by Subject|2|||
33692358|NCT02300220|63220962|FG000|Overall Study|Did not tolerate IMP|0|||
33692359|NCT02300220|63220963|FG001|Overall Study|Did not tolerate IMP|1|||
33692360|NCT02327130|63220987|FG000|Overall Study|Discharged in less than 5 days|5|||
33692361|NCT02327130|63220987|FG000|Overall Study|Physician Decision|2|||
33692362|NCT02327130|63220987|FG000|Overall Study|Unable to provide breath sample|1|||
33692363|NCT02327130|63220987|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
33692364|NCT02327130|63220987|FG000|Overall Study|Met exclusion criteria|3|||
33692365|NCT02326272|63221042|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33692366|NCT02326272|63221043|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
33692367|NCT02326272|63221044|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
33692368|NCT02326272|63221045|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33692369|NCT02326272|63221046|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33692370|NCT02326272|63221047|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33692371|NCT02326272|63221048|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33692372|NCT02326272|63221049|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33692373|NCT02326272|63221050|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33692374|NCT02326272|63221051|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33692375|NCT02326272|63221052|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33692376|NCT02326272|63221053|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33692377|NCT02326272|63221054|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33692378|NCT02326272|63221055|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33692379|NCT02326272|63221056|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33692380|NCT02326272|63221042|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
33692381|NCT02326272|63221043|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
33692382|NCT02326272|63221044|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33692383|NCT02326272|63221045|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33692384|NCT02326272|63221046|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33692385|NCT02326272|63221047|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33692386|NCT02326272|63221048|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33692387|NCT02326272|63221049|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33692388|NCT02326272|63221050|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33692389|NCT02326272|63221051|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33692390|NCT02326272|63221052|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33692391|NCT02326272|63221053|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33692392|NCT02326272|63221054|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33692393|NCT02326272|63221055|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33692394|NCT02326272|63221056|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33692395|NCT02326272|63221042|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
33692396|NCT02326272|63221043|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
33692397|NCT02326272|63221044|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
33692398|NCT02326272|63221045|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33692399|NCT02326272|63221046|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33692400|NCT02326272|63221047|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33692401|NCT02326272|63221048|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33692402|NCT02326272|63221049|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33692403|NCT02326272|63221050|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33692404|NCT02326272|63221051|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33692405|NCT02326272|63221052|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33692406|NCT02326272|63221053|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33692407|NCT02326272|63221054|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33692408|NCT02326272|63221055|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33692409|NCT02326272|63221056|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33692410|NCT02326272|63221042|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33692411|NCT02326272|63221043|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33692412|NCT02326272|63221044|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
33692413|NCT02326272|63221045|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33692414|NCT02326272|63221046|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33692415|NCT02326272|63221047|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33692416|NCT02326272|63221048|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33692417|NCT02326272|63221049|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33692418|NCT02326272|63221050|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33692419|NCT02326272|63221051|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33692420|NCT02326272|63221052|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33692421|NCT02326272|63221053|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33692422|NCT02326272|63221054|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33692423|NCT02326272|63221055|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33692424|NCT02326272|63221056|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33692425|NCT02326272|63221042|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33692426|NCT02326272|63221043|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33692427|NCT02326272|63221044|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
33692428|NCT02326272|63221045|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33692429|NCT02326272|63221046|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33692430|NCT02326272|63221047|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33692431|NCT02326272|63221048|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33692432|NCT02326272|63221049|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33692433|NCT02326272|63221050|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33692434|NCT02326272|63221051|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33692435|NCT02326272|63221052|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33692436|NCT02326272|63221053|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33692437|NCT02326272|63221054|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33692438|NCT02326272|63221055|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33692439|NCT02326272|63221056|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33692440|NCT02326272|63221042|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33692441|NCT02326272|63221043|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33692442|NCT02326272|63221044|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
33692443|NCT02326272|63221045|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33692444|NCT02326272|63221046|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33692445|NCT02326272|63221047|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33692446|NCT02326272|63221048|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33692447|NCT02326272|63221049|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33692448|NCT02326272|63221050|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33692449|NCT02326272|63221051|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33692450|NCT02326272|63221052|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33692451|NCT02326272|63221053|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33692452|NCT02326272|63221054|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33692453|NCT02326272|63221055|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33692454|NCT02326272|63221056|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33692455|NCT02326272|63221042|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33692456|NCT02326272|63221043|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33692457|NCT02326272|63221044|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
33692458|NCT02326272|63221045|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33692459|NCT02326272|63221046|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33692460|NCT02326272|63221047|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33692461|NCT02326272|63221048|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33692462|NCT02326272|63221049|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33692463|NCT02326272|63221050|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33692464|NCT02326272|63221051|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33692465|NCT02326272|63221052|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33692466|NCT02326272|63221053|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33692467|NCT02326272|63221054|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33692468|NCT02326272|63221055|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33692469|NCT02326272|63221056|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33692470|NCT02326272|63221042|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33692471|NCT02326272|63221043|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33692472|NCT02326272|63221044|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33692473|NCT02326272|63221045|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33692474|NCT02326272|63221046|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
33692475|NCT02326272|63221047|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
33692476|NCT02326272|63221048|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
33692477|NCT02326272|63221049|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
33692478|NCT02326272|63221050|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
33692479|NCT02326272|63221051|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33692480|NCT02326272|63221052|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33692481|NCT02326272|63221053|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33692482|NCT02326272|63221054|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33692483|NCT02326272|63221055|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33692484|NCT02326272|63221056|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33692485|NCT02326272|63221042|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33692486|NCT02326272|63221043|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33692487|NCT02326272|63221044|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33692488|NCT02326272|63221045|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33692489|NCT02326272|63221046|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33692490|NCT02326272|63221047|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
33692491|NCT02326272|63221048|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
33692492|NCT02326272|63221049|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33692493|NCT02326272|63221050|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
33692494|NCT02326272|63221051|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
33692495|NCT02326272|63221052|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33692496|NCT02326272|63221053|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33692497|NCT02326272|63221054|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33692498|NCT02326272|63221055|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33692499|NCT02326272|63221056|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33692500|NCT02326272|63221042|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33692501|NCT02326272|63221043|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33692502|NCT02326272|63221044|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33692503|NCT02326272|63221045|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33692504|NCT02326272|63221046|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33692505|NCT02326272|63221047|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
33692506|NCT02326272|63221048|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33692507|NCT02326272|63221049|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
33692508|NCT02326272|63221050|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33692509|NCT02326272|63221051|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33692510|NCT02326272|63221052|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33692511|NCT02326272|63221053|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33692512|NCT02326272|63221054|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33692513|NCT02326272|63221055|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33692514|NCT02326272|63221056|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33692515|NCT02326272|63221042|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33692516|NCT02326272|63221043|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33692517|NCT02326272|63221044|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33692518|NCT02326272|63221045|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33692519|NCT02326272|63221046|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33692520|NCT02326272|63221047|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
33692521|NCT02326272|63221048|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33692522|NCT02326272|63221049|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33692523|NCT02326272|63221050|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33692524|NCT02326272|63221051|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33692525|NCT02326272|63221052|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33692526|NCT02326272|63221053|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33692527|NCT02326272|63221054|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33692528|NCT02326272|63221055|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33692529|NCT02326272|63221056|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33692530|NCT02326272|63221042|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33692531|NCT02326272|63221043|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33692532|NCT02326272|63221044|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33692533|NCT02326272|63221045|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33692534|NCT02326272|63221046|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33692535|NCT02326272|63221047|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33692536|NCT02326272|63221048|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33692537|NCT02326272|63221049|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
33692538|NCT02326272|63221050|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33692539|NCT02326272|63221051|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33692540|NCT02326272|63221052|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33692541|NCT02326272|63221053|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33692542|NCT02326272|63221054|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33692543|NCT02326272|63221055|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33692544|NCT02326272|63221056|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33692545|NCT02326272|63221042|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33692546|NCT02326272|63221043|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33692547|NCT02326272|63221044|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33692548|NCT02326272|63221045|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33692549|NCT02326272|63221046|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33692550|NCT02326272|63221047|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33692551|NCT02326272|63221048|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
33692552|NCT02326272|63221049|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33692553|NCT02326272|63221050|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33692554|NCT02326272|63221051|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33692555|NCT02326272|63221052|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33692556|NCT02326272|63221053|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33692557|NCT02326272|63221054|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33692558|NCT02326272|63221055|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33692559|NCT02326272|63221056|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33692560|NCT02326272|63221042|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33692561|NCT02326272|63221043|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33692562|NCT02326272|63221044|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33692563|NCT02326272|63221045|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33692564|NCT02326272|63221046|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33692565|NCT02326272|63221047|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33692566|NCT02326272|63221048|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33692567|NCT02326272|63221049|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33692568|NCT02326272|63221050|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
33692569|NCT02326272|63221051|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33692570|NCT02326272|63221052|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33692571|NCT02326272|63221053|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33692572|NCT02326272|63221054|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33692573|NCT02326272|63221055|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33692574|NCT02326272|63221056|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33692575|NCT02326272|63221042|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33692576|NCT02326272|63221043|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33692577|NCT02326272|63221044|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33692578|NCT02326272|63221045|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33692579|NCT02326272|63221046|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33692580|NCT02326272|63221047|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
33692581|NCT02326272|63221048|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
33692582|NCT02326272|63221049|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
33692583|NCT02326272|63221050|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
33692584|NCT02326272|63221051|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33692585|NCT02326272|63221052|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33692586|NCT02326272|63221053|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33692587|NCT02326272|63221054|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33692588|NCT02326272|63221055|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33692589|NCT02326272|63221056|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33692590|NCT02326272|63221042|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33692591|NCT02326272|63221043|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33692592|NCT02326272|63221044|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33692593|NCT02326272|63221045|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33692594|NCT02326272|63221046|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33692595|NCT02326272|63221047|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
33692596|NCT02326272|63221048|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33692597|NCT02326272|63221049|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33692598|NCT02326272|63221050|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33692599|NCT02326272|63221051|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33692600|NCT02326272|63221052|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33692601|NCT02326272|63221053|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33692602|NCT02326272|63221054|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33692603|NCT02326272|63221055|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33692604|NCT02326272|63221056|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33692605|NCT02326272|63221042|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33692606|NCT02326272|63221043|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33692607|NCT02326272|63221044|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33692608|NCT02326272|63221045|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33692609|NCT02326272|63221046|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33692610|NCT02326272|63221047|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33692611|NCT02326272|63221048|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
33692612|NCT02326272|63221049|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33692613|NCT02326272|63221050|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33692614|NCT02326272|63221051|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33692615|NCT02326272|63221052|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33692616|NCT02326272|63221053|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33692617|NCT02326272|63221054|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33692618|NCT02326272|63221055|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33692619|NCT02326272|63221056|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33692620|NCT02326272|63221042|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
33692621|NCT02326272|63221043|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
33692622|NCT02326272|63221044|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
33692623|NCT02326272|63221045|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
33692624|NCT02326272|63221046|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
33692625|NCT02326272|63221047|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
33692626|NCT02326272|63221048|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
33692627|NCT02326272|63221049|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
33692628|NCT02326272|63221050|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
33692629|NCT02326272|63221051|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
33692630|NCT02326272|63221052|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
33692631|NCT02326272|63221053|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
33692632|NCT02326272|63221054|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
33692633|NCT02326272|63221055|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
33692634|NCT02326272|63221056|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
33692635|NCT02326272|63221042|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33692636|NCT02326272|63221043|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33692637|NCT02326272|63221044|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33692638|NCT02326272|63221045|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33692639|NCT02326272|63221046|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33692640|NCT02326272|63221047|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33692641|NCT02326272|63221048|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33692642|NCT02326272|63221049|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33692643|NCT02326272|63221050|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33692644|NCT02326272|63221051|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33692645|NCT02326272|63221052|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
33692646|NCT02326272|63221053|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
33692647|NCT02326272|63221054|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
33692648|NCT02326272|63221055|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33692649|NCT02326272|63221056|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
33692650|NCT02326272|63221042|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33692651|NCT02326272|63221043|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33692652|NCT02326272|63221044|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33692653|NCT02326272|63221045|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33692654|NCT02326272|63221046|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33692655|NCT02326272|63221047|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33692656|NCT02326272|63221048|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33692657|NCT02326272|63221049|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33692658|NCT02326272|63221050|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33692659|NCT02326272|63221051|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33692660|NCT02326272|63221052|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
33692661|NCT02326272|63221053|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33692662|NCT02326272|63221054|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
33692663|NCT02326272|63221055|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33692664|NCT02326272|63221056|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33692665|NCT02326272|63221042|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33692666|NCT02326272|63221043|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33692667|NCT02326272|63221044|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33692668|NCT02326272|63221045|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33692669|NCT02326272|63221046|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33692670|NCT02326272|63221047|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33692671|NCT02326272|63221048|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33692672|NCT02326272|63221049|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33692673|NCT02326272|63221050|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33692674|NCT02326272|63221051|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33692675|NCT02326272|63221052|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33692676|NCT02326272|63221053|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
33692677|NCT02326272|63221054|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33692678|NCT02326272|63221055|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33692679|NCT02326272|63221056|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33692680|NCT02326272|63221042|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33692681|NCT02326272|63221043|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33692682|NCT02326272|63221044|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33692683|NCT02326272|63221045|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33692684|NCT02326272|63221046|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33692685|NCT02326272|63221047|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33692686|NCT02326272|63221048|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33692687|NCT02326272|63221049|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33692688|NCT02326272|63221050|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33692689|NCT02326272|63221051|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33692690|NCT02326272|63221052|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
33692691|NCT02326272|63221053|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33692692|NCT02326272|63221054|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
33692693|NCT02326272|63221055|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33692694|NCT02326272|63221056|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
33692695|NCT02326272|63221042|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33692696|NCT02326272|63221043|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33692697|NCT02326272|63221044|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33692698|NCT02326272|63221045|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33692699|NCT02326272|63221046|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33692700|NCT02326272|63221047|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33692701|NCT02326272|63221048|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33692702|NCT02326272|63221049|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33692703|NCT02326272|63221050|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33692704|NCT02326272|63221051|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33692705|NCT02326272|63221052|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33692706|NCT02326272|63221053|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
33692707|NCT02326272|63221054|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33692708|NCT02326272|63221055|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33692709|NCT02326272|63221056|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
33692710|NCT02326272|63221042|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33692711|NCT02326272|63221043|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33692712|NCT02326272|63221044|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33692713|NCT02326272|63221045|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33692714|NCT02326272|63221046|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33692715|NCT02326272|63221047|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33692716|NCT02326272|63221048|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33692717|NCT02326272|63221049|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33692718|NCT02326272|63221050|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33692719|NCT02326272|63221051|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33692720|NCT02326272|63221052|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33692721|NCT02326272|63221053|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
33692722|NCT02326272|63221054|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
33692723|NCT02326272|63221055|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33692724|NCT02326272|63221056|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
33692725|NCT02326272|63221042|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33692726|NCT02326272|63221043|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33692727|NCT02326272|63221044|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33692728|NCT02326272|63221045|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33692729|NCT02326272|63221046|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33692730|NCT02326272|63221047|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33692731|NCT02326272|63221048|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33692732|NCT02326272|63221049|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33692733|NCT02326272|63221050|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33692734|NCT02326272|63221051|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33692735|NCT02326272|63221052|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33692736|NCT02326272|63221053|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
33692737|NCT02326272|63221054|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33692738|NCT02326272|63221055|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33692739|NCT02326272|63221056|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33692740|NCT02326272|63221042|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33692741|NCT02326272|63221043|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33692742|NCT02326272|63221044|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33692743|NCT02326272|63221045|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33692744|NCT02326272|63221046|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33692745|NCT02326272|63221047|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33692746|NCT02326272|63221048|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33692747|NCT02326272|63221049|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33692748|NCT02326272|63221050|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33692749|NCT02326272|63221051|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33692750|NCT02326272|63221052|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33692751|NCT02326272|63221053|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33692752|NCT02326272|63221054|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
33692753|NCT02326272|63221055|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33692754|NCT02326272|63221056|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33692755|NCT02325414|63221093|FG000|Overall Study|Withdrawal by Subject|3|||
33692756|NCT02325414|63221094|FG001|Overall Study|Withdrawal by Subject|1|||
33692757|NCT02325414|63221093|FG000|Overall Study|Lost to Follow-up|5|||
33692758|NCT02325414|63221094|FG001|Overall Study|Lost to Follow-up|5|||
33692759|NCT02349048|63221112|FG000|Overall Study|Withdrawal by Subject|4|||
33692760|NCT02349048|63221113|FG001|Overall Study|Withdrawal by Subject|0|||
33692761|NCT02349048|63221112|FG000|Overall Study|Lost to Follow-up|1|||
33692762|NCT02349048|63221113|FG001|Overall Study|Lost to Follow-up|0|||
33692763|NCT02299206|63221160|FG000|Overall Study|Lost to Follow-up|1|||
33692764|NCT02299206|63221160|FG000|Overall Study|Withdrawal by Subject|1|||
33692765|NCT02298192|63221179|FG000|Overall Study|Unclassified|3|||
33692766|NCT02298192|63221180|FG001|Overall Study|Unclassified|2|||
33692767|NCT02298192|63221179|FG000|Overall Study|Withdrawal criteria|2|||
33692768|NCT02298192|63221180|FG001|Overall Study|Withdrawal criteria|0|||
33692769|NCT02298192|63221179|FG000|Overall Study|Withdrawal by Subject|6|||
33692770|NCT02298192|63221180|FG001|Overall Study|Withdrawal by Subject|1|||
33692771|NCT02298192|63221179|FG000|Overall Study|Lost to Follow-up|2|||
33692772|NCT02298192|63221180|FG001|Overall Study|Lost to Follow-up|1|||
33692773|NCT02298192|63221179|FG000|Overall Study|Adverse Event|6|||
33692774|NCT02298192|63221180|FG001|Overall Study|Adverse Event|2|||
33692775|NCT02280408|63221306|FG000|Overall Study|Lost to Follow-up|0|||
33692776|NCT02280408|63221307|FG001|Overall Study|Lost to Follow-up|2|||
33692777|NCT02280408|63221308|FG002|Overall Study|Lost to Follow-up|0|||
33692778|NCT02280408|63221309|FG003|Overall Study|Lost to Follow-up|0|||
33692779|NCT02296476|63221385|FG000|Overall Study|Disease Progression|6|||
33692780|NCT02296476|63221386|FG001|Overall Study|Disease Progression|4|||
33692781|NCT02296476|63221387|FG002|Overall Study|Disease Progression|2|||
33692782|NCT00552032|63221428|FG000|Overall Study|Withdrawal by Subject|2|||
33692783|NCT00552032|63221429|FG001|Overall Study|Withdrawal by Subject|2|||
33692784|NCT00552032|63221428|FG000|Overall Study|Protocol Violation|7|||
33692785|NCT00552032|63221429|FG001|Overall Study|Protocol Violation|12|||
33692786|NCT00552032|63221428|FG000|Overall Study|Lost to Follow-up|8|||
33692787|NCT00552032|63221429|FG001|Overall Study|Lost to Follow-up|5|||
33692788|NCT03312530|63222236|FG000|Overall Study|Death|5|||
33692789|NCT03312530|63222237|FG001|Overall Study|Death|5|||
33692790|NCT03312530|63222238|FG002|Overall Study|Death|4|||
33692791|NCT03312530|63222239|FG003|Overall Study|Death|10|||
33692792|NCT03312530|63222240|FG004|Overall Study|Death|8|||
33692793|NCT03312530|63222236|FG000|Overall Study|Lost to Follow-up|0|||
33692794|NCT03312530|63222237|FG001|Overall Study|Lost to Follow-up|0|||
33692795|NCT03312530|63222238|FG002|Overall Study|Lost to Follow-up|0|||
33692796|NCT03312530|63222239|FG003|Overall Study|Lost to Follow-up|1|||
33692797|NCT03312530|63222240|FG004|Overall Study|Lost to Follow-up|0|||
33692798|NCT03312530|63222236|FG000|Overall Study|Participant in another sponsor study.|0|||
33692799|NCT03312530|63222237|FG001|Overall Study|Participant in another sponsor study.|0|||
33692800|NCT03312530|63222238|FG002|Overall Study|Participant in another sponsor study.|0|||
33692801|NCT03312530|63222239|FG003|Overall Study|Participant in another sponsor study.|1|||
33692802|NCT03312530|63222240|FG004|Overall Study|Participant in another sponsor study.|0|||
33692803|NCT03312530|63222236|FG000|Overall Study|Study terminated by sponsor|1|||
33692804|NCT03312530|63222237|FG001|Overall Study|Study terminated by sponsor|0|||
33692805|NCT03312530|63222238|FG002|Overall Study|Study terminated by sponsor|2|||
33692806|NCT03312530|63222239|FG003|Overall Study|Study terminated by sponsor|3|||
33692807|NCT03312530|63222240|FG004|Overall Study|Study terminated by sponsor|7|||
33692808|NCT03312530|63222236|FG000|Overall Study|Withdrawal by Subject|0|||
33692809|NCT03312530|63222237|FG001|Overall Study|Withdrawal by Subject|1|||
33692810|NCT03312530|63222238|FG002|Overall Study|Withdrawal by Subject|0|||
33692811|NCT03312530|63222239|FG003|Overall Study|Withdrawal by Subject|0|||
33692812|NCT03312530|63222240|FG004|Overall Study|Withdrawal by Subject|0|||
33692813|NCT03312530|63222236|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
33692814|NCT03312530|63222237|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
33692815|NCT03312530|63222238|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
33692816|NCT03312530|63222239|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
33692817|NCT03312530|63222240|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
33692818|NCT02296320|63222362|FG000|Overall Study|Withdrawal by Subject|4|||
33692819|NCT02296320|63222363|FG001|Overall Study|Withdrawal by Subject|0|||
33692820|NCT02296320|63222364|FG002|Overall Study|Withdrawal by Subject|2|||
33692821|NCT02296320|63222362|FG000|Overall Study|Death|24|||
33692822|NCT02296320|63222363|FG001|Overall Study|Death|3|||
33692823|NCT02296320|63222364|FG002|Overall Study|Death|27|||
33692824|NCT02296320|63222362|FG000|Overall Study|Lost to Follow-up|5|||
33692825|NCT02296320|63222363|FG001|Overall Study|Lost to Follow-up|2|||
33692826|NCT02296320|63222364|FG002|Overall Study|Lost to Follow-up|7|||
33692827|NCT02296320|63222362|FG000|Overall Study|Not treated|2|||
33692828|NCT02296320|63222363|FG001|Overall Study|Not treated|0|||
33692829|NCT02296320|63222364|FG002|Overall Study|Not treated|0|||
33692830|NCT02296320|63222362|FG000|Overall Study|Not - specified|0|||
33692831|NCT02296320|63222363|FG001|Overall Study|Not - specified|0|||
33692832|NCT02296320|63222364|FG002|Overall Study|Not - specified|1|||
33692833|NCT02296242|63222403|FG000|Overall Study|Death|1|||
33692834|NCT02296242|63222404|FG001|Overall Study|Death|1|||
33692835|NCT02296242|63222405|FG002|Overall Study|Death|1|||
33692836|NCT02296242|63222406|FG003|Overall Study|Death|1|||
33692837|NCT02296242|63222407|FG004|Overall Study|Death|1|||
33692838|NCT02296242|63222403|FG000|Overall Study|Withdrawal by Subject|0|||
33692839|NCT02296242|63222404|FG001|Overall Study|Withdrawal by Subject|0|||
33692840|NCT02296242|63222405|FG002|Overall Study|Withdrawal by Subject|1|||
33692841|NCT02296242|63222406|FG003|Overall Study|Withdrawal by Subject|1|||
33692842|NCT02296242|63222407|FG004|Overall Study|Withdrawal by Subject|3|||
33692843|NCT02296242|63222403|FG000|Overall Study|Disease Progression|1|||
33692844|NCT02296242|63222404|FG001|Overall Study|Disease Progression|3|||
33692845|NCT02296242|63222405|FG002|Overall Study|Disease Progression|2|||
33692846|NCT02296242|63222406|FG003|Overall Study|Disease Progression|8|||
33692847|NCT02296242|63222407|FG004|Overall Study|Disease Progression|11|||
33692848|NCT02296242|63222403|FG000|Overall Study|Unacceptable Toxicity|0|||
33692849|NCT02296242|63222404|FG001|Overall Study|Unacceptable Toxicity|0|||
33692850|NCT02296242|63222405|FG002|Overall Study|Unacceptable Toxicity|0|||
33692851|NCT02296242|63222406|FG003|Overall Study|Unacceptable Toxicity|0|||
33692852|NCT02296242|63222407|FG004|Overall Study|Unacceptable Toxicity|1|||
33692853|NCT02296242|63222403|FG000|Overall Study|Patient Condition Changed|0|||
33692854|NCT02296242|63222404|FG001|Overall Study|Patient Condition Changed|0|||
33692855|NCT02296242|63222405|FG002|Overall Study|Patient Condition Changed|2|||
33692856|NCT02296242|63222406|FG003|Overall Study|Patient Condition Changed|0|||
33692857|NCT02296242|63222407|FG004|Overall Study|Patient Condition Changed|1|||
33692858|NCT02296242|63222403|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
33692859|NCT02296242|63222404|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
33692860|NCT02296242|63222405|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
33692861|NCT02296242|63222406|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
33692862|NCT02296242|63222407|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
33692863|NCT02296242|63222403|FG000|Overall Study|Lost to Follow-up|1|||
33692864|NCT02296242|63222404|FG001|Overall Study|Lost to Follow-up|0|||
33692865|NCT02296242|63222405|FG002|Overall Study|Lost to Follow-up|0|||
33692866|NCT02296242|63222406|FG003|Overall Study|Lost to Follow-up|0|||
33692867|NCT02296242|63222407|FG004|Overall Study|Lost to Follow-up|0|||
33692868|NCT02296242|63222403|FG000|Overall Study|Need for Hydroxyurea|2|||
33692869|NCT02296242|63222404|FG001|Overall Study|Need for Hydroxyurea|0|||
33692870|NCT02296242|63222405|FG002|Overall Study|Need for Hydroxyurea|0|||
33692871|NCT02296242|63222406|FG003|Overall Study|Need for Hydroxyurea|0|||
33692872|NCT02296242|63222407|FG004|Overall Study|Need for Hydroxyurea|0|||
33692873|NCT02296242|63222403|FG000|Overall Study|Screened for Other Protocol|0|||
33692874|NCT02296242|63222404|FG001|Overall Study|Screened for Other Protocol|1|||
33692875|NCT02296242|63222405|FG002|Overall Study|Screened for Other Protocol|0|||
33692876|NCT02296242|63222406|FG003|Overall Study|Screened for Other Protocol|0|||
33692877|NCT02296242|63222407|FG004|Overall Study|Screened for Other Protocol|0|||
33692878|NCT02296242|63222403|FG000|Overall Study|Physician Decision|0|||
33692879|NCT02296242|63222404|FG001|Overall Study|Physician Decision|1|||
33692880|NCT02296242|63222405|FG002|Overall Study|Physician Decision|0|||
33692881|NCT02296242|63222406|FG003|Overall Study|Physician Decision|1|||
33692882|NCT02296242|63222407|FG004|Overall Study|Physician Decision|0|||
33692883|NCT02296242|63222403|FG000|Overall Study|Alternative Treatment|0|||
33692884|NCT02296242|63222404|FG001|Overall Study|Alternative Treatment|0|||
33692885|NCT02296242|63222405|FG002|Overall Study|Alternative Treatment|0|||
33692886|NCT02296242|63222406|FG003|Overall Study|Alternative Treatment|1|||
33692887|NCT02296242|63222407|FG004|Overall Study|Alternative Treatment|0|||
33692888|NCT02296242|63222403|FG000|Overall Study|Adverse Event|0|||
33692889|NCT02296242|63222404|FG001|Overall Study|Adverse Event|0|||
33692890|NCT02296242|63222405|FG002|Overall Study|Adverse Event|0|||
33692891|NCT02296242|63222406|FG003|Overall Study|Adverse Event|1|||
33692892|NCT02296242|63222407|FG004|Overall Study|Adverse Event|0|||
33692893|NCT02296242|63222403|FG000|Overall Study|Lack of Efficacy|0|||
33692894|NCT02296242|63222404|FG001|Overall Study|Lack of Efficacy|0|||
33692895|NCT02296242|63222405|FG002|Overall Study|Lack of Efficacy|0|||
33692896|NCT02296242|63222406|FG003|Overall Study|Lack of Efficacy|0|||
33692897|NCT02296242|63222407|FG004|Overall Study|Lack of Efficacy|3|||
33692898|NCT02295774|63222427|FG000|Overall Study|Physician Decision|1|||
33692899|NCT02295774|63222427|FG000|Overall Study|Withdrawal by Subject|2|||
33692900|NCT02294682|63222442|FG000|Overall Study|Could not swallow pills|1|||
33692901|NCT02294682|63222443|FG001|Overall Study|Could not swallow pills|0|||
33692902|NCT02294604|63222452|FG000|Overall Study|Did not provide samples for culture|0|||
33692903|NCT02294604|63222453|FG001|Overall Study|Did not provide samples for culture|1|||
33692904|NCT02294604|63222454|FG002|Overall Study|Did not provide samples for culture|0|||
33692905|NCT02294604|63222452|FG000|Overall Study|Culture contamination|1|||
33692906|NCT02294604|63222453|FG001|Overall Study|Culture contamination|2|||
33692907|NCT02294604|63222454|FG002|Overall Study|Culture contamination|0|||
33692908|NCT01645176|63222473|FG000|Overall Study|Lack of Efficacy|4|||
33692909|NCT01645176|63222473|FG000|Overall Study|did not complete final MRI|1|||
33692910|NCT02322216|63222488|FG000|Overall Study|Adverse Event|1|||
33692911|NCT02322216|63222489|FG001|Overall Study|Adverse Event|0|||
33692912|NCT02322216|63222488|FG000|Overall Study|Withdrawal by Subject|1|||
33692913|NCT02322216|63222489|FG001|Overall Study|Withdrawal by Subject|4|||
33692914|NCT01647516|63222530|FG000|Induction Period (IP)|Physician Decision|2|||
33692915|NCT01647516|63222531|FG001|Induction Period (IP)|Physician Decision|0|||
33692916|NCT01647516|63222532|FG002|Induction Period (IP)|Physician Decision|0|||
33692917|NCT01647516|63222533|FG003|Induction Period (IP)|Physician Decision|0|||
33692918|NCT01647516|63222534|FG004|Induction Period (IP)|Physician Decision|0|||
33692919|NCT01647516|63222535|FG005|Induction Period (IP)|Physician Decision|0|||
33692920|NCT01647516|63222530|FG000|Induction Period (IP)|Adverse Event|1|||
33692921|NCT01647516|63222531|FG001|Induction Period (IP)|Adverse Event|2|||
33692922|NCT01647516|63222532|FG002|Induction Period (IP)|Adverse Event|0|||
33692923|NCT01647516|63222533|FG003|Induction Period (IP)|Adverse Event|0|||
33692924|NCT01647516|63222534|FG004|Induction Period (IP)|Adverse Event|0|||
33692925|NCT01647516|63222535|FG005|Induction Period (IP)|Adverse Event|0|||
33692926|NCT01647516|63222530|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
33692927|NCT01647516|63222531|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
33692928|NCT01647516|63222532|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
33692929|NCT01647516|63222533|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
33692930|NCT01647516|63222534|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
33692931|NCT01647516|63222535|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
33692932|NCT01647516|63222530|FG000|Induction Period (IP)|Participant Choice|0|||
33692933|NCT01647516|63222531|FG001|Induction Period (IP)|Participant Choice|0|||
33692934|NCT01647516|63222532|FG002|Induction Period (IP)|Participant Choice|1|||
33692935|NCT01647516|63222533|FG003|Induction Period (IP)|Participant Choice|0|||
33692936|NCT01647516|63222534|FG004|Induction Period (IP)|Participant Choice|0|||
33692937|NCT01647516|63222535|FG005|Induction Period (IP)|Participant Choice|0|||
33692938|NCT01647516|63222530|FG000|Induction Period (IP)|Lack of Efficacy|1|||
33692939|NCT01647516|63222531|FG001|Induction Period (IP)|Lack of Efficacy|0|||
33692940|NCT01647516|63222532|FG002|Induction Period (IP)|Lack of Efficacy|0|||
33692941|NCT01647516|63222533|FG003|Induction Period (IP)|Lack of Efficacy|0|||
33692942|NCT01647516|63222534|FG004|Induction Period (IP)|Lack of Efficacy|0|||
33692943|NCT01647516|63222535|FG005|Induction Period (IP)|Lack of Efficacy|0|||
33692944|NCT01647516|63222530|FG000|Induction Period (IP)|No study drug received|1|||
33692945|NCT01647516|63222531|FG001|Induction Period (IP)|No study drug received|1|||
33692946|NCT01647516|63222532|FG002|Induction Period (IP)|No study drug received|0|||
33692947|NCT01647516|63222533|FG003|Induction Period (IP)|No study drug received|0|||
33692948|NCT01647516|63222534|FG004|Induction Period (IP)|No study drug received|0|||
33692949|NCT01647516|63222535|FG005|Induction Period (IP)|No study drug received|0|||
33692950|NCT01647516|63222530|FG000|Maintenance Period (MP)|Adverse Event|2|||
33692951|NCT01647516|63222531|FG001|Maintenance Period (MP)|Adverse Event|1|||
33692952|NCT01647516|63222532|FG002|Maintenance Period (MP)|Adverse Event|0|||
33692953|NCT01647516|63222533|FG003|Maintenance Period (MP)|Adverse Event|0|||
33692954|NCT01647516|63222534|FG004|Maintenance Period (MP)|Adverse Event|0|||
33692955|NCT01647516|63222535|FG005|Maintenance Period (MP)|Adverse Event|0|||
33692956|NCT01647516|63222530|FG000|Maintenance Period (MP)|Non-compliance|1|||
33692957|NCT01647516|63222531|FG001|Maintenance Period (MP)|Non-compliance|0|||
33692958|NCT01647516|63222532|FG002|Maintenance Period (MP)|Non-compliance|0|||
33596203|NCT02107131|62995166|FG000|Overall Study|Protocol Violation|0|||
33596204|NCT02107131|62995167|FG001|Overall Study|Protocol Violation|4|||
33596205|NCT02106975|62995177|FG000|Overall Study|Death|25|||
33692959|NCT01647516|63222533|FG003|Maintenance Period (MP)|Non-compliance|0|||
33692960|NCT01647516|63222534|FG004|Maintenance Period (MP)|Non-compliance|0|||
33692961|NCT01647516|63222535|FG005|Maintenance Period (MP)|Non-compliance|0|||
33692962|NCT01647516|63222530|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
33692963|NCT01647516|63222531|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
33692964|NCT01647516|63222532|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
33692965|NCT01647516|63222533|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
33692966|NCT01647516|63222534|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
33692967|NCT01647516|63222535|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
33596206|NCT02106975|62995178|FG001|Overall Study|Death|39|||
33692968|NCT01647516|63222530|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
33692969|NCT01647516|63222531|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
33692970|NCT01647516|63222532|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
33692971|NCT01647516|63222533|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
33692972|NCT01647516|63222534|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
33692973|NCT01647516|63222535|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
33692974|NCT01647516|63222530|FG000|Open-Label Period|Adverse Event|0|||
33692975|NCT01647516|63222531|FG001|Open-Label Period|Adverse Event|0|||
33692976|NCT01647516|63222532|FG002|Open-Label Period|Adverse Event|0|||
33692977|NCT01647516|63222533|FG003|Open-Label Period|Adverse Event|5|||
33692978|NCT01647516|63222534|FG004|Open-Label Period|Adverse Event|6|||
33692979|NCT01647516|63222535|FG005|Open-Label Period|Adverse Event|3|||
33692980|NCT01647516|63222530|FG000|Open-Label Period|Pregnancy|0|||
33692981|NCT01647516|63222531|FG001|Open-Label Period|Pregnancy|0|||
33692982|NCT01647516|63222532|FG002|Open-Label Period|Pregnancy|0|||
33692983|NCT01647516|63222533|FG003|Open-Label Period|Pregnancy|0|||
33692984|NCT01647516|63222534|FG004|Open-Label Period|Pregnancy|0|||
33692985|NCT01647516|63222535|FG005|Open-Label Period|Pregnancy|1|||
33692986|NCT01647516|63222530|FG000|Open-Label Period|Non-compliance|0|||
33692987|NCT01647516|63222531|FG001|Open-Label Period|Non-compliance|0|||
33692988|NCT01647516|63222532|FG002|Open-Label Period|Non-compliance|0|||
33692989|NCT01647516|63222533|FG003|Open-Label Period|Non-compliance|1|||
33692990|NCT01647516|63222534|FG004|Open-Label Period|Non-compliance|0|||
33692991|NCT01647516|63222535|FG005|Open-Label Period|Non-compliance|1|||
33692992|NCT01647516|63222530|FG000|Open-Label Period|Physician Decision|0|||
33692993|NCT01647516|63222531|FG001|Open-Label Period|Physician Decision|0|||
33692994|NCT01647516|63222532|FG002|Open-Label Period|Physician Decision|0|||
33692995|NCT01647516|63222533|FG003|Open-Label Period|Physician Decision|1|||
33692996|NCT01647516|63222534|FG004|Open-Label Period|Physician Decision|1|||
33692997|NCT01647516|63222535|FG005|Open-Label Period|Physician Decision|0|||
33692998|NCT01647516|63222530|FG000|Open-Label Period|Withdrawal by Subject|0|||
33692999|NCT01647516|63222531|FG001|Open-Label Period|Withdrawal by Subject|0|||
33693000|NCT01647516|63222532|FG002|Open-Label Period|Withdrawal by Subject|0|||
33693001|NCT01647516|63222533|FG003|Open-Label Period|Withdrawal by Subject|9|||
33693002|NCT01647516|63222534|FG004|Open-Label Period|Withdrawal by Subject|11|||
33693003|NCT01647516|63222535|FG005|Open-Label Period|Withdrawal by Subject|6|||
33693004|NCT01647516|63222530|FG000|Open-Label Period|Lost to Follow-up|0|||
33693005|NCT01647516|63222531|FG001|Open-Label Period|Lost to Follow-up|0|||
33693006|NCT01647516|63222532|FG002|Open-Label Period|Lost to Follow-up|0|||
33693007|NCT01647516|63222533|FG003|Open-Label Period|Lost to Follow-up|1|||
33693008|NCT01647516|63222534|FG004|Open-Label Period|Lost to Follow-up|0|||
33693009|NCT01647516|63222535|FG005|Open-Label Period|Lost to Follow-up|1|||
33693010|NCT01647516|63222530|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
33693011|NCT01647516|63222531|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
33693012|NCT01647516|63222532|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
33693013|NCT01647516|63222533|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
33693014|NCT01647516|63222534|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
33693015|NCT01647516|63222535|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
33693016|NCT01647516|63222530|FG000|Open-Label Period|Lack of Efficacy|0|||
33693017|NCT01647516|63222531|FG001|Open-Label Period|Lack of Efficacy|0|||
33693018|NCT01647516|63222532|FG002|Open-Label Period|Lack of Efficacy|0|||
33693019|NCT01647516|63222533|FG003|Open-Label Period|Lack of Efficacy|7|||
33693020|NCT01647516|63222534|FG004|Open-Label Period|Lack of Efficacy|9|||
33693021|NCT01647516|63222535|FG005|Open-Label Period|Lack of Efficacy|10|||
33693022|NCT01647516|63222530|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
33693023|NCT01647516|63222531|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
33693024|NCT01647516|63222532|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
33493187|NCT04364763|62871349|FG000|Overall Study|Death|1|||
33493188|NCT04364763|62871350|FG001|Overall Study|Death|2|||
33693025|NCT01647516|63222533|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
33693026|NCT01647516|63222534|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
33693027|NCT01647516|63222535|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
33693028|NCT01647516|63222530|FG000|Open-Label Period|No completion / discontinuation visit|0|||
33693029|NCT01647516|63222531|FG001|Open-Label Period|No completion / discontinuation visit|0|||
33693030|NCT01647516|63222532|FG002|Open-Label Period|No completion / discontinuation visit|0|||
33693031|NCT01647516|63222533|FG003|Open-Label Period|No completion / discontinuation visit|0|||
33693032|NCT01647516|63222534|FG004|Open-Label Period|No completion / discontinuation visit|2|||
33493189|NCT04364763|62871349|FG000|Overall Study|Lost to Follow-up|1|||
33693033|NCT01647516|63222535|FG005|Open-Label Period|No completion / discontinuation visit|1|||
33693034|NCT01647282|63222552|FG000|Overall Study|Physician Decision|7|||
33693035|NCT01647282|63222553|FG001|Overall Study|Physician Decision|5|||
33693036|NCT02321436|63222561|FG000|Overall Study|Withdrawal by Subject|1|||
33693037|NCT02321436|63222562|FG001|Overall Study|Withdrawal by Subject|0|||
33693038|NCT02321436|63222561|FG000|Overall Study|Lost to Follow-up|0|||
33693039|NCT02321436|63222562|FG001|Overall Study|Lost to Follow-up|1|||
33693040|NCT02319642|63222571|FG000|Overall Study|Adverse Event|2|||
33693041|NCT02319642|63222572|FG001|Overall Study|Adverse Event|4|||
33693042|NCT02319642|63222571|FG000|Overall Study|Lack of Efficacy|1|||
33693043|NCT02319642|63222572|FG001|Overall Study|Lack of Efficacy|1|||
33693044|NCT02319642|63222571|FG000|Overall Study|Withdrawal by Subject|1|||
33693045|NCT02319642|63222572|FG001|Overall Study|Withdrawal by Subject|1|||
33693046|NCT02280096|63222582|FG000|Overall Study|Pregnancy|1|||
33693047|NCT02280096|63222583|FG001|Overall Study|Pregnancy|0|||
33693048|NCT02280096|63222582|FG000|Overall Study|Functional neurological disorder|1|||
33693049|NCT02280096|63222583|FG001|Overall Study|Functional neurological disorder|0|||
33693050|NCT02280096|63222582|FG000|Overall Study|Lack of attachment|0|||
33693051|NCT02280096|63222583|FG001|Overall Study|Lack of attachment|1|||
33693052|NCT02279862|63222600|FG000|Overall Study|Study drug toxicity|3|||
33693053|NCT02279862|63222601|FG001|Overall Study|Study drug toxicity|6|||
33693054|NCT02279862|63222600|FG000|Overall Study|No longer meets criteria|0|||
33693055|NCT02279862|63222601|FG001|Overall Study|No longer meets criteria|1|||
33693056|NCT02279862|63222600|FG000|Overall Study|Administrative reason by sponsor|0|||
33693057|NCT02279862|63222601|FG001|Overall Study|Administrative reason by sponsor|1|||
33693058|NCT02279862|63222600|FG000|Overall Study|Disease progression|5|||
33693059|NCT02279862|63222601|FG001|Overall Study|Disease progression|2|||
33693060|NCT02279862|63222600|FG000|Overall Study|Study closed by sponsor|16|||
33693061|NCT02279862|63222601|FG001|Overall Study|Study closed by sponsor|13|||
33693062|NCT02279862|63222600|FG000|Overall Study|Other|1|||
33693063|NCT02279862|63222601|FG001|Overall Study|Other|2|||
33693064|NCT02279862|63222600|FG000|Overall Study|Withdrawal by Subject|1|||
33693065|NCT02279862|63222601|FG001|Overall Study|Withdrawal by Subject|0|||
33693066|NCT02318940|63222609|FG000|Overall Study|lost the record|1|||
33693067|NCT02318940|63222610|FG001|Overall Study|lost the record|0|||
33693068|NCT02294058|63222619|FG000|Overall Study|Adverse Event|16|||
33693069|NCT02294058|63222620|FG001|Overall Study|Adverse Event|7|||
33693070|NCT02294058|63222621|FG002|Overall Study|Adverse Event|13|||
33693071|NCT02294058|63222619|FG000|Overall Study|Lack of Efficacy|3|||
33693072|NCT02294058|63222620|FG001|Overall Study|Lack of Efficacy|3|||
33693073|NCT02294058|63222621|FG002|Overall Study|Lack of Efficacy|0|||
33693074|NCT02294058|63222619|FG000|Overall Study|Lost to Follow-up|1|||
33693075|NCT02294058|63222620|FG001|Overall Study|Lost to Follow-up|0|||
33693076|NCT02294058|63222621|FG002|Overall Study|Lost to Follow-up|2|||
33693077|NCT02294058|63222619|FG000|Overall Study|Withdrawal by Subject|10|||
33693078|NCT02294058|63222620|FG001|Overall Study|Withdrawal by Subject|14|||
33693079|NCT02294058|63222621|FG002|Overall Study|Withdrawal by Subject|13|||
33693080|NCT02294058|63222619|FG000|Overall Study|Physician Decision|2|||
33693081|NCT02294058|63222620|FG001|Overall Study|Physician Decision|1|||
33693082|NCT02294058|63222621|FG002|Overall Study|Physician Decision|0|||
33693083|NCT02294058|63222619|FG000|Overall Study|Miscellaneous|4|||
33693084|NCT02294058|63222620|FG001|Overall Study|Miscellaneous|1|||
33693085|NCT02294058|63222621|FG002|Overall Study|Miscellaneous|1|||
33693086|NCT05065619|63222632|FG000|Overall Study|Lost to Follow-up|1|||
33693087|NCT05065619|63222633|FG001|Overall Study|Lost to Follow-up|0|||
33693088|NCT05065619|63222632|FG000|Overall Study|Withdrawal by Subject|1|||
33693089|NCT05065619|63222633|FG001|Overall Study|Withdrawal by Subject|0|||
33693090|NCT02293902|63222642|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
33693091|NCT02293902|63222643|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
33693092|NCT02293902|63222644|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
33693093|NCT02293902|63222645|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
33693094|NCT02293902|63222646|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
33693095|NCT02293902|63222642|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
33693096|NCT02293902|63222643|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
33693097|NCT02293902|63222644|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
33693098|NCT02293902|63222645|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
33693099|NCT02293902|63222646|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
33693100|NCT02293902|63222642|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
33693101|NCT02293902|63222643|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
33693102|NCT02293902|63222644|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
33693103|NCT02293902|63222645|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
33693104|NCT02293902|63222646|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
33693105|NCT02293902|63222642|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
33693106|NCT02293902|63222643|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
33693107|NCT02293902|63222644|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
33693108|NCT02293902|63222645|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
33693109|NCT02293902|63222646|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
33693110|NCT02293902|63222642|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
33693111|NCT02293902|63222643|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
33693112|NCT02293902|63222644|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
33693113|NCT02293902|63222645|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
33693114|NCT02293902|63222646|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
33693115|NCT02278614|63222666|FG000|Overall Study|Withdrawal by Subject|3|||
33693116|NCT02278614|63222667|FG001|Overall Study|Withdrawal by Subject|5|||
33693117|NCT02278614|63222666|FG000|Overall Study|Adverse Event|1|||
33693118|NCT02278614|63222667|FG001|Overall Study|Adverse Event|0|||
33693119|NCT02278614|63222666|FG000|Overall Study|left eye was not eligible|1|||
33693120|NCT02278614|63222667|FG001|Overall Study|left eye was not eligible|0|||
33693121|NCT02318706|63222677|FG000|Double-blind Phase|Adverse Event|7|||
33693122|NCT02318706|63222678|FG001|Double-blind Phase|Adverse Event|4|||
33693123|NCT02318706|63222679|FG002|Double-blind Phase|Adverse Event|3|||
33693124|NCT02318706|63222680|FG003|Double-blind Phase|Adverse Event|10|||
33693125|NCT02318706|63222681|FG004|Double-blind Phase|Adverse Event|0|||
33693126|NCT02318706|63222677|FG000|Double-blind Phase|Lost to Follow-up|1|||
33693127|NCT02318706|63222678|FG001|Double-blind Phase|Lost to Follow-up|0|||
33693128|NCT02318706|63222679|FG002|Double-blind Phase|Lost to Follow-up|0|||
33693129|NCT02318706|63222680|FG003|Double-blind Phase|Lost to Follow-up|0|||
33693130|NCT02318706|63222681|FG004|Double-blind Phase|Lost to Follow-up|0|||
33693131|NCT02318706|63222677|FG000|Double-blind Phase|Protocol Violation|4|||
33693132|NCT02318706|63222678|FG001|Double-blind Phase|Protocol Violation|2|||
33693133|NCT02318706|63222679|FG002|Double-blind Phase|Protocol Violation|4|||
33693134|NCT02318706|63222680|FG003|Double-blind Phase|Protocol Violation|3|||
33693135|NCT02318706|63222681|FG004|Double-blind Phase|Protocol Violation|0|||
33693136|NCT02318706|63222677|FG000|Double-blind Phase|Withdrawal by Subject|9|||
33693137|NCT02318706|63222678|FG001|Double-blind Phase|Withdrawal by Subject|5|||
33693138|NCT02318706|63222679|FG002|Double-blind Phase|Withdrawal by Subject|7|||
33693139|NCT02318706|63222680|FG003|Double-blind Phase|Withdrawal by Subject|10|||
33693140|NCT02318706|63222681|FG004|Double-blind Phase|Withdrawal by Subject|0|||
33693141|NCT02318706|63222677|FG000|Double-blind Phase|Other|4|||
33693142|NCT02318706|63222678|FG001|Double-blind Phase|Other|1|||
33693143|NCT02318706|63222679|FG002|Double-blind Phase|Other|2|||
33693144|NCT02318706|63222680|FG003|Double-blind Phase|Other|1|||
33693145|NCT02318706|63222681|FG004|Double-blind Phase|Other|0|||
33693146|NCT02318706|63222677|FG000|Double-blind Phase|Death|0|||
33693147|NCT02318706|63222678|FG001|Double-blind Phase|Death|0|||
33693148|NCT02318706|63222679|FG002|Double-blind Phase|Death|2|||
33693149|NCT02318706|63222680|FG003|Double-blind Phase|Death|0|||
33693150|NCT02318706|63222681|FG004|Double-blind Phase|Death|0|||
33693151|NCT02318706|63222677|FG000|Open-label Extension Phase|Adverse Event|0|||
33693152|NCT02318706|63222678|FG001|Open-label Extension Phase|Adverse Event|0|||
33693153|NCT02318706|63222679|FG002|Open-label Extension Phase|Adverse Event|0|||
33693154|NCT02318706|63222680|FG003|Open-label Extension Phase|Adverse Event|0|||
33693155|NCT02318706|63222681|FG004|Open-label Extension Phase|Adverse Event|21|||
33693156|NCT02318706|63222677|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
33693157|NCT02318706|63222678|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
33693158|NCT02318706|63222679|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
33693159|NCT02318706|63222680|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
33693160|NCT02318706|63222681|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
33693161|NCT02318706|63222677|FG000|Open-label Extension Phase|Death|0|||
33693162|NCT02318706|63222678|FG001|Open-label Extension Phase|Death|0|||
33693163|NCT02318706|63222679|FG002|Open-label Extension Phase|Death|0|||
33693164|NCT02318706|63222680|FG003|Open-label Extension Phase|Death|0|||
33693165|NCT02318706|63222681|FG004|Open-label Extension Phase|Death|1|||
33693166|NCT02318706|63222677|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
33693167|NCT02318706|63222678|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
33693168|NCT02318706|63222679|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
33693169|NCT02318706|63222680|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
33693170|NCT02318706|63222681|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
33693171|NCT04583280|63222723|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
33693172|NCT04583280|63222724|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
33693173|NCT04489940|63222743|FG000|Overall Study|Other|2|||
33693174|NCT04489940|63222743|FG000|Overall Study|Withdrawal by Subject|2|||
33693175|NCT04489940|63222743|FG000|Overall Study|Death|5|||
33693176|NCT04489940|63222743|FG000|Overall Study|Lost to Follow-up|1|||
33693177|NCT04365257|63222749|FG000|Overall Study|Physician Decision|1|||
33693178|NCT04365257|63222750|FG001|Overall Study|Physician Decision|0|||
33693179|NCT04365257|63222749|FG000|Overall Study|Patient Noncompliance|1|||
33693180|NCT04365257|63222750|FG001|Overall Study|Patient Noncompliance|0|||
33693181|NCT04365257|63222749|FG000|Overall Study|Withdrawal by Subject|0|||
33693182|NCT04365257|63222750|FG001|Overall Study|Withdrawal by Subject|1|||
33693183|NCT03395223|63222782|FG000|Overall Study|Lost to Follow-up|3|||
33693184|NCT03395223|63222782|FG000|Overall Study|Other|1|||
33693185|NCT02864940|63222812|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
33693186|NCT02864940|63222813|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
33693187|NCT02756611|63222832|FG000|Overall Study|Death|70|||
33693188|NCT02756611|63222832|FG000|Overall Study|Withdrawal by Subject|2|||
33693189|NCT02756611|63222832|FG000|Overall Study|Lost to Follow-up|3|||
33693190|NCT02756611|63222832|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
33693191|NCT02756611|63222832|FG000|Overall Study|Other|10|||
33693192|NCT02624518|63222836|FG000|Overall Study|Physician Decision|1|||
33693193|NCT02287623|63222842|FG000|Overall Study|Protocol Violation|0|||
33693194|NCT02287623|63222843|FG001|Overall Study|Protocol Violation|1|||
33693195|NCT01794520|63222865|FG000|Overall Study|Adverse events- related to progression|0|||
33693196|NCT01794520|63222866|FG001|Overall Study|Adverse events- related to progression|0|||
33693197|NCT01794520|63222867|FG002|Overall Study|Adverse events- related to progression|1|||
33693198|NCT01794520|63222868|FG003|Overall Study|Adverse events- related to progression|2|||
33693199|NCT01794520|63222869|FG004|Overall Study|Adverse events- related to progression|0|||
33693200|NCT01794520|63222870|FG005|Overall Study|Adverse events- related to progression|1|||
33693201|NCT01794520|63222871|FG006|Overall Study|Adverse events- related to progression|0|||
33693202|NCT01794520|63222865|FG000|Overall Study|Adverse event- not related to progression|1|||
33693203|NCT01794520|63222866|FG001|Overall Study|Adverse event- not related to progression|1|||
33693204|NCT01794520|63222867|FG002|Overall Study|Adverse event- not related to progression|0|||
33693205|NCT01794520|63222868|FG003|Overall Study|Adverse event- not related to progression|0|||
33693206|NCT01794520|63222869|FG004|Overall Study|Adverse event- not related to progression|2|||
33693207|NCT01794520|63222870|FG005|Overall Study|Adverse event- not related to progression|0|||
33693208|NCT01794520|63222871|FG006|Overall Study|Adverse event- not related to progression|0|||
33693209|NCT01794520|63222865|FG000|Overall Study|Progressive disease|5|||
33693210|NCT01794520|63222866|FG001|Overall Study|Progressive disease|6|||
33693211|NCT01794520|63222867|FG002|Overall Study|Progressive disease|2|||
33693212|NCT01794520|63222868|FG003|Overall Study|Progressive disease|5|||
33693213|NCT01794520|63222869|FG004|Overall Study|Progressive disease|27|||
33693214|NCT01794520|63222870|FG005|Overall Study|Progressive disease|18|||
33693215|NCT01794520|63222871|FG006|Overall Study|Progressive disease|0|||
33693216|NCT01794520|63222865|FG000|Overall Study|Withdrew consent|0|||
33693217|NCT01794520|63222866|FG001|Overall Study|Withdrew consent|0|||
33693218|NCT01794520|63222867|FG002|Overall Study|Withdrew consent|1|||
33693219|NCT01794520|63222868|FG003|Overall Study|Withdrew consent|1|||
33693220|NCT01794520|63222869|FG004|Overall Study|Withdrew consent|0|||
33693221|NCT01794520|63222870|FG005|Overall Study|Withdrew consent|0|||
33693222|NCT01794520|63222871|FG006|Overall Study|Withdrew consent|0|||
33693223|NCT01794520|63222865|FG000|Overall Study|Lost to Follow-up|0|||
33693224|NCT01794520|63222866|FG001|Overall Study|Lost to Follow-up|0|||
33693225|NCT01794520|63222867|FG002|Overall Study|Lost to Follow-up|0|||
33693226|NCT01794520|63222868|FG003|Overall Study|Lost to Follow-up|0|||
33693227|NCT01794520|63222869|FG004|Overall Study|Lost to Follow-up|1|||
33693228|NCT01794520|63222870|FG005|Overall Study|Lost to Follow-up|0|||
33693229|NCT01794520|63222871|FG006|Overall Study|Lost to Follow-up|0|||
33693230|NCT01794520|63222865|FG000|Overall Study|Toxicity|0|||
33693231|NCT01794520|63222866|FG001|Overall Study|Toxicity|2|||
33693232|NCT01794520|63222867|FG002|Overall Study|Toxicity|0|||
33693233|NCT01794520|63222868|FG003|Overall Study|Toxicity|0|||
33693234|NCT01794520|63222869|FG004|Overall Study|Toxicity|0|||
33693235|NCT01794520|63222870|FG005|Overall Study|Toxicity|0|||
33693236|NCT01794520|63222871|FG006|Overall Study|Toxicity|0|||
33693237|NCT01794520|63222865|FG000|Overall Study|Study terminated by sponsor|0|||
33693238|NCT01794520|63222866|FG001|Overall Study|Study terminated by sponsor|0|||
33693239|NCT01794520|63222867|FG002|Overall Study|Study terminated by sponsor|1|||
33693240|NCT01794520|63222868|FG003|Overall Study|Study terminated by sponsor|0|||
33693241|NCT01794520|63222869|FG004|Overall Study|Study terminated by sponsor|1|||
33693242|NCT01794520|63222870|FG005|Overall Study|Study terminated by sponsor|0|||
33693243|NCT01794520|63222871|FG006|Overall Study|Study terminated by sponsor|7|||
33693244|NCT01794520|63222865|FG000|Overall Study|Death|0|||
33693245|NCT01794520|63222866|FG001|Overall Study|Death|0|||
33693246|NCT01794520|63222867|FG002|Overall Study|Death|0|||
33693247|NCT01794520|63222868|FG003|Overall Study|Death|0|||
33693248|NCT01794520|63222869|FG004|Overall Study|Death|1|||
33693249|NCT01794520|63222870|FG005|Overall Study|Death|0|||
33693250|NCT01794520|63222871|FG006|Overall Study|Death|22|||
33693251|NCT01794520|63222865|FG000|Overall Study|Other, not specified|0|||
33693252|NCT01794520|63222866|FG001|Overall Study|Other, not specified|0|||
33693253|NCT01794520|63222867|FG002|Overall Study|Other, not specified|1|||
33693254|NCT01794520|63222868|FG003|Overall Study|Other, not specified|1|||
33693255|NCT01794520|63222869|FG004|Overall Study|Other, not specified|4|||
33693256|NCT01794520|63222870|FG005|Overall Study|Other, not specified|1|||
33693257|NCT01794520|63222871|FG006|Overall Study|Other, not specified|2|||
33693258|NCT01774019|63222894|FG000|Overall Study|No longer meets protocol criteria|2|||
33693259|NCT01774019|63222895|FG001|Overall Study|No longer meets protocol criteria|0|||
33693260|NCT01774019|63222894|FG000|Overall Study|Withdrawal by Subject|1|||
33693261|NCT01774019|63222895|FG001|Overall Study|Withdrawal by Subject|0|||
33693262|NCT01774019|63222894|FG000|Overall Study|Surgery delayed > 120 days|1|||
33693263|NCT01774019|63222895|FG001|Overall Study|Surgery delayed > 120 days|0|||
33693264|NCT01774019|63222894|FG000|Overall Study|Patient refused surgery|1|||
33693265|NCT01774019|63222895|FG001|Overall Study|Patient refused surgery|1|||
33693266|NCT01774019|63222894|FG000|Overall Study|Unable to implant study device|1|||
33693267|NCT01774019|63222895|FG001|Overall Study|Unable to implant study device|0|||
33693268|NCT01774019|63222894|FG000|Overall Study|Lost to Follow-up|0|||
33693269|NCT01774019|63222895|FG001|Overall Study|Lost to Follow-up|3|||
33693270|NCT03251924|63223248|FG000|Overall Study|Disease Progression|6|||
33693271|NCT03251924|63223249|FG001|Overall Study|Disease Progression|6|||
33693272|NCT03251924|63223250|FG002|Overall Study|Disease Progression|7|||
33693273|NCT03251924|63223251|FG003|Overall Study|Disease Progression|8|||
33693274|NCT03251924|63223252|FG004|Overall Study|Disease Progression|8|||
33693275|NCT03251924|63223253|FG005|Overall Study|Disease Progression|7|||
33693276|NCT03251924|63223254|FG006|Overall Study|Disease Progression|6|||
33693277|NCT03251924|63223255|FG007|Overall Study|Disease Progression|10|||
33693278|NCT03251924|63223256|FG008|Overall Study|Disease Progression|6|||
33693279|NCT03251924|63223248|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
33693280|NCT03251924|63223249|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
33693281|NCT03251924|63223250|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
33693282|NCT03251924|63223251|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
33693283|NCT03251924|63223252|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
33693284|NCT03251924|63223253|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
33693285|NCT03251924|63223254|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
33693286|NCT03251924|63223255|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
33693287|NCT03251924|63223256|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
33693288|NCT03251924|63223248|FG000|Overall Study|Death|0|||
33693289|NCT03251924|63223249|FG001|Overall Study|Death|1|||
33693290|NCT03251924|63223250|FG002|Overall Study|Death|0|||
33693291|NCT03251924|63223251|FG003|Overall Study|Death|1|||
33693292|NCT03251924|63223252|FG004|Overall Study|Death|1|||
33693293|NCT03251924|63223253|FG005|Overall Study|Death|1|||
33693294|NCT03251924|63223254|FG006|Overall Study|Death|0|||
33693295|NCT03251924|63223255|FG007|Overall Study|Death|0|||
33693296|NCT03251924|63223256|FG008|Overall Study|Death|0|||
33693297|NCT03251924|63223248|FG000|Overall Study|Study Drug Toxicity|0|||
33693298|NCT03251924|63223249|FG001|Overall Study|Study Drug Toxicity|0|||
33693299|NCT03251924|63223250|FG002|Overall Study|Study Drug Toxicity|0|||
33693300|NCT03251924|63223251|FG003|Overall Study|Study Drug Toxicity|1|||
33693301|NCT03251924|63223252|FG004|Overall Study|Study Drug Toxicity|0|||
33693302|NCT03251924|63223253|FG005|Overall Study|Study Drug Toxicity|0|||
33693303|NCT03251924|63223254|FG006|Overall Study|Study Drug Toxicity|0|||
33693304|NCT03251924|63223255|FG007|Overall Study|Study Drug Toxicity|0|||
33693305|NCT03251924|63223256|FG008|Overall Study|Study Drug Toxicity|1|||
33693306|NCT03251924|63223248|FG000|Overall Study|Other Reasons|0|||
33693307|NCT03251924|63223249|FG001|Overall Study|Other Reasons|0|||
33693308|NCT03251924|63223250|FG002|Overall Study|Other Reasons|0|||
33596207|NCT02145429|62995186|FG000|Overall Study|Death|4|||
33693309|NCT03251924|63223251|FG003|Overall Study|Other Reasons|0|||
33693310|NCT03251924|63223252|FG004|Overall Study|Other Reasons|0|||
33693311|NCT03251924|63223253|FG005|Overall Study|Other Reasons|0|||
33693312|NCT03251924|63223254|FG006|Overall Study|Other Reasons|0|||
33693313|NCT03251924|63223255|FG007|Overall Study|Other Reasons|0|||
33693314|NCT03251924|63223256|FG008|Overall Study|Other Reasons|1|||
33693315|NCT03251924|63223248|FG000|Overall Study|Participant request to discontinue study treatment|0|||
33693316|NCT03251924|63223249|FG001|Overall Study|Participant request to discontinue study treatment|0|||
33693317|NCT03251924|63223250|FG002|Overall Study|Participant request to discontinue study treatment|0|||
33693318|NCT03251924|63223251|FG003|Overall Study|Participant request to discontinue study treatment|0|||
33693319|NCT03251924|63223252|FG004|Overall Study|Participant request to discontinue study treatment|0|||
33693320|NCT03251924|63223253|FG005|Overall Study|Participant request to discontinue study treatment|0|||
33693321|NCT03251924|63223254|FG006|Overall Study|Participant request to discontinue study treatment|0|||
33693322|NCT03251924|63223255|FG007|Overall Study|Participant request to discontinue study treatment|1|||
33693323|NCT03251924|63223256|FG008|Overall Study|Participant request to discontinue study treatment|0|||
33693324|NCT01350141|63223452|FG000|Overall Study|Lost to Follow-up|1|||
33693325|NCT01350141|63223453|FG001|Overall Study|Lost to Follow-up|0|||
33693326|NCT01350141|63223454|FG002|Overall Study|Lost to Follow-up|1|||
33693327|NCT01350141|63223452|FG000|Overall Study|Withdrawal by Subject|1|||
33693328|NCT01350141|63223453|FG001|Overall Study|Withdrawal by Subject|0|||
33693329|NCT01350141|63223454|FG002|Overall Study|Withdrawal by Subject|0|||
33693330|NCT01350141|63223452|FG000|Overall Study|Randomized but not treated|1|||
33693331|NCT01350141|63223453|FG001|Overall Study|Randomized but not treated|0|||
33693332|NCT01350141|63223454|FG002|Overall Study|Randomized but not treated|0|||
33693333|NCT05045625|63223993|FG000|Overall Study|Lost to Follow-up|3|||
33693334|NCT04830969|63224375|FG000|Overall Study|Withdrawal by Subject|6|||
33693335|NCT04830969|63224376|FG001|Overall Study|Withdrawal by Subject|2|||
33693336|NCT04830969|63224375|FG000|Overall Study|Protocol Violation|3|||
33693337|NCT04830969|63224376|FG001|Overall Study|Protocol Violation|9|||
33693338|NCT04830969|63224375|FG000|Overall Study|Lost to Follow-up|4|||
33693339|NCT04830969|63224376|FG001|Overall Study|Lost to Follow-up|4|||
33693340|NCT02384993|63224687|FG000|Overall Study|Adverse Event|0|||
33693341|NCT02384993|63224688|FG001|Overall Study|Adverse Event|1|||
33693342|NCT01352117|63224736|FG000|Overall Study|Death|15|||
33693343|NCT01352117|63224737|FG001|Overall Study|Death|16|||
33596208|NCT02145429|62995187|FG001|Overall Study|Death|5|||
33596209|NCT02145429|62995186|FG000|Overall Study|Lost to Follow-up|4|||
33596210|NCT02145429|62995187|FG001|Overall Study|Lost to Follow-up|3|||
33596211|NCT02145429|62995186|FG000|Overall Study|Withdrawal by Subject|8|||
33596212|NCT02145429|62995187|FG001|Overall Study|Withdrawal by Subject|3|||
33596213|NCT02144337|62995195|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
33596214|NCT02144337|62995196|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
33596215|NCT02144337|62995195|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
33596216|NCT02144337|62995196|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
33596217|NCT02144337|62995195|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
33596218|NCT02144337|62995196|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
33596219|NCT02144337|62995195|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
33596220|NCT02144337|62995196|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
33596221|NCT02144337|62995195|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
33596222|NCT02144337|62995196|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
33596223|NCT02520011|62995206|FG000|Overall Study|Adverse Event|0|||
33596224|NCT02520011|62995207|FG001|Overall Study|Adverse Event|1|||
33596225|NCT02520011|62995208|FG002|Overall Study|Adverse Event|2|||
33596226|NCT02520011|62995206|FG000|Overall Study|Death|0|||
33596227|NCT02520011|62995207|FG001|Overall Study|Death|8|||
33596228|NCT02520011|62995208|FG002|Overall Study|Death|1|||
33596229|NCT02520011|62995206|FG000|Overall Study|Lack of Efficacy|4|||
33596230|NCT02520011|62995207|FG001|Overall Study|Lack of Efficacy|26|||
33596231|NCT02520011|62995208|FG002|Overall Study|Lack of Efficacy|4|||
33693344|NCT01352117|63224736|FG000|Overall Study|Withdrawal by Subject|1|||
33596232|NCT02520011|62995206|FG000|Overall Study|Physician Decision|0|||
33596233|NCT02520011|62995207|FG001|Overall Study|Physician Decision|2|||
33596234|NCT02520011|62995208|FG002|Overall Study|Physician Decision|0|||
33693345|NCT01352117|63224737|FG001|Overall Study|Withdrawal by Subject|0|||
33596235|NCT02520011|62995206|FG000|Overall Study|Withdrawal by Subject|1|||
33596236|NCT02520011|62995207|FG001|Overall Study|Withdrawal by Subject|3|||
33596237|NCT02520011|62995208|FG002|Overall Study|Withdrawal by Subject|0|||
33693346|NCT01352117|63224736|FG000|Overall Study|Lost to Follow-up|2|||
33693347|NCT01352117|63224737|FG001|Overall Study|Lost to Follow-up|7|||
33693348|NCT01352117|63224736|FG000|Overall Study|Non-adherent to study requirements|1|||
33693349|NCT01352117|63224737|FG001|Overall Study|Non-adherent to study requirements|1|||
33693350|NCT01352117|63224736|FG000|Overall Study|Did not initiate study treatment|1|||
33693351|NCT01352117|63224737|FG001|Overall Study|Did not initiate study treatment|0|||
33693352|NCT01352117|63224736|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
33693353|NCT01352117|63224737|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
33693354|NCT03578237|63224808|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
33693355|NCT03578237|63224809|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
33693356|NCT04173507|63224888|FG000|Overall Study|On Treatment|3|||
33693357|NCT04173507|63224888|FG000|Overall Study|Adverse Event|3|||
33693358|NCT04173507|63224888|FG000|Overall Study|Progression/Relapse|34|||
33693359|NCT04173507|63224888|FG000|Overall Study|Death|2|||
33693360|NCT02220725|63224896|FG000|Overall Study|Lost to Follow-up|0|||
33693361|NCT02220725|63224897|FG001|Overall Study|Lost to Follow-up|0|||
33693362|NCT02220725|63224898|FG002|Overall Study|Lost to Follow-up|0|||
33693363|NCT02220725|63224899|FG003|Overall Study|Lost to Follow-up|1|||
33693364|NCT02220725|63224896|FG000|Overall Study|Withdrawal by Subject|0|||
33693365|NCT02220725|63224897|FG001|Overall Study|Withdrawal by Subject|0|||
33693366|NCT02220725|63224898|FG002|Overall Study|Withdrawal by Subject|0|||
33693367|NCT02220725|63224899|FG003|Overall Study|Withdrawal by Subject|1|||
33693368|NCT02259517|63224945|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
33693369|NCT02259517|63224946|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
33693370|NCT02259517|63224947|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
33693371|NCT02259517|63224945|FG000|Overall Study|Withdrawal by Subject|0|||
33693372|NCT02259517|63224946|FG001|Overall Study|Withdrawal by Subject|0|||
33693373|NCT02259517|63224947|FG002|Overall Study|Withdrawal by Subject|3|||
33693374|NCT02277990|63224990|FG000|Overall Study|Death|170|||
33693375|NCT02277990|63224991|FG001|Overall Study|Death|188|||
33693376|NCT02277990|63224990|FG000|Overall Study|Withdrawal by Subject|64|||
33693377|NCT02277990|63224991|FG001|Overall Study|Withdrawal by Subject|53|||
33693378|NCT02277990|63224990|FG000|Overall Study|Physician Decision|40|||
33693379|NCT02277990|63224991|FG001|Overall Study|Physician Decision|34|||
33693380|NCT02277990|63224990|FG000|Overall Study|Lost to Follow-up|66|||
33693381|NCT02277990|63224991|FG001|Overall Study|Lost to Follow-up|69|||
33693382|NCT02277990|63224990|FG000|Overall Study|Had other reason|26|||
33693383|NCT02277990|63224991|FG001|Overall Study|Had other reason|32|||
33693384|NCT02317614|63225013|FG000|Overall Study|Lost to Follow-up|1|||
33693385|NCT02317614|63225014|FG001|Overall Study|Lost to Follow-up|1|||
33693386|NCT02317614|63225013|FG000|Overall Study|Withdrawal by Subject|1|||
33693387|NCT02317614|63225014|FG001|Overall Study|Withdrawal by Subject|0|||
33693388|NCT02317614|63225013|FG000|Overall Study|Death|1|||
33693389|NCT02317614|63225014|FG001|Overall Study|Death|1|||
33693390|NCT02276040|63225027|FG000|Overall Study|Physician Decision|15|||
33693391|NCT02315664|63225033|FG000|Overall Study|Lost to Follow-up|1|||
33693392|NCT02315664|63225034|FG001|Overall Study|Lost to Follow-up|1|||
33693393|NCT02315664|63225033|FG000|Overall Study|Withdrawal by Subject|0|||
33693394|NCT02315664|63225034|FG001|Overall Study|Withdrawal by Subject|3|||
33693395|NCT02314728|63225062|FG000|Overall Study|Protocol Violation|1|||
33693396|NCT02314728|63225063|FG001|Overall Study|Protocol Violation|0|||
33693397|NCT02314728|63225062|FG000|Overall Study|Lost to Follow-up|0|||
33693398|NCT02314728|63225063|FG001|Overall Study|Lost to Follow-up|1|||
33693399|NCT02275338|63225082|FG000|Overall Study|Adverse Event|15|||
33693400|NCT02275338|63225082|FG000|Overall Study|Lack of Efficacy|3|||
33693401|NCT02275338|63225082|FG000|Overall Study|Withdrawal by Subject|4|||
33693402|NCT02275338|63225082|FG000|Overall Study|Disease progression (death)|1|||
33693403|NCT02275338|63225082|FG000|Overall Study|Ineligible to start Phase 2|4|||
33693404|NCT02275338|63225082|FG000|Overall Study|Reason not specified|5|||
33693405|NCT02275338|63225082|FG000|Overall Study|Does not meet entry criteria|1|||
33693406|NCT02313558|63225089|FG000|Overall Study|Withdrawal by Subject|2|||
33693407|NCT02313558|63225090|FG001|Overall Study|Withdrawal by Subject|0|||
33693408|NCT02313558|63225089|FG000|Overall Study|Lost to Follow-up|4|||
33693409|NCT02313558|63225090|FG001|Overall Study|Lost to Follow-up|4|||
33693410|NCT01646268|63225118|FG000|Overall Study|Adverse Event|6|||
33693411|NCT01646268|63225119|FG001|Overall Study|Adverse Event|7|||
33693412|NCT01646268|63225118|FG000|Overall Study|Lack of Efficacy|1|||
33693413|NCT01646268|63225119|FG001|Overall Study|Lack of Efficacy|3|||
33693414|NCT01646268|63225118|FG000|Overall Study|Protocol Violation|0|||
33693415|NCT01646268|63225119|FG001|Overall Study|Protocol Violation|1|||
33693416|NCT01646268|63225118|FG000|Overall Study|Withdrawal by Subject|2|||
33693417|NCT01646268|63225119|FG001|Overall Study|Withdrawal by Subject|5|||
33693418|NCT01646268|63225118|FG000|Overall Study|Other|2|||
33693419|NCT01646268|63225119|FG001|Overall Study|Other|0|||
33693420|NCT02275026|63225125|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
33693421|NCT02275026|63225125|FG000|Overall Study|Withdrawal by Subject|4|||
33493190|NCT04364763|62871350|FG001|Overall Study|Lost to Follow-up|0|||
33693422|NCT02275026|63225125|FG000|Overall Study|Ineligible due to medical history|13|||
33693423|NCT02275026|63225125|FG000|Overall Study|MRI malfunction precluded testing|1|||
33693424|NCT02275026|63225125|FG000|Overall Study|Ineligible after MRI findings|1|||
33693425|NCT02275026|63225125|FG000|Overall Study|Lost to Follow-up|2|||
33693426|NCT02275026|63225125|FG000|Overall Study|Scanner failure|1|||
33693427|NCT04579250|63225228|FG000|Overall Study|Withdrawal by Subject|1|||
33693428|NCT04579250|63225229|FG001|Overall Study|Withdrawal by Subject|1|||
33693429|NCT04579250|63225230|FG002|Overall Study|Withdrawal by Subject|0|||
33693430|NCT04579250|63225228|FG000|Overall Study|Lost to Follow-up|1|||
33693431|NCT04579250|63225229|FG001|Overall Study|Lost to Follow-up|1|||
33693432|NCT04579250|63225230|FG002|Overall Study|Lost to Follow-up|0|||
33693433|NCT04579250|63225228|FG000|Overall Study|Moved from area|0|||
33693434|NCT04579250|63225229|FG001|Overall Study|Moved from area|1|||
33693435|NCT04579250|63225230|FG002|Overall Study|Moved from area|2|||
33693436|NCT03175367|63225257|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
33693437|NCT03175367|63225258|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
33693438|NCT03175367|63225259|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
33693439|NCT03175367|63225260|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
33693440|NCT03175367|63225261|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
33693441|NCT03175367|63225262|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
33693442|NCT03175367|63225263|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
33693443|NCT03175367|63225257|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
33693444|NCT03175367|63225258|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
33693445|NCT03175367|63225259|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
33693446|NCT03175367|63225260|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
33693447|NCT03175367|63225261|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
33693448|NCT03175367|63225262|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
33693449|NCT03175367|63225263|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
33693450|NCT03175367|63225257|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
33693451|NCT03175367|63225258|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
33693452|NCT03175367|63225259|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
33693453|NCT03175367|63225260|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
33693454|NCT03175367|63225261|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
33693455|NCT03175367|63225262|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
33693456|NCT03175367|63225263|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
33693457|NCT03175367|63225257|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
33693458|NCT03175367|63225258|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
33693459|NCT03175367|63225259|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
33693460|NCT03175367|63225260|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
33693461|NCT03175367|63225261|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
33693462|NCT03175367|63225262|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
33693463|NCT03175367|63225263|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
33693464|NCT03175367|63225257|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33693465|NCT03175367|63225258|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33693466|NCT03175367|63225259|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
33693467|NCT03175367|63225260|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33693468|NCT03175367|63225261|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
33693469|NCT03175367|63225262|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33693470|NCT03175367|63225263|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33693471|NCT03175367|63225257|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
33693472|NCT03175367|63225258|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
33693473|NCT03175367|63225259|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
33693474|NCT03175367|63225260|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
33693475|NCT03175367|63225261|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
33693476|NCT03175367|63225262|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
33693477|NCT03175367|63225263|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
33693478|NCT03175367|63225257|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33693479|NCT03175367|63225258|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33693480|NCT03175367|63225259|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33693481|NCT03175367|63225260|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33693482|NCT03175367|63225261|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33693483|NCT03175367|63225262|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
33693484|NCT03175367|63225263|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
33693485|NCT03174275|63225320|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
33693486|NCT03174275|63225320|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
33693487|NCT03174275|63225320|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
33693488|NCT03174275|63225320|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
33693489|NCT03174275|63225320|FG000|Adjuvant Chemotherapy|Progression|1|||
33693490|NCT03174275|63225320|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
33693491|NCT03174275|63225320|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
33693492|NCT03174275|63225320|FG000|Adjuvant Durvalumab|Progression|1|||
33693493|NCT03174275|63225320|FG000|Adjuvant Durvalumab|Adverse Event|3|||
33693494|NCT03174275|63225320|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
33693495|NCT03174275|63225320|FG000|Adjuvant Radiotherapy|Progression|1|||
33693496|NCT03174275|63225320|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
33693497|NCT03990363|63225421|FG000|Overall Study|Withdrawal by Subject|10|||
33693498|NCT03990363|63225422|FG001|Overall Study|Withdrawal by Subject|9|||
33693499|NCT03990363|63225423|FG002|Overall Study|Withdrawal by Subject|18|||
33693500|NCT03990363|63225424|FG003|Overall Study|Withdrawal by Subject|11|||
33693501|NCT03990363|63225425|FG004|Overall Study|Withdrawal by Subject|9|||
33693502|NCT03990363|63225421|FG000|Overall Study|Physician Decision|1|||
33693503|NCT03990363|63225422|FG001|Overall Study|Physician Decision|0|||
33693504|NCT03990363|63225423|FG002|Overall Study|Physician Decision|0|||
33693505|NCT03990363|63225424|FG003|Overall Study|Physician Decision|0|||
33693506|NCT03990363|63225425|FG004|Overall Study|Physician Decision|0|||
33693507|NCT03990363|63225421|FG000|Overall Study|Adverse Event|1|||
33693508|NCT03990363|63225422|FG001|Overall Study|Adverse Event|3|||
33693509|NCT03990363|63225423|FG002|Overall Study|Adverse Event|2|||
33693510|NCT03990363|63225424|FG003|Overall Study|Adverse Event|2|||
33693511|NCT03990363|63225425|FG004|Overall Study|Adverse Event|0|||
33693512|NCT03990363|63225421|FG000|Overall Study|Death|14|||
33693513|NCT03990363|63225422|FG001|Overall Study|Death|8|||
33693514|NCT03990363|63225423|FG002|Overall Study|Death|14|||
33693515|NCT03990363|63225424|FG003|Overall Study|Death|10|||
33693516|NCT03990363|63225425|FG004|Overall Study|Death|11|||
33693517|NCT03990363|63225421|FG000|Overall Study|Failure to meet randomization criteria|0|||
33693518|NCT03990363|63225422|FG001|Overall Study|Failure to meet randomization criteria|1|||
33693519|NCT03990363|63225423|FG002|Overall Study|Failure to meet randomization criteria|1|||
33693520|NCT03990363|63225424|FG003|Overall Study|Failure to meet randomization criteria|0|||
33693521|NCT03990363|63225425|FG004|Overall Study|Failure to meet randomization criteria|0|||
33693522|NCT03990363|63225421|FG000|Overall Study|Lost to Follow-up|0|||
33693523|NCT03990363|63225422|FG001|Overall Study|Lost to Follow-up|0|||
33693524|NCT03990363|63225423|FG002|Overall Study|Lost to Follow-up|0|||
33693525|NCT03990363|63225424|FG003|Overall Study|Lost to Follow-up|1|||
33693526|NCT03990363|63225425|FG004|Overall Study|Lost to Follow-up|2|||
33693527|NCT03990363|63225421|FG000|Overall Study|Non-compliance with study drug|2|||
33693528|NCT03990363|63225422|FG001|Overall Study|Non-compliance with study drug|1|||
33693529|NCT03990363|63225423|FG002|Overall Study|Non-compliance with study drug|2|||
33693530|NCT03990363|63225424|FG003|Overall Study|Non-compliance with study drug|0|||
33693531|NCT03990363|63225425|FG004|Overall Study|Non-compliance with study drug|0|||
33693532|NCT03990363|63225421|FG000|Overall Study|Study terminated by sponsor|0|||
33693533|NCT03990363|63225422|FG001|Overall Study|Study terminated by sponsor|1|||
33693534|NCT03990363|63225423|FG002|Overall Study|Study terminated by sponsor|0|||
33693535|NCT03990363|63225424|FG003|Overall Study|Study terminated by sponsor|0|||
33693536|NCT03990363|63225425|FG004|Overall Study|Study terminated by sponsor|0|||
33693537|NCT03990363|63225421|FG000|Overall Study|Site terminated by sponsor|2|||
33693538|NCT03990363|63225422|FG001|Overall Study|Site terminated by sponsor|1|||
33693539|NCT03990363|63225423|FG002|Overall Study|Site terminated by sponsor|2|||
33693540|NCT03990363|63225424|FG003|Overall Study|Site terminated by sponsor|0|||
33693541|NCT03990363|63225425|FG004|Overall Study|Site terminated by sponsor|2|||
33693542|NCT03990363|63225421|FG000|Overall Study|Not categorized|5|||
33693543|NCT03990363|63225422|FG001|Overall Study|Not categorized|5|||
33693544|NCT03990363|63225423|FG002|Overall Study|Not categorized|3|||
33693545|NCT03990363|63225424|FG003|Overall Study|Not categorized|2|||
33693546|NCT03990363|63225425|FG004|Overall Study|Not categorized|2|||
33693547|NCT04661839|63225495|FG000|Overall Study|Not Treated|0|||
33693548|NCT04661839|63225496|FG001|Overall Study|Not Treated|0|||
33596238|NCT02520011|62995206|FG000|Overall Study|Protocol Deviation|0|||
33693549|NCT04661839|63225497|FG002|Overall Study|Not Treated|1|||
33693550|NCT04661839|63225498|FG003|Overall Study|Not Treated|0|||
33693551|NCT04661839|63225495|FG000|Overall Study|Lost to Follow-up|1|||
33693552|NCT04661839|63225496|FG001|Overall Study|Lost to Follow-up|0|||
33693553|NCT04661839|63225497|FG002|Overall Study|Lost to Follow-up|0|||
33693554|NCT04661839|63225498|FG003|Overall Study|Lost to Follow-up|1|||
33693555|NCT02240485|63225599|FG000|3 Months Post-admission|Lost to Follow-up|1|||
33693556|NCT02240485|63225600|FG001|3 Months Post-admission|Lost to Follow-up|5|||
33693557|NCT02240485|63225599|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
33693558|NCT02240485|63225600|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
33693559|NCT02240485|63225599|FG000|9 Months Post-admission|Lost to Follow-up|3|||
33693560|NCT02240485|63225600|FG001|9 Months Post-admission|Lost to Follow-up|1|||
33693561|NCT02240485|63225599|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
33693562|NCT02240485|63225600|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
33693563|NCT02240485|63225599|FG000|18 Months Post-admission|Lost to Follow-up|1|||
33693564|NCT02240485|63225600|FG001|18 Months Post-admission|Lost to Follow-up|1|||
33693565|NCT02240485|63225599|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
33693566|NCT02240485|63225600|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
33693567|NCT04149535|63225623|FG000|Overall Study|Death|11|||
33693568|NCT04149535|63225624|FG001|Overall Study|Death|7|||
33693569|NCT04149535|63225623|FG000|Overall Study|Physician Decision|10|||
33693570|NCT04149535|63225624|FG001|Overall Study|Physician Decision|4|||
33693571|NCT04149535|63225623|FG000|Overall Study|Withdrawal by Subject|6|||
33693572|NCT04149535|63225624|FG001|Overall Study|Withdrawal by Subject|7|||
33693573|NCT04149535|63225623|FG000|Overall Study|Not described|2|||
33693574|NCT04149535|63225624|FG001|Overall Study|Not described|0|||
33693575|NCT02210559|63225642|FG000|Overall Study|Progressive Disease|3|||
33693576|NCT02210559|63225643|FG001|Overall Study|Progressive Disease|2|||
33693577|NCT02210559|63225642|FG000|Overall Study|Adverse Event|2|||
33693578|NCT02210559|63225643|FG001|Overall Study|Adverse Event|2|||
33693579|NCT02210559|63225642|FG000|Overall Study|Physician Decision|1|||
33693580|NCT02210559|63225643|FG001|Overall Study|Physician Decision|0|||
33693581|NCT02210559|63225642|FG000|Overall Study|Withdrawal by Subject|0|||
33693582|NCT02210559|63225643|FG001|Overall Study|Withdrawal by Subject|1|||
33693583|NCT02210559|63225642|FG000|Overall Study|Other than specified|0|||
33693584|NCT02210559|63225643|FG001|Overall Study|Other than specified|1|||
33693585|NCT02073279|63225800|FG000|Double-blind Period|Adverse Event|1|||
33693586|NCT02073279|63225801|FG001|Double-blind Period|Adverse Event|1|||
33693587|NCT02073279|63225800|FG000|Double-blind Period|Switched to another treatment|1|||
33693588|NCT02073279|63225801|FG001|Double-blind Period|Switched to another treatment|2|||
33693589|NCT02073279|63225800|FG000|Double-blind Period|Protocol Violation|0|||
33693590|NCT02073279|63225801|FG001|Double-blind Period|Protocol Violation|1|||
33693591|NCT02073279|63225800|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
33693592|NCT02073279|63225801|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
33693593|NCT02073279|63225800|FG000|Double-blind Period|Withdrawal by Subject|2|||
33693594|NCT02073279|63225801|FG001|Double-blind Period|Withdrawal by Subject|2|||
33693595|NCT02073279|63225800|FG000|Open-label Extension Period|Adverse Event|1|||
33693596|NCT02073279|63225801|FG001|Open-label Extension Period|Adverse Event|0|||
33693597|NCT02073279|63225800|FG000|Open-label Extension Period|Lack of Efficacy|1|||
33693598|NCT02073279|63225801|FG001|Open-label Extension Period|Lack of Efficacy|0|||
33693599|NCT02073279|63225800|FG000|Open-label Extension Period|Lost to Follow-up|0|||
33693600|NCT02073279|63225801|FG001|Open-label Extension Period|Lost to Follow-up|4|||
33693601|NCT02073279|63225800|FG000|Open-label Extension Period|Switched to another treatment|1|||
33693602|NCT02073279|63225801|FG001|Open-label Extension Period|Switched to another treatment|4|||
33693603|NCT02073279|63225800|FG000|Open-label Extension Period|Protocol Violation|0|||
33693604|NCT02073279|63225801|FG001|Open-label Extension Period|Protocol Violation|1|||
33693605|NCT02073279|63225800|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
33693606|NCT02073279|63225801|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
33693607|NCT02073279|63225800|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
33693608|NCT02073279|63225801|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
33693609|NCT01673867|63226057|FG000|Randomization|Adverse event unrelated to study drug|1|||
33693610|NCT01673867|63226058|FG001|Randomization|Adverse event unrelated to study drug|0|||
33693611|NCT01673867|63226057|FG000|Randomization|Participant request to discontinue study treatment|0|||
33693612|NCT01673867|63226058|FG001|Randomization|Participant request to discontinue study treatment|4|||
33693613|NCT01673867|63226057|FG000|Randomization|Withdrawal by participant|0|||
33693614|NCT01673867|63226058|FG001|Randomization|Withdrawal by participant|12|||
33693615|NCT01673867|63226057|FG000|Randomization|Lost to Follow-up|0|||
33693616|NCT01673867|63226058|FG001|Randomization|Lost to Follow-up|1|||
33693617|NCT01673867|63226057|FG000|Randomization|Participant no longer meets study criteria|4|||
33693618|NCT01673867|63226058|FG001|Randomization|Participant no longer meets study criteria|5|||
33693619|NCT01673867|63226057|FG000|Treatment|Disease Progression|208|||
33693620|NCT01673867|63226058|FG001|Treatment|Disease Progression|178|||
33693621|NCT01673867|63226057|FG000|Treatment|Study Drug Toxicity|23|||
33693622|NCT01673867|63226058|FG001|Treatment|Study Drug Toxicity|43|||
33693623|NCT01673867|63226057|FG000|Treatment|Death|2|||
33693624|NCT01673867|63226058|FG001|Treatment|Death|3|||
33693625|NCT01673867|63226057|FG000|Treatment|Adverse event unrelated to study drug|23|||
33693626|NCT01673867|63226058|FG001|Treatment|Adverse event unrelated to study drug|10|||
33693627|NCT01673867|63226057|FG000|Treatment|Participant request to discontinue study treatment|7|||
33693628|NCT01673867|63226058|FG001|Treatment|Participant request to discontinue study treatment|17|||
33693629|NCT01673867|63226057|FG000|Treatment|Withdrawal by participant|5|||
33693630|NCT01673867|63226058|FG001|Treatment|Withdrawal by participant|5|||
33693631|NCT01673867|63226057|FG000|Treatment|Maximum clinical benefit|1|||
33693632|NCT01673867|63226058|FG001|Treatment|Maximum clinical benefit|10|||
33693633|NCT01673867|63226057|FG000|Treatment|Participant no longer meets study criteria|2|||
33693634|NCT01673867|63226058|FG001|Treatment|Participant no longer meets study criteria|0|||
33693635|NCT01673867|63226057|FG000|Treatment|Administrative reason by sponsor|3|||
33693636|NCT01673867|63226058|FG001|Treatment|Administrative reason by sponsor|0|||
33693637|NCT01673867|63226057|FG000|Treatment|Other reason|11|||
33693638|NCT01673867|63226058|FG001|Treatment|Other reason|2|||
33693639|NCT02041533|63226154|FG000|Pre-Treatment Period|Disease Progression|1|||
33693640|NCT02041533|63226155|FG001|Pre-Treatment Period|Disease Progression|1|||
33693641|NCT02041533|63226154|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
33693642|NCT02041533|63226155|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
33693643|NCT02041533|63226154|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
33693644|NCT02041533|63226155|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
33693645|NCT02041533|63226154|FG000|Treatment Period|Disease progression|189|||
33693646|NCT02041533|63226155|FG001|Treatment Period|Disease progression|146|||
33693647|NCT02041533|63226154|FG000|Treatment Period|Study drug toxicity|30|||
33693648|NCT02041533|63226155|FG001|Treatment Period|Study drug toxicity|34|||
33693649|NCT02041533|63226154|FG000|Treatment Period|Death|1|||
33693650|NCT02041533|63226155|FG001|Treatment Period|Death|0|||
33693651|NCT02041533|63226154|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
33693652|NCT02041533|63226155|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
33693653|NCT02041533|63226154|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
33693654|NCT02041533|63226155|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
33693655|NCT02041533|63226154|FG000|Treatment Period|Participant withdrew consent|2|||
33693656|NCT02041533|63226155|FG001|Treatment Period|Participant withdrew consent|2|||
33693657|NCT02041533|63226154|FG000|Treatment Period|Maximum clinical benefit|0|||
33693658|NCT02041533|63226155|FG001|Treatment Period|Maximum clinical benefit|18|||
33693659|NCT02041533|63226154|FG000|Treatment Period|Poor/Non-compliance|1|||
33693660|NCT02041533|63226155|FG001|Treatment Period|Poor/Non-compliance|0|||
33693661|NCT02041533|63226154|FG000|Treatment Period|Administrative reason by sponsor|1|||
33693662|NCT02041533|63226155|FG001|Treatment Period|Administrative reason by sponsor|0|||
33693663|NCT02041533|63226154|FG000|Treatment Period|Other reasons|9|||
33693664|NCT02041533|63226155|FG001|Treatment Period|Other reasons|2|||
33693665|NCT02041533|63226154|FG000|Treatment Period|Not Reported|0|||
33693666|NCT02041533|63226155|FG001|Treatment Period|Not Reported|1|||
33693667|NCT02907203|63226162|FG000|Overall Study|Death|1|||
33693668|NCT02907203|63226162|FG000|Overall Study|Lost to Follow-up|3|||
33693669|NCT02907203|63226162|FG000|Overall Study|Withdrawal by Subject|3|||
33693670|NCT02907203|63226162|FG000|Overall Study|Surgical bypass|1|||
33693671|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
33693672|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
33693673|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
33693674|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
33693675|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
33693676|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
33693677|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
33693678|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
33693679|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|Death|1|||
33693680|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|Death|1|||
33693681|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
33693682|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
33693683|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
33693684|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
33693685|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
33693686|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
33693687|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
33693688|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
33693689|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
33693690|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
33693691|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
33693692|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
33693693|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
33693694|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
33693695|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
33693696|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
33693697|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
33693698|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
33693699|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
33693700|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
33693701|NCT00559585|63227324|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
33693702|NCT00559585|63227325|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
33693703|NCT00559585|63227324|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
33693704|NCT00559585|63227325|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
33693705|NCT00559585|63227324|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
33693706|NCT00559585|63227325|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
33693707|NCT00559585|63227324|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
33693708|NCT00559585|63227325|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
33693709|NCT00559585|63227324|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
33693710|NCT00559585|63227325|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
33693711|NCT00559585|63227324|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
33693712|NCT00559585|63227325|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
33693713|NCT00559585|63227324|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
33693714|NCT00559585|63227325|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
33693715|NCT00559585|63227324|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
33693716|NCT00559585|63227325|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
33693717|NCT00559585|63227324|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
33693718|NCT00559585|63227325|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
33693719|NCT00559585|63227324|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
33693720|NCT00559585|63227325|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
33693721|NCT00559585|63227324|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
33693722|NCT00559585|63227325|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
33693723|NCT00559585|63227324|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
33693724|NCT00559585|63227325|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
33693725|NCT00559585|63227324|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
33693726|NCT00559585|63227325|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
33693727|NCT00559507|63227365|FG000|Overall Study|Not treated, patient ineligible|3|||
33693728|NCT00559273|63227633|FG000|Correction Period (20 Weeks)|Death|3|||
33693729|NCT00559273|63227634|FG001|Correction Period (20 Weeks)|Death|4|||
33693730|NCT00559273|63227633|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
33693731|NCT00559273|63227634|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
33693732|NCT00559273|63227633|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
33693733|NCT00559273|63227634|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
33693734|NCT00559273|63227633|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
33693735|NCT00559273|63227634|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
33693736|NCT00559273|63227633|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
33693737|NCT00559273|63227634|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
33693738|NCT00559273|63227633|FG000|Evaluation Period (8 Weeks)|Death|1|||
33693739|NCT00559273|63227634|FG001|Evaluation Period (8 Weeks)|Death|3|||
33693740|NCT00559273|63227633|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
33693741|NCT00559273|63227634|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
33693742|NCT00559273|63227633|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
33693743|NCT00559273|63227634|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
33693744|NCT00559273|63227633|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
33693745|NCT00559273|63227634|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
33693746|NCT00558259|63227689|FG000|Overall Study|Adverse Event|50|||
33693747|NCT00558259|63227690|FG001|Overall Study|Adverse Event|81|||
33693748|NCT00558259|63227689|FG000|Overall Study|Protocol Violation|9|||
33693749|NCT00558259|63227690|FG001|Overall Study|Protocol Violation|5|||
33693750|NCT00558259|63227689|FG000|Overall Study|Withdrawal by Subject|12|||
33693751|NCT00558259|63227690|FG001|Overall Study|Withdrawal by Subject|13|||
33693752|NCT00558103|63227837|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
33693753|NCT00558103|63227838|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
33693754|NCT00558103|63227839|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
33693755|NCT00558103|63227840|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
33693756|NCT00558103|63227841|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
33693757|NCT00558103|63227842|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
33693758|NCT00558103|63227837|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
33693759|NCT00558103|63227838|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
33693760|NCT00558103|63227839|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
33693761|NCT00558103|63227840|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
33693762|NCT00558103|63227841|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
33693763|NCT00558103|63227842|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
33693764|NCT00558103|63227837|FG000|Randomized Treatment Phase|Disease Progression|1|||
33693765|NCT00558103|63227838|FG001|Randomized Treatment Phase|Disease Progression|0|||
33693766|NCT00558103|63227839|FG002|Randomized Treatment Phase|Disease Progression|1|||
33693767|NCT00558103|63227840|FG003|Randomized Treatment Phase|Disease Progression|0|||
33693768|NCT00558103|63227841|FG004|Randomized Treatment Phase|Disease Progression|0|||
33693769|NCT00558103|63227842|FG005|Randomized Treatment Phase|Disease Progression|0|||
33693770|NCT00558103|63227837|FG000|Randomized Treatment Phase|Adverse Event|0|||
33693771|NCT00558103|63227838|FG001|Randomized Treatment Phase|Adverse Event|0|||
33693772|NCT00558103|63227839|FG002|Randomized Treatment Phase|Adverse Event|0|||
33693773|NCT00558103|63227840|FG003|Randomized Treatment Phase|Adverse Event|1|||
33693774|NCT00558103|63227841|FG004|Randomized Treatment Phase|Adverse Event|1|||
33693775|NCT00558103|63227842|FG005|Randomized Treatment Phase|Adverse Event|0|||
33693776|NCT00558103|63227837|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
33693777|NCT00558103|63227838|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
33693778|NCT00558103|63227839|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
33693779|NCT00558103|63227840|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
33693780|NCT00558103|63227841|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
33693781|NCT00558103|63227842|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
33693782|NCT00558103|63227837|FG000|Monotherapy Extension Phase|Disease Progression|0|||
33693783|NCT00558103|63227838|FG001|Monotherapy Extension Phase|Disease Progression|0|||
33693784|NCT00558103|63227839|FG002|Monotherapy Extension Phase|Disease Progression|0|||
33693785|NCT00558103|63227840|FG003|Monotherapy Extension Phase|Disease Progression|0|||
33693786|NCT00558103|63227841|FG004|Monotherapy Extension Phase|Disease Progression|0|||
33693787|NCT00558103|63227842|FG005|Monotherapy Extension Phase|Disease Progression|8|||
33693788|NCT00558025|63227879|FG000|Overall Study|Adverse Event|1|||
33693789|NCT00558025|63227880|FG001|Overall Study|Adverse Event|1|||
33693790|NCT00558025|63227879|FG000|Overall Study|Withdrawal by Subject|2|||
33693791|NCT00558025|63227880|FG001|Overall Study|Withdrawal by Subject|2|||
33693792|NCT00558025|63227879|FG000|Overall Study|Protocol Violation|1|||
33693793|NCT00558025|63227880|FG001|Overall Study|Protocol Violation|0|||
33693794|NCT00557323|63227933|FG000|Overall Study|Death|3|||
33693795|NCT00557323|63227933|FG000|Overall Study|Withdrawal by Subject|2|||
33693796|NCT00557323|63227933|FG000|Overall Study|Administrative change|2|||
33693797|NCT00557245|63227967|FG000|Overall Study|Lost to Follow-up|7|||
33693798|NCT00557245|63227968|FG001|Overall Study|Lost to Follow-up|8|||
33693799|NCT00557245|63227969|FG002|Overall Study|Lost to Follow-up|10|||
33693800|NCT00557245|63227967|FG000|Overall Study|Ineligible|5|||
33693801|NCT00557245|63227968|FG001|Overall Study|Ineligible|4|||
33693802|NCT00557245|63227969|FG002|Overall Study|Ineligible|2|||
33693803|NCT00556075|63228030|FG000|Overall Study|Lost to Follow-up|3|||
33693804|NCT00556075|63228031|FG001|Overall Study|Lost to Follow-up|0|||
33693805|NCT00556075|63228032|FG002|Overall Study|Lost to Follow-up|3|||
33693806|NCT00556075|63228030|FG000|Overall Study|Withdrawal by Subject|3|||
33693807|NCT00556075|63228031|FG001|Overall Study|Withdrawal by Subject|3|||
33693808|NCT00556075|63228032|FG002|Overall Study|Withdrawal by Subject|0|||
33693809|NCT00556075|63228030|FG000|Overall Study|Protocol Violation|1|||
33693810|NCT00556075|63228031|FG001|Overall Study|Protocol Violation|1|||
33693811|NCT00556075|63228032|FG002|Overall Study|Protocol Violation|3|||
33693812|NCT00556075|63228030|FG000|Overall Study|Not eligible|1|||
33693813|NCT00556075|63228031|FG001|Overall Study|Not eligible|1|||
33693814|NCT00556075|63228032|FG002|Overall Study|Not eligible|2|||
33693815|NCT00556075|63228030|FG000|Overall Study|Adverse Event|1|||
33693816|NCT00556075|63228031|FG001|Overall Study|Adverse Event|2|||
33693817|NCT00556075|63228032|FG002|Overall Study|Adverse Event|0|||
33693818|NCT00556075|63228030|FG000|Overall Study|Personal issues|4|||
33693819|NCT00556075|63228031|FG001|Overall Study|Personal issues|1|||
33693820|NCT00556075|63228032|FG002|Overall Study|Personal issues|0|||
33693821|NCT00556075|63228030|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
33693822|NCT00556075|63228031|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
33693823|NCT00556075|63228032|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
33693824|NCT02289690|63228063|FG000|Overall Study|Adverse Event Related to Progression|0|||
33693825|NCT02289690|63228064|FG001|Overall Study|Adverse Event Related to Progression|1|||
33693826|NCT02289690|63228065|FG002|Overall Study|Adverse Event Related to Progression|1|||
33693827|NCT02289690|63228066|FG003|Overall Study|Adverse Event Related to Progression|0|||
33693828|NCT02289690|63228067|FG004|Overall Study|Adverse Event Related to Progression|1|||
33693829|NCT02289690|63228068|FG005|Overall Study|Adverse Event Related to Progression|0|||
33693830|NCT02289690|63228069|FG006|Overall Study|Adverse Event Related to Progression|1|||
33693831|NCT02289690|63228070|FG007|Overall Study|Adverse Event Related to Progression|0|||
33693832|NCT02289690|63228071|FG008|Overall Study|Adverse Event Related to Progression|0|||
33693833|NCT02289690|63228072|FG009|Overall Study|Adverse Event Related to Progression|0|||
33693834|NCT02289690|63228063|FG000|Overall Study|Withdrawal by Subject|1|||
33693835|NCT02289690|63228064|FG001|Overall Study|Withdrawal by Subject|0|||
33693836|NCT02289690|63228065|FG002|Overall Study|Withdrawal by Subject|0|||
33693837|NCT02289690|63228066|FG003|Overall Study|Withdrawal by Subject|0|||
33693838|NCT02289690|63228067|FG004|Overall Study|Withdrawal by Subject|1|||
33693839|NCT02289690|63228068|FG005|Overall Study|Withdrawal by Subject|1|||
33693840|NCT02289690|63228069|FG006|Overall Study|Withdrawal by Subject|0|||
33693841|NCT02289690|63228070|FG007|Overall Study|Withdrawal by Subject|0|||
33693842|NCT02289690|63228071|FG008|Overall Study|Withdrawal by Subject|4|||
33693843|NCT02289690|63228072|FG009|Overall Study|Withdrawal by Subject|2|||
33693844|NCT02289690|63228063|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
33693845|NCT02289690|63228064|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
33693846|NCT02289690|63228065|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
33693847|NCT02289690|63228066|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
33693848|NCT02289690|63228067|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
33693849|NCT02289690|63228068|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
33693850|NCT02289690|63228069|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
33693851|NCT02289690|63228070|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
33693852|NCT02289690|63228071|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
33693853|NCT02289690|63228072|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
33693854|NCT02289690|63228063|FG000|Overall Study|Lost to Follow-up|0|||
33693855|NCT02289690|63228064|FG001|Overall Study|Lost to Follow-up|0|||
33693856|NCT02289690|63228065|FG002|Overall Study|Lost to Follow-up|0|||
33693857|NCT02289690|63228066|FG003|Overall Study|Lost to Follow-up|0|||
33693858|NCT02289690|63228067|FG004|Overall Study|Lost to Follow-up|0|||
33693859|NCT02289690|63228068|FG005|Overall Study|Lost to Follow-up|0|||
33693860|NCT02289690|63228069|FG006|Overall Study|Lost to Follow-up|0|||
33693861|NCT02289690|63228070|FG007|Overall Study|Lost to Follow-up|1|||
33693862|NCT02289690|63228071|FG008|Overall Study|Lost to Follow-up|0|||
33693863|NCT02289690|63228072|FG009|Overall Study|Lost to Follow-up|2|||
33693864|NCT02289690|63228063|FG000|Overall Study|Death|0|||
33693865|NCT02289690|63228064|FG001|Overall Study|Death|0|||
33693866|NCT02289690|63228065|FG002|Overall Study|Death|0|||
33693867|NCT02289690|63228066|FG003|Overall Study|Death|0|||
33693868|NCT02289690|63228067|FG004|Overall Study|Death|0|||
33693869|NCT02289690|63228068|FG005|Overall Study|Death|0|||
33693870|NCT02289690|63228069|FG006|Overall Study|Death|0|||
33693871|NCT02289690|63228070|FG007|Overall Study|Death|49|||
33693872|NCT02289690|63228071|FG008|Overall Study|Death|45|||
33693873|NCT02289690|63228072|FG009|Overall Study|Death|41|||
33693874|NCT02289690|63228063|FG000|Overall Study|Sponsor Discontinued Study|0|||
33693875|NCT02289690|63228064|FG001|Overall Study|Sponsor Discontinued Study|0|||
33693876|NCT02289690|63228065|FG002|Overall Study|Sponsor Discontinued Study|0|||
33693877|NCT02289690|63228066|FG003|Overall Study|Sponsor Discontinued Study|0|||
33693878|NCT02289690|63228067|FG004|Overall Study|Sponsor Discontinued Study|0|||
33693879|NCT02289690|63228068|FG005|Overall Study|Sponsor Discontinued Study|0|||
33693880|NCT02289690|63228069|FG006|Overall Study|Sponsor Discontinued Study|0|||
33693881|NCT02289690|63228070|FG007|Overall Study|Sponsor Discontinued Study|9|||
33693882|NCT02289690|63228071|FG008|Overall Study|Sponsor Discontinued Study|7|||
33693883|NCT02289690|63228072|FG009|Overall Study|Sponsor Discontinued Study|15|||
33693884|NCT02289690|63228063|FG000|Overall Study|Other|0|||
33693885|NCT02289690|63228064|FG001|Overall Study|Other|0|||
33693886|NCT02289690|63228065|FG002|Overall Study|Other|0|||
33693887|NCT02289690|63228066|FG003|Overall Study|Other|1|||
33693888|NCT02289690|63228067|FG004|Overall Study|Other|1|||
33693889|NCT02289690|63228068|FG005|Overall Study|Other|0|||
33693890|NCT02289690|63228069|FG006|Overall Study|Other|1|||
33693891|NCT02289690|63228070|FG007|Overall Study|Other|2|||
33693892|NCT02289690|63228071|FG008|Overall Study|Other|3|||
33693893|NCT02289690|63228072|FG009|Overall Study|Other|1|||
33693894|NCT02289456|63228175|FG000|Induction Period|Death|2|||
33693895|NCT02289456|63228175|FG000|Induction Period|Adverse Event|11|||
33693896|NCT02289456|63228175|FG000|Induction Period|Progressive Disease (PD)|4|||
33693897|NCT02289456|63228175|FG000|Induction Period|Symptomatic Deterioration|4|||
33693898|NCT02289456|63228175|FG000|Induction Period|Withdrawal by Subject|2|||
33693899|NCT02289456|63228175|FG000|Induction Period|Miscellaneous|1|||
33693900|NCT02289456|63228175|FG000|Monotherapy Period|Death|1|||
33693901|NCT02289456|63228175|FG000|Monotherapy Period|Adverse Event|1|||
33693902|NCT02289456|63228175|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
33693903|NCT02289456|63228175|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
33693904|NCT02289456|63228175|FG000|Monotherapy Period|Withdrawal by Subject|2|||
33693905|NCT02289456|63228175|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
33693906|NCT02289456|63228175|FG000|Monotherapy Period|Miscellaneous|1|||
33693907|NCT02274948|63228224|FG000|Overall Study|Lost to Follow-up|28|||
33693908|NCT02274948|63228225|FG001|Overall Study|Lost to Follow-up|25|||
33693909|NCT02274948|63228224|FG000|Overall Study|Withdrawal by Subject|64|||
33693910|NCT02274948|63228225|FG001|Overall Study|Withdrawal by Subject|58|||
33693911|NCT02274948|63228224|FG000|Overall Study|Stopped on family Practitioner advice|2|||
33693912|NCT02274948|63228225|FG001|Overall Study|Stopped on family Practitioner advice|5|||
33693913|NCT02274948|63228224|FG000|Overall Study|Left the area|4|||
33693914|NCT02274948|63228225|FG001|Overall Study|Left the area|3|||
33693915|NCT02274792|63228241|FG000|Overall Study|Withdrawal by Subject|13|||
33693916|NCT02274792|63228241|FG000|Overall Study|Lost to Follow-up|8|||
33693917|NCT02274792|63228241|FG000|Overall Study|Protocol Specified Criteria|2|||
33693918|NCT02274792|63228241|FG000|Overall Study|Sponsor Decision|2|||
33693919|NCT02274558|63228271|FG000|Overall Study|Adverse Event|2|||
33693920|NCT02274558|63228272|FG001|Overall Study|Adverse Event|4|||
33693921|NCT02274558|63228273|FG002|Overall Study|Adverse Event|2|||
33693922|NCT02274558|63228271|FG000|Overall Study|Non-compliance|2|||
33693923|NCT02274558|63228272|FG001|Overall Study|Non-compliance|1|||
33693924|NCT02274558|63228273|FG002|Overall Study|Non-compliance|0|||
33693925|NCT02274558|63228271|FG000|Overall Study|Withdrawal by Subject|1|||
33693926|NCT02274558|63228272|FG001|Overall Study|Withdrawal by Subject|5|||
33693927|NCT02274558|63228273|FG002|Overall Study|Withdrawal by Subject|4|||
33693928|NCT02274558|63228271|FG000|Overall Study|Death|0|||
33693929|NCT02274558|63228272|FG001|Overall Study|Death|0|||
33693930|NCT02274558|63228273|FG002|Overall Study|Death|1|||
33693931|NCT02274558|63228271|FG000|Overall Study|Lost to Follow-up|2|||
33693932|NCT02274558|63228272|FG001|Overall Study|Lost to Follow-up|1|||
33693933|NCT02274558|63228273|FG002|Overall Study|Lost to Follow-up|1|||
33693934|NCT02274558|63228271|FG000|Overall Study|Physician Decision|0|||
33693935|NCT02274558|63228272|FG001|Overall Study|Physician Decision|2|||
33693936|NCT02274558|63228273|FG002|Overall Study|Physician Decision|1|||
33693937|NCT02287896|63228290|FG000|Second Injection Visit|Withdrawal by Subject|0|||
33693938|NCT02287896|63228291|FG001|Second Injection Visit|Withdrawal by Subject|1|||
33693939|NCT00553501|63228349|FG000|Overall Study|Adverse Event|2|||
33693940|NCT00553501|63228349|FG000|Overall Study|Death|1|||
33693941|NCT00553501|63228349|FG000|Overall Study|Progression|1|||
33693942|NCT02287584|63228377|FG000|the Double-blind Phase|Adverse Event|17|||
33693943|NCT02287584|63228378|FG001|the Double-blind Phase|Adverse Event|17|||
33693944|NCT02287584|63228379|FG002|the Double-blind Phase|Adverse Event|12|||
33693945|NCT02287584|63228380|FG003|the Double-blind Phase|Adverse Event|0|||
33693946|NCT02287584|63228381|FG004|the Double-blind Phase|Adverse Event|0|||
33693947|NCT02287584|63228382|FG005|the Double-blind Phase|Adverse Event|0|||
33693948|NCT02287584|63228377|FG000|the Double-blind Phase|Lack of Efficacy|18|||
33693949|NCT02287584|63228378|FG001|the Double-blind Phase|Lack of Efficacy|8|||
33693950|NCT02287584|63228379|FG002|the Double-blind Phase|Lack of Efficacy|8|||
33693951|NCT02287584|63228380|FG003|the Double-blind Phase|Lack of Efficacy|0|||
33693952|NCT02287584|63228381|FG004|the Double-blind Phase|Lack of Efficacy|0|||
33693953|NCT02287584|63228382|FG005|the Double-blind Phase|Lack of Efficacy|0|||
33693954|NCT02287584|63228377|FG000|the Double-blind Phase|Lost to Follow-up|0|||
33693955|NCT02287584|63228378|FG001|the Double-blind Phase|Lost to Follow-up|1|||
33693956|NCT02287584|63228379|FG002|the Double-blind Phase|Lost to Follow-up|1|||
33693957|NCT02287584|63228380|FG003|the Double-blind Phase|Lost to Follow-up|0|||
33693958|NCT02287584|63228381|FG004|the Double-blind Phase|Lost to Follow-up|0|||
33693959|NCT02287584|63228382|FG005|the Double-blind Phase|Lost to Follow-up|0|||
33693960|NCT02287584|63228377|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
33693961|NCT02287584|63228378|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
33693962|NCT02287584|63228379|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
33693963|NCT02287584|63228380|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
33693964|NCT02287584|63228381|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
33693965|NCT02287584|63228382|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
33693966|NCT02287584|63228377|FG000|the Double-blind Phase|Pregnancy|0|||
33693967|NCT02287584|63228378|FG001|the Double-blind Phase|Pregnancy|1|||
33693968|NCT02287584|63228379|FG002|the Double-blind Phase|Pregnancy|0|||
33693969|NCT02287584|63228380|FG003|the Double-blind Phase|Pregnancy|0|||
33693970|NCT02287584|63228381|FG004|the Double-blind Phase|Pregnancy|0|||
33693971|NCT02287584|63228382|FG005|the Double-blind Phase|Pregnancy|0|||
33693972|NCT02287584|63228377|FG000|the Double-blind Phase|Protocol Violation|0|||
33693973|NCT02287584|63228378|FG001|the Double-blind Phase|Protocol Violation|3|||
33693974|NCT02287584|63228379|FG002|the Double-blind Phase|Protocol Violation|0|||
33693975|NCT02287584|63228380|FG003|the Double-blind Phase|Protocol Violation|0|||
33693976|NCT02287584|63228381|FG004|the Double-blind Phase|Protocol Violation|0|||
33693977|NCT02287584|63228382|FG005|the Double-blind Phase|Protocol Violation|0|||
33693978|NCT02287584|63228377|FG000|the Double-blind Phase|other reasons|0|||
33693979|NCT02287584|63228378|FG001|the Double-blind Phase|other reasons|0|||
33693980|NCT02287584|63228379|FG002|the Double-blind Phase|other reasons|1|||
33693981|NCT02287584|63228380|FG003|the Double-blind Phase|other reasons|0|||
33693982|NCT02287584|63228381|FG004|the Double-blind Phase|other reasons|0|||
33693983|NCT02287584|63228382|FG005|the Double-blind Phase|other reasons|0|||
33693984|NCT02287584|63228377|FG000|the Open-label Phase|Did not receive drug|0|||
33693985|NCT02287584|63228378|FG001|the Open-label Phase|Did not receive drug|0|||
33693986|NCT02287584|63228379|FG002|the Open-label Phase|Did not receive drug|0|||
33693987|NCT02287584|63228380|FG003|the Open-label Phase|Did not receive drug|7|||
33693988|NCT02287584|63228381|FG004|the Open-label Phase|Did not receive drug|6|||
33693989|NCT02287584|63228382|FG005|the Open-label Phase|Did not receive drug|4|||
33693990|NCT02287584|63228377|FG000|the Open-label Phase|Adverse Event|0|||
33693991|NCT02287584|63228378|FG001|the Open-label Phase|Adverse Event|0|||
33693992|NCT02287584|63228379|FG002|the Open-label Phase|Adverse Event|0|||
33693993|NCT02287584|63228380|FG003|the Open-label Phase|Adverse Event|15|||
33693994|NCT02287584|63228381|FG004|the Open-label Phase|Adverse Event|12|||
33693995|NCT02287584|63228382|FG005|the Open-label Phase|Adverse Event|16|||
33693996|NCT02287584|63228377|FG000|the Open-label Phase|Lack of Efficacy|0|||
33693997|NCT02287584|63228378|FG001|the Open-label Phase|Lack of Efficacy|0|||
33693998|NCT02287584|63228379|FG002|the Open-label Phase|Lack of Efficacy|0|||
33693999|NCT02287584|63228380|FG003|the Open-label Phase|Lack of Efficacy|8|||
33694000|NCT02287584|63228381|FG004|the Open-label Phase|Lack of Efficacy|3|||
33694001|NCT02287584|63228382|FG005|the Open-label Phase|Lack of Efficacy|7|||
33694002|NCT02287584|63228377|FG000|the Open-label Phase|Lost to Follow-up|0|||
33694003|NCT02287584|63228378|FG001|the Open-label Phase|Lost to Follow-up|0|||
33694004|NCT02287584|63228379|FG002|the Open-label Phase|Lost to Follow-up|0|||
33694005|NCT02287584|63228380|FG003|the Open-label Phase|Lost to Follow-up|4|||
33694006|NCT02287584|63228381|FG004|the Open-label Phase|Lost to Follow-up|1|||
33694007|NCT02287584|63228382|FG005|the Open-label Phase|Lost to Follow-up|2|||
33694008|NCT02287584|63228377|FG000|the Open-label Phase|Withdrawal by Subject|0|||
33694009|NCT02287584|63228378|FG001|the Open-label Phase|Withdrawal by Subject|0|||
33694010|NCT02287584|63228379|FG002|the Open-label Phase|Withdrawal by Subject|0|||
33694011|NCT02287584|63228380|FG003|the Open-label Phase|Withdrawal by Subject|18|||
33694012|NCT02287584|63228381|FG004|the Open-label Phase|Withdrawal by Subject|29|||
33694013|NCT02287584|63228382|FG005|the Open-label Phase|Withdrawal by Subject|21|||
33694014|NCT02287584|63228377|FG000|the Open-label Phase|non-compliance|0|||
33694015|NCT02287584|63228378|FG001|the Open-label Phase|non-compliance|0|||
33694016|NCT02287584|63228379|FG002|the Open-label Phase|non-compliance|0|||
33694017|NCT02287584|63228380|FG003|the Open-label Phase|non-compliance|2|||
33694018|NCT02287584|63228381|FG004|the Open-label Phase|non-compliance|5|||
33694019|NCT02287584|63228382|FG005|the Open-label Phase|non-compliance|1|||
33694020|NCT02287584|63228377|FG000|the Open-label Phase|other reasons|0|||
33694021|NCT02287584|63228378|FG001|the Open-label Phase|other reasons|0|||
33694022|NCT02287584|63228379|FG002|the Open-label Phase|other reasons|0|||
33694023|NCT02287584|63228380|FG003|the Open-label Phase|other reasons|3|||
33694024|NCT02287584|63228381|FG004|the Open-label Phase|other reasons|6|||
33694025|NCT02287584|63228382|FG005|the Open-label Phase|other reasons|6|||
33694026|NCT00553267|63228415|FG000|Overall Study|Adverse Event|8|||
33694027|NCT00553267|63228416|FG001|Overall Study|Adverse Event|10|||
33694028|NCT00553267|63228417|FG002|Overall Study|Adverse Event|5|||
33694029|NCT00553267|63228415|FG000|Overall Study|Non compliant with protocol|3|||
33694030|NCT00553267|63228416|FG001|Overall Study|Non compliant with protocol|3|||
33694031|NCT00553267|63228417|FG002|Overall Study|Non compliant with protocol|2|||
33694032|NCT00553267|63228415|FG000|Overall Study|Lost to Follow-up|0|||
33694033|NCT00553267|63228416|FG001|Overall Study|Lost to Follow-up|0|||
33694034|NCT00553267|63228417|FG002|Overall Study|Lost to Follow-up|1|||
33694035|NCT00553267|63228415|FG000|Overall Study|Consent withdrawn|2|||
33694036|NCT00553267|63228416|FG001|Overall Study|Consent withdrawn|3|||
33694037|NCT00553267|63228417|FG002|Overall Study|Consent withdrawn|1|||
33694038|NCT00553267|63228415|FG000|Overall Study|Specified category|1|||
33694039|NCT00553267|63228416|FG001|Overall Study|Specified category|2|||
33694040|NCT00553267|63228417|FG002|Overall Study|Specified category|1|||
33694041|NCT02271984|63228431|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33694042|NCT02271984|63228432|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33694043|NCT02271984|63228433|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33694044|NCT02271984|63228434|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33694045|NCT02271984|63228435|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33694046|NCT02271984|63228436|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
33694047|NCT02271984|63228437|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33694048|NCT02271984|63228438|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
33694049|NCT02271984|63228439|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33694050|NCT02271984|63228440|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33694051|NCT02271984|63228441|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33694052|NCT02271984|63228442|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33694053|NCT02287038|63228493|FG000|Overall Study|Stopped attending appointments|3|||
33694054|NCT02287038|63228494|FG001|Overall Study|Stopped attending appointments|2|||
33694055|NCT02287038|63228493|FG000|Overall Study|Anxiety after starting medication|0|||
33694056|NCT02287038|63228494|FG001|Overall Study|Anxiety after starting medication|1|||
33694057|NCT02287038|63228493|FG000|Overall Study|Nausea after starting medication|1|||
33694058|NCT02287038|63228494|FG001|Overall Study|Nausea after starting medication|0|||
33694059|NCT02287038|63228493|FG000|Overall Study|Abnormal ECG after starting medication|1|||
33694060|NCT02287038|63228494|FG001|Overall Study|Abnormal ECG after starting medication|0|||
33694061|NCT02286960|63228504|FG000|Overall Study|Lost to Follow-up|3|||
33694062|NCT02286960|63228505|FG001|Overall Study|Lost to Follow-up|3|||
33694063|NCT02286102|63228522|FG000|Overall Study|Screen Failure|1|||
33694064|NCT02286102|63228523|FG001|Overall Study|Screen Failure|1|||
33694065|NCT02285166|63228529|FG000|Overall Study|Case Report Forms Uncollected|564|||
33694066|NCT02285166|63228529|FG000|Overall Study|Protocol Deviation|402|||
33694067|NCT00555061|63228592|FG000|Overall Study|Adverse Event|3|||
33694068|NCT00555061|63228592|FG000|Overall Study|Protocol Violation|1|||
33694069|NCT00555061|63228592|FG000|Overall Study|Lost to Follow-up|2|||
33694070|NCT00555061|63228592|FG000|Overall Study|Withdrawal by Subject|2|||
33694071|NCT00555061|63228592|FG000|Overall Study|Participant enrolled, but never treated|1|||
33694072|NCT01642212|63228610|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
33694073|NCT01642212|63228611|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
33694074|NCT01642212|63228612|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
33694075|NCT01642212|63228613|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
33694076|NCT01642212|63228614|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
33694077|NCT01642212|63228610|FG000|Double-blind Treatment|Other|0|||
33694078|NCT01642212|63228611|FG001|Double-blind Treatment|Other|2|||
33694079|NCT01642212|63228612|FG002|Double-blind Treatment|Other|1|||
33694080|NCT01642212|63228613|FG003|Double-blind Treatment|Other|0|||
33694081|NCT01642212|63228614|FG004|Double-blind Treatment|Other|0|||
33694082|NCT01642212|63228610|FG000|Double-blind Treatment|Non-compliance|0|||
33694083|NCT01642212|63228611|FG001|Double-blind Treatment|Non-compliance|1|||
33694084|NCT01642212|63228612|FG002|Double-blind Treatment|Non-compliance|0|||
33694085|NCT01642212|63228613|FG003|Double-blind Treatment|Non-compliance|0|||
33694086|NCT01642212|63228614|FG004|Double-blind Treatment|Non-compliance|0|||
33694087|NCT01642212|63228610|FG000|Double-blind Treatment|Adverse Event|0|||
33694088|NCT01642212|63228611|FG001|Double-blind Treatment|Adverse Event|0|||
33694089|NCT01642212|63228612|FG002|Double-blind Treatment|Adverse Event|1|||
33694090|NCT01642212|63228613|FG003|Double-blind Treatment|Adverse Event|0|||
33694091|NCT01642212|63228614|FG004|Double-blind Treatment|Adverse Event|0|||
33694092|NCT01642212|63228610|FG000|Open-label Extension|Adverse Event|0|||
33694093|NCT01642212|63228611|FG001|Open-label Extension|Adverse Event|0|||
33694094|NCT01642212|63228612|FG002|Open-label Extension|Adverse Event|0|||
33694095|NCT01642212|63228613|FG003|Open-label Extension|Adverse Event|3|||
33694096|NCT01642212|63228614|FG004|Open-label Extension|Adverse Event|0|||
33694097|NCT01642212|63228610|FG000|Open-label Extension|Sponsor Decision|0|||
33694098|NCT01642212|63228611|FG001|Open-label Extension|Sponsor Decision|0|||
33694099|NCT01642212|63228612|FG002|Open-label Extension|Sponsor Decision|0|||
33694100|NCT01642212|63228613|FG003|Open-label Extension|Sponsor Decision|7|||
33694101|NCT01642212|63228614|FG004|Open-label Extension|Sponsor Decision|4|||
33694102|NCT01642212|63228610|FG000|Open-label Extension|Consent Withdrawn|0|||
33694103|NCT01642212|63228611|FG001|Open-label Extension|Consent Withdrawn|0|||
33694104|NCT01642212|63228612|FG002|Open-label Extension|Consent Withdrawn|0|||
33694105|NCT01642212|63228613|FG003|Open-label Extension|Consent Withdrawn|0|||
33694106|NCT01642212|63228614|FG004|Open-label Extension|Consent Withdrawn|2|||
33694107|NCT01642212|63228610|FG000|Open-label Extension|Lost to Follow-up|0|||
33694108|NCT01642212|63228611|FG001|Open-label Extension|Lost to Follow-up|0|||
33694109|NCT01642212|63228612|FG002|Open-label Extension|Lost to Follow-up|0|||
33694110|NCT01642212|63228613|FG003|Open-label Extension|Lost to Follow-up|0|||
33694111|NCT01642212|63228614|FG004|Open-label Extension|Lost to Follow-up|1|||
33694112|NCT01642212|63228610|FG000|Open-label Extension|Other|0|||
33694113|NCT01642212|63228611|FG001|Open-label Extension|Other|0|||
33694114|NCT01642212|63228612|FG002|Open-label Extension|Other|0|||
33694115|NCT01642212|63228613|FG003|Open-label Extension|Other|0|||
33694116|NCT01642212|63228614|FG004|Open-label Extension|Other|1|||
33694117|NCT00552175|63228639|FG000|Overall Study|Lack of Efficacy|2|||
33694118|NCT00552175|63228640|FG001|Overall Study|Lack of Efficacy|0|||
33694119|NCT00552175|63228641|FG002|Overall Study|Lack of Efficacy|1|||
33694120|NCT00552175|63228639|FG000|Overall Study|Adverse Event|9|||
33694121|NCT00552175|63228640|FG001|Overall Study|Adverse Event|9|||
33694122|NCT00552175|63228641|FG002|Overall Study|Adverse Event|10|||
33694123|NCT00552175|63228639|FG000|Overall Study|Withdrawal by Subject|2|||
33694124|NCT00552175|63228640|FG001|Overall Study|Withdrawal by Subject|2|||
33694125|NCT00552175|63228641|FG002|Overall Study|Withdrawal by Subject|1|||
33694126|NCT00552175|63228639|FG000|Overall Study|Lost to Follow-up|0|||
33694127|NCT00552175|63228640|FG001|Overall Study|Lost to Follow-up|0|||
33694128|NCT00552175|63228641|FG002|Overall Study|Lost to Follow-up|1|||
33694129|NCT00552175|63228639|FG000|Overall Study|Entry Criteria Not Met|1|||
33694130|NCT00552175|63228640|FG001|Overall Study|Entry Criteria Not Met|1|||
33694131|NCT00552175|63228641|FG002|Overall Study|Entry Criteria Not Met|0|||
33694132|NCT00552175|63228639|FG000|Overall Study|Reason Not Specified|3|||
33694133|NCT00552175|63228640|FG001|Overall Study|Reason Not Specified|1|||
33694134|NCT00552175|63228641|FG002|Overall Study|Reason Not Specified|1|||
33694135|NCT01644474|63228652|FG000|Overall Study|Poor compliance to protocol|1|||
33694136|NCT01644474|63228653|FG001|Overall Study|Poor compliance to protocol|0|||
33694137|NCT01644474|63228652|FG000|Overall Study|Consent withdrawn by participant|0|||
33694138|NCT01644474|63228653|FG001|Overall Study|Consent withdrawn by participant|1|||
33694139|NCT01644474|63228652|FG000|Overall Study|Participant moved|0|||
33694140|NCT01644474|63228653|FG001|Overall Study|Participant moved|1|||
33694141|NCT01644474|63228652|FG000|Overall Study|Adverse Event|4|||
33694142|NCT01644474|63228653|FG001|Overall Study|Adverse Event|5|||
33694143|NCT01644474|63228652|FG000|Overall Study|Site scheduling error|1|||
33694144|NCT01644474|63228653|FG001|Overall Study|Site scheduling error|1|||
33694145|NCT01644474|63228652|FG000|Overall Study|Protocol Violation|1|||
33694146|NCT01644474|63228653|FG001|Overall Study|Protocol Violation|0|||
33694147|NCT02285010|63228688|FG000|Overall Study|not abdominal hysterectomy|2|||
33694148|NCT02285010|63228689|FG001|Overall Study|not abdominal hysterectomy|0|||
33694149|NCT02285010|63228688|FG000|Overall Study|Not spinal anesthesia|3|||
33694150|NCT02285010|63228689|FG001|Overall Study|Not spinal anesthesia|1|||
33694151|NCT00551161|63228733|FG000|Overall Study|Withdrawal by Subject|1|||
33694152|NCT00550771|63228769|FG000|Overall Study|Adverse Event|11|||
33694153|NCT00550771|63228770|FG001|Overall Study|Adverse Event|3|||
33694154|NCT00550771|63228769|FG000|Overall Study|Discontinued for study-related reasons|0|||
33694155|NCT00550771|63228770|FG001|Overall Study|Discontinued for study-related reasons|1|||
33694156|NCT00550771|63228769|FG000|Overall Study|Physician Decision|2|||
33694157|NCT00550771|63228770|FG001|Overall Study|Physician Decision|0|||
33694158|NCT00550771|63228769|FG000|Overall Study|Withdrawal by Subject|0|||
33694159|NCT00550771|63228770|FG001|Overall Study|Withdrawal by Subject|1|||
33694160|NCT00550771|63228769|FG000|Overall Study|Protocol Violation|4|||
33694161|NCT00550771|63228770|FG001|Overall Study|Protocol Violation|5|||
33694162|NCT00550537|63228803|FG000|Overall Study|Death|18|||
33694163|NCT00550537|63228803|FG000|Overall Study|Adverse Event|20|||
33694164|NCT00550537|63228803|FG000|Overall Study|Disease progression before|46|||
33694165|NCT00550537|63228803|FG000|Overall Study|Withdrawal by Subject|7|||
33694166|NCT00550537|63228803|FG000|Overall Study|Change in treatment plan|4|||
33694167|NCT00550537|63228803|FG000|Overall Study|Other complicating ilness|3|||
33694168|NCT00550537|63228803|FG000|Overall Study|Declining performance status|2|||
33694169|NCT00550537|63228803|FG000|Overall Study|Treated closer to home|4|||
33694170|NCT00550147|63228821|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
33694171|NCT00550147|63228821|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
33694172|NCT00550147|63228821|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
33694173|NCT00550147|63228821|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
33694174|NCT00550147|63228821|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
33694175|NCT00550459|63229032|FG000|Overall Study|Adverse Event|0|||
33694176|NCT00550459|63229033|FG001|Overall Study|Adverse Event|2|||
33694177|NCT00550459|63229032|FG000|Overall Study|Withdrawal by Subject|1|||
33694178|NCT00550459|63229033|FG001|Overall Study|Withdrawal by Subject|1|||
33694179|NCT02823145|63229068|FG000|Enrollment|Other|1|||
33694180|NCT02823145|63229069|FG001|Enrollment|Other|0|||
33694181|NCT02823145|63229068|FG000|Treatment|Adverse Event|0|||
33694182|NCT02823145|63229069|FG001|Treatment|Adverse Event|11|||
33694183|NCT02823145|63229068|FG000|Treatment|Death|0|||
33694184|NCT02823145|63229069|FG001|Treatment|Death|3|||
33694185|NCT02823145|63229068|FG000|Treatment|Family Decision|0|||
33694186|NCT02823145|63229069|FG001|Treatment|Family Decision|1|||
33694187|NCT02823145|63229068|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
33694188|NCT02823145|63229069|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
33694189|NCT02823145|63229068|FG000|Treatment|Lack of Efficacy|0|||
33694190|NCT02823145|63229069|FG001|Treatment|Lack of Efficacy|48|||
33694191|NCT02823145|63229068|FG000|Treatment|Non-Compliance With E-Diary|0|||
33694192|NCT02823145|63229069|FG001|Treatment|Non-Compliance With E-Diary|1|||
33694193|NCT02823145|63229068|FG000|Treatment|Physician Decision|0|||
33694194|NCT02823145|63229069|FG001|Treatment|Physician Decision|2|||
33694195|NCT02823145|63229068|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
33694196|NCT02823145|63229069|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
33694197|NCT02823145|63229068|FG000|Treatment|Subject needed to take prohibited medication|0|||
33694198|NCT02823145|63229069|FG001|Treatment|Subject needed to take prohibited medication|1|||
33694199|NCT02823145|63229068|FG000|Treatment|Subject transferred to direct access programme|0|||
33694200|NCT02823145|63229069|FG001|Treatment|Subject transferred to direct access programme|1|||
33596239|NCT02520011|62995207|FG001|Overall Study|Protocol Deviation|1|||
33596240|NCT02520011|62995208|FG002|Overall Study|Protocol Deviation|0|||
33596241|NCT02520011|62995206|FG000|Overall Study|Patient went to hospice|0|||
33596242|NCT02520011|62995207|FG001|Overall Study|Patient went to hospice|1|||
33596243|NCT02520011|62995208|FG002|Overall Study|Patient went to hospice|0|||
33596244|NCT02520011|62995206|FG000|Overall Study|Progressive disease following response|0|||
33596245|NCT02520011|62995207|FG001|Overall Study|Progressive disease following response|4|||
33596246|NCT02520011|62995208|FG002|Overall Study|Progressive disease following response|2|||
33596247|NCT02519231|62995223|FG000|Overall Study|Lost to Follow-up|2|||
33596248|NCT02519231|62995224|FG001|Overall Study|Lost to Follow-up|5|||
33596249|NCT02519231|62995223|FG000|Overall Study|Withdrawal by Subject|0|||
33596250|NCT02519231|62995224|FG001|Overall Study|Withdrawal by Subject|1|||
33596251|NCT02106351|62995235|FG000|Treatment Cycle 1|Adverse Event|2|||
33596252|NCT02106351|62995236|FG001|Treatment Cycle 1|Adverse Event|0|||
33596253|NCT02106351|62995237|FG002|Treatment Cycle 1|Adverse Event|0|||
33596254|NCT02106351|62995235|FG000|Treatment Cycle 1|Consent withdrawn|1|||
33596255|NCT02106351|62995236|FG001|Treatment Cycle 1|Consent withdrawn|0|||
33596256|NCT02106351|62995237|FG002|Treatment Cycle 1|Consent withdrawn|2|||
33596257|NCT02106351|62995235|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
33596258|NCT02106351|62995236|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
33596259|NCT02106351|62995237|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
33694201|NCT02823145|63229068|FG000|Treatment|Switching to commercially available drug|0|||
33596260|NCT02106351|62995235|FG000|Treatment Cycle 1|Other|0|||
33596261|NCT02106351|62995236|FG001|Treatment Cycle 1|Other|3|||
33596262|NCT02106351|62995237|FG002|Treatment Cycle 1|Other|1|||
33694202|NCT02823145|63229069|FG001|Treatment|Switching to commercially available drug|11|||
33694203|NCT02823145|63229068|FG000|Treatment|Transitioned to commercial supply of medication|0|||
33694204|NCT02823145|63229069|FG001|Treatment|Transitioned to commercial supply of medication|1|||
33694205|NCT02823145|63229068|FG000|Treatment|Withdrawal By Caregiver|0|||
33694206|NCT02823145|63229069|FG001|Treatment|Withdrawal By Caregiver|1|||
33694207|NCT02823145|63229068|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
33694208|NCT02823145|63229069|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
33694209|NCT02823145|63229068|FG000|Treatment|Withdrawal by Subject|0|||
33694210|NCT02823145|63229069|FG001|Treatment|Withdrawal by Subject|16|||
33694211|NCT02823145|63229068|FG000|Treatment|Reason unknown|0|||
33694212|NCT02823145|63229069|FG001|Treatment|Reason unknown|1|||
33694213|NCT01643928|63229337|FG000|Overall Study|Lost to Follow-up|1|||
33694214|NCT01643928|63229338|FG001|Overall Study|Lost to Follow-up|0|||
33694215|NCT01643928|63229339|FG002|Overall Study|Lost to Follow-up|2|||
33694216|NCT01643928|63229340|FG003|Overall Study|Lost to Follow-up|0|||
33694217|NCT01643928|63229341|FG004|Overall Study|Lost to Follow-up|0|||
33694218|NCT01643928|63229337|FG000|Overall Study|Withdrawal by Subject|2|||
33694219|NCT01643928|63229338|FG001|Overall Study|Withdrawal by Subject|0|||
33694220|NCT01643928|63229339|FG002|Overall Study|Withdrawal by Subject|0|||
33694221|NCT01643928|63229340|FG003|Overall Study|Withdrawal by Subject|1|||
33694222|NCT01643928|63229341|FG004|Overall Study|Withdrawal by Subject|0|||
33694223|NCT01643928|63229337|FG000|Overall Study|Pregnancy|0|||
33694224|NCT01643928|63229338|FG001|Overall Study|Pregnancy|0|||
33694225|NCT01643928|63229339|FG002|Overall Study|Pregnancy|0|||
33694226|NCT01643928|63229340|FG003|Overall Study|Pregnancy|1|||
33694227|NCT01643928|63229341|FG004|Overall Study|Pregnancy|0|||
33694228|NCT01643928|63229337|FG000|Overall Study|Other|5|||
33694229|NCT01643928|63229338|FG001|Overall Study|Other|1|||
33694230|NCT01643928|63229339|FG002|Overall Study|Other|1|||
33694231|NCT01643928|63229340|FG003|Overall Study|Other|0|||
33694232|NCT01643928|63229341|FG004|Overall Study|Other|0|||
33694233|NCT01643928|63229337|FG000|Overall Study|Adverse Event|2|||
33694234|NCT01643928|63229338|FG001|Overall Study|Adverse Event|1|||
33694235|NCT01643928|63229339|FG002|Overall Study|Adverse Event|0|||
33694236|NCT01643928|63229340|FG003|Overall Study|Adverse Event|1|||
33694237|NCT01643928|63229341|FG004|Overall Study|Adverse Event|2|||
33694238|NCT03237845|63229552|FG000|Overall Study|Adverse Event|0|||
33694239|NCT03237845|63229553|FG001|Overall Study|Adverse Event|1|||
33694240|NCT03237845|63229552|FG000|Overall Study|Lost to Follow-up|13|||
33694241|NCT03237845|63229553|FG001|Overall Study|Lost to Follow-up|10|||
33694242|NCT03237845|63229552|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
33694243|NCT03237845|63229553|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
33694244|NCT03237845|63229552|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
33694245|NCT03237845|63229553|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
33694246|NCT03237845|63229552|FG000|Overall Study|Physician Decision|1|||
33694247|NCT03237845|63229553|FG001|Overall Study|Physician Decision|2|||
33694248|NCT03237845|63229552|FG000|Overall Study|Pregnancy|1|||
33694249|NCT03237845|63229553|FG001|Overall Study|Pregnancy|0|||
33694250|NCT03237845|63229552|FG000|Overall Study|Protocol Deviation|0|||
33493191|NCT04247815|62871367|FG000|Overall Study|Adverse Event|1|||
33694251|NCT03237845|63229553|FG001|Overall Study|Protocol Deviation|1|||
33694252|NCT03237845|63229552|FG000|Overall Study|Technical Problems|8|||
33694253|NCT03237845|63229553|FG001|Overall Study|Technical Problems|1|||
33694254|NCT03237845|63229552|FG000|Overall Study|Withdrawal by Subject|3|||
33694255|NCT03237845|63229553|FG001|Overall Study|Withdrawal by Subject|3|||
33694256|NCT03237845|63229552|FG000|Overall Study|Other Reasons|4|||
33694257|NCT03237845|63229553|FG001|Overall Study|Other Reasons|0|||
33694258|NCT01643850|63229640|FG000|Overall Study|Withdrawal by Subject|0|||
33401446|NCT00256867|62780477|FG003|Overall Study|Protocol Violation|1|||
33694259|NCT01643850|63229641|FG001|Overall Study|Withdrawal by Subject|0|||
33694260|NCT01643850|63229642|FG002|Overall Study|Withdrawal by Subject|0|||
33694261|NCT01643850|63229643|FG003|Overall Study|Withdrawal by Subject|0|||
33694262|NCT01643850|63229644|FG004|Overall Study|Withdrawal by Subject|1|||
33694263|NCT01643850|63229645|FG005|Overall Study|Withdrawal by Subject|0|||
33694264|NCT01643850|63229646|FG006|Overall Study|Withdrawal by Subject|0|||
33694265|NCT01643850|63229647|FG007|Overall Study|Withdrawal by Subject|0|||
33694266|NCT01643850|63229648|FG008|Overall Study|Withdrawal by Subject|0|||
33694267|NCT01643850|63229640|FG000|Overall Study|Lost to Follow-up|0|||
33694268|NCT01643850|63229641|FG001|Overall Study|Lost to Follow-up|0|||
33694269|NCT01643850|63229642|FG002|Overall Study|Lost to Follow-up|0|||
33694270|NCT01643850|63229643|FG003|Overall Study|Lost to Follow-up|0|||
33694271|NCT01643850|63229644|FG004|Overall Study|Lost to Follow-up|0|||
33694272|NCT01643850|63229645|FG005|Overall Study|Lost to Follow-up|0|||
33694273|NCT01643850|63229646|FG006|Overall Study|Lost to Follow-up|1|||
33694274|NCT01643850|63229647|FG007|Overall Study|Lost to Follow-up|0|||
33694275|NCT01643850|63229648|FG008|Overall Study|Lost to Follow-up|1|||
33694276|NCT01643850|63229640|FG000|Overall Study|Adverse Event|0|||
33694277|NCT01643850|63229641|FG001|Overall Study|Adverse Event|0|||
33694278|NCT01643850|63229642|FG002|Overall Study|Adverse Event|0|||
33694279|NCT01643850|63229643|FG003|Overall Study|Adverse Event|0|||
33694280|NCT01643850|63229644|FG004|Overall Study|Adverse Event|1|||
33694281|NCT01643850|63229645|FG005|Overall Study|Adverse Event|0|||
33694282|NCT01643850|63229646|FG006|Overall Study|Adverse Event|0|||
33694283|NCT01643850|63229647|FG007|Overall Study|Adverse Event|0|||
33694284|NCT01643850|63229648|FG008|Overall Study|Adverse Event|0|||
33694285|NCT01643850|63229640|FG000|Overall Study|Administrative Problems|0|||
33694286|NCT01643850|63229641|FG001|Overall Study|Administrative Problems|0|||
33694287|NCT01643850|63229642|FG002|Overall Study|Administrative Problems|1|||
33694288|NCT01643850|63229643|FG003|Overall Study|Administrative Problems|0|||
33694289|NCT01643850|63229644|FG004|Overall Study|Administrative Problems|1|||
33694290|NCT01643850|63229645|FG005|Overall Study|Administrative Problems|0|||
33694291|NCT01643850|63229646|FG006|Overall Study|Administrative Problems|0|||
33694292|NCT01643850|63229647|FG007|Overall Study|Administrative Problems|0|||
33694293|NCT01643850|63229648|FG008|Overall Study|Administrative Problems|0|||
33694294|NCT02271594|63229716|FG000|Overall Study|Study closed; recruiting failure|19|||
33694295|NCT02271594|63229717|FG001|Overall Study|Study closed; recruiting failure|12|||
33694296|NCT02535923|63229736|FG000|Overall Study|Lost to Follow-up|5|||
33694297|NCT02535923|63229737|FG001|Overall Study|Lost to Follow-up|5|||
33694298|NCT02535923|63229736|FG000|Overall Study|Withdrawal by Subject|4|||
33694299|NCT02535923|63229737|FG001|Overall Study|Withdrawal by Subject|3|||
33694300|NCT02270736|63229746|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
33694301|NCT02270736|63229747|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
33694302|NCT02270736|63229748|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
33694303|NCT02270736|63229749|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
33694304|NCT02270736|63229750|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
33694305|NCT02270736|63229746|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
33694306|NCT02270736|63229747|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
33694307|NCT02270736|63229748|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
33694308|NCT02270736|63229749|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
33694309|NCT02270736|63229750|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
33694310|NCT02270736|63229746|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
33694311|NCT02270736|63229747|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
33694312|NCT02270736|63229748|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
33694313|NCT02270736|63229749|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
33694314|NCT02270736|63229750|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
33694315|NCT02270736|63229746|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
33694316|NCT02270736|63229747|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
33694317|NCT02270736|63229748|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
33694318|NCT02270736|63229749|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
33694319|NCT02270736|63229750|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
33694320|NCT02270736|63229746|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
33694321|NCT02270736|63229747|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
33694322|NCT02270736|63229748|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
33694323|NCT02270736|63229749|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
33694324|NCT02270736|63229750|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
33694325|NCT02270736|63229746|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
33694326|NCT02270736|63229747|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
33694327|NCT02270736|63229748|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
33694328|NCT02270736|63229749|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
33694329|NCT02270736|63229750|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
33694330|NCT02270736|63229746|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
33694331|NCT02270736|63229747|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
33694332|NCT02270736|63229748|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
33694333|NCT02270736|63229749|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
33694334|NCT02270736|63229750|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
33694335|NCT02270736|63229746|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
33694336|NCT02270736|63229747|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
33694337|NCT02270736|63229748|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
33694338|NCT02270736|63229749|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
33694339|NCT02270736|63229750|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
33694340|NCT02270736|63229746|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
33694341|NCT02270736|63229747|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
33694342|NCT02270736|63229748|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
33694343|NCT02270736|63229749|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
33694344|NCT02270736|63229750|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
33694345|NCT02269098|63229765|FG000|Overall Study|Lost to Follow-up|14|||
33694346|NCT02269098|63229766|FG001|Overall Study|Lost to Follow-up|9|||
33694347|NCT02283762|63229894|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
33694348|NCT02283762|63229895|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
33694349|NCT02283762|63229894|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
33596263|NCT02106351|62995235|FG000|Treatment Cycle 1|Randomised but not treated|1|||
33596264|NCT02106351|62995236|FG001|Treatment Cycle 1|Randomised but not treated|0|||
33596265|NCT02106351|62995237|FG002|Treatment Cycle 1|Randomised but not treated|1|||
33596266|NCT02106351|62995235|FG000|Treatment Cycle 2|Adverse Event|0|||
33596267|NCT02106351|62995236|FG001|Treatment Cycle 2|Adverse Event|2|||
33596268|NCT02106351|62995237|FG002|Treatment Cycle 2|Adverse Event|0|||
33596269|NCT02106351|62995235|FG000|Treatment Cycle 2|Consent withdrawn|0|||
33596270|NCT02106351|62995236|FG001|Treatment Cycle 2|Consent withdrawn|1|||
33596271|NCT02106351|62995237|FG002|Treatment Cycle 2|Consent withdrawn|1|||
33596272|NCT02106351|62995235|FG000|Treatment Cycle 2|Other|0|||
33596273|NCT02106351|62995236|FG001|Treatment Cycle 2|Other|2|||
33596274|NCT02106351|62995237|FG002|Treatment Cycle 2|Other|2|||
33596275|NCT02106351|62995235|FG000|Treatment Cycle 3|Adverse Event|0|||
33596276|NCT02106351|62995236|FG001|Treatment Cycle 3|Adverse Event|1|||
33596277|NCT02106351|62995237|FG002|Treatment Cycle 3|Adverse Event|0|||
33596278|NCT02106351|62995235|FG000|Treatment Cycle 3|Consent withdrawn|0|||
33596279|NCT02106351|62995236|FG001|Treatment Cycle 3|Consent withdrawn|0|||
33596280|NCT02106351|62995237|FG002|Treatment Cycle 3|Consent withdrawn|2|||
33596281|NCT02106351|62995235|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
33596282|NCT02106351|62995236|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
33596283|NCT02106351|62995237|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
33596284|NCT02106351|62995235|FG000|Treatment Cycle 3|Other|0|||
33596285|NCT02106351|62995236|FG001|Treatment Cycle 3|Other|2|||
33596286|NCT02106351|62995237|FG002|Treatment Cycle 3|Other|3|||
33596287|NCT02106351|62995235|FG000|Treatment Cycle 4|Consent withdrawn|0|||
33596288|NCT02106351|62995236|FG001|Treatment Cycle 4|Consent withdrawn|0|||
33596289|NCT02106351|62995237|FG002|Treatment Cycle 4|Consent withdrawn|2|||
33596290|NCT02106351|62995235|FG000|Treatment Cycle 4|Other|0|||
33596291|NCT02106351|62995236|FG001|Treatment Cycle 4|Other|1|||
33596292|NCT02106351|62995237|FG002|Treatment Cycle 4|Other|0|||
33596293|NCT02143947|62995253|FG000|Overall Study|Lost to Follow-up|4|||
33596294|NCT02143947|62995254|FG001|Overall Study|Lost to Follow-up|2|||
33596295|NCT02075073|62995265|FG000|Overall Study|Withdrawal by Subject|0|||
33596296|NCT02075073|62995266|FG001|Overall Study|Withdrawal by Subject|1|||
33596297|NCT02075073|62995267|FG002|Overall Study|Withdrawal by Subject|0|||
33694350|NCT02283762|63229895|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
33694351|NCT02283762|63229894|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
33596298|NCT02074059|62995281|FG000|Overall Study|Death|0|||
33596299|NCT02074059|62995282|FG001|Overall Study|Death|0|||
33596300|NCT02074059|62995283|FG002|Overall Study|Death|0|||
33596301|NCT02074059|62995284|FG003|Overall Study|Death|0|||
33596302|NCT02074059|62995285|FG004|Overall Study|Death|1|||
33596303|NCT02074059|62995286|FG005|Overall Study|Death|1|||
33596304|NCT02143713|62995305|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
33596305|NCT02143713|62995306|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
33694352|NCT02283762|63229895|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
33694353|NCT02283762|63229894|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
33694354|NCT02283762|63229895|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
33694355|NCT02283762|63229894|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
33694356|NCT02283762|63229895|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
33694357|NCT02283762|63229894|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
33694358|NCT02283762|63229895|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
33694359|NCT02283762|63229894|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
33694360|NCT02283762|63229895|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
33694361|NCT02283762|63229894|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
33694362|NCT02283762|63229895|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
33694363|NCT02283762|63229894|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
33694364|NCT02283762|63229895|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
33694365|NCT02283762|63229894|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
33694366|NCT02283762|63229895|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
33694367|NCT02283762|63229894|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
33694368|NCT02283762|63229895|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
33694369|NCT02283762|63229894|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
33694370|NCT02283762|63229895|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
33694371|NCT02283294|63229995|FG000|Overall Study|Lost to Follow-up|1|||
33694372|NCT02283294|63229996|FG001|Overall Study|Lost to Follow-up|1|||
33694373|NCT02283294|63229995|FG000|Overall Study|Withdrawal by Subject|1|||
33694374|NCT02283294|63229996|FG001|Overall Study|Withdrawal by Subject|6|||
33694375|NCT02283294|63229995|FG000|Overall Study|Protocol Violation|1|||
33694376|NCT02283294|63229996|FG001|Overall Study|Protocol Violation|0|||
33694377|NCT02283294|63229995|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
33694378|NCT02283294|63229996|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
33694379|NCT02282982|63230012|FG000|Overall Study|Lost to Follow-up|15|||
33694380|NCT02282982|63230012|FG000|Overall Study|Withdrew consent|2|||
33694381|NCT02282982|63230012|FG000|Overall Study|Death|4|||
33694382|NCT02282982|63230012|FG000|Overall Study|Lack of product|156|||
33694383|NCT02282982|63230012|FG000|Overall Study|Palivizumab is ended|11|||
33694384|NCT02282982|63230012|FG000|Overall Study|Other, not specified|18|||
33694385|NCT02268864|63230054|FG000|Overall Study|Withdrawal by Subject|2|||
33694386|NCT02268864|63230055|FG001|Overall Study|Withdrawal by Subject|0|||
33694387|NCT02268864|63230056|FG002|Overall Study|Withdrawal by Subject|0|||
33694388|NCT02268864|63230054|FG000|Overall Study|Death|0|||
33694389|NCT02268864|63230055|FG001|Overall Study|Death|1|||
33694390|NCT02268864|63230056|FG002|Overall Study|Death|0|||
33694391|NCT02268786|63230085|FG000|Overall Study|No Euploid Embryos available|42|||
33694392|NCT02268786|63230086|FG001|Overall Study|No Euploid Embryos available|0|||
33694393|NCT02268786|63230085|FG000|Overall Study|Withdrawal by Subject|7|||
33694394|NCT02268786|63230086|FG001|Overall Study|Withdrawal by Subject|14|||
33694395|NCT02268786|63230085|FG000|Overall Study|Thaw Failure|6|||
33694396|NCT02268786|63230086|FG001|Overall Study|Thaw Failure|4|||
33694397|NCT02268786|63230085|FG000|Overall Study|Protocol Violation|1|||
33694398|NCT02268786|63230086|FG001|Overall Study|Protocol Violation|0|||
33694399|NCT02268396|63230101|FG000|Overall Study|Adverse Event|3|||
33694400|NCT02268396|63230101|FG000|Overall Study|Administrative|2|||
33694401|NCT02268396|63230101|FG000|Overall Study|Withdrawal by Subject|1|||
33694402|NCT02268396|63230101|FG000|Overall Study|Lost to Follow-up|2|||
33694403|NCT02268396|63230101|FG000|Overall Study|Protocol-Specified Criteria|2|||
33694404|NCT02268396|63230101|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
33694405|NCT02268084|63230107|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
33694406|NCT02268084|63230108|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
33694407|NCT02268084|63230107|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
33694408|NCT02268084|63230108|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
33694409|NCT01643772|63230137|FG000|Overall Study|Protocol Violation|0|||
33694410|NCT01643772|63230138|FG001|Overall Study|Protocol Violation|0|||
33694411|NCT01643772|63230139|FG002|Overall Study|Protocol Violation|0|||
33694412|NCT01643772|63230140|FG003|Overall Study|Protocol Violation|1|||
33694413|NCT01643772|63230137|FG000|Overall Study|Adverse Event|0|||
33694414|NCT01643772|63230138|FG001|Overall Study|Adverse Event|0|||
33694415|NCT01643772|63230139|FG002|Overall Study|Adverse Event|0|||
33694416|NCT01643772|63230140|FG003|Overall Study|Adverse Event|1|||
33694417|NCT02265744|63230243|FG000|Overall Study|Poor/Non-compliance|1|||
33694418|NCT02265744|63230244|FG001|Overall Study|Poor/Non-compliance|1|||
33694419|NCT02265744|63230245|FG002|Overall Study|Poor/Non-compliance|0|||
33694420|NCT02265744|63230246|FG003|Overall Study|Poor/Non-compliance|0|||
33694421|NCT02265744|63230247|FG004|Overall Study|Poor/Non-compliance|2|||
33694422|NCT02265744|63230243|FG000|Overall Study|Lost to Follow-up|0|||
33694423|NCT02265744|63230244|FG001|Overall Study|Lost to Follow-up|0|||
33694424|NCT02265744|63230245|FG002|Overall Study|Lost to Follow-up|0|||
33694425|NCT02265744|63230246|FG003|Overall Study|Lost to Follow-up|1|||
33694426|NCT02265744|63230247|FG004|Overall Study|Lost to Follow-up|0|||
33694427|NCT02265744|63230243|FG000|Overall Study|Death|0|||
33694428|NCT02265744|63230244|FG001|Overall Study|Death|0|||
33694429|NCT02265744|63230245|FG002|Overall Study|Death|0|||
33694430|NCT02265744|63230246|FG003|Overall Study|Death|2|||
33694431|NCT02265744|63230247|FG004|Overall Study|Death|0|||
33694432|NCT02265744|63230243|FG000|Overall Study|Withdrawal by Subject|2|||
33694433|NCT02265744|63230244|FG001|Overall Study|Withdrawal by Subject|0|||
33694434|NCT02265744|63230245|FG002|Overall Study|Withdrawal by Subject|0|||
33694435|NCT02265744|63230246|FG003|Overall Study|Withdrawal by Subject|2|||
33694436|NCT02265744|63230247|FG004|Overall Study|Withdrawal by Subject|0|||
33694437|NCT02265744|63230243|FG000|Overall Study|Participant request to discontinue|2|||
33694438|NCT02265744|63230244|FG001|Overall Study|Participant request to discontinue|2|||
33694439|NCT02265744|63230245|FG002|Overall Study|Participant request to discontinue|2|||
33694440|NCT02265744|63230246|FG003|Overall Study|Participant request to discontinue|0|||
33694441|NCT02265744|63230247|FG004|Overall Study|Participant request to discontinue|0|||
33694442|NCT02265744|63230243|FG000|Overall Study|Adverse Event|8|||
33694443|NCT02265744|63230244|FG001|Overall Study|Adverse Event|4|||
33694444|NCT02265744|63230245|FG002|Overall Study|Adverse Event|9|||
33694445|NCT02265744|63230246|FG003|Overall Study|Adverse Event|8|||
33694446|NCT02265744|63230247|FG004|Overall Study|Adverse Event|2|||
33694447|NCT02265744|63230243|FG000|Overall Study|Lack of Efficacy|2|||
33694448|NCT02265744|63230244|FG001|Overall Study|Lack of Efficacy|4|||
33694449|NCT02265744|63230245|FG002|Overall Study|Lack of Efficacy|3|||
33694450|NCT02265744|63230246|FG003|Overall Study|Lack of Efficacy|4|||
33694451|NCT02265744|63230247|FG004|Overall Study|Lack of Efficacy|5|||
33694452|NCT02265744|63230243|FG000|Overall Study|Reason not provided by Investigator|1|||
33694453|NCT02265744|63230244|FG001|Overall Study|Reason not provided by Investigator|0|||
33694454|NCT02265744|63230245|FG002|Overall Study|Reason not provided by Investigator|0|||
33694455|NCT02265744|63230246|FG003|Overall Study|Reason not provided by Investigator|2|||
33694456|NCT02265744|63230247|FG004|Overall Study|Reason not provided by Investigator|0|||
33694457|NCT02265744|63230243|FG000|Overall Study|Administrative reason by sponsor|3|||
33694458|NCT02265744|63230244|FG001|Overall Study|Administrative reason by sponsor|2|||
33694459|NCT02265744|63230245|FG002|Overall Study|Administrative reason by sponsor|2|||
33694460|NCT02265744|63230246|FG003|Overall Study|Administrative reason by sponsor|3|||
33694461|NCT02265744|63230247|FG004|Overall Study|Administrative reason by sponsor|3|||
33694462|NCT02265744|63230243|FG000|Overall Study|Subject no longer meets study criteria|0|||
33694463|NCT02265744|63230244|FG001|Overall Study|Subject no longer meets study criteria|0|||
33694464|NCT02265744|63230245|FG002|Overall Study|Subject no longer meets study criteria|0|||
33694465|NCT02265744|63230246|FG003|Overall Study|Subject no longer meets study criteria|0|||
33694466|NCT02265744|63230247|FG004|Overall Study|Subject no longer meets study criteria|1|||
33694467|NCT02265744|63230243|FG000|Overall Study|Pregnancy|1|||
33694468|NCT02265744|63230244|FG001|Overall Study|Pregnancy|2|||
33694469|NCT02265744|63230245|FG002|Overall Study|Pregnancy|1|||
33694470|NCT02265744|63230246|FG003|Overall Study|Pregnancy|1|||
33694471|NCT02265744|63230247|FG004|Overall Study|Pregnancy|0|||
33694472|NCT00085735|63230276|FG000|Overall Study|Adverse Event|1|||
33694473|NCT00085735|63230277|FG001|Overall Study|Adverse Event|0|||
33694474|NCT00085735|63230278|FG002|Overall Study|Adverse Event|0|||
33694475|NCT00085735|63230279|FG003|Overall Study|Adverse Event|0|||
33694476|NCT00085735|63230280|FG004|Overall Study|Adverse Event|0|||
33694477|NCT00085735|63230281|FG005|Overall Study|Adverse Event|0|||
33694478|NCT00085735|63230276|FG000|Overall Study|Lack of Efficacy|2|||
33694479|NCT00085735|63230277|FG001|Overall Study|Lack of Efficacy|4|||
33694480|NCT00085735|63230278|FG002|Overall Study|Lack of Efficacy|6|||
33694481|NCT00085735|63230279|FG003|Overall Study|Lack of Efficacy|3|||
33694482|NCT00085735|63230280|FG004|Overall Study|Lack of Efficacy|4|||
33694483|NCT00085735|63230281|FG005|Overall Study|Lack of Efficacy|3|||
33694484|NCT00085735|63230276|FG000|Overall Study|Lost to Follow-up|0|||
33694485|NCT00085735|63230277|FG001|Overall Study|Lost to Follow-up|1|||
33694486|NCT00085735|63230278|FG002|Overall Study|Lost to Follow-up|0|||
33694487|NCT00085735|63230279|FG003|Overall Study|Lost to Follow-up|0|||
33694488|NCT00085735|63230280|FG004|Overall Study|Lost to Follow-up|1|||
33694489|NCT00085735|63230281|FG005|Overall Study|Lost to Follow-up|0|||
33694490|NCT00085735|63230276|FG000|Overall Study|Physician Decision|2|||
33694491|NCT00085735|63230277|FG001|Overall Study|Physician Decision|3|||
33694492|NCT00085735|63230278|FG002|Overall Study|Physician Decision|2|||
33694493|NCT00085735|63230279|FG003|Overall Study|Physician Decision|3|||
33694494|NCT00085735|63230280|FG004|Overall Study|Physician Decision|11|||
33694495|NCT00085735|63230281|FG005|Overall Study|Physician Decision|8|||
33694496|NCT00085735|63230276|FG000|Overall Study|Protocol Violation|1|||
33694497|NCT00085735|63230277|FG001|Overall Study|Protocol Violation|0|||
33694498|NCT00085735|63230278|FG002|Overall Study|Protocol Violation|0|||
33694499|NCT00085735|63230279|FG003|Overall Study|Protocol Violation|0|||
33694500|NCT00085735|63230280|FG004|Overall Study|Protocol Violation|0|||
33694501|NCT00085735|63230281|FG005|Overall Study|Protocol Violation|0|||
33694502|NCT00085735|63230276|FG000|Overall Study|Withdrawal by Subject|1|||
33694503|NCT00085735|63230277|FG001|Overall Study|Withdrawal by Subject|0|||
33694504|NCT00085735|63230278|FG002|Overall Study|Withdrawal by Subject|4|||
33694505|NCT00085735|63230279|FG003|Overall Study|Withdrawal by Subject|5|||
33694506|NCT00085735|63230280|FG004|Overall Study|Withdrawal by Subject|7|||
33694507|NCT00085735|63230281|FG005|Overall Study|Withdrawal by Subject|8|||
33694508|NCT00085735|63230276|FG000|Overall Study|Patient ineligible|1|||
33694509|NCT00085735|63230277|FG001|Overall Study|Patient ineligible|0|||
33694510|NCT00085735|63230278|FG002|Overall Study|Patient ineligible|3|||
33694511|NCT00085735|63230279|FG003|Overall Study|Patient ineligible|7|||
33694512|NCT00085735|63230280|FG004|Overall Study|Patient ineligible|17|||
33694513|NCT00085735|63230281|FG005|Overall Study|Patient ineligible|8|||
33694514|NCT00085735|63230276|FG000|Overall Study|Excess residual disease|2|||
33694515|NCT00085735|63230277|FG001|Overall Study|Excess residual disease|2|||
33694516|NCT00085735|63230278|FG002|Overall Study|Excess residual disease|1|||
33694517|NCT00085735|63230279|FG003|Overall Study|Excess residual disease|1|||
33694518|NCT00085735|63230280|FG004|Overall Study|Excess residual disease|1|||
33694519|NCT00085735|63230281|FG005|Overall Study|Excess residual disease|4|||
33694520|NCT00085735|63230276|FG000|Overall Study|Reason not documented|1|||
33694521|NCT00085735|63230277|FG001|Overall Study|Reason not documented|0|||
33694522|NCT00085735|63230278|FG002|Overall Study|Reason not documented|1|||
33694523|NCT00085735|63230279|FG003|Overall Study|Reason not documented|0|||
33694524|NCT00085735|63230280|FG004|Overall Study|Reason not documented|1|||
33694525|NCT00085735|63230281|FG005|Overall Study|Reason not documented|0|||
33694526|NCT00085735|63230276|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
33694527|NCT00085735|63230277|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
33694528|NCT00085735|63230278|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
33694529|NCT00085735|63230279|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
33694530|NCT00085735|63230280|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
33694531|NCT00085735|63230281|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
33694532|NCT04537793|63230583|FG000|Part B (24 Weeks)|Adverse Event|0|||
33694533|NCT04537793|63230584|FG001|Part B (24 Weeks)|Adverse Event|1|||
33694534|NCT01938001|63231842|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
33694535|NCT01938001|63231843|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
33694536|NCT01938001|63231842|FG000|Pre-Treatment|Death|1|||
33694537|NCT01938001|63231843|FG001|Pre-Treatment|Death|0|||
33694538|NCT01938001|63231842|FG000|Treatment|Death|2|||
33694539|NCT01938001|63231843|FG001|Treatment|Death|0|||
33694540|NCT01938001|63231842|FG000|Treatment|Adverse Event|14|||
33694541|NCT01938001|63231843|FG001|Treatment|Adverse Event|8|||
33694542|NCT01938001|63231842|FG000|Treatment|Progressive Disease|21|||
33694543|NCT01938001|63231843|FG001|Treatment|Progressive Disease|54|||
33694544|NCT01938001|63231842|FG000|Treatment|Withdrawal by Subject|13|||
33694545|NCT01938001|63231843|FG001|Treatment|Withdrawal by Subject|7|||
33694546|NCT01938001|63231842|FG000|Treatment|Other reasons|2|||
33694547|NCT01938001|63231843|FG001|Treatment|Other reasons|1|||
33694548|NCT01066663|63232016|FG000|Overall Study|Adverse Event|0|||
33694549|NCT01066663|63232017|FG001|Overall Study|Adverse Event|0|||
33694550|NCT01066663|63232018|FG002|Overall Study|Adverse Event|1|||
33694551|NCT03930745|63234233|FG000|Overall Study|Lost to Follow-up|10|||
33694552|NCT03930745|63234234|FG001|Overall Study|Lost to Follow-up|5|||
33694553|NCT03930745|63234233|FG000|Overall Study|Withdrawal by Subject|1|||
33694554|NCT03930745|63234234|FG001|Overall Study|Withdrawal by Subject|2|||
33694555|NCT03930745|63234233|FG000|Overall Study|Protocol Violation|2|||
33694556|NCT03930745|63234234|FG001|Overall Study|Protocol Violation|2|||
33694557|NCT03930745|63234233|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
33694558|NCT03930745|63234234|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
33694559|NCT03930745|63234233|FG000|Overall Study|Adverse Event|0|||
33694560|NCT03930745|63234234|FG001|Overall Study|Adverse Event|1|||
33694561|NCT03930745|63234233|FG000|Overall Study|Pregnancy|0|||
33694562|NCT03930745|63234234|FG001|Overall Study|Pregnancy|1|||
33694563|NCT04473326|63236979|FG000|Overall Study|Death|0|||
33694564|NCT04473326|63236980|FG001|Overall Study|Death|1|||
33694565|NCT04473326|63236979|FG000|Overall Study|Withdrawal by Subject|1|||
33694566|NCT04473326|63236980|FG001|Overall Study|Withdrawal by Subject|2|||
33694567|NCT05239598|63237384|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
33694568|NCT05239598|63237385|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
33694569|NCT05239598|63237384|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
33694570|NCT05239598|63237385|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
33694571|NCT05010070|63237428|FG000|Overall Study|Lost to Follow-up|1|||
33694572|NCT05010070|63237428|FG000|Overall Study|Withdrawal by Subject|1|||
33694573|NCT04523480|63237457|FG000|Overall Study|Lost to Follow-up|30|||
33694574|NCT04523480|63237458|FG001|Overall Study|Lost to Follow-up|35|||
33694575|NCT04523480|63237459|FG002|Overall Study|Lost to Follow-up|0|||
33694576|NCT04454125|63237469|FG000|Overall Study|Lost to Follow-up|0|||
33694577|NCT04454125|63237470|FG001|Overall Study|Lost to Follow-up|1|||
33694578|NCT04307446|63237482|FG000|Overall Study|Lost to Follow-up|2|||
33694579|NCT04307446|63237483|FG001|Overall Study|Lost to Follow-up|0|||
33694580|NCT04143009|63237505|FG000|Pilot Trial|Lost to Follow-up|0|||
33694581|NCT04143009|63237506|FG001|Pilot Trial|Lost to Follow-up|1|||
33694582|NCT04143009|63237507|FG002|Pilot Trial|Lost to Follow-up|1|||
33694583|NCT04126317|63237517|FG000|Overall Study|Adverse Event|0|||
33694584|NCT04126317|63237518|FG001|Overall Study|Adverse Event|1|||
33694585|NCT04126317|63237517|FG000|Overall Study|Withdrawal by Subject|4|||
33694586|NCT04126317|63237518|FG001|Overall Study|Withdrawal by Subject|1|||
33694587|NCT04066894|63237524|FG000|Overall Study|Lack of Efficacy|1|||
33694588|NCT04066894|63237524|FG000|Overall Study|Screen Failure|1|||
33694589|NCT03929913|63237550|FG000|Overall Study|Death|4|||
33694590|NCT03929913|63237550|FG000|Overall Study|Lost to Follow-up|1|||
33694591|NCT03929913|63237550|FG000|Overall Study|Failed Procedure|2|||
33694592|NCT03832192|63237565|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
33694593|NCT03832192|63237566|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
33694594|NCT03748823|63237581|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
33694595|NCT03748823|63237582|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
33694596|NCT03748823|63237581|FG000|Extension Period|Withdrawal by Subject|1|||
33694597|NCT03748823|63237582|FG001|Extension Period|Withdrawal by Subject|2|||
33694598|NCT03748823|63237581|FG000|Extension Period|Death|0|||
33694599|NCT03748823|63237582|FG001|Extension Period|Death|1|||
33694600|NCT03748823|63237581|FG000|Extension Period|Protocol Violation|1|||
33694601|NCT03748823|63237582|FG001|Extension Period|Protocol Violation|0|||
33694602|NCT03748823|63237581|FG000|Extension Period|Ongoing in the Extension Period|41|||
33694603|NCT03748823|63237582|FG001|Extension Period|Ongoing in the Extension Period|84|||
33694604|NCT03738800|63237592|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
33694605|NCT03738800|63237593|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
33694606|NCT03738800|63237594|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33694607|NCT03738800|63237592|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
33694608|NCT03738800|63237593|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
33694609|NCT03738800|63237594|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
33694610|NCT03738800|63237592|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
33694611|NCT03738800|63237593|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
33694612|NCT03738800|63237594|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
33694613|NCT03682055|63237643|FG000|Overall Study|Lack of Efficacy|1|||
33694614|NCT03682055|63237644|FG001|Overall Study|Lack of Efficacy|2|||
33694615|NCT03682055|63237645|FG002|Overall Study|Lack of Efficacy|1|||
33694616|NCT03682055|63237646|FG003|Overall Study|Lack of Efficacy|2|||
33694617|NCT03682055|63237647|FG004|Overall Study|Lack of Efficacy|1|||
33694618|NCT03682055|63237648|FG005|Overall Study|Lack of Efficacy|3|||
33694619|NCT03682055|63237643|FG000|Overall Study|Withdrawal by Subject|0|||
33694620|NCT03682055|63237644|FG001|Overall Study|Withdrawal by Subject|0|||
33694621|NCT03682055|63237645|FG002|Overall Study|Withdrawal by Subject|0|||
33694622|NCT03682055|63237646|FG003|Overall Study|Withdrawal by Subject|0|||
33694623|NCT03682055|63237647|FG004|Overall Study|Withdrawal by Subject|0|||
33694624|NCT03682055|63237648|FG005|Overall Study|Withdrawal by Subject|1|||
33694625|NCT03682055|63237643|FG000|Overall Study|Termination of Study by Sponsor|0|||
33694626|NCT03682055|63237644|FG001|Overall Study|Termination of Study by Sponsor|0|||
33694627|NCT03682055|63237645|FG002|Overall Study|Termination of Study by Sponsor|0|||
33694628|NCT03682055|63237646|FG003|Overall Study|Termination of Study by Sponsor|0|||
33694629|NCT03682055|63237647|FG004|Overall Study|Termination of Study by Sponsor|0|||
33694630|NCT03682055|63237648|FG005|Overall Study|Termination of Study by Sponsor|3|||
33694631|NCT03596450|63237668|FG000|Overall Study|Death|4|||
33694632|NCT03596450|63237669|FG001|Overall Study|Death|4|||
33694633|NCT03596450|63237668|FG000|Overall Study|Protocol Violation|7|||
33694634|NCT03596450|63237669|FG001|Overall Study|Protocol Violation|12|||
33694635|NCT03596450|63237668|FG000|Overall Study|Lost to Follow-up|7|||
33694636|NCT03596450|63237669|FG001|Overall Study|Lost to Follow-up|6|||
33694637|NCT03596450|63237668|FG000|Overall Study|Adverse Event|9|||
33694638|NCT03596450|63237669|FG001|Overall Study|Adverse Event|6|||
33694639|NCT03596450|63237668|FG000|Overall Study|Withdrawal by Subject|16|||
33694640|NCT03596450|63237669|FG001|Overall Study|Withdrawal by Subject|9|||
33694641|NCT03596450|63237668|FG000|Overall Study|Accidentally Randomized|2|||
33694642|NCT03596450|63237669|FG001|Overall Study|Accidentally Randomized|0|||
33694643|NCT03596450|63237668|FG000|Overall Study|Other reasons|21|||
33694644|NCT03596450|63237669|FG001|Overall Study|Other reasons|22|||
33694645|NCT03596450|63237668|FG000|Overall Study|Missed the Year 1 study visit|56|||
33694646|NCT03596450|63237669|FG001|Overall Study|Missed the Year 1 study visit|50|||
33694647|NCT03547518|63237677|FG000|Overall Study|Lost to Follow-up|2|||
33694648|NCT03547518|63237678|FG001|Overall Study|Lost to Follow-up|0|||
33694649|NCT03519347|63237689|FG000|Interventional Crossover Period 1|Death|0|||
33694650|NCT03519347|63237690|FG001|Interventional Crossover Period 1|Death|0|||
33694651|NCT03519347|63237691|FG002|Interventional Crossover Period 1|Death|0|||
33694652|NCT03519347|63237692|FG003|Interventional Crossover Period 1|Death|1|||
33694653|NCT03199638|63237730|FG000|Overall Study|inability to drink glutamine during regularly|0|||
33694654|NCT03199638|63237731|FG001|Overall Study|inability to drink glutamine during regularly|2|||
33694655|NCT03015194|63237750|FG000|Overall Study|Death|10|||
33694656|NCT03015194|63237750|FG000|Overall Study|Withdrawal by Subject|2|||
33694657|NCT02873715|63237761|FG000|Overall Study|Lost to Follow-up|84|||
33694658|NCT02873715|63237762|FG001|Overall Study|Lost to Follow-up|94|||
33694659|NCT02873715|63237761|FG000|Overall Study|Withdrawal by Subject|7|||
33694660|NCT02873715|63237762|FG001|Overall Study|Withdrawal by Subject|26|||
33694661|NCT02840877|63237768|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
33694662|NCT02840877|63237768|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
33694663|NCT02840877|63237768|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
33694664|NCT02840877|63237768|FG000|Baseline to 12 Weeks|Death|1|||
33694665|NCT02840877|63237768|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
33694666|NCT02840877|63237768|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
33694667|NCT02840877|63237768|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
33694668|NCT02840877|63237768|FG000|12 Weeks to 6 Months|Treatment failure|1|||
33694669|NCT02840877|63237768|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
33694670|NCT02840877|63237768|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
33694671|NCT02840877|63237768|FG000|12 Weeks to 6 Months|Death|1|||
33694672|NCT02840877|63237768|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
33694673|NCT02840877|63237768|FG000|6 Months to 18 Months|Treatment failure|7|||
33694674|NCT02840877|63237768|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
33694675|NCT02840877|63237768|FG000|6 Months to 18 Months|Moved/transferred out|6|||
33694676|NCT02840877|63237768|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
33694677|NCT02840877|63237768|FG000|6 Months to 18 Months|Death|4|||
33694678|NCT02840877|63237768|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
33694679|NCT02840877|63237768|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
33694680|NCT02840877|63237768|FG000|6 Months to 18 Months|Still in study.|14|||
33694681|NCT02536300|63237784|FG000|Overall Study|Investigator's Discretion|17|||
33694682|NCT02536300|63237785|FG001|Overall Study|Investigator's Discretion|11|||
33694683|NCT02536300|63237786|FG002|Overall Study|Investigator's Discretion|2|||
33694684|NCT02536300|63237784|FG000|Overall Study|Progressive Disease|11|||
33694685|NCT02536300|63237785|FG001|Overall Study|Progressive Disease|7|||
33694686|NCT02536300|63237786|FG002|Overall Study|Progressive Disease|6|||
33694687|NCT02536300|63237784|FG000|Overall Study|Study Terminated by Sponsor|6|||
33694688|NCT02536300|63237785|FG001|Overall Study|Study Terminated by Sponsor|4|||
33694689|NCT02536300|63237786|FG002|Overall Study|Study Terminated by Sponsor|7|||
33694690|NCT02536300|63237784|FG000|Overall Study|Death|7|||
33694691|NCT02536300|63237785|FG001|Overall Study|Death|0|||
33694692|NCT02536300|63237786|FG002|Overall Study|Death|5|||
33694693|NCT02536300|63237784|FG000|Overall Study|Withdrew Consent|4|||
33694694|NCT02536300|63237785|FG001|Overall Study|Withdrew Consent|2|||
33694695|NCT02536300|63237786|FG002|Overall Study|Withdrew Consent|0|||
33694696|NCT02536300|63237784|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
33694697|NCT02536300|63237785|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
33694698|NCT02536300|63237786|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
33694699|NCT02536300|63237784|FG000|Overall Study|Enrolled but Never Treated|0|||
33694700|NCT02536300|63237785|FG001|Overall Study|Enrolled but Never Treated|0|||
33694701|NCT02536300|63237786|FG002|Overall Study|Enrolled but Never Treated|1|||
33694702|NCT02536300|63237784|FG000|Overall Study|Non-compliance With Study Drug|1|||
33694703|NCT02536300|63237785|FG001|Overall Study|Non-compliance With Study Drug|0|||
33694704|NCT02536300|63237786|FG002|Overall Study|Non-compliance With Study Drug|0|||
33694705|NCT02536300|63237784|FG000|Overall Study|Protocol Violation|0|||
33694706|NCT02536300|63237785|FG001|Overall Study|Protocol Violation|1|||
33694707|NCT02536300|63237786|FG002|Overall Study|Protocol Violation|0|||
33694708|NCT02499354|63237805|FG000|Overall Study|Withdrawal by Subject|1|||
33694709|NCT02499354|63237806|FG001|Overall Study|Withdrawal by Subject|0|||
33694710|NCT02365649|63237818|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33694711|NCT02365649|63237819|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33694712|NCT02365649|63237820|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33694713|NCT02365649|63237821|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
33694714|NCT02365649|63237822|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33694715|NCT02365649|63237823|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33694716|NCT02365649|63237824|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33694717|NCT02365649|63237825|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33694718|NCT02365649|63237826|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33694719|NCT02365649|63237827|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33694720|NCT02365649|63237818|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
33694721|NCT02365649|63237819|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
33694722|NCT02365649|63237820|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
33694723|NCT02365649|63237821|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
33694724|NCT02365649|63237822|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
33694725|NCT02365649|63237823|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
33694726|NCT02365649|63237824|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
33694727|NCT02365649|63237825|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
33694728|NCT02365649|63237826|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
33694729|NCT02365649|63237827|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
33694730|NCT02365649|63237818|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
33694731|NCT02365649|63237819|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
33694732|NCT02365649|63237820|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
33694733|NCT02365649|63237821|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
33694734|NCT02365649|63237822|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
33694735|NCT02365649|63237823|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
33694736|NCT02365649|63237824|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
33694737|NCT02365649|63237825|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
33694738|NCT02365649|63237826|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
33694739|NCT02365649|63237827|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
33694740|NCT02365649|63237818|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
33694741|NCT02365649|63237819|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
33694742|NCT02365649|63237820|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
33694743|NCT02365649|63237821|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
33694744|NCT02365649|63237822|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
33694745|NCT02365649|63237823|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
33694746|NCT02365649|63237824|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
33694747|NCT02365649|63237825|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
33694748|NCT02365649|63237826|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
33694749|NCT02365649|63237827|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
33694750|NCT02365649|63237818|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
33694751|NCT02365649|63237819|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
33694752|NCT02365649|63237820|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
33694753|NCT02365649|63237821|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
33694754|NCT02365649|63237822|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
33694755|NCT02365649|63237823|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
33694756|NCT02365649|63237824|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
33694757|NCT02365649|63237825|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
33694758|NCT02365649|63237826|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
33694759|NCT02365649|63237827|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
33694760|NCT02365649|63237818|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
33694761|NCT02365649|63237819|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
33694762|NCT02365649|63237820|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
33694763|NCT02365649|63237821|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
33694764|NCT02365649|63237822|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
33694765|NCT02365649|63237823|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
33694766|NCT02365649|63237824|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
33493192|NCT04247815|62871368|FG001|Overall Study|Adverse Event|0|||
33493193|NCT04247815|62871367|FG000|Overall Study|Withdrawal by Subject|1|||
33694767|NCT02365649|63237825|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
33694768|NCT02365649|63237826|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
33694769|NCT02365649|63237827|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
33694770|NCT02365649|63237818|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33694771|NCT02365649|63237819|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33694772|NCT02365649|63237820|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
33694773|NCT02365649|63237821|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33694774|NCT02365649|63237822|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33694775|NCT02365649|63237823|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33694776|NCT02365649|63237824|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33694777|NCT02365649|63237825|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33694778|NCT02365649|63237826|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33694779|NCT02365649|63237827|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33694780|NCT02365649|63237818|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33694781|NCT02365649|63237819|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33694782|NCT02365649|63237820|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33694783|NCT02365649|63237821|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33694784|NCT02365649|63237822|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33694785|NCT02365649|63237823|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33694786|NCT02365649|63237824|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
33694787|NCT02365649|63237825|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33694788|NCT02365649|63237826|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33694789|NCT02365649|63237827|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33694790|NCT02365649|63237818|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
33694791|NCT02365649|63237819|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
33694792|NCT02365649|63237820|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
33694793|NCT02365649|63237821|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
33694794|NCT02365649|63237822|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
33694795|NCT02365649|63237823|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
33694796|NCT02365649|63237824|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
33694797|NCT02365649|63237825|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
33694798|NCT02365649|63237826|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
33694799|NCT02365649|63237827|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
33694800|NCT02365649|63237818|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
33694801|NCT02365649|63237819|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
33694802|NCT02365649|63237820|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
33694803|NCT02365649|63237821|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
33694804|NCT02365649|63237822|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
33694805|NCT02365649|63237823|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
33694806|NCT02365649|63237824|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
33694807|NCT02365649|63237825|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
33694808|NCT02365649|63237826|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
33694809|NCT02365649|63237827|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
33694810|NCT02365649|63237818|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
33694811|NCT02365649|63237819|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
33694812|NCT02365649|63237820|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
33694813|NCT02365649|63237821|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
33694814|NCT02365649|63237822|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
33694815|NCT02365649|63237823|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
33694816|NCT02365649|63237824|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
33694817|NCT02365649|63237825|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
33694818|NCT02365649|63237826|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
33694819|NCT02365649|63237827|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
33694820|NCT02365649|63237818|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33694821|NCT02365649|63237819|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33694822|NCT02365649|63237820|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33694823|NCT02365649|63237821|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33694824|NCT02365649|63237822|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33694825|NCT02365649|63237823|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33694826|NCT02365649|63237824|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
33694827|NCT02365649|63237825|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33694828|NCT02365649|63237826|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
33694829|NCT02365649|63237827|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33694830|NCT01984346|63237857|FG000|Overall Study|Physician Decision|4|||
33694831|NCT01984346|63237858|FG001|Overall Study|Physician Decision|2|||
33694832|NCT01984346|63237857|FG000|Overall Study|Withdrawal by Subject|2|||
33694833|NCT01984346|63237858|FG001|Overall Study|Withdrawal by Subject|2|||
33694834|NCT01984346|63237857|FG000|Overall Study|Enrollment Closed|8|||
33694835|NCT01984346|63237858|FG001|Overall Study|Enrollment Closed|1|||
33694836|NCT01984346|63237857|FG000|Overall Study|Insurance Coverage|1|||
33694837|NCT01984346|63237858|FG001|Overall Study|Insurance Coverage|0|||
33694838|NCT01984346|63237857|FG000|Overall Study|Intra-operative Exclusion|2|||
33694839|NCT01984346|63237858|FG001|Overall Study|Intra-operative Exclusion|0|||
33694840|NCT01949662|63237866|FG000|Overall Study|Death|9|||
33694841|NCT01949662|63237867|FG001|Overall Study|Death|7|||
33694842|NCT01949662|63237866|FG000|Overall Study|Discharged before an agitation event|8|||
33694843|NCT01949662|63237867|FG001|Overall Study|Discharged before an agitation event|3|||
33694844|NCT01949662|63237866|FG000|Overall Study|Dropped out|1|||
33694845|NCT01949662|63237867|FG001|Overall Study|Dropped out|3|||
33694846|NCT01949662|63237866|FG000|Overall Study|Ineligible|0|||
33694847|NCT01949662|63237867|FG001|Overall Study|Ineligible|1|||
33694848|NCT01892722|63237875|FG000|Overall Study|Protocol deviation|0|||
33694849|NCT01892722|63237876|FG001|Overall Study|Protocol deviation|1|||
33694850|NCT01892722|63237875|FG000|Overall Study|Administrative problems|0|||
33694851|NCT01892722|63237876|FG001|Overall Study|Administrative problems|1|||
33694852|NCT01892722|63237875|FG000|Overall Study|Patient/guardian decision|0|||
33694853|NCT01892722|63237876|FG001|Overall Study|Patient/guardian decision|2|||
33694854|NCT01892722|63237875|FG000|Overall Study|Physician Decision|1|||
33694855|NCT01892722|63237876|FG001|Overall Study|Physician Decision|2|||
33694856|NCT01892722|63237875|FG000|Overall Study|Adverse Event|3|||
33694857|NCT01892722|63237876|FG001|Overall Study|Adverse Event|2|||
33694858|NCT01892722|63237875|FG000|Overall Study|Lack of Efficacy|0|||
33694859|NCT01892722|63237876|FG001|Overall Study|Lack of Efficacy|7|||
33694860|NCT01892722|63237875|FG000|Overall Study|Withdrawal by Subject|3|||
33694861|NCT01892722|63237876|FG001|Overall Study|Withdrawal by Subject|5|||
33694862|NCT01856686|63237884|FG000|Overall Study|Lost to Follow-up|5|||
33694863|NCT01856686|63237885|FG001|Overall Study|Lost to Follow-up|11|||
33694864|NCT01770145|63237891|FG000|Baseline|Adverse Event|20|||
33694865|NCT01770145|63237891|FG000|Baseline|Withdrawal by Subject|1|||
33694866|NCT01770145|63237891|FG000|Baseline|Lost to Follow-up|1|||
33694867|NCT01770145|63237891|FG000|Baseline|Unable to define optimal dose|4|||
33694868|NCT01770145|63237891|FG000|Treatment|Adverse Event|3|||
33694869|NCT01770145|63237891|FG000|Treatment|Withdrawal by Subject|1|||
33694870|NCT01749137|63237897|FG000|Overall Study|Adverse Event|4|||
33694871|NCT01749137|63237898|FG001|Overall Study|Adverse Event|4|||
33694872|NCT01749137|63237897|FG000|Overall Study|Lost to Follow-up|2|||
33694873|NCT01749137|63237898|FG001|Overall Study|Lost to Follow-up|3|||
33694874|NCT01749137|63237897|FG000|Overall Study|Physician Decision|1|||
33694875|NCT01749137|63237898|FG001|Overall Study|Physician Decision|0|||
33694876|NCT01749137|63237897|FG000|Overall Study|Withdrawal by Subject|8|||
33694877|NCT01749137|63237898|FG001|Overall Study|Withdrawal by Subject|4|||
33694878|NCT01726582|63237904|FG000|Overall Study|Physician Decision|99|||
33694879|NCT01726582|63237904|FG000|Overall Study|Death|85|||
33694880|NCT01385176|63237912|FG000|Randomization Phase|Death|1|||
33694881|NCT01385176|63237913|FG001|Randomization Phase|Death|2|||
33694882|NCT01385176|63237912|FG000|6-18 Month All VNS Active|Death|1|||
33694883|NCT01385176|63237913|FG001|6-18 Month All VNS Active|Death|2|||
33694884|NCT01385176|63237912|FG000|6-18 Month All VNS Active|Physician Decision|0|||
33694885|NCT01385176|63237913|FG001|6-18 Month All VNS Active|Physician Decision|1|||
33694886|NCT01385176|63237912|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
33694887|NCT01385176|63237913|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
33694888|NCT01385176|63237912|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
33694889|NCT01385176|63237913|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
33694890|NCT00794339|63237933|FG000|Overall Study|Withdrawal by Subject|3|||
33694891|NCT00794339|63237933|FG000|Overall Study|Ineligible|4|||
33694892|NCT00794339|63237933|FG000|Overall Study|Tx prior to ATSM|3|||
33694893|NCT00794339|63237933|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
33694894|NCT00794339|63237933|FG000|Overall Study|Tx not per protocol|1|||
33694895|NCT00506662|63237960|FG000|Overall Study|Adverse Event|0|||
33694896|NCT00506662|63237961|FG001|Overall Study|Adverse Event|2|||
33694897|NCT00506662|63237960|FG000|Overall Study|Lack of Efficacy|1|||
33694898|NCT00506662|63237961|FG001|Overall Study|Lack of Efficacy|0|||
33694899|NCT00506662|63237960|FG000|Overall Study|Protocol Violation|2|||
33694900|NCT00506662|63237961|FG001|Overall Study|Protocol Violation|4|||
33694901|NCT00506662|63237960|FG000|Overall Study|Trial terminated|10|||
33694902|NCT00506662|63237961|FG001|Overall Study|Trial terminated|16|||
33694903|NCT00506662|63237960|FG000|Overall Study|Not recorded|4|||
33694904|NCT00506662|63237961|FG001|Overall Study|Not recorded|6|||
33694905|NCT00161213|63237967|FG000|Overall Study|Withdrawal by Subject|1|||
33694906|NCT00161213|63237967|FG000|Overall Study|Evaluable for toxicity but not response|1|||
33694907|NCT00006436|63237975|FG000|Overall Study|Refused further treatment|2|||
33694908|NCT00006436|63237975|FG000|Overall Study|Declined to participate (before treatment started)|1|||
33694909|NCT03838484|63238213|FG000|Overall Study|Lost to Follow-up|0|||
33694910|NCT03838484|63238214|FG001|Overall Study|Lost to Follow-up|1|||
33694911|NCT03838484|63238215|FG002|Overall Study|Lost to Follow-up|0|||
33694912|NCT03838484|63238216|FG003|Overall Study|Lost to Follow-up|0|||
33694913|NCT01349192|63238448|FG000|Overall Study|Protocol Violation|0|||
33694914|NCT01349192|63238449|FG001|Overall Study|Protocol Violation|1|||
33694915|NCT01349192|63238448|FG000|Overall Study|Withdrawal by Subject|0|||
33694916|NCT01349192|63238449|FG001|Overall Study|Withdrawal by Subject|2|||
33694917|NCT01349192|63238448|FG000|Overall Study|Lost to Follow-up|1|||
33694918|NCT01349192|63238449|FG001|Overall Study|Lost to Follow-up|3|||
33694919|NCT01349192|63238448|FG000|Overall Study|Failure to adhere to Protocol|2|||
33694920|NCT01349192|63238449|FG001|Overall Study|Failure to adhere to Protocol|0|||
33694921|NCT01721876|63238804|FG000|Overall Study|Not treated|1|||
33694922|NCT01721876|63238805|FG001|Overall Study|Not treated|4|||
33694923|NCT01721876|63238804|FG000|Overall Study|Disease progression / relapse|123|||
33694924|NCT01721876|63238805|FG001|Overall Study|Disease progression / relapse|156|||
33694925|NCT01721876|63238804|FG000|Overall Study|Death|6|||
33694926|NCT01721876|63238805|FG001|Overall Study|Death|13|||
33694927|NCT01721876|63238804|FG000|Overall Study|Adverse Event|41|||
33694928|NCT01721876|63238805|FG001|Overall Study|Adverse Event|165|||
33694929|NCT01721876|63238804|FG000|Overall Study|Protocol Violation|2|||
33694930|NCT01721876|63238805|FG001|Overall Study|Protocol Violation|1|||
33694931|NCT01721876|63238804|FG000|Overall Study|Withdrawal by Subject|15|||
33694932|NCT01721876|63238805|FG001|Overall Study|Withdrawal by Subject|38|||
33694933|NCT01721876|63238804|FG000|Overall Study|Reason not listed|34|||
33694934|NCT01721876|63238805|FG001|Overall Study|Reason not listed|63|||
33694935|NCT01721876|63238804|FG000|Overall Study|Sponsor terminated trial|0|||
33694936|NCT01721876|63238805|FG001|Overall Study|Sponsor terminated trial|4|||
33694937|NCT02265510|63239036|FG000|Overall Study|Withdrawal by Subject|1|||
33694938|NCT02265510|63239037|FG001|Overall Study|Withdrawal by Subject|1|||
33694939|NCT02265510|63239038|FG002|Overall Study|Withdrawal by Subject|2|||
33694940|NCT02265510|63239039|FG003|Overall Study|Withdrawal by Subject|1|||
33694941|NCT02265510|63239040|FG004|Overall Study|Withdrawal by Subject|0|||
33694942|NCT02265510|63239041|FG005|Overall Study|Withdrawal by Subject|2|||
33694943|NCT02265510|63239042|FG006|Overall Study|Withdrawal by Subject|0|||
33694944|NCT02265510|63239043|FG007|Overall Study|Withdrawal by Subject|2|||
33694945|NCT02265510|63239044|FG008|Overall Study|Withdrawal by Subject|0|||
33694946|NCT02265510|63239045|FG009|Overall Study|Withdrawal by Subject|0|||
33694947|NCT02265510|63239046|FG010|Overall Study|Withdrawal by Subject|0|||
33694948|NCT02265510|63239047|FG011|Overall Study|Withdrawal by Subject|0|||
33694949|NCT02265510|63239048|FG012|Overall Study|Withdrawal by Subject|1|||
33694950|NCT02265510|63239049|FG013|Overall Study|Withdrawal by Subject|0|||
33694951|NCT02265510|63239036|FG000|Overall Study|Disease Progression|0|||
33694952|NCT02265510|63239037|FG001|Overall Study|Disease Progression|1|||
33694953|NCT02265510|63239038|FG002|Overall Study|Disease Progression|2|||
33694954|NCT02265510|63239039|FG003|Overall Study|Disease Progression|1|||
33694955|NCT02265510|63239040|FG004|Overall Study|Disease Progression|1|||
33694956|NCT02265510|63239041|FG005|Overall Study|Disease Progression|0|||
33694957|NCT02265510|63239042|FG006|Overall Study|Disease Progression|0|||
33694958|NCT02265510|63239043|FG007|Overall Study|Disease Progression|0|||
33694959|NCT02265510|63239044|FG008|Overall Study|Disease Progression|0|||
33694960|NCT02265510|63239045|FG009|Overall Study|Disease Progression|0|||
33694961|NCT02265510|63239046|FG010|Overall Study|Disease Progression|0|||
33694962|NCT02265510|63239047|FG011|Overall Study|Disease Progression|0|||
33694963|NCT02265510|63239048|FG012|Overall Study|Disease Progression|0|||
33694964|NCT02265510|63239049|FG013|Overall Study|Disease Progression|0|||
33694965|NCT02265510|63239036|FG000|Overall Study|Death|2|||
33694966|NCT02265510|63239037|FG001|Overall Study|Death|0|||
33694967|NCT02265510|63239038|FG002|Overall Study|Death|2|||
33694968|NCT02265510|63239039|FG003|Overall Study|Death|2|||
33694969|NCT02265510|63239040|FG004|Overall Study|Death|1|||
33694970|NCT02265510|63239041|FG005|Overall Study|Death|3|||
33694971|NCT02265510|63239042|FG006|Overall Study|Death|2|||
33694972|NCT02265510|63239043|FG007|Overall Study|Death|1|||
33694973|NCT02265510|63239044|FG008|Overall Study|Death|3|||
33694974|NCT02265510|63239045|FG009|Overall Study|Death|3|||
33694975|NCT02265510|63239046|FG010|Overall Study|Death|4|||
33694976|NCT02265510|63239047|FG011|Overall Study|Death|12|||
33694977|NCT02265510|63239048|FG012|Overall Study|Death|7|||
33694978|NCT02265510|63239049|FG013|Overall Study|Death|6|||
33694979|NCT02265510|63239036|FG000|Overall Study|Lost to Follow-up|0|||
33694980|NCT02265510|63239037|FG001|Overall Study|Lost to Follow-up|0|||
33694981|NCT02265510|63239038|FG002|Overall Study|Lost to Follow-up|0|||
33694982|NCT02265510|63239039|FG003|Overall Study|Lost to Follow-up|0|||
33694983|NCT02265510|63239040|FG004|Overall Study|Lost to Follow-up|1|||
33694984|NCT02265510|63239041|FG005|Overall Study|Lost to Follow-up|0|||
33694985|NCT02265510|63239042|FG006|Overall Study|Lost to Follow-up|0|||
33694986|NCT02265510|63239043|FG007|Overall Study|Lost to Follow-up|0|||
33694987|NCT02265510|63239044|FG008|Overall Study|Lost to Follow-up|0|||
33694988|NCT02265510|63239045|FG009|Overall Study|Lost to Follow-up|2|||
33694989|NCT02265510|63239046|FG010|Overall Study|Lost to Follow-up|0|||
33694990|NCT02265510|63239047|FG011|Overall Study|Lost to Follow-up|0|||
33694991|NCT02265510|63239048|FG012|Overall Study|Lost to Follow-up|0|||
33694992|NCT02265510|63239049|FG013|Overall Study|Lost to Follow-up|2|||
33694993|NCT02265510|63239036|FG000|Overall Study|Other|0|||
33694994|NCT02265510|63239037|FG001|Overall Study|Other|1|||
33694995|NCT02265510|63239038|FG002|Overall Study|Other|0|||
33694996|NCT02265510|63239039|FG003|Overall Study|Other|0|||
33694997|NCT02265510|63239040|FG004|Overall Study|Other|0|||
33694998|NCT02265510|63239041|FG005|Overall Study|Other|0|||
33694999|NCT02265510|63239042|FG006|Overall Study|Other|0|||
33695000|NCT02265510|63239043|FG007|Overall Study|Other|0|||
33695001|NCT02265510|63239044|FG008|Overall Study|Other|0|||
33695002|NCT02265510|63239045|FG009|Overall Study|Other|0|||
33695003|NCT02265510|63239046|FG010|Overall Study|Other|0|||
33695004|NCT02265510|63239047|FG011|Overall Study|Other|0|||
33695005|NCT02265510|63239048|FG012|Overall Study|Other|0|||
33695006|NCT02265510|63239049|FG013|Overall Study|Other|0|||
33695007|NCT02265510|63239036|FG000|Overall Study|Study Terminated by Sponsor|0|||
33695008|NCT02265510|63239037|FG001|Overall Study|Study Terminated by Sponsor|0|||
33695009|NCT02265510|63239038|FG002|Overall Study|Study Terminated by Sponsor|0|||
33695010|NCT02265510|63239039|FG003|Overall Study|Study Terminated by Sponsor|0|||
33695011|NCT02265510|63239040|FG004|Overall Study|Study Terminated by Sponsor|0|||
33695012|NCT02265510|63239041|FG005|Overall Study|Study Terminated by Sponsor|1|||
33695013|NCT02265510|63239042|FG006|Overall Study|Study Terminated by Sponsor|1|||
33695014|NCT02265510|63239043|FG007|Overall Study|Study Terminated by Sponsor|1|||
33695015|NCT02265510|63239044|FG008|Overall Study|Study Terminated by Sponsor|1|||
33695016|NCT02265510|63239045|FG009|Overall Study|Study Terminated by Sponsor|2|||
33695017|NCT02265510|63239046|FG010|Overall Study|Study Terminated by Sponsor|1|||
33695018|NCT02265510|63239047|FG011|Overall Study|Study Terminated by Sponsor|4|||
33695019|NCT02265510|63239048|FG012|Overall Study|Study Terminated by Sponsor|1|||
33695020|NCT02265510|63239049|FG013|Overall Study|Study Terminated by Sponsor|2|||
33695021|NCT01238211|63239150|FG000|Overall Study|Continues active treatment|31|||
33695022|NCT01238211|63239150|FG000|Overall Study|Adverse Event|7|||
33695023|NCT01238211|63239150|FG000|Overall Study|Death|4|||
33695024|NCT01238211|63239150|FG000|Overall Study|Relapse/Progression|2|||
33695025|NCT01238211|63239150|FG000|Overall Study|Withdrawal by Subject|7|||
33695026|NCT01238211|63239150|FG000|Overall Study|Non-protocol treatment|4|||
33695027|NCT01238211|63239150|FG000|Overall Study|Investigator/Patient Decision|3|||
33695028|NCT02264574|63239326|FG000|Overall Study|Death|21|||
33695029|NCT02264574|63239327|FG001|Overall Study|Death|21|||
33695030|NCT02264574|63239326|FG000|Overall Study|Withdrawal by Subject|8|||
33695031|NCT02264574|63239327|FG001|Overall Study|Withdrawal by Subject|6|||
33695032|NCT02264574|63239326|FG000|Overall Study|Other, Not Specified|0|||
33695033|NCT02264574|63239327|FG001|Overall Study|Other, Not Specified|3|||
33695034|NCT01641900|63239367|FG000|Overall Study|Withdrawal by Subject|2|||
33695035|NCT01641900|63239368|FG001|Overall Study|Withdrawal by Subject|2|||
33695036|NCT01640808|63239441|FG000|Overall Study|Unable to continue dynamic CT|14|||
33695037|NCT01640808|63239442|FG001|Overall Study|Unable to continue dynamic CT|4|||
33695038|NCT01640808|63239441|FG000|Overall Study|Withdrawal by Subject|12|||
33695039|NCT01640808|63239442|FG001|Overall Study|Withdrawal by Subject|4|||
33695040|NCT01640808|63239441|FG000|Overall Study|Lost to Follow-up|4|||
33695041|NCT01640808|63239442|FG001|Overall Study|Lost to Follow-up|0|||
33695042|NCT01640808|63239441|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
33695043|NCT01640808|63239442|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
33695044|NCT01640808|63239441|FG000|Overall Study|Administration of anticancer drugs|2|||
33695045|NCT01640808|63239442|FG001|Overall Study|Administration of anticancer drugs|1|||
33695046|NCT01640808|63239441|FG000|Overall Study|Physician Decision|19|||
33695047|NCT01640808|63239442|FG001|Overall Study|Physician Decision|5|||
33695048|NCT01640808|63239441|FG000|Overall Study|Randomized but not treated|4|||
33695049|NCT01640808|63239442|FG001|Overall Study|Randomized but not treated|2|||
33695050|NCT02263326|63239463|FG000|Overall Study|Lost to Follow-up|1|||
33695051|NCT02263326|63239464|FG001|Overall Study|Lost to Follow-up|1|||
33695052|NCT02260986|63239570|FG000|Overall Study|Adverse Event|24|||
33695053|NCT02260986|63239571|FG001|Overall Study|Adverse Event|0|||
33695054|NCT02260986|63239572|FG002|Overall Study|Adverse Event|11|||
33695055|NCT02260986|63239570|FG000|Overall Study|Lack of Efficacy|27|||
33695056|NCT02260986|63239571|FG001|Overall Study|Lack of Efficacy|3|||
33695057|NCT02260986|63239572|FG002|Overall Study|Lack of Efficacy|0|||
33695058|NCT02260986|63239570|FG000|Overall Study|Protocol Violation|14|||
33695059|NCT02260986|63239571|FG001|Overall Study|Protocol Violation|5|||
33695060|NCT02260986|63239572|FG002|Overall Study|Protocol Violation|16|||
33695061|NCT02260986|63239570|FG000|Overall Study|Car accident|0|||
33695062|NCT02260986|63239571|FG001|Overall Study|Car accident|0|||
33695063|NCT02260986|63239572|FG002|Overall Study|Car accident|1|||
33695064|NCT02260986|63239570|FG000|Overall Study|Withdrawal by Subject|17|||
33695065|NCT02260986|63239571|FG001|Overall Study|Withdrawal by Subject|4|||
33695066|NCT02260986|63239572|FG002|Overall Study|Withdrawal by Subject|9|||
33695067|NCT02260986|63239570|FG000|Overall Study|Incorrect randomization|0|||
33695068|NCT02260986|63239571|FG001|Overall Study|Incorrect randomization|1|||
33695069|NCT02260986|63239572|FG002|Overall Study|Incorrect randomization|0|||
33695070|NCT02260986|63239570|FG000|Overall Study|Lack of investigation product supply|2|||
33695071|NCT02260986|63239571|FG001|Overall Study|Lack of investigation product supply|0|||
33695072|NCT02260986|63239572|FG002|Overall Study|Lack of investigation product supply|1|||
33695073|NCT02260986|63239570|FG000|Overall Study|Lost to Follow-up|4|||
33695074|NCT02260986|63239571|FG001|Overall Study|Lost to Follow-up|0|||
33695075|NCT02260986|63239572|FG002|Overall Study|Lost to Follow-up|3|||
33695076|NCT02260986|63239570|FG000|Overall Study|Pregnancy|2|||
33695077|NCT02260986|63239571|FG001|Overall Study|Pregnancy|0|||
33695078|NCT02260986|63239572|FG002|Overall Study|Pregnancy|0|||
33695079|NCT02259582|63239588|FG000|Overall Study|Physician Decision|0|||
33695080|NCT02259582|63239589|FG001|Overall Study|Physician Decision|1|||
33695081|NCT02259582|63239590|FG002|Overall Study|Physician Decision|0|||
33695082|NCT02259582|63239588|FG000|Overall Study|Death|0|||
33695083|NCT02259582|63239589|FG001|Overall Study|Death|0|||
33695084|NCT02259582|63239590|FG002|Overall Study|Death|1|||
33695085|NCT02259582|63239588|FG000|Overall Study|Adverse Event|1|||
33695086|NCT02259582|63239589|FG001|Overall Study|Adverse Event|0|||
33695087|NCT02259582|63239590|FG002|Overall Study|Adverse Event|1|||
33695088|NCT02259582|63239588|FG000|Overall Study|Withdrawal by Subject|0|||
33695089|NCT02259582|63239589|FG001|Overall Study|Withdrawal by Subject|0|||
33695090|NCT02259582|63239590|FG002|Overall Study|Withdrawal by Subject|1|||
33695091|NCT02259582|63239588|FG000|Overall Study|Disease progression|14|||
33695092|NCT02259582|63239589|FG001|Overall Study|Disease progression|15|||
33695093|NCT02259582|63239590|FG002|Overall Study|Disease progression|17|||
33695094|NCT02259582|63239588|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
33695095|NCT02259582|63239589|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
33695096|NCT02259582|63239590|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
33695097|NCT03238651|63239603|FG000|Overall Study|Other|0|||
33695098|NCT03238651|63239604|FG001|Overall Study|Other|0|||
33695099|NCT03238651|63239605|FG002|Overall Study|Other|0|||
33695100|NCT03238651|63239606|FG003|Overall Study|Other|0|||
33695101|NCT03238651|63239607|FG004|Overall Study|Other|1|||
33695102|NCT03238651|63239603|FG000|Overall Study|Progressive Disease|2|||
33695103|NCT03238651|63239604|FG001|Overall Study|Progressive Disease|2|||
33695104|NCT03238651|63239605|FG002|Overall Study|Progressive Disease|2|||
33695105|NCT03238651|63239606|FG003|Overall Study|Progressive Disease|2|||
33695106|NCT03238651|63239607|FG004|Overall Study|Progressive Disease|0|||
33695107|NCT03238651|63239603|FG000|Overall Study|Withdrawal by Subject|0|||
33695108|NCT03238651|63239604|FG001|Overall Study|Withdrawal by Subject|1|||
33695109|NCT03238651|63239605|FG002|Overall Study|Withdrawal by Subject|0|||
33695110|NCT03238651|63239606|FG003|Overall Study|Withdrawal by Subject|1|||
33695111|NCT03238651|63239607|FG004|Overall Study|Withdrawal by Subject|0|||
33695112|NCT03238651|63239603|FG000|Overall Study|Adverse Event|1|||
33695113|NCT03238651|63239604|FG001|Overall Study|Adverse Event|3|||
33695114|NCT03238651|63239605|FG002|Overall Study|Adverse Event|2|||
33695115|NCT03238651|63239606|FG003|Overall Study|Adverse Event|0|||
33695116|NCT03238651|63239607|FG004|Overall Study|Adverse Event|0|||
33695117|NCT05490771|63239631|FG000|Overall Study|Disease progression|18|||
33695118|NCT05490771|63239631|FG000|Overall Study|Adverse Event|3|||
33695119|NCT05490771|63239631|FG000|Overall Study|Other complicating disease|1|||
33695120|NCT05490771|63239631|FG000|Overall Study|Withdrawal by Subject|3|||
33695121|NCT05490771|63239631|FG000|Overall Study|Physician Decision|1|||
33695122|NCT05490771|63239631|FG000|Overall Study|Still on treatment|2|||
33695123|NCT05490771|63239631|FG000|Overall Study|Never start protocol therapy|5|||
33695124|NCT05490771|63239631|FG000|Overall Study|Ineligible|2|||
33695125|NCT05346055|63239635|FG000|Overall Study|Withdrawal by Subject|1|||
33695126|NCT05346055|63239635|FG000|Overall Study|Protocol Violation|1|||
33695127|NCT05346055|63239635|FG000|Overall Study|Therapist decision|1|||
33695128|NCT05211739|63239645|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
33695129|NCT05211739|63239646|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
33695130|NCT05211739|63239645|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
33695131|NCT05211739|63239646|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
33695132|NCT05211739|63239645|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
33695133|NCT05211739|63239646|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
33695134|NCT05211739|63239645|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
33695135|NCT05211739|63239646|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
33695136|NCT05085405|63239674|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
33695137|NCT05085405|63239675|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
33695138|NCT05085405|63239676|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
33695139|NCT05085405|63239677|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
33695140|NCT05085405|63239678|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
33695141|NCT05085405|63239679|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
33695142|NCT05085405|63239674|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
33695143|NCT05085405|63239675|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
33695144|NCT05085405|63239676|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
33695145|NCT05085405|63239677|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
33695146|NCT05085405|63239678|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
33695147|NCT05085405|63239679|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
33695148|NCT04932941|63239691|FG000|Overall Study|Lost to Follow-up|3|||
33695149|NCT04932941|63239692|FG001|Overall Study|Lost to Follow-up|1|||
33695150|NCT04932941|63239691|FG000|Overall Study|Withdrawal by Subject|7|||
33695151|NCT04932941|63239692|FG001|Overall Study|Withdrawal by Subject|4|||
33695152|NCT04932941|63239691|FG000|Overall Study|Other|4|||
33695153|NCT04932941|63239692|FG001|Overall Study|Other|2|||
33695154|NCT04662073|63239752|FG000|Overall Study|Withdrawal by Subject|1|||
33695155|NCT04662073|63239753|FG001|Overall Study|Withdrawal by Subject|0|||
33695156|NCT04656418|63239761|FG000|Overall Study|Withdrawal by Subject|1|||
33695157|NCT04656418|63239762|FG001|Overall Study|Withdrawal by Subject|3|||
33695158|NCT04622306|63239769|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
33695159|NCT04622306|63239770|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
33695160|NCT04622306|63239771|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
33695161|NCT04622306|63239772|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
33695162|NCT04622306|63239773|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
33695163|NCT04622306|63239774|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
33695164|NCT04622306|63239769|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
33695165|NCT04622306|63239770|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
33695166|NCT04622306|63239771|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
33695167|NCT04622306|63239772|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
33695168|NCT04622306|63239773|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
33695169|NCT04622306|63239774|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
33695170|NCT04601103|63239786|FG000|Overall Study|Needed crown & cleaning|0|||
33695171|NCT04601103|63239787|FG001|Overall Study|Needed crown & cleaning|0|||
33695172|NCT04601103|63239788|FG002|Overall Study|Needed crown & cleaning|1|||
33695173|NCT04601103|63239786|FG000|Overall Study|study was terminated|18|||
33695174|NCT04601103|63239787|FG001|Overall Study|study was terminated|18|||
33695175|NCT04601103|63239788|FG002|Overall Study|study was terminated|16|||
33695176|NCT04575597|63239802|FG000|Overall Study|Death|0|||
33695177|NCT04575597|63239803|FG001|Overall Study|Death|0|||
33695178|NCT04575597|63239804|FG002|Overall Study|Death|0|||
33695179|NCT04575597|63239805|FG003|Overall Study|Death|1|||
33695180|NCT04575597|63239806|FG004|Overall Study|Death|3|||
33695181|NCT04575597|63239807|FG005|Overall Study|Death|14|||
33695182|NCT04575597|63239802|FG000|Overall Study|Lost to Follow-up|2|||
33695183|NCT04575597|63239803|FG001|Overall Study|Lost to Follow-up|1|||
33695184|NCT04575597|63239804|FG002|Overall Study|Lost to Follow-up|1|||
33695185|NCT04575597|63239805|FG003|Overall Study|Lost to Follow-up|2|||
33695186|NCT04575597|63239806|FG004|Overall Study|Lost to Follow-up|10|||
33695187|NCT04575597|63239807|FG005|Overall Study|Lost to Follow-up|8|||
33695188|NCT04575597|63239802|FG000|Overall Study|Withdrawal by Subject|2|||
33695189|NCT04575597|63239803|FG001|Overall Study|Withdrawal by Subject|2|||
33695190|NCT04575597|63239804|FG002|Overall Study|Withdrawal by Subject|4|||
33695191|NCT04575597|63239805|FG003|Overall Study|Withdrawal by Subject|2|||
33695192|NCT04575597|63239806|FG004|Overall Study|Withdrawal by Subject|25|||
33695193|NCT04575597|63239807|FG005|Overall Study|Withdrawal by Subject|28|||
33695194|NCT04575597|63239802|FG000|Overall Study|Not Recorded|0|||
33695195|NCT04575597|63239803|FG001|Overall Study|Not Recorded|0|||
33695196|NCT04575597|63239804|FG002|Overall Study|Not Recorded|0|||
33695197|NCT04575597|63239805|FG003|Overall Study|Not Recorded|0|||
33695198|NCT04575597|63239806|FG004|Overall Study|Not Recorded|0|||
33695199|NCT04575597|63239807|FG005|Overall Study|Not Recorded|2|||
33695200|NCT04575597|63239802|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33695201|NCT04575597|63239803|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33695202|NCT04575597|63239804|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33493194|NCT04247815|62871368|FG001|Overall Study|Withdrawal by Subject|0|||
33695203|NCT04575597|63239805|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33695204|NCT04575597|63239806|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
33695205|NCT04575597|63239807|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
33695206|NCT04546724|63239829|FG000|Overall Study|Withdrawal by Subject|145|||
33695207|NCT04546724|63239830|FG001|Overall Study|Withdrawal by Subject|41|||
33695208|NCT04546724|63239829|FG000|Overall Study|Adverse Event|1|||
33695209|NCT04546724|63239830|FG001|Overall Study|Adverse Event|1|||
33695210|NCT04546724|63239829|FG000|Overall Study|Lost to Follow-up|186|||
33695211|NCT04546724|63239830|FG001|Overall Study|Lost to Follow-up|63|||
33695212|NCT04546724|63239829|FG000|Overall Study|Physician Decision|8|||
33695213|NCT04546724|63239830|FG001|Overall Study|Physician Decision|2|||
33695214|NCT04546724|63239829|FG000|Overall Study|Death|2|||
33695215|NCT04546724|63239830|FG001|Overall Study|Death|1|||
33695216|NCT04546724|63239829|FG000|Overall Study|subject has been out of town|1|||
33695217|NCT04546724|63239830|FG001|Overall Study|subject has been out of town|0|||
33695218|NCT04546724|63239829|FG000|Overall Study|subject is incarcerated|2|||
33695219|NCT04546724|63239830|FG001|Overall Study|subject is incarcerated|0|||
33695220|NCT04546724|63239829|FG000|Overall Study|subject is relocating|12|||
33695221|NCT04546724|63239830|FG001|Overall Study|subject is relocating|4|||
33695222|NCT04546724|63239829|FG000|Overall Study|Subject in another study|1|||
33695223|NCT04546724|63239830|FG001|Overall Study|Subject in another study|1|||
33695224|NCT04514510|63239842|FG000|Overall Study|Lost to Follow-up|0|||
33695225|NCT04514510|63239843|FG001|Overall Study|Lost to Follow-up|1|||
33695226|NCT04514510|63239842|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
33695227|NCT04514510|63239843|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
33695228|NCT04439136|63239855|FG000|Overall Study|Ineligible|1|||
33695229|NCT04439136|63239855|FG000|Overall Study|Never Started Treatment|2|||
33695230|NCT04439136|63239855|FG000|Overall Study|Adverse Event|4|||
33695231|NCT04439136|63239855|FG000|Overall Study|Death|3|||
33695232|NCT04439136|63239855|FG000|Overall Study|Disease Progression|27|||
33695233|NCT04439136|63239855|FG000|Overall Study|Alternative Therapy|1|||
33695234|NCT04439136|63239855|FG000|Overall Study|Increased Tumor Burden|1|||
33695235|NCT04439136|63239855|FG000|Overall Study|Symptomatic Detrioration|1|||
33695236|NCT04439123|63239859|FG000|Overall Study|Adverse Event|11|||
33695237|NCT04439123|63239859|FG000|Overall Study|Death|1|||
33695238|NCT04439123|63239859|FG000|Overall Study|Disease progression|19|||
33695239|NCT04439123|63239859|FG000|Overall Study|Withdrawal by Subject|2|||
33695240|NCT04439123|63239859|FG000|Overall Study|Still on treatment|2|||
33695241|NCT04439110|63239863|FG000|Overall Study|Ineligible|2|||
33695242|NCT04439110|63239863|FG000|Overall Study|Adverse Event|4|||
33695243|NCT04439110|63239863|FG000|Overall Study|Death|2|||
33695244|NCT04439110|63239863|FG000|Overall Study|Disease proression|25|||
33695245|NCT04439110|63239863|FG000|Overall Study|Withdrawal by Subject|1|||
33695246|NCT04439110|63239863|FG000|Overall Study|Alternative therapy|1|||
33695247|NCT04439110|63239863|FG000|Overall Study|Other complicating disease|1|||
33695248|NCT04439110|63239863|FG000|Overall Study|Personal reasons|1|||
33695249|NCT04439110|63239863|FG000|Overall Study|Still on treatment|1|||
33695250|NCT04391842|63239867|FG000|Overall Study|Withdrawal by Subject|2|||
33695251|NCT04327024|63239890|FG000|Overall Study|Death|1|||
33695252|NCT04327024|63239891|FG001|Overall Study|Death|2|||
33695253|NCT04327024|63239892|FG002|Overall Study|Death|1|||
33695254|NCT04327024|63239890|FG000|Overall Study|Non-compliance with study drug|0|||
33695255|NCT04327024|63239891|FG001|Overall Study|Non-compliance with study drug|1|||
33695256|NCT04327024|63239892|FG002|Overall Study|Non-compliance with study drug|0|||
33695257|NCT04327024|63239890|FG000|Overall Study|Withdrawal by Subject|1|||
33695258|NCT04327024|63239891|FG001|Overall Study|Withdrawal by Subject|1|||
33695259|NCT04327024|63239892|FG002|Overall Study|Withdrawal by Subject|2|||
33695260|NCT04322149|63239905|FG000|Overall Study|Adverse Event|1|||
33695261|NCT04322149|63239906|FG001|Overall Study|Adverse Event|1|||
33695262|NCT04322149|63239907|FG002|Overall Study|Adverse Event|0|||
33695263|NCT04322149|63239908|FG003|Overall Study|Adverse Event|0|||
33695264|NCT04322149|63239905|FG000|Overall Study|Withdrawal by Subject|0|||
33695265|NCT04322149|63239906|FG001|Overall Study|Withdrawal by Subject|0|||
33695266|NCT04322149|63239907|FG002|Overall Study|Withdrawal by Subject|0|||
33695267|NCT04322149|63239908|FG003|Overall Study|Withdrawal by Subject|2|||
33695268|NCT04322149|63239905|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
33695269|NCT04322149|63239906|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
33695270|NCT04322149|63239907|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
33695271|NCT04322149|63239908|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
33695272|NCT04294459|63239929|FG000|Overall Study|Adverse Event|0|||
33695273|NCT04294459|63239930|FG001|Overall Study|Adverse Event|1|||
33695274|NCT04226742|63239939|FG000|Overall Study|Lost to Follow-up|16|||
33695275|NCT04226742|63239940|FG001|Overall Study|Lost to Follow-up|13|||
33695276|NCT04226742|63239939|FG000|Overall Study|Withdrawal by Subject|5|||
33695277|NCT04226742|63239940|FG001|Overall Study|Withdrawal by Subject|3|||
33695278|NCT04194528|63239946|FG000|Overall Study|Adverse Event|1|||
33695279|NCT04146012|63239978|FG000|Overall Study|Study Terminated|30|||
33695280|NCT04146012|63239979|FG001|Overall Study|Study Terminated|15|||
33695281|NCT04085458|63239985|FG000|Overall Study|Other|1|||
33695282|NCT04085458|63239985|FG000|Overall Study|Withdrawal by Subject|2|||
33695283|NCT04085458|63239985|FG000|Overall Study|Adverse Event|2|||
33695284|NCT04033159|63239991|FG000|Washout Period|Physician Decision|0|||
33695285|NCT04033159|63239992|FG001|Washout Period|Physician Decision|1|||
33695286|NCT04033159|63239993|FG002|Washout Period|Physician Decision|0|||
33695287|NCT04033159|63239991|FG000|Washout Period|Study terminated by Sponsor|0|||
33695288|NCT04033159|63239992|FG001|Washout Period|Study terminated by Sponsor|7|||
33695289|NCT04033159|63239993|FG002|Washout Period|Study terminated by Sponsor|0|||
33695290|NCT04033159|63239991|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
33695291|NCT04033159|63239992|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
33695292|NCT04033159|63239993|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
33695293|NCT03969888|63240009|FG000|Overall Study|Never Received Study Drug|0|||
33695294|NCT03969888|63240010|FG001|Overall Study|Never Received Study Drug|0|||
33695295|NCT03969888|63240011|FG002|Overall Study|Never Received Study Drug|1|||
33695296|NCT03969888|63240012|FG003|Overall Study|Never Received Study Drug|0|||
33695297|NCT03969888|63240013|FG004|Overall Study|Never Received Study Drug|0|||
33695298|NCT03969888|63240014|FG005|Overall Study|Never Received Study Drug|0|||
33695299|NCT03969888|63240015|FG006|Overall Study|Never Received Study Drug|1|||
33695300|NCT03969888|63240016|FG007|Overall Study|Never Received Study Drug|0|||
33695301|NCT03969888|63240009|FG000|Overall Study|Reason Not Specified|0|||
33695302|NCT03969888|63240010|FG001|Overall Study|Reason Not Specified|0|||
33695303|NCT03969888|63240011|FG002|Overall Study|Reason Not Specified|0|||
33695304|NCT03969888|63240012|FG003|Overall Study|Reason Not Specified|0|||
33695305|NCT03969888|63240013|FG004|Overall Study|Reason Not Specified|0|||
33695306|NCT03969888|63240014|FG005|Overall Study|Reason Not Specified|0|||
33695307|NCT03969888|63240015|FG006|Overall Study|Reason Not Specified|0|||
33695308|NCT03969888|63240016|FG007|Overall Study|Reason Not Specified|1|||
33695309|NCT03952559|63240040|FG000|Double Blind Treatment Period|Adverse Event|0|||
33695310|NCT03952559|63240041|FG001|Double Blind Treatment Period|Adverse Event|2|||
33695311|NCT03952559|63240042|FG002|Double Blind Treatment Period|Adverse Event|1|||
33695312|NCT03952559|63240043|FG003|Double Blind Treatment Period|Adverse Event|0|||
33695313|NCT03952559|63240044|FG004|Double Blind Treatment Period|Adverse Event|1|||
33695314|NCT03952559|63240040|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
33695315|NCT03952559|63240041|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
33695316|NCT03952559|63240042|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
33695317|NCT03952559|63240043|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
33695318|NCT03952559|63240044|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
33695319|NCT03952559|63240040|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
33695320|NCT03952559|63240041|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
33695321|NCT03952559|63240042|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
33695322|NCT03952559|63240043|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
33695323|NCT03952559|63240044|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
33695324|NCT03952559|63240040|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
33695325|NCT03952559|63240041|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
33695326|NCT03952559|63240042|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
33695327|NCT03952559|63240043|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
33695328|NCT03952559|63240044|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
33695329|NCT03945175|63240080|FG000|Overall Study|Did not meet inclusion criteria|31|||
33695330|NCT03945175|63240080|FG000|Overall Study|Withdrew consent|2|||
33695331|NCT03945175|63240080|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
33695332|NCT03945175|63240080|FG000|Overall Study|Early termination during Mydayis treatment|1|||
33695333|NCT03942406|63240091|FG000|Overall Study|Lost to Follow-up|4|||
33695334|NCT03942406|63240092|FG001|Overall Study|Lost to Follow-up|5|||
33695335|NCT03942406|63240093|FG002|Overall Study|Lost to Follow-up|3|||
33695336|NCT03942406|63240094|FG003|Overall Study|Lost to Follow-up|7|||
33695337|NCT03942406|63240095|FG004|Overall Study|Lost to Follow-up|1|||
33695338|NCT03942406|63240096|FG005|Overall Study|Lost to Follow-up|0|||
33695339|NCT03942406|63240097|FG006|Overall Study|Lost to Follow-up|0|||
33695340|NCT03942406|63240091|FG000|Overall Study|Withdrawal by Subject|3|||
33695341|NCT03942406|63240092|FG001|Overall Study|Withdrawal by Subject|1|||
33695342|NCT03942406|63240093|FG002|Overall Study|Withdrawal by Subject|1|||
33695343|NCT03942406|63240094|FG003|Overall Study|Withdrawal by Subject|3|||
33695344|NCT03942406|63240095|FG004|Overall Study|Withdrawal by Subject|0|||
33695345|NCT03942406|63240096|FG005|Overall Study|Withdrawal by Subject|0|||
33695346|NCT03942406|63240097|FG006|Overall Study|Withdrawal by Subject|0|||
33695347|NCT03942406|63240091|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
33695348|NCT03942406|63240092|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
33695349|NCT03942406|63240093|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
33695350|NCT03942406|63240094|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
33695351|NCT03942406|63240095|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
33695352|NCT03942406|63240096|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
33695353|NCT03942406|63240097|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
33695354|NCT03909100|63240131|FG000|Overall Study|Protocol Deviation|2|||
33695355|NCT03909100|63240131|FG000|Overall Study|Technical Problems|4|||
33695356|NCT03909100|63240131|FG000|Overall Study|Withdrawal by Subject|4|||
33695357|NCT03909100|63240131|FG000|Overall Study|Lost to Follow-up|1|||
33695358|NCT03909100|63240131|FG000|Overall Study|Reason not Specified|4|||
33695359|NCT03896295|63240153|FG000|Overall Study|Adverse Event|0|||
33695360|NCT03896295|63240154|FG001|Overall Study|Adverse Event|1|||
33695361|NCT03896295|63240153|FG000|Overall Study|COVID-19|7|||
33695362|NCT03896295|63240154|FG001|Overall Study|COVID-19|29|||
33695363|NCT03734666|63240204|FG000|Overall Study|Other|7|||
33695364|NCT03734666|63240205|FG001|Overall Study|Other|4|||
33695365|NCT03734666|63240204|FG000|Overall Study|Lost to Follow-up|12|||
33695366|NCT03734666|63240205|FG001|Overall Study|Lost to Follow-up|12|||
33695367|NCT03635489|63240218|FG000|Overall Study|Death|6|||
33695368|NCT03635489|63240219|FG001|Overall Study|Death|3|||
33695369|NCT03635489|63240218|FG000|Overall Study|Lost to Follow-up|0|||
33695370|NCT03635489|63240219|FG001|Overall Study|Lost to Follow-up|1|||
33695371|NCT03635489|63240218|FG000|Overall Study|Withdrawal by Subject|1|||
33695372|NCT03635489|63240219|FG001|Overall Study|Withdrawal by Subject|2|||
33695373|NCT03633617|63240230|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
33695374|NCT03633617|63240231|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
33695375|NCT03633617|63240232|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33695376|NCT03633617|63240233|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33695377|NCT03633617|63240234|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33695378|NCT03633617|63240235|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33695379|NCT03633617|63240236|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33695380|NCT03633617|63240237|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33695381|NCT03633617|63240238|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33695382|NCT03633617|63240239|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33695383|NCT03633617|63240240|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33695384|NCT03633617|63240230|FG000|Part A|Unconfirmed early termination visit|1|||
33695385|NCT03633617|63240231|FG001|Part A|Unconfirmed early termination visit|0|||
33695386|NCT03633617|63240232|FG002|Part A|Unconfirmed early termination visit|0|||
33695387|NCT03633617|63240233|FG003|Part A|Unconfirmed early termination visit|0|||
33695388|NCT03633617|63240234|FG004|Part A|Unconfirmed early termination visit|0|||
33695389|NCT03633617|63240235|FG005|Part A|Unconfirmed early termination visit|0|||
33695390|NCT03633617|63240236|FG006|Part A|Unconfirmed early termination visit|0|||
33695391|NCT03633617|63240237|FG007|Part A|Unconfirmed early termination visit|0|||
33695392|NCT03633617|63240238|FG008|Part A|Unconfirmed early termination visit|0|||
33695393|NCT03633617|63240239|FG009|Part A|Unconfirmed early termination visit|0|||
33695394|NCT03633617|63240240|FG010|Part A|Unconfirmed early termination visit|0|||
33695395|NCT03633617|63240230|FG000|Part A|Adverse Event|0|||
33695396|NCT03633617|63240231|FG001|Part A|Adverse Event|1|||
33695397|NCT03633617|63240232|FG002|Part A|Adverse Event|0|||
33695398|NCT03633617|63240233|FG003|Part A|Adverse Event|0|||
33695399|NCT03633617|63240234|FG004|Part A|Adverse Event|0|||
33695400|NCT03633617|63240235|FG005|Part A|Adverse Event|0|||
33695401|NCT03633617|63240236|FG006|Part A|Adverse Event|0|||
33695402|NCT03633617|63240237|FG007|Part A|Adverse Event|0|||
33695403|NCT03633617|63240238|FG008|Part A|Adverse Event|0|||
33695404|NCT03633617|63240239|FG009|Part A|Adverse Event|0|||
33695405|NCT03633617|63240240|FG010|Part A|Adverse Event|0|||
33695406|NCT03633617|63240230|FG000|Part A|Pregnancy|1|||
33695407|NCT03633617|63240231|FG001|Part A|Pregnancy|0|||
33695408|NCT03633617|63240232|FG002|Part A|Pregnancy|0|||
33695409|NCT03633617|63240233|FG003|Part A|Pregnancy|0|||
33695410|NCT03633617|63240234|FG004|Part A|Pregnancy|0|||
33695411|NCT03633617|63240235|FG005|Part A|Pregnancy|0|||
33695412|NCT03633617|63240236|FG006|Part A|Pregnancy|0|||
33695413|NCT03633617|63240237|FG007|Part A|Pregnancy|0|||
33695414|NCT03633617|63240238|FG008|Part A|Pregnancy|0|||
33695415|NCT03633617|63240239|FG009|Part A|Pregnancy|0|||
33695416|NCT03633617|63240240|FG010|Part A|Pregnancy|0|||
33695417|NCT03633617|63240230|FG000|Part A|Withdrawal by Subject|0|||
33695418|NCT03633617|63240231|FG001|Part A|Withdrawal by Subject|1|||
33695419|NCT03633617|63240232|FG002|Part A|Withdrawal by Subject|0|||
33695420|NCT03633617|63240233|FG003|Part A|Withdrawal by Subject|0|||
33695421|NCT03633617|63240234|FG004|Part A|Withdrawal by Subject|0|||
33695422|NCT03633617|63240235|FG005|Part A|Withdrawal by Subject|0|||
33695423|NCT03633617|63240236|FG006|Part A|Withdrawal by Subject|0|||
33401447|NCT00256867|62780478|FG004|Overall Study|Protocol Violation|0|||
33695424|NCT03633617|63240237|FG007|Part A|Withdrawal by Subject|0|||
33695425|NCT03633617|63240238|FG008|Part A|Withdrawal by Subject|0|||
33695426|NCT03633617|63240239|FG009|Part A|Withdrawal by Subject|0|||
33695427|NCT03633617|63240240|FG010|Part A|Withdrawal by Subject|0|||
33695428|NCT03633617|63240230|FG000|Part B|Adverse Event|0|||
33695429|NCT03633617|63240231|FG001|Part B|Adverse Event|0|||
33695430|NCT03633617|63240232|FG002|Part B|Adverse Event|2|||
33695431|NCT03633617|63240233|FG003|Part B|Adverse Event|2|||
33695432|NCT03633617|63240234|FG004|Part B|Adverse Event|1|||
33695433|NCT03633617|63240235|FG005|Part B|Adverse Event|0|||
33695434|NCT03633617|63240236|FG006|Part B|Adverse Event|0|||
33695435|NCT03633617|63240237|FG007|Part B|Adverse Event|0|||
33695436|NCT03633617|63240238|FG008|Part B|Adverse Event|0|||
33695437|NCT03633617|63240239|FG009|Part B|Adverse Event|0|||
33695438|NCT03633617|63240240|FG010|Part B|Adverse Event|0|||
33695439|NCT03633617|63240230|FG000|Part B|Withdrawal by Subject|0|||
33695440|NCT03633617|63240231|FG001|Part B|Withdrawal by Subject|0|||
33695441|NCT03633617|63240232|FG002|Part B|Withdrawal by Subject|1|||
33695442|NCT03633617|63240233|FG003|Part B|Withdrawal by Subject|0|||
33695443|NCT03633617|63240234|FG004|Part B|Withdrawal by Subject|2|||
33695444|NCT03633617|63240235|FG005|Part B|Withdrawal by Subject|0|||
33695445|NCT03633617|63240236|FG006|Part B|Withdrawal by Subject|0|||
33695446|NCT03633617|63240237|FG007|Part B|Withdrawal by Subject|0|||
33695447|NCT03633617|63240238|FG008|Part B|Withdrawal by Subject|0|||
33695448|NCT03633617|63240239|FG009|Part B|Withdrawal by Subject|0|||
33695449|NCT03633617|63240240|FG010|Part B|Withdrawal by Subject|0|||
33695450|NCT03633617|63240230|FG000|Part B|Lost to Follow-up|0|||
33695451|NCT03633617|63240231|FG001|Part B|Lost to Follow-up|0|||
33695452|NCT03633617|63240232|FG002|Part B|Lost to Follow-up|0|||
33695453|NCT03633617|63240233|FG003|Part B|Lost to Follow-up|0|||
33695454|NCT03633617|63240234|FG004|Part B|Lost to Follow-up|1|||
33695455|NCT03633617|63240235|FG005|Part B|Lost to Follow-up|0|||
33695456|NCT03633617|63240236|FG006|Part B|Lost to Follow-up|0|||
33695457|NCT03633617|63240237|FG007|Part B|Lost to Follow-up|0|||
33695458|NCT03633617|63240238|FG008|Part B|Lost to Follow-up|0|||
33695459|NCT03633617|63240239|FG009|Part B|Lost to Follow-up|0|||
33695460|NCT03633617|63240240|FG010|Part B|Lost to Follow-up|0|||
33695461|NCT03633617|63240230|FG000|Part B|Physician Decision|0|||
33695462|NCT03633617|63240231|FG001|Part B|Physician Decision|0|||
33695463|NCT03633617|63240232|FG002|Part B|Physician Decision|0|||
33695464|NCT03633617|63240233|FG003|Part B|Physician Decision|0|||
33695465|NCT03633617|63240234|FG004|Part B|Physician Decision|1|||
33695466|NCT03633617|63240235|FG005|Part B|Physician Decision|0|||
33695467|NCT03633617|63240236|FG006|Part B|Physician Decision|0|||
33695468|NCT03633617|63240237|FG007|Part B|Physician Decision|0|||
33695469|NCT03633617|63240238|FG008|Part B|Physician Decision|0|||
33695470|NCT03633617|63240239|FG009|Part B|Physician Decision|0|||
33695471|NCT03633617|63240240|FG010|Part B|Physician Decision|0|||
33695472|NCT03633617|63240230|FG000|Part B|COVID-19 Restrictions|0|||
33695473|NCT03633617|63240231|FG001|Part B|COVID-19 Restrictions|0|||
33695474|NCT03633617|63240232|FG002|Part B|COVID-19 Restrictions|1|||
33695475|NCT03633617|63240233|FG003|Part B|COVID-19 Restrictions|0|||
33695476|NCT03633617|63240234|FG004|Part B|COVID-19 Restrictions|0|||
33695477|NCT03633617|63240235|FG005|Part B|COVID-19 Restrictions|0|||
33695478|NCT03633617|63240236|FG006|Part B|COVID-19 Restrictions|0|||
33695479|NCT03633617|63240237|FG007|Part B|COVID-19 Restrictions|0|||
33695480|NCT03633617|63240238|FG008|Part B|COVID-19 Restrictions|0|||
33695481|NCT03633617|63240239|FG009|Part B|COVID-19 Restrictions|0|||
33695482|NCT03633617|63240240|FG010|Part B|COVID-19 Restrictions|0|||
33695483|NCT03633617|63240230|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33695484|NCT03633617|63240231|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33695485|NCT03633617|63240232|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
33695486|NCT03633617|63240233|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33695487|NCT03633617|63240234|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33695488|NCT03633617|63240235|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33695489|NCT03633617|63240236|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33695490|NCT03633617|63240237|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33695491|NCT03633617|63240238|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33695492|NCT03633617|63240239|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33695493|NCT03633617|63240240|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33695494|NCT03633617|63240230|FG000|Part C (& Follow-up)|Adverse Event|0|||
33695495|NCT03633617|63240231|FG001|Part C (& Follow-up)|Adverse Event|0|||
33695496|NCT03633617|63240232|FG002|Part C (& Follow-up)|Adverse Event|0|||
33695497|NCT03633617|63240233|FG003|Part C (& Follow-up)|Adverse Event|0|||
33695498|NCT03633617|63240234|FG004|Part C (& Follow-up)|Adverse Event|0|||
33695499|NCT03633617|63240235|FG005|Part C (& Follow-up)|Adverse Event|1|||
33695500|NCT03633617|63240236|FG006|Part C (& Follow-up)|Adverse Event|0|||
33695501|NCT03633617|63240237|FG007|Part C (& Follow-up)|Adverse Event|1|||
33695502|NCT03633617|63240238|FG008|Part C (& Follow-up)|Adverse Event|0|||
33695503|NCT03633617|63240239|FG009|Part C (& Follow-up)|Adverse Event|0|||
33695504|NCT03633617|63240240|FG010|Part C (& Follow-up)|Adverse Event|0|||
33695505|NCT03633617|63240230|FG000|Part C (& Follow-up)|Pregnancy|0|||
33695506|NCT03633617|63240231|FG001|Part C (& Follow-up)|Pregnancy|0|||
33695507|NCT03633617|63240232|FG002|Part C (& Follow-up)|Pregnancy|0|||
33695508|NCT03633617|63240233|FG003|Part C (& Follow-up)|Pregnancy|0|||
33695509|NCT03633617|63240234|FG004|Part C (& Follow-up)|Pregnancy|0|||
33695510|NCT03633617|63240235|FG005|Part C (& Follow-up)|Pregnancy|0|||
33695511|NCT03633617|63240236|FG006|Part C (& Follow-up)|Pregnancy|0|||
33695512|NCT03633617|63240237|FG007|Part C (& Follow-up)|Pregnancy|0|||
33695513|NCT03633617|63240238|FG008|Part C (& Follow-up)|Pregnancy|0|||
33695514|NCT03633617|63240239|FG009|Part C (& Follow-up)|Pregnancy|1|||
33695515|NCT03633617|63240240|FG010|Part C (& Follow-up)|Pregnancy|0|||
33695516|NCT03633617|63240230|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
33695517|NCT03633617|63240231|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
33695518|NCT03633617|63240232|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
33695519|NCT03633617|63240233|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
33695520|NCT03633617|63240234|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
33695521|NCT03633617|63240235|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
33695522|NCT03633617|63240236|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
33695523|NCT03633617|63240237|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
33695524|NCT03633617|63240238|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
33695525|NCT03633617|63240239|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
33695526|NCT03633617|63240240|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
33695527|NCT03633617|63240230|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
33695528|NCT03633617|63240231|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
33695529|NCT03633617|63240232|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
33695530|NCT03633617|63240233|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
33695531|NCT03633617|63240234|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
33695532|NCT03633617|63240235|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
33695533|NCT03633617|63240236|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
33695534|NCT03633617|63240237|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
33695535|NCT03633617|63240238|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
33695536|NCT03633617|63240239|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
33695537|NCT03633617|63240240|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
33695538|NCT03633617|63240230|FG000|Part C (& Follow-up)|Physician Decision|0|||
33695539|NCT03633617|63240231|FG001|Part C (& Follow-up)|Physician Decision|0|||
33695540|NCT03633617|63240232|FG002|Part C (& Follow-up)|Physician Decision|0|||
33695541|NCT03633617|63240233|FG003|Part C (& Follow-up)|Physician Decision|0|||
33695542|NCT03633617|63240234|FG004|Part C (& Follow-up)|Physician Decision|0|||
33695543|NCT03633617|63240235|FG005|Part C (& Follow-up)|Physician Decision|0|||
33695544|NCT03633617|63240236|FG006|Part C (& Follow-up)|Physician Decision|0|||
33695545|NCT03633617|63240237|FG007|Part C (& Follow-up)|Physician Decision|1|||
33695546|NCT03633617|63240238|FG008|Part C (& Follow-up)|Physician Decision|0|||
33695547|NCT03633617|63240239|FG009|Part C (& Follow-up)|Physician Decision|0|||
33695548|NCT03633617|63240240|FG010|Part C (& Follow-up)|Physician Decision|1|||
33695549|NCT03633617|63240230|FG000|Part C (& Follow-up)|COVID-19 related|0|||
33695550|NCT03633617|63240231|FG001|Part C (& Follow-up)|COVID-19 related|0|||
33695551|NCT03633617|63240232|FG002|Part C (& Follow-up)|COVID-19 related|0|||
33695552|NCT03633617|63240233|FG003|Part C (& Follow-up)|COVID-19 related|0|||
33695553|NCT03633617|63240234|FG004|Part C (& Follow-up)|COVID-19 related|0|||
33695554|NCT03633617|63240235|FG005|Part C (& Follow-up)|COVID-19 related|1|||
33695555|NCT03633617|63240236|FG006|Part C (& Follow-up)|COVID-19 related|0|||
33695556|NCT03633617|63240237|FG007|Part C (& Follow-up)|COVID-19 related|0|||
33695557|NCT03633617|63240238|FG008|Part C (& Follow-up)|COVID-19 related|0|||
33695558|NCT03633617|63240239|FG009|Part C (& Follow-up)|COVID-19 related|0|||
33695559|NCT03633617|63240240|FG010|Part C (& Follow-up)|COVID-19 related|0|||
33695560|NCT03633617|63240230|FG000|Part C (& Follow-up)|Protocol Violation|0|||
33695561|NCT03633617|63240231|FG001|Part C (& Follow-up)|Protocol Violation|0|||
33695562|NCT03633617|63240232|FG002|Part C (& Follow-up)|Protocol Violation|0|||
33695563|NCT03633617|63240233|FG003|Part C (& Follow-up)|Protocol Violation|0|||
33695564|NCT03633617|63240234|FG004|Part C (& Follow-up)|Protocol Violation|0|||
33695565|NCT03633617|63240235|FG005|Part C (& Follow-up)|Protocol Violation|0|||
33695566|NCT03633617|63240236|FG006|Part C (& Follow-up)|Protocol Violation|0|||
33695567|NCT03633617|63240237|FG007|Part C (& Follow-up)|Protocol Violation|0|||
33695568|NCT03633617|63240238|FG008|Part C (& Follow-up)|Protocol Violation|0|||
33695569|NCT03633617|63240239|FG009|Part C (& Follow-up)|Protocol Violation|3|||
33695570|NCT03633617|63240240|FG010|Part C (& Follow-up)|Protocol Violation|1|||
33695571|NCT03633617|63240230|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
33695572|NCT03633617|63240231|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
33695573|NCT03633617|63240232|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
33695574|NCT03633617|63240233|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
33695575|NCT03633617|63240234|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
33695576|NCT03633617|63240235|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
33695577|NCT03633617|63240236|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
33695578|NCT03633617|63240237|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
33695579|NCT03633617|63240238|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
33695580|NCT03633617|63240239|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
33695581|NCT03633617|63240240|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
33695582|NCT03631784|63240270|FG000|Overall Study|Death|48|||
33695583|NCT03631784|63240271|FG001|Overall Study|Death|28|||
33695584|NCT03631784|63240270|FG000|Overall Study|Lost to Follow-up|1|||
33695585|NCT03631784|63240271|FG001|Overall Study|Lost to Follow-up|0|||
33695586|NCT03631784|63240270|FG000|Overall Study|Withdrawal by Subject|0|||
33695587|NCT03631784|63240271|FG001|Overall Study|Withdrawal by Subject|3|||
33695588|NCT03631784|63240270|FG000|Overall Study|Participants Ongoing|63|||
33695589|NCT03631784|63240271|FG001|Overall Study|Participants Ongoing|71|||
33695590|NCT03617705|63240277|FG000|Overall Study|Withdrawal by Subject|2|||
33695591|NCT03617705|63240277|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
33695592|NCT03617705|63240277|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
33695593|NCT03607422|63240287|FG000|Overall Study|Adverse Event|7|||
33695594|NCT03607422|63240288|FG001|Overall Study|Adverse Event|3|||
33695595|NCT03607422|63240289|FG002|Overall Study|Adverse Event|2|||
33695596|NCT03607422|63240290|FG003|Overall Study|Adverse Event|0|||
33695597|NCT03607422|63240291|FG004|Overall Study|Adverse Event|2|||
33695598|NCT03607422|63240292|FG005|Overall Study|Adverse Event|0|||
33695599|NCT03607422|63240287|FG000|Overall Study|Withdrawal by Subject|11|||
33695600|NCT03607422|63240288|FG001|Overall Study|Withdrawal by Subject|3|||
33695601|NCT03607422|63240289|FG002|Overall Study|Withdrawal by Subject|6|||
33695602|NCT03607422|63240290|FG003|Overall Study|Withdrawal by Subject|2|||
33695603|NCT03607422|63240291|FG004|Overall Study|Withdrawal by Subject|0|||
33695604|NCT03607422|63240292|FG005|Overall Study|Withdrawal by Subject|0|||
33695605|NCT03607422|63240287|FG000|Overall Study|Lost to Follow-up|0|||
33695606|NCT03607422|63240288|FG001|Overall Study|Lost to Follow-up|0|||
33695607|NCT03607422|63240289|FG002|Overall Study|Lost to Follow-up|1|||
33695608|NCT03607422|63240290|FG003|Overall Study|Lost to Follow-up|0|||
33695609|NCT03607422|63240291|FG004|Overall Study|Lost to Follow-up|0|||
33695610|NCT03607422|63240292|FG005|Overall Study|Lost to Follow-up|0|||
33695611|NCT03607422|63240287|FG000|Overall Study|Other|12|||
33695612|NCT03607422|63240288|FG001|Overall Study|Other|4|||
33695613|NCT03607422|63240289|FG002|Overall Study|Other|1|||
33695614|NCT03607422|63240290|FG003|Overall Study|Other|2|||
33695615|NCT03607422|63240291|FG004|Overall Study|Other|0|||
33695616|NCT03607422|63240292|FG005|Overall Study|Other|2|||
33695617|NCT03607422|63240287|FG000|Overall Study|Ongoing at Time of Analysis|8|||
33695618|NCT03607422|63240288|FG001|Overall Study|Ongoing at Time of Analysis|0|||
33695619|NCT03607422|63240289|FG002|Overall Study|Ongoing at Time of Analysis|2|||
33695620|NCT03607422|63240290|FG003|Overall Study|Ongoing at Time of Analysis|1|||
33695621|NCT03607422|63240291|FG004|Overall Study|Ongoing at Time of Analysis|1|||
33695622|NCT03607422|63240292|FG005|Overall Study|Ongoing at Time of Analysis|1|||
33695623|NCT03568318|63240330|FG000|Overall Study|Adverse Event|3|||
33695624|NCT03568318|63240331|FG001|Overall Study|Adverse Event|1|||
33695625|NCT03568318|63240332|FG002|Overall Study|Adverse Event|1|||
33695626|NCT03568318|63240333|FG003|Overall Study|Adverse Event|0|||
33695627|NCT03568318|63240334|FG004|Overall Study|Adverse Event|1|||
33695628|NCT03568318|63240335|FG005|Overall Study|Adverse Event|0|||
33695629|NCT03568318|63240330|FG000|Overall Study|Withdrawal by Subject|6|||
33695630|NCT03568318|63240331|FG001|Overall Study|Withdrawal by Subject|5|||
33695631|NCT03568318|63240332|FG002|Overall Study|Withdrawal by Subject|2|||
33695632|NCT03568318|63240333|FG003|Overall Study|Withdrawal by Subject|1|||
33695633|NCT03568318|63240334|FG004|Overall Study|Withdrawal by Subject|0|||
33695634|NCT03568318|63240335|FG005|Overall Study|Withdrawal by Subject|0|||
33695635|NCT03568318|63240330|FG000|Overall Study|Lost to Follow-up|3|||
33695636|NCT03568318|63240331|FG001|Overall Study|Lost to Follow-up|2|||
33695637|NCT03568318|63240332|FG002|Overall Study|Lost to Follow-up|2|||
33695638|NCT03568318|63240333|FG003|Overall Study|Lost to Follow-up|2|||
33695639|NCT03568318|63240334|FG004|Overall Study|Lost to Follow-up|1|||
33695640|NCT03568318|63240335|FG005|Overall Study|Lost to Follow-up|0|||
33695641|NCT03568318|63240330|FG000|Overall Study|Other|3|||
33695642|NCT03568318|63240331|FG001|Overall Study|Other|1|||
33695643|NCT03568318|63240332|FG002|Overall Study|Other|3|||
33695644|NCT03568318|63240333|FG003|Overall Study|Other|0|||
33695645|NCT03568318|63240334|FG004|Overall Study|Other|0|||
33596306|NCT02143713|62995307|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
33596307|NCT02143713|62995308|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
33596308|NCT02143713|62995305|FG000|Treatment Period (6 Months)|Adverse Event|7|||
33596309|NCT02143713|62995306|FG001|Treatment Period (6 Months)|Adverse Event|8|||
33596310|NCT02143713|62995307|FG002|Treatment Period (6 Months)|Adverse Event|8|||
33596311|NCT02143713|62995308|FG003|Treatment Period (6 Months)|Adverse Event|9|||
33596312|NCT02143713|62995305|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
33596313|NCT02143713|62995306|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
33596314|NCT02143713|62995307|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
33596315|NCT02143713|62995308|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
33695646|NCT03568318|63240335|FG005|Overall Study|Other|0|||
33695647|NCT03568318|63240330|FG000|Overall Study|Ongoing at Time of Analysis|5|||
33695648|NCT03568318|63240331|FG001|Overall Study|Ongoing at Time of Analysis|3|||
33695649|NCT03568318|63240332|FG002|Overall Study|Ongoing at Time of Analysis|2|||
33695650|NCT03568318|63240333|FG003|Overall Study|Ongoing at Time of Analysis|1|||
33695651|NCT03568318|63240334|FG004|Overall Study|Ongoing at Time of Analysis|0|||
33695652|NCT03568318|63240335|FG005|Overall Study|Ongoing at Time of Analysis|0|||
33695653|NCT03550794|63240351|FG000|Overall Study|No longer met inclusion criteria|1|||
33695654|NCT03550794|63240352|FG001|Overall Study|No longer met inclusion criteria|2|||
33695655|NCT03550794|63240351|FG000|Overall Study|Goals of care changed|1|||
33695656|NCT03550794|63240352|FG001|Overall Study|Goals of care changed|0|||
33695657|NCT03550794|63240351|FG000|Overall Study|Withdrawal by Subject|2|||
33695658|NCT03550794|63240352|FG001|Overall Study|Withdrawal by Subject|0|||
33695659|NCT03550794|63240351|FG000|Overall Study|Death|0|||
33695660|NCT03550794|63240352|FG001|Overall Study|Death|1|||
33695661|NCT03459846|63240377|FG000|Overall Study|Death|52|||
33695662|NCT03459846|63240378|FG001|Overall Study|Death|46|||
33695663|NCT03459846|63240377|FG000|Overall Study|Study terminated by sponsor|24|||
33695664|NCT03459846|63240378|FG001|Overall Study|Study terminated by sponsor|28|||
33695665|NCT03459846|63240377|FG000|Overall Study|Withdrawal by Subject|2|||
33695666|NCT03459846|63240378|FG001|Overall Study|Withdrawal by Subject|2|||
33695667|NCT03427125|63240404|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
33695668|NCT03427125|63240405|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
33695669|NCT03427125|63240406|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
33695670|NCT03341273|63240421|FG000|Overall Study|Lost to Follow-up|7|||
33695671|NCT03341273|63240422|FG001|Overall Study|Lost to Follow-up|7|||
33695672|NCT03341273|63240421|FG000|Overall Study|Withdrawal by Subject|4|||
33695673|NCT03341273|63240422|FG001|Overall Study|Withdrawal by Subject|2|||
33695674|NCT03341273|63240421|FG000|Overall Study|Physician Decision|1|||
33695675|NCT03341273|63240422|FG001|Overall Study|Physician Decision|0|||
33695676|NCT03341273|63240421|FG000|Overall Study|Protocol Violation|0|||
33695677|NCT03341273|63240422|FG001|Overall Study|Protocol Violation|1|||
33695678|NCT03341273|63240421|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
33695679|NCT03341273|63240422|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
33695680|NCT03341273|63240421|FG000|Overall Study|Became ineligible after enrollment|1|||
33695681|NCT03341273|63240422|FG001|Overall Study|Became ineligible after enrollment|0|||
33695682|NCT03341273|63240421|FG000|Overall Study|Not Eligible at Enrollment|0|||
33695683|NCT03341273|63240422|FG001|Overall Study|Not Eligible at Enrollment|1|||
33695684|NCT03341273|63240421|FG000|Overall Study|Participant incarcerated|1|||
33695685|NCT03341273|63240422|FG001|Overall Study|Participant incarcerated|0|||
33695686|NCT03307785|63240439|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
33695687|NCT03307785|63240440|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
33695688|NCT03307785|63240441|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
33695689|NCT03307785|63240442|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
33695690|NCT03307785|63240443|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
33695691|NCT03307785|63240444|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
33695692|NCT03307785|63240445|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
33695693|NCT03307785|63240446|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
33695694|NCT03307785|63240447|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
33695695|NCT03307785|63240448|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
33695696|NCT03307785|63240449|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
33695697|NCT03307785|63240439|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
33695698|NCT03307785|63240440|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
33596316|NCT02143713|62995305|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
33695699|NCT03307785|63240441|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33695700|NCT03307785|63240442|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33695701|NCT03307785|63240443|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33695702|NCT03307785|63240444|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33695703|NCT03307785|63240445|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33695704|NCT03307785|63240446|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33695705|NCT03307785|63240447|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33695706|NCT03307785|63240448|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33695707|NCT03307785|63240449|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33695708|NCT03307785|63240439|FG000|Part A: Up to 28.5 Months|Death|4|||
33695709|NCT03307785|63240440|FG001|Part A: Up to 28.5 Months|Death|4|||
33695710|NCT03307785|63240441|FG002|Part A: Up to 28.5 Months|Death|0|||
33695711|NCT03307785|63240442|FG003|Part A: Up to 28.5 Months|Death|0|||
33695712|NCT03307785|63240443|FG004|Part A: Up to 28.5 Months|Death|0|||
33695713|NCT03307785|63240444|FG005|Part A: Up to 28.5 Months|Death|0|||
33695714|NCT03307785|63240445|FG006|Part A: Up to 28.5 Months|Death|0|||
33695715|NCT03307785|63240446|FG007|Part A: Up to 28.5 Months|Death|0|||
33695716|NCT03307785|63240447|FG008|Part A: Up to 28.5 Months|Death|0|||
33695717|NCT03307785|63240448|FG009|Part A: Up to 28.5 Months|Death|0|||
33695718|NCT03307785|63240449|FG010|Part A: Up to 28.5 Months|Death|0|||
33695719|NCT03307785|63240439|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
33695720|NCT03307785|63240440|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
33695721|NCT03307785|63240441|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
33695722|NCT03307785|63240442|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
33695723|NCT03307785|63240443|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
33695724|NCT03307785|63240444|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
33695725|NCT03307785|63240445|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
33695726|NCT03307785|63240446|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
33695727|NCT03307785|63240447|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
33695728|NCT03307785|63240448|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
33695729|NCT03307785|63240449|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
33695730|NCT03307785|63240439|FG000|Part B: Up to 28.5 Months|Disease progression|0|||
33695731|NCT03307785|63240440|FG001|Part B: Up to 28.5 Months|Disease progression|0|||
33695732|NCT03307785|63240441|FG002|Part B: Up to 28.5 Months|Disease progression|1|||
33695733|NCT03307785|63240442|FG003|Part B: Up to 28.5 Months|Disease progression|0|||
33695734|NCT03307785|63240443|FG004|Part B: Up to 28.5 Months|Disease progression|0|||
33695735|NCT03307785|63240444|FG005|Part B: Up to 28.5 Months|Disease progression|0|||
33695736|NCT03307785|63240445|FG006|Part B: Up to 28.5 Months|Disease progression|0|||
33695737|NCT03307785|63240446|FG007|Part B: Up to 28.5 Months|Disease progression|0|||
33695738|NCT03307785|63240447|FG008|Part B: Up to 28.5 Months|Disease progression|0|||
33695739|NCT03307785|63240448|FG009|Part B: Up to 28.5 Months|Disease progression|0|||
33695740|NCT03307785|63240449|FG010|Part B: Up to 28.5 Months|Disease progression|0|||
33695741|NCT03307785|63240439|FG000|Part B: Up to 28.5 Months|Physician Decision|0|||
33695742|NCT03307785|63240440|FG001|Part B: Up to 28.5 Months|Physician Decision|0|||
33695743|NCT03307785|63240441|FG002|Part B: Up to 28.5 Months|Physician Decision|1|||
33695744|NCT03307785|63240442|FG003|Part B: Up to 28.5 Months|Physician Decision|0|||
33695745|NCT03307785|63240443|FG004|Part B: Up to 28.5 Months|Physician Decision|0|||
33695746|NCT03307785|63240444|FG005|Part B: Up to 28.5 Months|Physician Decision|0|||
33695747|NCT03307785|63240445|FG006|Part B: Up to 28.5 Months|Physician Decision|0|||
33695748|NCT03307785|63240446|FG007|Part B: Up to 28.5 Months|Physician Decision|0|||
33695749|NCT03307785|63240447|FG008|Part B: Up to 28.5 Months|Physician Decision|0|||
33695750|NCT03307785|63240448|FG009|Part B: Up to 28.5 Months|Physician Decision|0|||
33695751|NCT03307785|63240449|FG010|Part B: Up to 28.5 Months|Physician Decision|0|||
33695752|NCT03307785|63240439|FG000|Part B: Up to 28.5 Months|Death|0|||
33695753|NCT03307785|63240440|FG001|Part B: Up to 28.5 Months|Death|0|||
33695754|NCT03307785|63240441|FG002|Part B: Up to 28.5 Months|Death|7|||
33695755|NCT03307785|63240442|FG003|Part B: Up to 28.5 Months|Death|0|||
33695756|NCT03307785|63240443|FG004|Part B: Up to 28.5 Months|Death|0|||
33695757|NCT03307785|63240444|FG005|Part B: Up to 28.5 Months|Death|0|||
33695758|NCT03307785|63240445|FG006|Part B: Up to 28.5 Months|Death|0|||
33695759|NCT03307785|63240446|FG007|Part B: Up to 28.5 Months|Death|0|||
33695760|NCT03307785|63240447|FG008|Part B: Up to 28.5 Months|Death|0|||
33695761|NCT03307785|63240448|FG009|Part B: Up to 28.5 Months|Death|0|||
33695762|NCT03307785|63240449|FG010|Part B: Up to 28.5 Months|Death|0|||
33695763|NCT03307785|63240439|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
33695764|NCT03307785|63240440|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
33695765|NCT03307785|63240441|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1|||
33695766|NCT03307785|63240442|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
33695767|NCT03307785|63240443|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
33695768|NCT03307785|63240444|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
33695769|NCT03307785|63240445|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
33695770|NCT03307785|63240446|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
33695771|NCT03307785|63240447|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
33695772|NCT03307785|63240448|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
33695773|NCT03307785|63240449|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
33695774|NCT03307785|63240439|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
33695775|NCT03307785|63240440|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
33695776|NCT03307785|63240441|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4|||
33695777|NCT03307785|63240442|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
33695778|NCT03307785|63240443|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
33695779|NCT03307785|63240444|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
33695780|NCT03307785|63240445|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
33695781|NCT03307785|63240446|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
33695782|NCT03307785|63240447|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
33695783|NCT03307785|63240448|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
33695784|NCT03307785|63240449|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
33695785|NCT03307785|63240439|FG000|Part C: Up to 22.5 Months|Disease progression|0|||
33695786|NCT03307785|63240440|FG001|Part C: Up to 22.5 Months|Disease progression|0|||
33695787|NCT03307785|63240441|FG002|Part C: Up to 22.5 Months|Disease progression|0|||
33695788|NCT03307785|63240442|FG003|Part C: Up to 22.5 Months|Disease progression|0|||
33695789|NCT03307785|63240443|FG004|Part C: Up to 22.5 Months|Disease progression|1|||
33695790|NCT03307785|63240444|FG005|Part C: Up to 22.5 Months|Disease progression|0|||
33695791|NCT03307785|63240445|FG006|Part C: Up to 22.5 Months|Disease progression|0|||
33695792|NCT03307785|63240446|FG007|Part C: Up to 22.5 Months|Disease progression|0|||
33695793|NCT03307785|63240447|FG008|Part C: Up to 22.5 Months|Disease progression|0|||
33695794|NCT03307785|63240448|FG009|Part C: Up to 22.5 Months|Disease progression|0|||
33695795|NCT03307785|63240449|FG010|Part C: Up to 22.5 Months|Disease progression|0|||
33695796|NCT03307785|63240439|FG000|Part C: Up to 22.5 Months|Physician Decision|0|||
33695797|NCT03307785|63240440|FG001|Part C: Up to 22.5 Months|Physician Decision|0|||
33695798|NCT03307785|63240441|FG002|Part C: Up to 22.5 Months|Physician Decision|0|||
33695799|NCT03307785|63240442|FG003|Part C: Up to 22.5 Months|Physician Decision|3|||
33695800|NCT03307785|63240443|FG004|Part C: Up to 22.5 Months|Physician Decision|1|||
33695801|NCT03307785|63240444|FG005|Part C: Up to 22.5 Months|Physician Decision|0|||
33695802|NCT03307785|63240445|FG006|Part C: Up to 22.5 Months|Physician Decision|0|||
33695803|NCT03307785|63240446|FG007|Part C: Up to 22.5 Months|Physician Decision|0|||
33695804|NCT03307785|63240447|FG008|Part C: Up to 22.5 Months|Physician Decision|0|||
33695805|NCT03307785|63240448|FG009|Part C: Up to 22.5 Months|Physician Decision|0|||
33695806|NCT03307785|63240449|FG010|Part C: Up to 22.5 Months|Physician Decision|0|||
33695807|NCT03307785|63240439|FG000|Part C: Up to 22.5 Months|Death|0|||
33695808|NCT03307785|63240440|FG001|Part C: Up to 22.5 Months|Death|0|||
33695809|NCT03307785|63240441|FG002|Part C: Up to 22.5 Months|Death|0|||
33695810|NCT03307785|63240442|FG003|Part C: Up to 22.5 Months|Death|1|||
33695811|NCT03307785|63240443|FG004|Part C: Up to 22.5 Months|Death|4|||
33695812|NCT03307785|63240444|FG005|Part C: Up to 22.5 Months|Death|0|||
33695813|NCT03307785|63240445|FG006|Part C: Up to 22.5 Months|Death|0|||
33695814|NCT03307785|63240446|FG007|Part C: Up to 22.5 Months|Death|0|||
33695815|NCT03307785|63240447|FG008|Part C: Up to 22.5 Months|Death|0|||
33695816|NCT03307785|63240448|FG009|Part C: Up to 22.5 Months|Death|0|||
33695817|NCT03307785|63240449|FG010|Part C: Up to 22.5 Months|Death|0|||
33695818|NCT03307785|63240439|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
33695819|NCT03307785|63240440|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
33695820|NCT03307785|63240441|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
33695821|NCT03307785|63240442|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1|||
33695822|NCT03307785|63240443|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
33695823|NCT03307785|63240444|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
33695824|NCT03307785|63240445|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
33695825|NCT03307785|63240446|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
33695826|NCT03307785|63240447|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
33695827|NCT03307785|63240448|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
33695828|NCT03307785|63240449|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
33695829|NCT03307785|63240439|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
33695830|NCT03307785|63240440|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
33695831|NCT03307785|63240441|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
33695832|NCT03307785|63240442|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
33695833|NCT03307785|63240443|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
33695834|NCT03307785|63240444|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
33695835|NCT03307785|63240445|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
33695836|NCT03307785|63240446|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
33695837|NCT03307785|63240447|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
33695838|NCT03307785|63240448|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
33695839|NCT03307785|63240449|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
33695840|NCT03307785|63240439|FG000|Part D: Up to 9.5 Months|Physician Decision|0|||
33695841|NCT03307785|63240440|FG001|Part D: Up to 9.5 Months|Physician Decision|0|||
33695842|NCT03307785|63240441|FG002|Part D: Up to 9.5 Months|Physician Decision|0|||
33695843|NCT03307785|63240442|FG003|Part D: Up to 9.5 Months|Physician Decision|0|||
33695844|NCT03307785|63240443|FG004|Part D: Up to 9.5 Months|Physician Decision|0|||
33695845|NCT03307785|63240444|FG005|Part D: Up to 9.5 Months|Physician Decision|1|||
33695846|NCT03307785|63240445|FG006|Part D: Up to 9.5 Months|Physician Decision|0|||
33695847|NCT03307785|63240446|FG007|Part D: Up to 9.5 Months|Physician Decision|0|||
33695848|NCT03307785|63240447|FG008|Part D: Up to 9.5 Months|Physician Decision|0|||
33695849|NCT03307785|63240448|FG009|Part D: Up to 9.5 Months|Physician Decision|0|||
33695850|NCT03307785|63240449|FG010|Part D: Up to 9.5 Months|Physician Decision|0|||
33695851|NCT03307785|63240439|FG000|Part D: Up to 9.5 Months|Death|0|||
33695852|NCT03307785|63240440|FG001|Part D: Up to 9.5 Months|Death|0|||
33695853|NCT03307785|63240441|FG002|Part D: Up to 9.5 Months|Death|0|||
33695854|NCT03307785|63240442|FG003|Part D: Up to 9.5 Months|Death|0|||
33695855|NCT03307785|63240443|FG004|Part D: Up to 9.5 Months|Death|0|||
33695856|NCT03307785|63240444|FG005|Part D: Up to 9.5 Months|Death|1|||
33695857|NCT03307785|63240445|FG006|Part D: Up to 9.5 Months|Death|0|||
33695858|NCT03307785|63240446|FG007|Part D: Up to 9.5 Months|Death|0|||
33695859|NCT03307785|63240447|FG008|Part D: Up to 9.5 Months|Death|0|||
33695860|NCT03307785|63240448|FG009|Part D: Up to 9.5 Months|Death|0|||
33695861|NCT03307785|63240449|FG010|Part D: Up to 9.5 Months|Death|0|||
33695862|NCT03307785|63240439|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
33695863|NCT03307785|63240440|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
33695864|NCT03307785|63240441|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
33695865|NCT03307785|63240442|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
33695866|NCT03307785|63240443|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
33695867|NCT03307785|63240444|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1|||
33695868|NCT03307785|63240445|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
33695869|NCT03307785|63240446|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
33695870|NCT03307785|63240447|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
33695871|NCT03307785|63240448|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
33695872|NCT03307785|63240449|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
33695873|NCT03307785|63240439|FG000|Part E: Up to 4.4 Months|Death|0|||
33695874|NCT03307785|63240440|FG001|Part E: Up to 4.4 Months|Death|0|||
33695875|NCT03307785|63240441|FG002|Part E: Up to 4.4 Months|Death|0|||
33695876|NCT03307785|63240442|FG003|Part E: Up to 4.4 Months|Death|0|||
33695877|NCT03307785|63240443|FG004|Part E: Up to 4.4 Months|Death|0|||
33695878|NCT03307785|63240444|FG005|Part E: Up to 4.4 Months|Death|0|||
33695879|NCT03307785|63240445|FG006|Part E: Up to 4.4 Months|Death|1|||
33695880|NCT03307785|63240446|FG007|Part E: Up to 4.4 Months|Death|0|||
33695881|NCT03307785|63240447|FG008|Part E: Up to 4.4 Months|Death|0|||
33695882|NCT03307785|63240448|FG009|Part E: Up to 4.4 Months|Death|0|||
33695883|NCT03307785|63240449|FG010|Part E: Up to 4.4 Months|Death|0|||
33695884|NCT03307785|63240439|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
33695885|NCT03307785|63240440|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
33695886|NCT03307785|63240441|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
33695887|NCT03307785|63240442|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
33695888|NCT03307785|63240443|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
33695889|NCT03307785|63240444|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
33695890|NCT03307785|63240445|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
33695891|NCT03307785|63240446|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
33695892|NCT03307785|63240447|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
33695893|NCT03307785|63240448|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
33695894|NCT03307785|63240449|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
33695895|NCT03307785|63240439|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
33695896|NCT03307785|63240440|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
33695897|NCT03307785|63240441|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
33695898|NCT03307785|63240442|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
33695899|NCT03307785|63240443|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
33695900|NCT03307785|63240444|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
33695901|NCT03307785|63240445|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
33695902|NCT03307785|63240446|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
33695903|NCT03307785|63240447|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
33695904|NCT03307785|63240448|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
33695905|NCT03307785|63240449|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
33695906|NCT03284710|63240474|FG000|Overall Study|Withdrawal by Subject|1|||
33695907|NCT03284710|63240475|FG001|Overall Study|Withdrawal by Subject|0|||
33695908|NCT03284710|63240476|FG002|Overall Study|Withdrawal by Subject|1|||
33695909|NCT03284710|63240477|FG003|Overall Study|Withdrawal by Subject|6|||
33695910|NCT03284710|63240474|FG000|Overall Study|Lost to Follow-up|3|||
33695911|NCT03284710|63240475|FG001|Overall Study|Lost to Follow-up|3|||
33695912|NCT03284710|63240476|FG002|Overall Study|Lost to Follow-up|1|||
33695913|NCT03284710|63240477|FG003|Overall Study|Lost to Follow-up|0|||
33695914|NCT03284710|63240474|FG000|Overall Study|Physician Decision|1|||
33695915|NCT03284710|63240475|FG001|Overall Study|Physician Decision|0|||
33695916|NCT03284710|63240476|FG002|Overall Study|Physician Decision|0|||
33695917|NCT03284710|63240477|FG003|Overall Study|Physician Decision|0|||
33695918|NCT03284710|63240474|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
33695919|NCT03284710|63240475|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
33695920|NCT03284710|63240476|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
33695921|NCT03284710|63240477|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
33695922|NCT03284710|63240474|FG000|Overall Study|HIV Infection|0|||
33695923|NCT03284710|63240475|FG001|Overall Study|HIV Infection|2|||
33695924|NCT03284710|63240476|FG002|Overall Study|HIV Infection|2|||
33695925|NCT03284710|63240477|FG003|Overall Study|HIV Infection|1|||
33695926|NCT03248167|63240496|FG000|Overall Study|Withdrawal by Subject|2|||
33695927|NCT03248167|63240497|FG001|Overall Study|Withdrawal by Subject|2|||
33695928|NCT03248167|63240496|FG000|Overall Study|Physician Decision|0|||
33695929|NCT03248167|63240497|FG001|Overall Study|Physician Decision|1|||
33695930|NCT03248167|63240496|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
33695931|NCT03248167|63240497|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
33695932|NCT03248167|63240496|FG000|Overall Study|Lost to Follow-up|1|||
33695933|NCT03248167|63240497|FG001|Overall Study|Lost to Follow-up|0|||
33695934|NCT03220737|63240511|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
33695935|NCT03220737|63240512|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
33695936|NCT03220737|63240513|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
33695937|NCT03220737|63240514|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
33695938|NCT03220737|63240515|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
33695939|NCT03220737|63240516|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
33695940|NCT03220737|63240517|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
33695941|NCT03220737|63240511|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
33695942|NCT03220737|63240512|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
33695943|NCT03220737|63240513|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
33695944|NCT03220737|63240514|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
33695945|NCT03220737|63240515|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
33695946|NCT03220737|63240516|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
33695947|NCT03220737|63240517|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
33695948|NCT03220737|63240511|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
33695949|NCT03220737|63240512|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
33695950|NCT03220737|63240513|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
33695951|NCT03220737|63240514|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
33695952|NCT03220737|63240515|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
33695953|NCT03220737|63240516|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
33695954|NCT03220737|63240517|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
33695955|NCT03220737|63240511|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
33695956|NCT03220737|63240512|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
33695957|NCT03220737|63240513|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
33695958|NCT03220737|63240514|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
33695959|NCT03220737|63240515|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
33695960|NCT03220737|63240516|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
33695961|NCT03220737|63240517|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
33695962|NCT03220737|63240511|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
33695963|NCT03220737|63240512|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
33695964|NCT03220737|63240513|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
33695965|NCT03220737|63240514|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
33695966|NCT03220737|63240515|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
33695967|NCT03220737|63240516|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
33695968|NCT03220737|63240517|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
33695969|NCT03220737|63240511|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
33695970|NCT03220737|63240512|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
33695971|NCT03220737|63240513|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
33695972|NCT03220737|63240514|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
33695973|NCT03220737|63240515|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
33695974|NCT03220737|63240516|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
33695975|NCT03220737|63240517|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
33695976|NCT03220737|63240511|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
33695977|NCT03220737|63240512|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
33695978|NCT03220737|63240513|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
33695979|NCT03220737|63240514|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
33695980|NCT03220737|63240515|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
33695981|NCT03220737|63240516|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
33695982|NCT03220737|63240517|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
33695983|NCT03220737|63240511|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
33695984|NCT03220737|63240512|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
33695985|NCT03220737|63240513|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
33695986|NCT03220737|63240514|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
33695987|NCT03220737|63240515|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
33695988|NCT03220737|63240516|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
33695989|NCT03220737|63240517|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
33695990|NCT03198728|63240541|FG000|Overall Study|Adverse Event|10|||
33695991|NCT03198728|63240542|FG001|Overall Study|Adverse Event|5|||
33695992|NCT03198728|63240541|FG000|Overall Study|Lost to Follow-up|21|||
33695993|NCT03198728|63240542|FG001|Overall Study|Lost to Follow-up|7|||
33695994|NCT03198728|63240541|FG000|Overall Study|Physician Decision|7|||
33695995|NCT03198728|63240542|FG001|Overall Study|Physician Decision|2|||
33695996|NCT03198728|63240541|FG000|Overall Study|Withdrawal by Subject|14|||
33695997|NCT03198728|63240542|FG001|Overall Study|Withdrawal by Subject|10|||
33695998|NCT03144804|63240574|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
33695999|NCT03142334|63240580|FG000|Overall Study|Death|18|||
33696000|NCT03142334|63240581|FG001|Overall Study|Death|33|||
33696001|NCT03142334|63240580|FG000|Overall Study|Withdrawal by Subject|15|||
33696002|NCT03142334|63240581|FG001|Overall Study|Withdrawal by Subject|11|||
33696003|NCT03142334|63240580|FG000|Overall Study|Ongoing on trial follow up|463|||
33696004|NCT03142334|63240581|FG001|Overall Study|Ongoing on trial follow up|454|||
33696005|NCT03126539|63240589|FG000|Overall Study|Lost to Follow-up|1|||
33696006|NCT03126539|63240590|FG001|Overall Study|Lost to Follow-up|1|||
33696007|NCT03126539|63240591|FG002|Overall Study|Lost to Follow-up|1|||
33696008|NCT03126539|63240592|FG003|Overall Study|Lost to Follow-up|0|||
33696009|NCT03126539|63240593|FG004|Overall Study|Lost to Follow-up|0|||
33696010|NCT03123250|63240606|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
33696011|NCT03099096|63240610|FG000|Overall Study|Adverse Event|1|||
33696012|NCT03099096|63240610|FG000|Overall Study|Physician Decision|1|||
33696013|NCT03043664|63240614|FG000|Overall Study|Lost to Follow-up|1|||
33696014|NCT03041467|63240620|FG000|Overall Study|Death|40|||
33696015|NCT03041467|63240621|FG001|Overall Study|Death|36|||
33696016|NCT03041467|63240620|FG000|Overall Study|Withdrawal by Subject|36|||
33696017|NCT03041467|63240621|FG001|Overall Study|Withdrawal by Subject|37|||
33696018|NCT03041467|63240620|FG000|Overall Study|Lost to Follow-up|6|||
33696019|NCT03041467|63240621|FG001|Overall Study|Lost to Follow-up|7|||
33696020|NCT03041467|63240620|FG000|Overall Study|Declined consent for study extension|21|||
33696021|NCT03041467|63240621|FG001|Overall Study|Declined consent for study extension|33|||
33696022|NCT03041467|63240620|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
33696023|NCT03041467|63240621|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
33696024|NCT03041467|63240620|FG000|Overall Study|48 Month visit not completed|9|||
33696025|NCT03041467|63240621|FG001|Overall Study|48 Month visit not completed|4|||
33696026|NCT03019406|63240633|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
33696027|NCT03019406|63240634|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
33696028|NCT03019406|63240635|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
33696029|NCT03019406|63240636|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
33696030|NCT02972593|63240651|FG000|Overall Study|Lost to Follow-up|19|||
33696031|NCT02972593|63240652|FG001|Overall Study|Lost to Follow-up|15|||
33696032|NCT02972593|63240651|FG000|Overall Study|Protocol Violation|1|||
33696033|NCT02972593|63240652|FG001|Overall Study|Protocol Violation|0|||
33696034|NCT02949700|63240664|FG000|Phase I|Withdrawal by Subject|1|||
33696035|NCT02949700|63240665|FG001|Phase I|Withdrawal by Subject|1|||
33696036|NCT02949700|63240666|FG002|Phase I|Withdrawal by Subject|0|||
33696037|NCT02949700|63240667|FG003|Phase I|Withdrawal by Subject|0|||
33696038|NCT02949700|63240664|FG000|Phase I|Protocol Violation|1|||
33696039|NCT02949700|63240665|FG001|Phase I|Protocol Violation|0|||
33696040|NCT02949700|63240666|FG002|Phase I|Protocol Violation|0|||
33696041|NCT02949700|63240667|FG003|Phase I|Protocol Violation|0|||
33696042|NCT02949700|63240664|FG000|Phase II|Withdrawal by Subject|0|||
33696043|NCT02949700|63240665|FG001|Phase II|Withdrawal by Subject|0|||
33696044|NCT02949700|63240666|FG002|Phase II|Withdrawal by Subject|0|||
33696045|NCT02949700|63240667|FG003|Phase II|Withdrawal by Subject|2|||
33696046|NCT02949700|63240664|FG000|Phase II|Protocol Violation|0|||
33696047|NCT02949700|63240665|FG001|Phase II|Protocol Violation|0|||
33696048|NCT02949700|63240666|FG002|Phase II|Protocol Violation|1|||
33696049|NCT02949700|63240667|FG003|Phase II|Protocol Violation|3|||
33696050|NCT02947087|63240678|FG000|Overall Study|Withdrawal by Subject|3|||
33696051|NCT02947087|63240679|FG001|Overall Study|Withdrawal by Subject|2|||
33696052|NCT02879448|63240687|FG000|Overall Study|No implant attempt|17|||
33696053|NCT02879448|63240688|FG001|Overall Study|No implant attempt|28|||
33696054|NCT02879448|63240687|FG000|Overall Study|Withdrawal by Subject|20|||
33696055|NCT02879448|63240688|FG001|Overall Study|Withdrawal by Subject|46|||
33696056|NCT02879448|63240687|FG000|Overall Study|Death|63|||
33696057|NCT02879448|63240688|FG001|Overall Study|Death|85|||
33696058|NCT02879448|63240687|FG000|Overall Study|Lost to Follow-up|3|||
33696059|NCT02879448|63240688|FG001|Overall Study|Lost to Follow-up|4|||
33696060|NCT02879448|63240687|FG000|Overall Study|Missing visit|34|||
33696061|NCT02879448|63240688|FG001|Overall Study|Missing visit|39|||
33696062|NCT02879448|63240687|FG000|Overall Study|Pending evaluation|1|||
33696063|NCT02879448|63240688|FG001|Overall Study|Pending evaluation|0|||
33696064|NCT02868216|63240696|FG000|Overall Study|Death|0|||
33696065|NCT02868216|63240697|FG001|Overall Study|Death|1|||
33696066|NCT02868216|63240696|FG000|Overall Study|coronary artery bypass|1|||
33696067|NCT02868216|63240697|FG001|Overall Study|coronary artery bypass|0|||
33696068|NCT02868216|63240696|FG000|Overall Study|Withdrawal by Subject|7|||
33696069|NCT02868216|63240697|FG001|Overall Study|Withdrawal by Subject|5|||
33696070|NCT02841995|63240706|FG000|Overall Study|Disease progression|5|||
33696071|NCT02841995|63240707|FG001|Overall Study|Disease progression|11|||
33696072|NCT02841995|63240708|FG002|Overall Study|Disease progression|8|||
33696073|NCT02841995|63240706|FG000|Overall Study|Withdrawal by Subject|2|||
33696074|NCT02841995|63240707|FG001|Overall Study|Withdrawal by Subject|4|||
33696075|NCT02841995|63240708|FG002|Overall Study|Withdrawal by Subject|4|||
33696076|NCT02841995|63240706|FG000|Overall Study|Adverse Event|2|||
33696077|NCT02841995|63240707|FG001|Overall Study|Adverse Event|0|||
33696078|NCT02841995|63240708|FG002|Overall Study|Adverse Event|1|||
33696079|NCT02841995|63240706|FG000|Overall Study|Investigator decision|2|||
33696080|NCT02841995|63240707|FG001|Overall Study|Investigator decision|0|||
33696081|NCT02841995|63240708|FG002|Overall Study|Investigator decision|1|||
33696082|NCT02841995|63240706|FG000|Overall Study|Death|0|||
33696083|NCT02841995|63240707|FG001|Overall Study|Death|0|||
33696084|NCT02841995|63240708|FG002|Overall Study|Death|2|||
33696085|NCT02841995|63240706|FG000|Overall Study|Noncompliance to protocol|1|||
33696086|NCT02841995|63240707|FG001|Overall Study|Noncompliance to protocol|0|||
33696087|NCT02841995|63240708|FG002|Overall Study|Noncompliance to protocol|0|||
33696088|NCT02841995|63240706|FG000|Overall Study|Sponsor decision|1|||
33696089|NCT02841995|63240707|FG001|Overall Study|Sponsor decision|0|||
33696090|NCT02841995|63240708|FG002|Overall Study|Sponsor decision|0|||
33696091|NCT02841995|63240706|FG000|Overall Study|Other|4|||
33696092|NCT02841995|63240707|FG001|Overall Study|Other|1|||
33696093|NCT02841995|63240708|FG002|Overall Study|Other|5|||
33696094|NCT02702414|63240727|FG000|Overall Study|Death|77|||
33696095|NCT02702414|63240728|FG001|Overall Study|Death|34|||
33696096|NCT02702414|63240727|FG000|Overall Study|Lost to Follow-up|0|||
33696097|NCT02702414|63240728|FG001|Overall Study|Lost to Follow-up|1|||
33696098|NCT02702414|63240727|FG000|Overall Study|Withdrawal by Subject|0|||
33696099|NCT02702414|63240728|FG001|Overall Study|Withdrawal by Subject|1|||
33696100|NCT02702414|63240727|FG000|Overall Study|Participants Ongoing in Study|27|||
33696101|NCT02702414|63240728|FG001|Overall Study|Participants Ongoing in Study|15|||
33696102|NCT02702414|63240727|FG000|Overall Study|Not Treated|1|||
33696103|NCT02702414|63240728|FG001|Overall Study|Not Treated|0|||
33696104|NCT02643966|63240736|FG000|First Screening Round|ineligible|1|||
33696105|NCT02643966|63240736|FG000|First Screening Round|excluded from analysis|2|||
33696106|NCT02643966|63240736|FG000|First Screening Round|Lost to Follow-up|56|||
33696107|NCT02643966|63240736|FG000|First Screening Round|Withdrawal by Subject|28|||
33696108|NCT02643966|63240736|FG000|First Screening Round|Death|1|||
33696109|NCT02643966|63240736|FG000|Between First and Second Screening|Lost to Follow-up|65|||
33696110|NCT02643966|63240736|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
33696111|NCT02643966|63240736|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
33696112|NCT02643966|63240736|FG000|Second Screening Round|Withdrawal by Subject|20|||
33696113|NCT02643966|63240736|FG000|Second Screening Round|Lost to Follow-up|57|||
33696114|NCT02643966|63240736|FG000|Second Screening Round|Physician Decision|2|||
33696115|NCT02643966|63240736|FG000|Second Screening Round|Death|4|||
33696116|NCT02643966|63240736|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
33696117|NCT02643966|63240736|FG000|Between Second and Third Screening|Death|1|||
33696118|NCT02643966|63240736|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
33696119|NCT02643966|63240736|FG000|Third Screening Round|PI excluded|2|||
33696120|NCT02643966|63240736|FG000|Third Screening Round|Lost to Follow-up|241|||
33696121|NCT02554383|63240765|FG000|Overall Study|Ineligible|3|||
33696122|NCT02554383|63240766|FG001|Overall Study|Ineligible|2|||
33696123|NCT02554383|63240765|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
33696124|NCT02554383|63240766|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
33696125|NCT02554383|63240765|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
33696126|NCT02554383|63240766|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
33696127|NCT02554383|63240765|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
33696128|NCT02554383|63240766|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
33696129|NCT02522871|63240774|FG000|Overall Study|Protocol Violation|1|||
33696130|NCT02522871|63240775|FG001|Overall Study|Protocol Violation|4|||
33696131|NCT02522871|63240774|FG000|Overall Study|Treated without randomization|1|||
33696132|NCT02522871|63240775|FG001|Overall Study|Treated without randomization|0|||
33696133|NCT02522871|63240774|FG000|Overall Study|Death|9|||
33696134|NCT02522871|63240775|FG001|Overall Study|Death|9|||
33696135|NCT02522871|63240774|FG000|Overall Study|Died in operating room prior to transplant|0|||
33696136|NCT02522871|63240775|FG001|Overall Study|Died in operating room prior to transplant|1|||
33696137|NCT02519439|63240790|FG000|Overall Study|Study Termination|19|||
33696138|NCT02519439|63240790|FG000|Overall Study|Withdrawal by Subject|1|||
33696139|NCT02519439|63240790|FG000|Overall Study|Adverse Event|1|||
33696140|NCT02500797|63240802|FG000|Overall Study|Cancel (rapid disease progression)|0|||
33696141|NCT02500797|63240803|FG001|Overall Study|Cancel (rapid disease progression)|0|||
33696142|NCT02500797|63240804|FG002|Overall Study|Cancel (rapid disease progression)|0|||
33696143|NCT02500797|63240805|FG003|Overall Study|Cancel (rapid disease progression)|0|||
33696144|NCT02500797|63240806|FG004|Overall Study|Cancel (rapid disease progression)|1|||
33696145|NCT02500797|63240807|FG005|Overall Study|Cancel (rapid disease progression)|1|||
33696146|NCT02500797|63240808|FG006|Overall Study|Cancel (rapid disease progression)|0|||
33696147|NCT02500797|63240809|FG007|Overall Study|Cancel (rapid disease progression)|0|||
33696148|NCT02500797|63240802|FG000|Overall Study|Withdrawal by Subject|1|||
33696149|NCT02500797|63240803|FG001|Overall Study|Withdrawal by Subject|0|||
33696150|NCT02500797|63240804|FG002|Overall Study|Withdrawal by Subject|0|||
33696151|NCT02500797|63240805|FG003|Overall Study|Withdrawal by Subject|0|||
33696152|NCT02500797|63240806|FG004|Overall Study|Withdrawal by Subject|0|||
33696153|NCT02500797|63240807|FG005|Overall Study|Withdrawal by Subject|0|||
33696154|NCT02500797|63240808|FG006|Overall Study|Withdrawal by Subject|0|||
33696155|NCT02500797|63240809|FG007|Overall Study|Withdrawal by Subject|0|||
33696156|NCT02147184|63240840|FG000|Overall Study|Lost to Follow-up|28|||
33696157|NCT02147184|63240841|FG001|Overall Study|Lost to Follow-up|15|||
33696158|NCT02147184|63240840|FG000|Overall Study|Study Burden|11|||
33696159|NCT02147184|63240841|FG001|Overall Study|Study Burden|7|||
33696160|NCT02147184|63240840|FG000|Overall Study|Pregnancy|6|||
33696161|NCT02147184|63240841|FG001|Overall Study|Pregnancy|0|||
33696162|NCT02147184|63240840|FG000|Overall Study|Moved out of state|3|||
33696163|NCT02147184|63240841|FG001|Overall Study|Moved out of state|3|||
33696164|NCT02147184|63240840|FG000|Overall Study|Physician Decision|0|||
33696165|NCT02147184|63240841|FG001|Overall Study|Physician Decision|2|||
33696166|NCT02147184|63240840|FG000|Overall Study|Other|1|||
33696167|NCT02147184|63240841|FG001|Overall Study|Other|0|||
33696168|NCT02101021|63240852|FG000|Overall Study|Death|4|||
33696169|NCT02101021|63240853|FG001|Overall Study|Death|3|||
33696170|NCT02101021|63240854|FG002|Overall Study|Death|6|||
33696171|NCT02101021|63240855|FG003|Overall Study|Death|0|||
33696172|NCT02101021|63240856|FG004|Overall Study|Death|3|||
33696173|NCT02101021|63240852|FG000|Overall Study|Withdrew Consent from study|1|||
33696174|NCT02101021|63240853|FG001|Overall Study|Withdrew Consent from study|1|||
33696175|NCT02101021|63240854|FG002|Overall Study|Withdrew Consent from study|0|||
33696176|NCT02101021|63240855|FG003|Overall Study|Withdrew Consent from study|2|||
33696177|NCT02101021|63240856|FG004|Overall Study|Withdrew Consent from study|0|||
33696178|NCT02101021|63240852|FG000|Overall Study|Lost to Follow-up|1|||
33696179|NCT02101021|63240853|FG001|Overall Study|Lost to Follow-up|0|||
33696180|NCT02101021|63240854|FG002|Overall Study|Lost to Follow-up|0|||
33696181|NCT02101021|63240855|FG003|Overall Study|Lost to Follow-up|0|||
33696182|NCT02101021|63240856|FG004|Overall Study|Lost to Follow-up|0|||
33696183|NCT02101021|63240852|FG000|Overall Study|Study Terminated by Sponsor|1|||
33696184|NCT02101021|63240853|FG001|Overall Study|Study Terminated by Sponsor|0|||
33696185|NCT02101021|63240854|FG002|Overall Study|Study Terminated by Sponsor|1|||
33696186|NCT02101021|63240855|FG003|Overall Study|Study Terminated by Sponsor|1|||
33696187|NCT02101021|63240856|FG004|Overall Study|Study Terminated by Sponsor|1|||
33696188|NCT02031536|63240881|FG000|Overall Study|ineligible|1|||
33696189|NCT02031536|63240882|FG001|Overall Study|ineligible|0|||
33696190|NCT02028455|63240896|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
33696191|NCT02028455|63240897|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
33696192|NCT02028455|63240898|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
33696193|NCT02028455|63240899|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
33696194|NCT02028455|63240900|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
33696195|NCT02028455|63240901|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
33696196|NCT02028455|63240902|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
33696197|NCT02028455|63240903|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
33696198|NCT02028455|63240896|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
33696199|NCT02028455|63240897|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
33696200|NCT02028455|63240898|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
33696201|NCT02028455|63240899|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
33696202|NCT02028455|63240900|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
33696203|NCT02028455|63240901|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
33696204|NCT02028455|63240902|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
33696205|NCT02028455|63240903|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
33696206|NCT02028455|63240896|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
33696207|NCT02028455|63240897|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
33696208|NCT02028455|63240898|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
33696209|NCT02028455|63240899|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
33696210|NCT02028455|63240900|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
33696211|NCT02028455|63240901|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
33696212|NCT02028455|63240902|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
33696213|NCT02028455|63240903|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
33696214|NCT02028455|63240896|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
33696215|NCT02028455|63240897|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
33696216|NCT02028455|63240898|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
33696217|NCT02028455|63240899|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
33696218|NCT02028455|63240900|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
33696219|NCT02028455|63240901|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
33696220|NCT02028455|63240902|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
33696221|NCT02028455|63240903|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
33696222|NCT02019641|63240927|FG000|10-Week Follow up|Withdrawal by investigator|2|||
33696223|NCT02019641|63240928|FG001|10-Week Follow up|Withdrawal by investigator|0|||
33696224|NCT02019641|63240929|FG002|10-Week Follow up|Withdrawal by investigator|0|||
33696225|NCT02019641|63240927|FG000|10-Week Follow up|Withdrawal by Subject|1|||
33696226|NCT02019641|63240928|FG001|10-Week Follow up|Withdrawal by Subject|1|||
33696227|NCT02019641|63240929|FG002|10-Week Follow up|Withdrawal by Subject|0|||
33696228|NCT02019641|63240927|FG000|20-Week Follow up|Withdrawal by investigator|0|||
33696229|NCT02019641|63240928|FG001|20-Week Follow up|Withdrawal by investigator|0|||
33696230|NCT02019641|63240929|FG002|20-Week Follow up|Withdrawal by investigator|1|||
33696231|NCT01964430|63240938|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
33696232|NCT01964430|63240939|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
33696233|NCT01964430|63240938|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
33696234|NCT01964430|63240939|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
33696235|NCT01964430|63240938|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
33696236|NCT01964430|63240939|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
33696237|NCT01964430|63240938|FG000|Treatment Period|Adverse Event|71|||
33696238|NCT01964430|63240939|FG001|Treatment Period|Adverse Event|37|||
33696239|NCT01964430|63240938|FG000|Treatment Period|Withdrawal by Subject|36|||
33696240|NCT01964430|63240939|FG001|Treatment Period|Withdrawal by Subject|27|||
33696241|NCT01964430|63240938|FG000|Treatment Period|Death|1|||
33696242|NCT01964430|63240939|FG001|Treatment Period|Death|3|||
33696243|NCT01964430|63240938|FG000|Treatment Period|Protocol Deviation|0|||
33696244|NCT01964430|63240939|FG001|Treatment Period|Protocol Deviation|1|||
33696245|NCT01964430|63240938|FG000|Treatment Period|Physician Decision|5|||
33696246|NCT01964430|63240939|FG001|Treatment Period|Physician Decision|4|||
33696247|NCT01964430|63240938|FG000|Treatment Period|Disease Relapse|28|||
33696248|NCT01964430|63240939|FG001|Treatment Period|Disease Relapse|38|||
33696249|NCT01964430|63240938|FG000|Treatment Period|Other reasons|1|||
33696250|NCT01964430|63240939|FG001|Treatment Period|Other reasons|3|||
33696251|NCT01898494|63240949|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
33696252|NCT01898494|63240950|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
33696253|NCT01898494|63240951|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
33696254|NCT01898494|63240952|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
33696255|NCT01898494|63240953|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
33696256|NCT01898494|63240949|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
33696257|NCT01898494|63240950|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
33696258|NCT01898494|63240951|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
33696259|NCT01898494|63240952|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
33696260|NCT01898494|63240953|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
33696261|NCT01898494|63240949|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
33696262|NCT01898494|63240950|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
33696263|NCT01898494|63240951|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
33696264|NCT01898494|63240952|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
33696265|NCT01898494|63240953|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
33696266|NCT01898494|63240949|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
33696267|NCT01898494|63240950|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
33696268|NCT01898494|63240951|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
33696269|NCT01898494|63240952|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
33696270|NCT01898494|63240953|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
33696271|NCT01898494|63240949|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
33696272|NCT01898494|63240950|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
33696273|NCT01898494|63240951|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
33696274|NCT01898494|63240952|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
33696275|NCT01898494|63240953|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
33696276|NCT01898494|63240949|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
33696277|NCT01898494|63240950|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
33696278|NCT01898494|63240951|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
33696279|NCT01898494|63240952|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
33696280|NCT01898494|63240953|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
33696281|NCT01898494|63240949|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
33696282|NCT01898494|63240950|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
33696283|NCT01898494|63240951|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
33696284|NCT01898494|63240952|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
33696285|NCT01898494|63240953|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
33696286|NCT01898494|63240949|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
33696287|NCT01898494|63240950|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
33696288|NCT01898494|63240951|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
33696289|NCT01898494|63240952|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
33696290|NCT01898494|63240953|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
33696291|NCT01898494|63240949|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
33696292|NCT01898494|63240950|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
33696293|NCT01898494|63240951|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
33696294|NCT01898494|63240952|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
33696295|NCT01898494|63240953|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
33696296|NCT01898494|63240949|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
33696297|NCT01898494|63240950|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
33696298|NCT01898494|63240951|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
33696299|NCT01898494|63240952|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
33696300|NCT01898494|63240953|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
33696301|NCT01898494|63240949|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
33696302|NCT01898494|63240950|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
33696303|NCT01898494|63240951|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
33696304|NCT01898494|63240952|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
33696305|NCT01898494|63240953|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
33696306|NCT01898494|63240949|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
33696307|NCT01898494|63240950|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
33696308|NCT01898494|63240951|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
33696309|NCT01898494|63240952|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
33696310|NCT01898494|63240953|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
33696311|NCT01898494|63240949|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
33696312|NCT01898494|63240950|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
33696313|NCT01898494|63240951|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
33696314|NCT01898494|63240952|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
33696315|NCT01898494|63240953|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
33696316|NCT01898494|63240949|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
33696317|NCT01898494|63240950|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
33696318|NCT01898494|63240951|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
33696319|NCT01898494|63240952|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
33696320|NCT01898494|63240953|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
33696321|NCT01863043|63240971|FG000|Overall Study|Death|6|||
33696322|NCT01863043|63240972|FG001|Overall Study|Death|1|||
33596317|NCT02143713|62995306|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
33696323|NCT01863043|63240971|FG000|Overall Study|Withdrawal by Subject|0|||
33696324|NCT01863043|63240972|FG001|Overall Study|Withdrawal by Subject|2|||
33696325|NCT01863043|63240971|FG000|Overall Study|Adverse Event|7|||
33696326|NCT01863043|63240972|FG001|Overall Study|Adverse Event|8|||
33696327|NCT01863043|63240971|FG000|Overall Study|exclusion criteria found after enrollment|0|||
33696328|NCT01863043|63240972|FG001|Overall Study|exclusion criteria found after enrollment|1|||
33696329|NCT01841359|63240978|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
33696330|NCT01841359|63240978|FG000|Overall Study|Concommitant medical issues|2|||
33696331|NCT01841359|63240978|FG000|Overall Study|Adverse Event|3|||
33696332|NCT01841359|63240978|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
33696333|NCT01824875|63240987|FG000|Overall Study|Disease progression|22|||
33696334|NCT01824875|63240988|FG001|Overall Study|Disease progression|15|||
33696335|NCT01824875|63240987|FG000|Overall Study|Withdrawal by Subject|5|||
33696336|NCT01824875|63240988|FG001|Overall Study|Withdrawal by Subject|4|||
33696337|NCT01824875|63240987|FG000|Overall Study|Adverse Event|4|||
33696338|NCT01824875|63240988|FG001|Overall Study|Adverse Event|10|||
33696339|NCT01824875|63240987|FG000|Overall Study|Alternative therapy|3|||
33696340|NCT01824875|63240988|FG001|Overall Study|Alternative therapy|0|||
33696341|NCT01824875|63240987|FG000|Overall Study|Complicating disease|1|||
33696342|NCT01824875|63240988|FG001|Overall Study|Complicating disease|0|||
33696343|NCT01824875|63240987|FG000|Overall Study|Physician Decision|0|||
33696344|NCT01824875|63240988|FG001|Overall Study|Physician Decision|1|||
33696345|NCT01824875|63240987|FG000|Overall Study|Non-compliance|1|||
33696346|NCT01824875|63240988|FG001|Overall Study|Non-compliance|1|||
33696347|NCT01824875|63240987|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
33696348|NCT01824875|63240988|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
33696349|NCT01824875|63240987|FG000|Overall Study|Administrative issues|0|||
33696350|NCT01824875|63240988|FG001|Overall Study|Administrative issues|2|||
33696351|NCT01824875|63240987|FG000|Overall Study|Ineligible or never started treatment|9|||
33696352|NCT01824875|63240988|FG001|Overall Study|Ineligible or never started treatment|5|||
33696353|NCT01824875|63240987|FG000|Overall Study|Other|0|||
33696354|NCT01824875|63240988|FG001|Overall Study|Other|2|||
33696355|NCT01660451|63241010|FG000|Overall Study|Protocol Violation|0|||
33696356|NCT01660451|63241011|FG001|Overall Study|Protocol Violation|1|||
33696357|NCT01660451|63241012|FG002|Overall Study|Protocol Violation|1|||
33696358|NCT01660451|63241010|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11|||
33696359|NCT01660451|63241011|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8|||
33696360|NCT01660451|63241012|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26|||
33696361|NCT01660451|63241010|FG000|Overall Study|AE with Clinical PD|1|||
33696362|NCT01660451|63241011|FG001|Overall Study|AE with Clinical PD|3|||
33696363|NCT01660451|63241012|FG002|Overall Study|AE with Clinical PD|9|||
33696364|NCT01660451|63241010|FG000|Overall Study|Sponsor Decision|0|||
33696365|NCT01660451|63241011|FG001|Overall Study|Sponsor Decision|0|||
33696366|NCT01660451|63241012|FG002|Overall Study|Sponsor Decision|1|||
33696367|NCT01660451|63241010|FG000|Overall Study|Protocol Deviation|0|||
33696368|NCT01660451|63241011|FG001|Overall Study|Protocol Deviation|0|||
33696369|NCT01660451|63241012|FG002|Overall Study|Protocol Deviation|1|||
33696370|NCT01660451|63241010|FG000|Overall Study|Physician Decision|1|||
33696371|NCT01660451|63241011|FG001|Overall Study|Physician Decision|2|||
33696372|NCT01660451|63241012|FG002|Overall Study|Physician Decision|5|||
33696373|NCT01660451|63241010|FG000|Overall Study|Withdrawal by Subject|1|||
33696374|NCT01660451|63241011|FG001|Overall Study|Withdrawal by Subject|0|||
33696375|NCT01660451|63241012|FG002|Overall Study|Withdrawal by Subject|16|||
33696376|NCT01660451|63241010|FG000|Overall Study|Ongoing with treatment|3|||
33696377|NCT01660451|63241011|FG001|Overall Study|Ongoing with treatment|3|||
33696378|NCT01660451|63241012|FG002|Overall Study|Ongoing with treatment|46|||
33401448|NCT00256867|62780479|FG005|Overall Study|Protocol Violation|1|||
33696379|NCT01390584|63241031|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
33696380|NCT01390584|63241032|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
33696381|NCT01390584|63241033|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
33696382|NCT01251965|63241045|FG000|Overall Study|Participant/physician decision|1|||
33696383|NCT01251965|63241046|FG001|Overall Study|Participant/physician decision|2|||
33696384|NCT01251965|63241047|FG002|Overall Study|Participant/physician decision|0|||
33696385|NCT01251965|63241045|FG000|Overall Study|Death|0|||
33696386|NCT01251965|63241046|FG001|Overall Study|Death|0|||
33696387|NCT01251965|63241047|FG002|Overall Study|Death|11|||
33696388|NCT01242800|63241058|FG000|Overall Study|Patient refusal|0|||
33696389|NCT01242800|63241059|FG001|Overall Study|Patient refusal|10|||
33696390|NCT01242800|63241058|FG000|Overall Study|Physician Decision|0|||
33696391|NCT01242800|63241059|FG001|Overall Study|Physician Decision|1|||
33696392|NCT01242800|63241058|FG000|Overall Study|Disease progression|0|||
33696393|NCT01242800|63241059|FG001|Overall Study|Disease progression|3|||
33696394|NCT01242800|63241058|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
33696395|NCT01242800|63241059|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
33696396|NCT01242800|63241058|FG000|Overall Study|Reasons not reported|0|||
33696397|NCT01242800|63241059|FG001|Overall Study|Reasons not reported|4|||
33696398|NCT01216683|63241068|FG000|Induction|Never started treatment|0|||
33696399|NCT01216683|63241069|FG001|Induction|Never started treatment|6|||
33696400|NCT01216683|63241070|FG002|Induction|Never started treatment|3|||
33696401|NCT01216683|63241068|FG000|Induction|Lack of Efficacy|4|||
33696402|NCT01216683|63241069|FG001|Induction|Lack of Efficacy|3|||
33696403|NCT01216683|63241070|FG002|Induction|Lack of Efficacy|7|||
33696404|NCT01216683|63241068|FG000|Induction|Adverse Event|0|||
33696405|NCT01216683|63241069|FG001|Induction|Adverse Event|5|||
33696406|NCT01216683|63241070|FG002|Induction|Adverse Event|5|||
33696407|NCT01216683|63241068|FG000|Induction|Death|0|||
33696408|NCT01216683|63241069|FG001|Induction|Death|0|||
33696409|NCT01216683|63241070|FG002|Induction|Death|2|||
33696410|NCT01216683|63241068|FG000|Induction|Withdrawal by Subject|0|||
33696411|NCT01216683|63241069|FG001|Induction|Withdrawal by Subject|4|||
33696412|NCT01216683|63241070|FG002|Induction|Withdrawal by Subject|2|||
33696413|NCT01216683|63241068|FG000|Induction|Other disease|0|||
33696414|NCT01216683|63241069|FG001|Induction|Other disease|1|||
33696415|NCT01216683|63241070|FG002|Induction|Other disease|2|||
33696416|NCT01216683|63241068|FG000|Continuation|Lack of Efficacy|3|||
33696417|NCT01216683|63241069|FG001|Continuation|Lack of Efficacy|2|||
33696418|NCT01216683|63241070|FG002|Continuation|Lack of Efficacy|7|||
33696419|NCT01216683|63241068|FG000|Continuation|Adverse Event|5|||
33696420|NCT01216683|63241069|FG001|Continuation|Adverse Event|3|||
33696421|NCT01216683|63241070|FG002|Continuation|Adverse Event|16|||
33696422|NCT01216683|63241068|FG000|Continuation|Death|1|||
33696423|NCT01216683|63241069|FG001|Continuation|Death|0|||
33696424|NCT01216683|63241070|FG002|Continuation|Death|2|||
33696425|NCT01216683|63241068|FG000|Continuation|Withdrawal by Subject|4|||
33696426|NCT01216683|63241069|FG001|Continuation|Withdrawal by Subject|5|||
33696427|NCT01216683|63241070|FG002|Continuation|Withdrawal by Subject|9|||
33696428|NCT01216683|63241068|FG000|Continuation|Other diseases|0|||
33696429|NCT01216683|63241069|FG001|Continuation|Other diseases|2|||
33696430|NCT01216683|63241070|FG002|Continuation|Other diseases|1|||
33696431|NCT01216683|63241068|FG000|Continuation|Physician Decision|1|||
33696432|NCT01216683|63241069|FG001|Continuation|Physician Decision|0|||
33696433|NCT01216683|63241070|FG002|Continuation|Physician Decision|1|||
33696434|NCT01216683|63241068|FG000|Continuation|Non-compliance|1|||
33696435|NCT01216683|63241069|FG001|Continuation|Non-compliance|0|||
33696436|NCT01216683|63241070|FG002|Continuation|Non-compliance|1|||
33696437|NCT01216683|63241068|FG000|Continuation|Insurance change|0|||
33696438|NCT01216683|63241069|FG001|Continuation|Insurance change|1|||
33696439|NCT01216683|63241070|FG002|Continuation|Insurance change|0|||
33696440|NCT01216683|63241068|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
33696441|NCT01216683|63241069|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
33696442|NCT01216683|63241070|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
33696443|NCT01216683|63241068|FG000|Continuation|Not reported|0|||
33696444|NCT01216683|63241069|FG001|Continuation|Not reported|0|||
33696445|NCT01216683|63241070|FG002|Continuation|Not reported|1|||
33696446|NCT01216683|63241068|FG000|Continuation|Never started treatment|0|||
33696447|NCT01216683|63241069|FG001|Continuation|Never started treatment|1|||
33696448|NCT01216683|63241070|FG002|Continuation|Never started treatment|5|||
33696449|NCT01145495|63241091|FG000|Overall Study|Adverse Event|6|||
33696450|NCT01145495|63241091|FG000|Overall Study|Withdrawal by Subject|6|||
33696451|NCT01145495|63241091|FG000|Overall Study|Disease progression after respone|2|||
33696452|NCT01124695|63241097|FG000|Overall Study|Disease progression|77|||
33696453|NCT01124695|63241097|FG000|Overall Study|Adverse Event|11|||
33696454|NCT01124695|63241097|FG000|Overall Study|Death|1|||
33696455|NCT01124695|63241097|FG000|Overall Study|Withdrawal by Subject|7|||
33696456|NCT01124695|63241097|FG000|Overall Study|Physician Decision|3|||
33696457|NCT01124695|63241097|FG000|Overall Study|Alternative therapy|9|||
33696458|NCT01124695|63241097|FG000|Overall Study|No documentation that patient went off treatment|4|||
33696459|NCT01124695|63241097|FG000|Overall Study|Ineligible|9|||
33696460|NCT01124695|63241097|FG000|Overall Study|Ineligible and never start treatment|2|||
33696461|NCT01084083|63241108|FG000|Overall Study|Adverse Event|5|||
33696462|NCT01084083|63241108|FG000|Overall Study|Death|1|||
33596318|NCT02143713|62995307|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
33596319|NCT02143713|62995308|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
33596320|NCT02143713|62995305|FG000|Treatment Period (6 Months)|Pregnancy|0|||
33596321|NCT02143713|62995306|FG001|Treatment Period (6 Months)|Pregnancy|2|||
33596322|NCT02143713|62995307|FG002|Treatment Period (6 Months)|Pregnancy|2|||
33596323|NCT02143713|62995308|FG003|Treatment Period (6 Months)|Pregnancy|0|||
33596324|NCT02143713|62995305|FG000|Treatment Period (6 Months)|Non-compliance|1|||
33596325|NCT02143713|62995306|FG001|Treatment Period (6 Months)|Non-compliance|0|||
33596326|NCT02143713|62995307|FG002|Treatment Period (6 Months)|Non-compliance|0|||
33596327|NCT02143713|62995308|FG003|Treatment Period (6 Months)|Non-compliance|3|||
33596328|NCT02143713|62995305|FG000|Treatment Period (6 Months)|Other|3|||
33596329|NCT02143713|62995306|FG001|Treatment Period (6 Months)|Other|0|||
33596330|NCT02143713|62995307|FG002|Treatment Period (6 Months)|Other|3|||
33596331|NCT02143713|62995308|FG003|Treatment Period (6 Months)|Other|2|||
33596332|NCT02143713|62995305|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
33596333|NCT02143713|62995306|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
33596334|NCT02143713|62995307|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
33596335|NCT02143713|62995308|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
33596336|NCT02143713|62995305|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
33596337|NCT02143713|62995306|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
33596338|NCT02143713|62995307|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
33596339|NCT02143713|62995308|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
33596340|NCT02143713|62995305|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
33596341|NCT02143713|62995306|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
33596342|NCT02143713|62995307|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
33596343|NCT02143713|62995308|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
33596344|NCT02143713|62995305|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
33596345|NCT02143713|62995306|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
33596346|NCT02143713|62995307|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
33596347|NCT02143713|62995308|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
33596348|NCT02143713|62995305|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
33596349|NCT02143713|62995306|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
33596350|NCT02143713|62995307|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
33596351|NCT02143713|62995308|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
33596352|NCT02143713|62995305|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
33596353|NCT02143713|62995306|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
33596354|NCT02143713|62995307|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
33596355|NCT02143713|62995308|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
33596356|NCT02143713|62995305|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
33596357|NCT02143713|62995306|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
33696463|NCT01084083|63241108|FG000|Overall Study|Withdrawal by Subject|2|||
33696464|NCT01084083|63241108|FG000|Overall Study|Complicating disease|1|||
33696465|NCT01084083|63241108|FG000|Overall Study|Other|2|||
33696466|NCT01084083|63241108|FG000|Overall Study|Never started assigned therapy|1|||
33696467|NCT01079780|63241116|FG000|Overall Study|Disease progression|43|||
33696468|NCT01079780|63241117|FG001|Overall Study|Disease progression|7|||
33696469|NCT01079780|63241118|FG002|Overall Study|Disease progression|31|||
33696470|NCT01079780|63241116|FG000|Overall Study|Adverse Event|13|||
33696471|NCT01079780|63241117|FG001|Overall Study|Adverse Event|5|||
33696472|NCT01079780|63241118|FG002|Overall Study|Adverse Event|7|||
33696473|NCT01079780|63241116|FG000|Overall Study|Death|2|||
33696474|NCT01079780|63241117|FG001|Overall Study|Death|0|||
33696475|NCT01079780|63241118|FG002|Overall Study|Death|2|||
33696476|NCT01079780|63241116|FG000|Overall Study|Withdrawal by Subject|6|||
33696477|NCT01079780|63241117|FG001|Overall Study|Withdrawal by Subject|4|||
33696478|NCT01079780|63241118|FG002|Overall Study|Withdrawal by Subject|4|||
33696479|NCT01079780|63241116|FG000|Overall Study|Alternative therapy|2|||
33696480|NCT01079780|63241117|FG001|Overall Study|Alternative therapy|0|||
33696481|NCT01079780|63241118|FG002|Overall Study|Alternative therapy|2|||
33696482|NCT01079780|63241116|FG000|Overall Study|Physician Decision|1|||
33696483|NCT01079780|63241117|FG001|Overall Study|Physician Decision|0|||
33696484|NCT01079780|63241118|FG002|Overall Study|Physician Decision|1|||
33696485|NCT01079780|63241116|FG000|Overall Study|Error made in lesion measurement|1|||
33696486|NCT01079780|63241117|FG001|Overall Study|Error made in lesion measurement|0|||
33696487|NCT01079780|63241118|FG002|Overall Study|Error made in lesion measurement|0|||
33696488|NCT01079780|63241116|FG000|Overall Study|Patient had surgery|1|||
33696489|NCT01079780|63241117|FG001|Overall Study|Patient had surgery|0|||
33696490|NCT01079780|63241118|FG002|Overall Study|Patient had surgery|0|||
33696491|NCT01079780|63241116|FG000|Overall Study|Treatment cycle delay|0|||
33696492|NCT01079780|63241117|FG001|Overall Study|Treatment cycle delay|0|||
33696493|NCT01079780|63241118|FG002|Overall Study|Treatment cycle delay|1|||
33696494|NCT01079780|63241116|FG000|Overall Study|Never started treatment|1|||
33696495|NCT01079780|63241117|FG001|Overall Study|Never started treatment|0|||
33696496|NCT01079780|63241118|FG002|Overall Study|Never started treatment|2|||
33696497|NCT01013961|63241128|FG000|Overall Study|Adverse Event|2|||
33696498|NCT01013961|63241129|FG001|Overall Study|Adverse Event|2|||
33696499|NCT01013961|63241128|FG000|Overall Study|Withdrawal by Subject|1|||
33696500|NCT01013961|63241129|FG001|Overall Study|Withdrawal by Subject|0|||
33696501|NCT01013961|63241128|FG000|Overall Study|Physician Decision|0|||
33696502|NCT01013961|63241129|FG001|Overall Study|Physician Decision|1|||
33696503|NCT00834093|63241144|FG000|Overall Study|Progressive Disease|3|||
33696504|NCT00834093|63241144|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
33696505|NCT00606294|63241150|FG000|Overall Study|Withdrawal by Subject|36|||
33696506|NCT00606294|63241151|FG001|Overall Study|Withdrawal by Subject|0|||
33696507|NCT00583596|63241157|FG000|Overall Study|Lost to Follow-up|110|||
33696508|NCT00583596|63241157|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
33696509|NCT00583596|63241157|FG000|Overall Study|Death|2|||
33696510|NCT00583596|63241157|FG000|Overall Study|Withdrawal by Subject|6|||
33696511|NCT00583596|63241157|FG000|Overall Study|Lost to Follow-up|94|||
33696512|NCT00583596|63241157|FG000|Overall Study|Data not complete|1|||
33696513|NCT00583596|63241157|FG000|Overall Study|Not consented|15|||
33696514|NCT00583596|63241157|FG000|Overall Study|Outside f-up window|26|||
33696515|NCT00316888|63241168|FG000|Overall Study|Adverse Event|4|||
33696516|NCT00316888|63241169|FG001|Overall Study|Adverse Event|5|||
33696517|NCT00316888|63241168|FG000|Overall Study|Withdrawal by Subject|2|||
33696518|NCT00316888|63241169|FG001|Overall Study|Withdrawal by Subject|2|||
33696519|NCT00316888|63241168|FG000|Overall Study|Not start protocol therapy|0|||
33696520|NCT00316888|63241169|FG001|Overall Study|Not start protocol therapy|1|||
33696521|NCT00274924|63241178|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
33696522|NCT00274924|63241179|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
33696523|NCT00274924|63241180|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
33696524|NCT00274924|63241178|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
33696525|NCT00274924|63241179|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
33696526|NCT00274924|63241180|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
33696527|NCT00274924|63241178|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
33696528|NCT00274924|63241179|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
33696529|NCT00274924|63241180|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
33696530|NCT00274924|63241178|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
33696531|NCT00274924|63241179|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
33696532|NCT00274924|63241180|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
33696533|NCT00274924|63241178|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
33696534|NCT00274924|63241179|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
33696535|NCT00274924|63241180|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
33696536|NCT00274924|63241178|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
33696537|NCT00274924|63241179|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
33696538|NCT00274924|63241180|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
33696539|NCT00274924|63241178|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
33696540|NCT00274924|63241179|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
33493195|NCT04247815|62871367|FG000|Overall Study|Protocol Violation|0|||
33493196|NCT04247815|62871368|FG001|Overall Study|Protocol Violation|1|||
33493197|NCT03432819|62871403|FG000|Overall Study|Lost to Follow-up|2|||
33493198|NCT03432819|62871404|FG001|Overall Study|Lost to Follow-up|2|||
33493199|NCT03432819|62871403|FG000|Overall Study|Withdrawal by Subject|5|||
33493200|NCT03432819|62871404|FG001|Overall Study|Withdrawal by Subject|3|||
33493201|NCT03272347|62871423|FG000|Overall Study|Death|0|||
33493202|NCT03272347|62871424|FG001|Overall Study|Death|0|||
33493203|NCT03272347|62871425|FG002|Overall Study|Death|0|||
33493204|NCT03272347|62871426|FG003|Overall Study|Death|1|||
33493205|NCT03272347|62871423|FG000|Overall Study|Lost to Follow-up|1|||
33493206|NCT03272347|62871424|FG001|Overall Study|Lost to Follow-up|3|||
33493207|NCT03272347|62871425|FG002|Overall Study|Lost to Follow-up|5|||
33596358|NCT02143713|62995307|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
33596359|NCT02143713|62995308|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
33596360|NCT02143713|62995305|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
33596361|NCT02143713|62995306|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
33596362|NCT02143713|62995307|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
33596363|NCT02143713|62995308|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
33596364|NCT02143713|62995305|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
33493208|NCT03272347|62871426|FG003|Overall Study|Lost to Follow-up|1|||
33493209|NCT03272347|62871423|FG000|Overall Study|Physician Decision|4|||
33493210|NCT03272347|62871424|FG001|Overall Study|Physician Decision|2|||
33493211|NCT03272347|62871425|FG002|Overall Study|Physician Decision|5|||
33493212|NCT03272347|62871426|FG003|Overall Study|Physician Decision|4|||
33493213|NCT03272347|62871423|FG000|Overall Study|Screen Failure|1|||
33493214|NCT03272347|62871424|FG001|Overall Study|Screen Failure|0|||
33493215|NCT03272347|62871425|FG002|Overall Study|Screen Failure|0|||
33596365|NCT02143713|62995306|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
33596366|NCT02143713|62995307|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
33596367|NCT02143713|62995308|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
33696541|NCT00274924|63241180|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
33696542|NCT00274924|63241178|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
33493216|NCT03272347|62871426|FG003|Overall Study|Screen Failure|0|||
33493217|NCT03272347|62871423|FG000|Overall Study|Withdrawal by Subject|5|||
33493218|NCT03272347|62871424|FG001|Overall Study|Withdrawal by Subject|1|||
33493219|NCT03272347|62871425|FG002|Overall Study|Withdrawal by Subject|2|||
33493220|NCT03272347|62871426|FG003|Overall Study|Withdrawal by Subject|1|||
33493221|NCT03259568|62871448|FG000|Overall Study|Participant performance was low|3|||
33493222|NCT03239470|62871458|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
33493223|NCT03239470|62871459|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
33493224|NCT03167723|62871465|FG000|Overall Study|Protocol Violation|4|||
33493225|NCT03167723|62871466|FG001|Overall Study|Protocol Violation|6|||
33493226|NCT03103152|62871478|FG000|Overall Study|Physician Decision|5|||
33493227|NCT03103152|62871479|FG001|Overall Study|Physician Decision|2|||
33493228|NCT03103152|62871480|FG002|Overall Study|Physician Decision|6|||
33696543|NCT00274924|63241179|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
33696544|NCT00274924|63241180|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
33696545|NCT00274924|63241178|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
33696546|NCT00274924|63241179|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
33696547|NCT00274924|63241180|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
33696548|NCT00274924|63241178|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
33696549|NCT00274924|63241179|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
33696550|NCT00274924|63241180|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
33696551|NCT00274924|63241178|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
33696552|NCT00274924|63241179|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
33696553|NCT00274924|63241180|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
33696554|NCT00274924|63241178|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
33696555|NCT00274924|63241179|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
33696556|NCT00274924|63241180|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
33493229|NCT03103152|62871481|FG003|Overall Study|Physician Decision|3|||
33493230|NCT03103152|62871482|FG004|Overall Study|Physician Decision|3|||
33696557|NCT00274924|63241178|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
33696558|NCT00274924|63241179|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
33696559|NCT00274924|63241180|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
33696560|NCT00104884|63241187|FG000|Overall Study|Disease progression|4|||
33696561|NCT00096174|63241191|FG000|Overall Study|Lack of Efficacy|9|||
33696562|NCT00096174|63241191|FG000|Overall Study|Adverse Event|15|||
33696563|NCT00096174|63241191|FG000|Overall Study|Death|6|||
33696564|NCT00096174|63241191|FG000|Overall Study|Withdrawal by Subject|15|||
33696565|NCT00096174|63241191|FG000|Overall Study|Not started protocol therapy|3|||
33696566|NCT00096174|63241191|FG000|Overall Study|Ineligible|6|||
33696567|NCT00096174|63241191|FG000|Overall Study|other reason|8|||
33696568|NCT00080938|63241195|FG000|Overall Study|Adverse Event|3|||
33696569|NCT00080938|63241195|FG000|Overall Study|Withdrawal by Subject|6|||
33696570|NCT00080938|63241195|FG000|Overall Study|Death|2|||
33696571|NCT00080938|63241195|FG000|Overall Study|Lack of Efficacy|7|||
33696572|NCT00080938|63241195|FG000|Overall Study|other disease|1|||
33696573|NCT00080938|63241195|FG000|Overall Study|Not started protocol therapy|1|||
33696574|NCT00080938|63241195|FG000|Overall Study|Ineligible|4|||
33696575|NCT00074282|63241199|FG000|Step 1|Adverse Event|32|||
33696576|NCT00074282|63241200|FG001|Step 1|Adverse Event|0|||
33696577|NCT00074282|63241201|FG002|Step 1|Adverse Event|0|||
33696578|NCT00074282|63241199|FG000|Step 1|Death|6|||
33696579|NCT00074282|63241200|FG001|Step 1|Death|0|||
33696580|NCT00074282|63241201|FG002|Step 1|Death|0|||
33696581|NCT00074282|63241199|FG000|Step 1|Withdrawal by Subject|7|||
33696582|NCT00074282|63241200|FG001|Step 1|Withdrawal by Subject|0|||
33696583|NCT00074282|63241201|FG002|Step 1|Withdrawal by Subject|0|||
33696584|NCT00074282|63241199|FG000|Step 1|Disease progression|2|||
33696585|NCT00074282|63241200|FG001|Step 1|Disease progression|0|||
33696586|NCT00074282|63241201|FG002|Step 1|Disease progression|0|||
33696587|NCT00074282|63241199|FG000|Step 1|Alternative therapy|2|||
33696588|NCT00074282|63241200|FG001|Step 1|Alternative therapy|0|||
33696589|NCT00074282|63241201|FG002|Step 1|Alternative therapy|0|||
33696590|NCT00074282|63241199|FG000|Step 1|Other complicating disease|2|||
33696591|NCT00074282|63241200|FG001|Step 1|Other complicating disease|0|||
33696592|NCT00074282|63241201|FG002|Step 1|Other complicating disease|0|||
33696593|NCT00074282|63241199|FG000|Step 1|Physician Decision|1|||
33696594|NCT00074282|63241200|FG001|Step 1|Physician Decision|0|||
33493231|NCT03103152|62871483|FG005|Overall Study|Physician Decision|1|||
33493232|NCT03103152|62871478|FG000|Overall Study|Protocol Violation|2|||
33493233|NCT03103152|62871479|FG001|Overall Study|Protocol Violation|2|||
33596368|NCT02519855|62995321|FG000|Overall Study|Adverse Event|0|||
33696595|NCT00074282|63241201|FG002|Step 1|Physician Decision|0|||
33696596|NCT00074282|63241199|FG000|Step 1|Ineligible|4|||
33696597|NCT00074282|63241200|FG001|Step 1|Ineligible|0|||
33493234|NCT03103152|62871480|FG002|Overall Study|Protocol Violation|1|||
33493235|NCT03103152|62871481|FG003|Overall Study|Protocol Violation|2|||
33696598|NCT00074282|63241201|FG002|Step 1|Ineligible|0|||
33696599|NCT00074282|63241199|FG000|Step 1|Never started treatment|2|||
33696600|NCT00074282|63241200|FG001|Step 1|Never started treatment|0|||
33696601|NCT00074282|63241201|FG002|Step 1|Never started treatment|0|||
33696602|NCT00074282|63241199|FG000|Step 2|Adverse Event|0|||
33696603|NCT00074282|63241200|FG001|Step 2|Adverse Event|2|||
33696604|NCT00074282|63241201|FG002|Step 2|Adverse Event|12|||
33696605|NCT00074282|63241199|FG000|Step 2|Disease progression|0|||
33696606|NCT00074282|63241200|FG001|Step 2|Disease progression|0|||
33696607|NCT00074282|63241201|FG002|Step 2|Disease progression|5|||
33696608|NCT00074282|63241199|FG000|Step 2|Death|0|||
33696609|NCT00074282|63241200|FG001|Step 2|Death|0|||
33696610|NCT00074282|63241201|FG002|Step 2|Death|3|||
33696611|NCT00074282|63241199|FG000|Step 2|Withdrawal by Subject|0|||
33696612|NCT00074282|63241200|FG001|Step 2|Withdrawal by Subject|0|||
33696613|NCT00074282|63241201|FG002|Step 2|Withdrawal by Subject|2|||
33696614|NCT00074282|63241199|FG000|Step 2|Physician Decision|0|||
33696615|NCT00074282|63241200|FG001|Step 2|Physician Decision|0|||
33696616|NCT00074282|63241201|FG002|Step 2|Physician Decision|1|||
33696617|NCT00074282|63241199|FG000|Step 2|Ineligible|0|||
33696618|NCT00074282|63241200|FG001|Step 2|Ineligible|0|||
33696619|NCT00074282|63241201|FG002|Step 2|Ineligible|1|||
33696620|NCT00071981|63241213|FG000|Overall Study|Lack of Efficacy|37|||
33696621|NCT00071981|63241214|FG001|Overall Study|Lack of Efficacy|29|||
33696622|NCT00071981|63241215|FG002|Overall Study|Lack of Efficacy|30|||
33696623|NCT00071981|63241216|FG003|Overall Study|Lack of Efficacy|43|||
33696624|NCT00071981|63241213|FG000|Overall Study|Adverse Event|4|||
33696625|NCT00071981|63241214|FG001|Overall Study|Adverse Event|4|||
33696626|NCT00071981|63241215|FG002|Overall Study|Adverse Event|3|||
33696627|NCT00071981|63241216|FG003|Overall Study|Adverse Event|1|||
33696628|NCT00071981|63241213|FG000|Overall Study|Death|0|||
33696629|NCT00071981|63241214|FG001|Overall Study|Death|0|||
33696630|NCT00071981|63241215|FG002|Overall Study|Death|1|||
33696631|NCT00071981|63241216|FG003|Overall Study|Death|1|||
33696632|NCT00071981|63241213|FG000|Overall Study|Withdrawal by Subject|3|||
33696633|NCT00071981|63241214|FG001|Overall Study|Withdrawal by Subject|1|||
33696634|NCT00071981|63241215|FG002|Overall Study|Withdrawal by Subject|0|||
33696635|NCT00071981|63241216|FG003|Overall Study|Withdrawal by Subject|0|||
33696636|NCT00071981|63241213|FG000|Overall Study|No protocol therapy|2|||
33696637|NCT00071981|63241214|FG001|Overall Study|No protocol therapy|5|||
33696638|NCT00071981|63241215|FG002|Overall Study|No protocol therapy|1|||
33696639|NCT00071981|63241216|FG003|Overall Study|No protocol therapy|0|||
33696640|NCT00071981|63241213|FG000|Overall Study|others (not specified in the study)|0|||
33696641|NCT00071981|63241214|FG001|Overall Study|others (not specified in the study)|2|||
33696642|NCT00071981|63241215|FG002|Overall Study|others (not specified in the study)|2|||
33696643|NCT00071981|63241216|FG003|Overall Study|others (not specified in the study)|0|||
33696644|NCT00070291|63241226|FG000|Step 1|Withdrawal by Subject|1|||
33696645|NCT00070291|63241226|FG000|Step 1|Adverse Event|1|||
33696646|NCT00070291|63241226|FG000|Step 2|Adverse Event|1|||
33696647|NCT00064350|63241233|FG000|Induction Treatment|Disease Progression|5|||
33696648|NCT00064350|63241234|FG001|Induction Treatment|Disease Progression|1|||
33696649|NCT00064350|63241235|FG002|Induction Treatment|Disease Progression|110|||
33696650|NCT00064350|63241233|FG000|Induction Treatment|Adverse Event|0|||
33696651|NCT00064350|63241234|FG001|Induction Treatment|Adverse Event|2|||
33696652|NCT00064350|63241235|FG002|Induction Treatment|Adverse Event|49|||
33696653|NCT00064350|63241233|FG000|Induction Treatment|Death|0|||
33696654|NCT00064350|63241234|FG001|Induction Treatment|Death|0|||
33696655|NCT00064350|63241235|FG002|Induction Treatment|Death|9|||
33696656|NCT00064350|63241233|FG000|Induction Treatment|Withdrawal by Subject|0|||
33696657|NCT00064350|63241234|FG001|Induction Treatment|Withdrawal by Subject|0|||
33696658|NCT00064350|63241235|FG002|Induction Treatment|Withdrawal by Subject|21|||
33696659|NCT00064350|63241233|FG000|Induction Treatment|Ineligible or never started treatment|3|||
33696660|NCT00064350|63241234|FG001|Induction Treatment|Ineligible or never started treatment|6|||
33696661|NCT00064350|63241235|FG002|Induction Treatment|Ineligible or never started treatment|34|||
33696662|NCT00064350|63241233|FG000|Induction Treatment|Other|0|||
33696663|NCT00064350|63241234|FG001|Induction Treatment|Other|0|||
33696664|NCT00064350|63241235|FG002|Induction Treatment|Other|13|||
33696665|NCT00064350|63241233|FG000|Randomization|Adverse Event|8|||
33696666|NCT00064350|63241234|FG001|Randomization|Adverse Event|3|||
33696667|NCT00064350|63241235|FG002|Randomization|Adverse Event|0|||
33696668|NCT00064350|63241233|FG000|Randomization|Death|3|||
33696669|NCT00064350|63241234|FG001|Randomization|Death|0|||
33696670|NCT00064350|63241235|FG002|Randomization|Death|0|||
33696671|NCT00064350|63241233|FG000|Randomization|Withdrawal by Subject|1|||
33696672|NCT00064350|63241234|FG001|Randomization|Withdrawal by Subject|0|||
33696673|NCT00064350|63241235|FG002|Randomization|Withdrawal by Subject|0|||
33696674|NCT00064350|63241233|FG000|Randomization|Ineligible or never started treatment|9|||
33696675|NCT00064350|63241234|FG001|Randomization|Ineligible or never started treatment|15|||
33696676|NCT00064350|63241235|FG002|Randomization|Ineligible or never started treatment|0|||
33696677|NCT00064350|63241233|FG000|Randomization|Other|5|||
33696678|NCT00064350|63241234|FG001|Randomization|Other|0|||
33696679|NCT00064350|63241235|FG002|Randomization|Other|0|||
33696680|NCT00064350|63241233|FG000|Cross-Over|Adverse Event|0|||
33696681|NCT00064350|63241234|FG001|Cross-Over|Adverse Event|1|||
33696682|NCT00064350|63241235|FG002|Cross-Over|Adverse Event|0|||
33696683|NCT00064350|63241233|FG000|Cross-Over|Death|1|||
33696684|NCT00064350|63241234|FG001|Cross-Over|Death|3|||
33696685|NCT00064350|63241235|FG002|Cross-Over|Death|0|||
33696686|NCT00064350|63241233|FG000|Cross-Over|Withdrawal by Subject|2|||
33696687|NCT00064350|63241234|FG001|Cross-Over|Withdrawal by Subject|2|||
33696688|NCT00064350|63241235|FG002|Cross-Over|Withdrawal by Subject|0|||
33696689|NCT00064350|63241233|FG000|Cross-Over|Ineligible or never started treatment|3|||
33696690|NCT00064350|63241234|FG001|Cross-Over|Ineligible or never started treatment|6|||
33696691|NCT00064350|63241235|FG002|Cross-Over|Ineligible or never started treatment|0|||
33696692|NCT00064350|63241233|FG000|Cross-Over|Other|0|||
33696693|NCT00064350|63241234|FG001|Cross-Over|Other|2|||
33696694|NCT00064350|63241235|FG002|Cross-Over|Other|0|||
33696695|NCT00063986|63241244|FG000|Overall Study|Withdrawal by Subject|1|||
33696696|NCT00063986|63241244|FG000|Overall Study|Ineligible|1|||
33696697|NCT00063986|63241244|FG000|Overall Study|Intra-operatively ineligible|4|||
33696698|NCT00057954|63241252|FG000|Overall Study|Death|1|||
33696699|NCT00057954|63241252|FG000|Overall Study|Disease progression|1|||
33696700|NCT00049530|63241256|FG000|Overall Study|Lack of Efficacy|25|||
33696701|NCT00049530|63241256|FG000|Overall Study|Adverse Event|2|||
33696702|NCT00049530|63241256|FG000|Overall Study|Death|1|||
33696703|NCT00049530|63241256|FG000|Overall Study|symptomatic deterioration|1|||
33696704|NCT00049530|63241256|FG000|Overall Study|ineligible|3|||
33696705|NCT00045305|63241260|FG000|Overall Study|Lack of Efficacy|6|||
33696706|NCT00045305|63241260|FG000|Overall Study|Adverse Event|3|||
33696707|NCT00045305|63241260|FG000|Overall Study|Death|3|||
33696708|NCT00045305|63241260|FG000|Overall Study|site error|2|||
33696709|NCT00033657|63241266|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
33696710|NCT00033657|63241267|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
33696711|NCT00033657|63241266|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
33696712|NCT00033657|63241267|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
33696713|NCT00033657|63241266|FG000|Neoadjuvant Chemotherapy|Death|1|||
33696714|NCT00033657|63241267|FG001|Neoadjuvant Chemotherapy|Death|1|||
33696715|NCT00033657|63241266|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
33696716|NCT00033657|63241267|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
33696717|NCT00033657|63241266|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
33696718|NCT00033657|63241267|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
33696719|NCT00033657|63241266|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
33696720|NCT00033657|63241267|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
33696721|NCT00033657|63241266|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
33696722|NCT00033657|63241267|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
33696723|NCT00033657|63241266|FG000|Surgical Resection|not complete resection|0|||
33696724|NCT00033657|63241267|FG001|Surgical Resection|not complete resection|3|||
33696725|NCT00033657|63241266|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
33696726|NCT00033657|63241267|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
33696727|NCT00033657|63241266|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
33696728|NCT00033657|63241267|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
33696729|NCT00033657|63241266|FG000|Adjuvant Chemotherapy|Death|2|||
33696730|NCT00033657|63241267|FG001|Adjuvant Chemotherapy|Death|1|||
33696731|NCT00033657|63241266|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
33696732|NCT00033657|63241267|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
33696733|NCT00033657|63241266|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
33696734|NCT00033657|63241267|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
33696735|NCT00033657|63241266|FG000|Adjuvant Chemotherapy|Other|0|||
33696736|NCT00033657|63241267|FG001|Adjuvant Chemotherapy|Other|2|||
33696737|NCT00003389|63241277|FG000|Overall Study|Disease progression|6|||
33696738|NCT00003389|63241278|FG001|Overall Study|Disease progression|1|||
33696739|NCT00003389|63241277|FG000|Overall Study|Adverse Event|13|||
33696740|NCT00003389|63241278|FG001|Overall Study|Adverse Event|2|||
33696741|NCT00003389|63241277|FG000|Overall Study|Death|0|||
33696742|NCT00003389|63241278|FG001|Overall Study|Death|3|||
33696743|NCT00003389|63241277|FG000|Overall Study|Withdrawal by Subject|12|||
33696744|NCT00003389|63241278|FG001|Overall Study|Withdrawal by Subject|5|||
33493236|NCT03103152|62871482|FG004|Overall Study|Protocol Violation|1|||
33493237|NCT03103152|62871483|FG005|Overall Study|Protocol Violation|1|||
33696745|NCT00003389|63241277|FG000|Overall Study|Alternative therapy|2|||
33696746|NCT00003389|63241278|FG001|Overall Study|Alternative therapy|1|||
33696747|NCT00003389|63241277|FG000|Overall Study|Complicating disease|1|||
33696748|NCT00003389|63241278|FG001|Overall Study|Complicating disease|0|||
33696749|NCT00003389|63241277|FG000|Overall Study|Off-treatment reason missing|31|||
33696750|NCT00003389|63241278|FG001|Overall Study|Off-treatment reason missing|21|||
33696751|NCT00003389|63241277|FG000|Overall Study|Ineligible|33|||
33696752|NCT00003389|63241278|FG001|Overall Study|Ineligible|27|||
33696753|NCT00003138|63241286|FG000|Step 1|Reasons off treatment not documented|60|||
33696754|NCT00003138|63241287|FG001|Step 1|Reasons off treatment not documented|57|||
33696755|NCT00003138|63241286|FG000|Step 1|Never started treatment|1|||
33696756|NCT00003138|63241287|FG001|Step 1|Never started treatment|0|||
33696757|NCT00003138|63241286|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
33696758|NCT00003138|63241287|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
33696759|NCT00003138|63241286|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
33696760|NCT00003138|63241287|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
33696761|NCT00003138|63241286|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
33696762|NCT00003138|63241287|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
33696763|NCT00003138|63241286|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
33696764|NCT00003138|63241287|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
33696765|NCT00002525|63241298|FG000|Overall Study|Adverse Event|36|||
33696766|NCT00002525|63241299|FG001|Overall Study|Adverse Event|0|||
33696767|NCT00002525|63241298|FG000|Overall Study|Death|5|||
33696768|NCT00002525|63241299|FG001|Overall Study|Death|0|||
33696769|NCT00002525|63241298|FG000|Overall Study|Withdrawal by Subject|11|||
33696770|NCT00002525|63241299|FG001|Overall Study|Withdrawal by Subject|0|||
33696771|NCT00002525|63241298|FG000|Overall Study|Start non-protocol therapy|1|||
33696772|NCT00002525|63241299|FG001|Overall Study|Start non-protocol therapy|0|||
33696773|NCT00002525|63241298|FG000|Overall Study|Other complicating disease|1|||
33696774|NCT00002525|63241299|FG001|Overall Study|Other complicating disease|0|||
33696775|NCT00002525|63241298|FG000|Overall Study|Duke's A, B1, D disease|92|||
33696776|NCT00002525|63241299|FG001|Overall Study|Duke's A, B1, D disease|0|||
33696777|NCT00002525|63241298|FG000|Overall Study|Error|6|||
33696778|NCT00002525|63241299|FG001|Overall Study|Error|0|||
33696779|NCT00002525|63241298|FG000|Overall Study|Other|26|||
33696780|NCT00002525|63241299|FG001|Overall Study|Other|0|||
33696781|NCT00002525|63241298|FG000|Overall Study|Never start protocol therapy|8|||
33696782|NCT00002525|63241299|FG001|Overall Study|Never start protocol therapy|0|||
33696783|NCT02259348|63241307|FG000|Overall Study|Donors|6|||
33696784|NCT02259348|63241307|FG000|Overall Study|Death|4|||
33696785|NCT02259114|63241564|FG000|Overall Study|Progressive Disease|14|||
33696786|NCT02259114|63241565|FG001|Overall Study|Progressive Disease|2|||
33696787|NCT02259114|63241566|FG002|Overall Study|Progressive Disease|10|||
33696788|NCT02259114|63241567|FG003|Overall Study|Progressive Disease|2|||
33696789|NCT02259114|63241568|FG004|Overall Study|Progressive Disease|5|||
33696790|NCT02259114|63241564|FG000|Overall Study|Adverse Event|2|||
33696791|NCT02259114|63241565|FG001|Overall Study|Adverse Event|1|||
33696792|NCT02259114|63241566|FG002|Overall Study|Adverse Event|0|||
33696793|NCT02259114|63241567|FG003|Overall Study|Adverse Event|0|||
33696794|NCT02259114|63241568|FG004|Overall Study|Adverse Event|1|||
33696795|NCT02259114|63241564|FG000|Overall Study|Death|3|||
33696796|NCT02259114|63241565|FG001|Overall Study|Death|0|||
33696797|NCT02259114|63241566|FG002|Overall Study|Death|1|||
33696798|NCT02259114|63241567|FG003|Overall Study|Death|0|||
33696799|NCT02259114|63241568|FG004|Overall Study|Death|0|||
33696800|NCT02259114|63241564|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
33696801|NCT02259114|63241565|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
33696802|NCT02259114|63241566|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
33696803|NCT02259114|63241567|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
33696804|NCT02259114|63241568|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
33696805|NCT02259114|63241564|FG000|Overall Study|Withdrawal by Subject|0|||
33696806|NCT02259114|63241565|FG001|Overall Study|Withdrawal by Subject|0|||
33696807|NCT02259114|63241566|FG002|Overall Study|Withdrawal by Subject|1|||
33696808|NCT02259114|63241567|FG003|Overall Study|Withdrawal by Subject|1|||
33696809|NCT02259114|63241568|FG004|Overall Study|Withdrawal by Subject|0|||
33696810|NCT02259114|63241564|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
33696811|NCT02259114|63241565|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
33696812|NCT02259114|63241566|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
33696813|NCT02259114|63241567|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
33696814|NCT02259114|63241568|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
33696815|NCT02259114|63241564|FG000|Overall Study|Not Treated|1|||
33696816|NCT02259114|63241565|FG001|Overall Study|Not Treated|0|||
33696817|NCT02259114|63241566|FG002|Overall Study|Not Treated|0|||
33696818|NCT02259114|63241567|FG003|Overall Study|Not Treated|0|||
33696819|NCT02259114|63241568|FG004|Overall Study|Not Treated|0|||
33696820|NCT02258334|63241623|FG000|Overall Study|Adverse Event|1|||
33696821|NCT02258334|63241624|FG001|Overall Study|Adverse Event|0|||
33696822|NCT02258334|63241625|FG002|Overall Study|Adverse Event|0|||
33696823|NCT02258334|63241626|FG003|Overall Study|Adverse Event|0|||
33696824|NCT04960202|63241663|FG000|Overall Study|Other|12|||
33696825|NCT04960202|63241664|FG001|Overall Study|Other|10|||
33696826|NCT04960202|63241663|FG000|Overall Study|Withdrawal by Subject|43|||
33696827|NCT04960202|63241664|FG001|Overall Study|Withdrawal by Subject|45|||
33696828|NCT04960202|63241663|FG000|Overall Study|Lost to Follow-up|20|||
33696829|NCT04960202|63241664|FG001|Overall Study|Lost to Follow-up|17|||
33696830|NCT04960202|63241663|FG000|Overall Study|Death|0|||
33696831|NCT04960202|63241664|FG001|Overall Study|Death|15|||
33696832|NCT02257632|63241734|FG000|Overall Study|Withdrawal by Subject|0|||
33696833|NCT02257632|63241735|FG001|Overall Study|Withdrawal by Subject|1|||
33696834|NCT02257632|63241734|FG000|Overall Study|Adverse Event|1|||
33696835|NCT02257632|63241735|FG001|Overall Study|Adverse Event|2|||
33696836|NCT01642914|63241769|FG000|Overall Study|Adverse Event|11|||
33696837|NCT01642914|63241770|FG001|Overall Study|Adverse Event|7|||
33696838|NCT01642914|63241771|FG002|Overall Study|Adverse Event|15|||
33696839|NCT01642914|63241769|FG000|Overall Study|Lack of Efficacy|9|||
33696840|NCT01642914|63241770|FG001|Overall Study|Lack of Efficacy|4|||
33696841|NCT01642914|63241771|FG002|Overall Study|Lack of Efficacy|2|||
33696842|NCT01642914|63241769|FG000|Overall Study|Protocol Violation|15|||
33696843|NCT01642914|63241770|FG001|Overall Study|Protocol Violation|13|||
33696844|NCT01642914|63241771|FG002|Overall Study|Protocol Violation|6|||
33696845|NCT01642914|63241769|FG000|Overall Study|Withdrawal by Subject|5|||
33696846|NCT01642914|63241770|FG001|Overall Study|Withdrawal by Subject|5|||
33696847|NCT01642914|63241771|FG002|Overall Study|Withdrawal by Subject|10|||
33696848|NCT01642914|63241769|FG000|Overall Study|Lost to Follow-up|5|||
33696849|NCT01642914|63241770|FG001|Overall Study|Lost to Follow-up|3|||
33696850|NCT01642914|63241771|FG002|Overall Study|Lost to Follow-up|7|||
33696851|NCT01642914|63241769|FG000|Overall Study|Other Reason|1|||
33696852|NCT01642914|63241770|FG001|Overall Study|Other Reason|0|||
33696853|NCT01642914|63241771|FG002|Overall Study|Other Reason|0|||
33696854|NCT01642602|63241830|FG000|Overall Study|Adverse Event|2|||
33696855|NCT02256540|63241896|FG000|Overall Study|Withdrawal by Subject|0|||
33696856|NCT02256540|63241897|FG001|Overall Study|Withdrawal by Subject|1|||
33696857|NCT02256540|63241898|FG002|Overall Study|Withdrawal by Subject|1|||
33696858|NCT02256540|63241896|FG000|Overall Study|Back pain preventing exercise|0|||
33696859|NCT02256540|63241897|FG001|Overall Study|Back pain preventing exercise|0|||
33696860|NCT02256540|63241898|FG002|Overall Study|Back pain preventing exercise|1|||
33696861|NCT01640184|63241922|FG000|Overall Study|Death|1|||
33696862|NCT01640184|63241923|FG001|Overall Study|Death|0|||
33696863|NCT01640184|63241924|FG002|Overall Study|Death|0|||
33696864|NCT01640184|63241922|FG000|Overall Study|Lost to Follow-up|4|||
33696865|NCT01640184|63241923|FG001|Overall Study|Lost to Follow-up|1|||
33696866|NCT01640184|63241924|FG002|Overall Study|Lost to Follow-up|0|||
33696867|NCT01640184|63241922|FG000|Overall Study|Physician Decision|3|||
33696868|NCT01640184|63241923|FG001|Overall Study|Physician Decision|0|||
33696869|NCT01640184|63241924|FG002|Overall Study|Physician Decision|0|||
33696870|NCT01640184|63241922|FG000|Overall Study|Withdrawal by Subject|0|||
33696871|NCT01640184|63241923|FG001|Overall Study|Withdrawal by Subject|1|||
33696872|NCT01640184|63241924|FG002|Overall Study|Withdrawal by Subject|1|||
33696873|NCT01640184|63241922|FG000|Overall Study|Protocol Violation|0|||
33696874|NCT01640184|63241923|FG001|Overall Study|Protocol Violation|0|||
33696875|NCT01640184|63241924|FG002|Overall Study|Protocol Violation|1|||
33696876|NCT02256384|63241944|FG000|Overall Study|Withdrawal by Subject|12|||
33696877|NCT02256384|63241944|FG000|Overall Study|Equipment not capturing data|2|||
33696878|NCT02255760|63241987|FG000|Overall Study|Lost to Follow-up|0|||
33696879|NCT02255760|63241988|FG001|Overall Study|Lost to Follow-up|1|||
33696880|NCT02255760|63241989|FG002|Overall Study|Lost to Follow-up|0|||
33696881|NCT02255760|63241990|FG003|Overall Study|Lost to Follow-up|0|||
33696882|NCT02255760|63241991|FG004|Overall Study|Lost to Follow-up|0|||
33696883|NCT01641822|63242087|FG000|Run-in Phase|Noncompliance with study drug|1|||
33696884|NCT01641822|63242088|FG001|Run-in Phase|Noncompliance with study drug|0|||
33696885|NCT01641822|63242089|FG002|Run-in Phase|Noncompliance with study drug|0|||
33696886|NCT01641822|63242087|FG000|Run-in Phase|Adverse Event|3|||
33696887|NCT01641822|63242088|FG001|Run-in Phase|Adverse Event|0|||
33696888|NCT01641822|63242089|FG002|Run-in Phase|Adverse Event|0|||
33696889|NCT01641822|63242087|FG000|Run-in Phase|Withdrew consent|1|||
33696890|NCT01641822|63242088|FG001|Run-in Phase|Withdrew consent|0|||
33696891|NCT01641822|63242089|FG002|Run-in Phase|Withdrew consent|0|||
33696892|NCT01641822|63242087|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
33696893|NCT01641822|63242088|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
33696894|NCT01641822|63242089|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
33696895|NCT01641822|63242087|FG000|Comparative Phase|Noncompliance with study drug|0|||
33696896|NCT01641822|63242088|FG001|Comparative Phase|Noncompliance with study drug|1|||
33493238|NCT03103152|62871478|FG000|Overall Study|Inter-current illness|0|||
33696897|NCT01641822|63242089|FG002|Comparative Phase|Noncompliance with study drug|0|||
33696898|NCT01641822|63242087|FG000|Comparative Phase|Investigator's discretion|0|||
33696899|NCT01641822|63242088|FG001|Comparative Phase|Investigator's discretion|0|||
33696900|NCT01641822|63242089|FG002|Comparative Phase|Investigator's discretion|1|||
33696901|NCT01641822|63242087|FG000|Comparative Phase|Pregnancy|0|||
33696902|NCT01641822|63242088|FG001|Comparative Phase|Pregnancy|0|||
33696903|NCT01641822|63242089|FG002|Comparative Phase|Pregnancy|1|||
33696904|NCT01641822|63242087|FG000|Comparative Phase|Adverse event, serious fatal|0|||
33696905|NCT01641822|63242088|FG001|Comparative Phase|Adverse event, serious fatal|1|||
33696906|NCT01641822|63242089|FG002|Comparative Phase|Adverse event, serious fatal|0|||
33696907|NCT01641822|63242087|FG000|Comparative Phase|Withdrew consent|0|||
33696908|NCT01641822|63242088|FG001|Comparative Phase|Withdrew consent|3|||
33696909|NCT01641822|63242089|FG002|Comparative Phase|Withdrew consent|7|||
33696910|NCT01641822|63242087|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
33696911|NCT01641822|63242088|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
33696912|NCT01641822|63242089|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
33696913|NCT01641198|63242169|FG000|After 12 Months of Function|Lost to Follow-up|3|||
33696914|NCT01641198|63242170|FG001|After 12 Months of Function|Lost to Follow-up|2|||
33696915|NCT01641198|63242171|FG002|After 12 Months of Function|Lost to Follow-up|2|||
33696916|NCT01641198|63242169|FG000|After 12 Months of Function|Protocol Violation|1|||
33696917|NCT01641198|63242170|FG001|After 12 Months of Function|Protocol Violation|0|||
33696918|NCT01641198|63242171|FG002|After 12 Months of Function|Protocol Violation|0|||
33696919|NCT01641198|63242169|FG000|After 12 Months of Function|Adverse Event|0|||
33696920|NCT01641198|63242170|FG001|After 12 Months of Function|Adverse Event|1|||
33696921|NCT01641198|63242171|FG002|After 12 Months of Function|Adverse Event|0|||
33696922|NCT01641198|63242169|FG000|After 24 Months of Function|Lost to Follow-up|4|||
33696923|NCT01641198|63242170|FG001|After 24 Months of Function|Lost to Follow-up|9|||
33696924|NCT01641198|63242171|FG002|After 24 Months of Function|Lost to Follow-up|6|||
33696925|NCT01641198|63242169|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
33696926|NCT01641198|63242170|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
33696927|NCT01641198|63242171|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
33696928|NCT01641198|63242169|FG000|At 15-20 Years of Function|Death|1|||
33696929|NCT01641198|63242170|FG001|At 15-20 Years of Function|Death|0|||
33696930|NCT01641198|63242171|FG002|At 15-20 Years of Function|Death|1|||
33696931|NCT01639560|63242256|FG000|Overall Study|Withdrawal by Subject|9|||
33696932|NCT01639560|63242257|FG001|Overall Study|Withdrawal by Subject|14|||
33696933|NCT01639560|63242256|FG000|Overall Study|Lack of Efficacy|1|||
33696934|NCT01639560|63242257|FG001|Overall Study|Lack of Efficacy|2|||
33696935|NCT01639560|63242256|FG000|Overall Study|Lost to Follow-up|9|||
33696936|NCT01639560|63242257|FG001|Overall Study|Lost to Follow-up|11|||
33696937|NCT01639560|63242256|FG000|Overall Study|Adverse Event|0|||
33696938|NCT01639560|63242257|FG001|Overall Study|Adverse Event|2|||
33696939|NCT01601652|63242279|FG000|Overall Study|Death|1|||
33696940|NCT03952130|63242317|FG000|Overall Study|Adverse Event|0|||
33696941|NCT03952130|63242318|FG001|Overall Study|Adverse Event|1|||
33696942|NCT03952130|63242317|FG000|Overall Study|Lost to Follow-up|1|||
33696943|NCT03952130|63242318|FG001|Overall Study|Lost to Follow-up|0|||
33696944|NCT03952130|63242317|FG000|Overall Study|Withdrawal by Subject|1|||
33696945|NCT03952130|63242318|FG001|Overall Study|Withdrawal by Subject|5|||
33696946|NCT01640964|63242362|FG000|Overall Study|Lost to Follow-up|0|||
33696947|NCT01640964|63242363|FG001|Overall Study|Lost to Follow-up|0|||
33696948|NCT01640964|63242364|FG002|Overall Study|Lost to Follow-up|1|||
33696949|NCT01640964|63242362|FG000|Overall Study|Protocol Deviation|1|||
33696950|NCT01640964|63242363|FG001|Overall Study|Protocol Deviation|1|||
33696951|NCT01640964|63242364|FG002|Overall Study|Protocol Deviation|2|||
33696952|NCT01638390|63242484|FG000|Overall Study|screening failures|21|||
33696953|NCT01600716|63242515|FG000|Overall Study|Other Reasons|3|||
33696954|NCT01600716|63242516|FG001|Overall Study|Other Reasons|1|||
33696955|NCT01600716|63242515|FG000|Overall Study|Personal Reasons|0|||
33696956|NCT01600716|63242516|FG001|Overall Study|Personal Reasons|2|||
33696957|NCT01600716|63242515|FG000|Overall Study|Lost to Follow-up|0|||
33696958|NCT01600716|63242516|FG001|Overall Study|Lost to Follow-up|2|||
33696959|NCT01600716|63242515|FG000|Overall Study|Pregnancy|1|||
33696960|NCT01600716|63242516|FG001|Overall Study|Pregnancy|0|||
33696961|NCT01600716|63242515|FG000|Overall Study|Lack of Efficacy|2|||
33696962|NCT01600716|63242516|FG001|Overall Study|Lack of Efficacy|1|||
33696963|NCT01600716|63242515|FG000|Overall Study|Adverse Event|1|||
33696964|NCT01600716|63242516|FG001|Overall Study|Adverse Event|1|||
33696965|NCT01600326|63242628|FG000|Overall Study|Lost to Follow-up|1|||
33696966|NCT01600326|63242629|FG001|Overall Study|Lost to Follow-up|1|||
33696967|NCT01637142|63242765|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
33696968|NCT01636986|63242783|FG000|Overall Study|Withdrawal by Subject|0|||
33696969|NCT01636986|63242784|FG001|Overall Study|Withdrawal by Subject|1|||
33696970|NCT01636986|63242783|FG000|Overall Study|Corneal Staining|0|||
33493239|NCT03103152|62871479|FG001|Overall Study|Inter-current illness|0|||
33493240|NCT03103152|62871480|FG002|Overall Study|Inter-current illness|1|||
33696971|NCT01636986|63242784|FG001|Overall Study|Corneal Staining|1|||
33696972|NCT01601496|63242870|FG000|Overall Study|Physician Decision|1|||
33696973|NCT01601496|63242870|FG000|Overall Study|Withdrawal by Subject|1|||
33696974|NCT01601496|63242870|FG000|Overall Study|Lost to Follow-up|6|||
33696975|NCT01601496|63242870|FG000|Overall Study|Death|4|||
33696976|NCT01601496|63242870|FG000|Overall Study|Other: patient refusal to continue|3|||
33696977|NCT03211832|63242876|FG000|Overall Study|No longer with agency|32|||
33696978|NCT03211832|63242877|FG001|Overall Study|No longer with agency|49|||
33696979|NCT03211832|63242878|FG002|Overall Study|No longer with agency|30|||
33696980|NCT03211832|63242876|FG000|Overall Study|Declined survey|3|||
33696981|NCT03211832|63242877|FG001|Overall Study|Declined survey|3|||
33696982|NCT03211832|63242878|FG002|Overall Study|Declined survey|2|||
33696983|NCT03211832|63242876|FG000|Overall Study|Not available during data collection|1|||
33696984|NCT03211832|63242877|FG001|Overall Study|Not available during data collection|0|||
33493241|NCT03103152|62871481|FG003|Overall Study|Inter-current illness|0|||
33696985|NCT03211832|63242878|FG002|Overall Study|Not available during data collection|2|||
33696986|NCT04887948|63242887|FG000|Overall Study|Death|1|||
33696987|NCT04887948|63242888|FG001|Overall Study|Death|0|||
33696988|NCT04887948|63242889|FG002|Overall Study|Death|0|||
33696989|NCT04887948|63242887|FG000|Overall Study|Lost to Follow-up|1|||
33696990|NCT04887948|63242888|FG001|Overall Study|Lost to Follow-up|0|||
33696991|NCT04887948|63242889|FG002|Overall Study|Lost to Follow-up|3|||
33696992|NCT04887948|63242887|FG000|Overall Study|Physician Decision|0|||
33696993|NCT04887948|63242888|FG001|Overall Study|Physician Decision|4|||
33696994|NCT04887948|63242889|FG002|Overall Study|Physician Decision|1|||
33696995|NCT04887948|63242887|FG000|Overall Study|Protocol Violation|1|||
33696996|NCT04887948|63242888|FG001|Overall Study|Protocol Violation|1|||
33696997|NCT04887948|63242889|FG002|Overall Study|Protocol Violation|0|||
33696998|NCT04887948|63242887|FG000|Overall Study|Withdrawal by Subject|0|||
33696999|NCT04887948|63242888|FG001|Overall Study|Withdrawal by Subject|6|||
33697000|NCT04887948|63242889|FG002|Overall Study|Withdrawal by Subject|1|||
33697001|NCT04887948|63242887|FG000|Overall Study|No longer met eligibility criteria|1|||
33697002|NCT04887948|63242888|FG001|Overall Study|No longer met eligibility criteria|2|||
33697003|NCT04887948|63242889|FG002|Overall Study|No longer met eligibility criteria|1|||
33697004|NCT04887948|63242887|FG000|Overall Study|Other|2|||
33697005|NCT04887948|63242888|FG001|Overall Study|Other|1|||
33697006|NCT04887948|63242889|FG002|Overall Study|Other|1|||
33697007|NCT01638000|63243027|FG000|Overall Study|Randomized but Never Received Drug|7|||
33697008|NCT01638000|63243028|FG001|Overall Study|Randomized but Never Received Drug|10|||
33697009|NCT01638000|63243027|FG000|Overall Study|Adverse Event|14|||
33697010|NCT01638000|63243028|FG001|Overall Study|Adverse Event|16|||
33697011|NCT01638000|63243027|FG000|Overall Study|Lack of Efficacy|5|||
33697012|NCT01638000|63243028|FG001|Overall Study|Lack of Efficacy|6|||
33697013|NCT01638000|63243027|FG000|Overall Study|Protocol Violation|11|||
33697014|NCT01638000|63243028|FG001|Overall Study|Protocol Violation|13|||
33697015|NCT01638000|63243027|FG000|Overall Study|Withdrawal by Subject|21|||
33697016|NCT01638000|63243028|FG001|Overall Study|Withdrawal by Subject|24|||
33697017|NCT01638000|63243027|FG000|Overall Study|Miscellaneous|2|||
33697018|NCT01638000|63243028|FG001|Overall Study|Miscellaneous|2|||
33697019|NCT01637922|63243087|FG000|Overall Study|Adverse Event|0|||
33697020|NCT01637922|63243088|FG001|Overall Study|Adverse Event|1|||
33697021|NCT01637922|63243087|FG000|Overall Study|Protocol Violation|0|||
33697022|NCT01637922|63243088|FG001|Overall Study|Protocol Violation|1|||
33697023|NCT01637922|63243087|FG000|Overall Study|Withdrawal by Subject|0|||
33697024|NCT01637922|63243088|FG001|Overall Study|Withdrawal by Subject|3|||
33697025|NCT01637922|63243087|FG000|Overall Study|Lost to Follow-up|2|||
33697026|NCT01637922|63243088|FG001|Overall Study|Lost to Follow-up|0|||
33697027|NCT03496662|63243293|FG000|Overall Study|Adverse Event|1|||
33596369|NCT02519855|62995322|FG001|Overall Study|Adverse Event|1|||
33596370|NCT02519855|62995321|FG000|Overall Study|Lost to Follow-up|3|||
33596371|NCT02519855|62995322|FG001|Overall Study|Lost to Follow-up|3|||
33697028|NCT03496662|63243294|FG001|Overall Study|Adverse Event|0|||
33697029|NCT03496662|63243295|FG002|Overall Study|Adverse Event|1|||
33596372|NCT02142387|62995330|FG000|Overall Study|<19 years old|49|||
33697030|NCT03496662|63243293|FG000|Overall Study|Physician Decision|1|||
33697031|NCT03496662|63243294|FG001|Overall Study|Physician Decision|0|||
33697032|NCT03496662|63243295|FG002|Overall Study|Physician Decision|3|||
33697033|NCT03496662|63243293|FG000|Overall Study|Withdrawal by Subject|0|||
33697034|NCT03496662|63243294|FG001|Overall Study|Withdrawal by Subject|0|||
33697035|NCT03496662|63243295|FG002|Overall Study|Withdrawal by Subject|2|||
33697036|NCT03496662|63243293|FG000|Overall Study|Death|0|||
33697037|NCT03496662|63243294|FG001|Overall Study|Death|0|||
33697038|NCT03496662|63243295|FG002|Overall Study|Death|2|||
33697039|NCT03496662|63243293|FG000|Overall Study|Noncompliance|0|||
33697040|NCT03496662|63243294|FG001|Overall Study|Noncompliance|0|||
33697041|NCT03496662|63243295|FG002|Overall Study|Noncompliance|1|||
33697042|NCT01638546|63243305|FG000|Overall Study|Adverse Event|1|||
33697043|NCT01638546|63243306|FG001|Overall Study|Adverse Event|3|||
33697044|NCT03172494|63243326|FG000|Overall Study|Adverse Event|5|||
33697045|NCT03172494|63243327|FG001|Overall Study|Adverse Event|1|||
33697046|NCT03172494|63243328|FG002|Overall Study|Adverse Event|15|||
33697047|NCT03172494|63243326|FG000|Overall Study|Protocol Violation|3|||
33697048|NCT03172494|63243327|FG001|Overall Study|Protocol Violation|2|||
33697049|NCT03172494|63243328|FG002|Overall Study|Protocol Violation|1|||
33697050|NCT03172494|63243326|FG000|Overall Study|Lack of Efficacy|0|||
33697051|NCT03172494|63243327|FG001|Overall Study|Lack of Efficacy|0|||
33697052|NCT03172494|63243328|FG002|Overall Study|Lack of Efficacy|4|||
33697053|NCT03172494|63243326|FG000|Overall Study|Pregnancy|0|||
33697054|NCT03172494|63243327|FG001|Overall Study|Pregnancy|1|||
33697055|NCT03172494|63243328|FG002|Overall Study|Pregnancy|0|||
33697056|NCT03172494|63243326|FG000|Overall Study|Withdrawal by Subject|10|||
33697057|NCT03172494|63243327|FG001|Overall Study|Withdrawal by Subject|8|||
33697058|NCT03172494|63243328|FG002|Overall Study|Withdrawal by Subject|8|||
33697059|NCT03172494|63243326|FG000|Overall Study|Severe hypoglycaemic episode|0|||
33697060|NCT03172494|63243327|FG001|Overall Study|Severe hypoglycaemic episode|0|||
33697061|NCT03172494|63243328|FG002|Overall Study|Severe hypoglycaemic episode|1|||
33697062|NCT03172494|63243326|FG000|Overall Study|Non-compliance towards treatment|2|||
33697063|NCT03172494|63243327|FG001|Overall Study|Non-compliance towards treatment|0|||
33697064|NCT03172494|63243328|FG002|Overall Study|Non-compliance towards treatment|0|||
33697065|NCT01636362|63243429|FG000|Overall Study|Physician Decision|6|||
33697066|NCT01636362|63243429|FG000|Overall Study|Subject healed, not returning|1|||
33697067|NCT01636362|63243429|FG000|Overall Study|Withdrawal by Subject|1|||
33697068|NCT02797184|63243458|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
33697069|NCT02797184|63243459|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
33697070|NCT03042468|63243501|FG000|Overall Study|Death|0|||
33697071|NCT03042468|63243502|FG001|Overall Study|Death|1|||
33697072|NCT03042468|63243503|FG002|Overall Study|Death|1|||
33697073|NCT03042468|63243504|FG003|Overall Study|Death|0|||
33697074|NCT03042468|63243505|FG004|Overall Study|Death|0|||
33697075|NCT03042468|63243506|FG005|Overall Study|Death|0|||
33697076|NCT03042468|63243501|FG000|Overall Study|Withdrawal by Subject|0|||
33697077|NCT03042468|63243502|FG001|Overall Study|Withdrawal by Subject|0|||
33697078|NCT03042468|63243503|FG002|Overall Study|Withdrawal by Subject|0|||
33697079|NCT03042468|63243504|FG003|Overall Study|Withdrawal by Subject|0|||
33697080|NCT03042468|63243505|FG004|Overall Study|Withdrawal by Subject|0|||
33697081|NCT03042468|63243506|FG005|Overall Study|Withdrawal by Subject|1|||
33697082|NCT03042468|63243501|FG000|Overall Study|Lost to Follow-up|0|||
33697083|NCT03042468|63243502|FG001|Overall Study|Lost to Follow-up|0|||
33697084|NCT03042468|63243503|FG002|Overall Study|Lost to Follow-up|0|||
33697085|NCT03042468|63243504|FG003|Overall Study|Lost to Follow-up|0|||
33697086|NCT03042468|63243505|FG004|Overall Study|Lost to Follow-up|1|||
33697087|NCT03042468|63243506|FG005|Overall Study|Lost to Follow-up|1|||
33697088|NCT01634178|63243524|FG000|Treatment Period 1|Adverse Event|0|||
33697089|NCT01634178|63243525|FG001|Treatment Period 1|Adverse Event|1|||
33697090|NCT01634178|63243524|FG000|Treatment Period 2|Adverse Event|1|||
33697091|NCT01634178|63243525|FG001|Treatment Period 2|Adverse Event|0|||
33697092|NCT02412306|63243567|FG000|Overall Study|Lost to Follow-up|0|||
33697093|NCT02412306|63243568|FG001|Overall Study|Lost to Follow-up|1|||
33697094|NCT02412306|63243569|FG002|Overall Study|Lost to Follow-up|0|||
33697095|NCT02412306|63243570|FG003|Overall Study|Lost to Follow-up|0|||
33697096|NCT02412306|63243571|FG004|Overall Study|Lost to Follow-up|0|||
33697097|NCT02412306|63243567|FG000|Overall Study|Withdrawal by Subject|0|||
33697098|NCT02412306|63243568|FG001|Overall Study|Withdrawal by Subject|0|||
33697099|NCT02412306|63243569|FG002|Overall Study|Withdrawal by Subject|1|||
33697100|NCT02412306|63243570|FG003|Overall Study|Withdrawal by Subject|0|||
33697101|NCT02412306|63243571|FG004|Overall Study|Withdrawal by Subject|0|||
33697102|NCT02412306|63243567|FG000|Overall Study|Death|5|||
33697103|NCT02412306|63243568|FG001|Overall Study|Death|7|||
33697104|NCT02412306|63243569|FG002|Overall Study|Death|15|||
33697105|NCT02412306|63243570|FG003|Overall Study|Death|0|||
33697106|NCT02412306|63243571|FG004|Overall Study|Death|2|||
33697107|NCT04285723|63243594|FG000|Overall Study|Subject decision|1|||
33697108|NCT04285723|63243595|FG001|Overall Study|Subject decision|2|||
33697109|NCT04285723|63243594|FG000|Overall Study|Physician Decision|1|||
33697110|NCT04285723|63243595|FG001|Overall Study|Physician Decision|0|||
33697111|NCT04285723|63243594|FG000|Overall Study|No efficiency|1|||
33697112|NCT04285723|63243595|FG001|Overall Study|No efficiency|0|||
33697113|NCT01352221|63243609|FG000|Double-blind Phase|Adverse Event|6|||
33697114|NCT01352221|63243610|FG001|Double-blind Phase|Adverse Event|4|||
33697115|NCT01352221|63243611|FG002|Double-blind Phase|Adverse Event|0|||
33697116|NCT01352221|63243612|FG003|Double-blind Phase|Adverse Event|0|||
33697117|NCT01352221|63243609|FG000|Double-blind Phase|Withdrawal by Subject|3|||
33697118|NCT01352221|63243610|FG001|Double-blind Phase|Withdrawal by Subject|5|||
33697119|NCT01352221|63243611|FG002|Double-blind Phase|Withdrawal by Subject|0|||
33697120|NCT01352221|63243612|FG003|Double-blind Phase|Withdrawal by Subject|0|||
33697121|NCT01352221|63243609|FG000|Double-blind Phase|Lost to Follow-up|0|||
33697122|NCT01352221|63243610|FG001|Double-blind Phase|Lost to Follow-up|1|||
33697123|NCT01352221|63243611|FG002|Double-blind Phase|Lost to Follow-up|0|||
33697124|NCT01352221|63243612|FG003|Double-blind Phase|Lost to Follow-up|0|||
33697125|NCT01352221|63243609|FG000|Double-blind Phase|Protocol Violation|0|||
33697126|NCT01352221|63243610|FG001|Double-blind Phase|Protocol Violation|1|||
33697127|NCT01352221|63243611|FG002|Double-blind Phase|Protocol Violation|0|||
33697128|NCT01352221|63243612|FG003|Double-blind Phase|Protocol Violation|0|||
33697129|NCT01352221|63243609|FG000|Open-label Phase|Physician Decision|0|||
33697130|NCT01352221|63243610|FG001|Open-label Phase|Physician Decision|0|||
33697131|NCT01352221|63243611|FG002|Open-label Phase|Physician Decision|2|||
33697132|NCT01352221|63243612|FG003|Open-label Phase|Physician Decision|1|||
33697133|NCT01352221|63243609|FG000|Open-label Phase|Pregnancy|0|||
33697134|NCT01352221|63243610|FG001|Open-label Phase|Pregnancy|0|||
33697135|NCT01352221|63243611|FG002|Open-label Phase|Pregnancy|1|||
33697136|NCT01352221|63243612|FG003|Open-label Phase|Pregnancy|0|||
33697137|NCT01352221|63243609|FG000|Open-label Phase|Adverse Event|0|||
33697138|NCT01352221|63243610|FG001|Open-label Phase|Adverse Event|0|||
33697139|NCT01352221|63243611|FG002|Open-label Phase|Adverse Event|8|||
33697140|NCT01352221|63243612|FG003|Open-label Phase|Adverse Event|4|||
33697141|NCT01352221|63243609|FG000|Open-label Phase|Withdrawal by Subject|0|||
33697142|NCT01352221|63243610|FG001|Open-label Phase|Withdrawal by Subject|0|||
33697143|NCT01352221|63243611|FG002|Open-label Phase|Withdrawal by Subject|1|||
33697144|NCT01352221|63243612|FG003|Open-label Phase|Withdrawal by Subject|6|||
33697145|NCT01352221|63243609|FG000|Open-label Phase|Worsening of IBD|0|||
33697146|NCT01352221|63243610|FG001|Open-label Phase|Worsening of IBD|0|||
33697147|NCT01352221|63243611|FG002|Open-label Phase|Worsening of IBD|1|||
33697148|NCT01352221|63243612|FG003|Open-label Phase|Worsening of IBD|0|||
33697149|NCT01634100|63243638|FG000|Overall Study|Withdrawal by Subject|1|||
33697150|NCT01634100|63243639|FG001|Overall Study|Withdrawal by Subject|0|||
33697151|NCT01634100|63243640|FG002|Overall Study|Withdrawal by Subject|1|||
33697152|NCT01634100|63243641|FG003|Overall Study|Withdrawal by Subject|0|||
33697153|NCT01634100|63243642|FG004|Overall Study|Withdrawal by Subject|0|||
33697154|NCT01634100|63243643|FG005|Overall Study|Withdrawal by Subject|0|||
33697155|NCT01633944|63243653|FG000|Open-label Titration Phase|Adverse Event|109|||
33697156|NCT01633944|63243654|FG001|Open-label Titration Phase|Adverse Event|0|||
33697157|NCT01633944|63243655|FG002|Open-label Titration Phase|Adverse Event|0|||
33697158|NCT01633944|63243653|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
33697159|NCT01633944|63243654|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
33697160|NCT01633944|63243655|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
33697161|NCT01633944|63243653|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
33697162|NCT01633944|63243654|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
33697163|NCT01633944|63243655|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
33697164|NCT01633944|63243653|FG000|Open-label Titration Phase|Protocol Violation|24|||
33697165|NCT01633944|63243654|FG001|Open-label Titration Phase|Protocol Violation|0|||
33697166|NCT01633944|63243655|FG002|Open-label Titration Phase|Protocol Violation|0|||
33697167|NCT01633944|63243653|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
33697168|NCT01633944|63243654|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
33697169|NCT01633944|63243655|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
33697170|NCT01633944|63243653|FG000|Open-label Titration Phase|Other|68|||
33697171|NCT01633944|63243654|FG001|Open-label Titration Phase|Other|0|||
33697172|NCT01633944|63243655|FG002|Open-label Titration Phase|Other|0|||
33697173|NCT01633944|63243653|FG000|Double-blind Treatment Phase|Adverse Event|0|||
33697174|NCT01633944|63243654|FG001|Double-blind Treatment Phase|Adverse Event|13|||
33697175|NCT01633944|63243655|FG002|Double-blind Treatment Phase|Adverse Event|7|||
33697176|NCT01633944|63243653|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
33697177|NCT01633944|63243654|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
33697178|NCT01633944|63243655|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
33697179|NCT01633944|63243653|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33697180|NCT01633944|63243654|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
33697181|NCT01633944|63243655|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
33697182|NCT01633944|63243653|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
33697183|NCT01633944|63243654|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
33697184|NCT01633944|63243655|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
33697185|NCT01633944|63243653|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
33697186|NCT01633944|63243654|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
33697187|NCT01633944|63243655|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
33697188|NCT01633944|63243653|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
33697189|NCT01633944|63243654|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
33697190|NCT01633944|63243655|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
33697191|NCT01633944|63243653|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
33697192|NCT01633944|63243654|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
33697193|NCT01633944|63243655|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
33697194|NCT01633944|63243653|FG000|Double-blind Treatment Phase|Other|0|||
33697195|NCT01633944|63243654|FG001|Double-blind Treatment Phase|Other|7|||
33697196|NCT01633944|63243655|FG002|Double-blind Treatment Phase|Other|0|||
33697197|NCT01633788|63243700|FG000|Overall Study|Adverse Event|1|||
33697198|NCT01633788|63243701|FG001|Overall Study|Adverse Event|3|||
33697199|NCT01633788|63243702|FG002|Overall Study|Adverse Event|3|||
33697200|NCT01633788|63243703|FG003|Overall Study|Adverse Event|3|||
33697201|NCT01633788|63243700|FG000|Overall Study|Lost to Follow-up|2|||
33697202|NCT01633788|63243701|FG001|Overall Study|Lost to Follow-up|2|||
33697203|NCT01633788|63243702|FG002|Overall Study|Lost to Follow-up|2|||
33697204|NCT01633788|63243703|FG003|Overall Study|Lost to Follow-up|0|||
33697205|NCT01633788|63243700|FG000|Overall Study|Personal Reasons|3|||
33697206|NCT01633788|63243701|FG001|Overall Study|Personal Reasons|1|||
33697207|NCT01633788|63243702|FG002|Overall Study|Personal Reasons|1|||
33401449|NCT00256867|62780480|FG006|Overall Study|Protocol Violation|0|||
33697208|NCT01633788|63243703|FG003|Overall Study|Personal Reasons|3|||
33697209|NCT01633788|63243700|FG000|Overall Study|Protocol Violation|1|||
33697210|NCT01633788|63243701|FG001|Overall Study|Protocol Violation|0|||
33697211|NCT01633788|63243702|FG002|Overall Study|Protocol Violation|1|||
33697212|NCT01633788|63243703|FG003|Overall Study|Protocol Violation|0|||
33697213|NCT01633788|63243700|FG000|Overall Study|Other Reasons|0|||
33697214|NCT01633788|63243701|FG001|Overall Study|Other Reasons|2|||
33697215|NCT01633788|63243702|FG002|Overall Study|Other Reasons|3|||
33697216|NCT01633788|63243703|FG003|Overall Study|Other Reasons|7|||
33697217|NCT04154943|63243713|FG000|Overall Study|Study Ongoing|68|||
33697218|NCT04154943|63243713|FG000|Overall Study|Lost to Follow-up|1|||
33697219|NCT04154943|63243713|FG000|Overall Study|Decision by the Investigator|1|||
33697220|NCT04154943|63243713|FG000|Overall Study|Death|5|||
33697221|NCT04154943|63243713|FG000|Overall Study|Withdrawal by Subject|4|||
33697222|NCT03476239|63243734|FG000|Overall Study|Withdrawal by Subject|10|||
33697223|NCT03476239|63243734|FG000|Overall Study|Death|80|||
33697224|NCT03476239|63243734|FG000|Overall Study|Lost to Follow-up|8|||
33697225|NCT03468985|63243742|FG000|Overall Study|Adverse Event|0|||
33697226|NCT03468985|63243743|FG001|Overall Study|Adverse Event|2|||
33697227|NCT03468985|63243744|FG002|Overall Study|Adverse Event|0|||
33697228|NCT03468985|63243745|FG003|Overall Study|Adverse Event|0|||
33697229|NCT03468985|63243742|FG000|Overall Study|Withdrawal by Subject|0|||
33697230|NCT03468985|63243743|FG001|Overall Study|Withdrawal by Subject|0|||
33697231|NCT03468985|63243744|FG002|Overall Study|Withdrawal by Subject|0|||
33697232|NCT03468985|63243745|FG003|Overall Study|Withdrawal by Subject|1|||
33697233|NCT02678312|63243760|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
33697234|NCT02678312|63243761|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
33697235|NCT02678312|63243762|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
33697236|NCT02678312|63243763|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
33697237|NCT02678312|63243764|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
33697238|NCT02678312|63243760|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
33697239|NCT02678312|63243761|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
33697240|NCT02678312|63243762|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
33697241|NCT02678312|63243763|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
33697242|NCT02678312|63243764|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
33697243|NCT02678312|63243760|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
33697244|NCT02678312|63243761|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
33697245|NCT02678312|63243762|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
33697246|NCT02678312|63243763|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
33697247|NCT02678312|63243764|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
33697248|NCT02678312|63243760|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
33697249|NCT02678312|63243761|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
33697250|NCT02678312|63243762|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
33697251|NCT02678312|63243763|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
33697252|NCT02678312|63243764|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
33697253|NCT02678312|63243760|FG000|Part 2 Double Blind Epoch|Death|0|||
33697254|NCT02678312|63243761|FG001|Part 2 Double Blind Epoch|Death|0|||
33697255|NCT02678312|63243762|FG002|Part 2 Double Blind Epoch|Death|0|||
33697256|NCT02678312|63243763|FG003|Part 2 Double Blind Epoch|Death|8|||
33697257|NCT02678312|63243764|FG004|Part 2 Double Blind Epoch|Death|12|||
33697258|NCT02678312|63243760|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
33697259|NCT02678312|63243761|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
33697260|NCT02678312|63243762|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
33697261|NCT02678312|63243763|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
33697262|NCT02678312|63243764|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
33697263|NCT02678312|63243760|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
33697264|NCT02678312|63243761|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
33697265|NCT02678312|63243762|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
33697266|NCT02678312|63243763|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
33697267|NCT02678312|63243764|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
33697268|NCT02678312|63243760|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
33697269|NCT02678312|63243761|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
33697270|NCT02678312|63243762|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
33697271|NCT02678312|63243763|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
33697272|NCT02678312|63243764|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
33697273|NCT02256631|63244011|FG000|Overall Study|Lost to Follow-up|1|||
33697274|NCT02256631|63244012|FG001|Overall Study|Lost to Follow-up|1|||
33697275|NCT02256631|63244013|FG002|Overall Study|Lost to Follow-up|0|||
33697276|NCT02256631|63244014|FG003|Overall Study|Lost to Follow-up|2|||
33697277|NCT02256631|63244015|FG004|Overall Study|Lost to Follow-up|0|||
33697278|NCT02256631|63244016|FG005|Overall Study|Lost to Follow-up|4|||
33697279|NCT02256631|63244017|FG006|Overall Study|Lost to Follow-up|1|||
33697280|NCT02256631|63244011|FG000|Overall Study|Withdrawal by Subject|0|||
33697281|NCT02256631|63244012|FG001|Overall Study|Withdrawal by Subject|0|||
33697282|NCT02256631|63244013|FG002|Overall Study|Withdrawal by Subject|0|||
33697283|NCT02256631|63244014|FG003|Overall Study|Withdrawal by Subject|1|||
33697284|NCT02256631|63244015|FG004|Overall Study|Withdrawal by Subject|1|||
33697285|NCT02256631|63244016|FG005|Overall Study|Withdrawal by Subject|0|||
33697286|NCT02256631|63244017|FG006|Overall Study|Withdrawal by Subject|1|||
33697287|NCT02256631|63244011|FG000|Overall Study|Unable to get to clinic|0|||
33697288|NCT02256631|63244012|FG001|Overall Study|Unable to get to clinic|2|||
33697289|NCT02256631|63244013|FG002|Overall Study|Unable to get to clinic|0|||
33697290|NCT02256631|63244014|FG003|Overall Study|Unable to get to clinic|1|||
33697291|NCT02256631|63244015|FG004|Overall Study|Unable to get to clinic|0|||
33697292|NCT02256631|63244016|FG005|Overall Study|Unable to get to clinic|1|||
33697293|NCT02256631|63244017|FG006|Overall Study|Unable to get to clinic|2|||
33697294|NCT02163733|63244115|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
33697295|NCT02163733|63244116|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
33697296|NCT02163733|63244117|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
33697297|NCT02163733|63244115|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
33697298|NCT02163733|63244116|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
33697299|NCT02163733|63244117|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
33697300|NCT02279745|63244147|FG000|Overall Study|Adverse Event|7|||
33697301|NCT02279745|63244147|FG000|Overall Study|Death|6|||
33697302|NCT02279745|63244147|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
33697303|NCT02279745|63244147|FG000|Overall Study|Withdrawal by Subject|2|||
33697304|NCT02279745|63244147|FG000|Overall Study|Pregnancy|1|||
33697305|NCT02279745|63244147|FG000|Overall Study|Study Non-compliance|1|||
33697306|NCT02279745|63244147|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
33697307|NCT01761877|63244186|FG000|Overall Study|Adverse Event|7|||
33697308|NCT01761877|63244187|FG001|Overall Study|Adverse Event|0|||
33697309|NCT01761877|63244186|FG000|Overall Study|Withdrawal by Subject|6|||
33697310|NCT01761877|63244187|FG001|Overall Study|Withdrawal by Subject|4|||
33697311|NCT01761877|63244186|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
33697312|NCT01761877|63244187|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
33697313|NCT01761877|63244186|FG000|Overall Study|Death|0|||
33697314|NCT01761877|63244187|FG001|Overall Study|Death|1|||
33697315|NCT01761877|63244186|FG000|Overall Study|MRI intolerant|1|||
33697316|NCT01761877|63244187|FG001|Overall Study|MRI intolerant|6|||
33697317|NCT03093259|63244437|FG000|Overall Study|Adverse Event|1|||
33697318|NCT03093259|63244438|FG001|Overall Study|Adverse Event|0|||
33697319|NCT03093259|63244437|FG000|Overall Study|Withdrawal by Subject|1|||
33697320|NCT03093259|63244438|FG001|Overall Study|Withdrawal by Subject|0|||
33697321|NCT02997865|63244730|FG000|Overall Study|Death|2|||
33697322|NCT02997865|63244731|FG001|Overall Study|Death|1|||
33697323|NCT02997865|63244730|FG000|Overall Study|Lost to Follow-up|6|||
33697324|NCT02997865|63244731|FG001|Overall Study|Lost to Follow-up|3|||
33697325|NCT02997865|63244730|FG000|Overall Study|Withdrawal by Subject|5|||
33697326|NCT02997865|63244731|FG001|Overall Study|Withdrawal by Subject|0|||
33697327|NCT01575834|63245960|FG000|Overall Study|Withdrawal by Subject|352|||
33697328|NCT01575834|63245961|FG001|Overall Study|Withdrawal by Subject|390|||
33697329|NCT01575834|63245960|FG000|Overall Study|Death|81|||
33697330|NCT01575834|63245961|FG001|Overall Study|Death|74|||
33697331|NCT01575834|63245960|FG000|Overall Study|Other|70|||
33697332|NCT01575834|63245961|FG001|Overall Study|Other|70|||
33697333|NCT01575834|63245960|FG000|Overall Study|Adverse Event|63|||
33697334|NCT01575834|63245961|FG001|Overall Study|Adverse Event|61|||
33697335|NCT01575834|63245960|FG000|Overall Study|Lost to Follow-up|55|||
33697336|NCT01575834|63245961|FG001|Overall Study|Lost to Follow-up|68|||
33697337|NCT01575834|63245960|FG000|Overall Study|Noncompliance|52|||
33697338|NCT01575834|63245961|FG001|Overall Study|Noncompliance|27|||
33697339|NCT01575834|63245960|FG000|Overall Study|Administrative decision|15|||
33697340|NCT01575834|63245961|FG001|Overall Study|Administrative decision|33|||
33697341|NCT01575834|63245960|FG000|Overall Study|Ineligibility Determined|5|||
33697342|NCT01575834|63245961|FG001|Overall Study|Ineligibility Determined|8|||
33697343|NCT01575834|63245960|FG000|Overall Study|Protocol Deviation|4|||
33697344|NCT01575834|63245961|FG001|Overall Study|Protocol Deviation|3|||
33697345|NCT01575834|63245960|FG000|Overall Study|Requirement for Alternative Therapy|2|||
33697346|NCT01575834|63245961|FG001|Overall Study|Requirement for Alternative Therapy|4|||
33697347|NCT02253654|63246073|FG000|Overall Study|Withdrawal by Subject|12|||
33697348|NCT02253654|63246074|FG001|Overall Study|Withdrawal by Subject|4|||
33697349|NCT02253654|63246073|FG000|Overall Study|Decision by Sponsor|1|||
33697350|NCT02253654|63246074|FG001|Overall Study|Decision by Sponsor|1|||
33697351|NCT02253654|63246073|FG000|Overall Study|Lost to Follow-up|2|||
33697352|NCT02253654|63246074|FG001|Overall Study|Lost to Follow-up|5|||
33697353|NCT02253654|63246073|FG000|Overall Study|Death|4|||
33697354|NCT02253654|63246074|FG001|Overall Study|Death|7|||
33697355|NCT02253654|63246073|FG000|Overall Study|Did Not Receive Study Treatment|4|||
33697356|NCT02253654|63246074|FG001|Overall Study|Did Not Receive Study Treatment|1|||
33697357|NCT02252406|63246082|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
33697358|NCT02252406|63246083|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
33697359|NCT02252406|63246082|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
33697360|NCT02252406|63246083|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
33697361|NCT02252406|63246082|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
33697362|NCT02252406|63246083|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
33697363|NCT02252406|63246082|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
33697364|NCT02252406|63246083|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
33697365|NCT02252406|63246082|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
33697366|NCT02252406|63246083|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
33697367|NCT02246478|63246093|FG000|Multiple-dose Phase|Protocol Violation|1|||
33697368|NCT02246478|63246094|FG001|Multiple-dose Phase|Protocol Violation|0|||
33697369|NCT02246478|63246095|FG002|Multiple-dose Phase|Protocol Violation|0|||
33697370|NCT02246478|63246096|FG003|Multiple-dose Phase|Protocol Violation|1|||
33697371|NCT02252016|63246115|FG000|Overall Study|Lost to Follow-up|2|||
33697372|NCT02252016|63246116|FG001|Overall Study|Lost to Follow-up|1|||
33697373|NCT02252016|63246115|FG000|Overall Study|Physician Decision|1|||
33697374|NCT02252016|63246116|FG001|Overall Study|Physician Decision|0|||
33697375|NCT02252016|63246115|FG000|Overall Study|Withdrawal by Subject|0|||
33697376|NCT02252016|63246116|FG001|Overall Study|Withdrawal by Subject|2|||
33697377|NCT02249832|63246122|FG000|Overall Study|Withdrawal by Subject|3|||
33697378|NCT02249832|63246122|FG000|Overall Study|Lost to Follow-up|10|||
33697379|NCT02248974|63246133|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
33697380|NCT02248974|63246134|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
33697381|NCT02248974|63246133|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
33697382|NCT02248974|63246134|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
33697383|NCT02248974|63246133|FG000|1-Day Follow-Up|Enrolled in another study|1|||
33697384|NCT02248974|63246134|FG001|1-Day Follow-Up|Enrolled in another study|0|||
33697385|NCT02248974|63246133|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
33697386|NCT02248974|63246134|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
33697387|NCT02248974|63246133|FG000|1-Week Follow-Up|Enrolled in another study|1|||
33697388|NCT02248974|63246134|FG001|1-Week Follow-Up|Enrolled in another study|1|||
33697389|NCT02248974|63246133|FG000|1-Week Follow-Up|Transferred to another facility|1|||
33697390|NCT02248974|63246134|FG001|1-Week Follow-Up|Transferred to another facility|0|||
33697391|NCT02248974|63246133|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
33697392|NCT02248974|63246134|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
33697393|NCT02248974|63246133|FG000|1-Week Follow-Up|Death|1|||
33697394|NCT02248974|63246134|FG001|1-Week Follow-Up|Death|1|||
33697395|NCT02248974|63246133|FG000|1-Week Follow-Up|Excluded because of age|0|||
33697396|NCT02248974|63246134|FG001|1-Week Follow-Up|Excluded because of age|1|||
33697397|NCT02248974|63246133|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
33697398|NCT02248974|63246134|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
33697399|NCT02248974|63246133|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
33697400|NCT02248974|63246134|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
33697401|NCT02248974|63246133|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
33697402|NCT02248974|63246134|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
33697403|NCT02248974|63246133|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
33697404|NCT02248974|63246134|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
33697405|NCT02248974|63246133|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
33697406|NCT02248974|63246134|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
33697407|NCT02246166|63246142|FG000|Overall Study|Protocol Violation|1|||
33697408|NCT02246166|63246143|FG001|Overall Study|Protocol Violation|0|||
33697409|NCT02706847|63246152|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
33697410|NCT02706847|63246153|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
33697411|NCT02706847|63246154|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
33697412|NCT02706847|63246155|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
33697413|NCT02706847|63246152|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
33697414|NCT02706847|63246153|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
33697415|NCT02706847|63246154|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
33697416|NCT02706847|63246155|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
33697417|NCT02706847|63246152|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
33697418|NCT02706847|63246153|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
33697419|NCT02706847|63246154|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
33697420|NCT02706847|63246155|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
33697421|NCT02706847|63246152|FG000|Period 1: Day 1 to Week 12|Other|4|||
33697422|NCT02706847|63246153|FG001|Period 1: Day 1 to Week 12|Other|4|||
33697423|NCT02706847|63246154|FG002|Period 1: Day 1 to Week 12|Other|2|||
33697424|NCT02706847|63246155|FG003|Period 1: Day 1 to Week 12|Other|2|||
33697425|NCT02706847|63246152|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
33697426|NCT02706847|63246153|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
33697427|NCT02706847|63246154|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
33697428|NCT02706847|63246155|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
33697429|NCT02706847|63246152|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
33697430|NCT02706847|63246153|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
33697431|NCT02706847|63246154|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
33697432|NCT02706847|63246155|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
33697433|NCT02706847|63246152|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
33697434|NCT02706847|63246153|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
33697435|NCT02706847|63246154|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
33697436|NCT02706847|63246155|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
33697437|NCT02706847|63246152|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
33697438|NCT02706847|63246153|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
33493242|NCT03103152|62871482|FG004|Overall Study|Inter-current illness|0|||
33697439|NCT02706847|63246154|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
33697440|NCT02706847|63246155|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
33697441|NCT02706847|63246152|FG000|Period 1: Week 12 to Week 24|Other|1|||
33697442|NCT02706847|63246153|FG001|Period 1: Week 12 to Week 24|Other|0|||
33697443|NCT02706847|63246154|FG002|Period 1: Week 12 to Week 24|Other|1|||
33697444|NCT02706847|63246155|FG003|Period 1: Week 12 to Week 24|Other|4|||
33697445|NCT02706847|63246152|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
33697446|NCT02706847|63246153|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
33697447|NCT02706847|63246154|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
33697448|NCT02706847|63246155|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
33697449|NCT02706847|63246152|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
33697450|NCT02706847|63246153|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
33697451|NCT02706847|63246154|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
33697452|NCT02706847|63246155|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
33697453|NCT02706847|63246152|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
33697454|NCT02706847|63246153|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
33697455|NCT02706847|63246154|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
33697456|NCT02706847|63246155|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
33697457|NCT02706847|63246152|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
33697458|NCT02706847|63246153|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
33697459|NCT02706847|63246154|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
33697460|NCT02706847|63246155|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
33697461|NCT02706847|63246152|FG000|Period 2: Week 24 to Week 260|Other|8|||
33697462|NCT02706847|63246153|FG001|Period 2: Week 24 to Week 260|Other|5|||
33697463|NCT02706847|63246154|FG002|Period 2: Week 24 to Week 260|Other|15|||
33697464|NCT02706847|63246155|FG003|Period 2: Week 24 to Week 260|Other|15|||
33697465|NCT02245620|63246168|FG000|Overall Study|Physician Decision|1|||
33697466|NCT02245620|63246169|FG001|Overall Study|Physician Decision|1|||
33697467|NCT02244996|63246177|FG000|Overall Study|Lack of Efficacy|2|||
33697468|NCT02244996|63246178|FG001|Overall Study|Lack of Efficacy|6|||
33697469|NCT02243280|63246213|FG000|Treated|Adverse Event|1|||
33697470|NCT02243280|63246214|FG001|Treated|Adverse Event|0|||
33697471|NCT02243280|63246215|FG002|Treated|Adverse Event|0|||
33697472|NCT02243280|63246216|FG003|Treated|Adverse Event|0|||
33697473|NCT02243280|63246217|FG004|Treated|Adverse Event|0|||
33697474|NCT02243280|63246218|FG005|Treated|Adverse Event|0|||
33697475|NCT02243280|63246219|FG006|Treated|Adverse Event|0|||
33697476|NCT02243280|63246220|FG007|Treated|Adverse Event|0|||
33697477|NCT02243280|63246221|FG008|Treated|Adverse Event|0|||
33697478|NCT02243280|63246222|FG009|Treated|Adverse Event|0|||
33697479|NCT02243280|63246223|FG010|Treated|Adverse Event|1|||
33697480|NCT02243280|63246213|FG000|Treated|Lost to Follow-up|0|||
33697481|NCT02243280|63246214|FG001|Treated|Lost to Follow-up|0|||
33697482|NCT02243280|63246215|FG002|Treated|Lost to Follow-up|0|||
33697483|NCT02243280|63246216|FG003|Treated|Lost to Follow-up|0|||
33697484|NCT02243280|63246217|FG004|Treated|Lost to Follow-up|0|||
33697485|NCT02243280|63246218|FG005|Treated|Lost to Follow-up|0|||
33697486|NCT02243280|63246219|FG006|Treated|Lost to Follow-up|0|||
33697487|NCT02243280|63246220|FG007|Treated|Lost to Follow-up|0|||
33697488|NCT02243280|63246221|FG008|Treated|Lost to Follow-up|1|||
33697489|NCT02243280|63246222|FG009|Treated|Lost to Follow-up|0|||
33697490|NCT02243280|63246223|FG010|Treated|Lost to Follow-up|2|||
33697491|NCT02248818|63246281|FG000|Screening|Protocol Violation|0|||
33697492|NCT02248818|63246282|FG001|Screening|Protocol Violation|0|||
33697493|NCT02248818|63246283|FG002|Screening|Protocol Violation|0|||
33697494|NCT02248818|63246284|FG003|Screening|Protocol Violation|0|||
33697495|NCT02248818|63246285|FG004|Screening|Protocol Violation|0|||
33697496|NCT02248818|63246286|FG005|Screening|Protocol Violation|0|||
33697497|NCT02248818|63246287|FG006|Screening|Protocol Violation|0|||
33697498|NCT02248818|63246288|FG007|Screening|Protocol Violation|0|||
33697499|NCT02248818|63246289|FG008|Screening|Protocol Violation|7|||
33697500|NCT02248818|63246281|FG000|Screening|Study fully enrolled|0|||
33697501|NCT02248818|63246282|FG001|Screening|Study fully enrolled|0|||
33697502|NCT02248818|63246283|FG002|Screening|Study fully enrolled|0|||
33697503|NCT02248818|63246284|FG003|Screening|Study fully enrolled|0|||
33697504|NCT02248818|63246285|FG004|Screening|Study fully enrolled|0|||
33697505|NCT02248818|63246286|FG005|Screening|Study fully enrolled|0|||
33697506|NCT02248818|63246287|FG006|Screening|Study fully enrolled|0|||
33697507|NCT02248818|63246288|FG007|Screening|Study fully enrolled|0|||
33697508|NCT02248818|63246289|FG008|Screening|Study fully enrolled|14|||
33697509|NCT02248818|63246281|FG000|Screening|Physician Decision|0|||
33697510|NCT02248818|63246282|FG001|Screening|Physician Decision|0|||
33697511|NCT02248818|63246283|FG002|Screening|Physician Decision|0|||
33697512|NCT02248818|63246284|FG003|Screening|Physician Decision|0|||
33697513|NCT02248818|63246285|FG004|Screening|Physician Decision|0|||
33697514|NCT02248818|63246286|FG005|Screening|Physician Decision|0|||
33697515|NCT02248818|63246287|FG006|Screening|Physician Decision|0|||
33697516|NCT02248818|63246288|FG007|Screening|Physician Decision|0|||
33697517|NCT02248818|63246289|FG008|Screening|Physician Decision|73|||
33697518|NCT02248818|63246281|FG000|Screening|Withdrawal by Subject|0|||
33697519|NCT02248818|63246282|FG001|Screening|Withdrawal by Subject|0|||
33697520|NCT02248818|63246283|FG002|Screening|Withdrawal by Subject|0|||
33697521|NCT02248818|63246284|FG003|Screening|Withdrawal by Subject|0|||
33697522|NCT02248818|63246285|FG004|Screening|Withdrawal by Subject|0|||
33697523|NCT02248818|63246286|FG005|Screening|Withdrawal by Subject|0|||
33697524|NCT02248818|63246287|FG006|Screening|Withdrawal by Subject|0|||
33697525|NCT02248818|63246288|FG007|Screening|Withdrawal by Subject|0|||
33697526|NCT02248818|63246289|FG008|Screening|Withdrawal by Subject|6|||
33697527|NCT02248818|63246281|FG000|Screening|Lost to Follow-up|0|||
33310750|NCT01233258|62686168|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
33310751|NCT01233258|62686169|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
33596373|NCT02142387|62995331|FG001|Overall Study|<19 years old|326|||
33697528|NCT02248818|63246282|FG001|Screening|Lost to Follow-up|0|||
33697529|NCT02248818|63246283|FG002|Screening|Lost to Follow-up|0|||
33697530|NCT02248818|63246284|FG003|Screening|Lost to Follow-up|0|||
33697531|NCT02248818|63246285|FG004|Screening|Lost to Follow-up|0|||
33697532|NCT02248818|63246286|FG005|Screening|Lost to Follow-up|0|||
33697533|NCT02248818|63246287|FG006|Screening|Lost to Follow-up|0|||
33697534|NCT02248818|63246288|FG007|Screening|Lost to Follow-up|0|||
33697535|NCT02248818|63246289|FG008|Screening|Lost to Follow-up|7|||
33697536|NCT02248818|63246281|FG000|Randomised Study|Administrative - randomization error|0|||
33697537|NCT02248818|63246282|FG001|Randomised Study|Administrative - randomization error|0|||
33697538|NCT02248818|63246283|FG002|Randomised Study|Administrative - randomization error|0|||
33697539|NCT02248818|63246284|FG003|Randomised Study|Administrative - randomization error|0|||
33697540|NCT02248818|63246285|FG004|Randomised Study|Administrative - randomization error|0|||
33697541|NCT02248818|63246286|FG005|Randomised Study|Administrative - randomization error|8|||
33697542|NCT02248818|63246287|FG006|Randomised Study|Administrative - randomization error|0|||
33697543|NCT02248818|63246288|FG007|Randomised Study|Administrative - randomization error|0|||
33697544|NCT02248818|63246289|FG008|Randomised Study|Administrative - randomization error|0|||
33697545|NCT02247960|63246318|FG000|Patient Consent and Randomization|Physician Decision|2|||
33697546|NCT02247960|63246319|FG001|Patient Consent and Randomization|Physician Decision|2|||
33697547|NCT02247960|63246318|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
33697548|NCT02247960|63246319|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
33697549|NCT02247960|63246318|FG000|Catheter Removed|Lost to Follow-up|7|||
33697550|NCT02247960|63246319|FG001|Catheter Removed|Lost to Follow-up|10|||
33697551|NCT02247804|63246408|FG000|Treatment Period 1|Adverse Event|9|||
33697552|NCT02247804|63246409|FG001|Treatment Period 1|Adverse Event|2|||
33697553|NCT02247804|63246410|FG002|Treatment Period 1|Adverse Event|0|||
33697554|NCT02247804|63246408|FG000|Treatment Period 1|Lack of Efficacy|0|||
33697555|NCT02247804|63246409|FG001|Treatment Period 1|Lack of Efficacy|0|||
33596374|NCT02142387|62995330|FG000|Overall Study|non-cardiac etiology|504|||
33596375|NCT02142387|62995331|FG001|Overall Study|non-cardiac etiology|3431|||
33596376|NCT02142387|62995330|FG000|Overall Study|CPR not performed|74|||
33596377|NCT02142387|62995331|FG001|Overall Study|CPR not performed|473|||
33596378|NCT02142387|62995330|FG000|Overall Study|witnessed by paramedic|139|||
33596379|NCT02142387|62995331|FG001|Overall Study|witnessed by paramedic|917|||
33596380|NCT02142387|62995330|FG000|Overall Study|incomplete data|1|||
33596381|NCT02142387|62995331|FG001|Overall Study|incomplete data|9|||
33596382|NCT02142387|62995330|FG000|Overall Study|occurred not at home|298|||
33596383|NCT02142387|62995331|FG001|Overall Study|occurred not at home|2474|||
33596384|NCT02518919|62995340|FG000|Overall Study|Protocol Violation|1|||
33596385|NCT02518919|62995341|FG001|Overall Study|Protocol Violation|1|||
33697556|NCT02247804|63246410|FG002|Treatment Period 1|Lack of Efficacy|2|||
33697557|NCT02247804|63246408|FG000|Treatment Period 1|Lost to Follow-up|1|||
33697558|NCT02247804|63246409|FG001|Treatment Period 1|Lost to Follow-up|0|||
33697559|NCT02247804|63246410|FG002|Treatment Period 1|Lost to Follow-up|2|||
33697560|NCT02247804|63246408|FG000|Treatment Period 1|Personal Reasons|7|||
33697561|NCT02247804|63246409|FG001|Treatment Period 1|Personal Reasons|1|||
33697562|NCT02247804|63246410|FG002|Treatment Period 1|Personal Reasons|2|||
33697563|NCT02247804|63246408|FG000|Treatment Period 1|Protocol Deviation|0|||
33697564|NCT02247804|63246409|FG001|Treatment Period 1|Protocol Deviation|0|||
33697565|NCT02247804|63246410|FG002|Treatment Period 1|Protocol Deviation|1|||
33596386|NCT02518919|62995342|FG002|Overall Study|Protocol Violation|2|||
33697566|NCT02247804|63246408|FG000|Treatment Period 1|Randomized but not Treated|5|||
33697567|NCT02247804|63246409|FG001|Treatment Period 1|Randomized but not Treated|1|||
33697568|NCT02247804|63246410|FG002|Treatment Period 1|Randomized but not Treated|1|||
33697569|NCT02247804|63246408|FG000|Treatment Period 2|Adverse Event|6|||
33697570|NCT02247804|63246409|FG001|Treatment Period 2|Adverse Event|3|||
33697571|NCT02247804|63246410|FG002|Treatment Period 2|Adverse Event|3|||
33697572|NCT02247804|63246408|FG000|Treatment Period 2|Lack of Efficacy|0|||
33697573|NCT02247804|63246409|FG001|Treatment Period 2|Lack of Efficacy|0|||
33697574|NCT02247804|63246410|FG002|Treatment Period 2|Lack of Efficacy|1|||
33697575|NCT02247804|63246408|FG000|Treatment Period 2|Lost to Follow-up|0|||
33697576|NCT02247804|63246409|FG001|Treatment Period 2|Lost to Follow-up|1|||
33697577|NCT02247804|63246410|FG002|Treatment Period 2|Lost to Follow-up|1|||
33697578|NCT02247804|63246408|FG000|Treatment Period 2|Personal Reasons|2|||
33697579|NCT02247804|63246409|FG001|Treatment Period 2|Personal Reasons|1|||
33697580|NCT02247804|63246410|FG002|Treatment Period 2|Personal Reasons|1|||
33697581|NCT02247804|63246408|FG000|Treatment Period 2|Reason not Specified|0|||
33697582|NCT02247804|63246409|FG001|Treatment Period 2|Reason not Specified|0|||
33697583|NCT02247804|63246410|FG002|Treatment Period 2|Reason not Specified|2|||
33697584|NCT02247804|63246408|FG000|Treatment Period 3|Adverse Event|4|||
33697585|NCT02247804|63246409|FG001|Treatment Period 3|Adverse Event|3|||
33697586|NCT02247804|63246410|FG002|Treatment Period 3|Adverse Event|3|||
33697587|NCT02247804|63246408|FG000|Treatment Period 3|Lack of Efficacy|0|||
33697588|NCT02247804|63246409|FG001|Treatment Period 3|Lack of Efficacy|1|||
33697589|NCT02247804|63246410|FG002|Treatment Period 3|Lack of Efficacy|0|||
33697590|NCT02247804|63246408|FG000|Treatment Period 3|Lost to Follow-up|1|||
33697591|NCT02247804|63246409|FG001|Treatment Period 3|Lost to Follow-up|2|||
33697592|NCT02247804|63246410|FG002|Treatment Period 3|Lost to Follow-up|2|||
33697593|NCT02247804|63246408|FG000|Treatment Period 3|Personal Reasons|4|||
33697594|NCT02247804|63246409|FG001|Treatment Period 3|Personal Reasons|3|||
33697595|NCT02247804|63246410|FG002|Treatment Period 3|Personal Reasons|2|||
33697596|NCT02247804|63246408|FG000|Treatment Period 3|Reason not Specified|2|||
33697597|NCT02247804|63246409|FG001|Treatment Period 3|Reason not Specified|1|||
33697598|NCT02247804|63246410|FG002|Treatment Period 3|Reason not Specified|3|||
33697599|NCT02243202|63246435|FG000|Overall Study|Adverse Event|5|||
33697600|NCT02243202|63246436|FG001|Overall Study|Adverse Event|6|||
33697601|NCT02243202|63246437|FG002|Overall Study|Adverse Event|10|||
33697602|NCT02243202|63246438|FG003|Overall Study|Adverse Event|4|||
33697603|NCT02243202|63246435|FG000|Overall Study|Lost to Follow-up|9|||
33697604|NCT02243202|63246436|FG001|Overall Study|Lost to Follow-up|9|||
33697605|NCT02243202|63246437|FG002|Overall Study|Lost to Follow-up|14|||
33697606|NCT02243202|63246438|FG003|Overall Study|Lost to Follow-up|11|||
33697607|NCT02243202|63246435|FG000|Overall Study|Protocol Violation|3|||
33697608|NCT02243202|63246436|FG001|Overall Study|Protocol Violation|1|||
33697609|NCT02243202|63246437|FG002|Overall Study|Protocol Violation|2|||
33697610|NCT02243202|63246438|FG003|Overall Study|Protocol Violation|1|||
33697611|NCT02243202|63246435|FG000|Overall Study|Withdrawal by Subject|7|||
33697612|NCT02243202|63246436|FG001|Overall Study|Withdrawal by Subject|6|||
33697613|NCT02243202|63246437|FG002|Overall Study|Withdrawal by Subject|4|||
33697614|NCT02243202|63246438|FG003|Overall Study|Withdrawal by Subject|4|||
33697615|NCT02243202|63246435|FG000|Overall Study|Other|1|||
33697616|NCT02243202|63246436|FG001|Overall Study|Other|3|||
33697617|NCT02243202|63246437|FG002|Overall Study|Other|1|||
33697618|NCT02243202|63246438|FG003|Overall Study|Other|2|||
33697619|NCT02243202|63246435|FG000|Overall Study|Randomized but not received treatment|0|||
33697620|NCT02243202|63246436|FG001|Overall Study|Randomized but not received treatment|0|||
33697621|NCT02243202|63246437|FG002|Overall Study|Randomized but not received treatment|0|||
33697622|NCT02243202|63246438|FG003|Overall Study|Randomized but not received treatment|1|||
33697623|NCT02243046|63246451|FG000|Overall Study|Lost to Follow-up|1|||
33697624|NCT02243046|63246452|FG001|Overall Study|Lost to Follow-up|1|||
33697625|NCT02243046|63246453|FG002|Overall Study|Lost to Follow-up|4|||
33697626|NCT02207946|63246463|FG000|Overall Study|Lost to Follow-up|1|||
33697627|NCT02207946|63246464|FG001|Overall Study|Lost to Follow-up|0|||
33697628|NCT02207946|63246463|FG000|Overall Study|Adverse Event|0|||
33697629|NCT02207946|63246464|FG001|Overall Study|Adverse Event|1|||
33697630|NCT03976076|63246471|FG000|Overall Study|Withdrawal by Subject|2|||
33697631|NCT03551210|63246670|FG000|Overall Study|Adverse Event|5|||
33697632|NCT03551210|63246671|FG001|Overall Study|Adverse Event|6|||
33697633|NCT03551210|63246670|FG000|Overall Study|Withdrawal by Subject|1|||
33697634|NCT03551210|63246671|FG001|Overall Study|Withdrawal by Subject|7|||
33697635|NCT03551210|63246670|FG000|Overall Study|Needed in other antibiotic treatment|2|||
33697636|NCT03551210|63246671|FG001|Overall Study|Needed in other antibiotic treatment|5|||
33697637|NCT03551210|63246670|FG000|Overall Study|Lost to Follow-up|1|||
33697638|NCT03551210|63246671|FG001|Overall Study|Lost to Follow-up|1|||
33697639|NCT03551210|63246670|FG000|Overall Study|Absence of visit 4 and 5|1|||
33697640|NCT03551210|63246671|FG001|Overall Study|Absence of visit 4 and 5|0|||
33697641|NCT03551210|63246670|FG000|Overall Study|No drug for dispensing|0|||
33697642|NCT03551210|63246671|FG001|Overall Study|No drug for dispensing|1|||
33697643|NCT02207634|63246808|FG000|Overall Study|Withdrawal by Subject|21|||
33697644|NCT02207634|63246809|FG001|Overall Study|Withdrawal by Subject|31|||
33697645|NCT02207634|63246808|FG000|Overall Study|Lost to Follow-up|1|||
33697646|NCT02207634|63246809|FG001|Overall Study|Lost to Follow-up|0|||
33697647|NCT03452228|63246852|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
33697648|NCT03452228|63246853|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
33697649|NCT03452228|63246854|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
33697650|NCT03452228|63246852|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
33697651|NCT03452228|63246853|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
33697652|NCT03452228|63246854|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
33697653|NCT03452228|63246852|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
33697654|NCT03452228|63246853|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
33697655|NCT03452228|63246854|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
33697656|NCT03452228|63246852|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
33697657|NCT03452228|63246853|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
33697658|NCT03452228|63246854|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
33697659|NCT02207556|63246917|FG000|Overall Study|Physician Decision|1|||
33697660|NCT02207556|63246918|FG001|Overall Study|Physician Decision|0|||
33697661|NCT02207556|63246917|FG000|Overall Study|Withdrawal by Subject|1|||
33697662|NCT02207556|63246918|FG001|Overall Study|Withdrawal by Subject|0|||
33697663|NCT02207556|63246917|FG000|Overall Study|Death|0|||
33697664|NCT02207556|63246918|FG001|Overall Study|Death|5|||
33697665|NCT03732638|63246933|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
33697666|NCT03732638|63246934|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
33697667|NCT03732638|63246933|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
33697668|NCT03732638|63246934|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
33697669|NCT03732638|63246933|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
33697670|NCT03732638|63246934|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
33697671|NCT03732638|63246933|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
33697672|NCT03732638|63246934|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
33697673|NCT03732638|63246933|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
33697674|NCT03732638|63246934|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
33697675|NCT03732638|63246933|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
33697676|NCT03732638|63246934|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
33697677|NCT03732638|63246933|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
33697678|NCT03732638|63246934|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
33697679|NCT03732638|63246933|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
33697680|NCT03732638|63246934|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
33697681|NCT03732638|63246933|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
33697682|NCT03732638|63246934|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
33697683|NCT03732638|63246933|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
33697684|NCT03732638|63246934|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
33697685|NCT03732638|63246933|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
33697686|NCT03732638|63246934|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
33697687|NCT03732638|63246933|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
33697688|NCT03732638|63246934|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
33697689|NCT03732638|63246933|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
33697690|NCT03732638|63246934|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
33697691|NCT03732638|63246933|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
33697692|NCT03732638|63246934|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
33697693|NCT03732638|63246933|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
33697694|NCT03732638|63246934|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
33697695|NCT03732638|63246933|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
33697696|NCT03732638|63246934|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
33697697|NCT03732638|63246933|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
33697698|NCT03732638|63246934|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
33697699|NCT03732638|63246933|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
33697700|NCT03732638|63246934|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
33697701|NCT03732638|63246933|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
33697702|NCT03732638|63246934|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
33697703|NCT03732638|63246933|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
33697704|NCT03732638|63246934|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
33697705|NCT03732638|63246933|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
33493243|NCT03103152|62871483|FG005|Overall Study|Inter-current illness|0|||
33493244|NCT03103152|62871478|FG000|Overall Study|Death|0|||
33596387|NCT02518685|62995352|FG000|Overall Study|Adverse Event|29|||
33697706|NCT03732638|63246934|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
33697707|NCT03732638|63246933|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
33697708|NCT03732638|63246934|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
33697709|NCT03732638|63246933|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
33697710|NCT03732638|63246934|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
33697711|NCT03732638|63246933|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
33697712|NCT03732638|63246934|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
33697713|NCT03266588|63246973|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
33697714|NCT03266588|63246974|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
33697715|NCT03266588|63246975|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
33697716|NCT03266588|63246973|FG000|Observational Period|Withdrawal by Subject|44|||
33697717|NCT03266588|63246974|FG001|Observational Period|Withdrawal by Subject|22|||
33697718|NCT03266588|63246975|FG002|Observational Period|Withdrawal by Subject|13|||
33697719|NCT03266588|63246973|FG000|Observational Period|Non-compliance|18|||
33697720|NCT03266588|63246974|FG001|Observational Period|Non-compliance|12|||
33697721|NCT03266588|63246975|FG002|Observational Period|Non-compliance|10|||
33697722|NCT03266588|63246973|FG000|Observational Period|Lost to Follow-up|8|||
33697723|NCT03266588|63246974|FG001|Observational Period|Lost to Follow-up|12|||
33697724|NCT03266588|63246975|FG002|Observational Period|Lost to Follow-up|4|||
33697725|NCT03266588|63246973|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
33697726|NCT03266588|63246974|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
33697727|NCT03266588|63246975|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
33697728|NCT03266588|63246973|FG000|Observational Period|Protocol Deviation|1|||
33697729|NCT03266588|63246974|FG001|Observational Period|Protocol Deviation|0|||
33697730|NCT03266588|63246975|FG002|Observational Period|Protocol Deviation|0|||
33697731|NCT03266588|63246973|FG000|Observational Period|Other Reasons|3|||
33697732|NCT03266588|63246974|FG001|Observational Period|Other Reasons|0|||
33697733|NCT03266588|63246975|FG002|Observational Period|Other Reasons|1|||
33697734|NCT03266588|63246973|FG000|Long-term Treatment Period|Adverse Event|33|||
33697735|NCT03266588|63246974|FG001|Long-term Treatment Period|Adverse Event|17|||
33697736|NCT03266588|63246975|FG002|Long-term Treatment Period|Adverse Event|8|||
33697737|NCT03266588|63246973|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
33697738|NCT03266588|63246974|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
33697739|NCT03266588|63246975|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
33697740|NCT03266588|63246973|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
33697741|NCT03266588|63246974|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
33697742|NCT03266588|63246975|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
33697743|NCT03266588|63246973|FG000|Long-term Treatment Period|Non-Compliance|126|||
33697744|NCT03266588|63246974|FG001|Long-term Treatment Period|Non-Compliance|57|||
33697745|NCT03266588|63246975|FG002|Long-term Treatment Period|Non-Compliance|7|||
33697746|NCT03266588|63246973|FG000|Long-term Treatment Period|Pregnancy|11|||
33697747|NCT03266588|63246974|FG001|Long-term Treatment Period|Pregnancy|5|||
33697748|NCT03266588|63246975|FG002|Long-term Treatment Period|Pregnancy|0|||
33697749|NCT03266588|63246973|FG000|Long-term Treatment Period|Protocol Deviation|17|||
33697750|NCT03266588|63246974|FG001|Long-term Treatment Period|Protocol Deviation|10|||
33697751|NCT03266588|63246975|FG002|Long-term Treatment Period|Protocol Deviation|4|||
33697752|NCT03266588|63246973|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
33697753|NCT03266588|63246974|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
33697754|NCT03266588|63246975|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
33697755|NCT03266588|63246973|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
33697756|NCT03266588|63246974|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
33697757|NCT03266588|63246975|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
33697758|NCT03266588|63246973|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
33697759|NCT03266588|63246974|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
33697760|NCT03266588|63246975|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
33697761|NCT03266588|63246973|FG000|Long-term Treatment Period|Other Reasons|5|||
33697762|NCT03266588|63246974|FG001|Long-term Treatment Period|Other Reasons|0|||
33697763|NCT03266588|63246975|FG002|Long-term Treatment Period|Other Reasons|0|||
33697764|NCT03266588|63246973|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
33697765|NCT03266588|63246974|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
33697766|NCT03266588|63246975|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
33697767|NCT03238196|63247039|FG000|Overall Study|Adverse Event|3|||
33697768|NCT03238196|63247040|FG001|Overall Study|Adverse Event|0|||
33697769|NCT03238196|63247041|FG002|Overall Study|Adverse Event|2|||
33697770|NCT03238196|63247042|FG003|Overall Study|Adverse Event|2|||
33697771|NCT03238196|63247039|FG000|Overall Study|Withdrawal by Subject|4|||
33697772|NCT03238196|63247040|FG001|Overall Study|Withdrawal by Subject|1|||
33697773|NCT03238196|63247041|FG002|Overall Study|Withdrawal by Subject|1|||
33697774|NCT03238196|63247042|FG003|Overall Study|Withdrawal by Subject|0|||
33697775|NCT03238196|63247039|FG000|Overall Study|Disease progression|14|||
33697776|NCT03238196|63247040|FG001|Overall Study|Disease progression|2|||
33697777|NCT03238196|63247041|FG002|Overall Study|Disease progression|3|||
33697778|NCT03238196|63247042|FG003|Overall Study|Disease progression|2|||
33697779|NCT03238196|63247039|FG000|Overall Study|Still on treatment|1|||
33697780|NCT03238196|63247040|FG001|Overall Study|Still on treatment|0|||
33697781|NCT03238196|63247041|FG002|Overall Study|Still on treatment|0|||
33697782|NCT03238196|63247042|FG003|Overall Study|Still on treatment|0|||
33697783|NCT03019640|63247061|FG000|Overall Study|Screen Failures|4|||
33697784|NCT03019640|63247061|FG000|Overall Study|Adverse Event|3|||
33697785|NCT03019640|63247061|FG000|Overall Study|Participant Relapsed|1|||
33697786|NCT02240706|63247129|FG000|Overall Study|Lack of Efficacy|2|||
33697787|NCT02240706|63247130|FG001|Overall Study|Lack of Efficacy|2|||
33697788|NCT02240706|63247131|FG002|Overall Study|Lack of Efficacy|2|||
33697789|NCT02240706|63247132|FG003|Overall Study|Lack of Efficacy|2|||
33697790|NCT02240706|63247133|FG004|Overall Study|Lack of Efficacy|5|||
33697791|NCT02240706|63247134|FG005|Overall Study|Lack of Efficacy|0|||
33697792|NCT02240706|63247135|FG006|Overall Study|Lack of Efficacy|0|||
33697793|NCT02240706|63247129|FG000|Overall Study|Adverse Event|1|||
33697794|NCT02240706|63247130|FG001|Overall Study|Adverse Event|0|||
33697795|NCT02240706|63247131|FG002|Overall Study|Adverse Event|1|||
33697796|NCT02240706|63247132|FG003|Overall Study|Adverse Event|0|||
33697797|NCT02240706|63247133|FG004|Overall Study|Adverse Event|2|||
33697798|NCT02240706|63247134|FG005|Overall Study|Adverse Event|0|||
33697799|NCT02240706|63247135|FG006|Overall Study|Adverse Event|0|||
33697800|NCT02240706|63247129|FG000|Overall Study|Progressive disease|0|||
33697801|NCT02240706|63247130|FG001|Overall Study|Progressive disease|0|||
33697802|NCT02240706|63247131|FG002|Overall Study|Progressive disease|0|||
33697803|NCT02240706|63247132|FG003|Overall Study|Progressive disease|0|||
33697804|NCT02240706|63247133|FG004|Overall Study|Progressive disease|1|||
33697805|NCT02240706|63247134|FG005|Overall Study|Progressive disease|0|||
33697806|NCT02240706|63247135|FG006|Overall Study|Progressive disease|0|||
33697807|NCT02240706|63247129|FG000|Overall Study|Dose limiting toxicity|0|||
33697808|NCT02240706|63247130|FG001|Overall Study|Dose limiting toxicity|0|||
33697809|NCT02240706|63247131|FG002|Overall Study|Dose limiting toxicity|0|||
33697810|NCT02240706|63247132|FG003|Overall Study|Dose limiting toxicity|0|||
33697811|NCT02240706|63247133|FG004|Overall Study|Dose limiting toxicity|1|||
33697812|NCT02240706|63247134|FG005|Overall Study|Dose limiting toxicity|0|||
33697813|NCT02240706|63247135|FG006|Overall Study|Dose limiting toxicity|0|||
33697814|NCT02240706|63247129|FG000|Overall Study|Refused to continue taking medication|0|||
33697815|NCT02240706|63247130|FG001|Overall Study|Refused to continue taking medication|1|||
33697816|NCT02240706|63247131|FG002|Overall Study|Refused to continue taking medication|3|||
33697817|NCT02240706|63247132|FG003|Overall Study|Refused to continue taking medication|1|||
33697818|NCT02240706|63247133|FG004|Overall Study|Refused to continue taking medication|2|||
33697819|NCT02240706|63247134|FG005|Overall Study|Refused to continue taking medication|0|||
33697820|NCT02240706|63247135|FG006|Overall Study|Refused to continue taking medication|0|||
33697821|NCT02240706|63247129|FG000|Overall Study|Insurance billing concerns|0|||
33697822|NCT02240706|63247130|FG001|Overall Study|Insurance billing concerns|0|||
33697823|NCT02240706|63247131|FG002|Overall Study|Insurance billing concerns|0|||
33697824|NCT02240706|63247132|FG003|Overall Study|Insurance billing concerns|1|||
33697825|NCT02240706|63247133|FG004|Overall Study|Insurance billing concerns|0|||
33697826|NCT02240706|63247134|FG005|Overall Study|Insurance billing concerns|0|||
33697827|NCT02240706|63247135|FG006|Overall Study|Insurance billing concerns|0|||
33697828|NCT01600092|63247160|FG000|Overall Study|Adverse Event|2|||
33697829|NCT01600092|63247161|FG001|Overall Study|Adverse Event|0|||
33697830|NCT01600092|63247160|FG000|Overall Study|Lost to Follow-up|4|||
33697831|NCT01600092|63247161|FG001|Overall Study|Lost to Follow-up|6|||
33697832|NCT01600092|63247160|FG000|Overall Study|Withdrawal by parent/guardian|8|||
33697833|NCT01600092|63247161|FG001|Overall Study|Withdrawal by parent/guardian|6|||
33697834|NCT01600092|63247160|FG000|Overall Study|Physician Decision|1|||
33697835|NCT01600092|63247161|FG001|Overall Study|Physician Decision|1|||
33697836|NCT01600092|63247160|FG000|Overall Study|Randomized but not vaccinated|3|||
33697837|NCT01600092|63247161|FG001|Overall Study|Randomized but not vaccinated|3|||
33697838|NCT02240628|63247173|FG000|Overall Study|Physician Decision|6|||
33697839|NCT02240628|63247174|FG001|Overall Study|Physician Decision|5|||
33697840|NCT02207400|63247196|FG000|Overall Study|Adverse Event|1|||
33697841|NCT02207400|63247197|FG001|Overall Study|Adverse Event|1|||
33697842|NCT02207400|63247196|FG000|Overall Study|Lost to Follow-up|6|||
33697843|NCT02207400|63247197|FG001|Overall Study|Lost to Follow-up|7|||
33697844|NCT02207400|63247196|FG000|Overall Study|Protocol Violation|1|||
33697845|NCT02207400|63247197|FG001|Overall Study|Protocol Violation|1|||
33697846|NCT02207400|63247196|FG000|Overall Study|Withdrawal by Subject|8|||
33697847|NCT02207400|63247197|FG001|Overall Study|Withdrawal by Subject|4|||
33697848|NCT02207400|63247196|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
33697849|NCT02207400|63247197|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
33697850|NCT02207244|63247565|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
33697851|NCT02207244|63247566|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
33697852|NCT02207244|63247567|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
33697853|NCT02207244|63247568|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33697854|NCT02207244|63247569|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33697855|NCT02207244|63247570|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33697856|NCT02207244|63247571|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33697857|NCT02207244|63247572|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33697858|NCT02207244|63247573|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33697859|NCT02207244|63247574|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33697860|NCT02207244|63247575|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33697861|NCT02207244|63247565|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
33697862|NCT02207244|63247566|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33697863|NCT02207244|63247567|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
33697864|NCT02207244|63247568|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33697865|NCT02207244|63247569|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33697866|NCT02207244|63247570|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33697867|NCT02207244|63247571|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33697868|NCT02207244|63247572|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33697869|NCT02207244|63247573|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33697870|NCT02207244|63247574|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33697871|NCT02207244|63247575|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33697872|NCT02207244|63247565|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
33697873|NCT02207244|63247566|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
33697874|NCT02207244|63247567|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
33697875|NCT02207244|63247568|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33697876|NCT02207244|63247569|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33697877|NCT02207244|63247570|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33697878|NCT02207244|63247571|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33697879|NCT02207244|63247572|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33697880|NCT02207244|63247573|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33697881|NCT02207244|63247574|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33697882|NCT02207244|63247575|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33697883|NCT02207244|63247565|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
33697884|NCT02207244|63247566|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
33697885|NCT02207244|63247567|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33697886|NCT02207244|63247568|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33697887|NCT02207244|63247569|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33697888|NCT02207244|63247570|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33697889|NCT02207244|63247571|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33697890|NCT02207244|63247572|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33697891|NCT02207244|63247573|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33697892|NCT02207244|63247574|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33697893|NCT02207244|63247575|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33697894|NCT02207244|63247565|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
33697895|NCT02207244|63247566|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
33697896|NCT02207244|63247567|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
33697897|NCT02207244|63247568|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33697898|NCT02207244|63247569|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33697899|NCT02207244|63247570|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33697900|NCT02207244|63247571|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33697901|NCT02207244|63247572|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33697902|NCT02207244|63247573|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33697903|NCT02207244|63247574|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33697904|NCT02207244|63247575|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33697905|NCT02207244|63247565|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33697906|NCT02207244|63247566|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
33697907|NCT02207244|63247567|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
33697908|NCT02207244|63247568|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33697909|NCT02207244|63247569|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33697910|NCT02207244|63247570|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33697911|NCT02207244|63247571|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33697912|NCT02207244|63247572|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33697913|NCT02207244|63247573|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33697914|NCT02207244|63247574|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33697915|NCT02207244|63247575|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33697916|NCT02207244|63247565|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
33697917|NCT02207244|63247566|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
33697918|NCT02207244|63247567|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
33697919|NCT02207244|63247568|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
33697920|NCT02207244|63247569|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
33697921|NCT02207244|63247570|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
33697922|NCT02207244|63247571|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
33697923|NCT02207244|63247572|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
33697924|NCT02207244|63247573|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
33697925|NCT02207244|63247574|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
33697926|NCT02207244|63247575|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
33697927|NCT02207244|63247565|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33697928|NCT02207244|63247566|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33697929|NCT02207244|63247567|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33697930|NCT02207244|63247568|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33697931|NCT02207244|63247569|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
33697932|NCT02207244|63247570|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
33697933|NCT02207244|63247571|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33697934|NCT02207244|63247572|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33697935|NCT02207244|63247573|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33697936|NCT02207244|63247574|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33697937|NCT02207244|63247575|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33697938|NCT02207244|63247565|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33697939|NCT02207244|63247566|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33697940|NCT02207244|63247567|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33697941|NCT02207244|63247568|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33697942|NCT02207244|63247569|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33697943|NCT02207244|63247570|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
33697944|NCT02207244|63247571|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33697945|NCT02207244|63247572|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33697946|NCT02207244|63247573|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33697947|NCT02207244|63247574|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33697948|NCT02207244|63247575|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33697949|NCT02207244|63247565|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33697950|NCT02207244|63247566|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33697951|NCT02207244|63247567|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33697952|NCT02207244|63247568|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
33697953|NCT02207244|63247569|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
33697954|NCT02207244|63247570|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
33697955|NCT02207244|63247571|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33697956|NCT02207244|63247572|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33697957|NCT02207244|63247573|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33697958|NCT02207244|63247574|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33697959|NCT02207244|63247575|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33697960|NCT02207244|63247565|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33697961|NCT02207244|63247566|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33697962|NCT02207244|63247567|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33697963|NCT02207244|63247568|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
33697964|NCT02207244|63247569|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
33697965|NCT02207244|63247570|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
33697966|NCT02207244|63247571|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33697967|NCT02207244|63247572|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33697968|NCT02207244|63247573|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33697969|NCT02207244|63247574|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33697970|NCT02207244|63247575|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33697971|NCT02207244|63247565|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33697972|NCT02207244|63247566|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33697973|NCT02207244|63247567|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33697974|NCT02207244|63247568|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
33697975|NCT02207244|63247569|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33697976|NCT02207244|63247570|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
33697977|NCT02207244|63247571|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33697978|NCT02207244|63247572|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33697979|NCT02207244|63247573|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33697980|NCT02207244|63247574|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33697981|NCT02207244|63247575|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33697982|NCT02207244|63247565|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
33697983|NCT02207244|63247566|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
33697984|NCT02207244|63247567|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
33697985|NCT02207244|63247568|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
33697986|NCT02207244|63247569|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
33697987|NCT02207244|63247570|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
33697988|NCT02207244|63247571|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
33697989|NCT02207244|63247572|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
33697990|NCT02207244|63247573|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
33697991|NCT02207244|63247574|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
33697992|NCT02207244|63247575|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
33697993|NCT02207244|63247565|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
33697994|NCT02207244|63247566|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
33697995|NCT02207244|63247567|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
33697996|NCT02207244|63247568|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
33697997|NCT02207244|63247569|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
33697998|NCT02207244|63247570|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
33697999|NCT02207244|63247571|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
33698000|NCT02207244|63247572|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
33698001|NCT02207244|63247573|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
33698002|NCT02207244|63247574|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
33698003|NCT02207244|63247575|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
33698004|NCT02207244|63247565|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33698005|NCT02207244|63247566|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33698006|NCT02207244|63247567|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33698007|NCT02207244|63247568|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33698008|NCT02207244|63247569|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33698009|NCT02207244|63247570|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33698010|NCT02207244|63247571|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33698011|NCT02207244|63247572|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
33698012|NCT02207244|63247573|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33698013|NCT02207244|63247574|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33698014|NCT02207244|63247575|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33698015|NCT02207244|63247565|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
33698016|NCT02207244|63247566|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
33698017|NCT02207244|63247567|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
33698018|NCT02207244|63247568|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
33698019|NCT02207244|63247569|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
33698020|NCT02207244|63247570|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
33698021|NCT02207244|63247571|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
33698022|NCT02207244|63247572|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
33698023|NCT02207244|63247573|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
33698024|NCT02207244|63247574|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
33698025|NCT02207244|63247575|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
33698026|NCT02207244|63247565|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33698027|NCT02207244|63247566|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33698028|NCT02207244|63247567|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33698029|NCT02207244|63247568|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33698030|NCT02207244|63247569|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33698031|NCT02207244|63247570|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33698032|NCT02207244|63247571|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
33698033|NCT02207244|63247572|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
33698034|NCT02207244|63247573|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33698035|NCT02207244|63247574|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
33698036|NCT02207244|63247575|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33698037|NCT02207244|63247565|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
33698038|NCT02207244|63247566|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
33698039|NCT02207244|63247567|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
33698040|NCT02207244|63247568|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
33698041|NCT02207244|63247569|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
33698042|NCT02207244|63247570|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
33698043|NCT02207244|63247571|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
33698044|NCT02207244|63247572|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
33698045|NCT02207244|63247573|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
33698046|NCT02207244|63247574|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
33698047|NCT02207244|63247575|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
33698048|NCT02207244|63247565|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33698049|NCT02207244|63247566|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33698050|NCT02207244|63247567|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33698051|NCT02207244|63247568|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33698052|NCT02207244|63247569|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33698053|NCT02207244|63247570|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33698054|NCT02207244|63247571|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33698055|NCT02207244|63247572|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
33698056|NCT02207244|63247573|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
33698057|NCT02207244|63247574|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33698058|NCT02207244|63247575|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33698059|NCT02207244|63247565|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33698060|NCT02207244|63247566|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33698061|NCT02207244|63247567|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33698062|NCT02207244|63247568|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33698063|NCT02207244|63247569|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33698064|NCT02207244|63247570|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33698065|NCT02207244|63247571|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33698066|NCT02207244|63247572|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33698067|NCT02207244|63247573|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
33698068|NCT02207244|63247574|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33698069|NCT02207244|63247575|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33698070|NCT02207244|63247565|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33698071|NCT02207244|63247566|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33698072|NCT02207244|63247567|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33698073|NCT02207244|63247568|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33698074|NCT02207244|63247569|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33698075|NCT02207244|63247570|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33698076|NCT02207244|63247571|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33698077|NCT02207244|63247572|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
33698078|NCT02207244|63247573|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33698079|NCT02207244|63247574|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33698080|NCT02207244|63247575|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33698081|NCT02207244|63247565|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33698082|NCT02207244|63247566|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33698083|NCT02207244|63247567|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33698084|NCT02207244|63247568|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33698085|NCT02207244|63247569|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33698086|NCT02207244|63247570|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33698087|NCT02207244|63247571|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
33698088|NCT02207244|63247572|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33698089|NCT02207244|63247573|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33698090|NCT02207244|63247574|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33698091|NCT02207244|63247575|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33698092|NCT02207244|63247565|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33698093|NCT02207244|63247566|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33698094|NCT02207244|63247567|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33698095|NCT02207244|63247568|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33698096|NCT02207244|63247569|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33698097|NCT02207244|63247570|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33698098|NCT02207244|63247571|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33698099|NCT02207244|63247572|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33698100|NCT02207244|63247573|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
33698101|NCT02207244|63247574|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33698102|NCT02207244|63247575|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
33698103|NCT02207244|63247565|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33698104|NCT02207244|63247566|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33698105|NCT02207244|63247567|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33698106|NCT02207244|63247568|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33698107|NCT02207244|63247569|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33698108|NCT02207244|63247570|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33698109|NCT02207244|63247571|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33698110|NCT02207244|63247572|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33698111|NCT02207244|63247573|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
33698112|NCT02207244|63247574|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33698113|NCT02207244|63247575|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
33698114|NCT02207244|63247565|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33698115|NCT02207244|63247566|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33698116|NCT02207244|63247567|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33698117|NCT02207244|63247568|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33698118|NCT02207244|63247569|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33698119|NCT02207244|63247570|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33698120|NCT02207244|63247571|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33698121|NCT02207244|63247572|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33698122|NCT02207244|63247573|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
33698123|NCT02207244|63247574|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33698124|NCT02207244|63247575|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
33698125|NCT02207244|63247565|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33698126|NCT02207244|63247566|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33698127|NCT02207244|63247567|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33698128|NCT02207244|63247568|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33698129|NCT02207244|63247569|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33698130|NCT02207244|63247570|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33698131|NCT02207244|63247571|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33698132|NCT02207244|63247572|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33698133|NCT02207244|63247573|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
33698134|NCT02207244|63247574|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33698135|NCT02207244|63247575|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
33698136|NCT02207244|63247565|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
33698137|NCT02207244|63247566|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
33698138|NCT02207244|63247567|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
33698139|NCT02207244|63247568|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
33698140|NCT02207244|63247569|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
33698141|NCT02207244|63247570|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
33698142|NCT02207244|63247571|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
33698143|NCT02207244|63247572|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
33698144|NCT02207244|63247573|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
33698145|NCT02207244|63247574|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
33698146|NCT02207244|63247575|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
33698147|NCT02207244|63247565|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
33698148|NCT02207244|63247566|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
33698149|NCT02207244|63247567|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
33698150|NCT02207244|63247568|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
33698151|NCT02207244|63247569|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
33698152|NCT02207244|63247570|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
33698153|NCT02207244|63247571|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
33698154|NCT02207244|63247572|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
33698155|NCT02207244|63247573|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
33698156|NCT02207244|63247574|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
33698157|NCT02207244|63247575|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
33698158|NCT02207244|63247565|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33698159|NCT02207244|63247566|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33698160|NCT02207244|63247567|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33698161|NCT02207244|63247568|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33698162|NCT02207244|63247569|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33698163|NCT02207244|63247570|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33698164|NCT02207244|63247571|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33698165|NCT02207244|63247572|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33698166|NCT02207244|63247573|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33698167|NCT02207244|63247574|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33698168|NCT02207244|63247575|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
33698169|NCT02207088|63247628|FG000|Overall Study|Adverse Event|2|||
33698170|NCT02206620|63247643|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
33698171|NCT02206620|63247644|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
33698172|NCT02206620|63247643|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
33698173|NCT02206620|63247644|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
33698174|NCT02239926|63247658|FG000|Overall Study|Withdrawal by Subject|0|||
33698175|NCT02239926|63247659|FG001|Overall Study|Withdrawal by Subject|1|||
33698176|NCT02239692|63247667|FG000|Overall Study|Incomplete colonoscopy|1|||
33698177|NCT02239692|63247668|FG001|Overall Study|Incomplete colonoscopy|2|||
33698178|NCT02239692|63247667|FG000|Overall Study|Adverse Event|0|||
33698179|NCT02239692|63247668|FG001|Overall Study|Adverse Event|1|||
33698180|NCT02239692|63247667|FG000|Overall Study|Physician Decision|0|||
33698181|NCT02239692|63247668|FG001|Overall Study|Physician Decision|1|||
33698182|NCT02239692|63247667|FG000|Overall Study|Lost to Follow-up|1|||
33698183|NCT02239692|63247668|FG001|Overall Study|Lost to Follow-up|4|||
33698184|NCT02239692|63247667|FG000|Overall Study|Withdrawal by Subject|3|||
33698185|NCT02239692|63247668|FG001|Overall Study|Withdrawal by Subject|5|||
33698186|NCT02239692|63247667|FG000|Overall Study|Other reason|1|||
33698187|NCT02239692|63247668|FG001|Overall Study|Other reason|0|||
33698188|NCT02206152|63247696|FG000|Pre-Randomization|Withdrawal by Subject|2|||
33698189|NCT02239536|63247704|FG000|Overall Study|Non-neoplastic polyp|23|||
33698190|NCT02239536|63247705|FG001|Overall Study|Non-neoplastic polyp|17|||
33698191|NCT02239224|63247715|FG000|Overall Study|Administrative|0|||
33698192|NCT02239224|63247716|FG001|Overall Study|Administrative|0|||
33698193|NCT02239224|63247717|FG002|Overall Study|Administrative|3|||
33698194|NCT02239224|63247718|FG003|Overall Study|Administrative|1|||
33698195|NCT01600014|63247728|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
33698196|NCT01600014|63247729|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
33698197|NCT01600014|63247728|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
33698198|NCT01600014|63247729|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
33698199|NCT01600014|63247728|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
33698200|NCT01600014|63247729|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
33698201|NCT01600014|63247728|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
33698202|NCT01600014|63247729|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
33698203|NCT01600014|63247728|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
33698204|NCT01600014|63247729|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
33698205|NCT01600014|63247728|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
33698206|NCT01600014|63247729|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
33698207|NCT01600014|63247728|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
33698208|NCT01600014|63247729|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
33698209|NCT01600014|63247728|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
33698210|NCT01600014|63247729|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
33698211|NCT01600014|63247728|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
33698212|NCT01600014|63247729|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
33698213|NCT01600014|63247728|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
33698214|NCT01600014|63247729|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
33698215|NCT01600014|63247728|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
33698216|NCT01600014|63247729|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
33698217|NCT01600014|63247728|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
33698218|NCT01600014|63247729|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
33698219|NCT01600014|63247728|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
33698220|NCT01600014|63247729|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
33698221|NCT01600014|63247728|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
33698222|NCT01600014|63247729|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
33698223|NCT01600014|63247728|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
33698224|NCT01600014|63247729|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
33698225|NCT01600014|63247728|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
33698226|NCT01600014|63247729|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
33698227|NCT01600014|63247728|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
33698228|NCT01600014|63247729|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
33698229|NCT02237196|63247751|FG000|Overall Study|Adverse Event|0|||
33698230|NCT02237196|63247752|FG001|Overall Study|Adverse Event|1|||
33698231|NCT02237196|63247753|FG002|Overall Study|Adverse Event|1|||
33698232|NCT02237196|63247754|FG003|Overall Study|Adverse Event|0|||
33698233|NCT02237196|63247751|FG000|Overall Study|Lost to Follow-up|4|||
33698234|NCT02237196|63247752|FG001|Overall Study|Lost to Follow-up|2|||
33698235|NCT02237196|63247753|FG002|Overall Study|Lost to Follow-up|4|||
33698236|NCT02237196|63247754|FG003|Overall Study|Lost to Follow-up|6|||
33698237|NCT02237196|63247751|FG000|Overall Study|Physician Decision|2|||
33698238|NCT02237196|63247752|FG001|Overall Study|Physician Decision|0|||
33698239|NCT02237196|63247753|FG002|Overall Study|Physician Decision|0|||
33698240|NCT02237196|63247754|FG003|Overall Study|Physician Decision|1|||
33698241|NCT02237196|63247751|FG000|Overall Study|Pregnancy|0|||
33698242|NCT02237196|63247752|FG001|Overall Study|Pregnancy|0|||
33698243|NCT02237196|63247753|FG002|Overall Study|Pregnancy|1|||
33698244|NCT02237196|63247754|FG003|Overall Study|Pregnancy|1|||
33698245|NCT02237196|63247751|FG000|Overall Study|Withdrawal by Subject|1|||
33698246|NCT02237196|63247752|FG001|Overall Study|Withdrawal by Subject|1|||
33698247|NCT02237196|63247753|FG002|Overall Study|Withdrawal by Subject|4|||
33698248|NCT02237196|63247754|FG003|Overall Study|Withdrawal by Subject|1|||
33698249|NCT02237196|63247751|FG000|Overall Study|Site Error|1|||
33698250|NCT02237196|63247752|FG001|Overall Study|Site Error|2|||
33698251|NCT02237196|63247753|FG002|Overall Study|Site Error|0|||
33698252|NCT02237196|63247754|FG003|Overall Study|Site Error|2|||
33698253|NCT02237118|63247770|FG000|Overall Study|Protocol Violation|0|||
33698254|NCT02237118|63247771|FG001|Overall Study|Protocol Violation|1|||
33698255|NCT02237118|63247770|FG000|Overall Study|consent withdrawn|1|||
33698256|NCT02237118|63247771|FG001|Overall Study|consent withdrawn|0|||
33698257|NCT02234622|63247787|FG000|Overall Study|Withdrawal by Subject|16|||
33698258|NCT02234622|63247788|FG001|Overall Study|Withdrawal by Subject|22|||
33698259|NCT02234622|63247787|FG000|Overall Study|Lost to Follow-up|27|||
33698260|NCT02234622|63247788|FG001|Overall Study|Lost to Follow-up|14|||
33698261|NCT03250273|63247798|FG000|Overall Study|Disease Progression|2|||
33698262|NCT03250273|63247799|FG001|Overall Study|Disease Progression|11|||
33698263|NCT03250273|63247798|FG000|Overall Study|Death|0|||
33698264|NCT03250273|63247799|FG001|Overall Study|Death|1|||
33698265|NCT02203032|63247805|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
33698266|NCT02203032|63247806|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
33698267|NCT02203032|63247807|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
33698268|NCT02203032|63247808|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
33698269|NCT02203032|63247805|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
33698270|NCT02203032|63247806|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
33698271|NCT02203032|63247807|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
33698272|NCT02203032|63247808|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
33698273|NCT02203032|63247805|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
33698274|NCT02203032|63247806|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
33698275|NCT02203032|63247807|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
33698276|NCT02203032|63247808|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
33698277|NCT02203032|63247805|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
33698278|NCT02203032|63247806|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
33698279|NCT02203032|63247807|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
33698280|NCT02203032|63247808|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
33698281|NCT02203032|63247805|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
33698282|NCT02203032|63247806|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
33698283|NCT02203032|63247807|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
33698284|NCT02203032|63247808|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
33698285|NCT02203032|63247805|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
33698286|NCT02203032|63247806|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
33698287|NCT02203032|63247807|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
33698288|NCT02203032|63247808|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
33698289|NCT02203032|63247805|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
33698290|NCT02203032|63247806|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
33698291|NCT02203032|63247807|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
33698292|NCT02203032|63247808|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
33698293|NCT02203032|63247805|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
33698294|NCT02203032|63247806|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
33698295|NCT02203032|63247807|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
33698296|NCT02203032|63247808|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
33698297|NCT02203032|63247805|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
33698298|NCT02203032|63247806|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
33698299|NCT02203032|63247807|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
33698300|NCT02203032|63247808|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
33698301|NCT02203032|63247805|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
33698302|NCT02203032|63247806|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
33698303|NCT02203032|63247807|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
33698304|NCT02203032|63247808|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
33698305|NCT02203032|63247805|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
33698306|NCT02203032|63247806|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
33596388|NCT02518685|62995353|FG001|Overall Study|Adverse Event|1|||
33596389|NCT02518685|62995352|FG000|Overall Study|Withdrawal by Subject|10|||
33596390|NCT02518685|62995353|FG001|Overall Study|Withdrawal by Subject|3|||
33596391|NCT02518685|62995352|FG000|Overall Study|relocation, study fatigue|7|||
33596392|NCT02518685|62995353|FG001|Overall Study|relocation, study fatigue|2|||
33596393|NCT02518685|62995352|FG000|Overall Study|Pregnancy|1|||
33596394|NCT02518685|62995353|FG001|Overall Study|Pregnancy|0|||
33596395|NCT02518685|62995352|FG000|Overall Study|Physician Decision|1|||
33596396|NCT02518685|62995353|FG001|Overall Study|Physician Decision|0|||
33596397|NCT02518685|62995352|FG000|Overall Study|Lost to Follow-up|1|||
33596398|NCT02518685|62995353|FG001|Overall Study|Lost to Follow-up|4|||
33596399|NCT02520089|62995362|FG000|Overall Study|Lost to Follow-up|3|||
33596400|NCT02520089|62995363|FG001|Overall Study|Lost to Follow-up|4|||
33596401|NCT02105961|62995372|FG000|Overall Study|Adverse Event|18|||
33596402|NCT02105961|62995373|FG001|Overall Study|Adverse Event|7|||
33596403|NCT02105961|62995374|FG002|Overall Study|Adverse Event|13|||
33596404|NCT02105961|62995372|FG000|Overall Study|Lack of Efficacy|3|||
33596405|NCT02105961|62995373|FG001|Overall Study|Lack of Efficacy|0|||
33596406|NCT02105961|62995374|FG002|Overall Study|Lack of Efficacy|3|||
33596407|NCT02105961|62995372|FG000|Overall Study|Lost to Follow-up|2|||
33596408|NCT02105961|62995373|FG001|Overall Study|Lost to Follow-up|0|||
33596409|NCT02105961|62995374|FG002|Overall Study|Lost to Follow-up|1|||
33596410|NCT02105961|62995372|FG000|Overall Study|Physician Decision|3|||
33596411|NCT02105961|62995373|FG001|Overall Study|Physician Decision|3|||
33596412|NCT02105961|62995374|FG002|Overall Study|Physician Decision|2|||
33596413|NCT02105961|62995372|FG000|Overall Study|Withdrawal by Subject|15|||
33596414|NCT02105961|62995373|FG001|Overall Study|Withdrawal by Subject|7|||
33596415|NCT02105961|62995374|FG002|Overall Study|Withdrawal by Subject|11|||
33596416|NCT02141997|62995387|FG000|Overall Study|Adverse Event|0|||
33596417|NCT02141997|62995388|FG001|Overall Study|Adverse Event|2|||
33596418|NCT02141997|62995389|FG002|Overall Study|Adverse Event|0|||
33596419|NCT02141997|62995390|FG003|Overall Study|Adverse Event|1|||
33596420|NCT02141997|62995387|FG000|Overall Study|Participant noncompliance|1|||
33596421|NCT02141997|62995388|FG001|Overall Study|Participant noncompliance|0|||
33596422|NCT02141997|62995389|FG002|Overall Study|Participant noncompliance|0|||
33596423|NCT02141997|62995390|FG003|Overall Study|Participant noncompliance|0|||
33596424|NCT02141997|62995387|FG000|Overall Study|Withdrew consent|1|||
33596425|NCT02141997|62995388|FG001|Overall Study|Withdrew consent|0|||
33596426|NCT02141997|62995389|FG002|Overall Study|Withdrew consent|3|||
33596427|NCT02141997|62995390|FG003|Overall Study|Withdrew consent|0|||
33596428|NCT02141997|62995387|FG000|Overall Study|Other|1|||
33596429|NCT02141997|62995388|FG001|Overall Study|Other|4|||
33596430|NCT02141997|62995389|FG002|Overall Study|Other|0|||
33596431|NCT02141997|62995390|FG003|Overall Study|Other|0|||
33596432|NCT01628367|62995402|FG000|Overall Study|Adverse Event|1|||
33596433|NCT01628367|62995403|FG001|Overall Study|Adverse Event|0|||
33596434|NCT01627899|62995409|FG000|Overall Study|Study terminated early by sponsor.|5|||
33596435|NCT02519777|62995416|FG000|Overall Study|Death|1|||
33596436|NCT02519777|62995417|FG001|Overall Study|Death|0|||
33596437|NCT02519777|62995418|FG002|Overall Study|Death|0|||
33596438|NCT02519777|62995416|FG000|Overall Study|Lost to Follow-up|0|||
33596439|NCT02519777|62995417|FG001|Overall Study|Lost to Follow-up|4|||
33596440|NCT02519777|62995418|FG002|Overall Study|Lost to Follow-up|2|||
33596441|NCT02519777|62995416|FG000|Overall Study|Withdrawal by Subject|3|||
33596442|NCT02519777|62995417|FG001|Overall Study|Withdrawal by Subject|1|||
33596443|NCT02519777|62995418|FG002|Overall Study|Withdrawal by Subject|0|||
33596444|NCT02519777|62995416|FG000|Overall Study|Severe Debilitation|1|||
33698307|NCT02203032|63247807|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
33698308|NCT02203032|63247808|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
33596445|NCT02519777|62995417|FG001|Overall Study|Severe Debilitation|1|||
33596446|NCT02519777|62995418|FG002|Overall Study|Severe Debilitation|1|||
33596447|NCT02519777|62995416|FG000|Overall Study|Not able to get to clinic|1|||
33596448|NCT02519777|62995417|FG001|Overall Study|Not able to get to clinic|2|||
33596449|NCT02519777|62995418|FG002|Overall Study|Not able to get to clinic|1|||
33596450|NCT02515331|62995429|FG000|Overall Study|Withdrawal by Subject|0|||
33596451|NCT02515331|62995430|FG001|Overall Study|Withdrawal by Subject|0|||
33596452|NCT02515331|62995431|FG002|Overall Study|Withdrawal by Subject|1|||
33596453|NCT02515331|62995429|FG000|Overall Study|Protocol deviation|0|||
33596454|NCT02515331|62995430|FG001|Overall Study|Protocol deviation|0|||
33596455|NCT02515331|62995431|FG002|Overall Study|Protocol deviation|3|||
33596456|NCT02515331|62995429|FG000|Overall Study|Adverse Event|2|||
33596457|NCT02515331|62995430|FG001|Overall Study|Adverse Event|0|||
33596458|NCT02515331|62995431|FG002|Overall Study|Adverse Event|0|||
33596459|NCT02515097|62995441|FG000|Overall Study|Lost to Follow-up|4|||
33596460|NCT02515097|62995442|FG001|Overall Study|Lost to Follow-up|2|||
33596461|NCT02515097|62995441|FG000|Overall Study|Withdrawal by Subject|1|||
33596462|NCT02515097|62995442|FG001|Overall Study|Withdrawal by Subject|3|||
33596463|NCT02515097|62995441|FG000|Overall Study|Adverse Event|2|||
33596464|NCT02515097|62995442|FG001|Overall Study|Adverse Event|1|||
33596465|NCT02141295|62995451|FG000|Overall Study|Adverse Event|1|||
33596466|NCT02141295|62995452|FG001|Overall Study|Adverse Event|18|||
33596467|NCT02141295|62995453|FG002|Overall Study|Adverse Event|11|||
33698309|NCT02203032|63247805|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
33698310|NCT02203032|63247806|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
33698311|NCT02203032|63247807|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
33698312|NCT02203032|63247808|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
33698313|NCT02169414|63247820|FG000|Overall Study|Withdrawal by Subject|1|||
33698314|NCT02169414|63247821|FG001|Overall Study|Withdrawal by Subject|0|||
33698315|NCT02169414|63247822|FG002|Overall Study|Withdrawal by Subject|0|||
33698316|NCT02169414|63247823|FG003|Overall Study|Withdrawal by Subject|0|||
33698317|NCT02169414|63247820|FG000|Overall Study|Adverse Event|0|||
33698318|NCT02169414|63247821|FG001|Overall Study|Adverse Event|1|||
33698319|NCT02169414|63247822|FG002|Overall Study|Adverse Event|0|||
33698320|NCT02169414|63247823|FG003|Overall Study|Adverse Event|0|||
33698321|NCT03213457|63247840|FG000|Overall Study|Not Treated|1|||
33698322|NCT03213457|63247841|FG001|Overall Study|Not Treated|1|||
33698323|NCT03213457|63247842|FG002|Overall Study|Not Treated|0|||
33698324|NCT03213457|63247840|FG000|Overall Study|Adverse Event|16|||
33698325|NCT03213457|63247841|FG001|Overall Study|Adverse Event|9|||
33698326|NCT03213457|63247842|FG002|Overall Study|Adverse Event|41|||
33698327|NCT03213457|63247840|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33698328|NCT03213457|63247841|FG001|Overall Study|Non-Compliance With Study Drug|2|||
33698329|NCT03213457|63247842|FG002|Overall Study|Non-Compliance With Study Drug|7|||
33698330|NCT03213457|63247840|FG000|Overall Study|Non-Compliance Other, Not Specified|0|||
33698331|NCT03213457|63247841|FG001|Overall Study|Non-Compliance Other, Not Specified|1|||
33698332|NCT03213457|63247842|FG002|Overall Study|Non-Compliance Other, Not Specified|5|||
33698333|NCT03213457|63247840|FG000|Overall Study|Withdrawal by Subject|18|||
33698334|NCT03213457|63247841|FG001|Overall Study|Withdrawal by Subject|7|||
33698335|NCT03213457|63247842|FG002|Overall Study|Withdrawal by Subject|35|||
33698336|NCT03213457|63247840|FG000|Overall Study|Lost to Follow-up|12|||
33698337|NCT03213457|63247841|FG001|Overall Study|Lost to Follow-up|12|||
33596468|NCT02141295|62995451|FG000|Overall Study|Physician Decision|2|||
33596469|NCT02141295|62995452|FG001|Overall Study|Physician Decision|19|||
33698338|NCT03213457|63247842|FG002|Overall Study|Lost to Follow-up|33|||
33698339|NCT03213457|63247840|FG000|Overall Study|Pregnancy|11|||
33698340|NCT03213457|63247841|FG001|Overall Study|Pregnancy|0|||
33698341|NCT03213457|63247842|FG002|Overall Study|Pregnancy|7|||
33698342|NCT03213457|63247840|FG000|Overall Study|Protocol Violation|1|||
33698343|NCT03213457|63247841|FG001|Overall Study|Protocol Violation|1|||
33698344|NCT03213457|63247842|FG002|Overall Study|Protocol Violation|6|||
33698345|NCT03213457|63247840|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4|||
33698346|NCT03213457|63247841|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0|||
33698347|NCT03213457|63247842|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2|||
33698348|NCT03213457|63247840|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
33698349|NCT03213457|63247841|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
33698350|NCT03213457|63247842|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3|||
33698351|NCT03213457|63247840|FG000|Overall Study|Lack of Efficacy|12|||
33698352|NCT03213457|63247841|FG001|Overall Study|Lack of Efficacy|2|||
33698353|NCT03213457|63247842|FG002|Overall Study|Lack of Efficacy|9|||
33698354|NCT03213457|63247840|FG000|Overall Study|Other, Not Specified|11|||
33698355|NCT03213457|63247841|FG001|Overall Study|Other, Not Specified|3|||
33698356|NCT03213457|63247842|FG002|Overall Study|Other, Not Specified|26|||
33698357|NCT02201940|63247852|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
33698358|NCT02201940|63247853|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
33698359|NCT02201940|63247852|FG000|Overall Study|Lack of Efficacy|2|||
33698360|NCT02201940|63247853|FG001|Overall Study|Lack of Efficacy|113|||
33698361|NCT02201940|63247852|FG000|Overall Study|Lost to Follow-up|5|||
33698362|NCT02201940|63247853|FG001|Overall Study|Lost to Follow-up|0|||
33698363|NCT02201940|63247852|FG000|Overall Study|Withdrew Consent|2|||
33698364|NCT02201940|63247853|FG001|Overall Study|Withdrew Consent|1|||
33698365|NCT02201940|63247852|FG000|Overall Study|Investigator's Discretion|1|||
33698366|NCT02201940|63247853|FG001|Overall Study|Investigator's Discretion|1|||
33698367|NCT02201940|63247852|FG000|Overall Study|Death|1|||
33698368|NCT02201940|63247853|FG001|Overall Study|Death|0|||
33698369|NCT02201940|63247852|FG000|Overall Study|Adverse Event|0|||
33698370|NCT02201940|63247853|FG001|Overall Study|Adverse Event|1|||
33698371|NCT02232984|63247859|FG000|Overall Study|Withdrawal by Subject|5|||
33698372|NCT02232984|63247859|FG000|Overall Study|Death|1|||
33698373|NCT02232984|63247859|FG000|Overall Study|Investigator withdrawal|10|||
33698374|NCT02232984|63247859|FG000|Overall Study|Device implant unsuccessful|53|||
33698375|NCT02232984|63247859|FG000|Overall Study|not disclosed by site|7|||
33698376|NCT02232984|63247859|FG000|Overall Study|Protocol Violation|1|||
33698377|NCT02169336|63247869|FG000|Overall Study|Lack of Efficacy|1|||
33698378|NCT02169336|63247870|FG001|Overall Study|Lack of Efficacy|1|||
33698379|NCT02169336|63247871|FG002|Overall Study|Lack of Efficacy|0|||
33698380|NCT02169336|63247869|FG000|Overall Study|Adverse Event|2|||
33698381|NCT02169336|63247870|FG001|Overall Study|Adverse Event|3|||
33698382|NCT02169336|63247871|FG002|Overall Study|Adverse Event|1|||
33698383|NCT02169336|63247869|FG000|Overall Study|Withdrawal by Subject|1|||
33698384|NCT02169336|63247870|FG001|Overall Study|Withdrawal by Subject|0|||
33698385|NCT02169336|63247871|FG002|Overall Study|Withdrawal by Subject|0|||
33698386|NCT02169336|63247869|FG000|Overall Study|Physician Decision|0|||
33698387|NCT02169336|63247870|FG001|Overall Study|Physician Decision|0|||
33698388|NCT02169336|63247871|FG002|Overall Study|Physician Decision|1|||
33698389|NCT02169336|63247869|FG000|Overall Study|Subject declined to continue dosing|0|||
33698390|NCT02169336|63247870|FG001|Overall Study|Subject declined to continue dosing|0|||
33698391|NCT02169336|63247871|FG002|Overall Study|Subject declined to continue dosing|1|||
33698392|NCT02609828|63247887|FG000|Overall Study|Adverse Event|8|||
33698393|NCT02609828|63247888|FG001|Overall Study|Adverse Event|1|||
33698394|NCT02609828|63247889|FG002|Overall Study|Adverse Event|0|||
33698395|NCT02609828|63247890|FG003|Overall Study|Adverse Event|6|||
33698396|NCT02609828|63247887|FG000|Overall Study|Death|15|||
33698397|NCT02609828|63247888|FG001|Overall Study|Death|1|||
33698398|NCT02609828|63247889|FG002|Overall Study|Death|1|||
33698399|NCT02609828|63247890|FG003|Overall Study|Death|19|||
33698400|NCT02609828|63247887|FG000|Overall Study|Insufficient clinical response|2|||
33698401|NCT02609828|63247888|FG001|Overall Study|Insufficient clinical response|1|||
33698402|NCT02609828|63247889|FG002|Overall Study|Insufficient clinical response|0|||
33698403|NCT02609828|63247890|FG003|Overall Study|Insufficient clinical response|0|||
33698404|NCT02609828|63247887|FG000|Overall Study|Lost to Follow-up|0|||
33698405|NCT02609828|63247888|FG001|Overall Study|Lost to Follow-up|0|||
33698406|NCT02609828|63247889|FG002|Overall Study|Lost to Follow-up|0|||
33698407|NCT02609828|63247890|FG003|Overall Study|Lost to Follow-up|1|||
33698408|NCT02609828|63247887|FG000|Overall Study|Protocol Violation|2|||
33698409|NCT02609828|63247888|FG001|Overall Study|Protocol Violation|0|||
33698410|NCT02609828|63247889|FG002|Overall Study|Protocol Violation|0|||
33698411|NCT02609828|63247890|FG003|Overall Study|Protocol Violation|1|||
33698412|NCT02609828|63247887|FG000|Overall Study|Withdrawal by Subject|12|||
33698413|NCT02609828|63247888|FG001|Overall Study|Withdrawal by Subject|1|||
33698414|NCT02609828|63247889|FG002|Overall Study|Withdrawal by Subject|0|||
33698415|NCT02609828|63247890|FG003|Overall Study|Withdrawal by Subject|10|||
33698416|NCT02609828|63247887|FG000|Overall Study|Other|3|||
33698417|NCT02609828|63247888|FG001|Overall Study|Other|0|||
33698418|NCT02609828|63247889|FG002|Overall Study|Other|0|||
33698419|NCT02609828|63247890|FG003|Overall Study|Other|6|||
33698420|NCT02609828|63247887|FG000|Overall Study|Randomized but not treated|1|||
33698421|NCT02609828|63247888|FG001|Overall Study|Randomized but not treated|0|||
33698422|NCT02609828|63247889|FG002|Overall Study|Randomized but not treated|0|||
33698423|NCT02609828|63247890|FG003|Overall Study|Randomized but not treated|0|||
33698424|NCT01632306|63247906|FG000|Overall Study|Protocol Violation|1|||
33698425|NCT01632306|63247907|FG001|Overall Study|Protocol Violation|0|||
33698426|NCT01632306|63247908|FG002|Overall Study|Protocol Violation|0|||
33698427|NCT02201784|63247916|FG000|Overall Study|Failure to achieve adequate block|2|||
33698428|NCT02201784|63247917|FG001|Overall Study|Failure to achieve adequate block|0|||
33698429|NCT02201472|63247923|FG000|Overall Study|Lack of Efficacy|2|||
33698430|NCT02168946|63247968|FG000|Overall Study|Adverse Event|8|||
33698431|NCT02168946|63247969|FG001|Overall Study|Adverse Event|5|||
33698432|NCT02168946|63247968|FG000|Overall Study|Lost to Follow-up|3|||
33698433|NCT02168946|63247969|FG001|Overall Study|Lost to Follow-up|0|||
33698434|NCT02168946|63247968|FG000|Overall Study|Subject unable to come back for visits|1|||
33698435|NCT02168946|63247969|FG001|Overall Study|Subject unable to come back for visits|0|||
33698436|NCT02168478|63247990|FG000|Overall Study|Withdrawal by Subject|1|||
33698437|NCT02168478|63247990|FG000|Overall Study|Did Not Consent to Participation|2|||
33698438|NCT02168478|63247990|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
33698439|NCT02200614|63249154|FG000|Double Blind Treatment|Adverse Event|86|||
33698440|NCT02200614|63249155|FG001|Double Blind Treatment|Adverse Event|48|||
33698441|NCT02200614|63249154|FG000|Double Blind Treatment|Confirmed metastasis|120|||
33698442|NCT02200614|63249155|FG001|Double Blind Treatment|Confirmed metastasis|140|||
33698443|NCT02200614|63249154|FG000|Double Blind Treatment|Judgment of the investigator|59|||
33698444|NCT02200614|63249155|FG001|Double Blind Treatment|Judgment of the investigator|99|||
33698445|NCT02200614|63249154|FG000|Double Blind Treatment|Metastasis by local reading|1|||
33698446|NCT02200614|63249155|FG001|Double Blind Treatment|Metastasis by local reading|3|||
33698447|NCT02200614|63249154|FG000|Double Blind Treatment|Other reason|6|||
33698448|NCT02200614|63249155|FG001|Double Blind Treatment|Other reason|2|||
33698449|NCT02200614|63249154|FG000|Double Blind Treatment|Personal reason|77|||
33698450|NCT02200614|63249155|FG001|Double Blind Treatment|Personal reason|85|||
33698451|NCT02200614|63249154|FG000|Double Blind Treatment|Protocol deviation|14|||
33698452|NCT02200614|63249155|FG001|Double Blind Treatment|Protocol deviation|7|||
33698453|NCT02200614|63249154|FG000|Double Blind Treatment|Not treated|1|||
33698454|NCT02200614|63249155|FG001|Double Blind Treatment|Not treated|0|||
33698455|NCT02200614|63249154|FG000|Open Label|Adverse Event|41|||
33698456|NCT02200614|63249155|FG001|Open Label|Adverse Event|11|||
33698457|NCT02200614|63249154|FG000|Open Label|Confirmed metastasis|1|||
33698458|NCT02200614|63249155|FG001|Open Label|Confirmed metastasis|0|||
33698459|NCT02200614|63249154|FG000|Open Label|Judgment of the investigator|29|||
33698460|NCT02200614|63249155|FG001|Open Label|Judgment of the investigator|2|||
33698461|NCT02200614|63249154|FG000|Open Label|Metastasis by local reading|138|||
33698462|NCT02200614|63249155|FG001|Open Label|Metastasis by local reading|27|||
33698463|NCT02200614|63249154|FG000|Open Label|Other reason|22|||
33698464|NCT02200614|63249155|FG001|Open Label|Other reason|4|||
33698465|NCT02200614|63249154|FG000|Open Label|Personal reason|60|||
33698466|NCT02200614|63249155|FG001|Open Label|Personal reason|8|||
33698467|NCT02200614|63249154|FG000|Open Label|Protocol deviation|3|||
33698468|NCT02200614|63249155|FG001|Open Label|Protocol deviation|2|||
33698469|NCT02200614|63249154|FG000|Open Label|Missing|2|||
33698470|NCT02200614|63249155|FG001|Open Label|Missing|2|||
33698471|NCT02231892|63249166|FG000|Overall Study|Lost to Follow-up|1|||
33698472|NCT02231892|63249167|FG001|Overall Study|Lost to Follow-up|0|||
33698473|NCT02231892|63249168|FG002|Overall Study|Lost to Follow-up|3|||
33698474|NCT02231892|63249166|FG000|Overall Study|Withdrawal by Subject|4|||
33698475|NCT02231892|63249167|FG001|Overall Study|Withdrawal by Subject|3|||
33698476|NCT02231892|63249168|FG002|Overall Study|Withdrawal by Subject|15|||
33698477|NCT02231892|63249166|FG000|Overall Study|Physician Decision|0|||
33698478|NCT02231892|63249167|FG001|Overall Study|Physician Decision|2|||
33698479|NCT02231892|63249168|FG002|Overall Study|Physician Decision|4|||
33698480|NCT02231892|63249166|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
33698481|NCT02231892|63249167|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
33698482|NCT02231892|63249168|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
33698483|NCT02231892|63249166|FG000|Overall Study|Participant motor threshold was >83%|0|||
33698484|NCT02231892|63249167|FG001|Overall Study|Participant motor threshold was >83%|0|||
33698485|NCT02231892|63249168|FG002|Overall Study|Participant motor threshold was >83%|9|||
33698486|NCT02231892|63249166|FG000|Overall Study|Could not find motor threshold|2|||
33698487|NCT02231892|63249167|FG001|Overall Study|Could not find motor threshold|0|||
33698488|NCT02231892|63249168|FG002|Overall Study|Could not find motor threshold|1|||
33698489|NCT02231892|63249166|FG000|Overall Study|Could not find reliable motor hotspot|0|||
33401450|NCT00256867|62780481|FG007|Overall Study|Protocol Violation|1|||
33698490|NCT02231892|63249167|FG001|Overall Study|Could not find reliable motor hotspot|0|||
33698491|NCT02231892|63249168|FG002|Overall Study|Could not find reliable motor hotspot|1|||
33698492|NCT02231580|63249184|FG000|Overall Study|Adverse Event|5|||
33698493|NCT02231580|63249185|FG001|Overall Study|Adverse Event|0|||
33698494|NCT02166606|63249193|FG000|Overall Study|Adverse Event|3|||
33698495|NCT02166606|63249193|FG000|Overall Study|Death|31|||
33698496|NCT02166606|63249193|FG000|Overall Study|Protocol Violation|7|||
33698497|NCT02166606|63249193|FG000|Overall Study|Lost to Follow-up|30|||
33698498|NCT02166606|63249193|FG000|Overall Study|Withdrawal by Subject|1|||
33698499|NCT02166606|63249193|FG000|Overall Study|Physician Decision|1|||
33698500|NCT02166606|63249193|FG000|Overall Study|Device upgrade|1|||
33698501|NCT02166606|63249193|FG000|Overall Study|Enrolled after End of Enrollment|4|||
33698502|NCT02230956|63249200|FG000|Overall Study|Adverse Event|1|||
33698503|NCT02230956|63249201|FG001|Overall Study|Adverse Event|1|||
33698504|NCT02230956|63249202|FG002|Overall Study|Adverse Event|0|||
33698505|NCT02230956|63249200|FG000|Overall Study|Lack of Efficacy|1|||
33698506|NCT02230956|63249201|FG001|Overall Study|Lack of Efficacy|1|||
33698507|NCT02230956|63249202|FG002|Overall Study|Lack of Efficacy|1|||
33698508|NCT02230956|63249200|FG000|Overall Study|Lost to Follow-up|1|||
33698509|NCT02230956|63249201|FG001|Overall Study|Lost to Follow-up|1|||
33698510|NCT02230956|63249202|FG002|Overall Study|Lost to Follow-up|2|||
33698511|NCT02230956|63249200|FG000|Overall Study|Personal Reasons|2|||
33698512|NCT02230956|63249201|FG001|Overall Study|Personal Reasons|1|||
33698513|NCT02230956|63249202|FG002|Overall Study|Personal Reasons|1|||
33698514|NCT02230956|63249200|FG000|Overall Study|Protocol Violation|0|||
33698515|NCT02230956|63249201|FG001|Overall Study|Protocol Violation|1|||
33698516|NCT02230956|63249202|FG002|Overall Study|Protocol Violation|1|||
33698517|NCT02230956|63249200|FG000|Overall Study|Other Miscellaneous Reason|0|||
33698518|NCT02230956|63249201|FG001|Overall Study|Other Miscellaneous Reason|1|||
33698519|NCT02230956|63249202|FG002|Overall Study|Other Miscellaneous Reason|2|||
33698520|NCT02230410|63249210|FG000|Overall Study|Screen Failure|3|||
33698521|NCT02230332|63249216|FG000|Overall Study|Adverse Event|2|||
33698522|NCT02230332|63249217|FG001|Overall Study|Adverse Event|1|||
33698523|NCT02230332|63249216|FG000|Overall Study|Lost to Follow-up|1|||
33698524|NCT02230332|63249217|FG001|Overall Study|Lost to Follow-up|0|||
33698525|NCT02230332|63249216|FG000|Overall Study|Protocol Violation|1|||
33698526|NCT02230332|63249217|FG001|Overall Study|Protocol Violation|0|||
33698527|NCT02230254|63249223|FG000|Overall Study|Lost to Follow-up|3|||
33698528|NCT02198664|63249229|FG000|Overall Study|Adverse Event|2|||
33698529|NCT02198664|63249230|FG001|Overall Study|Adverse Event|0|||
33698530|NCT02198664|63249229|FG000|Overall Study|Withdrawal by Subject|11|||
33698531|NCT02198664|63249230|FG001|Overall Study|Withdrawal by Subject|8|||
33698532|NCT02198664|63249229|FG000|Overall Study|Failure to tolerate|2|||
33698533|NCT02198664|63249230|FG001|Overall Study|Failure to tolerate|0|||
33698534|NCT02198664|63249229|FG000|Overall Study|Not stated|1|||
33698535|NCT02198664|63249230|FG001|Overall Study|Not stated|0|||
33698536|NCT02165826|63249241|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
33698537|NCT02165826|63249242|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
33698538|NCT02165826|63249243|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
33698539|NCT02165826|63249241|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
33698540|NCT02165826|63249242|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
33698541|NCT02165826|63249243|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
33698542|NCT02165826|63249241|FG000|Main Treatment Period|Lost to Follow-up|4|||
33698543|NCT02165826|63249242|FG001|Main Treatment Period|Lost to Follow-up|2|||
33698544|NCT02165826|63249243|FG002|Main Treatment Period|Lost to Follow-up|1|||
33698545|NCT02165826|63249241|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
33698546|NCT02165826|63249242|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
33698547|NCT02165826|63249243|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
33698548|NCT02165826|63249241|FG000|Main Treatment Period|Lack of Efficacy|2|||
33698549|NCT02165826|63249242|FG001|Main Treatment Period|Lack of Efficacy|0|||
33698550|NCT02165826|63249243|FG002|Main Treatment Period|Lack of Efficacy|0|||
33698551|NCT02165826|63249241|FG000|Main Treatment Period|Reason Not Specified|8|||
33698552|NCT02165826|63249242|FG001|Main Treatment Period|Reason Not Specified|5|||
33698553|NCT02165826|63249243|FG002|Main Treatment Period|Reason Not Specified|16|||
33698554|NCT02165826|63249241|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
33698555|NCT02165826|63249242|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
33698556|NCT02165826|63249243|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
33698557|NCT02165826|63249241|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
33698558|NCT02165826|63249242|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
33698559|NCT02165826|63249243|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
33698560|NCT02165826|63249241|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
33698561|NCT02165826|63249242|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
33698562|NCT02165826|63249243|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
33698563|NCT02165826|63249241|FG000|Down-Titration Period|Reason Not Specified|1|||
33698564|NCT02165826|63249242|FG001|Down-Titration Period|Reason Not Specified|0|||
33698565|NCT02165826|63249243|FG002|Down-Titration Period|Reason Not Specified|2|||
33698566|NCT02198040|63249280|FG000|Overall Study|Work reasons|0|||
33698567|NCT02198040|63249281|FG001|Overall Study|Work reasons|1|||
33698568|NCT02198040|63249282|FG002|Overall Study|Work reasons|0|||
33698569|NCT02198040|63249280|FG000|Overall Study|Withdrawal by Subject|0|||
33698570|NCT02198040|63249281|FG001|Overall Study|Withdrawal by Subject|0|||
33698571|NCT02198040|63249282|FG002|Overall Study|Withdrawal by Subject|1|||
33698572|NCT02197806|63249296|FG000|Overall Study|Adverse Event|0|||
33698573|NCT02197806|63249297|FG001|Overall Study|Adverse Event|1|||
33698574|NCT02197806|63249298|FG002|Overall Study|Adverse Event|0|||
33698575|NCT02197806|63249299|FG003|Overall Study|Adverse Event|1|||
33698576|NCT02229864|63249346|FG000|Overall Study|Death|2|||
33698577|NCT02229864|63249346|FG000|Overall Study|Lost to Follow-up|1|||
33698578|NCT02229552|63249350|FG000|Baseline|Withdrawal by Subject|6|||
33698579|NCT02229552|63249350|FG000|1-year Follow up|Withdrawal by Subject|7|||
33698580|NCT02229552|63249350|FG000|1-year Follow up|Lost to Follow-up|18|||
33698581|NCT02229552|63249350|FG000|2-Year Follow up|Withdrawal by Subject|9|||
33698582|NCT02229552|63249350|FG000|2-Year Follow up|Lost to Follow-up|17|||
33698583|NCT02229396|63249357|FG000|Overall Study|Adverse Event|6|||
33698584|NCT02229396|63249358|FG001|Overall Study|Adverse Event|12|||
33698585|NCT02229396|63249359|FG002|Overall Study|Adverse Event|12|||
33698586|NCT02229396|63249357|FG000|Overall Study|Death|2|||
33698587|NCT02229396|63249358|FG001|Overall Study|Death|3|||
33698588|NCT02229396|63249359|FG002|Overall Study|Death|1|||
33698589|NCT02229396|63249357|FG000|Overall Study|Lost to Follow-up|14|||
33698590|NCT02229396|63249358|FG001|Overall Study|Lost to Follow-up|14|||
33698591|NCT02229396|63249359|FG002|Overall Study|Lost to Follow-up|21|||
33698592|NCT02229396|63249357|FG000|Overall Study|Protocol Violation|2|||
33698593|NCT02229396|63249358|FG001|Overall Study|Protocol Violation|1|||
33698594|NCT02229396|63249359|FG002|Overall Study|Protocol Violation|0|||
33698595|NCT02229396|63249357|FG000|Overall Study|Patient Incorrectly Randomized|0|||
33698596|NCT02229396|63249358|FG001|Overall Study|Patient Incorrectly Randomized|0|||
33698597|NCT02229396|63249359|FG002|Overall Study|Patient Incorrectly Randomized|1|||
33698598|NCT02229396|63249357|FG000|Overall Study|Other|10|||
33698599|NCT02229396|63249358|FG001|Overall Study|Other|18|||
33698600|NCT02229396|63249359|FG002|Overall Study|Other|15|||
33698601|NCT02229396|63249357|FG000|Overall Study|Withdrawal by Subject|42|||
33698602|NCT02229396|63249358|FG001|Overall Study|Withdrawal by Subject|28|||
33698603|NCT02229396|63249359|FG002|Overall Study|Withdrawal by Subject|41|||
33698604|NCT02229396|63249357|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
33698605|NCT02229396|63249358|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
33698606|NCT02229396|63249359|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
33698607|NCT02229396|63249357|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
33698608|NCT02229396|63249358|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
33698609|NCT02229396|63249359|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
33698610|NCT02197416|63249374|FG000|Overall Study|Other reasons|0|||
33698611|NCT02197416|63249375|FG001|Overall Study|Other reasons|2|||
33698612|NCT02197416|63249376|FG002|Overall Study|Other reasons|5|||
33698613|NCT02197416|63249374|FG000|Overall Study|Withdrawal by Subject|0|||
33698614|NCT02197416|63249375|FG001|Overall Study|Withdrawal by Subject|2|||
33698615|NCT02197416|63249376|FG002|Overall Study|Withdrawal by Subject|1|||
33698616|NCT02197416|63249374|FG000|Overall Study|Protocol Violation|1|||
33698617|NCT02197416|63249375|FG001|Overall Study|Protocol Violation|0|||
33698618|NCT02197416|63249376|FG002|Overall Study|Protocol Violation|1|||
33698619|NCT02197416|63249374|FG000|Overall Study|Adverse Event|0|||
33698620|NCT02197416|63249375|FG001|Overall Study|Adverse Event|0|||
33698621|NCT02197416|63249376|FG002|Overall Study|Adverse Event|1|||
33698622|NCT02165202|63249384|FG000|Oral Phase|Refused further participation|5|||
33698623|NCT02165202|63249385|FG001|Oral Phase|Refused further participation|1|||
33698624|NCT02165202|63249384|FG000|Oral Phase|Study product Related Toxicity|1|||
33596470|NCT02141295|62995453|FG002|Overall Study|Physician Decision|14|||
33310752|NCT01233258|62686170|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
33698625|NCT02165202|63249385|FG001|Oral Phase|Study product Related Toxicity|0|||
33698626|NCT02165202|63249384|FG000|Oral Phase|Unable to contact Participant|1|||
33698627|NCT02165202|63249385|FG001|Oral Phase|Unable to contact Participant|1|||
33698628|NCT02165202|63249384|FG000|Oral Phase|Clinical reasons|1|||
33698629|NCT02165202|63249385|FG001|Oral Phase|Clinical reasons|0|||
33698630|NCT02165202|63249384|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
33698631|NCT02165202|63249385|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
33698632|NCT02165202|63249384|FG000|Oral Phase|CMC advised termination|1|||
33698633|NCT02165202|63249385|FG001|Oral Phase|CMC advised termination|0|||
33698634|NCT02165202|63249384|FG000|Oral Phase|Relocated, no follow-up planned|1|||
33698635|NCT02165202|63249385|FG001|Oral Phase|Relocated, no follow-up planned|0|||
33698636|NCT02165202|63249384|FG000|Oral Phase|Abnormal EKG|0|||
33698637|NCT02165202|63249385|FG001|Oral Phase|Abnormal EKG|1|||
33698638|NCT02165202|63249384|FG000|Injection Phase|Abnormal Lab Value|5|||
33698639|NCT02165202|63249385|FG001|Injection Phase|Abnormal Lab Value|1|||
33698640|NCT02165202|63249384|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
33698641|NCT02165202|63249385|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
33698642|NCT02165202|63249384|FG000|Injection Phase|Unable to attend within Visit Window|1|||
33698643|NCT02165202|63249385|FG001|Injection Phase|Unable to attend within Visit Window|0|||
33698644|NCT02165202|63249384|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
33698645|NCT02165202|63249385|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
33698646|NCT02165202|63249384|FG000|Injection Phase|End of Study|2|||
33698647|NCT02165202|63249385|FG001|Injection Phase|End of Study|1|||
33698648|NCT02165202|63249384|FG000|Injection Phase|Study Product related Toxicity|1|||
33698649|NCT02165202|63249385|FG001|Injection Phase|Study Product related Toxicity|0|||
33698650|NCT02165202|63249384|FG000|Injection Phase|No longer interested|0|||
33698651|NCT02165202|63249385|FG001|Injection Phase|No longer interested|1|||
33698652|NCT02165202|63249384|FG000|Injection Phase|Participant unwilling to comply|1|||
33698653|NCT02165202|63249385|FG001|Injection Phase|Participant unwilling to comply|0|||
33698654|NCT01628874|63249393|FG000|Overall Study|Physician Decision|1|||
33698655|NCT01628874|63249394|FG001|Overall Study|Physician Decision|1|||
33698656|NCT01628874|63249393|FG000|Overall Study|Age >4 months|4|||
33698657|NCT01628874|63249394|FG001|Overall Study|Age >4 months|2|||
33698658|NCT02196714|63249419|FG000|Overall Study|Protocol Violation|0|||
33698659|NCT02196714|63249420|FG001|Overall Study|Protocol Violation|0|||
33698660|NCT02196714|63249421|FG002|Overall Study|Protocol Violation|1|||
33698661|NCT02196714|63249422|FG003|Overall Study|Protocol Violation|0|||
33698662|NCT02196558|63249446|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
33698663|NCT02196558|63249447|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
33698664|NCT02196558|63249448|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
33698665|NCT02196558|63249446|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
33698666|NCT02196558|63249447|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
33698667|NCT02196558|63249448|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
33698668|NCT02196558|63249446|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
33698669|NCT02196558|63249447|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
33698670|NCT02196558|63249448|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
33698671|NCT02196558|63249446|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
33698672|NCT02196558|63249447|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
33698673|NCT02196558|63249448|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
33698674|NCT02196558|63249446|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
33698675|NCT02196558|63249447|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
33698676|NCT02196558|63249448|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
33698677|NCT02196324|63249469|FG000|Overall Study|Withdrawal by Subject|8|||
33698678|NCT02196324|63249470|FG001|Overall Study|Withdrawal by Subject|4|||
33698679|NCT02196324|63249469|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
33698680|NCT02196324|63249470|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
33698681|NCT02196324|63249469|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
33698682|NCT02196324|63249470|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
33698683|NCT02196324|63249469|FG000|Overall Study|Other|1|||
33698684|NCT02196324|63249470|FG001|Overall Study|Other|0|||
33698685|NCT02195700|63249478|FG000|Overall Study|Protocol Violation|0|||
33698686|NCT02195700|63249479|FG001|Overall Study|Protocol Violation|2|||
33698687|NCT02195700|63249478|FG000|Overall Study|Noncompliance|1|||
33698688|NCT02195700|63249479|FG001|Overall Study|Noncompliance|0|||
33698689|NCT02195700|63249478|FG000|Overall Study|Adverse Event|1|||
33698690|NCT02195700|63249479|FG001|Overall Study|Adverse Event|2|||
33698691|NCT02195700|63249478|FG000|Overall Study|Withdrawal by Subject|3|||
33698692|NCT02195700|63249479|FG001|Overall Study|Withdrawal by Subject|2|||
33698693|NCT02195700|63249478|FG000|Overall Study|Lost to Follow-up|1|||
33698694|NCT02195700|63249479|FG001|Overall Study|Lost to Follow-up|1|||
33698695|NCT02228460|63249494|FG000|Overall Study|Adverse Event|1|||
33698696|NCT02228460|63249494|FG000|Overall Study|Lost to Follow-up|1|||
33698697|NCT02227446|63249510|FG000|Overall Study|not eligible post randomization|18|||
33698698|NCT02227446|63249511|FG001|Overall Study|not eligible post randomization|29|||
33698699|NCT02227446|63249510|FG000|Overall Study|Withdrawal by Subject|4|||
33698700|NCT02227446|63249511|FG001|Overall Study|Withdrawal by Subject|5|||
33698701|NCT02227368|63249519|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
33698702|NCT02227368|63249520|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
33698703|NCT02227368|63249519|FG000|Overall Study|Lost to Follow-up|1|||
33698704|NCT02227368|63249520|FG001|Overall Study|Lost to Follow-up|0|||
33698705|NCT02227368|63249519|FG000|Overall Study|Adverse Event|1|||
33698706|NCT02227368|63249520|FG001|Overall Study|Adverse Event|0|||
33698707|NCT02162862|63249529|FG000|Overall Study|Lost to Follow-up|0|||
33698708|NCT02162862|63249530|FG001|Overall Study|Lost to Follow-up|11|||
33698709|NCT02162862|63249531|FG002|Overall Study|Lost to Follow-up|0|||
33698710|NCT02162862|63249529|FG000|Overall Study|Subject did not feel the med was needed|0|||
33698711|NCT02162862|63249530|FG001|Overall Study|Subject did not feel the med was needed|0|||
33698712|NCT02162862|63249531|FG002|Overall Study|Subject did not feel the med was needed|4|||
33698713|NCT02226198|63249569|FG000|Lead-in Phase|Protocol Violation|1|||
33698714|NCT02226198|63249570|FG001|Lead-in Phase|Protocol Violation|0|||
33698715|NCT02226198|63249571|FG002|Lead-in Phase|Protocol Violation|0|||
33698716|NCT02226198|63249569|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
33698717|NCT02226198|63249570|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
33698718|NCT02226198|63249571|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
33698719|NCT02226120|63249742|FG000|Overall Study|Adverse Event|60|||
33698720|NCT02226120|63249742|FG000|Overall Study|Death|172|||
33698721|NCT02226120|63249742|FG000|Overall Study|Study terminated by sponsor|1|||
33698722|NCT02226120|63249742|FG000|Overall Study|Technical problems|4|||
33698723|NCT02226120|63249742|FG000|Overall Study|Lost to Follow-up|13|||
33698724|NCT02226120|63249742|FG000|Overall Study|Physician Decision|21|||
33698725|NCT02226120|63249742|FG000|Overall Study|Withdrawal by parent/guardian|36|||
33698726|NCT02226120|63249742|FG000|Overall Study|Non-compliance with study drug|10|||
33698727|NCT02226120|63249742|FG000|Overall Study|Protocol deviation|1|||
33698728|NCT02226120|63249742|FG000|Overall Study|missing treatment disposition pages|2|||
33698729|NCT02194998|63249907|FG000|On-HCV Treatment|Did not pick up study medication|0|||
33698730|NCT02194998|63249908|FG001|On-HCV Treatment|Did not pick up study medication|1|||
33698731|NCT02194998|63249909|FG002|On-HCV Treatment|Did not pick up study medication|0|||
33698732|NCT02194998|63249910|FG003|On-HCV Treatment|Did not pick up study medication|0|||
33698733|NCT02194998|63249907|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
33698734|NCT02194998|63249908|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
33698735|NCT02194998|63249909|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
33698736|NCT02194998|63249910|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
33698737|NCT02194062|63249923|FG000|Overall Study|Lost to Follow-up|2|||
33698738|NCT02194062|63249924|FG001|Overall Study|Lost to Follow-up|2|||
33698739|NCT02194062|63249925|FG002|Overall Study|Lost to Follow-up|5|||
33698740|NCT02193828|63249946|FG000|Overall Study|Withdrawal by Subject|0|||
33698741|NCT02193828|63249947|FG001|Overall Study|Withdrawal by Subject|0|||
33698742|NCT02193828|63249948|FG002|Overall Study|Withdrawal by Subject|1|||
33698743|NCT02193828|63249949|FG003|Overall Study|Withdrawal by Subject|1|||
33698744|NCT02192970|63249970|FG000|Overall Study|Lost to Follow-up|6|||
33698745|NCT02192970|63249971|FG001|Overall Study|Lost to Follow-up|0|||
33698746|NCT02192190|63250155|FG000|Overall Study|Adverse Event|1|||
33698747|NCT02192190|63250156|FG001|Overall Study|Adverse Event|1|||
33698748|NCT02192190|63250157|FG002|Overall Study|Adverse Event|0|||
33698749|NCT02192190|63250158|FG003|Overall Study|Adverse Event|0|||
33698750|NCT02192190|63250159|FG004|Overall Study|Adverse Event|0|||
33698751|NCT02192190|63250160|FG005|Overall Study|Adverse Event|0|||
33698752|NCT02192190|63250155|FG000|Overall Study|Lost to Follow-up|3|||
33698753|NCT02192190|63250156|FG001|Overall Study|Lost to Follow-up|3|||
33698754|NCT02192190|63250157|FG002|Overall Study|Lost to Follow-up|2|||
33698755|NCT02192190|63250158|FG003|Overall Study|Lost to Follow-up|1|||
33698756|NCT02192190|63250159|FG004|Overall Study|Lost to Follow-up|4|||
33698757|NCT02192190|63250160|FG005|Overall Study|Lost to Follow-up|3|||
33698758|NCT02192190|63250155|FG000|Overall Study|Physician Decision|2|||
33698759|NCT02192190|63250156|FG001|Overall Study|Physician Decision|0|||
33698760|NCT02192190|63250157|FG002|Overall Study|Physician Decision|0|||
33698761|NCT02192190|63250158|FG003|Overall Study|Physician Decision|0|||
33698762|NCT02192190|63250159|FG004|Overall Study|Physician Decision|0|||
33698763|NCT02192190|63250160|FG005|Overall Study|Physician Decision|0|||
33698764|NCT02192190|63250155|FG000|Overall Study|Terminated by Sponsor|43|||
33698765|NCT02192190|63250156|FG001|Overall Study|Terminated by Sponsor|23|||
33698766|NCT02192190|63250157|FG002|Overall Study|Terminated by Sponsor|20|||
33698767|NCT02192190|63250158|FG003|Overall Study|Terminated by Sponsor|23|||
33698768|NCT02192190|63250159|FG004|Overall Study|Terminated by Sponsor|21|||
33698769|NCT02192190|63250160|FG005|Overall Study|Terminated by Sponsor|23|||
33698770|NCT02192190|63250155|FG000|Overall Study|Withdrawal by Subject|4|||
33698771|NCT02192190|63250156|FG001|Overall Study|Withdrawal by Subject|1|||
33698772|NCT02192190|63250157|FG002|Overall Study|Withdrawal by Subject|2|||
33698773|NCT02192190|63250158|FG003|Overall Study|Withdrawal by Subject|1|||
33698774|NCT02192190|63250159|FG004|Overall Study|Withdrawal by Subject|5|||
33698775|NCT02192190|63250160|FG005|Overall Study|Withdrawal by Subject|3|||
33698776|NCT02192190|63250155|FG000|Overall Study|Could not Keep Visit Schedule|1|||
33698777|NCT02192190|63250156|FG001|Overall Study|Could not Keep Visit Schedule|0|||
33698778|NCT02192190|63250157|FG002|Overall Study|Could not Keep Visit Schedule|0|||
33698779|NCT02192190|63250158|FG003|Overall Study|Could not Keep Visit Schedule|0|||
33698780|NCT02192190|63250159|FG004|Overall Study|Could not Keep Visit Schedule|0|||
33698781|NCT02192190|63250160|FG005|Overall Study|Could not Keep Visit Schedule|0|||
33698782|NCT02192190|63250155|FG000|Overall Study|Positive Drug Screen|0|||
33698783|NCT02192190|63250156|FG001|Overall Study|Positive Drug Screen|0|||
33698784|NCT02192190|63250157|FG002|Overall Study|Positive Drug Screen|0|||
33698785|NCT02192190|63250158|FG003|Overall Study|Positive Drug Screen|1|||
33698786|NCT02192190|63250159|FG004|Overall Study|Positive Drug Screen|0|||
33698787|NCT02192190|63250160|FG005|Overall Study|Positive Drug Screen|0|||
33698788|NCT02192190|63250155|FG000|Overall Study|Inadequate Pain Relief|0|||
33698789|NCT02192190|63250156|FG001|Overall Study|Inadequate Pain Relief|1|||
33698790|NCT02192190|63250157|FG002|Overall Study|Inadequate Pain Relief|1|||
33698791|NCT02192190|63250158|FG003|Overall Study|Inadequate Pain Relief|0|||
33698792|NCT02192190|63250159|FG004|Overall Study|Inadequate Pain Relief|0|||
33698793|NCT02192190|63250160|FG005|Overall Study|Inadequate Pain Relief|0|||
33698794|NCT02224638|63250188|FG000|Overall Study|Adverse Event|1|||
33698795|NCT02224638|63250189|FG001|Overall Study|Adverse Event|1|||
33698796|NCT02224560|63250204|FG000|Overall Study|Protocol Deviation|1|||
33698797|NCT02224560|63250205|FG001|Overall Study|Protocol Deviation|0|||
33698798|NCT02224560|63250206|FG002|Overall Study|Protocol Deviation|0|||
33698799|NCT02224560|63250204|FG000|Overall Study|Withdrawal by Subject|2|||
33698800|NCT02224560|63250205|FG001|Overall Study|Withdrawal by Subject|0|||
33698801|NCT02224560|63250206|FG002|Overall Study|Withdrawal by Subject|1|||
33698802|NCT02224560|63250204|FG000|Overall Study|Met Withdrawal Criteria|1|||
33698803|NCT02224560|63250205|FG001|Overall Study|Met Withdrawal Criteria|0|||
33698804|NCT02224560|63250206|FG002|Overall Study|Met Withdrawal Criteria|0|||
33698805|NCT02224560|63250204|FG000|Overall Study|Adverse Event|4|||
33698806|NCT02224560|63250205|FG001|Overall Study|Adverse Event|1|||
33698807|NCT02224560|63250206|FG002|Overall Study|Adverse Event|1|||
33698808|NCT02224560|63250204|FG000|Overall Study|Withdrawn by Investigator|1|||
33698809|NCT02224560|63250205|FG001|Overall Study|Withdrawn by Investigator|1|||
33698810|NCT02224560|63250206|FG002|Overall Study|Withdrawn by Investigator|0|||
33698811|NCT02161458|63250218|FG000|Overall Study|Withdrawal by Subject|0|||
33698812|NCT02161458|63250219|FG001|Overall Study|Withdrawal by Subject|4|||
33698813|NCT02161458|63250220|FG002|Overall Study|Withdrawal by Subject|4|||
33698814|NCT02161458|63250221|FG003|Overall Study|Withdrawal by Subject|0|||
33698815|NCT02161458|63250218|FG000|Overall Study|Lost to Follow-up|0|||
33698816|NCT02161458|63250219|FG001|Overall Study|Lost to Follow-up|2|||
33698817|NCT02161458|63250220|FG002|Overall Study|Lost to Follow-up|1|||
33698818|NCT02161458|63250221|FG003|Overall Study|Lost to Follow-up|0|||
33698819|NCT02223858|63250233|FG000|Overall Study|Death|1|||
33698820|NCT02223858|63250234|FG001|Overall Study|Death|1|||
33698821|NCT02223858|63250233|FG000|Overall Study|Lost to Follow-up|6|||
33698822|NCT02223858|63250234|FG001|Overall Study|Lost to Follow-up|11|||
33698823|NCT02223858|63250233|FG000|Overall Study|Withdrawal by Subject|8|||
33698824|NCT02223858|63250234|FG001|Overall Study|Withdrawal by Subject|5|||
33698825|NCT02223858|63250233|FG000|Overall Study|Refused|9|||
33698826|NCT02223858|63250234|FG001|Overall Study|Refused|9|||
33698827|NCT02223390|63250242|FG000|Overall Study|Lost to Follow-up|9|||
33698828|NCT02223390|63250243|FG001|Overall Study|Lost to Follow-up|4|||
33698829|NCT04914000|63252146|FG000|Overall Study|Lost to Follow-up|8|||
33698830|NCT04914000|63252146|FG000|Overall Study|Withdrawal by Subject|1|||
33698831|NCT04530825|63252163|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
33698832|NCT04530825|63252164|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
33698833|NCT04530825|63252165|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
33310753|NCT01233258|62686171|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
33698834|NCT04530825|63252166|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
33310754|NCT01233258|62686172|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
33698835|NCT04530825|63252163|FG000|Overall Study|Did not complete follow-up|3|||
33698836|NCT04530825|63252164|FG001|Overall Study|Did not complete follow-up|0|||
33698837|NCT04530825|63252165|FG002|Overall Study|Did not complete follow-up|0|||
33698838|NCT04530825|63252166|FG003|Overall Study|Did not complete follow-up|0|||
33698839|NCT04169373|63252180|FG000|Week 1 to Week 14|Adverse Event|1|||
33698840|NCT04169373|63252181|FG001|Week 1 to Week 14|Adverse Event|0|||
33698841|NCT04169373|63252182|FG002|Week 1 to Week 14|Adverse Event|1|||
33698842|NCT04169373|63252183|FG003|Week 1 to Week 14|Adverse Event|2|||
33698843|NCT04169373|63252180|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
33698844|NCT04169373|63252181|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
33698845|NCT04169373|63252182|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
33698846|NCT04169373|63252183|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
33698847|NCT04169373|63252180|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
33698848|NCT04169373|63252181|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
33698849|NCT04169373|63252182|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
33698850|NCT04169373|63252183|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
33698851|NCT04169373|63252180|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
33698852|NCT04169373|63252181|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
33698853|NCT04169373|63252182|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
33698854|NCT04169373|63252183|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
33698855|NCT04169373|63252180|FG000|Week 1 to Week 14|Other|1|||
33698856|NCT04169373|63252181|FG001|Week 1 to Week 14|Other|3|||
33698857|NCT04169373|63252182|FG002|Week 1 to Week 14|Other|3|||
33698858|NCT04169373|63252183|FG003|Week 1 to Week 14|Other|5|||
33698859|NCT04169373|63252180|FG000|Week 14 to Week 52|Adverse Event|1|||
33698860|NCT04169373|63252181|FG001|Week 14 to Week 52|Adverse Event|0|||
33698861|NCT04169373|63252182|FG002|Week 14 to Week 52|Adverse Event|0|||
33698862|NCT04169373|63252183|FG003|Week 14 to Week 52|Adverse Event|1|||
33698863|NCT04169373|63252180|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
33698864|NCT04169373|63252181|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
33698865|NCT04169373|63252182|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
33698866|NCT04169373|63252183|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
33698867|NCT04169373|63252180|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
33698868|NCT04169373|63252181|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
33698869|NCT04169373|63252182|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
33698870|NCT04169373|63252183|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
33698871|NCT04169373|63252180|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
33698872|NCT04169373|63252181|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
33698873|NCT04169373|63252182|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
33698874|NCT04169373|63252183|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
33698875|NCT04169373|63252180|FG000|Week 14 to Week 52|Other|4|||
33698876|NCT04169373|63252181|FG001|Week 14 to Week 52|Other|5|||
33698877|NCT04169373|63252182|FG002|Week 14 to Week 52|Other|4|||
33698878|NCT04169373|63252183|FG003|Week 14 to Week 52|Other|5|||
33698879|NCT04169373|63252180|FG000|Week 14 to Week 52|Ongoing|0|||
33698880|NCT04169373|63252181|FG001|Week 14 to Week 52|Ongoing|1|||
33698881|NCT04169373|63252182|FG002|Week 14 to Week 52|Ongoing|0|||
33698882|NCT04169373|63252183|FG003|Week 14 to Week 52|Ongoing|0|||
33698883|NCT04154930|63252198|FG000|Overall Study|Withdrawal by Subject|15|||
33698884|NCT04154930|63252199|FG001|Overall Study|Withdrawal by Subject|6|||
33698885|NCT04154930|63252198|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
33698886|NCT04154930|63252199|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
33698887|NCT04154930|63252198|FG000|Overall Study|Lost to Follow-up|14|||
33698888|NCT04154930|63252199|FG001|Overall Study|Lost to Follow-up|6|||
33698889|NCT04154930|63252198|FG000|Overall Study|Other|6|||
33698890|NCT04154930|63252199|FG001|Overall Study|Other|0|||
33698891|NCT04124471|63252205|FG000|Overall Study|screen failure|1|||
33698892|NCT04093024|63252211|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
33698893|NCT04093024|63252212|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
33698894|NCT04093024|63252211|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
33698895|NCT04093024|63252212|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
33698896|NCT04093024|63252211|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
33698897|NCT04093024|63252212|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
33698898|NCT04093024|63252211|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
33698899|NCT04093024|63252212|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
33698900|NCT03971474|63252248|FG000|Overall Study|Adverse Event|11|||
33698901|NCT03971474|63252249|FG001|Overall Study|Adverse Event|7|||
33698902|NCT03971474|63252248|FG000|Overall Study|Refusal unrelated to adverse event|5|||
33698903|NCT03971474|63252249|FG001|Overall Study|Refusal unrelated to adverse event|1|||
33698904|NCT03971474|63252248|FG000|Overall Study|Progression/relapse|40|||
33698905|NCT03971474|63252249|FG001|Overall Study|Progression/relapse|47|||
33698906|NCT03971474|63252248|FG000|Overall Study|Death|6|||
33698907|NCT03971474|63252249|FG001|Overall Study|Death|3|||
33698908|NCT03971474|63252248|FG000|Overall Study|Other - not protocol specified|5|||
33698909|NCT03971474|63252249|FG001|Overall Study|Other - not protocol specified|4|||
33493245|NCT03103152|62871479|FG001|Overall Study|Death|1|||
33493246|NCT03103152|62871480|FG002|Overall Study|Death|0|||
33698910|NCT03971474|63252248|FG000|Overall Study|On treatment|0|||
33698911|NCT03971474|63252249|FG001|Overall Study|On treatment|7|||
33698912|NCT03633929|63252256|FG000|Overall Study|Lost to Follow-up|1|||
33698913|NCT03633929|63252256|FG000|Overall Study|Did not login to software. Did not participate|3|||
33698914|NCT03625687|63252260|FG000|Overall Study|Death|1|||
33698915|NCT02869633|63252283|FG000|Overall Study|Death|2|||
33698916|NCT02869633|63252284|FG001|Overall Study|Death|1|||
33698917|NCT02869633|63252283|FG000|Overall Study|Patient refused follow-up|1|||
33698918|NCT02869633|63252284|FG001|Overall Study|Patient refused follow-up|0|||
33698919|NCT02869633|63252283|FG000|Overall Study|Provider discretion|1|||
33698920|NCT02869633|63252284|FG001|Overall Study|Provider discretion|0|||
33698921|NCT02869633|63252283|FG000|Overall Study|Investigator decision|1|||
33698922|NCT02869633|63252284|FG001|Overall Study|Investigator decision|0|||
33698923|NCT02869633|63252283|FG000|Overall Study|Lost to Follow-up|0|||
33698924|NCT02869633|63252284|FG001|Overall Study|Lost to Follow-up|1|||
33698925|NCT02869633|63252283|FG000|Overall Study|Not eligible|6|||
33698926|NCT02869633|63252284|FG001|Overall Study|Not eligible|1|||
33698927|NCT02869633|63252283|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
33698928|NCT02869633|63252284|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
33698929|NCT02869633|63252283|FG000|Overall Study|Withdrawal by Subject|0|||
33698930|NCT02869633|63252284|FG001|Overall Study|Withdrawal by Subject|1|||
33698931|NCT02785952|63252294|FG000|Overall Study|Adverse Event|31|||
33493247|NCT03103152|62871481|FG003|Overall Study|Death|0|||
33698932|NCT02785952|63252295|FG001|Overall Study|Adverse Event|19|||
33698933|NCT02785952|63252294|FG000|Overall Study|Refusal unrelated to adverse events|10|||
33493248|NCT03103152|62871482|FG004|Overall Study|Death|0|||
33493249|NCT03103152|62871483|FG005|Overall Study|Death|0|||
33698934|NCT02785952|63252295|FG001|Overall Study|Refusal unrelated to adverse events|5|||
33698935|NCT02785952|63252294|FG000|Overall Study|Disease progression/relapse|61|||
33698936|NCT02785952|63252295|FG001|Overall Study|Disease progression/relapse|89|||
33698937|NCT02785952|63252294|FG000|Overall Study|Death|11|||
33698938|NCT02785952|63252295|FG001|Overall Study|Death|7|||
33698939|NCT02785952|63252294|FG000|Overall Study|Other- not protocol specified|6|||
33698940|NCT02785952|63252295|FG001|Overall Study|Other- not protocol specified|4|||
33698941|NCT02785952|63252294|FG000|Overall Study|On protocol treatment|6|||
33698942|NCT02785952|63252295|FG001|Overall Study|On protocol treatment|3|||
33698943|NCT02674685|63252303|FG000|Overall Study|Withdrawal by Subject|4|||
33698944|NCT02654236|63252310|FG000|Overall Study|Withdrawal by Subject|0|||
33698945|NCT02654236|63252311|FG001|Overall Study|Withdrawal by Subject|0|||
33698946|NCT02654236|63252312|FG002|Overall Study|Withdrawal by Subject|2|||
33698947|NCT02372136|63252322|FG000|Overall Study|Death|3|||
33698948|NCT02372136|63252323|FG001|Overall Study|Death|1|||
33698949|NCT02194829|63252333|FG000|Overall Study|Adverse Event|2|||
33698950|NCT02194829|63252334|FG001|Overall Study|Adverse Event|2|||
33698951|NCT02194829|63252333|FG000|Overall Study|Death|0|||
33698952|NCT02194829|63252334|FG001|Overall Study|Death|1|||
33698953|NCT02194829|63252333|FG000|Overall Study|Disease progression|0|||
33698954|NCT02194829|63252334|FG001|Overall Study|Disease progression|1|||
33698955|NCT02194829|63252333|FG000|Overall Study|Withdrawal by Subject|0|||
33698956|NCT02194829|63252334|FG001|Overall Study|Withdrawal by Subject|1|||
33698957|NCT02194829|63252333|FG000|Overall Study|Never started protocol therapy|0|||
33698958|NCT02194829|63252334|FG001|Overall Study|Never started protocol therapy|1|||
33698959|NCT02087046|63252341|FG000|Overall Study|Adverse Event|4|||
33698960|NCT02087046|63252341|FG000|Overall Study|Death|1|||
33698961|NCT02087046|63252341|FG000|Overall Study|Lost to Follow-up|3|||
33698962|NCT02087046|63252341|FG000|Overall Study|Withdrawal by Subject|2|||
33698963|NCT02087046|63252341|FG000|Overall Study|Physician Decision|1|||
33698964|NCT01390038|63252350|FG000|Overall Study|Death|1|||
33698965|NCT01390038|63252350|FG000|Overall Study|Lost to Follow-up|1|||
33698966|NCT01390038|63252350|FG000|Overall Study|Withdrawal by Subject|4|||
33698967|NCT01390038|63252350|FG000|Overall Study|Simpliciti System Removal|2|||
33698968|NCT00621192|63252368|FG000|Overall Study|Withdrawal by Subject|0|||
33698969|NCT00621192|63252369|FG001|Overall Study|Withdrawal by Subject|0|||
33698970|NCT00621192|63252370|FG002|Overall Study|Withdrawal by Subject|2|||
33698971|NCT00621192|63252371|FG003|Overall Study|Withdrawal by Subject|0|||
33698972|NCT00621192|63252368|FG000|Overall Study|Physician Decision|1|||
33698973|NCT00621192|63252369|FG001|Overall Study|Physician Decision|3|||
33698974|NCT00621192|63252370|FG002|Overall Study|Physician Decision|0|||
33698975|NCT00621192|63252371|FG003|Overall Study|Physician Decision|0|||
33698976|NCT00621192|63252368|FG000|Overall Study|Protocol Violation|1|||
33698977|NCT00621192|63252369|FG001|Overall Study|Protocol Violation|0|||
33698978|NCT00621192|63252370|FG002|Overall Study|Protocol Violation|0|||
33698979|NCT00621192|63252371|FG003|Overall Study|Protocol Violation|1|||
33698980|NCT00621192|63252368|FG000|Overall Study|Adverse Event|0|||
33698981|NCT00621192|63252369|FG001|Overall Study|Adverse Event|1|||
33698982|NCT00621192|63252370|FG002|Overall Study|Adverse Event|0|||
33698983|NCT00621192|63252371|FG003|Overall Study|Adverse Event|1|||
33698984|NCT00621192|63252368|FG000|Overall Study|Death|2|||
33698985|NCT00621192|63252369|FG001|Overall Study|Death|5|||
33698986|NCT00621192|63252370|FG002|Overall Study|Death|0|||
33698987|NCT00621192|63252371|FG003|Overall Study|Death|0|||
33698988|NCT00621192|63252368|FG000|Overall Study|Final Assessments not Completed|0|||
33698989|NCT00621192|63252369|FG001|Overall Study|Final Assessments not Completed|0|||
33698990|NCT00621192|63252370|FG002|Overall Study|Final Assessments not Completed|3|||
33698991|NCT00621192|63252371|FG003|Overall Study|Final Assessments not Completed|1|||
33698992|NCT00364286|63252381|FG000|Overall Study|Withdrawal by Subject|1|||
33698993|NCT00364286|63252381|FG000|Overall Study|Adverse Event|2|||
33698994|NCT00278200|63252387|FG000|Overall Study|Death|1|||
33698995|NCT00278200|63252388|FG001|Overall Study|Death|3|||
33698996|NCT00278200|63252387|FG000|Overall Study|Physician Decision|0|||
33698997|NCT00278200|63252388|FG001|Overall Study|Physician Decision|1|||
33698998|NCT00255346|63252399|FG000|Overall Study|Adverse Event|1|||
33698999|NCT00255346|63252400|FG001|Overall Study|Adverse Event|0|||
33699000|NCT00255346|63252401|FG002|Overall Study|Adverse Event|0|||
33699001|NCT00255346|63252402|FG003|Overall Study|Adverse Event|0|||
33699002|NCT00255346|63252403|FG004|Overall Study|Adverse Event|0|||
33699003|NCT02222922|63254553|FG000|Overall Study|Death|0|||
33699004|NCT02222922|63254554|FG001|Overall Study|Death|0|||
33699005|NCT02222922|63254555|FG002|Overall Study|Death|0|||
33699006|NCT02222922|63254556|FG003|Overall Study|Death|0|||
33699007|NCT02222922|63254557|FG004|Overall Study|Death|13|||
33699008|NCT02222922|63254558|FG005|Overall Study|Death|0|||
33493250|NCT03103152|62871478|FG000|Overall Study|Adverse Event|0|||
33699009|NCT02222922|63254559|FG006|Overall Study|Death|0|||
33699010|NCT02222922|63254560|FG007|Overall Study|Death|0|||
33699011|NCT02222922|63254561|FG008|Overall Study|Death|2|||
33699012|NCT02222922|63254553|FG000|Overall Study|Lost to Follow-up|0|||
33699013|NCT02222922|63254554|FG001|Overall Study|Lost to Follow-up|0|||
33699014|NCT02222922|63254555|FG002|Overall Study|Lost to Follow-up|1|||
33699015|NCT02222922|63254556|FG003|Overall Study|Lost to Follow-up|0|||
33699016|NCT02222922|63254557|FG004|Overall Study|Lost to Follow-up|9|||
33699017|NCT02222922|63254558|FG005|Overall Study|Lost to Follow-up|1|||
33699018|NCT02222922|63254559|FG006|Overall Study|Lost to Follow-up|0|||
33699019|NCT02222922|63254560|FG007|Overall Study|Lost to Follow-up|0|||
33699020|NCT02222922|63254561|FG008|Overall Study|Lost to Follow-up|0|||
33699021|NCT02222922|63254553|FG000|Overall Study|Other|0|||
33699022|NCT02222922|63254554|FG001|Overall Study|Other|0|||
33699023|NCT02222922|63254555|FG002|Overall Study|Other|0|||
33699024|NCT02222922|63254556|FG003|Overall Study|Other|2|||
33699025|NCT02222922|63254557|FG004|Overall Study|Other|10|||
33699026|NCT02222922|63254558|FG005|Overall Study|Other|2|||
33699027|NCT02222922|63254559|FG006|Overall Study|Other|2|||
33699028|NCT02222922|63254560|FG007|Overall Study|Other|4|||
33699029|NCT02222922|63254561|FG008|Overall Study|Other|1|||
33699030|NCT02222922|63254553|FG000|Overall Study|Participant refused further follow-up|1|||
33699031|NCT02222922|63254554|FG001|Overall Study|Participant refused further follow-up|0|||
33699032|NCT02222922|63254555|FG002|Overall Study|Participant refused further follow-up|0|||
33699033|NCT02222922|63254556|FG003|Overall Study|Participant refused further follow-up|1|||
33699034|NCT02222922|63254557|FG004|Overall Study|Participant refused further follow-up|6|||
33699035|NCT02222922|63254558|FG005|Overall Study|Participant refused further follow-up|0|||
33699036|NCT02222922|63254559|FG006|Overall Study|Participant refused further follow-up|0|||
33699037|NCT02222922|63254560|FG007|Overall Study|Participant refused further follow-up|0|||
33699038|NCT02222922|63254561|FG008|Overall Study|Participant refused further follow-up|3|||
33699039|NCT02161146|63254613|FG000|Overall Study|Adverse Event|1|||
33699040|NCT02161146|63254614|FG001|Overall Study|Adverse Event|1|||
33699041|NCT02161146|63254615|FG002|Overall Study|Adverse Event|0|||
33699042|NCT02161146|63254616|FG003|Overall Study|Adverse Event|1|||
33699043|NCT02161146|63254617|FG004|Overall Study|Adverse Event|0|||
33699044|NCT02161146|63254613|FG000|Overall Study|Lost to Follow-up|0|||
33699045|NCT02161146|63254614|FG001|Overall Study|Lost to Follow-up|1|||
33699046|NCT02161146|63254615|FG002|Overall Study|Lost to Follow-up|0|||
33699047|NCT02161146|63254616|FG003|Overall Study|Lost to Follow-up|0|||
33699048|NCT02161146|63254617|FG004|Overall Study|Lost to Follow-up|0|||
33699049|NCT02161146|63254613|FG000|Overall Study|Personal Reasons|0|||
33699050|NCT02161146|63254614|FG001|Overall Study|Personal Reasons|1|||
33699051|NCT02161146|63254615|FG002|Overall Study|Personal Reasons|0|||
33699052|NCT02161146|63254616|FG003|Overall Study|Personal Reasons|2|||
33699053|NCT02161146|63254617|FG004|Overall Study|Personal Reasons|1|||
33699054|NCT02161146|63254613|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33699055|NCT02161146|63254614|FG001|Overall Study|Other Miscellaneous Reasons|1|||
33699056|NCT02161146|63254615|FG002|Overall Study|Other Miscellaneous Reasons|0|||
33699057|NCT02161146|63254616|FG003|Overall Study|Other Miscellaneous Reasons|0|||
33699058|NCT02161146|63254617|FG004|Overall Study|Other Miscellaneous Reasons|0|||
33699059|NCT02222688|63254852|FG000|Overall Study|Withdrawal by Subject|0|||
33699060|NCT02222688|63254853|FG001|Overall Study|Withdrawal by Subject|0|||
33699061|NCT02222688|63254854|FG002|Overall Study|Withdrawal by Subject|0|||
33699062|NCT02222688|63254855|FG003|Overall Study|Withdrawal by Subject|2|||
33699063|NCT02222688|63254856|FG004|Overall Study|Withdrawal by Subject|1|||
33699064|NCT02222688|63254857|FG005|Overall Study|Withdrawal by Subject|0|||
33699065|NCT02222688|63254858|FG006|Overall Study|Withdrawal by Subject|1|||
33699066|NCT02222688|63254852|FG000|Overall Study|Disease progression|1|||
33699067|NCT02222688|63254853|FG001|Overall Study|Disease progression|0|||
33699068|NCT02222688|63254854|FG002|Overall Study|Disease progression|0|||
33699069|NCT02222688|63254855|FG003|Overall Study|Disease progression|0|||
33699070|NCT02222688|63254856|FG004|Overall Study|Disease progression|0|||
33699071|NCT02222688|63254857|FG005|Overall Study|Disease progression|0|||
33699072|NCT02222688|63254858|FG006|Overall Study|Disease progression|0|||
33699073|NCT02159352|63254910|FG000|Overall Study|Adverse Event|3|||
33699074|NCT02159352|63254911|FG001|Overall Study|Adverse Event|1|||
33699075|NCT02159352|63254910|FG000|Overall Study|Withdrawal by Subject|0|||
33699076|NCT02159352|63254911|FG001|Overall Study|Withdrawal by Subject|1|||
33699077|NCT02187744|63254948|FG000|Study|Participant refused further follow-up|1|||
33699078|NCT02187744|63254949|FG001|Study|Participant refused further follow-up|0|||
33699079|NCT02187744|63254948|FG000|Study|Other|2|||
33699080|NCT02187744|63254949|FG001|Study|Other|1|||
33699081|NCT02187744|63254948|FG000|Study|Lost to Follow-up|0|||
33699082|NCT02187744|63254949|FG001|Study|Lost to Follow-up|2|||
33699083|NCT02187744|63254948|FG000|Study|Related adverse event, not serious|0|||
33699084|NCT02187744|63254949|FG001|Study|Related adverse event, not serious|2|||
33699085|NCT02187744|63254948|FG000|Study|Death|1|||
33699086|NCT02187744|63254949|FG001|Study|Death|0|||
33699087|NCT02187744|63254948|FG000|Study|Related adverse event, serious non-fatal|0|||
33699088|NCT02187744|63254949|FG001|Study|Related adverse event, serious non-fatal|1|||
33699089|NCT02187744|63254948|FG000|Treatment|Death|1|||
33699090|NCT02187744|63254949|FG001|Treatment|Death|0|||
33699091|NCT02187744|63254948|FG000|Treatment|Related adverse event, serious non-fatal|0|||
33699092|NCT02187744|63254949|FG001|Treatment|Related adverse event, serious non-fatal|1|||
33699093|NCT02187744|63254948|FG000|Treatment|Related adverse event, not serious|0|||
33699094|NCT02187744|63254949|FG001|Treatment|Related adverse event, not serious|2|||
33699095|NCT02187744|63254948|FG000|Treatment|Lost to Follow-up|0|||
33699096|NCT02187744|63254949|FG001|Treatment|Lost to Follow-up|1|||
33699097|NCT02187744|63254948|FG000|Treatment|Other|2|||
33699098|NCT02187744|63254949|FG001|Treatment|Other|0|||
33699099|NCT02187744|63254948|FG000|Treatment|Participant refused continued treatment|1|||
33699100|NCT02187744|63254949|FG001|Treatment|Participant refused continued treatment|1|||
33699101|NCT02186652|63255111|FG000|Overall Study|Lost to Follow-up|2|||
33699102|NCT02186652|63255112|FG001|Overall Study|Lost to Follow-up|0|||
33699103|NCT02185794|63255148|FG000|Overall Study|Enrolled but Never Dosed|1|||
33699104|NCT02185794|63255149|FG001|Overall Study|Enrolled but Never Dosed|6|||
33699105|NCT02185794|63255150|FG002|Overall Study|Enrolled but Never Dosed|3|||
33699106|NCT02185794|63255151|FG003|Overall Study|Enrolled but Never Dosed|1|||
33699107|NCT02185794|63255152|FG004|Overall Study|Enrolled but Never Dosed|1|||
33699108|NCT02185794|63255153|FG005|Overall Study|Enrolled but Never Dosed|0|||
33699109|NCT02185794|63255148|FG000|Overall Study|Investigator's Discretion|1|||
33699110|NCT02185794|63255149|FG001|Overall Study|Investigator's Discretion|0|||
33699111|NCT02185794|63255150|FG002|Overall Study|Investigator's Discretion|1|||
33699112|NCT02185794|63255151|FG003|Overall Study|Investigator's Discretion|2|||
33699113|NCT02185794|63255152|FG004|Overall Study|Investigator's Discretion|2|||
33699114|NCT02185794|63255153|FG005|Overall Study|Investigator's Discretion|15|||
33699115|NCT02185794|63255148|FG000|Overall Study|Withdrew Consent|2|||
33699116|NCT02185794|63255149|FG001|Overall Study|Withdrew Consent|5|||
33699117|NCT02185794|63255150|FG002|Overall Study|Withdrew Consent|10|||
33699118|NCT02185794|63255151|FG003|Overall Study|Withdrew Consent|2|||
33699119|NCT02185794|63255152|FG004|Overall Study|Withdrew Consent|0|||
33699120|NCT02185794|63255153|FG005|Overall Study|Withdrew Consent|0|||
33699121|NCT02185794|63255148|FG000|Overall Study|Lost to Follow-up|1|||
33699122|NCT02185794|63255149|FG001|Overall Study|Lost to Follow-up|2|||
33699123|NCT02185794|63255150|FG002|Overall Study|Lost to Follow-up|2|||
33699124|NCT02185794|63255151|FG003|Overall Study|Lost to Follow-up|3|||
33699125|NCT02185794|63255152|FG004|Overall Study|Lost to Follow-up|0|||
33699126|NCT02185794|63255153|FG005|Overall Study|Lost to Follow-up|1|||
33699127|NCT02221674|63255184|FG000|Overall Study|Lost to Follow-up|1|||
33699128|NCT02221674|63255185|FG001|Overall Study|Lost to Follow-up|0|||
33699129|NCT02221674|63255186|FG002|Overall Study|Lost to Follow-up|0|||
33699130|NCT02221284|63255201|FG000|Overall Study|Case Report Forms Uncollected|56|||
33699131|NCT02221284|63255201|FG000|Overall Study|Protocol Deviation|5|||
33699132|NCT02187042|63255362|FG000|Overall Study|Death|1|||
33699133|NCT02187042|63255363|FG001|Overall Study|Death|1|||
33699134|NCT02187042|63255362|FG000|Overall Study|Toxicity|6|||
33699135|NCT02187042|63255363|FG001|Overall Study|Toxicity|5|||
33699136|NCT02187042|63255362|FG000|Overall Study|Participant choice|1|||
33699137|NCT02187042|63255363|FG001|Overall Study|Participant choice|0|||
33699138|NCT02187042|63255362|FG000|Overall Study|Doctor choice|1|||
33699139|NCT02187042|63255363|FG001|Overall Study|Doctor choice|0|||
33699140|NCT02187042|63255362|FG000|Overall Study|Progressive disease|4|||
33699141|NCT02187042|63255363|FG001|Overall Study|Progressive disease|8|||
33699142|NCT02220894|63255537|FG000|Overall Study|Adverse Event|118|||
33699143|NCT02220894|63255538|FG001|Overall Study|Adverse Event|70|||
33699144|NCT02220894|63255537|FG000|Overall Study|Death|252|||
33699145|NCT02220894|63255538|FG001|Overall Study|Death|368|||
33699146|NCT02220894|63255537|FG000|Overall Study|Lost to Follow-up|0|||
33699147|NCT02220894|63255538|FG001|Overall Study|Lost to Follow-up|2|||
33699148|NCT02220894|63255537|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33699149|NCT02220894|63255538|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33699150|NCT02220894|63255537|FG000|Overall Study|Withdrawal by Subject|2|||
33699151|NCT02220894|63255538|FG001|Overall Study|Withdrawal by Subject|13|||
33699152|NCT02220894|63255537|FG000|Overall Study|Ongoing in Study|265|||
33699153|NCT02220894|63255538|FG001|Overall Study|Ongoing in Study|183|||
33699154|NCT02219334|63255555|FG000|Overall Study|Withdrawal by Subject|1|||
33699155|NCT02219334|63255556|FG001|Overall Study|Withdrawal by Subject|0|||
33699156|NCT02219334|63255555|FG000|Overall Study|Protocol Violation|7|||
33699157|NCT02219334|63255556|FG001|Overall Study|Protocol Violation|3|||
33699158|NCT02159040|63255574|FG000|Overall Study|Death|1|||
33699159|NCT02218008|63255599|FG000|Stage 1 (S1)|Adverse Event|6|||
33699160|NCT02218008|63255600|FG001|Stage 1 (S1)|Adverse Event|5|||
33699161|NCT02218008|63255601|FG002|Stage 1 (S1)|Adverse Event|11|||
33699162|NCT02218008|63255602|FG003|Stage 1 (S1)|Adverse Event|0|||
33699163|NCT02218008|63255603|FG004|Stage 1 (S1)|Adverse Event|0|||
33699164|NCT02218008|63255604|FG005|Stage 1 (S1)|Adverse Event|0|||
33699165|NCT02218008|63255599|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
33699166|NCT02218008|63255600|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
33699167|NCT02218008|63255601|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
33699168|NCT02218008|63255602|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
33699169|NCT02218008|63255603|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
33699170|NCT02218008|63255604|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
33699171|NCT02218008|63255599|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
33699172|NCT02218008|63255600|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
33699173|NCT02218008|63255601|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
33699174|NCT02218008|63255602|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
33699175|NCT02218008|63255603|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
33699176|NCT02218008|63255604|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
33699177|NCT02218008|63255599|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
33699178|NCT02218008|63255600|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
33699179|NCT02218008|63255601|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
33699180|NCT02218008|63255602|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
33699181|NCT02218008|63255603|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
33699182|NCT02218008|63255604|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
33699183|NCT02218008|63255599|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
33699184|NCT02218008|63255600|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
33699185|NCT02218008|63255601|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
33699186|NCT02218008|63255602|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
33699187|NCT02218008|63255603|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
33699188|NCT02218008|63255604|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
33699189|NCT02218008|63255599|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
33699190|NCT02218008|63255600|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
33699191|NCT02218008|63255601|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
33699192|NCT02218008|63255602|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
33699193|NCT02218008|63255603|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
33699194|NCT02218008|63255604|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
33699195|NCT02218008|63255599|FG000|Stage 1 (S1)|Pregnancy|0|||
33699196|NCT02218008|63255600|FG001|Stage 1 (S1)|Pregnancy|0|||
33699197|NCT02218008|63255601|FG002|Stage 1 (S1)|Pregnancy|1|||
33699198|NCT02218008|63255602|FG003|Stage 1 (S1)|Pregnancy|0|||
33699199|NCT02218008|63255603|FG004|Stage 1 (S1)|Pregnancy|0|||
33699200|NCT02218008|63255604|FG005|Stage 1 (S1)|Pregnancy|0|||
33699201|NCT02218008|63255599|FG000|Stage 1 (S1)|Protocol Violation|0|||
33699202|NCT02218008|63255600|FG001|Stage 1 (S1)|Protocol Violation|0|||
33699203|NCT02218008|63255601|FG002|Stage 1 (S1)|Protocol Violation|1|||
33699204|NCT02218008|63255602|FG003|Stage 1 (S1)|Protocol Violation|0|||
33699205|NCT02218008|63255603|FG004|Stage 1 (S1)|Protocol Violation|0|||
33699206|NCT02218008|63255604|FG005|Stage 1 (S1)|Protocol Violation|0|||
33699207|NCT02218008|63255599|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
33699208|NCT02218008|63255600|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
33699209|NCT02218008|63255601|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
33699210|NCT02218008|63255602|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
33699211|NCT02218008|63255603|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
33699212|NCT02218008|63255604|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
33699213|NCT02218008|63255599|FG000|Stage 2 (S2)|Adverse Event|0|||
33699214|NCT02218008|63255600|FG001|Stage 2 (S2)|Adverse Event|0|||
33699215|NCT02218008|63255601|FG002|Stage 2 (S2)|Adverse Event|0|||
33699216|NCT02218008|63255602|FG003|Stage 2 (S2)|Adverse Event|2|||
33699217|NCT02218008|63255603|FG004|Stage 2 (S2)|Adverse Event|3|||
33699218|NCT02218008|63255604|FG005|Stage 2 (S2)|Adverse Event|3|||
33699219|NCT02218008|63255599|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
33699220|NCT02218008|63255600|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
33699221|NCT02218008|63255601|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
33699222|NCT02218008|63255602|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
33699223|NCT02218008|63255603|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
33699224|NCT02218008|63255604|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
33699225|NCT02218008|63255599|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
33699226|NCT02218008|63255600|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
33699227|NCT02218008|63255601|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
33699228|NCT02218008|63255602|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
33699229|NCT02218008|63255603|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
33699230|NCT02218008|63255604|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
33699231|NCT02218008|63255599|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
33699232|NCT02218008|63255600|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
33699233|NCT02218008|63255601|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
33699234|NCT02218008|63255602|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
33699235|NCT02218008|63255603|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
33699236|NCT02218008|63255604|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
33699237|NCT02218008|63255599|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
33699238|NCT02218008|63255600|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
33699239|NCT02218008|63255601|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
33699240|NCT02218008|63255602|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
33699241|NCT02218008|63255603|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
33699242|NCT02218008|63255604|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
33699243|NCT01632150|63255701|FG000|Overall Study|Disease progression|27|||
33699244|NCT01632150|63255701|FG000|Overall Study|Study drug toxicity|1|||
33699245|NCT01632150|63255701|FG000|Overall Study|Unrelated adverse event|7|||
33699246|NCT01632150|63255701|FG000|Overall Study|Withdrawal by Subject|2|||
33699247|NCT01632150|63255701|FG000|Overall Study|Patient underwent autologous transplant|1|||
33699248|NCT01632150|63255701|FG000|Overall Study|Moved to compassionate program|2|||
33699249|NCT02185014|63255726|FG000|Overall Study|Adverse Event|18|||
33699250|NCT02185014|63255726|FG000|Overall Study|Withdrew Consent|8|||
33493251|NCT03103152|62871479|FG001|Overall Study|Adverse Event|0|||
33699251|NCT02185014|63255726|FG000|Overall Study|Lost to Follow-up|4|||
33699252|NCT02185014|63255726|FG000|Overall Study|Lack of Efficacy|14|||
33699253|NCT02185014|63255726|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
33699254|NCT02185014|63255726|FG000|Overall Study|Subject Noncompliance|1|||
33699255|NCT02185014|63255726|FG000|Overall Study|Other|4|||
33699256|NCT02184156|63255776|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
33699257|NCT02184156|63255777|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
33699258|NCT02184156|63255776|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
33699259|NCT02184156|63255777|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
33699260|NCT02158884|63255800|FG000|Baseline Assessment|Missed performance assessment|3|||
33699261|NCT02158884|63255800|FG000|Baseline Assessment|Missed SMFA|1|||
33699262|NCT02158884|63255800|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
33699263|NCT02158884|63255800|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
33699264|NCT02158884|63255800|FG000|6 Month Assessment|Missed SMFA|20|||
33699265|NCT02158884|63255800|FG000|12 Month Assessment|Missed SMFA|17|||
33699266|NCT02158806|63255843|FG000|Overall Study|Death|2|||
33699267|NCT02158806|63255844|FG001|Overall Study|Death|0|||
33699268|NCT02158806|63255843|FG000|Overall Study|Withdrawal by Subject|2|||
33699269|NCT02158806|63255844|FG001|Overall Study|Withdrawal by Subject|0|||
33699270|NCT02158806|63255843|FG000|Overall Study|Lost to Follow-up|0|||
33699271|NCT02158806|63255844|FG001|Overall Study|Lost to Follow-up|3|||
33699272|NCT02158806|63255843|FG000|Overall Study|Moved out of area|0|||
33699273|NCT02158806|63255844|FG001|Overall Study|Moved out of area|1|||
33699274|NCT02158806|63255843|FG000|Overall Study|Transferred to palliative care|0|||
33699275|NCT02158806|63255844|FG001|Overall Study|Transferred to palliative care|1|||
33699276|NCT02158728|63255875|FG000|Overall Study|no procedure according to CIP done|3|||
33699277|NCT02158728|63255875|FG000|Overall Study|no qualified dataset|24|||
33699278|NCT02157948|63255920|FG000|Overall Study|Withdrawal by Subject|4|||
33699279|NCT02157948|63255921|FG001|Overall Study|Withdrawal by Subject|5|||
33699280|NCT02157948|63255920|FG000|Overall Study|Lost to Follow-up|3|||
33699281|NCT02157948|63255921|FG001|Overall Study|Lost to Follow-up|2|||
33699282|NCT02157948|63255920|FG000|Overall Study|Protocol Specified Criteria|2|||
33699283|NCT02157948|63255921|FG001|Overall Study|Protocol Specified Criteria|1|||
33699284|NCT02157948|63255920|FG000|Overall Study|Decision by Sponsor|0|||
33699285|NCT02157948|63255921|FG001|Overall Study|Decision by Sponsor|1|||
33699286|NCT02182830|63255962|FG000|Overall Study|Not Treated|1|||
33699287|NCT02182830|63255963|FG001|Overall Study|Not Treated|1|||
33699288|NCT02182830|63255962|FG000|Overall Study|Trial stopped, reason missing|3|||
33699289|NCT02182830|63255963|FG001|Overall Study|Trial stopped, reason missing|3|||
33699290|NCT02182830|63255962|FG000|Overall Study|Consent withdrawn|8|||
33699291|NCT02182830|63255963|FG001|Overall Study|Consent withdrawn|8|||
33699292|NCT02182830|63255962|FG000|Overall Study|Lost to Follow-up|3|||
33699293|NCT02182830|63255963|FG001|Overall Study|Lost to Follow-up|3|||
33699294|NCT02182440|63256537|FG000|Overall Study|Adverse Event|0|||
33699295|NCT02182440|63256538|FG001|Overall Study|Adverse Event|1|||
33699296|NCT02182440|63256539|FG002|Overall Study|Adverse Event|0|||
33699297|NCT02182440|63256540|FG003|Overall Study|Adverse Event|0|||
33699298|NCT02182440|63256537|FG000|Overall Study|Death|31|||
33699299|NCT02182440|63256538|FG001|Overall Study|Death|8|||
33699300|NCT02182440|63256539|FG002|Overall Study|Death|5|||
33699301|NCT02182440|63256540|FG003|Overall Study|Death|16|||
33699302|NCT02182440|63256537|FG000|Overall Study|Protocol Violation|0|||
33699303|NCT02182440|63256538|FG001|Overall Study|Protocol Violation|1|||
33699304|NCT02182440|63256539|FG002|Overall Study|Protocol Violation|0|||
33699305|NCT02182440|63256540|FG003|Overall Study|Protocol Violation|0|||
33699306|NCT02182440|63256537|FG000|Overall Study|Physician Decision|1|||
33699307|NCT02182440|63256538|FG001|Overall Study|Physician Decision|0|||
33699308|NCT02182440|63256539|FG002|Overall Study|Physician Decision|0|||
33699309|NCT02182440|63256540|FG003|Overall Study|Physician Decision|0|||
33699310|NCT02182440|63256537|FG000|Overall Study|Withdrawal by Subject|1|||
33699311|NCT02182440|63256538|FG001|Overall Study|Withdrawal by Subject|1|||
33699312|NCT02182440|63256539|FG002|Overall Study|Withdrawal by Subject|3|||
33699313|NCT02182440|63256540|FG003|Overall Study|Withdrawal by Subject|4|||
33699314|NCT02182440|63256537|FG000|Overall Study|different, e.g adm other hospital|12|||
33699315|NCT02182440|63256538|FG001|Overall Study|different, e.g adm other hospital|3|||
33699316|NCT02182440|63256539|FG002|Overall Study|different, e.g adm other hospital|3|||
33699317|NCT02182440|63256540|FG003|Overall Study|different, e.g adm other hospital|10|||
33699318|NCT02181816|63256582|FG000|Overall Study|Case Report Forms Uncollected|38|||
33699319|NCT02181816|63256582|FG000|Overall Study|Protocol Deviation|21|||
33699320|NCT02156466|63256738|FG000|Overall Study|Adverse Event|0|||
33699321|NCT02156466|63256739|FG001|Overall Study|Adverse Event|0|||
33699322|NCT02156466|63256740|FG002|Overall Study|Adverse Event|1|||
33699323|NCT02156466|63256741|FG003|Overall Study|Adverse Event|1|||
33699324|NCT02156466|63256742|FG004|Overall Study|Adverse Event|0|||
33699325|NCT02156466|63256738|FG000|Overall Study|Quantiferon Positivity|0|||
33699326|NCT02156466|63256739|FG001|Overall Study|Quantiferon Positivity|0|||
33699327|NCT02156466|63256740|FG002|Overall Study|Quantiferon Positivity|0|||
33699328|NCT02156466|63256741|FG003|Overall Study|Quantiferon Positivity|1|||
33699329|NCT02156466|63256742|FG004|Overall Study|Quantiferon Positivity|0|||
33699330|NCT02216526|63256781|FG000|Overall Study|Adverse Event|1|||
33699331|NCT02216526|63256782|FG001|Overall Study|Adverse Event|1|||
33699332|NCT02216526|63256783|FG002|Overall Study|Adverse Event|0|||
33699333|NCT02216526|63256781|FG000|Overall Study|Death|0|||
33699334|NCT02216526|63256782|FG001|Overall Study|Death|1|||
33699335|NCT02216526|63256783|FG002|Overall Study|Death|3|||
33699336|NCT02216526|63256781|FG000|Overall Study|Protocol Violation|2|||
33699337|NCT02216526|63256782|FG001|Overall Study|Protocol Violation|0|||
33699338|NCT02216526|63256783|FG002|Overall Study|Protocol Violation|2|||
33699339|NCT02216526|63256781|FG000|Overall Study|Hospitalization|2|||
33699340|NCT02216526|63256782|FG001|Overall Study|Hospitalization|1|||
33699341|NCT02216526|63256783|FG002|Overall Study|Hospitalization|3|||
33699342|NCT02216214|63256823|FG000|Overall Study|Randomized Never Received Study Drug|1|||
33699343|NCT02216214|63256824|FG001|Overall Study|Randomized Never Received Study Drug|0|||
33699344|NCT02216214|63256823|FG000|Overall Study|Adverse Event|10|||
33699345|NCT02216214|63256824|FG001|Overall Study|Adverse Event|8|||
33699346|NCT02216214|63256823|FG000|Overall Study|Lack of Efficacy|2|||
33699347|NCT02216214|63256824|FG001|Overall Study|Lack of Efficacy|2|||
33699348|NCT02216214|63256823|FG000|Overall Study|Lost to Follow-up|3|||
33699349|NCT02216214|63256824|FG001|Overall Study|Lost to Follow-up|2|||
33699350|NCT02216214|63256823|FG000|Overall Study|Protocol Violation|4|||
33699351|NCT02216214|63256824|FG001|Overall Study|Protocol Violation|2|||
33699352|NCT02216214|63256823|FG000|Overall Study|Withdrawal by Subject|22|||
33699353|NCT02216214|63256824|FG001|Overall Study|Withdrawal by Subject|20|||
33699354|NCT02216214|63256823|FG000|Overall Study|Study Terminated By Sponsor|0|||
33699355|NCT02216214|63256824|FG001|Overall Study|Study Terminated By Sponsor|1|||
33699356|NCT02216214|63256823|FG000|Overall Study|Miscellaneous|1|||
33699357|NCT02216214|63256824|FG001|Overall Study|Miscellaneous|1|||
33699358|NCT02214186|63256855|FG000|Overall Study|Lost to Follow-up|1|||
33699359|NCT02214186|63256856|FG001|Overall Study|Lost to Follow-up|1|||
33699360|NCT02214186|63256855|FG000|Overall Study|Protocol Violation|1|||
33699361|NCT02214186|63256856|FG001|Overall Study|Protocol Violation|1|||
33699362|NCT02181504|63256912|FG000|Overall Study|Adverse Event|1|||
33699363|NCT02181504|63256913|FG001|Overall Study|Adverse Event|1|||
33699364|NCT02181504|63256914|FG002|Overall Study|Adverse Event|1|||
33699365|NCT02179398|63256944|FG000|Overall Study|Lack of obligatory data|3|||
33699366|NCT02179398|63256945|FG001|Overall Study|Lack of obligatory data|3|||
33699367|NCT02179398|63256944|FG000|Overall Study|Lost to Follow-up|0|||
33699368|NCT02179398|63256945|FG001|Overall Study|Lost to Follow-up|1|||
33699369|NCT02156076|63256959|FG000|Treatment Period|no longer meets study criteria|0|||
33699370|NCT02156076|63256960|FG001|Treatment Period|no longer meets study criteria|0|||
33699371|NCT02156076|63256961|FG002|Treatment Period|no longer meets study criteria|1|||
33699372|NCT02156076|63256962|FG003|Treatment Period|no longer meets study criteria|0|||
33699373|NCT02156076|63256959|FG000|Treatment Period|Poor/non-compliance|0|||
33699374|NCT02156076|63256960|FG001|Treatment Period|Poor/non-compliance|1|||
33699375|NCT02156076|63256961|FG002|Treatment Period|Poor/non-compliance|0|||
33699376|NCT02156076|63256962|FG003|Treatment Period|Poor/non-compliance|0|||
33699377|NCT02156076|63256959|FG000|Treatment Period|Lost to Follow-up|0|||
33699378|NCT02156076|63256960|FG001|Treatment Period|Lost to Follow-up|0|||
33699379|NCT02156076|63256961|FG002|Treatment Period|Lost to Follow-up|0|||
33699380|NCT02156076|63256962|FG003|Treatment Period|Lost to Follow-up|1|||
33699381|NCT02156076|63256959|FG000|Treatment Period|Withdrawal by Subject|0|||
33699382|NCT02156076|63256960|FG001|Treatment Period|Withdrawal by Subject|0|||
33699383|NCT02156076|63256961|FG002|Treatment Period|Withdrawal by Subject|1|||
33699384|NCT02156076|63256962|FG003|Treatment Period|Withdrawal by Subject|0|||
33699385|NCT02156076|63256959|FG000|Treatment Period|Subject request to discontinue treatment|0|||
33699386|NCT02156076|63256960|FG001|Treatment Period|Subject request to discontinue treatment|1|||
33699387|NCT02156076|63256961|FG002|Treatment Period|Subject request to discontinue treatment|0|||
33699388|NCT02156076|63256962|FG003|Treatment Period|Subject request to discontinue treatment|0|||
33699389|NCT02156076|63256959|FG000|Treatment Period|Adverse Event|0|||
33699390|NCT02156076|63256960|FG001|Treatment Period|Adverse Event|0|||
33699391|NCT02156076|63256961|FG002|Treatment Period|Adverse Event|0|||
33699392|NCT02156076|63256962|FG003|Treatment Period|Adverse Event|1|||
33699393|NCT02156076|63256959|FG000|Follow-up Period|Withdrawal by Subject|1|||
33699394|NCT02156076|63256960|FG001|Follow-up Period|Withdrawal by Subject|0|||
33699395|NCT02156076|63256961|FG002|Follow-up Period|Withdrawal by Subject|0|||
33699396|NCT02156076|63256962|FG003|Follow-up Period|Withdrawal by Subject|0|||
33699397|NCT02213094|63256974|FG000|Overall Study|Adverse Event|1|||
33699398|NCT02213094|63256975|FG001|Overall Study|Adverse Event|0|||
33699399|NCT02155608|63256983|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
33699400|NCT02155608|63256984|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
33699401|NCT02155608|63256983|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
33699402|NCT02155608|63256984|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
33699403|NCT01629966|63256999|FG000|Overall Study|Pregnancy|0|||
33699404|NCT01629966|63257000|FG001|Overall Study|Pregnancy|1|||
33699405|NCT01629966|63257001|FG002|Overall Study|Pregnancy|0|||
33699406|NCT01629966|63256999|FG000|Overall Study|Lost to Follow-up|10|||
33699407|NCT01629966|63257000|FG001|Overall Study|Lost to Follow-up|13|||
33699408|NCT01629966|63257001|FG002|Overall Study|Lost to Follow-up|9|||
33699409|NCT01629966|63256999|FG000|Overall Study|Withdrawal by Subject|8|||
33699410|NCT01629966|63257000|FG001|Overall Study|Withdrawal by Subject|9|||
33699411|NCT01629966|63257001|FG002|Overall Study|Withdrawal by Subject|16|||
33699412|NCT01629966|63256999|FG000|Overall Study|Protocol Violation|7|||
33699413|NCT01629966|63257000|FG001|Overall Study|Protocol Violation|9|||
33699414|NCT01629966|63257001|FG002|Overall Study|Protocol Violation|7|||
33699415|NCT01629966|63256999|FG000|Overall Study|Lack of Efficacy|5|||
33699416|NCT01629966|63257000|FG001|Overall Study|Lack of Efficacy|2|||
33699417|NCT01629966|63257001|FG002|Overall Study|Lack of Efficacy|4|||
33699418|NCT01629966|63256999|FG000|Overall Study|Adverse Event|11|||
33699419|NCT01629966|63257000|FG001|Overall Study|Adverse Event|18|||
33699420|NCT01629966|63257001|FG002|Overall Study|Adverse Event|30|||
33699421|NCT02177838|63257041|FG000|Overall Study|Withdrawal by Subject|1|||
33699422|NCT02177838|63257041|FG000|Overall Study|Physician Decision|1|||
33699423|NCT02177838|63257041|FG000|Overall Study|Death|1|||
33699424|NCT02177136|63257138|FG000|DB Phase|Withdrawal by Subject|2|||
33699425|NCT02177136|63257139|FG001|DB Phase|Withdrawal by Subject|0|||
33699426|NCT02177136|63257140|FG002|DB Phase|Withdrawal by Subject|0|||
33699427|NCT02177136|63257141|FG003|DB Phase|Withdrawal by Subject|0|||
33699428|NCT02177136|63257138|FG000|DB Phase|Discontinued Due to Pruritus|1|||
33699429|NCT02177136|63257139|FG001|DB Phase|Discontinued Due to Pruritus|3|||
33699430|NCT02177136|63257140|FG002|DB Phase|Discontinued Due to Pruritus|0|||
33699431|NCT02177136|63257141|FG003|DB Phase|Discontinued Due to Pruritus|0|||
33699432|NCT02177136|63257138|FG000|DB Phase|Adverse Event|3|||
33699433|NCT02177136|63257139|FG001|DB Phase|Adverse Event|2|||
33699434|NCT02177136|63257140|FG002|DB Phase|Adverse Event|3|||
33699435|NCT02177136|63257141|FG003|DB Phase|Adverse Event|0|||
33699436|NCT02177136|63257138|FG000|DB Phase|Protocol Violation|0|||
33699437|NCT02177136|63257139|FG001|DB Phase|Protocol Violation|0|||
33699438|NCT02177136|63257140|FG002|DB Phase|Protocol Violation|1|||
33699439|NCT02177136|63257141|FG003|DB Phase|Protocol Violation|0|||
33699440|NCT02177136|63257138|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
33699441|NCT02177136|63257139|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
33699442|NCT02177136|63257140|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
33699443|NCT02177136|63257141|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
33699444|NCT02177136|63257138|FG000|LTSE Phase|Withdrawal by Subject|0|||
33699445|NCT02177136|63257139|FG001|LTSE Phase|Withdrawal by Subject|0|||
33699446|NCT02177136|63257140|FG002|LTSE Phase|Withdrawal by Subject|0|||
33699447|NCT02177136|63257141|FG003|LTSE Phase|Withdrawal by Subject|6|||
33699448|NCT02177136|63257138|FG000|LTSE Phase|Adverse Event|0|||
33699449|NCT02177136|63257139|FG001|LTSE Phase|Adverse Event|0|||
33699450|NCT02177136|63257140|FG002|LTSE Phase|Adverse Event|0|||
33699451|NCT02177136|63257141|FG003|LTSE Phase|Adverse Event|10|||
33699452|NCT02177136|63257138|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
33699453|NCT02177136|63257139|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
33699454|NCT02177136|63257140|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
33699455|NCT02177136|63257141|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
33699456|NCT02177136|63257138|FG000|LTSE Phase|Physician Decision|0|||
33699457|NCT02177136|63257139|FG001|LTSE Phase|Physician Decision|0|||
33699458|NCT02177136|63257140|FG002|LTSE Phase|Physician Decision|0|||
33699459|NCT02177136|63257141|FG003|LTSE Phase|Physician Decision|2|||
33699460|NCT02177136|63257138|FG000|LTSE Phase|Lost to Follow-up|0|||
33699461|NCT02177136|63257139|FG001|LTSE Phase|Lost to Follow-up|0|||
33699462|NCT02177136|63257140|FG002|LTSE Phase|Lost to Follow-up|0|||
33699463|NCT02177136|63257141|FG003|LTSE Phase|Lost to Follow-up|1|||
33699464|NCT02177136|63257138|FG000|LTSE Phase|Participant Moved|0|||
33699465|NCT02177136|63257139|FG001|LTSE Phase|Participant Moved|0|||
33699466|NCT02177136|63257140|FG002|LTSE Phase|Participant Moved|0|||
33699467|NCT02177136|63257141|FG003|LTSE Phase|Participant Moved|1|||
33699468|NCT02176356|63257169|FG000|Overall Study|Screen Failure|14|||
33699469|NCT02176356|63257169|FG000|Overall Study|Lost to Follow-up|4|||
33699470|NCT02176356|63257169|FG000|Overall Study|Personal Reasons|3|||
33699471|NCT02176356|63257169|FG000|Overall Study|Other Miscellaneous Reasons|2|||
33699472|NCT02210208|63257179|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
33699473|NCT02210208|63257179|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
33699474|NCT02210208|63257179|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
33699475|NCT02209506|63257199|FG000|Overall Study|Withdrawal by Subject|0|||
33699476|NCT02209506|63257200|FG001|Overall Study|Withdrawal by Subject|0|||
33699477|NCT02209506|63257201|FG002|Overall Study|Withdrawal by Subject|0|||
33699478|NCT02209506|63257202|FG003|Overall Study|Withdrawal by Subject|0|||
33699479|NCT02209506|63257203|FG004|Overall Study|Withdrawal by Subject|1|||
33699480|NCT02153736|63257220|FG000|Overall Study|Lost to Follow-up|1|||
33699481|NCT02153736|63257221|FG001|Overall Study|Lost to Follow-up|0|||
33699482|NCT02153736|63257220|FG000|Overall Study|Medical status change made ineligible|1|||
33699483|NCT02153736|63257221|FG001|Overall Study|Medical status change made ineligible|0|||
33699484|NCT02153736|63257220|FG000|Overall Study|Death|0|||
33699485|NCT02153736|63257221|FG001|Overall Study|Death|1|||
33699486|NCT02153736|63257220|FG000|Overall Study|Withdrawal by Subject|0|||
33699487|NCT02153736|63257221|FG001|Overall Study|Withdrawal by Subject|1|||
33699488|NCT02175966|63257229|FG000|Follow-up Period|Lack of Efficacy|10|||
33699489|NCT02175966|63257230|FG001|Follow-up Period|Lack of Efficacy|6|||
33699490|NCT02153346|63257236|FG000|Overall Study|Lost to Follow-up|11|||
33699491|NCT02174562|63257243|FG000|Overall Study|Withdrawal by Subject|7|||
33699492|NCT02174562|63257244|FG001|Overall Study|Withdrawal by Subject|2|||
33699493|NCT02174562|63257243|FG000|Overall Study|Death|2|||
33699494|NCT02174562|63257244|FG001|Overall Study|Death|0|||
33699495|NCT02174562|63257243|FG000|Overall Study|Lost to Follow-up|0|||
33699496|NCT02174562|63257244|FG001|Overall Study|Lost to Follow-up|3|||
33699497|NCT02136576|63257253|FG000|Overall Study|Lost to Follow-up|2|||
33699498|NCT02136576|63257254|FG001|Overall Study|Lost to Follow-up|0|||
33699499|NCT02136576|63257255|FG002|Overall Study|Lost to Follow-up|0|||
33699500|NCT02153112|63257512|FG000|Overall Study|Adverse Event|0|||
33699501|NCT02153112|63257513|FG001|Overall Study|Adverse Event|0|||
33699502|NCT02153112|63257514|FG002|Overall Study|Adverse Event|1|||
33699503|NCT02153112|63257515|FG003|Overall Study|Adverse Event|0|||
33699504|NCT02153112|63257516|FG004|Overall Study|Adverse Event|0|||
33699505|NCT02153112|63257517|FG005|Overall Study|Adverse Event|0|||
33699506|NCT02153112|63257518|FG006|Overall Study|Adverse Event|0|||
33699507|NCT02153112|63257519|FG007|Overall Study|Adverse Event|0|||
33699508|NCT02153112|63257520|FG008|Overall Study|Adverse Event|0|||
33699509|NCT02153112|63257521|FG009|Overall Study|Adverse Event|0|||
33699510|NCT02153112|63257512|FG000|Overall Study|Lost to Follow-up|1|||
33699511|NCT02153112|63257513|FG001|Overall Study|Lost to Follow-up|1|||
33699512|NCT02153112|63257514|FG002|Overall Study|Lost to Follow-up|0|||
33699513|NCT02153112|63257515|FG003|Overall Study|Lost to Follow-up|0|||
33699514|NCT02153112|63257516|FG004|Overall Study|Lost to Follow-up|2|||
33699515|NCT02153112|63257517|FG005|Overall Study|Lost to Follow-up|1|||
33699516|NCT02153112|63257518|FG006|Overall Study|Lost to Follow-up|1|||
33699517|NCT02153112|63257519|FG007|Overall Study|Lost to Follow-up|0|||
33699518|NCT02153112|63257520|FG008|Overall Study|Lost to Follow-up|1|||
33699519|NCT02153112|63257521|FG009|Overall Study|Lost to Follow-up|1|||
33699520|NCT02153112|63257512|FG000|Overall Study|Withdrawal by Subject|3|||
33699521|NCT02153112|63257513|FG001|Overall Study|Withdrawal by Subject|1|||
33699522|NCT02153112|63257514|FG002|Overall Study|Withdrawal by Subject|2|||
33699523|NCT02153112|63257515|FG003|Overall Study|Withdrawal by Subject|2|||
33699524|NCT02153112|63257516|FG004|Overall Study|Withdrawal by Subject|1|||
33699525|NCT02153112|63257517|FG005|Overall Study|Withdrawal by Subject|1|||
33699526|NCT02153112|63257518|FG006|Overall Study|Withdrawal by Subject|7|||
33699527|NCT02153112|63257519|FG007|Overall Study|Withdrawal by Subject|2|||
33699528|NCT02153112|63257520|FG008|Overall Study|Withdrawal by Subject|13|||
33699529|NCT02153112|63257521|FG009|Overall Study|Withdrawal by Subject|12|||
33699530|NCT02153112|63257512|FG000|Overall Study|Reason not Specified|0|||
33699531|NCT02153112|63257513|FG001|Overall Study|Reason not Specified|0|||
33699532|NCT02153112|63257514|FG002|Overall Study|Reason not Specified|0|||
33699533|NCT02153112|63257515|FG003|Overall Study|Reason not Specified|0|||
33699534|NCT02153112|63257516|FG004|Overall Study|Reason not Specified|0|||
33699535|NCT02153112|63257517|FG005|Overall Study|Reason not Specified|0|||
33699536|NCT02153112|63257518|FG006|Overall Study|Reason not Specified|0|||
33699537|NCT02153112|63257519|FG007|Overall Study|Reason not Specified|0|||
33699538|NCT02153112|63257520|FG008|Overall Study|Reason not Specified|1|||
33699539|NCT02153112|63257521|FG009|Overall Study|Reason not Specified|1|||
33699540|NCT02133924|63257571|FG000|Overall Study|Death|38|||
33699541|NCT02133924|63257571|FG000|Overall Study|Physician Decision|1|||
33699542|NCT02133924|63257571|FG000|Overall Study|Withdrawal by Subject|3|||
33699543|NCT02173704|63257662|FG000|Overall Study|Adverse Event|1|||
33699544|NCT02173704|63257663|FG001|Overall Study|Adverse Event|0|||
33699545|NCT02173704|63257662|FG000|Overall Study|Lost to Follow-up|1|||
33699546|NCT02173704|63257663|FG001|Overall Study|Lost to Follow-up|0|||
33699547|NCT02173704|63257662|FG000|Overall Study|Other|1|||
33699548|NCT02173704|63257663|FG001|Overall Study|Other|0|||
33699549|NCT02173704|63257662|FG000|Overall Study|Protocol Violation|1|||
33699550|NCT02173704|63257663|FG001|Overall Study|Protocol Violation|0|||
33699551|NCT02173704|63257662|FG000|Overall Study|Withdrawal by Subject|9|||
33699552|NCT02173704|63257663|FG001|Overall Study|Withdrawal by Subject|4|||
33699553|NCT02173548|63257684|FG000|Overall Study|Lost to Follow-up|0|||
33699554|NCT02173548|63257685|FG001|Overall Study|Lost to Follow-up|2|||
33699555|NCT02173548|63257684|FG000|Overall Study|Withdrawal by Subject|1|||
33699556|NCT02173548|63257685|FG001|Overall Study|Withdrawal by Subject|0|||
33699557|NCT02173158|63257701|FG000|Efficacy Phase|Adverse Event|1|||
33699558|NCT02152566|63257723|FG000|Overall Study|Lost to Follow-up|1|||
33699559|NCT02152566|63257723|FG000|Overall Study|Withdrawal by Subject|2|||
33699560|NCT02171130|63257752|FG000|Overall Study|Death|1|||
33699561|NCT02171130|63257752|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
33699562|NCT02171130|63257752|FG000|Overall Study|Discontinued; Site Termination|5|||
33699563|NCT02171130|63257752|FG000|Overall Study|Withdrawal by Subject|3|||
33699564|NCT02171130|63257752|FG000|Overall Study|Physician Decision|1|||
33699565|NCT02171130|63257752|FG000|Overall Study|Lost to Follow-up|1|||
33699566|NCT02171130|63257752|FG000|Overall Study|Met Exclusion Criteria|1|||
33699567|NCT03603314|63263624|FG000|Overall Study|Lost to Follow-up|0|||
33699568|NCT03603314|63263625|FG001|Overall Study|Lost to Follow-up|3|||
33699569|NCT03603314|63263626|FG002|Overall Study|Lost to Follow-up|0|||
33699570|NCT03603314|63263624|FG000|Overall Study|Protocol Violation|0|||
33699571|NCT03603314|63263625|FG001|Overall Study|Protocol Violation|1|||
33699572|NCT03603314|63263626|FG002|Overall Study|Protocol Violation|0|||
33699573|NCT03603314|63263624|FG000|Overall Study|Adverse Event|2|||
33699574|NCT03603314|63263625|FG001|Overall Study|Adverse Event|0|||
33699575|NCT03603314|63263626|FG002|Overall Study|Adverse Event|0|||
33699576|NCT03603314|63263624|FG000|Overall Study|Physician Decision|1|||
33699577|NCT03603314|63263625|FG001|Overall Study|Physician Decision|1|||
33699578|NCT03603314|63263626|FG002|Overall Study|Physician Decision|0|||
33699579|NCT03603314|63263624|FG000|Overall Study|Withdrawal by Subject|4|||
33699580|NCT03603314|63263625|FG001|Overall Study|Withdrawal by Subject|5|||
33699581|NCT03603314|63263626|FG002|Overall Study|Withdrawal by Subject|3|||
33699582|NCT03603314|63263624|FG000|Overall Study|Other|0|||
33699583|NCT03603314|63263625|FG001|Overall Study|Other|1|||
33699584|NCT03603314|63263626|FG002|Overall Study|Other|0|||
33699585|NCT04302350|63263641|FG000|Overall Study|Physician Decision|1|||
33699586|NCT04302350|63263642|FG001|Overall Study|Physician Decision|1|||
33699587|NCT04302350|63263643|FG002|Overall Study|Physician Decision|2|||
33699588|NCT04302350|63263641|FG000|Overall Study|Lack of Efficacy|1|||
33699589|NCT04302350|63263642|FG001|Overall Study|Lack of Efficacy|1|||
33699590|NCT04302350|63263643|FG002|Overall Study|Lack of Efficacy|4|||
33699591|NCT04302350|63263641|FG000|Overall Study|Adverse Event|0|||
33699592|NCT04302350|63263642|FG001|Overall Study|Adverse Event|1|||
33699593|NCT04302350|63263643|FG002|Overall Study|Adverse Event|2|||
33699594|NCT02335424|63263665|FG000|Overall Study|Withdrawal by Subject|19|||
33699595|NCT02335424|63263665|FG000|Overall Study|Adverse Event|25|||
33699596|NCT02335424|63263665|FG000|Overall Study|Death|273|||
33699597|NCT02335424|63263665|FG000|Overall Study|Lost to Follow-up|3|||
33699598|NCT02335424|63263665|FG000|Overall Study|Physician Decision|13|||
33699599|NCT02335424|63263665|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
33699600|NCT02335424|63263665|FG000|Overall Study|Protocol Violation|1|||
33699601|NCT02335424|63263665|FG000|Overall Study|Screen failure|1|||
33699602|NCT03805412|63263672|FG000|Overall Study|Lost to Follow-up|0|||
33699603|NCT03805412|63263673|FG001|Overall Study|Lost to Follow-up|1|||
33699604|NCT04791319|63263693|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
33699605|NCT04791319|63263694|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
33699606|NCT04791319|63263695|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
33699607|NCT04791319|63263696|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
33699608|NCT04791319|63263697|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
33699609|NCT04791319|63263698|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
33699610|NCT04791319|63263699|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
33699611|NCT04791319|63263700|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
33699612|NCT04791319|63263701|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
33699613|NCT04791319|63263702|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
33699614|NCT04791319|63263703|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
33699615|NCT04791319|63263693|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
33699616|NCT04791319|63263694|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33699617|NCT04791319|63263695|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
33699618|NCT04791319|63263696|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
33699619|NCT04791319|63263697|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33699620|NCT04791319|63263698|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33699621|NCT04791319|63263699|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33699622|NCT04791319|63263700|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33699623|NCT04791319|63263701|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33699624|NCT04791319|63263702|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33699625|NCT04791319|63263703|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33699626|NCT04791319|63263693|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
33699627|NCT04791319|63263694|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
33699628|NCT04791319|63263695|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
33699629|NCT04791319|63263696|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
33699630|NCT04791319|63263697|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
33699631|NCT04791319|63263698|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
33699632|NCT04791319|63263699|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
33699633|NCT04791319|63263700|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
33699634|NCT04791319|63263701|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
33699635|NCT04791319|63263702|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
33699636|NCT04791319|63263703|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
33699637|NCT04791319|63263693|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
33699638|NCT04791319|63263694|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
33699639|NCT04791319|63263695|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
33699640|NCT04791319|63263696|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
33699641|NCT04791319|63263697|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
33699642|NCT04791319|63263698|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
33699643|NCT04791319|63263699|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
33699644|NCT04791319|63263700|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
33699645|NCT04791319|63263701|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
33699646|NCT04791319|63263702|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
33699647|NCT04791319|63263703|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
33699648|NCT04791319|63263693|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33699649|NCT04791319|63263694|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33699650|NCT04791319|63263695|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33699651|NCT04791319|63263696|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
33699652|NCT04791319|63263697|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33699653|NCT04791319|63263698|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33699654|NCT04791319|63263699|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33699655|NCT04791319|63263700|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33699656|NCT04791319|63263701|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33699657|NCT04791319|63263702|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33699658|NCT04791319|63263703|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33699659|NCT04791319|63263693|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
33699660|NCT04791319|63263694|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
33699661|NCT04791319|63263695|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
33699662|NCT04791319|63263696|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
33699663|NCT04791319|63263697|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
33493252|NCT03103152|62871480|FG002|Overall Study|Adverse Event|1|||
33699664|NCT04791319|63263698|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
33699665|NCT04791319|63263699|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
33699666|NCT04791319|63263700|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
33699667|NCT04791319|63263701|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
33699668|NCT04791319|63263702|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
33699669|NCT04791319|63263703|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
33699670|NCT04791319|63263693|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33699671|NCT04791319|63263694|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33699672|NCT04791319|63263695|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33699673|NCT04791319|63263696|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33699674|NCT04791319|63263697|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33699675|NCT04791319|63263698|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33699676|NCT04791319|63263699|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33699677|NCT04791319|63263700|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33699678|NCT04791319|63263701|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33699679|NCT04791319|63263702|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
33699680|NCT04791319|63263703|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33699681|NCT04791319|63263693|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
33699682|NCT04791319|63263694|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
33699683|NCT04791319|63263695|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
33699684|NCT04791319|63263696|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
33699685|NCT04791319|63263697|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
33699686|NCT04791319|63263698|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
33699687|NCT04791319|63263699|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
33699688|NCT04791319|63263700|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
33699689|NCT04791319|63263701|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
33699690|NCT04791319|63263702|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
33699691|NCT04791319|63263703|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
33699692|NCT04791319|63263693|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
33699693|NCT04791319|63263694|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
33699694|NCT04791319|63263695|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
33699695|NCT04791319|63263696|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
33699696|NCT04791319|63263697|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
33699697|NCT04791319|63263698|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
33699698|NCT04791319|63263699|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
33699699|NCT04791319|63263700|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
33699700|NCT04791319|63263701|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
33699701|NCT04791319|63263702|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
33699702|NCT04791319|63263703|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
33699703|NCT03472495|63263760|FG000|Overall Study|Treatment no longer indicated|1|||
33699704|NCT03472495|63263761|FG001|Overall Study|Treatment no longer indicated|2|||
33699705|NCT03472495|63263760|FG000|Overall Study|Physician Decision|0|||
33699706|NCT03472495|63263761|FG001|Overall Study|Physician Decision|2|||
33699707|NCT03234907|63263769|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
33699708|NCT03234907|63263770|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
33699709|NCT03234907|63263771|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
33699710|NCT03234907|63263772|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
33699711|NCT03234907|63263773|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
33699712|NCT03234907|63263774|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
33699713|NCT03234907|63263769|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
33699714|NCT03234907|63263770|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
33699715|NCT03234907|63263771|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
33699716|NCT03234907|63263772|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
33699717|NCT03234907|63263773|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
33699718|NCT03234907|63263774|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
33699719|NCT03234907|63263769|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
33699720|NCT03234907|63263770|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
33699721|NCT03234907|63263771|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
33699722|NCT03234907|63263772|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
33699723|NCT03234907|63263773|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
33699724|NCT03234907|63263774|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
33699725|NCT03234907|63263769|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
33699726|NCT03234907|63263770|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
33699727|NCT03234907|63263771|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
33699728|NCT03234907|63263772|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
33699729|NCT03234907|63263773|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
33699730|NCT03234907|63263774|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
33699731|NCT03234907|63263769|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
33699732|NCT03234907|63263770|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
33699733|NCT03234907|63263771|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
33699734|NCT03234907|63263772|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
33699735|NCT03234907|63263773|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
33699736|NCT03234907|63263774|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
33699737|NCT03234907|63263769|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
33699738|NCT03234907|63263770|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
33699739|NCT03234907|63263771|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
33699740|NCT03234907|63263772|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
33699741|NCT03234907|63263773|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
33699742|NCT03234907|63263774|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
33699743|NCT03234907|63263769|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
33699744|NCT03234907|63263770|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
33699745|NCT03234907|63263771|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
33699746|NCT03234907|63263772|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
33699747|NCT03234907|63263773|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
33699748|NCT03234907|63263774|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
33699749|NCT03818581|63263788|FG000|Overall Study|Adverse Event|1|||
33699750|NCT03818581|63263789|FG001|Overall Study|Adverse Event|0|||
33699751|NCT03818581|63263790|FG002|Overall Study|Adverse Event|0|||
33699752|NCT03818581|63263791|FG003|Overall Study|Adverse Event|0|||
33699753|NCT03818581|63263792|FG004|Overall Study|Adverse Event|0|||
33699754|NCT03818581|63263788|FG000|Overall Study|Covid-19|2|||
33699755|NCT03818581|63263789|FG001|Overall Study|Covid-19|0|||
33699756|NCT03818581|63263790|FG002|Overall Study|Covid-19|0|||
33699757|NCT03818581|63263791|FG003|Overall Study|Covid-19|0|||
33699758|NCT03818581|63263792|FG004|Overall Study|Covid-19|1|||
33699759|NCT03818581|63263788|FG000|Overall Study|Withdrawal by Subject|0|||
33699760|NCT03818581|63263789|FG001|Overall Study|Withdrawal by Subject|0|||
33699761|NCT03818581|63263790|FG002|Overall Study|Withdrawal by Subject|0|||
33699762|NCT03818581|63263791|FG003|Overall Study|Withdrawal by Subject|0|||
33699763|NCT03818581|63263792|FG004|Overall Study|Withdrawal by Subject|1|||
33699764|NCT03818581|63263788|FG000|Overall Study|No longer met study criteria|1|||
33699765|NCT03818581|63263789|FG001|Overall Study|No longer met study criteria|0|||
33699766|NCT03818581|63263790|FG002|Overall Study|No longer met study criteria|0|||
33699767|NCT03818581|63263791|FG003|Overall Study|No longer met study criteria|0|||
33699768|NCT03818581|63263792|FG004|Overall Study|No longer met study criteria|2|||
33699769|NCT03736447|63263806|FG000|Overall Study|Adverse Event|5|||
33699770|NCT03736447|63263807|FG001|Overall Study|Adverse Event|1|||
33699771|NCT03736447|63263806|FG000|Overall Study|Withdrawal by Subject|5|||
33699772|NCT03736447|63263807|FG001|Overall Study|Withdrawal by Subject|1|||
33699773|NCT03736447|63263806|FG000|Overall Study|Lost to Follow-up|1|||
33699774|NCT03736447|63263807|FG001|Overall Study|Lost to Follow-up|0|||
33699775|NCT03736447|63263806|FG000|Overall Study|Physician Decision|1|||
33699776|NCT03736447|63263807|FG001|Overall Study|Physician Decision|0|||
33699777|NCT03736447|63263806|FG000|Overall Study|Continued commitment to study treatment|3|||
33699778|NCT03736447|63263807|FG001|Overall Study|Continued commitment to study treatment|0|||
33699779|NCT03736447|63263806|FG000|Overall Study|Taste aversion to study product|0|||
33699780|NCT03736447|63263807|FG001|Overall Study|Taste aversion to study product|1|||
33699781|NCT02132754|63263856|FG000|Overall Study|Adverse Event|0|||
33699782|NCT02132754|63263857|FG001|Overall Study|Adverse Event|0|||
33596471|NCT02141295|62995451|FG000|Overall Study|Study terminated by sponsor|0|||
33596472|NCT02141295|62995452|FG001|Overall Study|Study terminated by sponsor|6|||
33699783|NCT02132754|63263858|FG002|Overall Study|Adverse Event|0|||
33699784|NCT02132754|63263859|FG003|Overall Study|Adverse Event|0|||
33699785|NCT02132754|63263860|FG004|Overall Study|Adverse Event|0|||
33699786|NCT02132754|63263861|FG005|Overall Study|Adverse Event|0|||
33699787|NCT02132754|63263862|FG006|Overall Study|Adverse Event|0|||
33699788|NCT02132754|63263863|FG007|Overall Study|Adverse Event|0|||
33699789|NCT02132754|63263864|FG008|Overall Study|Adverse Event|0|||
33699790|NCT02132754|63263865|FG009|Overall Study|Adverse Event|0|||
33699791|NCT02132754|63263866|FG010|Overall Study|Adverse Event|0|||
33699792|NCT02132754|63263867|FG011|Overall Study|Adverse Event|0|||
33699793|NCT02132754|63263868|FG012|Overall Study|Adverse Event|0|||
33699794|NCT02132754|63263869|FG013|Overall Study|Adverse Event|0|||
33699795|NCT02132754|63263870|FG014|Overall Study|Adverse Event|0|||
33699796|NCT02132754|63263871|FG015|Overall Study|Adverse Event|0|||
33699797|NCT02132754|63263872|FG016|Overall Study|Adverse Event|0|||
33699798|NCT02132754|63263873|FG017|Overall Study|Adverse Event|1|||
33699799|NCT02132754|63263874|FG018|Overall Study|Adverse Event|0|||
33699800|NCT02132754|63263875|FG019|Overall Study|Adverse Event|0|||
33699801|NCT02132754|63263876|FG020|Overall Study|Adverse Event|0|||
33699802|NCT02132754|63263877|FG021|Overall Study|Adverse Event|0|||
33699803|NCT02132754|63263878|FG022|Overall Study|Adverse Event|0|||
33699804|NCT02132754|63263879|FG023|Overall Study|Adverse Event|0|||
33699805|NCT02132754|63263880|FG024|Overall Study|Adverse Event|0|||
33699806|NCT02132754|63263881|FG025|Overall Study|Adverse Event|1|||
33699807|NCT02132754|63263882|FG026|Overall Study|Adverse Event|1|||
33699808|NCT02132754|63263883|FG027|Overall Study|Adverse Event|0|||
33699809|NCT02132754|63263884|FG028|Overall Study|Adverse Event|0|||
33699810|NCT02132754|63263885|FG029|Overall Study|Adverse Event|0|||
33699811|NCT02132754|63263886|FG030|Overall Study|Adverse Event|1|||
33699812|NCT02132754|63263887|FG031|Overall Study|Adverse Event|0|||
33699813|NCT02132754|63263888|FG032|Overall Study|Adverse Event|1|||
33699814|NCT02132754|63263889|FG033|Overall Study|Adverse Event|1|||
33699815|NCT02132754|63263856|FG000|Overall Study|Clinical Progression|0|||
33699816|NCT02132754|63263857|FG001|Overall Study|Clinical Progression|0|||
33699817|NCT02132754|63263858|FG002|Overall Study|Clinical Progression|0|||
33699818|NCT02132754|63263859|FG003|Overall Study|Clinical Progression|0|||
33699819|NCT02132754|63263860|FG004|Overall Study|Clinical Progression|0|||
33699820|NCT02132754|63263861|FG005|Overall Study|Clinical Progression|0|||
33699821|NCT02132754|63263862|FG006|Overall Study|Clinical Progression|0|||
33699822|NCT02132754|63263863|FG007|Overall Study|Clinical Progression|0|||
33699823|NCT02132754|63263864|FG008|Overall Study|Clinical Progression|0|||
33699824|NCT02132754|63263865|FG009|Overall Study|Clinical Progression|1|||
33699825|NCT02132754|63263866|FG010|Overall Study|Clinical Progression|0|||
33699826|NCT02132754|63263867|FG011|Overall Study|Clinical Progression|0|||
33699827|NCT02132754|63263868|FG012|Overall Study|Clinical Progression|0|||
33699828|NCT02132754|63263869|FG013|Overall Study|Clinical Progression|0|||
33699829|NCT02132754|63263870|FG014|Overall Study|Clinical Progression|0|||
33699830|NCT02132754|63263871|FG015|Overall Study|Clinical Progression|0|||
33699831|NCT02132754|63263872|FG016|Overall Study|Clinical Progression|1|||
33699832|NCT02132754|63263873|FG017|Overall Study|Clinical Progression|1|||
33699833|NCT02132754|63263874|FG018|Overall Study|Clinical Progression|0|||
33699834|NCT02132754|63263875|FG019|Overall Study|Clinical Progression|1|||
33699835|NCT02132754|63263876|FG020|Overall Study|Clinical Progression|0|||
33699836|NCT02132754|63263877|FG021|Overall Study|Clinical Progression|0|||
33699837|NCT02132754|63263878|FG022|Overall Study|Clinical Progression|1|||
33699838|NCT02132754|63263879|FG023|Overall Study|Clinical Progression|0|||
33699839|NCT02132754|63263880|FG024|Overall Study|Clinical Progression|1|||
33699840|NCT02132754|63263881|FG025|Overall Study|Clinical Progression|1|||
33699841|NCT02132754|63263882|FG026|Overall Study|Clinical Progression|0|||
33699842|NCT02132754|63263883|FG027|Overall Study|Clinical Progression|1|||
33699843|NCT02132754|63263884|FG028|Overall Study|Clinical Progression|1|||
33699844|NCT02132754|63263885|FG029|Overall Study|Clinical Progression|0|||
33699845|NCT02132754|63263886|FG030|Overall Study|Clinical Progression|1|||
33699846|NCT02132754|63263887|FG031|Overall Study|Clinical Progression|0|||
33699847|NCT02132754|63263888|FG032|Overall Study|Clinical Progression|0|||
33699848|NCT02132754|63263889|FG033|Overall Study|Clinical Progression|2|||
33699849|NCT02132754|63263856|FG000|Overall Study|Death|0|||
33699850|NCT02132754|63263857|FG001|Overall Study|Death|0|||
33699851|NCT02132754|63263858|FG002|Overall Study|Death|0|||
33699852|NCT02132754|63263859|FG003|Overall Study|Death|0|||
33699853|NCT02132754|63263860|FG004|Overall Study|Death|0|||
33699854|NCT02132754|63263861|FG005|Overall Study|Death|0|||
33699855|NCT02132754|63263862|FG006|Overall Study|Death|0|||
33699856|NCT02132754|63263863|FG007|Overall Study|Death|0|||
33699857|NCT02132754|63263864|FG008|Overall Study|Death|0|||
33699858|NCT02132754|63263865|FG009|Overall Study|Death|0|||
33699859|NCT02132754|63263866|FG010|Overall Study|Death|0|||
33699860|NCT02132754|63263867|FG011|Overall Study|Death|0|||
33699861|NCT02132754|63263868|FG012|Overall Study|Death|0|||
33699862|NCT02132754|63263869|FG013|Overall Study|Death|0|||
33699863|NCT02132754|63263870|FG014|Overall Study|Death|0|||
33699864|NCT02132754|63263871|FG015|Overall Study|Death|1|||
33699865|NCT02132754|63263872|FG016|Overall Study|Death|0|||
33699866|NCT02132754|63263873|FG017|Overall Study|Death|0|||
33699867|NCT02132754|63263874|FG018|Overall Study|Death|0|||
33493253|NCT03103152|62871481|FG003|Overall Study|Adverse Event|0|||
33699868|NCT02132754|63263875|FG019|Overall Study|Death|1|||
33699869|NCT02132754|63263876|FG020|Overall Study|Death|0|||
33699870|NCT02132754|63263877|FG021|Overall Study|Death|1|||
33699871|NCT02132754|63263878|FG022|Overall Study|Death|0|||
33699872|NCT02132754|63263879|FG023|Overall Study|Death|0|||
33699873|NCT02132754|63263880|FG024|Overall Study|Death|0|||
33699874|NCT02132754|63263881|FG025|Overall Study|Death|0|||
33699875|NCT02132754|63263882|FG026|Overall Study|Death|1|||
33699876|NCT02132754|63263883|FG027|Overall Study|Death|0|||
33699877|NCT02132754|63263884|FG028|Overall Study|Death|0|||
33699878|NCT02132754|63263885|FG029|Overall Study|Death|0|||
33699879|NCT02132754|63263886|FG030|Overall Study|Death|0|||
33699880|NCT02132754|63263887|FG031|Overall Study|Death|0|||
33699881|NCT02132754|63263888|FG032|Overall Study|Death|0|||
33699882|NCT02132754|63263889|FG033|Overall Study|Death|2|||
33699883|NCT02132754|63263856|FG000|Overall Study|Excluded Medication|0|||
33699884|NCT02132754|63263857|FG001|Overall Study|Excluded Medication|0|||
33699885|NCT02132754|63263858|FG002|Overall Study|Excluded Medication|0|||
33699886|NCT02132754|63263859|FG003|Overall Study|Excluded Medication|0|||
33699887|NCT02132754|63263860|FG004|Overall Study|Excluded Medication|0|||
33699888|NCT02132754|63263861|FG005|Overall Study|Excluded Medication|0|||
33699889|NCT02132754|63263862|FG006|Overall Study|Excluded Medication|0|||
33699890|NCT02132754|63263863|FG007|Overall Study|Excluded Medication|0|||
33699891|NCT02132754|63263864|FG008|Overall Study|Excluded Medication|0|||
33699892|NCT02132754|63263865|FG009|Overall Study|Excluded Medication|0|||
33699893|NCT02132754|63263866|FG010|Overall Study|Excluded Medication|0|||
33699894|NCT02132754|63263867|FG011|Overall Study|Excluded Medication|0|||
33699895|NCT02132754|63263868|FG012|Overall Study|Excluded Medication|0|||
33699896|NCT02132754|63263869|FG013|Overall Study|Excluded Medication|0|||
33699897|NCT02132754|63263870|FG014|Overall Study|Excluded Medication|0|||
33699898|NCT02132754|63263871|FG015|Overall Study|Excluded Medication|0|||
33699899|NCT02132754|63263872|FG016|Overall Study|Excluded Medication|0|||
33699900|NCT02132754|63263873|FG017|Overall Study|Excluded Medication|0|||
33699901|NCT02132754|63263874|FG018|Overall Study|Excluded Medication|0|||
33699902|NCT02132754|63263875|FG019|Overall Study|Excluded Medication|0|||
33699903|NCT02132754|63263876|FG020|Overall Study|Excluded Medication|1|||
33699904|NCT02132754|63263877|FG021|Overall Study|Excluded Medication|0|||
33699905|NCT02132754|63263878|FG022|Overall Study|Excluded Medication|0|||
33699906|NCT02132754|63263879|FG023|Overall Study|Excluded Medication|0|||
33699907|NCT02132754|63263880|FG024|Overall Study|Excluded Medication|0|||
33699908|NCT02132754|63263881|FG025|Overall Study|Excluded Medication|0|||
33699909|NCT02132754|63263882|FG026|Overall Study|Excluded Medication|0|||
33699910|NCT02132754|63263883|FG027|Overall Study|Excluded Medication|0|||
33699911|NCT02132754|63263884|FG028|Overall Study|Excluded Medication|0|||
33699912|NCT02132754|63263885|FG029|Overall Study|Excluded Medication|0|||
33699913|NCT02132754|63263886|FG030|Overall Study|Excluded Medication|0|||
33699914|NCT02132754|63263887|FG031|Overall Study|Excluded Medication|0|||
33699915|NCT02132754|63263888|FG032|Overall Study|Excluded Medication|0|||
33699916|NCT02132754|63263889|FG033|Overall Study|Excluded Medication|1|||
33699917|NCT02132754|63263856|FG000|Overall Study|Physician Decision|0|||
33699918|NCT02132754|63263857|FG001|Overall Study|Physician Decision|0|||
33699919|NCT02132754|63263858|FG002|Overall Study|Physician Decision|0|||
33699920|NCT02132754|63263859|FG003|Overall Study|Physician Decision|0|||
33699921|NCT02132754|63263860|FG004|Overall Study|Physician Decision|0|||
33699922|NCT02132754|63263861|FG005|Overall Study|Physician Decision|0|||
33699923|NCT02132754|63263862|FG006|Overall Study|Physician Decision|0|||
33699924|NCT02132754|63263863|FG007|Overall Study|Physician Decision|0|||
33699925|NCT02132754|63263864|FG008|Overall Study|Physician Decision|0|||
33699926|NCT02132754|63263865|FG009|Overall Study|Physician Decision|1|||
33699927|NCT02132754|63263866|FG010|Overall Study|Physician Decision|0|||
33699928|NCT02132754|63263867|FG011|Overall Study|Physician Decision|1|||
33699929|NCT02132754|63263868|FG012|Overall Study|Physician Decision|1|||
33699930|NCT02132754|63263869|FG013|Overall Study|Physician Decision|0|||
33699931|NCT02132754|63263870|FG014|Overall Study|Physician Decision|0|||
33699932|NCT02132754|63263871|FG015|Overall Study|Physician Decision|1|||
33699933|NCT02132754|63263872|FG016|Overall Study|Physician Decision|0|||
33699934|NCT02132754|63263873|FG017|Overall Study|Physician Decision|0|||
33493254|NCT03103152|62871482|FG004|Overall Study|Adverse Event|0|||
33699935|NCT02132754|63263874|FG018|Overall Study|Physician Decision|0|||
33699936|NCT02132754|63263875|FG019|Overall Study|Physician Decision|0|||
33699937|NCT02132754|63263876|FG020|Overall Study|Physician Decision|0|||
33699938|NCT02132754|63263877|FG021|Overall Study|Physician Decision|0|||
33699939|NCT02132754|63263878|FG022|Overall Study|Physician Decision|0|||
33699940|NCT02132754|63263879|FG023|Overall Study|Physician Decision|0|||
33699941|NCT02132754|63263880|FG024|Overall Study|Physician Decision|1|||
33699942|NCT02132754|63263881|FG025|Overall Study|Physician Decision|0|||
33699943|NCT02132754|63263882|FG026|Overall Study|Physician Decision|0|||
33699944|NCT02132754|63263883|FG027|Overall Study|Physician Decision|0|||
33699945|NCT02132754|63263884|FG028|Overall Study|Physician Decision|0|||
33699946|NCT02132754|63263885|FG029|Overall Study|Physician Decision|0|||
33699947|NCT02132754|63263886|FG030|Overall Study|Physician Decision|0|||
33699948|NCT02132754|63263887|FG031|Overall Study|Physician Decision|1|||
33699949|NCT02132754|63263888|FG032|Overall Study|Physician Decision|0|||
33699950|NCT02132754|63263889|FG033|Overall Study|Physician Decision|3|||
33699951|NCT02132754|63263856|FG000|Overall Study|Progressive Disease|1|||
33699952|NCT02132754|63263857|FG001|Overall Study|Progressive Disease|1|||
33699953|NCT02132754|63263858|FG002|Overall Study|Progressive Disease|1|||
33699954|NCT02132754|63263859|FG003|Overall Study|Progressive Disease|1|||
33699955|NCT02132754|63263860|FG004|Overall Study|Progressive Disease|1|||
33699956|NCT02132754|63263861|FG005|Overall Study|Progressive Disease|1|||
33699957|NCT02132754|63263862|FG006|Overall Study|Progressive Disease|1|||
33699958|NCT02132754|63263863|FG007|Overall Study|Progressive Disease|1|||
33699959|NCT02132754|63263864|FG008|Overall Study|Progressive Disease|1|||
33699960|NCT02132754|63263865|FG009|Overall Study|Progressive Disease|3|||
33699961|NCT02132754|63263866|FG010|Overall Study|Progressive Disease|3|||
33699962|NCT02132754|63263867|FG011|Overall Study|Progressive Disease|2|||
33699963|NCT02132754|63263868|FG012|Overall Study|Progressive Disease|2|||
33699964|NCT02132754|63263869|FG013|Overall Study|Progressive Disease|3|||
33699965|NCT02132754|63263870|FG014|Overall Study|Progressive Disease|2|||
33699966|NCT02132754|63263871|FG015|Overall Study|Progressive Disease|1|||
33699967|NCT02132754|63263872|FG016|Overall Study|Progressive Disease|2|||
33699968|NCT02132754|63263873|FG017|Overall Study|Progressive Disease|1|||
33699969|NCT02132754|63263874|FG018|Overall Study|Progressive Disease|3|||
33699970|NCT02132754|63263875|FG019|Overall Study|Progressive Disease|1|||
33699971|NCT02132754|63263876|FG020|Overall Study|Progressive Disease|1|||
33699972|NCT02132754|63263877|FG021|Overall Study|Progressive Disease|3|||
33699973|NCT02132754|63263878|FG022|Overall Study|Progressive Disease|2|||
33699974|NCT02132754|63263879|FG023|Overall Study|Progressive Disease|3|||
33699975|NCT02132754|63263880|FG024|Overall Study|Progressive Disease|0|||
33699976|NCT02132754|63263881|FG025|Overall Study|Progressive Disease|1|||
33699977|NCT02132754|63263882|FG026|Overall Study|Progressive Disease|2|||
33699978|NCT02132754|63263883|FG027|Overall Study|Progressive Disease|1|||
33699979|NCT02132754|63263884|FG028|Overall Study|Progressive Disease|2|||
33699980|NCT02132754|63263885|FG029|Overall Study|Progressive Disease|3|||
33699981|NCT02132754|63263886|FG030|Overall Study|Progressive Disease|1|||
33699982|NCT02132754|63263887|FG031|Overall Study|Progressive Disease|1|||
33699983|NCT02132754|63263888|FG032|Overall Study|Progressive Disease|3|||
33699984|NCT02132754|63263889|FG033|Overall Study|Progressive Disease|6|||
33699985|NCT02132754|63263856|FG000|Overall Study|Screen Failure|0|||
33699986|NCT02132754|63263857|FG001|Overall Study|Screen Failure|0|||
33699987|NCT02132754|63263858|FG002|Overall Study|Screen Failure|0|||
33699988|NCT02132754|63263859|FG003|Overall Study|Screen Failure|0|||
33699989|NCT02132754|63263860|FG004|Overall Study|Screen Failure|0|||
33699990|NCT02132754|63263861|FG005|Overall Study|Screen Failure|0|||
33699991|NCT02132754|63263862|FG006|Overall Study|Screen Failure|0|||
33699992|NCT02132754|63263863|FG007|Overall Study|Screen Failure|0|||
33699993|NCT02132754|63263864|FG008|Overall Study|Screen Failure|0|||
33699994|NCT02132754|63263865|FG009|Overall Study|Screen Failure|0|||
33699995|NCT02132754|63263866|FG010|Overall Study|Screen Failure|0|||
33699996|NCT02132754|63263867|FG011|Overall Study|Screen Failure|0|||
33699997|NCT02132754|63263868|FG012|Overall Study|Screen Failure|0|||
33699998|NCT02132754|63263869|FG013|Overall Study|Screen Failure|0|||
33699999|NCT02132754|63263870|FG014|Overall Study|Screen Failure|0|||
33700000|NCT02132754|63263871|FG015|Overall Study|Screen Failure|0|||
33700001|NCT02132754|63263872|FG016|Overall Study|Screen Failure|0|||
33700002|NCT02132754|63263873|FG017|Overall Study|Screen Failure|0|||
33700003|NCT02132754|63263874|FG018|Overall Study|Screen Failure|0|||
33700004|NCT02132754|63263875|FG019|Overall Study|Screen Failure|1|||
33700005|NCT02132754|63263876|FG020|Overall Study|Screen Failure|0|||
33700006|NCT02132754|63263877|FG021|Overall Study|Screen Failure|1|||
33700007|NCT02132754|63263878|FG022|Overall Study|Screen Failure|0|||
33700008|NCT02132754|63263879|FG023|Overall Study|Screen Failure|0|||
33700009|NCT02132754|63263880|FG024|Overall Study|Screen Failure|0|||
33700010|NCT02132754|63263881|FG025|Overall Study|Screen Failure|0|||
33700011|NCT02132754|63263882|FG026|Overall Study|Screen Failure|0|||
33700012|NCT02132754|63263883|FG027|Overall Study|Screen Failure|0|||
33700013|NCT02132754|63263884|FG028|Overall Study|Screen Failure|0|||
33700014|NCT02132754|63263885|FG029|Overall Study|Screen Failure|0|||
33700015|NCT02132754|63263886|FG030|Overall Study|Screen Failure|0|||
33700016|NCT02132754|63263887|FG031|Overall Study|Screen Failure|0|||
33493255|NCT03103152|62871483|FG005|Overall Study|Adverse Event|1|||
33700017|NCT02132754|63263888|FG032|Overall Study|Screen Failure|0|||
33700018|NCT02132754|63263889|FG033|Overall Study|Screen Failure|0|||
33700019|NCT02132754|63263856|FG000|Overall Study|Transferred to Extension Study|0|||
33700020|NCT02132754|63263857|FG001|Overall Study|Transferred to Extension Study|0|||
33700021|NCT02132754|63263858|FG002|Overall Study|Transferred to Extension Study|0|||
33700022|NCT02132754|63263859|FG003|Overall Study|Transferred to Extension Study|0|||
33700023|NCT02132754|63263860|FG004|Overall Study|Transferred to Extension Study|0|||
33700024|NCT02132754|63263861|FG005|Overall Study|Transferred to Extension Study|0|||
33700025|NCT02132754|63263862|FG006|Overall Study|Transferred to Extension Study|0|||
33700026|NCT02132754|63263863|FG007|Overall Study|Transferred to Extension Study|0|||
33700027|NCT02132754|63263864|FG008|Overall Study|Transferred to Extension Study|0|||
33700028|NCT02132754|63263865|FG009|Overall Study|Transferred to Extension Study|0|||
33700029|NCT02132754|63263866|FG010|Overall Study|Transferred to Extension Study|0|||
33700030|NCT02132754|63263867|FG011|Overall Study|Transferred to Extension Study|0|||
33700031|NCT02132754|63263868|FG012|Overall Study|Transferred to Extension Study|0|||
33700032|NCT02132754|63263869|FG013|Overall Study|Transferred to Extension Study|0|||
33700033|NCT02132754|63263870|FG014|Overall Study|Transferred to Extension Study|0|||
33700034|NCT02132754|63263871|FG015|Overall Study|Transferred to Extension Study|0|||
33700035|NCT02132754|63263872|FG016|Overall Study|Transferred to Extension Study|0|||
33700036|NCT02132754|63263873|FG017|Overall Study|Transferred to Extension Study|0|||
33700037|NCT02132754|63263874|FG018|Overall Study|Transferred to Extension Study|0|||
33700038|NCT02132754|63263875|FG019|Overall Study|Transferred to Extension Study|0|||
33700039|NCT02132754|63263876|FG020|Overall Study|Transferred to Extension Study|0|||
33700040|NCT02132754|63263877|FG021|Overall Study|Transferred to Extension Study|0|||
33700041|NCT02132754|63263878|FG022|Overall Study|Transferred to Extension Study|0|||
33700042|NCT02132754|63263879|FG023|Overall Study|Transferred to Extension Study|0|||
33700043|NCT02132754|63263880|FG024|Overall Study|Transferred to Extension Study|0|||
33700044|NCT02132754|63263881|FG025|Overall Study|Transferred to Extension Study|0|||
33700045|NCT02132754|63263882|FG026|Overall Study|Transferred to Extension Study|0|||
33700046|NCT02132754|63263883|FG027|Overall Study|Transferred to Extension Study|0|||
33700047|NCT02132754|63263884|FG028|Overall Study|Transferred to Extension Study|0|||
33700048|NCT02132754|63263885|FG029|Overall Study|Transferred to Extension Study|0|||
33700049|NCT02132754|63263886|FG030|Overall Study|Transferred to Extension Study|0|||
33700050|NCT02132754|63263887|FG031|Overall Study|Transferred to Extension Study|0|||
33700051|NCT02132754|63263888|FG032|Overall Study|Transferred to Extension Study|0|||
33700052|NCT02132754|63263889|FG033|Overall Study|Transferred to Extension Study|6|||
33700053|NCT02132754|63263856|FG000|Overall Study|Withdrawal by Subject|0|||
33700054|NCT02132754|63263857|FG001|Overall Study|Withdrawal by Subject|0|||
33700055|NCT02132754|63263858|FG002|Overall Study|Withdrawal by Subject|0|||
33700056|NCT02132754|63263859|FG003|Overall Study|Withdrawal by Subject|0|||
33700057|NCT02132754|63263860|FG004|Overall Study|Withdrawal by Subject|0|||
33700058|NCT02132754|63263861|FG005|Overall Study|Withdrawal by Subject|0|||
33700059|NCT02132754|63263862|FG006|Overall Study|Withdrawal by Subject|0|||
33700060|NCT02132754|63263863|FG007|Overall Study|Withdrawal by Subject|0|||
33700061|NCT02132754|63263864|FG008|Overall Study|Withdrawal by Subject|0|||
33700062|NCT02132754|63263865|FG009|Overall Study|Withdrawal by Subject|1|||
33700063|NCT02132754|63263866|FG010|Overall Study|Withdrawal by Subject|0|||
33700064|NCT02132754|63263867|FG011|Overall Study|Withdrawal by Subject|0|||
33700065|NCT02132754|63263868|FG012|Overall Study|Withdrawal by Subject|1|||
33700066|NCT02132754|63263869|FG013|Overall Study|Withdrawal by Subject|0|||
33700067|NCT02132754|63263870|FG014|Overall Study|Withdrawal by Subject|1|||
33700068|NCT02132754|63263871|FG015|Overall Study|Withdrawal by Subject|2|||
33700069|NCT02132754|63263872|FG016|Overall Study|Withdrawal by Subject|1|||
33700070|NCT02132754|63263873|FG017|Overall Study|Withdrawal by Subject|0|||
33700071|NCT02132754|63263874|FG018|Overall Study|Withdrawal by Subject|0|||
33700072|NCT02132754|63263875|FG019|Overall Study|Withdrawal by Subject|0|||
33700073|NCT02132754|63263876|FG020|Overall Study|Withdrawal by Subject|1|||
33700074|NCT02132754|63263877|FG021|Overall Study|Withdrawal by Subject|0|||
33700075|NCT02132754|63263878|FG022|Overall Study|Withdrawal by Subject|0|||
33700076|NCT02132754|63263879|FG023|Overall Study|Withdrawal by Subject|0|||
33700077|NCT02132754|63263880|FG024|Overall Study|Withdrawal by Subject|1|||
33700078|NCT02132754|63263881|FG025|Overall Study|Withdrawal by Subject|0|||
33700079|NCT02132754|63263882|FG026|Overall Study|Withdrawal by Subject|0|||
33700080|NCT02132754|63263883|FG027|Overall Study|Withdrawal by Subject|1|||
33700081|NCT02132754|63263884|FG028|Overall Study|Withdrawal by Subject|0|||
33700082|NCT02132754|63263885|FG029|Overall Study|Withdrawal by Subject|0|||
33700083|NCT02132754|63263886|FG030|Overall Study|Withdrawal by Subject|0|||
33700084|NCT02132754|63263887|FG031|Overall Study|Withdrawal by Subject|1|||
33700085|NCT02132754|63263888|FG032|Overall Study|Withdrawal by Subject|0|||
33700086|NCT02132754|63263889|FG033|Overall Study|Withdrawal by Subject|2|||
33700087|NCT02151786|63263999|FG000|Overall Study|Unavailability of Case Report Form|26|||
33700088|NCT02151786|63263999|FG000|Overall Study|Outside the Contract Period|1|||
33700089|NCT02151786|63263999|FG000|Overall Study|Randomized, not Treated|1|||
33700090|NCT02151786|63263999|FG000|Overall Study|Unavailability of Information|8|||
33700091|NCT02132130|63264007|FG000|Overall Study|Lost to Follow-up|0|||
33700092|NCT02132130|63264008|FG001|Overall Study|Lost to Follow-up|2|||
33700093|NCT02132130|63264009|FG002|Overall Study|Lost to Follow-up|0|||
33700094|NCT02132130|63264010|FG003|Overall Study|Lost to Follow-up|0|||
33700095|NCT02132130|63264007|FG000|Overall Study|Withdrawal by Subject|0|||
33493256|NCT03103152|62871478|FG000|Overall Study|Withdrawal by Subject|1|||
33700096|NCT02132130|63264008|FG001|Overall Study|Withdrawal by Subject|0|||
33700097|NCT02132130|63264009|FG002|Overall Study|Withdrawal by Subject|0|||
33700098|NCT02132130|63264010|FG003|Overall Study|Withdrawal by Subject|1|||
33700099|NCT02131662|63264029|FG000|Overall Study|Protocol Violation|1|||
33700100|NCT02131662|63264030|FG001|Overall Study|Protocol Violation|0|||
33700101|NCT02131662|63264031|FG002|Overall Study|Protocol Violation|0|||
33700102|NCT02131662|63264032|FG003|Overall Study|Protocol Violation|0|||
33700103|NCT02131662|63264033|FG004|Overall Study|Protocol Violation|0|||
33700104|NCT02131662|63264029|FG000|Overall Study|Other|2|||
33700105|NCT02131662|63264030|FG001|Overall Study|Other|4|||
33700106|NCT02131662|63264031|FG002|Overall Study|Other|3|||
33700107|NCT02131662|63264032|FG003|Overall Study|Other|3|||
33700108|NCT02131662|63264033|FG004|Overall Study|Other|4|||
33700109|NCT02131662|63264029|FG000|Overall Study|Adverse Event|0|||
33700110|NCT02131662|63264030|FG001|Overall Study|Adverse Event|1|||
33700111|NCT02131662|63264031|FG002|Overall Study|Adverse Event|1|||
33700112|NCT02131662|63264032|FG003|Overall Study|Adverse Event|1|||
33700113|NCT02131662|63264033|FG004|Overall Study|Adverse Event|3|||
33700114|NCT02131662|63264029|FG000|Overall Study|Pregnancy|0|||
33700115|NCT02131662|63264030|FG001|Overall Study|Pregnancy|1|||
33700116|NCT02131662|63264031|FG002|Overall Study|Pregnancy|0|||
33700117|NCT02131662|63264032|FG003|Overall Study|Pregnancy|1|||
33700118|NCT02131662|63264033|FG004|Overall Study|Pregnancy|0|||
33700119|NCT02131662|63264029|FG000|Overall Study|Wish for pregnancy|0|||
33700120|NCT02131662|63264030|FG001|Overall Study|Wish for pregnancy|0|||
33700121|NCT02131662|63264031|FG002|Overall Study|Wish for pregnancy|0|||
33700122|NCT02131662|63264032|FG003|Overall Study|Wish for pregnancy|0|||
33700123|NCT02131662|63264033|FG004|Overall Study|Wish for pregnancy|1|||
33700124|NCT02131662|63264029|FG000|Overall Study|Lack of Efficacy|1|||
33700125|NCT02131662|63264030|FG001|Overall Study|Lack of Efficacy|0|||
33700126|NCT02131662|63264031|FG002|Overall Study|Lack of Efficacy|0|||
33700127|NCT02131662|63264032|FG003|Overall Study|Lack of Efficacy|0|||
33700128|NCT02131662|63264033|FG004|Overall Study|Lack of Efficacy|1|||
33700129|NCT02131662|63264029|FG000|Overall Study|Withdrawal by Subject|1|||
33700130|NCT02131662|63264030|FG001|Overall Study|Withdrawal by Subject|5|||
33700131|NCT02131662|63264031|FG002|Overall Study|Withdrawal by Subject|1|||
33700132|NCT02131662|63264032|FG003|Overall Study|Withdrawal by Subject|5|||
33700133|NCT02131662|63264033|FG004|Overall Study|Withdrawal by Subject|6|||
33700134|NCT02131662|63264029|FG000|Overall Study|Lost to Follow-up|1|||
33700135|NCT02131662|63264030|FG001|Overall Study|Lost to Follow-up|3|||
33700136|NCT02131662|63264031|FG002|Overall Study|Lost to Follow-up|0|||
33700137|NCT02131662|63264032|FG003|Overall Study|Lost to Follow-up|9|||
33700138|NCT02131662|63264033|FG004|Overall Study|Lost to Follow-up|0|||
33700139|NCT02131662|63264029|FG000|Overall Study|Not treated|2|||
33700140|NCT02131662|63264030|FG001|Overall Study|Not treated|0|||
33700141|NCT02131662|63264031|FG002|Overall Study|Not treated|2|||
33700142|NCT02131662|63264032|FG003|Overall Study|Not treated|2|||
33700143|NCT02131662|63264033|FG004|Overall Study|Not treated|3|||
33700144|NCT02106156|63264052|FG000|Overall Study|Patient Died|19|||
33700145|NCT02106156|63264053|FG001|Overall Study|Patient Died|0|||
33700146|NCT02106156|63264054|FG002|Overall Study|Patient Died|0|||
33700147|NCT02106156|63264052|FG000|Overall Study|Lack of Tolerability|305|||
33700148|NCT02106156|63264053|FG001|Overall Study|Lack of Tolerability|3|||
33700149|NCT02106156|63264054|FG002|Overall Study|Lack of Tolerability|0|||
33700150|NCT02106156|63264052|FG000|Overall Study|Lack of Virological Response|1044|||
33700151|NCT02106156|63264053|FG001|Overall Study|Lack of Virological Response|8|||
33700152|NCT02106156|63264054|FG002|Overall Study|Lack of Virological Response|0|||
33700153|NCT02106156|63264052|FG000|Overall Study|Concomitant Disease|74|||
33700154|NCT02106156|63264053|FG001|Overall Study|Concomitant Disease|2|||
33700155|NCT02106156|63264054|FG002|Overall Study|Concomitant Disease|0|||
33700156|NCT02106156|63264052|FG000|Overall Study|Lack of Compliance|211|||
33700157|NCT02106156|63264053|FG001|Overall Study|Lack of Compliance|7|||
33700158|NCT02106156|63264054|FG002|Overall Study|Lack of Compliance|0|||
33700159|NCT02106156|63264052|FG000|Overall Study|Patients Request|307|||
33700160|NCT02106156|63264053|FG001|Overall Study|Patients Request|9|||
33700161|NCT02106156|63264054|FG002|Overall Study|Patients Request|0|||
33700162|NCT02106156|63264052|FG000|Overall Study|Lost to Follow-up|451|||
33700163|NCT02106156|63264053|FG001|Overall Study|Lost to Follow-up|8|||
33700164|NCT02106156|63264054|FG002|Overall Study|Lost to Follow-up|0|||
33700165|NCT02106156|63264052|FG000|Overall Study|Unplanned Event|82|||
33700166|NCT02106156|63264053|FG001|Overall Study|Unplanned Event|2|||
33700167|NCT02106156|63264054|FG002|Overall Study|Unplanned Event|0|||
33700168|NCT02106156|63264052|FG000|Overall Study|Change of Laboratory Parameter|10|||
33700169|NCT02106156|63264053|FG001|Overall Study|Change of Laboratory Parameter|0|||
33700170|NCT02106156|63264054|FG002|Overall Study|Change of Laboratory Parameter|0|||
33700171|NCT02106156|63264052|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
33700172|NCT02106156|63264053|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
33700173|NCT02106156|63264054|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
33700174|NCT02106156|63264052|FG000|Overall Study|Relocation/Change of Physician|40|||
33700175|NCT02106156|63264053|FG001|Overall Study|Relocation/Change of Physician|1|||
33700176|NCT02106156|63264054|FG002|Overall Study|Relocation/Change of Physician|0|||
33700177|NCT01598610|63264080|FG000|Overall Study|Adverse Event|1|||
33700178|NCT01625988|63264086|FG000|Overall Study|Lost to Follow-up|5|||
33700179|NCT01625988|63264087|FG001|Overall Study|Lost to Follow-up|6|||
33700180|NCT01625988|63264086|FG000|Overall Study|Withdrawal by Subject|8|||
33700181|NCT01625988|63264087|FG001|Overall Study|Withdrawal by Subject|3|||
33700182|NCT01625988|63264086|FG000|Overall Study|Adverse Event|0|||
33700183|NCT01625988|63264087|FG001|Overall Study|Adverse Event|1|||
33700184|NCT01625988|63264086|FG000|Overall Study|Lack of Efficacy|0|||
33700185|NCT01625988|63264087|FG001|Overall Study|Lack of Efficacy|1|||
33700186|NCT01625988|63264086|FG000|Overall Study|Randomized Inappropriately|1|||
33700187|NCT01625988|63264087|FG001|Overall Study|Randomized Inappropriately|0|||
33700188|NCT01625988|63264086|FG000|Overall Study|Protocol Violation|0|||
33700189|NCT01625988|63264087|FG001|Overall Study|Protocol Violation|2|||
33700190|NCT02131272|63264098|FG000|Overall Study|Withdrawal by parent|0|||
33700191|NCT02131272|63264099|FG001|Overall Study|Withdrawal by parent|1|||
33700192|NCT02131272|63264098|FG000|Overall Study|Withdrawal by Subject|0|||
33700193|NCT02131272|63264099|FG001|Overall Study|Withdrawal by Subject|1|||
33700194|NCT02131272|63264098|FG000|Overall Study|Withdrawal Criteria|1|||
33700195|NCT02131272|63264099|FG001|Overall Study|Withdrawal Criteria|0|||
33700196|NCT02130882|63264107|FG000|Overall Study|Withdrawal by Subject|0|||
33700197|NCT02130882|63264108|FG001|Overall Study|Withdrawal by Subject|1|||
33700198|NCT02130570|63264116|FG000|Overall Study|Death|3|||
33700199|NCT02130570|63264117|FG001|Overall Study|Death|5|||
33700200|NCT02130570|63264116|FG000|Overall Study|Withdrawal by Subject|6|||
33700201|NCT02130570|63264117|FG001|Overall Study|Withdrawal by Subject|3|||
33700202|NCT02130570|63264116|FG000|Overall Study|Part of practice that discontinued study|0|||
33700203|NCT02130570|63264117|FG001|Overall Study|Part of practice that discontinued study|5|||
33700204|NCT02149836|63264124|FG000|Overall Study|Withdrawal by Subject|1|||
33700205|NCT02130024|63264130|FG000|Overall Study|Adverse Event|10|||
33700206|NCT02130024|63264131|FG001|Overall Study|Adverse Event|11|||
33700207|NCT02130024|63264130|FG000|Overall Study|Death|2|||
33700208|NCT02130024|63264131|FG001|Overall Study|Death|2|||
33700209|NCT02130024|63264130|FG000|Overall Study|Lost to Follow-up|1|||
33700210|NCT02130024|63264131|FG001|Overall Study|Lost to Follow-up|1|||
33700211|NCT02130024|63264130|FG000|Overall Study|Physician Decision|1|||
33700212|NCT02130024|63264131|FG001|Overall Study|Physician Decision|3|||
33700213|NCT02130024|63264130|FG000|Overall Study|Protocol Deviation|4|||
33700214|NCT02130024|63264131|FG001|Overall Study|Protocol Deviation|0|||
33700215|NCT02130024|63264130|FG000|Overall Study|Site Administration Problems|1|||
33700216|NCT02130024|63264131|FG001|Overall Study|Site Administration Problems|0|||
33700217|NCT02130024|63264130|FG000|Overall Study|Subject Withdrew Consent|6|||
33700218|NCT02130024|63264131|FG001|Overall Study|Subject Withdrew Consent|14|||
33700219|NCT02105688|63264139|FG000|Part A: Double-Blind|Adverse Event|1|||
33700220|NCT02105688|63264140|FG001|Part A: Double-Blind|Adverse Event|0|||
33700221|NCT02105688|63264139|FG000|Part A: Double-Blind|Death|0|||
33700222|NCT02105688|63264140|FG001|Part A: Double-Blind|Death|1|||
33700223|NCT02105688|63264139|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
33700224|NCT02105688|63264140|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
33700225|NCT02105688|63264139|FG000|Part A: Double-Blind|Physician Decision|0|||
33700226|NCT02105688|63264140|FG001|Part A: Double-Blind|Physician Decision|1|||
33700227|NCT02105688|63264139|FG000|Part A: Double-Blind|Status Unknown|0|||
33700228|NCT02105688|63264140|FG001|Part A: Double-Blind|Status Unknown|2|||
33700229|NCT02105688|63264139|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
33700230|NCT02105688|63264140|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
33700231|NCT02105688|63264139|FG000|Part B: Observational Follow-up|Death|2|||
33700232|NCT02105688|63264140|FG001|Part B: Observational Follow-up|Death|1|||
33700233|NCT02105688|63264139|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
33700234|NCT02105688|63264140|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
33700235|NCT02105688|63264139|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
33700236|NCT02105688|63264140|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
33700237|NCT02105688|63264139|FG000|Part B: Observational Follow-up|Physician Decision|3|||
33700238|NCT02105688|63264140|FG001|Part B: Observational Follow-up|Physician Decision|1|||
33700239|NCT02105454|63264147|FG000|Overall Study|Withdrawal by Subject|1|||
33700240|NCT01625910|63264153|FG000|Overall Study|Lost to Follow-up|3|||
33700241|NCT01625910|63264154|FG001|Overall Study|Lost to Follow-up|4|||
33700242|NCT02104752|63264164|FG000|Overall Study|Withdrawal by Subject|1|||
33700243|NCT02104752|63264165|FG001|Overall Study|Withdrawal by Subject|0|||
33700244|NCT02104752|63264164|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
33700245|NCT02104752|63264165|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
33700246|NCT02102724|63264173|FG000|Overall Study|Lost to Follow-up|1|||
33700247|NCT02102724|63264174|FG001|Overall Study|Lost to Follow-up|0|||
33700248|NCT02102724|63264173|FG000|Overall Study|surgery for brain aneurysm|1|||
33700249|NCT02102724|63264174|FG001|Overall Study|surgery for brain aneurysm|1|||
33700250|NCT02102490|63264180|FG000|Overall Study|Death|6|||
33700251|NCT02102490|63264180|FG000|Overall Study|Lost to Follow-up|1|||
33700252|NCT02101554|63264187|FG000|Overall Study|Protocol Violation|0|||
33700253|NCT02101554|63264188|FG001|Overall Study|Protocol Violation|1|||
33700254|NCT02101554|63264189|FG002|Overall Study|Protocol Violation|0|||
33700255|NCT02101554|63264187|FG000|Overall Study|Insufficient Clinical Response|0|||
33700256|NCT02101554|63264188|FG001|Overall Study|Insufficient Clinical Response|2|||
33700257|NCT02101554|63264189|FG002|Overall Study|Insufficient Clinical Response|0|||
33700258|NCT02101554|63264187|FG000|Overall Study|Adverse Event|2|||
33700259|NCT02101554|63264188|FG001|Overall Study|Adverse Event|1|||
33700260|NCT02101554|63264189|FG002|Overall Study|Adverse Event|1|||
33700261|NCT02101554|63264187|FG000|Overall Study|Lost to Follow-up|0|||
33700262|NCT02101554|63264188|FG001|Overall Study|Lost to Follow-up|1|||
33700263|NCT02101554|63264189|FG002|Overall Study|Lost to Follow-up|0|||
33700264|NCT02101554|63264187|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
33700265|NCT02101554|63264188|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
33700266|NCT02101554|63264189|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
33700267|NCT02128932|63264200|FG000|Overall Study|Withdrawal by Subject|11|||
33700268|NCT02128932|63264201|FG001|Overall Study|Withdrawal by Subject|7|||
33700269|NCT02128932|63264202|FG002|Overall Study|Withdrawal by Subject|8|||
33700270|NCT02128932|63264200|FG000|Overall Study|Death|2|||
33700271|NCT02128932|63264201|FG001|Overall Study|Death|0|||
33700272|NCT02128932|63264202|FG002|Overall Study|Death|2|||
33700273|NCT02128932|63264200|FG000|Overall Study|Lost to Follow-up|2|||
33700274|NCT02128932|63264201|FG001|Overall Study|Lost to Follow-up|1|||
33700275|NCT02128932|63264202|FG002|Overall Study|Lost to Follow-up|1|||
33700276|NCT02128932|63264200|FG000|Overall Study|No reason for withdrawal|12|||
33700277|NCT02128932|63264201|FG001|Overall Study|No reason for withdrawal|11|||
33700278|NCT02128932|63264202|FG002|Overall Study|No reason for withdrawal|7|||
33700279|NCT02128542|63264212|FG000|Overall Study|Lost to Follow-up|3|||
33700280|NCT02128542|63264213|FG001|Overall Study|Lost to Follow-up|0|||
33700281|NCT02128542|63264212|FG000|Overall Study|Withdrew Consent|1|||
33700282|NCT02128542|63264213|FG001|Overall Study|Withdrew Consent|0|||
33700283|NCT02127372|63264223|FG000|Overall Study|Withdrawal by Subject|1|||
33700284|NCT02127372|63264224|FG001|Overall Study|Withdrawal by Subject|0|||
33700285|NCT02126826|63264238|FG000|Overall Study|Withdrawal by Subject|0|||
33700286|NCT02126826|63264239|FG001|Overall Study|Withdrawal by Subject|0|||
33700287|NCT02126826|63264240|FG002|Overall Study|Withdrawal by Subject|0|||
33700288|NCT02126826|63264241|FG003|Overall Study|Withdrawal by Subject|1|||
33700289|NCT02126826|63264242|FG004|Overall Study|Withdrawal by Subject|0|||
33700290|NCT02126826|63264243|FG005|Overall Study|Withdrawal by Subject|0|||
33700291|NCT02126826|63264244|FG006|Overall Study|Withdrawal by Subject|0|||
33700292|NCT02126670|63264269|FG000|Overall Study|Withdrawal by Subject|1|||
33700293|NCT02126670|63264270|FG001|Overall Study|Withdrawal by Subject|0|||
33700294|NCT02126670|63264271|FG002|Overall Study|Withdrawal by Subject|0|||
33700295|NCT02126670|63264272|FG003|Overall Study|Withdrawal by Subject|1|||
33700296|NCT02125734|63264284|FG000|Period 2|Adverse Event|0|||
33700297|NCT02125734|63264285|FG001|Period 2|Adverse Event|1|||
33700298|NCT02124798|63264291|FG000|Overall Study|Adverse Event|3|||
33700299|NCT02124798|63264291|FG000|Overall Study|Lost to Follow-up|1|||
33700300|NCT02146326|63264299|FG000|Overall Study|Lost to Follow-up|3|||
33700301|NCT02146326|63264300|FG001|Overall Study|Lost to Follow-up|3|||
33700302|NCT02146326|63264301|FG002|Overall Study|Lost to Follow-up|11|||
33700303|NCT02146326|63264302|FG003|Overall Study|Lost to Follow-up|19|||
33700304|NCT02146326|63264299|FG000|Overall Study|Withdrawal by Subject|2|||
33700305|NCT02146326|63264300|FG001|Overall Study|Withdrawal by Subject|1|||
33700306|NCT02146326|63264301|FG002|Overall Study|Withdrawal by Subject|15|||
33700307|NCT02146326|63264302|FG003|Overall Study|Withdrawal by Subject|11|||
33700308|NCT02146326|63264299|FG000|Overall Study|Separated from mental health center|23|||
33700309|NCT02146326|63264300|FG001|Overall Study|Separated from mental health center|33|||
33700310|NCT02146326|63264301|FG002|Overall Study|Separated from mental health center|0|||
33700311|NCT02146326|63264302|FG003|Overall Study|Separated from mental health center|0|||
33700312|NCT02146326|63264299|FG000|Overall Study|Incarcerated|0|||
33700313|NCT02146326|63264300|FG001|Overall Study|Incarcerated|0|||
33700314|NCT02146326|63264301|FG002|Overall Study|Incarcerated|3|||
33700315|NCT02146326|63264302|FG003|Overall Study|Incarcerated|8|||
33700316|NCT02146326|63264299|FG000|Overall Study|Death|0|||
33700317|NCT02146326|63264300|FG001|Overall Study|Death|0|||
33700318|NCT02146326|63264301|FG002|Overall Study|Death|4|||
33700319|NCT02146326|63264302|FG003|Overall Study|Death|4|||
33700320|NCT02146326|63264299|FG000|Overall Study|Unable to complete interview|0|||
33700321|NCT02146326|63264300|FG001|Overall Study|Unable to complete interview|0|||
33700322|NCT02146326|63264301|FG002|Overall Study|Unable to complete interview|10|||
33700323|NCT02146326|63264302|FG003|Overall Study|Unable to complete interview|6|||
33700324|NCT02146248|63264318|FG000|Overall Study|Withdrawal by Subject|2|||
33700325|NCT02145468|63264328|FG000|Overall Study|Withdrawal by Subject|5|||
33700326|NCT02145468|63264329|FG001|Overall Study|Withdrawal by Subject|8|||
33700327|NCT02124564|63264335|FG000|Treatment Period|Adverse Event|2|||
33700328|NCT02124564|63264335|FG000|Treatment Period|Lack of Efficacy|3|||
33700329|NCT02124564|63264335|FG000|Treatment Period|Withdrawal by Subject|2|||
33700330|NCT02145390|63264340|FG000|Overall Study|Withdrawal by Subject|1|||
33700331|NCT02100696|63264350|FG000|Induction Phase|Adverse Event|0|||
33700332|NCT02100696|63264351|FG001|Induction Phase|Adverse Event|0|||
33700333|NCT02100696|63264352|FG002|Induction Phase|Adverse Event|1|||
33700334|NCT02100696|63264353|FG003|Induction Phase|Adverse Event|0|||
33700335|NCT02100696|63264354|FG004|Induction Phase|Adverse Event|0|||
33700336|NCT02100696|63264355|FG005|Induction Phase|Adverse Event|0|||
33700337|NCT02100696|63264350|FG000|Induction Phase|Lost to Follow-up|1|||
33700338|NCT02100696|63264351|FG001|Induction Phase|Lost to Follow-up|0|||
33700339|NCT02100696|63264352|FG002|Induction Phase|Lost to Follow-up|1|||
33700340|NCT02100696|63264353|FG003|Induction Phase|Lost to Follow-up|0|||
33700341|NCT02100696|63264354|FG004|Induction Phase|Lost to Follow-up|0|||
33700342|NCT02100696|63264355|FG005|Induction Phase|Lost to Follow-up|0|||
33700343|NCT02100696|63264350|FG000|Induction Phase|Protocol Violation|0|||
33700344|NCT02100696|63264351|FG001|Induction Phase|Protocol Violation|1|||
33700345|NCT02100696|63264352|FG002|Induction Phase|Protocol Violation|1|||
33700346|NCT02100696|63264353|FG003|Induction Phase|Protocol Violation|0|||
33700347|NCT02100696|63264354|FG004|Induction Phase|Protocol Violation|0|||
33700348|NCT02100696|63264355|FG005|Induction Phase|Protocol Violation|0|||
33700349|NCT02100696|63264350|FG000|Induction Phase|Withdrawal by Subject|8|||
33700350|NCT02100696|63264351|FG001|Induction Phase|Withdrawal by Subject|2|||
33700351|NCT02100696|63264352|FG002|Induction Phase|Withdrawal by Subject|13|||
33700352|NCT02100696|63264353|FG003|Induction Phase|Withdrawal by Subject|0|||
33700353|NCT02100696|63264354|FG004|Induction Phase|Withdrawal by Subject|0|||
33700354|NCT02100696|63264355|FG005|Induction Phase|Withdrawal by Subject|0|||
33700355|NCT02100696|63264350|FG000|Induction Phase|Physician Decision|1|||
33700356|NCT02100696|63264351|FG001|Induction Phase|Physician Decision|0|||
33700357|NCT02100696|63264352|FG002|Induction Phase|Physician Decision|2|||
33700358|NCT02100696|63264353|FG003|Induction Phase|Physician Decision|0|||
33700359|NCT02100696|63264354|FG004|Induction Phase|Physician Decision|0|||
33700360|NCT02100696|63264355|FG005|Induction Phase|Physician Decision|0|||
33700361|NCT02100696|63264350|FG000|Induction Phase|Multiple Reasons|5|||
33700362|NCT02100696|63264351|FG001|Induction Phase|Multiple Reasons|2|||
33700363|NCT02100696|63264352|FG002|Induction Phase|Multiple Reasons|8|||
33700364|NCT02100696|63264353|FG003|Induction Phase|Multiple Reasons|0|||
33700365|NCT02100696|63264354|FG004|Induction Phase|Multiple Reasons|0|||
33700366|NCT02100696|63264355|FG005|Induction Phase|Multiple Reasons|0|||
33700367|NCT02100696|63264350|FG000|Maintenance Phase|Adverse Event|0|||
33700368|NCT02100696|63264351|FG001|Maintenance Phase|Adverse Event|0|||
33700369|NCT02100696|63264352|FG002|Maintenance Phase|Adverse Event|0|||
33700370|NCT02100696|63264353|FG003|Maintenance Phase|Adverse Event|0|||
33700371|NCT02100696|63264354|FG004|Maintenance Phase|Adverse Event|0|||
33700372|NCT02100696|63264355|FG005|Maintenance Phase|Adverse Event|2|||
33700373|NCT02100696|63264350|FG000|Maintenance Phase|Lost to Follow-up|0|||
33700374|NCT02100696|63264351|FG001|Maintenance Phase|Lost to Follow-up|0|||
33700375|NCT02100696|63264352|FG002|Maintenance Phase|Lost to Follow-up|0|||
33700376|NCT02100696|63264353|FG003|Maintenance Phase|Lost to Follow-up|0|||
33700377|NCT02100696|63264354|FG004|Maintenance Phase|Lost to Follow-up|1|||
33700378|NCT02100696|63264355|FG005|Maintenance Phase|Lost to Follow-up|0|||
33700379|NCT02100696|63264350|FG000|Maintenance Phase|Protocol Violation|0|||
33700380|NCT02100696|63264351|FG001|Maintenance Phase|Protocol Violation|0|||
33700381|NCT02100696|63264352|FG002|Maintenance Phase|Protocol Violation|0|||
33700382|NCT02100696|63264353|FG003|Maintenance Phase|Protocol Violation|0|||
33700383|NCT02100696|63264354|FG004|Maintenance Phase|Protocol Violation|1|||
33700384|NCT02100696|63264355|FG005|Maintenance Phase|Protocol Violation|0|||
33700385|NCT02100696|63264350|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33700386|NCT02100696|63264351|FG001|Maintenance Phase|Withdrawal by Subject|0|||
33700387|NCT02100696|63264352|FG002|Maintenance Phase|Withdrawal by Subject|0|||
33700388|NCT02100696|63264353|FG003|Maintenance Phase|Withdrawal by Subject|1|||
33700389|NCT02100696|63264354|FG004|Maintenance Phase|Withdrawal by Subject|4|||
33700390|NCT02100696|63264355|FG005|Maintenance Phase|Withdrawal by Subject|2|||
33700391|NCT02100696|63264350|FG000|Maintenance Phase|Physician Decision|0|||
33700392|NCT02100696|63264351|FG001|Maintenance Phase|Physician Decision|0|||
33700393|NCT02100696|63264352|FG002|Maintenance Phase|Physician Decision|0|||
33700394|NCT02100696|63264353|FG003|Maintenance Phase|Physician Decision|0|||
33700395|NCT02100696|63264354|FG004|Maintenance Phase|Physician Decision|1|||
33700396|NCT02100696|63264355|FG005|Maintenance Phase|Physician Decision|0|||
33700397|NCT02100696|63264350|FG000|Maintenance Phase|Multiple Reasons|0|||
33700398|NCT02100696|63264351|FG001|Maintenance Phase|Multiple Reasons|0|||
33700399|NCT02100696|63264352|FG002|Maintenance Phase|Multiple Reasons|0|||
33700400|NCT02100696|63264353|FG003|Maintenance Phase|Multiple Reasons|0|||
33700401|NCT02100696|63264354|FG004|Maintenance Phase|Multiple Reasons|2|||
33700402|NCT02100696|63264355|FG005|Maintenance Phase|Multiple Reasons|1|||
33700403|NCT02145156|63264379|FG000|Overall Study|No match to vaccination records|60|||
33700404|NCT02145156|63264380|FG001|Overall Study|No match to vaccination records|52|||
33700405|NCT02145156|63264381|FG002|Overall Study|No match to vaccination records|41|||
33700406|NCT02123472|63264389|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
33700407|NCT02123472|63264390|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
33700408|NCT02145078|63264396|FG000|Overall Study|Death|1|||
33700409|NCT02145078|63264396|FG000|Overall Study|Reason not given|3|||
33700410|NCT02144610|63264402|FG000|Overall Study|Physician Decision|1|||
33700411|NCT02144610|63264403|FG001|Overall Study|Physician Decision|0|||
33700412|NCT02144610|63264402|FG000|Overall Study|Withdrawal by Subject|1|||
33700413|NCT02144610|63264403|FG001|Overall Study|Withdrawal by Subject|5|||
33700414|NCT02144610|63264402|FG000|Overall Study|Death|2|||
33700415|NCT02144610|63264403|FG001|Overall Study|Death|2|||
33700416|NCT02144610|63264402|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
33700417|NCT02144610|63264403|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
33700418|NCT02144610|63264402|FG000|Overall Study|Other|0|||
33700419|NCT02144610|63264403|FG001|Overall Study|Other|1|||
33700420|NCT02100228|63264411|FG000|Overall Study|Other|19|||
33700421|NCT02100228|63264412|FG001|Overall Study|Other|19|||
33700422|NCT02100228|63264411|FG000|Overall Study|Administrative reason|0|||
33700423|NCT02100228|63264412|FG001|Overall Study|Administrative reason|1|||
33700424|NCT02100228|63264411|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
33700425|NCT02100228|63264412|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
33700426|NCT02100228|63264411|FG000|Overall Study|Non-compliance|0|||
33700427|NCT02100228|63264412|FG001|Overall Study|Non-compliance|3|||
33700428|NCT02100228|63264411|FG000|Overall Study|Lost to Follow-up|0|||
33700429|NCT02100228|63264412|FG001|Overall Study|Lost to Follow-up|1|||
33700430|NCT02100228|63264411|FG000|Overall Study|Withdrawal by Subject|27|||
33700431|NCT02100228|63264412|FG001|Overall Study|Withdrawal by Subject|37|||
33700432|NCT02100228|63264411|FG000|Overall Study|Adverse Event|16|||
33700433|NCT02100228|63264412|FG001|Overall Study|Adverse Event|12|||
33700434|NCT02100228|63264411|FG000|Overall Study|Death|1|||
33700435|NCT02100228|63264412|FG001|Overall Study|Death|1|||
33700436|NCT02099838|63264420|FG000|Overall Study|Death|1|||
33700437|NCT02099838|63264421|FG001|Overall Study|Death|0|||
33700438|NCT02099838|63264420|FG000|Overall Study|Lost to Follow-up|3|||
33700439|NCT02099838|63264421|FG001|Overall Study|Lost to Follow-up|1|||
33700440|NCT02099838|63264420|FG000|Overall Study|Withdrawal by Subject|0|||
33700441|NCT02099838|63264421|FG001|Overall Study|Withdrawal by Subject|1|||
33700442|NCT02144220|63264427|FG000|Overall Study|technology incompatibility|9|||
33700443|NCT02144220|63264427|FG000|Overall Study|Lack of Efficacy|4|||
33700444|NCT02144220|63264427|FG000|Overall Study|Physician Decision|3|||
33700445|NCT02144220|63264427|FG000|Overall Study|Withdrawal by Subject|2|||
33700446|NCT02144220|63264427|FG000|Overall Study|Protocol Violation|1|||
33700447|NCT02099682|63264431|FG000|Overall Study|Data Not Available|51|||
33700448|NCT02099682|63264431|FG000|Overall Study|Lost to Follow-up|31|||
33700449|NCT02099682|63264431|FG000|Overall Study|Other|29|||
33700450|NCT02142894|63264435|FG000|Overall Study|Protocol Violation|8|||
33700451|NCT02098746|63264439|FG000|Overall Study|Changes of Investigator|2|||
33700452|NCT02098746|63264439|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33700453|NCT02098746|63264439|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
33700454|NCT02098746|63264439|FG000|Overall Study|Data Not Available After Treatment|1|||
33700455|NCT02122770|63264447|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
33700456|NCT02122770|63264448|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
33700457|NCT02122770|63264449|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
33700458|NCT02122770|63264450|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
33700459|NCT02122770|63264451|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
33700460|NCT02122770|63264452|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
33700461|NCT02122770|63264447|FG000|Part A: Drug-drug Interaction 2|Other|0|||
33700462|NCT02122770|63264448|FG001|Part A: Drug-drug Interaction 2|Other|0|||
33700463|NCT02122770|63264449|FG002|Part A: Drug-drug Interaction 2|Other|1|||
33596473|NCT02141295|62995453|FG002|Overall Study|Study terminated by sponsor|6|||
33596474|NCT02141295|62995451|FG000|Overall Study|Non-compliance|0|||
33596475|NCT02141295|62995452|FG001|Overall Study|Non-compliance|1|||
33596476|NCT02141295|62995453|FG002|Overall Study|Non-compliance|0|||
33700464|NCT02122770|63264450|FG003|Part A: Drug-drug Interaction 2|Other|0|||
33700465|NCT02122770|63264451|FG004|Part A: Drug-drug Interaction 2|Other|0|||
33700466|NCT02122770|63264452|FG005|Part A: Drug-drug Interaction 2|Other|0|||
33700467|NCT02122770|63264447|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
33700468|NCT02122770|63264448|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
33700469|NCT02122770|63264449|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
33596477|NCT02141295|62995451|FG000|Overall Study|Progressive disease|3|||
33596478|NCT02141295|62995452|FG001|Overall Study|Progressive disease|32|||
33700470|NCT02122770|63264450|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
33700471|NCT02122770|63264451|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
33700472|NCT02122770|63264452|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
33700473|NCT02122770|63264447|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
33700474|NCT02122770|63264448|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
33700475|NCT02122770|63264449|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
33700476|NCT02122770|63264450|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
33596479|NCT02141295|62995453|FG002|Overall Study|Progressive disease|50|||
33596480|NCT02141295|62995451|FG000|Overall Study|Reason not specified|0|||
33596481|NCT02141295|62995452|FG001|Overall Study|Reason not specified|9|||
33596482|NCT02141295|62995453|FG002|Overall Study|Reason not specified|10|||
33596483|NCT02141295|62995451|FG000|Overall Study|Withdrawal by Subject|0|||
33596484|NCT02141295|62995452|FG001|Overall Study|Withdrawal by Subject|9|||
33596485|NCT02141295|62995453|FG002|Overall Study|Withdrawal by Subject|4|||
33596486|NCT02514551|62995465|FG000|Overall Study|Lost to Follow-up|0|||
33596487|NCT02514551|62995466|FG001|Overall Study|Lost to Follow-up|1|||
33596488|NCT02514551|62995465|FG000|Overall Study|Participant Never Treated|0|||
33596489|NCT02514551|62995466|FG001|Overall Study|Participant Never Treated|2|||
33596490|NCT02141217|62995475|FG000|Overall Study|Adverse Event|1|||
33596491|NCT02141217|62995476|FG001|Overall Study|Adverse Event|2|||
33596492|NCT02141217|62995475|FG000|Overall Study|Protocol Violation|1|||
33596493|NCT02141217|62995476|FG001|Overall Study|Protocol Violation|4|||
33596494|NCT02141217|62995475|FG000|Overall Study|Withdrawal by Subject|6|||
33596495|NCT02141217|62995476|FG001|Overall Study|Withdrawal by Subject|0|||
33596496|NCT02141217|62995475|FG000|Overall Study|Lost to Follow-up|1|||
33596497|NCT02141217|62995476|FG001|Overall Study|Lost to Follow-up|1|||
33596498|NCT02141217|62995475|FG000|Overall Study|Physician Decision|1|||
33596499|NCT02141217|62995476|FG001|Overall Study|Physician Decision|0|||
33596500|NCT02141217|62995475|FG000|Overall Study|Surgical Intervention|1|||
33596501|NCT02141217|62995476|FG001|Overall Study|Surgical Intervention|1|||
33596502|NCT02138253|62995487|FG000|Overall Study|Adverse Event|3|||
33596503|NCT02138253|62995488|FG001|Overall Study|Adverse Event|3|||
33596504|NCT02138253|62995487|FG000|Overall Study|Lost to Follow-up|2|||
33596505|NCT02138253|62995488|FG001|Overall Study|Lost to Follow-up|1|||
33596506|NCT02138253|62995487|FG000|Overall Study|Physician Decision|2|||
33596507|NCT02138253|62995488|FG001|Overall Study|Physician Decision|0|||
33596508|NCT02138253|62995487|FG000|Overall Study|Non compliance|1|||
33596509|NCT02138253|62995488|FG001|Overall Study|Non compliance|0|||
33596510|NCT02138253|62995487|FG000|Overall Study|Withdrawal by Subject|1|||
33596511|NCT02138253|62995488|FG001|Overall Study|Withdrawal by Subject|0|||
33596512|NCT02514473|62995496|FG000|Overall Study|Adverse Event|0|||
33596513|NCT02514473|62995497|FG001|Overall Study|Adverse Event|2|||
33596514|NCT02514473|62995496|FG000|Overall Study|Withdrawal by Subject|2|||
33596515|NCT02514473|62995497|FG001|Overall Study|Withdrawal by Subject|1|||
33596516|NCT02514473|62995496|FG000|Overall Study|Lost to Follow-up|0|||
33596517|NCT02514473|62995497|FG001|Overall Study|Lost to Follow-up|1|||
33596518|NCT02514473|62995496|FG000|Overall Study|Other|1|||
33596519|NCT02514473|62995497|FG001|Overall Study|Other|1|||
33596520|NCT02513771|62995506|FG000|Overall Study|Lost to Follow-up|1|||
33596521|NCT02513771|62995507|FG001|Overall Study|Lost to Follow-up|1|||
33596522|NCT02513771|62995506|FG000|Overall Study|Not being able to get to clinic|1|||
33596523|NCT02513771|62995507|FG001|Overall Study|Not being able to get to clinic|0|||
33596524|NCT02104947|62995515|FG000|Overall Study|Withdrawal by Subject|10|||
33596525|NCT02104947|62995516|FG001|Overall Study|Withdrawal by Subject|3|||
33596526|NCT02104947|62995515|FG000|Overall Study|Lost to Follow-up|4|||
33596527|NCT02104947|62995516|FG001|Overall Study|Lost to Follow-up|4|||
33596528|NCT02104947|62995515|FG000|Overall Study|Protocol Violation|6|||
33596529|NCT02104947|62995516|FG001|Overall Study|Protocol Violation|8|||
33596530|NCT02104947|62995515|FG000|Overall Study|Adverse Event|57|||
33596531|NCT02104947|62995516|FG001|Overall Study|Adverse Event|38|||
33596532|NCT02104947|62995515|FG000|Overall Study|Other than stated above|2|||
33596533|NCT02104947|62995516|FG001|Overall Study|Other than stated above|3|||
33596534|NCT02513459|62995526|FG000|Overall Study|Adverse Event|7|||
33596535|NCT02513459|62995526|FG000|Overall Study|Withdrew consent|5|||
33596536|NCT02513459|62995526|FG000|Overall Study|Loss of efficacy|2|||
33596537|NCT02513459|62995526|FG000|Overall Study|Pregnancy|2|||
33596538|NCT02513459|62995526|FG000|Overall Study|Subject decision|2|||
33596539|NCT02513459|62995526|FG000|Overall Study|Lack of response|1|||
33596540|NCT02513459|62995526|FG000|Overall Study|Reproductive plans|1|||
33596541|NCT02513459|62995526|FG000|Overall Study|Surgery planned-- not done|1|||
33596542|NCT02104557|62995535|FG000|Overall Study|Adverse Event|24|||
33596543|NCT02104557|62995535|FG000|Overall Study|Lost to Follow-up|34|||
33596544|NCT02104557|62995535|FG000|Overall Study|Violated the usage and dosage|14|||
33596545|NCT02104557|62995535|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
33596546|NCT02104557|62995535|FG000|Overall Study|Administered Sayana prior to the contract|1|||
33596547|NCT02104557|62995535|FG000|Overall Study|Other|17|||
33596548|NCT02104557|62995535|FG000|Overall Study|Change to other contraception methods|5|||
33596549|NCT02104557|62995535|FG000|Overall Study|Discontinuation due to no pain|1|||
33596550|NCT02104557|62995535|FG000|Overall Study|Withdrawal consent|2|||
33596551|NCT02104557|62995535|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
33596552|NCT02104557|62995535|FG000|Overall Study|Discontinuation of contraception|9|||
33596553|NCT02069379|62995541|FG000|Baseline Measurements|Lost to Follow-up|1|||
33596554|NCT02069379|62995542|FG001|Baseline Measurements|Lost to Follow-up|0|||
33596555|NCT02069379|62995543|FG002|Baseline Measurements|Lost to Follow-up|0|||
33596556|NCT02069379|62995544|FG003|Baseline Measurements|Lost to Follow-up|0|||
33596557|NCT02069379|62995541|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
33596558|NCT02069379|62995542|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
33596559|NCT02069379|62995543|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
33596560|NCT02069379|62995544|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
33596561|NCT02069379|62995541|FG000|First Treatment Arm|Lost to Follow-up|0|||
33596562|NCT02069379|62995542|FG001|First Treatment Arm|Lost to Follow-up|1|||
33596563|NCT02069379|62995543|FG002|First Treatment Arm|Lost to Follow-up|1|||
33596564|NCT02069379|62995544|FG003|First Treatment Arm|Lost to Follow-up|0|||
33596565|NCT02069379|62995541|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
33596566|NCT02069379|62995542|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
33596567|NCT02069379|62995543|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
33596568|NCT02069379|62995544|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
33596569|NCT02069379|62995541|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
33596570|NCT02069379|62995542|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
33596571|NCT02069379|62995543|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
33596572|NCT02069379|62995544|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
33596573|NCT02069379|62995541|FG000|Second Treatment Arm|Lost to Follow-up|0|||
33596574|NCT02069379|62995542|FG001|Second Treatment Arm|Lost to Follow-up|0|||
33596575|NCT02069379|62995543|FG002|Second Treatment Arm|Lost to Follow-up|1|||
33596576|NCT02069379|62995544|FG003|Second Treatment Arm|Lost to Follow-up|0|||
33596577|NCT02511431|62995560|FG000|Treatment|Lost to Follow-up|0|||
33596578|NCT02511431|62995561|FG001|Treatment|Lost to Follow-up|0|||
33596579|NCT02511431|62995562|FG002|Treatment|Lost to Follow-up|1|||
33596580|NCT02511431|62995563|FG003|Treatment|Lost to Follow-up|0|||
33596581|NCT02511431|62995564|FG004|Treatment|Lost to Follow-up|0|||
33596582|NCT02511431|62995565|FG005|Treatment|Lost to Follow-up|1|||
33596583|NCT02137785|62995582|FG000|Overall Study|Lost to Follow-up|1|||
33596584|NCT02137785|62995583|FG001|Overall Study|Lost to Follow-up|0|||
33596585|NCT02137785|62995582|FG000|Overall Study|Withdrawal by Subject|1|||
33596586|NCT02137785|62995583|FG001|Overall Study|Withdrawal by Subject|4|||
33596587|NCT02137785|62995582|FG000|Overall Study|subject moved out of state|1|||
33596588|NCT02137785|62995583|FG001|Overall Study|subject moved out of state|0|||
33596589|NCT01655069|62995593|FG000|Overall Study|Physician Decision|0|||
33596590|NCT01655069|62995594|FG001|Overall Study|Physician Decision|0|||
33596591|NCT01655069|62995595|FG002|Overall Study|Physician Decision|0|||
33596592|NCT01655069|62995596|FG003|Overall Study|Physician Decision|1|||
33700477|NCT02122770|63264451|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
33700478|NCT02122770|63264452|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
33700479|NCT02122770|63264447|FG000|Part B: Standard of Care|Adverse Event|0|||
33700480|NCT02122770|63264448|FG001|Part B: Standard of Care|Adverse Event|0|||
33700481|NCT02122770|63264449|FG002|Part B: Standard of Care|Adverse Event|0|||
33700482|NCT02122770|63264450|FG003|Part B: Standard of Care|Adverse Event|0|||
33700483|NCT02122770|63264451|FG004|Part B: Standard of Care|Adverse Event|4|||
33700484|NCT02122770|63264452|FG005|Part B: Standard of Care|Adverse Event|1|||
33700485|NCT02122770|63264447|FG000|Part B: Standard of Care|Other|0|||
33700486|NCT02122770|63264448|FG001|Part B: Standard of Care|Other|0|||
33700487|NCT02122770|63264449|FG002|Part B: Standard of Care|Other|0|||
33700488|NCT02122770|63264450|FG003|Part B: Standard of Care|Other|0|||
33700489|NCT02122770|63264451|FG004|Part B: Standard of Care|Other|0|||
33700490|NCT02122770|63264452|FG005|Part B: Standard of Care|Other|2|||
33700491|NCT02122770|63264447|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
33700492|NCT02122770|63264448|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
33700493|NCT02122770|63264449|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
33700494|NCT02122770|63264450|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
33700495|NCT02122770|63264451|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
33310755|NCT01233258|62686173|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
33596593|NCT01655069|62995593|FG000|Overall Study|Adverse Event|6|||
33596594|NCT01655069|62995594|FG001|Overall Study|Adverse Event|7|||
33700496|NCT02122770|63264452|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
33700497|NCT02122770|63264447|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
33700498|NCT02122770|63264448|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
33700499|NCT02122770|63264449|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
33700500|NCT02122770|63264450|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
33700501|NCT02122770|63264451|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
33596595|NCT01655069|62995595|FG002|Overall Study|Adverse Event|2|||
33596596|NCT01655069|62995596|FG003|Overall Study|Adverse Event|3|||
33700502|NCT02122770|63264452|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
33700503|NCT02122770|63264447|FG000|Part B: Standard of Care|Progressive Disease|0|||
33700504|NCT02122770|63264448|FG001|Part B: Standard of Care|Progressive Disease|0|||
33700505|NCT02122770|63264449|FG002|Part B: Standard of Care|Progressive Disease|0|||
33700506|NCT02122770|63264450|FG003|Part B: Standard of Care|Progressive Disease|0|||
33700507|NCT02122770|63264451|FG004|Part B: Standard of Care|Progressive Disease|10|||
33700508|NCT02122770|63264452|FG005|Part B: Standard of Care|Progressive Disease|8|||
33700509|NCT02122380|63264477|FG000|First Intervention (30 Days)|Adverse Event|1|||
33700510|NCT02122380|63264478|FG001|First Intervention (30 Days)|Adverse Event|0|||
33700511|NCT02122380|63264477|FG000|First Intervention (30 Days)|Physician Decision|0|||
33700512|NCT02122380|63264478|FG001|First Intervention (30 Days)|Physician Decision|1|||
33700513|NCT02122380|63264477|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
33700514|NCT02122380|63264478|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
33700515|NCT02122380|63264477|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
33700516|NCT02122380|63264478|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
33700517|NCT02122380|63264477|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
33700518|NCT02122380|63264478|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
33700519|NCT02122146|63264493|FG000|Part 1: Dose Escalation|Death|0|||
33700520|NCT02122146|63264494|FG001|Part 1: Dose Escalation|Death|1|||
33700521|NCT02122146|63264495|FG002|Part 1: Dose Escalation|Death|1|||
33700522|NCT02122146|63264496|FG003|Part 1: Dose Escalation|Death|0|||
33700523|NCT02122146|63264497|FG004|Part 1: Dose Escalation|Death|0|||
33700524|NCT02122146|63264498|FG005|Part 1: Dose Escalation|Death|0|||
33700525|NCT02122146|63264499|FG006|Part 1: Dose Escalation|Death|0|||
33700526|NCT02122146|63264500|FG007|Part 1: Dose Escalation|Death|0|||
33700527|NCT02122146|63264493|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
33700528|NCT02122146|63264494|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
33700529|NCT02122146|63264495|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
33700530|NCT02122146|63264496|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
33700531|NCT02122146|63264497|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
33700532|NCT02122146|63264498|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
33700533|NCT02122146|63264499|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
33700534|NCT02122146|63264500|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
33700535|NCT02122146|63264493|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33700536|NCT02122146|63264494|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33700537|NCT02122146|63264495|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33700538|NCT02122146|63264496|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
33700539|NCT02122146|63264497|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33700540|NCT02122146|63264498|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33700541|NCT02122146|63264499|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33700542|NCT02122146|63264500|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33700543|NCT02122146|63264493|FG000|Part 1: Dose Escalation|Other|1|||
33700544|NCT02122146|63264494|FG001|Part 1: Dose Escalation|Other|0|||
33700545|NCT02122146|63264495|FG002|Part 1: Dose Escalation|Other|0|||
33700546|NCT02122146|63264496|FG003|Part 1: Dose Escalation|Other|0|||
33700547|NCT02122146|63264497|FG004|Part 1: Dose Escalation|Other|0|||
33700548|NCT02122146|63264498|FG005|Part 1: Dose Escalation|Other|1|||
33700549|NCT02122146|63264499|FG006|Part 1: Dose Escalation|Other|1|||
33700550|NCT02122146|63264500|FG007|Part 1: Dose Escalation|Other|2|||
33700551|NCT02121834|63264526|FG000|Overall Study|Protocol Violation|0|||
33700552|NCT02121834|63264527|FG001|Overall Study|Protocol Violation|1|||
33700553|NCT02121834|63264528|FG002|Overall Study|Protocol Violation|0|||
33700554|NCT02121834|63264529|FG003|Overall Study|Protocol Violation|0|||
33700555|NCT02121834|63264530|FG004|Overall Study|Protocol Violation|0|||
33700556|NCT02121834|63264531|FG005|Overall Study|Protocol Violation|0|||
33700557|NCT02121834|63264532|FG006|Overall Study|Protocol Violation|0|||
33700558|NCT02121834|63264526|FG000|Overall Study|Withdrawal by Subject|0|||
33700559|NCT02121834|63264527|FG001|Overall Study|Withdrawal by Subject|1|||
33700560|NCT02121834|63264528|FG002|Overall Study|Withdrawal by Subject|1|||
33700561|NCT02121834|63264529|FG003|Overall Study|Withdrawal by Subject|0|||
33700562|NCT02121834|63264530|FG004|Overall Study|Withdrawal by Subject|0|||
33700563|NCT02121834|63264531|FG005|Overall Study|Withdrawal by Subject|0|||
33700564|NCT02121834|63264532|FG006|Overall Study|Withdrawal by Subject|0|||
33700565|NCT02121834|63264526|FG000|Overall Study|Lost to Follow-up|0|||
33700566|NCT02121834|63264527|FG001|Overall Study|Lost to Follow-up|0|||
33700567|NCT02121834|63264528|FG002|Overall Study|Lost to Follow-up|1|||
33700568|NCT02121834|63264529|FG003|Overall Study|Lost to Follow-up|0|||
33700569|NCT02121834|63264530|FG004|Overall Study|Lost to Follow-up|0|||
33700570|NCT02121834|63264531|FG005|Overall Study|Lost to Follow-up|0|||
33700571|NCT02121834|63264532|FG006|Overall Study|Lost to Follow-up|0|||
33700572|NCT02121756|63264560|FG000|Overall Study|Adverse Event|3|||
33700573|NCT02121756|63264561|FG001|Overall Study|Adverse Event|0|||
33700574|NCT02121756|63264560|FG000|Overall Study|Protocol Violation|1|||
33700575|NCT02121756|63264561|FG001|Overall Study|Protocol Violation|1|||
33700576|NCT02121756|63264560|FG000|Overall Study|Physician Decision|2|||
33700577|NCT02121756|63264561|FG001|Overall Study|Physician Decision|1|||
33700578|NCT02142504|63264573|FG000|Overall Study|Protocol Violation|2|||
33700579|NCT02142504|63264574|FG001|Overall Study|Protocol Violation|1|||
33700580|NCT02142504|63264575|FG002|Overall Study|Protocol Violation|2|||
33700581|NCT02142504|63264573|FG000|Overall Study|Adverse Event|2|||
33700582|NCT02142504|63264574|FG001|Overall Study|Adverse Event|3|||
33700583|NCT02142504|63264575|FG002|Overall Study|Adverse Event|4|||
33700584|NCT02142504|63264573|FG000|Overall Study|Lost to Follow-up|12|||
33700585|NCT02142504|63264574|FG001|Overall Study|Lost to Follow-up|19|||
33700586|NCT02142504|63264575|FG002|Overall Study|Lost to Follow-up|17|||
33700587|NCT02142504|63264573|FG000|Overall Study|Withdrawal by Subject|7|||
33700588|NCT02142504|63264574|FG001|Overall Study|Withdrawal by Subject|9|||
33700589|NCT02142504|63264575|FG002|Overall Study|Withdrawal by Subject|11|||
33700590|NCT02142504|63264573|FG000|Overall Study|Pregnancy|4|||
33700591|NCT02142504|63264574|FG001|Overall Study|Pregnancy|4|||
33700592|NCT02142504|63264575|FG002|Overall Study|Pregnancy|2|||
33700593|NCT02142504|63264573|FG000|Overall Study|Physician Decision|0|||
33700594|NCT02142504|63264574|FG001|Overall Study|Physician Decision|1|||
33700595|NCT02142504|63264575|FG002|Overall Study|Physician Decision|3|||
33700596|NCT02142504|63264573|FG000|Overall Study|Reason Not Specified|4|||
33700597|NCT02142504|63264574|FG001|Overall Study|Reason Not Specified|5|||
33700598|NCT02142504|63264575|FG002|Overall Study|Reason Not Specified|4|||
33700599|NCT02121522|63264583|FG000|Overall Study|Adverse Event|1|||
33700600|NCT02121210|63264589|FG000|Overall Study|Adverse Event|5|||
33700601|NCT02121210|63264590|FG001|Overall Study|Adverse Event|7|||
33700602|NCT02121210|63264589|FG000|Overall Study|Lack of Efficacy|2|||
33700603|NCT02121210|63264590|FG001|Overall Study|Lack of Efficacy|0|||
33700604|NCT02121210|63264589|FG000|Overall Study|Other than specified above|0|||
33700605|NCT02121210|63264590|FG001|Overall Study|Other than specified above|2|||
33700606|NCT02141490|63264599|FG000|Overall Study|Screening failures|4|||
33700607|NCT02141490|63264600|FG001|Overall Study|Screening failures|0|||
33700608|NCT02141490|63264601|FG002|Overall Study|Screening failures|0|||
33700609|NCT02097108|63264611|FG000|Overall Study|Adverse Event|1|||
33700610|NCT02097108|63264611|FG000|Overall Study|patient was abroad for 6 months|1|||
33700611|NCT02097030|63264617|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
33700612|NCT02097030|63264618|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
33700613|NCT02097030|63264617|FG000|First Intervention (3 Days)|Visual Acuity|0|||
33700614|NCT02097030|63264618|FG001|First Intervention (3 Days)|Visual Acuity|1|||
33700615|NCT02096952|63264628|FG000|Overall Study|Adverse Event|1|||
33700616|NCT02120898|63264635|FG000|Overall Study|Withdrawal by Subject|4|||
33700617|NCT02120898|63264636|FG001|Overall Study|Withdrawal by Subject|2|||
33700618|NCT02120898|63264637|FG002|Overall Study|Withdrawal by Subject|2|||
33700619|NCT02120898|63264635|FG000|Overall Study|Non-compliance with study drug|3|||
33700620|NCT02120898|63264636|FG001|Overall Study|Non-compliance with study drug|0|||
33700621|NCT02120898|63264637|FG002|Overall Study|Non-compliance with study drug|0|||
33700622|NCT02120898|63264635|FG000|Overall Study|Adverse Event|1|||
33700623|NCT02120898|63264636|FG001|Overall Study|Adverse Event|2|||
33700624|NCT02120898|63264637|FG002|Overall Study|Adverse Event|1|||
33700625|NCT02120898|63264635|FG000|Overall Study|Protocol Violation|1|||
33700626|NCT02120898|63264636|FG001|Overall Study|Protocol Violation|2|||
33700627|NCT02120898|63264637|FG002|Overall Study|Protocol Violation|0|||
33700628|NCT02120898|63264635|FG000|Overall Study|Lost to Follow-up|0|||
33700629|NCT02120898|63264636|FG001|Overall Study|Lost to Follow-up|0|||
33700630|NCT02120898|63264637|FG002|Overall Study|Lost to Follow-up|1|||
33700631|NCT02120664|63264650|FG000|Overall Study|Withdrawal by Subject|0|||
33700632|NCT02120664|63264651|FG001|Overall Study|Withdrawal by Subject|0|||
33700633|NCT02120664|63264652|FG002|Overall Study|Withdrawal by Subject|0|||
33700634|NCT02120664|63264653|FG003|Overall Study|Withdrawal by Subject|1|||
33700635|NCT02120664|63264654|FG004|Overall Study|Withdrawal by Subject|0|||
33700636|NCT01627860|63264669|FG000|Overall Study|Adverse Event|9|||
33700637|NCT01627860|63264670|FG001|Overall Study|Adverse Event|4|||
33700638|NCT01627860|63264669|FG000|Overall Study|Withdrawal by Subject|2|||
33700639|NCT01627860|63264670|FG001|Overall Study|Withdrawal by Subject|1|||
33700640|NCT01627860|63264669|FG000|Overall Study|Seizure frequency doubled|0|||
33700641|NCT01627860|63264670|FG001|Overall Study|Seizure frequency doubled|1|||
33700642|NCT01627860|63264669|FG000|Overall Study|Protocol Violation|1|||
33700643|NCT01627860|63264670|FG001|Overall Study|Protocol Violation|0|||
33700644|NCT01627782|63264680|FG000|Overall Study|Adverse Event|1|||
33700645|NCT01627782|63264681|FG001|Overall Study|Adverse Event|2|||
33700646|NCT01627782|63264682|FG002|Overall Study|Adverse Event|0|||
33700647|NCT01627782|63264683|FG003|Overall Study|Adverse Event|1|||
33700648|NCT01627782|63264680|FG000|Overall Study|Lack of Efficacy|11|||
33700649|NCT01627782|63264681|FG001|Overall Study|Lack of Efficacy|1|||
33700650|NCT01627782|63264682|FG002|Overall Study|Lack of Efficacy|15|||
33700651|NCT01627782|63264683|FG003|Overall Study|Lack of Efficacy|2|||
33700652|NCT01627782|63264680|FG000|Overall Study|Protocol Violation|1|||
33700653|NCT01627782|63264681|FG001|Overall Study|Protocol Violation|0|||
33700654|NCT01627782|63264682|FG002|Overall Study|Protocol Violation|0|||
33700655|NCT01627782|63264683|FG003|Overall Study|Protocol Violation|0|||
33700656|NCT01627782|63264680|FG000|Overall Study|Withdrawal by Subject|2|||
33700657|NCT01627782|63264681|FG001|Overall Study|Withdrawal by Subject|1|||
33700658|NCT01627782|63264682|FG002|Overall Study|Withdrawal by Subject|0|||
33700659|NCT01627782|63264683|FG003|Overall Study|Withdrawal by Subject|0|||
33700660|NCT01627782|63264680|FG000|Overall Study|Other|0|||
33700661|NCT01627782|63264681|FG001|Overall Study|Other|2|||
33700662|NCT01627782|63264682|FG002|Overall Study|Other|0|||
33700663|NCT01627782|63264683|FG003|Overall Study|Other|3|||
33700664|NCT01627782|63264680|FG000|Overall Study|Randomized But Not Treated|1|||
33700665|NCT01627782|63264681|FG001|Overall Study|Randomized But Not Treated|0|||
33700666|NCT01627782|63264682|FG002|Overall Study|Randomized But Not Treated|0|||
33700667|NCT01627782|63264683|FG003|Overall Study|Randomized But Not Treated|0|||
33700668|NCT01598532|63264695|FG000|Overall Study|Lost to Follow-up|3|||
33700669|NCT01598532|63264695|FG000|Overall Study|Did not meet inclusion criteria|8|||
33700670|NCT02119650|63264704|FG000|Overall Study|Adverse Event|3|||
33700671|NCT02119650|63264705|FG001|Overall Study|Adverse Event|4|||
33700672|NCT02119650|63264704|FG000|Overall Study|Subject decision|2|||
33700673|NCT02119650|63264705|FG001|Overall Study|Subject decision|3|||
33700674|NCT02119650|63264704|FG000|Overall Study|Disease progression|11|||
33700675|NCT02119650|63264705|FG001|Overall Study|Disease progression|14|||
33700676|NCT02119650|63264704|FG000|Overall Study|Death|5|||
33700677|NCT02119650|63264705|FG001|Overall Study|Death|1|||
33700678|NCT02119650|63264704|FG000|Overall Study|Noncompliance with study treatment|1|||
33700679|NCT02119650|63264705|FG001|Overall Study|Noncompliance with study treatment|1|||
33700680|NCT02119650|63264704|FG000|Overall Study|Study terminated by the sponsor|1|||
33700681|NCT02119650|63264705|FG001|Overall Study|Study terminated by the sponsor|0|||
33700682|NCT02119650|63264704|FG000|Overall Study|Physician Decision|0|||
33700683|NCT02119650|63264705|FG001|Overall Study|Physician Decision|2|||
33700684|NCT02119650|63264704|FG000|Overall Study|Multiple reasons for termination|2|||
33700685|NCT02119650|63264705|FG001|Overall Study|Multiple reasons for termination|1|||
33700686|NCT02119416|63264714|FG000|Overall Study|Protocol Violation|1|||
33700687|NCT02119416|63264715|FG001|Overall Study|Protocol Violation|1|||
33700688|NCT02119416|63264716|FG002|Overall Study|Protocol Violation|1|||
33700689|NCT02119416|63264714|FG000|Overall Study|wrong pubertal stage|1|||
33700690|NCT02119416|63264715|FG001|Overall Study|wrong pubertal stage|0|||
33700691|NCT02119416|63264716|FG002|Overall Study|wrong pubertal stage|1|||
33700692|NCT02140164|63264727|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
33700693|NCT02119260|63264738|FG000|Overall Study|Adverse Event|1|||
33700694|NCT02119260|63264739|FG001|Overall Study|Adverse Event|0|||
33700695|NCT02119260|63264740|FG002|Overall Study|Adverse Event|0|||
33700696|NCT02119260|63264741|FG003|Overall Study|Adverse Event|0|||
33700697|NCT02119260|63264742|FG004|Overall Study|Adverse Event|0|||
33700698|NCT02119260|63264743|FG005|Overall Study|Adverse Event|0|||
33700699|NCT02119260|63264744|FG006|Overall Study|Adverse Event|0|||
33700700|NCT02119260|63264738|FG000|Overall Study|Withdrew consent|0|||
33700701|NCT02119260|63264739|FG001|Overall Study|Withdrew consent|1|||
33700702|NCT02119260|63264740|FG002|Overall Study|Withdrew consent|1|||
33700703|NCT02119260|63264741|FG003|Overall Study|Withdrew consent|0|||
33700704|NCT02119260|63264742|FG004|Overall Study|Withdrew consent|0|||
33700705|NCT02119260|63264743|FG005|Overall Study|Withdrew consent|0|||
33700706|NCT02119260|63264744|FG006|Overall Study|Withdrew consent|0|||
33700707|NCT02119104|63264769|FG000|Overall Study|Protocol Violation|16|||
33700708|NCT02119026|63264775|FG000|1st-line Treatment|Adverse Event|9|||
33700709|NCT02119026|63264776|FG001|1st-line Treatment|Adverse Event|14|||
33700710|NCT02119026|63264775|FG000|1st-line Treatment|Physician Decision|3|||
33700711|NCT02119026|63264776|FG001|1st-line Treatment|Physician Decision|8|||
33700712|NCT02119026|63264775|FG000|1st-line Treatment|Withdrawal by Subject|4|||
33700713|NCT02119026|63264776|FG001|1st-line Treatment|Withdrawal by Subject|10|||
33700714|NCT02119026|63264775|FG000|1st-line Treatment|Patient condition or compliance|6|||
33700715|NCT02119026|63264776|FG001|1st-line Treatment|Patient condition or compliance|4|||
33700716|NCT02119026|63264775|FG000|1st-line Treatment|Surgery of metastases|2|||
33700717|NCT02119026|63264776|FG001|1st-line Treatment|Surgery of metastases|1|||
33700718|NCT02119026|63264775|FG000|1st-line Treatment|Death|2|||
33700719|NCT02119026|63264776|FG001|1st-line Treatment|Death|1|||
33700720|NCT02119026|63264775|FG000|2nd-line Treatment|Lost to Follow-up|2|||
33700721|NCT02119026|63264776|FG001|2nd-line Treatment|Lost to Follow-up|0|||
33700722|NCT02119026|63264775|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
33700723|NCT02119026|63264776|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
33700724|NCT02119026|63264775|FG000|2nd-line Treatment|Adverse Event|4|||
33700725|NCT02119026|63264776|FG001|2nd-line Treatment|Adverse Event|1|||
33700726|NCT02095158|63264782|FG000|Overall Study|Adverse Event|14|||
33700727|NCT02095158|63264782|FG000|Overall Study|Lack of Efficacy|3|||
33700728|NCT02095158|63264782|FG000|Overall Study|Pregnancy|1|||
33700729|NCT02095158|63264782|FG000|Overall Study|Lost to Follow-up|20|||
33700730|NCT02095158|63264782|FG000|Overall Study|Personal Reasons|35|||
33700731|NCT02095158|63264782|FG000|Overall Study|Protocol Violation|1|||
33700732|NCT02095158|63264782|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33700733|NCT02094612|63264788|FG000|Overall Study|Lost to Follow-up|47|||
33700734|NCT02094612|63264789|FG001|Overall Study|Lost to Follow-up|47|||
33700735|NCT02094612|63264788|FG000|Overall Study|Never started ADHD medication|32|||
33700736|NCT02094612|63264789|FG001|Overall Study|Never started ADHD medication|23|||
33700737|NCT02139306|63264797|FG000|Overall Study|Withdrawal by Subject|4|||
33700738|NCT02139306|63264798|FG001|Overall Study|Withdrawal by Subject|6|||
33700739|NCT02139306|63264797|FG000|Overall Study|Adverse Event|3|||
33700740|NCT02139306|63264798|FG001|Overall Study|Adverse Event|4|||
33700741|NCT02139306|63264797|FG000|Overall Study|Physician Decision|0|||
33700742|NCT02139306|63264798|FG001|Overall Study|Physician Decision|1|||
33700743|NCT02139306|63264797|FG000|Overall Study|Other Unspecified|2|||
33700744|NCT02139306|63264798|FG001|Overall Study|Other Unspecified|3|||
33700745|NCT02139306|63264797|FG000|Overall Study|Protocol Violation|4|||
33700746|NCT02139306|63264798|FG001|Overall Study|Protocol Violation|0|||
33700747|NCT02094300|63264805|FG000|Overall Study|Death|7|||
33700748|NCT02094300|63264805|FG000|Overall Study|Lost to Follow-up|10|||
33700749|NCT02094300|63264805|FG000|Overall Study|Still be eligible for follow-up|3|||
33700750|NCT02118792|63264811|FG000|Overall Study|Withdrawal by Subject|6|||
33700751|NCT02118792|63264812|FG001|Overall Study|Withdrawal by Subject|3|||
33700752|NCT02118792|63264811|FG000|Overall Study|Lost to Follow-up|4|||
33700753|NCT02118792|63264812|FG001|Overall Study|Lost to Follow-up|4|||
33700754|NCT02118792|63264811|FG000|Overall Study|Adverse Event|5|||
33700755|NCT02118792|63264812|FG001|Overall Study|Adverse Event|4|||
33700756|NCT02118792|63264811|FG000|Overall Study|Withdrawal by parent/guardian|14|||
33700757|NCT02118792|63264812|FG001|Overall Study|Withdrawal by parent/guardian|20|||
33700758|NCT02118792|63264811|FG000|Overall Study|Other|1|||
33700759|NCT02118792|63264812|FG001|Overall Study|Other|6|||
33700760|NCT02118792|63264811|FG000|Overall Study|Randomised but not treated|1|||
33700761|NCT02118792|63264812|FG001|Overall Study|Randomised but not treated|0|||
33700762|NCT02118714|63264820|FG000|Overall Study|Lost to Follow-up|2|||
33700763|NCT02118714|63264820|FG000|Overall Study|Protocol Violation|1|||
33700764|NCT02138916|63264827|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
33700765|NCT02138916|63264828|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
33700766|NCT02138916|63264829|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
33700767|NCT02138916|63264827|FG000|Overall Study|Death|14|||
33700768|NCT02138916|63264828|FG001|Overall Study|Death|11|||
33700769|NCT02138916|63264829|FG002|Overall Study|Death|12|||
33700770|NCT02138916|63264827|FG000|Overall Study|Withdrawal by Subject|27|||
33700771|NCT02138916|63264828|FG001|Overall Study|Withdrawal by Subject|31|||
33700772|NCT02138916|63264829|FG002|Overall Study|Withdrawal by Subject|32|||
33700773|NCT02138916|63264827|FG000|Overall Study|Study specific withdrawal criteria|0|||
33700774|NCT02138916|63264828|FG001|Overall Study|Study specific withdrawal criteria|0|||
33700775|NCT02138916|63264829|FG002|Overall Study|Study specific withdrawal criteria|1|||
33700776|NCT02138916|63264827|FG000|Overall Study|incorrect enrolment|1|||
33700777|NCT02138916|63264828|FG001|Overall Study|incorrect enrolment|1|||
33700778|NCT02138916|63264829|FG002|Overall Study|incorrect enrolment|0|||
33700779|NCT02138916|63264827|FG000|Overall Study|Severe non-compliance|1|||
33700780|NCT02138916|63264828|FG001|Overall Study|Severe non-compliance|2|||
33700781|NCT02138916|63264829|FG002|Overall Study|Severe non-compliance|1|||
33700782|NCT02138916|63264827|FG000|Overall Study|Lost to Follow-up|4|||
33700783|NCT02138916|63264828|FG001|Overall Study|Lost to Follow-up|2|||
33700784|NCT02138916|63264829|FG002|Overall Study|Lost to Follow-up|3|||
33700785|NCT02138916|63264827|FG000|Overall Study|Adverse Event|4|||
33700786|NCT02138916|63264828|FG001|Overall Study|Adverse Event|4|||
33700787|NCT02138916|63264829|FG002|Overall Study|Adverse Event|3|||
33700788|NCT02118012|63264839|FG000|Overall Study|Adverse Event|0|||
33700789|NCT02118012|63264840|FG001|Overall Study|Adverse Event|1|||
33700790|NCT02118012|63264839|FG000|Overall Study|Physician Decision|0|||
33700791|NCT02118012|63264840|FG001|Overall Study|Physician Decision|1|||
33700792|NCT02093520|63264848|FG000|Overall Study|Not treated|6|||
33700793|NCT02093520|63264849|FG001|Overall Study|Not treated|22|||
33700794|NCT02138838|63264857|FG000|Overall Study|Study Closure|7|||
33700795|NCT02138838|63264858|FG001|Overall Study|Study Closure|6|||
33700796|NCT02138838|63264857|FG000|Overall Study|Withdrawal by Subject|1|||
33700797|NCT02138838|63264858|FG001|Overall Study|Withdrawal by Subject|5|||
33700798|NCT02138214|63264867|FG000|Overall Study|Withdrawal by Subject|0|||
33700799|NCT02138214|63264868|FG001|Overall Study|Withdrawal by Subject|1|||
33700800|NCT02138214|63264869|FG002|Overall Study|Withdrawal by Subject|0|||
33700801|NCT02138214|63264867|FG000|Overall Study|Lost to Follow-up|0|||
33700802|NCT02138214|63264868|FG001|Overall Study|Lost to Follow-up|2|||
33700803|NCT02138214|63264869|FG002|Overall Study|Lost to Follow-up|4|||
33700804|NCT02138214|63264867|FG000|Overall Study|Screen Failure|0|||
33700805|NCT02138214|63264868|FG001|Overall Study|Screen Failure|1|||
33700806|NCT02138214|63264869|FG002|Overall Study|Screen Failure|0|||
33700807|NCT02092662|63264878|FG000|Overall Study|Lost to Follow-up|13|||
33700808|NCT02092662|63264879|FG001|Overall Study|Lost to Follow-up|0|||
33700809|NCT02092350|63264888|FG000|Overall Study|Adverse Event|0|||
33700810|NCT02092350|63264889|FG001|Overall Study|Adverse Event|3|||
33700811|NCT02092350|63264888|FG000|Overall Study|Death|2|||
33700812|NCT02092350|63264889|FG001|Overall Study|Death|5|||
33700813|NCT02092350|63264888|FG000|Overall Study|Lost to Follow-up|3|||
33700814|NCT02092350|63264889|FG001|Overall Study|Lost to Follow-up|1|||
33700815|NCT02092350|63264888|FG000|Overall Study|Protocol Violation|1|||
33700816|NCT02092350|63264889|FG001|Overall Study|Protocol Violation|0|||
33700817|NCT02092350|63264888|FG000|Overall Study|Physician Decision|1|||
33700818|NCT02092350|63264889|FG001|Overall Study|Physician Decision|1|||
33700819|NCT02092350|63264888|FG000|Overall Study|Screen Failure|1|||
33700820|NCT02092350|63264889|FG001|Overall Study|Screen Failure|0|||
33700821|NCT02092350|63264888|FG000|Overall Study|Withdrawal by Subject|2|||
33700822|NCT02092350|63264889|FG001|Overall Study|Withdrawal by Subject|2|||
33700823|NCT02117544|63264897|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
33700824|NCT02117544|63264898|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
33700825|NCT02138136|63264905|FG000|Overall Study|Protocol Violation|4|||
33700826|NCT02138136|63264905|FG000|Overall Study|Physician Decision|7|||
33700827|NCT02138136|63264905|FG000|Overall Study|Lack of Efficacy|35|||
33700828|NCT02138136|63264905|FG000|Overall Study|Pregnancy|2|||
33700829|NCT02138136|63264905|FG000|Overall Study|Adverse Event|18|||
33700830|NCT02138136|63264905|FG000|Overall Study|Withdrawal by Subject|36|||
33700831|NCT02138136|63264905|FG000|Overall Study|Lost to Follow-up|32|||
33700832|NCT02138136|63264905|FG000|Overall Study|Withdrawn by Sponsor|5|||
33700833|NCT01626690|63264912|FG000|Overall Study|Protocol Violation|1|||
33700834|NCT01626690|63264913|FG001|Overall Study|Protocol Violation|0|||
33700835|NCT01626690|63264912|FG000|Overall Study|Adverse Event|1|||
33700836|NCT01626690|63264913|FG001|Overall Study|Adverse Event|0|||
33700837|NCT01626456|63264923|FG000|Overall Study|Withdrawal by Subject|21|||
33700838|NCT01626456|63264924|FG001|Overall Study|Withdrawal by Subject|46|||
33700839|NCT01626456|63264923|FG000|Overall Study|Adverse Event|2|||
33700840|NCT01626456|63264924|FG001|Overall Study|Adverse Event|27|||
33700841|NCT01626456|63264923|FG000|Overall Study|Lost to Follow-up|2|||
33700842|NCT01626456|63264924|FG001|Overall Study|Lost to Follow-up|27|||
33700843|NCT01626456|63264923|FG000|Overall Study|Lack of Efficacy|6|||
33700844|NCT01626456|63264924|FG001|Overall Study|Lack of Efficacy|7|||
33700845|NCT01626456|63264923|FG000|Overall Study|Physician Decision|1|||
33700846|NCT01626456|63264924|FG001|Overall Study|Physician Decision|4|||
33700847|NCT01626456|63264923|FG000|Overall Study|Protocol Violation|1|||
33700848|NCT01626456|63264924|FG001|Overall Study|Protocol Violation|1|||
33700849|NCT01626456|63264923|FG000|Overall Study|Site Closure|2|||
33700850|NCT01626456|63264924|FG001|Overall Study|Site Closure|3|||
33700851|NCT01626456|63264923|FG000|Overall Study|Incarceration|0|||
33700852|NCT01626456|63264924|FG001|Overall Study|Incarceration|2|||
33700853|NCT02116608|63264942|FG000|Overall Study|Lost to Follow-up|0|||
33700854|NCT02116608|63264943|FG001|Overall Study|Lost to Follow-up|0|||
33700855|NCT02116608|63264944|FG002|Overall Study|Lost to Follow-up|1|||
33700856|NCT02116608|63264942|FG000|Overall Study|Physician Decision|0|||
33700857|NCT02116608|63264943|FG001|Overall Study|Physician Decision|1|||
33700858|NCT02116608|63264944|FG002|Overall Study|Physician Decision|0|||
33700859|NCT02116608|63264942|FG000|Overall Study|Death|0|||
33700860|NCT02116608|63264943|FG001|Overall Study|Death|1|||
33700861|NCT02116608|63264944|FG002|Overall Study|Death|0|||
33700862|NCT02092116|63264954|FG000|Overall Study|Withdrawal by Subject|0|||
33700863|NCT02092116|63264955|FG001|Overall Study|Withdrawal by Subject|3|||
33700864|NCT02092116|63264954|FG000|Overall Study|Adverse Event|0|||
33700865|NCT02092116|63264955|FG001|Overall Study|Adverse Event|1|||
33700866|NCT02091726|63264961|FG000|Overall Study|Lost to Follow-up|6|||
33700867|NCT02091414|63264965|FG000|Overall Study|Withdrawal by Subject|2|||
33700868|NCT02091414|63264965|FG000|Overall Study|Death|2|||
33700869|NCT02116530|63264971|FG000|Overall Study|Withdrawal by Subject|1|||
33700870|NCT02116530|63264972|FG001|Overall Study|Withdrawal by Subject|2|||
33700871|NCT02116530|63264971|FG000|Overall Study|Adverse Event|4|||
33700872|NCT02116530|63264972|FG001|Overall Study|Adverse Event|0|||
33700873|NCT02116530|63264971|FG000|Overall Study|Physician Decision|1|||
33700874|NCT02116530|63264972|FG001|Overall Study|Physician Decision|0|||
33700875|NCT02116530|63264971|FG000|Overall Study|Lost to Follow-up|1|||
33700876|NCT02116530|63264972|FG001|Overall Study|Lost to Follow-up|0|||
33700877|NCT02116530|63264971|FG000|Overall Study|Other Medical Problems|2|||
33700878|NCT02116530|63264972|FG001|Overall Study|Other Medical Problems|2|||
33700879|NCT02072226|63264980|FG000|Overall Study|Lost to Follow-up|11|||
33700880|NCT02072226|63264981|FG001|Overall Study|Lost to Follow-up|7|||
33700881|NCT02072226|63264980|FG000|Overall Study|Patient Non-compliance|2|||
33700882|NCT02072226|63264981|FG001|Overall Study|Patient Non-compliance|3|||
33700883|NCT02072226|63264980|FG000|Overall Study|Death|1|||
33700884|NCT02072226|63264981|FG001|Overall Study|Death|0|||
33700885|NCT02072226|63264980|FG000|Overall Study|Patient Withdrawal of Consent|1|||
33700886|NCT02072226|63264981|FG001|Overall Study|Patient Withdrawal of Consent|0|||
33700887|NCT02090634|63264989|FG000|Overall Study|Lost to Follow-up|0|||
33700888|NCT02090634|63264990|FG001|Overall Study|Lost to Follow-up|1|||
33700889|NCT02090634|63264989|FG000|Overall Study|Death|0|||
33700890|NCT02090634|63264990|FG001|Overall Study|Death|1|||
33700891|NCT02090634|63264989|FG000|Overall Study|Protocol Violation|3|||
33700892|NCT02090634|63264990|FG001|Overall Study|Protocol Violation|1|||
33700893|NCT02090634|63264989|FG000|Overall Study|Adverse Event|2|||
33700894|NCT02090634|63264990|FG001|Overall Study|Adverse Event|0|||
33700895|NCT02114892|63264998|FG000|Overall Study|Lost to Follow-up|1|||
33700896|NCT02114892|63264999|FG001|Overall Study|Lost to Follow-up|2|||
33700897|NCT02070978|63265008|FG000|Overall Study|Adverse Event|6|||
33700898|NCT02070978|63265009|FG001|Overall Study|Adverse Event|2|||
33700899|NCT02070978|63265010|FG002|Overall Study|Adverse Event|0|||
33700900|NCT02070978|63265008|FG000|Overall Study|Lost to Follow-up|1|||
33700901|NCT02070978|63265009|FG001|Overall Study|Lost to Follow-up|3|||
33700902|NCT02070978|63265010|FG002|Overall Study|Lost to Follow-up|4|||
33700903|NCT02070978|63265008|FG000|Overall Study|Withdrawal by Subject|3|||
33700904|NCT02070978|63265009|FG001|Overall Study|Withdrawal by Subject|5|||
33700905|NCT02070978|63265010|FG002|Overall Study|Withdrawal by Subject|3|||
33700906|NCT02070978|63265008|FG000|Overall Study|Protocol Violation|1|||
33700907|NCT02070978|63265009|FG001|Overall Study|Protocol Violation|0|||
33700908|NCT02070978|63265010|FG002|Overall Study|Protocol Violation|3|||
33700909|NCT02070978|63265008|FG000|Overall Study|Lack of Efficacy|0|||
33700910|NCT02070978|63265009|FG001|Overall Study|Lack of Efficacy|1|||
33700911|NCT02070978|63265010|FG002|Overall Study|Lack of Efficacy|0|||
33700912|NCT02070978|63265008|FG000|Overall Study|Death|0|||
33700913|NCT02070978|63265009|FG001|Overall Study|Death|0|||
33700914|NCT02070978|63265010|FG002|Overall Study|Death|2|||
33700915|NCT02070978|63265008|FG000|Overall Study|Un-specified|3|||
33700916|NCT02070978|63265009|FG001|Overall Study|Un-specified|2|||
33700917|NCT02070978|63265010|FG002|Overall Study|Un-specified|2|||
33700918|NCT02070978|63265008|FG000|Overall Study|Terminated by Sponsor|33|||
33700919|NCT02070978|63265009|FG001|Overall Study|Terminated by Sponsor|40|||
33700920|NCT02070978|63265010|FG002|Overall Study|Terminated by Sponsor|39|||
33700921|NCT02114268|63265024|FG000|Overall Study|Lost to Follow-up|4|||
33700922|NCT02114268|63265025|FG001|Overall Study|Lost to Follow-up|1|||
33700923|NCT02114268|63265026|FG002|Overall Study|Lost to Follow-up|1|||
33700924|NCT02114268|63265027|FG003|Overall Study|Lost to Follow-up|0|||
33700925|NCT02114268|63265028|FG004|Overall Study|Lost to Follow-up|0|||
33700926|NCT02114268|63265029|FG005|Overall Study|Lost to Follow-up|2|||
33700927|NCT02114268|63265024|FG000|Overall Study|Withdrawal by Subject|1|||
33700928|NCT02114268|63265025|FG001|Overall Study|Withdrawal by Subject|0|||
33700929|NCT02114268|63265026|FG002|Overall Study|Withdrawal by Subject|0|||
33700930|NCT02114268|63265027|FG003|Overall Study|Withdrawal by Subject|0|||
33700931|NCT02114268|63265028|FG004|Overall Study|Withdrawal by Subject|0|||
33700932|NCT02114268|63265029|FG005|Overall Study|Withdrawal by Subject|1|||
33700933|NCT02114268|63265024|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
33700934|NCT02114268|63265025|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
33700935|NCT02114268|63265026|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
33700936|NCT02114268|63265027|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
33700937|NCT02114268|63265028|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
33700938|NCT02114268|63265029|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
33700939|NCT02089230|63265051|FG000|Overall Study|Death|0|||
33700940|NCT02089230|63265052|FG001|Overall Study|Death|0|||
33700941|NCT02089230|63265053|FG002|Overall Study|Death|2|||
33700942|NCT02089230|63265051|FG000|Overall Study|Seeking Alternative Therapy|0|||
33700943|NCT02089230|63265052|FG001|Overall Study|Seeking Alternative Therapy|0|||
33700944|NCT02089230|63265053|FG002|Overall Study|Seeking Alternative Therapy|4|||
33700945|NCT02070744|63265065|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
33700946|NCT02070744|63265066|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
33700947|NCT02070744|63265067|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
33700948|NCT02070744|63265068|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
33700949|NCT02070744|63265069|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
33700950|NCT02070744|63265065|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
33700951|NCT02070744|63265066|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
33700952|NCT02070744|63265067|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
33700953|NCT02070744|63265068|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
33700954|NCT02070744|63265069|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
33700955|NCT02070744|63265065|FG000|OLE Phase (48 Weeks)|Other|0|||
33700956|NCT02070744|63265066|FG001|OLE Phase (48 Weeks)|Other|0|||
33700957|NCT02070744|63265067|FG002|OLE Phase (48 Weeks)|Other|0|||
33700958|NCT02070744|63265068|FG003|OLE Phase (48 Weeks)|Other|0|||
33700959|NCT02070744|63265069|FG004|OLE Phase (48 Weeks)|Other|1|||
33700960|NCT02113956|63265086|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
33700961|NCT02113956|63265087|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
33700962|NCT02113956|63265086|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
33700963|NCT02113956|63265087|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
33700964|NCT02113956|63265086|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
33700965|NCT02113956|63265087|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
33700966|NCT02070588|63265096|FG000|Overall Study|Withdrawal by Subject|29|||
33700967|NCT02070588|63265097|FG001|Overall Study|Withdrawal by Subject|1|||
33700968|NCT02070588|63265098|FG002|Overall Study|Withdrawal by Subject|0|||
33700969|NCT02070588|63265096|FG000|Overall Study|Writhdrawal due to early termination|9|||
33700970|NCT02070588|63265097|FG001|Overall Study|Writhdrawal due to early termination|0|||
33700971|NCT02070588|63265098|FG002|Overall Study|Writhdrawal due to early termination|0|||
33700972|NCT02070588|63265096|FG000|Overall Study|Adverse Event|1|||
33700973|NCT02070588|63265097|FG001|Overall Study|Adverse Event|0|||
33700974|NCT02070588|63265098|FG002|Overall Study|Adverse Event|0|||
33700975|NCT02111850|63265117|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33700976|NCT02111850|63265118|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33700977|NCT02111850|63265119|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33700978|NCT02111850|63265120|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33700979|NCT02111850|63265121|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
33700980|NCT02111850|63265122|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33700981|NCT02111850|63265123|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33700982|NCT02111850|63265124|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33700983|NCT02111850|63265125|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33700984|NCT02111850|63265126|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33700985|NCT02111850|63265127|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33700986|NCT02087904|63265157|FG000|Overall Study|Did Not Receive Study Drug|0|||
33700987|NCT02087904|63265158|FG001|Overall Study|Did Not Receive Study Drug|0|||
33700988|NCT02087904|63265159|FG002|Overall Study|Did Not Receive Study Drug|2|||
33700989|NCT02087904|63265160|FG003|Overall Study|Did Not Receive Study Drug|1|||
33700990|NCT02087904|63265157|FG000|Overall Study|Adverse Event|8|||
33700991|NCT02087904|63265158|FG001|Overall Study|Adverse Event|4|||
33700992|NCT02087904|63265159|FG002|Overall Study|Adverse Event|4|||
33700993|NCT02087904|63265160|FG003|Overall Study|Adverse Event|12|||
33700994|NCT02087904|63265157|FG000|Overall Study|Lack of Efficacy|3|||
33700995|NCT02087904|63265158|FG001|Overall Study|Lack of Efficacy|6|||
33700996|NCT02087904|63265159|FG002|Overall Study|Lack of Efficacy|3|||
33700997|NCT02087904|63265160|FG003|Overall Study|Lack of Efficacy|2|||
33700998|NCT02087904|63265157|FG000|Overall Study|Other|6|||
33700999|NCT02087904|63265158|FG001|Overall Study|Other|2|||
33701000|NCT02087904|63265159|FG002|Overall Study|Other|4|||
33701001|NCT02087904|63265160|FG003|Overall Study|Other|4|||
33701002|NCT02087904|63265157|FG000|Overall Study|Withdrawal by Subject|8|||
33701003|NCT02087904|63265158|FG001|Overall Study|Withdrawal by Subject|3|||
33701004|NCT02087904|63265159|FG002|Overall Study|Withdrawal by Subject|7|||
33701005|NCT02087904|63265160|FG003|Overall Study|Withdrawal by Subject|4|||
33701006|NCT02087904|63265157|FG000|Overall Study|Lost to Follow-up|0|||
33701007|NCT02087904|63265158|FG001|Overall Study|Lost to Follow-up|4|||
33701008|NCT02087904|63265159|FG002|Overall Study|Lost to Follow-up|2|||
33701009|NCT02087904|63265160|FG003|Overall Study|Lost to Follow-up|2|||
33701010|NCT02087670|63265172|FG000|Overall Study|Withdrawal by Subject|3|||
33701011|NCT02087670|63265173|FG001|Overall Study|Withdrawal by Subject|2|||
33701012|NCT02086968|63265181|FG000|Overall Study|Adverse Event|1|||
33701013|NCT02086968|63265182|FG001|Overall Study|Adverse Event|5|||
33701014|NCT02086968|63265181|FG000|Overall Study|Lost to Follow-up|2|||
33701015|NCT02086968|63265182|FG001|Overall Study|Lost to Follow-up|3|||
33701016|NCT02086968|63265181|FG000|Overall Study|Study drug received outside protocol|0|||
33701017|NCT02086968|63265182|FG001|Overall Study|Study drug received outside protocol|1|||
33701018|NCT02086968|63265181|FG000|Overall Study|Physician Decision|4|||
33701019|NCT02086968|63265182|FG001|Overall Study|Physician Decision|0|||
33701020|NCT02086968|63265181|FG000|Overall Study|Withdrawal by Subject|1|||
33701021|NCT02086968|63265182|FG001|Overall Study|Withdrawal by Subject|4|||
33701022|NCT02086110|63265190|FG000|Overall Study|Withdrawal by Subject|1|||
33701023|NCT02086110|63265191|FG001|Overall Study|Withdrawal by Subject|1|||
33701024|NCT02085252|63265200|FG000|Overall Study|Withdrawal of Consent|1|||
33701025|NCT02085252|63265201|FG001|Overall Study|Withdrawal of Consent|0|||
33701026|NCT02085252|63265200|FG000|Overall Study|Adverse Event|0|||
33701027|NCT02085252|63265201|FG001|Overall Study|Adverse Event|1|||
33596597|NCT01655069|62995593|FG000|Overall Study|Lack of Efficacy|0|||
33596598|NCT01655069|62995594|FG001|Overall Study|Lack of Efficacy|1|||
33596599|NCT01655069|62995595|FG002|Overall Study|Lack of Efficacy|0|||
33701028|NCT02085252|63265200|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
33701029|NCT02085252|63265201|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
33701030|NCT02085252|63265200|FG000|Overall Study|Reason Not Specified|0|||
33701031|NCT02085252|63265201|FG001|Overall Study|Reason Not Specified|1|||
33701032|NCT02085252|63265200|FG000|Overall Study|Reason Unknown|0|||
33701033|NCT02085252|63265201|FG001|Overall Study|Reason Unknown|1|||
33701034|NCT02084238|63265207|FG000|Overall Study|Lost to Follow-up|2|||
33701035|NCT02084082|63265220|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
33701036|NCT02084082|63265221|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
33701037|NCT02084082|63265222|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
33701038|NCT02084082|63265223|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
33701039|NCT02084082|63265220|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
33596600|NCT01655069|62995596|FG003|Overall Study|Lack of Efficacy|0|||
33701040|NCT02084082|63265221|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
33596601|NCT01655069|62995593|FG000|Overall Study|No Treatment Needed|0|||
33701041|NCT02084082|63265222|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
33701042|NCT02084082|63265223|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
33701043|NCT02083926|63265235|FG000|Overall Study|Withdrawal by Subject|1|||
33701044|NCT02083926|63265236|FG001|Overall Study|Withdrawal by Subject|0|||
33701045|NCT02083380|63265246|FG000|Overall Study|Lack of Efficacy|68|||
33701046|NCT02083380|63265247|FG001|Overall Study|Lack of Efficacy|79|||
33701047|NCT02083380|63265248|FG002|Overall Study|Lack of Efficacy|64|||
33701048|NCT02083380|63265246|FG000|Overall Study|Withdrawal by Subject|9|||
33701049|NCT02083380|63265247|FG001|Overall Study|Withdrawal by Subject|3|||
33701050|NCT02083380|63265248|FG002|Overall Study|Withdrawal by Subject|7|||
33701051|NCT02083380|63265246|FG000|Overall Study|Physician Decision|1|||
33701052|NCT02083380|63265247|FG001|Overall Study|Physician Decision|6|||
33701053|NCT02083380|63265248|FG002|Overall Study|Physician Decision|3|||
33701054|NCT02083380|63265246|FG000|Overall Study|Adverse Event|0|||
33701055|NCT02083380|63265247|FG001|Overall Study|Adverse Event|0|||
33701056|NCT02083380|63265248|FG002|Overall Study|Adverse Event|1|||
33701057|NCT02083380|63265246|FG000|Overall Study|Lost to Follow-up|5|||
33701058|NCT02083380|63265247|FG001|Overall Study|Lost to Follow-up|3|||
33701059|NCT02083380|63265248|FG002|Overall Study|Lost to Follow-up|3|||
33701060|NCT02083380|63265246|FG000|Overall Study|Other|8|||
33701061|NCT02083380|63265247|FG001|Overall Study|Other|4|||
33701062|NCT02083380|63265248|FG002|Overall Study|Other|6|||
33701063|NCT02109744|63265263|FG000|Overall Study|Death|1|||
33701064|NCT02109744|63265264|FG001|Overall Study|Death|1|||
33701065|NCT02109744|63265263|FG000|Overall Study|no marrow exam|1|||
33701066|NCT02109744|63265264|FG001|Overall Study|no marrow exam|0|||
33701067|NCT02109432|63265270|FG000|Overall Study|Withdrawal by Subject|1|||
33701068|NCT02109042|63265274|FG000|Overall Study|Sponsor Decision|15|||
33701069|NCT02066922|63265279|FG000|Overall Study|Adverse Event|1|||
33701070|NCT02108262|63265290|FG000|Overall Study|Non-compliance|0|||
33701071|NCT02108262|63265291|FG001|Overall Study|Non-compliance|2|||
33701072|NCT02108262|63265292|FG002|Overall Study|Non-compliance|1|||
33701073|NCT02108262|63265293|FG003|Overall Study|Non-compliance|1|||
33701074|NCT02108262|63265290|FG000|Overall Study|Randomized by error/screen failure|0|||
33701075|NCT02108262|63265291|FG001|Overall Study|Randomized by error/screen failure|0|||
33701076|NCT02108262|63265292|FG002|Overall Study|Randomized by error/screen failure|1|||
33701077|NCT02108262|63265293|FG003|Overall Study|Randomized by error/screen failure|0|||
33701078|NCT02108262|63265290|FG000|Overall Study|Distance to center|0|||
33701079|NCT02108262|63265291|FG001|Overall Study|Distance to center|1|||
33701080|NCT02108262|63265292|FG002|Overall Study|Distance to center|1|||
33701081|NCT02108262|63265293|FG003|Overall Study|Distance to center|0|||
33701082|NCT02108262|63265290|FG000|Overall Study|Adverse Event|0|||
33701083|NCT02108262|63265291|FG001|Overall Study|Adverse Event|11|||
33701084|NCT02108262|63265292|FG002|Overall Study|Adverse Event|6|||
33701085|NCT02108262|63265293|FG003|Overall Study|Adverse Event|12|||
33701086|NCT02108262|63265290|FG000|Overall Study|Death|0|||
33701087|NCT02108262|63265291|FG001|Overall Study|Death|2|||
33701088|NCT02108262|63265292|FG002|Overall Study|Death|2|||
33701089|NCT02108262|63265293|FG003|Overall Study|Death|1|||
33701090|NCT02108262|63265290|FG000|Overall Study|Lost to Follow-up|0|||
33701091|NCT02108262|63265291|FG001|Overall Study|Lost to Follow-up|0|||
33701092|NCT02108262|63265292|FG002|Overall Study|Lost to Follow-up|1|||
33701093|NCT02108262|63265293|FG003|Overall Study|Lost to Follow-up|0|||
33701094|NCT02108262|63265290|FG000|Overall Study|Physician Decision|0|||
33701095|NCT02108262|63265291|FG001|Overall Study|Physician Decision|0|||
33701096|NCT02108262|63265292|FG002|Overall Study|Physician Decision|2|||
33701097|NCT02108262|63265293|FG003|Overall Study|Physician Decision|0|||
33701098|NCT02108262|63265290|FG000|Overall Study|Withdrawal by Subject|0|||
33701099|NCT02108262|63265291|FG001|Overall Study|Withdrawal by Subject|7|||
33701100|NCT02108262|63265292|FG002|Overall Study|Withdrawal by Subject|3|||
33701101|NCT02108262|63265293|FG003|Overall Study|Withdrawal by Subject|4|||
33701102|NCT02108262|63265290|FG000|Overall Study|Due to key hepatic values|0|||
33701103|NCT02108262|63265291|FG001|Overall Study|Due to key hepatic values|1|||
33701104|NCT02108262|63265292|FG002|Overall Study|Due to key hepatic values|0|||
33701105|NCT02108262|63265293|FG003|Overall Study|Due to key hepatic values|0|||
33701106|NCT02108262|63265290|FG000|Overall Study|Unable to contact patient|0|||
33701107|NCT02108262|63265291|FG001|Overall Study|Unable to contact patient|3|||
33701108|NCT02108262|63265292|FG002|Overall Study|Unable to contact patient|1|||
33701109|NCT02108262|63265293|FG003|Overall Study|Unable to contact patient|2|||
33701110|NCT02108262|63265290|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
33701111|NCT02108262|63265291|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
33701112|NCT02108262|63265292|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
33701113|NCT02108262|63265293|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
33701114|NCT02108262|63265290|FG000|Overall Study|Patient did not want another infusion|0|||
33701115|NCT02108262|63265291|FG001|Overall Study|Patient did not want another infusion|3|||
33701116|NCT02108262|63265292|FG002|Overall Study|Patient did not want another infusion|3|||
33701117|NCT02108262|63265293|FG003|Overall Study|Patient did not want another infusion|2|||
33701118|NCT02108262|63265290|FG000|Overall Study|Vacation|0|||
33701119|NCT02108262|63265291|FG001|Overall Study|Vacation|1|||
33701120|NCT02108262|63265292|FG002|Overall Study|Vacation|0|||
33701121|NCT02108262|63265293|FG003|Overall Study|Vacation|0|||
33701122|NCT02108262|63265290|FG000|Overall Study|Patient decision|0|||
33701123|NCT02108262|63265291|FG001|Overall Study|Patient decision|7|||
33701124|NCT02108262|63265292|FG002|Overall Study|Patient decision|9|||
33701125|NCT02108262|63265293|FG003|Overall Study|Patient decision|14|||
33701126|NCT02108262|63265290|FG000|Overall Study|Missed IV due to pharmacy error|0|||
33701127|NCT02108262|63265291|FG001|Overall Study|Missed IV due to pharmacy error|0|||
33701128|NCT02108262|63265292|FG002|Overall Study|Missed IV due to pharmacy error|1|||
33701129|NCT02108262|63265293|FG003|Overall Study|Missed IV due to pharmacy error|0|||
33701130|NCT02107482|63265302|FG000|Overall Study|inconveinence|2|||
33701131|NCT02107482|63265302|FG000|Overall Study|Lost to Follow-up|1|||
33701132|NCT02107482|63265302|FG000|Overall Study|Lack of Efficacy|1|||
33701133|NCT02066298|63265312|FG000|Overall Study|Lost to Follow-up|3|||
33701134|NCT02066298|63265313|FG001|Overall Study|Lost to Follow-up|2|||
33701135|NCT02066298|63265314|FG002|Overall Study|Lost to Follow-up|3|||
33701136|NCT02066298|63265315|FG003|Overall Study|Lost to Follow-up|2|||
33701137|NCT02066298|63265316|FG004|Overall Study|Lost to Follow-up|3|||
33701138|NCT02066298|63265317|FG005|Overall Study|Lost to Follow-up|4|||
33701139|NCT02066298|63265312|FG000|Overall Study|Withdrawal by Subject|6|||
33701140|NCT02066298|63265313|FG001|Overall Study|Withdrawal by Subject|6|||
33701141|NCT02066298|63265314|FG002|Overall Study|Withdrawal by Subject|6|||
33701142|NCT02066298|63265315|FG003|Overall Study|Withdrawal by Subject|4|||
33701143|NCT02066298|63265316|FG004|Overall Study|Withdrawal by Subject|5|||
33701144|NCT02066298|63265317|FG005|Overall Study|Withdrawal by Subject|8|||
33701145|NCT02066298|63265312|FG000|Overall Study|Physician Decision|0|||
33701146|NCT02066298|63265313|FG001|Overall Study|Physician Decision|0|||
33701147|NCT02066298|63265314|FG002|Overall Study|Physician Decision|1|||
33701148|NCT02066298|63265315|FG003|Overall Study|Physician Decision|0|||
33701149|NCT02066298|63265316|FG004|Overall Study|Physician Decision|1|||
33701150|NCT02066298|63265317|FG005|Overall Study|Physician Decision|0|||
33701151|NCT02082912|63265331|FG000|Overall Study|Physician Decision|0|||
33701152|NCT02082912|63265332|FG001|Overall Study|Physician Decision|1|||
33701153|NCT02082522|63265340|FG000|Overall Study|Sponsor termination|5|||
33701154|NCT02082522|63265341|FG001|Overall Study|Sponsor termination|3|||
33701155|NCT02082522|63265340|FG000|Overall Study|Withdrawal by Subject|2|||
33701156|NCT02082522|63265341|FG001|Overall Study|Withdrawal by Subject|4|||
33701157|NCT02082522|63265340|FG000|Overall Study|Death|1|||
33701158|NCT02082522|63265341|FG001|Overall Study|Death|0|||
33701159|NCT02082522|63265340|FG000|Overall Study|Lost to Follow-up|1|||
33701160|NCT02082522|63265341|FG001|Overall Study|Lost to Follow-up|0|||
33701161|NCT02082522|63265340|FG000|Overall Study|Physician Decision|3|||
33701162|NCT02082522|63265341|FG001|Overall Study|Physician Decision|1|||
33701163|NCT02082522|63265340|FG000|Overall Study|Disease progression|2|||
33701164|NCT02082522|63265341|FG001|Overall Study|Disease progression|2|||
33701165|NCT02082522|63265340|FG000|Overall Study|Chemotherapy change|1|||
33701166|NCT02082522|63265341|FG001|Overall Study|Chemotherapy change|3|||
33701167|NCT02082210|63265353|FG000|Overall Study|Death|0|||
33701168|NCT02082210|63265354|FG001|Overall Study|Death|0|||
33701169|NCT02082210|63265355|FG002|Overall Study|Death|1|||
33701170|NCT02082210|63265356|FG003|Overall Study|Death|1|||
33701171|NCT02082210|63265357|FG004|Overall Study|Death|1|||
33701172|NCT02082210|63265358|FG005|Overall Study|Death|0|||
33701173|NCT02082210|63265353|FG000|Overall Study|Withdrawal by Subject|0|||
33701174|NCT02082210|63265354|FG001|Overall Study|Withdrawal by Subject|0|||
33701175|NCT02082210|63265355|FG002|Overall Study|Withdrawal by Subject|0|||
33701176|NCT02082210|63265356|FG003|Overall Study|Withdrawal by Subject|1|||
33701177|NCT02082210|63265357|FG004|Overall Study|Withdrawal by Subject|2|||
33701178|NCT02082210|63265358|FG005|Overall Study|Withdrawal by Subject|2|||
33701179|NCT02082210|63265353|FG000|Overall Study|Clinical Progression|0|||
33701180|NCT02082210|63265354|FG001|Overall Study|Clinical Progression|0|||
33701181|NCT02082210|63265355|FG002|Overall Study|Clinical Progression|0|||
33701182|NCT02082210|63265356|FG003|Overall Study|Clinical Progression|1|||
33701183|NCT02082210|63265357|FG004|Overall Study|Clinical Progression|0|||
33701184|NCT02082210|63265358|FG005|Overall Study|Clinical Progression|0|||
33701185|NCT02082210|63265353|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
33701186|NCT02082210|63265354|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
33701187|NCT02082210|63265355|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
33701188|NCT02082210|63265356|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
33701189|NCT02082210|63265357|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
33701190|NCT02082210|63265358|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
33701191|NCT02082210|63265353|FG000|Overall Study|Physician Decision|0|||
33701192|NCT02082210|63265354|FG001|Overall Study|Physician Decision|0|||
33701193|NCT02082210|63265355|FG002|Overall Study|Physician Decision|1|||
33701194|NCT02082210|63265356|FG003|Overall Study|Physician Decision|1|||
33701195|NCT02082210|63265357|FG004|Overall Study|Physician Decision|0|||
33701196|NCT02082210|63265358|FG005|Overall Study|Physician Decision|0|||
33701197|NCT02107092|63265384|FG000|Overall Study|Miscellaneous|3|||
33701198|NCT02107092|63265384|FG000|Overall Study|Subject compliance|3|||
33701199|NCT02107092|63265384|FG000|Overall Study|Hypo-or hyperkalemia|2|||
33701200|NCT02107092|63265384|FG000|Overall Study|Met ECG withdrawal criteria|3|||
33701201|NCT02107092|63265384|FG000|Overall Study|Physician Decision|3|||
33701202|NCT02107092|63265384|FG000|Overall Study|Lost to Follow-up|2|||
33701203|NCT02107092|63265384|FG000|Overall Study|Withdrawal by Subject|9|||
33701204|NCT02107092|63265384|FG000|Overall Study|Adverse Event|7|||
33701205|NCT02107092|63265384|FG000|Overall Study|Expected progression of CKD|12|||
33701206|NCT02107014|63265388|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
33701207|NCT01624974|63265394|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
33701208|NCT01624974|63265395|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
33701209|NCT01624974|63265394|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
33701210|NCT01624974|63265395|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
33701211|NCT01624974|63265394|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
33701212|NCT01624974|63265395|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
33701213|NCT01624974|63265394|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
33701214|NCT01624974|63265395|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
33701215|NCT01624974|63265394|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
33701216|NCT01624974|63265395|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
33701217|NCT01624974|63265394|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
33701218|NCT01624974|63265395|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
33701219|NCT01624974|63265394|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
33701220|NCT01624974|63265395|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
33701221|NCT01624974|63265394|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
33701222|NCT01624974|63265395|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
33701223|NCT01624974|63265394|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
33701224|NCT01624974|63265395|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
33701225|NCT01624974|63265394|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
33701226|NCT01624974|63265395|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
33701227|NCT01624974|63265394|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
33701228|NCT01624974|63265395|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
33701229|NCT01624974|63265394|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
33701230|NCT01624974|63265395|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
33701231|NCT02065518|63265406|FG000|Overall Study|Lost to Follow-up|3|||
33701232|NCT02065518|63265407|FG001|Overall Study|Lost to Follow-up|4|||
33701233|NCT02065518|63265408|FG002|Overall Study|Lost to Follow-up|0|||
33701234|NCT02065518|63265409|FG003|Overall Study|Lost to Follow-up|3|||
33701235|NCT02065518|63265406|FG000|Overall Study|Withdrawal by Subject|3|||
33701236|NCT02065518|63265407|FG001|Overall Study|Withdrawal by Subject|4|||
33701237|NCT02065518|63265408|FG002|Overall Study|Withdrawal by Subject|9|||
33701238|NCT02065518|63265409|FG003|Overall Study|Withdrawal by Subject|2|||
33701239|NCT01624662|63265423|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
33701240|NCT01624662|63265424|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
33701241|NCT01624662|63265425|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
33701242|NCT01624662|63265426|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
33701243|NCT01624662|63265423|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
33701244|NCT01624662|63265424|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
33701245|NCT01624662|63265425|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
33701246|NCT01624662|63265426|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
33701247|NCT01624662|63265423|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
33701248|NCT01624662|63265424|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
33701249|NCT01624662|63265425|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
33701250|NCT01624662|63265426|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
33701251|NCT01624662|63265423|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
33701252|NCT01624662|63265424|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
33596602|NCT01655069|62995594|FG001|Overall Study|No Treatment Needed|1|||
33701253|NCT01624662|63265425|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
33701254|NCT01624662|63265426|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
33701255|NCT01624662|63265423|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
33701256|NCT01624662|63265424|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
33701257|NCT01624662|63265425|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
33701258|NCT01624662|63265426|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
33701259|NCT01624662|63265423|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
33701260|NCT01624662|63265424|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
33701261|NCT01624662|63265425|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
33701262|NCT01624662|63265426|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
33701263|NCT01624662|63265423|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
33701264|NCT01624662|63265424|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
33701265|NCT01624662|63265425|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
33701266|NCT01624662|63265426|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
33701267|NCT01624506|63265449|FG000|Overall Study|Lost to Follow-up|29|||
33701268|NCT01624506|63265450|FG001|Overall Study|Lost to Follow-up|15|||
33701269|NCT01624506|63265449|FG000|Overall Study|Withdrawal by Subject|9|||
33701270|NCT01624506|63265450|FG001|Overall Study|Withdrawal by Subject|2|||
33701271|NCT01624506|63265449|FG000|Overall Study|Death|1|||
33701272|NCT01624506|63265450|FG001|Overall Study|Death|0|||
33701273|NCT01624506|63265449|FG000|Overall Study|LINX explants|23|||
33701274|NCT01624506|63265450|FG001|Overall Study|LINX explants|0|||
33701275|NCT01624506|63265449|FG000|Overall Study|Adverse Event|3|||
33701276|NCT01624506|63265450|FG001|Overall Study|Adverse Event|0|||
33701277|NCT02106390|63265459|FG000|Overall Study|Withdrawal by Subject|15|||
33701278|NCT02106390|63265460|FG001|Overall Study|Withdrawal by Subject|16|||
33701279|NCT02106390|63265461|FG002|Overall Study|Withdrawal by Subject|15|||
33701280|NCT02106390|63265459|FG000|Overall Study|Lost to Follow-up|25|||
33701281|NCT02106390|63265460|FG001|Overall Study|Lost to Follow-up|20|||
33701282|NCT02106390|63265461|FG002|Overall Study|Lost to Follow-up|13|||
33701283|NCT02106390|63265459|FG000|Overall Study|Other: Administrative Reason|8|||
33701284|NCT02106390|63265460|FG001|Overall Study|Other: Administrative Reason|5|||
33701285|NCT02106390|63265461|FG002|Overall Study|Other: Administrative Reason|12|||
33701286|NCT02106390|63265459|FG000|Overall Study|Other: Unspecified|1|||
33701287|NCT02106390|63265460|FG001|Overall Study|Other: Unspecified|4|||
33701288|NCT02106390|63265461|FG002|Overall Study|Other: Unspecified|2|||
33701289|NCT02106390|63265459|FG000|Overall Study|Adverse Event|0|||
33701290|NCT02106390|63265460|FG001|Overall Study|Adverse Event|2|||
33701291|NCT02106390|63265461|FG002|Overall Study|Adverse Event|1|||
33701292|NCT02106390|63265459|FG000|Overall Study|Protocol Violation|0|||
33701293|NCT02106390|63265460|FG001|Overall Study|Protocol Violation|1|||
33701294|NCT02106390|63265461|FG002|Overall Study|Protocol Violation|0|||
33701295|NCT02064894|63265475|FG000|Overall Study|Withdrawal by Subject|43|||
33701296|NCT02064894|63265476|FG001|Overall Study|Withdrawal by Subject|102|||
33701297|NCT02064894|63265477|FG002|Overall Study|Withdrawal by Subject|115|||
33701298|NCT02081586|63265489|FG000|Overall Study|Lost to Follow-up|0|||
33701299|NCT02081586|63265490|FG001|Overall Study|Lost to Follow-up|1|||
33701300|NCT02081586|63265491|FG002|Overall Study|Lost to Follow-up|0|||
33701301|NCT02081586|63265492|FG003|Overall Study|Lost to Follow-up|1|||
33701302|NCT02081586|63265489|FG000|Overall Study|Head injury not related to study|0|||
33701303|NCT02081586|63265490|FG001|Overall Study|Head injury not related to study|0|||
33701304|NCT02081586|63265491|FG002|Overall Study|Head injury not related to study|1|||
33701305|NCT02081586|63265492|FG003|Overall Study|Head injury not related to study|0|||
33701306|NCT02081196|63265504|FG000|Overall Study|Lost to Follow-up|1|||
33701307|NCT02064816|63265512|FG000|Overall Study|Adverse Event|3|||
33701308|NCT02064816|63265513|FG001|Overall Study|Adverse Event|2|||
33701309|NCT02064816|63265512|FG000|Overall Study|Withdrawal by Subject|2|||
33701310|NCT02064816|63265513|FG001|Overall Study|Withdrawal by Subject|1|||
33701311|NCT02064816|63265512|FG000|Overall Study|Lost to Follow-up|2|||
33701312|NCT02064816|63265513|FG001|Overall Study|Lost to Follow-up|1|||
33701313|NCT02064816|63265512|FG000|Overall Study|Therapeutic failure|0|||
33701314|NCT02064816|63265513|FG001|Overall Study|Therapeutic failure|1|||
33701315|NCT02064816|63265512|FG000|Overall Study|Other|1|||
33701316|NCT02064816|63265513|FG001|Overall Study|Other|3|||
33701317|NCT02080260|63265519|FG000|Overall Study|Death|18|||
33701318|NCT02080260|63265519|FG000|Overall Study|Withdrawal by Subject|1|||
33701319|NCT01624194|63265525|FG000|Overall Study|Lost to Follow-up|1|||
33701320|NCT01624194|63265526|FG001|Overall Study|Lost to Follow-up|0|||
33701321|NCT01624194|63265525|FG000|Overall Study|Withdrawal by Subject|1|||
33701322|NCT01624194|63265526|FG001|Overall Study|Withdrawal by Subject|0|||
33701323|NCT02079636|63265548|FG000|Overall Study|Death|2|||
33701324|NCT02079636|63265549|FG001|Overall Study|Death|1|||
33701325|NCT02079636|63265550|FG002|Overall Study|Death|0|||
33701326|NCT02079636|63265551|FG003|Overall Study|Death|5|||
33701327|NCT02079636|63265552|FG004|Overall Study|Death|1|||
33701328|NCT02079636|63265553|FG005|Overall Study|Death|2|||
33701329|NCT02079636|63265554|FG006|Overall Study|Death|1|||
33701330|NCT02079636|63265555|FG007|Overall Study|Death|0|||
33701331|NCT02079636|63265556|FG008|Overall Study|Death|0|||
33701332|NCT02079636|63265557|FG009|Overall Study|Death|0|||
33701333|NCT02079636|63265558|FG010|Overall Study|Death|0|||
33701334|NCT02079636|63265559|FG011|Overall Study|Death|1|||
33701335|NCT02079636|63265560|FG012|Overall Study|Death|1|||
33701336|NCT02079636|63265561|FG013|Overall Study|Death|0|||
33701337|NCT02079636|63265562|FG014|Overall Study|Death|2|||
33701338|NCT02079636|63265548|FG000|Overall Study|Adverse Event|1|||
33701339|NCT02079636|63265549|FG001|Overall Study|Adverse Event|1|||
33701340|NCT02079636|63265550|FG002|Overall Study|Adverse Event|0|||
33701341|NCT02079636|63265551|FG003|Overall Study|Adverse Event|1|||
33701342|NCT02079636|63265552|FG004|Overall Study|Adverse Event|1|||
33701343|NCT02079636|63265553|FG005|Overall Study|Adverse Event|2|||
33701344|NCT02079636|63265554|FG006|Overall Study|Adverse Event|0|||
33701345|NCT02079636|63265555|FG007|Overall Study|Adverse Event|0|||
33701346|NCT02079636|63265556|FG008|Overall Study|Adverse Event|0|||
33701347|NCT02079636|63265557|FG009|Overall Study|Adverse Event|0|||
33701348|NCT02079636|63265558|FG010|Overall Study|Adverse Event|0|||
33701349|NCT02079636|63265559|FG011|Overall Study|Adverse Event|0|||
33701350|NCT02079636|63265560|FG012|Overall Study|Adverse Event|0|||
33701351|NCT02079636|63265561|FG013|Overall Study|Adverse Event|0|||
33701352|NCT02079636|63265562|FG014|Overall Study|Adverse Event|0|||
33701353|NCT02079636|63265548|FG000|Overall Study|Progressive disease|0|||
33701354|NCT02079636|63265549|FG001|Overall Study|Progressive disease|0|||
33701355|NCT02079636|63265550|FG002|Overall Study|Progressive disease|0|||
33701356|NCT02079636|63265551|FG003|Overall Study|Progressive disease|2|||
33701357|NCT02079636|63265552|FG004|Overall Study|Progressive disease|0|||
33701358|NCT02079636|63265553|FG005|Overall Study|Progressive disease|0|||
33701359|NCT02079636|63265554|FG006|Overall Study|Progressive disease|0|||
33701360|NCT02079636|63265555|FG007|Overall Study|Progressive disease|0|||
33701361|NCT02079636|63265556|FG008|Overall Study|Progressive disease|0|||
33701362|NCT02079636|63265557|FG009|Overall Study|Progressive disease|0|||
33701363|NCT02079636|63265558|FG010|Overall Study|Progressive disease|0|||
33701364|NCT02079636|63265559|FG011|Overall Study|Progressive disease|0|||
33701365|NCT02079636|63265560|FG012|Overall Study|Progressive disease|1|||
33701366|NCT02079636|63265561|FG013|Overall Study|Progressive disease|0|||
33701367|NCT02079636|63265562|FG014|Overall Study|Progressive disease|0|||
33701368|NCT02079636|63265548|FG000|Overall Study|Withdrawal by Subject|0|||
33701369|NCT02079636|63265549|FG001|Overall Study|Withdrawal by Subject|0|||
33701370|NCT02079636|63265550|FG002|Overall Study|Withdrawal by Subject|0|||
33701371|NCT02079636|63265551|FG003|Overall Study|Withdrawal by Subject|4|||
33701372|NCT02079636|63265552|FG004|Overall Study|Withdrawal by Subject|0|||
33701373|NCT02079636|63265553|FG005|Overall Study|Withdrawal by Subject|1|||
33701374|NCT02079636|63265554|FG006|Overall Study|Withdrawal by Subject|0|||
33701375|NCT02079636|63265555|FG007|Overall Study|Withdrawal by Subject|0|||
33701376|NCT02079636|63265556|FG008|Overall Study|Withdrawal by Subject|0|||
33701377|NCT02079636|63265557|FG009|Overall Study|Withdrawal by Subject|2|||
33701378|NCT02079636|63265558|FG010|Overall Study|Withdrawal by Subject|1|||
33701379|NCT02079636|63265559|FG011|Overall Study|Withdrawal by Subject|1|||
33701380|NCT02079636|63265560|FG012|Overall Study|Withdrawal by Subject|1|||
33701381|NCT02079636|63265561|FG013|Overall Study|Withdrawal by Subject|0|||
33701382|NCT02079636|63265562|FG014|Overall Study|Withdrawal by Subject|2|||
33701383|NCT02079636|63265548|FG000|Overall Study|Physician Decision|0|||
33701384|NCT02079636|63265549|FG001|Overall Study|Physician Decision|0|||
33701385|NCT02079636|63265550|FG002|Overall Study|Physician Decision|0|||
33701386|NCT02079636|63265551|FG003|Overall Study|Physician Decision|0|||
33701387|NCT02079636|63265552|FG004|Overall Study|Physician Decision|0|||
33701388|NCT02079636|63265553|FG005|Overall Study|Physician Decision|1|||
33701389|NCT02079636|63265554|FG006|Overall Study|Physician Decision|0|||
33701390|NCT02079636|63265555|FG007|Overall Study|Physician Decision|0|||
33701391|NCT02079636|63265556|FG008|Overall Study|Physician Decision|0|||
33701392|NCT02079636|63265557|FG009|Overall Study|Physician Decision|1|||
33701393|NCT02079636|63265558|FG010|Overall Study|Physician Decision|1|||
33701394|NCT02079636|63265559|FG011|Overall Study|Physician Decision|0|||
33701395|NCT02079636|63265560|FG012|Overall Study|Physician Decision|0|||
33701396|NCT02079636|63265561|FG013|Overall Study|Physician Decision|0|||
33701397|NCT02079636|63265562|FG014|Overall Study|Physician Decision|1|||
33701398|NCT02079636|63265548|FG000|Overall Study|Lost to Follow-up|0|||
33701399|NCT02079636|63265549|FG001|Overall Study|Lost to Follow-up|0|||
33701400|NCT02079636|63265550|FG002|Overall Study|Lost to Follow-up|0|||
33701401|NCT02079636|63265551|FG003|Overall Study|Lost to Follow-up|0|||
33701402|NCT02079636|63265552|FG004|Overall Study|Lost to Follow-up|0|||
33701403|NCT02079636|63265553|FG005|Overall Study|Lost to Follow-up|0|||
33701404|NCT02079636|63265554|FG006|Overall Study|Lost to Follow-up|0|||
33701405|NCT02079636|63265555|FG007|Overall Study|Lost to Follow-up|1|||
33701406|NCT02079636|63265556|FG008|Overall Study|Lost to Follow-up|0|||
33701407|NCT02079636|63265557|FG009|Overall Study|Lost to Follow-up|0|||
33701408|NCT02079636|63265558|FG010|Overall Study|Lost to Follow-up|0|||
33701409|NCT02079636|63265559|FG011|Overall Study|Lost to Follow-up|0|||
33701410|NCT02079636|63265560|FG012|Overall Study|Lost to Follow-up|0|||
33701411|NCT02079636|63265561|FG013|Overall Study|Lost to Follow-up|0|||
33701412|NCT02079636|63265562|FG014|Overall Study|Lost to Follow-up|0|||
33701413|NCT02079246|63265626|FG000|OLEX|Withdrawal before treatment|1|||
33701414|NCT02079246|63265627|FG001|OLEX|Withdrawal before treatment|0|||
33701415|NCT02079246|63265626|FG000|OLEX|Death|11|||
33701416|NCT02079246|63265627|FG001|OLEX|Death|0|||
33701417|NCT02079246|63265626|FG000|OLEX|Adverse Event|66|||
33701418|NCT02079246|63265627|FG001|OLEX|Adverse Event|0|||
33701419|NCT02079246|63265626|FG000|OLEX|Withdrawal by Subject|60|||
33701420|NCT02079246|63265627|FG001|OLEX|Withdrawal by Subject|0|||
33701421|NCT02079246|63265626|FG000|OLEX|Lost to Follow-up|6|||
33701422|NCT02079246|63265627|FG001|OLEX|Lost to Follow-up|0|||
33701423|NCT02079246|63265626|FG000|OLEX|Protocol Violation|6|||
33701424|NCT02079246|63265627|FG001|OLEX|Protocol Violation|0|||
33701425|NCT02079246|63265626|FG000|OLEX|Lack of Efficacy|3|||
33701426|NCT02079246|63265627|FG001|OLEX|Lack of Efficacy|0|||
33701427|NCT02079246|63265626|FG000|OLEX|Results of the lead-in studies|58|||
33701428|NCT02079246|63265627|FG001|OLEX|Results of the lead-in studies|0|||
33701429|NCT02079246|63265626|FG000|OLEX|Other: Disallowed medication|8|||
33701430|NCT02079246|63265627|FG001|OLEX|Other: Disallowed medication|0|||
33596603|NCT01655069|62995595|FG002|Overall Study|No Treatment Needed|0|||
33701431|NCT02079246|63265626|FG000|OLEX|Other: Insufficient compliance|2|||
33701432|NCT02079246|63265627|FG001|OLEX|Other: Insufficient compliance|0|||
33701433|NCT02079246|63265626|FG000|OLEX|Other: Caregiver unavailable|3|||
33701434|NCT02079246|63265627|FG001|OLEX|Other: Caregiver unavailable|0|||
33701435|NCT02079246|63265626|FG000|OLEX|Other: Coordinator decision|1|||
33701436|NCT02079246|63265627|FG001|OLEX|Other: Coordinator decision|0|||
33701437|NCT02079246|63265626|FG000|OLEX|Other: Worsening of condition|1|||
33701438|NCT02079246|63265627|FG001|OLEX|Other: Worsening of condition|0|||
33701439|NCT02079246|63265626|FG000|OLEX|Other: Moved to nursing home|1|||
33701440|NCT02079246|63265627|FG001|OLEX|Other: Moved to nursing home|0|||
33701441|NCT02079246|63265626|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
33701442|NCT02079246|63265627|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
33701443|NCT02079246|63265626|FG000|OLEX-MEM|Adverse Event|0|||
33701444|NCT02079246|63265627|FG001|OLEX-MEM|Adverse Event|6|||
33701445|NCT02079246|63265626|FG000|OLEX-MEM|Withdrawal by Subject|0|||
33701446|NCT02079246|63265627|FG001|OLEX-MEM|Withdrawal by Subject|7|||
33701447|NCT02079246|63265626|FG000|OLEX-MEM|Protocol Violation|0|||
33701448|NCT02079246|63265627|FG001|OLEX-MEM|Protocol Violation|2|||
33701449|NCT02079246|63265626|FG000|OLEX-MEM|Lost to Follow-up|0|||
33701450|NCT02079246|63265627|FG001|OLEX-MEM|Lost to Follow-up|1|||
33701451|NCT02079246|63265626|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
33701452|NCT02079246|63265627|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
33701453|NCT02077374|63265638|FG000|Overall Study|Withdrawal by Subject|0|||
33701454|NCT02077374|63265639|FG001|Overall Study|Withdrawal by Subject|1|||
33701455|NCT02077374|63265638|FG000|Overall Study|Protocol Violation|0|||
33701456|NCT02077374|63265639|FG001|Overall Study|Protocol Violation|1|||
33701457|NCT02077140|63265653|FG000|Overall Study|Lost to Follow-up|4|||
33701458|NCT02077140|63265654|FG001|Overall Study|Lost to Follow-up|1|||
33701459|NCT02077140|63265655|FG002|Overall Study|Lost to Follow-up|2|||
33701460|NCT02077140|63265656|FG003|Overall Study|Lost to Follow-up|2|||
33701461|NCT02077140|63265657|FG004|Overall Study|Lost to Follow-up|3|||
33701462|NCT02077140|63265653|FG000|Overall Study|Withdrawal by Subject|0|||
33701463|NCT02077140|63265654|FG001|Overall Study|Withdrawal by Subject|1|||
33701464|NCT02077140|63265655|FG002|Overall Study|Withdrawal by Subject|0|||
33701465|NCT02077140|63265656|FG003|Overall Study|Withdrawal by Subject|2|||
33701466|NCT02077140|63265657|FG004|Overall Study|Withdrawal by Subject|2|||
33701467|NCT02047110|63265676|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
33701468|NCT02047110|63265677|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
33701469|NCT02047110|63265678|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
33701470|NCT02047110|63265679|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
33701471|NCT02047110|63265676|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
33701472|NCT02047110|63265677|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
33701473|NCT02047110|63265678|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
33701474|NCT02047110|63265679|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
33701475|NCT02047110|63265676|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
33701476|NCT02047110|63265677|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
33701477|NCT02047110|63265678|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
33701478|NCT02047110|63265679|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
33701479|NCT02047110|63265676|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
33701480|NCT02047110|63265677|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
33701481|NCT02047110|63265678|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
33701482|NCT02047110|63265679|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
33701483|NCT02047110|63265676|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
33701484|NCT02047110|63265677|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
33701485|NCT02047110|63265678|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
33701486|NCT02047110|63265679|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
33701487|NCT02047110|63265676|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
33701488|NCT02047110|63265677|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
33701489|NCT02047110|63265678|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
33701490|NCT02047110|63265679|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
33701491|NCT02047110|63265676|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
33701492|NCT02047110|63265677|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
33701493|NCT02047110|63265678|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
33701494|NCT02047110|63265679|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
33701495|NCT02047110|63265676|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
33701496|NCT02047110|63265677|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
33701497|NCT02047110|63265678|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
33701498|NCT02047110|63265679|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
33701499|NCT02047110|63265676|FG000|Escape Treatment Period|Adverse Event|1|||
33701500|NCT02047110|63265677|FG001|Escape Treatment Period|Adverse Event|2|||
33701501|NCT02047110|63265678|FG002|Escape Treatment Period|Adverse Event|2|||
33701502|NCT02047110|63265679|FG003|Escape Treatment Period|Adverse Event|0|||
33701503|NCT02047110|63265676|FG000|Escape Treatment Period|Other than specified|1|||
33701504|NCT02047110|63265677|FG001|Escape Treatment Period|Other than specified|2|||
33701505|NCT02047110|63265678|FG002|Escape Treatment Period|Other than specified|0|||
33701506|NCT02047110|63265679|FG003|Escape Treatment Period|Other than specified|1|||
33701507|NCT02047110|63265676|FG000|OLE Treatment Period|Other than specified|0|||
33701508|NCT02047110|63265677|FG001|OLE Treatment Period|Other than specified|0|||
33701509|NCT02047110|63265678|FG002|OLE Treatment Period|Other than specified|1|||
33701510|NCT02047110|63265679|FG003|OLE Treatment Period|Other than specified|0|||
33701511|NCT02046564|63265698|FG000|Overall Study|Adverse Event|6|||
33701512|NCT02046564|63265699|FG001|Overall Study|Adverse Event|3|||
33701513|NCT02046564|63265698|FG000|Overall Study|Physician Decision|0|||
33701514|NCT02046564|63265699|FG001|Overall Study|Physician Decision|1|||
33701515|NCT02046564|63265698|FG000|Overall Study|Protocol Violation|3|||
33701516|NCT02046564|63265699|FG001|Overall Study|Protocol Violation|1|||
33701517|NCT02046564|63265698|FG000|Overall Study|Withdrawal by Subject|4|||
33701518|NCT02046564|63265699|FG001|Overall Study|Withdrawal by Subject|10|||
33701519|NCT02046564|63265698|FG000|Overall Study|Subject met withdrawal criteria|2|||
33701520|NCT02046564|63265699|FG001|Overall Study|Subject met withdrawal criteria|5|||
33701521|NCT02046174|63265705|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
33701522|NCT02046174|63265706|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
33701523|NCT02045862|63265794|FG000|Overall Study|Death|0|||
33701524|NCT02045862|63265795|FG001|Overall Study|Death|0|||
33701525|NCT02045862|63265796|FG002|Overall Study|Death|1|||
33701526|NCT02045862|63265794|FG000|Overall Study|Miscellaneous|5|||
33701527|NCT02045862|63265795|FG001|Overall Study|Miscellaneous|0|||
33701528|NCT02045862|63265796|FG002|Overall Study|Miscellaneous|8|||
33701529|NCT02045862|63265794|FG000|Overall Study|Withdrawal by Patient|18|||
33701530|NCT02045862|63265795|FG001|Overall Study|Withdrawal by Patient|27|||
33701531|NCT02045862|63265796|FG002|Overall Study|Withdrawal by Patient|57|||
33701532|NCT02045862|63265794|FG000|Overall Study|Protocol Violation|0|||
33701533|NCT02045862|63265795|FG001|Overall Study|Protocol Violation|0|||
33701534|NCT02045862|63265796|FG002|Overall Study|Protocol Violation|6|||
33701535|NCT02045862|63265794|FG000|Overall Study|Lack of Efficacy|8|||
33701536|NCT02045862|63265795|FG001|Overall Study|Lack of Efficacy|4|||
33701537|NCT02045862|63265796|FG002|Overall Study|Lack of Efficacy|13|||
33701538|NCT02045862|63265794|FG000|Overall Study|Randomized but not Received Study Drug|0|||
33701539|NCT02045862|63265795|FG001|Overall Study|Randomized but not Received Study Drug|2|||
33701540|NCT02045862|63265796|FG002|Overall Study|Randomized but not Received Study Drug|8|||
33701541|NCT02045862|63265794|FG000|Overall Study|Adverse Event|7|||
33701542|NCT02045862|63265795|FG001|Overall Study|Adverse Event|5|||
33701543|NCT02045862|63265796|FG002|Overall Study|Adverse Event|27|||
33701544|NCT02045862|63265794|FG000|Overall Study|Lost to Follow-up|1|||
33701545|NCT02045862|63265795|FG001|Overall Study|Lost to Follow-up|2|||
33701546|NCT02045862|63265796|FG002|Overall Study|Lost to Follow-up|6|||
33701547|NCT02075658|63265806|FG000|Overall Study|Physician Decision|2|||
33701548|NCT02075658|63265807|FG001|Overall Study|Physician Decision|2|||
33701549|NCT02063880|63265815|FG000|Overall Study|Death|21|||
33701550|NCT02063880|63265816|FG001|Overall Study|Death|18|||
33701551|NCT02063880|63265815|FG000|Overall Study|Lost to Follow-up|7|||
33701552|NCT02063880|63265816|FG001|Overall Study|Lost to Follow-up|7|||
33701553|NCT02063880|63265815|FG000|Overall Study|Ineligible|0|||
33701554|NCT02063880|63265816|FG001|Overall Study|Ineligible|2|||
33701555|NCT02044848|63265824|FG000|Overall Study|Administrative Problems|2|||
33701556|NCT02044848|63265825|FG001|Overall Study|Administrative Problems|3|||
33701557|NCT02044458|63265833|FG000|Overall Study|Protocol Violation|3|||
33701558|NCT02044458|63265834|FG001|Overall Study|Protocol Violation|8|||
33701559|NCT02044302|63265842|FG000|Overall Study|study terminated|2|||
33701560|NCT02044302|63265843|FG001|Overall Study|study terminated|0|||
33701561|NCT02062944|63265847|FG000|Overall Study|Lost to Follow-up|1|||
33701562|NCT02062944|63265847|FG000|Overall Study|New hemotological disorder identified|1|||
33701563|NCT02062944|63265847|FG000|Overall Study|Uncontrolled Hypertension|1|||
33701564|NCT02062944|63265847|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
33701565|NCT02062632|63265852|FG000|Overall Study|No treatment data|1|||
33701566|NCT02062398|63265856|FG000|Overall Study|Implant removal|1|||
33701567|NCT02061540|63265860|FG000|Overall Study|Adverse Event|2|||
33701568|NCT02061540|63265860|FG000|Overall Study|Withdrawal by Subject|2|||
33701569|NCT02043366|63265875|FG000|Overall Study|Lost to Follow-up|2|||
33701570|NCT02043366|63265876|FG001|Overall Study|Lost to Follow-up|2|||
33701571|NCT02043366|63265877|FG002|Overall Study|Lost to Follow-up|2|||
33701572|NCT02043366|63265878|FG003|Overall Study|Lost to Follow-up|2|||
33701573|NCT02043366|63265879|FG004|Overall Study|Lost to Follow-up|2|||
33701574|NCT02043366|63265880|FG005|Overall Study|Lost to Follow-up|2|||
33701575|NCT02060370|63265896|FG000|Overall Study|Physician Decision|1|||
33701576|NCT01622088|63265900|FG000|Overall Study|Adverse Event|20|||
33701577|NCT01622088|63265900|FG000|Overall Study|Lost to Follow-up|1|||
33701578|NCT01622088|63265900|FG000|Overall Study|Withdrawal by Subject|20|||
33701579|NCT01622088|63265900|FG000|Overall Study|Investigator Decision|1|||
33701580|NCT01622088|63265900|FG000|Overall Study|Death|53|||
33701581|NCT01622088|63265900|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
33701582|NCT01621542|63265911|FG000|Overall Study|Adverse Event|0|||
33701583|NCT01621542|63265912|FG001|Overall Study|Adverse Event|0|||
33701584|NCT01621542|63265913|FG002|Overall Study|Adverse Event|1|||
33701585|NCT01621542|63265914|FG003|Overall Study|Adverse Event|3|||
33701586|NCT01621542|63265915|FG004|Overall Study|Adverse Event|0|||
33701587|NCT01621542|63265916|FG005|Overall Study|Adverse Event|0|||
33701588|NCT01621542|63265911|FG000|Overall Study|Death|0|||
33701589|NCT01621542|63265912|FG001|Overall Study|Death|1|||
33701590|NCT01621542|63265913|FG002|Overall Study|Death|0|||
33701591|NCT01621542|63265914|FG003|Overall Study|Death|0|||
33701592|NCT01621542|63265915|FG004|Overall Study|Death|0|||
33701593|NCT01621542|63265916|FG005|Overall Study|Death|0|||
33701594|NCT01621542|63265911|FG000|Overall Study|Physician Decision|1|||
33701595|NCT01621542|63265912|FG001|Overall Study|Physician Decision|0|||
33596604|NCT01655069|62995596|FG003|Overall Study|No Treatment Needed|0|||
33596605|NCT01655069|62995593|FG000|Overall Study|Withdrawal by Subject|2|||
33596606|NCT01655069|62995594|FG001|Overall Study|Withdrawal by Subject|3|||
33596607|NCT01655069|62995595|FG002|Overall Study|Withdrawal by Subject|0|||
33596608|NCT01655069|62995596|FG003|Overall Study|Withdrawal by Subject|0|||
33596609|NCT02068599|62995607|FG000|Overall Study|Adverse Event|4|||
33596610|NCT02068599|62995608|FG001|Overall Study|Adverse Event|1|||
33596611|NCT02068599|62995609|FG002|Overall Study|Adverse Event|1|||
33596612|NCT02068599|62995607|FG000|Overall Study|Withdrawal by Subject|2|||
33596613|NCT02068599|62995608|FG001|Overall Study|Withdrawal by Subject|7|||
33596614|NCT02068599|62995609|FG002|Overall Study|Withdrawal by Subject|5|||
33596615|NCT02068599|62995607|FG000|Overall Study|Protocol Violation|4|||
33701596|NCT01621542|63265913|FG002|Overall Study|Physician Decision|1|||
33701597|NCT01621542|63265914|FG003|Overall Study|Physician Decision|13|||
33701598|NCT01621542|63265915|FG004|Overall Study|Physician Decision|3|||
33701599|NCT01621542|63265916|FG005|Overall Study|Physician Decision|1|||
33701600|NCT01621542|63265911|FG000|Overall Study|Withdrawal by Subject|2|||
33701601|NCT01621542|63265912|FG001|Overall Study|Withdrawal by Subject|0|||
33701602|NCT01621542|63265913|FG002|Overall Study|Withdrawal by Subject|1|||
33701603|NCT01621542|63265914|FG003|Overall Study|Withdrawal by Subject|3|||
33701604|NCT01621542|63265915|FG004|Overall Study|Withdrawal by Subject|3|||
33701605|NCT01621542|63265916|FG005|Overall Study|Withdrawal by Subject|3|||
33701606|NCT01621542|63265911|FG000|Overall Study|progression/treatment failure|2|||
33701607|NCT01621542|63265912|FG001|Overall Study|progression/treatment failure|4|||
33701608|NCT01621542|63265913|FG002|Overall Study|progression/treatment failure|3|||
33701609|NCT01621542|63265914|FG003|Overall Study|progression/treatment failure|7|||
33596616|NCT02068599|62995608|FG001|Overall Study|Protocol Violation|2|||
33701610|NCT01621542|63265915|FG004|Overall Study|progression/treatment failure|3|||
33701611|NCT01621542|63265916|FG005|Overall Study|progression/treatment failure|5|||
33701612|NCT01621542|63265911|FG000|Overall Study|Protocol Violation|0|||
33701613|NCT01621542|63265912|FG001|Overall Study|Protocol Violation|0|||
33701614|NCT01621542|63265913|FG002|Overall Study|Protocol Violation|0|||
33701615|NCT01621542|63265914|FG003|Overall Study|Protocol Violation|1|||
33701616|NCT01621542|63265915|FG004|Overall Study|Protocol Violation|0|||
33701617|NCT01621542|63265916|FG005|Overall Study|Protocol Violation|0|||
33701618|NCT01621542|63265911|FG000|Overall Study|study stopped by sponsor|0|||
33701619|NCT01621542|63265912|FG001|Overall Study|study stopped by sponsor|0|||
33701620|NCT01621542|63265913|FG002|Overall Study|study stopped by sponsor|0|||
33701621|NCT01621542|63265914|FG003|Overall Study|study stopped by sponsor|1|||
33701622|NCT01621542|63265915|FG004|Overall Study|study stopped by sponsor|0|||
33701623|NCT01621542|63265916|FG005|Overall Study|study stopped by sponsor|0|||
33701624|NCT02021292|63265932|FG000|Overall Study|Physician Decision|0|||
33701625|NCT02021292|63265933|FG001|Overall Study|Physician Decision|1|||
33701626|NCT02021292|63265932|FG000|Overall Study|Lost to Follow-up|0|||
33701627|NCT02021292|63265933|FG001|Overall Study|Lost to Follow-up|1|||
33701628|NCT02021292|63265932|FG000|Overall Study|Death|0|||
33701629|NCT02021292|63265933|FG001|Overall Study|Death|1|||
33701630|NCT02059980|63265943|FG000|Overall Study|Lost to Follow-up|2|||
33701631|NCT02059980|63265944|FG001|Overall Study|Lost to Follow-up|1|||
33701632|NCT02043132|63265952|FG000|Overall Study|Lost to Follow-up|1|||
33701633|NCT02043132|63265953|FG001|Overall Study|Lost to Follow-up|1|||
33701634|NCT02043132|63265952|FG000|Overall Study|screen failures|4|||
33701635|NCT02043132|63265953|FG001|Overall Study|screen failures|8|||
33701636|NCT02059434|63265968|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
33701637|NCT02059434|63265969|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
33701638|NCT02059434|63265970|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
33701639|NCT02059434|63265971|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
33701640|NCT02059434|63265972|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
33701641|NCT02059434|63265973|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
33701642|NCT02059434|63265974|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
33701643|NCT02059434|63265975|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
33701644|NCT02059434|63265976|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
33701645|NCT02059434|63265968|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
33701646|NCT02059434|63265969|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
33701647|NCT02059434|63265970|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
33701648|NCT02059434|63265971|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
33701649|NCT02059434|63265972|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
33701650|NCT02059434|63265973|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
33701651|NCT02059434|63265974|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
33701652|NCT02059434|63265975|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
33701653|NCT02059434|63265976|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
33701654|NCT02059434|63265968|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
33701655|NCT02059434|63265969|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
33701656|NCT02059434|63265970|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
33701657|NCT02059434|63265971|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
33701658|NCT02059434|63265972|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
33701659|NCT02059434|63265973|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
33701660|NCT02059434|63265974|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
33701661|NCT02059434|63265975|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
33701662|NCT02059434|63265976|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
33701663|NCT02059434|63265968|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
33701664|NCT02059434|63265969|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
33701665|NCT02059434|63265970|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
33701666|NCT02059434|63265971|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
33701667|NCT02059434|63265972|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
33701668|NCT02059434|63265973|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
33701669|NCT02059434|63265974|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
33701670|NCT02059434|63265975|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
33701671|NCT02059434|63265976|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
33701672|NCT02059434|63265968|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33701673|NCT02059434|63265969|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33701674|NCT02059434|63265970|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33701675|NCT02059434|63265971|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33701676|NCT02059434|63265972|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33701677|NCT02059434|63265973|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33701678|NCT02059434|63265974|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33701679|NCT02059434|63265975|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33701680|NCT02059434|63265976|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
33701681|NCT02059278|63266006|FG000|Overall Study|Adverse Event|1|||
33701682|NCT02059278|63266007|FG001|Overall Study|Adverse Event|1|||
33701683|NCT02059278|63266006|FG000|Overall Study|Lost to Follow-up|1|||
33701684|NCT02059278|63266007|FG001|Overall Study|Lost to Follow-up|0|||
33701685|NCT02059278|63266006|FG000|Overall Study|Withdrawal by Subject|0|||
33701686|NCT02059278|63266007|FG001|Overall Study|Withdrawal by Subject|3|||
33701687|NCT02059278|63266006|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
33701688|NCT02059278|63266007|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
33701689|NCT02020512|63266013|FG000|Overall Study|Adverse Event|1|||
33701690|NCT02020512|63266013|FG000|Overall Study|Lost to Follow-up|3|||
33701691|NCT02020512|63266013|FG000|Overall Study|Protocol Violation|4|||
33701692|NCT02041962|63266019|FG000|Overall Study|Lost Aetna Coverage|43|||
33701693|NCT02041962|63266020|FG001|Overall Study|Lost Aetna Coverage|40|||
33701694|NCT02041962|63266019|FG000|Overall Study|Death|1|||
33701695|NCT02041962|63266020|FG001|Overall Study|Death|1|||
33701696|NCT02041962|63266019|FG000|Overall Study|Lost to Follow-up|37|||
33701697|NCT02041962|63266020|FG001|Overall Study|Lost to Follow-up|32|||
33701698|NCT02041962|63266019|FG000|Overall Study|Withdrawal by Subject|0|||
33701699|NCT02041962|63266020|FG001|Overall Study|Withdrawal by Subject|11|||
33701700|NCT02041494|63266028|FG000|Overall Study|Death|1|||
33701701|NCT02041494|63266029|FG001|Overall Study|Death|3|||
33701702|NCT02041494|63266028|FG000|Overall Study|Lost to Follow-up|2|||
33701703|NCT02041494|63266029|FG001|Overall Study|Lost to Follow-up|6|||
33701704|NCT02041494|63266028|FG000|Overall Study|study terminated|16|||
33701705|NCT02041494|63266029|FG001|Overall Study|study terminated|11|||
33701706|NCT02041104|63266060|FG000|Overall Study|Lost to Follow-up|1|||
33701707|NCT02041104|63266061|FG001|Overall Study|Lost to Follow-up|4|||
33701708|NCT02041104|63266060|FG000|Overall Study|discomfort during OGTT|0|||
33701709|NCT02041104|63266061|FG001|Overall Study|discomfort during OGTT|3|||
33701710|NCT02019420|63266071|FG000|Overall Study|Did not receive study drug|2|||
33701711|NCT02019420|63266072|FG001|Overall Study|Did not receive study drug|2|||
33701712|NCT02019420|63266071|FG000|Overall Study|Withdrawal by Subject|1|||
33701713|NCT02019420|63266072|FG001|Overall Study|Withdrawal by Subject|3|||
33701714|NCT02019420|63266071|FG000|Overall Study|At request of sponsor or investigator|0|||
33701715|NCT02019420|63266072|FG001|Overall Study|At request of sponsor or investigator|1|||
33701716|NCT02019420|63266071|FG000|Overall Study|Death|104|||
33701717|NCT02019420|63266072|FG001|Overall Study|Death|99|||
33701718|NCT02019420|63266071|FG000|Overall Study|Transferred to other care facility|1|||
33701719|NCT02019420|63266072|FG001|Overall Study|Transferred to other care facility|1|||
33701720|NCT02019264|63266080|FG000|Overall Study|Not treated|6|||
33701721|NCT02019264|63266081|FG001|Overall Study|Not treated|4|||
33701722|NCT02019264|63266080|FG000|Overall Study|Lost to Follow-up|50|||
33701723|NCT02019264|63266081|FG001|Overall Study|Lost to Follow-up|47|||
33701724|NCT02019264|63266080|FG000|Overall Study|Withdrawal by Subject|142|||
33701725|NCT02019264|63266081|FG001|Overall Study|Withdrawal by Subject|117|||
33701726|NCT02019264|63266080|FG000|Overall Study|Administrative reason|36|||
33701727|NCT02019264|63266081|FG001|Overall Study|Administrative reason|28|||
33701728|NCT02019264|63266080|FG000|Overall Study|Missing|14|||
33701729|NCT02019264|63266081|FG001|Overall Study|Missing|11|||
33701730|NCT02019108|63266089|FG000|Overall Study|Lost to Follow-up|5|||
33701731|NCT02019108|63266090|FG001|Overall Study|Lost to Follow-up|7|||
33701732|NCT02018562|63266098|FG000|Overall Study|Withdrawal by Subject|2|||
33701733|NCT02018562|63266099|FG001|Overall Study|Withdrawal by Subject|0|||
33701734|NCT02018562|63266098|FG000|Overall Study|Discharged prior to study completion|1|||
33701735|NCT02018562|63266099|FG001|Overall Study|Discharged prior to study completion|0|||
33701736|NCT02058966|63266105|FG000|Open-Label Methamphetamine|Adverse Event|1|||
33701737|NCT02058966|63266105|FG000|First Intervention|Withdrawal by Subject|1|||
33701738|NCT02017860|63266117|FG000|Overall Study|Adverse Event|1|||
33701739|NCT02017860|63266117|FG000|Overall Study|Withdrawal by Subject|1|||
33701740|NCT02040870|63266121|FG000|Overall Study|Completed treatment phase|6|||
33701741|NCT02040870|63266121|FG000|Overall Study|Adverse Event|7|||
33701742|NCT02040870|63266121|FG000|Overall Study|Progressive disease|58|||
33701743|NCT02040870|63266121|FG000|Overall Study|Physician Decision|6|||
33701744|NCT02040870|63266121|FG000|Overall Study|Subject/guardian decision|10|||
33701745|NCT02040870|63266121|FG000|Overall Study|Lost to Follow-up|3|||
33701746|NCT02040870|63266121|FG000|Overall Study|Death|13|||
33701747|NCT02016690|63266125|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
33701748|NCT02016690|63266125|FG000|Overall Study|Excluded from SAS: Duplication|2|||
33701749|NCT02016690|63266125|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
33701750|NCT02016690|63266125|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
33701751|NCT02016690|63266125|FG000|Overall Study|Did not meet inclusion criteria|13|||
33701752|NCT02016690|63266125|FG000|Overall Study|Hospitalized for RSV at study start|3|||
33701753|NCT02016300|63266131|FG000|Overall Study|Lost to Follow-up|0|||
33701754|NCT02016300|63266132|FG001|Overall Study|Lost to Follow-up|3|||
33701755|NCT02040090|63266140|FG000|Overall Study|Adverse Event|2|||
33701756|NCT02040090|63266141|FG001|Overall Study|Adverse Event|0|||
33701757|NCT02040090|63266140|FG000|Overall Study|Physician Decision|1|||
33701758|NCT02040090|63266141|FG001|Overall Study|Physician Decision|0|||
33701759|NCT02040090|63266140|FG000|Overall Study|Withdrawal by Subject|0|||
33701760|NCT02040090|63266141|FG001|Overall Study|Withdrawal by Subject|1|||
33701761|NCT02040090|63266140|FG000|Overall Study|Lost to Follow-up|0|||
33701762|NCT02040090|63266141|FG001|Overall Study|Lost to Follow-up|1|||
33701763|NCT02058498|63266147|FG000|Overall Study|Withdrawal by Subject|4|||
33701764|NCT02039778|63266151|FG000|Overall Study|Death|2|||
33701765|NCT02039778|63266151|FG000|Overall Study|Withdrawal by Subject|1|||
33701766|NCT02039778|63266151|FG000|Overall Study|Never started the protocol treatment|1|||
33701767|NCT02015754|63266155|FG000|Overall Study|Disease progression|5|||
33701768|NCT02015754|63266155|FG000|Overall Study|Change in treatment modality|5|||
33701769|NCT02015754|63266155|FG000|Overall Study|Lost to Follow-up|1|||
33701770|NCT02015676|63266162|FG000|Overall Study|Adverse Event|2|||
33701771|NCT02015676|63266163|FG001|Overall Study|Adverse Event|18|||
33701772|NCT02015676|63266164|FG002|Overall Study|Adverse Event|0|||
33701773|NCT02015676|63266162|FG000|Overall Study|Lack of Efficacy|2|||
33701774|NCT02015676|63266163|FG001|Overall Study|Lack of Efficacy|4|||
33701775|NCT02015676|63266164|FG002|Overall Study|Lack of Efficacy|0|||
33701776|NCT02015676|63266162|FG000|Overall Study|Protocol Violation|1|||
33701777|NCT02015676|63266163|FG001|Overall Study|Protocol Violation|0|||
33701778|NCT02015676|63266164|FG002|Overall Study|Protocol Violation|0|||
33701779|NCT02015676|63266162|FG000|Overall Study|Withdrawal by Subject|1|||
33701780|NCT02015676|63266163|FG001|Overall Study|Withdrawal by Subject|7|||
33701781|NCT02015676|63266164|FG002|Overall Study|Withdrawal by Subject|1|||
33701782|NCT02015676|63266162|FG000|Overall Study|Administrative reasons|0|||
33701783|NCT02015676|63266163|FG001|Overall Study|Administrative reasons|3|||
33701784|NCT02015676|63266164|FG002|Overall Study|Administrative reasons|1|||
33701785|NCT02015676|63266162|FG000|Overall Study|Death|0|||
33701786|NCT02015676|63266163|FG001|Overall Study|Death|1|||
33701787|NCT02015676|63266164|FG002|Overall Study|Death|0|||
33701788|NCT02015676|63266162|FG000|Overall Study|Disease progression|3|||
33701789|NCT02015676|63266163|FG001|Overall Study|Disease progression|1|||
33701790|NCT02015676|63266164|FG002|Overall Study|Disease progression|1|||
33701791|NCT02015520|63266172|FG000|Overall Study|Lack of Efficacy|1|||
33701792|NCT02015520|63266173|FG001|Overall Study|Lack of Efficacy|0|||
33701793|NCT02015520|63266174|FG002|Overall Study|Lack of Efficacy|3|||
33701794|NCT02015520|63266175|FG003|Overall Study|Lack of Efficacy|2|||
33701795|NCT02015520|63266172|FG000|Overall Study|Adverse Event|0|||
33701796|NCT02015520|63266173|FG001|Overall Study|Adverse Event|0|||
33701797|NCT02015520|63266174|FG002|Overall Study|Adverse Event|0|||
33701798|NCT02015520|63266175|FG003|Overall Study|Adverse Event|1|||
33701799|NCT02015520|63266172|FG000|Overall Study|Withdrawal by Subject|2|||
33701800|NCT02015520|63266173|FG001|Overall Study|Withdrawal by Subject|2|||
33701801|NCT02015520|63266174|FG002|Overall Study|Withdrawal by Subject|1|||
33701802|NCT02015520|63266175|FG003|Overall Study|Withdrawal by Subject|0|||
33701803|NCT02015520|63266172|FG000|Overall Study|Death|1|||
33701804|NCT02015520|63266173|FG001|Overall Study|Death|0|||
33701805|NCT02015520|63266174|FG002|Overall Study|Death|0|||
33701806|NCT02015520|63266175|FG003|Overall Study|Death|0|||
33701807|NCT02015520|63266172|FG000|Overall Study|Lost to Follow-up|0|||
33701808|NCT02015520|63266173|FG001|Overall Study|Lost to Follow-up|0|||
33701809|NCT02015520|63266174|FG002|Overall Study|Lost to Follow-up|1|||
33701810|NCT02015520|63266175|FG003|Overall Study|Lost to Follow-up|0|||
33701811|NCT02015520|63266172|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
33701812|NCT02015520|63266173|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
33701813|NCT02015520|63266174|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
33701814|NCT02015520|63266175|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
33701815|NCT02015520|63266172|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
33701816|NCT02015520|63266173|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
33701817|NCT02015520|63266174|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
33701818|NCT02015520|63266175|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
33701819|NCT02058108|63266187|FG000|Overall Study|Abnormal Laboratory Values|0|||
33701820|NCT02058108|63266188|FG001|Overall Study|Abnormal Laboratory Values|1|||
33701821|NCT02058108|63266187|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
33701822|NCT02058108|63266188|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
33701823|NCT02058108|63266187|FG000|Overall Study|No longer requires study drug|0|||
33701824|NCT02058108|63266188|FG001|Overall Study|No longer requires study drug|1|||
33701825|NCT02058108|63266187|FG000|Overall Study|Withdrawal by Subject|1|||
33701826|NCT02058108|63266188|FG001|Overall Study|Withdrawal by Subject|0|||
33701827|NCT02058108|63266187|FG000|Overall Study|Administrative problems|3|||
33701828|NCT02058108|63266188|FG001|Overall Study|Administrative problems|3|||
33701829|NCT02058108|63266187|FG000|Overall Study|Protocol Violation|0|||
33701830|NCT02058108|63266188|FG001|Overall Study|Protocol Violation|1|||
33701831|NCT02057874|63266196|FG000|Overall Study|participant did not return for scan|1|||
33701832|NCT02038920|63266203|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
33701833|NCT02038920|63266204|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
33701834|NCT02038920|63266205|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
33701835|NCT02038920|63266206|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
33701836|NCT02038920|63266207|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
33701837|NCT02038920|63266208|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
33701838|NCT02038920|63266203|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
33701839|NCT02038920|63266204|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
33701840|NCT02038920|63266205|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
33701841|NCT02038920|63266206|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
33701842|NCT02038920|63266207|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
33701843|NCT02038920|63266208|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
33701844|NCT02038920|63266203|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
33701845|NCT02038920|63266204|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
33701846|NCT02038920|63266205|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
33701847|NCT02038920|63266206|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
33701848|NCT02038920|63266207|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
33701849|NCT02038920|63266208|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
33701850|NCT02038920|63266203|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
33701851|NCT02038920|63266204|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
33701852|NCT02038920|63266205|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
33701853|NCT02038920|63266206|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
33701854|NCT02038920|63266207|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
33701855|NCT02038920|63266208|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
33701856|NCT02038920|63266203|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
33701857|NCT02038920|63266204|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
33701858|NCT02038920|63266205|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
33701859|NCT02038920|63266206|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
33701860|NCT02038920|63266207|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
33701861|NCT02038920|63266208|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
33701862|NCT02038920|63266203|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
33701863|NCT02038920|63266204|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
33701864|NCT02038920|63266205|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
33701865|NCT02038920|63266206|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
33701866|NCT02038920|63266207|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
33701867|NCT02038920|63266208|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
33701868|NCT02038920|63266203|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
33701869|NCT02038920|63266204|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
33701870|NCT02038920|63266205|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
33701871|NCT02038920|63266206|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
33701872|NCT02038920|63266207|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
33701873|NCT02038920|63266208|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
33701874|NCT02038920|63266203|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
33701875|NCT02038920|63266204|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
33701876|NCT02038920|63266205|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
33701877|NCT02038920|63266206|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
33701878|NCT02038920|63266207|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
33701879|NCT02038920|63266208|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
33701880|NCT02038920|63266203|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
33701881|NCT02038920|63266204|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
33701882|NCT02038920|63266205|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
33701883|NCT02038920|63266206|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
33701884|NCT02038920|63266207|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
33701885|NCT02038920|63266208|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
33701886|NCT02038920|63266203|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
33701887|NCT02038920|63266204|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
33701888|NCT02038920|63266205|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
33701889|NCT02038920|63266206|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
33701890|NCT02038920|63266207|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
33701891|NCT02038920|63266208|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
33701892|NCT02038920|63266203|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
33701893|NCT02038920|63266204|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
33701894|NCT02038920|63266205|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
33701895|NCT02038920|63266206|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
33701896|NCT02038920|63266207|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
33701897|NCT02038920|63266208|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
33701898|NCT02038920|63266203|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
33701899|NCT02038920|63266204|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
33701900|NCT02038920|63266205|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
33701901|NCT02038920|63266206|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
33701902|NCT02038920|63266207|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
33701903|NCT02038920|63266208|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
33701904|NCT02038764|63266230|FG000|Overall Study|Adverse Event|0|||
33701905|NCT02038764|63266231|FG001|Overall Study|Adverse Event|0|||
33701906|NCT02038764|63266232|FG002|Overall Study|Adverse Event|1|||
33701907|NCT02038764|63266233|FG003|Overall Study|Adverse Event|0|||
33701908|NCT02038764|63266234|FG004|Overall Study|Adverse Event|0|||
33701909|NCT02038764|63266230|FG000|Overall Study|Lost to Follow-up|0|||
33701910|NCT02038764|63266231|FG001|Overall Study|Lost to Follow-up|1|||
33701911|NCT02038764|63266232|FG002|Overall Study|Lost to Follow-up|0|||
33701912|NCT02038764|63266233|FG003|Overall Study|Lost to Follow-up|0|||
33701913|NCT02038764|63266234|FG004|Overall Study|Lost to Follow-up|0|||
33701914|NCT02038764|63266230|FG000|Overall Study|Withdrawal by Subject|0|||
33701915|NCT02038764|63266231|FG001|Overall Study|Withdrawal by Subject|0|||
33701916|NCT02038764|63266232|FG002|Overall Study|Withdrawal by Subject|0|||
33701917|NCT02038764|63266233|FG003|Overall Study|Withdrawal by Subject|0|||
33701918|NCT02038764|63266234|FG004|Overall Study|Withdrawal by Subject|1|||
33701919|NCT02038764|63266230|FG000|Overall Study|Other|1|||
33701920|NCT02038764|63266231|FG001|Overall Study|Other|0|||
33701921|NCT02038764|63266232|FG002|Overall Study|Other|1|||
33701922|NCT02038764|63266233|FG003|Overall Study|Other|0|||
33701923|NCT02038764|63266234|FG004|Overall Study|Other|0|||
33701924|NCT02057718|63266252|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
33701925|NCT02057718|63266253|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
33701926|NCT02057718|63266252|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
33701927|NCT02057718|63266253|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
33701928|NCT02057718|63266252|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
33701929|NCT02057718|63266253|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
33701930|NCT02057718|63266252|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
33701931|NCT02057718|63266253|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
33701932|NCT02057718|63266252|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
33701933|NCT02057718|63266253|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
33701934|NCT02057718|63266252|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
33701935|NCT02057718|63266253|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
33701936|NCT02057718|63266252|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
33701937|NCT02057718|63266253|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
33701938|NCT02057718|63266252|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
33701939|NCT02057718|63266253|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
33701940|NCT02057718|63266252|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
33701941|NCT02057718|63266253|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
33701942|NCT02057718|63266252|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
33701943|NCT02057718|63266253|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
33701944|NCT02057718|63266252|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
33701945|NCT02057718|63266253|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
33701946|NCT01622868|63266261|FG000|Overall Study|Protocol Violation|7|||
33701947|NCT01622868|63266262|FG001|Overall Study|Protocol Violation|0|||
33701948|NCT02014740|63266270|FG000|Overall Study|Lost to Follow-up|4|||
33701949|NCT02014740|63266271|FG001|Overall Study|Lost to Follow-up|4|||
33701950|NCT02014740|63266270|FG000|Overall Study|Withdrawal by Subject|2|||
33701951|NCT02014740|63266271|FG001|Overall Study|Withdrawal by Subject|1|||
33701952|NCT02014584|63266279|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
33701953|NCT02014584|63266280|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
33701954|NCT02014584|63266281|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
33701955|NCT02014584|63266282|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
33701956|NCT02014584|63266283|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
33701957|NCT02014584|63266284|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
33701958|NCT02014584|63266279|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
33701959|NCT02014584|63266280|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
33701960|NCT02014584|63266281|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
33701961|NCT02014584|63266282|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
33701962|NCT02014584|63266283|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
33701963|NCT02014584|63266284|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
33701964|NCT02014584|63266279|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
33701965|NCT02014584|63266280|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
33701966|NCT02014584|63266281|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
33701967|NCT02014584|63266282|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
33701968|NCT02014584|63266283|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
33701969|NCT02014584|63266284|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
33701970|NCT02014584|63266279|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
33701971|NCT02014584|63266280|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
33701972|NCT02014584|63266281|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
33701973|NCT02014584|63266282|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
33701974|NCT02014584|63266283|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
33701975|NCT02014584|63266284|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
33701976|NCT02014584|63266279|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
33701977|NCT02014584|63266280|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
33701978|NCT02014584|63266281|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
33701979|NCT02014584|63266282|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
33701980|NCT02014584|63266283|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
33701981|NCT02014584|63266284|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
33701982|NCT02014272|63266296|FG000|Intervention Period 1|Withdrawal by Subject|1|||
33701983|NCT02014272|63266297|FG001|Intervention Period 1|Withdrawal by Subject|0|||
33701984|NCT02014272|63266296|FG000|Intervention Period 1|Adverse Event|0|||
33701985|NCT02014272|63266297|FG001|Intervention Period 1|Adverse Event|1|||
33701986|NCT02037984|63266311|FG000|Overall Study|Lack of Efficacy|0|||
33701987|NCT02037984|63266312|FG001|Overall Study|Lack of Efficacy|0|||
33701988|NCT02037984|63266313|FG002|Overall Study|Lack of Efficacy|3|||
33701989|NCT02037984|63266314|FG003|Overall Study|Lack of Efficacy|10|||
33701990|NCT02037984|63266315|FG004|Overall Study|Lack of Efficacy|2|||
33701991|NCT02037984|63266316|FG005|Overall Study|Lack of Efficacy|2|||
33701992|NCT02037984|63266317|FG006|Overall Study|Lack of Efficacy|4|||
33701993|NCT02037984|63266318|FG007|Overall Study|Lack of Efficacy|3|||
33701994|NCT02037984|63266311|FG000|Overall Study|Lost to Follow-up|1|||
33701995|NCT02037984|63266312|FG001|Overall Study|Lost to Follow-up|0|||
33701996|NCT02037984|63266313|FG002|Overall Study|Lost to Follow-up|3|||
33701997|NCT02037984|63266314|FG003|Overall Study|Lost to Follow-up|5|||
33701998|NCT02037984|63266315|FG004|Overall Study|Lost to Follow-up|2|||
33701999|NCT02037984|63266316|FG005|Overall Study|Lost to Follow-up|2|||
33702000|NCT02037984|63266317|FG006|Overall Study|Lost to Follow-up|2|||
33702001|NCT02037984|63266318|FG007|Overall Study|Lost to Follow-up|4|||
33702002|NCT02037984|63266311|FG000|Overall Study|Physician Decision|0|||
33702003|NCT02037984|63266312|FG001|Overall Study|Physician Decision|0|||
33702004|NCT02037984|63266313|FG002|Overall Study|Physician Decision|0|||
33702005|NCT02037984|63266314|FG003|Overall Study|Physician Decision|0|||
33702006|NCT02037984|63266315|FG004|Overall Study|Physician Decision|0|||
33702007|NCT02037984|63266316|FG005|Overall Study|Physician Decision|0|||
33702008|NCT02037984|63266317|FG006|Overall Study|Physician Decision|1|||
33702009|NCT02037984|63266318|FG007|Overall Study|Physician Decision|0|||
33702010|NCT02037984|63266311|FG000|Overall Study|Protocol Violation|0|||
33702011|NCT02037984|63266312|FG001|Overall Study|Protocol Violation|0|||
33702012|NCT02037984|63266313|FG002|Overall Study|Protocol Violation|0|||
33702013|NCT02037984|63266314|FG003|Overall Study|Protocol Violation|0|||
33702014|NCT02037984|63266315|FG004|Overall Study|Protocol Violation|0|||
33702015|NCT02037984|63266316|FG005|Overall Study|Protocol Violation|1|||
33702016|NCT02037984|63266317|FG006|Overall Study|Protocol Violation|2|||
33702017|NCT02037984|63266318|FG007|Overall Study|Protocol Violation|0|||
33702018|NCT02037984|63266311|FG000|Overall Study|Technical Problems|0|||
33702019|NCT02037984|63266312|FG001|Overall Study|Technical Problems|0|||
33702020|NCT02037984|63266313|FG002|Overall Study|Technical Problems|3|||
33702021|NCT02037984|63266314|FG003|Overall Study|Technical Problems|3|||
33702022|NCT02037984|63266315|FG004|Overall Study|Technical Problems|2|||
33702023|NCT02037984|63266316|FG005|Overall Study|Technical Problems|3|||
33702024|NCT02037984|63266317|FG006|Overall Study|Technical Problems|4|||
33702025|NCT02037984|63266318|FG007|Overall Study|Technical Problems|2|||
33702026|NCT02037984|63266311|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33702027|NCT02037984|63266312|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33702028|NCT02037984|63266313|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
33702029|NCT02037984|63266314|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
33702030|NCT02037984|63266315|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
33702031|NCT02037984|63266316|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
33702032|NCT02037984|63266317|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
33702033|NCT02037984|63266318|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
33702034|NCT02037984|63266311|FG000|Overall Study|Withdrawal by Subject|0|||
33702035|NCT02037984|63266312|FG001|Overall Study|Withdrawal by Subject|0|||
33702036|NCT02037984|63266313|FG002|Overall Study|Withdrawal by Subject|0|||
33702037|NCT02037984|63266314|FG003|Overall Study|Withdrawal by Subject|1|||
33702038|NCT02037984|63266315|FG004|Overall Study|Withdrawal by Subject|1|||
33702039|NCT02037984|63266316|FG005|Overall Study|Withdrawal by Subject|3|||
33702040|NCT02037984|63266317|FG006|Overall Study|Withdrawal by Subject|0|||
33702041|NCT02037984|63266318|FG007|Overall Study|Withdrawal by Subject|1|||
33702042|NCT02057406|63266349|FG000|Overall Study|Physician Decision|0|||
33702043|NCT02057406|63266350|FG001|Overall Study|Physician Decision|0|||
33702044|NCT02057406|63266351|FG002|Overall Study|Physician Decision|2|||
33702045|NCT02057406|63266349|FG000|Overall Study|Withdrawal by Subject|0|||
33702046|NCT02057406|63266350|FG001|Overall Study|Withdrawal by Subject|2|||
33702047|NCT02057406|63266351|FG002|Overall Study|Withdrawal by Subject|0|||
33702048|NCT02057406|63266349|FG000|Overall Study|Lost to Follow-up|0|||
33702049|NCT02057406|63266350|FG001|Overall Study|Lost to Follow-up|0|||
33702050|NCT02057406|63266351|FG002|Overall Study|Lost to Follow-up|1|||
33702051|NCT02057406|63266349|FG000|Overall Study|Death|1|||
33702052|NCT02057406|63266350|FG001|Overall Study|Death|0|||
33702053|NCT02057406|63266351|FG002|Overall Study|Death|0|||
33702054|NCT02057406|63266349|FG000|Overall Study|Protocol Violation|0|||
33702055|NCT02057406|63266350|FG001|Overall Study|Protocol Violation|1|||
33702056|NCT02057406|63266351|FG002|Overall Study|Protocol Violation|0|||
33702057|NCT02057406|63266349|FG000|Overall Study|Patient transportation issues|0|||
33702058|NCT02057406|63266350|FG001|Overall Study|Patient transportation issues|0|||
33702059|NCT02057406|63266351|FG002|Overall Study|Patient transportation issues|1|||
33702060|NCT02036580|63266362|FG000|Overall Study|Withdrawal by Subject|0|||
33702061|NCT02036580|63266363|FG001|Overall Study|Withdrawal by Subject|1|||
33702062|NCT02036580|63266364|FG002|Overall Study|Withdrawal by Subject|0|||
33702063|NCT02036580|63266362|FG000|Overall Study|Adverse Event|1|||
33702064|NCT02036580|63266363|FG001|Overall Study|Adverse Event|0|||
33702065|NCT02036580|63266364|FG002|Overall Study|Adverse Event|0|||
33702066|NCT02014116|63266381|FG000|Overall Study|Progressive Disease|3|||
33702067|NCT02014116|63266382|FG001|Overall Study|Progressive Disease|4|||
33702068|NCT02014116|63266383|FG002|Overall Study|Progressive Disease|2|||
33702069|NCT02014116|63266384|FG003|Overall Study|Progressive Disease|6|||
33702070|NCT02014116|63266385|FG004|Overall Study|Progressive Disease|1|||
33702071|NCT02014116|63266386|FG005|Overall Study|Progressive Disease|13|||
33702072|NCT02014116|63266387|FG006|Overall Study|Progressive Disease|1|||
33702073|NCT02014116|63266388|FG007|Overall Study|Progressive Disease|3|||
33702074|NCT02014116|63266389|FG008|Overall Study|Progressive Disease|7|||
33702075|NCT02014116|63266381|FG000|Overall Study|Adverse Event|0|||
33702076|NCT02014116|63266382|FG001|Overall Study|Adverse Event|0|||
33702077|NCT02014116|63266383|FG002|Overall Study|Adverse Event|0|||
33702078|NCT02014116|63266384|FG003|Overall Study|Adverse Event|0|||
33702079|NCT02014116|63266385|FG004|Overall Study|Adverse Event|1|||
33702080|NCT02014116|63266386|FG005|Overall Study|Adverse Event|0|||
33702081|NCT02014116|63266387|FG006|Overall Study|Adverse Event|0|||
33702082|NCT02014116|63266388|FG007|Overall Study|Adverse Event|1|||
33702083|NCT02014116|63266389|FG008|Overall Study|Adverse Event|0|||
33702084|NCT02014116|63266381|FG000|Overall Study|Lost to Follow-up|0|||
33702085|NCT02014116|63266382|FG001|Overall Study|Lost to Follow-up|0|||
33702086|NCT02014116|63266383|FG002|Overall Study|Lost to Follow-up|0|||
33702087|NCT02014116|63266384|FG003|Overall Study|Lost to Follow-up|0|||
33702088|NCT02014116|63266385|FG004|Overall Study|Lost to Follow-up|0|||
33702089|NCT02014116|63266386|FG005|Overall Study|Lost to Follow-up|1|||
33702090|NCT02014116|63266387|FG006|Overall Study|Lost to Follow-up|0|||
33702091|NCT02014116|63266388|FG007|Overall Study|Lost to Follow-up|0|||
33702092|NCT02014116|63266389|FG008|Overall Study|Lost to Follow-up|1|||
33702093|NCT02014116|63266381|FG000|Overall Study|Death|0|||
33702094|NCT02014116|63266382|FG001|Overall Study|Death|0|||
33702095|NCT02014116|63266383|FG002|Overall Study|Death|0|||
33702096|NCT02014116|63266384|FG003|Overall Study|Death|0|||
33702097|NCT02014116|63266385|FG004|Overall Study|Death|0|||
33702098|NCT02014116|63266386|FG005|Overall Study|Death|0|||
33596617|NCT02068599|62995609|FG002|Overall Study|Protocol Violation|3|||
33596618|NCT02068599|62995607|FG000|Overall Study|Lost to Follow-up|1|||
33702099|NCT02014116|63266387|FG006|Overall Study|Death|0|||
33702100|NCT02014116|63266388|FG007|Overall Study|Death|1|||
33702101|NCT02014116|63266389|FG008|Overall Study|Death|1|||
33702102|NCT02014116|63266381|FG000|Overall Study|Withdrawal by Subject|0|||
33702103|NCT02014116|63266382|FG001|Overall Study|Withdrawal by Subject|0|||
33702104|NCT02014116|63266383|FG002|Overall Study|Withdrawal by Subject|1|||
33702105|NCT02014116|63266384|FG003|Overall Study|Withdrawal by Subject|1|||
33702106|NCT02014116|63266385|FG004|Overall Study|Withdrawal by Subject|0|||
33702107|NCT02014116|63266386|FG005|Overall Study|Withdrawal by Subject|1|||
33702108|NCT02014116|63266387|FG006|Overall Study|Withdrawal by Subject|0|||
33702109|NCT02014116|63266388|FG007|Overall Study|Withdrawal by Subject|0|||
33702110|NCT02014116|63266389|FG008|Overall Study|Withdrawal by Subject|0|||
33702111|NCT02014116|63266381|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
33702112|NCT02014116|63266382|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
33702113|NCT02014116|63266383|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
33702114|NCT02014116|63266384|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
33702115|NCT02014116|63266385|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
33702116|NCT02014116|63266386|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
33702117|NCT02014116|63266387|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
33702118|NCT02014116|63266388|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
33702119|NCT02014116|63266389|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
33702120|NCT02014116|63266381|FG000|Overall Study|Physician Decision|0|||
33702121|NCT02014116|63266382|FG001|Overall Study|Physician Decision|0|||
33702122|NCT02014116|63266383|FG002|Overall Study|Physician Decision|0|||
33702123|NCT02014116|63266384|FG003|Overall Study|Physician Decision|0|||
33702124|NCT02014116|63266385|FG004|Overall Study|Physician Decision|0|||
33702125|NCT02014116|63266386|FG005|Overall Study|Physician Decision|0|||
33702126|NCT02014116|63266387|FG006|Overall Study|Physician Decision|0|||
33702127|NCT02014116|63266388|FG007|Overall Study|Physician Decision|0|||
33702128|NCT02014116|63266389|FG008|Overall Study|Physician Decision|1|||
33702129|NCT02057250|63266416|FG000|AID Assessment Phase|Adverse Event|3|||
33702130|NCT02057250|63266417|FG001|AID Assessment Phase|Adverse Event|2|||
33702131|NCT02057250|63266418|FG002|AID Assessment Phase|Adverse Event|6|||
33702132|NCT02057250|63266419|FG003|AID Assessment Phase|Adverse Event|1|||
33702133|NCT02057250|63266420|FG004|AID Assessment Phase|Adverse Event|0|||
33702134|NCT02057250|63266416|FG000|AID Assessment Phase|Other than specified above|1|||
33702135|NCT02057250|63266417|FG001|AID Assessment Phase|Other than specified above|1|||
33702136|NCT02057250|63266418|FG002|AID Assessment Phase|Other than specified above|1|||
33702137|NCT02057250|63266419|FG003|AID Assessment Phase|Other than specified above|1|||
33702138|NCT02057250|63266420|FG004|AID Assessment Phase|Other than specified above|0|||
33702139|NCT02057250|63266416|FG000|Extension Phase|Adverse Event|0|||
33702140|NCT02057250|63266417|FG001|Extension Phase|Adverse Event|0|||
33702141|NCT02057250|63266418|FG002|Extension Phase|Adverse Event|0|||
33702142|NCT02057250|63266419|FG003|Extension Phase|Adverse Event|0|||
33702143|NCT02057250|63266420|FG004|Extension Phase|Adverse Event|15|||
33702144|NCT02057250|63266416|FG000|Extension Phase|Lack of Efficacy|0|||
33702145|NCT02057250|63266417|FG001|Extension Phase|Lack of Efficacy|0|||
33702146|NCT02057250|63266418|FG002|Extension Phase|Lack of Efficacy|0|||
33702147|NCT02057250|63266419|FG003|Extension Phase|Lack of Efficacy|0|||
33702148|NCT02057250|63266420|FG004|Extension Phase|Lack of Efficacy|10|||
33702149|NCT02057250|63266416|FG000|Extension Phase|Entered in this period but not treated|0|||
33702150|NCT02057250|63266417|FG001|Extension Phase|Entered in this period but not treated|0|||
33702151|NCT02057250|63266418|FG002|Extension Phase|Entered in this period but not treated|0|||
33702152|NCT02057250|63266419|FG003|Extension Phase|Entered in this period but not treated|0|||
33702153|NCT02057250|63266420|FG004|Extension Phase|Entered in this period but not treated|4|||
33702154|NCT02057250|63266416|FG000|Extension Phase|Other than specified above|0|||
33702155|NCT02057250|63266417|FG001|Extension Phase|Other than specified above|0|||
33702156|NCT02057250|63266418|FG002|Extension Phase|Other than specified above|0|||
33702157|NCT02057250|63266419|FG003|Extension Phase|Other than specified above|0|||
33702158|NCT02057250|63266420|FG004|Extension Phase|Other than specified above|7|||
33702159|NCT02036502|63266440|FG000|Part 1:Dose Determination/Escalation|Death|3|||
33702160|NCT02036502|63266441|FG001|Part 1:Dose Determination/Escalation|Death|2|||
33702161|NCT02036502|63266442|FG002|Part 1:Dose Determination/Escalation|Death|0|||
33702162|NCT02036502|63266443|FG003|Part 1:Dose Determination/Escalation|Death|0|||
33702163|NCT02036502|63266444|FG004|Part 1:Dose Determination/Escalation|Death|0|||
33702164|NCT02036502|63266445|FG005|Part 1:Dose Determination/Escalation|Death|0|||
33702165|NCT02036502|63266446|FG006|Part 1:Dose Determination/Escalation|Death|0|||
33702166|NCT02036502|63266447|FG007|Part 1:Dose Determination/Escalation|Death|0|||
33702167|NCT02036502|63266440|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
33702168|NCT02036502|63266441|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
33702169|NCT02036502|63266442|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
33702170|NCT02036502|63266443|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
33702171|NCT02036502|63266444|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
33702172|NCT02036502|63266445|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
33702173|NCT02036502|63266446|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
33702174|NCT02036502|63266447|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
33596619|NCT02068599|62995608|FG001|Overall Study|Lost to Follow-up|0|||
33702175|NCT02036502|63266440|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
33702176|NCT02036502|63266441|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
33702177|NCT02036502|63266442|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
33702178|NCT02036502|63266443|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
33702179|NCT02036502|63266444|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
33702180|NCT02036502|63266445|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
33702181|NCT02036502|63266446|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
33702182|NCT02036502|63266447|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
33702183|NCT02036502|63266440|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
33702184|NCT02036502|63266441|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
33702185|NCT02036502|63266442|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
33702186|NCT02036502|63266443|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
33702187|NCT02036502|63266444|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
33702188|NCT02036502|63266445|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
33702189|NCT02036502|63266446|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
33702190|NCT02036502|63266447|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
33702191|NCT02036502|63266440|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
33702192|NCT02036502|63266441|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
33702193|NCT02036502|63266442|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
33702194|NCT02036502|63266443|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
33702195|NCT02036502|63266444|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
33702196|NCT02036502|63266445|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
33702197|NCT02036502|63266446|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
33702198|NCT02036502|63266447|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
33702199|NCT02036502|63266440|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
33702200|NCT02036502|63266441|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
33702201|NCT02036502|63266442|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
33702202|NCT02036502|63266443|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
33702203|NCT02036502|63266444|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
33702204|NCT02036502|63266445|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
33702205|NCT02036502|63266446|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
33702206|NCT02036502|63266447|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
33702207|NCT02036502|63266440|FG000|Part 2:Dose Confirmation|Death|0|||
33702208|NCT02036502|63266441|FG001|Part 2:Dose Confirmation|Death|0|||
33702209|NCT02036502|63266442|FG002|Part 2:Dose Confirmation|Death|1|||
33702210|NCT02036502|63266443|FG003|Part 2:Dose Confirmation|Death|0|||
33702211|NCT02036502|63266444|FG004|Part 2:Dose Confirmation|Death|0|||
33702212|NCT02036502|63266445|FG005|Part 2:Dose Confirmation|Death|0|||
33702213|NCT02036502|63266446|FG006|Part 2:Dose Confirmation|Death|0|||
33702214|NCT02036502|63266447|FG007|Part 2:Dose Confirmation|Death|0|||
33702215|NCT02036502|63266440|FG000|Part 2:Dose Confirmation|Not treated|0|||
33702216|NCT02036502|63266441|FG001|Part 2:Dose Confirmation|Not treated|0|||
33702217|NCT02036502|63266442|FG002|Part 2:Dose Confirmation|Not treated|0|||
33702218|NCT02036502|63266443|FG003|Part 2:Dose Confirmation|Not treated|1|||
33702219|NCT02036502|63266444|FG004|Part 2:Dose Confirmation|Not treated|0|||
33702220|NCT02036502|63266445|FG005|Part 2:Dose Confirmation|Not treated|0|||
33702221|NCT02036502|63266446|FG006|Part 2:Dose Confirmation|Not treated|0|||
33702222|NCT02036502|63266447|FG007|Part 2:Dose Confirmation|Not treated|0|||
33702223|NCT02036502|63266440|FG000|Part 3:Dose Expansion|Adverse Event|0|||
33702224|NCT02036502|63266441|FG001|Part 3:Dose Expansion|Adverse Event|0|||
33702225|NCT02036502|63266442|FG002|Part 3:Dose Expansion|Adverse Event|0|||
33702226|NCT02036502|63266443|FG003|Part 3:Dose Expansion|Adverse Event|0|||
33702227|NCT02036502|63266444|FG004|Part 3:Dose Expansion|Adverse Event|0|||
33702228|NCT02036502|63266445|FG005|Part 3:Dose Expansion|Adverse Event|4|||
33702229|NCT02036502|63266446|FG006|Part 3:Dose Expansion|Adverse Event|0|||
33702230|NCT02036502|63266447|FG007|Part 3:Dose Expansion|Adverse Event|2|||
33702231|NCT02036502|63266440|FG000|Part 3:Dose Expansion|Death|0|||
33702232|NCT02036502|63266441|FG001|Part 3:Dose Expansion|Death|0|||
33702233|NCT02036502|63266442|FG002|Part 3:Dose Expansion|Death|0|||
33702234|NCT02036502|63266443|FG003|Part 3:Dose Expansion|Death|0|||
33702235|NCT02036502|63266444|FG004|Part 3:Dose Expansion|Death|0|||
33702236|NCT02036502|63266445|FG005|Part 3:Dose Expansion|Death|24|||
33702237|NCT02036502|63266446|FG006|Part 3:Dose Expansion|Death|0|||
33702238|NCT02036502|63266447|FG007|Part 3:Dose Expansion|Death|3|||
33702239|NCT02036502|63266440|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
33702240|NCT02036502|63266441|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
33702241|NCT02036502|63266442|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
33702242|NCT02036502|63266443|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
33702243|NCT02036502|63266444|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
33702244|NCT02036502|63266445|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
33702245|NCT02036502|63266446|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
33702246|NCT02036502|63266447|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
33702247|NCT02036502|63266440|FG000|Part 3:Dose Expansion|Physician Decision|0|||
33702248|NCT02036502|63266441|FG001|Part 3:Dose Expansion|Physician Decision|0|||
33702249|NCT02036502|63266442|FG002|Part 3:Dose Expansion|Physician Decision|0|||
33702250|NCT02036502|63266443|FG003|Part 3:Dose Expansion|Physician Decision|0|||
33702251|NCT02036502|63266444|FG004|Part 3:Dose Expansion|Physician Decision|0|||
33702252|NCT02036502|63266445|FG005|Part 3:Dose Expansion|Physician Decision|1|||
33702253|NCT02036502|63266446|FG006|Part 3:Dose Expansion|Physician Decision|0|||
33702254|NCT02036502|63266447|FG007|Part 3:Dose Expansion|Physician Decision|0|||
33702255|NCT02036502|63266440|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
33702256|NCT02036502|63266441|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
33702257|NCT02036502|63266442|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
33702258|NCT02036502|63266443|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
33702259|NCT02036502|63266444|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
33702260|NCT02036502|63266445|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
33702261|NCT02036502|63266446|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
33702262|NCT02036502|63266447|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
33702263|NCT02036502|63266440|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
33702264|NCT02036502|63266441|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
33702265|NCT02036502|63266442|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
33702266|NCT02036502|63266443|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
33702267|NCT02036502|63266444|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
33702268|NCT02036502|63266445|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
33702269|NCT02036502|63266446|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
33702270|NCT02036502|63266447|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
33702271|NCT02036502|63266440|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
33702272|NCT02036502|63266441|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
33702273|NCT02036502|63266442|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
33702274|NCT02036502|63266443|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
33702275|NCT02036502|63266444|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
33702276|NCT02036502|63266445|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
33702277|NCT02036502|63266446|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
33702278|NCT02036502|63266447|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
33702279|NCT02036502|63266440|FG000|Part 3:Dose Expansion|Not Treated|0|||
33702280|NCT02036502|63266441|FG001|Part 3:Dose Expansion|Not Treated|0|||
33702281|NCT02036502|63266442|FG002|Part 3:Dose Expansion|Not Treated|0|||
33702282|NCT02036502|63266443|FG003|Part 3:Dose Expansion|Not Treated|0|||
33702283|NCT02036502|63266444|FG004|Part 3:Dose Expansion|Not Treated|0|||
33702284|NCT02036502|63266445|FG005|Part 3:Dose Expansion|Not Treated|2|||
33702285|NCT02036502|63266446|FG006|Part 3:Dose Expansion|Not Treated|0|||
33702286|NCT02036502|63266447|FG007|Part 3:Dose Expansion|Not Treated|0|||
33702287|NCT02056626|63266471|FG000|Overall Study|patient did not follow directions|3|||
33702288|NCT02056626|63266472|FG001|Overall Study|patient did not follow directions|1|||
33702289|NCT02056626|63266473|FG002|Overall Study|patient did not follow directions|0|||
33702290|NCT02056626|63266474|FG003|Overall Study|patient did not follow directions|0|||
33702291|NCT02035332|63266484|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
33702292|NCT02056392|63266494|FG000|Overall Study|Lost to Follow-up|0|||
33702293|NCT02056392|63266495|FG001|Overall Study|Lost to Follow-up|1|||
33702294|NCT02056392|63266496|FG002|Overall Study|Lost to Follow-up|2|||
33702295|NCT02056392|63266497|FG003|Overall Study|Lost to Follow-up|0|||
33702296|NCT02056392|63266498|FG004|Overall Study|Lost to Follow-up|0|||
33702297|NCT02056392|63266499|FG005|Overall Study|Lost to Follow-up|0|||
33702298|NCT02056392|63266494|FG000|Overall Study|Protocol Violation|1|||
33702299|NCT02056392|63266495|FG001|Overall Study|Protocol Violation|0|||
33702300|NCT02056392|63266496|FG002|Overall Study|Protocol Violation|1|||
33702301|NCT02056392|63266497|FG003|Overall Study|Protocol Violation|0|||
33702302|NCT02056392|63266498|FG004|Overall Study|Protocol Violation|0|||
33702303|NCT02056392|63266499|FG005|Overall Study|Protocol Violation|0|||
33702304|NCT02056392|63266494|FG000|Overall Study|Withdrawal by Subject|1|||
33702305|NCT02056392|63266495|FG001|Overall Study|Withdrawal by Subject|0|||
33702306|NCT02056392|63266496|FG002|Overall Study|Withdrawal by Subject|0|||
33702307|NCT02056392|63266497|FG003|Overall Study|Withdrawal by Subject|0|||
33702308|NCT02056392|63266498|FG004|Overall Study|Withdrawal by Subject|1|||
33702309|NCT02056392|63266499|FG005|Overall Study|Withdrawal by Subject|0|||
33702310|NCT02034708|63266509|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
33702311|NCT02034708|63266510|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
33702312|NCT02034708|63266509|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
33702313|NCT02034708|63266510|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
33702314|NCT02034708|63266509|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
33702315|NCT02034708|63266510|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
33702316|NCT02034708|63266509|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
33702317|NCT02034708|63266510|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
33702318|NCT02034552|63266524|FG000|Overall Study|Never treated|3|||
33702319|NCT02034552|63266525|FG001|Overall Study|Never treated|2|||
33702320|NCT02034552|63266526|FG002|Overall Study|Never treated|0|||
33702321|NCT02034552|63266524|FG000|Overall Study|Radiological progression|3|||
33702322|NCT02034552|63266525|FG001|Overall Study|Radiological progression|5|||
33702323|NCT02034552|63266526|FG002|Overall Study|Radiological progression|4|||
33702324|NCT02034552|63266524|FG000|Overall Study|AE not assoc. with disease progression|1|||
33702325|NCT02034552|63266525|FG001|Overall Study|AE not assoc. with disease progression|4|||
33702326|NCT02034552|63266526|FG002|Overall Study|AE not assoc. with disease progression|2|||
33702327|NCT02034552|63266524|FG000|Overall Study|AE associated with disease progression|0|||
33702328|NCT02034552|63266525|FG001|Overall Study|AE associated with disease progression|1|||
33702329|NCT02034552|63266526|FG002|Overall Study|AE associated with disease progression|0|||
33702330|NCT02034552|63266524|FG000|Overall Study|Withdrawal by Subject|2|||
33702331|NCT02034552|63266525|FG001|Overall Study|Withdrawal by Subject|1|||
33702332|NCT02034552|63266526|FG002|Overall Study|Withdrawal by Subject|1|||
33702333|NCT02034552|63266524|FG000|Overall Study|Non-compliance with study drug|0|||
33702334|NCT02034552|63266525|FG001|Overall Study|Non-compliance with study drug|0|||
33702335|NCT02034552|63266526|FG002|Overall Study|Non-compliance with study drug|1|||
33702336|NCT02034552|63266524|FG000|Overall Study|Clinical progression|5|||
33702337|NCT02034552|63266525|FG001|Overall Study|Clinical progression|7|||
33702338|NCT02034552|63266526|FG002|Overall Study|Clinical progression|9|||
33702339|NCT02034474|63266536|FG000|Overall Study|Adverse Event|3|||
33702340|NCT02034474|63266537|FG001|Overall Study|Adverse Event|2|||
33702341|NCT02034474|63266536|FG000|Overall Study|Withdrawal by Subject|1|||
33702342|NCT02034474|63266537|FG001|Overall Study|Withdrawal by Subject|2|||
33702343|NCT02011542|63266545|FG000|Overall Study|Physician Decision|1|||
33702344|NCT02011386|63266549|FG000|Overall Study|Non-compliance|2|||
33702345|NCT02011386|63266549|FG000|Overall Study|Lack of Efficacy|3|||
33702346|NCT02010684|63266555|FG000|Overall Study|Lost to Follow-up|8|||
33702347|NCT02010684|63266556|FG001|Overall Study|Lost to Follow-up|18|||
33702348|NCT02010684|63266555|FG000|Overall Study|Withdrawal by Subject|4|||
33702349|NCT02010684|63266556|FG001|Overall Study|Withdrawal by Subject|5|||
33702350|NCT02034162|63266564|FG000|Double-blind|Lost to Follow-up|3|||
33702351|NCT02034162|63266565|FG001|Double-blind|Lost to Follow-up|0|||
33702352|NCT02034162|63266566|FG002|Double-blind|Lost to Follow-up|0|||
33702353|NCT02034162|63266564|FG000|Double-blind|Physician Decision|1|||
33702354|NCT02034162|63266565|FG001|Double-blind|Physician Decision|0|||
33702355|NCT02034162|63266566|FG002|Double-blind|Physician Decision|0|||
33702356|NCT02034162|63266564|FG000|Double-blind|Protocol Violation|0|||
33702357|NCT02034162|63266565|FG001|Double-blind|Protocol Violation|1|||
33702358|NCT02034162|63266566|FG002|Double-blind|Protocol Violation|0|||
33702359|NCT02034162|63266564|FG000|Double-blind|Withdrawal by Subject|5|||
33702360|NCT02034162|63266565|FG001|Double-blind|Withdrawal by Subject|7|||
33702361|NCT02034162|63266566|FG002|Double-blind|Withdrawal by Subject|0|||
33702362|NCT02034006|63266579|FG000|Overall Study|Withdrawal by Subject|7|||
33702363|NCT02034006|63266579|FG000|Overall Study|Lost to Follow-up|5|||
33702364|NCT02034006|63266579|FG000|Overall Study|Death|1|||
33702365|NCT02034006|63266579|FG000|Overall Study|Pregnancy|1|||
33702366|NCT02054910|63266588|FG000|Overall Study|Lost to Follow-up|4|||
33702367|NCT02054910|63266589|FG001|Overall Study|Lost to Follow-up|1|||
33702368|NCT02033850|63266599|FG000|Overall Study|Death|1|||
33702369|NCT02033850|63266600|FG001|Overall Study|Death|0|||
33702370|NCT02033850|63266599|FG000|Overall Study|unrelated medical reason|1|||
33702371|NCT02033850|63266600|FG001|Overall Study|unrelated medical reason|1|||
33702372|NCT02054130|63266610|FG000|Overall Study|Withdrawal by Subject|4|||
33702373|NCT02054130|63266611|FG001|Overall Study|Withdrawal by Subject|4|||
33702374|NCT02054130|63266612|FG002|Overall Study|Withdrawal by Subject|7|||
33702375|NCT02054130|63266613|FG003|Overall Study|Withdrawal by Subject|10|||
33702376|NCT02054130|63266610|FG000|Overall Study|Death|0|||
33702377|NCT02054130|63266611|FG001|Overall Study|Death|1|||
33702378|NCT02054130|63266612|FG002|Overall Study|Death|0|||
33702379|NCT02054130|63266613|FG003|Overall Study|Death|0|||
33702380|NCT02054130|63266610|FG000|Overall Study|Lost to Follow-up|0|||
33702381|NCT02054130|63266611|FG001|Overall Study|Lost to Follow-up|0|||
33702382|NCT02054130|63266612|FG002|Overall Study|Lost to Follow-up|1|||
33702383|NCT02054130|63266613|FG003|Overall Study|Lost to Follow-up|2|||
33702384|NCT02054130|63266610|FG000|Overall Study|Missed dose|4|||
33702385|NCT02054130|63266611|FG001|Overall Study|Missed dose|6|||
33702386|NCT02054130|63266612|FG002|Overall Study|Missed dose|7|||
33702387|NCT02054130|63266613|FG003|Overall Study|Missed dose|10|||
33702388|NCT02009046|63266628|FG000|Overall Study|Lost to Follow-up|256|||
33702389|NCT02009046|63266629|FG001|Overall Study|Lost to Follow-up|206|||
33702390|NCT02052960|63266645|FG000|Overall Study|Adverse Event|19|||
33702391|NCT02052960|63266646|FG001|Overall Study|Adverse Event|17|||
33702392|NCT02052960|63266645|FG000|Overall Study|Protocol Violation|4|||
33702393|NCT02052960|63266646|FG001|Overall Study|Protocol Violation|3|||
33702394|NCT02052960|63266645|FG000|Overall Study|Withdrawal by Subject|6|||
33702395|NCT02052960|63266646|FG001|Overall Study|Withdrawal by Subject|11|||
33702396|NCT02052960|63266645|FG000|Overall Study|Other|25|||
33702397|NCT02052960|63266646|FG001|Overall Study|Other|15|||
33702398|NCT02008890|63266658|FG000|Period 1|Withdrawal by Subject|7|||
33702399|NCT02008890|63266659|FG001|Period 1|Withdrawal by Subject|7|||
33702400|NCT02008890|63266660|FG002|Period 1|Withdrawal by Subject|5|||
33702401|NCT02008890|63266661|FG003|Period 1|Withdrawal by Subject|0|||
33702402|NCT02008890|63266662|FG004|Period 1|Withdrawal by Subject|0|||
33702403|NCT02008890|63266658|FG000|Period 1|Pregnancy|1|||
33702404|NCT02008890|63266659|FG001|Period 1|Pregnancy|0|||
33702405|NCT02008890|63266660|FG002|Period 1|Pregnancy|0|||
33702406|NCT02008890|63266661|FG003|Period 1|Pregnancy|0|||
33702407|NCT02008890|63266662|FG004|Period 1|Pregnancy|0|||
33702408|NCT02008890|63266658|FG000|Period 1|Physician Decision|1|||
33702409|NCT02008890|63266659|FG001|Period 1|Physician Decision|0|||
33702410|NCT02008890|63266660|FG002|Period 1|Physician Decision|1|||
33702411|NCT02008890|63266661|FG003|Period 1|Physician Decision|0|||
33702412|NCT02008890|63266662|FG004|Period 1|Physician Decision|0|||
33702413|NCT02008890|63266658|FG000|Period 1|Adverse Event|6|||
33702414|NCT02008890|63266659|FG001|Period 1|Adverse Event|8|||
33702415|NCT02008890|63266660|FG002|Period 1|Adverse Event|6|||
33702416|NCT02008890|63266661|FG003|Period 1|Adverse Event|0|||
33702417|NCT02008890|63266662|FG004|Period 1|Adverse Event|0|||
33702418|NCT02008890|63266658|FG000|Period 2|Adverse Event|12|||
33702419|NCT02008890|63266659|FG001|Period 2|Adverse Event|7|||
33702420|NCT02008890|63266660|FG002|Period 2|Adverse Event|0|||
33702421|NCT02008890|63266661|FG003|Period 2|Adverse Event|5|||
33702422|NCT02008890|63266662|FG004|Period 2|Adverse Event|5|||
33702423|NCT02008890|63266658|FG000|Period 2|Withdrawal by Subject|11|||
33702424|NCT02008890|63266659|FG001|Period 2|Withdrawal by Subject|8|||
33702425|NCT02008890|63266660|FG002|Period 2|Withdrawal by Subject|0|||
33702426|NCT02008890|63266661|FG003|Period 2|Withdrawal by Subject|7|||
33702427|NCT02008890|63266662|FG004|Period 2|Withdrawal by Subject|2|||
33702428|NCT02008890|63266658|FG000|Period 2|Physician Decision|4|||
33702429|NCT02008890|63266659|FG001|Period 2|Physician Decision|0|||
33702430|NCT02008890|63266660|FG002|Period 2|Physician Decision|0|||
33702431|NCT02008890|63266661|FG003|Period 2|Physician Decision|2|||
33702432|NCT02008890|63266662|FG004|Period 2|Physician Decision|1|||
33702433|NCT02008890|63266658|FG000|Period 2|Lost to Follow-up|0|||
33702434|NCT02008890|63266659|FG001|Period 2|Lost to Follow-up|0|||
33702435|NCT02008890|63266660|FG002|Period 2|Lost to Follow-up|1|||
33702436|NCT02008890|63266661|FG003|Period 2|Lost to Follow-up|0|||
33702437|NCT02008890|63266662|FG004|Period 2|Lost to Follow-up|0|||
33702438|NCT02008890|63266658|FG000|Extension Period|Withdrawal by Subject|3|||
33702439|NCT02008890|63266659|FG001|Extension Period|Withdrawal by Subject|2|||
33702440|NCT02008890|63266660|FG002|Extension Period|Withdrawal by Subject|0|||
33702441|NCT02008890|63266661|FG003|Extension Period|Withdrawal by Subject|4|||
33702442|NCT02008890|63266662|FG004|Extension Period|Withdrawal by Subject|2|||
33702443|NCT02008890|63266658|FG000|Extension Period|Lost to Follow-up|1|||
33702444|NCT02008890|63266659|FG001|Extension Period|Lost to Follow-up|0|||
33702445|NCT02008890|63266660|FG002|Extension Period|Lost to Follow-up|0|||
33702446|NCT02008890|63266661|FG003|Extension Period|Lost to Follow-up|0|||
33702447|NCT02008890|63266662|FG004|Extension Period|Lost to Follow-up|0|||
33702448|NCT02008890|63266658|FG000|Extension Period|Adverse Event|1|||
33702449|NCT02008890|63266659|FG001|Extension Period|Adverse Event|3|||
33702450|NCT02008890|63266660|FG002|Extension Period|Adverse Event|0|||
33702451|NCT02008890|63266661|FG003|Extension Period|Adverse Event|0|||
33702452|NCT02008890|63266662|FG004|Extension Period|Adverse Event|2|||
33702453|NCT02052414|63266677|FG000|Overall Study|Adverse Event|12|||
33702454|NCT02052414|63266677|FG000|Overall Study|Lack of Efficacy|2|||
33702455|NCT02052414|63266677|FG000|Overall Study|Withdrawal by Subject|3|||
33702456|NCT02007954|63266682|FG000|Overall Study|Received liver transplant|3|||
33702457|NCT02007954|63266682|FG000|Overall Study|Switch in treatment modality|2|||
33702458|NCT02007954|63266682|FG000|Overall Study|Disease progression and unrelated AE|1|||
33702459|NCT02007954|63266682|FG000|Overall Study|Death|1|||
33702460|NCT02049450|63266686|FG000|Overall Study|Adverse Event|2|||
33702461|NCT02049450|63266686|FG000|Overall Study|Withdrawal by Subject|1|||
33702462|NCT02049450|63266686|FG000|Overall Study|Patients/guardian decision|1|||
33702463|NCT02031432|63266697|FG000|Overall Study|Protocol Violation|1|||
33702464|NCT02031432|63266697|FG000|Overall Study|Lack of Efficacy|5|||
33702465|NCT02031432|63266697|FG000|Overall Study|Cancer Progression|2|||
33702466|NCT02031432|63266697|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
33702467|NCT02031432|63266697|FG000|Overall Study|Adverse Event|8|||
33702468|NCT02031432|63266697|FG000|Overall Study|Withdrawal by Subject|5|||
33702469|NCT02031432|63266697|FG000|Overall Study|Lost to Follow-up|1|||
33702470|NCT02031432|63266697|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
33702471|NCT02031432|63266697|FG000|Overall Study|Death|10|||
33702472|NCT02031276|63266704|FG000|Period 1 Double-blind IV|Adverse Event|6|||
33596620|NCT02068599|62995609|FG002|Overall Study|Lost to Follow-up|0|||
33702473|NCT02031276|63266705|FG001|Period 1 Double-blind IV|Adverse Event|5|||
33702474|NCT02031276|63266706|FG002|Period 1 Double-blind IV|Adverse Event|1|||
33702475|NCT02031276|63266704|FG000|Period 1 Double-blind IV|Other|0|||
33702476|NCT02031276|63266705|FG001|Period 1 Double-blind IV|Other|1|||
33702477|NCT02031276|63266706|FG002|Period 1 Double-blind IV|Other|0|||
33702478|NCT02031276|63266704|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
33702479|NCT02031276|63266705|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
33702480|NCT02031276|63266706|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
33702481|NCT02031276|63266704|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
33702482|NCT02031276|63266705|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
33702483|NCT02031276|63266706|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
33702484|NCT02031276|63266704|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
33702485|NCT02031276|63266705|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
33702486|NCT02031276|63266706|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
33702487|NCT02031276|63266704|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
33702488|NCT02031276|63266705|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
33702489|NCT02031276|63266706|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
33702490|NCT02031276|63266704|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
33702491|NCT02031276|63266705|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
33702492|NCT02031276|63266706|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
33702493|NCT02031276|63266704|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
33702494|NCT02031276|63266705|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
33702495|NCT02031276|63266706|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
33702496|NCT02031276|63266704|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
33702497|NCT02031276|63266705|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
33702498|NCT02031276|63266706|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
33702499|NCT02007720|63266720|FG000|Overall Study|Withdrawal by Subject|9|||
33702500|NCT02007720|63266721|FG001|Overall Study|Withdrawal by Subject|11|||
33702501|NCT02007720|63266720|FG000|Overall Study|study terminated by sponsor|58|||
33702502|NCT02007720|63266721|FG001|Overall Study|study terminated by sponsor|54|||
33702503|NCT02007720|63266720|FG000|Overall Study|technical problem|4|||
33702504|NCT02007720|63266721|FG001|Overall Study|technical problem|2|||
33702505|NCT02007720|63266720|FG000|Overall Study|patient followd less than 165 days|11|||
33702506|NCT02007720|63266721|FG001|Overall Study|patient followd less than 165 days|5|||
33702507|NCT01363440|63266731|FG000|Overall Study|Adverse Event|5|||
33702508|NCT01363440|63266732|FG001|Overall Study|Adverse Event|4|||
33702509|NCT01363440|63266733|FG002|Overall Study|Adverse Event|4|||
33702510|NCT01363440|63266731|FG000|Overall Study|Death|3|||
33702511|NCT01363440|63266732|FG001|Overall Study|Death|7|||
33702512|NCT01363440|63266733|FG002|Overall Study|Death|5|||
33702513|NCT01363440|63266731|FG000|Overall Study|Withdrawal by Subject|9|||
33702514|NCT01363440|63266732|FG001|Overall Study|Withdrawal by Subject|11|||
33702515|NCT01363440|63266733|FG002|Overall Study|Withdrawal by Subject|11|||
33702516|NCT01363440|63266731|FG000|Overall Study|Lost to Follow-up|2|||
33702517|NCT01363440|63266732|FG001|Overall Study|Lost to Follow-up|4|||
33702518|NCT01363440|63266733|FG002|Overall Study|Lost to Follow-up|5|||
33702519|NCT01363440|63266731|FG000|Overall Study|Other|4|||
33702520|NCT01363440|63266732|FG001|Overall Study|Other|5|||
33702521|NCT01363440|63266733|FG002|Overall Study|Other|2|||
33702522|NCT02007252|63266746|FG000|Overall Study|Administrative problems|3|||
33702523|NCT02007252|63266747|FG001|Overall Study|Administrative problems|7|||
33702524|NCT02007252|63266746|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33702525|NCT02007252|63266747|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33702526|NCT02007252|63266746|FG000|Overall Study|Adverse Event|7|||
33702527|NCT02007252|63266747|FG001|Overall Study|Adverse Event|4|||
33702528|NCT02007096|63266755|FG000|Overall Study|medication not available|2|||
33702529|NCT02007096|63266756|FG001|Overall Study|medication not available|0|||
33702530|NCT02007096|63266755|FG000|Overall Study|did not inject saline|0|||
33702531|NCT02007096|63266756|FG001|Overall Study|did not inject saline|3|||
33702532|NCT02007096|63266755|FG000|Overall Study|did not follow postoperative protocol|8|||
33702533|NCT02007096|63266756|FG001|Overall Study|did not follow postoperative protocol|11|||
33702534|NCT02007096|63266755|FG000|Overall Study|converted to open surgery|1|||
33702535|NCT02007096|63266756|FG001|Overall Study|converted to open surgery|1|||
33702536|NCT02007096|63266755|FG000|Overall Study|no mesh placed|0|||
33702537|NCT02007096|63266756|FG001|Overall Study|no mesh placed|1|||
33702538|NCT02006706|63266762|FG000|Overall Study|Lost to Follow-up|1|||
33702539|NCT02049138|63266769|FG000|Overall Study|Adverse Event|46|||
33702540|NCT02049138|63266770|FG001|Overall Study|Adverse Event|25|||
33702541|NCT02049138|63266771|FG002|Overall Study|Adverse Event|1|||
33702542|NCT02049138|63266769|FG000|Overall Study|Withdrawal by Subject|57|||
33702543|NCT02049138|63266770|FG001|Overall Study|Withdrawal by Subject|21|||
33702544|NCT02049138|63266771|FG002|Overall Study|Withdrawal by Subject|5|||
33702545|NCT02049138|63266769|FG000|Overall Study|Lost to Follow-up|18|||
33702546|NCT02049138|63266770|FG001|Overall Study|Lost to Follow-up|5|||
33596621|NCT02068599|62995607|FG000|Overall Study|Lack of Efficacy|0|||
33702547|NCT02049138|63266771|FG002|Overall Study|Lost to Follow-up|1|||
33702548|NCT02049138|63266769|FG000|Overall Study|Lack of Efficacy|10|||
33702549|NCT02049138|63266770|FG001|Overall Study|Lack of Efficacy|26|||
33702550|NCT02049138|63266771|FG002|Overall Study|Lack of Efficacy|1|||
33702551|NCT02049138|63266769|FG000|Overall Study|Non-Compliance|15|||
33702552|NCT02049138|63266770|FG001|Overall Study|Non-Compliance|6|||
33702553|NCT02049138|63266771|FG002|Overall Study|Non-Compliance|0|||
33702554|NCT02049138|63266769|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
33702555|NCT02049138|63266770|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
33702556|NCT02049138|63266771|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
33702557|NCT02049138|63266769|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
33702558|NCT02049138|63266770|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
33702559|NCT02049138|63266771|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
33702560|NCT02049138|63266769|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
33702561|NCT02049138|63266770|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
33702562|NCT02049138|63266771|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
33702563|NCT02049138|63266769|FG000|Overall Study|Other|15|||
33702564|NCT02049138|63266770|FG001|Overall Study|Other|13|||
33702565|NCT02049138|63266771|FG002|Overall Study|Other|0|||
33702566|NCT02049138|63266769|FG000|Overall Study|Missing|0|||
33702567|NCT02049138|63266770|FG001|Overall Study|Missing|1|||
33702568|NCT02049138|63266771|FG002|Overall Study|Missing|0|||
33702569|NCT02048904|63266782|FG000|Overall Study|Withdrawal by Subject|7|||
33702570|NCT02048904|63266782|FG000|Overall Study|Physician Decision|70|||
33702571|NCT02006628|63266788|FG000|Overall Study|Adverse Event|1|||
33702572|NCT02006628|63266789|FG001|Overall Study|Adverse Event|1|||
33702573|NCT02006628|63266788|FG000|Overall Study|Withdrawal by Subject|2|||
33702574|NCT02006628|63266789|FG001|Overall Study|Withdrawal by Subject|1|||
33702575|NCT02048826|63266797|FG000|Overall Study|Withdrawal by Subject|1|||
33702576|NCT02048826|63266798|FG001|Overall Study|Withdrawal by Subject|0|||
33702577|NCT02006472|63266809|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
33702578|NCT02006472|63266810|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
33702579|NCT02006472|63266811|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
33702580|NCT02006472|63266812|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
33702581|NCT02006472|63266813|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
33702582|NCT02006472|63266809|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
33702583|NCT02006472|63266810|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
33702584|NCT02006472|63266811|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
33702585|NCT02006472|63266812|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
33702586|NCT02006472|63266813|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
33702587|NCT02006472|63266809|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
33702588|NCT02006472|63266810|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
33702589|NCT02006472|63266811|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
33702590|NCT02006472|63266812|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
33702591|NCT02006472|63266813|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
33702592|NCT02006472|63266809|FG000|Period 1 (Through Week 26)|Other|1|||
33702593|NCT02006472|63266810|FG001|Period 1 (Through Week 26)|Other|5|||
33702594|NCT02006472|63266811|FG002|Period 1 (Through Week 26)|Other|0|||
33702595|NCT02006472|63266812|FG003|Period 1 (Through Week 26)|Other|2|||
33702596|NCT02006472|63266813|FG004|Period 1 (Through Week 26)|Other|3|||
33702597|NCT02006472|63266809|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
33702598|NCT02006472|63266810|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
33702599|NCT02006472|63266811|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
33702600|NCT02006472|63266812|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
33702601|NCT02006472|63266813|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
33702602|NCT02006472|63266809|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
33702603|NCT02006472|63266810|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
33702604|NCT02006472|63266811|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
33702605|NCT02006472|63266812|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
33702606|NCT02006472|63266813|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
33702607|NCT02006472|63266809|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
33702608|NCT02006472|63266810|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
33702609|NCT02006472|63266811|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
33702610|NCT02006472|63266812|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
33702611|NCT02006472|63266813|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
33702612|NCT02006472|63266809|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
33702613|NCT02006472|63266810|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
33702614|NCT02006472|63266811|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
33702615|NCT02006472|63266812|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
33702616|NCT02006472|63266813|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
33702617|NCT02006472|63266809|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
33702618|NCT02006472|63266810|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
33702619|NCT02006472|63266811|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
33702620|NCT02006472|63266812|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
33702621|NCT02006472|63266813|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
33702622|NCT02006472|63266809|FG000|Period 2 (Through Week 52)|Other|0|||
33702623|NCT02006472|63266810|FG001|Period 2 (Through Week 52)|Other|1|||
33702624|NCT02006472|63266811|FG002|Period 2 (Through Week 52)|Other|0|||
33702625|NCT02006472|63266812|FG003|Period 2 (Through Week 52)|Other|1|||
33702626|NCT02006472|63266813|FG004|Period 2 (Through Week 52)|Other|0|||
33702627|NCT02006472|63266809|FG000|Period 2 (Through Week 52)|Not treated|0|||
33702628|NCT02006472|63266810|FG001|Period 2 (Through Week 52)|Not treated|0|||
33702629|NCT02006472|63266811|FG002|Period 2 (Through Week 52)|Not treated|2|||
33702630|NCT02006472|63266812|FG003|Period 2 (Through Week 52)|Not treated|0|||
33702631|NCT02006472|63266813|FG004|Period 2 (Through Week 52)|Not treated|0|||
33702632|NCT02006472|63266809|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
33702633|NCT02006472|63266810|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
33702634|NCT02006472|63266811|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
33702635|NCT02006472|63266812|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
33702636|NCT02006472|63266813|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
33702637|NCT02006472|63266809|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
33702638|NCT02006472|63266810|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
33702639|NCT02006472|63266811|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
33702640|NCT02006472|63266812|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
33702641|NCT02006472|63266813|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
33702642|NCT02005692|63266830|FG000|Overall Study|Protocol Violation|1|||
33702643|NCT02005692|63266830|FG000|Overall Study|Withdrawal by Subject|1|||
33702644|NCT02005692|63266830|FG000|Overall Study|Discharged earlier than anticipated|5|||
33702645|NCT02029638|63266838|FG000|Overall Study|Death|0|||
33702646|NCT02029638|63266839|FG001|Overall Study|Death|0|||
33702647|NCT02029638|63266840|FG002|Overall Study|Death|1|||
33702648|NCT02029638|63266838|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
33702649|NCT02029638|63266839|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
33702650|NCT02029638|63266840|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
33702651|NCT02047734|63266851|FG000|Overall Study|Adverse Event|18|||
33702652|NCT02047734|63266852|FG001|Overall Study|Adverse Event|13|||
33702653|NCT02047734|63266853|FG002|Overall Study|Adverse Event|13|||
33702654|NCT02047734|63266851|FG000|Overall Study|Lack of Efficacy|4|||
33702655|NCT02047734|63266852|FG001|Overall Study|Lack of Efficacy|5|||
33702656|NCT02047734|63266853|FG002|Overall Study|Lack of Efficacy|1|||
33702657|NCT02047734|63266851|FG000|Overall Study|Protocol Violation|3|||
33702658|NCT02047734|63266852|FG001|Overall Study|Protocol Violation|1|||
33702659|NCT02047734|63266853|FG002|Overall Study|Protocol Violation|1|||
33702660|NCT02047734|63266851|FG000|Overall Study|Lost to Follow-up|1|||
33702661|NCT02047734|63266852|FG001|Overall Study|Lost to Follow-up|4|||
33702662|NCT02047734|63266853|FG002|Overall Study|Lost to Follow-up|0|||
33702663|NCT02047734|63266851|FG000|Overall Study|Death|0|||
33702664|NCT02047734|63266852|FG001|Overall Study|Death|1|||
33702665|NCT02047734|63266853|FG002|Overall Study|Death|0|||
33702666|NCT02047734|63266851|FG000|Overall Study|Withdrawal by Subject|30|||
33702667|NCT02047734|63266852|FG001|Overall Study|Withdrawal by Subject|31|||
33702668|NCT02047734|63266853|FG002|Overall Study|Withdrawal by Subject|19|||
33702669|NCT02047734|63266851|FG000|Overall Study|Physician Decision|7|||
33702670|NCT02047734|63266852|FG001|Overall Study|Physician Decision|6|||
33702671|NCT02047734|63266853|FG002|Overall Study|Physician Decision|5|||
33702672|NCT02047734|63266851|FG000|Overall Study|Miscellaneous|2|||
33702673|NCT02047734|63266852|FG001|Overall Study|Miscellaneous|4|||
33702674|NCT02047734|63266853|FG002|Overall Study|Miscellaneous|6|||
33702675|NCT02047734|63266851|FG000|Overall Study|Did Not Receive Study Drug|2|||
33702676|NCT02047734|63266852|FG001|Overall Study|Did Not Receive Study Drug|4|||
33702677|NCT02047734|63266853|FG002|Overall Study|Did Not Receive Study Drug|1|||
33702678|NCT02053350|63266861|FG000|Overall Study|Withdrawal by Subject|1|||
33702679|NCT02053350|63266861|FG000|Overall Study|Adverse Event|4|||
33702680|NCT01994850|63266865|FG000|Overall Study|Physician Decision|1|||
33702681|NCT01994850|63266865|FG000|Overall Study|Withdrawal by Subject|1|||
33702682|NCT02027844|63266872|FG000|Overall Study|Withdrawal by Subject|3|||
33702683|NCT02027844|63266873|FG001|Overall Study|Withdrawal by Subject|2|||
33702684|NCT02027844|63266874|FG002|Overall Study|Withdrawal by Subject|1|||
33702685|NCT02027844|63266872|FG000|Overall Study|Lost to Follow-up|0|||
33702686|NCT02027844|63266873|FG001|Overall Study|Lost to Follow-up|2|||
33702687|NCT02027844|63266874|FG002|Overall Study|Lost to Follow-up|1|||
33702688|NCT02027844|63266872|FG000|Overall Study|Protocol Violation|0|||
33702689|NCT02027844|63266873|FG001|Overall Study|Protocol Violation|2|||
33596622|NCT02068599|62995608|FG001|Overall Study|Lack of Efficacy|0|||
33702690|NCT02027844|63266874|FG002|Overall Study|Protocol Violation|0|||
33702691|NCT02027844|63266872|FG000|Overall Study|Incomlete data|2|||
33702692|NCT02027844|63266873|FG001|Overall Study|Incomlete data|0|||
33702693|NCT02027844|63266874|FG002|Overall Study|Incomlete data|0|||
33702694|NCT01994382|63266899|FG000|Overall Study|Informed consent withdrawn|0|||
33702695|NCT01994382|63266900|FG001|Overall Study|Informed consent withdrawn|0|||
33702696|NCT01994382|63266901|FG002|Overall Study|Informed consent withdrawn|0|||
33702697|NCT01994382|63266902|FG003|Overall Study|Informed consent withdrawn|0|||
33702698|NCT01994382|63266903|FG004|Overall Study|Informed consent withdrawn|0|||
33702699|NCT01994382|63266904|FG005|Overall Study|Informed consent withdrawn|0|||
33702700|NCT01994382|63266905|FG006|Overall Study|Informed consent withdrawn|1|||
33702701|NCT01994382|63266906|FG007|Overall Study|Informed consent withdrawn|0|||
33702702|NCT01994382|63266907|FG008|Overall Study|Informed consent withdrawn|0|||
33702703|NCT01994382|63266908|FG009|Overall Study|Informed consent withdrawn|0|||
33702704|NCT01994382|63266909|FG010|Overall Study|Informed consent withdrawn|0|||
33702705|NCT01994382|63266910|FG011|Overall Study|Informed consent withdrawn|0|||
33702706|NCT01994382|63266911|FG012|Overall Study|Informed consent withdrawn|0|||
33702707|NCT01994382|63266912|FG013|Overall Study|Informed consent withdrawn|0|||
33702708|NCT01994382|63266913|FG014|Overall Study|Informed consent withdrawn|0|||
33702709|NCT01994382|63266914|FG015|Overall Study|Informed consent withdrawn|0|||
33702710|NCT01994382|63266915|FG016|Overall Study|Informed consent withdrawn|0|||
33702711|NCT01994382|63266899|FG000|Overall Study|Progressive disease|3|||
33702712|NCT01994382|63266900|FG001|Overall Study|Progressive disease|4|||
33702713|NCT01994382|63266901|FG002|Overall Study|Progressive disease|4|||
33702714|NCT01994382|63266902|FG003|Overall Study|Progressive disease|3|||
33702715|NCT01994382|63266903|FG004|Overall Study|Progressive disease|2|||
33702716|NCT01994382|63266904|FG005|Overall Study|Progressive disease|3|||
33702717|NCT01994382|63266905|FG006|Overall Study|Progressive disease|3|||
33702718|NCT01994382|63266906|FG007|Overall Study|Progressive disease|6|||
33702719|NCT01994382|63266907|FG008|Overall Study|Progressive disease|2|||
33702720|NCT01994382|63266908|FG009|Overall Study|Progressive disease|2|||
33702721|NCT01994382|63266909|FG010|Overall Study|Progressive disease|13|||
33702722|NCT01994382|63266910|FG011|Overall Study|Progressive disease|8|||
33702723|NCT01994382|63266911|FG012|Overall Study|Progressive disease|7|||
33702724|NCT01994382|63266912|FG013|Overall Study|Progressive disease|3|||
33702725|NCT01994382|63266913|FG014|Overall Study|Progressive disease|6|||
33702726|NCT01994382|63266914|FG015|Overall Study|Progressive disease|44|||
33702727|NCT01994382|63266915|FG016|Overall Study|Progressive disease|28|||
33702728|NCT01994382|63266899|FG000|Overall Study|Physician Decision|0|||
33702729|NCT01994382|63266900|FG001|Overall Study|Physician Decision|1|||
33702730|NCT01994382|63266901|FG002|Overall Study|Physician Decision|0|||
33702731|NCT01994382|63266902|FG003|Overall Study|Physician Decision|0|||
33702732|NCT01994382|63266903|FG004|Overall Study|Physician Decision|0|||
33702733|NCT01994382|63266904|FG005|Overall Study|Physician Decision|0|||
33702734|NCT01994382|63266905|FG006|Overall Study|Physician Decision|0|||
33702735|NCT01994382|63266906|FG007|Overall Study|Physician Decision|0|||
33702736|NCT01994382|63266907|FG008|Overall Study|Physician Decision|0|||
33702737|NCT01994382|63266908|FG009|Overall Study|Physician Decision|0|||
33702738|NCT01994382|63266909|FG010|Overall Study|Physician Decision|3|||
33702739|NCT01994382|63266910|FG011|Overall Study|Physician Decision|1|||
33702740|NCT01994382|63266911|FG012|Overall Study|Physician Decision|1|||
33702741|NCT01994382|63266912|FG013|Overall Study|Physician Decision|0|||
33702742|NCT01994382|63266913|FG014|Overall Study|Physician Decision|1|||
33702743|NCT01994382|63266914|FG015|Overall Study|Physician Decision|4|||
33702744|NCT01994382|63266915|FG016|Overall Study|Physician Decision|2|||
33702745|NCT01994382|63266899|FG000|Overall Study|Death|0|||
33702746|NCT01994382|63266900|FG001|Overall Study|Death|0|||
33702747|NCT01994382|63266901|FG002|Overall Study|Death|0|||
33702748|NCT01994382|63266902|FG003|Overall Study|Death|0|||
33702749|NCT01994382|63266903|FG004|Overall Study|Death|1|||
33702750|NCT01994382|63266904|FG005|Overall Study|Death|0|||
33702751|NCT01994382|63266905|FG006|Overall Study|Death|0|||
33702752|NCT01994382|63266906|FG007|Overall Study|Death|0|||
33702753|NCT01994382|63266907|FG008|Overall Study|Death|1|||
33702754|NCT01994382|63266908|FG009|Overall Study|Death|1|||
33702755|NCT01994382|63266909|FG010|Overall Study|Death|0|||
33702756|NCT01994382|63266910|FG011|Overall Study|Death|0|||
33702757|NCT01994382|63266911|FG012|Overall Study|Death|0|||
33702758|NCT01994382|63266912|FG013|Overall Study|Death|0|||
33596623|NCT02068599|62995609|FG002|Overall Study|Lack of Efficacy|3|||
33596624|NCT02068599|62995607|FG000|Overall Study|Noncompliance|0|||
33702759|NCT01994382|63266913|FG014|Overall Study|Death|0|||
33702760|NCT01994382|63266914|FG015|Overall Study|Death|1|||
33702761|NCT01994382|63266915|FG016|Overall Study|Death|0|||
33702762|NCT01994382|63266899|FG000|Overall Study|Adverse Event|0|||
33702763|NCT01994382|63266900|FG001|Overall Study|Adverse Event|1|||
33702764|NCT01994382|63266901|FG002|Overall Study|Adverse Event|2|||
33702765|NCT01994382|63266902|FG003|Overall Study|Adverse Event|0|||
33702766|NCT01994382|63266903|FG004|Overall Study|Adverse Event|0|||
33702767|NCT01994382|63266904|FG005|Overall Study|Adverse Event|0|||
33702768|NCT01994382|63266905|FG006|Overall Study|Adverse Event|0|||
33596625|NCT02068599|62995608|FG001|Overall Study|Noncompliance|0|||
33702769|NCT01994382|63266906|FG007|Overall Study|Adverse Event|0|||
33702770|NCT01994382|63266907|FG008|Overall Study|Adverse Event|0|||
33702771|NCT01994382|63266908|FG009|Overall Study|Adverse Event|0|||
33702772|NCT01994382|63266909|FG010|Overall Study|Adverse Event|15|||
33702773|NCT01994382|63266910|FG011|Overall Study|Adverse Event|2|||
33702774|NCT01994382|63266911|FG012|Overall Study|Adverse Event|7|||
33702775|NCT01994382|63266912|FG013|Overall Study|Adverse Event|3|||
33702776|NCT01994382|63266913|FG014|Overall Study|Adverse Event|17|||
33702777|NCT01994382|63266914|FG015|Overall Study|Adverse Event|6|||
33702778|NCT01994382|63266915|FG016|Overall Study|Adverse Event|3|||
33702779|NCT01994382|63266899|FG000|Overall Study|Other than specified|0|||
33702780|NCT01994382|63266900|FG001|Overall Study|Other than specified|0|||
33702781|NCT01994382|63266901|FG002|Overall Study|Other than specified|0|||
33702782|NCT01994382|63266902|FG003|Overall Study|Other than specified|0|||
33702783|NCT01994382|63266903|FG004|Overall Study|Other than specified|0|||
33702784|NCT01994382|63266904|FG005|Overall Study|Other than specified|0|||
33702785|NCT01994382|63266905|FG006|Overall Study|Other than specified|0|||
33702786|NCT01994382|63266906|FG007|Overall Study|Other than specified|0|||
33702787|NCT01994382|63266907|FG008|Overall Study|Other than specified|0|||
33702788|NCT01994382|63266908|FG009|Overall Study|Other than specified|0|||
33702789|NCT01994382|63266909|FG010|Overall Study|Other than specified|2|||
33702790|NCT01994382|63266910|FG011|Overall Study|Other than specified|0|||
33702791|NCT01994382|63266911|FG012|Overall Study|Other than specified|2|||
33702792|NCT01994382|63266912|FG013|Overall Study|Other than specified|0|||
33702793|NCT01994382|63266913|FG014|Overall Study|Other than specified|0|||
33702794|NCT01994382|63266914|FG015|Overall Study|Other than specified|4|||
33702795|NCT01994382|63266915|FG016|Overall Study|Other than specified|4|||
33702796|NCT01994382|63266899|FG000|Overall Study|Withdrawal by Subject|0|||
33702797|NCT01994382|63266900|FG001|Overall Study|Withdrawal by Subject|0|||
33702798|NCT01994382|63266901|FG002|Overall Study|Withdrawal by Subject|0|||
33702799|NCT01994382|63266902|FG003|Overall Study|Withdrawal by Subject|0|||
33702800|NCT01994382|63266903|FG004|Overall Study|Withdrawal by Subject|0|||
33702801|NCT01994382|63266904|FG005|Overall Study|Withdrawal by Subject|0|||
33702802|NCT01994382|63266905|FG006|Overall Study|Withdrawal by Subject|0|||
33702803|NCT01994382|63266906|FG007|Overall Study|Withdrawal by Subject|0|||
33702804|NCT01994382|63266907|FG008|Overall Study|Withdrawal by Subject|0|||
33702805|NCT01994382|63266908|FG009|Overall Study|Withdrawal by Subject|0|||
33702806|NCT01994382|63266909|FG010|Overall Study|Withdrawal by Subject|6|||
33702807|NCT01994382|63266910|FG011|Overall Study|Withdrawal by Subject|0|||
33702808|NCT01994382|63266911|FG012|Overall Study|Withdrawal by Subject|2|||
33702809|NCT01994382|63266912|FG013|Overall Study|Withdrawal by Subject|0|||
33702810|NCT01994382|63266913|FG014|Overall Study|Withdrawal by Subject|4|||
33702811|NCT01994382|63266914|FG015|Overall Study|Withdrawal by Subject|3|||
33702812|NCT01994382|63266915|FG016|Overall Study|Withdrawal by Subject|0|||
33702813|NCT01994382|63266899|FG000|Overall Study|Lost to Follow-up|0|||
33702814|NCT01994382|63266900|FG001|Overall Study|Lost to Follow-up|0|||
33702815|NCT01994382|63266901|FG002|Overall Study|Lost to Follow-up|0|||
33702816|NCT01994382|63266902|FG003|Overall Study|Lost to Follow-up|0|||
33702817|NCT01994382|63266903|FG004|Overall Study|Lost to Follow-up|0|||
33702818|NCT01994382|63266904|FG005|Overall Study|Lost to Follow-up|0|||
33702819|NCT01994382|63266905|FG006|Overall Study|Lost to Follow-up|0|||
33702820|NCT01994382|63266906|FG007|Overall Study|Lost to Follow-up|0|||
33702821|NCT01994382|63266907|FG008|Overall Study|Lost to Follow-up|0|||
33702822|NCT01994382|63266908|FG009|Overall Study|Lost to Follow-up|0|||
33702823|NCT01994382|63266909|FG010|Overall Study|Lost to Follow-up|1|||
33702824|NCT01994382|63266910|FG011|Overall Study|Lost to Follow-up|0|||
33702825|NCT01994382|63266911|FG012|Overall Study|Lost to Follow-up|0|||
33702826|NCT01994382|63266912|FG013|Overall Study|Lost to Follow-up|0|||
33702827|NCT01994382|63266913|FG014|Overall Study|Lost to Follow-up|0|||
33702828|NCT01994382|63266914|FG015|Overall Study|Lost to Follow-up|0|||
33702829|NCT01994382|63266915|FG016|Overall Study|Lost to Follow-up|0|||
33702830|NCT01994382|63266899|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33702831|NCT01994382|63266900|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33702832|NCT01994382|63266901|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33702833|NCT01994382|63266902|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33702834|NCT01994382|63266903|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33702835|NCT01994382|63266904|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33702836|NCT01994382|63266905|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33702837|NCT01994382|63266906|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33702838|NCT01994382|63266907|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33702839|NCT01994382|63266908|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33702840|NCT01994382|63266909|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
33702841|NCT01994382|63266910|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33702842|NCT01994382|63266911|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
33702843|NCT01994382|63266912|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33702844|NCT01994382|63266913|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33702845|NCT01994382|63266914|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
33702846|NCT01994382|63266915|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
33702847|NCT01994382|63266899|FG000|Overall Study|Protocol violation/noncompliance|0|||
33702848|NCT01994382|63266900|FG001|Overall Study|Protocol violation/noncompliance|0|||
33702849|NCT01994382|63266901|FG002|Overall Study|Protocol violation/noncompliance|0|||
33702850|NCT01994382|63266902|FG003|Overall Study|Protocol violation/noncompliance|0|||
33702851|NCT01994382|63266903|FG004|Overall Study|Protocol violation/noncompliance|0|||
33702852|NCT01994382|63266904|FG005|Overall Study|Protocol violation/noncompliance|0|||
33702853|NCT01994382|63266905|FG006|Overall Study|Protocol violation/noncompliance|0|||
33702854|NCT01994382|63266906|FG007|Overall Study|Protocol violation/noncompliance|0|||
33702855|NCT01994382|63266907|FG008|Overall Study|Protocol violation/noncompliance|0|||
33702856|NCT01994382|63266908|FG009|Overall Study|Protocol violation/noncompliance|0|||
33702857|NCT01994382|63266909|FG010|Overall Study|Protocol violation/noncompliance|0|||
33702858|NCT01994382|63266910|FG011|Overall Study|Protocol violation/noncompliance|1|||
33702859|NCT01994382|63266911|FG012|Overall Study|Protocol violation/noncompliance|0|||
33702860|NCT01994382|63266912|FG013|Overall Study|Protocol violation/noncompliance|0|||
33702861|NCT01994382|63266913|FG014|Overall Study|Protocol violation/noncompliance|0|||
33702862|NCT01994382|63266914|FG015|Overall Study|Protocol violation/noncompliance|0|||
33702863|NCT01994382|63266915|FG016|Overall Study|Protocol violation/noncompliance|2|||
33702864|NCT01994382|63266899|FG000|Overall Study|Rolled over to Phase 2a|0|||
33702865|NCT01994382|63266900|FG001|Overall Study|Rolled over to Phase 2a|0|||
33702866|NCT01994382|63266901|FG002|Overall Study|Rolled over to Phase 2a|1|||
33702867|NCT01994382|63266902|FG003|Overall Study|Rolled over to Phase 2a|0|||
33702868|NCT01994382|63266903|FG004|Overall Study|Rolled over to Phase 2a|0|||
33702869|NCT01994382|63266904|FG005|Overall Study|Rolled over to Phase 2a|0|||
33702870|NCT01994382|63266905|FG006|Overall Study|Rolled over to Phase 2a|0|||
33702871|NCT01994382|63266906|FG007|Overall Study|Rolled over to Phase 2a|0|||
33702872|NCT01994382|63266907|FG008|Overall Study|Rolled over to Phase 2a|0|||
33702873|NCT01994382|63266908|FG009|Overall Study|Rolled over to Phase 2a|2|||
33702874|NCT01994382|63266909|FG010|Overall Study|Rolled over to Phase 2a|0|||
33702875|NCT01994382|63266910|FG011|Overall Study|Rolled over to Phase 2a|0|||
33702876|NCT01994382|63266911|FG012|Overall Study|Rolled over to Phase 2a|0|||
33702877|NCT01994382|63266912|FG013|Overall Study|Rolled over to Phase 2a|0|||
33702878|NCT01994382|63266913|FG014|Overall Study|Rolled over to Phase 2a|0|||
33702879|NCT01994382|63266914|FG015|Overall Study|Rolled over to Phase 2a|0|||
33702880|NCT01994382|63266915|FG016|Overall Study|Rolled over to Phase 2a|0|||
33702881|NCT02003898|63266958|FG000|Overall Study|Death|3|||
33702882|NCT02003898|63266958|FG000|Overall Study|Lost to Follow-up|12|||
33702883|NCT02003898|63266958|FG000|Overall Study|Withdrawal by Subject|52|||
33702884|NCT01994226|63266964|FG000|Overall Study|Protocol Violation|13|||
33702885|NCT01994226|63266965|FG001|Overall Study|Protocol Violation|10|||
33702886|NCT01994226|63266964|FG000|Overall Study|Early Cessation of treatment|6|||
33702887|NCT01994226|63266965|FG001|Overall Study|Early Cessation of treatment|11|||
33702888|NCT02002884|63266974|FG000|Main Period (MP)|Other|0|||
33702889|NCT02002884|63266975|FG001|Main Period (MP)|Other|3|||
33702890|NCT02002884|63266976|FG002|Main Period (MP)|Other|3|||
33702891|NCT02002884|63266977|FG003|Main Period (MP)|Other|0|||
33702892|NCT02002884|63266974|FG000|Main Period (MP)|Adverse Event|0|||
33702893|NCT02002884|63266975|FG001|Main Period (MP)|Adverse Event|1|||
33702894|NCT02002884|63266976|FG002|Main Period (MP)|Adverse Event|1|||
33702895|NCT02002884|63266977|FG003|Main Period (MP)|Adverse Event|0|||
33702896|NCT02002884|63266974|FG000|Main Period (MP)|Withdrawal by Subject|6|||
33702897|NCT02002884|63266975|FG001|Main Period (MP)|Withdrawal by Subject|2|||
33702898|NCT02002884|63266976|FG002|Main Period (MP)|Withdrawal by Subject|2|||
33702899|NCT02002884|63266977|FG003|Main Period (MP)|Withdrawal by Subject|0|||
33702900|NCT02002884|63266974|FG000|Main Period (MP)|Lost to Follow-up|0|||
33702901|NCT02002884|63266975|FG001|Main Period (MP)|Lost to Follow-up|0|||
33702902|NCT02002884|63266976|FG002|Main Period (MP)|Lost to Follow-up|2|||
33702903|NCT02002884|63266977|FG003|Main Period (MP)|Lost to Follow-up|0|||
33702904|NCT02002884|63266974|FG000|Open-Label Extension Period (OLEX)|Other|0|||
33702905|NCT02002884|63266975|FG001|Open-Label Extension Period (OLEX)|Other|0|||
33702906|NCT02002884|63266976|FG002|Open-Label Extension Period (OLEX)|Other|0|||
33702907|NCT02002884|63266977|FG003|Open-Label Extension Period (OLEX)|Other|24|||
33702908|NCT02002884|63266974|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
33702909|NCT02002884|63266975|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
33702910|NCT02002884|63266976|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
33702911|NCT02002884|63266977|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
33702912|NCT02002884|63266974|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
33702913|NCT02002884|63266975|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
33702914|NCT02002884|63266976|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
33310756|NCT01233258|62686168|FG000|First Intervention (6 Months)|Protocol Violation|0|||
33596626|NCT02068599|62995609|FG002|Overall Study|Noncompliance|1|||
33702915|NCT02002884|63266977|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
33702916|NCT02002884|63266974|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
33702917|NCT02002884|63266975|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
33702918|NCT02002884|63266976|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
33702919|NCT02002884|63266977|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
33702920|NCT02002884|63266974|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
33702921|NCT02002884|63266975|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
33702922|NCT02002884|63266976|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
33702923|NCT02002884|63266977|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
33702924|NCT02002182|63266989|FG000|Overall Study|Withdraw from study|3|||
33702925|NCT02002182|63266990|FG001|Overall Study|Withdraw from study|1|||
33702926|NCT02002182|63266989|FG000|Overall Study|Health Reasons|1|||
33702927|NCT02002182|63266990|FG001|Overall Study|Health Reasons|0|||
33702928|NCT02002182|63266989|FG000|Overall Study|Death|1|||
33702929|NCT02002182|63266990|FG001|Overall Study|Death|0|||
33702930|NCT01990950|63266996|FG000|Overall Study|Death|3|||
33702931|NCT01990950|63266996|FG000|Overall Study|Lost to Follow-up|2|||
33702932|NCT01990950|63266996|FG000|Overall Study|Withdrawal by Subject|6|||
33702933|NCT02001558|63267002|FG000|Overall Study|Lost to Follow-up|8|||
33702934|NCT02001558|63267003|FG001|Overall Study|Lost to Follow-up|14|||
33702935|NCT02023866|63267009|FG000|Overall Study|Non-compliance|2|||
33702936|NCT02023866|63267009|FG000|Overall Study|Adverse Event|3|||
33702937|NCT02023866|63267009|FG000|Overall Study|Withdrawal by Subject|1|||
33702938|NCT02023242|63267015|FG000|Overall Study|Lost to Follow-up|3|||
33702939|NCT02023242|63267016|FG001|Overall Study|Lost to Follow-up|1|||
33702940|NCT02023242|63267015|FG000|Overall Study|Death|0|||
33702941|NCT02023242|63267016|FG001|Overall Study|Death|1|||
33702942|NCT01967940|63267025|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
33702943|NCT01967940|63267026|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
33702944|NCT01967940|63267027|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
33702945|NCT01967940|63267028|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
33702946|NCT01967940|63267025|FG000|Part 2|Adverse Event|0|||
33702947|NCT01967940|63267026|FG001|Part 2|Adverse Event|0|||
33702948|NCT01967940|63267027|FG002|Part 2|Adverse Event|0|||
33702949|NCT01967940|63267028|FG003|Part 2|Adverse Event|1|||
33702950|NCT01967940|63267025|FG000|Part 2|Unknown Reason|0|||
33702951|NCT01967940|63267026|FG001|Part 2|Unknown Reason|0|||
33702952|NCT01967940|63267027|FG002|Part 2|Unknown Reason|0|||
33702953|NCT01967940|63267028|FG003|Part 2|Unknown Reason|1|||
33702954|NCT01990560|63267038|FG000|Overall Study|Withdrawal by Subject|1|||
33702955|NCT01998984|63267046|FG000|Overall Study|Adverse Event|0|||
33702956|NCT01998984|63267047|FG001|Overall Study|Adverse Event|0|||
33702957|NCT01998984|63267048|FG002|Overall Study|Adverse Event|0|||
33702958|NCT01998984|63267049|FG003|Overall Study|Adverse Event|1|||
33702959|NCT01998984|63267046|FG000|Overall Study|Lost to Follow-up|0|||
33702960|NCT01998984|63267047|FG001|Overall Study|Lost to Follow-up|1|||
33702961|NCT01998984|63267048|FG002|Overall Study|Lost to Follow-up|0|||
33702962|NCT01998984|63267049|FG003|Overall Study|Lost to Follow-up|1|||
33702963|NCT01998984|63267046|FG000|Overall Study|Withdrawal by Subject|0|||
33702964|NCT01998984|63267047|FG001|Overall Study|Withdrawal by Subject|0|||
33702965|NCT01998984|63267048|FG002|Overall Study|Withdrawal by Subject|1|||
33702966|NCT01998984|63267049|FG003|Overall Study|Withdrawal by Subject|0|||
33702967|NCT01998984|63267046|FG000|Overall Study|Other|0|||
33702968|NCT01998984|63267047|FG001|Overall Study|Other|0|||
33702969|NCT01998984|63267048|FG002|Overall Study|Other|0|||
33702970|NCT01998984|63267049|FG003|Overall Study|Other|1|||
33702971|NCT01967706|63267061|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
33702972|NCT01967706|63267062|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
33702973|NCT01967706|63267063|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
33702974|NCT01967706|63267064|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
33702975|NCT01967628|63267075|FG000|Overall Study|Withdrawal by Subject|2|||
33702976|NCT01967628|63267076|FG001|Overall Study|Withdrawal by Subject|0|||
33702977|NCT01967628|63267075|FG000|Overall Study|Unable to complete bronchoscopy|4|||
33596627|NCT01654601|62995619|FG000|1st Administration|Withdrawal by Subject|2|||
33702978|NCT01967628|63267076|FG001|Overall Study|Unable to complete bronchoscopy|6|||
33702979|NCT01967628|63267075|FG000|Overall Study|Lost to Follow-up|1|||
33702980|NCT01967628|63267076|FG001|Overall Study|Lost to Follow-up|0|||
33596628|NCT01654601|62995620|FG001|1st Administration|Withdrawal by Subject|0|||
33702981|NCT01967628|63267075|FG000|Overall Study|Low protein concentration in sample|20|||
33702982|NCT01967628|63267076|FG001|Overall Study|Low protein concentration in sample|25|||
33702983|NCT01998906|63267085|FG000|Overall Study|Participants ongoing in follow-up|77|||
33702984|NCT01998906|63267086|FG001|Overall Study|Participants ongoing in follow-up|60|||
33702985|NCT01998906|63267087|FG002|Overall Study|Participants ongoing in follow-up|58|||
33702986|NCT01998906|63267085|FG000|Overall Study|Death|21|||
33702987|NCT01998906|63267086|FG001|Overall Study|Death|30|||
33702988|NCT01998906|63267087|FG002|Overall Study|Death|17|||
33702989|NCT01998906|63267085|FG000|Overall Study|Lack of Efficacy|10|||
33702990|NCT01998906|63267086|FG001|Overall Study|Lack of Efficacy|9|||
33702991|NCT01998906|63267087|FG002|Overall Study|Lack of Efficacy|8|||
33702992|NCT01998906|63267085|FG000|Overall Study|Failure to return|0|||
33702993|NCT01998906|63267086|FG001|Overall Study|Failure to return|2|||
33702994|NCT01998906|63267087|FG002|Overall Study|Failure to return|4|||
33702995|NCT01998906|63267085|FG000|Overall Study|Violation of Selection Criteria|0|||
33702996|NCT01998906|63267086|FG001|Overall Study|Violation of Selection Criteria|0|||
33702997|NCT01998906|63267087|FG002|Overall Study|Violation of Selection Criteria|1|||
33702998|NCT01998906|63267085|FG000|Overall Study|Withdrawal by Subject|1|||
33702999|NCT01998906|63267086|FG001|Overall Study|Withdrawal by Subject|4|||
33703000|NCT01998906|63267087|FG002|Overall Study|Withdrawal by Subject|3|||
33703001|NCT01998906|63267085|FG000|Overall Study|Administrative/Other|2|||
33703002|NCT01998906|63267086|FG001|Overall Study|Administrative/Other|1|||
33703003|NCT01998906|63267087|FG002|Overall Study|Administrative/Other|3|||
33703004|NCT01998906|63267085|FG000|Overall Study|Other|3|||
33703005|NCT01998906|63267086|FG001|Overall Study|Other|8|||
33703006|NCT01998906|63267087|FG002|Overall Study|Other|4|||
33703007|NCT01967550|63267100|FG000|Overall Study|Withdrawal by Subject|1|||
33703008|NCT01967550|63267101|FG001|Overall Study|Withdrawal by Subject|0|||
33703009|NCT01967550|63267100|FG000|Overall Study|Adverse Event|2|||
33703010|NCT01967550|63267101|FG001|Overall Study|Adverse Event|0|||
33703011|NCT01967550|63267100|FG000|Overall Study|Protocol Violation|2|||
33703012|NCT01967550|63267101|FG001|Overall Study|Protocol Violation|1|||
33703013|NCT01967550|63267100|FG000|Overall Study|Non Compliance|0|||
33703014|NCT01967550|63267101|FG001|Overall Study|Non Compliance|1|||
33703015|NCT01989546|63267107|FG000|Overall Study|Clinical Progression|1|||
33703016|NCT01989546|63267107|FG000|Overall Study|Disease progression on study|8|||
33703017|NCT01997892|63267111|FG000|Overall Study|Physician Decision|2|||
33703018|NCT01997892|63267111|FG000|Overall Study|Lost to Follow-up|6|||
33703019|NCT01997892|63267111|FG000|Overall Study|Death|14|||
33703020|NCT01997892|63267111|FG000|Overall Study|Renal transplant|8|||
33703021|NCT01997892|63267111|FG000|Overall Study|Other|3|||
33703022|NCT01997892|63267111|FG000|Overall Study|Study completion data not recorded|35|||
33703023|NCT01989468|63267123|FG000|Overall Study|Adverse Event|10|||
33703024|NCT01989468|63267124|FG001|Overall Study|Adverse Event|15|||
33703025|NCT01989468|63267125|FG002|Overall Study|Adverse Event|4|||
33703026|NCT01989468|63267126|FG003|Overall Study|Adverse Event|5|||
33703027|NCT01989468|63267127|FG004|Overall Study|Adverse Event|4|||
33703028|NCT01989468|63267123|FG000|Overall Study|Lack of Efficacy|11|||
33703029|NCT01989468|63267124|FG001|Overall Study|Lack of Efficacy|11|||
33703030|NCT01989468|63267125|FG002|Overall Study|Lack of Efficacy|7|||
33703031|NCT01989468|63267126|FG003|Overall Study|Lack of Efficacy|4|||
33703032|NCT01989468|63267127|FG004|Overall Study|Lack of Efficacy|2|||
33703033|NCT01989468|63267123|FG000|Overall Study|Lost to Follow-up|5|||
33703034|NCT01989468|63267124|FG001|Overall Study|Lost to Follow-up|2|||
33703035|NCT01989468|63267125|FG002|Overall Study|Lost to Follow-up|0|||
33703036|NCT01989468|63267126|FG003|Overall Study|Lost to Follow-up|1|||
33703037|NCT01989468|63267127|FG004|Overall Study|Lost to Follow-up|1|||
33703038|NCT01989468|63267123|FG000|Overall Study|Physician Decision|4|||
33703039|NCT01989468|63267124|FG001|Overall Study|Physician Decision|1|||
33703040|NCT01989468|63267125|FG002|Overall Study|Physician Decision|0|||
33703041|NCT01989468|63267126|FG003|Overall Study|Physician Decision|1|||
33703042|NCT01989468|63267127|FG004|Overall Study|Physician Decision|0|||
33703043|NCT01989468|63267123|FG000|Overall Study|Pregnancy|0|||
33703044|NCT01989468|63267124|FG001|Overall Study|Pregnancy|1|||
33703045|NCT01989468|63267125|FG002|Overall Study|Pregnancy|0|||
33703046|NCT01989468|63267126|FG003|Overall Study|Pregnancy|0|||
33703047|NCT01989468|63267127|FG004|Overall Study|Pregnancy|0|||
33703048|NCT01989468|63267123|FG000|Overall Study|Technical Problems|3|||
33703049|NCT01989468|63267124|FG001|Overall Study|Technical Problems|1|||
33703050|NCT01989468|63267125|FG002|Overall Study|Technical Problems|3|||
33703051|NCT01989468|63267126|FG003|Overall Study|Technical Problems|1|||
33703052|NCT01989468|63267127|FG004|Overall Study|Technical Problems|0|||
33703053|NCT01989468|63267123|FG000|Overall Study|Subject Guardian Decision|11|||
33703054|NCT01989468|63267124|FG001|Overall Study|Subject Guardian Decision|6|||
33596629|NCT01654601|62995619|FG000|1st Administration|Protocol Violation|0|||
33596630|NCT01654601|62995620|FG001|1st Administration|Protocol Violation|2|||
33596631|NCT01654601|62995619|FG000|2nd Administration|Adverse Event|1|||
33703055|NCT01989468|63267125|FG002|Overall Study|Subject Guardian Decision|4|||
33703056|NCT01989468|63267126|FG003|Overall Study|Subject Guardian Decision|4|||
33703057|NCT01989468|63267127|FG004|Overall Study|Subject Guardian Decision|1|||
33703058|NCT01989468|63267123|FG000|Overall Study|Death|3|||
33703059|NCT01989468|63267124|FG001|Overall Study|Death|0|||
33703060|NCT01989468|63267125|FG002|Overall Study|Death|1|||
33703061|NCT01989468|63267126|FG003|Overall Study|Death|0|||
33703062|NCT01989468|63267127|FG004|Overall Study|Death|0|||
33703063|NCT01989156|63267143|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
33703064|NCT01989156|63267144|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
33703065|NCT01989156|63267145|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
33703066|NCT01989156|63267143|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
33703067|NCT01989156|63267144|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
33703068|NCT01989156|63267145|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
33703069|NCT01989156|63267143|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
33703070|NCT01989156|63267144|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
33703071|NCT01989156|63267145|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
33703072|NCT01989156|63267143|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
33703073|NCT01989156|63267144|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
33703074|NCT01989156|63267145|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
33703075|NCT01989156|63267143|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
33703076|NCT01989156|63267144|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
33703077|NCT01989156|63267145|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
33703078|NCT01989156|63267143|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
33703079|NCT01989156|63267144|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
33703080|NCT01989156|63267145|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
33703081|NCT01989156|63267143|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
33703082|NCT01989156|63267144|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
33703083|NCT01989156|63267145|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
33703084|NCT01989156|63267143|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
33703085|NCT01989156|63267144|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
33703086|NCT01989156|63267145|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
33703087|NCT01620762|63267156|FG000|Overall Study|Protocol Violation|1|||
33703088|NCT01620762|63267157|FG001|Overall Study|Protocol Violation|1|||
33703089|NCT01620762|63267158|FG002|Overall Study|Protocol Violation|1|||
33703090|NCT01620762|63267156|FG000|Overall Study|Adverse Event|9|||
33703091|NCT01620762|63267157|FG001|Overall Study|Adverse Event|5|||
33703092|NCT01620762|63267158|FG002|Overall Study|Adverse Event|2|||
33703093|NCT01620762|63267156|FG000|Overall Study|Withdrawal by Subject|23|||
33596632|NCT01654601|62995620|FG001|2nd Administration|Adverse Event|0|||
33596633|NCT01654601|62995619|FG000|2nd Administration|Protocol Violation|0|||
33596634|NCT01654601|62995620|FG001|2nd Administration|Protocol Violation|1|||
33596635|NCT01654523|62995626|FG000|Overall Study|Withdrawal by Subject|1|||
33596636|NCT02508935|62995630|FG000|Overall Study|Withdrawal by Subject|1|||
33703094|NCT01620762|63267157|FG001|Overall Study|Withdrawal by Subject|26|||
33703095|NCT01620762|63267158|FG002|Overall Study|Withdrawal by Subject|27|||
33703096|NCT01620762|63267156|FG000|Overall Study|Lost to Follow-up|11|||
33703097|NCT01620762|63267157|FG001|Overall Study|Lost to Follow-up|17|||
33703098|NCT01620762|63267158|FG002|Overall Study|Lost to Follow-up|10|||
33703099|NCT01620762|63267156|FG000|Overall Study|Protocol deviation|1|||
33703100|NCT01620762|63267157|FG001|Overall Study|Protocol deviation|1|||
33703101|NCT01620762|63267158|FG002|Overall Study|Protocol deviation|6|||
33703102|NCT01620762|63267156|FG000|Overall Study|Subject deterioration|0|||
33703103|NCT01620762|63267157|FG001|Overall Study|Subject deterioration|1|||
33703104|NCT01620762|63267158|FG002|Overall Study|Subject deterioration|1|||
33703105|NCT01620762|63267156|FG000|Overall Study|Non-specified|3|||
33703106|NCT01620762|63267157|FG001|Overall Study|Non-specified|6|||
33703107|NCT01620762|63267158|FG002|Overall Study|Non-specified|5|||
33703108|NCT01620762|63267156|FG000|Overall Study|Use of prohibted therapies|0|||
33703109|NCT01620762|63267157|FG001|Overall Study|Use of prohibted therapies|1|||
33703110|NCT01620762|63267158|FG002|Overall Study|Use of prohibted therapies|1|||
33703111|NCT01966068|63267168|FG000|Overall Study|Withdrawal by Subject|57|||
33703112|NCT01966068|63267168|FG000|Overall Study|Lost to Follow-up|81|||
33703113|NCT01620528|63267176|FG000|Treatment Period|Did Not Receive Study Drug|0|||
33703114|NCT01620528|63267177|FG001|Treatment Period|Did Not Receive Study Drug|0|||
33703115|NCT01620528|63267178|FG002|Treatment Period|Did Not Receive Study Drug|1|||
33703116|NCT01620528|63267176|FG000|Treatment Period|Withdrawal by Subject|35|||
33703117|NCT01620528|63267177|FG001|Treatment Period|Withdrawal by Subject|21|||
33703118|NCT01620528|63267178|FG002|Treatment Period|Withdrawal by Subject|16|||
33703119|NCT01620528|63267176|FG000|Treatment Period|Adverse Event|17|||
33703120|NCT01620528|63267177|FG001|Treatment Period|Adverse Event|13|||
33703121|NCT01620528|63267178|FG002|Treatment Period|Adverse Event|21|||
33703122|NCT01620528|63267176|FG000|Treatment Period|Lost to Follow-up|16|||
33703123|NCT01620528|63267177|FG001|Treatment Period|Lost to Follow-up|8|||
33703124|NCT01620528|63267178|FG002|Treatment Period|Lost to Follow-up|14|||
33703125|NCT01620528|63267176|FG000|Treatment Period|Other|9|||
33703126|NCT01620528|63267177|FG001|Treatment Period|Other|5|||
33703127|NCT01620528|63267178|FG002|Treatment Period|Other|7|||
33703128|NCT01620528|63267176|FG000|Treatment Period|Subject Noncompliant|11|||
33703129|NCT01620528|63267177|FG001|Treatment Period|Subject Noncompliant|2|||
33703130|NCT01620528|63267178|FG002|Treatment Period|Subject Noncompliant|2|||
33703131|NCT01620528|63267176|FG000|Treatment Period|Pregnancy|7|||
33703132|NCT01620528|63267177|FG001|Treatment Period|Pregnancy|2|||
33703133|NCT01620528|63267178|FG002|Treatment Period|Pregnancy|2|||
33703134|NCT01620528|63267176|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
33703135|NCT01620528|63267177|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
33703136|NCT01620528|63267178|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
33703137|NCT01620528|63267176|FG000|Treatment Period|Exclusionary Medication Received|0|||
33703138|NCT01620528|63267177|FG001|Treatment Period|Exclusionary Medication Received|1|||
33703139|NCT01620528|63267178|FG002|Treatment Period|Exclusionary Medication Received|0|||
33703140|NCT01620528|63267176|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
33703141|NCT01620528|63267177|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
33703142|NCT01620528|63267178|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
33703143|NCT01620528|63267176|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
33703144|NCT01620528|63267177|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
33703145|NCT01620528|63267178|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
33703146|NCT01620528|63267176|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
33703147|NCT01620528|63267177|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
33703148|NCT01620528|63267178|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
33703149|NCT01620528|63267176|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
33703150|NCT01620528|63267177|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
33703151|NCT01620528|63267178|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
33703152|NCT01620528|63267176|FG000|Post-Treatment Follow-Up Period|Other|6|||
33703153|NCT01620528|63267177|FG001|Post-Treatment Follow-Up Period|Other|4|||
33703154|NCT01620528|63267178|FG002|Post-Treatment Follow-Up Period|Other|2|||
33703155|NCT01965834|63267186|FG000|Overall Study|Lack of Efficacy|4|||
33703156|NCT01965600|63267190|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
33703157|NCT01965600|63267191|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
33703158|NCT01965600|63267192|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
33703159|NCT01965600|63267193|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
33703160|NCT01965600|63267190|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
33703161|NCT01965600|63267191|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
33703162|NCT01965600|63267192|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
33703163|NCT01965600|63267193|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
33703164|NCT01965600|63267190|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
33703165|NCT01965600|63267191|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
33703166|NCT01965600|63267192|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
33703167|NCT01965600|63267193|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
33703168|NCT01965600|63267190|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
33703169|NCT01965600|63267191|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
33703170|NCT01965600|63267192|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
33703171|NCT01965600|63267193|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
33703172|NCT01965600|63267190|FG000|Second Intervention|Study terminated by Sponsor|0|||
33703173|NCT01965600|63267191|FG001|Second Intervention|Study terminated by Sponsor|0|||
33703174|NCT01965600|63267192|FG002|Second Intervention|Study terminated by Sponsor|2|||
33703175|NCT01965600|63267193|FG003|Second Intervention|Study terminated by Sponsor|2|||
33703176|NCT01996332|63267201|FG000|Overall Study|Adverse Event|117|||
33703177|NCT01996332|63267201|FG000|Overall Study|Lack of Efficacy|1245|||
33703178|NCT01996332|63267201|FG000|Overall Study|Death|264|||
33703179|NCT01996332|63267201|FG000|Overall Study|Protocol Violation|9|||
33703180|NCT01996332|63267201|FG000|Overall Study|Withdrawal by Subject|71|||
33703181|NCT01996332|63267201|FG000|Overall Study|Other|20|||
33703182|NCT01996332|63267201|FG000|Overall Study|Clinical Deterioration|28|||
33703183|NCT01996332|63267201|FG000|Overall Study|Physician Decision|17|||
33703184|NCT01996332|63267201|FG000|Overall Study|Lost to Follow-up|34|||
33703185|NCT01996254|63267207|FG000|Overall Study|Change in Eligibility|0|||
33703186|NCT01996254|63267208|FG001|Overall Study|Change in Eligibility|2|||
33703187|NCT01996254|63267209|FG002|Overall Study|Change in Eligibility|0|||
33703188|NCT01996254|63267207|FG000|Overall Study|Withdrawal by Subject|0|||
33703189|NCT01996254|63267208|FG001|Overall Study|Withdrawal by Subject|3|||
33703190|NCT01996254|63267209|FG002|Overall Study|Withdrawal by Subject|4|||
33703191|NCT01996254|63267207|FG000|Overall Study|Lost to Follow-up|1|||
33703192|NCT01996254|63267208|FG001|Overall Study|Lost to Follow-up|0|||
33703193|NCT01996254|63267209|FG002|Overall Study|Lost to Follow-up|4|||
33703194|NCT01987986|63267223|FG000|Overall Study|Lost to Follow-up|1|||
33703195|NCT01987986|63267224|FG001|Overall Study|Lost to Follow-up|0|||
33703196|NCT01987986|63267225|FG002|Overall Study|Lost to Follow-up|0|||
33703197|NCT01987986|63267226|FG003|Overall Study|Lost to Follow-up|0|||
33703198|NCT01987986|63267223|FG000|Overall Study|Adverse Event|1|||
33703199|NCT01987986|63267224|FG001|Overall Study|Adverse Event|0|||
33703200|NCT01987986|63267225|FG002|Overall Study|Adverse Event|2|||
33703201|NCT01987986|63267226|FG003|Overall Study|Adverse Event|0|||
33703202|NCT01987908|63267236|FG000|Placebo Lead-in Period|Adverse Event|2|||
33703203|NCT01987908|63267237|FG001|Placebo Lead-in Period|Adverse Event|0|||
33703204|NCT01987908|63267238|FG002|Placebo Lead-in Period|Adverse Event|0|||
33703205|NCT01987908|63267236|FG000|Placebo Lead-in Period|Physician Decision|2|||
33703206|NCT01987908|63267237|FG001|Placebo Lead-in Period|Physician Decision|0|||
33703207|NCT01987908|63267238|FG002|Placebo Lead-in Period|Physician Decision|0|||
33703208|NCT01987908|63267236|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
33703209|NCT01987908|63267237|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
33703210|NCT01987908|63267238|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
33703211|NCT01987908|63267236|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
33703212|NCT01987908|63267237|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
33703213|NCT01987908|63267238|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
33703214|NCT01987908|63267236|FG000|Treatment Period|Adverse Event|0|||
33703215|NCT01987908|63267237|FG001|Treatment Period|Adverse Event|1|||
33703216|NCT01987908|63267238|FG002|Treatment Period|Adverse Event|1|||
33703217|NCT01987908|63267236|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
33703218|NCT01987908|63267237|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
33703219|NCT01987908|63267238|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
33703220|NCT01987908|63267236|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
33703221|NCT01987908|63267237|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
33703222|NCT01987908|63267238|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
33703223|NCT01995552|63267262|FG000|Overall Study|Protocol Violation|1|||
33703224|NCT01995552|63267262|FG000|Overall Study|Lack of Efficacy|15|||
33703225|NCT01995552|63267262|FG000|Overall Study|Death|1|||
33703226|NCT01987830|63267268|FG000|Overall Study|Never received baseline scan|1|||
33703227|NCT01987596|63267274|FG000|Overall Study|Physician Decision|1|||
33703228|NCT01987596|63267275|FG001|Overall Study|Physician Decision|0|||
33703229|NCT01987596|63267274|FG000|Overall Study|Progressive Disease; missing all period|0|||
33703230|NCT01987596|63267275|FG001|Overall Study|Progressive Disease; missing all period|1|||
33703231|NCT01964976|63267289|FG000|Overall Study|Protocol Violation|31|||
33703232|NCT01964898|63267298|FG000|Overall Study|ineligible post-randomization|1|||
33703233|NCT01964898|63267299|FG001|Overall Study|ineligible post-randomization|1|||
33703234|NCT01964898|63267298|FG000|Overall Study|did not receive the allocated interventi|2|||
33703235|NCT01964898|63267299|FG001|Overall Study|did not receive the allocated interventi|1|||
33703236|NCT01964898|63267298|FG000|Overall Study|Lost to Follow-up|3|||
33703237|NCT01964898|63267299|FG001|Overall Study|Lost to Follow-up|5|||
33703238|NCT01964898|63267298|FG000|Overall Study|Withdrawal by Subject|1|||
33703239|NCT01964898|63267299|FG001|Overall Study|Withdrawal by Subject|0|||
33703240|NCT01964352|63267309|FG000|Overall Study|Adverse Event|13|||
33703241|NCT01964352|63267310|FG001|Overall Study|Adverse Event|3|||
33703242|NCT01964352|63267311|FG002|Overall Study|Adverse Event|4|||
33703243|NCT01964352|63267312|FG003|Overall Study|Adverse Event|3|||
33703244|NCT01964352|63267309|FG000|Overall Study|Lack of Efficacy|6|||
33703245|NCT01964352|63267310|FG001|Overall Study|Lack of Efficacy|0|||
33703246|NCT01964352|63267311|FG002|Overall Study|Lack of Efficacy|0|||
33703247|NCT01964352|63267312|FG003|Overall Study|Lack of Efficacy|0|||
33703248|NCT01964352|63267309|FG000|Overall Study|Protocol Violation|2|||
33703249|NCT01964352|63267310|FG001|Overall Study|Protocol Violation|4|||
33703250|NCT01964352|63267311|FG002|Overall Study|Protocol Violation|0|||
33703251|NCT01964352|63267312|FG003|Overall Study|Protocol Violation|2|||
33703252|NCT01964352|63267309|FG000|Overall Study|Lost to Follow-up|1|||
33703253|NCT01964352|63267310|FG001|Overall Study|Lost to Follow-up|0|||
33703254|NCT01964352|63267311|FG002|Overall Study|Lost to Follow-up|0|||
33703255|NCT01964352|63267312|FG003|Overall Study|Lost to Follow-up|1|||
33703256|NCT01964352|63267309|FG000|Overall Study|Withdrawal by Subject|4|||
33703257|NCT01964352|63267310|FG001|Overall Study|Withdrawal by Subject|2|||
33703258|NCT01964352|63267311|FG002|Overall Study|Withdrawal by Subject|1|||
33703259|NCT01964352|63267312|FG003|Overall Study|Withdrawal by Subject|0|||
33703260|NCT01964352|63267309|FG000|Overall Study|Other than stated above|0|||
33703261|NCT01964352|63267310|FG001|Overall Study|Other than stated above|2|||
33703262|NCT01964352|63267311|FG002|Overall Study|Other than stated above|1|||
33703263|NCT01964352|63267312|FG003|Overall Study|Other than stated above|2|||
33703264|NCT01946412|63267322|FG000|Overall Study|Adverse Event|1|||
33703265|NCT01946412|63267322|FG000|Overall Study|Non-Compliance|1|||
33703266|NCT01946412|63267322|FG000|Overall Study|Continued with commercial Kalydeco|2|||
33703267|NCT01946412|63267322|FG000|Overall Study|Difficulty in swallowing|1|||
33703268|NCT01946178|63267328|FG000|Overall Study|Pregnancy|1|||
33703269|NCT01946178|63267328|FG000|Overall Study|Lost to Follow-up|1|||
33703270|NCT01945944|63267338|FG000|Overall Study|Adverse Event|0|||
33703271|NCT01945944|63267339|FG001|Overall Study|Adverse Event|2|||
33703272|NCT01945944|63267338|FG000|Overall Study|Physician Decision|1|||
33703273|NCT01945944|63267339|FG001|Overall Study|Physician Decision|0|||
33703274|NCT01945944|63267338|FG000|Overall Study|Withdrawal by Subject|0|||
33703275|NCT01945944|63267339|FG001|Overall Study|Withdrawal by Subject|1|||
33703276|NCT01945866|63267349|FG000|Overall Study|Eyes did not complete or were dropped|2|||
33703277|NCT01945866|63267350|FG001|Overall Study|Eyes did not complete or were dropped|0|||
33703278|NCT01986114|63267357|FG000|Overall Study|Adverse Event|59|||
33703279|NCT01986114|63267357|FG000|Overall Study|Lack of Efficacy|23|||
33703280|NCT01986114|63267357|FG000|Overall Study|Withdrawal by Subject|58|||
33703281|NCT01986114|63267357|FG000|Overall Study|Noncompliance|3|||
33703282|NCT01986114|63267357|FG000|Overall Study|Protocol Violation|1|||
33703283|NCT01986114|63267357|FG000|Overall Study|Lost to Follow-up|5|||
33703284|NCT01986114|63267357|FG000|Overall Study|Other reason|7|||
33703285|NCT01945710|63267370|FG000|Overall Study|Progressive Disease|5|||
33703286|NCT01945710|63267371|FG001|Overall Study|Progressive Disease|4|||
33703287|NCT01945710|63267372|FG002|Overall Study|Progressive Disease|3|||
33703288|NCT01945710|63267373|FG003|Overall Study|Progressive Disease|2|||
33703289|NCT01945710|63267374|FG004|Overall Study|Progressive Disease|7|||
33703290|NCT01945710|63267375|FG005|Overall Study|Progressive Disease|3|||
33703291|NCT01945710|63267376|FG006|Overall Study|Progressive Disease|19|||
33703292|NCT01945710|63267370|FG000|Overall Study|Adverse Event|0|||
33703293|NCT01945710|63267371|FG001|Overall Study|Adverse Event|1|||
33703294|NCT01945710|63267372|FG002|Overall Study|Adverse Event|0|||
33703295|NCT01945710|63267373|FG003|Overall Study|Adverse Event|0|||
33703296|NCT01945710|63267374|FG004|Overall Study|Adverse Event|0|||
33703297|NCT01945710|63267375|FG005|Overall Study|Adverse Event|0|||
33703298|NCT01945710|63267376|FG006|Overall Study|Adverse Event|0|||
33703299|NCT01945710|63267370|FG000|Overall Study|Other|2|||
33703300|NCT01945710|63267371|FG001|Overall Study|Other|0|||
33703301|NCT01945710|63267372|FG002|Overall Study|Other|3|||
33703302|NCT01945710|63267373|FG003|Overall Study|Other|1|||
33703303|NCT01945710|63267374|FG004|Overall Study|Other|1|||
33703304|NCT01945710|63267375|FG005|Overall Study|Other|0|||
33703305|NCT01945710|63267376|FG006|Overall Study|Other|4|||
33703306|NCT01945710|63267370|FG000|Overall Study|Withdrawal by Subject|0|||
33703307|NCT01945710|63267371|FG001|Overall Study|Withdrawal by Subject|1|||
33703308|NCT01945710|63267372|FG002|Overall Study|Withdrawal by Subject|1|||
33703309|NCT01945710|63267373|FG003|Overall Study|Withdrawal by Subject|0|||
33703310|NCT01945710|63267374|FG004|Overall Study|Withdrawal by Subject|1|||
33703311|NCT01945710|63267375|FG005|Overall Study|Withdrawal by Subject|0|||
33703312|NCT01945710|63267376|FG006|Overall Study|Withdrawal by Subject|0|||
33703313|NCT01945242|63267396|FG000|Overall Study|Physician Decision|3|||
33703314|NCT01945242|63267397|FG001|Overall Study|Physician Decision|3|||
33703315|NCT01945086|63267407|FG000|Overall Study|Withdrawal by Subject|1|||
33703316|NCT01945086|63267408|FG001|Overall Study|Withdrawal by Subject|0|||
33703317|NCT01945086|63267409|FG002|Overall Study|Withdrawal by Subject|1|||
33703318|NCT01945086|63267407|FG000|Overall Study|Adverse Event|0|||
33703319|NCT01945086|63267408|FG001|Overall Study|Adverse Event|0|||
33703320|NCT01945086|63267409|FG002|Overall Study|Adverse Event|1|||
33703321|NCT01963728|63267419|FG000|Overall Study|Study terminated early|0|||
33703322|NCT01963728|63267420|FG001|Overall Study|Study terminated early|1|||
33703323|NCT01963260|63267436|FG000|Overall Study|Withdrawal by Subject|2|||
33703324|NCT01963260|63267437|FG001|Overall Study|Withdrawal by Subject|0|||
33703325|NCT01963260|63267438|FG002|Overall Study|Withdrawal by Subject|0|||
33703326|NCT01963260|63267439|FG003|Overall Study|Withdrawal by Subject|1|||
33703327|NCT01963260|63267440|FG004|Overall Study|Withdrawal by Subject|2|||
33703328|NCT01963260|63267441|FG005|Overall Study|Withdrawal by Subject|0|||
33703329|NCT01963260|63267442|FG006|Overall Study|Withdrawal by Subject|0|||
33703330|NCT01963260|63267443|FG007|Overall Study|Withdrawal by Subject|0|||
33703331|NCT01963260|63267444|FG008|Overall Study|Withdrawal by Subject|0|||
33703332|NCT01963260|63267445|FG009|Overall Study|Withdrawal by Subject|0|||
33703333|NCT01962948|63267478|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
33703334|NCT01962948|63267479|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
33703335|NCT01962948|63267480|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
33703336|NCT01962948|63267481|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
33703337|NCT01985334|63267496|FG000|Overall Study|Administrative problems|1|||
33703338|NCT01985334|63267497|FG001|Overall Study|Administrative problems|1|||
33703339|NCT01985334|63267498|FG002|Overall Study|Administrative problems|0|||
33703340|NCT01985334|63267499|FG003|Overall Study|Administrative problems|2|||
33703341|NCT01985334|63267500|FG004|Overall Study|Administrative problems|0|||
33703342|NCT01985334|63267501|FG005|Overall Study|Administrative problems|1|||
33703343|NCT01985334|63267502|FG006|Overall Study|Administrative problems|1|||
33703344|NCT01985334|63267503|FG007|Overall Study|Administrative problems|3|||
33703345|NCT01985334|63267496|FG000|Overall Study|Death|1|||
33703346|NCT01985334|63267497|FG001|Overall Study|Death|0|||
33703347|NCT01985334|63267498|FG002|Overall Study|Death|0|||
33703348|NCT01985334|63267499|FG003|Overall Study|Death|3|||
33703349|NCT01985334|63267500|FG004|Overall Study|Death|0|||
33703350|NCT01985334|63267501|FG005|Overall Study|Death|0|||
33703351|NCT01985334|63267502|FG006|Overall Study|Death|1|||
33703352|NCT01985334|63267503|FG007|Overall Study|Death|2|||
33703353|NCT01985334|63267496|FG000|Overall Study|Worsening of disease|0|||
33703354|NCT01985334|63267497|FG001|Overall Study|Worsening of disease|0|||
33703355|NCT01985334|63267498|FG002|Overall Study|Worsening of disease|0|||
33703356|NCT01985334|63267499|FG003|Overall Study|Worsening of disease|1|||
33703357|NCT01985334|63267500|FG004|Overall Study|Worsening of disease|0|||
33703358|NCT01985334|63267501|FG005|Overall Study|Worsening of disease|3|||
33703359|NCT01985334|63267502|FG006|Overall Study|Worsening of disease|0|||
33703360|NCT01985334|63267503|FG007|Overall Study|Worsening of disease|1|||
33703361|NCT01985334|63267496|FG000|Overall Study|Other|2|||
33703362|NCT01985334|63267497|FG001|Overall Study|Other|9|||
33703363|NCT01985334|63267498|FG002|Overall Study|Other|7|||
33703364|NCT01985334|63267499|FG003|Overall Study|Other|17|||
33703365|NCT01985334|63267500|FG004|Overall Study|Other|4|||
33703366|NCT01985334|63267501|FG005|Overall Study|Other|8|||
33703367|NCT01985334|63267502|FG006|Overall Study|Other|4|||
33703368|NCT01985334|63267503|FG007|Overall Study|Other|7|||
33703369|NCT01985334|63267496|FG000|Overall Study|Protocol deviation|6|||
33703370|NCT01985334|63267497|FG001|Overall Study|Protocol deviation|31|||
33703371|NCT01985334|63267498|FG002|Overall Study|Protocol deviation|25|||
33703372|NCT01985334|63267499|FG003|Overall Study|Protocol deviation|84|||
33703373|NCT01985334|63267500|FG004|Overall Study|Protocol deviation|17|||
33703374|NCT01985334|63267501|FG005|Overall Study|Protocol deviation|47|||
33703375|NCT01985334|63267502|FG006|Overall Study|Protocol deviation|15|||
33703376|NCT01985334|63267503|FG007|Overall Study|Protocol deviation|42|||
33703377|NCT01985334|63267496|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
33703378|NCT01985334|63267497|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
33703379|NCT01985334|63267498|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
33703380|NCT01985334|63267499|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
33703381|NCT01985334|63267500|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
33703382|NCT01985334|63267501|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
33703383|NCT01985334|63267502|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
33703384|NCT01985334|63267503|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
33703385|NCT01985334|63267496|FG000|Overall Study|Subject withdrawal of consent|3|||
33703386|NCT01985334|63267497|FG001|Overall Study|Subject withdrawal of consent|6|||
33703387|NCT01985334|63267498|FG002|Overall Study|Subject withdrawal of consent|2|||
33703388|NCT01985334|63267499|FG003|Overall Study|Subject withdrawal of consent|28|||
33703389|NCT01985334|63267500|FG004|Overall Study|Subject withdrawal of consent|4|||
33703390|NCT01985334|63267501|FG005|Overall Study|Subject withdrawal of consent|19|||
33703391|NCT01985334|63267502|FG006|Overall Study|Subject withdrawal of consent|0|||
33703392|NCT01985334|63267503|FG007|Overall Study|Subject withdrawal of consent|20|||
33703393|NCT01985334|63267496|FG000|Overall Study|Adverse Event|0|||
33703394|NCT01985334|63267497|FG001|Overall Study|Adverse Event|8|||
33703395|NCT01985334|63267498|FG002|Overall Study|Adverse Event|2|||
33703396|NCT01985334|63267499|FG003|Overall Study|Adverse Event|26|||
33703397|NCT01985334|63267500|FG004|Overall Study|Adverse Event|3|||
33703398|NCT01985334|63267501|FG005|Overall Study|Adverse Event|18|||
33703399|NCT01985334|63267502|FG006|Overall Study|Adverse Event|3|||
33703400|NCT01985334|63267503|FG007|Overall Study|Adverse Event|15|||
33703401|NCT01985334|63267496|FG000|Overall Study|Other|4|||
33703402|NCT01985334|63267497|FG001|Overall Study|Other|2|||
33703403|NCT01985334|63267498|FG002|Overall Study|Other|3|||
33703404|NCT01985334|63267499|FG003|Overall Study|Other|10|||
33703405|NCT01985334|63267500|FG004|Overall Study|Other|1|||
33703406|NCT01985334|63267501|FG005|Overall Study|Other|6|||
33703407|NCT01985334|63267502|FG006|Overall Study|Other|2|||
33703408|NCT01985334|63267503|FG007|Overall Study|Other|2|||
33703409|NCT01985334|63267496|FG000|Overall Study|Medication non-compliance|0|||
33703410|NCT01985334|63267497|FG001|Overall Study|Medication non-compliance|4|||
33703411|NCT01985334|63267498|FG002|Overall Study|Medication non-compliance|1|||
33703412|NCT01985334|63267499|FG003|Overall Study|Medication non-compliance|6|||
33703413|NCT01985334|63267500|FG004|Overall Study|Medication non-compliance|2|||
33703414|NCT01985334|63267501|FG005|Overall Study|Medication non-compliance|3|||
33703415|NCT01985334|63267502|FG006|Overall Study|Medication non-compliance|1|||
33703416|NCT01985334|63267503|FG007|Overall Study|Medication non-compliance|3|||
33703417|NCT01985334|63267496|FG000|Overall Study|Use of prohibited treatment|1|||
33703418|NCT01985334|63267497|FG001|Overall Study|Use of prohibited treatment|4|||
33703419|NCT01985334|63267498|FG002|Overall Study|Use of prohibited treatment|1|||
33703420|NCT01985334|63267499|FG003|Overall Study|Use of prohibited treatment|2|||
33703421|NCT01985334|63267500|FG004|Overall Study|Use of prohibited treatment|1|||
33703422|NCT01985334|63267501|FG005|Overall Study|Use of prohibited treatment|6|||
33703423|NCT01985334|63267502|FG006|Overall Study|Use of prohibited treatment|2|||
33703424|NCT01985334|63267503|FG007|Overall Study|Use of prohibited treatment|0|||
33703425|NCT01985334|63267496|FG000|Overall Study|Investigator decision|0|||
33703426|NCT01985334|63267497|FG001|Overall Study|Investigator decision|3|||
33703427|NCT01985334|63267498|FG002|Overall Study|Investigator decision|0|||
33703428|NCT01985334|63267499|FG003|Overall Study|Investigator decision|7|||
33703429|NCT01985334|63267500|FG004|Overall Study|Investigator decision|1|||
33703430|NCT01985334|63267501|FG005|Overall Study|Investigator decision|1|||
33703431|NCT01985334|63267502|FG006|Overall Study|Investigator decision|0|||
33703432|NCT01985334|63267503|FG007|Overall Study|Investigator decision|4|||
33703433|NCT01985334|63267496|FG000|Overall Study|Lost to Follow-up|0|||
33703434|NCT01985334|63267497|FG001|Overall Study|Lost to Follow-up|2|||
33703435|NCT01985334|63267498|FG002|Overall Study|Lost to Follow-up|0|||
33703436|NCT01985334|63267499|FG003|Overall Study|Lost to Follow-up|3|||
33703437|NCT01985334|63267500|FG004|Overall Study|Lost to Follow-up|1|||
33703438|NCT01985334|63267501|FG005|Overall Study|Lost to Follow-up|4|||
33703439|NCT01985334|63267502|FG006|Overall Study|Lost to Follow-up|0|||
33703440|NCT01985334|63267503|FG007|Overall Study|Lost to Follow-up|3|||
33703441|NCT01944774|63267538|FG000|Overall Study|Withdrawal by Subject|2|||
33703442|NCT01944774|63267539|FG001|Overall Study|Withdrawal by Subject|3|||
33703443|NCT01944774|63267540|FG002|Overall Study|Withdrawal by Subject|3|||
33703444|NCT01944774|63267538|FG000|Overall Study|Adverse Event|3|||
33703445|NCT01944774|63267539|FG001|Overall Study|Adverse Event|2|||
33703446|NCT01944774|63267540|FG002|Overall Study|Adverse Event|3|||
33703447|NCT01944774|63267538|FG000|Overall Study|Lack of Efficacy|1|||
33703448|NCT01944774|63267539|FG001|Overall Study|Lack of Efficacy|2|||
33703449|NCT01944774|63267540|FG002|Overall Study|Lack of Efficacy|2|||
33703450|NCT01944774|63267538|FG000|Overall Study|Lost to Follow-up|0|||
33703451|NCT01944774|63267539|FG001|Overall Study|Lost to Follow-up|1|||
33703452|NCT01944774|63267540|FG002|Overall Study|Lost to Follow-up|0|||
33703453|NCT01944462|63267551|FG000|PPPP Educational Program|Lost to Follow-up|60|||
33703454|NCT01943292|63267559|FG000|Overall Study|Withdrawal by Subject|1|||
33703455|NCT01943292|63267560|FG001|Overall Study|Withdrawal by Subject|0|||
33703456|NCT01943292|63267561|FG002|Overall Study|Withdrawal by Subject|0|||
33703457|NCT01961544|63267569|FG000|Overall Study|Protocol Violation|1|||
33703458|NCT01961544|63267569|FG000|Overall Study|Withdrawal by Subject|7|||
33703459|NCT01961544|63267569|FG000|Overall Study|Adverse Event|1|||
33703460|NCT01961544|63267569|FG000|Overall Study|Physician Decision|2|||
33703461|NCT01961544|63267569|FG000|Overall Study|Poor Tolerance|1|||
33703462|NCT01961544|63267569|FG000|Overall Study|Aggravation of Steral Pain|1|||
33703463|NCT01942590|63267575|FG000|Overall Study|Withdrawal by Subject|0|||
33703464|NCT01942590|63267576|FG001|Overall Study|Withdrawal by Subject|1|||
33703465|NCT01942590|63267575|FG000|Overall Study|Adverse Event|1|||
33703466|NCT01942590|63267576|FG001|Overall Study|Adverse Event|0|||
33703467|NCT01984242|63267586|FG000|Overall Study|Death|52|||
33703468|NCT01984242|63267587|FG001|Overall Study|Death|50|||
33703469|NCT01984242|63267588|FG002|Overall Study|Death|52|||
33703470|NCT01984242|63267586|FG000|Overall Study|Withdrawal by Subject|5|||
33703471|NCT01984242|63267587|FG001|Overall Study|Withdrawal by Subject|3|||
33703472|NCT01984242|63267588|FG002|Overall Study|Withdrawal by Subject|10|||
33703473|NCT01984242|63267586|FG000|Overall Study|Physician Decision|0|||
33703474|NCT01984242|63267587|FG001|Overall Study|Physician Decision|0|||
33703475|NCT01984242|63267588|FG002|Overall Study|Physician Decision|1|||
33703476|NCT01984242|63267586|FG000|Overall Study|Lost to Follow-up|4|||
33703477|NCT01984242|63267587|FG001|Overall Study|Lost to Follow-up|0|||
33703478|NCT01984242|63267588|FG002|Overall Study|Lost to Follow-up|3|||
33703479|NCT01984242|63267586|FG000|Overall Study|Sponsor Decision|1|||
33703480|NCT01984242|63267587|FG001|Overall Study|Sponsor Decision|0|||
33703481|NCT01984242|63267588|FG002|Overall Study|Sponsor Decision|0|||
33703482|NCT01984242|63267586|FG000|Overall Study|Non-Compliance|1|||
33703483|NCT01984242|63267587|FG001|Overall Study|Non-Compliance|0|||
33703484|NCT01984242|63267588|FG002|Overall Study|Non-Compliance|0|||
33703485|NCT01984242|63267586|FG000|Overall Study|Study terminated by Sponsor|38|||
33703486|NCT01984242|63267587|FG001|Overall Study|Study terminated by Sponsor|50|||
33703487|NCT01984242|63267588|FG002|Overall Study|Study terminated by Sponsor|34|||
33703488|NCT01984242|63267586|FG000|Overall Study|Disease Progression|0|||
33703489|NCT01984242|63267587|FG001|Overall Study|Disease Progression|0|||
33703490|NCT01984242|63267588|FG002|Overall Study|Disease Progression|1|||
33703491|NCT01941498|63267604|FG000|Overall Study|Relocated out of state|1|||
33703492|NCT01960998|63267625|FG000|Overall Study|Lost to Follow-up|3|||
33596637|NCT02508935|62995630|FG000|Overall Study|Withdrawal by Caregiver|8|||
33596638|NCT02508935|62995630|FG000|Overall Study|Pain Score <4|1|||
33596639|NCT02508935|62995630|FG000|Overall Study|Emesis|3|||
33596640|NCT02508935|62995630|FG000|Overall Study|Adverse Event|3|||
33596641|NCT02508935|62995630|FG000|Overall Study|Protocol Violation|1|||
33596642|NCT02508935|62995630|FG000|Overall Study|Physician Decision|1|||
33596643|NCT02508935|62995630|FG000|Overall Study|Trial terminated by sponsor|5|||
33596644|NCT02508701|62995640|FG000|Overall Study|Lost to Follow-up|9|||
33596645|NCT02508701|62995641|FG001|Overall Study|Lost to Follow-up|5|||
33596646|NCT02508701|62995642|FG002|Overall Study|Lost to Follow-up|5|||
33596647|NCT02508701|62995643|FG003|Overall Study|Lost to Follow-up|3|||
33596648|NCT02507375|62995659|FG000|Overall Study|Progressive Disease|4|||
33596649|NCT02507375|62995660|FG001|Overall Study|Progressive Disease|5|||
33596650|NCT02507375|62995659|FG000|Overall Study|Death|0|||
33596651|NCT02507375|62995660|FG001|Overall Study|Death|1|||
33596652|NCT02507375|62995659|FG000|Overall Study|Refused treatment|0|||
33596653|NCT02507375|62995660|FG001|Overall Study|Refused treatment|1|||
33596654|NCT02507375|62995659|FG000|Overall Study|Adverse Event|0|||
33596655|NCT02507375|62995660|FG001|Overall Study|Adverse Event|1|||
33596656|NCT02507219|62995670|FG000|Overall Study|Physician Decision|1|||
33596657|NCT02507219|62995671|FG001|Overall Study|Physician Decision|0|||
33596658|NCT02507219|62995672|FG002|Overall Study|Physician Decision|0|||
33596659|NCT02507219|62995673|FG003|Overall Study|Physician Decision|0|||
33596660|NCT02507219|62995674|FG004|Overall Study|Physician Decision|0|||
33596661|NCT02507219|62995675|FG005|Overall Study|Physician Decision|0|||
33596662|NCT02507219|62995670|FG000|Overall Study|Withdrawal by Subject|0|||
33596663|NCT02507219|62995671|FG001|Overall Study|Withdrawal by Subject|0|||
33596664|NCT02507219|62995672|FG002|Overall Study|Withdrawal by Subject|0|||
33596665|NCT02507219|62995673|FG003|Overall Study|Withdrawal by Subject|0|||
33596666|NCT02507219|62995674|FG004|Overall Study|Withdrawal by Subject|1|||
33596667|NCT02507219|62995675|FG005|Overall Study|Withdrawal by Subject|0|||
33596668|NCT02483975|62995685|FG000|Overall Study|Adverse Event|0|||
33596669|NCT02483975|62995686|FG001|Overall Study|Adverse Event|1|||
33596670|NCT02483975|62995685|FG000|Overall Study|Lost to Follow-up|0|||
33596671|NCT02483975|62995686|FG001|Overall Study|Lost to Follow-up|1|||
33596672|NCT02483975|62995685|FG000|Overall Study|Physician Decision|2|||
33596673|NCT02483975|62995686|FG001|Overall Study|Physician Decision|0|||
33596674|NCT02047227|62995697|FG000|Overall Study|Adverse Event|2|||
33596675|NCT02047227|62995698|FG001|Overall Study|Adverse Event|4|||
33703493|NCT01960998|63267626|FG001|Overall Study|Lost to Follow-up|7|||
33703494|NCT01960998|63267625|FG000|Overall Study|Death|0|||
33703495|NCT01960998|63267626|FG001|Overall Study|Death|1|||
33703496|NCT01960998|63267625|FG000|Overall Study|Withdrawal by Subject|8|||
33703497|NCT01960998|63267626|FG001|Overall Study|Withdrawal by Subject|2|||
33596676|NCT02047227|62995697|FG000|Overall Study|Lost to Follow-up|0|||
33596677|NCT02047227|62995698|FG001|Overall Study|Lost to Follow-up|3|||
33596678|NCT02047227|62995697|FG000|Overall Study|Protocol Violation|1|||
33596679|NCT02047227|62995698|FG001|Overall Study|Protocol Violation|0|||
33596680|NCT02047227|62995697|FG000|Overall Study|Spontaneous pregnancy|1|||
33703498|NCT01960998|63267625|FG000|Overall Study|lost computer access|0|||
33596681|NCT02047227|62995698|FG001|Overall Study|Spontaneous pregnancy|0|||
33703499|NCT01960998|63267626|FG001|Overall Study|lost computer access|1|||
33596682|NCT02047227|62995697|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
33596683|NCT02047227|62995698|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
33596684|NCT02047227|62995697|FG000|Overall Study|No oocytes retrieved|21|||
33596685|NCT02047227|62995698|FG001|Overall Study|No oocytes retrieved|20|||
33596686|NCT02047227|62995697|FG000|Overall Study|No fertilization|61|||
33596687|NCT02047227|62995698|FG001|Overall Study|No fertilization|51|||
33596688|NCT02047227|62995697|FG000|Overall Study|Intention to freeze all embryos|1|||
33596689|NCT02047227|62995698|FG001|Overall Study|Intention to freeze all embryos|0|||
33596690|NCT02047227|62995697|FG000|Overall Study|All embryos discarded|12|||
33596691|NCT02047227|62995698|FG001|Overall Study|All embryos discarded|11|||
33596692|NCT02047227|62995697|FG000|Overall Study|Other|10|||
33596693|NCT02047227|62995698|FG001|Overall Study|Other|9|||
33596694|NCT02483585|62995706|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
33596695|NCT02483585|62995707|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
33596696|NCT02483585|62995706|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
33596697|NCT02483585|62995707|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
33596698|NCT02483585|62995706|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
33596699|NCT02483585|62995707|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
33596700|NCT02483585|62995706|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
33596701|NCT02483585|62995707|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
33596702|NCT02483585|62995706|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
33596703|NCT02483585|62995707|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
33596704|NCT02483585|62995706|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
33596705|NCT02483585|62995707|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
33596706|NCT02483585|62995706|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
33596707|NCT02483585|62995707|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
33596708|NCT02046993|62995719|FG000|Overall Study|Withdrawal by Subject|2|||
33596709|NCT02046993|62995720|FG001|Overall Study|Withdrawal by Subject|10|||
33596710|NCT02046993|62995719|FG000|Overall Study|Lost to Follow-up|1|||
33596711|NCT02046993|62995720|FG001|Overall Study|Lost to Follow-up|1|||
33596712|NCT02101983|62995730|FG000|Overall Study|Physician Decision|1|||
33596713|NCT02101983|62995731|FG001|Overall Study|Physician Decision|0|||
33596714|NCT02482805|62995740|FG000|Overall Study|Lost to Follow-up|4|||
33596715|NCT02482805|62995741|FG001|Overall Study|Lost to Follow-up|4|||
33596716|NCT02482805|62995742|FG002|Overall Study|Lost to Follow-up|0|||
33596717|NCT02503865|62995753|FG000|Overall Study|Moved out of area|1|||
33596718|NCT02503865|62995754|FG001|Overall Study|Moved out of area|8|||
33596719|NCT02503865|62995755|FG002|Overall Study|Moved out of area|0|||
33596720|NCT02503865|62995753|FG000|Overall Study|Refused treatment|4|||
33596721|NCT02503865|62995754|FG001|Overall Study|Refused treatment|39|||
33596722|NCT02503865|62995755|FG002|Overall Study|Refused treatment|2|||
33596723|NCT01623531|62995766|FG000|Overall Study|Death|1|||
33596724|NCT01623531|62995767|FG001|Overall Study|Death|0|||
33596725|NCT01623531|62995766|FG000|Overall Study|Protocol Violation|2|||
33596726|NCT01623531|62995767|FG001|Overall Study|Protocol Violation|1|||
33596727|NCT01623531|62995766|FG000|Overall Study|Missing data at primary outcome time poi|1|||
33596728|NCT01623531|62995767|FG001|Overall Study|Missing data at primary outcome time poi|1|||
33596729|NCT02503787|62995776|FG000|Enrollment|Withdrawal by Subject|6|||
33596730|NCT02503787|62995776|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
33596731|NCT02503787|62995776|FG000|Enrollment|Physician Decision|2|||
33596732|NCT02503787|62995776|FG000|Enrollment|Insurance issue|2|||
33596733|NCT02503787|62995776|FG000|Enrollment|Lost to Follow-up|1|||
33596734|NCT02503787|62995776|FG000|Enrollment|Study closure|1|||
33596735|NCT02503787|62995776|FG000|Enrollment|Adverse Event|1|||
33596736|NCT02503787|62995776|FG000|Enrollment|Protocol Violation|1|||
33596737|NCT02503787|62995776|FG000|Enrollment|Inability to implant system|1|||
33596738|NCT02503787|62995776|FG000|Enrollment|Unable to be programmed|1|||
33596739|NCT02503787|62995776|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
33596740|NCT02503787|62995776|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
33596741|NCT02503787|62995776|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
33596742|NCT02503787|62995776|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
33596743|NCT02503787|62995776|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
33596744|NCT02503787|62995776|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
33596745|NCT02482571|62995780|FG000|Overall Study|Adverse Event|1|||
33596746|NCT02482571|62995780|FG000|Overall Study|Scanner or Respiract failure|3|||
33596747|NCT02482571|62995780|FG000|Overall Study|Withdrawal by Subject|4|||
33596748|NCT02481947|62995787|FG000|Overall Study|Withdrawal by Subject|24|||
33596749|NCT02481947|62995788|FG001|Overall Study|Withdrawal by Subject|10|||
33596750|NCT02481947|62995787|FG000|Overall Study|Lost to Follow-up|11|||
33596751|NCT02481947|62995788|FG001|Overall Study|Lost to Follow-up|5|||
33596752|NCT02481947|62995787|FG000|Overall Study|Adverse Event|6|||
33596753|NCT02481947|62995788|FG001|Overall Study|Adverse Event|11|||
33596754|NCT02481947|62995787|FG000|Overall Study|Physician Decision|4|||
33596755|NCT02481947|62995788|FG001|Overall Study|Physician Decision|5|||
33596756|NCT02481947|62995787|FG000|Overall Study|Protocol Violation|1|||
33596757|NCT02481947|62995788|FG001|Overall Study|Protocol Violation|5|||
33596758|NCT02503085|62995794|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
33596759|NCT02503085|62995795|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
33596760|NCT02503085|62995796|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
33596761|NCT02503085|62995797|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
33596762|NCT02481869|62995806|FG000|Overall Study|Lost to Follow-up|3|||
33596763|NCT02481869|62995807|FG001|Overall Study|Lost to Follow-up|4|||
33596764|NCT02481869|62995806|FG000|Overall Study|Withdrawal by Subject|2|||
33596765|NCT02481869|62995807|FG001|Overall Study|Withdrawal by Subject|0|||
33596766|NCT02502149|62995814|FG000|Intermediate|Discontinued prematurely|1|||
33596767|NCT02502149|62995815|FG001|Intermediate|Discontinued prematurely|0|||
33596768|NCT02502149|62995816|FG002|Intermediate|Discontinued prematurely|0|||
33596769|NCT02502149|62995817|FG003|Intermediate|Discontinued prematurely|0|||
33596770|NCT02502149|62995818|FG004|Intermediate|Discontinued prematurely|0|||
33596771|NCT02480621|62995837|FG000|Randomization|Withdrawal by Subject|1|||
33596772|NCT02480621|62995838|FG001|Randomization|Withdrawal by Subject|0|||
33596773|NCT02480621|62995837|FG000|Randomization|Surgeon did not give intervention|0|||
33596774|NCT02480621|62995838|FG001|Randomization|Surgeon did not give intervention|1|||
33596775|NCT02480621|62995837|FG000|Follow Up|Lost to Follow-up|4|||
33596776|NCT02480621|62995838|FG001|Follow Up|Lost to Follow-up|2|||
33596777|NCT02046603|62995846|FG000|Overall Study|Other|11|||
33596778|NCT02046603|62995847|FG001|Overall Study|Other|66|||
33596779|NCT02046603|62995846|FG000|Overall Study|Protocol Violation|0|||
33596780|NCT02046603|62995847|FG001|Overall Study|Protocol Violation|1|||
33596781|NCT02046603|62995846|FG000|Overall Study|Participant/legal guardian decision|1|||
33596782|NCT02046603|62995847|FG001|Overall Study|Participant/legal guardian decision|3|||
33596783|NCT02046603|62995846|FG000|Overall Study|Physician Decision|2|||
33596784|NCT02046603|62995847|FG001|Overall Study|Physician Decision|1|||
33596785|NCT02046603|62995846|FG000|Overall Study|Lost to Follow-up|1|||
33596786|NCT02046603|62995847|FG001|Overall Study|Lost to Follow-up|2|||
33596787|NCT02046603|62995846|FG000|Overall Study|Death|0|||
33596788|NCT02046603|62995847|FG001|Overall Study|Death|1|||
33596789|NCT02046603|62995846|FG000|Overall Study|Adverse Event|0|||
33596790|NCT02046603|62995847|FG001|Overall Study|Adverse Event|1|||
33596791|NCT01885078|62995862|FG000|Treatment Period|Adverse Event|52|||
33596792|NCT01885078|62995863|FG001|Treatment Period|Adverse Event|136|||
33596793|NCT01885078|62995864|FG002|Treatment Period|Adverse Event|30|||
33596794|NCT01885078|62995865|FG003|Treatment Period|Adverse Event|73|||
33596795|NCT01885078|62995866|FG004|Treatment Period|Adverse Event|17|||
33596796|NCT01885078|62995867|FG005|Treatment Period|Adverse Event|72|||
33596797|NCT01885078|62995868|FG006|Treatment Period|Adverse Event|24|||
33596798|NCT01885078|62995869|FG007|Treatment Period|Adverse Event|5|||
33596799|NCT01885078|62995870|FG008|Treatment Period|Adverse Event|0|||
33596800|NCT01885078|62995871|FG009|Treatment Period|Adverse Event|0|||
33596801|NCT01885078|62995862|FG000|Treatment Period|Death|13|||
33596802|NCT01885078|62995863|FG001|Treatment Period|Death|33|||
33596803|NCT01885078|62995864|FG002|Treatment Period|Death|5|||
33596804|NCT01885078|62995865|FG003|Treatment Period|Death|9|||
33596805|NCT01885078|62995866|FG004|Treatment Period|Death|2|||
33596806|NCT01885078|62995867|FG005|Treatment Period|Death|10|||
33596807|NCT01885078|62995868|FG006|Treatment Period|Death|3|||
33596808|NCT01885078|62995869|FG007|Treatment Period|Death|2|||
33596809|NCT01885078|62995870|FG008|Treatment Period|Death|0|||
33596810|NCT01885078|62995871|FG009|Treatment Period|Death|0|||
33596811|NCT01885078|62995862|FG000|Treatment Period|Lack of Efficacy|12|||
33596812|NCT01885078|62995863|FG001|Treatment Period|Lack of Efficacy|33|||
33596813|NCT01885078|62995864|FG002|Treatment Period|Lack of Efficacy|10|||
33596814|NCT01885078|62995865|FG003|Treatment Period|Lack of Efficacy|23|||
33596815|NCT01885078|62995866|FG004|Treatment Period|Lack of Efficacy|24|||
33596816|NCT01885078|62995867|FG005|Treatment Period|Lack of Efficacy|58|||
33596817|NCT01885078|62995868|FG006|Treatment Period|Lack of Efficacy|9|||
33596818|NCT01885078|62995869|FG007|Treatment Period|Lack of Efficacy|5|||
33596819|NCT01885078|62995870|FG008|Treatment Period|Lack of Efficacy|0|||
33596820|NCT01885078|62995871|FG009|Treatment Period|Lack of Efficacy|0|||
33596821|NCT01885078|62995862|FG000|Treatment Period|Lost to Follow-up|16|||
33596822|NCT01885078|62995863|FG001|Treatment Period|Lost to Follow-up|19|||
33596823|NCT01885078|62995864|FG002|Treatment Period|Lost to Follow-up|7|||
33596824|NCT01885078|62995865|FG003|Treatment Period|Lost to Follow-up|9|||
33596825|NCT01885078|62995866|FG004|Treatment Period|Lost to Follow-up|2|||
33596826|NCT01885078|62995867|FG005|Treatment Period|Lost to Follow-up|8|||
33596827|NCT01885078|62995868|FG006|Treatment Period|Lost to Follow-up|2|||
33596828|NCT01885078|62995869|FG007|Treatment Period|Lost to Follow-up|0|||
33703500|NCT01941186|63267636|FG000|Follow-up|Lost to Follow-up|1|||
33703501|NCT01941186|63267637|FG001|Follow-up|Lost to Follow-up|0|||
33703502|NCT01960842|63267656|FG000|Overall Study|Adverse Event|1|||
33596829|NCT01885078|62995870|FG008|Treatment Period|Lost to Follow-up|0|||
33596830|NCT01885078|62995871|FG009|Treatment Period|Lost to Follow-up|0|||
33596831|NCT01885078|62995862|FG000|Treatment Period|Physician Decision|19|||
33596832|NCT01885078|62995863|FG001|Treatment Period|Physician Decision|21|||
33596833|NCT01885078|62995864|FG002|Treatment Period|Physician Decision|5|||
33596834|NCT01885078|62995865|FG003|Treatment Period|Physician Decision|12|||
33596835|NCT01885078|62995866|FG004|Treatment Period|Physician Decision|9|||
33596836|NCT01885078|62995867|FG005|Treatment Period|Physician Decision|24|||
33596837|NCT01885078|62995868|FG006|Treatment Period|Physician Decision|4|||
33596838|NCT01885078|62995869|FG007|Treatment Period|Physician Decision|3|||
33596839|NCT01885078|62995870|FG008|Treatment Period|Physician Decision|0|||
33596840|NCT01885078|62995871|FG009|Treatment Period|Physician Decision|0|||
33596841|NCT01885078|62995862|FG000|Treatment Period|Protocol Violation|3|||
33596842|NCT01885078|62995863|FG001|Treatment Period|Protocol Violation|5|||
33596843|NCT01885078|62995864|FG002|Treatment Period|Protocol Violation|0|||
33596844|NCT01885078|62995865|FG003|Treatment Period|Protocol Violation|3|||
33596845|NCT01885078|62995866|FG004|Treatment Period|Protocol Violation|1|||
33596846|NCT01885078|62995867|FG005|Treatment Period|Protocol Violation|6|||
33596847|NCT01885078|62995868|FG006|Treatment Period|Protocol Violation|0|||
33596848|NCT01885078|62995869|FG007|Treatment Period|Protocol Violation|0|||
33596849|NCT01885078|62995870|FG008|Treatment Period|Protocol Violation|0|||
33596850|NCT01885078|62995871|FG009|Treatment Period|Protocol Violation|0|||
33596851|NCT01885078|62995862|FG000|Treatment Period|Sponsor Decision|245|||
33596852|NCT01885078|62995863|FG001|Treatment Period|Sponsor Decision|648|||
33596853|NCT01885078|62995864|FG002|Treatment Period|Sponsor Decision|49|||
33596854|NCT01885078|62995865|FG003|Treatment Period|Sponsor Decision|90|||
33596855|NCT01885078|62995866|FG004|Treatment Period|Sponsor Decision|20|||
33596856|NCT01885078|62995867|FG005|Treatment Period|Sponsor Decision|38|||
33596857|NCT01885078|62995868|FG006|Treatment Period|Sponsor Decision|162|||
33596858|NCT01885078|62995869|FG007|Treatment Period|Sponsor Decision|3|||
33596859|NCT01885078|62995870|FG008|Treatment Period|Sponsor Decision|0|||
33596860|NCT01885078|62995871|FG009|Treatment Period|Sponsor Decision|0|||
33596861|NCT01885078|62995862|FG000|Treatment Period|Withdrawal by Subject|72|||
33596862|NCT01885078|62995863|FG001|Treatment Period|Withdrawal by Subject|132|||
33596863|NCT01885078|62995864|FG002|Treatment Period|Withdrawal by Subject|25|||
33596864|NCT01885078|62995865|FG003|Treatment Period|Withdrawal by Subject|63|||
33596865|NCT01885078|62995866|FG004|Treatment Period|Withdrawal by Subject|15|||
33596866|NCT01885078|62995867|FG005|Treatment Period|Withdrawal by Subject|34|||
33596867|NCT01885078|62995868|FG006|Treatment Period|Withdrawal by Subject|17|||
33596868|NCT01885078|62995869|FG007|Treatment Period|Withdrawal by Subject|10|||
33596869|NCT01885078|62995870|FG008|Treatment Period|Withdrawal by Subject|0|||
33596870|NCT01885078|62995871|FG009|Treatment Period|Withdrawal by Subject|0|||
33596871|NCT01885078|62995862|FG000|Treatment Period|Other|0|||
33596872|NCT01885078|62995863|FG001|Treatment Period|Other|0|||
33596873|NCT01885078|62995864|FG002|Treatment Period|Other|0|||
33596874|NCT01885078|62995865|FG003|Treatment Period|Other|1|||
33596875|NCT01885078|62995866|FG004|Treatment Period|Other|0|||
33596876|NCT01885078|62995867|FG005|Treatment Period|Other|0|||
33596877|NCT01885078|62995868|FG006|Treatment Period|Other|0|||
33596878|NCT01885078|62995869|FG007|Treatment Period|Other|0|||
33596879|NCT01885078|62995870|FG008|Treatment Period|Other|0|||
33596880|NCT01885078|62995871|FG009|Treatment Period|Other|0|||
33596881|NCT01885078|62995862|FG000|Step-down Period|Sponsor Decision|0|||
33596882|NCT01885078|62995863|FG001|Step-down Period|Sponsor Decision|0|||
33596883|NCT01885078|62995864|FG002|Step-down Period|Sponsor Decision|0|||
33596884|NCT01885078|62995865|FG003|Step-down Period|Sponsor Decision|0|||
33596885|NCT01885078|62995866|FG004|Step-down Period|Sponsor Decision|0|||
33596886|NCT01885078|62995867|FG005|Step-down Period|Sponsor Decision|0|||
33596887|NCT01885078|62995868|FG006|Step-down Period|Sponsor Decision|0|||
33596888|NCT01885078|62995869|FG007|Step-down Period|Sponsor Decision|0|||
33596889|NCT01885078|62995870|FG008|Step-down Period|Sponsor Decision|1|||
33596890|NCT01885078|62995871|FG009|Step-down Period|Sponsor Decision|1|||
33596891|NCT01885078|62995862|FG000|Step-down Period|Adverse Event|0|||
33596892|NCT01885078|62995863|FG001|Step-down Period|Adverse Event|0|||
33596893|NCT01885078|62995864|FG002|Step-down Period|Adverse Event|0|||
33596894|NCT01885078|62995865|FG003|Step-down Period|Adverse Event|0|||
33596895|NCT01885078|62995866|FG004|Step-down Period|Adverse Event|0|||
33596896|NCT01885078|62995867|FG005|Step-down Period|Adverse Event|0|||
33596897|NCT01885078|62995868|FG006|Step-down Period|Adverse Event|0|||
33596898|NCT01885078|62995869|FG007|Step-down Period|Adverse Event|0|||
33596899|NCT01885078|62995870|FG008|Step-down Period|Adverse Event|29|||
33596900|NCT01885078|62995871|FG009|Step-down Period|Adverse Event|38|||
33596901|NCT01885078|62995862|FG000|Step-down Period|Withdrawal by Subject|0|||
33596902|NCT01885078|62995863|FG001|Step-down Period|Withdrawal by Subject|0|||
33596903|NCT01885078|62995864|FG002|Step-down Period|Withdrawal by Subject|0|||
33703503|NCT01960842|63267656|FG000|Overall Study|Withdrawal by Subject|2|||
33703504|NCT01984164|63267662|FG000|Overall Study|Withdrawal by Subject|4|||
33703505|NCT01984164|63267663|FG001|Overall Study|Withdrawal by Subject|3|||
33703506|NCT01984164|63267662|FG000|Overall Study|Adverse Event|5|||
33596904|NCT01885078|62995865|FG003|Step-down Period|Withdrawal by Subject|0|||
33596905|NCT01885078|62995866|FG004|Step-down Period|Withdrawal by Subject|0|||
33596906|NCT01885078|62995867|FG005|Step-down Period|Withdrawal by Subject|0|||
33596907|NCT01885078|62995868|FG006|Step-down Period|Withdrawal by Subject|0|||
33596908|NCT01885078|62995869|FG007|Step-down Period|Withdrawal by Subject|0|||
33703507|NCT01984164|63267663|FG001|Overall Study|Adverse Event|19|||
33596909|NCT01885078|62995870|FG008|Step-down Period|Withdrawal by Subject|25|||
33596910|NCT01885078|62995871|FG009|Step-down Period|Withdrawal by Subject|15|||
33596911|NCT01885078|62995862|FG000|Step-down Period|Physician Decision|0|||
33596912|NCT01885078|62995863|FG001|Step-down Period|Physician Decision|0|||
33596913|NCT01885078|62995864|FG002|Step-down Period|Physician Decision|0|||
33703508|NCT01984164|63267662|FG000|Overall Study|Lost to Follow-up|1|||
33703509|NCT01984164|63267663|FG001|Overall Study|Lost to Follow-up|3|||
33703510|NCT01983930|63267671|FG000|Overall Study|Withdrawal by Subject|9|||
33703511|NCT01983930|63267672|FG001|Overall Study|Withdrawal by Subject|8|||
33703512|NCT01983930|63267671|FG000|Overall Study|Adverse Event|0|||
33703513|NCT01983930|63267672|FG001|Overall Study|Adverse Event|1|||
33703514|NCT01983774|63267685|FG000|Overall Study|Lung Transplant|0|||
33703515|NCT01983774|63267686|FG001|Overall Study|Lung Transplant|1|||
33703516|NCT01983774|63267685|FG000|Overall Study|Lost to Follow-up|1|||
33703517|NCT01983774|63267686|FG001|Overall Study|Lost to Follow-up|0|||
33703518|NCT01982682|63267694|FG000|Overall Study|Physician Decision|1|||
33703519|NCT01940484|63267699|FG000|Overall Study|Withdrawal by Subject|3|||
33703520|NCT01940484|63267699|FG000|Overall Study|Underwent transplantation|4|||
33703521|NCT01940484|63267699|FG000|Overall Study|Death|2|||
33703522|NCT01940484|63267699|FG000|Overall Study|Adverse Event|1|||
33703523|NCT01939548|63267706|FG000|Overall Study|Non compliance|0|||
33703524|NCT01939548|63267707|FG001|Overall Study|Non compliance|2|||
33703525|NCT01939548|63267708|FG002|Overall Study|Non compliance|0|||
33703526|NCT01939548|63267706|FG000|Overall Study|Study Terminated by Sponsor|17|||
33703527|NCT01939548|63267707|FG001|Overall Study|Study Terminated by Sponsor|19|||
33703528|NCT01939548|63267708|FG002|Overall Study|Study Terminated by Sponsor|12|||
33703529|NCT01939548|63267706|FG000|Overall Study|Insufficient Clinical Response|1|||
33703530|NCT01939548|63267707|FG001|Overall Study|Insufficient Clinical Response|0|||
33703531|NCT01939548|63267708|FG002|Overall Study|Insufficient Clinical Response|0|||
33703532|NCT01939548|63267706|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
33703533|NCT01939548|63267707|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
33703534|NCT01939548|63267708|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
33703535|NCT01939548|63267706|FG000|Overall Study|Withdrawal by Subject|4|||
33703536|NCT01939548|63267707|FG001|Overall Study|Withdrawal by Subject|4|||
33703537|NCT01939548|63267708|FG002|Overall Study|Withdrawal by Subject|1|||
33703538|NCT01939548|63267706|FG000|Overall Study|Protocol Violation|7|||
33703539|NCT01939548|63267707|FG001|Overall Study|Protocol Violation|6|||
33703540|NCT01939548|63267708|FG002|Overall Study|Protocol Violation|5|||
33703541|NCT01939548|63267706|FG000|Overall Study|Lost to Follow-up|5|||
33703542|NCT01939548|63267707|FG001|Overall Study|Lost to Follow-up|5|||
33703543|NCT01939548|63267708|FG002|Overall Study|Lost to Follow-up|3|||
33703544|NCT01939548|63267706|FG000|Overall Study|Adverse Event|2|||
33703545|NCT01939548|63267707|FG001|Overall Study|Adverse Event|9|||
33703546|NCT01939548|63267708|FG002|Overall Study|Adverse Event|7|||
33703547|NCT01939548|63267706|FG000|Overall Study|Death|0|||
33703548|NCT01939548|63267707|FG001|Overall Study|Death|0|||
33703549|NCT01939548|63267708|FG002|Overall Study|Death|1|||
33703550|NCT01939548|63267706|FG000|Overall Study|Participant dropped|0|||
33703551|NCT01939548|63267707|FG001|Overall Study|Participant dropped|0|||
33703552|NCT01939548|63267708|FG002|Overall Study|Participant dropped|1|||
33703553|NCT01939548|63267706|FG000|Overall Study|Participant unwilling to continue|0|||
33703554|NCT01939548|63267707|FG001|Overall Study|Participant unwilling to continue|1|||
33703555|NCT01939548|63267708|FG002|Overall Study|Participant unwilling to continue|0|||
33703556|NCT01939548|63267706|FG000|Overall Study|Participant withdrew consent|0|||
33703557|NCT01939548|63267707|FG001|Overall Study|Participant withdrew consent|2|||
33703558|NCT01939548|63267708|FG002|Overall Study|Participant withdrew consent|0|||
33703559|NCT01939548|63267706|FG000|Overall Study|Did not complete follow-up|0|||
33703560|NCT01939548|63267707|FG001|Overall Study|Did not complete follow-up|1|||
33703561|NCT01939548|63267708|FG002|Overall Study|Did not complete follow-up|0|||
33703562|NCT01960296|63267718|FG000|Overall Study|Postponed surgery|1|||
33703563|NCT01960296|63267719|FG001|Overall Study|Postponed surgery|0|||
33703564|NCT01960296|63267718|FG000|Overall Study|Received different procedure|1|||
33703565|NCT01960296|63267719|FG001|Overall Study|Received different procedure|3|||
33703566|NCT01982292|63267727|FG000|Overall Study|Adverse Event|2|||
33703567|NCT01982292|63267728|FG001|Overall Study|Adverse Event|0|||
33703568|NCT01982292|63267727|FG000|Overall Study|Death|1|||
33703569|NCT01982292|63267728|FG001|Overall Study|Death|0|||
33703570|NCT01982292|63267727|FG000|Overall Study|Lost to Follow-up|2|||
33703571|NCT01982292|63267728|FG001|Overall Study|Lost to Follow-up|0|||
33703572|NCT01982292|63267727|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
33703573|NCT01982292|63267728|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
33703574|NCT01982292|63267727|FG000|Overall Study|Protocol Deviation|1|||
33703575|NCT01982292|63267728|FG001|Overall Study|Protocol Deviation|0|||
33703576|NCT01982292|63267727|FG000|Overall Study|Patient/Guardian Decision|3|||
33703577|NCT01982292|63267728|FG001|Overall Study|Patient/Guardian Decision|1|||
33703578|NCT01982292|63267727|FG000|Overall Study|Technical Problems|2|||
33703579|NCT01982292|63267728|FG001|Overall Study|Technical Problems|0|||
33703580|NCT01939314|63267736|FG000|Overall Study|Withdrawal by Subject|3|||
33703581|NCT01939314|63267737|FG001|Overall Study|Withdrawal by Subject|1|||
33703582|NCT01939314|63267736|FG000|Overall Study|Protocol Violation|1|||
33703583|NCT01939314|63267737|FG001|Overall Study|Protocol Violation|0|||
33703584|NCT01939314|63267736|FG000|Overall Study|Pregnancy|0|||
33703585|NCT01939314|63267737|FG001|Overall Study|Pregnancy|1|||
33703586|NCT01939314|63267736|FG000|Overall Study|Lost to Follow-up|5|||
33703587|NCT01939314|63267737|FG001|Overall Study|Lost to Follow-up|6|||
33703588|NCT01939158|63267749|FG000|Overall Study|Adverse Event|1|||
33703589|NCT01939158|63267750|FG001|Overall Study|Adverse Event|0|||
33703590|NCT01939158|63267751|FG002|Overall Study|Adverse Event|0|||
33703591|NCT01939158|63267752|FG003|Overall Study|Adverse Event|0|||
33703592|NCT01939158|63267749|FG000|Overall Study|Withdrawal by Subject|22|||
33703593|NCT01939158|63267750|FG001|Overall Study|Withdrawal by Subject|25|||
33703594|NCT01939158|63267751|FG002|Overall Study|Withdrawal by Subject|15|||
33703595|NCT01939158|63267752|FG003|Overall Study|Withdrawal by Subject|17|||
33703596|NCT01939158|63267749|FG000|Overall Study|Migrated/moved from study area|5|||
33703597|NCT01939158|63267750|FG001|Overall Study|Migrated/moved from study area|7|||
33703598|NCT01939158|63267751|FG002|Overall Study|Migrated/moved from study area|3|||
33703599|NCT01939158|63267752|FG003|Overall Study|Migrated/moved from study area|6|||
33703600|NCT01939158|63267749|FG000|Overall Study|Lost to Follow-up|18|||
33703601|NCT01939158|63267750|FG001|Overall Study|Lost to Follow-up|17|||
33703602|NCT01939158|63267751|FG002|Overall Study|Lost to Follow-up|17|||
33703603|NCT01939158|63267752|FG003|Overall Study|Lost to Follow-up|17|||
33703604|NCT01939158|63267749|FG000|Overall Study|Death|0|||
33703605|NCT01939158|63267750|FG001|Overall Study|Death|0|||
33703606|NCT01939158|63267751|FG002|Overall Study|Death|1|||
33703607|NCT01939158|63267752|FG003|Overall Study|Death|1|||
33703608|NCT01939158|63267749|FG000|Overall Study|No longer meets eligibility criteria|0|||
33703609|NCT01939158|63267750|FG001|Overall Study|No longer meets eligibility criteria|0|||
33703610|NCT01939158|63267751|FG002|Overall Study|No longer meets eligibility criteria|1|||
33703611|NCT01939158|63267752|FG003|Overall Study|No longer meets eligibility criteria|0|||
33703612|NCT01939158|63267749|FG000|Overall Study|Other|1|||
33703613|NCT01939158|63267750|FG001|Overall Study|Other|3|||
33703614|NCT01939158|63267751|FG002|Overall Study|Other|4|||
33703615|NCT01939158|63267752|FG003|Overall Study|Other|3|||
33703616|NCT01939002|63267768|FG000|Overall Study|Adverse Event|13|||
33703617|NCT01939002|63267769|FG001|Overall Study|Adverse Event|13|||
33703618|NCT01939002|63267768|FG000|Overall Study|Withdrawal by Subject|5|||
33703619|NCT01939002|63267769|FG001|Overall Study|Withdrawal by Subject|3|||
33703620|NCT01939002|63267768|FG000|Overall Study|Other|1|||
33703621|NCT01939002|63267769|FG001|Overall Study|Other|2|||
33703622|NCT01938846|63267783|FG000|Overall Study|Progressive disease|26|||
33703623|NCT01938846|63267784|FG001|Overall Study|Progressive disease|18|||
33703624|NCT01938846|63267785|FG002|Overall Study|Progressive disease|16|||
33703625|NCT01938846|63267783|FG000|Overall Study|Adverse Event|8|||
33703626|NCT01938846|63267784|FG001|Overall Study|Adverse Event|4|||
33703627|NCT01938846|63267785|FG002|Overall Study|Adverse Event|3|||
33703628|NCT01938846|63267783|FG000|Overall Study|Withdrawal by Subject|2|||
33703629|NCT01938846|63267784|FG001|Overall Study|Withdrawal by Subject|2|||
33703630|NCT01938846|63267785|FG002|Overall Study|Withdrawal by Subject|1|||
33703631|NCT01938846|63267783|FG000|Overall Study|Other than listed|5|||
33703632|NCT01938846|63267784|FG001|Overall Study|Other than listed|1|||
33703633|NCT01938846|63267785|FG002|Overall Study|Other than listed|4|||
33703634|NCT01960140|63267826|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
33703635|NCT01981356|63267836|FG000|Overall Study|Lost to Follow-up|4|||
33703636|NCT01981356|63267837|FG001|Overall Study|Lost to Follow-up|1|||
33703637|NCT01981356|63267836|FG000|Overall Study|Withdrawal by Subject|1|||
33703638|NCT01981356|63267837|FG001|Overall Study|Withdrawal by Subject|1|||
33703639|NCT01981356|63267836|FG000|Overall Study|Protocol Violation|2|||
33703640|NCT01981356|63267837|FG001|Overall Study|Protocol Violation|0|||
33703641|NCT01981122|63267846|FG000|Overall Study|Withdrawal by Subject|0|||
33703642|NCT01981122|63267847|FG001|Overall Study|Withdrawal by Subject|2|||
33703643|NCT01981122|63267846|FG000|Overall Study|Protocol Violation|0|||
33703644|NCT01981122|63267847|FG001|Overall Study|Protocol Violation|1|||
33703645|NCT01981122|63267846|FG000|Overall Study|Lost to Follow-up|0|||
33596914|NCT01885078|62995865|FG003|Step-down Period|Physician Decision|0|||
33596915|NCT01885078|62995866|FG004|Step-down Period|Physician Decision|0|||
33703646|NCT01981122|63267847|FG001|Overall Study|Lost to Follow-up|1|||
33703647|NCT01981122|63267846|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
33703648|NCT01981122|63267847|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
33703649|NCT01981122|63267846|FG000|Overall Study|Death|14|||
33703650|NCT01981122|63267847|FG001|Overall Study|Death|15|||
33703651|NCT01959672|63267853|FG000|Overall Study|Death|1|||
33703652|NCT01980888|63267862|FG000|Overall Study|Study Terminated by Sponsor|116|||
33703653|NCT01980888|63267863|FG001|Overall Study|Study Terminated by Sponsor|122|||
33703654|NCT01980888|63267862|FG000|Overall Study|Withdrew Consent|17|||
33703655|NCT01980888|63267863|FG001|Overall Study|Withdrew Consent|6|||
33703656|NCT01980888|63267862|FG000|Overall Study|Investigator's Discretion|8|||
33703657|NCT01980888|63267863|FG001|Overall Study|Investigator's Discretion|3|||
33703658|NCT01980888|63267862|FG000|Overall Study|Non-Compliance with Study Drug|3|||
33703659|NCT01980888|63267863|FG001|Overall Study|Non-Compliance with Study Drug|2|||
33703660|NCT01937364|63267880|FG000|Overall Study|Adverse Event|2|||
33703661|NCT01937364|63267881|FG001|Overall Study|Adverse Event|1|||
33703662|NCT01979952|63267889|FG000|Overall Study|Adverse Event|4|||
33703663|NCT01979952|63267890|FG001|Overall Study|Adverse Event|5|||
33703664|NCT01979952|63267889|FG000|Overall Study|Protocol Violation|1|||
33703665|NCT01979952|63267890|FG001|Overall Study|Protocol Violation|0|||
33703666|NCT01979952|63267889|FG000|Overall Study|Withdrawal by Subject|2|||
33703667|NCT01979952|63267890|FG001|Overall Study|Withdrawal by Subject|1|||
33703668|NCT01979952|63267889|FG000|Overall Study|Other than specified above|1|||
33703669|NCT01979952|63267890|FG001|Overall Study|Other than specified above|0|||
33703670|NCT01999218|63267899|FG000|Overall Study|Hyperglycemia|18|||
33703671|NCT01999218|63267900|FG001|Overall Study|Hyperglycemia|17|||
33703672|NCT01999218|63267901|FG002|Overall Study|Hyperglycemia|17|||
33703673|NCT01999218|63267899|FG000|Overall Study|Lack of Efficacy|1|||
33703674|NCT01999218|63267900|FG001|Overall Study|Lack of Efficacy|0|||
33703675|NCT01999218|63267901|FG002|Overall Study|Lack of Efficacy|1|||
33703676|NCT01999218|63267899|FG000|Overall Study|Lost to Follow-up|22|||
33703677|NCT01999218|63267900|FG001|Overall Study|Lost to Follow-up|17|||
33703678|NCT01999218|63267901|FG002|Overall Study|Lost to Follow-up|18|||
33703679|NCT01999218|63267899|FG000|Overall Study|Non-Compliance With Study Drug|6|||
33703680|NCT01999218|63267900|FG001|Overall Study|Non-Compliance With Study Drug|4|||
33703681|NCT01999218|63267901|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33703682|NCT01999218|63267899|FG000|Overall Study|Physician Decision|1|||
33703683|NCT01999218|63267900|FG001|Overall Study|Physician Decision|4|||
33703684|NCT01999218|63267901|FG002|Overall Study|Physician Decision|6|||
33703685|NCT01999218|63267899|FG000|Overall Study|Protocol Violation|4|||
33703686|NCT01999218|63267900|FG001|Overall Study|Protocol Violation|5|||
33703687|NCT01999218|63267901|FG002|Overall Study|Protocol Violation|4|||
33703688|NCT01999218|63267899|FG000|Overall Study|Screen failure|0|||
33703689|NCT01999218|63267900|FG001|Overall Study|Screen failure|1|||
33703690|NCT01999218|63267901|FG002|Overall Study|Screen failure|0|||
33703691|NCT01999218|63267899|FG000|Overall Study|Study Terminated By Sponsor|7|||
33703692|NCT01999218|63267900|FG001|Overall Study|Study Terminated By Sponsor|5|||
33703693|NCT01999218|63267901|FG002|Overall Study|Study Terminated By Sponsor|12|||
33703694|NCT01999218|63267899|FG000|Overall Study|Participant moves|2|||
33703695|NCT01999218|63267900|FG001|Overall Study|Participant moves|5|||
33703696|NCT01999218|63267901|FG002|Overall Study|Participant moves|3|||
33703697|NCT01999218|63267899|FG000|Overall Study|Withdrawal by Subject|28|||
33703698|NCT01999218|63267900|FG001|Overall Study|Withdrawal by Subject|29|||
33703699|NCT01999218|63267901|FG002|Overall Study|Withdrawal by Subject|34|||
33703700|NCT01999218|63267899|FG000|Overall Study|Creatinine/eGFR|0|||
33703701|NCT01999218|63267900|FG001|Overall Study|Creatinine/eGFR|0|||
33703702|NCT01999218|63267901|FG002|Overall Study|Creatinine/eGFR|1|||
33703703|NCT01999218|63267899|FG000|Overall Study|Death|7|||
33703704|NCT01999218|63267900|FG001|Overall Study|Death|1|||
33703705|NCT01999218|63267901|FG002|Overall Study|Death|2|||
33703706|NCT01999218|63267899|FG000|Overall Study|Excluded Medication|1|||
33703707|NCT01999218|63267900|FG001|Overall Study|Excluded Medication|1|||
33703708|NCT01999218|63267901|FG002|Overall Study|Excluded Medication|2|||
33703709|NCT01999218|63267899|FG000|Overall Study|Adverse Event|9|||
33703710|NCT01999218|63267900|FG001|Overall Study|Adverse Event|7|||
33703711|NCT01999218|63267901|FG002|Overall Study|Adverse Event|7|||
33703712|NCT01999218|63267899|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
33703713|NCT01999218|63267900|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
33703714|NCT01999218|63267901|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
33703715|NCT01937130|63267913|FG000|Overall Study|Withdrawal by Subject|0|||
33703716|NCT01937130|63267914|FG001|Overall Study|Withdrawal by Subject|0|||
33703717|NCT01937130|63267915|FG002|Overall Study|Withdrawal by Subject|0|||
33703718|NCT01937130|63267916|FG003|Overall Study|Withdrawal by Subject|1|||
33703719|NCT01937130|63267913|FG000|Overall Study|Adverse Event|0|||
33703720|NCT01937130|63267914|FG001|Overall Study|Adverse Event|1|||
33703721|NCT01937130|63267915|FG002|Overall Study|Adverse Event|0|||
33703722|NCT01937130|63267916|FG003|Overall Study|Adverse Event|1|||
33703723|NCT01937130|63267913|FG000|Overall Study|Death|1|||
33703724|NCT01937130|63267914|FG001|Overall Study|Death|1|||
33703725|NCT01937130|63267915|FG002|Overall Study|Death|1|||
33703726|NCT01937130|63267916|FG003|Overall Study|Death|0|||
33703727|NCT01937130|63267913|FG000|Overall Study|Lost to Follow-up|2|||
33703728|NCT01937130|63267914|FG001|Overall Study|Lost to Follow-up|0|||
33703729|NCT01937130|63267915|FG002|Overall Study|Lost to Follow-up|2|||
33703730|NCT01937130|63267916|FG003|Overall Study|Lost to Follow-up|0|||
33703731|NCT01937130|63267913|FG000|Overall Study|Physician Decision|0|||
33703732|NCT01937130|63267914|FG001|Overall Study|Physician Decision|1|||
33703733|NCT01937130|63267915|FG002|Overall Study|Physician Decision|0|||
33703734|NCT01937130|63267916|FG003|Overall Study|Physician Decision|0|||
33703735|NCT01937130|63267913|FG000|Overall Study|Patients unable to swallow|0|||
33703736|NCT01937130|63267914|FG001|Overall Study|Patients unable to swallow|1|||
33703737|NCT01937130|63267915|FG002|Overall Study|Patients unable to swallow|0|||
33703738|NCT01937130|63267916|FG003|Overall Study|Patients unable to swallow|0|||
33703739|NCT01937130|63267913|FG000|Overall Study|Patient lost to FU due to death|2|||
33703740|NCT01937130|63267914|FG001|Overall Study|Patient lost to FU due to death|0|||
33703741|NCT01937130|63267915|FG002|Overall Study|Patient lost to FU due to death|0|||
33703742|NCT01937130|63267916|FG003|Overall Study|Patient lost to FU due to death|0|||
33703743|NCT01936974|63267928|FG000|Overall Study|Physician Decision|2|||
33703744|NCT01936974|63267929|FG001|Overall Study|Physician Decision|5|||
33703745|NCT01959516|63267935|FG000|Epoch 1|Adverse Event|4|||
33703746|NCT01959516|63267936|FG001|Epoch 1|Adverse Event|1|||
33703747|NCT01959516|63267935|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
33703748|NCT01959516|63267936|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
33703749|NCT01959516|63267935|FG000|Epoch 1|Subject withdrew consent|3|||
33703750|NCT01959516|63267936|FG001|Epoch 1|Subject withdrew consent|2|||
33703751|NCT01959516|63267935|FG000|Epoch 1|Administrative problems|1|||
33703752|NCT01959516|63267936|FG001|Epoch 1|Administrative problems|0|||
33703753|NCT01959516|63267935|FG000|Epoch 1|Use of prohibited treatment|1|||
33703754|NCT01959516|63267936|FG001|Epoch 1|Use of prohibited treatment|0|||
33703755|NCT01959516|63267935|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
33703756|NCT01959516|63267936|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
33703757|NCT01959516|63267935|FG000|Epoch 1|Protocol deviation|0|||
33703758|NCT01959516|63267936|FG001|Epoch 1|Protocol deviation|1|||
33703759|NCT01959516|63267935|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
33703760|NCT01959516|63267936|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
33703761|NCT01959516|63267935|FG000|Epoch 2|Subject withdrew consent|1|||
33703762|NCT01959516|63267936|FG001|Epoch 2|Subject withdrew consent|0|||
33703763|NCT01959516|63267935|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
33703764|NCT01959516|63267936|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
33703765|NCT01979016|63267944|FG000|Overall Study|Withdrawal by Subject|2|||
33703766|NCT01979016|63267945|FG001|Overall Study|Withdrawal by Subject|0|||
33703767|NCT01979016|63267944|FG000|Overall Study|Adverse Event|0|||
33703768|NCT01979016|63267945|FG001|Overall Study|Adverse Event|1|||
33703769|NCT01935336|63267955|FG000|Overall Study|Adverse Event|1|||
33703770|NCT01935336|63267956|FG001|Overall Study|Adverse Event|0|||
33703771|NCT01935336|63267957|FG002|Overall Study|Adverse Event|0|||
33703772|NCT01935336|63267958|FG003|Overall Study|Adverse Event|0|||
33703773|NCT01935336|63267955|FG000|Overall Study|Progressive disease|5|||
33703774|NCT01935336|63267956|FG001|Overall Study|Progressive disease|3|||
33703775|NCT01935336|63267957|FG002|Overall Study|Progressive disease|47|||
33703776|NCT01935336|63267958|FG003|Overall Study|Progressive disease|66|||
33703777|NCT01978236|63267974|FG000|Overall Study|Discontinued due to study close|2|||
33703778|NCT01977846|63267980|FG000|Total Study - Prospective|Death|0|||
33703779|NCT01977846|63267981|FG001|Total Study - Prospective|Death|1|||
33703780|NCT01977846|63267980|FG000|Total Study - Prospective|Lost to Follow-up|0|||
33703781|NCT01977846|63267981|FG001|Total Study - Prospective|Lost to Follow-up|8|||
33703782|NCT01977846|63267980|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
33703783|NCT01977846|63267981|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
33703784|NCT01977846|63267980|FG000|Total Study - Prospective|Not available at time of visit|0|||
33703785|NCT01977846|63267981|FG001|Total Study - Prospective|Not available at time of visit|5|||
33703786|NCT01977846|63267980|FG000|Total Study - Prospective|No show|0|||
33703787|NCT01977846|63267981|FG001|Total Study - Prospective|No show|1|||
33703788|NCT01977846|63267980|FG000|Total Study - Prospective|Protocol Violation|0|||
33703789|NCT01977846|63267981|FG001|Total Study - Prospective|Protocol Violation|1|||
33703790|NCT01934790|63267988|FG000|Treatment|Adverse Event|3|||
33703791|NCT01934790|63267988|FG000|Treatment|Clinical progression|6|||
33703792|NCT01934790|63267988|FG000|Treatment|Radiological progression|4|||
33703793|NCT01934790|63267988|FG000|Treatment|Withdrawal by Subject|2|||
33703794|NCT01934790|63267988|FG000|Treatment|Study drug never administered|1|||
33703795|NCT01934790|63267988|FG000|Active Follow up|Death|20|||
33703796|NCT01934790|63267988|FG000|Active Follow up|Physician Decision|2|||
33703797|NCT01934790|63267988|FG000|Active Follow up|Progressive disease|1|||
33703798|NCT01934790|63267988|FG000|Active Follow up|Other reason|1|||
33703799|NCT01934556|63267995|FG000|Overall Study|Withdrawal by Subject|0|||
33703800|NCT01934556|63267996|FG001|Overall Study|Withdrawal by Subject|1|||
33703801|NCT01934556|63267997|FG002|Overall Study|Withdrawal by Subject|1|||
33703802|NCT01934556|63267995|FG000|Overall Study|Lost to Follow-up|4|||
33703803|NCT01934556|63267996|FG001|Overall Study|Lost to Follow-up|10|||
33703804|NCT01934556|63267997|FG002|Overall Study|Lost to Follow-up|7|||
33703805|NCT01934556|63267995|FG000|Overall Study|Death|1|||
33703806|NCT01934556|63267996|FG001|Overall Study|Death|5|||
33703807|NCT01934556|63267997|FG002|Overall Study|Death|2|||
33703808|NCT01977690|63268007|FG000|Overall Study|Withdrawal by Subject|0|||
33703809|NCT01977690|63268008|FG001|Overall Study|Withdrawal by Subject|4|||
33703810|NCT01934010|63268083|FG000|Overall Study|Adverse Event|1|||
33703811|NCT01934010|63268084|FG001|Overall Study|Adverse Event|1|||
33703812|NCT01934010|63268085|FG002|Overall Study|Adverse Event|0|||
33703813|NCT01934010|63268083|FG000|Overall Study|Withdrawal by Subject|15|||
33703814|NCT01934010|63268084|FG001|Overall Study|Withdrawal by Subject|6|||
33703815|NCT01934010|63268085|FG002|Overall Study|Withdrawal by Subject|2|||
33703816|NCT01934010|63268083|FG000|Overall Study|Lost to Follow-up|7|||
33703817|NCT01934010|63268084|FG001|Overall Study|Lost to Follow-up|4|||
33703818|NCT01934010|63268085|FG002|Overall Study|Lost to Follow-up|0|||
33703819|NCT01620138|63268104|FG000|Overall Study|Withdrawal by Subject|3|||
33703820|NCT01620138|63268105|FG001|Overall Study|Withdrawal by Subject|0|||
33703821|NCT01620138|63268104|FG000|Overall Study|Lack of Efficacy|1|||
33703822|NCT01620138|63268105|FG001|Overall Study|Lack of Efficacy|0|||
33703823|NCT01620138|63268104|FG000|Overall Study|Adverse Event|2|||
33703824|NCT01620138|63268105|FG001|Overall Study|Adverse Event|0|||
33703825|NCT01977612|63268113|FG000|Overall Study|Lost to Follow-up|1|||
33703826|NCT01977612|63268114|FG001|Overall Study|Lost to Follow-up|1|||
33703827|NCT01932996|63268122|FG000|Overall Study|Protocol Violation|2|||
33703828|NCT01932996|63268123|FG001|Overall Study|Protocol Violation|0|||
33703829|NCT01932762|63268133|FG000|Overall Study|Withdrawal by Subject|1|||
33703830|NCT01932762|63268134|FG001|Overall Study|Withdrawal by Subject|2|||
33703831|NCT01932762|63268135|FG002|Overall Study|Withdrawal by Subject|0|||
33703832|NCT01932762|63268136|FG003|Overall Study|Withdrawal by Subject|0|||
33703833|NCT01932762|63268133|FG000|Overall Study|Lost to Follow-up|4|||
33703834|NCT01932762|63268134|FG001|Overall Study|Lost to Follow-up|0|||
33703835|NCT01932762|63268135|FG002|Overall Study|Lost to Follow-up|0|||
33703836|NCT01932762|63268136|FG003|Overall Study|Lost to Follow-up|1|||
33703837|NCT01932762|63268133|FG000|Overall Study|Physician Decision|1|||
33703838|NCT01932762|63268134|FG001|Overall Study|Physician Decision|0|||
33703839|NCT01932762|63268135|FG002|Overall Study|Physician Decision|0|||
33703840|NCT01932762|63268136|FG003|Overall Study|Physician Decision|0|||
33703841|NCT01618968|63268150|FG000|Overall Study|Adverse Event|1|||
33703842|NCT01618968|63268151|FG001|Overall Study|Adverse Event|0|||
33703843|NCT01618968|63268152|FG002|Overall Study|Adverse Event|0|||
33703844|NCT01618968|63268153|FG003|Overall Study|Adverse Event|0|||
33703845|NCT01618968|63268150|FG000|Overall Study|Death|0|||
33703846|NCT01618968|63268151|FG001|Overall Study|Death|0|||
33703847|NCT01618968|63268152|FG002|Overall Study|Death|0|||
33703848|NCT01618968|63268153|FG003|Overall Study|Death|1|||
33703849|NCT01932294|63268162|FG000|Overall Study|Death|43|||
33703850|NCT01932294|63268162|FG000|Overall Study|Lost to Follow-up|8|||
33703851|NCT01932294|63268162|FG000|Overall Study|VAD Implantation|20|||
33703852|NCT01932294|63268162|FG000|Overall Study|Heart Transplantation|16|||
33703853|NCT01932294|63268162|FG000|Overall Study|Transferred to other hospitals|12|||
33703854|NCT01931670|63268170|FG000|Treatment Period|Exclusionary Medication Received|1|||
33703855|NCT01931670|63268171|FG001|Treatment Period|Exclusionary Medication Received|1|||
33703856|NCT01931670|63268172|FG002|Treatment Period|Exclusionary Medication Received|1|||
33703857|NCT01931670|63268170|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
33703858|NCT01931670|63268171|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
33703859|NCT01931670|63268172|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
33703860|NCT01931670|63268170|FG000|Treatment Period|Subject Noncompliant|4|||
33703861|NCT01931670|63268171|FG001|Treatment Period|Subject Noncompliant|9|||
33703862|NCT01931670|63268172|FG002|Treatment Period|Subject Noncompliant|5|||
33703863|NCT01931670|63268170|FG000|Treatment Period|Adverse Event|19|||
33703864|NCT01931670|63268171|FG001|Treatment Period|Adverse Event|8|||
33703865|NCT01931670|63268172|FG002|Treatment Period|Adverse Event|21|||
33703866|NCT01931670|63268170|FG000|Treatment Period|Lack of Efficacy|11|||
33703867|NCT01931670|63268171|FG001|Treatment Period|Lack of Efficacy|2|||
33703868|NCT01931670|63268172|FG002|Treatment Period|Lack of Efficacy|2|||
33703869|NCT01931670|63268170|FG000|Treatment Period|Pregnancy|7|||
33703870|NCT01931670|63268171|FG001|Treatment Period|Pregnancy|2|||
33703871|NCT01931670|63268172|FG002|Treatment Period|Pregnancy|0|||
33703872|NCT01931670|63268170|FG000|Treatment Period|Other|8|||
33703873|NCT01931670|63268171|FG001|Treatment Period|Other|7|||
33703874|NCT01931670|63268172|FG002|Treatment Period|Other|2|||
33703875|NCT01931670|63268170|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
33703876|NCT01931670|63268171|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
33703877|NCT01931670|63268172|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
33703878|NCT01931670|63268170|FG000|Treatment Period|Lost to Follow-up|19|||
33703879|NCT01931670|63268171|FG001|Treatment Period|Lost to Follow-up|5|||
33703880|NCT01931670|63268172|FG002|Treatment Period|Lost to Follow-up|7|||
33703881|NCT01931670|63268170|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
33703882|NCT01931670|63268171|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
33703883|NCT01931670|63268172|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
33703884|NCT01931670|63268170|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
33703885|NCT01931670|63268171|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
33703886|NCT01931670|63268172|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
33703887|NCT01931670|63268170|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
33703888|NCT01931670|63268171|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
33703889|NCT01931670|63268172|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
33703890|NCT01931670|63268170|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
33703891|NCT01931670|63268171|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
33703892|NCT01931670|63268172|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
33703893|NCT01931670|63268170|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
33703894|NCT01931670|63268171|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
33703895|NCT01931670|63268172|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
33703896|NCT01931670|63268170|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
33703897|NCT01931670|63268171|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
33703898|NCT01931670|63268172|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
33703899|NCT01977456|63268180|FG000|Overall Study|Death|5|||
33703900|NCT01957644|63268189|FG000|Overall Study|Adverse Event|4|||
33703901|NCT01957644|63268190|FG001|Overall Study|Adverse Event|2|||
33703902|NCT01957644|63268191|FG002|Overall Study|Adverse Event|0|||
33703903|NCT01957644|63268192|FG003|Overall Study|Adverse Event|0|||
33703904|NCT01957644|63268193|FG004|Overall Study|Adverse Event|1|||
33703905|NCT01957644|63268189|FG000|Overall Study|Progressive disease / relapse|0|||
33703906|NCT01957644|63268190|FG001|Overall Study|Progressive disease / relapse|1|||
33703907|NCT01957644|63268191|FG002|Overall Study|Progressive disease / relapse|0|||
33703908|NCT01957644|63268192|FG003|Overall Study|Progressive disease / relapse|1|||
33703909|NCT01957644|63268193|FG004|Overall Study|Progressive disease / relapse|0|||
33703910|NCT01957644|63268189|FG000|Overall Study|Other reason|1|||
33703911|NCT01957644|63268190|FG001|Overall Study|Other reason|2|||
33703912|NCT01957644|63268191|FG002|Overall Study|Other reason|1|||
33703913|NCT01957644|63268192|FG003|Overall Study|Other reason|1|||
33703914|NCT01957644|63268193|FG004|Overall Study|Other reason|0|||
33703915|NCT01957644|63268189|FG000|Overall Study|Withdrawal by Subject|1|||
33703916|NCT01957644|63268190|FG001|Overall Study|Withdrawal by Subject|0|||
33703917|NCT01957644|63268191|FG002|Overall Study|Withdrawal by Subject|0|||
33703918|NCT01957644|63268192|FG003|Overall Study|Withdrawal by Subject|0|||
33703919|NCT01957644|63268193|FG004|Overall Study|Withdrawal by Subject|0|||
33703920|NCT01957644|63268189|FG000|Overall Study|Protocol Violation|0|||
33703921|NCT01957644|63268190|FG001|Overall Study|Protocol Violation|1|||
33703922|NCT01957644|63268191|FG002|Overall Study|Protocol Violation|0|||
33703923|NCT01957644|63268192|FG003|Overall Study|Protocol Violation|0|||
33703924|NCT01957644|63268193|FG004|Overall Study|Protocol Violation|0|||
33703925|NCT01931202|63268210|FG000|Overall Study|Withdrawal by Subject|0|||
33703926|NCT01931202|63268211|FG001|Overall Study|Withdrawal by Subject|0|||
33703927|NCT01931202|63268212|FG002|Overall Study|Withdrawal by Subject|2|||
33703928|NCT01931202|63268210|FG000|Overall Study|Lost to Follow-up|0|||
33703929|NCT01931202|63268211|FG001|Overall Study|Lost to Follow-up|5|||
33703930|NCT01931202|63268212|FG002|Overall Study|Lost to Follow-up|2|||
33703931|NCT01930890|63268227|FG000|Overall Study|Study Termination|14|||
33703932|NCT01930890|63268228|FG001|Overall Study|Study Termination|28|||
33703933|NCT01930890|63268229|FG002|Overall Study|Study Termination|13|||
33703934|NCT01930890|63268230|FG003|Overall Study|Study Termination|25|||
33703935|NCT01930890|63268227|FG000|Overall Study|Death|0|||
33703936|NCT01930890|63268228|FG001|Overall Study|Death|0|||
33703937|NCT01930890|63268229|FG002|Overall Study|Death|0|||
33703938|NCT01930890|63268230|FG003|Overall Study|Death|1|||
33703939|NCT01930890|63268227|FG000|Overall Study|Investigator Decision|0|||
33703940|NCT01930890|63268228|FG001|Overall Study|Investigator Decision|1|||
33703941|NCT01930890|63268229|FG002|Overall Study|Investigator Decision|0|||
33703942|NCT01930890|63268230|FG003|Overall Study|Investigator Decision|0|||
33703943|NCT01930890|63268227|FG000|Overall Study|Consent Withdrawn|0|||
33703944|NCT01930890|63268228|FG001|Overall Study|Consent Withdrawn|3|||
33703945|NCT01930890|63268229|FG002|Overall Study|Consent Withdrawn|0|||
33703946|NCT01930890|63268230|FG003|Overall Study|Consent Withdrawn|1|||
33703947|NCT01930890|63268227|FG000|Overall Study|Adverse Event|0|||
33703948|NCT01930890|63268228|FG001|Overall Study|Adverse Event|1|||
33703949|NCT01930890|63268229|FG002|Overall Study|Adverse Event|0|||
33703950|NCT01930890|63268230|FG003|Overall Study|Adverse Event|0|||
33703951|NCT01930188|63268243|FG000|Overall Study|unclassified|4|||
33703952|NCT01930188|63268244|FG001|Overall Study|unclassified|5|||
33703953|NCT01930188|63268245|FG002|Overall Study|unclassified|3|||
33703954|NCT01930188|63268243|FG000|Overall Study|Missing follow-up information|2|||
33703955|NCT01930188|63268244|FG001|Overall Study|Missing follow-up information|2|||
33703956|NCT01930188|63268245|FG002|Overall Study|Missing follow-up information|3|||
33703957|NCT01930188|63268243|FG000|Overall Study|Lost to Follow-up|5|||
33703958|NCT01930188|63268244|FG001|Overall Study|Lost to Follow-up|2|||
33703959|NCT01930188|63268245|FG002|Overall Study|Lost to Follow-up|2|||
33703960|NCT01930188|63268243|FG000|Overall Study|Death|2|||
33703961|NCT01930188|63268244|FG001|Overall Study|Death|1|||
33703962|NCT01930188|63268245|FG002|Overall Study|Death|3|||
33703963|NCT01930188|63268243|FG000|Overall Study|Withdrawal by Subject|9|||
33703964|NCT01930188|63268244|FG001|Overall Study|Withdrawal by Subject|11|||
33703965|NCT01930188|63268245|FG002|Overall Study|Withdrawal by Subject|8|||
33703966|NCT01977222|63268254|FG000|Overall Study|Withdrawal by Subject|1|||
33703967|NCT01957488|63268258|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
33703968|NCT01957488|63268259|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
33703969|NCT01957488|63268260|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
33703970|NCT01957488|63268261|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
33703971|NCT01957488|63268262|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
33703972|NCT01957488|63268263|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
33703973|NCT01957488|63268258|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
33703974|NCT01957488|63268259|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
33703975|NCT01957488|63268260|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
33703976|NCT01957488|63268261|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
33703977|NCT01957488|63268262|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
33703978|NCT01957488|63268263|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
33703979|NCT01957488|63268258|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
33703980|NCT01957488|63268259|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
33703981|NCT01957488|63268260|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
33703982|NCT01957488|63268261|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
33703983|NCT01957488|63268262|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
33703984|NCT01957488|63268263|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
33703985|NCT01957488|63268258|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
33493257|NCT03103152|62871479|FG001|Overall Study|Withdrawal by Subject|0|||
33703986|NCT01957488|63268259|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
33703987|NCT01957488|63268260|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
33703988|NCT01957488|63268261|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
33703989|NCT01957488|63268262|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
33703990|NCT01957488|63268263|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
33703991|NCT01957488|63268258|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
33703992|NCT01957488|63268259|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
33703993|NCT01957488|63268260|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
33703994|NCT01957488|63268261|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
33703995|NCT01957488|63268262|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
33703996|NCT01957488|63268263|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
33703997|NCT01957488|63268258|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
33703998|NCT01957488|63268259|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
33703999|NCT01957488|63268260|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
33704000|NCT01957488|63268261|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
33704001|NCT01957488|63268262|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
33704002|NCT01957488|63268263|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
33704003|NCT01957488|63268258|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
33704004|NCT01957488|63268259|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
33704005|NCT01957488|63268260|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
33704006|NCT01957488|63268261|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
33704007|NCT01957488|63268262|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
33704008|NCT01957488|63268263|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
33704009|NCT01957488|63268258|FG000|Test Period 2 (2 Weeks)|Other|1|||
33704010|NCT01957488|63268259|FG001|Test Period 2 (2 Weeks)|Other|0|||
33704011|NCT01957488|63268260|FG002|Test Period 2 (2 Weeks)|Other|0|||
33704012|NCT01957488|63268261|FG003|Test Period 2 (2 Weeks)|Other|0|||
33704013|NCT01957488|63268262|FG004|Test Period 2 (2 Weeks)|Other|0|||
33704014|NCT01957488|63268263|FG005|Test Period 2 (2 Weeks)|Other|0|||
33704015|NCT01957488|63268258|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
33704016|NCT01957488|63268259|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
33704017|NCT01957488|63268260|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
33704018|NCT01957488|63268261|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
33704019|NCT01957488|63268262|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
33704020|NCT01957488|63268263|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
33704021|NCT01957488|63268258|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
33704022|NCT01957488|63268259|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
33704023|NCT01957488|63268260|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
33704024|NCT01957488|63268261|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
33704025|NCT01957488|63268262|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
33704026|NCT01957488|63268263|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
33704027|NCT01957488|63268258|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
33704028|NCT01957488|63268259|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
33704029|NCT01957488|63268260|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
33704030|NCT01957488|63268261|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
33704031|NCT01957488|63268262|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
33704032|NCT01957488|63268263|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
33704033|NCT01957488|63268258|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
33704034|NCT01957488|63268259|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
33704035|NCT01957488|63268260|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
33704036|NCT01957488|63268261|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
33704037|NCT01957488|63268262|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
33704038|NCT01957488|63268263|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
33704039|NCT01957488|63268258|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
33704040|NCT01957488|63268259|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
33704041|NCT01957488|63268260|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
33704042|NCT01957488|63268261|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
33704043|NCT01957488|63268262|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
33704044|NCT01957488|63268263|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
33704045|NCT01976364|63268271|FG000|Main Study (36 Months)|Adverse Event|63|||
33704046|NCT01976364|63268272|FG001|Main Study (36 Months)|Adverse Event|0|||
33704047|NCT01976364|63268273|FG002|Main Study (36 Months)|Adverse Event|0|||
33704048|NCT01976364|63268271|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
33704049|NCT01976364|63268272|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
33704050|NCT01976364|63268273|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
33704051|NCT01976364|63268271|FG000|Main Study (36 Months)|Other|13|||
33704052|NCT01976364|63268272|FG001|Main Study (36 Months)|Other|0|||
33704053|NCT01976364|63268273|FG002|Main Study (36 Months)|Other|0|||
33704054|NCT01976364|63268271|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
33704055|NCT01976364|63268272|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
33704056|NCT01976364|63268273|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
33704057|NCT01976364|63268271|FG000|Main Study (36 Months)|Medication error|1|||
33704058|NCT01976364|63268272|FG001|Main Study (36 Months)|Medication error|0|||
33704059|NCT01976364|63268273|FG002|Main Study (36 Months)|Medication error|0|||
33704060|NCT01976364|63268271|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
33704061|NCT01976364|63268272|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
33704062|NCT01976364|63268273|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
33493258|NCT03103152|62871480|FG002|Overall Study|Withdrawal by Subject|1|||
33704063|NCT01976364|63268271|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
33704064|NCT01976364|63268272|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
33704065|NCT01976364|63268273|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
33704066|NCT01976364|63268271|FG000|Main Study (36 Months)|Protocol Violation|13|||
33704067|NCT01976364|63268272|FG001|Main Study (36 Months)|Protocol Violation|0|||
33704068|NCT01976364|63268273|FG002|Main Study (36 Months)|Protocol Violation|0|||
33704069|NCT01976364|63268271|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
33704070|NCT01976364|63268272|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
33704071|NCT01976364|63268273|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
33704072|NCT01976364|63268271|FG000|Main Study (36 Months)|Death|5|||
33704073|NCT01976364|63268272|FG001|Main Study (36 Months)|Death|0|||
33704074|NCT01976364|63268273|FG002|Main Study (36 Months)|Death|0|||
33704075|NCT01976364|63268271|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
33704076|NCT01976364|63268272|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
33704077|NCT01976364|63268273|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
33704078|NCT01976364|63268271|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
33704079|NCT01976364|63268272|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
33704080|NCT01976364|63268273|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
33704081|NCT01976364|63268271|FG000|Sub-study (12 Months)|Protocol Violation|0|||
33704082|NCT01976364|63268272|FG001|Sub-study (12 Months)|Protocol Violation|1|||
33704083|NCT01976364|63268273|FG002|Sub-study (12 Months)|Protocol Violation|1|||
33704084|NCT01976364|63268271|FG000|Sub-study (12 Months)|Adverse Event|0|||
33704085|NCT01976364|63268272|FG001|Sub-study (12 Months)|Adverse Event|4|||
33704086|NCT01976364|63268273|FG002|Sub-study (12 Months)|Adverse Event|3|||
33704087|NCT01956240|63268284|FG000|Overall Study|Lost to Follow-up|6|||
33704088|NCT01956240|63268285|FG001|Overall Study|Lost to Follow-up|20|||
33704089|NCT01956240|63268284|FG000|Overall Study|Adverse Event|17|||
33704090|NCT01956240|63268285|FG001|Overall Study|Adverse Event|4|||
33704091|NCT01929876|63268291|FG000|Period 2|Non-Compliance|1|||
33704092|NCT01929408|63268295|FG000|Overall Study|received HCT as initial treatment|8|||
33704093|NCT01929018|63268301|FG000|Overall Study|Lost to Follow-up|1|||
33704094|NCT01929018|63268302|FG001|Overall Study|Lost to Follow-up|0|||
33704095|NCT01929018|63268301|FG000|Overall Study|Hospitalization|0|||
33704096|NCT01929018|63268302|FG001|Overall Study|Hospitalization|1|||
33704097|NCT01928940|63268310|FG000|Overall Study|Adverse Event|0|||
33704098|NCT01928940|63268311|FG001|Overall Study|Adverse Event|1|||
33704099|NCT01928862|63268323|FG000|Overall Study|Lost to Follow-up|1|||
33704100|NCT01928862|63268324|FG001|Overall Study|Lost to Follow-up|0|||
33704101|NCT01928862|63268325|FG002|Overall Study|Lost to Follow-up|0|||
33704102|NCT01928862|63268326|FG003|Overall Study|Lost to Follow-up|0|||
33704103|NCT01928862|63268327|FG004|Overall Study|Lost to Follow-up|1|||
33704104|NCT01954056|63268342|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
33704105|NCT01954056|63268343|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
33704106|NCT01953354|63268351|FG000|Overall Study|Withdrawal by Subject|0|||
33704107|NCT01953354|63268352|FG001|Overall Study|Withdrawal by Subject|1|||
33704108|NCT01953354|63268351|FG000|Overall Study|Decision of Sponsor|0|||
33704109|NCT01953354|63268352|FG001|Overall Study|Decision of Sponsor|1|||
33704110|NCT01953354|63268351|FG000|Overall Study|Disease Exacerbation|1|||
33704111|NCT01953354|63268352|FG001|Overall Study|Disease Exacerbation|0|||
33704112|NCT01975272|63268361|FG000|Overall Study|Excluded after protocol amendment|1|||
33704113|NCT01975272|63268362|FG001|Overall Study|Excluded after protocol amendment|1|||
33704114|NCT01975272|63268363|FG002|Overall Study|Excluded after protocol amendment|2|||
33704115|NCT01951638|63268376|FG000|Treatment Period|Protocol Violation|0|||
33704116|NCT01951638|63268377|FG001|Treatment Period|Protocol Violation|0|||
33704117|NCT01951638|63268378|FG002|Treatment Period|Protocol Violation|0|||
33704118|NCT01951638|63268379|FG003|Treatment Period|Protocol Violation|2|||
33704119|NCT01951638|63268380|FG004|Treatment Period|Protocol Violation|0|||
33704120|NCT01951638|63268376|FG000|Treatment Period|Protocol-driven decision point|1|||
33704121|NCT01951638|63268377|FG001|Treatment Period|Protocol-driven decision point|3|||
33704122|NCT01951638|63268378|FG002|Treatment Period|Protocol-driven decision point|0|||
33704123|NCT01951638|63268379|FG003|Treatment Period|Protocol-driven decision point|0|||
33704124|NCT01951638|63268380|FG004|Treatment Period|Protocol-driven decision point|0|||
33704125|NCT01951638|63268376|FG000|Treatment Period|Logistical difficulties|0|||
33704126|NCT01951638|63268377|FG001|Treatment Period|Logistical difficulties|1|||
33704127|NCT01951638|63268378|FG002|Treatment Period|Logistical difficulties|1|||
33704128|NCT01951638|63268379|FG003|Treatment Period|Logistical difficulties|0|||
33704129|NCT01951638|63268380|FG004|Treatment Period|Logistical difficulties|0|||
33704130|NCT01951638|63268376|FG000|Treatment Period|Withdrawal by Subject|9|||
33704131|NCT01951638|63268377|FG001|Treatment Period|Withdrawal by Subject|6|||
33704132|NCT01951638|63268378|FG002|Treatment Period|Withdrawal by Subject|4|||
33704133|NCT01951638|63268379|FG003|Treatment Period|Withdrawal by Subject|5|||
33704134|NCT01951638|63268380|FG004|Treatment Period|Withdrawal by Subject|4|||
33704135|NCT01951638|63268376|FG000|Treatment Period|Death|0|||
33704136|NCT01951638|63268377|FG001|Treatment Period|Death|0|||
33704137|NCT01951638|63268378|FG002|Treatment Period|Death|0|||
33704138|NCT01951638|63268379|FG003|Treatment Period|Death|3|||
33704139|NCT01951638|63268380|FG004|Treatment Period|Death|1|||
33704140|NCT01951638|63268376|FG000|Treatment Period|Adverse Event|3|||
33704141|NCT01951638|63268377|FG001|Treatment Period|Adverse Event|4|||
33704142|NCT01951638|63268378|FG002|Treatment Period|Adverse Event|8|||
33704143|NCT01951638|63268379|FG003|Treatment Period|Adverse Event|6|||
33704144|NCT01951638|63268380|FG004|Treatment Period|Adverse Event|5|||
33704145|NCT01951638|63268376|FG000|Follow-up Period|Protocol Violation|0|||
33704146|NCT01951638|63268377|FG001|Follow-up Period|Protocol Violation|0|||
33704147|NCT01951638|63268378|FG002|Follow-up Period|Protocol Violation|0|||
33704148|NCT01951638|63268379|FG003|Follow-up Period|Protocol Violation|1|||
33704149|NCT01951638|63268380|FG004|Follow-up Period|Protocol Violation|0|||
33704150|NCT01951638|63268376|FG000|Follow-up Period|Logistical difficulties|0|||
33704151|NCT01951638|63268377|FG001|Follow-up Period|Logistical difficulties|2|||
33704152|NCT01951638|63268378|FG002|Follow-up Period|Logistical difficulties|0|||
33704153|NCT01951638|63268379|FG003|Follow-up Period|Logistical difficulties|0|||
33704154|NCT01951638|63268380|FG004|Follow-up Period|Logistical difficulties|1|||
33704155|NCT01951638|63268376|FG000|Follow-up Period|Withdrawal by Subject|1|||
33704156|NCT01951638|63268377|FG001|Follow-up Period|Withdrawal by Subject|5|||
33704157|NCT01951638|63268378|FG002|Follow-up Period|Withdrawal by Subject|2|||
33704158|NCT01951638|63268379|FG003|Follow-up Period|Withdrawal by Subject|1|||
33704159|NCT01951638|63268380|FG004|Follow-up Period|Withdrawal by Subject|2|||
33704160|NCT01951638|63268376|FG000|Follow-up Period|Lost to Follow-up|0|||
33704161|NCT01951638|63268377|FG001|Follow-up Period|Lost to Follow-up|1|||
33704162|NCT01951638|63268378|FG002|Follow-up Period|Lost to Follow-up|0|||
33704163|NCT01951638|63268379|FG003|Follow-up Period|Lost to Follow-up|1|||
33704164|NCT01951638|63268380|FG004|Follow-up Period|Lost to Follow-up|0|||
33704165|NCT01951638|63268376|FG000|Follow-up Period|Death|1|||
33704166|NCT01951638|63268377|FG001|Follow-up Period|Death|0|||
33704167|NCT01951638|63268378|FG002|Follow-up Period|Death|1|||
33704168|NCT01951638|63268379|FG003|Follow-up Period|Death|4|||
33704169|NCT01951638|63268380|FG004|Follow-up Period|Death|1|||
33704170|NCT01951638|63268376|FG000|Follow-up Period|Adverse Event|0|||
33704171|NCT01951638|63268377|FG001|Follow-up Period|Adverse Event|1|||
33704172|NCT01951638|63268378|FG002|Follow-up Period|Adverse Event|2|||
33704173|NCT01951638|63268379|FG003|Follow-up Period|Adverse Event|1|||
33704174|NCT01951638|63268380|FG004|Follow-up Period|Adverse Event|1|||
33704175|NCT01928472|63268396|FG000|Overall Study|Death|0|||
33704176|NCT01928472|63268397|FG001|Overall Study|Death|0|||
33704177|NCT01928472|63268398|FG002|Overall Study|Death|1|||
33704178|NCT01928472|63268399|FG003|Overall Study|Death|0|||
33704179|NCT01928472|63268396|FG000|Overall Study|Withdrawal by Subject|4|||
33704180|NCT01928472|63268397|FG001|Overall Study|Withdrawal by Subject|4|||
33704181|NCT01928472|63268398|FG002|Overall Study|Withdrawal by Subject|1|||
33704182|NCT01928472|63268399|FG003|Overall Study|Withdrawal by Subject|2|||
33704183|NCT01928472|63268396|FG000|Overall Study|Lost to Follow-up|2|||
33704184|NCT01928472|63268397|FG001|Overall Study|Lost to Follow-up|3|||
33704185|NCT01928472|63268398|FG002|Overall Study|Lost to Follow-up|4|||
33704186|NCT01928472|63268399|FG003|Overall Study|Lost to Follow-up|0|||
33704187|NCT01928472|63268396|FG000|Overall Study|Administrative Reason|2|||
33704188|NCT01928472|63268397|FG001|Overall Study|Administrative Reason|1|||
33704189|NCT01928472|63268398|FG002|Overall Study|Administrative Reason|0|||
33704190|NCT01928472|63268399|FG003|Overall Study|Administrative Reason|0|||
33704191|NCT01928472|63268396|FG000|Overall Study|Unclassified|0|||
33704192|NCT01928472|63268397|FG001|Overall Study|Unclassified|0|||
33704193|NCT01928472|63268398|FG002|Overall Study|Unclassified|1|||
33704194|NCT01928472|63268399|FG003|Overall Study|Unclassified|0|||
33704195|NCT01351415|63270260|FG000|Overall Study|Withdrawal by Subject|15|||
33704196|NCT01351415|63270261|FG001|Overall Study|Withdrawal by Subject|17|||
33704197|NCT01351415|63270260|FG000|Overall Study|Trial termination by the Sponsor|28|||
33704198|NCT01351415|63270261|FG001|Overall Study|Trial termination by the Sponsor|19|||
33704199|NCT01351415|63270260|FG000|Overall Study|Lost to Follow-up|5|||
33704200|NCT01351415|63270261|FG001|Overall Study|Lost to Follow-up|7|||
33704201|NCT01351415|63270260|FG000|Overall Study|Death|190|||
33704202|NCT01351415|63270261|FG001|Overall Study|Death|187|||
33704203|NCT01351415|63270260|FG000|Overall Study|Physician Decision|2|||
33704204|NCT01351415|63270261|FG001|Overall Study|Physician Decision|3|||
33704205|NCT01351415|63270260|FG000|Overall Study|Reason unknown|0|||
33704206|NCT01351415|63270261|FG001|Overall Study|Reason unknown|2|||
33704207|NCT01351415|63270260|FG000|Overall Study|Never Started|5|||
33704208|NCT01351415|63270261|FG001|Overall Study|Never Started|5|||
33704209|NCT04811339|63270369|FG000|Overall Study|lack of transportation not wanting to return|4|||
33704210|NCT04811339|63270370|FG001|Overall Study|lack of transportation not wanting to return|8|||
33704211|NCT04811339|63270371|FG002|Overall Study|lack of transportation not wanting to return|0|||
33704212|NCT04811339|63270369|FG000|Overall Study|Adverse Event|3|||
33704213|NCT04811339|63270370|FG001|Overall Study|Adverse Event|0|||
33704214|NCT04811339|63270371|FG002|Overall Study|Adverse Event|0|||
33704215|NCT04811339|63270369|FG000|Overall Study|Lost to Follow-up|1|||
33704216|NCT04811339|63270370|FG001|Overall Study|Lost to Follow-up|0|||
33704217|NCT04811339|63270371|FG002|Overall Study|Lost to Follow-up|0|||
33704218|NCT04811339|63270369|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
33704219|NCT04811339|63270370|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
33704220|NCT04811339|63270371|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
33704221|NCT04811339|63270369|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
33704222|NCT04811339|63270370|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
33704223|NCT04811339|63270371|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
33704224|NCT04811339|63270369|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
33704225|NCT04811339|63270370|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
33704226|NCT04811339|63270371|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
33704227|NCT04811339|63270369|FG000|Overall Study|Withdrawal by Subject|0|||
33704228|NCT04811339|63270370|FG001|Overall Study|Withdrawal by Subject|3|||
33704229|NCT04811339|63270371|FG002|Overall Study|Withdrawal by Subject|0|||
33704230|NCT04811339|63270369|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
33704231|NCT04811339|63270370|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
33704232|NCT04811339|63270371|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
33704233|NCT04811339|63270369|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
33704234|NCT04811339|63270370|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
33704235|NCT04811339|63270371|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
33704236|NCT04652453|63270384|FG000|Overall Study|Death|8|||
33704237|NCT04652453|63270385|FG001|Overall Study|Death|2|||
33704238|NCT04652453|63270386|FG002|Overall Study|Death|0|||
33704239|NCT04652453|63270384|FG000|Overall Study|Hospice|5|||
33704240|NCT04652453|63270385|FG001|Overall Study|Hospice|5|||
33704241|NCT04652453|63270386|FG002|Overall Study|Hospice|0|||
33704242|NCT04652453|63270384|FG000|Overall Study|Withdrawal by Subject|2|||
33704243|NCT04652453|63270385|FG001|Overall Study|Withdrawal by Subject|0|||
33704244|NCT04652453|63270386|FG002|Overall Study|Withdrawal by Subject|0|||
33704245|NCT04332107|63270394|FG000|Day 3|Lost to Follow-up|23|||
33704246|NCT04332107|63270395|FG001|Day 3|Lost to Follow-up|14|||
33704247|NCT04332107|63270394|FG000|Day 3|Missing outcome data|3|||
33704248|NCT04332107|63270395|FG001|Day 3|Missing outcome data|6|||
33704249|NCT04332107|63270394|FG000|Day 14|Lost to Follow-up|13|||
33704250|NCT04332107|63270395|FG001|Day 14|Lost to Follow-up|4|||
33704251|NCT04332107|63270394|FG000|Day 14|Missing outcome data|4|||
33704252|NCT04332107|63270395|FG001|Day 14|Missing outcome data|4|||
33704253|NCT04332107|63270394|FG000|Day 21|Lost to Follow-up|10|||
33704254|NCT04332107|63270395|FG001|Day 21|Lost to Follow-up|2|||
33704255|NCT03375203|63270410|FG000|Overall Study|Protocol Violation|0|||
33704256|NCT03375203|63270411|FG001|Overall Study|Protocol Violation|0|||
33704257|NCT03375203|63270412|FG002|Overall Study|Protocol Violation|1|||
33704258|NCT03375203|63270413|FG003|Overall Study|Protocol Violation|0|||
33704259|NCT03375203|63270414|FG004|Overall Study|Protocol Violation|0|||
33704260|NCT03375203|63270410|FG000|Overall Study|Adverse Event|2|||
33704261|NCT03375203|63270411|FG001|Overall Study|Adverse Event|3|||
33704262|NCT03375203|63270412|FG002|Overall Study|Adverse Event|0|||
33704263|NCT03375203|63270413|FG003|Overall Study|Adverse Event|2|||
33704264|NCT03375203|63270414|FG004|Overall Study|Adverse Event|2|||
33704265|NCT03375203|63270410|FG000|Overall Study|Withdrawal by Subject|3|||
33704266|NCT03375203|63270411|FG001|Overall Study|Withdrawal by Subject|0|||
33704267|NCT03375203|63270412|FG002|Overall Study|Withdrawal by Subject|1|||
33704268|NCT03375203|63270413|FG003|Overall Study|Withdrawal by Subject|0|||
33704269|NCT03375203|63270414|FG004|Overall Study|Withdrawal by Subject|2|||
33704270|NCT03375203|63270410|FG000|Overall Study|Non-compliance with study drug|1|||
33704271|NCT03375203|63270411|FG001|Overall Study|Non-compliance with study drug|0|||
33704272|NCT03375203|63270412|FG002|Overall Study|Non-compliance with study drug|0|||
33704273|NCT03375203|63270413|FG003|Overall Study|Non-compliance with study drug|0|||
33704274|NCT03375203|63270414|FG004|Overall Study|Non-compliance with study drug|0|||
33704275|NCT03375203|63270410|FG000|Overall Study|Randomized, not treated.|0|||
33704276|NCT03375203|63270411|FG001|Overall Study|Randomized, not treated.|1|||
33704277|NCT03375203|63270412|FG002|Overall Study|Randomized, not treated.|0|||
33704278|NCT03375203|63270413|FG003|Overall Study|Randomized, not treated.|0|||
33704279|NCT03375203|63270414|FG004|Overall Study|Randomized, not treated.|0|||
33704280|NCT03075839|63270436|FG000|Overall Study|Lost to Follow-up|4|||
33704281|NCT02919683|63270442|FG000|Post-Surgery Follow-Up|Death|2|||
33704282|NCT02919683|63270443|FG001|Post-Surgery Follow-Up|Death|2|||
33704283|NCT02919683|63270442|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
33704284|NCT02919683|63270443|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
33704285|NCT01928082|63270450|FG000|Overall Study|Study terminated.|1|||
33704286|NCT01972776|63270460|FG000|Part 1|Withdrawal by Subject|0|||
33493259|NCT03103152|62871481|FG003|Overall Study|Withdrawal by Subject|1|||
33704287|NCT01972776|63270461|FG001|Part 1|Withdrawal by Subject|0|||
33704288|NCT01972776|63270462|FG002|Part 1|Withdrawal by Subject|1|||
33704289|NCT01972776|63270463|FG003|Part 1|Withdrawal by Subject|0|||
33704290|NCT01972776|63270464|FG004|Part 1|Withdrawal by Subject|0|||
33704291|NCT01972776|63270465|FG005|Part 1|Withdrawal by Subject|0|||
33704292|NCT01972776|63270460|FG000|Part 1|Adverse Event|0|||
33704293|NCT01972776|63270461|FG001|Part 1|Adverse Event|0|||
33704294|NCT01972776|63270462|FG002|Part 1|Adverse Event|1|||
33704295|NCT01972776|63270463|FG003|Part 1|Adverse Event|1|||
33704296|NCT01972776|63270464|FG004|Part 1|Adverse Event|0|||
33704297|NCT01972776|63270465|FG005|Part 1|Adverse Event|0|||
33704298|NCT01972776|63270460|FG000|Part 2|Adverse Event|0|||
33704299|NCT01972776|63270461|FG001|Part 2|Adverse Event|0|||
33704300|NCT01972776|63270462|FG002|Part 2|Adverse Event|0|||
33704301|NCT01972776|63270463|FG003|Part 2|Adverse Event|0|||
33704302|NCT01972776|63270464|FG004|Part 2|Adverse Event|3|||
33704303|NCT01972776|63270465|FG005|Part 2|Adverse Event|0|||
33704304|NCT01972776|63270460|FG000|Part 2|Administrative problems|0|||
33704305|NCT01972776|63270461|FG001|Part 2|Administrative problems|0|||
33704306|NCT01972776|63270462|FG002|Part 2|Administrative problems|0|||
33704307|NCT01972776|63270463|FG003|Part 2|Administrative problems|0|||
33704308|NCT01972776|63270464|FG004|Part 2|Administrative problems|10|||
33704309|NCT01972776|63270465|FG005|Part 2|Administrative problems|7|||
33704310|NCT03763331|63270481|FG000|Overall Study|Lost to Follow-up|1|||
33704311|NCT03763331|63270482|FG001|Overall Study|Lost to Follow-up|0|||
33704312|NCT03763331|63270481|FG000|Overall Study|Withdrawal by Subject|1|||
33704313|NCT03763331|63270482|FG001|Overall Study|Withdrawal by Subject|0|||
33704314|NCT03763331|63270481|FG000|Overall Study|Non-compliance|0|||
33704315|NCT03763331|63270482|FG001|Overall Study|Non-compliance|3|||
33704316|NCT00001259|63270509|FG000|Study 2|Adverse Event|0|||
33704317|NCT00001259|63270510|FG001|Study 2|Adverse Event|0|||
33704318|NCT00001259|63270511|FG002|Study 2|Adverse Event|0|||
33704319|NCT00001259|63270512|FG003|Study 2|Adverse Event|0|||
33704320|NCT00001259|63270513|FG004|Study 2|Adverse Event|2|||
33704321|NCT00001259|63270514|FG005|Study 2|Adverse Event|0|||
33704322|NCT00001259|63270515|FG006|Study 2|Adverse Event|0|||
33704323|NCT01926444|63270529|FG000|Overall Study|Colonoscopy not performed|0|||
33704324|NCT01926444|63270530|FG001|Overall Study|Colonoscopy not performed|0|||
33704325|NCT01926444|63270531|FG002|Overall Study|Colonoscopy not performed|4|||
33704326|NCT01926444|63270532|FG003|Overall Study|Colonoscopy not performed|2|||
33704327|NCT05003167|63270542|FG000|Overall Study|Withdrawal by Subject|1|||
33704328|NCT04988035|63270548|FG000|Overall Study|Death|19|||
33704329|NCT04988035|63270549|FG001|Overall Study|Death|13|||
33704330|NCT04988035|63270548|FG000|Overall Study|Lost to Follow-up|12|||
33704331|NCT04988035|63270549|FG001|Overall Study|Lost to Follow-up|6|||
33704332|NCT04988035|63270548|FG000|Overall Study|Protocol Violation|0|||
33704333|NCT04988035|63270549|FG001|Overall Study|Protocol Violation|1|||
33704334|NCT04988035|63270548|FG000|Overall Study|Withdrawal by Subject|2|||
33704335|NCT04988035|63270549|FG001|Overall Study|Withdrawal by Subject|4|||
33704336|NCT04988035|63270548|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
33704337|NCT04988035|63270549|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
33704338|NCT04847674|63270567|FG000|Overall Study|Withdrawal by Subject|0|||
33704339|NCT04847674|63270568|FG001|Overall Study|Withdrawal by Subject|1|||
33704340|NCT04847674|63270569|FG002|Overall Study|Withdrawal by Subject|0|||
33704341|NCT04847674|63270567|FG000|Overall Study|Lost to Follow-up|0|||
33704342|NCT04847674|63270568|FG001|Overall Study|Lost to Follow-up|0|||
33704343|NCT04847674|63270569|FG002|Overall Study|Lost to Follow-up|2|||
33704344|NCT04847674|63270567|FG000|Overall Study|Other than specified|21|||
33704345|NCT04847674|63270568|FG001|Overall Study|Other than specified|20|||
33704346|NCT04847674|63270569|FG002|Overall Study|Other than specified|20|||
33704347|NCT04649060|63270581|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
33704348|NCT04649060|63270582|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
33704349|NCT04649060|63270581|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
33704350|NCT04649060|63270582|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
33704351|NCT04649060|63270581|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
33704352|NCT04649060|63270582|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
33704353|NCT04649060|63270581|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
33704354|NCT04649060|63270582|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
33704355|NCT04649060|63270581|FG000|Arm A/Arm B Treatment|Patient Request|1|||
33704356|NCT04649060|63270582|FG001|Arm A/Arm B Treatment|Patient Request|0|||
33704357|NCT04649060|63270581|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
33704358|NCT04649060|63270582|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
33704359|NCT04649060|63270581|FG000|Arm A/Arm B Treatment|Other|1|||
33704360|NCT04649060|63270582|FG001|Arm A/Arm B Treatment|Other|0|||
33704361|NCT04649060|63270581|FG000|Crossover (Arm B)|Adverse Event|0|||
33704362|NCT04649060|63270582|FG001|Crossover (Arm B)|Adverse Event|1|||
33704363|NCT04649060|63270581|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
33704364|NCT04649060|63270582|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
33704365|NCT04640272|63270589|FG000|Overall Study|Subject moved out of area|1|||
33704366|NCT04511650|63270596|FG000|Overall Study|Lost to Follow-up|1|||
33704367|NCT04511650|63270597|FG001|Overall Study|Lost to Follow-up|0|||
33704368|NCT04511650|63270598|FG002|Overall Study|Lost to Follow-up|0|||
33704369|NCT04511650|63270596|FG000|Overall Study|Withdrawal by Subject|1|||
33704370|NCT04511650|63270597|FG001|Overall Study|Withdrawal by Subject|0|||
33704371|NCT04511650|63270598|FG002|Overall Study|Withdrawal by Subject|0|||
33704372|NCT04511650|63270596|FG000|Overall Study|reason not provided|0|||
33704373|NCT04511650|63270597|FG001|Overall Study|reason not provided|0|||
33704374|NCT04511650|63270598|FG002|Overall Study|reason not provided|1|||
33704375|NCT04511650|63270596|FG000|Overall Study|Death|1|||
33704376|NCT04511650|63270597|FG001|Overall Study|Death|1|||
33704377|NCT04511650|63270598|FG002|Overall Study|Death|1|||
33704378|NCT04285580|63270630|FG000|Overall Study|Protocol Violation|0|||
33704379|NCT04285580|63270631|FG001|Overall Study|Protocol Violation|1|||
33704380|NCT04200248|63270649|FG000|Overall Study|Personal reasons|0|||
33704381|NCT04200248|63270650|FG001|Overall Study|Personal reasons|0|||
33704382|NCT04200248|63270651|FG002|Overall Study|Personal reasons|1|||
33704383|NCT04200248|63270649|FG000|Overall Study|Discontinued prior to treatment|3|||
33704384|NCT04200248|63270650|FG001|Overall Study|Discontinued prior to treatment|3|||
33704385|NCT04200248|63270651|FG002|Overall Study|Discontinued prior to treatment|2|||
33704386|NCT04137887|63270661|FG000|Overall Study|Death|102|||
33704387|NCT04137887|63270662|FG001|Overall Study|Death|92|||
33704388|NCT04137887|63270661|FG000|Overall Study|Withdrawal by Subject|2|||
33704389|NCT04137887|63270662|FG001|Overall Study|Withdrawal by Subject|3|||
33704390|NCT04137887|63270661|FG000|Overall Study|Randomized but not treated|0|||
33704391|NCT04137887|63270662|FG001|Overall Study|Randomized but not treated|1|||
33704392|NCT03557008|63270698|FG000|Overall Study|Withdrawal by Subject|2|||
33704393|NCT03557008|63270699|FG001|Overall Study|Withdrawal by Subject|2|||
33704394|NCT03557008|63270698|FG000|Overall Study|Early termination from study|3|||
33704395|NCT03557008|63270699|FG001|Overall Study|Early termination from study|1|||
33704396|NCT03040999|63270707|FG000|Overall Study|Lost to Follow-up|1|||
33704397|NCT03040999|63270708|FG001|Overall Study|Lost to Follow-up|0|||
33704398|NCT03040999|63270707|FG000|Overall Study|Withdrawal by Subject|7|||
33704399|NCT03040999|63270708|FG001|Overall Study|Withdrawal by Subject|12|||
33704400|NCT03040999|63270707|FG000|Overall Study|Death|128|||
33704401|NCT03040999|63270708|FG001|Overall Study|Death|138|||
33704402|NCT03040999|63270707|FG000|Overall Study|Participants Ongoing in Trial|266|||
33704403|NCT03040999|63270708|FG001|Overall Study|Participants Ongoing in Trial|252|||
33704404|NCT02990338|63270716|FG000|Overall Study|Ongoing|30|||
33704405|NCT02990338|63270717|FG001|Overall Study|Ongoing|36|||
33704406|NCT02366728|63270729|FG000|Overall Study|Death|0|||
33704407|NCT02366728|63270730|FG001|Overall Study|Death|0|||
33704408|NCT02366728|63270731|FG002|Overall Study|Death|1|||
33704409|NCT02366728|63270729|FG000|Overall Study|Adverse Event|1|||
33704410|NCT02366728|63270730|FG001|Overall Study|Adverse Event|0|||
33704411|NCT02366728|63270731|FG002|Overall Study|Adverse Event|0|||
33704412|NCT02366728|63270729|FG000|Overall Study|Screen Failure|2|||
33704413|NCT02366728|63270730|FG001|Overall Study|Screen Failure|1|||
33704414|NCT02366728|63270731|FG002|Overall Study|Screen Failure|0|||
33704415|NCT02366728|63270729|FG000|Overall Study|Only yielded 2 vaccines|1|||
33704416|NCT02366728|63270730|FG001|Overall Study|Only yielded 2 vaccines|0|||
33704417|NCT02366728|63270731|FG002|Overall Study|Only yielded 2 vaccines|0|||
33704418|NCT02355002|63270741|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
33704419|NCT02355002|63270742|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
33704420|NCT02355002|63270741|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
33704421|NCT02355002|63270742|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
33704422|NCT02355002|63270741|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
33704423|NCT02355002|63270742|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
33704424|NCT02355002|63270741|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
33704425|NCT02355002|63270742|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
33493260|NCT03103152|62871482|FG004|Overall Study|Withdrawal by Subject|1|||
33704426|NCT02355002|63270741|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
33704427|NCT02355002|63270742|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
33704428|NCT02355002|63270741|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
33704429|NCT02355002|63270742|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
33704430|NCT02355002|63270741|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
33704431|NCT02355002|63270742|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
33704432|NCT02246920|63270752|FG000|Overall Study|Adverse Event|3|||
33704433|NCT02246920|63270753|FG001|Overall Study|Adverse Event|1|||
33704434|NCT02246920|63270754|FG002|Overall Study|Adverse Event|1|||
33704435|NCT02246920|63270752|FG000|Overall Study|Lost to Follow-up|2|||
33704436|NCT02246920|63270753|FG001|Overall Study|Lost to Follow-up|1|||
33704437|NCT02246920|63270754|FG002|Overall Study|Lost to Follow-up|0|||
33704438|NCT02246920|63270752|FG000|Overall Study|Protocol Violation|2|||
33704439|NCT02246920|63270753|FG001|Overall Study|Protocol Violation|5|||
33704440|NCT02246920|63270754|FG002|Overall Study|Protocol Violation|1|||
33704441|NCT02246920|63270752|FG000|Overall Study|Withdrawal by Subject|0|||
33704442|NCT02246920|63270753|FG001|Overall Study|Withdrawal by Subject|0|||
33704443|NCT02246920|63270754|FG002|Overall Study|Withdrawal by Subject|1|||
33704444|NCT01832402|63270764|FG000|Overall Study|Lost to Follow-up|2|||
33704445|NCT01832402|63270765|FG001|Overall Study|Lost to Follow-up|0|||
33704446|NCT01832402|63270764|FG000|Overall Study|Withdrawal by Subject|3|||
33704447|NCT01832402|63270765|FG001|Overall Study|Withdrawal by Subject|3|||
33704448|NCT01832402|63270764|FG000|Overall Study|Declining Performance status|2|||
33704449|NCT01832402|63270765|FG001|Overall Study|Declining Performance status|1|||
33704450|NCT01661881|63270775|FG000|Overall Study|Disease Progression|1|||
33704451|NCT00667628|63270786|FG000|Overall Study|Lost to Follow-up|1|||
33704452|NCT00667628|63270787|FG001|Overall Study|Lost to Follow-up|0|||
33704453|NCT00667628|63270786|FG000|Overall Study|Death|6|||
33704454|NCT00667628|63270787|FG001|Overall Study|Death|6|||
33704455|NCT00667628|63270786|FG000|Overall Study|Investigator Considers in Best Interest|1|||
33704456|NCT00667628|63270787|FG001|Overall Study|Investigator Considers in Best Interest|0|||
33704457|NCT00667628|63270786|FG000|Overall Study|Sponsor Terminated Study|17|||
33704458|NCT00667628|63270787|FG001|Overall Study|Sponsor Terminated Study|21|||
33704459|NCT00321555|63270793|FG000|Overall Study|Developed antibodies|1|||
33704460|NCT00321555|63270793|FG000|Overall Study|Switched to alternative treatment|3|||
33704461|NCT00321555|63270793|FG000|Overall Study|Physician Decision|1|||
33704462|NCT00321555|63270793|FG000|Overall Study|Disease progression on study|1|||
33704463|NCT01597908|63270803|FG000|Randomized Phase|Death|217|||
33704464|NCT01597908|63270804|FG001|Randomized Phase|Death|238|||
33704465|NCT01597908|63270805|FG002|Randomized Phase|Death|0|||
33704466|NCT01597908|63270803|FG000|Randomized Phase|Sponsor Decision|93|||
33704467|NCT01597908|63270804|FG001|Randomized Phase|Sponsor Decision|39|||
33704468|NCT01597908|63270805|FG002|Randomized Phase|Sponsor Decision|0|||
33704469|NCT01597908|63270803|FG000|Randomized Phase|Lost to Follow-up|9|||
33704470|NCT01597908|63270804|FG001|Randomized Phase|Lost to Follow-up|16|||
33704471|NCT01597908|63270805|FG002|Randomized Phase|Lost to Follow-up|0|||
33704472|NCT01597908|63270803|FG000|Randomized Phase|Physician Decision|6|||
33704473|NCT01597908|63270804|FG001|Randomized Phase|Physician Decision|3|||
33704474|NCT01597908|63270805|FG002|Randomized Phase|Physician Decision|0|||
33704475|NCT01597908|63270803|FG000|Randomized Phase|Withdrawal by Subject|26|||
33704476|NCT01597908|63270804|FG001|Randomized Phase|Withdrawal by Subject|22|||
33704477|NCT01597908|63270805|FG002|Randomized Phase|Withdrawal by Subject|0|||
33704478|NCT01597908|63270803|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
33704479|NCT01597908|63270804|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
33704480|NCT01597908|63270805|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
33704481|NCT01597908|63270803|FG000|Crossover Phase|Death|0|||
33704482|NCT01597908|63270804|FG001|Crossover Phase|Death|0|||
33704483|NCT01597908|63270805|FG002|Crossover Phase|Death|11|||
33704484|NCT01597908|63270803|FG000|Crossover Phase|Withdrawal by Subject|0|||
33704485|NCT01597908|63270804|FG001|Crossover Phase|Withdrawal by Subject|0|||
33704486|NCT01597908|63270805|FG002|Crossover Phase|Withdrawal by Subject|3|||
33704487|NCT01597908|63270803|FG000|Crossover Phase|Sponsor Decision|0|||
33704488|NCT01597908|63270804|FG001|Crossover Phase|Sponsor Decision|0|||
33704489|NCT01597908|63270805|FG002|Crossover Phase|Sponsor Decision|20|||
33704490|NCT01951170|63270814|FG000|Overall Study|Investigator decision|1|||
33704491|NCT01951092|63270818|FG000|Overall Study|Lost to Follow-up|10|||
33704492|NCT01951092|63270818|FG000|Overall Study|Incarceration|1|||
33704493|NCT01951092|63270818|FG000|Overall Study|Transfer of Care|1|||
33704494|NCT01949532|63270824|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
33704495|NCT01949532|63270825|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
33704496|NCT01949142|63270833|FG000|Overall Study|Withdrawal of consent|1|||
33704497|NCT01949142|63270834|FG001|Overall Study|Withdrawal of consent|0|||
33704498|NCT01949142|63270833|FG000|Overall Study|Lost to Follow-up|1|||
33704499|NCT01949142|63270834|FG001|Overall Study|Lost to Follow-up|1|||
33704500|NCT01949142|63270833|FG000|Overall Study|Parent changed their mind|1|||
33704501|NCT01949142|63270834|FG001|Overall Study|Parent changed their mind|0|||
33704502|NCT01948908|63270844|FG000|Overall Study|Protocol Violation|1|||
33704503|NCT01948908|63270845|FG001|Overall Study|Protocol Violation|0|||
33704504|NCT01948908|63270846|FG002|Overall Study|Protocol Violation|2|||
33704505|NCT01925274|63270857|FG000|Overall Study|Death|1|||
33704506|NCT01925274|63270858|FG001|Overall Study|Death|0|||
33704507|NCT01925274|63270859|FG002|Overall Study|Death|0|||
33704508|NCT01925274|63270857|FG000|Overall Study|Lost to Follow-up|0|||
33704509|NCT01925274|63270858|FG001|Overall Study|Lost to Follow-up|1|||
33704510|NCT01925274|63270859|FG002|Overall Study|Lost to Follow-up|0|||
33704511|NCT01925274|63270857|FG000|Overall Study|Withdrawal by Subject|1|||
33704512|NCT01925274|63270858|FG001|Overall Study|Withdrawal by Subject|2|||
33704513|NCT01925274|63270859|FG002|Overall Study|Withdrawal by Subject|0|||
33704514|NCT01925274|63270857|FG000|Overall Study|Study terminated by sponsor|4|||
33704515|NCT01925274|63270858|FG001|Overall Study|Study terminated by sponsor|0|||
33704516|NCT01925274|63270859|FG002|Overall Study|Study terminated by sponsor|0|||
33704517|NCT01925274|63270857|FG000|Overall Study|Protocol amendment|1|||
33704518|NCT01925274|63270858|FG001|Overall Study|Protocol amendment|3|||
33704519|NCT01925274|63270859|FG002|Overall Study|Protocol amendment|6|||
33704520|NCT01948830|63270871|FG000|Overall Study|Physician Decision|1|||
33704521|NCT01948830|63270872|FG001|Overall Study|Physician Decision|3|||
33704522|NCT01948830|63270871|FG000|Overall Study|Protocol deviation|1|||
33704523|NCT01948830|63270872|FG001|Overall Study|Protocol deviation|2|||
33704524|NCT01948830|63270871|FG000|Overall Study|Lost to Follow-up|5|||
33704525|NCT01948830|63270872|FG001|Overall Study|Lost to Follow-up|4|||
33704526|NCT01948830|63270871|FG000|Overall Study|Withdrawal by Subject|14|||
33704527|NCT01948830|63270872|FG001|Overall Study|Withdrawal by Subject|17|||
33704528|NCT01948830|63270871|FG000|Overall Study|Adverse Event|9|||
33704529|NCT01948830|63270872|FG001|Overall Study|Adverse Event|2|||
33704530|NCT01948830|63270871|FG000|Overall Study|Death|3|||
33704531|NCT01948830|63270872|FG001|Overall Study|Death|4|||
33704532|NCT01972464|63270880|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
33704533|NCT01972464|63270881|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
33704534|NCT01972464|63270880|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
33704535|NCT01972464|63270881|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
33704536|NCT01972464|63270880|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
33704537|NCT01972464|63270881|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
33704538|NCT01972464|63270880|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
33704539|NCT01972464|63270881|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
33704540|NCT01948050|63270890|FG000|Overall Study|Withdrawal by Subject|0|||
33704541|NCT01948050|63270891|FG001|Overall Study|Withdrawal by Subject|1|||
33704542|NCT01947894|63270900|FG000|Overall Study|Other|3|||
33704543|NCT01947894|63270901|FG001|Overall Study|Other|4|||
33704544|NCT01947894|63270902|FG002|Overall Study|Other|3|||
33704545|NCT01947894|63270900|FG000|Overall Study|Withdrawal by Subject|12|||
33704546|NCT01947894|63270901|FG001|Overall Study|Withdrawal by Subject|4|||
33704547|NCT01947894|63270902|FG002|Overall Study|Withdrawal by Subject|1|||
33704548|NCT01947894|63270900|FG000|Overall Study|Death|12|||
33704549|NCT01947894|63270901|FG001|Overall Study|Death|1|||
33704550|NCT01947894|63270902|FG002|Overall Study|Death|0|||
33704551|NCT01947894|63270900|FG000|Overall Study|Physician Decision|2|||
33704552|NCT01947894|63270901|FG001|Overall Study|Physician Decision|0|||
33704553|NCT01947894|63270902|FG002|Overall Study|Physician Decision|0|||
33704554|NCT01947894|63270900|FG000|Overall Study|Adverse Event|5|||
33704555|NCT01947894|63270901|FG001|Overall Study|Adverse Event|1|||
33704556|NCT01947894|63270902|FG002|Overall Study|Adverse Event|0|||
33704557|NCT01947894|63270900|FG000|Overall Study|Switched to other growth hormone brand|53|||
33704558|NCT01947894|63270901|FG001|Overall Study|Switched to other growth hormone brand|8|||
33704559|NCT01947894|63270902|FG002|Overall Study|Switched to other growth hormone brand|23|||
33704560|NCT01947582|63270910|FG000|Overall Study|Withdrawal by Subject|1|||
33704561|NCT01924806|63270916|FG000|Overall Study|Physician Decision|2|||
33704562|NCT01924806|63270917|FG001|Overall Study|Physician Decision|1|||
33704563|NCT01924182|63270925|FG000|Overall Study|Withdrawal by Subject|1|||
33704564|NCT01924182|63270926|FG001|Overall Study|Withdrawal by Subject|0|||
33704565|NCT01972308|63270934|FG000|Overall Study|Withdrawal by Subject|0|||
33704566|NCT01972308|63270935|FG001|Overall Study|Withdrawal by Subject|1|||
33704567|NCT01972308|63270934|FG000|Overall Study|Lost to Follow-up|4|||
33704568|NCT01972308|63270935|FG001|Overall Study|Lost to Follow-up|6|||
33704569|NCT01972308|63270934|FG000|Overall Study|Death|4|||
33704570|NCT01972308|63270935|FG001|Overall Study|Death|1|||
33704571|NCT01946880|63270945|FG000|Overall Study|Lost to Follow-up|1|||
33704572|NCT01946880|63270946|FG001|Overall Study|Lost to Follow-up|0|||
33704573|NCT01946880|63270945|FG000|Overall Study|Physician Decision|1|||
33704574|NCT01946880|63270946|FG001|Overall Study|Physician Decision|1|||
33704575|NCT01946880|63270945|FG000|Overall Study|Withdrawal by Subject|3|||
33704576|NCT01946880|63270946|FG001|Overall Study|Withdrawal by Subject|2|||
33704577|NCT01946880|63270945|FG000|Overall Study|Met Primary Endpoint|1|||
33704578|NCT01946880|63270946|FG001|Overall Study|Met Primary Endpoint|0|||
33704579|NCT01946880|63270945|FG000|Overall Study|Personal and Family Issues|1|||
33704580|NCT01946880|63270946|FG001|Overall Study|Personal and Family Issues|0|||
33704581|NCT01972152|63270952|FG000|First Treatment Visit|Lost to Follow-up|0|||
33704582|NCT01972152|63270953|FG001|First Treatment Visit|Lost to Follow-up|1|||
33704583|NCT01972152|63270954|FG002|First Treatment Visit|Lost to Follow-up|0|||
33704584|NCT01972152|63270955|FG003|First Treatment Visit|Lost to Follow-up|0|||
33704585|NCT01972152|63270956|FG004|First Treatment Visit|Lost to Follow-up|0|||
33704586|NCT01972152|63270957|FG005|First Treatment Visit|Lost to Follow-up|0|||
33704587|NCT01972152|63270952|FG000|Second Treatment Visit|Protocol Violation|0|||
33704588|NCT01972152|63270953|FG001|Second Treatment Visit|Protocol Violation|1|||
33704589|NCT01972152|63270954|FG002|Second Treatment Visit|Protocol Violation|0|||
33704590|NCT01972152|63270955|FG003|Second Treatment Visit|Protocol Violation|0|||
33704591|NCT01972152|63270956|FG004|Second Treatment Visit|Protocol Violation|0|||
33704592|NCT01972152|63270957|FG005|Second Treatment Visit|Protocol Violation|0|||
33704593|NCT01972074|63270971|FG000|Overall Study|Adverse Event|4|||
33704594|NCT01972074|63270972|FG001|Overall Study|Adverse Event|1|||
33704595|NCT01972074|63270973|FG002|Overall Study|Adverse Event|0|||
33704596|NCT01972074|63270971|FG000|Overall Study|Lack of Efficacy|1|||
33704597|NCT01972074|63270972|FG001|Overall Study|Lack of Efficacy|1|||
33704598|NCT01972074|63270973|FG002|Overall Study|Lack of Efficacy|0|||
33704599|NCT01972074|63270971|FG000|Overall Study|Lost to Follow-up|0|||
33704600|NCT01972074|63270972|FG001|Overall Study|Lost to Follow-up|1|||
33704601|NCT01972074|63270973|FG002|Overall Study|Lost to Follow-up|1|||
33704602|NCT01972074|63270971|FG000|Overall Study|Withdrawal by Subject|1|||
33704603|NCT01972074|63270972|FG001|Overall Study|Withdrawal by Subject|1|||
33704604|NCT01972074|63270973|FG002|Overall Study|Withdrawal by Subject|1|||
33704605|NCT01972074|63270971|FG000|Overall Study|Scanner Unavailable|0|||
33704606|NCT01972074|63270972|FG001|Overall Study|Scanner Unavailable|0|||
33704607|NCT01972074|63270973|FG002|Overall Study|Scanner Unavailable|1|||
33704608|NCT01970982|63270983|FG000|Overall Study|Withdrawal by Subject|0|||
33704609|NCT01970982|63270984|FG001|Overall Study|Withdrawal by Subject|0|||
33704610|NCT01970982|63270985|FG002|Overall Study|Withdrawal by Subject|2|||
33704611|NCT01946802|63270994|FG000|Overall Study|Death|1|||
33704612|NCT01946802|63270994|FG000|Overall Study|Withdrawal by Subject|2|||
33704613|NCT01946802|63270994|FG000|Overall Study|Combined septic shock|1|||
33704614|NCT01946802|63270994|FG000|Overall Study|Protocol Violation|1|||
33704615|NCT01618266|63270998|FG000|Overall Study|Lost to Follow-up|9|||
33704616|NCT01618266|63270998|FG000|Overall Study|Treatment satisfaction|10|||
33704617|NCT01618266|63270998|FG000|Overall Study|Other reasons|11|||
33704618|NCT01618266|63270998|FG000|Overall Study|Lack of Efficacy|23|||
33704619|NCT01618266|63270998|FG000|Overall Study|Protocol Violation|43|||
33704620|NCT01919112|63271005|FG000|Secondary Analysis-day 30|Death|1|||
33704621|NCT01919112|63271006|FG001|Secondary Analysis-day 30|Death|1|||
33704622|NCT01919112|63271007|FG002|Secondary Analysis-day 30|Death|1|||
33704623|NCT01919112|63271005|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
33704624|NCT01919112|63271006|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
33704625|NCT01919112|63271007|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
33704626|NCT01918332|63271019|FG000|Overall Study|Adverse Event|0|||
33704627|NCT01918332|63271020|FG001|Overall Study|Adverse Event|0|||
33704628|NCT01918332|63271021|FG002|Overall Study|Adverse Event|0|||
33704629|NCT01918332|63271022|FG003|Overall Study|Adverse Event|1|||
33704630|NCT01918332|63271019|FG000|Overall Study|Withdrawal by Subject|2|||
33704631|NCT01918332|63271020|FG001|Overall Study|Withdrawal by Subject|3|||
33704632|NCT01918332|63271021|FG002|Overall Study|Withdrawal by Subject|2|||
33704633|NCT01918332|63271022|FG003|Overall Study|Withdrawal by Subject|3|||
33704634|NCT01918332|63271019|FG000|Overall Study|Protocol Violation|6|||
33704635|NCT01918332|63271020|FG001|Overall Study|Protocol Violation|2|||
33704636|NCT01918332|63271021|FG002|Overall Study|Protocol Violation|6|||
33704637|NCT01918332|63271022|FG003|Overall Study|Protocol Violation|3|||
33704638|NCT01918332|63271019|FG000|Overall Study|lipid result by central lab did not meet|0|||
33704639|NCT01918332|63271020|FG001|Overall Study|lipid result by central lab did not meet|0|||
33704640|NCT01918332|63271021|FG002|Overall Study|lipid result by central lab did not meet|1|||
33704641|NCT01918332|63271022|FG003|Overall Study|lipid result by central lab did not meet|0|||
33704642|NCT01922934|63271034|FG000|Eligible Patients|Death|0|||
33704643|NCT01922934|63271035|FG001|Eligible Patients|Death|7|||
33704644|NCT01922934|63271034|FG000|Eligible Patients|Physician Decision|17|||
33704645|NCT01922934|63271035|FG001|Eligible Patients|Physician Decision|0|||
33704646|NCT01922934|63271034|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
33704647|NCT01922934|63271035|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
33704648|NCT01922934|63271034|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
33704649|NCT01922934|63271035|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
33704650|NCT01922934|63271034|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
33704651|NCT01922934|63271035|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
33704652|NCT01922934|63271034|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
33704653|NCT01922934|63271035|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
33704654|NCT01970592|63271043|FG000|Overall Study|Withdrawal by Subject|4|||
33704655|NCT01970592|63271043|FG000|Overall Study|Physician Decision|1|||
33704656|NCT01970592|63271043|FG000|Overall Study|Adverse Event|1|||
33704657|NCT01920594|63271049|FG000|Overall Study|Adverse Event|4|||
33704658|NCT01920594|63271050|FG001|Overall Study|Adverse Event|2|||
33704659|NCT01920594|63271049|FG000|Overall Study|Lost to Follow-up|1|||
33704660|NCT01920594|63271050|FG001|Overall Study|Lost to Follow-up|0|||
33704661|NCT01920594|63271049|FG000|Overall Study|Recovery|2|||
33704662|NCT01920594|63271050|FG001|Overall Study|Recovery|0|||
33704663|NCT01920594|63271049|FG000|Overall Study|Investigator discretion|0|||
33704664|NCT01920594|63271050|FG001|Overall Study|Investigator discretion|1|||
33704665|NCT01917084|63271056|FG000|Overall Study|Withdrawal by Subject|1|||
33704666|NCT01917006|63271067|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
33704667|NCT01917006|63271068|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
33704668|NCT01917006|63271069|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
33704669|NCT01917006|63271070|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
33704670|NCT01917006|63271071|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
33704671|NCT01917006|63271072|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
33704672|NCT01917006|63271073|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
33704673|NCT01917006|63271074|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
33704674|NCT01917006|63271067|FG000|Randomized-treatment Period|Personal Reasons|0|||
33704675|NCT01917006|63271068|FG001|Randomized-treatment Period|Personal Reasons|0|||
33704676|NCT01917006|63271069|FG002|Randomized-treatment Period|Personal Reasons|0|||
33704677|NCT01917006|63271070|FG003|Randomized-treatment Period|Personal Reasons|0|||
33704678|NCT01917006|63271071|FG004|Randomized-treatment Period|Personal Reasons|0|||
33704679|NCT01917006|63271072|FG005|Randomized-treatment Period|Personal Reasons|1|||
33704680|NCT01917006|63271073|FG006|Randomized-treatment Period|Personal Reasons|0|||
33704681|NCT01917006|63271074|FG007|Randomized-treatment Period|Personal Reasons|0|||
33704682|NCT01917006|63271067|FG000|Randomized-treatment Period|Protocol Violation|1|||
33704683|NCT01917006|63271068|FG001|Randomized-treatment Period|Protocol Violation|0|||
33704684|NCT01917006|63271069|FG002|Randomized-treatment Period|Protocol Violation|0|||
33704685|NCT01917006|63271070|FG003|Randomized-treatment Period|Protocol Violation|0|||
33704686|NCT01917006|63271071|FG004|Randomized-treatment Period|Protocol Violation|0|||
33704687|NCT01917006|63271072|FG005|Randomized-treatment Period|Protocol Violation|0|||
33493261|NCT03103152|62871483|FG005|Overall Study|Withdrawal by Subject|1|||
33596916|NCT01885078|62995867|FG005|Step-down Period|Physician Decision|0|||
33596917|NCT01885078|62995868|FG006|Step-down Period|Physician Decision|0|||
33596918|NCT01885078|62995869|FG007|Step-down Period|Physician Decision|0|||
33596919|NCT01885078|62995870|FG008|Step-down Period|Physician Decision|7|||
33596920|NCT01885078|62995871|FG009|Step-down Period|Physician Decision|2|||
33596921|NCT01885078|62995862|FG000|Step-down Period|Death|0|||
33596922|NCT01885078|62995863|FG001|Step-down Period|Death|0|||
33596923|NCT01885078|62995864|FG002|Step-down Period|Death|0|||
33596924|NCT01885078|62995865|FG003|Step-down Period|Death|0|||
33596925|NCT01885078|62995866|FG004|Step-down Period|Death|0|||
33596926|NCT01885078|62995867|FG005|Step-down Period|Death|0|||
33596927|NCT01885078|62995868|FG006|Step-down Period|Death|0|||
33596928|NCT01885078|62995869|FG007|Step-down Period|Death|0|||
33596929|NCT01885078|62995870|FG008|Step-down Period|Death|4|||
33596930|NCT01885078|62995871|FG009|Step-down Period|Death|3|||
33596931|NCT01885078|62995862|FG000|Step-down Period|Lost to Follow-up|0|||
33596932|NCT01885078|62995863|FG001|Step-down Period|Lost to Follow-up|0|||
33596933|NCT01885078|62995864|FG002|Step-down Period|Lost to Follow-up|0|||
33596934|NCT01885078|62995865|FG003|Step-down Period|Lost to Follow-up|0|||
33596935|NCT01885078|62995866|FG004|Step-down Period|Lost to Follow-up|0|||
33596936|NCT01885078|62995867|FG005|Step-down Period|Lost to Follow-up|0|||
33596937|NCT01885078|62995868|FG006|Step-down Period|Lost to Follow-up|0|||
33596938|NCT01885078|62995869|FG007|Step-down Period|Lost to Follow-up|0|||
33596939|NCT01885078|62995870|FG008|Step-down Period|Lost to Follow-up|1|||
33596940|NCT01885078|62995871|FG009|Step-down Period|Lost to Follow-up|1|||
33596941|NCT01885078|62995862|FG000|Step-down Period|Lack of Efficacy|0|||
33596942|NCT01885078|62995863|FG001|Step-down Period|Lack of Efficacy|0|||
33596943|NCT01885078|62995864|FG002|Step-down Period|Lack of Efficacy|0|||
33596944|NCT01885078|62995865|FG003|Step-down Period|Lack of Efficacy|0|||
33704688|NCT01917006|63271073|FG006|Randomized-treatment Period|Protocol Violation|0|||
33704689|NCT01917006|63271074|FG007|Randomized-treatment Period|Protocol Violation|0|||
33704690|NCT01917006|63271067|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
33704691|NCT01917006|63271068|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
33704692|NCT01917006|63271069|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
33596945|NCT01885078|62995866|FG004|Step-down Period|Lack of Efficacy|0|||
33704693|NCT01917006|63271070|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
33704694|NCT01917006|63271071|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
33704695|NCT01917006|63271072|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
33704696|NCT01917006|63271073|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
33704697|NCT01917006|63271074|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
33704698|NCT01917006|63271067|FG000|Open-label Period|Adverse Event|0|||
33704699|NCT01917006|63271068|FG001|Open-label Period|Adverse Event|0|||
33704700|NCT01917006|63271069|FG002|Open-label Period|Adverse Event|0|||
33704701|NCT01917006|63271070|FG003|Open-label Period|Adverse Event|0|||
33704702|NCT01917006|63271071|FG004|Open-label Period|Adverse Event|0|||
33704703|NCT01917006|63271072|FG005|Open-label Period|Adverse Event|0|||
33704704|NCT01917006|63271073|FG006|Open-label Period|Adverse Event|0|||
33704705|NCT01917006|63271074|FG007|Open-label Period|Adverse Event|1|||
33704706|NCT01917006|63271067|FG000|Open-label Period|Lost to Follow-up|0|||
33704707|NCT01917006|63271068|FG001|Open-label Period|Lost to Follow-up|0|||
33704708|NCT01917006|63271069|FG002|Open-label Period|Lost to Follow-up|0|||
33704709|NCT01917006|63271070|FG003|Open-label Period|Lost to Follow-up|0|||
33704710|NCT01917006|63271071|FG004|Open-label Period|Lost to Follow-up|0|||
33704711|NCT01917006|63271072|FG005|Open-label Period|Lost to Follow-up|0|||
33596946|NCT01885078|62995867|FG005|Step-down Period|Lack of Efficacy|0|||
33704712|NCT01917006|63271073|FG006|Open-label Period|Lost to Follow-up|0|||
33704713|NCT01917006|63271074|FG007|Open-label Period|Lost to Follow-up|1|||
33704714|NCT01916304|63271091|FG000|Overall Study|Screening failure|17|||
33704715|NCT01916226|63271099|FG000|Overall Study|Adverse Event|1|||
33704716|NCT01916226|63271100|FG001|Overall Study|Adverse Event|0|||
33704717|NCT01916226|63271101|FG002|Overall Study|Adverse Event|1|||
33704718|NCT01916226|63271102|FG003|Overall Study|Adverse Event|1|||
33704719|NCT01916226|63271099|FG000|Overall Study|Lack of Efficacy|0|||
33704720|NCT01916226|63271100|FG001|Overall Study|Lack of Efficacy|0|||
33704721|NCT01916226|63271101|FG002|Overall Study|Lack of Efficacy|2|||
33704722|NCT01916226|63271102|FG003|Overall Study|Lack of Efficacy|1|||
33704723|NCT01916226|63271099|FG000|Overall Study|Protocol Violation|0|||
33704724|NCT01916226|63271100|FG001|Overall Study|Protocol Violation|1|||
33704725|NCT01916226|63271101|FG002|Overall Study|Protocol Violation|0|||
33704726|NCT01916226|63271102|FG003|Overall Study|Protocol Violation|1|||
33704727|NCT01916226|63271099|FG000|Overall Study|Physician Decision|0|||
33704728|NCT01916226|63271100|FG001|Overall Study|Physician Decision|0|||
33704729|NCT01916226|63271101|FG002|Overall Study|Physician Decision|0|||
33704730|NCT01916226|63271102|FG003|Overall Study|Physician Decision|1|||
33704731|NCT01969500|63271115|FG000|Overall Study|Death|0|||
33704732|NCT01969500|63271116|FG001|Overall Study|Death|1|||
33704733|NCT01969500|63271115|FG000|Overall Study|extended hospitalization|1|||
33704734|NCT01969500|63271116|FG001|Overall Study|extended hospitalization|1|||
33704735|NCT01915914|63271122|FG000|Acute Phase|Withdrawal by Subject|4|||
33704736|NCT01915914|63271123|FG001|Acute Phase|Withdrawal by Subject|0|||
33704737|NCT01915914|63271124|FG002|Acute Phase|Withdrawal by Subject|0|||
33704738|NCT01915914|63271125|FG003|Acute Phase|Withdrawal by Subject|0|||
33704739|NCT01915914|63271122|FG000|Acute Phase|Lost to Follow-up|4|||
33704740|NCT01915914|63271123|FG001|Acute Phase|Lost to Follow-up|0|||
33704741|NCT01915914|63271124|FG002|Acute Phase|Lost to Follow-up|0|||
33704742|NCT01915914|63271125|FG003|Acute Phase|Lost to Follow-up|0|||
33704743|NCT01915914|63271122|FG000|Acute Phase|Physician Decision|1|||
33704744|NCT01915914|63271123|FG001|Acute Phase|Physician Decision|0|||
33704745|NCT01915914|63271124|FG002|Acute Phase|Physician Decision|0|||
33704746|NCT01915914|63271125|FG003|Acute Phase|Physician Decision|0|||
33704747|NCT01915914|63271122|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
33704748|NCT01915914|63271123|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
33704749|NCT01915914|63271124|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
33704750|NCT01915914|63271125|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
33704751|NCT01915914|63271122|FG000|Acute Phase|"Not Achieved treatment success"|1|||
33704752|NCT01915914|63271123|FG001|Acute Phase|"Not Achieved treatment success"|0|||
33704753|NCT01915914|63271124|FG002|Acute Phase|"Not Achieved treatment success"|0|||
33704754|NCT01915914|63271125|FG003|Acute Phase|"Not Achieved treatment success"|0|||
33704755|NCT01915914|63271122|FG000|Acute Phase|Missing|1|||
33704756|NCT01915914|63271123|FG001|Acute Phase|Missing|0|||
33704757|NCT01915914|63271124|FG002|Acute Phase|Missing|0|||
33704758|NCT01915914|63271125|FG003|Acute Phase|Missing|0|||
33704759|NCT01915914|63271122|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33704760|NCT01915914|63271123|FG001|Maintenance Phase|Withdrawal by Subject|1|||
33704761|NCT01915914|63271124|FG002|Maintenance Phase|Withdrawal by Subject|1|||
33704762|NCT01915914|63271125|FG003|Maintenance Phase|Withdrawal by Subject|0|||
33704763|NCT01915914|63271122|FG000|Maintenance Phase|Lost to Follow-up|0|||
33704764|NCT01915914|63271123|FG001|Maintenance Phase|Lost to Follow-up|4|||
33704765|NCT01915914|63271124|FG002|Maintenance Phase|Lost to Follow-up|1|||
33704766|NCT01915914|63271125|FG003|Maintenance Phase|Lost to Follow-up|0|||
33704767|NCT01915914|63271122|FG000|Maintenance Phase|Missing|0|||
33704768|NCT01915914|63271123|FG001|Maintenance Phase|Missing|1|||
33704769|NCT01915914|63271124|FG002|Maintenance Phase|Missing|0|||
33704770|NCT01915914|63271125|FG003|Maintenance Phase|Missing|0|||
33704771|NCT01915914|63271122|FG000|Follow-up Phase|Withdrawal by Subject|0|||
33704772|NCT01915914|63271123|FG001|Follow-up Phase|Withdrawal by Subject|0|||
33704773|NCT01915914|63271124|FG002|Follow-up Phase|Withdrawal by Subject|0|||
33704774|NCT01915914|63271125|FG003|Follow-up Phase|Withdrawal by Subject|1|||
33704775|NCT01915914|63271122|FG000|Follow-up Phase|Physician Decision|0|||
33704776|NCT01915914|63271123|FG001|Follow-up Phase|Physician Decision|0|||
33704777|NCT01915914|63271124|FG002|Follow-up Phase|Physician Decision|0|||
33704778|NCT01915914|63271125|FG003|Follow-up Phase|Physician Decision|1|||
33704779|NCT01919970|63271145|FG000|Overall Study|Withdrawal by Subject|3|||
33704780|NCT01919970|63271146|FG001|Overall Study|Withdrawal by Subject|0|||
33704781|NCT01919814|63271152|FG000|Overall Study|Adverse Event|1|||
33493262|NCT03103152|62871478|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
33704782|NCT01919814|63271153|FG001|Overall Study|Adverse Event|0|||
33704783|NCT01919814|63271152|FG000|Overall Study|Protocol Violation|1|||
33704784|NCT01919814|63271153|FG001|Overall Study|Protocol Violation|0|||
33704785|NCT01919814|63271152|FG000|Overall Study|Withdrawal by Subject|1|||
33704786|NCT01919814|63271153|FG001|Overall Study|Withdrawal by Subject|0|||
33704787|NCT01968954|63271161|FG000|Overall Study|Adverse Event|6|||
33704788|NCT01968954|63271162|FG001|Overall Study|Adverse Event|3|||
33704789|NCT01968954|63271161|FG000|Overall Study|Death|1|||
33704790|NCT01968954|63271162|FG001|Overall Study|Death|2|||
33704791|NCT01968954|63271161|FG000|Overall Study|Lost to Follow-up|6|||
33704792|NCT01968954|63271162|FG001|Overall Study|Lost to Follow-up|4|||
33704793|NCT01968954|63271161|FG000|Overall Study|Withdrawal by Subject|20|||
33704794|NCT01968954|63271162|FG001|Overall Study|Withdrawal by Subject|23|||
33704795|NCT01968954|63271161|FG000|Overall Study|Other|7|||
33704796|NCT01968954|63271162|FG001|Overall Study|Other|8|||
33704797|NCT01968954|63271161|FG000|Overall Study|Protocol Violation|0|||
33704798|NCT01968954|63271162|FG001|Overall Study|Protocol Violation|1|||
33704799|NCT01968954|63271161|FG000|Overall Study|Did not met inclusion criteria|0|||
33704800|NCT01968954|63271162|FG001|Overall Study|Did not met inclusion criteria|2|||
33704801|NCT01919190|63271171|FG000|Overall Study|Intra-op findings, etc.|3|||
33704802|NCT01919190|63271172|FG001|Overall Study|Intra-op findings, etc.|0|||
33704803|NCT01620060|63271179|FG000|Overall Study|Adverse Event|9|||
33704804|NCT01620060|63271179|FG000|Overall Study|Protocol Violation|1|||
33704805|NCT01620060|63271179|FG000|Overall Study|Withdrawal by Subject|1|||
33704806|NCT01620060|63271179|FG000|Overall Study|Did not comply with Study Produre|1|||
33704807|NCT01620060|63271179|FG000|Overall Study|Family emergency|1|||
33704808|NCT01620060|63271179|FG000|Overall Study|Per Sponsor Decision|2|||
33704809|NCT01914666|63271186|FG000|Treatment Period|Lack of Efficacy|0|||
33704810|NCT01914666|63271187|FG001|Treatment Period|Lack of Efficacy|0|||
33704811|NCT01914666|63271188|FG002|Treatment Period|Lack of Efficacy|2|||
33704812|NCT01914666|63271186|FG000|Treatment Period|Adverse Event|10|||
33704813|NCT01914666|63271187|FG001|Treatment Period|Adverse Event|4|||
33704814|NCT01914666|63271188|FG002|Treatment Period|Adverse Event|2|||
33704815|NCT01914666|63271186|FG000|Treatment Period|Withdrawal by Subject|3|||
33704816|NCT01914666|63271187|FG001|Treatment Period|Withdrawal by Subject|2|||
33704817|NCT01914666|63271188|FG002|Treatment Period|Withdrawal by Subject|2|||
33704818|NCT01914666|63271186|FG000|Treatment Period|Physician Decision|0|||
33704819|NCT01914666|63271187|FG001|Treatment Period|Physician Decision|0|||
33704820|NCT01914666|63271188|FG002|Treatment Period|Physician Decision|2|||
33704821|NCT01913340|63271196|FG000|Overall Study|Death|2|||
33704822|NCT01913340|63271197|FG001|Overall Study|Death|5|||
33704823|NCT01913340|63271196|FG000|Overall Study|Lost to Follow-up|1|||
33704824|NCT01913340|63271197|FG001|Overall Study|Lost to Follow-up|1|||
33704825|NCT01864200|63271205|FG000|Overall Study|Lost to Follow-up|1|||
33704826|NCT01864200|63271206|FG001|Overall Study|Lost to Follow-up|3|||
33704827|NCT01864200|63271205|FG000|Overall Study|Protocol Violation|1|||
33704828|NCT01864200|63271206|FG001|Overall Study|Protocol Violation|0|||
33704829|NCT01912872|63271216|FG000|Overall Study|Lost to Follow-up|2|||
33704830|NCT01912872|63271217|FG001|Overall Study|Lost to Follow-up|3|||
33704831|NCT01912872|63271218|FG002|Overall Study|Lost to Follow-up|5|||
33704832|NCT01912872|63271219|FG003|Overall Study|Lost to Follow-up|5|||
33704833|NCT01912872|63271216|FG000|Overall Study|Other unspecified|3|||
33704834|NCT01912872|63271217|FG001|Overall Study|Other unspecified|1|||
33704835|NCT01912872|63271218|FG002|Overall Study|Other unspecified|3|||
33704836|NCT01912872|63271219|FG003|Overall Study|Other unspecified|0|||
33704837|NCT01912872|63271216|FG000|Overall Study|Informed consent withdrawn|0|||
33704838|NCT01912872|63271217|FG001|Overall Study|Informed consent withdrawn|0|||
33704839|NCT01912872|63271218|FG002|Overall Study|Informed consent withdrawn|1|||
33704840|NCT01912872|63271219|FG003|Overall Study|Informed consent withdrawn|1|||
33704841|NCT01912872|63271216|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
33704842|NCT01912872|63271217|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
33704843|NCT01912872|63271218|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
33704844|NCT01912872|63271219|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
33704845|NCT01912872|63271216|FG000|Overall Study|Protocol Violation|0|||
33704846|NCT01912872|63271217|FG001|Overall Study|Protocol Violation|0|||
33704847|NCT01912872|63271218|FG002|Overall Study|Protocol Violation|1|||
33704848|NCT01912872|63271219|FG003|Overall Study|Protocol Violation|0|||
33704849|NCT01912872|63271216|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33704850|NCT01912872|63271217|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33704851|NCT01912872|63271218|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33704852|NCT01912872|63271219|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
33704853|NCT01912872|63271216|FG000|Overall Study|Withdrawal of study medication|0|||
33704854|NCT01912872|63271217|FG001|Overall Study|Withdrawal of study medication|0|||
33704855|NCT01912872|63271218|FG002|Overall Study|Withdrawal of study medication|0|||
33704856|NCT01912872|63271219|FG003|Overall Study|Withdrawal of study medication|2|||
33704857|NCT01912872|63271216|FG000|Overall Study|Missing|0|||
33704858|NCT01912872|63271217|FG001|Overall Study|Missing|0|||
33704859|NCT01912872|63271218|FG002|Overall Study|Missing|0|||
33704860|NCT01912872|63271219|FG003|Overall Study|Missing|1|||
33704861|NCT01912404|63271232|FG000|Overall Study|Due to personal reasons|1|||
33704862|NCT01912404|63271233|FG001|Overall Study|Due to personal reasons|0|||
33704863|NCT01911780|63271241|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
33704864|NCT01911780|63271242|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
33704865|NCT01911780|63271241|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
33704866|NCT01911780|63271242|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
33704867|NCT01911780|63271241|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
33704868|NCT01911780|63271242|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
33704869|NCT01911780|63271241|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
33704870|NCT01911780|63271242|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
33704871|NCT01911780|63271241|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
33704872|NCT01911780|63271242|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
33704873|NCT01911780|63271241|FG000|Extension Period (52 Weeks)|Personal reason|1|||
33704874|NCT01911780|63271242|FG001|Extension Period (52 Weeks)|Personal reason|1|||
33704875|NCT01911546|63271252|FG000|Overall Study|Lost to Follow-up|1|||
33704876|NCT01911546|63271252|FG000|Overall Study|Everolimus was discontinued|5|||
33704877|NCT01910298|63271258|FG000|Overall Study|Adverse Event|1|||
33704878|NCT01910298|63271259|FG001|Overall Study|Adverse Event|0|||
33704879|NCT01910298|63271258|FG000|Overall Study|Withdrawal by Subject|2|||
33704880|NCT01910298|63271259|FG001|Overall Study|Withdrawal by Subject|7|||
33704881|NCT01910298|63271258|FG000|Overall Study|Protocol Deviation|0|||
33704882|NCT01910298|63271259|FG001|Overall Study|Protocol Deviation|5|||
33704883|NCT01910298|63271258|FG000|Overall Study|Lost to Follow-up|1|||
33704884|NCT01910298|63271259|FG001|Overall Study|Lost to Follow-up|1|||
33704885|NCT01910298|63271258|FG000|Overall Study|Study Terminated by Sponsor|1|||
33704886|NCT01910298|63271259|FG001|Overall Study|Study Terminated by Sponsor|17|||
33704887|NCT01910298|63271258|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33704888|NCT01910298|63271259|FG001|Overall Study|Other Miscellaneous Reasons|2|||
33704889|NCT01909674|63271267|FG000|Overall Study|Withdrawal by Subject|5|||
33704890|NCT01909674|63271268|FG001|Overall Study|Withdrawal by Subject|2|||
33704891|NCT01908816|63271278|FG000|Overall Study|Subject's no longer requires study drug|0|||
33704892|NCT01908816|63271279|FG001|Overall Study|Subject's no longer requires study drug|0|||
33704893|NCT01908816|63271280|FG002|Overall Study|Subject's no longer requires study drug|0|||
33704894|NCT01908816|63271281|FG003|Overall Study|Subject's no longer requires study drug|1|||
33704895|NCT01908816|63271278|FG000|Overall Study|Protocol deviation|1|||
33704896|NCT01908816|63271279|FG001|Overall Study|Protocol deviation|2|||
33704897|NCT01908816|63271280|FG002|Overall Study|Protocol deviation|1|||
33704898|NCT01908816|63271281|FG003|Overall Study|Protocol deviation|1|||
33704899|NCT01908816|63271278|FG000|Overall Study|Withdrawal by Subject|0|||
33704900|NCT01908816|63271279|FG001|Overall Study|Withdrawal by Subject|4|||
33704901|NCT01908816|63271280|FG002|Overall Study|Withdrawal by Subject|2|||
33704902|NCT01908816|63271281|FG003|Overall Study|Withdrawal by Subject|2|||
33704903|NCT01908816|63271278|FG000|Overall Study|Lost to Follow-up|3|||
33704904|NCT01908816|63271279|FG001|Overall Study|Lost to Follow-up|5|||
33704905|NCT01908816|63271280|FG002|Overall Study|Lost to Follow-up|4|||
33704906|NCT01908816|63271281|FG003|Overall Study|Lost to Follow-up|2|||
33704907|NCT01908816|63271278|FG000|Overall Study|Death|1|||
33704908|NCT01908816|63271279|FG001|Overall Study|Death|0|||
33704909|NCT01908816|63271280|FG002|Overall Study|Death|7|||
33704910|NCT01908816|63271281|FG003|Overall Study|Death|1|||
33704911|NCT01908816|63271278|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33704912|NCT01908816|63271279|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
33704913|NCT01908816|63271280|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
33704914|NCT01908816|63271281|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
33704915|NCT01908816|63271278|FG000|Overall Study|Early termination|87|||
33596947|NCT01885078|62995868|FG006|Step-down Period|Lack of Efficacy|0|||
33596948|NCT01885078|62995869|FG007|Step-down Period|Lack of Efficacy|0|||
33596949|NCT01885078|62995870|FG008|Step-down Period|Lack of Efficacy|1|||
33596950|NCT01885078|62995871|FG009|Step-down Period|Lack of Efficacy|0|||
33596951|NCT01885078|62995862|FG000|Step-down Period|Protocol Violation|0|||
33596952|NCT01885078|62995863|FG001|Step-down Period|Protocol Violation|0|||
33596953|NCT01885078|62995864|FG002|Step-down Period|Protocol Violation|0|||
33596954|NCT01885078|62995865|FG003|Step-down Period|Protocol Violation|0|||
33596955|NCT01885078|62995866|FG004|Step-down Period|Protocol Violation|0|||
33596956|NCT01885078|62995867|FG005|Step-down Period|Protocol Violation|0|||
33596957|NCT01885078|62995868|FG006|Step-down Period|Protocol Violation|0|||
33596958|NCT01885078|62995869|FG007|Step-down Period|Protocol Violation|0|||
33596959|NCT01885078|62995870|FG008|Step-down Period|Protocol Violation|1|||
33596960|NCT01885078|62995871|FG009|Step-down Period|Protocol Violation|1|||
33596961|NCT02046369|62995894|FG000|Overall Study|Adverse Event|3|||
33596962|NCT02046369|62995895|FG001|Overall Study|Adverse Event|3|||
33596963|NCT02046369|62995894|FG000|Overall Study|Lack of Efficacy|3|||
33596964|NCT02046369|62995895|FG001|Overall Study|Lack of Efficacy|3|||
33704916|NCT01908816|63271279|FG001|Overall Study|Early termination|60|||
33704917|NCT01908816|63271280|FG002|Overall Study|Early termination|43|||
33704918|NCT01908816|63271281|FG003|Overall Study|Early termination|28|||
33704919|NCT01908582|63271294|FG000|Period 2|Physician Decision|1|||
33704920|NCT01908582|63271294|FG000|Period 2|Withdrawal by Subject|1|||
33596965|NCT02046369|62995894|FG000|Overall Study|Lost to Follow-up|3|||
33596966|NCT02046369|62995895|FG001|Overall Study|Lost to Follow-up|3|||
33704921|NCT01908426|63271303|FG000|Overall Study|Adverse Event|98|||
33704922|NCT01908426|63271304|FG001|Overall Study|Adverse Event|11|||
33704923|NCT01908426|63271303|FG000|Overall Study|Clinical Deterioration|72|||
33704924|NCT01908426|63271304|FG001|Overall Study|Clinical Deterioration|38|||
33704925|NCT01908426|63271303|FG000|Overall Study|Lack of Efficacy|3|||
33704926|NCT01908426|63271304|FG001|Overall Study|Lack of Efficacy|0|||
33704927|NCT01908426|63271303|FG000|Overall Study|Lost to Follow-up|0|||
33704928|NCT01908426|63271304|FG001|Overall Study|Lost to Follow-up|1|||
33704929|NCT01908426|63271303|FG000|Overall Study|Physician Decision|3|||
33704930|NCT01908426|63271304|FG001|Overall Study|Physician Decision|3|||
33704931|NCT01908426|63271303|FG000|Overall Study|Withdrawal by Subject|11|||
33704932|NCT01908426|63271304|FG001|Overall Study|Withdrawal by Subject|6|||
33704933|NCT01908426|63271303|FG000|Overall Study|Progressive Disease|206|||
33704934|NCT01908426|63271304|FG001|Overall Study|Progressive Disease|152|||
33704935|NCT01908426|63271303|FG000|Overall Study|Protocol Violation|1|||
33704936|NCT01908426|63271304|FG001|Overall Study|Protocol Violation|0|||
33704937|NCT01908426|63271303|FG000|Overall Study|No Study Treatment Given|3|||
33704938|NCT01908426|63271304|FG001|Overall Study|No Study Treatment Given|0|||
33704939|NCT01907100|63271314|FG000|Overall Study|PD based on modified RECIST criteria|31|||
33704940|NCT01907100|63271315|FG001|Overall Study|PD based on modified RECIST criteria|32|||
33704941|NCT01907100|63271316|FG002|Overall Study|PD based on modified RECIST criteria|95|||
33704942|NCT01907100|63271317|FG003|Overall Study|PD based on modified RECIST criteria|92|||
33704943|NCT01907100|63271314|FG000|Overall Study|Withdrawal by Subject|2|||
33704944|NCT01907100|63271315|FG001|Overall Study|Withdrawal by Subject|5|||
33704945|NCT01907100|63271316|FG002|Overall Study|Withdrawal by Subject|10|||
33704946|NCT01907100|63271317|FG003|Overall Study|Withdrawal by Subject|13|||
33704947|NCT01907100|63271314|FG000|Overall Study|Protocol Violation|0|||
33704948|NCT01907100|63271315|FG001|Overall Study|Protocol Violation|0|||
33704949|NCT01907100|63271316|FG002|Overall Study|Protocol Violation|1|||
33704950|NCT01907100|63271317|FG003|Overall Study|Protocol Violation|1|||
33704951|NCT01907100|63271314|FG000|Overall Study|Lost to Follow-up|0|||
33704952|NCT01907100|63271315|FG001|Overall Study|Lost to Follow-up|0|||
33704953|NCT01907100|63271316|FG002|Overall Study|Lost to Follow-up|0|||
33704954|NCT01907100|63271317|FG003|Overall Study|Lost to Follow-up|1|||
33704955|NCT01907100|63271314|FG000|Overall Study|Not treated|2|||
33704956|NCT01907100|63271315|FG001|Overall Study|Not treated|0|||
33704957|NCT01907100|63271316|FG002|Overall Study|Not treated|1|||
33704958|NCT01907100|63271317|FG003|Overall Study|Not treated|2|||
33704959|NCT01907100|63271314|FG000|Overall Study|Other than reasons specified|1|||
33704960|NCT01907100|63271315|FG001|Overall Study|Other than reasons specified|0|||
33704961|NCT01907100|63271316|FG002|Overall Study|Other than reasons specified|10|||
33704962|NCT01907100|63271317|FG003|Overall Study|Other than reasons specified|6|||
33704963|NCT01907100|63271314|FG000|Overall Study|Adverse event (AE)|6|||
33704964|NCT01907100|63271315|FG001|Overall Study|Adverse event (AE)|3|||
33704965|NCT01907100|63271316|FG002|Overall Study|Adverse event (AE)|22|||
33704966|NCT01907100|63271317|FG003|Overall Study|Adverse event (AE)|23|||
33704967|NCT01907100|63271314|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
33704968|NCT01907100|63271315|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
33704969|NCT01907100|63271316|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
33704970|NCT01907100|63271317|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
33704971|NCT01889862|63271325|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
33704972|NCT01889862|63271326|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
33704973|NCT01889862|63271327|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
33596967|NCT02046369|62995894|FG000|Overall Study|Protocol Violation|1|||
33596968|NCT02046369|62995895|FG001|Overall Study|Protocol Violation|2|||
33596969|NCT02046369|62995894|FG000|Overall Study|Withdrawal by Subject|3|||
33596970|NCT02046369|62995895|FG001|Overall Study|Withdrawal by Subject|6|||
33596971|NCT02046369|62995894|FG000|Overall Study|never received study drug|0|||
33596972|NCT02046369|62995895|FG001|Overall Study|never received study drug|1|||
33596973|NCT02046369|62995894|FG000|Overall Study|non compliance|1|||
33596974|NCT02046369|62995895|FG001|Overall Study|non compliance|0|||
33596975|NCT02101359|62995903|FG000|Overall Study|Not included|23|||
33596976|NCT02101359|62995904|FG001|Overall Study|Not included|13|||
33596977|NCT02101359|62995903|FG000|Overall Study|Withdrawal by Subject|5|||
33596978|NCT02101359|62995904|FG001|Overall Study|Withdrawal by Subject|4|||
33596979|NCT02101359|62995903|FG000|Overall Study|Lost to Follow-up|1|||
33596980|NCT02101359|62995904|FG001|Overall Study|Lost to Follow-up|0|||
33596981|NCT02101359|62995903|FG000|Overall Study|Protocol Violation|0|||
33596982|NCT02101359|62995904|FG001|Overall Study|Protocol Violation|2|||
33596983|NCT02100969|62995910|FG000|Overall Study|Did not pass screening phase|1|||
33596984|NCT01885000|62995917|FG000|Overall Study|Adverse Event|1|||
33596985|NCT01885000|62995918|FG001|Overall Study|Adverse Event|0|||
33596986|NCT01885000|62995917|FG000|Overall Study|Withdrawal by Subject|1|||
33704974|NCT01889862|63271328|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
33596987|NCT01885000|62995918|FG001|Overall Study|Withdrawal by Subject|1|||
33596988|NCT01885000|62995917|FG000|Overall Study|Protocol Violation|0|||
33704975|NCT01889862|63271329|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
33704976|NCT01889862|63271325|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
33704977|NCT01889862|63271326|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
33704978|NCT01889862|63271327|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
33704979|NCT01889862|63271328|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
33704980|NCT01889862|63271329|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
33704981|NCT01889862|63271325|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
33704982|NCT01889862|63271326|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
33704983|NCT01889862|63271327|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
33704984|NCT01889862|63271328|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
33704985|NCT01889862|63271329|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
33704986|NCT01889862|63271325|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
33704987|NCT01889862|63271326|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
33704988|NCT01889862|63271327|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
33704989|NCT01889862|63271328|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
33704990|NCT01889862|63271329|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
33704991|NCT01889862|63271325|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
33704992|NCT01889862|63271326|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
33704993|NCT01889862|63271327|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
33704994|NCT01889862|63271328|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
33704995|NCT01889862|63271329|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
33704996|NCT01889862|63271325|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
33704997|NCT01889862|63271326|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
33704998|NCT01889862|63271327|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
33704999|NCT01889862|63271328|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
33705000|NCT01889862|63271329|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
33705001|NCT01889862|63271325|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
33705002|NCT01889862|63271326|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
33705003|NCT01889862|63271327|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
33705004|NCT01889862|63271328|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
33705005|NCT01889862|63271329|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
33705006|NCT01889862|63271325|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
33705007|NCT01889862|63271326|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
33705008|NCT01889862|63271327|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
33705009|NCT01889862|63271328|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
33705010|NCT01889862|63271329|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
33705011|NCT01889862|63271325|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
33705012|NCT01889862|63271326|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
33705013|NCT01889862|63271327|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
33705014|NCT01889862|63271328|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
33705015|NCT01889862|63271329|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
33705016|NCT01889862|63271325|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
33705017|NCT01889862|63271326|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
33705018|NCT01889862|63271327|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
33705019|NCT01889862|63271328|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
33705020|NCT01889862|63271329|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
33705021|NCT01887912|63271356|FG000|Overall Study|Serious adverse event|400|||
33705022|NCT01887912|63271357|FG001|Overall Study|Serious adverse event|198|||
33705023|NCT01887912|63271356|FG000|Overall Study|Other Adverse Event|34|||
33705024|NCT01887912|63271357|FG001|Overall Study|Other Adverse Event|15|||
33705025|NCT01887912|63271356|FG000|Overall Study|Protocol Violation|67|||
33705026|NCT01887912|63271357|FG001|Overall Study|Protocol Violation|37|||
33705027|NCT01887912|63271356|FG000|Overall Study|Lost to Follow-up|163|||
33705028|NCT01887912|63271357|FG001|Overall Study|Lost to Follow-up|74|||
33705029|NCT01887912|63271356|FG000|Overall Study|Withdrawal by Subject|606|||
33705030|NCT01887912|63271357|FG001|Overall Study|Withdrawal by Subject|349|||
33705031|NCT01887912|63271356|FG000|Overall Study|Other|122|||
33705032|NCT01887912|63271357|FG001|Overall Study|Other|58|||
33705033|NCT01887678|63271365|FG000|Overall Study|Adverse Event|4|||
33705034|NCT01887678|63271366|FG001|Overall Study|Adverse Event|6|||
33705035|NCT01887678|63271365|FG000|Overall Study|Exceeded rescue medication dosage|4|||
33705036|NCT01887678|63271366|FG001|Overall Study|Exceeded rescue medication dosage|5|||
33705037|NCT01887678|63271365|FG000|Overall Study|Withdrawal of consent|3|||
33705038|NCT01887678|63271366|FG001|Overall Study|Withdrawal of consent|4|||
33705039|NCT01887678|63271365|FG000|Overall Study|Lost to Follow-up|4|||
33705040|NCT01887678|63271366|FG001|Overall Study|Lost to Follow-up|2|||
33705041|NCT01887678|63271365|FG000|Overall Study|Deterioration of clinical condition|0|||
33705042|NCT01887678|63271366|FG001|Overall Study|Deterioration of clinical condition|4|||
33705043|NCT01887678|63271365|FG000|Overall Study|Lack of Efficacy|1|||
33705044|NCT01887678|63271366|FG001|Overall Study|Lack of Efficacy|2|||
33705045|NCT01887678|63271365|FG000|Overall Study|Non-compliance|0|||
33705046|NCT01887678|63271366|FG001|Overall Study|Non-compliance|3|||
33705047|NCT01887678|63271365|FG000|Overall Study|Specified|1|||
33705048|NCT01887678|63271366|FG001|Overall Study|Specified|2|||
33705049|NCT01887600|63271374|FG000|Overall Study|Death|39|||
33705050|NCT01887600|63271375|FG001|Overall Study|Death|16|||
33705051|NCT01887600|63271374|FG000|Overall Study|Lack of Efficacy|3|||
33705052|NCT01887600|63271375|FG001|Overall Study|Lack of Efficacy|26|||
33705053|NCT01887600|63271374|FG000|Overall Study|Lost to Follow-up|5|||
33705054|NCT01887600|63271375|FG001|Overall Study|Lost to Follow-up|1|||
33705055|NCT01887600|63271374|FG000|Overall Study|Physician Decision|7|||
33705056|NCT01887600|63271375|FG001|Overall Study|Physician Decision|8|||
33705057|NCT01887600|63271374|FG000|Overall Study|Protocol Deviation|3|||
33705058|NCT01887600|63271375|FG001|Overall Study|Protocol Deviation|0|||
33705059|NCT01887600|63271374|FG000|Overall Study|Withdrawal by Subject|58|||
33705060|NCT01887600|63271375|FG001|Overall Study|Withdrawal by Subject|52|||
33705061|NCT01887600|63271374|FG000|Overall Study|Adverse Event|21|||
33705062|NCT01887600|63271375|FG001|Overall Study|Adverse Event|9|||
33705063|NCT01887600|63271374|FG000|Overall Study|Non-compliance with study drug|3|||
33705064|NCT01887600|63271375|FG001|Overall Study|Non-compliance with study drug|0|||
33705065|NCT01887600|63271374|FG000|Overall Study|Miscellaneous|6|||
33705066|NCT01887600|63271375|FG001|Overall Study|Miscellaneous|2|||
33705067|NCT01887600|63271374|FG000|Overall Study|Progressive Disease|1|||
33705068|NCT01887600|63271375|FG001|Overall Study|Progressive Disease|0|||
33705069|NCT01887288|63271382|FG000|Overall Study|The study was terminated and the PI has|16|||
33705070|NCT01887210|63271388|FG000|Overall Study|Withdrawal by Subject|1|||
33705071|NCT01887210|63271389|FG001|Overall Study|Withdrawal by Subject|3|||
33705072|NCT01887210|63271388|FG000|Overall Study|Lost to Follow-up|0|||
33705073|NCT01887210|63271389|FG001|Overall Study|Lost to Follow-up|1|||
33705074|NCT01885182|63271420|FG000|Overall Study|Adverse Event|11|||
33705075|NCT01885182|63271421|FG001|Overall Study|Adverse Event|13|||
33705076|NCT01885182|63271420|FG000|Overall Study|Withdrawal by Subject|13|||
33705077|NCT01885182|63271421|FG001|Overall Study|Withdrawal by Subject|6|||
33705078|NCT01885182|63271420|FG000|Overall Study|Lost to Follow-up|2|||
33705079|NCT01885182|63271421|FG001|Overall Study|Lost to Follow-up|2|||
33705080|NCT01885182|63271420|FG000|Overall Study|Lack of Efficacy|8|||
33705081|NCT01885182|63271421|FG001|Overall Study|Lack of Efficacy|1|||
33705082|NCT01885104|63271431|FG000|Overall Study|Withdrawal of Consent|1|||
33705083|NCT01885104|63271432|FG001|Overall Study|Withdrawal of Consent|0|||
33705084|NCT01885104|63271431|FG000|Overall Study|Lost to Follow-up|0|||
33705085|NCT01885104|63271432|FG001|Overall Study|Lost to Follow-up|1|||
33705086|NCT01885104|63271431|FG000|Overall Study|Physician Decision|1|||
33705087|NCT01885104|63271432|FG001|Overall Study|Physician Decision|0|||
33705088|NCT01881750|63271440|FG000|Overall Study|Changes in concomitant therapies|2|||
33705089|NCT01881750|63271441|FG001|Overall Study|Changes in concomitant therapies|3|||
33705090|NCT01881750|63271440|FG000|Overall Study|Lost to Follow-up|0|||
33705091|NCT01881750|63271441|FG001|Overall Study|Lost to Follow-up|1|||
33705092|NCT01906008|63271451|FG000|Overall Study|Lost to Follow-up|2|||
33705093|NCT01906008|63271452|FG001|Overall Study|Lost to Follow-up|0|||
33705094|NCT01906008|63271451|FG000|Overall Study|Oxaliplatin toxicity|2|||
33705095|NCT01906008|63271452|FG001|Overall Study|Oxaliplatin toxicity|0|||
33705096|NCT01906008|63271451|FG000|Overall Study|Protocol Violation|0|||
33705097|NCT01906008|63271452|FG001|Overall Study|Protocol Violation|1|||
33705098|NCT01906008|63271451|FG000|Overall Study|Withdrawal by Subject|1|||
33705099|NCT01906008|63271452|FG001|Overall Study|Withdrawal by Subject|5|||
33705100|NCT01906008|63271451|FG000|Overall Study|Did not start study med|3|||
33705101|NCT01906008|63271452|FG001|Overall Study|Did not start study med|4|||
33705102|NCT01906008|63271451|FG000|Overall Study|Oxaliplatin stops|10|||
33705103|NCT01906008|63271452|FG001|Overall Study|Oxaliplatin stops|8|||
33705104|NCT01906008|63271451|FG000|Overall Study|Hospice|1|||
33705105|NCT01906008|63271452|FG001|Overall Study|Hospice|0|||
33705106|NCT01906008|63271451|FG000|Overall Study|Physician Decision|3|||
33705107|NCT01906008|63271452|FG001|Overall Study|Physician Decision|3|||
33705108|NCT01906008|63271451|FG000|Overall Study|Lack of compliance of study med|5|||
33705109|NCT01906008|63271452|FG001|Overall Study|Lack of compliance of study med|3|||
33705110|NCT01906008|63271451|FG000|Overall Study|Adverse Event|0|||
33705111|NCT01906008|63271452|FG001|Overall Study|Adverse Event|3|||
33705112|NCT01863732|63271462|FG000|Overall Study|Adverse Event|2|||
33705113|NCT01863732|63271463|FG001|Overall Study|Adverse Event|0|||
33705114|NCT01863732|63271464|FG002|Overall Study|Adverse Event|3|||
33705115|NCT01863732|63271465|FG003|Overall Study|Adverse Event|3|||
33705116|NCT01863732|63271462|FG000|Overall Study|Lack of Efficacy|1|||
33705117|NCT01863732|63271463|FG001|Overall Study|Lack of Efficacy|0|||
33493263|NCT03103152|62871479|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
33493264|NCT03103152|62871480|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
33705118|NCT01863732|63271464|FG002|Overall Study|Lack of Efficacy|2|||
33705119|NCT01863732|63271465|FG003|Overall Study|Lack of Efficacy|1|||
33705120|NCT01863732|63271462|FG000|Overall Study|Lost to Follow-up|2|||
33705121|NCT01863732|63271463|FG001|Overall Study|Lost to Follow-up|2|||
33705122|NCT01863732|63271464|FG002|Overall Study|Lost to Follow-up|1|||
33596989|NCT01885000|62995918|FG001|Overall Study|Protocol Violation|1|||
33705123|NCT01863732|63271465|FG003|Overall Study|Lost to Follow-up|1|||
33705124|NCT01863732|63271462|FG000|Overall Study|Physician Decision|1|||
33705125|NCT01863732|63271463|FG001|Overall Study|Physician Decision|0|||
33705126|NCT01863732|63271464|FG002|Overall Study|Physician Decision|1|||
33705127|NCT01863732|63271465|FG003|Overall Study|Physician Decision|0|||
33705128|NCT01863732|63271462|FG000|Overall Study|Pregnancy|0|||
33705129|NCT01863732|63271463|FG001|Overall Study|Pregnancy|0|||
33705130|NCT01863732|63271464|FG002|Overall Study|Pregnancy|0|||
33705131|NCT01863732|63271465|FG003|Overall Study|Pregnancy|1|||
33705132|NCT01863732|63271462|FG000|Overall Study|Technical problems|0|||
33705133|NCT01863732|63271463|FG001|Overall Study|Technical problems|1|||
33705134|NCT01863732|63271464|FG002|Overall Study|Technical problems|1|||
33705135|NCT01863732|63271465|FG003|Overall Study|Technical problems|0|||
33705136|NCT01863732|63271462|FG000|Overall Study|Subject/guardian decision|6|||
33705137|NCT01863732|63271463|FG001|Overall Study|Subject/guardian decision|9|||
33705138|NCT01863732|63271464|FG002|Overall Study|Subject/guardian decision|3|||
33705139|NCT01863732|63271465|FG003|Overall Study|Subject/guardian decision|1|||
33705140|NCT01863732|63271462|FG000|Overall Study|Death|1|||
33705141|NCT01863732|63271463|FG001|Overall Study|Death|0|||
33705142|NCT01863732|63271464|FG002|Overall Study|Death|0|||
33705143|NCT01863732|63271465|FG003|Overall Study|Death|1|||
33705144|NCT01905540|63271478|FG000|Period 3|Other|1|||
33705145|NCT01905540|63271479|FG001|Period 3|Other|0|||
33705146|NCT01905540|63271480|FG002|Period 3|Other|1|||
33705147|NCT01905540|63271481|FG003|Period 3|Other|1|||
33705148|NCT01904760|63271493|FG000|Overall Study|Protocol Violation|1|||
33705149|NCT01904760|63271494|FG001|Overall Study|Protocol Violation|0|||
33705150|NCT01904604|63271503|FG000|Overall Study|Withdrew before receiving dosing|0|||
33705151|NCT01904604|63271504|FG001|Overall Study|Withdrew before receiving dosing|1|||
33705152|NCT01904604|63271505|FG002|Overall Study|Withdrew before receiving dosing|0|||
33705153|NCT01904604|63271503|FG000|Overall Study|Non-compliance|1|||
33705154|NCT01904604|63271504|FG001|Overall Study|Non-compliance|0|||
33705155|NCT01904604|63271505|FG002|Overall Study|Non-compliance|0|||
33705156|NCT01904604|63271503|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
33705157|NCT01904604|63271504|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
33705158|NCT01904604|63271505|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
33705159|NCT01904604|63271503|FG000|Overall Study|Patch site reactions|1|||
33705160|NCT01904604|63271504|FG001|Overall Study|Patch site reactions|1|||
33705161|NCT01904604|63271505|FG002|Overall Study|Patch site reactions|0|||
33705162|NCT01904604|63271503|FG000|Overall Study|Increased syncope|0|||
33705163|NCT01904604|63271504|FG001|Overall Study|Increased syncope|1|||
33705164|NCT01904604|63271505|FG002|Overall Study|Increased syncope|0|||
33705165|NCT01904604|63271503|FG000|Overall Study|Unrelated illness|0|||
33705166|NCT01904604|63271504|FG001|Overall Study|Unrelated illness|1|||
33705167|NCT01904604|63271505|FG002|Overall Study|Unrelated illness|0|||
33705168|NCT01904604|63271503|FG000|Overall Study|Passed Week 52 OFC|1|||
33705169|NCT01904604|63271504|FG001|Overall Study|Passed Week 52 OFC|0|||
33705170|NCT01904604|63271505|FG002|Overall Study|Passed Week 52 OFC|0|||
33705171|NCT01904604|63271503|FG000|Overall Study|Withdrawal by Subject|1|||
33705172|NCT01904604|63271504|FG001|Overall Study|Withdrawal by Subject|2|||
33705173|NCT01904604|63271505|FG002|Overall Study|Withdrawal by Subject|0|||
33705174|NCT01904604|63271503|FG000|Overall Study|Participant Relocated|1|||
33705175|NCT01904604|63271504|FG001|Overall Study|Participant Relocated|1|||
33705176|NCT01904604|63271505|FG002|Overall Study|Participant Relocated|1|||
33705177|NCT01904604|63271503|FG000|Overall Study|Lost to Follow-up|0|||
33705178|NCT01904604|63271504|FG001|Overall Study|Lost to Follow-up|0|||
33705179|NCT01904604|63271505|FG002|Overall Study|Lost to Follow-up|1|||
33705180|NCT01904058|63271520|FG000|Overall Study|Adverse Event|2|||
33705181|NCT01904058|63271521|FG001|Overall Study|Adverse Event|0|||
33705182|NCT01904058|63271522|FG002|Overall Study|Adverse Event|0|||
33705183|NCT01904058|63271523|FG003|Overall Study|Adverse Event|0|||
33705184|NCT01904058|63271520|FG000|Overall Study|Withdrawal by Subject|1|||
33705185|NCT01904058|63271521|FG001|Overall Study|Withdrawal by Subject|0|||
33705186|NCT01904058|63271522|FG002|Overall Study|Withdrawal by Subject|1|||
33705187|NCT01904058|63271523|FG003|Overall Study|Withdrawal by Subject|0|||
33705188|NCT01904058|63271520|FG000|Overall Study|Pregnancy|0|||
33705189|NCT01904058|63271521|FG001|Overall Study|Pregnancy|0|||
33705190|NCT01904058|63271522|FG002|Overall Study|Pregnancy|0|||
33705191|NCT01904058|63271523|FG003|Overall Study|Pregnancy|1|||
33705192|NCT01881126|63271541|FG000|Overall Study|Non-compliance|1|||
33705193|NCT01881126|63271542|FG001|Overall Study|Non-compliance|1|||
33705194|NCT01881126|63271541|FG000|Overall Study|Adverse Event|0|||
33705195|NCT01881126|63271542|FG001|Overall Study|Adverse Event|1|||
33705196|NCT01614600|63271548|FG000|Overall Study|Unacceptable fit|1|||
33493265|NCT03103152|62871481|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
33705197|NCT01614600|63271548|FG000|Overall Study|Discomfort|1|||
33705198|NCT01614600|63271548|FG000|Overall Study|Unable to remove lens at the end of day|1|||
33705199|NCT01614600|63271548|FG000|Overall Study|Protocol deviation|1|||
33705200|NCT01880736|63271556|FG000|Overall Study|Adverse Event|0|||
33705201|NCT01880736|63271557|FG001|Overall Study|Adverse Event|0|||
33705202|NCT01880736|63271558|FG002|Overall Study|Adverse Event|0|||
33705203|NCT01880736|63271559|FG003|Overall Study|Adverse Event|1|||
33705204|NCT01880736|63271556|FG000|Overall Study|Withdrawal Criteria|1|||
33705205|NCT01880736|63271557|FG001|Overall Study|Withdrawal Criteria|2|||
33705206|NCT01880736|63271558|FG002|Overall Study|Withdrawal Criteria|1|||
33705207|NCT01880736|63271559|FG003|Overall Study|Withdrawal Criteria|5|||
33705208|NCT01880424|63271571|FG000|Overall Study|Adverse Event|7|||
33705209|NCT01880424|63271572|FG001|Overall Study|Adverse Event|6|||
33705210|NCT01880424|63271571|FG000|Overall Study|Lack of Efficacy|1|||
33705211|NCT01880424|63271572|FG001|Overall Study|Lack of Efficacy|4|||
33705212|NCT01880424|63271571|FG000|Overall Study|Lost to Follow-up|3|||
33705213|NCT01880424|63271572|FG001|Overall Study|Lost to Follow-up|2|||
33705214|NCT01880424|63271571|FG000|Overall Study|Protocol Violation|11|||
33705215|NCT01880424|63271572|FG001|Overall Study|Protocol Violation|13|||
33705216|NCT01880424|63271571|FG000|Overall Study|Withdrawal by Subject|10|||
33705217|NCT01880424|63271572|FG001|Overall Study|Withdrawal by Subject|30|||
33705218|NCT01880424|63271571|FG000|Overall Study|Other|1|||
33705219|NCT01880424|63271572|FG001|Overall Study|Other|0|||
33705220|NCT01862874|63271580|FG000|Overall Study|Randomized not treated|1|||
33705221|NCT01862874|63271581|FG001|Overall Study|Randomized not treated|0|||
33705222|NCT01862874|63271580|FG000|Overall Study|Adverse Event|0|||
33705223|NCT01862874|63271581|FG001|Overall Study|Adverse Event|3|||
33705224|NCT01862874|63271580|FG000|Overall Study|Lost to Follow-up|26|||
33705225|NCT01862874|63271581|FG001|Overall Study|Lost to Follow-up|29|||
33705226|NCT01862874|63271580|FG000|Overall Study|Physician Decision|5|||
33705227|NCT01862874|63271581|FG001|Overall Study|Physician Decision|3|||
33705228|NCT01862874|63271580|FG000|Overall Study|Withdrawn by parent/guardian|1|||
33705229|NCT01862874|63271581|FG001|Overall Study|Withdrawn by parent/guardian|1|||
33705230|NCT01862874|63271580|FG000|Overall Study|Withdrawal by Subject|46|||
33705231|NCT01862874|63271581|FG001|Overall Study|Withdrawal by Subject|40|||
33705232|NCT01862874|63271580|FG000|Overall Study|Death|0|||
33705233|NCT01862874|63271581|FG001|Overall Study|Death|1|||
33705234|NCT01879722|63271597|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33705235|NCT01879722|63271598|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
33705236|NCT01879722|63271599|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
33705237|NCT01879722|63271600|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
33705238|NCT01879722|63271601|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
33705239|NCT01879722|63271602|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
33705240|NCT01879722|63271603|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
33705241|NCT01879722|63271604|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
33705242|NCT01879722|63271605|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
33705243|NCT01879722|63271606|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
33705244|NCT01879722|63271597|FG000|Overall Study|Voluntary Withdrawal|0|||
33705245|NCT01879722|63271598|FG001|Overall Study|Voluntary Withdrawal|0|||
33705246|NCT01879722|63271599|FG002|Overall Study|Voluntary Withdrawal|0|||
33705247|NCT01879722|63271600|FG003|Overall Study|Voluntary Withdrawal|0|||
33705248|NCT01879722|63271601|FG004|Overall Study|Voluntary Withdrawal|0|||
33705249|NCT01879722|63271602|FG005|Overall Study|Voluntary Withdrawal|0|||
33705250|NCT01879722|63271603|FG006|Overall Study|Voluntary Withdrawal|0|||
33705251|NCT01879722|63271604|FG007|Overall Study|Voluntary Withdrawal|0|||
33705252|NCT01879722|63271605|FG008|Overall Study|Voluntary Withdrawal|1|||
33705253|NCT01879722|63271606|FG009|Overall Study|Voluntary Withdrawal|0|||
33705254|NCT01879410|63271633|FG000|Overall Study|Adverse Event|9|||
33705255|NCT01879410|63271634|FG001|Overall Study|Adverse Event|14|||
33705256|NCT01879410|63271633|FG000|Overall Study|Lack of Efficacy|4|||
33705257|NCT01879410|63271634|FG001|Overall Study|Lack of Efficacy|6|||
33705258|NCT01879410|63271633|FG000|Overall Study|Protocol Violation|1|||
33705259|NCT01879410|63271634|FG001|Overall Study|Protocol Violation|7|||
33705260|NCT01879410|63271633|FG000|Overall Study|Lost to Follow-up|2|||
33705261|NCT01879410|63271634|FG001|Overall Study|Lost to Follow-up|1|||
33705262|NCT01879410|63271633|FG000|Overall Study|Withdrawal by Subject|7|||
33705263|NCT01879410|63271634|FG001|Overall Study|Withdrawal by Subject|8|||
33705264|NCT01879410|63271633|FG000|Overall Study|Randomised in Error|1|||
33705265|NCT01879410|63271634|FG001|Overall Study|Randomised in Error|2|||
33705266|NCT01903434|63271640|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
33705267|NCT01903434|63271641|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
33705268|NCT01903434|63271640|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
33705269|NCT01903434|63271641|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
33705270|NCT01903356|63271647|FG000|Overall Study|Lost to Follow-up|7|||
33705271|NCT01903356|63271647|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
33705272|NCT01903356|63271647|FG000|Overall Study|Violated the dosage and administration|3|||
33705273|NCT01862796|63271654|FG000|Overall Study|Prohibited medications|0|||
33705274|NCT01862796|63271655|FG001|Overall Study|Prohibited medications|0|||
33705275|NCT01862796|63271656|FG002|Overall Study|Prohibited medications|1|||
33493266|NCT03103152|62871482|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
33705276|NCT01878084|63271664|FG000|Overall Study|Physician Decision|2|||
33705277|NCT01862640|63271673|FG000|Overall Study|Adverse Event|4|||
33705278|NCT01862640|63271674|FG001|Overall Study|Adverse Event|10|||
33705279|NCT01862640|63271675|FG002|Overall Study|Adverse Event|6|||
33705280|NCT01862640|63271676|FG003|Overall Study|Adverse Event|8|||
33705281|NCT01862640|63271673|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
33705282|NCT01862640|63271674|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
33705283|NCT01862640|63271675|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
33705284|NCT01862640|63271676|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
33705285|NCT01862640|63271673|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
33705286|NCT01862640|63271674|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
33705287|NCT01862640|63271675|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
33705288|NCT01862640|63271676|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
33705289|NCT01862640|63271673|FG000|Overall Study|Withdrawal by Subject|2|||
33705290|NCT01862640|63271674|FG001|Overall Study|Withdrawal by Subject|4|||
33705291|NCT01862640|63271675|FG002|Overall Study|Withdrawal by Subject|8|||
33705292|NCT01862640|63271676|FG003|Overall Study|Withdrawal by Subject|5|||
33705293|NCT01862640|63271673|FG000|Overall Study|Protocol Deviation|0|||
33705294|NCT01862640|63271674|FG001|Overall Study|Protocol Deviation|0|||
33705295|NCT01862640|63271675|FG002|Overall Study|Protocol Deviation|1|||
33705296|NCT01862640|63271676|FG003|Overall Study|Protocol Deviation|0|||
33705297|NCT01902966|63271685|FG000|Overall Study|Death|1|||
33705298|NCT01902966|63271685|FG000|Overall Study|Physician Decision|1|||
33705299|NCT01902966|63271685|FG000|Overall Study|Withdrawal by Subject|1|||
33705300|NCT01862484|63271691|FG000|Overall Study|Lack of Efficacy|1|||
33705301|NCT01862484|63271692|FG001|Overall Study|Lack of Efficacy|1|||
33705302|NCT01862484|63271691|FG000|Overall Study|Lost to Follow-up|1|||
33705303|NCT01862484|63271692|FG001|Overall Study|Lost to Follow-up|2|||
33705304|NCT01862484|63271691|FG000|Overall Study|Protocol Violation|0|||
33705305|NCT01862484|63271692|FG001|Overall Study|Protocol Violation|2|||
33705306|NCT01862484|63271691|FG000|Overall Study|Withdrawal by Subject|0|||
33705307|NCT01862484|63271692|FG001|Overall Study|Withdrawal by Subject|3|||
33705308|NCT01902888|63271698|FG000|Overall Study|Study Terminated|3|||
33705309|NCT01862328|63271709|FG000|Overall Study|Progressive Disease|3|||
33705310|NCT01862328|63271710|FG001|Overall Study|Progressive Disease|11|||
33705311|NCT01862328|63271711|FG002|Overall Study|Progressive Disease|5|||
33705312|NCT01862328|63271712|FG003|Overall Study|Progressive Disease|6|||
33705313|NCT01862328|63271713|FG004|Overall Study|Progressive Disease|7|||
33705314|NCT01862328|63271714|FG005|Overall Study|Progressive Disease|4|||
33705315|NCT01862328|63271715|FG006|Overall Study|Progressive Disease|3|||
33705316|NCT01862328|63271709|FG000|Overall Study|Adverse Event|0|||
33705317|NCT01862328|63271710|FG001|Overall Study|Adverse Event|4|||
33705318|NCT01862328|63271711|FG002|Overall Study|Adverse Event|0|||
33705319|NCT01862328|63271712|FG003|Overall Study|Adverse Event|1|||
33705320|NCT01862328|63271713|FG004|Overall Study|Adverse Event|0|||
33705321|NCT01862328|63271714|FG005|Overall Study|Adverse Event|2|||
33705322|NCT01862328|63271715|FG006|Overall Study|Adverse Event|4|||
33705323|NCT01862328|63271709|FG000|Overall Study|Other|0|||
33705324|NCT01862328|63271710|FG001|Overall Study|Other|2|||
33705325|NCT01862328|63271711|FG002|Overall Study|Other|1|||
33705326|NCT01862328|63271712|FG003|Overall Study|Other|0|||
33705327|NCT01862328|63271713|FG004|Overall Study|Other|4|||
33705328|NCT01862328|63271714|FG005|Overall Study|Other|0|||
33705329|NCT01862328|63271715|FG006|Overall Study|Other|1|||
33705330|NCT01862328|63271709|FG000|Overall Study|Withdrawal by Subject|1|||
33705331|NCT01862328|63271710|FG001|Overall Study|Withdrawal by Subject|1|||
33705332|NCT01862328|63271711|FG002|Overall Study|Withdrawal by Subject|0|||
33705333|NCT01862328|63271712|FG003|Overall Study|Withdrawal by Subject|0|||
33705334|NCT01862328|63271713|FG004|Overall Study|Withdrawal by Subject|1|||
33705335|NCT01862328|63271714|FG005|Overall Study|Withdrawal by Subject|1|||
33705336|NCT01862328|63271715|FG006|Overall Study|Withdrawal by Subject|1|||
33705337|NCT01862328|63271709|FG000|Overall Study|Symptomatic Deterioration|0|||
33705338|NCT01862328|63271710|FG001|Overall Study|Symptomatic Deterioration|0|||
33705339|NCT01862328|63271711|FG002|Overall Study|Symptomatic Deterioration|0|||
33705340|NCT01862328|63271712|FG003|Overall Study|Symptomatic Deterioration|0|||
33705341|NCT01862328|63271713|FG004|Overall Study|Symptomatic Deterioration|0|||
33705342|NCT01862328|63271714|FG005|Overall Study|Symptomatic Deterioration|0|||
33705343|NCT01862328|63271715|FG006|Overall Study|Symptomatic Deterioration|1|||
33705344|NCT01862250|63271737|FG000|Overall Study|Adverse Event|4|||
33705345|NCT01860846|63271741|FG000|Overall Study|Lost to Follow-up|33|||
33705346|NCT01901874|63271745|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
33705347|NCT01901874|63271745|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
33705348|NCT01901874|63271745|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
33705349|NCT01901874|63271745|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
33705350|NCT01901874|63271745|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
33705351|NCT01901874|63271745|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
33705352|NCT01860534|63271751|FG000|ROP #1|Needed treatment for ROP|0|||
33705353|NCT01860534|63271752|FG001|ROP #1|Needed treatment for ROP|1|||
33705354|NCT01860534|63271751|FG000|ROP #2|discharged prior to ROP #2|1|||
33705355|NCT01860534|63271752|FG001|ROP #2|discharged prior to ROP #2|0|||
33705356|NCT01901328|63271762|FG000|Overall Study|Lost to Follow-up|1|||
33705357|NCT01901328|63271763|FG001|Overall Study|Lost to Follow-up|0|||
33705358|NCT01901328|63271762|FG000|Overall Study|Physician Decision|0|||
33705359|NCT01901328|63271763|FG001|Overall Study|Physician Decision|1|||
33705360|NCT01901328|63271762|FG000|Overall Study|Protocol Violation|1|||
33705361|NCT01901328|63271763|FG001|Overall Study|Protocol Violation|1|||
33705362|NCT01901328|63271762|FG000|Overall Study|Study Terminated by Sponsor|19|||
33705363|NCT01901328|63271763|FG001|Overall Study|Study Terminated by Sponsor|16|||
33705364|NCT01901328|63271762|FG000|Overall Study|Withdrawal by Subject|1|||
33705365|NCT01901328|63271763|FG001|Overall Study|Withdrawal by Subject|2|||
33705366|NCT01901328|63271762|FG000|Overall Study|Lack of Efficacy|0|||
33705367|NCT01901328|63271763|FG001|Overall Study|Lack of Efficacy|1|||
33705368|NCT01859988|63271776|FG000|Overall Study|Withdrawal by Subject|6|||
33705369|NCT01859988|63271777|FG001|Overall Study|Withdrawal by Subject|3|||
33705370|NCT01859988|63271778|FG002|Overall Study|Withdrawal by Subject|4|||
33705371|NCT01859988|63271779|FG003|Overall Study|Withdrawal by Subject|3|||
33705372|NCT01859988|63271780|FG004|Overall Study|Withdrawal by Subject|2|||
33705373|NCT01859988|63271781|FG005|Overall Study|Withdrawal by Subject|2|||
33705374|NCT01859988|63271776|FG000|Overall Study|Lack of Efficacy|1|||
33705375|NCT01859988|63271777|FG001|Overall Study|Lack of Efficacy|1|||
33705376|NCT01859988|63271778|FG002|Overall Study|Lack of Efficacy|5|||
33705377|NCT01859988|63271779|FG003|Overall Study|Lack of Efficacy|0|||
33705378|NCT01859988|63271780|FG004|Overall Study|Lack of Efficacy|7|||
33705379|NCT01859988|63271781|FG005|Overall Study|Lack of Efficacy|9|||
33705380|NCT01859988|63271776|FG000|Overall Study|Physician Decision|1|||
33705381|NCT01859988|63271777|FG001|Overall Study|Physician Decision|3|||
33705382|NCT01859988|63271778|FG002|Overall Study|Physician Decision|1|||
33705383|NCT01859988|63271779|FG003|Overall Study|Physician Decision|3|||
33705384|NCT01859988|63271780|FG004|Overall Study|Physician Decision|4|||
33705385|NCT01859988|63271781|FG005|Overall Study|Physician Decision|1|||
33705386|NCT01859988|63271776|FG000|Overall Study|Adverse Event|2|||
33705387|NCT01859988|63271777|FG001|Overall Study|Adverse Event|1|||
33705388|NCT01859988|63271778|FG002|Overall Study|Adverse Event|3|||
33705389|NCT01859988|63271779|FG003|Overall Study|Adverse Event|1|||
33705390|NCT01859988|63271780|FG004|Overall Study|Adverse Event|2|||
33705391|NCT01859988|63271781|FG005|Overall Study|Adverse Event|2|||
33705392|NCT01859988|63271776|FG000|Overall Study|Lost to Follow-up|1|||
33705393|NCT01859988|63271777|FG001|Overall Study|Lost to Follow-up|2|||
33705394|NCT01859988|63271778|FG002|Overall Study|Lost to Follow-up|3|||
33705395|NCT01859988|63271779|FG003|Overall Study|Lost to Follow-up|0|||
33705396|NCT01859988|63271780|FG004|Overall Study|Lost to Follow-up|3|||
33705397|NCT01859988|63271781|FG005|Overall Study|Lost to Follow-up|2|||
33705398|NCT01859988|63271776|FG000|Overall Study|Protocol Violation|0|||
33705399|NCT01859988|63271777|FG001|Overall Study|Protocol Violation|0|||
33705400|NCT01859988|63271778|FG002|Overall Study|Protocol Violation|1|||
33705401|NCT01859988|63271779|FG003|Overall Study|Protocol Violation|0|||
33705402|NCT01859988|63271780|FG004|Overall Study|Protocol Violation|0|||
33705403|NCT01859988|63271781|FG005|Overall Study|Protocol Violation|0|||
33705404|NCT01859988|63271776|FG000|Overall Study|Other than specified above|0|||
33705405|NCT01859988|63271777|FG001|Overall Study|Other than specified above|2|||
33705406|NCT01859988|63271778|FG002|Overall Study|Other than specified above|11|||
33705407|NCT01859988|63271779|FG003|Overall Study|Other than specified above|3|||
33705408|NCT01859988|63271780|FG004|Overall Study|Other than specified above|5|||
33705409|NCT01859988|63271781|FG005|Overall Study|Other than specified above|3|||
33705410|NCT01859598|63271795|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
33705411|NCT01876446|63271803|FG000|Overall Study|Death|0|||
33705412|NCT01876446|63271804|FG001|Overall Study|Death|1|||
33705413|NCT01876446|63271803|FG000|Overall Study|Withdrawal by Subject|1|||
33705414|NCT01876446|63271804|FG001|Overall Study|Withdrawal by Subject|2|||
33705415|NCT01876446|63271803|FG000|Overall Study|Physician Decision|1|||
33705416|NCT01876446|63271804|FG001|Overall Study|Physician Decision|3|||
33705417|NCT01900626|63271812|FG000|Overall Study|study was closed due to low enrollment|1|||
33705418|NCT01900626|63271813|FG001|Overall Study|study was closed due to low enrollment|1|||
33705419|NCT01900314|63271823|FG000|Overall Study|Lost to Follow-up|1|||
33705420|NCT01900314|63271824|FG001|Overall Study|Lost to Follow-up|0|||
33705421|NCT01900314|63271823|FG000|Overall Study|Protocol Violation|0|||
33705422|NCT01900314|63271824|FG001|Overall Study|Protocol Violation|1|||
33705423|NCT01900314|63271823|FG000|Overall Study|Withdrawal by Subject|3|||
33705424|NCT01900314|63271824|FG001|Overall Study|Withdrawal by Subject|3|||
33705425|NCT01899768|63271831|FG000|Part A|Adverse Event|2|||
33705426|NCT01899768|63271831|FG000|Part A|Withdrawal by Subject|1|||
33705427|NCT01899768|63271831|FG000|Part B|Adverse Event|1|||
33705428|NCT01899768|63271831|FG000|Part B|Withdrawal by Subject|1|||
33705429|NCT01898598|63271841|FG000|Overall Study|Adverse Event|1|||
33705430|NCT01898598|63271842|FG001|Overall Study|Adverse Event|0|||
33705431|NCT01898598|63271841|FG000|Overall Study|Withdrawal by Subject|3|||
33705432|NCT01898598|63271842|FG001|Overall Study|Withdrawal by Subject|0|||
33705433|NCT01898598|63271841|FG000|Overall Study|Lost to Follow-up|0|||
33705434|NCT01898598|63271842|FG001|Overall Study|Lost to Follow-up|1|||
33705435|NCT01898598|63271841|FG000|Overall Study|Other|0|||
33705436|NCT01898598|63271842|FG001|Overall Study|Other|1|||
33705437|NCT01898442|63271851|FG000|Overall Study|Hemolysis/technical problems|1|||
33705438|NCT01898442|63271852|FG001|Overall Study|Hemolysis/technical problems|2|||
33705439|NCT01898442|63271853|FG002|Overall Study|Hemolysis/technical problems|2|||
33705440|NCT01898442|63271851|FG000|Overall Study|Patient vomited pills|0|||
33705441|NCT01898442|63271852|FG001|Overall Study|Patient vomited pills|0|||
33705442|NCT01898442|63271853|FG002|Overall Study|Patient vomited pills|1|||
33705443|NCT01898286|63271861|FG000|Overall Study|Withdrawal by Subject|1|||
33705444|NCT01898286|63271861|FG000|Overall Study|Protocol Violation|1|||
33705445|NCT01898286|63271861|FG000|Overall Study|Lost to Follow-up|1|||
33705446|NCT01898208|63271868|FG000|Overall Study|Positive blood culture|17|||
33705447|NCT01898208|63271869|FG001|Overall Study|Positive blood culture|23|||
33705448|NCT01898208|63271870|FG002|Overall Study|Positive blood culture|15|||
33705449|NCT01898208|63271868|FG000|Overall Study|Death/comfort care within 24 hours|10|||
33705450|NCT01898208|63271869|FG001|Overall Study|Death/comfort care within 24 hours|9|||
33705451|NCT01898208|63271870|FG002|Overall Study|Death/comfort care within 24 hours|8|||
33705452|NCT01898208|63271868|FG000|Overall Study|Negative Gram Stain|6|||
33705453|NCT01898208|63271869|FG001|Overall Study|Negative Gram Stain|9|||
33705454|NCT01898208|63271870|FG002|Overall Study|Negative Gram Stain|6|||
33705455|NCT01898208|63271868|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
33705456|NCT01898208|63271869|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
33705457|NCT01898208|63271870|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
33705458|NCT01898208|63271868|FG000|Overall Study|System/Technical Error|1|||
33705459|NCT01898208|63271869|FG001|Overall Study|System/Technical Error|2|||
33705460|NCT01898208|63271870|FG002|Overall Study|System/Technical Error|3|||
33705461|NCT01898208|63271868|FG000|Overall Study|Lost to Follow-up|3|||
33705462|NCT01898208|63271869|FG001|Overall Study|Lost to Follow-up|1|||
33705463|NCT01898208|63271870|FG002|Overall Study|Lost to Follow-up|1|||
33705464|NCT01898130|63271878|FG000|Treatment|Withdrawal by Subject|2|||
33705465|NCT01898130|63271878|FG000|Treatment|Progressive Disease|4|||
33705466|NCT01898130|63271878|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
33705467|NCT01876368|63271884|FG000|Overall Study|Adverse Event|2|||
33705468|NCT01876368|63271885|FG001|Overall Study|Adverse Event|5|||
33705469|NCT01876368|63271884|FG000|Overall Study|Lack of Efficacy|1|||
33705470|NCT01876368|63271885|FG001|Overall Study|Lack of Efficacy|0|||
33705471|NCT01876368|63271884|FG000|Overall Study|Lost to Follow-up|0|||
33705472|NCT01876368|63271885|FG001|Overall Study|Lost to Follow-up|1|||
33705473|NCT01876368|63271884|FG000|Overall Study|Non-compliance with study treatment|0|||
33705474|NCT01876368|63271885|FG001|Overall Study|Non-compliance with study treatment|1|||
33705475|NCT01876368|63271884|FG000|Overall Study|Physician Decision|0|||
33705476|NCT01876368|63271885|FG001|Overall Study|Physician Decision|2|||
33705477|NCT01876368|63271884|FG000|Overall Study|Protocol deviation|3|||
33705478|NCT01876368|63271885|FG001|Overall Study|Protocol deviation|3|||
33705479|NCT01876368|63271884|FG000|Overall Study|Subject/guardian decision|3|||
33705480|NCT01876368|63271885|FG001|Overall Study|Subject/guardian decision|1|||
33705481|NCT01874340|63271895|FG000|Overall Study|Study terminated by Sponsor|6|||
33705482|NCT01874340|63271896|FG001|Overall Study|Study terminated by Sponsor|8|||
33705483|NCT01874340|63271897|FG002|Overall Study|Study terminated by Sponsor|8|||
33705484|NCT01874340|63271898|FG003|Overall Study|Study terminated by Sponsor|4|||
33705485|NCT01874340|63271895|FG000|Overall Study|Withdrawal by Subject|0|||
33705486|NCT01874340|63271896|FG001|Overall Study|Withdrawal by Subject|0|||
33705487|NCT01874340|63271897|FG002|Overall Study|Withdrawal by Subject|0|||
33705488|NCT01874340|63271898|FG003|Overall Study|Withdrawal by Subject|1|||
33705489|NCT01897896|63271910|FG000|Overall Study|Death|1|||
33705490|NCT01897896|63271911|FG001|Overall Study|Death|0|||
33705491|NCT01897896|63271910|FG000|Overall Study|Adverse Event|11|||
33705492|NCT01897896|63271911|FG001|Overall Study|Adverse Event|1|||
33705493|NCT01897896|63271910|FG000|Overall Study|Lost to Follow-up|1|||
33705494|NCT01897896|63271911|FG001|Overall Study|Lost to Follow-up|0|||
33705495|NCT01897896|63271910|FG000|Overall Study|Non-compliance with study drug dosing|1|||
33705496|NCT01897896|63271911|FG001|Overall Study|Non-compliance with study drug dosing|1|||
33705497|NCT01897896|63271910|FG000|Overall Study|Withdrawal by Subject|7|||
33705498|NCT01897896|63271911|FG001|Overall Study|Withdrawal by Subject|1|||
33705499|NCT01897896|63271910|FG000|Overall Study|Require drug that interfere with study|1|||
33705500|NCT01897896|63271911|FG001|Overall Study|Require drug that interfere with study|4|||
33705501|NCT01897896|63271910|FG000|Overall Study|Protocol Violation|1|||
33705502|NCT01897896|63271911|FG001|Overall Study|Protocol Violation|1|||
33705503|NCT01897896|63271910|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
33705504|NCT01897896|63271911|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
33705505|NCT01897896|63271910|FG000|Overall Study|Caregiver can no longer participate|0|||
33705506|NCT01897896|63271911|FG001|Overall Study|Caregiver can no longer participate|2|||
33705507|NCT01897896|63271910|FG000|Overall Study|Other than specified|2|||
33705508|NCT01897896|63271911|FG001|Overall Study|Other than specified|1|||
33705509|NCT01858194|63271921|FG000|Overall Study|Total Artificial Heart Implant|0|||
33705510|NCT01858194|63271922|FG001|Overall Study|Total Artificial Heart Implant|1|||
33705511|NCT01858194|63271921|FG000|Overall Study|Lost to Follow-up|0|||
33705512|NCT01858194|63271922|FG001|Overall Study|Lost to Follow-up|1|||
33705513|NCT01873950|63271930|FG000|Period 5|Withdrawal by Subject|0|||
33705514|NCT01873950|63271931|FG001|Period 5|Withdrawal by Subject|0|||
33705515|NCT01873950|63271932|FG002|Period 5|Withdrawal by Subject|0|||
33705516|NCT01873950|63271933|FG003|Period 5|Withdrawal by Subject|1|||
33705517|NCT01873950|63271934|FG004|Period 5|Withdrawal by Subject|0|||
33705518|NCT01857102|63271948|FG000|Period 1|No longer meets Eligibility Criteria|0|||
33705519|NCT01857102|63271949|FG001|Period 1|No longer meets Eligibility Criteria|2|||
33705520|NCT01857102|63271948|FG000|Period 1|Lost to Follow-up|0|||
33705521|NCT01857102|63271949|FG001|Period 1|Lost to Follow-up|3|||
33705522|NCT01857102|63271948|FG000|Period 1|Unsatisfactory Lens Fit|1|||
33705523|NCT01857102|63271949|FG001|Period 1|Unsatisfactory Lens Fit|0|||
33705524|NCT01857102|63271948|FG000|Period 1|Unsatisfactory Visual Response|1|||
33705525|NCT01857102|63271949|FG001|Period 1|Unsatisfactory Visual Response|0|||
33705526|NCT01857102|63271948|FG000|Period 1|Physician Decision|1|||
33705527|NCT01857102|63271949|FG001|Period 1|Physician Decision|0|||
33705528|NCT01857102|63271948|FG000|Period 2|Lens Discomfort|1|||
33705529|NCT01857102|63271949|FG001|Period 2|Lens Discomfort|0|||
33705530|NCT01857102|63271948|FG000|Period 2|Unsatisfactory Lens Fit|1|||
33705531|NCT01857102|63271949|FG001|Period 2|Unsatisfactory Lens Fit|0|||
33705532|NCT01872078|63271961|FG000|Overall Study|Adverse Event|0|||
33705533|NCT01872078|63271962|FG001|Overall Study|Adverse Event|0|||
33705534|NCT01872078|63271963|FG002|Overall Study|Adverse Event|1|||
33705535|NCT01872078|63271964|FG003|Overall Study|Adverse Event|0|||
33705536|NCT01872078|63271961|FG000|Overall Study|Dose administration non-compliance|0|||
33705537|NCT01872078|63271962|FG001|Overall Study|Dose administration non-compliance|0|||
33705538|NCT01872078|63271963|FG002|Overall Study|Dose administration non-compliance|0|||
33705539|NCT01872078|63271964|FG003|Overall Study|Dose administration non-compliance|1|||
33705540|NCT01872078|63271961|FG000|Overall Study|Protocol Violation|0|||
33705541|NCT01872078|63271962|FG001|Overall Study|Protocol Violation|0|||
33705542|NCT01872078|63271963|FG002|Overall Study|Protocol Violation|1|||
33705543|NCT01872078|63271964|FG003|Overall Study|Protocol Violation|0|||
33705544|NCT01872078|63271961|FG000|Overall Study|Withdrawal by Subject|0|||
33705545|NCT01872078|63271962|FG001|Overall Study|Withdrawal by Subject|0|||
33705546|NCT01872078|63271963|FG002|Overall Study|Withdrawal by Subject|1|||
33705547|NCT01872078|63271964|FG003|Overall Study|Withdrawal by Subject|0|||
33705548|NCT01872078|63271961|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
33705549|NCT01872078|63271962|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
33705550|NCT01872078|63271963|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
33705551|NCT01872078|63271964|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
33705552|NCT01896726|63271974|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
33705553|NCT01896726|63271974|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
33705554|NCT01856790|63271981|FG000|Closed Loop Control|Withdrawal by Subject|2|||
33705555|NCT01856790|63271981|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
33705556|NCT01856322|63271995|FG000|Overall Study|off study due to lack of accrual|0|||
33705557|NCT01856322|63271996|FG001|Overall Study|off study due to lack of accrual|0|||
33705558|NCT01856322|63271997|FG002|Overall Study|off study due to lack of accrual|3|||
33705559|NCT01896102|63272004|FG000|Overall Study|Death|1|||
33705560|NCT01896102|63272004|FG000|Overall Study|Participant to receive allogenic transplant|2|||
33705561|NCT01871532|63272011|FG000|Overall Study|Withdrawal by Subject|1|||
33705562|NCT01871532|63272012|FG001|Overall Study|Withdrawal by Subject|2|||
33705563|NCT01855074|63272018|FG000|Overall Study|Adverse Event|1|||
33705564|NCT01855074|63272018|FG000|Overall Study|Lost to Follow-up|4|||
33705565|NCT01855074|63272018|FG000|Overall Study|Withdrawal by Subject|8|||
33705566|NCT01855074|63272018|FG000|Overall Study|Started but not treated|1|||
33705567|NCT01871142|63272022|FG000|Overall Study|Adverse Event|1|||
33705568|NCT01895322|63272036|FG000|Overall Study|Adverse Event|1|||
33705569|NCT01895322|63272036|FG000|Overall Study|Withdrawal by Subject|2|||
33705570|NCT01895322|63272036|FG000|Overall Study|Protocol Violation|10|||
33705571|NCT01894776|63272041|FG000|Overall Study|Withdrawal by Subject|1|||
33705572|NCT01894620|63272047|FG000|Overall Study|Withdrawal by Subject|0|||
33705573|NCT01894620|63272048|FG001|Overall Study|Withdrawal by Subject|1|||
33705574|NCT01854918|63272058|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
33705575|NCT01854918|63272059|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
33705576|NCT01854918|63272058|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
33705577|NCT01854918|63272059|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
33705578|NCT01854918|63272058|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
33705579|NCT01854918|63272059|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
33705580|NCT01854918|63272058|FG000|SOC-controlled Period (Year 1)|Death|5|||
33705581|NCT01854918|63272059|FG001|SOC-controlled Period (Year 1)|Death|5|||
33705582|NCT01854918|63272058|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
33705583|NCT01854918|63272059|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
33705584|NCT01854918|63272058|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
33705585|NCT01854918|63272059|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
33705586|NCT01854918|63272058|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
33705587|NCT01854918|63272059|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
33705588|NCT01854918|63272058|FG000|All-IP Period (Years 2 and 3)|Death|5|||
33705589|NCT01854918|63272059|FG001|All-IP Period (Years 2 and 3)|Death|16|||
33705590|NCT01894230|63272074|FG000|Overall Study|Lost to Follow-up|2|||
33705591|NCT01894230|63272075|FG001|Overall Study|Lost to Follow-up|2|||
33705592|NCT01894230|63272074|FG000|Overall Study|Withdrawal by Subject|4|||
33705593|NCT01894230|63272075|FG001|Overall Study|Withdrawal by Subject|4|||
33705594|NCT01894230|63272074|FG000|Overall Study|Non-adherent|0|||
33705595|NCT01894230|63272075|FG001|Overall Study|Non-adherent|1|||
33705596|NCT01894230|63272074|FG000|Overall Study|Death|1|||
33705597|NCT01894230|63272075|FG001|Overall Study|Death|0|||
33705598|NCT01894152|63272081|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
33705599|NCT01854528|63272087|FG000|Overall Study|Adverse Event|0|||
33705600|NCT01854528|63272088|FG001|Overall Study|Adverse Event|4|||
33705601|NCT01854528|63272087|FG000|Overall Study|Withdrawal by Subject|0|||
33705602|NCT01854528|63272088|FG001|Overall Study|Withdrawal by Subject|2|||
33705603|NCT01854528|63272087|FG000|Overall Study|Virologic Failure|0|||
33705604|NCT01854528|63272088|FG001|Overall Study|Virologic Failure|9|||
33705605|NCT01853982|63272096|FG000|Overall Study|Withdrawal by Subject|1|||
33705606|NCT01853982|63272097|FG001|Overall Study|Withdrawal by Subject|0|||
33705607|NCT01853982|63272096|FG000|Overall Study|Death|1|||
33705608|NCT01853982|63272097|FG001|Overall Study|Death|0|||
33705609|NCT01853982|63272096|FG000|Overall Study|Lost to Follow-up|0|||
33705610|NCT01853982|63272097|FG001|Overall Study|Lost to Follow-up|1|||
33705611|NCT01853280|63272105|FG000|Overall Study|Lack of Efficacy|2|||
33705612|NCT01853280|63272106|FG001|Overall Study|Lack of Efficacy|2|||
33705613|NCT01853280|63272105|FG000|Overall Study|Lost to Follow-up|0|||
33705614|NCT01853280|63272106|FG001|Overall Study|Lost to Follow-up|1|||
33705615|NCT01853280|63272105|FG000|Overall Study|Physician Decision|0|||
33705616|NCT01853280|63272106|FG001|Overall Study|Physician Decision|1|||
33705617|NCT01853280|63272105|FG000|Overall Study|Withdrawal by Subject|0|||
33705618|NCT01853280|63272106|FG001|Overall Study|Withdrawal by Subject|1|||
33705619|NCT01853280|63272105|FG000|Overall Study|Ineligible|0|||
33705620|NCT01853280|63272106|FG001|Overall Study|Ineligible|1|||
33705621|NCT01892436|63272116|FG000|Overall Study|Withdrawal by Subject|8|||
33705622|NCT01892436|63272117|FG001|Overall Study|Withdrawal by Subject|15|||
33705623|NCT01892436|63272118|FG002|Overall Study|Withdrawal by Subject|4|||
33705624|NCT01892436|63272119|FG003|Overall Study|Withdrawal by Subject|4|||
33705625|NCT01892436|63272116|FG000|Overall Study|Death|1|||
33705626|NCT01892436|63272117|FG001|Overall Study|Death|1|||
33705627|NCT01892436|63272118|FG002|Overall Study|Death|0|||
33705628|NCT01892436|63272119|FG003|Overall Study|Death|0|||
33705629|NCT01892436|63272116|FG000|Overall Study|Physician Decision|2|||
33705630|NCT01892436|63272117|FG001|Overall Study|Physician Decision|1|||
33705631|NCT01892436|63272118|FG002|Overall Study|Physician Decision|0|||
33705632|NCT01892436|63272119|FG003|Overall Study|Physician Decision|1|||
33705633|NCT01892436|63272116|FG000|Overall Study|Pregnancy|0|||
33705634|NCT01892436|63272117|FG001|Overall Study|Pregnancy|2|||
33705635|NCT01892436|63272118|FG002|Overall Study|Pregnancy|1|||
33705636|NCT01892436|63272119|FG003|Overall Study|Pregnancy|0|||
33705637|NCT01892436|63272116|FG000|Overall Study|Technical problems|2|||
33705638|NCT01892436|63272117|FG001|Overall Study|Technical problems|1|||
33705639|NCT01892436|63272118|FG002|Overall Study|Technical problems|1|||
33705640|NCT01892436|63272119|FG003|Overall Study|Technical problems|1|||
33705641|NCT01892436|63272116|FG000|Overall Study|Lack of Efficacy|1|||
33705642|NCT01892436|63272117|FG001|Overall Study|Lack of Efficacy|2|||
33705643|NCT01892436|63272118|FG002|Overall Study|Lack of Efficacy|2|||
33705644|NCT01892436|63272119|FG003|Overall Study|Lack of Efficacy|2|||
33705645|NCT01892436|63272116|FG000|Overall Study|Lost to Follow-up|1|||
33705646|NCT01892436|63272117|FG001|Overall Study|Lost to Follow-up|1|||
33705647|NCT01892436|63272118|FG002|Overall Study|Lost to Follow-up|1|||
33705648|NCT01892436|63272119|FG003|Overall Study|Lost to Follow-up|3|||
33705649|NCT01892436|63272116|FG000|Overall Study|non-compliance with treatment|1|||
33705650|NCT01892436|63272117|FG001|Overall Study|non-compliance with treatment|0|||
33705651|NCT01892436|63272118|FG002|Overall Study|non-compliance with treatment|0|||
33705652|NCT01892436|63272119|FG003|Overall Study|non-compliance with treatment|0|||
33705653|NCT01892436|63272116|FG000|Overall Study|Adverse Event|7|||
33705654|NCT01892436|63272117|FG001|Overall Study|Adverse Event|6|||
33705655|NCT01892436|63272118|FG002|Overall Study|Adverse Event|2|||
33705656|NCT01892436|63272119|FG003|Overall Study|Adverse Event|3|||
33705657|NCT01853046|63272131|FG000|Overall Study|Withdrawal by Subject|1|||
33705658|NCT01853046|63272132|FG001|Overall Study|Withdrawal by Subject|1|||
33705659|NCT01853046|63272131|FG000|Overall Study|Adverse Event|4|||
33705660|NCT01853046|63272132|FG001|Overall Study|Adverse Event|2|||
33705661|NCT01853046|63272131|FG000|Overall Study|Disease progression|13|||
33705662|NCT01853046|63272132|FG001|Overall Study|Disease progression|3|||
33705663|NCT01891890|63272142|FG000|Overall Study|Lost to Follow-up|0|||
33705664|NCT01891890|63272143|FG001|Overall Study|Lost to Follow-up|0|||
33705665|NCT01891890|63272144|FG002|Overall Study|Lost to Follow-up|1|||
33705666|NCT01891890|63272142|FG000|Overall Study|Study ended before endpoint reached|7|||
33705667|NCT01891890|63272143|FG001|Overall Study|Study ended before endpoint reached|3|||
33705668|NCT01891890|63272144|FG002|Overall Study|Study ended before endpoint reached|6|||
33705669|NCT01852812|63272155|FG000|Overall Study|Adverse Event|0|||
33705670|NCT01852812|63272156|FG001|Overall Study|Adverse Event|0|||
33705671|NCT01852812|63272157|FG002|Overall Study|Adverse Event|1|||
33705672|NCT01852812|63272155|FG000|Overall Study|Non-compliance With Study Drug|0|||
33705673|NCT01852812|63272156|FG001|Overall Study|Non-compliance With Study Drug|1|||
33705674|NCT01852812|63272157|FG002|Overall Study|Non-compliance With Study Drug|0|||
33705675|NCT01869348|63272167|FG000|Overall Study|Withdrawal by Subject|1|||
33705676|NCT01869348|63272168|FG001|Overall Study|Withdrawal by Subject|1|||
33705677|NCT01869192|63272176|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
33705678|NCT01869192|63272177|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
33705679|NCT01869192|63272176|FG000|Postoperative Chemotherapy|Physician Decision|0|||
33705680|NCT01869192|63272177|FG001|Postoperative Chemotherapy|Physician Decision|2|||
33705681|NCT01868646|63272185|FG000|Overall Study|Do not meet inclusion criteria|3|||
33705682|NCT01868646|63272186|FG001|Overall Study|Do not meet inclusion criteria|5|||
33705683|NCT01852110|63272194|FG000|Overall Study|Adverse Event|12|||
33705684|NCT01852110|63272195|FG001|Overall Study|Adverse Event|5|||
33705685|NCT01852110|63272196|FG002|Overall Study|Adverse Event|0|||
33705686|NCT01852110|63272197|FG003|Overall Study|Adverse Event|0|||
33705687|NCT01852110|63272198|FG004|Overall Study|Adverse Event|0|||
33705688|NCT01852110|63272199|FG005|Overall Study|Adverse Event|0|||
33705689|NCT01852110|63272194|FG000|Overall Study|Lost to Follow-up|1|||
33705690|NCT01852110|63272195|FG001|Overall Study|Lost to Follow-up|3|||
33705691|NCT01852110|63272196|FG002|Overall Study|Lost to Follow-up|0|||
33705692|NCT01852110|63272197|FG003|Overall Study|Lost to Follow-up|0|||
33705693|NCT01852110|63272198|FG004|Overall Study|Lost to Follow-up|0|||
33705694|NCT01852110|63272199|FG005|Overall Study|Lost to Follow-up|0|||
33705695|NCT01852110|63272194|FG000|Overall Study|Non-compliance with Study Drug|2|||
33705696|NCT01852110|63272195|FG001|Overall Study|Non-compliance with Study Drug|1|||
33705697|NCT01852110|63272196|FG002|Overall Study|Non-compliance with Study Drug|0|||
33705698|NCT01852110|63272197|FG003|Overall Study|Non-compliance with Study Drug|0|||
33705699|NCT01852110|63272198|FG004|Overall Study|Non-compliance with Study Drug|0|||
33705700|NCT01852110|63272199|FG005|Overall Study|Non-compliance with Study Drug|0|||
33705701|NCT01852110|63272194|FG000|Overall Study|Physician Decision|1|||
33705702|NCT01852110|63272195|FG001|Overall Study|Physician Decision|0|||
33705703|NCT01852110|63272196|FG002|Overall Study|Physician Decision|0|||
33705704|NCT01852110|63272197|FG003|Overall Study|Physician Decision|0|||
33705705|NCT01852110|63272198|FG004|Overall Study|Physician Decision|0|||
33705706|NCT01852110|63272199|FG005|Overall Study|Physician Decision|0|||
33705707|NCT01852110|63272194|FG000|Overall Study|Protocol Violation|0|||
33705708|NCT01852110|63272195|FG001|Overall Study|Protocol Violation|1|||
33705709|NCT01852110|63272196|FG002|Overall Study|Protocol Violation|0|||
33705710|NCT01852110|63272197|FG003|Overall Study|Protocol Violation|0|||
33705711|NCT01852110|63272198|FG004|Overall Study|Protocol Violation|0|||
33705712|NCT01852110|63272199|FG005|Overall Study|Protocol Violation|0|||
33705713|NCT01852110|63272194|FG000|Overall Study|Study Terminated by Sponsor|30|||
33705714|NCT01852110|63272195|FG001|Overall Study|Study Terminated by Sponsor|32|||
33705715|NCT01852110|63272196|FG002|Overall Study|Study Terminated by Sponsor|0|||
33705716|NCT01852110|63272197|FG003|Overall Study|Study Terminated by Sponsor|0|||
33705717|NCT01852110|63272198|FG004|Overall Study|Study Terminated by Sponsor|0|||
33705718|NCT01852110|63272199|FG005|Overall Study|Study Terminated by Sponsor|0|||
33705719|NCT01852110|63272194|FG000|Overall Study|Withdrawal by Subject|4|||
33705720|NCT01852110|63272195|FG001|Overall Study|Withdrawal by Subject|4|||
33705721|NCT01852110|63272196|FG002|Overall Study|Withdrawal by Subject|0|||
33705722|NCT01852110|63272197|FG003|Overall Study|Withdrawal by Subject|0|||
33705723|NCT01852110|63272198|FG004|Overall Study|Withdrawal by Subject|0|||
33705724|NCT01852110|63272199|FG005|Overall Study|Withdrawal by Subject|0|||
33705725|NCT01851720|63272215|FG000|Overall Study|Lost to Follow-up|0|||
33705726|NCT01851720|63272216|FG001|Overall Study|Lost to Follow-up|1|||
33705727|NCT01851330|63272225|FG000|Overall Study|Lack of Efficacy|10|||
33705728|NCT01851330|63272226|FG001|Overall Study|Lack of Efficacy|9|||
33705729|NCT01851330|63272227|FG002|Overall Study|Lack of Efficacy|2|||
33705730|NCT01851330|63272225|FG000|Overall Study|Lost to Follow-up|1|||
33705731|NCT01851330|63272226|FG001|Overall Study|Lost to Follow-up|6|||
33705732|NCT01851330|63272227|FG002|Overall Study|Lost to Follow-up|9|||
33705733|NCT01851330|63272225|FG000|Overall Study|Withdrew Consent|2|||
33705734|NCT01851330|63272226|FG001|Overall Study|Withdrew Consent|1|||
33705735|NCT01851330|63272227|FG002|Overall Study|Withdrew Consent|0|||
33705736|NCT01851330|63272225|FG000|Overall Study|Investigator's Discretion|0|||
33705737|NCT01851330|63272226|FG001|Overall Study|Investigator's Discretion|0|||
33705738|NCT01851330|63272227|FG002|Overall Study|Investigator's Discretion|1|||
33705739|NCT01868022|63272244|FG000|Overall Study|Withdrawal by Subject|0|||
33705740|NCT01868022|63272245|FG001|Overall Study|Withdrawal by Subject|0|||
33705741|NCT01868022|63272246|FG002|Overall Study|Withdrawal by Subject|1|||
33705742|NCT01868022|63272247|FG003|Overall Study|Withdrawal by Subject|1|||
33705743|NCT01868022|63272248|FG004|Overall Study|Withdrawal by Subject|0|||
33705744|NCT01868022|63272249|FG005|Overall Study|Withdrawal by Subject|0|||
33705745|NCT01868022|63272250|FG006|Overall Study|Withdrawal by Subject|0|||
33705746|NCT01868022|63272251|FG007|Overall Study|Withdrawal by Subject|1|||
33705747|NCT01868022|63272252|FG008|Overall Study|Withdrawal by Subject|0|||
33596990|NCT01884688|62995924|FG000|Overall Study|Screen Failure|2|||
33651350|NCT01971203|63062787|FG000|Overall Study|Withdrawal by Subject|5|||
33651351|NCT01971203|63062788|FG001|Overall Study|Withdrawal by Subject|6|||
33651352|NCT01971203|63062787|FG000|Overall Study|Adverse Event|1|||
33651353|NCT01971203|63062788|FG001|Overall Study|Adverse Event|0|||
33651354|NCT01605877|63062794|FG000|Overall Study|Withdrawal by Subject|1|||
33651355|NCT01970501|63062818|FG000|Overall Study|Discontinuation of study by sponsor|16|||
33651356|NCT01970501|63062819|FG001|Overall Study|Discontinuation of study by sponsor|14|||
33651357|NCT01970501|63062818|FG000|Overall Study|Withdrawal by Subject|6|||
33651358|NCT01970501|63062819|FG001|Overall Study|Withdrawal by Subject|7|||
33651359|NCT01970501|63062818|FG000|Overall Study|Adverse Event|2|||
33651360|NCT01970501|63062819|FG001|Overall Study|Adverse Event|4|||
33651361|NCT01970501|63062818|FG000|Overall Study|Death|1|||
33651362|NCT01970501|63062819|FG001|Overall Study|Death|3|||
33651363|NCT01970501|63062818|FG000|Overall Study|Physician Decision|2|||
33651364|NCT01970501|63062819|FG001|Overall Study|Physician Decision|0|||
33651365|NCT01969799|63062827|FG000|Overall Study|Adverse Event|0|||
33651366|NCT01969799|63062828|FG001|Overall Study|Adverse Event|1|||
33651367|NCT01969799|63062827|FG000|Overall Study|Death|16|||
33651368|NCT01969799|63062828|FG001|Overall Study|Death|11|||
33651369|NCT01969799|63062827|FG000|Overall Study|Lost to Follow-up|0|||
33651370|NCT01969799|63062828|FG001|Overall Study|Lost to Follow-up|2|||
33651371|NCT01969799|63062827|FG000|Overall Study|Physician Decision|1|||
33651372|NCT01969799|63062828|FG001|Overall Study|Physician Decision|0|||
33651373|NCT01969721|63062834|FG000|Overall Study|Adverse Event|3|||
33651374|NCT01969721|63062835|FG001|Overall Study|Adverse Event|8|||
33651375|NCT01969721|63062836|FG002|Overall Study|Adverse Event|3|||
33651376|NCT01969721|63062837|FG003|Overall Study|Adverse Event|2|||
33651377|NCT01969721|63062834|FG000|Overall Study|Lack of Efficacy|0|||
33651378|NCT01969721|63062835|FG001|Overall Study|Lack of Efficacy|0|||
33651379|NCT01969721|63062836|FG002|Overall Study|Lack of Efficacy|1|||
33651380|NCT01969721|63062837|FG003|Overall Study|Lack of Efficacy|0|||
33651381|NCT01969721|63062834|FG000|Overall Study|Non compliant with protocol|1|||
33651382|NCT01969721|63062835|FG001|Overall Study|Non compliant with protocol|1|||
33651383|NCT01969721|63062836|FG002|Overall Study|Non compliant with protocol|0|||
33651384|NCT01969721|63062837|FG003|Overall Study|Non compliant with protocol|2|||
33705748|NCT01868022|63272244|FG000|Overall Study|Adverse Event|0|||
33493267|NCT03103152|62871483|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
33705749|NCT01868022|63272245|FG001|Overall Study|Adverse Event|0|||
33705750|NCT01868022|63272246|FG002|Overall Study|Adverse Event|0|||
33705751|NCT01868022|63272247|FG003|Overall Study|Adverse Event|0|||
33705752|NCT01868022|63272248|FG004|Overall Study|Adverse Event|2|||
33705753|NCT01868022|63272249|FG005|Overall Study|Adverse Event|0|||
33705754|NCT01868022|63272250|FG006|Overall Study|Adverse Event|0|||
33705755|NCT01868022|63272251|FG007|Overall Study|Adverse Event|2|||
33705756|NCT01868022|63272252|FG008|Overall Study|Adverse Event|2|||
33705757|NCT01868022|63272244|FG000|Overall Study|Physician Decision|0|||
33705758|NCT01868022|63272245|FG001|Overall Study|Physician Decision|0|||
33705759|NCT01868022|63272246|FG002|Overall Study|Physician Decision|0|||
33705760|NCT01868022|63272247|FG003|Overall Study|Physician Decision|0|||
33705761|NCT01868022|63272248|FG004|Overall Study|Physician Decision|0|||
33705762|NCT01868022|63272249|FG005|Overall Study|Physician Decision|1|||
33705763|NCT01868022|63272250|FG006|Overall Study|Physician Decision|0|||
33705764|NCT01868022|63272251|FG007|Overall Study|Physician Decision|2|||
33705765|NCT01868022|63272252|FG008|Overall Study|Physician Decision|0|||
33705766|NCT01868022|63272244|FG000|Overall Study|Study closed/terminated|0|||
33705767|NCT01868022|63272245|FG001|Overall Study|Study closed/terminated|0|||
33705768|NCT01868022|63272246|FG002|Overall Study|Study closed/terminated|0|||
33705769|NCT01868022|63272247|FG003|Overall Study|Study closed/terminated|0|||
33705770|NCT01868022|63272248|FG004|Overall Study|Study closed/terminated|0|||
33705771|NCT01868022|63272249|FG005|Overall Study|Study closed/terminated|0|||
33705772|NCT01868022|63272250|FG006|Overall Study|Study closed/terminated|0|||
33705773|NCT01868022|63272251|FG007|Overall Study|Study closed/terminated|1|||
33705774|NCT01868022|63272252|FG008|Overall Study|Study closed/terminated|0|||
33705775|NCT01868022|63272244|FG000|Overall Study|Ongoing|0|||
33705776|NCT01868022|63272245|FG001|Overall Study|Ongoing|0|||
33705777|NCT01868022|63272246|FG002|Overall Study|Ongoing|0|||
33705778|NCT01868022|63272247|FG003|Overall Study|Ongoing|0|||
33705779|NCT01868022|63272248|FG004|Overall Study|Ongoing|0|||
33705780|NCT01868022|63272249|FG005|Overall Study|Ongoing|0|||
33705781|NCT01868022|63272250|FG006|Overall Study|Ongoing|0|||
33705782|NCT01868022|63272251|FG007|Overall Study|Ongoing|3|||
33705783|NCT01868022|63272252|FG008|Overall Study|Ongoing|0|||
33705784|NCT01850004|63272278|FG000|Overall Study|Poor/Non-compliance|1|||
33705785|NCT01850004|63272278|FG000|Overall Study|Participant Withdrew Consent|9|||
33705786|NCT01850004|63272278|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
33705787|NCT01850004|63272278|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
33705788|NCT01850004|63272278|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
33705789|NCT01850004|63272278|FG000|Overall Study|Other Reasons|2|||
33705790|NCT01850004|63272278|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
33705791|NCT01850004|63272278|FG000|Overall Study|Maximum Clinical Benefit|4|||
33705792|NCT01867710|63272286|FG000|Overall Study|Death|25|||
33705793|NCT01867710|63272287|FG001|Overall Study|Death|15|||
33705794|NCT01867710|63272288|FG002|Overall Study|Death|27|||
33705795|NCT01867710|63272289|FG003|Overall Study|Death|20|||
33705796|NCT01867710|63272286|FG000|Overall Study|Lost to Follow-up|3|||
33705797|NCT01867710|63272287|FG001|Overall Study|Lost to Follow-up|4|||
33705798|NCT01867710|63272288|FG002|Overall Study|Lost to Follow-up|3|||
33705799|NCT01867710|63272289|FG003|Overall Study|Lost to Follow-up|2|||
33705800|NCT01867710|63272286|FG000|Overall Study|Withdrawal of consent|2|||
33705801|NCT01867710|63272287|FG001|Overall Study|Withdrawal of consent|5|||
33705802|NCT01867710|63272288|FG002|Overall Study|Withdrawal of consent|1|||
33705803|NCT01867710|63272289|FG003|Overall Study|Withdrawal of consent|2|||
33705804|NCT01867710|63272286|FG000|Overall Study|Study Terminated by Sponsor|9|||
33705805|NCT01867710|63272287|FG001|Overall Study|Study Terminated by Sponsor|13|||
33705806|NCT01867710|63272288|FG002|Overall Study|Study Terminated by Sponsor|8|||
33705807|NCT01867710|63272289|FG003|Overall Study|Study Terminated by Sponsor|16|||
33705808|NCT01867710|63272286|FG000|Overall Study|Biochemical progression|0|||
33705809|NCT01867710|63272287|FG001|Overall Study|Biochemical progression|1|||
33705810|NCT01867710|63272288|FG002|Overall Study|Biochemical progression|0|||
33705811|NCT01867710|63272289|FG003|Overall Study|Biochemical progression|0|||
33705812|NCT01867710|63272286|FG000|Overall Study|Clinical progression|0|||
33705813|NCT01867710|63272287|FG001|Overall Study|Clinical progression|0|||
33705814|NCT01867710|63272288|FG002|Overall Study|Clinical progression|1|||
33705815|NCT01867710|63272289|FG003|Overall Study|Clinical progression|0|||
33705816|NCT01867710|63272286|FG000|Overall Study|Disease progression|1|||
33705817|NCT01867710|63272287|FG001|Overall Study|Disease progression|0|||
33705818|NCT01867710|63272288|FG002|Overall Study|Disease progression|0|||
33705819|NCT01867710|63272289|FG003|Overall Study|Disease progression|0|||
33705820|NCT01867710|63272286|FG000|Overall Study|Patient decision|0|||
33705821|NCT01867710|63272287|FG001|Overall Study|Patient decision|0|||
33705822|NCT01867710|63272288|FG002|Overall Study|Patient decision|0|||
33705823|NCT01867710|63272289|FG003|Overall Study|Patient decision|1|||
33705824|NCT01867710|63272286|FG000|Overall Study|Patient to follow subsequent treatment|0|||
33705825|NCT01867710|63272287|FG001|Overall Study|Patient to follow subsequent treatment|1|||
33705826|NCT01867710|63272288|FG002|Overall Study|Patient to follow subsequent treatment|0|||
33705827|NCT01867710|63272289|FG003|Overall Study|Patient to follow subsequent treatment|0|||
33705828|NCT01867710|63272286|FG000|Overall Study|Progressive disease|1|||
33705829|NCT01867710|63272287|FG001|Overall Study|Progressive disease|0|||
33705830|NCT01867710|63272288|FG002|Overall Study|Progressive disease|0|||
33705831|NCT01867710|63272289|FG003|Overall Study|Progressive disease|0|||
33705832|NCT01867710|63272286|FG000|Overall Study|Protocol Violation|0|||
33705833|NCT01867710|63272287|FG001|Overall Study|Protocol Violation|0|||
33705834|NCT01867710|63272288|FG002|Overall Study|Protocol Violation|0|||
33705835|NCT01867710|63272289|FG003|Overall Study|Protocol Violation|1|||
33705836|NCT01867710|63272286|FG000|Overall Study|PSA-progression|0|||
33705837|NCT01867710|63272287|FG001|Overall Study|PSA-progression|1|||
33705838|NCT01867710|63272288|FG002|Overall Study|PSA-progression|0|||
33705839|NCT01867710|63272289|FG003|Overall Study|PSA-progression|0|||
33705840|NCT01867710|63272286|FG000|Overall Study|Study medication no longer effective|0|||
33705841|NCT01867710|63272287|FG001|Overall Study|Study medication no longer effective|1|||
33705842|NCT01867710|63272288|FG002|Overall Study|Study medication no longer effective|0|||
33705843|NCT01867710|63272289|FG003|Overall Study|Study medication no longer effective|0|||
33705844|NCT01849848|63272299|FG000|Overall Study|Physician Decision|1|||
33705845|NCT01849848|63272299|FG000|Overall Study|Progression of the primary disease|3|||
33705846|NCT01849458|63272303|FG000|Overall Study|Lost to Follow-up|4|||
33705847|NCT01832766|63272307|FG000|Washout|Lost to Follow-up|0|||
33705848|NCT01832766|63272308|FG001|Washout|Lost to Follow-up|1|||
33705849|NCT01832532|63272316|FG000|Overall Study|Withdrawal by Subject|5|||
33705850|NCT01832532|63272317|FG001|Overall Study|Withdrawal by Subject|2|||
33705851|NCT01848990|63272326|FG000|Overall Study|Adverse Event|6|||
33705852|NCT01848990|63272327|FG001|Overall Study|Adverse Event|2|||
33705853|NCT01848990|63272328|FG002|Overall Study|Adverse Event|0|||
33705854|NCT01848990|63272326|FG000|Overall Study|Lost to Follow-up|6|||
33705855|NCT01848990|63272327|FG001|Overall Study|Lost to Follow-up|2|||
33705856|NCT01848990|63272328|FG002|Overall Study|Lost to Follow-up|2|||
33705857|NCT01848990|63272326|FG000|Overall Study|Protocol Violation|1|||
33705858|NCT01848990|63272327|FG001|Overall Study|Protocol Violation|1|||
33705859|NCT01848990|63272328|FG002|Overall Study|Protocol Violation|0|||
33705860|NCT01848990|63272326|FG000|Overall Study|Withdrawal by Subject|29|||
33705861|NCT01848990|63272327|FG001|Overall Study|Withdrawal by Subject|10|||
33705862|NCT01848990|63272328|FG002|Overall Study|Withdrawal by Subject|11|||
33705863|NCT01848990|63272326|FG000|Overall Study|Physician Decision|1|||
33705864|NCT01848990|63272327|FG001|Overall Study|Physician Decision|1|||
33705865|NCT01848990|63272328|FG002|Overall Study|Physician Decision|0|||
33705866|NCT01848990|63272326|FG000|Overall Study|Non Compliance|1|||
33705867|NCT01848990|63272327|FG001|Overall Study|Non Compliance|0|||
33705868|NCT01848990|63272328|FG002|Overall Study|Non Compliance|0|||
33705869|NCT01848990|63272326|FG000|Overall Study|Death|1|||
33705870|NCT01848990|63272327|FG001|Overall Study|Death|0|||
33705871|NCT01848990|63272328|FG002|Overall Study|Death|1|||
33705872|NCT01848990|63272326|FG000|Overall Study|Other|1|||
33705873|NCT01848990|63272327|FG001|Overall Study|Other|4|||
33705874|NCT01848990|63272328|FG002|Overall Study|Other|2|||
33705875|NCT01867086|63272340|FG000|Overall Study|Disease Progression|1|||
33705876|NCT01831596|63272344|FG000|Overall Study|Other|8|||
33705877|NCT01848834|63272353|FG000|Overall Study|Adverse Event|3|||
33705878|NCT01848834|63272354|FG001|Overall Study|Adverse Event|11|||
33705879|NCT01848834|63272355|FG002|Overall Study|Adverse Event|3|||
33705880|NCT01848834|63272356|FG003|Overall Study|Adverse Event|5|||
33705881|NCT01848834|63272357|FG004|Overall Study|Adverse Event|9|||
33705882|NCT01848834|63272353|FG000|Overall Study|Death|2|||
33705883|NCT01848834|63272354|FG001|Overall Study|Death|11|||
33705884|NCT01848834|63272355|FG002|Overall Study|Death|1|||
33705885|NCT01848834|63272356|FG003|Overall Study|Death|8|||
33705886|NCT01848834|63272357|FG004|Overall Study|Death|27|||
33705887|NCT01848834|63272353|FG000|Overall Study|Excluded Medication|5|||
33705888|NCT01848834|63272354|FG001|Overall Study|Excluded Medication|4|||
33705889|NCT01848834|63272355|FG002|Overall Study|Excluded Medication|3|||
33705890|NCT01848834|63272356|FG003|Overall Study|Excluded Medication|6|||
33705891|NCT01848834|63272357|FG004|Overall Study|Excluded Medication|6|||
33705892|NCT01848834|63272353|FG000|Overall Study|Lost to Follow-up|5|||
33705893|NCT01848834|63272354|FG001|Overall Study|Lost to Follow-up|5|||
33705894|NCT01848834|63272355|FG002|Overall Study|Lost to Follow-up|3|||
33705895|NCT01848834|63272356|FG003|Overall Study|Lost to Follow-up|0|||
33705896|NCT01848834|63272357|FG004|Overall Study|Lost to Follow-up|3|||
33705897|NCT01848834|63272353|FG000|Overall Study|Physician Decision|1|||
33705898|NCT01848834|63272354|FG001|Overall Study|Physician Decision|3|||
33705899|NCT01848834|63272355|FG002|Overall Study|Physician Decision|4|||
33705900|NCT01848834|63272356|FG003|Overall Study|Physician Decision|0|||
33705901|NCT01848834|63272357|FG004|Overall Study|Physician Decision|11|||
33705902|NCT01848834|63272353|FG000|Overall Study|Protocol Violation|0|||
33705903|NCT01848834|63272354|FG001|Overall Study|Protocol Violation|0|||
33705904|NCT01848834|63272355|FG002|Overall Study|Protocol Violation|0|||
33705905|NCT01848834|63272356|FG003|Overall Study|Protocol Violation|0|||
33705906|NCT01848834|63272357|FG004|Overall Study|Protocol Violation|1|||
33705907|NCT01848834|63272353|FG000|Overall Study|Sponsor Decision|1|||
33705908|NCT01848834|63272354|FG001|Overall Study|Sponsor Decision|1|||
33705909|NCT01848834|63272355|FG002|Overall Study|Sponsor Decision|0|||
33705910|NCT01848834|63272356|FG003|Overall Study|Sponsor Decision|1|||
33705911|NCT01848834|63272357|FG004|Overall Study|Sponsor Decision|1|||
33705912|NCT01848834|63272353|FG000|Overall Study|Withdrawal by Subject|2|||
33705913|NCT01848834|63272354|FG001|Overall Study|Withdrawal by Subject|13|||
33705914|NCT01848834|63272355|FG002|Overall Study|Withdrawal by Subject|10|||
33705915|NCT01848834|63272356|FG003|Overall Study|Withdrawal by Subject|6|||
33705916|NCT01848834|63272357|FG004|Overall Study|Withdrawal by Subject|36|||
33705917|NCT01867008|63272373|FG000|Overall Study|Withdrawal by Subject|1|||
33705918|NCT01848756|63272377|FG000|Overall Study|Adverse Event|1|||
33705919|NCT01848756|63272377|FG000|Overall Study|Withdrawal by Subject|1|||
33705920|NCT01848756|63272377|FG000|Overall Study|Enrolled in Error|1|||
33705921|NCT01830972|63272384|FG000|Part II|Withdrawal by Subject|2|||
33705922|NCT01830972|63272385|FG001|Part II|Withdrawal by Subject|2|||
33705923|NCT01830972|63272384|FG000|Part III|Withdrawal by Subject|1|||
33705924|NCT01830972|63272385|FG001|Part III|Withdrawal by Subject|0|||
33705925|NCT01830972|63272384|FG000|Part III|Noncompliance|1|||
33705926|NCT01830972|63272385|FG001|Part III|Noncompliance|0|||
33705927|NCT01830972|63272384|FG000|Part IV|Withdrawal by Subject|2|||
33705928|NCT01830972|63272385|FG001|Part IV|Withdrawal by Subject|1|||
33705929|NCT01830972|63272384|FG000|Part IV|Non-Compliance|1|||
33705930|NCT01830972|63272385|FG001|Part IV|Non-Compliance|0|||
33705931|NCT01848288|63272401|FG000|Overall Study|Death|1|||
33705932|NCT01848288|63272401|FG000|Overall Study|Protocol Violation|1|||
33705933|NCT01848288|63272401|FG000|Overall Study|Withdrawal by Subject|1|||
33705934|NCT01848210|63272408|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
33705935|NCT01848210|63272409|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
33705936|NCT01848210|63272408|FG000|Overall Study|Lost to Follow-up|24|||
33705937|NCT01848210|63272409|FG001|Overall Study|Lost to Follow-up|12|||
33705938|NCT01848210|63272408|FG000|Overall Study|Protocol Violation|3|||
33705939|NCT01848210|63272409|FG001|Overall Study|Protocol Violation|5|||
33705940|NCT01848210|63272408|FG000|Overall Study|Use of Forbidden Drugs|9|||
33705941|NCT01848210|63272409|FG001|Overall Study|Use of Forbidden Drugs|10|||
33705942|NCT01848210|63272408|FG000|Overall Study|Impedition Condition|5|||
33705943|NCT01848210|63272409|FG001|Overall Study|Impedition Condition|9|||
33705944|NCT01848210|63272408|FG000|Overall Study|Adverse Event|7|||
33705945|NCT01848210|63272409|FG001|Overall Study|Adverse Event|9|||
33705946|NCT01848210|63272408|FG000|Overall Study|Discontinuation Criterion|5|||
33705947|NCT01848210|63272409|FG001|Overall Study|Discontinuation Criterion|7|||
33705948|NCT01848210|63272408|FG000|Overall Study|Hypesensitivity|1|||
33705949|NCT01848210|63272409|FG001|Overall Study|Hypesensitivity|0|||
33705950|NCT01848210|63272408|FG000|Overall Study|Hepatic Function Alteration|4|||
33705951|NCT01848210|63272409|FG001|Overall Study|Hepatic Function Alteration|0|||
33705952|NCT01848210|63272408|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
33705953|NCT01848210|63272409|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
33705954|NCT01848210|63272408|FG000|Overall Study|Administrative|1|||
33705955|NCT01848210|63272409|FG001|Overall Study|Administrative|0|||
33705956|NCT01830816|63272418|FG000|Overall Study|Progressive Disease|12|||
33705957|NCT01830816|63272419|FG001|Overall Study|Progressive Disease|7|||
33705958|NCT01830816|63272420|FG002|Overall Study|Progressive Disease|7|||
33705959|NCT01830816|63272418|FG000|Overall Study|Adverse Event|3|||
33705960|NCT01830816|63272419|FG001|Overall Study|Adverse Event|4|||
33705961|NCT01830816|63272420|FG002|Overall Study|Adverse Event|0|||
33705962|NCT01830816|63272418|FG000|Overall Study|Study Terminated by Sponsor|1|||
33705963|NCT01830816|63272419|FG001|Overall Study|Study Terminated by Sponsor|1|||
33705964|NCT01830816|63272420|FG002|Overall Study|Study Terminated by Sponsor|0|||
33705965|NCT01830816|63272418|FG000|Overall Study|Withdrawal by Subject|1|||
33705966|NCT01830816|63272419|FG001|Overall Study|Withdrawal by Subject|1|||
33705967|NCT01830816|63272420|FG002|Overall Study|Withdrawal by Subject|0|||
33705968|NCT01830816|63272418|FG000|Overall Study|Lost to Follow-up|0|||
33705969|NCT01830816|63272419|FG001|Overall Study|Lost to Follow-up|1|||
33705970|NCT01830816|63272420|FG002|Overall Study|Lost to Follow-up|0|||
33705971|NCT01830816|63272418|FG000|Overall Study|Symptomatic Deterioration|1|||
33705972|NCT01830816|63272419|FG001|Overall Study|Symptomatic Deterioration|0|||
33705973|NCT01830816|63272420|FG002|Overall Study|Symptomatic Deterioration|0|||
33705974|NCT01830816|63272418|FG000|Overall Study|Reason not Specified|2|||
33705975|NCT01830816|63272419|FG001|Overall Study|Reason not Specified|0|||
33705976|NCT01830816|63272420|FG002|Overall Study|Reason not Specified|0|||
33705977|NCT01846416|63272434|FG000|Treatment Phase|Death|2|||
33705978|NCT01846416|63272435|FG001|Treatment Phase|Death|9|||
33705979|NCT01846416|63272436|FG002|Treatment Phase|Death|1|||
33705980|NCT01846416|63272434|FG000|Treatment Phase|Withdrawal by Subject|2|||
33705981|NCT01846416|63272435|FG001|Treatment Phase|Withdrawal by Subject|4|||
33705982|NCT01846416|63272436|FG002|Treatment Phase|Withdrawal by Subject|2|||
33705983|NCT01846416|63272434|FG000|Treatment Phase|Other|1|||
33705984|NCT01846416|63272435|FG001|Treatment Phase|Other|5|||
33705985|NCT01846416|63272436|FG002|Treatment Phase|Other|1|||
33705986|NCT01846416|63272434|FG000|Treatment Phase|Physician Decision|1|||
33705987|NCT01846416|63272435|FG001|Treatment Phase|Physician Decision|2|||
33705988|NCT01846416|63272436|FG002|Treatment Phase|Physician Decision|0|||
33705989|NCT01846416|63272434|FG000|Treatment Phase|Adverse Event|3|||
33705990|NCT01846416|63272435|FG001|Treatment Phase|Adverse Event|4|||
33705991|NCT01846416|63272436|FG002|Treatment Phase|Adverse Event|0|||
33705992|NCT01846416|63272434|FG000|Treatment Phase|Non-compliance|0|||
33705993|NCT01846416|63272435|FG001|Treatment Phase|Non-compliance|2|||
33705994|NCT01846416|63272436|FG002|Treatment Phase|Non-compliance|0|||
33705995|NCT01846416|63272434|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
33705996|NCT01846416|63272435|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
33705997|NCT01846416|63272436|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
33705998|NCT01846416|63272434|FG000|Treatment Phase|Progressive Disease|21|||
33705999|NCT01846416|63272435|FG001|Treatment Phase|Progressive Disease|63|||
33706000|NCT01846416|63272436|FG002|Treatment Phase|Progressive Disease|9|||
33706001|NCT01846416|63272434|FG000|Survival Follow-up|Death|21|||
33706002|NCT01846416|63272435|FG001|Survival Follow-up|Death|62|||
33706003|NCT01846416|63272436|FG002|Survival Follow-up|Death|9|||
33706004|NCT01846416|63272434|FG000|Survival Follow-up|Lost to Follow-up|0|||
33706005|NCT01846416|63272435|FG001|Survival Follow-up|Lost to Follow-up|2|||
33706006|NCT01846416|63272436|FG002|Survival Follow-up|Lost to Follow-up|2|||
33706007|NCT01846416|63272434|FG000|Survival Follow-up|Withdrawal by Subject|2|||
33706008|NCT01846416|63272435|FG001|Survival Follow-up|Withdrawal by Subject|7|||
33706009|NCT01846416|63272436|FG002|Survival Follow-up|Withdrawal by Subject|0|||
33706010|NCT01846416|63272434|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
33706011|NCT01846416|63272435|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
33706012|NCT01846416|63272436|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
33706013|NCT01846416|63272434|FG000|Survival Follow-up|Other|3|||
33706014|NCT01846416|63272435|FG001|Survival Follow-up|Other|1|||
33706015|NCT01846416|63272436|FG002|Survival Follow-up|Other|1|||
33706016|NCT01865448|63272447|FG000|Overall Study|Adverse Event|1|||
33706017|NCT01865448|63272448|FG001|Overall Study|Adverse Event|1|||
33706018|NCT01865448|63272447|FG000|Overall Study|Pregnancy|0|||
33706019|NCT01865448|63272448|FG001|Overall Study|Pregnancy|1|||
33706020|NCT01865448|63272447|FG000|Overall Study|dropout unrelated to study|1|||
33706021|NCT01865448|63272448|FG001|Overall Study|dropout unrelated to study|1|||
33706022|NCT01804140|63272455|FG000|Overall Study|No sampling or biopsy procedures done|114|||
33706023|NCT01846104|63272459|FG000|Overall Study|Withdrawal by Subject|1|||
33706024|NCT01803282|63272475|FG000|Overall Study|Progressive Disease|4|||
33706025|NCT01803282|63272476|FG001|Overall Study|Progressive Disease|3|||
33706026|NCT01803282|63272477|FG002|Overall Study|Progressive Disease|6|||
33706027|NCT01803282|63272478|FG003|Overall Study|Progressive Disease|22|||
33706028|NCT01803282|63272479|FG004|Overall Study|Progressive Disease|5|||
33706029|NCT01803282|63272480|FG005|Overall Study|Progressive Disease|8|||
33706030|NCT01803282|63272481|FG006|Overall Study|Progressive Disease|23|||
33706031|NCT01803282|63272482|FG007|Overall Study|Progressive Disease|24|||
33706032|NCT01803282|63272483|FG008|Overall Study|Progressive Disease|3|||
33706033|NCT01803282|63272484|FG009|Overall Study|Progressive Disease|29|||
33706034|NCT01803282|63272485|FG010|Overall Study|Progressive Disease|6|||
33310757|NCT01233258|62686169|FG001|First Intervention (6 Months)|Protocol Violation|0|||
33310758|NCT01233258|62686170|FG002|First Intervention (6 Months)|Protocol Violation|1|||
33310759|NCT01233258|62686171|FG003|First Intervention (6 Months)|Protocol Violation|0|||
33310760|NCT01233258|62686172|FG004|First Intervention (6 Months)|Protocol Violation|0|||
33310761|NCT01233258|62686173|FG005|First Intervention (6 Months)|Protocol Violation|0|||
33310762|NCT01233258|62686168|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
33310763|NCT01233258|62686169|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
33310764|NCT01233258|62686170|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
33596991|NCT01883362|62995930|FG000|Treatment|Adverse Event|1|||
33706035|NCT01803282|63272486|FG011|Overall Study|Progressive Disease|11|||
33706036|NCT01803282|63272475|FG000|Overall Study|Death|0|||
33706037|NCT01803282|63272476|FG001|Overall Study|Death|0|||
33706038|NCT01803282|63272477|FG002|Overall Study|Death|0|||
33706039|NCT01803282|63272478|FG003|Overall Study|Death|0|||
33706040|NCT01803282|63272479|FG004|Overall Study|Death|2|||
33706041|NCT01803282|63272480|FG005|Overall Study|Death|1|||
33706042|NCT01803282|63272481|FG006|Overall Study|Death|1|||
33706043|NCT01803282|63272482|FG007|Overall Study|Death|5|||
33706044|NCT01803282|63272483|FG008|Overall Study|Death|1|||
33706045|NCT01803282|63272484|FG009|Overall Study|Death|1|||
33706046|NCT01803282|63272485|FG010|Overall Study|Death|0|||
33706047|NCT01803282|63272486|FG011|Overall Study|Death|0|||
33706048|NCT01803282|63272475|FG000|Overall Study|Withdrew Consent|0|||
33706049|NCT01803282|63272476|FG001|Overall Study|Withdrew Consent|0|||
33706050|NCT01803282|63272477|FG002|Overall Study|Withdrew Consent|0|||
33706051|NCT01803282|63272478|FG003|Overall Study|Withdrew Consent|6|||
33706052|NCT01803282|63272479|FG004|Overall Study|Withdrew Consent|1|||
33706053|NCT01803282|63272480|FG005|Overall Study|Withdrew Consent|0|||
33706054|NCT01803282|63272481|FG006|Overall Study|Withdrew Consent|8|||
33706055|NCT01803282|63272482|FG007|Overall Study|Withdrew Consent|3|||
33706056|NCT01803282|63272483|FG008|Overall Study|Withdrew Consent|1|||
33706057|NCT01803282|63272484|FG009|Overall Study|Withdrew Consent|5|||
33706058|NCT01803282|63272485|FG010|Overall Study|Withdrew Consent|0|||
33706059|NCT01803282|63272486|FG011|Overall Study|Withdrew Consent|1|||
33706060|NCT01803282|63272475|FG000|Overall Study|Investigator's Discretion|0|||
33706061|NCT01803282|63272476|FG001|Overall Study|Investigator's Discretion|0|||
33706062|NCT01803282|63272477|FG002|Overall Study|Investigator's Discretion|0|||
33706063|NCT01803282|63272478|FG003|Overall Study|Investigator's Discretion|7|||
33706064|NCT01803282|63272479|FG004|Overall Study|Investigator's Discretion|2|||
33706065|NCT01803282|63272480|FG005|Overall Study|Investigator's Discretion|1|||
33706066|NCT01803282|63272481|FG006|Overall Study|Investigator's Discretion|7|||
33706067|NCT01803282|63272482|FG007|Overall Study|Investigator's Discretion|10|||
33706068|NCT01803282|63272483|FG008|Overall Study|Investigator's Discretion|6|||
33706069|NCT01803282|63272484|FG009|Overall Study|Investigator's Discretion|7|||
33706070|NCT01803282|63272485|FG010|Overall Study|Investigator's Discretion|1|||
33706071|NCT01803282|63272486|FG011|Overall Study|Investigator's Discretion|0|||
33706072|NCT01803282|63272475|FG000|Overall Study|Adverse Event|0|||
33706073|NCT01803282|63272476|FG001|Overall Study|Adverse Event|0|||
33706074|NCT01803282|63272477|FG002|Overall Study|Adverse Event|0|||
33706075|NCT01803282|63272478|FG003|Overall Study|Adverse Event|0|||
33706076|NCT01803282|63272479|FG004|Overall Study|Adverse Event|0|||
33706077|NCT01803282|63272480|FG005|Overall Study|Adverse Event|0|||
33706078|NCT01803282|63272481|FG006|Overall Study|Adverse Event|1|||
33706079|NCT01803282|63272482|FG007|Overall Study|Adverse Event|2|||
33706080|NCT01803282|63272483|FG008|Overall Study|Adverse Event|0|||
33706081|NCT01803282|63272484|FG009|Overall Study|Adverse Event|1|||
33706082|NCT01803282|63272485|FG010|Overall Study|Adverse Event|0|||
33706083|NCT01803282|63272486|FG011|Overall Study|Adverse Event|3|||
33706084|NCT01803282|63272475|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33706085|NCT01803282|63272476|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33706086|NCT01803282|63272477|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33706087|NCT01803282|63272478|FG003|Overall Study|Non-Compliance with Study Drug|1|||
33706088|NCT01803282|63272479|FG004|Overall Study|Non-Compliance with Study Drug|0|||
33706089|NCT01803282|63272480|FG005|Overall Study|Non-Compliance with Study Drug|0|||
33706090|NCT01803282|63272481|FG006|Overall Study|Non-Compliance with Study Drug|0|||
33706091|NCT01803282|63272482|FG007|Overall Study|Non-Compliance with Study Drug|0|||
33706092|NCT01803282|63272483|FG008|Overall Study|Non-Compliance with Study Drug|0|||
33706093|NCT01803282|63272484|FG009|Overall Study|Non-Compliance with Study Drug|0|||
33706094|NCT01803282|63272485|FG010|Overall Study|Non-Compliance with Study Drug|0|||
33706095|NCT01803282|63272486|FG011|Overall Study|Non-Compliance with Study Drug|0|||
33706096|NCT01803282|63272475|FG000|Overall Study|Unknown Reason|0|||
33706097|NCT01803282|63272476|FG001|Overall Study|Unknown Reason|0|||
33706098|NCT01803282|63272477|FG002|Overall Study|Unknown Reason|0|||
33706099|NCT01803282|63272478|FG003|Overall Study|Unknown Reason|0|||
33706100|NCT01803282|63272479|FG004|Overall Study|Unknown Reason|0|||
33706101|NCT01803282|63272480|FG005|Overall Study|Unknown Reason|0|||
33706102|NCT01803282|63272481|FG006|Overall Study|Unknown Reason|0|||
33706103|NCT01803282|63272482|FG007|Overall Study|Unknown Reason|1|||
33706104|NCT01803282|63272483|FG008|Overall Study|Unknown Reason|0|||
33706105|NCT01803282|63272484|FG009|Overall Study|Unknown Reason|0|||
33706106|NCT01803282|63272485|FG010|Overall Study|Unknown Reason|0|||
33706107|NCT01803282|63272486|FG011|Overall Study|Unknown Reason|0|||
33706108|NCT01803282|63272475|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
33706109|NCT01803282|63272476|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
33706110|NCT01803282|63272477|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
33706111|NCT01803282|63272478|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
33706112|NCT01803282|63272479|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
33706113|NCT01803282|63272480|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
33706114|NCT01803282|63272481|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
33706115|NCT01803282|63272482|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
33706116|NCT01803282|63272483|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
33706117|NCT01803282|63272484|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
33706118|NCT01803282|63272485|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
33706119|NCT01803282|63272486|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
33706120|NCT01803282|63272475|FG000|Overall Study|Enrolled but Never Treated|0|||
33706121|NCT01803282|63272476|FG001|Overall Study|Enrolled but Never Treated|0|||
33706122|NCT01803282|63272477|FG002|Overall Study|Enrolled but Never Treated|0|||
33706123|NCT01803282|63272478|FG003|Overall Study|Enrolled but Never Treated|0|||
33706124|NCT01803282|63272479|FG004|Overall Study|Enrolled but Never Treated|1|||
33706125|NCT01803282|63272480|FG005|Overall Study|Enrolled but Never Treated|0|||
33706126|NCT01803282|63272481|FG006|Overall Study|Enrolled but Never Treated|1|||
33706127|NCT01803282|63272482|FG007|Overall Study|Enrolled but Never Treated|1|||
33706128|NCT01803282|63272483|FG008|Overall Study|Enrolled but Never Treated|0|||
33706129|NCT01803282|63272484|FG009|Overall Study|Enrolled but Never Treated|1|||
33706130|NCT01803282|63272485|FG010|Overall Study|Enrolled but Never Treated|0|||
33706131|NCT01803282|63272486|FG011|Overall Study|Enrolled but Never Treated|0|||
33706132|NCT01844778|63272515|FG000|Overall Study|Protocol deviation|0|||
33706133|NCT01844778|63272516|FG001|Overall Study|Protocol deviation|1|||
33706134|NCT01844778|63272517|FG002|Overall Study|Protocol deviation|2|||
33706135|NCT01844778|63272515|FG000|Overall Study|Withdrawal by Subject|2|||
33706136|NCT01844778|63272516|FG001|Overall Study|Withdrawal by Subject|0|||
33706137|NCT01844778|63272517|FG002|Overall Study|Withdrawal by Subject|0|||
33706138|NCT01844778|63272515|FG000|Overall Study|Adverse Event|0|||
33706139|NCT01844778|63272516|FG001|Overall Study|Adverse Event|2|||
33706140|NCT01844778|63272517|FG002|Overall Study|Adverse Event|2|||
33706141|NCT01802580|63272531|FG000|Overall Study|Physician Decision|1|||
33706142|NCT01802580|63272532|FG001|Overall Study|Physician Decision|0|||
33706143|NCT01802580|63272531|FG000|Overall Study|Protocol Violation|2|||
33706144|NCT01802580|63272532|FG001|Overall Study|Protocol Violation|0|||
33706145|NCT01802580|63272531|FG000|Overall Study|Withdrawal by Subject|5|||
33706146|NCT01802580|63272532|FG001|Overall Study|Withdrawal by Subject|6|||
33706147|NCT01802580|63272531|FG000|Overall Study|Other|1|||
33706148|NCT01802580|63272532|FG001|Overall Study|Other|3|||
33706149|NCT01802580|63272531|FG000|Overall Study|Lack of Efficacy|0|||
33706150|NCT01802580|63272532|FG001|Overall Study|Lack of Efficacy|2|||
33706151|NCT01611090|63272540|FG000|Randomized Period|Lost to Follow-up|8|||
33706152|NCT01611090|63272541|FG001|Randomized Period|Lost to Follow-up|3|||
33706153|NCT01611090|63272542|FG002|Randomized Period|Lost to Follow-up|0|||
33706154|NCT01611090|63272540|FG000|Randomized Period|Withdrawal by Subject|22|||
33706155|NCT01611090|63272541|FG001|Randomized Period|Withdrawal by Subject|26|||
33706156|NCT01611090|63272542|FG002|Randomized Period|Withdrawal by Subject|0|||
33706157|NCT01611090|63272540|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
33706158|NCT01611090|63272541|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
33706159|NCT01611090|63272542|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
33706160|NCT01611090|63272540|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
33706161|NCT01611090|63272541|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
33706162|NCT01611090|63272542|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
33706163|NCT01844700|63272551|FG000|Overall Study|Lack of Efficacy|1|||
33706164|NCT01844700|63272552|FG001|Overall Study|Lack of Efficacy|0|||
33706165|NCT01844700|63272551|FG000|Overall Study|refused medication switch|1|||
33706166|NCT01844700|63272552|FG001|Overall Study|refused medication switch|0|||
33706167|NCT01844700|63272551|FG000|Overall Study|Withdrawal by Subject|1|||
33706168|NCT01844700|63272552|FG001|Overall Study|Withdrawal by Subject|0|||
33706169|NCT01844700|63272551|FG000|Overall Study|stopped taking meds|0|||
33706170|NCT01844700|63272552|FG001|Overall Study|stopped taking meds|1|||
33706171|NCT01844076|63272562|FG000|Overall Study|Adverse Event|1|||
33706172|NCT01844076|63272563|FG001|Overall Study|Adverse Event|0|||
33706173|NCT01844076|63272564|FG002|Overall Study|Adverse Event|0|||
33706174|NCT01844076|63272565|FG003|Overall Study|Adverse Event|0|||
33706175|NCT01844076|63272562|FG000|Overall Study|Withdrawal by Subject|1|||
33706176|NCT01844076|63272563|FG001|Overall Study|Withdrawal by Subject|0|||
33706177|NCT01844076|63272564|FG002|Overall Study|Withdrawal by Subject|0|||
33706178|NCT01844076|63272565|FG003|Overall Study|Withdrawal by Subject|0|||
33706179|NCT01826604|63272577|FG000|Overall Study|Lost to Follow-up|8|||
33706180|NCT01826604|63272578|FG001|Overall Study|Lost to Follow-up|9|||
33706181|NCT01843842|63272586|FG000|Overall Study|Do not meet inclusion criteria|1|||
33706182|NCT01843842|63272587|FG001|Overall Study|Do not meet inclusion criteria|1|||
33706183|NCT01826448|63272595|FG000|Overall Study|Adverse Event|1|||
33706184|NCT01826448|63272596|FG001|Overall Study|Adverse Event|3|||
33706185|NCT01826448|63272595|FG000|Overall Study|Disease progression|2|||
33706186|NCT01826448|63272596|FG001|Overall Study|Disease progression|4|||
33706187|NCT01826448|63272595|FG000|Overall Study|Withdrawal by Subject|1|||
33706188|NCT01826448|63272596|FG001|Overall Study|Withdrawal by Subject|0|||
33706189|NCT01826448|63272595|FG000|Overall Study|Physician Decision|0|||
33706190|NCT01826448|63272596|FG001|Overall Study|Physician Decision|1|||
33706191|NCT01826448|63272595|FG000|Overall Study|2 active cancers|0|||
33706192|NCT01826448|63272596|FG001|Overall Study|2 active cancers|1|||
33706193|NCT01826370|63272602|FG000|Overall Study|Protocol Violation|6|||
33706194|NCT01826370|63272602|FG000|Overall Study|Lost to Follow-up|12|||
33706195|NCT01826370|63272602|FG000|Overall Study|Other reason not defined above|2|||
33706196|NCT01826214|63272608|FG000|Overall Study|Adverse Event|7|||
33706197|NCT01826214|63272609|FG001|Overall Study|Adverse Event|6|||
33706198|NCT01826214|63272608|FG000|Overall Study|Death|3|||
33706199|NCT01826214|63272609|FG001|Overall Study|Death|1|||
33706200|NCT01826214|63272608|FG000|Overall Study|Lost to Follow-up|1|||
33706201|NCT01826214|63272609|FG001|Overall Study|Lost to Follow-up|0|||
33706202|NCT01826214|63272608|FG000|Overall Study|Physician Decision|0|||
33706203|NCT01826214|63272609|FG001|Overall Study|Physician Decision|2|||
33706204|NCT01826214|63272608|FG000|Overall Study|Progressive disease|22|||
33706205|NCT01826214|63272609|FG001|Overall Study|Progressive disease|21|||
33706206|NCT01826214|63272608|FG000|Overall Study|Study terminated by Sponsor|0|||
33706207|NCT01826214|63272609|FG001|Overall Study|Study terminated by Sponsor|1|||
33706208|NCT01826214|63272608|FG000|Overall Study|Subject/guardian decision|2|||
33706209|NCT01826214|63272609|FG001|Overall Study|Subject/guardian decision|3|||
33706210|NCT01843062|63272617|FG000|Overall Study|Protocol Violation|1|||
33706211|NCT01843062|63272618|FG001|Overall Study|Protocol Violation|0|||
33706212|NCT01843062|63272617|FG000|Overall Study|New treatment following progression|2|||
33596992|NCT01883362|62995931|FG001|Treatment|Adverse Event|8|||
33706213|NCT01843062|63272618|FG001|Overall Study|New treatment following progression|0|||
33706214|NCT01843062|63272617|FG000|Overall Study|Pregnancy|1|||
33706215|NCT01843062|63272618|FG001|Overall Study|Pregnancy|0|||
33706216|NCT01843062|63272617|FG000|Overall Study|Adverse Event|2|||
33706217|NCT01843062|63272618|FG001|Overall Study|Adverse Event|0|||
33706218|NCT01843062|63272617|FG000|Overall Study|Incorrect randomisation|1|||
33706219|NCT01843062|63272618|FG001|Overall Study|Incorrect randomisation|0|||
33706220|NCT01843062|63272617|FG000|Overall Study|Withdrawal by Subject|12|||
33706221|NCT01843062|63272618|FG001|Overall Study|Withdrawal by Subject|3|||
33706222|NCT01843062|63272617|FG000|Overall Study|Death|1|||
33706223|NCT01843062|63272618|FG001|Overall Study|Death|2|||
33706224|NCT01843062|63272617|FG000|Overall Study|Lost to Follow-up|2|||
33706225|NCT01843062|63272618|FG001|Overall Study|Lost to Follow-up|4|||
33706226|NCT01842438|63272626|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
33706227|NCT01842438|63272627|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
33706228|NCT01842438|63272626|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
33706229|NCT01842438|63272627|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
33706230|NCT01842438|63272626|FG000|T2: 6month Follow-up|Death|0|||
33706231|NCT01842438|63272627|FG001|T2: 6month Follow-up|Death|1|||
33706232|NCT01799226|63272639|FG000|Overall Study|Withdrawal by Subject|1|||
33706233|NCT01799226|63272640|FG001|Overall Study|Withdrawal by Subject|0|||
33706234|NCT01799226|63272639|FG000|Overall Study|Disqualified at Day 14|1|||
33706235|NCT01799226|63272640|FG001|Overall Study|Disqualified at Day 14|0|||
33706236|NCT01798992|63272650|FG000|Overall Study|Administrative withdrawal|0|||
33706237|NCT01798992|63272651|FG001|Overall Study|Administrative withdrawal|1|||
33706238|NCT01798992|63272652|FG002|Overall Study|Administrative withdrawal|0|||
33706239|NCT01798992|63272653|FG003|Overall Study|Administrative withdrawal|1|||
33706240|NCT01798992|63272650|FG000|Overall Study|Lost to Follow-up|0|||
33706241|NCT01798992|63272651|FG001|Overall Study|Lost to Follow-up|1|||
33706242|NCT01798992|63272652|FG002|Overall Study|Lost to Follow-up|1|||
33706243|NCT01798992|63272653|FG003|Overall Study|Lost to Follow-up|0|||
33706244|NCT01798992|63272650|FG000|Overall Study|Insufficient biopsy tissue|0|||
33706245|NCT01798992|63272651|FG001|Overall Study|Insufficient biopsy tissue|0|||
33706246|NCT01798992|63272652|FG002|Overall Study|Insufficient biopsy tissue|1|||
33706247|NCT01798992|63272653|FG003|Overall Study|Insufficient biopsy tissue|0|||
33706248|NCT01825200|63272664|FG000|Overall Study|Lost to Follow-up|5|||
33706249|NCT01825200|63272665|FG001|Overall Study|Lost to Follow-up|6|||
33706250|NCT01825200|63272664|FG000|Overall Study|Withdrawal by Subject|0|||
33706251|NCT01825200|63272665|FG001|Overall Study|Withdrawal by Subject|1|||
33706252|NCT01824576|63272671|FG000|Overall Study|Device deficiency|2|||
33706253|NCT01824498|63272681|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
33706254|NCT01824498|63272682|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
33706255|NCT01824498|63272683|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
33706256|NCT01824498|63272684|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
33706257|NCT01824498|63272685|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
33706258|NCT01824498|63272686|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
33706259|NCT01798134|63272694|FG000|Overall Study|Lost to Follow-up|1|||
33706260|NCT01798134|63272694|FG000|Overall Study|Withdrawal by Subject|3|||
33706261|NCT01798134|63272694|FG000|Overall Study|Death|2|||
33706262|NCT01798134|63272694|FG000|Overall Study|Adverse Event|3|||
33706263|NCT01798134|63272694|FG000|Overall Study|Physician Decision|3|||
33706264|NCT01798134|63272694|FG000|Overall Study|Liver transplant/surgery|4|||
33706265|NCT01798056|63272700|FG000|Overall Study|Serious Adverse Event|13|||
33706266|NCT01798056|63272701|FG001|Overall Study|Serious Adverse Event|12|||
33706267|NCT01798056|63272700|FG000|Overall Study|Withdrawal by Subject|12|||
33706268|NCT01798056|63272701|FG001|Overall Study|Withdrawal by Subject|9|||
33706269|NCT01798056|63272700|FG000|Overall Study|Migrated/moved from study area|1|||
33706270|NCT01798056|63272701|FG001|Overall Study|Migrated/moved from study area|1|||
33706271|NCT01798056|63272700|FG000|Overall Study|Lost to Follow-up|1|||
33706272|NCT01798056|63272701|FG001|Overall Study|Lost to Follow-up|1|||
33706273|NCT01798056|63272700|FG000|Overall Study|Other|0|||
33706274|NCT01798056|63272701|FG001|Overall Study|Other|2|||
33706275|NCT01824342|63272711|FG000|Overall Study|Withdrawal by Subject|0|||
33706276|NCT01824342|63272712|FG001|Overall Study|Withdrawal by Subject|3|||
33706277|NCT01824342|63272711|FG000|Overall Study|Adverse Event|1|||
33706278|NCT01824342|63272712|FG001|Overall Study|Adverse Event|1|||
33706279|NCT01824342|63272711|FG000|Overall Study|Disease Progression|1|||
33706280|NCT01824342|63272712|FG001|Overall Study|Disease Progression|1|||
33706281|NCT01824342|63272711|FG000|Overall Study|Physician Decision|5|||
33706282|NCT01824342|63272712|FG001|Overall Study|Physician Decision|0|||
33706283|NCT01824342|63272711|FG000|Overall Study|Death|2|||
33706284|NCT01824342|63272712|FG001|Overall Study|Death|0|||
33706285|NCT01841970|63272718|FG000|Overall Study|Withdrawal by Subject|1|||
33706286|NCT01841970|63272718|FG000|Overall Study|Physician Decision|2|||
33706287|NCT01841970|63272718|FG000|Overall Study|Lost to Follow-up|8|||
33706288|NCT01823328|63272727|FG000|Overall Study|Withdrawal by Subject|8|||
33706289|NCT01823328|63272728|FG001|Overall Study|Withdrawal by Subject|6|||
33706290|NCT01840410|63272736|FG000|Overall Study|Physician Decision|1|||
33706291|NCT01840410|63272737|FG001|Overall Study|Physician Decision|2|||
33706292|NCT01840410|63272736|FG000|Overall Study|Pregnancy|1|||
33706293|NCT01840410|63272737|FG001|Overall Study|Pregnancy|0|||
33706294|NCT01840410|63272736|FG000|Overall Study|Protocol deviation|1|||
33706295|NCT01840410|63272737|FG001|Overall Study|Protocol deviation|0|||
33706296|NCT01840410|63272736|FG000|Overall Study|Lost to Follow-up|1|||
33706297|NCT01840410|63272737|FG001|Overall Study|Lost to Follow-up|0|||
33706298|NCT01840410|63272736|FG000|Overall Study|Withdrawal by Subject|2|||
33706299|NCT01840410|63272737|FG001|Overall Study|Withdrawal by Subject|1|||
33706300|NCT01840410|63272736|FG000|Overall Study|Adverse Event|1|||
33706301|NCT01840410|63272737|FG001|Overall Study|Adverse Event|1|||
33706302|NCT01797432|63272745|FG000|Overall Study|Lost to Follow-up|1|||
33706303|NCT01797432|63272745|FG000|Overall Study|Adverse Event|1|||
33706304|NCT01797432|63272745|FG000|Overall Study|Withdrawal by Subject|1|||
33706305|NCT01797432|63272745|FG000|Overall Study|lived too far from study site|1|||
33706306|NCT01797120|63272751|FG000|Overall Study|Disesae progression|37|||
33706307|NCT01797120|63272752|FG001|Overall Study|Disesae progression|49|||
33706308|NCT01797120|63272751|FG000|Overall Study|Adverse Event|13|||
33706309|NCT01797120|63272752|FG001|Overall Study|Adverse Event|5|||
33706310|NCT01797120|63272751|FG000|Overall Study|Withdrawal by Subject|6|||
33706311|NCT01797120|63272752|FG001|Overall Study|Withdrawal by Subject|6|||
33706312|NCT01797120|63272751|FG000|Overall Study|Symptomatic progression|2|||
33706313|NCT01797120|63272752|FG001|Overall Study|Symptomatic progression|1|||
33706314|NCT01797120|63272751|FG000|Overall Study|Non-compliance|1|||
33706315|NCT01797120|63272752|FG001|Overall Study|Non-compliance|0|||
33706316|NCT01797120|63272751|FG000|Overall Study|Physician Decision|3|||
33706317|NCT01797120|63272752|FG001|Overall Study|Physician Decision|0|||
33706318|NCT01797120|63272751|FG000|Overall Study|still on treatment|2|||
33706319|NCT01797120|63272752|FG001|Overall Study|still on treatment|4|||
33706320|NCT01797120|63272751|FG000|Overall Study|never start protocol therapy|2|||
33706321|NCT01797120|63272752|FG001|Overall Study|never start protocol therapy|0|||
33706322|NCT01796964|63272760|FG000|Overall Study|Adverse Event|1|||
33706323|NCT01796964|63272761|FG001|Overall Study|Adverse Event|1|||
33706324|NCT01796964|63272760|FG000|Overall Study|Death|1|||
33706325|NCT01796964|63272761|FG001|Overall Study|Death|0|||
33706326|NCT01796964|63272760|FG000|Overall Study|Protocol Violation|0|||
33706327|NCT01796964|63272761|FG001|Overall Study|Protocol Violation|1|||
33706328|NCT01796964|63272760|FG000|Overall Study|Withdrawal by Subject|1|||
33706329|NCT01796964|63272761|FG001|Overall Study|Withdrawal by Subject|1|||
33706330|NCT01838694|63272770|FG000|Overall Study|Adverse Event|0|||
33706331|NCT01838694|63272771|FG001|Overall Study|Adverse Event|1|||
33706332|NCT01795638|63272782|FG000|Overall Study|Death|0|||
33706333|NCT01795638|63272783|FG001|Overall Study|Death|3|||
33706334|NCT01795638|63272782|FG000|Overall Study|transferred to quaternary hospital|2|||
33706335|NCT01795638|63272783|FG001|Overall Study|transferred to quaternary hospital|3|||
33706336|NCT01795638|63272782|FG000|Overall Study|Protocol Violation|3|||
33706337|NCT01795638|63272783|FG001|Overall Study|Protocol Violation|0|||
33706338|NCT01795638|63272782|FG000|Overall Study|discharged from hospital|7|||
33706339|NCT01795638|63272783|FG001|Overall Study|discharged from hospital|5|||
33706340|NCT01795638|63272782|FG000|Overall Study|Withdrawal by Subject|1|||
33706341|NCT01795638|63272783|FG001|Overall Study|Withdrawal by Subject|0|||
33706342|NCT01794780|63272797|FG000|Overall Study|Adverse Event|0|||
33706343|NCT01794780|63272798|FG001|Overall Study|Adverse Event|1|||
33706344|NCT01794780|63272799|FG002|Overall Study|Adverse Event|2|||
33706345|NCT01794780|63272800|FG003|Overall Study|Adverse Event|0|||
33706346|NCT01794780|63272801|FG004|Overall Study|Adverse Event|0|||
33706347|NCT01794780|63272802|FG005|Overall Study|Adverse Event|0|||
33706348|NCT01794780|63272803|FG006|Overall Study|Adverse Event|0|||
33706349|NCT01794780|63272804|FG007|Overall Study|Adverse Event|0|||
33706350|NCT01794780|63272797|FG000|Overall Study|Death|0|||
33706351|NCT01794780|63272798|FG001|Overall Study|Death|2|||
33706352|NCT01794780|63272799|FG002|Overall Study|Death|14|||
33706353|NCT01794780|63272800|FG003|Overall Study|Death|1|||
33706354|NCT01794780|63272801|FG004|Overall Study|Death|0|||
33706355|NCT01794780|63272802|FG005|Overall Study|Death|9|||
33706356|NCT01794780|63272803|FG006|Overall Study|Death|4|||
33706357|NCT01794780|63272804|FG007|Overall Study|Death|0|||
33706358|NCT01794780|63272797|FG000|Overall Study|Lost to Follow-up|10|||
33706359|NCT01794780|63272798|FG001|Overall Study|Lost to Follow-up|64|||
33706360|NCT01794780|63272799|FG002|Overall Study|Lost to Follow-up|165|||
33706361|NCT01794780|63272800|FG003|Overall Study|Lost to Follow-up|53|||
33706362|NCT01794780|63272801|FG004|Overall Study|Lost to Follow-up|2|||
33596993|NCT01883362|62995930|FG000|Treatment|Withdrawal by Subject|6|||
33596994|NCT01883362|62995931|FG001|Treatment|Withdrawal by Subject|2|||
33706363|NCT01794780|63272802|FG005|Overall Study|Lost to Follow-up|99|||
33706364|NCT01794780|63272803|FG006|Overall Study|Lost to Follow-up|30|||
33706365|NCT01794780|63272804|FG007|Overall Study|Lost to Follow-up|5|||
33706366|NCT01794780|63272797|FG000|Overall Study|Withdrew informed consent|7|||
33706367|NCT01794780|63272798|FG001|Overall Study|Withdrew informed consent|17|||
33706368|NCT01794780|63272799|FG002|Overall Study|Withdrew informed consent|36|||
33706369|NCT01794780|63272800|FG003|Overall Study|Withdrew informed consent|9|||
33706370|NCT01794780|63272801|FG004|Overall Study|Withdrew informed consent|0|||
33706371|NCT01794780|63272802|FG005|Overall Study|Withdrew informed consent|48|||
33706372|NCT01794780|63272803|FG006|Overall Study|Withdrew informed consent|4|||
33706373|NCT01794780|63272804|FG007|Overall Study|Withdrew informed consent|3|||
33706374|NCT01794780|63272797|FG000|Overall Study|Other|0|||
33706375|NCT01794780|63272798|FG001|Overall Study|Other|12|||
33706376|NCT01794780|63272799|FG002|Overall Study|Other|25|||
33706377|NCT01794780|63272800|FG003|Overall Study|Other|20|||
33706378|NCT01794780|63272801|FG004|Overall Study|Other|1|||
33706379|NCT01794780|63272802|FG005|Overall Study|Other|24|||
33706380|NCT01794780|63272803|FG006|Overall Study|Other|4|||
33706381|NCT01794780|63272804|FG007|Overall Study|Other|1|||
33706382|NCT01838616|63272831|FG000|Titration Period|Adverse Event|18|||
33706383|NCT01838616|63272832|FG001|Titration Period|Adverse Event|48|||
33706384|NCT01838616|63272831|FG000|Titration Period|Lack of Efficacy|5|||
33706385|NCT01838616|63272832|FG001|Titration Period|Lack of Efficacy|12|||
33706386|NCT01838616|63272831|FG000|Titration Period|Withdrawal by Subject|5|||
33706387|NCT01838616|63272832|FG001|Titration Period|Withdrawal by Subject|5|||
33706388|NCT01838616|63272831|FG000|Titration Period|Technical problems|1|||
33706389|NCT01838616|63272832|FG001|Titration Period|Technical problems|0|||
33706390|NCT01838616|63272831|FG000|Titration Period|Other|1|||
33706391|NCT01838616|63272832|FG001|Titration Period|Other|0|||
33706392|NCT01838616|63272831|FG000|Titration Period|Protocol Violation|0|||
33706393|NCT01838616|63272832|FG001|Titration Period|Protocol Violation|1|||
33706394|NCT01838616|63272831|FG000|Continuation Period|Lack of Efficacy|3|||
33706395|NCT01838616|63272832|FG001|Continuation Period|Lack of Efficacy|5|||
33706396|NCT01838616|63272831|FG000|Continuation Period|Adverse Event|8|||
33706397|NCT01838616|63272832|FG001|Continuation Period|Adverse Event|4|||
33706398|NCT01838616|63272831|FG000|Continuation Period|Protocol Violation|2|||
33706399|NCT01838616|63272832|FG001|Continuation Period|Protocol Violation|0|||
33706400|NCT01838616|63272831|FG000|Continuation Period|Lost to Follow-up|1|||
33706401|NCT01838616|63272832|FG001|Continuation Period|Lost to Follow-up|0|||
33706402|NCT01838616|63272831|FG000|Continuation Period|Withdrawal by Subject|0|||
33706403|NCT01838616|63272832|FG001|Continuation Period|Withdrawal by Subject|4|||
33706404|NCT01838616|63272831|FG000|Continuation Period|Technical problems|0|||
33706405|NCT01838616|63272832|FG001|Continuation Period|Technical problems|1|||
33706406|NCT01838616|63272831|FG000|Pick-up Arm|Lack of Efficacy|4|||
33706407|NCT01838616|63272832|FG001|Pick-up Arm|Lack of Efficacy|0|||
33706408|NCT01838616|63272831|FG000|Pick-up Arm|Adverse Event|9|||
33706409|NCT01838616|63272832|FG001|Pick-up Arm|Adverse Event|0|||
33706410|NCT01838616|63272831|FG000|Pick-up Arm|Withdrawal by Subject|1|||
33706411|NCT01838616|63272832|FG001|Pick-up Arm|Withdrawal by Subject|0|||
33706412|NCT01838616|63272831|FG000|Pick-up Arm|Technical problems|1|||
33706413|NCT01838616|63272832|FG001|Pick-up Arm|Technical problems|0|||
33706414|NCT01611792|63272845|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
33706415|NCT01611792|63272846|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
33706416|NCT01611792|63272845|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
33706417|NCT01611792|63272846|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
33706418|NCT01820364|63272853|FG000|Part I: LGX818|Death|1|||
33706419|NCT01820364|63272854|FG001|Part I: LGX818|Death|0|||
33706420|NCT01820364|63272853|FG000|Part I: LGX818|Administrative Problems|3|||
33706421|NCT01820364|63272854|FG001|Part I: LGX818|Administrative Problems|0|||
33706422|NCT01820364|63272853|FG000|Part I: LGX818|Adverse Event|6|||
33706423|NCT01820364|63272854|FG001|Part I: LGX818|Adverse Event|0|||
33706424|NCT01820364|63272853|FG000|Part I: LGX818|Disease Progression|4|||
33706425|NCT01820364|63272854|FG001|Part I: LGX818|Disease Progression|0|||
33706426|NCT01820364|63272853|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
33706427|NCT01820364|63272854|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
33706428|NCT01819506|63272862|FG000|Overall Study|Physician Decision|5|||
33706429|NCT01819506|63272863|FG001|Overall Study|Physician Decision|2|||
33706430|NCT01819506|63272862|FG000|Overall Study|Withdrawal by Subject|3|||
33706431|NCT01819506|63272863|FG001|Overall Study|Withdrawal by Subject|3|||
33706432|NCT01794000|63272871|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
33706433|NCT01794000|63272872|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
33706434|NCT01794000|63272871|FG000|Double-Blind Phase (DBP)|Death|1|||
33706435|NCT01794000|63272872|FG001|Double-Blind Phase (DBP)|Death|2|||
33706436|NCT01794000|63272871|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
33706437|NCT01794000|63272872|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
33706438|NCT01794000|63272871|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
33706439|NCT01794000|63272872|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
33706440|NCT01794000|63272871|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
33706441|NCT01794000|63272872|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
33706442|NCT01794000|63272871|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
33706443|NCT01794000|63272872|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
33706444|NCT01794000|63272871|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
33706445|NCT01794000|63272872|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
33706446|NCT01794000|63272871|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
33706447|NCT01794000|63272872|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
33706448|NCT01609296|63272879|FG000|Overall Study|Death|253|||
33706449|NCT01609296|63272879|FG000|Overall Study|Withdrawal by Subject|151|||
33706450|NCT01609296|63272879|FG000|Overall Study|Lost to Follow-up|21|||
33706451|NCT01609296|63272879|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
33706452|NCT01609296|63272879|FG000|Overall Study|missed visit but known to be alive|28|||
33706453|NCT01609218|63272887|FG000|Period 1|Adverse Event|3|||
33706454|NCT01609218|63272888|FG001|Period 1|Adverse Event|5|||
33706455|NCT01609218|63272887|FG000|Period 1|Sponsor Decision|0|||
33706456|NCT01609218|63272888|FG001|Period 1|Sponsor Decision|1|||
33706457|NCT01609218|63272887|FG000|Period 2|Adverse Event|1|||
33706458|NCT01609218|63272888|FG001|Period 2|Adverse Event|0|||
33706459|NCT01609062|63272896|FG000|Extension Phase|Terminated by Sponsor|14|||
33706460|NCT01609062|63272897|FG001|Extension Phase|Terminated by Sponsor|9|||
33706461|NCT01609062|63272896|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
33706462|NCT01609062|63272897|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
33706463|NCT01609062|63272896|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
33706464|NCT01609062|63272897|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
33706465|NCT01819272|63272910|FG000|Overall Study|Adverse Event|1|||
33706466|NCT01819272|63272911|FG001|Overall Study|Adverse Event|0|||
33706467|NCT01819272|63272912|FG002|Overall Study|Adverse Event|0|||
33706468|NCT01819272|63272913|FG003|Overall Study|Adverse Event|2|||
33706469|NCT01819272|63272914|FG004|Overall Study|Adverse Event|0|||
33706470|NCT01819272|63272915|FG005|Overall Study|Adverse Event|0|||
33706471|NCT01819272|63272910|FG000|Overall Study|Lost to Follow-up|3|||
33706472|NCT01819272|63272911|FG001|Overall Study|Lost to Follow-up|0|||
33706473|NCT01819272|63272912|FG002|Overall Study|Lost to Follow-up|1|||
33706474|NCT01819272|63272913|FG003|Overall Study|Lost to Follow-up|0|||
33706475|NCT01819272|63272914|FG004|Overall Study|Lost to Follow-up|0|||
33706476|NCT01819272|63272915|FG005|Overall Study|Lost to Follow-up|3|||
33706477|NCT01819272|63272910|FG000|Overall Study|Protocol Violation|0|||
33706478|NCT01819272|63272911|FG001|Overall Study|Protocol Violation|0|||
33706479|NCT01819272|63272912|FG002|Overall Study|Protocol Violation|0|||
33706480|NCT01819272|63272913|FG003|Overall Study|Protocol Violation|1|||
33706481|NCT01819272|63272914|FG004|Overall Study|Protocol Violation|2|||
33706482|NCT01819272|63272915|FG005|Overall Study|Protocol Violation|3|||
33706483|NCT01819272|63272910|FG000|Overall Study|Physician Decision|0|||
33706484|NCT01819272|63272911|FG001|Overall Study|Physician Decision|1|||
33706485|NCT01819272|63272912|FG002|Overall Study|Physician Decision|0|||
33706486|NCT01819272|63272913|FG003|Overall Study|Physician Decision|0|||
33706487|NCT01819272|63272914|FG004|Overall Study|Physician Decision|0|||
33706488|NCT01819272|63272915|FG005|Overall Study|Physician Decision|0|||
33706489|NCT01819272|63272910|FG000|Overall Study|Withdrawal of Consent|0|||
33706490|NCT01819272|63272911|FG001|Overall Study|Withdrawal of Consent|1|||
33706491|NCT01819272|63272912|FG002|Overall Study|Withdrawal of Consent|2|||
33706492|NCT01819272|63272913|FG003|Overall Study|Withdrawal of Consent|1|||
33706493|NCT01819272|63272914|FG004|Overall Study|Withdrawal of Consent|0|||
33706494|NCT01819272|63272915|FG005|Overall Study|Withdrawal of Consent|1|||
33706495|NCT01819272|63272910|FG000|Overall Study|Loss of Glucose Control|2|||
33706496|NCT01819272|63272911|FG001|Overall Study|Loss of Glucose Control|1|||
33706497|NCT01819272|63272912|FG002|Overall Study|Loss of Glucose Control|0|||
33706498|NCT01819272|63272913|FG003|Overall Study|Loss of Glucose Control|1|||
33706499|NCT01819272|63272914|FG004|Overall Study|Loss of Glucose Control|2|||
33706500|NCT01819272|63272915|FG005|Overall Study|Loss of Glucose Control|0|||
33706501|NCT01819194|63272929|FG000|Overall Study|Loss of study articles|2|||
33706502|NCT01611558|63272933|FG000|Induction Phase|Study drug toxicity|15|||
33706503|NCT01611558|63272933|FG000|Induction Phase|Disease progression|18|||
33706504|NCT01611558|63272933|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
33706505|NCT01611558|63272933|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
33706506|NCT01611558|63272933|FG000|Induction Phase|Death|1|||
33706507|NCT01611558|63272933|FG000|Maintenance Phase|Withdrawal by Subject|1|||
33706508|NCT01611558|63272933|FG000|Maintenance Phase|Elevated Uric acid|1|||
33706509|NCT01818726|63272940|FG000|Overall Study|Administrative reasons|5|||
33706510|NCT01818726|63272941|FG001|Overall Study|Administrative reasons|1|||
33706511|NCT01818726|63272940|FG000|Overall Study|Withdrawal by Subject|0|||
33706512|NCT01818726|63272941|FG001|Overall Study|Withdrawal by Subject|1|||
33706513|NCT01818726|63272940|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
33706514|NCT01818726|63272941|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
33706515|NCT01818336|63272947|FG000|Overall Study|Declined retest visit|0|||
33706516|NCT01818336|63272948|FG001|Overall Study|Declined retest visit|11|||
33706517|NCT01818336|63272947|FG000|Overall Study|Lost to Follow-up|0|||
33706518|NCT01818336|63272948|FG001|Overall Study|Lost to Follow-up|1|||
33706519|NCT01818258|63272956|FG000|Overall Study|Death|3|||
33706520|NCT01818258|63272957|FG001|Overall Study|Death|0|||
33706521|NCT01818258|63272956|FG000|Overall Study|Withdrawal by Subject|0|||
33706522|NCT01818258|63272957|FG001|Overall Study|Withdrawal by Subject|1|||
33706523|NCT01818258|63272956|FG000|Overall Study|Lost to Follow-up|0|||
33706524|NCT01818258|63272957|FG001|Overall Study|Lost to Follow-up|1|||
33706525|NCT01818258|63272956|FG000|Overall Study|Unable to Travel to Clinic|0|||
33706526|NCT01818258|63272957|FG001|Overall Study|Unable to Travel to Clinic|1|||
33706527|NCT01817790|63272966|FG000|Overall Study|Adverse Event|0|||
33706528|NCT01817790|63272967|FG001|Overall Study|Adverse Event|2|||
33706529|NCT01817790|63272966|FG000|Overall Study|Lost to Follow-up|0|||
33706530|NCT01817790|63272967|FG001|Overall Study|Lost to Follow-up|1|||
33706531|NCT01817790|63272966|FG000|Overall Study|Protocol Violation|2|||
33706532|NCT01817790|63272967|FG001|Overall Study|Protocol Violation|1|||
33706533|NCT01817790|63272966|FG000|Overall Study|Withdrawal by Subject|1|||
33706534|NCT01817790|63272967|FG001|Overall Study|Withdrawal by Subject|3|||
33706535|NCT01817790|63272966|FG000|Overall Study|Other: Could not attend appointment|1|||
33706536|NCT01817790|63272967|FG001|Overall Study|Other: Could not attend appointment|1|||
33706537|NCT01793688|63272975|FG000|Overall Study|Protocol Violation|2|||
33706538|NCT01793142|63272979|FG000|Overall Study|Randomized not treated|7|||
33706539|NCT01792830|63272994|FG000|Overall Study|Withdrawal by Subject|22|||
33706540|NCT01792830|63272995|FG001|Overall Study|Withdrawal by Subject|0|||
33706541|NCT01792830|63272996|FG002|Overall Study|Withdrawal by Subject|0|||
33706542|NCT01792830|63272997|FG003|Overall Study|Withdrawal by Subject|2|||
33706543|NCT01792830|63272998|FG004|Overall Study|Withdrawal by Subject|1|||
33706544|NCT01792830|63272999|FG005|Overall Study|Withdrawal by Subject|1|||
33706545|NCT01792830|63273000|FG006|Overall Study|Withdrawal by Subject|1|||
33706546|NCT01792830|63273001|FG007|Overall Study|Withdrawal by Subject|1|||
33706547|NCT01792830|63273002|FG008|Overall Study|Withdrawal by Subject|7|||
33706548|NCT01792830|63273003|FG009|Overall Study|Withdrawal by Subject|0|||
33706549|NCT01792830|63273004|FG010|Overall Study|Withdrawal by Subject|2|||
33706550|NCT01792830|63272994|FG000|Overall Study|Death|3|||
33706551|NCT01792830|63272995|FG001|Overall Study|Death|0|||
33706552|NCT01792830|63272996|FG002|Overall Study|Death|0|||
33706553|NCT01792830|63272997|FG003|Overall Study|Death|1|||
33706554|NCT01792830|63272998|FG004|Overall Study|Death|0|||
33706555|NCT01792830|63272999|FG005|Overall Study|Death|0|||
33706556|NCT01792830|63273000|FG006|Overall Study|Death|1|||
33706557|NCT01792830|63273001|FG007|Overall Study|Death|0|||
33706558|NCT01792830|63273002|FG008|Overall Study|Death|1|||
33706559|NCT01792830|63273003|FG009|Overall Study|Death|0|||
33706560|NCT01792830|63273004|FG010|Overall Study|Death|1|||
33706561|NCT01792830|63272994|FG000|Overall Study|Adverse Event|0|||
33706562|NCT01792830|63272995|FG001|Overall Study|Adverse Event|0|||
33706563|NCT01792830|63272996|FG002|Overall Study|Adverse Event|0|||
33706564|NCT01792830|63272997|FG003|Overall Study|Adverse Event|0|||
33706565|NCT01792830|63272998|FG004|Overall Study|Adverse Event|0|||
33706566|NCT01792830|63272999|FG005|Overall Study|Adverse Event|0|||
33706567|NCT01792830|63273000|FG006|Overall Study|Adverse Event|0|||
33706568|NCT01792830|63273001|FG007|Overall Study|Adverse Event|0|||
33706569|NCT01792830|63273002|FG008|Overall Study|Adverse Event|1|||
33706570|NCT01792830|63273003|FG009|Overall Study|Adverse Event|0|||
33706571|NCT01792830|63273004|FG010|Overall Study|Adverse Event|0|||
33706572|NCT01792518|63273036|FG000|Overall Study|Adverse Event|3|||
33706573|NCT01792518|63273037|FG001|Overall Study|Adverse Event|4|||
33706574|NCT01792518|63273036|FG000|Overall Study|Protocol Violation|0|||
33706575|NCT01792518|63273037|FG001|Overall Study|Protocol Violation|1|||
33706576|NCT01792518|63273036|FG000|Overall Study|Lost to Follow-up|3|||
33706577|NCT01792518|63273037|FG001|Overall Study|Lost to Follow-up|1|||
33706578|NCT01792518|63273036|FG000|Overall Study|Withdrawal by Subject|2|||
33706579|NCT01792518|63273037|FG001|Overall Study|Withdrawal by Subject|0|||
33706580|NCT01792518|63273036|FG000|Overall Study|Other Reason|0|||
33706581|NCT01792518|63273037|FG001|Overall Study|Other Reason|1|||
33706582|NCT01792284|63273043|FG000|Lead-in Period|Adverse Event|15|||
33706583|NCT01792284|63273044|FG001|Lead-in Period|Adverse Event|0|||
33706584|NCT01792284|63273045|FG002|Lead-in Period|Adverse Event|0|||
33706585|NCT01792284|63273043|FG000|Lead-in Period|Lost to Follow-up|2|||
33706586|NCT01792284|63273044|FG001|Lead-in Period|Lost to Follow-up|0|||
33706587|NCT01792284|63273045|FG002|Lead-in Period|Lost to Follow-up|0|||
33706588|NCT01792284|63273043|FG000|Lead-in Period|Protocol Violation|1|||
33706589|NCT01792284|63273044|FG001|Lead-in Period|Protocol Violation|0|||
33706590|NCT01792284|63273045|FG002|Lead-in Period|Protocol Violation|0|||
33706591|NCT01792284|63273043|FG000|Lead-in Period|Withdrawal by Subject|10|||
33706592|NCT01792284|63273044|FG001|Lead-in Period|Withdrawal by Subject|0|||
33706593|NCT01792284|63273045|FG002|Lead-in Period|Withdrawal by Subject|0|||
33706594|NCT01792284|63273043|FG000|Lead-in Period|Physician Decision|1|||
33706595|NCT01792284|63273044|FG001|Lead-in Period|Physician Decision|0|||
33706596|NCT01792284|63273045|FG002|Lead-in Period|Physician Decision|0|||
33706597|NCT01792284|63273043|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
33706598|NCT01792284|63273044|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
33706599|NCT01792284|63273045|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
33706600|NCT01792284|63273043|FG000|Randomization Period 1|Withdrawal by Subject|0|||
33706601|NCT01792284|63273044|FG001|Randomization Period 1|Withdrawal by Subject|1|||
33706602|NCT01792284|63273045|FG002|Randomization Period 1|Withdrawal by Subject|1|||
33706603|NCT01792284|63273043|FG000|Randomization Period 1|Physician Decision|0|||
33706604|NCT01792284|63273044|FG001|Randomization Period 1|Physician Decision|1|||
33706605|NCT01792284|63273045|FG002|Randomization Period 1|Physician Decision|1|||
33706606|NCT01792284|63273043|FG000|Randomization Period 1|Adverse Event|0|||
33706607|NCT01792284|63273044|FG001|Randomization Period 1|Adverse Event|0|||
33706608|NCT01792284|63273045|FG002|Randomization Period 1|Adverse Event|2|||
33706609|NCT01792284|63273043|FG000|Randomization Period 1|Lost to Follow-up|0|||
33706610|NCT01792284|63273044|FG001|Randomization Period 1|Lost to Follow-up|0|||
33706611|NCT01792284|63273045|FG002|Randomization Period 1|Lost to Follow-up|1|||
33706612|NCT01792284|63273043|FG000|Randomization Period 2|Protocol Violation|0|||
33706613|NCT01792284|63273044|FG001|Randomization Period 2|Protocol Violation|1|||
33706614|NCT01792284|63273045|FG002|Randomization Period 2|Protocol Violation|0|||
33706615|NCT01792284|63273043|FG000|Randomization Period 2|Withdrawal by Subject|0|||
33706616|NCT01792284|63273044|FG001|Randomization Period 2|Withdrawal by Subject|2|||
33706617|NCT01792284|63273045|FG002|Randomization Period 2|Withdrawal by Subject|0|||
33706618|NCT01791894|63273053|FG000|Overall Study|Adverse Event|1|||
33706619|NCT01837680|63273060|FG000|Overall Study|Lost to Follow-up|2|||
33706620|NCT01837680|63273061|FG001|Overall Study|Lost to Follow-up|2|||
33706621|NCT01837680|63273060|FG000|Overall Study|lack of insurance|0|||
33706622|NCT01837680|63273061|FG001|Overall Study|lack of insurance|2|||
33706623|NCT01837680|63273060|FG000|Overall Study|allergic reaction|6|||
33706624|NCT01837680|63273061|FG001|Overall Study|allergic reaction|0|||
33706625|NCT01837680|63273060|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
33706626|NCT01837680|63273061|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
33706627|NCT01836276|63273069|FG000|Overall Study|Lost to Follow-up|28|||
33706628|NCT01836276|63273070|FG001|Overall Study|Lost to Follow-up|51|||
33706629|NCT01790568|63273076|FG000|Overall Study|Progression prior to transplant|0|||
33706630|NCT01790568|63273077|FG001|Overall Study|Progression prior to transplant|1|||
33706631|NCT01610076|63273083|FG000|Overall Study|Technical issue with video|0|||
33706632|NCT01610076|63273084|FG001|Overall Study|Technical issue with video|1|||
33706633|NCT01610076|63273083|FG000|Overall Study|Lost to Follow-up|3|||
33706634|NCT01610076|63273084|FG001|Overall Study|Lost to Follow-up|4|||
33706635|NCT01836198|63273093|FG000|Part A, Period 2|Protocol Violation|0|||
33706636|NCT01836198|63273094|FG001|Part A, Period 2|Protocol Violation|1|||
33706637|NCT01836198|63273095|FG002|Part A, Period 2|Protocol Violation|0|||
33706638|NCT01816074|63273115|FG000|Phase 1|Time commitment issues|0|||
33706639|NCT01816074|63273116|FG001|Phase 1|Time commitment issues|0|||
33706640|NCT01816074|63273117|FG002|Phase 1|Time commitment issues|1|||
33706641|NCT01816074|63273118|FG003|Phase 1|Time commitment issues|0|||
33706642|NCT01816074|63273115|FG000|Phase 2|Time commitment Issues|0|||
33706643|NCT01816074|63273116|FG001|Phase 2|Time commitment Issues|2|||
33706644|NCT01816074|63273117|FG002|Phase 2|Time commitment Issues|0|||
33706645|NCT01816074|63273118|FG003|Phase 2|Time commitment Issues|0|||
33706646|NCT01816074|63273115|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
33706647|NCT01816074|63273116|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
33706648|NCT01816074|63273117|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
33706649|NCT01816074|63273118|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
33706650|NCT01816074|63273115|FG000|Phase 2|Physician Decision|0|||
33706651|NCT01816074|63273116|FG001|Phase 2|Physician Decision|0|||
33706652|NCT01816074|63273117|FG002|Phase 2|Physician Decision|0|||
33706653|NCT01816074|63273118|FG003|Phase 2|Physician Decision|1|||
33706654|NCT01816074|63273115|FG000|Phase 2|Withdrawal by Subject|1|||
33706655|NCT01816074|63273116|FG001|Phase 2|Withdrawal by Subject|0|||
33706656|NCT01816074|63273117|FG002|Phase 2|Withdrawal by Subject|0|||
33706657|NCT01816074|63273118|FG003|Phase 2|Withdrawal by Subject|0|||
33706658|NCT01815918|63273144|FG000|Overall Study|Patient samples not analyzable|3|||
33706659|NCT01815918|63273145|FG001|Overall Study|Patient samples not analyzable|4|||
33706660|NCT01815918|63273144|FG000|Overall Study|Lack of Efficacy|15|||
33706661|NCT01815918|63273145|FG001|Overall Study|Lack of Efficacy|15|||
33706662|NCT01789476|63273157|FG000|Overall Study|Lack of Efficacy|6|||
33706663|NCT01789476|63273158|FG001|Overall Study|Lack of Efficacy|2|||
33706664|NCT01789476|63273157|FG000|Overall Study|Adverse Event|1|||
33596995|NCT01883362|62995930|FG000|Treatment|Administrative problems|4|||
33706665|NCT01789476|63273158|FG001|Overall Study|Adverse Event|0|||
33706666|NCT01789476|63273157|FG000|Overall Study|Unable to get IV access|1|||
33706667|NCT01789476|63273158|FG001|Overall Study|Unable to get IV access|0|||
33706668|NCT01789320|63273164|FG000|Overall Study|Re-enrolled into study|1|||
33706669|NCT01789320|63273164|FG000|Overall Study|Lost to Follow-up|1|||
33706670|NCT01815840|63273170|FG000|Overall Study|Missing|1|||
33706671|NCT01815840|63273171|FG001|Overall Study|Missing|0|||
33706672|NCT01815840|63273170|FG000|Overall Study|Withdrew Consent|31|||
33706673|NCT01815840|63273171|FG001|Overall Study|Withdrew Consent|30|||
33706674|NCT01815840|63273170|FG000|Overall Study|Administrative/Other|1|||
33706675|NCT01815840|63273171|FG001|Overall Study|Administrative/Other|3|||
33706676|NCT01815840|63273170|FG000|Overall Study|Adverse Event|10|||
33706677|NCT01815840|63273171|FG001|Overall Study|Adverse Event|16|||
33706678|NCT01815840|63273170|FG000|Overall Study|Death|2|||
33706679|NCT01815840|63273171|FG001|Overall Study|Death|2|||
33706680|NCT01815840|63273170|FG000|Overall Study|Disease progression|3|||
33706681|NCT01815840|63273171|FG001|Overall Study|Disease progression|2|||
33706682|NCT01815840|63273170|FG000|Overall Study|Investigators Decision|2|||
33706683|NCT01815840|63273171|FG001|Overall Study|Investigators Decision|3|||
33706684|NCT01815840|63273170|FG000|Overall Study|Lost to Follow-up|3|||
33706685|NCT01815840|63273171|FG001|Overall Study|Lost to Follow-up|6|||
33706686|NCT01815840|63273170|FG000|Overall Study|Refused Treatment|5|||
33706687|NCT01815840|63273171|FG001|Overall Study|Refused Treatment|1|||
33706688|NCT01815840|63273170|FG000|Overall Study|Sponsor Termination Treatment|1|||
33706689|NCT01815840|63273171|FG001|Overall Study|Sponsor Termination Treatment|0|||
33706690|NCT01774110|63273177|FG000|Overall Study|Lost to Follow-up|7|||
33706691|NCT01788228|63273184|FG000|Overall Study|Migrated/moved from study area|1|||
33706692|NCT01788228|63273185|FG001|Overall Study|Migrated/moved from study area|0|||
33706693|NCT01607346|63273194|FG000|Overall Study|Adverse Event|3|||
33706694|NCT01787838|63273198|FG000|Overall Study|refused|1413|||
33706695|NCT01787760|63273205|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
33706696|NCT01787760|63273206|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
33706697|NCT01787760|63273207|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
33706698|NCT01787760|63273205|FG000|Overall Study|Decompensated on left exotropia|0|||
33706699|NCT01787760|63273206|FG001|Overall Study|Decompensated on left exotropia|0|||
33706700|NCT01787760|63273207|FG002|Overall Study|Decompensated on left exotropia|1|||
33706701|NCT01787760|63273205|FG000|Overall Study|Dryness|0|||
33706702|NCT01787760|63273206|FG001|Overall Study|Dryness|1|||
33706703|NCT01787760|63273207|FG002|Overall Study|Dryness|0|||
33706704|NCT01787760|63273205|FG000|Overall Study|Relocation|1|||
33706705|NCT01787760|63273206|FG001|Overall Study|Relocation|1|||
33706706|NCT01787760|63273207|FG002|Overall Study|Relocation|0|||
33706707|NCT01787760|63273205|FG000|Overall Study|Lens discomfort|3|||
33706708|NCT01787760|63273206|FG001|Overall Study|Lens discomfort|0|||
33706709|NCT01787760|63273207|FG002|Overall Study|Lens discomfort|0|||
33706710|NCT01787760|63273205|FG000|Overall Study|Lens handling difficulty|1|||
33706711|NCT01787760|63273206|FG001|Overall Study|Lens handling difficulty|2|||
33706712|NCT01787760|63273207|FG002|Overall Study|Lens handling difficulty|0|||
33706713|NCT01787760|63273205|FG000|Overall Study|Protocol Violation|6|||
33706714|NCT01787760|63273206|FG001|Overall Study|Protocol Violation|0|||
33706715|NCT01787760|63273207|FG002|Overall Study|Protocol Violation|1|||
33706716|NCT01787760|63273205|FG000|Overall Study|Withdrawal by Subject|5|||
33706717|NCT01787760|63273206|FG001|Overall Study|Withdrawal by Subject|1|||
33706718|NCT01787760|63273207|FG002|Overall Study|Withdrawal by Subject|2|||
33706719|NCT01787760|63273205|FG000|Overall Study|Lost to Follow-up|1|||
33706720|NCT01787760|63273206|FG001|Overall Study|Lost to Follow-up|0|||
33706721|NCT01787760|63273207|FG002|Overall Study|Lost to Follow-up|1|||
33706722|NCT01787760|63273205|FG000|Overall Study|Stroke|1|||
33706723|NCT01787760|63273206|FG001|Overall Study|Stroke|0|||
33706724|NCT01787760|63273207|FG002|Overall Study|Stroke|0|||
33706725|NCT01787760|63273205|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
33706726|NCT01787760|63273206|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
33706727|NCT01787760|63273207|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
33706728|NCT01787760|63273205|FG000|Overall Study|Unsatisfactory physiological response|2|||
33706729|NCT01787760|63273206|FG001|Overall Study|Unsatisfactory physiological response|4|||
33706730|NCT01787760|63273207|FG002|Overall Study|Unsatisfactory physiological response|0|||
33706731|NCT01787760|63273205|FG000|Overall Study|Unsatisfactory visual response|1|||
33706732|NCT01787760|63273206|FG001|Overall Study|Unsatisfactory visual response|1|||
33706733|NCT01787760|63273207|FG002|Overall Study|Unsatisfactory visual response|0|||
33706734|NCT01787760|63273205|FG000|Overall Study|Near vision blur|1|||
33706735|NCT01787760|63273206|FG001|Overall Study|Near vision blur|0|||
33706736|NCT01787760|63273207|FG002|Overall Study|Near vision blur|0|||
33706737|NCT01815138|63273218|FG000|Overall Study|Withdrawal by Subject|0|||
33706738|NCT01815138|63273219|FG001|Overall Study|Withdrawal by Subject|1|||
33706739|NCT01815138|63273218|FG000|Overall Study|Physician Decision|8|||
33706740|NCT01815138|63273219|FG001|Overall Study|Physician Decision|5|||
33706741|NCT01606800|63273227|FG000|Overall Study|Adverse Event|3|||
33706742|NCT01606800|63273228|FG001|Overall Study|Adverse Event|1|||
33706743|NCT01606800|63273227|FG000|Overall Study|Participant withdrew consent|0|||
33706744|NCT01606800|63273228|FG001|Overall Study|Participant withdrew consent|1|||
33706745|NCT01606800|63273227|FG000|Overall Study|Missing completion status|2|||
33706746|NCT01606800|63273228|FG001|Overall Study|Missing completion status|0|||
33706747|NCT01772550|63273237|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
33706748|NCT01772550|63273238|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
33706749|NCT01772550|63273239|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
33706750|NCT01772550|63273237|FG000|Overall Study|Adverse Event|0|||
33706751|NCT01772550|63273238|FG001|Overall Study|Adverse Event|0|||
33706752|NCT01772550|63273239|FG002|Overall Study|Adverse Event|1|||
33706753|NCT01787292|63273247|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
33706754|NCT01787292|63273248|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
33706755|NCT01787292|63273247|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
33706756|NCT01787292|63273248|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
33706757|NCT01814748|63273261|FG000|Overall Study|Lost to Follow-up|1|||
33706758|NCT01814748|63273262|FG001|Overall Study|Lost to Follow-up|2|||
33706759|NCT01814748|63273261|FG000|Overall Study|Study site terminated by sponsor|1|||
33706760|NCT01814748|63273262|FG001|Overall Study|Study site terminated by sponsor|1|||
33706761|NCT01814748|63273261|FG000|Overall Study|Withdrawal by Subject|6|||
33706762|NCT01814748|63273262|FG001|Overall Study|Withdrawal by Subject|4|||
33706763|NCT01814670|63273268|FG000|Overall Study|Protocol Violation|12|||
33706764|NCT01814046|63273274|FG000|Drug Administration|Death due to complications of RSV|1|||
33706765|NCT01814046|63273275|FG001|Drug Administration|Death due to complications of RSV|0|||
33706766|NCT01814046|63273276|FG002|Drug Administration|Death due to complications of RSV|0|||
33706767|NCT01813890|63273286|FG000|Overall Study|Adverse Event|0|||
33706768|NCT01813890|63273287|FG001|Overall Study|Adverse Event|3|||
33706769|NCT01813890|63273288|FG002|Overall Study|Adverse Event|4|||
33706770|NCT01813890|63273286|FG000|Overall Study|Lack of Efficacy|9|||
33706771|NCT01813890|63273287|FG001|Overall Study|Lack of Efficacy|1|||
33706772|NCT01813890|63273288|FG002|Overall Study|Lack of Efficacy|2|||
33706773|NCT01772316|63273296|FG000|Overall Study|Serious adverse event|1|||
33706774|NCT01772316|63273296|FG000|Overall Study|Inform consent withdrawn|1|||
33706775|NCT01772316|63273296|FG000|Overall Study|Withdrawn by sponsor decision|5|||
33706776|NCT01813422|63273302|FG000|Overall Study|Withdrawal by Subject|14|||
33706777|NCT01813422|63273303|FG001|Overall Study|Withdrawal by Subject|8|||
33706778|NCT01813422|63273302|FG000|Overall Study|Death|2|||
33706779|NCT01813422|63273303|FG001|Overall Study|Death|3|||
33706780|NCT01813422|63273302|FG000|Overall Study|Sponsor Decision|2|||
33706781|NCT01813422|63273303|FG001|Overall Study|Sponsor Decision|1|||
33706782|NCT01813422|63273302|FG000|Overall Study|Lost to Follow-up|2|||
33706783|NCT01813422|63273303|FG001|Overall Study|Lost to Follow-up|4|||
33706784|NCT01786668|63273313|FG000|Overall Study|Adverse Event|0|||
33706785|NCT01786668|63273314|FG001|Overall Study|Adverse Event|1|||
33706786|NCT01786668|63273315|FG002|Overall Study|Adverse Event|1|||
33706787|NCT01786668|63273316|FG003|Overall Study|Adverse Event|2|||
33706788|NCT01786668|63273313|FG000|Overall Study|Withdrawal by Subject|0|||
33706789|NCT01786668|63273314|FG001|Overall Study|Withdrawal by Subject|0|||
33706790|NCT01786668|63273315|FG002|Overall Study|Withdrawal by Subject|3|||
33706791|NCT01786668|63273316|FG003|Overall Study|Withdrawal by Subject|1|||
33706792|NCT01786668|63273313|FG000|Overall Study|Pregnancy|0|||
33706793|NCT01786668|63273314|FG001|Overall Study|Pregnancy|0|||
33706794|NCT01786668|63273315|FG002|Overall Study|Pregnancy|0|||
33706795|NCT01786668|63273316|FG003|Overall Study|Pregnancy|1|||
33706796|NCT01786668|63273313|FG000|Overall Study|Lost to Follow-up|1|||
33706797|NCT01786668|63273314|FG001|Overall Study|Lost to Follow-up|0|||
33706798|NCT01786668|63273315|FG002|Overall Study|Lost to Follow-up|1|||
33706799|NCT01786668|63273316|FG003|Overall Study|Lost to Follow-up|0|||
33706800|NCT01786512|63273337|FG000|Overall Study|Lost to Follow-up|0|||
33706801|NCT01786512|63273338|FG001|Overall Study|Lost to Follow-up|0|||
33706802|NCT01786512|63273339|FG002|Overall Study|Lost to Follow-up|0|||
33706803|NCT01786512|63273340|FG003|Overall Study|Lost to Follow-up|0|||
33706804|NCT01786512|63273341|FG004|Overall Study|Lost to Follow-up|0|||
33706805|NCT01786512|63273342|FG005|Overall Study|Lost to Follow-up|0|||
33706806|NCT01786512|63273343|FG006|Overall Study|Lost to Follow-up|0|||
33706807|NCT01786512|63273344|FG007|Overall Study|Lost to Follow-up|0|||
33706808|NCT01786512|63273345|FG008|Overall Study|Lost to Follow-up|0|||
33706809|NCT01786512|63273346|FG009|Overall Study|Lost to Follow-up|1|||
33706810|NCT01786512|63273347|FG010|Overall Study|Lost to Follow-up|0|||
33706811|NCT01786512|63273337|FG000|Overall Study|Decision by sponsor|0|||
33706812|NCT01786512|63273338|FG001|Overall Study|Decision by sponsor|0|||
33706813|NCT01786512|63273339|FG002|Overall Study|Decision by sponsor|0|||
33706814|NCT01786512|63273340|FG003|Overall Study|Decision by sponsor|0|||
33706815|NCT01786512|63273341|FG004|Overall Study|Decision by sponsor|0|||
33706816|NCT01786512|63273342|FG005|Overall Study|Decision by sponsor|0|||
33706817|NCT01786512|63273343|FG006|Overall Study|Decision by sponsor|0|||
33706818|NCT01786512|63273344|FG007|Overall Study|Decision by sponsor|0|||
33706819|NCT01786512|63273345|FG008|Overall Study|Decision by sponsor|0|||
33706820|NCT01786512|63273346|FG009|Overall Study|Decision by sponsor|0|||
33706821|NCT01786512|63273347|FG010|Overall Study|Decision by sponsor|2|||
33706822|NCT01786512|63273337|FG000|Overall Study|Withdrawal by Subject|0|||
33706823|NCT01786512|63273338|FG001|Overall Study|Withdrawal by Subject|1|||
33706824|NCT01786512|63273339|FG002|Overall Study|Withdrawal by Subject|0|||
33706825|NCT01786512|63273340|FG003|Overall Study|Withdrawal by Subject|0|||
33706826|NCT01786512|63273341|FG004|Overall Study|Withdrawal by Subject|0|||
33706827|NCT01786512|63273342|FG005|Overall Study|Withdrawal by Subject|0|||
33706828|NCT01786512|63273343|FG006|Overall Study|Withdrawal by Subject|1|||
33706829|NCT01786512|63273344|FG007|Overall Study|Withdrawal by Subject|0|||
33706830|NCT01786512|63273345|FG008|Overall Study|Withdrawal by Subject|0|||
33706831|NCT01786512|63273346|FG009|Overall Study|Withdrawal by Subject|3|||
33706832|NCT01786512|63273347|FG010|Overall Study|Withdrawal by Subject|7|||
33706833|NCT01786512|63273337|FG000|Overall Study|Death|0|||
33706834|NCT01786512|63273338|FG001|Overall Study|Death|0|||
33706835|NCT01786512|63273339|FG002|Overall Study|Death|0|||
33706836|NCT01786512|63273340|FG003|Overall Study|Death|0|||
33706837|NCT01786512|63273341|FG004|Overall Study|Death|0|||
33706838|NCT01786512|63273342|FG005|Overall Study|Death|0|||
33706839|NCT01786512|63273343|FG006|Overall Study|Death|0|||
33706840|NCT01786512|63273344|FG007|Overall Study|Death|0|||
33706841|NCT01786512|63273345|FG008|Overall Study|Death|4|||
33706842|NCT01786512|63273346|FG009|Overall Study|Death|1|||
33596996|NCT01883362|62995931|FG001|Treatment|Administrative problems|1|||
33706843|NCT01786512|63273347|FG010|Overall Study|Death|3|||
33706844|NCT01772160|63273379|FG000|Overall Study|Death|3|||
33706845|NCT01772160|63273379|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
33706846|NCT01772160|63273379|FG000|Overall Study|Consent withdrawal|3|||
33706847|NCT01772160|63273379|FG000|Overall Study|Migrated / moved from the study area|4|||
33706848|NCT01772160|63273379|FG000|Overall Study|Lost to Follow-up|30|||
33706849|NCT01772160|63273379|FG000|Overall Study|Other|5|||
33706850|NCT01770912|63273385|FG000|Overall Study|Lost to Follow-up|2|||
33706851|NCT01770912|63273386|FG001|Overall Study|Lost to Follow-up|0|||
33706852|NCT01811706|63273392|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
33706853|NCT01811706|63273393|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
33706854|NCT01811472|63273404|FG000|Overall Study|Adverse Event|1|||
33706855|NCT01811472|63273405|FG001|Overall Study|Adverse Event|0|||
33706856|NCT01811472|63273406|FG002|Overall Study|Adverse Event|4|||
33706857|NCT01811472|63273404|FG000|Overall Study|Lost to Follow-up|0|||
33706858|NCT01811472|63273405|FG001|Overall Study|Lost to Follow-up|0|||
33706859|NCT01811472|63273406|FG002|Overall Study|Lost to Follow-up|1|||
33706860|NCT01811472|63273404|FG000|Overall Study|Subject/guardian decision|1|||
33706861|NCT01811472|63273405|FG001|Overall Study|Subject/guardian decision|0|||
33706862|NCT01811472|63273406|FG002|Overall Study|Subject/guardian decision|0|||
33706863|NCT01811238|63273415|FG000|Overall Study|Withdrawal by Subject|42|||
33706864|NCT01811238|63273415|FG000|Overall Study|Adverse Event|25|||
33706865|NCT01811238|63273415|FG000|Overall Study|Protocol Violation|4|||
33706866|NCT01811238|63273415|FG000|Overall Study|Lack of Efficacy|4|||
33706867|NCT01811238|63273415|FG000|Overall Study|subject refused study medication|6|||
33706868|NCT01769508|63273420|FG000|Overall Study|Death|3|||
33706869|NCT01769508|63273420|FG000|Overall Study|Withdrawal by Subject|1|||
33706870|NCT01769508|63273420|FG000|Overall Study|Adverse Event|1|||
33706871|NCT01769508|63273420|FG000|Overall Study|Lost to Follow-up|1|||
33706872|NCT01810380|63273427|FG000|Overall Study|Randomised not treated|2|||
33706873|NCT01810380|63273428|FG001|Overall Study|Randomised not treated|1|||
33706874|NCT01810380|63273429|FG002|Overall Study|Randomised not treated|1|||
33706875|NCT01810380|63273427|FG000|Overall Study|Adverse Event|11|||
33706876|NCT01810380|63273428|FG001|Overall Study|Adverse Event|14|||
33706877|NCT01810380|63273429|FG002|Overall Study|Adverse Event|4|||
33706878|NCT01810380|63273427|FG000|Overall Study|Lack of Efficacy|24|||
33706879|NCT01810380|63273428|FG001|Overall Study|Lack of Efficacy|10|||
33706880|NCT01810380|63273429|FG002|Overall Study|Lack of Efficacy|11|||
33706881|NCT01810380|63273427|FG000|Overall Study|Protocol Violation|1|||
33706882|NCT01810380|63273428|FG001|Overall Study|Protocol Violation|0|||
33706883|NCT01810380|63273429|FG002|Overall Study|Protocol Violation|1|||
33706884|NCT01810380|63273427|FG000|Overall Study|Withdrawal by Subject|6|||
33706885|NCT01810380|63273428|FG001|Overall Study|Withdrawal by Subject|0|||
33706886|NCT01810380|63273429|FG002|Overall Study|Withdrawal by Subject|6|||
33706887|NCT01810380|63273427|FG000|Overall Study|Administrative or other reasons|11|||
33706888|NCT01810380|63273428|FG001|Overall Study|Administrative or other reasons|13|||
33706889|NCT01810380|63273429|FG002|Overall Study|Administrative or other reasons|9|||
33706890|NCT01769196|63273439|FG000|Overall Study|Adverse Event|24|||
33596997|NCT01883362|62995930|FG000|Treatment|Relapse|4|||
33596998|NCT01883362|62995931|FG001|Treatment|Relapse|2|||
33596999|NCT01883362|62995930|FG000|Treatment|Randomized, not treated|1|||
33706891|NCT01769196|63273440|FG001|Overall Study|Adverse Event|20|||
33706892|NCT01769196|63273439|FG000|Overall Study|Death|21|||
33597000|NCT01883362|62995931|FG001|Treatment|Randomized, not treated|1|||
33597001|NCT01883362|62995930|FG000|Post Treatment Follow-up|Protocol Violation|0|||
33597002|NCT01883362|62995931|FG001|Post Treatment Follow-up|Protocol Violation|1|||
33706893|NCT01769196|63273440|FG001|Overall Study|Death|26|||
33706894|NCT01769196|63273439|FG000|Overall Study|Investigator Discretion|7|||
33706895|NCT01769196|63273440|FG001|Overall Study|Investigator Discretion|3|||
33706896|NCT01769196|63273439|FG000|Overall Study|Lack of Efficacy|3|||
33706897|NCT01769196|63273440|FG001|Overall Study|Lack of Efficacy|2|||
33706898|NCT01769196|63273439|FG000|Overall Study|Progressive disease|11|||
33706899|NCT01769196|63273440|FG001|Overall Study|Progressive disease|6|||
33706900|NCT01769196|63273439|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
33706901|NCT01769196|63273440|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
33706902|NCT01769196|63273439|FG000|Overall Study|Protocol Violation|0|||
33706903|NCT01769196|63273440|FG001|Overall Study|Protocol Violation|3|||
33706904|NCT01769196|63273439|FG000|Overall Study|Study terminated by sponsor|160|||
33706905|NCT01769196|63273440|FG001|Overall Study|Study terminated by sponsor|161|||
33706906|NCT01769196|63273439|FG000|Overall Study|Participant never dosed with study drug|1|||
33706907|NCT01769196|63273440|FG001|Overall Study|Participant never dosed with study drug|0|||
33706908|NCT01769196|63273439|FG000|Overall Study|Withdrew consent|36|||
33706909|NCT01769196|63273440|FG001|Overall Study|Withdrew consent|40|||
33706910|NCT01810302|63273448|FG000|Overall Study|Death|1|||
33706911|NCT01810302|63273449|FG001|Overall Study|Death|0|||
33706912|NCT01810302|63273448|FG000|Overall Study|Physician Decision|0|||
33706913|NCT01810302|63273449|FG001|Overall Study|Physician Decision|1|||
33706914|NCT01783938|63273457|FG000|Overall Study|Disease Progression|18|||
33706915|NCT01783938|63273458|FG001|Overall Study|Disease Progression|41|||
33706916|NCT01783938|63273457|FG000|Overall Study|Study Drug Toxicity|27|||
33706917|NCT01783938|63273458|FG001|Overall Study|Study Drug Toxicity|14|||
33706918|NCT01783938|63273457|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
33706919|NCT01783938|63273458|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
33706920|NCT01783938|63273457|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
33706921|NCT01783938|63273458|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
33706922|NCT01783938|63273457|FG000|Overall Study|Participant Withdrew Consent|2|||
33706923|NCT01783938|63273458|FG001|Overall Study|Participant Withdrew Consent|0|||
33706924|NCT01783938|63273457|FG000|Overall Study|Maximum Clinical Benefit|1|||
33706925|NCT01783938|63273458|FG001|Overall Study|Maximum Clinical Benefit|0|||
33706926|NCT01783938|63273457|FG000|Overall Study|Other Reasons|3|||
33706927|NCT01783938|63273458|FG001|Overall Study|Other Reasons|1|||
33706928|NCT01768572|63273467|FG000|Overall Study|Adverse Event|7|||
33706929|NCT01768572|63273468|FG001|Overall Study|Adverse Event|8|||
33706930|NCT01768572|63273469|FG002|Overall Study|Adverse Event|4|||
33706931|NCT01768572|63273467|FG000|Overall Study|Lack of Efficacy|1|||
33706932|NCT01768572|63273468|FG001|Overall Study|Lack of Efficacy|3|||
33706933|NCT01768572|63273469|FG002|Overall Study|Lack of Efficacy|1|||
33706934|NCT01768572|63273467|FG000|Overall Study|Other, Not due to an adverse event|1|||
33706935|NCT01768572|63273468|FG001|Overall Study|Other, Not due to an adverse event|1|||
33706936|NCT01768572|63273469|FG002|Overall Study|Other, Not due to an adverse event|1|||
33706937|NCT01783548|63273479|FG000|Overall Study|Adverse Event|8|||
33706938|NCT01783548|63273480|FG001|Overall Study|Adverse Event|4|||
33706939|NCT01783548|63273479|FG000|Overall Study|Withdrawal by Subject|11|||
33706940|NCT01783548|63273480|FG001|Overall Study|Withdrawal by Subject|8|||
33706941|NCT01783548|63273479|FG000|Overall Study|Non-compliance|4|||
33706942|NCT01783548|63273480|FG001|Overall Study|Non-compliance|0|||
33706943|NCT01783548|63273479|FG000|Overall Study|Protocol Violation|2|||
33706944|NCT01783548|63273480|FG001|Overall Study|Protocol Violation|2|||
33706945|NCT01783548|63273479|FG000|Overall Study|Lost to Follow-up|8|||
33706946|NCT01783548|63273480|FG001|Overall Study|Lost to Follow-up|3|||
33706947|NCT01783548|63273479|FG000|Overall Study|Lack of Efficacy|1|||
33706948|NCT01783548|63273480|FG001|Overall Study|Lack of Efficacy|1|||
33706949|NCT01809210|63273493|FG000|Overall Study|Withdrawal by Subject|0|||
33706950|NCT01809210|63273494|FG001|Overall Study|Withdrawal by Subject|0|||
33706951|NCT01809210|63273495|FG002|Overall Study|Withdrawal by Subject|1|||
33706952|NCT01809210|63273496|FG003|Overall Study|Withdrawal by Subject|1|||
33706953|NCT01809210|63273497|FG004|Overall Study|Withdrawal by Subject|1|||
33706954|NCT01809210|63273498|FG005|Overall Study|Withdrawal by Subject|0|||
33706955|NCT01809210|63273499|FG006|Overall Study|Withdrawal by Subject|4|||
33706956|NCT01809210|63273493|FG000|Overall Study|Death|1|||
33706957|NCT01809210|63273494|FG001|Overall Study|Death|1|||
33706958|NCT01809210|63273495|FG002|Overall Study|Death|2|||
33706959|NCT01809210|63273496|FG003|Overall Study|Death|0|||
33706960|NCT01809210|63273497|FG004|Overall Study|Death|1|||
33706961|NCT01809210|63273498|FG005|Overall Study|Death|3|||
33706962|NCT01809210|63273499|FG006|Overall Study|Death|1|||
33706963|NCT01809132|63273518|FG000|Overall Study|Withdrawal by Subject|0|||
33706964|NCT01809132|63273519|FG001|Overall Study|Withdrawal by Subject|0|||
33706965|NCT01809132|63273520|FG002|Overall Study|Withdrawal by Subject|1|||
33706966|NCT01808508|63273531|FG000|Overall Study|Lost to Follow-up|1|||
33706967|NCT01808508|63273532|FG001|Overall Study|Lost to Follow-up|0|||
33706968|NCT01808508|63273533|FG002|Overall Study|Lost to Follow-up|0|||
33706969|NCT01766778|63273543|FG000|Overall Study|Adverse Event|4|||
33706970|NCT01766778|63273544|FG001|Overall Study|Adverse Event|4|||
33706971|NCT01766778|63273543|FG000|Overall Study|Withdrawal by Subject|1|||
33706972|NCT01766778|63273544|FG001|Overall Study|Withdrawal by Subject|0|||
33706973|NCT01808196|63273550|FG000|Overall Study|Lost to Follow-up|1|||
33706974|NCT01808118|63273554|FG000|Period 1|Adverse Event|15|||
33706975|NCT01808118|63273555|FG001|Period 1|Adverse Event|0|||
33706976|NCT01808118|63273556|FG002|Period 1|Adverse Event|0|||
33706977|NCT01808118|63273554|FG000|Period 1|Withdrew consent|24|||
33706978|NCT01808118|63273555|FG001|Period 1|Withdrew consent|0|||
33706979|NCT01808118|63273556|FG002|Period 1|Withdrew consent|0|||
33706980|NCT01808118|63273554|FG000|Period 1|Lost to Follow-up|9|||
33706981|NCT01808118|63273555|FG001|Period 1|Lost to Follow-up|0|||
33706982|NCT01808118|63273556|FG002|Period 1|Lost to Follow-up|0|||
33706983|NCT01808118|63273554|FG000|Period 1|Did not meet criteria for remission|303|||
33706984|NCT01808118|63273555|FG001|Period 1|Did not meet criteria for remission|0|||
33706985|NCT01808118|63273556|FG002|Period 1|Did not meet criteria for remission|0|||
33706986|NCT01808118|63273554|FG000|Period 1|Enrolled in error|7|||
33706987|NCT01808118|63273555|FG001|Period 1|Enrolled in error|0|||
33706988|NCT01808118|63273556|FG002|Period 1|Enrolled in error|0|||
33706989|NCT01808118|63273554|FG000|Period 1|Did not meet inclusion criteria|3|||
33706990|NCT01808118|63273555|FG001|Period 1|Did not meet inclusion criteria|0|||
33706991|NCT01808118|63273556|FG002|Period 1|Did not meet inclusion criteria|0|||
33706992|NCT01808118|63273554|FG000|Period 1|Non-conformance with inclusion criteria|3|||
33706993|NCT01808118|63273555|FG001|Period 1|Non-conformance with inclusion criteria|0|||
33706994|NCT01808118|63273556|FG002|Period 1|Non-conformance with inclusion criteria|0|||
33706995|NCT01808118|63273554|FG000|Period 1|Investigator decision: site closure|2|||
33706996|NCT01808118|63273555|FG001|Period 1|Investigator decision: site closure|0|||
33706997|NCT01808118|63273556|FG002|Period 1|Investigator decision: site closure|0|||
33706998|NCT01808118|63273554|FG000|Period 1|Non-compliance per sponsor|1|||
33706999|NCT01808118|63273555|FG001|Period 1|Non-compliance per sponsor|0|||
33707000|NCT01808118|63273556|FG002|Period 1|Non-compliance per sponsor|0|||
33707001|NCT01808118|63273554|FG000|Period 1|Lack of Efficacy|1|||
33707002|NCT01808118|63273555|FG001|Period 1|Lack of Efficacy|0|||
33707003|NCT01808118|63273556|FG002|Period 1|Lack of Efficacy|0|||
33707004|NCT01808118|63273554|FG000|Period 2|Adverse Event|0|||
33707005|NCT01808118|63273555|FG001|Period 2|Adverse Event|4|||
33707006|NCT01808118|63273556|FG002|Period 2|Adverse Event|0|||
33707007|NCT01808118|63273554|FG000|Period 2|Withdrew consent|0|||
33707008|NCT01808118|63273555|FG001|Period 2|Withdrew consent|7|||
33707009|NCT01808118|63273556|FG002|Period 2|Withdrew consent|6|||
33707010|NCT01808118|63273554|FG000|Period 2|Lost to Follow-up|0|||
33707011|NCT01808118|63273555|FG001|Period 2|Lost to Follow-up|0|||
33707012|NCT01808118|63273556|FG002|Period 2|Lost to Follow-up|2|||
33707013|NCT01808118|63273554|FG000|Period 2|Investigator no longer conducting trials|0|||
33707014|NCT01808118|63273555|FG001|Period 2|Investigator no longer conducting trials|1|||
33707015|NCT01808118|63273556|FG002|Period 2|Investigator no longer conducting trials|0|||
33707016|NCT01808118|63273554|FG000|Period 2|Switched to other therapy|0|||
33707017|NCT01808118|63273555|FG001|Period 2|Switched to other therapy|1|||
33707018|NCT01808118|63273556|FG002|Period 2|Switched to other therapy|0|||
33707019|NCT01807650|63273570|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
33707020|NCT01807650|63273570|FG000|Overall Study|Adverse Event|5|||
33707021|NCT01807650|63273570|FG000|Overall Study|Other|2|||
33707022|NCT01782690|63273611|FG000|Overall Study|Not reported|7|||
33707023|NCT01782690|63273611|FG000|Overall Study|Toxicity of gemcitabine|1|||
33707024|NCT01782690|63273611|FG000|Overall Study|Toxicity of erlotinib|1|||
33707025|NCT01782690|63273611|FG000|Overall Study|Lost to Follow-up|31|||
33707026|NCT01782690|63273611|FG000|Overall Study|Withdrawal of informed consent|2|||
33707027|NCT01782690|63273611|FG000|Overall Study|Absent rash|9|||
33707028|NCT01782690|63273611|FG000|Overall Study|Physician Decision|13|||
33707029|NCT01782690|63273611|FG000|Overall Study|Patient's wish|21|||
33707030|NCT01782690|63273611|FG000|Overall Study|Tumor progression|74|||
33707031|NCT01782690|63273611|FG000|Overall Study|Death|133|||
33707032|NCT01782690|63273611|FG000|Overall Study|Study completion unknown|7|||
33707033|NCT01782378|63273617|FG000|First Series|Lost to Follow-up|7|||
33707034|NCT01782378|63273618|FG001|First Series|Lost to Follow-up|8|||
33707035|NCT01782378|63273617|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
33707036|NCT01782378|63273618|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
33707037|NCT01782378|63273617|FG000|Second Series|Lost to Follow-up|8|||
33707038|NCT01782378|63273618|FG001|Second Series|Lost to Follow-up|7|||
33707039|NCT01782378|63273617|FG000|Second Series|Did not choose to complete S2 Optional|18|||
33707040|NCT01782378|63273618|FG001|Second Series|Did not choose to complete S2 Optional|0|||
33707041|NCT01766310|63273626|FG000|Overall Study|Lost to Follow-up|1|||
33707042|NCT01766310|63273627|FG001|Overall Study|Lost to Follow-up|3|||
33707043|NCT01765920|63273635|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
33707044|NCT01765920|63273636|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
33707045|NCT01765920|63273635|FG000|Overall Study|Patient code disclosure|0|||
33707046|NCT01765920|63273636|FG001|Overall Study|Patient code disclosure|1|||
33707047|NCT01782222|63273645|FG000|Overall Study|Adverse Event|4|||
33707048|NCT01782222|63273646|FG001|Overall Study|Adverse Event|5|||
33707049|NCT01782222|63273647|FG002|Overall Study|Adverse Event|3|||
33707050|NCT01782222|63273645|FG000|Overall Study|Lack of Efficacy|2|||
33707051|NCT01782222|63273646|FG001|Overall Study|Lack of Efficacy|1|||
33707052|NCT01782222|63273647|FG002|Overall Study|Lack of Efficacy|0|||
33707053|NCT01782222|63273645|FG000|Overall Study|Protocol Violation|1|||
33707054|NCT01782222|63273646|FG001|Overall Study|Protocol Violation|0|||
33707055|NCT01782222|63273647|FG002|Overall Study|Protocol Violation|0|||
33707056|NCT01782222|63273645|FG000|Overall Study|Withdrawal by Subject|1|||
33707057|NCT01782222|63273646|FG001|Overall Study|Withdrawal by Subject|4|||
33707058|NCT01782222|63273647|FG002|Overall Study|Withdrawal by Subject|1|||
33707059|NCT01782222|63273645|FG000|Overall Study|Moved to other state|0|||
33707060|NCT01782222|63273646|FG001|Overall Study|Moved to other state|1|||
33707061|NCT01782222|63273647|FG002|Overall Study|Moved to other state|0|||
33707062|NCT01781832|63273655|FG000|Overall Study|Withdrawal by Subject|1|||
33707063|NCT01807182|63273659|FG000|Overall Study|Death|1|||
33707064|NCT01807182|63273659|FG000|Overall Study|New therapy|1|||
33707065|NCT01807182|63273659|FG000|Overall Study|Moved to hospice care|1|||
33707066|NCT01806714|63273665|FG000|Overall Study|No functioning phone number|200|||
33707067|NCT01806714|63273666|FG001|Overall Study|No functioning phone number|170|||
33707068|NCT01765764|63273675|FG000|Treatment Period|Adverse Event|1|||
33707069|NCT01765764|63273676|FG001|Treatment Period|Adverse Event|2|||
33707070|NCT01765764|63273677|FG002|Treatment Period|Adverse Event|1|||
33707071|NCT01765764|63273675|FG000|Treatment Period|Lost to Follow-up|0|||
33707072|NCT01765764|63273676|FG001|Treatment Period|Lost to Follow-up|3|||
33707073|NCT01765764|63273677|FG002|Treatment Period|Lost to Follow-up|2|||
33707074|NCT01765764|63273675|FG000|Treatment Period|Personal Reasons|1|||
33707075|NCT01765764|63273676|FG001|Treatment Period|Personal Reasons|2|||
33707076|NCT01765764|63273677|FG002|Treatment Period|Personal Reasons|1|||
33707077|NCT01765764|63273675|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
33707078|NCT01765764|63273676|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
33707079|NCT01765764|63273677|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
33707080|NCT01806168|63273688|FG000|Overall Study|Adverse Event|1|||
33707081|NCT01806168|63273689|FG001|Overall Study|Adverse Event|0|||
33707082|NCT01806168|63273690|FG002|Overall Study|Adverse Event|0|||
33707083|NCT01806168|63273688|FG000|Overall Study|Withdrawal by Subject|0|||
33707084|NCT01806168|63273689|FG001|Overall Study|Withdrawal by Subject|1|||
33707085|NCT01806168|63273690|FG002|Overall Study|Withdrawal by Subject|2|||
33707086|NCT01806168|63273688|FG000|Overall Study|Protocol Violation|0|||
33707087|NCT01806168|63273689|FG001|Overall Study|Protocol Violation|0|||
33707088|NCT01806168|63273690|FG002|Overall Study|Protocol Violation|1|||
33707089|NCT01804842|63273704|FG000|Overall Study|Adverse Event|1|||
33707090|NCT01804842|63273705|FG001|Overall Study|Adverse Event|1|||
33707091|NCT01804842|63273706|FG002|Overall Study|Adverse Event|0|||
33707092|NCT01804842|63273704|FG000|Overall Study|Lost to Follow-up|1|||
33707093|NCT01804842|63273705|FG001|Overall Study|Lost to Follow-up|0|||
33707094|NCT01804842|63273706|FG002|Overall Study|Lost to Follow-up|0|||
33707095|NCT01804842|63273704|FG000|Overall Study|Non-Compliance|1|||
33707096|NCT01804842|63273705|FG001|Overall Study|Non-Compliance|1|||
33707097|NCT01804842|63273706|FG002|Overall Study|Non-Compliance|0|||
33707098|NCT01804842|63273704|FG000|Overall Study|Personal Reason|0|||
33707099|NCT01804842|63273705|FG001|Overall Study|Personal Reason|0|||
33707100|NCT01804842|63273706|FG002|Overall Study|Personal Reason|1|||
33707101|NCT01781286|63273714|FG000|Overall Study|Lost to Follow-up|0|||
33707102|NCT01781286|63273715|FG001|Overall Study|Lost to Follow-up|0|||
33707103|NCT01781286|63273716|FG002|Overall Study|Lost to Follow-up|0|||
33707104|NCT01781286|63273717|FG003|Overall Study|Lost to Follow-up|0|||
33707105|NCT01781286|63273718|FG004|Overall Study|Lost to Follow-up|0|||
33707106|NCT01781286|63273719|FG005|Overall Study|Lost to Follow-up|1|||
33707107|NCT01781286|63273714|FG000|Overall Study|Time Constraints|2|||
33707108|NCT01781286|63273715|FG001|Overall Study|Time Constraints|0|||
33707109|NCT01781286|63273716|FG002|Overall Study|Time Constraints|2|||
33707110|NCT01781286|63273717|FG003|Overall Study|Time Constraints|0|||
33707111|NCT01781286|63273718|FG004|Overall Study|Time Constraints|0|||
33707112|NCT01781286|63273719|FG005|Overall Study|Time Constraints|0|||
33707113|NCT01781286|63273714|FG000|Overall Study|Noncompliance|0|||
33707114|NCT01781286|63273715|FG001|Overall Study|Noncompliance|0|||
33707115|NCT01781286|63273716|FG002|Overall Study|Noncompliance|0|||
33707116|NCT01781286|63273717|FG003|Overall Study|Noncompliance|1|||
33707117|NCT01781286|63273718|FG004|Overall Study|Noncompliance|0|||
33707118|NCT01781286|63273719|FG005|Overall Study|Noncompliance|0|||
33707119|NCT01780974|63273731|FG000|Overall Study|Death|1|||
33707120|NCT01780974|63273732|FG001|Overall Study|Death|0|||
33707121|NCT01780974|63273731|FG000|Overall Study|Adverse Event|1|||
33707122|NCT01780974|63273732|FG001|Overall Study|Adverse Event|3|||
33707123|NCT01780662|63273741|FG000|Overall Study|Adverse Event|1|||
33707124|NCT01780662|63273742|FG001|Overall Study|Adverse Event|0|||
33707125|NCT01780662|63273743|FG002|Overall Study|Adverse Event|2|||
33707126|NCT01780662|63273741|FG000|Overall Study|Physician Decision|0|||
33707127|NCT01780662|63273742|FG001|Overall Study|Physician Decision|5|||
33707128|NCT01780662|63273743|FG002|Overall Study|Physician Decision|7|||
33707129|NCT01780662|63273741|FG000|Overall Study|Protocol Violation|0|||
33707130|NCT01780662|63273742|FG001|Overall Study|Protocol Violation|1|||
33707131|NCT01780662|63273743|FG002|Overall Study|Protocol Violation|0|||
33707132|NCT01780662|63273741|FG000|Overall Study|Ineligible|0|||
33707133|NCT01780662|63273742|FG001|Overall Study|Ineligible|0|||
33707134|NCT01780662|63273743|FG002|Overall Study|Ineligible|1|||
33707135|NCT01780584|63273755|FG000|Overall Study|Death|1|||
33707136|NCT01780584|63273756|FG001|Overall Study|Death|0|||
33707137|NCT01780584|63273757|FG002|Overall Study|Death|1|||
33707138|NCT01780584|63273755|FG000|Overall Study|Adverse Event|0|||
33707139|NCT01780584|63273756|FG001|Overall Study|Adverse Event|1|||
33707140|NCT01780584|63273757|FG002|Overall Study|Adverse Event|0|||
33707141|NCT01780584|63273755|FG000|Overall Study|Protocol Violation|0|||
33707142|NCT01780584|63273756|FG001|Overall Study|Protocol Violation|0|||
33707143|NCT01780584|63273757|FG002|Overall Study|Protocol Violation|1|||
33707144|NCT01780506|63273767|FG000|Double-Blind Phase|Randomized but not Treated|3|||
33707145|NCT01780506|63273768|FG001|Double-Blind Phase|Randomized but not Treated|2|||
33707146|NCT01780506|63273767|FG000|Double-Blind Phase|Adverse Event|4|||
33707147|NCT01780506|63273768|FG001|Double-Blind Phase|Adverse Event|14|||
33707148|NCT01780506|63273767|FG000|Double-Blind Phase|Death|1|||
33707149|NCT01780506|63273768|FG001|Double-Blind Phase|Death|2|||
33707150|NCT01780506|63273767|FG000|Double-Blind Phase|Pregnancy|2|||
33707151|NCT01780506|63273768|FG001|Double-Blind Phase|Pregnancy|1|||
33707152|NCT01780506|63273767|FG000|Double-Blind Phase|Lack of Efficacy|1|||
33707153|NCT01780506|63273768|FG001|Double-Blind Phase|Lack of Efficacy|1|||
33707154|NCT01780506|63273767|FG000|Double-Blind Phase|Investigator's Discretion|5|||
33707155|NCT01780506|63273768|FG001|Double-Blind Phase|Investigator's Discretion|2|||
33707156|NCT01780506|63273767|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
33707157|NCT01780506|63273768|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
33707158|NCT01780506|63273767|FG000|Double-Blind Phase|Protocol Violation|4|||
33707159|NCT01780506|63273768|FG001|Double-Blind Phase|Protocol Violation|3|||
33707160|NCT01780506|63273767|FG000|Double-Blind Phase|Withdrew Consent|23|||
33707161|NCT01780506|63273768|FG001|Double-Blind Phase|Withdrew Consent|24|||
33707162|NCT01780506|63273767|FG000|Double-Blind Phase|Lost to Follow-up|23|||
33707163|NCT01780506|63273768|FG001|Double-Blind Phase|Lost to Follow-up|26|||
33707164|NCT01780506|63273767|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
33707165|NCT01780506|63273768|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
33707166|NCT01779648|63273778|FG000|Overall Study|Protocol Violation|1|||
33707167|NCT01779648|63273779|FG001|Overall Study|Protocol Violation|0|||
33707168|NCT01762800|63273787|FG000|Overall Study|Adverse Event|8|||
33707169|NCT01762800|63273788|FG001|Overall Study|Adverse Event|13|||
33707170|NCT01762800|63273787|FG000|Overall Study|Lack of Efficacy|3|||
33707171|NCT01762800|63273788|FG001|Overall Study|Lack of Efficacy|2|||
33707172|NCT01762800|63273787|FG000|Overall Study|Study Closed/Terminated|0|||
33707173|NCT01762800|63273788|FG001|Overall Study|Study Closed/Terminated|1|||
33707174|NCT01762800|63273787|FG000|Overall Study|Physician Decision|1|||
33707175|NCT01762800|63273788|FG001|Overall Study|Physician Decision|1|||
33707176|NCT01762800|63273787|FG000|Overall Study|Withdrawal by Subject|7|||
33707177|NCT01762800|63273788|FG001|Overall Study|Withdrawal by Subject|4|||
33707178|NCT01597596|63273802|FG000|Overall Study|Study terminated by sponsor|1|||
33707179|NCT01597596|63273803|FG001|Overall Study|Study terminated by sponsor|0|||
33707180|NCT01597596|63273802|FG000|Overall Study|Physician Decision|0|||
33707181|NCT01597596|63273803|FG001|Overall Study|Physician Decision|1|||
33707182|NCT01778556|63273811|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
33707183|NCT01778556|63273812|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
33707184|NCT01778556|63273811|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
33707185|NCT01778556|63273812|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
33707186|NCT01778556|63273811|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
33707187|NCT01778556|63273812|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
33707188|NCT01778556|63273811|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
33707189|NCT01778556|63273812|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
33707190|NCT01761162|63273821|FG000|Overall Study|Withdrawal by Subject|3|||
33707191|NCT01778010|63273825|FG000|Overall Study|Withdrawal by Subject|2|||
33707192|NCT01778010|63273825|FG000|Overall Study|abnormal ECG before meds|1|||
33707193|NCT01778010|63273825|FG000|Overall Study|Arrested|1|||
33707194|NCT01778010|63273825|FG000|Overall Study|rash while on placebo|1|||
33707195|NCT01777932|63273842|FG000|Overall Study|Disease progression|136|||
33707196|NCT01777932|63273842|FG000|Overall Study|Death|3|||
33707197|NCT01777932|63273842|FG000|Overall Study|Adverse Event|34|||
33707198|NCT01777932|63273842|FG000|Overall Study|Lost to Follow-up|3|||
33707199|NCT01777932|63273842|FG000|Overall Study|Investigator decision|10|||
33707200|NCT01777932|63273842|FG000|Overall Study|Reimbursement limit|9|||
33707201|NCT01777932|63273842|FG000|Overall Study|Patient refused further treatment|10|||
33707202|NCT01777854|63273846|FG000|Overall Study|Physician Decision|3|||
33707203|NCT01777854|63273847|FG001|Overall Study|Physician Decision|3|||
33707204|NCT01777776|63273855|FG000|Overall Study|Adverse Event|2|||
33707205|NCT01777776|63273856|FG001|Overall Study|Adverse Event|4|||
33707206|NCT01777776|63273857|FG002|Overall Study|Adverse Event|0|||
33707207|NCT01777776|63273858|FG003|Overall Study|Adverse Event|0|||
33707208|NCT01777776|63273855|FG000|Overall Study|Disease Progression|4|||
33707209|NCT01777776|63273856|FG001|Overall Study|Disease Progression|8|||
33707210|NCT01777776|63273857|FG002|Overall Study|Disease Progression|6|||
33707211|NCT01777776|63273858|FG003|Overall Study|Disease Progression|3|||
33707212|NCT01777776|63273855|FG000|Overall Study|Withdrawal by Subject|0|||
33707213|NCT01777776|63273856|FG001|Overall Study|Withdrawal by Subject|0|||
33707214|NCT01777776|63273857|FG002|Overall Study|Withdrawal by Subject|0|||
33707215|NCT01777776|63273858|FG003|Overall Study|Withdrawal by Subject|1|||
33707216|NCT01777620|63273879|FG000|Overall Study|Subject Withdrawal|1|||
33707217|NCT01777620|63273880|FG001|Overall Study|Subject Withdrawal|0|||
33707218|NCT01777542|63273886|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
33707219|NCT01777542|63273887|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
33707220|NCT01736124|63273896|FG000|Post-intervention Assessment|Death|2|||
33707221|NCT01736124|63273897|FG001|Post-intervention Assessment|Death|2|||
33707222|NCT01736124|63273896|FG000|Post-intervention Assessment|lost computer access|1|||
33707223|NCT01736124|63273897|FG001|Post-intervention Assessment|lost computer access|1|||
33707224|NCT01736124|63273896|FG000|Post-intervention Assessment|Moved away|3|||
33707225|NCT01736124|63273897|FG001|Post-intervention Assessment|Moved away|1|||
33707226|NCT01736124|63273896|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
33707227|NCT01736124|63273897|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
33707228|NCT01736124|63273896|FG000|Post-intervention Assessment|Illness|3|||
33707229|NCT01736124|63273897|FG001|Post-intervention Assessment|Illness|2|||
33707230|NCT01736124|63273896|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
33707231|NCT01736124|63273897|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
33707232|NCT01736124|63273896|FG000|Post-intervention Assessment|Temporarily away|3|||
33707233|NCT01736124|63273897|FG001|Post-intervention Assessment|Temporarily away|1|||
33707234|NCT01736124|63273896|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
33707235|NCT01736124|63273897|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
33707236|NCT01736124|63273896|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
33707237|NCT01736124|63273897|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
33707238|NCT01736124|63273896|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
33707239|NCT01736124|63273897|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
33707240|NCT01736124|63273896|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
33707241|NCT01736124|63273897|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
33707242|NCT01736124|63273896|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
33707243|NCT01736124|63273897|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
33707244|NCT01736124|63273896|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
33707245|NCT01736124|63273897|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
33707246|NCT01736124|63273896|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
33707247|NCT01736124|63273897|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
33707248|NCT01736124|63273896|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
33707249|NCT01736124|63273897|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
33707250|NCT01736124|63273896|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
33707251|NCT01736124|63273897|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
33707252|NCT01759446|63273910|FG000|Overall Study|Protocol Violation|1|||
33707253|NCT01759446|63273911|FG001|Overall Study|Protocol Violation|0|||
33707254|NCT01759446|63273912|FG002|Overall Study|Protocol Violation|1|||
33707255|NCT01759446|63273913|FG003|Overall Study|Protocol Violation|0|||
33707256|NCT01759446|63273914|FG004|Overall Study|Protocol Violation|0|||
33707257|NCT01759446|63273910|FG000|Overall Study|Withdrawal by Subject|0|||
33707258|NCT01759446|63273911|FG001|Overall Study|Withdrawal by Subject|1|||
33707259|NCT01759446|63273912|FG002|Overall Study|Withdrawal by Subject|0|||
33707260|NCT01759446|63273913|FG003|Overall Study|Withdrawal by Subject|1|||
33707261|NCT01759446|63273914|FG004|Overall Study|Withdrawal by Subject|0|||
33707262|NCT01777308|63273928|FG000|Overall Study|Withdrawal by Subject|5|||
33707263|NCT01777308|63273929|FG001|Overall Study|Withdrawal by Subject|1|||
33707264|NCT01777308|63273928|FG000|Overall Study|Migrated/moved from study area|1|||
33707265|NCT01777308|63273929|FG001|Overall Study|Migrated/moved from study area|0|||
33707266|NCT01777308|63273928|FG000|Overall Study|Lost to Follow-up|7|||
33707267|NCT01777308|63273929|FG001|Overall Study|Lost to Follow-up|2|||
33707268|NCT01777308|63273928|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
33707269|NCT01777308|63273929|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
33707270|NCT01759368|63273938|FG000|Overall Study|Lost to Follow-up|1|||
33707271|NCT01759368|63273939|FG001|Overall Study|Lost to Follow-up|0|||
33707272|NCT01777152|63273949|FG000|Overall Study|Withdrawal by Subject|22|||
33707273|NCT01777152|63273950|FG001|Overall Study|Withdrawal by Subject|16|||
33707274|NCT01777152|63273949|FG000|Overall Study|Lost to Follow-up|3|||
33707275|NCT01777152|63273950|FG001|Overall Study|Lost to Follow-up|5|||
33707276|NCT01777152|63273949|FG000|Overall Study|Death|68|||
33707277|NCT01777152|63273950|FG001|Overall Study|Death|89|||
33707278|NCT01777152|63273949|FG000|Overall Study|Not eligible, no study drug received|1|||
33707279|NCT01777152|63273950|FG001|Overall Study|Not eligible, no study drug received|0|||
33707280|NCT01777152|63273949|FG000|Overall Study|Change of diagnosis|1|||
33707281|NCT01777152|63273950|FG001|Overall Study|Change of diagnosis|0|||
33707282|NCT01759290|63273957|FG000|Overall Study|Subjects withdrawn consent|5|||
33707283|NCT01759290|63273957|FG000|Overall Study|Physician Decision|2|||
33707284|NCT01759290|63273957|FG000|Overall Study|Death|17|||
33597003|NCT01883362|62995930|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
33707285|NCT01759290|63273957|FG000|Overall Study|Lost to Follow-up|53|||
33707286|NCT01759290|63273957|FG000|Overall Study|Unknown reason|4|||
33707287|NCT01758900|63273963|FG000|Overall Study|difficulty for further intubation|7|||
33707288|NCT01758900|63273964|FG001|Overall Study|difficulty for further intubation|8|||
33707289|NCT01757184|63273972|FG000|Double-blind Period|Adverse Event|1|||
33707290|NCT01757184|63273973|FG001|Double-blind Period|Adverse Event|0|||
33707291|NCT01757184|63273974|FG002|Double-blind Period|Adverse Event|0|||
33707292|NCT01757184|63273975|FG003|Double-blind Period|Adverse Event|0|||
33707293|NCT01757184|63273972|FG000|Open-label Period|Lost to Follow-up|0|||
33707294|NCT01757184|63273973|FG001|Open-label Period|Lost to Follow-up|0|||
33707295|NCT01757184|63273974|FG002|Open-label Period|Lost to Follow-up|2|||
33707296|NCT01757184|63273975|FG003|Open-label Period|Lost to Follow-up|0|||
33707297|NCT01757184|63273972|FG000|Open-label Period|Withdrawal by Subject|0|||
33707298|NCT01757184|63273973|FG001|Open-label Period|Withdrawal by Subject|0|||
33707299|NCT01757184|63273974|FG002|Open-label Period|Withdrawal by Subject|1|||
33707300|NCT01757184|63273975|FG003|Open-label Period|Withdrawal by Subject|1|||
33707301|NCT01757184|63273972|FG000|Open-label Period|Discontinued by Sponsor|0|||
33707302|NCT01757184|63273973|FG001|Open-label Period|Discontinued by Sponsor|0|||
33707303|NCT01757184|63273974|FG002|Open-label Period|Discontinued by Sponsor|1|||
33707304|NCT01757184|63273975|FG003|Open-label Period|Discontinued by Sponsor|2|||
33707305|NCT01775904|63273989|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
33707306|NCT01775904|63273989|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
33707307|NCT01775670|63274001|FG000|Overall Study|Lost to Follow-up|1|||
33707308|NCT01775670|63274002|FG001|Overall Study|Lost to Follow-up|1|||
33707309|NCT01775124|63274010|FG000|Core Period|Disease Progression|0|||
33707310|NCT01775124|63274011|FG001|Core Period|Disease Progression|1|||
33707311|NCT01775124|63274010|FG000|Core Period|Physician Decision|1|||
33707312|NCT01775124|63274011|FG001|Core Period|Physician Decision|1|||
33707313|NCT01775124|63274010|FG000|Core Period|Death|0|||
33707314|NCT01775124|63274011|FG001|Core Period|Death|1|||
33707315|NCT01775124|63274010|FG000|Core Period|Administrative problems|1|||
33707316|NCT01775124|63274011|FG001|Core Period|Administrative problems|0|||
33707317|NCT01775124|63274010|FG000|Core Period|Withdrawal by Subject|4|||
33707318|NCT01775124|63274011|FG001|Core Period|Withdrawal by Subject|2|||
33707319|NCT01775124|63274010|FG000|Core Period|Adverse Event|5|||
33707320|NCT01775124|63274011|FG001|Core Period|Adverse Event|5|||
33707321|NCT01775124|63274010|FG000|Extension Period|Adverse Event|3|||
33707322|NCT01775124|63274011|FG001|Extension Period|Adverse Event|2|||
33707323|NCT01775124|63274010|FG000|Extension Period|Physician Decision|0|||
33707324|NCT01775124|63274011|FG001|Extension Period|Physician Decision|2|||
33707325|NCT01775124|63274010|FG000|Extension Period|Administrative problems|0|||
33707326|NCT01775124|63274011|FG001|Extension Period|Administrative problems|1|||
33707327|NCT01775124|63274010|FG000|Extension Period|Lost to Follow-up|0|||
33707328|NCT01775124|63274011|FG001|Extension Period|Lost to Follow-up|1|||
33707329|NCT01775124|63274010|FG000|Extension Period|Withdrawal by Subject|9|||
33707330|NCT01775124|63274011|FG001|Extension Period|Withdrawal by Subject|12|||
33707331|NCT01733316|63274018|FG000|RP103 Phase|Non-compliance|1|||
33707332|NCT01733316|63274018|FG000|Long Term Extension Phase|Adverse Event|1|||
33707333|NCT01733316|63274018|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
33707334|NCT01733316|63274018|FG000|Long Term Extension Phase|Sponsor Decision|2|||
33707335|NCT01732926|63274031|FG000|Overall Study|Study Terminated by Sponsor|168|||
33707336|NCT01732926|63274032|FG001|Overall Study|Study Terminated by Sponsor|80|||
33707337|NCT01732926|63274031|FG000|Overall Study|Withdrawal by Subject|46|||
33707338|NCT01732926|63274032|FG001|Overall Study|Withdrawal by Subject|8|||
33707339|NCT01732926|63274031|FG000|Overall Study|Physician Decision|24|||
33707340|NCT01732926|63274032|FG001|Overall Study|Physician Decision|11|||
33707341|NCT01732926|63274031|FG000|Overall Study|Other Reason|21|||
33707342|NCT01732926|63274032|FG001|Overall Study|Other Reason|4|||
33707343|NCT01732926|63274031|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
33707344|NCT01732926|63274032|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
33707345|NCT01732926|63274031|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
33707346|NCT01732926|63274032|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
33707347|NCT01755858|63274040|FG000|Overall Study|Adverse Event|1|||
33707348|NCT01755858|63274041|FG001|Overall Study|Adverse Event|1|||
33707349|NCT01732770|63274051|FG000|Overall Study|Lost to Follow-up|2|||
33707350|NCT01732770|63274052|FG001|Overall Study|Lost to Follow-up|3|||
33707351|NCT01732770|63274051|FG000|Overall Study|Withdrawal by Subject|5|||
33707352|NCT01732770|63274052|FG001|Overall Study|Withdrawal by Subject|3|||
33707353|NCT01732770|63274051|FG000|Overall Study|Decision by Sponsor|2|||
33707354|NCT01732770|63274052|FG001|Overall Study|Decision by Sponsor|2|||
33707355|NCT01732770|63274051|FG000|Overall Study|Death|1|||
33707356|NCT01732770|63274052|FG001|Overall Study|Death|0|||
33707357|NCT01732692|63274060|FG000|Overall Study|Adverse Event|0|||
33707358|NCT01732692|63274061|FG001|Overall Study|Adverse Event|1|||
33707359|NCT01774968|63274069|FG000|Overall Study|Adverse Event|4|||
33707360|NCT01774968|63274070|FG001|Overall Study|Adverse Event|4|||
33707361|NCT01774968|63274069|FG000|Overall Study|Death|0|||
33707362|NCT01774968|63274070|FG001|Overall Study|Death|1|||
33707363|NCT01774968|63274069|FG000|Overall Study|Lost to Follow-up|1|||
33707364|NCT01774968|63274070|FG001|Overall Study|Lost to Follow-up|3|||
33707365|NCT01774968|63274069|FG000|Overall Study|Physician Decision|5|||
33707366|NCT01774968|63274070|FG001|Overall Study|Physician Decision|1|||
33707367|NCT01774968|63274069|FG000|Overall Study|Protocol Violation|14|||
33707368|NCT01774968|63274070|FG001|Overall Study|Protocol Violation|13|||
33707369|NCT01774968|63274069|FG000|Overall Study|Sponsor Decision|0|||
33707370|NCT01774968|63274070|FG001|Overall Study|Sponsor Decision|2|||
33707371|NCT01774968|63274069|FG000|Overall Study|Withdrawal by Subject|6|||
33707372|NCT01774968|63274070|FG001|Overall Study|Withdrawal by Subject|11|||
33707373|NCT01774344|63274078|FG000|Overall Study|Withdrawal by Subject|3|||
33493268|NCT03103152|62871478|FG000|Overall Study|Unacceptable side effects|0|||
33493269|NCT03103152|62871479|FG001|Overall Study|Unacceptable side effects|0|||
33493270|NCT03103152|62871480|FG002|Overall Study|Unacceptable side effects|0|||
33493271|NCT03103152|62871481|FG003|Overall Study|Unacceptable side effects|0|||
33493272|NCT03103152|62871482|FG004|Overall Study|Unacceptable side effects|0|||
33493273|NCT03103152|62871483|FG005|Overall Study|Unacceptable side effects|1|||
33493274|NCT03103152|62871478|FG000|Overall Study|Lost to Follow-up|0|||
33493275|NCT03103152|62871479|FG001|Overall Study|Lost to Follow-up|1|||
33493276|NCT03103152|62871480|FG002|Overall Study|Lost to Follow-up|0|||
33493277|NCT03103152|62871481|FG003|Overall Study|Lost to Follow-up|1|||
33493278|NCT03103152|62871482|FG004|Overall Study|Lost to Follow-up|0|||
33493279|NCT03103152|62871483|FG005|Overall Study|Lost to Follow-up|1|||
33493280|NCT03103152|62871478|FG000|Overall Study|Testicular pain|0|||
33493281|NCT03103152|62871479|FG001|Overall Study|Testicular pain|0|||
33493282|NCT03103152|62871480|FG002|Overall Study|Testicular pain|0|||
33597004|NCT01883362|62995931|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
33597005|NCT01883362|62995930|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
33707374|NCT01774344|63274079|FG001|Overall Study|Withdrawal by Subject|10|||
33707375|NCT01774344|63274078|FG000|Overall Study|Protocol Violation|0|||
33707376|NCT01774344|63274079|FG001|Overall Study|Protocol Violation|1|||
33707377|NCT01774344|63274078|FG000|Overall Study|Lost to Follow-up|4|||
33707378|NCT01774344|63274079|FG001|Overall Study|Lost to Follow-up|10|||
33707379|NCT01774344|63274078|FG000|Overall Study|End of survival follow-up not available|2|||
33707380|NCT01774344|63274079|FG001|Overall Study|End of survival follow-up not available|2|||
33707381|NCT01774344|63274078|FG000|Overall Study|Data collection finished|4|||
33707382|NCT01774344|63274079|FG001|Overall Study|Data collection finished|14|||
33707383|NCT01774344|63274078|FG000|Overall Study|Other|0|||
33707384|NCT01774344|63274079|FG001|Overall Study|Other|1|||
33707385|NCT01774344|63274078|FG000|Overall Study|Did not enter Survival Follow up|49|||
33707386|NCT01774344|63274079|FG001|Overall Study|Did not enter Survival Follow up|83|||
33707387|NCT01732536|63274087|FG000|Overall Study|Withdrawal by Subject|1|||
33707388|NCT01732536|63274088|FG001|Overall Study|Withdrawal by Subject|1|||
33707389|NCT01755702|63274097|FG000|Wash Out Period I|Other Reason|3|||
33707390|NCT01755702|63274097|FG000|Washout Period II|Other Reason|5|||
33707391|NCT01732458|63274111|FG000|Overall Study|Lost to Follow-up|0|||
33707392|NCT01732458|63274112|FG001|Overall Study|Lost to Follow-up|2|||
33707393|NCT01732458|63274113|FG002|Overall Study|Lost to Follow-up|0|||
33707394|NCT01732458|63274114|FG003|Overall Study|Lost to Follow-up|0|||
33707395|NCT01732458|63274111|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33707396|NCT01732458|63274112|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33707397|NCT01732458|63274113|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33707398|NCT01732458|63274114|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33707399|NCT01732458|63274111|FG000|Overall Study|Physician Decision|1|||
33707400|NCT01732458|63274112|FG001|Overall Study|Physician Decision|2|||
33707401|NCT01732458|63274113|FG002|Overall Study|Physician Decision|2|||
33707402|NCT01732458|63274114|FG003|Overall Study|Physician Decision|0|||
33707403|NCT01732458|63274111|FG000|Overall Study|Protocol Violation|2|||
33707404|NCT01732458|63274112|FG001|Overall Study|Protocol Violation|0|||
33707405|NCT01732458|63274113|FG002|Overall Study|Protocol Violation|0|||
33707406|NCT01732458|63274114|FG003|Overall Study|Protocol Violation|2|||
33707407|NCT01732458|63274111|FG000|Overall Study|Screen Failure|0|||
33707408|NCT01732458|63274112|FG001|Overall Study|Screen Failure|1|||
33707409|NCT01732458|63274113|FG002|Overall Study|Screen Failure|0|||
33707410|NCT01732458|63274114|FG003|Overall Study|Screen Failure|0|||
33707411|NCT01731990|63274138|FG000|Overall Study|Adverse Event|1|||
33707412|NCT01731990|63274139|FG001|Overall Study|Adverse Event|5|||
33707413|NCT01731990|63274138|FG000|Overall Study|Withdrawal by Subject|1|||
33707414|NCT01731990|63274139|FG001|Overall Study|Withdrawal by Subject|1|||
33707415|NCT01731990|63274138|FG000|Overall Study|Protocol deviation|1|||
33707416|NCT01731990|63274139|FG001|Overall Study|Protocol deviation|2|||
33707417|NCT01731990|63274138|FG000|Overall Study|Death|1|||
33707418|NCT01731990|63274139|FG001|Overall Study|Death|0|||
33707419|NCT01708902|63274152|FG000|Overall Study|Adverse Event|3|||
33707420|NCT01708902|63274153|FG001|Overall Study|Adverse Event|4|||
33707421|NCT01708902|63274154|FG002|Overall Study|Adverse Event|9|||
33707422|NCT01708902|63274155|FG003|Overall Study|Adverse Event|2|||
33707423|NCT01708902|63274156|FG004|Overall Study|Adverse Event|7|||
33493283|NCT03103152|62871481|FG003|Overall Study|Testicular pain|1|||
33493284|NCT03103152|62871482|FG004|Overall Study|Testicular pain|0|||
33707424|NCT01708902|63274157|FG005|Overall Study|Adverse Event|3|||
33707425|NCT01708902|63274158|FG006|Overall Study|Adverse Event|5|||
33707426|NCT01708902|63274152|FG000|Overall Study|Lack of Efficacy|3|||
33707427|NCT01708902|63274153|FG001|Overall Study|Lack of Efficacy|1|||
33707428|NCT01708902|63274154|FG002|Overall Study|Lack of Efficacy|0|||
33707429|NCT01708902|63274155|FG003|Overall Study|Lack of Efficacy|0|||
33707430|NCT01708902|63274156|FG004|Overall Study|Lack of Efficacy|0|||
33493285|NCT03103152|62871483|FG005|Overall Study|Testicular pain|0|||
33493286|NCT03033901|62871497|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
33493287|NCT03033901|62871497|FG000|Overall Study|Refused PSG|23|||
33493288|NCT03033901|62871497|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
33493289|NCT03033901|62871497|FG000|Overall Study|Missing Oximetry Data|3|||
33493290|NCT02315196|62871540|FG000|Overall Study|Withdrew consent|9|||
33493291|NCT02059005|62871546|FG000|Overall Study|Death|1|||
33493292|NCT02059005|62871547|FG001|Overall Study|Death|3|||
33493293|NCT02059005|62871546|FG000|Overall Study|Lost to Follow-up|19|||
33493294|NCT02059005|62871547|FG001|Overall Study|Lost to Follow-up|19|||
33493295|NCT02059005|62871546|FG000|Overall Study|Incarceration|0|||
33493296|NCT02059005|62871547|FG001|Overall Study|Incarceration|1|||
33493297|NCT02059005|62871546|FG000|Overall Study|Inpatient|0|||
33493298|NCT02059005|62871547|FG001|Overall Study|Inpatient|1|||
33493299|NCT01393821|62871557|FG000|Overall Study|Cancel|1|||
33493300|NCT01393821|62871558|FG001|Overall Study|Cancel|1|||
33493301|NCT01393821|62871557|FG000|Overall Study|not evaluable for primary endpoint|4|||
33493302|NCT01393821|62871558|FG001|Overall Study|not evaluable for primary endpoint|2|||
33493303|NCT00496873|62871570|FG000|Overall Study|Ineligible|2|||
33493304|NCT00496873|62871570|FG000|Overall Study|Death|2|||
33493305|NCT00496873|62871570|FG000|Overall Study|Withdrawal by Subject|3|||
33493306|NCT00492778|62871576|FG000|Overall Study|Ineligible by Pathology Review|8|||
33493307|NCT00492778|62871577|FG001|Overall Study|Ineligible by Pathology Review|1|||
33493308|NCT03775681|62871611|FG000|Overall Study|Physician Decision|3|||
33493309|NCT03774823|62871617|FG000|Overall Study|Withdrawal by Subject|1|||
33493310|NCT03774823|62871618|FG001|Overall Study|Withdrawal by Subject|1|||
33493311|NCT03149042|62871624|FG000|Overall Study|Invasive FFR not performed|21|||
33493312|NCT03149042|62871624|FG000|Overall Study|Poor CT Image Quality|1|||
33493313|NCT03149042|62871624|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
33493314|NCT03774433|62871629|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
33493315|NCT03136484|62871635|FG000|Overall Study|Withdrawal by Subject|19|||
33493316|NCT03136484|62871636|FG001|Overall Study|Withdrawal by Subject|14|||
33493317|NCT03136484|62871635|FG000|Overall Study|Lost to Follow-up|7|||
33493318|NCT03136484|62871636|FG001|Overall Study|Lost to Follow-up|8|||
33493319|NCT03136484|62871635|FG000|Overall Study|Death|1|||
33493320|NCT03136484|62871636|FG001|Overall Study|Death|0|||
33493321|NCT03922711|62871645|FG000|Overall Study|Adverse Event|3|||
33493322|NCT03922711|62871646|FG001|Overall Study|Adverse Event|2|||
33493323|NCT03922711|62871647|FG002|Overall Study|Adverse Event|2|||
33493324|NCT03922711|62871645|FG000|Overall Study|Protocol Violation|1|||
33493325|NCT03922711|62871646|FG001|Overall Study|Protocol Violation|0|||
33493326|NCT03922711|62871647|FG002|Overall Study|Protocol Violation|0|||
33493327|NCT03922711|62871645|FG000|Overall Study|Withdrawal by Subject|0|||
33493328|NCT03922711|62871646|FG001|Overall Study|Withdrawal by Subject|3|||
33493329|NCT03922711|62871647|FG002|Overall Study|Withdrawal by Subject|1|||
33493330|NCT03922711|62871645|FG000|Overall Study|Not further specified|0|||
33493331|NCT03922711|62871646|FG001|Overall Study|Not further specified|0|||
33493332|NCT03922711|62871647|FG002|Overall Study|Not further specified|1|||
33493333|NCT02877680|62871656|FG000|Overall Study|Lost to Follow-up|1|||
33493334|NCT02877680|62871657|FG001|Overall Study|Lost to Follow-up|1|||
33493335|NCT03141086|62871669|FG000|Overall Study|Study Terminated By Sponsor|1|||
33493336|NCT03141086|62871670|FG001|Overall Study|Study Terminated By Sponsor|1|||
33493337|NCT03141086|62871669|FG000|Overall Study|Withdrawal by Subject|0|||
33493338|NCT03141086|62871670|FG001|Overall Study|Withdrawal by Subject|1|||
33493339|NCT03141086|62871669|FG000|Overall Study|Protocol Violation|0|||
33493340|NCT03141086|62871670|FG001|Overall Study|Protocol Violation|1|||
33493341|NCT03141086|62871669|FG000|Overall Study|Adverse Event|0|||
33493342|NCT03141086|62871670|FG001|Overall Study|Adverse Event|2|||
33493343|NCT03135548|62871679|FG000|Overall Study|Lost to Follow-up|3|||
33493344|NCT03135548|62871680|FG001|Overall Study|Lost to Follow-up|0|||
33493345|NCT03135548|62871681|FG002|Overall Study|Lost to Follow-up|0|||
33493346|NCT03135548|62871679|FG000|Overall Study|Withdrawal by Subject|2|||
33493347|NCT03135548|62871680|FG001|Overall Study|Withdrawal by Subject|2|||
33493348|NCT03135548|62871681|FG002|Overall Study|Withdrawal by Subject|1|||
33493349|NCT03135548|62871679|FG000|Overall Study|Other than listed|0|||
33493350|NCT03135548|62871680|FG001|Overall Study|Other than listed|2|||
33597006|NCT01883362|62995931|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
33597007|NCT01883362|62995930|FG000|Post Treatment Follow-up|Administrative problems|2|||
33707431|NCT01708902|63274157|FG005|Overall Study|Lack of Efficacy|1|||
33493351|NCT03135548|62871681|FG002|Overall Study|Other than listed|2|||
33493352|NCT03134222|62871692|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
33493353|NCT03134222|62871693|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
33493354|NCT03134222|62871694|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
33493355|NCT03134222|62871695|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
33493356|NCT03134222|62871696|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
33493357|NCT03134222|62871692|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
33493358|NCT03134222|62871693|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
33493359|NCT03134222|62871694|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
33493360|NCT03134222|62871695|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
33493361|NCT03134222|62871696|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
33707432|NCT01708902|63274158|FG006|Overall Study|Lack of Efficacy|0|||
33707433|NCT01708902|63274152|FG000|Overall Study|Non compliance with protocol|0|||
33707434|NCT01708902|63274153|FG001|Overall Study|Non compliance with protocol|2|||
33707435|NCT01708902|63274154|FG002|Overall Study|Non compliance with protocol|1|||
33707436|NCT01708902|63274155|FG003|Overall Study|Non compliance with protocol|3|||
33707437|NCT01708902|63274156|FG004|Overall Study|Non compliance with protocol|0|||
33707438|NCT01708902|63274157|FG005|Overall Study|Non compliance with protocol|0|||
33707439|NCT01708902|63274158|FG006|Overall Study|Non compliance with protocol|0|||
33707440|NCT01708902|63274152|FG000|Overall Study|Lost to Follow-up|2|||
33707441|NCT01708902|63274153|FG001|Overall Study|Lost to Follow-up|1|||
33707442|NCT01708902|63274154|FG002|Overall Study|Lost to Follow-up|2|||
33707443|NCT01708902|63274155|FG003|Overall Study|Lost to Follow-up|2|||
33707444|NCT01708902|63274156|FG004|Overall Study|Lost to Follow-up|0|||
33707445|NCT01708902|63274157|FG005|Overall Study|Lost to Follow-up|0|||
33707446|NCT01708902|63274158|FG006|Overall Study|Lost to Follow-up|1|||
33707447|NCT01708902|63274152|FG000|Overall Study|Refused to continue trial medication|8|||
33707448|NCT01708902|63274153|FG001|Overall Study|Refused to continue trial medication|0|||
33707449|NCT01708902|63274154|FG002|Overall Study|Refused to continue trial medication|4|||
33707450|NCT01708902|63274155|FG003|Overall Study|Refused to continue trial medication|2|||
33707451|NCT01708902|63274156|FG004|Overall Study|Refused to continue trial medication|8|||
33707452|NCT01708902|63274157|FG005|Overall Study|Refused to continue trial medication|1|||
33707453|NCT01708902|63274158|FG006|Overall Study|Refused to continue trial medication|1|||
33707454|NCT01708902|63274152|FG000|Overall Study|Other Reason|1|||
33707455|NCT01708902|63274153|FG001|Overall Study|Other Reason|0|||
33707456|NCT01708902|63274154|FG002|Overall Study|Other Reason|1|||
33707457|NCT01708902|63274155|FG003|Overall Study|Other Reason|1|||
33707458|NCT01708902|63274156|FG004|Overall Study|Other Reason|1|||
33707459|NCT01708902|63274157|FG005|Overall Study|Other Reason|2|||
33707460|NCT01708902|63274158|FG006|Overall Study|Other Reason|0|||
33707461|NCT01755546|63274177|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
33707462|NCT01755546|63274177|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
33707463|NCT01755546|63274177|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
33707464|NCT01755546|63274177|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
33707465|NCT01755546|63274177|FG000|Titration Phase|Adverse Event|11|||
33707466|NCT01755546|63274177|FG000|Titration Phase|Lack of Efficacy|18|||
33707467|NCT01755546|63274177|FG000|Titration Phase|Protocol Violation|9|||
33707468|NCT01755546|63274177|FG000|Titration Phase|Lost to Follow-up|2|||
33707469|NCT01755546|63274177|FG000|Titration Phase|Other and Continuing|22|||
33707470|NCT01755546|63274177|FG000|Titration Phase|Withdrawal by Subject|8|||
33707471|NCT01755546|63274177|FG000|Long Term Treatment|Adverse Event|12|||
33707472|NCT01755546|63274177|FG000|Long Term Treatment|Lack of Efficacy|6|||
33707473|NCT01755546|63274177|FG000|Long Term Treatment|Protocol Violation|10|||
33707474|NCT01755546|63274177|FG000|Long Term Treatment|Withdrawal by Subject|35|||
33707475|NCT01755546|63274177|FG000|Long Term Treatment|Lost to Follow-up|17|||
33707476|NCT01755546|63274177|FG000|Long Term Treatment|other and ongoing|41|||
33707477|NCT01755234|63274183|FG000|Overall Study|Lost to Follow-up|11|||
33707478|NCT01755234|63274184|FG001|Overall Study|Lost to Follow-up|6|||
33707479|NCT01755234|63274183|FG000|Overall Study|Change in surgical case|2|||
33707480|NCT01755234|63274184|FG001|Overall Study|Change in surgical case|1|||
33707481|NCT01755234|63274183|FG000|Overall Study|case cancelled|1|||
33707482|NCT01755234|63274184|FG001|Overall Study|case cancelled|0|||
33707483|NCT01755234|63274183|FG000|Overall Study|Withdrawal by Subject|0|||
33707484|NCT01755234|63274184|FG001|Overall Study|Withdrawal by Subject|1|||
33707485|NCT01755234|63274183|FG000|Overall Study|unblinded|1|||
33707486|NCT01755234|63274184|FG001|Overall Study|unblinded|0|||
33707487|NCT01731912|63274190|FG000|Overall Study|noncompliance|2|||
33493362|NCT03134222|62871692|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
33493363|NCT03134222|62871693|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
33707488|NCT01731678|63274194|FG000|Overall Study|Withdrawal by Subject|3|||
33707489|NCT01731678|63274194|FG000|Overall Study|Did not meet inclusion criteria|1|||
33707490|NCT01731678|63274194|FG000|Overall Study|RMT too high, making TMS difficult|3|||
33707491|NCT01731600|63274200|FG000|Overall Study|Adverse Event|2|||
33707492|NCT01731600|63274201|FG001|Overall Study|Adverse Event|0|||
33707493|NCT01731600|63274200|FG000|Overall Study|Withdrawal criteria|1|||
33707494|NCT01731600|63274201|FG001|Overall Study|Withdrawal criteria|0|||
33707495|NCT01731600|63274200|FG000|Overall Study|Other reasons|3|||
33707496|NCT01731600|63274201|FG001|Overall Study|Other reasons|0|||
33707497|NCT01730586|63274211|FG000|Overall Study|Progressive Disease|2|||
33707498|NCT01730586|63274211|FG000|Overall Study|Inadequate Trial|8|||
33707499|NCT01730586|63274211|FG000|Overall Study|Adverse Event|2|||
33707500|NCT01730586|63274211|FG000|Overall Study|Hospice|1|||
33707501|NCT01707030|63274219|FG000|Overall Study|Death|1|||
33707502|NCT01707030|63274220|FG001|Overall Study|Death|1|||
33707503|NCT01707030|63274219|FG000|Overall Study|Withdrawal by Subject|2|||
33707504|NCT01707030|63274220|FG001|Overall Study|Withdrawal by Subject|3|||
33707505|NCT01707030|63274219|FG000|Overall Study|Lost to Follow-up|8|||
33707506|NCT01707030|63274220|FG001|Overall Study|Lost to Follow-up|13|||
33707507|NCT01755156|63274232|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
33707508|NCT01755156|63274233|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
33707509|NCT01755156|63274232|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
33707510|NCT01755156|63274233|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
33707511|NCT01755156|63274232|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
33707512|NCT01755156|63274233|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
33707513|NCT01755156|63274232|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
33707514|NCT01755156|63274233|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
33707515|NCT01755156|63274232|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
33707516|NCT01755156|63274233|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
33707517|NCT01755156|63274232|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
33707518|NCT01755156|63274233|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
33707519|NCT01755156|63274232|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
33707520|NCT01755156|63274233|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
33707521|NCT01755156|63274232|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
33707522|NCT01755156|63274233|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
33707523|NCT01755156|63274232|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
33707524|NCT01755156|63274233|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
33707525|NCT01755156|63274232|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
33707526|NCT01755156|63274233|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
33707527|NCT01755156|63274232|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
33707528|NCT01755156|63274233|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
33707529|NCT01754922|63274245|FG000|Overall Study|Adverse Event|0|||
33707530|NCT01754922|63274246|FG001|Overall Study|Adverse Event|1|||
33707531|NCT01754766|63274256|FG000|Overall Study|Personal reasons|1|||
33707532|NCT01754766|63274257|FG001|Overall Study|Personal reasons|1|||
33707533|NCT01754766|63274258|FG002|Overall Study|Personal reasons|0|||
33707534|NCT01754376|63274266|FG000|Overall Study|Adverse Event|1|||
33707535|NCT01754376|63274266|FG000|Overall Study|Lack of Efficacy|2|||
33707536|NCT01605396|63274273|FG000|Overall Study|Adverse Event|5|||
33707537|NCT01605396|63274274|FG001|Overall Study|Adverse Event|3|||
33707538|NCT01605396|63274273|FG000|Overall Study|Lost to Follow-up|1|||
33707539|NCT01605396|63274274|FG001|Overall Study|Lost to Follow-up|0|||
33707540|NCT01605396|63274273|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33707541|NCT01605396|63274274|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33707542|NCT01605396|63274273|FG000|Overall Study|Physician Decision|2|||
33707543|NCT01605396|63274274|FG001|Overall Study|Physician Decision|2|||
33707544|NCT01605396|63274273|FG000|Overall Study|Progressive Disease|23|||
33707545|NCT01605396|63274274|FG001|Overall Study|Progressive Disease|27|||
33707546|NCT01605396|63274273|FG000|Overall Study|Withdrawal by Subject|4|||
33707547|NCT01605396|63274274|FG001|Overall Study|Withdrawal by Subject|2|||
33707548|NCT01605396|63274273|FG000|Overall Study|Transfer Off Study|4|||
33707549|NCT01605396|63274274|FG001|Overall Study|Transfer Off Study|5|||
33707550|NCT01730118|63274287|FG000|Dose Escalation|Death on study|5|||
33707551|NCT01730118|63274288|FG001|Dose Escalation|Death on study|7|||
33707552|NCT01730118|63274289|FG002|Dose Escalation|Death on study|2|||
33707553|NCT01730118|63274290|FG003|Dose Escalation|Death on study|6|||
33597008|NCT01883362|62995931|FG001|Post Treatment Follow-up|Administrative problems|0|||
33597009|NCT01883362|62995930|FG000|Post Treatment Follow-up|Death|8|||
33597010|NCT01883362|62995931|FG001|Post Treatment Follow-up|Death|4|||
33597011|NCT01883362|62995930|FG000|Post Treatment Follow-up|Relapse|1|||
33597012|NCT01883362|62995931|FG001|Post Treatment Follow-up|Relapse|2|||
33597013|NCT02100813|62995949|FG000|Overall Study|Adverse Event|0|||
33597014|NCT02100813|62995950|FG001|Overall Study|Adverse Event|0|||
33597015|NCT02100813|62995951|FG002|Overall Study|Adverse Event|0|||
33597016|NCT02100813|62995952|FG003|Overall Study|Adverse Event|0|||
33597017|NCT02100813|62995953|FG004|Overall Study|Adverse Event|0|||
33597018|NCT02100813|62995954|FG005|Overall Study|Adverse Event|0|||
33597019|NCT02100813|62995955|FG006|Overall Study|Adverse Event|0|||
33597020|NCT02100813|62995956|FG007|Overall Study|Adverse Event|1|||
33597021|NCT01930162|62995978|FG000|Overall Study|Abnormal test procedure result(s)|4|||
33597022|NCT01930162|62995978|FG000|Overall Study|Death|1|||
33597023|NCT02045979|62995986|FG000|Overall Study|Informed Consent Withdrawn|2|||
33597024|NCT02045979|62995987|FG001|Overall Study|Informed Consent Withdrawn|0|||
33597025|NCT02045979|62995988|FG002|Overall Study|Informed Consent Withdrawn|1|||
33707554|NCT01730118|63274291|FG004|Dose Escalation|Death on study|0|||
33707555|NCT01730118|63274292|FG005|Dose Escalation|Death on study|0|||
33707556|NCT01730118|63274293|FG006|Dose Escalation|Death on study|0|||
33707557|NCT01730118|63274287|FG000|Dose Escalation|Died before treatment|0|||
33707558|NCT01730118|63274288|FG001|Dose Escalation|Died before treatment|0|||
33707559|NCT01730118|63274289|FG002|Dose Escalation|Died before treatment|0|||
33707560|NCT01730118|63274290|FG003|Dose Escalation|Died before treatment|0|||
33707561|NCT01730118|63274291|FG004|Dose Escalation|Died before treatment|0|||
33707562|NCT01730118|63274292|FG005|Dose Escalation|Died before treatment|0|||
33707563|NCT01730118|63274293|FG006|Dose Escalation|Died before treatment|1|||
33707564|NCT01730118|63274287|FG000|Dose Escalation|Chose to start a different treatment|1|||
33707565|NCT01730118|63274288|FG001|Dose Escalation|Chose to start a different treatment|0|||
33707566|NCT01730118|63274289|FG002|Dose Escalation|Chose to start a different treatment|0|||
33707567|NCT01730118|63274290|FG003|Dose Escalation|Chose to start a different treatment|0|||
33707568|NCT01730118|63274291|FG004|Dose Escalation|Chose to start a different treatment|0|||
33707569|NCT01730118|63274292|FG005|Dose Escalation|Chose to start a different treatment|0|||
33707570|NCT01730118|63274293|FG006|Dose Escalation|Chose to start a different treatment|0|||
33707571|NCT01730118|63274287|FG000|Dose Escalation|Withdrawal by Subject|0|||
33707572|NCT01730118|63274288|FG001|Dose Escalation|Withdrawal by Subject|0|||
33707573|NCT01730118|63274289|FG002|Dose Escalation|Withdrawal by Subject|1|||
33707574|NCT01730118|63274290|FG003|Dose Escalation|Withdrawal by Subject|0|||
33707575|NCT01730118|63274291|FG004|Dose Escalation|Withdrawal by Subject|0|||
33707576|NCT01730118|63274292|FG005|Dose Escalation|Withdrawal by Subject|0|||
33707577|NCT01730118|63274293|FG006|Dose Escalation|Withdrawal by Subject|0|||
33707578|NCT01730118|63274287|FG000|Dose Escalation|Disease progression prior to treatment|0|||
33707579|NCT01730118|63274288|FG001|Dose Escalation|Disease progression prior to treatment|0|||
33707580|NCT01730118|63274289|FG002|Dose Escalation|Disease progression prior to treatment|0|||
33707581|NCT01730118|63274290|FG003|Dose Escalation|Disease progression prior to treatment|0|||
33707582|NCT01730118|63274291|FG004|Dose Escalation|Disease progression prior to treatment|0|||
33707583|NCT01730118|63274292|FG005|Dose Escalation|Disease progression prior to treatment|0|||
33707584|NCT01730118|63274293|FG006|Dose Escalation|Disease progression prior to treatment|1|||
33707585|NCT01730118|63274287|FG000|Dose Expansion|Death|0|||
33707586|NCT01730118|63274288|FG001|Dose Expansion|Death|0|||
33707587|NCT01730118|63274289|FG002|Dose Expansion|Death|0|||
33707588|NCT01730118|63274290|FG003|Dose Expansion|Death|0|||
33707589|NCT01730118|63274291|FG004|Dose Expansion|Death|1|||
33707590|NCT01730118|63274292|FG005|Dose Expansion|Death|0|||
33707591|NCT01730118|63274293|FG006|Dose Expansion|Death|0|||
33707592|NCT01730118|63274287|FG000|Dose Expansion|Other medical condition|0|||
33707593|NCT01730118|63274288|FG001|Dose Expansion|Other medical condition|0|||
33707594|NCT01730118|63274289|FG002|Dose Expansion|Other medical condition|0|||
33707595|NCT01730118|63274290|FG003|Dose Expansion|Other medical condition|0|||
33707596|NCT01730118|63274291|FG004|Dose Expansion|Other medical condition|1|||
33707597|NCT01730118|63274292|FG005|Dose Expansion|Other medical condition|0|||
33707598|NCT01730118|63274293|FG006|Dose Expansion|Other medical condition|0|||
33707599|NCT01730118|63274287|FG000|Dose Expansion|Withdrawal by Subject|0|||
33707600|NCT01730118|63274288|FG001|Dose Expansion|Withdrawal by Subject|0|||
33707601|NCT01730118|63274289|FG002|Dose Expansion|Withdrawal by Subject|0|||
33707602|NCT01730118|63274290|FG003|Dose Expansion|Withdrawal by Subject|0|||
33707603|NCT01730118|63274291|FG004|Dose Expansion|Withdrawal by Subject|1|||
33707604|NCT01730118|63274292|FG005|Dose Expansion|Withdrawal by Subject|0|||
33707605|NCT01730118|63274293|FG006|Dose Expansion|Withdrawal by Subject|0|||
33707606|NCT01730118|63274287|FG000|Dose Expansion|Disease progression|0|||
33707607|NCT01730118|63274288|FG001|Dose Expansion|Disease progression|0|||
33707608|NCT01730118|63274289|FG002|Dose Expansion|Disease progression|0|||
33707609|NCT01730118|63274290|FG003|Dose Expansion|Disease progression|0|||
33707610|NCT01730118|63274291|FG004|Dose Expansion|Disease progression|0|||
33707611|NCT01730118|63274292|FG005|Dose Expansion|Disease progression|1|||
33707612|NCT01730118|63274293|FG006|Dose Expansion|Disease progression|0|||
33707613|NCT01730118|63274287|FG000|Dose Expansion|Inability to return|0|||
33707614|NCT01730118|63274288|FG001|Dose Expansion|Inability to return|0|||
33707615|NCT01730118|63274289|FG002|Dose Expansion|Inability to return|0|||
33597026|NCT02045979|62995986|FG000|Overall Study|not specified above|0|||
33707616|NCT01730118|63274290|FG003|Dose Expansion|Inability to return|0|||
33707617|NCT01730118|63274291|FG004|Dose Expansion|Inability to return|0|||
33707618|NCT01730118|63274292|FG005|Dose Expansion|Inability to return|1|||
33597027|NCT02045979|62995987|FG001|Overall Study|not specified above|1|||
33707619|NCT01730118|63274293|FG006|Dose Expansion|Inability to return|0|||
33707620|NCT01730118|63274287|FG000|Dose Expansion|Physician Decision|0|||
33707621|NCT01730118|63274288|FG001|Dose Expansion|Physician Decision|0|||
33707622|NCT01730118|63274289|FG002|Dose Expansion|Physician Decision|0|||
33707623|NCT01730118|63274290|FG003|Dose Expansion|Physician Decision|0|||
33707624|NCT01730118|63274291|FG004|Dose Expansion|Physician Decision|0|||
33707625|NCT01730118|63274292|FG005|Dose Expansion|Physician Decision|1|||
33707626|NCT01730118|63274293|FG006|Dose Expansion|Physician Decision|0|||
33707627|NCT01730040|63274317|FG000|Overall Study|Randomized but not treated|0|||
33707628|NCT01730040|63274318|FG001|Overall Study|Randomized but not treated|0|||
33707629|NCT01730040|63274319|FG002|Overall Study|Randomized but not treated|0|||
33707630|NCT01730040|63274320|FG003|Overall Study|Randomized but not treated|0|||
33707631|NCT01730040|63274321|FG004|Overall Study|Randomized but not treated|0|||
33707632|NCT01730040|63274322|FG005|Overall Study|Randomized but not treated|1|||
33707633|NCT01730040|63274323|FG006|Overall Study|Randomized but not treated|0|||
33707634|NCT01730040|63274317|FG000|Overall Study|Subject moved|0|||
33707635|NCT01730040|63274318|FG001|Overall Study|Subject moved|0|||
33707636|NCT01730040|63274319|FG002|Overall Study|Subject moved|1|||
33707637|NCT01730040|63274320|FG003|Overall Study|Subject moved|0|||
33707638|NCT01730040|63274321|FG004|Overall Study|Subject moved|0|||
33707639|NCT01730040|63274322|FG005|Overall Study|Subject moved|0|||
33707640|NCT01730040|63274323|FG006|Overall Study|Subject moved|1|||
33707641|NCT01730040|63274317|FG000|Overall Study|Physician Decision|0|||
33707642|NCT01730040|63274318|FG001|Overall Study|Physician Decision|0|||
33707643|NCT01730040|63274319|FG002|Overall Study|Physician Decision|0|||
33707644|NCT01730040|63274320|FG003|Overall Study|Physician Decision|0|||
33707645|NCT01730040|63274321|FG004|Overall Study|Physician Decision|0|||
33707646|NCT01730040|63274322|FG005|Overall Study|Physician Decision|1|||
33707647|NCT01730040|63274323|FG006|Overall Study|Physician Decision|1|||
33707648|NCT01730040|63274317|FG000|Overall Study|Other than specified|7|||
33707649|NCT01730040|63274318|FG001|Overall Study|Other than specified|8|||
33707650|NCT01730040|63274319|FG002|Overall Study|Other than specified|5|||
33707651|NCT01730040|63274320|FG003|Overall Study|Other than specified|5|||
33707652|NCT01730040|63274321|FG004|Overall Study|Other than specified|5|||
33707653|NCT01730040|63274322|FG005|Overall Study|Other than specified|4|||
33707654|NCT01730040|63274323|FG006|Overall Study|Other than specified|4|||
33707655|NCT01730040|63274317|FG000|Overall Study|Adverse Event|4|||
33707656|NCT01730040|63274318|FG001|Overall Study|Adverse Event|3|||
33707657|NCT01730040|63274319|FG002|Overall Study|Adverse Event|5|||
33707658|NCT01730040|63274320|FG003|Overall Study|Adverse Event|3|||
33707659|NCT01730040|63274321|FG004|Overall Study|Adverse Event|1|||
33707660|NCT01730040|63274322|FG005|Overall Study|Adverse Event|1|||
33707661|NCT01730040|63274323|FG006|Overall Study|Adverse Event|2|||
33707662|NCT01730040|63274317|FG000|Overall Study|Poor compliance to protocol|2|||
33707663|NCT01730040|63274318|FG001|Overall Study|Poor compliance to protocol|4|||
33707664|NCT01730040|63274319|FG002|Overall Study|Poor compliance to protocol|0|||
33707665|NCT01730040|63274320|FG003|Overall Study|Poor compliance to protocol|0|||
33707666|NCT01730040|63274321|FG004|Overall Study|Poor compliance to protocol|0|||
33707667|NCT01730040|63274322|FG005|Overall Study|Poor compliance to protocol|0|||
33707668|NCT01730040|63274323|FG006|Overall Study|Poor compliance to protocol|1|||
33707669|NCT01706328|63274341|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
33707670|NCT01706328|63274342|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33707671|NCT01706328|63274343|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33707672|NCT01706328|63274341|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
33707673|NCT01706328|63274342|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
33597028|NCT02045979|62995988|FG002|Overall Study|not specified above|0|||
33597029|NCT01929226|62995998|FG000|Overall Study|Lost to Follow-up|4|||
33597030|NCT01929226|62995999|FG001|Overall Study|Lost to Follow-up|0|||
33597031|NCT01929226|62995998|FG000|Overall Study|Withdrawal by Subject|1|||
33597032|NCT01929226|62995999|FG001|Overall Study|Withdrawal by Subject|1|||
33597033|NCT02045433|62996006|FG000|Overall Study|Withdrawal by Subject|1|||
33597034|NCT01911442|62996013|FG000|Overall Study|Adverse Event|2|||
33597035|NCT01911442|62996014|FG001|Overall Study|Adverse Event|2|||
33597036|NCT01911442|62996015|FG002|Overall Study|Adverse Event|4|||
33597037|NCT01911442|62996013|FG000|Overall Study|Lack of Efficacy|1|||
33707674|NCT01706328|63274343|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
33707675|NCT01706328|63274341|FG000|2-week Run-in Period|Physician Decision|4|||
33707676|NCT01706328|63274342|FG001|2-week Run-in Period|Physician Decision|0|||
33707677|NCT01706328|63274343|FG002|2-week Run-in Period|Physician Decision|0|||
33707678|NCT01706328|63274341|FG000|2-week Run-in Period|Adverse Event|4|||
33707679|NCT01706328|63274342|FG001|2-week Run-in Period|Adverse Event|0|||
33707680|NCT01706328|63274343|FG002|2-week Run-in Period|Adverse Event|0|||
33707681|NCT01706328|63274341|FG000|2-week Run-in Period|Lost to Follow-up|2|||
33707682|NCT01706328|63274342|FG001|2-week Run-in Period|Lost to Follow-up|0|||
33707683|NCT01706328|63274343|FG002|2-week Run-in Period|Lost to Follow-up|0|||
33707684|NCT01706328|63274341|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
33707685|NCT01706328|63274342|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
33707686|NCT01706328|63274343|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
33707687|NCT01706328|63274341|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
33707688|NCT01706328|63274342|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
33707689|NCT01706328|63274343|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
33707690|NCT01706328|63274341|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
33707691|NCT01706328|63274342|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
33707692|NCT01706328|63274343|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
33707693|NCT01706328|63274341|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
33707694|NCT01706328|63274342|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
33707695|NCT01706328|63274343|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
33707696|NCT01706328|63274341|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
33707697|NCT01706328|63274342|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
33707698|NCT01706328|63274343|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
33707699|NCT01706328|63274341|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
33707700|NCT01706328|63274342|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
33707701|NCT01706328|63274343|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
33707702|NCT01706328|63274341|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33707703|NCT01706328|63274342|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
33707704|NCT01706328|63274343|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
33707705|NCT01753518|63274351|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
33707706|NCT01753518|63274352|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
33310765|NCT01233258|62686171|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
33493364|NCT03134222|62871694|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
33707707|NCT01753518|63274351|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
33707708|NCT01753518|63274352|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
33707709|NCT01753518|63274351|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
33707710|NCT01753518|63274352|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
33707711|NCT01753518|63274351|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
33707712|NCT01753518|63274352|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
33707713|NCT01706250|63274358|FG000|Overall Study|Lost to Follow-up|2|||
33707714|NCT01729728|63274370|FG000|Overall Study|Adverse Event|0|||
33707715|NCT01729728|63274371|FG001|Overall Study|Adverse Event|6|||
33707716|NCT01729728|63274372|FG002|Overall Study|Adverse Event|0|||
33707717|NCT01729728|63274370|FG000|Overall Study|Protocol Violation|1|||
33707718|NCT01729728|63274371|FG001|Overall Study|Protocol Violation|0|||
33707719|NCT01729728|63274372|FG002|Overall Study|Protocol Violation|1|||
33707720|NCT01729026|63274505|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
33707721|NCT01729026|63274506|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
33707722|NCT01729026|63274505|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
33707723|NCT01729026|63274506|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
33707724|NCT01728792|63274520|FG000|Overall Study|Withdrawal of Consent|1|||
33707725|NCT01728792|63274521|FG001|Overall Study|Withdrawal of Consent|1|||
33707726|NCT01728792|63274522|FG002|Overall Study|Withdrawal of Consent|0|||
33707727|NCT01728792|63274523|FG003|Overall Study|Withdrawal of Consent|1|||
33707728|NCT01728792|63274524|FG004|Overall Study|Withdrawal of Consent|0|||
33707729|NCT01728792|63274520|FG000|Overall Study|Lost to Follow-up|2|||
33707730|NCT01728792|63274521|FG001|Overall Study|Lost to Follow-up|1|||
33707731|NCT01728792|63274522|FG002|Overall Study|Lost to Follow-up|4|||
33707732|NCT01728792|63274523|FG003|Overall Study|Lost to Follow-up|2|||
33707733|NCT01728792|63274524|FG004|Overall Study|Lost to Follow-up|0|||
33707734|NCT01752036|63274536|FG000|Overall Study|Death|2|||
33707735|NCT01728324|63274544|FG000|Termination of DBV|Adverse Event|14|||
33707736|NCT01728324|63274545|FG001|Termination of DBV|Adverse Event|13|||
33707737|NCT01728324|63274546|FG002|Termination of DBV|Adverse Event|4|||
33707738|NCT01728324|63274544|FG000|Termination of DBV|Lack of Efficacy|14|||
33707739|NCT01728324|63274545|FG001|Termination of DBV|Lack of Efficacy|12|||
33707740|NCT01728324|63274546|FG002|Termination of DBV|Lack of Efficacy|8|||
33707741|NCT01728324|63274544|FG000|Termination of DBV|Withdrawal by Subject|9|||
33707742|NCT01728324|63274545|FG001|Termination of DBV|Withdrawal by Subject|6|||
33707743|NCT01728324|63274546|FG002|Termination of DBV|Withdrawal by Subject|2|||
33707744|NCT01728324|63274544|FG000|Termination of DBV|Other than stated|1|||
33707745|NCT01728324|63274545|FG001|Termination of DBV|Other than stated|3|||
33707746|NCT01728324|63274546|FG002|Termination of DBV|Other than stated|0|||
33707747|NCT01728324|63274544|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
33707748|NCT01728324|63274545|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
33707749|NCT01728324|63274546|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
33707750|NCT01728324|63274544|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
33707751|NCT01728324|63274545|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
33707752|NCT01728324|63274546|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
33707753|NCT01728324|63274544|FG000|Termination of FDV|Adverse Event|14|||
33707754|NCT01728324|63274545|FG001|Termination of FDV|Adverse Event|13|||
33707755|NCT01728324|63274546|FG002|Termination of FDV|Adverse Event|4|||
33707756|NCT01728324|63274544|FG000|Termination of FDV|Lack of Efficacy|14|||
33707757|NCT01728324|63274545|FG001|Termination of FDV|Lack of Efficacy|12|||
33707758|NCT01728324|63274546|FG002|Termination of FDV|Lack of Efficacy|8|||
33707759|NCT01728324|63274544|FG000|Termination of FDV|Withdrawal by Subject|9|||
33707760|NCT01728324|63274545|FG001|Termination of FDV|Withdrawal by Subject|6|||
33707761|NCT01728324|63274546|FG002|Termination of FDV|Withdrawal by Subject|2|||
33707762|NCT01728324|63274544|FG000|Termination of FDV|Other than stated|1|||
33707763|NCT01728324|63274545|FG001|Termination of FDV|Other than stated|3|||
33707764|NCT01728324|63274546|FG002|Termination of FDV|Other than stated|0|||
33707765|NCT01728324|63274544|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
33707766|NCT01728324|63274545|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
33707767|NCT01728324|63274546|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
33707768|NCT01728324|63274544|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
33707769|NCT01728324|63274545|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
33707770|NCT01728324|63274546|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
33707771|NCT01728324|63274544|FG000|Termination of RBV|Adverse Event|15|||
33707772|NCT01728324|63274545|FG001|Termination of RBV|Adverse Event|16|||
33707773|NCT01728324|63274546|FG002|Termination of RBV|Adverse Event|5|||
33707774|NCT01728324|63274544|FG000|Termination of RBV|Lack of Efficacy|14|||
33707775|NCT01728324|63274545|FG001|Termination of RBV|Lack of Efficacy|11|||
33707776|NCT01728324|63274546|FG002|Termination of RBV|Lack of Efficacy|7|||
33707777|NCT01728324|63274544|FG000|Termination of RBV|Withdrawal by Subject|9|||
33707778|NCT01728324|63274545|FG001|Termination of RBV|Withdrawal by Subject|5|||
33707779|NCT01728324|63274546|FG002|Termination of RBV|Withdrawal by Subject|2|||
33707780|NCT01728324|63274544|FG000|Termination of RBV|Other than stated|1|||
33707781|NCT01728324|63274545|FG001|Termination of RBV|Other than stated|3|||
33707782|NCT01728324|63274546|FG002|Termination of RBV|Other than stated|1|||
33707783|NCT01728324|63274544|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
33707784|NCT01728324|63274545|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
33707785|NCT01728324|63274546|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
33707786|NCT01728324|63274544|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
33707787|NCT01728324|63274545|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
33707788|NCT01728324|63274546|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
33707789|NCT01728246|63274558|FG000|Overall Study|Participant needed rescue medication|1|||
33707790|NCT01728246|63274559|FG001|Overall Study|Participant needed rescue medication|5|||
33707791|NCT01728246|63274558|FG000|Overall Study|Protocol Violation|1|||
33707792|NCT01728246|63274559|FG001|Overall Study|Protocol Violation|0|||
33707793|NCT01728246|63274558|FG000|Overall Study|Withdrawal by Subject|2|||
33707794|NCT01728246|63274559|FG001|Overall Study|Withdrawal by Subject|3|||
33707795|NCT01728246|63274558|FG000|Overall Study|Lost to Follow-up|23|||
33707796|NCT01728246|63274559|FG001|Overall Study|Lost to Follow-up|22|||
33707797|NCT01728246|63274558|FG000|Overall Study|Lack of Efficacy|1|||
33707798|NCT01728246|63274559|FG001|Overall Study|Lack of Efficacy|1|||
33707799|NCT01728246|63274558|FG000|Overall Study|Adverse Event|8|||
33707800|NCT01728246|63274559|FG001|Overall Study|Adverse Event|5|||
33707801|NCT01705236|63274565|FG000|Overall Study|Lost to Follow-up|1|||
33707802|NCT01705236|63274565|FG000|Overall Study|Administrative problems|2|||
33707803|NCT01705236|63274565|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
33707804|NCT01705236|63274565|FG000|Overall Study|Protocol Violation|3|||
33707805|NCT01705236|63274565|FG000|Overall Study|Abnormal test procedure result(s)|4|||
33707806|NCT01705236|63274565|FG000|Overall Study|Abnormal laboratory value(s)|4|||
33707807|NCT01705236|63274565|FG000|Overall Study|Withdrawal by Subject|5|||
33707808|NCT01705236|63274565|FG000|Overall Study|Adverse Event|5|||
33707809|NCT01705080|63274572|FG000|Overall Study|Missed visit|10|||
33707810|NCT01705080|63274573|FG001|Overall Study|Missed visit|4|||
33707811|NCT01705080|63274574|FG002|Overall Study|Missed visit|1|||
33707812|NCT01705080|63274572|FG000|Overall Study|Death|4|||
33707813|NCT01705080|63274573|FG001|Overall Study|Death|4|||
33707814|NCT01705080|63274574|FG002|Overall Study|Death|6|||
33707815|NCT01705080|63274572|FG000|Overall Study|Withdrawal by Subject|61|||
33707816|NCT01705080|63274573|FG001|Overall Study|Withdrawal by Subject|44|||
33707817|NCT01705080|63274574|FG002|Overall Study|Withdrawal by Subject|9|||
33707818|NCT01704846|63274584|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33707819|NCT01704846|63274585|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33707820|NCT01751802|63274593|FG000|Overall Study|Adverse Event|4|||
33707821|NCT01751802|63274594|FG001|Overall Study|Adverse Event|2|||
33707822|NCT01704456|63274608|FG000|Overall Study|Lost to Follow-up|8|||
33707823|NCT01704456|63274609|FG001|Overall Study|Lost to Follow-up|14|||
33707824|NCT01703988|63274619|FG000|Overall Study|Investigator Judgment|0|||
33707825|NCT01703988|63274620|FG001|Overall Study|Investigator Judgment|0|||
33707826|NCT01703988|63274621|FG002|Overall Study|Investigator Judgment|0|||
33707827|NCT01703988|63274622|FG003|Overall Study|Investigator Judgment|1|||
33707828|NCT01703832|63274635|FG000|Overall Study|Withdrawal by Subject|1|||
33707829|NCT01703832|63274636|FG001|Overall Study|Withdrawal by Subject|0|||
33707830|NCT01703286|63274642|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
33707831|NCT01703286|63274643|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
33707832|NCT01703286|63274644|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
33707833|NCT01703286|63274645|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
33707834|NCT01703286|63274646|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
33707835|NCT01703286|63274647|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
33707836|NCT01703286|63274642|FG000|Period 2 Including Washout|Adverse Event|0|||
33707837|NCT01703286|63274643|FG001|Period 2 Including Washout|Adverse Event|0|||
33707838|NCT01703286|63274644|FG002|Period 2 Including Washout|Adverse Event|0|||
33707839|NCT01703286|63274645|FG003|Period 2 Including Washout|Adverse Event|1|||
33707840|NCT01703286|63274646|FG004|Period 2 Including Washout|Adverse Event|0|||
33707841|NCT01703286|63274647|FG005|Period 2 Including Washout|Adverse Event|0|||
33707842|NCT01703208|63274660|FG000|Overall Study|Death|61|||
33707843|NCT01703208|63274661|FG001|Overall Study|Death|48|||
33707844|NCT01703208|63274660|FG000|Overall Study|Lack of Efficacy|1|||
33707845|NCT01703208|63274661|FG001|Overall Study|Lack of Efficacy|2|||
33707846|NCT01703208|63274660|FG000|Overall Study|Lost to Follow-up|68|||
33707847|NCT01703208|63274661|FG001|Overall Study|Lost to Follow-up|62|||
33707848|NCT01703208|63274660|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33707849|NCT01703208|63274661|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33707850|NCT01703208|63274660|FG000|Overall Study|Excluded Medication|1|||
33707851|NCT01703208|63274661|FG001|Overall Study|Excluded Medication|2|||
33707852|NCT01703208|63274660|FG000|Overall Study|Site Discontinued Study Participation|23|||
33707853|NCT01703208|63274661|FG001|Overall Study|Site Discontinued Study Participation|27|||
33707854|NCT01703208|63274660|FG000|Overall Study|Physician Decision|11|||
33597038|NCT01911442|62996014|FG001|Overall Study|Lack of Efficacy|1|||
33597039|NCT01911442|62996015|FG002|Overall Study|Lack of Efficacy|1|||
33597040|NCT01911442|62996013|FG000|Overall Study|Lost to Follow-up|2|||
33597041|NCT01911442|62996014|FG001|Overall Study|Lost to Follow-up|0|||
33597042|NCT01911442|62996015|FG002|Overall Study|Lost to Follow-up|1|||
33597043|NCT01911442|62996013|FG000|Overall Study|Withdrawal by Subject|1|||
33597044|NCT01911442|62996014|FG001|Overall Study|Withdrawal by Subject|0|||
33597045|NCT01911442|62996015|FG002|Overall Study|Withdrawal by Subject|6|||
33597046|NCT01911442|62996013|FG000|Overall Study|Mother's Work Schedule|0|||
33597047|NCT01911442|62996014|FG001|Overall Study|Mother's Work Schedule|1|||
33597048|NCT01911442|62996015|FG002|Overall Study|Mother's Work Schedule|0|||
33597049|NCT01928758|62996029|FG000|Overall Study|Lost to Follow-up|14|||
33597050|NCT01928758|62996030|FG001|Overall Study|Lost to Follow-up|9|||
33597051|NCT01928758|62996029|FG000|Overall Study|Withdrawal by Subject|5|||
33707855|NCT01703208|63274661|FG001|Overall Study|Physician Decision|13|||
33707856|NCT01703208|63274660|FG000|Overall Study|Progressive disease|2|||
33707857|NCT01703208|63274661|FG001|Overall Study|Progressive disease|2|||
33707858|NCT01703208|63274660|FG000|Overall Study|Protocol Violation|1|||
33707859|NCT01703208|63274661|FG001|Overall Study|Protocol Violation|1|||
33707860|NCT01703208|63274660|FG000|Overall Study|Study Terminated by Sponsor|1710|||
33707861|NCT01703208|63274661|FG001|Overall Study|Study Terminated by Sponsor|1716|||
33707862|NCT01703208|63274660|FG000|Overall Study|Withdrawal by Subject|205|||
33597052|NCT01928758|62996030|FG001|Overall Study|Withdrawal by Subject|2|||
33597053|NCT01928758|62996029|FG000|Overall Study|Adverse Event|3|||
33707863|NCT01703208|63274661|FG001|Overall Study|Withdrawal by Subject|209|||
33707864|NCT01703208|63274660|FG000|Overall Study|Adverse Event|14|||
33707865|NCT01703208|63274661|FG001|Overall Study|Adverse Event|19|||
33707866|NCT01703208|63274660|FG000|Overall Study|Technical Problems|0|||
33707867|NCT01703208|63274661|FG001|Overall Study|Technical Problems|1|||
33707868|NCT01703208|63274660|FG000|Overall Study|Protocol Deviation|2|||
33707869|NCT01703208|63274661|FG001|Overall Study|Protocol Deviation|0|||
33707870|NCT01727700|63274670|FG000|Overall Study|Adverse Event|0|||
33707871|NCT01727700|63274671|FG001|Overall Study|Adverse Event|7|||
33707872|NCT01727700|63274672|FG002|Overall Study|Adverse Event|1|||
33707873|NCT01727700|63274670|FG000|Overall Study|Particpant withdrew consent|0|||
33707874|NCT01727700|63274671|FG001|Overall Study|Particpant withdrew consent|3|||
33707875|NCT01727700|63274672|FG002|Overall Study|Particpant withdrew consent|1|||
33707876|NCT01727700|63274670|FG000|Overall Study|Protocol Violation|2|||
33707877|NCT01727700|63274671|FG001|Overall Study|Protocol Violation|0|||
33707878|NCT01727700|63274672|FG002|Overall Study|Protocol Violation|0|||
33707879|NCT01727154|63274680|FG000|Overall Study|Death|17|||
33707880|NCT01727154|63274680|FG000|Overall Study|Withdrawal by Subject|14|||
33707881|NCT01727154|63274680|FG000|Overall Study|Subject Withdrew Consent|18|||
33707882|NCT01727154|63274680|FG000|Overall Study|Study Terminated|6|||
33707883|NCT01727154|63274680|FG000|Overall Study|No Discontinuation Documentation|4|||
33707884|NCT01725750|63274686|FG000|Overall Study|Adverse Event|1|||
33707885|NCT01725750|63274687|FG001|Overall Study|Adverse Event|0|||
33707886|NCT01725750|63274686|FG000|Overall Study|Lost to Follow-up|1|||
33707887|NCT01725750|63274687|FG001|Overall Study|Lost to Follow-up|1|||
33707888|NCT01725750|63274686|FG000|Overall Study|Withdrawal by Subject|0|||
33707889|NCT01725750|63274687|FG001|Overall Study|Withdrawal by Subject|9|||
33707890|NCT01725282|63274699|FG000|Overall Study|Adverse Event|1|||
33707891|NCT01725282|63274700|FG001|Overall Study|Adverse Event|3|||
33707892|NCT01725282|63274701|FG002|Overall Study|Adverse Event|6|||
33707893|NCT01725282|63274702|FG003|Overall Study|Adverse Event|4|||
33707894|NCT01725282|63274699|FG000|Overall Study|Exacerbation of Target Disease|1|||
33707895|NCT01725282|63274700|FG001|Overall Study|Exacerbation of Target Disease|0|||
33707896|NCT01725282|63274701|FG002|Overall Study|Exacerbation of Target Disease|0|||
33707897|NCT01725282|63274702|FG003|Overall Study|Exacerbation of Target Disease|1|||
33707898|NCT01725282|63274699|FG000|Overall Study|Met Exclusion Criteria|0|||
33707899|NCT01725282|63274700|FG001|Overall Study|Met Exclusion Criteria|0|||
33707900|NCT01725282|63274701|FG002|Overall Study|Met Exclusion Criteria|1|||
33707901|NCT01725282|63274702|FG003|Overall Study|Met Exclusion Criteria|0|||
33707902|NCT01725282|63274699|FG000|Overall Study|Study Site Withdrawal|0|||
33707903|NCT01725282|63274700|FG001|Overall Study|Study Site Withdrawal|1|||
33707904|NCT01725282|63274701|FG002|Overall Study|Study Site Withdrawal|0|||
33707905|NCT01725282|63274702|FG003|Overall Study|Study Site Withdrawal|0|||
33707906|NCT01725282|63274699|FG000|Overall Study|Withdrawal by Subject|0|||
33707907|NCT01725282|63274700|FG001|Overall Study|Withdrawal by Subject|0|||
33707908|NCT01725282|63274701|FG002|Overall Study|Withdrawal by Subject|1|||
33707909|NCT01725282|63274702|FG003|Overall Study|Withdrawal by Subject|1|||
33707910|NCT01725282|63274699|FG000|Overall Study|Lack of Efficacy|0|||
33707911|NCT01725282|63274700|FG001|Overall Study|Lack of Efficacy|1|||
33707912|NCT01725282|63274701|FG002|Overall Study|Lack of Efficacy|0|||
33707913|NCT01725282|63274702|FG003|Overall Study|Lack of Efficacy|1|||
33707914|NCT01725126|63274718|FG000|Overall Study|Protocol Violation|0|||
33707915|NCT01725126|63274719|FG001|Overall Study|Protocol Violation|1|||
33707916|NCT01725126|63274720|FG002|Overall Study|Protocol Violation|0|||
33707917|NCT01725126|63274721|FG003|Overall Study|Protocol Violation|0|||
33707918|NCT01725126|63274722|FG004|Overall Study|Protocol Violation|0|||
33707919|NCT01725126|63274723|FG005|Overall Study|Protocol Violation|0|||
33707920|NCT01725126|63274718|FG000|Overall Study|Withdrawal by Subject|0|||
33707921|NCT01725126|63274719|FG001|Overall Study|Withdrawal by Subject|0|||
33707922|NCT01725126|63274720|FG002|Overall Study|Withdrawal by Subject|0|||
33707923|NCT01725126|63274721|FG003|Overall Study|Withdrawal by Subject|1|||
33707924|NCT01725126|63274722|FG004|Overall Study|Withdrawal by Subject|0|||
33707925|NCT01725126|63274723|FG005|Overall Study|Withdrawal by Subject|0|||
33707926|NCT01751724|63274748|FG000|Overall Study|extubated bef.start assigned treatment|1|||
33707927|NCT01751724|63274749|FG001|Overall Study|extubated bef.start assigned treatment|0|||
33707928|NCT01751724|63274748|FG000|Overall Study|withdrawn by parent|0|||
33707929|NCT01751724|63274749|FG001|Overall Study|withdrawn by parent|2|||
33707930|NCT01751646|63274757|FG000|Overall Study|Lost to Follow-up|5|||
33707931|NCT01751646|63274758|FG001|Overall Study|Lost to Follow-up|1|||
33707932|NCT01751646|63274757|FG000|Overall Study|Withdrawal by Subject|0|||
33707933|NCT01751646|63274758|FG001|Overall Study|Withdrawal by Subject|4|||
33707934|NCT01751646|63274757|FG000|Overall Study|Starting hormone therapy|1|||
33707935|NCT01751646|63274758|FG001|Overall Study|Starting hormone therapy|0|||
33707936|NCT01751646|63274757|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
33707937|NCT01751646|63274758|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
33707938|NCT01751646|63274757|FG000|Overall Study|Inadvertent enrollment|1|||
33707939|NCT01751646|63274758|FG001|Overall Study|Inadvertent enrollment|1|||
33707940|NCT01751646|63274757|FG000|Overall Study|Moved out of the area|1|||
33707941|NCT01751646|63274758|FG001|Overall Study|Moved out of the area|5|||
33707942|NCT01751646|63274757|FG000|Overall Study|Inability to attend required visits|0|||
33707943|NCT01751646|63274758|FG001|Overall Study|Inability to attend required visits|1|||
33707944|NCT01751646|63274757|FG000|Overall Study|Off study due to multiple obligations|0|||
33707945|NCT01751646|63274758|FG001|Overall Study|Off study due to multiple obligations|1|||
33707946|NCT01751646|63274757|FG000|Overall Study|Fails to comply with study requirements|0|||
33707947|NCT01751646|63274758|FG001|Overall Study|Fails to comply with study requirements|1|||
33707948|NCT01751646|63274757|FG000|Overall Study|Childcare issues|1|||
33707949|NCT01751646|63274758|FG001|Overall Study|Childcare issues|1|||
33707950|NCT01751568|63274771|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
33707951|NCT01751568|63274772|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
33707952|NCT01751568|63274773|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
33707953|NCT01751412|63274781|FG000|Overall Study|Disease Progression Before Treatment|1|||
33707954|NCT01751178|63274788|FG000|Overall Study|Adverse Event|2|||
33707955|NCT01751178|63274789|FG001|Overall Study|Adverse Event|0|||
33707956|NCT01751178|63274790|FG002|Overall Study|Adverse Event|0|||
33707957|NCT01751178|63274788|FG000|Overall Study|Other Reason (unknown)|1|||
33707958|NCT01751178|63274789|FG001|Overall Study|Other Reason (unknown)|0|||
33707959|NCT01751178|63274790|FG002|Overall Study|Other Reason (unknown)|2|||
33707960|NCT01606254|63274806|FG000|Overall Study|Withdrawal by Subject|1|||
33707961|NCT01606254|63274807|FG001|Overall Study|Withdrawal by Subject|3|||
33707962|NCT01606254|63274808|FG002|Overall Study|Withdrawal by Subject|0|||
33707963|NCT01606254|63274809|FG003|Overall Study|Withdrawal by Subject|2|||
33707964|NCT01606254|63274806|FG000|Overall Study|Adverse Event|1|||
33707965|NCT01606254|63274807|FG001|Overall Study|Adverse Event|1|||
33707966|NCT01606254|63274808|FG002|Overall Study|Adverse Event|0|||
33707967|NCT01606254|63274809|FG003|Overall Study|Adverse Event|1|||
33707968|NCT01750242|63274819|FG000|Overall Study|Unreadable Images|3|||
33707969|NCT01723254|63274832|FG000|Overall Study|Conflict with work schedule|0|||
33707970|NCT01723254|63274833|FG001|Overall Study|Conflict with work schedule|0|||
33707971|NCT01723254|63274834|FG002|Overall Study|Conflict with work schedule|0|||
33707972|NCT01723254|63274835|FG003|Overall Study|Conflict with work schedule|0|||
33707973|NCT01723254|63274836|FG004|Overall Study|Conflict with work schedule|0|||
33707974|NCT01723254|63274837|FG005|Overall Study|Conflict with work schedule|0|||
33707975|NCT01723254|63274838|FG006|Overall Study|Conflict with work schedule|0|||
33707976|NCT01723254|63274839|FG007|Overall Study|Conflict with work schedule|1|||
33707977|NCT01723254|63274832|FG000|Overall Study|Personal issues|0|||
33707978|NCT01723254|63274833|FG001|Overall Study|Personal issues|0|||
33707979|NCT01723254|63274834|FG002|Overall Study|Personal issues|0|||
33707980|NCT01723254|63274835|FG003|Overall Study|Personal issues|0|||
33707981|NCT01723254|63274836|FG004|Overall Study|Personal issues|0|||
33707982|NCT01723254|63274837|FG005|Overall Study|Personal issues|1|||
33707983|NCT01723254|63274838|FG006|Overall Study|Personal issues|0|||
33707984|NCT01723254|63274839|FG007|Overall Study|Personal issues|0|||
33707985|NCT01723254|63274832|FG000|Overall Study|No longer have time to participate|0|||
33707986|NCT01723254|63274833|FG001|Overall Study|No longer have time to participate|0|||
33707987|NCT01723254|63274834|FG002|Overall Study|No longer have time to participate|0|||
33707988|NCT01723254|63274835|FG003|Overall Study|No longer have time to participate|1|||
33707989|NCT01723254|63274836|FG004|Overall Study|No longer have time to participate|0|||
33707990|NCT01723254|63274837|FG005|Overall Study|No longer have time to participate|0|||
33707991|NCT01723254|63274838|FG006|Overall Study|No longer have time to participate|0|||
33707992|NCT01723254|63274839|FG007|Overall Study|No longer have time to participate|0|||
33707993|NCT01723254|63274832|FG000|Overall Study|Move/Left to another country/city|0|||
33707994|NCT01723254|63274833|FG001|Overall Study|Move/Left to another country/city|0|||
33707995|NCT01723254|63274834|FG002|Overall Study|Move/Left to another country/city|2|||
33707996|NCT01723254|63274835|FG003|Overall Study|Move/Left to another country/city|1|||
33707997|NCT01723254|63274836|FG004|Overall Study|Move/Left to another country/city|1|||
33707998|NCT01723254|63274837|FG005|Overall Study|Move/Left to another country/city|0|||
33707999|NCT01723254|63274838|FG006|Overall Study|Move/Left to another country/city|0|||
33708000|NCT01723254|63274839|FG007|Overall Study|Move/Left to another country/city|0|||
33708001|NCT01723254|63274832|FG000|Overall Study|Protocol Violation|0|||
33708002|NCT01723254|63274833|FG001|Overall Study|Protocol Violation|1|||
33708003|NCT01723254|63274834|FG002|Overall Study|Protocol Violation|0|||
33708004|NCT01723254|63274835|FG003|Overall Study|Protocol Violation|0|||
33708005|NCT01723254|63274836|FG004|Overall Study|Protocol Violation|0|||
33708006|NCT01723254|63274837|FG005|Overall Study|Protocol Violation|0|||
33708007|NCT01723254|63274838|FG006|Overall Study|Protocol Violation|0|||
33708008|NCT01723254|63274839|FG007|Overall Study|Protocol Violation|0|||
33708009|NCT01723254|63274832|FG000|Overall Study|Withdrawal by Subject|1|||
33708010|NCT01723254|63274833|FG001|Overall Study|Withdrawal by Subject|2|||
33708011|NCT01723254|63274834|FG002|Overall Study|Withdrawal by Subject|1|||
33708012|NCT01723254|63274835|FG003|Overall Study|Withdrawal by Subject|0|||
33708013|NCT01723254|63274836|FG004|Overall Study|Withdrawal by Subject|1|||
33708014|NCT01723254|63274837|FG005|Overall Study|Withdrawal by Subject|1|||
33708015|NCT01723254|63274838|FG006|Overall Study|Withdrawal by Subject|1|||
33708016|NCT01723254|63274839|FG007|Overall Study|Withdrawal by Subject|2|||
33708017|NCT01722162|63274859|FG000|Overall Study|Withdrawal by Subject|1|||
33708018|NCT01722162|63274860|FG001|Overall Study|Withdrawal by Subject|1|||
33708019|NCT01722162|63274859|FG000|Overall Study|Found ineligible|1|||
33708020|NCT01722162|63274860|FG001|Overall Study|Found ineligible|0|||
33708021|NCT01722162|63274859|FG000|Overall Study|Unrelated to study adverse event|2|||
33708022|NCT01722162|63274860|FG001|Overall Study|Unrelated to study adverse event|2|||
33708023|NCT01722162|63274859|FG000|Overall Study|Adverse Event|1|||
33708024|NCT01722162|63274860|FG001|Overall Study|Adverse Event|1|||
33708025|NCT01722162|63274859|FG000|Overall Study|Insurance denial post enrollment|0|||
33708026|NCT01722162|63274860|FG001|Overall Study|Insurance denial post enrollment|1|||
33708027|NCT01722162|63274859|FG000|Overall Study|Noncompliance|0|||
33708028|NCT01722162|63274860|FG001|Overall Study|Noncompliance|1|||
33708029|NCT01721772|63274868|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
33708030|NCT01721772|63274869|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
33708031|NCT01721772|63274868|FG000|Pre-Treatment|Poor/non-compliance|0|||
33708032|NCT01721772|63274869|FG001|Pre-Treatment|Poor/non-compliance|1|||
33708033|NCT01721772|63274868|FG000|Pre-Treatment|Participant withdrew consent|0|||
33708034|NCT01721772|63274869|FG001|Pre-Treatment|Participant withdrew consent|1|||
33708035|NCT01721772|63274868|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
33708036|NCT01721772|63274869|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
33708037|NCT01721772|63274868|FG000|Treatment|Disease progression|119|||
33708038|NCT01721772|63274869|FG001|Treatment|Disease progression|168|||
33708039|NCT01721772|63274868|FG000|Treatment|Study drug toxicity|19|||
33708040|NCT01721772|63274869|FG001|Treatment|Study drug toxicity|10|||
33708041|NCT01721772|63274868|FG000|Treatment|Adverse event unrelated to study drug|7|||
33708042|NCT01721772|63274869|FG001|Treatment|Adverse event unrelated to study drug|7|||
33708043|NCT01721772|63274868|FG000|Treatment|Maximum clinical benefit|16|||
33708044|NCT01721772|63274869|FG001|Treatment|Maximum clinical benefit|4|||
33708045|NCT01721772|63274868|FG000|Treatment|Other|19|||
33708046|NCT01721772|63274869|FG001|Treatment|Other|2|||
33708047|NCT01721772|63274868|FG000|Treatment|Participant withdrew consent|2|||
33708048|NCT01721772|63274869|FG001|Treatment|Participant withdrew consent|5|||
33708049|NCT01721772|63274868|FG000|Treatment|Participant request to discontinue study treatment|21|||
33708050|NCT01721772|63274869|FG001|Treatment|Participant request to discontinue study treatment|8|||
33708051|NCT01721772|63274868|FG000|Treatment|Death|1|||
33708052|NCT01721772|63274869|FG001|Treatment|Death|0|||
33708053|NCT01721772|63274868|FG000|Treatment|Not reported|1|||
33708054|NCT01721772|63274869|FG001|Treatment|Not reported|0|||
33708055|NCT01721772|63274868|FG000|Treatment|Poor/non-compliance|1|||
33708056|NCT01721772|63274869|FG001|Treatment|Poor/non-compliance|0|||
33708057|NCT01721772|63274868|FG000|Treatment|Lost to Follow-up|0|||
33708058|NCT01721772|63274869|FG001|Treatment|Lost to Follow-up|1|||
33708059|NCT01702428|63274879|FG000|Overall Study|Adverse Event|2|||
33708060|NCT01702428|63274880|FG001|Overall Study|Adverse Event|0|||
33708061|NCT01702428|63274881|FG002|Overall Study|Adverse Event|0|||
33708062|NCT01702428|63274882|FG003|Overall Study|Adverse Event|0|||
33708063|NCT01702428|63274879|FG000|Overall Study|Lost to Follow-up|33|||
33708064|NCT01702428|63274880|FG001|Overall Study|Lost to Follow-up|41|||
33708065|NCT01702428|63274881|FG002|Overall Study|Lost to Follow-up|37|||
33708066|NCT01702428|63274882|FG003|Overall Study|Lost to Follow-up|44|||
33708067|NCT01702428|63274879|FG000|Overall Study|Parents cannot assist to site|1|||
33708068|NCT01702428|63274880|FG001|Overall Study|Parents cannot assist to site|0|||
33708069|NCT01702428|63274881|FG002|Overall Study|Parents cannot assist to site|1|||
33708070|NCT01702428|63274882|FG003|Overall Study|Parents cannot assist to site|0|||
33708071|NCT01702428|63274879|FG000|Overall Study|Lost Coverage|0|||
33708072|NCT01702428|63274880|FG001|Overall Study|Lost Coverage|0|||
33708073|NCT01702428|63274881|FG002|Overall Study|Lost Coverage|0|||
33708074|NCT01702428|63274882|FG003|Overall Study|Lost Coverage|1|||
33708075|NCT01702428|63274879|FG000|Overall Study|Lost Health Plan|3|||
33708076|NCT01702428|63274880|FG001|Overall Study|Lost Health Plan|5|||
33708077|NCT01702428|63274881|FG002|Overall Study|Lost Health Plan|0|||
33708078|NCT01702428|63274882|FG003|Overall Study|Lost Health Plan|2|||
33708079|NCT01702428|63274879|FG000|Overall Study|Mother transferred care|0|||
33708080|NCT01702428|63274880|FG001|Overall Study|Mother transferred care|1|||
33708081|NCT01702428|63274881|FG002|Overall Study|Mother transferred care|0|||
33708082|NCT01702428|63274882|FG003|Overall Study|Mother transferred care|0|||
33708083|NCT01702428|63274879|FG000|Overall Study|Parents too busy|1|||
33708084|NCT01702428|63274880|FG001|Overall Study|Parents too busy|0|||
33708085|NCT01702428|63274881|FG002|Overall Study|Parents too busy|0|||
33708086|NCT01702428|63274882|FG003|Overall Study|Parents too busy|0|||
33708087|NCT01702428|63274879|FG000|Overall Study|Protocol Violation|3|||
33708088|NCT01702428|63274880|FG001|Overall Study|Protocol Violation|0|||
33708089|NCT01702428|63274881|FG002|Overall Study|Protocol Violation|1|||
33708090|NCT01702428|63274882|FG003|Overall Study|Protocol Violation|0|||
33708091|NCT01702428|63274879|FG000|Overall Study|Withdrawal by Subject|21|||
33708092|NCT01702428|63274880|FG001|Overall Study|Withdrawal by Subject|23|||
33708093|NCT01702428|63274881|FG002|Overall Study|Withdrawal by Subject|14|||
33708094|NCT01702428|63274882|FG003|Overall Study|Withdrawal by Subject|10|||
33708095|NCT01701258|63274903|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
33708096|NCT01701258|63274904|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
33708097|NCT01701258|63274905|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
33708098|NCT01701258|63274906|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
33708099|NCT01701258|63274907|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
33708100|NCT01701258|63274908|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
33708101|NCT01701258|63274909|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
33708102|NCT01701258|63274910|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
33708103|NCT01701258|63274911|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
33708104|NCT01701258|63274912|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
33708105|NCT01701258|63274913|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
33708106|NCT01701258|63274914|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
33708107|NCT01701258|63274915|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
33708108|NCT01701258|63274903|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
33708109|NCT01701258|63274904|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
33708110|NCT01701258|63274905|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
33708111|NCT01701258|63274906|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
33708112|NCT01701258|63274907|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
33708113|NCT01701258|63274908|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
33708114|NCT01701258|63274909|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
33708115|NCT01701258|63274910|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
33708116|NCT01701258|63274911|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
33708117|NCT01701258|63274912|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
33708118|NCT01701258|63274913|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
33708119|NCT01701258|63274914|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
33597054|NCT01928758|62996030|FG001|Overall Study|Adverse Event|5|||
33597055|NCT01928758|62996029|FG000|Overall Study|Protocol Violation|3|||
33597056|NCT01928758|62996030|FG001|Overall Study|Protocol Violation|4|||
33597057|NCT01910116|62996039|FG000|Overall Study|Adverse Event|0|||
33597058|NCT01910116|62996040|FG001|Overall Study|Adverse Event|3|||
33597059|NCT01910116|62996039|FG000|Overall Study|Lack of Efficacy|3|||
33597060|NCT01910116|62996040|FG001|Overall Study|Lack of Efficacy|4|||
33597061|NCT01910116|62996039|FG000|Overall Study|Lost to Follow-up|1|||
33597062|NCT01910116|62996040|FG001|Overall Study|Lost to Follow-up|0|||
33597063|NCT01910116|62996039|FG000|Overall Study|Protocol Violation|1|||
33597064|NCT01910116|62996040|FG001|Overall Study|Protocol Violation|2|||
33597065|NCT01910116|62996039|FG000|Overall Study|Withdrawal by Subject|8|||
33597066|NCT01910116|62996040|FG001|Overall Study|Withdrawal by Subject|3|||
33597067|NCT01910116|62996039|FG000|Overall Study|uncertain allocation|1|||
33597068|NCT01910116|62996040|FG001|Overall Study|uncertain allocation|3|||
33597069|NCT01910116|62996039|FG000|Overall Study|incomplete data|0|||
33597070|NCT01910116|62996040|FG001|Overall Study|incomplete data|1|||
33597071|NCT01614886|62996048|FG000|Overall Study|Adverse Event|15|||
33597072|NCT01614886|62996049|FG001|Overall Study|Adverse Event|20|||
33597073|NCT01614886|62996048|FG000|Overall Study|Withdrawal by Subject|4|||
33597074|NCT01614886|62996049|FG001|Overall Study|Withdrawal by Subject|4|||
33597075|NCT01614886|62996048|FG000|Overall Study|Death|1|||
33597076|NCT01614886|62996049|FG001|Overall Study|Death|0|||
33597077|NCT01614886|62996048|FG000|Overall Study|Protocol deviation|0|||
33597078|NCT01614886|62996049|FG001|Overall Study|Protocol deviation|2|||
33597079|NCT01880554|62996055|FG000|Overall Study|Protocol Violation|14|||
33597080|NCT01880554|62996055|FG000|Overall Study|Simon's design requirements|2|||
33597081|NCT02100657|62996063|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
33597082|NCT02100657|62996064|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
33597083|NCT02100657|62996065|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
33597084|NCT02100657|62996063|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
33597085|NCT02100657|62996064|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
33597086|NCT02100657|62996065|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
33597087|NCT02100657|62996063|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
33597088|NCT02100657|62996064|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
33708120|NCT01701258|63274915|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
33708121|NCT01701258|63274903|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
33708122|NCT01701258|63274904|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
33708123|NCT01701258|63274905|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
33708124|NCT01701258|63274906|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
33597089|NCT02100657|62996065|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
33708125|NCT01701258|63274907|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
33708126|NCT01701258|63274908|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
33708127|NCT01701258|63274909|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
33708128|NCT01701258|63274910|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
33708129|NCT01701258|63274911|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
33708130|NCT01701258|63274912|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
33708131|NCT01701258|63274913|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
33708132|NCT01701258|63274914|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
33708133|NCT01701258|63274915|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
33708134|NCT01701258|63274903|FG000|Assessment and Scheduling|Investigator Terminated|2|||
33708135|NCT01701258|63274904|FG001|Assessment and Scheduling|Investigator Terminated|0|||
33708136|NCT01701258|63274905|FG002|Assessment and Scheduling|Investigator Terminated|0|||
33708137|NCT01701258|63274906|FG003|Assessment and Scheduling|Investigator Terminated|0|||
33708138|NCT01701258|63274907|FG004|Assessment and Scheduling|Investigator Terminated|0|||
33708139|NCT01701258|63274908|FG005|Assessment and Scheduling|Investigator Terminated|0|||
33708140|NCT01701258|63274909|FG006|Assessment and Scheduling|Investigator Terminated|0|||
33708141|NCT01701258|63274910|FG007|Assessment and Scheduling|Investigator Terminated|0|||
33708142|NCT01701258|63274911|FG008|Assessment and Scheduling|Investigator Terminated|0|||
33708143|NCT01701258|63274912|FG009|Assessment and Scheduling|Investigator Terminated|0|||
33708144|NCT01701258|63274913|FG010|Assessment and Scheduling|Investigator Terminated|0|||
33708145|NCT01701258|63274914|FG011|Assessment and Scheduling|Investigator Terminated|0|||
33708146|NCT01701258|63274915|FG012|Assessment and Scheduling|Investigator Terminated|0|||
33708147|NCT01700946|63274945|FG000|Overall Study|Lost to Follow-up|1|||
33708148|NCT01700946|63274946|FG001|Overall Study|Lost to Follow-up|0|||
33708149|NCT01700946|63274945|FG000|Overall Study|Physician Decision|7|||
33708150|NCT01700946|63274946|FG001|Overall Study|Physician Decision|12|||
33708151|NCT01700946|63274945|FG000|Overall Study|Withdrawal by Subject|0|||
33708152|NCT01700946|63274946|FG001|Overall Study|Withdrawal by Subject|2|||
33708153|NCT01700946|63274945|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
33708154|NCT01700946|63274946|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
33708155|NCT01700946|63274945|FG000|Overall Study|Relapse|2|||
33708156|NCT01700946|63274946|FG001|Overall Study|Relapse|1|||
33708157|NCT01700946|63274945|FG000|Overall Study|Unacceptable toxicity|1|||
33708158|NCT01700946|63274946|FG001|Overall Study|Unacceptable toxicity|0|||
33708159|NCT01748994|63274958|FG000|Overall Study|Lost to Follow-up|8|||
33708160|NCT01748994|63274959|FG001|Overall Study|Lost to Follow-up|6|||
33708161|NCT01721070|63274965|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
33708162|NCT01748760|63274974|FG000|Overall Study|Withdrawal by Subject|1|||
33708163|NCT01748760|63274975|FG001|Overall Study|Withdrawal by Subject|1|||
33708164|NCT01748760|63274974|FG000|Overall Study|Lost to Follow-up|5|||
33708165|NCT01748760|63274975|FG001|Overall Study|Lost to Follow-up|1|||
33708166|NCT01748292|63274983|FG000|Overall Study|Adverse Event|2|||
33708167|NCT01748292|63274984|FG001|Overall Study|Adverse Event|4|||
33708168|NCT01748292|63274983|FG000|Overall Study|Lost to Follow-up|0|||
33708169|NCT01748292|63274984|FG001|Overall Study|Lost to Follow-up|3|||
33708170|NCT01748292|63274983|FG000|Overall Study|Death|0|||
33708171|NCT01748292|63274984|FG001|Overall Study|Death|3|||
33708172|NCT01748292|63274983|FG000|Overall Study|Withdrawal by Subject|0|||
33708173|NCT01748292|63274984|FG001|Overall Study|Withdrawal by Subject|2|||
33708174|NCT01720602|63274990|FG000|Overall Study|Adverse Event|3|||
33708175|NCT01720602|63274990|FG000|Overall Study|Progressive disease on therapy|2|||
33708176|NCT01746732|63274994|FG000|Lead-In Period|Withdrawal by Subject|1|||
33708177|NCT01746732|63274995|FG001|Lead-In Period|Withdrawal by Subject|0|||
33708178|NCT01746732|63274996|FG002|Lead-In Period|Withdrawal by Subject|0|||
33708179|NCT01746732|63274994|FG000|Period 1|Physician Decision|0|||
33708180|NCT01746732|63274995|FG001|Period 1|Physician Decision|1|||
33708181|NCT01746732|63274996|FG002|Period 1|Physician Decision|0|||
33708182|NCT01746732|63274994|FG000|Period 2|Withdrawal by Subject|0|||
33708183|NCT01746732|63274995|FG001|Period 2|Withdrawal by Subject|0|||
33708184|NCT01746732|63274996|FG002|Period 2|Withdrawal by Subject|2|||
33708185|NCT01746732|63274994|FG000|Period 2|Adverse Event|0|||
33708186|NCT01746732|63274995|FG001|Period 2|Adverse Event|0|||
33310766|NCT01233258|62686172|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
33310767|NCT01233258|62686173|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
33310768|NCT01232868|62686190|FG000|Overall Study|Lost to Follow-up|2|||
33310769|NCT01232868|62686191|FG001|Overall Study|Lost to Follow-up|4|||
33310770|NCT01232790|62686197|FG000|Randomization|Withdrawal by Subject|2|||
33310771|NCT01232790|62686198|FG001|Randomization|Withdrawal by Subject|0|||
33310772|NCT01232790|62686197|FG000|Randomization|Protocol Violation|0|||
33310773|NCT01232790|62686198|FG001|Randomization|Protocol Violation|1|||
33310774|NCT01232790|62686197|FG000|Randomization|Physician Decision|0|||
33310775|NCT01232790|62686198|FG001|Randomization|Physician Decision|1|||
33310776|NCT01232790|62686197|FG000|Initial Assessment|Withdrawal by Subject|0|||
33310777|NCT01232790|62686198|FG001|Initial Assessment|Withdrawal by Subject|1|||
33310778|NCT01232790|62686197|FG000|First Crossover|Withdrawal by Subject|1|||
33310779|NCT01232790|62686198|FG001|First Crossover|Withdrawal by Subject|0|||
33310780|NCT01232790|62686197|FG000|Second Crossover|Withdrawal by Subject|1|||
33310781|NCT01232790|62686198|FG001|Second Crossover|Withdrawal by Subject|2|||
33310782|NCT01232556|62686216|FG000|Overall Study|Withdrawal by Subject|21|||
33310783|NCT01232556|62686217|FG001|Overall Study|Withdrawal by Subject|17|||
33310784|NCT01232556|62686216|FG000|Overall Study|Death|97|||
33310785|NCT01232556|62686217|FG001|Overall Study|Death|97|||
33310786|NCT01232556|62686216|FG000|Overall Study|Lost to Follow-up|0|||
33310787|NCT01232556|62686217|FG001|Overall Study|Lost to Follow-up|2|||
33310788|NCT01232556|62686216|FG000|Overall Study|Terminated by Sponsor|35|||
33310789|NCT01232556|62686217|FG001|Overall Study|Terminated by Sponsor|51|||
33310790|NCT01232556|62686216|FG000|Overall Study|Other|6|||
33310791|NCT01232556|62686217|FG001|Overall Study|Other|4|||
33310792|NCT00946153|62686228|FG000|Phase 2|Adverse Event|0|||
33310793|NCT00946153|62686229|FG001|Phase 2|Adverse Event|0|||
33310794|NCT00946153|62686230|FG002|Phase 2|Adverse Event|0|||
33310795|NCT00946153|62686231|FG003|Phase 2|Adverse Event|0|||
33310796|NCT00946153|62686232|FG004|Phase 2|Adverse Event|6|||
33310797|NCT00946153|62686228|FG000|Phase 2|Need more reduction of dose|0|||
33310798|NCT00946153|62686229|FG001|Phase 2|Need more reduction of dose|0|||
33310799|NCT00946153|62686230|FG002|Phase 2|Need more reduction of dose|0|||
33310800|NCT00946153|62686231|FG003|Phase 2|Need more reduction of dose|0|||
33310801|NCT00946153|62686232|FG004|Phase 2|Need more reduction of dose|2|||
33310802|NCT00946153|62686228|FG000|Phase 2|Physician Decision|0|||
33310803|NCT00946153|62686229|FG001|Phase 2|Physician Decision|0|||
33310804|NCT00946153|62686230|FG002|Phase 2|Physician Decision|0|||
33310805|NCT00946153|62686231|FG003|Phase 2|Physician Decision|0|||
33310806|NCT00946153|62686232|FG004|Phase 2|Physician Decision|1|||
33310807|NCT00946153|62686228|FG000|Phase 2|14 days washout for recovery due to AE|0|||
33310808|NCT00946153|62686229|FG001|Phase 2|14 days washout for recovery due to AE|0|||
33310809|NCT00946153|62686230|FG002|Phase 2|14 days washout for recovery due to AE|0|||
33310810|NCT00946153|62686231|FG003|Phase 2|14 days washout for recovery due to AE|0|||
33310811|NCT00946153|62686232|FG004|Phase 2|14 days washout for recovery due to AE|4|||
33310812|NCT01160289|62686254|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
33310813|NCT01160289|62686255|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
33310814|NCT01160289|62686256|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
33310815|NCT01160289|62686257|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
33310816|NCT01160289|62686258|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
33310817|NCT01160289|62686259|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
33310818|NCT01160289|62686254|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
33310819|NCT01160289|62686255|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
33310820|NCT01160289|62686256|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
33310821|NCT01160289|62686257|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
33310822|NCT01160289|62686258|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
33310823|NCT01160289|62686259|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
33310824|NCT01160289|62686254|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
33310825|NCT01160289|62686255|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
33310826|NCT01160289|62686256|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
33310827|NCT01160289|62686257|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
33310828|NCT01160289|62686258|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
33310829|NCT01160289|62686259|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
33310830|NCT01160289|62686254|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
33310831|NCT01160289|62686255|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
33310832|NCT01160289|62686256|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
33310833|NCT01160289|62686257|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
33310834|NCT01160289|62686258|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
33310835|NCT01160289|62686259|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
33310836|NCT01160289|62686254|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
33310837|NCT01160289|62686255|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
33310838|NCT01160289|62686256|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
33310839|NCT01160289|62686257|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
33310840|NCT01160289|62686258|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
33310841|NCT01160289|62686259|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
33310842|NCT01160289|62686254|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
33310843|NCT01160289|62686255|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
33310844|NCT01160289|62686256|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
33310845|NCT01160289|62686257|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
33310846|NCT01160289|62686258|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
33310847|NCT01160289|62686259|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
33310848|NCT01160289|62686254|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
33310849|NCT01160289|62686255|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
33310850|NCT01160289|62686256|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
33310851|NCT01160289|62686257|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
33310852|NCT01160289|62686258|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
33310853|NCT01160289|62686259|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
33310854|NCT01160289|62686254|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
33310855|NCT01160289|62686255|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
33310856|NCT01160289|62686256|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
33310857|NCT01160289|62686257|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
33401451|NCT00256867|62780474|FG000|Overall Study|Withdrawal by Subject|0|||
33401452|NCT00256867|62780475|FG001|Overall Study|Withdrawal by Subject|0|||
33401453|NCT00256867|62780476|FG002|Overall Study|Withdrawal by Subject|1|||
33401454|NCT00256867|62780477|FG003|Overall Study|Withdrawal by Subject|1|||
33401455|NCT00256867|62780478|FG004|Overall Study|Withdrawal by Subject|2|||
33401456|NCT00256867|62780479|FG005|Overall Study|Withdrawal by Subject|2|||
33401457|NCT00256867|62780480|FG006|Overall Study|Withdrawal by Subject|3|||
33401458|NCT00256867|62780481|FG007|Overall Study|Withdrawal by Subject|2|||
33401459|NCT00256867|62780474|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
33401460|NCT00256867|62780475|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
33401461|NCT00256867|62780476|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
33401462|NCT00256867|62780477|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
33401463|NCT00256867|62780478|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
33401464|NCT00256867|62780479|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
33401465|NCT00256867|62780480|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
33401466|NCT00256867|62780481|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
33401467|NCT00256867|62780474|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
33401468|NCT00256867|62780475|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
33401469|NCT00256867|62780476|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
33401470|NCT00256867|62780477|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
33401471|NCT00256867|62780478|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
33401472|NCT00256867|62780479|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
33401473|NCT00256867|62780480|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
33401474|NCT00256867|62780481|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
33401475|NCT00256867|62780474|FG000|Overall Study|Investigator's Decision|0|||
33401476|NCT00256867|62780475|FG001|Overall Study|Investigator's Decision|0|||
33401477|NCT00256867|62780476|FG002|Overall Study|Investigator's Decision|0|||
33401478|NCT00256867|62780477|FG003|Overall Study|Investigator's Decision|0|||
33401479|NCT00256867|62780478|FG004|Overall Study|Investigator's Decision|1|||
33401480|NCT00256867|62780479|FG005|Overall Study|Investigator's Decision|0|||
33401481|NCT00256867|62780480|FG006|Overall Study|Investigator's Decision|0|||
33401482|NCT00256867|62780481|FG007|Overall Study|Investigator's Decision|0|||
33401483|NCT00256867|62780474|FG000|Overall Study|Non-compliance with study medication|0|||
33401484|NCT00256867|62780475|FG001|Overall Study|Non-compliance with study medication|0|||
33401485|NCT00256867|62780476|FG002|Overall Study|Non-compliance with study medication|0|||
33401486|NCT00256867|62780477|FG003|Overall Study|Non-compliance with study medication|0|||
33401487|NCT00256867|62780478|FG004|Overall Study|Non-compliance with study medication|0|||
33401488|NCT00256867|62780479|FG005|Overall Study|Non-compliance with study medication|0|||
33401489|NCT00256867|62780480|FG006|Overall Study|Non-compliance with study medication|0|||
33401490|NCT00256867|62780481|FG007|Overall Study|Non-compliance with study medication|1|||
33401491|NCT00256867|62780474|FG000|Overall Study|Participant travelled Overseas|0|||
33401492|NCT00256867|62780475|FG001|Overall Study|Participant travelled Overseas|1|||
33401493|NCT00256867|62780476|FG002|Overall Study|Participant travelled Overseas|0|||
33401494|NCT00256867|62780477|FG003|Overall Study|Participant travelled Overseas|0|||
33401495|NCT00256867|62780478|FG004|Overall Study|Participant travelled Overseas|0|||
33401496|NCT00256867|62780479|FG005|Overall Study|Participant travelled Overseas|0|||
33401497|NCT00256867|62780480|FG006|Overall Study|Participant travelled Overseas|0|||
33401498|NCT00256867|62780481|FG007|Overall Study|Participant travelled Overseas|0|||
33401499|NCT00256867|62780474|FG000|Overall Study|Participant out of assessment window|0|||
33401500|NCT00256867|62780475|FG001|Overall Study|Participant out of assessment window|0|||
33401501|NCT00256867|62780476|FG002|Overall Study|Participant out of assessment window|1|||
33401502|NCT00256867|62780477|FG003|Overall Study|Participant out of assessment window|0|||
33401503|NCT00256867|62780478|FG004|Overall Study|Participant out of assessment window|0|||
33401504|NCT00256867|62780479|FG005|Overall Study|Participant out of assessment window|0|||
33708187|NCT01746732|63274996|FG002|Period 2|Adverse Event|1|||
33708188|NCT01746732|63274994|FG000|Period 2|Lost to Follow-up|0|||
33708189|NCT01746732|63274995|FG001|Period 2|Lost to Follow-up|0|||
33708190|NCT01746732|63274996|FG002|Period 2|Lost to Follow-up|1|||
33708191|NCT01720524|63275006|FG000|Part A|Insufficient Clinical Response|2|||
33708192|NCT01720524|63275007|FG001|Part A|Insufficient Clinical Response|4|||
33708193|NCT01720524|63275006|FG000|Part A|Adverse Event|2|||
33708194|NCT01720524|63275007|FG001|Part A|Adverse Event|2|||
33708195|NCT01720524|63275006|FG000|Part A|Death|2|||
33708196|NCT01720524|63275007|FG001|Part A|Death|1|||
33708197|NCT01720524|63275006|FG000|Part A|Lost to Follow-up|0|||
33708198|NCT01720524|63275007|FG001|Part A|Lost to Follow-up|1|||
33708199|NCT01720524|63275006|FG000|Part A|Missed 28 day follow-up visit|1|||
33708200|NCT01720524|63275007|FG001|Part A|Missed 28 day follow-up visit|1|||
33708201|NCT01720524|63275006|FG000|Part A|Withdrawal by Subject|0|||
33708202|NCT01720524|63275007|FG001|Part A|Withdrawal by Subject|1|||
33708203|NCT01720524|63275006|FG000|Part A|Other|0|||
33708204|NCT01720524|63275007|FG001|Part A|Other|1|||
33708205|NCT01720524|63275006|FG000|Part A|Lost to Follow-up|0|||
33708206|NCT01720524|63275007|FG001|Part A|Lost to Follow-up|1|||
33708207|NCT01720524|63275006|FG000|Part B|No longer willing to participate in study|1|||
33708208|NCT01720524|63275007|FG001|Part B|No longer willing to participate in study|4|||
33708209|NCT01720524|63275006|FG000|Part B|Other|2|||
33708210|NCT01720524|63275007|FG001|Part B|Other|0|||
33708211|NCT01720524|63275006|FG000|Part B|Lost to Follow-up|2|||
33708212|NCT01720524|63275007|FG001|Part B|Lost to Follow-up|3|||
33708213|NCT01720524|63275006|FG000|Part B|Death|0|||
33708214|NCT01720524|63275007|FG001|Part B|Death|2|||
33708215|NCT01720446|63275019|FG000|Overall Study|Lost to Follow-up|12|||
33708216|NCT01720446|63275020|FG001|Overall Study|Lost to Follow-up|6|||
33708217|NCT01720446|63275021|FG002|Overall Study|Lost to Follow-up|16|||
33708218|NCT01720446|63275022|FG003|Overall Study|Lost to Follow-up|16|||
33708219|NCT01720446|63275019|FG000|Overall Study|Withdrawal by Subject|2|||
33708220|NCT01720446|63275020|FG001|Overall Study|Withdrawal by Subject|5|||
33708221|NCT01720446|63275021|FG002|Overall Study|Withdrawal by Subject|4|||
33708222|NCT01720446|63275022|FG003|Overall Study|Withdrawal by Subject|4|||
33708223|NCT01746108|63275038|FG000|Overall Study|Migrated /moved from study area|0|||
33708224|NCT01746108|63275039|FG001|Overall Study|Migrated /moved from study area|1|||
33708225|NCT01746108|63275040|FG002|Overall Study|Migrated /moved from study area|0|||
33708226|NCT01746108|63275038|FG000|Overall Study|Adverse event, non-fatal|0|||
33708227|NCT01746108|63275039|FG001|Overall Study|Adverse event, non-fatal|1|||
33708228|NCT01746108|63275040|FG002|Overall Study|Adverse event, non-fatal|0|||
33708229|NCT01746108|63275038|FG000|Overall Study|Withdrawal by Subject|0|||
33708230|NCT01746108|63275039|FG001|Overall Study|Withdrawal by Subject|1|||
33708231|NCT01746108|63275040|FG002|Overall Study|Withdrawal by Subject|0|||
33708232|NCT01746108|63275038|FG000|Overall Study|Lost to Follow-up|0|||
33708233|NCT01746108|63275039|FG001|Overall Study|Lost to Follow-up|1|||
33708234|NCT01746108|63275040|FG002|Overall Study|Lost to Follow-up|0|||
33708235|NCT01717638|63275069|FG000|Overall Study|Lost to Follow-up|0|||
33708236|NCT01717638|63275070|FG001|Overall Study|Lost to Follow-up|0|||
33708237|NCT01717638|63275071|FG002|Overall Study|Lost to Follow-up|0|||
33708238|NCT01717638|63275072|FG003|Overall Study|Lost to Follow-up|0|||
33708239|NCT01717638|63275073|FG004|Overall Study|Lost to Follow-up|0|||
33708240|NCT01717638|63275074|FG005|Overall Study|Lost to Follow-up|1|||
33708241|NCT01717638|63275075|FG006|Overall Study|Lost to Follow-up|0|||
33708242|NCT01717638|63275076|FG007|Overall Study|Lost to Follow-up|0|||
33708243|NCT01717638|63275077|FG008|Overall Study|Lost to Follow-up|0|||
33708244|NCT01717638|63275078|FG009|Overall Study|Lost to Follow-up|0|||
33708245|NCT01717638|63275079|FG010|Overall Study|Lost to Follow-up|0|||
33708246|NCT01717638|63275080|FG011|Overall Study|Lost to Follow-up|0|||
33708247|NCT01717638|63275081|FG012|Overall Study|Lost to Follow-up|0|||
33708248|NCT01717638|63275069|FG000|Overall Study|Father in hospital|0|||
33708249|NCT01717638|63275070|FG001|Overall Study|Father in hospital|0|||
33708250|NCT01717638|63275071|FG002|Overall Study|Father in hospital|0|||
33708251|NCT01717638|63275072|FG003|Overall Study|Father in hospital|0|||
33708252|NCT01717638|63275073|FG004|Overall Study|Father in hospital|0|||
33708253|NCT01717638|63275074|FG005|Overall Study|Father in hospital|0|||
33708254|NCT01717638|63275075|FG006|Overall Study|Father in hospital|0|||
33708255|NCT01717638|63275076|FG007|Overall Study|Father in hospital|0|||
33708256|NCT01717638|63275077|FG008|Overall Study|Father in hospital|0|||
33708257|NCT01717638|63275078|FG009|Overall Study|Father in hospital|0|||
33708258|NCT01717638|63275079|FG010|Overall Study|Father in hospital|0|||
33708259|NCT01717638|63275080|FG011|Overall Study|Father in hospital|0|||
33708260|NCT01717638|63275081|FG012|Overall Study|Father in hospital|1|||
33708261|NCT01717638|63275069|FG000|Overall Study|Withdrawal by Subject|0|||
33708262|NCT01717638|63275070|FG001|Overall Study|Withdrawal by Subject|1|||
33708263|NCT01717638|63275071|FG002|Overall Study|Withdrawal by Subject|1|||
33708264|NCT01717638|63275072|FG003|Overall Study|Withdrawal by Subject|0|||
33708265|NCT01717638|63275073|FG004|Overall Study|Withdrawal by Subject|1|||
33708266|NCT01717638|63275074|FG005|Overall Study|Withdrawal by Subject|0|||
33708267|NCT01717638|63275075|FG006|Overall Study|Withdrawal by Subject|2|||
33708268|NCT01717638|63275076|FG007|Overall Study|Withdrawal by Subject|1|||
33708269|NCT01717638|63275077|FG008|Overall Study|Withdrawal by Subject|2|||
33708270|NCT01717638|63275078|FG009|Overall Study|Withdrawal by Subject|1|||
33708271|NCT01717638|63275079|FG010|Overall Study|Withdrawal by Subject|0|||
33708272|NCT01717638|63275080|FG011|Overall Study|Withdrawal by Subject|0|||
33708273|NCT01717638|63275081|FG012|Overall Study|Withdrawal by Subject|18|||
33708274|NCT01745094|63275119|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
33708275|NCT01745094|63275120|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
33708276|NCT01745094|63275121|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
33708277|NCT01745094|63275122|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
33708278|NCT01745094|63275119|FG000|Overall Study|Adverse Event|0|||
33708279|NCT01745094|63275120|FG001|Overall Study|Adverse Event|0|||
33708280|NCT01745094|63275121|FG002|Overall Study|Adverse Event|3|||
33708281|NCT01745094|63275122|FG003|Overall Study|Adverse Event|0|||
33708282|NCT01745094|63275119|FG000|Overall Study|Withdrawal by Subject|2|||
33708283|NCT01745094|63275120|FG001|Overall Study|Withdrawal by Subject|0|||
33708284|NCT01745094|63275121|FG002|Overall Study|Withdrawal by Subject|1|||
33708285|NCT01745094|63275122|FG003|Overall Study|Withdrawal by Subject|2|||
33708286|NCT01745094|63275119|FG000|Overall Study|Protocol Violation|1|||
33708287|NCT01745094|63275120|FG001|Overall Study|Protocol Violation|0|||
33708288|NCT01745094|63275121|FG002|Overall Study|Protocol Violation|3|||
33708289|NCT01745094|63275122|FG003|Overall Study|Protocol Violation|1|||
33708290|NCT01745094|63275119|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
33708291|NCT01745094|63275120|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
33708292|NCT01745094|63275121|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
33708293|NCT01745094|63275122|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
33708294|NCT01745094|63275119|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
33708295|NCT01745094|63275120|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
33708296|NCT01745094|63275121|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
33708297|NCT01745094|63275122|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
33708298|NCT01745094|63275119|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
33708299|NCT01745094|63275120|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
33708300|NCT01745094|63275121|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
33708301|NCT01745094|63275122|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
33708302|NCT01697748|63275137|FG000|Overall Study|ineligible skin incision|1|||
33708303|NCT01697748|63275138|FG001|Overall Study|ineligible skin incision|2|||
33708304|NCT01697748|63275137|FG000|Overall Study|ineligible uterine incision|4|||
33708305|NCT01697748|63275138|FG001|Overall Study|ineligible uterine incision|1|||
33708306|NCT01697748|63275137|FG000|Overall Study|Lost to Follow-up|53|||
33708307|NCT01697748|63275138|FG001|Overall Study|Lost to Follow-up|65|||
33708308|NCT01717326|63275164|FG000|Overall Study|Death|0|||
33708309|NCT01717326|63275165|FG001|Overall Study|Death|0|||
33708310|NCT01717326|63275166|FG002|Overall Study|Death|0|||
33708311|NCT01717326|63275167|FG003|Overall Study|Death|0|||
33708312|NCT01717326|63275168|FG004|Overall Study|Death|0|||
33708313|NCT01717326|63275169|FG005|Overall Study|Death|0|||
33708314|NCT01717326|63275170|FG006|Overall Study|Death|0|||
33708315|NCT01717326|63275171|FG007|Overall Study|Death|0|||
33708316|NCT01717326|63275172|FG008|Overall Study|Death|0|||
33708317|NCT01717326|63275173|FG009|Overall Study|Death|0|||
33708318|NCT01717326|63275174|FG010|Overall Study|Death|1|||
33708319|NCT01717326|63275175|FG011|Overall Study|Death|0|||
33708320|NCT01717326|63275176|FG012|Overall Study|Death|0|||
33708321|NCT01717326|63275177|FG013|Overall Study|Death|0|||
33708322|NCT01717326|63275178|FG014|Overall Study|Death|0|||
33708323|NCT01717326|63275179|FG015|Overall Study|Death|0|||
33708324|NCT01717326|63275180|FG016|Overall Study|Death|0|||
33708325|NCT01717326|63275181|FG017|Overall Study|Death|0|||
33708326|NCT01717326|63275182|FG018|Overall Study|Death|0|||
33708327|NCT01717326|63275183|FG019|Overall Study|Death|0|||
33708328|NCT01717326|63275164|FG000|Overall Study|Lost to Follow-up|3|||
33708329|NCT01717326|63275165|FG001|Overall Study|Lost to Follow-up|0|||
33708330|NCT01717326|63275166|FG002|Overall Study|Lost to Follow-up|0|||
33708331|NCT01717326|63275167|FG003|Overall Study|Lost to Follow-up|2|||
33708332|NCT01717326|63275168|FG004|Overall Study|Lost to Follow-up|1|||
33708333|NCT01717326|63275169|FG005|Overall Study|Lost to Follow-up|0|||
33708334|NCT01717326|63275170|FG006|Overall Study|Lost to Follow-up|1|||
33708335|NCT01717326|63275171|FG007|Overall Study|Lost to Follow-up|0|||
33708336|NCT01717326|63275172|FG008|Overall Study|Lost to Follow-up|0|||
33708337|NCT01717326|63275173|FG009|Overall Study|Lost to Follow-up|0|||
33708338|NCT01717326|63275174|FG010|Overall Study|Lost to Follow-up|1|||
33708339|NCT01717326|63275175|FG011|Overall Study|Lost to Follow-up|0|||
33708340|NCT01717326|63275176|FG012|Overall Study|Lost to Follow-up|0|||
33708341|NCT01717326|63275177|FG013|Overall Study|Lost to Follow-up|0|||
33708342|NCT01717326|63275178|FG014|Overall Study|Lost to Follow-up|0|||
33708343|NCT01717326|63275179|FG015|Overall Study|Lost to Follow-up|2|||
33708344|NCT01717326|63275180|FG016|Overall Study|Lost to Follow-up|1|||
33708345|NCT01717326|63275181|FG017|Overall Study|Lost to Follow-up|0|||
33708346|NCT01717326|63275182|FG018|Overall Study|Lost to Follow-up|2|||
33708347|NCT01717326|63275183|FG019|Overall Study|Lost to Follow-up|3|||
33708348|NCT01717326|63275164|FG000|Overall Study|Physician Decision|0|||
33708349|NCT01717326|63275165|FG001|Overall Study|Physician Decision|0|||
33708350|NCT01717326|63275166|FG002|Overall Study|Physician Decision|0|||
33708351|NCT01717326|63275167|FG003|Overall Study|Physician Decision|0|||
33708352|NCT01717326|63275168|FG004|Overall Study|Physician Decision|0|||
33708353|NCT01717326|63275169|FG005|Overall Study|Physician Decision|0|||
33708354|NCT01717326|63275170|FG006|Overall Study|Physician Decision|0|||
33708355|NCT01717326|63275171|FG007|Overall Study|Physician Decision|0|||
33708356|NCT01717326|63275172|FG008|Overall Study|Physician Decision|0|||
33708357|NCT01717326|63275173|FG009|Overall Study|Physician Decision|1|||
33708358|NCT01717326|63275174|FG010|Overall Study|Physician Decision|0|||
33708359|NCT01717326|63275175|FG011|Overall Study|Physician Decision|0|||
33708360|NCT01717326|63275176|FG012|Overall Study|Physician Decision|0|||
33708361|NCT01717326|63275177|FG013|Overall Study|Physician Decision|0|||
33708362|NCT01717326|63275178|FG014|Overall Study|Physician Decision|0|||
33708363|NCT01717326|63275179|FG015|Overall Study|Physician Decision|0|||
33708364|NCT01717326|63275180|FG016|Overall Study|Physician Decision|0|||
33708365|NCT01717326|63275181|FG017|Overall Study|Physician Decision|0|||
33708366|NCT01717326|63275182|FG018|Overall Study|Physician Decision|0|||
33708367|NCT01717326|63275183|FG019|Overall Study|Physician Decision|0|||
33708368|NCT01717326|63275164|FG000|Overall Study|Protocol Violation|0|||
33708369|NCT01717326|63275165|FG001|Overall Study|Protocol Violation|0|||
33708370|NCT01717326|63275166|FG002|Overall Study|Protocol Violation|0|||
33708371|NCT01717326|63275167|FG003|Overall Study|Protocol Violation|0|||
33708372|NCT01717326|63275168|FG004|Overall Study|Protocol Violation|1|||
33708373|NCT01717326|63275169|FG005|Overall Study|Protocol Violation|0|||
33708374|NCT01717326|63275170|FG006|Overall Study|Protocol Violation|0|||
33708375|NCT01717326|63275171|FG007|Overall Study|Protocol Violation|0|||
33708376|NCT01717326|63275172|FG008|Overall Study|Protocol Violation|0|||
33708377|NCT01717326|63275173|FG009|Overall Study|Protocol Violation|0|||
33708378|NCT01717326|63275174|FG010|Overall Study|Protocol Violation|0|||
33708379|NCT01717326|63275175|FG011|Overall Study|Protocol Violation|0|||
33708380|NCT01717326|63275176|FG012|Overall Study|Protocol Violation|0|||
33708381|NCT01717326|63275177|FG013|Overall Study|Protocol Violation|0|||
33708382|NCT01717326|63275178|FG014|Overall Study|Protocol Violation|0|||
33708383|NCT01717326|63275179|FG015|Overall Study|Protocol Violation|0|||
33708384|NCT01717326|63275180|FG016|Overall Study|Protocol Violation|0|||
33708385|NCT01717326|63275181|FG017|Overall Study|Protocol Violation|0|||
33708386|NCT01717326|63275182|FG018|Overall Study|Protocol Violation|0|||
33708387|NCT01717326|63275183|FG019|Overall Study|Protocol Violation|0|||
33708388|NCT01717326|63275164|FG000|Overall Study|Withdrawal by Subject|0|||
33708389|NCT01717326|63275165|FG001|Overall Study|Withdrawal by Subject|1|||
33708390|NCT01717326|63275166|FG002|Overall Study|Withdrawal by Subject|0|||
33708391|NCT01717326|63275167|FG003|Overall Study|Withdrawal by Subject|0|||
33708392|NCT01717326|63275168|FG004|Overall Study|Withdrawal by Subject|0|||
33708393|NCT01717326|63275169|FG005|Overall Study|Withdrawal by Subject|0|||
33708394|NCT01717326|63275170|FG006|Overall Study|Withdrawal by Subject|0|||
33708395|NCT01717326|63275171|FG007|Overall Study|Withdrawal by Subject|0|||
33708396|NCT01717326|63275172|FG008|Overall Study|Withdrawal by Subject|0|||
33708397|NCT01717326|63275173|FG009|Overall Study|Withdrawal by Subject|1|||
33708398|NCT01717326|63275174|FG010|Overall Study|Withdrawal by Subject|0|||
33708399|NCT01717326|63275175|FG011|Overall Study|Withdrawal by Subject|0|||
33708400|NCT01717326|63275176|FG012|Overall Study|Withdrawal by Subject|1|||
33708401|NCT01717326|63275177|FG013|Overall Study|Withdrawal by Subject|0|||
33708402|NCT01717326|63275178|FG014|Overall Study|Withdrawal by Subject|0|||
33708403|NCT01717326|63275179|FG015|Overall Study|Withdrawal by Subject|1|||
33708404|NCT01717326|63275180|FG016|Overall Study|Withdrawal by Subject|0|||
33708405|NCT01717326|63275181|FG017|Overall Study|Withdrawal by Subject|0|||
33708406|NCT01717326|63275182|FG018|Overall Study|Withdrawal by Subject|2|||
33708407|NCT01717326|63275183|FG019|Overall Study|Withdrawal by Subject|3|||
33708408|NCT01697592|63275235|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
33708409|NCT01697592|63275236|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33708410|NCT01697592|63275237|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33708411|NCT01697592|63275238|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33708412|NCT01697592|63275239|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33708413|NCT01697592|63275240|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33708414|NCT01697592|63275241|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33708415|NCT01697592|63275242|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33708416|NCT01697592|63275243|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33708417|NCT01697592|63275244|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33708418|NCT01697592|63275235|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33708419|NCT01697592|63275236|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33708420|NCT01697592|63275237|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33708421|NCT01697592|63275238|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33708422|NCT01697592|63275239|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33708423|NCT01697592|63275240|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
33708424|NCT01697592|63275241|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33708425|NCT01697592|63275242|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33708426|NCT01697592|63275243|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33708427|NCT01697592|63275244|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33708428|NCT01697592|63275235|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
33708429|NCT01697592|63275236|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33708430|NCT01697592|63275237|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33708431|NCT01697592|63275238|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33708432|NCT01697592|63275239|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33708433|NCT01697592|63275240|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33708434|NCT01697592|63275241|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33708435|NCT01697592|63275242|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33708436|NCT01697592|63275243|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33708437|NCT01697592|63275244|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33708438|NCT01697592|63275235|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
33708439|NCT01697592|63275236|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
33708440|NCT01697592|63275237|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
33708441|NCT01697592|63275238|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
33708442|NCT01697592|63275239|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
33708443|NCT01697592|63275240|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
33708444|NCT01697592|63275241|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
33708445|NCT01697592|63275242|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
33708446|NCT01697592|63275243|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
33708447|NCT01697592|63275244|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
33708448|NCT01697592|63275235|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
33708449|NCT01697592|63275236|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
33708450|NCT01697592|63275237|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
33708451|NCT01697592|63275238|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
33708452|NCT01697592|63275239|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
33708453|NCT01697592|63275240|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
33708454|NCT01697592|63275241|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
33708455|NCT01697592|63275242|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
33708456|NCT01697592|63275243|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
33708457|NCT01697592|63275244|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
33708458|NCT01697592|63275235|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
33708459|NCT01697592|63275236|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33708460|NCT01697592|63275237|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33708461|NCT01697592|63275238|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
33708462|NCT01697592|63275239|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33708463|NCT01697592|63275240|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33708464|NCT01697592|63275241|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33708465|NCT01697592|63275242|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33708466|NCT01697592|63275243|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33708467|NCT01697592|63275244|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33708468|NCT01697592|63275235|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
33708469|NCT01697592|63275236|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
33708470|NCT01697592|63275237|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
33708471|NCT01697592|63275238|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
33708472|NCT01697592|63275239|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
33708473|NCT01697592|63275240|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
33708474|NCT01697592|63275241|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
33708475|NCT01697592|63275242|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
33708476|NCT01697592|63275243|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
33708477|NCT01697592|63275244|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
33708478|NCT01697592|63275235|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
33708479|NCT01697592|63275236|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
33708480|NCT01697592|63275237|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
33708481|NCT01697592|63275238|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
33708482|NCT01697592|63275239|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
33708483|NCT01697592|63275240|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
33708484|NCT01697592|63275241|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
33708485|NCT01697592|63275242|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
33708486|NCT01697592|63275243|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
33708487|NCT01697592|63275244|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
33708488|NCT01744782|63275280|FG000|Overall Study|Death|1|||
33708489|NCT01744392|63275284|FG000|Overall Study|Physician Decision|1|||
33708490|NCT01604850|63275291|FG000|Overall Study|Enrolled but never treated|0|||
33708491|NCT01604850|63275292|FG001|Overall Study|Enrolled but never treated|1|||
33708492|NCT01604850|63275291|FG000|Overall Study|Efficacy Failure|50|||
33708493|NCT01604850|63275292|FG001|Overall Study|Efficacy Failure|29|||
33708494|NCT01604850|63275291|FG000|Overall Study|Lost to Follow-up|1|||
33708495|NCT01604850|63275292|FG001|Overall Study|Lost to Follow-up|0|||
33708496|NCT01604850|63275291|FG000|Overall Study|Subject withdrew consent|1|||
33708497|NCT01604850|63275292|FG001|Overall Study|Subject withdrew consent|0|||
33708498|NCT01742286|63275305|FG000|Escalation Phase|Administrative problems|1|||
33708499|NCT01742286|63275306|FG001|Escalation Phase|Administrative problems|1|||
33708500|NCT01742286|63275307|FG002|Escalation Phase|Administrative problems|0|||
33708501|NCT01742286|63275308|FG003|Escalation Phase|Administrative problems|0|||
33708502|NCT01742286|63275309|FG004|Escalation Phase|Administrative problems|0|||
33708503|NCT01742286|63275310|FG005|Escalation Phase|Administrative problems|0|||
33708504|NCT01742286|63275311|FG006|Escalation Phase|Administrative problems|2|||
33708505|NCT01742286|63275305|FG000|Escalation Phase|Adverse Event|0|||
33708506|NCT01742286|63275306|FG001|Escalation Phase|Adverse Event|1|||
33708507|NCT01742286|63275307|FG002|Escalation Phase|Adverse Event|2|||
33708508|NCT01742286|63275308|FG003|Escalation Phase|Adverse Event|0|||
33708509|NCT01742286|63275309|FG004|Escalation Phase|Adverse Event|0|||
33708510|NCT01742286|63275310|FG005|Escalation Phase|Adverse Event|1|||
33708511|NCT01742286|63275311|FG006|Escalation Phase|Adverse Event|0|||
33708512|NCT01742286|63275305|FG000|Escalation Phase|Disease progression|3|||
33708513|NCT01742286|63275306|FG001|Escalation Phase|Disease progression|7|||
33708514|NCT01742286|63275307|FG002|Escalation Phase|Disease progression|4|||
33708515|NCT01742286|63275308|FG003|Escalation Phase|Disease progression|1|||
33708516|NCT01742286|63275309|FG004|Escalation Phase|Disease progression|4|||
33708517|NCT01742286|63275310|FG005|Escalation Phase|Disease progression|3|||
33708518|NCT01742286|63275311|FG006|Escalation Phase|Disease progression|2|||
33708519|NCT01742286|63275305|FG000|Escalation Phase|Death|0|||
33708520|NCT01742286|63275306|FG001|Escalation Phase|Death|0|||
33708521|NCT01742286|63275307|FG002|Escalation Phase|Death|0|||
33708522|NCT01742286|63275308|FG003|Escalation Phase|Death|0|||
33708523|NCT01742286|63275309|FG004|Escalation Phase|Death|0|||
33708524|NCT01742286|63275310|FG005|Escalation Phase|Death|1|||
33708525|NCT01742286|63275311|FG006|Escalation Phase|Death|0|||
33708526|NCT01742286|63275305|FG000|Escalation Phase|Physician Decision|0|||
33708527|NCT01742286|63275306|FG001|Escalation Phase|Physician Decision|3|||
33708528|NCT01742286|63275307|FG002|Escalation Phase|Physician Decision|0|||
33708529|NCT01742286|63275308|FG003|Escalation Phase|Physician Decision|1|||
33708530|NCT01742286|63275309|FG004|Escalation Phase|Physician Decision|0|||
33708531|NCT01742286|63275310|FG005|Escalation Phase|Physician Decision|0|||
33708532|NCT01742286|63275311|FG006|Escalation Phase|Physician Decision|2|||
33708533|NCT01742286|63275305|FG000|Escalation Phase|Subject/guardian decision|1|||
33708534|NCT01742286|63275306|FG001|Escalation Phase|Subject/guardian decision|0|||
33708535|NCT01742286|63275307|FG002|Escalation Phase|Subject/guardian decision|0|||
33708536|NCT01742286|63275308|FG003|Escalation Phase|Subject/guardian decision|0|||
33708537|NCT01742286|63275309|FG004|Escalation Phase|Subject/guardian decision|0|||
33708538|NCT01742286|63275310|FG005|Escalation Phase|Subject/guardian decision|0|||
33708539|NCT01742286|63275311|FG006|Escalation Phase|Subject/guardian decision|0|||
33708540|NCT01742286|63275305|FG000|Expansion Phase|Administrative problems|0|||
33708541|NCT01742286|63275306|FG001|Expansion Phase|Administrative problems|0|||
33708542|NCT01742286|63275307|FG002|Expansion Phase|Administrative problems|0|||
33708543|NCT01742286|63275308|FG003|Expansion Phase|Administrative problems|0|||
33708544|NCT01742286|63275309|FG004|Expansion Phase|Administrative problems|0|||
33708545|NCT01742286|63275310|FG005|Expansion Phase|Administrative problems|0|||
33708546|NCT01742286|63275311|FG006|Expansion Phase|Administrative problems|5|||
33708547|NCT01742286|63275305|FG000|Expansion Phase|Physician Decision|0|||
33708548|NCT01742286|63275306|FG001|Expansion Phase|Physician Decision|0|||
33708549|NCT01742286|63275307|FG002|Expansion Phase|Physician Decision|4|||
33708550|NCT01742286|63275308|FG003|Expansion Phase|Physician Decision|0|||
33708551|NCT01742286|63275309|FG004|Expansion Phase|Physician Decision|0|||
33708552|NCT01742286|63275310|FG005|Expansion Phase|Physician Decision|0|||
33708553|NCT01742286|63275311|FG006|Expansion Phase|Physician Decision|9|||
33708554|NCT01742286|63275305|FG000|Expansion Phase|Adverse Event|0|||
33708555|NCT01742286|63275306|FG001|Expansion Phase|Adverse Event|0|||
33708556|NCT01742286|63275307|FG002|Expansion Phase|Adverse Event|0|||
33708557|NCT01742286|63275308|FG003|Expansion Phase|Adverse Event|0|||
33708558|NCT01742286|63275309|FG004|Expansion Phase|Adverse Event|0|||
33708559|NCT01742286|63275310|FG005|Expansion Phase|Adverse Event|0|||
33708560|NCT01742286|63275311|FG006|Expansion Phase|Adverse Event|6|||
33708561|NCT01742286|63275305|FG000|Expansion Phase|Disease progression|0|||
33708562|NCT01742286|63275306|FG001|Expansion Phase|Disease progression|0|||
33708563|NCT01742286|63275307|FG002|Expansion Phase|Disease progression|3|||
33708564|NCT01742286|63275308|FG003|Expansion Phase|Disease progression|0|||
33708565|NCT01742286|63275309|FG004|Expansion Phase|Disease progression|0|||
33708566|NCT01742286|63275310|FG005|Expansion Phase|Disease progression|0|||
33708567|NCT01742286|63275311|FG006|Expansion Phase|Disease progression|15|||
33708568|NCT01742286|63275305|FG000|Expansion Phase|Withdrawal by Subject|0|||
33708569|NCT01742286|63275306|FG001|Expansion Phase|Withdrawal by Subject|0|||
33708570|NCT01742286|63275307|FG002|Expansion Phase|Withdrawal by Subject|0|||
33708571|NCT01742286|63275308|FG003|Expansion Phase|Withdrawal by Subject|0|||
33708572|NCT01742286|63275309|FG004|Expansion Phase|Withdrawal by Subject|0|||
33708573|NCT01742286|63275310|FG005|Expansion Phase|Withdrawal by Subject|0|||
33708574|NCT01742286|63275311|FG006|Expansion Phase|Withdrawal by Subject|1|||
33708575|NCT01697358|63275336|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
33708576|NCT01697358|63275337|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
33708577|NCT01697358|63275336|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
33708578|NCT01697358|63275337|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
33708579|NCT01697358|63275336|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
33708580|NCT01697358|63275337|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
33708581|NCT01697358|63275336|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
33708582|NCT01697358|63275337|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
33708583|NCT01697358|63275336|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
33708584|NCT01697358|63275337|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
33708585|NCT01697358|63275336|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
33708586|NCT01697358|63275337|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
33708587|NCT01697358|63275336|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
33708588|NCT01697358|63275337|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
33708589|NCT01697358|63275336|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
33708590|NCT01697358|63275337|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
33708591|NCT01697358|63275336|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
33708592|NCT01697358|63275337|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
33708593|NCT01697358|63275336|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
33708594|NCT01697358|63275337|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
33708595|NCT01716234|63275350|FG000|Overall Study|Protocol Violation|0|||
33708596|NCT01716234|63275351|FG001|Overall Study|Protocol Violation|0|||
33708597|NCT01716234|63275352|FG002|Overall Study|Protocol Violation|0|||
33708598|NCT01716234|63275353|FG003|Overall Study|Protocol Violation|1|||
33708599|NCT01716234|63275354|FG004|Overall Study|Protocol Violation|1|||
33708600|NCT01716234|63275355|FG005|Overall Study|Protocol Violation|1|||
33708601|NCT01716234|63275356|FG006|Overall Study|Protocol Violation|0|||
33708602|NCT01716234|63275350|FG000|Overall Study|Lack of Efficacy|0|||
33708603|NCT01716234|63275351|FG001|Overall Study|Lack of Efficacy|0|||
33708604|NCT01716234|63275352|FG002|Overall Study|Lack of Efficacy|0|||
33708605|NCT01716234|63275353|FG003|Overall Study|Lack of Efficacy|1|||
33708606|NCT01716234|63275354|FG004|Overall Study|Lack of Efficacy|0|||
33708607|NCT01716234|63275355|FG005|Overall Study|Lack of Efficacy|0|||
33708608|NCT01716234|63275356|FG006|Overall Study|Lack of Efficacy|0|||
33708609|NCT01716234|63275350|FG000|Overall Study|Did not meet protocol eligibility|0|||
33708610|NCT01716234|63275351|FG001|Overall Study|Did not meet protocol eligibility|0|||
33708611|NCT01716234|63275352|FG002|Overall Study|Did not meet protocol eligibility|1|||
33708612|NCT01716234|63275353|FG003|Overall Study|Did not meet protocol eligibility|0|||
33708613|NCT01716234|63275354|FG004|Overall Study|Did not meet protocol eligibility|0|||
33708614|NCT01716234|63275355|FG005|Overall Study|Did not meet protocol eligibility|4|||
33708615|NCT01716234|63275356|FG006|Overall Study|Did not meet protocol eligibility|0|||
33708616|NCT01716234|63275350|FG000|Overall Study|Adverse Event|7|||
33708617|NCT01716234|63275351|FG001|Overall Study|Adverse Event|10|||
33708618|NCT01716234|63275352|FG002|Overall Study|Adverse Event|2|||
33708619|NCT01716234|63275353|FG003|Overall Study|Adverse Event|8|||
33708620|NCT01716234|63275354|FG004|Overall Study|Adverse Event|3|||
33708621|NCT01716234|63275355|FG005|Overall Study|Adverse Event|6|||
33708622|NCT01716234|63275356|FG006|Overall Study|Adverse Event|0|||
33708623|NCT01716234|63275350|FG000|Overall Study|Withdrawal by Subject|3|||
33708624|NCT01716234|63275351|FG001|Overall Study|Withdrawal by Subject|0|||
33708625|NCT01716234|63275352|FG002|Overall Study|Withdrawal by Subject|2|||
33708626|NCT01716234|63275353|FG003|Overall Study|Withdrawal by Subject|2|||
33708627|NCT01716234|63275354|FG004|Overall Study|Withdrawal by Subject|1|||
33708628|NCT01716234|63275355|FG005|Overall Study|Withdrawal by Subject|3|||
33708629|NCT01716234|63275356|FG006|Overall Study|Withdrawal by Subject|0|||
33708630|NCT01716156|63275375|FG000|Overall Study|Protocol Violation|1|||
33708631|NCT01716156|63275376|FG001|Overall Study|Protocol Violation|0|||
33708632|NCT01716156|63275377|FG002|Overall Study|Protocol Violation|0|||
33708633|NCT01716156|63275375|FG000|Overall Study|Withdrawal by Subject|0|||
33708634|NCT01716156|63275376|FG001|Overall Study|Withdrawal by Subject|1|||
33708635|NCT01716156|63275377|FG002|Overall Study|Withdrawal by Subject|2|||
33708636|NCT01716156|63275375|FG000|Overall Study|Lost to Follow-up|1|||
33708637|NCT01716156|63275376|FG001|Overall Study|Lost to Follow-up|0|||
33708638|NCT01716156|63275377|FG002|Overall Study|Lost to Follow-up|0|||
33708639|NCT01739790|63275391|FG000|Overall Study|Early Trial Termination|2|||
33708640|NCT01739790|63275392|FG001|Overall Study|Early Trial Termination|4|||
33708641|NCT01696032|63275402|FG000|Overall Study|Withdrawal by Subject|0|||
33708642|NCT01696032|63275403|FG001|Overall Study|Withdrawal by Subject|0|||
33708643|NCT01696032|63275404|FG002|Overall Study|Withdrawal by Subject|1|||
33708644|NCT01696032|63275405|FG003|Overall Study|Withdrawal by Subject|2|||
33708645|NCT01696032|63275402|FG000|Overall Study|Death|14|||
33708646|NCT01696032|63275403|FG001|Overall Study|Death|4|||
33708647|NCT01696032|63275404|FG002|Overall Study|Death|43|||
33708648|NCT01696032|63275405|FG003|Overall Study|Death|18|||
33708649|NCT01696032|63275402|FG000|Overall Study|Lost to Follow-up|0|||
33708650|NCT01696032|63275403|FG001|Overall Study|Lost to Follow-up|1|||
33708651|NCT01696032|63275404|FG002|Overall Study|Lost to Follow-up|0|||
33708652|NCT01696032|63275405|FG003|Overall Study|Lost to Follow-up|0|||
33708653|NCT01696032|63275402|FG000|Overall Study|Database lock|0|||
33708654|NCT01696032|63275403|FG001|Overall Study|Database lock|1|||
33708655|NCT01696032|63275404|FG002|Overall Study|Database lock|7|||
33708656|NCT01696032|63275405|FG003|Overall Study|Database lock|2|||
33708657|NCT01695954|63275421|FG000|Overall Study|Withdrawal by Subject|4|||
33708658|NCT01695954|63275422|FG001|Overall Study|Withdrawal by Subject|0|||
33708659|NCT01695954|63275421|FG000|Overall Study|Adverse Event|0|||
33708660|NCT01695954|63275422|FG001|Overall Study|Adverse Event|2|||
33708661|NCT01694706|63275430|FG000|Overall Study|Adverse Event|0|||
33708662|NCT01694706|63275431|FG001|Overall Study|Adverse Event|1|||
33708663|NCT01694706|63275432|FG002|Overall Study|Adverse Event|0|||
33708664|NCT01694706|63275430|FG000|Overall Study|other reason not defined above|1|||
33708665|NCT01694706|63275431|FG001|Overall Study|other reason not defined above|0|||
33708666|NCT01694706|63275432|FG002|Overall Study|other reason not defined above|0|||
33708667|NCT01693692|63275444|FG000|Overall Study|Withdrawal by Subject|12|||
33708668|NCT01693692|63275445|FG001|Overall Study|Withdrawal by Subject|10|||
33708669|NCT01693692|63275446|FG002|Overall Study|Withdrawal by Subject|11|||
33708670|NCT01693692|63275444|FG000|Overall Study|Adverse Event|7|||
33708671|NCT01693692|63275445|FG001|Overall Study|Adverse Event|14|||
33708672|NCT01693692|63275446|FG002|Overall Study|Adverse Event|9|||
33708673|NCT01693692|63275444|FG000|Overall Study|Physician Decision|0|||
33708674|NCT01693692|63275445|FG001|Overall Study|Physician Decision|0|||
33708675|NCT01693692|63275446|FG002|Overall Study|Physician Decision|1|||
33708676|NCT01693692|63275444|FG000|Overall Study|Protocol Violation|5|||
33708677|NCT01693692|63275445|FG001|Overall Study|Protocol Violation|4|||
33708678|NCT01693692|63275446|FG002|Overall Study|Protocol Violation|6|||
33708679|NCT01693692|63275444|FG000|Overall Study|Lost to Follow-up|2|||
33708680|NCT01693692|63275445|FG001|Overall Study|Lost to Follow-up|2|||
33708681|NCT01693692|63275446|FG002|Overall Study|Lost to Follow-up|3|||
33708682|NCT01693692|63275444|FG000|Overall Study|Other|4|||
33708683|NCT01693692|63275445|FG001|Overall Study|Other|4|||
33708684|NCT01693692|63275446|FG002|Overall Study|Other|6|||
33708685|NCT01693614|63275457|FG000|Overall Study|Adverse Event|7|||
33708686|NCT01693614|63275458|FG001|Overall Study|Adverse Event|11|||
33708687|NCT01693614|63275459|FG002|Overall Study|Adverse Event|5|||
33708688|NCT01693614|63275457|FG000|Overall Study|Disease progression|11|||
33708689|NCT01693614|63275458|FG001|Overall Study|Disease progression|8|||
33708690|NCT01693614|63275459|FG002|Overall Study|Disease progression|7|||
33708691|NCT01693614|63275457|FG000|Overall Study|Protocol Violation|5|||
33708692|NCT01693614|63275458|FG001|Overall Study|Protocol Violation|2|||
33708693|NCT01693614|63275459|FG002|Overall Study|Protocol Violation|1|||
33708694|NCT01693614|63275457|FG000|Overall Study|Death|1|||
33708695|NCT01693614|63275458|FG001|Overall Study|Death|0|||
33708696|NCT01693614|63275459|FG002|Overall Study|Death|0|||
33708697|NCT01693614|63275457|FG000|Overall Study|Physician Decision|1|||
33708698|NCT01693614|63275458|FG001|Overall Study|Physician Decision|1|||
33708699|NCT01693614|63275459|FG002|Overall Study|Physician Decision|4|||
33708700|NCT01693614|63275457|FG000|Overall Study|Withdrawal by subject/guardian|0|||
33708701|NCT01693614|63275458|FG001|Overall Study|Withdrawal by subject/guardian|0|||
33708702|NCT01693614|63275459|FG002|Overall Study|Withdrawal by subject/guardian|2|||
33708703|NCT01693614|63275457|FG000|Overall Study|Withdrawal by Subject|1|||
33708704|NCT01693614|63275458|FG001|Overall Study|Withdrawal by Subject|0|||
33708705|NCT01693614|63275459|FG002|Overall Study|Withdrawal by Subject|5|||
33708706|NCT01715298|63275470|FG000|Overall Study|Lost to Follow-up|0|||
33708707|NCT01715298|63275471|FG001|Overall Study|Lost to Follow-up|2|||
33708708|NCT01715298|63275470|FG000|Overall Study|Patient/guardian decision|7|||
33708709|NCT01715298|63275471|FG001|Overall Study|Patient/guardian decision|9|||
33708710|NCT01713582|63275498|FG000|Overall Study|Disease progression|3|||
33708711|NCT01713582|63275499|FG001|Overall Study|Disease progression|3|||
33708712|NCT01713582|63275500|FG002|Overall Study|Disease progression|3|||
33708713|NCT01713582|63275501|FG003|Overall Study|Disease progression|2|||
33708714|NCT01713582|63275502|FG004|Overall Study|Disease progression|3|||
33708715|NCT01713582|63275503|FG005|Overall Study|Disease progression|3|||
33708716|NCT01713582|63275504|FG006|Overall Study|Disease progression|3|||
33708717|NCT01713582|63275505|FG007|Overall Study|Disease progression|3|||
33708718|NCT01713582|63275506|FG008|Overall Study|Disease progression|3|||
33708719|NCT01713582|63275507|FG009|Overall Study|Disease progression|11|||
33708720|NCT01713582|63275508|FG010|Overall Study|Disease progression|10|||
33708721|NCT01713582|63275509|FG011|Overall Study|Disease progression|5|||
33708722|NCT01713582|63275510|FG012|Overall Study|Disease progression|3|||
33708723|NCT01713582|63275511|FG013|Overall Study|Disease progression|3|||
33708724|NCT01713582|63275512|FG014|Overall Study|Disease progression|6|||
33708725|NCT01713582|63275513|FG015|Overall Study|Disease progression|6|||
33708726|NCT01713582|63275514|FG016|Overall Study|Disease progression|5|||
33708727|NCT01713582|63275515|FG017|Overall Study|Disease progression|2|||
33708728|NCT01713582|63275516|FG018|Overall Study|Disease progression|3|||
33708729|NCT01713582|63275517|FG019|Overall Study|Disease progression|5|||
33708730|NCT01713582|63275518|FG020|Overall Study|Disease progression|15|||
33708731|NCT01713582|63275498|FG000|Overall Study|Death|0|||
33708732|NCT01713582|63275499|FG001|Overall Study|Death|0|||
33708733|NCT01713582|63275500|FG002|Overall Study|Death|0|||
33708734|NCT01713582|63275501|FG003|Overall Study|Death|1|||
33708735|NCT01713582|63275502|FG004|Overall Study|Death|1|||
33708736|NCT01713582|63275503|FG005|Overall Study|Death|3|||
33708737|NCT01713582|63275504|FG006|Overall Study|Death|3|||
33708738|NCT01713582|63275505|FG007|Overall Study|Death|2|||
33708739|NCT01713582|63275506|FG008|Overall Study|Death|3|||
33708740|NCT01713582|63275507|FG009|Overall Study|Death|4|||
33708741|NCT01713582|63275508|FG010|Overall Study|Death|3|||
33708742|NCT01713582|63275509|FG011|Overall Study|Death|0|||
33708743|NCT01713582|63275510|FG012|Overall Study|Death|0|||
33708744|NCT01713582|63275511|FG013|Overall Study|Death|0|||
33708745|NCT01713582|63275512|FG014|Overall Study|Death|0|||
33708746|NCT01713582|63275513|FG015|Overall Study|Death|0|||
33708747|NCT01713582|63275514|FG016|Overall Study|Death|0|||
33708748|NCT01713582|63275515|FG017|Overall Study|Death|0|||
33708749|NCT01713582|63275516|FG018|Overall Study|Death|0|||
33708750|NCT01713582|63275517|FG019|Overall Study|Death|0|||
33708751|NCT01713582|63275518|FG020|Overall Study|Death|0|||
33708752|NCT01713582|63275498|FG000|Overall Study|Adverse event-related|0|||
33708753|NCT01713582|63275499|FG001|Overall Study|Adverse event-related|0|||
33708754|NCT01713582|63275500|FG002|Overall Study|Adverse event-related|0|||
33708755|NCT01713582|63275501|FG003|Overall Study|Adverse event-related|0|||
33708756|NCT01713582|63275502|FG004|Overall Study|Adverse event-related|0|||
33708757|NCT01713582|63275503|FG005|Overall Study|Adverse event-related|0|||
33708758|NCT01713582|63275504|FG006|Overall Study|Adverse event-related|0|||
33708759|NCT01713582|63275505|FG007|Overall Study|Adverse event-related|0|||
33708760|NCT01713582|63275506|FG008|Overall Study|Adverse event-related|0|||
33708761|NCT01713582|63275507|FG009|Overall Study|Adverse event-related|1|||
33708762|NCT01713582|63275508|FG010|Overall Study|Adverse event-related|1|||
33708763|NCT01713582|63275509|FG011|Overall Study|Adverse event-related|0|||
33708764|NCT01713582|63275510|FG012|Overall Study|Adverse event-related|0|||
33708765|NCT01713582|63275511|FG013|Overall Study|Adverse event-related|0|||
33708766|NCT01713582|63275512|FG014|Overall Study|Adverse event-related|0|||
33708767|NCT01713582|63275513|FG015|Overall Study|Adverse event-related|0|||
33708768|NCT01713582|63275514|FG016|Overall Study|Adverse event-related|0|||
33708769|NCT01713582|63275515|FG017|Overall Study|Adverse event-related|0|||
33708770|NCT01713582|63275516|FG018|Overall Study|Adverse event-related|1|||
33708771|NCT01713582|63275517|FG019|Overall Study|Adverse event-related|0|||
33708772|NCT01713582|63275518|FG020|Overall Study|Adverse event-related|0|||
33708773|NCT01713582|63275498|FG000|Overall Study|Adverse event-unrelated|0|||
33708774|NCT01713582|63275499|FG001|Overall Study|Adverse event-unrelated|0|||
33708775|NCT01713582|63275500|FG002|Overall Study|Adverse event-unrelated|0|||
33708776|NCT01713582|63275501|FG003|Overall Study|Adverse event-unrelated|0|||
33708777|NCT01713582|63275502|FG004|Overall Study|Adverse event-unrelated|0|||
33708778|NCT01713582|63275503|FG005|Overall Study|Adverse event-unrelated|1|||
33708779|NCT01713582|63275504|FG006|Overall Study|Adverse event-unrelated|1|||
33708780|NCT01713582|63275505|FG007|Overall Study|Adverse event-unrelated|1|||
33708781|NCT01713582|63275506|FG008|Overall Study|Adverse event-unrelated|0|||
33708782|NCT01713582|63275507|FG009|Overall Study|Adverse event-unrelated|0|||
33708783|NCT01713582|63275508|FG010|Overall Study|Adverse event-unrelated|0|||
33708784|NCT01713582|63275509|FG011|Overall Study|Adverse event-unrelated|0|||
33708785|NCT01713582|63275510|FG012|Overall Study|Adverse event-unrelated|0|||
33708786|NCT01713582|63275511|FG013|Overall Study|Adverse event-unrelated|1|||
33708787|NCT01713582|63275512|FG014|Overall Study|Adverse event-unrelated|1|||
33708788|NCT01713582|63275513|FG015|Overall Study|Adverse event-unrelated|0|||
33708789|NCT01713582|63275514|FG016|Overall Study|Adverse event-unrelated|0|||
33708790|NCT01713582|63275515|FG017|Overall Study|Adverse event-unrelated|0|||
33708791|NCT01713582|63275516|FG018|Overall Study|Adverse event-unrelated|0|||
33708792|NCT01713582|63275517|FG019|Overall Study|Adverse event-unrelated|0|||
33708793|NCT01713582|63275518|FG020|Overall Study|Adverse event-unrelated|0|||
33708794|NCT01713582|63275498|FG000|Overall Study|Withdrawal of consent|0|||
33708795|NCT01713582|63275499|FG001|Overall Study|Withdrawal of consent|0|||
33708796|NCT01713582|63275500|FG002|Overall Study|Withdrawal of consent|1|||
33708797|NCT01713582|63275501|FG003|Overall Study|Withdrawal of consent|0|||
33708798|NCT01713582|63275502|FG004|Overall Study|Withdrawal of consent|0|||
33708799|NCT01713582|63275503|FG005|Overall Study|Withdrawal of consent|1|||
33708800|NCT01713582|63275504|FG006|Overall Study|Withdrawal of consent|0|||
33708801|NCT01713582|63275505|FG007|Overall Study|Withdrawal of consent|0|||
33708802|NCT01713582|63275506|FG008|Overall Study|Withdrawal of consent|0|||
33708803|NCT01713582|63275507|FG009|Overall Study|Withdrawal of consent|1|||
33708804|NCT01713582|63275508|FG010|Overall Study|Withdrawal of consent|0|||
33708805|NCT01713582|63275509|FG011|Overall Study|Withdrawal of consent|0|||
33708806|NCT01713582|63275510|FG012|Overall Study|Withdrawal of consent|0|||
33708807|NCT01713582|63275511|FG013|Overall Study|Withdrawal of consent|0|||
33708808|NCT01713582|63275512|FG014|Overall Study|Withdrawal of consent|0|||
33708809|NCT01713582|63275513|FG015|Overall Study|Withdrawal of consent|0|||
33708810|NCT01713582|63275514|FG016|Overall Study|Withdrawal of consent|0|||
33708811|NCT01713582|63275515|FG017|Overall Study|Withdrawal of consent|0|||
33708812|NCT01713582|63275516|FG018|Overall Study|Withdrawal of consent|1|||
33708813|NCT01713582|63275517|FG019|Overall Study|Withdrawal of consent|0|||
33708814|NCT01713582|63275518|FG020|Overall Study|Withdrawal of consent|0|||
33708815|NCT01713582|63275498|FG000|Overall Study|Lack of Efficacy|0|||
33708816|NCT01713582|63275499|FG001|Overall Study|Lack of Efficacy|0|||
33708817|NCT01713582|63275500|FG002|Overall Study|Lack of Efficacy|0|||
33708818|NCT01713582|63275501|FG003|Overall Study|Lack of Efficacy|0|||
33708819|NCT01713582|63275502|FG004|Overall Study|Lack of Efficacy|0|||
33708820|NCT01713582|63275503|FG005|Overall Study|Lack of Efficacy|0|||
33708821|NCT01713582|63275504|FG006|Overall Study|Lack of Efficacy|0|||
33708822|NCT01713582|63275505|FG007|Overall Study|Lack of Efficacy|0|||
33708823|NCT01713582|63275506|FG008|Overall Study|Lack of Efficacy|0|||
33708824|NCT01713582|63275507|FG009|Overall Study|Lack of Efficacy|1|||
33708825|NCT01713582|63275508|FG010|Overall Study|Lack of Efficacy|2|||
33708826|NCT01713582|63275509|FG011|Overall Study|Lack of Efficacy|0|||
33708827|NCT01713582|63275510|FG012|Overall Study|Lack of Efficacy|0|||
33708828|NCT01713582|63275511|FG013|Overall Study|Lack of Efficacy|0|||
33708829|NCT01713582|63275512|FG014|Overall Study|Lack of Efficacy|0|||
33708830|NCT01713582|63275513|FG015|Overall Study|Lack of Efficacy|0|||
33708831|NCT01713582|63275514|FG016|Overall Study|Lack of Efficacy|0|||
33708832|NCT01713582|63275515|FG017|Overall Study|Lack of Efficacy|0|||
33708833|NCT01713582|63275516|FG018|Overall Study|Lack of Efficacy|0|||
33708834|NCT01713582|63275517|FG019|Overall Study|Lack of Efficacy|0|||
33708835|NCT01713582|63275518|FG020|Overall Study|Lack of Efficacy|0|||
33708836|NCT01713582|63275498|FG000|Overall Study|Withdrawal by Subject|0|||
33708837|NCT01713582|63275499|FG001|Overall Study|Withdrawal by Subject|0|||
33708838|NCT01713582|63275500|FG002|Overall Study|Withdrawal by Subject|0|||
33708839|NCT01713582|63275501|FG003|Overall Study|Withdrawal by Subject|0|||
33708840|NCT01713582|63275502|FG004|Overall Study|Withdrawal by Subject|0|||
33708841|NCT01713582|63275503|FG005|Overall Study|Withdrawal by Subject|0|||
33708842|NCT01713582|63275504|FG006|Overall Study|Withdrawal by Subject|0|||
33708843|NCT01713582|63275505|FG007|Overall Study|Withdrawal by Subject|0|||
33708844|NCT01713582|63275506|FG008|Overall Study|Withdrawal by Subject|0|||
33708845|NCT01713582|63275507|FG009|Overall Study|Withdrawal by Subject|0|||
33708846|NCT01713582|63275508|FG010|Overall Study|Withdrawal by Subject|0|||
33708847|NCT01713582|63275509|FG011|Overall Study|Withdrawal by Subject|0|||
33708848|NCT01713582|63275510|FG012|Overall Study|Withdrawal by Subject|0|||
33708849|NCT01713582|63275511|FG013|Overall Study|Withdrawal by Subject|0|||
33708850|NCT01713582|63275512|FG014|Overall Study|Withdrawal by Subject|0|||
33708851|NCT01713582|63275513|FG015|Overall Study|Withdrawal by Subject|0|||
33708852|NCT01713582|63275514|FG016|Overall Study|Withdrawal by Subject|0|||
33708853|NCT01713582|63275515|FG017|Overall Study|Withdrawal by Subject|1|||
33708854|NCT01713582|63275516|FG018|Overall Study|Withdrawal by Subject|0|||
33708855|NCT01713582|63275517|FG019|Overall Study|Withdrawal by Subject|0|||
33708856|NCT01713582|63275518|FG020|Overall Study|Withdrawal by Subject|0|||
33708857|NCT01713582|63275498|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
33708858|NCT01713582|63275499|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
33708859|NCT01713582|63275500|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
33708860|NCT01713582|63275501|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
33708861|NCT01713582|63275502|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
33708862|NCT01713582|63275503|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
33708863|NCT01713582|63275504|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
33708864|NCT01713582|63275505|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
33708865|NCT01713582|63275506|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
33708866|NCT01713582|63275507|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
33708867|NCT01713582|63275508|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
33708868|NCT01713582|63275509|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
33708869|NCT01713582|63275510|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
33708870|NCT01713582|63275511|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
33708871|NCT01713582|63275512|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
33708872|NCT01713582|63275513|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
33708873|NCT01713582|63275514|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
33708874|NCT01713582|63275515|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
33708875|NCT01713582|63275516|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
33708876|NCT01713582|63275517|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
33708877|NCT01713582|63275518|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
33708878|NCT01713582|63275498|FG000|Overall Study|Disease progression and adverse event|0|||
33708879|NCT01713582|63275499|FG001|Overall Study|Disease progression and adverse event|0|||
33708880|NCT01713582|63275500|FG002|Overall Study|Disease progression and adverse event|0|||
33708881|NCT01713582|63275501|FG003|Overall Study|Disease progression and adverse event|0|||
33708882|NCT01713582|63275502|FG004|Overall Study|Disease progression and adverse event|0|||
33708883|NCT01713582|63275503|FG005|Overall Study|Disease progression and adverse event|0|||
33708884|NCT01713582|63275504|FG006|Overall Study|Disease progression and adverse event|0|||
33708885|NCT01713582|63275505|FG007|Overall Study|Disease progression and adverse event|0|||
33708886|NCT01713582|63275506|FG008|Overall Study|Disease progression and adverse event|0|||
33708887|NCT01713582|63275507|FG009|Overall Study|Disease progression and adverse event|0|||
33708888|NCT01713582|63275508|FG010|Overall Study|Disease progression and adverse event|0|||
33708889|NCT01713582|63275509|FG011|Overall Study|Disease progression and adverse event|0|||
33708890|NCT01713582|63275510|FG012|Overall Study|Disease progression and adverse event|0|||
33708891|NCT01713582|63275511|FG013|Overall Study|Disease progression and adverse event|0|||
33708892|NCT01713582|63275512|FG014|Overall Study|Disease progression and adverse event|0|||
33708893|NCT01713582|63275513|FG015|Overall Study|Disease progression and adverse event|0|||
33708894|NCT01713582|63275514|FG016|Overall Study|Disease progression and adverse event|1|||
33708895|NCT01713582|63275515|FG017|Overall Study|Disease progression and adverse event|0|||
33708896|NCT01713582|63275516|FG018|Overall Study|Disease progression and adverse event|0|||
33708897|NCT01713582|63275517|FG019|Overall Study|Disease progression and adverse event|0|||
33708898|NCT01713582|63275518|FG020|Overall Study|Disease progression and adverse event|0|||
33708899|NCT01739400|63275578|FG000|Overall Study|Physician Decision|3|||
33708900|NCT01739400|63275579|FG001|Overall Study|Physician Decision|0|||
33708901|NCT01739400|63275578|FG000|Overall Study|Lost to Follow-up|2|||
33708902|NCT01739400|63275579|FG001|Overall Study|Lost to Follow-up|0|||
33708903|NCT01739400|63275578|FG000|Overall Study|Death|5|||
33708904|NCT01739400|63275579|FG001|Overall Study|Death|2|||
33708905|NCT01739400|63275578|FG000|Overall Study|Withdrawal by Subject|7|||
33708906|NCT01739400|63275579|FG001|Overall Study|Withdrawal by Subject|7|||
33708907|NCT01713348|63275588|FG000|Overall Study|Withdrawal by Subject|3|||
33708908|NCT01713348|63275589|FG001|Overall Study|Withdrawal by Subject|2|||
33708909|NCT01713348|63275590|FG002|Overall Study|Withdrawal by Subject|2|||
33708910|NCT01713348|63275591|FG003|Overall Study|Withdrawal by Subject|0|||
33708911|NCT01713348|63275588|FG000|Overall Study|Lost to Follow-up|1|||
33708912|NCT01713348|63275589|FG001|Overall Study|Lost to Follow-up|0|||
33708913|NCT01713348|63275590|FG002|Overall Study|Lost to Follow-up|0|||
33708914|NCT01713348|63275591|FG003|Overall Study|Lost to Follow-up|0|||
33708915|NCT01737996|63275604|FG000|Overall Study|Adverse Event|0|||
33708916|NCT01737996|63275605|FG001|Overall Study|Adverse Event|1|||
33708917|NCT01737996|63275606|FG002|Overall Study|Adverse Event|1|||
33708918|NCT01737996|63275604|FG000|Overall Study|Withdrawal by Subject|0|||
33708919|NCT01737996|63275605|FG001|Overall Study|Withdrawal by Subject|0|||
33708920|NCT01737996|63275606|FG002|Overall Study|Withdrawal by Subject|1|||
33708921|NCT01713036|63275614|FG000|Overall Study|Death|1|||
33708922|NCT01712334|63275624|FG000|Treatment Period 1|Randomized in Error|0|||
33708923|NCT01712334|63275625|FG001|Treatment Period 1|Randomized in Error|2|||
33708924|NCT01712256|63275631|FG000|Overall Study|Lost to Follow-up|1|||
33708925|NCT01712178|63275637|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
33708926|NCT01712178|63275638|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
33708927|NCT01712178|63275637|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
33708928|NCT01712178|63275638|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
33708929|NCT01712178|63275637|FG000|Overall Study|Lost to Follow-up|0|||
33708930|NCT01712178|63275638|FG001|Overall Study|Lost to Follow-up|1|||
33708931|NCT01693068|63275646|FG000|Randomization Period|On-study|2|||
33708932|NCT01693068|63275647|FG001|Randomization Period|On-study|5|||
33708933|NCT01693068|63275648|FG002|Randomization Period|On-study|0|||
33708934|NCT01693068|63275646|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
33708935|NCT01693068|63275647|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
33708936|NCT01693068|63275648|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
33708937|NCT01691898|63275662|FG000|Overall Study|Death|34|||
33708938|NCT01691898|63275663|FG001|Overall Study|Death|32|||
33708939|NCT01691898|63275664|FG002|Overall Study|Death|6|||
33708940|NCT01691898|63275665|FG003|Overall Study|Death|3|||
33708941|NCT01691898|63275666|FG004|Overall Study|Death|8|||
33708942|NCT01691898|63275667|FG005|Overall Study|Death|31|||
33708943|NCT01691898|63275662|FG000|Overall Study|Adverse Event|0|||
33708944|NCT01691898|63275663|FG001|Overall Study|Adverse Event|1|||
33708945|NCT01691898|63275664|FG002|Overall Study|Adverse Event|0|||
33708946|NCT01691898|63275665|FG003|Overall Study|Adverse Event|1|||
33708947|NCT01691898|63275666|FG004|Overall Study|Adverse Event|1|||
33708948|NCT01691898|63275667|FG005|Overall Study|Adverse Event|0|||
33708949|NCT01691898|63275662|FG000|Overall Study|Progression of Disease|1|||
33708950|NCT01691898|63275663|FG001|Overall Study|Progression of Disease|2|||
33708951|NCT01691898|63275664|FG002|Overall Study|Progression of Disease|1|||
33708952|NCT01691898|63275665|FG003|Overall Study|Progression of Disease|0|||
33708953|NCT01691898|63275666|FG004|Overall Study|Progression of Disease|0|||
33708954|NCT01691898|63275667|FG005|Overall Study|Progression of Disease|1|||
33708955|NCT01691898|63275662|FG000|Overall Study|Lost to Follow-up|3|||
33708956|NCT01691898|63275663|FG001|Overall Study|Lost to Follow-up|1|||
33708957|NCT01691898|63275664|FG002|Overall Study|Lost to Follow-up|0|||
33708958|NCT01691898|63275665|FG003|Overall Study|Lost to Follow-up|0|||
33708959|NCT01691898|63275666|FG004|Overall Study|Lost to Follow-up|1|||
33708960|NCT01691898|63275667|FG005|Overall Study|Lost to Follow-up|0|||
33708961|NCT01691898|63275662|FG000|Overall Study|Withdrawal by Subject|9|||
33708962|NCT01691898|63275663|FG001|Overall Study|Withdrawal by Subject|8|||
33708963|NCT01691898|63275664|FG002|Overall Study|Withdrawal by Subject|2|||
33708964|NCT01691898|63275665|FG003|Overall Study|Withdrawal by Subject|1|||
33708965|NCT01691898|63275666|FG004|Overall Study|Withdrawal by Subject|3|||
33708966|NCT01691898|63275667|FG005|Overall Study|Withdrawal by Subject|3|||
33708967|NCT01691898|63275662|FG000|Overall Study|Non-Compliance|0|||
33708968|NCT01691898|63275663|FG001|Overall Study|Non-Compliance|0|||
33708969|NCT01691898|63275664|FG002|Overall Study|Non-Compliance|0|||
33708970|NCT01691898|63275665|FG003|Overall Study|Non-Compliance|0|||
33708971|NCT01691898|63275666|FG004|Overall Study|Non-Compliance|1|||
33708972|NCT01691898|63275667|FG005|Overall Study|Non-Compliance|0|||
33708973|NCT01737840|63275701|FG000|Overall Study|Diagnosed with an other pathology|2|||
33708974|NCT01737840|63275702|FG001|Overall Study|Diagnosed with an other pathology|2|||
33708975|NCT01691820|63275712|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
33708976|NCT01691820|63275713|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
33708977|NCT01691820|63275712|FG000|Overall Study|Migrated/moved from study area|7|||
33708978|NCT01691820|63275713|FG001|Overall Study|Migrated/moved from study area|4|||
33708979|NCT01691820|63275712|FG000|Overall Study|Lost to Follow-up|6|||
33708980|NCT01691820|63275713|FG001|Overall Study|Lost to Follow-up|17|||
33708981|NCT01691820|63275712|FG000|Overall Study|Other (unspecified)|4|||
33708982|NCT01691820|63275713|FG001|Overall Study|Other (unspecified)|1|||
33708983|NCT01711866|63275723|FG000|Overall Study|Noncompliant|3|||
33708984|NCT01711866|63275723|FG000|Overall Study|Withdrawal by Subject|3|||
33708985|NCT01711866|63275723|FG000|Overall Study|Adverse Event|2|||
33708986|NCT01737762|63275729|FG000|Overall Study|Adverse Event|2|||
33708987|NCT01737762|63275730|FG001|Overall Study|Adverse Event|2|||
33708988|NCT01737762|63275729|FG000|Overall Study|Lost to Follow-up|1|||
33708989|NCT01737762|63275730|FG001|Overall Study|Lost to Follow-up|0|||
33708990|NCT01737762|63275729|FG000|Overall Study|Withdrawal by Subject|2|||
33708991|NCT01737762|63275730|FG001|Overall Study|Withdrawal by Subject|2|||
33708992|NCT01737762|63275729|FG000|Overall Study|Progressive disease|1|||
33708993|NCT01737762|63275730|FG001|Overall Study|Progressive disease|2|||
33708994|NCT01737762|63275729|FG000|Overall Study|Physician Decision|1|||
33708995|NCT01737762|63275730|FG001|Overall Study|Physician Decision|1|||
33708996|NCT01737762|63275729|FG000|Overall Study|Moved from area|2|||
33708997|NCT01737762|63275730|FG001|Overall Study|Moved from area|1|||
33708998|NCT01737762|63275729|FG000|Overall Study|Trial termination|11|||
33708999|NCT01737762|63275730|FG001|Overall Study|Trial termination|9|||
33709000|NCT01691508|63275738|FG000|Overall Study|Adverse Event|3|||
33709001|NCT01691508|63275739|FG001|Overall Study|Adverse Event|3|||
33709002|NCT01691508|63275738|FG000|Overall Study|Withdrawal by Subject|1|||
33709003|NCT01691508|63275739|FG001|Overall Study|Withdrawal by Subject|0|||
33709004|NCT01682460|63275745|FG000|Overall Study|Withdrawal by Subject|2|||
33709005|NCT01682460|63275745|FG000|Overall Study|Did not meet inclusion criteria|2|||
33709006|NCT01691430|63275751|FG000|Overall Study|Death|17|||
33709007|NCT01691430|63275752|FG001|Overall Study|Death|16|||
33709008|NCT01691430|63275751|FG000|Overall Study|Withdrawal by Subject|5|||
33709009|NCT01691430|63275752|FG001|Overall Study|Withdrawal by Subject|1|||
33709010|NCT01691430|63275751|FG000|Overall Study|Lost to Follow-up|0|||
33709011|NCT01691430|63275752|FG001|Overall Study|Lost to Follow-up|3|||
33709012|NCT01709838|63275758|FG000|Overall Study|Withdrawal by Subject|21|||
33709013|NCT01709838|63275758|FG000|Overall Study|Lost to Follow-up|16|||
33709014|NCT01709838|63275758|FG000|Overall Study|Pregnancy|10|||
33709015|NCT01709838|63275758|FG000|Overall Study|Subject/guardian decision|8|||
33709016|NCT01709838|63275758|FG000|Overall Study|Adverse Event|4|||
33709017|NCT01709838|63275758|FG000|Overall Study|Physician Decision|4|||
33709018|NCT01709838|63275758|FG000|Overall Study|Death|3|||
33709019|NCT01709838|63275758|FG000|Overall Study|Protocol Violation|1|||
33709020|NCT01682226|63275764|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
33709021|NCT01682226|63275764|FG000|Overall Study|Participants did not receive treatment|2|||
33709022|NCT01682226|63275764|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
33709023|NCT01688466|63275770|FG000|Overall Study|Withdrawal by Subject|2|||
33709024|NCT01688466|63275771|FG001|Overall Study|Withdrawal by Subject|1|||
33709025|NCT01688466|63275770|FG000|Overall Study|Death|0|||
33709026|NCT01688466|63275771|FG001|Overall Study|Death|1|||
33709027|NCT01688466|63275770|FG000|Overall Study|Adverse Event|0|||
33709028|NCT01688466|63275771|FG001|Overall Study|Adverse Event|4|||
33709029|NCT01688466|63275770|FG000|Overall Study|Not evaluable|0|||
33709030|NCT01688466|63275771|FG001|Overall Study|Not evaluable|1|||
33709031|NCT01682148|63275779|FG000|Overall Study|Withdrawal by Subject|2|||
33709032|NCT01682148|63275780|FG001|Overall Study|Withdrawal by Subject|0|||
33709033|NCT01682148|63275779|FG000|Overall Study|Lost to Follow-up|1|||
33709034|NCT01682148|63275780|FG001|Overall Study|Lost to Follow-up|2|||
33709035|NCT01682148|63275779|FG000|Overall Study|Protocol Violation|1|||
33709036|NCT01682148|63275780|FG001|Overall Study|Protocol Violation|1|||
33709037|NCT01681992|63275794|FG000|Overall Study|Adverse Event|3|||
33709038|NCT01681992|63275795|FG001|Overall Study|Adverse Event|2|||
33709039|NCT01681992|63275796|FG002|Overall Study|Adverse Event|3|||
33709040|NCT01681992|63275794|FG000|Overall Study|Lost to Follow-up|36|||
33709041|NCT01681992|63275795|FG001|Overall Study|Lost to Follow-up|38|||
33709042|NCT01681992|63275796|FG002|Overall Study|Lost to Follow-up|53|||
33709043|NCT01681992|63275794|FG000|Overall Study|As Per Sponsor Decision|0|||
33709044|NCT01681992|63275795|FG001|Overall Study|As Per Sponsor Decision|0|||
33709045|NCT01681992|63275796|FG002|Overall Study|As Per Sponsor Decision|1|||
33709046|NCT01681992|63275794|FG000|Overall Study|Protocol Violation|0|||
33709047|NCT01681992|63275795|FG001|Overall Study|Protocol Violation|0|||
33709048|NCT01681992|63275796|FG002|Overall Study|Protocol Violation|1|||
33709049|NCT01681992|63275794|FG000|Overall Study|Withdrawal by Subject|27|||
33709050|NCT01681992|63275795|FG001|Overall Study|Withdrawal by Subject|30|||
33709051|NCT01681992|63275796|FG002|Overall Study|Withdrawal by Subject|25|||
33709052|NCT01687998|63275806|FG000|Overall Study|Withdrawal by Subject|49|||
33709053|NCT01687998|63275807|FG001|Overall Study|Withdrawal by Subject|51|||
33709054|NCT01687998|63275806|FG000|Overall Study|Known to be Alive at Study End|54|||
33709055|NCT01687998|63275807|FG001|Overall Study|Known to be Alive at Study End|62|||
33709056|NCT01687998|63275806|FG000|Overall Study|Lost to Follow-up|9|||
33709057|NCT01687998|63275807|FG001|Overall Study|Lost to Follow-up|7|||
33709058|NCT01681836|63275813|FG000|Second Intervention|Withdrawal by Subject|0|||
33709059|NCT01681836|63275814|FG001|Second Intervention|Withdrawal by Subject|1|||
33709060|NCT01681368|63275820|FG000|Overall Study|Refused further treatment|1|||
33709061|NCT01681368|63275820|FG000|Overall Study|Refused further follow up|1|||
33709062|NCT01681212|63275824|FG000|Overall Study|No longer met study criteria|5|||
33709063|NCT01681212|63275824|FG000|Overall Study|Administrative reason by sponsor|1|||
33709064|NCT01687296|63275830|FG000|Overall Study|Lack of Efficacy|1|||
33709065|NCT01687296|63275831|FG001|Overall Study|Lack of Efficacy|1|||
33709066|NCT01687296|63275830|FG000|Overall Study|Protocol Violation|0|||
33709067|NCT01687296|63275831|FG001|Overall Study|Protocol Violation|1|||
33709068|NCT01687296|63275830|FG000|Overall Study|Withdrawal by Subject|6|||
33709069|NCT01687296|63275831|FG001|Overall Study|Withdrawal by Subject|3|||
33709070|NCT01568892|63275852|FG000|Open-label Phase|Adverse Event|2|||
33709071|NCT01568892|63275853|FG001|Open-label Phase|Adverse Event|0|||
33709072|NCT01568892|63275852|FG000|Open-label Phase|Lack of Efficacy|4|||
33709073|NCT01568892|63275853|FG001|Open-label Phase|Lack of Efficacy|2|||
33709074|NCT01568892|63275852|FG000|Open-label Phase|Lost to Follow-up|0|||
33709075|NCT01568892|63275853|FG001|Open-label Phase|Lost to Follow-up|1|||
33709076|NCT01568112|63275864|FG000|Overall Study|Randomized But Not Treated|0|||
33709077|NCT01568112|63275865|FG001|Overall Study|Randomized But Not Treated|1|||
33709078|NCT01568112|63275866|FG002|Overall Study|Randomized But Not Treated|0|||
33709079|NCT01568112|63275867|FG003|Overall Study|Randomized But Not Treated|0|||
33709080|NCT01568112|63275864|FG000|Overall Study|Withdrew due to Adverse Event|2|||
33709081|NCT01568112|63275865|FG001|Overall Study|Withdrew due to Adverse Event|4|||
33709082|NCT01568112|63275866|FG002|Overall Study|Withdrew due to Adverse Event|6|||
33709083|NCT01568112|63275867|FG003|Overall Study|Withdrew due to Adverse Event|3|||
33709084|NCT01568112|63275864|FG000|Overall Study|Lost to Follow-up|0|||
33709085|NCT01568112|63275865|FG001|Overall Study|Lost to Follow-up|0|||
33709086|NCT01568112|63275866|FG002|Overall Study|Lost to Follow-up|0|||
33709087|NCT01568112|63275867|FG003|Overall Study|Lost to Follow-up|1|||
33709088|NCT01568112|63275864|FG000|Overall Study|Withdrawal by Subject|2|||
33709089|NCT01568112|63275865|FG001|Overall Study|Withdrawal by Subject|3|||
33709090|NCT01568112|63275866|FG002|Overall Study|Withdrawal by Subject|0|||
33709091|NCT01568112|63275867|FG003|Overall Study|Withdrawal by Subject|7|||
33709092|NCT01568112|63275864|FG000|Overall Study|Withdrawal by Physician|1|||
33709093|NCT01568112|63275865|FG001|Overall Study|Withdrawal by Physician|0|||
33709094|NCT01568112|63275866|FG002|Overall Study|Withdrawal by Physician|1|||
33709095|NCT01568112|63275867|FG003|Overall Study|Withdrawal by Physician|1|||
33709096|NCT01568034|63275878|FG000|Overall Study|Withdrawal by Subject|1|||
33709097|NCT01568034|63275879|FG001|Overall Study|Withdrawal by Subject|0|||
33709098|NCT01568034|63275880|FG002|Overall Study|Withdrawal by Subject|0|||
33709099|NCT01568034|63275881|FG003|Overall Study|Withdrawal by Subject|0|||
33709100|NCT01687218|63275897|FG000|Overall Study|Withdrawal by Subject|2|||
33709101|NCT01687218|63275898|FG001|Overall Study|Withdrawal by Subject|3|||
33709102|NCT01687218|63275899|FG002|Overall Study|Withdrawal by Subject|0|||
33709103|NCT01687218|63275900|FG003|Overall Study|Withdrawal by Subject|1|||
33709104|NCT01687218|63275901|FG004|Overall Study|Withdrawal by Subject|1|||
33709105|NCT01687218|63275902|FG005|Overall Study|Withdrawal by Subject|0|||
33709106|NCT01687218|63275897|FG000|Overall Study|Relocated, no follow-up planned|1|||
33709107|NCT01687218|63275898|FG001|Overall Study|Relocated, no follow-up planned|0|||
33709108|NCT01687218|63275899|FG002|Overall Study|Relocated, no follow-up planned|1|||
33709109|NCT01687218|63275900|FG003|Overall Study|Relocated, no follow-up planned|1|||
33709110|NCT01687218|63275901|FG004|Overall Study|Relocated, no follow-up planned|0|||
33709111|NCT01687218|63275902|FG005|Overall Study|Relocated, no follow-up planned|0|||
33709112|NCT01686828|63275914|FG000|Overall Study|Physician Decision|1|||
33709113|NCT01686828|63275915|FG001|Overall Study|Physician Decision|0|||
33709114|NCT01686828|63275916|FG002|Overall Study|Physician Decision|0|||
33709115|NCT01686828|63275917|FG003|Overall Study|Physician Decision|0|||
33709116|NCT01686828|63275914|FG000|Overall Study|New Job|0|||
33709117|NCT01686828|63275915|FG001|Overall Study|New Job|1|||
33709118|NCT01686828|63275916|FG002|Overall Study|New Job|0|||
33709119|NCT01686828|63275917|FG003|Overall Study|New Job|0|||
33709120|NCT01686828|63275914|FG000|Overall Study|Weight Loss|0|||
33709121|NCT01686828|63275915|FG001|Overall Study|Weight Loss|0|||
33709122|NCT01686828|63275916|FG002|Overall Study|Weight Loss|1|||
33709123|NCT01686828|63275917|FG003|Overall Study|Weight Loss|0|||
33709124|NCT01686438|63275934|FG000|Overall Study|Lost to Follow-up|8|||
33709125|NCT01686438|63275935|FG001|Overall Study|Lost to Follow-up|9|||
33709126|NCT01686438|63275936|FG002|Overall Study|Lost to Follow-up|10|||
33709127|NCT01686438|63275934|FG000|Overall Study|Adverse Event|0|||
33709128|NCT01686438|63275935|FG001|Overall Study|Adverse Event|0|||
33709129|NCT01686438|63275936|FG002|Overall Study|Adverse Event|1|||
33709130|NCT01686438|63275934|FG000|Overall Study|Protocol Violation|0|||
33709131|NCT01686438|63275935|FG001|Overall Study|Protocol Violation|0|||
33709132|NCT01686438|63275936|FG002|Overall Study|Protocol Violation|1|||
33709133|NCT01686438|63275934|FG000|Overall Study|Withdrawal by Subject|0|||
33709134|NCT01686438|63275935|FG001|Overall Study|Withdrawal by Subject|0|||
33709135|NCT01686438|63275936|FG002|Overall Study|Withdrawal by Subject|1|||
33709136|NCT01593696|63275950|FG000|Dose Escalation|Progressive Disease|2|||
33709137|NCT01593696|63275951|FG001|Dose Escalation|Progressive Disease|0|||
33709138|NCT01593696|63275952|FG002|Dose Escalation|Progressive Disease|0|||
33709139|NCT01593696|63275953|FG003|Dose Escalation|Progressive Disease|0|||
33709140|NCT01593696|63275950|FG000|Dose Expansion|Fungal infection|0|||
33709141|NCT01593696|63275951|FG001|Dose Expansion|Fungal infection|0|||
33709142|NCT01593696|63275952|FG002|Dose Expansion|Fungal infection|1|||
33709143|NCT01593696|63275953|FG003|Dose Expansion|Fungal infection|0|||
33709144|NCT01592760|63275966|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
33709145|NCT01592760|63275967|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
33709146|NCT01592760|63275968|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
33709147|NCT01696188|63275981|FG000|Overall Study|Protocol Violation|1|||
33709148|NCT01696188|63275982|FG001|Overall Study|Protocol Violation|1|||
33709149|NCT01603602|63275991|FG000|Overall Study|Adverse Event|1|||
33709150|NCT01603602|63275992|FG001|Overall Study|Adverse Event|0|||
33709151|NCT01603602|63275993|FG002|Overall Study|Adverse Event|0|||
33709152|NCT01603602|63275991|FG000|Overall Study|Personal Reasons|1|||
33709153|NCT01603602|63275992|FG001|Overall Study|Personal Reasons|0|||
33709154|NCT01603602|63275993|FG002|Overall Study|Personal Reasons|1|||
33709155|NCT01684878|63276005|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
33709156|NCT01684878|63276006|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
33709157|NCT01684878|63276007|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
33709158|NCT01684878|63276008|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
33709159|NCT01684878|63276005|FG000|Part 1: Safety Run in Phase|Death|15|||
33709160|NCT01684878|63276006|FG001|Part 1: Safety Run in Phase|Death|20|||
33709161|NCT01684878|63276007|FG002|Part 1: Safety Run in Phase|Death|0|||
33709162|NCT01684878|63276008|FG003|Part 1: Safety Run in Phase|Death|0|||
33709163|NCT01684878|63276005|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
33709164|NCT01684878|63276006|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
33709165|NCT01684878|63276007|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
33709166|NCT01684878|63276008|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
33709167|NCT01684878|63276005|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
33709168|NCT01684878|63276006|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
33709169|NCT01684878|63276007|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
33709170|NCT01684878|63276008|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
33709171|NCT01684878|63276005|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
33709172|NCT01684878|63276006|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
33709173|NCT01684878|63276007|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
33709174|NCT01684878|63276008|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
33709175|NCT01684878|63276005|FG000|Part 2: Randomized Phase|Death|0|||
33709176|NCT01684878|63276006|FG001|Part 2: Randomized Phase|Death|0|||
33709177|NCT01684878|63276007|FG002|Part 2: Randomized Phase|Death|62|||
33709178|NCT01684878|63276008|FG003|Part 2: Randomized Phase|Death|68|||
33709179|NCT01684878|63276005|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
33709180|NCT01684878|63276006|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
33709181|NCT01684878|63276007|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
33709182|NCT01684878|63276008|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
33709183|NCT01684878|63276005|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
33709184|NCT01684878|63276006|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
33709185|NCT01684878|63276007|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
33709186|NCT01684878|63276008|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
33709187|NCT01684722|63276022|FG000|Overall Study|Lost to Follow-up|78|||
33709188|NCT01684722|63276023|FG001|Overall Study|Lost to Follow-up|56|||
33709189|NCT01684722|63276024|FG002|Overall Study|Lost to Follow-up|75|||
33709190|NCT01684722|63276025|FG003|Overall Study|Lost to Follow-up|89|||
33709191|NCT01684722|63276022|FG000|Overall Study|Death|19|||
33709192|NCT01684722|63276023|FG001|Overall Study|Death|21|||
33709193|NCT01684722|63276024|FG002|Overall Study|Death|19|||
33709194|NCT01684722|63276025|FG003|Overall Study|Death|21|||
33709195|NCT01592292|63276042|FG000|Overall Study|Follow-up loss|3|||
33709196|NCT01592292|63276043|FG001|Overall Study|Follow-up loss|3|||
33709197|NCT01592292|63276044|FG002|Overall Study|Follow-up loss|1|||
33709198|NCT01592292|63276045|FG003|Overall Study|Follow-up loss|0|||
33709199|NCT01592292|63276042|FG000|Overall Study|Withdrew consent|2|||
33709200|NCT01592292|63276043|FG001|Overall Study|Withdrew consent|1|||
33709201|NCT01592292|63276044|FG002|Overall Study|Withdrew consent|0|||
33709202|NCT01592292|63276045|FG003|Overall Study|Withdrew consent|0|||
33709203|NCT01592292|63276042|FG000|Overall Study|Other|1|||
33709204|NCT01592292|63276043|FG001|Overall Study|Other|1|||
33709205|NCT01592292|63276044|FG002|Overall Study|Other|2|||
33709206|NCT01592292|63276045|FG003|Overall Study|Other|1|||
33709207|NCT01590888|63276054|FG000|Overall Study|Adverse Event|3|||
33709208|NCT01590888|63276055|FG001|Overall Study|Adverse Event|0|||
33709209|NCT01590888|63276056|FG002|Overall Study|Adverse Event|1|||
33709210|NCT01590888|63276054|FG000|Overall Study|Lost to Follow-up|1|||
33709211|NCT01590888|63276055|FG001|Overall Study|Lost to Follow-up|0|||
33709212|NCT01590888|63276056|FG002|Overall Study|Lost to Follow-up|0|||
33709213|NCT01565928|63276064|FG000|Overall Study|Adverse Event|3|||
33709214|NCT01565928|63276064|FG000|Overall Study|Other|3|||
33709215|NCT01565928|63276064|FG000|Overall Study|Progressive Disease|13|||
33709216|NCT01565928|63276064|FG000|Overall Study|Withdrawal by Subject|1|||
33709217|NCT01565928|63276064|FG000|Overall Study|Death|2|||
33709218|NCT01565850|63276073|FG000|Overall Study|Adverse Event|0|||
33709219|NCT01565850|63276074|FG001|Overall Study|Adverse Event|1|||
33709220|NCT01565850|63276073|FG000|Overall Study|Lost to Follow-up|12|||
33709221|NCT01565850|63276074|FG001|Overall Study|Lost to Follow-up|4|||
33709222|NCT01565850|63276073|FG000|Overall Study|Investigator's Discretion|2|||
33709223|NCT01565850|63276074|FG001|Overall Study|Investigator's Discretion|1|||
33709224|NCT01565850|63276073|FG000|Overall Study|Participant noncompliance|2|||
33709225|NCT01565850|63276074|FG001|Overall Study|Participant noncompliance|0|||
33709226|NCT01565850|63276073|FG000|Overall Study|Withdrew Consent|4|||
33709227|NCT01565850|63276074|FG001|Overall Study|Withdrew Consent|2|||
33709228|NCT01565694|63276080|FG000|Dose-Titration Period|Adverse Event|4|||
33709229|NCT01565694|63276080|FG000|Dose-Titration Period|Protocol Violation|10|||
33709230|NCT01565694|63276080|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
33709231|NCT01543152|63276089|FG000|Overall Study|Withdrawal by Subject|0|||
33709232|NCT01543152|63276090|FG001|Overall Study|Withdrawal by Subject|2|||
33709233|NCT01543152|63276091|FG002|Overall Study|Withdrawal by Subject|0|||
33709234|NCT01543152|63276092|FG003|Overall Study|Withdrawal by Subject|0|||
33709235|NCT01543152|63276093|FG004|Overall Study|Withdrawal by Subject|0|||
33709236|NCT01590810|63276110|FG000|Overall Study|Physician Decision|0|||
33709237|NCT01590810|63276111|FG001|Overall Study|Physician Decision|1|||
33709238|NCT01590810|63276112|FG002|Overall Study|Physician Decision|1|||
33709239|NCT01590810|63276113|FG003|Overall Study|Physician Decision|0|||
33709240|NCT01590810|63276114|FG004|Overall Study|Physician Decision|0|||
33709241|NCT01542528|63276149|FG000|Overall Study|Lost to Follow-up|2|||
33709242|NCT01542528|63276150|FG001|Overall Study|Lost to Follow-up|1|||
33709243|NCT01542528|63276149|FG000|Overall Study|Physician Decision|1|||
33709244|NCT01542528|63276150|FG001|Overall Study|Physician Decision|0|||
33709245|NCT01542528|63276149|FG000|Overall Study|Withdrawal by Subject|9|||
33709246|NCT01542528|63276150|FG001|Overall Study|Withdrawal by Subject|6|||
33709247|NCT01565148|63276160|FG000|Overall Study|Withdrawal by Subject|1|||
33709248|NCT01565148|63276161|FG001|Overall Study|Withdrawal by Subject|1|||
33709249|NCT01565148|63276162|FG002|Overall Study|Withdrawal by Subject|1|||
33709250|NCT01565148|63276163|FG003|Overall Study|Withdrawal by Subject|2|||
33709251|NCT01565148|63276160|FG000|Overall Study|Lost to Follow-up|4|||
33709252|NCT01565148|63276161|FG001|Overall Study|Lost to Follow-up|4|||
33709253|NCT01565148|63276162|FG002|Overall Study|Lost to Follow-up|0|||
33709254|NCT01565148|63276163|FG003|Overall Study|Lost to Follow-up|3|||
33709255|NCT01565148|63276160|FG000|Overall Study|Rescue Therapy|8|||
33709256|NCT01565148|63276161|FG001|Overall Study|Rescue Therapy|5|||
33709257|NCT01565148|63276162|FG002|Overall Study|Rescue Therapy|5|||
33709258|NCT01565148|63276163|FG003|Overall Study|Rescue Therapy|8|||
33709259|NCT01565148|63276160|FG000|Overall Study|Death|0|||
33709260|NCT01565148|63276161|FG001|Overall Study|Death|0|||
33709261|NCT01565148|63276162|FG002|Overall Study|Death|1|||
33709262|NCT01565148|63276163|FG003|Overall Study|Death|0|||
33709263|NCT01565148|63276160|FG000|Overall Study|Physician Decision|2|||
33709264|NCT01565148|63276161|FG001|Overall Study|Physician Decision|5|||
33709265|NCT01565148|63276162|FG002|Overall Study|Physician Decision|0|||
33709266|NCT01565148|63276163|FG003|Overall Study|Physician Decision|0|||
33709267|NCT01564758|63276177|FG000|Overall Study|Death|8|||
33709268|NCT01564758|63276177|FG000|Overall Study|Adverse Event|3|||
33709269|NCT01564758|63276177|FG000|Overall Study|Other|3|||
33709270|NCT01541826|63276184|FG000|Overall Study|Lost to Follow-up|2|||
33709271|NCT01541826|63276185|FG001|Overall Study|Lost to Follow-up|3|||
33709272|NCT01541826|63276186|FG002|Overall Study|Lost to Follow-up|0|||
33709273|NCT01541826|63276184|FG000|Overall Study|Withdrawal by Subject|2|||
33709274|NCT01541826|63276185|FG001|Overall Study|Withdrawal by Subject|0|||
33709275|NCT01541826|63276186|FG002|Overall Study|Withdrawal by Subject|0|||
33709276|NCT01541748|63276194|FG000|Overall Study|Lost to Follow-up|17|||
33709277|NCT01541748|63276194|FG000|Overall Study|Moved out of state|1|||
33709278|NCT01541748|63276194|FG000|Overall Study|Withdrawal by Subject|7|||
33709279|NCT01541748|63276194|FG000|Overall Study|Screen failure|5|||
33709280|NCT01541748|63276194|FG000|Overall Study|Did not receive study device|1|||
33709281|NCT01589094|63276207|FG000|Overall Study|Did not receive treatment|2|||
33709282|NCT01563978|63276213|FG000|Overall Study|Physician Decision|1|||
33709283|NCT01563978|63276214|FG001|Overall Study|Physician Decision|0|||
33709284|NCT01563978|63276213|FG000|Overall Study|Lost to Follow-up|1|||
33709285|NCT01563978|63276214|FG001|Overall Study|Lost to Follow-up|0|||
33709286|NCT01563978|63276213|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
33709287|NCT01563978|63276214|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
33709288|NCT01563978|63276213|FG000|Overall Study|Adverse Event|1|||
33709289|NCT01563978|63276214|FG001|Overall Study|Adverse Event|2|||
33709290|NCT01563354|63276223|FG000|Core Phase|Adverse Event|5|||
33709291|NCT01563354|63276224|FG001|Core Phase|Adverse Event|15|||
33709292|NCT01563354|63276225|FG002|Core Phase|Adverse Event|13|||
33709293|NCT01563354|63276223|FG000|Core Phase|Withdrawal by Subject|1|||
33709294|NCT01563354|63276224|FG001|Core Phase|Withdrawal by Subject|0|||
33709295|NCT01563354|63276225|FG002|Core Phase|Withdrawal by Subject|3|||
33709296|NCT01563354|63276223|FG000|Core Phase|Lost to Follow-up|1|||
33709297|NCT01563354|63276224|FG001|Core Phase|Lost to Follow-up|0|||
33709298|NCT01563354|63276225|FG002|Core Phase|Lost to Follow-up|0|||
33709299|NCT01563354|63276223|FG000|Core Phase|Death|1|||
33709300|NCT01563354|63276224|FG001|Core Phase|Death|5|||
33709301|NCT01563354|63276225|FG002|Core Phase|Death|2|||
33709302|NCT01563354|63276223|FG000|Core Phase|Diseasse progression|18|||
33709303|NCT01563354|63276224|FG001|Core Phase|Diseasse progression|7|||
33709304|NCT01563354|63276225|FG002|Core Phase|Diseasse progression|8|||
33709305|NCT01563354|63276223|FG000|Core Phase|Protocol deviation|2|||
33709306|NCT01563354|63276224|FG001|Core Phase|Protocol deviation|0|||
33709307|NCT01563354|63276225|FG002|Core Phase|Protocol deviation|0|||
33709308|NCT01563354|63276223|FG000|Core Phase|PI decision - did not enter extension|0|||
33709309|NCT01563354|63276224|FG001|Core Phase|PI decision - did not enter extension|1|||
33709310|NCT01563354|63276225|FG002|Core Phase|PI decision - did not enter extension|0|||
33709311|NCT01563354|63276223|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
33709312|NCT01563354|63276224|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
33709313|NCT01563354|63276225|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
33709314|NCT01563354|63276223|FG000|Extension Phase|Adverse Event|0|||
33709315|NCT01563354|63276224|FG001|Extension Phase|Adverse Event|3|||
33709316|NCT01563354|63276225|FG002|Extension Phase|Adverse Event|2|||
33709317|NCT01563354|63276223|FG000|Extension Phase|Withdrawal by Subject|0|||
33709318|NCT01563354|63276224|FG001|Extension Phase|Withdrawal by Subject|1|||
33709319|NCT01563354|63276225|FG002|Extension Phase|Withdrawal by Subject|0|||
33709320|NCT01563354|63276223|FG000|Extension Phase|Administration problems|3|||
33709321|NCT01563354|63276224|FG001|Extension Phase|Administration problems|2|||
33709322|NCT01563354|63276225|FG002|Extension Phase|Administration problems|3|||
33709323|NCT01563354|63276223|FG000|Extension Phase|Disease progression|9|||
33493365|NCT03134222|62871695|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
33493366|NCT03134222|62871696|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
33493367|NCT03134222|62871692|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
33493368|NCT03134222|62871693|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
33493369|NCT03134222|62871694|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
33709324|NCT01563354|63276224|FG001|Extension Phase|Disease progression|8|||
33709325|NCT01563354|63276225|FG002|Extension Phase|Disease progression|10|||
33709326|NCT01588548|63276239|FG000|Overall Study|Withdrawal by Subject|0|||
33709327|NCT01588548|63276240|FG001|Overall Study|Withdrawal by Subject|1|||
33709328|NCT01588548|63276241|FG002|Overall Study|Withdrawal by Subject|1|||
33709329|NCT01588548|63276242|FG003|Overall Study|Withdrawal by Subject|1|||
33709330|NCT01588548|63276243|FG004|Overall Study|Withdrawal by Subject|2|||
33709331|NCT01588548|63276244|FG005|Overall Study|Withdrawal by Subject|3|||
33709332|NCT01588548|63276239|FG000|Overall Study|Adverse Event|0|||
33709333|NCT01588548|63276240|FG001|Overall Study|Adverse Event|0|||
33709334|NCT01588548|63276241|FG002|Overall Study|Adverse Event|1|||
33709335|NCT01588548|63276242|FG003|Overall Study|Adverse Event|2|||
33709336|NCT01588548|63276243|FG004|Overall Study|Adverse Event|1|||
33709337|NCT01588548|63276244|FG005|Overall Study|Adverse Event|0|||
33709338|NCT01588548|63276239|FG000|Overall Study|Condition Under Investigation Worsened|3|||
33709339|NCT01588548|63276240|FG001|Overall Study|Condition Under Investigation Worsened|6|||
33709340|NCT01588548|63276241|FG002|Overall Study|Condition Under Investigation Worsened|4|||
33709341|NCT01588548|63276242|FG003|Overall Study|Condition Under Investigation Worsened|4|||
33709342|NCT01588548|63276243|FG004|Overall Study|Condition Under Investigation Worsened|3|||
33709343|NCT01588548|63276244|FG005|Overall Study|Condition Under Investigation Worsened|3|||
33709344|NCT01587924|63276262|FG000|Overall Study|Adverse Event|0|||
33709345|NCT01587924|63276263|FG001|Overall Study|Adverse Event|2|||
33709346|NCT01587924|63276264|FG002|Overall Study|Adverse Event|0|||
33709347|NCT01587924|63276265|FG003|Overall Study|Adverse Event|0|||
33709348|NCT01587924|63276262|FG000|Overall Study|Protocol Violation|2|||
33709349|NCT01587924|63276263|FG001|Overall Study|Protocol Violation|1|||
33709350|NCT01587924|63276264|FG002|Overall Study|Protocol Violation|2|||
33709351|NCT01587924|63276265|FG003|Overall Study|Protocol Violation|1|||
33709352|NCT01587924|63276262|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
33709353|NCT01587924|63276263|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
33597090|NCT02100657|62996063|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
33709354|NCT01587924|63276264|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
33709355|NCT01587924|63276265|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
33709356|NCT01587924|63276262|FG000|Overall Study|Withdrawal by Subject|0|||
33709357|NCT01587924|63276263|FG001|Overall Study|Withdrawal by Subject|1|||
33709358|NCT01587924|63276264|FG002|Overall Study|Withdrawal by Subject|1|||
33709359|NCT01587924|63276265|FG003|Overall Study|Withdrawal by Subject|0|||
33709360|NCT01539642|63276277|FG000|Overall Study|Lack of Efficacy|20|||
33709361|NCT01539642|63276278|FG001|Overall Study|Lack of Efficacy|18|||
33709362|NCT01539642|63276277|FG000|Overall Study|Patient ready for early discharge|8|||
33709363|NCT01539642|63276278|FG001|Overall Study|Patient ready for early discharge|7|||
33709364|NCT01539642|63276277|FG000|Overall Study|Adverse Event|6|||
33709365|NCT01539642|63276278|FG001|Overall Study|Adverse Event|4|||
33709366|NCT01539642|63276277|FG000|Overall Study|Withdrawal by Subject|2|||
33709367|NCT01539642|63276278|FG001|Overall Study|Withdrawal by Subject|2|||
33709368|NCT01586364|63276284|FG000|Overall Study|Withdrawal by Subject|40|||
33709369|NCT01586364|63276284|FG000|Overall Study|Adverse Event|37|||
33709370|NCT01586364|63276284|FG000|Overall Study|Lost to Follow-up|17|||
33709371|NCT01586364|63276284|FG000|Overall Study|Protocol Violation|16|||
33709372|NCT01586364|63276284|FG000|Overall Study|Lack of Efficacy|1|||
33709373|NCT01586364|63276284|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
33709374|NCT01586364|63276284|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
33709375|NCT01586364|63276284|FG000|Overall Study|Other-Site closure due to PI illness|1|||
33709376|NCT01586364|63276284|FG000|Overall Study|Other-PI discretion, site closing|2|||
33709377|NCT01586364|63276284|FG000|Overall Study|Other-Not specified|1|||
33709378|NCT01538628|63276290|FG000|Overall Study|Withdrawal by Subject|1|||
33709379|NCT01538628|63276291|FG001|Overall Study|Withdrawal by Subject|1|||
33709380|NCT01538628|63276290|FG000|Overall Study|Lost to Follow-up|0|||
33709381|NCT01538628|63276291|FG001|Overall Study|Lost to Follow-up|1|||
33709382|NCT01538472|63276298|FG000|Overall Study|Disease Progression|3|||
33709383|NCT01538472|63276298|FG000|Overall Study|Death|1|||
33709384|NCT01562028|63276304|FG000|Overall Study|Withdrawal by Subject|1|||
33709385|NCT01562028|63276305|FG001|Overall Study|Withdrawal by Subject|1|||
33709386|NCT01562028|63276304|FG000|Overall Study|Lost to Follow-up|2|||
33709387|NCT01562028|63276305|FG001|Overall Study|Lost to Follow-up|1|||
33709388|NCT01585584|63276311|FG000|Overall Study|Lack of Efficacy|1|||
33709389|NCT01585584|63276311|FG000|Overall Study|Withdrawal by Subject|1|||
33709390|NCT01585584|63276311|FG000|Overall Study|Physician Decision|2|||
33709391|NCT01561560|63276315|FG000|First Two Weeks of Wear|Time/job conflict|0|||
33709392|NCT01561560|63276316|FG001|First Two Weeks of Wear|Time/job conflict|1|||
33709393|NCT01561560|63276315|FG000|First Two Weeks of Wear|Adverse Event|0|||
33709394|NCT01561560|63276316|FG001|First Two Weeks of Wear|Adverse Event|1|||
33709395|NCT01561560|63276315|FG000|Second Two Weeks of Wear|Adverse Event|0|||
33709396|NCT01561560|63276316|FG001|Second Two Weeks of Wear|Adverse Event|1|||
33709397|NCT01537068|63276324|FG000|Overall Study|Lost to Follow-up|2|||
33709398|NCT01537068|63276325|FG001|Overall Study|Lost to Follow-up|1|||
33709399|NCT01537068|63276324|FG000|Overall Study|Adverse Event|0|||
33709400|NCT01537068|63276325|FG001|Overall Study|Adverse Event|1|||
33709401|NCT01537068|63276324|FG000|Overall Study|Withdrawal by Subject|1|||
33709402|NCT01537068|63276325|FG001|Overall Study|Withdrawal by Subject|1|||
33597091|NCT02100657|62996064|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
33597092|NCT02100657|62996065|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
33597093|NCT02100657|62996063|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
33597094|NCT02100657|62996064|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
33597095|NCT02100657|62996065|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
33597096|NCT02100657|62996063|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
33597097|NCT02100657|62996064|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
33597098|NCT02100657|62996065|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
33597099|NCT02100657|62996063|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
33597100|NCT02100657|62996064|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
33597101|NCT02100657|62996065|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
33597102|NCT02100657|62996063|FG000|Cohort 3: Dose Level 3|Death|0|||
33597103|NCT02100657|62996064|FG001|Cohort 3: Dose Level 3|Death|0|||
33597104|NCT02100657|62996065|FG002|Cohort 3: Dose Level 3|Death|1|||
33597105|NCT02100657|62996063|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
33597106|NCT02100657|62996064|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
33709403|NCT01537068|63276324|FG000|Overall Study|Lack of Efficacy|1|||
33709404|NCT01537068|63276325|FG001|Overall Study|Lack of Efficacy|0|||
33709405|NCT01585428|63276333|FG000|Overall Study|Death during treatment|1|||
33709406|NCT01585428|63276334|FG001|Overall Study|Death during treatment|0|||
33597107|NCT02100657|62996065|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
33709407|NCT01585272|63276341|FG000|Overall Study|Adverse Event|22|||
33709408|NCT01585272|63276341|FG000|Overall Study|Protocol Violation|7|||
33709409|NCT01585272|63276341|FG000|Overall Study|Withdrawal by Subject|10|||
33709410|NCT01560780|63276347|FG000|Overall Study|Death|2|||
33709411|NCT01560780|63276348|FG001|Overall Study|Death|1|||
33709412|NCT01560780|63276347|FG000|Overall Study|Patient Preference|11|||
33709413|NCT01560780|63276348|FG001|Overall Study|Patient Preference|11|||
33709414|NCT01585038|63276356|FG000|Overall Study|Adverse Event|2|||
33709415|NCT01585038|63276357|FG001|Overall Study|Adverse Event|2|||
33709416|NCT01560234|63276371|FG000|Overall Study|Lost to Follow-up|3|||
33709417|NCT01560234|63276372|FG001|Overall Study|Lost to Follow-up|0|||
33709418|NCT01560234|63276373|FG002|Overall Study|Lost to Follow-up|1|||
33709419|NCT01560234|63276374|FG003|Overall Study|Lost to Follow-up|0|||
33709420|NCT01560234|63276375|FG004|Overall Study|Lost to Follow-up|0|||
33709421|NCT01560234|63276376|FG005|Overall Study|Lost to Follow-up|2|||
33709422|NCT01560234|63276377|FG006|Overall Study|Lost to Follow-up|0|||
33709423|NCT01560234|63276378|FG007|Overall Study|Lost to Follow-up|2|||
33709424|NCT01559844|63276396|FG000|Overall Study|Consent Withdrawn|7|||
33709425|NCT01559844|63276396|FG000|Overall Study|Death|5|||
33709426|NCT01559844|63276396|FG000|Overall Study|Efficacy Failure|10|||
33709427|NCT01559844|63276396|FG000|Overall Study|No Longer A Transplant Candidate|3|||
33709428|NCT01584648|63276402|FG000|Overall Study|Death|136|||
33709429|NCT01584648|63276403|FG001|Overall Study|Death|146|||
33709430|NCT01584648|63276402|FG000|Overall Study|Lost to Follow-up|9|||
33709431|NCT01584648|63276403|FG001|Overall Study|Lost to Follow-up|9|||
33709432|NCT01584648|63276402|FG000|Overall Study|Investigator discretion|3|||
33709433|NCT01584648|63276403|FG001|Overall Study|Investigator discretion|2|||
33709434|NCT01584648|63276402|FG000|Overall Study|Withdrew consent|13|||
33709435|NCT01584648|63276403|FG001|Overall Study|Withdrew consent|4|||
33709436|NCT01584648|63276402|FG000|Overall Study|Study closed/terminated|50|||
33709437|NCT01584648|63276403|FG001|Overall Study|Study closed/terminated|23|||
33709438|NCT01584648|63276402|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
33709439|NCT01584648|63276403|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
33709440|NCT01559454|63276414|FG000|Overall Study|Lost to Follow-up|3|||
33709441|NCT01559454|63276415|FG001|Overall Study|Lost to Follow-up|2|||
33709442|NCT01559454|63276414|FG000|Overall Study|Withdrawal by Subject|0|||
33709443|NCT01559454|63276415|FG001|Overall Study|Withdrawal by Subject|1|||
33709444|NCT01559454|63276414|FG000|Overall Study|Physician Decision|0|||
33709445|NCT01559454|63276415|FG001|Overall Study|Physician Decision|1|||
33709446|NCT01559454|63276414|FG000|Overall Study|Protocol Violation|0|||
33709447|NCT01559454|63276415|FG001|Overall Study|Protocol Violation|1|||
33709448|NCT01559454|63276414|FG000|Overall Study|Lack of Efficacy|0|||
33709449|NCT01559454|63276415|FG001|Overall Study|Lack of Efficacy|1|||
33709450|NCT01584024|63276421|FG000|Overall Study|Lost to Follow-up|10|||
33709451|NCT01584024|63276421|FG000|Overall Study|Withdrawal by Subject|3|||
33709452|NCT01583166|63276428|FG000|Overall Study|Withdrawal by Subject|4|||
33709453|NCT01583166|63276429|FG001|Overall Study|Withdrawal by Subject|6|||
33709454|NCT01535274|63276437|FG000|Overall Study|Determined to be ineligible|0|||
33709455|NCT01535274|63276438|FG001|Overall Study|Determined to be ineligible|1|||
33709456|NCT01535274|63276437|FG000|Overall Study|Misallocated to propofol intervention|0|||
33709457|NCT01535274|63276438|FG001|Overall Study|Misallocated to propofol intervention|1|||
33709458|NCT01558752|63276448|FG000|Overall Study|Physician Decision|2|||
33709459|NCT01558752|63276449|FG001|Overall Study|Physician Decision|0|||
33709460|NCT01582854|63276457|FG000|Overall Study|Death|8|||
33709461|NCT01582854|63276458|FG001|Overall Study|Death|5|||
33709462|NCT01582854|63276457|FG000|Overall Study|Adverse Event|2|||
33709463|NCT01582854|63276458|FG001|Overall Study|Adverse Event|3|||
33709464|NCT01582854|63276457|FG000|Overall Study|Withdrawal by Participant|8|||
33709465|NCT01582854|63276458|FG001|Overall Study|Withdrawal by Participant|11|||
33709466|NCT01582854|63276457|FG000|Overall Study|Lost to Follow-up|1|||
33597108|NCT02100657|62996063|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
33597109|NCT02100657|62996064|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
33597110|NCT02100657|62996065|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
33597111|NCT02100657|62996063|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
33597112|NCT02100657|62996064|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
33709467|NCT01582854|63276458|FG001|Overall Study|Lost to Follow-up|2|||
33597113|NCT02100657|62996065|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
33709468|NCT01582854|63276457|FG000|Overall Study|Physician Decision|0|||
33709469|NCT01582854|63276458|FG001|Overall Study|Physician Decision|1|||
33709470|NCT01582854|63276457|FG000|Overall Study|Recurrent Stroke|13|||
33709471|NCT01582854|63276458|FG001|Overall Study|Recurrent Stroke|8|||
33709472|NCT01582854|63276457|FG000|Overall Study|Disallowed Concomitant Medication|3|||
33709473|NCT01582854|63276458|FG001|Overall Study|Disallowed Concomitant Medication|2|||
33709474|NCT01582854|63276457|FG000|Overall Study|Carotid or Neurosurgery|0|||
33709475|NCT01582854|63276458|FG001|Overall Study|Carotid or Neurosurgery|1|||
33709476|NCT01582854|63276457|FG000|Overall Study|General Anaesthesia|0|||
33709477|NCT01582854|63276458|FG001|Overall Study|General Anaesthesia|1|||
33709478|NCT01582854|63276457|FG000|Overall Study|Other Miscellaneous Reason|1|||
33709479|NCT01582854|63276458|FG001|Overall Study|Other Miscellaneous Reason|0|||
33709480|NCT01582308|63276464|FG000|Period 1|Withdrawal by Subject|0|||
33709481|NCT01582308|63276465|FG001|Period 1|Withdrawal by Subject|0|||
33709482|NCT01582308|63276466|FG002|Period 1|Withdrawal by Subject|0|||
33709483|NCT01582308|63276467|FG003|Period 1|Withdrawal by Subject|0|||
33709484|NCT01582308|63276468|FG004|Period 1|Withdrawal by Subject|0|||
33709485|NCT01582308|63276469|FG005|Period 1|Withdrawal by Subject|0|||
33401505|NCT00256867|62780480|FG006|Overall Study|Participant out of assessment window|0|||
33401506|NCT00256867|62780481|FG007|Overall Study|Participant out of assessment window|0|||
33401507|NCT00256867|62780474|FG000|Overall Study|Withdrawal by participant|0|||
33401508|NCT00256867|62780475|FG001|Overall Study|Withdrawal by participant|0|||
33401509|NCT00256867|62780476|FG002|Overall Study|Withdrawal by participant|0|||
33401510|NCT00256867|62780477|FG003|Overall Study|Withdrawal by participant|0|||
33401511|NCT00256867|62780478|FG004|Overall Study|Withdrawal by participant|0|||
33401512|NCT00256867|62780479|FG005|Overall Study|Withdrawal by participant|1|||
33401513|NCT00256867|62780480|FG006|Overall Study|Withdrawal by participant|0|||
33401514|NCT00256867|62780481|FG007|Overall Study|Withdrawal by participant|0|||
33401515|NCT00731939|62780504|FG000|Overall Study|Adverse Event|6|||
33401516|NCT00731939|62780504|FG000|Overall Study|Lost to Follow-up|15|||
33709486|NCT01582308|63276470|FG006|Period 1|Withdrawal by Subject|1|||
33709487|NCT01582308|63276471|FG007|Period 1|Withdrawal by Subject|0|||
33709488|NCT01582308|63276472|FG008|Period 1|Withdrawal by Subject|0|||
33709489|NCT01582308|63276473|FG009|Period 1|Withdrawal by Subject|0|||
33709490|NCT01582308|63276464|FG000|10-day Washout Following Period 1|Physician Decision|0|||
33709491|NCT01582308|63276465|FG001|10-day Washout Following Period 1|Physician Decision|0|||
33709492|NCT01582308|63276466|FG002|10-day Washout Following Period 1|Physician Decision|0|||
33709493|NCT01582308|63276467|FG003|10-day Washout Following Period 1|Physician Decision|0|||
33709494|NCT01582308|63276468|FG004|10-day Washout Following Period 1|Physician Decision|1|||
33709495|NCT01582308|63276469|FG005|10-day Washout Following Period 1|Physician Decision|0|||
33709496|NCT01582308|63276470|FG006|10-day Washout Following Period 1|Physician Decision|0|||
33709497|NCT01582308|63276471|FG007|10-day Washout Following Period 1|Physician Decision|0|||
33709498|NCT01582308|63276472|FG008|10-day Washout Following Period 1|Physician Decision|0|||
33709499|NCT01582308|63276473|FG009|10-day Washout Following Period 1|Physician Decision|0|||
33709500|NCT01582308|63276464|FG000|Period 4|Physician Decision|1|||
33709501|NCT01582308|63276465|FG001|Period 4|Physician Decision|0|||
33709502|NCT01582308|63276466|FG002|Period 4|Physician Decision|0|||
33709503|NCT01582308|63276467|FG003|Period 4|Physician Decision|0|||
33709504|NCT01582308|63276468|FG004|Period 4|Physician Decision|0|||
33709505|NCT01582308|63276469|FG005|Period 4|Physician Decision|1|||
33709506|NCT01582308|63276470|FG006|Period 4|Physician Decision|0|||
33709507|NCT01582308|63276471|FG007|Period 4|Physician Decision|0|||
33709508|NCT01582308|63276472|FG008|Period 4|Physician Decision|0|||
33709509|NCT01582308|63276473|FG009|Period 4|Physician Decision|1|||
33709510|NCT01558674|63276488|FG000|Part 1|Study Terminated by Sponsor|10|||
33709511|NCT01558674|63276489|FG001|Part 1|Study Terminated by Sponsor|0|||
33709512|NCT01558674|63276488|FG000|Part 1|Withdrawal by Subject|1|||
33709513|NCT01558674|63276489|FG001|Part 1|Withdrawal by Subject|0|||
33709514|NCT01558596|63276510|FG000|Overall Study|Withdrawal by Subject|1|||
33709515|NCT01558596|63276511|FG001|Overall Study|Withdrawal by Subject|0|||
33709516|NCT01558596|63276510|FG000|Overall Study|surgery elsewhere or cancelled|1|||
33709517|NCT01558596|63276511|FG001|Overall Study|surgery elsewhere or cancelled|1|||
33709518|NCT01558596|63276510|FG000|Overall Study|Protocol Violation|1|||
33709519|NCT01558596|63276511|FG001|Overall Study|Protocol Violation|0|||
33709520|NCT01535040|63276519|FG000|Overall Study|Physician Decision|0|||
33709521|NCT01535040|63276520|FG001|Overall Study|Physician Decision|1|||
33709522|NCT01535040|63276519|FG000|Overall Study|Withdrawal by Subject|13|||
33709523|NCT01535040|63276520|FG001|Overall Study|Withdrawal by Subject|10|||
33709524|NCT01535040|63276519|FG000|Overall Study|Never Started|9|||
33709525|NCT01535040|63276520|FG001|Overall Study|Never Started|4|||
33709526|NCT01535040|63276519|FG000|Overall Study|Toxicity|7|||
33709527|NCT01535040|63276520|FG001|Overall Study|Toxicity|5|||
33709528|NCT01535040|63276519|FG000|Overall Study|Multiple Reasons|1|||
33709529|NCT01535040|63276520|FG001|Overall Study|Multiple Reasons|1|||
33709530|NCT01534962|63276530|FG000|Overall Study|Randomized but did not start treatment|2|||
33709531|NCT01534962|63276531|FG001|Overall Study|Randomized but did not start treatment|0|||
33709532|NCT01534962|63276532|FG002|Overall Study|Randomized but did not start treatment|0|||
33709533|NCT01534962|63276533|FG003|Overall Study|Randomized but did not start treatment|1|||
33709534|NCT01534962|63276530|FG000|Overall Study|Discontinued at AF recurrence|35|||
33709535|NCT01534962|63276531|FG001|Overall Study|Discontinued at AF recurrence|26|||
33709536|NCT01534962|63276532|FG002|Overall Study|Discontinued at AF recurrence|24|||
33401517|NCT00731939|62780504|FG000|Overall Study|Not implanted with study device|9|||
33709537|NCT01534962|63276533|FG003|Overall Study|Discontinued at AF recurrence|31|||
33709538|NCT01582152|63276545|FG000|Overall Study|Disease Progression|4|||
33709539|NCT01582152|63276546|FG001|Overall Study|Disease Progression|5|||
33709540|NCT01582152|63276545|FG000|Overall Study|Adverse Event|2|||
33709541|NCT01582152|63276546|FG001|Overall Study|Adverse Event|1|||
33709542|NCT01581684|63276562|FG000|Overall Study|Other reason not defined|0|||
33709543|NCT01581684|63276563|FG001|Overall Study|Other reason not defined|0|||
33709544|NCT01581684|63276564|FG002|Overall Study|Other reason not defined|0|||
33709545|NCT01581684|63276565|FG003|Overall Study|Other reason not defined|0|||
33709546|NCT01581684|63276566|FG004|Overall Study|Other reason not defined|0|||
33709547|NCT01581684|63276567|FG005|Overall Study|Other reason not defined|0|||
33709548|NCT01581684|63276568|FG006|Overall Study|Other reason not defined|0|||
33709549|NCT01581684|63276569|FG007|Overall Study|Other reason not defined|0|||
33709550|NCT01581684|63276570|FG008|Overall Study|Other reason not defined|1|||
33709551|NCT01581684|63276571|FG009|Overall Study|Other reason not defined|0|||
33709552|NCT01557582|63276604|FG000|Overall Study|Protocol Violation|4|||
33709553|NCT01557582|63276604|FG000|Overall Study|Operator error|2|||
33709554|NCT01557504|63276610|FG000|Overall Study|Physician Decision|1|||
33709555|NCT01557504|63276611|FG001|Overall Study|Physician Decision|0|||
33709556|NCT01557348|63276625|FG000|Overall Study|Adverse Event|6|||
33709557|NCT01557348|63276626|FG001|Overall Study|Adverse Event|16|||
33709558|NCT01557348|63276625|FG000|Overall Study|Infusion reaction event|5|||
33709559|NCT01557348|63276626|FG001|Overall Study|Infusion reaction event|5|||
33709560|NCT01557348|63276625|FG000|Overall Study|Death|7|||
33709561|NCT01557348|63276626|FG001|Overall Study|Death|4|||
33709562|NCT01557348|63276625|FG000|Overall Study|Insufficient Therapeutic Response|13|||
33709563|NCT01557348|63276626|FG001|Overall Study|Insufficient Therapeutic Response|28|||
33709564|NCT01557348|63276625|FG000|Overall Study|Withdrawal by Subject|5|||
33709565|NCT01557348|63276626|FG001|Overall Study|Withdrawal by Subject|4|||
33709566|NCT01557348|63276625|FG000|Overall Study|Lost to Follow-up|26|||
33709567|NCT01557348|63276626|FG001|Overall Study|Lost to Follow-up|22|||
33709568|NCT01557348|63276625|FG000|Overall Study|Administrative|18|||
33709569|NCT01557348|63276626|FG001|Overall Study|Administrative|11|||
33709570|NCT01580670|63276633|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
33709571|NCT01580670|63276633|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
33709572|NCT01534260|63276639|FG000|Overall Study|Adverse Event|1|||
33709573|NCT01534260|63276640|FG001|Overall Study|Adverse Event|8|||
33709574|NCT01534260|63276639|FG000|Overall Study|Death|2|||
33709575|NCT01534260|63276640|FG001|Overall Study|Death|0|||
33709576|NCT01534260|63276639|FG000|Overall Study|Lack of Efficacy|1|||
33709577|NCT01534260|63276640|FG001|Overall Study|Lack of Efficacy|1|||
33709578|NCT01534260|63276639|FG000|Overall Study|Withdrawal by Subject|1|||
33709579|NCT01534260|63276640|FG001|Overall Study|Withdrawal by Subject|3|||
33709580|NCT01534260|63276639|FG000|Overall Study|Disease Progression|8|||
33709581|NCT01534260|63276640|FG001|Overall Study|Disease Progression|6|||
33709582|NCT01534260|63276639|FG000|Overall Study|Physician Decision|3|||
33709583|NCT01534260|63276640|FG001|Overall Study|Physician Decision|1|||
33709584|NCT01534260|63276639|FG000|Overall Study|No treatment, per protocol|0|||
33709585|NCT01534260|63276640|FG001|Overall Study|No treatment, per protocol|1|||
33709586|NCT01534182|63276648|FG000|Overall Study|Administrative problems|1|||
33709587|NCT01534182|63276649|FG001|Overall Study|Administrative problems|0|||
33709588|NCT01534182|63276648|FG000|Overall Study|Withdrawal by Subject|4|||
33709589|NCT01534182|63276649|FG001|Overall Study|Withdrawal by Subject|7|||
33709590|NCT01534182|63276648|FG000|Overall Study|Adverse Event|7|||
33709591|NCT01534182|63276649|FG001|Overall Study|Adverse Event|3|||
33709592|NCT01579812|63276656|FG000|Overall Study|Ineligible after treatment start|40|||
33709593|NCT01579812|63276656|FG000|Overall Study|Patient choice|3|||
33709594|NCT01579812|63276656|FG000|Overall Study|Noncompliance|3|||
33709595|NCT01579812|63276656|FG000|Overall Study|Withdrawal by Subject|6|||
33709596|NCT01533714|63276669|FG000|Overall Study|Adverse Event|0|||
33709597|NCT01533714|63276670|FG001|Overall Study|Adverse Event|1|||
33709598|NCT01533714|63276671|FG002|Overall Study|Adverse Event|2|||
33709599|NCT01533714|63276672|FG003|Overall Study|Adverse Event|2|||
33401518|NCT00731939|62780504|FG000|Overall Study|Withdrawal by Subject|2|||
33493370|NCT03134222|62871695|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
33709600|NCT01533714|63276673|FG004|Overall Study|Adverse Event|2|||
33709601|NCT01533714|63276674|FG005|Overall Study|Adverse Event|1|||
33709602|NCT01533714|63276669|FG000|Overall Study|Lack of Efficacy|0|||
33401519|NCT00731939|62780504|FG000|Overall Study|Did not meet enrollment criteria|2|||
33401520|NCT00731783|62780510|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
33401521|NCT00731783|62780511|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
33401522|NCT00731783|62780510|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
33401523|NCT00731783|62780511|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
33401524|NCT00731783|62780510|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
33401525|NCT00731783|62780511|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
33709603|NCT01533714|63276670|FG001|Overall Study|Lack of Efficacy|0|||
33709604|NCT01533714|63276671|FG002|Overall Study|Lack of Efficacy|0|||
33401526|NCT00731783|62780510|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
33401527|NCT00731783|62780511|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
33709605|NCT01533714|63276672|FG003|Overall Study|Lack of Efficacy|0|||
33709606|NCT01533714|63276673|FG004|Overall Study|Lack of Efficacy|0|||
33709607|NCT01533714|63276674|FG005|Overall Study|Lack of Efficacy|1|||
33709608|NCT01533714|63276669|FG000|Overall Study|Withdrawal by Subject|0|||
33709609|NCT01533714|63276670|FG001|Overall Study|Withdrawal by Subject|1|||
33709610|NCT01533714|63276671|FG002|Overall Study|Withdrawal by Subject|0|||
33709611|NCT01533714|63276672|FG003|Overall Study|Withdrawal by Subject|1|||
33709612|NCT01533714|63276673|FG004|Overall Study|Withdrawal by Subject|1|||
33709613|NCT01533714|63276674|FG005|Overall Study|Withdrawal by Subject|0|||
33709614|NCT01533714|63276669|FG000|Overall Study|Exclusion criteria|0|||
33709615|NCT01533714|63276670|FG001|Overall Study|Exclusion criteria|1|||
33709616|NCT01533714|63276671|FG002|Overall Study|Exclusion criteria|0|||
33709617|NCT01533714|63276672|FG003|Overall Study|Exclusion criteria|0|||
33709618|NCT01533714|63276673|FG004|Overall Study|Exclusion criteria|0|||
33709619|NCT01533714|63276674|FG005|Overall Study|Exclusion criteria|0|||
33709620|NCT01533714|63276669|FG000|Overall Study|Positive for purified protein derivative|0|||
33709621|NCT01533714|63276670|FG001|Overall Study|Positive for purified protein derivative|0|||
33709622|NCT01533714|63276671|FG002|Overall Study|Positive for purified protein derivative|1|||
33709623|NCT01533714|63276672|FG003|Overall Study|Positive for purified protein derivative|0|||
33709624|NCT01533714|63276673|FG004|Overall Study|Positive for purified protein derivative|1|||
33709625|NCT01533714|63276674|FG005|Overall Study|Positive for purified protein derivative|0|||
33709626|NCT01533714|63276669|FG000|Overall Study|Withdrawal criteria|0|||
33709627|NCT01533714|63276670|FG001|Overall Study|Withdrawal criteria|0|||
33709628|NCT01533714|63276671|FG002|Overall Study|Withdrawal criteria|1|||
33709629|NCT01533714|63276672|FG003|Overall Study|Withdrawal criteria|0|||
33709630|NCT01533714|63276673|FG004|Overall Study|Withdrawal criteria|3|||
33709631|NCT01533714|63276674|FG005|Overall Study|Withdrawal criteria|1|||
33709632|NCT01533714|63276669|FG000|Overall Study|Ineligibility reason|0|||
33709633|NCT01533714|63276670|FG001|Overall Study|Ineligibility reason|0|||
33709634|NCT01533714|63276671|FG002|Overall Study|Ineligibility reason|0|||
33709635|NCT01533714|63276672|FG003|Overall Study|Ineligibility reason|1|||
33709636|NCT01533714|63276673|FG004|Overall Study|Ineligibility reason|0|||
33709637|NCT01533714|63276674|FG005|Overall Study|Ineligibility reason|0|||
33709638|NCT01533246|63276688|FG000|Overall Study|Adverse Event|1|||
33709639|NCT01533246|63276688|FG000|Overall Study|Withdrawal by Subject|1|||
33709640|NCT01579578|63276694|FG000|Overall Study|Death|4|||
33709641|NCT01579578|63276695|FG001|Overall Study|Death|1|||
33709642|NCT01579578|63276694|FG000|Overall Study|Lost to Follow-up|1|||
33709643|NCT01579578|63276695|FG001|Overall Study|Lost to Follow-up|1|||
33709644|NCT01579578|63276694|FG000|Overall Study|Withdrawal by Subject|2|||
33709645|NCT01579578|63276695|FG001|Overall Study|Withdrawal by Subject|1|||
33709646|NCT01579578|63276694|FG000|Overall Study|Eligibility criteria|3|||
33709647|NCT01579578|63276695|FG001|Overall Study|Eligibility criteria|9|||
33709648|NCT01579578|63276694|FG000|Overall Study|Ongoing|3|||
33709649|NCT01579578|63276695|FG001|Overall Study|Ongoing|0|||
33709650|NCT01578486|63276701|FG000|Overall Study|Physician Decision|3|||
33709651|NCT01578486|63276701|FG000|Overall Study|Withdrawal by Subject|2|||
33709652|NCT01532934|63276707|FG000|Overall Study|Lost to Follow-up|11|||
33709653|NCT01532934|63276708|FG001|Overall Study|Lost to Follow-up|11|||
33709654|NCT01532934|63276707|FG000|Overall Study|In controlled environment|3|||
33709655|NCT01532934|63276708|FG001|Overall Study|In controlled environment|2|||
33709656|NCT01532388|63276718|FG000|3-month Follow-up|Lost to Follow-up|68|||
33709657|NCT01532388|63276719|FG001|3-month Follow-up|Lost to Follow-up|68|||
33709658|NCT01532388|63276718|FG000|6-month Follow-up|Lost to Follow-up|74|||
33709659|NCT01532388|63276719|FG001|6-month Follow-up|Lost to Follow-up|66|||
33709660|NCT01532388|63276718|FG000|12-month Follow-up|Lost to Follow-up|69|||
33709661|NCT01532388|63276719|FG001|12-month Follow-up|Lost to Follow-up|67|||
33709662|NCT01555164|63276727|FG000|Overall Study|Adverse Event|5|||
33709663|NCT01555164|63276728|FG001|Overall Study|Adverse Event|7|||
33709664|NCT01555164|63276727|FG000|Overall Study|Hyperglycemia|0|||
33709665|NCT01555164|63276728|FG001|Overall Study|Hyperglycemia|1|||
33709666|NCT01555164|63276727|FG000|Overall Study|Investigator's Discretion|2|||
33709667|NCT01555164|63276728|FG001|Overall Study|Investigator's Discretion|2|||
33709668|NCT01555164|63276727|FG000|Overall Study|Lost to Follow-up|4|||
33709669|NCT01555164|63276728|FG001|Overall Study|Lost to Follow-up|3|||
33709670|NCT01555164|63276727|FG000|Overall Study|Protocol Violation|9|||
33709671|NCT01555164|63276728|FG001|Overall Study|Protocol Violation|5|||
33709672|NCT01555164|63276727|FG000|Overall Study|Subject Non-compliance|14|||
33709673|NCT01555164|63276728|FG001|Overall Study|Subject Non-compliance|6|||
33709674|NCT01555164|63276727|FG000|Overall Study|Subject Withdrew Consent|6|||
33709675|NCT01555164|63276728|FG001|Overall Study|Subject Withdrew Consent|11|||
33709676|NCT01578330|63276734|FG000|Overall Study|Adverse Event|2|||
33709677|NCT01578330|63276734|FG000|Overall Study|Protocol Violation|5|||
33709678|NCT01577160|63276738|FG000|Overall Study|Adverse Event|9|||
33709679|NCT01577160|63276738|FG000|Overall Study|Lack of Efficacy|15|||
33709680|NCT01577160|63276738|FG000|Overall Study|Lost to Follow-up|40|||
33709681|NCT01577160|63276738|FG000|Overall Study|Withdrawal by Subject|18|||
33709682|NCT01577160|63276738|FG000|Overall Study|Subject Uncooperative|7|||
33709683|NCT01577160|63276738|FG000|Overall Study|Other|9|||
33709684|NCT01554618|63276744|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
33709685|NCT01554618|63276745|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
33709686|NCT01554618|63276744|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
33709687|NCT01554618|63276745|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
33709688|NCT01554618|63276744|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
33709689|NCT01554618|63276745|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
33709690|NCT01554618|63276744|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
33709691|NCT01554618|63276745|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
33709692|NCT01554618|63276744|FG000|Open-Label Extension Period|Physician Decision|0|||
33709693|NCT01554618|63276745|FG001|Open-Label Extension Period|Physician Decision|1|||
33709694|NCT01554618|63276744|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
33709695|NCT01554618|63276745|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
33709696|NCT01531998|63276755|FG000|Overall Study|Withdrawal by Subject|3|||
33709697|NCT01576146|63276759|FG000|Extension Period 1|Adverse Event|2|||
33709698|NCT01576146|63276759|FG000|Extension Period 1|Death|2|||
33709699|NCT01576146|63276759|FG000|Extension Period 1|Physician Decision|2|||
33709700|NCT01576146|63276759|FG000|Extension Period 1|Withdrawal by Subject|1|||
33709701|NCT01576146|63276759|FG000|Extension Period 1|Lost to Follow-up|1|||
33709702|NCT01576146|63276759|FG000|Extension Period 1|Parathyroidectomy|1|||
33709703|NCT01576146|63276759|FG000|Extension Period 1|Renal Transplant|1|||
33597114|NCT02100657|62996063|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
33597115|NCT02100657|62996064|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
33597116|NCT02100657|62996065|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
33597117|NCT02100657|62996063|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
33597118|NCT02100657|62996064|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
33597119|NCT02100657|62996065|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
33597120|NCT02067663|62996076|FG000|Overall Study|Lost to Follow-up|13|||
33597121|NCT02067663|62996077|FG001|Overall Study|Lost to Follow-up|14|||
33597122|NCT01909804|62996095|FG000|Overall Study|Randomized but Never Treated|0|||
33597123|NCT01909804|62996096|FG001|Overall Study|Randomized but Never Treated|0|||
33597124|NCT01909804|62996097|FG002|Overall Study|Randomized but Never Treated|0|||
33597125|NCT01909804|62996098|FG003|Overall Study|Randomized but Never Treated|0|||
33597126|NCT01909804|62996099|FG004|Overall Study|Randomized but Never Treated|0|||
33597127|NCT01909804|62996100|FG005|Overall Study|Randomized but Never Treated|0|||
33597128|NCT01909804|62996101|FG006|Overall Study|Randomized but Never Treated|1|||
33597129|NCT01909804|62996102|FG007|Overall Study|Randomized but Never Treated|0|||
33597130|NCT01909804|62996103|FG008|Overall Study|Randomized but Never Treated|0|||
33597131|NCT01909804|62996104|FG009|Overall Study|Randomized but Never Treated|0|||
33597132|NCT01909804|62996105|FG010|Overall Study|Randomized but Never Treated|0|||
33597133|NCT01909804|62996106|FG011|Overall Study|Randomized but Never Treated|1|||
33597134|NCT01909804|62996095|FG000|Overall Study|Death|0|||
33597135|NCT01909804|62996096|FG001|Overall Study|Death|0|||
33597136|NCT01909804|62996097|FG002|Overall Study|Death|0|||
33597137|NCT01909804|62996098|FG003|Overall Study|Death|0|||
33597138|NCT01909804|62996099|FG004|Overall Study|Death|0|||
33597139|NCT01909804|62996100|FG005|Overall Study|Death|0|||
33597140|NCT01909804|62996101|FG006|Overall Study|Death|0|||
33597141|NCT01909804|62996102|FG007|Overall Study|Death|0|||
33597142|NCT01909804|62996103|FG008|Overall Study|Death|0|||
33597143|NCT01909804|62996104|FG009|Overall Study|Death|0|||
33597144|NCT01909804|62996105|FG010|Overall Study|Death|1|||
33597145|NCT01909804|62996106|FG011|Overall Study|Death|0|||
33597146|NCT01909804|62996095|FG000|Overall Study|Lack of Efficacy|4|||
33597147|NCT01909804|62996096|FG001|Overall Study|Lack of Efficacy|1|||
33597148|NCT01909804|62996097|FG002|Overall Study|Lack of Efficacy|0|||
33597149|NCT01909804|62996098|FG003|Overall Study|Lack of Efficacy|0|||
33597150|NCT01909804|62996099|FG004|Overall Study|Lack of Efficacy|7|||
33597151|NCT01909804|62996100|FG005|Overall Study|Lack of Efficacy|3|||
33597152|NCT01909804|62996101|FG006|Overall Study|Lack of Efficacy|1|||
33709704|NCT01576146|63276759|FG000|Extension Period 2|Sponsor Decision|13|||
33709705|NCT01576146|63276759|FG000|Extension Period 2|Death|1|||
33597153|NCT01909804|62996102|FG007|Overall Study|Lack of Efficacy|1|||
33597154|NCT01909804|62996103|FG008|Overall Study|Lack of Efficacy|0|||
33597155|NCT01909804|62996104|FG009|Overall Study|Lack of Efficacy|1|||
33597156|NCT01909804|62996105|FG010|Overall Study|Lack of Efficacy|0|||
33709706|NCT01576146|63276759|FG000|Extension Period 2|Adverse Event|1|||
33709707|NCT01576146|63276759|FG000|Extension Period 2|Renal Transplant|1|||
33597157|NCT01909804|62996106|FG011|Overall Study|Lack of Efficacy|1|||
33597158|NCT01909804|62996095|FG000|Overall Study|Withdrew Consent|0|||
33597159|NCT01909804|62996096|FG001|Overall Study|Withdrew Consent|0|||
33597160|NCT01909804|62996097|FG002|Overall Study|Withdrew Consent|0|||
33709708|NCT01576146|63276759|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
33709709|NCT01553916|63276763|FG000|Overall Study|Withdrawal by Subject|2|||
33709710|NCT01553916|63276763|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
33709711|NCT01553136|63276769|FG000|Overall Study|Adverse Event|3|||
33709712|NCT01553136|63276770|FG001|Overall Study|Adverse Event|2|||
33709713|NCT01553136|63276769|FG000|Overall Study|Withdrawal by Subject|2|||
33709714|NCT01553136|63276770|FG001|Overall Study|Withdrawal by Subject|3|||
33709715|NCT01553136|63276769|FG000|Overall Study|Lost to Follow-up|4|||
33709716|NCT01553136|63276770|FG001|Overall Study|Lost to Follow-up|10|||
33709717|NCT01553136|63276769|FG000|Overall Study|Physician Decision|2|||
33709718|NCT01553136|63276770|FG001|Overall Study|Physician Decision|3|||
33709719|NCT01553136|63276769|FG000|Overall Study|Scheduling Difficulties|5|||
33709720|NCT01553136|63276770|FG001|Overall Study|Scheduling Difficulties|4|||
33709721|NCT01552902|63276779|FG000|Overall Study|Adverse Event|1|||
33709722|NCT01552902|63276780|FG001|Overall Study|Adverse Event|15|||
33709723|NCT01552902|63276781|FG002|Overall Study|Adverse Event|14|||
33709724|NCT01552902|63276779|FG000|Overall Study|Protocol Violation|3|||
33709725|NCT01552902|63276780|FG001|Overall Study|Protocol Violation|3|||
33709726|NCT01552902|63276781|FG002|Overall Study|Protocol Violation|3|||
33709727|NCT01552902|63276779|FG000|Overall Study|Lack of Efficacy|4|||
33310858|NCT01160289|62686258|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
33310859|NCT01160289|62686259|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
33310860|NCT01160289|62686254|FG000|Post-Randomization Period|Adverse Event|0|||
33310861|NCT01160289|62686255|FG001|Post-Randomization Period|Adverse Event|4|||
33310862|NCT01160289|62686256|FG002|Post-Randomization Period|Adverse Event|4|||
33310863|NCT01160289|62686257|FG003|Post-Randomization Period|Adverse Event|2|||
33310864|NCT01160289|62686258|FG004|Post-Randomization Period|Adverse Event|0|||
33310865|NCT01160289|62686259|FG005|Post-Randomization Period|Adverse Event|0|||
33310866|NCT01160289|62686254|FG000|Post-Randomization Period|Death|0|||
33310867|NCT01160289|62686255|FG001|Post-Randomization Period|Death|0|||
33310868|NCT01160289|62686256|FG002|Post-Randomization Period|Death|0|||
33310869|NCT01160289|62686257|FG003|Post-Randomization Period|Death|1|||
33597161|NCT01909804|62996098|FG003|Overall Study|Withdrew Consent|0|||
33597162|NCT01909804|62996099|FG004|Overall Study|Withdrew Consent|1|||
33597163|NCT01909804|62996100|FG005|Overall Study|Withdrew Consent|1|||
33310870|NCT01160289|62686258|FG004|Post-Randomization Period|Death|0|||
33310871|NCT01160289|62686259|FG005|Post-Randomization Period|Death|0|||
33310872|NCT01160289|62686254|FG000|Post-Randomization Period|Lack of Efficacy|0|||
33310873|NCT01160289|62686255|FG001|Post-Randomization Period|Lack of Efficacy|1|||
33310874|NCT01160289|62686256|FG002|Post-Randomization Period|Lack of Efficacy|0|||
33310875|NCT01160289|62686257|FG003|Post-Randomization Period|Lack of Efficacy|3|||
33310876|NCT01160289|62686258|FG004|Post-Randomization Period|Lack of Efficacy|0|||
33310877|NCT01160289|62686259|FG005|Post-Randomization Period|Lack of Efficacy|0|||
33310878|NCT01160289|62686254|FG000|Post-Randomization Period|Lost to Follow-up|0|||
33310879|NCT01160289|62686255|FG001|Post-Randomization Period|Lost to Follow-up|3|||
33709728|NCT01552902|63276780|FG001|Overall Study|Lack of Efficacy|3|||
33709729|NCT01552902|63276781|FG002|Overall Study|Lack of Efficacy|1|||
33709730|NCT01552902|63276779|FG000|Overall Study|Withdrawal by Subject|1|||
33310880|NCT01160289|62686256|FG002|Post-Randomization Period|Lost to Follow-up|2|||
33310881|NCT01160289|62686257|FG003|Post-Randomization Period|Lost to Follow-up|5|||
33310882|NCT01160289|62686258|FG004|Post-Randomization Period|Lost to Follow-up|3|||
33310883|NCT01160289|62686259|FG005|Post-Randomization Period|Lost to Follow-up|4|||
33310884|NCT01160289|62686254|FG000|Post-Randomization Period|Physician Decision|0|||
33310885|NCT01160289|62686255|FG001|Post-Randomization Period|Physician Decision|0|||
33597164|NCT01909804|62996101|FG006|Overall Study|Withdrew Consent|0|||
33709731|NCT01552902|63276780|FG001|Overall Study|Withdrawal by Subject|9|||
33310886|NCT01160289|62686256|FG002|Post-Randomization Period|Physician Decision|1|||
33310887|NCT01160289|62686257|FG003|Post-Randomization Period|Physician Decision|0|||
33310888|NCT01160289|62686258|FG004|Post-Randomization Period|Physician Decision|0|||
33310889|NCT01160289|62686259|FG005|Post-Randomization Period|Physician Decision|0|||
33310890|NCT01160289|62686254|FG000|Post-Randomization Period|Protocol Violation|0|||
33310891|NCT01160289|62686255|FG001|Post-Randomization Period|Protocol Violation|4|||
33310892|NCT01160289|62686256|FG002|Post-Randomization Period|Protocol Violation|2|||
33310893|NCT01160289|62686257|FG003|Post-Randomization Period|Protocol Violation|0|||
33310894|NCT01160289|62686258|FG004|Post-Randomization Period|Protocol Violation|1|||
33310895|NCT01160289|62686259|FG005|Post-Randomization Period|Protocol Violation|3|||
33310896|NCT01160289|62686254|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
33709732|NCT01552902|63276781|FG002|Overall Study|Withdrawal by Subject|6|||
33709733|NCT01552902|63276779|FG000|Overall Study|Lost to Follow-up|1|||
33709734|NCT01552902|63276780|FG001|Overall Study|Lost to Follow-up|3|||
33709735|NCT01552902|63276781|FG002|Overall Study|Lost to Follow-up|6|||
33709736|NCT01552902|63276779|FG000|Overall Study|Other|3|||
33709737|NCT01552902|63276780|FG001|Overall Study|Other|4|||
33709738|NCT01552902|63276781|FG002|Overall Study|Other|3|||
33709739|NCT01529346|63276807|FG000|Overall Study|Lost to Follow-up|2|||
33709740|NCT01529346|63276808|FG001|Overall Study|Lost to Follow-up|0|||
33709741|NCT01529346|63276809|FG002|Overall Study|Lost to Follow-up|1|||
33709742|NCT01529346|63276810|FG003|Overall Study|Lost to Follow-up|0|||
33709743|NCT01529346|63276811|FG004|Overall Study|Lost to Follow-up|0|||
33709744|NCT01529346|63276807|FG000|Overall Study|Other|0|||
33709745|NCT01529346|63276808|FG001|Overall Study|Other|1|||
33709746|NCT01529346|63276809|FG002|Overall Study|Other|1|||
33709747|NCT01529346|63276810|FG003|Overall Study|Other|0|||
33709748|NCT01529346|63276811|FG004|Overall Study|Other|0|||
33709749|NCT01529268|63276835|FG000|Overall Study|Lost to Follow-up|9|||
33709750|NCT01529268|63276836|FG001|Overall Study|Lost to Follow-up|3|||
33709751|NCT01529268|63276835|FG000|Overall Study|Moved|3|||
33709752|NCT01529268|63276836|FG001|Overall Study|Moved|0|||
33709753|NCT01529112|63276844|FG000|Overall Study|Adverse Event|2|||
33709754|NCT01529112|63276845|FG001|Overall Study|Adverse Event|0|||
33493371|NCT03134222|62871696|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
33493372|NCT03134222|62871692|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
33709755|NCT01529112|63276844|FG000|Overall Study|Death|59|||
33709756|NCT01529112|63276845|FG001|Overall Study|Death|38|||
33709757|NCT01529112|63276844|FG000|Overall Study|Protocol Violation|1|||
33709758|NCT01529112|63276845|FG001|Overall Study|Protocol Violation|0|||
33709759|NCT01529112|63276844|FG000|Overall Study|Withdrawal by Subject|7|||
33493373|NCT03134222|62871693|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
33493374|NCT03134222|62871694|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
33709760|NCT01529112|63276845|FG001|Overall Study|Withdrawal by Subject|3|||
33709761|NCT01551420|63276853|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
33709762|NCT01551420|63276854|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
33709763|NCT01551420|63276853|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
33709764|NCT01551420|63276854|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
33709765|NCT01551420|63276853|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
33709766|NCT01551420|63276854|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
33709767|NCT01551420|63276853|FG000|Screened for Part B Eligibility|Declined participation|8|||
33709768|NCT01551420|63276854|FG001|Screened for Part B Eligibility|Declined participation|1|||
33709769|NCT01551420|63276853|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
33709770|NCT01551420|63276854|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
33709771|NCT01551420|63276853|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
33709772|NCT01551420|63276854|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
33709773|NCT01551420|63276853|FG000|Home Use (Part B)|Withdrawal by staff|0|||
33709774|NCT01551420|63276854|FG001|Home Use (Part B)|Withdrawal by staff|1|||
33709775|NCT01575054|63276862|FG000|Overall Study|Other Reasons|5|||
33709776|NCT01575054|63276863|FG001|Overall Study|Other Reasons|3|||
33709777|NCT01575054|63276862|FG000|Overall Study|Protocol Violation|2|||
33709778|NCT01575054|63276863|FG001|Overall Study|Protocol Violation|1|||
33709779|NCT01575054|63276862|FG000|Overall Study|Personal Reasons|10|||
33709780|NCT01575054|63276863|FG001|Overall Study|Personal Reasons|11|||
33709781|NCT01575054|63276862|FG000|Overall Study|Lost to Follow-up|3|||
33709782|NCT01575054|63276863|FG001|Overall Study|Lost to Follow-up|3|||
33709783|NCT01575054|63276862|FG000|Overall Study|Adverse Event|9|||
33709784|NCT01575054|63276863|FG001|Overall Study|Adverse Event|8|||
33709785|NCT01528254|63276871|FG000|Overall Study|Administrative problems|96|||
33709786|NCT01528254|63276872|FG001|Overall Study|Administrative problems|94|||
33709787|NCT01528254|63276871|FG000|Overall Study|Adverse Event|28|||
33709788|NCT01528254|63276872|FG001|Overall Study|Adverse Event|44|||
33709789|NCT01528254|63276871|FG000|Overall Study|Lost to Follow-up|17|||
33709790|NCT01528254|63276872|FG001|Overall Study|Lost to Follow-up|24|||
33709791|NCT01528254|63276871|FG000|Overall Study|Death|13|||
33709792|NCT01528254|63276872|FG001|Overall Study|Death|9|||
33709793|NCT01528254|63276871|FG000|Overall Study|Protocol deviation|9|||
33709794|NCT01528254|63276872|FG001|Overall Study|Protocol deviation|19|||
33709795|NCT01528254|63276871|FG000|Overall Study|New therapy for study indication|8|||
33709796|NCT01528254|63276872|FG001|Overall Study|New therapy for study indication|6|||
33709797|NCT01528254|63276871|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
33709798|NCT01528254|63276872|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
33709799|NCT01528254|63276871|FG000|Overall Study|Withdrawal by Subject|5|||
33709800|NCT01528254|63276872|FG001|Overall Study|Withdrawal by Subject|4|||
33709801|NCT01528254|63276871|FG000|Overall Study|Abnormal laboratory value(s)|3|||
33709802|NCT01528254|63276872|FG001|Overall Study|Abnormal laboratory value(s)|7|||
33709803|NCT01528254|63276871|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33709804|NCT01528254|63276872|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33709805|NCT01528254|63276871|FG000|Overall Study|No longer requires study drug|1|||
33709806|NCT01528254|63276872|FG001|Overall Study|No longer requires study drug|1|||
33709807|NCT01574352|63276881|FG000|Overall Study|Withdrawal by Subject|6|||
33709808|NCT01574352|63276882|FG001|Overall Study|Withdrawal by Subject|13|||
33709809|NCT01574352|63276881|FG000|Overall Study|Injury in non-camp related sport|1|||
33709810|NCT01574352|63276882|FG001|Overall Study|Injury in non-camp related sport|0|||
33709811|NCT01527006|63276890|FG000|Core Study|Adverse Event|0|||
33709812|NCT01527006|63276891|FG001|Core Study|Adverse Event|2|||
33709813|NCT01527006|63276890|FG000|Core Study|Lost to Follow-up|0|||
33709814|NCT01527006|63276891|FG001|Core Study|Lost to Follow-up|1|||
33709815|NCT01527006|63276890|FG000|Core Study|Subject Choice|1|||
33709816|NCT01527006|63276891|FG001|Core Study|Subject Choice|0|||
33709817|NCT01527006|63276890|FG000|Core Study|Inadequate Therapeutic Effect|1|||
33709818|NCT01527006|63276891|FG001|Core Study|Inadequate Therapeutic Effect|0|||
33709819|NCT01527006|63276890|FG000|Core Study|Withdrawal by Subject|0|||
33709820|NCT01527006|63276891|FG001|Core Study|Withdrawal by Subject|1|||
33709821|NCT01527006|63276890|FG000|Core Study|Other|0|||
33709822|NCT01527006|63276891|FG001|Core Study|Other|2|||
33709823|NCT01527006|63276890|FG000|Extension Phase|Adverse Event|4|||
33709824|NCT01527006|63276891|FG001|Extension Phase|Adverse Event|2|||
33709825|NCT01527006|63276890|FG000|Extension Phase|Lost to Follow-up|0|||
33709826|NCT01527006|63276891|FG001|Extension Phase|Lost to Follow-up|1|||
33709827|NCT01527006|63276890|FG000|Extension Phase|Subject Choice|1|||
33709828|NCT01527006|63276891|FG001|Extension Phase|Subject Choice|1|||
33709829|NCT01527006|63276890|FG000|Extension Phase|Inadequate therapeutic effect|1|||
33709830|NCT01527006|63276891|FG001|Extension Phase|Inadequate therapeutic effect|1|||
33709831|NCT01527006|63276890|FG000|Extension Phase|Other|0|||
33709832|NCT01527006|63276891|FG001|Extension Phase|Other|3|||
33709833|NCT01526928|63276909|FG000|Overall Study|Progressive Disease|35|||
33709834|NCT01526928|63276910|FG001|Overall Study|Progressive Disease|17|||
33709835|NCT01526928|63276911|FG002|Overall Study|Progressive Disease|150|||
33709836|NCT01526928|63276912|FG003|Overall Study|Progressive Disease|182|||
33709837|NCT01526928|63276913|FG004|Overall Study|Progressive Disease|76|||
33709838|NCT01526928|63276914|FG005|Overall Study|Progressive Disease|4|||
33709839|NCT01526928|63276909|FG000|Overall Study|Adverse Event|2|||
33709840|NCT01526928|63276910|FG001|Overall Study|Adverse Event|1|||
33709841|NCT01526928|63276911|FG002|Overall Study|Adverse Event|29|||
33709842|NCT01526928|63276912|FG003|Overall Study|Adverse Event|40|||
33709843|NCT01526928|63276913|FG004|Overall Study|Adverse Event|13|||
33709844|NCT01526928|63276914|FG005|Overall Study|Adverse Event|2|||
33709845|NCT01526928|63276909|FG000|Overall Study|Death|0|||
33709846|NCT01526928|63276910|FG001|Overall Study|Death|0|||
33709847|NCT01526928|63276911|FG002|Overall Study|Death|3|||
33709848|NCT01526928|63276912|FG003|Overall Study|Death|0|||
33709849|NCT01526928|63276913|FG004|Overall Study|Death|0|||
33709850|NCT01526928|63276914|FG005|Overall Study|Death|0|||
33709851|NCT01526928|63276909|FG000|Overall Study|Withdrawal by Subject|1|||
33709852|NCT01526928|63276910|FG001|Overall Study|Withdrawal by Subject|0|||
33709853|NCT01526928|63276911|FG002|Overall Study|Withdrawal by Subject|13|||
33709854|NCT01526928|63276912|FG003|Overall Study|Withdrawal by Subject|11|||
33709855|NCT01526928|63276913|FG004|Overall Study|Withdrawal by Subject|3|||
33709856|NCT01526928|63276914|FG005|Overall Study|Withdrawal by Subject|0|||
33709857|NCT01526928|63276909|FG000|Overall Study|Physician Decision|0|||
33709858|NCT01526928|63276910|FG001|Overall Study|Physician Decision|0|||
33709859|NCT01526928|63276911|FG002|Overall Study|Physician Decision|2|||
33709860|NCT01526928|63276912|FG003|Overall Study|Physician Decision|5|||
33709861|NCT01526928|63276913|FG004|Overall Study|Physician Decision|0|||
33709862|NCT01526928|63276914|FG005|Overall Study|Physician Decision|0|||
33709863|NCT01526928|63276909|FG000|Overall Study|Other Reason|0|||
33709864|NCT01526928|63276910|FG001|Overall Study|Other Reason|1|||
33709865|NCT01526928|63276911|FG002|Overall Study|Other Reason|11|||
33709866|NCT01526928|63276912|FG003|Overall Study|Other Reason|4|||
33709867|NCT01526928|63276913|FG004|Overall Study|Other Reason|1|||
33597165|NCT01909804|62996102|FG007|Overall Study|Withdrew Consent|0|||
33709868|NCT01526928|63276914|FG005|Overall Study|Other Reason|0|||
33709869|NCT01526928|63276909|FG000|Overall Study|Lost to Follow-up|0|||
33709870|NCT01526928|63276910|FG001|Overall Study|Lost to Follow-up|0|||
33597166|NCT01909804|62996103|FG008|Overall Study|Withdrew Consent|0|||
33597167|NCT01909804|62996104|FG009|Overall Study|Withdrew Consent|0|||
33709871|NCT01526928|63276911|FG002|Overall Study|Lost to Follow-up|0|||
33709872|NCT01526928|63276912|FG003|Overall Study|Lost to Follow-up|1|||
33709873|NCT01526928|63276913|FG004|Overall Study|Lost to Follow-up|0|||
33709874|NCT01526928|63276914|FG005|Overall Study|Lost to Follow-up|0|||
33709875|NCT01526928|63276909|FG000|Overall Study|Protocol Deviation|0|||
33709876|NCT01526928|63276910|FG001|Overall Study|Protocol Deviation|0|||
33709877|NCT01526928|63276911|FG002|Overall Study|Protocol Deviation|0|||
33597168|NCT01909804|62996105|FG010|Overall Study|Withdrew Consent|0|||
33401528|NCT00724451|62780517|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
33401529|NCT00724451|62780517|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
33401530|NCT00724451|62780517|FG000|Overall Study|Not Eligible for Treatment|431|||
33597169|NCT01909804|62996106|FG011|Overall Study|Withdrew Consent|0|||
33597170|NCT01909804|62996095|FG000|Overall Study|Protocol Violation|0|||
33597171|NCT01909804|62996096|FG001|Overall Study|Protocol Violation|0|||
33597172|NCT01909804|62996097|FG002|Overall Study|Protocol Violation|0|||
33597173|NCT01909804|62996098|FG003|Overall Study|Protocol Violation|0|||
33597174|NCT01909804|62996099|FG004|Overall Study|Protocol Violation|0|||
33597175|NCT01909804|62996100|FG005|Overall Study|Protocol Violation|0|||
33597176|NCT01909804|62996101|FG006|Overall Study|Protocol Violation|0|||
33597177|NCT01909804|62996102|FG007|Overall Study|Protocol Violation|0|||
33401531|NCT00724451|62780517|FG000|Overall Study|Participant Refused Treatment|89|||
33401532|NCT00724451|62780517|FG000|Overall Study|Never Started Treatment|89|||
33401533|NCT00724451|62780517|FG000|Overall Study|Unknown; No Data Sources Available|9|||
33401534|NCT00724451|62780517|FG000|Overall Study|Physician Decision|116|||
33401535|NCT00724451|62780517|FG000|Overall Study|Withdrawal by Subject|45|||
33401536|NCT00724451|62780517|FG000|Overall Study|Investigator + Participant Decision|13|||
33401537|NCT00724373|62780521|FG000|Overall Study|Adverse Event|41|||
33401538|NCT00724373|62780521|FG000|Overall Study|Lack of Efficacy|82|||
33401539|NCT00724373|62780521|FG000|Overall Study|Lost to Follow-up|7|||
33401540|NCT00724373|62780521|FG000|Overall Study|Non-compliance|2|||
33401541|NCT00724373|62780521|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
33401542|NCT00724373|62780521|FG000|Overall Study|Participant moved away|1|||
33401543|NCT00724373|62780521|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
33401544|NCT00724373|62780521|FG000|Overall Study|Only to have 24 week regimen|1|||
33401545|NCT00724373|62780521|FG000|Overall Study|Viral Relapse|1|||
33401546|NCT00724373|62780521|FG000|Overall Study|Acute HCV infection|1|||
33597178|NCT01909804|62996103|FG008|Overall Study|Protocol Violation|0|||
33597179|NCT01909804|62996104|FG009|Overall Study|Protocol Violation|0|||
33401547|NCT00724373|62780521|FG000|Overall Study|Drug Relapse|1|||
33401548|NCT00724373|62780521|FG000|Overall Study|Tolerability|23|||
33597180|NCT01909804|62996105|FG010|Overall Study|Protocol Violation|0|||
33597181|NCT01909804|62996106|FG011|Overall Study|Protocol Violation|1|||
33597182|NCT01880086|62996130|FG000|Overall Study|Lost to Follow-up|1|||
33401549|NCT00724061|62780525|FG000|Dose Escalation Phase|Adverse Event|2|||
33401550|NCT00724061|62780525|FG000|Dose Escalation Phase|Disease Progression|3|||
33401551|NCT00731549|62780529|FG000|Overall Study|Lost to Follow-up|19|||
33401552|NCT00731549|62780529|FG000|Overall Study|Met withdrawal criteria|24|||
33401553|NCT00731549|62780529|FG000|Overall Study|Physician Decision|16|||
33401554|NCT00731549|62780529|FG000|Overall Study|Withdrawal by Subject|89|||
33401555|NCT00731549|62780529|FG000|Overall Study|Protocol deviation|1|||
33401556|NCT00731549|62780529|FG000|Overall Study|Adverse Event|31|||
33401557|NCT00731549|62780529|FG000|Overall Study|Lack of efficacy with AE|37|||
33401558|NCT00731549|62780529|FG000|Overall Study|Lack of efficacy without AE|6|||
33401559|NCT00730925|62780574|FG000|Overall Study|Progressive Disease|21|||
33401560|NCT00730925|62780574|FG000|Overall Study|Dose reducing Event|2|||
33597183|NCT01880086|62996131|FG001|Overall Study|Lost to Follow-up|1|||
33597184|NCT01879852|62996139|FG000|Overall Study|Withdrawal by Subject|2|||
33597185|NCT01879852|62996140|FG001|Overall Study|Withdrawal by Subject|0|||
33597186|NCT01879618|62996146|FG000|Overall Study|Does not meet entrance criteria|1|||
33597187|NCT01879618|62996146|FG000|Overall Study|Withdrawal by Subject|1|||
33401561|NCT00730925|62780574|FG000|Overall Study|Other Averse Event|7|||
33401562|NCT00730925|62780574|FG000|Overall Study|Protocol Violation|1|||
33597188|NCT01879618|62996146|FG000|Overall Study|Surgery;changed schedule; not available|8|||
33709878|NCT01526928|63276912|FG003|Overall Study|Protocol Deviation|2|||
33709879|NCT01526928|63276913|FG004|Overall Study|Protocol Deviation|0|||
33709880|NCT01526928|63276914|FG005|Overall Study|Protocol Deviation|0|||
33709881|NCT01526928|63276909|FG000|Overall Study|Missing|0|||
33709882|NCT01526928|63276910|FG001|Overall Study|Missing|0|||
33709883|NCT01526928|63276911|FG002|Overall Study|Missing|1|||
33709884|NCT01526928|63276912|FG003|Overall Study|Missing|0|||
33709885|NCT01526928|63276913|FG004|Overall Study|Missing|2|||
33709886|NCT01526928|63276914|FG005|Overall Study|Missing|0|||
33709887|NCT01549860|63276972|FG000|Overall Study|Withdrawal by Subject|1|||
33709888|NCT01549860|63276973|FG001|Overall Study|Withdrawal by Subject|0|||
33709889|NCT01549860|63276972|FG000|Overall Study|Physician Decision|1|||
33709890|NCT01549860|63276973|FG001|Overall Study|Physician Decision|1|||
33709891|NCT01549392|63276981|FG000|Overall Study|Withdrawal by Subject|1|||
33709892|NCT01549392|63276982|FG001|Overall Study|Withdrawal by Subject|0|||
33709893|NCT01526148|63276990|FG000|Overall Study|Adverse Event|6|||
33709894|NCT01526148|63276991|FG001|Overall Study|Adverse Event|5|||
33709895|NCT01526148|63276990|FG000|Overall Study|Lost to Follow-up|3|||
33709896|NCT01526148|63276991|FG001|Overall Study|Lost to Follow-up|6|||
33709897|NCT01526148|63276990|FG000|Overall Study|Withdrawal by Subject|2|||
33709898|NCT01526148|63276991|FG001|Overall Study|Withdrawal by Subject|0|||
33709899|NCT01526148|63276990|FG000|Overall Study|Unstable Medical Condition|1|||
33709900|NCT01526148|63276991|FG001|Overall Study|Unstable Medical Condition|0|||
33709901|NCT01526148|63276990|FG000|Overall Study|Unable to discontinue concomitant med|1|||
33709902|NCT01526148|63276991|FG001|Overall Study|Unable to discontinue concomitant med|0|||
33709903|NCT01526148|63276990|FG000|Overall Study|Moved out of state|1|||
33709904|NCT01526148|63276991|FG001|Overall Study|Moved out of state|0|||
33709905|NCT01526148|63276990|FG000|Overall Study|Incarcerated|0|||
33709906|NCT01526148|63276991|FG001|Overall Study|Incarcerated|2|||
33709907|NCT01572948|63276999|FG000|Overall Study|Lost to Follow-up|1|||
33709908|NCT01572948|63277000|FG001|Overall Study|Lost to Follow-up|0|||
33709909|NCT01572948|63276999|FG000|Overall Study|unable to contact|0|||
33709910|NCT01572948|63277000|FG001|Overall Study|unable to contact|1|||
33709911|NCT01525602|63277018|FG000|Overall Study|Adverse Event|1|||
33709912|NCT01525602|63277019|FG001|Overall Study|Adverse Event|0|||
33709913|NCT01525602|63277020|FG002|Overall Study|Adverse Event|1|||
33709914|NCT01525602|63277021|FG003|Overall Study|Adverse Event|1|||
33709915|NCT01525602|63277022|FG004|Overall Study|Adverse Event|3|||
33709916|NCT01525602|63277023|FG005|Overall Study|Adverse Event|3|||
33709917|NCT01525602|63277024|FG006|Overall Study|Adverse Event|0|||
33709918|NCT01525602|63277025|FG007|Overall Study|Adverse Event|1|||
33709919|NCT01525602|63277018|FG000|Overall Study|Disease progression|6|||
33709920|NCT01525602|63277019|FG001|Overall Study|Disease progression|3|||
33709921|NCT01525602|63277020|FG002|Overall Study|Disease progression|2|||
33709922|NCT01525602|63277021|FG003|Overall Study|Disease progression|5|||
33709923|NCT01525602|63277022|FG004|Overall Study|Disease progression|22|||
33709924|NCT01525602|63277023|FG005|Overall Study|Disease progression|2|||
33709925|NCT01525602|63277024|FG006|Overall Study|Disease progression|3|||
33709926|NCT01525602|63277025|FG007|Overall Study|Disease progression|3|||
33493375|NCT03134222|62871695|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
33709927|NCT01525602|63277018|FG000|Overall Study|Clinical progression|2|||
33709928|NCT01525602|63277019|FG001|Overall Study|Clinical progression|0|||
33709929|NCT01525602|63277020|FG002|Overall Study|Clinical progression|0|||
33709930|NCT01525602|63277021|FG003|Overall Study|Clinical progression|0|||
33709931|NCT01525602|63277022|FG004|Overall Study|Clinical progression|0|||
33709932|NCT01525602|63277023|FG005|Overall Study|Clinical progression|0|||
33709933|NCT01525602|63277024|FG006|Overall Study|Clinical progression|1|||
33709934|NCT01525602|63277025|FG007|Overall Study|Clinical progression|1|||
33709935|NCT01525602|63277018|FG000|Overall Study|Non-compliance|0|||
33493376|NCT03134222|62871696|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
33709936|NCT01525602|63277019|FG001|Overall Study|Non-compliance|0|||
33709937|NCT01525602|63277020|FG002|Overall Study|Non-compliance|0|||
33709938|NCT01525602|63277021|FG003|Overall Study|Non-compliance|0|||
33709939|NCT01525602|63277022|FG004|Overall Study|Non-compliance|1|||
33709940|NCT01525602|63277023|FG005|Overall Study|Non-compliance|0|||
33709941|NCT01525602|63277024|FG006|Overall Study|Non-compliance|0|||
33709942|NCT01525602|63277025|FG007|Overall Study|Non-compliance|0|||
33709943|NCT01525602|63277018|FG000|Overall Study|Withdrawal by Subject|0|||
33709944|NCT01525602|63277019|FG001|Overall Study|Withdrawal by Subject|0|||
33709945|NCT01525602|63277020|FG002|Overall Study|Withdrawal by Subject|0|||
33709946|NCT01525602|63277021|FG003|Overall Study|Withdrawal by Subject|0|||
33709947|NCT01525602|63277022|FG004|Overall Study|Withdrawal by Subject|3|||
33709948|NCT01525602|63277023|FG005|Overall Study|Withdrawal by Subject|1|||
33709949|NCT01525602|63277024|FG006|Overall Study|Withdrawal by Subject|0|||
33709950|NCT01525602|63277025|FG007|Overall Study|Withdrawal by Subject|1|||
33709951|NCT01525602|63277018|FG000|Overall Study|Physician Decision|0|||
33709952|NCT01525602|63277019|FG001|Overall Study|Physician Decision|0|||
33709953|NCT01525602|63277020|FG002|Overall Study|Physician Decision|0|||
33709954|NCT01525602|63277021|FG003|Overall Study|Physician Decision|0|||
33709955|NCT01525602|63277022|FG004|Overall Study|Physician Decision|3|||
33709956|NCT01525602|63277023|FG005|Overall Study|Physician Decision|0|||
33709957|NCT01525602|63277024|FG006|Overall Study|Physician Decision|1|||
33709958|NCT01525602|63277025|FG007|Overall Study|Physician Decision|0|||
33709959|NCT01525602|63277018|FG000|Overall Study|Death|0|||
33709960|NCT01525602|63277019|FG001|Overall Study|Death|0|||
33709961|NCT01525602|63277020|FG002|Overall Study|Death|0|||
33709962|NCT01525602|63277021|FG003|Overall Study|Death|0|||
33709963|NCT01525602|63277022|FG004|Overall Study|Death|1|||
33709964|NCT01525602|63277023|FG005|Overall Study|Death|1|||
33709965|NCT01525602|63277024|FG006|Overall Study|Death|0|||
33709966|NCT01525602|63277025|FG007|Overall Study|Death|0|||
33597189|NCT01879618|62996146|FG000|Overall Study|Protocol Violation|6|||
33709967|NCT01525602|63277018|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
33709968|NCT01525602|63277019|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
33709969|NCT01525602|63277020|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
33709970|NCT01525602|63277021|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
33709971|NCT01525602|63277022|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
33709972|NCT01525602|63277023|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
33310897|NCT01160289|62686255|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
33310898|NCT01160289|62686256|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
33310899|NCT01160289|62686257|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
33310900|NCT01160289|62686258|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
33310901|NCT01160289|62686259|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
33597190|NCT01879618|62996146|FG000|Overall Study|Adverse Event|5|||
33597191|NCT01926886|62996150|FG000|Overall Study|Administrative/other|1|||
33310902|NCT01160289|62686254|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
33597192|NCT01926886|62996151|FG001|Overall Study|Administrative/other|0|||
33597193|NCT01926886|62996150|FG000|Overall Study|Adverse event/intercurrent illness|4|||
33597194|NCT01926886|62996151|FG001|Overall Study|Adverse event/intercurrent illness|0|||
33597195|NCT01926886|62996150|FG000|Overall Study|Disease progression/recurrence|4|||
33597196|NCT01926886|62996151|FG001|Overall Study|Disease progression/recurrence|0|||
33597197|NCT01926886|62996150|FG000|Overall Study|Withdrawal by Subject|15|||
33597198|NCT01926886|62996151|FG001|Overall Study|Withdrawal by Subject|0|||
33597199|NCT01926886|62996150|FG000|Overall Study|Failure to return|3|||
33597200|NCT01926886|62996151|FG001|Overall Study|Failure to return|0|||
33597201|NCT01926886|62996150|FG000|Overall Study|Recurrence of disease|1|||
33597202|NCT01926886|62996151|FG001|Overall Study|Recurrence of disease|0|||
33597203|NCT01926886|62996150|FG000|Overall Study|Progression of disease|2|||
33597204|NCT01926886|62996151|FG001|Overall Study|Progression of disease|0|||
33597205|NCT01926886|62996150|FG000|Overall Study|Death|1|||
33597206|NCT01926886|62996151|FG001|Overall Study|Death|0|||
33597207|NCT01926886|62996150|FG000|Overall Study|Did not cooperate|1|||
33597208|NCT01926886|62996151|FG001|Overall Study|Did not cooperate|0|||
33597209|NCT01909336|62996160|FG000|Overall Study|Lost to Follow-up|4|||
33597210|NCT01909336|62996161|FG001|Overall Study|Lost to Follow-up|2|||
33597211|NCT01909336|62996162|FG002|Overall Study|Lost to Follow-up|2|||
33597212|NCT01909336|62996160|FG000|Overall Study|Physician Decision|0|||
33597213|NCT01909336|62996161|FG001|Overall Study|Physician Decision|1|||
33597214|NCT01909336|62996162|FG002|Overall Study|Physician Decision|1|||
33597215|NCT01926028|62996173|FG000|Overall Study|Lost to Follow-up|7|||
33597216|NCT01926028|62996174|FG001|Overall Study|Lost to Follow-up|6|||
33597217|NCT01926028|62996175|FG002|Overall Study|Lost to Follow-up|0|||
33597218|NCT01926028|62996173|FG000|Overall Study|Physician Decision|1|||
33597219|NCT01926028|62996174|FG001|Overall Study|Physician Decision|5|||
33597220|NCT01926028|62996175|FG002|Overall Study|Physician Decision|0|||
33597221|NCT01926028|62996173|FG000|Overall Study|Withdrawal by Subject|9|||
33597222|NCT01926028|62996174|FG001|Overall Study|Withdrawal by Subject|9|||
33597223|NCT01926028|62996175|FG002|Overall Study|Withdrawal by Subject|2|||
33597224|NCT01926028|62996173|FG000|Overall Study|Non compliance or other reasons|4|||
33597225|NCT01926028|62996174|FG001|Overall Study|Non compliance or other reasons|2|||
33597226|NCT01926028|62996175|FG002|Overall Study|Non compliance or other reasons|0|||
33597227|NCT01925950|62996186|FG000|Part 2|Withdrawal by Subject|1|||
33310903|NCT01160289|62686255|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
33310904|NCT01160289|62686256|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
33310905|NCT01160289|62686257|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
33310906|NCT01160289|62686258|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
33310907|NCT01160289|62686259|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
33310908|NCT01160289|62686254|FG000|Post-Randomization Period|Sponsor Decision|0|||
33310909|NCT01160289|62686255|FG001|Post-Randomization Period|Sponsor Decision|1|||
33310910|NCT01160289|62686256|FG002|Post-Randomization Period|Sponsor Decision|0|||
33310911|NCT01160289|62686257|FG003|Post-Randomization Period|Sponsor Decision|0|||
33310912|NCT01160289|62686258|FG004|Post-Randomization Period|Sponsor Decision|0|||
33310913|NCT01160289|62686259|FG005|Post-Randomization Period|Sponsor Decision|0|||
33310914|NCT01159665|62686278|FG000|Overall Study|Withdrawal by Subject|0|||
33310915|NCT01159665|62686279|FG001|Overall Study|Withdrawal by Subject|1|||
33310916|NCT01159665|62686280|FG002|Overall Study|Withdrawal by Subject|0|||
33310917|NCT01159665|62686281|FG003|Overall Study|Withdrawal by Subject|0|||
33310918|NCT01159665|62686282|FG004|Overall Study|Withdrawal by Subject|0|||
33310919|NCT01159665|62686283|FG005|Overall Study|Withdrawal by Subject|0|||
33310920|NCT01159431|62686299|FG000|Overall Study|Adverse Event|1|||
33310921|NCT01159431|62686300|FG001|Overall Study|Adverse Event|2|||
33310922|NCT01159431|62686299|FG000|Overall Study|non-compliance|1|||
33310923|NCT01159431|62686300|FG001|Overall Study|non-compliance|1|||
33310924|NCT01159431|62686299|FG000|Overall Study|Lack of Efficacy|0|||
33709973|NCT01525602|63277024|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
33709974|NCT01525602|63277025|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
33709975|NCT01549002|63277052|FG000|Overall Study|Excessive pain|0|||
33709976|NCT01549002|63277053|FG001|Overall Study|Excessive pain|2|||
33709977|NCT01549002|63277052|FG000|Overall Study|Moderate sedation required|0|||
33310925|NCT01159431|62686300|FG001|Overall Study|Lack of Efficacy|3|||
33310926|NCT01158261|62686313|FG000|Overall Study|Lost to Follow-up|9|||
33310927|NCT01158261|62686313|FG000|Overall Study|Death|7|||
33310928|NCT01158261|62686313|FG000|Overall Study|Withdrawal by Subject|1|||
33310929|NCT01157169|62686319|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
33310930|NCT01157169|62686320|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
33310931|NCT01157169|62686319|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
33310932|NCT01157169|62686320|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
33310933|NCT01231620|62686329|FG000|Overall Study|Physician Decision|3|||
33310934|NCT01231620|62686330|FG001|Overall Study|Physician Decision|5|||
33310935|NCT01231620|62686331|FG002|Overall Study|Physician Decision|10|||
33709978|NCT01549002|63277053|FG001|Overall Study|Moderate sedation required|2|||
33709979|NCT01548768|63277063|FG000|Overall Study|Withdrawal by Subject|0|||
33709980|NCT01548768|63277064|FG001|Overall Study|Withdrawal by Subject|2|||
33709981|NCT01548768|63277065|FG002|Overall Study|Withdrawal by Subject|1|||
33709982|NCT01548768|63277066|FG003|Overall Study|Withdrawal by Subject|0|||
33310936|NCT01231620|62686329|FG000|Overall Study|Death|12|||
33310937|NCT01231620|62686330|FG001|Overall Study|Death|14|||
33310938|NCT01231620|62686331|FG002|Overall Study|Death|11|||
33310939|NCT01231620|62686329|FG000|Overall Study|Adverse Event|2|||
33310940|NCT01231620|62686330|FG001|Overall Study|Adverse Event|2|||
33310941|NCT01231620|62686331|FG002|Overall Study|Adverse Event|1|||
33310942|NCT01231620|62686329|FG000|Overall Study|Withdrawal by Subject|6|||
33310943|NCT01231620|62686330|FG001|Overall Study|Withdrawal by Subject|6|||
33310944|NCT01231620|62686331|FG002|Overall Study|Withdrawal by Subject|8|||
33709983|NCT01548768|63277063|FG000|Overall Study|Physician Decision|1|||
33310945|NCT01231620|62686329|FG000|Overall Study|Lost to Follow-up|3|||
33310946|NCT01231620|62686330|FG001|Overall Study|Lost to Follow-up|4|||
33709984|NCT01548768|63277064|FG001|Overall Study|Physician Decision|0|||
33709985|NCT01548768|63277065|FG002|Overall Study|Physician Decision|0|||
33310947|NCT01231620|62686331|FG002|Overall Study|Lost to Follow-up|9|||
33310948|NCT01231464|62686341|FG000|Overall Study|Adverse Event|0|||
33310949|NCT01231464|62686342|FG001|Overall Study|Adverse Event|1|||
33310950|NCT01231464|62686341|FG000|Overall Study|Protocol Violation|1|||
33310951|NCT01231464|62686342|FG001|Overall Study|Protocol Violation|2|||
33310952|NCT01231464|62686341|FG000|Overall Study|Lost to Follow-up|1|||
33310953|NCT01231464|62686342|FG001|Overall Study|Lost to Follow-up|2|||
33310954|NCT01231464|62686341|FG000|Overall Study|Withdrawal by Subject|3|||
33310955|NCT01231464|62686342|FG001|Overall Study|Withdrawal by Subject|2|||
33310956|NCT01156311|62686352|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
33310957|NCT01156311|62686353|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
33310958|NCT01156311|62686354|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
33310959|NCT01156311|62686355|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
33310960|NCT01156311|62686352|FG000|2-Month Monotherapy Period|Physician Decision|0|||
33310961|NCT01156311|62686353|FG001|2-Month Monotherapy Period|Physician Decision|1|||
33310962|NCT01156311|62686354|FG002|2-Month Monotherapy Period|Physician Decision|0|||
33310963|NCT01156311|62686355|FG003|2-Month Monotherapy Period|Physician Decision|0|||
33310964|NCT01156311|62686352|FG000|2-Month Monotherapy Period|Other|1|||
33310965|NCT01156311|62686353|FG001|2-Month Monotherapy Period|Other|0|||
33310966|NCT01156311|62686354|FG002|2-Month Monotherapy Period|Other|0|||
33310967|NCT01156311|62686355|FG003|2-Month Monotherapy Period|Other|0|||
33310968|NCT01156311|62686352|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
33709986|NCT01548768|63277066|FG003|Overall Study|Physician Decision|0|||
33709987|NCT01548768|63277063|FG000|Overall Study|Adverse Event|0|||
33709988|NCT01548768|63277064|FG001|Overall Study|Adverse Event|0|||
33709989|NCT01548768|63277065|FG002|Overall Study|Adverse Event|0|||
33709990|NCT01548768|63277066|FG003|Overall Study|Adverse Event|1|||
33709991|NCT01548768|63277063|FG000|Overall Study|Non-Compliance|0|||
33310969|NCT01156311|62686353|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
33310970|NCT01156311|62686354|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
33709992|NCT01548768|63277064|FG001|Overall Study|Non-Compliance|0|||
33709993|NCT01548768|63277065|FG002|Overall Study|Non-Compliance|0|||
33709994|NCT01548768|63277066|FG003|Overall Study|Non-Compliance|3|||
33709995|NCT01572792|63277083|FG000|Lead-in Study|Lost to Follow-up|5|||
33709996|NCT01572792|63277084|FG001|Lead-in Study|Lost to Follow-up|9|||
33709997|NCT01572792|63277085|FG002|Lead-in Study|Lost to Follow-up|4|||
33709998|NCT01572792|63277086|FG003|Lead-in Study|Lost to Follow-up|2|||
33709999|NCT01572792|63277087|FG004|Lead-in Study|Lost to Follow-up|4|||
33710000|NCT01572792|63277083|FG000|Lead-in Study|Withdrawal by Subject|22|||
33710001|NCT01572792|63277084|FG001|Lead-in Study|Withdrawal by Subject|11|||
33710002|NCT01572792|63277085|FG002|Lead-in Study|Withdrawal by Subject|12|||
33710003|NCT01572792|63277086|FG003|Lead-in Study|Withdrawal by Subject|24|||
33710004|NCT01572792|63277087|FG004|Lead-in Study|Withdrawal by Subject|11|||
33710005|NCT01572792|63277083|FG000|Lead-in Study|Protocol Violation|19|||
33710006|NCT01572792|63277084|FG001|Lead-in Study|Protocol Violation|10|||
33710007|NCT01572792|63277085|FG002|Lead-in Study|Protocol Violation|12|||
33710008|NCT01572792|63277086|FG003|Lead-in Study|Protocol Violation|13|||
33710009|NCT01572792|63277087|FG004|Lead-in Study|Protocol Violation|21|||
33710010|NCT01572792|63277083|FG000|Lead-in Study|Lack of Efficacy|20|||
33710011|NCT01572792|63277084|FG001|Lead-in Study|Lack of Efficacy|5|||
33710012|NCT01572792|63277085|FG002|Lead-in Study|Lack of Efficacy|4|||
33710013|NCT01572792|63277086|FG003|Lead-in Study|Lack of Efficacy|8|||
33710014|NCT01572792|63277087|FG004|Lead-in Study|Lack of Efficacy|10|||
33710015|NCT01572792|63277083|FG000|Lead-in Study|Adverse Event|21|||
33310971|NCT01156311|62686355|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
33310972|NCT01156311|62686352|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
33310973|NCT01156311|62686353|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
33310974|NCT01156311|62686354|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
33310975|NCT01156311|62686355|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
33310976|NCT01156311|62686352|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
33710016|NCT01572792|63277084|FG001|Lead-in Study|Adverse Event|21|||
33710017|NCT01572792|63277085|FG002|Lead-in Study|Adverse Event|22|||
33710018|NCT01572792|63277086|FG003|Lead-in Study|Adverse Event|16|||
33710019|NCT01572792|63277087|FG004|Lead-in Study|Adverse Event|14|||
33710020|NCT01572792|63277083|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
33710021|NCT01572792|63277084|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
33710022|NCT01572792|63277085|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
33710023|NCT01572792|63277086|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
33710024|NCT01572792|63277087|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
33710025|NCT01572792|63277083|FG000|Extension Study|Lost to Follow-up|6|||
33710026|NCT01572792|63277084|FG001|Extension Study|Lost to Follow-up|2|||
33710027|NCT01572792|63277085|FG002|Extension Study|Lost to Follow-up|0|||
33710028|NCT01572792|63277086|FG003|Extension Study|Lost to Follow-up|3|||
33710029|NCT01572792|63277087|FG004|Extension Study|Lost to Follow-up|3|||
33710030|NCT01572792|63277083|FG000|Extension Study|Withdrawal by Subject|7|||
33710031|NCT01572792|63277084|FG001|Extension Study|Withdrawal by Subject|6|||
33710032|NCT01572792|63277085|FG002|Extension Study|Withdrawal by Subject|11|||
33710033|NCT01572792|63277086|FG003|Extension Study|Withdrawal by Subject|8|||
33710034|NCT01572792|63277087|FG004|Extension Study|Withdrawal by Subject|14|||
33710035|NCT01572792|63277083|FG000|Extension Study|Protocol Violation|0|||
33710036|NCT01572792|63277084|FG001|Extension Study|Protocol Violation|4|||
33710037|NCT01572792|63277085|FG002|Extension Study|Protocol Violation|3|||
33710038|NCT01572792|63277086|FG003|Extension Study|Protocol Violation|4|||
33710039|NCT01572792|63277087|FG004|Extension Study|Protocol Violation|3|||
33710040|NCT01572792|63277083|FG000|Extension Study|Lack of Efficacy|2|||
33710041|NCT01572792|63277084|FG001|Extension Study|Lack of Efficacy|3|||
33310977|NCT01156311|62686353|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
33310978|NCT01156311|62686354|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
33310979|NCT01156311|62686355|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
33310980|NCT01156311|62686352|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
33310981|NCT01156311|62686353|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
33493377|NCT03134222|62871692|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
33597228|NCT01925950|62996187|FG001|Part 2|Withdrawal by Subject|0|||
33597229|NCT01878292|62996196|FG000|Randomized|Protocol Violation|1|||
33597230|NCT01878292|62996197|FG001|Randomized|Protocol Violation|0|||
33597231|NCT01878292|62996198|FG002|Randomized|Protocol Violation|0|||
33597232|NCT01878292|62996196|FG000|Randomized|Lost to Follow-up|1|||
33597233|NCT01878292|62996197|FG001|Randomized|Lost to Follow-up|0|||
33597234|NCT01878292|62996198|FG002|Randomized|Lost to Follow-up|0|||
33597235|NCT01878292|62996196|FG000|Randomized|Adverse Event|1|||
33597236|NCT01878292|62996197|FG001|Randomized|Adverse Event|0|||
33597237|NCT01878292|62996198|FG002|Randomized|Adverse Event|0|||
33597238|NCT01878292|62996196|FG000|Double-blind Treatment Period|Other Reasons|2|||
33597239|NCT01878292|62996197|FG001|Double-blind Treatment Period|Other Reasons|0|||
33597240|NCT01878292|62996198|FG002|Double-blind Treatment Period|Other Reasons|0|||
33597241|NCT01878292|62996196|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
33597242|NCT01878292|62996197|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
33597243|NCT01878292|62996198|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
33597244|NCT01878292|62996196|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
33597245|NCT01878292|62996197|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
33597246|NCT01878292|62996198|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
33597247|NCT01878292|62996196|FG000|Double-blind Treatment Period|Protocol Violation|3|||
33597248|NCT01878292|62996197|FG001|Double-blind Treatment Period|Protocol Violation|4|||
33597249|NCT01878292|62996198|FG002|Double-blind Treatment Period|Protocol Violation|2|||
33597250|NCT01878292|62996196|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
33597251|NCT01878292|62996197|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
33597252|NCT01878292|62996198|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
33597253|NCT01878292|62996196|FG000|Double-blind Treatment Period|Adverse Event|4|||
33597254|NCT01878292|62996197|FG001|Double-blind Treatment Period|Adverse Event|9|||
33597255|NCT01878292|62996198|FG002|Double-blind Treatment Period|Adverse Event|8|||
33597256|NCT01878292|62996196|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
33597257|NCT01878292|62996197|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
33597258|NCT01878292|62996198|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
33597259|NCT01908634|62996206|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
33597260|NCT01908634|62996206|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
33597261|NCT01878214|62996216|FG000|Overall Study|Withdrawal by Subject|18|||
33597262|NCT01878214|62996217|FG001|Overall Study|Withdrawal by Subject|7|||
33710042|NCT01572792|63277085|FG002|Extension Study|Lack of Efficacy|3|||
33310982|NCT01156311|62686354|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
33597263|NCT01878214|62996216|FG000|Overall Study|Death|0|||
33597264|NCT01878214|62996217|FG001|Overall Study|Death|1|||
33597265|NCT01878214|62996216|FG000|Overall Study|Lost to Follow-up|35|||
33597266|NCT01878214|62996217|FG001|Overall Study|Lost to Follow-up|36|||
33597267|NCT01907854|62996225|FG000|Overall Study|Protocol Violation|1|||
33597268|NCT01907854|62996226|FG001|Overall Study|Protocol Violation|1|||
33597269|NCT01907854|62996225|FG000|Overall Study|Withdrawal by Subject|9|||
33597270|NCT01907854|62996226|FG001|Overall Study|Withdrawal by Subject|7|||
33710043|NCT01572792|63277086|FG003|Extension Study|Lack of Efficacy|2|||
33710044|NCT01572792|63277087|FG004|Extension Study|Lack of Efficacy|2|||
33710045|NCT01572792|63277083|FG000|Extension Study|Adverse Event|7|||
33310983|NCT01156311|62686355|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
33310984|NCT01156311|62686352|FG000|6-month Add-on Therapy Period|Other|0|||
33310985|NCT01156311|62686353|FG001|6-month Add-on Therapy Period|Other|0|||
33310986|NCT01156311|62686354|FG002|6-month Add-on Therapy Period|Other|1|||
33310987|NCT01156311|62686355|FG003|6-month Add-on Therapy Period|Other|2|||
33310988|NCT01230060|62686366|FG000|Overall Study|Withdrawal by Subject|1|||
33310989|NCT01155531|62686374|FG000|Overall Study|Adverse Event|0|||
33310990|NCT01155531|62686375|FG001|Overall Study|Adverse Event|0|||
33310991|NCT01155531|62686376|FG002|Overall Study|Adverse Event|1|||
33310992|NCT01155531|62686377|FG003|Overall Study|Adverse Event|0|||
33310993|NCT01155531|62686374|FG000|Overall Study|Lost to Follow-up|0|||
33310994|NCT01155531|62686375|FG001|Overall Study|Lost to Follow-up|0|||
33310995|NCT01155531|62686376|FG002|Overall Study|Lost to Follow-up|0|||
33310996|NCT01155531|62686377|FG003|Overall Study|Lost to Follow-up|1|||
33310997|NCT01155531|62686374|FG000|Overall Study|Withdrawal by Subject|1|||
33310998|NCT01155531|62686375|FG001|Overall Study|Withdrawal by Subject|0|||
33310999|NCT01155531|62686376|FG002|Overall Study|Withdrawal by Subject|1|||
33311000|NCT01155531|62686377|FG003|Overall Study|Withdrawal by Subject|0|||
33311001|NCT01155219|62686389|FG000|Overall Study|Adverse Event|3|||
33311002|NCT01155219|62686390|FG001|Overall Study|Adverse Event|1|||
33311003|NCT01155219|62686389|FG000|Overall Study|non-medical reason|1|||
33311004|NCT01155219|62686390|FG001|Overall Study|non-medical reason|2|||
33311005|NCT01229436|62686396|FG000|Overall Study|Withdrawal by Subject|2|||
33311006|NCT01229436|62686396|FG000|Overall Study|Lost to Follow-up|3|||
33311007|NCT01155141|62686400|FG000|Overall Study|Withdrawal by Subject|1|||
33311008|NCT01155141|62686400|FG000|Overall Study|Screen Failure|1|||
33311009|NCT01155063|62686404|FG000|Overall Study|Adverse Event|1|||
33311010|NCT01155063|62686404|FG000|Overall Study|Withdrawal by Subject|1|||
33311011|NCT01155063|62686404|FG000|Overall Study|Study terminated by sponsor|87|||
33311012|NCT01154673|62686410|FG000|Overall Study|Lost to Follow-up|1|||
33311013|NCT01154673|62686411|FG001|Overall Study|Lost to Follow-up|0|||
33311014|NCT01154673|62686410|FG000|Overall Study|moved out of province|1|||
33311015|NCT01154673|62686411|FG001|Overall Study|moved out of province|0|||
33311016|NCT01154283|62686419|FG000|0-6 Weeks|Withdrawal by Subject|7|||
33311017|NCT01154283|62686420|FG001|0-6 Weeks|Withdrawal by Subject|2|||
33311018|NCT01154283|62686419|FG000|0-6 Weeks|Death|0|||
33311019|NCT01154283|62686420|FG001|0-6 Weeks|Death|1|||
33311020|NCT01154283|62686419|FG000|7-12 Weeks|Death|1|||
33311021|NCT01154283|62686420|FG001|7-12 Weeks|Death|0|||
33311022|NCT01154283|62686419|FG000|7-12 Weeks|Withdrawal by Subject|0|||
33311023|NCT01154283|62686420|FG001|7-12 Weeks|Withdrawal by Subject|1|||
33311024|NCT00944125|62686426|FG000|3 to 6 Months|Withdrawal by Subject|0|||
33311025|NCT00944125|62686427|FG001|3 to 6 Months|Withdrawal by Subject|2|||
33311026|NCT00944125|62686426|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
33311027|NCT00944125|62686427|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
33311028|NCT00912223|62686433|FG000|Overall Study|Withdrawal by Subject|1|||
33311029|NCT00912223|62686433|FG000|Overall Study|Not transplanted|1|||
33311030|NCT00912223|62686433|FG000|Overall Study|Transformed disease|1|||
33311031|NCT01154127|62686439|FG000|Period 1 (21 Days)|Adverse Event|3|||
33311032|NCT01154127|62686440|FG001|Period 1 (21 Days)|Adverse Event|4|||
33311033|NCT01154127|62686439|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
33311034|NCT01154127|62686440|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
33311035|NCT01154127|62686439|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
33311036|NCT01154127|62686440|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
33311037|NCT01154127|62686439|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
33311038|NCT01154127|62686440|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
33311039|NCT01154127|62686439|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
33311040|NCT01154127|62686440|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
33311041|NCT01228734|62686448|FG000|Overall Study|Randomized, but not treated|0|||
33311042|NCT01228734|62686449|FG001|Overall Study|Randomized, but not treated|4|||
33311043|NCT01227954|62686455|FG000|Overall Study|Protocol Violation|6|||
33311044|NCT01227954|62686455|FG000|Overall Study|No protocol treatment|7|||
33311045|NCT01153971|62686459|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
33311046|NCT01153971|62686459|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
33311047|NCT01153971|62686459|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
33311048|NCT01153971|62686459|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
33311049|NCT01153971|62686459|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
33311050|NCT01153971|62686459|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
33311051|NCT01153971|62686459|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
33311052|NCT01153893|62686465|FG000|Overall Study|Adverse Event|1|||
33311053|NCT01153893|62686466|FG001|Overall Study|Adverse Event|0|||
33311054|NCT00951379|62686474|FG000|Overall Study|Adverse Event|4|||
33311055|NCT00951379|62686475|FG001|Overall Study|Adverse Event|1|||
33311056|NCT00951379|62686474|FG000|Overall Study|Withdrawal by Subject|1|||
33311057|NCT00951379|62686475|FG001|Overall Study|Withdrawal by Subject|0|||
33311058|NCT00951379|62686474|FG000|Overall Study|Noncompliance|1|||
33311059|NCT00951379|62686475|FG001|Overall Study|Noncompliance|0|||
33311060|NCT00951379|62686474|FG000|Overall Study|Disease Progression|0|||
33311061|NCT00951379|62686475|FG001|Overall Study|Disease Progression|1|||
33311062|NCT01153815|62686491|FG000|Overall Study|Adverse Event|3|||
33311063|NCT01153815|62686492|FG001|Overall Study|Adverse Event|1|||
33311064|NCT01153815|62686491|FG000|Overall Study|Withdrawal by Subject|6|||
33311065|NCT01153815|62686492|FG001|Overall Study|Withdrawal by Subject|4|||
33311066|NCT01153425|62686500|FG000|Overall Study|Withdrawal by Subject|3|||
33311067|NCT01153425|62686501|FG001|Overall Study|Withdrawal by Subject|3|||
33311068|NCT01153347|62686512|FG000|Overall Study|Withdrawal by Subject|7|||
33311069|NCT01153347|62686513|FG001|Overall Study|Withdrawal by Subject|7|||
33311070|NCT01153347|62686514|FG002|Overall Study|Withdrawal by Subject|7|||
33311071|NCT01153347|62686515|FG003|Overall Study|Withdrawal by Subject|7|||
33311072|NCT01153347|62686512|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33311073|NCT01153347|62686513|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33311074|NCT01153347|62686514|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
33311075|NCT01153347|62686515|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
33311076|NCT01153347|62686512|FG000|Overall Study|Adverse Event|3|||
33311077|NCT01153347|62686513|FG001|Overall Study|Adverse Event|9|||
33311078|NCT01153347|62686514|FG002|Overall Study|Adverse Event|21|||
33311079|NCT01153347|62686515|FG003|Overall Study|Adverse Event|7|||
33311080|NCT01153347|62686512|FG000|Overall Study|Severe non-compliance to protocol|6|||
33311081|NCT01153347|62686513|FG001|Overall Study|Severe non-compliance to protocol|7|||
33311082|NCT01153347|62686514|FG002|Overall Study|Severe non-compliance to protocol|4|||
33311083|NCT01153347|62686515|FG003|Overall Study|Severe non-compliance to protocol|3|||
33311084|NCT01153347|62686512|FG000|Overall Study|Condition under investigation worsened|1|||
33311085|NCT01153347|62686513|FG001|Overall Study|Condition under investigation worsened|1|||
33311086|NCT01153347|62686514|FG002|Overall Study|Condition under investigation worsened|0|||
33311087|NCT01153347|62686515|FG003|Overall Study|Condition under investigation worsened|0|||
33311088|NCT01153347|62686512|FG000|Overall Study|Lack of Efficacy|2|||
33311089|NCT01153347|62686513|FG001|Overall Study|Lack of Efficacy|2|||
33311090|NCT01153347|62686514|FG002|Overall Study|Lack of Efficacy|0|||
33311091|NCT01153347|62686515|FG003|Overall Study|Lack of Efficacy|4|||
33311092|NCT01153347|62686512|FG000|Overall Study|Study-specific withdrawal criteria|4|||
33311093|NCT01153347|62686513|FG001|Overall Study|Study-specific withdrawal criteria|3|||
33311094|NCT01153347|62686514|FG002|Overall Study|Study-specific withdrawal criteria|1|||
33311095|NCT01153347|62686515|FG003|Overall Study|Study-specific withdrawal criteria|2|||
33311096|NCT01153347|62686512|FG000|Overall Study|Lost to Follow-up|4|||
33311097|NCT01153347|62686513|FG001|Overall Study|Lost to Follow-up|9|||
33311098|NCT01153347|62686514|FG002|Overall Study|Lost to Follow-up|11|||
33311099|NCT01153347|62686515|FG003|Overall Study|Lost to Follow-up|8|||
33311100|NCT01153347|62686512|FG000|Overall Study|Other|5|||
33311101|NCT01153347|62686513|FG001|Overall Study|Other|5|||
33311102|NCT01153347|62686514|FG002|Overall Study|Other|4|||
33311103|NCT01153347|62686515|FG003|Overall Study|Other|0|||
33311104|NCT01153347|62686512|FG000|Overall Study|Death|1|||
33710046|NCT01572792|63277084|FG001|Extension Study|Adverse Event|6|||
33710047|NCT01572792|63277085|FG002|Extension Study|Adverse Event|5|||
33710048|NCT01572792|63277086|FG003|Extension Study|Adverse Event|6|||
33710049|NCT01572792|63277087|FG004|Extension Study|Adverse Event|4|||
33710050|NCT01572792|63277083|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
33710051|NCT01572792|63277084|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
33710052|NCT01572792|63277085|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
33710053|NCT01572792|63277086|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
33710054|NCT01572792|63277087|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
33710055|NCT01547598|63277102|FG000|Overall Study|Withdrew consent|1|||
33710056|NCT01547598|63277103|FG001|Overall Study|Withdrew consent|1|||
33710057|NCT01547598|63277102|FG000|Overall Study|Lost to Follow-up|1|||
33710058|NCT01547598|63277103|FG001|Overall Study|Lost to Follow-up|1|||
33710059|NCT01547598|63277102|FG000|Overall Study|Adverse Event|1|||
33710060|NCT01547598|63277103|FG001|Overall Study|Adverse Event|1|||
33710061|NCT01547598|63277102|FG000|Overall Study|Protocol Violation|1|||
33710062|NCT01547598|63277103|FG001|Overall Study|Protocol Violation|1|||
33311105|NCT01153347|62686513|FG001|Overall Study|Death|0|||
33311106|NCT01153347|62686514|FG002|Overall Study|Death|0|||
33311107|NCT01153347|62686515|FG003|Overall Study|Death|0|||
33311108|NCT01153269|62686525|FG000|Overall Study|Withdrawal by Subject|1|||
33311109|NCT01153269|62686525|FG000|Overall Study|Antiretroviral therapy break|1|||
33311110|NCT01152021|62686534|FG000|Overall Study|Adverse Event|4|||
33710063|NCT01547598|63277102|FG000|Overall Study|Other Miscellaneous Reasons|2|||
33311111|NCT01152021|62686535|FG001|Overall Study|Adverse Event|4|||
33311112|NCT01152021|62686534|FG000|Overall Study|Study drug had expired|1|||
33311113|NCT01152021|62686535|FG001|Overall Study|Study drug had expired|0|||
33311114|NCT01152021|62686534|FG000|Overall Study|Physician Decision|1|||
33311115|NCT01152021|62686535|FG001|Overall Study|Physician Decision|1|||
33311116|NCT01152021|62686534|FG000|Overall Study|No access to study drug in Pharmacy|0|||
33311117|NCT01152021|62686535|FG001|Overall Study|No access to study drug in Pharmacy|1|||
33311118|NCT01151085|62686543|FG000|Overall Study|Lost to Follow-up|31|||
33311119|NCT01151085|62686543|FG000|Overall Study|Protocol Violation|25|||
33311120|NCT01149681|62686554|FG000|Overall Study|Withdrawal by Subject|7|||
33311121|NCT01149681|62686554|FG000|Overall Study|Progressive disease|1|||
33311122|NCT01149681|62686554|FG000|Overall Study|Physician Decision|2|||
33311123|NCT01149681|62686554|FG000|Overall Study|adverse events nonrelated study drug|2|||
33311124|NCT01149369|62686561|FG000|Overall Study|Adverse Event|6|||
33311125|NCT01149369|62686562|FG001|Overall Study|Adverse Event|3|||
33311126|NCT01740427|62686570|FG000|Overall Study|Ongoing|45|||
33311127|NCT01740427|62686571|FG001|Overall Study|Ongoing|5|||
33311128|NCT01740427|62686570|FG000|Overall Study|Objective Progression or Relapse|281|||
33311129|NCT01740427|62686571|FG001|Overall Study|Objective Progression or Relapse|171|||
33311130|NCT01740427|62686570|FG000|Overall Study|Adverse Event|31|||
33311131|NCT01740427|62686571|FG001|Overall Study|Adverse Event|9|||
33311132|NCT01740427|62686570|FG000|Overall Study|Global Deterioration of Health Status|28|||
33311133|NCT01740427|62686571|FG001|Overall Study|Global Deterioration of Health Status|12|||
33311134|NCT01740427|62686570|FG000|Overall Study|Participant Refused Continued Treatment|26|||
33311135|NCT01740427|62686571|FG001|Overall Study|Participant Refused Continued Treatment|15|||
33311136|NCT01740427|62686570|FG000|Overall Study|Unspecified reasons|15|||
33311137|NCT01740427|62686571|FG001|Overall Study|Unspecified reasons|4|||
33311138|NCT01740427|62686570|FG000|Overall Study|Death|10|||
33311139|NCT01740427|62686571|FG001|Overall Study|Death|3|||
33311140|NCT01740427|62686570|FG000|Overall Study|Protocol Violation|5|||
33311141|NCT01740427|62686571|FG001|Overall Study|Protocol Violation|3|||
33311142|NCT01740427|62686570|FG000|Overall Study|Lost to Follow-up|2|||
33311143|NCT01740427|62686571|FG001|Overall Study|Lost to Follow-up|0|||
33311144|NCT01740427|62686570|FG000|Overall Study|Site Terminated by Sponsor|1|||
33311145|NCT01740427|62686571|FG001|Overall Study|Site Terminated by Sponsor|0|||
33311146|NCT01149057|62686577|FG000|Overall Study|Lack of Efficacy|16|||
33311147|NCT01149057|62686577|FG000|Overall Study|Adverse Event|13|||
33311148|NCT01149057|62686577|FG000|Overall Study|Withdrawal by Subject|9|||
33311149|NCT01149057|62686577|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
33311150|NCT01149057|62686577|FG000|Overall Study|B Cell Depletion|4|||
33311151|NCT01149057|62686577|FG000|Overall Study|Participant Non-Compliance|2|||
33311152|NCT01149057|62686577|FG000|Overall Study|Lost to Follow-up|1|||
33311153|NCT01149057|62686577|FG000|Overall Study|High Parathyroid Hormone Value|1|||
33311154|NCT01149057|62686577|FG000|Overall Study|Other|6|||
33311155|NCT01227564|62686584|FG000|Overall Study|No Longer Willing to Participate|4|||
33311156|NCT01227564|62686585|FG001|Overall Study|No Longer Willing to Participate|2|||
33311157|NCT01227564|62686586|FG002|Overall Study|No Longer Willing to Participate|5|||
33311158|NCT01227564|62686584|FG000|Overall Study|Participant moved to another town|0|||
33311159|NCT01227564|62686585|FG001|Overall Study|Participant moved to another town|0|||
33311160|NCT01227564|62686586|FG002|Overall Study|Participant moved to another town|1|||
33311161|NCT01148979|62686602|FG000|Overall Study|Lost to Follow-up|0|||
33311162|NCT01148979|62686603|FG001|Overall Study|Lost to Follow-up|1|||
33311163|NCT01148511|62686611|FG000|Exposed to Study Drug|Protocol Violation|2|||
33311164|NCT01148511|62686612|FG001|Exposed to Study Drug|Protocol Violation|0|||
33311165|NCT01148511|62686613|FG002|Exposed to Study Drug|Protocol Violation|0|||
33311166|NCT01148511|62686611|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
33311167|NCT01148511|62686612|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
33311168|NCT01148511|62686613|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
33311169|NCT01148511|62686611|FG000|Randomized|Adverse Event|0|||
33311170|NCT01148511|62686612|FG001|Randomized|Adverse Event|1|||
33311171|NCT01148511|62686613|FG002|Randomized|Adverse Event|0|||
33311172|NCT01148511|62686611|FG000|Randomized|Protocol Violation|0|||
33311173|NCT01148511|62686612|FG001|Randomized|Protocol Violation|2|||
33311174|NCT01148511|62686613|FG002|Randomized|Protocol Violation|1|||
33311175|NCT01148511|62686611|FG000|Randomized|Lost to Follow-up|0|||
33311176|NCT01148511|62686612|FG001|Randomized|Lost to Follow-up|1|||
33311177|NCT01148511|62686613|FG002|Randomized|Lost to Follow-up|1|||
33311178|NCT01148511|62686611|FG000|Randomized|Consent withdrawal|0|||
33311179|NCT01148511|62686612|FG001|Randomized|Consent withdrawal|5|||
33311180|NCT01148511|62686613|FG002|Randomized|Consent withdrawal|3|||
33311181|NCT01148511|62686611|FG000|Randomized|Other|0|||
33311182|NCT01148511|62686612|FG001|Randomized|Other|1|||
33311183|NCT01148511|62686613|FG002|Randomized|Other|1|||
33311184|NCT00547339|62686624|FG000|Overall Study|Physician Decision|0|||
33311185|NCT00547339|62686625|FG001|Overall Study|Physician Decision|0|||
33311186|NCT00547339|62686626|FG002|Overall Study|Physician Decision|1|||
33311187|NCT00547339|62686627|FG003|Overall Study|Physician Decision|0|||
33311188|NCT01227252|62686650|FG000|Overall Study|Sponsor Decision|0|||
33311189|NCT01227252|62686651|FG001|Overall Study|Sponsor Decision|1|||
33311190|NCT01227252|62686652|FG002|Overall Study|Sponsor Decision|0|||
33311191|NCT01227252|62686653|FG003|Overall Study|Sponsor Decision|0|||
33311192|NCT01227252|62686650|FG000|Overall Study|Lost to Follow-up|0|||
33311193|NCT01227252|62686651|FG001|Overall Study|Lost to Follow-up|1|||
33311194|NCT01227252|62686652|FG002|Overall Study|Lost to Follow-up|0|||
33311195|NCT01227252|62686653|FG003|Overall Study|Lost to Follow-up|0|||
33311196|NCT01227252|62686650|FG000|Overall Study|Withdrawal by Subject|0|||
33311197|NCT01227252|62686651|FG001|Overall Study|Withdrawal by Subject|1|||
33311198|NCT01227252|62686652|FG002|Overall Study|Withdrawal by Subject|0|||
33311199|NCT01227252|62686653|FG003|Overall Study|Withdrawal by Subject|0|||
33311200|NCT01227018|62686666|FG000|Overall Study|Disease progression|9|||
33311201|NCT01227018|62686666|FG000|Overall Study|Toxicity|2|||
33311202|NCT01227018|62686666|FG000|Overall Study|Withdrew after beginning treatment|4|||
33311203|NCT01226472|62686680|FG000|Overall Study|Progressive Disease|1|||
33311204|NCT01225146|62686686|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
33311205|NCT01225146|62686687|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
33311206|NCT01223196|62686697|FG000|Overall Study|Lost to Follow-up|2|||
33311207|NCT01223196|62686698|FG001|Overall Study|Lost to Follow-up|0|||
33311208|NCT01223196|62686697|FG000|Overall Study|Physician Decision|1|||
33311209|NCT01223196|62686698|FG001|Overall Study|Physician Decision|0|||
33311210|NCT01223196|62686697|FG000|Overall Study|Withdrawal by Subject|1|||
33311211|NCT01223196|62686698|FG001|Overall Study|Withdrawal by Subject|0|||
33311212|NCT01222416|62686708|FG000|Overall Study|ineligible;metastasis|3|||
33311213|NCT01222416|62686709|FG001|Overall Study|ineligible;metastasis|0|||
33311214|NCT01222416|62686708|FG000|Overall Study|Adverse Event|4|||
33311215|NCT01222416|62686709|FG001|Overall Study|Adverse Event|0|||
33311216|NCT01222416|62686708|FG000|Overall Study|Withdrawal by Subject|5|||
33311217|NCT01222416|62686709|FG001|Overall Study|Withdrawal by Subject|0|||
33311218|NCT01222416|62686708|FG000|Overall Study|scheduling|6|||
33311219|NCT01222416|62686709|FG001|Overall Study|scheduling|0|||
33311220|NCT01222416|62686708|FG000|Overall Study|missed view/scan|1|||
33311221|NCT01222416|62686709|FG001|Overall Study|missed view/scan|0|||
33311222|NCT01222416|62686708|FG000|Overall Study|Death|1|||
33311223|NCT01222416|62686709|FG001|Overall Study|Death|0|||
33311224|NCT01222104|62686715|FG000|Overall Study|Lost to Follow-up|37|||
33311225|NCT01222104|62686715|FG000|Overall Study|Death|10|||
33311226|NCT01221948|62686725|FG000|Overall Study|Physician Decision|5|||
33311227|NCT01221948|62686725|FG000|Overall Study|Withdrawal by Subject|2|||
33311228|NCT01221948|62686725|FG000|Overall Study|not disclosed|2|||
33311229|NCT01221948|62686725|FG000|Overall Study|Death|1|||
33311230|NCT01221948|62686725|FG000|Overall Study|Protocol Violation|4|||
33311231|NCT01221090|62686733|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
33311232|NCT01221090|62686734|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
33311233|NCT01221090|62686735|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
33311234|NCT01221090|62686736|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
33311235|NCT01221090|62686733|FG000|Overall Study|Withdrawal by Subject|0|||
33311236|NCT01221090|62686734|FG001|Overall Study|Withdrawal by Subject|22|||
33311237|NCT01221090|62686735|FG002|Overall Study|Withdrawal by Subject|27|||
33311238|NCT01221090|62686736|FG003|Overall Study|Withdrawal by Subject|2|||
33311239|NCT00950911|62686748|FG000|Overall Study|Adverse Event|0|||
33311240|NCT00950911|62686749|FG001|Overall Study|Adverse Event|2|||
33311241|NCT00950911|62686748|FG000|Overall Study|Death|4|||
33311242|NCT00950911|62686749|FG001|Overall Study|Death|6|||
33311243|NCT00950911|62686748|FG000|Overall Study|Disease progression|2|||
33311244|NCT00950911|62686749|FG001|Overall Study|Disease progression|2|||
33311245|NCT00950911|62686748|FG000|Overall Study|Consent withdrawn|1|||
33311246|NCT00950911|62686749|FG001|Overall Study|Consent withdrawn|3|||
33311247|NCT00950911|62686748|FG000|Overall Study|Administrative decision|3|||
33311248|NCT00950911|62686749|FG001|Overall Study|Administrative decision|1|||
33311249|NCT00950911|62686748|FG000|Overall Study|Ineligibility determined|1|||
33311250|NCT00950911|62686749|FG001|Overall Study|Ineligibility determined|0|||
33311251|NCT00950911|62686748|FG000|Overall Study|Noncompliance|1|||
33311252|NCT00950911|62686749|FG001|Overall Study|Noncompliance|0|||
33311253|NCT00950911|62686748|FG000|Overall Study|Poor performance status|0|||
33311254|NCT00950911|62686749|FG001|Overall Study|Poor performance status|1|||
33311255|NCT01220856|62686757|FG000|Overall Study|graft loss|3|||
33311256|NCT01220856|62686758|FG001|Overall Study|graft loss|3|||
33311257|NCT01220856|62686757|FG000|Overall Study|Lost to Follow-up|1|||
33311258|NCT01220856|62686758|FG001|Overall Study|Lost to Follow-up|0|||
33311259|NCT01218594|62686767|FG000|Overall Study|Death|1|||
33311260|NCT01218594|62686767|FG000|Overall Study|Withdrawal by Subject|3|||
33311261|NCT01218594|62686767|FG000|Overall Study|Adverse Event|2|||
33311262|NCT01218594|62686767|FG000|Overall Study|Physician Decision|6|||
33311263|NCT01610557|62686775|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
33311264|NCT01610557|62686776|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
33311265|NCT01610557|62686777|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
33710064|NCT01547598|63277103|FG001|Overall Study|Other Miscellaneous Reasons|1|||
33710065|NCT01547286|63277110|FG000|Overall Study|Did not meet all eligibility criteria|1|||
33710066|NCT01547286|63277110|FG000|Overall Study|Physician Decision|1|||
33710067|NCT01547130|63277117|FG000|Overall Study|Lost to Follow-up|9|||
33710068|NCT01547130|63277118|FG001|Overall Study|Lost to Follow-up|5|||
33710069|NCT01524978|63277143|FG000|Overall Study|Other|16|||
33710070|NCT01524978|63277144|FG001|Overall Study|Other|2|||
33311266|NCT01610557|62686778|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
33311267|NCT01610557|62686779|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
33311268|NCT01610557|62686775|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
33311269|NCT01610557|62686776|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
33311270|NCT01610557|62686777|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
33311271|NCT01610557|62686778|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
33311272|NCT01610557|62686779|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
33311273|NCT00943735|62686790|FG000|Overall Study|Adverse Event|12|||
33311274|NCT00943735|62686790|FG000|Overall Study|Withdrawal by Subject|8|||
33311275|NCT00943735|62686790|FG000|Overall Study|Death|1|||
33311276|NCT00943735|62686790|FG000|Overall Study|Other|8|||
33311277|NCT00943735|62686790|FG000|Overall Study|Other|3|||
33311278|NCT00943579|62686796|FG000|Overall Study|Adverse Event|4|||
33311279|NCT00943579|62686797|FG001|Overall Study|Adverse Event|3|||
33311280|NCT00943579|62686796|FG000|Overall Study|Lack of Efficacy|2|||
33311281|NCT00943579|62686797|FG001|Overall Study|Lack of Efficacy|2|||
33311282|NCT01147809|62686812|FG000|Phase I (168 Days)|Adverse Event|0|||
33311283|NCT01147809|62686813|FG001|Phase I (168 Days)|Adverse Event|0|||
33311284|NCT01147809|62686814|FG002|Phase I (168 Days)|Adverse Event|0|||
33311285|NCT01147809|62686815|FG003|Phase I (168 Days)|Adverse Event|1|||
33710071|NCT01524978|63277145|FG002|Overall Study|Other|1|||
33710072|NCT01524978|63277146|FG003|Overall Study|Other|2|||
33710073|NCT01524978|63277147|FG004|Overall Study|Other|1|||
33710074|NCT01524978|63277148|FG005|Overall Study|Other|3|||
33311286|NCT01147809|62686816|FG004|Phase I (168 Days)|Adverse Event|0|||
33311287|NCT01147809|62686817|FG005|Phase I (168 Days)|Adverse Event|0|||
33311288|NCT01147809|62686812|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
33311289|NCT01147809|62686813|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
33311290|NCT01147809|62686814|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
33311291|NCT01147809|62686815|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
33311292|NCT01147809|62686816|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
33311293|NCT01147809|62686817|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
33311294|NCT01147809|62686812|FG000|Phase I (168 Days)|Physician Decision|0|||
33311295|NCT01147809|62686813|FG001|Phase I (168 Days)|Physician Decision|1|||
33311296|NCT01147809|62686814|FG002|Phase I (168 Days)|Physician Decision|2|||
33311297|NCT01147809|62686815|FG003|Phase I (168 Days)|Physician Decision|0|||
33311298|NCT01147809|62686816|FG004|Phase I (168 Days)|Physician Decision|0|||
33311299|NCT01147809|62686817|FG005|Phase I (168 Days)|Physician Decision|0|||
33311300|NCT01147809|62686812|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
33311301|NCT01147809|62686813|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
33311302|NCT01147809|62686814|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
33311303|NCT01147809|62686815|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
33311304|NCT01147809|62686816|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
33311305|NCT01147809|62686817|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
33311306|NCT01147809|62686812|FG000|Phase II (168 Days)|Adverse Event|0|||
33311307|NCT01147809|62686813|FG001|Phase II (168 Days)|Adverse Event|0|||
33493378|NCT03134222|62871693|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
33311308|NCT01147809|62686814|FG002|Phase II (168 Days)|Adverse Event|0|||
33311309|NCT01147809|62686815|FG003|Phase II (168 Days)|Adverse Event|0|||
33311310|NCT01147809|62686816|FG004|Phase II (168 Days)|Adverse Event|3|||
33710075|NCT01524978|63277149|FG006|Overall Study|Other|17|||
33710076|NCT01524978|63277150|FG007|Overall Study|Other|1|||
33710077|NCT01524978|63277151|FG008|Overall Study|Other|2|||
33311311|NCT01147809|62686817|FG005|Phase II (168 Days)|Adverse Event|6|||
33311312|NCT01147809|62686812|FG000|Phase II (168 Days)|Protocol Violation|0|||
33311313|NCT01147809|62686813|FG001|Phase II (168 Days)|Protocol Violation|0|||
33311314|NCT01147809|62686814|FG002|Phase II (168 Days)|Protocol Violation|0|||
33311315|NCT01147809|62686815|FG003|Phase II (168 Days)|Protocol Violation|0|||
33311316|NCT01147809|62686816|FG004|Phase II (168 Days)|Protocol Violation|0|||
33311317|NCT01147809|62686817|FG005|Phase II (168 Days)|Protocol Violation|1|||
33311318|NCT01147809|62686812|FG000|Phase II (168 Days)|Physician Decision|0|||
33311319|NCT01147809|62686813|FG001|Phase II (168 Days)|Physician Decision|0|||
33311320|NCT01147809|62686814|FG002|Phase II (168 Days)|Physician Decision|0|||
33311321|NCT01147809|62686815|FG003|Phase II (168 Days)|Physician Decision|0|||
33311322|NCT01147809|62686816|FG004|Phase II (168 Days)|Physician Decision|5|||
33311323|NCT01147809|62686817|FG005|Phase II (168 Days)|Physician Decision|11|||
33311324|NCT01147809|62686812|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
33311325|NCT01147809|62686813|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
33311326|NCT01147809|62686814|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
33311327|NCT01147809|62686815|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
33311328|NCT01147809|62686816|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
33311329|NCT01147809|62686817|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
33311330|NCT01147809|62686812|FG000|Phase II (168 Days)|Ongoing|0|||
33311331|NCT01147809|62686813|FG001|Phase II (168 Days)|Ongoing|0|||
33311332|NCT01147809|62686814|FG002|Phase II (168 Days)|Ongoing|0|||
33311333|NCT01147809|62686815|FG003|Phase II (168 Days)|Ongoing|0|||
33311334|NCT01147809|62686816|FG004|Phase II (168 Days)|Ongoing|1|||
33311335|NCT01147809|62686817|FG005|Phase II (168 Days)|Ongoing|0|||
33311336|NCT00943111|62686834|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
33311337|NCT00943111|62686835|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
33311338|NCT00943111|62686836|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
33311339|NCT00943111|62686834|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
33311340|NCT00943111|62686835|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
33311341|NCT00943111|62686836|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
33311342|NCT00943111|62686834|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
33311343|NCT00943111|62686835|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
33311344|NCT00943111|62686836|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
33311345|NCT00943111|62686834|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
33311346|NCT00943111|62686835|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
33311347|NCT00943111|62686836|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
33311348|NCT00943111|62686834|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
33311349|NCT00943111|62686835|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
33311350|NCT00943111|62686836|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
33311351|NCT00943111|62686834|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
33311352|NCT00943111|62686835|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
33311353|NCT00943111|62686836|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
33311354|NCT00943111|62686834|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
33311355|NCT00943111|62686835|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
33311356|NCT00943111|62686836|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
33311357|NCT00943111|62686834|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
33311358|NCT00943111|62686835|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
33311359|NCT00943111|62686836|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
33311360|NCT01147497|62686845|FG000|Overall Study|failed insertion|2|||
33311361|NCT01147497|62686846|FG001|Overall Study|failed insertion|0|||
33311362|NCT01147341|62686854|FG000|Double Blind Period|Lack of Efficacy|1|||
33311363|NCT01147341|62686855|FG001|Double Blind Period|Lack of Efficacy|1|||
33311364|NCT01147341|62686854|FG000|Double Blind Period|Withdrawal by Subject|0|||
33311365|NCT01147341|62686855|FG001|Double Blind Period|Withdrawal by Subject|1|||
33311366|NCT01147341|62686854|FG000|Open Label Period|Lack of Efficacy|3|||
33311367|NCT01147341|62686855|FG001|Open Label Period|Lack of Efficacy|0|||
33311368|NCT01147341|62686854|FG000|Open Label Period|Subject moved|1|||
33311369|NCT01147341|62686855|FG001|Open Label Period|Subject moved|0|||
33311370|NCT00950755|62686861|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
33311371|NCT00950755|62686861|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
33311372|NCT00950755|62686861|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
33311373|NCT00950755|62686861|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
33311374|NCT00950755|62686861|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
33311375|NCT00950755|62686861|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
33311376|NCT00950755|62686861|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
33311377|NCT00950755|62686861|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
33311378|NCT00950755|62686861|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
33311379|NCT00950755|62686861|FG000|Long-Term Follow-Up|Death|8|||
33311380|NCT01147107|62686867|FG000|Overall Study|Lack of Efficacy|5|||
33311381|NCT01147107|62686868|FG001|Overall Study|Lack of Efficacy|0|||
33311382|NCT01147107|62686867|FG000|Overall Study|Withdrawal by Subject|1|||
33311383|NCT01147107|62686868|FG001|Overall Study|Withdrawal by Subject|1|||
33311384|NCT00942409|62686874|FG000|Overall Study|Lack of Efficacy|1|||
33311385|NCT00942409|62686874|FG000|Overall Study|study drug unavailable|2|||
33311386|NCT01146951|62686880|FG000|Overall Study|Adverse Event|4|||
33311387|NCT01146951|62686881|FG001|Overall Study|Adverse Event|1|||
33311388|NCT01146873|62686889|FG000|Overall Study|Transfer out|0|||
33311389|NCT01146873|62686890|FG001|Overall Study|Transfer out|6|||
33311390|NCT01146795|62686896|FG000|Overall Study|Withdrawal by Subject|4|||
33311391|NCT01146795|62686896|FG000|Overall Study|Adverse Event|6|||
33311392|NCT01146795|62686896|FG000|Overall Study|Still in treatment at study closure|10|||
33311393|NCT01146561|62686900|FG000|Overall Study|Withdrawal by Subject|1|||
33311394|NCT01146561|62686900|FG000|Overall Study|Lost to Follow-up|1|||
33311395|NCT00942175|62686908|FG000|Overall Study|Adverse Event|2|||
33311396|NCT00942175|62686909|FG001|Overall Study|Adverse Event|1|||
33311397|NCT00942175|62686910|FG002|Overall Study|Adverse Event|0|||
33311398|NCT00942175|62686911|FG003|Overall Study|Adverse Event|0|||
33311399|NCT00942175|62686908|FG000|Overall Study|Protocol Violation|0|||
33311400|NCT00942175|62686909|FG001|Overall Study|Protocol Violation|1|||
33311401|NCT00942175|62686910|FG002|Overall Study|Protocol Violation|2|||
33311402|NCT00942175|62686911|FG003|Overall Study|Protocol Violation|0|||
33311403|NCT00942175|62686908|FG000|Overall Study|Pregnancy|0|||
33311404|NCT00942175|62686909|FG001|Overall Study|Pregnancy|0|||
33311405|NCT00942175|62686910|FG002|Overall Study|Pregnancy|0|||
33311406|NCT00942175|62686911|FG003|Overall Study|Pregnancy|1|||
33311407|NCT00942175|62686908|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
33311408|NCT00942175|62686909|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
33311409|NCT00942175|62686910|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
33311410|NCT00942175|62686911|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
33311411|NCT00942175|62686908|FG000|Overall Study|Low Platelet Count|0|||
33311412|NCT00942175|62686909|FG001|Overall Study|Low Platelet Count|2|||
33311413|NCT00942175|62686910|FG002|Overall Study|Low Platelet Count|0|||
33311414|NCT00942175|62686911|FG003|Overall Study|Low Platelet Count|0|||
33311415|NCT01145625|62686931|FG000|Overall Study|Lost to Follow-up|8|||
33311416|NCT01145625|62686932|FG001|Overall Study|Lost to Follow-up|9|||
33311417|NCT01145625|62686931|FG000|Overall Study|Adverse Event|6|||
33311418|NCT01145625|62686932|FG001|Overall Study|Adverse Event|4|||
33311419|NCT01145625|62686931|FG000|Overall Study|Protocol Violation|3|||
33311420|NCT01145625|62686932|FG001|Overall Study|Protocol Violation|1|||
33311421|NCT01145625|62686931|FG000|Overall Study|Withdrawal by Subject|7|||
33311422|NCT01145625|62686932|FG001|Overall Study|Withdrawal by Subject|16|||
33311423|NCT01145625|62686931|FG000|Overall Study|Pregnancy|0|||
33311424|NCT01145625|62686932|FG001|Overall Study|Pregnancy|1|||
33311425|NCT01144377|62686943|FG000|52 Week Treatment Period|Adverse Event|0|||
33311426|NCT01144377|62686944|FG001|52 Week Treatment Period|Adverse Event|0|||
33311427|NCT01144377|62686945|FG002|52 Week Treatment Period|Adverse Event|3|||
33311428|NCT01144377|62686946|FG003|52 Week Treatment Period|Adverse Event|2|||
33311429|NCT01144377|62686947|FG004|52 Week Treatment Period|Adverse Event|1|||
33311430|NCT01144377|62686943|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
33311431|NCT01144377|62686944|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
33311432|NCT01144377|62686945|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
33311433|NCT01144377|62686946|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
33311434|NCT01144377|62686947|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
33311435|NCT01144377|62686943|FG000|52 Week Treatment Period|Protocol Violation|0|||
33311436|NCT01144377|62686944|FG001|52 Week Treatment Period|Protocol Violation|0|||
33311437|NCT01144377|62686945|FG002|52 Week Treatment Period|Protocol Violation|0|||
33311438|NCT01144377|62686946|FG003|52 Week Treatment Period|Protocol Violation|0|||
33311439|NCT01144377|62686947|FG004|52 Week Treatment Period|Protocol Violation|1|||
33311440|NCT01144377|62686943|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
33311441|NCT01144377|62686944|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
33311442|NCT01144377|62686945|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
33311443|NCT01144377|62686946|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
33311444|NCT01144377|62686947|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
33311445|NCT01144377|62686943|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
33311446|NCT01144377|62686944|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
33311447|NCT01144377|62686945|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
33311448|NCT01144377|62686946|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
33311449|NCT01144377|62686947|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
33311450|NCT01144377|62686943|FG000|52 Week Treatment Period|Sponsor Decision|0|||
33311451|NCT01144377|62686944|FG001|52 Week Treatment Period|Sponsor Decision|0|||
33311452|NCT01144377|62686945|FG002|52 Week Treatment Period|Sponsor Decision|0|||
33311453|NCT01144377|62686946|FG003|52 Week Treatment Period|Sponsor Decision|0|||
33311454|NCT01144377|62686947|FG004|52 Week Treatment Period|Sponsor Decision|1|||
33493379|NCT03134222|62871694|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
33493380|NCT03134222|62871695|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
33597271|NCT01907854|62996225|FG000|Overall Study|Lost to Follow-up|2|||
33597272|NCT01907854|62996226|FG001|Overall Study|Lost to Follow-up|2|||
33597273|NCT01907854|62996225|FG000|Overall Study|Unclassified|4|||
33597274|NCT01907854|62996226|FG001|Overall Study|Unclassified|3|||
33597275|NCT02480153|62996234|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
33597276|NCT02480153|62996235|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
33597277|NCT02480153|62996236|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
33597278|NCT02480153|62996234|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
33597279|NCT02480153|62996235|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
33493381|NCT03134222|62871696|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
33311455|NCT01144377|62686943|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
33311456|NCT01144377|62686944|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
33311457|NCT01144377|62686945|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
33311458|NCT01144377|62686946|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
33311459|NCT01144377|62686947|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
33311460|NCT01144377|62686943|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
33311461|NCT01144377|62686944|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
33311462|NCT01144377|62686945|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
33311463|NCT01144377|62686946|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
33311464|NCT01144377|62686947|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
33311465|NCT01144377|62686943|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
33311466|NCT01144377|62686944|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
33311467|NCT01144377|62686945|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
33311468|NCT01144377|62686946|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
33311469|NCT01144377|62686947|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
33311470|NCT00950599|62686969|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33311471|NCT00950599|62686970|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33311472|NCT00950599|62686971|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33311473|NCT00950599|62686972|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
33311474|NCT00950599|62686973|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33311475|NCT00950599|62686974|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33311476|NCT00950599|62686975|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33311477|NCT00950599|62686976|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33311478|NCT00950599|62686977|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33311479|NCT00950599|62686978|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33311480|NCT00950599|62686969|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33311481|NCT00950599|62686970|FG001|Double-Blind Treatment Period|Adverse Event|1|||
33311482|NCT00950599|62686971|FG002|Double-Blind Treatment Period|Adverse Event|1|||
33311483|NCT00950599|62686972|FG003|Double-Blind Treatment Period|Adverse Event|1|||
33311484|NCT00950599|62686973|FG004|Double-Blind Treatment Period|Adverse Event|1|||
33311485|NCT00950599|62686974|FG005|Double-Blind Treatment Period|Adverse Event|1|||
33311486|NCT00950599|62686975|FG006|Double-Blind Treatment Period|Adverse Event|0|||
33311487|NCT00950599|62686976|FG007|Double-Blind Treatment Period|Adverse Event|0|||
33311488|NCT00950599|62686977|FG008|Double-Blind Treatment Period|Adverse Event|0|||
33311489|NCT00950599|62686978|FG009|Double-Blind Treatment Period|Adverse Event|0|||
33311490|NCT00950599|62686969|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
33311491|NCT00950599|62686970|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
33311492|NCT00950599|62686971|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
33311493|NCT00950599|62686972|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
33311494|NCT00950599|62686973|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
33311495|NCT00950599|62686974|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
33311496|NCT00950599|62686975|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
33311497|NCT00950599|62686976|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
33311498|NCT00950599|62686977|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
33311499|NCT00950599|62686978|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
33311500|NCT00950599|62686969|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33311501|NCT00950599|62686970|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
33311502|NCT00950599|62686971|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
33311503|NCT00950599|62686972|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
33311504|NCT00950599|62686973|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
33311505|NCT00950599|62686974|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
33311506|NCT00950599|62686975|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
33311507|NCT00950599|62686976|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
33311508|NCT00950599|62686977|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
33311509|NCT00950599|62686978|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
33311510|NCT00950599|62686969|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
33311511|NCT00950599|62686970|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
33311512|NCT00950599|62686971|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
33311513|NCT00950599|62686972|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
33311514|NCT00950599|62686973|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
33311515|NCT00950599|62686974|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
33311516|NCT00950599|62686975|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
33311517|NCT00950599|62686976|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
33311518|NCT00950599|62686977|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
33311519|NCT00950599|62686978|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
33311520|NCT00950599|62686969|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33311521|NCT00950599|62686970|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33311522|NCT00950599|62686971|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33311523|NCT00950599|62686972|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33311524|NCT00950599|62686973|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
33311525|NCT00950599|62686974|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
33311526|NCT00950599|62686975|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33311527|NCT00950599|62686976|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33311528|NCT00950599|62686977|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33311529|NCT00950599|62686978|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33311530|NCT00950599|62686969|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
33311531|NCT00950599|62686970|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
33311532|NCT00950599|62686971|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
33311533|NCT00950599|62686972|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
33311534|NCT00950599|62686973|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
33311535|NCT00950599|62686974|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
33311536|NCT00950599|62686975|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
33311537|NCT00950599|62686976|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
33311538|NCT00950599|62686977|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
33311539|NCT00950599|62686978|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
33311540|NCT00950599|62686969|FG000|Follow-Up Period|Adverse Event|0|||
33311541|NCT00950599|62686970|FG001|Follow-Up Period|Adverse Event|0|||
33311542|NCT00950599|62686971|FG002|Follow-Up Period|Adverse Event|0|||
33311543|NCT00950599|62686972|FG003|Follow-Up Period|Adverse Event|0|||
33311544|NCT00950599|62686973|FG004|Follow-Up Period|Adverse Event|0|||
33311545|NCT00950599|62686974|FG005|Follow-Up Period|Adverse Event|0|||
33311546|NCT00950599|62686975|FG006|Follow-Up Period|Adverse Event|0|||
33311547|NCT00950599|62686976|FG007|Follow-Up Period|Adverse Event|0|||
33311548|NCT00950599|62686977|FG008|Follow-Up Period|Adverse Event|1|||
33311549|NCT00950599|62686978|FG009|Follow-Up Period|Adverse Event|0|||
33311550|NCT00950599|62686969|FG000|Follow-Up Period|Lack of Efficacy|0|||
33311551|NCT00950599|62686970|FG001|Follow-Up Period|Lack of Efficacy|0|||
33311552|NCT00950599|62686971|FG002|Follow-Up Period|Lack of Efficacy|0|||
33311553|NCT00950599|62686972|FG003|Follow-Up Period|Lack of Efficacy|0|||
33311554|NCT00950599|62686973|FG004|Follow-Up Period|Lack of Efficacy|0|||
33311555|NCT00950599|62686974|FG005|Follow-Up Period|Lack of Efficacy|0|||
33311556|NCT00950599|62686975|FG006|Follow-Up Period|Lack of Efficacy|0|||
33311557|NCT00950599|62686976|FG007|Follow-Up Period|Lack of Efficacy|0|||
33311558|NCT00950599|62686977|FG008|Follow-Up Period|Lack of Efficacy|3|||
33311559|NCT00950599|62686978|FG009|Follow-Up Period|Lack of Efficacy|0|||
33311560|NCT00950599|62686969|FG000|Follow-Up Period|Lost to Follow-up|0|||
33311561|NCT00950599|62686970|FG001|Follow-Up Period|Lost to Follow-up|0|||
33311562|NCT00950599|62686971|FG002|Follow-Up Period|Lost to Follow-up|0|||
33311563|NCT00950599|62686972|FG003|Follow-Up Period|Lost to Follow-up|0|||
33311564|NCT00950599|62686973|FG004|Follow-Up Period|Lost to Follow-up|0|||
33311565|NCT00950599|62686974|FG005|Follow-Up Period|Lost to Follow-up|0|||
33311566|NCT00950599|62686975|FG006|Follow-Up Period|Lost to Follow-up|0|||
33311567|NCT00950599|62686976|FG007|Follow-Up Period|Lost to Follow-up|0|||
33311568|NCT00950599|62686977|FG008|Follow-Up Period|Lost to Follow-up|5|||
33311569|NCT00950599|62686978|FG009|Follow-Up Period|Lost to Follow-up|1|||
33311570|NCT00950599|62686969|FG000|Follow-Up Period|Physician Decision|0|||
33311571|NCT00950599|62686970|FG001|Follow-Up Period|Physician Decision|0|||
33311572|NCT00950599|62686971|FG002|Follow-Up Period|Physician Decision|0|||
33311573|NCT00950599|62686972|FG003|Follow-Up Period|Physician Decision|0|||
33311574|NCT00950599|62686973|FG004|Follow-Up Period|Physician Decision|0|||
33311575|NCT00950599|62686974|FG005|Follow-Up Period|Physician Decision|0|||
33311576|NCT00950599|62686975|FG006|Follow-Up Period|Physician Decision|0|||
33311577|NCT00950599|62686976|FG007|Follow-Up Period|Physician Decision|0|||
33311578|NCT00950599|62686977|FG008|Follow-Up Period|Physician Decision|1|||
33311579|NCT00950599|62686978|FG009|Follow-Up Period|Physician Decision|0|||
33311580|NCT00950599|62686969|FG000|Follow-Up Period|Poor/Noncompliance|0|||
33311581|NCT00950599|62686970|FG001|Follow-Up Period|Poor/Noncompliance|0|||
33311582|NCT00950599|62686971|FG002|Follow-Up Period|Poor/Noncompliance|0|||
33311583|NCT00950599|62686972|FG003|Follow-Up Period|Poor/Noncompliance|0|||
33311584|NCT00950599|62686973|FG004|Follow-Up Period|Poor/Noncompliance|0|||
33311585|NCT00950599|62686974|FG005|Follow-Up Period|Poor/Noncompliance|0|||
33311586|NCT00950599|62686975|FG006|Follow-Up Period|Poor/Noncompliance|0|||
33311587|NCT00950599|62686976|FG007|Follow-Up Period|Poor/Noncompliance|0|||
33311588|NCT00950599|62686977|FG008|Follow-Up Period|Poor/Noncompliance|1|||
33311589|NCT00950599|62686978|FG009|Follow-Up Period|Poor/Noncompliance|0|||
33311590|NCT00950599|62686969|FG000|Follow-Up Period|Subject withdrew Consent|0|||
33311591|NCT00950599|62686970|FG001|Follow-Up Period|Subject withdrew Consent|0|||
33311592|NCT00950599|62686971|FG002|Follow-Up Period|Subject withdrew Consent|0|||
33311593|NCT00950599|62686972|FG003|Follow-Up Period|Subject withdrew Consent|0|||
33311594|NCT00950599|62686973|FG004|Follow-Up Period|Subject withdrew Consent|0|||
33311595|NCT00950599|62686974|FG005|Follow-Up Period|Subject withdrew Consent|0|||
33311596|NCT00950599|62686975|FG006|Follow-Up Period|Subject withdrew Consent|0|||
33311597|NCT00950599|62686976|FG007|Follow-Up Period|Subject withdrew Consent|0|||
33311598|NCT00950599|62686977|FG008|Follow-Up Period|Subject withdrew Consent|2|||
33311599|NCT00950599|62686978|FG009|Follow-Up Period|Subject withdrew Consent|1|||
33311600|NCT01144299|62687003|FG000|Overall Study|Lost to Follow-up|1|||
33311601|NCT01144299|62687004|FG001|Overall Study|Lost to Follow-up|0|||
33311602|NCT01144299|62687003|FG000|Overall Study|Withdrawal by Subject|1|||
33311603|NCT01144299|62687004|FG001|Overall Study|Withdrawal by Subject|0|||
33311604|NCT01143207|62687010|FG000|Overall Study|Lost to Follow-up|2|||
33710078|NCT01524978|63277152|FG009|Overall Study|Other|2|||
33710079|NCT01524978|63277153|FG010|Overall Study|Other|5|||
33710080|NCT01524978|63277143|FG000|Overall Study|Withdrawal by Subject|12|||
33710081|NCT01524978|63277144|FG001|Overall Study|Withdrawal by Subject|0|||
33710082|NCT01524978|63277145|FG002|Overall Study|Withdrawal by Subject|1|||
33710083|NCT01524978|63277146|FG003|Overall Study|Withdrawal by Subject|1|||
33710084|NCT01524978|63277147|FG004|Overall Study|Withdrawal by Subject|3|||
33710085|NCT01524978|63277148|FG005|Overall Study|Withdrawal by Subject|1|||
33710086|NCT01524978|63277149|FG006|Overall Study|Withdrawal by Subject|6|||
33710087|NCT01524978|63277150|FG007|Overall Study|Withdrawal by Subject|2|||
33710088|NCT01524978|63277151|FG008|Overall Study|Withdrawal by Subject|4|||
33710089|NCT01524978|63277152|FG009|Overall Study|Withdrawal by Subject|0|||
33710090|NCT01524978|63277153|FG010|Overall Study|Withdrawal by Subject|5|||
33710091|NCT01524978|63277143|FG000|Overall Study|Lost to Follow-up|0|||
33710092|NCT01524978|63277144|FG001|Overall Study|Lost to Follow-up|0|||
33710093|NCT01524978|63277145|FG002|Overall Study|Lost to Follow-up|3|||
33710094|NCT01524978|63277146|FG003|Overall Study|Lost to Follow-up|0|||
33710095|NCT01524978|63277147|FG004|Overall Study|Lost to Follow-up|1|||
33311605|NCT01143051|62687020|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
33311606|NCT01143051|62687021|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
33311607|NCT01143051|62687022|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
33311608|NCT01143051|62687023|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
33311609|NCT01143051|62687024|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
33311610|NCT01143051|62687025|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
33311611|NCT01143051|62687020|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
33311612|NCT01143051|62687021|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
33311613|NCT01143051|62687022|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
33311614|NCT01143051|62687023|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
33311615|NCT01143051|62687024|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
33311616|NCT01143051|62687025|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
33311617|NCT01142661|62687035|FG000|Overall Study|Adverse Event|2|||
33311618|NCT01142661|62687035|FG000|Overall Study|Withdrawal by Subject|1|||
33311619|NCT01142661|62687035|FG000|Overall Study|Physician Decision|1|||
33311620|NCT01142193|62687041|FG000|Overall Study|Adverse Event|12|||
33311621|NCT01142193|62687042|FG001|Overall Study|Adverse Event|4|||
33311622|NCT01142193|62687041|FG000|Overall Study|Lack of Efficacy|2|||
33311623|NCT01142193|62687042|FG001|Overall Study|Lack of Efficacy|1|||
33311624|NCT01142193|62687041|FG000|Overall Study|Physician Decision|1|||
33311625|NCT01142193|62687042|FG001|Overall Study|Physician Decision|1|||
33311626|NCT01142193|62687041|FG000|Overall Study|Withdrawal by Subject|4|||
33311627|NCT01142193|62687042|FG001|Overall Study|Withdrawal by Subject|3|||
33311628|NCT01142193|62687041|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
33311629|NCT01142193|62687042|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
33311630|NCT01142193|62687041|FG000|Overall Study|Other|1|||
33710096|NCT01524978|63277148|FG005|Overall Study|Lost to Follow-up|1|||
33710097|NCT01524978|63277149|FG006|Overall Study|Lost to Follow-up|2|||
33710098|NCT01524978|63277150|FG007|Overall Study|Lost to Follow-up|0|||
33710099|NCT01524978|63277151|FG008|Overall Study|Lost to Follow-up|1|||
33710100|NCT01524978|63277152|FG009|Overall Study|Lost to Follow-up|1|||
33710101|NCT01524978|63277153|FG010|Overall Study|Lost to Follow-up|1|||
33710102|NCT01524978|63277143|FG000|Overall Study|Death|34|||
33710103|NCT01524978|63277144|FG001|Overall Study|Death|2|||
33710104|NCT01524978|63277145|FG002|Overall Study|Death|5|||
33710105|NCT01524978|63277146|FG003|Overall Study|Death|24|||
33710106|NCT01524978|63277147|FG004|Overall Study|Death|4|||
33710107|NCT01524978|63277148|FG005|Overall Study|Death|4|||
33710108|NCT01524978|63277149|FG006|Overall Study|Death|1|||
33710109|NCT01524978|63277150|FG007|Overall Study|Death|9|||
33710110|NCT01524978|63277151|FG008|Overall Study|Death|5|||
33710111|NCT01524978|63277152|FG009|Overall Study|Death|6|||
33710112|NCT01524978|63277153|FG010|Overall Study|Death|17|||
33710113|NCT01524900|63277173|FG000|Overall Study|Lost to Follow-up|3|||
33710114|NCT01524900|63277174|FG001|Overall Study|Lost to Follow-up|12|||
33710115|NCT01524900|63277175|FG002|Overall Study|Lost to Follow-up|1|||
33710116|NCT01524900|63277176|FG003|Overall Study|Lost to Follow-up|0|||
33710117|NCT01524900|63277177|FG004|Overall Study|Lost to Follow-up|0|||
33311631|NCT01142193|62687042|FG001|Overall Study|Other|2|||
33311632|NCT01142115|62687048|FG000|First Intervention|Lack of Efficacy|1|||
33311633|NCT01142115|62687049|FG001|First Intervention|Lack of Efficacy|1|||
33311634|NCT01142115|62687048|FG000|First Intervention|Adverse Event|1|||
33710118|NCT01524900|63277173|FG000|Overall Study|Other reason than stated above|1|||
33710119|NCT01524900|63277174|FG001|Overall Study|Other reason than stated above|1|||
33710120|NCT01524900|63277175|FG002|Overall Study|Other reason than stated above|0|||
33710121|NCT01524900|63277176|FG003|Overall Study|Other reason than stated above|0|||
33710122|NCT01524900|63277177|FG004|Overall Study|Other reason than stated above|0|||
33311635|NCT01142115|62687049|FG001|First Intervention|Adverse Event|0|||
33311636|NCT01140477|62687056|FG000|Overall Study|Lost to Follow-up|4|||
33311637|NCT01140477|62687057|FG001|Overall Study|Lost to Follow-up|0|||
33311638|NCT01140477|62687056|FG000|Overall Study|Withdrawal by Subject|1|||
33311639|NCT01140477|62687057|FG001|Overall Study|Withdrawal by Subject|4|||
33311640|NCT01140477|62687056|FG000|Overall Study|Surgical complication preventing implant|2|||
33311641|NCT01140477|62687057|FG001|Overall Study|Surgical complication preventing implant|0|||
33311642|NCT01140477|62687056|FG000|Overall Study|Death|1|||
33311643|NCT01140477|62687057|FG001|Overall Study|Death|1|||
33311644|NCT01140477|62687056|FG000|Overall Study|Subject explanted|0|||
33311645|NCT01140477|62687057|FG001|Overall Study|Subject explanted|1|||
33311646|NCT01139775|62687066|FG000|Overall Study|Adverse Event|0|||
33311647|NCT01139775|62687067|FG001|Overall Study|Adverse Event|6|||
33311648|NCT01139775|62687068|FG002|Overall Study|Adverse Event|2|||
33311649|NCT01139775|62687066|FG000|Overall Study|Protocol Violation|0|||
33311650|NCT01139775|62687067|FG001|Overall Study|Protocol Violation|5|||
33311651|NCT01139775|62687068|FG002|Overall Study|Protocol Violation|0|||
33311652|NCT01139775|62687066|FG000|Overall Study|Withdrawal by Subject|1|||
33311653|NCT01139775|62687067|FG001|Overall Study|Withdrawal by Subject|0|||
33311654|NCT01139775|62687068|FG002|Overall Study|Withdrawal by Subject|2|||
33311655|NCT01139775|62687066|FG000|Overall Study|Physician Decision|0|||
33311656|NCT01139775|62687067|FG001|Overall Study|Physician Decision|2|||
33311657|NCT01139775|62687068|FG002|Overall Study|Physician Decision|2|||
33311658|NCT01283516|62687087|FG000|Overall Study|Adverse Event|0|||
33311659|NCT01283516|62687088|FG001|Overall Study|Adverse Event|0|||
33311660|NCT01283516|62687089|FG002|Overall Study|Adverse Event|0|||
33311661|NCT01283516|62687090|FG003|Overall Study|Adverse Event|0|||
33311662|NCT01283516|62687091|FG004|Overall Study|Adverse Event|0|||
33311663|NCT01283516|62687092|FG005|Overall Study|Adverse Event|0|||
33311664|NCT01283516|62687093|FG006|Overall Study|Adverse Event|2|||
33311665|NCT01283516|62687094|FG007|Overall Study|Adverse Event|0|||
33311666|NCT01283516|62687095|FG008|Overall Study|Adverse Event|28|||
33311667|NCT01283516|62687087|FG000|Overall Study|Death|0|||
33311668|NCT01283516|62687088|FG001|Overall Study|Death|0|||
33311669|NCT01283516|62687089|FG002|Overall Study|Death|0|||
33311670|NCT01283516|62687090|FG003|Overall Study|Death|0|||
33311671|NCT01283516|62687091|FG004|Overall Study|Death|0|||
33311672|NCT01283516|62687092|FG005|Overall Study|Death|1|||
33311673|NCT01283516|62687093|FG006|Overall Study|Death|0|||
33311674|NCT01283516|62687094|FG007|Overall Study|Death|1|||
33311675|NCT01283516|62687095|FG008|Overall Study|Death|12|||
33311676|NCT01283516|62687087|FG000|Overall Study|Disease Progression|2|||
33311677|NCT01283516|62687088|FG001|Overall Study|Disease Progression|2|||
33311678|NCT01283516|62687089|FG002|Overall Study|Disease Progression|3|||
33311679|NCT01283516|62687090|FG003|Overall Study|Disease Progression|3|||
33311680|NCT01283516|62687091|FG004|Overall Study|Disease Progression|13|||
33311681|NCT01283516|62687092|FG005|Overall Study|Disease Progression|8|||
33311682|NCT01283516|62687093|FG006|Overall Study|Disease Progression|6|||
33311683|NCT01283516|62687094|FG007|Overall Study|Disease Progression|3|||
33311684|NCT01283516|62687095|FG008|Overall Study|Disease Progression|139|||
33710123|NCT01524900|63277173|FG000|Overall Study|No reason documented|2|||
33710124|NCT01524900|63277174|FG001|Overall Study|No reason documented|1|||
33311685|NCT01283516|62687087|FG000|Overall Study|Withdrawal by Subject|0|||
33311686|NCT01283516|62687088|FG001|Overall Study|Withdrawal by Subject|0|||
33311687|NCT01283516|62687089|FG002|Overall Study|Withdrawal by Subject|0|||
33311688|NCT01283516|62687090|FG003|Overall Study|Withdrawal by Subject|0|||
33311689|NCT01283516|62687091|FG004|Overall Study|Withdrawal by Subject|1|||
33710125|NCT01524900|63277175|FG002|Overall Study|No reason documented|0|||
33710126|NCT01524900|63277176|FG003|Overall Study|No reason documented|1|||
33710127|NCT01524900|63277177|FG004|Overall Study|No reason documented|0|||
33710128|NCT01524198|63277192|FG000|Overall Study|Protocol Violation|8|||
33710129|NCT01524198|63277193|FG001|Overall Study|Protocol Violation|6|||
33710130|NCT01524198|63277192|FG000|Overall Study|Withdrawal by Subject|15|||
33710131|NCT01524198|63277193|FG001|Overall Study|Withdrawal by Subject|10|||
33311690|NCT01283516|62687092|FG005|Overall Study|Withdrawal by Subject|0|||
33311691|NCT01283516|62687093|FG006|Overall Study|Withdrawal by Subject|1|||
33311692|NCT01283516|62687094|FG007|Overall Study|Withdrawal by Subject|0|||
33311693|NCT01283516|62687095|FG008|Overall Study|Withdrawal by Subject|36|||
33710132|NCT01523886|63277201|FG000|Overall Study|surgery cancelled|0|||
33311694|NCT01283516|62687087|FG000|Overall Study|Administrative problems|0|||
33311695|NCT01283516|62687088|FG001|Overall Study|Administrative problems|0|||
33311696|NCT01283516|62687089|FG002|Overall Study|Administrative problems|0|||
33311697|NCT01283516|62687090|FG003|Overall Study|Administrative problems|0|||
33311698|NCT01283516|62687091|FG004|Overall Study|Administrative problems|0|||
33311699|NCT01283516|62687092|FG005|Overall Study|Administrative problems|1|||
33311700|NCT01283516|62687093|FG006|Overall Study|Administrative problems|1|||
33311701|NCT01283516|62687094|FG007|Overall Study|Administrative problems|1|||
33311702|NCT01283516|62687095|FG008|Overall Study|Administrative problems|39|||
33311703|NCT01283516|62687087|FG000|Overall Study|Lost to Follow-up|0|||
33311704|NCT01283516|62687088|FG001|Overall Study|Lost to Follow-up|0|||
33311705|NCT01283516|62687089|FG002|Overall Study|Lost to Follow-up|0|||
33311706|NCT01283516|62687090|FG003|Overall Study|Lost to Follow-up|0|||
33311707|NCT01283516|62687091|FG004|Overall Study|Lost to Follow-up|0|||
33311708|NCT01283516|62687092|FG005|Overall Study|Lost to Follow-up|0|||
33311709|NCT01283516|62687093|FG006|Overall Study|Lost to Follow-up|0|||
33311710|NCT01283516|62687094|FG007|Overall Study|Lost to Follow-up|0|||
33311711|NCT01283516|62687095|FG008|Overall Study|Lost to Follow-up|1|||
33311712|NCT01137435|62687123|FG000|Overall Study|Lost to Follow-up|24|||
33311713|NCT01137435|62687123|FG000|Overall Study|Off label usage|4|||
33311714|NCT01283282|62687127|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
33311715|NCT01283282|62687128|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
33311716|NCT01283282|62687127|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
33311717|NCT01283282|62687128|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
33311718|NCT01283282|62687127|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
33311719|NCT01283282|62687128|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
33311720|NCT01282814|62687137|FG000|First Intervention|Emesis During Dosing Interval|0|||
33311721|NCT01282814|62687138|FG001|First Intervention|Emesis During Dosing Interval|3|||
33311722|NCT01282814|62687137|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
33311723|NCT01282814|62687138|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
33311724|NCT00941863|62687149|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
33311725|NCT00941863|62687150|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
33311726|NCT00941863|62687151|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
33311727|NCT00941863|62687152|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
33311728|NCT00941863|62687153|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
33311729|NCT00941863|62687149|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
33311730|NCT00941863|62687150|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
33311731|NCT00941863|62687151|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
33311732|NCT00941863|62687152|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
33311733|NCT00941863|62687153|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
33311734|NCT00941863|62687149|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
33311735|NCT00941863|62687150|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
33311736|NCT00941863|62687151|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
33311737|NCT00941863|62687152|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
33311738|NCT00941863|62687153|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
33311739|NCT00941863|62687149|FG000|Until Primary Completion Date (PCD)|Death|0|||
33311740|NCT00941863|62687150|FG001|Until Primary Completion Date (PCD)|Death|0|||
33311741|NCT00941863|62687151|FG002|Until Primary Completion Date (PCD)|Death|1|||
33311742|NCT00941863|62687152|FG003|Until Primary Completion Date (PCD)|Death|2|||
33311743|NCT00941863|62687153|FG004|Until Primary Completion Date (PCD)|Death|7|||
33311744|NCT00941863|62687149|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
33311745|NCT00941863|62687150|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
33311746|NCT00941863|62687151|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
33311747|NCT00941863|62687152|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
33311748|NCT00941863|62687153|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
33311749|NCT00941863|62687149|FG000|Continued After PCD|Withdrawal by Subject|0|||
33311750|NCT00941863|62687150|FG001|Continued After PCD|Withdrawal by Subject|0|||
33311751|NCT00941863|62687151|FG002|Continued After PCD|Withdrawal by Subject|0|||
33311752|NCT00941863|62687152|FG003|Continued After PCD|Withdrawal by Subject|0|||
33311753|NCT00941863|62687153|FG004|Continued After PCD|Withdrawal by Subject|1|||
33311754|NCT00941863|62687149|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
33311755|NCT00941863|62687150|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
33311756|NCT00941863|62687151|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
33311757|NCT00941863|62687152|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
33311758|NCT00941863|62687153|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
33311759|NCT01282424|62687169|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
33311760|NCT01282424|62687169|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
33311761|NCT01282424|62687169|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
33311762|NCT01282424|62687169|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
33311763|NCT01282424|62687169|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
33311764|NCT01282424|62687169|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
33311765|NCT01282424|62687169|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
33311766|NCT01282424|62687169|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
33311767|NCT01281956|62687173|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
33311768|NCT01281956|62687174|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
33311769|NCT01279850|62687183|FG000|Overall Study|Protocol Violation|50|||
33311770|NCT01279850|62687183|FG000|Overall Study|No Drug Administration Information|7|||
33311771|NCT01279850|62687183|FG000|Overall Study|No Visit After Treatment|34|||
33311772|NCT00949975|62687191|FG000|Overall Study|Voluntary discontinuation|6|||
33311773|NCT00949975|62687192|FG001|Overall Study|Voluntary discontinuation|5|||
33311774|NCT00949975|62687193|FG002|Overall Study|Voluntary discontinuation|3|||
33311775|NCT00949975|62687194|FG003|Overall Study|Voluntary discontinuation|6|||
33311776|NCT00949975|62687191|FG000|Overall Study|Adverse Event|11|||
33311777|NCT00949975|62687192|FG001|Overall Study|Adverse Event|11|||
33311778|NCT00949975|62687193|FG002|Overall Study|Adverse Event|10|||
33311779|NCT00949975|62687194|FG003|Overall Study|Adverse Event|10|||
33311780|NCT00949975|62687191|FG000|Overall Study|Safety reason|0|||
33311781|NCT00949975|62687192|FG001|Overall Study|Safety reason|1|||
33311782|NCT00949975|62687193|FG002|Overall Study|Safety reason|0|||
33311783|NCT00949975|62687194|FG003|Overall Study|Safety reason|0|||
33311784|NCT00949975|62687191|FG000|Overall Study|Study-specific criteria|0|||
33311785|NCT00949975|62687192|FG001|Overall Study|Study-specific criteria|1|||
33311786|NCT00949975|62687193|FG002|Overall Study|Study-specific criteria|1|||
33311787|NCT00949975|62687194|FG003|Overall Study|Study-specific criteria|0|||
33311788|NCT00949975|62687191|FG000|Overall Study|Incorrect enrolment|5|||
33311789|NCT00949975|62687192|FG001|Overall Study|Incorrect enrolment|10|||
33311790|NCT00949975|62687193|FG002|Overall Study|Incorrect enrolment|4|||
33311791|NCT00949975|62687194|FG003|Overall Study|Incorrect enrolment|7|||
33311792|NCT00949975|62687191|FG000|Overall Study|Severe non-compliance|3|||
33311793|NCT00949975|62687192|FG001|Overall Study|Severe non-compliance|1|||
33311794|NCT00949975|62687193|FG002|Overall Study|Severe non-compliance|0|||
33311795|NCT00949975|62687194|FG003|Overall Study|Severe non-compliance|2|||
33311796|NCT00949975|62687191|FG000|Overall Study|Lost to Follow-up|1|||
33311797|NCT00949975|62687192|FG001|Overall Study|Lost to Follow-up|0|||
33311798|NCT00949975|62687193|FG002|Overall Study|Lost to Follow-up|1|||
33311799|NCT00949975|62687194|FG003|Overall Study|Lost to Follow-up|3|||
33311800|NCT00949975|62687191|FG000|Overall Study|Other|1|||
33597280|NCT02480153|62996236|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
33597281|NCT02480153|62996234|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
33597282|NCT02480153|62996235|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
33710133|NCT01523886|63277202|FG001|Overall Study|surgery cancelled|1|||
33710134|NCT01546038|63277214|FG000|Overall Study|Death|15|||
33710135|NCT01546038|63277215|FG001|Overall Study|Death|6|||
33710136|NCT01546038|63277216|FG002|Overall Study|Death|4|||
33710137|NCT01546038|63277217|FG003|Overall Study|Death|2|||
33710138|NCT01546038|63277218|FG004|Overall Study|Death|9|||
33710139|NCT01546038|63277219|FG005|Overall Study|Death|3|||
33710140|NCT01546038|63277220|FG006|Overall Study|Death|46|||
33311801|NCT00949975|62687192|FG001|Overall Study|Other|0|||
33311802|NCT00949975|62687193|FG002|Overall Study|Other|0|||
33311803|NCT00949975|62687194|FG003|Overall Study|Other|0|||
33710141|NCT01546038|63277221|FG007|Overall Study|Death|76|||
33710142|NCT01546038|63277222|FG008|Overall Study|Death|39|||
33710143|NCT01546038|63277214|FG000|Overall Study|Lost to Follow-up|0|||
33710144|NCT01546038|63277215|FG001|Overall Study|Lost to Follow-up|0|||
33710145|NCT01546038|63277216|FG002|Overall Study|Lost to Follow-up|0|||
33311804|NCT00939055|62687206|FG000|Overall Study|Discontinuation prior to procedure|4|||
33311805|NCT00939055|62687207|FG001|Overall Study|Discontinuation prior to procedure|0|||
33311806|NCT01136967|62687216|FG000|Overall Study|Adverse Event|9|||
33311807|NCT01136967|62687217|FG001|Overall Study|Adverse Event|12|||
33710146|NCT01546038|63277217|FG003|Overall Study|Lost to Follow-up|0|||
33710147|NCT01546038|63277218|FG004|Overall Study|Lost to Follow-up|1|||
33311808|NCT01136967|62687216|FG000|Overall Study|Participant Choice|8|||
33597283|NCT02480153|62996236|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
33311809|NCT01136967|62687217|FG001|Overall Study|Participant Choice|3|||
33710148|NCT01546038|63277219|FG005|Overall Study|Lost to Follow-up|0|||
33710149|NCT01546038|63277220|FG006|Overall Study|Lost to Follow-up|2|||
33311810|NCT01136967|62687216|FG000|Overall Study|Lost to Follow-up|0|||
33311811|NCT01136967|62687217|FG001|Overall Study|Lost to Follow-up|1|||
33710150|NCT01546038|63277221|FG007|Overall Study|Lost to Follow-up|1|||
33710151|NCT01546038|63277222|FG008|Overall Study|Lost to Follow-up|0|||
33710152|NCT01546038|63277214|FG000|Overall Study|Withdrawal by Subject|1|||
33710153|NCT01546038|63277215|FG001|Overall Study|Withdrawal by Subject|0|||
33710154|NCT01546038|63277216|FG002|Overall Study|Withdrawal by Subject|0|||
33710155|NCT01546038|63277217|FG003|Overall Study|Withdrawal by Subject|1|||
33710156|NCT01546038|63277218|FG004|Overall Study|Withdrawal by Subject|0|||
33710157|NCT01546038|63277219|FG005|Overall Study|Withdrawal by Subject|1|||
33710158|NCT01546038|63277220|FG006|Overall Study|Withdrawal by Subject|3|||
33710159|NCT01546038|63277221|FG007|Overall Study|Withdrawal by Subject|3|||
33710160|NCT01546038|63277222|FG008|Overall Study|Withdrawal by Subject|1|||
33710161|NCT01546038|63277214|FG000|Overall Study|: Randomized, not treated|0|||
33710162|NCT01546038|63277215|FG001|Overall Study|: Randomized, not treated|0|||
33710163|NCT01546038|63277216|FG002|Overall Study|: Randomized, not treated|0|||
33710164|NCT01546038|63277217|FG003|Overall Study|: Randomized, not treated|0|||
33710165|NCT01546038|63277218|FG004|Overall Study|: Randomized, not treated|0|||
33597284|NCT02480153|62996234|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
33710166|NCT01546038|63277219|FG005|Overall Study|: Randomized, not treated|0|||
33710167|NCT01546038|63277220|FG006|Overall Study|: Randomized, not treated|2|||
33710168|NCT01546038|63277221|FG007|Overall Study|: Randomized, not treated|4|||
33710169|NCT01546038|63277222|FG008|Overall Study|: Randomized, not treated|3|||
33710170|NCT01571232|63277274|FG000|Overall Study|Lost to Follow-up|0|||
33710171|NCT01571232|63277275|FG001|Overall Study|Lost to Follow-up|1|||
33710172|NCT01571232|63277274|FG000|Overall Study|Withdrawal by Subject|1|||
33710173|NCT01571232|63277275|FG001|Overall Study|Withdrawal by Subject|0|||
33710174|NCT01544478|63277282|FG000|Overall Study|Adverse Event|1|||
33710175|NCT01544478|63277282|FG000|Overall Study|Death|1|||
33710176|NCT01544478|63277282|FG000|Overall Study|Lost to Follow-up|48|||
33710177|NCT01544478|63277282|FG000|Overall Study|Physician Decision|15|||
33710178|NCT01544478|63277282|FG000|Overall Study|Pregnancy|1|||
33710179|NCT01544478|63277282|FG000|Overall Study|Withdrawal by Subject|52|||
33710180|NCT01522950|63277289|FG000|Overall Study|Withdrawal by Subject|3|||
33710181|NCT01522950|63277290|FG001|Overall Study|Withdrawal by Subject|2|||
33710182|NCT01522950|63277291|FG002|Overall Study|Withdrawal by Subject|1|||
33710183|NCT01522950|63277289|FG000|Overall Study|Adverse Event|3|||
33710184|NCT01522950|63277290|FG001|Overall Study|Adverse Event|1|||
33710185|NCT01522950|63277291|FG002|Overall Study|Adverse Event|1|||
33710186|NCT01522950|63277289|FG000|Overall Study|Protocol Violation|0|||
33710187|NCT01522950|63277290|FG001|Overall Study|Protocol Violation|0|||
33311812|NCT01136967|62687216|FG000|Overall Study|Withdrawal by Subject|1|||
33311813|NCT01136967|62687217|FG001|Overall Study|Withdrawal by Subject|2|||
33311814|NCT01136967|62687216|FG000|Overall Study|Clinical Progression|3|||
33710188|NCT01522950|63277291|FG002|Overall Study|Protocol Violation|2|||
33710189|NCT01522950|63277289|FG000|Overall Study|Death|0|||
33710190|NCT01522950|63277290|FG001|Overall Study|Death|1|||
33710191|NCT01522950|63277291|FG002|Overall Study|Death|1|||
33710192|NCT01522950|63277289|FG000|Overall Study|Study Medication Sensitivity|0|||
33710193|NCT01522950|63277290|FG001|Overall Study|Study Medication Sensitivity|1|||
33710194|NCT01522950|63277291|FG002|Overall Study|Study Medication Sensitivity|0|||
33311815|NCT01136967|62687217|FG001|Overall Study|Clinical Progression|5|||
33710195|NCT01522404|63277301|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
33710196|NCT01522404|63277302|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
33710197|NCT01522404|63277301|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
33710198|NCT01522404|63277302|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
33311816|NCT01136967|62687216|FG000|Overall Study|Radiation|1|||
33311817|NCT01136967|62687217|FG001|Overall Study|Radiation|0|||
33311818|NCT01136967|62687216|FG000|Overall Study|Non-compliance|1|||
33311819|NCT01136967|62687217|FG001|Overall Study|Non-compliance|0|||
33311820|NCT01136967|62687216|FG000|Overall Study|Investigator's Choice|1|||
33311821|NCT01136967|62687217|FG001|Overall Study|Investigator's Choice|1|||
33311822|NCT01136967|62687216|FG000|Overall Study|Increase in Lesion Size|0|||
33311823|NCT01136967|62687217|FG001|Overall Study|Increase in Lesion Size|2|||
33311824|NCT01136967|62687216|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
33311825|NCT01136967|62687217|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
33311826|NCT01218516|62687225|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
33311827|NCT01218516|62687226|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
33311828|NCT01218516|62687227|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
33311829|NCT01218516|62687228|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
33311830|NCT01218516|62687225|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
33597285|NCT02480153|62996235|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
33597286|NCT02480153|62996236|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
33597287|NCT02480153|62996234|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
33597288|NCT02480153|62996235|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
33597289|NCT02480153|62996236|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
33597290|NCT02480153|62996234|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
33597291|NCT02480153|62996235|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
33597292|NCT02480153|62996236|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
33597293|NCT02480153|62996234|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
33710199|NCT01522404|63277301|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
33710200|NCT01522404|63277302|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
33710201|NCT01570686|63277318|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33710202|NCT01570686|63277319|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33710203|NCT01570686|63277318|FG000|Overall Study|Administrative problems|0|||
33710204|NCT01570686|63277319|FG001|Overall Study|Administrative problems|1|||
33710205|NCT01570686|63277318|FG000|Overall Study|Adverse Event|8|||
33710206|NCT01570686|63277319|FG001|Overall Study|Adverse Event|6|||
33710207|NCT01570686|63277318|FG000|Overall Study|Lost to Follow-up|4|||
33710208|NCT01570686|63277319|FG001|Overall Study|Lost to Follow-up|3|||
33710209|NCT01570686|63277318|FG000|Overall Study|Protocol Deviation|3|||
33710210|NCT01570686|63277319|FG001|Overall Study|Protocol Deviation|0|||
33710211|NCT01570686|63277318|FG000|Overall Study|Withdrawal by Subject|4|||
33710212|NCT01570686|63277319|FG001|Overall Study|Withdrawal by Subject|4|||
33710213|NCT01570686|63277318|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33710214|NCT01570686|63277319|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33710215|NCT01522248|63277327|FG000|Overall Study|Lost to Follow-up|1|||
33710216|NCT01522248|63277328|FG001|Overall Study|Lost to Follow-up|0|||
33597294|NCT02480153|62996235|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
33710217|NCT01543776|63277341|FG000|Overall Study|Withdrawal by Subject|2|||
33710218|NCT01543776|63277342|FG001|Overall Study|Withdrawal by Subject|2|||
33311831|NCT01218516|62687226|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
33311832|NCT01218516|62687227|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
33710219|NCT01518192|63277351|FG000|Overall Study|Lost to Follow-up|29|||
33710220|NCT01518192|63277352|FG001|Overall Study|Lost to Follow-up|26|||
33311833|NCT01218516|62687228|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
33311834|NCT01218516|62687225|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
33311835|NCT01218516|62687226|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
33311836|NCT01218516|62687227|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
33311837|NCT01218516|62687228|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
33311838|NCT01218516|62687225|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
33311839|NCT01218516|62687226|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
33311840|NCT01218516|62687227|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
33311841|NCT01218516|62687228|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
33311842|NCT01218516|62687225|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
33311843|NCT01218516|62687226|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
33311844|NCT01218516|62687227|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
33311845|NCT01218516|62687228|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
33311846|NCT01218516|62687225|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
33311847|NCT01218516|62687226|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
33311848|NCT01218516|62687227|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
33311849|NCT01218516|62687228|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
33311850|NCT01218516|62687225|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
33311851|NCT01218516|62687226|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
33311852|NCT01218516|62687227|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
33311853|NCT01218516|62687228|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
33311854|NCT01218516|62687225|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
33311855|NCT01218516|62687226|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
33311856|NCT01218516|62687227|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
33311857|NCT01218516|62687228|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
33311858|NCT01218516|62687225|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
33311859|NCT01218516|62687226|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
33311860|NCT01218516|62687227|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
33311861|NCT01218516|62687228|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
33311862|NCT01218516|62687225|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
33597295|NCT02480153|62996236|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
33597296|NCT02480153|62996234|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
33597297|NCT02480153|62996235|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
33597298|NCT02480153|62996236|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
33597299|NCT02480153|62996234|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
33597300|NCT02480153|62996235|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
33597301|NCT02480153|62996236|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
33597302|NCT02480153|62996234|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
33597303|NCT02480153|62996235|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
33597304|NCT02480153|62996236|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
33710221|NCT01518192|63277353|FG002|Overall Study|Lost to Follow-up|35|||
33311863|NCT01218516|62687226|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
33311864|NCT01218516|62687227|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
33311865|NCT01218516|62687228|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
33311866|NCT01218516|62687225|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
33311867|NCT01218516|62687226|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
33311868|NCT01218516|62687227|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
33311869|NCT01218516|62687228|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
33311870|NCT01218516|62687225|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
33311871|NCT01218516|62687226|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
33311872|NCT01218516|62687227|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
33493382|NCT03134222|62871692|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
33710222|NCT01517802|63277367|FG000|Overall Study|Death|1|||
33710223|NCT01520922|63277373|FG000|Treatment Phase|Physician Decision|2|||
33710224|NCT01520922|63277374|FG001|Treatment Phase|Physician Decision|1|||
33710225|NCT01520922|63277373|FG000|Treatment Phase|Progression|0|||
33710226|NCT01520922|63277374|FG001|Treatment Phase|Progression|2|||
33710227|NCT01520922|63277373|FG000|Treatment Phase|Adverse Event|3|||
33710228|NCT01520922|63277374|FG001|Treatment Phase|Adverse Event|5|||
33710229|NCT01520922|63277373|FG000|Follow up|Lost to Follow-up|0|||
33710230|NCT01520922|63277374|FG001|Follow up|Lost to Follow-up|1|||
33710231|NCT01520922|63277373|FG000|Survival Follow-up|Withdrawal by Subject|1|||
33710232|NCT01520922|63277374|FG001|Survival Follow-up|Withdrawal by Subject|0|||
33710233|NCT01569438|63277382|FG000|Overall Study|Lack of Efficacy|1|||
33710234|NCT01569438|63277383|FG001|Overall Study|Lack of Efficacy|2|||
33710235|NCT01569438|63277382|FG000|Overall Study|Withdrawal by Subject|0|||
33710236|NCT01569438|63277383|FG001|Overall Study|Withdrawal by Subject|3|||
33710237|NCT01569438|63277382|FG000|Overall Study|Adverse Event|2|||
33710238|NCT01569438|63277383|FG001|Overall Study|Adverse Event|15|||
33710239|NCT01569438|63277382|FG000|Overall Study|Protocol Violation|2|||
33710240|NCT01569438|63277383|FG001|Overall Study|Protocol Violation|0|||
33710241|NCT01569438|63277382|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
33710242|NCT01569438|63277383|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
33710243|NCT01569438|63277382|FG000|Overall Study|Sponsor/Physician decision|1|||
33710244|NCT01569438|63277383|FG001|Overall Study|Sponsor/Physician decision|1|||
33710245|NCT01569438|63277382|FG000|Overall Study|Unable to adhere to study schedule|0|||
33710246|NCT01569438|63277383|FG001|Overall Study|Unable to adhere to study schedule|1|||
33710247|NCT01517412|63277391|FG000|Overall Study|Adverse Event|10|||
33710248|NCT01517412|63277392|FG001|Overall Study|Adverse Event|11|||
33710249|NCT01517412|63277391|FG000|Overall Study|Lack of Efficacy|10|||
33710250|NCT01517412|63277392|FG001|Overall Study|Lack of Efficacy|5|||
33710251|NCT01517412|63277391|FG000|Overall Study|Poor compliance to protocol|8|||
33710252|NCT01517412|63277392|FG001|Overall Study|Poor compliance to protocol|3|||
33710253|NCT01517412|63277391|FG000|Overall Study|Other than specified above|8|||
33710254|NCT01517412|63277392|FG001|Overall Study|Other than specified above|5|||
33710255|NCT01517178|63277398|FG000|Period 1|Adverse Event|1|||
33710256|NCT01517178|63277399|FG001|Period 1|Adverse Event|2|||
33710257|NCT01517178|63277398|FG000|Period 1|Lack of Efficacy|0|||
33710258|NCT01517178|63277399|FG001|Period 1|Lack of Efficacy|1|||
33710259|NCT01517178|63277398|FG000|Period 1|E.g. study termination|3|||
33710260|NCT01517178|63277399|FG001|Period 1|E.g. study termination|1|||
33710261|NCT01517178|63277398|FG000|Period 1|Withdrawal by Subject|0|||
33710262|NCT01517178|63277399|FG001|Period 1|Withdrawal by Subject|1|||
33710263|NCT01517178|63277398|FG000|Period 2|Adverse Event|1|||
33710264|NCT01517178|63277399|FG001|Period 2|Adverse Event|0|||
33710265|NCT01517178|63277398|FG000|Period 2|Withdrawal by Subject|3|||
33710266|NCT01517178|63277399|FG001|Period 2|Withdrawal by Subject|0|||
33710267|NCT01517178|63277398|FG000|Period 2|E.g. study termination|2|||
33710268|NCT01517178|63277399|FG001|Period 2|E.g. study termination|2|||
33710269|NCT01489956|63277407|FG000|Overall Study|Lost to Follow-up|1|||
33710270|NCT01489956|63277408|FG001|Overall Study|Lost to Follow-up|0|||
33710271|NCT01489956|63277409|FG002|Overall Study|Lost to Follow-up|0|||
33710272|NCT01489956|63277407|FG000|Overall Study|Withdrawal by Subject|0|||
33710273|NCT01489956|63277408|FG001|Overall Study|Withdrawal by Subject|0|||
33710274|NCT01489956|63277409|FG002|Overall Study|Withdrawal by Subject|1|||
33710275|NCT01516008|63277420|FG000|Overall Study|Adverse Event|0|||
33710276|NCT01516008|63277421|FG001|Overall Study|Adverse Event|2|||
33710277|NCT01516008|63277422|FG002|Overall Study|Adverse Event|7|||
33710278|NCT01516008|63277420|FG000|Overall Study|Lack of Efficacy|44|||
33710279|NCT01516008|63277421|FG001|Overall Study|Lack of Efficacy|14|||
33710280|NCT01516008|63277422|FG002|Overall Study|Lack of Efficacy|10|||
33710281|NCT01516008|63277420|FG000|Overall Study|Protocol Violation|1|||
33710282|NCT01516008|63277421|FG001|Overall Study|Protocol Violation|0|||
33311873|NCT01218516|62687228|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
33311874|NCT00938431|62687241|FG000|Overall Study|Adverse Event|5|||
33311875|NCT00938431|62687242|FG001|Overall Study|Adverse Event|8|||
33311876|NCT00938431|62687243|FG002|Overall Study|Adverse Event|6|||
33710283|NCT01516008|63277422|FG002|Overall Study|Protocol Violation|0|||
33311877|NCT00938431|62687241|FG000|Overall Study|Lack of Efficacy|0|||
33710284|NCT01516008|63277420|FG000|Overall Study|Reason not specified|0|||
33710285|NCT01516008|63277421|FG001|Overall Study|Reason not specified|0|||
33710286|NCT01516008|63277422|FG002|Overall Study|Reason not specified|1|||
33710287|NCT01489254|63277433|FG000|Double-blind Part|Adverse Event|7|||
33710288|NCT01489254|63277434|FG001|Double-blind Part|Adverse Event|2|||
33710289|NCT01489254|63277435|FG002|Double-blind Part|Adverse Event|2|||
33710290|NCT01489254|63277436|FG003|Double-blind Part|Adverse Event|0|||
33311878|NCT00938431|62687242|FG001|Overall Study|Lack of Efficacy|1|||
33311879|NCT00938431|62687243|FG002|Overall Study|Lack of Efficacy|0|||
33311880|NCT00938431|62687241|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
33311881|NCT00938431|62687242|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
33311882|NCT00938431|62687243|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
33311883|NCT00938431|62687241|FG000|Overall Study|Dosing compliance issue|0|||
33311884|NCT00938431|62687242|FG001|Overall Study|Dosing compliance issue|0|||
33311885|NCT00938431|62687243|FG002|Overall Study|Dosing compliance issue|1|||
33311886|NCT00938431|62687241|FG000|Overall Study|Reached maximum dose early|0|||
33311887|NCT00938431|62687242|FG001|Overall Study|Reached maximum dose early|0|||
33311888|NCT00938431|62687243|FG002|Overall Study|Reached maximum dose early|1|||
33311889|NCT01136811|62687255|FG000|Overall Study|Physician Decision|11|||
33311890|NCT00949117|62687261|FG000|Overall Study|Lack of Efficacy|2|||
33311891|NCT00949117|62687262|FG001|Overall Study|Lack of Efficacy|3|||
33311892|NCT00949117|62687261|FG000|Overall Study|Protocol Violation|1|||
33311893|NCT00949117|62687262|FG001|Overall Study|Protocol Violation|1|||
33311894|NCT00949117|62687261|FG000|Overall Study|Adverse Event|0|||
33311895|NCT00949117|62687262|FG001|Overall Study|Adverse Event|1|||
33311896|NCT00938041|62687270|FG000|Overall Study|Lost to Follow-up|6|||
33311897|NCT00938041|62687270|FG000|Overall Study|Received Alternative Therapy|1|||
33311898|NCT00938041|62687270|FG000|Overall Study|Progressive Disease|5|||
33311899|NCT00938041|62687270|FG000|Overall Study|Death|12|||
33311900|NCT00938041|62687270|FG000|Overall Study|Adrenal Insufficiency|3|||
33311901|NCT01218438|62687274|FG000|Epoch 1|Physician Decision|2|||
33311902|NCT01218438|62687274|FG000|Epoch 1|Adverse Event|1|||
33311903|NCT01218438|62687274|FG000|Epoch 3|Withdrawal by Subject|3|||
33311904|NCT01218438|62687274|FG000|Epoch 3|Adverse Event|1|||
33311905|NCT01218438|62687274|FG000|Epoch 4|Physician Decision|1|||
33311906|NCT01218438|62687274|FG000|Epoch 4|Withdrawal by Subject|2|||
33311907|NCT00935701|62687348|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
33311908|NCT01277510|62687355|FG000|Double-blind Phase|Non-compliance|0|||
33311909|NCT01277510|62687356|FG001|Double-blind Phase|Non-compliance|1|||
33311910|NCT01277510|62687355|FG000|Double-blind Phase|Adverse Event|1|||
33311911|NCT01277510|62687356|FG001|Double-blind Phase|Adverse Event|0|||
33311912|NCT01277510|62687355|FG000|Double-blind Phase|Withdrawal by Subject|2|||
33311913|NCT01277510|62687356|FG001|Double-blind Phase|Withdrawal by Subject|0|||
33311914|NCT01277510|62687355|FG000|Double-blind Phase|Administrative decision|7|||
33311915|NCT01277510|62687356|FG001|Double-blind Phase|Administrative decision|9|||
33311916|NCT01277510|62687355|FG000|Double-blind Phase|Death|0|||
33311917|NCT01277510|62687356|FG001|Double-blind Phase|Death|1|||
33710291|NCT01489254|63277433|FG000|Double-blind Part|Pregnancy|1|||
33710292|NCT01489254|63277434|FG001|Double-blind Part|Pregnancy|3|||
33710293|NCT01489254|63277435|FG002|Double-blind Part|Pregnancy|0|||
33710294|NCT01489254|63277436|FG003|Double-blind Part|Pregnancy|0|||
33710295|NCT01489254|63277433|FG000|Double-blind Part|Withdrawal by Subject|12|||
33710296|NCT01489254|63277434|FG001|Double-blind Part|Withdrawal by Subject|20|||
33710297|NCT01489254|63277435|FG002|Double-blind Part|Withdrawal by Subject|1|||
33710298|NCT01489254|63277436|FG003|Double-blind Part|Withdrawal by Subject|0|||
33710299|NCT01489254|63277433|FG000|Double-blind Part|Lost to Follow-up|1|||
33710300|NCT01489254|63277434|FG001|Double-blind Part|Lost to Follow-up|2|||
33710301|NCT01489254|63277435|FG002|Double-blind Part|Lost to Follow-up|0|||
33710302|NCT01489254|63277436|FG003|Double-blind Part|Lost to Follow-up|0|||
33710303|NCT01489254|63277433|FG000|Double-blind Part|Other reasons for not completing study|4|||
33710304|NCT01489254|63277434|FG001|Double-blind Part|Other reasons for not completing study|6|||
33710305|NCT01489254|63277435|FG002|Double-blind Part|Other reasons for not completing study|0|||
33710306|NCT01489254|63277436|FG003|Double-blind Part|Other reasons for not completing study|0|||
33710307|NCT01489254|63277433|FG000|Open-label Extension Part|Adverse Event|0|||
33710308|NCT01489254|63277434|FG001|Open-label Extension Part|Adverse Event|0|||
33710309|NCT01489254|63277435|FG002|Open-label Extension Part|Adverse Event|0|||
33710310|NCT01489254|63277436|FG003|Open-label Extension Part|Adverse Event|10|||
33311918|NCT01277510|62687355|FG000|Double-blind Phase|Protocol-specified criteria|2|||
33311919|NCT01277510|62687356|FG001|Double-blind Phase|Protocol-specified criteria|6|||
33311920|NCT01277510|62687355|FG000|Double-blind Phase|Other|1|||
33311921|NCT01277510|62687356|FG001|Double-blind Phase|Other|1|||
33311922|NCT01277510|62687355|FG000|Open-label Phase|Administrative decision|4|||
33311923|NCT01277510|62687356|FG001|Open-label Phase|Administrative decision|3|||
33311924|NCT01277510|62687355|FG000|Open-label Phase|Protocol-specified criteria|1|||
33311925|NCT01277510|62687356|FG001|Open-label Phase|Protocol-specified criteria|0|||
33311926|NCT01277510|62687355|FG000|Open-label Phase|Never received investigational product|2|||
33311927|NCT01277510|62687356|FG001|Open-label Phase|Never received investigational product|0|||
33311928|NCT00937495|62687364|FG000|Overall Study|Protocol Violation|2|||
33311929|NCT01268306|62687368|FG000|Overall Study|Lost to Follow-up|1|||
33311930|NCT00936715|62687372|FG000|Overall Study|Investigators Discretion|1|||
33311931|NCT00936715|62687372|FG000|Overall Study|Protocol Violation|1|||
33311932|NCT00936715|62687372|FG000|Overall Study|Safety or Tolerability Reasons|4|||
33311933|NCT01267994|62687376|FG000|Overall Study|Adverse Event|2|||
33311934|NCT00934843|62687383|FG000|Overall Study|Protocol Violation|0|||
33311935|NCT00934843|62687384|FG001|Overall Study|Protocol Violation|1|||
33311936|NCT01266902|62687392|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
33311937|NCT01266902|62687393|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
33311938|NCT01266902|62687394|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
33311939|NCT01266902|62687392|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
33311940|NCT01266902|62687393|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
33311941|NCT01266902|62687394|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
33311942|NCT01266902|62687392|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
33311943|NCT01266902|62687393|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
33311944|NCT01266902|62687394|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
33311945|NCT01266902|62687392|FG000|Period 1 (Main Study)|Adverse Event|3|||
33311946|NCT01266902|62687393|FG001|Period 1 (Main Study)|Adverse Event|11|||
33311947|NCT01266902|62687394|FG002|Period 1 (Main Study)|Adverse Event|0|||
33311948|NCT01266902|62687392|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
33311949|NCT01266902|62687393|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
33311950|NCT01266902|62687394|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
33311951|NCT01266902|62687392|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
33311952|NCT01266902|62687393|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
33311953|NCT01266902|62687394|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
33311954|NCT01266902|62687392|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
33311955|NCT01266902|62687393|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
33311956|NCT01266902|62687394|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
33311957|NCT01266902|62687392|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
33311958|NCT01266902|62687393|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
33311959|NCT01266902|62687394|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
33311960|NCT01266902|62687392|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
33311961|NCT01266902|62687393|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
33311962|NCT01266902|62687394|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
33311963|NCT01266902|62687392|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
33311964|NCT01266902|62687393|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
33311965|NCT01266902|62687394|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
33311966|NCT01266824|62687404|FG000|Overall Study|Study terminated prior to completion|2|||
33311967|NCT01266824|62687405|FG001|Overall Study|Study terminated prior to completion|3|||
33311968|NCT01266590|62687411|FG000|Overall Study|Adverse Event|3|||
33311969|NCT01266590|62687411|FG000|Overall Study|Lost to Follow-up|1|||
33311970|NCT01266590|62687411|FG000|Overall Study|Withdrawal by Subject|1|||
33311971|NCT01266590|62687411|FG000|Overall Study|Physician Decision|1|||
33311972|NCT01266122|62687420|FG000|Overall Study|Lost to Follow-up|6|||
33311973|NCT01266122|62687421|FG001|Overall Study|Lost to Follow-up|6|||
33311974|NCT01265498|62687429|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
33311975|NCT01265498|62687430|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
33311976|NCT01265420|62687436|FG000|Overall Study|Lost to Follow-up|1|||
33311977|NCT01264718|62687442|FG000|Overall Study|Lost to Follow-up|3|||
33311978|NCT01264718|62687443|FG001|Overall Study|Lost to Follow-up|2|||
33311979|NCT01264718|62687442|FG000|Overall Study|Withdrawal by Subject|9|||
33311980|NCT01264718|62687443|FG001|Overall Study|Withdrawal by Subject|15|||
33311981|NCT01264718|62687442|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
33493383|NCT03134222|62871693|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
33597305|NCT02480153|62996234|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
33311982|NCT01264718|62687443|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
33311983|NCT01264016|62687449|FG000|Overall Study|Withdrawal by Subject|1|||
33311984|NCT01264016|62687449|FG000|Overall Study|Felt faint at sight of blood|1|||
33311985|NCT01263782|62687458|FG000|Overall Study|Death|0|||
33311986|NCT01263782|62687459|FG001|Overall Study|Death|0|||
33311987|NCT01263782|62687460|FG002|Overall Study|Death|1|||
33311988|NCT01263782|62687461|FG003|Overall Study|Death|0|||
33311989|NCT01263782|62687458|FG000|Overall Study|Progressive disease|0|||
33311990|NCT01263782|62687459|FG001|Overall Study|Progressive disease|0|||
33311991|NCT01263782|62687460|FG002|Overall Study|Progressive disease|0|||
33311992|NCT01263782|62687461|FG003|Overall Study|Progressive disease|1|||
33311993|NCT01263782|62687458|FG000|Overall Study|Too early|0|||
33311994|NCT01263782|62687459|FG001|Overall Study|Too early|0|||
33311995|NCT01263782|62687460|FG002|Overall Study|Too early|1|||
33311996|NCT01263782|62687461|FG003|Overall Study|Too early|0|||
33311997|NCT01263782|62687458|FG000|Overall Study|Inevaluable|0|||
33311998|NCT01263782|62687459|FG001|Overall Study|Inevaluable|0|||
33311999|NCT01263782|62687460|FG002|Overall Study|Inevaluable|1|||
33312000|NCT01263782|62687461|FG003|Overall Study|Inevaluable|0|||
33312001|NCT01263704|62687471|FG000|Overall Study|Progressive disease|18|||
33312002|NCT01263704|62687471|FG000|Overall Study|Adverse Event|3|||
33312003|NCT01263704|62687471|FG000|Overall Study|Death|2|||
33312004|NCT01263704|62687471|FG000|Overall Study|Patient withdrew consent|2|||
33312005|NCT01263704|62687471|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
33312006|NCT01263704|62687471|FG000|Overall Study|Lost to Follow-up|1|||
33312007|NCT01263704|62687471|FG000|Overall Study|Colon metastases|1|||
33312008|NCT01263704|62687471|FG000|Overall Study|Principal Investigator (PI) decision|1|||
33312009|NCT01263470|62687481|FG000|Overall Study|Adverse Event|2|||
33312010|NCT01263470|62687482|FG001|Overall Study|Adverse Event|2|||
33312011|NCT01263470|62687483|FG002|Overall Study|Adverse Event|1|||
33312012|NCT01263470|62687484|FG003|Overall Study|Adverse Event|1|||
33312013|NCT01263470|62687485|FG004|Overall Study|Adverse Event|2|||
33312014|NCT01263470|62687486|FG005|Overall Study|Adverse Event|2|||
33312015|NCT01263470|62687481|FG000|Overall Study|Protocol Violation|0|||
33312016|NCT01263470|62687482|FG001|Overall Study|Protocol Violation|1|||
33312017|NCT01263470|62687483|FG002|Overall Study|Protocol Violation|0|||
33312018|NCT01263470|62687484|FG003|Overall Study|Protocol Violation|0|||
33312019|NCT01263470|62687485|FG004|Overall Study|Protocol Violation|0|||
33312020|NCT01263470|62687486|FG005|Overall Study|Protocol Violation|1|||
33312021|NCT01263470|62687481|FG000|Overall Study|Withdrawal by Subject|0|||
33312022|NCT01263470|62687482|FG001|Overall Study|Withdrawal by Subject|1|||
33312023|NCT01263470|62687483|FG002|Overall Study|Withdrawal by Subject|1|||
33312024|NCT01263470|62687484|FG003|Overall Study|Withdrawal by Subject|2|||
33312025|NCT01263470|62687485|FG004|Overall Study|Withdrawal by Subject|0|||
33312026|NCT01263470|62687486|FG005|Overall Study|Withdrawal by Subject|2|||
33312027|NCT01263470|62687481|FG000|Overall Study|Lack of Efficacy|0|||
33312028|NCT01263470|62687482|FG001|Overall Study|Lack of Efficacy|0|||
33312029|NCT01263470|62687483|FG002|Overall Study|Lack of Efficacy|2|||
33312030|NCT01263470|62687484|FG003|Overall Study|Lack of Efficacy|0|||
33312031|NCT01263470|62687485|FG004|Overall Study|Lack of Efficacy|0|||
33312032|NCT01263470|62687486|FG005|Overall Study|Lack of Efficacy|0|||
33312033|NCT01263470|62687481|FG000|Overall Study|Participant Unavailability|0|||
33312034|NCT01263470|62687482|FG001|Overall Study|Participant Unavailability|1|||
33312035|NCT01263470|62687483|FG002|Overall Study|Participant Unavailability|0|||
33312036|NCT01263470|62687484|FG003|Overall Study|Participant Unavailability|0|||
33312037|NCT01263470|62687485|FG004|Overall Study|Participant Unavailability|0|||
33312038|NCT01263470|62687486|FG005|Overall Study|Participant Unavailability|0|||
33312039|NCT01263470|62687481|FG000|Overall Study|Study Drug Non-compliance|0|||
33312040|NCT01263470|62687482|FG001|Overall Study|Study Drug Non-compliance|0|||
33597306|NCT02480153|62996235|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
33597307|NCT02480153|62996236|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
33710311|NCT01489254|63277433|FG000|Open-label Extension Part|Pregnancy|0|||
33710312|NCT01489254|63277434|FG001|Open-label Extension Part|Pregnancy|0|||
33710313|NCT01489254|63277435|FG002|Open-label Extension Part|Pregnancy|0|||
33710314|NCT01489254|63277436|FG003|Open-label Extension Part|Pregnancy|3|||
33710315|NCT01489254|63277433|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
33710316|NCT01489254|63277434|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
33710317|NCT01489254|63277435|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
33710318|NCT01489254|63277436|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
33710319|NCT01489254|63277433|FG000|Open-label Extension Part|Protocol Violation|0|||
33710320|NCT01489254|63277434|FG001|Open-label Extension Part|Protocol Violation|0|||
33710321|NCT01489254|63277435|FG002|Open-label Extension Part|Protocol Violation|0|||
33710322|NCT01489254|63277436|FG003|Open-label Extension Part|Protocol Violation|1|||
33710323|NCT01489254|63277433|FG000|Open-label Extension Part|Lost to Follow-up|0|||
33312041|NCT01263470|62687483|FG002|Overall Study|Study Drug Non-compliance|0|||
33312042|NCT01263470|62687484|FG003|Overall Study|Study Drug Non-compliance|0|||
33312043|NCT01263470|62687485|FG004|Overall Study|Study Drug Non-compliance|1|||
33312044|NCT01263470|62687486|FG005|Overall Study|Study Drug Non-compliance|0|||
33312045|NCT01262456|62687503|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
33312046|NCT01262456|62687504|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
33312047|NCT01262456|62687505|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
33312048|NCT01262456|62687503|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
33312049|NCT01262456|62687504|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
33312050|NCT01262456|62687505|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
33312051|NCT01262456|62687503|FG000|3-Month Double-Blind Period|Adverse Event|6|||
33312052|NCT01262456|62687504|FG001|3-Month Double-Blind Period|Adverse Event|4|||
33312053|NCT01262456|62687505|FG002|3-Month Double-Blind Period|Adverse Event|8|||
33312054|NCT01262456|62687503|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
33312055|NCT01262456|62687504|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
33312056|NCT01262456|62687505|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
33312057|NCT01262456|62687503|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
33312058|NCT01262456|62687504|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
33312059|NCT01262456|62687505|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
33312060|NCT01262456|62687503|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
33312061|NCT01262456|62687504|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
33312062|NCT01262456|62687505|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
33312063|NCT01262456|62687503|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
33312064|NCT01262456|62687504|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
33312065|NCT01262456|62687505|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
33312066|NCT01262456|62687503|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
33312067|NCT01262456|62687504|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
33312068|NCT01262456|62687505|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
33312069|NCT01262456|62687503|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
33312070|NCT01262456|62687504|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
33312071|NCT01262456|62687505|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
33312072|NCT00932893|62687523|FG000|Overall Study|Death|115|||
33312073|NCT00932893|62687524|FG001|Overall Study|Death|24|||
33312074|NCT00932893|62687523|FG000|Overall Study|Lost to Follow-up|8|||
33312075|NCT00932893|62687524|FG001|Overall Study|Lost to Follow-up|0|||
33312076|NCT00932893|62687523|FG000|Overall Study|Withdrawal by Subject|5|||
33312077|NCT00932893|62687524|FG001|Overall Study|Withdrawal by Subject|2|||
33312078|NCT00932893|62687523|FG000|Overall Study|Other|5|||
33312079|NCT00932893|62687524|FG001|Overall Study|Other|144|||
33312080|NCT01260896|62687533|FG000|First Intervention|Withdrawn Due to Emesis|2|||
33312081|NCT01260896|62687534|FG001|First Intervention|Withdrawn Due to Emesis|0|||
33312082|NCT00932737|62687542|FG000|Overall Study|Not treated in second episode|1|||
33312083|NCT00932737|62687543|FG001|Overall Study|Not treated in second episode|0|||
33312084|NCT00932737|62687542|FG000|Overall Study|Adverse Event|0|||
33312085|NCT00932737|62687543|FG001|Overall Study|Adverse Event|1|||
33312086|NCT00939523|62687549|FG000|Overall Study|Lack of Efficacy|1|||
33312087|NCT00939523|62687549|FG000|Overall Study|Physician Decision|2|||
33312088|NCT01260584|62687557|FG000|Period 1|Protocol Violation|0|||
33312089|NCT01260584|62687558|FG001|Period 1|Protocol Violation|0|||
33312090|NCT01260584|62687559|FG002|Period 1|Protocol Violation|1|||
33312091|NCT01260584|62687560|FG003|Period 1|Protocol Violation|1|||
33312092|NCT01260584|62687557|FG000|Period 1|Adverse Event|0|||
33312093|NCT01260584|62687558|FG001|Period 1|Adverse Event|0|||
33493384|NCT03134222|62871694|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
33493385|NCT03134222|62871695|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
33493386|NCT03134222|62871696|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
33493387|NCT03134222|62871692|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
33493388|NCT03134222|62871693|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
33312094|NCT01260584|62687559|FG002|Period 1|Adverse Event|1|||
33312095|NCT01260584|62687560|FG003|Period 1|Adverse Event|0|||
33312096|NCT01260584|62687557|FG000|Period 2|Protocol Violation|0|||
33312097|NCT01260584|62687558|FG001|Period 2|Protocol Violation|2|||
33312098|NCT01260584|62687559|FG002|Period 2|Protocol Violation|3|||
33312099|NCT01260584|62687560|FG003|Period 2|Protocol Violation|1|||
33312100|NCT01260584|62687557|FG000|Period 2|Adverse Event|1|||
33312101|NCT01260584|62687558|FG001|Period 2|Adverse Event|0|||
33312102|NCT01260584|62687559|FG002|Period 2|Adverse Event|2|||
33312103|NCT01260584|62687560|FG003|Period 2|Adverse Event|0|||
33312104|NCT01260584|62687557|FG000|Period 2|Withdrawal by Subject|0|||
33312105|NCT01260584|62687558|FG001|Period 2|Withdrawal by Subject|1|||
33312106|NCT01260584|62687559|FG002|Period 2|Withdrawal by Subject|0|||
33312107|NCT01260584|62687560|FG003|Period 2|Withdrawal by Subject|0|||
33312108|NCT00927589|62687570|FG000|Overall Study|Death|1|||
33312109|NCT00927589|62687570|FG000|Overall Study|Physician Decision|1|||
33312110|NCT00927589|62687570|FG000|Overall Study|Withdrawal by Subject|3|||
33312111|NCT00927589|62687570|FG000|Overall Study|Adverse Event|2|||
33312112|NCT00927589|62687570|FG000|Overall Study|Disease Progression|8|||
33312113|NCT00927589|62687570|FG000|Overall Study|Non-compliance|1|||
33312114|NCT00932425|62687576|FG000|Overall Study|Lost to Follow-up|0|||
33312115|NCT00932425|62687577|FG001|Overall Study|Lost to Follow-up|1|||
33312116|NCT00932425|62687576|FG000|Overall Study|Withdrawal by Subject|0|||
33312117|NCT00932425|62687577|FG001|Overall Study|Withdrawal by Subject|1|||
33312118|NCT05867342|62687583|FG000|Overall Study|Investigator Decision|3|||
33312119|NCT05867342|62687584|FG001|Overall Study|Investigator Decision|3|||
33312120|NCT04340362|62687619|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
33312121|NCT04024462|62687641|FG000|Overall Study|Withdrawal by Subject|6|||
33312122|NCT04024462|62687642|FG001|Overall Study|Withdrawal by Subject|7|||
33312123|NCT04024462|62687641|FG000|Overall Study|Progressive Disease|0|||
33312124|NCT04024462|62687642|FG001|Overall Study|Progressive Disease|1|||
33312125|NCT04024462|62687641|FG000|Overall Study|Adverse Event|0|||
33312126|NCT04024462|62687642|FG001|Overall Study|Adverse Event|1|||
33312127|NCT04024462|62687641|FG000|Overall Study|Death|0|||
33312128|NCT04024462|62687642|FG001|Overall Study|Death|1|||
33312129|NCT04024462|62687641|FG000|Overall Study|Lost to Follow-up|1|||
33312130|NCT04024462|62687642|FG001|Overall Study|Lost to Follow-up|0|||
33312131|NCT04024462|62687641|FG000|Overall Study|Ongoing in the Study|94|||
33312132|NCT04024462|62687642|FG001|Overall Study|Ongoing in the Study|89|||
33312133|NCT03980808|62687650|FG000|Overall Study|Lost to Follow-up|2|||
33312134|NCT03980808|62687651|FG001|Overall Study|Lost to Follow-up|2|||
33312135|NCT03943953|62687668|FG000|Trial of ITG 1|Lost to Follow-up|19|||
33312136|NCT03943953|62687669|FG001|Trial of ITG 1|Lost to Follow-up|1|||
33312137|NCT03943953|62687668|FG000|Trial of ITG 2|Lost to Follow-up|8|||
33312138|NCT03943953|62687669|FG001|Trial of ITG 2|Lost to Follow-up|0|||
33312139|NCT03943953|62687668|FG000|Trial of ITG 3|Lost to Follow-up|2|||
33312140|NCT03943953|62687669|FG001|Trial of ITG 3|Lost to Follow-up|0|||
33312141|NCT03943953|62687668|FG000|Trial of ITG 4|Lost to Follow-up|2|||
33312142|NCT03943953|62687669|FG001|Trial of ITG 4|Lost to Follow-up|0|||
33312143|NCT03670628|62687679|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
33312144|NCT03670628|62687680|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
33312145|NCT03670628|62687679|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
33312146|NCT03670628|62687680|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
33312147|NCT03637764|62687690|FG000|Overall Study|Adverse Event|2|||
33312148|NCT03637764|62687691|FG001|Overall Study|Adverse Event|0|||
33312149|NCT03637764|62687692|FG002|Overall Study|Adverse Event|0|||
33312150|NCT03637764|62687693|FG003|Overall Study|Adverse Event|1|||
33312151|NCT03637764|62687690|FG000|Overall Study|Progressive Disease|23|||
33312152|NCT03637764|62687691|FG001|Overall Study|Progressive Disease|23|||
33312153|NCT03637764|62687692|FG002|Overall Study|Progressive Disease|18|||
33312154|NCT03637764|62687693|FG003|Overall Study|Progressive Disease|31|||
33312155|NCT03637764|62687690|FG000|Overall Study|Withdrawal by Subject|1|||
33312156|NCT03637764|62687691|FG001|Overall Study|Withdrawal by Subject|3|||
33312157|NCT03637764|62687692|FG002|Overall Study|Withdrawal by Subject|0|||
33312158|NCT03637764|62687693|FG003|Overall Study|Withdrawal by Subject|1|||
33312159|NCT03483116|62687723|FG000|Overall Study|Adverse Event|0|||
33312160|NCT03483116|62687724|FG001|Overall Study|Adverse Event|1|||
33312161|NCT03483116|62687725|FG002|Overall Study|Adverse Event|0|||
33312162|NCT03483116|62687726|FG003|Overall Study|Adverse Event|1|||
33312163|NCT03483116|62687723|FG000|Overall Study|Protocol Violation|1|||
33312164|NCT03483116|62687724|FG001|Overall Study|Protocol Violation|0|||
33710324|NCT01489254|63277434|FG001|Open-label Extension Part|Lost to Follow-up|0|||
33312165|NCT03483116|62687725|FG002|Overall Study|Protocol Violation|0|||
33312166|NCT03483116|62687726|FG003|Overall Study|Protocol Violation|7|||
33312167|NCT03483116|62687723|FG000|Overall Study|Lost to Follow-up|9|||
33312168|NCT03483116|62687724|FG001|Overall Study|Lost to Follow-up|4|||
33312169|NCT03483116|62687725|FG002|Overall Study|Lost to Follow-up|9|||
33312170|NCT03483116|62687726|FG003|Overall Study|Lost to Follow-up|5|||
33312171|NCT03483116|62687723|FG000|Overall Study|Death|1|||
33710325|NCT01489254|63277435|FG002|Open-label Extension Part|Lost to Follow-up|0|||
33710326|NCT01489254|63277436|FG003|Open-label Extension Part|Lost to Follow-up|9|||
33710327|NCT01489254|63277433|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
33710328|NCT01489254|63277434|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
33710329|NCT01489254|63277435|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
33710330|NCT01489254|63277436|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
33710331|NCT01489020|63277451|FG000|Overall Study|Withdrawal by Subject|1|||
33710332|NCT01489020|63277452|FG001|Overall Study|Withdrawal by Subject|0|||
33710333|NCT01489020|63277453|FG002|Overall Study|Withdrawal by Subject|0|||
33710334|NCT01489020|63277454|FG003|Overall Study|Withdrawal by Subject|0|||
33710335|NCT01489020|63277455|FG004|Overall Study|Withdrawal by Subject|0|||
33312172|NCT03483116|62687724|FG001|Overall Study|Death|0|||
33312173|NCT03483116|62687725|FG002|Overall Study|Death|2|||
33312174|NCT03483116|62687726|FG003|Overall Study|Death|1|||
33312175|NCT03483116|62687723|FG000|Overall Study|Withdrawal by Subject|14|||
33597308|NCT02480153|62996234|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
33597309|NCT02480153|62996235|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
33597310|NCT02480153|62996236|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
33597311|NCT02480153|62996234|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
33597312|NCT02480153|62996235|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
33597313|NCT02480153|62996236|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
33597314|NCT02480153|62996234|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
33597315|NCT02480153|62996235|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
33597316|NCT02480153|62996236|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
33597317|NCT02480153|62996234|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
33597318|NCT02480153|62996235|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
33597319|NCT02480153|62996236|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
33597320|NCT02480153|62996234|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
33597321|NCT02480153|62996235|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
33597322|NCT02480153|62996236|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
33597323|NCT02480153|62996234|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
33597324|NCT02480153|62996235|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
33597325|NCT02480153|62996236|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
33597326|NCT02480153|62996234|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
33597327|NCT02480153|62996235|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
33597328|NCT02480153|62996236|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
33597329|NCT02500979|62996261|FG000|Period 1|Hyperglycemia|1|||
33312176|NCT03483116|62687724|FG001|Overall Study|Withdrawal by Subject|16|||
33312177|NCT03483116|62687725|FG002|Overall Study|Withdrawal by Subject|14|||
33312178|NCT03483116|62687726|FG003|Overall Study|Withdrawal by Subject|16|||
33312179|NCT03483116|62687723|FG000|Overall Study|Unknown other reason|3|||
33493389|NCT03134222|62871694|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
33493390|NCT03134222|62871695|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
33493391|NCT03134222|62871696|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
33493392|NCT03769753|62871706|FG000|Overall Study|Not Treated|6|||
33312180|NCT03483116|62687724|FG001|Overall Study|Unknown other reason|2|||
33312181|NCT03483116|62687725|FG002|Overall Study|Unknown other reason|1|||
33312182|NCT03483116|62687726|FG003|Overall Study|Unknown other reason|1|||
33597330|NCT02500979|62996262|FG001|Period 1|Hyperglycemia|0|||
33597331|NCT02500979|62996261|FG000|Period 1|Severe non-compliance to protocol|0|||
33597332|NCT02500979|62996262|FG001|Period 1|Severe non-compliance to protocol|1|||
33597333|NCT02500979|62996261|FG000|Period 1|Adverse Event|1|||
33597334|NCT02500979|62996262|FG001|Period 1|Adverse Event|0|||
33493393|NCT03769753|62871706|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
33597335|NCT02500979|62996261|FG000|Period 1|Subject decision|2|||
33597336|NCT02500979|62996262|FG001|Period 1|Subject decision|0|||
33597337|NCT02500979|62996261|FG000|Period 2|Change in risk|1|||
33597338|NCT02500979|62996262|FG001|Period 2|Change in risk|0|||
33597339|NCT02500901|62996268|FG000|Overall Study|Disease ProgressionDD|2|||
33597340|NCT02479139|62996278|FG000|Overall Study|Lost to Follow-up|2|||
33597341|NCT02479139|62996279|FG001|Overall Study|Lost to Follow-up|4|||
33597342|NCT02479139|62996280|FG002|Overall Study|Lost to Follow-up|4|||
33597343|NCT02479139|62996281|FG003|Overall Study|Lost to Follow-up|2|||
33597344|NCT02479139|62996282|FG004|Overall Study|Lost to Follow-up|3|||
33597345|NCT02479139|62996283|FG005|Overall Study|Lost to Follow-up|5|||
33597346|NCT02479139|62996278|FG000|Overall Study|Withdrew Consent|5|||
33597347|NCT02479139|62996279|FG001|Overall Study|Withdrew Consent|6|||
33597348|NCT02479139|62996280|FG002|Overall Study|Withdrew Consent|1|||
33312201|NCT02811861|62687776|FG000|Overall Study|Radiological Disease Progression|123|||
33597349|NCT02479139|62996281|FG003|Overall Study|Withdrew Consent|4|||
33597350|NCT02479139|62996282|FG004|Overall Study|Withdrew Consent|1|||
33597351|NCT02479139|62996283|FG005|Overall Study|Withdrew Consent|1|||
33597352|NCT02479139|62996278|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
33597353|NCT02479139|62996279|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
33312202|NCT02811861|62687777|FG001|Overall Study|Radiological Disease Progression|97|||
33312203|NCT02811861|62687778|FG002|Overall Study|Radiological Disease Progression|174|||
33312204|NCT02811861|62687776|FG000|Overall Study|Clinical Disease Progression|20|||
33312205|NCT02811861|62687777|FG001|Overall Study|Clinical Disease Progression|19|||
33312206|NCT02811861|62687778|FG002|Overall Study|Clinical Disease Progression|22|||
33493394|NCT03263923|62871721|FG000|Overall Study|Withdrawal by Subject|10|||
33312207|NCT02811861|62687776|FG000|Overall Study|Adverse Event|63|||
33312208|NCT02811861|62687777|FG001|Overall Study|Adverse Event|60|||
33312209|NCT02811861|62687778|FG002|Overall Study|Adverse Event|41|||
33312210|NCT02811861|62687776|FG000|Overall Study|Lost to Follow-up|0|||
33312211|NCT02811861|62687777|FG001|Overall Study|Lost to Follow-up|0|||
33312212|NCT02811861|62687778|FG002|Overall Study|Lost to Follow-up|1|||
33312213|NCT02811861|62687776|FG000|Overall Study|Subject Choice|29|||
33312214|NCT02811861|62687777|FG001|Overall Study|Subject Choice|17|||
33312215|NCT02811861|62687778|FG002|Overall Study|Subject Choice|23|||
33312216|NCT02811861|62687776|FG000|Overall Study|Withdrawal by Subject|4|||
33312217|NCT02811861|62687777|FG001|Overall Study|Withdrawal by Subject|4|||
33312218|NCT02811861|62687778|FG002|Overall Study|Withdrawal by Subject|9|||
33312219|NCT02811861|62687776|FG000|Overall Study|Other|4|||
33493395|NCT03263923|62871722|FG001|Overall Study|Withdrawal by Subject|8|||
33493396|NCT03263923|62871721|FG000|Overall Study|Lost to Follow-up|15|||
33493397|NCT03263923|62871722|FG001|Overall Study|Lost to Follow-up|13|||
33493398|NCT03139604|62871732|FG000|Overall Study|Other|7|||
33710336|NCT01489020|63277456|FG005|Overall Study|Withdrawal by Subject|0|||
33710337|NCT01489020|63277451|FG000|Overall Study|Adverse Event|0|||
33710338|NCT01489020|63277452|FG001|Overall Study|Adverse Event|0|||
33710339|NCT01489020|63277453|FG002|Overall Study|Adverse Event|3|||
33710340|NCT01489020|63277454|FG003|Overall Study|Adverse Event|0|||
33710341|NCT01489020|63277455|FG004|Overall Study|Adverse Event|3|||
33493399|NCT03139604|62871733|FG001|Overall Study|Other|3|||
33493400|NCT03139604|62871732|FG000|Overall Study|Withdrawal by Subject|16|||
33710342|NCT01489020|63277456|FG005|Overall Study|Adverse Event|0|||
33710343|NCT01489020|63277451|FG000|Overall Study|Concomitant disease|0|||
33710344|NCT01489020|63277452|FG001|Overall Study|Concomitant disease|0|||
33710345|NCT01489020|63277453|FG002|Overall Study|Concomitant disease|0|||
33710346|NCT01489020|63277454|FG003|Overall Study|Concomitant disease|0|||
33710347|NCT01489020|63277455|FG004|Overall Study|Concomitant disease|3|||
33710348|NCT01489020|63277456|FG005|Overall Study|Concomitant disease|0|||
33710349|NCT01514760|63277476|FG000|Overall Study|Lost to Follow-up|2|||
33710350|NCT01514682|63277482|FG000|Overall Study|Withdrawal by Subject|2|||
33710351|NCT01514682|63277483|FG001|Overall Study|Withdrawal by Subject|3|||
33710352|NCT01514682|63277482|FG000|Overall Study|Physician Decision|4|||
33710353|NCT01514682|63277483|FG001|Overall Study|Physician Decision|3|||
33710354|NCT01514448|63277491|FG000|Overall Study|Death|7|||
33493401|NCT03139604|62871733|FG001|Overall Study|Withdrawal by Subject|17|||
33493402|NCT03139604|62871732|FG000|Overall Study|Physician Decision|1|||
33493403|NCT03139604|62871733|FG001|Overall Study|Physician Decision|2|||
33493404|NCT03139604|62871732|FG000|Overall Study|Lost to Follow-up|3|||
33312220|NCT02811861|62687777|FG001|Overall Study|Other|13|||
33312221|NCT02811861|62687778|FG002|Overall Study|Other|3|||
33312222|NCT02811861|62687776|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
33312223|NCT02811861|62687777|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
33312224|NCT02811861|62687778|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
33312225|NCT02811861|62687776|FG000|Overall Study|Randomized but not treated|2|||
33493405|NCT03139604|62871733|FG001|Overall Study|Lost to Follow-up|1|||
33493406|NCT03139604|62871732|FG000|Overall Study|Death|65|||
33493407|NCT03139604|62871733|FG001|Overall Study|Death|67|||
33493408|NCT03139604|62871732|FG000|Overall Study|Study Terminated by Sponsor|122|||
33493409|NCT03139604|62871733|FG001|Overall Study|Study Terminated by Sponsor|127|||
33493410|NCT03139604|62871732|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
33493411|NCT03139604|62871733|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
33493412|NCT03139448|62871742|FG000|Overall Study|Lack of Efficacy|6|||
33493413|NCT03139448|62871743|FG001|Overall Study|Lack of Efficacy|7|||
33493414|NCT03139448|62871742|FG000|Overall Study|Location of procedure changed|2|||
33493415|NCT03139448|62871743|FG001|Overall Study|Location of procedure changed|8|||
33312226|NCT02811861|62687777|FG001|Overall Study|Randomized but not treated|3|||
33312227|NCT02811861|62687778|FG002|Overall Study|Randomized but not treated|17|||
33312228|NCT02744612|62687788|FG000|Overall Study|Withdrawal by Subject|0|||
33312229|NCT02744612|62687789|FG001|Overall Study|Withdrawal by Subject|2|||
33312230|NCT02700451|62687798|FG000|Overall Study|Protocol Violation|2|||
33312231|NCT02700451|62687799|FG001|Overall Study|Protocol Violation|2|||
33312232|NCT02700451|62687800|FG002|Overall Study|Protocol Violation|3|||
33312233|NCT02700451|62687798|FG000|Overall Study|Discontinued intervention|14|||
33312234|NCT02700451|62687799|FG001|Overall Study|Discontinued intervention|15|||
33312235|NCT02700451|62687800|FG002|Overall Study|Discontinued intervention|14|||
33312236|NCT02623426|62687811|FG000|Overall Study|Lost to Follow-up|0|||
33312237|NCT02623426|62687812|FG001|Overall Study|Lost to Follow-up|0|||
33710355|NCT01514448|63277492|FG001|Overall Study|Death|8|||
33710356|NCT01514448|63277491|FG000|Overall Study|Withdrawal by Subject|2|||
33312238|NCT02623426|62687813|FG002|Overall Study|Lost to Follow-up|1|||
33312239|NCT02623426|62687811|FG000|Overall Study|Withdrawal by Subject|1|||
33493416|NCT03139448|62871742|FG000|Overall Study|Withdrawal by Subject|3|||
33493417|NCT03139448|62871743|FG001|Overall Study|Withdrawal by Subject|6|||
33710357|NCT01514448|63277492|FG001|Overall Study|Withdrawal by Subject|0|||
33312240|NCT02623426|62687812|FG001|Overall Study|Withdrawal by Subject|2|||
33312241|NCT02623426|62687813|FG002|Overall Study|Withdrawal by Subject|2|||
33312242|NCT02580058|62687824|FG000|Overall Study|Adverse Event|16|||
33493418|NCT03139448|62871742|FG000|Overall Study|Screen fail|1|||
33493419|NCT03139448|62871743|FG001|Overall Study|Screen fail|3|||
33493420|NCT03139448|62871742|FG000|Overall Study|Physician Decision|0|||
33493421|NCT03139448|62871743|FG001|Overall Study|Physician Decision|2|||
33493422|NCT02875340|62871749|FG000|Overall Study|Death|2|||
33493423|NCT02875340|62871749|FG000|Overall Study|Withdrawal by Subject|2|||
33493424|NCT02875340|62871749|FG000|Overall Study|Physician Decision|3|||
33493425|NCT02875340|62871749|FG000|Overall Study|Adverse Event|1|||
33493426|NCT03237325|62871761|FG000|Overall Study|Lost to Follow-up|3|||
33493427|NCT03237325|62871762|FG001|Overall Study|Lost to Follow-up|5|||
33493428|NCT03237325|62871761|FG000|Overall Study|Physician Decision|2|||
33493429|NCT03237325|62871762|FG001|Overall Study|Physician Decision|4|||
33493430|NCT03237325|62871761|FG000|Overall Study|Withdrawal by Subject|9|||
33493431|NCT03237325|62871762|FG001|Overall Study|Withdrawal by Subject|12|||
33493432|NCT03237325|62871761|FG000|Overall Study|Noncompliance with Study Procedures|1|||
33493433|NCT03237325|62871762|FG001|Overall Study|Noncompliance with Study Procedures|1|||
33493434|NCT03237325|62871761|FG000|Overall Study|Termination by Sponsor|0|||
33493435|NCT03237325|62871762|FG001|Overall Study|Termination by Sponsor|1|||
33493436|NCT03237325|62871761|FG000|Overall Study|Reason other than described|0|||
33493437|NCT03237325|62871762|FG001|Overall Study|Reason other than described|2|||
33493438|NCT03113383|62871768|FG000|Overall Study|Death|4|||
33493439|NCT03113383|62871769|FG001|Overall Study|Death|0|||
33493440|NCT03131960|62871790|FG000|Overall Study|Adverse Event|0|||
33493441|NCT03131960|62871791|FG001|Overall Study|Adverse Event|1|||
33597354|NCT02479139|62996280|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
33597355|NCT02479139|62996281|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
33710358|NCT01514448|63277491|FG000|Overall Study|Lost to Follow-up|2|||
33710359|NCT01514448|63277492|FG001|Overall Study|Lost to Follow-up|0|||
33710360|NCT01514448|63277491|FG000|Overall Study|New Cancer Therapy|1|||
33710361|NCT01514448|63277492|FG001|Overall Study|New Cancer Therapy|0|||
33710362|NCT01514370|63277501|FG000|Overall Study|Protocol Violation|2|||
33710363|NCT01514370|63277502|FG001|Overall Study|Protocol Violation|3|||
33710364|NCT01514370|63277501|FG000|Overall Study|Lost to Follow-up|0|||
33710365|NCT01514370|63277502|FG001|Overall Study|Lost to Follow-up|2|||
33710366|NCT01514370|63277501|FG000|Overall Study|Withdrawal by Subject|2|||
33710367|NCT01514370|63277502|FG001|Overall Study|Withdrawal by Subject|1|||
33710368|NCT01514370|63277501|FG000|Overall Study|Adverse Event|1|||
33710369|NCT01514370|63277502|FG001|Overall Study|Adverse Event|3|||
33710370|NCT01514370|63277501|FG000|Overall Study|Other|6|||
33710371|NCT01514370|63277502|FG001|Overall Study|Other|7|||
33710372|NCT01519674|63277512|FG000|Overall Study|Adverse Event|3|||
33710373|NCT01519674|63277513|FG001|Overall Study|Adverse Event|3|||
33710374|NCT01519674|63277514|FG002|Overall Study|Adverse Event|0|||
33710375|NCT01519674|63277512|FG000|Overall Study|Lack of Efficacy|1|||
33710376|NCT01519674|63277513|FG001|Overall Study|Lack of Efficacy|1|||
33710377|NCT01519674|63277514|FG002|Overall Study|Lack of Efficacy|1|||
33710378|NCT01519674|63277512|FG000|Overall Study|Protocol Violation|0|||
33710379|NCT01519674|63277513|FG001|Overall Study|Protocol Violation|3|||
33710380|NCT01519674|63277514|FG002|Overall Study|Protocol Violation|1|||
33710381|NCT01519674|63277512|FG000|Overall Study|Withdrawal Criteria|7|||
33710382|NCT01519674|63277513|FG001|Overall Study|Withdrawal Criteria|2|||
33710383|NCT01519674|63277514|FG002|Overall Study|Withdrawal Criteria|7|||
33710384|NCT01519674|63277512|FG000|Overall Study|Unsclassified|10|||
33710385|NCT01519674|63277513|FG001|Overall Study|Unsclassified|4|||
33493442|NCT03225170|62871800|FG000|Overall Study|Lost to Follow-up|4|||
33493443|NCT03225170|62871801|FG001|Overall Study|Lost to Follow-up|4|||
33493444|NCT03225170|62871802|FG002|Overall Study|Lost to Follow-up|0|||
33493445|NCT03225170|62871800|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
33493446|NCT03225170|62871801|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
33493447|NCT03225170|62871802|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
33493448|NCT02115139|62871808|FG000|Overall Study|Protocol Violation|1|||
33493449|NCT02115139|62871808|FG000|Overall Study|treatment discontinuation|6|||
33597356|NCT02479139|62996282|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
33597357|NCT02479139|62996283|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
33710386|NCT01519674|63277514|FG002|Overall Study|Unsclassified|3|||
33710387|NCT01519518|63277524|FG000|Overall Study|Consent not available|7|||
33710388|NCT01519518|63277525|FG001|Overall Study|Consent not available|10|||
33312243|NCT02580058|62687825|FG001|Overall Study|Adverse Event|30|||
33493450|NCT01763827|62871856|FG000|Overall Study|Withdrawal by Subject|1|||
33493451|NCT01763827|62871857|FG001|Overall Study|Withdrawal by Subject|0|||
33493452|NCT01763827|62871858|FG002|Overall Study|Withdrawal by Subject|0|||
33493453|NCT01763827|62871859|FG003|Overall Study|Withdrawal by Subject|0|||
33710389|NCT01519206|63277531|FG000|Overall Study|Lost to Follow-up|3|||
33710390|NCT01519206|63277531|FG000|Overall Study|Missed Visit|2|||
33710391|NCT01518972|63277544|FG000|Overall Study|Lost to Follow-up|2|||
33493454|NCT01763827|62871860|FG004|Overall Study|Withdrawal by Subject|2|||
33493455|NCT01763827|62871861|FG005|Overall Study|Withdrawal by Subject|0|||
33493456|NCT01763827|62871856|FG000|Overall Study|Decision by sponsor|2|||
33312244|NCT02580058|62687826|FG002|Overall Study|Adverse Event|20|||
33312245|NCT02580058|62687824|FG000|Overall Study|Death|4|||
33312246|NCT02580058|62687825|FG001|Overall Study|Death|4|||
33312247|NCT02580058|62687826|FG002|Overall Study|Death|5|||
33312248|NCT02580058|62687824|FG000|Overall Study|Physician Decision|1|||
33312249|NCT02580058|62687825|FG001|Overall Study|Physician Decision|3|||
33312250|NCT02580058|62687826|FG002|Overall Study|Physician Decision|11|||
33312251|NCT02580058|62687824|FG000|Overall Study|Other|5|||
33312252|NCT02580058|62687825|FG001|Overall Study|Other|1|||
33312253|NCT02580058|62687826|FG002|Overall Study|Other|3|||
33312254|NCT02580058|62687824|FG000|Overall Study|Withdrawal by Subject|4|||
33312255|NCT02580058|62687825|FG001|Overall Study|Withdrawal by Subject|7|||
33312256|NCT02580058|62687826|FG002|Overall Study|Withdrawal by Subject|31|||
33312257|NCT02580058|62687824|FG000|Overall Study|Global Deterioration of Health Status|19|||
33312258|NCT02580058|62687825|FG001|Overall Study|Global Deterioration of Health Status|18|||
33312259|NCT02580058|62687826|FG002|Overall Study|Global Deterioration of Health Status|24|||
33312260|NCT02580058|62687824|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
33312261|NCT02580058|62687825|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33312262|NCT02580058|62687826|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
33312263|NCT02580058|62687824|FG000|Overall Study|Progressive Disease|137|||
33493457|NCT01763827|62871857|FG001|Overall Study|Decision by sponsor|0|||
33493458|NCT01763827|62871858|FG002|Overall Study|Decision by sponsor|3|||
33493459|NCT01763827|62871859|FG003|Overall Study|Decision by sponsor|0|||
33493460|NCT01763827|62871860|FG004|Overall Study|Decision by sponsor|2|||
33493461|NCT01763827|62871861|FG005|Overall Study|Decision by sponsor|1|||
33493462|NCT01763827|62871856|FG000|Overall Study|Lost to Follow-up|0|||
33493463|NCT01763827|62871857|FG001|Overall Study|Lost to Follow-up|1|||
33493464|NCT01763827|62871858|FG002|Overall Study|Lost to Follow-up|1|||
33493465|NCT01763827|62871859|FG003|Overall Study|Lost to Follow-up|1|||
33493466|NCT01763827|62871860|FG004|Overall Study|Lost to Follow-up|2|||
33493467|NCT01763827|62871861|FG005|Overall Study|Lost to Follow-up|1|||
33493468|NCT01732783|62871914|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
33312264|NCT02580058|62687825|FG001|Overall Study|Progressive Disease|125|||
33312265|NCT02580058|62687826|FG002|Overall Study|Progressive Disease|94|||
33312266|NCT02580058|62687824|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33312267|NCT02580058|62687825|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33312268|NCT02580058|62687826|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33312269|NCT02539394|62687838|FG000|Overall Study|Protocol Violation|1|||
33312270|NCT02539394|62687839|FG001|Overall Study|Protocol Violation|3|||
33312271|NCT02539394|62687838|FG000|Overall Study|Lost to Follow-up|1|||
33312272|NCT02539394|62687839|FG001|Overall Study|Lost to Follow-up|2|||
33312273|NCT02539394|62687838|FG000|Overall Study|Incomplete dataset|6|||
33312274|NCT02539394|62687839|FG001|Overall Study|Incomplete dataset|6|||
33312275|NCT02412670|62687853|FG000|Overall Study|Adverse Event|4|||
33312276|NCT02412670|62687854|FG001|Overall Study|Adverse Event|1|||
33312277|NCT02412670|62687853|FG000|Overall Study|Physician Decision|1|||
33312278|NCT02412670|62687854|FG001|Overall Study|Physician Decision|0|||
33312279|NCT02412670|62687853|FG000|Overall Study|Withdrawal by Subject|1|||
33312280|NCT02412670|62687854|FG001|Overall Study|Withdrawal by Subject|0|||
33312281|NCT02412670|62687853|FG000|Overall Study|Ineligible|1|||
33312282|NCT02412670|62687854|FG001|Overall Study|Ineligible|0|||
33312283|NCT01358877|62687862|FG000|Overall Study|Death|80|||
33312284|NCT01358877|62687863|FG001|Overall Study|Death|89|||
33312285|NCT01358877|62687862|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
33312286|NCT01358877|62687863|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
33312287|NCT01358877|62687862|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
33493469|NCT01732783|62871915|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
33493470|NCT01732783|62871916|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
33493471|NCT01732783|62871914|FG000|Overall Study|Death|13|||
33710392|NCT01518972|63277545|FG001|Overall Study|Lost to Follow-up|1|||
33710393|NCT01518972|63277544|FG000|Overall Study|Withdrawal by Subject|1|||
33493472|NCT01732783|62871915|FG001|Overall Study|Death|4|||
33312288|NCT01358877|62687863|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
33312289|NCT01358877|62687862|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
33312290|NCT01358877|62687863|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
33493473|NCT01732783|62871916|FG002|Overall Study|Death|1|||
33493474|NCT01732783|62871914|FG000|Overall Study|Lost to Follow-up|7|||
33312291|NCT01358877|62687862|FG000|Overall Study|Other|142|||
33312292|NCT01358877|62687863|FG001|Overall Study|Other|129|||
33312293|NCT01084252|62687890|FG000|Phase 1 (120 Weeks)|Adverse Event|0|||
33312294|NCT01084252|62687891|FG001|Phase 1 (120 Weeks)|Adverse Event|0|||
33493475|NCT01732783|62871915|FG001|Overall Study|Lost to Follow-up|1|||
33493476|NCT01732783|62871916|FG002|Overall Study|Lost to Follow-up|1|||
33493477|NCT01732783|62871914|FG000|Overall Study|Administrative Decision|8|||
33493478|NCT01732783|62871915|FG001|Overall Study|Administrative Decision|2|||
33493479|NCT01732783|62871916|FG002|Overall Study|Administrative Decision|1|||
33493480|NCT01732783|62871914|FG000|Overall Study|Withdrawal by Subject|1|||
33493481|NCT01732783|62871915|FG001|Overall Study|Withdrawal by Subject|0|||
33493482|NCT01732783|62871916|FG002|Overall Study|Withdrawal by Subject|0|||
33493483|NCT02787850|62871943|FG000|Overall Study|Withdrawal by Subject|0|||
33493484|NCT02787850|62871944|FG001|Overall Study|Withdrawal by Subject|1|||
33493485|NCT01375777|62871968|FG000|Overall Study|Withdrawal by Subject|0|||
33493486|NCT01375777|62871969|FG001|Overall Study|Withdrawal by Subject|2|||
33493487|NCT01375777|62871970|FG002|Overall Study|Withdrawal by Subject|1|||
33493488|NCT01375777|62871971|FG003|Overall Study|Withdrawal by Subject|0|||
33493489|NCT01375777|62871972|FG004|Overall Study|Withdrawal by Subject|1|||
33493490|NCT01375777|62871973|FG005|Overall Study|Withdrawal by Subject|1|||
33493491|NCT01375777|62871974|FG006|Overall Study|Withdrawal by Subject|1|||
33493492|NCT01375777|62871975|FG007|Overall Study|Withdrawal by Subject|2|||
33493493|NCT01375777|62871976|FG008|Overall Study|Withdrawal by Subject|1|||
33493494|NCT01375777|62871968|FG000|Overall Study|Lost to Follow-up|1|||
33493495|NCT01375777|62871969|FG001|Overall Study|Lost to Follow-up|0|||
33493496|NCT01375777|62871970|FG002|Overall Study|Lost to Follow-up|0|||
33493497|NCT01375777|62871971|FG003|Overall Study|Lost to Follow-up|0|||
33493498|NCT01375777|62871972|FG004|Overall Study|Lost to Follow-up|0|||
33493499|NCT01375777|62871973|FG005|Overall Study|Lost to Follow-up|0|||
33493500|NCT01375777|62871974|FG006|Overall Study|Lost to Follow-up|1|||
33493501|NCT01375777|62871975|FG007|Overall Study|Lost to Follow-up|0|||
33493502|NCT01375777|62871976|FG008|Overall Study|Lost to Follow-up|0|||
33493503|NCT01375777|62871968|FG000|Overall Study|Other|1|||
33493504|NCT01375777|62871969|FG001|Overall Study|Other|1|||
33493505|NCT01375777|62871970|FG002|Overall Study|Other|0|||
33710394|NCT01518972|63277545|FG001|Overall Study|Withdrawal by Subject|0|||
33312295|NCT01084252|62687892|FG002|Phase 1 (120 Weeks)|Adverse Event|1|||
33312296|NCT01084252|62687893|FG003|Phase 1 (120 Weeks)|Adverse Event|1|||
33312297|NCT01084252|62687894|FG004|Phase 1 (120 Weeks)|Adverse Event|1|||
33312298|NCT01084252|62687895|FG005|Phase 1 (120 Weeks)|Adverse Event|0|||
33312299|NCT01084252|62687896|FG006|Phase 1 (120 Weeks)|Adverse Event|1|||
33312300|NCT01084252|62687897|FG007|Phase 1 (120 Weeks)|Adverse Event|0|||
33312301|NCT01084252|62687898|FG008|Phase 1 (120 Weeks)|Adverse Event|0|||
33710395|NCT01518972|63277544|FG000|Overall Study|Moved from area|1|||
33710396|NCT01518972|63277545|FG001|Overall Study|Moved from area|0|||
33710397|NCT01518972|63277544|FG000|Overall Study|Transportation problems|1|||
33710398|NCT01518972|63277545|FG001|Overall Study|Transportation problems|0|||
33710399|NCT01518972|63277544|FG000|Overall Study|Exclusionary medical condition|1|||
33710400|NCT01518972|63277545|FG001|Overall Study|Exclusionary medical condition|0|||
33710401|NCT01518972|63277544|FG000|Overall Study|Missed safety visits|0|||
33710402|NCT01518972|63277545|FG001|Overall Study|Missed safety visits|1|||
33710403|NCT01518972|63277544|FG000|Overall Study|Exclusionary medication|0|||
33710404|NCT01518972|63277545|FG001|Overall Study|Exclusionary medication|1|||
33710405|NCT01518972|63277544|FG000|Overall Study|Declined medication starting on day 12|0|||
33710406|NCT01518972|63277545|FG001|Overall Study|Declined medication starting on day 12|1|||
33710407|NCT01514136|63277553|FG000|Test Period 1; Test A|Protocol Violation|1|||
33710408|NCT01514136|63277554|FG001|Test Period 1; Test A|Protocol Violation|0|||
33312302|NCT01084252|62687899|FG009|Phase 1 (120 Weeks)|Adverse Event|0|||
33312303|NCT01084252|62687900|FG010|Phase 1 (120 Weeks)|Adverse Event|0|||
33312304|NCT01084252|62687901|FG011|Phase 1 (120 Weeks)|Adverse Event|0|||
33493506|NCT01375777|62871971|FG003|Overall Study|Other|0|||
33493507|NCT01375777|62871972|FG004|Overall Study|Other|0|||
33493508|NCT01375777|62871973|FG005|Overall Study|Other|0|||
33493509|NCT01375777|62871974|FG006|Overall Study|Other|0|||
33493510|NCT01375777|62871975|FG007|Overall Study|Other|0|||
33493511|NCT01375777|62871976|FG008|Overall Study|Other|1|||
33710409|NCT01514136|63277555|FG002|Test Period 1; Test A|Protocol Violation|0|||
33312305|NCT01084252|62687902|FG012|Phase 1 (120 Weeks)|Adverse Event|0|||
33312306|NCT01084252|62687903|FG013|Phase 1 (120 Weeks)|Adverse Event|0|||
33312307|NCT01084252|62687890|FG000|Phase 1 (120 Weeks)|Progressive disease|15|||
33710410|NCT01514136|63277556|FG003|Test Period 1; Test A|Protocol Violation|0|||
33710411|NCT01514136|63277557|FG004|Test Period 1; Test A|Protocol Violation|0|||
33710412|NCT01514136|63277558|FG005|Test Period 1; Test A|Protocol Violation|0|||
33710413|NCT01514136|63277559|FG006|Test Period 1; Test A|Protocol Violation|0|||
33710414|NCT01514136|63277560|FG007|Test Period 1; Test A|Protocol Violation|0|||
33710415|NCT01514136|63277553|FG000|Test Period 1; Test A|Break from study holiday|2|||
33710416|NCT01514136|63277554|FG001|Test Period 1; Test A|Break from study holiday|0|||
33710417|NCT01514136|63277555|FG002|Test Period 1; Test A|Break from study holiday|0|||
33710418|NCT01514136|63277556|FG003|Test Period 1; Test A|Break from study holiday|0|||
33710419|NCT01514136|63277557|FG004|Test Period 1; Test A|Break from study holiday|0|||
33710420|NCT01514136|63277558|FG005|Test Period 1; Test A|Break from study holiday|0|||
33710421|NCT01514136|63277559|FG006|Test Period 1; Test A|Break from study holiday|0|||
33710422|NCT01514136|63277560|FG007|Test Period 1; Test A|Break from study holiday|0|||
33710423|NCT01514136|63277553|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
33710424|NCT01514136|63277554|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
33710425|NCT01514136|63277555|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
33710426|NCT01514136|63277556|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
33710427|NCT01514136|63277557|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
33710428|NCT01514136|63277558|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
33710429|NCT01514136|63277559|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
33710430|NCT01514136|63277560|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
33710431|NCT01514136|63277553|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
33710432|NCT01514136|63277554|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
33710433|NCT01514136|63277555|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
33710434|NCT01514136|63277556|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
33710435|NCT01514136|63277557|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
33710436|NCT01514136|63277558|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
33710437|NCT01514136|63277559|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
33710438|NCT01514136|63277560|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
33710439|NCT01514136|63277553|FG000|Test Period 2; Test A*|Adverse Event|0|||
33710440|NCT01514136|63277554|FG001|Test Period 2; Test A*|Adverse Event|0|||
33710441|NCT01514136|63277555|FG002|Test Period 2; Test A*|Adverse Event|0|||
33710442|NCT01514136|63277556|FG003|Test Period 2; Test A*|Adverse Event|0|||
33710443|NCT01514136|63277557|FG004|Test Period 2; Test A*|Adverse Event|1|||
33710444|NCT01514136|63277558|FG005|Test Period 2; Test A*|Adverse Event|0|||
33710445|NCT01514136|63277559|FG006|Test Period 2; Test A*|Adverse Event|0|||
33710446|NCT01514136|63277560|FG007|Test Period 2; Test A*|Adverse Event|0|||
33710447|NCT01514136|63277553|FG000|Test Period 2; Test A*|Holiday|0|||
33710448|NCT01514136|63277554|FG001|Test Period 2; Test A*|Holiday|0|||
33710449|NCT01514136|63277555|FG002|Test Period 2; Test A*|Holiday|0|||
33710450|NCT01514136|63277556|FG003|Test Period 2; Test A*|Holiday|0|||
33312308|NCT01084252|62687891|FG001|Phase 1 (120 Weeks)|Progressive disease|5|||
33312309|NCT01084252|62687892|FG002|Phase 1 (120 Weeks)|Progressive disease|2|||
33493512|NCT02431702|62871996|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
33493513|NCT02431702|62871997|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
33493514|NCT02431702|62871998|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
33493515|NCT02431702|62871999|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
33493516|NCT02431702|62872000|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
33493517|NCT02431702|62872001|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
33493518|NCT02431702|62872002|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
33493519|NCT02431702|62871996|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
33493520|NCT02431702|62871997|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
33493521|NCT02431702|62871998|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
33493522|NCT02431702|62871999|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
33493523|NCT02431702|62872000|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
33493524|NCT02431702|62872001|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
33493525|NCT02431702|62872002|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
33493526|NCT02431702|62871996|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
33493527|NCT02431702|62871997|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
33493528|NCT02431702|62871998|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
33493529|NCT02431702|62871999|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
33493530|NCT02431702|62872000|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
33493531|NCT02431702|62872001|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
33710451|NCT01514136|63277557|FG004|Test Period 2; Test A*|Holiday|1|||
33710452|NCT01514136|63277558|FG005|Test Period 2; Test A*|Holiday|0|||
33710453|NCT01514136|63277559|FG006|Test Period 2; Test A*|Holiday|0|||
33312310|NCT01084252|62687893|FG003|Phase 1 (120 Weeks)|Progressive disease|22|||
33493532|NCT02431702|62872002|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
33710454|NCT01514136|63277560|FG007|Test Period 2; Test A*|Holiday|0|||
33710455|NCT01514136|63277553|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
33312311|NCT01084252|62687894|FG004|Phase 1 (120 Weeks)|Progressive disease|16|||
33493533|NCT02431702|62871996|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
33493534|NCT02431702|62871997|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
33493535|NCT02431702|62871998|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
33493536|NCT02431702|62871999|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
33493537|NCT02431702|62872000|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
33493538|NCT02431702|62872001|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
33493539|NCT02431702|62872002|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
33493540|NCT02431702|62871996|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
33493541|NCT02431702|62871997|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
33493542|NCT02431702|62871998|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
33493543|NCT02431702|62871999|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
33493544|NCT02431702|62872000|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
33493545|NCT02431702|62872001|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
33493546|NCT02431702|62872002|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
33493547|NCT02431702|62871996|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
33493548|NCT02431702|62871997|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
33493549|NCT02431702|62871998|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
33493550|NCT02431702|62871999|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
33493551|NCT02431702|62872000|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
33493552|NCT02431702|62872001|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
33493553|NCT02431702|62872002|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
33493554|NCT02431702|62871996|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
33493555|NCT02431702|62871997|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
33493556|NCT02431702|62871998|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
33493557|NCT02431702|62871999|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
33493558|NCT02431702|62872000|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
33493559|NCT02431702|62872001|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
33493560|NCT02431702|62872002|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
33493561|NCT02431702|62871996|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
33493562|NCT02431702|62871997|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
33493563|NCT02431702|62871998|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
33493564|NCT02431702|62871999|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
33493565|NCT02431702|62872000|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
33493566|NCT02431702|62872001|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
33493567|NCT02431702|62872002|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
33493568|NCT02431702|62871996|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
33493569|NCT02431702|62871997|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
33493570|NCT02431702|62871998|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
33493571|NCT02431702|62871999|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
33493572|NCT02431702|62872000|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
33493573|NCT02431702|62872001|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
33493574|NCT02431702|62872002|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
33493575|NCT02431702|62871996|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
33493576|NCT02431702|62871997|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
33493577|NCT02431702|62871998|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
33493578|NCT02431702|62871999|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
33493579|NCT02431702|62872000|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
33493580|NCT02431702|62872001|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
33493581|NCT02431702|62872002|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
33493582|NCT02431702|62871996|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
33493583|NCT02431702|62871997|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
33493584|NCT02431702|62871998|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
33493585|NCT02431702|62871999|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
33493586|NCT02431702|62872000|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
33493587|NCT02431702|62872001|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
33493588|NCT02431702|62872002|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
33493589|NCT02431702|62871996|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
33493590|NCT02431702|62871997|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
33493591|NCT02431702|62871998|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
33493592|NCT02431702|62871999|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
33493593|NCT02431702|62872000|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
33493594|NCT02431702|62872001|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
33493595|NCT02431702|62872002|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
33493596|NCT02431702|62871996|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
33493597|NCT02431702|62871997|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
33493598|NCT02431702|62871998|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
33493599|NCT02431702|62871999|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
33493600|NCT02431702|62872000|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
33493601|NCT02431702|62872001|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
33493602|NCT02431702|62872002|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
33493603|NCT02431702|62871996|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
33493604|NCT02431702|62871997|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
33597358|NCT02479139|62996278|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33597359|NCT02479139|62996279|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33597360|NCT02479139|62996280|FG002|Overall Study|Other Miscellaneous Reasons|1|||
33597361|NCT02479139|62996281|FG003|Overall Study|Other Miscellaneous Reasons|1|||
33597362|NCT02479139|62996282|FG004|Overall Study|Other Miscellaneous Reasons|1|||
33597363|NCT02479139|62996283|FG005|Overall Study|Other Miscellaneous Reasons|0|||
33493605|NCT02431702|62871998|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
33493606|NCT02431702|62871999|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
33493607|NCT02431702|62872000|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
33493608|NCT02431702|62872001|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
33493609|NCT02431702|62872002|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
33493610|NCT02431702|62871996|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
33493611|NCT02431702|62871997|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
33493612|NCT02431702|62871998|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
33493613|NCT02431702|62871999|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
33597364|NCT02478359|62996299|FG000|Overall Study|Disenrolled from health plan|106|||
33597365|NCT02478359|62996300|FG001|Overall Study|Disenrolled from health plan|65|||
33597366|NCT01877668|62996313|FG000|Overall Study|Death|0|||
33597367|NCT01877668|62996314|FG001|Overall Study|Death|0|||
33597368|NCT01877668|62996315|FG002|Overall Study|Death|0|||
33710456|NCT01514136|63277554|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
33710457|NCT01514136|63277555|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
33710458|NCT01514136|63277556|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
33710459|NCT01514136|63277557|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
33710460|NCT01514136|63277558|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
33710461|NCT01514136|63277559|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
33710462|NCT01514136|63277560|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
33710463|NCT01514136|63277553|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
33710464|NCT01514136|63277554|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
33710465|NCT01514136|63277555|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
33710466|NCT01514136|63277556|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
33710467|NCT01514136|63277557|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
33710468|NCT01514136|63277558|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
33710469|NCT01514136|63277559|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
33710470|NCT01514136|63277560|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
33710471|NCT01514136|63277553|FG000|Test Period 2; Test C*|holiday|0|||
33710472|NCT01514136|63277554|FG001|Test Period 2; Test C*|holiday|0|||
33493614|NCT02431702|62872000|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
33493615|NCT02431702|62872001|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
33493616|NCT02431702|62872002|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
33597369|NCT01877668|62996316|FG003|Overall Study|Death|1|||
33597370|NCT01877668|62996317|FG004|Overall Study|Death|0|||
33710473|NCT01514136|63277555|FG002|Test Period 2; Test C*|holiday|0|||
33710474|NCT01514136|63277556|FG003|Test Period 2; Test C*|holiday|0|||
33710475|NCT01514136|63277557|FG004|Test Period 2; Test C*|holiday|0|||
33710476|NCT01514136|63277558|FG005|Test Period 2; Test C*|holiday|0|||
33710477|NCT01514136|63277559|FG006|Test Period 2; Test C*|holiday|1|||
33710478|NCT01514136|63277560|FG007|Test Period 2; Test C*|holiday|0|||
33710479|NCT01514136|63277553|FG000|Test Period 2; Test C*|Protocol Violation|0|||
33710480|NCT01514136|63277554|FG001|Test Period 2; Test C*|Protocol Violation|0|||
33710481|NCT01514136|63277555|FG002|Test Period 2; Test C*|Protocol Violation|0|||
33710482|NCT01514136|63277556|FG003|Test Period 2; Test C*|Protocol Violation|0|||
33710483|NCT01514136|63277557|FG004|Test Period 2; Test C*|Protocol Violation|0|||
33710484|NCT01514136|63277558|FG005|Test Period 2; Test C*|Protocol Violation|0|||
33710485|NCT01514136|63277559|FG006|Test Period 2; Test C*|Protocol Violation|1|||
33710486|NCT01514136|63277560|FG007|Test Period 2; Test C*|Protocol Violation|0|||
33710487|NCT01513590|63277588|FG000|Overall Study|Adverse Event|2|||
33710488|NCT01513590|63277589|FG001|Overall Study|Adverse Event|3|||
33710489|NCT01513590|63277588|FG000|Overall Study|Withdrawal Criteria|3|||
33710490|NCT01513590|63277589|FG001|Overall Study|Withdrawal Criteria|0|||
33710491|NCT01513590|63277588|FG000|Overall Study|Unclassified|5|||
33710492|NCT01513590|63277589|FG001|Overall Study|Unclassified|10|||
33710493|NCT01512264|63277599|FG000|Overall Study|Lost to Follow-up|0|||
33710494|NCT01512264|63277600|FG001|Overall Study|Lost to Follow-up|0|||
33710495|NCT01512264|63277601|FG002|Overall Study|Lost to Follow-up|0|||
33710496|NCT01512264|63277602|FG003|Overall Study|Lost to Follow-up|1|||
33710497|NCT01512108|63277614|FG000|Overall Study|Adverse Event|9|||
33710498|NCT01512108|63277615|FG001|Overall Study|Adverse Event|4|||
33710499|NCT01512108|63277614|FG000|Overall Study|Protocol Violation|1|||
33710500|NCT01512108|63277615|FG001|Overall Study|Protocol Violation|2|||
33710501|NCT01512108|63277614|FG000|Overall Study|Withdrawal Criteria|1|||
33710502|NCT01512108|63277615|FG001|Overall Study|Withdrawal Criteria|0|||
33710503|NCT01512108|63277614|FG000|Overall Study|Unclassified|11|||
33710504|NCT01512108|63277615|FG001|Overall Study|Unclassified|3|||
33710505|NCT01486758|63277623|FG000|Overall Study|Lost to Follow-up|0|||
33710506|NCT01486758|63277624|FG001|Overall Study|Lost to Follow-up|1|||
33710507|NCT01463982|63277635|FG000|Overall Study|Withdrawal by Subject|0|||
33710508|NCT01463982|63277636|FG001|Overall Study|Withdrawal by Subject|1|||
33710509|NCT01463982|63277637|FG002|Overall Study|Withdrawal by Subject|1|||
33710510|NCT01463982|63277638|FG003|Overall Study|Withdrawal by Subject|0|||
33710511|NCT01463982|63277635|FG000|Overall Study|Treatment delay over 5 week|0|||
33710512|NCT01463982|63277636|FG001|Overall Study|Treatment delay over 5 week|0|||
33493617|NCT02086552|62872035|FG000|Overall Study|Withdrawal by Subject|1|||
33493618|NCT03131570|62872080|FG000|Overall Study|Adverse Event|1|||
33493619|NCT03131570|62872081|FG001|Overall Study|Adverse Event|0|||
33493620|NCT02930018|62872091|FG000|Overall Study|Lost to Follow-up|1|||
33493621|NCT02930018|62872092|FG001|Overall Study|Lost to Follow-up|1|||
33493622|NCT02930018|62872091|FG000|Overall Study|Withdrawal by Subject|5|||
33493623|NCT02930018|62872092|FG001|Overall Study|Withdrawal by Subject|2|||
33493624|NCT02875028|62872100|FG000|Washout Period|Withdrawal by Subject|0|||
33493625|NCT02875028|62872101|FG001|Washout Period|Withdrawal by Subject|1|||
33493626|NCT00943618|62872112|FG000|Overall Study|Lost to Follow-up|38|||
33493627|NCT00943618|62872113|FG001|Overall Study|Lost to Follow-up|48|||
33493628|NCT00943618|62872114|FG002|Overall Study|Lost to Follow-up|20|||
33493629|NCT00943618|62872112|FG000|Overall Study|Discontinued Medication|17|||
33493630|NCT00943618|62872113|FG001|Overall Study|Discontinued Medication|29|||
33493631|NCT00943618|62872114|FG002|Overall Study|Discontinued Medication|11|||
33493632|NCT02710084|62872137|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
33493633|NCT02710084|62872138|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
33493634|NCT02849990|62872145|FG000|Overall Study|Adverse Event|1|||
33597371|NCT01877668|62996313|FG000|Overall Study|No longer met study criteria|1|||
33710513|NCT01463982|63277637|FG002|Overall Study|Treatment delay over 5 week|1|||
33710514|NCT01463982|63277638|FG003|Overall Study|Treatment delay over 5 week|0|||
33710515|NCT01486446|63277650|FG000|Overall Study|Adverse Event|1|||
33710516|NCT01486446|63277651|FG001|Overall Study|Adverse Event|0|||
33710517|NCT01485354|63277657|FG000|Overall Study|Withdrawal by Subject|5|||
33710518|NCT01510158|63277664|FG000|Overall Study|Adverse Event|7|||
33710519|NCT01510158|63277665|FG001|Overall Study|Adverse Event|8|||
33710520|NCT01510158|63277666|FG002|Overall Study|Adverse Event|5|||
33710521|NCT01510158|63277664|FG000|Overall Study|Gout flare|1|||
33710522|NCT01510158|63277665|FG001|Overall Study|Gout flare|0|||
33710523|NCT01510158|63277666|FG002|Overall Study|Gout flare|0|||
33312312|NCT01084252|62687895|FG005|Phase 1 (120 Weeks)|Progressive disease|6|||
33493635|NCT02849990|62872145|FG000|Overall Study|Withdrawal by Subject|1|||
33493636|NCT02017964|62872149|FG000|Overall Study|Patient deemed ineligible|1|||
33493637|NCT01956110|62872155|FG000|Overall Study|Protocol Violation|25|||
33710524|NCT01510158|63277664|FG000|Overall Study|Protocol Violation|17|||
33493638|NCT01956110|62872156|FG001|Overall Study|Protocol Violation|11|||
33493639|NCT01956110|62872155|FG000|Overall Study|Adverse Event|9|||
33493640|NCT01956110|62872156|FG001|Overall Study|Adverse Event|10|||
33493641|NCT01956110|62872155|FG000|Overall Study|Personal reasons|1|||
33493642|NCT01956110|62872156|FG001|Overall Study|Personal reasons|1|||
33597372|NCT01877668|62996314|FG001|Overall Study|No longer met study criteria|0|||
33597373|NCT01877668|62996315|FG002|Overall Study|No longer met study criteria|1|||
33597374|NCT01877668|62996316|FG003|Overall Study|No longer met study criteria|0|||
33597375|NCT01877668|62996317|FG004|Overall Study|No longer met study criteria|0|||
33710525|NCT01510158|63277665|FG001|Overall Study|Protocol Violation|16|||
33710526|NCT01510158|63277666|FG002|Overall Study|Protocol Violation|24|||
33710527|NCT01510158|63277664|FG000|Overall Study|Sponsor terminated study.|2|||
33710528|NCT01510158|63277665|FG001|Overall Study|Sponsor terminated study.|0|||
33710529|NCT01510158|63277666|FG002|Overall Study|Sponsor terminated study.|2|||
33710530|NCT01510158|63277664|FG000|Overall Study|Lost to Follow-up|13|||
33710531|NCT01510158|63277665|FG001|Overall Study|Lost to Follow-up|16|||
33710532|NCT01510158|63277666|FG002|Overall Study|Lost to Follow-up|9|||
33710533|NCT01510158|63277664|FG000|Overall Study|Withdrawal by Subject|10|||
33710534|NCT01510158|63277665|FG001|Overall Study|Withdrawal by Subject|13|||
33710535|NCT01510158|63277666|FG002|Overall Study|Withdrawal by Subject|10|||
33710536|NCT01510158|63277664|FG000|Overall Study|Death|1|||
33710537|NCT01510158|63277665|FG001|Overall Study|Death|0|||
33710538|NCT01510158|63277666|FG002|Overall Study|Death|0|||
33710539|NCT01485120|63277683|FG000|Overall Study|Withdrawal by Subject|2|||
33493643|NCT03116828|62872187|FG000|Overall Study|Adverse Event|1|||
33493644|NCT03116828|62872188|FG001|Overall Study|Adverse Event|10|||
33493645|NCT03116828|62872187|FG000|Overall Study|Withdrawal by Subject|4|||
33493646|NCT03116828|62872188|FG001|Overall Study|Withdrawal by Subject|8|||
33493647|NCT03116828|62872187|FG000|Overall Study|OTHER|3|||
33493648|NCT03116828|62872188|FG001|Overall Study|OTHER|3|||
33493649|NCT03938272|62872196|FG000|Overall Study|Withdrawal by Subject|1|||
33493650|NCT03938272|62872197|FG001|Overall Study|Withdrawal by Subject|0|||
33493651|NCT03938272|62872196|FG000|Overall Study|Physician Decision|0|||
33493652|NCT03938272|62872197|FG001|Overall Study|Physician Decision|2|||
33493653|NCT03938272|62872196|FG000|Overall Study|Study termination by sponsor|10|||
33493654|NCT03938272|62872197|FG001|Overall Study|Study termination by sponsor|8|||
33710540|NCT01484496|63277690|FG000|Period 1|Protocol Violation|3|||
33710541|NCT01484496|63277691|FG001|Period 1|Protocol Violation|4|||
33710542|NCT01484496|63277692|FG002|Period 1|Protocol Violation|0|||
33312313|NCT01084252|62687896|FG006|Phase 1 (120 Weeks)|Progressive disease|5|||
33710543|NCT01484496|63277693|FG003|Period 1|Protocol Violation|0|||
33710544|NCT01484496|63277690|FG000|Period 1|Physician Decision|5|||
33710545|NCT01484496|63277691|FG001|Period 1|Physician Decision|1|||
33710546|NCT01484496|63277692|FG002|Period 1|Physician Decision|0|||
33710547|NCT01484496|63277693|FG003|Period 1|Physician Decision|0|||
33710548|NCT01484496|63277690|FG000|Period 1|Lack of Efficacy|10|||
33710549|NCT01484496|63277691|FG001|Period 1|Lack of Efficacy|15|||
33710550|NCT01484496|63277692|FG002|Period 1|Lack of Efficacy|0|||
33710551|NCT01484496|63277693|FG003|Period 1|Lack of Efficacy|0|||
33710552|NCT01484496|63277690|FG000|Period 1|Adverse Event|25|||
33710553|NCT01484496|63277691|FG001|Period 1|Adverse Event|40|||
33710554|NCT01484496|63277692|FG002|Period 1|Adverse Event|0|||
33710555|NCT01484496|63277693|FG003|Period 1|Adverse Event|0|||
33710556|NCT01484496|63277690|FG000|Period 1|Withdrawal by Subject|15|||
33710557|NCT01484496|63277691|FG001|Period 1|Withdrawal by Subject|12|||
33710558|NCT01484496|63277692|FG002|Period 1|Withdrawal by Subject|0|||
33710559|NCT01484496|63277693|FG003|Period 1|Withdrawal by Subject|0|||
33710560|NCT01484496|63277690|FG000|Period 1|Lost to Follow-up|2|||
33710561|NCT01484496|63277691|FG001|Period 1|Lost to Follow-up|6|||
33710562|NCT01484496|63277692|FG002|Period 1|Lost to Follow-up|0|||
33710563|NCT01484496|63277693|FG003|Period 1|Lost to Follow-up|0|||
33493679|NCT03126344|62872223|FG000|Overall Study|Lost to Follow-up|0|||
33493680|NCT03126344|62872224|FG001|Overall Study|Lost to Follow-up|0|||
33493681|NCT03126344|62872225|FG002|Overall Study|Lost to Follow-up|5|||
33493682|NCT03115112|62872246|FG000|Overall Study|Adverse Event|5|||
33493683|NCT03115112|62872247|FG001|Overall Study|Adverse Event|1|||
33493684|NCT03115112|62872246|FG000|Overall Study|Withdrawal by Subject|4|||
33493685|NCT03115112|62872247|FG001|Overall Study|Withdrawal by Subject|2|||
33710564|NCT01484496|63277690|FG000|Period 1|Positive Pregnancy|1|||
33710565|NCT01484496|63277691|FG001|Period 1|Positive Pregnancy|6|||
33710566|NCT01484496|63277692|FG002|Period 1|Positive Pregnancy|0|||
33710567|NCT01484496|63277693|FG003|Period 1|Positive Pregnancy|0|||
33710568|NCT01484496|63277690|FG000|Period 1|Treatment Failure|3|||
33710569|NCT01484496|63277691|FG001|Period 1|Treatment Failure|6|||
33710570|NCT01484496|63277692|FG002|Period 1|Treatment Failure|0|||
33710571|NCT01484496|63277693|FG003|Period 1|Treatment Failure|0|||
33710572|NCT01484496|63277690|FG000|Period 1|Lack of Compliance|2|||
33710573|NCT01484496|63277691|FG001|Period 1|Lack of Compliance|1|||
33710574|NCT01484496|63277692|FG002|Period 1|Lack of Compliance|0|||
33493686|NCT03115112|62872246|FG000|Overall Study|Lost to Follow-up|0|||
33493687|NCT03115112|62872247|FG001|Overall Study|Lost to Follow-up|1|||
33493688|NCT03115112|62872246|FG000|Overall Study|Death|1|||
33493689|NCT03115112|62872247|FG001|Overall Study|Death|0|||
33493690|NCT03115112|62872246|FG000|Overall Study|Pregnancy|1|||
33493691|NCT03115112|62872247|FG001|Overall Study|Pregnancy|0|||
33493692|NCT03115112|62872246|FG000|Overall Study|Site closure|1|||
33493693|NCT03115112|62872247|FG001|Overall Study|Site closure|1|||
33493694|NCT03556358|62872266|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
33493695|NCT03556358|62872267|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
33493696|NCT03556358|62872266|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
33493697|NCT03556358|62872267|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
33493698|NCT03556358|62872266|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
33493699|NCT03556358|62872267|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
33493700|NCT03556358|62872266|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
33493701|NCT03556358|62872267|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
33493702|NCT03556358|62872266|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
33493703|NCT03556358|62872267|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
33493704|NCT03556358|62872266|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
33493705|NCT03556358|62872267|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
33493706|NCT03556358|62872266|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
33493707|NCT03556358|62872267|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
33710575|NCT01484496|63277693|FG003|Period 1|Lack of Compliance|0|||
33710576|NCT01484496|63277690|FG000|Period 1|Unable to Visit Site|0|||
33710577|NCT01484496|63277691|FG001|Period 1|Unable to Visit Site|2|||
33710578|NCT01484496|63277692|FG002|Period 1|Unable to Visit Site|0|||
33710579|NCT01484496|63277693|FG003|Period 1|Unable to Visit Site|0|||
33710580|NCT01484496|63277690|FG000|Period 2|Lack of Efficacy|0|||
33710581|NCT01484496|63277691|FG001|Period 2|Lack of Efficacy|0|||
33710582|NCT01484496|63277692|FG002|Period 2|Lack of Efficacy|1|||
33710583|NCT01484496|63277693|FG003|Period 2|Lack of Efficacy|3|||
33710584|NCT01484496|63277690|FG000|Period 2|Adverse Event|0|||
33710585|NCT01484496|63277691|FG001|Period 2|Adverse Event|0|||
33710586|NCT01484496|63277692|FG002|Period 2|Adverse Event|5|||
33710587|NCT01484496|63277693|FG003|Period 2|Adverse Event|13|||
33710588|NCT01484496|63277690|FG000|Period 2|Other|0|||
33710589|NCT01484496|63277691|FG001|Period 2|Other|0|||
33710590|NCT01484496|63277692|FG002|Period 2|Other|9|||
33710591|NCT01484496|63277693|FG003|Period 2|Other|6|||
33493720|NCT03118934|62872309|FG000|Overall Study|Adverse Event|0|||
33493721|NCT03118934|62872310|FG001|Overall Study|Adverse Event|0|||
33493722|NCT03118934|62872311|FG002|Overall Study|Adverse Event|0|||
33493723|NCT03118934|62872312|FG003|Overall Study|Adverse Event|0|||
33312314|NCT01084252|62687897|FG007|Phase 1 (120 Weeks)|Progressive disease|6|||
33312315|NCT01084252|62687898|FG008|Phase 1 (120 Weeks)|Progressive disease|0|||
33312316|NCT01084252|62687899|FG009|Phase 1 (120 Weeks)|Progressive disease|0|||
33312317|NCT01084252|62687900|FG010|Phase 1 (120 Weeks)|Progressive disease|0|||
33312318|NCT01084252|62687901|FG011|Phase 1 (120 Weeks)|Progressive disease|0|||
33312319|NCT01084252|62687902|FG012|Phase 1 (120 Weeks)|Progressive disease|0|||
33312320|NCT01084252|62687903|FG013|Phase 1 (120 Weeks)|Progressive disease|0|||
33312321|NCT01084252|62687890|FG000|Phase 1 (120 Weeks)|Other than specified above|1|||
33312322|NCT01084252|62687891|FG001|Phase 1 (120 Weeks)|Other than specified above|1|||
33312323|NCT01084252|62687892|FG002|Phase 1 (120 Weeks)|Other than specified above|0|||
33312324|NCT01084252|62687893|FG003|Phase 1 (120 Weeks)|Other than specified above|3|||
33312325|NCT01084252|62687894|FG004|Phase 1 (120 Weeks)|Other than specified above|1|||
33312326|NCT01084252|62687895|FG005|Phase 1 (120 Weeks)|Other than specified above|0|||
33312327|NCT01084252|62687896|FG006|Phase 1 (120 Weeks)|Other than specified above|1|||
33493724|NCT03118934|62872313|FG004|Overall Study|Adverse Event|0|||
33312328|NCT01084252|62687897|FG007|Phase 1 (120 Weeks)|Other than specified above|1|||
33312329|NCT01084252|62687898|FG008|Phase 1 (120 Weeks)|Other than specified above|0|||
33312330|NCT01084252|62687899|FG009|Phase 1 (120 Weeks)|Other than specified above|0|||
33312331|NCT01084252|62687900|FG010|Phase 1 (120 Weeks)|Other than specified above|0|||
33312332|NCT01084252|62687901|FG011|Phase 1 (120 Weeks)|Other than specified above|0|||
33312333|NCT01084252|62687902|FG012|Phase 1 (120 Weeks)|Other than specified above|0|||
33312334|NCT01084252|62687903|FG013|Phase 1 (120 Weeks)|Other than specified above|0|||
33312335|NCT01084252|62687890|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
33312336|NCT01084252|62687891|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
33312337|NCT01084252|62687892|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
33312338|NCT01084252|62687893|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
33312339|NCT01084252|62687894|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
33312340|NCT01084252|62687895|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
33312341|NCT01084252|62687896|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
33312342|NCT01084252|62687897|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
33312343|NCT01084252|62687898|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
33312344|NCT01084252|62687899|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
33312345|NCT01084252|62687900|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
33312346|NCT01084252|62687901|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1|||
33493725|NCT03118934|62872314|FG005|Overall Study|Adverse Event|1|||
33493726|NCT03118934|62872309|FG000|Overall Study|Physician Decision|0|||
33493727|NCT03118934|62872310|FG001|Overall Study|Physician Decision|0|||
33493728|NCT03118934|62872311|FG002|Overall Study|Physician Decision|0|||
33493729|NCT03118934|62872312|FG003|Overall Study|Physician Decision|0|||
33493730|NCT03118934|62872313|FG004|Overall Study|Physician Decision|0|||
33493731|NCT03118934|62872314|FG005|Overall Study|Physician Decision|1|||
33493732|NCT03118934|62872309|FG000|Overall Study|Discontinued prior to exposure|0|||
33493733|NCT03118934|62872310|FG001|Overall Study|Discontinued prior to exposure|1|||
33312347|NCT01084252|62687902|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
33312348|NCT01084252|62687903|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
33312349|NCT01084252|62687890|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
33312350|NCT01084252|62687891|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
33312351|NCT01084252|62687892|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
33312352|NCT01084252|62687893|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
33312353|NCT01084252|62687894|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
33312354|NCT01084252|62687895|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
33493734|NCT03118934|62872311|FG002|Overall Study|Discontinued prior to exposure|1|||
33493735|NCT03118934|62872312|FG003|Overall Study|Discontinued prior to exposure|1|||
33493736|NCT03118934|62872313|FG004|Overall Study|Discontinued prior to exposure|2|||
33493737|NCT03118934|62872314|FG005|Overall Study|Discontinued prior to exposure|0|||
33493738|NCT03114488|62872324|FG000|Time Period 2|Withdrawal by Subject|1|||
33493739|NCT03114488|62872325|FG001|Time Period 2|Withdrawal by Subject|3|||
33493740|NCT03135262|62872344|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
33493741|NCT03135262|62872345|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
33493742|NCT03135262|62872346|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
33493743|NCT03135262|62872347|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
33493744|NCT03135262|62872348|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
33493745|NCT03135262|62872344|FG000|Overall Study|Progression of disease|0|||
33493746|NCT03135262|62872345|FG001|Overall Study|Progression of disease|0|||
33493747|NCT03135262|62872346|FG002|Overall Study|Progression of disease|0|||
33493748|NCT03135262|62872347|FG003|Overall Study|Progression of disease|1|||
33312355|NCT01084252|62687896|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
33312356|NCT01084252|62687897|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
33312357|NCT01084252|62687898|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20|||
33312358|NCT01084252|62687899|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18|||
33312359|NCT01084252|62687900|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17|||
33312360|NCT01084252|62687901|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19|||
33312361|NCT01084252|62687902|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
33312362|NCT01084252|62687903|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
33312363|NCT01084252|62687890|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
33312364|NCT01084252|62687891|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
33312365|NCT01084252|62687892|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
33312366|NCT01084252|62687893|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
33312367|NCT01084252|62687894|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
33312368|NCT01084252|62687895|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
33312369|NCT01084252|62687896|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
33312370|NCT01084252|62687897|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
33312371|NCT01084252|62687898|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2|||
33493749|NCT03135262|62872348|FG004|Overall Study|Progression of disease|0|||
33312372|NCT01084252|62687899|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
33312373|NCT01084252|62687900|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4|||
33312374|NCT01084252|62687901|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3|||
33312375|NCT01084252|62687902|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
33312376|NCT01084252|62687903|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
33312377|NCT01084252|62687890|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
33312378|NCT01084252|62687891|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
33312379|NCT01084252|62687892|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
33312380|NCT01084252|62687893|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
33312381|NCT01084252|62687894|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
33312382|NCT01084252|62687895|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
33312383|NCT01084252|62687896|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
33312384|NCT01084252|62687897|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
33312385|NCT01084252|62687898|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1|||
33312386|NCT01084252|62687899|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4|||
33312387|NCT01084252|62687900|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
33312388|NCT01084252|62687901|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
33312389|NCT01084252|62687902|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
33312390|NCT01084252|62687903|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
33312391|NCT01084252|62687890|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
33312392|NCT01084252|62687891|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
33312393|NCT01084252|62687892|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
33312394|NCT01084252|62687893|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
33312395|NCT01084252|62687894|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
33312396|NCT01084252|62687895|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
33312397|NCT01084252|62687896|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
33312398|NCT01084252|62687897|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
33312399|NCT01084252|62687898|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
33312400|NCT01084252|62687899|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
33312401|NCT01084252|62687900|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
33312402|NCT01084252|62687901|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
33312403|NCT01084252|62687902|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13|||
33312404|NCT01084252|62687903|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5|||
33312405|NCT01084252|62687890|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
33312406|NCT01084252|62687891|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
33312407|NCT01084252|62687892|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
33312408|NCT01084252|62687893|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
33312409|NCT01084252|62687894|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
33312410|NCT01084252|62687895|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
33312411|NCT01084252|62687896|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
33312412|NCT01084252|62687897|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
33312413|NCT01084252|62687898|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
33312414|NCT01084252|62687899|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
33312415|NCT01084252|62687900|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
33312416|NCT01084252|62687901|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
33312417|NCT01084252|62687902|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70|||
33312418|NCT01084252|62687903|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33|||
33312419|NCT01084252|62687890|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
33312420|NCT01084252|62687891|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
33312421|NCT01084252|62687892|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
33312422|NCT01084252|62687893|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
33312423|NCT01084252|62687894|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
33312424|NCT01084252|62687895|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
33312425|NCT01084252|62687896|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
33312426|NCT01084252|62687897|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
33312427|NCT01084252|62687898|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
33312428|NCT01084252|62687899|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
33312429|NCT01084252|62687900|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
33312430|NCT01084252|62687901|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
33312431|NCT01084252|62687902|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1|||
33312432|NCT01084252|62687903|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
33493750|NCT03135262|62872344|FG000|Overall Study|Death|6|||
33312433|NCT01084252|62687890|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
33312434|NCT01084252|62687891|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
33312435|NCT01084252|62687892|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
33493751|NCT03135262|62872345|FG001|Overall Study|Death|2|||
33493752|NCT03135262|62872346|FG002|Overall Study|Death|2|||
33493753|NCT03135262|62872347|FG003|Overall Study|Death|2|||
33312436|NCT01084252|62687893|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
33312437|NCT01084252|62687894|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
33312438|NCT01084252|62687895|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
33312439|NCT01084252|62687896|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
33312440|NCT01084252|62687897|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
33312441|NCT01084252|62687898|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
33312442|NCT01084252|62687899|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
33312443|NCT01084252|62687900|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
33312444|NCT01084252|62687901|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
33312445|NCT01084252|62687902|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12|||
33312446|NCT01084252|62687903|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2|||
33312447|NCT01084252|62687890|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
33312448|NCT01084252|62687891|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
33312449|NCT01084252|62687892|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
33312450|NCT01084252|62687893|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
33312451|NCT01084252|62687894|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
33312452|NCT01084252|62687895|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
33312453|NCT01084252|62687896|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
33312454|NCT01084252|62687897|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
33312455|NCT01084252|62687898|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
33312456|NCT01084252|62687899|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
33312457|NCT01084252|62687900|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
33312458|NCT01084252|62687901|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
33312459|NCT01084252|62687902|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13|||
33312460|NCT01084252|62687903|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15|||
33312461|NCT01084252|62687890|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
33312462|NCT01084252|62687891|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
33312463|NCT01084252|62687892|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
33312464|NCT01084252|62687893|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
33312465|NCT01084252|62687894|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
33312466|NCT01084252|62687895|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
33312467|NCT01084252|62687896|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
33312468|NCT01084252|62687897|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
33312469|NCT01084252|62687898|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
33312470|NCT01084252|62687899|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
33312471|NCT01084252|62687900|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
33312472|NCT01084252|62687901|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
33312473|NCT01084252|62687902|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1|||
33312474|NCT01084252|62687903|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
33312475|NCT05111145|62687974|FG000|Overall Study|Commercial drug is available for participant|76|||
33312476|NCT05111145|62687974|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
33312477|NCT04823130|62687993|FG000|Overall Study|Withdrawal by Subject|2|||
33312478|NCT04823130|62687994|FG001|Overall Study|Withdrawal by Subject|3|||
33312479|NCT04823130|62687993|FG000|Overall Study|Failure to meet inclusion criteria|6|||
33312480|NCT04823130|62687994|FG001|Overall Study|Failure to meet inclusion criteria|4|||
33312481|NCT04823130|62687993|FG000|Overall Study|Other-unspecified|1|||
33312482|NCT04823130|62687994|FG001|Overall Study|Other-unspecified|0|||
33312483|NCT04402385|62688053|FG000|Overall Study|Withdrawal by Subject|4|||
33312484|NCT04402385|62688054|FG001|Overall Study|Withdrawal by Subject|4|||
33312485|NCT04402385|62688053|FG000|Overall Study|Lost to Follow-up|1|||
33312486|NCT04402385|62688054|FG001|Overall Study|Lost to Follow-up|1|||
33312487|NCT04402385|62688053|FG000|Overall Study|Physician Decision|0|||
33312488|NCT04402385|62688054|FG001|Overall Study|Physician Decision|1|||
33312489|NCT04060680|62688062|FG000|Overall Study|Unsuccessful implant|17|||
33312490|NCT04060680|62688062|FG000|Overall Study|Adverse Event|3|||
33312491|NCT04060680|62688062|FG000|Overall Study|Death|2|||
33312492|NCT04060680|62688062|FG000|Overall Study|Study product no longer in use|1|||
33312493|NCT04060680|62688062|FG000|Overall Study|Withdrawal by Subject|1|||
33312494|NCT03785210|62688069|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
33312495|NCT03785210|62688070|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
33312496|NCT03750968|62688078|FG000|Overall Study|Adverse Event|2|||
33312497|NCT03750968|62688079|FG001|Overall Study|Adverse Event|0|||
33312498|NCT03750968|62688078|FG000|Overall Study|Lost to Follow-up|1|||
33312499|NCT03750968|62688079|FG001|Overall Study|Lost to Follow-up|3|||
33312500|NCT03690388|62688091|FG000|Overall Study|Adverse Event|8|||
33312501|NCT03690388|62688092|FG001|Overall Study|Adverse Event|1|||
33312502|NCT03690388|62688091|FG000|Overall Study|Radiographic Progression|14|||
33493754|NCT03135262|62872348|FG004|Overall Study|Death|0|||
33312503|NCT03690388|62688092|FG001|Overall Study|Radiographic Progression|29|||
33493755|NCT03135262|62872344|FG000|Overall Study|Withdrawal by Subject|0|||
33312504|NCT03690388|62688091|FG000|Overall Study|Clinical deterioration|10|||
33312505|NCT03690388|62688092|FG001|Overall Study|Clinical deterioration|6|||
33312506|NCT03690388|62688091|FG000|Overall Study|Withdrawal by Subject|2|||
33312507|NCT03690388|62688092|FG001|Overall Study|Withdrawal by Subject|0|||
33312508|NCT03690388|62688091|FG000|Overall Study|Lack of Efficacy|1|||
33312509|NCT03690388|62688092|FG001|Overall Study|Lack of Efficacy|0|||
33312510|NCT03690388|62688091|FG000|Overall Study|Lost to Follow-up|1|||
33312511|NCT03690388|62688092|FG001|Overall Study|Lost to Follow-up|0|||
33312512|NCT03619213|62688104|FG000|Overall Study|Lost to Follow-up|2|||
33312513|NCT03619213|62688105|FG001|Overall Study|Lost to Follow-up|1|||
33312514|NCT03619213|62688104|FG000|Overall Study|Withdrawal by Subject|8|||
33312515|NCT03619213|62688105|FG001|Overall Study|Withdrawal by Subject|10|||
33312516|NCT03342690|62688111|FG000|Overall Study|Missing Information|9|||
33312517|NCT03342690|62688111|FG000|Overall Study|Protocol Violation|16|||
33312518|NCT03257267|62688130|FG000|Overall Study|Adverse Event|9|||
33710592|NCT01509846|63277706|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
33710593|NCT01509846|63277707|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
33710594|NCT01509846|63277708|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
33710595|NCT01509846|63277709|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
33710596|NCT01509846|63277710|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
33710597|NCT01509846|63277706|FG000|Received Vaccination 2|Illness|0|||
33710598|NCT01509846|63277707|FG001|Received Vaccination 2|Illness|0|||
33710599|NCT01509846|63277708|FG002|Received Vaccination 2|Illness|0|||
33710600|NCT01509846|63277709|FG003|Received Vaccination 2|Illness|0|||
33710601|NCT01509846|63277710|FG004|Received Vaccination 2|Illness|1|||
33710602|NCT01509846|63277706|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
33710603|NCT01509846|63277707|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
33710604|NCT01509846|63277708|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
33710605|NCT01509846|63277709|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
33710606|NCT01509846|63277710|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
33710607|NCT01509846|63277706|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
33710608|NCT01509846|63277707|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
33710609|NCT01509846|63277708|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
33710610|NCT01509846|63277709|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
33710611|NCT01509846|63277710|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
33710612|NCT01509846|63277706|FG000|Received Vaccination 3|Pregnancy|0|||
33710613|NCT01509846|63277707|FG001|Received Vaccination 3|Pregnancy|0|||
33710614|NCT01509846|63277708|FG002|Received Vaccination 3|Pregnancy|0|||
33710615|NCT01509846|63277709|FG003|Received Vaccination 3|Pregnancy|1|||
33710616|NCT01509846|63277710|FG004|Received Vaccination 3|Pregnancy|0|||
33710617|NCT01509846|63277706|FG000|Received Vaccination 3|Lost to Follow-up|0|||
33710618|NCT01509846|63277707|FG001|Received Vaccination 3|Lost to Follow-up|0|||
33710619|NCT01509846|63277708|FG002|Received Vaccination 3|Lost to Follow-up|1|||
33710620|NCT01509846|63277709|FG003|Received Vaccination 3|Lost to Follow-up|0|||
33312519|NCT03257267|62688131|FG001|Overall Study|Adverse Event|7|||
33312520|NCT03257267|62688130|FG000|Overall Study|Death|92|||
33312521|NCT03257267|62688131|FG001|Overall Study|Death|95|||
33312522|NCT03257267|62688130|FG000|Overall Study|Lost to Follow-up|2|||
33312523|NCT03257267|62688131|FG001|Overall Study|Lost to Follow-up|2|||
33312524|NCT03257267|62688130|FG000|Overall Study|Non-compliance with Study Drug|0|||
33312525|NCT03257267|62688131|FG001|Overall Study|Non-compliance with Study Drug|1|||
33312526|NCT03257267|62688130|FG000|Overall Study|Participant Decision|34|||
33312527|NCT03257267|62688131|FG001|Overall Study|Participant Decision|42|||
33312528|NCT03257267|62688130|FG000|Overall Study|Physician Decision|1|||
33312529|NCT03257267|62688131|FG001|Overall Study|Physician Decision|3|||
33312530|NCT03257267|62688130|FG000|Overall Study|Disease Progression|98|||
33312531|NCT03257267|62688131|FG001|Overall Study|Disease Progression|117|||
33312532|NCT03257267|62688130|FG000|Overall Study|Withdrawal of Consent|8|||
33312533|NCT03257267|62688131|FG001|Overall Study|Withdrawal of Consent|26|||
33312534|NCT03257267|62688130|FG000|Overall Study|Study Ongoing|53|||
33312535|NCT03257267|62688131|FG001|Overall Study|Study Ongoing|11|||
33312536|NCT02991456|62688148|FG000|Overall Study|Adverse Event|2|||
33710621|NCT01509846|63277710|FG004|Received Vaccination 3|Lost to Follow-up|0|||
33710622|NCT01462344|63277731|FG000|Overall Study|Withdrawal by Subject|245|||
33710623|NCT01462344|63277732|FG001|Overall Study|Withdrawal by Subject|226|||
33710624|NCT01462344|63277731|FG000|Overall Study|Adverse Event|24|||
33312537|NCT02991456|62688149|FG001|Overall Study|Adverse Event|0|||
33493756|NCT03135262|62872345|FG001|Overall Study|Withdrawal by Subject|0|||
33710625|NCT01462344|63277732|FG001|Overall Study|Adverse Event|23|||
33312538|NCT02991456|62688148|FG000|Overall Study|Lost to Follow-up|0|||
33312539|NCT02991456|62688149|FG001|Overall Study|Lost to Follow-up|2|||
33312540|NCT02991456|62688148|FG000|Overall Study|Withdrawal by Subject|1|||
33312541|NCT02991456|62688149|FG001|Overall Study|Withdrawal by Subject|0|||
33312542|NCT02842827|62688166|FG000|Overall Study|Adverse Event|0|||
33312543|NCT02842827|62688167|FG001|Overall Study|Adverse Event|1|||
33312544|NCT02842827|62688168|FG002|Overall Study|Adverse Event|0|||
33710626|NCT01462344|63277731|FG000|Overall Study|Asthma Exacerbation|34|||
33312545|NCT02842827|62688169|FG003|Overall Study|Adverse Event|1|||
33312546|NCT02842827|62688170|FG004|Overall Study|Adverse Event|0|||
33312547|NCT02842827|62688171|FG005|Overall Study|Adverse Event|1|||
33312548|NCT02842827|62688172|FG006|Overall Study|Adverse Event|0|||
33312549|NCT02842827|62688173|FG007|Overall Study|Adverse Event|0|||
33312550|NCT02842827|62688166|FG000|Overall Study|Death|1|||
33312551|NCT02842827|62688167|FG001|Overall Study|Death|0|||
33312552|NCT02842827|62688168|FG002|Overall Study|Death|2|||
33312553|NCT02842827|62688169|FG003|Overall Study|Death|3|||
33312554|NCT02842827|62688170|FG004|Overall Study|Death|2|||
33312555|NCT02842827|62688171|FG005|Overall Study|Death|1|||
33312556|NCT02842827|62688172|FG006|Overall Study|Death|0|||
33312557|NCT02842827|62688173|FG007|Overall Study|Death|4|||
33312558|NCT02842827|62688166|FG000|Overall Study|Physician Decision|1|||
33312559|NCT02842827|62688167|FG001|Overall Study|Physician Decision|3|||
33312560|NCT02842827|62688168|FG002|Overall Study|Physician Decision|0|||
33312561|NCT02842827|62688169|FG003|Overall Study|Physician Decision|0|||
33312562|NCT02842827|62688170|FG004|Overall Study|Physician Decision|1|||
33312563|NCT02842827|62688171|FG005|Overall Study|Physician Decision|4|||
33312564|NCT02842827|62688172|FG006|Overall Study|Physician Decision|2|||
33312565|NCT02842827|62688173|FG007|Overall Study|Physician Decision|1|||
33312566|NCT02842827|62688166|FG000|Overall Study|Protocol Defined Disease Progression|0|||
33312567|NCT02842827|62688167|FG001|Overall Study|Protocol Defined Disease Progression|0|||
33312568|NCT02842827|62688168|FG002|Overall Study|Protocol Defined Disease Progression|0|||
33312569|NCT02842827|62688169|FG003|Overall Study|Protocol Defined Disease Progression|0|||
33312570|NCT02842827|62688170|FG004|Overall Study|Protocol Defined Disease Progression|0|||
33312571|NCT02842827|62688171|FG005|Overall Study|Protocol Defined Disease Progression|1|||
33312572|NCT02842827|62688172|FG006|Overall Study|Protocol Defined Disease Progression|0|||
33312573|NCT02842827|62688173|FG007|Overall Study|Protocol Defined Disease Progression|0|||
33312574|NCT02842827|62688166|FG000|Overall Study|Participant Withdrawal of Consent|1|||
33312575|NCT02842827|62688167|FG001|Overall Study|Participant Withdrawal of Consent|2|||
33312576|NCT02842827|62688168|FG002|Overall Study|Participant Withdrawal of Consent|2|||
33312577|NCT02842827|62688169|FG003|Overall Study|Participant Withdrawal of Consent|2|||
33312578|NCT02842827|62688170|FG004|Overall Study|Participant Withdrawal of Consent|2|||
33312579|NCT02842827|62688171|FG005|Overall Study|Participant Withdrawal of Consent|1|||
33312580|NCT02842827|62688172|FG006|Overall Study|Participant Withdrawal of Consent|2|||
33312581|NCT02842827|62688173|FG007|Overall Study|Participant Withdrawal of Consent|1|||
33312582|NCT02432274|62688199|FG000|Overall Study|Death|2|||
33312583|NCT02432274|62688200|FG001|Overall Study|Death|6|||
33312584|NCT02432274|62688201|FG002|Overall Study|Death|7|||
33312585|NCT02432274|62688202|FG003|Overall Study|Death|0|||
33312586|NCT02432274|62688203|FG004|Overall Study|Death|27|||
33312587|NCT02432274|62688204|FG005|Overall Study|Death|7|||
33312588|NCT02432274|62688205|FG006|Overall Study|Death|9|||
33312589|NCT02432274|62688206|FG007|Overall Study|Death|14|||
33312590|NCT02432274|62688199|FG000|Overall Study|Withdrawal of Consent|0|||
33312591|NCT02432274|62688200|FG001|Overall Study|Withdrawal of Consent|0|||
33312592|NCT02432274|62688201|FG002|Overall Study|Withdrawal of Consent|0|||
33312593|NCT02432274|62688202|FG003|Overall Study|Withdrawal of Consent|0|||
33312594|NCT02432274|62688203|FG004|Overall Study|Withdrawal of Consent|2|||
33312595|NCT02432274|62688204|FG005|Overall Study|Withdrawal of Consent|0|||
33312596|NCT02432274|62688205|FG006|Overall Study|Withdrawal of Consent|1|||
33312597|NCT02432274|62688206|FG007|Overall Study|Withdrawal of Consent|2|||
33312598|NCT02393859|62688242|FG000|Overall Study|Decision by Sponsor|2|||
33312599|NCT02393859|62688243|FG001|Overall Study|Decision by Sponsor|4|||
33312600|NCT02393859|62688242|FG000|Overall Study|Withdrawal by Subject|11|||
33312601|NCT02393859|62688243|FG001|Overall Study|Withdrawal by Subject|6|||
33312602|NCT02393859|62688242|FG000|Overall Study|Death|27|||
33312603|NCT02393859|62688243|FG001|Overall Study|Death|10|||
33312604|NCT02393859|62688242|FG000|Overall Study|Lost to Follow-up|1|||
33312605|NCT02393859|62688243|FG001|Overall Study|Lost to Follow-up|1|||
33312606|NCT02197234|62688250|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
33312607|NCT02197234|62688250|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1|||
33312608|NCT02197234|62688250|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
33312609|NCT02197234|62688250|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
33312610|NCT02197234|62688250|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
33312611|NCT02197234|62688250|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
33312612|NCT02197234|62688250|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
33312613|NCT02096588|62688259|FG000|Overall Study|Lack of Efficacy|2|||
33312614|NCT02096588|62688260|FG001|Overall Study|Lack of Efficacy|0|||
33312615|NCT02096588|62688259|FG000|Overall Study|Withdrawal by Subject|0|||
33312616|NCT02096588|62688260|FG001|Overall Study|Withdrawal by Subject|1|||
33312617|NCT01359592|62688266|FG000|Initial Registration|Adverse Event|1|||
33312618|NCT01359592|62688267|FG001|Initial Registration|Adverse Event|0|||
33312619|NCT01359592|62688268|FG002|Initial Registration|Adverse Event|0|||
33312620|NCT01359592|62688269|FG003|Initial Registration|Adverse Event|0|||
33312621|NCT01359592|62688266|FG000|Initial Registration|Death|1|||
33312622|NCT01359592|62688267|FG001|Initial Registration|Death|0|||
33312623|NCT01359592|62688268|FG002|Initial Registration|Death|0|||
33312624|NCT01359592|62688269|FG003|Initial Registration|Death|0|||
33312625|NCT01359592|62688266|FG000|Initial Registration|Other reason not protocol specified|1|||
33312626|NCT01359592|62688267|FG001|Initial Registration|Other reason not protocol specified|0|||
33312627|NCT01359592|62688268|FG002|Initial Registration|Other reason not protocol specified|0|||
33312628|NCT01359592|62688269|FG003|Initial Registration|Other reason not protocol specified|0|||
33312629|NCT01359592|62688266|FG000|Initial Registration|Ineligible|26|||
33312630|NCT01359592|62688267|FG001|Initial Registration|Ineligible|0|||
33312631|NCT01359592|62688268|FG002|Initial Registration|Ineligible|0|||
33312632|NCT01359592|62688269|FG003|Initial Registration|Ineligible|0|||
33312633|NCT01359592|62688266|FG000|PET-Directed Therapy|Adverse Event|0|||
33312634|NCT01359592|62688267|FG001|PET-Directed Therapy|Adverse Event|0|||
33312635|NCT01359592|62688268|FG002|PET-Directed Therapy|Adverse Event|1|||
33312636|NCT01359592|62688269|FG003|PET-Directed Therapy|Adverse Event|0|||
33312637|NCT01359592|62688266|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
33312638|NCT01359592|62688267|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
33312639|NCT01359592|62688268|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
33312640|NCT01359592|62688269|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
33312641|NCT01359592|62688266|FG000|PET-Directed Therapy|Ineligible|0|||
33312642|NCT01359592|62688267|FG001|PET-Directed Therapy|Ineligible|0|||
33312643|NCT01359592|62688268|FG002|PET-Directed Therapy|Ineligible|24|||
33312644|NCT01359592|62688269|FG003|PET-Directed Therapy|Ineligible|0|||
33312645|NCT00699816|62688286|FG000|Overall Study|Protocol Violation|1|||
33312646|NCT00699816|62688287|FG001|Overall Study|Protocol Violation|3|||
33312647|NCT00697073|62688293|FG000|Overall Study|Withdrawal by Subject|2|||
33312648|NCT00697073|62688293|FG000|Overall Study|Pregnancy|1|||
33312649|NCT00697073|62688293|FG000|Overall Study|non compliance and other|6|||
33312650|NCT00653432|62688299|FG000|Overall Study|Adverse Event|4|||
33312651|NCT00653432|62688300|FG001|Overall Study|Adverse Event|1|||
33312652|NCT00653432|62688299|FG000|Overall Study|Withdrawal by Subject|4|||
33312653|NCT00653432|62688300|FG001|Overall Study|Withdrawal by Subject|5|||
33312654|NCT00653432|62688299|FG000|Overall Study|Lost to Follow-up|7|||
33312655|NCT00653432|62688300|FG001|Overall Study|Lost to Follow-up|6|||
33493757|NCT03135262|62872346|FG002|Overall Study|Withdrawal by Subject|1|||
33710627|NCT01462344|63277732|FG001|Overall Study|Asthma Exacerbation|35|||
33312656|NCT00653432|62688299|FG000|Overall Study|Use/Need of Con Therapy|2|||
33312657|NCT00653432|62688300|FG001|Overall Study|Use/Need of Con Therapy|1|||
33493758|NCT03135262|62872347|FG003|Overall Study|Withdrawal by Subject|0|||
33312658|NCT00653432|62688299|FG000|Overall Study|Other - Reason Not Provided|5|||
33312659|NCT00653432|62688300|FG001|Overall Study|Other - Reason Not Provided|3|||
33312660|NCT00446043|62688319|FG000|Overall Study|Adverse Event|9|||
33312661|NCT00446043|62688319|FG000|Overall Study|Withdrawal by Subject|70|||
33312662|NCT00446043|62688319|FG000|Overall Study|Protocol Violation|2|||
33312663|NCT00446043|62688319|FG000|Overall Study|Lost to Follow-up|42|||
33312664|NCT00446043|62688319|FG000|Overall Study|Pregnancy|2|||
33312665|NCT00400725|62688326|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
33312666|NCT00400725|62688327|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
33312667|NCT00400725|62688328|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
33312668|NCT00400725|62688326|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
33312669|NCT00400725|62688327|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
33312670|NCT00400725|62688328|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
33312671|NCT00400725|62688326|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
33710628|NCT01462344|63277731|FG000|Overall Study|Lack of Efficacy|5|||
33312672|NCT00400725|62688327|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
33312673|NCT00400725|62688328|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
33312674|NCT00400725|62688326|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
33312675|NCT00400725|62688327|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
33312676|NCT00400725|62688328|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
33312677|NCT00400725|62688326|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
33312678|NCT00400725|62688327|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
33312679|NCT00400725|62688328|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
33312680|NCT00400725|62688326|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
33312681|NCT00400725|62688327|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
33312682|NCT00400725|62688328|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
33312683|NCT00400725|62688326|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
33312684|NCT00400725|62688327|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
33312685|NCT00400725|62688328|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
33312686|NCT00400725|62688326|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
33312687|NCT00400725|62688327|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
33312688|NCT00400725|62688328|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
33312689|NCT00400725|62688326|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
33312690|NCT00400725|62688327|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
33312691|NCT00400725|62688328|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
33312692|NCT00099437|62688344|FG000|Overall Study|Lost to Follow-up|30|||
33710629|NCT01462344|63277732|FG001|Overall Study|Lack of Efficacy|6|||
33710630|NCT01462344|63277731|FG000|Overall Study|Protocol Violation|68|||
33710631|NCT01462344|63277732|FG001|Overall Study|Protocol Violation|53|||
33710632|NCT01462344|63277731|FG000|Overall Study|Lost to Follow-up|7|||
33710633|NCT01462344|63277732|FG001|Overall Study|Lost to Follow-up|7|||
33312693|NCT00099437|62688345|FG001|Overall Study|Lost to Follow-up|33|||
33312694|NCT00099437|62688344|FG000|Overall Study|Death|293|||
33710634|NCT01484028|63277738|FG000|Period 1|Lost to Follow-up|0|||
33710635|NCT01484028|63277739|FG001|Period 1|Lost to Follow-up|1|||
33710636|NCT01484028|63277740|FG002|Period 1|Lost to Follow-up|0|||
33710637|NCT01484028|63277741|FG003|Period 1|Lost to Follow-up|0|||
33312695|NCT00099437|62688345|FG001|Overall Study|Death|261|||
33312696|NCT00099437|62688344|FG000|Overall Study|Withdrawal by Subject|6|||
33312697|NCT00099437|62688345|FG001|Overall Study|Withdrawal by Subject|10|||
33312698|NCT00099437|62688344|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
33312699|NCT00099437|62688345|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
33312700|NCT00932113|62688353|FG000|Overall Study|Lost to Follow-up|1|||
33312701|NCT00932113|62688354|FG001|Overall Study|Lost to Follow-up|0|||
33312702|NCT00931801|62688363|FG000|Overall Study|Adverse Event|0|||
33710638|NCT01484028|63277738|FG000|Period 1|Non-Compliance to Protocol|0|||
33710639|NCT01484028|63277739|FG001|Period 1|Non-Compliance to Protocol|1|||
33710640|NCT01484028|63277740|FG002|Period 1|Non-Compliance to Protocol|0|||
33710641|NCT01484028|63277741|FG003|Period 1|Non-Compliance to Protocol|1|||
33312703|NCT00931801|62688364|FG001|Overall Study|Adverse Event|0|||
33312704|NCT00931801|62688365|FG002|Overall Study|Adverse Event|1|||
33312705|NCT00931801|62688363|FG000|Overall Study|Lost to Follow-up|0|||
33312706|NCT00931801|62688364|FG001|Overall Study|Lost to Follow-up|1|||
33312707|NCT00931801|62688365|FG002|Overall Study|Lost to Follow-up|0|||
33312708|NCT00931801|62688363|FG000|Overall Study|Withdrawal by Subject|1|||
33312709|NCT00931801|62688364|FG001|Overall Study|Withdrawal by Subject|0|||
33312710|NCT00931801|62688365|FG002|Overall Study|Withdrawal by Subject|0|||
33312711|NCT00931801|62688363|FG000|Overall Study|Confirmed Virologic Failure|0|||
33312712|NCT00931801|62688364|FG001|Overall Study|Confirmed Virologic Failure|0|||
33312713|NCT00931801|62688365|FG002|Overall Study|Confirmed Virologic Failure|3|||
33312714|NCT00931723|62688379|FG000|Overall Study|Withdrawal by Subject|11|||
33312715|NCT00931723|62688380|FG001|Overall Study|Withdrawal by Subject|13|||
33710642|NCT01484028|63277738|FG000|Period 1|Lens Discomfort|0|||
33710643|NCT01484028|63277739|FG001|Period 1|Lens Discomfort|1|||
33710644|NCT01484028|63277740|FG002|Period 1|Lens Discomfort|0|||
33710645|NCT01484028|63277741|FG003|Period 1|Lens Discomfort|0|||
33710646|NCT01462266|63277751|FG000|Overall Study|Adverse Event|7|||
33710647|NCT01462266|63277752|FG001|Overall Study|Adverse Event|6|||
33710648|NCT01462266|63277751|FG000|Overall Study|Death|2|||
33710649|NCT01462266|63277752|FG001|Overall Study|Death|1|||
33710650|NCT01462266|63277751|FG000|Overall Study|Lack of Efficacy|0|||
33710651|NCT01462266|63277752|FG001|Overall Study|Lack of Efficacy|2|||
33710652|NCT01462266|63277751|FG000|Overall Study|Lost to Follow-up|4|||
33312716|NCT00931723|62688379|FG000|Overall Study|Adverse Event|6|||
33312717|NCT00931723|62688380|FG001|Overall Study|Adverse Event|13|||
33312718|NCT00931723|62688379|FG000|Overall Study|Lithium found in blood|0|||
33312719|NCT00931723|62688380|FG001|Overall Study|Lithium found in blood|1|||
33312720|NCT00931723|62688379|FG000|Overall Study|Condition under investigation worsened|1|||
33312721|NCT00931723|62688380|FG001|Overall Study|Condition under investigation worsened|2|||
33312722|NCT00931723|62688379|FG000|Overall Study|Lost to Follow-up|1|||
33312723|NCT00931723|62688380|FG001|Overall Study|Lost to Follow-up|2|||
33312724|NCT00931723|62688379|FG000|Overall Study|Study-specific discontinuation criteria|1|||
33312725|NCT00931723|62688380|FG001|Overall Study|Study-specific discontinuation criteria|1|||
33312726|NCT00931723|62688379|FG000|Overall Study|Severe non-compliance to protocol|2|||
33312727|NCT00931723|62688380|FG001|Overall Study|Severe non-compliance to protocol|0|||
33312728|NCT00931723|62688379|FG000|Overall Study|Safety reasons|0|||
33312729|NCT00931723|62688380|FG001|Overall Study|Safety reasons|1|||
33312730|NCT00931723|62688379|FG000|Overall Study|Took prohibited concomitant medication|0|||
33312731|NCT00931723|62688380|FG001|Overall Study|Took prohibited concomitant medication|1|||
33312732|NCT00931723|62688379|FG000|Overall Study|Lack or insufficient theraputic response|2|||
33312733|NCT00931723|62688380|FG001|Overall Study|Lack or insufficient theraputic response|5|||
33312734|NCT00931723|62688379|FG000|Overall Study|Sponsor decision|1|||
33312735|NCT00931723|62688380|FG001|Overall Study|Sponsor decision|0|||
33312736|NCT00931723|62688379|FG000|Overall Study|Late hospital discharge|1|||
33312737|NCT00931723|62688380|FG001|Overall Study|Late hospital discharge|0|||
33312738|NCT00931411|62688388|FG000|First Intervention - 42 Days|Adverse Event|2|||
33312739|NCT00931411|62688389|FG001|First Intervention - 42 Days|Adverse Event|3|||
33312740|NCT00931411|62688388|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
33312741|NCT00931411|62688389|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
33312742|NCT00931411|62688388|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
33312743|NCT00931411|62688389|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
33710653|NCT01462266|63277752|FG001|Overall Study|Lost to Follow-up|3|||
33710654|NCT01462266|63277751|FG000|Overall Study|Non-compliance with study drug|3|||
33710655|NCT01462266|63277752|FG001|Overall Study|Non-compliance with study drug|0|||
33710656|NCT01462266|63277751|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
33710657|NCT01462266|63277752|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
33710658|NCT01462266|63277751|FG000|Overall Study|Physician Decision|2|||
33710659|NCT01462266|63277752|FG001|Overall Study|Physician Decision|5|||
33710660|NCT01462266|63277751|FG000|Overall Study|Protocol Violation|1|||
33710661|NCT01462266|63277752|FG001|Overall Study|Protocol Violation|3|||
33710662|NCT01462266|63277751|FG000|Overall Study|Withdrawal by Subject|7|||
33710663|NCT01462266|63277752|FG001|Overall Study|Withdrawal by Subject|2|||
33597376|NCT01877668|62996313|FG000|Overall Study|Insufficient clinical response|0|||
33710664|NCT01462266|63277751|FG000|Overall Study|Screen failure|1|||
33710665|NCT01462266|63277752|FG001|Overall Study|Screen failure|1|||
33710666|NCT01508910|63277761|FG000|Treatment|Death|2|||
33312744|NCT00931255|62688401|FG000|Overall Study|Follow up biopsy not done|2|||
33312745|NCT00931255|62688402|FG001|Overall Study|Follow up biopsy not done|3|||
33312746|NCT00930553|62688408|FG000|Overall Study|Adverse Event|1|||
33312747|NCT00930553|62688408|FG000|Overall Study|Lack of Efficacy|7|||
33312748|NCT00930553|62688408|FG000|Overall Study|Physician Decision|39|||
33312749|NCT00930553|62688408|FG000|Overall Study|Protocol Violation|1|||
33312750|NCT00930553|62688408|FG000|Overall Study|Pregnancy|1|||
33312751|NCT00930553|62688408|FG000|Overall Study|Withdrawal by Subject|88|||
33493759|NCT03135262|62872348|FG004|Overall Study|Withdrawal by Subject|1|||
33493760|NCT03135262|62872344|FG000|Overall Study|Study terminated by sponsor|2|||
33493761|NCT03135262|62872345|FG001|Overall Study|Study terminated by sponsor|4|||
33493762|NCT03135262|62872346|FG002|Overall Study|Study terminated by sponsor|4|||
33493763|NCT03135262|62872347|FG003|Overall Study|Study terminated by sponsor|3|||
33493764|NCT03135262|62872348|FG004|Overall Study|Study terminated by sponsor|0|||
33493765|NCT03535194|62872383|FG000|Induction Period|Adverse Event|2|||
33493766|NCT03535194|62872384|FG001|Induction Period|Adverse Event|2|||
33493767|NCT03535194|62872385|FG002|Induction Period|Adverse Event|1|||
33493768|NCT03535194|62872386|FG003|Induction Period|Adverse Event|3|||
33493769|NCT03535194|62872387|FG004|Induction Period|Adverse Event|0|||
33493770|NCT03535194|62872383|FG000|Induction Period|Death|0|||
33710667|NCT01508910|63277762|FG001|Treatment|Death|3|||
33710668|NCT01508910|63277763|FG002|Treatment|Death|2|||
33710669|NCT01508910|63277764|FG003|Treatment|Death|0|||
33710670|NCT01508910|63277761|FG000|Treatment|Lost to Follow-up|0|||
33710671|NCT01508910|63277762|FG001|Treatment|Lost to Follow-up|0|||
33710672|NCT01508910|63277763|FG002|Treatment|Lost to Follow-up|2|||
33597377|NCT01877668|62996314|FG001|Overall Study|Insufficient clinical response|1|||
33597378|NCT01877668|62996315|FG002|Overall Study|Insufficient clinical response|2|||
33597379|NCT01877668|62996316|FG003|Overall Study|Insufficient clinical response|2|||
33597380|NCT01877668|62996317|FG004|Overall Study|Insufficient clinical response|0|||
33597381|NCT01877668|62996313|FG000|Overall Study|Lost to Follow-up|0|||
33597382|NCT01877668|62996314|FG001|Overall Study|Lost to Follow-up|2|||
33597383|NCT01877668|62996315|FG002|Overall Study|Lost to Follow-up|1|||
33597384|NCT01877668|62996316|FG003|Overall Study|Lost to Follow-up|0|||
33597385|NCT01877668|62996317|FG004|Overall Study|Lost to Follow-up|0|||
33597386|NCT01877668|62996313|FG000|Overall Study|Withdrawal by Subject|2|||
33597387|NCT01877668|62996314|FG001|Overall Study|Withdrawal by Subject|0|||
33597388|NCT01877668|62996315|FG002|Overall Study|Withdrawal by Subject|3|||
33597389|NCT01877668|62996316|FG003|Overall Study|Withdrawal by Subject|2|||
33597390|NCT01877668|62996317|FG004|Overall Study|Withdrawal by Subject|2|||
33597391|NCT01877668|62996313|FG000|Overall Study|Other|1|||
33597392|NCT01877668|62996314|FG001|Overall Study|Other|1|||
33597393|NCT01877668|62996315|FG002|Overall Study|Other|1|||
33597394|NCT01877668|62996316|FG003|Overall Study|Other|1|||
33597395|NCT01877668|62996317|FG004|Overall Study|Other|3|||
33597396|NCT01877668|62996313|FG000|Overall Study|Protocol Violation|1|||
33597397|NCT01877668|62996314|FG001|Overall Study|Protocol Violation|1|||
33597398|NCT01877668|62996315|FG002|Overall Study|Protocol Violation|0|||
33597399|NCT01877668|62996316|FG003|Overall Study|Protocol Violation|0|||
33597400|NCT01877668|62996317|FG004|Overall Study|Protocol Violation|3|||
33597401|NCT01877668|62996313|FG000|Overall Study|Adverse event related to study drug|2|||
33597402|NCT01877668|62996314|FG001|Overall Study|Adverse event related to study drug|2|||
33597403|NCT01877668|62996315|FG002|Overall Study|Adverse event related to study drug|2|||
33597404|NCT01877668|62996316|FG003|Overall Study|Adverse event related to study drug|2|||
33597405|NCT01877668|62996317|FG004|Overall Study|Adverse event related to study drug|1|||
33597406|NCT01877668|62996313|FG000|Overall Study|Adverse event unrelated to study drug|4|||
33597407|NCT01877668|62996314|FG001|Overall Study|Adverse event unrelated to study drug|1|||
33597408|NCT01877668|62996315|FG002|Overall Study|Adverse event unrelated to study drug|2|||
33597409|NCT01877668|62996316|FG003|Overall Study|Adverse event unrelated to study drug|0|||
33597410|NCT01877668|62996317|FG004|Overall Study|Adverse event unrelated to study drug|1|||
33312752|NCT00930553|62688408|FG000|Overall Study|Lost to Follow-up|25|||
33312753|NCT00930553|62688408|FG000|Overall Study|Death|9|||
33312754|NCT00930553|62688408|FG000|Overall Study|Study terminated by sponsor|24|||
33312755|NCT00930553|62688408|FG000|Overall Study|Other than specified above|28|||
33493771|NCT03535194|62872384|FG001|Induction Period|Death|1|||
33597411|NCT01877278|62996335|FG000|Overall Study|Lost to Follow-up|3|||
33597412|NCT01877278|62996336|FG001|Overall Study|Lost to Follow-up|3|||
33597413|NCT01906372|62996342|FG000|Overall Study|Withdrawal by Subject|2|||
33312756|NCT00929695|62688432|FG000|Overall Study|Death|2|||
33312757|NCT00929695|62688433|FG001|Overall Study|Death|1|||
33312758|NCT00929695|62688432|FG000|Overall Study|Withdrawal by Subject|0|||
33312759|NCT00929695|62688433|FG001|Overall Study|Withdrawal by Subject|2|||
33312760|NCT00929695|62688432|FG000|Overall Study|discharge home|4|||
33312761|NCT00929695|62688433|FG001|Overall Study|discharge home|3|||
33312762|NCT00929695|62688432|FG000|Overall Study|incorrect stratification|2|||
33312763|NCT00929695|62688433|FG001|Overall Study|incorrect stratification|0|||
33312764|NCT00927355|62688446|FG000|Overall Study|Adverse Event|1|||
33312765|NCT00927355|62688447|FG001|Overall Study|Adverse Event|1|||
33312766|NCT00923845|62688467|FG000|Induction Therapy|Poor performance status|0|||
33312767|NCT00923845|62688468|FG001|Induction Therapy|Poor performance status|2|||
33312768|NCT00922987|62688475|FG000|Overall Study|Insufficient clinical response|1|||
33312769|NCT00922987|62688475|FG000|Overall Study|Protocol Violation|2|||
33312770|NCT00922987|62688475|FG000|Overall Study|Adverse Event|1|||
33312771|NCT00928135|62688481|FG000|Overall Study|Withdrawal by Subject|1|||
33312772|NCT00928135|62688482|FG001|Overall Study|Withdrawal by Subject|0|||
33312773|NCT00928057|62688490|FG000|Overall Study|Adverse Event|1|||
33312774|NCT00928057|62688491|FG001|Overall Study|Adverse Event|2|||
33312775|NCT00928057|62688490|FG000|Overall Study|Withdrawal by Subject|1|||
33312776|NCT00928057|62688491|FG001|Overall Study|Withdrawal by Subject|0|||
33597414|NCT01925170|62996347|FG000|Overall Study|Unverified cancer status|53|||
33312777|NCT00928057|62688490|FG000|Overall Study|Lost to Follow-up|0|||
33312778|NCT00928057|62688491|FG001|Overall Study|Lost to Follow-up|1|||
33312779|NCT00928057|62688490|FG000|Overall Study|Protocol Violation|0|||
33312780|NCT00928057|62688491|FG001|Overall Study|Protocol Violation|1|||
33312781|NCT00927901|62688507|FG000|Treatment Period 1|Subject withdrew consent|0|||
33493772|NCT03535194|62872385|FG002|Induction Period|Death|0|||
33312782|NCT00927901|62688508|FG001|Treatment Period 1|Subject withdrew consent|0|||
33312783|NCT00927901|62688509|FG002|Treatment Period 1|Subject withdrew consent|1|||
33493773|NCT03535194|62872386|FG003|Induction Period|Death|0|||
33597415|NCT01925014|62996355|FG000|Overall Study|Inappropriate enrollment|4|||
33597416|NCT01925014|62996356|FG001|Overall Study|Inappropriate enrollment|6|||
33597417|NCT01925014|62996355|FG000|Overall Study|Withdrawal by Subject|5|||
33597418|NCT01925014|62996356|FG001|Overall Study|Withdrawal by Subject|13|||
33710673|NCT01508910|63277764|FG003|Treatment|Lost to Follow-up|1|||
33710674|NCT01508910|63277761|FG000|Treatment|Withdrawal by Subject|0|||
33710675|NCT01508910|63277762|FG001|Treatment|Withdrawal by Subject|1|||
33710676|NCT01508910|63277763|FG002|Treatment|Withdrawal by Subject|6|||
33710677|NCT01508910|63277764|FG003|Treatment|Withdrawal by Subject|1|||
33710678|NCT01508910|63277761|FG000|Treatment|Sponsor Decision|0|||
33710679|NCT01508910|63277762|FG001|Treatment|Sponsor Decision|0|||
33710680|NCT01508910|63277763|FG002|Treatment|Sponsor Decision|0|||
33710681|NCT01508910|63277764|FG003|Treatment|Sponsor Decision|1|||
33710682|NCT01462110|63277778|FG000|Overall Study|Adverse Event|1|||
33710683|NCT01462110|63277779|FG001|Overall Study|Adverse Event|0|||
33710684|NCT01508676|63277787|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
33710685|NCT01508676|63277788|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
33710686|NCT01508676|63277787|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
33710687|NCT01508676|63277788|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
33710688|NCT01508676|63277787|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
33710689|NCT01508676|63277788|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
33710690|NCT01508676|63277787|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
33710691|NCT01508676|63277788|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
33710692|NCT01508676|63277787|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
33710693|NCT01508676|63277788|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
33710694|NCT01508130|63277797|FG000|Overall Study|Adverse Event|81|||
33710695|NCT01508130|63277798|FG001|Overall Study|Adverse Event|28|||
33710696|NCT01508130|63277797|FG000|Overall Study|Death|3|||
33710697|NCT01508130|63277798|FG001|Overall Study|Death|1|||
33710698|NCT01508130|63277797|FG000|Overall Study|Protocol Violation|2|||
33710699|NCT01508130|63277798|FG001|Overall Study|Protocol Violation|0|||
33710700|NCT01508130|63277797|FG000|Overall Study|Lost to Follow-up|25|||
33710701|NCT01508130|63277798|FG001|Overall Study|Lost to Follow-up|2|||
33710702|NCT01508130|63277797|FG000|Overall Study|Withdrawal by Subject|3|||
33710703|NCT01508130|63277798|FG001|Overall Study|Withdrawal by Subject|3|||
33710704|NCT01508130|63277797|FG000|Overall Study|Subject's substantial non-compliance|25|||
33710705|NCT01508130|63277798|FG001|Overall Study|Subject's substantial non-compliance|9|||
33710706|NCT01508130|63277797|FG000|Overall Study|Insufficient therapeutic response|74|||
33710707|NCT01508130|63277798|FG001|Overall Study|Insufficient therapeutic response|23|||
33710708|NCT01508130|63277797|FG000|Overall Study|Administrative|14|||
33710709|NCT01508130|63277798|FG001|Overall Study|Administrative|3|||
33710710|NCT01482312|63277806|FG000|Period 1, 90 Minutes of Wear|Other|1|||
33710711|NCT01482312|63277807|FG001|Period 1, 90 Minutes of Wear|Other|0|||
33710712|NCT01482312|63277808|FG002|Period 1, 90 Minutes of Wear|Other|0|||
33710713|NCT01482312|63277806|FG000|Period 2, 90 Minutes of Wear|Other|1|||
33710714|NCT01482312|63277807|FG001|Period 2, 90 Minutes of Wear|Other|0|||
33710715|NCT01482312|63277808|FG002|Period 2, 90 Minutes of Wear|Other|0|||
33710716|NCT01461096|63277818|FG000|Overall Study|Death|3|||
33710717|NCT01461096|63277819|FG001|Overall Study|Death|6|||
33710718|NCT01461096|63277818|FG000|Overall Study|Severe debilitation, unable to continue|1|||
33710719|NCT01461096|63277819|FG001|Overall Study|Severe debilitation, unable to continue|1|||
33710720|NCT01461096|63277818|FG000|Overall Study|Subj not able to get to clinic|15|||
33710721|NCT01461096|63277819|FG001|Overall Study|Subj not able to get to clinic|13|||
33710722|NCT01461096|63277818|FG000|Overall Study|Site is closing|27|||
33710723|NCT01461096|63277819|FG001|Overall Study|Site is closing|30|||
33710724|NCT01461096|63277818|FG000|Overall Study|Withdrawal by Subject|5|||
33710725|NCT01461096|63277819|FG001|Overall Study|Withdrawal by Subject|3|||
33710726|NCT01461096|63277818|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
33710727|NCT01461096|63277819|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
33710728|NCT01461096|63277818|FG000|Overall Study|Lost to Follow-up|8|||
33710729|NCT01461096|63277819|FG001|Overall Study|Lost to Follow-up|4|||
33710730|NCT01507896|63277826|FG000|Overall Study|Withdrawal by Subject|1|||
33710731|NCT01507896|63277826|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
33710732|NCT01507662|63277841|FG000|Overall Study|Death|26|||
33710733|NCT01507662|63277842|FG001|Overall Study|Death|18|||
33710734|NCT01507662|63277841|FG000|Overall Study|Withdrawal by Subject|290|||
33710735|NCT01507662|63277842|FG001|Overall Study|Withdrawal by Subject|287|||
33710736|NCT01507662|63277841|FG000|Overall Study|Lost to Follow-up|498|||
33710737|NCT01507662|63277842|FG001|Overall Study|Lost to Follow-up|523|||
33710738|NCT01507662|63277841|FG000|Overall Study|Proxy interview done|2|||
33710739|NCT01507662|63277842|FG001|Overall Study|Proxy interview done|3|||
33710740|NCT01506960|63277848|FG000|Overall Study|Did not meet angiographic criteria|47|||
33493774|NCT03535194|62872387|FG004|Induction Period|Death|0|||
33710741|NCT01480674|63277854|FG000|Overall Study|Death|23|||
33710742|NCT01480674|63277854|FG000|Overall Study|Lost to Follow-up|2|||
33710743|NCT01480674|63277854|FG000|Overall Study|visit not done|10|||
33710744|NCT01506882|63277860|FG000|Overall Study|Lack of Efficacy|4|||
33710745|NCT01506882|63277861|FG001|Overall Study|Lack of Efficacy|3|||
33710746|NCT01506882|63277860|FG000|Overall Study|Lost to Follow-up|1|||
33710747|NCT01506882|63277861|FG001|Overall Study|Lost to Follow-up|0|||
33710748|NCT01506882|63277860|FG000|Overall Study|Withdrawal by Subject|9|||
33710749|NCT01506882|63277861|FG001|Overall Study|Withdrawal by Subject|3|||
33312784|NCT00927901|62688510|FG003|Treatment Period 1|Subject withdrew consent|0|||
33312785|NCT00927901|62688507|FG000|Treatment Period 4|Adverse Event|0|||
33312786|NCT00927901|62688508|FG001|Treatment Period 4|Adverse Event|0|||
33312787|NCT00927901|62688509|FG002|Treatment Period 4|Adverse Event|0|||
33312788|NCT00927901|62688510|FG003|Treatment Period 4|Adverse Event|1|||
33312789|NCT00927901|62688507|FG000|Treatment Period 4|Subject withdrew consent|0|||
33312790|NCT00927901|62688508|FG001|Treatment Period 4|Subject withdrew consent|0|||
33312791|NCT00927901|62688509|FG002|Treatment Period 4|Subject withdrew consent|1|||
33312792|NCT00927901|62688510|FG003|Treatment Period 4|Subject withdrew consent|0|||
33312793|NCT01218204|62688525|FG000|Part B Washout|Adverse Event|0|||
33312794|NCT01218204|62688526|FG001|Part B Washout|Adverse Event|1|||
33312795|NCT01218204|62688527|FG002|Part B Washout|Adverse Event|0|||
33312796|NCT01218204|62688528|FG003|Part B Washout|Adverse Event|0|||
33312797|NCT01218204|62688525|FG000|Part B Washout|Lost to Follow-up|0|||
33312798|NCT01218204|62688526|FG001|Part B Washout|Lost to Follow-up|2|||
33312799|NCT01218204|62688527|FG002|Part B Washout|Lost to Follow-up|0|||
33312800|NCT01218204|62688528|FG003|Part B Washout|Lost to Follow-up|0|||
33312801|NCT01218204|62688525|FG000|Part B Washout|Physician Decision|0|||
33312802|NCT01218204|62688526|FG001|Part B Washout|Physician Decision|14|||
33312803|NCT01218204|62688527|FG002|Part B Washout|Physician Decision|0|||
33312804|NCT01218204|62688528|FG003|Part B Washout|Physician Decision|0|||
33312805|NCT01218204|62688525|FG000|Part B Washout|Withdrawal by Subject|0|||
33312806|NCT01218204|62688526|FG001|Part B Washout|Withdrawal by Subject|14|||
33312807|NCT01218204|62688527|FG002|Part B Washout|Withdrawal by Subject|0|||
33312808|NCT01218204|62688528|FG003|Part B Washout|Withdrawal by Subject|0|||
33312809|NCT01218204|62688525|FG000|Part B Washout|Reached defined stopping criteria|0|||
33493775|NCT03535194|62872383|FG000|Induction Period|Lack of Efficacy|1|||
33597419|NCT01876810|62996362|FG000|Overall Study|Physician Decision|0|||
33597420|NCT01876810|62996363|FG001|Overall Study|Physician Decision|1|||
33597421|NCT01876732|62996372|FG000|Overall Study|MMA was not over 800mg/dL|75|||
33597422|NCT01905592|62996379|FG000|Overall Study|Disease Progression|51|||
33597423|NCT01905592|62996380|FG001|Overall Study|Disease Progression|110|||
33597424|NCT01905592|62996379|FG000|Overall Study|Toxicity|1|||
33597425|NCT01905592|62996380|FG001|Overall Study|Toxicity|16|||
33597426|NCT01905592|62996379|FG000|Overall Study|Physician Decision|0|||
33312810|NCT01218204|62688526|FG001|Part B Washout|Reached defined stopping criteria|2|||
33312811|NCT01218204|62688527|FG002|Part B Washout|Reached defined stopping criteria|0|||
33312812|NCT01218204|62688528|FG003|Part B Washout|Reached defined stopping criteria|0|||
33312813|NCT01218204|62688525|FG000|Part B Washout|Did not meet continuation criteria|0|||
33493776|NCT03535194|62872384|FG001|Induction Period|Lack of Efficacy|3|||
33493777|NCT03535194|62872385|FG002|Induction Period|Lack of Efficacy|2|||
33493778|NCT03535194|62872386|FG003|Induction Period|Lack of Efficacy|2|||
33493779|NCT03535194|62872387|FG004|Induction Period|Lack of Efficacy|0|||
33493780|NCT03535194|62872383|FG000|Induction Period|Lost to Follow-up|3|||
33493781|NCT03535194|62872384|FG001|Induction Period|Lost to Follow-up|5|||
33493782|NCT03535194|62872385|FG002|Induction Period|Lost to Follow-up|2|||
33493783|NCT03535194|62872386|FG003|Induction Period|Lost to Follow-up|3|||
33493784|NCT03535194|62872387|FG004|Induction Period|Lost to Follow-up|0|||
33493785|NCT03535194|62872383|FG000|Induction Period|Physician Decision|1|||
33493786|NCT03535194|62872384|FG001|Induction Period|Physician Decision|1|||
33493787|NCT03535194|62872385|FG002|Induction Period|Physician Decision|0|||
33493788|NCT03535194|62872386|FG003|Induction Period|Physician Decision|0|||
33493789|NCT03535194|62872387|FG004|Induction Period|Physician Decision|0|||
33493790|NCT03535194|62872383|FG000|Induction Period|Protocol Violation|1|||
33493791|NCT03535194|62872384|FG001|Induction Period|Protocol Violation|0|||
33493792|NCT03535194|62872385|FG002|Induction Period|Protocol Violation|0|||
33493793|NCT03535194|62872386|FG003|Induction Period|Protocol Violation|1|||
33493794|NCT03535194|62872387|FG004|Induction Period|Protocol Violation|0|||
33493795|NCT03535194|62872383|FG000|Induction Period|Screen Failure|0|||
33493796|NCT03535194|62872384|FG001|Induction Period|Screen Failure|1|||
33493797|NCT03535194|62872385|FG002|Induction Period|Screen Failure|0|||
33493798|NCT03535194|62872386|FG003|Induction Period|Screen Failure|0|||
33493799|NCT03535194|62872387|FG004|Induction Period|Screen Failure|0|||
33493800|NCT03535194|62872383|FG000|Induction Period|Withdrawal by Subject|3|||
33493801|NCT03535194|62872384|FG001|Induction Period|Withdrawal by Subject|4|||
33493802|NCT03535194|62872385|FG002|Induction Period|Withdrawal by Subject|3|||
33493803|NCT03535194|62872386|FG003|Induction Period|Withdrawal by Subject|2|||
33710750|NCT01506882|63277860|FG000|Overall Study|SAE, non-fatal|2|||
33312814|NCT01218204|62688526|FG001|Part B Washout|Did not meet continuation criteria|112|||
33312815|NCT01218204|62688527|FG002|Part B Washout|Did not meet continuation criteria|0|||
33493804|NCT03535194|62872387|FG004|Induction Period|Withdrawal by Subject|0|||
33493805|NCT03535194|62872383|FG000|Maintenance Period|Adverse Event|6|||
33493806|NCT03535194|62872384|FG001|Maintenance Period|Adverse Event|5|||
33493807|NCT03535194|62872385|FG002|Maintenance Period|Adverse Event|1|||
33493808|NCT03535194|62872386|FG003|Maintenance Period|Adverse Event|11|||
33493809|NCT03535194|62872387|FG004|Maintenance Period|Adverse Event|4|||
33493810|NCT03535194|62872383|FG000|Maintenance Period|Lack of Efficacy|3|||
33312816|NCT01218204|62688528|FG003|Part B Washout|Did not meet continuation criteria|0|||
33312817|NCT01218204|62688525|FG000|Part B Run-in|Adverse Event|0|||
33312818|NCT01218204|62688526|FG001|Part B Run-in|Adverse Event|0|||
33312819|NCT01218204|62688527|FG002|Part B Run-in|Adverse Event|1|||
33312820|NCT01218204|62688528|FG003|Part B Run-in|Adverse Event|0|||
33312821|NCT01218204|62688525|FG000|Part B Run-in|Protocol Violation|0|||
33312822|NCT01218204|62688526|FG001|Part B Run-in|Protocol Violation|0|||
33312823|NCT01218204|62688527|FG002|Part B Run-in|Protocol Violation|2|||
33312824|NCT01218204|62688528|FG003|Part B Run-in|Protocol Violation|0|||
33312825|NCT01218204|62688525|FG000|Part B Run-in|Withdrawal by Subject|0|||
33312826|NCT01218204|62688526|FG001|Part B Run-in|Withdrawal by Subject|0|||
33312827|NCT01218204|62688527|FG002|Part B Run-in|Withdrawal by Subject|3|||
33312828|NCT01218204|62688528|FG003|Part B Run-in|Withdrawal by Subject|0|||
33312829|NCT01218204|62688525|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
33312830|NCT01218204|62688526|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
33312831|NCT01218204|62688527|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
33312832|NCT01218204|62688528|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
33312833|NCT01218204|62688525|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
33312834|NCT01218204|62688526|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
33312835|NCT01218204|62688527|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
33312836|NCT01218204|62688528|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
33312837|NCT00926575|62688577|FG000|Overall Study|Adverse Event|1|||
33312838|NCT00926575|62688578|FG001|Overall Study|Adverse Event|1|||
33312839|NCT00926575|62688577|FG000|Overall Study|Death|4|||
33312840|NCT00926575|62688578|FG001|Overall Study|Death|4|||
33312841|NCT00926575|62688577|FG000|Overall Study|Lost to Follow-up|1|||
33312842|NCT00926575|62688578|FG001|Overall Study|Lost to Follow-up|1|||
33312843|NCT00926575|62688577|FG000|Overall Study|Physician Decision|1|||
33312844|NCT00926575|62688578|FG001|Overall Study|Physician Decision|2|||
33312845|NCT00926575|62688577|FG000|Overall Study|Protocol Violation|1|||
33312846|NCT00926575|62688578|FG001|Overall Study|Protocol Violation|0|||
33312847|NCT00926575|62688577|FG000|Overall Study|Withdrawal by Subject|8|||
33312848|NCT00926575|62688578|FG001|Overall Study|Withdrawal by Subject|9|||
33312849|NCT01218126|62688588|FG000|Overall Study|Adverse Event|8|||
33312850|NCT01218126|62688589|FG001|Overall Study|Adverse Event|10|||
33312851|NCT01218126|62688590|FG002|Overall Study|Adverse Event|12|||
33312852|NCT01218126|62688591|FG003|Overall Study|Adverse Event|16|||
33312853|NCT01218126|62688588|FG000|Overall Study|Lack of Efficacy|7|||
33312854|NCT01218126|62688589|FG001|Overall Study|Lack of Efficacy|2|||
33312855|NCT01218126|62688590|FG002|Overall Study|Lack of Efficacy|2|||
33312856|NCT01218126|62688591|FG003|Overall Study|Lack of Efficacy|6|||
33312857|NCT01218126|62688588|FG000|Overall Study|Protocol Violation|5|||
33312858|NCT01218126|62688589|FG001|Overall Study|Protocol Violation|2|||
33312859|NCT01218126|62688590|FG002|Overall Study|Protocol Violation|2|||
33312860|NCT01218126|62688591|FG003|Overall Study|Protocol Violation|3|||
33312861|NCT01218126|62688588|FG000|Overall Study|Protocol-defined stopping criteria|1|||
33312862|NCT01218126|62688589|FG001|Overall Study|Protocol-defined stopping criteria|1|||
33312863|NCT01218126|62688590|FG002|Overall Study|Protocol-defined stopping criteria|0|||
33312864|NCT01218126|62688591|FG003|Overall Study|Protocol-defined stopping criteria|0|||
33312865|NCT01218126|62688588|FG000|Overall Study|Lost to Follow-up|0|||
33312866|NCT01218126|62688589|FG001|Overall Study|Lost to Follow-up|0|||
33312867|NCT01218126|62688590|FG002|Overall Study|Lost to Follow-up|0|||
33312868|NCT01218126|62688591|FG003|Overall Study|Lost to Follow-up|2|||
33312869|NCT01218126|62688588|FG000|Overall Study|Physician Decision|1|||
33312870|NCT01218126|62688589|FG001|Overall Study|Physician Decision|2|||
33312871|NCT01218126|62688590|FG002|Overall Study|Physician Decision|4|||
33312872|NCT01218126|62688591|FG003|Overall Study|Physician Decision|2|||
33312873|NCT01218126|62688588|FG000|Overall Study|Withdrawal by Subject|2|||
33312874|NCT01218126|62688589|FG001|Overall Study|Withdrawal by Subject|5|||
33312875|NCT01218126|62688590|FG002|Overall Study|Withdrawal by Subject|4|||
33312876|NCT01218126|62688591|FG003|Overall Study|Withdrawal by Subject|6|||
33710751|NCT01506882|63277861|FG001|Overall Study|SAE, non-fatal|0|||
33312877|NCT01217892|62688605|FG000|Overall Study|Adverse Event|1|||
33312878|NCT01217892|62688606|FG001|Overall Study|Adverse Event|1|||
33312879|NCT01217892|62688607|FG002|Overall Study|Adverse Event|1|||
33312880|NCT01217892|62688608|FG003|Overall Study|Adverse Event|0|||
33312881|NCT01217892|62688605|FG000|Overall Study|Withdrawal by Subject|0|||
33710752|NCT01506882|63277860|FG000|Overall Study|AE, non-serious non-fatal|3|||
33710753|NCT01506882|63277861|FG001|Overall Study|AE, non-serious non-fatal|1|||
33312882|NCT01217892|62688606|FG001|Overall Study|Withdrawal by Subject|2|||
33312883|NCT01217892|62688607|FG002|Overall Study|Withdrawal by Subject|1|||
33312884|NCT01217892|62688608|FG003|Overall Study|Withdrawal by Subject|0|||
33312885|NCT01217892|62688605|FG000|Overall Study|Lab value|1|||
33312886|NCT01217892|62688606|FG001|Overall Study|Lab value|0|||
33312887|NCT01217892|62688607|FG002|Overall Study|Lab value|1|||
33312888|NCT01217892|62688608|FG003|Overall Study|Lab value|0|||
33312889|NCT01217892|62688605|FG000|Overall Study|Subject no longer meets study criteria|5|||
33312890|NCT01217892|62688606|FG001|Overall Study|Subject no longer meets study criteria|2|||
33312891|NCT01217892|62688607|FG002|Overall Study|Subject no longer meets study criteria|4|||
33312892|NCT01217892|62688608|FG003|Overall Study|Subject no longer meets study criteria|8|||
33312893|NCT01217892|62688605|FG000|Overall Study|Incorrect enrollment|0|||
33312894|NCT01217892|62688606|FG001|Overall Study|Incorrect enrollment|1|||
33312895|NCT01217892|62688607|FG002|Overall Study|Incorrect enrollment|1|||
33312896|NCT01217892|62688608|FG003|Overall Study|Incorrect enrollment|0|||
33312897|NCT01217892|62688605|FG000|Overall Study|Poor/Non-Compliance|0|||
33312898|NCT01217892|62688606|FG001|Overall Study|Poor/Non-Compliance|0|||
33312899|NCT01217892|62688607|FG002|Overall Study|Poor/Non-Compliance|1|||
33312900|NCT01217892|62688608|FG003|Overall Study|Poor/Non-Compliance|0|||
33312901|NCT01217814|62688621|FG000|Overall Study|Adverse Event|1|||
33312902|NCT01217814|62688622|FG001|Overall Study|Adverse Event|1|||
33312903|NCT01217814|62688623|FG002|Overall Study|Adverse Event|0|||
33312904|NCT01217814|62688621|FG000|Overall Study|Lack of Efficacy|0|||
33312905|NCT01217814|62688622|FG001|Overall Study|Lack of Efficacy|0|||
33312906|NCT01217814|62688623|FG002|Overall Study|Lack of Efficacy|1|||
33312907|NCT01217190|62688634|FG000|Second Dosing|Withdrawal by Subject|0|||
33312908|NCT01217190|62688635|FG001|Second Dosing|Withdrawal by Subject|2|||
33312909|NCT01136733|62688651|FG000|Phase 1b|Adverse Event|0|||
33312910|NCT01136733|62688652|FG001|Phase 1b|Adverse Event|3|||
33312911|NCT01136733|62688653|FG002|Phase 1b|Adverse Event|1|||
33312912|NCT01136733|62688654|FG003|Phase 1b|Adverse Event|0|||
33312913|NCT01136733|62688655|FG004|Phase 1b|Adverse Event|0|||
33312914|NCT01136733|62688656|FG005|Phase 1b|Adverse Event|0|||
33710754|NCT01506882|63277860|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
33710755|NCT01506882|63277861|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
33710756|NCT01506882|63277860|FG000|Overall Study|Other Reason|2|||
33710757|NCT01506882|63277861|FG001|Overall Study|Other Reason|0|||
33710758|NCT01506726|63277871|FG000|Overall Study|Adverse Event|1|||
33710759|NCT01506726|63277872|FG001|Overall Study|Adverse Event|2|||
33710760|NCT01505868|63277883|FG000|Overall Study|Withdrawal by Subject|1|||
33710761|NCT01505868|63277884|FG001|Overall Study|Withdrawal by Subject|0|||
33710762|NCT01505868|63277885|FG002|Overall Study|Withdrawal by Subject|0|||
33710763|NCT01505868|63277886|FG003|Overall Study|Withdrawal by Subject|0|||
33710764|NCT01505868|63277887|FG004|Overall Study|Withdrawal by Subject|0|||
33710765|NCT01505634|63277902|FG000|Overall Study|Withdrawal by Subject|2|||
33710766|NCT01505634|63277903|FG001|Overall Study|Withdrawal by Subject|5|||
33710767|NCT01505634|63277904|FG002|Overall Study|Withdrawal by Subject|1|||
33710768|NCT01505634|63277902|FG000|Overall Study|Physician Decision|1|||
33710769|NCT01505634|63277903|FG001|Overall Study|Physician Decision|1|||
33710770|NCT01505634|63277904|FG002|Overall Study|Physician Decision|0|||
33710771|NCT01505634|63277902|FG000|Overall Study|Adverse Event|1|||
33710772|NCT01505634|63277903|FG001|Overall Study|Adverse Event|0|||
33710773|NCT01505634|63277904|FG002|Overall Study|Adverse Event|0|||
33710774|NCT01505634|63277902|FG000|Overall Study|Insufficient supply of drug at site|1|||
33710775|NCT01505634|63277903|FG001|Overall Study|Insufficient supply of drug at site|0|||
33710776|NCT01505634|63277904|FG002|Overall Study|Insufficient supply of drug at site|0|||
33710777|NCT01505634|63277902|FG000|Overall Study|Protocol Violation|2|||
33710778|NCT01505634|63277903|FG001|Overall Study|Protocol Violation|0|||
33710779|NCT01505634|63277904|FG002|Overall Study|Protocol Violation|0|||
33710780|NCT01505634|63277902|FG000|Overall Study|Lost to Follow-up|1|||
33710781|NCT01505634|63277903|FG001|Overall Study|Lost to Follow-up|4|||
33710782|NCT01505634|63277904|FG002|Overall Study|Lost to Follow-up|4|||
33710783|NCT01505634|63277902|FG000|Overall Study|Death|1|||
33710784|NCT01505634|63277903|FG001|Overall Study|Death|0|||
33710785|NCT01505634|63277904|FG002|Overall Study|Death|0|||
33710786|NCT01505634|63277902|FG000|Overall Study|In a conflict zone|0|||
33312915|NCT01136733|62688657|FG006|Phase 1b|Adverse Event|0|||
33312916|NCT01136733|62688651|FG000|Phase 1b|Participant Choice|0|||
33312917|NCT01136733|62688652|FG001|Phase 1b|Participant Choice|0|||
33312918|NCT01136733|62688653|FG002|Phase 1b|Participant Choice|1|||
33312919|NCT01136733|62688654|FG003|Phase 1b|Participant Choice|0|||
33312920|NCT01136733|62688655|FG004|Phase 1b|Participant Choice|0|||
33710787|NCT01505634|63277903|FG001|Overall Study|In a conflict zone|0|||
33710788|NCT01505634|63277904|FG002|Overall Study|In a conflict zone|1|||
33312921|NCT01136733|62688656|FG005|Phase 1b|Participant Choice|0|||
33312922|NCT01136733|62688657|FG006|Phase 1b|Participant Choice|0|||
33597427|NCT01905592|62996380|FG001|Overall Study|Physician Decision|2|||
33312923|NCT01136733|62688651|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
33312924|NCT01136733|62688652|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
33312925|NCT01136733|62688653|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
33312926|NCT01136733|62688654|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
33312927|NCT01136733|62688655|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
33312928|NCT01136733|62688656|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
33312929|NCT01136733|62688657|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
33312930|NCT01136733|62688651|FG000|Phase 1b|Clinical Progression|1|||
33312931|NCT01136733|62688652|FG001|Phase 1b|Clinical Progression|1|||
33312932|NCT01136733|62688653|FG002|Phase 1b|Clinical Progression|0|||
33312933|NCT01136733|62688654|FG003|Phase 1b|Clinical Progression|0|||
33312934|NCT01136733|62688655|FG004|Phase 1b|Clinical Progression|0|||
33312935|NCT01136733|62688656|FG005|Phase 1b|Clinical Progression|0|||
33312936|NCT01136733|62688657|FG006|Phase 1b|Clinical Progression|0|||
33312937|NCT01136733|62688651|FG000|Phase 2|Disease Progression|0|||
33312938|NCT01136733|62688652|FG001|Phase 2|Disease Progression|0|||
33312939|NCT01136733|62688653|FG002|Phase 2|Disease Progression|0|||
33312940|NCT01136733|62688654|FG003|Phase 2|Disease Progression|0|||
33312941|NCT01136733|62688655|FG004|Phase 2|Disease Progression|30|||
33312942|NCT01136733|62688656|FG005|Phase 2|Disease Progression|32|||
33312943|NCT01136733|62688657|FG006|Phase 2|Disease Progression|38|||
33312944|NCT01136733|62688651|FG000|Phase 2|Adverse Event|0|||
33312945|NCT01136733|62688652|FG001|Phase 2|Adverse Event|0|||
33312946|NCT01136733|62688653|FG002|Phase 2|Adverse Event|0|||
33312947|NCT01136733|62688654|FG003|Phase 2|Adverse Event|0|||
33312948|NCT01136733|62688655|FG004|Phase 2|Adverse Event|11|||
33312949|NCT01136733|62688656|FG005|Phase 2|Adverse Event|13|||
33312950|NCT01136733|62688657|FG006|Phase 2|Adverse Event|5|||
33312951|NCT01136733|62688651|FG000|Phase 2|Participant Choice|0|||
33312952|NCT01136733|62688652|FG001|Phase 2|Participant Choice|0|||
33312953|NCT01136733|62688653|FG002|Phase 2|Participant Choice|0|||
33312954|NCT01136733|62688654|FG003|Phase 2|Participant Choice|0|||
33312955|NCT01136733|62688655|FG004|Phase 2|Participant Choice|3|||
33312956|NCT01136733|62688656|FG005|Phase 2|Participant Choice|0|||
33312957|NCT01136733|62688657|FG006|Phase 2|Participant Choice|1|||
33312958|NCT01136733|62688651|FG000|Phase 2|Administrative-Withdrew Consent|0|||
33312959|NCT01136733|62688652|FG001|Phase 2|Administrative-Withdrew Consent|0|||
33312960|NCT01136733|62688653|FG002|Phase 2|Administrative-Withdrew Consent|0|||
33493811|NCT03535194|62872384|FG001|Maintenance Period|Lack of Efficacy|2|||
33493812|NCT03535194|62872385|FG002|Maintenance Period|Lack of Efficacy|5|||
33493813|NCT03535194|62872386|FG003|Maintenance Period|Lack of Efficacy|9|||
33493814|NCT03535194|62872387|FG004|Maintenance Period|Lack of Efficacy|0|||
33493815|NCT03535194|62872383|FG000|Maintenance Period|Lost to Follow-up|4|||
33493816|NCT03535194|62872384|FG001|Maintenance Period|Lost to Follow-up|2|||
33493817|NCT03535194|62872385|FG002|Maintenance Period|Lost to Follow-up|1|||
33493818|NCT03535194|62872386|FG003|Maintenance Period|Lost to Follow-up|5|||
33493819|NCT03535194|62872387|FG004|Maintenance Period|Lost to Follow-up|2|||
33597428|NCT01905592|62996379|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
33312961|NCT01136733|62688654|FG003|Phase 2|Administrative-Withdrew Consent|0|||
33312962|NCT01136733|62688655|FG004|Phase 2|Administrative-Withdrew Consent|1|||
33312963|NCT01136733|62688656|FG005|Phase 2|Administrative-Withdrew Consent|0|||
33312964|NCT01136733|62688657|FG006|Phase 2|Administrative-Withdrew Consent|0|||
33312965|NCT01136733|62688651|FG000|Phase 2|Other|0|||
33312966|NCT01136733|62688652|FG001|Phase 2|Other|0|||
33312967|NCT01136733|62688653|FG002|Phase 2|Other|0|||
33312968|NCT01136733|62688654|FG003|Phase 2|Other|0|||
33312969|NCT01136733|62688655|FG004|Phase 2|Other|6|||
33312970|NCT01136733|62688656|FG005|Phase 2|Other|7|||
33312971|NCT01136733|62688657|FG006|Phase 2|Other|6|||
33312972|NCT01136655|62688687|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
33312973|NCT01136655|62688687|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
33312974|NCT01136655|62688687|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
33312975|NCT01136655|62688687|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
33312976|NCT01135017|62688702|FG000|Overall Study|Adverse Event|3|||
33312977|NCT01135017|62688703|FG001|Overall Study|Adverse Event|8|||
33312978|NCT01135017|62688702|FG000|Overall Study|Other than above|3|||
33312979|NCT01135017|62688703|FG001|Overall Study|Other than above|4|||
33493820|NCT03535194|62872383|FG000|Maintenance Period|Other|1|||
33493821|NCT03535194|62872384|FG001|Maintenance Period|Other|2|||
33493822|NCT03535194|62872385|FG002|Maintenance Period|Other|0|||
33493823|NCT03535194|62872386|FG003|Maintenance Period|Other|0|||
33493824|NCT03535194|62872387|FG004|Maintenance Period|Other|0|||
33493825|NCT03535194|62872383|FG000|Maintenance Period|Physician Decision|1|||
33493826|NCT03535194|62872384|FG001|Maintenance Period|Physician Decision|2|||
33493827|NCT03535194|62872385|FG002|Maintenance Period|Physician Decision|0|||
33493828|NCT03535194|62872386|FG003|Maintenance Period|Physician Decision|2|||
33493829|NCT03535194|62872387|FG004|Maintenance Period|Physician Decision|0|||
33493830|NCT03535194|62872383|FG000|Maintenance Period|Pregnancy|0|||
33597429|NCT01905592|62996380|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
33597430|NCT01905592|62996379|FG000|Overall Study|Protocol Violation|0|||
33597431|NCT01905592|62996380|FG001|Overall Study|Protocol Violation|1|||
33312980|NCT01134939|62688717|FG000|Overall Study|Adverse Event|9|||
33312981|NCT01134939|62688718|FG001|Overall Study|Adverse Event|3|||
33312982|NCT01134939|62688719|FG002|Overall Study|Adverse Event|4|||
33312983|NCT01134939|62688720|FG003|Overall Study|Adverse Event|5|||
33312984|NCT01134939|62688721|FG004|Overall Study|Adverse Event|5|||
33312985|NCT01134939|62688722|FG005|Overall Study|Adverse Event|5|||
33710789|NCT01460628|63277912|FG000|Overall Study|Adverse Event|3|||
33710790|NCT01460628|63277912|FG000|Overall Study|Withdrawal by Subject|2|||
33710791|NCT01480596|63277918|FG000|Overall Study|Adverse Event|3|||
33710792|NCT01480596|63277919|FG001|Overall Study|Adverse Event|0|||
33710793|NCT01480596|63277918|FG000|Overall Study|MG exacerbation or change in medication|2|||
33710794|NCT01480596|63277919|FG001|Overall Study|MG exacerbation or change in medication|2|||
33710795|NCT01480284|63277927|FG000|Overall Study|Withdrawal by Subject|2|||
33710796|NCT01480284|63277928|FG001|Overall Study|Withdrawal by Subject|0|||
33710797|NCT01480284|63277927|FG000|Overall Study|Adverse Event|1|||
33710798|NCT01480284|63277928|FG001|Overall Study|Adverse Event|0|||
33710799|NCT01480284|63277927|FG000|Overall Study|Study closed/terminated|3|||
33710800|NCT01480284|63277928|FG001|Overall Study|Study closed/terminated|0|||
33710801|NCT01480284|63277927|FG000|Overall Study|Lost to Follow-up|1|||
33710802|NCT01480284|63277928|FG001|Overall Study|Lost to Follow-up|0|||
33710803|NCT01480284|63277927|FG000|Overall Study|Physician Decision|1|||
33710804|NCT01480284|63277928|FG001|Overall Study|Physician Decision|0|||
33710805|NCT01459614|63277936|FG000|Overall Study|Adverse Event|1|||
33710806|NCT01459614|63277937|FG001|Overall Study|Adverse Event|0|||
33710807|NCT01459068|63277945|FG000|Overall Study|Withdrawal by Subject|8|||
33710808|NCT01459068|63277946|FG001|Overall Study|Withdrawal by Subject|18|||
33710809|NCT01459068|63277945|FG000|Overall Study|Lost to Follow-up|31|||
33710810|NCT01459068|63277946|FG001|Overall Study|Lost to Follow-up|15|||
33312986|NCT01134939|62688723|FG006|Overall Study|Adverse Event|1|||
33312987|NCT01134939|62688724|FG007|Overall Study|Adverse Event|0|||
33312988|NCT01134939|62688717|FG000|Overall Study|Lack of Efficacy|2|||
33312989|NCT01134939|62688718|FG001|Overall Study|Lack of Efficacy|5|||
33312990|NCT01134939|62688719|FG002|Overall Study|Lack of Efficacy|1|||
33597432|NCT01905592|62996379|FG000|Overall Study|Sponsor's decision|1|||
33710811|NCT01459068|63277945|FG000|Overall Study|Death|0|||
33710812|NCT01459068|63277946|FG001|Overall Study|Death|1|||
33312991|NCT01134939|62688720|FG003|Overall Study|Lack of Efficacy|0|||
33312992|NCT01134939|62688721|FG004|Overall Study|Lack of Efficacy|3|||
33312993|NCT01134939|62688722|FG005|Overall Study|Lack of Efficacy|0|||
33312994|NCT01134939|62688723|FG006|Overall Study|Lack of Efficacy|1|||
33312995|NCT01134939|62688724|FG007|Overall Study|Lack of Efficacy|0|||
33312996|NCT01134939|62688717|FG000|Overall Study|Lost to Follow-up|2|||
33312997|NCT01134939|62688718|FG001|Overall Study|Lost to Follow-up|3|||
33312998|NCT01134939|62688719|FG002|Overall Study|Lost to Follow-up|0|||
33312999|NCT01134939|62688720|FG003|Overall Study|Lost to Follow-up|1|||
33313000|NCT01134939|62688721|FG004|Overall Study|Lost to Follow-up|2|||
33313001|NCT01134939|62688722|FG005|Overall Study|Lost to Follow-up|1|||
33313002|NCT01134939|62688723|FG006|Overall Study|Lost to Follow-up|0|||
33313003|NCT01134939|62688724|FG007|Overall Study|Lost to Follow-up|0|||
33313004|NCT01134939|62688717|FG000|Overall Study|Death|0|||
33313005|NCT01134939|62688718|FG001|Overall Study|Death|1|||
33313006|NCT01134939|62688719|FG002|Overall Study|Death|0|||
33313007|NCT01134939|62688720|FG003|Overall Study|Death|0|||
33313008|NCT01134939|62688721|FG004|Overall Study|Death|0|||
33313009|NCT01134939|62688722|FG005|Overall Study|Death|0|||
33493831|NCT03535194|62872384|FG001|Maintenance Period|Pregnancy|0|||
33710813|NCT01458522|63277954|FG000|Overall Study|Withdrawal by Subject|2|||
33710814|NCT01458522|63277955|FG001|Overall Study|Withdrawal by Subject|2|||
33313010|NCT01134939|62688723|FG006|Overall Study|Death|0|||
33313011|NCT01134939|62688724|FG007|Overall Study|Death|0|||
33313012|NCT01134939|62688717|FG000|Overall Study|Termination page not available|4|||
33313013|NCT01134939|62688718|FG001|Overall Study|Termination page not available|6|||
33493832|NCT03535194|62872385|FG002|Maintenance Period|Pregnancy|0|||
33493833|NCT03535194|62872386|FG003|Maintenance Period|Pregnancy|2|||
33493834|NCT03535194|62872387|FG004|Maintenance Period|Pregnancy|0|||
33597433|NCT01905592|62996380|FG001|Overall Study|Sponsor's decision|1|||
33710815|NCT01458522|63277954|FG000|Overall Study|Physician Decision|1|||
33313014|NCT01134939|62688719|FG002|Overall Study|Termination page not available|5|||
33313015|NCT01134939|62688720|FG003|Overall Study|Termination page not available|8|||
33313016|NCT01134939|62688721|FG004|Overall Study|Termination page not available|0|||
33313017|NCT01134939|62688722|FG005|Overall Study|Termination page not available|3|||
33313018|NCT01134939|62688723|FG006|Overall Study|Termination page not available|7|||
33313019|NCT01134939|62688724|FG007|Overall Study|Termination page not available|0|||
33313020|NCT01134783|62688740|FG000|Overall Study|Pregnancy|16|||
33313021|NCT01134783|62688741|FG001|Overall Study|Pregnancy|8|||
33313022|NCT01134783|62688740|FG000|Overall Study|Withdrawal by Subject|15|||
33313023|NCT01134783|62688741|FG001|Overall Study|Withdrawal by Subject|9|||
33313024|NCT01134783|62688740|FG000|Overall Study|Lost to Follow-up|5|||
33313025|NCT01134783|62688741|FG001|Overall Study|Lost to Follow-up|20|||
33313026|NCT01134705|62688753|FG000|Overall Study|Adverse Event|1|||
33313027|NCT01134705|62688754|FG001|Overall Study|Adverse Event|7|||
33313028|NCT01134705|62688753|FG000|Overall Study|Withdrawal by Subject|6|||
33313029|NCT01134705|62688754|FG001|Overall Study|Withdrawal by Subject|6|||
33313030|NCT01134705|62688753|FG000|Overall Study|Pregnancy|1|||
33313031|NCT01134705|62688754|FG001|Overall Study|Pregnancy|0|||
33313032|NCT01134705|62688753|FG000|Overall Study|Lost to Follow-up|5|||
33313033|NCT01134705|62688754|FG001|Overall Study|Lost to Follow-up|2|||
33313034|NCT01134705|62688753|FG000|Overall Study|Protocol Violation|1|||
33313035|NCT01134705|62688754|FG001|Overall Study|Protocol Violation|1|||
33313036|NCT01134705|62688753|FG000|Overall Study|Other|1|||
33313037|NCT01134705|62688754|FG001|Overall Study|Other|6|||
33313038|NCT00927823|62688760|FG000|Continuous Dosing Period|Death|0|||
33313039|NCT00927823|62688761|FG001|Continuous Dosing Period|Death|0|||
33313040|NCT00927823|62688762|FG002|Continuous Dosing Period|Death|6|||
33313041|NCT00927823|62688763|FG003|Continuous Dosing Period|Death|0|||
33313042|NCT00927823|62688760|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
33313043|NCT00927823|62688761|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
33313044|NCT00927823|62688762|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
33313045|NCT00927823|62688763|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
33313046|NCT00927823|62688760|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
33313047|NCT00927823|62688761|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
33313048|NCT00927823|62688762|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
33313049|NCT00927823|62688763|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
33313050|NCT00927823|62688760|FG000|Continuous Dosing Period|Other|1|||
33313051|NCT00927823|62688761|FG001|Continuous Dosing Period|Other|2|||
33313052|NCT00927823|62688762|FG002|Continuous Dosing Period|Other|9|||
33313053|NCT00927823|62688763|FG003|Continuous Dosing Period|Other|3|||
33313054|NCT01134627|62688782|FG000|Overall Study|Adverse Event|47|||
33313055|NCT01134627|62688783|FG001|Overall Study|Adverse Event|31|||
33313056|NCT01134627|62688782|FG000|Overall Study|Lost to Follow-up|1|||
33313057|NCT01134627|62688783|FG001|Overall Study|Lost to Follow-up|2|||
33313058|NCT01134627|62688782|FG000|Overall Study|Protocol Violation|3|||
33313059|NCT01134627|62688783|FG001|Overall Study|Protocol Violation|5|||
33313060|NCT01134627|62688782|FG000|Overall Study|Lack of Efficacy|2|||
33313061|NCT01134627|62688783|FG001|Overall Study|Lack of Efficacy|12|||
33313062|NCT01134627|62688782|FG000|Overall Study|Withdrawal by Subject|4|||
33313063|NCT01134627|62688783|FG001|Overall Study|Withdrawal by Subject|3|||
33313064|NCT01134627|62688782|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
33313065|NCT01134627|62688783|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
33313066|NCT01134627|62688782|FG000|Overall Study|Other|11|||
33313067|NCT01134627|62688783|FG001|Overall Study|Other|14|||
33313068|NCT01134393|62688789|FG000|Overall Study|Adverse Event|18|||
33313069|NCT01134393|62688789|FG000|Overall Study|Lack of Efficacy|2|||
33313070|NCT01134393|62688789|FG000|Overall Study|Protocol Violation|12|||
33313071|NCT01134393|62688789|FG000|Overall Study|Lost to Follow-up|3|||
33313072|NCT01134393|62688789|FG000|Overall Study|Withdrawal by Subject|11|||
33313073|NCT01134393|62688789|FG000|Overall Study|Other|6|||
33313074|NCT00922441|62688797|FG000|Overall Study|Protocol Violation|0|||
33313075|NCT00922441|62688798|FG001|Overall Study|Protocol Violation|0|||
33313076|NCT00922441|62688799|FG002|Overall Study|Protocol Violation|2|||
33313077|NCT00922441|62688797|FG000|Overall Study|Withdrawal by Subject|0|||
33313078|NCT00922441|62688798|FG001|Overall Study|Withdrawal by Subject|0|||
33313079|NCT00922441|62688799|FG002|Overall Study|Withdrawal by Subject|1|||
33313080|NCT01217112|62688812|FG000|Overall Study|Adverse Event|0|||
33313081|NCT01217112|62688813|FG001|Overall Study|Adverse Event|2|||
33313082|NCT01217112|62688814|FG002|Overall Study|Adverse Event|0|||
33313083|NCT01217112|62688815|FG003|Overall Study|Adverse Event|2|||
33313084|NCT01217112|62688816|FG004|Overall Study|Adverse Event|0|||
33313085|NCT01217112|62688812|FG000|Overall Study|Withdrawal by Subject|0|||
33313086|NCT01217112|62688813|FG001|Overall Study|Withdrawal by Subject|0|||
33313087|NCT01217112|62688814|FG002|Overall Study|Withdrawal by Subject|1|||
33313088|NCT01217112|62688815|FG003|Overall Study|Withdrawal by Subject|0|||
33313089|NCT01217112|62688816|FG004|Overall Study|Withdrawal by Subject|0|||
33313090|NCT01217112|62688812|FG000|Overall Study|Physician Decision|0|||
33313091|NCT01217112|62688813|FG001|Overall Study|Physician Decision|0|||
33313092|NCT01217112|62688814|FG002|Overall Study|Physician Decision|0|||
33313093|NCT01217112|62688815|FG003|Overall Study|Physician Decision|0|||
33313094|NCT01217112|62688816|FG004|Overall Study|Physician Decision|1|||
33313095|NCT01216332|62688830|FG000|Overall Study|Withdrawal by Subject|4|||
33313096|NCT01216332|62688831|FG001|Overall Study|Withdrawal by Subject|0|||
33313097|NCT00922207|62688840|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
33313098|NCT00922207|62688841|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
33313099|NCT00922207|62688842|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
33313100|NCT00922207|62688840|FG000|Overall Study|Insufficient Therapeutic Response|0|||
33313101|NCT00922207|62688841|FG001|Overall Study|Insufficient Therapeutic Response|0|||
33313102|NCT00922207|62688842|FG002|Overall Study|Insufficient Therapeutic Response|1|||
33313103|NCT00922207|62688840|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
33313104|NCT00922207|62688841|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
33313105|NCT00922207|62688842|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
33313106|NCT00922207|62688840|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
33313107|NCT00922207|62688841|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
33313108|NCT00922207|62688842|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
33313109|NCT00922207|62688840|FG000|Overall Study|Withdrew Consent|2|||
33313110|NCT00922207|62688841|FG001|Overall Study|Withdrew Consent|5|||
33313111|NCT00922207|62688842|FG002|Overall Study|Withdrew Consent|2|||
33313112|NCT00922207|62688840|FG000|Overall Study|Abnormality of Laboratory Test|0|||
33313113|NCT00922207|62688841|FG001|Overall Study|Abnormality of Laboratory Test|1|||
33313114|NCT00922207|62688842|FG002|Overall Study|Abnormality of Laboratory Test|1|||
33313115|NCT01134315|62688852|FG000|Overall Study|Adverse Event|1|||
33313116|NCT01134315|62688853|FG001|Overall Study|Adverse Event|2|||
33313117|NCT01134315|62688852|FG000|Overall Study|Other Reason|8|||
33313118|NCT01134315|62688853|FG001|Overall Study|Other Reason|17|||
33313119|NCT01216176|62688862|FG000|Overall Study|Adverse Event|0|||
33313120|NCT01216176|62688863|FG001|Overall Study|Adverse Event|8|||
33313121|NCT01216176|62688864|FG002|Overall Study|Adverse Event|0|||
33313122|NCT01216176|62688862|FG000|Overall Study|Physician Decision|0|||
33313123|NCT01216176|62688863|FG001|Overall Study|Physician Decision|0|||
33313124|NCT01216176|62688864|FG002|Overall Study|Physician Decision|1|||
33313125|NCT01133847|62688876|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
33313126|NCT01133847|62688877|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
33313127|NCT01133847|62688878|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
33313128|NCT01133847|62688876|FG000|Follow-Up Phase|Lost to Follow-up|1|||
33313129|NCT01133847|62688877|FG001|Follow-Up Phase|Lost to Follow-up|3|||
33313130|NCT01133847|62688878|FG002|Follow-Up Phase|Lost to Follow-up|7|||
33313131|NCT01133379|62688890|FG000|Overall Study|Withdrawal by Subject|0|||
33313132|NCT01133379|62688891|FG001|Overall Study|Withdrawal by Subject|1|||
33313133|NCT01133379|62688892|FG002|Overall Study|Withdrawal by Subject|1|||
33313134|NCT01133379|62688890|FG000|Overall Study|Lost to Follow-up|1|||
33313135|NCT01133379|62688891|FG001|Overall Study|Lost to Follow-up|1|||
33313136|NCT01133379|62688892|FG002|Overall Study|Lost to Follow-up|1|||
33313137|NCT01133067|62688900|FG000|Overall Study|Death|136|||
33313138|NCT01133067|62688900|FG000|Overall Study|Lost to Follow-up|3|||
33313139|NCT01132755|62688904|FG000|Overall Study|Procedure not done due to medical reason|23|||
33313140|NCT01132755|62688904|FG000|Overall Study|Protocol Violation|15|||
33313141|NCT01132755|62688904|FG000|Overall Study|Withdrawal by Subject|4|||
33313142|NCT00919711|62688910|FG000|Overall Study|Withdrawal by Subject|15|||
33313143|NCT00919711|62688911|FG001|Overall Study|Withdrawal by Subject|7|||
33313144|NCT00919711|62688910|FG000|Overall Study|Adverse Event|13|||
33313145|NCT00919711|62688911|FG001|Overall Study|Adverse Event|3|||
33313146|NCT00919711|62688910|FG000|Overall Study|Other|1|||
33313147|NCT00919711|62688911|FG001|Overall Study|Other|2|||
33313148|NCT00919711|62688910|FG000|Overall Study|Administrative Decision|0|||
33313149|NCT00919711|62688911|FG001|Overall Study|Administrative Decision|1|||
33313150|NCT00919711|62688910|FG000|Overall Study|Lost to Follow-up|2|||
33313151|NCT00919711|62688911|FG001|Overall Study|Lost to Follow-up|0|||
33313152|NCT00919711|62688910|FG000|Overall Study|Death|1|||
33313153|NCT00919711|62688911|FG001|Overall Study|Death|0|||
33313154|NCT00919711|62688910|FG000|Overall Study|Noncompliance|1|||
33313155|NCT00919711|62688911|FG001|Overall Study|Noncompliance|0|||
33313156|NCT01131585|62688919|FG000|Overall Study|Adverse Event|0|||
33313157|NCT01131585|62688920|FG001|Overall Study|Adverse Event|2|||
33313158|NCT01131585|62688919|FG000|Overall Study|Abnormal laboratory value|1|||
33597434|NCT01905592|62996379|FG000|Overall Study|Not treated|7|||
33597435|NCT01905592|62996380|FG001|Overall Study|Not treated|3|||
33313159|NCT01131585|62688920|FG001|Overall Study|Abnormal laboratory value|0|||
33313160|NCT01131585|62688919|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33313161|NCT01131585|62688920|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33313162|NCT01131585|62688919|FG000|Overall Study|Protocol Violation|2|||
33313163|NCT01131585|62688920|FG001|Overall Study|Protocol Violation|1|||
33313164|NCT01131585|62688919|FG000|Overall Study|Withdrawal by Subject|3|||
33313165|NCT01131585|62688920|FG001|Overall Study|Withdrawal by Subject|3|||
33597436|NCT01905592|62996379|FG000|Overall Study|Withdrawal by Subject|10|||
33313166|NCT01131585|62688919|FG000|Overall Study|Lost to Follow-up|0|||
33313167|NCT01131585|62688920|FG001|Overall Study|Lost to Follow-up|1|||
33313168|NCT01131585|62688919|FG000|Overall Study|Administrative problems|1|||
33313169|NCT01131585|62688920|FG001|Overall Study|Administrative problems|1|||
33313170|NCT01131585|62688919|FG000|Overall Study|Study termination|78|||
33313171|NCT01131585|62688920|FG001|Overall Study|Study termination|32|||
33313172|NCT01131507|62688926|FG000|Overall Study|Adverse Event|1|||
33313173|NCT01131507|62688926|FG000|Overall Study|Lost to Follow-up|1|||
33313174|NCT01131507|62688926|FG000|Overall Study|Withdrawal by Subject|1|||
33313175|NCT01131351|62688932|FG000|Overall Study|Adverse Event|0|||
33313176|NCT01131351|62688933|FG001|Overall Study|Adverse Event|2|||
33313177|NCT01131351|62688932|FG000|Overall Study|Protocol Deviation|0|||
33313178|NCT01131351|62688933|FG001|Overall Study|Protocol Deviation|1|||
33313179|NCT00919633|62688943|FG000|Overall Study|Adverse Event|1|||
33313180|NCT00919633|62688944|FG001|Overall Study|Adverse Event|9|||
33313181|NCT00919633|62688945|FG002|Overall Study|Adverse Event|12|||
33313182|NCT00919633|62688946|FG003|Overall Study|Adverse Event|10|||
33313183|NCT00919633|62688943|FG000|Overall Study|Death|0|||
33313184|NCT00919633|62688944|FG001|Overall Study|Death|0|||
33313185|NCT00919633|62688945|FG002|Overall Study|Death|2|||
33313186|NCT00919633|62688946|FG003|Overall Study|Death|0|||
33313187|NCT00919633|62688943|FG000|Overall Study|Lack of Efficacy|17|||
33313188|NCT00919633|62688944|FG001|Overall Study|Lack of Efficacy|3|||
33313189|NCT00919633|62688945|FG002|Overall Study|Lack of Efficacy|2|||
33313190|NCT00919633|62688946|FG003|Overall Study|Lack of Efficacy|3|||
33313191|NCT00919633|62688943|FG000|Overall Study|Withdrawal by Subject|1|||
33313192|NCT00919633|62688944|FG001|Overall Study|Withdrawal by Subject|2|||
33710816|NCT01458522|63277955|FG001|Overall Study|Physician Decision|9|||
33710817|NCT01505010|63277969|FG000|Overall Study|Protocol Violation|0|||
33710818|NCT01505010|63277970|FG001|Overall Study|Protocol Violation|1|||
33710819|NCT01505010|63277969|FG000|Overall Study|Lost to Follow-up|0|||
33710820|NCT01505010|63277970|FG001|Overall Study|Lost to Follow-up|1|||
33710821|NCT01458366|63277981|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
33710822|NCT01458366|63277982|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
33710823|NCT01458366|63277983|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
33710824|NCT01458366|63277984|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
33710825|NCT01458366|63277985|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
33710826|NCT01458366|63277981|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
33710827|NCT01458366|63277982|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
33710828|NCT01458366|63277983|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
33710829|NCT01458366|63277984|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
33710830|NCT01458366|63277985|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
33710831|NCT01458210|63277993|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
33313193|NCT00919633|62688945|FG002|Overall Study|Withdrawal by Subject|4|||
33313194|NCT00919633|62688946|FG003|Overall Study|Withdrawal by Subject|3|||
33313195|NCT00919633|62688943|FG000|Overall Study|Lost to Follow-up|3|||
33313196|NCT00919633|62688944|FG001|Overall Study|Lost to Follow-up|1|||
33313197|NCT00919633|62688945|FG002|Overall Study|Lost to Follow-up|0|||
33313198|NCT00919633|62688946|FG003|Overall Study|Lost to Follow-up|2|||
33313199|NCT00919633|62688943|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
33313200|NCT00919633|62688944|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
33710832|NCT01458210|63277993|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
33710833|NCT01458210|63277993|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
33710834|NCT01458210|63277993|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
33710835|NCT01478958|63278003|FG000|Overall Study|Withdrawal by Subject|1|||
33710836|NCT01478958|63278004|FG001|Overall Study|Withdrawal by Subject|1|||
33710837|NCT01478958|63278005|FG002|Overall Study|Withdrawal by Subject|1|||
33710838|NCT01478958|63278003|FG000|Overall Study|Weight loss|1|||
33710839|NCT01478958|63278004|FG001|Overall Study|Weight loss|0|||
33710840|NCT01478958|63278005|FG002|Overall Study|Weight loss|0|||
33710841|NCT01478958|63278003|FG000|Overall Study|Re-located|0|||
33710842|NCT01478958|63278004|FG001|Overall Study|Re-located|1|||
33710843|NCT01478958|63278005|FG002|Overall Study|Re-located|0|||
33710844|NCT01478958|63278003|FG000|Overall Study|Unable to comply|0|||
33710845|NCT01478958|63278004|FG001|Overall Study|Unable to comply|0|||
33710846|NCT01478958|63278005|FG002|Overall Study|Unable to comply|2|||
33710847|NCT01458132|63278015|FG000|Overall Study|Other|15|||
33710848|NCT01458132|63278016|FG001|Overall Study|Other|3|||
33710849|NCT01457352|63278024|FG000|Period 1|Adverse Event|2|||
33710850|NCT01457352|63278025|FG001|Period 1|Adverse Event|0|||
33710851|NCT01457352|63278024|FG000|Period 1|Withdrawal by Subject|2|||
33710852|NCT01457352|63278025|FG001|Period 1|Withdrawal by Subject|0|||
33710853|NCT01457352|63278024|FG000|Period 1|Physician Decision|2|||
33710854|NCT01457352|63278025|FG001|Period 1|Physician Decision|0|||
33710855|NCT01457352|63278024|FG000|Period 1|MS related disease progression|1|||
33710856|NCT01457352|63278025|FG001|Period 1|MS related disease progression|0|||
33710857|NCT01457352|63278024|FG000|Period 1|Withdrawn|1|||
33710858|NCT01457352|63278025|FG001|Period 1|Withdrawn|0|||
33313201|NCT00919633|62688945|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
33313202|NCT00919633|62688946|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
33313203|NCT00919633|62688943|FG000|Overall Study|Protocol Violation|0|||
33313204|NCT00919633|62688944|FG001|Overall Study|Protocol Violation|0|||
33313205|NCT00919633|62688945|FG002|Overall Study|Protocol Violation|0|||
33313206|NCT00919633|62688946|FG003|Overall Study|Protocol Violation|1|||
33313207|NCT00919633|62688943|FG000|Overall Study|Physician Decision|0|||
33313208|NCT00919633|62688944|FG001|Overall Study|Physician Decision|0|||
33313209|NCT00919633|62688945|FG002|Overall Study|Physician Decision|0|||
33313210|NCT00919633|62688946|FG003|Overall Study|Physician Decision|1|||
33313211|NCT00919633|62688943|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
33313212|NCT00919633|62688944|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
33313213|NCT00919633|62688945|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
33313214|NCT00919633|62688946|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
33313215|NCT00919633|62688943|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
33313216|NCT00919633|62688944|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
33313217|NCT00919633|62688945|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
33313218|NCT00919633|62688946|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
33313219|NCT01130883|62688956|FG000|Overall Study|Patient Noncompliance|6|||
33313220|NCT01130883|62688956|FG000|Overall Study|Reason Unknown|1|||
33313221|NCT01130883|62688956|FG000|Overall Study|Adverse Event|3|||
33313222|NCT00926029|62688963|FG000|Overall Study|Lost to Follow-up|2|||
33313223|NCT00926029|62688964|FG001|Overall Study|Lost to Follow-up|1|||
33313224|NCT00926029|62688965|FG002|Overall Study|Lost to Follow-up|1|||
33313225|NCT01130493|62688975|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
33313226|NCT01130493|62688976|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
33313227|NCT01130493|62688977|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
33313228|NCT01130493|62688975|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
33313229|NCT01130493|62688976|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
33313230|NCT01130493|62688977|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
33313231|NCT01130493|62688975|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
33313232|NCT01130493|62688976|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
33313233|NCT01130493|62688977|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
33313234|NCT01130493|62688975|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
33313235|NCT01130493|62688976|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
33313236|NCT01130493|62688977|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
33313237|NCT01130493|62688975|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
33313238|NCT01130493|62688976|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
33313239|NCT01130493|62688977|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
33313240|NCT01130493|62688975|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
33313241|NCT01130493|62688976|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
33313242|NCT01130493|62688977|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
33313243|NCT01130493|62688975|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
33313244|NCT01130493|62688976|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
33313245|NCT01130493|62688977|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
33313246|NCT01130493|62688975|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
33313247|NCT01130493|62688976|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
33313248|NCT01130493|62688977|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
33313249|NCT01130493|62688975|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
33313250|NCT01130493|62688976|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
33313251|NCT01130493|62688977|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
33313252|NCT01130493|62688975|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
33313253|NCT01130493|62688976|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
33313254|NCT01130493|62688977|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
33313255|NCT01130493|62688975|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
33313256|NCT01130493|62688976|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
33313257|NCT01130493|62688977|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
33313258|NCT01130493|62688975|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
33313259|NCT01130493|62688976|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
33313260|NCT01130493|62688977|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
33313261|NCT01130493|62688975|FG000|Part 2: OLE|Adverse Event|0|||
33313262|NCT01130493|62688976|FG001|Part 2: OLE|Adverse Event|2|||
33313263|NCT01130493|62688977|FG002|Part 2: OLE|Adverse Event|1|||
33313264|NCT01130493|62688975|FG000|Part 2: OLE|Withdrawal by Subject|0|||
33313265|NCT01130493|62688976|FG001|Part 2: OLE|Withdrawal by Subject|1|||
33313266|NCT01130493|62688977|FG002|Part 2: OLE|Withdrawal by Subject|4|||
33313267|NCT01130337|62688988|FG000|Overall Study|Withdrawal by Subject|3|||
33313268|NCT01130337|62688988|FG000|Overall Study|Principal investigator decision|1|||
33313269|NCT01130337|62688988|FG000|Overall Study|Death|1|||
33313270|NCT01130337|62688988|FG000|Overall Study|Disease progression|1|||
33313271|NCT01130337|62688988|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
33313272|NCT01130337|62688988|FG000|Overall Study|Surgical resection (R2)|1|||
33313273|NCT01130103|62688994|FG000|Randomized Treatment|Adverse Event|1|||
33313274|NCT01130103|62688995|FG001|Randomized Treatment|Adverse Event|1|||
33313275|NCT01130103|62688994|FG000|Randomized Treatment|Lost to Follow-up|1|||
33313276|NCT01130103|62688995|FG001|Randomized Treatment|Lost to Follow-up|0|||
33313277|NCT01130103|62688994|FG000|Randomized Treatment|Protocol Violation|3|||
33313278|NCT01130103|62688995|FG001|Randomized Treatment|Protocol Violation|2|||
33710859|NCT01457352|63278024|FG000|Period 1|withdrew per sponsor|1|||
33710860|NCT01457352|63278025|FG001|Period 1|withdrew per sponsor|0|||
33710861|NCT01457352|63278024|FG000|Period 1|Protocol Violation|4|||
33710862|NCT01457352|63278025|FG001|Period 1|Protocol Violation|0|||
33710863|NCT01457352|63278024|FG000|Period 1|Did not meet eligibility criteria|3|||
33710864|NCT01457352|63278025|FG001|Period 1|Did not meet eligibility criteria|0|||
33710865|NCT01457352|63278024|FG000|Period 2|Withdrawal by Subject|23|||
33710866|NCT01457352|63278025|FG001|Period 2|Withdrawal by Subject|0|||
33710867|NCT01457352|63278024|FG000|Period 2|Adverse Event|22|||
33710868|NCT01457352|63278025|FG001|Period 2|Adverse Event|0|||
33710869|NCT01457352|63278024|FG000|Period 2|no analysis|10|||
33313279|NCT01130103|62688994|FG000|Randomized Treatment|Withdrawal by Subject|1|||
33313280|NCT01130103|62688995|FG001|Randomized Treatment|Withdrawal by Subject|2|||
33313281|NCT01130103|62688994|FG000|Maintenance Treatment|Lack of Efficacy|0|||
33313282|NCT01130103|62688995|FG001|Maintenance Treatment|Lack of Efficacy|1|||
33313283|NCT01130103|62688994|FG000|Maintenance Treatment|Lost to Follow-up|1|||
33313284|NCT01130103|62688995|FG001|Maintenance Treatment|Lost to Follow-up|1|||
33313285|NCT01130103|62688994|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
33313286|NCT01130103|62688995|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
33313287|NCT01129557|62689004|FG000|Overall Study|Adverse Event|1|||
33313288|NCT01129557|62689005|FG001|Overall Study|Adverse Event|2|||
33313289|NCT01129557|62689006|FG002|Overall Study|Adverse Event|2|||
33313290|NCT01129557|62689004|FG000|Overall Study|Novartis terminated study early|3|||
33313291|NCT01129557|62689005|FG001|Overall Study|Novartis terminated study early|3|||
33313292|NCT01129557|62689006|FG002|Overall Study|Novartis terminated study early|2|||
33313293|NCT01129011|62689027|FG000|Overall Study|Adverse Event|20|||
33313294|NCT01129011|62689028|FG001|Overall Study|Adverse Event|30|||
33313295|NCT01129011|62689027|FG000|Overall Study|Withdrawal by Subject|24|||
33313296|NCT01129011|62689028|FG001|Overall Study|Withdrawal by Subject|8|||
33313297|NCT01129011|62689027|FG000|Overall Study|Lost to Follow-up|6|||
33313298|NCT01129011|62689028|FG001|Overall Study|Lost to Follow-up|7|||
33313299|NCT01129011|62689027|FG000|Overall Study|Duodenal Ulcer|2|||
33313300|NCT01129011|62689028|FG001|Overall Study|Duodenal Ulcer|8|||
33313301|NCT01129011|62689027|FG000|Overall Study|misc|7|||
33313302|NCT01129011|62689028|FG001|Overall Study|misc|4|||
33313303|NCT00919867|62689040|FG000|First Intervention|Withdrawal by Subject|0|||
33313304|NCT00919867|62689041|FG001|First Intervention|Withdrawal by Subject|0|||
33313305|NCT00919867|62689042|FG002|First Intervention|Withdrawal by Subject|1|||
33313306|NCT00919867|62689043|FG003|First Intervention|Withdrawal by Subject|0|||
33313307|NCT00919867|62689044|FG004|First Intervention|Withdrawal by Subject|0|||
33313308|NCT00919867|62689045|FG005|First Intervention|Withdrawal by Subject|0|||
33313309|NCT00919867|62689040|FG000|First Intervention|Physician Decision|0|||
33313310|NCT00919867|62689041|FG001|First Intervention|Physician Decision|0|||
33313311|NCT00919867|62689042|FG002|First Intervention|Physician Decision|0|||
33313312|NCT00919867|62689043|FG003|First Intervention|Physician Decision|0|||
33313313|NCT00919867|62689044|FG004|First Intervention|Physician Decision|0|||
33313314|NCT00919867|62689045|FG005|First Intervention|Physician Decision|1|||
33313315|NCT01215942|62689055|FG000|Treatment Period|Adverse Event|15|||
33313316|NCT01215942|62689056|FG001|Treatment Period|Adverse Event|26|||
33313317|NCT01215942|62689055|FG000|Treatment Period|Death|2|||
33313318|NCT01215942|62689056|FG001|Treatment Period|Death|4|||
33313319|NCT01215942|62689055|FG000|Treatment Period|Lack of Efficacy|23|||
33313320|NCT01215942|62689056|FG001|Treatment Period|Lack of Efficacy|62|||
33710870|NCT01457352|63278025|FG001|Period 2|no analysis|0|||
33710871|NCT01457352|63278024|FG000|Period 2|Lack of Efficacy|8|||
33313321|NCT01215942|62689055|FG000|Treatment Period|Lost to Follow-up|3|||
33313322|NCT01215942|62689056|FG001|Treatment Period|Lost to Follow-up|4|||
33313323|NCT01215942|62689055|FG000|Treatment Period|Withdrawal by Subject|17|||
33710872|NCT01457352|63278025|FG001|Period 2|Lack of Efficacy|0|||
33710873|NCT01457352|63278024|FG000|Period 2|Protocol Violation|4|||
33710874|NCT01457352|63278025|FG001|Period 2|Protocol Violation|0|||
33710875|NCT01457352|63278024|FG000|Period 2|Sponsor's withdrawal|7|||
33710876|NCT01457352|63278025|FG001|Period 2|Sponsor's withdrawal|0|||
33710877|NCT01457352|63278024|FG000|Period 2|Lost to Follow-up|1|||
33710878|NCT01457352|63278025|FG001|Period 2|Lost to Follow-up|0|||
33710879|NCT01457352|63278024|FG000|Period 2|dose change|1|||
33710880|NCT01457352|63278025|FG001|Period 2|dose change|0|||
33710881|NCT01457352|63278024|FG000|Period 2|Physician Decision|1|||
33313324|NCT01215942|62689056|FG001|Treatment Period|Withdrawal by Subject|40|||
33313325|NCT01215942|62689055|FG000|Treatment Period|Physician Decision|5|||
33313326|NCT01215942|62689056|FG001|Treatment Period|Physician Decision|5|||
33313327|NCT01215942|62689055|FG000|Treatment Period|Protocol Violation|0|||
33313328|NCT01215942|62689056|FG001|Treatment Period|Protocol Violation|1|||
33313329|NCT01215942|62689055|FG000|Treatment Period|Sponsor Decision|349|||
33313330|NCT01215942|62689056|FG001|Treatment Period|Sponsor Decision|530|||
33313331|NCT01215942|62689055|FG000|Post-Treatment Follow-Up Period|Death|0|||
33313332|NCT01215942|62689056|FG001|Post-Treatment Follow-Up Period|Death|1|||
33313333|NCT01215942|62689055|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
33313334|NCT01215942|62689056|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
33313335|NCT01215942|62689055|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
33313336|NCT01215942|62689056|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
33313337|NCT01215942|62689055|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
33313338|NCT01215942|62689056|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
33313339|NCT01215942|62689055|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
33313340|NCT01215942|62689056|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
33313341|NCT01128621|62689075|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
33313342|NCT01128621|62689076|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
33313343|NCT00918463|62689098|FG000|Overall Study|Death|1|||
33313344|NCT00918463|62689098|FG000|Overall Study|Lack of Efficacy|1|||
33313345|NCT01128543|62689102|FG000|Overall Study|Withdrawal by Subject|3|||
33313346|NCT01128543|62689102|FG000|Overall Study|Protocol Violation|1|||
33313347|NCT01128387|62689108|FG000|Overall Study|Physician Decision|0|||
33313348|NCT01128387|62689109|FG001|Overall Study|Physician Decision|1|||
33313349|NCT01214850|62689118|FG000|Overall Study|Withdrawal by Subject|38|||
33313350|NCT01214850|62689119|FG001|Overall Study|Withdrawal by Subject|31|||
33313351|NCT01214850|62689120|FG002|Overall Study|Withdrawal by Subject|28|||
33313352|NCT01214850|62689118|FG000|Overall Study|Lost to Follow-up|124|||
33313353|NCT01214850|62689119|FG001|Overall Study|Lost to Follow-up|98|||
33710882|NCT01457352|63278025|FG001|Period 2|Physician Decision|0|||
33710883|NCT01457352|63278024|FG000|Period 2|Did not meet eligibility criteria|3|||
33710884|NCT01457352|63278025|FG001|Period 2|Did not meet eligibility criteria|0|||
33710885|NCT01457352|63278024|FG000|Period 3|Adverse Event|1|||
33313354|NCT01214850|62689120|FG002|Overall Study|Lost to Follow-up|123|||
33710886|NCT01457352|63278025|FG001|Period 3|Adverse Event|1|||
33710887|NCT01457352|63278024|FG000|Period 3|Withdrawal by Subject|0|||
33710888|NCT01457352|63278025|FG001|Period 3|Withdrawal by Subject|2|||
33710889|NCT01457352|63278024|FG000|Period 3|incorrect treatment|0|||
33710890|NCT01457352|63278025|FG001|Period 3|incorrect treatment|1|||
33710891|NCT01457352|63278024|FG000|Period 3|Sponsor's withdrawal|0|||
33710892|NCT01457352|63278025|FG001|Period 3|Sponsor's withdrawal|1|||
33710893|NCT01457118|63278039|FG000|Overall Study|Adverse Event|1|||
33710894|NCT01457118|63278040|FG001|Overall Study|Adverse Event|0|||
33710895|NCT01457118|63278041|FG002|Overall Study|Adverse Event|0|||
33710896|NCT01457118|63278042|FG003|Overall Study|Adverse Event|1|||
33710897|NCT01457118|63278039|FG000|Overall Study|Clinical Progression|0|||
33710898|NCT01457118|63278040|FG001|Overall Study|Clinical Progression|1|||
33710899|NCT01457118|63278041|FG002|Overall Study|Clinical Progression|0|||
33710900|NCT01457118|63278042|FG003|Overall Study|Clinical Progression|1|||
33710901|NCT01457118|63278039|FG000|Overall Study|Physician Decision|2|||
33710902|NCT01457118|63278040|FG001|Overall Study|Physician Decision|0|||
33710903|NCT01457118|63278041|FG002|Overall Study|Physician Decision|0|||
33710904|NCT01457118|63278042|FG003|Overall Study|Physician Decision|0|||
33710905|NCT01457118|63278039|FG000|Overall Study|Progressive Disease by RECIST|12|||
33710906|NCT01457118|63278040|FG001|Overall Study|Progressive Disease by RECIST|3|||
33710907|NCT01457118|63278041|FG002|Overall Study|Progressive Disease by RECIST|1|||
33710908|NCT01457118|63278042|FG003|Overall Study|Progressive Disease by RECIST|0|||
33710909|NCT01457118|63278039|FG000|Overall Study|Withdrawal by Subject|5|||
33710910|NCT01457118|63278040|FG001|Overall Study|Withdrawal by Subject|0|||
33710911|NCT01457118|63278041|FG002|Overall Study|Withdrawal by Subject|0|||
33710912|NCT01457118|63278042|FG003|Overall Study|Withdrawal by Subject|0|||
33710913|NCT01456962|63278054|FG000|Overall Study|Lost to Follow-up|2|||
33710914|NCT01456962|63278055|FG001|Overall Study|Lost to Follow-up|1|||
33710915|NCT01501110|63278063|FG000|Overall Study|Death|0|||
33710916|NCT01501110|63278064|FG001|Overall Study|Death|1|||
33710917|NCT01500720|63278072|FG000|Overall Study|Randomized But Not Treated|1|||
33710918|NCT01500720|63278073|FG001|Overall Study|Randomized But Not Treated|1|||
33710919|NCT01500720|63278072|FG000|Overall Study|Other|4|||
33710920|NCT01500720|63278073|FG001|Overall Study|Other|8|||
33710921|NCT01500252|63278081|FG000|Overall Study|Death|4|||
33313355|NCT01214850|62689118|FG000|Overall Study|Protocol Violation|5|||
33313356|NCT01214850|62689119|FG001|Overall Study|Protocol Violation|5|||
33313357|NCT01214850|62689120|FG002|Overall Study|Protocol Violation|6|||
33313358|NCT01214850|62689118|FG000|Overall Study|Adverse event or death|11|||
33313359|NCT01214850|62689119|FG001|Overall Study|Adverse event or death|8|||
33313360|NCT01214850|62689120|FG002|Overall Study|Adverse event or death|3|||
33313361|NCT01214850|62689118|FG000|Overall Study|Inappropriate enrollment|2|||
33313362|NCT01214850|62689119|FG001|Overall Study|Inappropriate enrollment|1|||
33313363|NCT01214850|62689120|FG002|Overall Study|Inappropriate enrollment|0|||
33313364|NCT01214850|62689118|FG000|Overall Study|Administrative reason|1|||
33313365|NCT01214850|62689119|FG001|Overall Study|Administrative reason|0|||
33313366|NCT01214850|62689120|FG002|Overall Study|Administrative reason|0|||
33313367|NCT01214850|62689118|FG000|Overall Study|Unable to classify|2|||
33313368|NCT01214850|62689119|FG001|Overall Study|Unable to classify|1|||
33313369|NCT01214850|62689120|FG002|Overall Study|Unable to classify|1|||
33313370|NCT01128153|62689133|FG000|Overall Study|Adverse Event|1|||
33313371|NCT01128153|62689134|FG001|Overall Study|Adverse Event|3|||
33313372|NCT01128153|62689133|FG000|Overall Study|Condition under investigation worsened|8|||
33313373|NCT01128153|62689134|FG001|Overall Study|Condition under investigation worsened|7|||
33313374|NCT01128153|62689133|FG000|Overall Study|Withdrawal by Subject|2|||
33313375|NCT01128153|62689134|FG001|Overall Study|Withdrawal by Subject|3|||
33313376|NCT01128153|62689133|FG000|Overall Study|Incorrect enrolment to study|2|||
33313377|NCT01128153|62689134|FG001|Overall Study|Incorrect enrolment to study|1|||
33313378|NCT01128153|62689133|FG000|Overall Study|Protocol Violation|2|||
33313379|NCT01128153|62689134|FG001|Overall Study|Protocol Violation|0|||
33313380|NCT01128153|62689133|FG000|Overall Study|Developed discontinuation criteria|1|||
33313381|NCT01128153|62689134|FG001|Overall Study|Developed discontinuation criteria|1|||
33710922|NCT01500252|63278082|FG001|Overall Study|Death|2|||
33710923|NCT01500252|63278081|FG000|Overall Study|Lost to Follow-up|5|||
33710924|NCT01500252|63278082|FG001|Overall Study|Lost to Follow-up|4|||
33710925|NCT01476696|63278089|FG000|Overall Study|Sponsor decision|2|||
33313382|NCT00925015|62689143|FG000|Overall Study|Adverse Event|1|||
33313383|NCT00925015|62689144|FG001|Overall Study|Adverse Event|2|||
33710926|NCT01476696|63278090|FG001|Overall Study|Sponsor decision|1|||
33710927|NCT01476696|63278091|FG002|Overall Study|Sponsor decision|0|||
33313384|NCT00925015|62689145|FG002|Overall Study|Adverse Event|1|||
33710928|NCT01476696|63278089|FG000|Overall Study|Withdrawal by Subject|1|||
33710929|NCT01476696|63278090|FG001|Overall Study|Withdrawal by Subject|0|||
33710930|NCT01476696|63278091|FG002|Overall Study|Withdrawal by Subject|0|||
33710931|NCT01500096|63278108|FG000|Overall Study|Lost to Follow-up|1|||
33710932|NCT01500096|63278109|FG001|Overall Study|Lost to Follow-up|0|||
33710933|NCT01500096|63278110|FG002|Overall Study|Lost to Follow-up|0|||
33597437|NCT01905592|62996380|FG001|Overall Study|Withdrawal by Subject|2|||
33597438|NCT01876420|62996386|FG000|Overall Study|Missed 30 day visit|1|||
33597439|NCT01875874|62996390|FG000|Overall Study|Death|3|||
33597440|NCT02500121|62996397|FG000|Overall Study|Lost to Follow-up|0|||
33597441|NCT02500121|62996398|FG001|Overall Study|Lost to Follow-up|1|||
33597442|NCT02500121|62996397|FG000|Overall Study|Withdrawal by Subject|1|||
33597443|NCT02500121|62996398|FG001|Overall Study|Withdrawal by Subject|1|||
33597444|NCT02500121|62996397|FG000|Overall Study|Death|26|||
33597445|NCT02500121|62996398|FG001|Overall Study|Death|24|||
33597446|NCT01875250|62996408|FG000|Overall Study|Adverse Event|2|||
33597447|NCT01875250|62996409|FG001|Overall Study|Adverse Event|0|||
33597448|NCT01904032|62996419|FG000|Overall Study|Adverse Event|3|||
33597449|NCT01904032|62996420|FG001|Overall Study|Adverse Event|1|||
33597450|NCT01904032|62996419|FG000|Overall Study|Lost to Follow-up|4|||
33313385|NCT00925015|62689143|FG000|Overall Study|Physician Decision|0|||
33313386|NCT00925015|62689144|FG001|Overall Study|Physician Decision|1|||
33313387|NCT00925015|62689145|FG002|Overall Study|Physician Decision|0|||
33313388|NCT00925015|62689143|FG000|Overall Study|Progressive Disease|7|||
33313389|NCT00925015|62689144|FG001|Overall Study|Progressive Disease|3|||
33313390|NCT00925015|62689145|FG002|Overall Study|Progressive Disease|4|||
33313391|NCT00925015|62689143|FG000|Overall Study|Withdrawal by Subject|0|||
33313392|NCT00925015|62689144|FG001|Overall Study|Withdrawal by Subject|0|||
33313393|NCT00925015|62689145|FG002|Overall Study|Withdrawal by Subject|1|||
33313394|NCT01127763|62689157|FG000|Overall Study|Adverse Event|2|||
33313395|NCT01127763|62689157|FG000|Overall Study|Withdrawal by Subject|1|||
33313396|NCT01127763|62689157|FG000|Overall Study|Physician Decision|2|||
33313397|NCT01127607|62689167|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
33313398|NCT01127607|62689168|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
33313399|NCT01127607|62689167|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
33313400|NCT01127607|62689168|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
33313401|NCT00924781|62689195|FG000|Overall Study|Study terminated by sponsor|12|||
33313402|NCT00924781|62689196|FG001|Overall Study|Study terminated by sponsor|10|||
33313403|NCT01127451|62689214|FG000|Overall Study|Other|2|||
33313404|NCT01127451|62689215|FG001|Overall Study|Other|1|||
33313405|NCT01127451|62689214|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
33313406|NCT01127451|62689215|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
33313407|NCT01127451|62689214|FG000|Overall Study|Death|22|||
33313408|NCT01127451|62689215|FG001|Overall Study|Death|17|||
33313409|NCT01127451|62689214|FG000|Overall Study|Lost to Follow-up|3|||
33313410|NCT01127451|62689215|FG001|Overall Study|Lost to Follow-up|0|||
33313411|NCT01127451|62689214|FG000|Overall Study|Administrative Reason by Sponsor|2|||
33313412|NCT01127451|62689215|FG001|Overall Study|Administrative Reason by Sponsor|2|||
33313413|NCT01127373|62689221|FG000|Overall Study|Not Treated|3|||
33313414|NCT01127373|62689221|FG000|Overall Study|Lost to Follow-up|7|||
33313415|NCT01127373|62689221|FG000|Overall Study|Withdrawal by Subject|1|||
33313416|NCT01127373|62689221|FG000|Overall Study|Disease progression|1|||
33313417|NCT01127139|62689225|FG000|Overall Study|Adverse Event|40|||
33313418|NCT01127139|62689225|FG000|Overall Study|Incompliance|12|||
33313419|NCT01127139|62689225|FG000|Overall Study|Lack of Efficacy|4|||
33313420|NCT01127139|62689225|FG000|Overall Study|Reason not specified|1|||
33313421|NCT01214616|62689236|FG000|Overall Study|Progressive disease|2|||
33313422|NCT01214616|62689237|FG001|Overall Study|Progressive disease|2|||
33313423|NCT01214616|62689238|FG002|Overall Study|Progressive disease|2|||
33313424|NCT01214616|62689239|FG003|Overall Study|Progressive disease|4|||
33313425|NCT01214616|62689236|FG000|Overall Study|Dose limiting toxicity|0|||
33313426|NCT01214616|62689237|FG001|Overall Study|Dose limiting toxicity|2|||
33313427|NCT01214616|62689238|FG002|Overall Study|Dose limiting toxicity|0|||
33313428|NCT01214616|62689239|FG003|Overall Study|Dose limiting toxicity|0|||
33313429|NCT01214616|62689236|FG000|Overall Study|Other adverse events|0|||
33313430|NCT01214616|62689237|FG001|Overall Study|Other adverse events|1|||
33313431|NCT01214616|62689238|FG002|Overall Study|Other adverse events|1|||
33313432|NCT01214616|62689239|FG003|Overall Study|Other adverse events|1|||
33313433|NCT01214616|62689236|FG000|Overall Study|Withdrawal by Subject|1|||
33313434|NCT01214616|62689237|FG001|Overall Study|Withdrawal by Subject|0|||
33313435|NCT01214616|62689238|FG002|Overall Study|Withdrawal by Subject|0|||
33597451|NCT01904032|62996420|FG001|Overall Study|Lost to Follow-up|2|||
33313436|NCT01214616|62689239|FG003|Overall Study|Withdrawal by Subject|1|||
33313437|NCT01213836|62689259|FG000|Period 1, First Intervention|Adverse Event|2|||
33313438|NCT01213836|62689260|FG001|Period 1, First Intervention|Adverse Event|1|||
33313439|NCT01213836|62689259|FG000|Period 1, First Intervention|Protocol Violation|0|||
33313440|NCT01213836|62689260|FG001|Period 1, First Intervention|Protocol Violation|1|||
33313441|NCT01213836|62689259|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
33710934|NCT01500096|63278111|FG003|Overall Study|Lost to Follow-up|2|||
33313442|NCT01213836|62689260|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
33313443|NCT01127061|62689271|FG000|Overall Study|Lost to Follow-up|7|||
33597452|NCT01903876|62996428|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
33597453|NCT01903876|62996429|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
33313444|NCT01127061|62689272|FG001|Overall Study|Lost to Follow-up|10|||
33313445|NCT01127061|62689271|FG000|Overall Study|Physician Decision|3|||
33313446|NCT01127061|62689272|FG001|Overall Study|Physician Decision|3|||
33313447|NCT00924703|62689278|FG000|Overall Study|Withdrawal by Subject|11|||
33313448|NCT00924703|62689278|FG000|Overall Study|Physician Decision|5|||
33313449|NCT00924703|62689278|FG000|Overall Study|Lost to Follow-up|3|||
33313450|NCT00924703|62689278|FG000|Overall Study|Adverse Event|2|||
33313451|NCT00924703|62689278|FG000|Overall Study|Withdrawal by Sponsor|1|||
33313452|NCT01213524|62689284|FG000|Baseline|Withdrawal by Subject|5|||
33313453|NCT01213524|62689284|FG000|Baseline|high breath alcohol levels|1|||
33313454|NCT01213524|62689284|FG000|Baseline|Physician Decision|1|||
33313455|NCT01213524|62689284|FG000|Session 2|Withdrawal by Subject|5|||
33313456|NCT01213524|62689284|FG000|Session 3|Withdrawal by Subject|4|||
33313457|NCT01213524|62689284|FG000|Session 4|Physician Decision|1|||
33313458|NCT01213524|62689284|FG000|Session 4|Withdrawal by Subject|2|||
33313459|NCT01212744|62689295|FG000|Overall Study|Withdrawal by Subject|1|||
33313460|NCT01212588|62689303|FG000|Overall Study|Physician Decision|0|||
33313461|NCT01212588|62689304|FG001|Overall Study|Physician Decision|1|||
33313462|NCT01212588|62689303|FG000|Overall Study|Protocol Violation|1|||
33313463|NCT01212588|62689304|FG001|Overall Study|Protocol Violation|1|||
33313464|NCT00918385|62689312|FG000|Monotherapy|Adverse Event|1|||
33313465|NCT00918385|62689313|FG001|Monotherapy|Adverse Event|6|||
33313466|NCT00918385|62689312|FG000|Monotherapy|Complicating illness|1|||
33313467|NCT00918385|62689313|FG001|Monotherapy|Complicating illness|0|||
33313468|NCT00918385|62689312|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
33313469|NCT00918385|62689313|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
33313470|NCT00918385|62689312|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
33597454|NCT01903876|62996428|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
33313471|NCT00918385|62689313|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
33313472|NCT00918385|62689312|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
33313473|NCT00918385|62689313|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
33313474|NCT00918385|62689312|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
33313475|NCT00918385|62689313|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
33313476|NCT01211262|62689323|FG000|Overall Study|Progressive Disease|18|||
33313477|NCT01211262|62689324|FG001|Overall Study|Progressive Disease|9|||
33313478|NCT01211262|62689323|FG000|Overall Study|Adverse Event|4|||
33313479|NCT01211262|62689324|FG001|Overall Study|Adverse Event|0|||
33313480|NCT01211262|62689323|FG000|Overall Study|Withdrawal of Consent|1|||
33313481|NCT01211262|62689324|FG001|Overall Study|Withdrawal of Consent|0|||
33313482|NCT01211262|62689323|FG000|Overall Study|Other|0|||
33313483|NCT01211262|62689324|FG001|Overall Study|Other|1|||
33313484|NCT01211184|62689336|FG000|Overall Study|Withdrawal by Subject|0|||
33597455|NCT01903876|62996429|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
33597456|NCT01921348|62996437|FG000|Overall Study|Withdrawal by Subject|1|||
33597457|NCT01921348|62996438|FG001|Overall Study|Withdrawal by Subject|0|||
33597458|NCT01921348|62996437|FG000|Overall Study|Lost to Follow-up|0|||
33597459|NCT01921348|62996438|FG001|Overall Study|Lost to Follow-up|2|||
33597460|NCT01921270|62996444|FG000|Overall Study|Withdrawal by Subject|1|||
33597461|NCT02325739|62996459|FG000|Phase I Part|Adverse Event|1|||
33597462|NCT02325739|62996460|FG001|Phase I Part|Adverse Event|0|||
33597463|NCT02325739|62996461|FG002|Phase I Part|Adverse Event|1|||
33597464|NCT02325739|62996462|FG003|Phase I Part|Adverse Event|2|||
33597465|NCT02325739|62996463|FG004|Phase I Part|Adverse Event|3|||
33597466|NCT02325739|62996464|FG005|Phase I Part|Adverse Event|1|||
33597467|NCT02325739|62996465|FG006|Phase I Part|Adverse Event|0|||
33597468|NCT02325739|62996466|FG007|Phase I Part|Adverse Event|2|||
33597469|NCT02325739|62996467|FG008|Phase I Part|Adverse Event|0|||
33597470|NCT02325739|62996468|FG009|Phase I Part|Adverse Event|0|||
33597471|NCT02325739|62996469|FG010|Phase I Part|Adverse Event|0|||
33313485|NCT01211184|62689337|FG001|Overall Study|Withdrawal by Subject|2|||
33313486|NCT01211184|62689338|FG002|Overall Study|Withdrawal by Subject|1|||
33313487|NCT00924469|62689351|FG000|Overall Study|Adverse Event|2|||
33313488|NCT00924469|62689352|FG001|Overall Study|Adverse Event|0|||
33313489|NCT00924469|62689351|FG000|Overall Study|Withdrawal by Subject|0|||
33313490|NCT00924469|62689352|FG001|Overall Study|Withdrawal by Subject|1|||
33313491|NCT00924469|62689351|FG000|Overall Study|Lost to Follow-up|0|||
33313492|NCT00924469|62689352|FG001|Overall Study|Lost to Follow-up|1|||
33313493|NCT00924313|62689358|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
33597472|NCT02325739|62996459|FG000|Phase I Part|Progressive disease|9|||
33597473|NCT02325739|62996460|FG001|Phase I Part|Progressive disease|6|||
33597474|NCT02325739|62996461|FG002|Phase I Part|Progressive disease|3|||
33710935|NCT01455012|63278123|FG000|Overall Study|Adverse Event|0|||
33313494|NCT01209780|62689366|FG000|Overall Study|Adverse Event|0|||
33313495|NCT01209780|62689367|FG001|Overall Study|Adverse Event|1|||
33313496|NCT01209780|62689368|FG002|Overall Study|Adverse Event|0|||
33597475|NCT02325739|62996462|FG003|Phase I Part|Progressive disease|23|||
33597476|NCT02325739|62996463|FG004|Phase I Part|Progressive disease|14|||
33597477|NCT02325739|62996464|FG005|Phase I Part|Progressive disease|6|||
33597478|NCT02325739|62996465|FG006|Phase I Part|Progressive disease|6|||
33597479|NCT02325739|62996466|FG007|Phase I Part|Progressive disease|3|||
33710936|NCT01455012|63278124|FG001|Overall Study|Adverse Event|2|||
33710937|NCT01455012|63278123|FG000|Overall Study|Lack of Efficacy|6|||
33710938|NCT01455012|63278124|FG001|Overall Study|Lack of Efficacy|1|||
33710939|NCT01455012|63278123|FG000|Overall Study|Withdrawal by Subject|3|||
33710940|NCT01455012|63278124|FG001|Overall Study|Withdrawal by Subject|1|||
33710941|NCT01455012|63278123|FG000|Overall Study|Unknown reason|2|||
33313497|NCT01209780|62689369|FG003|Overall Study|Adverse Event|0|||
33313498|NCT01209780|62689370|FG004|Overall Study|Adverse Event|0|||
33313499|NCT01209780|62689366|FG000|Overall Study|Withdrawal by Subject|9|||
33313500|NCT01209780|62689367|FG001|Overall Study|Withdrawal by Subject|2|||
33313501|NCT01209780|62689368|FG002|Overall Study|Withdrawal by Subject|1|||
33313502|NCT01209780|62689369|FG003|Overall Study|Withdrawal by Subject|1|||
33313503|NCT01209780|62689370|FG004|Overall Study|Withdrawal by Subject|0|||
33313504|NCT01209780|62689366|FG000|Overall Study|Lost to Follow-up|17|||
33313505|NCT01209780|62689367|FG001|Overall Study|Lost to Follow-up|12|||
33313506|NCT01209780|62689368|FG002|Overall Study|Lost to Follow-up|3|||
33313507|NCT01209780|62689369|FG003|Overall Study|Lost to Follow-up|9|||
33313508|NCT01209780|62689370|FG004|Overall Study|Lost to Follow-up|4|||
33313509|NCT01209780|62689366|FG000|Overall Study|Protocol Violation|0|||
33313510|NCT01209780|62689367|FG001|Overall Study|Protocol Violation|1|||
33313511|NCT01209780|62689368|FG002|Overall Study|Protocol Violation|0|||
33313512|NCT01209780|62689369|FG003|Overall Study|Protocol Violation|0|||
33313513|NCT01209780|62689370|FG004|Overall Study|Protocol Violation|0|||
33313514|NCT01209780|62689366|FG000|Overall Study|Inappropriate enrollment|0|||
33313515|NCT01209780|62689367|FG001|Overall Study|Inappropriate enrollment|2|||
33313516|NCT01209780|62689368|FG002|Overall Study|Inappropriate enrollment|0|||
33313517|NCT01209780|62689369|FG003|Overall Study|Inappropriate enrollment|0|||
33313518|NCT01209780|62689370|FG004|Overall Study|Inappropriate enrollment|1|||
33313519|NCT00916357|62689383|FG000|Period 1|Withdrawal by Subject|1|||
33313520|NCT00916357|62689384|FG001|Period 1|Withdrawal by Subject|0|||
33313521|NCT00916357|62689385|FG002|Period 1|Withdrawal by Subject|0|||
33313522|NCT00916357|62689386|FG003|Period 1|Withdrawal by Subject|0|||
33313523|NCT00916357|62689387|FG004|Period 1|Withdrawal by Subject|0|||
33313524|NCT00916357|62689388|FG005|Period 1|Withdrawal by Subject|0|||
33401563|NCT00730925|62780574|FG000|Overall Study|Withdrawal by Subject|1|||
33401564|NCT00730925|62780574|FG000|Overall Study|Switch to combination therapy|8|||
33401565|NCT00730925|62780574|FG000|Overall Study|Other|1|||
33401566|NCT00236899|62780582|FG000|Overall Study|Adverse Event (Study Related)|1|||
33401567|NCT00236899|62780583|FG001|Overall Study|Adverse Event (Study Related)|1|||
33401568|NCT00236899|62780584|FG002|Overall Study|Adverse Event (Study Related)|2|||
33401569|NCT00236899|62780585|FG003|Overall Study|Adverse Event (Study Related)|1|||
33401570|NCT00236899|62780582|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
33401571|NCT00236899|62780583|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
33401572|NCT00236899|62780584|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
33401573|NCT00236899|62780585|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
33401574|NCT00236899|62780582|FG000|Overall Study|Death (Study Disease)|1|||
33401575|NCT00236899|62780583|FG001|Overall Study|Death (Study Disease)|4|||
33401576|NCT00236899|62780584|FG002|Overall Study|Death (Study Disease)|0|||
33401577|NCT00236899|62780585|FG003|Overall Study|Death (Study Disease)|0|||
33401578|NCT00236899|62780582|FG000|Overall Study|Death (Not Study Related)|2|||
33401579|NCT00236899|62780583|FG001|Overall Study|Death (Not Study Related)|0|||
33401580|NCT00236899|62780584|FG002|Overall Study|Death (Not Study Related)|0|||
33401581|NCT00236899|62780585|FG003|Overall Study|Death (Not Study Related)|0|||
33401582|NCT00236899|62780582|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
33710942|NCT01455012|63278124|FG001|Overall Study|Unknown reason|0|||
33710943|NCT01454778|63278130|FG000|Overall Study|Lost to Follow-up|2|||
33710944|NCT01454778|63278130|FG000|Overall Study|Death|1|||
33710945|NCT01454076|63278139|FG000|Overall Study|Other|2|||
33710946|NCT01454076|63278140|FG001|Overall Study|Other|0|||
33710947|NCT01454076|63278141|FG002|Overall Study|Other|0|||
33710948|NCT01454076|63278142|FG003|Overall Study|Other|1|||
33710949|NCT01454076|63278143|FG004|Overall Study|Other|2|||
33401583|NCT00236899|62780583|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
33401584|NCT00236899|62780584|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
33401585|NCT00236899|62780585|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
33401586|NCT00236899|62780582|FG000|Overall Study|Lost to Follow-up|0|||
33597480|NCT02325739|62996467|FG008|Phase I Part|Progressive disease|0|||
33597481|NCT02325739|62996468|FG009|Phase I Part|Progressive disease|0|||
33710950|NCT01454076|63278139|FG000|Overall Study|Withdrawal by Subject|3|||
33313525|NCT00916357|62689383|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
33313526|NCT00916357|62689384|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
33313527|NCT00916357|62689385|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
33401587|NCT00236899|62780583|FG001|Overall Study|Lost to Follow-up|1|||
33401588|NCT00236899|62780584|FG002|Overall Study|Lost to Follow-up|0|||
33401589|NCT00236899|62780585|FG003|Overall Study|Lost to Follow-up|0|||
33710951|NCT01454076|63278140|FG001|Overall Study|Withdrawal by Subject|4|||
33401590|NCT00236899|62780582|FG000|Overall Study|Entry Criteria Exclusion|0|||
33401591|NCT00236899|62780583|FG001|Overall Study|Entry Criteria Exclusion|1|||
33401592|NCT00236899|62780584|FG002|Overall Study|Entry Criteria Exclusion|1|||
33401593|NCT00236899|62780585|FG003|Overall Study|Entry Criteria Exclusion|0|||
33401594|NCT00236899|62780582|FG000|Overall Study|Protocol Violation|1|||
33401595|NCT00236899|62780583|FG001|Overall Study|Protocol Violation|0|||
33401596|NCT00236899|62780584|FG002|Overall Study|Protocol Violation|0|||
33401597|NCT00236899|62780585|FG003|Overall Study|Protocol Violation|0|||
33401598|NCT00236899|62780582|FG000|Overall Study|Withdrawal by Subject|6|||
33401599|NCT00236899|62780583|FG001|Overall Study|Withdrawal by Subject|4|||
33401600|NCT00236899|62780584|FG002|Overall Study|Withdrawal by Subject|5|||
33401601|NCT00236899|62780585|FG003|Overall Study|Withdrawal by Subject|2|||
33401602|NCT00236899|62780582|FG000|Overall Study|Physician Decision|7|||
33401603|NCT00236899|62780583|FG001|Overall Study|Physician Decision|8|||
33401604|NCT00236899|62780584|FG002|Overall Study|Physician Decision|7|||
33401605|NCT00236899|62780585|FG003|Overall Study|Physician Decision|6|||
33401606|NCT00236899|62780582|FG000|Overall Study|Satisfactory Response|2|||
33401607|NCT00236899|62780583|FG001|Overall Study|Satisfactory Response|0|||
33401608|NCT00236899|62780584|FG002|Overall Study|Satisfactory Response|0|||
33401609|NCT00236899|62780585|FG003|Overall Study|Satisfactory Response|1|||
33710952|NCT01454076|63278141|FG002|Overall Study|Withdrawal by Subject|2|||
33710953|NCT01454076|63278142|FG003|Overall Study|Withdrawal by Subject|1|||
33710954|NCT01454076|63278143|FG004|Overall Study|Withdrawal by Subject|2|||
33710955|NCT01454076|63278139|FG000|Overall Study|Adverse Event|8|||
33710956|NCT01454076|63278140|FG001|Overall Study|Adverse Event|2|||
33710957|NCT01454076|63278141|FG002|Overall Study|Adverse Event|7|||
33710958|NCT01454076|63278142|FG003|Overall Study|Adverse Event|0|||
33710959|NCT01454076|63278143|FG004|Overall Study|Adverse Event|2|||
33710960|NCT01453998|63278167|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
33710961|NCT01453998|63278168|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
33710962|NCT01453998|63278169|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
33710963|NCT01453374|63278180|FG000|Overall Study|Adverse Event|7|||
33710964|NCT01453374|63278180|FG000|Overall Study|Lack of Efficacy|1|||
33710965|NCT01453374|63278180|FG000|Overall Study|Lost to Follow-up|3|||
33710966|NCT01453374|63278180|FG000|Overall Study|Withdrawal by Subject|5|||
33710967|NCT01453374|63278180|FG000|Overall Study|Incarcerated|2|||
33710968|NCT01453296|63278186|FG000|Treatment Period 1|Adverse Event|0|||
33710969|NCT01453296|63278187|FG001|Treatment Period 1|Adverse Event|1|||
33710970|NCT01453296|63278186|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
33710971|NCT01453296|63278187|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
33710972|NCT01453296|63278186|FG000|Treatment Period 2|Adverse Event|1|||
33710973|NCT01453296|63278187|FG001|Treatment Period 2|Adverse Event|0|||
33313528|NCT00916357|62689386|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
33313529|NCT00916357|62689387|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
33313530|NCT00916357|62689388|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
33313531|NCT01209624|62689397|FG000|Overall Study|Death|2|||
33313532|NCT01209624|62689397|FG000|Overall Study|Adverse Event|13|||
33313533|NCT01209624|62689397|FG000|Overall Study|Lack of Efficacy|17|||
33313534|NCT01209624|62689397|FG000|Overall Study|Lost to Follow-up|290|||
33313535|NCT01209624|62689397|FG000|Overall Study|Other|4|||
33313536|NCT00916279|62689401|FG000|Overall Study|Death|2|||
33313537|NCT00916279|62689401|FG000|Overall Study|Lost to Follow-up|2|||
33313538|NCT01209078|62689410|FG000|Overall Study|Adverse Event|5|||
33313539|NCT01209078|62689411|FG001|Overall Study|Adverse Event|0|||
33313540|NCT01209078|62689410|FG000|Overall Study|Lost to Follow-up|4|||
33313541|NCT01209078|62689411|FG001|Overall Study|Lost to Follow-up|0|||
33313542|NCT01209078|62689410|FG000|Overall Study|Physician Decision|5|||
33313543|NCT01209078|62689411|FG001|Overall Study|Physician Decision|2|||
33313544|NCT01209078|62689410|FG000|Overall Study|Withdrawal by Subject|2|||
33313545|NCT01209078|62689411|FG001|Overall Study|Withdrawal by Subject|1|||
33401610|NCT00236899|62780582|FG000|Overall Study|Lack of Efficacy|18|||
33710974|NCT01453296|63278186|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33710975|NCT01453296|63278187|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33710976|NCT01453140|63278193|FG000|Overall Study|Adverse Event|3|||
33401611|NCT00236899|62780583|FG001|Overall Study|Lack of Efficacy|18|||
33710977|NCT01499940|63278201|FG000|Overall Study|Study was withdrawn before completion.|9|||
33710978|NCT01499160|63278205|FG000|Overall Study|Adverse Event|1|||
33710979|NCT01499160|63278205|FG000|Overall Study|Withdrawal by Subject|1|||
33710980|NCT01498692|63278210|FG000|Overall Study|Death|4|||
33710981|NCT01498692|63278210|FG000|Overall Study|Withdrawal by Subject|1|||
33313546|NCT01207596|62689419|FG000|Overall Study|Physician Decision|4|||
33313547|NCT01207596|62689419|FG000|Overall Study|Lack of Efficacy|1|||
33313548|NCT01207596|62689419|FG000|Overall Study|Adverse Event|3|||
33401612|NCT00236899|62780584|FG002|Overall Study|Lack of Efficacy|25|||
33401613|NCT00236899|62780585|FG003|Overall Study|Lack of Efficacy|23|||
33401614|NCT00611130|62780604|FG000|Overall Study|Lost to Follow-up|25|||
33401615|NCT00611130|62780605|FG001|Overall Study|Lost to Follow-up|29|||
33401616|NCT00611130|62780604|FG000|Overall Study|Protocol noncompliance|7|||
33401617|NCT00611130|62780605|FG001|Overall Study|Protocol noncompliance|6|||
33401618|NCT00611130|62780604|FG000|Overall Study|Withdrawal by Subject|6|||
33401619|NCT00611130|62780605|FG001|Overall Study|Withdrawal by Subject|5|||
33401620|NCT00611130|62780604|FG000|Overall Study|Other|5|||
33401621|NCT00611130|62780605|FG001|Overall Study|Other|4|||
33401622|NCT00611130|62780604|FG000|Overall Study|Incarceration|3|||
33401623|NCT00611130|62780605|FG001|Overall Study|Incarceration|2|||
33401624|NCT00611130|62780604|FG000|Overall Study|Administrative|1|||
33401625|NCT00611130|62780605|FG001|Overall Study|Administrative|1|||
33401626|NCT00611130|62780604|FG000|Overall Study|Adverse Event|1|||
33401627|NCT00611130|62780605|FG001|Overall Study|Adverse Event|0|||
33401628|NCT00611130|62780604|FG000|Overall Study|Death|1|||
33401629|NCT00611130|62780605|FG001|Overall Study|Death|0|||
33401630|NCT00256243|62780612|FG000|Overall Study|Lost to Follow-up|2|||
33401631|NCT00256243|62780612|FG000|Overall Study|Death|7|||
33401632|NCT00256243|62780612|FG000|Overall Study|Not treated|1|||
33401633|NCT00236197|62780619|FG000|Overall Study|Withdrawal by Subject|3|||
33401634|NCT00236197|62780620|FG001|Overall Study|Withdrawal by Subject|2|||
33401635|NCT00236197|62780619|FG000|Overall Study|Lost to Follow-up|1|||
33401636|NCT00236197|62780620|FG001|Overall Study|Lost to Follow-up|5|||
33401637|NCT00236197|62780619|FG000|Overall Study|Protocol Violation|0|||
33493835|NCT03535194|62872383|FG000|Maintenance Period|Protocol Violation|0|||
33313549|NCT01207596|62689419|FG000|Overall Study|Withdrawal by Subject|1|||
33313550|NCT00915343|62689423|FG000|Part B - Open Label Period|Treatment switch|0|||
33313551|NCT00915343|62689424|FG001|Part B - Open Label Period|Treatment switch|0|||
33313552|NCT00915343|62689425|FG002|Part B - Open Label Period|Treatment switch|1|||
33313553|NCT00915343|62689423|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
33313554|NCT00915343|62689424|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
33313555|NCT00915343|62689425|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
33313556|NCT00911989|62689437|FG000|Overall Study|Adverse Event|1|||
33313557|NCT00910273|62689443|FG000|Overall Study|Lack of Efficacy|6|||
33313558|NCT00910273|62689444|FG001|Overall Study|Lack of Efficacy|9|||
33313559|NCT00910273|62689443|FG000|Overall Study|Adverse Event|1|||
33313560|NCT00910273|62689444|FG001|Overall Study|Adverse Event|1|||
33313561|NCT00910273|62689443|FG000|Overall Study|Withdrawal by Subject|1|||
33313562|NCT00910273|62689444|FG001|Overall Study|Withdrawal by Subject|0|||
33313563|NCT00910273|62689443|FG000|Overall Study|Discontinuation of study by sponsor|8|||
33313564|NCT00910273|62689444|FG001|Overall Study|Discontinuation of study by sponsor|2|||
33313565|NCT00910273|62689443|FG000|Overall Study|Protocol Violation|1|||
33313566|NCT00910273|62689444|FG001|Overall Study|Protocol Violation|0|||
33313567|NCT00910273|62689443|FG000|Overall Study|Lost to Follow-up|1|||
33313568|NCT00910273|62689444|FG001|Overall Study|Lost to Follow-up|1|||
33313569|NCT00910039|62689450|FG000|Overall Study|Physician Decision|1|||
33313570|NCT00909181|62689458|FG000|Overall Study|Lost to Follow-up|39|||
33313571|NCT00909181|62689459|FG001|Overall Study|Lost to Follow-up|18|||
33313572|NCT00909181|62689460|FG002|Overall Study|Lost to Follow-up|33|||
33401638|NCT00236197|62780620|FG001|Overall Study|Protocol Violation|3|||
33401639|NCT00236197|62780619|FG000|Overall Study|Medication non-compliance|1|||
33401640|NCT00236197|62780620|FG001|Overall Study|Medication non-compliance|2|||
33401641|NCT00236197|62780619|FG000|Overall Study|Other|0|||
33401642|NCT00236197|62780620|FG001|Overall Study|Other|2|||
33401643|NCT00278629|62780626|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
33401644|NCT00612690|62780633|FG000|Overall Study|Lost to Follow-up|72|||
33313573|NCT01286987|62689483|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
33313574|NCT01286987|62689484|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
33401645|NCT00612690|62780634|FG001|Overall Study|Lost to Follow-up|98|||
33401646|NCT00612690|62780633|FG000|Overall Study|Withdrawal by Subject|32|||
33401647|NCT00612690|62780634|FG001|Overall Study|Withdrawal by Subject|20|||
33401648|NCT00612690|62780633|FG000|Overall Study|Withdrawal by Site|11|||
33401649|NCT00612690|62780634|FG001|Overall Study|Withdrawal by Site|0|||
33401650|NCT00278473|62780644|FG000|Overall Study|drop out|4|||
33401651|NCT00278473|62780645|FG001|Overall Study|drop out|3|||
33401652|NCT00278395|62780651|FG000|Overall Study|Adverse Event|2|||
33401653|NCT00278395|62780651|FG000|Overall Study|Nonevaluable|1|||
33401654|NCT00612534|62780662|FG000|Overall Study|Adverse Event|0|||
33401655|NCT00612534|62780663|FG001|Overall Study|Adverse Event|4|||
33401656|NCT00612534|62780664|FG002|Overall Study|Adverse Event|2|||
33401657|NCT00612534|62780665|FG003|Overall Study|Adverse Event|1|||
33401658|NCT00612534|62780662|FG000|Overall Study|Lack of Efficacy|13|||
33401659|NCT00612534|62780663|FG001|Overall Study|Lack of Efficacy|12|||
33401660|NCT00612534|62780664|FG002|Overall Study|Lack of Efficacy|5|||
33401661|NCT00612534|62780665|FG003|Overall Study|Lack of Efficacy|16|||
33401662|NCT00612534|62780662|FG000|Overall Study|Other Reason|0|||
33401663|NCT00612534|62780663|FG001|Overall Study|Other Reason|1|||
33401664|NCT00612534|62780664|FG002|Overall Study|Other Reason|0|||
33401665|NCT00612534|62780665|FG003|Overall Study|Other Reason|0|||
33401666|NCT00736853|62780675|FG000|Open-Label Period|Physician Decision|2|||
33401667|NCT00736853|62780676|FG001|Open-Label Period|Physician Decision|0|||
33401668|NCT00736853|62780677|FG002|Open-Label Period|Physician Decision|0|||
33401669|NCT00736853|62780675|FG000|Open-Label Period|Adverse Event|31|||
33401670|NCT00736853|62780676|FG001|Open-Label Period|Adverse Event|0|||
33401671|NCT00736853|62780677|FG002|Open-Label Period|Adverse Event|0|||
33401672|NCT00736853|62780675|FG000|Open-Label Period|Withdrawal by Subject|16|||
33401673|NCT00736853|62780676|FG001|Open-Label Period|Withdrawal by Subject|0|||
33401674|NCT00736853|62780677|FG002|Open-Label Period|Withdrawal by Subject|0|||
33401675|NCT00736853|62780675|FG000|Open-Label Period|Started but not treated|42|||
33401676|NCT00736853|62780676|FG001|Open-Label Period|Started but not treated|0|||
33401677|NCT00736853|62780677|FG002|Open-Label Period|Started but not treated|0|||
33401678|NCT00736853|62780675|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
33401679|NCT00736853|62780676|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
33313575|NCT01286987|62689485|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
33313576|NCT01286987|62689486|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
33313577|NCT01286987|62689487|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
33313578|NCT01286987|62689488|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
33313579|NCT01286987|62689489|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
33313580|NCT01286987|62689490|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
33710982|NCT01498692|63278210|FG000|Overall Study|Missed 12-month visit|3|||
33710983|NCT01498068|63278216|FG000|Overall Study|Withdrawal by Subject|1|||
33401680|NCT00736853|62780677|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
33401681|NCT00736853|62780675|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
33401682|NCT00736853|62780676|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
33401683|NCT00736853|62780677|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
33401684|NCT00736853|62780675|FG000|Double-Blind Period|Lack of Efficacy|0|||
33401685|NCT00736853|62780676|FG001|Double-Blind Period|Lack of Efficacy|19|||
33401686|NCT00736853|62780677|FG002|Double-Blind Period|Lack of Efficacy|42|||
33401687|NCT00736853|62780675|FG000|Double-Blind Period|Adverse Event|0|||
33401688|NCT00736853|62780676|FG001|Double-Blind Period|Adverse Event|3|||
33401689|NCT00736853|62780677|FG002|Double-Blind Period|Adverse Event|2|||
33401690|NCT00736853|62780675|FG000|Double-Blind Period|Withdrawal by Subject|0|||
33401691|NCT00736853|62780676|FG001|Double-Blind Period|Withdrawal by Subject|1|||
33401692|NCT00736853|62780677|FG002|Double-Blind Period|Withdrawal by Subject|4|||
33401693|NCT00736853|62780675|FG000|Double-Blind Period|Ineligible to participate the study|0|||
33401694|NCT00736853|62780676|FG001|Double-Blind Period|Ineligible to participate the study|1|||
33401695|NCT00736853|62780677|FG002|Double-Blind Period|Ineligible to participate the study|0|||
33401696|NCT00730847|62780686|FG000|Overall Study|Adverse Event|1|||
33401697|NCT00730847|62780686|FG000|Overall Study|Protocol Violation|2|||
33710984|NCT01498068|63278217|FG001|Overall Study|Withdrawal by Subject|1|||
33710985|NCT01497366|63278225|FG000|Overall Study|Virologic failure|2|||
33313581|NCT01286987|62689491|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
33313582|NCT01286987|62689492|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
33401698|NCT00730847|62780686|FG000|Overall Study|Withdrawal by Subject|16|||
33401699|NCT00730847|62780686|FG000|Overall Study|Lost to Follow-up|67|||
33401700|NCT00730847|62780686|FG000|Overall Study|Unknown completion status|21|||
33401701|NCT00730847|62780686|FG000|Overall Study|Other|24|||
33401702|NCT00573066|62780690|FG000|Overall Study|Exclusion criteria|18|||
33401703|NCT00573066|62780690|FG000|Overall Study|IV malfunction|1|||
33401704|NCT00573066|62780690|FG000|Overall Study|Postoperative bleeding|1|||
33401705|NCT00612456|62780697|FG000|Overall Study|Adverse Event|1|||
33710986|NCT01497366|63278226|FG001|Overall Study|Virologic failure|50|||
33401706|NCT00612456|62780698|FG001|Overall Study|Adverse Event|0|||
33597482|NCT02325739|62996469|FG010|Phase I Part|Progressive disease|0|||
33597483|NCT02325739|62996459|FG000|Phase I Part|Subject/guardian decision|1|||
33313583|NCT01286987|62689493|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
33401707|NCT00612456|62780699|FG002|Overall Study|Adverse Event|0|||
33401708|NCT00612456|62780697|FG000|Overall Study|Lack of Efficacy|1|||
33401709|NCT00612456|62780698|FG001|Overall Study|Lack of Efficacy|1|||
33401710|NCT00612456|62780699|FG002|Overall Study|Lack of Efficacy|0|||
33401711|NCT00612456|62780697|FG000|Overall Study|Withdrawal by Subject|0|||
33401712|NCT00612456|62780698|FG001|Overall Study|Withdrawal by Subject|1|||
33401713|NCT00612456|62780699|FG002|Overall Study|Withdrawal by Subject|0|||
33401714|NCT00730691|62780714|FG000|Overall Study|Adverse Event|4|||
33401715|NCT00730691|62780715|FG001|Overall Study|Adverse Event|8|||
33401716|NCT00730691|62780716|FG002|Overall Study|Adverse Event|11|||
33401717|NCT00730691|62780717|FG003|Overall Study|Adverse Event|11|||
33401718|NCT00730691|62780718|FG004|Overall Study|Adverse Event|23|||
33401719|NCT00730691|62780714|FG000|Overall Study|Lack of Efficacy|4|||
33401720|NCT00730691|62780715|FG001|Overall Study|Lack of Efficacy|4|||
33401721|NCT00730691|62780716|FG002|Overall Study|Lack of Efficacy|2|||
33401722|NCT00730691|62780717|FG003|Overall Study|Lack of Efficacy|1|||
33401723|NCT00730691|62780718|FG004|Overall Study|Lack of Efficacy|1|||
33401724|NCT00730691|62780714|FG000|Overall Study|Non-compliance with Study Drug|6|||
33401725|NCT00730691|62780715|FG001|Overall Study|Non-compliance with Study Drug|1|||
33401726|NCT00730691|62780716|FG002|Overall Study|Non-compliance with Study Drug|6|||
33401727|NCT00730691|62780717|FG003|Overall Study|Non-compliance with Study Drug|3|||
33401728|NCT00730691|62780718|FG004|Overall Study|Non-compliance with Study Drug|3|||
33401729|NCT00730691|62780714|FG000|Overall Study|Protocol Deviations|3|||
33401730|NCT00730691|62780715|FG001|Overall Study|Protocol Deviations|5|||
33401731|NCT00730691|62780716|FG002|Overall Study|Protocol Deviations|3|||
33401732|NCT00730691|62780717|FG003|Overall Study|Protocol Deviations|7|||
33401733|NCT00730691|62780718|FG004|Overall Study|Protocol Deviations|5|||
33401734|NCT00730691|62780714|FG000|Overall Study|Withdrawal of Consent|7|||
33401735|NCT00730691|62780715|FG001|Overall Study|Withdrawal of Consent|9|||
33401736|NCT00730691|62780716|FG002|Overall Study|Withdrawal of Consent|3|||
33401737|NCT00730691|62780717|FG003|Overall Study|Withdrawal of Consent|6|||
33401738|NCT00730691|62780718|FG004|Overall Study|Withdrawal of Consent|3|||
33401739|NCT00730691|62780714|FG000|Overall Study|Lost to Follow-up|11|||
33401740|NCT00730691|62780715|FG001|Overall Study|Lost to Follow-up|8|||
33401741|NCT00730691|62780716|FG002|Overall Study|Lost to Follow-up|13|||
33401742|NCT00730691|62780717|FG003|Overall Study|Lost to Follow-up|15|||
33401743|NCT00730691|62780718|FG004|Overall Study|Lost to Follow-up|13|||
33401744|NCT00730691|62780714|FG000|Overall Study|Other|1|||
33401745|NCT00730691|62780715|FG001|Overall Study|Other|1|||
33401746|NCT00730691|62780716|FG002|Overall Study|Other|1|||
33401747|NCT00730691|62780717|FG003|Overall Study|Other|2|||
33401748|NCT00730691|62780718|FG004|Overall Study|Other|2|||
33401749|NCT00235495|62780732|FG000|Overall Study|Death|52|||
33401750|NCT00235495|62780733|FG001|Overall Study|Death|42|||
33401751|NCT00235495|62780732|FG000|Overall Study|Withdrawal by Subject|5|||
33401752|NCT00235495|62780733|FG001|Overall Study|Withdrawal by Subject|3|||
33401753|NCT00235495|62780732|FG000|Overall Study|Lost to Follow-up|11|||
33401754|NCT00235495|62780733|FG001|Overall Study|Lost to Follow-up|13|||
33401755|NCT00235495|62780732|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
33401756|NCT00235495|62780733|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
33401757|NCT00278161|62780739|FG000|Overall Study|Death|11|||
33401758|NCT00255151|62780746|FG000|Overall Study|Adverse Event|10|||
33401759|NCT00255151|62780747|FG001|Overall Study|Adverse Event|6|||
33401760|NCT00255151|62780748|FG002|Overall Study|Adverse Event|9|||
33401761|NCT00255151|62780746|FG000|Overall Study|Lost to Follow-up|4|||
33401762|NCT00255151|62780747|FG001|Overall Study|Lost to Follow-up|3|||
33401763|NCT00255151|62780748|FG002|Overall Study|Lost to Follow-up|4|||
33401764|NCT00255151|62780746|FG000|Overall Study|Withdrawal by Subject|18|||
33401765|NCT00255151|62780747|FG001|Overall Study|Withdrawal by Subject|17|||
33401766|NCT00255151|62780748|FG002|Overall Study|Withdrawal by Subject|8|||
33401767|NCT00255151|62780746|FG000|Overall Study|Noncompliance|0|||
33401768|NCT00255151|62780747|FG001|Overall Study|Noncompliance|1|||
33493836|NCT03535194|62872384|FG001|Maintenance Period|Protocol Violation|1|||
33493837|NCT03535194|62872385|FG002|Maintenance Period|Protocol Violation|0|||
33597484|NCT02325739|62996460|FG001|Phase I Part|Subject/guardian decision|0|||
33313584|NCT01286987|62689494|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
33313585|NCT01286987|62689495|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
33313586|NCT01286987|62689496|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
33313587|NCT01286987|62689497|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
33313588|NCT01286987|62689483|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
33313589|NCT01286987|62689484|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
33313590|NCT01286987|62689485|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
33401769|NCT00255151|62780748|FG002|Overall Study|Noncompliance|2|||
33401770|NCT00255151|62780746|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
33401771|NCT00255151|62780747|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
33401772|NCT00255151|62780748|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
33401773|NCT00255151|62780746|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
33401774|NCT00255151|62780747|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
33401775|NCT00255151|62780748|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
33401776|NCT00255151|62780746|FG000|Overall Study|Possible Barrett's Esophagus|1|||
33401777|NCT00255151|62780747|FG001|Overall Study|Possible Barrett's Esophagus|3|||
33401778|NCT00255151|62780748|FG002|Overall Study|Possible Barrett's Esophagus|8|||
33401779|NCT00255151|62780746|FG000|Overall Study|Esophageal Stricture|0|||
33401780|NCT00255151|62780747|FG001|Overall Study|Esophageal Stricture|0|||
33313591|NCT01286987|62689486|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
33597485|NCT02325739|62996461|FG002|Phase I Part|Subject/guardian decision|1|||
33597486|NCT02325739|62996462|FG003|Phase I Part|Subject/guardian decision|1|||
33597487|NCT02325739|62996463|FG004|Phase I Part|Subject/guardian decision|0|||
33597488|NCT02325739|62996464|FG005|Phase I Part|Subject/guardian decision|0|||
33313592|NCT01286987|62689487|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
33313593|NCT01286987|62689488|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
33313594|NCT01286987|62689489|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
33313595|NCT01286987|62689490|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
33313596|NCT01286987|62689491|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
33313597|NCT01286987|62689492|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
33313598|NCT01286987|62689493|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
33313599|NCT01286987|62689494|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
33313600|NCT01286987|62689495|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
33313601|NCT01286987|62689496|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
33313602|NCT01286987|62689497|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
33313603|NCT01286987|62689483|FG000|Part 1: Dose Escalation|Physician Decision|0|||
33313604|NCT01286987|62689484|FG001|Part 1: Dose Escalation|Physician Decision|0|||
33313605|NCT01286987|62689485|FG002|Part 1: Dose Escalation|Physician Decision|0|||
33313606|NCT01286987|62689486|FG003|Part 1: Dose Escalation|Physician Decision|0|||
33313607|NCT01286987|62689487|FG004|Part 1: Dose Escalation|Physician Decision|1|||
33313608|NCT01286987|62689488|FG005|Part 1: Dose Escalation|Physician Decision|0|||
33313609|NCT01286987|62689489|FG006|Part 1: Dose Escalation|Physician Decision|0|||
33313610|NCT01286987|62689490|FG007|Part 1: Dose Escalation|Physician Decision|0|||
33313611|NCT01286987|62689491|FG008|Part 1: Dose Escalation|Physician Decision|0|||
33313612|NCT01286987|62689492|FG009|Part 1: Dose Escalation|Physician Decision|0|||
33313613|NCT01286987|62689493|FG010|Part 1: Dose Escalation|Physician Decision|0|||
33313614|NCT01286987|62689494|FG011|Part 1: Dose Escalation|Physician Decision|0|||
33313615|NCT01286987|62689495|FG012|Part 1: Dose Escalation|Physician Decision|0|||
33313616|NCT01286987|62689496|FG013|Part 1: Dose Escalation|Physician Decision|0|||
33313617|NCT01286987|62689497|FG014|Part 1: Dose Escalation|Physician Decision|0|||
33313618|NCT01286987|62689483|FG000|Part 2: Dose Expansion|Death|0|||
33313619|NCT01286987|62689484|FG001|Part 2: Dose Expansion|Death|0|||
33313620|NCT01286987|62689485|FG002|Part 2: Dose Expansion|Death|0|||
33313621|NCT01286987|62689486|FG003|Part 2: Dose Expansion|Death|0|||
33313622|NCT01286987|62689487|FG004|Part 2: Dose Expansion|Death|0|||
33313623|NCT01286987|62689488|FG005|Part 2: Dose Expansion|Death|0|||
33313624|NCT01286987|62689489|FG006|Part 2: Dose Expansion|Death|0|||
33313625|NCT01286987|62689490|FG007|Part 2: Dose Expansion|Death|0|||
33313626|NCT01286987|62689491|FG008|Part 2: Dose Expansion|Death|0|||
33313627|NCT01286987|62689492|FG009|Part 2: Dose Expansion|Death|0|||
33313628|NCT01286987|62689493|FG010|Part 2: Dose Expansion|Death|0|||
33313629|NCT01286987|62689494|FG011|Part 2: Dose Expansion|Death|0|||
33313630|NCT01286987|62689495|FG012|Part 2: Dose Expansion|Death|1|||
33313631|NCT01286987|62689496|FG013|Part 2: Dose Expansion|Death|1|||
33313632|NCT01286987|62689497|FG014|Part 2: Dose Expansion|Death|0|||
33313633|NCT01286987|62689483|FG000|Part 2: Dose Expansion|Physician Decision|0|||
33313634|NCT01286987|62689484|FG001|Part 2: Dose Expansion|Physician Decision|0|||
33313635|NCT01286987|62689485|FG002|Part 2: Dose Expansion|Physician Decision|0|||
33313636|NCT01286987|62689486|FG003|Part 2: Dose Expansion|Physician Decision|0|||
33401781|NCT00255151|62780748|FG002|Overall Study|Esophageal Stricture|1|||
33401782|NCT00255151|62780746|FG000|Overall Study|Therapeutic Failure|11|||
33597489|NCT02325739|62996465|FG006|Phase I Part|Subject/guardian decision|0|||
33313637|NCT01286987|62689487|FG004|Part 2: Dose Expansion|Physician Decision|0|||
33313638|NCT01286987|62689488|FG005|Part 2: Dose Expansion|Physician Decision|0|||
33313639|NCT01286987|62689489|FG006|Part 2: Dose Expansion|Physician Decision|0|||
33313640|NCT01286987|62689490|FG007|Part 2: Dose Expansion|Physician Decision|0|||
33313641|NCT01286987|62689491|FG008|Part 2: Dose Expansion|Physician Decision|0|||
33401783|NCT00255151|62780747|FG001|Overall Study|Therapeutic Failure|2|||
33597490|NCT02325739|62996466|FG007|Phase I Part|Subject/guardian decision|1|||
33710987|NCT01497366|63278225|FG000|Overall Study|Lost to Follow-up|11|||
33313642|NCT01286987|62689492|FG009|Part 2: Dose Expansion|Physician Decision|0|||
33313643|NCT01286987|62689493|FG010|Part 2: Dose Expansion|Physician Decision|1|||
33401784|NCT00255151|62780748|FG002|Overall Study|Therapeutic Failure|3|||
33710988|NCT01497366|63278226|FG001|Overall Study|Lost to Follow-up|10|||
33710989|NCT01497366|63278225|FG000|Overall Study|Withdrawal by Subject|6|||
33710990|NCT01497366|63278226|FG001|Overall Study|Withdrawal by Subject|6|||
33710991|NCT01497366|63278225|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
33710992|NCT01497366|63278226|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
33710993|NCT01497366|63278225|FG000|Overall Study|Other|5|||
33710994|NCT01497366|63278226|FG001|Overall Study|Other|0|||
33710995|NCT01497366|63278225|FG000|Overall Study|Death|1|||
33710996|NCT01497366|63278226|FG001|Overall Study|Death|1|||
33710997|NCT01497366|63278225|FG000|Overall Study|Randomized but not treated|7|||
33710998|NCT01497366|63278226|FG001|Overall Study|Randomized but not treated|21|||
33710999|NCT01475838|63278235|FG000|Randomized Phase|Randomized but Not Treated|0|||
33711000|NCT01475838|63278236|FG001|Randomized Phase|Randomized but Not Treated|5|||
33711001|NCT01475838|63278235|FG000|Randomized Phase|Adverse Event|6|||
33711002|NCT01475838|63278236|FG001|Randomized Phase|Adverse Event|1|||
33711003|NCT01475838|63278235|FG000|Randomized Phase|Pregnancy|0|||
33711004|NCT01475838|63278236|FG001|Randomized Phase|Pregnancy|1|||
33711005|NCT01475838|63278235|FG000|Randomized Phase|Investigators Discretion|1|||
33711006|NCT01475838|63278236|FG001|Randomized Phase|Investigators Discretion|2|||
33711007|NCT01475838|63278235|FG000|Randomized Phase|Withdrew Consent|10|||
33711008|NCT01475838|63278236|FG001|Randomized Phase|Withdrew Consent|14|||
33711009|NCT01475838|63278235|FG000|Randomized Phase|Lost to Follow-up|3|||
33711010|NCT01475838|63278236|FG001|Randomized Phase|Lost to Follow-up|4|||
33711011|NCT01475838|63278235|FG000|Randomized Phase|Participant Noncompliance|1|||
33711012|NCT01475838|63278236|FG001|Randomized Phase|Participant Noncompliance|5|||
33711013|NCT01475838|63278235|FG000|Randomized Phase|Protocol Violation|9|||
33711014|NCT01475838|63278236|FG001|Randomized Phase|Protocol Violation|4|||
33711015|NCT01475838|63278235|FG000|Extension Phase|Participant Noncompliance|1|||
33711016|NCT01475838|63278236|FG001|Extension Phase|Participant Noncompliance|0|||
33711017|NCT01451814|63278245|FG000|Overall Study|Withdrawal by Subject|1|||
33711018|NCT01451814|63278246|FG001|Overall Study|Withdrawal by Subject|1|||
33711019|NCT01451814|63278245|FG000|Overall Study|Lost to Follow-up|5|||
33711020|NCT01451814|63278246|FG001|Overall Study|Lost to Follow-up|4|||
33711021|NCT01475370|63278255|FG000|Overall Study|Exacerbation of primary disease|2|||
33711022|NCT01475370|63278256|FG001|Overall Study|Exacerbation of primary disease|2|||
33711023|NCT01475370|63278257|FG002|Overall Study|Exacerbation of primary disease|2|||
33711024|NCT01475370|63278255|FG000|Overall Study|Study drug administration difficult|0|||
33711025|NCT01475370|63278256|FG001|Overall Study|Study drug administration difficult|1|||
33711026|NCT01475370|63278257|FG002|Overall Study|Study drug administration difficult|1|||
33711027|NCT01475370|63278255|FG000|Overall Study|Other than specified|1|||
33711028|NCT01475370|63278256|FG001|Overall Study|Other than specified|0|||
33711029|NCT01475370|63278257|FG002|Overall Study|Other than specified|0|||
33711030|NCT01496430|63278268|FG000|Overall Study|Adverse Event|0|||
33711031|NCT01496430|63278269|FG001|Overall Study|Adverse Event|0|||
33711032|NCT01496430|63278270|FG002|Overall Study|Adverse Event|1|||
33711033|NCT01496430|63278268|FG000|Overall Study|Major Protocol Deviation|0|||
33711034|NCT01496430|63278269|FG001|Overall Study|Major Protocol Deviation|0|||
33711035|NCT01496430|63278270|FG002|Overall Study|Major Protocol Deviation|1|||
33711036|NCT01496430|63278268|FG000|Overall Study|Lost to Follow-up|2|||
33711037|NCT01496430|63278269|FG001|Overall Study|Lost to Follow-up|3|||
33711038|NCT01496430|63278270|FG002|Overall Study|Lost to Follow-up|1|||
33711039|NCT01496430|63278268|FG000|Overall Study|Voluntary Withdrawal|2|||
33711040|NCT01496430|63278269|FG001|Overall Study|Voluntary Withdrawal|1|||
33711041|NCT01496430|63278270|FG002|Overall Study|Voluntary Withdrawal|6|||
33711042|NCT01496430|63278268|FG000|Overall Study|Principal Investigator Discretion|0|||
33711043|NCT01496430|63278269|FG001|Overall Study|Principal Investigator Discretion|1|||
33711044|NCT01496430|63278270|FG002|Overall Study|Principal Investigator Discretion|1|||
33711045|NCT01496430|63278268|FG000|Overall Study|Other|2|||
33711046|NCT01496430|63278269|FG001|Overall Study|Other|0|||
33711047|NCT01496430|63278270|FG002|Overall Study|Other|0|||
33711048|NCT01451424|63278282|FG000|Overall Study|Withdrawal by Subject|1|||
33711049|NCT01451424|63278283|FG001|Overall Study|Withdrawal by Subject|1|||
33711050|NCT01451424|63278284|FG002|Overall Study|Withdrawal by Subject|0|||
33711051|NCT01451424|63278285|FG003|Overall Study|Withdrawal by Subject|2|||
33711052|NCT01451424|63278282|FG000|Overall Study|Lost to Follow-up|0|||
33711053|NCT01451424|63278283|FG001|Overall Study|Lost to Follow-up|1|||
33711054|NCT01451424|63278284|FG002|Overall Study|Lost to Follow-up|0|||
33711055|NCT01451424|63278285|FG003|Overall Study|Lost to Follow-up|1|||
33313644|NCT01286987|62689494|FG011|Part 2: Dose Expansion|Physician Decision|1|||
33711056|NCT01451424|63278282|FG000|Overall Study|Physician Decision|0|||
33711057|NCT01451424|63278283|FG001|Overall Study|Physician Decision|0|||
33711058|NCT01451424|63278284|FG002|Overall Study|Physician Decision|1|||
33711059|NCT01451424|63278285|FG003|Overall Study|Physician Decision|1|||
33711060|NCT01451424|63278282|FG000|Overall Study|Adverse Event|0|||
33711061|NCT01451424|63278283|FG001|Overall Study|Adverse Event|0|||
33711062|NCT01451424|63278284|FG002|Overall Study|Adverse Event|0|||
33313645|NCT01286987|62689495|FG012|Part 2: Dose Expansion|Physician Decision|0|||
33711063|NCT01451424|63278285|FG003|Overall Study|Adverse Event|1|||
33711064|NCT01475214|63278303|FG000|Overall Study|Lost to Follow-up|1|||
33711065|NCT01475214|63278304|FG001|Overall Study|Lost to Follow-up|0|||
33711066|NCT01475214|63278305|FG002|Overall Study|Lost to Follow-up|1|||
33711067|NCT01475214|63278303|FG000|Overall Study|Physician Decision|2|||
33711068|NCT01475214|63278304|FG001|Overall Study|Physician Decision|0|||
33711069|NCT01475214|63278305|FG002|Overall Study|Physician Decision|0|||
33711070|NCT01475214|63278303|FG000|Overall Study|Withdrawal by Subject|2|||
33711071|NCT01475214|63278304|FG001|Overall Study|Withdrawal by Subject|4|||
33711072|NCT01475214|63278305|FG002|Overall Study|Withdrawal by Subject|1|||
33711073|NCT01496274|63278316|FG000|Overall Study|Protocol Violation|0|||
33711074|NCT01496274|63278317|FG001|Overall Study|Protocol Violation|1|||
33711075|NCT01496274|63278316|FG000|Overall Study|Adverse Event|1|||
33711076|NCT01496274|63278317|FG001|Overall Study|Adverse Event|1|||
33711077|NCT01496274|63278316|FG000|Overall Study|Withdrawal by Subject|2|||
33711078|NCT01496274|63278317|FG001|Overall Study|Withdrawal by Subject|0|||
33711079|NCT01496274|63278316|FG000|Overall Study|Lost to Follow-up|0|||
33711080|NCT01496274|63278317|FG001|Overall Study|Lost to Follow-up|3|||
33711081|NCT01475136|63278342|FG000|Overall Study|Sponsor Decision|0|||
33711082|NCT01475136|63278343|FG001|Overall Study|Sponsor Decision|1|||
33711083|NCT01475136|63278344|FG002|Overall Study|Sponsor Decision|0|||
33711084|NCT01475136|63278345|FG003|Overall Study|Sponsor Decision|0|||
33711085|NCT01475136|63278342|FG000|Overall Study|Entry Criteria Not Met|0|||
33711086|NCT01475136|63278343|FG001|Overall Study|Entry Criteria Not Met|2|||
33711087|NCT01475136|63278344|FG002|Overall Study|Entry Criteria Not Met|3|||
33711088|NCT01475136|63278345|FG003|Overall Study|Entry Criteria Not Met|1|||
33711089|NCT01475136|63278342|FG000|Overall Study|Withdrawal by Subject|0|||
33711090|NCT01475136|63278343|FG001|Overall Study|Withdrawal by Subject|0|||
33711091|NCT01475136|63278344|FG002|Overall Study|Withdrawal by Subject|0|||
33711092|NCT01475136|63278345|FG003|Overall Study|Withdrawal by Subject|2|||
33711093|NCT01475136|63278342|FG000|Overall Study|Adverse Event|1|||
33711094|NCT01475136|63278343|FG001|Overall Study|Adverse Event|0|||
33711095|NCT01475136|63278344|FG002|Overall Study|Adverse Event|0|||
33711096|NCT01475136|63278345|FG003|Overall Study|Adverse Event|1|||
33711097|NCT01475136|63278342|FG000|Overall Study|Death|0|||
33711098|NCT01475136|63278343|FG001|Overall Study|Death|0|||
33711099|NCT01475136|63278344|FG002|Overall Study|Death|0|||
33711100|NCT01475136|63278345|FG003|Overall Study|Death|1|||
33711101|NCT01474746|63278357|FG000|Overall Study|Lost to Follow-up|1|||
33711102|NCT01474746|63278358|FG001|Overall Study|Lost to Follow-up|1|||
33711103|NCT01474746|63278357|FG000|Overall Study|Withdrawal by Subject|2|||
33711104|NCT01474746|63278358|FG001|Overall Study|Withdrawal by Subject|1|||
33711105|NCT01450800|63278366|FG000|Overall Study|Protocol Violation|1|||
33711106|NCT01450800|63278367|FG001|Overall Study|Protocol Violation|3|||
33711107|NCT01474512|63278378|FG000|Induction Period|Adverse Event|6|||
33711108|NCT01474512|63278379|FG001|Induction Period|Adverse Event|10|||
33711109|NCT01474512|63278380|FG002|Induction Period|Adverse Event|10|||
33711110|NCT01474512|63278381|FG003|Induction Period|Adverse Event|0|||
33711111|NCT01474512|63278382|FG004|Induction Period|Adverse Event|0|||
33711112|NCT01474512|63278383|FG005|Induction Period|Adverse Event|0|||
33711113|NCT01474512|63278384|FG006|Induction Period|Adverse Event|0|||
33711114|NCT01474512|63278385|FG007|Induction Period|Adverse Event|0|||
33711115|NCT01474512|63278386|FG008|Induction Period|Adverse Event|0|||
33711116|NCT01474512|63278387|FG009|Induction Period|Adverse Event|0|||
33711117|NCT01474512|63278388|FG010|Induction Period|Adverse Event|0|||
33711118|NCT01474512|63278389|FG011|Induction Period|Adverse Event|0|||
33711119|NCT01474512|63278390|FG012|Induction Period|Adverse Event|0|||
33711120|NCT01474512|63278391|FG013|Induction Period|Adverse Event|0|||
33711121|NCT01474512|63278392|FG014|Induction Period|Adverse Event|0|||
33711122|NCT01474512|63278393|FG015|Induction Period|Adverse Event|0|||
33711123|NCT01474512|63278394|FG016|Induction Period|Adverse Event|0|||
33711124|NCT01474512|63278395|FG017|Induction Period|Adverse Event|0|||
33711125|NCT01474512|63278378|FG000|Induction Period|Lack of Efficacy|7|||
33711126|NCT01474512|63278379|FG001|Induction Period|Lack of Efficacy|1|||
33711127|NCT01474512|63278380|FG002|Induction Period|Lack of Efficacy|0|||
33711128|NCT01474512|63278381|FG003|Induction Period|Lack of Efficacy|0|||
33711129|NCT01474512|63278382|FG004|Induction Period|Lack of Efficacy|0|||
33711130|NCT01474512|63278383|FG005|Induction Period|Lack of Efficacy|0|||
33711131|NCT01474512|63278384|FG006|Induction Period|Lack of Efficacy|0|||
33711132|NCT01474512|63278385|FG007|Induction Period|Lack of Efficacy|0|||
33711133|NCT01474512|63278386|FG008|Induction Period|Lack of Efficacy|0|||
33711134|NCT01474512|63278387|FG009|Induction Period|Lack of Efficacy|0|||
33711135|NCT01474512|63278388|FG010|Induction Period|Lack of Efficacy|0|||
33711136|NCT01474512|63278389|FG011|Induction Period|Lack of Efficacy|0|||
33711137|NCT01474512|63278390|FG012|Induction Period|Lack of Efficacy|0|||
33711138|NCT01474512|63278391|FG013|Induction Period|Lack of Efficacy|0|||
33711139|NCT01474512|63278392|FG014|Induction Period|Lack of Efficacy|0|||
33711140|NCT01474512|63278393|FG015|Induction Period|Lack of Efficacy|0|||
33711141|NCT01474512|63278394|FG016|Induction Period|Lack of Efficacy|0|||
33711142|NCT01474512|63278395|FG017|Induction Period|Lack of Efficacy|0|||
33711143|NCT01474512|63278378|FG000|Induction Period|Withdrawal by Subject|6|||
33711144|NCT01474512|63278379|FG001|Induction Period|Withdrawal by Subject|6|||
33711145|NCT01474512|63278380|FG002|Induction Period|Withdrawal by Subject|5|||
33711146|NCT01474512|63278381|FG003|Induction Period|Withdrawal by Subject|0|||
33711147|NCT01474512|63278382|FG004|Induction Period|Withdrawal by Subject|0|||
33711148|NCT01474512|63278383|FG005|Induction Period|Withdrawal by Subject|0|||
33711149|NCT01474512|63278384|FG006|Induction Period|Withdrawal by Subject|0|||
33711150|NCT01474512|63278385|FG007|Induction Period|Withdrawal by Subject|0|||
33711151|NCT01474512|63278386|FG008|Induction Period|Withdrawal by Subject|0|||
33711152|NCT01474512|63278387|FG009|Induction Period|Withdrawal by Subject|0|||
33711153|NCT01474512|63278388|FG010|Induction Period|Withdrawal by Subject|0|||
33711154|NCT01474512|63278389|FG011|Induction Period|Withdrawal by Subject|0|||
33711155|NCT01474512|63278390|FG012|Induction Period|Withdrawal by Subject|0|||
33711156|NCT01474512|63278391|FG013|Induction Period|Withdrawal by Subject|0|||
33711157|NCT01474512|63278392|FG014|Induction Period|Withdrawal by Subject|0|||
33711158|NCT01474512|63278393|FG015|Induction Period|Withdrawal by Subject|0|||
33711159|NCT01474512|63278394|FG016|Induction Period|Withdrawal by Subject|0|||
33711160|NCT01474512|63278395|FG017|Induction Period|Withdrawal by Subject|0|||
33711161|NCT01474512|63278378|FG000|Induction Period|Protocol Violation|3|||
33711162|NCT01474512|63278379|FG001|Induction Period|Protocol Violation|6|||
33711163|NCT01474512|63278380|FG002|Induction Period|Protocol Violation|0|||
33711164|NCT01474512|63278381|FG003|Induction Period|Protocol Violation|0|||
33711165|NCT01474512|63278382|FG004|Induction Period|Protocol Violation|0|||
33711166|NCT01474512|63278383|FG005|Induction Period|Protocol Violation|0|||
33711167|NCT01474512|63278384|FG006|Induction Period|Protocol Violation|0|||
33711168|NCT01474512|63278385|FG007|Induction Period|Protocol Violation|0|||
33711169|NCT01474512|63278386|FG008|Induction Period|Protocol Violation|0|||
33711170|NCT01474512|63278387|FG009|Induction Period|Protocol Violation|0|||
33313646|NCT01286987|62689496|FG013|Part 2: Dose Expansion|Physician Decision|1|||
33313647|NCT01286987|62689497|FG014|Part 2: Dose Expansion|Physician Decision|0|||
33313648|NCT01286987|62689483|FG000|Part 2: Dose Expansion|Other|0|||
33313649|NCT01286987|62689484|FG001|Part 2: Dose Expansion|Other|0|||
33313650|NCT01286987|62689485|FG002|Part 2: Dose Expansion|Other|0|||
33313651|NCT01286987|62689486|FG003|Part 2: Dose Expansion|Other|0|||
33313652|NCT01286987|62689487|FG004|Part 2: Dose Expansion|Other|0|||
33313653|NCT01286987|62689488|FG005|Part 2: Dose Expansion|Other|0|||
33313654|NCT01286987|62689489|FG006|Part 2: Dose Expansion|Other|0|||
33313655|NCT01286987|62689490|FG007|Part 2: Dose Expansion|Other|0|||
33313656|NCT01286987|62689491|FG008|Part 2: Dose Expansion|Other|0|||
33313657|NCT01286987|62689492|FG009|Part 2: Dose Expansion|Other|0|||
33313658|NCT01286987|62689493|FG010|Part 2: Dose Expansion|Other|0|||
33313659|NCT01286987|62689494|FG011|Part 2: Dose Expansion|Other|0|||
33313660|NCT01286987|62689495|FG012|Part 2: Dose Expansion|Other|0|||
33313661|NCT01286987|62689496|FG013|Part 2: Dose Expansion|Other|1|||
33313662|NCT01286987|62689497|FG014|Part 2: Dose Expansion|Other|0|||
33313663|NCT01286987|62689483|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
33313664|NCT01286987|62689484|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
33313665|NCT01286987|62689485|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
33313666|NCT01286987|62689486|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
33313667|NCT01286987|62689487|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
33313668|NCT01286987|62689488|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
33313669|NCT01286987|62689489|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
33313670|NCT01286987|62689490|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
33313671|NCT01286987|62689491|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
33313672|NCT01286987|62689492|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
33313673|NCT01286987|62689493|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
33711171|NCT01474512|63278388|FG010|Induction Period|Protocol Violation|0|||
33711172|NCT01474512|63278389|FG011|Induction Period|Protocol Violation|0|||
33711173|NCT01474512|63278390|FG012|Induction Period|Protocol Violation|0|||
33711174|NCT01474512|63278391|FG013|Induction Period|Protocol Violation|0|||
33711175|NCT01474512|63278392|FG014|Induction Period|Protocol Violation|0|||
33711176|NCT01474512|63278393|FG015|Induction Period|Protocol Violation|0|||
33711177|NCT01474512|63278394|FG016|Induction Period|Protocol Violation|0|||
33711178|NCT01474512|63278395|FG017|Induction Period|Protocol Violation|0|||
33711179|NCT01474512|63278378|FG000|Induction Period|Sponsor Decision|1|||
33313674|NCT01286987|62689494|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
33313675|NCT01286987|62689495|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
33313676|NCT01286987|62689496|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
33313677|NCT01286987|62689497|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
33313678|NCT01286987|62689483|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
33313679|NCT01286987|62689484|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
33711180|NCT01474512|63278379|FG001|Induction Period|Sponsor Decision|1|||
33711181|NCT01474512|63278380|FG002|Induction Period|Sponsor Decision|1|||
33711182|NCT01474512|63278381|FG003|Induction Period|Sponsor Decision|0|||
33711183|NCT01474512|63278382|FG004|Induction Period|Sponsor Decision|0|||
33711184|NCT01474512|63278383|FG005|Induction Period|Sponsor Decision|0|||
33711185|NCT01474512|63278384|FG006|Induction Period|Sponsor Decision|0|||
33711186|NCT01474512|63278385|FG007|Induction Period|Sponsor Decision|0|||
33711187|NCT01474512|63278386|FG008|Induction Period|Sponsor Decision|0|||
33711188|NCT01474512|63278387|FG009|Induction Period|Sponsor Decision|0|||
33711189|NCT01474512|63278388|FG010|Induction Period|Sponsor Decision|0|||
33711190|NCT01474512|63278389|FG011|Induction Period|Sponsor Decision|0|||
33711191|NCT01474512|63278390|FG012|Induction Period|Sponsor Decision|0|||
33711192|NCT01474512|63278391|FG013|Induction Period|Sponsor Decision|0|||
33711193|NCT01474512|63278392|FG014|Induction Period|Sponsor Decision|0|||
33711194|NCT01474512|63278393|FG015|Induction Period|Sponsor Decision|0|||
33711195|NCT01474512|63278394|FG016|Induction Period|Sponsor Decision|0|||
33711196|NCT01474512|63278395|FG017|Induction Period|Sponsor Decision|0|||
33711197|NCT01474512|63278378|FG000|Induction Period|Lost to Follow-up|1|||
33711198|NCT01474512|63278379|FG001|Induction Period|Lost to Follow-up|0|||
33711199|NCT01474512|63278380|FG002|Induction Period|Lost to Follow-up|2|||
33711200|NCT01474512|63278381|FG003|Induction Period|Lost to Follow-up|0|||
33711201|NCT01474512|63278382|FG004|Induction Period|Lost to Follow-up|0|||
33711202|NCT01474512|63278383|FG005|Induction Period|Lost to Follow-up|0|||
33711203|NCT01474512|63278384|FG006|Induction Period|Lost to Follow-up|0|||
33711204|NCT01474512|63278385|FG007|Induction Period|Lost to Follow-up|0|||
33711205|NCT01474512|63278386|FG008|Induction Period|Lost to Follow-up|0|||
33711206|NCT01474512|63278387|FG009|Induction Period|Lost to Follow-up|0|||
33711207|NCT01474512|63278388|FG010|Induction Period|Lost to Follow-up|0|||
33711208|NCT01474512|63278389|FG011|Induction Period|Lost to Follow-up|0|||
33711209|NCT01474512|63278390|FG012|Induction Period|Lost to Follow-up|0|||
33711210|NCT01474512|63278391|FG013|Induction Period|Lost to Follow-up|0|||
33711211|NCT01474512|63278392|FG014|Induction Period|Lost to Follow-up|0|||
33711212|NCT01474512|63278393|FG015|Induction Period|Lost to Follow-up|0|||
33711213|NCT01474512|63278394|FG016|Induction Period|Lost to Follow-up|0|||
33711214|NCT01474512|63278395|FG017|Induction Period|Lost to Follow-up|0|||
33711215|NCT01474512|63278378|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33711216|NCT01474512|63278379|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33313680|NCT01286987|62689485|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
33313681|NCT01286987|62689486|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
33313682|NCT01286987|62689487|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
33401785|NCT00658658|62780761|FG000|Overall Study|Withdrawal by Subject|0|||
33401786|NCT00658658|62780762|FG001|Overall Study|Withdrawal by Subject|1|||
33401787|NCT00658658|62780763|FG002|Overall Study|Withdrawal by Subject|0|||
33401788|NCT00658658|62780764|FG003|Overall Study|Withdrawal by Subject|0|||
33401789|NCT00658658|62780765|FG004|Overall Study|Withdrawal by Subject|0|||
33401790|NCT00658658|62780761|FG000|Overall Study|Death|4|||
33401791|NCT00658658|62780762|FG001|Overall Study|Death|0|||
33401792|NCT00658658|62780763|FG002|Overall Study|Death|0|||
33401793|NCT00658658|62780764|FG003|Overall Study|Death|1|||
33313683|NCT01286987|62689488|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
33313684|NCT01286987|62689489|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
33313685|NCT01286987|62689490|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
33313686|NCT01286987|62689491|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
33313687|NCT01286987|62689492|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
33313688|NCT01286987|62689493|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
33313689|NCT01286987|62689494|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
33401794|NCT00658658|62780765|FG004|Overall Study|Death|1|||
33401795|NCT00658658|62780761|FG000|Overall Study|Disease Progression|0|||
33401796|NCT00658658|62780762|FG001|Overall Study|Disease Progression|1|||
33401797|NCT00658658|62780763|FG002|Overall Study|Disease Progression|0|||
33401798|NCT00658658|62780764|FG003|Overall Study|Disease Progression|1|||
33401799|NCT00658658|62780765|FG004|Overall Study|Disease Progression|3|||
33401800|NCT00658658|62780761|FG000|Overall Study|Protocol-specified Criteria|1|||
33401801|NCT00658658|62780762|FG001|Overall Study|Protocol-specified Criteria|0|||
33401802|NCT00658658|62780763|FG002|Overall Study|Protocol-specified Criteria|0|||
33401803|NCT00658658|62780764|FG003|Overall Study|Protocol-specified Criteria|0|||
33711217|NCT01474512|63278380|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33711218|NCT01474512|63278381|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
33711219|NCT01474512|63278382|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
33711220|NCT01474512|63278383|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
33711221|NCT01474512|63278384|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
33711222|NCT01474512|63278385|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33711223|NCT01474512|63278386|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33711224|NCT01474512|63278387|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33313690|NCT01286987|62689495|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
33313691|NCT01286987|62689496|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
33401804|NCT00658658|62780765|FG004|Overall Study|Protocol-specified Criteria|0|||
33401805|NCT00658658|62780761|FG000|Overall Study|Other|0|||
33401806|NCT00658658|62780762|FG001|Overall Study|Other|0|||
33401807|NCT00658658|62780763|FG002|Overall Study|Other|0|||
33401808|NCT00658658|62780764|FG003|Overall Study|Other|0|||
33401809|NCT00658658|62780765|FG004|Overall Study|Other|1|||
33401810|NCT00723203|62780777|FG000|Overall Study|Withdrawal by Subject|3|||
33401811|NCT00233389|62780783|FG000|Overall Study|Adverse Event|5|||
33401812|NCT00233389|62780784|FG001|Overall Study|Adverse Event|5|||
33401813|NCT00233389|62780783|FG000|Overall Study|Lack of Efficacy|11|||
33711225|NCT01474512|63278388|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33711226|NCT01474512|63278389|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33711227|NCT01474512|63278390|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33711228|NCT01474512|63278391|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33711229|NCT01474512|63278392|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33711230|NCT01474512|63278393|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33711231|NCT01474512|63278394|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33711232|NCT01474512|63278395|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33711233|NCT01474512|63278378|FG000|Maintenance Period|Adverse Event|0|||
33711234|NCT01474512|63278379|FG001|Maintenance Period|Adverse Event|0|||
33711235|NCT01474512|63278380|FG002|Maintenance Period|Adverse Event|0|||
33711236|NCT01474512|63278381|FG003|Maintenance Period|Adverse Event|4|||
33711237|NCT01474512|63278382|FG004|Maintenance Period|Adverse Event|2|||
33711238|NCT01474512|63278383|FG005|Maintenance Period|Adverse Event|7|||
33711239|NCT01474512|63278384|FG006|Maintenance Period|Adverse Event|0|||
33711240|NCT01474512|63278385|FG007|Maintenance Period|Adverse Event|19|||
33711241|NCT01474512|63278386|FG008|Maintenance Period|Adverse Event|1|||
33711242|NCT01474512|63278387|FG009|Maintenance Period|Adverse Event|3|||
33711243|NCT01474512|63278388|FG010|Maintenance Period|Adverse Event|0|||
33711244|NCT01474512|63278389|FG011|Maintenance Period|Adverse Event|0|||
33711245|NCT01474512|63278390|FG012|Maintenance Period|Adverse Event|0|||
33711246|NCT01474512|63278391|FG013|Maintenance Period|Adverse Event|0|||
33711247|NCT01474512|63278392|FG014|Maintenance Period|Adverse Event|0|||
33711248|NCT01474512|63278393|FG015|Maintenance Period|Adverse Event|0|||
33711249|NCT01474512|63278394|FG016|Maintenance Period|Adverse Event|0|||
33711250|NCT01474512|63278395|FG017|Maintenance Period|Adverse Event|0|||
33711251|NCT01474512|63278378|FG000|Maintenance Period|Withdrawal by Subject|0|||
33711252|NCT01474512|63278379|FG001|Maintenance Period|Withdrawal by Subject|0|||
33711253|NCT01474512|63278380|FG002|Maintenance Period|Withdrawal by Subject|0|||
33711254|NCT01474512|63278381|FG003|Maintenance Period|Withdrawal by Subject|6|||
33711255|NCT01474512|63278382|FG004|Maintenance Period|Withdrawal by Subject|2|||
33711256|NCT01474512|63278383|FG005|Maintenance Period|Withdrawal by Subject|3|||
33711257|NCT01474512|63278384|FG006|Maintenance Period|Withdrawal by Subject|1|||
33711258|NCT01474512|63278385|FG007|Maintenance Period|Withdrawal by Subject|6|||
33711259|NCT01474512|63278386|FG008|Maintenance Period|Withdrawal by Subject|3|||
33711260|NCT01474512|63278387|FG009|Maintenance Period|Withdrawal by Subject|1|||
33711261|NCT01474512|63278388|FG010|Maintenance Period|Withdrawal by Subject|0|||
33711262|NCT01474512|63278389|FG011|Maintenance Period|Withdrawal by Subject|0|||
33711263|NCT01474512|63278390|FG012|Maintenance Period|Withdrawal by Subject|0|||
33711264|NCT01474512|63278391|FG013|Maintenance Period|Withdrawal by Subject|0|||
33711265|NCT01474512|63278392|FG014|Maintenance Period|Withdrawal by Subject|0|||
33711266|NCT01474512|63278393|FG015|Maintenance Period|Withdrawal by Subject|0|||
33711267|NCT01474512|63278394|FG016|Maintenance Period|Withdrawal by Subject|0|||
33711268|NCT01474512|63278395|FG017|Maintenance Period|Withdrawal by Subject|0|||
33711269|NCT01474512|63278378|FG000|Maintenance Period|Lost to Follow-up|0|||
33711270|NCT01474512|63278379|FG001|Maintenance Period|Lost to Follow-up|0|||
33711271|NCT01474512|63278380|FG002|Maintenance Period|Lost to Follow-up|0|||
33313692|NCT01286987|62689497|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
33313693|NCT01286987|62689483|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33313694|NCT01286987|62689484|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33313695|NCT01286987|62689485|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33313696|NCT01286987|62689486|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33313697|NCT01286987|62689487|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33313698|NCT01286987|62689488|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33313699|NCT01286987|62689489|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33313700|NCT01286987|62689490|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33401814|NCT00233389|62780784|FG001|Overall Study|Lack of Efficacy|8|||
33401815|NCT00233389|62780783|FG000|Overall Study|Lost to Follow-up|1|||
33401816|NCT00233389|62780784|FG001|Overall Study|Lost to Follow-up|1|||
33401817|NCT00233389|62780783|FG000|Overall Study|Physician Decision|1|||
33401818|NCT00233389|62780784|FG001|Overall Study|Physician Decision|0|||
33711272|NCT01474512|63278381|FG003|Maintenance Period|Lost to Follow-up|3|||
33711273|NCT01474512|63278382|FG004|Maintenance Period|Lost to Follow-up|3|||
33711274|NCT01474512|63278383|FG005|Maintenance Period|Lost to Follow-up|0|||
33711275|NCT01474512|63278384|FG006|Maintenance Period|Lost to Follow-up|0|||
33313701|NCT01286987|62689491|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33401819|NCT00233389|62780783|FG000|Overall Study|Protocol Violation|0|||
33401820|NCT00233389|62780784|FG001|Overall Study|Protocol Violation|1|||
33711276|NCT01474512|63278385|FG007|Maintenance Period|Lost to Follow-up|2|||
33711277|NCT01474512|63278386|FG008|Maintenance Period|Lost to Follow-up|1|||
33711278|NCT01474512|63278387|FG009|Maintenance Period|Lost to Follow-up|1|||
33711279|NCT01474512|63278388|FG010|Maintenance Period|Lost to Follow-up|0|||
33711280|NCT01474512|63278389|FG011|Maintenance Period|Lost to Follow-up|0|||
33711281|NCT01474512|63278390|FG012|Maintenance Period|Lost to Follow-up|0|||
33711282|NCT01474512|63278391|FG013|Maintenance Period|Lost to Follow-up|0|||
33711283|NCT01474512|63278392|FG014|Maintenance Period|Lost to Follow-up|0|||
33711284|NCT01474512|63278393|FG015|Maintenance Period|Lost to Follow-up|0|||
33711285|NCT01474512|63278394|FG016|Maintenance Period|Lost to Follow-up|0|||
33711286|NCT01474512|63278395|FG017|Maintenance Period|Lost to Follow-up|0|||
33711287|NCT01474512|63278378|FG000|Maintenance Period|Death|0|||
33711288|NCT01474512|63278379|FG001|Maintenance Period|Death|0|||
33711289|NCT01474512|63278380|FG002|Maintenance Period|Death|0|||
33711290|NCT01474512|63278381|FG003|Maintenance Period|Death|0|||
33711291|NCT01474512|63278382|FG004|Maintenance Period|Death|0|||
33711292|NCT01474512|63278383|FG005|Maintenance Period|Death|2|||
33711293|NCT01474512|63278384|FG006|Maintenance Period|Death|0|||
33711294|NCT01474512|63278385|FG007|Maintenance Period|Death|0|||
33711295|NCT01474512|63278386|FG008|Maintenance Period|Death|0|||
33711296|NCT01474512|63278387|FG009|Maintenance Period|Death|0|||
33711297|NCT01474512|63278388|FG010|Maintenance Period|Death|0|||
33711298|NCT01474512|63278389|FG011|Maintenance Period|Death|0|||
33711299|NCT01474512|63278390|FG012|Maintenance Period|Death|0|||
33711300|NCT01474512|63278391|FG013|Maintenance Period|Death|0|||
33711301|NCT01474512|63278392|FG014|Maintenance Period|Death|0|||
33711302|NCT01474512|63278393|FG015|Maintenance Period|Death|0|||
33711303|NCT01474512|63278394|FG016|Maintenance Period|Death|0|||
33711304|NCT01474512|63278395|FG017|Maintenance Period|Death|0|||
33711305|NCT01474512|63278378|FG000|Maintenance Period|Physician Decision|0|||
33711306|NCT01474512|63278379|FG001|Maintenance Period|Physician Decision|0|||
33711307|NCT01474512|63278380|FG002|Maintenance Period|Physician Decision|0|||
33711308|NCT01474512|63278381|FG003|Maintenance Period|Physician Decision|0|||
33711309|NCT01474512|63278382|FG004|Maintenance Period|Physician Decision|0|||
33711310|NCT01474512|63278383|FG005|Maintenance Period|Physician Decision|1|||
33711311|NCT01474512|63278384|FG006|Maintenance Period|Physician Decision|0|||
33711312|NCT01474512|63278385|FG007|Maintenance Period|Physician Decision|2|||
33711313|NCT01474512|63278386|FG008|Maintenance Period|Physician Decision|0|||
33711314|NCT01474512|63278387|FG009|Maintenance Period|Physician Decision|0|||
33711315|NCT01474512|63278388|FG010|Maintenance Period|Physician Decision|0|||
33711316|NCT01474512|63278389|FG011|Maintenance Period|Physician Decision|0|||
33711317|NCT01474512|63278390|FG012|Maintenance Period|Physician Decision|0|||
33711318|NCT01474512|63278391|FG013|Maintenance Period|Physician Decision|0|||
33711319|NCT01474512|63278392|FG014|Maintenance Period|Physician Decision|0|||
33711320|NCT01474512|63278393|FG015|Maintenance Period|Physician Decision|0|||
33313702|NCT01286987|62689492|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33313703|NCT01286987|62689493|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
33313704|NCT01286987|62689494|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33313705|NCT01286987|62689495|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33313706|NCT01286987|62689496|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33313707|NCT01286987|62689497|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33313708|NCT01286753|62689540|FG000|Overall Study|Adverse Event|7|||
33313709|NCT01286753|62689541|FG001|Overall Study|Adverse Event|6|||
33313710|NCT01286753|62689540|FG000|Overall Study|Progression|11|||
33313711|NCT01286753|62689541|FG001|Overall Study|Progression|13|||
33313712|NCT01286753|62689540|FG000|Overall Study|Refused Treatment|1|||
33313713|NCT01286753|62689541|FG001|Overall Study|Refused Treatment|0|||
33313714|NCT01286753|62689540|FG000|Overall Study|Withdrawal of Consent|0|||
33313715|NCT01286753|62689541|FG001|Overall Study|Withdrawal of Consent|2|||
33313716|NCT01286753|62689540|FG000|Overall Study|Discontinued to Join Extension Study|6|||
33313717|NCT01286753|62689541|FG001|Overall Study|Discontinued to Join Extension Study|4|||
33313718|NCT01286753|62689540|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
33313719|NCT01286753|62689541|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
33711321|NCT01474512|63278394|FG016|Maintenance Period|Physician Decision|0|||
33711322|NCT01474512|63278395|FG017|Maintenance Period|Physician Decision|0|||
33711323|NCT01474512|63278378|FG000|Maintenance Period|Clinical Relapse|0|||
33711324|NCT01474512|63278379|FG001|Maintenance Period|Clinical Relapse|0|||
33711325|NCT01474512|63278380|FG002|Maintenance Period|Clinical Relapse|0|||
33711326|NCT01474512|63278381|FG003|Maintenance Period|Clinical Relapse|1|||
33711327|NCT01474512|63278382|FG004|Maintenance Period|Clinical Relapse|0|||
33313720|NCT01286129|62689550|FG000|Overall Study|Withdrawal by Subject|4|||
33313721|NCT01286129|62689551|FG001|Overall Study|Withdrawal by Subject|1|||
33711328|NCT01474512|63278383|FG005|Maintenance Period|Clinical Relapse|0|||
33711329|NCT01474512|63278384|FG006|Maintenance Period|Clinical Relapse|0|||
33711330|NCT01474512|63278385|FG007|Maintenance Period|Clinical Relapse|0|||
33313722|NCT01286129|62689550|FG000|Overall Study|Could not comply with study requirements|4|||
33313723|NCT01286129|62689551|FG001|Overall Study|Could not comply with study requirements|4|||
33711331|NCT01474512|63278386|FG008|Maintenance Period|Clinical Relapse|0|||
33711332|NCT01474512|63278387|FG009|Maintenance Period|Clinical Relapse|0|||
33711333|NCT01474512|63278388|FG010|Maintenance Period|Clinical Relapse|0|||
33711334|NCT01474512|63278389|FG011|Maintenance Period|Clinical Relapse|0|||
33711335|NCT01474512|63278390|FG012|Maintenance Period|Clinical Relapse|0|||
33711336|NCT01474512|63278391|FG013|Maintenance Period|Clinical Relapse|0|||
33711337|NCT01474512|63278392|FG014|Maintenance Period|Clinical Relapse|0|||
33711338|NCT01474512|63278393|FG015|Maintenance Period|Clinical Relapse|0|||
33711339|NCT01474512|63278394|FG016|Maintenance Period|Clinical Relapse|0|||
33711340|NCT01474512|63278395|FG017|Maintenance Period|Clinical Relapse|0|||
33711341|NCT01474512|63278378|FG000|Maintenance Period|Lack of Efficacy|0|||
33711342|NCT01474512|63278379|FG001|Maintenance Period|Lack of Efficacy|0|||
33711343|NCT01474512|63278380|FG002|Maintenance Period|Lack of Efficacy|0|||
33711344|NCT01474512|63278381|FG003|Maintenance Period|Lack of Efficacy|1|||
33711345|NCT01474512|63278382|FG004|Maintenance Period|Lack of Efficacy|0|||
33711346|NCT01474512|63278383|FG005|Maintenance Period|Lack of Efficacy|0|||
33711347|NCT01474512|63278384|FG006|Maintenance Period|Lack of Efficacy|0|||
33711348|NCT01474512|63278385|FG007|Maintenance Period|Lack of Efficacy|11|||
33711349|NCT01474512|63278386|FG008|Maintenance Period|Lack of Efficacy|11|||
33711350|NCT01474512|63278387|FG009|Maintenance Period|Lack of Efficacy|12|||
33711351|NCT01474512|63278388|FG010|Maintenance Period|Lack of Efficacy|0|||
33711352|NCT01474512|63278389|FG011|Maintenance Period|Lack of Efficacy|0|||
33711353|NCT01474512|63278390|FG012|Maintenance Period|Lack of Efficacy|0|||
33711354|NCT01474512|63278391|FG013|Maintenance Period|Lack of Efficacy|0|||
33711355|NCT01474512|63278392|FG014|Maintenance Period|Lack of Efficacy|0|||
33711356|NCT01474512|63278393|FG015|Maintenance Period|Lack of Efficacy|0|||
33711357|NCT01474512|63278394|FG016|Maintenance Period|Lack of Efficacy|0|||
33711358|NCT01474512|63278395|FG017|Maintenance Period|Lack of Efficacy|0|||
33711359|NCT01474512|63278378|FG000|Maintenance Period|Protocol Violation|0|||
33711360|NCT01474512|63278379|FG001|Maintenance Period|Protocol Violation|0|||
33711361|NCT01474512|63278380|FG002|Maintenance Period|Protocol Violation|0|||
33711362|NCT01474512|63278381|FG003|Maintenance Period|Protocol Violation|1|||
33711363|NCT01474512|63278382|FG004|Maintenance Period|Protocol Violation|0|||
33711364|NCT01474512|63278383|FG005|Maintenance Period|Protocol Violation|0|||
33711365|NCT01474512|63278384|FG006|Maintenance Period|Protocol Violation|0|||
33711366|NCT01474512|63278385|FG007|Maintenance Period|Protocol Violation|1|||
33711367|NCT01474512|63278386|FG008|Maintenance Period|Protocol Violation|0|||
33711368|NCT01474512|63278387|FG009|Maintenance Period|Protocol Violation|1|||
33711369|NCT01474512|63278388|FG010|Maintenance Period|Protocol Violation|0|||
33711370|NCT01474512|63278389|FG011|Maintenance Period|Protocol Violation|0|||
33711371|NCT01474512|63278390|FG012|Maintenance Period|Protocol Violation|0|||
33711372|NCT01474512|63278391|FG013|Maintenance Period|Protocol Violation|0|||
33711373|NCT01474512|63278392|FG014|Maintenance Period|Protocol Violation|0|||
33711374|NCT01474512|63278393|FG015|Maintenance Period|Protocol Violation|0|||
33711375|NCT01474512|63278394|FG016|Maintenance Period|Protocol Violation|0|||
33711376|NCT01474512|63278395|FG017|Maintenance Period|Protocol Violation|0|||
33711377|NCT01474512|63278378|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
33711378|NCT01474512|63278379|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
33711379|NCT01474512|63278380|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
33711380|NCT01474512|63278381|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
33711381|NCT01474512|63278382|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
33711382|NCT01474512|63278383|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
33711383|NCT01474512|63278384|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
33711384|NCT01474512|63278385|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
33711385|NCT01474512|63278386|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
33597491|NCT02325739|62996467|FG008|Phase I Part|Subject/guardian decision|0|||
33711386|NCT01474512|63278387|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
33711387|NCT01474512|63278388|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
33711388|NCT01474512|63278389|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
33711389|NCT01474512|63278390|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
33711390|NCT01474512|63278391|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
33711391|NCT01474512|63278392|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
33711392|NCT01474512|63278393|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
33711393|NCT01474512|63278394|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
33313724|NCT01285349|62689562|FG000|Overall Study|Lost to Follow-up|27|||
33313725|NCT01285349|62689563|FG001|Overall Study|Lost to Follow-up|20|||
33313726|NCT01285349|62689564|FG002|Overall Study|Lost to Follow-up|27|||
33313727|NCT01284959|62689576|FG000|Overall Study|Withdrawal by Subject|1|||
33313728|NCT01284959|62689577|FG001|Overall Study|Withdrawal by Subject|0|||
33313729|NCT01284959|62689578|FG002|Overall Study|Withdrawal by Subject|0|||
33401821|NCT00233389|62780783|FG000|Overall Study|Withdrawal by Subject|0|||
33313730|NCT01284959|62689576|FG000|Overall Study|Adverse Event|0|||
33313731|NCT01284959|62689577|FG001|Overall Study|Adverse Event|0|||
33711394|NCT01474512|63278395|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
33711395|NCT01474512|63278378|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
33711396|NCT01474512|63278379|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
33711397|NCT01474512|63278380|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
33711398|NCT01474512|63278381|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
33711399|NCT01474512|63278382|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
33711400|NCT01474512|63278383|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
33711401|NCT01474512|63278384|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
33711402|NCT01474512|63278385|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
33711403|NCT01474512|63278386|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
33711404|NCT01474512|63278387|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
33711405|NCT01474512|63278388|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
33711406|NCT01474512|63278389|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
33711407|NCT01474512|63278390|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
33711408|NCT01474512|63278391|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
33711409|NCT01474512|63278392|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
33711410|NCT01474512|63278393|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
33711411|NCT01474512|63278394|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
33711412|NCT01474512|63278395|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
33711413|NCT01474512|63278378|FG000|Long-Term Extension Period|Adverse Event|0|||
33711414|NCT01474512|63278379|FG001|Long-Term Extension Period|Adverse Event|0|||
33711415|NCT01474512|63278380|FG002|Long-Term Extension Period|Adverse Event|0|||
33711416|NCT01474512|63278381|FG003|Long-Term Extension Period|Adverse Event|0|||
33711417|NCT01474512|63278382|FG004|Long-Term Extension Period|Adverse Event|0|||
33711418|NCT01474512|63278383|FG005|Long-Term Extension Period|Adverse Event|0|||
33711419|NCT01474512|63278384|FG006|Long-Term Extension Period|Adverse Event|0|||
33711420|NCT01474512|63278385|FG007|Long-Term Extension Period|Adverse Event|0|||
33711421|NCT01474512|63278386|FG008|Long-Term Extension Period|Adverse Event|0|||
33711422|NCT01474512|63278387|FG009|Long-Term Extension Period|Adverse Event|0|||
33711423|NCT01474512|63278388|FG010|Long-Term Extension Period|Adverse Event|0|||
33711424|NCT01474512|63278389|FG011|Long-Term Extension Period|Adverse Event|1|||
33711425|NCT01474512|63278390|FG012|Long-Term Extension Period|Adverse Event|57|||
33711426|NCT01474512|63278391|FG013|Long-Term Extension Period|Adverse Event|58|||
33711427|NCT01474512|63278392|FG014|Long-Term Extension Period|Adverse Event|0|||
33711428|NCT01474512|63278393|FG015|Long-Term Extension Period|Adverse Event|0|||
33711429|NCT01474512|63278394|FG016|Long-Term Extension Period|Adverse Event|0|||
33711430|NCT01474512|63278395|FG017|Long-Term Extension Period|Adverse Event|0|||
33711431|NCT01474512|63278378|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
33711432|NCT01474512|63278379|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
33711433|NCT01474512|63278380|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
33711434|NCT01474512|63278381|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
33711435|NCT01474512|63278382|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
33711436|NCT01474512|63278383|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
33711437|NCT01474512|63278384|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
33711438|NCT01474512|63278385|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
33711439|NCT01474512|63278386|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
33711440|NCT01474512|63278387|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
33711441|NCT01474512|63278388|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
33711442|NCT01474512|63278389|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
33711443|NCT01474512|63278390|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
33711444|NCT01474512|63278391|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
33711445|NCT01474512|63278392|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
33711446|NCT01474512|63278393|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
33711447|NCT01474512|63278394|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
33711448|NCT01474512|63278395|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
33711449|NCT01474512|63278378|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
33711450|NCT01474512|63278379|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
33711451|NCT01474512|63278380|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
33711452|NCT01474512|63278381|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
33313732|NCT01284959|62689578|FG002|Overall Study|Adverse Event|1|||
33313733|NCT01284491|62689586|FG000|Overall Study|Study termination|13|||
33313734|NCT01283009|62689594|FG000|Overall Study|Death|83|||
33313735|NCT01283009|62689595|FG001|Overall Study|Death|78|||
33313736|NCT01283009|62689594|FG000|Overall Study|Study ended early|23|||
33313737|NCT01283009|62689595|FG001|Overall Study|Study ended early|26|||
33313738|NCT01283009|62689594|FG000|Overall Study|Withdrawal by Subject|10|||
33711453|NCT01474512|63278382|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
33711454|NCT01474512|63278383|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
33711455|NCT01474512|63278384|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
33313739|NCT01283009|62689595|FG001|Overall Study|Withdrawal by Subject|8|||
33313740|NCT01283009|62689594|FG000|Overall Study|Physician Decision|1|||
33313741|NCT01283009|62689595|FG001|Overall Study|Physician Decision|1|||
33711456|NCT01474512|63278385|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
33711457|NCT01474512|63278386|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
33711458|NCT01474512|63278387|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
33711459|NCT01474512|63278388|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
33711460|NCT01474512|63278389|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
33711461|NCT01474512|63278390|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
33711462|NCT01474512|63278391|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
33711463|NCT01474512|63278392|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
33711464|NCT01474512|63278393|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
33711465|NCT01474512|63278394|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
33711466|NCT01474512|63278395|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
33711467|NCT01474512|63278378|FG000|Long-Term Extension Period|Physician Decision|0|||
33711468|NCT01474512|63278379|FG001|Long-Term Extension Period|Physician Decision|0|||
33711469|NCT01474512|63278380|FG002|Long-Term Extension Period|Physician Decision|0|||
33711470|NCT01474512|63278381|FG003|Long-Term Extension Period|Physician Decision|0|||
33711471|NCT01474512|63278382|FG004|Long-Term Extension Period|Physician Decision|0|||
33711472|NCT01474512|63278383|FG005|Long-Term Extension Period|Physician Decision|0|||
33711473|NCT01474512|63278384|FG006|Long-Term Extension Period|Physician Decision|0|||
33711474|NCT01474512|63278385|FG007|Long-Term Extension Period|Physician Decision|0|||
33711475|NCT01474512|63278386|FG008|Long-Term Extension Period|Physician Decision|0|||
33711476|NCT01474512|63278387|FG009|Long-Term Extension Period|Physician Decision|0|||
33711477|NCT01474512|63278388|FG010|Long-Term Extension Period|Physician Decision|0|||
33711478|NCT01474512|63278389|FG011|Long-Term Extension Period|Physician Decision|0|||
33711479|NCT01474512|63278390|FG012|Long-Term Extension Period|Physician Decision|21|||
33711480|NCT01474512|63278391|FG013|Long-Term Extension Period|Physician Decision|21|||
33711481|NCT01474512|63278392|FG014|Long-Term Extension Period|Physician Decision|0|||
33711482|NCT01474512|63278393|FG015|Long-Term Extension Period|Physician Decision|0|||
33711483|NCT01474512|63278394|FG016|Long-Term Extension Period|Physician Decision|0|||
33711484|NCT01474512|63278395|FG017|Long-Term Extension Period|Physician Decision|0|||
33711485|NCT01474512|63278378|FG000|Long-Term Extension Period|Clinical Relapse|0|||
33711486|NCT01474512|63278379|FG001|Long-Term Extension Period|Clinical Relapse|0|||
33711487|NCT01474512|63278380|FG002|Long-Term Extension Period|Clinical Relapse|0|||
33711488|NCT01474512|63278381|FG003|Long-Term Extension Period|Clinical Relapse|0|||
33711489|NCT01474512|63278382|FG004|Long-Term Extension Period|Clinical Relapse|0|||
33711490|NCT01474512|63278383|FG005|Long-Term Extension Period|Clinical Relapse|0|||
33711491|NCT01474512|63278384|FG006|Long-Term Extension Period|Clinical Relapse|0|||
33711492|NCT01474512|63278385|FG007|Long-Term Extension Period|Clinical Relapse|0|||
33711493|NCT01474512|63278386|FG008|Long-Term Extension Period|Clinical Relapse|0|||
33711494|NCT01474512|63278387|FG009|Long-Term Extension Period|Clinical Relapse|0|||
33711495|NCT01474512|63278388|FG010|Long-Term Extension Period|Clinical Relapse|0|||
33711496|NCT01474512|63278389|FG011|Long-Term Extension Period|Clinical Relapse|0|||
33711497|NCT01474512|63278390|FG012|Long-Term Extension Period|Clinical Relapse|9|||
33711498|NCT01474512|63278391|FG013|Long-Term Extension Period|Clinical Relapse|9|||
33711499|NCT01474512|63278392|FG014|Long-Term Extension Period|Clinical Relapse|0|||
33711500|NCT01474512|63278393|FG015|Long-Term Extension Period|Clinical Relapse|0|||
33711501|NCT01474512|63278394|FG016|Long-Term Extension Period|Clinical Relapse|0|||
33711502|NCT01474512|63278395|FG017|Long-Term Extension Period|Clinical Relapse|0|||
33711503|NCT01474512|63278378|FG000|Long-Term Extension Period|Death|0|||
33711504|NCT01474512|63278379|FG001|Long-Term Extension Period|Death|0|||
33711505|NCT01474512|63278380|FG002|Long-Term Extension Period|Death|0|||
33711506|NCT01474512|63278381|FG003|Long-Term Extension Period|Death|0|||
33711507|NCT01474512|63278382|FG004|Long-Term Extension Period|Death|0|||
33711508|NCT01474512|63278383|FG005|Long-Term Extension Period|Death|0|||
33711509|NCT01474512|63278384|FG006|Long-Term Extension Period|Death|0|||
33711510|NCT01474512|63278385|FG007|Long-Term Extension Period|Death|0|||
33711511|NCT01474512|63278386|FG008|Long-Term Extension Period|Death|0|||
33711512|NCT01474512|63278387|FG009|Long-Term Extension Period|Death|0|||
33711513|NCT01474512|63278388|FG010|Long-Term Extension Period|Death|0|||
33711514|NCT01474512|63278389|FG011|Long-Term Extension Period|Death|0|||
33711515|NCT01474512|63278390|FG012|Long-Term Extension Period|Death|9|||
33711516|NCT01474512|63278391|FG013|Long-Term Extension Period|Death|9|||
33711517|NCT01474512|63278392|FG014|Long-Term Extension Period|Death|0|||
33711518|NCT01474512|63278393|FG015|Long-Term Extension Period|Death|0|||
33711519|NCT01474512|63278394|FG016|Long-Term Extension Period|Death|0|||
33711520|NCT01474512|63278395|FG017|Long-Term Extension Period|Death|0|||
33711521|NCT01474512|63278378|FG000|Long-Term Extension Period|Sponsor Decision|0|||
33711522|NCT01474512|63278379|FG001|Long-Term Extension Period|Sponsor Decision|0|||
33711523|NCT01474512|63278380|FG002|Long-Term Extension Period|Sponsor Decision|0|||
33711524|NCT01474512|63278381|FG003|Long-Term Extension Period|Sponsor Decision|0|||
33711525|NCT01474512|63278382|FG004|Long-Term Extension Period|Sponsor Decision|0|||
33711526|NCT01474512|63278383|FG005|Long-Term Extension Period|Sponsor Decision|0|||
33711527|NCT01474512|63278384|FG006|Long-Term Extension Period|Sponsor Decision|0|||
33711528|NCT01474512|63278385|FG007|Long-Term Extension Period|Sponsor Decision|0|||
33711529|NCT01474512|63278386|FG008|Long-Term Extension Period|Sponsor Decision|0|||
33711530|NCT01474512|63278387|FG009|Long-Term Extension Period|Sponsor Decision|0|||
33711531|NCT01474512|63278388|FG010|Long-Term Extension Period|Sponsor Decision|0|||
33711532|NCT01474512|63278389|FG011|Long-Term Extension Period|Sponsor Decision|0|||
33711533|NCT01474512|63278390|FG012|Long-Term Extension Period|Sponsor Decision|6|||
33711534|NCT01474512|63278391|FG013|Long-Term Extension Period|Sponsor Decision|6|||
33711535|NCT01474512|63278392|FG014|Long-Term Extension Period|Sponsor Decision|0|||
33711536|NCT01474512|63278393|FG015|Long-Term Extension Period|Sponsor Decision|0|||
33711537|NCT01474512|63278394|FG016|Long-Term Extension Period|Sponsor Decision|0|||
33711538|NCT01474512|63278395|FG017|Long-Term Extension Period|Sponsor Decision|0|||
33711539|NCT01474512|63278378|FG000|Long-Term Extension Period|Protocol Violation|0|||
33711540|NCT01474512|63278379|FG001|Long-Term Extension Period|Protocol Violation|0|||
33711541|NCT01474512|63278380|FG002|Long-Term Extension Period|Protocol Violation|0|||
33711542|NCT01474512|63278381|FG003|Long-Term Extension Period|Protocol Violation|0|||
33711543|NCT01474512|63278382|FG004|Long-Term Extension Period|Protocol Violation|0|||
33711544|NCT01474512|63278383|FG005|Long-Term Extension Period|Protocol Violation|0|||
33711545|NCT01474512|63278384|FG006|Long-Term Extension Period|Protocol Violation|0|||
33711546|NCT01474512|63278385|FG007|Long-Term Extension Period|Protocol Violation|0|||
33711547|NCT01474512|63278386|FG008|Long-Term Extension Period|Protocol Violation|0|||
33711548|NCT01474512|63278387|FG009|Long-Term Extension Period|Protocol Violation|0|||
33711549|NCT01474512|63278388|FG010|Long-Term Extension Period|Protocol Violation|0|||
33711550|NCT01474512|63278389|FG011|Long-Term Extension Period|Protocol Violation|0|||
33711551|NCT01474512|63278390|FG012|Long-Term Extension Period|Protocol Violation|5|||
33711552|NCT01474512|63278391|FG013|Long-Term Extension Period|Protocol Violation|5|||
33711553|NCT01474512|63278392|FG014|Long-Term Extension Period|Protocol Violation|0|||
33711554|NCT01474512|63278393|FG015|Long-Term Extension Period|Protocol Violation|0|||
33313742|NCT01283009|62689594|FG000|Overall Study|Lost to Follow-up|1|||
33313743|NCT01283009|62689595|FG001|Overall Study|Lost to Follow-up|0|||
33313744|NCT01283009|62689594|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
33313745|NCT01283009|62689595|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
33313746|NCT01282463|62689604|FG000|Overall Study|Lost to Follow-up|1|||
33313747|NCT01282463|62689605|FG001|Overall Study|Lost to Follow-up|0|||
33313748|NCT01282463|62689606|FG002|Overall Study|Lost to Follow-up|0|||
33313749|NCT01282463|62689604|FG000|Overall Study|Withdrawal by Subject|6|||
33313750|NCT01282463|62689605|FG001|Overall Study|Withdrawal by Subject|2|||
33313751|NCT01282463|62689606|FG002|Overall Study|Withdrawal by Subject|3|||
33313752|NCT01282463|62689604|FG000|Overall Study|"Never Treated Death"|0|||
33313753|NCT01282463|62689605|FG001|Overall Study|"Never Treated Death"|1|||
33313754|NCT01282463|62689606|FG002|Overall Study|"Never Treated Death"|0|||
33313755|NCT01282463|62689604|FG000|Overall Study|"Never Treated PD"|0|||
33313756|NCT01282463|62689605|FG001|Overall Study|"Never Treated PD"|1|||
33313757|NCT01282463|62689606|FG002|Overall Study|"Never Treated PD"|0|||
33313758|NCT01282463|62689604|FG000|Overall Study|Protocol Violation|0|||
33313759|NCT01282463|62689605|FG001|Overall Study|Protocol Violation|0|||
33313760|NCT01282463|62689606|FG002|Overall Study|Protocol Violation|1|||
33313761|NCT01282463|62689604|FG000|Overall Study|Physician Decision|1|||
33313762|NCT01282463|62689605|FG001|Overall Study|Physician Decision|0|||
33313763|NCT01282463|62689606|FG002|Overall Study|Physician Decision|0|||
33313764|NCT01282229|62689622|FG000|Overall Study|Protocol Violation|2|||
33313765|NCT01281917|62689640|FG000|Overall Study|Withdrawal by Subject|1|||
33313766|NCT01281839|62689646|FG000|Overall Study|Lost to Follow-up|6|||
33401822|NCT00233389|62780784|FG001|Overall Study|Withdrawal by Subject|1|||
33711555|NCT01474512|63278394|FG016|Long-Term Extension Period|Protocol Violation|0|||
33711556|NCT01474512|63278395|FG017|Long-Term Extension Period|Protocol Violation|0|||
33711557|NCT01474512|63278378|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33711558|NCT01474512|63278379|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33313767|NCT01281839|62689647|FG001|Overall Study|Lost to Follow-up|3|||
33313768|NCT01281839|62689646|FG000|Overall Study|Withdrawal by Subject|4|||
33313769|NCT01281839|62689647|FG001|Overall Study|Withdrawal by Subject|10|||
33401823|NCT00649220|62780790|FG000|Overall Study|Adverse Event|2|||
33597492|NCT02325739|62996468|FG009|Phase I Part|Subject/guardian decision|0|||
33313770|NCT01281839|62689646|FG000|Overall Study|Reason not specified|0|||
33711559|NCT01474512|63278380|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33711560|NCT01474512|63278381|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33711561|NCT01474512|63278382|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33711562|NCT01474512|63278383|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33711563|NCT01474512|63278384|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33711564|NCT01474512|63278385|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33711565|NCT01474512|63278386|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33711566|NCT01474512|63278387|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33711567|NCT01474512|63278388|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33711568|NCT01474512|63278389|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33711569|NCT01474512|63278390|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
33711570|NCT01474512|63278391|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
33711571|NCT01474512|63278392|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33711572|NCT01474512|63278393|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33711573|NCT01474512|63278394|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33711574|NCT01474512|63278395|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33711575|NCT01474512|63278378|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33597493|NCT02325739|62996469|FG010|Phase I Part|Subject/guardian decision|0|||
33313771|NCT01281839|62689647|FG001|Overall Study|Reason not specified|1|||
33313772|NCT01281137|62689655|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
33313773|NCT01281137|62689656|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
33313774|NCT01281137|62689655|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
33313775|NCT01281137|62689656|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
33313776|NCT01281137|62689655|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
33313777|NCT01281137|62689656|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
33313778|NCT01281137|62689655|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
33313779|NCT01281137|62689656|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
33313780|NCT01281137|62689655|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
33313781|NCT01281137|62689656|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
33313782|NCT01280981|62689680|FG000|Overall Study|Withdrawal by Subject|11|||
33313783|NCT01280981|62689680|FG000|Overall Study|Protocol Violation|2|||
33313784|NCT01280981|62689680|FG000|Overall Study|Lack of Efficacy|13|||
33313785|NCT01280981|62689680|FG000|Overall Study|Lost to Follow-up|3|||
33597494|NCT02325739|62996459|FG000|Phase I Part|Death|0|||
33597495|NCT02325739|62996460|FG001|Phase I Part|Death|0|||
33597496|NCT02325739|62996461|FG002|Phase I Part|Death|0|||
33597497|NCT02325739|62996462|FG003|Phase I Part|Death|0|||
33597498|NCT02325739|62996463|FG004|Phase I Part|Death|2|||
33711576|NCT01474512|63278379|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711577|NCT01474512|63278380|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711578|NCT01474512|63278381|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711579|NCT01474512|63278382|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711580|NCT01474512|63278383|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711581|NCT01474512|63278384|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711582|NCT01474512|63278385|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711583|NCT01474512|63278386|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711584|NCT01474512|63278387|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711585|NCT01474512|63278388|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711586|NCT01474512|63278389|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
33711587|NCT01474512|63278390|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711588|NCT01474512|63278391|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711589|NCT01474512|63278392|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711590|NCT01474512|63278393|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711591|NCT01474512|63278394|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711592|NCT01474512|63278395|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33711593|NCT01474512|63278378|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
33711594|NCT01474512|63278379|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
33711595|NCT01474512|63278380|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
33711596|NCT01474512|63278381|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
33711597|NCT01474512|63278382|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
33711598|NCT01474512|63278383|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
33711599|NCT01474512|63278384|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
33711600|NCT01474512|63278385|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
33711601|NCT01474512|63278386|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
33711602|NCT01474512|63278387|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
33711603|NCT01474512|63278388|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
33711604|NCT01474512|63278389|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
33711605|NCT01474512|63278390|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
33711606|NCT01474512|63278391|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
33711607|NCT01474512|63278392|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
33711608|NCT01474512|63278393|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
33711609|NCT01474512|63278394|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
33711610|NCT01474512|63278395|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
33711611|NCT01474512|63278378|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33711612|NCT01474512|63278379|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33711613|NCT01474512|63278380|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33711614|NCT01474512|63278381|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33711615|NCT01474512|63278382|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33711616|NCT01474512|63278383|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33711617|NCT01474512|63278384|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33711618|NCT01474512|63278385|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33711619|NCT01474512|63278386|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33711620|NCT01474512|63278387|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33711621|NCT01474512|63278388|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33711622|NCT01474512|63278389|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33711623|NCT01474512|63278390|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33711624|NCT01474512|63278391|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33711625|NCT01474512|63278392|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
33711626|NCT01474512|63278393|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
33711627|NCT01474512|63278394|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
33711628|NCT01474512|63278395|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
33711629|NCT01474512|63278378|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33711630|NCT01474512|63278379|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33711631|NCT01474512|63278380|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33711632|NCT01474512|63278381|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33711633|NCT01474512|63278382|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33711634|NCT01474512|63278383|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33711635|NCT01474512|63278384|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33711636|NCT01474512|63278385|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33711637|NCT01474512|63278386|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33711638|NCT01474512|63278387|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33711639|NCT01474512|63278388|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33711640|NCT01474512|63278389|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33711641|NCT01474512|63278390|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33711642|NCT01474512|63278391|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33711643|NCT01474512|63278392|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
33711644|NCT01474512|63278393|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
33711645|NCT01474512|63278394|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
33711646|NCT01474512|63278395|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
33711647|NCT01474512|63278378|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33711648|NCT01474512|63278379|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33401824|NCT00649220|62780790|FG000|Overall Study|Withdrawal by Subject|1|||
33711649|NCT01474512|63278380|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33711650|NCT01474512|63278381|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33711651|NCT01474512|63278382|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33711652|NCT01474512|63278383|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33711653|NCT01474512|63278384|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33711654|NCT01474512|63278385|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33711655|NCT01474512|63278386|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33711656|NCT01474512|63278387|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33711657|NCT01474512|63278388|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33711658|NCT01474512|63278389|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33711659|NCT01474512|63278390|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33711660|NCT01474512|63278391|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33711661|NCT01474512|63278392|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33711662|NCT01474512|63278393|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33711663|NCT01474512|63278394|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
33711664|NCT01474512|63278395|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
33711665|NCT01474512|63278378|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
33711666|NCT01474512|63278379|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
33711667|NCT01474512|63278380|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
33711668|NCT01474512|63278381|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
33711669|NCT01474512|63278382|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
33711670|NCT01474512|63278383|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
33711671|NCT01474512|63278384|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
33711672|NCT01474512|63278385|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
33711673|NCT01474512|63278386|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
33711674|NCT01474512|63278387|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
33711675|NCT01474512|63278388|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
33711676|NCT01474512|63278389|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
33711677|NCT01474512|63278390|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
33711678|NCT01474512|63278391|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
33711679|NCT01474512|63278392|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
33711680|NCT01474512|63278393|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
33711681|NCT01474512|63278394|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
33711682|NCT01474512|63278395|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
33711683|NCT01474512|63278378|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711684|NCT01474512|63278379|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711685|NCT01474512|63278380|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711686|NCT01474512|63278381|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711687|NCT01474512|63278382|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711688|NCT01474512|63278383|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711689|NCT01474512|63278384|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711690|NCT01474512|63278385|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711691|NCT01474512|63278386|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711692|NCT01474512|63278387|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711693|NCT01474512|63278388|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711694|NCT01474512|63278389|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711695|NCT01474512|63278390|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711696|NCT01474512|63278391|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711697|NCT01474512|63278392|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711698|NCT01474512|63278393|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
33711699|NCT01474512|63278394|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
33711700|NCT01474512|63278395|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
33711701|NCT01474512|63278378|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
33711702|NCT01474512|63278379|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
33711703|NCT01474512|63278380|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
33711704|NCT01474512|63278381|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
33711705|NCT01474512|63278382|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
33711706|NCT01474512|63278383|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
33711707|NCT01474512|63278384|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
33711708|NCT01474512|63278385|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
33711709|NCT01474512|63278386|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
33711710|NCT01474512|63278387|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
33711711|NCT01474512|63278388|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
33711712|NCT01474512|63278389|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
33711713|NCT01474512|63278390|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
33711714|NCT01474512|63278391|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
33711715|NCT01474512|63278392|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
33711716|NCT01474512|63278393|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
33711717|NCT01474512|63278394|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
33711718|NCT01474512|63278395|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
33711719|NCT01474512|63278378|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711720|NCT01474512|63278379|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711721|NCT01474512|63278380|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711722|NCT01474512|63278381|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711723|NCT01474512|63278382|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711724|NCT01474512|63278383|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711725|NCT01474512|63278384|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711726|NCT01474512|63278385|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711727|NCT01474512|63278386|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711728|NCT01474512|63278387|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711729|NCT01474512|63278388|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711730|NCT01474512|63278389|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711731|NCT01474512|63278390|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711732|NCT01474512|63278391|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711733|NCT01474512|63278392|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
33711734|NCT01474512|63278393|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711735|NCT01474512|63278394|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
33711736|NCT01474512|63278395|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
33711737|NCT01474512|63278378|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711738|NCT01474512|63278379|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711739|NCT01474512|63278380|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711740|NCT01474512|63278381|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711741|NCT01474512|63278382|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711742|NCT01474512|63278383|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711743|NCT01474512|63278384|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711744|NCT01474512|63278385|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711745|NCT01474512|63278386|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711746|NCT01474512|63278387|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711747|NCT01474512|63278388|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711748|NCT01474512|63278389|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711749|NCT01474512|63278390|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711750|NCT01474512|63278391|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711751|NCT01474512|63278392|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
33711752|NCT01474512|63278393|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711753|NCT01474512|63278394|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33711754|NCT01474512|63278395|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
33711755|NCT01474512|63278378|FG000|Post-Treatment Follow-Up|Death|0|||
33711756|NCT01474512|63278379|FG001|Post-Treatment Follow-Up|Death|0|||
33711757|NCT01474512|63278380|FG002|Post-Treatment Follow-Up|Death|0|||
33711758|NCT01474512|63278381|FG003|Post-Treatment Follow-Up|Death|0|||
33711759|NCT01474512|63278382|FG004|Post-Treatment Follow-Up|Death|0|||
33711760|NCT01474512|63278383|FG005|Post-Treatment Follow-Up|Death|0|||
33711761|NCT01474512|63278384|FG006|Post-Treatment Follow-Up|Death|0|||
33711762|NCT01474512|63278385|FG007|Post-Treatment Follow-Up|Death|0|||
33711763|NCT01474512|63278386|FG008|Post-Treatment Follow-Up|Death|0|||
33711764|NCT01474512|63278387|FG009|Post-Treatment Follow-Up|Death|0|||
33711765|NCT01474512|63278388|FG010|Post-Treatment Follow-Up|Death|0|||
33711766|NCT01474512|63278389|FG011|Post-Treatment Follow-Up|Death|0|||
33711767|NCT01474512|63278390|FG012|Post-Treatment Follow-Up|Death|0|||
33711768|NCT01474512|63278391|FG013|Post-Treatment Follow-Up|Death|0|||
33711769|NCT01474512|63278392|FG014|Post-Treatment Follow-Up|Death|0|||
33711770|NCT01474512|63278393|FG015|Post-Treatment Follow-Up|Death|0|||
33711771|NCT01474512|63278394|FG016|Post-Treatment Follow-Up|Death|1|||
33711772|NCT01474512|63278395|FG017|Post-Treatment Follow-Up|Death|0|||
33711773|NCT01474434|63278429|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
33711774|NCT01474434|63278430|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
33711775|NCT01474434|63278431|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
33711776|NCT01474434|63278432|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
33711777|NCT01474434|63278429|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
33711778|NCT01474434|63278430|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
33711779|NCT01474434|63278431|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
33711780|NCT01474434|63278432|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
33711781|NCT01474434|63278429|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
33711782|NCT01474434|63278430|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
33711783|NCT01474434|63278431|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
33711784|NCT01474434|63278432|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
33711785|NCT01473732|63278448|FG000|Overall Study|Adverse Event|1|||
33711786|NCT01473732|63278449|FG001|Overall Study|Adverse Event|0|||
33711787|NCT01473732|63278448|FG000|Overall Study|Death|1|||
33711788|NCT01473732|63278449|FG001|Overall Study|Death|0|||
33711789|NCT01450098|63278457|FG000|Period 3|Protocol Violation|0|||
33711790|NCT01450098|63278458|FG001|Period 3|Protocol Violation|1|||
33711791|NCT01450098|63278457|FG000|Period 3|Withdrawal by Subject|0|||
33711792|NCT01450098|63278458|FG001|Period 3|Withdrawal by Subject|2|||
33711793|NCT01449708|63278473|FG000|Overall Study|Protocol Violation|0|||
33401825|NCT00654368|62780797|FG000|Overall Study|Ineligibility determined|6|||
33401826|NCT00654368|62780798|FG001|Overall Study|Ineligibility determined|0|||
33401827|NCT00654368|62780799|FG002|Overall Study|Ineligibility determined|0|||
33711794|NCT01449708|63278474|FG001|Overall Study|Protocol Violation|1|||
33711795|NCT01449708|63278473|FG000|Overall Study|surgical complication|1|||
33711796|NCT01449708|63278474|FG001|Overall Study|surgical complication|2|||
33711797|NCT01449708|63278473|FG000|Overall Study|respiratory failure|1|||
33711798|NCT01449708|63278474|FG001|Overall Study|respiratory failure|0|||
33711799|NCT01449630|63278492|FG000|Period 1|Physician Decision|1|||
33711800|NCT01449630|63278493|FG001|Period 1|Physician Decision|0|||
33711801|NCT01449630|63278494|FG002|Period 1|Physician Decision|0|||
33711802|NCT01449630|63278495|FG003|Period 1|Physician Decision|1|||
33711803|NCT01449630|63278496|FG004|Period 1|Physician Decision|0|||
33711804|NCT01449630|63278497|FG005|Period 1|Physician Decision|0|||
33711805|NCT01449630|63278498|FG006|Period 1|Physician Decision|0|||
33711806|NCT01449630|63278499|FG007|Period 1|Physician Decision|0|||
33711807|NCT01449630|63278500|FG008|Period 1|Physician Decision|0|||
33711808|NCT01449630|63278492|FG000|Period 1|Sponsor Decision|0|||
33711809|NCT01449630|63278493|FG001|Period 1|Sponsor Decision|0|||
33711810|NCT01449630|63278494|FG002|Period 1|Sponsor Decision|0|||
33401828|NCT00654368|62780797|FG000|Overall Study|Protocol deviation|3|||
33711811|NCT01449630|63278495|FG003|Period 1|Sponsor Decision|0|||
33711812|NCT01449630|63278496|FG004|Period 1|Sponsor Decision|0|||
33711813|NCT01449630|63278497|FG005|Period 1|Sponsor Decision|1|||
33711814|NCT01449630|63278498|FG006|Period 1|Sponsor Decision|0|||
33711815|NCT01449630|63278499|FG007|Period 1|Sponsor Decision|0|||
33711816|NCT01449630|63278500|FG008|Period 1|Sponsor Decision|0|||
33711817|NCT01449630|63278492|FG000|Period 2|Sponsor Decision|0|||
33493838|NCT03535194|62872386|FG003|Maintenance Period|Protocol Violation|0|||
33711818|NCT01449630|63278493|FG001|Period 2|Sponsor Decision|0|||
33711819|NCT01449630|63278494|FG002|Period 2|Sponsor Decision|0|||
33711820|NCT01449630|63278495|FG003|Period 2|Sponsor Decision|0|||
33711821|NCT01449630|63278496|FG004|Period 2|Sponsor Decision|0|||
33711822|NCT01449630|63278497|FG005|Period 2|Sponsor Decision|0|||
33711823|NCT01449630|63278498|FG006|Period 2|Sponsor Decision|1|||
33711824|NCT01449630|63278499|FG007|Period 2|Sponsor Decision|0|||
33711825|NCT01449630|63278500|FG008|Period 2|Sponsor Decision|0|||
33711826|NCT01493778|63278522|FG000|Overall Study|Withdrawal by Subject|8|||
33711827|NCT01473420|63278537|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
33711828|NCT01473420|63278538|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
33711829|NCT01473420|63278537|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
33711830|NCT01473420|63278538|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
33711831|NCT01473420|63278537|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
33711832|NCT01473420|63278538|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
33711833|NCT01473420|63278537|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
33711834|NCT01473420|63278538|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
33711835|NCT01473420|63278537|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
33711836|NCT01473420|63278538|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
33711837|NCT01473420|63278537|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
33711838|NCT01473420|63278538|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
33711839|NCT01473420|63278537|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
33711840|NCT01473420|63278538|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
33711841|NCT01473420|63278537|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
33711842|NCT01473420|63278538|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
33711843|NCT01473420|63278537|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
33711844|NCT01473420|63278538|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
33711845|NCT01473420|63278537|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
33711846|NCT01473420|63278538|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
33711847|NCT01473420|63278537|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
33711848|NCT01473420|63278538|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
33711849|NCT01473420|63278537|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
33711850|NCT01473420|63278538|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
33711851|NCT01473420|63278537|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
33711852|NCT01473420|63278538|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
33711853|NCT01492686|63278552|FG000|Double-blind Phase|Adverse Event|0|||
33711854|NCT01492686|63278553|FG001|Double-blind Phase|Adverse Event|2|||
33711855|NCT01492686|63278552|FG000|Double-blind Phase|Physician Decision|0|||
33711856|NCT01492686|63278553|FG001|Double-blind Phase|Physician Decision|1|||
33711857|NCT01492686|63278552|FG000|Double-blind Phase|Withdrawal by Subject|0|||
33711858|NCT01492686|63278553|FG001|Double-blind Phase|Withdrawal by Subject|2|||
33711859|NCT01492686|63278552|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
33711860|NCT01492686|63278553|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
33711861|NCT01492686|63278552|FG000|Open-label Phase|Adverse Event|1|||
33711862|NCT01492686|63278553|FG001|Open-label Phase|Adverse Event|2|||
33711863|NCT01492686|63278552|FG000|Open-label Phase|Physician Decision|1|||
33711864|NCT01492686|63278553|FG001|Open-label Phase|Physician Decision|0|||
33711865|NCT01492686|63278552|FG000|Open-label Phase|Withdrawal by Subject|6|||
33711866|NCT01492686|63278553|FG001|Open-label Phase|Withdrawal by Subject|7|||
33711867|NCT01492686|63278552|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
33711868|NCT01492686|63278553|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
33711869|NCT01449006|63278563|FG000|Overall Study|Lost to Follow-up|1|||
33711870|NCT01449006|63278564|FG001|Overall Study|Lost to Follow-up|0|||
33711871|NCT01449006|63278563|FG000|Overall Study|Withdrawal by Subject|1|||
33711872|NCT01449006|63278564|FG001|Overall Study|Withdrawal by Subject|0|||
33711873|NCT01449006|63278563|FG000|Overall Study|Protocol Violation|1|||
33711874|NCT01449006|63278564|FG001|Overall Study|Protocol Violation|0|||
33711875|NCT01448850|63278572|FG000|Overall Study|Death|3|||
33711876|NCT01448850|63278573|FG001|Overall Study|Death|6|||
33711877|NCT01448850|63278572|FG000|Overall Study|Withdrawal by Subject|13|||
33711878|NCT01448850|63278573|FG001|Overall Study|Withdrawal by Subject|21|||
33711879|NCT01448850|63278572|FG000|Overall Study|Lost to Follow-up|3|||
33711880|NCT01448850|63278573|FG001|Overall Study|Lost to Follow-up|1|||
33711881|NCT01448850|63278572|FG000|Overall Study|Other|15|||
33711882|NCT01448850|63278573|FG001|Overall Study|Other|12|||
33711883|NCT01491672|63278583|FG000|Overall Study|Lost to Follow-up|0|||
33711884|NCT01491672|63278584|FG001|Overall Study|Lost to Follow-up|4|||
33711885|NCT01491672|63278585|FG002|Overall Study|Lost to Follow-up|1|||
33711886|NCT01491672|63278583|FG000|Overall Study|Withdrawal by Subject|6|||
33711887|NCT01491672|63278584|FG001|Overall Study|Withdrawal by Subject|7|||
33711888|NCT01491672|63278585|FG002|Overall Study|Withdrawal by Subject|0|||
33711889|NCT01491672|63278583|FG000|Overall Study|Adverse Event|8|||
33711890|NCT01491672|63278584|FG001|Overall Study|Adverse Event|10|||
33711891|NCT01491672|63278585|FG002|Overall Study|Adverse Event|4|||
33711892|NCT01491672|63278583|FG000|Overall Study|Disease progression|42|||
33711893|NCT01491672|63278584|FG001|Overall Study|Disease progression|34|||
33711894|NCT01491672|63278585|FG002|Overall Study|Disease progression|6|||
33711895|NCT01491672|63278583|FG000|Overall Study|Protocol deviation|0|||
33711896|NCT01491672|63278584|FG001|Overall Study|Protocol deviation|1|||
33313786|NCT01280981|62689680|FG000|Overall Study|Adverse Event|6|||
33313787|NCT01280981|62689680|FG000|Overall Study|Irregular or discontinued menses|3|||
33313788|NCT01280981|62689680|FG000|Overall Study|Failed to return|45|||
33313789|NCT01280981|62689680|FG000|Overall Study|Non-compliance with protocol|3|||
33313790|NCT01280981|62689680|FG000|Overall Study|Withdrawal of consent|3|||
33313791|NCT01280981|62689680|FG000|Overall Study|Elective surgery|2|||
33313792|NCT01280981|62689680|FG000|Overall Study|Study site closure|1|||
33313793|NCT01280903|62689686|FG000|Overall Study|Lost to Follow-up|23|||
33313794|NCT01280903|62689687|FG001|Overall Study|Lost to Follow-up|16|||
33313795|NCT01280591|62689697|FG000|Overall Study|Withdrawal by Subject|0|||
33313796|NCT01280591|62689698|FG001|Overall Study|Withdrawal by Subject|0|||
33313797|NCT01280591|62689699|FG002|Overall Study|Withdrawal by Subject|0|||
33313798|NCT01280591|62689700|FG003|Overall Study|Withdrawal by Subject|2|||
33313799|NCT01280591|62689697|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
33313800|NCT01280591|62689698|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
33313801|NCT01280591|62689699|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
33313802|NCT01280591|62689700|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
33313803|NCT01280357|62689710|FG000|Overall Study|Excluded no internal monitoring|14|||
33313804|NCT01280357|62689710|FG000|Overall Study|IInsufficient data/No data supplied|12|||
33313805|NCT01274351|62689717|FG000|Overall Study|Lost to Follow-up|1|||
33313806|NCT01274351|62689717|FG000|Overall Study|patient not compliant with the protocol|1|||
33313807|NCT01274351|62689717|FG000|Overall Study|Pregnancy|1|||
33313808|NCT01274351|62689717|FG000|Overall Study|Death|2|||
33313809|NCT01274351|62689717|FG000|Overall Study|Withdrawal by Subject|3|||
33313810|NCT01274351|62689717|FG000|Overall Study|Adverse Event|8|||
33313811|NCT01274351|62689717|FG000|Overall Study|progression of disease|3|||
33313812|NCT01274351|62689717|FG000|Overall Study|hospitalization|1|||
33313813|NCT01271933|62689721|FG000|Single-Blind Phase|Lack of Efficacy|37|||
33313814|NCT01271933|62689722|FG001|Single-Blind Phase|Lack of Efficacy|0|||
33313815|NCT01271933|62689723|FG002|Single-Blind Phase|Lack of Efficacy|0|||
33313816|NCT01271933|62689721|FG000|Single-Blind Phase|Lost to Follow-up|10|||
33313817|NCT01271933|62689722|FG001|Single-Blind Phase|Lost to Follow-up|0|||
33313818|NCT01271933|62689723|FG002|Single-Blind Phase|Lost to Follow-up|0|||
33313819|NCT01271933|62689721|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
33313820|NCT01271933|62689722|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
33313821|NCT01271933|62689723|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
33313822|NCT01271933|62689721|FG000|Single-Blind Phase|Protocol Violation|3|||
33313823|NCT01271933|62689722|FG001|Single-Blind Phase|Protocol Violation|0|||
33313824|NCT01271933|62689723|FG002|Single-Blind Phase|Protocol Violation|0|||
33313825|NCT01271933|62689721|FG000|Single-Blind Phase|Adverse Event|52|||
33313826|NCT01271933|62689722|FG001|Single-Blind Phase|Adverse Event|0|||
33313827|NCT01271933|62689723|FG002|Single-Blind Phase|Adverse Event|0|||
33313828|NCT01271933|62689721|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
33313829|NCT01271933|62689722|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
33711897|NCT01491672|63278585|FG002|Overall Study|Protocol deviation|0|||
33711898|NCT01491672|63278583|FG000|Overall Study|Death|0|||
33711899|NCT01491672|63278584|FG001|Overall Study|Death|4|||
33711900|NCT01491672|63278585|FG002|Overall Study|Death|0|||
33711901|NCT01447446|63278601|FG000|Overall Study|Death|6|||
33313830|NCT01271933|62689723|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
33313831|NCT01271933|62689721|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
33711902|NCT01447446|63278602|FG001|Overall Study|Death|3|||
33711903|NCT01447446|63278603|FG002|Overall Study|Death|2|||
33711904|NCT01447446|63278604|FG003|Overall Study|Death|1|||
33711905|NCT01447446|63278605|FG004|Overall Study|Death|7|||
33313832|NCT01271933|62689722|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
33711906|NCT01447446|63278606|FG005|Overall Study|Death|0|||
33711907|NCT01447446|63278601|FG000|Overall Study|Adverse Event|3|||
33711908|NCT01447446|63278602|FG001|Overall Study|Adverse Event|0|||
33711909|NCT01447446|63278603|FG002|Overall Study|Adverse Event|1|||
33711910|NCT01447446|63278604|FG003|Overall Study|Adverse Event|0|||
33313833|NCT01271933|62689723|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
33313834|NCT01271933|62689721|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
33313835|NCT01271933|62689722|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
33313836|NCT01271933|62689723|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
33313837|NCT01271933|62689721|FG000|Double-Blind Phase|Randomized but not treated|0|||
33313838|NCT01271933|62689722|FG001|Double-Blind Phase|Randomized but not treated|0|||
33313839|NCT01271933|62689723|FG002|Double-Blind Phase|Randomized but not treated|1|||
33313840|NCT01271933|62689721|FG000|Double-Blind Phase|Lack of Efficacy|0|||
33313841|NCT01271933|62689722|FG001|Double-Blind Phase|Lack of Efficacy|6|||
33313842|NCT01271933|62689723|FG002|Double-Blind Phase|Lack of Efficacy|9|||
33313843|NCT01271933|62689721|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33313844|NCT01271933|62689722|FG001|Double-Blind Phase|Lost to Follow-up|1|||
33313845|NCT01271933|62689723|FG002|Double-Blind Phase|Lost to Follow-up|1|||
33313846|NCT01271933|62689721|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
33313847|NCT01271933|62689722|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
33313848|NCT01271933|62689723|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
33313849|NCT01271933|62689721|FG000|Double-Blind Phase|Adverse Event|0|||
33313850|NCT01271933|62689722|FG001|Double-Blind Phase|Adverse Event|3|||
33313851|NCT01271933|62689723|FG002|Double-Blind Phase|Adverse Event|0|||
33313852|NCT01271933|62689721|FG000|Double-Blind Phase|Participant request-personal reason|0|||
33313853|NCT01271933|62689722|FG001|Double-Blind Phase|Participant request-personal reason|1|||
33313854|NCT01271933|62689723|FG002|Double-Blind Phase|Participant request-personal reason|0|||
33313855|NCT01269125|62689736|FG000|Overall Study|Adverse Event|3|||
33313856|NCT01269125|62689737|FG001|Overall Study|Adverse Event|5|||
33313857|NCT01269125|62689738|FG002|Overall Study|Adverse Event|0|||
33313858|NCT01269125|62689736|FG000|Overall Study|Lost to Follow-up|4|||
33313859|NCT01269125|62689737|FG001|Overall Study|Lost to Follow-up|0|||
33313860|NCT01269125|62689738|FG002|Overall Study|Lost to Follow-up|0|||
33313861|NCT01268891|62689748|FG000|Overall Study|Adverse Event|3|||
33313862|NCT01268891|62689749|FG001|Overall Study|Adverse Event|7|||
33313863|NCT01268891|62689748|FG000|Overall Study|Lack of Efficacy|1|||
33313864|NCT01268891|62689749|FG001|Overall Study|Lack of Efficacy|0|||
33313865|NCT01268891|62689748|FG000|Overall Study|Withdrawal of Consent|3|||
33313866|NCT01268891|62689749|FG001|Overall Study|Withdrawal of Consent|1|||
33313867|NCT01268891|62689748|FG000|Overall Study|Administrative or other reason(s)|1|||
33313868|NCT01268891|62689749|FG001|Overall Study|Administrative or other reason(s)|0|||
33313869|NCT01268501|62689755|FG000|Overall Study|Lost to Follow-up|1|||
33313870|NCT01268501|62689755|FG000|Overall Study|Withdrawal by Subject|3|||
33313871|NCT01268501|62689755|FG000|Overall Study|Unacceptable Subjective Vision|3|||
33313872|NCT01268501|62689755|FG000|Overall Study|Handling Difficulties|2|||
33313873|NCT01268267|62689759|FG000|Overall Study|Protocol Violation|1|||
33313874|NCT01267253|62689764|FG000|Overall Study|Ineligible - required test not done|1|||
33313875|NCT01267253|62689764|FG000|Overall Study|Inevaluable-never received study treatme|2|||
33313876|NCT01266317|62689768|FG000|Overall Study|Withdrawal by Subject|2|||
33313877|NCT01266161|62689774|FG000|Overall Study|Ineligible|1|||
33313878|NCT01266161|62689775|FG001|Overall Study|Ineligible|0|||
33313879|NCT01266161|62689774|FG000|Overall Study|Lack of Efficacy|0|||
33313880|NCT01266161|62689775|FG001|Overall Study|Lack of Efficacy|1|||
33313881|NCT01266161|62689774|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
33313882|NCT01266161|62689775|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
33313883|NCT01265849|62689784|FG000|Overall Study|Randomized//Treatment not initiated|1|||
33313884|NCT01265849|62689785|FG001|Overall Study|Randomized//Treatment not initiated|4|||
33313885|NCT01265849|62689786|FG002|Overall Study|Randomized//Treatment not initiated|0|||
33313886|NCT01265849|62689784|FG000|Overall Study|Physician Decision|1|||
33313887|NCT01265849|62689785|FG001|Overall Study|Physician Decision|2|||
33313888|NCT01265849|62689786|FG002|Overall Study|Physician Decision|0|||
33313889|NCT01265849|62689784|FG000|Overall Study|Lost to Follow-up|18|||
33313890|NCT01265849|62689785|FG001|Overall Study|Lost to Follow-up|15|||
33313891|NCT01265849|62689786|FG002|Overall Study|Lost to Follow-up|5|||
33313892|NCT01265849|62689784|FG000|Overall Study|Not otherwise specified|1|||
33313893|NCT01265849|62689785|FG001|Overall Study|Not otherwise specified|6|||
33313894|NCT01265849|62689786|FG002|Overall Study|Not otherwise specified|1|||
33313895|NCT01265849|62689784|FG000|Overall Study|Withdrawal by Subject|25|||
33313896|NCT01265849|62689785|FG001|Overall Study|Withdrawal by Subject|34|||
33313897|NCT01265849|62689786|FG002|Overall Study|Withdrawal by Subject|13|||
33313898|NCT01265615|62689802|FG000|Overall Study|Protocol Violation|2|||
33313899|NCT01265615|62689803|FG001|Overall Study|Protocol Violation|2|||
33313900|NCT01265615|62689804|FG002|Overall Study|Protocol Violation|4|||
33313901|NCT01265615|62689805|FG003|Overall Study|Protocol Violation|3|||
33313902|NCT01264835|62689815|FG000|Overall Study|Lost to Follow-up|1|||
33313903|NCT01264679|62689819|FG000|Overall Study|Participation in Another Clinical Trial|1|||
33313904|NCT01264679|62689819|FG000|Overall Study|Physician Decision|1|||
33313905|NCT01264679|62689819|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
33313906|NCT01264679|62689819|FG000|Overall Study|Withdrawal by Subject|1|||
33313907|NCT01263665|62689824|FG000|Overall Study|Withdrew Consent|1|||
33313908|NCT01263665|62689824|FG000|Overall Study|Lost to Follow-up|3|||
33711911|NCT01447446|63278605|FG004|Overall Study|Adverse Event|2|||
33711912|NCT01447446|63278606|FG005|Overall Study|Adverse Event|0|||
33711913|NCT01447446|63278601|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
33711914|NCT01447446|63278602|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
33711915|NCT01447446|63278603|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
33711916|NCT01447446|63278604|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
33711917|NCT01447446|63278605|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
33711918|NCT01447446|63278606|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
33711919|NCT01447446|63278601|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
33313909|NCT01263665|62689824|FG000|Overall Study|Death|2|||
33313910|NCT01263665|62689824|FG000|Overall Study|Amputation above the ankle|1|||
33313911|NCT01263665|62689824|FG000|Overall Study|Surgical Bypass|2|||
33313912|NCT01263509|62689830|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
33313913|NCT01263509|62689831|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
33313914|NCT01263509|62689832|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
33711920|NCT01447446|63278602|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
33313915|NCT01263509|62689833|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
33313916|NCT01263509|62689830|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
33313917|NCT01263509|62689831|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
33313918|NCT01263509|62689832|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
33313919|NCT01263509|62689833|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
33313920|NCT01263509|62689830|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33313921|NCT01263509|62689831|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33313922|NCT01263509|62689832|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
33313923|NCT01263509|62689833|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
33313924|NCT01263509|62689830|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
33313925|NCT01263509|62689831|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
33313926|NCT01263509|62689832|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33313927|NCT01263509|62689833|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33313928|NCT01263509|62689830|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
33313929|NCT01263509|62689831|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
33313930|NCT01263509|62689832|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
33313931|NCT01263509|62689833|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
33313932|NCT01263197|62689841|FG000|First Intervention (Period 1)|Adverse Event|0|||
33313933|NCT01263197|62689842|FG001|First Intervention (Period 1)|Adverse Event|0|||
33313934|NCT01263197|62689843|FG002|First Intervention (Period 1)|Adverse Event|0|||
33313935|NCT01263197|62689844|FG003|First Intervention (Period 1)|Adverse Event|0|||
33313936|NCT01263197|62689845|FG004|First Intervention (Period 1)|Adverse Event|0|||
33313937|NCT01263197|62689846|FG005|First Intervention (Period 1)|Adverse Event|1|||
33313938|NCT01263197|62689841|FG000|Washout Period 1|Protocol Violation|0|||
33313939|NCT01263197|62689842|FG001|Washout Period 1|Protocol Violation|0|||
33313940|NCT01263197|62689843|FG002|Washout Period 1|Protocol Violation|0|||
33313941|NCT01263197|62689844|FG003|Washout Period 1|Protocol Violation|0|||
33313942|NCT01263197|62689845|FG004|Washout Period 1|Protocol Violation|1|||
33313943|NCT01263197|62689846|FG005|Washout Period 1|Protocol Violation|0|||
33313944|NCT01263197|62689841|FG000|Washout Period 2|Physician Decision|0|||
33313945|NCT01263197|62689842|FG001|Washout Period 2|Physician Decision|0|||
33313946|NCT01263197|62689843|FG002|Washout Period 2|Physician Decision|0|||
33313947|NCT01263197|62689844|FG003|Washout Period 2|Physician Decision|0|||
33313948|NCT01263197|62689845|FG004|Washout Period 2|Physician Decision|0|||
33313949|NCT01263197|62689846|FG005|Washout Period 2|Physician Decision|1|||
33313950|NCT01263197|62689841|FG000|Washout Period 2|Protocol Violation|0|||
33313951|NCT01263197|62689842|FG001|Washout Period 2|Protocol Violation|0|||
33313952|NCT01263197|62689843|FG002|Washout Period 2|Protocol Violation|0|||
33313953|NCT01263197|62689844|FG003|Washout Period 2|Protocol Violation|1|||
33313954|NCT01263197|62689845|FG004|Washout Period 2|Protocol Violation|0|||
33313955|NCT01263197|62689846|FG005|Washout Period 2|Protocol Violation|0|||
33313956|NCT01263197|62689841|FG000|Third Intervention (Period 3)|Adverse Event|0|||
33313957|NCT01263197|62689842|FG001|Third Intervention (Period 3)|Adverse Event|1|||
33313958|NCT01263197|62689843|FG002|Third Intervention (Period 3)|Adverse Event|0|||
33313959|NCT01263197|62689844|FG003|Third Intervention (Period 3)|Adverse Event|0|||
33313960|NCT01263197|62689845|FG004|Third Intervention (Period 3)|Adverse Event|0|||
33313961|NCT01263197|62689846|FG005|Third Intervention (Period 3)|Adverse Event|0|||
33313962|NCT01263119|62689860|FG000|Period 1|Protocol Violation|2|||
33313963|NCT01263119|62689860|FG000|Period 2|Adverse Event|2|||
33313964|NCT01262651|62689870|FG000|Overall Study|Adverse Event|40|||
33313965|NCT01262651|62689871|FG001|Overall Study|Adverse Event|35|||
33313966|NCT01262651|62689870|FG000|Overall Study|Withdrawal by Subject|15|||
33313967|NCT01262651|62689871|FG001|Overall Study|Withdrawal by Subject|11|||
33313968|NCT01262651|62689870|FG000|Overall Study|Withdrawal by Investigator|2|||
33313969|NCT01262651|62689871|FG001|Overall Study|Withdrawal by Investigator|2|||
33313970|NCT01262651|62689870|FG000|Overall Study|Met Withdrawal Criteria|1|||
33313971|NCT01262651|62689871|FG001|Overall Study|Met Withdrawal Criteria|0|||
33313972|NCT01262573|62689879|FG000|Overall Study|Withdrawal by Subject|0|||
33313973|NCT01262573|62689880|FG001|Overall Study|Withdrawal by Subject|1|||
33313974|NCT01262027|62689886|FG000|Overall Study|Adverse Event|1|||
33313975|NCT01262027|62689886|FG000|Overall Study|Withdrawal by Subject|3|||
33313976|NCT01262027|62689886|FG000|Overall Study|Protocol Violation|1|||
33313977|NCT01261793|62689893|FG000|Overall Study|Lack of Efficacy|44|||
33313978|NCT01261793|62689894|FG001|Overall Study|Lack of Efficacy|37|||
33401829|NCT00654368|62780798|FG001|Overall Study|Protocol deviation|2|||
33313979|NCT01261793|62689895|FG002|Overall Study|Lack of Efficacy|32|||
33313980|NCT01261793|62689893|FG000|Overall Study|Protocol Violation|3|||
33313981|NCT01261793|62689894|FG001|Overall Study|Protocol Violation|5|||
33313982|NCT01261793|62689895|FG002|Overall Study|Protocol Violation|6|||
33313983|NCT01261793|62689893|FG000|Overall Study|Lost to Follow-up|10|||
33313984|NCT01261793|62689894|FG001|Overall Study|Lost to Follow-up|3|||
33313985|NCT01261793|62689895|FG002|Overall Study|Lost to Follow-up|7|||
33313986|NCT01261793|62689893|FG000|Overall Study|Withdrawal by Subject|12|||
33313987|NCT01261793|62689894|FG001|Overall Study|Withdrawal by Subject|14|||
33313988|NCT01261793|62689895|FG002|Overall Study|Withdrawal by Subject|14|||
33313989|NCT01261793|62689893|FG000|Overall Study|Death|3|||
33313990|NCT01261793|62689894|FG001|Overall Study|Death|1|||
33313991|NCT01261793|62689895|FG002|Overall Study|Death|0|||
33313992|NCT01261793|62689893|FG000|Overall Study|Adverse Event|9|||
33313993|NCT01261793|62689894|FG001|Overall Study|Adverse Event|24|||
33313994|NCT01261793|62689895|FG002|Overall Study|Adverse Event|19|||
33313995|NCT01261793|62689893|FG000|Overall Study|Patient non-availability|1|||
33313996|NCT01261793|62689894|FG001|Overall Study|Patient non-availability|1|||
33313997|NCT01261793|62689895|FG002|Overall Study|Patient non-availability|1|||
33313998|NCT01261793|62689893|FG000|Overall Study|Suspected pregnancy|1|||
33313999|NCT01261793|62689894|FG001|Overall Study|Suspected pregnancy|1|||
33314000|NCT01261793|62689895|FG002|Overall Study|Suspected pregnancy|0|||
33314001|NCT01261793|62689893|FG000|Overall Study|Patient non-compliance|1|||
33711921|NCT01447446|63278603|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
33711922|NCT01447446|63278604|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
33711923|NCT01447446|63278605|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
33711924|NCT01447446|63278606|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
33711925|NCT01447446|63278601|FG000|Overall Study|Administrative/Other|34|||
33711926|NCT01447446|63278602|FG001|Overall Study|Administrative/Other|9|||
33711927|NCT01447446|63278603|FG002|Overall Study|Administrative/Other|10|||
33314002|NCT01261793|62689894|FG001|Overall Study|Patient non-compliance|0|||
33314003|NCT01261793|62689895|FG002|Overall Study|Patient non-compliance|1|||
33314004|NCT01261793|62689893|FG000|Overall Study|Patient pregnant|1|||
33314005|NCT01261793|62689894|FG001|Overall Study|Patient pregnant|0|||
33314006|NCT01261793|62689895|FG002|Overall Study|Patient pregnant|0|||
33314007|NCT01261793|62689893|FG000|Overall Study|Outside the study area|0|||
33314008|NCT01261793|62689894|FG001|Overall Study|Outside the study area|2|||
33314009|NCT01261793|62689895|FG002|Overall Study|Outside the study area|1|||
33711928|NCT01447446|63278604|FG003|Overall Study|Administrative/Other|2|||
33711929|NCT01447446|63278605|FG004|Overall Study|Administrative/Other|33|||
33711930|NCT01447446|63278606|FG005|Overall Study|Administrative/Other|4|||
33711931|NCT01447446|63278601|FG000|Overall Study|SVR12 Assessment|13|||
33314010|NCT01261793|62689893|FG000|Overall Study|Lack of efficacy & patient not available|0|||
33314011|NCT01261793|62689894|FG001|Overall Study|Lack of efficacy & patient not available|1|||
33711932|NCT01447446|63278602|FG001|Overall Study|SVR12 Assessment|1|||
33314012|NCT01261793|62689895|FG002|Overall Study|Lack of efficacy & patient not available|0|||
33314013|NCT01261793|62689893|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
33314014|NCT01261793|62689894|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
33314015|NCT01261793|62689895|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
33314016|NCT01261793|62689893|FG000|Overall Study|Randomization error|0|||
33314017|NCT01261793|62689894|FG001|Overall Study|Randomization error|1|||
33314018|NCT01261793|62689895|FG002|Overall Study|Randomization error|0|||
33314019|NCT01261793|62689893|FG000|Overall Study|Patient unable to start IV line|0|||
33711933|NCT01447446|63278603|FG002|Overall Study|SVR12 Assessment|2|||
33711934|NCT01447446|63278604|FG003|Overall Study|SVR12 Assessment|1|||
33711935|NCT01447446|63278605|FG004|Overall Study|SVR12 Assessment|5|||
33711936|NCT01447446|63278606|FG005|Overall Study|SVR12 Assessment|5|||
33711937|NCT01447446|63278601|FG000|Overall Study|New Treatment Started|8|||
33711938|NCT01447446|63278602|FG001|Overall Study|New Treatment Started|2|||
33711939|NCT01447446|63278603|FG002|Overall Study|New Treatment Started|1|||
33711940|NCT01447446|63278604|FG003|Overall Study|New Treatment Started|0|||
33711941|NCT01447446|63278605|FG004|Overall Study|New Treatment Started|2|||
33711942|NCT01447446|63278606|FG005|Overall Study|New Treatment Started|0|||
33711943|NCT01447446|63278601|FG000|Overall Study|Reason not Specified|1|||
33711944|NCT01447446|63278602|FG001|Overall Study|Reason not Specified|1|||
33711945|NCT01447446|63278603|FG002|Overall Study|Reason not Specified|1|||
33711946|NCT01447446|63278604|FG003|Overall Study|Reason not Specified|1|||
33711947|NCT01447446|63278605|FG004|Overall Study|Reason not Specified|1|||
33711948|NCT01447446|63278606|FG005|Overall Study|Reason not Specified|0|||
33711949|NCT01490814|63278628|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
33711950|NCT01490814|63278629|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
33711951|NCT01490814|63278628|FG000|Overall Study|Physician Decision|1|||
33711952|NCT01490814|63278629|FG001|Overall Study|Physician Decision|0|||
33711953|NCT01490814|63278628|FG000|Overall Study|Withdrawal by Subject|0|||
33711954|NCT01490814|63278629|FG001|Overall Study|Withdrawal by Subject|5|||
33711955|NCT01471782|63278641|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
33711956|NCT01471782|63278642|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
33711957|NCT01471782|63278643|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
33711958|NCT01471782|63278644|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
33711959|NCT01471782|63278645|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
33711960|NCT01471782|63278646|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
33711961|NCT01471782|63278641|FG000|Overall Study|Lack of Efficacy|1|||
33711962|NCT01471782|63278642|FG001|Overall Study|Lack of Efficacy|2|||
33711963|NCT01471782|63278643|FG002|Overall Study|Lack of Efficacy|1|||
33711964|NCT01471782|63278644|FG003|Overall Study|Lack of Efficacy|1|||
33711965|NCT01471782|63278645|FG004|Overall Study|Lack of Efficacy|5|||
33711966|NCT01471782|63278646|FG005|Overall Study|Lack of Efficacy|18|||
33711967|NCT01471782|63278641|FG000|Overall Study|Adverse Event|1|||
33711968|NCT01471782|63278642|FG001|Overall Study|Adverse Event|1|||
33711969|NCT01471782|63278643|FG002|Overall Study|Adverse Event|2|||
33711970|NCT01471782|63278644|FG003|Overall Study|Adverse Event|2|||
33711971|NCT01471782|63278645|FG004|Overall Study|Adverse Event|3|||
33711972|NCT01471782|63278646|FG005|Overall Study|Adverse Event|1|||
33711973|NCT01471782|63278641|FG000|Overall Study|Other|0|||
33711974|NCT01471782|63278642|FG001|Overall Study|Other|0|||
33711975|NCT01471782|63278643|FG002|Overall Study|Other|1|||
33711976|NCT01471782|63278644|FG003|Overall Study|Other|1|||
33711977|NCT01471782|63278645|FG004|Overall Study|Other|6|||
33711978|NCT01471782|63278646|FG005|Overall Study|Other|5|||
33711979|NCT01471782|63278641|FG000|Overall Study|Change of Chemotherapy|1|||
33314020|NCT01261793|62689894|FG001|Overall Study|Patient unable to start IV line|0|||
33314021|NCT01261793|62689895|FG002|Overall Study|Patient unable to start IV line|1|||
33711980|NCT01471782|63278642|FG001|Overall Study|Change of Chemotherapy|1|||
33711981|NCT01471782|63278643|FG002|Overall Study|Change of Chemotherapy|0|||
33711982|NCT01471782|63278644|FG003|Overall Study|Change of Chemotherapy|0|||
33711983|NCT01471782|63278645|FG004|Overall Study|Change of Chemotherapy|1|||
33711984|NCT01471782|63278646|FG005|Overall Study|Change of Chemotherapy|4|||
33711985|NCT01471782|63278641|FG000|Overall Study|Disease Relapse|0|||
33711986|NCT01471782|63278642|FG001|Overall Study|Disease Relapse|0|||
33711987|NCT01471782|63278643|FG002|Overall Study|Disease Relapse|0|||
33711988|NCT01471782|63278644|FG003|Overall Study|Disease Relapse|1|||
33711989|NCT01471782|63278645|FG004|Overall Study|Disease Relapse|2|||
33711990|NCT01471782|63278646|FG005|Overall Study|Disease Relapse|1|||
33711991|NCT01471782|63278641|FG000|Overall Study|Physician Decision|0|||
33711992|NCT01471782|63278642|FG001|Overall Study|Physician Decision|0|||
33711993|NCT01471782|63278643|FG002|Overall Study|Physician Decision|0|||
33711994|NCT01471782|63278644|FG003|Overall Study|Physician Decision|0|||
33711995|NCT01471782|63278645|FG004|Overall Study|Physician Decision|3|||
33401830|NCT00654368|62780799|FG002|Overall Study|Protocol deviation|1|||
33401831|NCT00654368|62780797|FG000|Overall Study|Non-compliance|2|||
33401832|NCT00654368|62780798|FG001|Overall Study|Non-compliance|1|||
33401833|NCT00654368|62780799|FG002|Overall Study|Non-compliance|2|||
33401834|NCT00654368|62780797|FG000|Overall Study|Withdrawal by Subject|5|||
33401835|NCT00654368|62780798|FG001|Overall Study|Withdrawal by Subject|2|||
33401836|NCT00654368|62780799|FG002|Overall Study|Withdrawal by Subject|2|||
33401837|NCT00654368|62780797|FG000|Overall Study|Disease progression|21|||
33401838|NCT00654368|62780798|FG001|Overall Study|Disease progression|31|||
33401839|NCT00654368|62780799|FG002|Overall Study|Disease progression|13|||
33401840|NCT00654368|62780797|FG000|Overall Study|Requirement for alternative therapy|1|||
33401841|NCT00654368|62780798|FG001|Overall Study|Requirement for alternative therapy|1|||
33401842|NCT00654368|62780799|FG002|Overall Study|Requirement for alternative therapy|1|||
33401843|NCT00654368|62780797|FG000|Overall Study|Physician Decision|0|||
33401844|NCT00654368|62780798|FG001|Overall Study|Physician Decision|0|||
33401845|NCT00654368|62780799|FG002|Overall Study|Physician Decision|2|||
33401846|NCT00654368|62780797|FG000|Overall Study|Death|1|||
33401847|NCT00654368|62780798|FG001|Overall Study|Death|0|||
33401848|NCT00654368|62780799|FG002|Overall Study|Death|0|||
33401849|NCT00654368|62780797|FG000|Overall Study|Pregnancy|0|||
33401850|NCT00654368|62780798|FG001|Overall Study|Pregnancy|0|||
33401851|NCT00654368|62780799|FG002|Overall Study|Pregnancy|2|||
33401852|NCT00654368|62780797|FG000|Overall Study|Other|0|||
33401853|NCT00654368|62780798|FG001|Overall Study|Other|2|||
33401854|NCT00654368|62780799|FG002|Overall Study|Other|3|||
33401855|NCT00654368|62780797|FG000|Overall Study|Adverse Event|14|||
33401856|NCT00654368|62780798|FG001|Overall Study|Adverse Event|9|||
33401857|NCT00654368|62780799|FG002|Overall Study|Adverse Event|6|||
33401858|NCT00647426|62780806|FG000|Overall Study|Withdrawal by Subject|2|||
33401859|NCT00647348|62780813|FG000|Overall Study|Lost to Follow-up|3|||
33401860|NCT00647348|62780814|FG001|Overall Study|Lost to Follow-up|6|||
33401861|NCT00647270|62780823|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
33401862|NCT00647270|62780824|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
33401863|NCT00647270|62780825|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
33401864|NCT00647270|62780823|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
33401865|NCT00647270|62780824|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
33711996|NCT01471782|63278646|FG005|Overall Study|Physician Decision|8|||
33711997|NCT01471782|63278641|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33711998|NCT01471782|63278642|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33711999|NCT01471782|63278643|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
33712000|NCT01471782|63278644|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
33712001|NCT01471782|63278645|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
33712002|NCT01471782|63278646|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
33712003|NCT01471782|63278641|FG000|Overall Study|Death|0|||
33712004|NCT01471782|63278642|FG001|Overall Study|Death|0|||
33712005|NCT01471782|63278643|FG002|Overall Study|Death|0|||
33712006|NCT01471782|63278644|FG003|Overall Study|Death|0|||
33712007|NCT01471782|63278645|FG004|Overall Study|Death|0|||
33712008|NCT01471782|63278646|FG005|Overall Study|Death|1|||
33712009|NCT01490580|63278673|FG000|Overall Study|Parents withdrew consent|0|||
33712010|NCT01490580|63278674|FG001|Overall Study|Parents withdrew consent|2|||
33712011|NCT01490190|63278684|FG000|Overall Study|Withdrawal by Subject|9|||
33712012|NCT01490190|63278684|FG000|Overall Study|Adverse Event|17|||
33712013|NCT01490190|63278684|FG000|Overall Study|Protocol Violation|5|||
33712014|NCT01490190|63278684|FG000|Overall Study|Lost to Follow-up|13|||
33314022|NCT01261325|62689906|FG000|Overall Study|Lack of Efficacy|1|||
33314023|NCT01261325|62689907|FG001|Overall Study|Lack of Efficacy|1|||
33314024|NCT01261325|62689908|FG002|Overall Study|Lack of Efficacy|0|||
33314025|NCT01261325|62689906|FG000|Overall Study|Withdrawal by Subject|2|||
33314026|NCT01261325|62689907|FG001|Overall Study|Withdrawal by Subject|2|||
33314027|NCT01261325|62689908|FG002|Overall Study|Withdrawal by Subject|4|||
33314028|NCT01261325|62689906|FG000|Overall Study|SAE, non-fatal|1|||
33314029|NCT01261325|62689907|FG001|Overall Study|SAE, non-fatal|5|||
33712015|NCT01490190|63278684|FG000|Overall Study|Relocation|1|||
33712016|NCT01490190|63278684|FG000|Overall Study|Inconvenience|1|||
33712017|NCT01490190|63278684|FG000|Overall Study|Ring expulsion|2|||
33712018|NCT01446042|63278691|FG000|Overall Study|Withdrawal by Subject|12|||
33712019|NCT01446042|63278692|FG001|Overall Study|Withdrawal by Subject|2|||
33712020|NCT01446042|63278693|FG002|Overall Study|Withdrawal by Subject|4|||
33712021|NCT01446042|63278691|FG000|Overall Study|Adverse Event|1|||
33712022|NCT01446042|63278692|FG001|Overall Study|Adverse Event|0|||
33712023|NCT01446042|63278693|FG002|Overall Study|Adverse Event|4|||
33712024|NCT01446042|63278691|FG000|Overall Study|Lost to Follow-up|5|||
33712025|NCT01446042|63278692|FG001|Overall Study|Lost to Follow-up|0|||
33712026|NCT01446042|63278693|FG002|Overall Study|Lost to Follow-up|0|||
33712027|NCT01446042|63278691|FG000|Overall Study|Other reasons|2|||
33712028|NCT01446042|63278692|FG001|Overall Study|Other reasons|1|||
33712029|NCT01446042|63278693|FG002|Overall Study|Other reasons|1|||
33712030|NCT01445886|63278701|FG000|Overall Study|Lost to Follow-up|2|||
33712031|NCT01445886|63278701|FG000|Overall Study|Protocol Violation|3|||
33712032|NCT01470612|63278709|FG000|Overall Study|Adverse Event|20|||
33712033|NCT01470612|63278710|FG001|Overall Study|Adverse Event|80|||
33712034|NCT01470612|63278709|FG000|Overall Study|Death|0|||
33712035|NCT01470612|63278710|FG001|Overall Study|Death|1|||
33712036|NCT01470612|63278709|FG000|Overall Study|Lack of Efficacy|20|||
33712037|NCT01470612|63278710|FG001|Overall Study|Lack of Efficacy|326|||
33712038|NCT01470612|63278709|FG000|Overall Study|Lost to Follow-up|2|||
33712039|NCT01470612|63278710|FG001|Overall Study|Lost to Follow-up|5|||
33314030|NCT01261325|62689908|FG002|Overall Study|SAE, non-fatal|1|||
33314031|NCT01261325|62689906|FG000|Overall Study|AE, non-serious non-fatal|9|||
33314032|NCT01261325|62689907|FG001|Overall Study|AE, non-serious non-fatal|15|||
33314033|NCT01261325|62689908|FG002|Overall Study|AE, non-serious non-fatal|13|||
33314034|NCT01261325|62689906|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
33314035|NCT01261325|62689907|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33314036|NCT01261325|62689908|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33314037|NCT01261325|62689906|FG000|Overall Study|Non Compliance|2|||
33314038|NCT01261325|62689907|FG001|Overall Study|Non Compliance|0|||
33314039|NCT01261325|62689908|FG002|Overall Study|Non Compliance|0|||
33314040|NCT01261325|62689906|FG000|Overall Study|Patient Randomized by Mistake|0|||
33314041|NCT01261325|62689907|FG001|Overall Study|Patient Randomized by Mistake|1|||
33314042|NCT01261325|62689908|FG002|Overall Study|Patient Randomized by Mistake|0|||
33314043|NCT01261325|62689906|FG000|Overall Study|Erroneously Randomized|1|||
33314044|NCT01261325|62689907|FG001|Overall Study|Erroneously Randomized|0|||
33314045|NCT01261325|62689908|FG002|Overall Study|Erroneously Randomized|0|||
33314046|NCT01261325|62689906|FG000|Overall Study|Screen Failure|1|||
33314047|NCT01261325|62689907|FG001|Overall Study|Screen Failure|0|||
33314048|NCT01261325|62689908|FG002|Overall Study|Screen Failure|0|||
33314049|NCT01261325|62689906|FG000|Overall Study|Randomized in Error|0|||
33314050|NCT01261325|62689907|FG001|Overall Study|Randomized in Error|0|||
33314051|NCT01261325|62689908|FG002|Overall Study|Randomized in Error|1|||
33314052|NCT01261325|62689906|FG000|Overall Study|Protocol Violation|0|||
33314053|NCT01261325|62689907|FG001|Overall Study|Protocol Violation|3|||
33314054|NCT01261325|62689908|FG002|Overall Study|Protocol Violation|1|||
33314055|NCT01261325|62689906|FG000|Overall Study|Lost to Follow-up|0|||
33314056|NCT01261325|62689907|FG001|Overall Study|Lost to Follow-up|1|||
33314057|NCT01261325|62689908|FG002|Overall Study|Lost to Follow-up|3|||
33314058|NCT01261325|62689906|FG000|Overall Study|AE, serious fatal|0|||
33314059|NCT01261325|62689907|FG001|Overall Study|AE, serious fatal|0|||
33314060|NCT01261325|62689908|FG002|Overall Study|AE, serious fatal|2|||
33314061|NCT01260701|62689919|FG000|Overall Study|Adverse Event|9|||
33314062|NCT01260701|62689919|FG000|Overall Study|Withdrawal by Subject|2|||
33314063|NCT01260701|62689919|FG000|Overall Study|Progression|53|||
33314064|NCT01260701|62689919|FG000|Overall Study|Death|2|||
33712040|NCT01470612|63278709|FG000|Overall Study|Did not meet entrance criteria|0|||
33314065|NCT01260701|62689919|FG000|Overall Study|Not protocol specified|3|||
33314066|NCT01260701|62689919|FG000|Overall Study|Under review|1|||
33314067|NCT01260701|62689919|FG000|Overall Study|Ineligible|4|||
33314068|NCT01260701|62689919|FG000|Overall Study|Did not begin protocol therapy|1|||
33597499|NCT02325739|62996464|FG005|Phase I Part|Death|0|||
33712041|NCT01470612|63278710|FG001|Overall Study|Did not meet entrance criteria|1|||
33314069|NCT01260467|62689923|FG000|Overall Study|Withdrawal by Subject|2|||
33314070|NCT01260311|62689929|FG000|Overall Study|Adverse Event|11|||
33314071|NCT01260311|62689929|FG000|Overall Study|Lack of Efficacy|4|||
33314072|NCT01260311|62689929|FG000|Overall Study|Lost to Follow-up|25|||
33712042|NCT01470612|63278709|FG000|Overall Study|Pregnancy|2|||
33712043|NCT01470612|63278710|FG001|Overall Study|Pregnancy|10|||
33712044|NCT01470612|63278709|FG000|Overall Study|Protocol Violation|2|||
33314073|NCT01260311|62689929|FG000|Overall Study|Withdrawal by Subject|6|||
33314074|NCT01260311|62689929|FG000|Overall Study|Financial Constraints|77|||
33314075|NCT01260311|62689929|FG000|Overall Study|Gone to Province|2|||
33712045|NCT01470612|63278710|FG001|Overall Study|Protocol Violation|7|||
33712046|NCT01470612|63278709|FG000|Overall Study|Withdrawal by Subject|24|||
33712047|NCT01470612|63278710|FG001|Overall Study|Withdrawal by Subject|79|||
33712048|NCT01470612|63278709|FG000|Overall Study|Other|14|||
33712049|NCT01470612|63278710|FG001|Overall Study|Other|156|||
33712050|NCT01445730|63278716|FG000|Overall Study|Adverse Event|1|||
33712051|NCT01445730|63278716|FG000|Overall Study|For the advice of a dentist|1|||
33314076|NCT01260311|62689929|FG000|Overall Study|Medication Stopped|1|||
33401866|NCT00647270|62780825|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
33401867|NCT00647270|62780823|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
33712052|NCT01445730|63278716|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
33712053|NCT01445652|63278722|FG000|Overall Study|Not comfortable in lenses|5|||
33314077|NCT01260311|62689929|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
33314078|NCT01259375|62689933|FG000|Overall Study|Adverse Event|1|||
33314079|NCT01940471|62689950|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
33597500|NCT02325739|62996465|FG006|Phase I Part|Death|0|||
33712054|NCT01445652|63278723|FG001|Overall Study|Not comfortable in lenses|0|||
33712055|NCT01445652|63278722|FG000|Overall Study|Failed to attend scheduled visit|2|||
33712056|NCT01445652|63278723|FG001|Overall Study|Failed to attend scheduled visit|3|||
33712057|NCT01445652|63278722|FG000|Overall Study|Failed teach session|2|||
33712058|NCT01445652|63278723|FG001|Overall Study|Failed teach session|0|||
33712059|NCT01445652|63278722|FG000|Overall Study|Adverse Event|1|||
33712060|NCT01445652|63278723|FG001|Overall Study|Adverse Event|0|||
33712061|NCT01470144|63278729|FG000|Overall Study|Adverse Event|2|||
33712062|NCT01470144|63278729|FG000|Overall Study|Death|1|||
33712063|NCT01470144|63278729|FG000|Overall Study|Lung transplant|6|||
33712064|NCT01470144|63278729|FG000|Overall Study|Patient's and investigator's decision|1|||
33712065|NCT01443858|63278736|FG000|Overall Study|Withdrawal by Subject|9|||
33712066|NCT01443858|63278737|FG001|Overall Study|Withdrawal by Subject|8|||
33712067|NCT01443858|63278738|FG002|Overall Study|Withdrawal by Subject|5|||
33712068|NCT01443858|63278736|FG000|Overall Study|Lack of Efficacy|1|||
33712069|NCT01443858|63278737|FG001|Overall Study|Lack of Efficacy|0|||
33712070|NCT01443858|63278738|FG002|Overall Study|Lack of Efficacy|0|||
33712071|NCT01443858|63278736|FG000|Overall Study|Lost to Follow-up|5|||
33712072|NCT01443858|63278737|FG001|Overall Study|Lost to Follow-up|5|||
33712073|NCT01443858|63278738|FG002|Overall Study|Lost to Follow-up|2|||
33712074|NCT01443078|63278746|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
33712075|NCT01443078|63278746|FG000|Overall Study|Withdrawal by Subject|1|||
33712076|NCT01443078|63278746|FG000|Overall Study|Patient had brain mets|1|||
33712077|NCT01439880|63278752|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
33712078|NCT01439880|63278753|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
33712079|NCT01439880|63278752|FG000|SOC-controlled Period (Year 1)|Death|2|||
33712080|NCT01439880|63278753|FG001|SOC-controlled Period (Year 1)|Death|1|||
33712081|NCT01439880|63278752|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
33712082|NCT01439880|63278753|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
33712083|NCT01439880|63278752|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
33712084|NCT01439880|63278753|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
33712085|NCT01439880|63278752|FG000|SOC-controlled Period (Year 1)|Other|8|||
33712086|NCT01439880|63278753|FG001|SOC-controlled Period (Year 1)|Other|13|||
33712087|NCT01439880|63278752|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
33712088|NCT01439880|63278753|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
33712089|NCT01439880|63278752|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
33712090|NCT01439880|63278753|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
33712091|NCT01439880|63278752|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
33597501|NCT02325739|62996466|FG007|Phase I Part|Death|0|||
33712092|NCT01439880|63278753|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
33712093|NCT01439880|63278752|FG000|All-IP Period (Years 2 to 5)|Death|3|||
33712094|NCT01439880|63278753|FG001|All-IP Period (Years 2 to 5)|Death|13|||
33712095|NCT01439880|63278752|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
33712096|NCT01439880|63278753|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
33712097|NCT01439880|63278752|FG000|All-IP Period (Years 2 to 5)|Other|14|||
33314080|NCT01940471|62689951|FG001|Double-Blind Phase|Randomized but Never Treated|1|||
33314081|NCT01940471|62689950|FG000|Double-Blind Phase|Withdrew Consent|13|||
33314082|NCT01940471|62689951|FG001|Double-Blind Phase|Withdrew Consent|7|||
33314083|NCT01940471|62689950|FG000|Double-Blind Phase|Adverse Event|1|||
33314084|NCT01940471|62689951|FG001|Double-Blind Phase|Adverse Event|2|||
33314085|NCT01940471|62689950|FG000|Double-Blind Phase|Lost to Follow-up|3|||
33314086|NCT01940471|62689951|FG001|Double-Blind Phase|Lost to Follow-up|2|||
33314087|NCT01940471|62689950|FG000|Double-Blind Phase|Pregnancy|2|||
33712098|NCT01439880|63278753|FG001|All-IP Period (Years 2 to 5)|Other|31|||
33712099|NCT01439880|63278752|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
33712100|NCT01439880|63278753|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
33712101|NCT01469364|63278770|FG000|Overall Study|Adverse Event|1|||
33712102|NCT01469364|63278770|FG000|Overall Study|Withdrawal by Subject|1|||
33712103|NCT01439724|63278776|FG000|Overall Study|missing consultation|9|||
33712104|NCT01439724|63278777|FG001|Overall Study|missing consultation|8|||
33712105|NCT01439568|63278785|FG000|Overall Study|Lost to Follow-up|1|||
33712106|NCT01439568|63278786|FG001|Overall Study|Lost to Follow-up|0|||
33712107|NCT01439568|63278785|FG000|Overall Study|Withdrawal by Subject|2|||
33712108|NCT01439568|63278786|FG001|Overall Study|Withdrawal by Subject|2|||
33712109|NCT01469052|63278798|FG000|Overall Study|Adverse Event|2|||
33712110|NCT01469052|63278799|FG001|Overall Study|Adverse Event|3|||
33712111|NCT01469052|63278800|FG002|Overall Study|Adverse Event|0|||
33712112|NCT01469052|63278801|FG003|Overall Study|Adverse Event|2|||
33712113|NCT01469052|63278802|FG004|Overall Study|Adverse Event|0|||
33712114|NCT01469052|63278803|FG005|Overall Study|Adverse Event|1|||
33712115|NCT01469052|63278798|FG000|Overall Study|Progressive disease|3|||
33712116|NCT01469052|63278799|FG001|Overall Study|Progressive disease|0|||
33712117|NCT01469052|63278800|FG002|Overall Study|Progressive disease|5|||
33712118|NCT01469052|63278801|FG003|Overall Study|Progressive disease|3|||
33712119|NCT01469052|63278802|FG004|Overall Study|Progressive disease|7|||
33712120|NCT01469052|63278803|FG005|Overall Study|Progressive disease|2|||
33712121|NCT01469052|63278798|FG000|Overall Study|Lack of Efficacy|0|||
33712122|NCT01469052|63278799|FG001|Overall Study|Lack of Efficacy|0|||
33712123|NCT01469052|63278800|FG002|Overall Study|Lack of Efficacy|0|||
33712124|NCT01469052|63278801|FG003|Overall Study|Lack of Efficacy|0|||
33712125|NCT01469052|63278802|FG004|Overall Study|Lack of Efficacy|0|||
33712126|NCT01469052|63278803|FG005|Overall Study|Lack of Efficacy|2|||
33712127|NCT01469052|63278798|FG000|Overall Study|Moved to rollover protocol|1|||
33712128|NCT01469052|63278799|FG001|Overall Study|Moved to rollover protocol|0|||
33712129|NCT01469052|63278800|FG002|Overall Study|Moved to rollover protocol|1|||
33712130|NCT01469052|63278801|FG003|Overall Study|Moved to rollover protocol|0|||
33712131|NCT01469052|63278802|FG004|Overall Study|Moved to rollover protocol|0|||
33712132|NCT01469052|63278803|FG005|Overall Study|Moved to rollover protocol|1|||
33712133|NCT01469052|63278798|FG000|Overall Study|Other|0|||
33712134|NCT01469052|63278799|FG001|Overall Study|Other|1|||
33712135|NCT01469052|63278800|FG002|Overall Study|Other|0|||
33712136|NCT01469052|63278801|FG003|Overall Study|Other|0|||
33314088|NCT01940471|62689951|FG001|Double-Blind Phase|Pregnancy|1|||
33712137|NCT01469052|63278802|FG004|Overall Study|Other|1|||
33712138|NCT01469052|63278803|FG005|Overall Study|Other|0|||
33712139|NCT01468818|63278815|FG000|Overall Study|Death during treatment|2|||
33712140|NCT01442376|63278822|FG000|Overall Study|Adverse Event|0|||
33712141|NCT01442376|63278823|FG001|Overall Study|Adverse Event|3|||
33712142|NCT01442376|63278824|FG002|Overall Study|Adverse Event|2|||
33712143|NCT01442376|63278822|FG000|Overall Study|Death|0|||
33712144|NCT01442376|63278823|FG001|Overall Study|Death|1|||
33712145|NCT01442376|63278824|FG002|Overall Study|Death|1|||
33712146|NCT01442376|63278822|FG000|Overall Study|Withdrawal of consent|0|||
33712147|NCT01442376|63278823|FG001|Overall Study|Withdrawal of consent|0|||
33712148|NCT01442376|63278824|FG002|Overall Study|Withdrawal of consent|1|||
33712149|NCT01442376|63278822|FG000|Overall Study|Patients not treated|2|||
33712150|NCT01442376|63278823|FG001|Overall Study|Patients not treated|3|||
33712151|NCT01442376|63278824|FG002|Overall Study|Patients not treated|1|||
33712152|NCT01442376|63278822|FG000|Overall Study|Not eligible for subsequent cycles|1|||
33712153|NCT01442376|63278823|FG001|Overall Study|Not eligible for subsequent cycles|2|||
33712154|NCT01442376|63278824|FG002|Overall Study|Not eligible for subsequent cycles|0|||
33712155|NCT01442064|63278838|FG000|Overall Study|Adverse Event|2|||
33712156|NCT01442064|63278839|FG001|Overall Study|Adverse Event|2|||
33314089|NCT01940471|62689950|FG000|Double-Blind Phase|Investigator's Discretion|5|||
33314090|NCT01940471|62689951|FG001|Double-Blind Phase|Investigator's Discretion|0|||
33314091|NCT01940471|62689950|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
33314092|NCT01940471|62689951|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
33314093|NCT01940471|62689950|FG000|Double-Blind Phase|Protocol-Specified Criteria|1|||
33314094|NCT01940471|62689951|FG001|Double-Blind Phase|Protocol-Specified Criteria|0|||
33314095|NCT01940471|62689950|FG000|Double-Blind Phase|Death|1|||
33314096|NCT01940471|62689951|FG001|Double-Blind Phase|Death|0|||
33314097|NCT01940471|62689950|FG000|Double-Blind Phase|Lack of Efficacy|1|||
33314098|NCT01940471|62689951|FG001|Double-Blind Phase|Lack of Efficacy|0|||
33314099|NCT01940471|62689950|FG000|Double-Blind Phase|Protocol Violation|0|||
33314100|NCT01940471|62689951|FG001|Double-Blind Phase|Protocol Violation|1|||
33314101|NCT01940471|62689950|FG000|Double-Blind Phase|Still in Double-Blind Phase|539|||
33314102|NCT01940471|62689951|FG001|Double-Blind Phase|Still in Double-Blind Phase|270|||
33314103|NCT01940471|62689950|FG000|Open-Label Extension|Still in Open-Label Extension Phase|14|||
33314104|NCT01940471|62689951|FG001|Open-Label Extension|Still in Open-Label Extension Phase|8|||
33314105|NCT01259297|62689966|FG000|Double Blind Randomized Period|Death|1|||
33314106|NCT01259297|62689967|FG001|Double Blind Randomized Period|Death|1|||
33314107|NCT01259297|62689968|FG002|Double Blind Randomized Period|Death|1|||
33314108|NCT01259297|62689969|FG003|Double Blind Randomized Period|Death|2|||
33314109|NCT01259297|62689970|FG004|Double Blind Randomized Period|Death|1|||
33314110|NCT01259297|62689971|FG005|Double Blind Randomized Period|Death|5|||
33314111|NCT01259297|62689972|FG006|Double Blind Randomized Period|Death|2|||
33314112|NCT01259297|62689973|FG007|Double Blind Randomized Period|Death|1|||
33314113|NCT01259297|62689966|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
33314114|NCT01259297|62689967|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
33314115|NCT01259297|62689968|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
33314116|NCT01259297|62689969|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
33314117|NCT01259297|62689970|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
33314118|NCT01259297|62689971|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
33314119|NCT01259297|62689972|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
33314120|NCT01259297|62689973|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
33314121|NCT01259297|62689966|FG000|Double Blind Randomized Period|Other reasons|0|||
33314122|NCT01259297|62689967|FG001|Double Blind Randomized Period|Other reasons|1|||
33314123|NCT01259297|62689968|FG002|Double Blind Randomized Period|Other reasons|0|||
33314124|NCT01259297|62689969|FG003|Double Blind Randomized Period|Other reasons|0|||
33314125|NCT01259297|62689970|FG004|Double Blind Randomized Period|Other reasons|1|||
33314126|NCT01259297|62689971|FG005|Double Blind Randomized Period|Other reasons|2|||
33314127|NCT01259297|62689972|FG006|Double Blind Randomized Period|Other reasons|3|||
33314128|NCT01259297|62689973|FG007|Double Blind Randomized Period|Other reasons|1|||
33314129|NCT01126437|62689993|FG000|Overall Study|Not treated|11|||
33314130|NCT01126437|62689994|FG001|Overall Study|Not treated|18|||
33314131|NCT01126437|62689995|FG002|Overall Study|Not treated|19|||
33314132|NCT01126437|62689993|FG000|Overall Study|Sites with data irregularities/fraud|6|||
33314133|NCT01126437|62689994|FG001|Overall Study|Sites with data irregularities/fraud|6|||
33314134|NCT01126437|62689995|FG002|Overall Study|Sites with data irregularities/fraud|7|||
33314135|NCT01126437|62689993|FG000|Overall Study|Adverse Event|602|||
33314136|NCT01126437|62689994|FG001|Overall Study|Adverse Event|606|||
33401868|NCT00647270|62780824|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
33712157|NCT01442064|63278840|FG002|Overall Study|Adverse Event|2|||
33314137|NCT01126437|62689995|FG002|Overall Study|Adverse Event|635|||
33314138|NCT01126437|62689993|FG000|Overall Study|Lack of Efficacy|65|||
33314139|NCT01126437|62689994|FG001|Overall Study|Lack of Efficacy|60|||
33314140|NCT01126437|62689995|FG002|Overall Study|Lack of Efficacy|59|||
33314141|NCT01126437|62689993|FG000|Overall Study|Protocol Violation|64|||
33314142|NCT01126437|62689994|FG001|Overall Study|Protocol Violation|66|||
33314143|NCT01126437|62689995|FG002|Overall Study|Protocol Violation|41|||
33314144|NCT01126437|62689993|FG000|Overall Study|Lost to Follow-up|52|||
33401869|NCT00647270|62780825|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
33712158|NCT01442064|63278841|FG003|Overall Study|Adverse Event|1|||
33314145|NCT01126437|62689994|FG001|Overall Study|Lost to Follow-up|63|||
33314146|NCT01126437|62689995|FG002|Overall Study|Lost to Follow-up|55|||
33314147|NCT01126437|62689993|FG000|Overall Study|Withdrawal by Subject|331|||
33314148|NCT01126437|62689994|FG001|Overall Study|Withdrawal by Subject|335|||
33314149|NCT01126437|62689995|FG002|Overall Study|Withdrawal by Subject|319|||
33314150|NCT01126437|62689993|FG000|Overall Study|Other reason not specified|210|||
33314151|NCT01126437|62689994|FG001|Overall Study|Other reason not specified|176|||
33314152|NCT01126437|62689995|FG002|Overall Study|Other reason not specified|178|||
33314153|NCT01258595|62690005|FG000|Overall Study|Lost to Follow-up|1|||
33314154|NCT01258595|62690006|FG001|Overall Study|Lost to Follow-up|0|||
33314155|NCT01258595|62690005|FG000|Overall Study|Withdrawal by Subject|0|||
33314156|NCT01258595|62690006|FG001|Overall Study|Withdrawal by Subject|1|||
33314157|NCT01257737|62690014|FG000|Overall Study|Lost to Follow-up|1|||
33314158|NCT01257737|62690015|FG001|Overall Study|Lost to Follow-up|2|||
33314159|NCT01257737|62690014|FG000|Overall Study|Liver transplant|1|||
33314160|NCT01257737|62690015|FG001|Overall Study|Liver transplant|0|||
33314161|NCT01257737|62690014|FG000|Overall Study|Relocation out of the country|0|||
33314162|NCT01257737|62690015|FG001|Overall Study|Relocation out of the country|1|||
33314163|NCT01257737|62690014|FG000|Overall Study|Withdrew from study|0|||
33314164|NCT01257737|62690015|FG001|Overall Study|Withdrew from study|1|||
33314165|NCT01126359|62690022|FG000|First Intervention (20-minutes)|Physician Decision|0|||
33314166|NCT01126359|62690023|FG001|First Intervention (20-minutes)|Physician Decision|1|||
33314167|NCT01125813|62690033|FG000|Overall Study|Death|1|||
33314168|NCT01125813|62690033|FG000|Overall Study|Withdrawal by Subject|1|||
33314169|NCT01125813|62690033|FG000|Overall Study|Screen Failures|4|||
33314170|NCT00996892|62690037|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
33314171|NCT00996892|62690038|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
33314172|NCT00996892|62690039|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
33314173|NCT00996892|62690040|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
33314174|NCT00996892|62690041|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
33597502|NCT02325739|62996467|FG008|Phase I Part|Death|0|||
33314175|NCT00996892|62690042|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
33314176|NCT00996892|62690043|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
33314177|NCT00996892|62690044|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
33314178|NCT00996892|62690045|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
33314179|NCT00996892|62690046|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
33314180|NCT00996892|62690047|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
33314181|NCT00996892|62690048|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
33314182|NCT00996892|62690049|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
33314183|NCT00996892|62690050|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
33314184|NCT00996892|62690051|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
33314185|NCT00996892|62690052|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
33314186|NCT00996892|62690053|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
33314187|NCT00996892|62690054|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
33314188|NCT00996892|62690055|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
33314189|NCT00996892|62690056|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
33314190|NCT00996892|62690037|FG000|Dose-Escalation Stage 1|Death|1|||
33314191|NCT00996892|62690038|FG001|Dose-Escalation Stage 1|Death|0|||
33712159|NCT01442064|63278842|FG004|Overall Study|Adverse Event|2|||
33314192|NCT00996892|62690039|FG002|Dose-Escalation Stage 1|Death|0|||
33314193|NCT00996892|62690040|FG003|Dose-Escalation Stage 1|Death|0|||
33314194|NCT00996892|62690041|FG004|Dose-Escalation Stage 1|Death|0|||
33314195|NCT00996892|62690042|FG005|Dose-Escalation Stage 1|Death|1|||
33712160|NCT01442064|63278843|FG005|Overall Study|Adverse Event|0|||
33712161|NCT01442064|63278838|FG000|Overall Study|Death|0|||
33712162|NCT01442064|63278839|FG001|Overall Study|Death|1|||
33712163|NCT01442064|63278840|FG002|Overall Study|Death|3|||
33712164|NCT01442064|63278841|FG003|Overall Study|Death|3|||
33712165|NCT01442064|63278842|FG004|Overall Study|Death|1|||
33712166|NCT01442064|63278843|FG005|Overall Study|Death|3|||
33712167|NCT01442064|63278838|FG000|Overall Study|Lost to Follow-up|5|||
33712168|NCT01442064|63278839|FG001|Overall Study|Lost to Follow-up|5|||
33712169|NCT01442064|63278840|FG002|Overall Study|Lost to Follow-up|1|||
33712170|NCT01442064|63278841|FG003|Overall Study|Lost to Follow-up|1|||
33712171|NCT01442064|63278842|FG004|Overall Study|Lost to Follow-up|3|||
33712172|NCT01442064|63278843|FG005|Overall Study|Lost to Follow-up|3|||
33712173|NCT01442064|63278838|FG000|Overall Study|Physician Decision|1|||
33712174|NCT01442064|63278839|FG001|Overall Study|Physician Decision|1|||
33712175|NCT01442064|63278840|FG002|Overall Study|Physician Decision|2|||
33712176|NCT01442064|63278841|FG003|Overall Study|Physician Decision|3|||
33314196|NCT00996892|62690043|FG006|Dose-Escalation Stage 1|Death|0|||
33314197|NCT00996892|62690044|FG007|Dose-Escalation Stage 1|Death|0|||
33314198|NCT00996892|62690045|FG008|Dose-Escalation Stage 1|Death|0|||
33314199|NCT00996892|62690046|FG009|Dose-Escalation Stage 1|Death|0|||
33712177|NCT01442064|63278842|FG004|Overall Study|Physician Decision|3|||
33314200|NCT00996892|62690047|FG010|Dose-Escalation Stage 1|Death|0|||
33314201|NCT00996892|62690048|FG011|Dose-Escalation Stage 1|Death|0|||
33314202|NCT00996892|62690049|FG012|Dose-Escalation Stage 1|Death|0|||
33314203|NCT00996892|62690050|FG013|Dose-Escalation Stage 1|Death|0|||
33314204|NCT00996892|62690051|FG014|Dose-Escalation Stage 1|Death|0|||
33712178|NCT01442064|63278843|FG005|Overall Study|Physician Decision|1|||
33712179|NCT01442064|63278838|FG000|Overall Study|Withdrawal by Subject|6|||
33712180|NCT01442064|63278839|FG001|Overall Study|Withdrawal by Subject|3|||
33712181|NCT01442064|63278840|FG002|Overall Study|Withdrawal by Subject|2|||
33712182|NCT01442064|63278841|FG003|Overall Study|Withdrawal by Subject|2|||
33712183|NCT01442064|63278842|FG004|Overall Study|Withdrawal by Subject|2|||
33712184|NCT01442064|63278843|FG005|Overall Study|Withdrawal by Subject|1|||
33712185|NCT01442064|63278838|FG000|Overall Study|Sponsor decision|82|||
33712186|NCT01442064|63278839|FG001|Overall Study|Sponsor decision|88|||
33712187|NCT01442064|63278840|FG002|Overall Study|Sponsor decision|92|||
33712188|NCT01442064|63278841|FG003|Overall Study|Sponsor decision|88|||
33712189|NCT01442064|63278842|FG004|Overall Study|Sponsor decision|95|||
33712190|NCT01442064|63278843|FG005|Overall Study|Sponsor decision|87|||
33712191|NCT01442064|63278838|FG000|Overall Study|Subject non-compliance|0|||
33712192|NCT01442064|63278839|FG001|Overall Study|Subject non-compliance|0|||
33712193|NCT01442064|63278840|FG002|Overall Study|Subject non-compliance|0|||
33712194|NCT01442064|63278841|FG003|Overall Study|Subject non-compliance|0|||
33314205|NCT00996892|62690052|FG015|Dose-Escalation Stage 1|Death|0|||
33314206|NCT00996892|62690053|FG016|Dose-Escalation Stage 1|Death|0|||
33314207|NCT00996892|62690054|FG017|Dose-Escalation Stage 1|Death|0|||
33314208|NCT00996892|62690055|FG018|Dose-Escalation Stage 1|Death|0|||
33314209|NCT00996892|62690056|FG019|Dose-Escalation Stage 1|Death|0|||
33314210|NCT00996892|62690037|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
33314211|NCT00996892|62690038|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
33314212|NCT00996892|62690039|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
33314213|NCT00996892|62690040|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
33314214|NCT00996892|62690041|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
33314215|NCT00996892|62690042|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
33314216|NCT00996892|62690043|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
33314217|NCT00996892|62690044|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
33314218|NCT00996892|62690045|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
33314219|NCT00996892|62690046|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
33314220|NCT00996892|62690047|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
33314221|NCT00996892|62690048|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
33314222|NCT00996892|62690049|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
33314223|NCT00996892|62690050|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
33314224|NCT00996892|62690051|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
33314225|NCT00996892|62690052|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
33314226|NCT00996892|62690053|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
33314227|NCT00996892|62690054|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
33314228|NCT00996892|62690055|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
33314229|NCT00996892|62690056|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
33314230|NCT00996892|62690037|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33314231|NCT00996892|62690038|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
33314232|NCT00996892|62690039|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33314233|NCT00996892|62690040|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
33314234|NCT00996892|62690041|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
33314235|NCT00996892|62690042|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
33314236|NCT00996892|62690043|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
33314237|NCT00996892|62690044|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33314238|NCT00996892|62690045|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33314239|NCT00996892|62690046|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33314240|NCT00996892|62690047|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33314241|NCT00996892|62690048|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33314242|NCT00996892|62690049|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33314243|NCT00996892|62690050|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33314244|NCT00996892|62690051|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33314245|NCT00996892|62690052|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33314246|NCT00996892|62690053|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33314247|NCT00996892|62690054|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33314248|NCT00996892|62690055|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33314249|NCT00996892|62690056|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33314250|NCT00996892|62690037|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
33314251|NCT00996892|62690038|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
33314252|NCT00996892|62690039|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
33314253|NCT00996892|62690040|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
33314254|NCT00996892|62690041|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
33314255|NCT00996892|62690042|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
33314256|NCT00996892|62690043|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
33314257|NCT00996892|62690044|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
33314258|NCT00996892|62690045|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
33314259|NCT00996892|62690046|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
33314260|NCT00996892|62690047|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
33314261|NCT00996892|62690048|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
33314262|NCT00996892|62690049|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
33314263|NCT00996892|62690050|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
33314264|NCT00996892|62690051|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
33314265|NCT00996892|62690052|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
33314266|NCT00996892|62690053|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
33314267|NCT00996892|62690054|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
33314268|NCT00996892|62690055|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
33314269|NCT00996892|62690056|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
33314270|NCT00996892|62690037|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
33314271|NCT00996892|62690038|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
33314272|NCT00996892|62690039|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
33314273|NCT00996892|62690040|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
33314274|NCT00996892|62690041|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
33314275|NCT00996892|62690042|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
33314276|NCT00996892|62690043|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
33314277|NCT00996892|62690044|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
33314278|NCT00996892|62690045|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
33314279|NCT00996892|62690046|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
33314280|NCT00996892|62690047|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
33314281|NCT00996892|62690048|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
33314282|NCT00996892|62690049|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
33314283|NCT00996892|62690050|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
33401870|NCT00647270|62780823|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
33401871|NCT00647270|62780824|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
33314284|NCT00996892|62690051|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
33314285|NCT00996892|62690052|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
33314286|NCT00996892|62690053|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
33314287|NCT00996892|62690054|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
33314288|NCT00996892|62690055|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
33314289|NCT00996892|62690056|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
33314290|NCT00996892|62690037|FG000|Dose-Escalation Stage 1A|Death|0|||
33314291|NCT00996892|62690038|FG001|Dose-Escalation Stage 1A|Death|0|||
33314292|NCT00996892|62690039|FG002|Dose-Escalation Stage 1A|Death|0|||
33314293|NCT00996892|62690040|FG003|Dose-Escalation Stage 1A|Death|0|||
33314294|NCT00996892|62690041|FG004|Dose-Escalation Stage 1A|Death|0|||
33314295|NCT00996892|62690042|FG005|Dose-Escalation Stage 1A|Death|0|||
33314296|NCT00996892|62690043|FG006|Dose-Escalation Stage 1A|Death|0|||
33314297|NCT00996892|62690044|FG007|Dose-Escalation Stage 1A|Death|0|||
33314298|NCT00996892|62690045|FG008|Dose-Escalation Stage 1A|Death|0|||
33314299|NCT00996892|62690046|FG009|Dose-Escalation Stage 1A|Death|2|||
33314300|NCT00996892|62690047|FG010|Dose-Escalation Stage 1A|Death|0|||
33314301|NCT00996892|62690048|FG011|Dose-Escalation Stage 1A|Death|1|||
33314302|NCT00996892|62690049|FG012|Dose-Escalation Stage 1A|Death|1|||
33314303|NCT00996892|62690050|FG013|Dose-Escalation Stage 1A|Death|0|||
33314304|NCT00996892|62690051|FG014|Dose-Escalation Stage 1A|Death|0|||
33314305|NCT00996892|62690052|FG015|Dose-Escalation Stage 1A|Death|0|||
33314306|NCT00996892|62690053|FG016|Dose-Escalation Stage 1A|Death|0|||
33314307|NCT00996892|62690054|FG017|Dose-Escalation Stage 1A|Death|0|||
33314308|NCT00996892|62690055|FG018|Dose-Escalation Stage 1A|Death|0|||
33401872|NCT00647270|62780825|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
33401873|NCT00647270|62780823|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
33314309|NCT00996892|62690056|FG019|Dose-Escalation Stage 1A|Death|0|||
33314310|NCT00996892|62690037|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
33314311|NCT00996892|62690038|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
33314312|NCT00996892|62690039|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
33314313|NCT00996892|62690040|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
33314314|NCT00996892|62690041|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
33314315|NCT00996892|62690042|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
33314316|NCT00996892|62690043|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
33314317|NCT00996892|62690044|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
33314318|NCT00996892|62690045|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
33314319|NCT00996892|62690046|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
33314320|NCT00996892|62690047|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
33314321|NCT00996892|62690048|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
33314322|NCT00996892|62690049|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
33314323|NCT00996892|62690050|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
33314324|NCT00996892|62690051|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
33314325|NCT00996892|62690052|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
33314326|NCT00996892|62690053|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
33314327|NCT00996892|62690054|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
33314328|NCT00996892|62690055|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
33314329|NCT00996892|62690056|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
33314330|NCT00996892|62690037|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314331|NCT00996892|62690038|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314332|NCT00996892|62690039|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314333|NCT00996892|62690040|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314334|NCT00996892|62690041|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314335|NCT00996892|62690042|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314336|NCT00996892|62690043|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314337|NCT00996892|62690044|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314338|NCT00996892|62690045|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314339|NCT00996892|62690046|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
33314340|NCT00996892|62690047|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
33314341|NCT00996892|62690048|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
33314342|NCT00996892|62690049|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
33314343|NCT00996892|62690050|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314344|NCT00996892|62690051|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314345|NCT00996892|62690052|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314346|NCT00996892|62690053|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314347|NCT00996892|62690054|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314348|NCT00996892|62690055|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314349|NCT00996892|62690056|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33314350|NCT00996892|62690037|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
33314351|NCT00996892|62690038|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
33314352|NCT00996892|62690039|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
33314353|NCT00996892|62690040|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
33314354|NCT00996892|62690041|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
33314355|NCT00996892|62690042|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
33314356|NCT00996892|62690043|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
33314357|NCT00996892|62690044|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
33314358|NCT00996892|62690045|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
33314359|NCT00996892|62690046|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
33314360|NCT00996892|62690047|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
33314361|NCT00996892|62690048|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
33314362|NCT00996892|62690049|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
33314363|NCT00996892|62690050|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
33314364|NCT00996892|62690051|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
33314365|NCT00996892|62690052|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
33314366|NCT00996892|62690053|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
33314367|NCT00996892|62690054|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
33314368|NCT00996892|62690055|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
33314369|NCT00996892|62690056|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
33314370|NCT00996892|62690037|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
33314371|NCT00996892|62690038|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
33314372|NCT00996892|62690039|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
33314373|NCT00996892|62690040|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
33314374|NCT00996892|62690041|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
33314375|NCT00996892|62690042|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
33314376|NCT00996892|62690043|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
33314377|NCT00996892|62690044|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
33597503|NCT02325739|62996468|FG009|Phase I Part|Death|0|||
33597504|NCT02325739|62996469|FG010|Phase I Part|Death|0|||
33712195|NCT01442064|63278842|FG004|Overall Study|Subject non-compliance|0|||
33712196|NCT01442064|63278843|FG005|Overall Study|Subject non-compliance|2|||
33712197|NCT01442064|63278838|FG000|Overall Study|Condition mandated other intervention|1|||
33712198|NCT01442064|63278839|FG001|Overall Study|Condition mandated other intervention|1|||
33712199|NCT01442064|63278840|FG002|Overall Study|Condition mandated other intervention|2|||
33712200|NCT01442064|63278841|FG003|Overall Study|Condition mandated other intervention|0|||
33712201|NCT01442064|63278842|FG004|Overall Study|Condition mandated other intervention|0|||
33712202|NCT01442064|63278843|FG005|Overall Study|Condition mandated other intervention|2|||
33712203|NCT01467960|63278866|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
33712204|NCT01467960|63278867|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
33712205|NCT01467960|63278868|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
33712206|NCT01467960|63278869|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
33712207|NCT01467960|63278870|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
33712208|NCT01467960|63278871|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
33712209|NCT01441596|63278888|FG000|Overall Study|Other reason not defined below|0|||
33712210|NCT01441596|63278889|FG001|Overall Study|Other reason not defined below|2|||
33712211|NCT01441596|63278890|FG002|Overall Study|Other reason not defined below|1|||
33712212|NCT01441596|63278888|FG000|Overall Study|Withdrawal by Subject|4|||
33712213|NCT01441596|63278889|FG001|Overall Study|Withdrawal by Subject|0|||
33712214|NCT01441596|63278890|FG002|Overall Study|Withdrawal by Subject|2|||
33712215|NCT01441596|63278888|FG000|Overall Study|Not treated|0|||
33712216|NCT01441596|63278889|FG001|Overall Study|Not treated|1|||
33712217|NCT01441596|63278890|FG002|Overall Study|Not treated|1|||
33712218|NCT01441440|63278901|FG000|Overall Study|Death|1|||
33712219|NCT01441440|63278902|FG001|Overall Study|Death|0|||
33712220|NCT01441440|63278903|FG002|Overall Study|Death|1|||
33712221|NCT01441440|63278901|FG000|Overall Study|Adverse Event|2|||
33712222|NCT01441440|63278902|FG001|Overall Study|Adverse Event|9|||
33712223|NCT01441440|63278903|FG002|Overall Study|Adverse Event|9|||
33712224|NCT01441440|63278901|FG000|Overall Study|Lost to Follow-up|0|||
33712225|NCT01441440|63278902|FG001|Overall Study|Lost to Follow-up|2|||
33712226|NCT01441440|63278903|FG002|Overall Study|Lost to Follow-up|1|||
33712227|NCT01441440|63278901|FG000|Overall Study|Withdrawal by Subject|11|||
33712228|NCT01441440|63278902|FG001|Overall Study|Withdrawal by Subject|9|||
33712229|NCT01441440|63278903|FG002|Overall Study|Withdrawal by Subject|9|||
33712230|NCT01441440|63278901|FG000|Overall Study|Pregnancy|1|||
33712231|NCT01441440|63278902|FG001|Overall Study|Pregnancy|0|||
33712232|NCT01441440|63278903|FG002|Overall Study|Pregnancy|0|||
33712233|NCT01441440|63278901|FG000|Overall Study|Lack of Efficacy|1|||
33712234|NCT01441440|63278902|FG001|Overall Study|Lack of Efficacy|0|||
33712235|NCT01441440|63278903|FG002|Overall Study|Lack of Efficacy|1|||
33712236|NCT01441440|63278901|FG000|Overall Study|Moving|0|||
33712237|NCT01441440|63278902|FG001|Overall Study|Moving|1|||
33712238|NCT01441440|63278903|FG002|Overall Study|Moving|1|||
33712239|NCT01441440|63278901|FG000|Overall Study|Work-related matter|0|||
33712240|NCT01441440|63278902|FG001|Overall Study|Work-related matter|1|||
33712241|NCT01441440|63278903|FG002|Overall Study|Work-related matter|0|||
33314378|NCT00996892|62690045|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
33314379|NCT00996892|62690046|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
33314380|NCT00996892|62690047|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
33314381|NCT00996892|62690048|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
33314382|NCT00996892|62690049|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
33314383|NCT00996892|62690050|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
33314384|NCT00996892|62690051|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
33314385|NCT00996892|62690052|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
33314386|NCT00996892|62690053|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
33314387|NCT00996892|62690054|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
33314388|NCT00996892|62690055|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
33314389|NCT00996892|62690056|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
33314390|NCT00996892|62690037|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
33314391|NCT00996892|62690038|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
33314392|NCT00996892|62690039|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
33314393|NCT00996892|62690040|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
33314394|NCT00996892|62690041|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
33314395|NCT00996892|62690042|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
33314396|NCT00996892|62690043|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
33314397|NCT00996892|62690044|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
33314398|NCT00996892|62690045|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
33314399|NCT00996892|62690046|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
33314400|NCT00996892|62690047|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
33314401|NCT00996892|62690048|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
33314402|NCT00996892|62690049|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
33314403|NCT00996892|62690050|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
33314404|NCT00996892|62690051|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
33314405|NCT00996892|62690052|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
33314406|NCT00996892|62690053|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
33314407|NCT00996892|62690054|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
33314408|NCT00996892|62690055|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
33314409|NCT00996892|62690056|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
33314410|NCT00996892|62690037|FG000|Expansion Stage 2|Adverse Event|0|||
33314411|NCT00996892|62690038|FG001|Expansion Stage 2|Adverse Event|0|||
33314412|NCT00996892|62690039|FG002|Expansion Stage 2|Adverse Event|0|||
33314413|NCT00996892|62690040|FG003|Expansion Stage 2|Adverse Event|0|||
33314414|NCT00996892|62690041|FG004|Expansion Stage 2|Adverse Event|0|||
33314415|NCT00996892|62690042|FG005|Expansion Stage 2|Adverse Event|0|||
33314416|NCT00996892|62690043|FG006|Expansion Stage 2|Adverse Event|0|||
33314417|NCT00996892|62690044|FG007|Expansion Stage 2|Adverse Event|0|||
33314418|NCT00996892|62690045|FG008|Expansion Stage 2|Adverse Event|0|||
33314419|NCT00996892|62690046|FG009|Expansion Stage 2|Adverse Event|0|||
33314420|NCT00996892|62690047|FG010|Expansion Stage 2|Adverse Event|0|||
33401874|NCT00647270|62780824|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
33401875|NCT00647270|62780825|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
33314421|NCT00996892|62690048|FG011|Expansion Stage 2|Adverse Event|0|||
33314422|NCT00996892|62690049|FG012|Expansion Stage 2|Adverse Event|0|||
33314423|NCT00996892|62690050|FG013|Expansion Stage 2|Adverse Event|0|||
33314424|NCT00996892|62690051|FG014|Expansion Stage 2|Adverse Event|0|||
33314425|NCT00996892|62690052|FG015|Expansion Stage 2|Adverse Event|0|||
33597505|NCT02325739|62996459|FG000|Phase II Part|Adverse Event|0|||
33712242|NCT01441440|63278901|FG000|Overall Study|Difficllty in keeping the schedule|1|||
33314426|NCT00996892|62690053|FG016|Expansion Stage 2|Adverse Event|0|||
33314427|NCT00996892|62690054|FG017|Expansion Stage 2|Adverse Event|0|||
33314428|NCT00996892|62690055|FG018|Expansion Stage 2|Adverse Event|3|||
33314429|NCT00996892|62690056|FG019|Expansion Stage 2|Adverse Event|0|||
33314430|NCT00996892|62690037|FG000|Expansion Stage 2|Death|0|||
33314431|NCT00996892|62690038|FG001|Expansion Stage 2|Death|0|||
33314432|NCT00996892|62690039|FG002|Expansion Stage 2|Death|0|||
33314433|NCT00996892|62690040|FG003|Expansion Stage 2|Death|0|||
33314434|NCT00996892|62690041|FG004|Expansion Stage 2|Death|0|||
33314435|NCT00996892|62690042|FG005|Expansion Stage 2|Death|0|||
33314436|NCT00996892|62690043|FG006|Expansion Stage 2|Death|0|||
33314437|NCT00996892|62690044|FG007|Expansion Stage 2|Death|0|||
33314438|NCT00996892|62690045|FG008|Expansion Stage 2|Death|0|||
33314439|NCT00996892|62690046|FG009|Expansion Stage 2|Death|0|||
33314440|NCT00996892|62690047|FG010|Expansion Stage 2|Death|0|||
33314441|NCT00996892|62690048|FG011|Expansion Stage 2|Death|0|||
33314442|NCT00996892|62690049|FG012|Expansion Stage 2|Death|0|||
33314443|NCT00996892|62690050|FG013|Expansion Stage 2|Death|0|||
33314444|NCT00996892|62690051|FG014|Expansion Stage 2|Death|0|||
33314445|NCT00996892|62690052|FG015|Expansion Stage 2|Death|0|||
33314446|NCT00996892|62690053|FG016|Expansion Stage 2|Death|0|||
33314447|NCT00996892|62690054|FG017|Expansion Stage 2|Death|0|||
33314448|NCT00996892|62690055|FG018|Expansion Stage 2|Death|2|||
33314449|NCT00996892|62690056|FG019|Expansion Stage 2|Death|0|||
33314450|NCT00996892|62690037|FG000|Expansion Stage 2|Physician Decision|0|||
33314451|NCT00996892|62690038|FG001|Expansion Stage 2|Physician Decision|0|||
33314452|NCT00996892|62690039|FG002|Expansion Stage 2|Physician Decision|0|||
33314453|NCT00996892|62690040|FG003|Expansion Stage 2|Physician Decision|0|||
33314454|NCT00996892|62690041|FG004|Expansion Stage 2|Physician Decision|0|||
33314455|NCT00996892|62690042|FG005|Expansion Stage 2|Physician Decision|0|||
33314456|NCT00996892|62690043|FG006|Expansion Stage 2|Physician Decision|0|||
33314457|NCT00996892|62690044|FG007|Expansion Stage 2|Physician Decision|0|||
33314458|NCT00996892|62690045|FG008|Expansion Stage 2|Physician Decision|0|||
33314459|NCT00996892|62690046|FG009|Expansion Stage 2|Physician Decision|0|||
33314460|NCT00996892|62690047|FG010|Expansion Stage 2|Physician Decision|0|||
33314461|NCT00996892|62690048|FG011|Expansion Stage 2|Physician Decision|0|||
33314462|NCT00996892|62690049|FG012|Expansion Stage 2|Physician Decision|0|||
33314463|NCT00996892|62690050|FG013|Expansion Stage 2|Physician Decision|0|||
33314464|NCT00996892|62690051|FG014|Expansion Stage 2|Physician Decision|0|||
33314465|NCT00996892|62690052|FG015|Expansion Stage 2|Physician Decision|0|||
33314466|NCT00996892|62690053|FG016|Expansion Stage 2|Physician Decision|0|||
33314467|NCT00996892|62690054|FG017|Expansion Stage 2|Physician Decision|0|||
33314468|NCT00996892|62690055|FG018|Expansion Stage 2|Physician Decision|1|||
33314469|NCT00996892|62690056|FG019|Expansion Stage 2|Physician Decision|0|||
33314470|NCT00996892|62690037|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
33314471|NCT00996892|62690038|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
33314472|NCT00996892|62690039|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
33314473|NCT00996892|62690040|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
33314474|NCT00996892|62690041|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
33314475|NCT00996892|62690042|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
33314476|NCT00996892|62690043|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
33314477|NCT00996892|62690044|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
33597506|NCT02325739|62996460|FG001|Phase II Part|Adverse Event|0|||
33597507|NCT02325739|62996461|FG002|Phase II Part|Adverse Event|0|||
33597508|NCT02325739|62996462|FG003|Phase II Part|Adverse Event|0|||
33597509|NCT02325739|62996463|FG004|Phase II Part|Adverse Event|0|||
33597510|NCT02325739|62996464|FG005|Phase II Part|Adverse Event|0|||
33597511|NCT02325739|62996465|FG006|Phase II Part|Adverse Event|0|||
33597512|NCT02325739|62996466|FG007|Phase II Part|Adverse Event|0|||
33314478|NCT00996892|62690045|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
33314479|NCT00996892|62690046|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
33314480|NCT00996892|62690047|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
33314481|NCT00996892|62690048|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
33314482|NCT00996892|62690049|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
33314483|NCT00996892|62690050|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
33314484|NCT00996892|62690051|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
33314485|NCT00996892|62690052|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
33597513|NCT02325739|62996467|FG008|Phase II Part|Adverse Event|4|||
33314486|NCT00996892|62690053|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
33314487|NCT00996892|62690054|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
33314488|NCT00996892|62690055|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
33314489|NCT00996892|62690056|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
33712243|NCT01441440|63278902|FG001|Overall Study|Difficllty in keeping the schedule|1|||
33712244|NCT01441440|63278903|FG002|Overall Study|Difficllty in keeping the schedule|0|||
33712245|NCT01438476|63278913|FG000|Overall Study|Protocol Violation|1|||
33712246|NCT01438476|63278914|FG001|Overall Study|Protocol Violation|0|||
33712247|NCT01438476|63278913|FG000|Overall Study|Withdrawal by Subject|1|||
33712248|NCT01438476|63278914|FG001|Overall Study|Withdrawal by Subject|0|||
33712249|NCT01438476|63278913|FG000|Overall Study|No Surgery- Disease|8|||
33712250|NCT01438476|63278914|FG001|Overall Study|No Surgery- Disease|10|||
33712251|NCT01438476|63278913|FG000|Overall Study|Communication barrier|0|||
33712252|NCT01438476|63278914|FG001|Overall Study|Communication barrier|1|||
33712253|NCT01467570|63278922|FG000|Overall Study|Lost to Follow-up|8|||
33712254|NCT01467570|63278923|FG001|Overall Study|Lost to Follow-up|9|||
33712255|NCT01437540|63278933|FG000|Overall Study|Not listed below|7|||
33712256|NCT01437540|63278934|FG001|Overall Study|Not listed below|6|||
33712257|NCT01437540|63278933|FG000|Overall Study|COPD exacerbation|13|||
33712258|NCT01437540|63278934|FG001|Overall Study|COPD exacerbation|3|||
33712259|NCT01437540|63278933|FG000|Overall Study|Lost to Follow-up|3|||
33712260|NCT01437540|63278934|FG001|Overall Study|Lost to Follow-up|5|||
33712261|NCT01437540|63278933|FG000|Overall Study|Lack of Efficacy|23|||
33712262|NCT01437540|63278934|FG001|Overall Study|Lack of Efficacy|11|||
33712263|NCT01437540|63278933|FG000|Overall Study|Protocol Violation|24|||
33712264|NCT01437540|63278934|FG001|Overall Study|Protocol Violation|12|||
33712265|NCT01437540|63278933|FG000|Overall Study|Adverse Event|26|||
33712266|NCT01437540|63278934|FG001|Overall Study|Adverse Event|13|||
33712267|NCT01437540|63278933|FG000|Overall Study|Withdrawal by Subject|31|||
33712268|NCT01437540|63278934|FG001|Overall Study|Withdrawal by Subject|15|||
33712269|NCT01440972|63278942|FG000|Overall Study|Withdrawal by Subject|3|||
33712270|NCT01440972|63278943|FG001|Overall Study|Withdrawal by Subject|2|||
33712271|NCT01420536|63278951|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
33712272|NCT01420536|63278952|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
33712273|NCT01420068|63278962|FG000|Overall Study|Administrative problems|1|||
33712274|NCT01420068|63278963|FG001|Overall Study|Administrative problems|3|||
33712275|NCT01420068|63278962|FG000|Overall Study|Withdrawal by Subject|1|||
33712276|NCT01420068|63278963|FG001|Overall Study|Withdrawal by Subject|2|||
33712277|NCT01467492|63278971|FG000|Overall Study|Withdrawal by Subject|6|||
33712278|NCT01467492|63278972|FG001|Overall Study|Withdrawal by Subject|4|||
33712279|NCT01467492|63278971|FG000|Overall Study|Study Terminated by Sponsor|6|||
33712280|NCT01467492|63278972|FG001|Overall Study|Study Terminated by Sponsor|4|||
33712281|NCT01467492|63278971|FG000|Overall Study|Adverse Event|4|||
33712282|NCT01467492|63278972|FG001|Overall Study|Adverse Event|3|||
33712283|NCT01467492|63278971|FG000|Overall Study|Lost to Follow-up|3|||
33712284|NCT01467492|63278972|FG001|Overall Study|Lost to Follow-up|2|||
33712285|NCT01467492|63278971|FG000|Overall Study|Undefined|2|||
33712286|NCT01467492|63278972|FG001|Overall Study|Undefined|0|||
33712287|NCT01467492|63278971|FG000|Overall Study|Enrolled But Not Treated|1|||
33712288|NCT01467492|63278972|FG001|Overall Study|Enrolled But Not Treated|0|||
33712289|NCT01466790|63278987|FG000|Overall Study|Adverse Event|1|||
33712290|NCT01466790|63278988|FG001|Overall Study|Adverse Event|0|||
33712291|NCT01466790|63278989|FG002|Overall Study|Adverse Event|0|||
33712292|NCT01466790|63278990|FG003|Overall Study|Adverse Event|0|||
33712293|NCT01466790|63278991|FG004|Overall Study|Adverse Event|2|||
33712294|NCT01466790|63278992|FG005|Overall Study|Adverse Event|0|||
33712295|NCT01466790|63278993|FG006|Overall Study|Adverse Event|0|||
33712296|NCT01466790|63278994|FG007|Overall Study|Adverse Event|0|||
33712297|NCT01466790|63278987|FG000|Overall Study|Lost to Follow-up|2|||
33712298|NCT01466790|63278988|FG001|Overall Study|Lost to Follow-up|0|||
33712299|NCT01466790|63278989|FG002|Overall Study|Lost to Follow-up|0|||
33712300|NCT01466790|63278990|FG003|Overall Study|Lost to Follow-up|0|||
33712301|NCT01466790|63278991|FG004|Overall Study|Lost to Follow-up|0|||
33712302|NCT01466790|63278992|FG005|Overall Study|Lost to Follow-up|0|||
33712303|NCT01466790|63278993|FG006|Overall Study|Lost to Follow-up|0|||
33712304|NCT01466790|63278994|FG007|Overall Study|Lost to Follow-up|0|||
33712305|NCT01466790|63278987|FG000|Overall Study|Withdrawal by Subject|1|||
33712306|NCT01466790|63278988|FG001|Overall Study|Withdrawal by Subject|1|||
33314490|NCT00996892|62690037|FG000|Expansion Stage 2|Disease Progression|0|||
33401876|NCT00647270|62780823|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
33401877|NCT00647270|62780824|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
33401878|NCT00647270|62780825|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
33401879|NCT00647270|62780823|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
33401880|NCT00647270|62780824|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
33401881|NCT00647270|62780825|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
33401882|NCT00645944|62780838|FG000|Randomized|Withdrawal by Subject|1|||
33314491|NCT00996892|62690038|FG001|Expansion Stage 2|Disease Progression|0|||
33314492|NCT00996892|62690039|FG002|Expansion Stage 2|Disease Progression|0|||
33314493|NCT00996892|62690040|FG003|Expansion Stage 2|Disease Progression|0|||
33314494|NCT00996892|62690041|FG004|Expansion Stage 2|Disease Progression|0|||
33314495|NCT00996892|62690042|FG005|Expansion Stage 2|Disease Progression|0|||
33314496|NCT00996892|62690043|FG006|Expansion Stage 2|Disease Progression|0|||
33314497|NCT00996892|62690044|FG007|Expansion Stage 2|Disease Progression|0|||
33314498|NCT00996892|62690045|FG008|Expansion Stage 2|Disease Progression|0|||
33314499|NCT00996892|62690046|FG009|Expansion Stage 2|Disease Progression|0|||
33314500|NCT00996892|62690047|FG010|Expansion Stage 2|Disease Progression|0|||
33314501|NCT00996892|62690048|FG011|Expansion Stage 2|Disease Progression|0|||
33314502|NCT00996892|62690049|FG012|Expansion Stage 2|Disease Progression|0|||
33314503|NCT00996892|62690050|FG013|Expansion Stage 2|Disease Progression|0|||
33314504|NCT00996892|62690051|FG014|Expansion Stage 2|Disease Progression|0|||
33314505|NCT00996892|62690052|FG015|Expansion Stage 2|Disease Progression|0|||
33314506|NCT00996892|62690053|FG016|Expansion Stage 2|Disease Progression|0|||
33314507|NCT00996892|62690054|FG017|Expansion Stage 2|Disease Progression|0|||
33314508|NCT00996892|62690055|FG018|Expansion Stage 2|Disease Progression|28|||
33314509|NCT00996892|62690056|FG019|Expansion Stage 2|Disease Progression|0|||
33314510|NCT00996892|62690037|FG000|Expansion Stage 2A|Adverse Event|0|||
33314511|NCT00996892|62690038|FG001|Expansion Stage 2A|Adverse Event|0|||
33314512|NCT00996892|62690039|FG002|Expansion Stage 2A|Adverse Event|0|||
33314513|NCT00996892|62690040|FG003|Expansion Stage 2A|Adverse Event|0|||
33314514|NCT00996892|62690041|FG004|Expansion Stage 2A|Adverse Event|0|||
33314515|NCT00996892|62690042|FG005|Expansion Stage 2A|Adverse Event|0|||
33314516|NCT00996892|62690043|FG006|Expansion Stage 2A|Adverse Event|0|||
33314517|NCT00996892|62690044|FG007|Expansion Stage 2A|Adverse Event|0|||
33314518|NCT00996892|62690045|FG008|Expansion Stage 2A|Adverse Event|0|||
33314519|NCT00996892|62690046|FG009|Expansion Stage 2A|Adverse Event|0|||
33314520|NCT00996892|62690047|FG010|Expansion Stage 2A|Adverse Event|0|||
33314521|NCT00996892|62690048|FG011|Expansion Stage 2A|Adverse Event|0|||
33314522|NCT00996892|62690049|FG012|Expansion Stage 2A|Adverse Event|0|||
33314523|NCT00996892|62690050|FG013|Expansion Stage 2A|Adverse Event|0|||
33314524|NCT00996892|62690051|FG014|Expansion Stage 2A|Adverse Event|0|||
33314525|NCT00996892|62690052|FG015|Expansion Stage 2A|Adverse Event|0|||
33314526|NCT00996892|62690053|FG016|Expansion Stage 2A|Adverse Event|0|||
33314527|NCT00996892|62690054|FG017|Expansion Stage 2A|Adverse Event|0|||
33314528|NCT00996892|62690055|FG018|Expansion Stage 2A|Adverse Event|0|||
33314529|NCT00996892|62690056|FG019|Expansion Stage 2A|Adverse Event|8|||
33314530|NCT00996892|62690037|FG000|Expansion Stage 2A|Physician Decision|0|||
33314531|NCT00996892|62690038|FG001|Expansion Stage 2A|Physician Decision|0|||
33314532|NCT00996892|62690039|FG002|Expansion Stage 2A|Physician Decision|0|||
33314533|NCT00996892|62690040|FG003|Expansion Stage 2A|Physician Decision|0|||
33314534|NCT00996892|62690041|FG004|Expansion Stage 2A|Physician Decision|0|||
33314535|NCT00996892|62690042|FG005|Expansion Stage 2A|Physician Decision|0|||
33314536|NCT00996892|62690043|FG006|Expansion Stage 2A|Physician Decision|0|||
33314537|NCT00996892|62690044|FG007|Expansion Stage 2A|Physician Decision|0|||
33314538|NCT00996892|62690045|FG008|Expansion Stage 2A|Physician Decision|0|||
33314539|NCT00996892|62690046|FG009|Expansion Stage 2A|Physician Decision|0|||
33314540|NCT00996892|62690047|FG010|Expansion Stage 2A|Physician Decision|0|||
33314541|NCT00996892|62690048|FG011|Expansion Stage 2A|Physician Decision|0|||
33314542|NCT00996892|62690049|FG012|Expansion Stage 2A|Physician Decision|0|||
33314543|NCT00996892|62690050|FG013|Expansion Stage 2A|Physician Decision|0|||
33314544|NCT00996892|62690051|FG014|Expansion Stage 2A|Physician Decision|0|||
33314545|NCT00996892|62690052|FG015|Expansion Stage 2A|Physician Decision|0|||
33314546|NCT00996892|62690053|FG016|Expansion Stage 2A|Physician Decision|0|||
33314547|NCT00996892|62690054|FG017|Expansion Stage 2A|Physician Decision|0|||
33314548|NCT00996892|62690055|FG018|Expansion Stage 2A|Physician Decision|0|||
33314549|NCT00996892|62690056|FG019|Expansion Stage 2A|Physician Decision|2|||
33314550|NCT00996892|62690037|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
33314551|NCT00996892|62690038|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
33314552|NCT00996892|62690039|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
33314553|NCT00996892|62690040|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
33314554|NCT00996892|62690041|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
33314555|NCT00996892|62690042|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
33314556|NCT00996892|62690043|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
33314557|NCT00996892|62690044|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
33314558|NCT00996892|62690045|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
33314559|NCT00996892|62690046|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
33314560|NCT00996892|62690047|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
33314561|NCT00996892|62690048|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
33314562|NCT00996892|62690049|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
33314563|NCT00996892|62690050|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
33314564|NCT00996892|62690051|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
33314565|NCT00996892|62690052|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
33314566|NCT00996892|62690053|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
33314567|NCT00996892|62690054|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
33314568|NCT00996892|62690055|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
33314569|NCT00996892|62690056|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
33314570|NCT00996892|62690037|FG000|Expansion Stage 2A|Disease Progression|0|||
33314571|NCT00996892|62690038|FG001|Expansion Stage 2A|Disease Progression|0|||
33314572|NCT00996892|62690039|FG002|Expansion Stage 2A|Disease Progression|0|||
33314573|NCT00996892|62690040|FG003|Expansion Stage 2A|Disease Progression|0|||
33314574|NCT00996892|62690041|FG004|Expansion Stage 2A|Disease Progression|0|||
33314575|NCT00996892|62690042|FG005|Expansion Stage 2A|Disease Progression|0|||
33314576|NCT00996892|62690043|FG006|Expansion Stage 2A|Disease Progression|0|||
33314577|NCT00996892|62690044|FG007|Expansion Stage 2A|Disease Progression|0|||
33314578|NCT00996892|62690045|FG008|Expansion Stage 2A|Disease Progression|0|||
33314579|NCT00996892|62690046|FG009|Expansion Stage 2A|Disease Progression|0|||
33314580|NCT00996892|62690047|FG010|Expansion Stage 2A|Disease Progression|0|||
33314581|NCT00996892|62690048|FG011|Expansion Stage 2A|Disease Progression|0|||
33314582|NCT00996892|62690049|FG012|Expansion Stage 2A|Disease Progression|0|||
33314583|NCT00996892|62690050|FG013|Expansion Stage 2A|Disease Progression|0|||
33314584|NCT00996892|62690051|FG014|Expansion Stage 2A|Disease Progression|0|||
33314585|NCT00996892|62690052|FG015|Expansion Stage 2A|Disease Progression|0|||
33314586|NCT00996892|62690053|FG016|Expansion Stage 2A|Disease Progression|0|||
33314587|NCT00996892|62690054|FG017|Expansion Stage 2A|Disease Progression|0|||
33314588|NCT00996892|62690055|FG018|Expansion Stage 2A|Disease Progression|0|||
33314589|NCT00996892|62690056|FG019|Expansion Stage 2A|Disease Progression|31|||
33314590|NCT01257581|62690120|FG000|Overall Study|Early Termination|3|||
33314591|NCT01257581|62690121|FG001|Overall Study|Early Termination|1|||
33314592|NCT01257581|62690122|FG002|Overall Study|Early Termination|2|||
33314593|NCT01257581|62690120|FG000|Overall Study|Death|2|||
33314594|NCT01257581|62690121|FG001|Overall Study|Death|2|||
33314595|NCT01257581|62690122|FG002|Overall Study|Death|4|||
33314596|NCT01257503|62690132|FG000|Overall Study|Lost to Follow-up|7|||
33314597|NCT01257503|62690133|FG001|Overall Study|Lost to Follow-up|10|||
33314598|NCT01257503|62690132|FG000|Overall Study|Over 5 years old at enrollment|0|||
33314599|NCT01257503|62690133|FG001|Overall Study|Over 5 years old at enrollment|1|||
33314600|NCT01257503|62690132|FG000|Overall Study|strep culture positive at enrollment|1|||
33314601|NCT01257503|62690133|FG001|Overall Study|strep culture positive at enrollment|0|||
33314602|NCT00995566|62690139|FG000|Overall Study|Adverse Event|2|||
33314603|NCT00995566|62690139|FG000|Overall Study|Early study termination|52|||
33314604|NCT01257425|62690145|FG000|Overall Study|Lack of Efficacy|3|||
33314605|NCT01257425|62690146|FG001|Overall Study|Lack of Efficacy|3|||
33314606|NCT01257425|62690145|FG000|Overall Study|Adverse Event|1|||
33314607|NCT01257425|62690146|FG001|Overall Study|Adverse Event|1|||
33314608|NCT01257425|62690145|FG000|Overall Study|Protocol Violation|1|||
33314609|NCT01257425|62690146|FG001|Overall Study|Protocol Violation|1|||
33314610|NCT01257425|62690145|FG000|Overall Study|Withdrawal by Subject|0|||
33314611|NCT01257425|62690146|FG001|Overall Study|Withdrawal by Subject|1|||
33314612|NCT01257425|62690145|FG000|Overall Study|Death|1|||
33314613|NCT01257425|62690146|FG001|Overall Study|Death|0|||
33314614|NCT00995488|62690152|FG000|Overall Study|Withdrawal by Subject|1|||
33314615|NCT01256879|62690156|FG000|Overall Study|Withdrawal by Subject|1|||
33314616|NCT01125189|62690169|FG000|Treatment Period|Lack of Efficacy|15|||
33314617|NCT01125189|62690170|FG001|Treatment Period|Lack of Efficacy|18|||
33314618|NCT01125189|62690171|FG002|Treatment Period|Lack of Efficacy|25|||
33314619|NCT01125189|62690169|FG000|Treatment Period|Adverse Event|7|||
33314620|NCT01125189|62690170|FG001|Treatment Period|Adverse Event|8|||
33314621|NCT01125189|62690171|FG002|Treatment Period|Adverse Event|8|||
33314622|NCT01125189|62690169|FG000|Treatment Period|Withdrawal by Subject|3|||
33314623|NCT01125189|62690170|FG001|Treatment Period|Withdrawal by Subject|1|||
33314624|NCT01125189|62690171|FG002|Treatment Period|Withdrawal by Subject|1|||
33314625|NCT01125189|62690169|FG000|Treatment Period|Death|1|||
33314626|NCT01125189|62690170|FG001|Treatment Period|Death|0|||
33314627|NCT01125189|62690171|FG002|Treatment Period|Death|0|||
33314628|NCT01125189|62690169|FG000|Treatment Period|Lost to Follow-up|1|||
33314629|NCT01125189|62690170|FG001|Treatment Period|Lost to Follow-up|2|||
33314630|NCT01125189|62690171|FG002|Treatment Period|Lost to Follow-up|1|||
33314631|NCT01125189|62690169|FG000|Treatment Period|Poor compliance/noncompliance|0|||
33314632|NCT01125189|62690170|FG001|Treatment Period|Poor compliance/noncompliance|1|||
33493839|NCT03535194|62872387|FG004|Maintenance Period|Protocol Violation|0|||
33712307|NCT01466790|63278989|FG002|Overall Study|Withdrawal by Subject|0|||
33712308|NCT01466790|63278990|FG003|Overall Study|Withdrawal by Subject|0|||
33712309|NCT01466790|63278991|FG004|Overall Study|Withdrawal by Subject|1|||
33712310|NCT01466790|63278992|FG005|Overall Study|Withdrawal by Subject|0|||
33712311|NCT01466790|63278993|FG006|Overall Study|Withdrawal by Subject|1|||
33712312|NCT01466790|63278994|FG007|Overall Study|Withdrawal by Subject|1|||
33712313|NCT01418352|63279012|FG000|Overall Study|Lost to Follow-up|2|||
33712314|NCT01418352|63279013|FG001|Overall Study|Lost to Follow-up|0|||
33712315|NCT01418352|63279014|FG002|Overall Study|Lost to Follow-up|0|||
33712316|NCT01418352|63279015|FG003|Overall Study|Lost to Follow-up|0|||
33712317|NCT01418352|63279012|FG000|Overall Study|Adverse Event|0|||
33712318|NCT01418352|63279013|FG001|Overall Study|Adverse Event|1|||
33712319|NCT01418352|63279014|FG002|Overall Study|Adverse Event|0|||
33712320|NCT01418352|63279015|FG003|Overall Study|Adverse Event|0|||
33712321|NCT01418352|63279012|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
33712322|NCT01418352|63279013|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
33712323|NCT01418352|63279014|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
33712324|NCT01418352|63279015|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
33712325|NCT01418352|63279012|FG000|Overall Study|Subject Withdrew Consent|0|||
33712326|NCT01418352|63279013|FG001|Overall Study|Subject Withdrew Consent|1|||
33712327|NCT01418352|63279014|FG002|Overall Study|Subject Withdrew Consent|2|||
33712328|NCT01418352|63279015|FG003|Overall Study|Subject Withdrew Consent|1|||
33712329|NCT01418352|63279012|FG000|Overall Study|Protocol Deviation|0|||
33712330|NCT01418352|63279013|FG001|Overall Study|Protocol Deviation|0|||
33712331|NCT01418352|63279014|FG002|Overall Study|Protocol Deviation|1|||
33712332|NCT01418352|63279015|FG003|Overall Study|Protocol Deviation|0|||
33712333|NCT01418352|63279012|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
33712334|NCT01418352|63279013|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
33712335|NCT01418352|63279014|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
33712336|NCT01418352|63279015|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
33712337|NCT01436370|63279033|FG000|Overall Study|Lost to Follow-up|0|||
33712338|NCT01436370|63279034|FG001|Overall Study|Lost to Follow-up|0|||
33712339|NCT01436370|63279035|FG002|Overall Study|Lost to Follow-up|0|||
33314633|NCT01125189|62690171|FG002|Treatment Period|Poor compliance/noncompliance|0|||
33314634|NCT01125189|62690169|FG000|Treatment Period|Participants requested to discontinue|1|||
33314635|NCT01125189|62690170|FG001|Treatment Period|Participants requested to discontinue|3|||
33314636|NCT01125189|62690171|FG002|Treatment Period|Participants requested to discontinue|4|||
33314637|NCT01125189|62690169|FG000|Treatment Period|Other reasons|1|||
33314638|NCT01125189|62690170|FG001|Treatment Period|Other reasons|1|||
33314639|NCT01125189|62690171|FG002|Treatment Period|Other reasons|0|||
33401883|NCT00645944|62780839|FG001|Randomized|Withdrawal by Subject|2|||
33401884|NCT00645944|62780838|FG000|Received Medication|Adverse Event|2|||
33401885|NCT00645944|62780839|FG001|Received Medication|Adverse Event|1|||
33401886|NCT00645944|62780838|FG000|Received Medication|Withdrawal by Subject|1|||
33401887|NCT00645944|62780839|FG001|Received Medication|Withdrawal by Subject|1|||
33401888|NCT00645944|62780838|FG000|Received Medication|Lost to Follow-up|1|||
33493840|NCT03535194|62872383|FG000|Maintenance Period|Withdrawal by Subject|7|||
33597514|NCT02325739|62996468|FG009|Phase II Part|Adverse Event|5|||
33314640|NCT01125189|62690169|FG000|Treatment Period|Completed 24 week treatment period only|2|||
33314641|NCT01125189|62690170|FG001|Treatment Period|Completed 24 week treatment period only|1|||
33314642|NCT01125189|62690171|FG002|Treatment Period|Completed 24 week treatment period only|2|||
33314643|NCT01125189|62690169|FG000|Follow up Period|Withdrawal by Subject|3|||
33314644|NCT01125189|62690170|FG001|Follow up Period|Withdrawal by Subject|2|||
33314645|NCT01125189|62690171|FG002|Follow up Period|Withdrawal by Subject|5|||
33314646|NCT01125189|62690169|FG000|Follow up Period|Death|1|||
33314647|NCT01125189|62690170|FG001|Follow up Period|Death|0|||
33314648|NCT01125189|62690171|FG002|Follow up Period|Death|0|||
33314649|NCT01125189|62690169|FG000|Follow up Period|Lost to Follow-up|12|||
33314650|NCT01125189|62690170|FG001|Follow up Period|Lost to Follow-up|9|||
33314651|NCT01125189|62690171|FG002|Follow up Period|Lost to Follow-up|6|||
33314652|NCT01125189|62690169|FG000|Follow up Period|Other reasons|4|||
33314653|NCT01125189|62690170|FG001|Follow up Period|Other reasons|4|||
33314654|NCT01125189|62690171|FG002|Follow up Period|Other reasons|5|||
33314655|NCT01256567|62690182|FG000|Overall Study|Withdrawal by Subject|1|||
33314656|NCT00996736|62690189|FG000|Overall Study|Death|1|||
33314657|NCT00996736|62690190|FG001|Overall Study|Death|1|||
33314658|NCT00996736|62690189|FG000|Overall Study|Lost to Follow-up|15|||
33314659|NCT00996736|62690190|FG001|Overall Study|Lost to Follow-up|14|||
33314660|NCT00996736|62690189|FG000|Overall Study|Visit not within 3-month window|5|||
33314661|NCT00996736|62690190|FG001|Overall Study|Visit not within 3-month window|3|||
33314662|NCT00996658|62690198|FG000|Overall Study|Adverse Event|2|||
33314663|NCT00996658|62690199|FG001|Overall Study|Adverse Event|5|||
33314664|NCT00996658|62690198|FG000|Overall Study|Protocol Violation|0|||
33314665|NCT00996658|62690199|FG001|Overall Study|Protocol Violation|1|||
33314666|NCT00996658|62690198|FG000|Overall Study|Lost to Follow-up|2|||
33314667|NCT00996658|62690199|FG001|Overall Study|Lost to Follow-up|5|||
33314668|NCT00996658|62690198|FG000|Overall Study|Non-compliance issues|3|||
33314669|NCT00996658|62690199|FG001|Overall Study|Non-compliance issues|3|||
33314670|NCT00996658|62690198|FG000|Overall Study|Other|9|||
33314671|NCT00996658|62690199|FG001|Overall Study|Other|7|||
33314672|NCT01124643|62690205|FG000|Overall Study|Death|1|||
33314673|NCT01256411|62690213|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
33314674|NCT01256411|62690214|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
33314675|NCT01256411|62690215|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
33314676|NCT01256411|62690216|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
33314677|NCT01256411|62690217|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
33314678|NCT01256411|62690218|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
33314679|NCT01256411|62690213|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
33314680|NCT01256411|62690214|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
33314681|NCT01256411|62690215|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
33314682|NCT01256411|62690216|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
33314683|NCT01256411|62690217|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
33314684|NCT01256411|62690218|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
33597515|NCT02325739|62996469|FG010|Phase II Part|Adverse Event|1|||
33597516|NCT02325739|62996459|FG000|Phase II Part|Physician Decision|0|||
33712340|NCT01436370|63279036|FG003|Overall Study|Lost to Follow-up|0|||
33712341|NCT01436370|63279037|FG004|Overall Study|Lost to Follow-up|1|||
33314685|NCT01256411|62690213|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
33314686|NCT01256411|62690214|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
33314687|NCT01256411|62690215|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
33314688|NCT01256411|62690216|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
33314689|NCT01256411|62690217|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
33314690|NCT01256411|62690218|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
33314691|NCT01256411|62690213|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
33314692|NCT01256411|62690214|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
33314693|NCT01256411|62690215|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
33314694|NCT01256411|62690216|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
33314695|NCT01256411|62690217|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
33401889|NCT00645944|62780839|FG001|Received Medication|Lost to Follow-up|0|||
33712342|NCT01436370|63279038|FG005|Overall Study|Lost to Follow-up|0|||
33712343|NCT01436370|63279039|FG006|Overall Study|Lost to Follow-up|0|||
33712344|NCT01436370|63279040|FG007|Overall Study|Lost to Follow-up|0|||
33712345|NCT01465464|63279068|FG000|Overall Study|Adverse Event|96|||
33712346|NCT01465464|63279069|FG001|Overall Study|Adverse Event|49|||
33712347|NCT01465464|63279068|FG000|Overall Study|Lack of Efficacy|139|||
33712348|NCT01465464|63279069|FG001|Overall Study|Lack of Efficacy|190|||
33712349|NCT01465464|63279068|FG000|Overall Study|Physician Decision|13|||
33401890|NCT00645944|62780838|FG000|Received Medication|Protocol Violation|2|||
33712350|NCT01465464|63279069|FG001|Overall Study|Physician Decision|5|||
33712351|NCT01465464|63279068|FG000|Overall Study|Protocol Violation|1|||
33712352|NCT01465464|63279069|FG001|Overall Study|Protocol Violation|1|||
33712353|NCT01465464|63279068|FG000|Overall Study|Withdrawal by Subject|46|||
33712354|NCT01465464|63279069|FG001|Overall Study|Withdrawal by Subject|30|||
33712355|NCT01465464|63279068|FG000|Overall Study|Other|9|||
33712356|NCT01465464|63279069|FG001|Overall Study|Other|3|||
33712357|NCT01465464|63279068|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
33712358|NCT01465464|63279069|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
33712359|NCT01417104|63279077|FG000|Overall Study|Withdrawal by Subject|5|||
33712360|NCT01417104|63279078|FG001|Overall Study|Withdrawal by Subject|1|||
33712361|NCT01417104|63279077|FG000|Overall Study|Failure to make contact|0|||
33712362|NCT01417104|63279078|FG001|Overall Study|Failure to make contact|1|||
33712363|NCT01417104|63279077|FG000|Overall Study|Adverse Event|1|||
33712364|NCT01417104|63279078|FG001|Overall Study|Adverse Event|0|||
33712365|NCT01465386|63279084|FG000|Overall Study|Lack of Efficacy|3|||
33712366|NCT01465386|63279084|FG000|Overall Study|Adverse Event|1|||
33712367|NCT01465230|63279088|FG000|Overall Study|Withdrawal by Subject|2|||
33712368|NCT01435356|63279094|FG000|Overall Study|Adverse Event|2|||
33712369|NCT01435356|63279095|FG001|Overall Study|Adverse Event|0|||
33314696|NCT01256411|62690218|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
33314697|NCT01256411|62690213|FG000|Extension by Maximum Treatment|Adverse Event|4|||
33314698|NCT01256411|62690214|FG001|Extension by Maximum Treatment|Adverse Event|2|||
33314699|NCT01256411|62690215|FG002|Extension by Maximum Treatment|Adverse Event|1|||
33314700|NCT01256411|62690216|FG003|Extension by Maximum Treatment|Adverse Event|0|||
33314701|NCT01256411|62690217|FG004|Extension by Maximum Treatment|Adverse Event|0|||
33314702|NCT01256411|62690218|FG005|Extension by Maximum Treatment|Adverse Event|0|||
33314703|NCT01256411|62690213|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
33314704|NCT01256411|62690214|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
33314705|NCT01256411|62690215|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
33314706|NCT01256411|62690216|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
33314707|NCT01256411|62690217|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
33712370|NCT01435356|63279094|FG000|Overall Study|Disease progression/recurrence|17|||
33712371|NCT01435356|63279095|FG001|Overall Study|Disease progression/recurrence|10|||
33712372|NCT01435356|63279094|FG000|Overall Study|Protocol Violation|0|||
33712373|NCT01435356|63279095|FG001|Overall Study|Protocol Violation|1|||
33712374|NCT01435356|63279094|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
33712375|NCT01435356|63279095|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
33712376|NCT01435356|63279094|FG000|Overall Study|Withdrawal by Subject|1|||
33712377|NCT01435356|63279095|FG001|Overall Study|Withdrawal by Subject|1|||
33712378|NCT01435356|63279094|FG000|Overall Study|Facial palsy|1|||
33712379|NCT01435356|63279095|FG001|Overall Study|Facial palsy|0|||
33712380|NCT01435356|63279094|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
33712381|NCT01435356|63279095|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
33712382|NCT01435356|63279094|FG000|Overall Study|Physician Decision|1|||
33712383|NCT01435356|63279095|FG001|Overall Study|Physician Decision|0|||
33712384|NCT01435356|63279094|FG000|Overall Study|Patient decision|3|||
33712385|NCT01435356|63279095|FG001|Overall Study|Patient decision|0|||
33712386|NCT01435356|63279094|FG000|Overall Study|Patient moved to another city|1|||
33712387|NCT01435356|63279095|FG001|Overall Study|Patient moved to another city|1|||
33712388|NCT01435122|63279101|FG000|Overall Study|Early withdrawal due to toxicity|8|||
33712389|NCT01434810|63279107|FG000|Overall Study|Did not receive treatment|11|||
33712390|NCT01434810|63279108|FG001|Overall Study|Did not receive treatment|3|||
33712391|NCT01434810|63279107|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
33712392|NCT01434810|63279108|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
33712393|NCT01393626|63279118|FG000|Overall Study|Adverse Event|2|||
33712394|NCT01393626|63279119|FG001|Overall Study|Adverse Event|1|||
33712395|NCT01393626|63279120|FG002|Overall Study|Adverse Event|5|||
33712396|NCT01393626|63279121|FG003|Overall Study|Adverse Event|0|||
33712397|NCT01393626|63279118|FG000|Overall Study|Did not meet entrance criteria|1|||
33712398|NCT01393626|63279119|FG001|Overall Study|Did not meet entrance criteria|0|||
33712399|NCT01393626|63279120|FG002|Overall Study|Did not meet entrance criteria|0|||
33712400|NCT01393626|63279121|FG003|Overall Study|Did not meet entrance criteria|0|||
33712401|NCT01393626|63279118|FG000|Overall Study|Lack of Efficacy|6|||
33712402|NCT01393626|63279119|FG001|Overall Study|Lack of Efficacy|6|||
33712403|NCT01393626|63279120|FG002|Overall Study|Lack of Efficacy|4|||
33712404|NCT01393626|63279121|FG003|Overall Study|Lack of Efficacy|1|||
33712405|NCT01393626|63279118|FG000|Overall Study|Lost to Follow-up|1|||
33712406|NCT01393626|63279119|FG001|Overall Study|Lost to Follow-up|1|||
33712407|NCT01393626|63279120|FG002|Overall Study|Lost to Follow-up|1|||
33712408|NCT01393626|63279121|FG003|Overall Study|Lost to Follow-up|0|||
33712409|NCT01393626|63279118|FG000|Overall Study|Withdrawal by Subject|6|||
33712410|NCT01393626|63279119|FG001|Overall Study|Withdrawal by Subject|4|||
33712411|NCT01393626|63279120|FG002|Overall Study|Withdrawal by Subject|0|||
33314708|NCT01256411|62690218|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
33314709|NCT01256411|62690213|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
33314710|NCT01256411|62690214|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
33314711|NCT01256411|62690215|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
33314712|NCT01256411|62690216|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
33314713|NCT01256411|62690217|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
33314714|NCT01256411|62690218|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
33314715|NCT01256411|62690213|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
33314716|NCT01256411|62690214|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
33314717|NCT01256411|62690215|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
33314718|NCT01256411|62690216|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
33314719|NCT01256411|62690217|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
33314720|NCT01256411|62690218|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
33314721|NCT01256411|62690213|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
33314722|NCT01256411|62690214|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
33314723|NCT01256411|62690215|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
33314724|NCT01256411|62690216|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
33314725|NCT01256411|62690217|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
33314726|NCT01256411|62690218|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
33314727|NCT01256411|62690213|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
33314728|NCT01256411|62690214|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
33314729|NCT01256411|62690215|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
33314730|NCT01256411|62690216|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
33314731|NCT01256411|62690217|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
33314732|NCT01256411|62690218|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
33314733|NCT00996580|62690232|FG000|Overall Study|Adverse Event|466|||
33314734|NCT00996580|62690232|FG000|Overall Study|Lost to Follow-up|480|||
33314735|NCT00996580|62690232|FG000|Overall Study|Noncompliance with the protocol|137|||
33314736|NCT00996580|62690232|FG000|Overall Study|Physician Decision|5|||
33314737|NCT00996580|62690232|FG000|Overall Study|Pregnancy|68|||
33314738|NCT00996580|62690232|FG000|Overall Study|Protocol Violation|16|||
33314739|NCT00996580|62690232|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
33314740|NCT00996580|62690232|FG000|Overall Study|Withdrawal by Subject|217|||
33314741|NCT00996580|62690232|FG000|Overall Study|Other|29|||
33314742|NCT01124175|62690241|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
33712412|NCT01393626|63279121|FG003|Overall Study|Withdrawal by Subject|0|||
33712413|NCT01393626|63279118|FG000|Overall Study|Other|1|||
33712414|NCT01393626|63279119|FG001|Overall Study|Other|0|||
33712415|NCT01393626|63279120|FG002|Overall Study|Other|0|||
33712416|NCT01393626|63279121|FG003|Overall Study|Other|0|||
33712417|NCT01393626|63279118|FG000|Overall Study|Protocol Violation|1|||
33712418|NCT01393626|63279119|FG001|Overall Study|Protocol Violation|0|||
33712419|NCT01393626|63279120|FG002|Overall Study|Protocol Violation|2|||
33712420|NCT01393626|63279121|FG003|Overall Study|Protocol Violation|0|||
33712421|NCT01434654|63279140|FG000|Overall Study|Withdrawal by Subject|1|||
33712422|NCT01434654|63279141|FG001|Overall Study|Withdrawal by Subject|0|||
33712423|NCT01434654|63279140|FG000|Overall Study|Lost to Follow-up|1|||
33712424|NCT01434654|63279141|FG001|Overall Study|Lost to Follow-up|0|||
33712425|NCT01393158|63279151|FG000|Overall Study|Adverse Event|1|||
33712426|NCT01393158|63279152|FG001|Overall Study|Adverse Event|0|||
33712427|NCT01413360|63279164|FG000|Overall Study|Lost to Follow-up|2|||
33712428|NCT01413360|63279164|FG000|Overall Study|Adverse Event|1|||
33712429|NCT01413204|63279171|FG000|Overall Study|Adverse Event|1|||
33712430|NCT01413204|63279172|FG001|Overall Study|Adverse Event|2|||
33712431|NCT01413204|63279173|FG002|Overall Study|Adverse Event|2|||
33712432|NCT01413204|63279171|FG000|Overall Study|Physician Decision|3|||
33712433|NCT01413204|63279172|FG001|Overall Study|Physician Decision|0|||
33314743|NCT01124175|62690242|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
33712434|NCT01413204|63279173|FG002|Overall Study|Physician Decision|2|||
33712435|NCT01413204|63279171|FG000|Overall Study|Withdrawal by Subject|1|||
33712436|NCT01413204|63279172|FG001|Overall Study|Withdrawal by Subject|4|||
33712437|NCT01413204|63279173|FG002|Overall Study|Withdrawal by Subject|4|||
33712438|NCT01413204|63279171|FG000|Overall Study|Clearly not eligible for the study|0|||
33712439|NCT01413204|63279172|FG001|Overall Study|Clearly not eligible for the study|0|||
33712440|NCT01413204|63279173|FG002|Overall Study|Clearly not eligible for the study|1|||
33712441|NCT01413204|63279171|FG000|Overall Study|Fasting plasma glucose level increased|1|||
33712442|NCT01413204|63279172|FG001|Overall Study|Fasting plasma glucose level increased|0|||
33712443|NCT01413204|63279173|FG002|Overall Study|Fasting plasma glucose level increased|10|||
33712444|NCT01392378|63279186|FG000|Infant Series|Adverse Event|0|||
33712445|NCT01392378|63279187|FG001|Infant Series|Adverse Event|0|||
33712446|NCT01392378|63279188|FG002|Infant Series|Adverse Event|0|||
33712447|NCT01392378|63279189|FG003|Infant Series|Adverse Event|1|||
33712448|NCT01392378|63279190|FG004|Infant Series|Adverse Event|0|||
33712449|NCT01392378|63279186|FG000|Infant Series|Lost to Follow-up|0|||
33712450|NCT01392378|63279187|FG001|Infant Series|Lost to Follow-up|0|||
33712451|NCT01392378|63279188|FG002|Infant Series|Lost to Follow-up|0|||
33712452|NCT01392378|63279189|FG003|Infant Series|Lost to Follow-up|1|||
33712453|NCT01392378|63279190|FG004|Infant Series|Lost to Follow-up|0|||
33712454|NCT01392378|63279186|FG000|Infant Series|Protocol Violation|0|||
33712455|NCT01392378|63279187|FG001|Infant Series|Protocol Violation|1|||
33712456|NCT01392378|63279188|FG002|Infant Series|Protocol Violation|0|||
33712457|NCT01392378|63279189|FG003|Infant Series|Protocol Violation|0|||
33712458|NCT01392378|63279190|FG004|Infant Series|Protocol Violation|0|||
33712459|NCT01392378|63279186|FG000|Infant Series|Withdrawal by Parent|4|||
33712460|NCT01392378|63279187|FG001|Infant Series|Withdrawal by Parent|1|||
33712461|NCT01392378|63279188|FG002|Infant Series|Withdrawal by Parent|0|||
33314744|NCT01256177|62690250|FG000|Overall Study|Withdrawal by Subject|23|||
33401891|NCT00645944|62780839|FG001|Received Medication|Protocol Violation|1|||
33314745|NCT01256177|62690251|FG001|Overall Study|Withdrawal by Subject|22|||
33314746|NCT01256177|62690250|FG000|Overall Study|Lost to Follow-up|2|||
33314747|NCT01256177|62690251|FG001|Overall Study|Lost to Follow-up|2|||
33314748|NCT01256177|62690250|FG000|Overall Study|Adverse Event|8|||
33314749|NCT01256177|62690251|FG001|Overall Study|Adverse Event|9|||
33314750|NCT01256177|62690250|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
33314751|NCT01256177|62690251|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
33314752|NCT01256177|62690250|FG000|Overall Study|Condition under Investigation Worsened|1|||
33314753|NCT01256177|62690251|FG001|Overall Study|Condition under Investigation Worsened|0|||
33314754|NCT01256177|62690250|FG000|Overall Study|Lack of Efficacy|11|||
33314755|NCT01256177|62690251|FG001|Overall Study|Lack of Efficacy|2|||
33314756|NCT01256177|62690250|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
33314757|NCT01256177|62690251|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
33314758|NCT00999544|62690257|FG000|Overall Study|Withdrawal by Subject|1|||
33314759|NCT01124097|62690294|FG000|Overall Study|Withdrawal by Subject|4|||
33314760|NCT01124097|62690295|FG001|Overall Study|Withdrawal by Subject|3|||
33314761|NCT01124097|62690296|FG002|Overall Study|Withdrawal by Subject|2|||
33314762|NCT01124097|62690297|FG003|Overall Study|Withdrawal by Subject|3|||
33314763|NCT01124097|62690294|FG000|Overall Study|Lack of Efficacy|2|||
33314764|NCT01124097|62690295|FG001|Overall Study|Lack of Efficacy|3|||
33314765|NCT01124097|62690296|FG002|Overall Study|Lack of Efficacy|1|||
33401892|NCT00646958|62780848|FG000|Overall Study|Lack of Efficacy|1|||
33401893|NCT00646958|62780849|FG001|Overall Study|Lack of Efficacy|0|||
33401894|NCT00646958|62780850|FG002|Overall Study|Lack of Efficacy|0|||
33401895|NCT00646958|62780848|FG000|Overall Study|Adverse Event|4|||
33401896|NCT00646958|62780849|FG001|Overall Study|Adverse Event|0|||
33401897|NCT00646958|62780850|FG002|Overall Study|Adverse Event|0|||
33401898|NCT00646958|62780848|FG000|Overall Study|Lost to Follow-up|1|||
33401899|NCT00646958|62780849|FG001|Overall Study|Lost to Follow-up|5|||
33712462|NCT01392378|63279189|FG003|Infant Series|Withdrawal by Parent|0|||
33712463|NCT01392378|63279190|FG004|Infant Series|Withdrawal by Parent|0|||
33712464|NCT01392378|63279186|FG000|After Infant Series|Lost to Follow-up|0|||
33712465|NCT01392378|63279187|FG001|After Infant Series|Lost to Follow-up|0|||
33712466|NCT01392378|63279188|FG002|After Infant Series|Lost to Follow-up|1|||
33712467|NCT01392378|63279189|FG003|After Infant Series|Lost to Follow-up|0|||
33712468|NCT01392378|63279190|FG004|After Infant Series|Lost to Follow-up|0|||
33712469|NCT01392378|63279186|FG000|After Infant Series|Withdrawal by Parent|0|||
33712470|NCT01392378|63279187|FG001|After Infant Series|Withdrawal by Parent|1|||
33712471|NCT01392378|63279188|FG002|After Infant Series|Withdrawal by Parent|1|||
33712472|NCT01392378|63279189|FG003|After Infant Series|Withdrawal by Parent|0|||
33712473|NCT01392378|63279190|FG004|After Infant Series|Withdrawal by Parent|1|||
33712474|NCT01392378|63279186|FG000|Toddler Dose|Lost to Follow-up|0|||
33712475|NCT01392378|63279187|FG001|Toddler Dose|Lost to Follow-up|0|||
33712476|NCT01392378|63279188|FG002|Toddler Dose|Lost to Follow-up|0|||
33712477|NCT01392378|63279189|FG003|Toddler Dose|Lost to Follow-up|1|||
33712478|NCT01392378|63279190|FG004|Toddler Dose|Lost to Follow-up|0|||
33712479|NCT01392378|63279186|FG000|Toddler Dose|Withdrawal by Parent|0|||
33712480|NCT01392378|63279187|FG001|Toddler Dose|Withdrawal by Parent|1|||
33712481|NCT01392378|63279188|FG002|Toddler Dose|Withdrawal by Parent|0|||
33712482|NCT01392378|63279189|FG003|Toddler Dose|Withdrawal by Parent|1|||
33712483|NCT01392378|63279190|FG004|Toddler Dose|Withdrawal by Parent|1|||
33712484|NCT01412424|63279212|FG000|Core Treatment Period|Treatment Failure|24|||
33712485|NCT01412424|63279212|FG000|Core Treatment Period|Adverse Event|21|||
33712486|NCT01412424|63279212|FG000|Core Treatment Period|Patient Request|5|||
33712487|NCT01412424|63279212|FG000|Core Treatment Period|Lost to Follow-up|2|||
33712488|NCT01412424|63279212|FG000|Core Treatment Period|Sponsor Request|1|||
33712489|NCT01412424|63279212|FG000|Extension Treatment Period|Adverse Event|2|||
33401900|NCT00646958|62780850|FG002|Overall Study|Lost to Follow-up|7|||
33401901|NCT00646958|62780848|FG000|Overall Study|Protocol Violation|1|||
33401902|NCT00646958|62780849|FG001|Overall Study|Protocol Violation|1|||
33401903|NCT00646958|62780850|FG002|Overall Study|Protocol Violation|0|||
33401904|NCT00646958|62780848|FG000|Overall Study|Abnormal screening lab tests|1|||
33401905|NCT00646958|62780849|FG001|Overall Study|Abnormal screening lab tests|1|||
33401906|NCT00646958|62780850|FG002|Overall Study|Abnormal screening lab tests|0|||
33712490|NCT01412424|63279212|FG000|Extension Treatment Period|Treatment Failure|2|||
33314766|NCT01124097|62690297|FG003|Overall Study|Lack of Efficacy|3|||
33314767|NCT01124097|62690294|FG000|Overall Study|Adverse Event|24|||
33401907|NCT00646958|62780848|FG000|Overall Study|Withdrawal by Subject|1|||
33712491|NCT01412424|63279212|FG000|Extension Treatment Period|Patient Request|2|||
33712492|NCT01433250|63279224|FG000|Overall Study|Protocol Violation|0|||
33712493|NCT01433250|63279225|FG001|Overall Study|Protocol Violation|1|||
33712494|NCT01433250|63279224|FG000|Overall Study|Withdrawal by Subject|3|||
33314768|NCT01124097|62690295|FG001|Overall Study|Adverse Event|15|||
33712495|NCT01433250|63279225|FG001|Overall Study|Withdrawal by Subject|2|||
33314769|NCT01124097|62690296|FG002|Overall Study|Adverse Event|15|||
33401908|NCT00646958|62780849|FG001|Overall Study|Withdrawal by Subject|2|||
33712496|NCT01433172|63279234|FG000|Overall Study|Withdrawal by Subject|0|||
33314770|NCT01124097|62690297|FG003|Overall Study|Adverse Event|7|||
33314771|NCT01124097|62690294|FG000|Overall Study|Protocol Violation|2|||
33314772|NCT01124097|62690295|FG001|Overall Study|Protocol Violation|0|||
33314773|NCT01124097|62690296|FG002|Overall Study|Protocol Violation|2|||
33314774|NCT01124097|62690297|FG003|Overall Study|Protocol Violation|1|||
33314775|NCT01124097|62690294|FG000|Overall Study|Physician Decision|2|||
33314776|NCT01124097|62690295|FG001|Overall Study|Physician Decision|1|||
33314777|NCT01124097|62690296|FG002|Overall Study|Physician Decision|0|||
33314778|NCT01124097|62690297|FG003|Overall Study|Physician Decision|0|||
33314779|NCT01123941|62690309|FG000|Overall Study|Lost to Follow-up|2|||
33314780|NCT01123941|62690310|FG001|Overall Study|Lost to Follow-up|1|||
33314781|NCT01123395|62690316|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
33314782|NCT01123395|62690317|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
33314783|NCT01255787|62690327|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
33314784|NCT01255787|62690328|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
33314785|NCT01255787|62690329|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
33314786|NCT01255787|62690330|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
33314787|NCT01255787|62690327|FG000|Overall Study|Major Protocol Deviation|1|||
33314788|NCT01255787|62690328|FG001|Overall Study|Major Protocol Deviation|1|||
33314789|NCT01255787|62690329|FG002|Overall Study|Major Protocol Deviation|0|||
33314790|NCT01255787|62690330|FG003|Overall Study|Major Protocol Deviation|4|||
33314791|NCT01255787|62690327|FG000|Overall Study|Lost to Follow-up|1|||
33314792|NCT01255787|62690328|FG001|Overall Study|Lost to Follow-up|2|||
33314793|NCT01255787|62690329|FG002|Overall Study|Lost to Follow-up|4|||
33314794|NCT01255787|62690330|FG003|Overall Study|Lost to Follow-up|2|||
33314795|NCT01255787|62690327|FG000|Overall Study|Withdrawal of Consent|3|||
33314796|NCT01255787|62690328|FG001|Overall Study|Withdrawal of Consent|9|||
33314797|NCT01255787|62690329|FG002|Overall Study|Withdrawal of Consent|3|||
33314798|NCT01255787|62690330|FG003|Overall Study|Withdrawal of Consent|4|||
33314799|NCT01255787|62690327|FG000|Overall Study|Pregnancy|0|||
33314800|NCT01255787|62690328|FG001|Overall Study|Pregnancy|0|||
33314801|NCT01255787|62690329|FG002|Overall Study|Pregnancy|0|||
33314802|NCT01255787|62690330|FG003|Overall Study|Pregnancy|1|||
33314803|NCT01255787|62690327|FG000|Overall Study|Lack of Efficacy|2|||
33314804|NCT01255787|62690328|FG001|Overall Study|Lack of Efficacy|2|||
33314805|NCT01255787|62690329|FG002|Overall Study|Lack of Efficacy|2|||
33314806|NCT01255787|62690330|FG003|Overall Study|Lack of Efficacy|2|||
33314807|NCT01255787|62690327|FG000|Overall Study|Noncompliance with Study Drug|3|||
33314808|NCT01255787|62690328|FG001|Overall Study|Noncompliance with Study Drug|1|||
33314809|NCT01255787|62690329|FG002|Overall Study|Noncompliance with Study Drug|0|||
33314810|NCT01255787|62690330|FG003|Overall Study|Noncompliance with Study Drug|0|||
33314811|NCT01123161|62690342|FG000|Overall Study|Lost to Follow-up|1|||
33314812|NCT01123161|62690343|FG001|Overall Study|Lost to Follow-up|0|||
33314813|NCT01123161|62690342|FG000|Overall Study|Withdrawal by Subject|1|||
33314814|NCT01123161|62690343|FG001|Overall Study|Withdrawal by Subject|0|||
33314815|NCT01255631|62690354|FG000|Overall Study|poor enrollment, no data analyzed|9|||
33314816|NCT01255631|62690355|FG001|Overall Study|poor enrollment, no data analyzed|6|||
33314817|NCT00999466|62690364|FG000|Main Part|Withdrawal by Subject|0|||
33314818|NCT00999466|62690365|FG001|Main Part|Withdrawal by Subject|0|||
33314819|NCT00999466|62690366|FG002|Main Part|Withdrawal by Subject|2|||
33314820|NCT00999466|62690364|FG000|Main Part|Adverse Event|0|||
33314821|NCT00999466|62690365|FG001|Main Part|Adverse Event|4|||
33314822|NCT00999466|62690366|FG002|Main Part|Adverse Event|2|||
33314823|NCT01255163|62690376|FG000|Overall Study|Withdrawal by Subject|1|||
33314824|NCT01255163|62690377|FG001|Overall Study|Withdrawal by Subject|0|||
33314825|NCT01255163|62690376|FG000|Overall Study|Lost to Follow-up|2|||
33314826|NCT01255163|62690377|FG001|Overall Study|Lost to Follow-up|0|||
33314827|NCT01255163|62690376|FG000|Overall Study|Adverse Event|0|||
33314828|NCT01255163|62690377|FG001|Overall Study|Adverse Event|2|||
33314829|NCT01255163|62690376|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
33314830|NCT01255163|62690377|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
33314831|NCT01123083|62690387|FG000|Overall Study|Investigator recommendation|1|||
33314832|NCT01123083|62690388|FG001|Overall Study|Investigator recommendation|1|||
33314833|NCT01123083|62690387|FG000|Overall Study|Administrative reasons|0|||
33314834|NCT01123083|62690388|FG001|Overall Study|Administrative reasons|4|||
33314835|NCT01123083|62690387|FG000|Overall Study|Lost to Follow-up|2|||
33314836|NCT01123083|62690388|FG001|Overall Study|Lost to Follow-up|6|||
33314837|NCT01123083|62690387|FG000|Overall Study|Adverse Event|1|||
33314838|NCT01123083|62690388|FG001|Overall Study|Adverse Event|0|||
33314839|NCT01123083|62690387|FG000|Overall Study|Withdrew for another reason not covered|0|||
33314840|NCT01123083|62690388|FG001|Overall Study|Withdrew for another reason not covered|1|||
33314841|NCT01123083|62690387|FG000|Overall Study|Participant/legal representative request|7|||
33314842|NCT01123083|62690388|FG001|Overall Study|Participant/legal representative request|3|||
33314843|NCT01254305|62690397|FG000|Overall Study|Adverse Event|6|||
33314844|NCT01254305|62690398|FG001|Overall Study|Adverse Event|3|||
33314845|NCT01254305|62690399|FG002|Overall Study|Adverse Event|2|||
33314846|NCT01254305|62690397|FG000|Overall Study|Lack of Efficacy|1|||
33314847|NCT01254305|62690398|FG001|Overall Study|Lack of Efficacy|0|||
33314848|NCT01254305|62690399|FG002|Overall Study|Lack of Efficacy|1|||
33314849|NCT01254305|62690397|FG000|Overall Study|Protocol Violation|1|||
33314850|NCT01254305|62690398|FG001|Overall Study|Protocol Violation|7|||
33314851|NCT01254305|62690399|FG002|Overall Study|Protocol Violation|3|||
33314852|NCT01254305|62690397|FG000|Overall Study|Withdrawal by Subject|4|||
33314853|NCT01254305|62690398|FG001|Overall Study|Withdrawal by Subject|2|||
33314854|NCT01254305|62690399|FG002|Overall Study|Withdrawal by Subject|4|||
33314855|NCT01254305|62690397|FG000|Overall Study|Lost to Follow-up|10|||
33314856|NCT01254305|62690398|FG001|Overall Study|Lost to Follow-up|6|||
33314857|NCT01254305|62690399|FG002|Overall Study|Lost to Follow-up|5|||
33314858|NCT01254305|62690397|FG000|Overall Study|Other Reasons|0|||
33314859|NCT01254305|62690398|FG001|Overall Study|Other Reasons|0|||
33314860|NCT01254305|62690399|FG002|Overall Study|Other Reasons|2|||
33314861|NCT01122927|62690410|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
33314862|NCT01122927|62690411|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
33314863|NCT01122927|62690410|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
33314864|NCT01122927|62690411|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
33314865|NCT01122927|62690410|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
33314866|NCT01122927|62690411|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
33314867|NCT01122927|62690410|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
33314868|NCT01122927|62690411|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
33314869|NCT01122927|62690410|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
33314870|NCT01122927|62690411|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
33314871|NCT01122927|62690410|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
33314872|NCT01122927|62690411|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
33314873|NCT01122927|62690410|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
33314874|NCT01122927|62690411|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
33314875|NCT01122927|62690410|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
33314876|NCT01122927|62690411|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
33314877|NCT01122927|62690410|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
33314878|NCT01122927|62690411|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
33314879|NCT01122927|62690410|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
33314880|NCT01122927|62690411|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
33314881|NCT01122927|62690410|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
33314882|NCT01122927|62690411|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
33314883|NCT01122927|62690410|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
33314884|NCT01122927|62690411|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
33314885|NCT01254227|62690421|FG000|Overall Study|Withdrawal by Subject|6|||
33314886|NCT01254227|62690421|FG000|Overall Study|Lost to Follow-up|6|||
33314887|NCT01254227|62690421|FG000|Overall Study|Adverse Event|5|||
33314888|NCT01254227|62690421|FG000|Overall Study|Abnormal test procedure result|5|||
33314889|NCT01254227|62690421|FG000|Overall Study|Administrative problems|2|||
33314890|NCT01254227|62690421|FG000|Overall Study|Death|1|||
33314891|NCT01254227|62690421|FG000|Overall Study|Protocol deviation|1|||
33314892|NCT00995410|62690425|FG000|Overall Study|Adverse Event|51|||
33314893|NCT00995410|62690425|FG000|Overall Study|Withdrawal by Subject|7|||
33314894|NCT00995410|62690425|FG000|Overall Study|Lost to Follow-up|2|||
33314895|NCT00995410|62690425|FG000|Overall Study|Misc|28|||
33314896|NCT00995020|62690431|FG000|Overall Study|margin analysis not performed|2|||
33314897|NCT00995020|62690432|FG001|Overall Study|margin analysis not performed|5|||
33314898|NCT00995020|62690431|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
33314899|NCT00995020|62690432|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
33314900|NCT01122381|62690442|FG000|Overall Study|study terminated early|0|||
33314901|NCT01122381|62690443|FG001|Overall Study|study terminated early|1|||
33314902|NCT00996034|62690449|FG000|Overall Study|Lost to Follow-up|2|||
33314903|NCT00996034|62690449|FG000|Overall Study|withdrawn by PI|1|||
33314904|NCT01253447|62690453|FG000|Overall Study|Adverse Event|2|||
33314905|NCT01121991|62690458|FG000|Overall Study|Lack of Ovarian Response|2|||
33314906|NCT01121991|62690458|FG000|Overall Study|No Oocytes Retrieved|3|||
33712497|NCT01433172|63279235|FG001|Overall Study|Withdrawal by Subject|1|||
33712498|NCT01433172|63279236|FG002|Overall Study|Withdrawal by Subject|0|||
33712499|NCT01433172|63279234|FG000|Overall Study|Disease Progression|0|||
33712500|NCT01433172|63279235|FG001|Overall Study|Disease Progression|0|||
33712501|NCT01433172|63279236|FG002|Overall Study|Disease Progression|1|||
33712502|NCT01433172|63279234|FG000|Overall Study|Death|0|||
33712503|NCT01433172|63279235|FG001|Overall Study|Death|2|||
33712504|NCT01433172|63279236|FG002|Overall Study|Death|0|||
33712505|NCT01432938|63279244|FG000|First Intervention|Protocol Violation|1|||
33712506|NCT01432938|63279245|FG001|First Intervention|Protocol Violation|0|||
33712507|NCT01432938|63279244|FG000|First Intervention|Physician Decision|1|||
33712508|NCT01432938|63279245|FG001|First Intervention|Physician Decision|0|||
33712509|NCT01432938|63279244|FG000|Second Intervention|Adverse Event|1|||
33712510|NCT01432938|63279245|FG001|Second Intervention|Adverse Event|0|||
33712511|NCT01392300|63279254|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
33712512|NCT01392300|63279255|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
33712513|NCT01392300|63279256|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
33712514|NCT01392300|63279254|FG000|Main Period (MP)|Withdrawal by Subject|5|||
33712515|NCT01392300|63279255|FG001|Main Period (MP)|Withdrawal by Subject|1|||
33712516|NCT01392300|63279256|FG002|Main Period (MP)|Withdrawal by Subject|0|||
33712517|NCT01392300|63279254|FG000|Main Period (MP)|Lost to Follow-up|3|||
33712518|NCT01392300|63279255|FG001|Main Period (MP)|Lost to Follow-up|3|||
33712519|NCT01392300|63279256|FG002|Main Period (MP)|Lost to Follow-up|0|||
33712520|NCT01392300|63279254|FG000|Main Period (MP)|Non-compliance|1|||
33712521|NCT01392300|63279255|FG001|Main Period (MP)|Non-compliance|0|||
33712522|NCT01392300|63279256|FG002|Main Period (MP)|Non-compliance|0|||
33712523|NCT01392300|63279254|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
33712524|NCT01392300|63279255|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
33712525|NCT01392300|63279256|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
33712526|NCT01392300|63279254|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
33712527|NCT01392300|63279255|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
33712528|NCT01392300|63279256|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
33712529|NCT01392300|63279254|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
33712530|NCT01392300|63279255|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
33712531|NCT01392300|63279256|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
33712532|NCT01392300|63279254|FG000|Open Label Extension (OLEX) Period|Death|0|||
33712533|NCT01392300|63279255|FG001|Open Label Extension (OLEX) Period|Death|0|||
33712534|NCT01392300|63279256|FG002|Open Label Extension (OLEX) Period|Death|4|||
33712535|NCT01392300|63279254|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
33712536|NCT01392300|63279255|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
33712537|NCT01392300|63279256|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
33712538|NCT01392300|63279254|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
33712539|NCT01392300|63279255|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
33712540|NCT01392300|63279256|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
33712541|NCT01392300|63279254|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
33712542|NCT01392300|63279255|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
33712543|NCT01392300|63279256|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
33712544|NCT01432626|63279263|FG000|Overall Study|LV function recovered|2|||
33712545|NCT01432626|63279263|FG000|Overall Study|Withdrawal by Subject|2|||
33712546|NCT01432626|63279263|FG000|Overall Study|Only 1 image competed|2|||
33712547|NCT01432626|63279263|FG000|Overall Study|Imaging agent not available|1|||
33712548|NCT01391832|63279269|FG000|Overall Study|Withdrawal by Subject|21|||
33712549|NCT01391832|63279270|FG001|Overall Study|Withdrawal by Subject|22|||
33712550|NCT01391832|63279269|FG000|Overall Study|Lost to Follow-up|0|||
33712551|NCT01391832|63279270|FG001|Overall Study|Lost to Follow-up|1|||
33712552|NCT01410474|63279278|FG000|Overall Study|Withdrawal by Subject|0|||
33712553|NCT01410474|63279279|FG001|Overall Study|Withdrawal by Subject|1|||
33712554|NCT01391130|63279294|FG000|Overall Study|Withdrawal by Subject|3|||
33712555|NCT01391130|63279295|FG001|Overall Study|Withdrawal by Subject|2|||
33712556|NCT01391130|63279294|FG000|Overall Study|Physician Decision|2|||
33712557|NCT01391130|63279295|FG001|Overall Study|Physician Decision|3|||
33712558|NCT01391130|63279294|FG000|Overall Study|Did not Receive Drug|1|||
33712559|NCT01391130|63279295|FG001|Overall Study|Did not Receive Drug|1|||
33712560|NCT01410240|63279304|FG000|Overall Study|Physician Decision|0|||
33314907|NCT01121991|62690458|FG000|Overall Study|No Fertilization|1|||
33712561|NCT01410240|63279305|FG001|Overall Study|Physician Decision|0|||
33314908|NCT00994240|62690464|FG000|Overall Study|Lost to Follow-up|3|||
33401909|NCT00646958|62780850|FG002|Overall Study|Withdrawal by Subject|0|||
33401910|NCT00646958|62780848|FG000|Overall Study|Did not receive study drug|2|||
33401911|NCT00646958|62780849|FG001|Overall Study|Did not receive study drug|0|||
33314909|NCT00994240|62690465|FG001|Overall Study|Lost to Follow-up|2|||
33401912|NCT00646958|62780850|FG002|Overall Study|Did not receive study drug|2|||
33314910|NCT00994240|62690464|FG000|Overall Study|Withdrawal by Subject|1|||
33314911|NCT00994240|62690465|FG001|Overall Study|Withdrawal by Subject|0|||
33314912|NCT00994240|62690464|FG000|Overall Study|study termination|2|||
33401913|NCT00642746|62780860|FG000|Overall Study|Patient unevaluable|1|||
33401914|NCT00642746|62780861|FG001|Overall Study|Patient unevaluable|0|||
33401915|NCT00642668|62780867|FG000|Overall Study|Lost to Follow-up|1|||
33401916|NCT00642668|62780867|FG000|Overall Study|Adverse Event|2|||
33401917|NCT00642668|62780867|FG000|Overall Study|Death|2|||
33401918|NCT00642668|62780867|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33314913|NCT00994240|62690465|FG001|Overall Study|study termination|3|||
33314914|NCT01253369|62690471|FG000|Overall Study|Adverse Event|4|||
33314915|NCT01253369|62690471|FG000|Overall Study|Withdrawal by Subject|2|||
33314916|NCT01253369|62690471|FG000|Overall Study|Death|1|||
33314917|NCT01253369|62690471|FG000|Overall Study|Progressive disease|23|||
33314918|NCT01253369|62690471|FG000|Overall Study|Not Evaluable|3|||
33314919|NCT01121913|62690475|FG000|First Intervention Period|Adverse Event|0|||
33314920|NCT01121913|62690476|FG001|First Intervention Period|Adverse Event|0|||
33314921|NCT01121913|62690477|FG002|First Intervention Period|Adverse Event|1|||
33314922|NCT01121913|62690478|FG003|First Intervention Period|Adverse Event|0|||
33314923|NCT01121913|62690475|FG000|First Washout Period|Withdrawal by Subject|1|||
33314924|NCT01121913|62690476|FG001|First Washout Period|Withdrawal by Subject|0|||
33314925|NCT01121913|62690477|FG002|First Washout Period|Withdrawal by Subject|0|||
33314926|NCT01121913|62690478|FG003|First Washout Period|Withdrawal by Subject|0|||
33314927|NCT01121913|62690475|FG000|Second Intervention Period|Adverse Event|0|||
33314928|NCT01121913|62690476|FG001|Second Intervention Period|Adverse Event|0|||
33314929|NCT01121913|62690477|FG002|Second Intervention Period|Adverse Event|1|||
33314930|NCT01121913|62690478|FG003|Second Intervention Period|Adverse Event|0|||
33314931|NCT01121913|62690475|FG000|Second Washout Period|Withdrawal by Subject|0|||
33314932|NCT01121913|62690476|FG001|Second Washout Period|Withdrawal by Subject|0|||
33314933|NCT01121913|62690477|FG002|Second Washout Period|Withdrawal by Subject|1|||
33314934|NCT01121913|62690478|FG003|Second Washout Period|Withdrawal by Subject|0|||
33314935|NCT01121913|62690475|FG000|Third Washout Period|Adverse Event|1|||
33314936|NCT01121913|62690476|FG001|Third Washout Period|Adverse Event|0|||
33314937|NCT01121913|62690477|FG002|Third Washout Period|Adverse Event|0|||
33314938|NCT01121913|62690478|FG003|Third Washout Period|Adverse Event|0|||
33314939|NCT00994162|62690490|FG000|Overall Study|Withdrawal by Subject|1|||
33314940|NCT00994162|62690490|FG000|Overall Study|Lost to Follow-up|2|||
33314941|NCT00994162|62690490|FG000|Overall Study|Product Complaint|1|||
33314942|NCT00994162|62690490|FG000|Overall Study|Poor Compliance|5|||
33314943|NCT00994162|62690490|FG000|Overall Study|Lack of Response|3|||
33314944|NCT00994162|62690490|FG000|Overall Study|Discharged from Hospital|4|||
33314945|NCT00994162|62690490|FG000|Overall Study|Death|2|||
33314946|NCT00994162|62690490|FG000|Overall Study|Care Transferred to Another Physician|2|||
33314947|NCT00994162|62690490|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
33314948|NCT00994162|62690490|FG000|Overall Study|Physician Decision|2|||
33314949|NCT00994162|62690490|FG000|Overall Study|Surrounding Wound Erythematous|1|||
33314950|NCT00994162|62690490|FG000|Overall Study|Machine Losing Vaccum|1|||
33314951|NCT00994162|62690490|FG000|Overall Study|Patient Lived Too Far Away|1|||
33314952|NCT00994162|62690490|FG000|Overall Study|Above Knee Amputation|1|||
33401919|NCT00642668|62780867|FG000|Overall Study|Failure to Return|1|||
33401920|NCT00642668|62780867|FG000|Overall Study|Dialysis Initiation|5|||
33314953|NCT00994162|62690490|FG000|Overall Study|Reason Not Reported By Site|1|||
33314954|NCT00993928|62690497|FG000|Overall Study|Withdrawal by Subject|4|||
33314955|NCT00993928|62690498|FG001|Overall Study|Withdrawal by Subject|7|||
33314956|NCT00993928|62690497|FG000|Overall Study|ineligible|1|||
33314957|NCT00993928|62690498|FG001|Overall Study|ineligible|0|||
33401921|NCT00642668|62780867|FG000|Overall Study|Blood Transfusion|2|||
33401922|NCT00729833|62780871|FG000|Overall Study|Death|5|||
33401923|NCT00729833|62780872|FG001|Overall Study|Death|1|||
33314958|NCT01253291|62690513|FG000|Overall Study|Withdrawal by Subject|1|||
33314959|NCT01253291|62690514|FG001|Overall Study|Withdrawal by Subject|1|||
33314960|NCT01253291|62690515|FG002|Overall Study|Withdrawal by Subject|0|||
33314961|NCT01253291|62690516|FG003|Overall Study|Withdrawal by Subject|0|||
33401924|NCT00729833|62780873|FG002|Overall Study|Death|3|||
33314962|NCT01253291|62690517|FG004|Overall Study|Withdrawal by Subject|0|||
33314963|NCT01253291|62690513|FG000|Overall Study|Adverse Event|0|||
33314964|NCT01253291|62690514|FG001|Overall Study|Adverse Event|1|||
33314965|NCT01253291|62690515|FG002|Overall Study|Adverse Event|0|||
33314966|NCT01253291|62690516|FG003|Overall Study|Adverse Event|0|||
33314967|NCT01253291|62690517|FG004|Overall Study|Adverse Event|0|||
33314968|NCT01253291|62690513|FG000|Overall Study|Lack of Efficacy|1|||
33314969|NCT01253291|62690514|FG001|Overall Study|Lack of Efficacy|0|||
33314970|NCT01253291|62690515|FG002|Overall Study|Lack of Efficacy|0|||
33314971|NCT01253291|62690516|FG003|Overall Study|Lack of Efficacy|0|||
33314972|NCT01253291|62690517|FG004|Overall Study|Lack of Efficacy|0|||
33314973|NCT01253291|62690513|FG000|Overall Study|Physician Decision|2|||
33314974|NCT01253291|62690514|FG001|Overall Study|Physician Decision|0|||
33314975|NCT01253291|62690515|FG002|Overall Study|Physician Decision|0|||
33314976|NCT01253291|62690516|FG003|Overall Study|Physician Decision|0|||
33314977|NCT01253291|62690517|FG004|Overall Study|Physician Decision|2|||
33314978|NCT01121757|62690532|FG000|First Drug|Death|1|||
33314979|NCT01121757|62690533|FG001|First Drug|Death|0|||
33314980|NCT01121757|62690532|FG000|First Drug|Disease Progression|0|||
33314981|NCT01121757|62690533|FG001|First Drug|Disease Progression|2|||
33314982|NCT01121757|62690532|FG000|Combination|Physician Decision|0|||
33314983|NCT01121757|62690533|FG001|Combination|Physician Decision|1|||
33314984|NCT01121757|62690532|FG000|Combination|Disease Progression|2|||
33314985|NCT01121757|62690533|FG001|Combination|Disease Progression|0|||
33314986|NCT01253135|62690541|FG000|Original Protocol|Protocol Amendment|15|||
33314987|NCT01253135|62690541|FG000|Amended Protocol|Non-compliance|1|||
33314988|NCT00993616|62690549|FG000|Overall Study|No tumor at entry|1|||
33314989|NCT00993616|62690549|FG000|Overall Study|Never treated|1|||
33314990|NCT01120899|62690559|FG000|Overall Study|Withdrawal by Subject|3|||
33314991|NCT01120275|62690563|FG000|Overall Study|Adverse Event|3|||
33314992|NCT01120275|62690563|FG000|Overall Study|Progression|27|||
33314993|NCT01120275|62690563|FG000|Overall Study|Ineligible|3|||
33314994|NCT01120275|62690563|FG000|Overall Study|Withdrawal by Subject|1|||
33314995|NCT01120275|62690563|FG000|Overall Study|Refusal|1|||
33314996|NCT01120275|62690563|FG000|Overall Study|Not specific|1|||
33314997|NCT00991510|62690570|FG000|Period I (Days 1-14)|Adverse Event|1|||
33314998|NCT00991510|62690571|FG001|Period I (Days 1-14)|Adverse Event|0|||
33314999|NCT00991510|62690570|FG000|Period III (Days 29-112)|Adverse Event|1|||
33315000|NCT00991510|62690571|FG001|Period III (Days 29-112)|Adverse Event|1|||
33315001|NCT01119963|62690583|FG000|Overall Study|Lost to Follow-up|1|||
33315002|NCT01119963|62690584|FG001|Overall Study|Lost to Follow-up|1|||
33315003|NCT01252667|62690598|FG000|Overall Study|Transplant aborted post-conditioning|0|||
33315004|NCT01252667|62690599|FG001|Overall Study|Transplant aborted post-conditioning|0|||
33315005|NCT01252667|62690600|FG002|Overall Study|Transplant aborted post-conditioning|0|||
33315006|NCT01252667|62690601|FG003|Overall Study|Transplant aborted post-conditioning|0|||
33315007|NCT01252667|62690602|FG004|Overall Study|Transplant aborted post-conditioning|0|||
33315008|NCT01252667|62690603|FG005|Overall Study|Transplant aborted post-conditioning|1|||
33315009|NCT01119105|62690620|FG000|Overall Study|Withdrawal by Subject|1|||
33315010|NCT01119105|62690621|FG001|Overall Study|Withdrawal by Subject|1|||
33315011|NCT01119105|62690622|FG002|Overall Study|Withdrawal by Subject|1|||
33315012|NCT01119105|62690620|FG000|Overall Study|Lost to Follow-up|0|||
33315013|NCT01119105|62690621|FG001|Overall Study|Lost to Follow-up|2|||
33315014|NCT01119105|62690622|FG002|Overall Study|Lost to Follow-up|5|||
33315015|NCT01119105|62690620|FG000|Overall Study|Adverse Event|1|||
33315016|NCT01119105|62690621|FG001|Overall Study|Adverse Event|0|||
33315017|NCT01119105|62690622|FG002|Overall Study|Adverse Event|1|||
33315018|NCT01119105|62690620|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
33315019|NCT01119105|62690621|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
33315020|NCT01119105|62690622|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
33315021|NCT01119105|62690620|FG000|Overall Study|Other|1|||
33315022|NCT01119105|62690621|FG001|Overall Study|Other|1|||
33315023|NCT01119105|62690622|FG002|Overall Study|Other|0|||
33315024|NCT01118949|62690630|FG000|Overall Study|Adverse Event|5|||
33315025|NCT01118949|62690630|FG000|Overall Study|Withdrawal by Subject|4|||
33315026|NCT01252355|62690637|FG000|Overall Study|Adverse Event|9|||
33315027|NCT01252355|62690638|FG001|Overall Study|Adverse Event|17|||
33315028|NCT01252355|62690639|FG002|Overall Study|Adverse Event|22|||
33315029|NCT01252355|62690637|FG000|Overall Study|Lack of Efficacy|6|||
33315030|NCT01252355|62690638|FG001|Overall Study|Lack of Efficacy|4|||
33315031|NCT01252355|62690639|FG002|Overall Study|Lack of Efficacy|2|||
33315032|NCT01252355|62690637|FG000|Overall Study|Lost to Follow-up|0|||
33315033|NCT01252355|62690638|FG001|Overall Study|Lost to Follow-up|0|||
33315034|NCT01252355|62690639|FG002|Overall Study|Lost to Follow-up|1|||
33315035|NCT01252355|62690637|FG000|Overall Study|Poor Compliance to Protocol|1|||
33315036|NCT01252355|62690638|FG001|Overall Study|Poor Compliance to Protocol|1|||
33493841|NCT03535194|62872384|FG001|Maintenance Period|Withdrawal by Subject|2|||
33315037|NCT01252355|62690639|FG002|Overall Study|Poor Compliance to Protocol|1|||
33315038|NCT01252355|62690637|FG000|Overall Study|Progressive Disease|2|||
33597517|NCT02325739|62996460|FG001|Phase II Part|Physician Decision|0|||
33315039|NCT01252355|62690638|FG001|Overall Study|Progressive Disease|0|||
33315040|NCT01252355|62690639|FG002|Overall Study|Progressive Disease|0|||
33315041|NCT01252355|62690637|FG000|Overall Study|Sponsor Early Termination of Study|149|||
33315042|NCT01252355|62690638|FG001|Overall Study|Sponsor Early Termination of Study|149|||
33315043|NCT01252355|62690639|FG002|Overall Study|Sponsor Early Termination of Study|146|||
33315044|NCT01252355|62690637|FG000|Overall Study|Randomized but not Treated|2|||
33315045|NCT01252355|62690638|FG001|Overall Study|Randomized but not Treated|0|||
33315046|NCT01252355|62690639|FG002|Overall Study|Randomized but not Treated|0|||
33315047|NCT01252355|62690637|FG000|Overall Study|Other Than Above|8|||
33315048|NCT01252355|62690638|FG001|Overall Study|Other Than Above|7|||
33315049|NCT01252355|62690639|FG002|Overall Study|Other Than Above|7|||
33315050|NCT01118325|62690650|FG000|Overall Study|Adverse Event|1|||
33315051|NCT01118325|62690651|FG001|Overall Study|Adverse Event|0|||
33315052|NCT01118325|62690652|FG002|Overall Study|Adverse Event|1|||
33315053|NCT01117857|62690673|FG000|Overall Study|Lost to Follow-up|4|||
33315054|NCT01117857|62690673|FG000|Overall Study|Withdrawal by Subject|4|||
33315055|NCT01117857|62690673|FG000|Overall Study|Physician Decision|1|||
33315056|NCT01251887|62690680|FG000|Overall Study|Scheduling conflict|1|||
33315057|NCT01251887|62690681|FG001|Overall Study|Scheduling conflict|2|||
33315058|NCT01251887|62690682|FG002|Overall Study|Scheduling conflict|2|||
33315059|NCT01251887|62690680|FG000|Overall Study|Physician Decision|0|||
33315060|NCT01251887|62690681|FG001|Overall Study|Physician Decision|1|||
33315061|NCT01251887|62690682|FG002|Overall Study|Physician Decision|0|||
33315062|NCT00991276|62690696|FG000|First Intervention Period|Adverse Event|0|||
33315063|NCT00991276|62690697|FG001|First Intervention Period|Adverse Event|1|||
33315064|NCT00991276|62690698|FG002|First Intervention Period|Adverse Event|0|||
33315065|NCT00991276|62690699|FG003|First Intervention Period|Adverse Event|1|||
33315066|NCT00991276|62690700|FG004|First Intervention Period|Adverse Event|0|||
33315067|NCT00991276|62690701|FG005|First Intervention Period|Adverse Event|0|||
33315068|NCT00991276|62690696|FG000|First Intervention Period|Protocol Violation|0|||
33315069|NCT00991276|62690697|FG001|First Intervention Period|Protocol Violation|0|||
33315070|NCT00991276|62690698|FG002|First Intervention Period|Protocol Violation|0|||
33315071|NCT00991276|62690699|FG003|First Intervention Period|Protocol Violation|0|||
33315072|NCT00991276|62690700|FG004|First Intervention Period|Protocol Violation|2|||
33315073|NCT00991276|62690701|FG005|First Intervention Period|Protocol Violation|0|||
33315074|NCT00991276|62690696|FG000|First Intervention Period|Insufficient clinical response|0|||
33315075|NCT00991276|62690697|FG001|First Intervention Period|Insufficient clinical response|0|||
33315076|NCT00991276|62690698|FG002|First Intervention Period|Insufficient clinical response|0|||
33315077|NCT00991276|62690699|FG003|First Intervention Period|Insufficient clinical response|0|||
33315078|NCT00991276|62690700|FG004|First Intervention Period|Insufficient clinical response|1|||
33315079|NCT00991276|62690701|FG005|First Intervention Period|Insufficient clinical response|0|||
33315080|NCT00991276|62690696|FG000|First Intervention Period|Other|0|||
33315081|NCT00991276|62690697|FG001|First Intervention Period|Other|0|||
33315082|NCT00991276|62690698|FG002|First Intervention Period|Other|0|||
33315083|NCT00991276|62690699|FG003|First Intervention Period|Other|1|||
33315084|NCT00991276|62690700|FG004|First Intervention Period|Other|1|||
33315085|NCT00991276|62690701|FG005|First Intervention Period|Other|0|||
33315086|NCT00991276|62690696|FG000|First Intervention Period|Withdrawal by Subject|0|||
33315087|NCT00991276|62690697|FG001|First Intervention Period|Withdrawal by Subject|1|||
33315088|NCT00991276|62690698|FG002|First Intervention Period|Withdrawal by Subject|0|||
33315089|NCT00991276|62690699|FG003|First Intervention Period|Withdrawal by Subject|1|||
33315090|NCT00991276|62690700|FG004|First Intervention Period|Withdrawal by Subject|0|||
33315091|NCT00991276|62690701|FG005|First Intervention Period|Withdrawal by Subject|1|||
33315092|NCT00991276|62690696|FG000|First Intervention Period|Lost to Follow-up|0|||
33315093|NCT00991276|62690697|FG001|First Intervention Period|Lost to Follow-up|1|||
33315094|NCT00991276|62690698|FG002|First Intervention Period|Lost to Follow-up|0|||
33315095|NCT00991276|62690699|FG003|First Intervention Period|Lost to Follow-up|1|||
33315096|NCT00991276|62690700|FG004|First Intervention Period|Lost to Follow-up|0|||
33315097|NCT00991276|62690701|FG005|First Intervention Period|Lost to Follow-up|0|||
33315098|NCT00991276|62690696|FG000|Second Intervention Period|Adverse Event|0|||
33315099|NCT00991276|62690697|FG001|Second Intervention Period|Adverse Event|2|||
33315100|NCT00991276|62690698|FG002|Second Intervention Period|Adverse Event|0|||
33315101|NCT00991276|62690699|FG003|Second Intervention Period|Adverse Event|1|||
33315102|NCT00991276|62690700|FG004|Second Intervention Period|Adverse Event|1|||
33315103|NCT00991276|62690701|FG005|Second Intervention Period|Adverse Event|0|||
33315104|NCT00991276|62690696|FG000|Second Intervention Period|Protocol Violation|1|||
33315105|NCT00991276|62690697|FG001|Second Intervention Period|Protocol Violation|0|||
33315106|NCT00991276|62690698|FG002|Second Intervention Period|Protocol Violation|0|||
33315107|NCT00991276|62690699|FG003|Second Intervention Period|Protocol Violation|0|||
33315108|NCT00991276|62690700|FG004|Second Intervention Period|Protocol Violation|0|||
33315109|NCT00991276|62690701|FG005|Second Intervention Period|Protocol Violation|0|||
33315110|NCT00991276|62690696|FG000|Second Intervention Period|Other|0|||
33401925|NCT00729833|62780874|FG003|Overall Study|Death|5|||
33315111|NCT00991276|62690697|FG001|Second Intervention Period|Other|0|||
33315112|NCT00991276|62690698|FG002|Second Intervention Period|Other|0|||
33315113|NCT00991276|62690699|FG003|Second Intervention Period|Other|1|||
33315114|NCT00991276|62690700|FG004|Second Intervention Period|Other|0|||
33315115|NCT00991276|62690701|FG005|Second Intervention Period|Other|1|||
33315116|NCT00991276|62690696|FG000|Third Intervention Period|Protocol Violation|1|||
33315117|NCT00991276|62690697|FG001|Third Intervention Period|Protocol Violation|0|||
33315118|NCT00991276|62690698|FG002|Third Intervention Period|Protocol Violation|0|||
33315119|NCT00991276|62690699|FG003|Third Intervention Period|Protocol Violation|0|||
33315120|NCT00991276|62690700|FG004|Third Intervention Period|Protocol Violation|0|||
33315121|NCT00991276|62690701|FG005|Third Intervention Period|Protocol Violation|0|||
33315122|NCT00991276|62690696|FG000|Third Intervention Period|Other|0|||
33315123|NCT00991276|62690697|FG001|Third Intervention Period|Other|0|||
33315124|NCT00991276|62690698|FG002|Third Intervention Period|Other|0|||
33315125|NCT00991276|62690699|FG003|Third Intervention Period|Other|0|||
33315126|NCT00991276|62690700|FG004|Third Intervention Period|Other|0|||
33401926|NCT00729833|62780871|FG000|Overall Study|Study Terminated by Sponsor|0|||
33401927|NCT00729833|62780872|FG001|Overall Study|Study Terminated by Sponsor|0|||
33401928|NCT00729833|62780873|FG002|Overall Study|Study Terminated by Sponsor|1|||
33712562|NCT01410240|63279306|FG002|Overall Study|Physician Decision|1|||
33712563|NCT01410240|63279304|FG000|Overall Study|Missed week 6 assessments|1|||
33712564|NCT01410240|63279305|FG001|Overall Study|Missed week 6 assessments|1|||
33712565|NCT01410240|63279306|FG002|Overall Study|Missed week 6 assessments|1|||
33712566|NCT01409928|63279315|FG000|Overall Study|Physician Decision|12|||
33712567|NCT01431534|63279322|FG000|Treatment Phase|Adverse Event|0|||
33712568|NCT01431534|63279323|FG001|Treatment Phase|Adverse Event|0|||
33712569|NCT01431534|63279324|FG002|Treatment Phase|Adverse Event|1|||
33712570|NCT01431534|63279322|FG000|Treatment Phase|Progressive Disease|4|||
33712571|NCT01431534|63279323|FG001|Treatment Phase|Progressive Disease|3|||
33712572|NCT01431534|63279324|FG002|Treatment Phase|Progressive Disease|10|||
33712573|NCT01409382|63279334|FG000|Overall Study|Lost to Follow-up|1|||
33712574|NCT01409382|63279335|FG001|Overall Study|Lost to Follow-up|1|||
33712575|NCT01409382|63279334|FG000|Overall Study|Protocol Violation|0|||
33712576|NCT01409382|63279335|FG001|Overall Study|Protocol Violation|3|||
33712577|NCT01409382|63279334|FG000|Overall Study|Multiple pregnancy|2|||
33712578|NCT01409382|63279335|FG001|Overall Study|Multiple pregnancy|4|||
33712579|NCT01409382|63279334|FG000|Overall Study|Still pregnant when study ended|13|||
33712580|NCT01409382|63279335|FG001|Overall Study|Still pregnant when study ended|2|||
33712581|NCT01409382|63279334|FG000|Overall Study|Did not manage to get pregnant|64|||
33712582|NCT01409382|63279335|FG001|Overall Study|Did not manage to get pregnant|70|||
33712583|NCT01409382|63279334|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
33712584|NCT01409382|63279335|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
33712585|NCT01408914|63279348|FG000|Overall Study|Could not complete tx in protocol period|5|||
33712586|NCT01408914|63279349|FG001|Overall Study|Could not complete tx in protocol period|5|||
33712587|NCT01408914|63279350|FG002|Overall Study|Could not complete tx in protocol period|6|||
33712588|NCT01408914|63279348|FG000|Overall Study|Lost to Follow-up|4|||
33712589|NCT01408914|63279349|FG001|Overall Study|Lost to Follow-up|1|||
33712590|NCT01408914|63279350|FG002|Overall Study|Lost to Follow-up|2|||
33712591|NCT01408914|63279348|FG000|Overall Study|Physician Decision|1|||
33712592|NCT01408914|63279349|FG001|Overall Study|Physician Decision|1|||
33712593|NCT01408914|63279350|FG002|Overall Study|Physician Decision|0|||
33712594|NCT01408914|63279348|FG000|Overall Study|Withdrawal by Subject|1|||
33712595|NCT01408914|63279349|FG001|Overall Study|Withdrawal by Subject|0|||
33712596|NCT01408914|63279350|FG002|Overall Study|Withdrawal by Subject|1|||
33712597|NCT01408914|63279348|FG000|Overall Study|Moved out of study jurisdiction|1|||
33712598|NCT01408914|63279349|FG001|Overall Study|Moved out of study jurisdiction|1|||
33712599|NCT01408914|63279350|FG002|Overall Study|Moved out of study jurisdiction|0|||
33712600|NCT01408914|63279348|FG000|Overall Study|Late exclusion|0|||
33712601|NCT01408914|63279349|FG001|Overall Study|Late exclusion|3|||
33315127|NCT00991276|62690701|FG005|Third Intervention Period|Other|1|||
33315128|NCT00991276|62690696|FG000|Third Intervention Period|Adverse Event|0|||
33315129|NCT00991276|62690697|FG001|Third Intervention Period|Adverse Event|0|||
33315130|NCT00991276|62690698|FG002|Third Intervention Period|Adverse Event|1|||
33315131|NCT00991276|62690699|FG003|Third Intervention Period|Adverse Event|0|||
33315132|NCT00991276|62690700|FG004|Third Intervention Period|Adverse Event|0|||
33315133|NCT00991276|62690701|FG005|Third Intervention Period|Adverse Event|0|||
33315134|NCT00991276|62690696|FG000|Third Intervention Period|Withdrawal by Subject|0|||
33315135|NCT00991276|62690697|FG001|Third Intervention Period|Withdrawal by Subject|0|||
33315136|NCT00991276|62690698|FG002|Third Intervention Period|Withdrawal by Subject|0|||
33712602|NCT01408914|63279350|FG002|Overall Study|Late exclusion|3|||
33712603|NCT01408914|63279348|FG000|Overall Study|Change in local TB/HIV norms|0|||
33712604|NCT01408914|63279349|FG001|Overall Study|Change in local TB/HIV norms|1|||
33712605|NCT01408914|63279350|FG002|Overall Study|Change in local TB/HIV norms|1|||
33712606|NCT01431144|63279360|FG000|Overall Study|Implant mobility and removal|2|||
33712607|NCT01431144|63279361|FG001|Overall Study|Implant mobility and removal|0|||
33315137|NCT00991276|62690699|FG003|Third Intervention Period|Withdrawal by Subject|1|||
33712608|NCT01430754|63279370|FG000|Run-In Phase|Circadian Period Ineligible|24|||
33401929|NCT00729833|62780874|FG003|Overall Study|Study Terminated by Sponsor|0|||
33401930|NCT00729833|62780871|FG000|Overall Study|Lost to Follow-up|1|||
33401931|NCT00729833|62780872|FG001|Overall Study|Lost to Follow-up|0|||
33401932|NCT00729833|62780873|FG002|Overall Study|Lost to Follow-up|0|||
33401933|NCT00729833|62780874|FG003|Overall Study|Lost to Follow-up|0|||
33315138|NCT00991276|62690700|FG004|Third Intervention Period|Withdrawal by Subject|0|||
33315139|NCT00991276|62690701|FG005|Third Intervention Period|Withdrawal by Subject|0|||
33315140|NCT00990652|62690710|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
33315141|NCT00990652|62690710|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
33315142|NCT00990340|62690717|FG000|First 14-day Treatment|Not Compliant|2|||
33315143|NCT00990340|62690718|FG001|First 14-day Treatment|Not Compliant|1|||
33315144|NCT00990340|62690717|FG000|First 14-day Treatment|Lost to Follow-up|2|||
33315145|NCT00990340|62690718|FG001|First 14-day Treatment|Lost to Follow-up|1|||
33315146|NCT00990340|62690717|FG000|First 14-day Treatment|Protocol Violation|2|||
33315147|NCT00990340|62690718|FG001|First 14-day Treatment|Protocol Violation|2|||
33315148|NCT01207440|62690733|FG000|Overall Study|Adverse Event|46|||
33315149|NCT01207440|62690734|FG001|Overall Study|Adverse Event|11|||
33315150|NCT01207440|62690735|FG002|Overall Study|Adverse Event|7|||
33315151|NCT01207440|62690736|FG003|Overall Study|Adverse Event|2|||
33315152|NCT01207440|62690737|FG004|Overall Study|Adverse Event|6|||
33401934|NCT00729833|62780871|FG000|Overall Study|Withdrawal by Subject|3|||
33401935|NCT00729833|62780872|FG001|Overall Study|Withdrawal by Subject|1|||
33401936|NCT00729833|62780873|FG002|Overall Study|Withdrawal by Subject|3|||
33401937|NCT00729833|62780874|FG003|Overall Study|Withdrawal by Subject|0|||
33712609|NCT01430754|63279371|FG001|Run-In Phase|Circadian Period Ineligible|0|||
33712610|NCT01430754|63279370|FG000|Run-In Phase|Protocol Violation|6|||
33712611|NCT01430754|63279371|FG001|Run-In Phase|Protocol Violation|0|||
33712612|NCT01430754|63279370|FG000|Run-In Phase|Adverse Event|2|||
33712613|NCT01430754|63279371|FG001|Run-In Phase|Adverse Event|0|||
33712614|NCT01430754|63279370|FG000|Run-In Phase|Other|2|||
33712615|NCT01430754|63279371|FG001|Run-In Phase|Other|0|||
33712616|NCT01430754|63279370|FG000|Run-In Phase|Withdrawal by Subject|2|||
33712617|NCT01430754|63279371|FG001|Run-In Phase|Withdrawal by Subject|0|||
33712618|NCT01430754|63279370|FG000|Run-In Phase|Lost to Follow-up|1|||
33712619|NCT01430754|63279371|FG001|Run-In Phase|Lost to Follow-up|0|||
33712620|NCT01390428|63279385|FG000|Overall Study|Elective Surgery|0|||
33712621|NCT01390428|63279386|FG001|Overall Study|Elective Surgery|0|||
33712622|NCT01390428|63279387|FG002|Overall Study|Elective Surgery|0|||
33712623|NCT01390428|63279388|FG003|Overall Study|Elective Surgery|0|||
33712624|NCT01390428|63279389|FG004|Overall Study|Elective Surgery|1|||
33712625|NCT01390428|63279390|FG005|Overall Study|Elective Surgery|0|||
33712626|NCT01390428|63279385|FG000|Overall Study|Withdrawal by Subject|0|||
33712627|NCT01390428|63279386|FG001|Overall Study|Withdrawal by Subject|0|||
33712628|NCT01390428|63279387|FG002|Overall Study|Withdrawal by Subject|1|||
33712629|NCT01390428|63279388|FG003|Overall Study|Withdrawal by Subject|0|||
33712630|NCT01390428|63279389|FG004|Overall Study|Withdrawal by Subject|0|||
33712631|NCT01390428|63279390|FG005|Overall Study|Withdrawal by Subject|0|||
33712632|NCT01430130|63279404|FG000|Overall Study|Lost to Follow-up|1|||
33712633|NCT01430130|63279404|FG000|Overall Study|Infection on Control Side of Incision|1|||
33712634|NCT01407354|63279410|FG000|First Intervention|Withdrawal by Subject|0|||
33712635|NCT01407354|63279411|FG001|First Intervention|Withdrawal by Subject|2|||
33712636|NCT01407354|63279410|FG000|First Intervention|Adverse Event|1|||
33712637|NCT01407354|63279411|FG001|First Intervention|Adverse Event|0|||
33712638|NCT01407354|63279410|FG000|First Intervention|Physician Decision|1|||
33712639|NCT01407354|63279411|FG001|First Intervention|Physician Decision|0|||
33712640|NCT01407276|63279426|FG000|Overall Study|Withdrawal by Subject|0|||
33712641|NCT01407276|63279427|FG001|Overall Study|Withdrawal by Subject|0|||
33712642|NCT01407276|63279428|FG002|Overall Study|Withdrawal by Subject|0|||
33712643|NCT01407276|63279429|FG003|Overall Study|Withdrawal by Subject|0|||
33712644|NCT01407276|63279430|FG004|Overall Study|Withdrawal by Subject|0|||
33712645|NCT01407276|63279431|FG005|Overall Study|Withdrawal by Subject|0|||
33712646|NCT01407276|63279432|FG006|Overall Study|Withdrawal by Subject|0|||
33712647|NCT01407276|63279433|FG007|Overall Study|Withdrawal by Subject|1|||
33712648|NCT01390272|63279460|FG000|Overall Study|Death|3|||
33712649|NCT01390272|63279461|FG001|Overall Study|Death|2|||
33712650|NCT01390272|63279460|FG000|Overall Study|Withdrawal by Subject|9|||
33712651|NCT01390272|63279461|FG001|Overall Study|Withdrawal by Subject|5|||
33712652|NCT01390272|63279460|FG000|Overall Study|Patient moved, no longer eligible|5|||
33712653|NCT01390272|63279461|FG001|Overall Study|Patient moved, no longer eligible|8|||
33712654|NCT01429584|63279469|FG000|Overall Study|Withdrawal by Subject|1|||
33712655|NCT01429584|63279470|FG001|Overall Study|Withdrawal by Subject|0|||
33712656|NCT01429584|63279469|FG000|Overall Study|Protocol Violation|0|||
33712657|NCT01429584|63279470|FG001|Overall Study|Protocol Violation|1|||
33712658|NCT01406652|63279478|FG000|Overall Study|Lost-to-follow-up|3|||
33712659|NCT01406652|63279479|FG001|Overall Study|Lost-to-follow-up|4|||
33712660|NCT01406652|63279478|FG000|Overall Study|Withdrawal by Subject|2|||
33315153|NCT01207440|62690738|FG005|Overall Study|Adverse Event|6|||
33315154|NCT01207440|62690739|FG006|Overall Study|Adverse Event|2|||
33315155|NCT01207440|62690733|FG000|Overall Study|Death|6|||
33315156|NCT01207440|62690734|FG001|Overall Study|Death|3|||
33315157|NCT01207440|62690735|FG002|Overall Study|Death|2|||
33315158|NCT01207440|62690736|FG003|Overall Study|Death|2|||
33315159|NCT01207440|62690737|FG004|Overall Study|Death|7|||
33315160|NCT01207440|62690738|FG005|Overall Study|Death|5|||
33315161|NCT01207440|62690739|FG006|Overall Study|Death|1|||
33315162|NCT01207440|62690733|FG000|Overall Study|Lack of Efficacy|13|||
33315163|NCT01207440|62690734|FG001|Overall Study|Lack of Efficacy|2|||
33315164|NCT01207440|62690735|FG002|Overall Study|Lack of Efficacy|5|||
33315165|NCT01207440|62690736|FG003|Overall Study|Lack of Efficacy|1|||
33315166|NCT01207440|62690737|FG004|Overall Study|Lack of Efficacy|2|||
33315167|NCT01207440|62690738|FG005|Overall Study|Lack of Efficacy|3|||
33315168|NCT01207440|62690739|FG006|Overall Study|Lack of Efficacy|0|||
33315169|NCT01207440|62690733|FG000|Overall Study|Lost to Follow-up|0|||
33315170|NCT01207440|62690734|FG001|Overall Study|Lost to Follow-up|0|||
33315171|NCT01207440|62690735|FG002|Overall Study|Lost to Follow-up|2|||
33315172|NCT01207440|62690736|FG003|Overall Study|Lost to Follow-up|1|||
33315173|NCT01207440|62690737|FG004|Overall Study|Lost to Follow-up|0|||
33315174|NCT01207440|62690738|FG005|Overall Study|Lost to Follow-up|0|||
33315175|NCT01207440|62690739|FG006|Overall Study|Lost to Follow-up|0|||
33315176|NCT01207440|62690733|FG000|Overall Study|Non-compliance with Study Drug|3|||
33315177|NCT01207440|62690734|FG001|Overall Study|Non-compliance with Study Drug|0|||
33315178|NCT01207440|62690735|FG002|Overall Study|Non-compliance with Study Drug|1|||
33315179|NCT01207440|62690736|FG003|Overall Study|Non-compliance with Study Drug|0|||
33315180|NCT01207440|62690737|FG004|Overall Study|Non-compliance with Study Drug|0|||
33315181|NCT01207440|62690738|FG005|Overall Study|Non-compliance with Study Drug|0|||
33315182|NCT01207440|62690739|FG006|Overall Study|Non-compliance with Study Drug|0|||
33315183|NCT01207440|62690733|FG000|Overall Study|Physician Decision|6|||
33315184|NCT01207440|62690734|FG001|Overall Study|Physician Decision|5|||
33315185|NCT01207440|62690735|FG002|Overall Study|Physician Decision|5|||
33315186|NCT01207440|62690736|FG003|Overall Study|Physician Decision|0|||
33315187|NCT01207440|62690737|FG004|Overall Study|Physician Decision|1|||
33315188|NCT01207440|62690738|FG005|Overall Study|Physician Decision|0|||
33315189|NCT01207440|62690739|FG006|Overall Study|Physician Decision|0|||
33315190|NCT01207440|62690733|FG000|Overall Study|Progressive Disease|19|||
33315191|NCT01207440|62690734|FG001|Overall Study|Progressive Disease|10|||
33315192|NCT01207440|62690735|FG002|Overall Study|Progressive Disease|19|||
33315193|NCT01207440|62690736|FG003|Overall Study|Progressive Disease|7|||
33315194|NCT01207440|62690737|FG004|Overall Study|Progressive Disease|23|||
33315195|NCT01207440|62690738|FG005|Overall Study|Progressive Disease|27|||
33315196|NCT01207440|62690739|FG006|Overall Study|Progressive Disease|0|||
33315197|NCT01207440|62690733|FG000|Overall Study|Protocol Violation|2|||
33315198|NCT01207440|62690734|FG001|Overall Study|Protocol Violation|0|||
33315199|NCT01207440|62690735|FG002|Overall Study|Protocol Violation|0|||
33315200|NCT01207440|62690736|FG003|Overall Study|Protocol Violation|0|||
33315201|NCT01207440|62690737|FG004|Overall Study|Protocol Violation|0|||
33315202|NCT01207440|62690738|FG005|Overall Study|Protocol Violation|0|||
33315203|NCT01207440|62690739|FG006|Overall Study|Protocol Violation|0|||
33315204|NCT01207440|62690733|FG000|Overall Study|Site Terminated by Sponsor|69|||
33315205|NCT01207440|62690734|FG001|Overall Study|Site Terminated by Sponsor|19|||
33315206|NCT01207440|62690735|FG002|Overall Study|Site Terminated by Sponsor|12|||
33315207|NCT01207440|62690736|FG003|Overall Study|Site Terminated by Sponsor|2|||
33315208|NCT01207440|62690737|FG004|Overall Study|Site Terminated by Sponsor|3|||
33315209|NCT01207440|62690738|FG005|Overall Study|Site Terminated by Sponsor|0|||
33315210|NCT01207440|62690739|FG006|Overall Study|Site Terminated by Sponsor|2|||
33315211|NCT01207440|62690733|FG000|Overall Study|Withdrawal by Subject|29|||
33315212|NCT01207440|62690734|FG001|Overall Study|Withdrawal by Subject|4|||
33315213|NCT01207440|62690735|FG002|Overall Study|Withdrawal by Subject|5|||
33315214|NCT01207440|62690736|FG003|Overall Study|Withdrawal by Subject|3|||
33315215|NCT01207440|62690737|FG004|Overall Study|Withdrawal by Subject|2|||
33315216|NCT01207440|62690738|FG005|Overall Study|Withdrawal by Subject|2|||
33315217|NCT01207440|62690739|FG006|Overall Study|Withdrawal by Subject|0|||
33315218|NCT01207440|62690733|FG000|Overall Study|Reason Not Specified|10|||
33315219|NCT01207440|62690734|FG001|Overall Study|Reason Not Specified|10|||
33315220|NCT01207440|62690735|FG002|Overall Study|Reason Not Specified|7|||
33315221|NCT01207440|62690736|FG003|Overall Study|Reason Not Specified|0|||
33315222|NCT01207440|62690737|FG004|Overall Study|Reason Not Specified|4|||
33315223|NCT01207440|62690738|FG005|Overall Study|Reason Not Specified|3|||
33315224|NCT01207440|62690739|FG006|Overall Study|Reason Not Specified|0|||
33315225|NCT00990184|62690761|FG000|Overall Study|Physician Decision|1|||
33315226|NCT00986830|62690767|FG000|Overall Study|Death|1|||
33315227|NCT00986830|62690767|FG000|Overall Study|Lost to Follow-up|1|||
33315228|NCT00986830|62690767|FG000|Overall Study|Lack of Efficacy|1|||
33315229|NCT00986830|62690767|FG000|Overall Study|Unable to access sinus with device|5|||
33315230|NCT00990106|62690773|FG000|Overall Study|"too busy to continue"|1|||
33315231|NCT00990106|62690774|FG001|Overall Study|"too busy to continue"|2|||
33315232|NCT00990106|62690773|FG000|Overall Study|Lost to Follow-up|1|||
33315233|NCT00990106|62690774|FG001|Overall Study|Lost to Follow-up|3|||
33315234|NCT00990106|62690773|FG000|Overall Study|Withdrawal by Subject|2|||
33315235|NCT00990106|62690774|FG001|Overall Study|Withdrawal by Subject|1|||
33315236|NCT00990106|62690773|FG000|Overall Study|opted for open label prazosin|1|||
33315237|NCT00990106|62690774|FG001|Overall Study|opted for open label prazosin|1|||
33315238|NCT00990106|62690773|FG000|Overall Study|relocation/deployment|4|||
33315239|NCT00990106|62690774|FG001|Overall Study|relocation/deployment|1|||
33315240|NCT00990106|62690773|FG000|Overall Study|started exclusionary medication|0|||
33315241|NCT00990106|62690774|FG001|Overall Study|started exclusionary medication|1|||
33315242|NCT00990106|62690773|FG000|Overall Study|planned major surgery|0|||
33315243|NCT00990106|62690774|FG001|Overall Study|planned major surgery|1|||
33315244|NCT00990106|62690773|FG000|Overall Study|scheduling conflicts|0|||
33315245|NCT00990106|62690774|FG001|Overall Study|scheduling conflicts|2|||
33315246|NCT00983476|62690783|FG000|Overall Study|Did not receive intervention|17|||
33315247|NCT00983476|62690784|FG001|Overall Study|Did not receive intervention|22|||
33315248|NCT00983476|62690785|FG002|Overall Study|Did not receive intervention|0|||
33315249|NCT00982228|62690829|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
33315250|NCT00982228|62690830|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
33315251|NCT00982228|62690829|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
33712661|NCT01406652|63279479|FG001|Overall Study|Withdrawal by Subject|2|||
33712662|NCT01406652|63279478|FG000|Overall Study|Insufficient follow-up|5|||
33712663|NCT01406652|63279479|FG001|Overall Study|Insufficient follow-up|4|||
33712664|NCT01406652|63279478|FG000|Overall Study|Infection not sure|10|||
33712665|NCT01406652|63279479|FG001|Overall Study|Infection not sure|10|||
33712666|NCT01406574|63279487|FG000|Overall Study|Adverse Event|0|||
33712667|NCT01406574|63279488|FG001|Overall Study|Adverse Event|0|||
33712668|NCT01406574|63279489|FG002|Overall Study|Adverse Event|1|||
33712669|NCT01406574|63279490|FG003|Overall Study|Adverse Event|3|||
33712670|NCT01406574|63279487|FG000|Overall Study|Physician Decision|0|||
33712671|NCT01406574|63279488|FG001|Overall Study|Physician Decision|0|||
33712672|NCT01406574|63279489|FG002|Overall Study|Physician Decision|0|||
33315252|NCT00982228|62690830|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
33315253|NCT00982228|62690829|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
33315254|NCT00982228|62690830|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
33315255|NCT00982228|62690829|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
33315256|NCT00982228|62690830|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
33315257|NCT00982228|62690829|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
33315258|NCT00982228|62690830|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
33315259|NCT00982228|62690829|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
33315260|NCT00982228|62690830|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
33315261|NCT00982228|62690829|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
33315262|NCT00982228|62690830|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
33315263|NCT00982228|62690829|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
33315264|NCT00982228|62690830|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
33315265|NCT00982228|62690829|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
33315266|NCT00982228|62690830|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
33315267|NCT00982228|62690829|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
33315268|NCT00982228|62690830|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
33315269|NCT01260350|62690856|FG000|Overall Study|Lack of Efficacy|0|||
33315270|NCT01260350|62690857|FG001|Overall Study|Lack of Efficacy|0|||
33315271|NCT01260350|62690858|FG002|Overall Study|Lack of Efficacy|0|||
33315272|NCT01260350|62690859|FG003|Overall Study|Lack of Efficacy|0|||
33315273|NCT01260350|62690860|FG004|Overall Study|Lack of Efficacy|0|||
33315274|NCT01260350|62690861|FG005|Overall Study|Lack of Efficacy|0|||
33315275|NCT01260350|62690862|FG006|Overall Study|Lack of Efficacy|0|||
33315276|NCT01260350|62690863|FG007|Overall Study|Lack of Efficacy|0|||
33315277|NCT01260350|62690864|FG008|Overall Study|Lack of Efficacy|0|||
33315278|NCT01260350|62690865|FG009|Overall Study|Lack of Efficacy|0|||
33315279|NCT01260350|62690866|FG010|Overall Study|Lack of Efficacy|0|||
33315280|NCT01260350|62690867|FG011|Overall Study|Lack of Efficacy|0|||
33315281|NCT01260350|62690868|FG012|Overall Study|Lack of Efficacy|0|||
33315282|NCT01260350|62690869|FG013|Overall Study|Lack of Efficacy|0|||
33315283|NCT01260350|62690870|FG014|Overall Study|Lack of Efficacy|0|||
33315284|NCT01260350|62690871|FG015|Overall Study|Lack of Efficacy|0|||
33315285|NCT01260350|62690872|FG016|Overall Study|Lack of Efficacy|0|||
33712673|NCT01406574|63279490|FG003|Overall Study|Physician Decision|1|||
33315286|NCT01260350|62690873|FG017|Overall Study|Lack of Efficacy|1|||
33315287|NCT01260350|62690874|FG018|Overall Study|Lack of Efficacy|0|||
33315288|NCT01260350|62690875|FG019|Overall Study|Lack of Efficacy|0|||
33493842|NCT03535194|62872385|FG002|Maintenance Period|Withdrawal by Subject|1|||
33597518|NCT02325739|62996461|FG002|Phase II Part|Physician Decision|0|||
33712674|NCT01406574|63279487|FG000|Overall Study|Withdrawal by Subject|0|||
33712675|NCT01406574|63279488|FG001|Overall Study|Withdrawal by Subject|1|||
33315289|NCT01260350|62690876|FG020|Overall Study|Lack of Efficacy|3|||
33315290|NCT01260350|62690877|FG021|Overall Study|Lack of Efficacy|0|||
33315291|NCT01260350|62690856|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315292|NCT01260350|62690857|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315293|NCT01260350|62690858|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315294|NCT01260350|62690859|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315295|NCT01260350|62690860|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315296|NCT01260350|62690861|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315297|NCT01260350|62690862|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315298|NCT01260350|62690863|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315299|NCT01260350|62690864|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
33315300|NCT01260350|62690865|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315301|NCT01260350|62690866|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315302|NCT01260350|62690867|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315303|NCT01260350|62690868|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315304|NCT01260350|62690869|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315305|NCT01260350|62690870|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315306|NCT01260350|62690871|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315307|NCT01260350|62690872|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315308|NCT01260350|62690873|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315309|NCT01260350|62690874|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315310|NCT01260350|62690875|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315311|NCT01260350|62690876|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315312|NCT01260350|62690877|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33315313|NCT01260194|62690931|FG000|Overall Study|Withdrawal of Consent|1|||
33315314|NCT01259726|62690939|FG000|Overall Study|Death|1|||
33315315|NCT01259726|62690940|FG001|Overall Study|Death|0|||
33315316|NCT01259726|62690941|FG002|Overall Study|Death|0|||
33315317|NCT01259726|62690942|FG003|Overall Study|Death|0|||
33315318|NCT01259726|62690939|FG000|Overall Study|Physician Decision|2|||
33315319|NCT01259726|62690940|FG001|Overall Study|Physician Decision|0|||
33315320|NCT01259726|62690941|FG002|Overall Study|Physician Decision|1|||
33315321|NCT01259726|62690942|FG003|Overall Study|Physician Decision|1|||
33315322|NCT01259726|62690939|FG000|Overall Study|Withdrawal by Subject|1|||
33315323|NCT01259726|62690940|FG001|Overall Study|Withdrawal by Subject|3|||
33315324|NCT01259726|62690941|FG002|Overall Study|Withdrawal by Subject|2|||
33315325|NCT01259726|62690942|FG003|Overall Study|Withdrawal by Subject|1|||
33315326|NCT01259726|62690939|FG000|Overall Study|Lost to Follow-up|1|||
33315327|NCT01259726|62690940|FG001|Overall Study|Lost to Follow-up|1|||
33315328|NCT01259726|62690941|FG002|Overall Study|Lost to Follow-up|1|||
33315329|NCT01259726|62690942|FG003|Overall Study|Lost to Follow-up|3|||
33315330|NCT01259492|62690956|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
33315331|NCT01259492|62690957|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
33315332|NCT01259492|62690958|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
33315333|NCT01259492|62690959|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
33315334|NCT01259492|62690956|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
33315335|NCT01259492|62690957|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
33315336|NCT01259492|62690958|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
33315337|NCT01259492|62690959|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
33315338|NCT01259492|62690956|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
33315339|NCT01259492|62690957|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
33315340|NCT01259492|62690958|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
33315341|NCT01259492|62690959|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
33315342|NCT01259492|62690956|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
33315343|NCT01259492|62690957|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
33315344|NCT01259492|62690958|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
33315345|NCT01259492|62690959|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
33315346|NCT01259492|62690956|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
33315347|NCT01259492|62690957|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
33315348|NCT01259492|62690958|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
33315349|NCT01259492|62690959|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
33315350|NCT01259492|62690956|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
33315351|NCT01259492|62690957|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
33315352|NCT01259492|62690958|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
33315353|NCT01259492|62690959|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
33315354|NCT01259492|62690956|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
33712676|NCT01406574|63279489|FG002|Overall Study|Withdrawal by Subject|0|||
33712677|NCT01406574|63279490|FG003|Overall Study|Withdrawal by Subject|0|||
33712678|NCT01406574|63279487|FG000|Overall Study|Definite progression of primary disease|1|||
33712679|NCT01406574|63279488|FG001|Overall Study|Definite progression of primary disease|0|||
33712680|NCT01406574|63279489|FG002|Overall Study|Definite progression of primary disease|0|||
33712681|NCT01406574|63279490|FG003|Overall Study|Definite progression of primary disease|0|||
33712682|NCT01405950|63279503|FG000|Overall Study|Withdrawal by Subject|1|||
33712683|NCT01405950|63279504|FG001|Overall Study|Withdrawal by Subject|0|||
33712684|NCT01405950|63279505|FG002|Overall Study|Withdrawal by Subject|0|||
33712685|NCT01405950|63279506|FG003|Overall Study|Withdrawal by Subject|0|||
33712686|NCT01405560|63279514|FG000|Overall Study|Physician Decision|1|||
33712687|NCT01428882|63279520|FG000|Overall Study|Lack of Efficacy|2|||
33712688|NCT01428882|63279521|FG001|Overall Study|Lack of Efficacy|7|||
33712689|NCT01428882|63279520|FG000|Overall Study|Protocol Violation|4|||
33712690|NCT01428882|63279521|FG001|Overall Study|Protocol Violation|3|||
33712691|NCT01428258|63279529|FG000|Intervention 1|Withdrawal by Subject|2|||
33712692|NCT01428258|63279530|FG001|Intervention 1|Withdrawal by Subject|0|||
33712693|NCT01389882|63279546|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
33712694|NCT01389882|63279547|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
33712695|NCT01389882|63279546|FG000|Overall Study|Withdrawal by Subject|0|||
33712696|NCT01389882|63279547|FG001|Overall Study|Withdrawal by Subject|1|||
33712697|NCT01442688|63279555|FG000|First Intervention|Withdrawal by Subject|1|||
33712698|NCT01442688|63279556|FG001|First Intervention|Withdrawal by Subject|0|||
33712699|NCT01442688|63279555|FG000|First Intervention|subject incarcerated|1|||
33712700|NCT01442688|63279556|FG001|First Intervention|subject incarcerated|0|||
33712701|NCT01442688|63279555|FG000|Second Intervention|Adverse Event|1|||
33712702|NCT01442688|63279556|FG001|Second Intervention|Adverse Event|0|||
33712703|NCT01466166|63279562|FG000|Overall Study|Death|1|||
33712704|NCT01466166|63279562|FG000|Overall Study|Lost to Follow-up|7|||
33712705|NCT01466166|63279562|FG000|Overall Study|Infusion Reaction (IR)|27|||
33712706|NCT01466166|63279562|FG000|Overall Study|Adverse Event (Other than IR)|11|||
33712707|NCT01466166|63279562|FG000|Overall Study|Elevated Serum Uric Acid|78|||
33712708|NCT01466166|63279562|FG000|Overall Study|Withdrawal by Subject|13|||
33712709|NCT01466166|63279562|FG000|Overall Study|Sponsor Decision|4|||
33712710|NCT01466166|63279562|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
33712711|NCT01466166|63279562|FG000|Overall Study|Other|20|||
33712712|NCT01426854|63279568|FG000|Overall Study|Adverse Event|1|||
33712713|NCT01426854|63279569|FG001|Overall Study|Adverse Event|5|||
33712714|NCT01426854|63279568|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
33712715|NCT01426854|63279569|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
33712716|NCT01426854|63279568|FG000|Overall Study|Lost to Follow-up|3|||
33712717|NCT01426854|63279569|FG001|Overall Study|Lost to Follow-up|0|||
33712718|NCT01426854|63279568|FG000|Overall Study|Noncompliance|0|||
33712719|NCT01426854|63279569|FG001|Overall Study|Noncompliance|1|||
33712720|NCT01426854|63279568|FG000|Overall Study|Treatment Failure|0|||
33712721|NCT01426854|63279569|FG001|Overall Study|Treatment Failure|16|||
33712722|NCT01426854|63279568|FG000|Overall Study|Protocol Deviation|0|||
33712723|NCT01426854|63279569|FG001|Overall Study|Protocol Deviation|1|||
33712724|NCT01426854|63279568|FG000|Overall Study|Other|3|||
33712725|NCT01426854|63279569|FG001|Overall Study|Other|2|||
33712726|NCT01426386|63279581|FG000|Overall Study|Adverse Event|0|||
33712727|NCT01426386|63279582|FG001|Overall Study|Adverse Event|1|||
33712728|NCT01426386|63279583|FG002|Overall Study|Adverse Event|0|||
33712729|NCT01426386|63279584|FG003|Overall Study|Adverse Event|0|||
33712730|NCT01426386|63279585|FG004|Overall Study|Adverse Event|0|||
33712731|NCT01426386|63279586|FG005|Overall Study|Adverse Event|0|||
33712732|NCT01426386|63279581|FG000|Overall Study|Did not attend scheduled visit|1|||
33712733|NCT01426386|63279582|FG001|Overall Study|Did not attend scheduled visit|4|||
33712734|NCT01426386|63279583|FG002|Overall Study|Did not attend scheduled visit|0|||
33712735|NCT01426386|63279584|FG003|Overall Study|Did not attend scheduled visit|0|||
33712736|NCT01426386|63279585|FG004|Overall Study|Did not attend scheduled visit|2|||
33712737|NCT01426386|63279586|FG005|Overall Study|Did not attend scheduled visit|1|||
33712738|NCT01426386|63279581|FG000|Overall Study|Poor response|2|||
33712739|NCT01426386|63279582|FG001|Overall Study|Poor response|1|||
33712740|NCT01426386|63279583|FG002|Overall Study|Poor response|2|||
33712741|NCT01426386|63279584|FG003|Overall Study|Poor response|0|||
33712742|NCT01426386|63279585|FG004|Overall Study|Poor response|1|||
33315355|NCT01259492|62690957|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
33712743|NCT01426386|63279586|FG005|Overall Study|Poor response|0|||
33315356|NCT01259492|62690958|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
33712744|NCT01426386|63279581|FG000|Overall Study|Personal reasons|0|||
33712745|NCT01426386|63279582|FG001|Overall Study|Personal reasons|0|||
33712746|NCT01426386|63279583|FG002|Overall Study|Personal reasons|0|||
33712747|NCT01426386|63279584|FG003|Overall Study|Personal reasons|0|||
33712748|NCT01426386|63279585|FG004|Overall Study|Personal reasons|1|||
33712749|NCT01426386|63279586|FG005|Overall Study|Personal reasons|0|||
33712750|NCT01404234|63279600|FG000|Overall Study|Withdrawal by Subject|2|||
33712751|NCT01403610|63279608|FG000|Overall Study|Withdrawal by Subject|2|||
33712752|NCT01403610|63279609|FG001|Overall Study|Withdrawal by Subject|0|||
33712753|NCT01403610|63279610|FG002|Overall Study|Withdrawal by Subject|0|||
33315357|NCT01259492|62690959|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
33315358|NCT01259492|62690956|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
33315359|NCT01259492|62690957|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
33315360|NCT01259492|62690958|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
33315361|NCT01259492|62690959|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
33315362|NCT01259492|62690956|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
33315363|NCT01259492|62690957|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
33315364|NCT01259492|62690958|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
33712754|NCT01403610|63279611|FG003|Overall Study|Withdrawal by Subject|0|||
33712755|NCT01403610|63279608|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
33712756|NCT01403610|63279609|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
33712757|NCT01403610|63279610|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
33712758|NCT01403610|63279611|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
33712759|NCT01403064|63279625|FG000|Overall Study|Death|0|||
33712760|NCT01403064|63279626|FG001|Overall Study|Death|0|||
33712761|NCT01403064|63279627|FG002|Overall Study|Death|1|||
33712762|NCT01403064|63279628|FG003|Overall Study|Death|1|||
33712763|NCT01403064|63279625|FG000|Overall Study|Withdrawal by Subject|0|||
33712764|NCT01403064|63279626|FG001|Overall Study|Withdrawal by Subject|0|||
33712765|NCT01403064|63279627|FG002|Overall Study|Withdrawal by Subject|1|||
33712766|NCT01403064|63279628|FG003|Overall Study|Withdrawal by Subject|1|||
33712767|NCT01403064|63279625|FG000|Overall Study|Other|1|||
33712768|NCT01403064|63279626|FG001|Overall Study|Other|0|||
33712769|NCT01403064|63279627|FG002|Overall Study|Other|2|||
33712770|NCT01403064|63279628|FG003|Overall Study|Other|1|||
33712771|NCT01402986|63279647|FG000|Overall Study|Withdrawal by Subject|7|||
33712772|NCT01402986|63279648|FG001|Overall Study|Withdrawal by Subject|10|||
33712773|NCT01402986|63279649|FG002|Overall Study|Withdrawal by Subject|7|||
33712774|NCT01402986|63279650|FG003|Overall Study|Withdrawal by Subject|13|||
33712775|NCT01402986|63279647|FG000|Overall Study|Death|0|||
33712776|NCT01402986|63279648|FG001|Overall Study|Death|0|||
33712777|NCT01402986|63279649|FG002|Overall Study|Death|0|||
33712778|NCT01402986|63279650|FG003|Overall Study|Death|2|||
33712779|NCT01402986|63279647|FG000|Overall Study|Lost to Follow-up|0|||
33712780|NCT01402986|63279648|FG001|Overall Study|Lost to Follow-up|0|||
33712781|NCT01402986|63279649|FG002|Overall Study|Lost to Follow-up|0|||
33712782|NCT01402986|63279650|FG003|Overall Study|Lost to Follow-up|1|||
33712783|NCT01402986|63279647|FG000|Overall Study|Other|2|||
33712784|NCT01402986|63279648|FG001|Overall Study|Other|5|||
33712785|NCT01402986|63279649|FG002|Overall Study|Other|1|||
33712786|NCT01402986|63279650|FG003|Overall Study|Other|6|||
33712787|NCT01402908|63279662|FG000|Overall Study|Withdrawal by Subject|30|||
33712788|NCT01402908|63279663|FG001|Overall Study|Withdrawal by Subject|17|||
33712789|NCT01402908|63279662|FG000|Overall Study|Lost to Follow-up|3|||
33712790|NCT01402908|63279663|FG001|Overall Study|Lost to Follow-up|1|||
33712791|NCT01402908|63279662|FG000|Overall Study|Physician Decision|1|||
33315365|NCT01259492|62690959|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
33315366|NCT01259492|62690956|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
33315367|NCT01259492|62690957|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
33315368|NCT01259492|62690958|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
33315369|NCT01259492|62690959|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
33315370|NCT01259492|62690956|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
33315371|NCT01259492|62690957|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
33315372|NCT01259492|62690958|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
33315373|NCT01259492|62690959|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
33315374|NCT01259492|62690956|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
33315375|NCT01259492|62690957|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
33315376|NCT01259492|62690958|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
33315377|NCT01259492|62690959|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
33315378|NCT01259492|62690956|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
33315379|NCT01259492|62690957|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
33315380|NCT01259492|62690958|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
33315381|NCT01259492|62690959|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
33712792|NCT01402908|63279663|FG001|Overall Study|Physician Decision|0|||
33712793|NCT01389258|63279669|FG000|Overall Study|Lost to Follow-up|5|||
33712794|NCT01389102|63279679|FG000|Overall Study|Adverse Event|1|||
33328300|NCT01200290|62704703|FG000|Post-Treatment Follow-Up Period|Death|2|||
33712795|NCT01389102|63279680|FG001|Overall Study|Adverse Event|3|||
33712796|NCT01389102|63279681|FG002|Overall Study|Adverse Event|2|||
33712797|NCT01389102|63279682|FG003|Overall Study|Adverse Event|2|||
33712798|NCT01389102|63279683|FG004|Overall Study|Adverse Event|2|||
33712799|NCT01389102|63279684|FG005|Overall Study|Adverse Event|2|||
33315382|NCT01259492|62690956|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
33315383|NCT01259492|62690957|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
33315384|NCT01259492|62690958|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
33315385|NCT01259492|62690959|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
33315386|NCT01259492|62690956|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
33712800|NCT01389102|63279679|FG000|Overall Study|Hurricane Katrina|4|||
33712801|NCT01389102|63279680|FG001|Overall Study|Hurricane Katrina|2|||
33712802|NCT01389102|63279681|FG002|Overall Study|Hurricane Katrina|3|||
33712803|NCT01389102|63279682|FG003|Overall Study|Hurricane Katrina|0|||
33712804|NCT01389102|63279683|FG004|Overall Study|Hurricane Katrina|3|||
33712805|NCT01389102|63279684|FG005|Overall Study|Hurricane Katrina|1|||
33712806|NCT01389102|63279679|FG000|Overall Study|Lost to Follow-up|4|||
33712807|NCT01389102|63279680|FG001|Overall Study|Lost to Follow-up|1|||
33712808|NCT01389102|63279681|FG002|Overall Study|Lost to Follow-up|1|||
33712809|NCT01389102|63279682|FG003|Overall Study|Lost to Follow-up|2|||
33712810|NCT01389102|63279683|FG004|Overall Study|Lost to Follow-up|4|||
33712811|NCT01389102|63279684|FG005|Overall Study|Lost to Follow-up|1|||
33712812|NCT01389102|63279679|FG000|Overall Study|Protocol Violation|0|||
33712813|NCT01389102|63279680|FG001|Overall Study|Protocol Violation|0|||
33712814|NCT01389102|63279681|FG002|Overall Study|Protocol Violation|3|||
33712815|NCT01389102|63279682|FG003|Overall Study|Protocol Violation|0|||
33712816|NCT01389102|63279683|FG004|Overall Study|Protocol Violation|1|||
33712817|NCT01389102|63279684|FG005|Overall Study|Protocol Violation|1|||
33712818|NCT01389102|63279679|FG000|Overall Study|Withdrawal by Subject|7|||
33712819|NCT01389102|63279680|FG001|Overall Study|Withdrawal by Subject|4|||
33712820|NCT01389102|63279681|FG002|Overall Study|Withdrawal by Subject|9|||
33712821|NCT01389102|63279682|FG003|Overall Study|Withdrawal by Subject|2|||
33712822|NCT01389102|63279683|FG004|Overall Study|Withdrawal by Subject|3|||
33712823|NCT01389102|63279684|FG005|Overall Study|Withdrawal by Subject|3|||
33712824|NCT01389102|63279679|FG000|Overall Study|Subject Traveling Out of Country|0|||
33712825|NCT01389102|63279680|FG001|Overall Study|Subject Traveling Out of Country|0|||
33712826|NCT01389102|63279681|FG002|Overall Study|Subject Traveling Out of Country|0|||
33712827|NCT01389102|63279682|FG003|Overall Study|Subject Traveling Out of Country|1|||
33712828|NCT01389102|63279683|FG004|Overall Study|Subject Traveling Out of Country|0|||
33712829|NCT01389102|63279684|FG005|Overall Study|Subject Traveling Out of Country|0|||
33712830|NCT01389102|63279679|FG000|Overall Study|Subject Moved|2|||
33712831|NCT01389102|63279680|FG001|Overall Study|Subject Moved|0|||
33712832|NCT01389102|63279681|FG002|Overall Study|Subject Moved|1|||
33712833|NCT01389102|63279682|FG003|Overall Study|Subject Moved|0|||
33712834|NCT01389102|63279683|FG004|Overall Study|Subject Moved|0|||
33712835|NCT01389102|63279684|FG005|Overall Study|Subject Moved|0|||
33712836|NCT01389102|63279679|FG000|Overall Study|Unavailable due to husband's illness|0|||
33712837|NCT01389102|63279680|FG001|Overall Study|Unavailable due to husband's illness|1|||
33712838|NCT01389102|63279681|FG002|Overall Study|Unavailable due to husband's illness|0|||
33712839|NCT01389102|63279682|FG003|Overall Study|Unavailable due to husband's illness|0|||
33712840|NCT01389102|63279683|FG004|Overall Study|Unavailable due to husband's illness|0|||
33712841|NCT01389102|63279684|FG005|Overall Study|Unavailable due to husband's illness|0|||
33712842|NCT01389102|63279679|FG000|Overall Study|Investigator Judgement|0|||
33712843|NCT01389102|63279680|FG001|Overall Study|Investigator Judgement|1|||
33712844|NCT01389102|63279681|FG002|Overall Study|Investigator Judgement|0|||
33712845|NCT01389102|63279682|FG003|Overall Study|Investigator Judgement|0|||
33712846|NCT01389102|63279683|FG004|Overall Study|Investigator Judgement|0|||
33712847|NCT01389102|63279684|FG005|Overall Study|Investigator Judgement|0|||
33712848|NCT01402284|63279704|FG000|Overall Study|Withdrawal consent|2|||
33712849|NCT01402284|63279704|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
33712850|NCT01402284|63279704|FG000|Overall Study|Physician Decision|1|||
33712851|NCT01402284|63279704|FG000|Overall Study|Disease progression on study|10|||
33712852|NCT01388790|63279708|FG000|Overall Study|Ongoing at data cut-off date|8|||
33712853|NCT01388478|63279712|FG000|Overall Study|Adverse Event|4|||
33712854|NCT01388478|63279712|FG000|Overall Study|Withdrawal by Subject|1|||
33712855|NCT01424670|63279718|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
33712856|NCT01424670|63279719|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
33712857|NCT01424670|63279718|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
33712858|NCT01424670|63279719|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
33712859|NCT01424670|63279718|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
33712860|NCT01424670|63279719|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
33712861|NCT01424670|63279718|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
33315387|NCT01259492|62690957|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
33401938|NCT00729833|62780871|FG000|Overall Study|Unspecified Reasons|11|||
33401939|NCT00729833|62780872|FG001|Overall Study|Unspecified Reasons|5|||
33712862|NCT01424670|63279719|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
33712863|NCT01424670|63279718|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
33712864|NCT01424670|63279719|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
33712865|NCT01424670|63279718|FG000|Continuation Period|Adverse Event|13|||
33315388|NCT01259492|62690958|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
33315389|NCT01259492|62690959|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
33315390|NCT01259492|62690956|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
33315391|NCT01259492|62690957|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
33315392|NCT01259492|62690958|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
33315393|NCT01259492|62690959|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
33712866|NCT01424670|63279719|FG001|Continuation Period|Adverse Event|5|||
33712867|NCT01424670|63279718|FG000|Continuation Period|Lost to Follow-up|2|||
33712868|NCT01424670|63279719|FG001|Continuation Period|Lost to Follow-up|0|||
33712869|NCT01424670|63279718|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
33712870|NCT01424670|63279719|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
33712871|NCT01424670|63279718|FG000|Continuation Period|Physician Decision|5|||
33712872|NCT01424670|63279719|FG001|Continuation Period|Physician Decision|4|||
33712873|NCT01424670|63279718|FG000|Continuation Period|Withdrawal by Subject|13|||
33712874|NCT01424670|63279719|FG001|Continuation Period|Withdrawal by Subject|4|||
33712875|NCT01424514|63279727|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
33712876|NCT01424514|63279728|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
33712877|NCT01424514|63279727|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
33712878|NCT01424514|63279728|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
33712879|NCT01400958|63279741|FG000|Overall Study|Physician Decision|0|||
33712880|NCT01400958|63279742|FG001|Overall Study|Physician Decision|1|||
33712881|NCT01400958|63279741|FG000|Overall Study|Withdrawal by Subject|0|||
33712882|NCT01400958|63279742|FG001|Overall Study|Withdrawal by Subject|1|||
33712883|NCT01400958|63279741|FG000|Overall Study|Adverse Event|1|||
33712884|NCT01400958|63279742|FG001|Overall Study|Adverse Event|0|||
33712885|NCT01388166|63279748|FG000|Overall Study|Adverse Event|16|||
33712886|NCT01388166|63279748|FG000|Overall Study|Lost to Follow-up|30|||
33712887|NCT01388166|63279748|FG000|Overall Study|Others than specified above|13|||
33712888|NCT01400412|63279754|FG000|Overall Study|Lost to Follow-up|4|||
33712889|NCT01400412|63279755|FG001|Overall Study|Lost to Follow-up|7|||
33712890|NCT01400412|63279754|FG000|Overall Study|Withdrawal by Subject|3|||
33712891|NCT01400412|63279755|FG001|Overall Study|Withdrawal by Subject|4|||
33712892|NCT01400412|63279754|FG000|Overall Study|Unable to complete|3|||
33712893|NCT01400412|63279755|FG001|Overall Study|Unable to complete|3|||
33712894|NCT01400412|63279754|FG000|Overall Study|Never started study treatment|0|||
33712895|NCT01400412|63279755|FG001|Overall Study|Never started study treatment|3|||
33712896|NCT01422876|63279773|FG000|Week 24|Lost to Follow-up|1|||
33712897|NCT01422876|63279774|FG001|Week 24|Lost to Follow-up|1|||
33712898|NCT01422876|63279775|FG002|Week 24|Lost to Follow-up|2|||
33712899|NCT01422876|63279776|FG003|Week 24|Lost to Follow-up|4|||
33712900|NCT01422876|63279777|FG004|Week 24|Lost to Follow-up|2|||
33712901|NCT01422876|63279778|FG005|Week 24|Lost to Follow-up|0|||
33712902|NCT01422876|63279779|FG006|Week 24|Lost to Follow-up|1|||
33712903|NCT01422876|63279780|FG007|Week 24|Lost to Follow-up|3|||
33712904|NCT01422876|63279781|FG008|Week 24|Lost to Follow-up|3|||
33712905|NCT01422876|63279782|FG009|Week 24|Lost to Follow-up|4|||
33712906|NCT01422876|63279773|FG000|Week 24|Consent withdrawn|5|||
33712907|NCT01422876|63279774|FG001|Week 24|Consent withdrawn|1|||
33712908|NCT01422876|63279775|FG002|Week 24|Consent withdrawn|3|||
33712909|NCT01422876|63279776|FG003|Week 24|Consent withdrawn|4|||
33712910|NCT01422876|63279777|FG004|Week 24|Consent withdrawn|5|||
33712911|NCT01422876|63279778|FG005|Week 24|Consent withdrawn|6|||
33712912|NCT01422876|63279779|FG006|Week 24|Consent withdrawn|5|||
33712913|NCT01422876|63279780|FG007|Week 24|Consent withdrawn|4|||
33712914|NCT01422876|63279781|FG008|Week 24|Consent withdrawn|3|||
33712915|NCT01422876|63279782|FG009|Week 24|Consent withdrawn|6|||
33712916|NCT01422876|63279773|FG000|Week 24|Death|0|||
33712917|NCT01422876|63279774|FG001|Week 24|Death|1|||
33712918|NCT01422876|63279775|FG002|Week 24|Death|0|||
33712919|NCT01422876|63279776|FG003|Week 24|Death|0|||
33712920|NCT01422876|63279777|FG004|Week 24|Death|0|||
33712921|NCT01422876|63279778|FG005|Week 24|Death|0|||
33712922|NCT01422876|63279779|FG006|Week 24|Death|0|||
33712923|NCT01422876|63279780|FG007|Week 24|Death|0|||
33315394|NCT01259492|62690956|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
33401940|NCT00729833|62780873|FG002|Overall Study|Unspecified Reasons|5|||
33712924|NCT01422876|63279781|FG008|Week 24|Death|0|||
33712925|NCT01422876|63279782|FG009|Week 24|Death|0|||
33712926|NCT01422876|63279773|FG000|Week 52|Lost to Follow-up|3|||
33712927|NCT01422876|63279774|FG001|Week 52|Lost to Follow-up|5|||
33712928|NCT01422876|63279775|FG002|Week 52|Lost to Follow-up|7|||
33712929|NCT01422876|63279776|FG003|Week 52|Lost to Follow-up|5|||
33712930|NCT01422876|63279777|FG004|Week 52|Lost to Follow-up|8|||
33712931|NCT01422876|63279778|FG005|Week 52|Lost to Follow-up|5|||
33712932|NCT01422876|63279779|FG006|Week 52|Lost to Follow-up|5|||
33712933|NCT01422876|63279780|FG007|Week 52|Lost to Follow-up|8|||
33712934|NCT01422876|63279781|FG008|Week 52|Lost to Follow-up|7|||
33712935|NCT01422876|63279782|FG009|Week 52|Lost to Follow-up|8|||
33712936|NCT01422876|63279773|FG000|Week 52|Consent withdrawn|9|||
33712937|NCT01422876|63279774|FG001|Week 52|Consent withdrawn|4|||
33315395|NCT01259492|62690957|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
33315396|NCT01259492|62690958|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
33315397|NCT01259492|62690959|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
33315398|NCT01259492|62690956|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
33315399|NCT01259492|62690957|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
33315400|NCT01259492|62690958|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
33315401|NCT01259492|62690959|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
33315402|NCT01259492|62690956|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
33315403|NCT01259492|62690957|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
33315404|NCT01259492|62690958|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
33315405|NCT01259492|62690959|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
33315406|NCT01259492|62690956|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
33315407|NCT01259492|62690957|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
33315408|NCT01259492|62690958|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
33315409|NCT01259492|62690959|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
33315410|NCT01117623|62690976|FG000|Overall Study|Adverse Event|0|||
33315411|NCT01117623|62690977|FG001|Overall Study|Adverse Event|2|||
33315412|NCT01117623|62690978|FG002|Overall Study|Adverse Event|4|||
33315413|NCT01117623|62690979|FG003|Overall Study|Adverse Event|0|||
33315414|NCT01117623|62690980|FG004|Overall Study|Adverse Event|2|||
33315415|NCT01117623|62690981|FG005|Overall Study|Adverse Event|0|||
33712938|NCT01422876|63279775|FG002|Week 52|Consent withdrawn|6|||
33712939|NCT01422876|63279776|FG003|Week 52|Consent withdrawn|12|||
33712940|NCT01422876|63279777|FG004|Week 52|Consent withdrawn|7|||
33712941|NCT01422876|63279778|FG005|Week 52|Consent withdrawn|12|||
33712942|NCT01422876|63279779|FG006|Week 52|Consent withdrawn|10|||
33712943|NCT01422876|63279780|FG007|Week 52|Consent withdrawn|12|||
33712944|NCT01422876|63279781|FG008|Week 52|Consent withdrawn|13|||
33712945|NCT01422876|63279782|FG009|Week 52|Consent withdrawn|9|||
33712946|NCT01422876|63279773|FG000|Week 52|Death|0|||
33712947|NCT01422876|63279774|FG001|Week 52|Death|1|||
33712948|NCT01422876|63279775|FG002|Week 52|Death|0|||
33712949|NCT01422876|63279776|FG003|Week 52|Death|1|||
33712950|NCT01422876|63279777|FG004|Week 52|Death|0|||
33712951|NCT01422876|63279778|FG005|Week 52|Death|0|||
33712952|NCT01422876|63279779|FG006|Week 52|Death|1|||
33712953|NCT01422876|63279780|FG007|Week 52|Death|3|||
33712954|NCT01422876|63279781|FG008|Week 52|Death|1|||
33712955|NCT01422876|63279782|FG009|Week 52|Death|0|||
33712956|NCT01422720|63279800|FG000|Overall Study|Adverse Event|16|||
33712957|NCT01422720|63279800|FG000|Overall Study|Lack of Efficacy|1|||
33712958|NCT01422720|63279800|FG000|Overall Study|Withdrawal by Subject|4|||
33712959|NCT01422720|63279800|FG000|Overall Study|Ineligibility|1|||
33712960|NCT01387932|63279810|FG000|Randomized and Treated|Physician Decision|3|||
33712961|NCT01387932|63279811|FG001|Randomized and Treated|Physician Decision|2|||
33712962|NCT01387932|63279810|FG000|Randomized and Treated|Withdrawal by Subject|4|||
33712963|NCT01387932|63279811|FG001|Randomized and Treated|Withdrawal by Subject|2|||
33712964|NCT01387932|63279810|FG000|Survival Follow-up|Liver Transplant|24|||
33712965|NCT01387932|63279811|FG001|Survival Follow-up|Liver Transplant|28|||
33712966|NCT01387932|63279810|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
33712967|NCT01387932|63279811|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
33712968|NCT01387932|63279810|FG000|Survival Follow-up|Withdrawal by Subject|2|||
33712969|NCT01387932|63279811|FG001|Survival Follow-up|Withdrawal by Subject|4|||
33712970|NCT01387932|63279810|FG000|Survival Follow-up|Lost to Follow-up|6|||
33712971|NCT01387932|63279811|FG001|Survival Follow-up|Lost to Follow-up|5|||
33712972|NCT01422408|63279819|FG000|Overall Study|Adverse Event|1|||
33712973|NCT01422408|63279819|FG000|Overall Study|Withdrawal by Subject|3|||
33712974|NCT01399788|63279823|FG000|First Intervention Period|Adverse Event|1|||
33712975|NCT01399788|63279824|FG001|First Intervention Period|Adverse Event|0|||
33712976|NCT01387542|63279830|FG000|Overall Study|Adverse Event|3|||
33712977|NCT01387542|63279830|FG000|Overall Study|Withdrawal by Subject|1|||
33712978|NCT01387542|63279830|FG000|Overall Study|Changed diagnosis|1|||
33712979|NCT01387542|63279830|FG000|Overall Study|Insufficient response|1|||
33712980|NCT01387542|63279830|FG000|Overall Study|Non-compliant|1|||
33712981|NCT01387542|63279830|FG000|Overall Study|Lost to Follow-up|1|||
33712982|NCT01387230|63279837|FG000|Overall Study|Adverse Event|0|||
33712983|NCT01387230|63279838|FG001|Overall Study|Adverse Event|1|||
33712984|NCT01387230|63279839|FG002|Overall Study|Adverse Event|3|||
33712985|NCT01387230|63279837|FG000|Overall Study|Lack of Efficacy|8|||
33712986|NCT01387230|63279838|FG001|Overall Study|Lack of Efficacy|5|||
33315416|NCT01117623|62690982|FG006|Overall Study|Adverse Event|0|||
33712987|NCT01387230|63279839|FG002|Overall Study|Lack of Efficacy|4|||
33712988|NCT01387230|63279837|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
33712989|NCT01387230|63279838|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
33712990|NCT01387230|63279839|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
33712991|NCT01387230|63279837|FG000|Overall Study|Lost to Follow-up|0|||
33315417|NCT01117623|62690983|FG007|Overall Study|Adverse Event|2|||
33315418|NCT01117623|62690976|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
33315419|NCT01117623|62690977|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
33315420|NCT01117623|62690978|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
33315421|NCT01117623|62690979|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
33315422|NCT01117623|62690980|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
33315423|NCT01117623|62690981|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
33315424|NCT01117623|62690982|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
33315425|NCT01117623|62690983|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
33315426|NCT01117623|62690976|FG000|Overall Study|Withdrawal by Subject|0|||
33315427|NCT01117623|62690977|FG001|Overall Study|Withdrawal by Subject|0|||
33315428|NCT01117623|62690978|FG002|Overall Study|Withdrawal by Subject|2|||
33315429|NCT01117623|62690979|FG003|Overall Study|Withdrawal by Subject|0|||
33315430|NCT01117623|62690980|FG004|Overall Study|Withdrawal by Subject|0|||
33315431|NCT01117623|62690981|FG005|Overall Study|Withdrawal by Subject|1|||
33315432|NCT01117623|62690982|FG006|Overall Study|Withdrawal by Subject|1|||
33315433|NCT01117623|62690983|FG007|Overall Study|Withdrawal by Subject|1|||
33315434|NCT01117623|62690976|FG000|Overall Study|Non-compliance with study medication|0|||
33315435|NCT01117623|62690977|FG001|Overall Study|Non-compliance with study medication|0|||
33315436|NCT01117623|62690978|FG002|Overall Study|Non-compliance with study medication|0|||
33315437|NCT01117623|62690979|FG003|Overall Study|Non-compliance with study medication|0|||
33315438|NCT01117623|62690980|FG004|Overall Study|Non-compliance with study medication|0|||
33315439|NCT01117623|62690981|FG005|Overall Study|Non-compliance with study medication|0|||
33315440|NCT01117623|62690982|FG006|Overall Study|Non-compliance with study medication|0|||
33315441|NCT01117623|62690983|FG007|Overall Study|Non-compliance with study medication|1|||
33315442|NCT01117623|62690976|FG000|Overall Study|Invest. text: completed all planned txs|0|||
33315443|NCT01117623|62690977|FG001|Overall Study|Invest. text: completed all planned txs|0|||
33315444|NCT01117623|62690978|FG002|Overall Study|Invest. text: completed all planned txs|0|||
33315445|NCT01117623|62690979|FG003|Overall Study|Invest. text: completed all planned txs|0|||
33315446|NCT01117623|62690980|FG004|Overall Study|Invest. text: completed all planned txs|0|||
33315447|NCT01117623|62690981|FG005|Overall Study|Invest. text: completed all planned txs|1|||
33315448|NCT01117623|62690982|FG006|Overall Study|Invest. text: completed all planned txs|0|||
33315449|NCT01117623|62690983|FG007|Overall Study|Invest. text: completed all planned txs|0|||
33315450|NCT01116687|62691003|FG000|Overall Study|Withdrawal by Subject|4|||
33315451|NCT01114737|62691009|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
33315452|NCT01114737|62691010|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
33315453|NCT01114737|62691009|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
33315454|NCT01114737|62691010|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
33315455|NCT01114737|62691009|FG000|Randomized Treatment Period|Pregnancy|1|||
33315456|NCT01114737|62691010|FG001|Randomized Treatment Period|Pregnancy|0|||
33315457|NCT01114737|62691009|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
33315458|NCT01114737|62691010|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
33315459|NCT01114737|62691009|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
33315460|NCT01114737|62691010|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
33315461|NCT01114737|62691009|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
33315462|NCT01114737|62691010|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
33315463|NCT01113879|62691033|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
33315464|NCT01113879|62691034|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
33315465|NCT00979576|62691045|FG000|Combination Treatment Phase|Progressive disease|3|||
33315466|NCT00979576|62691046|FG001|Combination Treatment Phase|Progressive disease|1|||
33315467|NCT00979576|62691047|FG002|Combination Treatment Phase|Progressive disease|5|||
33315468|NCT00979576|62691045|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
33315469|NCT00979576|62691046|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
33315470|NCT00979576|62691047|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
33315471|NCT00979576|62691045|FG000|Combination Treatment Phase|Adverse Event|0|||
33315472|NCT00979576|62691046|FG001|Combination Treatment Phase|Adverse Event|2|||
33315473|NCT00979576|62691047|FG002|Combination Treatment Phase|Adverse Event|2|||
33315474|NCT00979576|62691045|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
33315475|NCT00979576|62691046|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
33315476|NCT00979576|62691047|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
33315477|NCT00979420|62691060|FG000|Overall Study|Adverse Event|1|||
33315478|NCT00979420|62691061|FG001|Overall Study|Adverse Event|0|||
33315479|NCT00979420|62691062|FG002|Overall Study|Adverse Event|0|||
33315480|NCT00979420|62691063|FG003|Overall Study|Adverse Event|0|||
33315481|NCT00979420|62691060|FG000|Overall Study|Lack of Efficacy|3|||
33315482|NCT00979420|62691061|FG001|Overall Study|Lack of Efficacy|0|||
33315483|NCT00979420|62691062|FG002|Overall Study|Lack of Efficacy|1|||
33315484|NCT00979420|62691063|FG003|Overall Study|Lack of Efficacy|1|||
33315485|NCT00979420|62691060|FG000|Overall Study|Other reasons not related to Viramune|3|||
33315486|NCT00979420|62691061|FG001|Overall Study|Other reasons not related to Viramune|0|||
33315487|NCT00979420|62691062|FG002|Overall Study|Other reasons not related to Viramune|0|||
33315488|NCT00979420|62691063|FG003|Overall Study|Other reasons not related to Viramune|1|||
33315489|NCT02702180|62691074|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
33315490|NCT02702180|62691075|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
33315491|NCT02702180|62691076|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33315492|NCT02702180|62691074|FG000|Double-blind Treatment Period|Adverse Event|0|||
33315493|NCT02702180|62691075|FG001|Double-blind Treatment Period|Adverse Event|0|||
33315494|NCT02702180|62691076|FG002|Double-blind Treatment Period|Adverse Event|1|||
33315495|NCT02702180|62691074|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
33315496|NCT02702180|62691075|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
33315497|NCT02702180|62691076|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
33315498|NCT02702180|62691074|FG000|Double-blind Treatment Period|Protocol Violation|0|||
33315499|NCT02702180|62691075|FG001|Double-blind Treatment Period|Protocol Violation|0|||
33315500|NCT02702180|62691076|FG002|Double-blind Treatment Period|Protocol Violation|2|||
33315501|NCT02702180|62691074|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
33315502|NCT02702180|62691075|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
33315503|NCT02702180|62691076|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
33315504|NCT02702180|62691074|FG000|Open-label Treatment Period|Withdrawn in error|0|||
33315505|NCT02702180|62691075|FG001|Open-label Treatment Period|Withdrawn in error|0|||
33315506|NCT02702180|62691076|FG002|Open-label Treatment Period|Withdrawn in error|1|||
33712992|NCT01387230|63279838|FG001|Overall Study|Lost to Follow-up|0|||
33712993|NCT01387230|63279839|FG002|Overall Study|Lost to Follow-up|1|||
33712994|NCT01387230|63279837|FG000|Overall Study|Withdrawal by Subject|4|||
33712995|NCT01387230|63279838|FG001|Overall Study|Withdrawal by Subject|1|||
33712996|NCT01387230|63279839|FG002|Overall Study|Withdrawal by Subject|0|||
33712997|NCT01387074|63279847|FG000|Overall Study|Lost to Follow-up|7|||
33712998|NCT01387074|63279847|FG000|Overall Study|Lack of Efficacy|1|||
33712999|NCT01386606|63279855|FG000|Overall Study|Adverse Event|0|||
33713000|NCT01386606|63279856|FG001|Overall Study|Adverse Event|1|||
33713001|NCT01386606|63279857|FG002|Overall Study|Adverse Event|0|||
33713002|NCT01386606|63279858|FG003|Overall Study|Adverse Event|0|||
33713003|NCT01386606|63279855|FG000|Overall Study|Withdrawal by Subject|0|||
33713004|NCT01386606|63279856|FG001|Overall Study|Withdrawal by Subject|1|||
33713005|NCT01386606|63279857|FG002|Overall Study|Withdrawal by Subject|1|||
33713006|NCT01386606|63279858|FG003|Overall Study|Withdrawal by Subject|0|||
33713007|NCT01386606|63279855|FG000|Overall Study|Protocol Violation|1|||
33713008|NCT01386606|63279856|FG001|Overall Study|Protocol Violation|0|||
33713009|NCT01386606|63279857|FG002|Overall Study|Protocol Violation|1|||
33713010|NCT01386606|63279858|FG003|Overall Study|Protocol Violation|1|||
33713011|NCT01386606|63279855|FG000|Overall Study|Lost to Follow-up|2|||
33713012|NCT01386606|63279856|FG001|Overall Study|Lost to Follow-up|0|||
33713013|NCT01386606|63279857|FG002|Overall Study|Lost to Follow-up|0|||
33713014|NCT01386606|63279858|FG003|Overall Study|Lost to Follow-up|0|||
33713015|NCT01386606|63279855|FG000|Overall Study|Subject incarcerated|0|||
33713016|NCT01386606|63279856|FG001|Overall Study|Subject incarcerated|1|||
33713017|NCT01386606|63279857|FG002|Overall Study|Subject incarcerated|0|||
33713018|NCT01386606|63279858|FG003|Overall Study|Subject incarcerated|0|||
33713019|NCT01386606|63279855|FG000|Overall Study|Unable to draw PK|1|||
33713020|NCT01386606|63279856|FG001|Overall Study|Unable to draw PK|0|||
33713021|NCT01386606|63279857|FG002|Overall Study|Unable to draw PK|0|||
33713022|NCT01386606|63279858|FG003|Overall Study|Unable to draw PK|0|||
33713023|NCT01386606|63279855|FG000|Overall Study|T levels too high|0|||
33713024|NCT01386606|63279856|FG001|Overall Study|T levels too high|1|||
33713025|NCT01386606|63279857|FG002|Overall Study|T levels too high|1|||
33713026|NCT01386606|63279858|FG003|Overall Study|T levels too high|0|||
33713027|NCT01385748|63279875|FG000|Overall Study|Withdrawal by Subject|7|||
33713028|NCT01385748|63279876|FG001|Overall Study|Withdrawal by Subject|4|||
33713029|NCT01385748|63279877|FG002|Overall Study|Withdrawal by Subject|5|||
33713030|NCT01385748|63279875|FG000|Overall Study|Noncompliance|3|||
33713031|NCT01385748|63279876|FG001|Overall Study|Noncompliance|1|||
33713032|NCT01385748|63279877|FG002|Overall Study|Noncompliance|6|||
33713033|NCT01385748|63279875|FG000|Overall Study|Other|1|||
33713034|NCT01385748|63279876|FG001|Overall Study|Other|7|||
33315507|NCT00980980|62691088|FG000|Overall Study|Withdrawal by Hospital|0|||
33713035|NCT01385748|63279877|FG002|Overall Study|Other|1|||
33315508|NCT00980980|62691089|FG001|Overall Study|Withdrawal by Hospital|1|||
33315509|NCT00980980|62691090|FG002|Overall Study|Withdrawal by Hospital|0|||
33315510|NCT00980200|62691101|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
33315511|NCT00980200|62691102|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
33401941|NCT00729833|62780874|FG003|Overall Study|Unspecified Reasons|1|||
33713036|NCT01385748|63279875|FG000|Overall Study|Adverse Event|4|||
33713037|NCT01385748|63279876|FG001|Overall Study|Adverse Event|2|||
33713038|NCT01385748|63279877|FG002|Overall Study|Adverse Event|1|||
33713039|NCT01397448|63279892|FG000|Overall Study|Adverse Event|4|||
33713040|NCT01397448|63279893|FG001|Overall Study|Adverse Event|4|||
33713041|NCT01397448|63279894|FG002|Overall Study|Adverse Event|6|||
33315512|NCT00980200|62691103|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
33315513|NCT00980200|62691104|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
33315514|NCT00980200|62691105|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
33315515|NCT00980200|62691101|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
33315516|NCT00980200|62691102|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
33315517|NCT00980200|62691103|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
33315518|NCT00980200|62691104|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
33597519|NCT02325739|62996462|FG003|Phase II Part|Physician Decision|0|||
33597520|NCT02325739|62996463|FG004|Phase II Part|Physician Decision|0|||
33597521|NCT02325739|62996464|FG005|Phase II Part|Physician Decision|0|||
33597522|NCT02325739|62996465|FG006|Phase II Part|Physician Decision|0|||
33597523|NCT02325739|62996466|FG007|Phase II Part|Physician Decision|0|||
33597524|NCT02325739|62996467|FG008|Phase II Part|Physician Decision|0|||
33597525|NCT02325739|62996468|FG009|Phase II Part|Physician Decision|1|||
33597526|NCT02325739|62996469|FG010|Phase II Part|Physician Decision|0|||
33597527|NCT02325739|62996459|FG000|Phase II Part|Progressive disease|0|||
33597528|NCT02325739|62996460|FG001|Phase II Part|Progressive disease|0|||
33597529|NCT02325739|62996461|FG002|Phase II Part|Progressive disease|0|||
33597530|NCT02325739|62996462|FG003|Phase II Part|Progressive disease|0|||
33597531|NCT02325739|62996463|FG004|Phase II Part|Progressive disease|0|||
33597532|NCT02325739|62996464|FG005|Phase II Part|Progressive disease|0|||
33597533|NCT02325739|62996465|FG006|Phase II Part|Progressive disease|0|||
33597534|NCT02325739|62996466|FG007|Phase II Part|Progressive disease|0|||
33713042|NCT01397448|63279892|FG000|Overall Study|Withdrawal by Subject|4|||
33713043|NCT01397448|63279893|FG001|Overall Study|Withdrawal by Subject|4|||
33713044|NCT01397448|63279894|FG002|Overall Study|Withdrawal by Subject|3|||
33713045|NCT01397448|63279892|FG000|Overall Study|Lack of Efficacy|2|||
33713046|NCT01397448|63279893|FG001|Overall Study|Lack of Efficacy|0|||
33713047|NCT01397448|63279894|FG002|Overall Study|Lack of Efficacy|5|||
33713048|NCT01397448|63279892|FG000|Overall Study|Other|8|||
33713049|NCT01397448|63279893|FG001|Overall Study|Other|7|||
33713050|NCT01397448|63279894|FG002|Overall Study|Other|4|||
33713051|NCT01385202|63279902|FG000|Overall Study|Lost to Follow-up|6|||
33713052|NCT01385202|63279902|FG000|Overall Study|Not Eligible|11|||
33713053|NCT01385202|63279902|FG000|Overall Study|Withdrawn|1|||
33713054|NCT01384734|63279913|FG000|Overall Study|Adverse Event|0|||
33713055|NCT01384734|63279914|FG001|Overall Study|Adverse Event|3|||
33713056|NCT01384734|63279915|FG002|Overall Study|Adverse Event|0|||
33713057|NCT01384734|63279916|FG003|Overall Study|Adverse Event|2|||
33713058|NCT01384734|63279917|FG004|Overall Study|Adverse Event|7|||
33315519|NCT00980200|62691105|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
33315520|NCT00979654|62691117|FG000|Overall Study|Lost to Follow-up|1|||
33597535|NCT02325739|62996467|FG008|Phase II Part|Progressive disease|22|||
33713059|NCT01384734|63279913|FG000|Overall Study|Death|1|||
33713060|NCT01384734|63279914|FG001|Overall Study|Death|0|||
33713061|NCT01384734|63279915|FG002|Overall Study|Death|1|||
33315521|NCT00979654|62691117|FG000|Overall Study|Withdrawal by Subject|22|||
33315522|NCT00979654|62691117|FG000|Overall Study|Death|1|||
33597536|NCT02325739|62996468|FG009|Phase II Part|Progressive disease|29|||
33597537|NCT02325739|62996469|FG010|Phase II Part|Progressive disease|18|||
33597538|NCT02325739|62996459|FG000|Phase II Part|Subject/guardian decision|0|||
33713062|NCT01384734|63279916|FG003|Overall Study|Death|0|||
33713063|NCT01384734|63279917|FG004|Overall Study|Death|0|||
33713064|NCT01384734|63279913|FG000|Overall Study|Continuation criteria not met|0|||
33315523|NCT00979654|62691117|FG000|Overall Study|Lack of Efficacy|6|||
33315524|NCT00979654|62691117|FG000|Overall Study|Adverse Event|1|||
33315525|NCT00979654|62691117|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
33315526|NCT00979654|62691117|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
33315527|NCT00979654|62691117|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
33315528|NCT00979654|62691117|FG000|Overall Study|Serious Adverse Event|1|||
33315529|NCT00979654|62691117|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
33315530|NCT00978562|62691121|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
33315531|NCT02865460|62691129|FG000|Overall Study|Adverse Event|1|||
33315532|NCT02865460|62691130|FG001|Overall Study|Adverse Event|0|||
33315533|NCT02865460|62691129|FG000|Overall Study|Withdrawal by Subject|1|||
33315534|NCT02865460|62691130|FG001|Overall Study|Withdrawal by Subject|1|||
33315535|NCT02865460|62691129|FG000|Overall Study|Lost to Follow-up|7|||
33315536|NCT02865460|62691130|FG001|Overall Study|Lost to Follow-up|4|||
33315537|NCT02865460|62691129|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
33315538|NCT02865460|62691130|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
33315539|NCT01206816|62691143|FG000|Overall Study|Protocol Violation|0|||
33315540|NCT01206816|62691144|FG001|Overall Study|Protocol Violation|0|||
33315541|NCT01206816|62691145|FG002|Overall Study|Protocol Violation|1|||
33315542|NCT01206816|62691146|FG003|Overall Study|Protocol Violation|0|||
33315543|NCT01206816|62691147|FG004|Overall Study|Protocol Violation|0|||
33315544|NCT01206816|62691148|FG005|Overall Study|Protocol Violation|0|||
33315545|NCT01206816|62691149|FG006|Overall Study|Protocol Violation|0|||
33315546|NCT01206816|62691143|FG000|Overall Study|Withdrawal by Subject|0|||
33315547|NCT01206816|62691144|FG001|Overall Study|Withdrawal by Subject|0|||
33315548|NCT01206816|62691145|FG002|Overall Study|Withdrawal by Subject|1|||
33315549|NCT01206816|62691146|FG003|Overall Study|Withdrawal by Subject|0|||
33315550|NCT01206816|62691147|FG004|Overall Study|Withdrawal by Subject|0|||
33315551|NCT01206816|62691148|FG005|Overall Study|Withdrawal by Subject|0|||
33315552|NCT01206816|62691149|FG006|Overall Study|Withdrawal by Subject|0|||
33315553|NCT01206816|62691143|FG000|Overall Study|Progressive disease|3|||
33315554|NCT01206816|62691144|FG001|Overall Study|Progressive disease|3|||
33315555|NCT01206816|62691145|FG002|Overall Study|Progressive disease|13|||
33315556|NCT01206816|62691146|FG003|Overall Study|Progressive disease|3|||
33315557|NCT01206816|62691147|FG004|Overall Study|Progressive disease|3|||
33315558|NCT01206816|62691148|FG005|Overall Study|Progressive disease|16|||
33315559|NCT01206816|62691149|FG006|Overall Study|Progressive disease|3|||
33315560|NCT01206816|62691143|FG000|Overall Study|Other AE|0|||
33315561|NCT01206816|62691144|FG001|Overall Study|Other AE|0|||
33315562|NCT01206816|62691145|FG002|Overall Study|Other AE|4|||
33315563|NCT01206816|62691146|FG003|Overall Study|Other AE|0|||
33315564|NCT01206816|62691147|FG004|Overall Study|Other AE|0|||
33315565|NCT01206816|62691148|FG005|Overall Study|Other AE|3|||
33315566|NCT01206816|62691149|FG006|Overall Study|Other AE|2|||
33315567|NCT01206816|62691143|FG000|Overall Study|other than stated above|0|||
33315568|NCT01206816|62691144|FG001|Overall Study|other than stated above|0|||
33315569|NCT01206816|62691145|FG002|Overall Study|other than stated above|1|||
33315570|NCT01206816|62691146|FG003|Overall Study|other than stated above|0|||
33315571|NCT01206816|62691147|FG004|Overall Study|other than stated above|0|||
33315572|NCT01206816|62691148|FG005|Overall Study|other than stated above|0|||
33315573|NCT01206816|62691149|FG006|Overall Study|other than stated above|1|||
33315574|NCT01206582|62691171|FG000|Overall Study|Withdrew prior to study|1|||
33315575|NCT01206582|62691172|FG001|Overall Study|Withdrew prior to study|0|||
33315576|NCT01206582|62691171|FG000|Overall Study|Discontinued intervention before week 8|1|||
33315577|NCT01206582|62691172|FG001|Overall Study|Discontinued intervention before week 8|2|||
33315578|NCT01259102|62691183|FG000|Overall Study|Adverse Event|1|||
33315579|NCT01259102|62691184|FG001|Overall Study|Adverse Event|0|||
33315580|NCT01259102|62691185|FG002|Overall Study|Adverse Event|1|||
33315581|NCT01259102|62691186|FG003|Overall Study|Adverse Event|1|||
33315582|NCT01259102|62691187|FG004|Overall Study|Adverse Event|0|||
33315583|NCT01259102|62691183|FG000|Overall Study|Other|0|||
33315584|NCT01259102|62691184|FG001|Overall Study|Other|0|||
33315585|NCT01259102|62691185|FG002|Overall Study|Other|1|||
33315586|NCT01259102|62691186|FG003|Overall Study|Other|1|||
33315587|NCT01259102|62691187|FG004|Overall Study|Other|1|||
33315588|NCT00978250|62691203|FG000|Overall Study|Late determination of ineligibility|0|||
33315589|NCT00978250|62691204|FG001|Overall Study|Late determination of ineligibility|1|||
33315590|NCT00978250|62691205|FG002|Overall Study|Late determination of ineligibility|0|||
33315591|NCT00978250|62691206|FG003|Overall Study|Late determination of ineligibility|1|||
33315592|NCT01259024|62691218|FG000|Overall Study|Physician Decision|1|||
33315593|NCT01257698|62691224|FG000|Overall Study|Protocol Violation|4|||
33315594|NCT01257698|62691225|FG001|Overall Study|Protocol Violation|0|||
33315595|NCT01257542|62691233|FG000|Overall Study|Protocol Violation|3|||
33315596|NCT01257542|62691234|FG001|Overall Study|Protocol Violation|5|||
33315597|NCT01257542|62691233|FG000|Overall Study|Withdrawal by Subject|0|||
33315598|NCT01257542|62691234|FG001|Overall Study|Withdrawal by Subject|2|||
33315599|NCT01257230|62691243|FG000|Overall Study|Not Treated|0|||
33315600|NCT01257230|62691244|FG001|Overall Study|Not Treated|0|||
33315601|NCT01257230|62691245|FG002|Overall Study|Not Treated|1|||
33315602|NCT01257230|62691243|FG000|Overall Study|Adverse Event|2|||
33713065|NCT01384734|63279914|FG001|Overall Study|Continuation criteria not met|0|||
33713066|NCT01384734|63279915|FG002|Overall Study|Continuation criteria not met|1|||
33713067|NCT01384734|63279916|FG003|Overall Study|Continuation criteria not met|1|||
33713068|NCT01384734|63279917|FG004|Overall Study|Continuation criteria not met|0|||
33713069|NCT01384734|63279913|FG000|Overall Study|Lack of Efficacy|3|||
33713070|NCT01384734|63279914|FG001|Overall Study|Lack of Efficacy|7|||
33713071|NCT01384734|63279915|FG002|Overall Study|Lack of Efficacy|4|||
33713072|NCT01384734|63279916|FG003|Overall Study|Lack of Efficacy|4|||
33713073|NCT01384734|63279917|FG004|Overall Study|Lack of Efficacy|2|||
33713074|NCT01384734|63279913|FG000|Overall Study|Lost to Follow-up|5|||
33713075|NCT01384734|63279914|FG001|Overall Study|Lost to Follow-up|3|||
33713076|NCT01384734|63279915|FG002|Overall Study|Lost to Follow-up|3|||
33713077|NCT01384734|63279916|FG003|Overall Study|Lost to Follow-up|8|||
33713078|NCT01384734|63279917|FG004|Overall Study|Lost to Follow-up|5|||
33713079|NCT01384734|63279913|FG000|Overall Study|Non-compliance with study drug|1|||
33713080|NCT01384734|63279914|FG001|Overall Study|Non-compliance with study drug|2|||
33713081|NCT01384734|63279915|FG002|Overall Study|Non-compliance with study drug|6|||
33713082|NCT01384734|63279916|FG003|Overall Study|Non-compliance with study drug|0|||
33713083|NCT01384734|63279917|FG004|Overall Study|Non-compliance with study drug|2|||
33713084|NCT01384734|63279913|FG000|Overall Study|Pregnancy|0|||
33713085|NCT01384734|63279914|FG001|Overall Study|Pregnancy|1|||
33713086|NCT01384734|63279915|FG002|Overall Study|Pregnancy|0|||
33713087|NCT01384734|63279916|FG003|Overall Study|Pregnancy|0|||
33713088|NCT01384734|63279917|FG004|Overall Study|Pregnancy|1|||
33713089|NCT01384734|63279913|FG000|Overall Study|Sponsor terminated|0|||
33713090|NCT01384734|63279914|FG001|Overall Study|Sponsor terminated|0|||
33713091|NCT01384734|63279915|FG002|Overall Study|Sponsor terminated|0|||
33713092|NCT01384734|63279916|FG003|Overall Study|Sponsor terminated|0|||
33713093|NCT01384734|63279917|FG004|Overall Study|Sponsor terminated|1|||
33713094|NCT01384734|63279913|FG000|Overall Study|Withdrawal by Subject|5|||
33713095|NCT01384734|63279914|FG001|Overall Study|Withdrawal by Subject|5|||
33713096|NCT01384734|63279915|FG002|Overall Study|Withdrawal by Subject|6|||
33713097|NCT01384734|63279916|FG003|Overall Study|Withdrawal by Subject|7|||
33713098|NCT01384734|63279917|FG004|Overall Study|Withdrawal by Subject|9|||
33713099|NCT01384734|63279913|FG000|Overall Study|Investigator relocating|0|||
33713100|NCT01384734|63279914|FG001|Overall Study|Investigator relocating|2|||
33713101|NCT01384734|63279915|FG002|Overall Study|Investigator relocating|0|||
33713102|NCT01384734|63279916|FG003|Overall Study|Investigator relocating|3|||
33713103|NCT01384734|63279917|FG004|Overall Study|Investigator relocating|1|||
33713104|NCT01384734|63279913|FG000|Overall Study|Unable to come back for visit|1|||
33713105|NCT01384734|63279914|FG001|Overall Study|Unable to come back for visit|0|||
33713106|NCT01384734|63279915|FG002|Overall Study|Unable to come back for visit|1|||
33713107|NCT01384734|63279916|FG003|Overall Study|Unable to come back for visit|1|||
33713108|NCT01384734|63279917|FG004|Overall Study|Unable to come back for visit|0|||
33713109|NCT01384734|63279913|FG000|Overall Study|Prison|0|||
33713110|NCT01384734|63279914|FG001|Overall Study|Prison|0|||
33713111|NCT01384734|63279915|FG002|Overall Study|Prison|1|||
33713112|NCT01384734|63279916|FG003|Overall Study|Prison|0|||
33713113|NCT01384734|63279917|FG004|Overall Study|Prison|0|||
33713114|NCT01384734|63279913|FG000|Overall Study|As per Exclusion criteria|0|||
33713115|NCT01384734|63279914|FG001|Overall Study|As per Exclusion criteria|1|||
33713116|NCT01384734|63279915|FG002|Overall Study|As per Exclusion criteria|0|||
33315603|NCT01257230|62691244|FG001|Overall Study|Adverse Event|0|||
33315604|NCT01257230|62691245|FG002|Overall Study|Adverse Event|0|||
33315605|NCT01257230|62691243|FG000|Overall Study|Lack of Efficacy|0|||
33315606|NCT01257230|62691244|FG001|Overall Study|Lack of Efficacy|1|||
33315607|NCT01257230|62691245|FG002|Overall Study|Lack of Efficacy|0|||
33315608|NCT01257230|62691243|FG000|Overall Study|Protocol Violation|3|||
33315609|NCT01257230|62691244|FG001|Overall Study|Protocol Violation|0|||
33315610|NCT01257230|62691245|FG002|Overall Study|Protocol Violation|1|||
33315611|NCT01257230|62691243|FG000|Overall Study|Withdrawal by Subject|0|||
33315612|NCT01257230|62691244|FG001|Overall Study|Withdrawal by Subject|4|||
33713117|NCT01384734|63279916|FG003|Overall Study|As per Exclusion criteria|0|||
33597539|NCT02325739|62996460|FG001|Phase II Part|Subject/guardian decision|0|||
33713118|NCT01384734|63279917|FG004|Overall Study|As per Exclusion criteria|0|||
33315613|NCT01257230|62691245|FG002|Overall Study|Withdrawal by Subject|1|||
33315614|NCT01257230|62691243|FG000|Overall Study|Other reason not defined above|1|||
33713119|NCT01384734|63279913|FG000|Overall Study|Missed End of treatment visit|0|||
33713120|NCT01384734|63279914|FG001|Overall Study|Missed End of treatment visit|0|||
33315615|NCT01257230|62691244|FG001|Overall Study|Other reason not defined above|5|||
33315616|NCT01257230|62691245|FG002|Overall Study|Other reason not defined above|3|||
33315617|NCT01113801|62691258|FG000|Overall Study|Adverse Event|4|||
33315618|NCT01113801|62691259|FG001|Overall Study|Adverse Event|0|||
33315619|NCT01113801|62691260|FG002|Overall Study|Adverse Event|2|||
33315620|NCT01113801|62691261|FG003|Overall Study|Adverse Event|6|||
33315621|NCT01113801|62691258|FG000|Overall Study|Death|4|||
33315622|NCT01113801|62691259|FG001|Overall Study|Death|5|||
33315623|NCT01113801|62691260|FG002|Overall Study|Death|3|||
33315624|NCT01113801|62691261|FG003|Overall Study|Death|4|||
33315625|NCT01113801|62691258|FG000|Overall Study|Protocol Violation|0|||
33315626|NCT01113801|62691259|FG001|Overall Study|Protocol Violation|1|||
33315627|NCT01113801|62691260|FG002|Overall Study|Protocol Violation|0|||
33315628|NCT01113801|62691261|FG003|Overall Study|Protocol Violation|0|||
33315629|NCT01113801|62691258|FG000|Overall Study|Withdrawal by Subject|9|||
33315630|NCT01113801|62691259|FG001|Overall Study|Withdrawal by Subject|7|||
33315631|NCT01113801|62691260|FG002|Overall Study|Withdrawal by Subject|7|||
33315632|NCT01113801|62691261|FG003|Overall Study|Withdrawal by Subject|8|||
33315633|NCT01113801|62691258|FG000|Overall Study|Physician Decision|2|||
33315634|NCT01113801|62691259|FG001|Overall Study|Physician Decision|2|||
33315635|NCT01113801|62691260|FG002|Overall Study|Physician Decision|3|||
33315636|NCT01113801|62691261|FG003|Overall Study|Physician Decision|3|||
33315637|NCT01113801|62691258|FG000|Overall Study|Sponsor Decision|15|||
33315638|NCT01113801|62691259|FG001|Overall Study|Sponsor Decision|21|||
33315639|NCT01113801|62691260|FG002|Overall Study|Sponsor Decision|20|||
33315640|NCT01113801|62691261|FG003|Overall Study|Sponsor Decision|15|||
33315641|NCT01113801|62691258|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
33315642|NCT01113801|62691259|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
33315643|NCT01113801|62691260|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
33315644|NCT01113801|62691261|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
33315645|NCT01256684|62691274|FG000|Overall Study|Adverse Event|1|||
33315646|NCT01256684|62691275|FG001|Overall Study|Adverse Event|4|||
33315647|NCT01256684|62691276|FG002|Overall Study|Adverse Event|2|||
33315648|NCT01256684|62691274|FG000|Overall Study|Withdrawal by Subject|4|||
33315649|NCT01256684|62691275|FG001|Overall Study|Withdrawal by Subject|0|||
33315650|NCT01256684|62691276|FG002|Overall Study|Withdrawal by Subject|2|||
33315651|NCT01256684|62691274|FG000|Overall Study|Physician Decision|0|||
33315652|NCT01256684|62691275|FG001|Overall Study|Physician Decision|1|||
33315653|NCT01256684|62691276|FG002|Overall Study|Physician Decision|0|||
33315654|NCT01256684|62691274|FG000|Overall Study|Lack of Efficacy|0|||
33315655|NCT01256684|62691275|FG001|Overall Study|Lack of Efficacy|1|||
33315656|NCT01256684|62691276|FG002|Overall Study|Lack of Efficacy|1|||
33315657|NCT01256684|62691274|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
33315658|NCT01256684|62691275|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
33315659|NCT01256684|62691276|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
33315660|NCT01204710|62691286|FG000|Randomization Treatment|Lost to Follow-up|1|||
33315661|NCT01204710|62691287|FG001|Randomization Treatment|Lost to Follow-up|0|||
33315662|NCT01204710|62691286|FG000|Randomization Treatment|Withdrawal by Subject|6|||
33315663|NCT01204710|62691287|FG001|Randomization Treatment|Withdrawal by Subject|5|||
33315664|NCT01204710|62691286|FG000|Randomization Treatment|Physician Decision|3|||
33315665|NCT01204710|62691287|FG001|Randomization Treatment|Physician Decision|2|||
33315666|NCT01204710|62691286|FG000|Randomization Treatment|Entry criteria not met|0|||
33315667|NCT01204710|62691287|FG001|Randomization Treatment|Entry criteria not met|1|||
33315668|NCT01204710|62691286|FG000|Randomization Treatment|Adverse Event|4|||
33315669|NCT01204710|62691287|FG001|Randomization Treatment|Adverse Event|2|||
33315670|NCT01204710|62691286|FG000|Randomization Treatment|Sponsor Decision|0|||
33315671|NCT01204710|62691287|FG001|Randomization Treatment|Sponsor Decision|1|||
33315672|NCT01204710|62691286|FG000|Randomization Treatment|Worsening of General condition|0|||
33315673|NCT01204710|62691287|FG001|Randomization Treatment|Worsening of General condition|1|||
33315674|NCT01204710|62691286|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
33315675|NCT01204710|62691287|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
33315676|NCT01204710|62691286|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
33315677|NCT01204710|62691287|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
33315678|NCT01204710|62691286|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
33315679|NCT01204710|62691287|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
33493843|NCT03535194|62872386|FG003|Maintenance Period|Withdrawal by Subject|8|||
33597540|NCT02325739|62996461|FG002|Phase II Part|Subject/guardian decision|0|||
33713121|NCT01384734|63279915|FG002|Overall Study|Missed End of treatment visit|0|||
33315680|NCT01204710|62691286|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
33315681|NCT01204710|62691287|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
33315682|NCT01256450|62691302|FG000|Open-label Titration|Adverse Event|39|||
33315683|NCT01256450|62691303|FG001|Open-label Titration|Adverse Event|0|||
33315684|NCT01256450|62691304|FG002|Open-label Titration|Adverse Event|0|||
33315685|NCT01256450|62691302|FG000|Open-label Titration|Lost to Follow-up|7|||
33315686|NCT01256450|62691303|FG001|Open-label Titration|Lost to Follow-up|0|||
33315687|NCT01256450|62691304|FG002|Open-label Titration|Lost to Follow-up|0|||
33315688|NCT01256450|62691302|FG000|Open-label Titration|Lack of analgesic effect|30|||
33315689|NCT01256450|62691303|FG001|Open-label Titration|Lack of analgesic effect|0|||
33315690|NCT01256450|62691304|FG002|Open-label Titration|Lack of analgesic effect|0|||
33315691|NCT01256450|62691302|FG000|Open-label Titration|Non-compliance|9|||
33315692|NCT01256450|62691303|FG001|Open-label Titration|Non-compliance|0|||
33315693|NCT01256450|62691304|FG002|Open-label Titration|Non-compliance|0|||
33315694|NCT01256450|62691302|FG000|Open-label Titration|Screen failure|1|||
33315695|NCT01256450|62691303|FG001|Open-label Titration|Screen failure|0|||
33315696|NCT01256450|62691304|FG002|Open-label Titration|Screen failure|0|||
33315697|NCT01256450|62691302|FG000|Open-label Titration|Other|13|||
33315698|NCT01256450|62691303|FG001|Open-label Titration|Other|0|||
33315699|NCT01256450|62691304|FG002|Open-label Titration|Other|0|||
33315700|NCT01256450|62691302|FG000|Double-blind Treatment|Adverse Event|0|||
33315701|NCT01256450|62691303|FG001|Double-blind Treatment|Adverse Event|8|||
33315702|NCT01256450|62691304|FG002|Double-blind Treatment|Adverse Event|6|||
33315703|NCT01256450|62691302|FG000|Double-blind Treatment|Lost to Follow-up|0|||
33315704|NCT01256450|62691303|FG001|Double-blind Treatment|Lost to Follow-up|1|||
33315705|NCT01256450|62691304|FG002|Double-blind Treatment|Lost to Follow-up|7|||
33315706|NCT01256450|62691302|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
33315707|NCT01256450|62691303|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
33315708|NCT01256450|62691304|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
33315709|NCT01256450|62691302|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
33315710|NCT01256450|62691303|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
33315711|NCT01256450|62691304|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
33315712|NCT01256450|62691302|FG000|Double-blind Treatment|Non-compliance|0|||
33315713|NCT01256450|62691303|FG001|Double-blind Treatment|Non-compliance|5|||
33315714|NCT01256450|62691304|FG002|Double-blind Treatment|Non-compliance|4|||
33315715|NCT01256450|62691302|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
33315716|NCT01256450|62691303|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
33315717|NCT01256450|62691304|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
33315718|NCT01256450|62691302|FG000|Double-blind Treatment|Other|0|||
33315719|NCT01256450|62691303|FG001|Double-blind Treatment|Other|9|||
33315720|NCT01256450|62691304|FG002|Double-blind Treatment|Other|12|||
33315721|NCT01204398|62691311|FG000|Overall Study|Adverse Event|1|||
33315722|NCT01111851|62691317|FG000|Overall Study|All planned PET scans were not obtained.|2|||
33315723|NCT01111851|62691318|FG001|Overall Study|All planned PET scans were not obtained.|0|||
33315724|NCT01256294|62691324|FG000|Overall Study|Adverse Event|1|||
33315725|NCT01256294|62691325|FG001|Overall Study|Adverse Event|0|||
33315726|NCT01256294|62691324|FG000|Overall Study|Withdrawal by Subject|1|||
33315727|NCT01256294|62691325|FG001|Overall Study|Withdrawal by Subject|1|||
33315728|NCT01256294|62691324|FG000|Overall Study|Protocol deviation|2|||
33315729|NCT01256294|62691325|FG001|Overall Study|Protocol deviation|1|||
33315730|NCT01256060|62691331|FG000|Overall Study|Lost to Follow-up|0|||
33315731|NCT01256060|62691332|FG001|Overall Study|Lost to Follow-up|1|||
33315732|NCT01256060|62691333|FG002|Overall Study|Lost to Follow-up|0|||
33315733|NCT01256060|62691334|FG003|Overall Study|Lost to Follow-up|0|||
33315734|NCT01255904|62691342|FG000|Overall Study|Physician Decision|1|||
33315735|NCT01255904|62691343|FG001|Overall Study|Physician Decision|4|||
33315736|NCT01255670|62691351|FG000|Overall Study|Adverse Event|10|||
33315737|NCT01255670|62691352|FG001|Overall Study|Adverse Event|10|||
33315738|NCT01255670|62691351|FG000|Overall Study|Lost to Follow-up|16|||
33315739|NCT01255670|62691352|FG001|Overall Study|Lost to Follow-up|10|||
33315740|NCT01255592|62691360|FG000|Overall Study|Adverse Event|5|||
33315741|NCT01255592|62691361|FG001|Overall Study|Adverse Event|0|||
33597541|NCT02325739|62996462|FG003|Phase II Part|Subject/guardian decision|0|||
33315742|NCT01255592|62691360|FG000|Overall Study|Withdrawal by Subject|1|||
33315743|NCT01255592|62691361|FG001|Overall Study|Withdrawal by Subject|0|||
33315744|NCT01255592|62691360|FG000|Overall Study|Other|0|||
33315745|NCT01255592|62691361|FG001|Overall Study|Other|1|||
33315746|NCT01255436|62691370|FG000|Overall Study|Lost to Follow-up|178|||
33315747|NCT01255436|62691371|FG001|Overall Study|Lost to Follow-up|191|||
33315748|NCT01255436|62691370|FG000|Overall Study|Death, stroke, or MI|4|||
33315749|NCT01255436|62691371|FG001|Overall Study|Death, stroke, or MI|3|||
33315750|NCT01203930|62691379|FG000|Overall Study|Disease Progression|0|||
33315751|NCT01203930|62691380|FG001|Overall Study|Disease Progression|4|||
33315752|NCT01203930|62691379|FG000|Overall Study|Death|3|||
33315753|NCT01203930|62691380|FG001|Overall Study|Death|1|||
33315754|NCT01203930|62691379|FG000|Overall Study|Withdrew Consent|1|||
33315755|NCT01203930|62691380|FG001|Overall Study|Withdrew Consent|10|||
33315756|NCT01203930|62691379|FG000|Overall Study|Investigator Request|0|||
33315757|NCT01203930|62691380|FG001|Overall Study|Investigator Request|8|||
33315758|NCT01203930|62691379|FG000|Overall Study|Study Terminated by Sponsor|0|||
33315759|NCT01203930|62691380|FG001|Overall Study|Study Terminated by Sponsor|12|||
33315760|NCT01203930|62691379|FG000|Overall Study|Poor tolerance of study drug|0|||
33315761|NCT01203930|62691380|FG001|Overall Study|Poor tolerance of study drug|1|||
33315762|NCT01203930|62691379|FG000|Overall Study|Adverse Event|17|||
33315763|NCT01203930|62691380|FG001|Overall Study|Adverse Event|5|||
33315764|NCT01254890|62691390|FG000|Overall Study|Ineligible|0|||
33597542|NCT02325739|62996463|FG004|Phase II Part|Subject/guardian decision|0|||
33597543|NCT02325739|62996464|FG005|Phase II Part|Subject/guardian decision|0|||
33315765|NCT01254890|62691391|FG001|Overall Study|Ineligible|3|||
33315766|NCT01254890|62691390|FG000|Overall Study|Withdrawal by Subject|1|||
33315767|NCT01254890|62691391|FG001|Overall Study|Withdrawal by Subject|2|||
33315768|NCT01254890|62691390|FG000|Overall Study|Disease Progression|0|||
33315769|NCT01254890|62691391|FG001|Overall Study|Disease Progression|5|||
33315770|NCT01203852|62691396|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
33315771|NCT01203852|62691396|FG000|Washout 2 Weeks|Physician Decision|46|||
33315772|NCT01105533|62691403|FG000|Overall Study|Death|0|||
33315773|NCT01105533|62691404|FG001|Overall Study|Death|0|||
33315774|NCT01105533|62691405|FG002|Overall Study|Death|0|||
33315775|NCT01105533|62691406|FG003|Overall Study|Death|0|||
33315776|NCT01105533|62691407|FG004|Overall Study|Death|1|||
33315777|NCT01105533|62691408|FG005|Overall Study|Death|0|||
33315778|NCT01105533|62691409|FG006|Overall Study|Death|0|||
33315779|NCT01105533|62691410|FG007|Overall Study|Death|0|||
33315780|NCT01105533|62691411|FG008|Overall Study|Death|0|||
33401942|NCT00645788|62780889|FG000|Overall Study|Did not receive study drug|1|||
33401943|NCT00645788|62780890|FG001|Overall Study|Did not receive study drug|1|||
33401944|NCT00645788|62780891|FG002|Overall Study|Did not receive study drug|0|||
33315781|NCT01105533|62691403|FG000|Overall Study|Lack of Efficacy|1|||
33315782|NCT01105533|62691404|FG001|Overall Study|Lack of Efficacy|1|||
33315783|NCT01105533|62691405|FG002|Overall Study|Lack of Efficacy|3|||
33315784|NCT01105533|62691406|FG003|Overall Study|Lack of Efficacy|3|||
33315785|NCT01105533|62691407|FG004|Overall Study|Lack of Efficacy|4|||
33315786|NCT01105533|62691408|FG005|Overall Study|Lack of Efficacy|5|||
33315787|NCT01105533|62691409|FG006|Overall Study|Lack of Efficacy|3|||
33315788|NCT01105533|62691410|FG007|Overall Study|Lack of Efficacy|2|||
33315789|NCT01105533|62691411|FG008|Overall Study|Lack of Efficacy|9|||
33315790|NCT01105533|62691403|FG000|Overall Study|Adverse Event|0|||
33315791|NCT01105533|62691404|FG001|Overall Study|Adverse Event|0|||
33315792|NCT01105533|62691405|FG002|Overall Study|Adverse Event|0|||
33315793|NCT01105533|62691406|FG003|Overall Study|Adverse Event|0|||
33315794|NCT01105533|62691407|FG004|Overall Study|Adverse Event|1|||
33315795|NCT01105533|62691408|FG005|Overall Study|Adverse Event|2|||
33315796|NCT01105533|62691409|FG006|Overall Study|Adverse Event|2|||
33315797|NCT01105533|62691410|FG007|Overall Study|Adverse Event|0|||
33315798|NCT01105533|62691411|FG008|Overall Study|Adverse Event|1|||
33315799|NCT01105533|62691403|FG000|Overall Study|Other|0|||
33315800|NCT01105533|62691404|FG001|Overall Study|Other|0|||
33315801|NCT01105533|62691405|FG002|Overall Study|Other|0|||
33315802|NCT01105533|62691406|FG003|Overall Study|Other|0|||
33315803|NCT01105533|62691407|FG004|Overall Study|Other|1|||
33315804|NCT01105533|62691408|FG005|Overall Study|Other|0|||
33315805|NCT01105533|62691409|FG006|Overall Study|Other|3|||
33315806|NCT01105533|62691410|FG007|Overall Study|Other|1|||
33315807|NCT01105533|62691411|FG008|Overall Study|Other|2|||
33315808|NCT01105533|62691403|FG000|Overall Study|Physician Decision|0|||
33315809|NCT01105533|62691404|FG001|Overall Study|Physician Decision|0|||
33315810|NCT01105533|62691405|FG002|Overall Study|Physician Decision|0|||
33315811|NCT01105533|62691406|FG003|Overall Study|Physician Decision|0|||
33315812|NCT01105533|62691407|FG004|Overall Study|Physician Decision|0|||
33315813|NCT01105533|62691408|FG005|Overall Study|Physician Decision|0|||
33315814|NCT01105533|62691409|FG006|Overall Study|Physician Decision|0|||
33315815|NCT01105533|62691410|FG007|Overall Study|Physician Decision|1|||
33315816|NCT01105533|62691411|FG008|Overall Study|Physician Decision|0|||
33315817|NCT01203072|62691429|FG000|Overall Study|Adverse Event|5|||
33315818|NCT01203072|62691430|FG001|Overall Study|Adverse Event|3|||
33315819|NCT01203072|62691431|FG002|Overall Study|Adverse Event|2|||
33315820|NCT01203072|62691432|FG003|Overall Study|Adverse Event|4|||
33315821|NCT01203072|62691433|FG004|Overall Study|Adverse Event|2|||
33315822|NCT01203072|62691429|FG000|Overall Study|Lack of Efficacy|1|||
33315823|NCT01203072|62691430|FG001|Overall Study|Lack of Efficacy|0|||
33315824|NCT01203072|62691431|FG002|Overall Study|Lack of Efficacy|0|||
33315825|NCT01203072|62691432|FG003|Overall Study|Lack of Efficacy|0|||
33315826|NCT01203072|62691433|FG004|Overall Study|Lack of Efficacy|0|||
33315827|NCT01203072|62691429|FG000|Overall Study|Lost to Follow-up|0|||
33315828|NCT01203072|62691430|FG001|Overall Study|Lost to Follow-up|1|||
33315829|NCT01203072|62691431|FG002|Overall Study|Lost to Follow-up|0|||
33315830|NCT01203072|62691432|FG003|Overall Study|Lost to Follow-up|0|||
33315831|NCT01203072|62691433|FG004|Overall Study|Lost to Follow-up|0|||
33315832|NCT01203072|62691429|FG000|Overall Study|Protocol Violation|2|||
33315833|NCT01203072|62691430|FG001|Overall Study|Protocol Violation|0|||
33315834|NCT01203072|62691431|FG002|Overall Study|Protocol Violation|0|||
33315835|NCT01203072|62691432|FG003|Overall Study|Protocol Violation|0|||
33315836|NCT01203072|62691433|FG004|Overall Study|Protocol Violation|1|||
33315837|NCT01203072|62691429|FG000|Overall Study|Withdrawal by Subject|2|||
33315838|NCT01203072|62691430|FG001|Overall Study|Withdrawal by Subject|2|||
33315839|NCT01203072|62691431|FG002|Overall Study|Withdrawal by Subject|1|||
33315840|NCT01203072|62691432|FG003|Overall Study|Withdrawal by Subject|2|||
33315841|NCT01203072|62691433|FG004|Overall Study|Withdrawal by Subject|3|||
33315842|NCT01105377|62691447|FG000|Overall Study|Withdrawal by Subject|0|||
33315843|NCT01105377|62691448|FG001|Overall Study|Withdrawal by Subject|1|||
33315844|NCT01105065|62691454|FG000|Overall Study|Adverse Event|5|||
33315845|NCT01105065|62691454|FG000|Overall Study|Technical Problems|1|||
33315846|NCT01111539|62691460|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
33315847|NCT01111539|62691461|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33315848|NCT01111539|62691462|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33315849|NCT01111539|62691463|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33315850|NCT01111539|62691464|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33315851|NCT01111539|62691460|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
33315852|NCT01111539|62691461|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33315853|NCT01111539|62691462|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33315854|NCT01111539|62691463|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33315855|NCT01111539|62691464|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33315856|NCT01111539|62691460|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
33315857|NCT01111539|62691461|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33315858|NCT01111539|62691462|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33315859|NCT01111539|62691463|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33315860|NCT01111539|62691464|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33315861|NCT01111539|62691460|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
33315862|NCT01111539|62691461|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
33315863|NCT01111539|62691462|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
33315864|NCT01111539|62691463|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
33315865|NCT01111539|62691464|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
33315866|NCT01111539|62691460|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
33315867|NCT01111539|62691461|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
33315868|NCT01111539|62691462|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
33315869|NCT01111539|62691463|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
33315870|NCT01111539|62691464|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
33315871|NCT01111539|62691460|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
33315872|NCT01111539|62691461|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33315873|NCT01111539|62691462|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33315874|NCT01111539|62691463|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33315875|NCT01111539|62691464|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33315876|NCT01111539|62691460|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
33315877|NCT01111539|62691461|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
33315878|NCT01111539|62691462|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
33315879|NCT01111539|62691463|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
33315880|NCT01111539|62691464|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
33315881|NCT01111539|62691460|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
33315882|NCT01111539|62691461|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
33315883|NCT01111539|62691462|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
33315884|NCT01111539|62691463|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
33315885|NCT01111539|62691464|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
33315886|NCT01111539|62691460|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33315887|NCT01111539|62691461|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33315888|NCT01111539|62691462|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
33315889|NCT01111539|62691463|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33315890|NCT01111539|62691464|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
33315891|NCT01111539|62691460|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
33315892|NCT01111539|62691461|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
33315893|NCT01111539|62691462|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
33315894|NCT01111539|62691463|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
33315895|NCT01111539|62691464|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
33315896|NCT01111539|62691460|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
33315897|NCT01111539|62691461|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
33315898|NCT01111539|62691462|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
33315899|NCT01111539|62691463|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
33315900|NCT01111539|62691464|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
33315901|NCT01111539|62691460|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
33315902|NCT01111539|62691461|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
33315903|NCT01111539|62691462|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
33315904|NCT01111539|62691463|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
33315905|NCT01111539|62691464|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
33315906|NCT01111539|62691460|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
33315907|NCT01111539|62691461|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
33315908|NCT01111539|62691462|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
33315909|NCT01111539|62691463|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
33315910|NCT01111539|62691464|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
33315911|NCT01111539|62691460|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33315912|NCT01111539|62691461|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33315913|NCT01111539|62691462|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33315914|NCT01111539|62691463|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33315915|NCT01111539|62691464|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
33315916|NCT01111149|62691477|FG000|Overall Study|Protocol Violation|1|||
33315917|NCT01111149|62691478|FG001|Overall Study|Protocol Violation|1|||
33315918|NCT01111149|62691479|FG002|Overall Study|Protocol Violation|2|||
33315919|NCT01111149|62691477|FG000|Overall Study|Withdrawal by Subject|1|||
33315920|NCT01111149|62691478|FG001|Overall Study|Withdrawal by Subject|0|||
33315921|NCT01111149|62691479|FG002|Overall Study|Withdrawal by Subject|2|||
33315922|NCT01254656|62691490|FG000|Overall Study|Discontinued due to termination of study|40|||
33315923|NCT01254656|62691491|FG001|Overall Study|Discontinued due to termination of study|39|||
33315924|NCT01254656|62691492|FG002|Overall Study|Discontinued due to termination of study|13|||
33315925|NCT01254656|62691490|FG000|Overall Study|Lack of Efficacy|3|||
33315926|NCT01254656|62691491|FG001|Overall Study|Lack of Efficacy|0|||
33315927|NCT01254656|62691492|FG002|Overall Study|Lack of Efficacy|0|||
33315928|NCT01254656|62691490|FG000|Overall Study|Lost to Follow-up|1|||
33315929|NCT01254656|62691491|FG001|Overall Study|Lost to Follow-up|0|||
33315930|NCT01254656|62691492|FG002|Overall Study|Lost to Follow-up|2|||
33315931|NCT01254656|62691490|FG000|Overall Study|Withdrawal by Subject|2|||
33315932|NCT01254656|62691491|FG001|Overall Study|Withdrawal by Subject|2|||
33315933|NCT01254656|62691492|FG002|Overall Study|Withdrawal by Subject|1|||
33315934|NCT01254656|62691490|FG000|Overall Study|Pregnancy|0|||
33315935|NCT01254656|62691491|FG001|Overall Study|Pregnancy|0|||
33315936|NCT01254656|62691492|FG002|Overall Study|Pregnancy|2|||
33315937|NCT01254656|62691490|FG000|Overall Study|Adverse Event|1|||
33315938|NCT01254656|62691491|FG001|Overall Study|Adverse Event|1|||
33315939|NCT01254656|62691492|FG002|Overall Study|Adverse Event|0|||
33315940|NCT01254656|62691490|FG000|Overall Study|Death|0|||
33315941|NCT01254656|62691491|FG001|Overall Study|Death|1|||
33315942|NCT01254656|62691492|FG002|Overall Study|Death|0|||
33315943|NCT01110915|62691502|FG000|Overall Study|Death|2|||
33315944|NCT01110915|62691503|FG001|Overall Study|Death|1|||
33315945|NCT01110915|62691502|FG000|Overall Study|Lost to Follow-up|1|||
33315946|NCT01110915|62691503|FG001|Overall Study|Lost to Follow-up|0|||
33315947|NCT01110915|62691502|FG000|Overall Study|Withdrawal by Subject|7|||
33315948|NCT01110915|62691503|FG001|Overall Study|Withdrawal by Subject|1|||
33315949|NCT01254344|62691512|FG000|Overall Study|Adverse Event|2|||
33315950|NCT01254344|62691513|FG001|Overall Study|Adverse Event|5|||
33315951|NCT01254344|62691512|FG000|Overall Study|Physician Decision|7|||
33713122|NCT01384734|63279916|FG003|Overall Study|Missed End of treatment visit|1|||
33713123|NCT01384734|63279917|FG004|Overall Study|Missed End of treatment visit|0|||
33713124|NCT01384734|63279913|FG000|Overall Study|Adhesion problem|0|||
33713125|NCT01384734|63279914|FG001|Overall Study|Adhesion problem|0|||
33713126|NCT01384734|63279915|FG002|Overall Study|Adhesion problem|0|||
33713127|NCT01384734|63279916|FG003|Overall Study|Adhesion problem|1|||
33315952|NCT01254344|62691513|FG001|Overall Study|Physician Decision|4|||
33315953|NCT01254344|62691512|FG000|Overall Study|Protocol Violation|1|||
33315954|NCT01254344|62691513|FG001|Overall Study|Protocol Violation|4|||
33315955|NCT01254344|62691512|FG000|Overall Study|Withdrawal by Subject|3|||
33315956|NCT01254344|62691513|FG001|Overall Study|Withdrawal by Subject|6|||
33315957|NCT01102803|62691521|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
33315958|NCT01102803|62691522|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
33315959|NCT01102803|62691521|FG000|Post to Follow-Up|Lost to Follow-up|1|||
33315960|NCT01102803|62691522|FG001|Post to Follow-Up|Lost to Follow-up|3|||
33315961|NCT01254188|62691530|FG000|Overall Study|Disease Progression|6|||
33315962|NCT01254188|62691530|FG000|Overall Study|Protocol Violation|6|||
33315963|NCT01254188|62691530|FG000|Overall Study|Pregnancy|2|||
33315964|NCT01254188|62691530|FG000|Overall Study|Death|4|||
33315965|NCT01254188|62691530|FG000|Overall Study|Lost to Follow-up|5|||
33315966|NCT01254188|62691530|FG000|Overall Study|Withdrawal by Subject|7|||
33315967|NCT01254188|62691530|FG000|Overall Study|Adverse Event|43|||
33315968|NCT01254188|62691530|FG000|Overall Study|per investigator discretion|20|||
33315969|NCT01109979|62691536|FG000|Overall Study|Physician Decision|2|||
33315970|NCT01109979|62691537|FG001|Overall Study|Physician Decision|0|||
33315971|NCT01109979|62691536|FG000|Overall Study|Withdrawal by Subject|0|||
33315972|NCT01109979|62691537|FG001|Overall Study|Withdrawal by Subject|1|||
33315973|NCT01102491|62691545|FG000|Overall Study|Protocol Violation|11|||
33315974|NCT01102491|62691546|FG001|Overall Study|Protocol Violation|12|||
33315975|NCT01102257|62691554|FG000|Overall Study|Adverse Event|1|||
33315976|NCT01102257|62691555|FG001|Overall Study|Adverse Event|0|||
33713128|NCT01384734|63279917|FG004|Overall Study|Adhesion problem|0|||
33713129|NCT01384734|63279913|FG000|Overall Study|Early termination|0|||
33713130|NCT01384734|63279914|FG001|Overall Study|Early termination|0|||
33315977|NCT01102257|62691554|FG000|Overall Study|Adverse Event|1|||
33315978|NCT01102257|62691555|FG001|Overall Study|Adverse Event|0|||
33713131|NCT01384734|63279915|FG002|Overall Study|Early termination|0|||
33315979|NCT01253564|62691561|FG000|Overall Study|Disease Progression|22|||
33315980|NCT01253564|62691561|FG000|Overall Study|Withdrawal by Subject|1|||
33315981|NCT01253564|62691561|FG000|Overall Study|Serious Adverse Event|1|||
33315982|NCT01108809|62691565|FG000|Overall Study|Adverse Event|3|||
33315983|NCT01108809|62691565|FG000|Overall Study|Lost to Follow-up|1|||
33315984|NCT01253408|62691573|FG000|Overall Study|Adverse Event|0|||
33315985|NCT01253408|62691574|FG001|Overall Study|Adverse Event|1|||
33315986|NCT01253408|62691575|FG002|Overall Study|Adverse Event|0|||
33315987|NCT01253174|62691583|FG000|Period 1|Randomized but not treated|0|||
33315988|NCT01253174|62691584|FG001|Period 1|Randomized but not treated|1|||
33315989|NCT01253174|62691585|FG002|Period 1|Randomized but not treated|1|||
33315990|NCT01253174|62691586|FG003|Period 1|Randomized but not treated|0|||
33315991|NCT01253174|62691587|FG004|Period 1|Randomized but not treated|1|||
33315992|NCT01253174|62691588|FG005|Period 1|Randomized but not treated|0|||
33315993|NCT01253174|62691583|FG000|Period 2|Adverse Event|0|||
33315994|NCT01253174|62691584|FG001|Period 2|Adverse Event|0|||
33315995|NCT01253174|62691585|FG002|Period 2|Adverse Event|1|||
33315996|NCT01253174|62691586|FG003|Period 2|Adverse Event|0|||
33315997|NCT01253174|62691587|FG004|Period 2|Adverse Event|0|||
33315998|NCT01253174|62691588|FG005|Period 2|Adverse Event|0|||
33315999|NCT01253174|62691583|FG000|Period 3|Withdrawal by Subject|0|||
33316000|NCT01253174|62691584|FG001|Period 3|Withdrawal by Subject|1|||
33316001|NCT01253174|62691585|FG002|Period 3|Withdrawal by Subject|0|||
33713132|NCT01384734|63279916|FG003|Overall Study|Early termination|0|||
33713133|NCT01384734|63279917|FG004|Overall Study|Early termination|1|||
33713134|NCT01384734|63279913|FG000|Overall Study|Physician Decision|1|||
33713135|NCT01384734|63279914|FG001|Overall Study|Physician Decision|0|||
33713136|NCT01384734|63279915|FG002|Overall Study|Physician Decision|0|||
33713137|NCT01384734|63279916|FG003|Overall Study|Physician Decision|0|||
33713138|NCT01384734|63279917|FG004|Overall Study|Physician Decision|0|||
33713139|NCT01396512|63279928|FG000|Overall Study|Withdrawal by Subject|0|||
33713140|NCT01396512|63279929|FG001|Overall Study|Withdrawal by Subject|1|||
33713141|NCT01396434|63279938|FG000|Overall Study|Lost to Follow-up|1|||
33713142|NCT01396434|63279939|FG001|Overall Study|Lost to Follow-up|0|||
33713143|NCT01396434|63279940|FG002|Overall Study|Lost to Follow-up|0|||
33713144|NCT01396434|63279938|FG000|Overall Study|Other|10|||
33713145|NCT01396434|63279939|FG001|Overall Study|Other|0|||
33713146|NCT01396434|63279940|FG002|Overall Study|Other|0|||
33713147|NCT01383954|63279948|FG000|Overall Study|Lack of Efficacy|2|||
33713148|NCT01383954|63279948|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
33713149|NCT01383954|63279948|FG000|Overall Study|Adverse Event|1|||
33713150|NCT01383954|63279948|FG000|Overall Study|Reason Not Specified|9|||
33713151|NCT01383486|63279952|FG000|Overall Study|Lost to Follow-up|10|||
33713152|NCT01383486|63279952|FG000|Overall Study|Incomplete information for analysis|2|||
33713153|NCT01383486|63279952|FG000|Overall Study|Did not take any product|6|||
33713154|NCT01383174|63279959|FG000|3 Month Assessment|Death|0|||
33713155|NCT01383174|63279960|FG001|3 Month Assessment|Death|1|||
33713156|NCT01383174|63279959|FG000|3 Month Assessment|Lost to Follow-up|2|||
33713157|NCT01383174|63279960|FG001|3 Month Assessment|Lost to Follow-up|0|||
33713158|NCT01383174|63279959|FG000|3 Month Assessment|Refused to complete|4|||
33713159|NCT01383174|63279960|FG001|3 Month Assessment|Refused to complete|0|||
33713160|NCT01383174|63279959|FG000|6 Month Assessment|Lost to Follow-up|1|||
33713161|NCT01383174|63279960|FG001|6 Month Assessment|Lost to Follow-up|1|||
33713162|NCT01383174|63279959|FG000|6 Month Assessment|Refused to complete|4|||
33713163|NCT01383174|63279960|FG001|6 Month Assessment|Refused to complete|0|||
33713164|NCT01396278|63279971|FG000|Overall Study|Adverse Event|0|||
33713165|NCT01396278|63279972|FG001|Overall Study|Adverse Event|0|||
33713166|NCT01396278|63279973|FG002|Overall Study|Adverse Event|0|||
33713167|NCT01396278|63279974|FG003|Overall Study|Adverse Event|2|||
33713168|NCT01396278|63279975|FG004|Overall Study|Adverse Event|0|||
33713169|NCT01396278|63279971|FG000|Overall Study|Withdraw due to trial termination|2|||
33713170|NCT01396278|63279972|FG001|Overall Study|Withdraw due to trial termination|1|||
33713171|NCT01396278|63279973|FG002|Overall Study|Withdraw due to trial termination|1|||
33713172|NCT01396278|63279974|FG003|Overall Study|Withdraw due to trial termination|0|||
33316002|NCT01253174|62691586|FG003|Period 3|Withdrawal by Subject|0|||
33713173|NCT01396278|63279975|FG004|Overall Study|Withdraw due to trial termination|2|||
33713174|NCT01383096|63279990|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
33713175|NCT01383096|63279991|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
33713176|NCT01383096|63279992|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
33713177|NCT01383096|63279990|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
33713178|NCT01383096|63279991|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
33713179|NCT01383096|63279992|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
33713180|NCT01383096|63279990|FG000|Third Intervention (8 Days)|Elevated AST|0|||
33713181|NCT01383096|63279991|FG001|Third Intervention (8 Days)|Elevated AST|1|||
33713182|NCT01383096|63279992|FG002|Third Intervention (8 Days)|Elevated AST|0|||
33713183|NCT01383096|63279990|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
33316003|NCT01253174|62691587|FG004|Period 3|Withdrawal by Subject|1|||
33316004|NCT01253174|62691588|FG005|Period 3|Withdrawal by Subject|0|||
33316005|NCT01253174|62691583|FG000|Period 3|Pregnancy|0|||
33316006|NCT01253174|62691584|FG001|Period 3|Pregnancy|0|||
33316007|NCT01253174|62691585|FG002|Period 3|Pregnancy|1|||
33316008|NCT01253174|62691586|FG003|Period 3|Pregnancy|0|||
33316009|NCT01253174|62691587|FG004|Period 3|Pregnancy|0|||
33316010|NCT01253174|62691588|FG005|Period 3|Pregnancy|0|||
33316011|NCT01108731|62691599|FG000|Overall Study|Withdrawal by Subject|1|||
33316012|NCT01108731|62691600|FG001|Overall Study|Withdrawal by Subject|1|||
33316013|NCT01108731|62691599|FG000|Overall Study|Adverse Event|3|||
33316014|NCT01108731|62691600|FG001|Overall Study|Adverse Event|3|||
33316015|NCT01253018|62691608|FG000|Overall Study|Lost to Follow-up|1|||
33316016|NCT01253018|62691609|FG001|Overall Study|Lost to Follow-up|1|||
33316017|NCT01253018|62691608|FG000|Overall Study|Robot Repair Issues|2|||
33316018|NCT01253018|62691609|FG001|Overall Study|Robot Repair Issues|0|||
33316019|NCT01253018|62691608|FG000|Overall Study|Withdrawal by Subject|1|||
33316020|NCT01253018|62691609|FG001|Overall Study|Withdrawal by Subject|1|||
33316021|NCT01108341|62691616|FG000|Overall Study|Death|2|||
33316022|NCT01108341|62691616|FG000|Overall Study|Withdrawal by Subject|1|||
33316023|NCT01108341|62691616|FG000|Overall Study|Lost to Follow-up|1|||
33316024|NCT01108341|62691616|FG000|Overall Study|Other|1|||
33316025|NCT01108263|62691622|FG000|Overall Study|Adverse Event|0|||
33316026|NCT01108263|62691623|FG001|Overall Study|Adverse Event|1|||
33316027|NCT01108185|62691629|FG000|Overall Study|Non-compliance|15|||
33316028|NCT01108185|62691629|FG000|Overall Study|Lost to Follow-up|12|||
33316029|NCT01252940|62691635|FG000|Main Study Phase|Randomized but not treated|4|||
33316030|NCT01252940|62691636|FG001|Main Study Phase|Randomized but not treated|2|||
33316031|NCT01252940|62691635|FG000|Main Study Phase|Adverse Event|3|||
33316032|NCT01252940|62691636|FG001|Main Study Phase|Adverse Event|1|||
33316033|NCT01252940|62691635|FG000|Main Study Phase|Lack of Efficacy|1|||
33316034|NCT01252940|62691636|FG001|Main Study Phase|Lack of Efficacy|0|||
33316035|NCT01252940|62691635|FG000|Main Study Phase|Lost to Follow-up|6|||
33316036|NCT01252940|62691636|FG001|Main Study Phase|Lost to Follow-up|1|||
33316037|NCT01252940|62691635|FG000|Main Study Phase|Physician Decision|1|||
33316038|NCT01252940|62691636|FG001|Main Study Phase|Physician Decision|0|||
33316039|NCT01252940|62691635|FG000|Main Study Phase|Protocol Violation|4|||
33316040|NCT01252940|62691636|FG001|Main Study Phase|Protocol Violation|2|||
33316041|NCT01252940|62691635|FG000|Main Study Phase|Withdrawal by Subject|6|||
33316042|NCT01252940|62691636|FG001|Main Study Phase|Withdrawal by Subject|5|||
33316043|NCT01252940|62691635|FG000|Main Study Phase|Subject Non-compliance|1|||
33316044|NCT01252940|62691636|FG001|Main Study Phase|Subject Non-compliance|1|||
33316045|NCT01252940|62691635|FG000|Extension Phase|Adverse Event|2|||
33316046|NCT01252940|62691636|FG001|Extension Phase|Adverse Event|1|||
33316047|NCT01252940|62691635|FG000|Extension Phase|Lack of Efficacy|1|||
33316048|NCT01252940|62691636|FG001|Extension Phase|Lack of Efficacy|0|||
33316049|NCT01252940|62691635|FG000|Extension Phase|Lost to Follow-up|5|||
33316050|NCT01252940|62691636|FG001|Extension Phase|Lost to Follow-up|0|||
33316051|NCT01252940|62691635|FG000|Extension Phase|Physician Decision|0|||
33316052|NCT01252940|62691636|FG001|Extension Phase|Physician Decision|1|||
33316053|NCT01252940|62691635|FG000|Extension Phase|Subject Non-compliance|1|||
33316054|NCT01252940|62691636|FG001|Extension Phase|Subject Non-compliance|0|||
33316055|NCT01252940|62691635|FG000|Extension Phase|Withdrawal by Subject|1|||
33316056|NCT01252940|62691636|FG001|Extension Phase|Withdrawal by Subject|1|||
33316057|NCT01252238|62691646|FG000|Overall Study|Sponsor terminated study|4|||
33316058|NCT01252238|62691647|FG001|Overall Study|Sponsor terminated study|4|||
33316059|NCT01252238|62691648|FG002|Overall Study|Sponsor terminated study|4|||
33316060|NCT01101477|62691662|FG000|Overall Study|Protocol Violation|5|||
33316061|NCT01101477|62691663|FG001|Overall Study|Protocol Violation|3|||
33316062|NCT01101477|62691664|FG002|Overall Study|Protocol Violation|1|||
33316063|NCT01251770|62691674|FG000|Overall Study|Protocol Violation|13|||
33316064|NCT01251770|62691675|FG001|Overall Study|Protocol Violation|7|||
33316065|NCT01101321|62691681|FG000|Period 1|Withdrawal by Subject|1|||
33316066|NCT01101321|62691682|FG001|Period 1|Withdrawal by Subject|1|||
33316067|NCT01101321|62691681|FG000|Period 1|Adverse Event|3|||
33316068|NCT01101321|62691682|FG001|Period 1|Adverse Event|3|||
33316069|NCT01101165|62691688|FG000|Period 1|Adverse Event|1|||
33316070|NCT01101165|62691689|FG001|Period 1|Adverse Event|2|||
33316071|NCT01101165|62691688|FG000|Period 1|Withdrawal by Subject|0|||
33316072|NCT01101165|62691689|FG001|Period 1|Withdrawal by Subject|2|||
33316073|NCT01101165|62691688|FG000|Period 1|Positive Drug Screen|0|||
33316074|NCT01101165|62691689|FG001|Period 1|Positive Drug Screen|1|||
33316075|NCT01101165|62691688|FG000|Period 1|Lost to Follow-up|1|||
33316076|NCT01101165|62691689|FG001|Period 1|Lost to Follow-up|0|||
33316077|NCT01101165|62691688|FG000|Period 2|Withdrawal by Subject|3|||
33316078|NCT01101165|62691689|FG001|Period 2|Withdrawal by Subject|1|||
33316079|NCT01101165|62691688|FG000|Period 2|Adverse Event|1|||
33401945|NCT00645788|62780892|FG003|Overall Study|Did not receive study drug|0|||
33316080|NCT01101165|62691689|FG001|Period 2|Adverse Event|0|||
33316081|NCT01100853|62691697|FG000|Overall Study|Lost to Follow-up|11|||
33597544|NCT02325739|62996465|FG006|Phase II Part|Subject/guardian decision|0|||
33597545|NCT02325739|62996466|FG007|Phase II Part|Subject/guardian decision|0|||
33597546|NCT02325739|62996467|FG008|Phase II Part|Subject/guardian decision|4|||
33597547|NCT02325739|62996468|FG009|Phase II Part|Subject/guardian decision|1|||
33597548|NCT02325739|62996469|FG010|Phase II Part|Subject/guardian decision|1|||
33597549|NCT01903720|62996514|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
33597550|NCT01903720|62996514|FG000|Overall Study|Adverse Event|1|||
33597551|NCT01903720|62996514|FG000|Overall Study|Rescinding of informed consent|2|||
33597552|NCT01903720|62996514|FG000|Overall Study|Lost to Follow-up|2|||
33597553|NCT01903720|62996514|FG000|Overall Study|Treatment with alternative drug|1|||
33597554|NCT02366689|62996521|FG000|Overall Study|Withdrawal by Subject|1|||
33597555|NCT02366689|62996522|FG001|Overall Study|Withdrawal by Subject|0|||
33597556|NCT02366689|62996523|FG002|Overall Study|Withdrawal by Subject|1|||
33597557|NCT02366689|62996521|FG000|Overall Study|Lost to Follow-up|3|||
33597558|NCT02366689|62996522|FG001|Overall Study|Lost to Follow-up|2|||
33597559|NCT02366689|62996523|FG002|Overall Study|Lost to Follow-up|0|||
33597560|NCT02366689|62996521|FG000|Overall Study|Pregnancy|0|||
33597561|NCT02366689|62996522|FG001|Overall Study|Pregnancy|1|||
33597562|NCT02366689|62996523|FG002|Overall Study|Pregnancy|1|||
33597563|NCT01903252|62996533|FG000|Double-Blind Induction|Adverse Event|20|||
33597564|NCT01903252|62996534|FG001|Double-Blind Induction|Adverse Event|18|||
33597565|NCT01903252|62996535|FG002|Double-Blind Induction|Adverse Event|0|||
33597566|NCT01903252|62996536|FG003|Double-Blind Induction|Adverse Event|0|||
33597567|NCT01903252|62996537|FG004|Double-Blind Induction|Adverse Event|0|||
33713184|NCT01383096|63279991|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
33713185|NCT01383096|63279992|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
33713186|NCT01383096|63279990|FG000|Third Intervention (8 Days)|Adverse Event|1|||
33713187|NCT01383096|63279991|FG001|Third Intervention (8 Days)|Adverse Event|0|||
33713188|NCT01383096|63279992|FG002|Third Intervention (8 Days)|Adverse Event|0|||
33713189|NCT01383096|63279990|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
33713190|NCT01383096|63279991|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
33316082|NCT01100853|62691698|FG001|Overall Study|Lost to Follow-up|6|||
33316083|NCT01100853|62691697|FG000|Overall Study|Received <4 study injections|10|||
33316084|NCT01100853|62691698|FG001|Overall Study|Received <4 study injections|13|||
33316085|NCT01100853|62691697|FG000|Overall Study|Withdrawal by Subject|6|||
33316086|NCT01100853|62691698|FG001|Overall Study|Withdrawal by Subject|4|||
33316087|NCT01100307|62691706|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
33316088|NCT01100307|62691707|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
33316089|NCT01100307|62691706|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
33316090|NCT01100307|62691707|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
33316091|NCT01100307|62691706|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
33316092|NCT01100307|62691707|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
33316093|NCT01100307|62691706|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
33316094|NCT01100307|62691707|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
33316095|NCT01100307|62691706|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
33316096|NCT01100307|62691707|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
33316097|NCT01100307|62691706|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
33316098|NCT01100307|62691707|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
33316099|NCT01100073|62691715|FG000|Overall Study|Lack of Efficacy|4|||
33316100|NCT01100073|62691715|FG000|Overall Study|Insufficient Tolerability|21|||
33316101|NCT01100073|62691715|FG000|Overall Study|Withdrawal by Subject|13|||
33316102|NCT01100073|62691715|FG000|Overall Study|Lost to Follow-up|39|||
33597568|NCT01903252|62996538|FG005|Double-Blind Induction|Adverse Event|0|||
33597569|NCT01903252|62996533|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
33597570|NCT01903252|62996534|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
33597571|NCT01903252|62996535|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
33597572|NCT01903252|62996536|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
33597573|NCT01903252|62996537|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
33597574|NCT01903252|62996538|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
33713191|NCT01383096|63279992|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
33316103|NCT01100073|62691715|FG000|Overall Study|Lack of effect + patient's wish|2|||
33316104|NCT01100073|62691715|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
33713192|NCT01383096|63279990|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
33713193|NCT01383096|63279991|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
33713194|NCT01383096|63279992|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
33713195|NCT01383096|63279990|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
33713196|NCT01383096|63279991|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
33713197|NCT01383096|63279992|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
33713198|NCT01383096|63279990|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
33713199|NCT01383096|63279991|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
33713200|NCT01383096|63279992|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
33713201|NCT01383096|63279990|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
33713202|NCT01383096|63279991|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
33713203|NCT01383096|63279992|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
33713204|NCT01383096|63279990|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
33713205|NCT01383096|63279991|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
33713206|NCT01383096|63279992|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
33713207|NCT01383018|63280029|FG000|Overall Study|Adverse Event|14|||
33713208|NCT01383018|63280029|FG000|Overall Study|Death|10|||
33713209|NCT01383018|63280029|FG000|Overall Study|Lost to Follow-up|5|||
33713210|NCT01383018|63280029|FG000|Overall Study|Physician Decision|5|||
33713211|NCT01383018|63280029|FG000|Overall Study|Withdrawal by Subject|9|||
33713212|NCT01383018|63280029|FG000|Overall Study|Subject not implanted|76|||
33713213|NCT01383018|63280029|FG000|Overall Study|Missed Visit|247|||
33713214|NCT01383018|63280029|FG000|Overall Study|Site closed early-not compliance related|7|||
33713215|NCT01383018|63280029|FG000|Overall Study|Patient moved away from site|1|||
33713216|NCT01383018|63280029|FG000|Overall Study|Subject Incarcerated|1|||
33713217|NCT01382940|63280043|FG000|Overall Study|Adverse Event|19|||
33713218|NCT01382940|63280043|FG000|Overall Study|Lost to Follow-up|4|||
33713219|NCT01382940|63280043|FG000|Overall Study|Physician Decision|7|||
33713220|NCT01382940|63280043|FG000|Overall Study|Withdrawal by Subject|23|||
33713221|NCT01382940|63280043|FG000|Overall Study|Protocol Violation|20|||
33713222|NCT01381926|63280049|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
33713223|NCT01381926|63280050|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
33713224|NCT01381926|63280049|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
33713225|NCT01381926|63280050|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
33713226|NCT01395888|63280060|FG000|2-week Run-in Period|Adverse Event|2|||
33713227|NCT01395888|63280061|FG001|2-week Run-in Period|Adverse Event|0|||
33713228|NCT01395888|63280062|FG002|2-week Run-in Period|Adverse Event|0|||
33713229|NCT01395888|63280060|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
33401946|NCT00645788|62780889|FG000|Overall Study|Adverse Event|4|||
33401947|NCT00645788|62780890|FG001|Overall Study|Adverse Event|9|||
33401948|NCT00645788|62780891|FG002|Overall Study|Adverse Event|5|||
33401949|NCT00645788|62780892|FG003|Overall Study|Adverse Event|3|||
33401950|NCT00645788|62780889|FG000|Overall Study|Lost to Follow-up|1|||
33401951|NCT00645788|62780890|FG001|Overall Study|Lost to Follow-up|0|||
33401952|NCT00645788|62780891|FG002|Overall Study|Lost to Follow-up|0|||
33713230|NCT01395888|63280061|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
33713231|NCT01395888|63280062|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
33713232|NCT01395888|63280060|FG000|2-week Run-in Period|Lost to Follow-up|1|||
33713233|NCT01395888|63280061|FG001|2-week Run-in Period|Lost to Follow-up|0|||
33713234|NCT01395888|63280062|FG002|2-week Run-in Period|Lost to Follow-up|0|||
33713235|NCT01395888|63280060|FG000|2-week Run-in Period|Protocol Violation|2|||
33713236|NCT01395888|63280061|FG001|2-week Run-in Period|Protocol Violation|0|||
33713237|NCT01395888|63280062|FG002|2-week Run-in Period|Protocol Violation|0|||
33713238|NCT01395888|63280060|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
33713239|NCT01395888|63280061|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
33713240|NCT01395888|63280062|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
33401953|NCT00645788|62780892|FG003|Overall Study|Lost to Follow-up|0|||
33493844|NCT03535194|62872387|FG004|Maintenance Period|Withdrawal by Subject|0|||
33713241|NCT01395888|63280060|FG000|Treatment Period (TP)|Adverse Event|0|||
33713242|NCT01395888|63280061|FG001|Treatment Period (TP)|Adverse Event|7|||
33713243|NCT01395888|63280062|FG002|Treatment Period (TP)|Adverse Event|6|||
33713244|NCT01395888|63280060|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
33401954|NCT00645788|62780889|FG000|Overall Study|Protocol Violation|1|||
33713245|NCT01395888|63280061|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
33713246|NCT01395888|63280062|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
33713247|NCT01395888|63280060|FG000|Treatment Period (TP)|Protocol Violation|0|||
33713248|NCT01395888|63280061|FG001|Treatment Period (TP)|Protocol Violation|1|||
33713249|NCT01395888|63280062|FG002|Treatment Period (TP)|Protocol Violation|5|||
33713250|NCT01395888|63280060|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
33401955|NCT00645788|62780890|FG001|Overall Study|Protocol Violation|0|||
33713251|NCT01395888|63280061|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
33713252|NCT01395888|63280062|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
33713253|NCT01395888|63280060|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
33713254|NCT01395888|63280061|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
33713255|NCT01395888|63280062|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
33713256|NCT01395810|63280072|FG000|Overall Study|Adverse Event|0|||
33713257|NCT01395810|63280073|FG001|Overall Study|Adverse Event|1|||
33713258|NCT01395810|63280074|FG002|Overall Study|Adverse Event|0|||
33713259|NCT01395810|63280075|FG003|Overall Study|Adverse Event|0|||
33713260|NCT01395810|63280072|FG000|Overall Study|Lack of Efficacy|0|||
33713261|NCT01395810|63280073|FG001|Overall Study|Lack of Efficacy|1|||
33713262|NCT01395810|63280074|FG002|Overall Study|Lack of Efficacy|0|||
33713263|NCT01395810|63280075|FG003|Overall Study|Lack of Efficacy|0|||
33713264|NCT01395810|63280072|FG000|Overall Study|Withdrawal criteria|0|||
33713265|NCT01395810|63280073|FG001|Overall Study|Withdrawal criteria|2|||
33713266|NCT01395810|63280074|FG002|Overall Study|Withdrawal criteria|0|||
33713267|NCT01395810|63280075|FG003|Overall Study|Withdrawal criteria|0|||
33713268|NCT01395810|63280072|FG000|Overall Study|Unclassified|2|||
33713269|NCT01395810|63280073|FG001|Overall Study|Unclassified|0|||
33713270|NCT01395810|63280074|FG002|Overall Study|Unclassified|0|||
33713271|NCT01395810|63280075|FG003|Overall Study|Unclassified|0|||
33713272|NCT01381692|63280088|FG000|Overall Study|Adverse Event|1|||
33713273|NCT01381692|63280089|FG001|Overall Study|Adverse Event|0|||
33713274|NCT01381692|63280090|FG002|Overall Study|Adverse Event|0|||
33713275|NCT01381692|63280091|FG003|Overall Study|Adverse Event|0|||
33713276|NCT01381692|63280092|FG004|Overall Study|Adverse Event|0|||
33713277|NCT01381692|63280093|FG005|Overall Study|Adverse Event|0|||
33713278|NCT01395030|63280101|FG000|Overall Study|Did not complete FCH PET/CT|7|||
33713279|NCT01381068|63280109|FG000|Overall Study|Death|1|||
33713280|NCT01381068|63280110|FG001|Overall Study|Death|0|||
33713281|NCT01394952|63280118|FG000|Overall Study|Lost to Follow-up|0|||
33713282|NCT01394952|63280119|FG001|Overall Study|Lost to Follow-up|5|||
33713283|NCT01394952|63280118|FG000|Overall Study|Withdrawal by Subject|10|||
33713284|NCT01394952|63280119|FG001|Overall Study|Withdrawal by Subject|5|||
33713285|NCT01394952|63280118|FG000|Overall Study|Physician Decision|2|||
33713286|NCT01394952|63280119|FG001|Overall Study|Physician Decision|0|||
33713287|NCT01394952|63280118|FG000|Overall Study|Sponsor Decision|5|||
33713288|NCT01394952|63280119|FG001|Overall Study|Sponsor Decision|7|||
33713289|NCT01394718|63280127|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
33713290|NCT01394718|63280128|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
33713291|NCT01394250|63280136|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
33713292|NCT01394250|63280137|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
33713293|NCT01394250|63280136|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
33713294|NCT01394250|63280137|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
33713295|NCT01380990|63280145|FG000|Overall Study|Treatment Failure|1|||
33713296|NCT01380990|63280146|FG001|Overall Study|Treatment Failure|0|||
33713297|NCT01380990|63280145|FG000|Overall Study|Death|0|||
33713298|NCT01380990|63280146|FG001|Overall Study|Death|1|||
33713299|NCT01380834|63280158|FG000|Overall Study|Physician Decision|1|||
33713300|NCT01380834|63280159|FG001|Overall Study|Physician Decision|0|||
33713301|NCT00214422|63280168|FG000|Overall Study|Physician Decision|2|||
33713302|NCT00214422|63280169|FG001|Overall Study|Physician Decision|0|||
33713303|NCT00214422|63280170|FG002|Overall Study|Physician Decision|0|||
33713304|NCT00214422|63280168|FG000|Overall Study|Developed esophageal ca|1|||
33713305|NCT00214422|63280169|FG001|Overall Study|Developed esophageal ca|0|||
33713306|NCT00214422|63280170|FG002|Overall Study|Developed esophageal ca|0|||
33713307|NCT00214422|63280168|FG000|Overall Study|Pt taken off study|1|||
33713308|NCT00214422|63280169|FG001|Overall Study|Pt taken off study|1|||
33713309|NCT00214422|63280170|FG002|Overall Study|Pt taken off study|0|||
33713310|NCT00214422|63280168|FG000|Overall Study|Disease progression on study|1|||
33713311|NCT00214422|63280169|FG001|Overall Study|Disease progression on study|0|||
33713312|NCT00214422|63280170|FG002|Overall Study|Disease progression on study|0|||
33713313|NCT00214422|63280168|FG000|Overall Study|Unable to make a radiation treatment|0|||
33713314|NCT00214422|63280169|FG001|Overall Study|Unable to make a radiation treatment|0|||
33713315|NCT00214422|63280170|FG002|Overall Study|Unable to make a radiation treatment|1|||
33713316|NCT00218634|63280184|FG000|Overall Study|Lost to Follow-up|8|||
33713317|NCT00218634|63280185|FG001|Overall Study|Lost to Follow-up|15|||
33713318|NCT00217620|63280194|FG000|Overall Study|Adverse Event|2|||
33713319|NCT00217620|63280194|FG000|Overall Study|Progression|31|||
33713320|NCT00217620|63280194|FG000|Overall Study|Not Protocol Specified|4|||
33713321|NCT00217620|63280194|FG000|Overall Study|Ineligible|13|||
33713322|NCT00217620|63280194|FG000|Overall Study|Never received treatment|1|||
33713323|NCT00217464|63280202|FG000|Overall Study|Progression|15|||
33713324|NCT00217464|63280202|FG000|Overall Study|Other|2|||
33713325|NCT00214500|63280206|FG000|Treatment Period|Adverse Event|1|||
33713326|NCT00214500|63280206|FG000|Extension Period|Withdrawal by Subject|2|||
33713327|NCT00211536|63280215|FG000|Overall Study|Withdrawal by Subject|2|||
33713328|NCT00211536|63280216|FG001|Overall Study|Withdrawal by Subject|2|||
33713329|NCT00211536|63280215|FG000|Overall Study|Physician Decision|0|||
33713330|NCT00211536|63280216|FG001|Overall Study|Physician Decision|5|||
33713331|NCT00211536|63280215|FG000|Overall Study|Adverse Event|2|||
33713332|NCT00211536|63280216|FG001|Overall Study|Adverse Event|0|||
33713333|NCT03192462|63280279|FG000|Overall Study|Death|13|||
33713334|NCT03192462|63280280|FG001|Overall Study|Death|11|||
33713335|NCT03192462|63280281|FG002|Overall Study|Death|9|||
33713336|NCT03192462|63280279|FG000|Overall Study|Lost to Follow-up|0|||
33713337|NCT03192462|63280280|FG001|Overall Study|Lost to Follow-up|1|||
33713338|NCT03192462|63280281|FG002|Overall Study|Lost to Follow-up|0|||
33713339|NCT03192462|63280279|FG000|Overall Study|On follow up|0|||
33713340|NCT03192462|63280280|FG001|Overall Study|On follow up|0|||
33713341|NCT03192462|63280281|FG002|Overall Study|On follow up|3|||
33713342|NCT03028740|63280304|FG000|Overall Study|Did not Receive Study Drug|4|||
33713343|NCT03028740|63280305|FG001|Overall Study|Did not Receive Study Drug|5|||
33713344|NCT03028740|63280304|FG000|Overall Study|Adverse Event|8|||
33713345|NCT03028740|63280305|FG001|Overall Study|Adverse Event|26|||
33713346|NCT03028740|63280304|FG000|Overall Study|Lack of Efficacy|0|||
33713347|NCT03028740|63280305|FG001|Overall Study|Lack of Efficacy|1|||
33713348|NCT03028740|63280304|FG000|Overall Study|Withdrawal by Subject|48|||
33713349|NCT03028740|63280305|FG001|Overall Study|Withdrawal by Subject|101|||
33713350|NCT03028740|63280304|FG000|Overall Study|Lost to Follow-up|30|||
33713351|NCT03028740|63280305|FG001|Overall Study|Lost to Follow-up|54|||
33713352|NCT03028740|63280304|FG000|Overall Study|Physician Decision|4|||
33713353|NCT03028740|63280305|FG001|Overall Study|Physician Decision|11|||
33713354|NCT03028740|63280304|FG000|Overall Study|Protocol Violation|4|||
33713355|NCT03028740|63280305|FG001|Overall Study|Protocol Violation|8|||
33713356|NCT03028740|63280304|FG000|Overall Study|Non-compliance with Study Drug|0|||
33713357|NCT03028740|63280305|FG001|Overall Study|Non-compliance with Study Drug|2|||
33713358|NCT03028740|63280304|FG000|Overall Study|Study Terminated by Sponsor|467|||
33713359|NCT03028740|63280305|FG001|Overall Study|Study Terminated by Sponsor|917|||
33713360|NCT03028740|63280304|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
33713361|NCT03028740|63280305|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
33713362|NCT03028740|63280304|FG000|Overall Study|Reason not Specified|1|||
33713363|NCT03028740|63280305|FG001|Overall Study|Reason not Specified|5|||
33713364|NCT02980692|63280328|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
33713365|NCT02980692|63280329|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
33713366|NCT02980692|63280330|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
33713367|NCT02980692|63280331|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
33713368|NCT02980692|63280332|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
33713369|NCT02980692|63280328|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
33713370|NCT02980692|63280329|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
33713371|NCT02980692|63280330|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
33713372|NCT02980692|63280331|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
33713373|NCT02980692|63280332|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
33713374|NCT02980692|63280328|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
33713375|NCT02980692|63280329|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
33713376|NCT02980692|63280330|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
33713377|NCT02980692|63280331|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
33713378|NCT02980692|63280332|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
33713379|NCT02980692|63280328|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
33713380|NCT02980692|63280329|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
33713381|NCT02980692|63280330|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
33713382|NCT02980692|63280331|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
33713383|NCT02980692|63280332|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
33713384|NCT02980692|63280328|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
33713385|NCT02980692|63280329|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
33316105|NCT01100073|62691715|FG000|Overall Study|Other|8|||
33316106|NCT01100073|62691715|FG000|Overall Study|Missing|5|||
33316107|NCT01099917|62691719|FG000|Overall Study|Adverse Event|3|||
33713386|NCT02980692|63280330|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
33316108|NCT01099917|62691719|FG000|Overall Study|Not Treated|24|||
33713387|NCT02980692|63280331|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
33713388|NCT02980692|63280332|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
33316109|NCT01099215|62691725|FG000|Overall Study|Withdrawal by Subject|1|||
33713389|NCT02980692|63280328|FG000|Double Blind Placebo Controlled Period|Other|1|||
33713390|NCT02980692|63280329|FG001|Double Blind Placebo Controlled Period|Other|0|||
33316110|NCT01099215|62691726|FG001|Overall Study|Withdrawal by Subject|0|||
33316111|NCT01099215|62691725|FG000|Overall Study|Adverse Event|0|||
33316112|NCT01099215|62691726|FG001|Overall Study|Adverse Event|1|||
33316113|NCT01097655|62691732|FG000|Overall Study|Withdrawal by Subject|1|||
33316114|NCT01097655|62691732|FG000|Overall Study|Subject Documented Twice|1|||
33316115|NCT01097655|62691732|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
33316116|NCT01107405|62691741|FG000|Overall Study|Adverse Event|1|||
33316117|NCT01107405|62691742|FG001|Overall Study|Adverse Event|1|||
33316118|NCT01107405|62691743|FG002|Overall Study|Adverse Event|0|||
33316119|NCT01107405|62691744|FG003|Overall Study|Adverse Event|0|||
33316120|NCT01107405|62691745|FG004|Overall Study|Adverse Event|2|||
33316121|NCT01107405|62691741|FG000|Overall Study|Withdrawal by Subject|1|||
33316122|NCT01107405|62691742|FG001|Overall Study|Withdrawal by Subject|0|||
33316123|NCT01107405|62691743|FG002|Overall Study|Withdrawal by Subject|1|||
33316124|NCT01107405|62691744|FG003|Overall Study|Withdrawal by Subject|2|||
33316125|NCT01107405|62691745|FG004|Overall Study|Withdrawal by Subject|1|||
33316126|NCT01107405|62691741|FG000|Overall Study|Protocol Violation|0|||
33316127|NCT01107405|62691742|FG001|Overall Study|Protocol Violation|0|||
33316128|NCT01107405|62691743|FG002|Overall Study|Protocol Violation|1|||
33316129|NCT01107405|62691744|FG003|Overall Study|Protocol Violation|1|||
33316130|NCT01107405|62691745|FG004|Overall Study|Protocol Violation|0|||
33316131|NCT01097577|62691759|FG000|Overall Study|Adverse Event|0|||
33316132|NCT01097577|62691760|FG001|Overall Study|Adverse Event|1|||
33316133|NCT01097421|62691766|FG000|Overall Study|Adverse Event|8|||
33316134|NCT01097421|62691766|FG000|Overall Study|Protocol Violation|2|||
33316135|NCT01097421|62691766|FG000|Overall Study|Lost to Follow-up|1|||
33316136|NCT01097421|62691766|FG000|Overall Study|Withdrawal by Subject|3|||
33316137|NCT01251614|62691773|FG000|Overall Study|Adverse Event|1|||
33316138|NCT01251614|62691774|FG001|Overall Study|Adverse Event|0|||
33316139|NCT01251614|62691775|FG002|Overall Study|Adverse Event|1|||
33316140|NCT01251614|62691773|FG000|Overall Study|Lack of Efficacy|1|||
33316141|NCT01251614|62691774|FG001|Overall Study|Lack of Efficacy|9|||
33316142|NCT01251614|62691775|FG002|Overall Study|Lack of Efficacy|4|||
33316143|NCT01251614|62691773|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
33316144|NCT01251614|62691774|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
33316145|NCT01251614|62691775|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
33316146|NCT01251614|62691773|FG000|Overall Study|Pregnancy|0|||
33316147|NCT01251614|62691774|FG001|Overall Study|Pregnancy|0|||
33316148|NCT01251614|62691775|FG002|Overall Study|Pregnancy|2|||
33316149|NCT01251614|62691773|FG000|Overall Study|Loss of Disease Control|0|||
33316150|NCT01251614|62691774|FG001|Overall Study|Loss of Disease Control|1|||
33316151|NCT01251614|62691775|FG002|Overall Study|Loss of Disease Control|0|||
33316152|NCT01251614|62691773|FG000|Overall Study|Withdrawal by Subject|0|||
33316153|NCT01251614|62691774|FG001|Overall Study|Withdrawal by Subject|2|||
33316154|NCT01251614|62691775|FG002|Overall Study|Withdrawal by Subject|1|||
33316155|NCT01251614|62691773|FG000|Overall Study|Lost to Follow-up|0|||
33316156|NCT01251614|62691774|FG001|Overall Study|Lost to Follow-up|1|||
33316157|NCT01251614|62691775|FG002|Overall Study|Lost to Follow-up|0|||
33316158|NCT01106625|62691796|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
33316159|NCT01106625|62691797|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
33316160|NCT01106625|62691798|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
33316161|NCT01106625|62691796|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
33316162|NCT01106625|62691797|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
33316163|NCT01106625|62691798|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
33316164|NCT01106625|62691796|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
33316165|NCT01106625|62691797|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
33316166|NCT01106625|62691798|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
33316167|NCT01106625|62691796|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
33316168|NCT01106625|62691797|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
33316169|NCT01106625|62691798|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
33316170|NCT01106625|62691796|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
33316171|NCT01106625|62691797|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
33316172|NCT01106625|62691798|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
33316173|NCT01106625|62691796|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
33316174|NCT01106625|62691797|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
33316175|NCT01106625|62691798|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
33316176|NCT01106625|62691796|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
33316177|NCT01106625|62691797|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
33316178|NCT01106625|62691798|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
33316179|NCT01106625|62691796|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
33316180|NCT01106625|62691797|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
33316181|NCT01106625|62691798|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33316182|NCT01106625|62691796|FG000|Core Period: Baseline to Week 26|Other|8|||
33316183|NCT01106625|62691797|FG001|Core Period: Baseline to Week 26|Other|7|||
33316184|NCT01106625|62691798|FG002|Core Period: Baseline to Week 26|Other|4|||
33713391|NCT02980692|63280330|FG002|Double Blind Placebo Controlled Period|Other|0|||
33713392|NCT02980692|63280331|FG003|Double Blind Placebo Controlled Period|Other|0|||
33713393|NCT02980692|63280332|FG004|Double Blind Placebo Controlled Period|Other|1|||
33713394|NCT02980692|63280328|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
33713395|NCT02980692|63280329|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
33713396|NCT02980692|63280330|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
33713397|NCT02980692|63280331|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
33713398|NCT02980692|63280332|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
33713399|NCT02980692|63280328|FG000|Double-blind Follow-up Period|Adverse Event|0|||
33713400|NCT02980692|63280329|FG001|Double-blind Follow-up Period|Adverse Event|0|||
33713401|NCT02980692|63280330|FG002|Double-blind Follow-up Period|Adverse Event|0|||
33713402|NCT02980692|63280331|FG003|Double-blind Follow-up Period|Adverse Event|1|||
33597575|NCT01903252|62996533|FG000|Double-Blind Induction|Physician Decision|2|||
33597576|NCT01903252|62996534|FG001|Double-Blind Induction|Physician Decision|3|||
33597577|NCT01903252|62996535|FG002|Double-Blind Induction|Physician Decision|0|||
33597578|NCT01903252|62996536|FG003|Double-Blind Induction|Physician Decision|0|||
33597579|NCT01903252|62996537|FG004|Double-Blind Induction|Physician Decision|0|||
33597580|NCT01903252|62996538|FG005|Double-Blind Induction|Physician Decision|0|||
33597581|NCT01903252|62996533|FG000|Double-Blind Induction|non-compliance,|7|||
33597582|NCT01903252|62996534|FG001|Double-Blind Induction|non-compliance,|7|||
33597583|NCT01903252|62996535|FG002|Double-Blind Induction|non-compliance,|0|||
33597584|NCT01903252|62996536|FG003|Double-Blind Induction|non-compliance,|0|||
33597585|NCT01903252|62996537|FG004|Double-Blind Induction|non-compliance,|0|||
33597586|NCT01903252|62996538|FG005|Double-Blind Induction|non-compliance,|0|||
33597587|NCT01903252|62996533|FG000|Extended Induction, Open-Label|Adverse Event|0|||
33597588|NCT01903252|62996534|FG001|Extended Induction, Open-Label|Adverse Event|0|||
33597589|NCT01903252|62996535|FG002|Extended Induction, Open-Label|Adverse Event|17|||
33597590|NCT01903252|62996536|FG003|Extended Induction, Open-Label|Adverse Event|0|||
33597591|NCT01903252|62996537|FG004|Extended Induction, Open-Label|Adverse Event|0|||
33597592|NCT01903252|62996538|FG005|Extended Induction, Open-Label|Adverse Event|0|||
33597593|NCT01903252|62996533|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
33597594|NCT01903252|62996534|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
33597595|NCT01903252|62996535|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
33597596|NCT01903252|62996536|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
33597597|NCT01903252|62996537|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
33597598|NCT01903252|62996538|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
33597599|NCT01903252|62996533|FG000|Extended Induction, Open-Label|Physician Decision|0|||
33597600|NCT01903252|62996534|FG001|Extended Induction, Open-Label|Physician Decision|0|||
33713403|NCT02980692|63280332|FG004|Double-blind Follow-up Period|Adverse Event|1|||
33713404|NCT02980692|63280328|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
33713405|NCT02980692|63280329|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
33713406|NCT02980692|63280330|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
33713407|NCT02980692|63280331|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
33713408|NCT02980692|63280332|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
33713409|NCT02980692|63280328|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
33713410|NCT02980692|63280329|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
33713411|NCT02980692|63280330|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
33597601|NCT01903252|62996535|FG002|Extended Induction, Open-Label|Physician Decision|1|||
33597602|NCT01903252|62996536|FG003|Extended Induction, Open-Label|Physician Decision|0|||
33597603|NCT01903252|62996537|FG004|Extended Induction, Open-Label|Physician Decision|0|||
33713412|NCT02980692|63280331|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
33713413|NCT02980692|63280332|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
33713414|NCT02980692|63280328|FG000|Double-blind Follow-up Period|Pregnancy|0|||
33713415|NCT02980692|63280329|FG001|Double-blind Follow-up Period|Pregnancy|0|||
33713416|NCT02980692|63280330|FG002|Double-blind Follow-up Period|Pregnancy|1|||
33713417|NCT02980692|63280331|FG003|Double-blind Follow-up Period|Pregnancy|1|||
33713418|NCT02980692|63280332|FG004|Double-blind Follow-up Period|Pregnancy|0|||
33713419|NCT02980692|63280328|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
33713420|NCT02980692|63280329|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
33713421|NCT02980692|63280330|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
33713422|NCT02980692|63280331|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
33713423|NCT02980692|63280332|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
33713424|NCT02980692|63280328|FG000|Double-blind Follow-up Period|Other|0|||
33316185|NCT01106625|62691796|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
33316186|NCT01106625|62691797|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
33316187|NCT01106625|62691798|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
33713425|NCT02980692|63280329|FG001|Double-blind Follow-up Period|Other|0|||
33713426|NCT02980692|63280330|FG002|Double-blind Follow-up Period|Other|1|||
33713427|NCT02980692|63280331|FG003|Double-blind Follow-up Period|Other|1|||
33713428|NCT02980692|63280332|FG004|Double-blind Follow-up Period|Other|3|||
33713429|NCT00089778|63280638|FG000|Overall Study|Protocol Violation|0|||
33713430|NCT00089778|63280639|FG001|Overall Study|Protocol Violation|0|||
33713431|NCT00089778|63280640|FG002|Overall Study|Protocol Violation|1|||
33713432|NCT00089544|63280652|FG000|Overall Study|Ineligible|1|||
33713433|NCT00089544|63280653|FG001|Overall Study|Ineligible|0|||
33713434|NCT00089076|63280659|FG000|Overall Study|Alternate Therapy|1|||
33713435|NCT00089076|63280659|FG000|Overall Study|Withdrawal by Subject|2|||
33713436|NCT00089076|63280659|FG000|Overall Study|Progression|7|||
33713437|NCT00088374|63280663|FG000|Overall Study|patient did not receive any 17AAG|1|||
33713438|NCT00088374|63280663|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
33316188|NCT01106625|62691796|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
33713439|NCT00087594|63280669|FG000|Overall Study|Adverse Event|2|||
33316189|NCT01106625|62691797|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
33316190|NCT01106625|62691798|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
33316191|NCT01106625|62691796|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
33316192|NCT01106625|62691797|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33316193|NCT01106625|62691798|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
33316194|NCT01106625|62691796|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33316195|NCT01106625|62691797|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
33316196|NCT01106625|62691798|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33316197|NCT01106625|62691796|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
33316198|NCT01106625|62691797|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33316199|NCT01106625|62691798|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33316200|NCT01106625|62691796|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
33316201|NCT01106625|62691797|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
33316202|NCT01106625|62691798|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
33316203|NCT01106625|62691796|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
33316204|NCT01106625|62691797|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
33316205|NCT01106625|62691798|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
33316206|NCT01106625|62691796|FG000|Extension Period: Week 26 to Week 52|Other|5|||
33316207|NCT01106625|62691797|FG001|Extension Period: Week 26 to Week 52|Other|5|||
33316208|NCT01106625|62691798|FG002|Extension Period: Week 26 to Week 52|Other|4|||
33316209|NCT01251380|62691809|FG000|Overall Study|Other (Not otherwise specified)|12|||
33316210|NCT01251380|62691809|FG000|Overall Study|Withdrawal by Subject|6|||
33316211|NCT01251380|62691809|FG000|Overall Study|Lack of Efficacy|1|||
33316212|NCT01251380|62691809|FG000|Overall Study|Adverse Event|1|||
33597604|NCT01903252|62996538|FG005|Extended Induction, Open-Label|Physician Decision|0|||
33597605|NCT01903252|62996533|FG000|Maintenance, Open-Label|Adverse Event|0|||
33597606|NCT01903252|62996534|FG001|Maintenance, Open-Label|Adverse Event|0|||
33597607|NCT01903252|62996535|FG002|Maintenance, Open-Label|Adverse Event|0|||
33597608|NCT01903252|62996536|FG003|Maintenance, Open-Label|Adverse Event|3|||
33597609|NCT01903252|62996537|FG004|Maintenance, Open-Label|Adverse Event|9|||
33597610|NCT01903252|62996538|FG005|Maintenance, Open-Label|Adverse Event|14|||
33597611|NCT01903252|62996533|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
33597612|NCT01903252|62996534|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
33713440|NCT00087594|63280670|FG001|Overall Study|Adverse Event|3|||
33713441|NCT00087594|63280669|FG000|Overall Study|Lost to Follow-up|0|||
33713442|NCT00087594|63280670|FG001|Overall Study|Lost to Follow-up|2|||
33713443|NCT00087594|63280669|FG000|Overall Study|Withdrawal by Subject|4|||
33713444|NCT00087594|63280670|FG001|Overall Study|Withdrawal by Subject|2|||
33316213|NCT01251380|62691809|FG000|Overall Study|Lost to Follow-up|2|||
33316214|NCT01251146|62691820|FG000|Overall Study|Lost to Follow-up|3|||
33316215|NCT01251146|62691821|FG001|Overall Study|Lost to Follow-up|10|||
33316216|NCT01096017|62691827|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
33316217|NCT01096017|62691828|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
33316218|NCT01106157|62691836|FG000|Overall Study|Withdrawal by Subject|1|||
33316219|NCT01106157|62691837|FG001|Overall Study|Withdrawal by Subject|0|||
33316220|NCT01094301|62691843|FG000|Trial Stage|Withdrawal by Subject|1|||
33316221|NCT01094301|62691843|FG000|Implant Stage|Adverse Event|1|||
33316222|NCT01094301|62691843|FG000|Implant Stage|Protocol Violation|1|||
33316223|NCT01094301|62691843|FG000|Implant Stage|Withdrawal by Subject|2|||
33316224|NCT01094301|62691843|FG000|Implant Stage|No return of pain|4|||
33316225|NCT01093755|62691851|FG000|Overall Study|Withdrawal by Subject|3|||
33316226|NCT01093755|62691852|FG001|Overall Study|Withdrawal by Subject|4|||
33316227|NCT01093599|62691860|FG000|Overall Study|Lost to Follow-up|32|||
33316228|NCT01093599|62691861|FG001|Overall Study|Lost to Follow-up|46|||
33316229|NCT01092663|62691869|FG000|Overall Study|Withdrawal by Subject|3|||
33316230|NCT01092663|62691870|FG001|Overall Study|Withdrawal by Subject|2|||
33316231|NCT01092663|62691869|FG000|Overall Study|Glucose >300mg/dL|1|||
33316232|NCT01092663|62691870|FG001|Overall Study|Glucose >300mg/dL|0|||
33316233|NCT01092663|62691869|FG000|Overall Study|High fasting triglyceride|2|||
33316234|NCT01092663|62691870|FG001|Overall Study|High fasting triglyceride|0|||
33316235|NCT01092663|62691869|FG000|Overall Study|Adverse Event|1|||
33316236|NCT01092663|62691870|FG001|Overall Study|Adverse Event|1|||
33316237|NCT01092663|62691869|FG000|Overall Study|Protocol Violation|0|||
33316238|NCT01092663|62691870|FG001|Overall Study|Protocol Violation|1|||
33316239|NCT01078623|62691881|FG000|Treatment Period 1|Adverse Event|1|||
33316240|NCT01078623|62691882|FG001|Treatment Period 1|Adverse Event|1|||
33316241|NCT01078623|62691883|FG002|Treatment Period 1|Adverse Event|1|||
33316242|NCT01078623|62691884|FG003|Treatment Period 1|Adverse Event|0|||
33316243|NCT01078623|62691885|FG004|Treatment Period 1|Adverse Event|0|||
33316244|NCT01078623|62691886|FG005|Treatment Period 1|Adverse Event|0|||
33316245|NCT01078623|62691887|FG006|Treatment Period 1|Adverse Event|1|||
33316246|NCT01078623|62691888|FG007|Treatment Period 1|Adverse Event|0|||
33316247|NCT01078623|62691889|FG008|Treatment Period 1|Adverse Event|1|||
33316248|NCT01078623|62691890|FG009|Treatment Period 1|Adverse Event|1|||
33316249|NCT01078623|62691891|FG010|Treatment Period 1|Adverse Event|0|||
33316250|NCT01078623|62691892|FG011|Treatment Period 1|Adverse Event|0|||
33316251|NCT01078623|62691893|FG012|Treatment Period 1|Adverse Event|0|||
33316252|NCT01078623|62691894|FG013|Treatment Period 1|Adverse Event|0|||
33316253|NCT01078623|62691895|FG014|Treatment Period 1|Adverse Event|0|||
33316254|NCT01078623|62691896|FG015|Treatment Period 1|Adverse Event|0|||
33316255|NCT01078623|62691897|FG016|Treatment Period 1|Adverse Event|0|||
33316256|NCT01078623|62691898|FG017|Treatment Period 1|Adverse Event|0|||
33316257|NCT01078623|62691899|FG018|Treatment Period 1|Adverse Event|0|||
33316258|NCT01078623|62691900|FG019|Treatment Period 1|Adverse Event|0|||
33316259|NCT01078623|62691881|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33316260|NCT01078623|62691882|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33316261|NCT01078623|62691883|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33316262|NCT01078623|62691884|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33316263|NCT01078623|62691885|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33316264|NCT01078623|62691886|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33316265|NCT01078623|62691887|FG006|Treatment Period 1|Withdrawal by Subject|0|||
33316266|NCT01078623|62691888|FG007|Treatment Period 1|Withdrawal by Subject|1|||
33316267|NCT01078623|62691889|FG008|Treatment Period 1|Withdrawal by Subject|0|||
33316268|NCT01078623|62691890|FG009|Treatment Period 1|Withdrawal by Subject|0|||
33316269|NCT01078623|62691891|FG010|Treatment Period 1|Withdrawal by Subject|1|||
33316270|NCT01078623|62691892|FG011|Treatment Period 1|Withdrawal by Subject|0|||
33316271|NCT01078623|62691893|FG012|Treatment Period 1|Withdrawal by Subject|0|||
33316272|NCT01078623|62691894|FG013|Treatment Period 1|Withdrawal by Subject|0|||
33316273|NCT01078623|62691895|FG014|Treatment Period 1|Withdrawal by Subject|0|||
33316274|NCT01078623|62691896|FG015|Treatment Period 1|Withdrawal by Subject|0|||
33316275|NCT01078623|62691897|FG016|Treatment Period 1|Withdrawal by Subject|0|||
33316276|NCT01078623|62691898|FG017|Treatment Period 1|Withdrawal by Subject|0|||
33316277|NCT01078623|62691899|FG018|Treatment Period 1|Withdrawal by Subject|0|||
33401956|NCT00645788|62780891|FG002|Overall Study|Protocol Violation|2|||
33316278|NCT01078623|62691900|FG019|Treatment Period 1|Withdrawal by Subject|0|||
33316279|NCT01078623|62691881|FG000|Treatment Period 1|Protocol Violation|0|||
33316280|NCT01078623|62691882|FG001|Treatment Period 1|Protocol Violation|0|||
33316281|NCT01078623|62691883|FG002|Treatment Period 1|Protocol Violation|0|||
33316282|NCT01078623|62691884|FG003|Treatment Period 1|Protocol Violation|0|||
33316283|NCT01078623|62691885|FG004|Treatment Period 1|Protocol Violation|0|||
33316284|NCT01078623|62691886|FG005|Treatment Period 1|Protocol Violation|1|||
33316285|NCT01078623|62691887|FG006|Treatment Period 1|Protocol Violation|0|||
33316286|NCT01078623|62691888|FG007|Treatment Period 1|Protocol Violation|0|||
33316287|NCT01078623|62691889|FG008|Treatment Period 1|Protocol Violation|0|||
33316288|NCT01078623|62691890|FG009|Treatment Period 1|Protocol Violation|0|||
33316289|NCT01078623|62691891|FG010|Treatment Period 1|Protocol Violation|0|||
33316290|NCT01078623|62691892|FG011|Treatment Period 1|Protocol Violation|0|||
33316291|NCT01078623|62691893|FG012|Treatment Period 1|Protocol Violation|0|||
33316292|NCT01078623|62691894|FG013|Treatment Period 1|Protocol Violation|0|||
33316293|NCT01078623|62691895|FG014|Treatment Period 1|Protocol Violation|0|||
33316294|NCT01078623|62691896|FG015|Treatment Period 1|Protocol Violation|0|||
33316295|NCT01078623|62691897|FG016|Treatment Period 1|Protocol Violation|0|||
33316296|NCT01078623|62691898|FG017|Treatment Period 1|Protocol Violation|0|||
33316297|NCT01078623|62691899|FG018|Treatment Period 1|Protocol Violation|0|||
33316298|NCT01078623|62691900|FG019|Treatment Period 1|Protocol Violation|0|||
33316299|NCT01078623|62691881|FG000|Treatment Period 2|Adverse Event|0|||
33316300|NCT01078623|62691882|FG001|Treatment Period 2|Adverse Event|0|||
33316301|NCT01078623|62691883|FG002|Treatment Period 2|Adverse Event|0|||
33316302|NCT01078623|62691884|FG003|Treatment Period 2|Adverse Event|0|||
33316303|NCT01078623|62691885|FG004|Treatment Period 2|Adverse Event|0|||
33316304|NCT01078623|62691886|FG005|Treatment Period 2|Adverse Event|0|||
33316305|NCT01078623|62691887|FG006|Treatment Period 2|Adverse Event|1|||
33316306|NCT01078623|62691888|FG007|Treatment Period 2|Adverse Event|0|||
33316307|NCT01078623|62691889|FG008|Treatment Period 2|Adverse Event|0|||
33316308|NCT01078623|62691890|FG009|Treatment Period 2|Adverse Event|0|||
33316309|NCT01078623|62691891|FG010|Treatment Period 2|Adverse Event|0|||
33316310|NCT01078623|62691892|FG011|Treatment Period 2|Adverse Event|0|||
33316311|NCT01078623|62691893|FG012|Treatment Period 2|Adverse Event|0|||
33316312|NCT01078623|62691894|FG013|Treatment Period 2|Adverse Event|0|||
33316313|NCT01078623|62691895|FG014|Treatment Period 2|Adverse Event|0|||
33316314|NCT01078623|62691896|FG015|Treatment Period 2|Adverse Event|0|||
33316315|NCT01078623|62691897|FG016|Treatment Period 2|Adverse Event|0|||
33316316|NCT01078623|62691898|FG017|Treatment Period 2|Adverse Event|0|||
33316317|NCT01078623|62691899|FG018|Treatment Period 2|Adverse Event|1|||
33316318|NCT01078623|62691900|FG019|Treatment Period 2|Adverse Event|0|||
33316319|NCT01078623|62691881|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33316320|NCT01078623|62691882|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33316321|NCT01078623|62691883|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33316322|NCT01078623|62691884|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33316323|NCT01078623|62691885|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33316324|NCT01078623|62691886|FG005|Treatment Period 2|Withdrawal by Subject|1|||
33316325|NCT01078623|62691887|FG006|Treatment Period 2|Withdrawal by Subject|0|||
33316326|NCT01078623|62691888|FG007|Treatment Period 2|Withdrawal by Subject|0|||
33316327|NCT01078623|62691889|FG008|Treatment Period 2|Withdrawal by Subject|0|||
33316328|NCT01078623|62691890|FG009|Treatment Period 2|Withdrawal by Subject|0|||
33316329|NCT01078623|62691891|FG010|Treatment Period 2|Withdrawal by Subject|0|||
33316330|NCT01078623|62691892|FG011|Treatment Period 2|Withdrawal by Subject|0|||
33316331|NCT01078623|62691893|FG012|Treatment Period 2|Withdrawal by Subject|0|||
33316332|NCT01078623|62691894|FG013|Treatment Period 2|Withdrawal by Subject|0|||
33316333|NCT01078623|62691895|FG014|Treatment Period 2|Withdrawal by Subject|0|||
33316334|NCT01078623|62691896|FG015|Treatment Period 2|Withdrawal by Subject|0|||
33316335|NCT01078623|62691897|FG016|Treatment Period 2|Withdrawal by Subject|0|||
33316336|NCT01078623|62691898|FG017|Treatment Period 2|Withdrawal by Subject|0|||
33316337|NCT01078623|62691899|FG018|Treatment Period 2|Withdrawal by Subject|0|||
33401957|NCT00645788|62780892|FG003|Overall Study|Protocol Violation|0|||
33597613|NCT01903252|62996535|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
33597614|NCT01903252|62996536|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
33316338|NCT01078623|62691900|FG019|Treatment Period 2|Withdrawal by Subject|0|||
33316339|NCT01078623|62691881|FG000|Treatment Period 3|Adverse Event|0|||
33316340|NCT01078623|62691882|FG001|Treatment Period 3|Adverse Event|0|||
33316341|NCT01078623|62691883|FG002|Treatment Period 3|Adverse Event|0|||
33316342|NCT01078623|62691884|FG003|Treatment Period 3|Adverse Event|0|||
33597615|NCT01903252|62996537|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
33316343|NCT01078623|62691885|FG004|Treatment Period 3|Adverse Event|1|||
33316344|NCT01078623|62691886|FG005|Treatment Period 3|Adverse Event|0|||
33597616|NCT01903252|62996538|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
33316345|NCT01078623|62691887|FG006|Treatment Period 3|Adverse Event|0|||
33316346|NCT01078623|62691888|FG007|Treatment Period 3|Adverse Event|0|||
33316347|NCT01078623|62691889|FG008|Treatment Period 3|Adverse Event|0|||
33316348|NCT01078623|62691890|FG009|Treatment Period 3|Adverse Event|0|||
33316349|NCT01078623|62691891|FG010|Treatment Period 3|Adverse Event|0|||
33316350|NCT01078623|62691892|FG011|Treatment Period 3|Adverse Event|0|||
33316351|NCT01078623|62691893|FG012|Treatment Period 3|Adverse Event|0|||
33316352|NCT01078623|62691894|FG013|Treatment Period 3|Adverse Event|1|||
33316353|NCT01078623|62691895|FG014|Treatment Period 3|Adverse Event|0|||
33316354|NCT01078623|62691896|FG015|Treatment Period 3|Adverse Event|0|||
33316355|NCT01078623|62691897|FG016|Treatment Period 3|Adverse Event|0|||
33316356|NCT01078623|62691898|FG017|Treatment Period 3|Adverse Event|0|||
33316357|NCT01078623|62691899|FG018|Treatment Period 3|Adverse Event|0|||
33316358|NCT01078623|62691900|FG019|Treatment Period 3|Adverse Event|0|||
33316359|NCT01078623|62691881|FG000|Treatment Period 4|Adverse Event|0|||
33316360|NCT01078623|62691882|FG001|Treatment Period 4|Adverse Event|0|||
33316361|NCT01078623|62691883|FG002|Treatment Period 4|Adverse Event|1|||
33316362|NCT01078623|62691884|FG003|Treatment Period 4|Adverse Event|0|||
33316363|NCT01078623|62691885|FG004|Treatment Period 4|Adverse Event|0|||
33316364|NCT01078623|62691886|FG005|Treatment Period 4|Adverse Event|0|||
33316365|NCT01078623|62691887|FG006|Treatment Period 4|Adverse Event|0|||
33316366|NCT01078623|62691888|FG007|Treatment Period 4|Adverse Event|0|||
33316367|NCT01078623|62691889|FG008|Treatment Period 4|Adverse Event|0|||
33316368|NCT01078623|62691890|FG009|Treatment Period 4|Adverse Event|0|||
33316369|NCT01078623|62691891|FG010|Treatment Period 4|Adverse Event|0|||
33316370|NCT01078623|62691892|FG011|Treatment Period 4|Adverse Event|0|||
33316371|NCT01078623|62691893|FG012|Treatment Period 4|Adverse Event|0|||
33316372|NCT01078623|62691894|FG013|Treatment Period 4|Adverse Event|0|||
33316373|NCT01078623|62691895|FG014|Treatment Period 4|Adverse Event|0|||
33316374|NCT01078623|62691896|FG015|Treatment Period 4|Adverse Event|0|||
33316375|NCT01078623|62691897|FG016|Treatment Period 4|Adverse Event|0|||
33316376|NCT01078623|62691898|FG017|Treatment Period 4|Adverse Event|0|||
33316377|NCT01078623|62691899|FG018|Treatment Period 4|Adverse Event|0|||
33316378|NCT01078623|62691900|FG019|Treatment Period 4|Adverse Event|0|||
33316379|NCT01078623|62691881|FG000|Treatment Period 4|Withdrawal by Subject|0|||
33316380|NCT01078623|62691882|FG001|Treatment Period 4|Withdrawal by Subject|0|||
33316381|NCT01078623|62691883|FG002|Treatment Period 4|Withdrawal by Subject|0|||
33401958|NCT00645788|62780889|FG000|Overall Study|Withdrawal by Subject|0|||
33401959|NCT00645788|62780890|FG001|Overall Study|Withdrawal by Subject|1|||
33401960|NCT00645788|62780891|FG002|Overall Study|Withdrawal by Subject|0|||
33401961|NCT00645788|62780892|FG003|Overall Study|Withdrawal by Subject|2|||
33401962|NCT00645788|62780889|FG000|Overall Study|Pulmonary exacerbation|13|||
33597617|NCT01903252|62996533|FG000|Maintenance, Open-Label|Other|0|||
33597618|NCT01903252|62996534|FG001|Maintenance, Open-Label|Other|0|||
33597619|NCT01903252|62996535|FG002|Maintenance, Open-Label|Other|0|||
33713445|NCT00087594|63280669|FG000|Overall Study|Lack of Efficacy|2|||
33713446|NCT00087594|63280670|FG001|Overall Study|Lack of Efficacy|5|||
33713447|NCT00087516|63280679|FG000|Overall Study|Adverse Event|10|||
33713448|NCT00087516|63280680|FG001|Overall Study|Adverse Event|10|||
33713449|NCT00087516|63280681|FG002|Overall Study|Adverse Event|3|||
33713450|NCT00087516|63280682|FG003|Overall Study|Adverse Event|6|||
33713451|NCT00087516|63280679|FG000|Overall Study|Lack of Efficacy|82|||
33713452|NCT00087516|63280680|FG001|Overall Study|Lack of Efficacy|80|||
33713453|NCT00087516|63280681|FG002|Overall Study|Lack of Efficacy|39|||
33713454|NCT00087516|63280682|FG003|Overall Study|Lack of Efficacy|29|||
33713455|NCT00087516|63280679|FG000|Overall Study|Lost to Follow-up|8|||
33713456|NCT00087516|63280680|FG001|Overall Study|Lost to Follow-up|6|||
33713457|NCT00087516|63280681|FG002|Overall Study|Lost to Follow-up|5|||
33713458|NCT00087516|63280682|FG003|Overall Study|Lost to Follow-up|5|||
33713459|NCT00087516|63280679|FG000|Overall Study|Protocol Violation|4|||
33713460|NCT00087516|63280680|FG001|Overall Study|Protocol Violation|8|||
33713461|NCT00087516|63280681|FG002|Overall Study|Protocol Violation|3|||
33713462|NCT00087516|63280682|FG003|Overall Study|Protocol Violation|6|||
33713463|NCT00087516|63280679|FG000|Overall Study|Withdrawal by Subject|16|||
33713464|NCT00087516|63280680|FG001|Overall Study|Withdrawal by Subject|27|||
33316382|NCT01078623|62691884|FG003|Treatment Period 4|Withdrawal by Subject|0|||
33316383|NCT01078623|62691885|FG004|Treatment Period 4|Withdrawal by Subject|0|||
33316384|NCT01078623|62691886|FG005|Treatment Period 4|Withdrawal by Subject|0|||
33316385|NCT01078623|62691887|FG006|Treatment Period 4|Withdrawal by Subject|0|||
33316386|NCT01078623|62691888|FG007|Treatment Period 4|Withdrawal by Subject|0|||
33713465|NCT00087516|63280681|FG002|Overall Study|Withdrawal by Subject|11|||
33713466|NCT00087516|63280682|FG003|Overall Study|Withdrawal by Subject|12|||
33713467|NCT00087516|63280679|FG000|Overall Study|Site terminated|0|||
33316387|NCT01078623|62691889|FG008|Treatment Period 4|Withdrawal by Subject|0|||
33316388|NCT01078623|62691890|FG009|Treatment Period 4|Withdrawal by Subject|0|||
33316389|NCT01078623|62691891|FG010|Treatment Period 4|Withdrawal by Subject|0|||
33316390|NCT01078623|62691892|FG011|Treatment Period 4|Withdrawal by Subject|0|||
33316391|NCT01078623|62691893|FG012|Treatment Period 4|Withdrawal by Subject|0|||
33316392|NCT01078623|62691894|FG013|Treatment Period 4|Withdrawal by Subject|0|||
33316393|NCT01078623|62691895|FG014|Treatment Period 4|Withdrawal by Subject|0|||
33316394|NCT01078623|62691896|FG015|Treatment Period 4|Withdrawal by Subject|1|||
33316395|NCT01078623|62691897|FG016|Treatment Period 4|Withdrawal by Subject|0|||
33316396|NCT01078623|62691898|FG017|Treatment Period 4|Withdrawal by Subject|0|||
33316397|NCT01078623|62691899|FG018|Treatment Period 4|Withdrawal by Subject|0|||
33316398|NCT01078623|62691900|FG019|Treatment Period 4|Withdrawal by Subject|0|||
33316399|NCT01092507|62691914|FG000|Overall Study|Withdrawal by Subject|2|||
33316400|NCT01092507|62691915|FG001|Overall Study|Withdrawal by Subject|0|||
33316401|NCT01078545|62691921|FG000|Overall Study|Lost to Follow-up|13|||
33316402|NCT01078545|62691921|FG000|Overall Study|Physician Decision|6|||
33316403|NCT01078545|62691921|FG000|Overall Study|Withdrawal by Subject|3|||
33316404|NCT01078545|62691921|FG000|Overall Study|Death|3|||
33316405|NCT01078545|62691921|FG000|Overall Study|Participant moved to another physician|1|||
33316406|NCT01202760|62691928|FG000|Overall Study|Entry Criteria Not Met|0|||
33316407|NCT01202760|62691929|FG001|Overall Study|Entry Criteria Not Met|3|||
33316408|NCT01202760|62691930|FG002|Overall Study|Entry Criteria Not Met|1|||
33316409|NCT01202760|62691928|FG000|Overall Study|Adverse Event|11|||
33316410|NCT01202760|62691929|FG001|Overall Study|Adverse Event|9|||
33316411|NCT01202760|62691930|FG002|Overall Study|Adverse Event|10|||
33316412|NCT01202760|62691928|FG000|Overall Study|Death|2|||
33316413|NCT01202760|62691929|FG001|Overall Study|Death|1|||
33316414|NCT01202760|62691930|FG002|Overall Study|Death|0|||
33316415|NCT01202760|62691928|FG000|Overall Study|Lack of Efficacy|6|||
33316416|NCT01202760|62691929|FG001|Overall Study|Lack of Efficacy|8|||
33316417|NCT01202760|62691930|FG002|Overall Study|Lack of Efficacy|7|||
33316418|NCT01202760|62691928|FG000|Overall Study|Lost to Follow-up|0|||
33316419|NCT01202760|62691929|FG001|Overall Study|Lost to Follow-up|2|||
33316420|NCT01202760|62691930|FG002|Overall Study|Lost to Follow-up|1|||
33316421|NCT01202760|62691928|FG000|Overall Study|Parent / Caregiver Decision|0|||
33316422|NCT01202760|62691929|FG001|Overall Study|Parent / Caregiver Decision|1|||
33316423|NCT01202760|62691930|FG002|Overall Study|Parent / Caregiver Decision|0|||
33316424|NCT01202760|62691928|FG000|Overall Study|Withdrawal by Subject|17|||
33316425|NCT01202760|62691929|FG001|Overall Study|Withdrawal by Subject|18|||
33316426|NCT01202760|62691930|FG002|Overall Study|Withdrawal by Subject|14|||
33316427|NCT01202760|62691928|FG000|Overall Study|Physician Decision|0|||
33316428|NCT01202760|62691929|FG001|Overall Study|Physician Decision|1|||
33316429|NCT01202760|62691930|FG002|Overall Study|Physician Decision|0|||
33316430|NCT01202760|62691928|FG000|Overall Study|Protocol Violation|7|||
33316431|NCT01202760|62691929|FG001|Overall Study|Protocol Violation|5|||
33316432|NCT01202760|62691930|FG002|Overall Study|Protocol Violation|2|||
33316433|NCT01202760|62691928|FG000|Overall Study|Sponsor Decision|4|||
33316434|NCT01202760|62691929|FG001|Overall Study|Sponsor Decision|4|||
33316435|NCT01202760|62691930|FG002|Overall Study|Sponsor Decision|0|||
33316436|NCT01091259|62691950|FG000|Overall Study|Adverse Event|3|||
33316437|NCT01091259|62691950|FG000|Overall Study|Lack of Efficacy|2|||
33316438|NCT01091103|62691954|FG000|Overall Study|Adverse Event|1|||
33316439|NCT01091103|62691954|FG000|Overall Study|Progressive Disease|3|||
33316440|NCT01078389|62691962|FG000|Overall Study|Adverse Event|10|||
33597620|NCT01903252|62996536|FG003|Maintenance, Open-Label|Other|2|||
33713468|NCT00087516|63280680|FG001|Overall Study|Site terminated|2|||
33713469|NCT00087516|63280681|FG002|Overall Study|Site terminated|1|||
33713470|NCT00087516|63280682|FG003|Overall Study|Site terminated|0|||
33316441|NCT01078389|62691963|FG001|Overall Study|Adverse Event|6|||
33316442|NCT01078389|62691962|FG000|Overall Study|Major Protocol Deviation|2|||
33316443|NCT01078389|62691963|FG001|Overall Study|Major Protocol Deviation|0|||
33316444|NCT01078389|62691962|FG000|Overall Study|Lost to Follow-up|23|||
33316445|NCT01078389|62691963|FG001|Overall Study|Lost to Follow-up|23|||
33316446|NCT01078389|62691962|FG000|Overall Study|Voluntary Withdrawal|20|||
33316447|NCT01078389|62691963|FG001|Overall Study|Voluntary Withdrawal|36|||
33316448|NCT01078389|62691962|FG000|Overall Study|Other|9|||
33316449|NCT01078389|62691963|FG001|Overall Study|Other|2|||
33316450|NCT01090323|62691971|FG000|Overall Study|Adverse Event|12|||
33316451|NCT01090323|62691972|FG001|Overall Study|Adverse Event|2|||
33316452|NCT01090323|62691971|FG000|Overall Study|Abnormal Lab Values|3|||
33316453|NCT01090323|62691972|FG001|Overall Study|Abnormal Lab Values|1|||
33316454|NCT01090323|62691971|FG000|Overall Study|Abnormal Test Procedure Results|2|||
33316455|NCT01090323|62691972|FG001|Overall Study|Abnormal Test Procedure Results|0|||
33316456|NCT01090323|62691971|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33316457|NCT01090323|62691972|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33316458|NCT01090323|62691971|FG000|Overall Study|Condition no longer requires drug|5|||
33316459|NCT01090323|62691972|FG001|Overall Study|Condition no longer requires drug|4|||
33316460|NCT01090323|62691971|FG000|Overall Study|Protocol Violation|2|||
33316461|NCT01090323|62691972|FG001|Overall Study|Protocol Violation|1|||
33316462|NCT01090323|62691971|FG000|Overall Study|Withdrew consent|33|||
33316463|NCT01090323|62691972|FG001|Overall Study|Withdrew consent|11|||
33316464|NCT01090323|62691971|FG000|Overall Study|Lost to Follow-up|11|||
33401963|NCT00645788|62780890|FG001|Overall Study|Pulmonary exacerbation|16|||
33401964|NCT00645788|62780891|FG002|Overall Study|Pulmonary exacerbation|11|||
33401965|NCT00645788|62780892|FG003|Overall Study|Pulmonary exacerbation|9|||
33401966|NCT00642356|62780904|FG000|Overall Study|Adverse Event|1|||
33401967|NCT00642356|62780905|FG001|Overall Study|Adverse Event|0|||
33401968|NCT00642356|62780904|FG000|Overall Study|Protocol Violation|0|||
33401969|NCT00642356|62780905|FG001|Overall Study|Protocol Violation|3|||
33401970|NCT00642356|62780904|FG000|Overall Study|Lack of Efficacy|1|||
33316465|NCT01090323|62691972|FG001|Overall Study|Lost to Follow-up|6|||
33316466|NCT01090323|62691971|FG000|Overall Study|Administrative problems|6|||
33316467|NCT01090323|62691972|FG001|Overall Study|Administrative problems|4|||
33316468|NCT01090323|62691971|FG000|Overall Study|Death|1|||
33316469|NCT01090323|62691972|FG001|Overall Study|Death|2|||
33316470|NCT01090323|62691971|FG000|Overall Study|Stopped end of core|7|||
33316471|NCT01090323|62691972|FG001|Overall Study|Stopped end of core|0|||
33316472|NCT01090323|62691971|FG000|Overall Study|Stopped end of extension 1#|3|||
33316473|NCT01090323|62691972|FG001|Overall Study|Stopped end of extension 1#|1|||
33316474|NCT01078155|62691978|FG000|Overall Study|Adverse Event|7|||
33316475|NCT01078155|62691978|FG000|Overall Study|Lack of Efficacy|16|||
33316476|NCT01078155|62691978|FG000|Overall Study|Participant's Decision|6|||
33316477|NCT01078155|62691978|FG000|Overall Study|Lost to Follow-up|15|||
33316478|NCT01201356|62691982|FG000|Overall Study|Adverse Event|170|||
33316479|NCT01201356|62691982|FG000|Overall Study|Abnormal laboratory value(s)|51|||
33316480|NCT01201356|62691982|FG000|Overall Study|Abnormal test procedure result(s)|3|||
33316481|NCT01201356|62691982|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
33316482|NCT01201356|62691982|FG000|Overall Study|Condition no longer requires study drug|12|||
33316483|NCT01201356|62691982|FG000|Overall Study|Withdrawal by Subject|144|||
33316484|NCT01201356|62691982|FG000|Overall Study|Lost to Follow-up|50|||
33316485|NCT01201356|62691982|FG000|Overall Study|administrative problems|74|||
33316486|NCT01201356|62691982|FG000|Overall Study|Death|16|||
33316487|NCT01201356|62691982|FG000|Overall Study|Protocol Violation|12|||
33316488|NCT01200810|62691988|FG000|Overall Study|Physician Decision|1|||
33316489|NCT01200810|62691989|FG001|Overall Study|Physician Decision|0|||
33316490|NCT01200810|62691988|FG000|Overall Study|Withdrawal by Subject|1|||
33316491|NCT01200810|62691989|FG001|Overall Study|Withdrawal by Subject|2|||
33316492|NCT01200810|62691988|FG000|Overall Study|Sponsor stopped making study drug|3|||
33316493|NCT01200810|62691989|FG001|Overall Study|Sponsor stopped making study drug|3|||
33316494|NCT01200342|62691995|FG000|Overall Study|Disease Progression|1|||
33316495|NCT01199016|62691999|FG000|Overall Study|No longer meets eligibility criteria|4|||
33316496|NCT01199016|62691999|FG000|Overall Study|Entrance criteria|5|||
33316497|NCT01199016|62691999|FG000|Overall Study|Protocol Violation|9|||
33316498|NCT01199016|62691999|FG000|Overall Study|Other|13|||
33401971|NCT00642356|62780905|FG001|Overall Study|Lack of Efficacy|0|||
33401972|NCT00642278|62780918|FG000|Overall Study|Adverse Event|2|||
33713471|NCT00087516|63280679|FG000|Overall Study|Protocol specified discontinuation|35|||
33713472|NCT00087516|63280680|FG001|Overall Study|Protocol specified discontinuation|33|||
33713473|NCT00087516|63280681|FG002|Overall Study|Protocol specified discontinuation|33|||
33713474|NCT00087516|63280682|FG003|Overall Study|Protocol specified discontinuation|26|||
33713475|NCT00087516|63280679|FG000|Overall Study|Patient moved|3|||
33713476|NCT00087516|63280680|FG001|Overall Study|Patient moved|2|||
33713477|NCT00087516|63280681|FG002|Overall Study|Patient moved|1|||
33713478|NCT00087516|63280682|FG003|Overall Study|Patient moved|0|||
33713479|NCT00087516|63280679|FG000|Overall Study|Patient was non-compliant|3|||
33713480|NCT00087516|63280680|FG001|Overall Study|Patient was non-compliant|1|||
33713481|NCT00087516|63280681|FG002|Overall Study|Patient was non-compliant|0|||
33713482|NCT00087516|63280682|FG003|Overall Study|Patient was non-compliant|0|||
33713483|NCT00087516|63280679|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
33713484|NCT00087516|63280680|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
33316499|NCT01199016|62691999|FG000|Overall Study|Withdrawal by Subject|21|||
33316500|NCT01199016|62691999|FG000|Overall Study|Lost to Follow-up|25|||
33316501|NCT01198548|62692003|FG000|Overall Study|Disease Progression|9|||
33316502|NCT01198548|62692003|FG000|Overall Study|Administrative Decision|1|||
33316503|NCT01198470|62692007|FG000|Overall Study|Adverse Event|2|||
33316504|NCT00977938|62692015|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
33316505|NCT00977938|62692016|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
33316506|NCT00977938|62692017|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
33316507|NCT00977938|62692018|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
33316508|NCT00977938|62692015|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
33316509|NCT00977938|62692016|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
33316510|NCT00977938|62692017|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
33316511|NCT00977938|62692018|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
33316512|NCT00977938|62692015|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
33316513|NCT00977938|62692016|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
33316514|NCT00977938|62692017|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
33316515|NCT00977938|62692018|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
33316516|NCT00977938|62692015|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
33316517|NCT00977938|62692016|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
33316518|NCT00977938|62692017|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
33316519|NCT00977938|62692018|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
33316520|NCT00977938|62692015|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
33316521|NCT00977938|62692016|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
33316522|NCT00977938|62692017|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
33316523|NCT00977938|62692018|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
33316524|NCT00977938|62692015|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
33316525|NCT00977938|62692016|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
33316526|NCT00977938|62692017|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
33316527|NCT00977938|62692018|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
33316528|NCT02716675|62692033|FG000|Overall Study|Death|2|||
33316529|NCT02716675|62692034|FG001|Overall Study|Death|3|||
33316530|NCT02716675|62692035|FG002|Overall Study|Death|0|||
33316531|NCT02716675|62692033|FG000|Overall Study|Physician Decision|2|||
33316532|NCT02716675|62692034|FG001|Overall Study|Physician Decision|1|||
33316533|NCT02716675|62692035|FG002|Overall Study|Physician Decision|1|||
33316534|NCT02716675|62692033|FG000|Overall Study|Lost to Follow-up|100|||
33316535|NCT02716675|62692034|FG001|Overall Study|Lost to Follow-up|87|||
33316536|NCT02716675|62692035|FG002|Overall Study|Lost to Follow-up|99|||
33316537|NCT02716675|62692033|FG000|Overall Study|Withdrawal by Subject|22|||
33316538|NCT02716675|62692034|FG001|Overall Study|Withdrawal by Subject|25|||
33316539|NCT02716675|62692035|FG002|Overall Study|Withdrawal by Subject|20|||
33316540|NCT02716675|62692033|FG000|Overall Study|Protocol Violation|0|||
33316541|NCT02716675|62692034|FG001|Overall Study|Protocol Violation|3|||
33316542|NCT02716675|62692035|FG002|Overall Study|Protocol Violation|1|||
33316543|NCT02716675|62692033|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
33316544|NCT02716675|62692034|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
33316545|NCT02716675|62692035|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
33316546|NCT02716675|62692033|FG000|Overall Study|Other|38|||
33316547|NCT02716675|62692034|FG001|Overall Study|Other|47|||
33316548|NCT02716675|62692035|FG002|Overall Study|Other|48|||
33316549|NCT00977548|62692048|FG000|Overall Study|Ineligible|4|||
33316550|NCT00977548|62692048|FG000|Overall Study|Adverse Event|8|||
33316551|NCT00977548|62692048|FG000|Overall Study|Withdrawal by Subject|1|||
33316552|NCT01090011|62692052|FG000|Overall Study|Progressive disease|128|||
33316553|NCT01090011|62692052|FG000|Overall Study|Adverse Event|32|||
33316554|NCT01090011|62692052|FG000|Overall Study|Protocol Violation|1|||
33316555|NCT01090011|62692052|FG000|Overall Study|Refusal to start/continue medication|5|||
33316556|NCT01090011|62692052|FG000|Overall Study|Other reason not defined above|5|||
33316557|NCT01251653|62692073|FG000|Overall Study|Progressive Disease|1|||
33316558|NCT01251653|62692074|FG001|Overall Study|Progressive Disease|7|||
33316559|NCT01251653|62692075|FG002|Overall Study|Progressive Disease|16|||
33316560|NCT01251653|62692076|FG003|Overall Study|Progressive Disease|4|||
33316561|NCT01251653|62692077|FG004|Overall Study|Progressive Disease|0|||
33316562|NCT01251653|62692078|FG005|Overall Study|Progressive Disease|17|||
33316563|NCT01251653|62692079|FG006|Overall Study|Progressive Disease|14|||
33316564|NCT01251653|62692080|FG007|Overall Study|Progressive Disease|7|||
33316565|NCT01251653|62692081|FG008|Overall Study|Progressive Disease|5|||
33316566|NCT01251653|62692073|FG000|Overall Study|Dose-limiting toxicity|0|||
33316567|NCT01251653|62692074|FG001|Overall Study|Dose-limiting toxicity|1|||
33713485|NCT00087516|63280681|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
33316568|NCT01251653|62692075|FG002|Overall Study|Dose-limiting toxicity|1|||
33316569|NCT01251653|62692076|FG003|Overall Study|Dose-limiting toxicity|1|||
33713486|NCT00087516|63280682|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
33316570|NCT01251653|62692077|FG004|Overall Study|Dose-limiting toxicity|0|||
33316571|NCT01251653|62692078|FG005|Overall Study|Dose-limiting toxicity|0|||
33401973|NCT00642278|62780919|FG001|Overall Study|Adverse Event|1|||
33597621|NCT01903252|62996537|FG004|Maintenance, Open-Label|Other|6|||
33597622|NCT01903252|62996538|FG005|Maintenance, Open-Label|Other|2|||
33713487|NCT00087516|63280679|FG000|Overall Study|Other|0|||
33316572|NCT01251653|62692079|FG006|Overall Study|Dose-limiting toxicity|2|||
33316573|NCT01251653|62692080|FG007|Overall Study|Dose-limiting toxicity|0|||
33316574|NCT01251653|62692081|FG008|Overall Study|Dose-limiting toxicity|0|||
33316575|NCT01251653|62692073|FG000|Overall Study|Adverse Event|1|||
33316576|NCT01251653|62692074|FG001|Overall Study|Adverse Event|0|||
33316577|NCT01251653|62692075|FG002|Overall Study|Adverse Event|2|||
33316578|NCT01251653|62692076|FG003|Overall Study|Adverse Event|1|||
33316579|NCT01251653|62692077|FG004|Overall Study|Adverse Event|1|||
33316580|NCT01251653|62692078|FG005|Overall Study|Adverse Event|0|||
33316581|NCT01251653|62692079|FG006|Overall Study|Adverse Event|2|||
33316582|NCT01251653|62692080|FG007|Overall Study|Adverse Event|2|||
33316583|NCT01251653|62692081|FG008|Overall Study|Adverse Event|1|||
33316584|NCT01251653|62692073|FG000|Overall Study|Withdrawal by Subject|1|||
33316585|NCT01251653|62692074|FG001|Overall Study|Withdrawal by Subject|0|||
33316586|NCT01251653|62692075|FG002|Overall Study|Withdrawal by Subject|1|||
33316587|NCT01251653|62692076|FG003|Overall Study|Withdrawal by Subject|0|||
33316588|NCT01251653|62692077|FG004|Overall Study|Withdrawal by Subject|1|||
33316589|NCT01251653|62692078|FG005|Overall Study|Withdrawal by Subject|1|||
33316590|NCT01251653|62692079|FG006|Overall Study|Withdrawal by Subject|0|||
33316591|NCT01251653|62692080|FG007|Overall Study|Withdrawal by Subject|1|||
33316592|NCT01251653|62692081|FG008|Overall Study|Withdrawal by Subject|0|||
33316593|NCT01251653|62692073|FG000|Overall Study|Other reason not mentioned above|0|||
33713488|NCT00087516|63280680|FG001|Overall Study|Other|0|||
33316594|NCT01251653|62692074|FG001|Overall Study|Other reason not mentioned above|0|||
33316595|NCT01251653|62692075|FG002|Overall Study|Other reason not mentioned above|0|||
33316596|NCT01251653|62692076|FG003|Overall Study|Other reason not mentioned above|0|||
33316597|NCT01251653|62692077|FG004|Overall Study|Other reason not mentioned above|0|||
33316598|NCT01251653|62692078|FG005|Overall Study|Other reason not mentioned above|0|||
33316599|NCT01251653|62692079|FG006|Overall Study|Other reason not mentioned above|0|||
33316600|NCT01251653|62692080|FG007|Overall Study|Other reason not mentioned above|2|||
33316601|NCT01251653|62692081|FG008|Overall Study|Other reason not mentioned above|0|||
33316602|NCT00910663|62692119|FG000|Period 1|Withdrawal by Subject|0|||
33316603|NCT00910663|62692120|FG001|Period 1|Withdrawal by Subject|1|||
33316604|NCT01077375|62692128|FG000|Overall Study|Adverse Event|2|||
33316605|NCT01077375|62692129|FG001|Overall Study|Adverse Event|15|||
33316606|NCT01077375|62692128|FG000|Overall Study|Lack of Efficacy|6|||
33316607|NCT01077375|62692129|FG001|Overall Study|Lack of Efficacy|8|||
33316608|NCT01077375|62692128|FG000|Overall Study|Withdrawal by Subject|0|||
33316609|NCT01077375|62692129|FG001|Overall Study|Withdrawal by Subject|6|||
33713489|NCT00087516|63280681|FG002|Overall Study|Other|1|||
33713490|NCT00087516|63280682|FG003|Overall Study|Other|0|||
33713491|NCT00087126|63280696|FG000|Overall Study|Ineligible - second primary|1|||
33713492|NCT00087126|63280696|FG000|Overall Study|Never treated|1|||
33713493|NCT03490734|63280709|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
33713494|NCT03490734|63280710|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
33713495|NCT03490734|63280711|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
33713496|NCT03490734|63280712|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
33713497|NCT03490734|63280709|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
33713498|NCT03490734|63280710|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
33713499|NCT03490734|63280711|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
33713500|NCT03490734|63280712|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
33713501|NCT03490734|63280709|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
33713502|NCT03490734|63280710|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
33713503|NCT03490734|63280711|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
33713504|NCT03490734|63280712|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
33713505|NCT03490734|63280709|FG000|Post-intervention Scan Visit|Adverse Event|2|||
33713506|NCT03490734|63280710|FG001|Post-intervention Scan Visit|Adverse Event|0|||
33713507|NCT03490734|63280711|FG002|Post-intervention Scan Visit|Adverse Event|0|||
33713508|NCT03490734|63280712|FG003|Post-intervention Scan Visit|Adverse Event|0|||
33316610|NCT01077375|62692128|FG000|Overall Study|Lost to Follow-up|2|||
33316611|NCT01077375|62692129|FG001|Overall Study|Lost to Follow-up|5|||
33316612|NCT01077375|62692128|FG000|Overall Study|Other Reason|0|||
33316613|NCT01077375|62692129|FG001|Overall Study|Other Reason|1|||
33316614|NCT01250873|62692137|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
33316615|NCT01250873|62692137|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
33316616|NCT01250171|62692146|FG000|Overall Study|Administrative reasons|1|||
33316617|NCT01250171|62692147|FG001|Overall Study|Administrative reasons|0|||
33316618|NCT01250171|62692148|FG002|Overall Study|Administrative reasons|0|||
33713509|NCT03490734|63280709|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
33713510|NCT03490734|63280710|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
33713511|NCT03490734|63280711|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
33713512|NCT03490734|63280712|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
33316619|NCT01077063|62692158|FG000|Overall Study|Adverse Event|3|||
33316620|NCT01077063|62692159|FG001|Overall Study|Adverse Event|0|||
33316621|NCT01077063|62692158|FG000|Overall Study|Death|1|||
33316622|NCT01077063|62692159|FG001|Overall Study|Death|1|||
33713513|NCT03490734|63280709|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
33316623|NCT01077063|62692158|FG000|Overall Study|Withdrawal by Subject|0|||
33316624|NCT01077063|62692159|FG001|Overall Study|Withdrawal by Subject|2|||
33316625|NCT01248065|62692167|FG000|Overall Study|Lost to Follow-up|3|||
33316626|NCT01248065|62692168|FG001|Overall Study|Lost to Follow-up|5|||
33316627|NCT01248065|62692167|FG000|Overall Study|Withdrawal by Subject|14|||
33316628|NCT01248065|62692168|FG001|Overall Study|Withdrawal by Subject|11|||
33316629|NCT01248065|62692167|FG000|Overall Study|Adverse Event|3|||
33316630|NCT01248065|62692168|FG001|Overall Study|Adverse Event|0|||
33316631|NCT01248065|62692167|FG000|Overall Study|Third treatment failure event|3|||
33316632|NCT01248065|62692168|FG001|Overall Study|Third treatment failure event|1|||
33316633|NCT01248065|62692167|FG000|Overall Study|Other|3|||
33316634|NCT01248065|62692168|FG001|Overall Study|Other|5|||
33316635|NCT01250756|62692176|FG000|Infant Series|Withdrawal by Subject|4|||
33316636|NCT01250756|62692177|FG001|Infant Series|Withdrawal by Subject|5|||
33316637|NCT01250756|62692176|FG000|Infant Series|Randomized, Not Vaccinated|2|||
33316638|NCT01250756|62692177|FG001|Infant Series|Randomized, Not Vaccinated|2|||
33316639|NCT01250756|62692176|FG000|Infant Series|Other|22|||
33316640|NCT01250756|62692177|FG001|Infant Series|Other|0|||
33316641|NCT01250756|62692176|FG000|After Infant Series|Adverse Event|5|||
33316642|NCT01250756|62692177|FG001|After Infant Series|Adverse Event|2|||
33316643|NCT01250756|62692176|FG000|After Infant Series|Withdrawal by Subject|4|||
33316644|NCT01250756|62692177|FG001|After Infant Series|Withdrawal by Subject|1|||
33316645|NCT01250756|62692176|FG000|After Infant Series|Other|2|||
33316646|NCT01250756|62692177|FG001|After Infant Series|Other|1|||
33316647|NCT01250756|62692176|FG000|Toddler Dose|Adverse Event|0|||
33316648|NCT01250756|62692177|FG001|Toddler Dose|Adverse Event|1|||
33316649|NCT01250756|62692176|FG000|After Toddler Dose|Adverse Event|0|||
33316650|NCT01250756|62692177|FG001|After Toddler Dose|Adverse Event|1|||
33316651|NCT01250054|62692189|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
33316652|NCT01250054|62692190|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
33316653|NCT00977470|62692198|FG000|Overall Study|Lack of Efficacy|32|||
33316654|NCT00977470|62692199|FG001|Overall Study|Lack of Efficacy|30|||
33316655|NCT00977470|62692198|FG000|Overall Study|Physician Decision|2|||
33316656|NCT00977470|62692199|FG001|Overall Study|Physician Decision|0|||
33316657|NCT00977470|62692198|FG000|Overall Study|Adverse Event|1|||
33316658|NCT00977470|62692199|FG001|Overall Study|Adverse Event|2|||
33316659|NCT00977470|62692198|FG000|Overall Study|Protocol Violation|1|||
33316660|NCT00977470|62692199|FG001|Overall Study|Protocol Violation|0|||
33316661|NCT00977470|62692198|FG000|Overall Study|Withdrawal by Subject|0|||
33316662|NCT00977470|62692199|FG001|Overall Study|Withdrawal by Subject|2|||
33316663|NCT00977470|62692198|FG000|Overall Study|Death|0|||
33316664|NCT00977470|62692199|FG001|Overall Study|Death|2|||
33316665|NCT00977470|62692198|FG000|Overall Study|clinical decline|0|||
33316666|NCT00977470|62692199|FG001|Overall Study|clinical decline|1|||
33316667|NCT00977470|62692198|FG000|Overall Study|prolonged recovery post-surgery|0|||
33316668|NCT00977470|62692199|FG001|Overall Study|prolonged recovery post-surgery|1|||
33316669|NCT00977470|62692198|FG000|Overall Study|Still on-study|2|||
33316670|NCT00977470|62692199|FG001|Overall Study|Still on-study|0|||
33316671|NCT01245374|62692205|FG000|Overall Study|Protocol Violation|1|||
33713514|NCT03490734|63280710|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
33316672|NCT01245374|62692205|FG000|Overall Study|Withdrawal by Subject|3|||
33316673|NCT00977314|62692212|FG000|Overall Study|Withdrawal by Subject|1|||
33316674|NCT00977314|62692213|FG001|Overall Study|Withdrawal by Subject|0|||
33316675|NCT00977314|62692212|FG000|Overall Study|Physician Decision|1|||
33316676|NCT00977314|62692213|FG001|Overall Study|Physician Decision|0|||
33316677|NCT01087203|62692221|FG000|Overall Study|Lost to Follow-up|2|||
33713515|NCT03490734|63280711|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
33713516|NCT03490734|63280712|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
33713517|NCT00086346|63280723|FG000|Randomization|Did not receive test article|4|||
33713518|NCT00086346|63280724|FG001|Randomization|Did not receive test article|4|||
33713519|NCT00086346|63280723|FG000|Patients Dosed With Test Article|Adverse Event|94|||
33713520|NCT00086346|63280724|FG001|Patients Dosed With Test Article|Adverse Event|11|||
33713521|NCT00086346|63280723|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
33713522|NCT00086346|63280724|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
33713523|NCT00086346|63280723|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
33597623|NCT01920958|62996556|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
33713524|NCT00086346|63280724|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
33713525|NCT00086346|63280723|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
33316678|NCT01087203|62692222|FG001|Overall Study|Lost to Follow-up|0|||
33316679|NCT01087203|62692221|FG000|Overall Study|Withdrawal by Subject|2|||
33316680|NCT01087203|62692222|FG001|Overall Study|Withdrawal by Subject|6|||
33316681|NCT01087203|62692221|FG000|Overall Study|Lack of Efficacy|1|||
33316682|NCT01087203|62692222|FG001|Overall Study|Lack of Efficacy|2|||
33316683|NCT01087203|62692221|FG000|Overall Study|Study terminated by sponsor|27|||
33316684|NCT01087203|62692222|FG001|Overall Study|Study terminated by sponsor|27|||
33316685|NCT01246583|62692233|FG000|Overall Study|Lost to Follow-up|0|||
33713526|NCT00086346|63280724|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
33713527|NCT00086346|63280723|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
33713528|NCT00086346|63280724|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
33713529|NCT00086346|63280723|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
33713530|NCT00086346|63280724|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
33316686|NCT01246583|62692234|FG001|Overall Study|Lost to Follow-up|0|||
33316687|NCT01246583|62692235|FG002|Overall Study|Lost to Follow-up|0|||
33316688|NCT01246583|62692236|FG003|Overall Study|Lost to Follow-up|1|||
33316689|NCT01246583|62692233|FG000|Overall Study|Protocol Violation|0|||
33316690|NCT01246583|62692234|FG001|Overall Study|Protocol Violation|0|||
33316691|NCT01246583|62692235|FG002|Overall Study|Protocol Violation|1|||
33316692|NCT01246583|62692236|FG003|Overall Study|Protocol Violation|0|||
33316693|NCT01246583|62692233|FG000|Overall Study|Withdrawal by Subject|1|||
33316694|NCT01246583|62692234|FG001|Overall Study|Withdrawal by Subject|0|||
33316695|NCT01246583|62692235|FG002|Overall Study|Withdrawal by Subject|0|||
33316696|NCT01246583|62692236|FG003|Overall Study|Withdrawal by Subject|0|||
33316697|NCT01084239|62692249|FG000|28-Day Follow-up|Lost to Follow-up|4|||
33316698|NCT01084239|62692250|FG001|28-Day Follow-up|Lost to Follow-up|9|||
33316699|NCT01244906|62692258|FG000|Overall Study|Death|2|||
33316700|NCT01244906|62692258|FG000|Overall Study|Progression of disease post treatment|6|||
33316701|NCT01080807|62692264|FG000|Overall Study|Adverse Event|9|||
33316702|NCT01080807|62692265|FG001|Overall Study|Adverse Event|1|||
33316703|NCT01080807|62692264|FG000|Overall Study|Lack of Efficacy|0|||
33316704|NCT01080807|62692265|FG001|Overall Study|Lack of Efficacy|1|||
33316705|NCT01080807|62692264|FG000|Overall Study|Withdrawal by Subject|7|||
33316706|NCT01080807|62692265|FG001|Overall Study|Withdrawal by Subject|2|||
33316707|NCT01080807|62692264|FG000|Overall Study|Protocol Violation|7|||
33316708|NCT01080807|62692265|FG001|Overall Study|Protocol Violation|6|||
33316709|NCT01080807|62692264|FG000|Overall Study|Lost to Follow-up|6|||
33316710|NCT01080807|62692265|FG001|Overall Study|Lost to Follow-up|4|||
33316711|NCT01080807|62692264|FG000|Overall Study|Noncompliance with drug administration|1|||
33713531|NCT00085566|63280733|FG000|Overall Study|Adverse Event|0|||
33713532|NCT00085566|63280734|FG001|Overall Study|Adverse Event|0|||
33713533|NCT00085566|63280735|FG002|Overall Study|Adverse Event|10|||
33713534|NCT00085566|63280733|FG000|Overall Study|Patient Not treated|0|||
33713535|NCT00085566|63280734|FG001|Overall Study|Patient Not treated|0|||
33316712|NCT01080807|62692265|FG001|Overall Study|Noncompliance with drug administration|1|||
33316713|NCT01080807|62692264|FG000|Overall Study|Noncompliance to study procedures|1|||
33316714|NCT01080807|62692265|FG001|Overall Study|Noncompliance to study procedures|1|||
33316715|NCT01080807|62692264|FG000|Overall Study|Began working day shift|0|||
33316716|NCT01080807|62692265|FG001|Overall Study|Began working day shift|2|||
33316717|NCT01080807|62692264|FG000|Overall Study|Laid off or terminated from job|1|||
33316718|NCT01080807|62692265|FG001|Overall Study|Laid off or terminated from job|2|||
33316719|NCT01080807|62692264|FG000|Overall Study|Stopped working consistent night shifts|0|||
33316720|NCT01080807|62692265|FG001|Overall Study|Stopped working consistent night shifts|1|||
33316721|NCT01080807|62692264|FG000|Overall Study|Work schedule changing|1|||
33316722|NCT01080807|62692265|FG001|Overall Study|Work schedule changing|1|||
33316723|NCT01080807|62692264|FG000|Overall Study|Work schedule and travel|0|||
33316724|NCT01080807|62692265|FG001|Overall Study|Work schedule and travel|1|||
33316725|NCT01080807|62692264|FG000|Overall Study|Switched to first shift|1|||
33316726|NCT01080807|62692265|FG001|Overall Study|Switched to first shift|0|||
33316727|NCT01080807|62692264|FG000|Overall Study|Moved away without notifying center|1|||
33316728|NCT01080807|62692265|FG001|Overall Study|Moved away without notifying center|0|||
33316729|NCT01076361|62692271|FG000|Overall Study|22 leads were excluded from analysis|21|||
33316730|NCT01079949|62692277|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
33316731|NCT01079949|62692278|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
33316732|NCT01079949|62692277|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
33316733|NCT01079949|62692278|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
33316734|NCT01079949|62692277|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
33401974|NCT00642278|62780920|FG002|Overall Study|Adverse Event|3|||
33316735|NCT01079949|62692278|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
33316736|NCT01079949|62692277|FG000|Overall Study|Randomized but not treated|1|||
33316737|NCT01079949|62692278|FG001|Overall Study|Randomized but not treated|0|||
33316738|NCT00910429|62692286|FG000|Overall Study|Death|18|||
33316739|NCT00910429|62692287|FG001|Overall Study|Death|12|||
33316740|NCT00910429|62692286|FG000|Overall Study|Withdrawal by Subject|3|||
33316741|NCT00910429|62692287|FG001|Overall Study|Withdrawal by Subject|2|||
33316742|NCT00910429|62692286|FG000|Overall Study|Protocol Violation|1|||
33316743|NCT00910429|62692287|FG001|Overall Study|Protocol Violation|0|||
33316744|NCT00910429|62692286|FG000|Overall Study|Lost to Follow-up|2|||
33316745|NCT00910429|62692287|FG001|Overall Study|Lost to Follow-up|1|||
33316746|NCT00910429|62692286|FG000|Overall Study|Adverse Event|10|||
33316747|NCT00910429|62692287|FG001|Overall Study|Adverse Event|5|||
33316748|NCT00910429|62692286|FG000|Overall Study|Drug non-compliance|1|||
33316749|NCT00910429|62692287|FG001|Overall Study|Drug non-compliance|0|||
33316750|NCT00910429|62692286|FG000|Overall Study|Lack of Efficacy|4|||
33316751|NCT00910429|62692287|FG001|Overall Study|Lack of Efficacy|1|||
33316752|NCT00909727|62692295|FG000|Overall Study|Adverse Event|1|||
33316753|NCT00909727|62692296|FG001|Overall Study|Adverse Event|0|||
33316754|NCT00909727|62692295|FG000|Overall Study|Wrong Genotype|1|||
33316755|NCT00909727|62692296|FG001|Overall Study|Wrong Genotype|0|||
33316756|NCT00909727|62692295|FG000|Overall Study|Withdrawal of Consent|1|||
33316757|NCT00909727|62692296|FG001|Overall Study|Withdrawal of Consent|0|||
33316758|NCT00909727|62692295|FG000|Overall Study|Prohibited Medication|1|||
33316759|NCT00909727|62692296|FG001|Overall Study|Prohibited Medication|0|||
33316760|NCT00977080|62692306|FG000|Overall Study|Adverse Event|2|||
33316761|NCT00977080|62692307|FG001|Overall Study|Adverse Event|7|||
33316762|NCT00977080|62692308|FG002|Overall Study|Adverse Event|7|||
33316763|NCT00977080|62692309|FG003|Overall Study|Adverse Event|7|||
33316764|NCT00977080|62692306|FG000|Overall Study|Withdrawal by Subject|1|||
33316765|NCT00977080|62692307|FG001|Overall Study|Withdrawal by Subject|5|||
33316766|NCT00977080|62692308|FG002|Overall Study|Withdrawal by Subject|1|||
33316767|NCT00977080|62692309|FG003|Overall Study|Withdrawal by Subject|5|||
33316768|NCT00977080|62692306|FG000|Overall Study|Protocol Violation|7|||
33316769|NCT00977080|62692307|FG001|Overall Study|Protocol Violation|3|||
33316770|NCT00977080|62692308|FG002|Overall Study|Protocol Violation|4|||
33316771|NCT00977080|62692309|FG003|Overall Study|Protocol Violation|3|||
33316772|NCT00977080|62692306|FG000|Overall Study|Noncompliance|0|||
33316773|NCT00977080|62692307|FG001|Overall Study|Noncompliance|2|||
33316774|NCT00977080|62692308|FG002|Overall Study|Noncompliance|1|||
33316775|NCT00977080|62692309|FG003|Overall Study|Noncompliance|0|||
33316776|NCT00977080|62692306|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
33316777|NCT00977080|62692307|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
33316778|NCT00977080|62692308|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
33316779|NCT00977080|62692309|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
33316780|NCT00977080|62692306|FG000|Overall Study|Required kidney transplantation|1|||
33401975|NCT00642278|62780921|FG003|Overall Study|Adverse Event|1|||
33401976|NCT00642278|62780922|FG004|Overall Study|Adverse Event|2|||
33713536|NCT00085566|63280735|FG002|Overall Study|Patient Not treated|3|||
33713537|NCT00085566|63280733|FG000|Overall Study|Clinical progression|0|||
33713538|NCT00085566|63280734|FG001|Overall Study|Clinical progression|0|||
33713539|NCT00085566|63280735|FG002|Overall Study|Clinical progression|1|||
33713540|NCT00085098|63280745|FG000|Overall Study|Withdrawal by Subject|0|||
33713541|NCT00085098|63280746|FG001|Overall Study|Withdrawal by Subject|1|||
33713542|NCT00085098|63280745|FG000|Overall Study|Ineligible|1|||
33713543|NCT00085098|63280746|FG001|Overall Study|Ineligible|1|||
33713544|NCT00084864|63280759|FG000|Overall Study|Adverse Event|1|||
33713545|NCT00084864|63280760|FG001|Overall Study|Adverse Event|0|||
33713546|NCT00084864|63280761|FG002|Overall Study|Adverse Event|0|||
33713547|NCT00084864|63280762|FG003|Overall Study|Adverse Event|0|||
33713548|NCT00084318|63280774|FG000|Overall Study|Withdrawal by Subject|5|||
33713549|NCT00084318|63280775|FG001|Overall Study|Withdrawal by Subject|2|||
33713550|NCT00084318|63280774|FG000|Overall Study|Protocol Violation|15|||
33401977|NCT00642278|62780923|FG005|Overall Study|Adverse Event|2|||
33401978|NCT00642278|62780924|FG006|Overall Study|Adverse Event|0|||
33713551|NCT00084318|63280775|FG001|Overall Study|Protocol Violation|11|||
33713552|NCT00084318|63280774|FG000|Overall Study|No protocol treatment|2|||
33713553|NCT00084318|63280775|FG001|Overall Study|No protocol treatment|0|||
33713554|NCT00084084|63280783|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
33713555|NCT00084084|63280783|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
33713556|NCT00083616|63280788|FG000|Overall Study|Disease Progression|16|||
33713557|NCT00083616|63280788|FG000|Overall Study|Lost to Follow-up|1|||
33713558|NCT00083616|63280788|FG000|Overall Study|Physician Decision|2|||
33713559|NCT00083616|63280788|FG000|Overall Study|Withdrawal by Subject|3|||
33713560|NCT00083616|63280788|FG000|Overall Study|Ineligibility determined|2|||
33713561|NCT00083616|63280788|FG000|Overall Study|Non-compliance|1|||
33713562|NCT00083616|63280788|FG000|Overall Study|Other|6|||
33713563|NCT00083226|63280792|FG000|Overall Study|Lack of Efficacy|19|||
33713564|NCT00083226|63280792|FG000|Overall Study|Adverse Event|9|||
33713565|NCT00083226|63280792|FG000|Overall Study|Death|4|||
33713566|NCT00083226|63280792|FG000|Overall Study|Withdrawal by Subject|4|||
33713567|NCT00083226|63280792|FG000|Overall Study|Other|2|||
33713568|NCT00083226|63280792|FG000|Overall Study|ineligible or not receiving treatment|4|||
33713569|NCT00082758|63280799|FG000|Overall Study|Adverse Event|0|||
33713570|NCT00082758|63280800|FG001|Overall Study|Adverse Event|2|||
33713571|NCT00082758|63280801|FG002|Overall Study|Adverse Event|0|||
33713572|NCT00082758|63280799|FG000|Overall Study|Lack of Efficacy|12|||
33713573|NCT00082758|63280800|FG001|Overall Study|Lack of Efficacy|13|||
33713574|NCT00082758|63280801|FG002|Overall Study|Lack of Efficacy|0|||
33713575|NCT00082758|63280799|FG000|Overall Study|Physician Decision|0|||
33713576|NCT00082758|63280800|FG001|Overall Study|Physician Decision|1|||
33713577|NCT00082758|63280801|FG002|Overall Study|Physician Decision|0|||
33713578|NCT00082758|63280799|FG000|Overall Study|Withdrawal by Subject|3|||
33713579|NCT00082758|63280800|FG001|Overall Study|Withdrawal by Subject|0|||
33713580|NCT00082758|63280801|FG002|Overall Study|Withdrawal by Subject|0|||
33713581|NCT00082758|63280799|FG000|Overall Study|Protocol Violation|0|||
33713582|NCT00082758|63280800|FG001|Overall Study|Protocol Violation|1|||
33713583|NCT00082758|63280801|FG002|Overall Study|Protocol Violation|0|||
33713584|NCT00088452|63280812|FG000|Overall Study|Did not receive intervention|1|||
33713585|NCT00088452|63280813|FG001|Overall Study|Did not receive intervention|0|||
33713586|NCT00088452|63280814|FG002|Overall Study|Did not receive intervention|1|||
33713587|NCT04686084|63280904|FG000|Overall Study|Lost to Follow-up|1|||
33713588|NCT04685538|63280911|FG000|Overall Study|Adverse Event|0|||
33713589|NCT04685538|63280912|FG001|Overall Study|Adverse Event|1|||
33713590|NCT04685538|63280911|FG000|Overall Study|Lost to Follow-up|0|||
33713591|NCT04685538|63280912|FG001|Overall Study|Lost to Follow-up|2|||
33713592|NCT04213326|63280924|FG000|Overall Study|Consent withdrawn|51|||
33713593|NCT04213326|63280925|FG001|Overall Study|Consent withdrawn|241|||
33713594|NCT04213326|63280924|FG000|Overall Study|Lost to Follow-up|50|||
33713595|NCT04213326|63280925|FG001|Overall Study|Lost to Follow-up|902|||
33713596|NCT04213326|63280924|FG000|Overall Study|Protocol Violation|3|||
33713597|NCT04213326|63280925|FG001|Overall Study|Protocol Violation|25|||
33713598|NCT04213326|63280924|FG000|Overall Study|Participant eligibility changed|106|||
33713599|NCT04213326|63280925|FG001|Overall Study|Participant eligibility changed|19|||
33713600|NCT04213326|63280924|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
33713601|NCT04213326|63280925|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
33713602|NCT04213326|63280924|FG000|Overall Study|Incomplete study visit|0|||
33713603|NCT04213326|63280925|FG001|Overall Study|Incomplete study visit|367|||
33713604|NCT01625286|63280938|FG000|Overall Study|Adverse Event|0|||
33713605|NCT01625286|63280939|FG001|Overall Study|Adverse Event|0|||
33713606|NCT01625286|63280940|FG002|Overall Study|Adverse Event|0|||
33316781|NCT00977080|62692307|FG001|Overall Study|Required kidney transplantation|3|||
33316782|NCT00977080|62692308|FG002|Overall Study|Required kidney transplantation|3|||
33316783|NCT00977080|62692309|FG003|Overall Study|Required kidney transplantation|1|||
33316784|NCT00977080|62692306|FG000|Overall Study|Travel for family reasons|1|||
33316785|NCT00977080|62692307|FG001|Overall Study|Travel for family reasons|0|||
33316786|NCT00977080|62692308|FG002|Overall Study|Travel for family reasons|0|||
33713607|NCT01625286|63280941|FG003|Overall Study|Adverse Event|0|||
33713608|NCT01625286|63280942|FG004|Overall Study|Adverse Event|1|||
33713609|NCT01625286|63280943|FG005|Overall Study|Adverse Event|2|||
33713610|NCT01625286|63280944|FG006|Overall Study|Adverse Event|1|||
33713611|NCT01625286|63280938|FG000|Overall Study|Death|0|||
33713612|NCT01625286|63280939|FG001|Overall Study|Death|0|||
33713613|NCT01625286|63280940|FG002|Overall Study|Death|1|||
33713614|NCT01625286|63280941|FG003|Overall Study|Death|1|||
33713615|NCT01625286|63280942|FG004|Overall Study|Death|0|||
33713616|NCT01625286|63280943|FG005|Overall Study|Death|11|||
33713617|NCT01625286|63280944|FG006|Overall Study|Death|16|||
33713618|NCT01625286|63280938|FG000|Overall Study|Withdrawal by Subject|0|||
33713619|NCT01625286|63280939|FG001|Overall Study|Withdrawal by Subject|1|||
33713620|NCT01625286|63280940|FG002|Overall Study|Withdrawal by Subject|0|||
33713621|NCT01625286|63280941|FG003|Overall Study|Withdrawal by Subject|1|||
33316787|NCT00977080|62692309|FG003|Overall Study|Travel for family reasons|0|||
33316788|NCT00975676|62692321|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
33316789|NCT00975676|62692322|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
33316790|NCT00975286|62692335|FG000|Overall Study|Adverse Event|9|||
33316791|NCT00975286|62692336|FG001|Overall Study|Adverse Event|19|||
33316792|NCT00975286|62692335|FG000|Overall Study|Protocol Violation|1|||
33316793|NCT00975286|62692336|FG001|Overall Study|Protocol Violation|2|||
33316794|NCT00975286|62692335|FG000|Overall Study|Withdrawal by Subject|0|||
33316795|NCT00975286|62692336|FG001|Overall Study|Withdrawal by Subject|2|||
33316796|NCT00975286|62692335|FG000|Overall Study|Familial and Personal Reasons|2|||
33316797|NCT00975286|62692336|FG001|Overall Study|Familial and Personal Reasons|2|||
33316798|NCT00975286|62692335|FG000|Overall Study|Poor Compliance to Protocol|0|||
33316799|NCT00975286|62692336|FG001|Overall Study|Poor Compliance to Protocol|2|||
33316800|NCT00975286|62692335|FG000|Overall Study|Sponsor Decision|0|||
33316801|NCT00975286|62692336|FG001|Overall Study|Sponsor Decision|2|||
33713622|NCT01625286|63280942|FG004|Overall Study|Withdrawal by Subject|0|||
33713623|NCT01625286|63280943|FG005|Overall Study|Withdrawal by Subject|0|||
33713624|NCT01625286|63280944|FG006|Overall Study|Withdrawal by Subject|1|||
33713625|NCT01625286|63280938|FG000|Overall Study|Any reason not specifically recorded|0|||
33713626|NCT01625286|63280939|FG001|Overall Study|Any reason not specifically recorded|0|||
33713627|NCT01625286|63280940|FG002|Overall Study|Any reason not specifically recorded|0|||
33713628|NCT01625286|63280941|FG003|Overall Study|Any reason not specifically recorded|0|||
33713629|NCT01625286|63280942|FG004|Overall Study|Any reason not specifically recorded|0|||
33713630|NCT01625286|63280943|FG005|Overall Study|Any reason not specifically recorded|1|||
33713631|NCT01625286|63280944|FG006|Overall Study|Any reason not specifically recorded|0|||
33713632|NCT01625286|63280938|FG000|Overall Study|Progressive disease|6|||
33713633|NCT01625286|63280939|FG001|Overall Study|Progressive disease|3|||
33713634|NCT01625286|63280940|FG002|Overall Study|Progressive disease|4|||
33713635|NCT01625286|63280941|FG003|Overall Study|Progressive disease|5|||
33713636|NCT01625286|63280942|FG004|Overall Study|Progressive disease|5|||
33713637|NCT01625286|63280943|FG005|Overall Study|Progressive disease|0|||
33713638|NCT01625286|63280944|FG006|Overall Study|Progressive disease|0|||
33713639|NCT01625286|63280938|FG000|Overall Study|Lost to Follow-up|0|||
33713640|NCT01625286|63280939|FG001|Overall Study|Lost to Follow-up|0|||
33713641|NCT01625286|63280940|FG002|Overall Study|Lost to Follow-up|0|||
33713642|NCT01625286|63280941|FG003|Overall Study|Lost to Follow-up|0|||
33713643|NCT01625286|63280942|FG004|Overall Study|Lost to Follow-up|0|||
33713644|NCT01625286|63280943|FG005|Overall Study|Lost to Follow-up|0|||
33713645|NCT01625286|63280944|FG006|Overall Study|Lost to Follow-up|1|||
33713646|NCT04083222|63280989|FG000|Overall Study|Voluntary Withdrawal|0|||
33713647|NCT04083222|63280990|FG001|Overall Study|Voluntary Withdrawal|1|||
33713648|NCT04083222|63280989|FG000|Overall Study|Reason not Specified|0|||
33713649|NCT04083222|63280990|FG001|Overall Study|Reason not Specified|1|||
33713650|NCT03286842|63280996|FG000|Overall Study|Patients rolled over to another study|80|||
33713651|NCT03037476|63281004|FG000|Overall Study|Lost to Follow-up|63|||
33713652|NCT03037476|63281005|FG001|Overall Study|Lost to Follow-up|46|||
33713653|NCT00639678|63281020|FG000|Overall Study|Withdrawal by Subject|3|||
33713654|NCT00639678|63281021|FG001|Overall Study|Withdrawal by Subject|0|||
33713655|NCT00639678|63281022|FG002|Overall Study|Withdrawal by Subject|4|||
33713656|NCT00639678|63281023|FG003|Overall Study|Withdrawal by Subject|0|||
33713657|NCT00639678|63281020|FG000|Overall Study|Lost to Follow-up|1|||
33713658|NCT00639678|63281021|FG001|Overall Study|Lost to Follow-up|0|||
33713659|NCT00639678|63281022|FG002|Overall Study|Lost to Follow-up|6|||
33713660|NCT00639678|63281023|FG003|Overall Study|Lost to Follow-up|0|||
33713661|NCT00639678|63281020|FG000|Overall Study|Adverse Event|0|||
33713662|NCT00639678|63281021|FG001|Overall Study|Adverse Event|1|||
33713663|NCT00639678|63281022|FG002|Overall Study|Adverse Event|0|||
33713664|NCT00639678|63281023|FG003|Overall Study|Adverse Event|0|||
33713665|NCT00639678|63281020|FG000|Overall Study|Lack of Compliance|0|||
33316802|NCT00907777|62692344|FG000|Overall Study|Withdrawal by Subject|0|||
33316803|NCT00907777|62692345|FG001|Overall Study|Withdrawal by Subject|1|||
33316804|NCT00908011|62692353|FG000|Overall Study|Withdrawal by Subject|2|||
33316805|NCT00908011|62692354|FG001|Overall Study|Withdrawal by Subject|2|||
33316806|NCT00976456|62692362|FG000|Overall Study|Adverse Event|17|||
33316807|NCT00976456|62692363|FG001|Overall Study|Adverse Event|22|||
33316808|NCT00976456|62692362|FG000|Overall Study|Death|7|||
33316809|NCT00976456|62692363|FG001|Overall Study|Death|9|||
33316810|NCT00976456|62692362|FG000|Overall Study|Lack of Efficacy|5|||
33316811|NCT00976456|62692363|FG001|Overall Study|Lack of Efficacy|2|||
33316812|NCT00976456|62692362|FG000|Overall Study|Withdrawal by Subject|3|||
33316813|NCT00976456|62692363|FG001|Overall Study|Withdrawal by Subject|1|||
33316814|NCT00976456|62692362|FG000|Overall Study|screening failure, unknown|11|||
33316815|NCT00976456|62692363|FG001|Overall Study|screening failure, unknown|4|||
33316816|NCT01243151|62692374|FG000|Overall Study|Adverse Event|0|||
33316817|NCT01243151|62692375|FG001|Overall Study|Adverse Event|1|||
33316818|NCT01243151|62692376|FG002|Overall Study|Adverse Event|0|||
33316819|NCT01243151|62692377|FG003|Overall Study|Adverse Event|0|||
33316820|NCT01243151|62692378|FG004|Overall Study|Adverse Event|0|||
33316821|NCT01243151|62692374|FG000|Overall Study|Protocol Violation|0|||
33316822|NCT01243151|62692375|FG001|Overall Study|Protocol Violation|0|||
33316823|NCT01243151|62692376|FG002|Overall Study|Protocol Violation|1|||
33316824|NCT01243151|62692377|FG003|Overall Study|Protocol Violation|0|||
33316825|NCT01243151|62692378|FG004|Overall Study|Protocol Violation|0|||
33316826|NCT01243151|62692374|FG000|Overall Study|Other|0|||
33316827|NCT01243151|62692375|FG001|Overall Study|Other|0|||
33316828|NCT01243151|62692376|FG002|Overall Study|Other|0|||
33316829|NCT01243151|62692377|FG003|Overall Study|Other|1|||
33316830|NCT01243151|62692378|FG004|Overall Study|Other|0|||
33316831|NCT01243151|62692374|FG000|Overall Study|Randomized but not treated|0|||
33316832|NCT01243151|62692375|FG001|Overall Study|Randomized but not treated|0|||
33316833|NCT01243151|62692376|FG002|Overall Study|Randomized but not treated|0|||
33316834|NCT01243151|62692377|FG003|Overall Study|Randomized but not treated|1|||
33316835|NCT01243151|62692378|FG004|Overall Study|Randomized but not treated|0|||
33316836|NCT00993148|62692394|FG000|Overall Study|Lost to Follow-up|2|||
33316837|NCT00993148|62692394|FG000|Overall Study|never initiated treatment|1|||
33316838|NCT00907621|62692400|FG000|Overall Study|Lost to Follow-up|6|||
33316839|NCT00907621|62692401|FG001|Overall Study|Lost to Follow-up|3|||
33316840|NCT00907621|62692400|FG000|Overall Study|intercurrent febrile illness|1|||
33316841|NCT00907621|62692401|FG001|Overall Study|intercurrent febrile illness|1|||
33316842|NCT00907153|62692420|FG000|Overall Study|Lost to Follow-up|1|||
33316843|NCT00907153|62692421|FG001|Overall Study|Lost to Follow-up|1|||
33316844|NCT00907153|62692420|FG000|Overall Study|Withdrawal by Subject|1|||
33316845|NCT00907153|62692421|FG001|Overall Study|Withdrawal by Subject|3|||
33316846|NCT00904033|62692431|FG000|Overall Study|Withdrawal by Subject|1|||
33316847|NCT00904033|62692432|FG001|Overall Study|Withdrawal by Subject|1|||
33316848|NCT00904033|62692433|FG002|Overall Study|Withdrawal by Subject|0|||
33316849|NCT00904033|62692434|FG003|Overall Study|Withdrawal by Subject|0|||
33316850|NCT00904033|62692431|FG000|Overall Study|Physician Decision|0|||
33316851|NCT00904033|62692432|FG001|Overall Study|Physician Decision|0|||
33316852|NCT00904033|62692433|FG002|Overall Study|Physician Decision|1|||
33316853|NCT00904033|62692434|FG003|Overall Study|Physician Decision|0|||
33316854|NCT00904033|62692431|FG000|Overall Study|Unable to obtain final blood draw|0|||
33316855|NCT00904033|62692432|FG001|Overall Study|Unable to obtain final blood draw|0|||
33316856|NCT00904033|62692433|FG002|Overall Study|Unable to obtain final blood draw|0|||
33316857|NCT00904033|62692434|FG003|Overall Study|Unable to obtain final blood draw|2|||
33316858|NCT00903877|62692445|FG000|Overall Study|Did not meet study criteria|33|||
33316859|NCT00903877|62692445|FG000|Overall Study|Withdrawal by Subject|3|||
33316860|NCT00903877|62692445|FG000|Overall Study|Adverse Event|2|||
33316861|NCT00903877|62692445|FG000|Overall Study|Lost to Follow-up|1|||
33316862|NCT00903877|62692445|FG000|Overall Study|Participation put on hold|4|||
33316863|NCT01241591|62692453|FG000|Overall Study|Lack of Efficacy|5|||
33316864|NCT01241591|62692454|FG001|Overall Study|Lack of Efficacy|2|||
33316865|NCT01241591|62692455|FG002|Overall Study|Lack of Efficacy|2|||
33316866|NCT01241591|62692456|FG003|Overall Study|Lack of Efficacy|3|||
33316867|NCT01241591|62692453|FG000|Overall Study|Protocol Violation|5|||
33316868|NCT01241591|62692454|FG001|Overall Study|Protocol Violation|2|||
33401979|NCT00642278|62780918|FG000|Overall Study|Lack of Efficacy|0|||
33316869|NCT01241591|62692455|FG002|Overall Study|Protocol Violation|3|||
33316870|NCT01241591|62692456|FG003|Overall Study|Protocol Violation|0|||
33316871|NCT01241591|62692453|FG000|Overall Study|Lost to Follow-up|1|||
33316872|NCT01241591|62692454|FG001|Overall Study|Lost to Follow-up|2|||
33401980|NCT00642278|62780919|FG001|Overall Study|Lack of Efficacy|1|||
33316873|NCT01241591|62692455|FG002|Overall Study|Lost to Follow-up|2|||
33316874|NCT01241591|62692456|FG003|Overall Study|Lost to Follow-up|2|||
33316875|NCT01241591|62692453|FG000|Overall Study|Screen Failure|3|||
33316876|NCT01241591|62692454|FG001|Overall Study|Screen Failure|2|||
33316877|NCT01241591|62692455|FG002|Overall Study|Screen Failure|1|||
33316878|NCT01241591|62692456|FG003|Overall Study|Screen Failure|0|||
33316879|NCT01241591|62692453|FG000|Overall Study|Withdrawal by Subject|6|||
33316880|NCT01241591|62692454|FG001|Overall Study|Withdrawal by Subject|4|||
33316881|NCT01241591|62692455|FG002|Overall Study|Withdrawal by Subject|2|||
33316882|NCT01241591|62692456|FG003|Overall Study|Withdrawal by Subject|2|||
33316883|NCT01241591|62692453|FG000|Overall Study|Other|0|||
33316884|NCT01241591|62692454|FG001|Overall Study|Other|1|||
33316885|NCT01241591|62692455|FG002|Overall Study|Other|0|||
33316886|NCT01241591|62692456|FG003|Overall Study|Other|1|||
33316887|NCT01241591|62692453|FG000|Overall Study|Adverse Event|3|||
33316888|NCT01241591|62692454|FG001|Overall Study|Adverse Event|11|||
33713666|NCT00639678|63281021|FG001|Overall Study|Lack of Compliance|0|||
33713667|NCT00639678|63281022|FG002|Overall Study|Lack of Compliance|1|||
33713668|NCT00639678|63281023|FG003|Overall Study|Lack of Compliance|0|||
33713669|NCT00638508|63281048|FG000|Overall Study|Physician Decision|5|||
33713670|NCT00638508|63281049|FG001|Overall Study|Physician Decision|2|||
33713671|NCT00637806|63281062|FG000|Double-blind Phase|Study Discontinued|2|||
33713672|NCT00637806|63281063|FG001|Double-blind Phase|Study Discontinued|0|||
33713673|NCT00637806|63281064|FG002|Double-blind Phase|Study Discontinued|1|||
33713674|NCT00637806|63281065|FG003|Double-blind Phase|Study Discontinued|0|||
33713675|NCT00637806|63281062|FG000|Extension Phase|Study Discontinued|0|||
33713676|NCT00637806|63281063|FG001|Extension Phase|Study Discontinued|0|||
33713677|NCT00637806|63281064|FG002|Extension Phase|Study Discontinued|0|||
33713678|NCT00637806|63281065|FG003|Extension Phase|Study Discontinued|1|||
33713679|NCT00637728|63281076|FG000|Double-blind Phase|Adverse Event|1|||
33713680|NCT00637728|63281077|FG001|Double-blind Phase|Adverse Event|0|||
33713681|NCT00637728|63281078|FG002|Double-blind Phase|Adverse Event|0|||
33316889|NCT01241591|62692455|FG002|Overall Study|Adverse Event|12|||
33316890|NCT01241591|62692456|FG003|Overall Study|Adverse Event|4|||
33316891|NCT00906373|62692468|FG000|Overall Study|Withdrawal by Subject|0|||
33316892|NCT00906373|62692469|FG001|Overall Study|Withdrawal by Subject|5|||
33316893|NCT00906373|62692468|FG000|Overall Study|Other|0|||
33316894|NCT00906373|62692469|FG001|Overall Study|Other|1|||
33316895|NCT00906373|62692468|FG000|Overall Study|Still on treatment at cutoff date|0|||
33316896|NCT00906373|62692469|FG001|Overall Study|Still on treatment at cutoff date|2|||
33316897|NCT00905437|62692482|FG000|Overall Study|Adverse Event|3|||
33316898|NCT00905437|62692483|FG001|Overall Study|Adverse Event|2|||
33316899|NCT00905437|62692482|FG000|Overall Study|Lost to Follow-up|0|||
33316900|NCT00905437|62692483|FG001|Overall Study|Lost to Follow-up|1|||
33316901|NCT00905437|62692482|FG000|Overall Study|Withdrawal by Subject|0|||
33316902|NCT00905437|62692483|FG001|Overall Study|Withdrawal by Subject|1|||
33316903|NCT00905437|62692482|FG000|Overall Study|Other|5|||
33316904|NCT00905437|62692483|FG001|Overall Study|Other|6|||
33316905|NCT01238861|62692495|FG000|Overall Study|Lost to Follow-up|4|||
33316906|NCT01238861|62692496|FG001|Overall Study|Lost to Follow-up|2|||
33316907|NCT01238861|62692497|FG002|Overall Study|Lost to Follow-up|3|||
33316908|NCT01238861|62692498|FG003|Overall Study|Lost to Follow-up|1|||
33316909|NCT01238861|62692499|FG004|Overall Study|Lost to Follow-up|1|||
33316910|NCT01238861|62692500|FG005|Overall Study|Lost to Follow-up|2|||
33316911|NCT01238861|62692495|FG000|Overall Study|Unplanned surgery|1|||
33316912|NCT01238861|62692496|FG001|Overall Study|Unplanned surgery|0|||
33316913|NCT01238861|62692497|FG002|Overall Study|Unplanned surgery|0|||
33316914|NCT01238861|62692498|FG003|Overall Study|Unplanned surgery|0|||
33316915|NCT01238861|62692499|FG004|Overall Study|Unplanned surgery|0|||
33316916|NCT01238861|62692500|FG005|Overall Study|Unplanned surgery|0|||
33316917|NCT01238861|62692495|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
33316918|NCT01238861|62692496|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
33316919|NCT01238861|62692497|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
33316920|NCT01238861|62692498|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
33316921|NCT01238861|62692499|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
33316922|NCT01238861|62692500|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
33316923|NCT01238861|62692495|FG000|Overall Study|Incorrect enrollment/randomization|0|||
33713682|NCT00637728|63281076|FG000|Double-blind Phase|Non-compliance|2|||
33713683|NCT00637728|63281077|FG001|Double-blind Phase|Non-compliance|0|||
33713684|NCT00637728|63281078|FG002|Double-blind Phase|Non-compliance|0|||
33316924|NCT01238861|62692496|FG001|Overall Study|Incorrect enrollment/randomization|0|||
33316925|NCT01238861|62692497|FG002|Overall Study|Incorrect enrollment/randomization|1|||
33316926|NCT01238861|62692498|FG003|Overall Study|Incorrect enrollment/randomization|0|||
33316927|NCT01238861|62692499|FG004|Overall Study|Incorrect enrollment/randomization|1|||
33316928|NCT01238861|62692500|FG005|Overall Study|Incorrect enrollment/randomization|0|||
33316929|NCT01238861|62692495|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
33493845|NCT03535194|62872383|FG000|Post-Treatment Followup Period|Adverse Event|4|||
33597624|NCT01613716|62996560|FG000|Overall Study|screen failures|3|||
33713685|NCT00637728|63281076|FG000|Double-blind Phase|Study Discontinued|1|||
33713686|NCT00637728|63281077|FG001|Double-blind Phase|Study Discontinued|1|||
33316930|NCT01238861|62692496|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
33316931|NCT01238861|62692497|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
33713687|NCT00637728|63281078|FG002|Double-blind Phase|Study Discontinued|0|||
33316932|NCT01238861|62692498|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
33316933|NCT01238861|62692499|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
33316934|NCT01238861|62692500|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
33316935|NCT01238861|62692495|FG000|Overall Study|Subject moved out of state/area|0|||
33316936|NCT01238861|62692496|FG001|Overall Study|Subject moved out of state/area|0|||
33316937|NCT01238861|62692497|FG002|Overall Study|Subject moved out of state/area|1|||
33316938|NCT01238861|62692498|FG003|Overall Study|Subject moved out of state/area|1|||
33316939|NCT01238861|62692499|FG004|Overall Study|Subject moved out of state/area|0|||
33316940|NCT01238861|62692500|FG005|Overall Study|Subject moved out of state/area|0|||
33316941|NCT01238861|62692495|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
33316942|NCT01238861|62692496|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
33316943|NCT01238861|62692497|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
33316944|NCT01238861|62692498|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
33316945|NCT01238861|62692499|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
33316946|NCT01238861|62692500|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
33316947|NCT01238861|62692495|FG000|Overall Study|Personal problems|0|||
33316948|NCT01238861|62692496|FG001|Overall Study|Personal problems|0|||
33316949|NCT01238861|62692497|FG002|Overall Study|Personal problems|0|||
33316950|NCT01238861|62692498|FG003|Overall Study|Personal problems|1|||
33316951|NCT01238861|62692499|FG004|Overall Study|Personal problems|0|||
33316952|NCT01238861|62692500|FG005|Overall Study|Personal problems|0|||
33316953|NCT01238861|62692495|FG000|Overall Study|Unable to continue visits|0|||
33316954|NCT01238861|62692496|FG001|Overall Study|Unable to continue visits|0|||
33316955|NCT01238861|62692497|FG002|Overall Study|Unable to continue visits|0|||
33316956|NCT01238861|62692498|FG003|Overall Study|Unable to continue visits|1|||
33316957|NCT01238861|62692499|FG004|Overall Study|Unable to continue visits|0|||
33316958|NCT01238861|62692500|FG005|Overall Study|Unable to continue visits|1|||
33316959|NCT01238861|62692495|FG000|Overall Study|Serious adverse event|0|||
33316960|NCT01238861|62692496|FG001|Overall Study|Serious adverse event|0|||
33316961|NCT01238861|62692497|FG002|Overall Study|Serious adverse event|0|||
33316962|NCT01238861|62692498|FG003|Overall Study|Serious adverse event|0|||
33316963|NCT01238861|62692499|FG004|Overall Study|Serious adverse event|0|||
33316964|NCT01238861|62692500|FG005|Overall Study|Serious adverse event|1|||
33316965|NCT01238861|62692495|FG000|Overall Study|Lack of compliance|0|||
33316966|NCT01238861|62692496|FG001|Overall Study|Lack of compliance|0|||
33316967|NCT01238861|62692497|FG002|Overall Study|Lack of compliance|0|||
33316968|NCT01238861|62692498|FG003|Overall Study|Lack of compliance|0|||
33316969|NCT01238861|62692499|FG004|Overall Study|Lack of compliance|0|||
33316970|NCT01238861|62692500|FG005|Overall Study|Lack of compliance|1|||
33316971|NCT01238861|62692495|FG000|Overall Study|Adverse Event|0|||
33316972|NCT01238861|62692496|FG001|Overall Study|Adverse Event|1|||
33316973|NCT01238861|62692497|FG002|Overall Study|Adverse Event|0|||
33316974|NCT01238861|62692498|FG003|Overall Study|Adverse Event|0|||
33316975|NCT01238861|62692499|FG004|Overall Study|Adverse Event|0|||
33713688|NCT00637572|63281087|FG000|Overall Study|Adverse Event|1|||
33713689|NCT00637572|63281088|FG001|Overall Study|Adverse Event|2|||
33713690|NCT00637572|63281087|FG000|Overall Study|Death|0|||
33713691|NCT00637572|63281088|FG001|Overall Study|Death|1|||
33713692|NCT00637572|63281087|FG000|Overall Study|Lost to Follow-up|0|||
33713693|NCT00637572|63281088|FG001|Overall Study|Lost to Follow-up|1|||
33713694|NCT00637572|63281087|FG000|Overall Study|Physician Decision|1|||
33713695|NCT00637572|63281088|FG001|Overall Study|Physician Decision|1|||
33713696|NCT00637572|63281087|FG000|Overall Study|Withdrawal by Subject|0|||
33713697|NCT00637572|63281088|FG001|Overall Study|Withdrawal by Subject|2|||
33713698|NCT00637572|63281087|FG000|Overall Study|Illicit Drug Use|1|||
33316976|NCT01238861|62692500|FG005|Overall Study|Adverse Event|0|||
33316977|NCT01238861|62692495|FG000|Overall Study|Withdrawal by Subject|6|||
33316978|NCT01238861|62692496|FG001|Overall Study|Withdrawal by Subject|5|||
33316979|NCT01238861|62692497|FG002|Overall Study|Withdrawal by Subject|4|||
33316980|NCT01238861|62692498|FG003|Overall Study|Withdrawal by Subject|8|||
33316981|NCT01238861|62692499|FG004|Overall Study|Withdrawal by Subject|10|||
33316982|NCT01238861|62692500|FG005|Overall Study|Withdrawal by Subject|9|||
33316983|NCT00903409|62692523|FG000|Overall Study|Adverse Event|11|||
33316984|NCT00903409|62692524|FG001|Overall Study|Adverse Event|9|||
33316985|NCT00903409|62692523|FG000|Overall Study|Non-compliance with Protocol|1|||
33713699|NCT00637572|63281088|FG001|Overall Study|Illicit Drug Use|0|||
33713700|NCT00637416|63281096|FG000|Overall Study|Lost to Follow-up|1|||
33316986|NCT00903409|62692524|FG001|Overall Study|Non-compliance with Protocol|1|||
33316987|NCT00903409|62692523|FG000|Overall Study|Laboratory Abnormality|2|||
33316988|NCT00903409|62692524|FG001|Overall Study|Laboratory Abnormality|0|||
33316989|NCT00903409|62692523|FG000|Overall Study|Withdrawal by Subject|8|||
33316990|NCT00903409|62692524|FG001|Overall Study|Withdrawal by Subject|8|||
33316991|NCT00903409|62692523|FG000|Overall Study|Other|2|||
33316992|NCT00903409|62692524|FG001|Overall Study|Other|3|||
33713701|NCT00637416|63281097|FG001|Overall Study|Lost to Follow-up|1|||
33316993|NCT00903409|62692523|FG000|Overall Study|Lost to Follow-up|2|||
33316994|NCT00903409|62692524|FG001|Overall Study|Lost to Follow-up|6|||
33316995|NCT01237223|62692538|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
33316996|NCT01237223|62692539|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
33316997|NCT01237223|62692540|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
33316998|NCT01237223|62692541|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
33316999|NCT01237223|62692542|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
33317000|NCT01237223|62692543|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
33317001|NCT01237223|62692538|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
33317002|NCT01237223|62692539|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
33317003|NCT01237223|62692540|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
33317004|NCT01237223|62692541|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
33317005|NCT01237223|62692542|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
33317006|NCT01237223|62692543|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
33317007|NCT01237223|62692538|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
33317008|NCT01237223|62692539|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
33317009|NCT01237223|62692540|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
33317010|NCT01237223|62692541|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
33317011|NCT01237223|62692542|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
33317012|NCT01237223|62692543|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
33317013|NCT01237223|62692538|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
33317014|NCT01237223|62692539|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
33317015|NCT01237223|62692540|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
33317016|NCT01237223|62692541|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
33317017|NCT01237223|62692542|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
33317018|NCT01237223|62692543|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
33317019|NCT01237223|62692538|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
33317020|NCT01237223|62692539|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
33317021|NCT01237223|62692540|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
33317022|NCT01237223|62692541|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
33317023|NCT01237223|62692542|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
33317024|NCT01237223|62692543|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
33317025|NCT01237223|62692538|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
33317026|NCT01237223|62692539|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
33317027|NCT01237223|62692540|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
33317028|NCT01237223|62692541|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
33317029|NCT01237223|62692542|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
33317030|NCT01237223|62692543|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
33317031|NCT01237223|62692538|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
33317032|NCT01237223|62692539|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
33317033|NCT01237223|62692540|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
33713702|NCT00637416|63281096|FG000|Overall Study|Unable to take study drug|0|||
33713703|NCT00637416|63281097|FG001|Overall Study|Unable to take study drug|1|||
33713704|NCT00636792|63281103|FG000|Overall Study|Adverse Event|16|||
33713705|NCT00636792|63281103|FG000|Overall Study|Physician Decision|7|||
33713706|NCT00636792|63281103|FG000|Overall Study|Progressive Disease|4|||
33713707|NCT00636792|63281103|FG000|Overall Study|Withdrawal by Subject|3|||
33713708|NCT00636792|63281103|FG000|Overall Study|Other|3|||
33713709|NCT00636636|63281135|FG000|Overall Study|Other reason|4|||
33713710|NCT00636636|63281136|FG001|Overall Study|Other reason|6|||
33713711|NCT00636636|63281135|FG000|Overall Study|Adverse Event|19|||
33713712|NCT00636636|63281136|FG001|Overall Study|Adverse Event|8|||
33713713|NCT00636636|63281135|FG000|Overall Study|Lack of Efficacy|7|||
33317034|NCT01237223|62692541|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
33401981|NCT00642278|62780920|FG002|Overall Study|Lack of Efficacy|0|||
33401982|NCT00642278|62780921|FG003|Overall Study|Lack of Efficacy|0|||
33493846|NCT03535194|62872384|FG001|Post-Treatment Followup Period|Adverse Event|5|||
33597625|NCT01613716|62996560|FG000|Overall Study|Lost to Follow-up|4|||
33597626|NCT01872910|62996570|FG000|Overall Study|Lost to Follow-up|2|||
33597627|NCT01872910|62996571|FG001|Overall Study|Lost to Follow-up|0|||
33597628|NCT01872910|62996572|FG002|Overall Study|Lost to Follow-up|2|||
33597629|NCT01872910|62996573|FG003|Overall Study|Lost to Follow-up|0|||
33597630|NCT01872910|62996574|FG004|Overall Study|Lost to Follow-up|0|||
33597631|NCT01872910|62996575|FG005|Overall Study|Lost to Follow-up|0|||
33597632|NCT01920568|62996590|FG000|Overall Study|Adverse Event|27|||
33597633|NCT01920568|62996591|FG001|Overall Study|Adverse Event|8|||
33713714|NCT00636636|63281136|FG001|Overall Study|Lack of Efficacy|12|||
33713715|NCT00636636|63281135|FG000|Overall Study|Protocol Violation|2|||
33713716|NCT00636636|63281136|FG001|Overall Study|Protocol Violation|2|||
33597634|NCT01920568|62996590|FG000|Overall Study|Protocol Violation|5|||
33597635|NCT01920568|62996591|FG001|Overall Study|Protocol Violation|3|||
33597636|NCT01920568|62996590|FG000|Overall Study|Lost to Follow-up|2|||
33597637|NCT01920568|62996591|FG001|Overall Study|Lost to Follow-up|2|||
33597638|NCT01920568|62996590|FG000|Overall Study|Physician Decision|13|||
33597639|NCT01920568|62996591|FG001|Overall Study|Physician Decision|4|||
33597640|NCT01920568|62996590|FG000|Overall Study|Withdrawal by Subject|79|||
33597641|NCT01920568|62996591|FG001|Overall Study|Withdrawal by Subject|55|||
33597642|NCT01920568|62996590|FG000|Overall Study|Death due to disease progression|25|||
33317035|NCT01237223|62692542|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
33317036|NCT01237223|62692543|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
33317037|NCT01237223|62692538|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
33317038|NCT01237223|62692539|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
33317039|NCT01237223|62692540|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
33317040|NCT01237223|62692541|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
33317041|NCT01237223|62692542|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
33317042|NCT01237223|62692543|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
33317043|NCT01237223|62692538|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
33317044|NCT01237223|62692539|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
33317045|NCT01237223|62692540|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
33317046|NCT01237223|62692541|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
33317047|NCT01237223|62692542|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
33317048|NCT01237223|62692543|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
33317049|NCT01237223|62692538|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
33317050|NCT01237223|62692539|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
33317051|NCT01237223|62692540|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
33317052|NCT01237223|62692541|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
33317053|NCT01237223|62692542|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
33317054|NCT01237223|62692543|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
33317055|NCT01236755|62692559|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
33317056|NCT01236755|62692559|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
33317057|NCT01236755|62692559|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
33317058|NCT01236755|62692559|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
33317059|NCT01236365|62692566|FG000|Overall Study|Lost to Follow-up|0|||
33317060|NCT01236365|62692567|FG001|Overall Study|Lost to Follow-up|2|||
33317061|NCT01236365|62692566|FG000|Overall Study|Moved Out of State|1|||
33317062|NCT01236365|62692567|FG001|Overall Study|Moved Out of State|0|||
33317063|NCT01236365|62692566|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
33317064|NCT01236365|62692567|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
33317065|NCT01235975|62692587|FG000|Overall Study|Serious Adverse Event|0|||
33317066|NCT01235975|62692588|FG001|Overall Study|Serious Adverse Event|1|||
33317067|NCT01235975|62692587|FG000|Overall Study|Withdrawal by Subject|8|||
33317068|NCT01235975|62692588|FG001|Overall Study|Withdrawal by Subject|2|||
33317069|NCT01235975|62692587|FG000|Overall Study|Migrated/moved from study area|2|||
33317070|NCT01235975|62692588|FG001|Overall Study|Migrated/moved from study area|1|||
33317071|NCT01235975|62692587|FG000|Overall Study|Lost to Follow-up|7|||
33317072|NCT01235975|62692588|FG001|Overall Study|Lost to Follow-up|3|||
33317073|NCT00903331|62692596|FG000|Overall Study|Death|4|||
33317074|NCT00903331|62692597|FG001|Overall Study|Death|8|||
33317075|NCT00903331|62692596|FG000|Overall Study|Withdrawal of consent|1|||
33317076|NCT00903331|62692597|FG001|Overall Study|Withdrawal of consent|8|||
33317077|NCT00903331|62692596|FG000|Overall Study|Lung transplant|0|||
33317078|NCT00903331|62692597|FG001|Overall Study|Lung transplant|2|||
33317079|NCT01235741|62692606|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
33317080|NCT01235741|62692607|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
33317081|NCT01235741|62692608|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
33317082|NCT01235741|62692606|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
33317083|NCT01235741|62692607|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
33317084|NCT01235741|62692608|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
33317085|NCT01235741|62692606|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
33317086|NCT01235741|62692607|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
33317087|NCT01235741|62692608|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
33317088|NCT01235741|62692606|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
33401983|NCT00642278|62780922|FG004|Overall Study|Lack of Efficacy|0|||
33597643|NCT01920568|62996591|FG001|Overall Study|Death due to disease progression|12|||
33597644|NCT01902628|62996598|FG000|Overall Study|Withdrawal of participant's consent|7|||
33597645|NCT01902628|62996598|FG000|Overall Study|Adverse Event|41|||
33597646|NCT01902628|62996598|FG000|Overall Study|Lost to Follow-up|35|||
33597647|NCT01920178|62996604|FG000|Overall Study|Lost to Follow-up|2|||
33317089|NCT01235741|62692607|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
33317090|NCT01235741|62692608|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
33317091|NCT01235741|62692606|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
33317092|NCT01235741|62692607|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
33317093|NCT01235741|62692608|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
33317094|NCT01235741|62692606|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
33317095|NCT01235741|62692607|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
33317096|NCT01235741|62692608|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
33317097|NCT01235741|62692606|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
33317098|NCT01235741|62692607|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
33317099|NCT01235741|62692608|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
33317100|NCT01235741|62692606|FG000|Randomized to Treatment|Adverse Event|0|||
33317101|NCT01235741|62692607|FG001|Randomized to Treatment|Adverse Event|1|||
33317102|NCT01235741|62692608|FG002|Randomized to Treatment|Adverse Event|1|||
33317103|NCT01235741|62692606|FG000|Randomized to Treatment|Sponsor terminated study|0|||
33317104|NCT01235741|62692607|FG001|Randomized to Treatment|Sponsor terminated study|35|||
33317105|NCT01235741|62692608|FG002|Randomized to Treatment|Sponsor terminated study|34|||
33317106|NCT01235741|62692606|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
33317107|NCT01235741|62692607|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
33317108|NCT01235741|62692608|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
33317109|NCT01235741|62692606|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
33317110|NCT01235741|62692607|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
33317111|NCT01235741|62692608|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
33317112|NCT01235741|62692606|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
33317113|NCT01235741|62692607|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
33317114|NCT01235741|62692608|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
33317115|NCT01235507|62692620|FG000|Overall Study|Adverse Event|1|||
33317116|NCT01235507|62692620|FG000|Overall Study|Withdrawal by Subject|1|||
33317117|NCT01235351|62692626|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
33317118|NCT01235351|62692627|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
33317119|NCT01076205|62692637|FG000|Overall Study|Adverse Drug Reaction|299|||
33317120|NCT01076205|62692637|FG000|Overall Study|Lack of Effectiveness|1423|||
33317121|NCT01076205|62692637|FG000|Overall Study|Other Reason|1075|||
33317122|NCT01076205|62692637|FG000|Overall Study|Unknown Reason|71|||
33317123|NCT01076205|62692637|FG000|Overall Study|Lost to Follow-up|3151|||
33317124|NCT01234883|62692659|FG000|Overall Study|Early treatment release|8|||
33317125|NCT01234883|62692660|FG001|Overall Study|Early treatment release|10|||
33317126|NCT01234883|62692659|FG000|Overall Study|Parent/guardian withdrew consent|1|||
33317127|NCT01234883|62692660|FG001|Overall Study|Parent/guardian withdrew consent|2|||
33317128|NCT01234883|62692659|FG000|Overall Study|Technical difficulties with IV infusion|0|||
33317129|NCT01234883|62692660|FG001|Overall Study|Technical difficulties with IV infusion|1|||
33317130|NCT01234883|62692659|FG000|Overall Study|Inclusion/exclusion failure|1|||
33317131|NCT01234883|62692660|FG001|Overall Study|Inclusion/exclusion failure|0|||
33317132|NCT01234649|62692668|FG000|Overall Study|Withdrawal by Subject|32|||
33317133|NCT01234649|62692669|FG001|Overall Study|Withdrawal by Subject|26|||
33317134|NCT01234649|62692668|FG000|Overall Study|Pregnancy|6|||
33317135|NCT01234649|62692669|FG001|Overall Study|Pregnancy|6|||
33713717|NCT00636636|63281135|FG000|Overall Study|Lost to Follow-up|0|||
33713718|NCT00636636|63281136|FG001|Overall Study|Lost to Follow-up|1|||
33713719|NCT00636636|63281135|FG000|Overall Study|Death|0|||
33713720|NCT00636636|63281136|FG001|Overall Study|Death|1|||
33317136|NCT01234649|62692668|FG000|Overall Study|intolerant to side effects|4|||
33317137|NCT01234649|62692669|FG001|Overall Study|intolerant to side effects|3|||
33317138|NCT01234649|62692668|FG000|Overall Study|Allergic reaction|1|||
33317139|NCT01234649|62692669|FG001|Overall Study|Allergic reaction|0|||
33317140|NCT01234649|62692668|FG000|Overall Study|Lack of Efficacy|0|||
33317141|NCT01234649|62692669|FG001|Overall Study|Lack of Efficacy|3|||
33317142|NCT01075815|62692677|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
33317143|NCT01075815|62692678|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
33317144|NCT01075815|62692677|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
33317145|NCT01075815|62692678|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
33317146|NCT01075815|62692677|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
33317147|NCT01075815|62692678|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
33317148|NCT01075191|62692684|FG000|Overall Study|Death|1|||
33317149|NCT01075191|62692684|FG000|Overall Study|Intensification|3|||
33317150|NCT01075191|62692684|FG000|Overall Study|Co-morbidities|1|||
33317151|NCT01075191|62692684|FG000|Overall Study|Adverse Event|4|||
33317152|NCT01075191|62692684|FG000|Overall Study|Noncompliance|3|||
33317153|NCT01075191|62692684|FG000|Overall Study|Therapy Break|3|||
33317154|NCT01075191|62692684|FG000|Overall Study|Patient's Wish|2|||
33713721|NCT00636636|63281135|FG000|Overall Study|Withdrawal by Subject|4|||
33713722|NCT00636636|63281136|FG001|Overall Study|Withdrawal by Subject|9|||
33317155|NCT01075191|62692684|FG000|Overall Study|Unknown Reasons|1|||
33317156|NCT00905359|62692690|FG000|Overall Study|Lost to Follow-up|17|||
33317157|NCT00905359|62692691|FG001|Overall Study|Lost to Follow-up|10|||
33317158|NCT00905359|62692690|FG000|Overall Study|Death|2|||
33317159|NCT00905359|62692691|FG001|Overall Study|Death|0|||
33317160|NCT00905359|62692690|FG000|Overall Study|Withdrawal consent|5|||
33317161|NCT00905359|62692691|FG001|Overall Study|Withdrawal consent|6|||
33317162|NCT01072149|62692697|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317163|NCT01072149|62692698|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317164|NCT01072149|62692699|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
33317165|NCT01072149|62692700|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317166|NCT01072149|62692701|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317167|NCT01072149|62692702|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317168|NCT01072149|62692703|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317169|NCT01072149|62692704|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317170|NCT01072149|62692705|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317171|NCT01072149|62692706|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317172|NCT01072149|62692707|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317173|NCT01072149|62692708|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317174|NCT01072149|62692709|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317175|NCT01072149|62692710|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317176|NCT01072149|62692711|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317177|NCT01072149|62692712|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317178|NCT01072149|62692713|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317179|NCT01072149|62692714|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33317180|NCT01072149|62692697|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317181|NCT01072149|62692698|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317182|NCT01072149|62692699|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317183|NCT01072149|62692700|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317184|NCT01072149|62692701|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317185|NCT01072149|62692702|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317186|NCT01072149|62692703|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317187|NCT01072149|62692704|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317188|NCT01072149|62692705|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317189|NCT01072149|62692706|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317190|NCT01072149|62692707|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317191|NCT01072149|62692708|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33713723|NCT00635778|63281149|FG000|Overall Study|Adverse Event|1|||
33713724|NCT00635778|63281150|FG001|Overall Study|Adverse Event|0|||
33713725|NCT00635778|63281151|FG002|Overall Study|Adverse Event|0|||
33713726|NCT00635778|63281152|FG003|Overall Study|Adverse Event|3|||
33713727|NCT00635778|63281153|FG004|Overall Study|Adverse Event|3|||
33713728|NCT00635778|63281154|FG005|Overall Study|Adverse Event|6|||
33713729|NCT00635778|63281155|FG006|Overall Study|Adverse Event|1|||
33713730|NCT00635778|63281149|FG000|Overall Study|Withdrawal by Subject|0|||
33713731|NCT00635778|63281150|FG001|Overall Study|Withdrawal by Subject|0|||
33713732|NCT00635778|63281151|FG002|Overall Study|Withdrawal by Subject|0|||
33713733|NCT00635778|63281152|FG003|Overall Study|Withdrawal by Subject|1|||
33713734|NCT00635778|63281153|FG004|Overall Study|Withdrawal by Subject|0|||
33713735|NCT00635778|63281154|FG005|Overall Study|Withdrawal by Subject|1|||
33713736|NCT00635778|63281155|FG006|Overall Study|Withdrawal by Subject|1|||
33713737|NCT00635778|63281149|FG000|Overall Study|Progressive disease|0|||
33713738|NCT00635778|63281150|FG001|Overall Study|Progressive disease|3|||
33713739|NCT00635778|63281151|FG002|Overall Study|Progressive disease|3|||
33713740|NCT00635778|63281152|FG003|Overall Study|Progressive disease|4|||
33713741|NCT00635778|63281153|FG004|Overall Study|Progressive disease|5|||
33713742|NCT00635778|63281154|FG005|Overall Study|Progressive disease|14|||
33713743|NCT00635778|63281155|FG006|Overall Study|Progressive disease|4|||
33713744|NCT00634920|63281175|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
33713745|NCT00634920|63281176|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
33713746|NCT00634920|63281177|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
33713747|NCT00634920|63281175|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
33317192|NCT01072149|62692709|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317193|NCT01072149|62692710|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317194|NCT01072149|62692711|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317195|NCT01072149|62692712|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317196|NCT01072149|62692713|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33317197|NCT01072149|62692714|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
33713748|NCT00634920|63281176|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
33713749|NCT00634920|63281177|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
33713750|NCT00634920|63281175|FG000|Period 1 - Pre-Randomization|Rejections|0|||
33713751|NCT00634920|63281176|FG001|Period 1 - Pre-Randomization|Rejections|0|||
33713752|NCT00634920|63281177|FG002|Period 1 - Pre-Randomization|Rejections|55|||
33713753|NCT00634920|63281175|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
33713754|NCT00634920|63281176|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
33713755|NCT00634920|63281177|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
33713756|NCT00634920|63281175|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
33713757|NCT00634920|63281176|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
33713758|NCT00634920|63281177|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
33713759|NCT00634920|63281175|FG000|Period 1 - Pre-Randomization|Other issues|0|||
33713760|NCT00634920|63281176|FG001|Period 1 - Pre-Randomization|Other issues|0|||
33713761|NCT00634920|63281177|FG002|Period 1 - Pre-Randomization|Other issues|6|||
33713762|NCT00634920|63281175|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
33713763|NCT00634920|63281176|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
33713764|NCT00634920|63281177|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
33713765|NCT00634920|63281175|FG000|Period 2 - Post-Randomization|Rejection|11|||
33713766|NCT00634920|63281176|FG001|Period 2 - Post-Randomization|Rejection|5|||
33713767|NCT00634920|63281177|FG002|Period 2 - Post-Randomization|Rejection|0|||
33713768|NCT00634920|63281175|FG000|Period 2 - Post-Randomization|Death|2|||
33713769|NCT00634920|63281176|FG001|Period 2 - Post-Randomization|Death|5|||
33713770|NCT00634920|63281177|FG002|Period 2 - Post-Randomization|Death|0|||
33713771|NCT00634920|63281175|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
33713772|NCT00634920|63281176|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
33713773|NCT00634920|63281177|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
33713774|NCT00634920|63281175|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
33713775|NCT00634920|63281176|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
33713776|NCT00634920|63281177|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
33713777|NCT00634842|63281185|FG000|Overall Study|Adverse Event|2|||
33713778|NCT00634842|63281186|FG001|Overall Study|Adverse Event|3|||
33713779|NCT00634842|63281185|FG000|Overall Study|Protocol Violation|8|||
33713780|NCT00634842|63281186|FG001|Overall Study|Protocol Violation|4|||
33713781|NCT00634842|63281185|FG000|Overall Study|Move to another state|1|||
33713782|NCT00634842|63281186|FG001|Overall Study|Move to another state|0|||
33713783|NCT00634842|63281185|FG000|Overall Study|Inclusion criteria were not met|1|||
33713784|NCT00634842|63281186|FG001|Overall Study|Inclusion criteria were not met|0|||
33713785|NCT00634842|63281185|FG000|Overall Study|Lost to Follow-up|1|||
33713786|NCT00634842|63281186|FG001|Overall Study|Lost to Follow-up|2|||
33713787|NCT00634842|63281185|FG000|Overall Study|Physician Decision|1|||
33713788|NCT00634842|63281186|FG001|Overall Study|Physician Decision|0|||
33713789|NCT00634842|63281185|FG000|Overall Study|Withdrawal by Subject|1|||
33713790|NCT00634842|63281186|FG001|Overall Study|Withdrawal by Subject|3|||
33713791|NCT00634842|63281185|FG000|Overall Study|Lack of time and intolerance to drug|0|||
33713792|NCT00634842|63281186|FG001|Overall Study|Lack of time and intolerance to drug|1|||
33713793|NCT00634842|63281185|FG000|Overall Study|Discontinued due to injection|0|||
33713794|NCT00634842|63281186|FG001|Overall Study|Discontinued due to injection|2|||
33713795|NCT00634842|63281185|FG000|Overall Study|No need of study drug to treat diabetes|0|||
33713796|NCT00634842|63281186|FG001|Overall Study|No need of study drug to treat diabetes|1|||
33317198|NCT01072149|62692697|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317199|NCT01072149|62692698|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317200|NCT01072149|62692699|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317201|NCT01072149|62692700|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317202|NCT01072149|62692701|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317203|NCT01072149|62692702|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317204|NCT01072149|62692703|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317205|NCT01072149|62692704|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317206|NCT01072149|62692705|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317207|NCT01072149|62692706|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317208|NCT01072149|62692707|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
33317209|NCT01072149|62692708|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317210|NCT01072149|62692709|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317211|NCT01072149|62692710|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317212|NCT01072149|62692711|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33713797|NCT00634842|63281185|FG000|Overall Study|No wish to keep taking Avandia|0|||
33713798|NCT00634842|63281186|FG001|Overall Study|No wish to keep taking Avandia|1|||
33317213|NCT01072149|62692712|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317214|NCT01072149|62692713|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317215|NCT01072149|62692714|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33317216|NCT01072149|62692697|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33713799|NCT00634842|63281185|FG000|Overall Study|Subject off study drug for too long|0|||
33713800|NCT00634842|63281186|FG001|Overall Study|Subject off study drug for too long|1|||
33713801|NCT00633984|63281194|FG000|Overall Study|Lost to Follow-up|0|||
33713802|NCT00633984|63281195|FG001|Overall Study|Lost to Follow-up|6|||
33713803|NCT00633984|63281194|FG000|Overall Study|Withdrawal by Subject|8|||
33317217|NCT01072149|62692698|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
33317218|NCT01072149|62692699|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33317219|NCT01072149|62692700|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33317220|NCT01072149|62692701|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33317221|NCT01072149|62692702|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33317222|NCT01072149|62692703|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33317223|NCT01072149|62692704|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33317224|NCT01072149|62692705|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33317225|NCT01072149|62692706|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33317226|NCT01072149|62692707|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33317227|NCT01072149|62692708|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33317228|NCT01072149|62692709|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33317229|NCT01072149|62692710|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33713804|NCT00633984|63281195|FG001|Overall Study|Withdrawal by Subject|7|||
33713805|NCT00633984|63281194|FG000|Overall Study|Hospitalized|1|||
33713806|NCT00633984|63281195|FG001|Overall Study|Hospitalized|0|||
33713807|NCT01921218|63281223|FG000|Overall Study|Death|2|||
33713808|NCT01921218|63281224|FG001|Overall Study|Death|1|||
33713809|NCT01921218|63281223|FG000|Overall Study|Withdrawal by Subject|0|||
33713810|NCT01921218|63281224|FG001|Overall Study|Withdrawal by Subject|2|||
33713811|NCT01921218|63281223|FG000|Overall Study|Kidney transplant|1|||
33713812|NCT01921218|63281224|FG001|Overall Study|Kidney transplant|1|||
33713813|NCT00633750|63281230|FG000|Overall Study|Adverse Event|2|||
33713814|NCT00633750|63281230|FG000|Overall Study|Withdrawal by Subject|3|||
33713815|NCT00633360|63281238|FG000|Overall Study|Lost to Follow-up|1|||
33713816|NCT00633360|63281239|FG001|Overall Study|Lost to Follow-up|1|||
33713817|NCT00633360|63281238|FG000|Overall Study|Adverse Event|3|||
33713818|NCT00633360|63281239|FG001|Overall Study|Adverse Event|1|||
33713819|NCT00633360|63281238|FG000|Overall Study|Protocol Violation|0|||
33713820|NCT00633360|63281239|FG001|Overall Study|Protocol Violation|1|||
33713821|NCT00633126|63281247|FG000|Overall Study|Did not receive full dose|1|||
33713822|NCT00989664|63281251|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
33713823|NCT00989664|63281251|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
33713824|NCT00989664|63281251|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
33713825|NCT00989664|63281251|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
33713826|NCT00989664|63281251|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
33713827|NCT00989664|63281251|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
33713828|NCT00989664|63281251|FG000|Long-Term Follow-Up|Death|3|||
33713829|NCT00632736|63281257|FG000|Overall Study|Adverse Event|104|||
33713830|NCT00632736|63281257|FG000|Overall Study|Lost to Follow-up|15|||
33713831|NCT00632736|63281257|FG000|Overall Study|Protocol Violation|14|||
33713832|NCT00632736|63281257|FG000|Overall Study|Withdrawal by Subject|99|||
33713833|NCT00632736|63281257|FG000|Overall Study|Lack of Efficacy|5|||
33713834|NCT00632736|63281257|FG000|Overall Study|Sponsor terminated study|5|||
33713835|NCT00632736|63281257|FG000|Overall Study|Non-compliance|10|||
33713836|NCT00632736|63281257|FG000|Overall Study|Other|16|||
33713837|NCT00989196|63281261|FG000|Treatment Period|Lost to Follow-up|1|||
33713838|NCT00989196|63281262|FG001|Treatment Period|Lost to Follow-up|0|||
33713839|NCT00632502|63281270|FG000|Overall Study|Adverse Event|0|||
33713840|NCT00632502|63281271|FG001|Overall Study|Adverse Event|1|||
33713841|NCT00632502|63281270|FG000|Overall Study|Randomized not treated|3|||
33317230|NCT01072149|62692711|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33317231|NCT01072149|62692712|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33317232|NCT01072149|62692713|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33317233|NCT01072149|62692714|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33317234|NCT01072149|62692697|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317235|NCT01072149|62692698|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317236|NCT01072149|62692699|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
33317237|NCT01072149|62692700|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317238|NCT01072149|62692701|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317239|NCT01072149|62692702|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317240|NCT01072149|62692703|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317241|NCT01072149|62692704|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317242|NCT01072149|62692705|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33493847|NCT03535194|62872385|FG002|Post-Treatment Followup Period|Adverse Event|1|||
33713842|NCT00632502|63281271|FG001|Overall Study|Randomized not treated|0|||
33713843|NCT00632424|63281281|FG000|Overall Study|Disease Progression|17|||
33713844|NCT00632424|63281281|FG000|Overall Study|Study Drug Toxicity|1|||
33713845|NCT00631488|63281298|FG000|Overall Study|Adverse Event|1|||
33713846|NCT00631488|63281299|FG001|Overall Study|Adverse Event|0|||
33713847|NCT00631488|63281300|FG002|Overall Study|Adverse Event|0|||
33317243|NCT01072149|62692706|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317244|NCT01072149|62692707|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317245|NCT01072149|62692708|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317246|NCT01072149|62692709|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317247|NCT01072149|62692710|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317248|NCT01072149|62692711|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317249|NCT01072149|62692712|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317250|NCT01072149|62692713|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317251|NCT01072149|62692714|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33317252|NCT01072149|62692697|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
33317253|NCT01072149|62692698|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
33317254|NCT01072149|62692699|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
33317255|NCT01072149|62692700|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
33713848|NCT00631488|63281298|FG000|Overall Study|Lost to Follow-up|2|||
33713849|NCT00631488|63281299|FG001|Overall Study|Lost to Follow-up|2|||
33713850|NCT00631488|63281300|FG002|Overall Study|Lost to Follow-up|0|||
33713851|NCT00631488|63281298|FG000|Overall Study|Physician Decision|1|||
33713852|NCT00631488|63281299|FG001|Overall Study|Physician Decision|0|||
33713853|NCT00631488|63281300|FG002|Overall Study|Physician Decision|1|||
33713854|NCT00631488|63281298|FG000|Overall Study|Protocol Violation|0|||
33713855|NCT00631488|63281299|FG001|Overall Study|Protocol Violation|0|||
33713856|NCT00631488|63281300|FG002|Overall Study|Protocol Violation|1|||
33713857|NCT00988884|63281310|FG000|Overall Study|Adverse Event|0|||
33713858|NCT00988884|63281311|FG001|Overall Study|Adverse Event|1|||
33713859|NCT00988884|63281310|FG000|Overall Study|Lost to Follow-up|20|||
33713860|NCT00988884|63281311|FG001|Overall Study|Lost to Follow-up|16|||
33713861|NCT00988884|63281310|FG000|Overall Study|Protocol Violation|0|||
33713862|NCT00988884|63281311|FG001|Overall Study|Protocol Violation|1|||
33713863|NCT00988884|63281310|FG000|Overall Study|Withdrawal by Subject|15|||
33713864|NCT00988884|63281311|FG001|Overall Study|Withdrawal by Subject|18|||
33713865|NCT00631020|63281317|FG000|Overall Study|Lost to Follow-up|7|||
33713866|NCT00631020|63281317|FG000|Overall Study|Incarcerated|1|||
33713867|NCT00987402|63281323|FG000|Overall Study|Insufficient data entry|86|||
33713868|NCT00987402|63281324|FG001|Overall Study|Insufficient data entry|98|||
33713869|NCT00630864|63281330|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
33713870|NCT00630864|63281330|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
33713871|NCT00630786|63281337|FG000|Overall Study|Physician Decision|0|||
33713872|NCT00630786|63281338|FG001|Overall Study|Physician Decision|0|||
33713873|NCT00630786|63281339|FG002|Overall Study|Physician Decision|1|||
33713874|NCT00630786|63281337|FG000|Overall Study|Withdrawal by Subject|0|||
33713875|NCT00630786|63281338|FG001|Overall Study|Withdrawal by Subject|1|||
33713876|NCT00630786|63281339|FG002|Overall Study|Withdrawal by Subject|1|||
33713877|NCT00630786|63281337|FG000|Overall Study|Lost to Follow-up|0|||
33713878|NCT00630786|63281338|FG001|Overall Study|Lost to Follow-up|1|||
33713879|NCT00630786|63281339|FG002|Overall Study|Lost to Follow-up|0|||
33713880|NCT00630786|63281337|FG000|Overall Study|Other|1|||
33713881|NCT00630786|63281338|FG001|Overall Study|Other|0|||
33713882|NCT00630786|63281339|FG002|Overall Study|Other|0|||
33713883|NCT00630396|63281345|FG000|Overall Study|Death|4|||
33713884|NCT00630396|63281345|FG000|Overall Study|Lost to Follow-up|3|||
33713885|NCT00985686|63281353|FG000|Overall Study|Lost to Follow-up|1|||
33713886|NCT00985686|63281354|FG001|Overall Study|Lost to Follow-up|1|||
33713887|NCT00985686|63281355|FG002|Overall Study|Lost to Follow-up|0|||
33317256|NCT01072149|62692701|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
33317257|NCT01072149|62692702|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
33317258|NCT01072149|62692703|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
33317259|NCT01072149|62692704|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
33317260|NCT01072149|62692705|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
33317261|NCT01072149|62692706|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
33317262|NCT01072149|62692707|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
33317263|NCT01072149|62692708|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
33317264|NCT01072149|62692709|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
33317265|NCT01072149|62692710|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
33317266|NCT01072149|62692711|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
33317267|NCT01072149|62692712|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
33317268|NCT01072149|62692713|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
33713888|NCT00985686|63281356|FG003|Overall Study|Lost to Follow-up|2|||
33713889|NCT03098394|63281366|FG000|Overall Study|Pregnancy|0|||
33713890|NCT03098394|63281367|FG001|Overall Study|Pregnancy|1|||
33713891|NCT00984594|63281378|FG000|Overall Study|Lost to Follow-up|1|||
33317269|NCT01072149|62692714|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
33401984|NCT00642278|62780923|FG005|Overall Study|Lack of Efficacy|0|||
33713892|NCT00984594|63281379|FG001|Overall Study|Lost to Follow-up|0|||
33713893|NCT00984594|63281378|FG000|Overall Study|Withdrawal by Subject|0|||
33713894|NCT00984594|63281379|FG001|Overall Study|Withdrawal by Subject|1|||
33713895|NCT00984204|63281387|FG000|Overall Study|Death|1|||
33713896|NCT00984204|63281387|FG000|Overall Study|Lost to Follow-up|4|||
33713897|NCT00984204|63281387|FG000|Overall Study|Lack of Efficacy|10|||
33713898|NCT00983892|63281393|FG000|Overall Study|Withdrawal by Subject|10|||
33713899|NCT00983892|63281394|FG001|Overall Study|Withdrawal by Subject|12|||
33713900|NCT00983580|63281402|FG000|Overall Study|Cancel Prior to treatment|1|||
33713901|NCT00983580|63281403|FG001|Overall Study|Cancel Prior to treatment|3|||
33713902|NCT00983580|63281402|FG000|Overall Study|Protocol Violation|1|||
33713903|NCT00983580|63281403|FG001|Overall Study|Protocol Violation|1|||
33713904|NCT00983580|63281402|FG000|Overall Study|Ineligible|3|||
33713905|NCT00983580|63281403|FG001|Overall Study|Ineligible|0|||
33713906|NCT00982878|63281410|FG000|Overall Study|Physician Decision|1|||
33713907|NCT00982488|63281419|FG000|Overall Study|Administrative reason by sponsor|81|||
33713908|NCT00982488|63281420|FG001|Overall Study|Administrative reason by sponsor|3|||
33713909|NCT00982488|63281421|FG002|Overall Study|Administrative reason by sponsor|11|||
33713910|NCT00982488|63281422|FG003|Overall Study|Administrative reason by sponsor|0|||
33713911|NCT00982488|63281423|FG004|Overall Study|Administrative reason by sponsor|0|||
33713912|NCT00982488|63281419|FG000|Overall Study|Adverse event unrelated to study drug|5|||
33713913|NCT00982488|63281420|FG001|Overall Study|Adverse event unrelated to study drug|1|||
33713914|NCT00982488|63281421|FG002|Overall Study|Adverse event unrelated to study drug|0|||
33713915|NCT00982488|63281422|FG003|Overall Study|Adverse event unrelated to study drug|0|||
33713916|NCT00982488|63281423|FG004|Overall Study|Adverse event unrelated to study drug|0|||
33713917|NCT00982488|63281419|FG000|Overall Study|Death|11|||
33713918|NCT00982488|63281420|FG001|Overall Study|Death|0|||
33713919|NCT00982488|63281421|FG002|Overall Study|Death|2|||
33713920|NCT00982488|63281422|FG003|Overall Study|Death|0|||
33713921|NCT00982488|63281423|FG004|Overall Study|Death|0|||
33713922|NCT00982488|63281419|FG000|Overall Study|Disease progression|30|||
33713923|NCT00982488|63281420|FG001|Overall Study|Disease progression|5|||
33713924|NCT00982488|63281421|FG002|Overall Study|Disease progression|10|||
33713925|NCT00982488|63281422|FG003|Overall Study|Disease progression|1|||
33713926|NCT00982488|63281423|FG004|Overall Study|Disease progression|1|||
33713927|NCT00982488|63281419|FG000|Overall Study|Lost to Follow-up|1|||
33713928|NCT00982488|63281420|FG001|Overall Study|Lost to Follow-up|0|||
33713929|NCT00982488|63281421|FG002|Overall Study|Lost to Follow-up|0|||
33713930|NCT00982488|63281422|FG003|Overall Study|Lost to Follow-up|0|||
33713931|NCT00982488|63281423|FG004|Overall Study|Lost to Follow-up|0|||
33713932|NCT00982488|63281419|FG000|Overall Study|Maximum clinical benefit|1|||
33713933|NCT00982488|63281420|FG001|Overall Study|Maximum clinical benefit|1|||
33713934|NCT00982488|63281421|FG002|Overall Study|Maximum clinical benefit|1|||
33713935|NCT00982488|63281422|FG003|Overall Study|Maximum clinical benefit|0|||
33713936|NCT00982488|63281423|FG004|Overall Study|Maximum clinical benefit|0|||
33713937|NCT00982488|63281419|FG000|Overall Study|Other|15|||
33713938|NCT00982488|63281420|FG001|Overall Study|Other|1|||
33713939|NCT00982488|63281421|FG002|Overall Study|Other|3|||
33713940|NCT00982488|63281422|FG003|Overall Study|Other|1|||
33713941|NCT00982488|63281423|FG004|Overall Study|Other|0|||
33713942|NCT00982488|63281419|FG000|Overall Study|Poor compliance/noncompliance|0|||
33713943|NCT00982488|63281420|FG001|Overall Study|Poor compliance/noncompliance|1|||
33713944|NCT00982488|63281421|FG002|Overall Study|Poor compliance/noncompliance|0|||
33713945|NCT00982488|63281422|FG003|Overall Study|Poor compliance/noncompliance|0|||
33713946|NCT00982488|63281423|FG004|Overall Study|Poor compliance/noncompliance|0|||
33713947|NCT00982488|63281419|FG000|Overall Study|Stem cell transplant|2|||
33713948|NCT00982488|63281420|FG001|Overall Study|Stem cell transplant|0|||
33713949|NCT00982488|63281421|FG002|Overall Study|Stem cell transplant|0|||
33713950|NCT00982488|63281422|FG003|Overall Study|Stem cell transplant|1|||
33713951|NCT00982488|63281423|FG004|Overall Study|Stem cell transplant|0|||
33317270|NCT01072149|62692697|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
33317271|NCT01072149|62692698|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
33317272|NCT01072149|62692699|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
33317273|NCT01072149|62692700|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
33317274|NCT01072149|62692701|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
33317275|NCT01072149|62692702|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
33317276|NCT01072149|62692703|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
33317277|NCT01072149|62692704|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
33317278|NCT01072149|62692705|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
33317279|NCT01072149|62692706|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
33713952|NCT00982488|63281419|FG000|Overall Study|Study drug toxicity|34|||
33713953|NCT00982488|63281420|FG001|Overall Study|Study drug toxicity|1|||
33713954|NCT00982488|63281421|FG002|Overall Study|Study drug toxicity|6|||
33713955|NCT00982488|63281422|FG003|Overall Study|Study drug toxicity|0|||
33713956|NCT00982488|63281423|FG004|Overall Study|Study drug toxicity|0|||
33713957|NCT00982488|63281419|FG000|Overall Study|Withdrawal by Subject|5|||
33713958|NCT00982488|63281420|FG001|Overall Study|Withdrawal by Subject|1|||
33713959|NCT00982488|63281421|FG002|Overall Study|Withdrawal by Subject|1|||
33713960|NCT00982488|63281422|FG003|Overall Study|Withdrawal by Subject|0|||
33713961|NCT00982488|63281423|FG004|Overall Study|Withdrawal by Subject|0|||
33713962|NCT00982410|63281437|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
33713963|NCT00982410|63281438|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
33713964|NCT00982410|63281437|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
33713965|NCT00982410|63281438|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
33713966|NCT00982410|63281437|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
33713967|NCT00982410|63281438|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
33713968|NCT00982410|63281437|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
33713969|NCT00982410|63281438|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
33713970|NCT00982410|63281437|FG000|6-month Follow-up Assessment|participant no transportation|1|||
33713971|NCT00982410|63281438|FG001|6-month Follow-up Assessment|participant no transportation|0|||
33713972|NCT00982410|63281437|FG000|6-month Follow-up Assessment|incarceration|0|||
33713973|NCT00982410|63281438|FG001|6-month Follow-up Assessment|incarceration|2|||
33713974|NCT00982410|63281437|FG000|6-month Follow-up Assessment|patent surgery|0|||
33713975|NCT00982410|63281438|FG001|6-month Follow-up Assessment|patent surgery|1|||
33713976|NCT00982410|63281437|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
33713977|NCT00982410|63281438|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
33713978|NCT00982410|63281437|FG000|12-month Follow-up Assessment|Death|0|||
33713979|NCT00982410|63281438|FG001|12-month Follow-up Assessment|Death|2|||
33713980|NCT00982410|63281437|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
33713981|NCT00982410|63281438|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
33713982|NCT00982410|63281437|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
33713983|NCT00982410|63281438|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
33713984|NCT00982410|63281437|FG000|12-month Follow-up Assessment|incarceration|2|||
33713985|NCT00982410|63281438|FG001|12-month Follow-up Assessment|incarceration|1|||
33713986|NCT00982410|63281437|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
33713987|NCT00982410|63281438|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
33713988|NCT00982020|63281447|FG000|Overall Study|Adverse Event|19|||
33713989|NCT00982020|63281448|FG001|Overall Study|Adverse Event|15|||
33713990|NCT00982020|63281447|FG000|Overall Study|Withdrawal by Subject|11|||
33713991|NCT00982020|63281448|FG001|Overall Study|Withdrawal by Subject|14|||
33713992|NCT00982020|63281447|FG000|Overall Study|Lost to Follow-up|5|||
33713993|NCT00982020|63281448|FG001|Overall Study|Lost to Follow-up|11|||
33713994|NCT00982020|63281447|FG000|Overall Study|Lack of Efficacy|10|||
33713995|NCT00982020|63281448|FG001|Overall Study|Lack of Efficacy|4|||
33713996|NCT00982020|63281447|FG000|Overall Study|Parent/Caregiver Decision|5|||
33713997|NCT00982020|63281448|FG001|Overall Study|Parent/Caregiver Decision|5|||
33713998|NCT00982020|63281447|FG000|Overall Study|Treatment Non-compliance|3|||
33713999|NCT00982020|63281448|FG001|Overall Study|Treatment Non-compliance|6|||
33714000|NCT00982020|63281447|FG000|Overall Study|Physician Decision|2|||
33714001|NCT00982020|63281448|FG001|Overall Study|Physician Decision|5|||
33714002|NCT00982020|63281447|FG000|Overall Study|Entry Criteria Not Met|2|||
33714003|NCT00982020|63281448|FG001|Overall Study|Entry Criteria Not Met|1|||
33317280|NCT01072149|62692707|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
33317281|NCT01072149|62692708|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
33317282|NCT01072149|62692709|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
33317283|NCT01072149|62692710|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
33317284|NCT01072149|62692711|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
33317285|NCT01072149|62692712|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
33317286|NCT01072149|62692713|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
33317287|NCT01072149|62692714|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
33317288|NCT01072149|62692697|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33317289|NCT01072149|62692698|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33317290|NCT01072149|62692699|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33317291|NCT01072149|62692700|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33317292|NCT01072149|62692701|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33317293|NCT01072149|62692702|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33317294|NCT01072149|62692703|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33317295|NCT01072149|62692704|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33317296|NCT01072149|62692705|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33714004|NCT00982020|63281447|FG000|Overall Study|Protocol Violation|0|||
33714005|NCT00982020|63281448|FG001|Overall Study|Protocol Violation|2|||
33714006|NCT00982020|63281447|FG000|Overall Study|Clinical Relapse|0|||
33714007|NCT00982020|63281448|FG001|Overall Study|Clinical Relapse|1|||
33714008|NCT00981084|63281461|FG000|Post Intervention (Data Analysis)|poor effort|1|||
33714009|NCT00981084|63281462|FG001|Post Intervention (Data Analysis)|poor effort|1|||
33714010|NCT00981084|63281461|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
33317297|NCT01072149|62692706|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33317298|NCT01072149|62692707|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33317299|NCT01072149|62692708|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33317300|NCT01072149|62692709|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33317301|NCT01072149|62692710|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33317302|NCT01072149|62692711|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33317303|NCT01072149|62692712|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
33317304|NCT01072149|62692713|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33317305|NCT01072149|62692714|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33714011|NCT00981084|63281462|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
33714012|NCT00980148|63281472|FG000|Overall Study|Discharged from facility|89|||
33714013|NCT00980148|63281473|FG001|Overall Study|Discharged from facility|96|||
33714014|NCT00980148|63281472|FG000|Overall Study|Received other antichlamydia treatment|20|||
33714015|NCT00980148|63281473|FG001|Overall Study|Received other antichlamydia treatment|14|||
33714016|NCT00980148|63281472|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
33714017|NCT00980148|63281473|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
33714018|NCT00980148|63281472|FG000|Overall Study|Various other reasons|8|||
33714019|NCT00980148|63281473|FG001|Overall Study|Various other reasons|9|||
33714020|NCT04553406|63281510|FG000|Overall Study|Study Discontinuation|0|||
33714021|NCT04553406|63281511|FG001|Overall Study|Study Discontinuation|1|||
33714022|NCT03033576|63281519|FG000|Overall Study|Ineligible|1|||
33714023|NCT03033576|63281520|FG001|Overall Study|Ineligible|1|||
33714024|NCT03033576|63281519|FG000|Overall Study|Adverse Event|4|||
33714025|NCT03033576|63281520|FG001|Overall Study|Adverse Event|20|||
33714026|NCT03033576|63281519|FG000|Overall Study|Progression/relapse|9|||
33714027|NCT03033576|63281520|FG001|Overall Study|Progression/relapse|36|||
33714028|NCT03033576|63281519|FG000|Overall Study|Death|1|||
33714029|NCT03033576|63281520|FG001|Overall Study|Death|1|||
33714030|NCT03033576|63281519|FG000|Overall Study|Patient refusal|1|||
33714031|NCT03033576|63281520|FG001|Overall Study|Patient refusal|6|||
33714032|NCT03033576|63281519|FG000|Overall Study|Other, unspecified reasons|0|||
33714033|NCT03033576|63281520|FG001|Overall Study|Other, unspecified reasons|4|||
33714034|NCT03033576|63281519|FG000|Overall Study|Currently on protocol therapy|0|||
33714035|NCT03033576|63281520|FG001|Overall Study|Currently on protocol therapy|2|||
33714036|NCT04129944|63281530|FG000|Overall Study|Death|0|||
33714037|NCT04129944|63281531|FG001|Overall Study|Death|0|||
33714038|NCT04129944|63281532|FG002|Overall Study|Death|0|||
33714039|NCT04129944|63281533|FG003|Overall Study|Death|1|||
33714040|NCT04129944|63281530|FG000|Overall Study|Lost to Follow-up|1|||
33714041|NCT04129944|63281531|FG001|Overall Study|Lost to Follow-up|0|||
33714042|NCT04129944|63281532|FG002|Overall Study|Lost to Follow-up|0|||
33714043|NCT04129944|63281533|FG003|Overall Study|Lost to Follow-up|0|||
33714044|NCT04129944|63281530|FG000|Overall Study|Withdrawal by Subject|1|||
33714045|NCT04129944|63281531|FG001|Overall Study|Withdrawal by Subject|0|||
33714046|NCT04129944|63281532|FG002|Overall Study|Withdrawal by Subject|1|||
33714047|NCT04129944|63281533|FG003|Overall Study|Withdrawal by Subject|2|||
33714048|NCT03829332|63281597|FG000|Overall Study|Death|145|||
33714049|NCT03829332|63281598|FG001|Overall Study|Death|135|||
33317306|NCT01072149|62692697|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
33317307|NCT01072149|62692698|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
33317308|NCT01072149|62692699|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
33317309|NCT01072149|62692700|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
33317310|NCT01072149|62692701|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
33317311|NCT01072149|62692702|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
33317312|NCT01072149|62692703|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
33317313|NCT01072149|62692704|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
33317314|NCT01072149|62692705|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
33317315|NCT01072149|62692706|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
33317316|NCT01072149|62692707|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
33317317|NCT01072149|62692708|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
33317318|NCT01072149|62692709|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
33317319|NCT01072149|62692710|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
33317320|NCT01072149|62692711|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
33714050|NCT03829332|63281597|FG000|Overall Study|Withdrawal by Subject|10|||
33714051|NCT03829332|63281598|FG001|Overall Study|Withdrawal by Subject|4|||
33714052|NCT03829332|63281597|FG000|Overall Study|Ongoing in Study|154|||
33714053|NCT03829332|63281598|FG001|Overall Study|Ongoing in Study|175|||
33714054|NCT02914314|63281618|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
33714055|NCT02914314|63281619|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
33714056|NCT02914314|63281620|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
33714057|NCT02914314|63281621|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
33714058|NCT02914314|63281618|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
33317321|NCT01072149|62692712|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
33317322|NCT01072149|62692713|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
33317323|NCT01072149|62692714|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
33317324|NCT01072149|62692697|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317325|NCT01072149|62692698|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317326|NCT01072149|62692699|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317327|NCT01072149|62692700|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317328|NCT01072149|62692701|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317329|NCT01072149|62692702|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317330|NCT01072149|62692703|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317331|NCT01072149|62692704|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317332|NCT01072149|62692705|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317333|NCT01072149|62692706|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317334|NCT01072149|62692707|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317335|NCT01072149|62692708|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317336|NCT01072149|62692709|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
33317337|NCT01072149|62692710|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317338|NCT01072149|62692711|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317339|NCT01072149|62692712|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317340|NCT01072149|62692713|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33317341|NCT01072149|62692714|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33714059|NCT02914314|63281619|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
33714060|NCT02914314|63281620|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
33714061|NCT02914314|63281621|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
33714062|NCT02914314|63281618|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
33714063|NCT02914314|63281619|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
33714064|NCT02914314|63281620|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
33714065|NCT02914314|63281621|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
33714066|NCT02914314|63281618|FG000|Extension Phase (Up to 32 Weeks)|Participant choice|0|||
33714067|NCT02914314|63281619|FG001|Extension Phase (Up to 32 Weeks)|Participant choice|0|||
33714068|NCT02914314|63281620|FG002|Extension Phase (Up to 32 Weeks)|Participant choice|1|||
33714069|NCT02914314|63281621|FG003|Extension Phase (Up to 32 Weeks)|Participant choice|0|||
33714070|NCT02914314|63281618|FG000|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|0|||
33714071|NCT02914314|63281619|FG001|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|0|||
33714072|NCT02914314|63281620|FG002|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|1|||
33714073|NCT02914314|63281621|FG003|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|0|||
33714074|NCT01899144|63283253|FG000|Treatment Period 2|Other|1|||
33714075|NCT01899144|63283253|FG000|Treatment Period 3|Other|2|||
33714076|NCT01899144|63283253|FG000|Treatment Period 5|Other|1|||
33714077|NCT03821844|63283867|FG000|Overall Study|Death|37|||
33714078|NCT03821844|63283868|FG001|Overall Study|Death|31|||
33714079|NCT03821844|63283867|FG000|Overall Study|Discharged|10|||
33714080|NCT03821844|63283868|FG001|Overall Study|Discharged|14|||
33714081|NCT03821844|63283867|FG000|Overall Study|Not present in facility at followup|2|||
33714082|NCT03821844|63283868|FG001|Overall Study|Not present in facility at followup|3|||
33714083|NCT01796106|63285319|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
33714084|NCT01796106|63285320|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
33714085|NCT01168219|63286512|FG000|Overall Study|off study before starting treatment|2|||
33714086|NCT01168219|63286512|FG000|Overall Study|withdrew before transplant|1|||
33714087|NCT01168219|63286512|FG000|Overall Study|ineligible due to CML|2|||
33714088|NCT01115803|63286523|FG000|Overall Study|Withdrawal by Subject|0|||
33317342|NCT01072149|62692697|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33317343|NCT01072149|62692698|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33317344|NCT01072149|62692699|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
33317345|NCT01072149|62692700|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33317346|NCT01072149|62692701|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33317347|NCT01072149|62692702|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33317348|NCT01072149|62692703|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33317349|NCT01072149|62692704|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33317350|NCT01072149|62692705|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33317351|NCT01072149|62692706|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33317352|NCT01072149|62692707|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33317353|NCT01072149|62692708|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33317354|NCT01072149|62692709|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33317355|NCT01072149|62692710|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
33317356|NCT01072149|62692711|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33317357|NCT01072149|62692712|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33493848|NCT03535194|62872386|FG003|Post-Treatment Followup Period|Adverse Event|8|||
33597648|NCT01920178|62996605|FG001|Overall Study|Lost to Follow-up|1|||
33493849|NCT03535194|62872387|FG004|Post-Treatment Followup Period|Adverse Event|0|||
33597649|NCT01901848|62996613|FG000|Randomized and Treated|Lost to Follow-up|3|||
33714089|NCT01115803|63286524|FG001|Overall Study|Withdrawal by Subject|0|||
33317358|NCT01072149|62692713|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33714090|NCT01115803|63286525|FG002|Overall Study|Withdrawal by Subject|0|||
33317359|NCT01072149|62692714|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33317360|NCT01071915|62692724|FG000|Overall Study|Adverse Event|3|||
33317361|NCT01071915|62692724|FG000|Overall Study|Physician Decision|2|||
33317362|NCT01071915|62692724|FG000|Overall Study|Withdrawal by Subject|2|||
33317363|NCT01071915|62692724|FG000|Overall Study|Miscellaneous Reasons|2|||
33317364|NCT00904969|62692728|FG000|Overall Study|Lost to Follow-up|4|||
33317365|NCT00904969|62692728|FG000|Overall Study|Withdrawal by Subject|3|||
33317366|NCT00904969|62692728|FG000|Overall Study|Additional Treatments|11|||
33317367|NCT00904969|62692728|FG000|Overall Study|Case Aborted; Subject Exited|1|||
33317368|NCT01070979|62692750|FG000|Overall Study|Adverse Event|2|||
33317369|NCT01070979|62692751|FG001|Overall Study|Adverse Event|3|||
33317370|NCT01070979|62692752|FG002|Overall Study|Adverse Event|3|||
33317371|NCT01070979|62692750|FG000|Overall Study|Lost to Follow-up|2|||
33317372|NCT01070979|62692751|FG001|Overall Study|Lost to Follow-up|1|||
33317373|NCT01070979|62692752|FG002|Overall Study|Lost to Follow-up|1|||
33317374|NCT01070979|62692750|FG000|Overall Study|Protocol Violation|0|||
33317375|NCT01070979|62692751|FG001|Overall Study|Protocol Violation|2|||
33317376|NCT01070979|62692752|FG002|Overall Study|Protocol Violation|6|||
33317377|NCT01070979|62692750|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
33317378|NCT01070979|62692751|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
33317379|NCT01070979|62692752|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
33317380|NCT01070979|62692750|FG000|Overall Study|Withdrawal by Subject|3|||
33317381|NCT01070979|62692751|FG001|Overall Study|Withdrawal by Subject|1|||
33317382|NCT01070979|62692752|FG002|Overall Study|Withdrawal by Subject|1|||
33317383|NCT01070979|62692750|FG000|Overall Study|No study drug taken|0|||
33317384|NCT01070979|62692751|FG001|Overall Study|No study drug taken|1|||
33317385|NCT01070979|62692752|FG002|Overall Study|No study drug taken|0|||
33317386|NCT01234337|62692762|FG000|Overall Study|Adverse Event|58|||
33317387|NCT01234337|62692763|FG001|Overall Study|Adverse Event|21|||
33317388|NCT01234337|62692762|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
33317389|NCT01234337|62692763|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
33317390|NCT01234337|62692762|FG000|Overall Study|Investi. decision not protocol driven|5|||
33317391|NCT01234337|62692763|FG001|Overall Study|Investi. decision not protocol driven|6|||
33317392|NCT01234337|62692762|FG000|Overall Study|Non-compliant with study medication|3|||
33317393|NCT01234337|62692763|FG001|Overall Study|Non-compliant with study medication|2|||
33317394|NCT01234337|62692762|FG000|Overall Study|Randomized but not treated|6|||
33317395|NCT01234337|62692763|FG001|Overall Study|Randomized but not treated|4|||
33317396|NCT01234337|62692762|FG000|Overall Study|Lost to Follow-up|0|||
33317397|NCT01234337|62692763|FG001|Overall Study|Lost to Follow-up|1|||
33317398|NCT01234337|62692762|FG000|Overall Study|Protocol Violation|2|||
33317399|NCT01234337|62692763|FG001|Overall Study|Protocol Violation|3|||
33317400|NCT01234337|62692762|FG000|Overall Study|Withdrawal by Subject|11|||
33317401|NCT01234337|62692763|FG001|Overall Study|Withdrawal by Subject|9|||
33317402|NCT01234337|62692762|FG000|Overall Study|Death|0|||
33317403|NCT01234337|62692763|FG001|Overall Study|Death|1|||
33317404|NCT01234337|62692762|FG000|Overall Study|Switch to commercial drug|0|||
33317405|NCT01234337|62692763|FG001|Overall Study|Switch to commercial drug|1|||
33317406|NCT01070043|62692771|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
33317407|NCT01070043|62692772|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
33317408|NCT01070043|62692773|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
33317409|NCT01070043|62692771|FG000|Double-Blind Treatment|Adverse Event|0|||
33317410|NCT01070043|62692772|FG001|Double-Blind Treatment|Adverse Event|0|||
33317411|NCT01070043|62692773|FG002|Double-Blind Treatment|Adverse Event|2|||
33317412|NCT01074255|62692779|FG000|Overall Study|Did not receive EMEND|2|||
33317413|NCT01073943|62692785|FG000|Overall Study|Withdrawal by Subject|8|||
33317414|NCT01073943|62692786|FG001|Overall Study|Withdrawal by Subject|2|||
33317415|NCT01073943|62692785|FG000|Overall Study|Protocol Violation|2|||
33317416|NCT01073943|62692786|FG001|Overall Study|Protocol Violation|1|||
33317417|NCT01073943|62692785|FG000|Overall Study|Adverse Event|1|||
33317418|NCT01073943|62692786|FG001|Overall Study|Adverse Event|1|||
33317419|NCT01073943|62692785|FG000|Overall Study|Lost to Follow-up|0|||
33317420|NCT01073943|62692786|FG001|Overall Study|Lost to Follow-up|2|||
33317421|NCT01073943|62692785|FG000|Overall Study|Power outage; colonoscopy not done|1|||
33317422|NCT01073943|62692786|FG001|Overall Study|Power outage; colonoscopy not done|0|||
33317423|NCT01073943|62692785|FG000|Overall Study|Subject forgot|0|||
33317424|NCT01073943|62692786|FG001|Overall Study|Subject forgot|1|||
33317425|NCT01073943|62692785|FG000|Overall Study|Unable to return for follow-up|0|||
33317426|NCT01073943|62692786|FG001|Overall Study|Unable to return for follow-up|1|||
33317427|NCT01073943|62692785|FG000|Overall Study|Could not tolerate prep|1|||
33317428|NCT01073943|62692786|FG001|Overall Study|Could not tolerate prep|0|||
33317429|NCT01073865|62692794|FG000|Overall Study|Reasons other than below|19|||
33317430|NCT01073865|62692795|FG001|Overall Study|Reasons other than below|31|||
33317431|NCT01073865|62692794|FG000|Overall Study|Lost to Follow-up|1|||
33317432|NCT01073865|62692795|FG001|Overall Study|Lost to Follow-up|1|||
33317433|NCT01073865|62692794|FG000|Overall Study|Death|3|||
33317434|NCT01073865|62692795|FG001|Overall Study|Death|2|||
33317435|NCT01073865|62692794|FG000|Overall Study|Withdrawal by Subject|5|||
33317436|NCT01073865|62692795|FG001|Overall Study|Withdrawal by Subject|5|||
33317437|NCT04862065|62692804|FG000|Screening|Protocol Violation|54|||
33317438|NCT04862065|62692805|FG001|Screening|Protocol Violation|0|||
33317439|NCT04862065|62692806|FG002|Screening|Protocol Violation|0|||
33317440|NCT04862065|62692804|FG000|Screening|Insufficient Sample|1|||
33317441|NCT04862065|62692805|FG001|Screening|Insufficient Sample|0|||
33317442|NCT04862065|62692806|FG002|Screening|Insufficient Sample|0|||
33317443|NCT04862065|62692804|FG000|Follow-Up|Lost to Follow-up|3|||
33317444|NCT04862065|62692805|FG001|Follow-Up|Lost to Follow-up|0|||
33317445|NCT04862065|62692806|FG002|Follow-Up|Lost to Follow-up|0|||
33317446|NCT01073631|62692812|FG000|Overall Study|Death|82|||
33317447|NCT01073631|62692812|FG000|Overall Study|Adverse Event|24|||
33317448|NCT01073631|62692812|FG000|Overall Study|Other|63|||
33317449|NCT01073163|62692816|FG000|Overall Study|Adverse Event|1|||
33317450|NCT01073163|62692816|FG000|Overall Study|Disease Progression|1|||
33317451|NCT01073163|62692816|FG000|Overall Study|Early termination|1|||
33317452|NCT01072929|62692827|FG000|Overall Study|Adverse Event|8|||
33317453|NCT01072929|62692828|FG001|Overall Study|Adverse Event|11|||
33317454|NCT01072929|62692829|FG002|Overall Study|Adverse Event|2|||
33317455|NCT01072929|62692827|FG000|Overall Study|Lack of Efficacy|7|||
33317456|NCT01072929|62692828|FG001|Overall Study|Lack of Efficacy|4|||
33714091|NCT01115803|63286526|FG003|Overall Study|Withdrawal by Subject|0|||
33714092|NCT01115803|63286527|FG004|Overall Study|Withdrawal by Subject|0|||
33714093|NCT01115803|63286528|FG005|Overall Study|Withdrawal by Subject|0|||
33714094|NCT01115803|63286529|FG006|Overall Study|Withdrawal by Subject|1|||
33714095|NCT01115803|63286523|FG000|Overall Study|Lost to Follow-up|0|||
33714096|NCT01115803|63286524|FG001|Overall Study|Lost to Follow-up|0|||
33714097|NCT01115803|63286525|FG002|Overall Study|Lost to Follow-up|1|||
33714098|NCT01115803|63286526|FG003|Overall Study|Lost to Follow-up|0|||
33714099|NCT01115803|63286527|FG004|Overall Study|Lost to Follow-up|0|||
33714100|NCT01115803|63286528|FG005|Overall Study|Lost to Follow-up|0|||
33714101|NCT01115803|63286529|FG006|Overall Study|Lost to Follow-up|0|||
33714102|NCT01115803|63286523|FG000|Overall Study|Progressive Disease during Cycle1|0|||
33714103|NCT01115803|63286524|FG001|Overall Study|Progressive Disease during Cycle1|0|||
33714104|NCT01115803|63286525|FG002|Overall Study|Progressive Disease during Cycle1|0|||
33714105|NCT01115803|63286526|FG003|Overall Study|Progressive Disease during Cycle1|0|||
33714106|NCT01115803|63286527|FG004|Overall Study|Progressive Disease during Cycle1|0|||
33714107|NCT01115803|63286528|FG005|Overall Study|Progressive Disease during Cycle1|0|||
33714108|NCT01115803|63286529|FG006|Overall Study|Progressive Disease during Cycle1|1|||
33714109|NCT01115569|63286550|FG000|Conversion/Titration Phase|Adverse Event|59|||
33714110|NCT01115569|63286551|FG001|Conversion/Titration Phase|Adverse Event|0|||
33714111|NCT01115569|63286550|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
33317457|NCT01072929|62692829|FG002|Overall Study|Lack of Efficacy|0|||
33317458|NCT01072929|62692827|FG000|Overall Study|Withdrawal by Subject|7|||
33317459|NCT01072929|62692828|FG001|Overall Study|Withdrawal by Subject|15|||
33317460|NCT01072929|62692829|FG002|Overall Study|Withdrawal by Subject|3|||
33317461|NCT01072929|62692827|FG000|Overall Study|Protocol Violation|13|||
33317462|NCT01072929|62692828|FG001|Overall Study|Protocol Violation|11|||
33317463|NCT01072929|62692829|FG002|Overall Study|Protocol Violation|2|||
33317464|NCT01072929|62692827|FG000|Overall Study|Lost to Follow-up|8|||
33317465|NCT01072929|62692828|FG001|Overall Study|Lost to Follow-up|4|||
33714112|NCT01115569|63286551|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
33714113|NCT01115569|63286550|FG000|Conversion/Titration Phase|Physician Decision|5|||
33714114|NCT01115569|63286551|FG001|Conversion/Titration Phase|Physician Decision|0|||
33714115|NCT01115569|63286550|FG000|Conversion/Titration Phase|Protocol Violation|68|||
33714116|NCT01115569|63286551|FG001|Conversion/Titration Phase|Protocol Violation|0|||
33714117|NCT01115569|63286550|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
33714118|NCT01115569|63286551|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
33714119|NCT01115569|63286550|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
33714120|NCT01115569|63286551|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
33714121|NCT01115569|63286550|FG000|Maintenance Phase|Adverse Event|0|||
33714122|NCT01115569|63286551|FG001|Maintenance Phase|Adverse Event|43|||
33317466|NCT01072929|62692829|FG002|Overall Study|Lost to Follow-up|1|||
33714123|NCT01115569|63286550|FG000|Maintenance Phase|Lost to Follow-up|0|||
33714124|NCT01115569|63286551|FG001|Maintenance Phase|Lost to Follow-up|8|||
33714125|NCT01115569|63286550|FG000|Maintenance Phase|Physician Decision|0|||
33714126|NCT01115569|63286551|FG001|Maintenance Phase|Physician Decision|3|||
33714127|NCT01115569|63286550|FG000|Maintenance Phase|Protocol Violation|0|||
33714128|NCT01115569|63286551|FG001|Maintenance Phase|Protocol Violation|9|||
33714129|NCT01115569|63286550|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33317467|NCT01072929|62692827|FG000|Overall Study|Noncompliance with study medication|0|||
33317468|NCT01072929|62692828|FG001|Overall Study|Noncompliance with study medication|3|||
33317469|NCT01072929|62692829|FG002|Overall Study|Noncompliance with study medication|0|||
33317470|NCT01072929|62692827|FG000|Overall Study|Noncompliance with study procedures|1|||
33317471|NCT01072929|62692828|FG001|Overall Study|Noncompliance with study procedures|0|||
33714130|NCT01115569|63286551|FG001|Maintenance Phase|Withdrawal by Subject|27|||
33714131|NCT01115569|63286550|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
33714132|NCT01115569|63286551|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
33714133|NCT01115569|63286550|FG000|Maintenance Phase|Administrative|0|||
33714134|NCT01115569|63286551|FG001|Maintenance Phase|Administrative|1|||
33714135|NCT01107886|63286558|FG000|Overall Study|Lost to Follow-up|15|||
33714136|NCT01107886|63286559|FG001|Overall Study|Lost to Follow-up|13|||
33714137|NCT01107886|63286558|FG000|Overall Study|Withdrawal by Subject|180|||
33714138|NCT01107886|63286559|FG001|Overall Study|Withdrawal by Subject|196|||
33714139|NCT01107886|63286558|FG000|Overall Study|Administrative withdrawal of consent|7|||
33714140|NCT01107886|63286559|FG001|Overall Study|Administrative withdrawal of consent|5|||
33714141|NCT01107457|63286570|FG000|Part A|Adverse Event|1|||
33714142|NCT01107457|63286571|FG001|Part A|Adverse Event|2|||
33714143|NCT01107457|63286572|FG002|Part A|Adverse Event|1|||
33714144|NCT01107457|63286573|FG003|Part A|Adverse Event|0|||
33714145|NCT01107457|63286574|FG004|Part A|Adverse Event|0|||
33714146|NCT01107457|63286575|FG005|Part A|Adverse Event|0|||
33714147|NCT01107457|63286570|FG000|Part A|Withdrawal by Subject|3|||
33714148|NCT01107457|63286571|FG001|Part A|Withdrawal by Subject|3|||
33714149|NCT01107457|63286572|FG002|Part A|Withdrawal by Subject|0|||
33714150|NCT01107457|63286573|FG003|Part A|Withdrawal by Subject|3|||
33714151|NCT01107457|63286574|FG004|Part A|Withdrawal by Subject|1|||
33714152|NCT01107457|63286575|FG005|Part A|Withdrawal by Subject|0|||
33714153|NCT01107457|63286570|FG000|Part A|Lost to Follow-up|0|||
33714154|NCT01107457|63286571|FG001|Part A|Lost to Follow-up|1|||
33714155|NCT01107457|63286572|FG002|Part A|Lost to Follow-up|0|||
33714156|NCT01107457|63286573|FG003|Part A|Lost to Follow-up|0|||
33714157|NCT01107457|63286574|FG004|Part A|Lost to Follow-up|0|||
33714158|NCT01107457|63286575|FG005|Part A|Lost to Follow-up|0|||
33714159|NCT01107457|63286570|FG000|Part A|Lack of Efficacy|1|||
33714160|NCT01107457|63286571|FG001|Part A|Lack of Efficacy|0|||
33714161|NCT01107457|63286572|FG002|Part A|Lack of Efficacy|0|||
33714162|NCT01107457|63286573|FG003|Part A|Lack of Efficacy|0|||
33714163|NCT01107457|63286574|FG004|Part A|Lack of Efficacy|0|||
33714164|NCT01107457|63286575|FG005|Part A|Lack of Efficacy|0|||
33714165|NCT01107457|63286570|FG000|Part A|Protocol Violation|0|||
33714166|NCT01107457|63286571|FG001|Part A|Protocol Violation|1|||
33714167|NCT01107457|63286572|FG002|Part A|Protocol Violation|0|||
33714168|NCT01107457|63286573|FG003|Part A|Protocol Violation|0|||
33317472|NCT01072929|62692829|FG002|Overall Study|Noncompliance with study procedures|1|||
33317473|NCT01072929|62692827|FG000|Overall Study|Other|0|||
33317474|NCT01072929|62692828|FG001|Overall Study|Other|3|||
33317475|NCT01072929|62692829|FG002|Overall Study|Other|0|||
33317476|NCT01231607|62692843|FG000|Overall Study|Adverse Event|0|||
33317477|NCT01231607|62692844|FG001|Overall Study|Adverse Event|8|||
33317478|NCT01231607|62692845|FG002|Overall Study|Adverse Event|4|||
33317479|NCT01231607|62692846|FG003|Overall Study|Adverse Event|4|||
33317480|NCT01231607|62692847|FG004|Overall Study|Adverse Event|5|||
33317481|NCT01231607|62692843|FG000|Overall Study|Lost to Follow-up|13|||
33317482|NCT01231607|62692844|FG001|Overall Study|Lost to Follow-up|11|||
33317483|NCT01231607|62692845|FG002|Overall Study|Lost to Follow-up|10|||
33317484|NCT01231607|62692846|FG003|Overall Study|Lost to Follow-up|10|||
33317485|NCT01231607|62692847|FG004|Overall Study|Lost to Follow-up|4|||
33317486|NCT01231607|62692843|FG000|Overall Study|Physician Decision|4|||
33317487|NCT01231607|62692844|FG001|Overall Study|Physician Decision|4|||
33317488|NCT01231607|62692845|FG002|Overall Study|Physician Decision|3|||
33317489|NCT01231607|62692846|FG003|Overall Study|Physician Decision|5|||
33317490|NCT01231607|62692847|FG004|Overall Study|Physician Decision|4|||
33317491|NCT01231607|62692843|FG000|Overall Study|Protocol Violation|3|||
33317492|NCT01231607|62692844|FG001|Overall Study|Protocol Violation|2|||
33597650|NCT01901848|62996614|FG001|Randomized and Treated|Lost to Follow-up|6|||
33714169|NCT01107457|63286574|FG004|Part A|Protocol Violation|0|||
33714170|NCT01107457|63286575|FG005|Part A|Protocol Violation|0|||
33714171|NCT01107457|63286570|FG000|Part B and C|Adverse Event|0|||
33714172|NCT01107457|63286571|FG001|Part B and C|Adverse Event|0|||
33714173|NCT01107457|63286572|FG002|Part B and C|Adverse Event|0|||
33714174|NCT01107457|63286573|FG003|Part B and C|Adverse Event|0|||
33714175|NCT01107457|63286574|FG004|Part B and C|Adverse Event|0|||
33714176|NCT01107457|63286575|FG005|Part B and C|Adverse Event|12|||
33317493|NCT01231607|62692845|FG002|Overall Study|Protocol Violation|0|||
33317494|NCT01231607|62692846|FG003|Overall Study|Protocol Violation|2|||
33317495|NCT01231607|62692847|FG004|Overall Study|Protocol Violation|2|||
33317496|NCT01231607|62692843|FG000|Overall Study|Withdrawal by Subject|9|||
33317497|NCT01231607|62692844|FG001|Overall Study|Withdrawal by Subject|9|||
33317498|NCT01231607|62692845|FG002|Overall Study|Withdrawal by Subject|14|||
33317499|NCT01231607|62692846|FG003|Overall Study|Withdrawal by Subject|17|||
33714177|NCT01107457|63286570|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
33714178|NCT01107457|63286571|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
33714179|NCT01107457|63286572|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
33714180|NCT01107457|63286573|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
33714181|NCT01107457|63286574|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
33317500|NCT01231607|62692847|FG004|Overall Study|Withdrawal by Subject|9|||
33317501|NCT01231373|62692866|FG000|Overall Study|Withdrew consent prior to randomization|2|||
33317502|NCT01231373|62692867|FG001|Overall Study|Withdrew consent prior to randomization|1|||
33317503|NCT01231373|62692868|FG002|Overall Study|Withdrew consent prior to randomization|0|||
33317504|NCT01231373|62692869|FG003|Overall Study|Withdrew consent prior to randomization|0|||
33317505|NCT01231373|62692866|FG000|Overall Study|Lost to Follow-up|0|||
33317506|NCT01231373|62692867|FG001|Overall Study|Lost to Follow-up|0|||
33317507|NCT01231373|62692868|FG002|Overall Study|Lost to Follow-up|0|||
33317508|NCT01231373|62692869|FG003|Overall Study|Lost to Follow-up|1|||
33317509|NCT01231373|62692866|FG000|Overall Study|Withdrew Consent|1|||
33317510|NCT01231373|62692867|FG001|Overall Study|Withdrew Consent|0|||
33317511|NCT01231373|62692868|FG002|Overall Study|Withdrew Consent|0|||
33317512|NCT01231373|62692869|FG003|Overall Study|Withdrew Consent|0|||
33317513|NCT00975130|62692881|FG000|Study Part 1|Adverse Event|150|||
33317514|NCT00975130|62692882|FG001|Study Part 1|Adverse Event|0|||
33317515|NCT00975130|62692883|FG002|Study Part 1|Adverse Event|0|||
33317516|NCT00975130|62692881|FG000|Study Part 1|Lost to Follow-up|19|||
33317517|NCT00975130|62692882|FG001|Study Part 1|Lost to Follow-up|0|||
33317518|NCT00975130|62692883|FG002|Study Part 1|Lost to Follow-up|0|||
33317519|NCT00975130|62692881|FG000|Study Part 1|Withdrawal by Subject|61|||
33317520|NCT00975130|62692882|FG001|Study Part 1|Withdrawal by Subject|0|||
33317521|NCT00975130|62692883|FG002|Study Part 1|Withdrawal by Subject|0|||
33317522|NCT00975130|62692881|FG000|Study Part 1|Protocol Violation|13|||
33317523|NCT00975130|62692882|FG001|Study Part 1|Protocol Violation|0|||
33317524|NCT00975130|62692883|FG002|Study Part 1|Protocol Violation|0|||
33317525|NCT00975130|62692881|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
33317526|NCT00975130|62692882|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
33317527|NCT00975130|62692883|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
33317528|NCT00975130|62692881|FG000|Study Part 1|Administrative|4|||
33317529|NCT00975130|62692882|FG001|Study Part 1|Administrative|0|||
33317530|NCT00975130|62692883|FG002|Study Part 1|Administrative|0|||
33317531|NCT00975130|62692881|FG000|Study Part 1|Withdrew Consent|24|||
33317532|NCT00975130|62692882|FG001|Study Part 1|Withdrew Consent|0|||
33317533|NCT00975130|62692883|FG002|Study Part 1|Withdrew Consent|0|||
33317534|NCT00975130|62692881|FG000|Study Part 2|Adverse Event|0|||
33317535|NCT00975130|62692882|FG001|Study Part 2|Adverse Event|14|||
33317536|NCT00975130|62692883|FG002|Study Part 2|Adverse Event|7|||
33317537|NCT00975130|62692881|FG000|Study Part 2|Lost to Follow-up|0|||
33317538|NCT00975130|62692882|FG001|Study Part 2|Lost to Follow-up|0|||
33317539|NCT00975130|62692883|FG002|Study Part 2|Lost to Follow-up|1|||
33317540|NCT00975130|62692881|FG000|Study Part 2|Withdrawal by Subject|0|||
33317541|NCT00975130|62692882|FG001|Study Part 2|Withdrawal by Subject|13|||
33317542|NCT00975130|62692883|FG002|Study Part 2|Withdrawal by Subject|5|||
33317543|NCT00975130|62692881|FG000|Study Part 2|Withdrew Consent|0|||
33317544|NCT00975130|62692882|FG001|Study Part 2|Withdrew Consent|6|||
33317545|NCT00975130|62692883|FG002|Study Part 2|Withdrew Consent|2|||
33317546|NCT00975130|62692881|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
33317547|NCT00975130|62692882|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
33317548|NCT00975130|62692883|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
33317549|NCT00975130|62692881|FG000|Study Part 2|Administrative|0|||
33317550|NCT00975130|62692882|FG001|Study Part 2|Administrative|1|||
33317551|NCT00975130|62692883|FG002|Study Part 2|Administrative|0|||
33317552|NCT00975130|62692881|FG000|Study Part 2|Protocol Violation|0|||
33317553|NCT00975130|62692882|FG001|Study Part 2|Protocol Violation|0|||
33401985|NCT00642278|62780924|FG006|Overall Study|Lack of Efficacy|0|||
33401986|NCT00642278|62780918|FG000|Overall Study|Lost to Follow-up|5|||
33401987|NCT00642278|62780919|FG001|Overall Study|Lost to Follow-up|1|||
33401988|NCT00642278|62780920|FG002|Overall Study|Lost to Follow-up|0|||
33401989|NCT00642278|62780921|FG003|Overall Study|Lost to Follow-up|1|||
33401990|NCT00642278|62780922|FG004|Overall Study|Lost to Follow-up|0|||
33401991|NCT00642278|62780923|FG005|Overall Study|Lost to Follow-up|1|||
33401992|NCT00642278|62780924|FG006|Overall Study|Lost to Follow-up|1|||
33401993|NCT00642278|62780918|FG000|Overall Study|Physician Decision|0|||
33401994|NCT00642278|62780919|FG001|Overall Study|Physician Decision|0|||
33401995|NCT00642278|62780920|FG002|Overall Study|Physician Decision|0|||
33317554|NCT00975130|62692883|FG002|Study Part 2|Protocol Violation|1|||
33401996|NCT00642278|62780921|FG003|Overall Study|Physician Decision|1|||
33317555|NCT01230827|62692900|FG000|Overall Study|Lost to Follow-up|0|||
33317556|NCT01230827|62692901|FG001|Overall Study|Lost to Follow-up|0|||
33317557|NCT01230827|62692902|FG002|Overall Study|Lost to Follow-up|1|||
33317558|NCT01230827|62692903|FG003|Overall Study|Lost to Follow-up|3|||
33317559|NCT01230827|62692900|FG000|Overall Study|Withdrawal by Subject|1|||
33317560|NCT01230827|62692901|FG001|Overall Study|Withdrawal by Subject|0|||
33401997|NCT00642278|62780922|FG004|Overall Study|Physician Decision|0|||
33401998|NCT00642278|62780923|FG005|Overall Study|Physician Decision|0|||
33401999|NCT00642278|62780924|FG006|Overall Study|Physician Decision|0|||
33317561|NCT01230827|62692902|FG002|Overall Study|Withdrawal by Subject|3|||
33317562|NCT01230827|62692903|FG003|Overall Study|Withdrawal by Subject|2|||
33317563|NCT01230827|62692900|FG000|Overall Study|Lack of Efficacy|14|||
33317564|NCT01230827|62692901|FG001|Overall Study|Lack of Efficacy|1|||
33317565|NCT01230827|62692902|FG002|Overall Study|Lack of Efficacy|2|||
33317566|NCT01230827|62692903|FG003|Overall Study|Lack of Efficacy|3|||
33317567|NCT01230827|62692900|FG000|Overall Study|Adverse Event|4|||
33317568|NCT01230827|62692901|FG001|Overall Study|Adverse Event|2|||
33317569|NCT01230827|62692902|FG002|Overall Study|Adverse Event|3|||
33317570|NCT01230827|62692903|FG003|Overall Study|Adverse Event|7|||
33317571|NCT01230827|62692900|FG000|Overall Study|Recovery|0|||
33317572|NCT01230827|62692901|FG001|Overall Study|Recovery|6|||
33317573|NCT01230827|62692902|FG002|Overall Study|Recovery|0|||
33317574|NCT01230827|62692903|FG003|Overall Study|Recovery|0|||
33317575|NCT01230827|62692900|FG000|Overall Study|Study terminated by Sponsor|0|||
33714182|NCT01107457|63286575|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
33714183|NCT01107457|63286570|FG000|Part B and C|Physician Decision|0|||
33714184|NCT01107457|63286571|FG001|Part B and C|Physician Decision|0|||
33714185|NCT01107457|63286572|FG002|Part B and C|Physician Decision|0|||
33714186|NCT01107457|63286573|FG003|Part B and C|Physician Decision|0|||
33714187|NCT01107457|63286574|FG004|Part B and C|Physician Decision|0|||
33714188|NCT01107457|63286575|FG005|Part B and C|Physician Decision|3|||
33714189|NCT01107457|63286570|FG000|Part B and C|Lack of Efficacy|0|||
33714190|NCT01107457|63286571|FG001|Part B and C|Lack of Efficacy|0|||
33714191|NCT01107457|63286572|FG002|Part B and C|Lack of Efficacy|0|||
33714192|NCT01107457|63286573|FG003|Part B and C|Lack of Efficacy|0|||
33714193|NCT01107457|63286574|FG004|Part B and C|Lack of Efficacy|0|||
33714194|NCT01107457|63286575|FG005|Part B and C|Lack of Efficacy|7|||
33714195|NCT01107457|63286570|FG000|Part B and C|Lost to Follow-up|0|||
33714196|NCT01107457|63286571|FG001|Part B and C|Lost to Follow-up|0|||
33714197|NCT01107457|63286572|FG002|Part B and C|Lost to Follow-up|0|||
33714198|NCT01107457|63286573|FG003|Part B and C|Lost to Follow-up|0|||
33714199|NCT01107457|63286574|FG004|Part B and C|Lost to Follow-up|0|||
33714200|NCT01107457|63286575|FG005|Part B and C|Lost to Follow-up|10|||
33714201|NCT01107457|63286570|FG000|Part B and C|Protocol Violation|0|||
33714202|NCT01107457|63286571|FG001|Part B and C|Protocol Violation|0|||
33714203|NCT01107457|63286572|FG002|Part B and C|Protocol Violation|0|||
33714204|NCT01107457|63286573|FG003|Part B and C|Protocol Violation|0|||
33714205|NCT01107457|63286574|FG004|Part B and C|Protocol Violation|0|||
33714206|NCT01107457|63286575|FG005|Part B and C|Protocol Violation|1|||
33714207|NCT01107457|63286570|FG000|Part B and C|Sponsor Decision|0|||
33714208|NCT01107457|63286571|FG001|Part B and C|Sponsor Decision|0|||
33317576|NCT01230827|62692901|FG001|Overall Study|Study terminated by Sponsor|2|||
33317577|NCT01230827|62692902|FG002|Overall Study|Study terminated by Sponsor|56|||
33317578|NCT01230827|62692903|FG003|Overall Study|Study terminated by Sponsor|63|||
33317579|NCT01230749|62692915|FG000|Overall Study|Adverse Event|0|||
33317580|NCT01230749|62692916|FG001|Overall Study|Adverse Event|0|||
33317581|NCT01230749|62692917|FG002|Overall Study|Adverse Event|0|||
33317582|NCT01230749|62692918|FG003|Overall Study|Adverse Event|1|||
33317583|NCT01230749|62692915|FG000|Overall Study|Physician Decision|0|||
33317584|NCT01230749|62692916|FG001|Overall Study|Physician Decision|0|||
33317585|NCT01230749|62692917|FG002|Overall Study|Physician Decision|1|||
33317586|NCT01230749|62692918|FG003|Overall Study|Physician Decision|0|||
33317587|NCT01230749|62692915|FG000|Overall Study|Withdrawal by Subject|0|||
33317588|NCT01230749|62692916|FG001|Overall Study|Withdrawal by Subject|1|||
33317589|NCT01230749|62692917|FG002|Overall Study|Withdrawal by Subject|0|||
33317590|NCT01230749|62692918|FG003|Overall Study|Withdrawal by Subject|0|||
33317591|NCT01230749|62692915|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
33317592|NCT01230749|62692916|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
33317593|NCT01230749|62692917|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
33317594|NCT01230749|62692918|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
33597651|NCT01901848|62996613|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
33714209|NCT01107457|63286572|FG002|Part B and C|Sponsor Decision|0|||
33714210|NCT01107457|63286573|FG003|Part B and C|Sponsor Decision|0|||
33714211|NCT01107457|63286574|FG004|Part B and C|Sponsor Decision|0|||
33714212|NCT01107457|63286575|FG005|Part B and C|Sponsor Decision|66|||
33714213|NCT01107457|63286570|FG000|Part B and C|Withdrawal by Subject|0|||
33714214|NCT01107457|63286571|FG001|Part B and C|Withdrawal by Subject|0|||
33317595|NCT00903175|62692933|FG000|Period 1 - First Line|Adverse Event|36|||
33317596|NCT00903175|62692934|FG001|Period 1 - First Line|Adverse Event|50|||
33317597|NCT00903175|62692933|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
33317598|NCT00903175|62692934|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
33317599|NCT00903175|62692933|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
33317600|NCT00903175|62692934|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
33714215|NCT01107457|63286572|FG002|Part B and C|Withdrawal by Subject|0|||
33714216|NCT01107457|63286573|FG003|Part B and C|Withdrawal by Subject|0|||
33714217|NCT01107457|63286574|FG004|Part B and C|Withdrawal by Subject|0|||
33714218|NCT01107457|63286575|FG005|Part B and C|Withdrawal by Subject|16|||
33317601|NCT00903175|62692933|FG000|Period 1 - First Line|Protocol Violation|3|||
33317602|NCT00903175|62692934|FG001|Period 1 - First Line|Protocol Violation|3|||
33317603|NCT00903175|62692933|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
33317604|NCT00903175|62692934|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
33317605|NCT00903175|62692933|FG000|Period 1 - First Line|Administrative problems|12|||
33317606|NCT00903175|62692934|FG001|Period 1 - First Line|Administrative problems|13|||
33317607|NCT00903175|62692933|FG000|Period 1 - First Line|Death|17|||
33317608|NCT00903175|62692934|FG001|Period 1 - First Line|Death|10|||
33317609|NCT00903175|62692933|FG000|Period 2 - Second Line|Missing|1|||
33317610|NCT00903175|62692934|FG001|Period 2 - Second Line|Missing|0|||
33317611|NCT00903175|62692933|FG000|Period 2 - Second Line|Adverse Event|16|||
33317612|NCT00903175|62692934|FG001|Period 2 - Second Line|Adverse Event|20|||
33317613|NCT00903175|62692933|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
33317614|NCT00903175|62692934|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
33317615|NCT00903175|62692933|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
33317616|NCT00903175|62692934|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
33317617|NCT00903175|62692933|FG000|Period 2 - Second Line|Administrative problems|19|||
33317618|NCT00903175|62692934|FG001|Period 2 - Second Line|Administrative problems|9|||
33317619|NCT00903175|62692933|FG000|Period 2 - Second Line|Death|5|||
33317620|NCT00903175|62692934|FG001|Period 2 - Second Line|Death|2|||
33317621|NCT01229735|62692942|FG000|Overall Study|Lack of Efficacy|8|||
33317622|NCT01229735|62692943|FG001|Overall Study|Lack of Efficacy|8|||
33317623|NCT01229735|62692942|FG000|Overall Study|Protocol Violation|13|||
33317624|NCT01229735|62692943|FG001|Overall Study|Protocol Violation|8|||
33317625|NCT01229735|62692942|FG000|Overall Study|Lost to Follow-up|0|||
33317626|NCT01229735|62692943|FG001|Overall Study|Lost to Follow-up|2|||
33317627|NCT01229735|62692942|FG000|Overall Study|Withdrawal by Subject|18|||
33317628|NCT01229735|62692943|FG001|Overall Study|Withdrawal by Subject|17|||
33317629|NCT01229735|62692942|FG000|Overall Study|Other Reason|13|||
33317630|NCT01229735|62692943|FG001|Overall Study|Other Reason|10|||
33317631|NCT01229735|62692942|FG000|Overall Study|SAE, non-fatal|0|||
33317632|NCT01229735|62692943|FG001|Overall Study|SAE, non-fatal|4|||
33317633|NCT01229735|62692942|FG000|Overall Study|AE, non-serious non-fatal|13|||
33317634|NCT01229735|62692943|FG001|Overall Study|AE, non-serious non-fatal|17|||
33317635|NCT01229735|62692942|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33317636|NCT01229735|62692943|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
33317637|NCT00974974|62692962|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
33317638|NCT00974974|62692963|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
33317639|NCT00974974|62692962|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
33317640|NCT00974974|62692963|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
33317641|NCT00974974|62692962|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
33317642|NCT00974974|62692963|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
33317643|NCT00974974|62692962|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
33317644|NCT00974974|62692963|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
33317645|NCT00974974|62692962|FG000|IR CD-LD Dose Adjustment|Various|0|||
33317646|NCT00974974|62692963|FG001|IR CD-LD Dose Adjustment|Various|9|||
33317647|NCT00974974|62692962|FG000|IPX066 Dose Conversion|Adverse Event|23|||
33317648|NCT00974974|62692963|FG001|IPX066 Dose Conversion|Adverse Event|0|||
33317649|NCT00974974|62692962|FG000|IPX066 Dose Conversion|Death|2|||
33317650|NCT00974974|62692963|FG001|IPX066 Dose Conversion|Death|0|||
33317651|NCT00974974|62692962|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
33317652|NCT00974974|62692963|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
33317653|NCT00974974|62692962|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
33317654|NCT00974974|62692963|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
33317655|NCT00974974|62692962|FG000|IPX066 Dose Conversion|Various|3|||
33317656|NCT00974974|62692963|FG001|IPX066 Dose Conversion|Various|0|||
33317657|NCT00974974|62692962|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
33317658|NCT00974974|62692963|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
33317659|NCT00974974|62692962|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
33317660|NCT00974974|62692963|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
33317661|NCT00974974|62692962|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
33317662|NCT00974974|62692963|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
33317663|NCT00974974|62692962|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
33317664|NCT00974974|62692963|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
33317665|NCT00974974|62692962|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
33714219|NCT01107457|63286570|FG000|Part B and C|Clinical Relapse|0|||
33317666|NCT00974974|62692963|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
33317667|NCT00974974|62692962|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
33317668|NCT00974974|62692963|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
33317669|NCT00974974|62692962|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
33317670|NCT00974974|62692963|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
33317671|NCT00974974|62692962|FG000|Maintenance - Double Blind Treatment|Various|4|||
33317672|NCT00974974|62692963|FG001|Maintenance - Double Blind Treatment|Various|0|||
33714220|NCT01107457|63286571|FG001|Part B and C|Clinical Relapse|0|||
33714221|NCT01107457|63286572|FG002|Part B and C|Clinical Relapse|0|||
33714222|NCT01107457|63286573|FG003|Part B and C|Clinical Relapse|0|||
33714223|NCT01107457|63286574|FG004|Part B and C|Clinical Relapse|0|||
33714224|NCT01107457|63286575|FG005|Part B and C|Clinical Relapse|4|||
33714225|NCT04545385|63286605|FG000|Overall Study|Withdrawal by Subject|2|||
33714226|NCT04545385|63286606|FG001|Overall Study|Withdrawal by Subject|0|||
33714227|NCT04545385|63286605|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
33714228|NCT04545385|63286606|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
33714229|NCT04545385|63286605|FG000|Overall Study|Study termination|10|||
33714230|NCT04545385|63286606|FG001|Overall Study|Study termination|10|||
33714231|NCT04545385|63286605|FG000|Overall Study|Sponsor decision|2|||
33714232|NCT04545385|63286606|FG001|Overall Study|Sponsor decision|2|||
33714233|NCT04545385|63286605|FG000|Overall Study|Other than specified|1|||
33714234|NCT04545385|63286606|FG001|Overall Study|Other than specified|0|||
33714235|NCT03783026|63286621|FG000|Treatment Phase|Adverse Event|15|||
33714236|NCT03783026|63286621|FG000|Treatment Phase|Lack of Efficacy|11|||
33714237|NCT03783026|63286621|FG000|Treatment Phase|Withdrawal by Subject|6|||
33714238|NCT03783026|63286621|FG000|Treatment Phase|Lost to Follow-up|2|||
33714239|NCT03783026|63286621|FG000|Treatment Phase|Protocol Deviation|8|||
33714240|NCT03783026|63286621|FG000|Treatment Phase|Did Not Receive Treatment|1|||
33714241|NCT03783026|63286621|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
33714242|NCT03635112|63286638|FG000|Overall Study|Adverse Event|5|||
33714243|NCT03635112|63286639|FG001|Overall Study|Adverse Event|9|||
33714244|NCT03635112|63286640|FG002|Overall Study|Adverse Event|14|||
33714245|NCT03635112|63286638|FG000|Overall Study|Lost to Follow-up|1|||
33714246|NCT03635112|63286639|FG001|Overall Study|Lost to Follow-up|0|||
33714247|NCT03635112|63286640|FG002|Overall Study|Lost to Follow-up|1|||
33714248|NCT03635112|63286638|FG000|Overall Study|Physician Decision|5|||
33714249|NCT03635112|63286639|FG001|Overall Study|Physician Decision|7|||
33714250|NCT03635112|63286640|FG002|Overall Study|Physician Decision|5|||
33714251|NCT03635112|63286638|FG000|Overall Study|Protocol Violation|0|||
33714252|NCT03635112|63286639|FG001|Overall Study|Protocol Violation|0|||
33714253|NCT03635112|63286640|FG002|Overall Study|Protocol Violation|1|||
33714254|NCT03635112|63286638|FG000|Overall Study|Study Terminated by Sponsor|11|||
33714255|NCT03635112|63286639|FG001|Overall Study|Study Terminated by Sponsor|17|||
33714256|NCT03635112|63286640|FG002|Overall Study|Study Terminated by Sponsor|21|||
33714257|NCT03635112|63286638|FG000|Overall Study|Withdrawal by Subject|4|||
33714258|NCT03635112|63286639|FG001|Overall Study|Withdrawal by Subject|9|||
33714259|NCT03635112|63286640|FG002|Overall Study|Withdrawal by Subject|7|||
33714260|NCT03635112|63286638|FG000|Overall Study|Miscellaneous|0|||
33714261|NCT03635112|63286639|FG001|Overall Study|Miscellaneous|0|||
33714262|NCT03635112|63286640|FG002|Overall Study|Miscellaneous|1|||
33714263|NCT03588728|63286653|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
33714264|NCT03588728|63286654|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
33714265|NCT03588728|63286655|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
33714266|NCT03588728|63286656|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
33714267|NCT03588728|63286653|FG000|Overall Study|Lab shut down due to COVID-19|0|||
33714268|NCT03588728|63286654|FG001|Overall Study|Lab shut down due to COVID-19|0|||
33714269|NCT03588728|63286655|FG002|Overall Study|Lab shut down due to COVID-19|0|||
33714270|NCT03588728|63286656|FG003|Overall Study|Lab shut down due to COVID-19|1|||
33714271|NCT03588728|63286653|FG000|Overall Study|multiple technical issues|1|||
33714272|NCT03588728|63286654|FG001|Overall Study|multiple technical issues|0|||
33714273|NCT03588728|63286655|FG002|Overall Study|multiple technical issues|0|||
33714274|NCT03588728|63286656|FG003|Overall Study|multiple technical issues|0|||
33714275|NCT03588728|63286653|FG000|Overall Study|Hospitalized for COVID|1|||
33714276|NCT03588728|63286654|FG001|Overall Study|Hospitalized for COVID|0|||
33714277|NCT03588728|63286655|FG002|Overall Study|Hospitalized for COVID|0|||
33714278|NCT03588728|63286656|FG003|Overall Study|Hospitalized for COVID|0|||
33714279|NCT03588728|63286653|FG000|Overall Study|Schedule change unable to attend sessions|1|||
33714280|NCT03588728|63286654|FG001|Overall Study|Schedule change unable to attend sessions|0|||
33714281|NCT03588728|63286655|FG002|Overall Study|Schedule change unable to attend sessions|0|||
33714282|NCT03588728|63286656|FG003|Overall Study|Schedule change unable to attend sessions|0|||
33714283|NCT02987543|63286678|FG000|Overall Study|Ongoing study at data cut off|49|||
33714284|NCT02987543|63286679|FG001|Overall Study|Ongoing study at data cut off|21|||
33714285|NCT02987543|63286680|FG002|Overall Study|Ongoing study at data cut off|19|||
33714286|NCT02987543|63286681|FG003|Overall Study|Ongoing study at data cut off|12|||
33714287|NCT02987543|63286678|FG000|Overall Study|Death|88|||
33714288|NCT02987543|63286679|FG001|Overall Study|Death|54|||
33714289|NCT02987543|63286680|FG002|Overall Study|Death|67|||
33714290|NCT02987543|63286681|FG003|Overall Study|Death|28|||
33714291|NCT02987543|63286678|FG000|Overall Study|Lost to Follow-up|3|||
33714292|NCT02987543|63286679|FG001|Overall Study|Lost to Follow-up|0|||
33714293|NCT02987543|63286680|FG002|Overall Study|Lost to Follow-up|1|||
33714294|NCT02987543|63286681|FG003|Overall Study|Lost to Follow-up|0|||
33714295|NCT02987543|63286678|FG000|Overall Study|Screen failure|0|||
33714296|NCT02987543|63286679|FG001|Overall Study|Screen failure|0|||
33714297|NCT02987543|63286680|FG002|Overall Study|Screen failure|0|||
33714298|NCT02987543|63286681|FG003|Overall Study|Screen failure|1|||
33714299|NCT02987543|63286678|FG000|Overall Study|Withdrawal by Subject|21|||
33714300|NCT02987543|63286679|FG001|Overall Study|Withdrawal by Subject|7|||
33714301|NCT02987543|63286680|FG002|Overall Study|Withdrawal by Subject|7|||
33714302|NCT02987543|63286681|FG003|Overall Study|Withdrawal by Subject|6|||
33714303|NCT02987543|63286678|FG000|Overall Study|Study terminated by sponsor|1|||
33714304|NCT02987543|63286679|FG001|Overall Study|Study terminated by sponsor|0|||
33714305|NCT02987543|63286680|FG002|Overall Study|Study terminated by sponsor|0|||
33714306|NCT02987543|63286681|FG003|Overall Study|Study terminated by sponsor|0|||
33714307|NCT02987543|63286678|FG000|Overall Study|Investigator decision|0|||
33714308|NCT02987543|63286679|FG001|Overall Study|Investigator decision|1|||
33714309|NCT02987543|63286680|FG002|Overall Study|Investigator decision|0|||
33714310|NCT02987543|63286681|FG003|Overall Study|Investigator decision|0|||
33714311|NCT02987543|63286678|FG000|Overall Study|Disease progression|0|||
33714312|NCT02987543|63286679|FG001|Overall Study|Disease progression|0|||
33714313|NCT02987543|63286680|FG002|Overall Study|Disease progression|0|||
33714314|NCT02987543|63286681|FG003|Overall Study|Disease progression|1|||
33714315|NCT02983045|63286697|FG000|Overall Study|Withdrawal by Subject|0|||
33714316|NCT02983045|63286698|FG001|Overall Study|Withdrawal by Subject|1|||
33402000|NCT00642278|62780918|FG000|Overall Study|Protocol Violation|0|||
33597652|NCT01901848|62996614|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
33597653|NCT01901614|62996622|FG000|Overall Study|Adverse Event|0|||
33597654|NCT01901614|62996623|FG001|Overall Study|Adverse Event|1|||
33597655|NCT01901614|62996622|FG000|Overall Study|Lost to Follow-up|1|||
33714317|NCT02983045|63286699|FG002|Overall Study|Withdrawal by Subject|0|||
33714318|NCT02983045|63286700|FG003|Overall Study|Withdrawal by Subject|5|||
33402001|NCT00642278|62780919|FG001|Overall Study|Protocol Violation|0|||
33402002|NCT00642278|62780920|FG002|Overall Study|Protocol Violation|1|||
33402003|NCT00642278|62780921|FG003|Overall Study|Protocol Violation|1|||
33402004|NCT00642278|62780922|FG004|Overall Study|Protocol Violation|0|||
33402005|NCT00642278|62780923|FG005|Overall Study|Protocol Violation|1|||
33402006|NCT00642278|62780924|FG006|Overall Study|Protocol Violation|2|||
33402007|NCT00642278|62780918|FG000|Overall Study|Withdrawal by Subject|1|||
33402008|NCT00642278|62780919|FG001|Overall Study|Withdrawal by Subject|1|||
33402009|NCT00642278|62780920|FG002|Overall Study|Withdrawal by Subject|1|||
33317673|NCT01233869|62692973|FG000|Initial Treatment Period (24 Months)|Death|1|||
33317674|NCT01233869|62692974|FG001|Initial Treatment Period (24 Months)|Death|0|||
33317675|NCT01233869|62692975|FG002|Initial Treatment Period (24 Months)|Death|0|||
33317676|NCT01233869|62692976|FG003|Initial Treatment Period (24 Months)|Death|0|||
33317677|NCT01233869|62692973|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
33317678|NCT01233869|62692974|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
33317679|NCT01233869|62692975|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
33317680|NCT01233869|62692976|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
33317681|NCT01233869|62692973|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
33317682|NCT01233869|62692974|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
33317683|NCT01233869|62692975|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
33317684|NCT01233869|62692976|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
33317685|NCT01233869|62692973|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
33493850|NCT03535194|62872383|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
33493851|NCT03535194|62872384|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
33597656|NCT01901614|62996623|FG001|Overall Study|Lost to Follow-up|0|||
33714319|NCT02983045|63286701|FG004|Overall Study|Withdrawal by Subject|0|||
33714320|NCT02983045|63286702|FG005|Overall Study|Withdrawal by Subject|72|||
33714321|NCT02983045|63286703|FG006|Overall Study|Withdrawal by Subject|0|||
33714322|NCT02983045|63286704|FG007|Overall Study|Withdrawal by Subject|0|||
33714323|NCT02983045|63286705|FG008|Overall Study|Withdrawal by Subject|0|||
33714324|NCT02983045|63286706|FG009|Overall Study|Withdrawal by Subject|2|||
33714325|NCT02983045|63286697|FG000|Overall Study|Lost to Follow-up|0|||
33714326|NCT02983045|63286698|FG001|Overall Study|Lost to Follow-up|0|||
33317686|NCT01233869|62692974|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
33317687|NCT01233869|62692975|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
33714327|NCT02983045|63286699|FG002|Overall Study|Lost to Follow-up|0|||
33714328|NCT02983045|63286700|FG003|Overall Study|Lost to Follow-up|0|||
33714329|NCT02983045|63286701|FG004|Overall Study|Lost to Follow-up|0|||
33714330|NCT02983045|63286702|FG005|Overall Study|Lost to Follow-up|10|||
33714331|NCT02983045|63286703|FG006|Overall Study|Lost to Follow-up|0|||
33714332|NCT02983045|63286704|FG007|Overall Study|Lost to Follow-up|0|||
33317688|NCT01233869|62692976|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
33317689|NCT01233869|62692973|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
33402010|NCT00642278|62780921|FG003|Overall Study|Withdrawal by Subject|3|||
33714333|NCT02983045|63286705|FG008|Overall Study|Lost to Follow-up|0|||
33714334|NCT02983045|63286706|FG009|Overall Study|Lost to Follow-up|0|||
33714335|NCT02564263|63286730|FG000|Overall Study|Adverse Event|31|||
33714336|NCT02564263|63286731|FG001|Overall Study|Adverse Event|29|||
33714337|NCT02564263|63286730|FG000|Overall Study|Death|270|||
33714338|NCT02564263|63286731|FG001|Overall Study|Death|262|||
33714339|NCT02564263|63286730|FG000|Overall Study|Withdrawal by Subject|4|||
33714340|NCT02564263|63286731|FG001|Overall Study|Withdrawal by Subject|19|||
33714341|NCT02564263|63286730|FG000|Overall Study|Sponsor's decision|9|||
33714342|NCT02564263|63286731|FG001|Overall Study|Sponsor's decision|4|||
33714343|NCT02379819|63286738|FG000|Overall Study|Withdrawal by Subject|10|||
33714344|NCT02379819|63286738|FG000|Overall Study|Death|2|||
33714345|NCT02379819|63286738|FG000|Overall Study|Lack of Efficacy|1|||
33714346|NCT02379819|63286738|FG000|Overall Study|Lost to Follow-up|1|||
33714347|NCT02368886|63286746|FG000|Overall Study|Cancel|1|||
33714348|NCT02368886|63286747|FG001|Overall Study|Cancel|1|||
33714349|NCT02368886|63286748|FG002|Overall Study|Cancel|1|||
33714350|NCT02368886|63286749|FG003|Overall Study|Cancel|3|||
33714351|NCT02368886|63286746|FG000|Overall Study|Ineligible|0|||
33714352|NCT02368886|63286747|FG001|Overall Study|Ineligible|0|||
33714353|NCT02368886|63286748|FG002|Overall Study|Ineligible|0|||
33714354|NCT02368886|63286749|FG003|Overall Study|Ineligible|1|||
33714355|NCT02227238|63286763|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
33714356|NCT02227238|63286764|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
33714357|NCT02227238|63286765|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
33714358|NCT02227238|63286763|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
33714359|NCT02227238|63286764|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
33714360|NCT02227238|63286765|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
33714361|NCT02227238|63286763|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
33714362|NCT02227238|63286764|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
33714363|NCT02227238|63286765|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
33714364|NCT02227238|63286763|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
33714365|NCT02227238|63286764|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
33714366|NCT02227238|63286765|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
33714367|NCT02227238|63286763|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
33597657|NCT01901614|62996622|FG000|Overall Study|Screen Fail|1|||
33714368|NCT02227238|63286764|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
33714369|NCT02227238|63286765|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
33714370|NCT02227238|63286763|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
33714371|NCT02227238|63286764|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
33714372|NCT02227238|63286765|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
33714373|NCT02227238|63286763|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
33714374|NCT02227238|63286764|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
33714375|NCT02227238|63286765|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
33714376|NCT02227238|63286763|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
33714377|NCT02227238|63286764|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
33714378|NCT02227238|63286765|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
33714379|NCT02227238|63286763|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
33714380|NCT02227238|63286764|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
33714381|NCT02227238|63286765|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
33714382|NCT02227238|63286763|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
33714383|NCT02227238|63286764|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
33714384|NCT02227238|63286765|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
33714385|NCT02227238|63286763|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
33714386|NCT02227238|63286764|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
33714387|NCT02227238|63286765|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
33714388|NCT02227238|63286763|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
33714389|NCT02227238|63286764|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
33714390|NCT02227238|63286765|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
33714391|NCT02227238|63286763|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
33714392|NCT02227238|63286764|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
33714393|NCT02227238|63286765|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
33714394|NCT02227238|63286763|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
33714395|NCT02227238|63286764|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
33714396|NCT02227238|63286765|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
33714397|NCT02126969|63286786|FG000|Overall Study|Withdrawal by Subject|1|||
33714398|NCT02126969|63286787|FG001|Overall Study|Withdrawal by Subject|2|||
33714399|NCT01715285|63286795|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
33714400|NCT01715285|63286796|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
33714401|NCT01715285|63286797|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
33714402|NCT01715285|63286795|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
33714403|NCT01715285|63286796|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
33714404|NCT01715285|63286797|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
33714405|NCT01715285|63286795|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
33714406|NCT01715285|63286796|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
33714407|NCT01715285|63286797|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
33714408|NCT01715285|63286795|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
33714409|NCT01715285|63286796|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
33714410|NCT01715285|63286797|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
33714411|NCT01715285|63286795|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
33714412|NCT01715285|63286796|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
33714413|NCT01715285|63286797|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
33714414|NCT01715285|63286795|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
33714415|NCT01715285|63286796|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
33714416|NCT01715285|63286797|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
33714417|NCT01715285|63286795|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
33714418|NCT01715285|63286796|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
33714419|NCT01715285|63286797|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
33317690|NCT01233869|62692974|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
33402011|NCT00642278|62780922|FG004|Overall Study|Withdrawal by Subject|6|||
33402012|NCT00642278|62780923|FG005|Overall Study|Withdrawal by Subject|2|||
33402013|NCT00642278|62780924|FG006|Overall Study|Withdrawal by Subject|2|||
33402014|NCT00642278|62780918|FG000|Overall Study|Noncompliance with study drug regimen|0|||
33402015|NCT00642278|62780919|FG001|Overall Study|Noncompliance with study drug regimen|0|||
33402016|NCT00642278|62780920|FG002|Overall Study|Noncompliance with study drug regimen|0|||
33402017|NCT00642278|62780921|FG003|Overall Study|Noncompliance with study drug regimen|1|||
33597658|NCT01901614|62996623|FG001|Overall Study|Screen Fail|0|||
33317691|NCT01233869|62692975|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
33317692|NCT01233869|62692976|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
33317693|NCT01233869|62692973|FG000|Extended Treatment Period (46 Months)|Other|3|||
33317694|NCT01233869|62692974|FG001|Extended Treatment Period (46 Months)|Other|0|||
33317695|NCT01233869|62692975|FG002|Extended Treatment Period (46 Months)|Other|0|||
33317696|NCT01233869|62692976|FG003|Extended Treatment Period (46 Months)|Other|3|||
33317697|NCT01233869|62692973|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
33317698|NCT01233869|62692974|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
33317699|NCT01233869|62692975|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
33317700|NCT01233869|62692976|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
33317701|NCT00992992|62692986|FG000|Overall Study|Lost to Follow-up|3|||
33402018|NCT00642278|62780922|FG004|Overall Study|Noncompliance with study drug regimen|0|||
33402019|NCT00642278|62780923|FG005|Overall Study|Noncompliance with study drug regimen|0|||
33402020|NCT00642278|62780924|FG006|Overall Study|Noncompliance with study drug regimen|0|||
33402021|NCT00642278|62780918|FG000|Overall Study|Other|2|||
33402022|NCT00642278|62780919|FG001|Overall Study|Other|1|||
33402023|NCT00642278|62780920|FG002|Overall Study|Other|0|||
33402024|NCT00642278|62780921|FG003|Overall Study|Other|1|||
33402025|NCT00642278|62780922|FG004|Overall Study|Other|0|||
33714420|NCT01715285|63286795|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
33714421|NCT01715285|63286796|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
33714422|NCT01715285|63286797|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
33714423|NCT01715285|63286795|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
33714424|NCT01715285|63286796|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
33714425|NCT01715285|63286797|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
33714426|NCT01715285|63286795|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
33714427|NCT01715285|63286796|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
33714428|NCT01715285|63286797|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
33714429|NCT01715285|63286795|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
33714430|NCT01715285|63286796|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
33714431|NCT01715285|63286797|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
33714432|NCT01715285|63286795|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
33714433|NCT01715285|63286796|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
33714434|NCT01715285|63286797|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
33714435|NCT01715285|63286795|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
33714436|NCT01715285|63286796|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
33714437|NCT01715285|63286797|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
33714438|NCT01715285|63286795|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
33714439|NCT01715285|63286796|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
33714440|NCT01715285|63286797|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
33714441|NCT01250496|63286806|FG000|Overall Study|Study terminated|124|||
33714442|NCT01250496|63286807|FG001|Overall Study|Study terminated|124|||
33714443|NCT01105975|63286823|FG000|Overall Study|Adverse Event|2|||
33714444|NCT01105975|63286824|FG001|Overall Study|Adverse Event|1|||
33317702|NCT00992992|62692986|FG000|Overall Study|Death|16|||
33317703|NCT00992992|62692986|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
33317704|NCT00992992|62692986|FG000|Overall Study|Sponsor Closed the Study|4|||
33317705|NCT00992836|62692990|FG000|Overall Study|Lost to Follow-up|1|||
33317706|NCT00992836|62692990|FG000|Overall Study|Withdrawal by Subject|2|||
33317707|NCT00992836|62692990|FG000|Overall Study|Protocol Violation|2|||
33317708|NCT00992446|62693000|FG000|Overall Study|Disease Progression|1|||
33317709|NCT00992446|62693000|FG000|Overall Study|Withdrawal by Subject|2|||
33317710|NCT00992446|62693000|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
33317711|NCT04344301|62693006|FG000|Overall Study|Withdrawal by Subject|1|||
33317712|NCT04344301|62693007|FG001|Overall Study|Withdrawal by Subject|0|||
33317713|NCT04344301|62693006|FG000|Overall Study|Death|0|||
33317714|NCT04344301|62693007|FG001|Overall Study|Death|1|||
33317715|NCT00970294|62693014|FG000|Overall Study|Physician Decision|4|||
33317716|NCT00970294|62693014|FG000|Overall Study|Withdrawal by Subject|1|||
33317717|NCT00969436|62693021|FG000|Overall Study|Protocol Violation|1|||
33317718|NCT00969436|62693022|FG001|Overall Study|Protocol Violation|3|||
33317719|NCT00969436|62693023|FG002|Overall Study|Protocol Violation|0|||
33317720|NCT00969436|62693021|FG000|Overall Study|Migrated/moved from study area|12|||
33317721|NCT00969436|62693022|FG001|Overall Study|Migrated/moved from study area|10|||
33317722|NCT00969436|62693023|FG002|Overall Study|Migrated/moved from study area|2|||
33317723|NCT00969436|62693021|FG000|Overall Study|Father - serious health problem|0|||
33317724|NCT00969436|62693022|FG001|Overall Study|Father - serious health problem|0|||
33317725|NCT00969436|62693023|FG002|Overall Study|Father - serious health problem|1|||
33317726|NCT00969436|62693021|FG000|Overall Study|Parents personal problem|0|||
33402026|NCT00642278|62780923|FG005|Overall Study|Other|1|||
33402027|NCT00642278|62780924|FG006|Overall Study|Other|0|||
33402028|NCT00543543|62780944|FG000|Base Study|Adverse Event|1|||
33402029|NCT00543543|62780945|FG001|Base Study|Adverse Event|11|||
33402030|NCT00543543|62780946|FG002|Base Study|Adverse Event|0|||
33402031|NCT00543543|62780947|FG003|Base Study|Adverse Event|5|||
33317727|NCT00969436|62693022|FG001|Overall Study|Parents personal problem|0|||
33317728|NCT00969436|62693023|FG002|Overall Study|Parents personal problem|1|||
33714445|NCT01105975|63286825|FG002|Overall Study|Adverse Event|5|||
33714446|NCT01105975|63286826|FG003|Overall Study|Adverse Event|1|||
33714447|NCT01105975|63286827|FG004|Overall Study|Adverse Event|0|||
33317729|NCT00969436|62693021|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
33317730|NCT00969436|62693022|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
33317731|NCT00969436|62693023|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
33402032|NCT00543543|62780944|FG000|Base Study|Lost to Follow-up|12|||
33402033|NCT00543543|62780945|FG001|Base Study|Lost to Follow-up|749|||
33402034|NCT00543543|62780946|FG002|Base Study|Lost to Follow-up|9|||
33714448|NCT01105975|63286828|FG005|Overall Study|Adverse Event|1|||
33317732|NCT00969436|62693021|FG000|Overall Study|Withdrawal by Subject|3|||
33317733|NCT00969436|62693022|FG001|Overall Study|Withdrawal by Subject|0|||
33317734|NCT00969436|62693023|FG002|Overall Study|Withdrawal by Subject|2|||
33317735|NCT00969436|62693021|FG000|Overall Study|Lost to Follow-up|8|||
33317736|NCT00969436|62693022|FG001|Overall Study|Lost to Follow-up|8|||
33317737|NCT00969436|62693023|FG002|Overall Study|Lost to Follow-up|5|||
33317738|NCT00900757|62693031|FG000|Overall Study|screen failure|19|||
33493852|NCT03535194|62872385|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
33493853|NCT03535194|62872386|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
33493854|NCT03535194|62872387|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
33493855|NCT03535194|62872383|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
33493856|NCT03535194|62872384|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
33493857|NCT03535194|62872385|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
33493858|NCT03535194|62872386|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
33493859|NCT03535194|62872387|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
33714449|NCT01105975|63286829|FG006|Overall Study|Adverse Event|2|||
33714450|NCT01105975|63286830|FG007|Overall Study|Adverse Event|4|||
33714451|NCT01105975|63286831|FG008|Overall Study|Adverse Event|1|||
33714452|NCT01105975|63286832|FG009|Overall Study|Adverse Event|4|||
33714453|NCT01105975|63286823|FG000|Overall Study|Withdrawal by Subject|2|||
33714454|NCT01105975|63286824|FG001|Overall Study|Withdrawal by Subject|2|||
33714455|NCT01105975|63286825|FG002|Overall Study|Withdrawal by Subject|2|||
33714456|NCT01105975|63286826|FG003|Overall Study|Withdrawal by Subject|0|||
33714457|NCT01105975|63286827|FG004|Overall Study|Withdrawal by Subject|4|||
33714458|NCT01105975|63286828|FG005|Overall Study|Withdrawal by Subject|1|||
33317739|NCT00969280|62693037|FG000|Overall Study|Protocol Violation|2|||
33317740|NCT00969280|62693038|FG001|Overall Study|Protocol Violation|1|||
33317741|NCT00969280|62693037|FG000|Overall Study|Withdrawal by Subject|0|||
33317742|NCT00969280|62693038|FG001|Overall Study|Withdrawal by Subject|1|||
33317743|NCT00969280|62693037|FG000|Overall Study|infection of influenza A(H1N1)|0|||
33317744|NCT00969280|62693038|FG001|Overall Study|infection of influenza A(H1N1)|1|||
33317745|NCT00969124|62693044|FG000|Overall Study|Protocol Violation|2|||
33317746|NCT00969124|62693044|FG000|Overall Study|Inadequate bowel preparation|15|||
33317747|NCT00969124|62693044|FG000|Overall Study|Inability to reach cecum|9|||
33317748|NCT00969124|62693044|FG000|Overall Study|Previously unrecognized disease|3|||
33317749|NCT00969124|62693044|FG000|Overall Study|Technical error|1|||
33317750|NCT00900601|62693049|FG000|Overall Study|Physician Decision|1|||
33317751|NCT00901927|62693076|FG000|Overall Study|Lack of Efficacy|1|||
33317752|NCT00901927|62693076|FG000|Overall Study|Protocol Violation|3|||
33317753|NCT00901927|62693076|FG000|Overall Study|Withdrawal by Subject|2|||
33317754|NCT00968968|62693082|FG000|Overall Study|Study closed/terminated|10|||
33317755|NCT00968968|62693083|FG001|Overall Study|Study closed/terminated|10|||
33317756|NCT00968968|62693082|FG000|Overall Study|Protocol defined stopping criteria|3|||
33317757|NCT00968968|62693083|FG001|Overall Study|Protocol defined stopping criteria|1|||
33317758|NCT00968968|62693082|FG000|Overall Study|Withdrawal by Subject|2|||
33317759|NCT00968968|62693083|FG001|Overall Study|Withdrawal by Subject|0|||
33317760|NCT00968968|62693082|FG000|Overall Study|Physician Decision|1|||
33317761|NCT00968968|62693083|FG001|Overall Study|Physician Decision|2|||
33317762|NCT00968968|62693082|FG000|Overall Study|Lost to Follow-up|0|||
33317763|NCT00968968|62693083|FG001|Overall Study|Lost to Follow-up|1|||
33317764|NCT00973102|62693092|FG000|Overall Study|Protocol Violation|1|||
33317765|NCT00973102|62693093|FG001|Overall Study|Protocol Violation|0|||
33317766|NCT00973102|62693092|FG000|Overall Study|Prisoner|0|||
33317767|NCT00973102|62693093|FG001|Overall Study|Prisoner|1|||
33317768|NCT00901459|62693099|FG000|Overall Study|Withdrawal by Subject|6|||
33317769|NCT00896233|62693110|FG000|Overall Study|Claustrophobia during MRI|1|||
33317770|NCT00899431|62693135|FG000|Overall Study|Physician Decision|1|||
33317771|NCT00899431|62693136|FG001|Overall Study|Physician Decision|0|||
33317772|NCT00899431|62693137|FG002|Overall Study|Physician Decision|0|||
33402035|NCT00543543|62780947|FG003|Base Study|Lost to Follow-up|701|||
33402036|NCT00543543|62780944|FG000|Base Study|Physician Decision|0|||
33402037|NCT00543543|62780945|FG001|Base Study|Physician Decision|4|||
33402038|NCT00543543|62780946|FG002|Base Study|Physician Decision|0|||
33402039|NCT00543543|62780947|FG003|Base Study|Physician Decision|7|||
33402040|NCT00543543|62780944|FG000|Base Study|Protocol Violation|0|||
33402041|NCT00543543|62780945|FG001|Base Study|Protocol Violation|6|||
33402042|NCT00543543|62780946|FG002|Base Study|Protocol Violation|0|||
33402043|NCT00543543|62780947|FG003|Base Study|Protocol Violation|6|||
33402044|NCT00543543|62780944|FG000|Base Study|Withdrawal by Subject|7|||
33714459|NCT01105975|63286829|FG006|Overall Study|Withdrawal by Subject|2|||
33714460|NCT01105975|63286830|FG007|Overall Study|Withdrawal by Subject|1|||
33317773|NCT00899353|62693148|FG000|Overall Study|Adverse Event|2|||
33317774|NCT00899353|62693148|FG000|Overall Study|Lost to Follow-up|1|||
33402045|NCT00543543|62780945|FG001|Base Study|Withdrawal by Subject|482|||
33402046|NCT00543543|62780946|FG002|Base Study|Withdrawal by Subject|5|||
33493860|NCT03535194|62872383|FG000|Post-Treatment Followup Period|Other|1|||
33493861|NCT03535194|62872384|FG001|Post-Treatment Followup Period|Other|0|||
33317775|NCT00899353|62693148|FG000|Overall Study|Withdrawal by Subject|2|||
33317776|NCT00898807|62693171|FG000|Overall Study|Withdrawal by Subject|5|||
33317777|NCT00898807|62693172|FG001|Overall Study|Withdrawal by Subject|3|||
33317778|NCT00898807|62693171|FG000|Overall Study|Family pressure to discontinue|2|||
33714461|NCT01105975|63286831|FG008|Overall Study|Withdrawal by Subject|0|||
33714462|NCT01105975|63286832|FG009|Overall Study|Withdrawal by Subject|3|||
33714463|NCT01105975|63286823|FG000|Overall Study|Lost to Follow-up|1|||
33714464|NCT01105975|63286824|FG001|Overall Study|Lost to Follow-up|0|||
33714465|NCT01105975|63286825|FG002|Overall Study|Lost to Follow-up|0|||
33714466|NCT01105975|63286826|FG003|Overall Study|Lost to Follow-up|1|||
33714467|NCT01105975|63286827|FG004|Overall Study|Lost to Follow-up|1|||
33714468|NCT01105975|63286828|FG005|Overall Study|Lost to Follow-up|0|||
33714469|NCT01105975|63286829|FG006|Overall Study|Lost to Follow-up|0|||
33714470|NCT01105975|63286830|FG007|Overall Study|Lost to Follow-up|0|||
33714471|NCT01105975|63286831|FG008|Overall Study|Lost to Follow-up|1|||
33714472|NCT01105975|63286832|FG009|Overall Study|Lost to Follow-up|0|||
33714473|NCT01105975|63286823|FG000|Overall Study|Physician Decision|0|||
33714474|NCT01105975|63286824|FG001|Overall Study|Physician Decision|0|||
33714475|NCT01105975|63286825|FG002|Overall Study|Physician Decision|0|||
33714476|NCT01105975|63286826|FG003|Overall Study|Physician Decision|0|||
33714477|NCT01105975|63286827|FG004|Overall Study|Physician Decision|0|||
33714478|NCT01105975|63286828|FG005|Overall Study|Physician Decision|0|||
33714479|NCT01105975|63286829|FG006|Overall Study|Physician Decision|2|||
33714480|NCT01105975|63286830|FG007|Overall Study|Physician Decision|0|||
33714481|NCT01105975|63286831|FG008|Overall Study|Physician Decision|0|||
33714482|NCT01105975|63286832|FG009|Overall Study|Physician Decision|0|||
33714483|NCT01105975|63286823|FG000|Overall Study|Protocol Violation|0|||
33714484|NCT01105975|63286824|FG001|Overall Study|Protocol Violation|2|||
33714485|NCT01105975|63286825|FG002|Overall Study|Protocol Violation|2|||
33714486|NCT01105975|63286826|FG003|Overall Study|Protocol Violation|0|||
33714487|NCT01105975|63286827|FG004|Overall Study|Protocol Violation|1|||
33714488|NCT01105975|63286828|FG005|Overall Study|Protocol Violation|1|||
33317779|NCT00898807|62693172|FG001|Overall Study|Family pressure to discontinue|2|||
33317780|NCT00898807|62693171|FG000|Overall Study|Lost to Follow-up|1|||
33317781|NCT00898807|62693172|FG001|Overall Study|Lost to Follow-up|3|||
33317782|NCT00898807|62693171|FG000|Overall Study|Death|0|||
33317783|NCT00898807|62693172|FG001|Overall Study|Death|1|||
33317784|NCT01229267|62693183|FG000|Overall Study|Adverse Event|4|||
33317785|NCT01229267|62693184|FG001|Overall Study|Adverse Event|6|||
33317786|NCT01229267|62693185|FG002|Overall Study|Adverse Event|3|||
33317787|NCT01229267|62693186|FG003|Overall Study|Adverse Event|2|||
33317788|NCT01229267|62693187|FG004|Overall Study|Adverse Event|10|||
33317789|NCT01229267|62693183|FG000|Overall Study|Death|40|||
33317790|NCT01229267|62693184|FG001|Overall Study|Death|37|||
33317791|NCT01229267|62693185|FG002|Overall Study|Death|35|||
33317792|NCT01229267|62693186|FG003|Overall Study|Death|13|||
33317793|NCT01229267|62693187|FG004|Overall Study|Death|103|||
33317794|NCT01229267|62693183|FG000|Overall Study|Withdrawal by Subject|23|||
33317795|NCT01229267|62693184|FG001|Overall Study|Withdrawal by Subject|22|||
33317796|NCT01229267|62693185|FG002|Overall Study|Withdrawal by Subject|32|||
33317797|NCT01229267|62693186|FG003|Overall Study|Withdrawal by Subject|14|||
33317798|NCT01229267|62693187|FG004|Overall Study|Withdrawal by Subject|59|||
33317799|NCT01229267|62693183|FG000|Overall Study|Protocol Violation|0|||
33317800|NCT01229267|62693184|FG001|Overall Study|Protocol Violation|1|||
33317801|NCT01229267|62693185|FG002|Overall Study|Protocol Violation|0|||
33317802|NCT01229267|62693186|FG003|Overall Study|Protocol Violation|0|||
33317803|NCT01229267|62693187|FG004|Overall Study|Protocol Violation|0|||
33317804|NCT01229267|62693183|FG000|Overall Study|Progressive disease|0|||
33317805|NCT01229267|62693184|FG001|Overall Study|Progressive disease|0|||
33317806|NCT01229267|62693185|FG002|Overall Study|Progressive disease|0|||
33317807|NCT01229267|62693186|FG003|Overall Study|Progressive disease|0|||
33714489|NCT01105975|63286829|FG006|Overall Study|Protocol Violation|1|||
33714490|NCT01105975|63286830|FG007|Overall Study|Protocol Violation|1|||
33317808|NCT01229267|62693187|FG004|Overall Study|Progressive disease|1|||
33317809|NCT01229267|62693183|FG000|Overall Study|Physician Decision|8|||
33317810|NCT01229267|62693184|FG001|Overall Study|Physician Decision|11|||
33317811|NCT01229267|62693185|FG002|Overall Study|Physician Decision|8|||
33317812|NCT01229267|62693186|FG003|Overall Study|Physician Decision|3|||
33714491|NCT01105975|63286831|FG008|Overall Study|Protocol Violation|2|||
33714492|NCT01105975|63286832|FG009|Overall Study|Protocol Violation|2|||
33714493|NCT01105975|63286823|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
33714494|NCT01105975|63286824|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
33714495|NCT01105975|63286825|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
33714496|NCT01105975|63286826|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
33714497|NCT01105975|63286827|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
33317813|NCT01229267|62693187|FG004|Overall Study|Physician Decision|25|||
33317814|NCT01229267|62693183|FG000|Overall Study|Lost to Follow-up|6|||
33317815|NCT01229267|62693184|FG001|Overall Study|Lost to Follow-up|5|||
33714498|NCT01105975|63286828|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
33317816|NCT01229267|62693185|FG002|Overall Study|Lost to Follow-up|8|||
33317817|NCT01229267|62693186|FG003|Overall Study|Lost to Follow-up|3|||
33317818|NCT01229267|62693187|FG004|Overall Study|Lost to Follow-up|22|||
33317819|NCT00897715|62693196|FG000|Overall Study|Lost to Follow-up|0|||
33317820|NCT00897715|62693197|FG001|Overall Study|Lost to Follow-up|1|||
33317821|NCT00897715|62693196|FG000|Overall Study|Physician Decision|1|||
33317822|NCT00897715|62693197|FG001|Overall Study|Physician Decision|0|||
33317823|NCT00897715|62693196|FG000|Overall Study|increased risk of infection|1|||
33317824|NCT00897715|62693197|FG001|Overall Study|increased risk of infection|0|||
33317825|NCT01229111|62693203|FG000|Overall Study|Death|1|||
33317826|NCT00894361|62693209|FG000|Overall Study|deaths and less than 2 years followup|24|||
33317827|NCT00894361|62693210|FG001|Overall Study|deaths and less than 2 years followup|64|||
33317828|NCT01228175|62693220|FG000|Overall Study|Lost to Follow-up|64|||
33317829|NCT01228175|62693221|FG001|Overall Study|Lost to Follow-up|50|||
33317830|NCT01228175|62693220|FG000|Overall Study|Withdrawal by Subject|1|||
33317831|NCT01228175|62693221|FG001|Overall Study|Withdrawal by Subject|2|||
33317832|NCT01228175|62693220|FG000|Overall Study|Physician Decision|1|||
33317833|NCT01228175|62693221|FG001|Overall Study|Physician Decision|1|||
33317834|NCT01228019|62693227|FG000|Overall Study|Dose Violation|70|||
33317835|NCT01228019|62693227|FG000|Overall Study|Duplicate enrollment|1|||
33317836|NCT01228019|62693227|FG000|Overall Study|Missing pre-treatment data|72|||
33317837|NCT01228019|62693227|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
33317838|NCT01228019|62693227|FG000|Overall Study|Violation of Entry Criterion|9|||
33317839|NCT02987959|62693231|FG000|Overall Study|Grantor stopped supply of drugs|6|||
33317840|NCT01227707|62693235|FG000|Overall Study|Adverse Event|10|||
33317841|NCT01227707|62693235|FG000|Overall Study|Progression of disease|3|||
33317842|NCT01227707|62693235|FG000|Overall Study|Withdrawal by Subject|1|||
33317843|NCT01227707|62693235|FG000|Overall Study|Patient non-compliance|3|||
33317844|NCT01227707|62693235|FG000|Overall Study|Medical decision|6|||
33317845|NCT01227707|62693235|FG000|Overall Study|Death|1|||
33317846|NCT00895843|62693241|FG000|Overall Study|Protocol Violation|12|||
33317847|NCT00895843|62693242|FG001|Overall Study|Protocol Violation|12|||
33317848|NCT00895453|62693251|FG000|Overall Study|Lost to Follow-up|25|||
33317849|NCT00895453|62693252|FG001|Overall Study|Lost to Follow-up|25|||
33317850|NCT00895453|62693253|FG002|Overall Study|Lost to Follow-up|23|||
33317851|NCT00893971|62693261|FG000|Overall Study|Physician Decision|3|||
33317852|NCT00893737|62693274|FG000|Overall Study|Adverse Event|4|||
33317853|NCT00893737|62693274|FG000|Overall Study|Withdrawal by Subject|2|||
33317854|NCT00893737|62693274|FG000|Overall Study|Lost to Follow-up|6|||
33317855|NCT00893113|62693280|FG000|Overall Study|Lost to Follow-up|4|||
33317856|NCT00893113|62693281|FG001|Overall Study|Lost to Follow-up|8|||
33317857|NCT00893113|62693280|FG000|Overall Study|Early Termination|1|||
33317858|NCT00893113|62693281|FG001|Overall Study|Early Termination|1|||
33402047|NCT00543543|62780947|FG003|Base Study|Withdrawal by Subject|503|||
33402048|NCT00543543|62780944|FG000|Extension Study|Adverse Event|0|||
33402049|NCT00543543|62780945|FG001|Extension Study|Adverse Event|0|||
33402050|NCT00543543|62780946|FG002|Extension Study|Adverse Event|0|||
33402051|NCT00543543|62780947|FG003|Extension Study|Adverse Event|5|||
33402052|NCT00543543|62780944|FG000|Extension Study|Lost to Follow-up|0|||
33402053|NCT00543543|62780945|FG001|Extension Study|Lost to Follow-up|0|||
33714499|NCT01105975|63286829|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
33714500|NCT01105975|63286830|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
33714501|NCT01105975|63286831|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
33714502|NCT01105975|63286832|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
33714503|NCT00831623|63286873|FG000|Overall Study|Withdrawal by Subject|9|||
33714504|NCT00831623|63286873|FG000|Overall Study|Lost to Follow-up|1|||
33714505|NCT00831623|63286873|FG000|Overall Study|Not 2 years post-treatment|12|||
33714506|NCT00079417|63286877|FG000|Overall Study|Physician Decision|2|||
33714507|NCT00079417|63286877|FG000|Overall Study|Ineligible|7|||
33714508|NCT05292755|63291806|FG000|Overall Study|Lost to Follow-up|5|||
33317859|NCT00893113|62693280|FG000|Overall Study|Withdrew Consent|8|||
33317860|NCT00893113|62693281|FG001|Overall Study|Withdrew Consent|7|||
33317861|NCT00892957|62693289|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
33402054|NCT00543543|62780946|FG002|Extension Study|Lost to Follow-up|0|||
33714509|NCT05292755|63291807|FG001|Overall Study|Lost to Follow-up|9|||
33714510|NCT04590781|63291821|FG000|Overall Study|Death|0|||
33714511|NCT04590781|63291822|FG001|Overall Study|Death|2|||
33714512|NCT04590781|63291821|FG000|Overall Study|Withdrawal by Subject|2|||
33317862|NCT00892957|62693290|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
33317863|NCT00892957|62693289|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
33317864|NCT00892957|62693290|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
33317865|NCT00968812|62693313|FG000|Overall Study|Adverse Event|30|||
33317866|NCT00968812|62693314|FG001|Overall Study|Adverse Event|46|||
33317867|NCT00968812|62693315|FG002|Overall Study|Adverse Event|33|||
33317868|NCT00968812|62693313|FG000|Overall Study|Death|2|||
33317869|NCT00968812|62693314|FG001|Overall Study|Death|2|||
33402055|NCT00543543|62780947|FG003|Extension Study|Lost to Follow-up|77|||
33402056|NCT00543543|62780944|FG000|Extension Study|Physician Decision|0|||
33714513|NCT04590781|63291822|FG001|Overall Study|Withdrawal by Subject|0|||
33714514|NCT04248868|63291829|FG000|Overall Study|Death|1|||
33714515|NCT04248868|63291829|FG000|Overall Study|Lost to Follow-up|3|||
33714516|NCT04248868|63291829|FG000|Overall Study|Protocol Violation|2|||
33714517|NCT04211831|63291836|FG000|Overall Study|Withdrawal by Subject|4|||
33714518|NCT04211831|63291837|FG001|Overall Study|Withdrawal by Subject|1|||
33714519|NCT04211831|63291838|FG002|Overall Study|Withdrawal by Subject|1|||
33714520|NCT04211831|63291836|FG000|Overall Study|Protocol Violation|0|||
33714521|NCT04211831|63291837|FG001|Overall Study|Protocol Violation|0|||
33714522|NCT04211831|63291838|FG002|Overall Study|Protocol Violation|1|||
33714523|NCT04211831|63291836|FG000|Overall Study|Adverse Event|0|||
33714524|NCT04211831|63291837|FG001|Overall Study|Adverse Event|1|||
33714525|NCT04211831|63291838|FG002|Overall Study|Adverse Event|0|||
33714526|NCT04211831|63291836|FG000|Overall Study|Lack of Efficacy|0|||
33714527|NCT04211831|63291837|FG001|Overall Study|Lack of Efficacy|0|||
33714528|NCT04211831|63291838|FG002|Overall Study|Lack of Efficacy|1|||
33714529|NCT04211831|63291836|FG000|Overall Study|Lost to Follow-up|0|||
33714530|NCT04211831|63291837|FG001|Overall Study|Lost to Follow-up|0|||
33714531|NCT04211831|63291838|FG002|Overall Study|Lost to Follow-up|2|||
33714532|NCT04211831|63291836|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
33714533|NCT04211831|63291837|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
33714534|NCT04211831|63291838|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
33714535|NCT04211831|63291836|FG000|Overall Study|Other|0|||
33714536|NCT04211831|63291837|FG001|Overall Study|Other|1|||
33714537|NCT04211831|63291838|FG002|Overall Study|Other|0|||
33714538|NCT04067518|63291896|FG000|Overall Study|Adverse Event|1|||
33714539|NCT04067518|63291897|FG001|Overall Study|Adverse Event|3|||
33714540|NCT04067518|63291896|FG000|Overall Study|Screen failures|0|||
33714541|NCT04067518|63291897|FG001|Overall Study|Screen failures|1|||
33714542|NCT04067518|63291896|FG000|Overall Study|Enrolled but not treated|0|||
33714543|NCT04067518|63291897|FG001|Overall Study|Enrolled but not treated|1|||
33714544|NCT03912233|63291938|FG000|Overall Study|Adverse Event|1|||
33714545|NCT03912233|63291939|FG001|Overall Study|Adverse Event|0|||
33714546|NCT03912233|63291940|FG002|Overall Study|Adverse Event|0|||
33714547|NCT03912233|63291941|FG003|Overall Study|Adverse Event|0|||
33714548|NCT03912233|63291942|FG004|Overall Study|Adverse Event|0|||
33714549|NCT03912233|63291943|FG005|Overall Study|Adverse Event|0|||
33714550|NCT03912233|63291938|FG000|Overall Study|Physician Decision|1|||
33714551|NCT03912233|63291939|FG001|Overall Study|Physician Decision|0|||
33714552|NCT03912233|63291940|FG002|Overall Study|Physician Decision|0|||
33714553|NCT03912233|63291941|FG003|Overall Study|Physician Decision|0|||
33714554|NCT03912233|63291942|FG004|Overall Study|Physician Decision|0|||
33714555|NCT03912233|63291943|FG005|Overall Study|Physician Decision|0|||
33714556|NCT03912233|63291938|FG000|Overall Study|Other|0|||
33714557|NCT03912233|63291939|FG001|Overall Study|Other|0|||
33714558|NCT03912233|63291940|FG002|Overall Study|Other|0|||
33714559|NCT03912233|63291941|FG003|Overall Study|Other|0|||
33714560|NCT03912233|63291942|FG004|Overall Study|Other|7|||
33714561|NCT03912233|63291943|FG005|Overall Study|Other|12|||
33714562|NCT03834519|63291967|FG000|Overall Study|Ongoing|234|||
33714563|NCT03834519|63291968|FG001|Overall Study|Ongoing|111|||
33714564|NCT03834519|63291967|FG000|Overall Study|Withdrawal by Subject|4|||
33714565|NCT03834519|63291968|FG001|Overall Study|Withdrawal by Subject|7|||
33714566|NCT03834519|63291967|FG000|Overall Study|Death|291|||
33714567|NCT03834519|63291968|FG001|Overall Study|Death|146|||
33714568|NCT03546062|63291995|FG000|Overall Study|Adverse Event|6|||
33714569|NCT03546062|63291996|FG001|Overall Study|Adverse Event|5|||
33714570|NCT03546062|63291997|FG002|Overall Study|Adverse Event|8|||
33714571|NCT03539952|63292007|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
33714572|NCT03539952|63292008|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
33714573|NCT03539952|63292007|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
33714574|NCT03539952|63292008|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
33714575|NCT03539952|63292007|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
33714576|NCT03539952|63292008|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
33714577|NCT03539952|63292007|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
33714578|NCT03539952|63292008|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
33714579|NCT03539952|63292007|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
33714580|NCT03539952|63292008|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
33714581|NCT03539952|63292007|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
33714582|NCT03539952|63292008|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
33714583|NCT03539952|63292007|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
33714584|NCT03539952|63292008|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
33714585|NCT02929108|63292040|FG000|Overall Study|Hospice patient death|100|||
33714586|NCT02929108|63292041|FG001|Overall Study|Hospice patient death|64|||
33714587|NCT02929108|63292042|FG002|Overall Study|Hospice patient death|28|||
33714588|NCT02929108|63292043|FG003|Overall Study|Hospice patient death|46|||
33714589|NCT02929108|63292044|FG004|Overall Study|Hospice patient death|55|||
33714590|NCT02929108|63292045|FG005|Overall Study|Hospice patient death|28|||
33714591|NCT02929108|63292046|FG006|Overall Study|Hospice patient death|78|||
33714592|NCT02661295|63292054|FG000|Overall Study|Death|1|||
33714593|NCT02661295|63292054|FG000|Overall Study|Transferred Out|1|||
33714594|NCT02661295|63292054|FG000|Overall Study|Kidney Transplant|1|||
33714595|NCT02661295|63292054|FG000|Overall Study|Withdrawn due to side effects|8|||
33714596|NCT02661295|63292054|FG000|Overall Study|Withdrawn due to access type|1|||
33714597|NCT02661295|63292054|FG000|Overall Study|Withdrawn due to allergies|1|||
33714598|NCT02661295|63292054|FG000|Overall Study|Withdrawn due to non-compliance|1|||
33714599|NCT02661295|63292054|FG000|Overall Study|Withdrawal by Subject|3|||
33714600|NCT02661295|63292054|FG000|Overall Study|Failed screening|2|||
33714601|NCT02527434|63292061|FG000|Overall Study|Lost to Follow-up|2|||
33714602|NCT02527434|63292062|FG001|Overall Study|Lost to Follow-up|2|||
33714603|NCT02527434|63292063|FG002|Overall Study|Lost to Follow-up|0|||
33714604|NCT02527434|63292061|FG000|Overall Study|Death|19|||
33714605|NCT02527434|63292062|FG001|Overall Study|Death|6|||
33714606|NCT02527434|63292063|FG002|Overall Study|Death|17|||
33714607|NCT02527434|63292061|FG000|Overall Study|Withdrawal by Subject|5|||
33714608|NCT02527434|63292062|FG001|Overall Study|Withdrawal by Subject|3|||
33714609|NCT02527434|63292063|FG002|Overall Study|Withdrawal by Subject|3|||
33714610|NCT02527434|63292061|FG000|Overall Study|Reason Not Specified|1|||
33714611|NCT02527434|63292062|FG001|Overall Study|Reason Not Specified|0|||
33714612|NCT02527434|63292063|FG002|Overall Study|Reason Not Specified|0|||
33714613|NCT02527434|63292061|FG000|Overall Study|Site closure|1|||
33714614|NCT02527434|63292062|FG001|Overall Study|Site closure|0|||
33714615|NCT02527434|63292063|FG002|Overall Study|Site closure|0|||
33714616|NCT02412748|63292101|FG000|Overall Study|Lost to Follow-up|38|||
33714617|NCT02412748|63292102|FG001|Overall Study|Lost to Follow-up|39|||
33714618|NCT01844726|63292127|FG000|Overall Study|Withdrawal by Subject|0|||
33714619|NCT01844726|63292128|FG001|Overall Study|Withdrawal by Subject|1|||
33714620|NCT01844726|63292127|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
33714621|NCT01844726|63292128|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
33714622|NCT02538666|63297689|FG000|Pre-Treatment|Disease progression|1|||
33714623|NCT02538666|63297690|FG001|Pre-Treatment|Disease progression|0|||
33714624|NCT02538666|63297691|FG002|Pre-Treatment|Disease progression|0|||
33714625|NCT02538666|63297689|FG000|Pre-Treatment|no longer meets study criteria|1|||
33714626|NCT02538666|63297690|FG001|Pre-Treatment|no longer meets study criteria|0|||
33317870|NCT00968812|62693315|FG002|Overall Study|Death|1|||
33317871|NCT00968812|62693313|FG000|Overall Study|Lack of Efficacy|9|||
33317872|NCT00968812|62693314|FG001|Overall Study|Lack of Efficacy|7|||
33317873|NCT00968812|62693315|FG002|Overall Study|Lack of Efficacy|16|||
33317874|NCT00968812|62693313|FG000|Overall Study|Lost to Follow-up|17|||
33317875|NCT00968812|62693314|FG001|Overall Study|Lost to Follow-up|12|||
33317876|NCT00968812|62693315|FG002|Overall Study|Lost to Follow-up|11|||
33317877|NCT00968812|62693313|FG000|Overall Study|Physician Decision|8|||
33317878|NCT00968812|62693314|FG001|Overall Study|Physician Decision|5|||
33317879|NCT00968812|62693315|FG002|Overall Study|Physician Decision|9|||
33317880|NCT00968812|62693313|FG000|Overall Study|Protocol Violation|7|||
33317881|NCT00968812|62693314|FG001|Overall Study|Protocol Violation|4|||
33317882|NCT00968812|62693315|FG002|Overall Study|Protocol Violation|3|||
33317883|NCT00968812|62693313|FG000|Overall Study|Withdrawal by Subject|17|||
33317884|NCT00968812|62693314|FG001|Overall Study|Withdrawal by Subject|23|||
33317885|NCT00968812|62693315|FG002|Overall Study|Withdrawal by Subject|25|||
33317886|NCT00968812|62693313|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
33317887|NCT00968812|62693314|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
33317888|NCT00968812|62693315|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
33317889|NCT00968812|62693313|FG000|Overall Study|Noncompliance with study drug|4|||
33317890|NCT00968812|62693314|FG001|Overall Study|Noncompliance with study drug|1|||
33317891|NCT00968812|62693315|FG002|Overall Study|Noncompliance with study drug|6|||
33714627|NCT02538666|63297691|FG002|Pre-Treatment|no longer meets study criteria|0|||
33714628|NCT02538666|63297689|FG000|Pre-Treatment|Withdrew Consent|0|||
33714629|NCT02538666|63297690|FG001|Pre-Treatment|Withdrew Consent|1|||
33317892|NCT00968812|62693313|FG000|Overall Study|Unable to take rescue therapy|12|||
33317893|NCT00968812|62693314|FG001|Overall Study|Unable to take rescue therapy|12|||
33317894|NCT00968812|62693315|FG002|Overall Study|Unable to take rescue therapy|17|||
33714630|NCT02538666|63297691|FG002|Pre-Treatment|Withdrew Consent|1|||
33714631|NCT02538666|63297689|FG000|Treatment|Disease progression|270|||
33714632|NCT02538666|63297690|FG001|Treatment|Disease progression|227|||
33317895|NCT00968812|62693313|FG000|Overall Study|Other|25|||
33317896|NCT00968812|62693314|FG001|Overall Study|Other|37|||
33317897|NCT00968812|62693315|FG002|Overall Study|Other|40|||
33402057|NCT00543543|62780945|FG001|Extension Study|Physician Decision|0|||
33714633|NCT02538666|63297691|FG002|Treatment|Disease progression|165|||
33714634|NCT02538666|63297689|FG000|Treatment|Study drug toxicity|1|||
33714635|NCT02538666|63297690|FG001|Treatment|Study drug toxicity|29|||
33714636|NCT02538666|63297691|FG002|Treatment|Study drug toxicity|92|||
33714637|NCT02538666|63297689|FG000|Treatment|Death|0|||
33714638|NCT02538666|63297690|FG001|Treatment|Death|2|||
33714639|NCT02538666|63297691|FG002|Treatment|Death|3|||
33714640|NCT02538666|63297689|FG000|Treatment|Adverse event unrelated to study drug|8|||
33714641|NCT02538666|63297690|FG001|Treatment|Adverse event unrelated to study drug|10|||
33714642|NCT02538666|63297691|FG002|Treatment|Adverse event unrelated to study drug|15|||
33714643|NCT02538666|63297689|FG000|Treatment|Participant request to discontinue study treatment|3|||
33714644|NCT02538666|63297690|FG001|Treatment|Participant request to discontinue study treatment|6|||
33714645|NCT02538666|63297691|FG002|Treatment|Participant request to discontinue study treatment|11|||
33714646|NCT02538666|63297689|FG000|Treatment|Participant withdrew consent|2|||
33714647|NCT02538666|63297690|FG001|Treatment|Participant withdrew consent|5|||
33714648|NCT02538666|63297691|FG002|Treatment|Participant withdrew consent|3|||
33714649|NCT02538666|63297689|FG000|Treatment|Lost to Follow-up|0|||
33714650|NCT02538666|63297690|FG001|Treatment|Lost to Follow-up|1|||
33714651|NCT02538666|63297691|FG002|Treatment|Lost to Follow-up|1|||
33714652|NCT02538666|63297689|FG000|Treatment|Maximum clinical benefit|4|||
33714653|NCT02538666|63297690|FG001|Treatment|Maximum clinical benefit|3|||
33714654|NCT02538666|63297691|FG002|Treatment|Maximum clinical benefit|4|||
33714655|NCT02538666|63297689|FG000|Treatment|Poor/non-compliance|0|||
33714656|NCT02538666|63297690|FG001|Treatment|Poor/non-compliance|1|||
33714657|NCT02538666|63297691|FG002|Treatment|Poor/non-compliance|0|||
33714658|NCT02538666|63297689|FG000|Treatment|Participant no longer meets study criteria|0|||
33714659|NCT02538666|63297690|FG001|Treatment|Participant no longer meets study criteria|2|||
33714660|NCT02538666|63297691|FG002|Treatment|Participant no longer meets study criteria|0|||
33714661|NCT02538666|63297689|FG000|Treatment|Administrative reason by sponsor|0|||
33714662|NCT02538666|63297690|FG001|Treatment|Administrative reason by sponsor|0|||
33714663|NCT02538666|63297691|FG002|Treatment|Administrative reason by sponsor|1|||
33714664|NCT02538666|63297689|FG000|Treatment|Other reasons|8|||
33714665|NCT02538666|63297690|FG001|Treatment|Other reasons|15|||
33317898|NCT00992056|62693328|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
33317899|NCT00992056|62693329|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
33317900|NCT00992056|62693328|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
33317901|NCT00992056|62693329|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
33317902|NCT00972322|62693337|FG000|Overall Study|Adverse Event|2|||
33317903|NCT00972322|62693338|FG001|Overall Study|Adverse Event|1|||
33317904|NCT00972322|62693337|FG000|Overall Study|Positive drug screen|0|||
33317905|NCT00972322|62693338|FG001|Overall Study|Positive drug screen|1|||
33317906|NCT00972322|62693337|FG000|Overall Study|Lost to Follow-up|0|||
33317907|NCT00972322|62693338|FG001|Overall Study|Lost to Follow-up|1|||
33317908|NCT00972322|62693337|FG000|Overall Study|Consistently high glucose values|1|||
33317909|NCT00972322|62693338|FG001|Overall Study|Consistently high glucose values|0|||
33317910|NCT00967798|62693346|FG000|Overall Study|Withdrawal by Subject|5|||
33317911|NCT00967798|62693347|FG001|Overall Study|Withdrawal by Subject|2|||
33317912|NCT00967798|62693346|FG000|Overall Study|Lost to Follow-up|4|||
33317913|NCT00967798|62693347|FG001|Overall Study|Lost to Follow-up|1|||
33317914|NCT00965458|62693355|FG000|Overall Study|Adverse Event|1|||
33317915|NCT00965458|62693356|FG001|Overall Study|Adverse Event|0|||
33317916|NCT00965458|62693355|FG000|Overall Study|Lost to Follow-up|1|||
33317917|NCT00965458|62693356|FG001|Overall Study|Lost to Follow-up|3|||
33317918|NCT00965458|62693355|FG000|Overall Study|Withdrawal by Subject|0|||
33317919|NCT00965458|62693356|FG001|Overall Study|Withdrawal by Subject|1|||
33317920|NCT00972244|62693369|FG000|Overall Study|Incorrect Enrolment|1|||
33317921|NCT00972244|62693370|FG001|Overall Study|Incorrect Enrolment|0|||
33317922|NCT00972244|62693371|FG002|Overall Study|Incorrect Enrolment|0|||
33317923|NCT00972244|62693372|FG003|Overall Study|Incorrect Enrolment|0|||
33317924|NCT00972244|62693373|FG004|Overall Study|Incorrect Enrolment|0|||
33317925|NCT00972244|62693369|FG000|Overall Study|Adverse Event|0|||
33317926|NCT00972244|62693370|FG001|Overall Study|Adverse Event|1|||
33317927|NCT00972244|62693371|FG002|Overall Study|Adverse Event|1|||
33317928|NCT00972244|62693372|FG003|Overall Study|Adverse Event|0|||
33317929|NCT00972244|62693373|FG004|Overall Study|Adverse Event|0|||
33317930|NCT00972244|62693369|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
33317931|NCT00972244|62693370|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
33317932|NCT00972244|62693371|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
33317933|NCT00972244|62693372|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
33317934|NCT00972244|62693373|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
33317935|NCT00972244|62693369|FG000|Overall Study|Withdrawal by Subject|1|||
33714666|NCT02538666|63297691|FG002|Treatment|Other reasons|5|||
33714667|NCT02538666|63297689|FG000|Treatment|Not reported|2|||
33714668|NCT02538666|63297690|FG001|Treatment|Not reported|2|||
33714669|NCT02538666|63297691|FG002|Treatment|Not reported|2|||
33714670|NCT02407236|63297745|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
33714671|NCT02407236|63297746|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
33714672|NCT02407236|63297747|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
33317936|NCT00972244|62693370|FG001|Overall Study|Withdrawal by Subject|2|||
33317937|NCT00972244|62693371|FG002|Overall Study|Withdrawal by Subject|1|||
33317938|NCT00972244|62693372|FG003|Overall Study|Withdrawal by Subject|0|||
33317939|NCT00972244|62693373|FG004|Overall Study|Withdrawal by Subject|1|||
33317940|NCT00972244|62693369|FG000|Overall Study|Safety|0|||
33317941|NCT00972244|62693370|FG001|Overall Study|Safety|0|||
33317942|NCT00972244|62693371|FG002|Overall Study|Safety|0|||
33317943|NCT00972244|62693372|FG003|Overall Study|Safety|0|||
33317944|NCT00972244|62693373|FG004|Overall Study|Safety|1|||
33317945|NCT00972244|62693369|FG000|Overall Study|Death|1|||
33317946|NCT00972244|62693370|FG001|Overall Study|Death|0|||
33317947|NCT00972244|62693371|FG002|Overall Study|Death|0|||
33317948|NCT00972244|62693372|FG003|Overall Study|Death|0|||
33317949|NCT00972244|62693373|FG004|Overall Study|Death|0|||
33317950|NCT00972244|62693369|FG000|Overall Study|Various|0|||
33317951|NCT00972244|62693370|FG001|Overall Study|Various|0|||
33317952|NCT00972244|62693371|FG002|Overall Study|Various|0|||
33317953|NCT00972244|62693372|FG003|Overall Study|Various|0|||
33317954|NCT00972244|62693373|FG004|Overall Study|Various|2|||
33317955|NCT00892723|62693388|FG000|Overall Study|Lost to Follow-up|1|||
33317956|NCT00892723|62693389|FG001|Overall Study|Lost to Follow-up|3|||
33317957|NCT00892723|62693390|FG002|Overall Study|Lost to Follow-up|1|||
33317958|NCT00892723|62693388|FG000|Overall Study|Withdrawal by Subject|1|||
33714673|NCT02407236|63297748|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
33714674|NCT02407236|63297749|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
33714675|NCT02407236|63297750|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
33714676|NCT02407236|63297751|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
33714677|NCT02407236|63297752|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
33714678|NCT02407236|63297753|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
33714679|NCT02407236|63297754|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
33714680|NCT02407236|63297755|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
33714681|NCT02407236|63297756|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
33714682|NCT02407236|63297757|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
33714683|NCT02407236|63297745|FG000|Induction Study (8 Weeks)|Death|0|||
33714684|NCT02407236|63297746|FG001|Induction Study (8 Weeks)|Death|0|||
33714685|NCT02407236|63297747|FG002|Induction Study (8 Weeks)|Death|1|||
33714686|NCT02407236|63297748|FG003|Induction Study (8 Weeks)|Death|0|||
33714687|NCT02407236|63297749|FG004|Induction Study (8 Weeks)|Death|0|||
33714688|NCT02407236|63297750|FG005|Induction Study (8 Weeks)|Death|0|||
33714689|NCT02407236|63297751|FG006|Induction Study (8 Weeks)|Death|0|||
33714690|NCT02407236|63297752|FG007|Induction Study (8 Weeks)|Death|0|||
33714691|NCT02407236|63297753|FG008|Induction Study (8 Weeks)|Death|0|||
33714692|NCT02407236|63297754|FG009|Induction Study (8 Weeks)|Death|0|||
33714693|NCT02407236|63297755|FG010|Induction Study (8 Weeks)|Death|0|||
33714694|NCT02407236|63297756|FG011|Induction Study (8 Weeks)|Death|0|||
33714695|NCT02407236|63297757|FG012|Induction Study (8 Weeks)|Death|0|||
33714696|NCT02407236|63297745|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
33714697|NCT02407236|63297746|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
33714698|NCT02407236|63297747|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
33714699|NCT02407236|63297748|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33714700|NCT02407236|63297749|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33714701|NCT02407236|63297750|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33714702|NCT02407236|63297751|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33714703|NCT02407236|63297752|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33714704|NCT02407236|63297753|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33714705|NCT02407236|63297754|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33714706|NCT02407236|63297755|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33714707|NCT02407236|63297756|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33714708|NCT02407236|63297757|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33714709|NCT02407236|63297745|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33714710|NCT02407236|63297746|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33714711|NCT02407236|63297747|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
33714712|NCT02407236|63297748|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33714713|NCT02407236|63297749|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33317959|NCT00892723|62693389|FG001|Overall Study|Withdrawal by Subject|1|||
33714714|NCT02407236|63297750|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33714715|NCT02407236|63297751|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33714716|NCT02407236|63297752|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33714717|NCT02407236|63297753|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33714718|NCT02407236|63297754|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33714719|NCT02407236|63297755|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33317960|NCT00892723|62693390|FG002|Overall Study|Withdrawal by Subject|1|||
33317961|NCT03811912|62693433|FG000|Overall Study|Withdrew Consent|4|||
33317962|NCT03811912|62693434|FG001|Overall Study|Withdrew Consent|2|||
33317963|NCT00971932|62693440|FG000|Overall Study|Withdrawal by Subject|1|||
33317964|NCT00971932|62693440|FG000|Overall Study|Investigator's decision|2|||
33317965|NCT00971932|62693440|FG000|Overall Study|Ongoing|4|||
33714720|NCT02407236|63297756|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33714721|NCT02407236|63297757|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33714722|NCT02407236|63297745|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
33714723|NCT02407236|63297746|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
33714724|NCT02407236|63297747|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
33714725|NCT02407236|63297748|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
33714726|NCT02407236|63297749|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
33714727|NCT02407236|63297750|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
33714728|NCT02407236|63297751|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
33714729|NCT02407236|63297752|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
33714730|NCT02407236|63297753|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
33714731|NCT02407236|63297754|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
33714732|NCT02407236|63297755|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
33714733|NCT02407236|63297756|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
33714734|NCT02407236|63297757|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
33714735|NCT02407236|63297745|FG000|Induction Study (8 Weeks)|Other|2|||
33714736|NCT02407236|63297746|FG001|Induction Study (8 Weeks)|Other|1|||
33714737|NCT02407236|63297747|FG002|Induction Study (8 Weeks)|Other|5|||
33714738|NCT02407236|63297748|FG003|Induction Study (8 Weeks)|Other|0|||
33714739|NCT02407236|63297749|FG004|Induction Study (8 Weeks)|Other|0|||
33714740|NCT02407236|63297750|FG005|Induction Study (8 Weeks)|Other|0|||
33714741|NCT02407236|63297751|FG006|Induction Study (8 Weeks)|Other|0|||
33714742|NCT02407236|63297752|FG007|Induction Study (8 Weeks)|Other|0|||
33714743|NCT02407236|63297753|FG008|Induction Study (8 Weeks)|Other|0|||
33714744|NCT02407236|63297754|FG009|Induction Study (8 Weeks)|Other|0|||
33714745|NCT02407236|63297755|FG010|Induction Study (8 Weeks)|Other|0|||
33714746|NCT02407236|63297756|FG011|Induction Study (8 Weeks)|Other|0|||
33714747|NCT02407236|63297757|FG012|Induction Study (8 Weeks)|Other|0|||
33317966|NCT00970684|62693444|FG000|Overall Study|Lack of Efficacy|5|||
33317967|NCT00970684|62693444|FG000|Overall Study|Adverse Event|4|||
33714748|NCT02407236|63297745|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
33714749|NCT02407236|63297746|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
33714750|NCT02407236|63297747|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
33714751|NCT02407236|63297748|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
33317968|NCT00970684|62693444|FG000|Overall Study|Withdrawal by Subject|1|||
33317969|NCT00967330|62693450|FG000|Overall Study|Protocol Violation|3|||
33317970|NCT00967330|62693451|FG001|Overall Study|Protocol Violation|4|||
33317971|NCT00967330|62693450|FG000|Overall Study|Regular|10|||
33317972|NCT00967330|62693451|FG001|Overall Study|Regular|3|||
33317973|NCT00967330|62693450|FG000|Overall Study|Withdrawal by Subject|6|||
33317974|NCT00967330|62693451|FG001|Overall Study|Withdrawal by Subject|0|||
33317975|NCT00967330|62693450|FG000|Overall Study|Lost to Follow-up|1|||
33317976|NCT00967330|62693451|FG001|Overall Study|Lost to Follow-up|1|||
33317977|NCT00967330|62693450|FG000|Overall Study|Death|102|||
33317978|NCT00967330|62693451|FG001|Overall Study|Death|51|||
33317979|NCT00967330|62693450|FG000|Overall Study|Severe protocol deviation|0|||
33317980|NCT00967330|62693451|FG001|Overall Study|Severe protocol deviation|1|||
33317981|NCT00967018|62693457|FG000|Overall Study|Adverse Event|2|||
33317982|NCT00967018|62693457|FG000|Overall Study|Physician Decision|7|||
33317983|NCT00967018|62693457|FG000|Overall Study|Lost to Follow-up|2|||
33317984|NCT00967018|62693457|FG000|Overall Study|Withdrawal by Subject|1|||
33317985|NCT00967018|62693457|FG000|Overall Study|Miscellaneous Reasons|9|||
33317986|NCT00965146|62693461|FG000|Overall Study|Death|7|||
33317987|NCT00965146|62693461|FG000|Overall Study|Lost to Follow-up|22|||
33317988|NCT00965146|62693461|FG000|Overall Study|Withdrawal by Subject|17|||
33317989|NCT00965146|62693461|FG000|Overall Study|Unable to return|1|||
33317990|NCT00965146|62693461|FG000|Overall Study|Unwilling to return|11|||
33317991|NCT00965146|62693461|FG000|Overall Study|Intercurrent illness|1|||
33317992|NCT00965146|62693461|FG000|Overall Study|Revision / Removal of Study Implant|6|||
33317993|NCT00965146|62693461|FG000|Overall Study|Overall Study Termination|145|||
33317994|NCT00966940|62693467|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
33317995|NCT00966940|62693468|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
33317996|NCT00966940|62693467|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
33317997|NCT00966940|62693468|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
33317998|NCT00965848|62693474|FG000|Overall Study|Protocol Violation|3|||
33714752|NCT02407236|63297749|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
33714753|NCT02407236|63297750|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
33714754|NCT02407236|63297751|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
33317999|NCT00965848|62693475|FG001|Overall Study|Protocol Violation|0|||
33318000|NCT00965848|62693476|FG002|Overall Study|Protocol Violation|1|||
33714755|NCT02407236|63297752|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
33714756|NCT02407236|63297753|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
33714757|NCT02407236|63297754|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
33714758|NCT02407236|63297755|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
33714759|NCT02407236|63297756|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
33714760|NCT02407236|63297757|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
33318001|NCT00965848|62693474|FG000|Overall Study|Death|11|||
33318002|NCT00965848|62693475|FG001|Overall Study|Death|1|||
33318003|NCT00965848|62693476|FG002|Overall Study|Death|5|||
33318004|NCT00965848|62693474|FG000|Overall Study|Lost to Follow-up|0|||
33318005|NCT00965848|62693475|FG001|Overall Study|Lost to Follow-up|0|||
33318006|NCT00965848|62693476|FG002|Overall Study|Lost to Follow-up|1|||
33318007|NCT00965848|62693474|FG000|Overall Study|Withdrawal by Subject|1|||
33318008|NCT00965848|62693475|FG001|Overall Study|Withdrawal by Subject|0|||
33318009|NCT00965848|62693476|FG002|Overall Study|Withdrawal by Subject|0|||
33318010|NCT00965848|62693474|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
33318011|NCT00965848|62693475|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
33318012|NCT00965848|62693476|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
33318013|NCT00965848|62693474|FG000|Overall Study|Not Clinically Evaluable|7|||
33318014|NCT00965848|62693475|FG001|Overall Study|Not Clinically Evaluable|1|||
33318015|NCT00965848|62693476|FG002|Overall Study|Not Clinically Evaluable|1|||
33318016|NCT00965848|62693474|FG000|Overall Study|Other|5|||
33318017|NCT00965848|62693475|FG001|Overall Study|Other|0|||
33318018|NCT00965848|62693476|FG002|Overall Study|Other|1|||
33318019|NCT00961636|62693487|FG000|Overall Study|Adverse Event|35|||
33318020|NCT00961636|62693488|FG001|Overall Study|Adverse Event|54|||
33318021|NCT00961636|62693489|FG002|Overall Study|Adverse Event|13|||
33318022|NCT00961636|62693487|FG000|Overall Study|Flushing Symptoms|29|||
33318023|NCT00961636|62693488|FG001|Overall Study|Flushing Symptoms|46|||
33318024|NCT00961636|62693489|FG002|Overall Study|Flushing Symptoms|3|||
33318025|NCT00961636|62693487|FG000|Overall Study|Lost to Follow-up|2|||
33318026|NCT00961636|62693488|FG001|Overall Study|Lost to Follow-up|3|||
33318027|NCT00961636|62693489|FG002|Overall Study|Lost to Follow-up|1|||
33318028|NCT00961636|62693487|FG000|Overall Study|Physician Decision|3|||
33318029|NCT00961636|62693488|FG001|Overall Study|Physician Decision|1|||
33318030|NCT00961636|62693489|FG002|Overall Study|Physician Decision|1|||
33318031|NCT00961636|62693487|FG000|Overall Study|Protocol Violation|9|||
33318032|NCT00961636|62693488|FG001|Overall Study|Protocol Violation|5|||
33318033|NCT00961636|62693489|FG002|Overall Study|Protocol Violation|1|||
33318034|NCT00961636|62693487|FG000|Overall Study|Withdrawal by Subject|29|||
33318035|NCT00961636|62693488|FG001|Overall Study|Withdrawal by Subject|22|||
33318036|NCT00961636|62693489|FG002|Overall Study|Withdrawal by Subject|13|||
33318037|NCT00964678|62693497|FG000|Overall Study|Physician Decision|4|||
33318038|NCT00964366|62693504|FG000|Overall Study|Did not qualify at Day 1|1|||
33318039|NCT00964366|62693505|FG001|Overall Study|Did not qualify at Day 1|0|||
33318040|NCT00964366|62693504|FG000|Overall Study|Withdrawal by Subject|0|||
33714761|NCT02407236|63297745|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33714762|NCT02407236|63297746|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33714763|NCT02407236|63297747|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33714764|NCT02407236|63297748|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
33714765|NCT02407236|63297749|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
33714766|NCT02407236|63297750|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
33714767|NCT02407236|63297751|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
33318041|NCT00964366|62693505|FG001|Overall Study|Withdrawal by Subject|1|||
33318042|NCT00960154|62693513|FG000|Overall Study|Study termination|25|||
33318043|NCT00960154|62693514|FG001|Overall Study|Study termination|25|||
33318044|NCT00960076|62693522|FG000|Overall Study|Adverse Event|1|||
33318045|NCT00960076|62693523|FG001|Overall Study|Adverse Event|7|||
33318046|NCT00960076|62693522|FG000|Overall Study|No longer met study criteria|1|||
33318047|NCT00960076|62693523|FG001|Overall Study|No longer met study criteria|5|||
33318048|NCT00960076|62693522|FG000|Overall Study|Withdrawal by Subject|1|||
33318049|NCT00960076|62693523|FG001|Overall Study|Withdrawal by Subject|2|||
33318050|NCT00960076|62693522|FG000|Overall Study|Lost to Follow-up|3|||
33318051|NCT00960076|62693523|FG001|Overall Study|Lost to Follow-up|3|||
33318052|NCT00960076|62693522|FG000|Overall Study|Severe non-compliance to protocol|1|||
33318053|NCT00960076|62693523|FG001|Overall Study|Severe non-compliance to protocol|2|||
33318054|NCT00960076|62693522|FG000|Overall Study|Hyperglycemia|1|||
33318055|NCT00960076|62693523|FG001|Overall Study|Hyperglycemia|5|||
33318056|NCT00960076|62693522|FG000|Overall Study|Did not attend the termination visit|0|||
33714768|NCT02407236|63297752|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
33714769|NCT02407236|63297753|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33318057|NCT00960076|62693523|FG001|Overall Study|Did not attend the termination visit|1|||
33318058|NCT01227629|62693539|FG000|Overall Study|Adverse Event|2|||
33318059|NCT01227629|62693540|FG001|Overall Study|Adverse Event|2|||
33318060|NCT01227629|62693541|FG002|Overall Study|Adverse Event|1|||
33318061|NCT01227629|62693542|FG003|Overall Study|Adverse Event|6|||
33318062|NCT01227629|62693543|FG004|Overall Study|Adverse Event|1|||
33318063|NCT01227629|62693544|FG005|Overall Study|Adverse Event|1|||
33318064|NCT01227629|62693545|FG006|Overall Study|Adverse Event|6|||
33318065|NCT01227629|62693546|FG007|Overall Study|Adverse Event|6|||
33318066|NCT01227629|62693547|FG008|Overall Study|Adverse Event|4|||
33318067|NCT01227629|62693548|FG009|Overall Study|Adverse Event|0|||
33318068|NCT01227629|62693539|FG000|Overall Study|Protocol Violation|0|||
33318069|NCT01227629|62693540|FG001|Overall Study|Protocol Violation|0|||
33318070|NCT01227629|62693541|FG002|Overall Study|Protocol Violation|0|||
33318071|NCT01227629|62693542|FG003|Overall Study|Protocol Violation|1|||
33318072|NCT01227629|62693543|FG004|Overall Study|Protocol Violation|0|||
33318073|NCT01227629|62693544|FG005|Overall Study|Protocol Violation|0|||
33318074|NCT01227629|62693545|FG006|Overall Study|Protocol Violation|0|||
33318075|NCT01227629|62693546|FG007|Overall Study|Protocol Violation|0|||
33318076|NCT01227629|62693547|FG008|Overall Study|Protocol Violation|0|||
33318077|NCT01227629|62693548|FG009|Overall Study|Protocol Violation|0|||
33318078|NCT01227629|62693539|FG000|Overall Study|Lost to Follow-up|0|||
33318079|NCT01227629|62693540|FG001|Overall Study|Lost to Follow-up|0|||
33318080|NCT01227629|62693541|FG002|Overall Study|Lost to Follow-up|0|||
33318081|NCT01227629|62693542|FG003|Overall Study|Lost to Follow-up|0|||
33318082|NCT01227629|62693543|FG004|Overall Study|Lost to Follow-up|1|||
33318083|NCT01227629|62693544|FG005|Overall Study|Lost to Follow-up|0|||
33318084|NCT01227629|62693545|FG006|Overall Study|Lost to Follow-up|0|||
33318085|NCT01227629|62693546|FG007|Overall Study|Lost to Follow-up|0|||
33318086|NCT01227629|62693547|FG008|Overall Study|Lost to Follow-up|0|||
33318087|NCT01227629|62693548|FG009|Overall Study|Lost to Follow-up|0|||
33318088|NCT01227629|62693539|FG000|Overall Study|Withdrawal by Subject|0|||
33318089|NCT01227629|62693540|FG001|Overall Study|Withdrawal by Subject|0|||
33318090|NCT01227629|62693541|FG002|Overall Study|Withdrawal by Subject|0|||
33318091|NCT01227629|62693542|FG003|Overall Study|Withdrawal by Subject|0|||
33318092|NCT01227629|62693543|FG004|Overall Study|Withdrawal by Subject|0|||
33318093|NCT01227629|62693544|FG005|Overall Study|Withdrawal by Subject|0|||
33318094|NCT01227629|62693545|FG006|Overall Study|Withdrawal by Subject|2|||
33318095|NCT01227629|62693546|FG007|Overall Study|Withdrawal by Subject|0|||
33318096|NCT01227629|62693547|FG008|Overall Study|Withdrawal by Subject|0|||
33318097|NCT01227629|62693548|FG009|Overall Study|Withdrawal by Subject|1|||
33318098|NCT01227629|62693539|FG000|Overall Study|Other|0|||
33318099|NCT01227629|62693540|FG001|Overall Study|Other|0|||
33318100|NCT01227629|62693541|FG002|Overall Study|Other|0|||
33318101|NCT01227629|62693542|FG003|Overall Study|Other|1|||
33318102|NCT01227629|62693543|FG004|Overall Study|Other|0|||
33318103|NCT01227629|62693544|FG005|Overall Study|Other|0|||
33318104|NCT01227629|62693545|FG006|Overall Study|Other|0|||
33318105|NCT01227629|62693546|FG007|Overall Study|Other|0|||
33318106|NCT01227629|62693547|FG008|Overall Study|Other|2|||
33318107|NCT01227629|62693548|FG009|Overall Study|Other|1|||
33318108|NCT00963820|62693594|FG000|Dose Escalation Phase|Progressive Disease|3|||
33318109|NCT00963820|62693595|FG001|Dose Escalation Phase|Progressive Disease|3|||
33318110|NCT00963820|62693596|FG002|Dose Escalation Phase|Progressive Disease|3|||
33318111|NCT00963820|62693597|FG003|Dose Escalation Phase|Progressive Disease|3|||
33318112|NCT00963820|62693598|FG004|Dose Escalation Phase|Progressive Disease|4|||
33318113|NCT00963820|62693599|FG005|Dose Escalation Phase|Progressive Disease|3|||
33318114|NCT00963820|62693600|FG006|Dose Escalation Phase|Progressive Disease|3|||
33318115|NCT00963820|62693601|FG007|Dose Escalation Phase|Progressive Disease|2|||
33318116|NCT00963820|62693602|FG008|Dose Escalation Phase|Progressive Disease|0|||
33318117|NCT00963820|62693603|FG009|Dose Escalation Phase|Progressive Disease|0|||
33318118|NCT00963820|62693604|FG010|Dose Escalation Phase|Progressive Disease|0|||
33318119|NCT00963820|62693605|FG011|Dose Escalation Phase|Progressive Disease|0|||
33318120|NCT00963820|62693594|FG000|Dose Escalation Phase|Adverse Event|0|||
33714770|NCT02407236|63297754|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33714771|NCT02407236|63297755|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33714772|NCT02407236|63297756|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33714773|NCT02407236|63297757|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33714774|NCT02407236|63297745|FG000|Maintenance Study (44 Weeks)|Other|0|||
33714775|NCT02407236|63297746|FG001|Maintenance Study (44 Weeks)|Other|0|||
33714776|NCT02407236|63297747|FG002|Maintenance Study (44 Weeks)|Other|0|||
33714777|NCT02407236|63297748|FG003|Maintenance Study (44 Weeks)|Other|5|||
33318121|NCT00963820|62693595|FG001|Dose Escalation Phase|Adverse Event|0|||
33318122|NCT00963820|62693596|FG002|Dose Escalation Phase|Adverse Event|0|||
33318123|NCT00963820|62693597|FG003|Dose Escalation Phase|Adverse Event|0|||
33318124|NCT00963820|62693598|FG004|Dose Escalation Phase|Adverse Event|0|||
33318125|NCT00963820|62693599|FG005|Dose Escalation Phase|Adverse Event|0|||
33318126|NCT00963820|62693600|FG006|Dose Escalation Phase|Adverse Event|3|||
33318127|NCT00963820|62693601|FG007|Dose Escalation Phase|Adverse Event|1|||
33318128|NCT00963820|62693602|FG008|Dose Escalation Phase|Adverse Event|0|||
33318129|NCT00963820|62693603|FG009|Dose Escalation Phase|Adverse Event|0|||
33318130|NCT00963820|62693604|FG010|Dose Escalation Phase|Adverse Event|0|||
33318131|NCT00963820|62693605|FG011|Dose Escalation Phase|Adverse Event|0|||
33318132|NCT00963820|62693594|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
33318133|NCT00963820|62693595|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
33318134|NCT00963820|62693596|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
33318135|NCT00963820|62693597|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
33318136|NCT00963820|62693598|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
33318137|NCT00963820|62693599|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
33714778|NCT02407236|63297749|FG004|Maintenance Study (44 Weeks)|Other|7|||
33714779|NCT02407236|63297750|FG005|Maintenance Study (44 Weeks)|Other|8|||
33714780|NCT02407236|63297751|FG006|Maintenance Study (44 Weeks)|Other|4|||
33714781|NCT02407236|63297752|FG007|Maintenance Study (44 Weeks)|Other|6|||
33714782|NCT02407236|63297753|FG008|Maintenance Study (44 Weeks)|Other|0|||
33714783|NCT02407236|63297754|FG009|Maintenance Study (44 Weeks)|Other|0|||
33714784|NCT02407236|63297755|FG010|Maintenance Study (44 Weeks)|Other|0|||
33714785|NCT02407236|63297756|FG011|Maintenance Study (44 Weeks)|Other|0|||
33714786|NCT02407236|63297757|FG012|Maintenance Study (44 Weeks)|Other|0|||
33714787|NCT02407236|63297745|FG000|Maintenance Study (44 Weeks)|Death|0|||
33714788|NCT02407236|63297746|FG001|Maintenance Study (44 Weeks)|Death|0|||
33714789|NCT02407236|63297747|FG002|Maintenance Study (44 Weeks)|Death|0|||
33318138|NCT00963820|62693600|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
33318139|NCT00963820|62693601|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
33318140|NCT00963820|62693602|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
33318141|NCT00963820|62693603|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
33318142|NCT00963820|62693604|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
33318143|NCT00963820|62693605|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
33318144|NCT00963820|62693594|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33318145|NCT00963820|62693595|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33318146|NCT00963820|62693596|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33318147|NCT00963820|62693597|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33318148|NCT00963820|62693598|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33318149|NCT00963820|62693599|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33318150|NCT00963820|62693600|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
33714790|NCT02407236|63297748|FG003|Maintenance Study (44 Weeks)|Death|0|||
33714791|NCT02407236|63297749|FG004|Maintenance Study (44 Weeks)|Death|0|||
33714792|NCT02407236|63297750|FG005|Maintenance Study (44 Weeks)|Death|0|||
33714793|NCT02407236|63297751|FG006|Maintenance Study (44 Weeks)|Death|0|||
33714794|NCT02407236|63297752|FG007|Maintenance Study (44 Weeks)|Death|1|||
33714795|NCT02407236|63297753|FG008|Maintenance Study (44 Weeks)|Death|0|||
33714796|NCT02407236|63297754|FG009|Maintenance Study (44 Weeks)|Death|0|||
33714797|NCT02407236|63297755|FG010|Maintenance Study (44 Weeks)|Death|0|||
33714798|NCT02407236|63297756|FG011|Maintenance Study (44 Weeks)|Death|0|||
33714799|NCT02407236|63297757|FG012|Maintenance Study (44 Weeks)|Death|0|||
33714800|NCT02407236|63297745|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33714801|NCT02407236|63297746|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33714802|NCT02407236|63297747|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33714803|NCT02407236|63297748|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33714804|NCT02407236|63297749|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33714805|NCT02407236|63297750|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33714806|NCT02407236|63297751|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33714807|NCT02407236|63297752|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33714808|NCT02407236|63297753|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
33714809|NCT02407236|63297754|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
33714810|NCT02407236|63297755|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
33714811|NCT02407236|63297756|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
33714812|NCT02407236|63297757|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
33714813|NCT02407236|63297745|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33714814|NCT02407236|63297746|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33714815|NCT02407236|63297747|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33714816|NCT02407236|63297748|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33714817|NCT02407236|63297749|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33714818|NCT02407236|63297750|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33714819|NCT02407236|63297751|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33714820|NCT02407236|63297752|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33714821|NCT02407236|63297753|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33714822|NCT02407236|63297754|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33714823|NCT02407236|63297755|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
33318151|NCT00963820|62693601|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33318152|NCT00963820|62693602|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33318153|NCT00963820|62693603|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33318154|NCT00963820|62693604|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33714824|NCT02407236|63297756|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33714825|NCT02407236|63297757|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33714826|NCT02407236|63297745|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33318155|NCT00963820|62693605|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33318156|NCT00963820|62693594|FG000|Expansion Phase|Progressive Disease|0|||
33714827|NCT02407236|63297746|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33714828|NCT02407236|63297747|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33714829|NCT02407236|63297748|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33714830|NCT02407236|63297749|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33714831|NCT02407236|63297750|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33714832|NCT02407236|63297751|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33714833|NCT02407236|63297752|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33714834|NCT02407236|63297753|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
33714835|NCT02407236|63297754|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
33714836|NCT02407236|63297755|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
33714837|NCT02407236|63297756|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
33714838|NCT02407236|63297757|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
33714839|NCT02407236|63297745|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
33714840|NCT02407236|63297746|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
33714841|NCT02407236|63297747|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
33714842|NCT02407236|63297748|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
33714843|NCT02407236|63297749|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
33714844|NCT02407236|63297750|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
33714845|NCT02407236|63297751|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
33714846|NCT02407236|63297752|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
33714847|NCT02407236|63297753|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
33714848|NCT02407236|63297754|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
33714849|NCT02407236|63297755|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
33714850|NCT02407236|63297756|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
33318157|NCT00963820|62693595|FG001|Expansion Phase|Progressive Disease|0|||
33318158|NCT00963820|62693596|FG002|Expansion Phase|Progressive Disease|0|||
33318159|NCT00963820|62693597|FG003|Expansion Phase|Progressive Disease|0|||
33318160|NCT00963820|62693598|FG004|Expansion Phase|Progressive Disease|0|||
33318161|NCT00963820|62693599|FG005|Expansion Phase|Progressive Disease|0|||
33318162|NCT00963820|62693600|FG006|Expansion Phase|Progressive Disease|0|||
33318163|NCT00963820|62693601|FG007|Expansion Phase|Progressive Disease|0|||
33318164|NCT00963820|62693602|FG008|Expansion Phase|Progressive Disease|8|||
33318165|NCT00963820|62693603|FG009|Expansion Phase|Progressive Disease|6|||
33318166|NCT00963820|62693604|FG010|Expansion Phase|Progressive Disease|4|||
33318167|NCT00963820|62693605|FG011|Expansion Phase|Progressive Disease|2|||
33318168|NCT00963820|62693594|FG000|Expansion Phase|Adverse Event|0|||
33318169|NCT00963820|62693595|FG001|Expansion Phase|Adverse Event|0|||
33318170|NCT00963820|62693596|FG002|Expansion Phase|Adverse Event|0|||
33318171|NCT00963820|62693597|FG003|Expansion Phase|Adverse Event|0|||
33318172|NCT00963820|62693598|FG004|Expansion Phase|Adverse Event|0|||
33318173|NCT00963820|62693599|FG005|Expansion Phase|Adverse Event|0|||
33318174|NCT00963820|62693600|FG006|Expansion Phase|Adverse Event|0|||
33318175|NCT00963820|62693601|FG007|Expansion Phase|Adverse Event|0|||
33318176|NCT00963820|62693602|FG008|Expansion Phase|Adverse Event|1|||
33318177|NCT00963820|62693603|FG009|Expansion Phase|Adverse Event|3|||
33318178|NCT00963820|62693604|FG010|Expansion Phase|Adverse Event|0|||
33318179|NCT00963820|62693605|FG011|Expansion Phase|Adverse Event|0|||
33318180|NCT00963820|62693594|FG000|Expansion Phase|Withdrawal by Subject|0|||
33318181|NCT00963820|62693595|FG001|Expansion Phase|Withdrawal by Subject|0|||
33318182|NCT00963820|62693596|FG002|Expansion Phase|Withdrawal by Subject|0|||
33318183|NCT00963820|62693597|FG003|Expansion Phase|Withdrawal by Subject|0|||
33318184|NCT00963820|62693598|FG004|Expansion Phase|Withdrawal by Subject|0|||
33318185|NCT00963820|62693599|FG005|Expansion Phase|Withdrawal by Subject|0|||
33318186|NCT00963820|62693600|FG006|Expansion Phase|Withdrawal by Subject|0|||
33318187|NCT00963820|62693601|FG007|Expansion Phase|Withdrawal by Subject|0|||
33318188|NCT00963820|62693602|FG008|Expansion Phase|Withdrawal by Subject|1|||
33318189|NCT00963820|62693603|FG009|Expansion Phase|Withdrawal by Subject|0|||
33318190|NCT00963820|62693604|FG010|Expansion Phase|Withdrawal by Subject|1|||
33318191|NCT00963820|62693605|FG011|Expansion Phase|Withdrawal by Subject|1|||
33318192|NCT00963820|62693594|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33318193|NCT00963820|62693595|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33318194|NCT00963820|62693596|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33318195|NCT00963820|62693597|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33318196|NCT00963820|62693598|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33318197|NCT00963820|62693599|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33493862|NCT03535194|62872385|FG002|Post-Treatment Followup Period|Other|0|||
33318198|NCT00963820|62693600|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33318199|NCT00963820|62693601|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33318200|NCT00963820|62693602|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33318201|NCT00963820|62693603|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33318202|NCT00963820|62693604|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33318203|NCT00963820|62693605|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
33318204|NCT01227395|62693624|FG000|Overall Study|Protocol Violation|0|||
33318205|NCT01227395|62693625|FG001|Overall Study|Protocol Violation|1|||
33318206|NCT01226459|62693652|FG000|Overall Study|Adverse Event|2|||
33318207|NCT01226459|62693653|FG001|Overall Study|Adverse Event|8|||
33318208|NCT01226459|62693652|FG000|Overall Study|Protocol Violation|4|||
33318209|NCT01226459|62693653|FG001|Overall Study|Protocol Violation|3|||
33318210|NCT01226459|62693652|FG000|Overall Study|Withdrawal by Subject|10|||
33318211|NCT01226459|62693653|FG001|Overall Study|Withdrawal by Subject|13|||
33318212|NCT01226459|62693652|FG000|Overall Study|Lost to Follow-up|4|||
33318213|NCT01226459|62693653|FG001|Overall Study|Lost to Follow-up|8|||
33318214|NCT01226459|62693652|FG000|Overall Study|Pregnancy|1|||
33318215|NCT01226459|62693653|FG001|Overall Study|Pregnancy|0|||
33318216|NCT01225991|62693659|FG000|Overall Study|Withdrawal by Subject|6|||
33318217|NCT00959374|62693663|FG000|Overall Study|Withdrawal by Subject|2|||
33318218|NCT00959374|62693663|FG000|Overall Study|Lost to Follow-up|14|||
33318219|NCT00959374|62693663|FG000|Overall Study|Death|1|||
33318220|NCT00959374|62693663|FG000|Overall Study|Protocol Violation|1|||
33318221|NCT00959374|62693663|FG000|Overall Study|Implant Removed/Not Replaced|4|||
33318222|NCT00959374|62693663|FG000|Overall Study|Physician Decision|1|||
33318223|NCT01225835|62693673|FG000|Overall Study|Completed protocol|2|||
33318224|NCT01225835|62693674|FG001|Overall Study|Completed protocol|1|||
33318225|NCT01225835|62693673|FG000|Overall Study|Did not meet hCG criterion|2|||
33318226|NCT01225835|62693674|FG001|Overall Study|Did not meet hCG criterion|0|||
33318227|NCT01225835|62693673|FG000|Overall Study|Adverse Event|2|||
33318228|NCT01225835|62693674|FG001|Overall Study|Adverse Event|1|||
33402058|NCT00543543|62780946|FG002|Extension Study|Physician Decision|0|||
33402059|NCT00543543|62780947|FG003|Extension Study|Physician Decision|7|||
33402060|NCT00543543|62780944|FG000|Extension Study|Pregnancy|0|||
33402061|NCT00543543|62780945|FG001|Extension Study|Pregnancy|0|||
33402062|NCT00543543|62780946|FG002|Extension Study|Pregnancy|0|||
33402063|NCT00543543|62780947|FG003|Extension Study|Pregnancy|6|||
33402064|NCT00543543|62780944|FG000|Extension Study|Protocol Violation|0|||
33402065|NCT00543543|62780945|FG001|Extension Study|Protocol Violation|0|||
33402066|NCT00543543|62780946|FG002|Extension Study|Protocol Violation|0|||
33402067|NCT00543543|62780947|FG003|Extension Study|Protocol Violation|11|||
33402068|NCT00543543|62780944|FG000|Extension Study|Withdrawal by Subject|0|||
33402069|NCT00543543|62780945|FG001|Extension Study|Withdrawal by Subject|0|||
33402070|NCT00543543|62780946|FG002|Extension Study|Withdrawal by Subject|0|||
33714851|NCT02407236|63297757|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
33714852|NCT01893138|63297785|FG000|Double-Blind Period|Withdrawal by Subject|1|||
33714853|NCT01893138|63297786|FG001|Double-Blind Period|Withdrawal by Subject|1|||
33714854|NCT01893138|63297785|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
33714855|NCT01893138|63297786|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
33714856|NCT01893138|63297785|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
33714857|NCT01893138|63297786|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
33714858|NCT01893138|63297785|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
33714859|NCT01893138|63297786|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
33714860|NCT01893138|63297785|FG000|Open Label - Unblinded Period|Adverse Event|1|||
33714861|NCT01893138|63297786|FG001|Open Label - Unblinded Period|Adverse Event|0|||
33714862|NCT04309500|63297798|FG000|Overall Study|Lost to Follow-up|1|||
33714863|NCT04309500|63297799|FG001|Overall Study|Lost to Follow-up|0|||
33714864|NCT04309500|63297800|FG002|Overall Study|Lost to Follow-up|0|||
33714865|NCT04309500|63297801|FG003|Overall Study|Lost to Follow-up|0|||
33714866|NCT03671304|63299136|FG000|Overall Study|study terminated|7|||
33714867|NCT03517722|63299142|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
33714868|NCT03517722|63299143|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
33714869|NCT03517722|63299142|FG000|Double Blind Period: Week 0-52|Death|0|||
33714870|NCT03517722|63299143|FG001|Double Blind Period: Week 0-52|Death|4|||
33714871|NCT03517722|63299142|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
33714872|NCT03517722|63299143|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
33714873|NCT03517722|63299142|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
33714874|NCT03517722|63299143|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
33714875|NCT03517722|63299142|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
33402071|NCT00543543|62780947|FG003|Extension Study|Withdrawal by Subject|120|||
33402072|NCT00645164|62780962|FG000|Overall Study|Lost to Follow-up|2|||
33714876|NCT03517722|63299143|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
33714877|NCT03517722|63299142|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
33318229|NCT01225835|62693673|FG000|Overall Study|Other|1|||
33318230|NCT01225835|62693674|FG001|Overall Study|Other|1|||
33318231|NCT00962650|62693686|FG000|Overall Study|Transgastric DP was not completed|2|||
33318232|NCT00958828|62693694|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
33318233|NCT00958828|62693695|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
33318234|NCT00958828|62693694|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
33402073|NCT00645164|62780962|FG000|Overall Study|Withdrawal by Subject|4|||
33402074|NCT00645164|62780962|FG000|Overall Study|Protocol Violation|1|||
33402075|NCT00723125|62780968|FG000|Overall Study|Met Dx|1|||
33714878|NCT03517722|63299143|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
33714879|NCT03517722|63299142|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
33714880|NCT03517722|63299143|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
33714881|NCT03517722|63299142|FG000|Double Blind Period: Week 0-52|Other|4|||
33714882|NCT03517722|63299143|FG001|Double Blind Period: Week 0-52|Other|3|||
33714883|NCT03517722|63299142|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
33714884|NCT03517722|63299143|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
33714885|NCT03517722|63299142|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
33714886|NCT03517722|63299143|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
33714887|NCT03517722|63299142|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
33714888|NCT03517722|63299143|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
33402076|NCT00723125|62780969|FG001|Overall Study|Met Dx|0|||
33402077|NCT00723125|62780968|FG000|Overall Study|Withdrawal by Subject|15|||
33402078|NCT00723125|62780969|FG001|Overall Study|Withdrawal by Subject|6|||
33402079|NCT00723125|62780968|FG000|Overall Study|Adverse Event|2|||
33402080|NCT00723125|62780969|FG001|Overall Study|Adverse Event|0|||
33402081|NCT00722423|62780983|FG000|Overall Study|Protocol Violation|0|||
33402082|NCT00722423|62780984|FG001|Overall Study|Protocol Violation|1|||
33402083|NCT00640562|62780994|FG000|Overall Study|Adverse Event|8|||
33402084|NCT00640562|62780995|FG001|Overall Study|Adverse Event|5|||
33402085|NCT00640562|62780994|FG000|Overall Study|Lack of Efficacy|1|||
33402086|NCT00640562|62780995|FG001|Overall Study|Lack of Efficacy|4|||
33402087|NCT00640562|62780994|FG000|Overall Study|Protocol Violation|2|||
33402088|NCT00640562|62780995|FG001|Overall Study|Protocol Violation|4|||
33402089|NCT00640562|62780994|FG000|Overall Study|Withdrawal by Subject|6|||
33402090|NCT00640562|62780995|FG001|Overall Study|Withdrawal by Subject|10|||
33493863|NCT03535194|62872386|FG003|Post-Treatment Followup Period|Other|5|||
33318235|NCT00958828|62693695|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
33318236|NCT00960934|62693707|FG000|Overall Study|Adverse Event|2|||
33318237|NCT00960934|62693708|FG001|Overall Study|Adverse Event|3|||
33318238|NCT00960934|62693709|FG002|Overall Study|Adverse Event|3|||
33318239|NCT00960934|62693710|FG003|Overall Study|Adverse Event|2|||
33318240|NCT00960934|62693711|FG004|Overall Study|Adverse Event|4|||
33318241|NCT00960934|62693712|FG005|Overall Study|Adverse Event|3|||
33318242|NCT00960934|62693707|FG000|Overall Study|Lack of Efficacy|1|||
33318243|NCT00960934|62693708|FG001|Overall Study|Lack of Efficacy|0|||
33318244|NCT00960934|62693709|FG002|Overall Study|Lack of Efficacy|0|||
33318245|NCT00960934|62693710|FG003|Overall Study|Lack of Efficacy|0|||
33318246|NCT00960934|62693711|FG004|Overall Study|Lack of Efficacy|0|||
33318247|NCT00960934|62693712|FG005|Overall Study|Lack of Efficacy|0|||
33318248|NCT00960934|62693707|FG000|Overall Study|Lost to Follow-up|0|||
33318249|NCT00960934|62693708|FG001|Overall Study|Lost to Follow-up|1|||
33318250|NCT00960934|62693709|FG002|Overall Study|Lost to Follow-up|0|||
33318251|NCT00960934|62693710|FG003|Overall Study|Lost to Follow-up|0|||
33318252|NCT00960934|62693711|FG004|Overall Study|Lost to Follow-up|0|||
33318253|NCT00960934|62693712|FG005|Overall Study|Lost to Follow-up|0|||
33318254|NCT00960934|62693707|FG000|Overall Study|Other|2|||
33318255|NCT00960934|62693708|FG001|Overall Study|Other|1|||
33318256|NCT00960934|62693709|FG002|Overall Study|Other|5|||
33318257|NCT00960934|62693710|FG003|Overall Study|Other|4|||
33318258|NCT00960934|62693711|FG004|Overall Study|Other|2|||
33318259|NCT00960934|62693712|FG005|Overall Study|Other|2|||
33318260|NCT00960934|62693707|FG000|Overall Study|Physician Decision|0|||
33318261|NCT00960934|62693708|FG001|Overall Study|Physician Decision|1|||
33318262|NCT00960934|62693709|FG002|Overall Study|Physician Decision|0|||
33318263|NCT00960934|62693710|FG003|Overall Study|Physician Decision|0|||
33318264|NCT00960934|62693711|FG004|Overall Study|Physician Decision|0|||
33318265|NCT00960934|62693712|FG005|Overall Study|Physician Decision|0|||
33318266|NCT00960934|62693707|FG000|Overall Study|Progressive Disease|1|||
33318267|NCT00960934|62693708|FG001|Overall Study|Progressive Disease|1|||
33318268|NCT00960934|62693709|FG002|Overall Study|Progressive Disease|0|||
33318269|NCT00960934|62693710|FG003|Overall Study|Progressive Disease|0|||
33318270|NCT00960934|62693711|FG004|Overall Study|Progressive Disease|1|||
33318271|NCT00960934|62693712|FG005|Overall Study|Progressive Disease|1|||
33318272|NCT00960934|62693707|FG000|Overall Study|Protocol Violation|3|||
33318273|NCT00960934|62693708|FG001|Overall Study|Protocol Violation|4|||
33318274|NCT00960934|62693709|FG002|Overall Study|Protocol Violation|0|||
33318275|NCT00960934|62693710|FG003|Overall Study|Protocol Violation|3|||
33318276|NCT00960934|62693711|FG004|Overall Study|Protocol Violation|3|||
33318277|NCT00960934|62693712|FG005|Overall Study|Protocol Violation|2|||
33318278|NCT00960934|62693707|FG000|Overall Study|Withdrawal by Subject|5|||
33318279|NCT00960934|62693708|FG001|Overall Study|Withdrawal by Subject|6|||
33318280|NCT00960934|62693709|FG002|Overall Study|Withdrawal by Subject|4|||
33402091|NCT00640562|62780994|FG000|Overall Study|Known risperidone intolerance|0|||
33402092|NCT00640562|62780995|FG001|Overall Study|Known risperidone intolerance|1|||
33402093|NCT00640562|62780994|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
33493864|NCT03535194|62872387|FG004|Post-Treatment Followup Period|Other|0|||
33318281|NCT00960934|62693710|FG003|Overall Study|Withdrawal by Subject|5|||
33318282|NCT00960934|62693711|FG004|Overall Study|Withdrawal by Subject|5|||
33318283|NCT00960934|62693712|FG005|Overall Study|Withdrawal by Subject|7|||
33318284|NCT00960934|62693707|FG000|Overall Study|Study Terminated by Sponsor|50|||
33318285|NCT00960934|62693708|FG001|Overall Study|Study Terminated by Sponsor|46|||
33318286|NCT00960934|62693709|FG002|Overall Study|Study Terminated by Sponsor|52|||
33318287|NCT00960934|62693710|FG003|Overall Study|Study Terminated by Sponsor|50|||
33318288|NCT00960934|62693711|FG004|Overall Study|Study Terminated by Sponsor|49|||
33318289|NCT00960934|62693712|FG005|Overall Study|Study Terminated by Sponsor|49|||
33318290|NCT00892177|62693729|FG000|Phase II|Ineligible|0|||
33318291|NCT00892177|62693730|FG001|Phase II|Ineligible|0|||
33318292|NCT00892177|62693731|FG002|Phase II|Ineligible|0|||
33318293|NCT00892177|62693732|FG003|Phase II|Ineligible|0|||
33318294|NCT00892177|62693733|FG004|Phase II|Ineligible|1|||
33318295|NCT00892177|62693734|FG005|Phase II|Ineligible|1|||
33318296|NCT00892177|62693729|FG000|Phase II|Withdrawal by Subject|0|||
33597659|NCT01901302|62996631|FG000|Overall Study|Adverse Event|2|||
33714889|NCT03517722|63299142|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
33714890|NCT03517722|63299143|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
33714891|NCT03517722|63299142|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
33714892|NCT03517722|63299143|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
33714893|NCT03447990|63299157|FG000|Overall Study|Withdrawal by Subject|0|||
33714894|NCT03447990|63299158|FG001|Overall Study|Withdrawal by Subject|0|||
33714895|NCT03447990|63299159|FG002|Overall Study|Withdrawal by Subject|0|||
33714896|NCT03447990|63299160|FG003|Overall Study|Withdrawal by Subject|0|||
33714897|NCT03447990|63299161|FG004|Overall Study|Withdrawal by Subject|0|||
33714898|NCT03447990|63299162|FG005|Overall Study|Withdrawal by Subject|0|||
33714899|NCT03447990|63299163|FG006|Overall Study|Withdrawal by Subject|1|||
33714900|NCT01376778|63299215|FG000|Overall Study|Lost to Follow-up|3|||
33714901|NCT01376778|63299216|FG001|Overall Study|Lost to Follow-up|2|||
33714902|NCT01074294|63299225|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
33714903|NCT01074294|63299226|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
33714904|NCT01074294|63299227|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
33714905|NCT01074294|63299228|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
33714906|NCT01074294|63299225|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
33714907|NCT01074294|63299226|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
33714908|NCT01074294|63299227|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
33714909|NCT01074294|63299228|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
33714910|NCT01074294|63299225|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
33714911|NCT01074294|63299226|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
33714912|NCT01074294|63299227|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
33714913|NCT01074294|63299228|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
33714914|NCT01074294|63299225|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
33714915|NCT01074294|63299226|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
33714916|NCT01074294|63299227|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
33714917|NCT01074294|63299228|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
33714918|NCT01074294|63299225|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
33714919|NCT01074294|63299226|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
33714920|NCT01074294|63299227|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
33714921|NCT01074294|63299228|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
33714922|NCT01074294|63299225|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
33714923|NCT01074294|63299226|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
33714924|NCT01074294|63299227|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
33714925|NCT01074294|63299228|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
33714926|NCT01074294|63299225|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
33714927|NCT01074294|63299226|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
33714928|NCT01074294|63299227|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
33714929|NCT01074294|63299228|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
33714930|NCT01074294|63299225|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
33714931|NCT01074294|63299226|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
33714932|NCT01074294|63299227|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
33714933|NCT01074294|63299228|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
33714934|NCT01074294|63299225|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
33714935|NCT01074294|63299226|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
33714936|NCT01074294|63299227|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
33597660|NCT01901302|62996632|FG001|Overall Study|Adverse Event|1|||
33597661|NCT01901302|62996631|FG000|Overall Study|Lack of Efficacy|0|||
33318297|NCT00892177|62693730|FG001|Phase II|Withdrawal by Subject|0|||
33318298|NCT00892177|62693731|FG002|Phase II|Withdrawal by Subject|0|||
33318299|NCT00892177|62693732|FG003|Phase II|Withdrawal by Subject|0|||
33714937|NCT01074294|63299228|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
33714938|NCT01074294|63299225|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
33714939|NCT01074294|63299226|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
33714940|NCT01074294|63299227|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
33714941|NCT01074294|63299228|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
33714942|NCT01074294|63299225|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
33714943|NCT01074294|63299226|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
33714944|NCT01074294|63299227|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
33714945|NCT01074294|63299228|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
33714946|NCT01074294|63299225|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
33714947|NCT01074294|63299226|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
33714948|NCT01074294|63299227|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
33714949|NCT01074294|63299228|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
33714950|NCT01074294|63299225|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
33714951|NCT01074294|63299226|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
33714952|NCT01074294|63299227|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
33714953|NCT01074294|63299228|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
33714954|NCT04753437|63300217|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33714955|NCT04753437|63300218|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
33714956|NCT04753437|63300217|FG000|Overall Study|Liver Function Test Abnormalities|2|||
33714957|NCT04753437|63300218|FG001|Overall Study|Liver Function Test Abnormalities|4|||
33714958|NCT04605094|63300226|FG000|Overall Study|Adverse Event|2|||
33714959|NCT04605094|63300227|FG001|Overall Study|Adverse Event|2|||
33714960|NCT04605094|63300226|FG000|Overall Study|Lost to Follow-up|1|||
33714961|NCT04605094|63300227|FG001|Overall Study|Lost to Follow-up|4|||
33714962|NCT04605094|63300226|FG000|Overall Study|Physician Decision|2|||
33714963|NCT04605094|63300227|FG001|Overall Study|Physician Decision|2|||
33714964|NCT04605094|63300226|FG000|Overall Study|Study terminated by Sponsor|31|||
33318300|NCT00892177|62693733|FG004|Phase II|Withdrawal by Subject|4|||
33318301|NCT00892177|62693734|FG005|Phase II|Withdrawal by Subject|1|||
33318302|NCT00962104|62693751|FG000|Overall Study|Adverse Event|10|||
33318303|NCT00962104|62693752|FG001|Overall Study|Adverse Event|3|||
33318304|NCT00962104|62693751|FG000|Overall Study|Entry Criteria Not Met|1|||
33318305|NCT00962104|62693752|FG001|Overall Study|Entry Criteria Not Met|2|||
33318306|NCT00962104|62693751|FG000|Overall Study|Lack of Efficacy|0|||
33318307|NCT00962104|62693752|FG001|Overall Study|Lack of Efficacy|1|||
33318308|NCT00962104|62693751|FG000|Overall Study|Lost to Follow-up|10|||
33318309|NCT00962104|62693752|FG001|Overall Study|Lost to Follow-up|4|||
33318310|NCT00962104|62693751|FG000|Overall Study|Physician Decision|1|||
33318311|NCT00962104|62693752|FG001|Overall Study|Physician Decision|0|||
33714965|NCT04605094|63300227|FG001|Overall Study|Study terminated by Sponsor|33|||
33714966|NCT04605094|63300226|FG000|Overall Study|Withdrawal by Subject|22|||
33714967|NCT04605094|63300227|FG001|Overall Study|Withdrawal by Subject|19|||
33714968|NCT04605094|63300226|FG000|Overall Study|Other|1|||
33318312|NCT00962104|62693751|FG000|Overall Study|Protocol Violation|6|||
33318313|NCT00962104|62693752|FG001|Overall Study|Protocol Violation|8|||
33318314|NCT00962104|62693751|FG000|Overall Study|Sponsor Decision|0|||
33318315|NCT00962104|62693752|FG001|Overall Study|Sponsor Decision|1|||
33318316|NCT00962104|62693751|FG000|Overall Study|Withdrawal by Subject|10|||
33318317|NCT00962104|62693752|FG001|Overall Study|Withdrawal by Subject|6|||
33318318|NCT00962104|62693751|FG000|Overall Study|Other|2|||
33318319|NCT00962104|62693752|FG001|Overall Study|Other|0|||
33714969|NCT04605094|63300227|FG001|Overall Study|Other|1|||
33714970|NCT04526210|63300236|FG000|Overall Study|Sponsor decision|7|||
33714971|NCT04526210|63300237|FG001|Overall Study|Sponsor decision|5|||
33714972|NCT04526210|63300236|FG000|Overall Study|Withdrawal by Subject|3|||
33714973|NCT04526210|63300237|FG001|Overall Study|Withdrawal by Subject|2|||
33714974|NCT04149964|63300255|FG000|Overall Study|Lost to Follow-up|19|||
33714975|NCT04149964|63300256|FG001|Overall Study|Lost to Follow-up|18|||
33714976|NCT03842969|63300282|FG000|Overall Study|Participant declined follow-up visit|0|||
33714977|NCT03842969|63300283|FG001|Overall Study|Participant declined follow-up visit|1|||
33714978|NCT03842969|63300284|FG002|Overall Study|Participant declined follow-up visit|0|||
33714979|NCT03842969|63300282|FG000|Overall Study|Sponsor's decision|12|||
33597662|NCT01901302|62996632|FG001|Overall Study|Lack of Efficacy|2|||
33714980|NCT03842969|63300283|FG001|Overall Study|Sponsor's decision|99|||
33597663|NCT01901302|62996631|FG000|Overall Study|Study Terminated by Sponsor|23|||
33318320|NCT02821000|62693758|FG000|Overall Study|Death|44|||
33318321|NCT02821000|62693758|FG000|Overall Study|Withdrawal by Subject|1|||
33318322|NCT02821000|62693758|FG000|Overall Study|Ongoing in Study|58|||
33318323|NCT00892099|62693765|FG000|Overall Study|Death|1|||
33318324|NCT00892099|62693766|FG001|Overall Study|Death|0|||
33714981|NCT03842969|63300284|FG002|Overall Study|Sponsor's decision|61|||
33714982|NCT03842969|63300282|FG000|Overall Study|Pregnancy|0|||
33714983|NCT03842969|63300283|FG001|Overall Study|Pregnancy|0|||
33714984|NCT03842969|63300284|FG002|Overall Study|Pregnancy|1|||
33714985|NCT03842969|63300282|FG000|Overall Study|Death|1|||
33714986|NCT03842969|63300283|FG001|Overall Study|Death|0|||
33714987|NCT03842969|63300284|FG002|Overall Study|Death|1|||
33714988|NCT03842969|63300282|FG000|Overall Study|Withdrawal by Subject|3|||
33714989|NCT03842969|63300283|FG001|Overall Study|Withdrawal by Subject|30|||
33714990|NCT03842969|63300284|FG002|Overall Study|Withdrawal by Subject|18|||
33714991|NCT03842969|63300282|FG000|Overall Study|Protocol Violation|1|||
33714992|NCT03842969|63300283|FG001|Overall Study|Protocol Violation|1|||
33714993|NCT03842969|63300284|FG002|Overall Study|Protocol Violation|0|||
33714994|NCT03842969|63300282|FG000|Overall Study|Physician Decision|0|||
33714995|NCT03842969|63300283|FG001|Overall Study|Physician Decision|3|||
33714996|NCT03842969|63300284|FG002|Overall Study|Physician Decision|0|||
33714997|NCT03842969|63300282|FG000|Overall Study|Lost to Follow-up|0|||
33714998|NCT03842969|63300283|FG001|Overall Study|Lost to Follow-up|2|||
33714999|NCT03842969|63300284|FG002|Overall Study|Lost to Follow-up|0|||
33715000|NCT03842969|63300282|FG000|Overall Study|Adverse Event|0|||
33715001|NCT03842969|63300283|FG001|Overall Study|Adverse Event|2|||
33715002|NCT03842969|63300284|FG002|Overall Study|Adverse Event|0|||
33715003|NCT03122106|63300301|FG000|Overall Study|Not enough tissue|1|||
33715004|NCT03122106|63300301|FG000|Overall Study|Disease progression during screening|2|||
33715005|NCT03122106|63300301|FG000|Overall Study|Poor RNA quality for vaccine|1|||
33715006|NCT02938520|63300311|FG000|Overall Study|On-going at the time of analysis|258|||
33715007|NCT02938520|63300312|FG001|Overall Study|On-going at the time of analysis|261|||
33318325|NCT00892099|62693767|FG002|Overall Study|Death|1|||
33318326|NCT00892099|62693765|FG000|Overall Study|Adverse Event|1|||
33318327|NCT00892099|62693766|FG001|Overall Study|Adverse Event|0|||
33318328|NCT00892099|62693767|FG002|Overall Study|Adverse Event|0|||
33318329|NCT00892099|62693765|FG000|Overall Study|replocated|1|||
33318330|NCT00892099|62693766|FG001|Overall Study|replocated|0|||
33318331|NCT00892099|62693767|FG002|Overall Study|replocated|2|||
33318332|NCT00892099|62693765|FG000|Overall Study|Prolonged hospitalization|1|||
33318333|NCT00892099|62693766|FG001|Overall Study|Prolonged hospitalization|0|||
33318334|NCT00892099|62693767|FG002|Overall Study|Prolonged hospitalization|1|||
33715008|NCT02938520|63300311|FG000|Overall Study|Physician Decision|2|||
33715009|NCT02938520|63300312|FG001|Overall Study|Physician Decision|5|||
33715010|NCT02938520|63300311|FG000|Overall Study|Lost to Follow-up|2|||
33715011|NCT02938520|63300312|FG001|Overall Study|Lost to Follow-up|2|||
33715012|NCT02938520|63300311|FG000|Overall Study|Withdrawal by Subject|7|||
33715013|NCT02938520|63300312|FG001|Overall Study|Withdrawal by Subject|7|||
33715014|NCT02938520|63300311|FG000|Overall Study|Protocol Violation|0|||
33715015|NCT02938520|63300312|FG001|Overall Study|Protocol Violation|1|||
33715016|NCT02938520|63300311|FG000|Overall Study|Lack of Efficacy|5|||
33715017|NCT02938520|63300312|FG001|Overall Study|Lack of Efficacy|3|||
33715018|NCT02938520|63300311|FG000|Overall Study|Adverse Event|9|||
33715019|NCT02938520|63300312|FG001|Overall Study|Adverse Event|4|||
33715020|NCT02764541|63300329|FG000|Overall Study|Withdrawal by Subject|0|||
33715021|NCT02764541|63300330|FG001|Overall Study|Withdrawal by Subject|0|||
33715022|NCT02764541|63300331|FG002|Overall Study|Withdrawal by Subject|0|||
33715023|NCT02764541|63300332|FG003|Overall Study|Withdrawal by Subject|0|||
33715024|NCT02764541|63300333|FG004|Overall Study|Withdrawal by Subject|1|||
33715025|NCT02764541|63300334|FG005|Overall Study|Withdrawal by Subject|1|||
33715026|NCT02764541|63300335|FG006|Overall Study|Withdrawal by Subject|0|||
33318335|NCT00892099|62693765|FG000|Overall Study|no further details|1|||
33318336|NCT00892099|62693766|FG001|Overall Study|no further details|0|||
33597664|NCT01901302|62996632|FG001|Overall Study|Study Terminated by Sponsor|20|||
33597665|NCT01901302|62996631|FG000|Overall Study|Withdrawal by Subject|2|||
33597666|NCT01901302|62996632|FG001|Overall Study|Withdrawal by Subject|0|||
33597667|NCT01919398|62996641|FG000|Overall Study|Progressive Disease|0|||
33597668|NCT01919398|62996642|FG001|Overall Study|Progressive Disease|0|||
33597669|NCT01919398|62996643|FG002|Overall Study|Progressive Disease|4|||
33597670|NCT02500043|62996653|FG000|Overall Study|Randomized, but not Treated|2|||
33597671|NCT02500043|62996654|FG001|Overall Study|Randomized, but not Treated|2|||
33597672|NCT02500043|62996653|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
33597673|NCT02500043|62996654|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
33597674|NCT02500043|62996653|FG000|Overall Study|Adverse Event|33|||
33597675|NCT02500043|62996654|FG001|Overall Study|Adverse Event|11|||
33597676|NCT02500043|62996653|FG000|Overall Study|Clinical Progression|54|||
33597677|NCT02500043|62996654|FG001|Overall Study|Clinical Progression|35|||
33597678|NCT02500043|62996653|FG000|Overall Study|Radiological Progression|192|||
33715027|NCT02764541|63300336|FG007|Overall Study|Withdrawal by Subject|1|||
33715028|NCT02764541|63300329|FG000|Overall Study|Adverse Event|1|||
33318337|NCT00892099|62693767|FG002|Overall Study|no further details|1|||
33318338|NCT00892099|62693765|FG000|Overall Study|kidney function recovered|0|||
33318339|NCT00892099|62693766|FG001|Overall Study|kidney function recovered|1|||
33318340|NCT00892099|62693767|FG002|Overall Study|kidney function recovered|0|||
33715029|NCT02764541|63300330|FG001|Overall Study|Adverse Event|0|||
33715030|NCT02764541|63300331|FG002|Overall Study|Adverse Event|0|||
33715031|NCT02764541|63300332|FG003|Overall Study|Adverse Event|0|||
33715032|NCT02764541|63300333|FG004|Overall Study|Adverse Event|0|||
33715033|NCT02764541|63300334|FG005|Overall Study|Adverse Event|0|||
33715034|NCT02764541|63300335|FG006|Overall Study|Adverse Event|1|||
33715035|NCT02764541|63300336|FG007|Overall Study|Adverse Event|0|||
33715036|NCT02764541|63300329|FG000|Overall Study|Metastasis|1|||
33715037|NCT02764541|63300330|FG001|Overall Study|Metastasis|0|||
33715038|NCT02764541|63300331|FG002|Overall Study|Metastasis|0|||
33715039|NCT02764541|63300332|FG003|Overall Study|Metastasis|0|||
33318341|NCT00892099|62693765|FG000|Overall Study|investigator decision|0|||
33318342|NCT00892099|62693766|FG001|Overall Study|investigator decision|0|||
33318343|NCT00892099|62693767|FG002|Overall Study|investigator decision|1|||
33318344|NCT00892099|62693765|FG000|Overall Study|Lost to Follow-up|0|||
33318345|NCT00892099|62693766|FG001|Overall Study|Lost to Follow-up|0|||
33318346|NCT00892099|62693767|FG002|Overall Study|Lost to Follow-up|1|||
33318347|NCT00960856|62693775|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
33318348|NCT00960856|62693776|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
33318349|NCT00960856|62693777|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
33318350|NCT00960856|62693778|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
33318351|NCT00960856|62693775|FG000|Washout Period of 7 Days|Adverse Event|0|||
33318352|NCT00960856|62693776|FG001|Washout Period of 7 Days|Adverse Event|0|||
33318353|NCT00960856|62693777|FG002|Washout Period of 7 Days|Adverse Event|1|||
33318354|NCT00960856|62693778|FG003|Washout Period of 7 Days|Adverse Event|0|||
33318355|NCT00958438|62693791|FG000|Overall Study|Protocol Violation|3|||
33318356|NCT00958438|62693792|FG001|Overall Study|Protocol Violation|2|||
33715040|NCT02764541|63300333|FG004|Overall Study|Metastasis|0|||
33715041|NCT02764541|63300334|FG005|Overall Study|Metastasis|0|||
33715042|NCT02764541|63300335|FG006|Overall Study|Metastasis|0|||
33715043|NCT02764541|63300336|FG007|Overall Study|Metastasis|0|||
33715044|NCT02764541|63300329|FG000|Overall Study|Disease progression|1|||
33715045|NCT02764541|63300330|FG001|Overall Study|Disease progression|1|||
33715046|NCT02764541|63300331|FG002|Overall Study|Disease progression|0|||
33715047|NCT02764541|63300332|FG003|Overall Study|Disease progression|0|||
33715048|NCT02764541|63300333|FG004|Overall Study|Disease progression|0|||
33715049|NCT02764541|63300334|FG005|Overall Study|Disease progression|0|||
33715050|NCT02764541|63300335|FG006|Overall Study|Disease progression|0|||
33715051|NCT02764541|63300336|FG007|Overall Study|Disease progression|1|||
33715052|NCT02764541|63300329|FG000|Overall Study|Protocol Violation|0|||
33715053|NCT02764541|63300330|FG001|Overall Study|Protocol Violation|0|||
33715054|NCT02764541|63300331|FG002|Overall Study|Protocol Violation|0|||
33715055|NCT02764541|63300332|FG003|Overall Study|Protocol Violation|1|||
33715056|NCT02764541|63300333|FG004|Overall Study|Protocol Violation|0|||
33318357|NCT00958438|62693793|FG002|Overall Study|Protocol Violation|2|||
33318358|NCT00958438|62693791|FG000|Overall Study|Withdrawal by Subject|4|||
33318359|NCT00958438|62693792|FG001|Overall Study|Withdrawal by Subject|2|||
33318360|NCT00958438|62693793|FG002|Overall Study|Withdrawal by Subject|1|||
33318361|NCT00958438|62693791|FG000|Overall Study|Adverse Event|0|||
33318362|NCT00958438|62693792|FG001|Overall Study|Adverse Event|3|||
33318363|NCT00958438|62693793|FG002|Overall Study|Adverse Event|0|||
33318364|NCT00958438|62693791|FG000|Overall Study|Physician Decision|1|||
33318365|NCT00958438|62693792|FG001|Overall Study|Physician Decision|0|||
33318366|NCT00958438|62693793|FG002|Overall Study|Physician Decision|1|||
33318367|NCT00958438|62693791|FG000|Overall Study|Other than specified above|2|||
33318368|NCT00958438|62693792|FG001|Overall Study|Other than specified above|3|||
33318369|NCT00958438|62693793|FG002|Overall Study|Other than specified above|2|||
33318370|NCT00958360|62693803|FG000|Overall Study|Withdrawal by Subject|3|||
33318371|NCT00958360|62693804|FG001|Overall Study|Withdrawal by Subject|1|||
33597679|NCT02500043|62996654|FG001|Overall Study|Radiological Progression|110|||
33318372|NCT00958360|62693803|FG000|Overall Study|Death|6|||
33597680|NCT02500043|62996653|FG000|Overall Study|Physician's Decision|11|||
33715057|NCT02764541|63300334|FG005|Overall Study|Protocol Violation|1|||
33715058|NCT02764541|63300335|FG006|Overall Study|Protocol Violation|0|||
33715059|NCT02764541|63300336|FG007|Overall Study|Protocol Violation|0|||
33715060|NCT02764541|63300329|FG000|Overall Study|Physician Decision|0|||
33715061|NCT02764541|63300330|FG001|Overall Study|Physician Decision|0|||
33715062|NCT02764541|63300331|FG002|Overall Study|Physician Decision|0|||
33318373|NCT00958360|62693804|FG001|Overall Study|Death|7|||
33318374|NCT00958360|62693803|FG000|Overall Study|Physician Decision|2|||
33318375|NCT00958360|62693804|FG001|Overall Study|Physician Decision|1|||
33318376|NCT00958360|62693803|FG000|Overall Study|Lost to Follow-up|0|||
33318377|NCT00958360|62693804|FG001|Overall Study|Lost to Follow-up|1|||
33597681|NCT02500043|62996654|FG001|Overall Study|Physician's Decision|3|||
33715063|NCT02764541|63300332|FG003|Overall Study|Physician Decision|1|||
33715064|NCT02764541|63300333|FG004|Overall Study|Physician Decision|0|||
33715065|NCT02764541|63300334|FG005|Overall Study|Physician Decision|0|||
33715066|NCT02764541|63300335|FG006|Overall Study|Physician Decision|0|||
33715067|NCT02764541|63300336|FG007|Overall Study|Physician Decision|1|||
33715068|NCT02764541|63300329|FG000|Overall Study|Three Cycles completed before surgery|0|||
33715069|NCT02764541|63300330|FG001|Overall Study|Three Cycles completed before surgery|0|||
33715070|NCT02764541|63300331|FG002|Overall Study|Three Cycles completed before surgery|0|||
33715071|NCT02764541|63300332|FG003|Overall Study|Three Cycles completed before surgery|1|||
33715072|NCT02764541|63300333|FG004|Overall Study|Three Cycles completed before surgery|0|||
33715073|NCT02764541|63300334|FG005|Overall Study|Three Cycles completed before surgery|0|||
33318378|NCT00888433|62693812|FG000|Overall Study|Withdrawal by Subject|1|||
33318379|NCT00888433|62693813|FG001|Overall Study|Withdrawal by Subject|2|||
33318380|NCT00888433|62693812|FG000|Overall Study|Missed Visit|2|||
33493865|NCT03535194|62872383|FG000|Post-Treatment Followup Period|Physician Decision|0|||
33493866|NCT03535194|62872384|FG001|Post-Treatment Followup Period|Physician Decision|2|||
33493867|NCT03535194|62872385|FG002|Post-Treatment Followup Period|Physician Decision|1|||
33493868|NCT03535194|62872386|FG003|Post-Treatment Followup Period|Physician Decision|1|||
33493869|NCT03535194|62872387|FG004|Post-Treatment Followup Period|Physician Decision|0|||
33493870|NCT03535194|62872383|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
33493871|NCT03535194|62872384|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
33493872|NCT03535194|62872385|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
33493873|NCT03535194|62872386|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
33493874|NCT03535194|62872387|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33493875|NCT03559530|62872411|FG000|Overall Study|non-location of medical records|44|||
33493876|NCT03559530|62872412|FG001|Overall Study|non-location of medical records|0|||
33715074|NCT02764541|63300335|FG006|Overall Study|Three Cycles completed before surgery|0|||
33715075|NCT02764541|63300336|FG007|Overall Study|Three Cycles completed before surgery|0|||
33715076|NCT02764541|63300329|FG000|Overall Study|Patient Compliance|0|||
33493877|NCT03559530|62872411|FG000|Overall Study|culture results not considered for treat|29|||
33493878|NCT03559530|62872412|FG001|Overall Study|culture results not considered for treat|0|||
33493879|NCT03559530|62872411|FG000|Overall Study|duplicate cases|8|||
33493880|NCT03559530|62872412|FG001|Overall Study|duplicate cases|0|||
33493881|NCT03559530|62872411|FG000|Overall Study|other species of Acinetobacte|7|||
33493882|NCT03559530|62872412|FG001|Overall Study|other species of Acinetobacte|0|||
33493883|NCT03559530|62872411|FG000|Overall Study|contamination / colonization|3|||
33493884|NCT03559530|62872412|FG001|Overall Study|contamination / colonization|0|||
33493885|NCT03124784|62872440|FG000|Overall Study|Adverse Event|1|||
33493886|NCT03124784|62872440|FG000|Overall Study|Computer/Equip Malfunction|1|||
33493887|NCT03531840|62872448|FG000|Overall Study|Death on study|3|||
33493888|NCT03531840|62872449|FG001|Overall Study|Death on study|2|||
33493889|NCT03531840|62872450|FG002|Overall Study|Death on study|1|||
33493890|NCT03531840|62872451|FG003|Overall Study|Death on study|2|||
33493891|NCT03531840|62872448|FG000|Overall Study|Death during follow up|2|||
33493892|NCT03531840|62872449|FG001|Overall Study|Death during follow up|3|||
33493893|NCT03531840|62872450|FG002|Overall Study|Death during follow up|4|||
33493894|NCT03531840|62872451|FG003|Overall Study|Death during follow up|1|||
33493895|NCT03110900|62872468|FG000|Overall Study|Sponsor withdrew|1|||
33493896|NCT03110900|62872469|FG001|Overall Study|Sponsor withdrew|1|||
33493897|NCT03867734|62872475|FG000|Overall Study|Lost to Follow-up|2|||
33493898|NCT03446456|62872485|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
33493899|NCT03446456|62872486|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
33493900|NCT03446456|62872485|FG000|Overall Study|Lost to Follow-up|1|||
33493901|NCT03446456|62872486|FG001|Overall Study|Lost to Follow-up|3|||
33715077|NCT02764541|63300330|FG001|Overall Study|Patient Compliance|0|||
33715078|NCT02764541|63300331|FG002|Overall Study|Patient Compliance|1|||
33715079|NCT02764541|63300332|FG003|Overall Study|Patient Compliance|0|||
33715080|NCT02764541|63300333|FG004|Overall Study|Patient Compliance|0|||
33715081|NCT02764541|63300334|FG005|Overall Study|Patient Compliance|0|||
33715082|NCT02764541|63300335|FG006|Overall Study|Patient Compliance|0|||
33715083|NCT02764541|63300336|FG007|Overall Study|Patient Compliance|0|||
33715084|NCT02764541|63300329|FG000|Overall Study|Death|0|||
33715085|NCT02764541|63300330|FG001|Overall Study|Death|0|||
33493902|NCT03446456|62872485|FG000|Overall Study|Participant failed the toxicology test|1|||
33715086|NCT02764541|63300331|FG002|Overall Study|Death|0|||
33493903|NCT03446456|62872486|FG001|Overall Study|Participant failed the toxicology test|0|||
33493904|NCT03446456|62872485|FG000|Overall Study|Break down of the experimental equipment|1|||
33493905|NCT03446456|62872486|FG001|Overall Study|Break down of the experimental equipment|0|||
33715087|NCT02764541|63300332|FG003|Overall Study|Death|0|||
33715088|NCT02764541|63300333|FG004|Overall Study|Death|0|||
33715089|NCT02764541|63300334|FG005|Overall Study|Death|0|||
33715090|NCT02764541|63300335|FG006|Overall Study|Death|1|||
33715091|NCT02764541|63300336|FG007|Overall Study|Death|0|||
33715092|NCT02764541|63300329|FG000|Overall Study|Insurance reasons|0|||
33715093|NCT02764541|63300330|FG001|Overall Study|Insurance reasons|0|||
33715094|NCT02764541|63300331|FG002|Overall Study|Insurance reasons|0|||
33715095|NCT02764541|63300332|FG003|Overall Study|Insurance reasons|0|||
33715096|NCT02764541|63300333|FG004|Overall Study|Insurance reasons|0|||
33715097|NCT02764541|63300334|FG005|Overall Study|Insurance reasons|0|||
33715098|NCT02764541|63300335|FG006|Overall Study|Insurance reasons|1|||
33715099|NCT02764541|63300336|FG007|Overall Study|Insurance reasons|0|||
33715100|NCT02587065|63300356|FG000|Overall Study|Adverse Event|14|||
33715101|NCT02587065|63300356|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
33715102|NCT02587065|63300356|FG000|Overall Study|Non-adherence to the Protocol|3|||
33715103|NCT02587065|63300356|FG000|Overall Study|Discontinuation of Study Medication|2|||
33715104|NCT02587065|63300356|FG000|Overall Study|Reason not Specified|3|||
33715105|NCT02544503|63300366|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
33715106|NCT02544503|63300367|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
33715107|NCT02544503|63300366|FG000|Overall Study|Lost to Follow-up|9|||
33715108|NCT02544503|63300367|FG001|Overall Study|Lost to Follow-up|0|||
33493906|NCT03495102|62872495|FG000|Overall Study|Adverse Event|5|||
33493907|NCT03495102|62872496|FG001|Overall Study|Adverse Event|7|||
33597682|NCT02500043|62996653|FG000|Overall Study|Withdrawal by Subject|14|||
33318381|NCT00888433|62693813|FG001|Overall Study|Missed Visit|1|||
33318382|NCT01243424|62693821|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
33318383|NCT01243424|62693822|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
33318384|NCT01243424|62693821|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
33318385|NCT01243424|62693822|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
33318386|NCT01243424|62693821|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
33318387|NCT01243424|62693822|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
33318388|NCT01243424|62693821|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
33318389|NCT01243424|62693822|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
33318390|NCT01243424|62693821|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
33318391|NCT01243424|62693822|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
33318392|NCT01243424|62693821|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
33318393|NCT01243424|62693822|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
33318394|NCT01243424|62693821|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
33318395|NCT01243424|62693822|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
33318396|NCT01243424|62693821|FG000|Discontinuation From Treatment|Not treated|5|||
33318397|NCT01243424|62693822|FG001|Discontinuation From Treatment|Not treated|4|||
33318398|NCT01243424|62693821|FG000|Discontinuation From Treatment|Adverse Event|457|||
33318399|NCT01243424|62693822|FG001|Discontinuation From Treatment|Adverse Event|523|||
33493908|NCT03495102|62872497|FG002|Overall Study|Adverse Event|10|||
33597683|NCT02500043|62996654|FG001|Overall Study|Withdrawal by Subject|4|||
33597684|NCT02500043|62996653|FG000|Overall Study|Death|11|||
33597685|NCT02500043|62996654|FG001|Overall Study|Death|2|||
33597686|NCT02500043|62996653|FG000|Overall Study|Protocol Deviation|1|||
33597687|NCT02500043|62996654|FG001|Overall Study|Protocol Deviation|0|||
33597688|NCT02499575|62996662|FG000|Overall Study|Protocol Violation|0|||
33597689|NCT02499575|62996663|FG001|Overall Study|Protocol Violation|1|||
33597690|NCT02065791|62996671|FG000|Overall Study|Closed Site|1|||
33597691|NCT02065791|62996672|FG001|Overall Study|Closed Site|1|||
33597692|NCT02065791|62996671|FG000|Overall Study|Withdrawal by Subject|11|||
33715109|NCT02544503|63300366|FG000|Overall Study|Withdrawal by Subject|1|||
33715110|NCT02544503|63300367|FG001|Overall Study|Withdrawal by Subject|0|||
33715111|NCT01705977|63300375|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
33597693|NCT02065791|62996672|FG001|Overall Study|Withdrawal by Subject|5|||
33597694|NCT02065791|62996671|FG000|Overall Study|Lost to Follow-up|13|||
33597695|NCT02065791|62996672|FG001|Overall Study|Lost to Follow-up|9|||
33597696|NCT02499263|62996678|FG000|Overall Study|Lost to Follow-up|9|||
33715112|NCT01705977|63300376|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
33318400|NCT01243424|62693821|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
33318401|NCT01243424|62693822|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
33318402|NCT01243424|62693821|FG000|Discontinuation From Treatment|Protocol Violation|46|||
33318403|NCT01243424|62693822|FG001|Discontinuation From Treatment|Protocol Violation|47|||
33318404|NCT01243424|62693821|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
33318405|NCT01243424|62693822|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
33318406|NCT01243424|62693821|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
33318407|NCT01243424|62693822|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
33318408|NCT01243424|62693821|FG000|Discontinuation From Treatment|Other than listed above|230|||
33318409|NCT01243424|62693822|FG001|Discontinuation From Treatment|Other than listed above|211|||
33318410|NCT00887809|62693831|FG000|Overall Study|Patient Not Treated|3|||
33318411|NCT00887809|62693832|FG001|Overall Study|Patient Not Treated|0|||
33318412|NCT00887809|62693831|FG000|Overall Study|Death|1|||
33318413|NCT00887809|62693832|FG001|Overall Study|Death|0|||
33318414|NCT00958126|62693846|FG000|Overall Study|Serious Adverse Event|0|||
33318415|NCT00958126|62693847|FG001|Overall Study|Serious Adverse Event|2|||
33318416|NCT00958126|62693848|FG002|Overall Study|Serious Adverse Event|0|||
33318417|NCT00958126|62693849|FG003|Overall Study|Serious Adverse Event|0|||
33318418|NCT00958126|62693850|FG004|Overall Study|Serious Adverse Event|0|||
33318419|NCT00958126|62693851|FG005|Overall Study|Serious Adverse Event|0|||
33318420|NCT00958126|62693852|FG006|Overall Study|Serious Adverse Event|1|||
33318421|NCT00958126|62693853|FG007|Overall Study|Serious Adverse Event|0|||
33318422|NCT00958126|62693846|FG000|Overall Study|Withdrawal by Subject|0|||
33318423|NCT00958126|62693847|FG001|Overall Study|Withdrawal by Subject|2|||
33318424|NCT00958126|62693848|FG002|Overall Study|Withdrawal by Subject|0|||
33318425|NCT00958126|62693849|FG003|Overall Study|Withdrawal by Subject|0|||
33318426|NCT00958126|62693850|FG004|Overall Study|Withdrawal by Subject|0|||
33318427|NCT00958126|62693851|FG005|Overall Study|Withdrawal by Subject|0|||
33318428|NCT00958126|62693852|FG006|Overall Study|Withdrawal by Subject|0|||
33318429|NCT00958126|62693853|FG007|Overall Study|Withdrawal by Subject|0|||
33318430|NCT00958126|62693846|FG000|Overall Study|Moved away from study area|0|||
33318431|NCT00958126|62693847|FG001|Overall Study|Moved away from study area|0|||
33318432|NCT00958126|62693848|FG002|Overall Study|Moved away from study area|1|||
33318433|NCT00958126|62693849|FG003|Overall Study|Moved away from study area|1|||
33318434|NCT00958126|62693850|FG004|Overall Study|Moved away from study area|0|||
33318435|NCT00958126|62693851|FG005|Overall Study|Moved away from study area|0|||
33318436|NCT00958126|62693852|FG006|Overall Study|Moved away from study area|0|||
33318437|NCT00958126|62693853|FG007|Overall Study|Moved away from study area|0|||
33318438|NCT00958126|62693846|FG000|Overall Study|Lost to Follow-up|1|||
33318439|NCT00958126|62693847|FG001|Overall Study|Lost to Follow-up|5|||
33318440|NCT00958126|62693848|FG002|Overall Study|Lost to Follow-up|9|||
33318441|NCT00958126|62693849|FG003|Overall Study|Lost to Follow-up|8|||
33318442|NCT00958126|62693850|FG004|Overall Study|Lost to Follow-up|0|||
33318443|NCT00958126|62693851|FG005|Overall Study|Lost to Follow-up|0|||
33318444|NCT00958126|62693852|FG006|Overall Study|Lost to Follow-up|0|||
33318445|NCT00958126|62693853|FG007|Overall Study|Lost to Follow-up|0|||
33318446|NCT00958126|62693846|FG000|Overall Study|Sponsor/Investigator decision|0|||
33318447|NCT00958126|62693847|FG001|Overall Study|Sponsor/Investigator decision|0|||
33318448|NCT00958126|62693848|FG002|Overall Study|Sponsor/Investigator decision|0|||
33318449|NCT00958126|62693849|FG003|Overall Study|Sponsor/Investigator decision|1|||
33715113|NCT01705977|63300375|FG000|Treatment Period (Year 1)|Adverse Event|57|||
33715114|NCT01705977|63300376|FG001|Treatment Period (Year 1)|Adverse Event|49|||
33715115|NCT01705977|63300375|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
33318450|NCT00958126|62693850|FG004|Overall Study|Sponsor/Investigator decision|0|||
33318451|NCT00958126|62693851|FG005|Overall Study|Sponsor/Investigator decision|0|||
33318452|NCT00958126|62693852|FG006|Overall Study|Sponsor/Investigator decision|0|||
33318453|NCT00958126|62693853|FG007|Overall Study|Sponsor/Investigator decision|0|||
33318454|NCT00958126|62693846|FG000|Overall Study|Other Reason|0|||
33318455|NCT00958126|62693847|FG001|Overall Study|Other Reason|0|||
33318456|NCT00958126|62693848|FG002|Overall Study|Other Reason|0|||
33318457|NCT00958126|62693849|FG003|Overall Study|Other Reason|1|||
33318458|NCT00958126|62693850|FG004|Overall Study|Other Reason|0|||
33318459|NCT00958126|62693851|FG005|Overall Study|Other Reason|1|||
33318460|NCT00958126|62693852|FG006|Overall Study|Other Reason|0|||
33318461|NCT00958126|62693853|FG007|Overall Study|Other Reason|0|||
33318462|NCT00887341|62693877|FG000|Overall Study|Refused treatment|1|||
33318463|NCT00887341|62693878|FG001|Overall Study|Refused treatment|0|||
33318464|NCT00887341|62693877|FG000|Overall Study|Withdrawal by Subject|1|||
33318465|NCT00887341|62693878|FG001|Overall Study|Withdrawal by Subject|1|||
33318466|NCT00887341|62693877|FG000|Overall Study|Adverse Event|0|||
33715116|NCT01705977|63300376|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
33318467|NCT00887341|62693878|FG001|Overall Study|Adverse Event|1|||
33318468|NCT00887341|62693877|FG000|Overall Study|Lost to Follow-up|0|||
33493909|NCT03495102|62872495|FG000|Overall Study|Death|3|||
33493910|NCT03495102|62872496|FG001|Overall Study|Death|4|||
33318469|NCT00887341|62693878|FG001|Overall Study|Lost to Follow-up|1|||
33318470|NCT00886795|62693884|FG000|Overall Study|Lack of Efficacy|1|||
33318471|NCT00889681|62693901|FG000|Overall Study|Not meeting qualification Criteria|2|||
33318472|NCT00889681|62693901|FG000|Overall Study|Insurance disapproval|1|||
33318473|NCT00957658|62693905|FG000|Overall Study|Death|1|||
33318474|NCT00957658|62693905|FG000|Overall Study|Lost to Follow-up|4|||
33318475|NCT00957658|62693905|FG000|Overall Study|Withdrawal by Subject|12|||
33318476|NCT00957658|62693905|FG000|Overall Study|Revision|1|||
33318477|NCT00957658|62693905|FG000|Overall Study|Incomplete 2 yr data|28|||
33318478|NCT00957658|62693905|FG000|Overall Study|Site termination|10|||
33318479|NCT00957658|62693905|FG000|Overall Study|unwilling/unable to return|2|||
33318480|NCT00957658|62693905|FG000|Overall Study|surgery cancelled|2|||
33318481|NCT00957658|62693905|FG000|Overall Study|Protocol Violation|5|||
33318482|NCT00953680|62693911|FG000|Period 1|Withdrawal by Subject|0|||
33318483|NCT00953680|62693912|FG001|Period 1|Withdrawal by Subject|1|||
33318484|NCT00890929|62693918|FG000|Overall Study|Death before treatment|2|||
33318485|NCT00890929|62693918|FG000|Overall Study|Withdrawal by Subject|3|||
33318486|NCT00890929|62693918|FG000|Overall Study|Physician Decision|1|||
33318487|NCT00886639|62693922|FG000|Overall Study|acute exacerbation|14|||
33318488|NCT00886639|62693922|FG000|Overall Study|non-compliance|2|||
33318489|NCT00889603|62693926|FG000|Overall Study|Adverse Event|7|||
33318490|NCT00889603|62693926|FG000|Overall Study|Death|3|||
33318491|NCT00889603|62693926|FG000|Overall Study|Lost to Follow-up|19|||
33318492|NCT00889603|62693926|FG000|Overall Study|No longer willing to participant in stud|4|||
33318493|NCT00889603|62693926|FG000|Overall Study|Other|4|||
33318494|NCT00886483|62693932|FG000|Overall Study|Lost to Follow-up|0|||
33318495|NCT00886483|62693933|FG001|Overall Study|Lost to Follow-up|1|||
33318496|NCT00886483|62693932|FG000|Overall Study|Pursue medications|1|||
33318497|NCT00886483|62693933|FG001|Overall Study|Pursue medications|2|||
33318498|NCT00886483|62693932|FG000|Overall Study|Distance to center, poor grades|1|||
33318499|NCT00886483|62693933|FG001|Overall Study|Distance to center, poor grades|0|||
33318500|NCT00886015|62693949|FG000|Overall Study|Death|0|||
33318501|NCT00886015|62693950|FG001|Overall Study|Death|2|||
33318502|NCT00890695|62693958|FG000|Overall Study|Protocol Violation|1|||
33318503|NCT00890695|62693959|FG001|Overall Study|Protocol Violation|0|||
33318504|NCT00957580|62693968|FG000|Overall Study|Ongoing at data cut-off|0|||
33318505|NCT00957580|62693969|FG001|Overall Study|Ongoing at data cut-off|1|||
33318506|NCT00957580|62693970|FG002|Overall Study|Ongoing at data cut-off|0|||
33318507|NCT00957580|62693968|FG000|Overall Study|Enrolled but not treated|0|||
33318508|NCT00957580|62693969|FG001|Overall Study|Enrolled but not treated|1|||
33318509|NCT00957580|62693970|FG002|Overall Study|Enrolled but not treated|0|||
33318510|NCT00957424|62693991|FG000|Overall Study|Lost to Follow-up|19|||
33318511|NCT00957424|62693991|FG000|Overall Study|Protocol Violation|3|||
33318512|NCT00957424|62693991|FG000|Overall Study|Withdrawal by Subject|1|||
33318513|NCT01061151|62693999|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
33318514|NCT01061151|62694000|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
33318515|NCT01061151|62694001|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
33318516|NCT01061151|62694002|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
33318517|NCT01061151|62693999|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
33318518|NCT01061151|62694000|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
33318519|NCT01061151|62694001|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
33318520|NCT01061151|62694002|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
33318521|NCT01061151|62693999|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
33318522|NCT01061151|62694000|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
33318523|NCT01061151|62694001|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
33318524|NCT01061151|62694002|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
33318525|NCT01061151|62693999|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
33318526|NCT01061151|62694000|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
33318527|NCT01061151|62694001|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
33318528|NCT01061151|62694002|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
33318529|NCT01061151|62693999|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
33318530|NCT01061151|62694000|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
33318531|NCT01061151|62694001|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
33318532|NCT01061151|62694002|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
33318533|NCT01061151|62693999|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
33318534|NCT01061151|62694000|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
33318535|NCT01061151|62694001|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
33318536|NCT01061151|62694002|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
33318537|NCT01061151|62693999|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
33318538|NCT01061151|62694000|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
33318539|NCT01061151|62694001|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
33318540|NCT01061151|62694002|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
33318541|NCT01061151|62693999|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
33318542|NCT01061151|62694000|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
33318543|NCT01061151|62694001|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
33318544|NCT01061151|62694002|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
33318545|NCT01061151|62693999|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
33318546|NCT01061151|62694000|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
33318547|NCT01061151|62694001|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
33318548|NCT01061151|62694002|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
33318549|NCT01061151|62693999|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
33318550|NCT01061151|62694000|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
33318551|NCT01061151|62694001|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
33318552|NCT01061151|62694002|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
33318553|NCT01061151|62693999|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
33318554|NCT01061151|62694000|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
33318555|NCT01061151|62694001|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
33318556|NCT01061151|62694002|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
33318557|NCT01061151|62693999|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
33318558|NCT01061151|62694000|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
33318559|NCT01061151|62694001|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
33318560|NCT01061151|62694002|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
33318561|NCT01061151|62693999|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
33318562|NCT01061151|62694000|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
33318563|NCT01061151|62694001|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
33318564|NCT01061151|62694002|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
33318565|NCT01061151|62693999|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
33318566|NCT01061151|62694000|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
33715117|NCT01705977|63300375|FG000|Treatment Period (Year 1)|Site closure|3|||
33715118|NCT01705977|63300376|FG001|Treatment Period (Year 1)|Site closure|2|||
33715119|NCT01705977|63300375|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
33715120|NCT01705977|63300376|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
33715121|NCT01705977|63300375|FG000|Treatment Period (Year 1)|Physician Decision|48|||
33715122|NCT01705977|63300376|FG001|Treatment Period (Year 1)|Physician Decision|38|||
33715123|NCT01705977|63300375|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
33715124|NCT01705977|63300376|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
33715125|NCT01705977|63300375|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
33715126|NCT01705977|63300376|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
33715127|NCT01705977|63300375|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
33715128|NCT01705977|63300376|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
33715129|NCT01705977|63300375|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
33715130|NCT01705977|63300376|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
33715131|NCT01705977|63300375|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
33715132|NCT01705977|63300376|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
33715133|NCT01705977|63300375|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
33715134|NCT01705977|63300376|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
33715135|NCT01474889|63300385|FG000|Overall Study|Physician Decision|1|||
33715136|NCT01474889|63300386|FG001|Overall Study|Physician Decision|0|||
33715137|NCT01474889|63300387|FG002|Overall Study|Physician Decision|0|||
33715138|NCT01474889|63300385|FG000|Overall Study|Did not meet inclusion|1|||
33715139|NCT01474889|63300386|FG001|Overall Study|Did not meet inclusion|0|||
33715140|NCT01474889|63300387|FG002|Overall Study|Did not meet inclusion|0|||
33715141|NCT01474889|63300385|FG000|Overall Study|Withdrawal by Subject|0|||
33715142|NCT01474889|63300386|FG001|Overall Study|Withdrawal by Subject|1|||
33715143|NCT01474889|63300387|FG002|Overall Study|Withdrawal by Subject|0|||
33715144|NCT01236560|63300399|FG000|Overall Study|Adverse Event|0|||
33715145|NCT01236560|63300400|FG001|Overall Study|Adverse Event|2|||
33715146|NCT01236560|63300401|FG002|Overall Study|Adverse Event|1|||
33715147|NCT01236560|63300402|FG003|Overall Study|Adverse Event|3|||
33715148|NCT01236560|63300403|FG004|Overall Study|Adverse Event|0|||
33715149|NCT01236560|63300404|FG005|Overall Study|Adverse Event|0|||
33715150|NCT01236560|63300399|FG000|Overall Study|Death|0|||
33715151|NCT01236560|63300400|FG001|Overall Study|Death|1|||
33715152|NCT01236560|63300401|FG002|Overall Study|Death|0|||
33715153|NCT01236560|63300402|FG003|Overall Study|Death|1|||
33715154|NCT01236560|63300403|FG004|Overall Study|Death|0|||
33493911|NCT03495102|62872497|FG002|Overall Study|Death|4|||
33715155|NCT01236560|63300404|FG005|Overall Study|Death|0|||
33715156|NCT01236560|63300399|FG000|Overall Study|Lost to Follow-up|0|||
33715157|NCT01236560|63300400|FG001|Overall Study|Lost to Follow-up|1|||
33715158|NCT01236560|63300401|FG002|Overall Study|Lost to Follow-up|1|||
33715159|NCT01236560|63300402|FG003|Overall Study|Lost to Follow-up|0|||
33715160|NCT01236560|63300403|FG004|Overall Study|Lost to Follow-up|0|||
33715161|NCT01236560|63300404|FG005|Overall Study|Lost to Follow-up|0|||
33715162|NCT01236560|63300399|FG000|Overall Study|Physician Decision|0|||
33715163|NCT01236560|63300400|FG001|Overall Study|Physician Decision|1|||
33715164|NCT01236560|63300401|FG002|Overall Study|Physician Decision|8|||
33715165|NCT01236560|63300402|FG003|Overall Study|Physician Decision|0|||
33715166|NCT01236560|63300403|FG004|Overall Study|Physician Decision|0|||
33715167|NCT01236560|63300404|FG005|Overall Study|Physician Decision|0|||
33715168|NCT01236560|63300399|FG000|Overall Study|Withdrawal by Subject|0|||
33715169|NCT01236560|63300400|FG001|Overall Study|Withdrawal by Subject|0|||
33715170|NCT01236560|63300401|FG002|Overall Study|Withdrawal by Subject|1|||
33715171|NCT01236560|63300402|FG003|Overall Study|Withdrawal by Subject|2|||
33715172|NCT01236560|63300403|FG004|Overall Study|Withdrawal by Subject|0|||
33715173|NCT01236560|63300404|FG005|Overall Study|Withdrawal by Subject|0|||
33715174|NCT01236560|63300399|FG000|Overall Study|Progressive disease|5|||
33715175|NCT01236560|63300400|FG001|Overall Study|Progressive disease|19|||
33715176|NCT01236560|63300401|FG002|Overall Study|Progressive disease|9|||
33715177|NCT01236560|63300402|FG003|Overall Study|Progressive disease|16|||
33715178|NCT01236560|63300403|FG004|Overall Study|Progressive disease|0|||
33715179|NCT01236560|63300404|FG005|Overall Study|Progressive disease|0|||
33715180|NCT01231906|63300416|FG000|Overall Study|Lack of Efficacy|75|||
33715181|NCT01231906|63300417|FG001|Overall Study|Lack of Efficacy|68|||
33715182|NCT01231906|63300416|FG000|Overall Study|Lost to Follow-up|1|||
33715183|NCT01231906|63300417|FG001|Overall Study|Lost to Follow-up|0|||
33715184|NCT01231906|63300416|FG000|Overall Study|Physician Decision|34|||
33715185|NCT01231906|63300417|FG001|Overall Study|Physician Decision|24|||
33715186|NCT01231906|63300416|FG000|Overall Study|Withdrawal by Subject|0|||
33318567|NCT01061151|62694001|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
33715187|NCT01231906|63300417|FG001|Overall Study|Withdrawal by Subject|4|||
33715188|NCT01231906|63300416|FG000|Overall Study|Ineligible|10|||
33715189|NCT01231906|63300417|FG001|Overall Study|Ineligible|3|||
33715190|NCT01231906|63300416|FG000|Overall Study|No treatment|1|||
33715191|NCT01231906|63300417|FG001|Overall Study|No treatment|2|||
33715192|NCT00724048|63300427|FG000|Overall Study|Adverse Event|1|||
33715193|NCT00724048|63300428|FG001|Overall Study|Adverse Event|1|||
33715194|NCT00724048|63300429|FG002|Overall Study|Adverse Event|1|||
33715195|NCT00724048|63300430|FG003|Overall Study|Adverse Event|0|||
33715196|NCT00724048|63300427|FG000|Overall Study|Lost to Follow-up|0|||
33715197|NCT00724048|63300428|FG001|Overall Study|Lost to Follow-up|1|||
33715198|NCT00724048|63300429|FG002|Overall Study|Lost to Follow-up|0|||
33715199|NCT00724048|63300430|FG003|Overall Study|Lost to Follow-up|0|||
33715200|NCT00724048|63300427|FG000|Overall Study|Withdrawal by Subject|1|||
33715201|NCT00724048|63300428|FG001|Overall Study|Withdrawal by Subject|2|||
33715202|NCT00724048|63300429|FG002|Overall Study|Withdrawal by Subject|1|||
33715203|NCT00724048|63300430|FG003|Overall Study|Withdrawal by Subject|2|||
33715204|NCT00724048|63300427|FG000|Overall Study|Investigator decision|0|||
33715205|NCT00724048|63300428|FG001|Overall Study|Investigator decision|0|||
33715206|NCT00724048|63300429|FG002|Overall Study|Investigator decision|1|||
33715207|NCT00724048|63300430|FG003|Overall Study|Investigator decision|0|||
33715208|NCT00724048|63300427|FG000|Overall Study|Did not tolerate study drug|0|||
33715209|NCT00724048|63300428|FG001|Overall Study|Did not tolerate study drug|0|||
33715210|NCT00724048|63300429|FG002|Overall Study|Did not tolerate study drug|0|||
33715211|NCT00724048|63300430|FG003|Overall Study|Did not tolerate study drug|1|||
33715212|NCT00724048|63300427|FG000|Overall Study|Other than specified|1|||
33715213|NCT00724048|63300428|FG001|Overall Study|Other than specified|1|||
33715214|NCT00724048|63300429|FG002|Overall Study|Other than specified|0|||
33715215|NCT00724048|63300430|FG003|Overall Study|Other than specified|0|||
33715216|NCT00304070|63300443|FG000|Overall Study|Death|0|||
33715217|NCT00304070|63300444|FG001|Overall Study|Death|0|||
33715218|NCT00304070|63300445|FG002|Overall Study|Death|3|||
33715219|NCT00304070|63300443|FG000|Overall Study|Lost to Follow-up|0|||
33715220|NCT00304070|63300444|FG001|Overall Study|Lost to Follow-up|0|||
33715221|NCT00304070|63300445|FG002|Overall Study|Lost to Follow-up|1|||
33715222|NCT00304070|63300443|FG000|Overall Study|Physician Decision|0|||
33715223|NCT00304070|63300444|FG001|Overall Study|Physician Decision|0|||
33715224|NCT00304070|63300445|FG002|Overall Study|Physician Decision|3|||
33715225|NCT00304070|63300443|FG000|Overall Study|Withdrawal by Subject|0|||
33715226|NCT00304070|63300444|FG001|Overall Study|Withdrawal by Subject|0|||
33715227|NCT00304070|63300445|FG002|Overall Study|Withdrawal by Subject|1|||
33715228|NCT00304070|63300443|FG000|Overall Study|Progressive Disease|3|||
33715229|NCT00304070|63300444|FG001|Overall Study|Progressive Disease|7|||
33318568|NCT01061151|62694002|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
33715230|NCT00304070|63300445|FG002|Overall Study|Progressive Disease|4|||
33715231|NCT00160680|63300459|FG000|Overall Study|Adverse Event|0|||
33318569|NCT01061151|62693999|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
33715232|NCT00160680|63300460|FG001|Overall Study|Adverse Event|1|||
33715233|NCT00160680|63300459|FG000|Overall Study|Lack of Efficacy|2|||
33715234|NCT00160680|63300460|FG001|Overall Study|Lack of Efficacy|1|||
33715235|NCT00160680|63300459|FG000|Overall Study|Lost to Follow-up|3|||
33715236|NCT00160680|63300460|FG001|Overall Study|Lost to Follow-up|2|||
33318570|NCT01061151|62694000|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
33318571|NCT01061151|62694001|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
33318572|NCT01061151|62694002|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
33318573|NCT01241552|62694026|FG000|Overall Study|Lack of Efficacy|1|||
33318574|NCT01241552|62694027|FG001|Overall Study|Lack of Efficacy|0|||
33318575|NCT01241552|62694028|FG002|Overall Study|Lack of Efficacy|0|||
33318576|NCT01241552|62694029|FG003|Overall Study|Lack of Efficacy|0|||
33318577|NCT01241552|62694026|FG000|Overall Study|Death|26|||
33318578|NCT01241552|62694027|FG001|Overall Study|Death|30|||
33318579|NCT01241552|62694028|FG002|Overall Study|Death|20|||
33318580|NCT01241552|62694029|FG003|Overall Study|Death|25|||
33318581|NCT01241552|62694026|FG000|Overall Study|Adverse Event|1|||
33318582|NCT01241552|62694027|FG001|Overall Study|Adverse Event|1|||
33318583|NCT01241552|62694028|FG002|Overall Study|Adverse Event|0|||
33318584|NCT01241552|62694029|FG003|Overall Study|Adverse Event|0|||
33715237|NCT00160680|63300459|FG000|Overall Study|Withdrawal by Subject|4|||
33715238|NCT00160680|63300460|FG001|Overall Study|Withdrawal by Subject|9|||
33715239|NCT04556838|63301303|FG000|Overall Study|Withdrawal by Subject|3|||
33715240|NCT04556838|63301304|FG001|Overall Study|Withdrawal by Subject|1|||
33715241|NCT04556838|63301305|FG002|Overall Study|Withdrawal by Subject|2|||
33715242|NCT04556838|63301303|FG000|Overall Study|Adverse Event|0|||
33715243|NCT04556838|63301304|FG001|Overall Study|Adverse Event|1|||
33715244|NCT04556838|63301305|FG002|Overall Study|Adverse Event|1|||
33715245|NCT04556838|63301303|FG000|Overall Study|Lost to Follow-up|0|||
33715246|NCT04556838|63301304|FG001|Overall Study|Lost to Follow-up|0|||
33715247|NCT04556838|63301305|FG002|Overall Study|Lost to Follow-up|2|||
33715248|NCT04556838|63301303|FG000|Overall Study|Subject travel|0|||
33715249|NCT04556838|63301304|FG001|Overall Study|Subject travel|1|||
33715250|NCT04556838|63301305|FG002|Overall Study|Subject travel|0|||
33715251|NCT04556838|63301303|FG000|Overall Study|Physician Decision|1|||
33715252|NCT04556838|63301304|FG001|Overall Study|Physician Decision|0|||
33715253|NCT04556838|63301305|FG002|Overall Study|Physician Decision|0|||
33715254|NCT03671148|63301328|FG000|Overall Study|Adverse Event|3|||
33715255|NCT03671148|63301329|FG001|Overall Study|Adverse Event|2|||
33715256|NCT03671148|63301328|FG000|Overall Study|Withdrawal by Subject|8|||
33715257|NCT03671148|63301329|FG001|Overall Study|Withdrawal by Subject|2|||
33715258|NCT03671148|63301328|FG000|Overall Study|Lost to Follow-up|1|||
33715259|NCT03671148|63301329|FG001|Overall Study|Lost to Follow-up|2|||
33715260|NCT03671148|63301328|FG000|Overall Study|Lack of Efficacy|7|||
33715261|NCT03671148|63301329|FG001|Overall Study|Lack of Efficacy|2|||
33715262|NCT03671148|63301328|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
33715263|NCT03671148|63301329|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
33715264|NCT03671148|63301328|FG000|Overall Study|Other|1|||
33715265|NCT03671148|63301329|FG001|Overall Study|Other|0|||
33715266|NCT03671148|63301328|FG000|Overall Study|Incomplete Randomization Visit|1|||
33715267|NCT03671148|63301329|FG001|Overall Study|Incomplete Randomization Visit|0|||
33715268|NCT01430442|63301343|FG000|Overall Study|Subject Withdrew Consent|3|||
33715269|NCT01430442|63301344|FG001|Overall Study|Subject Withdrew Consent|0|||
33715270|NCT01430442|63301345|FG002|Overall Study|Subject Withdrew Consent|1|||
33715271|NCT01430442|63301346|FG003|Overall Study|Subject Withdrew Consent|0|||
33715272|NCT01430442|63301347|FG004|Overall Study|Subject Withdrew Consent|2|||
33715273|NCT01430442|63301348|FG005|Overall Study|Subject Withdrew Consent|1|||
33715274|NCT01430442|63301349|FG006|Overall Study|Subject Withdrew Consent|5|||
33715275|NCT01430442|63301350|FG007|Overall Study|Subject Withdrew Consent|2|||
33715276|NCT01430442|63301343|FG000|Overall Study|Lost to Follow-up|2|||
33715277|NCT01430442|63301344|FG001|Overall Study|Lost to Follow-up|0|||
33715278|NCT01430442|63301345|FG002|Overall Study|Lost to Follow-up|1|||
33715279|NCT01430442|63301346|FG003|Overall Study|Lost to Follow-up|2|||
33715280|NCT01430442|63301347|FG004|Overall Study|Lost to Follow-up|2|||
33715281|NCT01430442|63301348|FG005|Overall Study|Lost to Follow-up|1|||
33715282|NCT01430442|63301349|FG006|Overall Study|Lost to Follow-up|5|||
33318585|NCT01241552|62694026|FG000|Overall Study|Technical Problems|2|||
33318586|NCT01241552|62694027|FG001|Overall Study|Technical Problems|0|||
33715283|NCT01430442|63301350|FG007|Overall Study|Lost to Follow-up|1|||
33715284|NCT01430442|63301343|FG000|Overall Study|Pregnancy|1|||
33715285|NCT01430442|63301344|FG001|Overall Study|Pregnancy|0|||
33715286|NCT01430442|63301345|FG002|Overall Study|Pregnancy|0|||
33715287|NCT01430442|63301346|FG003|Overall Study|Pregnancy|0|||
33715288|NCT01430442|63301347|FG004|Overall Study|Pregnancy|0|||
33318587|NCT01241552|62694028|FG002|Overall Study|Technical Problems|2|||
33715289|NCT01430442|63301348|FG005|Overall Study|Pregnancy|1|||
33715290|NCT01430442|63301349|FG006|Overall Study|Pregnancy|0|||
33715291|NCT01430442|63301350|FG007|Overall Study|Pregnancy|0|||
33715292|NCT01430442|63301343|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
33715293|NCT01430442|63301344|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
33318588|NCT01241552|62694029|FG003|Overall Study|Technical Problems|2|||
33715294|NCT01430442|63301345|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
33715295|NCT01430442|63301346|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
33715296|NCT01430442|63301347|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
33715297|NCT01430442|63301348|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
33715298|NCT01430442|63301349|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
33715299|NCT01430442|63301350|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
33715300|NCT01420926|63301370|FG000|Overall Study|Adverse Event|6|||
33715301|NCT01420926|63301371|FG001|Overall Study|Adverse Event|4|||
33715302|NCT01420926|63301370|FG000|Overall Study|Death|18|||
33715303|NCT01420926|63301371|FG001|Overall Study|Death|17|||
33715304|NCT01420926|63301370|FG000|Overall Study|Withdrawal by Subject|11|||
33715305|NCT01420926|63301371|FG001|Overall Study|Withdrawal by Subject|17|||
33715306|NCT01420926|63301370|FG000|Overall Study|Non-protocol treatment|17|||
33715307|NCT01420926|63301371|FG001|Overall Study|Non-protocol treatment|20|||
33715308|NCT01420926|63301370|FG000|Overall Study|Physician Decision|8|||
33715309|NCT01420926|63301371|FG001|Overall Study|Physician Decision|5|||
33715310|NCT04303572|63301927|FG000|Overall Study|Study closed due to poor enrollment|1|||
33715311|NCT03551730|63301959|FG000|Overall Study|Adverse Event|1|||
33715312|NCT03551730|63301960|FG001|Overall Study|Adverse Event|0|||
33715313|NCT03551730|63301961|FG002|Overall Study|Adverse Event|0|||
33715314|NCT03551730|63301962|FG003|Overall Study|Adverse Event|0|||
33715315|NCT02656290|63301972|FG000|Overall Study|Subjects Remain On Study|26|||
33715316|NCT02534844|63301978|FG000|Part B|Withdrawal by Subject|0|||
33715317|NCT02534844|63301979|FG001|Part B|Withdrawal by Subject|0|||
33715318|NCT02534844|63301980|FG002|Part B|Withdrawal by Subject|0|||
33715319|NCT02534844|63301981|FG003|Part B|Withdrawal by Subject|0|||
33715320|NCT02534844|63301982|FG004|Part B|Withdrawal by Subject|2|||
33715321|NCT02534844|63301983|FG005|Part B|Withdrawal by Subject|1|||
33715322|NCT01818492|63302000|FG000|Overall Study|Adverse Event|2|||
33715323|NCT01818492|63302000|FG000|Overall Study|Death|3|||
33715324|NCT01818492|63302000|FG000|Overall Study|Withdrawal by Subject|1|||
33715325|NCT01818492|63302000|FG000|Overall Study|Additional therapy when not allowed PP|4|||
33715326|NCT01239030|63302010|FG000|Double Blind|Adverse Event|0|||
33715327|NCT01239030|63302011|FG001|Double Blind|Adverse Event|1|||
33715328|NCT01239030|63302012|FG002|Double Blind|Adverse Event|0|||
33715329|NCT01239030|63302013|FG003|Double Blind|Adverse Event|2|||
33715330|NCT01239030|63302014|FG004|Double Blind|Adverse Event|0|||
33715331|NCT01239030|63302010|FG000|Double Blind|Withdrawal by Subject|0|||
33715332|NCT01239030|63302011|FG001|Double Blind|Withdrawal by Subject|1|||
33715333|NCT01239030|63302012|FG002|Double Blind|Withdrawal by Subject|1|||
33715334|NCT01239030|63302013|FG003|Double Blind|Withdrawal by Subject|0|||
33715335|NCT01239030|63302014|FG004|Double Blind|Withdrawal by Subject|1|||
33715336|NCT01239030|63302010|FG000|Double Blind|Lost to Follow-up|1|||
33715337|NCT01239030|63302011|FG001|Double Blind|Lost to Follow-up|1|||
33715338|NCT01239030|63302012|FG002|Double Blind|Lost to Follow-up|0|||
33715339|NCT01239030|63302013|FG003|Double Blind|Lost to Follow-up|0|||
33715340|NCT01239030|63302014|FG004|Double Blind|Lost to Follow-up|0|||
33715341|NCT01239030|63302010|FG000|Double Blind|Physician Decision|0|||
33715342|NCT01239030|63302011|FG001|Double Blind|Physician Decision|1|||
33715343|NCT01239030|63302012|FG002|Double Blind|Physician Decision|0|||
33715344|NCT01239030|63302013|FG003|Double Blind|Physician Decision|0|||
33715345|NCT01239030|63302014|FG004|Double Blind|Physician Decision|0|||
33715346|NCT01239030|63302010|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
33715347|NCT01239030|63302011|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
33715348|NCT01239030|63302012|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
33715349|NCT01239030|63302013|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
33715350|NCT01239030|63302014|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
33715351|NCT01239030|63302010|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
33715352|NCT01239030|63302011|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
33715353|NCT01239030|63302012|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
33715354|NCT01239030|63302013|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
33715355|NCT01239030|63302014|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
33715356|NCT01239030|63302010|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
33715357|NCT01239030|63302011|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
33715358|NCT01239030|63302012|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
33715359|NCT01239030|63302013|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
33715360|NCT01239030|63302014|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
33715361|NCT01239030|63302010|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
33715362|NCT01239030|63302011|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
33715363|NCT01239030|63302012|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
33715364|NCT01239030|63302013|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
33715365|NCT01239030|63302014|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
33715366|NCT01086540|63302029|FG000|Overall Study|Death|3|||
33318589|NCT01241552|62694026|FG000|Overall Study|Progressive Disease|0|||
33715367|NCT01086540|63302030|FG001|Overall Study|Death|1|||
33715368|NCT01086540|63302029|FG000|Overall Study|Physician Decision|2|||
33715369|NCT01086540|63302030|FG001|Overall Study|Physician Decision|1|||
33715370|NCT01086540|63302029|FG000|Overall Study|Addition of new therapy for PAH|1|||
33715371|NCT01086540|63302030|FG001|Overall Study|Addition of new therapy for PAH|0|||
33715372|NCT04567524|63305336|FG000|Overall Study|Adverse Event|1|||
33715373|NCT04567524|63305337|FG001|Overall Study|Adverse Event|1|||
33715374|NCT04567524|63305338|FG002|Overall Study|Adverse Event|0|||
33715375|NCT04567524|63305339|FG003|Overall Study|Adverse Event|0|||
33715376|NCT04567524|63305336|FG000|Overall Study|Withdrawal by Subject|2|||
33715377|NCT04567524|63305337|FG001|Overall Study|Withdrawal by Subject|0|||
33715378|NCT04567524|63305338|FG002|Overall Study|Withdrawal by Subject|0|||
33715379|NCT04567524|63305339|FG003|Overall Study|Withdrawal by Subject|1|||
33715380|NCT03370302|63305375|FG000|Dose Escalation Phase|Other|0|||
33715381|NCT03370302|63305376|FG001|Dose Escalation Phase|Other|1|||
33715382|NCT03370302|63305377|FG002|Dose Escalation Phase|Other|1|||
33715383|NCT03370302|63305378|FG003|Dose Escalation Phase|Other|0|||
33715384|NCT03370302|63305379|FG004|Dose Escalation Phase|Other|0|||
33715385|NCT03370302|63305380|FG005|Dose Escalation Phase|Other|0|||
33715386|NCT03370302|63305375|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
33715387|NCT03370302|63305376|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
33715388|NCT03370302|63305377|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
33715389|NCT03370302|63305378|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
33715390|NCT03370302|63305379|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
33318590|NCT01241552|62694027|FG001|Overall Study|Progressive Disease|0|||
33318591|NCT01241552|62694028|FG002|Overall Study|Progressive Disease|1|||
33318592|NCT01241552|62694029|FG003|Overall Study|Progressive Disease|2|||
33318593|NCT01241552|62694026|FG000|Overall Study|Protocol Violation|0|||
33318594|NCT01241552|62694027|FG001|Overall Study|Protocol Violation|2|||
33318595|NCT01241552|62694028|FG002|Overall Study|Protocol Violation|6|||
33318596|NCT01241552|62694029|FG003|Overall Study|Protocol Violation|1|||
33318597|NCT01241552|62694026|FG000|Overall Study|Withdrawal by Subject|7|||
33318598|NCT01241552|62694027|FG001|Overall Study|Withdrawal by Subject|15|||
33318599|NCT01241552|62694028|FG002|Overall Study|Withdrawal by Subject|14|||
33318600|NCT01241552|62694029|FG003|Overall Study|Withdrawal by Subject|15|||
33318601|NCT01241552|62694026|FG000|Overall Study|Physician Decision|2|||
33318602|NCT01241552|62694027|FG001|Overall Study|Physician Decision|4|||
33318603|NCT01241552|62694028|FG002|Overall Study|Physician Decision|2|||
33715391|NCT03370302|63305380|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
33715392|NCT03370302|63305375|FG000|Dose Escalation Phase|Adverse Event|1|||
33715393|NCT03370302|63305376|FG001|Dose Escalation Phase|Adverse Event|0|||
33715394|NCT03370302|63305377|FG002|Dose Escalation Phase|Adverse Event|2|||
33715395|NCT03370302|63305378|FG003|Dose Escalation Phase|Adverse Event|0|||
33715396|NCT03370302|63305379|FG004|Dose Escalation Phase|Adverse Event|0|||
33715397|NCT03370302|63305380|FG005|Dose Escalation Phase|Adverse Event|0|||
33715398|NCT03370302|63305375|FG000|Dose Escalation Phase|Progressive Disease|2|||
33715399|NCT03370302|63305376|FG001|Dose Escalation Phase|Progressive Disease|4|||
33715400|NCT03370302|63305377|FG002|Dose Escalation Phase|Progressive Disease|2|||
33715401|NCT03370302|63305378|FG003|Dose Escalation Phase|Progressive Disease|0|||
33715402|NCT03370302|63305379|FG004|Dose Escalation Phase|Progressive Disease|3|||
33715403|NCT03370302|63305380|FG005|Dose Escalation Phase|Progressive Disease|1|||
33715404|NCT03370302|63305375|FG000|Dose Expansion Phase|Progressive Disease|0|||
33715405|NCT03370302|63305376|FG001|Dose Expansion Phase|Progressive Disease|0|||
33715406|NCT03370302|63305377|FG002|Dose Expansion Phase|Progressive Disease|0|||
33715407|NCT03370302|63305378|FG003|Dose Expansion Phase|Progressive Disease|6|||
33715408|NCT03370302|63305379|FG004|Dose Expansion Phase|Progressive Disease|0|||
33715409|NCT03370302|63305380|FG005|Dose Expansion Phase|Progressive Disease|0|||
33715410|NCT03327324|63305404|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33715411|NCT03327324|63305405|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
33715412|NCT03327324|63305406|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33715413|NCT03327324|63305407|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
33715414|NCT03327324|63305408|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33715415|NCT03327324|63305409|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
33715416|NCT03327324|63305404|FG000|Baseline (Month 0-Month 3)|Refused|0|||
33715417|NCT03327324|63305405|FG001|Baseline (Month 0-Month 3)|Refused|0|||
33715418|NCT03327324|63305406|FG002|Baseline (Month 0-Month 3)|Refused|0|||
33318604|NCT01241552|62694029|FG003|Overall Study|Physician Decision|3|||
33318605|NCT01241552|62694026|FG000|Overall Study|Lost to Follow-up|2|||
33715419|NCT03327324|63305407|FG003|Baseline (Month 0-Month 3)|Refused|0|||
33715420|NCT03327324|63305408|FG004|Baseline (Month 0-Month 3)|Refused|1|||
33715421|NCT03327324|63305409|FG005|Baseline (Month 0-Month 3)|Refused|0|||
33318606|NCT01241552|62694027|FG001|Overall Study|Lost to Follow-up|11|||
33715422|NCT03327324|63305404|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
33715423|NCT03327324|63305405|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
33715424|NCT03327324|63305406|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
33318607|NCT01241552|62694028|FG002|Overall Study|Lost to Follow-up|15|||
33318608|NCT01241552|62694029|FG003|Overall Study|Lost to Follow-up|16|||
33318609|NCT00948922|62694042|FG000|Overall Study|Did not start study treatment|2|||
33318610|NCT00948922|62694043|FG001|Overall Study|Did not start study treatment|5|||
33318611|NCT00948922|62694044|FG002|Overall Study|Did not start study treatment|0|||
33318612|NCT00948922|62694042|FG000|Overall Study|Withdrawal by Subject|0|||
33318613|NCT00948922|62694043|FG001|Overall Study|Withdrawal by Subject|2|||
33318614|NCT00948922|62694044|FG002|Overall Study|Withdrawal by Subject|1|||
33318615|NCT00948922|62694042|FG000|Overall Study|Death|3|||
33318616|NCT00948922|62694043|FG001|Overall Study|Death|0|||
33318617|NCT00948922|62694044|FG002|Overall Study|Death|0|||
33318618|NCT00948922|62694042|FG000|Overall Study|Disease progression|0|||
33318619|NCT00948922|62694043|FG001|Overall Study|Disease progression|1|||
33318620|NCT00948922|62694044|FG002|Overall Study|Disease progression|0|||
33318621|NCT00948922|62694042|FG000|Overall Study|Insurance issues|1|||
33318622|NCT00948922|62694043|FG001|Overall Study|Insurance issues|0|||
33318623|NCT00948922|62694044|FG002|Overall Study|Insurance issues|0|||
33318624|NCT00948922|62694042|FG000|Overall Study|Transplant eligibility issues|2|||
33318625|NCT00948922|62694043|FG001|Overall Study|Transplant eligibility issues|3|||
33318626|NCT00948922|62694044|FG002|Overall Study|Transplant eligibility issues|0|||
33318627|NCT00948922|62694042|FG000|Overall Study|Not evaluable at time of analysis|0|||
33318628|NCT00948922|62694043|FG001|Overall Study|Not evaluable at time of analysis|3|||
33318629|NCT00948922|62694044|FG002|Overall Study|Not evaluable at time of analysis|0|||
33318630|NCT01239992|62694056|FG000|Overall Study|Withdrawal by Subject|2|||
33318631|NCT01072539|62694060|FG000|Overall Study|Treated prior to the Site Initiation|1|||
33318632|NCT01072539|62694060|FG000|Overall Study|Protocol Violation|2|||
33318633|NCT01239680|62694066|FG000|Overall Study|Withdrawal by Subject|2|||
33318634|NCT01239680|62694067|FG001|Overall Study|Withdrawal by Subject|0|||
33318635|NCT01238900|62694073|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
33402094|NCT00640562|62780995|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
33402095|NCT00640562|62780994|FG000|Overall Study|Low study drug dose|0|||
33402096|NCT00640562|62780995|FG001|Overall Study|Low study drug dose|1|||
33402097|NCT00640562|62780994|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
33402098|NCT00640562|62780995|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
33715425|NCT03327324|63305407|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
33715426|NCT03327324|63305408|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
33715427|NCT03327324|63305409|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
33715428|NCT03327324|63305404|FG000|Baseline (Month 0-Month 3)|Death|0|||
33715429|NCT03327324|63305405|FG001|Baseline (Month 0-Month 3)|Death|0|||
33715430|NCT03327324|63305406|FG002|Baseline (Month 0-Month 3)|Death|0|||
33715431|NCT03327324|63305407|FG003|Baseline (Month 0-Month 3)|Death|0|||
33715432|NCT03327324|63305408|FG004|Baseline (Month 0-Month 3)|Death|1|||
33715433|NCT03327324|63305409|FG005|Baseline (Month 0-Month 3)|Death|0|||
33715434|NCT03327324|63305404|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33715435|NCT03327324|63305405|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33715436|NCT03327324|63305406|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33715437|NCT03327324|63305407|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33715438|NCT03327324|63305408|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33715439|NCT03327324|63305409|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
33715440|NCT03327324|63305404|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33715441|NCT03327324|63305405|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33715442|NCT03327324|63305406|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
33715443|NCT03327324|63305407|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33402099|NCT00585923|62781003|FG000|Overall Study|Physician decided not to continue|31|||
33402100|NCT00585923|62781004|FG001|Overall Study|Physician decided not to continue|33|||
33402101|NCT00721955|62781013|FG000|Overall Study|Adverse Event|0|||
33402102|NCT00721955|62781014|FG001|Overall Study|Adverse Event|0|||
33402103|NCT00721955|62781015|FG002|Overall Study|Adverse Event|2|||
33318636|NCT01238900|62694073|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
33318637|NCT01238822|62694078|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
33318638|NCT01238588|62694088|FG000|Overall Study|Withdrawal by Subject|1|||
33318639|NCT01238588|62694088|FG000|Overall Study|Physician Decision|2|||
33402104|NCT00585689|62781023|FG000|Overall Study|Received different ABI-007 schedule|3|||
33402105|NCT00585689|62781023|FG000|Overall Study|Adverse Event|1|||
33402106|NCT00585689|62781023|FG000|Overall Study|Patient Declined Surgery|1|||
33318640|NCT01047501|62694095|FG000|Overall Study|Adverse Event|7|||
33318641|NCT01047501|62694096|FG001|Overall Study|Adverse Event|8|||
33318642|NCT01047501|62694097|FG002|Overall Study|Adverse Event|5|||
33402107|NCT00585689|62781023|FG000|Overall Study|Patient had unresectable disease|1|||
33715444|NCT03327324|63305408|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33715445|NCT03327324|63305409|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33715446|NCT03327324|63305404|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
33715447|NCT03327324|63305405|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
33715448|NCT03327324|63305406|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
33715449|NCT03327324|63305407|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
33715450|NCT03327324|63305408|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
33715451|NCT03327324|63305409|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
33715452|NCT03327324|63305404|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
33715453|NCT03327324|63305405|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
33715454|NCT03327324|63305406|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
33715455|NCT03327324|63305407|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
33715456|NCT03327324|63305408|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
33715457|NCT03327324|63305409|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
33715458|NCT03327324|63305404|FG000|Intervention (Month 3-Month 6)|Death|1|||
33715459|NCT03327324|63305405|FG001|Intervention (Month 3-Month 6)|Death|0|||
33318643|NCT01047501|62694095|FG000|Overall Study|Withdrew Consent|6|||
33318644|NCT01047501|62694096|FG001|Overall Study|Withdrew Consent|2|||
33318645|NCT01047501|62694097|FG002|Overall Study|Withdrew Consent|4|||
33318646|NCT01047501|62694095|FG000|Overall Study|Lost to Follow-up|0|||
33318647|NCT01047501|62694096|FG001|Overall Study|Lost to Follow-up|1|||
33318648|NCT01047501|62694097|FG002|Overall Study|Lost to Follow-up|1|||
33318649|NCT01047501|62694095|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
33318650|NCT01047501|62694096|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
33318651|NCT01047501|62694097|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
33318652|NCT01047501|62694095|FG000|Overall Study|Death|1|||
33318653|NCT01047501|62694096|FG001|Overall Study|Death|0|||
33402108|NCT00585689|62781023|FG000|Overall Study|Death|1|||
33402109|NCT00721799|62781027|FG000|Overall Study|Withdrawal by Subject|7|||
33402110|NCT00721799|62781027|FG000|Overall Study|withdraw by subject after scan 1|1|||
33402111|NCT00729365|62781034|FG000|Overall Study|Physician Decision|33|||
33715460|NCT03327324|63305406|FG002|Intervention (Month 3-Month 6)|Death|1|||
33715461|NCT03327324|63305407|FG003|Intervention (Month 3-Month 6)|Death|1|||
33715462|NCT03327324|63305408|FG004|Intervention (Month 3-Month 6)|Death|1|||
33715463|NCT03327324|63305409|FG005|Intervention (Month 3-Month 6)|Death|0|||
33715464|NCT03327324|63305404|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33715465|NCT03327324|63305405|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33715466|NCT03327324|63305406|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33715467|NCT03327324|63305407|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33715468|NCT03327324|63305408|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33715469|NCT03327324|63305409|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
33715470|NCT03327324|63305404|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
33715471|NCT03327324|63305405|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33715472|NCT03327324|63305406|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33715473|NCT03327324|63305407|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33715474|NCT03327324|63305408|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33715475|NCT03327324|63305409|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33715476|NCT03327324|63305404|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
33715477|NCT03327324|63305405|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
33715478|NCT03327324|63305406|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
33715479|NCT03327324|63305407|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
33715480|NCT03327324|63305408|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
33715481|NCT03327324|63305409|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
33715482|NCT03327324|63305404|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
33715483|NCT03327324|63305405|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
33402112|NCT00729365|62781035|FG001|Overall Study|Physician Decision|6|||
33402113|NCT00729365|62781036|FG002|Overall Study|Physician Decision|7|||
33402114|NCT00254293|62781052|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
33402115|NCT00254293|62781053|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
33493912|NCT03495102|62872495|FG000|Overall Study|Lost to Follow-up|15|||
33318654|NCT01047501|62694097|FG002|Overall Study|Death|0|||
33715484|NCT03327324|63305406|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
33715485|NCT03327324|63305407|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
33715486|NCT03327324|63305408|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
33715487|NCT03327324|63305409|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
33715488|NCT03327324|63305404|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33715489|NCT03327324|63305405|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33715490|NCT03327324|63305406|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33715491|NCT03327324|63305407|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
33715492|NCT03327324|63305408|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
33715493|NCT03327324|63305409|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33715494|NCT03327324|63305404|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
33715495|NCT03327324|63305405|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
33318655|NCT01047501|62694095|FG000|Overall Study|Other discontinuation|1|||
33318656|NCT01047501|62694096|FG001|Overall Study|Other discontinuation|0|||
33318657|NCT01047501|62694097|FG002|Overall Study|Other discontinuation|1|||
33318658|NCT01047501|62694095|FG000|Overall Study|Investigator judgement|0|||
33318659|NCT01047501|62694096|FG001|Overall Study|Investigator judgement|0|||
33318660|NCT01047501|62694097|FG002|Overall Study|Investigator judgement|1|||
33318661|NCT01238120|62694109|FG000|Overall Study|Withdrawal by Subject|4|||
33318662|NCT01238120|62694110|FG001|Overall Study|Withdrawal by Subject|1|||
33318663|NCT01238120|62694111|FG002|Overall Study|Withdrawal by Subject|2|||
33318664|NCT01238120|62694112|FG003|Overall Study|Withdrawal by Subject|5|||
33318665|NCT01238120|62694109|FG000|Overall Study|Lost to Follow-up|2|||
33318666|NCT01238120|62694110|FG001|Overall Study|Lost to Follow-up|0|||
33318667|NCT01238120|62694111|FG002|Overall Study|Lost to Follow-up|1|||
33318668|NCT01238120|62694112|FG003|Overall Study|Lost to Follow-up|1|||
33318669|NCT01238120|62694109|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
33318670|NCT01238120|62694110|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
33318671|NCT01238120|62694111|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
33318672|NCT01238120|62694112|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
33318673|NCT01237340|62694122|FG000|Overall Study|Adverse Event|3|||
33318674|NCT01237340|62694122|FG000|Overall Study|Withdrawal by Subject|1|||
33318675|NCT01237340|62694122|FG000|Overall Study|Early termination of the trial|36|||
33318676|NCT01045707|62694131|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
33318677|NCT01045707|62694132|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
33318678|NCT01045707|62694131|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
33318679|NCT01045707|62694132|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
33318680|NCT01045707|62694131|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
33318681|NCT01045707|62694132|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
33318682|NCT01045707|62694131|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
33318683|NCT01045707|62694132|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
33318684|NCT01045707|62694131|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
33318685|NCT01045707|62694132|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
33318686|NCT01045707|62694131|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
33318687|NCT01045707|62694132|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
33318688|NCT01045707|62694131|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
33318689|NCT01045707|62694132|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
33318690|NCT01045707|62694131|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
33318691|NCT01045707|62694132|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
33318692|NCT01045707|62694131|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
33318693|NCT01045707|62694132|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
33318694|NCT01054599|62694140|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
33318695|NCT01054599|62694141|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
33318696|NCT01054599|62694140|FG000|Overall Study|Protocol Violation|1|||
33318697|NCT01054599|62694141|FG001|Overall Study|Protocol Violation|0|||
33318698|NCT01054599|62694140|FG000|Overall Study|Spells/seizure-like episodes|1|||
33318699|NCT01054599|62694141|FG001|Overall Study|Spells/seizure-like episodes|1|||
33318700|NCT01054599|62694140|FG000|Overall Study|Timing/scheduling difficulties|1|||
33318701|NCT01054599|62694141|FG001|Overall Study|Timing/scheduling difficulties|1|||
33402116|NCT00254293|62781054|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
33493913|NCT03495102|62872496|FG001|Overall Study|Lost to Follow-up|16|||
33318702|NCT01054599|62694140|FG000|Overall Study|Visual impairment, WTAR <80|0|||
33318703|NCT01054599|62694141|FG001|Overall Study|Visual impairment, WTAR <80|1|||
33318704|NCT01054599|62694140|FG000|Overall Study|Lost to Follow-up|0|||
33318705|NCT01054599|62694141|FG001|Overall Study|Lost to Follow-up|2|||
33402117|NCT00254293|62781055|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
33402118|NCT00254293|62781056|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
33318706|NCT01054599|62694140|FG000|Overall Study|Adverse Event|0|||
33318707|NCT01054599|62694141|FG001|Overall Study|Adverse Event|1|||
33318708|NCT01054599|62694140|FG000|Overall Study|Withdrawal by Subject|0|||
33318709|NCT01054599|62694141|FG001|Overall Study|Withdrawal by Subject|1|||
33318710|NCT00948766|62694149|FG000|Core Study|Adverse Event|73|||
33318711|NCT00948766|62694150|FG001|Core Study|Adverse Event|51|||
33318712|NCT00948766|62694149|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
33318713|NCT00948766|62694150|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
33318714|NCT00948766|62694149|FG000|Core Study|Patient Withdrew Consent|27|||
33318715|NCT00948766|62694150|FG001|Core Study|Patient Withdrew Consent|46|||
33318716|NCT00948766|62694149|FG000|Core Study|Lost to Follow-up|3|||
33318717|NCT00948766|62694150|FG001|Core Study|Lost to Follow-up|2|||
33318718|NCT00948766|62694149|FG000|Core Study|Administrative Problems|2|||
33318719|NCT00948766|62694150|FG001|Core Study|Administrative Problems|2|||
33318720|NCT00948766|62694149|FG000|Core Study|Death|1|||
33318721|NCT00948766|62694150|FG001|Core Study|Death|1|||
33318722|NCT00948766|62694149|FG000|Core Study|Protocol Deviation|8|||
33318723|NCT00948766|62694150|FG001|Core Study|Protocol Deviation|10|||
33318724|NCT00948766|62694149|FG000|Extension Study|Adverse Event|43|||
33318725|NCT00948766|62694150|FG001|Extension Study|Adverse Event|0|||
33318726|NCT00948766|62694149|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
33318727|NCT00948766|62694150|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
33318728|NCT00948766|62694149|FG000|Extension Study|Study Drug No Longer Required|1|||
33318729|NCT00948766|62694150|FG001|Extension Study|Study Drug No Longer Required|0|||
33318730|NCT00948766|62694149|FG000|Extension Study|Patient Withdrew Consent|32|||
33318731|NCT00948766|62694150|FG001|Extension Study|Patient Withdrew Consent|0|||
33318732|NCT00948766|62694149|FG000|Extension Study|Lost to Follow-up|8|||
33318733|NCT00948766|62694150|FG001|Extension Study|Lost to Follow-up|0|||
33318734|NCT00948766|62694149|FG000|Extension Study|Administrative Problems|1|||
33318735|NCT00948766|62694150|FG001|Extension Study|Administrative Problems|0|||
33318736|NCT00948766|62694149|FG000|Extension Study|Death|4|||
33715496|NCT03327324|63305406|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
33715497|NCT03327324|63305407|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
33715498|NCT03327324|63305408|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
33715499|NCT03327324|63305409|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
33715500|NCT03327324|63305404|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
33715501|NCT03327324|63305405|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
33715502|NCT03327324|63305406|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
33715503|NCT03327324|63305407|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
33318737|NCT00948766|62694150|FG001|Extension Study|Death|0|||
33318738|NCT01053663|62694160|FG000|Overall Study|Death|2|||
33318739|NCT01053663|62694160|FG000|Overall Study|Lost to Follow-up|1|||
33318740|NCT01053663|62694160|FG000|Overall Study|Poor IV Access|1|||
33318741|NCT01053663|62694160|FG000|Overall Study|Transferred to Another Hospital|1|||
33318742|NCT01053663|62694160|FG000|Overall Study|Negative Influenza Diagnosis|1|||
33318743|NCT01235546|62694172|FG000|Overall Study|Staff error, medication not administered|1|||
33318744|NCT01235546|62694173|FG001|Overall Study|Staff error, medication not administered|0|||
33318745|NCT01235546|62694172|FG000|Overall Study|Protocol Violation|1|||
33318746|NCT01235546|62694173|FG001|Overall Study|Protocol Violation|1|||
33318747|NCT01053429|62694188|FG000|Overall Study|Adverse Event|64|||
33318748|NCT01053429|62694188|FG000|Overall Study|Other|309|||
33318749|NCT01233284|62694192|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
33318750|NCT01233284|62694193|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33318751|NCT01233284|62694194|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33318752|NCT01233284|62694195|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33318753|NCT01233284|62694196|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33318754|NCT01233284|62694192|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
33318755|NCT01233284|62694193|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
33318756|NCT01233284|62694194|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
33318757|NCT01233284|62694195|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
33318758|NCT01233284|62694196|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
33318759|NCT01233284|62694192|FG000|Period 1 (4 Weeks)|Other|0|||
33318760|NCT01233284|62694193|FG001|Period 1 (4 Weeks)|Other|0|||
33318761|NCT01233284|62694194|FG002|Period 1 (4 Weeks)|Other|1|||
33318762|NCT01233284|62694195|FG003|Period 1 (4 Weeks)|Other|0|||
33318763|NCT01233284|62694196|FG004|Period 1 (4 Weeks)|Other|0|||
33318764|NCT01233284|62694192|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33318765|NCT01233284|62694193|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33318766|NCT01233284|62694194|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
33318767|NCT01233284|62694195|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33318768|NCT01233284|62694196|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33318769|NCT01233284|62694192|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
33318770|NCT01233284|62694193|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
33318771|NCT01233284|62694194|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
33318772|NCT01233284|62694195|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
33318773|NCT01233284|62694196|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
33318774|NCT01233284|62694192|FG000|Period 3 (4 Weeks)|Other|0|||
33318775|NCT01233284|62694193|FG001|Period 3 (4 Weeks)|Other|0|||
33318776|NCT01233284|62694194|FG002|Period 3 (4 Weeks)|Other|0|||
33318777|NCT01233284|62694195|FG003|Period 3 (4 Weeks)|Other|1|||
33318778|NCT01233284|62694196|FG004|Period 3 (4 Weeks)|Other|0|||
33318779|NCT01233284|62694192|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
33318780|NCT01233284|62694193|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
33318781|NCT01233284|62694194|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
33318782|NCT01233284|62694195|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
33318783|NCT01233284|62694196|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
33318784|NCT01233284|62694192|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
33318785|NCT01233284|62694193|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
33318786|NCT01233284|62694194|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
33318787|NCT01233284|62694195|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
33318788|NCT01233284|62694196|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
33318789|NCT00948688|62694206|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
33318790|NCT00948688|62694207|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
33318791|NCT00948688|62694206|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
33318792|NCT00948688|62694207|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
33318793|NCT00948688|62694206|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
33318794|NCT00948688|62694207|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
33318795|NCT01233050|62694216|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
33318796|NCT01233050|62694217|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
33318797|NCT01232894|62694225|FG000|Overall Study|Lost to Follow-up|0|||
33318798|NCT01232894|62694226|FG001|Overall Study|Lost to Follow-up|1|||
33318799|NCT01232894|62694225|FG000|Overall Study|Death|1|||
33318800|NCT01232894|62694226|FG001|Overall Study|Death|0|||
33318801|NCT01232894|62694225|FG000|Overall Study|Protocol Violation|1|||
33318802|NCT01232894|62694226|FG001|Overall Study|Protocol Violation|1|||
33318803|NCT01232894|62694225|FG000|Overall Study|Withdrawal by Subject|8|||
33318804|NCT01232894|62694226|FG001|Overall Study|Withdrawal by Subject|5|||
33318805|NCT01232894|62694225|FG000|Overall Study|Physician Decision|2|||
33318806|NCT01232894|62694226|FG001|Overall Study|Physician Decision|1|||
33318807|NCT01049217|62694234|FG000|Overall Study|Adverse Event|2|||
33318808|NCT01049217|62694235|FG001|Overall Study|Adverse Event|1|||
33318809|NCT01049217|62694234|FG000|Overall Study|Lack of Efficacy|1|||
33318810|NCT01049217|62694235|FG001|Overall Study|Lack of Efficacy|1|||
33318811|NCT01049217|62694234|FG000|Overall Study|Lost to Follow-up|3|||
33318812|NCT01049217|62694235|FG001|Overall Study|Lost to Follow-up|8|||
33318813|NCT01049217|62694234|FG000|Overall Study|Withdrawal by Subject|4|||
33318814|NCT01049217|62694235|FG001|Overall Study|Withdrawal by Subject|3|||
33318815|NCT01049217|62694234|FG000|Overall Study|Protocol Violation|1|||
33318816|NCT01049217|62694235|FG001|Overall Study|Protocol Violation|3|||
33318817|NCT01049217|62694234|FG000|Overall Study|Pregnancy|1|||
33318818|NCT01049217|62694235|FG001|Overall Study|Pregnancy|0|||
33318819|NCT01049217|62694234|FG000|Overall Study|Study Terminated by Sponsor|43|||
33318820|NCT01049217|62694235|FG001|Overall Study|Study Terminated by Sponsor|43|||
33318821|NCT01049217|62694234|FG000|Overall Study|Other|1|||
33318822|NCT01049217|62694235|FG001|Overall Study|Other|2|||
33318823|NCT01049217|62694234|FG000|Overall Study|Randomized but not Treated|0|||
33318824|NCT01049217|62694235|FG001|Overall Study|Randomized but not Treated|2|||
33318825|NCT01232738|62694241|FG000|Overall Study|Death|3|||
33318826|NCT01232738|62694241|FG000|Overall Study|Physician Decision|2|||
33318827|NCT01232738|62694241|FG000|Overall Study|Lost to Follow-up|1|||
33318828|NCT01232738|62694241|FG000|Overall Study|Withdrawal by Subject|2|||
33318829|NCT01232738|62694241|FG000|Overall Study|Adverse Event|5|||
33318830|NCT00957268|62694254|FG000|Overall Study|Voluntary Withdrawal|0|||
33318831|NCT00957268|62694255|FG001|Overall Study|Voluntary Withdrawal|0|||
33318832|NCT00957268|62694256|FG002|Overall Study|Voluntary Withdrawal|1|||
33318833|NCT00957268|62694257|FG003|Overall Study|Voluntary Withdrawal|0|||
33318834|NCT00957268|62694258|FG004|Overall Study|Voluntary Withdrawal|0|||
33318835|NCT01230788|62694270|FG000|Overall Study|Prescribed exclusion drug|1|||
33318836|NCT01230710|62694274|FG000|Overall Study|Disease Progression|41|||
33318837|NCT01230710|62694274|FG000|Overall Study|Lost to Follow-up|3|||
33318838|NCT01230710|62694274|FG000|Overall Study|Death|4|||
33318839|NCT01230710|62694274|FG000|Overall Study|Withdrawal of Consent|1|||
33318840|NCT01230554|62694278|FG000|Overall Study|Lost to Follow-up|2|||
33318841|NCT01230554|62694278|FG000|Overall Study|Inability to maintain visit schedule|1|||
33318842|NCT01040793|62694282|FG000|Overall Study|Adverse Event|5|||
33318843|NCT01040793|62694283|FG001|Overall Study|Adverse Event|3|||
33318844|NCT01040793|62694284|FG002|Overall Study|Adverse Event|0|||
33318845|NCT01040793|62694285|FG003|Overall Study|Adverse Event|2|||
33318846|NCT01040793|62694286|FG004|Overall Study|Adverse Event|2|||
33318847|NCT01040793|62694287|FG005|Overall Study|Adverse Event|1|||
33318848|NCT01040793|62694282|FG000|Overall Study|Protocol Violation|1|||
33318849|NCT01040793|62694283|FG001|Overall Study|Protocol Violation|1|||
33318850|NCT01040793|62694284|FG002|Overall Study|Protocol Violation|1|||
33318851|NCT01040793|62694285|FG003|Overall Study|Protocol Violation|0|||
33318852|NCT01040793|62694286|FG004|Overall Study|Protocol Violation|1|||
33318853|NCT01040793|62694287|FG005|Overall Study|Protocol Violation|0|||
33318854|NCT01040793|62694282|FG000|Overall Study|Lost to Follow-up|0|||
33318855|NCT01040793|62694283|FG001|Overall Study|Lost to Follow-up|1|||
33318856|NCT01040793|62694284|FG002|Overall Study|Lost to Follow-up|1|||
33318857|NCT01040793|62694285|FG003|Overall Study|Lost to Follow-up|0|||
33318858|NCT01040793|62694286|FG004|Overall Study|Lost to Follow-up|0|||
33318859|NCT01040793|62694287|FG005|Overall Study|Lost to Follow-up|0|||
33318860|NCT01040793|62694282|FG000|Overall Study|Withdrawal by Subject|0|||
33318861|NCT01040793|62694283|FG001|Overall Study|Withdrawal by Subject|0|||
33318862|NCT01040793|62694284|FG002|Overall Study|Withdrawal by Subject|0|||
33318863|NCT01040793|62694285|FG003|Overall Study|Withdrawal by Subject|2|||
33318864|NCT01040793|62694286|FG004|Overall Study|Withdrawal by Subject|0|||
33318865|NCT01040793|62694287|FG005|Overall Study|Withdrawal by Subject|0|||
33318866|NCT01040793|62694282|FG000|Overall Study|Other reasons not listed above|0|||
33318867|NCT01040793|62694283|FG001|Overall Study|Other reasons not listed above|0|||
33318868|NCT01040793|62694284|FG002|Overall Study|Other reasons not listed above|1|||
33318869|NCT01040793|62694285|FG003|Overall Study|Other reasons not listed above|0|||
33318870|NCT01040793|62694286|FG004|Overall Study|Other reasons not listed above|1|||
33318871|NCT01040793|62694287|FG005|Overall Study|Other reasons not listed above|0|||
33318872|NCT00948064|62694300|FG000|Phase I|No treatment received|1|||
33318873|NCT00948064|62694301|FG001|Phase I|No treatment received|0|||
33318874|NCT00948064|62694302|FG002|Phase I|No treatment received|0|||
33318875|NCT00948064|62694300|FG000|Phase II|Physician Decision|0|||
33318876|NCT00948064|62694301|FG001|Phase II|Physician Decision|0|||
33318877|NCT00948064|62694302|FG002|Phase II|Physician Decision|1|||
33318878|NCT00948064|62694300|FG000|Phase II|Withdrawal by Subject|0|||
33318879|NCT00948064|62694301|FG001|Phase II|Withdrawal by Subject|1|||
33318880|NCT00948064|62694302|FG002|Phase II|Withdrawal by Subject|0|||
33318881|NCT00953524|62694316|FG000|Overall Study|Adverse Event|2|||
33318882|NCT00953524|62694317|FG001|Overall Study|Adverse Event|0|||
33318883|NCT00953524|62694318|FG002|Overall Study|Adverse Event|1|||
33318884|NCT00953524|62694319|FG003|Overall Study|Adverse Event|2|||
33318885|NCT00953524|62694316|FG000|Overall Study|Protocol Violation|18|||
33318886|NCT00953524|62694317|FG001|Overall Study|Protocol Violation|10|||
33318887|NCT00953524|62694318|FG002|Overall Study|Protocol Violation|11|||
33318888|NCT00953524|62694319|FG003|Overall Study|Protocol Violation|6|||
33318889|NCT00953524|62694316|FG000|Overall Study|Lost to Follow-up|0|||
33318890|NCT00953524|62694317|FG001|Overall Study|Lost to Follow-up|1|||
33318891|NCT00953524|62694318|FG002|Overall Study|Lost to Follow-up|1|||
33318892|NCT00953524|62694319|FG003|Overall Study|Lost to Follow-up|0|||
33318893|NCT00953524|62694316|FG000|Overall Study|Withdrawal by Subject|2|||
33318894|NCT00953524|62694317|FG001|Overall Study|Withdrawal by Subject|4|||
33318895|NCT00953524|62694318|FG002|Overall Study|Withdrawal by Subject|1|||
33318896|NCT00953524|62694319|FG003|Overall Study|Withdrawal by Subject|0|||
33318897|NCT01040403|62694338|FG000|Overall Study|Adverse Event|10|||
33318898|NCT01040403|62694338|FG000|Overall Study|Protocol Violation|2|||
33318899|NCT01040403|62694338|FG000|Overall Study|Lost to Follow-up|1|||
33318900|NCT01040403|62694338|FG000|Overall Study|Not treated|1|||
33318901|NCT01040403|62694338|FG000|Overall Study|Other reason not defined above|6|||
33715504|NCT03327324|63305408|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
33715505|NCT03327324|63305409|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
33715506|NCT03252522|63305415|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
33715507|NCT03252522|63305416|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
33715508|NCT03252522|63305417|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
33715509|NCT03252522|63305415|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
33715510|NCT03252522|63305416|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
33715511|NCT03252522|63305417|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
33715512|NCT03252522|63305415|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
33715513|NCT03252522|63305416|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
33715514|NCT03252522|63305417|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
33715515|NCT03252522|63305415|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
33715516|NCT03252522|63305416|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
33715517|NCT03252522|63305417|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
33715518|NCT03252522|63305415|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
33318902|NCT00957034|62694360|FG000|Overall Study|Adverse Event|0|||
33318903|NCT00957034|62694361|FG001|Overall Study|Adverse Event|1|||
33318904|NCT00957034|62694362|FG002|Overall Study|Adverse Event|1|||
33318905|NCT00957034|62694360|FG000|Overall Study|Sponsor Terminated Study|6|||
33318906|NCT00957034|62694361|FG001|Overall Study|Sponsor Terminated Study|1|||
33318907|NCT00957034|62694362|FG002|Overall Study|Sponsor Terminated Study|5|||
33318908|NCT00957034|62694360|FG000|Overall Study|Withdrawal by Subject|0|||
33402119|NCT00254293|62781057|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
33318909|NCT00957034|62694361|FG001|Overall Study|Withdrawal by Subject|2|||
33318910|NCT00957034|62694362|FG002|Overall Study|Withdrawal by Subject|0|||
33318911|NCT00953056|62694376|FG000|Overall Study|Withdrew Consent|0|||
33715519|NCT03252522|63305416|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
33715520|NCT03252522|63305417|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
33715521|NCT03252522|63305415|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
33715522|NCT03252522|63305416|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
33715523|NCT03252522|63305417|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
33715524|NCT03252522|63305415|FG000|Phase 2: Open Label|Adverse Event|0|||
33715525|NCT03252522|63305416|FG001|Phase 2: Open Label|Adverse Event|0|||
33715526|NCT03252522|63305417|FG002|Phase 2: Open Label|Adverse Event|2|||
33715527|NCT03252522|63305415|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
33715528|NCT03252522|63305416|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
33715529|NCT03252522|63305417|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
33715530|NCT02756364|63305432|FG000|Overall Study|Site Terminated by Sponsor|24|||
33715531|NCT02756364|63305433|FG001|Overall Study|Site Terminated by Sponsor|30|||
33715532|NCT02756364|63305434|FG002|Overall Study|Site Terminated by Sponsor|21|||
33715533|NCT02756364|63305432|FG000|Overall Study|Death|20|||
33318912|NCT00953056|62694377|FG001|Overall Study|Withdrew Consent|0|||
33318913|NCT00953056|62694378|FG002|Overall Study|Withdrew Consent|0|||
33715534|NCT02756364|63305433|FG001|Overall Study|Death|15|||
33715535|NCT02756364|63305434|FG002|Overall Study|Death|18|||
33715536|NCT02756364|63305432|FG000|Overall Study|Withdrawal by Patient|2|||
33715537|NCT02756364|63305433|FG001|Overall Study|Withdrawal by Patient|1|||
33715538|NCT02756364|63305434|FG002|Overall Study|Withdrawal by Patient|8|||
33715539|NCT02756364|63305432|FG000|Overall Study|Lost to Follow-up|0|||
33715540|NCT02756364|63305433|FG001|Overall Study|Lost to Follow-up|1|||
33715541|NCT02756364|63305434|FG002|Overall Study|Lost to Follow-up|1|||
33715542|NCT01906476|63305444|FG000|Overall Study|Lost to Follow-up|17|||
33715543|NCT01906476|63305445|FG001|Overall Study|Lost to Follow-up|16|||
33715544|NCT05343624|63305451|FG000|Overall Study|Chart review not completed|1|||
33715545|NCT04208412|63305493|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
33715546|NCT04208412|63305494|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
33715547|NCT04208412|63305493|FG000|Overall Study|Withdrawal by Subject|1|||
33715548|NCT04208412|63305494|FG001|Overall Study|Withdrawal by Subject|0|||
33715549|NCT04208412|63305493|FG000|Overall Study|Lost to Follow-up|0|||
33715550|NCT04208412|63305494|FG001|Overall Study|Lost to Follow-up|1|||
33715551|NCT04095858|63305504|FG000|Overall Study|Death|1|||
33715552|NCT04095858|63305505|FG001|Overall Study|Death|0|||
33715553|NCT04095858|63305504|FG000|Overall Study|Study terminated by Sponsor|2|||
33715554|NCT04095858|63305505|FG001|Overall Study|Study terminated by Sponsor|4|||
33715555|NCT03937986|63305511|FG000|Overall Study|COVID-19 Pandemic|1|||
33715556|NCT03738150|63305526|FG000|Base Study|Withdrawal by Subject|1|||
33715557|NCT03738150|63305526|FG000|Extension Study|Withdrawal by Subject|1|||
33715558|NCT03567174|63305542|FG000|Overall Study|Death|24|||
33715559|NCT03567174|63305543|FG001|Overall Study|Death|31|||
33715560|NCT03567174|63305542|FG000|Overall Study|Lost to Follow-up|165|||
33715561|NCT03567174|63305543|FG001|Overall Study|Lost to Follow-up|174|||
33715562|NCT03529110|63305554|FG000|Overall Study|Progressive Disease|66|||
33715563|NCT03529110|63305555|FG001|Overall Study|Progressive Disease|158|||
33715564|NCT03529110|63305554|FG000|Overall Study|Clinical Progression|4|||
33715565|NCT03529110|63305555|FG001|Overall Study|Clinical Progression|12|||
33715566|NCT03529110|63305554|FG000|Overall Study|Adverse Event|35|||
33715567|NCT03529110|63305555|FG001|Overall Study|Adverse Event|17|||
33715568|NCT03529110|63305554|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
33715569|NCT03529110|63305555|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
33715570|NCT03529110|63305554|FG000|Overall Study|Lack of Efficacy|3|||
33715571|NCT03529110|63305555|FG001|Overall Study|Lack of Efficacy|3|||
33715572|NCT03529110|63305554|FG000|Overall Study|Physician Decision|2|||
33715573|NCT03529110|63305555|FG001|Overall Study|Physician Decision|8|||
33715574|NCT03529110|63305554|FG000|Overall Study|Miscellaneous|2|||
33715575|NCT03529110|63305555|FG001|Overall Study|Miscellaneous|5|||
33715576|NCT02663622|63305586|FG000|Overall Study|Death|3|||
33318914|NCT00953056|62694379|FG003|Overall Study|Withdrew Consent|0|||
33715577|NCT02663622|63305587|FG001|Overall Study|Death|1|||
33715578|NCT02663622|63305588|FG002|Overall Study|Death|1|||
33715579|NCT02663622|63305589|FG003|Overall Study|Death|8|||
33715580|NCT02663622|63305586|FG000|Overall Study|Protocol Violation|0|||
33715581|NCT02663622|63305587|FG001|Overall Study|Protocol Violation|0|||
33318915|NCT00953056|62694380|FG004|Overall Study|Withdrew Consent|2|||
33318916|NCT00953056|62694381|FG005|Overall Study|Withdrew Consent|3|||
33318917|NCT00953056|62694376|FG000|Overall Study|Serious Adverse Event|0|||
33402120|NCT00254293|62781058|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
33715582|NCT02663622|63305588|FG002|Overall Study|Protocol Violation|0|||
33715583|NCT02663622|63305589|FG003|Overall Study|Protocol Violation|1|||
33715584|NCT02545998|63305615|FG000|Overall Study|Lost to Follow-up|12|||
33715585|NCT02545998|63305616|FG001|Overall Study|Lost to Follow-up|3|||
33715586|NCT02545998|63305615|FG000|Overall Study|Withdrawal by Subject|3|||
33715587|NCT02545998|63305616|FG001|Overall Study|Withdrawal by Subject|2|||
33715588|NCT02257242|63305640|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
33715589|NCT02257242|63305641|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33715590|NCT02257242|63305642|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33715591|NCT02257242|63305643|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33318918|NCT00953056|62694377|FG001|Overall Study|Serious Adverse Event|0|||
33318919|NCT00953056|62694378|FG002|Overall Study|Serious Adverse Event|0|||
33318920|NCT00953056|62694379|FG003|Overall Study|Serious Adverse Event|0|||
33318921|NCT00953056|62694380|FG004|Overall Study|Serious Adverse Event|0|||
33318922|NCT00953056|62694381|FG005|Overall Study|Serious Adverse Event|1|||
33318923|NCT00952822|62694406|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
33318924|NCT00952822|62694407|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
33318925|NCT00952822|62694408|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
33318926|NCT00952822|62694409|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
33318927|NCT00952822|62694406|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
33318928|NCT00952822|62694407|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
33715592|NCT02257242|63305644|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33715593|NCT02257242|63305645|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33715594|NCT02257242|63305646|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33715595|NCT02257242|63305647|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33715596|NCT02257242|63305648|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33715597|NCT01943916|63305678|FG000|Overall Study|Technically invalid images|10|||
33715598|NCT01943916|63305678|FG000|Overall Study|Enrollment Failure|23|||
33715599|NCT01943916|63305678|FG000|Overall Study|Pilot Phase exclusion|100|||
33715600|NCT01943916|63305678|FG000|Overall Study|Quality Assurance Reader Fail|130|||
33715601|NCT01943916|63305678|FG000|Overall Study|Technical Failure|39|||
33715602|NCT01943916|63305678|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
33715603|NCT01943916|63305678|FG000|Overall Study|No Truth Panel Review|38|||
33715604|NCT01943916|63305678|FG000|Overall Study|Protocol Deviation|1|||
33715605|NCT01564368|63305687|FG000|Overall Study|Ineligible|18|||
33715606|NCT01564368|63305687|FG000|Overall Study|Not Randomized in Parent study|116|||
33715607|NCT01564368|63305687|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
33715608|NCT01564368|63305687|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
33715609|NCT00281658|63305695|FG000|Randomized Phase|Adverse Event|0|||
33402121|NCT00254293|62781052|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
33402122|NCT00254293|62781053|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
33402123|NCT00254293|62781054|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
33402124|NCT00254293|62781055|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
33402125|NCT00254293|62781056|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
33402126|NCT00254293|62781057|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
33402127|NCT00254293|62781058|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
33402128|NCT00254293|62781052|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
33402129|NCT00254293|62781053|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
33402130|NCT00254293|62781054|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
33402131|NCT00254293|62781055|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
33402132|NCT00254293|62781056|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
33402133|NCT00254293|62781057|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
33402134|NCT00254293|62781058|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
33402135|NCT00254293|62781052|FG000|LTE Open Label Variable SC Dosing|Death|0|||
33402136|NCT00254293|62781053|FG001|LTE Open Label Variable SC Dosing|Death|0|||
33402137|NCT00254293|62781054|FG002|LTE Open Label Variable SC Dosing|Death|1|||
33402138|NCT00254293|62781055|FG003|LTE Open Label Variable SC Dosing|Death|0|||
33402139|NCT00254293|62781056|FG004|LTE Open Label Variable SC Dosing|Death|0|||
33402140|NCT00254293|62781057|FG005|LTE Open Label Variable SC Dosing|Death|0|||
33402141|NCT00254293|62781058|FG006|LTE Open Label Variable SC Dosing|Death|0|||
33402142|NCT00254293|62781052|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
33402143|NCT00254293|62781053|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
33402144|NCT00254293|62781054|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
33402145|NCT00254293|62781055|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
33402146|NCT00254293|62781056|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
33402147|NCT00254293|62781057|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
33402148|NCT00254293|62781058|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
33402149|NCT00254293|62781052|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
33715610|NCT00281658|63305696|FG001|Randomized Phase|Adverse Event|2|||
33402150|NCT00254293|62781053|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
33318929|NCT00952822|62694408|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
33493914|NCT03495102|62872497|FG002|Overall Study|Lost to Follow-up|17|||
33318930|NCT00952822|62694409|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
33318931|NCT01038297|62694423|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
33318932|NCT01038297|62694424|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
33318933|NCT01038297|62694425|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
33318934|NCT00955708|62694442|FG000|Overall Study|Death|269|||
33318935|NCT00955708|62694442|FG000|Overall Study|Lost to Follow-up|72|||
33318936|NCT00955708|62694442|FG000|Overall Study|Physician Decision|36|||
33318937|NCT00955708|62694442|FG000|Overall Study|Protocol Violation|134|||
33318938|NCT00955708|62694442|FG000|Overall Study|Registry Conclusion|186|||
33318939|NCT00955708|62694442|FG000|Overall Study|Product removed from service|94|||
33318940|NCT00955708|62694442|FG000|Overall Study|Patient Refused to participate further|116|||
33318941|NCT00955708|62694442|FG000|Overall Study|Closure of study location|60|||
33318942|NCT00955708|62694442|FG000|Overall Study|Patient changed care provider/moved|91|||
33318943|NCT01037985|62694446|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
33318944|NCT01037985|62694447|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
33318945|NCT01037985|62694446|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
33715611|NCT00281658|63305697|FG002|Randomized Phase|Adverse Event|0|||
33715612|NCT00281658|63305698|FG003|Randomized Phase|Adverse Event|0|||
33715613|NCT00281658|63305695|FG000|Randomized Phase|Lost to Follow-up|34|||
33715614|NCT00281658|63305696|FG001|Randomized Phase|Lost to Follow-up|27|||
33715615|NCT00281658|63305697|FG002|Randomized Phase|Lost to Follow-up|0|||
33715616|NCT00281658|63305698|FG003|Randomized Phase|Lost to Follow-up|0|||
33715617|NCT00281658|63305695|FG000|Randomized Phase|Withdrawal by Subject|8|||
33715618|NCT00281658|63305696|FG001|Randomized Phase|Withdrawal by Subject|7|||
33715619|NCT00281658|63305697|FG002|Randomized Phase|Withdrawal by Subject|0|||
33715620|NCT00281658|63305698|FG003|Randomized Phase|Withdrawal by Subject|0|||
33715621|NCT00281658|63305695|FG000|Randomized Phase|Study closed/terminated|1|||
33715622|NCT00281658|63305696|FG001|Randomized Phase|Study closed/terminated|1|||
33715623|NCT00281658|63305697|FG002|Randomized Phase|Study closed/terminated|0|||
33715624|NCT00281658|63305698|FG003|Randomized Phase|Study closed/terminated|0|||
33318946|NCT01037985|62694447|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
33318947|NCT01037985|62694446|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
33318948|NCT01037985|62694447|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
33318949|NCT01037985|62694446|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
33318950|NCT01037985|62694447|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
33318951|NCT00955474|62694459|FG000|Overall Study|Physician Decision|7|||
33318952|NCT00955474|62694460|FG001|Overall Study|Physician Decision|5|||
33318953|NCT01229150|62694472|FG000|Overall Study|Toxicity|2|||
33318954|NCT01229150|62694473|FG001|Overall Study|Toxicity|2|||
33318955|NCT01229150|62694474|FG002|Overall Study|Toxicity|0|||
33318956|NCT01229150|62694475|FG003|Overall Study|Toxicity|0|||
33318957|NCT00952588|62694491|FG000|Overall Study|Death|28|||
33318958|NCT00952588|62694492|FG001|Overall Study|Death|13|||
33318959|NCT00952588|62694491|FG000|Overall Study|Withdrawal by Subject|2|||
33318960|NCT00952588|62694492|FG001|Overall Study|Withdrawal by Subject|5|||
33318961|NCT00952588|62694491|FG000|Overall Study|Adverse Event|2|||
33318962|NCT00952588|62694492|FG001|Overall Study|Adverse Event|3|||
33318963|NCT00952588|62694491|FG000|Overall Study|Lost to Follow-up|2|||
33318964|NCT00952588|62694492|FG001|Overall Study|Lost to Follow-up|0|||
33318965|NCT00952588|62694491|FG000|Overall Study|Physician Decision|0|||
33318966|NCT00952588|62694492|FG001|Overall Study|Physician Decision|1|||
33318967|NCT00952588|62694491|FG000|Overall Study|Lack of Efficacy|2|||
33318968|NCT00952588|62694492|FG001|Overall Study|Lack of Efficacy|2|||
33318969|NCT01227902|62694502|FG000|Overall Study|Adverse Event|12|||
33318970|NCT01227902|62694503|FG001|Overall Study|Adverse Event|8|||
33318971|NCT01227902|62694504|FG002|Overall Study|Adverse Event|11|||
33318972|NCT01227902|62694505|FG003|Overall Study|Adverse Event|4|||
33318973|NCT01227902|62694502|FG000|Overall Study|Lack of Efficacy|1|||
33318974|NCT01227902|62694503|FG001|Overall Study|Lack of Efficacy|2|||
33318975|NCT01227902|62694504|FG002|Overall Study|Lack of Efficacy|2|||
33318976|NCT01227902|62694505|FG003|Overall Study|Lack of Efficacy|1|||
33715625|NCT00281658|63305695|FG000|Randomized Phase|Disease progression|36|||
33715626|NCT00281658|63305696|FG001|Randomized Phase|Disease progression|27|||
33318977|NCT01227902|62694502|FG000|Overall Study|Protocol Violation|1|||
33318978|NCT01227902|62694503|FG001|Overall Study|Protocol Violation|0|||
33318979|NCT01227902|62694504|FG002|Overall Study|Protocol Violation|0|||
33318980|NCT01227902|62694505|FG003|Overall Study|Protocol Violation|0|||
33318981|NCT01227902|62694502|FG000|Overall Study|Lost to Follow-up|0|||
33318982|NCT01227902|62694503|FG001|Overall Study|Lost to Follow-up|0|||
33318983|NCT01227902|62694504|FG002|Overall Study|Lost to Follow-up|1|||
33318984|NCT01227902|62694505|FG003|Overall Study|Lost to Follow-up|2|||
33318985|NCT01227902|62694502|FG000|Overall Study|Physician Decision|0|||
33318986|NCT01227902|62694503|FG001|Overall Study|Physician Decision|1|||
33318987|NCT01227902|62694504|FG002|Overall Study|Physician Decision|1|||
33318988|NCT01227902|62694505|FG003|Overall Study|Physician Decision|0|||
33715627|NCT00281658|63305697|FG002|Randomized Phase|Disease progression|0|||
33318989|NCT01227902|62694502|FG000|Overall Study|Withdrawal by Subject|4|||
33318990|NCT01227902|62694503|FG001|Overall Study|Withdrawal by Subject|2|||
33715628|NCT00281658|63305698|FG003|Randomized Phase|Disease progression|0|||
33715629|NCT00281658|63305695|FG000|Randomized Phase|Physician Decision|1|||
33715630|NCT00281658|63305696|FG001|Randomized Phase|Physician Decision|1|||
33715631|NCT00281658|63305697|FG002|Randomized Phase|Physician Decision|0|||
33715632|NCT00281658|63305698|FG003|Randomized Phase|Physician Decision|0|||
33715633|NCT00281658|63305695|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
33715634|NCT00281658|63305696|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
33715635|NCT00281658|63305697|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
33715636|NCT00281658|63305698|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
33715637|NCT00281658|63305695|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
33715638|NCT00281658|63305696|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
33715639|NCT00281658|63305697|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
33715640|NCT00281658|63305698|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
33715641|NCT00281658|63305695|FG000|Randomized Phase|Treatment ongoing|1|||
33715642|NCT00281658|63305696|FG001|Randomized Phase|Treatment ongoing|0|||
33715643|NCT00281658|63305697|FG002|Randomized Phase|Treatment ongoing|0|||
33715644|NCT00281658|63305698|FG003|Randomized Phase|Treatment ongoing|0|||
33715645|NCT00281658|63305695|FG000|Open Label Phase|Adverse Event|0|||
33715646|NCT00281658|63305696|FG001|Open Label Phase|Adverse Event|0|||
33715647|NCT00281658|63305697|FG002|Open Label Phase|Adverse Event|1|||
33715648|NCT00281658|63305698|FG003|Open Label Phase|Adverse Event|0|||
33715649|NCT00281658|63305695|FG000|Open Label Phase|Lost to Follow-up|0|||
33715650|NCT00281658|63305696|FG001|Open Label Phase|Lost to Follow-up|0|||
33715651|NCT00281658|63305697|FG002|Open Label Phase|Lost to Follow-up|16|||
33715652|NCT00281658|63305698|FG003|Open Label Phase|Lost to Follow-up|2|||
33715653|NCT00281658|63305695|FG000|Open Label Phase|Withdrawal by Subject|0|||
33715654|NCT00281658|63305696|FG001|Open Label Phase|Withdrawal by Subject|0|||
33715655|NCT00281658|63305697|FG002|Open Label Phase|Withdrawal by Subject|3|||
33715656|NCT00281658|63305698|FG003|Open Label Phase|Withdrawal by Subject|2|||
33715657|NCT00281658|63305695|FG000|Open Label Phase|Disease progression|0|||
33715658|NCT00281658|63305696|FG001|Open Label Phase|Disease progression|0|||
33715659|NCT00281658|63305697|FG002|Open Label Phase|Disease progression|18|||
33715660|NCT00281658|63305698|FG003|Open Label Phase|Disease progression|0|||
33715661|NCT00281658|63305695|FG000|Open Label Phase|Physician Decision|0|||
33715662|NCT00281658|63305696|FG001|Open Label Phase|Physician Decision|0|||
33715663|NCT00281658|63305697|FG002|Open Label Phase|Physician Decision|1|||
33715664|NCT00281658|63305698|FG003|Open Label Phase|Physician Decision|0|||
33715665|NCT00281658|63305695|FG000|Open Label Phase|Relocation of patient|0|||
33715666|NCT00281658|63305696|FG001|Open Label Phase|Relocation of patient|0|||
33715667|NCT00281658|63305697|FG002|Open Label Phase|Relocation of patient|1|||
33715668|NCT00281658|63305698|FG003|Open Label Phase|Relocation of patient|0|||
33715669|NCT00281658|63305695|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
33715670|NCT00281658|63305696|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
33715671|NCT00281658|63305697|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
33715672|NCT00281658|63305698|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
33715673|NCT02758626|63307091|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
33715674|NCT02758626|63307092|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
33715675|NCT02758626|63307091|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
33715676|NCT02758626|63307092|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
33715677|NCT02758626|63307091|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
33715678|NCT02758626|63307092|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
33715679|NCT02758626|63307091|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
33715680|NCT02758626|63307092|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
33715681|NCT02357784|63307098|FG000|Overall Study|Withdrawal by Subject|1|||
33715682|NCT01448616|63307105|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
33715683|NCT01448616|63307106|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
33715684|NCT01448616|63307107|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
33715685|NCT01448616|63307108|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
33715686|NCT01448616|63307105|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
33715687|NCT01448616|63307106|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
33715688|NCT01448616|63307107|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
33715689|NCT01448616|63307108|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
33715690|NCT01448616|63307105|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
33715691|NCT01448616|63307106|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
33715692|NCT01448616|63307107|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
33715693|NCT01448616|63307108|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
33318991|NCT01227902|62694504|FG002|Overall Study|Withdrawal by Subject|4|||
33318992|NCT01227902|62694505|FG003|Overall Study|Withdrawal by Subject|3|||
33715694|NCT01448616|63307105|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
33715695|NCT01448616|63307106|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
33715696|NCT01448616|63307107|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
33715697|NCT01448616|63307108|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
33715698|NCT01448616|63307105|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
33715699|NCT01448616|63307106|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
33715700|NCT01448616|63307107|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
33715701|NCT01448616|63307108|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
33715702|NCT00074412|63307145|FG000|Overall Study|Death|30|||
33715703|NCT00074412|63307146|FG001|Overall Study|Death|26|||
33715704|NCT00074412|63307145|FG000|Overall Study|Lost to Follow-up|52|||
33715705|NCT00074412|63307146|FG001|Overall Study|Lost to Follow-up|58|||
33715706|NCT04505592|63308152|FG000|Overall Study|Death|2|||
33715707|NCT04505592|63308153|FG001|Overall Study|Death|1|||
33597697|NCT02499263|62996678|FG000|Overall Study|Participant's withdrawal of consent|4|||
33597698|NCT02499263|62996678|FG000|Overall Study|Lack of Efficacy|22|||
33597699|NCT02499263|62996678|FG000|Overall Study|investigator's judgment|12|||
33597700|NCT02499263|62996678|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
33318993|NCT00946192|62694519|FG000|Overall Study|Lost to Follow-up|6|||
33318994|NCT00946192|62694520|FG001|Overall Study|Lost to Follow-up|11|||
33318995|NCT00946192|62694521|FG002|Overall Study|Lost to Follow-up|9|||
33597701|NCT02499263|62996678|FG000|Overall Study|Participant's decision|3|||
33318996|NCT00946192|62694519|FG000|Overall Study|Withdrawal by Subject|10|||
33318997|NCT00946192|62694520|FG001|Overall Study|Withdrawal by Subject|7|||
33318998|NCT00946192|62694521|FG002|Overall Study|Withdrawal by Subject|3|||
33318999|NCT00946192|62694519|FG000|Overall Study|Did not start medication|2|||
33319000|NCT00946192|62694520|FG001|Overall Study|Did not start medication|0|||
33319001|NCT00946192|62694521|FG002|Overall Study|Did not start medication|0|||
33319002|NCT01037127|62694531|FG000|Overall Study|Lost to Follow-up|2|||
33319003|NCT01037127|62694532|FG001|Overall Study|Lost to Follow-up|4|||
33319004|NCT01037127|62694531|FG000|Overall Study|Physician Decision|1|||
33319005|NCT01037127|62694532|FG001|Overall Study|Physician Decision|0|||
33319006|NCT01037127|62694531|FG000|Overall Study|Study Closed Terminated|2|||
33319007|NCT01037127|62694532|FG001|Overall Study|Study Closed Terminated|17|||
33319008|NCT00946114|62694550|FG000|Overall Study|Death|5|||
33319009|NCT00946114|62694551|FG001|Overall Study|Death|2|||
33319010|NCT00946114|62694550|FG000|Overall Study|Other|1|||
33319011|NCT00946114|62694551|FG001|Overall Study|Other|0|||
33319012|NCT00946114|62694550|FG000|Overall Study|Withdrawal by Subject|2|||
33319013|NCT00946114|62694551|FG001|Overall Study|Withdrawal by Subject|0|||
33319014|NCT01038921|62694559|FG000|Overall Study|Withdrawal by Subject|1|||
33319015|NCT01038921|62694560|FG001|Overall Study|Withdrawal by Subject|0|||
33319016|NCT01038921|62694559|FG000|Overall Study|Physician Decision|1|||
33319017|NCT01038921|62694560|FG001|Overall Study|Physician Decision|0|||
33319018|NCT01038687|62694569|FG000|Overall Study|Adverse Event|0|||
33319019|NCT01038687|62694570|FG001|Overall Study|Adverse Event|2|||
33319020|NCT01038687|62694571|FG002|Overall Study|Adverse Event|1|||
33319021|NCT01081912|62694579|FG000|Conversion/Titration|Adverse Event|47|||
33319022|NCT01081912|62694580|FG001|Conversion/Titration|Adverse Event|0|||
33319023|NCT01081912|62694581|FG002|Conversion/Titration|Adverse Event|0|||
33402151|NCT00254293|62781054|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
33319024|NCT01081912|62694579|FG000|Conversion/Titration|Lack of Efficacy|17|||
33319025|NCT01081912|62694580|FG001|Conversion/Titration|Lack of Efficacy|0|||
33402152|NCT00254293|62781055|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
33319026|NCT01081912|62694581|FG002|Conversion/Titration|Lack of Efficacy|0|||
33402153|NCT00254293|62781056|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
33319027|NCT01081912|62694579|FG000|Conversion/Titration|Lost to Follow-up|5|||
33319028|NCT01081912|62694580|FG001|Conversion/Titration|Lost to Follow-up|0|||
33319029|NCT01081912|62694581|FG002|Conversion/Titration|Lost to Follow-up|0|||
33319030|NCT01081912|62694579|FG000|Conversion/Titration|Physician Decision|2|||
33319031|NCT01081912|62694580|FG001|Conversion/Titration|Physician Decision|0|||
33319032|NCT01081912|62694581|FG002|Conversion/Titration|Physician Decision|0|||
33319033|NCT01081912|62694579|FG000|Conversion/Titration|Protocol Violation|67|||
33319034|NCT01081912|62694580|FG001|Conversion/Titration|Protocol Violation|0|||
33319035|NCT01081912|62694581|FG002|Conversion/Titration|Protocol Violation|0|||
33319036|NCT01081912|62694579|FG000|Conversion/Titration|Withdrawal by Subject|23|||
33319037|NCT01081912|62694580|FG001|Conversion/Titration|Withdrawal by Subject|0|||
33319038|NCT01081912|62694581|FG002|Conversion/Titration|Withdrawal by Subject|0|||
33319039|NCT01081912|62694579|FG000|Conversion/Titration|Non-Compliance|47|||
33319040|NCT01081912|62694580|FG001|Conversion/Titration|Non-Compliance|0|||
33319041|NCT01081912|62694581|FG002|Conversion/Titration|Non-Compliance|0|||
33319042|NCT01081912|62694579|FG000|Maintenance Treatment|Adverse Event|0|||
33319043|NCT01081912|62694580|FG001|Maintenance Treatment|Adverse Event|2|||
33319044|NCT01081912|62694581|FG002|Maintenance Treatment|Adverse Event|12|||
33319045|NCT01081912|62694579|FG000|Maintenance Treatment|Lack of Efficacy|0|||
33319046|NCT01081912|62694580|FG001|Maintenance Treatment|Lack of Efficacy|14|||
33319047|NCT01081912|62694581|FG002|Maintenance Treatment|Lack of Efficacy|64|||
33319048|NCT01081912|62694579|FG000|Maintenance Treatment|Lost to Follow-up|0|||
33319049|NCT01081912|62694580|FG001|Maintenance Treatment|Lost to Follow-up|1|||
33319050|NCT01081912|62694581|FG002|Maintenance Treatment|Lost to Follow-up|0|||
33319051|NCT01081912|62694579|FG000|Maintenance Treatment|Physician Decision|0|||
33319052|NCT01081912|62694580|FG001|Maintenance Treatment|Physician Decision|0|||
33319053|NCT01081912|62694581|FG002|Maintenance Treatment|Physician Decision|1|||
33319054|NCT01081912|62694579|FG000|Maintenance Treatment|Protocol Violation|0|||
33319055|NCT01081912|62694580|FG001|Maintenance Treatment|Protocol Violation|1|||
33319056|NCT01081912|62694581|FG002|Maintenance Treatment|Protocol Violation|2|||
33402154|NCT00254293|62781057|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
33319057|NCT01081912|62694579|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
33319058|NCT01081912|62694580|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
33319059|NCT01081912|62694581|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
33319060|NCT01081912|62694579|FG000|Maintenance Treatment|Non-Compliance|0|||
33319061|NCT01081912|62694580|FG001|Maintenance Treatment|Non-Compliance|4|||
33319062|NCT01081912|62694581|FG002|Maintenance Treatment|Non-Compliance|7|||
33319063|NCT01081912|62694579|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
33319064|NCT01081912|62694580|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
33319065|NCT01081912|62694581|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
33319066|NCT01038609|62694593|FG000|Overall Study|Adverse Event|0|||
33319067|NCT01038609|62694594|FG001|Overall Study|Adverse Event|0|||
33319068|NCT01038609|62694595|FG002|Overall Study|Adverse Event|1|||
33319069|NCT01038609|62694596|FG003|Overall Study|Adverse Event|0|||
33319070|NCT01038609|62694597|FG004|Overall Study|Adverse Event|0|||
33319071|NCT01038609|62694593|FG000|Overall Study|Dosing Error|0|||
33319072|NCT01038609|62694594|FG001|Overall Study|Dosing Error|0|||
33402155|NCT00254293|62781058|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
33319073|NCT01038609|62694595|FG002|Overall Study|Dosing Error|0|||
33319074|NCT01038609|62694596|FG003|Overall Study|Dosing Error|1|||
33319075|NCT01038609|62694597|FG004|Overall Study|Dosing Error|1|||
33319076|NCT01038609|62694593|FG000|Overall Study|Death in the Family|1|||
33319077|NCT01038609|62694594|FG001|Overall Study|Death in the Family|0|||
33319078|NCT01038609|62694595|FG002|Overall Study|Death in the Family|0|||
33319079|NCT01038609|62694596|FG003|Overall Study|Death in the Family|0|||
33319080|NCT01038609|62694597|FG004|Overall Study|Death in the Family|0|||
33319081|NCT01038609|62694593|FG000|Overall Study|Refusal of Blood Draws|0|||
33319082|NCT01038609|62694594|FG001|Overall Study|Refusal of Blood Draws|1|||
33319083|NCT01038609|62694595|FG002|Overall Study|Refusal of Blood Draws|0|||
33319084|NCT01038609|62694596|FG003|Overall Study|Refusal of Blood Draws|0|||
33319085|NCT01038609|62694597|FG004|Overall Study|Refusal of Blood Draws|0|||
33319086|NCT02357134|62694613|FG000|Overall Study|Lost to Follow-up|1|||
33319087|NCT02357134|62694614|FG001|Overall Study|Lost to Follow-up|0|||
33319088|NCT02357134|62694615|FG002|Overall Study|Lost to Follow-up|0|||
33319089|NCT02357134|62694616|FG003|Overall Study|Lost to Follow-up|0|||
33319090|NCT00745420|62694626|FG000|Overall Study|Ineligible|1|||
33319091|NCT02853370|62694630|FG000|Overall Study|Physician Decision|1|||
33319092|NCT02853370|62694630|FG000|Overall Study|Lack of Efficacy|2|||
33319093|NCT02853370|62694630|FG000|Overall Study|Death|1|||
33319094|NCT02853370|62694630|FG000|Overall Study|Adverse Event|4|||
33319095|NCT02853370|62694630|FG000|Overall Study|Withdrawal by Subject|3|||
33319096|NCT01879072|62694635|FG000|Overall Study|Withdrawal by Subject|121|||
33319097|NCT01879072|62694635|FG000|Overall Study|Not Transplanted|30|||
33319098|NCT00954538|62694641|FG000|Part III|Withdrawal by Subject|0|||
33319099|NCT00954538|62694642|FG001|Part III|Withdrawal by Subject|0|||
33319100|NCT00954538|62694643|FG002|Part III|Withdrawal by Subject|0|||
33493915|NCT03495102|62872495|FG000|Overall Study|Physician Decision|2|||
33319101|NCT00954538|62694644|FG003|Part III|Withdrawal by Subject|0|||
33319102|NCT00954538|62694645|FG004|Part III|Withdrawal by Subject|1|||
33319103|NCT00954538|62694646|FG005|Part III|Withdrawal by Subject|0|||
33319104|NCT00943852|62694655|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33319105|NCT00943852|62694656|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33319106|NCT00943852|62694657|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33319107|NCT00943852|62694658|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
33319108|NCT00943852|62694659|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33319109|NCT00943852|62694660|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33319110|NCT00943852|62694661|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33319111|NCT00943852|62694662|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33319112|NCT00943852|62694663|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33402156|NCT00254293|62781052|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
33319113|NCT00943852|62694664|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33319114|NCT00943852|62694655|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33319115|NCT00943852|62694656|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33319116|NCT00943852|62694657|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33319117|NCT00943852|62694658|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33319118|NCT00943852|62694659|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33319119|NCT00943852|62694660|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
33319120|NCT00943852|62694661|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33319121|NCT00943852|62694662|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33319122|NCT00943852|62694663|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33319123|NCT00943852|62694664|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33319124|NCT00943852|62694655|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33319125|NCT00943852|62694656|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33319126|NCT00943852|62694657|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33319127|NCT00943852|62694658|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33319128|NCT00943852|62694659|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33319129|NCT00943852|62694660|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33319130|NCT00943852|62694661|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
33319131|NCT00943852|62694662|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33319132|NCT00943852|62694663|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33319133|NCT00943852|62694664|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33319134|NCT00943852|62694655|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33319135|NCT00943852|62694656|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33319136|NCT00943852|62694657|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33319137|NCT00943852|62694658|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33319138|NCT00943852|62694659|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33319139|NCT00943852|62694660|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33319140|NCT00943852|62694661|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33319141|NCT00943852|62694662|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
33319142|NCT00943852|62694663|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33319143|NCT00943852|62694664|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33319144|NCT00943852|62694655|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
33319145|NCT00943852|62694656|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
33319146|NCT00943852|62694657|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
33319147|NCT00943852|62694658|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
33319148|NCT00943852|62694659|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
33319149|NCT00943852|62694660|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
33319150|NCT00943852|62694661|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
33319151|NCT00943852|62694662|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
33402157|NCT00254293|62781053|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
33319152|NCT00943852|62694663|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
33319153|NCT00943852|62694664|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
33319154|NCT00952276|62694679|FG000|Overall Study|Withdrawal by Subject|1|||
33319155|NCT00952276|62694680|FG001|Overall Study|Withdrawal by Subject|0|||
33319156|NCT00952276|62694681|FG002|Overall Study|Withdrawal by Subject|0|||
33319157|NCT00952276|62694682|FG003|Overall Study|Withdrawal by Subject|1|||
33319158|NCT00952276|62694683|FG004|Overall Study|Withdrawal by Subject|0|||
33319159|NCT00943384|62694695|FG000|Overall Study|Dispositioned prior to treatment|23|||
33319160|NCT00943384|62694695|FG000|Overall Study|Treated off protocol-protocol violation|5|||
33319161|NCT00943384|62694695|FG000|Overall Study|Lost to Follow-up|16|||
33319162|NCT00943384|62694695|FG000|Overall Study|Withdrawal by Subject|5|||
33319163|NCT00943306|62694699|FG000|Overall Study|Physician Decision|1|||
33319164|NCT00943306|62694699|FG000|Overall Study|Death|1|||
33319165|NCT00943306|62694699|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
33319166|NCT01198002|62694706|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
33319167|NCT01198002|62694707|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
33319168|NCT01198002|62694708|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
33319169|NCT01198002|62694706|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
33319170|NCT01198002|62694707|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
33319171|NCT01198002|62694708|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
33319172|NCT01198002|62694706|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
33319173|NCT01198002|62694707|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
33319174|NCT01198002|62694708|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
33319175|NCT01198002|62694706|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
33319176|NCT01198002|62694707|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
33319177|NCT01198002|62694708|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
33319178|NCT01198002|62694706|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
33402158|NCT00254293|62781054|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
33319179|NCT01198002|62694707|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
33319180|NCT01198002|62694708|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
33493916|NCT03495102|62872496|FG001|Overall Study|Physician Decision|0|||
33319181|NCT01198002|62694706|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
33319182|NCT01198002|62694707|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
33319183|NCT01198002|62694708|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
33319184|NCT01198002|62694706|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
33319185|NCT01198002|62694707|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
33319186|NCT01198002|62694708|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
33319187|NCT01198002|62694706|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
33319188|NCT01198002|62694707|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
33319189|NCT01198002|62694708|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
33319190|NCT01198002|62694706|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
33319191|NCT01198002|62694707|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
33319192|NCT01198002|62694708|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
33319193|NCT01198002|62694706|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
33402159|NCT00254293|62781055|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
33402160|NCT00254293|62781056|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
33402161|NCT00254293|62781057|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
33402162|NCT00254293|62781058|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
33402163|NCT00254293|62781052|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
33402164|NCT00254293|62781053|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
33402165|NCT00254293|62781054|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
33402166|NCT00254293|62781055|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
33402167|NCT00254293|62781056|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
33402168|NCT00254293|62781057|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
33402169|NCT00254293|62781058|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
33493917|NCT03495102|62872497|FG002|Overall Study|Physician Decision|2|||
33319194|NCT01198002|62694707|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
33319195|NCT01198002|62694708|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
33319196|NCT01198002|62694706|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
33319197|NCT01198002|62694707|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
33319198|NCT01198002|62694708|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
33319199|NCT01198002|62694706|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
33319200|NCT01198002|62694707|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
33319201|NCT01198002|62694708|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
33319202|NCT01198002|62694706|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
33319203|NCT01198002|62694707|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
33319204|NCT01198002|62694708|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
33493918|NCT03495102|62872495|FG000|Overall Study|Withdrawal by Subject|25|||
33319205|NCT01198002|62694706|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
33319206|NCT01198002|62694707|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
33319207|NCT01198002|62694708|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
33319208|NCT01198002|62694706|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
33319209|NCT01198002|62694707|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
33319210|NCT01198002|62694708|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
33319211|NCT01197534|62694741|FG000|Overall Study|Not reported|16|||
33319212|NCT01197534|62694742|FG001|Overall Study|Not reported|10|||
33319213|NCT01197534|62694743|FG002|Overall Study|Not reported|16|||
33319214|NCT01197534|62694741|FG000|Overall Study|Enrolment in long term extension|57|||
33319215|NCT01197534|62694742|FG001|Overall Study|Enrolment in long term extension|66|||
33319216|NCT01197534|62694743|FG002|Overall Study|Enrolment in long term extension|119|||
33319217|NCT01197534|62694741|FG000|Overall Study|Severe non-compliance to protocol|3|||
33319218|NCT01197534|62694742|FG001|Overall Study|Severe non-compliance to protocol|4|||
33319219|NCT01197534|62694743|FG002|Overall Study|Severe non-compliance to protocol|1|||
33319220|NCT01197534|62694741|FG000|Overall Study|Lack of therapeutic response|9|||
33319221|NCT01197534|62694742|FG001|Overall Study|Lack of therapeutic response|4|||
33319222|NCT01197534|62694743|FG002|Overall Study|Lack of therapeutic response|9|||
33319223|NCT01197534|62694741|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
33319224|NCT01197534|62694742|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
33319225|NCT01197534|62694743|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
33319226|NCT01197534|62694741|FG000|Overall Study|Lost to Follow-up|1|||
33319227|NCT01197534|62694742|FG001|Overall Study|Lost to Follow-up|4|||
33319228|NCT01197534|62694743|FG002|Overall Study|Lost to Follow-up|2|||
33319229|NCT01197534|62694741|FG000|Overall Study|Adverse Event|35|||
33319230|NCT01197534|62694742|FG001|Overall Study|Adverse Event|36|||
33319231|NCT01197534|62694743|FG002|Overall Study|Adverse Event|24|||
33319232|NCT01197378|62694754|FG000|Overall Study|Adverse Event|3|||
33319233|NCT01197378|62694754|FG000|Overall Study|Withdrawal by Subject|1|||
33319234|NCT01197378|62694754|FG000|Overall Study|Physician Decision|1|||
33319235|NCT01197378|62694754|FG000|Overall Study|Other|2|||
33319236|NCT01197300|62694760|FG000|Overall Study|Lost to Follow-up|0|||
33319237|NCT01197300|62694761|FG001|Overall Study|Lost to Follow-up|1|||
33319238|NCT01197300|62694760|FG000|Overall Study|Protocol Violation|0|||
33319239|NCT01197300|62694761|FG001|Overall Study|Protocol Violation|1|||
33319240|NCT01196988|62694776|FG000|Overall Study|Adverse Event|1|||
33319241|NCT01196988|62694777|FG001|Overall Study|Adverse Event|2|||
33319242|NCT01196988|62694778|FG002|Overall Study|Adverse Event|0|||
33319243|NCT01196988|62694779|FG003|Overall Study|Adverse Event|0|||
33319244|NCT01196988|62694776|FG000|Overall Study|Withdrawal by Subject|5|||
33319245|NCT01196988|62694777|FG001|Overall Study|Withdrawal by Subject|1|||
33319246|NCT01196988|62694778|FG002|Overall Study|Withdrawal by Subject|4|||
33319247|NCT01196988|62694779|FG003|Overall Study|Withdrawal by Subject|0|||
33319248|NCT01196988|62694776|FG000|Overall Study|Lost to Follow-up|16|||
33319249|NCT01196988|62694777|FG001|Overall Study|Lost to Follow-up|29|||
33319250|NCT01196988|62694778|FG002|Overall Study|Lost to Follow-up|21|||
33319251|NCT01196988|62694779|FG003|Overall Study|Lost to Follow-up|1|||
33319252|NCT01196988|62694776|FG000|Overall Study|Other|2|||
33319253|NCT01196988|62694777|FG001|Overall Study|Other|0|||
33319254|NCT01196988|62694778|FG002|Overall Study|Other|0|||
33319255|NCT01196988|62694779|FG003|Overall Study|Other|0|||
33319256|NCT01196052|62694790|FG000|Overall Study|Adverse Event|9|||
33319257|NCT01196052|62694790|FG000|Overall Study|Lost to Follow-up|1|||
33319258|NCT01196052|62694790|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
33319259|NCT01196052|62694790|FG000|Overall Study|Reason not Specified|5|||
33319260|NCT01196052|62694790|FG000|Overall Study|Withdrawal by Subject|6|||
33319261|NCT01195662|62694797|FG000|Double Blind Treatment Period|Adverse Event|4|||
33319262|NCT01195662|62694798|FG001|Double Blind Treatment Period|Adverse Event|1|||
33319263|NCT01195662|62694799|FG002|Double Blind Treatment Period|Adverse Event|2|||
33319264|NCT01195662|62694797|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
33319265|NCT01195662|62694798|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
33319266|NCT01195662|62694799|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
33319267|NCT01195662|62694797|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
33319268|NCT01195662|62694798|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
33319269|NCT01195662|62694799|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
33319270|NCT01195662|62694797|FG000|Double Blind Treatment Period|Administrative reason|2|||
33319271|NCT01195662|62694798|FG001|Double Blind Treatment Period|Administrative reason|1|||
33319272|NCT01195662|62694799|FG002|Double Blind Treatment Period|Administrative reason|1|||
33319273|NCT01195662|62694797|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
33319274|NCT01195662|62694798|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
33319275|NCT01195662|62694799|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
33319276|NCT01195662|62694797|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
33319277|NCT01195662|62694798|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
33319278|NCT01195662|62694799|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
33319279|NCT01195662|62694797|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
33319280|NCT01195662|62694798|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
33319281|NCT01195662|62694799|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
33319282|NCT01195662|62694797|FG000|Double Blind Treatment Period|Non-specified|3|||
33319283|NCT01195662|62694798|FG001|Double Blind Treatment Period|Non-specified|0|||
33319284|NCT01195662|62694799|FG002|Double Blind Treatment Period|Non-specified|0|||
33319285|NCT01195662|62694797|FG000|Double Blind Treatment Period|Missing disposition information|0|||
33319286|NCT01195662|62694798|FG001|Double Blind Treatment Period|Missing disposition information|1|||
33319287|NCT01195662|62694799|FG002|Double Blind Treatment Period|Missing disposition information|1|||
33319288|NCT01195662|62694797|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
33319289|NCT01195662|62694798|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
33319290|NCT01195662|62694799|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
33319291|NCT01195662|62694797|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
33319292|NCT01195662|62694798|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
33319293|NCT01195662|62694799|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
33319294|NCT01195272|62694808|FG000|Overall Study|Adverse Event|1|||
33319295|NCT01195272|62694808|FG000|Overall Study|Lack of Efficacy|3|||
33319296|NCT01194804|62694812|FG000|Overall Study|Withdrawal by Subject|1|||
33319297|NCT01194414|62694836|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
33402170|NCT00254293|62781052|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
33319298|NCT01194414|62694837|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
33319299|NCT01194414|62694838|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
33319300|NCT01194414|62694839|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
33319301|NCT01194414|62694836|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
33319302|NCT01194414|62694837|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
33319303|NCT01194414|62694838|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
33319304|NCT01194414|62694839|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
33319305|NCT01194414|62694836|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
33319306|NCT01194414|62694837|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
33319307|NCT01194414|62694838|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
33319308|NCT01194414|62694839|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
33319309|NCT01194414|62694836|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
33319310|NCT01194414|62694837|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
33319311|NCT01194414|62694838|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
33319312|NCT01194414|62694839|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
33319313|NCT01194414|62694836|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
33319314|NCT01194414|62694837|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
33319315|NCT01194414|62694838|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
33319316|NCT01194414|62694839|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
33319317|NCT01194414|62694836|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
33319318|NCT01194414|62694837|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
33319319|NCT01194414|62694838|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
33319320|NCT01194414|62694839|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
33319321|NCT01194414|62694836|FG000|24 Weeks Double Blind Period|Other|0|||
33319322|NCT01194414|62694837|FG001|24 Weeks Double Blind Period|Other|1|||
33319323|NCT01194414|62694838|FG002|24 Weeks Double Blind Period|Other|0|||
33319324|NCT01194414|62694839|FG003|24 Weeks Double Blind Period|Other|0|||
33319325|NCT01194414|62694836|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
33319326|NCT01194414|62694837|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
33319327|NCT01194414|62694838|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
33319328|NCT01194414|62694839|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
33319329|NCT01194414|62694836|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
33319330|NCT01194414|62694837|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
33319331|NCT01194414|62694838|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
33319332|NCT01194414|62694839|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
33319333|NCT01194414|62694836|FG000|24 Weeks Double Blind Period|Death|0|||
33319334|NCT01194414|62694837|FG001|24 Weeks Double Blind Period|Death|1|||
33319335|NCT01194414|62694838|FG002|24 Weeks Double Blind Period|Death|0|||
33319336|NCT01194414|62694839|FG003|24 Weeks Double Blind Period|Death|0|||
33319337|NCT01194414|62694836|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
33319338|NCT01194414|62694837|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
33319339|NCT01194414|62694838|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
33319340|NCT01194414|62694839|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
33402171|NCT00254293|62781053|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
33493919|NCT03495102|62872496|FG001|Overall Study|Withdrawal by Subject|36|||
33319341|NCT01194414|62694836|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
33319342|NCT01194414|62694837|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
33319343|NCT01194414|62694838|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
33319344|NCT01194414|62694839|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
33319345|NCT01194414|62694836|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
33319346|NCT01194414|62694837|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
33319347|NCT01194414|62694838|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
33319348|NCT01194414|62694839|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
33319349|NCT01194414|62694836|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
33319350|NCT01194414|62694837|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
33319351|NCT01194414|62694838|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
33319352|NCT01194414|62694839|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
33319353|NCT01194414|62694836|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
33319354|NCT01194414|62694837|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
33319355|NCT01194414|62694838|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
33319356|NCT01194414|62694839|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
33319357|NCT01194414|62694836|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
33319358|NCT01194414|62694837|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
33597702|NCT02499263|62996678|FG000|Overall Study|Pregnancy|1|||
33319359|NCT01194414|62694838|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
33319360|NCT01194414|62694839|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
33319361|NCT01194414|62694836|FG000|72 Weeks Open Label Extension|Other|2|||
33319362|NCT01194414|62694837|FG001|72 Weeks Open Label Extension|Other|1|||
33319363|NCT01194414|62694838|FG002|72 Weeks Open Label Extension|Other|0|||
33319364|NCT01194414|62694839|FG003|72 Weeks Open Label Extension|Other|0|||
33319365|NCT01194414|62694836|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
33319366|NCT01194414|62694837|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
33319367|NCT01194414|62694838|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
33319368|NCT01194414|62694839|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
33319369|NCT01194414|62694836|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
33402172|NCT00254293|62781054|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
33402173|NCT00254293|62781055|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
33402174|NCT00254293|62781056|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
33402175|NCT00254293|62781057|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
33402176|NCT00254293|62781058|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
33319370|NCT01194414|62694837|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
33319371|NCT01194414|62694838|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
33319372|NCT01194414|62694839|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
33319373|NCT01194414|62694836|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
33319374|NCT01194414|62694837|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
33319375|NCT01194414|62694838|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
33319376|NCT01194414|62694839|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
33319377|NCT01194414|62694836|FG000|72 Weeks Open Label Extension|Death|1|||
33319378|NCT01194414|62694837|FG001|72 Weeks Open Label Extension|Death|2|||
33319379|NCT01194414|62694838|FG002|72 Weeks Open Label Extension|Death|0|||
33319380|NCT01194414|62694839|FG003|72 Weeks Open Label Extension|Death|2|||
33319381|NCT01194258|62694851|FG000|Titration Period|Withdrawal by Subject|6|||
33319382|NCT01194258|62694852|FG001|Titration Period|Withdrawal by Subject|0|||
33319383|NCT01194258|62694853|FG002|Titration Period|Withdrawal by Subject|0|||
33319384|NCT01194258|62694854|FG003|Titration Period|Withdrawal by Subject|0|||
33402177|NCT00254293|62781052|FG000|LTE Open Label Variable SC Dosing|Other|0|||
33319385|NCT01194258|62694855|FG004|Titration Period|Withdrawal by Subject|0|||
33319386|NCT01194258|62694851|FG000|Titration Period|Lost to Follow-up|2|||
33597703|NCT01654289|62996685|FG000|Overall Study|Withdrawal by Subject|10|||
33319387|NCT01194258|62694852|FG001|Titration Period|Lost to Follow-up|0|||
33319388|NCT01194258|62694853|FG002|Titration Period|Lost to Follow-up|0|||
33319389|NCT01194258|62694854|FG003|Titration Period|Lost to Follow-up|0|||
33319390|NCT01194258|62694855|FG004|Titration Period|Lost to Follow-up|0|||
33319391|NCT01194258|62694851|FG000|Titration Period|Titration failure|3|||
33319392|NCT01194258|62694852|FG001|Titration Period|Titration failure|0|||
33319393|NCT01194258|62694853|FG002|Titration Period|Titration failure|0|||
33319394|NCT01194258|62694854|FG003|Titration Period|Titration failure|0|||
33319395|NCT01194258|62694855|FG004|Titration Period|Titration failure|0|||
33319396|NCT01194258|62694851|FG000|Period 1 (12 Weeks)|Death|0|||
33319397|NCT01194258|62694852|FG001|Period 1 (12 Weeks)|Death|0|||
33319398|NCT01194258|62694853|FG002|Period 1 (12 Weeks)|Death|0|||
33319399|NCT01194258|62694854|FG003|Period 1 (12 Weeks)|Death|0|||
33319400|NCT01194258|62694855|FG004|Period 1 (12 Weeks)|Death|1|||
33319401|NCT01194258|62694851|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
33319402|NCT01194258|62694852|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
33319403|NCT01194258|62694853|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
33319404|NCT01194258|62694854|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
33319405|NCT01194258|62694855|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
33319406|NCT01194258|62694851|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
33319407|NCT01194258|62694852|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
33319408|NCT01194258|62694853|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
33319409|NCT01194258|62694854|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
33319410|NCT01194258|62694855|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
33319411|NCT01194258|62694851|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33319412|NCT01194258|62694852|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33319413|NCT01194258|62694853|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33319414|NCT01194258|62694854|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33319415|NCT01194258|62694855|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33319416|NCT01193556|62694868|FG000|Overall Study|Study termination|26|||
33319417|NCT01193556|62694869|FG001|Overall Study|Study termination|25|||
33319418|NCT00951496|62694882|FG000|Overall Study|Did not initiate study treatment|10|||
33319419|NCT00951496|62694883|FG001|Overall Study|Did not initiate study treatment|8|||
33319420|NCT00951496|62694884|FG002|Overall Study|Did not initiate study treatment|13|||
33319421|NCT01193244|62694897|FG000|Overall Study|Withdrawal by Subject|79|||
33402178|NCT00254293|62781053|FG001|LTE Open Label Variable SC Dosing|Other|0|||
33319422|NCT01193244|62694898|FG001|Overall Study|Withdrawal by Subject|97|||
33319423|NCT01193244|62694897|FG000|Overall Study|Other|303|||
33319424|NCT01193244|62694898|FG001|Overall Study|Other|278|||
33319425|NCT01193244|62694897|FG000|Overall Study|Lost to Follow-up|6|||
33319426|NCT01193244|62694898|FG001|Overall Study|Lost to Follow-up|15|||
33319427|NCT01192152|62694904|FG000|Period 1|left prematurely (while on treatment B)|0|||
33319428|NCT01192152|62694905|FG001|Period 1|left prematurely (while on treatment B)|1|||
33402179|NCT00254293|62781054|FG002|LTE Open Label Variable SC Dosing|Other|2|||
33319429|NCT01192152|62694904|FG000|Period 3|family emergency|1|||
33319430|NCT01192152|62694905|FG001|Period 3|family emergency|0|||
33319431|NCT01191840|62694915|FG000|Overall Study|withdrew consent|2|||
33319432|NCT01191840|62694916|FG001|Overall Study|withdrew consent|1|||
33319433|NCT01191840|62694915|FG000|Overall Study|Subject discontinued treatment|1|||
33319434|NCT01191840|62694916|FG001|Overall Study|Subject discontinued treatment|2|||
33319435|NCT01191840|62694915|FG000|Overall Study|Lost to Follow-up|4|||
33319436|NCT01191840|62694916|FG001|Overall Study|Lost to Follow-up|6|||
33319437|NCT01191840|62694915|FG000|Overall Study|Non Staph Infection|4|||
33319438|NCT01191840|62694916|FG001|Overall Study|Non Staph Infection|3|||
33319439|NCT01191840|62694915|FG000|Overall Study|ineligible at enrollment|1|||
33319440|NCT01191840|62694916|FG001|Overall Study|ineligible at enrollment|0|||
33319441|NCT01191840|62694915|FG000|Overall Study|IRB approval lapse|0|||
33319442|NCT01191840|62694916|FG001|Overall Study|IRB approval lapse|2|||
33319443|NCT01191840|62694915|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
33319444|NCT01191840|62694916|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
33319445|NCT01191840|62694915|FG000|Overall Study|Withdrawal by Subject|2|||
33493920|NCT03495102|62872497|FG002|Overall Study|Withdrawal by Subject|18|||
33319446|NCT01191840|62694916|FG001|Overall Study|Withdrawal by Subject|0|||
33319447|NCT00943072|62694928|FG000|Overall Study|Adverse Event|0|||
33319448|NCT00943072|62694929|FG001|Overall Study|Adverse Event|3|||
33319449|NCT00943072|62694928|FG000|Overall Study|Death|0|||
33319450|NCT00943072|62694929|FG001|Overall Study|Death|2|||
33319451|NCT00943072|62694928|FG000|Overall Study|Withdrawal by Subject|3|||
33319452|NCT00943072|62694929|FG001|Overall Study|Withdrawal by Subject|1|||
33319453|NCT00943072|62694928|FG000|Overall Study|Protocol Violation|0|||
33319454|NCT00943072|62694929|FG001|Overall Study|Protocol Violation|1|||
33319455|NCT00943072|62694928|FG000|Overall Study|Lost to Follow-up|1|||
33319456|NCT00943072|62694929|FG001|Overall Study|Lost to Follow-up|2|||
33319457|NCT00943072|62694928|FG000|Overall Study|Lack of Efficacy|0|||
33319458|NCT00943072|62694929|FG001|Overall Study|Lack of Efficacy|4|||
33319459|NCT00943072|62694928|FG000|Overall Study|Other|1|||
33319460|NCT00943072|62694929|FG001|Overall Study|Other|1|||
33597704|NCT01654289|62996686|FG001|Overall Study|Withdrawal by Subject|8|||
33597705|NCT01654289|62996687|FG002|Overall Study|Withdrawal by Subject|5|||
33597706|NCT01654289|62996685|FG000|Overall Study|Withdrew from intervention only|17|||
33597707|NCT01654289|62996686|FG001|Overall Study|Withdrew from intervention only|20|||
33597708|NCT01654289|62996687|FG002|Overall Study|Withdrew from intervention only|0|||
33597709|NCT02499029|62996697|FG000|Overall Study|Lost to Follow-up|2|||
33597710|NCT02499029|62996698|FG001|Overall Study|Lost to Follow-up|2|||
33597711|NCT02499029|62996697|FG000|Overall Study|Physician Decision|2|||
33597712|NCT02499029|62996698|FG001|Overall Study|Physician Decision|1|||
33597713|NCT02499029|62996697|FG000|Overall Study|Death|1|||
33597714|NCT02499029|62996698|FG001|Overall Study|Death|0|||
33597715|NCT04968353|62996708|FG000|Overall Study|Non-compliance|1|||
33597716|NCT04968353|62996709|FG001|Overall Study|Non-compliance|0|||
33597717|NCT04968353|62996710|FG002|Overall Study|Non-compliance|2|||
33597718|NCT04968353|62996711|FG003|Overall Study|Non-compliance|0|||
33597719|NCT02065713|62996723|FG000|Overall Study|Adverse Event|0|||
33597720|NCT02065713|62996724|FG001|Overall Study|Adverse Event|1|||
33597721|NCT02065713|62996723|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33597722|NCT02065713|62996724|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33597723|NCT02497781|62996732|FG000|Overall Study|Withdrawal by Subject|2|||
33597724|NCT02497781|62996733|FG001|Overall Study|Withdrawal by Subject|0|||
33597725|NCT02497781|62996732|FG000|Overall Study|Lack of Efficacy|0|||
33597726|NCT02497781|62996733|FG001|Overall Study|Lack of Efficacy|1|||
33597727|NCT02497781|62996732|FG000|Overall Study|Randomised but not treated|1|||
33597728|NCT02497781|62996733|FG001|Overall Study|Randomised but not treated|1|||
33597729|NCT02497781|62996732|FG000|Overall Study|Lost to Follow-up|1|||
33597730|NCT02497781|62996733|FG001|Overall Study|Lost to Follow-up|1|||
33597731|NCT02497469|62996741|FG000|Overall Study|Randomized but not Treated|0|||
33597732|NCT02497469|62996742|FG001|Overall Study|Randomized but not Treated|2|||
33597733|NCT02497469|62996741|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
33597734|NCT02497469|62996742|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
33597735|NCT02497469|62996741|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
33597736|NCT02497469|62996742|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
33597737|NCT02497469|62996741|FG000|Overall Study|Significant Protocol Deviation|4|||
33597738|NCT02497469|62996742|FG001|Overall Study|Significant Protocol Deviation|5|||
33597739|NCT02497469|62996741|FG000|Overall Study|Lost to Follow-up|14|||
33319461|NCT00942994|62694939|FG000|Overall Study|Adverse Event|7|||
33319462|NCT00942994|62694940|FG001|Overall Study|Adverse Event|4|||
33319463|NCT00942994|62694939|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33597740|NCT02497469|62996742|FG001|Overall Study|Lost to Follow-up|4|||
33597741|NCT02497469|62996741|FG000|Overall Study|Voluntary Withdrawal|39|||
33597742|NCT02497469|62996742|FG001|Overall Study|Voluntary Withdrawal|41|||
33319464|NCT00942994|62694940|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33597743|NCT02497469|62996741|FG000|Overall Study|Pregnancy|1|||
33493921|NCT03495102|62872495|FG000|Overall Study|Protocol Violation|1|||
33493922|NCT03495102|62872496|FG001|Overall Study|Protocol Violation|1|||
33319465|NCT00942994|62694939|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33319466|NCT00942994|62694940|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33319467|NCT00942994|62694939|FG000|Overall Study|Patient withdrew consent|5|||
33319468|NCT00942994|62694940|FG001|Overall Study|Patient withdrew consent|8|||
33319469|NCT00942994|62694939|FG000|Overall Study|Lost to Follow-up|1|||
33319470|NCT00942994|62694940|FG001|Overall Study|Lost to Follow-up|4|||
33319471|NCT00942994|62694939|FG000|Overall Study|Protocol deviation|1|||
33319472|NCT00942994|62694940|FG001|Overall Study|Protocol deviation|2|||
33319473|NCT00942604|62694948|FG000|Overall Study|Protocol Violation|1|||
33319474|NCT00942604|62694949|FG001|Overall Study|Protocol Violation|1|||
33319475|NCT00942604|62694948|FG000|Overall Study|Adverse Event|0|||
33319476|NCT00942604|62694949|FG001|Overall Study|Adverse Event|1|||
33319477|NCT00942604|62694948|FG000|Overall Study|Withdrawal by Subject|0|||
33319478|NCT00942604|62694949|FG001|Overall Study|Withdrawal by Subject|1|||
33319479|NCT00942604|62694948|FG000|Overall Study|Patient relocation|1|||
33319480|NCT00942604|62694949|FG001|Overall Study|Patient relocation|1|||
33319481|NCT01188564|62694957|FG000|Double-blind Phase|randomized not treated|1|||
33319482|NCT01188564|62694958|FG001|Double-blind Phase|randomized not treated|0|||
33319483|NCT01187550|62694966|FG000|Overall Study|Protocol Violation|3|||
33319484|NCT01187550|62694967|FG001|Overall Study|Protocol Violation|1|||
33319485|NCT01187550|62694966|FG000|Overall Study|Other|3|||
33319486|NCT01187550|62694967|FG001|Overall Study|Other|0|||
33319487|NCT01187550|62694966|FG000|Overall Study|Randomized but not treated|8|||
33319488|NCT01187550|62694967|FG001|Overall Study|Randomized but not treated|0|||
33319489|NCT01186770|62694977|FG000|Overall Study|Ineligibility|0|||
33319490|NCT01186770|62694978|FG001|Overall Study|Ineligibility|0|||
33319491|NCT01186770|62694979|FG002|Overall Study|Ineligibility|2|||
33319492|NCT01186770|62694980|FG003|Overall Study|Ineligibility|0|||
33319493|NCT01186770|62694977|FG000|Overall Study|Protocol Violation|7|||
33319494|NCT01186770|62694978|FG001|Overall Study|Protocol Violation|9|||
33319495|NCT01186770|62694979|FG002|Overall Study|Protocol Violation|12|||
33319496|NCT01186770|62694980|FG003|Overall Study|Protocol Violation|14|||
33319497|NCT01186770|62694977|FG000|Overall Study|Adverse Event|2|||
33319498|NCT01186770|62694978|FG001|Overall Study|Adverse Event|9|||
33319499|NCT01186770|62694979|FG002|Overall Study|Adverse Event|7|||
33319500|NCT01186770|62694980|FG003|Overall Study|Adverse Event|9|||
33319501|NCT01186770|62694977|FG000|Overall Study|Withdrawal by Subject|15|||
33319502|NCT01186770|62694978|FG001|Overall Study|Withdrawal by Subject|13|||
33319503|NCT01186770|62694979|FG002|Overall Study|Withdrawal by Subject|11|||
33319504|NCT01186770|62694980|FG003|Overall Study|Withdrawal by Subject|17|||
33402180|NCT00254293|62781055|FG003|LTE Open Label Variable SC Dosing|Other|0|||
33402181|NCT00254293|62781056|FG004|LTE Open Label Variable SC Dosing|Other|0|||
33402182|NCT00254293|62781057|FG005|LTE Open Label Variable SC Dosing|Other|0|||
33319505|NCT01186770|62694977|FG000|Overall Study|Lost to Follow-up|10|||
33319506|NCT01186770|62694978|FG001|Overall Study|Lost to Follow-up|6|||
33319507|NCT01186770|62694979|FG002|Overall Study|Lost to Follow-up|14|||
33319508|NCT01186770|62694980|FG003|Overall Study|Lost to Follow-up|9|||
33319509|NCT01186770|62694977|FG000|Overall Study|Insufficient response to treatment|7|||
33319510|NCT01186770|62694978|FG001|Overall Study|Insufficient response to treatment|8|||
33319511|NCT01186770|62694979|FG002|Overall Study|Insufficient response to treatment|5|||
33319512|NCT01186770|62694980|FG003|Overall Study|Insufficient response to treatment|7|||
33319513|NCT01186770|62694977|FG000|Overall Study|Other than specified|0|||
33319514|NCT01186770|62694978|FG001|Overall Study|Other than specified|1|||
33319515|NCT01186770|62694979|FG002|Overall Study|Other than specified|1|||
33319516|NCT01186770|62694980|FG003|Overall Study|Other than specified|2|||
33319517|NCT01186692|62694990|FG000|Overall Study|Not Catheterized|11|||
33319518|NCT01186692|62694990|FG000|Overall Study|Futher testing contraindicated implant|19|||
33319519|NCT01186692|62694990|FG000|Overall Study|Adverse Event|2|||
33319520|NCT01186458|62694998|FG000|Overall Study|Adverse Event|1|||
33319521|NCT01185834|62695002|FG000|Overall Study|Lost to Follow-up|2|||
33319522|NCT01185834|62695002|FG000|Overall Study|Discomfort|4|||
33319523|NCT01185834|62695002|FG000|Overall Study|Biomicroscopy|4|||
33319524|NCT01185834|62695002|FG000|Overall Study|Time/Job Conflict|2|||
33319525|NCT01185834|62695002|FG000|Overall Study|Early exit - Site error|2|||
33319526|NCT01185600|62695008|FG000|Overall Study|Adverse Event|1|||
33319527|NCT01185600|62695009|FG001|Overall Study|Adverse Event|1|||
33319528|NCT01185600|62695008|FG000|Overall Study|Death|0|||
33319529|NCT01185600|62695009|FG001|Overall Study|Death|1|||
33319530|NCT01185600|62695008|FG000|Overall Study|Lost to Follow-up|0|||
33319531|NCT01185600|62695009|FG001|Overall Study|Lost to Follow-up|5|||
33319532|NCT01185600|62695008|FG000|Overall Study|Physician Decision|29|||
33319533|NCT01185600|62695009|FG001|Overall Study|Physician Decision|35|||
33319534|NCT01185600|62695008|FG000|Overall Study|Withdrawal by Subject|1|||
33319535|NCT01185600|62695009|FG001|Overall Study|Withdrawal by Subject|1|||
33319536|NCT01185600|62695008|FG000|Overall Study|Hold by DSMB|1|||
33319537|NCT01185600|62695009|FG001|Overall Study|Hold by DSMB|2|||
33319538|NCT01185522|62695018|FG000|Overall Study|Lack of Efficacy|28|||
33319539|NCT01185522|62695018|FG000|Overall Study|Lost to Follow-up|19|||
33319540|NCT01185522|62695018|FG000|Overall Study|Withdrawal by Subject|10|||
33319541|NCT01185522|62695018|FG000|Overall Study|Poor tolerance|39|||
33319542|NCT01185522|62695018|FG000|Overall Study|Other reasons|12|||
33319543|NCT01185366|62695025|FG000|First Line Therapy|Insurance Coverage Denied|1|||
33319544|NCT01185366|62695026|FG001|First Line Therapy|Insurance Coverage Denied|1|||
33319545|NCT01185366|62695025|FG000|First Line Therapy|Withdrawal by Subject|1|||
33319546|NCT01185366|62695026|FG001|First Line Therapy|Withdrawal by Subject|0|||
33319547|NCT01185366|62695025|FG000|First Line Therapy|Lack of Metastatic Site|1|||
33319548|NCT01185366|62695026|FG001|First Line Therapy|Lack of Metastatic Site|0|||
33319549|NCT01185366|62695025|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
33319550|NCT01185366|62695026|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
33319551|NCT01185366|62695025|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
33319552|NCT01185366|62695026|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
33319553|NCT01185366|62695025|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
33319554|NCT01185366|62695026|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
33319555|NCT01185366|62695025|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
33319556|NCT01185366|62695026|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
33319557|NCT01185288|62695036|FG000|Overall Study|Adverse Event|7|||
33319558|NCT01185288|62695037|FG001|Overall Study|Adverse Event|6|||
33319559|NCT01185288|62695036|FG000|Overall Study|Withdrawal by Subject|6|||
33319560|NCT01185288|62695037|FG001|Overall Study|Withdrawal by Subject|4|||
33319561|NCT01185288|62695036|FG000|Overall Study|Lost to Follow-up|2|||
33319562|NCT01185288|62695037|FG001|Overall Study|Lost to Follow-up|5|||
33319563|NCT01185288|62695036|FG000|Overall Study|Lack of Efficacy|2|||
33319564|NCT01185288|62695037|FG001|Overall Study|Lack of Efficacy|0|||
33319565|NCT01185288|62695036|FG000|Overall Study|Investigator discretion|1|||
33319566|NCT01185288|62695037|FG001|Overall Study|Investigator discretion|0|||
33319567|NCT01185288|62695036|FG000|Overall Study|Did not meet inclusion criteria|1|||
33319568|NCT01185288|62695037|FG001|Overall Study|Did not meet inclusion criteria|0|||
33319569|NCT01185288|62695036|FG000|Overall Study|Noncompliance|0|||
33319570|NCT01185288|62695037|FG001|Overall Study|Noncompliance|1|||
33319571|NCT01184508|62695045|FG000|Overall Study|Adverse Event|4|||
33319572|NCT01184508|62695046|FG001|Overall Study|Adverse Event|6|||
33319573|NCT01184508|62695045|FG000|Overall Study|Lack of Efficacy|1|||
33319574|NCT01184508|62695046|FG001|Overall Study|Lack of Efficacy|1|||
33319575|NCT01184508|62695045|FG000|Overall Study|Lost to Follow-up|1|||
33319576|NCT01184508|62695046|FG001|Overall Study|Lost to Follow-up|1|||
33319577|NCT01184508|62695045|FG000|Overall Study|Physician Decision|1|||
33319578|NCT01184508|62695046|FG001|Overall Study|Physician Decision|0|||
33319579|NCT01184508|62695045|FG000|Overall Study|Protocol Violation|3|||
33319580|NCT01184508|62695046|FG001|Overall Study|Protocol Violation|1|||
33319581|NCT01184508|62695045|FG000|Overall Study|Sponsor Decision|5|||
33319582|NCT01184508|62695046|FG001|Overall Study|Sponsor Decision|2|||
33319583|NCT01184508|62695045|FG000|Overall Study|Withdrawal by Subject|1|||
33319584|NCT01184508|62695046|FG001|Overall Study|Withdrawal by Subject|3|||
33319585|NCT01184508|62695045|FG000|Overall Study|Randomized, Not Treated|0|||
33319586|NCT01184508|62695046|FG001|Overall Study|Randomized, Not Treated|1|||
33319587|NCT01184118|62695053|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
33319588|NCT01184118|62695053|FG000|Overall Study|No physiologic confirmation of asthma|8|||
33319589|NCT01184118|62695053|FG000|Overall Study|FEV1 <60% predicted|2|||
33319590|NCT01184118|62695053|FG000|Overall Study|Exclusionary medical condition|2|||
33319591|NCT01184118|62695053|FG000|Overall Study|Withdrawal by Subject|5|||
33319592|NCT01183884|62695057|FG000|Overall Study|Progressive Disease|26|||
33319593|NCT01183884|62695057|FG000|Overall Study|Adverse Event|3|||
33319594|NCT01183884|62695057|FG000|Overall Study|Withdrawal by Subject|1|||
33319595|NCT01183884|62695057|FG000|Overall Study|Other Complicating Disease|3|||
33319596|NCT01183884|62695057|FG000|Overall Study|Not Treated|1|||
33319597|NCT01183884|62695057|FG000|Overall Study|Other|4|||
33319598|NCT01183260|62695063|FG000|Overall Study|Intraop screen failure|2|||
33319599|NCT01183260|62695064|FG001|Overall Study|Intraop screen failure|0|||
33319600|NCT01183260|62695063|FG000|Overall Study|Withdrawal by Subject|1|||
33319601|NCT01183260|62695064|FG001|Overall Study|Withdrawal by Subject|1|||
33319602|NCT01183260|62695063|FG000|Overall Study|Revised within 30 days|0|||
33319603|NCT01183260|62695064|FG001|Overall Study|Revised within 30 days|1|||
33319604|NCT01183260|62695063|FG000|Overall Study|Death|1|||
33319605|NCT01183260|62695064|FG001|Overall Study|Death|0|||
33319606|NCT01191762|62695072|FG000|Overall Study|Adverse Event|1|||
33319607|NCT01191762|62695073|FG001|Overall Study|Adverse Event|0|||
33319608|NCT01723774|62695082|FG000|Neoadjuvant|Ki67 > 10%|4|||
33319609|NCT01723774|62695083|FG001|Neoadjuvant|Ki67 > 10%|0|||
33319610|NCT01723774|62695084|FG002|Neoadjuvant|Ki67 > 10%|10|||
33319611|NCT01723774|62695085|FG003|Neoadjuvant|Ki67 > 10%|0|||
33319612|NCT01723774|62695082|FG000|Neoadjuvant|Withdrawal by Subject|3|||
33319613|NCT01723774|62695083|FG001|Neoadjuvant|Withdrawal by Subject|1|||
33319614|NCT01723774|62695084|FG002|Neoadjuvant|Withdrawal by Subject|0|||
33319615|NCT01723774|62695085|FG003|Neoadjuvant|Withdrawal by Subject|0|||
33319616|NCT01723774|62695082|FG000|Neoadjuvant|Disease progression|0|||
33319617|NCT01723774|62695083|FG001|Neoadjuvant|Disease progression|1|||
33319618|NCT01723774|62695084|FG002|Neoadjuvant|Disease progression|1|||
33319619|NCT01723774|62695085|FG003|Neoadjuvant|Disease progression|0|||
33319620|NCT01723774|62695082|FG000|Neoadjuvant|Adverse Event|0|||
33319621|NCT01723774|62695083|FG001|Neoadjuvant|Adverse Event|1|||
33319622|NCT01723774|62695084|FG002|Neoadjuvant|Adverse Event|2|||
33319623|NCT01723774|62695085|FG003|Neoadjuvant|Adverse Event|0|||
33319624|NCT01723774|62695082|FG000|Neoadjuvant|High estradiol|0|||
33319625|NCT01723774|62695083|FG001|Neoadjuvant|High estradiol|1|||
33319626|NCT01723774|62695084|FG002|Neoadjuvant|High estradiol|0|||
33319627|NCT01723774|62695085|FG003|Neoadjuvant|High estradiol|0|||
33319628|NCT01723774|62695082|FG000|Adjuvant|Still on active treatment|0|||
33319629|NCT01723774|62695083|FG001|Adjuvant|Still on active treatment|0|||
33493923|NCT03495102|62872497|FG002|Overall Study|Protocol Violation|0|||
33493924|NCT03495102|62872495|FG000|Overall Study|Site Closure|3|||
33319630|NCT01723774|62695084|FG002|Adjuvant|Still on active treatment|0|||
33319631|NCT01723774|62695085|FG003|Adjuvant|Still on active treatment|1|||
33319632|NCT01190514|62695094|FG000|First Intervention (Period 1)|Adverse Event|1|||
33319633|NCT01190514|62695095|FG001|First Intervention (Period 1)|Adverse Event|0|||
33319634|NCT01190514|62695096|FG002|First Intervention (Period 1)|Adverse Event|0|||
33319635|NCT01190514|62695097|FG003|First Intervention (Period 1)|Adverse Event|0|||
33493925|NCT03495102|62872496|FG001|Overall Study|Site Closure|1|||
33319636|NCT01190514|62695094|FG000|Third Intervention (Period 3)|Adverse Event|1|||
33493926|NCT03495102|62872497|FG002|Overall Study|Site Closure|2|||
33319637|NCT01190514|62695095|FG001|Third Intervention (Period 3)|Adverse Event|0|||
33319638|NCT01190514|62695096|FG002|Third Intervention (Period 3)|Adverse Event|0|||
33319639|NCT01190514|62695097|FG003|Third Intervention (Period 3)|Adverse Event|0|||
33319640|NCT01190436|62695107|FG000|Overall Study|Lost to Follow-up|35|||
33319641|NCT01190436|62695107|FG000|Overall Study|Other|4|||
33319642|NCT01035255|62695114|FG000|Overall Study|Death|724|||
33319643|NCT01035255|62695115|FG001|Overall Study|Death|844|||
33319644|NCT01035255|62695114|FG000|Overall Study|Lost to Follow-up|2|||
33319645|NCT01035255|62695115|FG001|Overall Study|Lost to Follow-up|5|||
33319646|NCT01035255|62695114|FG000|Overall Study|patient's request|15|||
33319647|NCT01035255|62695115|FG001|Overall Study|patient's request|13|||
33319648|NCT01190124|62695124|FG000|Overall Study|Death|3|||
33319649|NCT01190124|62695125|FG001|Overall Study|Death|0|||
33319650|NCT01190124|62695126|FG002|Overall Study|Death|0|||
33319651|NCT01190124|62695124|FG000|Overall Study|Therapeutic Failure|12|||
33319652|NCT01190124|62695125|FG001|Overall Study|Therapeutic Failure|0|||
33319653|NCT01190124|62695126|FG002|Overall Study|Therapeutic Failure|1|||
33319654|NCT01190124|62695124|FG000|Overall Study|Lost to Follow-up|2|||
33319655|NCT01190124|62695125|FG001|Overall Study|Lost to Follow-up|0|||
33319656|NCT01190124|62695126|FG002|Overall Study|Lost to Follow-up|0|||
33319657|NCT01189890|62695139|FG000|Overall Study|Adverse Event|3|||
33319658|NCT01189890|62695140|FG001|Overall Study|Adverse Event|4|||
33319659|NCT01189890|62695139|FG000|Overall Study|Lack of Efficacy|7|||
33319660|NCT01189890|62695140|FG001|Overall Study|Lack of Efficacy|2|||
33319661|NCT01189890|62695139|FG000|Overall Study|Lost to Follow-up|1|||
33319662|NCT01189890|62695140|FG001|Overall Study|Lost to Follow-up|7|||
33319663|NCT01189890|62695139|FG000|Overall Study|Protocol Violation|1|||
33319664|NCT01189890|62695140|FG001|Overall Study|Protocol Violation|5|||
33319665|NCT01189890|62695139|FG000|Overall Study|Withdrawal by Subject|15|||
33319666|NCT01189890|62695140|FG001|Overall Study|Withdrawal by Subject|11|||
33319667|NCT01189890|62695139|FG000|Overall Study|Non Compliance|0|||
33319668|NCT01189890|62695140|FG001|Overall Study|Non Compliance|1|||
33319669|NCT01189890|62695139|FG000|Overall Study|Physician Decision|5|||
33319670|NCT01189890|62695140|FG001|Overall Study|Physician Decision|4|||
33319671|NCT01189890|62695139|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
33319672|NCT01189890|62695140|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
33319673|NCT01189812|62695148|FG000|Overall Study|Withdrawal by Subject|2|||
33319674|NCT01189812|62695149|FG001|Overall Study|Withdrawal by Subject|3|||
33319675|NCT01189812|62695148|FG000|Overall Study|Adverse Event|1|||
33319676|NCT01189812|62695149|FG001|Overall Study|Adverse Event|0|||
33319677|NCT01189812|62695148|FG000|Overall Study|Out of Window|4|||
33319678|NCT01189812|62695149|FG001|Overall Study|Out of Window|3|||
33319679|NCT01189812|62695148|FG000|Overall Study|Moved out of State|1|||
33319680|NCT01189812|62695149|FG001|Overall Study|Moved out of State|2|||
33319681|NCT00950950|62695157|FG000|Overall Study|Adverse Event|1|||
33319682|NCT00950950|62695158|FG001|Overall Study|Adverse Event|0|||
33319683|NCT00950950|62695157|FG000|Overall Study|Withdrawal by Subject|0|||
33319684|NCT00950950|62695158|FG001|Overall Study|Withdrawal by Subject|1|||
33319685|NCT00950872|62695165|FG000|Overall Study|Withdrawal by Subject|1|||
33319686|NCT00950872|62695165|FG000|Overall Study|Did not have surgery|2|||
33319687|NCT01189500|62695169|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
33319688|NCT01189500|62695169|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
33319689|NCT00938860|62695178|FG000|Overall Study|Adverse Event|2|||
33319690|NCT00938860|62695179|FG001|Overall Study|Adverse Event|1|||
33319691|NCT00938860|62695178|FG000|Overall Study|Abnormal laboratory values|2|||
33319692|NCT00938860|62695179|FG001|Overall Study|Abnormal laboratory values|2|||
33319693|NCT00938860|62695178|FG000|Overall Study|Withdrawal by Subject|11|||
33319694|NCT00938860|62695179|FG001|Overall Study|Withdrawal by Subject|8|||
33319695|NCT00938860|62695178|FG000|Overall Study|Lost to Follow-up|4|||
33319696|NCT00938860|62695179|FG001|Overall Study|Lost to Follow-up|4|||
33319697|NCT00938860|62695178|FG000|Overall Study|Administration problems|2|||
33319698|NCT00938860|62695179|FG001|Overall Study|Administration problems|0|||
33319699|NCT00938860|62695178|FG000|Overall Study|Death|1|||
33319700|NCT00938860|62695179|FG001|Overall Study|Death|1|||
33319701|NCT00938860|62695178|FG000|Overall Study|Protocol Violation|3|||
33319702|NCT00938860|62695179|FG001|Overall Study|Protocol Violation|1|||
33319703|NCT00938470|62695187|FG000|Overall Study|Disease Progression|3|||
33319704|NCT00938470|62695188|FG001|Overall Study|Disease Progression|0|||
33319705|NCT00938470|62695187|FG000|Overall Study|Alternate Treatment|1|||
33319706|NCT00938470|62695188|FG001|Overall Study|Alternate Treatment|0|||
33319707|NCT00938470|62695187|FG000|Overall Study|Death|3|||
33319708|NCT00938470|62695188|FG001|Overall Study|Death|2|||
33319709|NCT00938470|62695187|FG000|Overall Study|Other Reason|0|||
33319710|NCT00938470|62695188|FG001|Overall Study|Other Reason|1|||
33319711|NCT00938392|62695196|FG000|Overall Study|Adverse Event|0|||
33319712|NCT00938392|62695197|FG001|Overall Study|Adverse Event|1|||
33319713|NCT00938392|62695196|FG000|Overall Study|Withdrawal by Subject|0|||
33319714|NCT00938392|62695197|FG001|Overall Study|Withdrawal by Subject|1|||
33319715|NCT00938392|62695196|FG000|Overall Study|Lost to Follow-up|2|||
33319716|NCT00938392|62695197|FG001|Overall Study|Lost to Follow-up|2|||
33319717|NCT01022853|62695208|FG000|Overall Study|Progressive disease|2|||
33319718|NCT01022853|62695209|FG001|Overall Study|Progressive disease|3|||
33319719|NCT01022853|62695210|FG002|Overall Study|Progressive disease|11|||
33319720|NCT01022853|62695211|FG003|Overall Study|Progressive disease|7|||
33319721|NCT01022853|62695212|FG004|Overall Study|Progressive disease|1|||
33319722|NCT01022853|62695208|FG000|Overall Study|Dose-limiting toxicity|0|||
33319723|NCT01022853|62695209|FG001|Overall Study|Dose-limiting toxicity|0|||
33319724|NCT01022853|62695210|FG002|Overall Study|Dose-limiting toxicity|0|||
33319725|NCT01022853|62695211|FG003|Overall Study|Dose-limiting toxicity|0|||
33319726|NCT01022853|62695212|FG004|Overall Study|Dose-limiting toxicity|1|||
33319727|NCT01022853|62695208|FG000|Overall Study|Withdrawal by Subject|0|||
33319728|NCT01022853|62695209|FG001|Overall Study|Withdrawal by Subject|1|||
33319729|NCT01022853|62695210|FG002|Overall Study|Withdrawal by Subject|1|||
33319730|NCT01022853|62695211|FG003|Overall Study|Withdrawal by Subject|1|||
33319731|NCT01022853|62695212|FG004|Overall Study|Withdrawal by Subject|0|||
33319732|NCT01022853|62695208|FG000|Overall Study|Other not stated above|1|||
33319733|NCT01022853|62695209|FG001|Overall Study|Other not stated above|0|||
33319734|NCT01022853|62695210|FG002|Overall Study|Other not stated above|1|||
33319735|NCT01022853|62695211|FG003|Overall Study|Other not stated above|0|||
33319736|NCT01022853|62695212|FG004|Overall Study|Other not stated above|0|||
33319737|NCT01034709|62695229|FG000|Overall Study|Protocol Violation|9|||
33402183|NCT00254293|62781058|FG006|LTE Open Label Variable SC Dosing|Other|0|||
33402184|NCT00254293|62781052|FG000|LTE Open Label Fixed Dosing|Death|0|||
33402185|NCT00254293|62781053|FG001|LTE Open Label Fixed Dosing|Death|0|||
33402186|NCT00254293|62781054|FG002|LTE Open Label Fixed Dosing|Death|0|||
33402187|NCT00254293|62781055|FG003|LTE Open Label Fixed Dosing|Death|0|||
33402188|NCT00254293|62781056|FG004|LTE Open Label Fixed Dosing|Death|0|||
33319738|NCT01034709|62695230|FG001|Overall Study|Protocol Violation|16|||
33319739|NCT00937768|62695238|FG000|Overall Study|Refused Further Treatment|3|||
33319740|NCT00937768|62695239|FG001|Overall Study|Refused Further Treatment|2|||
33319741|NCT00937768|62695238|FG000|Overall Study|Disease Progression|1|||
33319742|NCT00937768|62695239|FG001|Overall Study|Disease Progression|1|||
33319743|NCT00937768|62695238|FG000|Overall Study|Alternate Treatment|0|||
33493927|NCT03495102|62872495|FG000|Overall Study|Non-compliance|1|||
33319744|NCT00937768|62695239|FG001|Overall Study|Alternate Treatment|1|||
33319745|NCT00937768|62695238|FG000|Overall Study|No Further Funding|4|||
33319746|NCT00937768|62695239|FG001|Overall Study|No Further Funding|4|||
33319747|NCT00940888|62695245|FG000|Overall Study|Unsuccessful Implant|4|||
33319748|NCT00940888|62695245|FG000|Overall Study|Death|461|||
33319749|NCT00940888|62695245|FG000|Overall Study|Withdrawn - Non-Death|364|||
33319750|NCT00940888|62695245|FG000|Overall Study|Lost to Follow-up|6|||
33319751|NCT01189266|62695252|FG000|Overall Study|Adverse Event|1|||
33319752|NCT01189266|62695253|FG001|Overall Study|Adverse Event|0|||
33319753|NCT01189266|62695254|FG002|Overall Study|Adverse Event|5|||
33319754|NCT01189266|62695252|FG000|Overall Study|Death|0|||
33319755|NCT01189266|62695253|FG001|Overall Study|Death|0|||
33319756|NCT01189266|62695254|FG002|Overall Study|Death|5|||
33319757|NCT01189266|62695252|FG000|Overall Study|Lack of Efficacy|4|||
33319758|NCT01189266|62695253|FG001|Overall Study|Lack of Efficacy|5|||
33319759|NCT01189266|62695254|FG002|Overall Study|Lack of Efficacy|44|||
33319760|NCT01189266|62695252|FG000|Overall Study|Physician Decision|0|||
33319761|NCT01189266|62695253|FG001|Overall Study|Physician Decision|0|||
33319762|NCT01189266|62695254|FG002|Overall Study|Physician Decision|1|||
33319763|NCT01189266|62695252|FG000|Overall Study|Protocol Violation|0|||
33319764|NCT01189266|62695253|FG001|Overall Study|Protocol Violation|1|||
33319765|NCT01189266|62695254|FG002|Overall Study|Protocol Violation|1|||
33319766|NCT01189266|62695252|FG000|Overall Study|Withdrawal by Subject|0|||
33319767|NCT01189266|62695253|FG001|Overall Study|Withdrawal by Subject|0|||
33319768|NCT01189266|62695254|FG002|Overall Study|Withdrawal by Subject|1|||
33319769|NCT01189266|62695252|FG000|Overall Study|Patient refuses further therapy|1|||
33493928|NCT03495102|62872496|FG001|Overall Study|Non-compliance|0|||
33493929|NCT03495102|62872497|FG002|Overall Study|Non-compliance|0|||
33493930|NCT03495102|62872495|FG000|Overall Study|Participant Duplicated at Another Site|0|||
33402189|NCT00254293|62781057|FG005|LTE Open Label Fixed Dosing|Death|0|||
33402190|NCT00254293|62781058|FG006|LTE Open Label Fixed Dosing|Death|3|||
33597744|NCT02497469|62996742|FG001|Overall Study|Pregnancy|1|||
33597745|NCT02497469|62996741|FG000|Overall Study|Lack of Efficacy|86|||
33597746|NCT02497469|62996742|FG001|Overall Study|Lack of Efficacy|40|||
33597747|NCT02497469|62996741|FG000|Overall Study|Reason not Specified|6|||
33597748|NCT02497469|62996742|FG001|Overall Study|Reason not Specified|6|||
33597749|NCT02497391|62996748|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
33597750|NCT02497391|62996749|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
33597751|NCT02497391|62996750|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
33597752|NCT02497391|62996751|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
33597753|NCT02497391|62996752|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
33597754|NCT02497391|62996753|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
33597755|NCT02497391|62996748|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
33597756|NCT02497391|62996749|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
33597757|NCT02497391|62996750|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
33597758|NCT02497391|62996751|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
33597759|NCT02497391|62996752|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
33597760|NCT02497391|62996753|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
33402191|NCT00254293|62781052|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
33402192|NCT00254293|62781053|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
33493931|NCT03495102|62872496|FG001|Overall Study|Participant Duplicated at Another Site|0|||
33319770|NCT01189266|62695253|FG001|Overall Study|Patient refuses further therapy|0|||
33319771|NCT01189266|62695254|FG002|Overall Study|Patient refuses further therapy|7|||
33319772|NCT01189266|62695252|FG000|Overall Study|No treatment|0|||
33319773|NCT01189266|62695253|FG001|Overall Study|No treatment|0|||
33319774|NCT01189266|62695254|FG002|Overall Study|No treatment|1|||
33319775|NCT01189032|62695266|FG000|Overall Study|Adverse Event|1|||
33319776|NCT01189032|62695267|FG001|Overall Study|Adverse Event|3|||
33319777|NCT01189032|62695268|FG002|Overall Study|Adverse Event|4|||
33319778|NCT01189032|62695266|FG000|Overall Study|Lack of Efficacy|2|||
33319779|NCT01189032|62695267|FG001|Overall Study|Lack of Efficacy|3|||
33319780|NCT01189032|62695268|FG002|Overall Study|Lack of Efficacy|0|||
33319781|NCT01189032|62695266|FG000|Overall Study|Withdrawal by Subject|1|||
33319782|NCT01189032|62695267|FG001|Overall Study|Withdrawal by Subject|0|||
33319783|NCT01189032|62695268|FG002|Overall Study|Withdrawal by Subject|1|||
33493932|NCT03495102|62872497|FG002|Overall Study|Participant Duplicated at Another Site|1|||
33319784|NCT01189032|62695266|FG000|Overall Study|Protocol Violation|1|||
33319785|NCT01189032|62695267|FG001|Overall Study|Protocol Violation|1|||
33319786|NCT01189032|62695268|FG002|Overall Study|Protocol Violation|1|||
33319787|NCT01188798|62695278|FG000|Overall Study|Death|0|||
33319788|NCT01188798|62695279|FG001|Overall Study|Death|1|||
33319789|NCT01188798|62695278|FG000|Overall Study|Required additional transplant|1|||
33319790|NCT01188798|62695279|FG001|Overall Study|Required additional transplant|1|||
33319791|NCT01188798|62695278|FG000|Overall Study|Protocol closure|1|||
33319792|NCT01188798|62695279|FG001|Overall Study|Protocol closure|1|||
33319793|NCT01183104|62695288|FG000|Overall Study|Adverse Event|8|||
33319794|NCT01183104|62695289|FG001|Overall Study|Adverse Event|6|||
33319795|NCT01183104|62695288|FG000|Overall Study|Death|0|||
33319796|NCT01183104|62695289|FG001|Overall Study|Death|1|||
33319797|NCT01183104|62695288|FG000|Overall Study|Lost to Follow-up|14|||
33319798|NCT01183104|62695289|FG001|Overall Study|Lost to Follow-up|7|||
33319799|NCT01183104|62695288|FG000|Overall Study|Physician Decision|5|||
33319800|NCT01183104|62695289|FG001|Overall Study|Physician Decision|8|||
33319801|NCT01183104|62695288|FG000|Overall Study|Withdrawal by Subject|6|||
33319802|NCT01183104|62695289|FG001|Overall Study|Withdrawal by Subject|11|||
33319803|NCT01183104|62695288|FG000|Overall Study|Nonparticipation in Extension Study|39|||
33319804|NCT01183104|62695289|FG001|Overall Study|Nonparticipation in Extension Study|50|||
33402193|NCT00254293|62781054|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
33402194|NCT00254293|62781055|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
33402195|NCT00254293|62781056|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
33402196|NCT00254293|62781057|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
33402197|NCT00254293|62781058|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
33402198|NCT00254293|62781052|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
33402199|NCT00254293|62781053|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
33402200|NCT00254293|62781054|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
33402201|NCT00254293|62781055|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
33402202|NCT00254293|62781056|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
33319805|NCT01183104|62695288|FG000|Overall Study|Did not receive study drug|5|||
33402203|NCT00254293|62781057|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
33319806|NCT01183104|62695289|FG001|Overall Study|Did not receive study drug|9|||
33402204|NCT00254293|62781058|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
33319807|NCT01163292|62695297|FG000|Overall Study|Lack of Efficacy|9|||
33319808|NCT01163292|62695298|FG001|Overall Study|Lack of Efficacy|0|||
33319809|NCT01163292|62695297|FG000|Overall Study|Adverse Event|6|||
33402205|NCT00254293|62781052|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
33319810|NCT01163292|62695298|FG001|Overall Study|Adverse Event|0|||
33597761|NCT02497391|62996748|FG000|Period 3 (14 Days)|Adverse Event|0|||
33597762|NCT02497391|62996749|FG001|Period 3 (14 Days)|Adverse Event|1|||
33597763|NCT02497391|62996750|FG002|Period 3 (14 Days)|Adverse Event|0|||
33597764|NCT02497391|62996751|FG003|Period 3 (14 Days)|Adverse Event|0|||
33597765|NCT02497391|62996752|FG004|Period 3 (14 Days)|Adverse Event|0|||
33597766|NCT02497391|62996753|FG005|Period 3 (14 Days)|Adverse Event|0|||
33402206|NCT00254293|62781053|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
33402207|NCT00254293|62781054|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
33402208|NCT00254293|62781055|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
33402209|NCT00254293|62781056|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
33402210|NCT00254293|62781057|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
33319811|NCT01163292|62695297|FG000|Overall Study|Initiation of biological therapy|0|||
33319812|NCT01163292|62695298|FG001|Overall Study|Initiation of biological therapy|15|||
33319813|NCT01163292|62695297|FG000|Overall Study|Sufficient response to adalimumab|8|||
33319814|NCT01163292|62695298|FG001|Overall Study|Sufficient response to adalimumab|0|||
33319815|NCT01163292|62695297|FG000|Overall Study|Refusal to receive adalimumab|7|||
33319816|NCT01163292|62695298|FG001|Overall Study|Refusal to receive adalimumab|0|||
33319817|NCT01163292|62695297|FG000|Overall Study|Economic reasons|6|||
33319818|NCT01163292|62695298|FG001|Overall Study|Economic reasons|0|||
33319819|NCT01163292|62695297|FG000|Overall Study|No further visits|5|||
33319820|NCT01163292|62695298|FG001|Overall Study|No further visits|7|||
33319821|NCT00950248|62695306|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
33319822|NCT00950248|62695307|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
33319823|NCT00950248|62695308|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
33319824|NCT00950248|62695306|FG000|Year 1: Baseline|worsening of symptoms|2|||
33319825|NCT00950248|62695307|FG001|Year 1: Baseline|worsening of symptoms|0|||
33319826|NCT00950248|62695308|FG002|Year 1: Baseline|worsening of symptoms|0|||
33319827|NCT00950248|62695306|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
33319828|NCT00950248|62695307|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
33319829|NCT00950248|62695308|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
33319830|NCT00950248|62695306|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
33319831|NCT00950248|62695307|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
33319832|NCT00950248|62695308|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
33319833|NCT00950248|62695306|FG000|Year 2&3 Treatment Randomization|Death|0|||
33319834|NCT00950248|62695307|FG001|Year 2&3 Treatment Randomization|Death|0|||
33319835|NCT00950248|62695308|FG002|Year 2&3 Treatment Randomization|Death|1|||
33319836|NCT00950248|62695306|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
33319837|NCT00950248|62695307|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
33319838|NCT00950248|62695308|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
33319839|NCT00950170|62695315|FG000|Overall Study|Parent/Legal Guardian Request|1|||
33597767|NCT02497391|62996748|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
33597768|NCT02497391|62996749|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
33597769|NCT02497391|62996750|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
33597770|NCT02497391|62996751|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
33597771|NCT02497391|62996752|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
33597772|NCT02497391|62996753|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
33597773|NCT02497391|62996748|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
33597774|NCT02497391|62996749|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
33597775|NCT02497391|62996750|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
33597776|NCT02497391|62996751|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
33597777|NCT02497391|62996752|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
33597778|NCT02497391|62996753|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
33597779|NCT02476175|62996761|FG000|Overall Study|Adverse Event|2|||
33597780|NCT02065557|62996768|FG000|Induction Period|Withdrawal by Subject|2|||
33597781|NCT02065557|62996769|FG001|Induction Period|Withdrawal by Subject|1|||
33597782|NCT02065557|62996770|FG002|Induction Period|Withdrawal by Subject|0|||
33597783|NCT02065557|62996771|FG003|Induction Period|Withdrawal by Subject|0|||
33597784|NCT02065557|62996772|FG004|Induction Period|Withdrawal by Subject|0|||
33597785|NCT02065557|62996773|FG005|Induction Period|Withdrawal by Subject|0|||
33597786|NCT02065557|62996768|FG000|Induction Period|Lack of Efficacy|2|||
33597787|NCT02065557|62996769|FG001|Induction Period|Lack of Efficacy|1|||
33597788|NCT02065557|62996770|FG002|Induction Period|Lack of Efficacy|1|||
33597789|NCT02065557|62996771|FG003|Induction Period|Lack of Efficacy|0|||
33597790|NCT02065557|62996772|FG004|Induction Period|Lack of Efficacy|0|||
33597791|NCT02065557|62996773|FG005|Induction Period|Lack of Efficacy|0|||
33597792|NCT02065557|62996768|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
33597793|NCT02065557|62996769|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
33597794|NCT02065557|62996770|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
33597795|NCT02065557|62996771|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
33597796|NCT02065557|62996772|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
33597797|NCT02065557|62996773|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
33597798|NCT02065557|62996768|FG000|Induction Period|Non-Responder at Week 8|4|||
33597799|NCT02065557|62996769|FG001|Induction Period|Non-Responder at Week 8|4|||
33597800|NCT02065557|62996770|FG002|Induction Period|Non-Responder at Week 8|0|||
33597801|NCT02065557|62996771|FG003|Induction Period|Non-Responder at Week 8|0|||
33597802|NCT02065557|62996772|FG004|Induction Period|Non-Responder at Week 8|0|||
33597803|NCT02065557|62996773|FG005|Induction Period|Non-Responder at Week 8|0|||
33597804|NCT02065557|62996768|FG000|Induction Period|Adverse Event|1|||
33597805|NCT02065557|62996769|FG001|Induction Period|Adverse Event|1|||
33597806|NCT02065557|62996770|FG002|Induction Period|Adverse Event|0|||
33597807|NCT02065557|62996771|FG003|Induction Period|Adverse Event|0|||
33597808|NCT02065557|62996772|FG004|Induction Period|Adverse Event|0|||
33597809|NCT02065557|62996773|FG005|Induction Period|Adverse Event|0|||
33597810|NCT02065557|62996768|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
33597811|NCT02065557|62996769|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
33597812|NCT02065557|62996770|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
33597813|NCT02065557|62996771|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
33597814|NCT02065557|62996772|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
33597815|NCT02065557|62996773|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
33597816|NCT02065557|62996768|FG000|Maintenance Period|Withdrawal by Subject|0|||
33597817|NCT02065557|62996769|FG001|Maintenance Period|Withdrawal by Subject|0|||
33597818|NCT02065557|62996770|FG002|Maintenance Period|Withdrawal by Subject|0|||
33597819|NCT02065557|62996771|FG003|Maintenance Period|Withdrawal by Subject|0|||
33597820|NCT02065557|62996772|FG004|Maintenance Period|Withdrawal by Subject|2|||
33597821|NCT02065557|62996773|FG005|Maintenance Period|Withdrawal by Subject|1|||
33597822|NCT02065557|62996768|FG000|Maintenance Period|Lack of Efficacy|0|||
33597823|NCT02065557|62996769|FG001|Maintenance Period|Lack of Efficacy|0|||
33597824|NCT02065557|62996770|FG002|Maintenance Period|Lack of Efficacy|0|||
33597825|NCT02065557|62996771|FG003|Maintenance Period|Lack of Efficacy|0|||
33597826|NCT02065557|62996772|FG004|Maintenance Period|Lack of Efficacy|5|||
33597827|NCT02065557|62996773|FG005|Maintenance Period|Lack of Efficacy|2|||
33597828|NCT02065557|62996768|FG000|Maintenance Period|Subject Non-Compliance|0|||
33597829|NCT02065557|62996769|FG001|Maintenance Period|Subject Non-Compliance|0|||
33597830|NCT02065557|62996770|FG002|Maintenance Period|Subject Non-Compliance|0|||
33597831|NCT02065557|62996771|FG003|Maintenance Period|Subject Non-Compliance|0|||
33597832|NCT02065557|62996772|FG004|Maintenance Period|Subject Non-Compliance|0|||
33597833|NCT02065557|62996773|FG005|Maintenance Period|Subject Non-Compliance|1|||
33597834|NCT02065245|62996805|FG000|Infusion 1|Lost to Follow-up|0|||
33597835|NCT02065245|62996806|FG001|Infusion 1|Lost to Follow-up|0|||
33597836|NCT02065245|62996807|FG002|Infusion 1|Lost to Follow-up|0|||
33597837|NCT02065245|62996808|FG003|Infusion 1|Lost to Follow-up|0|||
33597838|NCT02065245|62996809|FG004|Infusion 1|Lost to Follow-up|0|||
33319840|NCT00950170|62695315|FG000|Overall Study|Adverse Event|2|||
33319841|NCT00950170|62695315|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
33319842|NCT01227824|62695339|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
33319843|NCT01227824|62695340|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
33319844|NCT01227824|62695341|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
33319845|NCT01227824|62695339|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
33319846|NCT01227824|62695340|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
33319847|NCT01227824|62695341|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
33319848|NCT01227824|62695339|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
33319849|NCT01227824|62695340|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
33319850|NCT01227824|62695341|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
33319851|NCT01227824|62695339|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
33319852|NCT01227824|62695340|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
33319853|NCT01227824|62695341|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
33319854|NCT01227824|62695339|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
33319855|NCT01227824|62695340|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
33319856|NCT01227824|62695341|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
33319857|NCT01227824|62695339|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
33319858|NCT01227824|62695340|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
33319859|NCT01227824|62695341|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
33319860|NCT01227824|62695339|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
33319861|NCT01227824|62695340|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
33319862|NCT01227824|62695341|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
33319863|NCT01227824|62695339|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
33319864|NCT01227824|62695340|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
33319865|NCT01227824|62695341|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
33319866|NCT01227824|62695339|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
33319867|NCT01227824|62695340|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
33319868|NCT01227824|62695341|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
33319869|NCT01227824|62695339|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
33319870|NCT01227824|62695340|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
33319871|NCT01227824|62695341|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
33319872|NCT01227824|62695339|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
33319873|NCT01227824|62695340|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
33319874|NCT01227824|62695341|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
33319875|NCT01227824|62695339|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
33319876|NCT01227824|62695340|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
33319877|NCT01227824|62695341|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
33319878|NCT01227824|62695339|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
33319879|NCT01227824|62695340|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
33319880|NCT01227824|62695341|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
33319881|NCT01227824|62695339|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
33319882|NCT01227824|62695340|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
33319883|NCT01227824|62695341|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
33319884|NCT01227824|62695339|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
33319885|NCT01227824|62695340|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
33319886|NCT01227824|62695341|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
33319887|NCT00949702|62695348|FG000|Overall Study|Death|40|||
33319888|NCT00949702|62695348|FG000|Overall Study|Disease progression|7|||
33319889|NCT00949702|62695348|FG000|Overall Study|Withdrawal of consent|1|||
33319890|NCT01034631|62695355|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
33319891|NCT01034631|62695356|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
33319892|NCT01034631|62695357|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
33319893|NCT01034631|62695355|FG000|Phase II|Not Evaluable per protocol|0|||
33319894|NCT01034631|62695356|FG001|Phase II|Not Evaluable per protocol|0|||
33319895|NCT01034631|62695357|FG002|Phase II|Not Evaluable per protocol|2|||
33319896|NCT01034631|62695355|FG000|Phase II|Determined Ineligible per protocol|0|||
33319897|NCT01034631|62695356|FG001|Phase II|Determined Ineligible per protocol|1|||
33597839|NCT02065245|62996810|FG005|Infusion 1|Lost to Follow-up|0|||
33597840|NCT02065245|62996811|FG006|Infusion 1|Lost to Follow-up|1|||
33319898|NCT01034631|62695357|FG002|Phase II|Determined Ineligible per protocol|0|||
33319899|NCT01227668|62695369|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
33319900|NCT01227668|62695370|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
33319901|NCT01227668|62695369|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
33319902|NCT01227668|62695370|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
33319903|NCT01227668|62695369|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
33319904|NCT01227668|62695370|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
33319905|NCT01227668|62695369|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
33319906|NCT01227668|62695370|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
33319907|NCT01227668|62695369|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
33319908|NCT01227668|62695370|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
33319909|NCT01227668|62695369|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
33319910|NCT01227668|62695370|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
33319911|NCT01227668|62695369|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
33319912|NCT01227668|62695370|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
33319913|NCT01227668|62695369|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
33319914|NCT01227668|62695370|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
33319915|NCT01227668|62695369|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
33319916|NCT01227668|62695370|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
33319917|NCT01227668|62695369|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
33319918|NCT01227668|62695370|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
33319919|NCT01227668|62695369|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
33319920|NCT01227668|62695370|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
33319921|NCT01227668|62695369|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
33319922|NCT01227668|62695370|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
33319923|NCT01227512|62695382|FG000|Overall Study|Physician Decision|6|||
33319924|NCT01227512|62695383|FG001|Overall Study|Physician Decision|6|||
33319925|NCT01227512|62695382|FG000|Overall Study|Adverse Event|4|||
33319926|NCT01227512|62695383|FG001|Overall Study|Adverse Event|3|||
33319927|NCT01227512|62695382|FG000|Overall Study|Withdrawal by Subject|3|||
33319928|NCT01227512|62695383|FG001|Overall Study|Withdrawal by Subject|0|||
33319929|NCT01227512|62695382|FG000|Overall Study|Participant met withdrawal criteria|0|||
33319930|NCT01227512|62695383|FG001|Overall Study|Participant met withdrawal criteria|1|||
33319931|NCT01227278|62695393|FG000|Overall Study|Withdrawal by Subject|4|||
33319932|NCT01227278|62695394|FG001|Overall Study|Withdrawal by Subject|4|||
33319933|NCT01227278|62695393|FG000|Overall Study|Death|0|||
33319934|NCT01227278|62695394|FG001|Overall Study|Death|2|||
33319935|NCT01227278|62695393|FG000|Overall Study|Other|1|||
33319936|NCT01227278|62695394|FG001|Overall Study|Other|2|||
33319937|NCT01034397|62695402|FG000|Overall Study|Lack of compliance|0|||
33319938|NCT01034397|62695403|FG001|Overall Study|Lack of compliance|1|||
33319939|NCT01034397|62695402|FG000|Overall Study|Lack of Efficacy|3|||
33319940|NCT01034397|62695403|FG001|Overall Study|Lack of Efficacy|0|||
33319941|NCT01034397|62695402|FG000|Overall Study|Adverse Event|4|||
33319942|NCT01034397|62695403|FG001|Overall Study|Adverse Event|0|||
33319943|NCT01034397|62695402|FG000|Overall Study|Other|0|||
33319944|NCT01034397|62695403|FG001|Overall Study|Other|1|||
33319945|NCT01227044|62695420|FG000|Overall Study|Lost to Follow-up|5|||
33319946|NCT01227044|62695421|FG001|Overall Study|Lost to Follow-up|7|||
33597841|NCT02065245|62996805|FG000|Infusion 1|Death|0|||
33597842|NCT02065245|62996806|FG001|Infusion 1|Death|0|||
33597843|NCT02065245|62996807|FG002|Infusion 1|Death|1|||
33597844|NCT02065245|62996808|FG003|Infusion 1|Death|0|||
33597845|NCT02065245|62996809|FG004|Infusion 1|Death|1|||
33319947|NCT01227044|62695420|FG000|Overall Study|Discontinued Intervention|1|||
33319948|NCT01227044|62695421|FG001|Overall Study|Discontinued Intervention|2|||
33597846|NCT02065245|62996810|FG005|Infusion 1|Death|0|||
33597847|NCT02065245|62996811|FG006|Infusion 1|Death|0|||
33597848|NCT02065245|62996805|FG000|Infusion 2|Death|0|||
33402211|NCT00254293|62781058|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
33402212|NCT00254293|62781052|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
33402213|NCT00254293|62781053|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
33402214|NCT00254293|62781054|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
33402215|NCT00254293|62781055|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
33402216|NCT00254293|62781056|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
33402217|NCT00254293|62781057|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
33402218|NCT00254293|62781058|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
33402219|NCT00254293|62781052|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
33402220|NCT00254293|62781053|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
33402221|NCT00254293|62781054|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
33402222|NCT00254293|62781055|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
33402223|NCT00254293|62781056|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
33402224|NCT00254293|62781057|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
33319949|NCT01225952|62695430|FG000|Overall Study|Lost to Follow-up|1|||
33319950|NCT01225952|62695431|FG001|Overall Study|Lost to Follow-up|0|||
33319951|NCT01225952|62695432|FG002|Overall Study|Lost to Follow-up|0|||
33319952|NCT01225952|62695430|FG000|Overall Study|Study Eye Explanted|0|||
33319953|NCT01225952|62695431|FG001|Overall Study|Study Eye Explanted|0|||
33319954|NCT01225952|62695432|FG002|Overall Study|Study Eye Explanted|1|||
33319955|NCT01225952|62695430|FG000|Overall Study|Withdrawal by Subject|4|||
33319956|NCT01225952|62695431|FG001|Overall Study|Withdrawal by Subject|4|||
33319957|NCT01225952|62695432|FG002|Overall Study|Withdrawal by Subject|5|||
33319958|NCT01225952|62695430|FG000|Overall Study|Surgical complications|1|||
33319959|NCT01225952|62695431|FG001|Overall Study|Surgical complications|0|||
33319960|NCT01225952|62695432|FG002|Overall Study|Surgical complications|0|||
33319961|NCT01034163|62695442|FG000|Overall Study|Treatment completed as per protocol|8|||
33319962|NCT01034163|62695443|FG001|Overall Study|Treatment completed as per protocol|7|||
33319963|NCT01034163|62695442|FG000|Overall Study|Withdrawal by Subject|8|||
33319964|NCT01034163|62695443|FG001|Overall Study|Withdrawal by Subject|2|||
33319965|NCT01034163|62695442|FG000|Overall Study|Protocol deviation|1|||
33319966|NCT01034163|62695443|FG001|Overall Study|Protocol deviation|0|||
33319967|NCT01034163|62695442|FG000|Overall Study|Disease progression|3|||
33319968|NCT01034163|62695443|FG001|Overall Study|Disease progression|4|||
33319969|NCT01034163|62695442|FG000|Overall Study|Adverse Event|6|||
33319970|NCT01034163|62695443|FG001|Overall Study|Adverse Event|0|||
33319971|NCT01034163|62695442|FG000|Overall Study|Administrative problems|0|||
33319972|NCT01034163|62695443|FG001|Overall Study|Administrative problems|1|||
33319973|NCT01034163|62695442|FG000|Overall Study|Abnormal laboratory value|1|||
33319974|NCT01034163|62695443|FG001|Overall Study|Abnormal laboratory value|0|||
33319975|NCT01033851|62695451|FG000|Overall Study|Withdrawal by Subject|3|||
33319976|NCT01033851|62695452|FG001|Overall Study|Withdrawal by Subject|7|||
33319977|NCT01162122|62695460|FG000|Overall Study|Withdrawal by Subject|52|||
33319978|NCT01162122|62695461|FG001|Overall Study|Withdrawal by Subject|43|||
33319979|NCT01162122|62695460|FG000|Overall Study|Lost to Follow-up|73|||
33319980|NCT01162122|62695461|FG001|Overall Study|Lost to Follow-up|91|||
33319981|NCT01162122|62695460|FG000|Overall Study|Adverse Event|3|||
33319982|NCT01162122|62695461|FG001|Overall Study|Adverse Event|2|||
33319983|NCT01162122|62695460|FG000|Overall Study|Death|51|||
33319984|NCT01162122|62695461|FG001|Overall Study|Death|46|||
33319985|NCT01162122|62695460|FG000|Overall Study|Protocol Violation|2|||
33319986|NCT01162122|62695461|FG001|Overall Study|Protocol Violation|2|||
33319987|NCT01162122|62695460|FG000|Overall Study|Inappropriate enrollment|5|||
33319988|NCT01162122|62695461|FG001|Overall Study|Inappropriate enrollment|4|||
33319989|NCT01162122|62695460|FG000|Overall Study|Administrative reason|1|||
33319990|NCT01162122|62695461|FG001|Overall Study|Administrative reason|1|||
33319991|NCT01162122|62695460|FG000|Overall Study|Unable to classify|3|||
33319992|NCT01162122|62695461|FG001|Overall Study|Unable to classify|7|||
33319993|NCT01162122|62695460|FG000|Overall Study|Missing primary reason|1|||
33319994|NCT01162122|62695461|FG001|Overall Study|Missing primary reason|0|||
33319995|NCT01033071|62695473|FG000|Overall Study|Adverse Event|28|||
33319996|NCT01033071|62695474|FG001|Overall Study|Adverse Event|51|||
33402225|NCT00254293|62781058|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
33402226|NCT00254293|62781052|FG000|LTE Open Label Fixed Dosing|Other|0|||
33402227|NCT00254293|62781053|FG001|LTE Open Label Fixed Dosing|Other|0|||
33402228|NCT00254293|62781054|FG002|LTE Open Label Fixed Dosing|Other|0|||
33402229|NCT00254293|62781055|FG003|LTE Open Label Fixed Dosing|Other|0|||
33402230|NCT00254293|62781056|FG004|LTE Open Label Fixed Dosing|Other|0|||
33402231|NCT00254293|62781057|FG005|LTE Open Label Fixed Dosing|Other|0|||
33402232|NCT00254293|62781058|FG006|LTE Open Label Fixed Dosing|Other|1|||
33402233|NCT00736385|62781103|FG000|Overall Study|Withdrawal by Subject|2|||
33402234|NCT00736385|62781104|FG001|Overall Study|Withdrawal by Subject|2|||
33402235|NCT00736385|62781103|FG000|Overall Study|Adverse Event|0|||
33402236|NCT00736385|62781104|FG001|Overall Study|Adverse Event|1|||
33402237|NCT00585221|62781110|FG000|Overall Study|Protocol Violation|8|||
33402238|NCT00253747|62781116|FG000|Overall Study|Lost to Follow-up|13|||
33402239|NCT00253747|62781117|FG001|Overall Study|Lost to Follow-up|14|||
33319997|NCT01033071|62695475|FG002|Overall Study|Adverse Event|26|||
33319998|NCT01033071|62695473|FG000|Overall Study|Protocol Violation|0|||
33319999|NCT01033071|62695474|FG001|Overall Study|Protocol Violation|2|||
33320000|NCT01033071|62695475|FG002|Overall Study|Protocol Violation|1|||
33320001|NCT01033071|62695473|FG000|Overall Study|Lost to Follow-up|4|||
33320002|NCT01033071|62695474|FG001|Overall Study|Lost to Follow-up|5|||
33320003|NCT01033071|62695475|FG002|Overall Study|Lost to Follow-up|5|||
33402240|NCT00253747|62781116|FG000|Overall Study|Withdrawal by Subject|10|||
33597849|NCT02065245|62996806|FG001|Infusion 2|Death|0|||
33597850|NCT02065245|62996807|FG002|Infusion 2|Death|0|||
33402241|NCT00253747|62781117|FG001|Overall Study|Withdrawal by Subject|11|||
33402242|NCT00253747|62781116|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
33402243|NCT00253747|62781117|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
33402244|NCT00252733|62781135|FG000|Overall Study|Withdrawal by Subject|73|||
33402245|NCT00252733|62781136|FG001|Overall Study|Withdrawal by Subject|67|||
33402246|NCT00252733|62781135|FG000|Overall Study|Death|7|||
33402247|NCT00252733|62781136|FG001|Overall Study|Death|5|||
33320004|NCT01033071|62695473|FG000|Overall Study|Withdrawal by Subject|17|||
33320005|NCT01033071|62695474|FG001|Overall Study|Withdrawal by Subject|14|||
33320006|NCT01033071|62695475|FG002|Overall Study|Withdrawal by Subject|11|||
33320007|NCT01033071|62695473|FG000|Overall Study|Lack of Efficacy|0|||
33320008|NCT01033071|62695474|FG001|Overall Study|Lack of Efficacy|1|||
33320009|NCT01033071|62695475|FG002|Overall Study|Lack of Efficacy|1|||
33320010|NCT01033071|62695473|FG000|Overall Study|Other|6|||
33320011|NCT01033071|62695474|FG001|Overall Study|Other|4|||
33320012|NCT01033071|62695475|FG002|Overall Study|Other|3|||
33320013|NCT01032915|62695487|FG000|Overall Study|Adverse Event|2|||
33320014|NCT01032915|62695488|FG001|Overall Study|Adverse Event|2|||
33320015|NCT01032915|62695489|FG002|Overall Study|Adverse Event|1|||
33320016|NCT01032915|62695490|FG003|Overall Study|Adverse Event|1|||
33320017|NCT01032915|62695487|FG000|Overall Study|Abnormal test procedure result|0|||
33320018|NCT01032915|62695488|FG001|Overall Study|Abnormal test procedure result|0|||
33320019|NCT01032915|62695489|FG002|Overall Study|Abnormal test procedure result|1|||
33320020|NCT01032915|62695490|FG003|Overall Study|Abnormal test procedure result|0|||
33320021|NCT01032915|62695487|FG000|Overall Study|Withdrawal by Subject|0|||
33402248|NCT00252733|62781135|FG000|Overall Study|Lost to Follow-up|12|||
33402249|NCT00252733|62781136|FG001|Overall Study|Lost to Follow-up|6|||
33402250|NCT00252733|62781135|FG000|Overall Study|Multiple Reasons|14|||
33402251|NCT00252733|62781136|FG001|Overall Study|Multiple Reasons|14|||
33320022|NCT01032915|62695488|FG001|Overall Study|Withdrawal by Subject|3|||
33320023|NCT01032915|62695489|FG002|Overall Study|Withdrawal by Subject|1|||
33320024|NCT01032915|62695490|FG003|Overall Study|Withdrawal by Subject|1|||
33320025|NCT01032915|62695487|FG000|Overall Study|Administrative reasons|5|||
33320026|NCT01032915|62695488|FG001|Overall Study|Administrative reasons|6|||
33320027|NCT01032915|62695489|FG002|Overall Study|Administrative reasons|4|||
33320028|NCT01032915|62695490|FG003|Overall Study|Administrative reasons|4|||
33320029|NCT01032915|62695487|FG000|Overall Study|Protocol Violation|1|||
33493933|NCT03495102|62872495|FG000|Overall Study|Primary Care Physician Recommendation|0|||
33597851|NCT02065245|62996808|FG003|Infusion 2|Death|0|||
33320030|NCT01032915|62695488|FG001|Overall Study|Protocol Violation|0|||
33320031|NCT01032915|62695489|FG002|Overall Study|Protocol Violation|0|||
33320032|NCT01032915|62695490|FG003|Overall Study|Protocol Violation|1|||
33320033|NCT01161498|62695502|FG000|Overall Study|Disease Progression|0|||
33320034|NCT01161498|62695503|FG001|Overall Study|Disease Progression|1|||
33320035|NCT01180998|62695512|FG000|Overall Study|Poor Vision|0|||
33320036|NCT01180998|62695513|FG001|Overall Study|Poor Vision|2|||
33320037|NCT01180998|62695514|FG002|Overall Study|Poor Vision|2|||
33320038|NCT01180998|62695512|FG000|Overall Study|Lost to Follow-up|0|||
33320039|NCT01180998|62695513|FG001|Overall Study|Lost to Follow-up|0|||
33320040|NCT01180998|62695514|FG002|Overall Study|Lost to Follow-up|1|||
33320041|NCT01180998|62695512|FG000|Overall Study|Protocol Violation|1|||
33320042|NCT01180998|62695513|FG001|Overall Study|Protocol Violation|2|||
33320043|NCT01180998|62695514|FG002|Overall Study|Protocol Violation|0|||
33320044|NCT01180998|62695512|FG000|Overall Study|Withdrawal by Subject|0|||
33320045|NCT01180998|62695513|FG001|Overall Study|Withdrawal by Subject|0|||
33320046|NCT01180998|62695514|FG002|Overall Study|Withdrawal by Subject|1|||
33320047|NCT01180998|62695512|FG000|Overall Study|Poor comfort|3|||
33320048|NCT01180998|62695513|FG001|Overall Study|Poor comfort|0|||
33320049|NCT01180998|62695514|FG002|Overall Study|Poor comfort|4|||
33320050|NCT01180998|62695512|FG000|Overall Study|Poor lens handling|0|||
33320051|NCT01180998|62695513|FG001|Overall Study|Poor lens handling|0|||
33320052|NCT01180998|62695514|FG002|Overall Study|Poor lens handling|2|||
33320053|NCT01029795|62695525|FG000|Overall Study|Entry Criteria Not Met|2|||
33320054|NCT01029795|62695526|FG001|Overall Study|Entry Criteria Not Met|1|||
33320055|NCT01029795|62695525|FG000|Overall Study|Physician Decision|2|||
33320056|NCT01029795|62695526|FG001|Overall Study|Physician Decision|1|||
33320057|NCT01029795|62695525|FG000|Overall Study|Sponsor Decision|11|||
33320058|NCT01029795|62695526|FG001|Overall Study|Sponsor Decision|17|||
33320059|NCT01029795|62695525|FG000|Overall Study|Withdrawal by Subject|1|||
33320060|NCT01029795|62695526|FG001|Overall Study|Withdrawal by Subject|3|||
33320061|NCT01032837|62695536|FG000|Overall Study|Adverse event/internal illness|0|||
33320062|NCT01032837|62695537|FG001|Overall Study|Adverse event/internal illness|1|||
33320063|NCT01032837|62695538|FG002|Overall Study|Adverse event/internal illness|0|||
33320064|NCT01032837|62695539|FG003|Overall Study|Adverse event/internal illness|1|||
33402252|NCT00275821|62781145|FG000|Overall Study|Adverse Event|4|||
33402253|NCT00275821|62781146|FG001|Overall Study|Adverse Event|12|||
33320065|NCT01032837|62695536|FG000|Overall Study|Withdrew consent|0|||
33320066|NCT01032837|62695537|FG001|Overall Study|Withdrew consent|2|||
33320067|NCT01032837|62695538|FG002|Overall Study|Withdrew consent|0|||
33320068|NCT01032837|62695539|FG003|Overall Study|Withdrew consent|1|||
33320069|NCT01032837|62695536|FG000|Overall Study|Failed to return|0|||
33320070|NCT01032837|62695537|FG001|Overall Study|Failed to return|0|||
33320071|NCT01032837|62695538|FG002|Overall Study|Failed to return|1|||
33320072|NCT01032837|62695539|FG003|Overall Study|Failed to return|0|||
33320073|NCT01032837|62695536|FG000|Overall Study|Refused treatment|0|||
33320074|NCT01032837|62695537|FG001|Overall Study|Refused treatment|0|||
33320075|NCT01032837|62695538|FG002|Overall Study|Refused treatment|0|||
33320076|NCT01032837|62695539|FG003|Overall Study|Refused treatment|1|||
33320077|NCT01180296|62695551|FG000|Overall Study|Protocol Violation|1|||
33320078|NCT01180296|62695552|FG001|Overall Study|Protocol Violation|2|||
33320079|NCT01160640|62695562|FG000|Overall Study|Physician Decision|3|||
33320080|NCT01160640|62695563|FG001|Overall Study|Physician Decision|3|||
33320081|NCT01160640|62695562|FG000|Overall Study|Incarceration|1|||
33320082|NCT01160640|62695563|FG001|Overall Study|Incarceration|0|||
33320083|NCT01160640|62695562|FG000|Overall Study|Withdrawal by Subject|0|||
33320084|NCT01160640|62695563|FG001|Overall Study|Withdrawal by Subject|3|||
33320085|NCT01160484|62695571|FG000|Overall Study|Lack of Efficacy|9|||
33320086|NCT01160484|62695571|FG000|Overall Study|Adverse Event|6|||
33320087|NCT01160484|62695571|FG000|Overall Study|Withdrawal by Subject|2|||
33320088|NCT01160484|62695571|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
33320089|NCT01032291|62695578|FG000|Safety Lead-in|Adverse Event|1|||
33320090|NCT01032291|62695579|FG001|Safety Lead-in|Adverse Event|0|||
33320091|NCT01032291|62695580|FG002|Safety Lead-in|Adverse Event|0|||
33320092|NCT01032291|62695578|FG000|Safety Lead-in|Death|1|||
33320093|NCT01032291|62695579|FG001|Safety Lead-in|Death|0|||
33320094|NCT01032291|62695580|FG002|Safety Lead-in|Death|0|||
33320095|NCT01032291|62695578|FG000|Proof of Concept|Adverse Event|0|||
33320096|NCT01032291|62695579|FG001|Proof of Concept|Adverse Event|5|||
33320097|NCT01032291|62695580|FG002|Proof of Concept|Adverse Event|1|||
33320098|NCT01032291|62695578|FG000|Proof of Concept|Death|0|||
33320099|NCT01032291|62695579|FG001|Proof of Concept|Death|1|||
33320100|NCT01032291|62695580|FG002|Proof of Concept|Death|2|||
33320101|NCT01032291|62695578|FG000|Proof of Concept|Lack of Efficacy|0|||
33597852|NCT02065245|62996809|FG004|Infusion 2|Death|0|||
33320102|NCT01032291|62695579|FG001|Proof of Concept|Lack of Efficacy|1|||
33320103|NCT01032291|62695580|FG002|Proof of Concept|Lack of Efficacy|0|||
33597853|NCT02065245|62996810|FG005|Infusion 2|Death|0|||
33597854|NCT02065245|62996811|FG006|Infusion 2|Death|1|||
33597855|NCT02065245|62996805|FG000|Infusion 3|Lost to Follow-up|1|||
33597856|NCT02065245|62996806|FG001|Infusion 3|Lost to Follow-up|1|||
33597857|NCT02065245|62996807|FG002|Infusion 3|Lost to Follow-up|0|||
33597858|NCT02065245|62996808|FG003|Infusion 3|Lost to Follow-up|0|||
33597859|NCT02065245|62996809|FG004|Infusion 3|Lost to Follow-up|0|||
33597860|NCT02065245|62996810|FG005|Infusion 3|Lost to Follow-up|0|||
33597861|NCT02065245|62996811|FG006|Infusion 3|Lost to Follow-up|0|||
33597862|NCT02043015|62996827|FG000|Overall Study|Lost to Follow-up|4|||
33597863|NCT02043015|62996827|FG000|Overall Study|Withdrawal by Subject|4|||
33597864|NCT02043015|62996827|FG000|Overall Study|Removed once target enrollment reached|15|||
33597865|NCT02043015|62996827|FG000|Overall Study|Participant moved away from study city|4|||
33597866|NCT02043015|62996827|FG000|Overall Study|Incarceration|1|||
33597867|NCT02064231|62996833|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
33597868|NCT02064231|62996834|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
33597869|NCT02064231|62996835|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
33597870|NCT02064231|62996836|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
33597871|NCT02064231|62996833|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
33597872|NCT02064231|62996834|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
33597873|NCT02064231|62996835|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
33597874|NCT02064231|62996836|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
33597875|NCT02064231|62996833|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
33597876|NCT02064231|62996834|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
33597877|NCT02064231|62996835|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
33597878|NCT02064231|62996836|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
33597879|NCT02064231|62996833|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
33597880|NCT02064231|62996834|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
33597881|NCT02064231|62996835|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
33597882|NCT02064231|62996836|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
33597883|NCT02063217|62996851|FG000|Overall Study|Withdrawal by Subject|1|||
33597884|NCT02063217|62996852|FG001|Overall Study|Withdrawal by Subject|0|||
33597885|NCT02063217|62996853|FG002|Overall Study|Withdrawal by Subject|0|||
33597886|NCT02497001|62996865|FG000|Overall Study|Lost to Follow-up|10|||
33320104|NCT01032291|62695578|FG000|Proof of Concept|Never Received Study Drug|0|||
33320105|NCT01032291|62695579|FG001|Proof of Concept|Never Received Study Drug|1|||
33597887|NCT02497001|62996866|FG001|Overall Study|Lost to Follow-up|2|||
33320106|NCT01032291|62695580|FG002|Proof of Concept|Never Received Study Drug|0|||
33320107|NCT01159938|62695594|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
33320108|NCT01159938|62695595|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
33320109|NCT01159938|62695596|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
33320110|NCT01159938|62695597|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
33320111|NCT01159938|62695598|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
33320112|NCT01029405|62695623|FG000|Overall Study|Withdrawal by Subject|0|||
33320113|NCT01029405|62695624|FG001|Overall Study|Withdrawal by Subject|1|||
33320114|NCT01029405|62695625|FG002|Overall Study|Withdrawal by Subject|2|||
33320115|NCT01029405|62695626|FG003|Overall Study|Withdrawal by Subject|0|||
33320116|NCT01029405|62695623|FG000|Overall Study|Protocol Violation|0|||
33320117|NCT01029405|62695624|FG001|Overall Study|Protocol Violation|0|||
33320118|NCT01029405|62695625|FG002|Overall Study|Protocol Violation|0|||
33320119|NCT01029405|62695626|FG003|Overall Study|Protocol Violation|1|||
33402254|NCT00275821|62781147|FG002|Overall Study|Adverse Event|5|||
33402255|NCT00275821|62781145|FG000|Overall Study|Administrative problems|3|||
33402256|NCT00275821|62781146|FG001|Overall Study|Administrative problems|4|||
33402257|NCT00275821|62781147|FG002|Overall Study|Administrative problems|4|||
33402258|NCT00275821|62781145|FG000|Overall Study|Withdrawal by Subject|0|||
33402259|NCT00275821|62781146|FG001|Overall Study|Withdrawal by Subject|2|||
33402260|NCT00275821|62781147|FG002|Overall Study|Withdrawal by Subject|1|||
33402261|NCT00275821|62781145|FG000|Overall Study|Lost to Follow-up|0|||
33402262|NCT00275821|62781146|FG001|Overall Study|Lost to Follow-up|1|||
33402263|NCT00275821|62781147|FG002|Overall Study|Lost to Follow-up|1|||
33402264|NCT00275821|62781145|FG000|Overall Study|Death|0|||
33320120|NCT01029405|62695623|FG000|Overall Study|Adverse Event|0|||
33320121|NCT01029405|62695624|FG001|Overall Study|Adverse Event|0|||
33402265|NCT00275821|62781146|FG001|Overall Study|Death|2|||
33402266|NCT00275821|62781147|FG002|Overall Study|Death|1|||
33320122|NCT01029405|62695625|FG002|Overall Study|Adverse Event|1|||
33320123|NCT01029405|62695626|FG003|Overall Study|Adverse Event|1|||
33402267|NCT00275821|62781145|FG000|Overall Study|Lack of Efficacy|2|||
33597888|NCT02497001|62996867|FG002|Overall Study|Lost to Follow-up|0|||
33597889|NCT02497001|62996868|FG003|Overall Study|Lost to Follow-up|2|||
33597890|NCT02497001|62996865|FG000|Overall Study|Adverse Event|28|||
33597891|NCT02497001|62996866|FG001|Overall Study|Adverse Event|30|||
33597892|NCT02497001|62996867|FG002|Overall Study|Adverse Event|11|||
33597893|NCT02497001|62996868|FG003|Overall Study|Adverse Event|11|||
33597894|NCT02497001|62996865|FG000|Overall Study|Withdrawal by Subject|14|||
33597895|NCT02497001|62996866|FG001|Overall Study|Withdrawal by Subject|37|||
33597896|NCT02497001|62996867|FG002|Overall Study|Withdrawal by Subject|19|||
33597897|NCT02497001|62996868|FG003|Overall Study|Withdrawal by Subject|15|||
33597898|NCT02497001|62996865|FG000|Overall Study|Physician Decision|5|||
33597899|NCT02497001|62996866|FG001|Overall Study|Physician Decision|11|||
33320124|NCT01029405|62695623|FG000|Overall Study|Lost to Follow-up|2|||
33320125|NCT01029405|62695624|FG001|Overall Study|Lost to Follow-up|1|||
33320126|NCT01029405|62695625|FG002|Overall Study|Lost to Follow-up|1|||
33320127|NCT01029405|62695626|FG003|Overall Study|Lost to Follow-up|2|||
33320128|NCT01029405|62695623|FG000|Overall Study|Other|0|||
33320129|NCT01029405|62695624|FG001|Overall Study|Other|1|||
33320130|NCT01029405|62695625|FG002|Overall Study|Other|0|||
33320131|NCT01029405|62695626|FG003|Overall Study|Other|1|||
33320132|NCT01021683|62695636|FG000|Overall Study|Lack of Efficacy|12|||
33320133|NCT01021683|62695636|FG000|Overall Study|Recovery of neutrophil count|51|||
33320134|NCT01021683|62695636|FG000|Overall Study|Other|8|||
33320135|NCT01021293|62695642|FG000|Overall Study|Serious Adverse Event|2|||
33320136|NCT01021293|62695643|FG001|Overall Study|Serious Adverse Event|1|||
33320137|NCT01021293|62695642|FG000|Overall Study|Adverse Event|2|||
33320138|NCT01021293|62695643|FG001|Overall Study|Adverse Event|1|||
33320139|NCT01021293|62695642|FG000|Overall Study|Withdrawal by Subject|1|||
33320140|NCT01021293|62695643|FG001|Overall Study|Withdrawal by Subject|3|||
33320141|NCT01021293|62695642|FG000|Overall Study|Migrated/moved from study area|6|||
33320142|NCT01021293|62695643|FG001|Overall Study|Migrated/moved from study area|18|||
33320143|NCT01021293|62695642|FG000|Overall Study|Lost to Follow-up|1|||
33320144|NCT01021293|62695643|FG001|Overall Study|Lost to Follow-up|1|||
33320145|NCT04625725|62695652|FG000|Overall Study|Death|4|||
33320146|NCT04625725|62695653|FG001|Overall Study|Death|4|||
33320147|NCT04625725|62695652|FG000|Overall Study|Lost to Follow-up|11|||
33320148|NCT04625725|62695653|FG001|Overall Study|Lost to Follow-up|8|||
33320149|NCT04625725|62695652|FG000|Overall Study|Physician Decision|1|||
33320150|NCT04625725|62695653|FG001|Overall Study|Physician Decision|0|||
33320151|NCT04625725|62695652|FG000|Overall Study|Withdrawal by Subject|56|||
33320152|NCT04625725|62695653|FG001|Overall Study|Withdrawal by Subject|32|||
33320153|NCT04625725|62695652|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|18|||
33320154|NCT04625725|62695653|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|10|||
33402268|NCT00275821|62781146|FG001|Overall Study|Lack of Efficacy|1|||
33402269|NCT00275821|62781147|FG002|Overall Study|Lack of Efficacy|0|||
33402270|NCT00275821|62781145|FG000|Overall Study|Protocol Violation|5|||
33402271|NCT00275821|62781146|FG001|Overall Study|Protocol Violation|1|||
33402272|NCT00275821|62781147|FG002|Overall Study|Protocol Violation|0|||
33402273|NCT00275509|62781157|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
33402274|NCT00275509|62781158|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
33402275|NCT00252577|62781164|FG000|Overall Study|Lost to Follow-up|20|||
33402276|NCT00252499|62781171|FG000|Overall Study|Lost to Follow-up|1|||
33402277|NCT00252499|62781172|FG001|Overall Study|Lost to Follow-up|0|||
33402278|NCT00252499|62781173|FG002|Overall Study|Lost to Follow-up|0|||
33402279|NCT00252187|62781183|FG000|Overall Study|Adverse Event|3|||
33402280|NCT00252187|62781184|FG001|Overall Study|Adverse Event|1|||
33402281|NCT00252187|62781183|FG000|Overall Study|Withdrawal by Subject|1|||
33402282|NCT00252187|62781184|FG001|Overall Study|Withdrawal by Subject|0|||
33402283|NCT00572910|62781196|FG000|Overall Study|Adverse Event|1|||
33402284|NCT00572910|62781197|FG001|Overall Study|Adverse Event|2|||
33402285|NCT00572910|62781198|FG002|Overall Study|Adverse Event|0|||
33320155|NCT04625725|62695652|FG000|Overall Study|Ongoing in study|3409|||
33320156|NCT04625725|62695653|FG001|Overall Study|Ongoing in study|1700|||
33320157|NCT04625725|62695652|FG000|Overall Study|Protocol Deviation|1|||
33402286|NCT00572910|62781199|FG003|Overall Study|Adverse Event|2|||
33402287|NCT00572910|62781200|FG004|Overall Study|Adverse Event|0|||
33402288|NCT00572910|62781201|FG005|Overall Study|Adverse Event|0|||
33402289|NCT00572910|62781202|FG006|Overall Study|Adverse Event|4|||
33402290|NCT00572910|62781203|FG007|Overall Study|Adverse Event|2|||
33402291|NCT00572910|62781204|FG008|Overall Study|Adverse Event|1|||
33320158|NCT04625725|62695653|FG001|Overall Study|Protocol Deviation|0|||
33320159|NCT01021215|62695661|FG000|Overall Study|Lost to Follow-up|3|||
33320160|NCT01021215|62695662|FG001|Overall Study|Lost to Follow-up|0|||
33402292|NCT00572910|62781205|FG009|Overall Study|Adverse Event|3|||
33402293|NCT00572910|62781206|FG010|Overall Study|Adverse Event|2|||
33402294|NCT00572910|62781196|FG000|Overall Study|Lost to Follow-up|0|||
33402295|NCT00572910|62781197|FG001|Overall Study|Lost to Follow-up|1|||
33402296|NCT00572910|62781198|FG002|Overall Study|Lost to Follow-up|1|||
33402297|NCT00572910|62781199|FG003|Overall Study|Lost to Follow-up|2|||
33402298|NCT00572910|62781200|FG004|Overall Study|Lost to Follow-up|1|||
33402299|NCT00572910|62781201|FG005|Overall Study|Lost to Follow-up|0|||
33402300|NCT00572910|62781202|FG006|Overall Study|Lost to Follow-up|0|||
33402301|NCT00572910|62781203|FG007|Overall Study|Lost to Follow-up|0|||
33402302|NCT00572910|62781204|FG008|Overall Study|Lost to Follow-up|0|||
33402303|NCT00572910|62781205|FG009|Overall Study|Lost to Follow-up|1|||
33402304|NCT00572910|62781206|FG010|Overall Study|Lost to Follow-up|0|||
33402305|NCT00572910|62781196|FG000|Overall Study|Withdrawal by Subject|3|||
33402306|NCT00572910|62781197|FG001|Overall Study|Withdrawal by Subject|0|||
33402307|NCT00572910|62781198|FG002|Overall Study|Withdrawal by Subject|1|||
33402308|NCT00572910|62781199|FG003|Overall Study|Withdrawal by Subject|0|||
33402309|NCT00572910|62781200|FG004|Overall Study|Withdrawal by Subject|1|||
33402310|NCT00572910|62781201|FG005|Overall Study|Withdrawal by Subject|3|||
33402311|NCT00572910|62781202|FG006|Overall Study|Withdrawal by Subject|0|||
33402312|NCT00572910|62781203|FG007|Overall Study|Withdrawal by Subject|2|||
33402313|NCT00572910|62781204|FG008|Overall Study|Withdrawal by Subject|2|||
33402314|NCT00572910|62781205|FG009|Overall Study|Withdrawal by Subject|2|||
33402315|NCT00572910|62781206|FG010|Overall Study|Withdrawal by Subject|1|||
33402316|NCT00163657|62781244|FG000|Overall Study|Death|12|||
33402317|NCT00163657|62781245|FG001|Overall Study|Death|14|||
33402318|NCT00163657|62781246|FG002|Overall Study|Death|19|||
33402319|NCT00163657|62781244|FG000|Overall Study|graft loss|4|||
33402320|NCT00163657|62781245|FG001|Overall Study|graft loss|1|||
33402321|NCT00163657|62781246|FG002|Overall Study|graft loss|2|||
33402322|NCT00163657|62781244|FG000|Overall Study|Withdrawal by Subject|2|||
33402323|NCT00163657|62781245|FG001|Overall Study|Withdrawal by Subject|3|||
33402324|NCT00163657|62781246|FG002|Overall Study|Withdrawal by Subject|2|||
33402325|NCT00163657|62781244|FG000|Overall Study|Physician Decision|0|||
33402326|NCT00163657|62781245|FG001|Overall Study|Physician Decision|1|||
33402327|NCT00163657|62781246|FG002|Overall Study|Physician Decision|1|||
33402328|NCT00163657|62781244|FG000|Overall Study|Non Compliance|1|||
33402329|NCT00163657|62781245|FG001|Overall Study|Non Compliance|0|||
33402330|NCT00163657|62781246|FG002|Overall Study|Non Compliance|0|||
33402331|NCT00163657|62781244|FG000|Overall Study|Lost to Follow-up|1|||
33402332|NCT00163657|62781245|FG001|Overall Study|Lost to Follow-up|3|||
33402333|NCT00163657|62781246|FG002|Overall Study|Lost to Follow-up|10|||
33402334|NCT00163657|62781244|FG000|Overall Study|Other reason|0|||
33402335|NCT00163657|62781245|FG001|Overall Study|Other reason|1|||
33402336|NCT00163657|62781246|FG002|Overall Study|Other reason|3|||
33402337|NCT00609492|62781257|FG000|Overall Study|Withdrawal by Subject|0|||
33402338|NCT00609492|62781258|FG001|Overall Study|Withdrawal by Subject|2|||
33402339|NCT00609492|62781259|FG002|Overall Study|Withdrawal by Subject|3|||
33402340|NCT00609492|62781257|FG000|Overall Study|Lost to Follow-up|1|||
33402341|NCT00609492|62781258|FG001|Overall Study|Lost to Follow-up|1|||
33402342|NCT00609492|62781259|FG002|Overall Study|Lost to Follow-up|4|||
33402343|NCT00230971|62781271|FG000|Randomization|No study drug administered|3|||
33402344|NCT00230971|62781272|FG001|Randomization|No study drug administered|3|||
33402345|NCT00230971|62781271|FG000|Baseline Participants|Lost to Follow-up|5|||
33402346|NCT00230971|62781272|FG001|Baseline Participants|Lost to Follow-up|12|||
33402347|NCT00230971|62781271|FG000|Baseline Participants|Death|6|||
33402348|NCT00230971|62781272|FG001|Baseline Participants|Death|5|||
33402349|NCT00230971|62781271|FG000|Baseline Participants|Withdrawal by Subject|7|||
33402350|NCT00230971|62781272|FG001|Baseline Participants|Withdrawal by Subject|1|||
33402351|NCT00230971|62781271|FG000|Baseline Participants|Adverse Event|1|||
33402352|NCT00230971|62781272|FG001|Baseline Participants|Adverse Event|0|||
33402353|NCT00230971|62781271|FG000|Baseline Participants|No bacteria observed|1|||
33402354|NCT00230971|62781272|FG001|Baseline Participants|No bacteria observed|0|||
33402355|NCT00230971|62781271|FG000|Baseline Participants|Failure to return|1|||
33402356|NCT00230971|62781272|FG001|Baseline Participants|Failure to return|1|||
33402357|NCT00230971|62781271|FG000|Baseline Participants|Reintervention|1|||
33402358|NCT00230971|62781272|FG001|Baseline Participants|Reintervention|0|||
33402359|NCT00211081|62781278|FG000|Overall Study|Withdrawal by Subject|2|||
33402360|NCT00609336|62781282|FG000|Overall Study|Protocol Violation|3|||
33402361|NCT00609336|62781282|FG000|Overall Study|Death|1|||
33402362|NCT00609336|62781282|FG000|Overall Study|LA or Met at Surgery|9|||
33402363|NCT00612066|62781287|FG000|Overall Study|Adverse Event|1|||
33402364|NCT00573144|62781293|FG000|Overall Study|Withdrawal by Subject|2|||
33402365|NCT00573144|62781294|FG001|Overall Study|Withdrawal by Subject|3|||
33402366|NCT00640328|62781306|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
33402367|NCT00640328|62781307|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
33402368|NCT00640328|62781308|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
33402369|NCT00640328|62781309|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
33402370|NCT00640328|62781310|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
33402371|NCT00640328|62781311|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
33402372|NCT00640328|62781306|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
33493934|NCT03495102|62872496|FG001|Overall Study|Primary Care Physician Recommendation|1|||
33402373|NCT00640328|62781307|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
33493935|NCT03495102|62872497|FG002|Overall Study|Primary Care Physician Recommendation|0|||
33493936|NCT03495102|62872495|FG000|Overall Study|Relocated to Another Country|0|||
33597900|NCT02497001|62996867|FG002|Overall Study|Physician Decision|5|||
33320161|NCT01021137|62695672|FG000|Overall Study|Lost to Follow-up|9|||
33320162|NCT01021137|62695673|FG001|Overall Study|Lost to Follow-up|4|||
33597901|NCT02497001|62996868|FG003|Overall Study|Physician Decision|1|||
33597902|NCT02497001|62996865|FG000|Overall Study|subjects that were not treated|1|||
33597903|NCT02497001|62996866|FG001|Overall Study|subjects that were not treated|2|||
33597904|NCT02497001|62996867|FG002|Overall Study|subjects that were not treated|2|||
33597905|NCT02497001|62996868|FG003|Overall Study|subjects that were not treated|1|||
33597906|NCT02497001|62996865|FG000|Overall Study|Major Protocol Deviation|3|||
33597907|NCT02497001|62996866|FG001|Overall Study|Major Protocol Deviation|4|||
33597908|NCT02497001|62996867|FG002|Overall Study|Major Protocol Deviation|4|||
33597909|NCT02497001|62996868|FG003|Overall Study|Major Protocol Deviation|4|||
33597910|NCT02497001|62996865|FG000|Overall Study|Lack of Efficacy|10|||
33597911|NCT02497001|62996866|FG001|Overall Study|Lack of Efficacy|16|||
33402374|NCT00640328|62781308|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
33402375|NCT00640328|62781309|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
33402376|NCT00640328|62781310|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
33402377|NCT00640328|62781311|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
33402378|NCT00640328|62781306|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
33402379|NCT00640328|62781307|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
33402380|NCT00640328|62781308|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
33597912|NCT02497001|62996867|FG002|Overall Study|Lack of Efficacy|6|||
33597913|NCT02497001|62996868|FG003|Overall Study|Lack of Efficacy|6|||
33597914|NCT02497001|62996865|FG000|Overall Study|Protocol Violation|3|||
33597915|NCT02497001|62996866|FG001|Overall Study|Protocol Violation|1|||
33320163|NCT01021137|62695674|FG002|Overall Study|Lost to Follow-up|2|||
33320164|NCT01021137|62695675|FG003|Overall Study|Lost to Follow-up|6|||
33320165|NCT01021137|62695672|FG000|Overall Study|Withdrawal by Subject|1|||
33320166|NCT01021137|62695673|FG001|Overall Study|Withdrawal by Subject|0|||
33320167|NCT01021137|62695674|FG002|Overall Study|Withdrawal by Subject|0|||
33320168|NCT01021137|62695675|FG003|Overall Study|Withdrawal by Subject|3|||
33320169|NCT01020981|62695688|FG000|Overall Study|Did not return mailed survey|74|||
33320170|NCT01020981|62695689|FG001|Overall Study|Did not return mailed survey|58|||
33320171|NCT01020981|62695688|FG000|Overall Study|Survey returned undeliverable|8|||
33320172|NCT01020981|62695689|FG001|Overall Study|Survey returned undeliverable|32|||
33320173|NCT01020981|62695688|FG000|Overall Study|Participant declined to complete survey|2|||
33320174|NCT01020981|62695689|FG001|Overall Study|Participant declined to complete survey|0|||
33320175|NCT01020747|62695697|FG000|Overall Study|Withdrawal by Subject|1|||
33597916|NCT02497001|62996867|FG002|Overall Study|Protocol Violation|3|||
33597917|NCT02497001|62996868|FG003|Overall Study|Protocol Violation|1|||
33597918|NCT02366143|62996884|FG000|Overall Study|Death|307|||
33597919|NCT02366143|62996885|FG001|Overall Study|Death|278|||
33597920|NCT02366143|62996886|FG002|Overall Study|Death|280|||
33597921|NCT02366143|62996884|FG000|Overall Study|Lost to Follow-up|2|||
33597922|NCT02366143|62996885|FG001|Overall Study|Lost to Follow-up|4|||
33597923|NCT02366143|62996886|FG002|Overall Study|Lost to Follow-up|2|||
33597924|NCT02366143|62996884|FG000|Overall Study|Physician Decision|1|||
33597925|NCT02366143|62996885|FG001|Overall Study|Physician Decision|2|||
33597926|NCT02366143|62996886|FG002|Overall Study|Physician Decision|1|||
33597927|NCT02366143|62996884|FG000|Overall Study|Protocol Violation|0|||
33597928|NCT02366143|62996885|FG001|Overall Study|Protocol Violation|0|||
33597929|NCT02366143|62996886|FG002|Overall Study|Protocol Violation|2|||
33597930|NCT02366143|62996884|FG000|Overall Study|Withdrawal by Subject|16|||
33597931|NCT02366143|62996885|FG001|Overall Study|Withdrawal by Subject|17|||
33597932|NCT02366143|62996886|FG002|Overall Study|Withdrawal by Subject|22|||
33597933|NCT02366143|62996884|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
33597934|NCT02366143|62996885|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
33320176|NCT01020435|62695704|FG000|Overall Study|Lost to Follow-up|0|||
33320177|NCT01020435|62695705|FG001|Overall Study|Lost to Follow-up|1|||
33402381|NCT00640328|62781309|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
33402382|NCT00640328|62781310|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
33402383|NCT00640328|62781311|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
33402384|NCT00640328|62781306|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
33402385|NCT00640328|62781307|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
33402386|NCT00640328|62781308|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
33402387|NCT00640328|62781309|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
33402388|NCT00640328|62781310|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
33402389|NCT00640328|62781311|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
33402390|NCT00163189|62781332|FG000|Overall Study|Other|6|||
33402391|NCT00163189|62781332|FG000|Overall Study|Lost to Follow-up|1|||
33402392|NCT00163189|62781332|FG000|Overall Study|Protocol Violation|2|||
33402393|NCT00163189|62781332|FG000|Overall Study|Death|3|||
33402394|NCT00163189|62781332|FG000|Overall Study|Adverse Event|6|||
33402395|NCT00163189|62781332|FG000|Overall Study|Lack of Efficacy|7|||
33320178|NCT01031979|62695714|FG000|Overall Study|Lost to Follow-up|5|||
33320179|NCT01031979|62695715|FG001|Overall Study|Lost to Follow-up|4|||
33402396|NCT00163189|62781332|FG000|Overall Study|Study terminated by sponsor|11|||
33402397|NCT00163189|62781332|FG000|Overall Study|Withdrawal by Subject|11|||
33402398|NCT00163189|62781332|FG000|Overall Study|Did not meet continuation criterion|16|||
33402399|NCT00162097|62781340|FG000|Overall Study|Participant no longer met study criteria|0|||
33402400|NCT00162097|62781341|FG001|Overall Study|Participant no longer met study criteria|0|||
33402401|NCT00162097|62781342|FG002|Overall Study|Participant no longer met study criteria|0|||
33402402|NCT00162097|62781343|FG003|Overall Study|Participant no longer met study criteria|1|||
33402403|NCT00640016|62781363|FG000|Overall Study|Withdrawal by Subject|0|||
33402404|NCT00640016|62781364|FG001|Overall Study|Withdrawal by Subject|1|||
33402405|NCT00640016|62781365|FG002|Overall Study|Withdrawal by Subject|0|||
33320180|NCT01020123|62695728|FG000|Main Period|Withdrawal by Subject|6|||
33320181|NCT01020123|62695729|FG001|Main Period|Withdrawal by Subject|5|||
33320182|NCT01020123|62695730|FG002|Main Period|Withdrawal by Subject|3|||
33320183|NCT01020123|62695731|FG003|Main Period|Withdrawal by Subject|1|||
33320184|NCT01020123|62695732|FG004|Main Period|Withdrawal by Subject|6|||
33320185|NCT01020123|62695733|FG005|Main Period|Withdrawal by Subject|3|||
33320186|NCT01020123|62695734|FG006|Main Period|Withdrawal by Subject|2|||
33402406|NCT00640016|62781366|FG003|Overall Study|Withdrawal by Subject|0|||
33402407|NCT00640016|62781363|FG000|Overall Study|Study termination|2|||
33402408|NCT00640016|62781364|FG001|Overall Study|Study termination|1|||
33402409|NCT00640016|62781365|FG002|Overall Study|Study termination|3|||
33402410|NCT00640016|62781366|FG003|Overall Study|Study termination|2|||
33402411|NCT00640016|62781363|FG000|Overall Study|Adverse Event|0|||
33402412|NCT00640016|62781364|FG001|Overall Study|Adverse Event|0|||
33402413|NCT00640016|62781365|FG002|Overall Study|Adverse Event|0|||
33402414|NCT00640016|62781366|FG003|Overall Study|Adverse Event|1|||
33402415|NCT00608868|62781383|FG000|Overall Study|Withdrawal by Subject|7|||
33402416|NCT00608868|62781383|FG000|Overall Study|Protocol Violation|3|||
33402417|NCT00608868|62781383|FG000|Overall Study|Lost to Follow-up|2|||
33402418|NCT00608868|62781383|FG000|Overall Study|Adverse Event|1|||
33402419|NCT00608868|62781383|FG000|Overall Study|Physician Decision|2|||
33402420|NCT00608322|62781389|FG000|Overall Study|Death|2|||
33402421|NCT00608322|62781390|FG001|Overall Study|Death|1|||
33402422|NCT00608244|62781396|FG000|Overall Study|Adverse Event|1|||
33402423|NCT00608244|62781396|FG000|Overall Study|Low trough levels|1|||
33402424|NCT00605280|62781406|FG000|Year 1|Protocol Violation|0|||
33402425|NCT00605280|62781407|FG001|Year 1|Protocol Violation|0|||
33402426|NCT00605280|62781408|FG002|Year 1|Protocol Violation|0|||
33402427|NCT00605280|62781409|FG003|Year 1|Protocol Violation|1|||
33402428|NCT00605280|62781406|FG000|Year 1|Adverse Event|3|||
33402429|NCT00605280|62781407|FG001|Year 1|Adverse Event|1|||
33402430|NCT00605280|62781408|FG002|Year 1|Adverse Event|1|||
33402431|NCT00605280|62781409|FG003|Year 1|Adverse Event|5|||
33402432|NCT00605280|62781406|FG000|Year 1|Physician Decision|7|||
33402433|NCT00605280|62781407|FG001|Year 1|Physician Decision|4|||
33402434|NCT00605280|62781408|FG002|Year 1|Physician Decision|0|||
33402435|NCT00605280|62781409|FG003|Year 1|Physician Decision|6|||
33402436|NCT00605280|62781406|FG000|Year 1|Withdrawal by Subject|2|||
33402437|NCT00605280|62781407|FG001|Year 1|Withdrawal by Subject|4|||
33402438|NCT00605280|62781408|FG002|Year 1|Withdrawal by Subject|0|||
33320187|NCT01020123|62695728|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
33320188|NCT01020123|62695729|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
33320189|NCT01020123|62695730|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
33320190|NCT01020123|62695731|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
33320191|NCT01020123|62695732|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
33320192|NCT01020123|62695733|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
33320193|NCT01020123|62695734|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
33320194|NCT01020123|62695728|FG000|Main Period|Adverse Event|5|||
33320195|NCT01020123|62695729|FG001|Main Period|Adverse Event|2|||
33320196|NCT01020123|62695730|FG002|Main Period|Adverse Event|2|||
33320197|NCT01020123|62695731|FG003|Main Period|Adverse Event|1|||
33320198|NCT01020123|62695732|FG004|Main Period|Adverse Event|1|||
33320199|NCT01020123|62695733|FG005|Main Period|Adverse Event|2|||
33320200|NCT01020123|62695734|FG006|Main Period|Adverse Event|1|||
33320201|NCT01020123|62695728|FG000|Main Period|Protocol Violation|4|||
33320202|NCT01020123|62695729|FG001|Main Period|Protocol Violation|4|||
33320203|NCT01020123|62695730|FG002|Main Period|Protocol Violation|2|||
33320204|NCT01020123|62695731|FG003|Main Period|Protocol Violation|5|||
33320205|NCT01020123|62695732|FG004|Main Period|Protocol Violation|2|||
33320206|NCT01020123|62695733|FG005|Main Period|Protocol Violation|3|||
33320207|NCT01020123|62695734|FG006|Main Period|Protocol Violation|2|||
33320208|NCT01020123|62695728|FG000|Main Period|Lost to Follow-up|0|||
33402439|NCT00605280|62781409|FG003|Year 1|Withdrawal by Subject|4|||
33402440|NCT00605280|62781406|FG000|Year 1|Other|2|||
33402441|NCT00605280|62781407|FG001|Year 1|Other|1|||
33402442|NCT00605280|62781408|FG002|Year 1|Other|0|||
33402443|NCT00605280|62781409|FG003|Year 1|Other|1|||
33402444|NCT00605280|62781406|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
33320209|NCT01020123|62695729|FG001|Main Period|Lost to Follow-up|2|||
33320210|NCT01020123|62695730|FG002|Main Period|Lost to Follow-up|0|||
33320211|NCT01020123|62695731|FG003|Main Period|Lost to Follow-up|0|||
33402445|NCT00605280|62781407|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
33597935|NCT02366143|62996886|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
33402446|NCT00605280|62781408|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
33402447|NCT00605280|62781409|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
33402448|NCT00605280|62781406|FG000|Year 2|Adverse Event|4|||
33402449|NCT00605280|62781407|FG001|Year 2|Adverse Event|0|||
33402450|NCT00605280|62781408|FG002|Year 2|Adverse Event|2|||
33402451|NCT00605280|62781409|FG003|Year 2|Adverse Event|4|||
33402452|NCT00605280|62781406|FG000|Year 2|Physician Decision|11|||
33402453|NCT00605280|62781407|FG001|Year 2|Physician Decision|6|||
33402454|NCT00605280|62781408|FG002|Year 2|Physician Decision|4|||
33402455|NCT00605280|62781409|FG003|Year 2|Physician Decision|11|||
33402456|NCT00605280|62781406|FG000|Year 2|Withdrawal by Subject|4|||
33402457|NCT00605280|62781407|FG001|Year 2|Withdrawal by Subject|0|||
33402458|NCT00605280|62781408|FG002|Year 2|Withdrawal by Subject|0|||
33402459|NCT00605280|62781409|FG003|Year 2|Withdrawal by Subject|4|||
33402460|NCT00605280|62781406|FG000|Year 2|Other|1|||
33402461|NCT00605280|62781407|FG001|Year 2|Other|0|||
33402462|NCT00605280|62781408|FG002|Year 2|Other|0|||
33402463|NCT00605280|62781409|FG003|Year 2|Other|1|||
33402464|NCT00605280|62781406|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
33402465|NCT00605280|62781407|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
33402466|NCT00605280|62781408|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
33402467|NCT00605280|62781409|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
33402468|NCT00605280|62781406|FG000|Year 3 Extension|Adverse Event|2|||
33402469|NCT00605280|62781407|FG001|Year 3 Extension|Adverse Event|0|||
33402470|NCT00605280|62781408|FG002|Year 3 Extension|Adverse Event|0|||
33402471|NCT00605280|62781409|FG003|Year 3 Extension|Adverse Event|2|||
33402472|NCT00605280|62781406|FG000|Year 3 Extension|Physician Decision|0|||
33402473|NCT00605280|62781407|FG001|Year 3 Extension|Physician Decision|0|||
33402474|NCT00605280|62781408|FG002|Year 3 Extension|Physician Decision|0|||
33402475|NCT00605280|62781409|FG003|Year 3 Extension|Physician Decision|2|||
33402476|NCT00605280|62781406|FG000|Year 3 Extension|Withdrawal by Subject|2|||
33402477|NCT00605280|62781407|FG001|Year 3 Extension|Withdrawal by Subject|0|||
33402478|NCT00605280|62781408|FG002|Year 3 Extension|Withdrawal by Subject|0|||
33402479|NCT00605280|62781409|FG003|Year 3 Extension|Withdrawal by Subject|5|||
33402480|NCT00605280|62781406|FG000|Year 3 Extension|Other|2|||
33402481|NCT00605280|62781407|FG001|Year 3 Extension|Other|0|||
33402482|NCT00605280|62781408|FG002|Year 3 Extension|Other|0|||
33402483|NCT00605280|62781409|FG003|Year 3 Extension|Other|0|||
33402484|NCT00605280|62781406|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
33402485|NCT00605280|62781407|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
33320212|NCT01020123|62695732|FG004|Main Period|Lost to Follow-up|0|||
33320213|NCT01020123|62695733|FG005|Main Period|Lost to Follow-up|0|||
33320214|NCT01020123|62695734|FG006|Main Period|Lost to Follow-up|0|||
33320215|NCT01020123|62695728|FG000|Main Period|Unclasified|2|||
33320216|NCT01020123|62695729|FG001|Main Period|Unclasified|0|||
33320217|NCT01020123|62695730|FG002|Main Period|Unclasified|1|||
33320218|NCT01020123|62695731|FG003|Main Period|Unclasified|0|||
33320219|NCT01020123|62695732|FG004|Main Period|Unclasified|1|||
33320220|NCT01020123|62695733|FG005|Main Period|Unclasified|3|||
33320221|NCT01020123|62695734|FG006|Main Period|Unclasified|6|||
33320222|NCT01020123|62695728|FG000|Extention Period|Withdrawal by Subject|2|||
33320223|NCT01020123|62695729|FG001|Extention Period|Withdrawal by Subject|1|||
33320224|NCT01020123|62695730|FG002|Extention Period|Withdrawal by Subject|1|||
33402486|NCT00605280|62781408|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
33320225|NCT01020123|62695731|FG003|Extention Period|Withdrawal by Subject|0|||
33402487|NCT00605280|62781409|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
33320226|NCT01020123|62695732|FG004|Extention Period|Withdrawal by Subject|0|||
33320227|NCT01020123|62695733|FG005|Extention Period|Withdrawal by Subject|0|||
33402488|NCT00607386|62781419|FG000|Overall Study|Physician Decision|1|||
33402489|NCT00638690|62781425|FG000|Overall Study|Death|655|||
33402490|NCT00638690|62781426|FG001|Overall Study|Death|335|||
33402491|NCT00638690|62781425|FG000|Overall Study|Withdrawal by Subject|22|||
33402492|NCT00638690|62781426|FG001|Overall Study|Withdrawal by Subject|5|||
33402493|NCT00638690|62781425|FG000|Overall Study|Lost to Follow-up|4|||
33402494|NCT00638690|62781426|FG001|Overall Study|Lost to Follow-up|2|||
33402495|NCT00543387|62781442|FG000|Panel 1 + Panel 2|Adverse Event|0|||
33402496|NCT00543387|62781443|FG001|Panel 1 + Panel 2|Adverse Event|1|||
33402497|NCT00543387|62781444|FG002|Panel 1 + Panel 2|Adverse Event|0|||
33402498|NCT00543387|62781445|FG003|Panel 1 + Panel 2|Adverse Event|0|||
33402499|NCT00543387|62781446|FG004|Panel 1 + Panel 2|Adverse Event|0|||
33402500|NCT00543387|62781447|FG005|Panel 1 + Panel 2|Adverse Event|0|||
33402501|NCT00543387|62781448|FG006|Panel 1 + Panel 2|Adverse Event|0|||
33402502|NCT00543387|62781449|FG007|Panel 1 + Panel 2|Adverse Event|1|||
33402503|NCT00543387|62781450|FG008|Panel 1 + Panel 2|Adverse Event|1|||
33402504|NCT00543387|62781451|FG009|Panel 1 + Panel 2|Adverse Event|0|||
33402505|NCT00543387|62781452|FG010|Panel 1 + Panel 2|Adverse Event|0|||
33402506|NCT00543387|62781442|FG000|Panel 1 + Panel 2|Physician Decision|0|||
33402507|NCT00543387|62781443|FG001|Panel 1 + Panel 2|Physician Decision|0|||
33402508|NCT00543387|62781444|FG002|Panel 1 + Panel 2|Physician Decision|1|||
33402509|NCT00543387|62781445|FG003|Panel 1 + Panel 2|Physician Decision|0|||
33402510|NCT00543387|62781446|FG004|Panel 1 + Panel 2|Physician Decision|0|||
33402511|NCT00543387|62781447|FG005|Panel 1 + Panel 2|Physician Decision|0|||
33402512|NCT00543387|62781448|FG006|Panel 1 + Panel 2|Physician Decision|0|||
33402513|NCT00543387|62781449|FG007|Panel 1 + Panel 2|Physician Decision|1|||
33402514|NCT00543387|62781450|FG008|Panel 1 + Panel 2|Physician Decision|0|||
33402515|NCT00543387|62781451|FG009|Panel 1 + Panel 2|Physician Decision|0|||
33402516|NCT00543387|62781452|FG010|Panel 1 + Panel 2|Physician Decision|0|||
33402517|NCT00543387|62781442|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
33402518|NCT00543387|62781443|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
33402519|NCT00543387|62781444|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
33402520|NCT00543387|62781445|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
33402521|NCT00543387|62781446|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
33402522|NCT00543387|62781447|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
33402523|NCT00543387|62781448|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
33402524|NCT00543387|62781449|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
33402525|NCT00543387|62781450|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
33402526|NCT00543387|62781451|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
33402527|NCT00543387|62781452|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
33402528|NCT00543387|62781442|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33402529|NCT00543387|62781443|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33402530|NCT00543387|62781444|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33402531|NCT00543387|62781445|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33402532|NCT00543387|62781446|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33402533|NCT00543387|62781447|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33402534|NCT00543387|62781448|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
33402535|NCT00543387|62781449|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33402536|NCT00543387|62781450|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33402537|NCT00543387|62781451|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33402538|NCT00543387|62781452|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33402539|NCT00543387|62781442|FG000|Crossover Participants|Progressive Disease|0|||
33402540|NCT00543387|62781443|FG001|Crossover Participants|Progressive Disease|0|||
33402541|NCT00543387|62781444|FG002|Crossover Participants|Progressive Disease|0|||
33402542|NCT00543387|62781445|FG003|Crossover Participants|Progressive Disease|0|||
33402543|NCT00543387|62781446|FG004|Crossover Participants|Progressive Disease|0|||
33402544|NCT00543387|62781447|FG005|Crossover Participants|Progressive Disease|0|||
33320228|NCT01020123|62695734|FG006|Extention Period|Withdrawal by Subject|0|||
33320229|NCT01020123|62695728|FG000|Extention Period|Adverse Event|0|||
33320230|NCT01020123|62695729|FG001|Extention Period|Adverse Event|0|||
33320231|NCT01020123|62695730|FG002|Extention Period|Adverse Event|0|||
33320232|NCT01020123|62695731|FG003|Extention Period|Adverse Event|1|||
33320233|NCT01020123|62695732|FG004|Extention Period|Adverse Event|0|||
33320234|NCT01020123|62695733|FG005|Extention Period|Adverse Event|0|||
33320235|NCT01020123|62695734|FG006|Extention Period|Adverse Event|0|||
33320236|NCT01020123|62695728|FG000|Extention Period|Protocol Violation|1|||
33320237|NCT01020123|62695729|FG001|Extention Period|Protocol Violation|1|||
33320238|NCT01020123|62695730|FG002|Extention Period|Protocol Violation|1|||
33402545|NCT00543387|62781448|FG006|Crossover Participants|Progressive Disease|0|||
33402546|NCT00543387|62781449|FG007|Crossover Participants|Progressive Disease|0|||
33402547|NCT00543387|62781450|FG008|Crossover Participants|Progressive Disease|0|||
33402548|NCT00543387|62781451|FG009|Crossover Participants|Progressive Disease|1|||
33402549|NCT00543387|62781452|FG010|Crossover Participants|Progressive Disease|2|||
33402550|NCT00543387|62781442|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
33402551|NCT00543387|62781443|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
33402552|NCT00543387|62781444|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
33402553|NCT00543387|62781445|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
33402554|NCT00543387|62781446|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
33402555|NCT00543387|62781447|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
33402556|NCT00543387|62781448|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
33402557|NCT00543387|62781449|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
33402558|NCT00543387|62781450|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
33402559|NCT00543387|62781451|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
33402560|NCT00543387|62781452|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
33402561|NCT00635570|62781482|FG000|Overall Study|Lost to Follow-up|8|||
33402562|NCT00635570|62781483|FG001|Overall Study|Lost to Follow-up|8|||
33402563|NCT00635570|62781482|FG000|Overall Study|Withdrawal by Subject|1|||
33402564|NCT00635570|62781483|FG001|Overall Study|Withdrawal by Subject|1|||
33402565|NCT00635570|62781482|FG000|Overall Study|Adverse Event|2|||
33402566|NCT00635570|62781483|FG001|Overall Study|Adverse Event|0|||
33402567|NCT00635570|62781482|FG000|Overall Study|Physician Decision|1|||
33402568|NCT00635570|62781483|FG001|Overall Study|Physician Decision|0|||
33402569|NCT00635570|62781482|FG000|Overall Study|Did not complete survey|2|||
33402570|NCT00635570|62781483|FG001|Overall Study|Did not complete survey|1|||
33402571|NCT00635570|62781482|FG000|Overall Study|Early termination(No sexual activity)|1|||
33402572|NCT00635570|62781483|FG001|Overall Study|Early termination(No sexual activity)|1|||
33402573|NCT00635492|62781491|FG000|Overall Study|Death|12|||
33402574|NCT00635492|62781492|FG001|Overall Study|Death|40|||
33402575|NCT00635492|62781491|FG000|Overall Study|Lost to Follow-up|151|||
33402576|NCT00635492|62781492|FG001|Overall Study|Lost to Follow-up|172|||
33402577|NCT00635492|62781491|FG000|Overall Study|Physician Decision|32|||
33402578|NCT00635492|62781492|FG001|Overall Study|Physician Decision|22|||
33402579|NCT00635492|62781491|FG000|Overall Study|Sponsor decision|2|||
33402580|NCT00635492|62781492|FG001|Overall Study|Sponsor decision|3|||
33402581|NCT00635492|62781491|FG000|Overall Study|Withdrawal by Subject|82|||
33402582|NCT00635492|62781492|FG001|Overall Study|Withdrawal by Subject|45|||
33402583|NCT00543309|62781505|FG000|Overall Study|Physician Decision|0|||
33402584|NCT00543309|62781506|FG001|Overall Study|Physician Decision|1|||
33402585|NCT00543309|62781507|FG002|Overall Study|Physician Decision|0|||
33402586|NCT00569582|62781516|FG000|Overall Study|Withdrawal by Subject|5|||
33402587|NCT00569582|62781516|FG000|Overall Study|Death|2|||
33402588|NCT00569582|62781516|FG000|Overall Study|Adverse Event|7|||
33402589|NCT00569582|62781516|FG000|Overall Study|Subject was too ill to travel.|1|||
33402590|NCT00569582|62781516|FG000|Overall Study|Subject was non-compliant.|1|||
33402591|NCT00721409|62781523|FG000|Overall Study|Global deterioration of health status|2|||
33402592|NCT00721409|62781524|FG001|Overall Study|Global deterioration of health status|6|||
33402593|NCT00721409|62781525|FG002|Overall Study|Global deterioration of health status|3|||
33402594|NCT00721409|62781523|FG000|Overall Study|Death|0|||
33402595|NCT00721409|62781524|FG001|Overall Study|Death|1|||
33402596|NCT00721409|62781525|FG002|Overall Study|Death|0|||
33402597|NCT00721409|62781523|FG000|Overall Study|Randomized not Treated|0|||
33402598|NCT00721409|62781524|FG001|Overall Study|Randomized not Treated|1|||
33402599|NCT00721409|62781525|FG002|Overall Study|Randomized not Treated|4|||
33402600|NCT00721409|62781523|FG000|Overall Study|Reason not specified|1|||
33402601|NCT00721409|62781524|FG001|Overall Study|Reason not specified|0|||
33402602|NCT00721409|62781525|FG002|Overall Study|Reason not specified|2|||
33402603|NCT00721409|62781523|FG000|Overall Study|Adverse Event|0|||
33402604|NCT00721409|62781524|FG001|Overall Study|Adverse Event|13|||
33402605|NCT00721409|62781525|FG002|Overall Study|Adverse Event|2|||
33402606|NCT00721409|62781523|FG000|Overall Study|Lost to Follow-up|0|||
33402607|NCT00721409|62781524|FG001|Overall Study|Lost to Follow-up|0|||
33402608|NCT00721409|62781525|FG002|Overall Study|Lost to Follow-up|1|||
33402609|NCT00721409|62781523|FG000|Overall Study|Withdrawal by Subject|1|||
33402610|NCT00721409|62781524|FG001|Overall Study|Withdrawal by Subject|6|||
33402611|NCT00721409|62781525|FG002|Overall Study|Withdrawal by Subject|5|||
33402612|NCT00721409|62781523|FG000|Overall Study|Objective progression or relapse|8|||
33402613|NCT00721409|62781524|FG001|Overall Study|Objective progression or relapse|55|||
33402614|NCT00721409|62781525|FG002|Overall Study|Objective progression or relapse|62|||
33402615|NCT00542997|62781549|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
33402616|NCT00542997|62781549|FG000|Wash in / Wash Out Period|Adverse Event|3|||
33320239|NCT01020123|62695731|FG003|Extention Period|Protocol Violation|0|||
33320240|NCT01020123|62695732|FG004|Extention Period|Protocol Violation|0|||
33320241|NCT01020123|62695733|FG005|Extention Period|Protocol Violation|0|||
33320242|NCT01020123|62695734|FG006|Extention Period|Protocol Violation|1|||
33320243|NCT01020123|62695728|FG000|Extention Period|Lost to Follow-up|0|||
33320244|NCT01020123|62695729|FG001|Extention Period|Lost to Follow-up|0|||
33320245|NCT01020123|62695730|FG002|Extention Period|Lost to Follow-up|0|||
33320246|NCT01020123|62695731|FG003|Extention Period|Lost to Follow-up|0|||
33320247|NCT01020123|62695732|FG004|Extention Period|Lost to Follow-up|0|||
33320248|NCT01020123|62695733|FG005|Extention Period|Lost to Follow-up|2|||
33320249|NCT01020123|62695734|FG006|Extention Period|Lost to Follow-up|0|||
33320250|NCT01028391|62695775|FG000|Overall Study|Adverse Event|4|||
33320251|NCT01028391|62695776|FG001|Overall Study|Adverse Event|0|||
33320252|NCT01028391|62695775|FG000|Overall Study|Lack of Efficacy|0|||
33402617|NCT00542997|62781549|FG000|Efficacy Period|Adverse Event|3|||
33402618|NCT00572832|62781558|FG000|Overall Study|Lost to Follow-up|0|||
33402619|NCT00572832|62781559|FG001|Overall Study|Lost to Follow-up|11|||
33402620|NCT00572832|62781558|FG000|Overall Study|Pregnancy|0|||
33402621|NCT00572832|62781559|FG001|Overall Study|Pregnancy|1|||
33402622|NCT03917823|62781567|FG000|Overall Study|Lost to Follow-up|1|||
33402623|NCT03917823|62781568|FG001|Overall Study|Lost to Follow-up|1|||
33402624|NCT03917823|62781567|FG000|Overall Study|Withdrawal by Subject|0|||
33402625|NCT03917823|62781568|FG001|Overall Study|Withdrawal by Subject|1|||
33402626|NCT00229723|62781581|FG000|Concomitant Phase|Adverse Event|4|||
33402627|NCT00229723|62781582|FG001|Concomitant Phase|Adverse Event|2|||
33402628|NCT00229723|62781583|FG002|Concomitant Phase|Adverse Event|5|||
33402629|NCT00229723|62781584|FG003|Concomitant Phase|Adverse Event|2|||
33402630|NCT00229723|62781585|FG004|Concomitant Phase|Adverse Event|0|||
33402631|NCT00229723|62781586|FG005|Concomitant Phase|Adverse Event|1|||
33402632|NCT00229723|62781587|FG006|Concomitant Phase|Adverse Event|2|||
33402633|NCT00229723|62781581|FG000|Concomitant Phase|Objective disease progression|0|||
33402634|NCT00229723|62781582|FG001|Concomitant Phase|Objective disease progression|0|||
33402635|NCT00229723|62781583|FG002|Concomitant Phase|Objective disease progression|0|||
33402636|NCT00229723|62781584|FG003|Concomitant Phase|Objective disease progression|0|||
33402637|NCT00229723|62781585|FG004|Concomitant Phase|Objective disease progression|0|||
33402638|NCT00229723|62781586|FG005|Concomitant Phase|Objective disease progression|0|||
33320253|NCT01028391|62695776|FG001|Overall Study|Lack of Efficacy|2|||
33320254|NCT01028391|62695775|FG000|Overall Study|Lost to Follow-up|3|||
33320255|NCT01028391|62695776|FG001|Overall Study|Lost to Follow-up|4|||
33320256|NCT01028391|62695775|FG000|Overall Study|Physician Decision|0|||
33320257|NCT01028391|62695776|FG001|Overall Study|Physician Decision|1|||
33320258|NCT01028391|62695775|FG000|Overall Study|Withdrawal by Subject|6|||
33320259|NCT01028391|62695776|FG001|Overall Study|Withdrawal by Subject|3|||
33320260|NCT01028391|62695775|FG000|Overall Study|Needed excluded medication|1|||
33320261|NCT01028391|62695776|FG001|Overall Study|Needed excluded medication|1|||
33320262|NCT01179672|62695784|FG000|Overall Study|Adverse Event|17|||
33320263|NCT01179672|62695785|FG001|Overall Study|Adverse Event|8|||
33320264|NCT01179672|62695784|FG000|Overall Study|Withdrawal by Subject|10|||
33320265|NCT01179672|62695785|FG001|Overall Study|Withdrawal by Subject|12|||
33402639|NCT00229723|62781587|FG006|Concomitant Phase|Objective disease progression|0|||
33320266|NCT01179672|62695784|FG000|Overall Study|Entry Criteria Not Met|0|||
33320267|NCT01179672|62695785|FG001|Overall Study|Entry Criteria Not Met|2|||
33320268|NCT01179672|62695784|FG000|Overall Study|Lost to Follow-up|0|||
33402640|NCT00229723|62781581|FG000|Concomitant Phase|Clinical progression|0|||
33402641|NCT00229723|62781582|FG001|Concomitant Phase|Clinical progression|0|||
33402642|NCT00229723|62781583|FG002|Concomitant Phase|Clinical progression|0|||
33402643|NCT00229723|62781584|FG003|Concomitant Phase|Clinical progression|0|||
33402644|NCT00229723|62781585|FG004|Concomitant Phase|Clinical progression|0|||
33402645|NCT00229723|62781586|FG005|Concomitant Phase|Clinical progression|0|||
33402646|NCT00229723|62781587|FG006|Concomitant Phase|Clinical progression|1|||
33402647|NCT00229723|62781581|FG000|Concomitant Phase|Lost to Follow-up|0|||
33402648|NCT00229723|62781582|FG001|Concomitant Phase|Lost to Follow-up|0|||
33402649|NCT00229723|62781583|FG002|Concomitant Phase|Lost to Follow-up|0|||
33402650|NCT00229723|62781584|FG003|Concomitant Phase|Lost to Follow-up|0|||
33402651|NCT00229723|62781585|FG004|Concomitant Phase|Lost to Follow-up|1|||
33402652|NCT00229723|62781586|FG005|Concomitant Phase|Lost to Follow-up|0|||
33402653|NCT00229723|62781587|FG006|Concomitant Phase|Lost to Follow-up|0|||
33402654|NCT00229723|62781581|FG000|Concomitant Phase|Informed consent withdrawn|3|||
33402655|NCT00229723|62781582|FG001|Concomitant Phase|Informed consent withdrawn|2|||
33402656|NCT00229723|62781583|FG002|Concomitant Phase|Informed consent withdrawn|0|||
33402657|NCT00229723|62781584|FG003|Concomitant Phase|Informed consent withdrawn|2|||
33402658|NCT00229723|62781585|FG004|Concomitant Phase|Informed consent withdrawn|0|||
33402659|NCT00229723|62781586|FG005|Concomitant Phase|Informed consent withdrawn|0|||
33402660|NCT00229723|62781587|FG006|Concomitant Phase|Informed consent withdrawn|0|||
33402661|NCT00229723|62781581|FG000|Concomitant Phase|Severe non-compliance|0|||
33402662|NCT00229723|62781582|FG001|Concomitant Phase|Severe non-compliance|1|||
33402663|NCT00229723|62781583|FG002|Concomitant Phase|Severe non-compliance|0|||
33402664|NCT00229723|62781584|FG003|Concomitant Phase|Severe non-compliance|0|||
33402665|NCT00229723|62781585|FG004|Concomitant Phase|Severe non-compliance|1|||
33402666|NCT00229723|62781586|FG005|Concomitant Phase|Severe non-compliance|0|||
33402667|NCT00229723|62781587|FG006|Concomitant Phase|Severe non-compliance|0|||
33402668|NCT00229723|62781581|FG000|Concomitant Phase|Other|3|||
33597936|NCT02366143|62996884|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
33597937|NCT02366143|62996885|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
33597938|NCT02366143|62996886|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
33597939|NCT02366143|62996884|FG000|Overall Study|Randomization Error|1|||
33597940|NCT02366143|62996885|FG001|Overall Study|Randomization Error|0|||
33597941|NCT02366143|62996886|FG002|Overall Study|Randomization Error|0|||
33320269|NCT01179672|62695785|FG001|Overall Study|Lost to Follow-up|1|||
33320270|NCT01179672|62695784|FG000|Overall Study|Protocol Violation|2|||
33320271|NCT01179672|62695785|FG001|Overall Study|Protocol Violation|2|||
33320272|NCT01179672|62695784|FG000|Overall Study|Physician Decision|1|||
33320273|NCT01179672|62695785|FG001|Overall Study|Physician Decision|1|||
33320274|NCT01030965|62695799|FG000|Overall Study|Lack of Efficacy|3|||
33320275|NCT01030965|62695800|FG001|Overall Study|Lack of Efficacy|2|||
33320276|NCT01030965|62695801|FG002|Overall Study|Lack of Efficacy|0|||
33320277|NCT01030965|62695802|FG003|Overall Study|Lack of Efficacy|3|||
33320278|NCT01030965|62695799|FG000|Overall Study|Protocol Violation|1|||
33320279|NCT01030965|62695800|FG001|Overall Study|Protocol Violation|1|||
33320280|NCT01030965|62695801|FG002|Overall Study|Protocol Violation|1|||
33597942|NCT02366143|62996884|FG000|Overall Study|PI Move and Site Closure|1|||
33597943|NCT02366143|62996885|FG001|Overall Study|PI Move and Site Closure|0|||
33320281|NCT01030965|62695802|FG003|Overall Study|Protocol Violation|1|||
33320282|NCT01030965|62695799|FG000|Overall Study|Adverse Event|0|||
33320283|NCT01030965|62695800|FG001|Overall Study|Adverse Event|1|||
33320284|NCT01030965|62695801|FG002|Overall Study|Adverse Event|2|||
33320285|NCT01030965|62695802|FG003|Overall Study|Adverse Event|1|||
33320286|NCT01030965|62695799|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
33320287|NCT01030965|62695800|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
33320288|NCT01030965|62695801|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
33320289|NCT01030965|62695802|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
33320290|NCT01030965|62695799|FG000|Overall Study|Withdrawal by Subject|0|||
33320291|NCT01030965|62695800|FG001|Overall Study|Withdrawal by Subject|1|||
33320292|NCT01030965|62695801|FG002|Overall Study|Withdrawal by Subject|0|||
33597944|NCT02366143|62996886|FG002|Overall Study|PI Move and Site Closure|1|||
33597945|NCT02366143|62996884|FG000|Overall Study|Study Terminated By Sponsor|0|||
33597946|NCT02366143|62996885|FG001|Overall Study|Study Terminated By Sponsor|0|||
33597947|NCT02366143|62996886|FG002|Overall Study|Study Terminated By Sponsor|2|||
33597948|NCT02366143|62996884|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
33597949|NCT02366143|62996885|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
33320293|NCT01030965|62695802|FG003|Overall Study|Withdrawal by Subject|2|||
33320294|NCT01179516|62695815|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
33402669|NCT00229723|62781582|FG001|Concomitant Phase|Other|0|||
33402670|NCT00229723|62781583|FG002|Concomitant Phase|Other|1|||
33402671|NCT00229723|62781584|FG003|Concomitant Phase|Other|1|||
33402672|NCT00229723|62781585|FG004|Concomitant Phase|Other|0|||
33402673|NCT00229723|62781586|FG005|Concomitant Phase|Other|2|||
33320295|NCT01179516|62695816|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
33402674|NCT00229723|62781587|FG006|Concomitant Phase|Other|0|||
33320296|NCT01179516|62695817|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
33320297|NCT01179516|62695815|FG000|Overall Study|Lack of Efficacy|4|||
33320298|NCT01179516|62695816|FG001|Overall Study|Lack of Efficacy|2|||
33320299|NCT01179516|62695817|FG002|Overall Study|Lack of Efficacy|0|||
33320300|NCT01179516|62695815|FG000|Overall Study|Noncompliance with Study Drug|2|||
33320301|NCT01179516|62695816|FG001|Overall Study|Noncompliance with Study Drug|0|||
33320302|NCT01179516|62695817|FG002|Overall Study|Noncompliance with Study Drug|1|||
33320303|NCT01179516|62695815|FG000|Overall Study|Protocol Deviations|4|||
33320304|NCT01179516|62695816|FG001|Overall Study|Protocol Deviations|3|||
33320305|NCT01179516|62695817|FG002|Overall Study|Protocol Deviations|3|||
33320306|NCT01179516|62695815|FG000|Overall Study|Withdrawal of Consent|2|||
33320307|NCT01179516|62695816|FG001|Overall Study|Withdrawal of Consent|6|||
33320308|NCT01179516|62695817|FG002|Overall Study|Withdrawal of Consent|10|||
33320309|NCT01179516|62695815|FG000|Overall Study|Lost to Follow-up|7|||
33320310|NCT01179516|62695816|FG001|Overall Study|Lost to Follow-up|7|||
33320311|NCT01179516|62695817|FG002|Overall Study|Lost to Follow-up|3|||
33320312|NCT01179516|62695815|FG000|Overall Study|Other|2|||
33320313|NCT01179516|62695816|FG001|Overall Study|Other|0|||
33320314|NCT01179516|62695817|FG002|Overall Study|Other|2|||
33320315|NCT01018953|62695825|FG000|Overall Study|Adverse Event|2|||
33320316|NCT01018953|62695825|FG000|Overall Study|Withdrawal by Subject|1|||
33320317|NCT01018953|62695825|FG000|Overall Study|Study termination by sponsor|5|||
33320318|NCT01158924|62695832|FG000|Overall Study|Withdrawal by Subject|1|||
33320319|NCT01158924|62695833|FG001|Overall Study|Withdrawal by Subject|2|||
33320320|NCT01158924|62695832|FG000|Overall Study|Lost to Follow-up|0|||
33320321|NCT01158924|62695833|FG001|Overall Study|Lost to Follow-up|1|||
33320322|NCT01027845|62695841|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
33320323|NCT01027845|62695842|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
33320324|NCT01027845|62695843|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
33320325|NCT01027845|62695844|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
33320326|NCT01027845|62695841|FG000|Primary Vaccination Phase|Adverse Event|1|||
33320327|NCT01027845|62695842|FG001|Primary Vaccination Phase|Adverse Event|0|||
33320328|NCT01027845|62695843|FG002|Primary Vaccination Phase|Adverse Event|0|||
33320329|NCT01027845|62695844|FG003|Primary Vaccination Phase|Adverse Event|0|||
33320330|NCT01027845|62695841|FG000|Primary Vaccination Phase|Protocol Violation|1|||
33320331|NCT01027845|62695842|FG001|Primary Vaccination Phase|Protocol Violation|0|||
33320332|NCT01027845|62695843|FG002|Primary Vaccination Phase|Protocol Violation|0|||
33320333|NCT01027845|62695844|FG003|Primary Vaccination Phase|Protocol Violation|0|||
33320334|NCT01027845|62695841|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
33320335|NCT01027845|62695842|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
33320336|NCT01027845|62695843|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
33320337|NCT01027845|62695844|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
33320338|NCT01027845|62695841|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
33320339|NCT01027845|62695842|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
33320340|NCT01027845|62695843|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
33320341|NCT01027845|62695844|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
33320342|NCT01027845|62695841|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
33320343|NCT01027845|62695842|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
33320344|NCT01027845|62695843|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
33320345|NCT01027845|62695844|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
33320346|NCT01017549|62695853|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
33320347|NCT01017549|62695853|FG000|One-year Follow-up|Lost to Follow-up|2|||
33320348|NCT01017549|62695853|FG000|One-year Follow-up|Withdrawal by Subject|5|||
33320349|NCT01017549|62695853|FG000|5 Year Follow-up|Lost to Follow-up|9|||
33320350|NCT01017549|62695853|FG000|5 Year Follow-up|Mastectomy|3|||
33320351|NCT01030341|62695857|FG000|Overall Study|Withdrawal by Subject|1|||
33320352|NCT01030341|62695857|FG000|Overall Study|Lost to Follow-up|2|||
33320353|NCT01026831|62695863|FG000|Overall Study|Adverse Event|4|||
33320354|NCT01026831|62695864|FG001|Overall Study|Adverse Event|3|||
33320355|NCT01026831|62695863|FG000|Overall Study|Lost to Follow-up|2|||
33320356|NCT01026831|62695864|FG001|Overall Study|Lost to Follow-up|0|||
33320357|NCT01026831|62695863|FG000|Overall Study|Physician Decision|1|||
33320358|NCT01026831|62695864|FG001|Overall Study|Physician Decision|1|||
33493937|NCT03495102|62872496|FG001|Overall Study|Relocated to Another Country|1|||
33402675|NCT00229723|62781581|FG000|Maintenance Phase|Adverse Event|7|||
33402676|NCT00229723|62781582|FG001|Maintenance Phase|Adverse Event|2|||
33402677|NCT00229723|62781583|FG002|Maintenance Phase|Adverse Event|1|||
33402678|NCT00229723|62781584|FG003|Maintenance Phase|Adverse Event|4|||
33402679|NCT00229723|62781585|FG004|Maintenance Phase|Adverse Event|7|||
33402680|NCT00229723|62781586|FG005|Maintenance Phase|Adverse Event|5|||
33402681|NCT00229723|62781587|FG006|Maintenance Phase|Adverse Event|2|||
33402682|NCT00229723|62781581|FG000|Maintenance Phase|Objective disease progression|5|||
33402683|NCT00229723|62781582|FG001|Maintenance Phase|Objective disease progression|5|||
33320359|NCT01026831|62695863|FG000|Overall Study|Protocol Violation|0|||
33320360|NCT01026831|62695864|FG001|Overall Study|Protocol Violation|2|||
33320361|NCT01026831|62695863|FG000|Overall Study|Withdrawal by Subject|7|||
33320362|NCT01026831|62695864|FG001|Overall Study|Withdrawal by Subject|5|||
33320363|NCT01016067|62695872|FG000|Overall Study|Lost to Follow-up|1|||
33320364|NCT01016067|62695873|FG001|Overall Study|Lost to Follow-up|2|||
33320365|NCT01016067|62695872|FG000|Overall Study|Physician Decision|1|||
33402684|NCT00229723|62781583|FG002|Maintenance Phase|Objective disease progression|3|||
33402685|NCT00229723|62781584|FG003|Maintenance Phase|Objective disease progression|6|||
33402686|NCT00229723|62781585|FG004|Maintenance Phase|Objective disease progression|2|||
33402687|NCT00229723|62781586|FG005|Maintenance Phase|Objective disease progression|9|||
33402688|NCT00229723|62781587|FG006|Maintenance Phase|Objective disease progression|5|||
33402689|NCT00229723|62781581|FG000|Maintenance Phase|Clinical progression|4|||
33402690|NCT00229723|62781582|FG001|Maintenance Phase|Clinical progression|1|||
33402691|NCT00229723|62781583|FG002|Maintenance Phase|Clinical progression|2|||
33402692|NCT00229723|62781584|FG003|Maintenance Phase|Clinical progression|2|||
33402693|NCT00229723|62781585|FG004|Maintenance Phase|Clinical progression|1|||
33402694|NCT00229723|62781586|FG005|Maintenance Phase|Clinical progression|1|||
33402695|NCT00229723|62781587|FG006|Maintenance Phase|Clinical progression|1|||
33402696|NCT00229723|62781581|FG000|Maintenance Phase|Lost to Follow-up|0|||
33402697|NCT00229723|62781582|FG001|Maintenance Phase|Lost to Follow-up|1|||
33402698|NCT00229723|62781583|FG002|Maintenance Phase|Lost to Follow-up|2|||
33402699|NCT00229723|62781584|FG003|Maintenance Phase|Lost to Follow-up|2|||
33402700|NCT00229723|62781585|FG004|Maintenance Phase|Lost to Follow-up|0|||
33402701|NCT00229723|62781586|FG005|Maintenance Phase|Lost to Follow-up|0|||
33402702|NCT00229723|62781587|FG006|Maintenance Phase|Lost to Follow-up|1|||
33402703|NCT00229723|62781581|FG000|Maintenance Phase|Informed consent withdrawn|1|||
33597950|NCT02366143|62996886|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
33597951|NCT02366143|62996884|FG000|Overall Study|Patient moved to roll-over study|1|||
33597952|NCT02366143|62996885|FG001|Overall Study|Patient moved to roll-over study|19|||
33597953|NCT02366143|62996886|FG002|Overall Study|Patient moved to roll-over study|28|||
33597954|NCT02366143|62996884|FG000|Overall Study|Patient moved to commercial stock|0|||
33597955|NCT02366143|62996885|FG001|Overall Study|Patient moved to commercial stock|0|||
33597956|NCT02366143|62996886|FG002|Overall Study|Patient moved to commercial stock|1|||
33320366|NCT01016067|62695873|FG001|Overall Study|Physician Decision|1|||
33402704|NCT00229723|62781582|FG001|Maintenance Phase|Informed consent withdrawn|0|||
33402705|NCT00229723|62781583|FG002|Maintenance Phase|Informed consent withdrawn|0|||
33320367|NCT01016067|62695872|FG000|Overall Study|Withdrew due to Relocation|0|||
33493938|NCT03495102|62872497|FG002|Overall Study|Relocated to Another Country|0|||
33402706|NCT00229723|62781584|FG003|Maintenance Phase|Informed consent withdrawn|1|||
33402707|NCT00229723|62781585|FG004|Maintenance Phase|Informed consent withdrawn|1|||
33402708|NCT00229723|62781586|FG005|Maintenance Phase|Informed consent withdrawn|1|||
33597957|NCT02366143|62996884|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
33402709|NCT00229723|62781587|FG006|Maintenance Phase|Informed consent withdrawn|0|||
33402710|NCT00229723|62781581|FG000|Maintenance Phase|Severe non-compliance|3|||
33402711|NCT00229723|62781582|FG001|Maintenance Phase|Severe non-compliance|1|||
33402712|NCT00229723|62781583|FG002|Maintenance Phase|Severe non-compliance|0|||
33402713|NCT00229723|62781584|FG003|Maintenance Phase|Severe non-compliance|0|||
33402714|NCT00229723|62781585|FG004|Maintenance Phase|Severe non-compliance|1|||
33402715|NCT00229723|62781586|FG005|Maintenance Phase|Severe non-compliance|0|||
33402716|NCT00229723|62781587|FG006|Maintenance Phase|Severe non-compliance|0|||
33402717|NCT00229723|62781581|FG000|Maintenance Phase|Other|5|||
33402718|NCT00229723|62781582|FG001|Maintenance Phase|Other|4|||
33402719|NCT00229723|62781583|FG002|Maintenance Phase|Other|1|||
33402720|NCT00229723|62781584|FG003|Maintenance Phase|Other|2|||
33402721|NCT00229723|62781585|FG004|Maintenance Phase|Other|3|||
33402722|NCT00229723|62781586|FG005|Maintenance Phase|Other|3|||
33402723|NCT00229723|62781587|FG006|Maintenance Phase|Other|1|||
33402724|NCT00606684|62781609|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
33402725|NCT00606684|62781610|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
33402726|NCT00606684|62781611|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
33402727|NCT00606684|62781612|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
33597958|NCT02366143|62996885|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
33597959|NCT02366143|62996886|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
33402728|NCT00606684|62781613|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
33402729|NCT00606684|62781614|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
33402730|NCT00606684|62781615|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
33402731|NCT00606684|62781609|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
33402732|NCT00606684|62781610|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
33402733|NCT00606684|62781611|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
33402734|NCT00606684|62781612|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
33402735|NCT00606684|62781613|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
33402736|NCT00606684|62781614|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
33402737|NCT00606684|62781615|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
33402738|NCT00606684|62781609|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
33402739|NCT00606684|62781610|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
33402740|NCT00606684|62781611|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
33402741|NCT00606684|62781612|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
33402742|NCT00606684|62781613|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
33402743|NCT00606684|62781614|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
33402744|NCT00606684|62781615|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
33402745|NCT00606684|62781609|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
33402746|NCT00606684|62781610|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
33402747|NCT00606684|62781611|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
33402748|NCT00606684|62781612|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
33402749|NCT00606684|62781613|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
33320368|NCT01016067|62695873|FG001|Overall Study|Withdrew due to Relocation|1|||
33597960|NCT02366143|62996884|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
33597961|NCT02366143|62996885|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
33402750|NCT00606684|62781614|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
33402751|NCT00606684|62781615|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
33402752|NCT00606684|62781609|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
33402753|NCT00606684|62781610|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
33402754|NCT00606684|62781611|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
33402755|NCT00606684|62781612|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
33402756|NCT00606684|62781613|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
33402757|NCT00606684|62781614|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
33402758|NCT00606684|62781615|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
33402759|NCT00606684|62781609|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
33402760|NCT00606684|62781610|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
33402761|NCT00606684|62781611|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
33402762|NCT00606684|62781612|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
33402763|NCT00606684|62781613|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
33402764|NCT00606684|62781614|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
33320369|NCT01015833|62695881|FG000|Overall Study|Death|1|||
33320370|NCT01015833|62695882|FG001|Overall Study|Death|0|||
33320371|NCT01015833|62695881|FG000|Overall Study|Withdrawal by Subject|3|||
33402765|NCT00606684|62781615|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
33402766|NCT00606684|62781609|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
33402767|NCT00606684|62781610|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
33402768|NCT00606684|62781611|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
33402769|NCT00606684|62781612|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
33402770|NCT00606684|62781613|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
33402771|NCT00606684|62781614|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
33402772|NCT00606684|62781615|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
33402773|NCT00606684|62781609|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33402774|NCT00606684|62781610|FG001|Double-Blind Treatment Period|Adverse Event|3|||
33402775|NCT00606684|62781611|FG002|Double-Blind Treatment Period|Adverse Event|2|||
33402776|NCT00606684|62781612|FG003|Double-Blind Treatment Period|Adverse Event|4|||
33402777|NCT00606684|62781613|FG004|Double-Blind Treatment Period|Adverse Event|2|||
33402778|NCT00606684|62781614|FG005|Double-Blind Treatment Period|Adverse Event|0|||
33402779|NCT00606684|62781615|FG006|Double-Blind Treatment Period|Adverse Event|1|||
33402780|NCT00606684|62781609|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
33402781|NCT00606684|62781610|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
33402782|NCT00606684|62781611|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
33402783|NCT00606684|62781612|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
33402784|NCT00606684|62781613|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
33402785|NCT00606684|62781614|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
33402786|NCT00606684|62781615|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
33402787|NCT00606684|62781609|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
33320372|NCT01015833|62695882|FG001|Overall Study|Withdrawal by Subject|2|||
33320373|NCT01015833|62695881|FG000|Overall Study|Adverse Event|0|||
33320374|NCT01015833|62695882|FG001|Overall Study|Adverse Event|1|||
33402788|NCT00606684|62781610|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
33402789|NCT00606684|62781611|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
33402790|NCT00606684|62781612|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
33402791|NCT00606684|62781613|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
33402792|NCT00606684|62781614|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
33402793|NCT00606684|62781615|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
33402794|NCT00606684|62781609|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
33402795|NCT00606684|62781610|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
33402796|NCT00606684|62781611|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
33402797|NCT00606684|62781612|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
33402798|NCT00606684|62781613|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
33402799|NCT00606684|62781614|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
33402800|NCT00606684|62781615|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
33402801|NCT00606684|62781609|FG000|Double-Blind Treatment Period|Physician Decision|0|||
33402802|NCT00606684|62781610|FG001|Double-Blind Treatment Period|Physician Decision|5|||
33402803|NCT00606684|62781611|FG002|Double-Blind Treatment Period|Physician Decision|1|||
33402804|NCT00606684|62781612|FG003|Double-Blind Treatment Period|Physician Decision|0|||
33402805|NCT00606684|62781613|FG004|Double-Blind Treatment Period|Physician Decision|3|||
33402806|NCT00606684|62781614|FG005|Double-Blind Treatment Period|Physician Decision|1|||
33402807|NCT00606684|62781615|FG006|Double-Blind Treatment Period|Physician Decision|2|||
33402808|NCT00606684|62781609|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33402809|NCT00606684|62781610|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33402810|NCT00606684|62781611|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33402811|NCT00606684|62781612|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
33402812|NCT00606684|62781613|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33402813|NCT00606684|62781614|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
33402814|NCT00606684|62781615|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33402815|NCT00627926|62781632|FG000|Overall Study|Adverse Event|26|||
33402816|NCT00627926|62781633|FG001|Overall Study|Adverse Event|37|||
33402817|NCT00627926|62781634|FG002|Overall Study|Adverse Event|36|||
33402818|NCT00627926|62781632|FG000|Overall Study|Death|1|||
33402819|NCT00627926|62781633|FG001|Overall Study|Death|0|||
33402820|NCT00627926|62781634|FG002|Overall Study|Death|0|||
33402821|NCT00627926|62781632|FG000|Overall Study|Lost to Follow-up|4|||
33402822|NCT00627926|62781633|FG001|Overall Study|Lost to Follow-up|3|||
33402823|NCT00627926|62781634|FG002|Overall Study|Lost to Follow-up|4|||
33402824|NCT00627926|62781632|FG000|Overall Study|Withdrawal by Subject|2|||
33402825|NCT00627926|62781633|FG001|Overall Study|Withdrawal by Subject|1|||
33402826|NCT00627926|62781634|FG002|Overall Study|Withdrawal by Subject|0|||
33402827|NCT00627926|62781632|FG000|Overall Study|Lack of Efficacy|118|||
33402828|NCT00627926|62781633|FG001|Overall Study|Lack of Efficacy|40|||
33402829|NCT00627926|62781634|FG002|Overall Study|Lack of Efficacy|38|||
33402830|NCT00627926|62781632|FG000|Overall Study|Noncompliance/unspecified|8|||
33402831|NCT00627926|62781633|FG001|Overall Study|Noncompliance/unspecified|23|||
33402832|NCT00627926|62781634|FG002|Overall Study|Noncompliance/unspecified|17|||
33402833|NCT00228553|62781642|FG000|Overall Study|Adverse Event|112|||
33402834|NCT00228553|62781642|FG000|Overall Study|Lack of Efficacy|34|||
33402835|NCT00228553|62781642|FG000|Overall Study|Lost to Follow-up|67|||
33402836|NCT00228553|62781642|FG000|Overall Study|Physician Decision|48|||
33402837|NCT00228553|62781642|FG000|Overall Study|Protocol Violation|6|||
33402838|NCT00228553|62781642|FG000|Overall Study|Withdrawal by Subject|115|||
33402839|NCT00228553|62781642|FG000|Overall Study|Pregnancy|2|||
33402840|NCT00228553|62781642|FG000|Overall Study|Miscellaneous|46|||
33402841|NCT00643916|62781652|FG000|Overall Study|Protocol Violation|0|||
33597962|NCT02366143|62996886|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
33597963|NCT02366143|62996884|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
33597964|NCT02366143|62996885|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
33597965|NCT02366143|62996886|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
33597966|NCT02366143|62996884|FG000|Overall Study|Requester's instructions|1|||
33597967|NCT02366143|62996885|FG001|Overall Study|Requester's instructions|1|||
33597968|NCT02366143|62996886|FG002|Overall Study|Requester's instructions|1|||
33597969|NCT02366143|62996884|FG000|Overall Study|Uneligible|0|||
33597970|NCT02366143|62996885|FG001|Overall Study|Uneligible|1|||
33597971|NCT02366143|62996886|FG002|Overall Study|Uneligible|0|||
33597972|NCT02366143|62996884|FG000|Overall Study|Post Trial Migration|0|||
33597973|NCT02366143|62996885|FG001|Overall Study|Post Trial Migration|1|||
33597974|NCT02366143|62996886|FG002|Overall Study|Post Trial Migration|0|||
33320375|NCT01015833|62695881|FG000|Overall Study|Physician Decision|2|||
33320376|NCT01015833|62695882|FG001|Overall Study|Physician Decision|0|||
33320377|NCT01015833|62695881|FG000|Overall Study|Symptomatic deterioration|0|||
33320378|NCT01015833|62695882|FG001|Overall Study|Symptomatic deterioration|1|||
33320379|NCT01015833|62695881|FG000|Overall Study|Other|5|||
33320380|NCT01015833|62695882|FG001|Overall Study|Other|1|||
33320381|NCT01015833|62695881|FG000|Overall Study|Motor Vehicle Accidents|1|||
33320382|NCT01015833|62695882|FG001|Overall Study|Motor Vehicle Accidents|0|||
33320383|NCT01015833|62695881|FG000|Overall Study|Did not start treatment|1|||
33320384|NCT01015833|62695882|FG001|Overall Study|Did not start treatment|0|||
33320385|NCT01015677|62695900|FG000|Overall Study|Adverse Event|0|||
33320386|NCT01015677|62695901|FG001|Overall Study|Adverse Event|1|||
33320387|NCT01015677|62695902|FG002|Overall Study|Adverse Event|0|||
33320388|NCT01015677|62695900|FG000|Overall Study|Lack of Efficacy|0|||
33320389|NCT01015677|62695901|FG001|Overall Study|Lack of Efficacy|1|||
33597975|NCT02366143|62996884|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
33597976|NCT02366143|62996885|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
33597977|NCT02366143|62996886|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
33597978|NCT02366143|62996884|FG000|Overall Study|Patient switched to PTAP|0|||
33597979|NCT02366143|62996885|FG001|Overall Study|Patient switched to PTAP|1|||
33597980|NCT02366143|62996886|FG002|Overall Study|Patient switched to PTAP|0|||
33597981|NCT02366143|62996884|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
33597982|NCT02366143|62996885|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
33597983|NCT02366143|62996886|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
33597984|NCT02098395|62996902|FG000|Overall Study|Protocol Violation|2|||
33597985|NCT02098395|62996903|FG001|Overall Study|Protocol Violation|2|||
33597986|NCT02098395|62996904|FG002|Overall Study|Protocol Violation|0|||
33597987|NCT02098395|62996905|FG003|Overall Study|Protocol Violation|7|||
33597988|NCT02098395|62996902|FG000|Overall Study|Withdrawal by Subject|10|||
33597989|NCT02098395|62996903|FG001|Overall Study|Withdrawal by Subject|10|||
33597990|NCT02098395|62996904|FG002|Overall Study|Withdrawal by Subject|5|||
33597991|NCT02098395|62996905|FG003|Overall Study|Withdrawal by Subject|13|||
33597992|NCT02098395|62996902|FG000|Overall Study|Adverse Event|12|||
33597993|NCT02098395|62996903|FG001|Overall Study|Adverse Event|19|||
33597994|NCT02098395|62996904|FG002|Overall Study|Adverse Event|34|||
33597995|NCT02098395|62996905|FG003|Overall Study|Adverse Event|2|||
33320390|NCT01015677|62695902|FG002|Overall Study|Lack of Efficacy|0|||
33320391|NCT01015677|62695900|FG000|Overall Study|Protocol Violation|0|||
33320392|NCT01015677|62695901|FG001|Overall Study|Protocol Violation|1|||
33402842|NCT00643916|62781653|FG001|Overall Study|Protocol Violation|1|||
33402843|NCT00643916|62781654|FG002|Overall Study|Protocol Violation|1|||
33402844|NCT00643916|62781655|FG003|Overall Study|Protocol Violation|1|||
33402845|NCT00643916|62781656|FG004|Overall Study|Protocol Violation|0|||
33402846|NCT00643916|62781657|FG005|Overall Study|Protocol Violation|0|||
33402847|NCT00643916|62781652|FG000|Overall Study|Lost to Follow-up|0|||
33402848|NCT00643916|62781653|FG001|Overall Study|Lost to Follow-up|1|||
33402849|NCT00643916|62781654|FG002|Overall Study|Lost to Follow-up|0|||
33402850|NCT00643916|62781655|FG003|Overall Study|Lost to Follow-up|0|||
33402851|NCT00643916|62781656|FG004|Overall Study|Lost to Follow-up|0|||
33402852|NCT00643916|62781657|FG005|Overall Study|Lost to Follow-up|0|||
33402853|NCT00643916|62781652|FG000|Overall Study|Withdrawal by Subject|2|||
33402854|NCT00643916|62781653|FG001|Overall Study|Withdrawal by Subject|2|||
33402855|NCT00643916|62781654|FG002|Overall Study|Withdrawal by Subject|2|||
33402856|NCT00643916|62781655|FG003|Overall Study|Withdrawal by Subject|1|||
33402857|NCT00643916|62781656|FG004|Overall Study|Withdrawal by Subject|0|||
33320393|NCT01015677|62695902|FG002|Overall Study|Protocol Violation|0|||
33320394|NCT01015677|62695900|FG000|Overall Study|Withdrawal by Subject|1|||
33320395|NCT01015677|62695901|FG001|Overall Study|Withdrawal by Subject|1|||
33320396|NCT01015677|62695902|FG002|Overall Study|Withdrawal by Subject|0|||
33320397|NCT01225211|62695942|FG000|Overall Study|Adverse Event|0|||
33320398|NCT01225211|62695943|FG001|Overall Study|Adverse Event|0|||
33402858|NCT00643916|62781657|FG005|Overall Study|Withdrawal by Subject|1|||
33402859|NCT00643916|62781652|FG000|Overall Study|Not Vaccinated|2|||
33402860|NCT00643916|62781653|FG001|Overall Study|Not Vaccinated|2|||
33597996|NCT02098395|62996902|FG000|Overall Study|Lost to Follow-up|2|||
33597997|NCT02098395|62996903|FG001|Overall Study|Lost to Follow-up|1|||
33597998|NCT02098395|62996904|FG002|Overall Study|Lost to Follow-up|0|||
33402861|NCT00643916|62781654|FG002|Overall Study|Not Vaccinated|3|||
33402862|NCT00643916|62781655|FG003|Overall Study|Not Vaccinated|0|||
33320399|NCT01225211|62695944|FG002|Overall Study|Adverse Event|1|||
33320400|NCT01225211|62695945|FG003|Overall Study|Adverse Event|0|||
33320401|NCT01225211|62695946|FG004|Overall Study|Adverse Event|0|||
33320402|NCT01225211|62695947|FG005|Overall Study|Adverse Event|0|||
33320403|NCT01225211|62695948|FG006|Overall Study|Adverse Event|0|||
33402863|NCT00643916|62781656|FG004|Overall Study|Not Vaccinated|2|||
33402864|NCT00643916|62781657|FG005|Overall Study|Not Vaccinated|0|||
33402865|NCT00160693|62781671|FG000|Overall Study|Adverse Event|97|||
33402866|NCT00160693|62781671|FG000|Overall Study|Lack of Efficacy|30|||
33402867|NCT00160693|62781671|FG000|Overall Study|Protocol Violation|24|||
33402868|NCT00160693|62781671|FG000|Overall Study|Lost to Follow-up|15|||
33402869|NCT00160693|62781671|FG000|Overall Study|Withdrawal by Subject|54|||
33402870|NCT00160693|62781671|FG000|Overall Study|Study terminated by sponsor|15|||
33402871|NCT00643760|62781680|FG000|Overall Study|Adverse Event|11|||
33402872|NCT00643760|62781681|FG001|Overall Study|Adverse Event|5|||
33402873|NCT00643760|62781682|FG002|Overall Study|Adverse Event|12|||
33402874|NCT00643760|62781683|FG003|Overall Study|Adverse Event|21|||
33402875|NCT00643760|62781684|FG004|Overall Study|Adverse Event|6|||
33402876|NCT00643760|62781680|FG000|Overall Study|Lack of Efficacy|3|||
33402877|NCT00643760|62781681|FG001|Overall Study|Lack of Efficacy|1|||
33402878|NCT00643760|62781682|FG002|Overall Study|Lack of Efficacy|0|||
33402879|NCT00643760|62781683|FG003|Overall Study|Lack of Efficacy|4|||
33402880|NCT00643760|62781684|FG004|Overall Study|Lack of Efficacy|3|||
33402881|NCT00643760|62781680|FG000|Overall Study|Protocol Violation|7|||
33402882|NCT00643760|62781681|FG001|Overall Study|Protocol Violation|6|||
33320404|NCT01225211|62695949|FG007|Overall Study|Adverse Event|0|||
33320405|NCT01225211|62695950|FG008|Overall Study|Adverse Event|0|||
33320406|NCT01225211|62695951|FG009|Overall Study|Adverse Event|1|||
33320407|NCT01225211|62695942|FG000|Overall Study|Withdrawal by Subject|0|||
33320408|NCT01225211|62695943|FG001|Overall Study|Withdrawal by Subject|0|||
33320409|NCT01225211|62695944|FG002|Overall Study|Withdrawal by Subject|0|||
33320410|NCT01225211|62695945|FG003|Overall Study|Withdrawal by Subject|0|||
33320411|NCT01225211|62695946|FG004|Overall Study|Withdrawal by Subject|0|||
33320412|NCT01225211|62695947|FG005|Overall Study|Withdrawal by Subject|0|||
33320413|NCT01225211|62695948|FG006|Overall Study|Withdrawal by Subject|1|||
33320414|NCT01225211|62695949|FG007|Overall Study|Withdrawal by Subject|0|||
33320415|NCT01225211|62695950|FG008|Overall Study|Withdrawal by Subject|1|||
33320416|NCT01225211|62695951|FG009|Overall Study|Withdrawal by Subject|3|||
33320417|NCT01225211|62695942|FG000|Overall Study|Other|0|||
33320418|NCT01225211|62695943|FG001|Overall Study|Other|0|||
33402883|NCT00643760|62781682|FG002|Overall Study|Protocol Violation|4|||
33402884|NCT00643760|62781683|FG003|Overall Study|Protocol Violation|4|||
33402885|NCT00643760|62781684|FG004|Overall Study|Protocol Violation|6|||
33402886|NCT00643760|62781680|FG000|Overall Study|Lost to Follow-up|6|||
33402887|NCT00643760|62781681|FG001|Overall Study|Lost to Follow-up|2|||
33402888|NCT00643760|62781682|FG002|Overall Study|Lost to Follow-up|1|||
33402889|NCT00643760|62781683|FG003|Overall Study|Lost to Follow-up|3|||
33402890|NCT00643760|62781684|FG004|Overall Study|Lost to Follow-up|3|||
33402891|NCT00643760|62781680|FG000|Overall Study|Investigator Discretion|0|||
33320419|NCT01225211|62695944|FG002|Overall Study|Other|0|||
33402892|NCT00643760|62781681|FG001|Overall Study|Investigator Discretion|0|||
33320420|NCT01225211|62695945|FG003|Overall Study|Other|0|||
33402893|NCT00643760|62781682|FG002|Overall Study|Investigator Discretion|0|||
33402894|NCT00643760|62781683|FG003|Overall Study|Investigator Discretion|2|||
33320421|NCT01225211|62695946|FG004|Overall Study|Other|0|||
33320422|NCT01225211|62695947|FG005|Overall Study|Other|0|||
33320423|NCT01225211|62695948|FG006|Overall Study|Other|0|||
33320424|NCT01225211|62695949|FG007|Overall Study|Other|0|||
33597999|NCT02098395|62996905|FG003|Overall Study|Lost to Follow-up|3|||
33598000|NCT02098395|62996902|FG000|Overall Study|Unclassified|0|||
33598001|NCT02098395|62996903|FG001|Overall Study|Unclassified|0|||
33598002|NCT02098395|62996904|FG002|Overall Study|Unclassified|3|||
33598003|NCT02098395|62996905|FG003|Overall Study|Unclassified|2|||
33598004|NCT02041923|62996917|FG000|Overall Study|Lost to Follow-up|26|||
33598005|NCT02041923|62996918|FG001|Overall Study|Lost to Follow-up|30|||
33598006|NCT02062437|62996926|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
33598007|NCT02062437|62996926|FG000|Overall Study|Patient not available for the 2y visit|18|||
33598008|NCT02062437|62996926|FG000|Overall Study|Death|2|||
33598009|NCT02062437|62996926|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
33598010|NCT02365519|62996932|FG000|Randomized and Treated|Adverse Event|0|||
33598011|NCT02365519|62996933|FG001|Randomized and Treated|Adverse Event|1|||
33598012|NCT02365519|62996934|FG002|Randomized and Treated|Adverse Event|0|||
33598013|NCT02365519|62996932|FG000|Randomized and Treated|Withdrawal by Subject|0|||
33598014|NCT02365519|62996933|FG001|Randomized and Treated|Withdrawal by Subject|1|||
33598015|NCT02365519|62996934|FG002|Randomized and Treated|Withdrawal by Subject|1|||
33598016|NCT02061813|62996943|FG000|Overall Study|Withdrawal by Subject|1|||
33598017|NCT02061813|62996943|FG000|Overall Study|Protocol Violation|2|||
33598018|NCT02096835|62996953|FG000|Overall Study|Withdrawal by Subject|1|||
33598019|NCT02096835|62996954|FG001|Overall Study|Withdrawal by Subject|0|||
33598020|NCT02096835|62996955|FG002|Overall Study|Withdrawal by Subject|0|||
33598021|NCT02096835|62996953|FG000|Overall Study|converted to open procedures|1|||
33598022|NCT02096835|62996954|FG001|Overall Study|converted to open procedures|0|||
33598023|NCT02096835|62996955|FG002|Overall Study|converted to open procedures|0|||
33598024|NCT02096835|62996953|FG000|Overall Study|Lost to Follow-up|1|||
33402895|NCT00643760|62781684|FG004|Overall Study|Investigator Discretion|0|||
33598025|NCT02096835|62996954|FG001|Overall Study|Lost to Follow-up|0|||
33598026|NCT02096835|62996955|FG002|Overall Study|Lost to Follow-up|1|||
33598027|NCT02324569|62996965|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
33598028|NCT02324569|62996966|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
33598029|NCT02324569|62996965|FG000|Overall Study|Voluntary Withdrawal|3|||
33598030|NCT02324569|62996966|FG001|Overall Study|Voluntary Withdrawal|6|||
33598031|NCT02324569|62996965|FG000|Overall Study|Lack of Efficacy|2|||
33598032|NCT02324569|62996966|FG001|Overall Study|Lack of Efficacy|3|||
33598033|NCT02324569|62996965|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
33598034|NCT02324569|62996966|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
33598035|NCT02324569|62996965|FG000|Overall Study|Inconvenient Schedule|2|||
33598036|NCT02324569|62996966|FG001|Overall Study|Inconvenient Schedule|0|||
33598037|NCT02294773|62996974|FG000|Overall Study|Withdrawal by Subject|0|||
33598038|NCT02294773|62996975|FG001|Overall Study|Withdrawal by Subject|2|||
33598039|NCT02365285|62996985|FG000|Overall Study|Physician Decision|0|||
33598040|NCT02365285|62996986|FG001|Overall Study|Physician Decision|1|||
33320425|NCT01225211|62695950|FG008|Overall Study|Other|0|||
33320426|NCT01225211|62695951|FG009|Overall Study|Other|1|||
33320427|NCT01224821|62696034|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
33598041|NCT02365285|62996987|FG002|Overall Study|Physician Decision|1|||
33598042|NCT02365285|62996988|FG003|Overall Study|Physician Decision|0|||
33598043|NCT02365285|62996985|FG000|Overall Study|Adverse Event|0|||
33598044|NCT02365285|62996986|FG001|Overall Study|Adverse Event|0|||
33598045|NCT02365285|62996987|FG002|Overall Study|Adverse Event|0|||
33598046|NCT02365285|62996988|FG003|Overall Study|Adverse Event|2|||
33598047|NCT02041299|62997002|FG000|Overall Study|Adverse Event|9|||
33598048|NCT02041299|62997003|FG001|Overall Study|Adverse Event|3|||
33598049|NCT02041299|62997002|FG000|Overall Study|Lost to Follow-up|4|||
33598050|NCT02041299|62997003|FG001|Overall Study|Lost to Follow-up|1|||
33598051|NCT02041299|62997002|FG000|Overall Study|Physician Decision|1|||
33598052|NCT02041299|62997003|FG001|Overall Study|Physician Decision|1|||
33598053|NCT02041299|62997002|FG000|Overall Study|Withdrawal by Subject|13|||
33598054|NCT02041299|62997003|FG001|Overall Study|Withdrawal by Subject|7|||
33320428|NCT01224821|62696034|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
33598055|NCT02041299|62997002|FG000|Overall Study|Protocol Violation|11|||
33598056|NCT02041299|62997003|FG001|Overall Study|Protocol Violation|4|||
33320429|NCT01224821|62696034|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
33320430|NCT01224821|62696034|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
33320431|NCT01224821|62696034|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
33320432|NCT01224821|62696034|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
33320433|NCT01224821|62696034|FG000|Long-Term Follow-Up|Death|2|||
33320434|NCT01224821|62696034|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
33320435|NCT01224431|62696051|FG000|Overall Study|not randomized|0|||
33320436|NCT01224431|62696052|FG001|Overall Study|not randomized|4|||
33598057|NCT02041299|62997002|FG000|Overall Study|Termination of the study|7|||
33598058|NCT02041299|62997003|FG001|Overall Study|Termination of the study|3|||
33598059|NCT02041299|62997002|FG000|Overall Study|Required bone marrow transplant|0|||
33598060|NCT02041299|62997003|FG001|Overall Study|Required bone marrow transplant|1|||
33598061|NCT02041299|62997002|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
33598062|NCT02041299|62997003|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
33598063|NCT01645735|62997015|FG000|Overall Study|Physician Decision|2|||
33320437|NCT01224431|62696051|FG000|Overall Study|no video record|0|||
33320438|NCT01224431|62696052|FG001|Overall Study|no video record|1|||
33320439|NCT01223183|62696062|FG000|Imaging Day 1|Physician Decision|0|||
33320440|NCT01223183|62696063|FG001|Imaging Day 1|Physician Decision|1|||
33320441|NCT01223183|62696062|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
33320442|NCT01223183|62696063|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
33320443|NCT01223183|62696062|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
33402896|NCT00643760|62781680|FG000|Overall Study|Withdrawal by Subject|3|||
33402897|NCT00643760|62781681|FG001|Overall Study|Withdrawal by Subject|1|||
33598064|NCT01645735|62997016|FG001|Overall Study|Physician Decision|0|||
33598065|NCT01645735|62997015|FG000|Overall Study|Withdrawal by Subject|1|||
33598066|NCT01645735|62997016|FG001|Overall Study|Withdrawal by Subject|0|||
33598067|NCT01645735|62997015|FG000|Overall Study|Protocol Violation|1|||
33598068|NCT01645735|62997016|FG001|Overall Study|Protocol Violation|0|||
33598069|NCT01645735|62997015|FG000|Overall Study|Adverse Event|0|||
33598070|NCT01645735|62997016|FG001|Overall Study|Adverse Event|1|||
33598071|NCT02365207|62997023|FG000|Overall Study|Withdrawal by Subject|1|||
33598072|NCT02365207|62997023|FG000|Overall Study|Physician Decision|1|||
33598073|NCT01645111|62997027|FG000|Overall Study|Did not require Clevidipine|15|||
33598074|NCT02364037|62997033|FG000|Overall Study|Withdrawal by Subject|7|||
33598075|NCT02364037|62997034|FG001|Overall Study|Withdrawal by Subject|4|||
33598076|NCT02364037|62997033|FG000|Overall Study|Lost to Follow-up|37|||
33598077|NCT02364037|62997034|FG001|Overall Study|Lost to Follow-up|49|||
33598078|NCT01919164|62997045|FG000|Overall Study|Adverse Event|6|||
33598079|NCT01919164|62997046|FG001|Overall Study|Adverse Event|4|||
33598080|NCT01919164|62997047|FG002|Overall Study|Adverse Event|9|||
33598081|NCT01919164|62997048|FG003|Overall Study|Adverse Event|3|||
33598082|NCT01919164|62997049|FG004|Overall Study|Adverse Event|2|||
33598083|NCT01919164|62997045|FG000|Overall Study|Lost to Follow-up|2|||
33598084|NCT01919164|62997046|FG001|Overall Study|Lost to Follow-up|2|||
33598085|NCT01919164|62997047|FG002|Overall Study|Lost to Follow-up|2|||
33598086|NCT01919164|62997048|FG003|Overall Study|Lost to Follow-up|0|||
33598087|NCT01919164|62997049|FG004|Overall Study|Lost to Follow-up|4|||
33598088|NCT01919164|62997045|FG000|Overall Study|Death|1|||
33598089|NCT01919164|62997046|FG001|Overall Study|Death|0|||
33598090|NCT01919164|62997047|FG002|Overall Study|Death|0|||
33598091|NCT01919164|62997048|FG003|Overall Study|Death|0|||
33598092|NCT01919164|62997049|FG004|Overall Study|Death|0|||
33598093|NCT01919164|62997045|FG000|Overall Study|Protocol Violation|6|||
33598094|NCT01919164|62997046|FG001|Overall Study|Protocol Violation|0|||
33598095|NCT01919164|62997047|FG002|Overall Study|Protocol Violation|3|||
33598096|NCT01919164|62997048|FG003|Overall Study|Protocol Violation|2|||
33598097|NCT01919164|62997049|FG004|Overall Study|Protocol Violation|2|||
33598098|NCT01919164|62997045|FG000|Overall Study|Disease progression|2|||
33598099|NCT01919164|62997046|FG001|Overall Study|Disease progression|2|||
33598100|NCT01919164|62997047|FG002|Overall Study|Disease progression|1|||
33598101|NCT01919164|62997048|FG003|Overall Study|Disease progression|2|||
33598102|NCT01919164|62997049|FG004|Overall Study|Disease progression|1|||
33598103|NCT01919164|62997045|FG000|Overall Study|Withdrew consent|13|||
33598104|NCT01919164|62997046|FG001|Overall Study|Withdrew consent|13|||
33598105|NCT01919164|62997047|FG002|Overall Study|Withdrew consent|14|||
33598106|NCT01919164|62997048|FG003|Overall Study|Withdrew consent|14|||
33598107|NCT01919164|62997049|FG004|Overall Study|Withdrew consent|9|||
33598108|NCT01919164|62997045|FG000|Overall Study|Other Un-specified|13|||
33598109|NCT01919164|62997046|FG001|Overall Study|Other Un-specified|9|||
33598110|NCT01919164|62997047|FG002|Overall Study|Other Un-specified|8|||
33598111|NCT01919164|62997048|FG003|Overall Study|Other Un-specified|7|||
33598112|NCT01919164|62997049|FG004|Overall Study|Other Un-specified|15|||
33598113|NCT01901224|62997061|FG000|Overall Study|study was not funded and terminated|2|||
33598114|NCT01901146|62997067|FG000|Neoadjuvant Phase|Death|1|||
33598115|NCT01901146|62997068|FG001|Neoadjuvant Phase|Death|2|||
33598116|NCT01901146|62997069|FG002|Neoadjuvant Phase|Death|0|||
33598117|NCT01901146|62997070|FG003|Neoadjuvant Phase|Death|0|||
33598118|NCT01901146|62997071|FG004|Neoadjuvant Phase|Death|0|||
33598119|NCT01901146|62997067|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
33598120|NCT01901146|62997068|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
33598121|NCT01901146|62997069|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
33598122|NCT01901146|62997070|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
33598123|NCT01901146|62997071|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
33598124|NCT01901146|62997067|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
33598125|NCT01901146|62997068|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
33598126|NCT01901146|62997069|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
33598127|NCT01901146|62997070|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
33598128|NCT01901146|62997071|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
33598129|NCT01901146|62997067|FG000|Neoadjuvant Phase|Physician Decision|1|||
33598130|NCT01901146|62997068|FG001|Neoadjuvant Phase|Physician Decision|2|||
33598131|NCT01901146|62997069|FG002|Neoadjuvant Phase|Physician Decision|0|||
33598132|NCT01901146|62997070|FG003|Neoadjuvant Phase|Physician Decision|0|||
33598133|NCT01901146|62997071|FG004|Neoadjuvant Phase|Physician Decision|0|||
33598134|NCT01901146|62997067|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
33598135|NCT01901146|62997068|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
33598136|NCT01901146|62997069|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
33598137|NCT01901146|62997070|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
33598138|NCT01901146|62997071|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
33598139|NCT01901146|62997067|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
33598140|NCT01901146|62997068|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
33598141|NCT01901146|62997069|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
33598142|NCT01901146|62997070|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
33598143|NCT01901146|62997071|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
33598144|NCT01901146|62997067|FG000|Adjuvant Phase|Other|0|||
33598145|NCT01901146|62997068|FG001|Adjuvant Phase|Other|0|||
33598146|NCT01901146|62997069|FG002|Adjuvant Phase|Other|1|||
33598147|NCT01901146|62997070|FG003|Adjuvant Phase|Other|0|||
33598148|NCT01901146|62997071|FG004|Adjuvant Phase|Other|0|||
33598149|NCT01901146|62997067|FG000|Adjuvant Phase|Death|0|||
33598150|NCT01901146|62997068|FG001|Adjuvant Phase|Death|0|||
33598151|NCT01901146|62997069|FG002|Adjuvant Phase|Death|0|||
33598152|NCT01901146|62997070|FG003|Adjuvant Phase|Death|0|||
33598153|NCT01901146|62997071|FG004|Adjuvant Phase|Death|3|||
33598154|NCT01901146|62997067|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
33598155|NCT01901146|62997068|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
33598156|NCT01901146|62997069|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
33598157|NCT01901146|62997070|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
33598158|NCT01901146|62997071|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
33598159|NCT01901146|62997067|FG000|Adjuvant Phase|Physician Decision|0|||
33598160|NCT01901146|62997068|FG001|Adjuvant Phase|Physician Decision|0|||
33598161|NCT01901146|62997069|FG002|Adjuvant Phase|Physician Decision|9|||
33320444|NCT01223183|62696063|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
33320445|NCT01223027|62696072|FG000|Overall Study|Adverse Event|20|||
33320446|NCT01223027|62696073|FG001|Overall Study|Adverse Event|10|||
33320447|NCT01223027|62696072|FG000|Overall Study|Death|42|||
33320448|NCT01223027|62696073|FG001|Overall Study|Death|42|||
33320449|NCT01223027|62696072|FG000|Overall Study|Lost to Follow-up|2|||
33320450|NCT01223027|62696073|FG001|Overall Study|Lost to Follow-up|1|||
33320451|NCT01223027|62696072|FG000|Overall Study|Physician Decision|4|||
33598162|NCT01901146|62997070|FG003|Adjuvant Phase|Physician Decision|2|||
33598163|NCT01901146|62997071|FG004|Adjuvant Phase|Physician Decision|4|||
33598164|NCT01901146|62997067|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
33598165|NCT01901146|62997068|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
33598166|NCT01901146|62997069|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
33598167|NCT01901146|62997070|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
33598168|NCT01901146|62997071|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
33598169|NCT01644643|62997084|FG000|Overall Study|Death|1|||
33598170|NCT01644643|62997085|FG001|Overall Study|Death|0|||
33598171|NCT01644643|62997086|FG002|Overall Study|Death|3|||
33598172|NCT01644643|62997087|FG003|Overall Study|Death|3|||
33598173|NCT01644643|62997084|FG000|Overall Study|Lost to Follow-up|0|||
33598174|NCT01644643|62997085|FG001|Overall Study|Lost to Follow-up|0|||
33598175|NCT01644643|62997086|FG002|Overall Study|Lost to Follow-up|0|||
33598176|NCT01644643|62997087|FG003|Overall Study|Lost to Follow-up|4|||
33598177|NCT01644643|62997084|FG000|Overall Study|Withdrawal by Subject|1|||
33598178|NCT01644643|62997085|FG001|Overall Study|Withdrawal by Subject|0|||
33598179|NCT01644643|62997086|FG002|Overall Study|Withdrawal by Subject|2|||
33598180|NCT01644643|62997087|FG003|Overall Study|Withdrawal by Subject|1|||
33598181|NCT01644643|62997084|FG000|Overall Study|Other Eligibility criteria|0|||
33598182|NCT01644643|62997085|FG001|Overall Study|Other Eligibility criteria|0|||
33598183|NCT01644643|62997086|FG002|Overall Study|Other Eligibility criteria|0|||
33598184|NCT01644643|62997087|FG003|Overall Study|Other Eligibility criteria|2|||
33598185|NCT01864564|62997105|FG000|Overall Study|Lost to Follow-up|17|||
33598186|NCT01864564|62997106|FG001|Overall Study|Lost to Follow-up|23|||
33598187|NCT01864564|62997105|FG000|Overall Study|Withdrawal by Subject|20|||
33598188|NCT01864564|62997106|FG001|Overall Study|Withdrawal by Subject|11|||
33598189|NCT01864564|62997105|FG000|Overall Study|Protocol Violation|0|||
33598190|NCT01864564|62997106|FG001|Overall Study|Protocol Violation|27|||
33598191|NCT01864564|62997105|FG000|Overall Study|not reported|0|||
33598192|NCT01864564|62997106|FG001|Overall Study|not reported|34|||
33598193|NCT01864174|62997114|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
33598194|NCT01864174|62997115|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
33598195|NCT01864174|62997114|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
33598196|NCT01864174|62997115|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
33598197|NCT01864174|62997114|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
33598198|NCT01864174|62997115|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
33598199|NCT01864174|62997114|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
33598200|NCT01864174|62997115|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
33598201|NCT01864174|62997114|FG000|Double Blind - Compliant Randomized|Death|1|||
33598202|NCT01864174|62997115|FG001|Double Blind - Compliant Randomized|Death|0|||
33598203|NCT01864174|62997114|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
33598204|NCT01864174|62997115|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
33598205|NCT01864174|62997114|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
33598206|NCT01864174|62997115|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
33598207|NCT01864174|62997114|FG000|Double Blind - Compliant Randomized|Other|6|||
33598208|NCT01864174|62997115|FG001|Double Blind - Compliant Randomized|Other|10|||
33598209|NCT01864174|62997114|FG000|Off Treatment Follow-Up|Other|2|||
33598210|NCT01864174|62997115|FG001|Off Treatment Follow-Up|Other|0|||
33598211|NCT01864174|62997114|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
33598212|NCT01864174|62997115|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
33598213|NCT01900444|62997121|FG000|Overall Study|Protocol Violation|2|||
33598214|NCT01900444|62997121|FG000|Overall Study|Lost to Follow-up|1|||
33598215|NCT02294227|62997128|FG000|Overall Study|Death|0|||
33598216|NCT02294227|62997129|FG001|Overall Study|Death|0|||
33598217|NCT02294227|62997130|FG002|Overall Study|Death|1|||
33320452|NCT01223027|62696073|FG001|Overall Study|Physician Decision|8|||
33320453|NCT01223027|62696072|FG000|Overall Study|Progressive Disease|167|||
33320454|NCT01223027|62696073|FG001|Overall Study|Progressive Disease|183|||
33320455|NCT01223027|62696072|FG000|Overall Study|Protocol Violation|2|||
33598218|NCT02294227|62997128|FG000|Overall Study|Subject/Guardian Decision|6|||
33598219|NCT02294227|62997129|FG001|Overall Study|Subject/Guardian Decision|3|||
33598220|NCT02294227|62997130|FG002|Overall Study|Subject/Guardian Decision|7|||
33598221|NCT02294227|62997128|FG000|Overall Study|Physician Decision|1|||
33598222|NCT02294227|62997129|FG001|Overall Study|Physician Decision|2|||
33598223|NCT02294227|62997130|FG002|Overall Study|Physician Decision|1|||
33402898|NCT00643760|62781682|FG002|Overall Study|Withdrawal by Subject|2|||
33402899|NCT00643760|62781683|FG003|Overall Study|Withdrawal by Subject|4|||
33402900|NCT00643760|62781684|FG004|Overall Study|Withdrawal by Subject|1|||
33402901|NCT00643682|62781698|FG000|Overall Study|did not keep appointment|522|||
33402902|NCT00643682|62781699|FG001|Overall Study|did not keep appointment|509|||
33402903|NCT00643604|62781705|FG000|Overall Study|Death|1|||
33402904|NCT00603798|62781712|FG000|Overall Study|Adverse Event|4|||
33402905|NCT00603798|62781713|FG001|Overall Study|Adverse Event|2|||
33402906|NCT00603798|62781714|FG002|Overall Study|Adverse Event|1|||
33402907|NCT00603798|62781712|FG000|Overall Study|Withdrawal by Subject|4|||
33402908|NCT00603798|62781713|FG001|Overall Study|Withdrawal by Subject|3|||
33402909|NCT00603798|62781714|FG002|Overall Study|Withdrawal by Subject|4|||
33402910|NCT00603798|62781712|FG000|Overall Study|Lost to Follow-up|1|||
33402911|NCT00603798|62781713|FG001|Overall Study|Lost to Follow-up|0|||
33320456|NCT01223027|62696073|FG001|Overall Study|Protocol Violation|1|||
33320457|NCT01223027|62696072|FG000|Overall Study|Subject/guardian decicion|18|||
33320458|NCT01223027|62696073|FG001|Overall Study|Subject/guardian decicion|16|||
33320459|NCT01223027|62696072|FG000|Overall Study|New therapy for study indication|17|||
33320460|NCT01223027|62696073|FG001|Overall Study|New therapy for study indication|8|||
33320461|NCT01223027|62696072|FG000|Overall Study|Study terminated by sponsor|2|||
33320462|NCT01223027|62696073|FG001|Overall Study|Study terminated by sponsor|8|||
33320463|NCT01015287|62696081|FG000|Overall Study|Death|21|||
33320464|NCT01015287|62696082|FG001|Overall Study|Death|16|||
33320465|NCT01015287|62696081|FG000|Overall Study|Adverse Event|1|||
33320466|NCT01015287|62696082|FG001|Overall Study|Adverse Event|0|||
33320467|NCT01015287|62696081|FG000|Overall Study|Sponsor Decision|3|||
33320468|NCT01015287|62696082|FG001|Overall Study|Sponsor Decision|7|||
33320469|NCT01015287|62696081|FG000|Overall Study|Physician Decision|19|||
33320470|NCT01015287|62696082|FG001|Overall Study|Physician Decision|21|||
33320471|NCT01015287|62696081|FG000|Overall Study|Withdrawal by Subject|14|||
33320472|NCT01015287|62696082|FG001|Overall Study|Withdrawal by Subject|19|||
33320473|NCT01015287|62696081|FG000|Overall Study|Entry Criteria not Met|11|||
33320474|NCT01015287|62696082|FG001|Overall Study|Entry Criteria not Met|14|||
33320475|NCT01015287|62696081|FG000|Overall Study|Lost to Follow-up|2|||
33320476|NCT01015287|62696082|FG001|Overall Study|Lost to Follow-up|1|||
33320477|NCT01015287|62696081|FG000|Overall Study|Protocol Violation|1|||
33320478|NCT01015287|62696082|FG001|Overall Study|Protocol Violation|1|||
33320479|NCT01015131|62696090|FG000|Overall Study|Physician Decision|1|||
33320480|NCT01015131|62696090|FG000|Overall Study|Protocol Violation|1|||
33320481|NCT01015131|62696090|FG000|Overall Study|Withdrawal by Subject|2|||
33320482|NCT01015131|62696090|FG000|Overall Study|Other Protocol Specified Criteria|4|||
33402912|NCT00603798|62781714|FG002|Overall Study|Lost to Follow-up|1|||
33402913|NCT00603798|62781712|FG000|Overall Study|Non-compliance with study procedures|0|||
33320483|NCT01222715|62696096|FG000|Overall Study|Adverse Event|0|||
33320484|NCT01222715|62696097|FG001|Overall Study|Adverse Event|4|||
33320485|NCT01222715|62696096|FG000|Overall Study|Death|0|||
33320486|NCT01222715|62696097|FG001|Overall Study|Death|1|||
33320487|NCT01222715|62696096|FG000|Overall Study|Lack of Efficacy|22|||
33402914|NCT00603798|62781713|FG001|Overall Study|Non-compliance with study procedures|1|||
33402915|NCT00603798|62781714|FG002|Overall Study|Non-compliance with study procedures|0|||
33402916|NCT00603798|62781712|FG000|Overall Study|Not due to AE|1|||
33320488|NCT01222715|62696097|FG001|Overall Study|Lack of Efficacy|14|||
33320489|NCT01222715|62696096|FG000|Overall Study|Physician Decision|12|||
33320490|NCT01222715|62696097|FG001|Overall Study|Physician Decision|2|||
33320491|NCT01222715|62696096|FG000|Overall Study|Refusal of further protocol therapy|0|||
33320492|NCT01222715|62696097|FG001|Overall Study|Refusal of further protocol therapy|4|||
33320493|NCT01222715|62696096|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
33320494|NCT01222715|62696097|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
33320495|NCT01222715|62696096|FG000|Overall Study|Ineligible|0|||
33320496|NCT01222715|62696097|FG001|Overall Study|Ineligible|1|||
33320497|NCT01222715|62696096|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
33320498|NCT01222715|62696097|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
33320499|NCT01222403|62696105|FG000|Overall Study|Inappropriate enrollment|0|||
33320500|NCT01222403|62696106|FG001|Overall Study|Inappropriate enrollment|2|||
33320501|NCT01222247|62696114|FG000|Overall Study|Lost to Follow-up|2|||
33320502|NCT01222247|62696115|FG001|Overall Study|Lost to Follow-up|2|||
33320503|NCT01014975|62696121|FG000|Overall Study|Withdrawal by Subject|1|||
33320504|NCT01014975|62696122|FG001|Overall Study|Withdrawal by Subject|0|||
33320505|NCT01014975|62696123|FG002|Overall Study|Withdrawal by Subject|1|||
33320506|NCT01014975|62696121|FG000|Overall Study|Death|3|||
33320507|NCT01014975|62696122|FG001|Overall Study|Death|3|||
33320508|NCT01014975|62696123|FG002|Overall Study|Death|4|||
33320509|NCT01014975|62696121|FG000|Overall Study|Lost to Follow-up|0|||
33320510|NCT01014975|62696122|FG001|Overall Study|Lost to Follow-up|0|||
33320511|NCT01014975|62696123|FG002|Overall Study|Lost to Follow-up|1|||
33320512|NCT01221623|62696133|FG000|Overall Study|Withdrawal by Subject|19|||
33402917|NCT00603798|62781713|FG001|Overall Study|Not due to AE|1|||
33320513|NCT01221623|62696134|FG001|Overall Study|Withdrawal by Subject|8|||
33320514|NCT01221623|62696133|FG000|Overall Study|Lost to Follow-up|7|||
33320515|NCT01221623|62696134|FG001|Overall Study|Lost to Follow-up|1|||
33402918|NCT00603798|62781714|FG002|Overall Study|Not due to AE|4|||
33402919|NCT00630812|62781724|FG000|Randomisation to First Dose|Adverse Event|1|||
33402920|NCT00630812|62781725|FG001|Randomisation to First Dose|Adverse Event|1|||
33402921|NCT00630812|62781724|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
33402922|NCT00630812|62781725|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
33402923|NCT00630812|62781724|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
33402924|NCT00630812|62781725|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
33402925|NCT00630812|62781724|FG000|Randomisation to First Dose|Protocol Violation|4|||
33402926|NCT00630812|62781725|FG001|Randomisation to First Dose|Protocol Violation|1|||
33402927|NCT00630812|62781724|FG000|Double Blind Treatment Period|Adverse Event|13|||
33402928|NCT00630812|62781725|FG001|Double Blind Treatment Period|Adverse Event|5|||
33402929|NCT00630812|62781724|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
33402930|NCT00630812|62781725|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
33402931|NCT00630812|62781724|FG000|Double Blind Treatment Period|Physician Decision|2|||
33402932|NCT00630812|62781725|FG001|Double Blind Treatment Period|Physician Decision|1|||
33402933|NCT00630812|62781724|FG000|Double Blind Treatment Period|Protocol Violation|1|||
33402934|NCT00630812|62781725|FG001|Double Blind Treatment Period|Protocol Violation|0|||
33402935|NCT00630812|62781724|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
33402936|NCT00630812|62781725|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
33402937|NCT00630812|62781724|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
33402938|NCT00630812|62781725|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
33402939|NCT00630812|62781724|FG000|Double Blind Treatment Period|Non-compliance|0|||
33402940|NCT00630812|62781725|FG001|Double Blind Treatment Period|Non-compliance|1|||
33402941|NCT00629798|62781731|FG000|Overall Study|Not Treated|4|||
33402942|NCT00160615|62781737|FG000|Overall Study|Adverse Event|5|||
33402943|NCT00160615|62781738|FG001|Overall Study|Adverse Event|12|||
33402944|NCT00160615|62781737|FG000|Overall Study|Withdrawal by Subject|0|||
33402945|NCT00160615|62781738|FG001|Overall Study|Withdrawal by Subject|2|||
33402946|NCT00160615|62781737|FG000|Overall Study|Lack of Efficacy|11|||
33402947|NCT00160615|62781738|FG001|Overall Study|Lack of Efficacy|23|||
33402948|NCT00160615|62781737|FG000|Overall Study|Patient decision|1|||
33402949|NCT00160615|62781738|FG001|Overall Study|Patient decision|2|||
33402950|NCT00160615|62781737|FG000|Overall Study|Investigator decision|1|||
33402951|NCT00160615|62781738|FG001|Overall Study|Investigator decision|1|||
33402952|NCT00160615|62781737|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
33402953|NCT00160615|62781738|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
33402954|NCT00160615|62781737|FG000|Overall Study|Switch to surgical treatment|0|||
33402955|NCT00160615|62781738|FG001|Overall Study|Switch to surgical treatment|2|||
33402956|NCT00160615|62781737|FG000|Overall Study|Non-compliance was suspected|0|||
33320516|NCT01221623|62696133|FG000|Overall Study|Adverse Event|6|||
33320517|NCT01221623|62696134|FG001|Overall Study|Adverse Event|3|||
33402957|NCT00160615|62781738|FG001|Overall Study|Non-compliance was suspected|1|||
33402958|NCT00160615|62781737|FG000|Overall Study|Poor compliance|0|||
33402959|NCT00160615|62781738|FG001|Overall Study|Poor compliance|1|||
33402960|NCT00643448|62781749|FG000|Overall Study|Lack of Efficacy|2|||
33402961|NCT00643448|62781750|FG001|Overall Study|Lack of Efficacy|0|||
33402962|NCT00643448|62781751|FG002|Overall Study|Lack of Efficacy|4|||
33402963|NCT00643448|62781749|FG000|Overall Study|Adverse Event|2|||
33402964|NCT00643448|62781750|FG001|Overall Study|Adverse Event|2|||
33320518|NCT01221623|62696133|FG000|Overall Study|Death|1|||
33320519|NCT01221623|62696134|FG001|Overall Study|Death|0|||
33320520|NCT01221623|62696133|FG000|Overall Study|Other|5|||
33320521|NCT01221623|62696134|FG001|Overall Study|Other|2|||
33320522|NCT01014585|62696144|FG000|Overall Study|Adverse Event|0|||
33320523|NCT01014585|62696145|FG001|Overall Study|Adverse Event|2|||
33402965|NCT00643448|62781751|FG002|Overall Study|Adverse Event|2|||
33320524|NCT01014585|62696146|FG002|Overall Study|Adverse Event|0|||
33320525|NCT01014585|62696147|FG003|Overall Study|Adverse Event|3|||
33402966|NCT00643448|62781749|FG000|Overall Study|QTcF>550 ms|0|||
33598224|NCT02294227|62997128|FG000|Overall Study|Lost to Follow-up|1|||
33598225|NCT02294227|62997129|FG001|Overall Study|Lost to Follow-up|0|||
33598226|NCT02294227|62997130|FG002|Overall Study|Lost to Follow-up|0|||
33598227|NCT02294227|62997128|FG000|Overall Study|Lack of Efficacy|11|||
33598228|NCT02294227|62997129|FG001|Overall Study|Lack of Efficacy|12|||
33598229|NCT02294227|62997130|FG002|Overall Study|Lack of Efficacy|8|||
33598230|NCT02294227|62997128|FG000|Overall Study|Adverse Event|6|||
33598231|NCT02294227|62997129|FG001|Overall Study|Adverse Event|8|||
33598232|NCT02294227|62997130|FG002|Overall Study|Adverse Event|2|||
33598233|NCT02496767|62997144|FG000|Open-label Lead-in Phase|Adverse Event|176|||
33598234|NCT02496767|62997145|FG001|Open-label Lead-in Phase|Adverse Event|0|||
33320526|NCT01014585|62696144|FG000|Overall Study|Withdrawal by Subject|2|||
33320527|NCT01014585|62696145|FG001|Overall Study|Withdrawal by Subject|0|||
33320528|NCT01014585|62696146|FG002|Overall Study|Withdrawal by Subject|1|||
33320529|NCT01014585|62696147|FG003|Overall Study|Withdrawal by Subject|3|||
33320530|NCT01014585|62696144|FG000|Overall Study|Lost to Follow-up|0|||
33320531|NCT01014585|62696145|FG001|Overall Study|Lost to Follow-up|0|||
33320532|NCT01014585|62696146|FG002|Overall Study|Lost to Follow-up|0|||
33320533|NCT01014585|62696147|FG003|Overall Study|Lost to Follow-up|2|||
33320534|NCT01014585|62696144|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
33320535|NCT01014585|62696145|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
33320536|NCT01014585|62696146|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
33320537|NCT01014585|62696147|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
33320538|NCT01221233|62696159|FG000|Overall Study|Withdrawal by Subject|3|||
33598235|NCT02496767|62997146|FG002|Open-label Lead-in Phase|Adverse Event|0|||
33598236|NCT02496767|62997147|FG003|Open-label Lead-in Phase|Adverse Event|0|||
33402967|NCT00643448|62781750|FG001|Overall Study|QTcF>550 ms|3|||
33402968|NCT00643448|62781751|FG002|Overall Study|QTcF>550 ms|0|||
33402969|NCT00604500|62781761|FG000|Overall Study|Adverse Event|2|||
33402970|NCT00604500|62781761|FG000|Overall Study|Protocol Violation|2|||
33402971|NCT00604500|62781761|FG000|Overall Study|Treatment Failure|1|||
33402972|NCT00604500|62781761|FG000|Overall Study|Withdrawal by Subject|4|||
33402973|NCT00604500|62781761|FG000|Overall Study|Administrative|1|||
33402974|NCT00604500|62781761|FG000|Overall Study|Did not meet protocol eligibility|1|||
33402975|NCT00627458|62781768|FG000|Overall Study|Migrated from study area|1|||
33402976|NCT00627458|62781769|FG001|Overall Study|Migrated from study area|0|||
33402977|NCT00627458|62781770|FG002|Overall Study|Migrated from study area|1|||
33402978|NCT00627458|62781768|FG000|Overall Study|Withdrawal by Subject|2|||
33402979|NCT00627458|62781769|FG001|Overall Study|Withdrawal by Subject|6|||
33402980|NCT00627458|62781770|FG002|Overall Study|Withdrawal by Subject|5|||
33402981|NCT00627458|62781768|FG000|Overall Study|Lost to Follow-up|1|||
33402982|NCT00627458|62781769|FG001|Overall Study|Lost to Follow-up|1|||
33402983|NCT00627458|62781770|FG002|Overall Study|Lost to Follow-up|0|||
33402984|NCT00542919|62781782|FG000|Overall Study|Adverse Event|1|||
33402985|NCT00542919|62781783|FG001|Overall Study|Adverse Event|5|||
33402986|NCT00542919|62781784|FG002|Overall Study|Adverse Event|1|||
33402987|NCT00542919|62781782|FG000|Overall Study|Withdrawal by Subject|1|||
33402988|NCT00542919|62781783|FG001|Overall Study|Withdrawal by Subject|0|||
33402989|NCT00542919|62781784|FG002|Overall Study|Withdrawal by Subject|3|||
33402990|NCT00542919|62781782|FG000|Overall Study|Physician Decision|2|||
33402991|NCT00542919|62781783|FG001|Overall Study|Physician Decision|2|||
33402992|NCT00542919|62781784|FG002|Overall Study|Physician Decision|1|||
33320539|NCT01221233|62696160|FG001|Overall Study|Withdrawal by Subject|1|||
33320540|NCT01220609|62696166|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
33320541|NCT01220609|62696166|FG000|Overall Study|Ineligible- Wrong cell type|1|||
33320542|NCT01220609|62696166|FG000|Overall Study|Ineligible-Never treated|1|||
33320543|NCT01220297|62696178|FG000|Overall Study|Death|2|||
33320544|NCT01220297|62696178|FG000|Overall Study|Lost to Follow-up|1|||
33320545|NCT01219985|62696184|FG000|Overall Study|Physician Decision|20|||
33320546|NCT01218659|62696192|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
33320547|NCT01218659|62696193|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
33320548|NCT01218659|62696194|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
33320549|NCT01218659|62696192|FG000|18-Month Randomized Period|Did not receive study drug|0|||
33320550|NCT01218659|62696193|FG001|18-Month Randomized Period|Did not receive study drug|3|||
33320551|NCT01218659|62696194|FG002|18-Month Randomized Period|Did not receive study drug|0|||
33320552|NCT01218659|62696192|FG000|12-Month OLE|Withdrawal by Subject|0|||
33320553|NCT01218659|62696193|FG001|12-Month OLE|Withdrawal by Subject|0|||
33320554|NCT01218659|62696194|FG002|12-Month OLE|Withdrawal by Subject|2|||
33320555|NCT01218659|62696192|FG000|12-Month OLE|Physician Decision|0|||
33320556|NCT01218659|62696193|FG001|12-Month OLE|Physician Decision|0|||
33320557|NCT01218659|62696194|FG002|12-Month OLE|Physician Decision|1|||
33320558|NCT01218659|62696192|FG000|12-Month OLE|Lost to Follow-up|0|||
33320559|NCT01218659|62696193|FG001|12-Month OLE|Lost to Follow-up|0|||
33320560|NCT01218659|62696194|FG002|12-Month OLE|Lost to Follow-up|1|||
33320561|NCT01218659|62696192|FG000|12-Month OLE|Pregnancy|0|||
33320562|NCT01218659|62696193|FG001|12-Month OLE|Pregnancy|0|||
33402993|NCT00542919|62781782|FG000|Overall Study|Sponsor Decision|1|||
33402994|NCT00542919|62781783|FG001|Overall Study|Sponsor Decision|0|||
33402995|NCT00542919|62781784|FG002|Overall Study|Sponsor Decision|0|||
33402996|NCT00542919|62781782|FG000|Overall Study|Lost to Follow-up|2|||
33402997|NCT00542919|62781783|FG001|Overall Study|Lost to Follow-up|0|||
33402998|NCT00542919|62781784|FG002|Overall Study|Lost to Follow-up|1|||
33320563|NCT01218659|62696194|FG002|12-Month OLE|Pregnancy|1|||
33320564|NCT01218659|62696192|FG000|12-Month OLE|Lack of Efficacy|0|||
33320565|NCT01218659|62696193|FG001|12-Month OLE|Lack of Efficacy|0|||
33320566|NCT01218659|62696194|FG002|12-Month OLE|Lack of Efficacy|1|||
33402999|NCT00159913|62781811|FG000|Overall Study|Adverse Event|1|||
33403000|NCT00159913|62781812|FG001|Overall Study|Adverse Event|0|||
33403001|NCT00159913|62781813|FG002|Overall Study|Adverse Event|1|||
33403002|NCT00159913|62781814|FG003|Overall Study|Adverse Event|0|||
33403003|NCT00159913|62781811|FG000|Overall Study|Withdrawal by Subject|0|||
33403004|NCT00159913|62781812|FG001|Overall Study|Withdrawal by Subject|0|||
33403005|NCT00159913|62781813|FG002|Overall Study|Withdrawal by Subject|0|||
33403006|NCT00159913|62781814|FG003|Overall Study|Withdrawal by Subject|1|||
33403007|NCT00159913|62781811|FG000|Overall Study|Lost to Follow-up|0|||
33403008|NCT00159913|62781812|FG001|Overall Study|Lost to Follow-up|0|||
33403009|NCT00159913|62781813|FG002|Overall Study|Lost to Follow-up|0|||
33320567|NCT01218659|62696192|FG000|12-Month OLE|Declined to participate in the OLE|0|||
33320568|NCT01218659|62696193|FG001|12-Month OLE|Declined to participate in the OLE|0|||
33320569|NCT01218659|62696194|FG002|12-Month OLE|Declined to participate in the OLE|4|||
33320570|NCT00940498|62696209|FG000|Overall Study|Death|2|||
33320571|NCT00940498|62696210|FG001|Overall Study|Death|0|||
33320572|NCT00940498|62696211|FG002|Overall Study|Death|0|||
33320573|NCT00940498|62696212|FG003|Overall Study|Death|1|||
33320574|NCT00940498|62696213|FG004|Overall Study|Death|5|||
33320575|NCT00940498|62696214|FG005|Overall Study|Death|0|||
33320576|NCT00940498|62696215|FG006|Overall Study|Death|1|||
33320577|NCT00940498|62696216|FG007|Overall Study|Death|0|||
33320578|NCT00940498|62696209|FG000|Overall Study|Lost to Follow-up|1|||
33320579|NCT00940498|62696210|FG001|Overall Study|Lost to Follow-up|1|||
33320580|NCT00940498|62696211|FG002|Overall Study|Lost to Follow-up|2|||
33320581|NCT00940498|62696212|FG003|Overall Study|Lost to Follow-up|0|||
33403010|NCT00159913|62781814|FG003|Overall Study|Lost to Follow-up|1|||
33403011|NCT00159913|62781811|FG000|Overall Study|Protocol Violation|1|||
33403012|NCT00159913|62781812|FG001|Overall Study|Protocol Violation|0|||
33320582|NCT00940498|62696213|FG004|Overall Study|Lost to Follow-up|1|||
33403013|NCT00159913|62781813|FG002|Overall Study|Protocol Violation|1|||
33320583|NCT00940498|62696214|FG005|Overall Study|Lost to Follow-up|0|||
33320584|NCT00940498|62696215|FG006|Overall Study|Lost to Follow-up|0|||
33598237|NCT02496767|62997148|FG004|Open-label Lead-in Phase|Adverse Event|0|||
33598238|NCT02496767|62997149|FG005|Open-label Lead-in Phase|Adverse Event|0|||
33598239|NCT02496767|62997150|FG006|Open-label Lead-in Phase|Adverse Event|0|||
33598240|NCT02496767|62997151|FG007|Open-label Lead-in Phase|Adverse Event|0|||
33598241|NCT02496767|62997144|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
33598242|NCT02496767|62997145|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
33598243|NCT02496767|62997146|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
33598244|NCT02496767|62997147|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
33598245|NCT02496767|62997148|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
33598246|NCT02496767|62997149|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
33598247|NCT02496767|62997150|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
33598248|NCT02496767|62997151|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
33598249|NCT02496767|62997144|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
33598250|NCT02496767|62997145|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
33598251|NCT02496767|62997146|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
33598252|NCT02496767|62997147|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
33598253|NCT02496767|62997148|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
33598254|NCT02496767|62997149|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
33598255|NCT02496767|62997150|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
33598256|NCT02496767|62997151|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
33598257|NCT02496767|62997144|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
33598258|NCT02496767|62997145|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
33598259|NCT02496767|62997146|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
33598260|NCT02496767|62997147|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
33598261|NCT02496767|62997148|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
33598262|NCT02496767|62997149|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
33598263|NCT02496767|62997150|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
33598264|NCT02496767|62997151|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
33598265|NCT02496767|62997144|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
33598266|NCT02496767|62997145|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
33598267|NCT02496767|62997146|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
33598268|NCT02496767|62997147|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
33598269|NCT02496767|62997148|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
33598270|NCT02496767|62997149|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
33598271|NCT02496767|62997150|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
33598272|NCT02496767|62997151|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
33598273|NCT02496767|62997144|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
33598274|NCT02496767|62997145|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
33598275|NCT02496767|62997146|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
33598276|NCT02496767|62997147|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
33598277|NCT02496767|62997148|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
33598278|NCT02496767|62997149|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
33598279|NCT02496767|62997150|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
33598280|NCT02496767|62997151|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
33598281|NCT02496767|62997144|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
33598282|NCT02496767|62997145|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
33598283|NCT02496767|62997146|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
33598284|NCT02496767|62997147|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
33598285|NCT02496767|62997148|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
33598286|NCT02496767|62997149|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
33598287|NCT02496767|62997150|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
33598288|NCT02496767|62997151|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
33598289|NCT02496767|62997144|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33598290|NCT02496767|62997145|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
33598291|NCT02496767|62997146|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
33598292|NCT02496767|62997147|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
33598293|NCT02496767|62997148|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
33598294|NCT02496767|62997149|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33598295|NCT02496767|62997150|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33598296|NCT02496767|62997151|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33598297|NCT02496767|62997144|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
33598298|NCT02496767|62997145|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
33598299|NCT02496767|62997146|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
33598300|NCT02496767|62997147|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
33403014|NCT00159913|62781814|FG003|Overall Study|Protocol Violation|0|||
33320585|NCT00940498|62696216|FG007|Overall Study|Lost to Follow-up|1|||
33320586|NCT00940498|62696209|FG000|Overall Study|Disease Progression|0|||
33320587|NCT00940498|62696210|FG001|Overall Study|Disease Progression|0|||
33320588|NCT00940498|62696211|FG002|Overall Study|Disease Progression|1|||
33320589|NCT00940498|62696212|FG003|Overall Study|Disease Progression|1|||
33320590|NCT00940498|62696213|FG004|Overall Study|Disease Progression|0|||
33320591|NCT00940498|62696214|FG005|Overall Study|Disease Progression|1|||
33403015|NCT00604188|62781828|FG000|Overall Study|Adverse Event|1|||
33403016|NCT00604188|62781829|FG001|Overall Study|Adverse Event|4|||
33320592|NCT00940498|62696215|FG006|Overall Study|Disease Progression|0|||
33403017|NCT00604188|62781828|FG000|Overall Study|Lost to Follow-up|17|||
33320593|NCT00940498|62696216|FG007|Overall Study|Disease Progression|0|||
33403018|NCT00604188|62781829|FG001|Overall Study|Lost to Follow-up|15|||
33320594|NCT00940498|62696209|FG000|Overall Study|Physician Decision|0|||
33403019|NCT00604188|62781828|FG000|Overall Study|Withdrawal by Subject|5|||
33403020|NCT00604188|62781829|FG001|Overall Study|Withdrawal by Subject|1|||
33403021|NCT00604188|62781828|FG000|Overall Study|Non-compliance with protocol|4|||
33403022|NCT00604188|62781829|FG001|Overall Study|Non-compliance with protocol|4|||
33403023|NCT00604188|62781828|FG000|Overall Study|Did not receive study drug|0|||
33403024|NCT00604188|62781829|FG001|Overall Study|Did not receive study drug|1|||
33403025|NCT03913377|62781837|FG000|Period 1|Test Article no longer available|0|||
33493939|NCT03495102|62872495|FG000|Overall Study|Participant was in Rehabilitation|1|||
33320595|NCT00940498|62696210|FG001|Overall Study|Physician Decision|0|||
33320596|NCT00940498|62696211|FG002|Overall Study|Physician Decision|0|||
33320597|NCT00940498|62696212|FG003|Overall Study|Physician Decision|0|||
33320598|NCT00940498|62696213|FG004|Overall Study|Physician Decision|2|||
33320599|NCT00940498|62696214|FG005|Overall Study|Physician Decision|0|||
33320600|NCT00940498|62696215|FG006|Overall Study|Physician Decision|0|||
33320601|NCT00940498|62696216|FG007|Overall Study|Physician Decision|0|||
33320602|NCT00940498|62696209|FG000|Overall Study|Not treated due to disease related pain|0|||
33320603|NCT00940498|62696210|FG001|Overall Study|Not treated due to disease related pain|0|||
33320604|NCT00940498|62696211|FG002|Overall Study|Not treated due to disease related pain|0|||
33320605|NCT00940498|62696212|FG003|Overall Study|Not treated due to disease related pain|0|||
33320606|NCT00940498|62696213|FG004|Overall Study|Not treated due to disease related pain|1|||
33320607|NCT00940498|62696214|FG005|Overall Study|Not treated due to disease related pain|0|||
33320608|NCT00940498|62696215|FG006|Overall Study|Not treated due to disease related pain|0|||
33320609|NCT00940498|62696216|FG007|Overall Study|Not treated due to disease related pain|0|||
33320610|NCT00940342|62696243|FG000|Overall Study|Adverse Event|0|||
33320611|NCT00940342|62696244|FG001|Overall Study|Adverse Event|2|||
33320612|NCT00940342|62696245|FG002|Overall Study|Adverse Event|1|||
33320613|NCT00936910|62696253|FG000|Overall Study|Lack of Efficacy|3|||
33320614|NCT00940108|62696262|FG000|Overall Study|Adverse Event|2|||
33320615|NCT00940108|62696263|FG001|Overall Study|Adverse Event|4|||
33320616|NCT00940108|62696264|FG002|Overall Study|Adverse Event|0|||
33320617|NCT00940108|62696265|FG003|Overall Study|Adverse Event|2|||
33320618|NCT00940108|62696262|FG000|Overall Study|Withdrew Consent|2|||
33320619|NCT00940108|62696263|FG001|Overall Study|Withdrew Consent|1|||
33320620|NCT00940108|62696264|FG002|Overall Study|Withdrew Consent|0|||
33320621|NCT00940108|62696265|FG003|Overall Study|Withdrew Consent|1|||
33320622|NCT00940108|62696262|FG000|Overall Study|Dose 2 contraindicated|1|||
33320623|NCT00940108|62696263|FG001|Overall Study|Dose 2 contraindicated|1|||
33320624|NCT00940108|62696264|FG002|Overall Study|Dose 2 contraindicated|0|||
33320625|NCT00940108|62696265|FG003|Overall Study|Dose 2 contraindicated|1|||
33320626|NCT00940108|62696262|FG000|Overall Study|Declined further vaccination|0|||
33320627|NCT00940108|62696263|FG001|Overall Study|Declined further vaccination|1|||
33320628|NCT00940108|62696264|FG002|Overall Study|Declined further vaccination|3|||
33320629|NCT00940108|62696265|FG003|Overall Study|Declined further vaccination|0|||
33320630|NCT00940108|62696262|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
33320631|NCT00940108|62696263|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
33320632|NCT00940108|62696264|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
33320633|NCT00940108|62696265|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
33320634|NCT00940108|62696262|FG000|Overall Study|Viral illness after Dose 1|0|||
33320635|NCT00940108|62696263|FG001|Overall Study|Viral illness after Dose 1|1|||
33320636|NCT00940108|62696264|FG002|Overall Study|Viral illness after Dose 1|0|||
33403026|NCT03913377|62781838|FG001|Period 1|Test Article no longer available|1|||
33403027|NCT03913377|62781839|FG002|Period 1|Test Article no longer available|0|||
33403028|NCT03913377|62781837|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
33403029|NCT03913377|62781838|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
33403030|NCT03913377|62781839|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
33403031|NCT00227539|62781846|FG000|Overall Study|Protocol Violation|1|||
33403032|NCT00227305|62781850|FG000|Overall Study|Adverse Event|40|||
33403033|NCT00227305|62781850|FG000|Overall Study|Withdrawal by Subject|42|||
33320637|NCT00940108|62696265|FG003|Overall Study|Viral illness after Dose 1|0|||
33320638|NCT00940108|62696262|FG000|Overall Study|Diagnosed with H1N1|0|||
33320639|NCT00940108|62696263|FG001|Overall Study|Diagnosed with H1N1|0|||
33320640|NCT00940108|62696264|FG002|Overall Study|Diagnosed with H1N1|0|||
33320641|NCT00940108|62696265|FG003|Overall Study|Diagnosed with H1N1|1|||
33320642|NCT00936598|62696277|FG000|Overall Study|Withdrawal by Subject|1|||
33320643|NCT00936598|62696278|FG001|Overall Study|Withdrawal by Subject|0|||
33320644|NCT00936598|62696277|FG000|Overall Study|Ineligible after consent|1|||
33320645|NCT00936598|62696278|FG001|Overall Study|Ineligible after consent|0|||
33320646|NCT01025817|62696286|FG000|Completed Study Medication|Adverse Event|66|||
33403034|NCT00227305|62781850|FG000|Overall Study|Lost to Follow-up|33|||
33403035|NCT00227305|62781850|FG000|Overall Study|Study specific discontinuation|13|||
33403036|NCT00227305|62781850|FG000|Overall Study|MOVED OUT OF AREA|3|||
33403037|NCT00227305|62781850|FG000|Overall Study|Lack of Efficacy|7|||
33403038|NCT00227305|62781850|FG000|Overall Study|Physician Decision|3|||
33320647|NCT01025817|62696287|FG001|Completed Study Medication|Adverse Event|39|||
33403039|NCT00227305|62781850|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
33403040|NCT00227305|62781850|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
33403041|NCT00227305|62781850|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
33403042|NCT00720941|62781856|FG000|Overall Study|Death|334|||
33403043|NCT00720941|62781857|FG001|Overall Study|Death|335|||
33403044|NCT00720941|62781856|FG000|Overall Study|Protocol Violation|0|||
33403045|NCT00720941|62781857|FG001|Overall Study|Protocol Violation|2|||
33403046|NCT00720941|62781856|FG000|Overall Study|Lost to Follow-up|17|||
33403047|NCT00720941|62781857|FG001|Overall Study|Lost to Follow-up|15|||
33403048|NCT00720941|62781856|FG000|Overall Study|Physician Decision|1|||
33403049|NCT00720941|62781857|FG001|Overall Study|Physician Decision|5|||
33403050|NCT00720941|62781856|FG000|Overall Study|Withdrawal by Subject|27|||
33403051|NCT00720941|62781857|FG001|Overall Study|Withdrawal by Subject|35|||
33403052|NCT00720941|62781856|FG000|Overall Study|Ongoing|34|||
33403053|NCT00720941|62781857|FG001|Overall Study|Ongoing|23|||
33403054|NCT00585533|62781863|FG000|Overall Study|objective or symptomatic progression|9|||
33403055|NCT00628862|62781870|FG000|Overall Study|Adverse Event|6|||
33403056|NCT00628862|62781871|FG001|Overall Study|Adverse Event|8|||
33403057|NCT00628862|62781872|FG002|Overall Study|Adverse Event|10|||
33403058|NCT00628862|62781870|FG000|Overall Study|Withdrawal by Subject|4|||
33403059|NCT00628862|62781871|FG001|Overall Study|Withdrawal by Subject|6|||
33403060|NCT00628862|62781872|FG002|Overall Study|Withdrawal by Subject|11|||
33403061|NCT00628862|62781870|FG000|Overall Study|Lost to Follow-up|0|||
33403062|NCT00628862|62781871|FG001|Overall Study|Lost to Follow-up|2|||
33403063|NCT00628862|62781872|FG002|Overall Study|Lost to Follow-up|1|||
33403064|NCT00628862|62781870|FG000|Overall Study|Protocol Violation|1|||
33403065|NCT00628862|62781871|FG001|Overall Study|Protocol Violation|0|||
33403066|NCT00628862|62781872|FG002|Overall Study|Protocol Violation|0|||
33403067|NCT00628862|62781870|FG000|Overall Study|COPD Exacerbation|0|||
33403068|NCT00628862|62781871|FG001|Overall Study|COPD Exacerbation|1|||
33403069|NCT00628862|62781872|FG002|Overall Study|COPD Exacerbation|0|||
33403070|NCT00584987|62781884|FG000|Overall Study|Protocol Violation|1|||
33403071|NCT00584987|62781885|FG001|Overall Study|Protocol Violation|1|||
33403072|NCT00584987|62781886|FG002|Overall Study|Protocol Violation|1|||
33403073|NCT00584987|62781887|FG003|Overall Study|Protocol Violation|0|||
33403074|NCT00584987|62781884|FG000|Overall Study|Adverse Event|0|||
33403075|NCT00584987|62781885|FG001|Overall Study|Adverse Event|0|||
33403076|NCT00584987|62781886|FG002|Overall Study|Adverse Event|0|||
33403077|NCT00584987|62781887|FG003|Overall Study|Adverse Event|1|||
33403078|NCT00727961|62781897|FG000|Overall Study|Lost to Follow-up|1|||
33403079|NCT00727961|62781897|FG000|Overall Study|Adverse Event|4|||
33403080|NCT00727961|62781897|FG000|Overall Study|Patient's refusal|2|||
33403081|NCT00727961|62781897|FG000|Overall Study|Progression|30|||
33403082|NCT00568958|62781903|FG000|Allocation|Withdrawal by Subject|7|||
33403083|NCT00568958|62781904|FG001|Allocation|Withdrawal by Subject|3|||
33403084|NCT00568958|62781903|FG000|Allocation|Physician Decision|2|||
33403085|NCT00568958|62781904|FG001|Allocation|Physician Decision|0|||
33403086|NCT00568958|62781903|FG000|Follow-Up|Withdrawal by Subject|6|||
33403087|NCT00568958|62781904|FG001|Follow-Up|Withdrawal by Subject|6|||
33403088|NCT00568958|62781903|FG000|Follow-Up|Physician Decision|1|||
33403089|NCT00568958|62781904|FG001|Follow-Up|Physician Decision|1|||
33403090|NCT00568958|62781903|FG000|Follow-Up|Family Emergency|1|||
33403091|NCT00568958|62781904|FG001|Follow-Up|Family Emergency|0|||
33403092|NCT00568958|62781903|FG000|Follow-Up|Adverse Event|1|||
33403093|NCT00568958|62781904|FG001|Follow-Up|Adverse Event|0|||
33403094|NCT00727649|62781912|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
33403095|NCT00727649|62781913|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
33403096|NCT00727649|62781912|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
33403097|NCT00727649|62781913|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
33403098|NCT00727649|62781912|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
33403099|NCT00727649|62781913|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
33403100|NCT00727649|62781912|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
33403101|NCT00727649|62781913|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
33403102|NCT00727649|62781912|FG000|Second Intervention (4-weeks)|Death|1|||
33403103|NCT00727649|62781913|FG001|Second Intervention (4-weeks)|Death|0|||
33403104|NCT00727649|62781912|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
33403105|NCT00727649|62781913|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
33403106|NCT00727649|62781912|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
33403107|NCT00727649|62781913|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
33320648|NCT01025817|62696286|FG000|Completed Study Medication|Protocol Deviation|9|||
33320649|NCT01025817|62696287|FG001|Completed Study Medication|Protocol Deviation|8|||
33320650|NCT01025817|62696286|FG000|Completed Study Medication|Withdrawal by Subject|8|||
33320651|NCT01025817|62696287|FG001|Completed Study Medication|Withdrawal by Subject|9|||
33320652|NCT01025817|62696286|FG000|Completed Study Medication|Administrative problems|7|||
33320653|NCT01025817|62696287|FG001|Completed Study Medication|Administrative problems|5|||
33320654|NCT01025817|62696286|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
33403108|NCT00568334|62781923|FG000|Overall Study|Withdrawal by Subject|0|||
33403109|NCT00568334|62781924|FG001|Overall Study|Withdrawal by Subject|1|||
33403110|NCT00568334|62781923|FG000|Overall Study|Lost to Follow-up|1|||
33403111|NCT00568334|62781924|FG001|Overall Study|Lost to Follow-up|0|||
33403112|NCT00727571|62781934|FG000|Overall Study|Ineligibility determined|1|||
33403113|NCT00727571|62781935|FG001|Overall Study|Ineligibility determined|1|||
33403114|NCT00727571|62781936|FG002|Overall Study|Ineligibility determined|1|||
33403115|NCT00727571|62781937|FG003|Overall Study|Ineligibility determined|0|||
33403116|NCT00727571|62781934|FG000|Overall Study|Death|0|||
33403117|NCT00727571|62781935|FG001|Overall Study|Death|19|||
33403118|NCT00727571|62781936|FG002|Overall Study|Death|5|||
33403119|NCT00727571|62781937|FG003|Overall Study|Death|1|||
33403120|NCT00727571|62781934|FG000|Overall Study|Physician Decision|0|||
33403121|NCT00727571|62781935|FG001|Overall Study|Physician Decision|5|||
33403122|NCT00727571|62781936|FG002|Overall Study|Physician Decision|0|||
33403123|NCT00727571|62781937|FG003|Overall Study|Physician Decision|0|||
33403124|NCT00727571|62781934|FG000|Overall Study|Withdrawal by Subject|0|||
33403125|NCT00727571|62781935|FG001|Overall Study|Withdrawal by Subject|10|||
33403126|NCT00727571|62781936|FG002|Overall Study|Withdrawal by Subject|11|||
33403127|NCT00727571|62781937|FG003|Overall Study|Withdrawal by Subject|0|||
33403128|NCT00727571|62781934|FG000|Overall Study|Subject Non Compliance|0|||
33403129|NCT00727571|62781935|FG001|Overall Study|Subject Non Compliance|6|||
33403130|NCT00727571|62781936|FG002|Overall Study|Subject Non Compliance|0|||
33403131|NCT00727571|62781937|FG003|Overall Study|Subject Non Compliance|4|||
33403132|NCT00727571|62781934|FG000|Overall Study|Dismissed from nursing home|0|||
33320655|NCT01025817|62696287|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
33320656|NCT01025817|62696286|FG000|Completed Study Medication|Abnormal test procedure|4|||
33320657|NCT01025817|62696287|FG001|Completed Study Medication|Abnormal test procedure|0|||
33320658|NCT01025817|62696286|FG000|Completed Study Medication|Graft loss|2|||
33320659|NCT01025817|62696287|FG001|Completed Study Medication|Graft loss|5|||
33320660|NCT01025817|62696286|FG000|Completed Study Medication|Death|2|||
33320661|NCT01025817|62696287|FG001|Completed Study Medication|Death|2|||
33320662|NCT01025817|62696286|FG000|Completed Study Medication|Abnormal lab values|0|||
33403133|NCT00727571|62781935|FG001|Overall Study|Dismissed from nursing home|9|||
33403134|NCT00727571|62781936|FG002|Overall Study|Dismissed from nursing home|5|||
33598301|NCT02496767|62997148|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
33403135|NCT00727571|62781937|FG003|Overall Study|Dismissed from nursing home|0|||
33403136|NCT00727571|62781934|FG000|Overall Study|Hospitalization|0|||
33403137|NCT00727571|62781935|FG001|Overall Study|Hospitalization|1|||
33320663|NCT01025817|62696287|FG001|Completed Study Medication|Abnormal lab values|2|||
33320664|NCT01025817|62696286|FG000|Completed Study Medication|Subject no longer required study drug|0|||
33320665|NCT01025817|62696287|FG001|Completed Study Medication|Subject no longer required study drug|1|||
33320666|NCT01025817|62696286|FG000|Completed Study Medication|Lost to Follow-up|0|||
33320667|NCT01025817|62696287|FG001|Completed Study Medication|Lost to Follow-up|1|||
33320668|NCT01025817|62696286|FG000|Completed Study|Withdrawal by Subject|8|||
33320669|NCT01025817|62696287|FG001|Completed Study|Withdrawal by Subject|16|||
33320670|NCT01025817|62696286|FG000|Completed Study|Death|6|||
33320671|NCT01025817|62696287|FG001|Completed Study|Death|5|||
33320672|NCT01025817|62696286|FG000|Completed Study|Missing|2|||
33403138|NCT00727571|62781936|FG002|Overall Study|Hospitalization|0|||
33403139|NCT00727571|62781937|FG003|Overall Study|Hospitalization|1|||
33403140|NCT00727571|62781934|FG000|Overall Study|AE not leading to hospitalization|0|||
33403141|NCT00727571|62781935|FG001|Overall Study|AE not leading to hospitalization|0|||
33403142|NCT00727571|62781936|FG002|Overall Study|AE not leading to hospitalization|2|||
33403143|NCT00727571|62781937|FG003|Overall Study|AE not leading to hospitalization|0|||
33403144|NCT00727571|62781934|FG000|Overall Study|Other|0|||
33403145|NCT00727571|62781935|FG001|Overall Study|Other|4|||
33403146|NCT00727571|62781936|FG002|Overall Study|Other|6|||
33403147|NCT00727571|62781937|FG003|Overall Study|Other|0|||
33403148|NCT00225277|62781949|FG000|Overall Study|Adverse Event|30|||
33403149|NCT00225277|62781950|FG001|Overall Study|Adverse Event|34|||
33403150|NCT00225277|62781949|FG000|Overall Study|Lack of Efficacy|4|||
33403151|NCT00225277|62781950|FG001|Overall Study|Lack of Efficacy|1|||
33403152|NCT00225277|62781949|FG000|Overall Study|Lost to Follow-up|4|||
33403153|NCT00225277|62781950|FG001|Overall Study|Lost to Follow-up|6|||
33403154|NCT00225277|62781949|FG000|Overall Study|Physician Decision|6|||
33403155|NCT00225277|62781950|FG001|Overall Study|Physician Decision|8|||
33403156|NCT00225277|62781949|FG000|Overall Study|Protocol Violation|6|||
33403157|NCT00225277|62781950|FG001|Overall Study|Protocol Violation|3|||
33403158|NCT00225277|62781949|FG000|Overall Study|Withdrawal by Subject|40|||
33403159|NCT00225277|62781950|FG001|Overall Study|Withdrawal by Subject|34|||
33403160|NCT00225277|62781949|FG000|Overall Study|Other|7|||
33403161|NCT00225277|62781950|FG001|Overall Study|Other|9|||
33403162|NCT00567996|62781959|FG000|Overall Study|Adverse Event|18|||
33403163|NCT00567996|62781960|FG001|Overall Study|Adverse Event|16|||
33403164|NCT00567996|62781961|FG002|Overall Study|Adverse Event|13|||
33403165|NCT00567996|62781959|FG000|Overall Study|Protocol Deviation|9|||
33403166|NCT00567996|62781960|FG001|Overall Study|Protocol Deviation|11|||
33403167|NCT00567996|62781961|FG002|Overall Study|Protocol Deviation|13|||
33403168|NCT00567996|62781959|FG000|Overall Study|Withdrawal by Subject|8|||
33403169|NCT00567996|62781960|FG001|Overall Study|Withdrawal by Subject|12|||
33403170|NCT00567996|62781961|FG002|Overall Study|Withdrawal by Subject|22|||
33403171|NCT00567996|62781959|FG000|Overall Study|Abnormal Lab value(s)|2|||
33403172|NCT00567996|62781960|FG001|Overall Study|Abnormal Lab value(s)|1|||
33403173|NCT00567996|62781961|FG002|Overall Study|Abnormal Lab value(s)|2|||
33403174|NCT00567996|62781959|FG000|Overall Study|Abnormal test procedure result(s)|2|||
33403175|NCT00567996|62781960|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33403176|NCT00567996|62781961|FG002|Overall Study|Abnormal test procedure result(s)|1|||
33403177|NCT00567996|62781959|FG000|Overall Study|Lost to Follow-up|2|||
33403178|NCT00567996|62781960|FG001|Overall Study|Lost to Follow-up|5|||
33403179|NCT00567996|62781961|FG002|Overall Study|Lost to Follow-up|2|||
33403180|NCT00567996|62781959|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33403181|NCT00567996|62781960|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33403182|NCT00567996|62781961|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
33320673|NCT01025817|62696287|FG001|Completed Study|Missing|0|||
33320674|NCT01025817|62696286|FG000|Completed Study|Lost to Follow-up|0|||
33320675|NCT01025817|62696287|FG001|Completed Study|Lost to Follow-up|1|||
33320676|NCT00939640|62696293|FG000|Overall Study|Physician Decision|1|||
33320677|NCT01218113|62696305|FG000|Overall Study|Withdrawal by Subject|1|||
33320678|NCT01218113|62696306|FG001|Overall Study|Withdrawal by Subject|0|||
33320679|NCT01218113|62696307|FG002|Overall Study|Withdrawal by Subject|1|||
33320680|NCT01218113|62696305|FG000|Overall Study|Lost to Follow-up|4|||
33320681|NCT01218113|62696306|FG001|Overall Study|Lost to Follow-up|1|||
33320682|NCT01218113|62696307|FG002|Overall Study|Lost to Follow-up|4|||
33403183|NCT00567996|62781959|FG000|Overall Study|Administrative problems|1|||
33403184|NCT00567996|62781960|FG001|Overall Study|Administrative problems|1|||
33403185|NCT00567996|62781961|FG002|Overall Study|Administrative problems|0|||
33320683|NCT01218113|62696305|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
33403186|NCT00567996|62781959|FG000|Overall Study|Death|1|||
33403187|NCT00567996|62781960|FG001|Overall Study|Death|0|||
33403188|NCT00567996|62781961|FG002|Overall Study|Death|2|||
33403189|NCT00567996|62781959|FG000|Overall Study|Patient's inability to use the device|0|||
33403190|NCT00567996|62781960|FG001|Overall Study|Patient's inability to use the device|1|||
33403191|NCT00567996|62781961|FG002|Overall Study|Patient's inability to use the device|0|||
33403192|NCT00224887|62781975|FG000|Overall Study|Pregnancy|6|||
33403193|NCT00224887|62781976|FG001|Overall Study|Pregnancy|6|||
33403194|NCT00148759|62781984|FG000|Overall Study|Withdrawal by Subject|1|||
33403195|NCT00148759|62781985|FG001|Overall Study|Withdrawal by Subject|1|||
33403196|NCT00148759|62781984|FG000|Overall Study|Lost to Follow-up|1|||
33403197|NCT00148759|62781985|FG001|Overall Study|Lost to Follow-up|0|||
33403198|NCT00717275|62781991|FG000|Overall Study|Premature study termination.|3|||
33403199|NCT00584909|62781995|FG000|Overall Study|Adverse Event|4|||
33403200|NCT00147823|62782001|FG000|Overall Study|Lost to Follow-up|6|||
33403201|NCT00147823|62782002|FG001|Overall Study|Lost to Follow-up|12|||
33403202|NCT00147823|62782001|FG000|Overall Study|Physician Decision|1|||
33403203|NCT00147823|62782002|FG001|Overall Study|Physician Decision|0|||
33403204|NCT00147823|62782001|FG000|Overall Study|Withdrawal by Subject|0|||
33403205|NCT00147823|62782002|FG001|Overall Study|Withdrawal by Subject|1|||
33403206|NCT00147823|62782001|FG000|Overall Study|Did not receive vitoss due to infection|6|||
33403207|NCT00147823|62782002|FG001|Overall Study|Did not receive vitoss due to infection|2|||
33320684|NCT01218113|62696306|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
33320685|NCT01218113|62696307|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
33320686|NCT03873493|62696322|FG000|Overall Study|Withdrawal by Subject|1|||
33320687|NCT03873493|62696322|FG000|Overall Study|Death|9|||
33320688|NCT03873493|62696322|FG000|Overall Study|Lost to Follow-up|1|||
33320689|NCT03873493|62696322|FG000|Overall Study|Study Terminated by Sponsor|1|||
33320690|NCT03873493|62696322|FG000|Overall Study|Other|2|||
33320691|NCT00939484|62696342|FG000|Overall Study|Progression/Relapse|8|||
33320692|NCT00939484|62696343|FG001|Overall Study|Progression/Relapse|20|||
33320693|NCT00939484|62696344|FG002|Overall Study|Progression/Relapse|3|||
33320694|NCT01010217|62696359|FG000|Overall Study|Lost to Follow-up|4|||
33320695|NCT01010217|62696360|FG001|Overall Study|Lost to Follow-up|5|||
33320696|NCT01010217|62696361|FG002|Overall Study|Lost to Follow-up|1|||
33320697|NCT01010217|62696362|FG003|Overall Study|Lost to Follow-up|0|||
33320698|NCT01010217|62696363|FG004|Overall Study|Lost to Follow-up|0|||
33320699|NCT01010217|62696359|FG000|Overall Study|Withdrawal by Subject|1|||
33320700|NCT01010217|62696360|FG001|Overall Study|Withdrawal by Subject|0|||
33320701|NCT01010217|62696361|FG002|Overall Study|Withdrawal by Subject|0|||
33320702|NCT01010217|62696362|FG003|Overall Study|Withdrawal by Subject|0|||
33320703|NCT01010217|62696363|FG004|Overall Study|Withdrawal by Subject|0|||
33403208|NCT00717197|62782008|FG000|Overall Study|Unable to purchase study drug|5|||
33403209|NCT00717197|62782008|FG000|Overall Study|Tumor Progression|1|||
33403210|NCT00717197|62782008|FG000|Overall Study|Physician Decision|1|||
33403211|NCT00147745|62782015|FG000|Overall Study|Withdrawal by Subject|1|||
33403212|NCT00147745|62782016|FG001|Overall Study|Withdrawal by Subject|0|||
33403213|NCT00147745|62782017|FG002|Overall Study|Withdrawal by Subject|0|||
33403214|NCT00642902|62782029|FG000|Overall Study|Adverse Event|0|||
33403215|NCT00642902|62782030|FG001|Overall Study|Adverse Event|1|||
33403216|NCT00642902|62782031|FG002|Overall Study|Adverse Event|3|||
33403217|NCT00642902|62782032|FG003|Overall Study|Adverse Event|1|||
33403218|NCT00642902|62782029|FG000|Overall Study|Lost to Follow-up|1|||
33403219|NCT00642902|62782030|FG001|Overall Study|Lost to Follow-up|1|||
33403220|NCT00642902|62782031|FG002|Overall Study|Lost to Follow-up|0|||
33403221|NCT00642902|62782032|FG003|Overall Study|Lost to Follow-up|0|||
33403222|NCT00642902|62782029|FG000|Overall Study|Lack of Efficacy|0|||
33403223|NCT00642902|62782030|FG001|Overall Study|Lack of Efficacy|3|||
33403224|NCT00642902|62782031|FG002|Overall Study|Lack of Efficacy|3|||
33493940|NCT03495102|62872496|FG001|Overall Study|Participant was in Rehabilitation|0|||
33493941|NCT03495102|62872497|FG002|Overall Study|Participant was in Rehabilitation|0|||
33403225|NCT00642902|62782032|FG003|Overall Study|Lack of Efficacy|0|||
33403226|NCT00642902|62782029|FG000|Overall Study|Death|1|||
33403227|NCT00642902|62782030|FG001|Overall Study|Death|0|||
33320704|NCT01010217|62696359|FG000|Overall Study|Physician Decision|0|||
33320705|NCT01010217|62696360|FG001|Overall Study|Physician Decision|0|||
33403228|NCT00642902|62782031|FG002|Overall Study|Death|0|||
33403229|NCT00642902|62782032|FG003|Overall Study|Death|0|||
33403230|NCT00642902|62782029|FG000|Overall Study|Premature termination of clinical trial|37|||
33320706|NCT01010217|62696361|FG002|Overall Study|Physician Decision|0|||
33320707|NCT01010217|62696362|FG003|Overall Study|Physician Decision|6|||
33320708|NCT01010217|62696363|FG004|Overall Study|Physician Decision|3|||
33320709|NCT01217957|62696380|FG000|Phase 1|Withdrawal by Patient|1|||
33320710|NCT01217957|62696381|FG001|Phase 1|Withdrawal by Patient|0|||
33320711|NCT01217957|62696382|FG002|Phase 1|Withdrawal by Patient|1|||
33320712|NCT01217957|62696383|FG003|Phase 1|Withdrawal by Patient|1|||
33320713|NCT01217957|62696384|FG004|Phase 1|Withdrawal by Patient|0|||
33320714|NCT01217957|62696380|FG000|Phase 2|Withdrawal by Patient|0|||
33320715|NCT01217957|62696381|FG001|Phase 2|Withdrawal by Patient|0|||
33320716|NCT01217957|62696382|FG002|Phase 2|Withdrawal by Patient|0|||
33320717|NCT01217957|62696383|FG003|Phase 2|Withdrawal by Patient|0|||
33320718|NCT01217957|62696384|FG004|Phase 2|Withdrawal by Patient|1|||
33320719|NCT00939094|62696407|FG000|Overall Study|Adverse Event|9|||
33320720|NCT00939094|62696408|FG001|Overall Study|Adverse Event|0|||
33320721|NCT00939094|62696407|FG000|Overall Study|Withdrawal by Subject|1|||
33320722|NCT00939094|62696408|FG001|Overall Study|Withdrawal by Subject|6|||
33320723|NCT00939094|62696407|FG000|Overall Study|Lost to Follow-up|1|||
33320724|NCT00939094|62696408|FG001|Overall Study|Lost to Follow-up|1|||
33320725|NCT00939094|62696407|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33320726|NCT00939094|62696408|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33320727|NCT00939094|62696407|FG000|Overall Study|Severe non-compliance to protocol|0|||
33320728|NCT00939094|62696408|FG001|Overall Study|Severe non-compliance to protocol|1|||
33320729|NCT00939094|62696407|FG000|Overall Study|Study stopped by sponsor|0|||
33320730|NCT00939094|62696408|FG001|Overall Study|Study stopped by sponsor|2|||
33320731|NCT00939094|62696407|FG000|Overall Study|Abnormal ECG findings|1|||
33320732|NCT00939094|62696408|FG001|Overall Study|Abnormal ECG findings|0|||
33320733|NCT01217801|62696416|FG000|Period 1|Protocol Violation|1|||
33320734|NCT01217801|62696417|FG001|Period 1|Protocol Violation|1|||
33320735|NCT01217801|62696416|FG000|Period 1|Withdrawal by Subject|0|||
33320736|NCT01217801|62696417|FG001|Period 1|Withdrawal by Subject|1|||
33320737|NCT00935818|62696425|FG000|Overall Study|Withdrawal by Subject|45|||
33403231|NCT00642902|62782030|FG001|Overall Study|Premature termination of clinical trial|32|||
33320738|NCT00935818|62696426|FG001|Overall Study|Withdrawal by Subject|50|||
33320739|NCT00935818|62696425|FG000|Overall Study|Lost to Follow-up|40|||
33320740|NCT00935818|62696426|FG001|Overall Study|Lost to Follow-up|42|||
33320741|NCT00935818|62696425|FG000|Overall Study|Adverse Event|6|||
33403232|NCT00642902|62782031|FG002|Overall Study|Premature termination of clinical trial|35|||
33403233|NCT00642902|62782032|FG003|Overall Study|Premature termination of clinical trial|35|||
33403234|NCT00642902|62782029|FG000|Overall Study|Randomized, but not treated|0|||
33403235|NCT00642902|62782030|FG001|Overall Study|Randomized, but not treated|0|||
33403236|NCT00642902|62782031|FG002|Overall Study|Randomized, but not treated|1|||
33403237|NCT00642902|62782032|FG003|Overall Study|Randomized, but not treated|0|||
33403238|NCT00642902|62782029|FG000|Overall Study|Other|1|||
33403239|NCT00642902|62782030|FG001|Overall Study|Other|5|||
33403240|NCT00642902|62782031|FG002|Overall Study|Other|1|||
33403241|NCT00642902|62782032|FG003|Overall Study|Other|4|||
33403242|NCT00224107|62782044|FG000|Overall Study|Adverse Event|20|||
33403243|NCT00224107|62782045|FG001|Overall Study|Adverse Event|6|||
33403244|NCT00224107|62782044|FG000|Overall Study|Protocol Violation|2|||
33403245|NCT00224107|62782045|FG001|Overall Study|Protocol Violation|3|||
33403246|NCT00224107|62782044|FG000|Overall Study|Withdrawal by Subject|1|||
33403247|NCT00224107|62782045|FG001|Overall Study|Withdrawal by Subject|4|||
33403248|NCT00224107|62782044|FG000|Overall Study|Lack of Efficacy|2|||
33403249|NCT00224107|62782045|FG001|Overall Study|Lack of Efficacy|0|||
33403250|NCT00224107|62782044|FG000|Overall Study|Lost to Follow-up|4|||
33403251|NCT00224107|62782045|FG001|Overall Study|Lost to Follow-up|0|||
33403252|NCT00224107|62782044|FG000|Overall Study|Physician Decision|1|||
33403253|NCT00224107|62782045|FG001|Overall Study|Physician Decision|0|||
33320742|NCT00935818|62696426|FG001|Overall Study|Adverse Event|7|||
33320743|NCT00935818|62696425|FG000|Overall Study|Physician Decision|0|||
33320744|NCT00935818|62696426|FG001|Overall Study|Physician Decision|1|||
33320745|NCT01216319|62696432|FG000|Overall Study|Lost to Follow-up|2|||
33320746|NCT01216319|62696432|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
33320747|NCT00936208|62696438|FG000|Overall Study|Protocol Violation|37|||
33320748|NCT00936208|62696439|FG001|Overall Study|Protocol Violation|22|||
33320749|NCT01216163|62696448|FG000|Overall Study|Withdrawal by Subject|1|||
33320750|NCT01216163|62696449|FG001|Overall Study|Withdrawal by Subject|1|||
33320751|NCT01216163|62696450|FG002|Overall Study|Withdrawal by Subject|0|||
33320752|NCT00933244|62696461|FG000|Overall Study|Withdrawal by Subject|5|||
33320753|NCT00933244|62696462|FG001|Overall Study|Withdrawal by Subject|1|||
33320754|NCT00933244|62696463|FG002|Overall Study|Withdrawal by Subject|3|||
33320755|NCT00930046|62696473|FG000|Overall Study|Wound catheter malfunctioned|1|||
33320756|NCT00930046|62696474|FG001|Overall Study|Wound catheter malfunctioned|2|||
33320757|NCT00935584|62696482|FG000|Overall Study|Withdrawal by Subject|9|||
33320758|NCT00935584|62696483|FG001|Overall Study|Withdrawal by Subject|0|||
33320759|NCT00935584|62696482|FG000|Overall Study|Death|3|||
33320760|NCT00935584|62696483|FG001|Overall Study|Death|0|||
33320761|NCT00935584|62696482|FG000|Overall Study|Lost to Follow-up|8|||
33320762|NCT00935584|62696483|FG001|Overall Study|Lost to Follow-up|0|||
33320763|NCT00935584|62696482|FG000|Overall Study|No show|9|||
33320764|NCT00935584|62696483|FG001|Overall Study|No show|0|||
33320765|NCT00935584|62696482|FG000|Overall Study|Relocated|3|||
33320766|NCT00935584|62696483|FG001|Overall Study|Relocated|0|||
33320767|NCT00935584|62696482|FG000|Overall Study|Patient changed provider|3|||
33320768|NCT00935584|62696483|FG001|Overall Study|Patient changed provider|0|||
33320769|NCT00935584|62696482|FG000|Overall Study|Provider dropped out of study|14|||
33320770|NCT00935584|62696483|FG001|Overall Study|Provider dropped out of study|4|||
33320771|NCT01215851|62696493|FG000|Treatment Period|Adverse Event|1|||
33320772|NCT01215851|62696494|FG001|Treatment Period|Adverse Event|1|||
33403254|NCT00224107|62782044|FG000|Overall Study|Other|1|||
33403255|NCT00224107|62782045|FG001|Overall Study|Other|1|||
33403256|NCT00720083|62782053|FG000|Overall Study|Ineligible|1|||
33320773|NCT01215851|62696495|FG002|Treatment Period|Adverse Event|1|||
33403257|NCT00720083|62782054|FG001|Overall Study|Ineligible|2|||
33403258|NCT00209131|62782062|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
33403259|NCT00209131|62782063|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
33403260|NCT00224029|62782069|FG000|Overall Study|Lost to Follow-up|1|||
33320774|NCT01215851|62696496|FG003|Treatment Period|Adverse Event|3|||
33320775|NCT01215851|62696497|FG004|Treatment Period|Adverse Event|0|||
33320776|NCT01215851|62696498|FG005|Treatment Period|Adverse Event|1|||
33320777|NCT01215851|62696493|FG000|Follow up Period|Lost to Follow-up|0|||
33320778|NCT01215851|62696494|FG001|Follow up Period|Lost to Follow-up|0|||
33320779|NCT01215851|62696495|FG002|Follow up Period|Lost to Follow-up|0|||
33403261|NCT00224029|62782069|FG000|Overall Study|Withdrawal by Subject|4|||
33403262|NCT00224029|62782069|FG000|Overall Study|Other|1|||
33403263|NCT00223795|62782073|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
33403264|NCT00223795|62782074|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
33403265|NCT00223795|62782073|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
33403266|NCT00223795|62782074|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
33403267|NCT00719849|62782083|FG000|Overall Study|Death|0|||
33403268|NCT00719849|62782084|FG001|Overall Study|Death|1|||
33403269|NCT03907683|62782090|FG000|Overall Study|Pregnancy|1|||
33403270|NCT03907683|62782090|FG000|Overall Study|Withdrawal by Subject|1|||
33403271|NCT00626522|62782100|FG000|Overall Study|Protocol Violation|0|||
33403272|NCT00626522|62782101|FG001|Overall Study|Protocol Violation|0|||
33403273|NCT00626522|62782102|FG002|Overall Study|Protocol Violation|0|||
33403274|NCT00626522|62782103|FG003|Overall Study|Protocol Violation|0|||
33403275|NCT00626522|62782104|FG004|Overall Study|Protocol Violation|1|||
33403276|NCT00626522|62782105|FG005|Overall Study|Protocol Violation|0|||
33403277|NCT00626522|62782100|FG000|Overall Study|Adverse Event|2|||
33403278|NCT00626522|62782101|FG001|Overall Study|Adverse Event|1|||
33403279|NCT00626522|62782102|FG002|Overall Study|Adverse Event|2|||
33403280|NCT00626522|62782103|FG003|Overall Study|Adverse Event|0|||
33403281|NCT00626522|62782104|FG004|Overall Study|Adverse Event|1|||
33403282|NCT00626522|62782105|FG005|Overall Study|Adverse Event|1|||
33403283|NCT00626522|62782100|FG000|Overall Study|Withdrawal by Subject|2|||
33403284|NCT00626522|62782101|FG001|Overall Study|Withdrawal by Subject|5|||
33403285|NCT00626522|62782102|FG002|Overall Study|Withdrawal by Subject|5|||
33403286|NCT00626522|62782103|FG003|Overall Study|Withdrawal by Subject|0|||
33403287|NCT00626522|62782104|FG004|Overall Study|Withdrawal by Subject|4|||
33403288|NCT00626522|62782105|FG005|Overall Study|Withdrawal by Subject|1|||
33403289|NCT00626522|62782100|FG000|Overall Study|COPD exacerbation|0|||
33403290|NCT00626522|62782101|FG001|Overall Study|COPD exacerbation|0|||
33403291|NCT00626522|62782102|FG002|Overall Study|COPD exacerbation|0|||
33403292|NCT00626522|62782103|FG003|Overall Study|COPD exacerbation|1|||
33403293|NCT00626522|62782104|FG004|Overall Study|COPD exacerbation|1|||
33403294|NCT00626522|62782105|FG005|Overall Study|COPD exacerbation|0|||
33403295|NCT00626522|62782100|FG000|Overall Study|Lost to Follow-up|0|||
33403296|NCT00626522|62782101|FG001|Overall Study|Lost to Follow-up|1|||
33403297|NCT00626522|62782102|FG002|Overall Study|Lost to Follow-up|0|||
33403298|NCT00626522|62782103|FG003|Overall Study|Lost to Follow-up|0|||
33403299|NCT00626522|62782104|FG004|Overall Study|Lost to Follow-up|0|||
33403300|NCT00626522|62782105|FG005|Overall Study|Lost to Follow-up|0|||
33403301|NCT00626522|62782100|FG000|Overall Study|Inconsistent reason reported|1|||
33403302|NCT00626522|62782101|FG001|Overall Study|Inconsistent reason reported|0|||
33403303|NCT00626522|62782102|FG002|Overall Study|Inconsistent reason reported|0|||
33403304|NCT00626522|62782103|FG003|Overall Study|Inconsistent reason reported|0|||
33403305|NCT00626522|62782104|FG004|Overall Study|Inconsistent reason reported|0|||
33403306|NCT00626522|62782105|FG005|Overall Study|Inconsistent reason reported|0|||
33403307|NCT00626522|62782100|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
33403308|NCT00626522|62782101|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
33403309|NCT00626522|62782102|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
33403310|NCT00626522|62782103|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
33403311|NCT00626522|62782104|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
33403312|NCT00626522|62782105|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
33403313|NCT00540423|62782130|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33403314|NCT00540423|62782131|FG001|Double-Blind Treatment Period|Adverse Event|1|||
33403315|NCT00540423|62782132|FG002|Double-Blind Treatment Period|Adverse Event|0|||
33403316|NCT00540423|62782130|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
33403317|NCT00540423|62782131|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
33403318|NCT00540423|62782132|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
33320780|NCT01215851|62696496|FG003|Follow up Period|Lost to Follow-up|0|||
33320781|NCT01215851|62696497|FG004|Follow up Period|Lost to Follow-up|0|||
33320782|NCT01215851|62696498|FG005|Follow up Period|Lost to Follow-up|1|||
33403319|NCT00566982|62782152|FG000|Overall Study|Adverse Event|6|||
33403320|NCT00566982|62782153|FG001|Overall Study|Adverse Event|48|||
33320783|NCT00933166|62696513|FG000|Overall Study|Lost to Follow-up|4|||
33320784|NCT00933166|62696513|FG000|Overall Study|Lack of Efficacy|9|||
33320785|NCT00933166|62696513|FG000|Overall Study|Unavailable|4|||
33320786|NCT00933166|62696513|FG000|Overall Study|Withdrawal by Subject|1|||
33403321|NCT00566982|62782152|FG000|Overall Study|Withdrawal by Subject|1|||
33403322|NCT00566982|62782153|FG001|Overall Study|Withdrawal by Subject|14|||
33403323|NCT00566982|62782152|FG000|Overall Study|Protocol Violation|1|||
33403324|NCT00566982|62782153|FG001|Overall Study|Protocol Violation|4|||
33403325|NCT00566982|62782152|FG000|Overall Study|Lost to Follow-up|0|||
33403326|NCT00566982|62782153|FG001|Overall Study|Lost to Follow-up|1|||
33403327|NCT00566982|62782152|FG000|Overall Study|Other-family problems & doctor's request|0|||
33320787|NCT00935272|62696519|FG000|Overall Study|Lost to Follow-up|10|||
33320788|NCT00935272|62696520|FG001|Overall Study|Lost to Follow-up|3|||
33403328|NCT00566982|62782153|FG001|Overall Study|Other-family problems & doctor's request|2|||
33403329|NCT00624338|62782165|FG000|Overall Study|Adverse Event|14|||
33403330|NCT00624338|62782166|FG001|Overall Study|Adverse Event|14|||
33403331|NCT00624338|62782167|FG002|Overall Study|Adverse Event|18|||
33403332|NCT00624338|62782165|FG000|Overall Study|Lost to Follow-up|1|||
33403333|NCT00624338|62782166|FG001|Overall Study|Lost to Follow-up|0|||
33403334|NCT00624338|62782167|FG002|Overall Study|Lost to Follow-up|0|||
33403335|NCT00624338|62782165|FG000|Overall Study|Lack of Efficacy|11|||
33403336|NCT00624338|62782166|FG001|Overall Study|Lack of Efficacy|3|||
33403337|NCT00624338|62782167|FG002|Overall Study|Lack of Efficacy|14|||
33403338|NCT00624338|62782165|FG000|Overall Study|Protocol Violation|3|||
33403339|NCT00624338|62782166|FG001|Overall Study|Protocol Violation|3|||
33403340|NCT00624338|62782167|FG002|Overall Study|Protocol Violation|2|||
33403341|NCT00624338|62782165|FG000|Overall Study|Death|0|||
33403342|NCT00624338|62782166|FG001|Overall Study|Death|2|||
33403343|NCT00624338|62782167|FG002|Overall Study|Death|0|||
33403344|NCT00624338|62782165|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
33403345|NCT00624338|62782166|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
33403346|NCT00624338|62782167|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
33403347|NCT00624338|62782165|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
33403348|NCT00624338|62782166|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
33403349|NCT00624338|62782167|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
33403350|NCT00624338|62782165|FG000|Overall Study|Other|15|||
33403351|NCT00624338|62782166|FG001|Overall Study|Other|5|||
33403352|NCT00624338|62782167|FG002|Overall Study|Other|9|||
33403353|NCT00624338|62782165|FG000|Overall Study|Randomized but not treated|2|||
33403354|NCT00624338|62782166|FG001|Overall Study|Randomized but not treated|1|||
33403355|NCT00624338|62782167|FG002|Overall Study|Randomized but not treated|3|||
33403356|NCT03977454|62782177|FG000|Overall Study|immediate postoperative revision|2|||
33403357|NCT03977454|62782178|FG001|Overall Study|immediate postoperative revision|2|||
33403358|NCT00538785|62782186|FG000|Overall Study|Death|9|||
33403359|NCT00538785|62782187|FG001|Overall Study|Death|10|||
33403360|NCT00538785|62782186|FG000|Overall Study|Withdrawal of consent|9|||
33403361|NCT00538785|62782187|FG001|Overall Study|Withdrawal of consent|7|||
33403362|NCT00538785|62782186|FG000|Overall Study|Lost to Follow-up|1|||
33403363|NCT00538785|62782187|FG001|Overall Study|Lost to Follow-up|0|||
33403364|NCT00538629|62782193|FG000|Overall Study|At subject's request|1|||
33403365|NCT00538629|62782193|FG000|Overall Study|Adverse Event|2|||
33403366|NCT00538629|62782193|FG000|Overall Study|Lack of Efficacy|12|||
33403367|NCT00538629|62782193|FG000|Overall Study|Lost to Follow-up|6|||
33403368|NCT00538629|62782193|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
33403369|NCT00622700|62782200|FG000|Core Treatment Period|Randomized but Not Treated|0|||
33403370|NCT00622700|62782201|FG001|Core Treatment Period|Randomized but Not Treated|2|||
33403371|NCT00622700|62782202|FG002|Core Treatment Period|Randomized but Not Treated|2|||
33403372|NCT00622700|62782203|FG003|Core Treatment Period|Randomized but Not Treated|0|||
33403373|NCT00622700|62782204|FG004|Core Treatment Period|Randomized but Not Treated|0|||
33403374|NCT00622700|62782205|FG005|Core Treatment Period|Randomized but Not Treated|0|||
33403375|NCT00622700|62782206|FG006|Core Treatment Period|Randomized but Not Treated|0|||
33403376|NCT00622700|62782200|FG000|Core Treatment Period|Adverse Event|18|||
33403377|NCT00622700|62782201|FG001|Core Treatment Period|Adverse Event|25|||
33403378|NCT00622700|62782202|FG002|Core Treatment Period|Adverse Event|18|||
33403379|NCT00622700|62782203|FG003|Core Treatment Period|Adverse Event|0|||
33403380|NCT00622700|62782204|FG004|Core Treatment Period|Adverse Event|0|||
33403381|NCT00622700|62782205|FG005|Core Treatment Period|Adverse Event|0|||
33403382|NCT00622700|62782206|FG006|Core Treatment Period|Adverse Event|0|||
33403383|NCT00622700|62782200|FG000|Core Treatment Period|Lack of Efficacy|19|||
33403384|NCT00622700|62782201|FG001|Core Treatment Period|Lack of Efficacy|6|||
33403385|NCT00622700|62782202|FG002|Core Treatment Period|Lack of Efficacy|12|||
33403386|NCT00622700|62782203|FG003|Core Treatment Period|Lack of Efficacy|0|||
33403387|NCT00622700|62782204|FG004|Core Treatment Period|Lack of Efficacy|0|||
33403388|NCT00622700|62782205|FG005|Core Treatment Period|Lack of Efficacy|0|||
33403389|NCT00622700|62782206|FG006|Core Treatment Period|Lack of Efficacy|0|||
33403390|NCT00622700|62782200|FG000|Core Treatment Period|Lost to Follow-up|1|||
33403391|NCT00622700|62782201|FG001|Core Treatment Period|Lost to Follow-up|1|||
33403392|NCT00622700|62782202|FG002|Core Treatment Period|Lost to Follow-up|1|||
33403393|NCT00622700|62782203|FG003|Core Treatment Period|Lost to Follow-up|0|||
33403394|NCT00622700|62782204|FG004|Core Treatment Period|Lost to Follow-up|0|||
33403395|NCT00622700|62782205|FG005|Core Treatment Period|Lost to Follow-up|0|||
33403396|NCT00622700|62782206|FG006|Core Treatment Period|Lost to Follow-up|0|||
33403397|NCT00622700|62782200|FG000|Core Treatment Period|Death|1|||
33403398|NCT00622700|62782201|FG001|Core Treatment Period|Death|0|||
33403399|NCT00622700|62782202|FG002|Core Treatment Period|Death|0|||
33403400|NCT00622700|62782203|FG003|Core Treatment Period|Death|0|||
33403401|NCT00622700|62782204|FG004|Core Treatment Period|Death|0|||
33403402|NCT00622700|62782205|FG005|Core Treatment Period|Death|0|||
33403403|NCT00622700|62782206|FG006|Core Treatment Period|Death|0|||
33320789|NCT00935272|62696519|FG000|Overall Study|Withdrawal by Subject|8|||
33320790|NCT00935272|62696520|FG001|Overall Study|Withdrawal by Subject|2|||
33320791|NCT00935272|62696519|FG000|Overall Study|Physician Decision|1|||
33320792|NCT00935272|62696520|FG001|Overall Study|Physician Decision|0|||
33320793|NCT00935272|62696519|FG000|Overall Study|Protocol Violation|0|||
33320794|NCT00935272|62696520|FG001|Overall Study|Protocol Violation|1|||
33320795|NCT01010061|62696529|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
33320796|NCT01010061|62696530|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
33320797|NCT01010061|62696529|FG000|Overall Study|Disease Progression|2|||
33320798|NCT01010061|62696530|FG001|Overall Study|Disease Progression|8|||
33320799|NCT01010061|62696529|FG000|Overall Study|Withdrew Consent|5|||
33320800|NCT01010061|62696530|FG001|Overall Study|Withdrew Consent|1|||
33403404|NCT00622700|62782200|FG000|Core Treatment Period|Progressive Disease|3|||
33403405|NCT00622700|62782201|FG001|Core Treatment Period|Progressive Disease|1|||
33403406|NCT00622700|62782202|FG002|Core Treatment Period|Progressive Disease|0|||
33320801|NCT01010061|62696529|FG000|Overall Study|Death|3|||
33320802|NCT01010061|62696530|FG001|Overall Study|Death|6|||
33320803|NCT01010061|62696529|FG000|Overall Study|Administrative/Other|0|||
33403407|NCT00622700|62782203|FG003|Core Treatment Period|Progressive Disease|0|||
33403408|NCT00622700|62782204|FG004|Core Treatment Period|Progressive Disease|0|||
33320804|NCT01010061|62696530|FG001|Overall Study|Administrative/Other|1|||
33320805|NCT01010061|62696529|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
33403409|NCT00622700|62782205|FG005|Core Treatment Period|Progressive Disease|0|||
33403410|NCT00622700|62782206|FG006|Core Treatment Period|Progressive Disease|0|||
33403411|NCT00622700|62782200|FG000|Core Treatment Period|Withdrawal by Subject|12|||
33403412|NCT00622700|62782201|FG001|Core Treatment Period|Withdrawal by Subject|18|||
33403413|NCT00622700|62782202|FG002|Core Treatment Period|Withdrawal by Subject|15|||
33403414|NCT00622700|62782203|FG003|Core Treatment Period|Withdrawal by Subject|0|||
33403415|NCT00622700|62782204|FG004|Core Treatment Period|Withdrawal by Subject|0|||
33403416|NCT00622700|62782205|FG005|Core Treatment Period|Withdrawal by Subject|0|||
33403417|NCT00622700|62782206|FG006|Core Treatment Period|Withdrawal by Subject|0|||
33403418|NCT00622700|62782200|FG000|Core Treatment Period|Other than specified above|2|||
33403419|NCT00622700|62782201|FG001|Core Treatment Period|Other than specified above|2|||
33403420|NCT00622700|62782202|FG002|Core Treatment Period|Other than specified above|5|||
33403421|NCT00622700|62782203|FG003|Core Treatment Period|Other than specified above|0|||
33403422|NCT00622700|62782204|FG004|Core Treatment Period|Other than specified above|0|||
33403423|NCT00622700|62782205|FG005|Core Treatment Period|Other than specified above|0|||
33403424|NCT00622700|62782206|FG006|Core Treatment Period|Other than specified above|0|||
33403425|NCT00622700|62782200|FG000|Extension Treatment Period|Adverse Event|0|||
33403426|NCT00622700|62782201|FG001|Extension Treatment Period|Adverse Event|0|||
33403427|NCT00622700|62782202|FG002|Extension Treatment Period|Adverse Event|0|||
33403428|NCT00622700|62782203|FG003|Extension Treatment Period|Adverse Event|5|||
33403429|NCT00622700|62782204|FG004|Extension Treatment Period|Adverse Event|9|||
33403430|NCT00622700|62782205|FG005|Extension Treatment Period|Adverse Event|6|||
33403431|NCT00622700|62782206|FG006|Extension Treatment Period|Adverse Event|8|||
33403432|NCT00622700|62782200|FG000|Extension Treatment Period|Lack of Efficacy|0|||
33403433|NCT00622700|62782201|FG001|Extension Treatment Period|Lack of Efficacy|0|||
33320806|NCT01010061|62696530|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
33320807|NCT01010061|62696529|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33320808|NCT01010061|62696530|FG001|Overall Study|Insufficient Therapeutic Response|5|||
33320809|NCT01010061|62696529|FG000|Overall Study|Violation of Selection Criteria|0|||
33320810|NCT01010061|62696530|FG001|Overall Study|Violation of Selection Criteria|1|||
33320811|NCT01010061|62696529|FG000|Overall Study|Did Not Receive Treatment|2|||
33320812|NCT01010061|62696530|FG001|Overall Study|Did Not Receive Treatment|2|||
33320813|NCT00929734|62696550|FG000|Overall Study|Lost to Follow-up|2|||
33403434|NCT00622700|62782202|FG002|Extension Treatment Period|Lack of Efficacy|0|||
33403435|NCT00622700|62782203|FG003|Extension Treatment Period|Lack of Efficacy|2|||
33320814|NCT00929734|62696551|FG001|Overall Study|Lost to Follow-up|1|||
33320815|NCT00929734|62696550|FG000|Overall Study|Withdrawal by Subject|0|||
33320816|NCT00929734|62696551|FG001|Overall Study|Withdrawal by Subject|2|||
33320817|NCT01013883|62696559|FG000|Overall Study|Lost to Follow-up|2|||
33320818|NCT01013883|62696560|FG001|Overall Study|Lost to Follow-up|2|||
33403436|NCT00622700|62782204|FG004|Extension Treatment Period|Lack of Efficacy|8|||
33403437|NCT00622700|62782205|FG005|Extension Treatment Period|Lack of Efficacy|1|||
33403438|NCT00622700|62782206|FG006|Extension Treatment Period|Lack of Efficacy|9|||
33403439|NCT00622700|62782200|FG000|Extension Treatment Period|Protocol Violation|0|||
33403440|NCT00622700|62782201|FG001|Extension Treatment Period|Protocol Violation|0|||
33403441|NCT00622700|62782202|FG002|Extension Treatment Period|Protocol Violation|0|||
33403442|NCT00622700|62782203|FG003|Extension Treatment Period|Protocol Violation|0|||
33403443|NCT00622700|62782204|FG004|Extension Treatment Period|Protocol Violation|0|||
33403444|NCT00622700|62782205|FG005|Extension Treatment Period|Protocol Violation|2|||
33403445|NCT00622700|62782206|FG006|Extension Treatment Period|Protocol Violation|0|||
33403446|NCT00622700|62782200|FG000|Extension Treatment Period|Lost to Follow-up|0|||
33403447|NCT00622700|62782201|FG001|Extension Treatment Period|Lost to Follow-up|0|||
33403448|NCT00622700|62782202|FG002|Extension Treatment Period|Lost to Follow-up|0|||
33403449|NCT00622700|62782203|FG003|Extension Treatment Period|Lost to Follow-up|0|||
33403450|NCT00622700|62782204|FG004|Extension Treatment Period|Lost to Follow-up|1|||
33403451|NCT00622700|62782205|FG005|Extension Treatment Period|Lost to Follow-up|0|||
33403452|NCT00622700|62782206|FG006|Extension Treatment Period|Lost to Follow-up|0|||
33403453|NCT00622700|62782200|FG000|Extension Treatment Period|Progressive Disease|0|||
33403454|NCT00622700|62782201|FG001|Extension Treatment Period|Progressive Disease|0|||
33403455|NCT00622700|62782202|FG002|Extension Treatment Period|Progressive Disease|0|||
33403456|NCT00622700|62782203|FG003|Extension Treatment Period|Progressive Disease|1|||
33403457|NCT00622700|62782204|FG004|Extension Treatment Period|Progressive Disease|2|||
33403458|NCT00622700|62782205|FG005|Extension Treatment Period|Progressive Disease|0|||
33403459|NCT00622700|62782206|FG006|Extension Treatment Period|Progressive Disease|2|||
33403460|NCT00622700|62782200|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
33403461|NCT00622700|62782201|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
33403462|NCT00622700|62782202|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
33403463|NCT00622700|62782203|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
33403464|NCT00622700|62782204|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
33403465|NCT00622700|62782205|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
33403466|NCT00622700|62782206|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
33403467|NCT00622700|62782200|FG000|Extension Treatment Period|Missing|0|||
33403468|NCT00622700|62782201|FG001|Extension Treatment Period|Missing|0|||
33403469|NCT00622700|62782202|FG002|Extension Treatment Period|Missing|0|||
33403470|NCT00622700|62782203|FG003|Extension Treatment Period|Missing|2|||
33403471|NCT00622700|62782204|FG004|Extension Treatment Period|Missing|3|||
33403472|NCT00622700|62782205|FG005|Extension Treatment Period|Missing|1|||
33403473|NCT00622700|62782206|FG006|Extension Treatment Period|Missing|0|||
33403474|NCT00622700|62782200|FG000|Extension Treatment Period|Other than specified above|0|||
33403475|NCT00622700|62782201|FG001|Extension Treatment Period|Other than specified above|0|||
33403476|NCT00622700|62782202|FG002|Extension Treatment Period|Other than specified above|0|||
33403477|NCT00622700|62782203|FG003|Extension Treatment Period|Other than specified above|0|||
33403478|NCT00622700|62782204|FG004|Extension Treatment Period|Other than specified above|0|||
33403479|NCT00622700|62782205|FG005|Extension Treatment Period|Other than specified above|1|||
33403480|NCT00622700|62782206|FG006|Extension Treatment Period|Other than specified above|1|||
33403481|NCT00538473|62782225|FG000|Overall Study|Adverse Event|1|||
33403482|NCT00538473|62782226|FG001|Overall Study|Adverse Event|0|||
33403483|NCT00622466|62782232|FG000|Overall Study|Death|1|||
33403484|NCT00622466|62782232|FG000|Overall Study|Adverse Event|1|||
33403485|NCT00622466|62782232|FG000|Overall Study|Withdrawal by Subject|2|||
33403486|NCT00537771|62782238|FG000|Overall Study|Withdrawal by Subject|6|||
33403487|NCT00537771|62782239|FG001|Overall Study|Withdrawal by Subject|23|||
33403488|NCT00537771|62782238|FG000|Overall Study|Adverse Event|8|||
33403489|NCT00537771|62782239|FG001|Overall Study|Adverse Event|15|||
33403490|NCT00537771|62782238|FG000|Overall Study|Lost to Follow-up|9|||
33403491|NCT00537771|62782239|FG001|Overall Study|Lost to Follow-up|15|||
33403492|NCT00537771|62782238|FG000|Overall Study|Protocol Violation|2|||
33403493|NCT00537771|62782239|FG001|Overall Study|Protocol Violation|6|||
33403494|NCT00537771|62782238|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
33403495|NCT00537771|62782239|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
33403496|NCT00623480|62782247|FG000|Overall Study|Lost to Follow-up|0|||
33403497|NCT00623480|62782248|FG001|Overall Study|Lost to Follow-up|1|||
33403498|NCT00623480|62782247|FG000|Overall Study|Withdrawal by Subject|2|||
33403499|NCT00623480|62782248|FG001|Overall Study|Withdrawal by Subject|4|||
33320819|NCT01009983|62696566|FG000|Overall Study|necessary scans not completed|1|||
33320820|NCT01215227|62696580|FG000|Overall Study|Adverse Event|11|||
33320821|NCT01215227|62696581|FG001|Overall Study|Adverse Event|11|||
33320822|NCT01215227|62696582|FG002|Overall Study|Adverse Event|4|||
33320823|NCT01215227|62696583|FG003|Overall Study|Adverse Event|8|||
33320824|NCT01215227|62696584|FG004|Overall Study|Adverse Event|7|||
33320825|NCT01215227|62696585|FG005|Overall Study|Adverse Event|6|||
33320826|NCT01215227|62696580|FG000|Overall Study|Treatment Failure|8|||
33403500|NCT00623480|62782247|FG000|Overall Study|Lack of Efficacy|1|||
33403501|NCT00623480|62782248|FG001|Overall Study|Lack of Efficacy|0|||
33320827|NCT01215227|62696581|FG001|Overall Study|Treatment Failure|4|||
33320828|NCT01215227|62696582|FG002|Overall Study|Treatment Failure|1|||
33320829|NCT01215227|62696583|FG003|Overall Study|Treatment Failure|5|||
33320830|NCT01215227|62696584|FG004|Overall Study|Treatment Failure|1|||
33320831|NCT01215227|62696585|FG005|Overall Study|Treatment Failure|1|||
33320832|NCT01215227|62696580|FG000|Overall Study|Lost to Follow-up|1|||
33320833|NCT01215227|62696581|FG001|Overall Study|Lost to Follow-up|4|||
33320834|NCT01215227|62696582|FG002|Overall Study|Lost to Follow-up|1|||
33320835|NCT01215227|62696583|FG003|Overall Study|Lost to Follow-up|1|||
33320836|NCT01215227|62696584|FG004|Overall Study|Lost to Follow-up|1|||
33320837|NCT01215227|62696585|FG005|Overall Study|Lost to Follow-up|2|||
33320838|NCT01215227|62696580|FG000|Overall Study|Subject Withdrew Consent|16|||
33320839|NCT01215227|62696581|FG001|Overall Study|Subject Withdrew Consent|20|||
33320840|NCT01215227|62696582|FG002|Overall Study|Subject Withdrew Consent|7|||
33320841|NCT01215227|62696583|FG003|Overall Study|Subject Withdrew Consent|10|||
33320842|NCT01215227|62696584|FG004|Overall Study|Subject Withdrew Consent|11|||
33403502|NCT00623480|62782247|FG000|Overall Study|Non-compliant with study medication|4|||
33403503|NCT00623480|62782248|FG001|Overall Study|Non-compliant with study medication|0|||
33403504|NCT00623480|62782247|FG000|Overall Study|Protocol Violation|0|||
33403505|NCT00623480|62782248|FG001|Overall Study|Protocol Violation|1|||
33403506|NCT00623480|62782247|FG000|Overall Study|Site closed by sponsor|0|||
33403507|NCT00623480|62782248|FG001|Overall Study|Site closed by sponsor|1|||
33403508|NCT02513667|62782256|FG000|Overall Study|Withdrawal by Subject|0|||
33403509|NCT02513667|62782257|FG001|Overall Study|Withdrawal by Subject|1|||
33403510|NCT03823911|62782266|FG000|Overall Study|Lost to Follow-up|1|||
33403511|NCT03823911|62782267|FG001|Overall Study|Lost to Follow-up|5|||
33403512|NCT03823911|62782268|FG002|Overall Study|Lost to Follow-up|2|||
33403513|NCT03823911|62782266|FG000|Overall Study|Did not meet eligibility criteria|13|||
33403514|NCT03823911|62782267|FG001|Overall Study|Did not meet eligibility criteria|7|||
33403515|NCT03823911|62782268|FG002|Overall Study|Did not meet eligibility criteria|4|||
33403516|NCT03823911|62782266|FG000|Overall Study|Death|0|||
33403517|NCT03823911|62782267|FG001|Overall Study|Death|1|||
33403518|NCT03823911|62782268|FG002|Overall Study|Death|0|||
33403519|NCT00621764|62782279|FG000|Overall Study|Protocol Violation|0|||
33403520|NCT00621764|62782280|FG001|Overall Study|Protocol Violation|0|||
33403521|NCT00621764|62782281|FG002|Overall Study|Protocol Violation|0|||
33403522|NCT00621764|62782282|FG003|Overall Study|Protocol Violation|1|||
33403523|NCT00510718|62782300|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
33403524|NCT00510718|62782301|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
33403525|NCT00510718|62782300|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
33403526|NCT00510718|62782301|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
33403527|NCT00510718|62782300|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
33403528|NCT00510718|62782301|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
33403529|NCT00510718|62782300|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
33403530|NCT00510718|62782301|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
33403531|NCT00510718|62782300|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
33403532|NCT00510718|62782301|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
33403533|NCT00510718|62782300|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
33320843|NCT01215227|62696585|FG005|Overall Study|Subject Withdrew Consent|8|||
33320844|NCT01215227|62696580|FG000|Overall Study|Non-Compliance With Protocol|2|||
33320845|NCT01215227|62696581|FG001|Overall Study|Non-Compliance With Protocol|6|||
33320846|NCT01215227|62696582|FG002|Overall Study|Non-Compliance With Protocol|1|||
33320847|NCT01215227|62696583|FG003|Overall Study|Non-Compliance With Protocol|0|||
33320848|NCT01215227|62696584|FG004|Overall Study|Non-Compliance With Protocol|0|||
33320849|NCT01215227|62696585|FG005|Overall Study|Non-Compliance With Protocol|0|||
33403534|NCT00510718|62782301|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
33403535|NCT00537381|62782322|FG000|Overall Study|Adverse Event|13|||
33403536|NCT00537381|62782323|FG001|Overall Study|Adverse Event|9|||
33403537|NCT00537381|62782322|FG000|Overall Study|Death|3|||
33403538|NCT00537381|62782323|FG001|Overall Study|Death|3|||
33403539|NCT00537381|62782322|FG000|Overall Study|Withdrawal by Subject|5|||
33403540|NCT00537381|62782323|FG001|Overall Study|Withdrawal by Subject|14|||
33320850|NCT01215227|62696580|FG000|Overall Study|Administrative|83|||
33320851|NCT01215227|62696581|FG001|Overall Study|Administrative|73|||
33320852|NCT01215227|62696582|FG002|Overall Study|Administrative|42|||
33320853|NCT01215227|62696583|FG003|Overall Study|Administrative|24|||
33403541|NCT00537381|62782322|FG000|Overall Study|Physician Decision|7|||
33403542|NCT00537381|62782323|FG001|Overall Study|Physician Decision|6|||
33403543|NCT00537381|62782322|FG000|Overall Study|Disease Progression|9|||
33403544|NCT00537381|62782323|FG001|Overall Study|Disease Progression|18|||
33403545|NCT00537381|62782322|FG000|Overall Study|Sponsor decision|14|||
33403546|NCT00537381|62782323|FG001|Overall Study|Sponsor decision|9|||
33403547|NCT00537381|62782322|FG000|Overall Study|Other|5|||
33403548|NCT00537381|62782323|FG001|Overall Study|Other|3|||
33403549|NCT03791398|62782334|FG000|Overall Study|Progression of Disease Under Study|2|||
33403550|NCT03791398|62782335|FG001|Overall Study|Progression of Disease Under Study|0|||
33403551|NCT03791398|62782336|FG002|Overall Study|Progression of Disease Under Study|0|||
33403552|NCT00517192|62782342|FG000|Overall Study|Adverse Event|1|||
33403553|NCT00517192|62782343|FG001|Overall Study|Adverse Event|1|||
33403554|NCT00517192|62782342|FG000|Overall Study|Lost to Follow-up|1|||
33403555|NCT00517192|62782343|FG001|Overall Study|Lost to Follow-up|1|||
33403556|NCT00517192|62782342|FG000|Overall Study|Withdrawal by Subject|1|||
33403557|NCT00517192|62782343|FG001|Overall Study|Withdrawal by Subject|0|||
33320854|NCT01215227|62696584|FG004|Overall Study|Administrative|28|||
33320855|NCT01215227|62696585|FG005|Overall Study|Administrative|40|||
33320856|NCT01215227|62696580|FG000|Overall Study|Missing Status|0|||
33320857|NCT01215227|62696581|FG001|Overall Study|Missing Status|1|||
33320858|NCT01215227|62696582|FG002|Overall Study|Missing Status|0|||
33320859|NCT01215227|62696583|FG003|Overall Study|Missing Status|0|||
33320860|NCT01215227|62696584|FG004|Overall Study|Missing Status|0|||
33320861|NCT01215227|62696585|FG005|Overall Study|Missing Status|0|||
33320862|NCT01215227|62696580|FG000|Overall Study|Randomized but not treated|0|||
33320863|NCT01215227|62696581|FG001|Overall Study|Randomized but not treated|0|||
33320864|NCT01215227|62696582|FG002|Overall Study|Randomized but not treated|1|||
33320865|NCT01215227|62696583|FG003|Overall Study|Randomized but not treated|1|||
33320866|NCT01215227|62696584|FG004|Overall Study|Randomized but not treated|0|||
33320867|NCT01215227|62696585|FG005|Overall Study|Randomized but not treated|1|||
33320868|NCT01009515|62696599|FG000|Overall Study|Withdrawal by Subject|3|||
33403558|NCT00517192|62782342|FG000|Overall Study|Early termination of the trial|16|||
33403559|NCT00517192|62782343|FG001|Overall Study|Early termination of the trial|18|||
33403560|NCT00625820|62782349|FG000|Overall Study|Withdrawal by Subject|1|||
33403561|NCT00145327|62782357|FG000|Overall Study|Withdrawal by Subject|77|||
33403562|NCT00145327|62782358|FG001|Overall Study|Withdrawal by Subject|72|||
33403563|NCT00145327|62782359|FG002|Overall Study|Withdrawal by Subject|164|||
33320869|NCT01214915|62696603|FG000|Overall Study|Adverse Event|8|||
33320870|NCT01214915|62696603|FG000|Overall Study|Lack of Efficacy|3|||
33320871|NCT01009281|62696607|FG000|Overall Study|Administrative problems|7|||
33320872|NCT01009203|62696611|FG000|Overall Study|Withdrawal by Subject|1|||
33403564|NCT00145327|62782357|FG000|Overall Study|Death|26|||
33403565|NCT00145327|62782358|FG001|Overall Study|Death|18|||
33403566|NCT00145327|62782359|FG002|Overall Study|Death|30|||
33403567|NCT00145327|62782357|FG000|Overall Study|Adverse Event|14|||
33320873|NCT01009203|62696611|FG000|Overall Study|Adverse Event|5|||
33320874|NCT01009203|62696611|FG000|Overall Study|Treatment-unrelated death|1|||
33320875|NCT01009047|62696617|FG000|Overall Study|Adverse Event|5|||
33403568|NCT00145327|62782358|FG001|Overall Study|Adverse Event|11|||
33403569|NCT00145327|62782359|FG002|Overall Study|Adverse Event|22|||
33403570|NCT00145327|62782357|FG000|Overall Study|Lost to Follow-up|9|||
33403571|NCT00145327|62782358|FG001|Overall Study|Lost to Follow-up|14|||
33403572|NCT00145327|62782359|FG002|Overall Study|Lost to Follow-up|14|||
33403573|NCT00145327|62782357|FG000|Overall Study|Administrative problems|12|||
33403574|NCT00145327|62782358|FG001|Overall Study|Administrative problems|9|||
33403575|NCT00145327|62782359|FG002|Overall Study|Administrative problems|13|||
33403576|NCT00145327|62782357|FG000|Overall Study|Protocol Violation|2|||
33403577|NCT00145327|62782358|FG001|Overall Study|Protocol Violation|0|||
33403578|NCT00145327|62782359|FG002|Overall Study|Protocol Violation|2|||
33403579|NCT00145327|62782357|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33403580|NCT00145327|62782358|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33493942|NCT03105362|62872505|FG000|Overall Study|Withdrawal by Subject|1|||
33493943|NCT03105362|62872505|FG000|Overall Study|Lost to Follow-up|1|||
33493944|NCT03559218|62872514|FG000|Overall Study|Withdrawal by Subject|1|||
33403581|NCT00145327|62782359|FG002|Overall Study|Abnormal laboratory value(s)|2|||
33403582|NCT00145327|62782357|FG000|Overall Study|Missing - not stated|1|||
33403583|NCT00145327|62782358|FG001|Overall Study|Missing - not stated|0|||
33403584|NCT00145327|62782359|FG002|Overall Study|Missing - not stated|1|||
33403585|NCT00510484|62782369|FG000|Wash-out Period|Adverse Event|0|||
33403586|NCT00510484|62782370|FG001|Wash-out Period|Adverse Event|1|||
33403587|NCT00622388|62782376|FG000|Overall Study|Disease Progression|47|||
33403588|NCT00622388|62782376|FG000|Overall Study|Adverse Event|6|||
33403589|NCT00622388|62782376|FG000|Overall Study|Protocol Violation|3|||
33403590|NCT00622388|62782376|FG000|Overall Study|Participant Refusal|1|||
33403591|NCT00622388|62782376|FG000|Overall Study|Death|3|||
33403592|NCT00622388|62782376|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
33403593|NCT00622388|62782376|FG000|Overall Study|Took Prohibited Medication|2|||
33403594|NCT00622388|62782376|FG000|Overall Study|Withdrew Consent|1|||
33403595|NCT00622388|62782376|FG000|Overall Study|Insurance Expired|1|||
33403596|NCT01156389|62782383|FG000|Overall Study|Elevated liver enzymes|4|||
33403597|NCT01156389|62782384|FG001|Overall Study|Elevated liver enzymes|0|||
33403598|NCT01156389|62782383|FG000|Overall Study|Vomiting|0|||
33403599|NCT01156389|62782384|FG001|Overall Study|Vomiting|1|||
33403600|NCT01105767|62782393|FG000|Overall Study|Lost to Follow-up|1160|||
33403601|NCT01105767|62782394|FG001|Overall Study|Lost to Follow-up|1614|||
33403602|NCT01105767|62782395|FG002|Overall Study|Lost to Follow-up|1184|||
33403603|NCT03693430|62782405|FG000|Overall Study|Lost to Follow-up|3|||
33403604|NCT03693430|62782406|FG001|Overall Study|Lost to Follow-up|14|||
33403605|NCT03693430|62782405|FG000|Overall Study|Death|1|||
33403606|NCT03693430|62782406|FG001|Overall Study|Death|0|||
33403607|NCT03693430|62782405|FG000|Overall Study|Withdrawal by Subject|0|||
33403608|NCT03693430|62782406|FG001|Overall Study|Withdrawal by Subject|4|||
33403609|NCT00625742|62782412|FG000|Overall Study|Disease Progression|2|||
33403610|NCT00625742|62782412|FG000|Overall Study|Withdrawal by Subject|1|||
33403611|NCT00625742|62782412|FG000|Overall Study|Adverse Event|4|||
33403612|NCT00625742|62782412|FG000|Overall Study|Lost to Follow-up|4|||
33403613|NCT00625742|62782412|FG000|Overall Study|Ineligible|1|||
33403614|NCT00621296|62782425|FG000|Overall Study|Adverse Event|2|||
33403615|NCT00621296|62782425|FG000|Overall Study|Lack of Efficacy|1|||
33403616|NCT00621296|62782425|FG000|Overall Study|Physician Decision|7|||
33403617|NCT00621296|62782425|FG000|Overall Study|Unmatch Criteria|1|||
33403618|NCT00621296|62782425|FG000|Overall Study|Stopping Criteria|3|||
33598302|NCT02496767|62997149|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
33598303|NCT02496767|62997150|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
33320876|NCT01009047|62696618|FG001|Overall Study|Adverse Event|0|||
33320877|NCT01009047|62696617|FG000|Overall Study|Lost to Follow-up|0|||
33320878|NCT01009047|62696618|FG001|Overall Study|Lost to Follow-up|2|||
33320879|NCT01009047|62696617|FG000|Overall Study|Lack of Efficacy|4|||
33320880|NCT01009047|62696618|FG001|Overall Study|Lack of Efficacy|11|||
33320881|NCT01009047|62696617|FG000|Overall Study|Withdrawal by consent|16|||
33320882|NCT01009047|62696618|FG001|Overall Study|Withdrawal by consent|11|||
33320883|NCT01009047|62696617|FG000|Overall Study|Other|3|||
33320884|NCT01009047|62696618|FG001|Overall Study|Other|2|||
33320885|NCT01025193|62696624|FG000|Overall Study|Protocol Violation|1|||
33320886|NCT01025193|62696624|FG000|Overall Study|Adverse Event|3|||
33320887|NCT01025037|62696632|FG000|Overall Study|Adverse Event|3|||
33320888|NCT01025037|62696632|FG000|Overall Study|Lost to Follow-up|7|||
33493945|NCT03559218|62872515|FG001|Overall Study|Withdrawal by Subject|0|||
33320889|NCT01025037|62696632|FG000|Overall Study|Withdrawal by Subject|1|||
33320890|NCT01214837|62696639|FG000|Overall Study|Death|0|||
33320891|NCT01214837|62696640|FG001|Overall Study|Death|0|||
33320892|NCT01214837|62696641|FG002|Overall Study|Death|1|||
33403619|NCT00537303|62782431|FG000|Overall Study|Adverse Event|1|||
33403620|NCT00537303|62782432|FG001|Overall Study|Adverse Event|4|||
33403621|NCT00537303|62782431|FG000|Overall Study|Lack of Efficacy|6|||
33403622|NCT00537303|62782432|FG001|Overall Study|Lack of Efficacy|7|||
33403623|NCT00537303|62782431|FG000|Overall Study|Protocol Violation|8|||
33403624|NCT00537303|62782432|FG001|Overall Study|Protocol Violation|4|||
33403625|NCT00537303|62782431|FG000|Overall Study|Withdrawal criteria|3|||
33403626|NCT00537303|62782432|FG001|Overall Study|Withdrawal criteria|3|||
33403627|NCT00537303|62782431|FG000|Overall Study|Unclassified|8|||
33403628|NCT00537303|62782432|FG001|Overall Study|Unclassified|7|||
33403629|NCT00505414|62782440|FG000|Titration Phase|Adverse Event|0|||
33403630|NCT00505414|62782441|FG001|Titration Phase|Adverse Event|0|||
33403631|NCT00505414|62782442|FG002|Titration Phase|Adverse Event|0|||
33403632|NCT00505414|62782443|FG003|Titration Phase|Adverse Event|8|||
33403633|NCT00505414|62782444|FG004|Titration Phase|Adverse Event|3|||
33403634|NCT00505414|62782440|FG000|Titration Phase|Death|0|||
33403635|NCT00505414|62782441|FG001|Titration Phase|Death|0|||
33403636|NCT00505414|62782442|FG002|Titration Phase|Death|0|||
33403637|NCT00505414|62782443|FG003|Titration Phase|Death|2|||
33403638|NCT00505414|62782444|FG004|Titration Phase|Death|0|||
33403639|NCT00505414|62782440|FG000|Titration Phase|Lack of Efficacy|0|||
33403640|NCT00505414|62782441|FG001|Titration Phase|Lack of Efficacy|0|||
33403641|NCT00505414|62782442|FG002|Titration Phase|Lack of Efficacy|0|||
33403642|NCT00505414|62782443|FG003|Titration Phase|Lack of Efficacy|10|||
33403643|NCT00505414|62782444|FG004|Titration Phase|Lack of Efficacy|1|||
33403644|NCT00505414|62782440|FG000|Titration Phase|Protocol Violation|0|||
33403645|NCT00505414|62782441|FG001|Titration Phase|Protocol Violation|0|||
33403646|NCT00505414|62782442|FG002|Titration Phase|Protocol Violation|0|||
33403647|NCT00505414|62782443|FG003|Titration Phase|Protocol Violation|0|||
33403648|NCT00505414|62782444|FG004|Titration Phase|Protocol Violation|1|||
33403649|NCT00505414|62782440|FG000|Titration Phase|Withdrawal by Subject|0|||
33403650|NCT00505414|62782441|FG001|Titration Phase|Withdrawal by Subject|0|||
33403651|NCT00505414|62782442|FG002|Titration Phase|Withdrawal by Subject|0|||
33403652|NCT00505414|62782443|FG003|Titration Phase|Withdrawal by Subject|3|||
33403653|NCT00505414|62782444|FG004|Titration Phase|Withdrawal by Subject|4|||
33403654|NCT00505414|62782440|FG000|Titration Phase|Underlying disease and therapy required|0|||
33403655|NCT00505414|62782441|FG001|Titration Phase|Underlying disease and therapy required|0|||
33403656|NCT00505414|62782442|FG002|Titration Phase|Underlying disease and therapy required|0|||
33403657|NCT00505414|62782443|FG003|Titration Phase|Underlying disease and therapy required|7|||
33403658|NCT00505414|62782444|FG004|Titration Phase|Underlying disease and therapy required|3|||
33403659|NCT00505414|62782440|FG000|Maintenance Phase|Adverse Event|2|||
33403660|NCT00505414|62782441|FG001|Maintenance Phase|Adverse Event|2|||
33403661|NCT00505414|62782442|FG002|Maintenance Phase|Adverse Event|3|||
33403662|NCT00505414|62782443|FG003|Maintenance Phase|Adverse Event|0|||
33403663|NCT00505414|62782444|FG004|Maintenance Phase|Adverse Event|0|||
33403664|NCT00505414|62782440|FG000|Maintenance Phase|Death|2|||
33403665|NCT00505414|62782441|FG001|Maintenance Phase|Death|0|||
33403666|NCT00505414|62782442|FG002|Maintenance Phase|Death|1|||
33403667|NCT00505414|62782443|FG003|Maintenance Phase|Death|0|||
33403668|NCT00505414|62782444|FG004|Maintenance Phase|Death|0|||
33403669|NCT00505414|62782440|FG000|Maintenance Phase|Lack of Efficacy|2|||
33403670|NCT00505414|62782441|FG001|Maintenance Phase|Lack of Efficacy|1|||
33493946|NCT03104816|62872524|FG000|Overall Study|Lack of Efficacy|0|||
33403671|NCT00505414|62782442|FG002|Maintenance Phase|Lack of Efficacy|1|||
33403672|NCT00505414|62782443|FG003|Maintenance Phase|Lack of Efficacy|0|||
33403673|NCT00505414|62782444|FG004|Maintenance Phase|Lack of Efficacy|0|||
33403674|NCT00505414|62782440|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33403675|NCT00505414|62782441|FG001|Maintenance Phase|Withdrawal by Subject|0|||
33403676|NCT00505414|62782442|FG002|Maintenance Phase|Withdrawal by Subject|1|||
33403677|NCT00505414|62782443|FG003|Maintenance Phase|Withdrawal by Subject|0|||
33403678|NCT00505414|62782444|FG004|Maintenance Phase|Withdrawal by Subject|0|||
33403679|NCT00505414|62782440|FG000|Maintenance Phase|underlying disease and therapy required|0|||
33403680|NCT00505414|62782441|FG001|Maintenance Phase|underlying disease and therapy required|2|||
33403681|NCT00505414|62782442|FG002|Maintenance Phase|underlying disease and therapy required|2|||
33403682|NCT00505414|62782443|FG003|Maintenance Phase|underlying disease and therapy required|0|||
33403683|NCT00505414|62782444|FG004|Maintenance Phase|underlying disease and therapy required|0|||
33403684|NCT00625586|62782460|FG000|Overall Study|Adverse Event|1|||
33403685|NCT00144781|62782482|FG000|Overall Study|Adverse Event|0|||
33403686|NCT00144781|62782483|FG001|Overall Study|Adverse Event|1|||
33403687|NCT00144781|62782484|FG002|Overall Study|Adverse Event|0|||
33403688|NCT00144781|62782485|FG003|Overall Study|Adverse Event|0|||
33403689|NCT00144781|62782482|FG000|Overall Study|Non-compliant|0|||
33403690|NCT00144781|62782483|FG001|Overall Study|Non-compliant|1|||
33403691|NCT00144781|62782484|FG002|Overall Study|Non-compliant|0|||
33403692|NCT00144781|62782485|FG003|Overall Study|Non-compliant|0|||
33403693|NCT00621140|62782501|FG000|Overall Study|Adverse Event|4|||
33320893|NCT01214837|62696639|FG000|Overall Study|Adverse Event|1|||
33320894|NCT01214837|62696640|FG001|Overall Study|Adverse Event|2|||
33320895|NCT01214837|62696641|FG002|Overall Study|Adverse Event|1|||
33320896|NCT01214837|62696639|FG000|Overall Study|Withdrawal by Subject|27|||
33320897|NCT01214837|62696640|FG001|Overall Study|Withdrawal by Subject|36|||
33320898|NCT01214837|62696641|FG002|Overall Study|Withdrawal by Subject|28|||
33320899|NCT01214837|62696639|FG000|Overall Study|Lost to Follow-up|20|||
33320900|NCT01214837|62696640|FG001|Overall Study|Lost to Follow-up|15|||
33320901|NCT01214837|62696641|FG002|Overall Study|Lost to Follow-up|21|||
33403694|NCT00621140|62782502|FG001|Overall Study|Adverse Event|5|||
33403695|NCT00621140|62782501|FG000|Overall Study|Lost to Follow-up|1|||
33403696|NCT00621140|62782502|FG001|Overall Study|Lost to Follow-up|2|||
33403697|NCT00621140|62782501|FG000|Overall Study|Withdrawal by Subject|4|||
33403698|NCT00621140|62782502|FG001|Overall Study|Withdrawal by Subject|6|||
33403699|NCT00621140|62782501|FG000|Overall Study|Other incl. lack of efficacy|6|||
33403700|NCT00621140|62782502|FG001|Overall Study|Other incl. lack of efficacy|5|||
33403701|NCT00207727|62782513|FG000|Overall Study|Withdrawal by Subject|0|||
33403702|NCT00207727|62782514|FG001|Overall Study|Withdrawal by Subject|0|||
33403703|NCT00207727|62782515|FG002|Overall Study|Withdrawal by Subject|0|||
33403704|NCT00207727|62782516|FG003|Overall Study|Withdrawal by Subject|0|||
33403705|NCT00207727|62782517|FG004|Overall Study|Withdrawal by Subject|1|||
33403706|NCT00207727|62782513|FG000|Overall Study|Lost to Follow-up|0|||
33403707|NCT00207727|62782514|FG001|Overall Study|Lost to Follow-up|1|||
33403708|NCT00207727|62782515|FG002|Overall Study|Lost to Follow-up|0|||
33403709|NCT00207727|62782516|FG003|Overall Study|Lost to Follow-up|0|||
33403710|NCT00207727|62782517|FG004|Overall Study|Lost to Follow-up|0|||
33403711|NCT00207727|62782513|FG000|Overall Study|Other|38|||
33403712|NCT00207727|62782514|FG001|Overall Study|Other|41|||
33403713|NCT00207727|62782515|FG002|Overall Study|Other|41|||
33403714|NCT00207727|62782516|FG003|Overall Study|Other|37|||
33403715|NCT00207727|62782517|FG004|Overall Study|Other|33|||
33403716|NCT00504556|62782534|FG000|Overall Study|Adverse Event|11|||
33403717|NCT00504556|62782535|FG001|Overall Study|Adverse Event|11|||
33403718|NCT00504556|62782536|FG002|Overall Study|Adverse Event|14|||
33598304|NCT02496767|62997151|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
33598305|NCT02496767|62997144|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33598306|NCT02496767|62997145|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
33598307|NCT02496767|62997146|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33598308|NCT02496767|62997147|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
33598309|NCT02496767|62997148|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
33598310|NCT02496767|62997149|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33598311|NCT02496767|62997150|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33598312|NCT02496767|62997151|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33598313|NCT02496767|62997144|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
33598314|NCT02496767|62997145|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
33598315|NCT02496767|62997146|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
33598316|NCT02496767|62997147|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
33598317|NCT02496767|62997148|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
33598318|NCT02496767|62997149|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
33598319|NCT02496767|62997150|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
33598320|NCT02496767|62997151|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
33598321|NCT02496767|62997144|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
33598322|NCT02496767|62997145|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
33598323|NCT02496767|62997146|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
33598324|NCT02496767|62997147|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
33598325|NCT02496767|62997148|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
33403719|NCT00504556|62782537|FG003|Overall Study|Adverse Event|13|||
33403720|NCT00504556|62782538|FG004|Overall Study|Adverse Event|5|||
33403721|NCT00504556|62782534|FG000|Overall Study|Death|3|||
33403722|NCT00504556|62782535|FG001|Overall Study|Death|3|||
33403723|NCT00504556|62782536|FG002|Overall Study|Death|1|||
33403724|NCT00504556|62782537|FG003|Overall Study|Death|0|||
33403725|NCT00504556|62782538|FG004|Overall Study|Death|2|||
33403726|NCT00504556|62782534|FG000|Overall Study|Protocol Violation|1|||
33403727|NCT00504556|62782535|FG001|Overall Study|Protocol Violation|3|||
33403728|NCT00504556|62782536|FG002|Overall Study|Protocol Violation|2|||
33403729|NCT00504556|62782537|FG003|Overall Study|Protocol Violation|1|||
33403730|NCT00504556|62782538|FG004|Overall Study|Protocol Violation|2|||
33403731|NCT00504556|62782534|FG000|Overall Study|Lost to Follow-up|0|||
33403732|NCT00504556|62782535|FG001|Overall Study|Lost to Follow-up|0|||
33403733|NCT00504556|62782536|FG002|Overall Study|Lost to Follow-up|1|||
33403734|NCT00504556|62782537|FG003|Overall Study|Lost to Follow-up|1|||
33403735|NCT00504556|62782538|FG004|Overall Study|Lost to Follow-up|1|||
33403736|NCT00504556|62782534|FG000|Overall Study|Withdrawal by Subject|16|||
33403737|NCT00504556|62782535|FG001|Overall Study|Withdrawal by Subject|16|||
33493947|NCT03104816|62872525|FG001|Overall Study|Lack of Efficacy|2|||
33403738|NCT00504556|62782536|FG002|Overall Study|Withdrawal by Subject|7|||
33403739|NCT00504556|62782537|FG003|Overall Study|Withdrawal by Subject|8|||
33403740|NCT00504556|62782538|FG004|Overall Study|Withdrawal by Subject|12|||
33320902|NCT01214837|62696639|FG000|Overall Study|Inappropriate Enrolment|0|||
33320903|NCT01214837|62696640|FG001|Overall Study|Inappropriate Enrolment|1|||
33320904|NCT01214837|62696641|FG002|Overall Study|Inappropriate Enrolment|2|||
33320905|NCT01214837|62696639|FG000|Overall Study|Administrative Reason|2|||
33320906|NCT01214837|62696640|FG001|Overall Study|Administrative Reason|6|||
33320907|NCT01214837|62696641|FG002|Overall Study|Administrative Reason|4|||
33320908|NCT01214837|62696639|FG000|Overall Study|Protocol Violation|3|||
33403741|NCT00504556|62782534|FG000|Overall Study|administrative reasons|0|||
33403742|NCT00504556|62782535|FG001|Overall Study|administrative reasons|2|||
33403743|NCT00504556|62782536|FG002|Overall Study|administrative reasons|2|||
33403744|NCT00504556|62782537|FG003|Overall Study|administrative reasons|1|||
33320909|NCT01214837|62696640|FG001|Overall Study|Protocol Violation|1|||
33320910|NCT01214837|62696641|FG002|Overall Study|Protocol Violation|5|||
33320911|NCT01214837|62696639|FG000|Overall Study|Unable to Classify|1|||
33320912|NCT01214837|62696640|FG001|Overall Study|Unable to Classify|3|||
33320913|NCT01214837|62696641|FG002|Overall Study|Unable to Classify|0|||
33320914|NCT01024959|62696650|FG000|Overall Study|ineligible|12|||
33320915|NCT01024959|62696650|FG000|Overall Study|results not evaluable|12|||
33320916|NCT01024959|62696650|FG000|Overall Study|missing results required for analysis|17|||
33320917|NCT03672175|62696662|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
33320918|NCT03672175|62696663|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
33320919|NCT03672175|62696664|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
33320920|NCT03672175|62696662|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
33320921|NCT03672175|62696663|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
33320922|NCT03672175|62696664|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
33403745|NCT00504556|62782538|FG004|Overall Study|administrative reasons|2|||
33403746|NCT00504556|62782534|FG000|Overall Study|did not meet entry criteria|2|||
33403747|NCT00504556|62782535|FG001|Overall Study|did not meet entry criteria|0|||
33403748|NCT00504556|62782536|FG002|Overall Study|did not meet entry criteria|1|||
33403749|NCT00504556|62782537|FG003|Overall Study|did not meet entry criteria|1|||
33403750|NCT00504556|62782538|FG004|Overall Study|did not meet entry criteria|0|||
33403751|NCT00504556|62782534|FG000|Overall Study|data monitor committee decision|0|||
33403752|NCT00504556|62782535|FG001|Overall Study|data monitor committee decision|0|||
33403753|NCT00504556|62782536|FG002|Overall Study|data monitor committee decision|0|||
33403754|NCT00504556|62782537|FG003|Overall Study|data monitor committee decision|100|||
33403755|NCT00504556|62782538|FG004|Overall Study|data monitor committee decision|0|||
33403756|NCT00504556|62782534|FG000|Overall Study|Other|2|||
33403757|NCT00504556|62782535|FG001|Overall Study|Other|2|||
33403758|NCT00504556|62782536|FG002|Overall Study|Other|2|||
33403759|NCT00504556|62782537|FG003|Overall Study|Other|3|||
33403760|NCT00504556|62782538|FG004|Overall Study|Other|0|||
33403761|NCT00504556|62782534|FG000|Overall Study|not in safety analysis set|0|||
33403762|NCT00504556|62782535|FG001|Overall Study|not in safety analysis set|1|||
33403763|NCT00504556|62782536|FG002|Overall Study|not in safety analysis set|1|||
33403764|NCT00504556|62782537|FG003|Overall Study|not in safety analysis set|0|||
33403765|NCT00504556|62782538|FG004|Overall Study|not in safety analysis set|1|||
33403766|NCT00206323|62782552|FG000|Overall Study|Lack of Efficacy|4|||
33403767|NCT00206323|62782553|FG001|Overall Study|Lack of Efficacy|1|||
33403768|NCT00206323|62782552|FG000|Overall Study|Adverse Event|1|||
33403769|NCT00206323|62782553|FG001|Overall Study|Adverse Event|1|||
33403770|NCT00206323|62782552|FG000|Overall Study|Lost to Follow-up|1|||
33403771|NCT00206323|62782553|FG001|Overall Study|Lost to Follow-up|1|||
33403772|NCT03903159|62782559|FG000|Overall Study|Discharged with Staff Approval|2|||
33403773|NCT03903159|62782559|FG000|Overall Study|Discharged at Staff Request|2|||
33403774|NCT03903159|62782559|FG000|Overall Study|Discharged Against Staff Advice|1|||
33403775|NCT00205855|62782563|FG000|Overall Study|Only received temporary implants|16|||
33403776|NCT00205855|62782563|FG000|Overall Study|Withdrawal by Subject|5|||
33403777|NCT00536991|62782567|FG000|Overall Study|Withdrawal by Subject|10|||
33403778|NCT00536991|62782567|FG000|Overall Study|Physician Decision|1|||
33403779|NCT00536991|62782567|FG000|Overall Study|patient ineligible|2|||
33403780|NCT03902613|62782572|FG000|Overall Study|Physician Decision|1|||
33403781|NCT00504166|62782578|FG000|Overall Study|Adverse Event|1|||
33403782|NCT00504166|62782579|FG001|Overall Study|Adverse Event|4|||
33403783|NCT00504166|62782578|FG000|Overall Study|Withdrawal by Subject|3|||
33403784|NCT00504166|62782579|FG001|Overall Study|Withdrawal by Subject|6|||
33403785|NCT00504166|62782578|FG000|Overall Study|Physician Decision|1|||
33403786|NCT00504166|62782579|FG001|Overall Study|Physician Decision|1|||
33403787|NCT00504166|62782578|FG000|Overall Study|Lost to Follow-up|1|||
33403788|NCT00504166|62782579|FG001|Overall Study|Lost to Follow-up|3|||
33403789|NCT00509236|62782587|FG000|Overall Study|Adverse Event|7|||
33403790|NCT00509236|62782588|FG001|Overall Study|Adverse Event|9|||
33403791|NCT00509236|62782587|FG000|Overall Study|Withdrawal by Subject|5|||
33403792|NCT00509236|62782588|FG001|Overall Study|Withdrawal by Subject|10|||
33403793|NCT00509236|62782587|FG000|Overall Study|Protocol Violation|3|||
33403794|NCT00509236|62782588|FG001|Overall Study|Protocol Violation|0|||
33403795|NCT00509236|62782587|FG000|Overall Study|Excluded Medication|1|||
33403796|NCT00509236|62782588|FG001|Overall Study|Excluded Medication|1|||
33403797|NCT00509236|62782587|FG000|Overall Study|Scheduled Kidney Transplant|1|||
33403798|NCT00509236|62782588|FG001|Overall Study|Scheduled Kidney Transplant|0|||
33403799|NCT00508924|62782598|FG000|Overall Study|Protocol Violation|0|||
33403800|NCT00508924|62782599|FG001|Overall Study|Protocol Violation|0|||
33403801|NCT00508924|62782600|FG002|Overall Study|Protocol Violation|1|||
33403802|NCT00508924|62782601|FG003|Overall Study|Protocol Violation|1|||
33403803|NCT00620750|62782611|FG000|Overall Study|Lost to Follow-up|25|||
33403804|NCT00508144|62782615|FG000|Overall Study|Not eligible|6|||
33403805|NCT00508144|62782615|FG000|Overall Study|Death|5|||
33403806|NCT00621842|62782619|FG000|Overall Study|Adverse Event|6|||
33403807|NCT00621842|62782619|FG000|Overall Study|Withdrawal by Subject|7|||
33403808|NCT00621842|62782619|FG000|Overall Study|Protocol Violation|4|||
33403809|NCT00621842|62782619|FG000|Overall Study|Lack of Efficacy|2|||
33403810|NCT00503776|62782627|FG000|Overall Study|Withdrawal by Subject|1|||
33403811|NCT00503776|62782628|FG001|Overall Study|Withdrawal by Subject|0|||
33403812|NCT00503776|62782629|FG002|Overall Study|Withdrawal by Subject|1|||
33403813|NCT00503776|62782630|FG003|Overall Study|Withdrawal by Subject|1|||
33403814|NCT00503776|62782627|FG000|Overall Study|Physician Decision|0|||
33403815|NCT00503776|62782628|FG001|Overall Study|Physician Decision|0|||
33403816|NCT00503776|62782629|FG002|Overall Study|Physician Decision|1|||
33403817|NCT00503776|62782630|FG003|Overall Study|Physician Decision|1|||
33403818|NCT00619112|62782647|FG000|Overall Study|Adverse Event|1|||
33403819|NCT00619112|62782648|FG001|Overall Study|Adverse Event|2|||
33403820|NCT00619502|62782659|FG000|Overall Study|Lost to Follow-up|8|||
33403821|NCT00619502|62782660|FG001|Overall Study|Lost to Follow-up|10|||
33403822|NCT00618956|62782670|FG000|Overall Study|Adverse Event|10|||
33403823|NCT00618956|62782671|FG001|Overall Study|Adverse Event|34|||
33403824|NCT00618956|62782670|FG000|Overall Study|Lack of Efficacy|2|||
33403825|NCT00618956|62782671|FG001|Overall Study|Lack of Efficacy|1|||
33403826|NCT00618956|62782670|FG000|Overall Study|Withdrawal by Subject|5|||
33403827|NCT00618956|62782671|FG001|Overall Study|Withdrawal by Subject|7|||
33403828|NCT00618956|62782670|FG000|Overall Study|Lost to Follow-up|4|||
33403829|NCT00618956|62782671|FG001|Overall Study|Lost to Follow-up|5|||
33403830|NCT00618956|62782670|FG000|Overall Study|Protocol Violation|2|||
33403831|NCT00618956|62782671|FG001|Overall Study|Protocol Violation|2|||
33403832|NCT00618956|62782670|FG000|Overall Study|did not meet criteria, non-compliance|2|||
33403833|NCT00618956|62782671|FG001|Overall Study|did not meet criteria, non-compliance|1|||
33403834|NCT00716417|62782693|FG000|Overall Study|Adverse Event|0|||
33403835|NCT00716417|62782694|FG001|Overall Study|Adverse Event|0|||
33403836|NCT00716417|62782695|FG002|Overall Study|Adverse Event|2|||
33403837|NCT00716417|62782696|FG003|Overall Study|Adverse Event|1|||
33403838|NCT00716417|62782697|FG004|Overall Study|Adverse Event|0|||
33403839|NCT00716417|62782698|FG005|Overall Study|Adverse Event|0|||
33403840|NCT00716417|62782699|FG006|Overall Study|Adverse Event|3|||
33403841|NCT00716417|62782700|FG007|Overall Study|Adverse Event|1|||
33403842|NCT00716417|62782701|FG008|Overall Study|Adverse Event|0|||
33403843|NCT00716417|62782702|FG009|Overall Study|Adverse Event|3|||
33403844|NCT00716417|62782693|FG000|Overall Study|Withdrawal by Subject|0|||
33403845|NCT00716417|62782694|FG001|Overall Study|Withdrawal by Subject|1|||
33403846|NCT00716417|62782695|FG002|Overall Study|Withdrawal by Subject|0|||
33403847|NCT00716417|62782696|FG003|Overall Study|Withdrawal by Subject|2|||
33403848|NCT00716417|62782697|FG004|Overall Study|Withdrawal by Subject|0|||
33403849|NCT00716417|62782698|FG005|Overall Study|Withdrawal by Subject|0|||
33403850|NCT00716417|62782699|FG006|Overall Study|Withdrawal by Subject|1|||
33403851|NCT00716417|62782700|FG007|Overall Study|Withdrawal by Subject|0|||
33403852|NCT00716417|62782701|FG008|Overall Study|Withdrawal by Subject|0|||
33403853|NCT00716417|62782702|FG009|Overall Study|Withdrawal by Subject|0|||
33403854|NCT00716417|62782693|FG000|Overall Study|Progressive disease|3|||
33403855|NCT00716417|62782694|FG001|Overall Study|Progressive disease|5|||
33403856|NCT00716417|62782695|FG002|Overall Study|Progressive disease|3|||
33403857|NCT00716417|62782696|FG003|Overall Study|Progressive disease|8|||
33403858|NCT00716417|62782697|FG004|Overall Study|Progressive disease|0|||
33403859|NCT00716417|62782698|FG005|Overall Study|Progressive disease|3|||
33403860|NCT00716417|62782699|FG006|Overall Study|Progressive disease|3|||
33403861|NCT00716417|62782700|FG007|Overall Study|Progressive disease|1|||
33403862|NCT00716417|62782701|FG008|Overall Study|Progressive disease|5|||
33403863|NCT00716417|62782702|FG009|Overall Study|Progressive disease|0|||
33598326|NCT02496767|62997149|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
33598327|NCT02496767|62997150|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
33403864|NCT00716417|62782693|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
33403865|NCT00716417|62782694|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
33598328|NCT02496767|62997151|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
33403866|NCT00716417|62782695|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
33403867|NCT00716417|62782696|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
33403868|NCT00716417|62782697|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
33403869|NCT00716417|62782698|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
33403870|NCT00716417|62782699|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
33403871|NCT00716417|62782700|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
33403872|NCT00716417|62782701|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
33403873|NCT00716417|62782702|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
33403874|NCT00716417|62782693|FG000|Overall Study|On patient request due to toxicities|0|||
33403875|NCT00716417|62782694|FG001|Overall Study|On patient request due to toxicities|0|||
33403876|NCT00716417|62782695|FG002|Overall Study|On patient request due to toxicities|0|||
33403877|NCT00716417|62782696|FG003|Overall Study|On patient request due to toxicities|0|||
33403878|NCT00716417|62782697|FG004|Overall Study|On patient request due to toxicities|0|||
33403879|NCT00716417|62782698|FG005|Overall Study|On patient request due to toxicities|0|||
33403880|NCT00716417|62782699|FG006|Overall Study|On patient request due to toxicities|0|||
33403881|NCT00716417|62782700|FG007|Overall Study|On patient request due to toxicities|1|||
33403882|NCT00716417|62782701|FG008|Overall Study|On patient request due to toxicities|0|||
33403883|NCT00716417|62782702|FG009|Overall Study|On patient request due to toxicities|0|||
33403884|NCT00719537|62782728|FG000|Overall Study|Withdrawal by Subject|1|||
33403885|NCT00719537|62782729|FG001|Overall Study|Withdrawal by Subject|0|||
33403886|NCT00719537|62782728|FG000|Overall Study|Lost to Follow-up|0|||
33403887|NCT00719537|62782729|FG001|Overall Study|Lost to Follow-up|1|||
33403888|NCT00715949|62782735|FG000|Overall Study|could not finish first test|4|||
33403889|NCT00503698|62782741|FG000|Overall Study|Protocol Violation|5|||
33403890|NCT00503698|62782742|FG001|Overall Study|Protocol Violation|6|||
33403891|NCT00503698|62782741|FG000|Overall Study|Adverse Event|52|||
33403892|NCT00503698|62782742|FG001|Overall Study|Adverse Event|41|||
33403893|NCT00503698|62782741|FG000|Overall Study|Death|1|||
33403894|NCT00503698|62782742|FG001|Overall Study|Death|0|||
33403895|NCT00503698|62782741|FG000|Overall Study|Lack of Efficacy|3|||
33403896|NCT00503698|62782742|FG001|Overall Study|Lack of Efficacy|4|||
33403897|NCT00503698|62782741|FG000|Overall Study|Trial terminated|216|||
33403898|NCT00503698|62782742|FG001|Overall Study|Trial terminated|253|||
33403899|NCT00503698|62782741|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
33403900|NCT00503698|62782742|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
33403901|NCT00503698|62782741|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
33403902|NCT00503698|62782742|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
33403903|NCT00503698|62782741|FG000|Overall Study|Any condition in exclusion criteria|4|||
33403904|NCT00503698|62782742|FG001|Overall Study|Any condition in exclusion criteria|6|||
33403905|NCT00503698|62782741|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
33403906|NCT00503698|62782742|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
33403907|NCT00503698|62782741|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
33403908|NCT00503698|62782742|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
33403909|NCT00503698|62782741|FG000|Overall Study|Critically ill|2|||
33403910|NCT00503698|62782742|FG001|Overall Study|Critically ill|0|||
33403911|NCT00503698|62782741|FG000|Overall Study|Unclassified|48|||
33403912|NCT00503698|62782742|FG001|Overall Study|Unclassified|32|||
33403913|NCT00503698|62782741|FG000|Overall Study|Not exposed to trial drug|11|||
33403914|NCT00503698|62782742|FG001|Overall Study|Not exposed to trial drug|6|||
33403915|NCT00573794|62782757|FG000|Overall Study|Adverse Event|81|||
33403916|NCT00573794|62782757|FG000|Overall Study|Withdrew Consent|90|||
33403917|NCT00573794|62782757|FG000|Overall Study|Lost to Follow-up|13|||
33403918|NCT00573794|62782757|FG000|Overall Study|Protocol Violation|6|||
33403919|NCT00573794|62782757|FG000|Overall Study|Lack of Efficacy|94|||
33403920|NCT00573794|62782757|FG000|Overall Study|Other|46|||
33403921|NCT00715793|62782761|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
33403922|NCT00715793|62782762|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
33403923|NCT00715793|62782761|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
33403924|NCT00715793|62782762|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
33403925|NCT00718523|62782771|FG000|Overall Study|Withdrawal by Subject|5|||
33403926|NCT00718523|62782772|FG001|Overall Study|Withdrawal by Subject|7|||
33403927|NCT00718523|62782771|FG000|Overall Study|Death|13|||
33403928|NCT00718523|62782772|FG001|Overall Study|Death|17|||
33403929|NCT00715559|62782778|FG000|Overall Study|medication not tolerated - nausea|1|||
33403930|NCT00620282|62782794|FG000|Overall Study|Adverse Event|0|||
33403931|NCT00620282|62782795|FG001|Overall Study|Adverse Event|1|||
33403932|NCT00620282|62782796|FG002|Overall Study|Adverse Event|0|||
33403933|NCT00620282|62782794|FG000|Overall Study|Arterial line unable to be placed|0|||
33403934|NCT00620282|62782795|FG001|Overall Study|Arterial line unable to be placed|0|||
33403935|NCT00620282|62782796|FG002|Overall Study|Arterial line unable to be placed|1|||
33403936|NCT00620282|62782794|FG000|Overall Study|Withdrawal by Subject|0|||
33403937|NCT00620282|62782795|FG001|Overall Study|Withdrawal by Subject|1|||
33403938|NCT00620282|62782796|FG002|Overall Study|Withdrawal by Subject|0|||
33493948|NCT03104816|62872526|FG002|Overall Study|Lack of Efficacy|0|||
33598329|NCT02496767|62997144|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
33598330|NCT02496767|62997145|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
33598331|NCT02496767|62997146|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
33598332|NCT02496767|62997147|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
33598333|NCT02496767|62997148|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
33598334|NCT02496767|62997149|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
33598335|NCT02496767|62997150|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
33598336|NCT02496767|62997151|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
33598337|NCT02496767|62997144|FG000|Double-blind, Withdrawal Phase|Death|0|||
33598338|NCT02496767|62997145|FG001|Double-blind, Withdrawal Phase|Death|0|||
33598339|NCT02496767|62997146|FG002|Double-blind, Withdrawal Phase|Death|0|||
33598340|NCT02496767|62997147|FG003|Double-blind, Withdrawal Phase|Death|0|||
33598341|NCT02496767|62997148|FG004|Double-blind, Withdrawal Phase|Death|0|||
33598342|NCT02496767|62997149|FG005|Double-blind, Withdrawal Phase|Death|0|||
33598343|NCT02496767|62997150|FG006|Double-blind, Withdrawal Phase|Death|1|||
33598344|NCT02496767|62997151|FG007|Double-blind, Withdrawal Phase|Death|2|||
33403939|NCT00515086|62782808|FG000|Overall Study|Adverse Event|1|||
33403940|NCT00515086|62782809|FG001|Overall Study|Adverse Event|1|||
33403941|NCT00515086|62782810|FG002|Overall Study|Adverse Event|2|||
33403942|NCT00515086|62782811|FG003|Overall Study|Adverse Event|3|||
33403943|NCT00515086|62782808|FG000|Overall Study|Administrative|1|||
33403944|NCT00515086|62782809|FG001|Overall Study|Administrative|1|||
33403945|NCT00515086|62782810|FG002|Overall Study|Administrative|0|||
33403946|NCT00515086|62782811|FG003|Overall Study|Administrative|0|||
33403947|NCT00515086|62782808|FG000|Overall Study|Withdrawal by Subject|1|||
33403948|NCT00515086|62782809|FG001|Overall Study|Withdrawal by Subject|0|||
33403949|NCT00515086|62782810|FG002|Overall Study|Withdrawal by Subject|0|||
33403950|NCT00515086|62782811|FG003|Overall Study|Withdrawal by Subject|1|||
33403951|NCT00515086|62782808|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
33403952|NCT00515086|62782809|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33403953|NCT00515086|62782810|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
33403954|NCT00515086|62782811|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
33403955|NCT00515086|62782808|FG000|Overall Study|Lost to Follow-up|1|||
33403956|NCT00515086|62782809|FG001|Overall Study|Lost to Follow-up|0|||
33403957|NCT00515086|62782810|FG002|Overall Study|Lost to Follow-up|0|||
33403958|NCT00515086|62782811|FG003|Overall Study|Lost to Follow-up|0|||
33403959|NCT00515086|62782808|FG000|Overall Study|Study drug no longer required|0|||
33403960|NCT00515086|62782809|FG001|Overall Study|Study drug no longer required|1|||
33403961|NCT00515086|62782810|FG002|Overall Study|Study drug no longer required|0|||
33403962|NCT00515086|62782811|FG003|Overall Study|Study drug no longer required|0|||
33403963|NCT00515086|62782808|FG000|Overall Study|Death|2|||
33403964|NCT00515086|62782809|FG001|Overall Study|Death|0|||
33403965|NCT00515086|62782810|FG002|Overall Study|Death|0|||
33403966|NCT00515086|62782811|FG003|Overall Study|Death|0|||
33403967|NCT00618410|62782827|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
33403968|NCT00618410|62782828|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
33403969|NCT00618722|62782838|FG000|Overall Study|Refusal of Treatment|0|||
33403970|NCT00618722|62782839|FG001|Overall Study|Refusal of Treatment|0|||
33403971|NCT00618722|62782840|FG002|Overall Study|Refusal of Treatment|1|||
33403972|NCT00618722|62782841|FG003|Overall Study|Refusal of Treatment|0|||
33403973|NCT00618722|62782838|FG000|Overall Study|Patient Request|1|||
33403974|NCT00618722|62782839|FG001|Overall Study|Patient Request|1|||
33403975|NCT00618722|62782840|FG002|Overall Study|Patient Request|1|||
33403976|NCT00618722|62782841|FG003|Overall Study|Patient Request|1|||
33403977|NCT00618722|62782838|FG000|Overall Study|Inability to Complete Study Procedure|0|||
33403978|NCT00618722|62782839|FG001|Overall Study|Inability to Complete Study Procedure|1|||
33403979|NCT00618722|62782840|FG002|Overall Study|Inability to Complete Study Procedure|0|||
33403980|NCT00618722|62782841|FG003|Overall Study|Inability to Complete Study Procedure|0|||
33403981|NCT00618722|62782838|FG000|Overall Study|Lost to Follow-up|2|||
33403982|NCT00618722|62782839|FG001|Overall Study|Lost to Follow-up|0|||
33403983|NCT00618722|62782840|FG002|Overall Study|Lost to Follow-up|0|||
33403984|NCT00618722|62782841|FG003|Overall Study|Lost to Follow-up|2|||
33403985|NCT00618722|62782838|FG000|Overall Study|Miscellaneous Reasons|0|||
33403986|NCT00618722|62782839|FG001|Overall Study|Miscellaneous Reasons|0|||
33403987|NCT00618722|62782840|FG002|Overall Study|Miscellaneous Reasons|1|||
33403988|NCT00618722|62782841|FG003|Overall Study|Miscellaneous Reasons|1|||
33403989|NCT00507442|62782855|FG000|Overall Study|Adverse Event|8|||
33403990|NCT00507442|62782856|FG001|Overall Study|Adverse Event|11|||
33403991|NCT00507442|62782857|FG002|Overall Study|Adverse Event|4|||
33403992|NCT00507442|62782858|FG003|Overall Study|Adverse Event|1|||
33403993|NCT00507442|62782855|FG000|Overall Study|Protocol Violation|0|||
33403994|NCT00507442|62782856|FG001|Overall Study|Protocol Violation|1|||
33403995|NCT00507442|62782857|FG002|Overall Study|Protocol Violation|0|||
33403996|NCT00507442|62782858|FG003|Overall Study|Protocol Violation|0|||
33403997|NCT00507442|62782855|FG000|Overall Study|Lost to Follow-up|0|||
33403998|NCT00507442|62782856|FG001|Overall Study|Lost to Follow-up|0|||
33403999|NCT00507442|62782857|FG002|Overall Study|Lost to Follow-up|1|||
33404000|NCT00507442|62782858|FG003|Overall Study|Lost to Follow-up|0|||
33404001|NCT00507442|62782855|FG000|Overall Study|Physician Decision|0|||
33404002|NCT00507442|62782856|FG001|Overall Study|Physician Decision|2|||
33404003|NCT00507442|62782857|FG002|Overall Study|Physician Decision|4|||
33404004|NCT00507442|62782858|FG003|Overall Study|Physician Decision|1|||
33404005|NCT00507442|62782855|FG000|Overall Study|Progressive Disease|2|||
33404006|NCT00507442|62782856|FG001|Overall Study|Progressive Disease|4|||
33404007|NCT00507442|62782857|FG002|Overall Study|Progressive Disease|2|||
33404008|NCT00507442|62782858|FG003|Overall Study|Progressive Disease|0|||
33404009|NCT00507442|62782855|FG000|Overall Study|Withdrawal by Subject|4|||
33404010|NCT00507442|62782856|FG001|Overall Study|Withdrawal by Subject|4|||
33404011|NCT00507442|62782857|FG002|Overall Study|Withdrawal by Subject|2|||
33404012|NCT00507442|62782858|FG003|Overall Study|Withdrawal by Subject|1|||
33404013|NCT00507442|62782855|FG000|Overall Study|Other|2|||
33404014|NCT00507442|62782856|FG001|Overall Study|Other|5|||
33404015|NCT00507442|62782857|FG002|Overall Study|Other|2|||
33404016|NCT00507442|62782858|FG003|Overall Study|Other|2|||
33404017|NCT00619892|62782874|FG000|Overall Study|Adverse Event|3|||
33404018|NCT00619892|62782875|FG001|Overall Study|Adverse Event|0|||
33404019|NCT00619892|62782874|FG000|Overall Study|Lost to Follow-up|0|||
33404020|NCT00619892|62782875|FG001|Overall Study|Lost to Follow-up|1|||
33404021|NCT00619892|62782874|FG000|Overall Study|Intercurrent illness|0|||
33404022|NCT00619892|62782875|FG001|Overall Study|Intercurrent illness|1|||
33404023|NCT00507130|62782887|FG000|Overall Study|Lost to Follow-up|0|||
33404024|NCT00507130|62782888|FG001|Overall Study|Lost to Follow-up|0|||
33404025|NCT00507130|62782889|FG002|Overall Study|Lost to Follow-up|1|||
33404026|NCT00507130|62782890|FG003|Overall Study|Lost to Follow-up|1|||
33404027|NCT00507130|62782887|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
33404028|NCT00507130|62782888|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
33404029|NCT00507130|62782889|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
33320923|NCT03672175|62696662|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
33320924|NCT03672175|62696663|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
33320925|NCT03672175|62696664|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
33320926|NCT03672175|62696662|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
33320927|NCT03672175|62696663|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
33320928|NCT03672175|62696664|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
33320929|NCT03672175|62696662|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
33404030|NCT00507130|62782890|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
33404031|NCT00503308|62782902|FG000|Overall Study|Protocol Violation|2|||
33404032|NCT00503308|62782903|FG001|Overall Study|Protocol Violation|1|||
33320930|NCT03672175|62696663|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
33404033|NCT03893565|62782914|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
33404034|NCT03893565|62782915|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
33404035|NCT03893565|62782916|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
33404036|NCT03893565|62782917|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
33404037|NCT03893565|62782918|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
33404038|NCT03893565|62782919|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
33404039|NCT03893565|62782920|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
33404040|NCT03893565|62782921|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
33404041|NCT03893565|62782922|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
33404042|NCT03893565|62782914|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33404043|NCT03893565|62782915|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
33404044|NCT03893565|62782916|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33404045|NCT03893565|62782917|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33404046|NCT03893565|62782918|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33404047|NCT03893565|62782919|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33404048|NCT03893565|62782920|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33404049|NCT03893565|62782921|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33404050|NCT03893565|62782922|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33404051|NCT03893565|62782914|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33404052|NCT03893565|62782915|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
33404053|NCT03893565|62782916|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33404054|NCT03893565|62782917|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
33404055|NCT03893565|62782918|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33404056|NCT03893565|62782919|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33404057|NCT03893565|62782920|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33404058|NCT03893565|62782921|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33404059|NCT03893565|62782922|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33404060|NCT03893565|62782914|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
33404061|NCT03893565|62782915|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
33404062|NCT03893565|62782916|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
33404063|NCT03893565|62782917|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
33404064|NCT03893565|62782918|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
33404065|NCT03893565|62782919|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
33404066|NCT03893565|62782920|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
33404067|NCT03893565|62782921|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
33404068|NCT03893565|62782922|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
33404069|NCT03893565|62782914|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
33404070|NCT03893565|62782915|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
33404071|NCT03893565|62782916|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
33404072|NCT03893565|62782917|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33404073|NCT03893565|62782918|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
33404074|NCT03893565|62782919|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33404075|NCT03893565|62782920|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33404076|NCT03893565|62782921|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33404077|NCT03893565|62782922|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33404078|NCT03893565|62782914|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33404079|NCT03893565|62782915|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
33404080|NCT03893565|62782916|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33404081|NCT03893565|62782917|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33404082|NCT03893565|62782918|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33404083|NCT03893565|62782919|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33404084|NCT03893565|62782920|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33404085|NCT03893565|62782921|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33404086|NCT03893565|62782922|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33404087|NCT03893565|62782914|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404088|NCT03893565|62782915|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404089|NCT03893565|62782916|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404090|NCT03893565|62782917|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
33404091|NCT03893565|62782918|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404092|NCT03893565|62782919|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404093|NCT03893565|62782920|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404094|NCT03893565|62782921|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404095|NCT03893565|62782922|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404096|NCT03893565|62782914|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
33404097|NCT03893565|62782915|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
33404098|NCT03893565|62782916|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
33404099|NCT03893565|62782917|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
33404100|NCT03893565|62782918|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
33404101|NCT03893565|62782919|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
33404102|NCT03893565|62782920|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
33404103|NCT03893565|62782921|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
33404104|NCT03893565|62782922|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
33404105|NCT03893565|62782914|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
33404106|NCT03893565|62782915|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
33404107|NCT03893565|62782916|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
33404108|NCT03893565|62782917|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
33404109|NCT03893565|62782918|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
33493949|NCT03104816|62872524|FG000|Overall Study|Protocol Violation|2|||
33404110|NCT03893565|62782919|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
33404111|NCT03893565|62782920|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
33404112|NCT03893565|62782921|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
33404113|NCT03893565|62782922|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
33404114|NCT03893565|62782914|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33404115|NCT03893565|62782915|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33404116|NCT03893565|62782916|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33404117|NCT03893565|62782917|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33404118|NCT03893565|62782918|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33404119|NCT03893565|62782919|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33404120|NCT03893565|62782920|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
33404121|NCT03893565|62782921|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33404122|NCT03893565|62782922|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33404123|NCT03893565|62782914|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
33404124|NCT03893565|62782915|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
33404125|NCT03893565|62782916|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
33404126|NCT03893565|62782917|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
33404127|NCT03893565|62782918|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
33404128|NCT03893565|62782919|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
33404129|NCT03893565|62782920|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
33404130|NCT03893565|62782921|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
33404131|NCT03893565|62782922|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
33404132|NCT03893565|62782914|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
33404133|NCT03893565|62782915|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
33404134|NCT03893565|62782916|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
33404135|NCT03893565|62782917|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
33404136|NCT03893565|62782918|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
33404137|NCT03893565|62782919|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
33404138|NCT03893565|62782920|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
33404139|NCT03893565|62782921|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
33404140|NCT03893565|62782922|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
33404141|NCT03893565|62782914|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33404142|NCT03893565|62782915|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33404143|NCT03893565|62782916|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33404144|NCT03893565|62782917|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33404145|NCT03893565|62782918|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33404146|NCT03893565|62782919|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33404147|NCT03893565|62782920|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33598345|NCT02496767|62997144|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
33598346|NCT02496767|62997145|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
33598347|NCT02496767|62997146|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
33598348|NCT02496767|62997147|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
33598349|NCT02496767|62997148|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
33404148|NCT03893565|62782921|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
33404149|NCT03893565|62782922|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33404150|NCT03893565|62782914|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33404151|NCT03893565|62782915|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33404152|NCT03893565|62782916|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33404153|NCT03893565|62782917|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33404154|NCT03893565|62782918|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33404155|NCT03893565|62782919|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33404156|NCT03893565|62782920|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33404157|NCT03893565|62782921|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
33404158|NCT03893565|62782922|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33404159|NCT03893565|62782914|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404160|NCT03893565|62782915|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404161|NCT03893565|62782916|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404162|NCT03893565|62782917|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404163|NCT03893565|62782918|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404164|NCT03893565|62782919|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404165|NCT03893565|62782920|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404166|NCT03893565|62782921|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
33404167|NCT03893565|62782922|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33404168|NCT03893565|62782914|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33404169|NCT03893565|62782915|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33404170|NCT03893565|62782916|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33598350|NCT02496767|62997149|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
33404171|NCT03893565|62782917|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33404172|NCT03893565|62782918|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33404173|NCT03893565|62782919|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33404174|NCT03893565|62782920|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33404175|NCT03893565|62782921|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33404176|NCT03893565|62782922|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
33404177|NCT00502996|62782941|FG000|Overall Study|Lost to Follow-up|9|||
33404178|NCT00502996|62782941|FG000|Overall Study|Protocol Violation|2|||
33404179|NCT00502996|62782941|FG000|Overall Study|Treatment failure|25|||
33404180|NCT00502996|62782941|FG000|Overall Study|Withdrawal Informed Consent|6|||
33404181|NCT00502996|62782941|FG000|Overall Study|Adverse Event|2|||
33404182|NCT00715403|62782952|FG000|Overall Study|Progressive disease|0|||
33404183|NCT00715403|62782953|FG001|Overall Study|Progressive disease|1|||
33404184|NCT00715403|62782954|FG002|Overall Study|Progressive disease|3|||
33404185|NCT00715403|62782955|FG003|Overall Study|Progressive disease|9|||
33404186|NCT00715403|62782956|FG004|Overall Study|Progressive disease|5|||
33404187|NCT00715403|62782957|FG005|Overall Study|Progressive disease|14|||
33404188|NCT00715403|62782958|FG006|Overall Study|Progressive disease|1|||
33598351|NCT02496767|62997150|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
33598352|NCT02496767|62997151|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
33404189|NCT00715403|62782952|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
33404190|NCT00715403|62782953|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
33404191|NCT00715403|62782954|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
33404192|NCT00715403|62782955|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
33404193|NCT00715403|62782956|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
33404194|NCT00715403|62782957|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
33404195|NCT00715403|62782958|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
33404196|NCT00715403|62782952|FG000|Overall Study|Other Adverse Event than DLT|1|||
33404197|NCT00715403|62782953|FG001|Overall Study|Other Adverse Event than DLT|0|||
33404198|NCT00715403|62782954|FG002|Overall Study|Other Adverse Event than DLT|0|||
33404199|NCT00715403|62782955|FG003|Overall Study|Other Adverse Event than DLT|0|||
33404200|NCT00715403|62782956|FG004|Overall Study|Other Adverse Event than DLT|0|||
33404201|NCT00715403|62782957|FG005|Overall Study|Other Adverse Event than DLT|2|||
33404202|NCT00715403|62782958|FG006|Overall Study|Other Adverse Event than DLT|0|||
33404203|NCT00715403|62782952|FG000|Overall Study|Protocol Violation|0|||
33404204|NCT00715403|62782953|FG001|Overall Study|Protocol Violation|0|||
33404205|NCT00715403|62782954|FG002|Overall Study|Protocol Violation|0|||
33404206|NCT00715403|62782955|FG003|Overall Study|Protocol Violation|0|||
33404207|NCT00715403|62782956|FG004|Overall Study|Protocol Violation|0|||
33404208|NCT00715403|62782957|FG005|Overall Study|Protocol Violation|1|||
33404209|NCT00715403|62782958|FG006|Overall Study|Protocol Violation|0|||
33404210|NCT00715403|62782952|FG000|Overall Study|Other reason not defined above|0|||
33404211|NCT00715403|62782953|FG001|Overall Study|Other reason not defined above|0|||
33404212|NCT00715403|62782954|FG002|Overall Study|Other reason not defined above|1|||
33404213|NCT00715403|62782955|FG003|Overall Study|Other reason not defined above|0|||
33404214|NCT00715403|62782956|FG004|Overall Study|Other reason not defined above|1|||
33404215|NCT00715403|62782957|FG005|Overall Study|Other reason not defined above|1|||
33404216|NCT00715403|62782958|FG006|Overall Study|Other reason not defined above|0|||
33404217|NCT00502840|62782974|FG000|Overall Study|Adverse Event|5|||
33404218|NCT00502840|62782974|FG000|Overall Study|Additional or changed therapy|48|||
33404219|NCT00502840|62782974|FG000|Overall Study|Lack of Efficacy|11|||
33404220|NCT00502840|62782974|FG000|Overall Study|Protocol Violation|4|||
33404221|NCT00502840|62782974|FG000|Overall Study|Withdrawal by Subject|5|||
33404222|NCT00502840|62782974|FG000|Overall Study|Lost to Follow-up|6|||
33404223|NCT00502840|62782974|FG000|Overall Study|Administrative problems|1|||
33404224|NCT00502840|62782974|FG000|Overall Study|Other|20|||
33404225|NCT00515008|62782981|FG000|Overall Study|Lost to Follow-up|1|||
33404226|NCT00515008|62782982|FG001|Overall Study|Lost to Follow-up|0|||
33404227|NCT00515008|62782981|FG000|Overall Study|Declined|0|||
33404228|NCT00515008|62782982|FG001|Overall Study|Declined|3|||
33404229|NCT00515008|62782981|FG000|Overall Study|Left the Boston Area|1|||
33404230|NCT00515008|62782982|FG001|Overall Study|Left the Boston Area|1|||
33404231|NCT00515008|62782981|FG000|Overall Study|Scheduling conflict|1|||
33404232|NCT00515008|62782982|FG001|Overall Study|Scheduling conflict|0|||
33404233|NCT00514540|62782991|FG000|First-Line Chemo|Withdrawal by Subject|1|||
33404234|NCT00514540|62782991|FG000|First-Line Chemo|Protocol Violation|7|||
33404235|NCT00514540|62782991|FG000|Second-Line|Physician/Patient Decision|31|||
33404236|NCT00713609|62783009|FG000|Overall Study|Adverse Event|2|||
33404237|NCT00713609|62783010|FG001|Overall Study|Adverse Event|0|||
33404238|NCT00713609|62783011|FG002|Overall Study|Adverse Event|2|||
33404239|NCT00713609|62783012|FG003|Overall Study|Adverse Event|2|||
33404240|NCT00713609|62783013|FG004|Overall Study|Adverse Event|3|||
33404241|NCT00713609|62783014|FG005|Overall Study|Adverse Event|1|||
33404242|NCT00713609|62783009|FG000|Overall Study|Lost to Follow-up|5|||
33404243|NCT00713609|62783010|FG001|Overall Study|Lost to Follow-up|7|||
33404244|NCT00713609|62783011|FG002|Overall Study|Lost to Follow-up|5|||
33404245|NCT00713609|62783012|FG003|Overall Study|Lost to Follow-up|5|||
33404246|NCT00713609|62783013|FG004|Overall Study|Lost to Follow-up|7|||
33404247|NCT00713609|62783014|FG005|Overall Study|Lost to Follow-up|0|||
33404248|NCT00713609|62783009|FG000|Overall Study|Lack of Efficacy|1|||
33404249|NCT00713609|62783010|FG001|Overall Study|Lack of Efficacy|3|||
33404250|NCT00713609|62783011|FG002|Overall Study|Lack of Efficacy|0|||
33404251|NCT00713609|62783012|FG003|Overall Study|Lack of Efficacy|0|||
33404252|NCT00713609|62783013|FG004|Overall Study|Lack of Efficacy|1|||
33404253|NCT00713609|62783014|FG005|Overall Study|Lack of Efficacy|0|||
33404254|NCT00713609|62783009|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
33404255|NCT00713609|62783010|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
33404256|NCT00713609|62783011|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
33404257|NCT00713609|62783012|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
33404258|NCT00713609|62783013|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
33404259|NCT00713609|62783014|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
33404260|NCT00713609|62783009|FG000|Overall Study|Withdrawal by Subject|6|||
33404261|NCT00713609|62783010|FG001|Overall Study|Withdrawal by Subject|1|||
33404262|NCT00713609|62783011|FG002|Overall Study|Withdrawal by Subject|5|||
33404263|NCT00713609|62783012|FG003|Overall Study|Withdrawal by Subject|1|||
33404264|NCT00713609|62783013|FG004|Overall Study|Withdrawal by Subject|5|||
33404265|NCT00713609|62783014|FG005|Overall Study|Withdrawal by Subject|7|||
33404266|NCT00713609|62783009|FG000|Overall Study|Protocol Violation|6|||
33404267|NCT00713609|62783010|FG001|Overall Study|Protocol Violation|3|||
33404268|NCT00713609|62783011|FG002|Overall Study|Protocol Violation|1|||
33404269|NCT00713609|62783012|FG003|Overall Study|Protocol Violation|1|||
33404270|NCT00713609|62783013|FG004|Overall Study|Protocol Violation|2|||
33404271|NCT00713609|62783014|FG005|Overall Study|Protocol Violation|0|||
33404272|NCT00513682|62783028|FG000|Washout Phase|Adverse Event|2|||
33404273|NCT00493012|62783037|FG000|Overall Study|Lost to Follow-up|18|||
33404274|NCT00493012|62783038|FG001|Overall Study|Lost to Follow-up|17|||
33404275|NCT05144477|62783046|FG000|Overall Study|Withdrawal by Subject|1|||
33404276|NCT05144477|62783047|FG001|Overall Study|Withdrawal by Subject|1|||
33404277|NCT00617708|62783063|FG000|Overall Study|Adverse Event|0|||
33404278|NCT00617708|62783064|FG001|Overall Study|Adverse Event|6|||
33404279|NCT00617708|62783065|FG002|Overall Study|Adverse Event|9|||
33404280|NCT00617708|62783063|FG000|Overall Study|Withdrawal by Subject|1|||
33404281|NCT00617708|62783064|FG001|Overall Study|Withdrawal by Subject|1|||
33404282|NCT00617708|62783065|FG002|Overall Study|Withdrawal by Subject|7|||
33404283|NCT00617708|62783063|FG000|Overall Study|Death|0|||
33404284|NCT00617708|62783064|FG001|Overall Study|Death|6|||
33404285|NCT00617708|62783065|FG002|Overall Study|Death|5|||
33404286|NCT00617708|62783063|FG000|Overall Study|Progression/Relapse|7|||
33404287|NCT00617708|62783064|FG001|Overall Study|Progression/Relapse|40|||
33404288|NCT00617708|62783065|FG002|Overall Study|Progression/Relapse|36|||
33404289|NCT00617708|62783063|FG000|Overall Study|Not protocol specified|1|||
33404290|NCT00617708|62783064|FG001|Overall Study|Not protocol specified|4|||
33404291|NCT00617708|62783065|FG002|Overall Study|Not protocol specified|2|||
33404292|NCT00617708|62783063|FG000|Overall Study|Not eligible|1|||
33404293|NCT00617708|62783064|FG001|Overall Study|Not eligible|3|||
33404294|NCT00617708|62783065|FG002|Overall Study|Not eligible|5|||
33404295|NCT03894969|62783080|FG000|Overall Study|Adverse Event|0|||
33404296|NCT03894969|62783081|FG001|Overall Study|Adverse Event|2|||
33404297|NCT03894969|62783082|FG002|Overall Study|Adverse Event|0|||
33404298|NCT03894969|62783083|FG003|Overall Study|Adverse Event|1|||
33404299|NCT03894969|62783084|FG004|Overall Study|Adverse Event|2|||
33404300|NCT03894969|62783080|FG000|Overall Study|Lost to Follow-up|3|||
33404301|NCT03894969|62783081|FG001|Overall Study|Lost to Follow-up|1|||
33404302|NCT03894969|62783082|FG002|Overall Study|Lost to Follow-up|1|||
33404303|NCT03894969|62783083|FG003|Overall Study|Lost to Follow-up|0|||
33404304|NCT03894969|62783084|FG004|Overall Study|Lost to Follow-up|0|||
33404305|NCT03894969|62783080|FG000|Overall Study|Withdrawal by Subject|2|||
33404306|NCT03894969|62783081|FG001|Overall Study|Withdrawal by Subject|1|||
33404307|NCT03894969|62783082|FG002|Overall Study|Withdrawal by Subject|3|||
33404308|NCT03894969|62783083|FG003|Overall Study|Withdrawal by Subject|4|||
33404309|NCT03894969|62783084|FG004|Overall Study|Withdrawal by Subject|8|||
33404310|NCT03894969|62783080|FG000|Overall Study|Other|0|||
33404311|NCT03894969|62783081|FG001|Overall Study|Other|0|||
33404312|NCT03894969|62783082|FG002|Overall Study|Other|0|||
33404313|NCT03894969|62783083|FG003|Overall Study|Other|0|||
33404314|NCT03894969|62783084|FG004|Overall Study|Other|3|||
33404315|NCT03894969|62783080|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
33404316|NCT03894969|62783081|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
33404317|NCT03894969|62783082|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
33404318|NCT03894969|62783083|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
33404319|NCT03894969|62783084|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
33404320|NCT03894969|62783080|FG000|Overall Study|Solicited Adverse Event|0|||
33404321|NCT03894969|62783081|FG001|Overall Study|Solicited Adverse Event|1|||
33404322|NCT03894969|62783082|FG002|Overall Study|Solicited Adverse Event|0|||
33404323|NCT03894969|62783083|FG003|Overall Study|Solicited Adverse Event|0|||
33404324|NCT03894969|62783084|FG004|Overall Study|Solicited Adverse Event|0|||
33404325|NCT03894813|62783100|FG000|Overall Study|Adverse Event|1|||
33404326|NCT03894813|62783101|FG001|Overall Study|Adverse Event|1|||
33404327|NCT03894813|62783100|FG000|Overall Study|Lack of Efficacy|3|||
33404328|NCT03894813|62783101|FG001|Overall Study|Lack of Efficacy|3|||
33404329|NCT03894813|62783100|FG000|Overall Study|Lost to Follow-up|1|||
33404330|NCT03894813|62783101|FG001|Overall Study|Lost to Follow-up|0|||
33404331|NCT03894813|62783100|FG000|Overall Study|Pregnancy|2|||
33404332|NCT03894813|62783101|FG001|Overall Study|Pregnancy|1|||
33404333|NCT03894813|62783100|FG000|Overall Study|Protocol Violation|3|||
33404334|NCT03894813|62783101|FG001|Overall Study|Protocol Violation|7|||
33404335|NCT03894813|62783100|FG000|Overall Study|Withdrawal by Subject|1|||
33404336|NCT03894813|62783101|FG001|Overall Study|Withdrawal by Subject|3|||
33404337|NCT03894813|62783100|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
33404338|NCT03894813|62783101|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
33404339|NCT00615992|62783107|FG000|Overall Study|Protocol Violation|67|||
33404340|NCT03892707|62783113|FG000|Overall Study|Screen failure|6|||
33404341|NCT03892707|62783114|FG001|Overall Study|Screen failure|0|||
33404342|NCT03892707|62783113|FG000|Overall Study|Pain resolution|0|||
33404343|NCT03892707|62783114|FG001|Overall Study|Pain resolution|4|||
33404344|NCT03892707|62783113|FG000|Overall Study|Withdrawal by Subject|0|||
33404345|NCT03892707|62783114|FG001|Overall Study|Withdrawal by Subject|1|||
33404346|NCT03892707|62783113|FG000|Overall Study|Other (long business trip)|0|||
33404347|NCT03892707|62783114|FG001|Overall Study|Other (long business trip)|1|||
33404348|NCT00615914|62783121|FG000|Overall Study|Adverse Event|274|||
33404349|NCT00615914|62783121|FG000|Overall Study|Death|20|||
33404350|NCT00615914|62783121|FG000|Overall Study|Lack of Efficacy|59|||
33404351|NCT00615914|62783121|FG000|Overall Study|Lost to Follow-up|187|||
33404352|NCT00615914|62783121|FG000|Overall Study|Withdrawal by Subject|16|||
33404353|NCT00615914|62783121|FG000|Overall Study|Physician Decision|4|||
33404354|NCT00615914|62783121|FG000|Overall Study|No data was collected.|65|||
33404355|NCT00615914|62783121|FG000|Overall Study|No treatment|2|||
33404356|NCT00615914|62783121|FG000|Overall Study|Irregularly enrolled patients|10|||
33404357|NCT00513604|62783131|FG000|Overall Study|Not treated|2|||
33404358|NCT00513604|62783132|FG001|Overall Study|Not treated|0|||
33404359|NCT00513604|62783133|FG002|Overall Study|Not treated|1|||
33404360|NCT00513604|62783134|FG003|Overall Study|Not treated|0|||
33404361|NCT00513604|62783135|FG004|Overall Study|Not treated|0|||
33404362|NCT00513604|62783131|FG000|Overall Study|Death during treatment|0|||
33404363|NCT00513604|62783132|FG001|Overall Study|Death during treatment|3|||
33404364|NCT00513604|62783133|FG002|Overall Study|Death during treatment|2|||
33404365|NCT00513604|62783134|FG003|Overall Study|Death during treatment|0|||
33404366|NCT00513604|62783135|FG004|Overall Study|Death during treatment|0|||
33404367|NCT00534105|62783149|FG000|Overall Study|Lost to Follow-up|23|||
33404368|NCT00534105|62783150|FG001|Overall Study|Lost to Follow-up|39|||
33404369|NCT00573248|62783165|FG000|Overall Study|scheduling conflicts|15|||
33404370|NCT00573248|62783166|FG001|Overall Study|scheduling conflicts|11|||
33404371|NCT00532935|62783174|FG000|Overall Study|Adverse Event|11|||
33404372|NCT00532935|62783175|FG001|Overall Study|Adverse Event|12|||
33404373|NCT00532935|62783174|FG000|Overall Study|Lack of Efficacy|0|||
33404374|NCT00532935|62783175|FG001|Overall Study|Lack of Efficacy|3|||
33404375|NCT00532935|62783174|FG000|Overall Study|Lost to Follow-up|10|||
33404376|NCT00532935|62783175|FG001|Overall Study|Lost to Follow-up|6|||
33404377|NCT00532935|62783174|FG000|Overall Study|Physician Decision|4|||
33404378|NCT00532935|62783175|FG001|Overall Study|Physician Decision|5|||
33404379|NCT00532935|62783174|FG000|Overall Study|Pregnancy|1|||
33404380|NCT00532935|62783175|FG001|Overall Study|Pregnancy|0|||
33320931|NCT03672175|62696664|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
33320932|NCT03672175|62696662|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
33404381|NCT00532935|62783174|FG000|Overall Study|Protocol Violation|4|||
33404382|NCT00532935|62783175|FG001|Overall Study|Protocol Violation|2|||
33404383|NCT00532935|62783174|FG000|Overall Study|Withdrawal by Subject|10|||
33404384|NCT00532935|62783175|FG001|Overall Study|Withdrawal by Subject|9|||
33404385|NCT00532935|62783174|FG000|Overall Study|Protocol Specific Criteria|11|||
33404386|NCT00532935|62783175|FG001|Overall Study|Protocol Specific Criteria|15|||
33320933|NCT03672175|62696663|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
33320934|NCT03672175|62696664|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
33320935|NCT03672175|62696662|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
33320936|NCT03672175|62696663|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
33320937|NCT03672175|62696664|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
33320938|NCT03672175|62696662|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
33404387|NCT03016312|62783183|FG000|Overall Study|Death|194|||
33404388|NCT03016312|62783184|FG001|Overall Study|Death|164|||
33404389|NCT03016312|62783183|FG000|Overall Study|Lost to Follow-up|11|||
33404390|NCT03016312|62783184|FG001|Overall Study|Lost to Follow-up|12|||
33404391|NCT03016312|62783183|FG000|Overall Study|Started new therapy, loss of contact|2|||
33404392|NCT03016312|62783184|FG001|Overall Study|Started new therapy, loss of contact|1|||
33404393|NCT03016312|62783183|FG000|Overall Study|Physician Decision|0|||
33404394|NCT03016312|62783184|FG001|Overall Study|Physician Decision|2|||
33404395|NCT03016312|62783183|FG000|Overall Study|Withdrawal by Subject|34|||
33404396|NCT03016312|62783184|FG001|Overall Study|Withdrawal by Subject|39|||
33404397|NCT00512902|62783190|FG000|Overall Study|Adverse Event|7|||
33404398|NCT00512902|62783190|FG000|Overall Study|Lost to Follow-up|1|||
33404399|NCT00492232|62783196|FG000|Placebo Run-in|Adverse Event|0|||
33404400|NCT00492232|62783197|FG001|Placebo Run-in|Adverse Event|2|||
33404401|NCT00492232|62783196|FG000|Placebo Run-in|Protocol Violation|0|||
33404402|NCT00492232|62783197|FG001|Placebo Run-in|Protocol Violation|3|||
33404403|NCT00492232|62783196|FG000|Placebo Run-in|Lost to Follow-up|0|||
33404404|NCT00492232|62783197|FG001|Placebo Run-in|Lost to Follow-up|3|||
33404405|NCT00492232|62783196|FG000|Placebo Run-in|Withdrawal by Subject|0|||
33404406|NCT00492232|62783197|FG001|Placebo Run-in|Withdrawal by Subject|8|||
33404407|NCT00492232|62783196|FG000|Placebo Run-in|Pregnancy|0|||
33404408|NCT00492232|62783197|FG001|Placebo Run-in|Pregnancy|1|||
33404409|NCT00492232|62783196|FG000|Placebo Run-in|Entrance criteria not met|0|||
33404410|NCT00492232|62783197|FG001|Placebo Run-in|Entrance criteria not met|45|||
33404411|NCT00492232|62783196|FG000|Placebo Run-in|Other|0|||
33404412|NCT00492232|62783197|FG001|Placebo Run-in|Other|6|||
33404413|NCT00492232|62783196|FG000|Placebo Run-in|Missing|0|||
33404414|NCT00492232|62783197|FG001|Placebo Run-in|Missing|2|||
33404415|NCT00492232|62783196|FG000|Double-Blind Treatment|Adverse Event|1|||
33404416|NCT00492232|62783197|FG001|Double-Blind Treatment|Adverse Event|2|||
33404417|NCT00492232|62783196|FG000|Double-Blind Treatment|Protocol Violation|3|||
33404418|NCT00492232|62783197|FG001|Double-Blind Treatment|Protocol Violation|7|||
33404419|NCT00492232|62783196|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
33404420|NCT00492232|62783197|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
33404421|NCT00492232|62783196|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
33404422|NCT00492232|62783197|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
33404423|NCT00492232|62783196|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
33404424|NCT00492232|62783197|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
33404425|NCT00492232|62783196|FG000|Double-Blind Treatment|Other|6|||
33404426|NCT00492232|62783197|FG001|Double-Blind Treatment|Other|5|||
33404427|NCT00492232|62783196|FG000|Double-Blind Treatment|Randomized not treated|1|||
33404428|NCT00492232|62783197|FG001|Double-Blind Treatment|Randomized not treated|0|||
33404429|NCT00492232|62783196|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
33404430|NCT00492232|62783197|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
33404431|NCT00491764|62783209|FG000|Overall Study|Adverse Event|1|||
33404432|NCT00491764|62783210|FG001|Overall Study|Adverse Event|2|||
33404433|NCT00491764|62783211|FG002|Overall Study|Adverse Event|4|||
33404434|NCT00491764|62783212|FG003|Overall Study|Adverse Event|4|||
33404435|NCT00491764|62783213|FG004|Overall Study|Adverse Event|0|||
33404436|NCT00491764|62783214|FG005|Overall Study|Adverse Event|1|||
33598353|NCT02496533|62997167|FG000|Overall Study|Lack of data on outcome|3|||
33598354|NCT02496533|62997168|FG001|Overall Study|Lack of data on outcome|0|||
33598355|NCT02496533|62997167|FG000|Overall Study|Patient did not complete all measures|0|||
33598356|NCT02496533|62997168|FG001|Overall Study|Patient did not complete all measures|4|||
33598357|NCT02496533|62997167|FG000|Overall Study|Late for radiologic testing|0|||
33598358|NCT02496533|62997168|FG001|Overall Study|Late for radiologic testing|2|||
33598359|NCT02496221|62997174|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
33598360|NCT02496221|62997175|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
33598361|NCT02496221|62997174|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
33598362|NCT02496221|62997175|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
33598363|NCT02496221|62997174|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
33598364|NCT02496221|62997175|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
33598365|NCT02475629|62997183|FG000|Overall Study|Adverse Event|1|||
33598366|NCT02475629|62997183|FG000|Overall Study|Death|4|||
33598367|NCT02475629|62997183|FG000|Overall Study|Physician Decision|1|||
33598368|NCT02475629|62997183|FG000|Overall Study|Withdrawal by Subject|1|||
33598369|NCT02475629|62997183|FG000|Overall Study|Lost to Follow-up|1|||
33598370|NCT02475629|62997183|FG000|Overall Study|Subject non-compliance|1|||
33598371|NCT02475395|62997189|FG000|Overall Study|Protocol Violation|30|||
33598372|NCT02475395|62997190|FG001|Overall Study|Protocol Violation|3|||
33598373|NCT01653743|62997198|FG000|Overall Study|Withdrawal by Subject|1|||
33598374|NCT01653743|62997199|FG001|Overall Study|Withdrawal by Subject|0|||
33598375|NCT01653743|62997198|FG000|Overall Study|Investigator discretion|3|||
33598376|NCT01653743|62997199|FG001|Overall Study|Investigator discretion|0|||
33598377|NCT02293993|62997209|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
33598378|NCT02293993|62997210|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
33598379|NCT02293993|62997211|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
33598380|NCT02293993|62997212|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
33598381|NCT02293993|62997209|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
33598382|NCT02293993|62997210|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
33598383|NCT02293993|62997211|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
33598384|NCT02293993|62997212|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
33598385|NCT02293993|62997209|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
33404437|NCT00491764|62783209|FG000|Overall Study|Lost to Follow-up|0|||
33404438|NCT00491764|62783210|FG001|Overall Study|Lost to Follow-up|1|||
33404439|NCT00491764|62783211|FG002|Overall Study|Lost to Follow-up|0|||
33404440|NCT00491764|62783212|FG003|Overall Study|Lost to Follow-up|1|||
33404441|NCT00491764|62783213|FG004|Overall Study|Lost to Follow-up|0|||
33404442|NCT00491764|62783214|FG005|Overall Study|Lost to Follow-up|3|||
33404443|NCT00491764|62783209|FG000|Overall Study|Withdrawal by Subject|2|||
33404444|NCT00491764|62783210|FG001|Overall Study|Withdrawal by Subject|3|||
33404445|NCT00491764|62783211|FG002|Overall Study|Withdrawal by Subject|1|||
33404446|NCT00491764|62783212|FG003|Overall Study|Withdrawal by Subject|2|||
33404447|NCT00491764|62783213|FG004|Overall Study|Withdrawal by Subject|2|||
33404448|NCT00491764|62783214|FG005|Overall Study|Withdrawal by Subject|4|||
33404449|NCT00491764|62783209|FG000|Overall Study|Non Compliance with the Protocol|1|||
33404450|NCT00491764|62783210|FG001|Overall Study|Non Compliance with the Protocol|0|||
33404451|NCT00491764|62783211|FG002|Overall Study|Non Compliance with the Protocol|0|||
33404452|NCT00491764|62783212|FG003|Overall Study|Non Compliance with the Protocol|0|||
33404453|NCT00491764|62783213|FG004|Overall Study|Non Compliance with the Protocol|0|||
33404454|NCT00491764|62783214|FG005|Overall Study|Non Compliance with the Protocol|0|||
33404455|NCT00491764|62783209|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
33404456|NCT00491764|62783210|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
33404457|NCT00491764|62783211|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
33404458|NCT00491764|62783212|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
33404459|NCT00491764|62783213|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
33404460|NCT00491764|62783214|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
33404461|NCT00491764|62783209|FG000|Overall Study|Administrative|1|||
33404462|NCT00491764|62783210|FG001|Overall Study|Administrative|0|||
33404463|NCT00491764|62783211|FG002|Overall Study|Administrative|2|||
33404464|NCT00491764|62783212|FG003|Overall Study|Administrative|1|||
33404465|NCT00491764|62783213|FG004|Overall Study|Administrative|0|||
33404466|NCT00491764|62783214|FG005|Overall Study|Administrative|0|||
33404467|NCT00491608|62783228|FG000|Overall Study|Death|2|||
33404468|NCT00491608|62783228|FG000|Overall Study|Withdrawal by Subject|1|||
33404469|NCT00615836|62783236|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
33404470|NCT00615836|62783237|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
33404471|NCT00615836|62783238|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
33404472|NCT00615836|62783239|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
33404473|NCT00615836|62783240|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
33404474|NCT00615836|62783236|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
33404475|NCT00615836|62783237|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
33404476|NCT00615836|62783238|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
33404477|NCT00615836|62783239|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
33404478|NCT00615836|62783240|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
33404479|NCT00615836|62783236|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
33404480|NCT00615836|62783237|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
33404481|NCT00615836|62783238|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
33404482|NCT00615836|62783239|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
33404483|NCT00615836|62783240|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
33404484|NCT00615836|62783236|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
33404485|NCT00615836|62783237|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
33404486|NCT00615836|62783238|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
33404487|NCT00615836|62783239|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
33404488|NCT00615836|62783240|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
33404489|NCT00615836|62783236|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
33404490|NCT00615836|62783237|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
33404491|NCT00615836|62783238|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
33404492|NCT00615836|62783239|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
33404493|NCT00615836|62783240|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
33404494|NCT00615836|62783236|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
33404495|NCT00615836|62783237|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
33404496|NCT00615836|62783238|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
33404497|NCT00615836|62783239|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
33404498|NCT00615836|62783240|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
33404499|NCT00615836|62783236|FG000|Extension Study (FE992026 CS31)|Other|10|||
33404500|NCT00615836|62783237|FG001|Extension Study (FE992026 CS31)|Other|7|||
33404501|NCT00615836|62783238|FG002|Extension Study (FE992026 CS31)|Other|8|||
33404502|NCT00615836|62783239|FG003|Extension Study (FE992026 CS31)|Other|8|||
33404503|NCT00615836|62783240|FG004|Extension Study (FE992026 CS31)|Other|0|||
33404504|NCT00615836|62783236|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
33404505|NCT00615836|62783237|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
33404506|NCT00615836|62783238|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
33404507|NCT00615836|62783239|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
33404508|NCT00615836|62783240|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
33404509|NCT00615836|62783236|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
33404510|NCT00615836|62783237|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
33404511|NCT00615836|62783238|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
33404512|NCT00615836|62783239|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
33404513|NCT00615836|62783240|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
33404514|NCT00491530|62783259|FG000|Overall Study|Adverse Event|6|||
33404515|NCT00491530|62783260|FG001|Overall Study|Adverse Event|1|||
33404516|NCT00491530|62783261|FG002|Overall Study|Adverse Event|2|||
33404517|NCT00491530|62783259|FG000|Overall Study|Withdrawal by Subject|3|||
33404518|NCT00491530|62783260|FG001|Overall Study|Withdrawal by Subject|0|||
33404519|NCT00491530|62783261|FG002|Overall Study|Withdrawal by Subject|0|||
33404520|NCT00491530|62783259|FG000|Overall Study|Lost to Follow-up|3|||
33404521|NCT00491530|62783260|FG001|Overall Study|Lost to Follow-up|2|||
33320939|NCT03672175|62696663|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
33404522|NCT00491530|62783261|FG002|Overall Study|Lost to Follow-up|2|||
33320940|NCT03672175|62696664|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
33320941|NCT03672175|62696662|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
33320942|NCT03672175|62696663|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
33320943|NCT03672175|62696664|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
33320944|NCT03672175|62696662|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
33320945|NCT03672175|62696663|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
33404523|NCT00491530|62783259|FG000|Overall Study|Lack of Efficacy|0|||
33404524|NCT00491530|62783260|FG001|Overall Study|Lack of Efficacy|1|||
33404525|NCT00491530|62783261|FG002|Overall Study|Lack of Efficacy|0|||
33404526|NCT00491530|62783259|FG000|Overall Study|Investigator Discretion|0|||
33404527|NCT00491530|62783260|FG001|Overall Study|Investigator Discretion|1|||
33404528|NCT00491530|62783261|FG002|Overall Study|Investigator Discretion|0|||
33404529|NCT00491530|62783259|FG000|Overall Study|Patient Request|0|||
33404530|NCT00491530|62783260|FG001|Overall Study|Patient Request|1|||
33404531|NCT00491530|62783261|FG002|Overall Study|Patient Request|0|||
33404532|NCT00491530|62783259|FG000|Overall Study|Use of Prohibited Medication|0|||
33404533|NCT00491530|62783260|FG001|Overall Study|Use of Prohibited Medication|0|||
33404534|NCT00491530|62783261|FG002|Overall Study|Use of Prohibited Medication|1|||
33404535|NCT00617240|62783271|FG000|Overall Study|Lack of Efficacy|1|||
33404536|NCT00617240|62783272|FG001|Overall Study|Lack of Efficacy|0|||
33404537|NCT00615290|62783278|FG000|Overall Study|Adverse Event|2|||
33404538|NCT00615290|62783278|FG000|Overall Study|Lost to Follow-up|3|||
33404539|NCT00615290|62783278|FG000|Overall Study|Withdrawal by Subject|1|||
33404540|NCT00615290|62783278|FG000|Overall Study|Other|2|||
33404541|NCT00501046|62783284|FG000|Overall Study|Adverse Event|21|||
33404542|NCT00501046|62783285|FG001|Overall Study|Adverse Event|25|||
33404543|NCT00501046|62783284|FG000|Overall Study|Death|23|||
33404544|NCT00501046|62783285|FG001|Overall Study|Death|30|||
33404545|NCT00501046|62783284|FG000|Overall Study|Lost to Follow-up|14|||
33404546|NCT00501046|62783285|FG001|Overall Study|Lost to Follow-up|13|||
33404547|NCT00501046|62783284|FG000|Overall Study|Physician Decision|7|||
33404548|NCT00501046|62783285|FG001|Overall Study|Physician Decision|2|||
33404549|NCT00501046|62783284|FG000|Overall Study|Pregnancy|0|||
33404550|NCT00501046|62783285|FG001|Overall Study|Pregnancy|3|||
33404551|NCT00501046|62783284|FG000|Overall Study|Protocol Violation|2|||
33404552|NCT00501046|62783285|FG001|Overall Study|Protocol Violation|1|||
33404553|NCT00501046|62783284|FG000|Overall Study|Withdrawal by Subject|84|||
33404554|NCT00501046|62783285|FG001|Overall Study|Withdrawal by Subject|83|||
33404555|NCT00501046|62783284|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
33404556|NCT00501046|62783285|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
33404557|NCT00533949|62783295|FG000|Overall Study|Protocol Violation|12|||
33404558|NCT00533949|62783296|FG001|Overall Study|Protocol Violation|12|||
33404559|NCT00533949|62783297|FG002|Overall Study|Protocol Violation|9|||
33404560|NCT00533949|62783298|FG003|Overall Study|Protocol Violation|9|||
33404561|NCT00533949|62783295|FG000|Overall Study|Withdrawal by Subject|3|||
33404562|NCT00533949|62783296|FG001|Overall Study|Withdrawal by Subject|2|||
33404563|NCT00533949|62783297|FG002|Overall Study|Withdrawal by Subject|1|||
33404564|NCT00533949|62783298|FG003|Overall Study|Withdrawal by Subject|1|||
33404565|NCT00485134|62783324|FG000|Overall Study|Lost to Follow-up|1|||
33404566|NCT00485134|62783325|FG001|Overall Study|Lost to Follow-up|0|||
33404567|NCT00485134|62783326|FG002|Overall Study|Lost to Follow-up|0|||
33404568|NCT00485134|62783327|FG003|Overall Study|Lost to Follow-up|0|||
33404569|NCT00485134|62783328|FG004|Overall Study|Lost to Follow-up|0|||
33404570|NCT00485134|62783329|FG005|Overall Study|Lost to Follow-up|0|||
33404571|NCT00485134|62783330|FG006|Overall Study|Lost to Follow-up|0|||
33404572|NCT00485134|62783331|FG007|Overall Study|Lost to Follow-up|0|||
33404573|NCT00485134|62783324|FG000|Overall Study|Withdrawal by Subject|0|||
33404574|NCT00485134|62783325|FG001|Overall Study|Withdrawal by Subject|1|||
33404575|NCT00485134|62783326|FG002|Overall Study|Withdrawal by Subject|0|||
33404576|NCT00485134|62783327|FG003|Overall Study|Withdrawal by Subject|0|||
33404577|NCT00485134|62783328|FG004|Overall Study|Withdrawal by Subject|0|||
33404578|NCT00485134|62783329|FG005|Overall Study|Withdrawal by Subject|0|||
33404579|NCT00485134|62783330|FG006|Overall Study|Withdrawal by Subject|0|||
33404580|NCT00485134|62783331|FG007|Overall Study|Withdrawal by Subject|0|||
33404581|NCT00485134|62783324|FG000|Overall Study|Change in health status|0|||
33404582|NCT00485134|62783325|FG001|Overall Study|Change in health status|1|||
33404583|NCT00485134|62783326|FG002|Overall Study|Change in health status|2|||
33404584|NCT00485134|62783327|FG003|Overall Study|Change in health status|1|||
33404585|NCT00485134|62783328|FG004|Overall Study|Change in health status|0|||
33404586|NCT00485134|62783329|FG005|Overall Study|Change in health status|1|||
33404587|NCT00485134|62783330|FG006|Overall Study|Change in health status|0|||
33598386|NCT02293993|62997210|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
33404588|NCT00485134|62783331|FG007|Overall Study|Change in health status|0|||
33404589|NCT00485134|62783324|FG000|Overall Study|Withdrew for adverse event|0|||
33404590|NCT00485134|62783325|FG001|Overall Study|Withdrew for adverse event|0|||
33404591|NCT00485134|62783326|FG002|Overall Study|Withdrew for adverse event|1|||
33404592|NCT00485134|62783327|FG003|Overall Study|Withdrew for adverse event|0|||
33404593|NCT00485134|62783328|FG004|Overall Study|Withdrew for adverse event|0|||
33404594|NCT00485134|62783329|FG005|Overall Study|Withdrew for adverse event|0|||
33404595|NCT00485134|62783330|FG006|Overall Study|Withdrew for adverse event|0|||
33404596|NCT00485134|62783331|FG007|Overall Study|Withdrew for adverse event|0|||
33404597|NCT00485134|62783324|FG000|Overall Study|Positive drug test|0|||
33404598|NCT00485134|62783325|FG001|Overall Study|Positive drug test|0|||
33404599|NCT00485134|62783326|FG002|Overall Study|Positive drug test|0|||
33404600|NCT00485134|62783327|FG003|Overall Study|Positive drug test|0|||
33404601|NCT00485134|62783328|FG004|Overall Study|Positive drug test|2|||
33404602|NCT00485134|62783329|FG005|Overall Study|Positive drug test|1|||
33404603|NCT00485134|62783330|FG006|Overall Study|Positive drug test|0|||
33404604|NCT00485134|62783331|FG007|Overall Study|Positive drug test|0|||
33404605|NCT00485134|62783324|FG000|Overall Study|Non-compliance|0|||
33404606|NCT00485134|62783325|FG001|Overall Study|Non-compliance|0|||
33320946|NCT03672175|62696664|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
33320947|NCT03672175|62696662|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
33320948|NCT03672175|62696663|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
33320949|NCT03672175|62696664|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
33320950|NCT03672175|62696662|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
33404607|NCT00485134|62783326|FG002|Overall Study|Non-compliance|0|||
33404608|NCT00485134|62783327|FG003|Overall Study|Non-compliance|0|||
33404609|NCT00485134|62783328|FG004|Overall Study|Non-compliance|1|||
33404610|NCT00485134|62783329|FG005|Overall Study|Non-compliance|2|||
33404611|NCT00485134|62783330|FG006|Overall Study|Non-compliance|2|||
33404612|NCT00485134|62783331|FG007|Overall Study|Non-compliance|0|||
33404613|NCT00485134|62783324|FG000|Overall Study|Unable to comply with study schedule|0|||
33404614|NCT00485134|62783325|FG001|Overall Study|Unable to comply with study schedule|0|||
33404615|NCT00485134|62783326|FG002|Overall Study|Unable to comply with study schedule|0|||
33404616|NCT00485134|62783327|FG003|Overall Study|Unable to comply with study schedule|0|||
33404617|NCT00485134|62783328|FG004|Overall Study|Unable to comply with study schedule|0|||
33320951|NCT03672175|62696663|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
33320952|NCT03672175|62696664|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
33320953|NCT01008423|62696692|FG000|Overall Study|Adverse Event|13|||
33320954|NCT01008423|62696693|FG001|Overall Study|Adverse Event|6|||
33320955|NCT01008423|62696692|FG000|Overall Study|Withdrawal by Subject|4|||
33320956|NCT01008423|62696693|FG001|Overall Study|Withdrawal by Subject|7|||
33320957|NCT01008423|62696692|FG000|Overall Study|Lost to Follow-up|0|||
33320958|NCT01008423|62696693|FG001|Overall Study|Lost to Follow-up|2|||
33320959|NCT01008423|62696692|FG000|Overall Study|Low Cortisol|0|||
33320960|NCT01008423|62696693|FG001|Overall Study|Low Cortisol|1|||
33320961|NCT01008423|62696692|FG000|Overall Study|Lack of Efficacy|0|||
33320962|NCT01008423|62696693|FG001|Overall Study|Lack of Efficacy|5|||
33320963|NCT01008423|62696692|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
33404618|NCT00485134|62783329|FG005|Overall Study|Unable to comply with study schedule|0|||
33404619|NCT00485134|62783330|FG006|Overall Study|Unable to comply with study schedule|0|||
33320964|NCT01008423|62696693|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
33493950|NCT03104816|62872525|FG001|Overall Study|Protocol Violation|0|||
33320965|NCT01008423|62696692|FG000|Overall Study|Personal Conflict|1|||
33320966|NCT01008423|62696693|FG001|Overall Study|Personal Conflict|0|||
33320967|NCT01008423|62696692|FG000|Overall Study|Other|0|||
33404620|NCT00485134|62783331|FG007|Overall Study|Unable to comply with study schedule|1|||
33404621|NCT00485134|62783324|FG000|Overall Study|Pregnancy|0|||
33404622|NCT00485134|62783325|FG001|Overall Study|Pregnancy|0|||
33404623|NCT00485134|62783326|FG002|Overall Study|Pregnancy|0|||
33404624|NCT00485134|62783327|FG003|Overall Study|Pregnancy|0|||
33404625|NCT00485134|62783328|FG004|Overall Study|Pregnancy|0|||
33404626|NCT00485134|62783329|FG005|Overall Study|Pregnancy|0|||
33404627|NCT00485134|62783330|FG006|Overall Study|Pregnancy|1|||
33404628|NCT00485134|62783331|FG007|Overall Study|Pregnancy|0|||
33404629|NCT00583115|62783343|FG000|Overall Study|Death|1|||
33404630|NCT00532779|62783350|FG000|Overall Study|Adverse Event|122|||
33404631|NCT00532779|62783351|FG001|Overall Study|Adverse Event|112|||
33404632|NCT00532779|62783352|FG002|Overall Study|Adverse Event|56|||
33404633|NCT00532779|62783350|FG000|Overall Study|Lost to Follow-up|76|||
33404634|NCT00532779|62783351|FG001|Overall Study|Lost to Follow-up|65|||
33404635|NCT00532779|62783352|FG002|Overall Study|Lost to Follow-up|66|||
33404636|NCT00532779|62783350|FG000|Overall Study|Withdrawal by Subject|63|||
33404637|NCT00532779|62783351|FG001|Overall Study|Withdrawal by Subject|60|||
33404638|NCT00532779|62783352|FG002|Overall Study|Withdrawal by Subject|90|||
33404639|NCT00532779|62783350|FG000|Overall Study|Lack of Efficacy|12|||
33404640|NCT00532779|62783351|FG001|Overall Study|Lack of Efficacy|12|||
33404641|NCT00532779|62783352|FG002|Overall Study|Lack of Efficacy|40|||
33404642|NCT00532779|62783350|FG000|Overall Study|Protocol Violation|5|||
33404643|NCT00532779|62783351|FG001|Overall Study|Protocol Violation|9|||
33404644|NCT00532779|62783352|FG002|Overall Study|Protocol Violation|7|||
33404645|NCT00532779|62783350|FG000|Overall Study|Pregnancy|2|||
33404646|NCT00532779|62783351|FG001|Overall Study|Pregnancy|5|||
33404647|NCT00532779|62783352|FG002|Overall Study|Pregnancy|3|||
33404648|NCT00532779|62783350|FG000|Overall Study|Death|0|||
33404649|NCT00532779|62783351|FG001|Overall Study|Death|1|||
33404650|NCT00532779|62783352|FG002|Overall Study|Death|0|||
33404651|NCT00532779|62783350|FG000|Overall Study|Drug noncompliance, moved, other|14|||
33404652|NCT00532779|62783351|FG001|Overall Study|Drug noncompliance, moved, other|23|||
33404653|NCT00532779|62783352|FG002|Overall Study|Drug noncompliance, moved, other|29|||
33404654|NCT00500266|62783360|FG000|Overall Study|Death|3|||
33404655|NCT00500266|62783360|FG000|Overall Study|Lost to Follow-up|3|||
33404656|NCT00500266|62783360|FG000|Overall Study|Withdrawal by Subject|3|||
33404657|NCT00500266|62783360|FG000|Overall Study|Assigned, not treated|4|||
33404658|NCT00500110|62783365|FG000|Overall Study|Withdrawal by Subject|3|||
33404659|NCT00534495|62783371|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
33404660|NCT00534495|62783372|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
33404661|NCT00534495|62783373|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
33404662|NCT00534495|62783371|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
33404663|NCT00534495|62783372|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
33404664|NCT00534495|62783373|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
33404665|NCT00534495|62783371|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
33404666|NCT00534495|62783372|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
33404667|NCT00534495|62783373|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
33404668|NCT00534495|62783371|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
33404669|NCT00534495|62783372|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
33404670|NCT00534495|62783373|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
33404671|NCT00534495|62783371|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
33404672|NCT00534495|62783372|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
33404673|NCT00534495|62783373|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
33404674|NCT00534495|62783371|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
33404675|NCT00534495|62783372|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
33404676|NCT00534495|62783373|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
33404677|NCT00534495|62783371|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
33404678|NCT00534495|62783372|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
33404679|NCT00534495|62783373|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
33404680|NCT00534495|62783371|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
33404681|NCT00534495|62783372|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
33404682|NCT00534495|62783373|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
33404683|NCT00534495|62783371|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
33404684|NCT00534495|62783372|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
33404685|NCT00534495|62783373|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
33404686|NCT00484198|62783397|FG000|Overall Study|Participant Withdrew Consent|12|||
33493951|NCT03104816|62872526|FG002|Overall Study|Protocol Violation|2|||
33493952|NCT03559062|62872537|FG000|Overall Study|Other|0|||
33493953|NCT03559062|62872538|FG001|Overall Study|Other|1|||
33320968|NCT01008423|62696693|FG001|Overall Study|Other|1|||
33320969|NCT01012947|62696704|FG000|Overall Study|Lost to Follow-up|131|||
33320970|NCT01012947|62696705|FG001|Overall Study|Lost to Follow-up|135|||
33320971|NCT01012947|62696706|FG002|Overall Study|Lost to Follow-up|130|||
33320972|NCT01012947|62696707|FG003|Overall Study|Lost to Follow-up|118|||
33320973|NCT01012947|62696708|FG004|Overall Study|Lost to Follow-up|142|||
33320974|NCT01214603|62696740|FG000|Overall Study|Adverse Event|0|||
33320975|NCT01214603|62696741|FG001|Overall Study|Adverse Event|0|||
33320976|NCT01214603|62696742|FG002|Overall Study|Adverse Event|1|||
33320977|NCT01214603|62696740|FG000|Overall Study|Death|1|||
33320978|NCT01214603|62696741|FG001|Overall Study|Death|0|||
33320979|NCT01214603|62696742|FG002|Overall Study|Death|0|||
33320980|NCT01214603|62696740|FG000|Overall Study|Progressive Disease|4|||
33320981|NCT01214603|62696741|FG001|Overall Study|Progressive Disease|1|||
33493954|NCT03559062|62872539|FG002|Overall Study|Other|0|||
33493955|NCT00089791|62872550|FG000|Overall Study|Physician Decision|6|||
33320982|NCT01214603|62696742|FG002|Overall Study|Progressive Disease|3|||
33320983|NCT01212185|62696753|FG000|Overall Study|Protocol Violation|2|||
33320984|NCT01212185|62696754|FG001|Overall Study|Protocol Violation|1|||
33320985|NCT01995175|62696760|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
33320986|NCT01995175|62696760|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
33320987|NCT01995175|62696760|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
33404687|NCT00484198|62783398|FG001|Overall Study|Participant Withdrew Consent|21|||
33404688|NCT00484198|62783399|FG002|Overall Study|Participant Withdrew Consent|47|||
33404689|NCT00484198|62783400|FG003|Overall Study|Participant Withdrew Consent|59|||
33404690|NCT00484198|62783397|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
33404691|NCT00484198|62783398|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
33404692|NCT00484198|62783399|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
33404693|NCT00484198|62783400|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
33404694|NCT00484198|62783397|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
33404695|NCT00484198|62783398|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
33404696|NCT00484198|62783399|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
33404697|NCT00484198|62783400|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
33404698|NCT00484198|62783397|FG000|Overall Study|Adverse Event|3|||
33404699|NCT00484198|62783398|FG001|Overall Study|Adverse Event|11|||
33404700|NCT00484198|62783399|FG002|Overall Study|Adverse Event|32|||
33404701|NCT00484198|62783400|FG003|Overall Study|Adverse Event|31|||
33404702|NCT00484198|62783397|FG000|Overall Study|Protocol Violation|0|||
33404703|NCT00484198|62783398|FG001|Overall Study|Protocol Violation|5|||
33404704|NCT00484198|62783399|FG002|Overall Study|Protocol Violation|6|||
33404705|NCT00484198|62783400|FG003|Overall Study|Protocol Violation|8|||
33404706|NCT00484198|62783397|FG000|Overall Study|Other|7|||
33404707|NCT00484198|62783398|FG001|Overall Study|Other|10|||
33404708|NCT00484198|62783399|FG002|Overall Study|Other|31|||
33404709|NCT00484198|62783400|FG003|Overall Study|Other|28|||
33404710|NCT00499486|62783415|FG000|Overall Study|Withdrawal by Subject|16|||
33404711|NCT00499252|62783419|FG000|Overall Study|Adverse Event|3|||
33404712|NCT00499252|62783419|FG000|Overall Study|Refused further treatment|2|||
33404713|NCT00499252|62783419|FG000|Overall Study|Ineligible|4|||
33404714|NCT00499252|62783419|FG000|Overall Study|<no further label>|3|||
33404715|NCT00499174|62783429|FG000|Overall Study|Physician Decision|78|||
33404716|NCT00499174|62783430|FG001|Overall Study|Physician Decision|9|||
33404717|NCT03775421|62783438|FG000|Overall Study|Lost to Follow-up|2|||
33404718|NCT03775421|62783438|FG000|Overall Study|Withdrawal by Subject|10|||
33404719|NCT03775421|62783438|FG000|Overall Study|Physician Decision|3|||
33404720|NCT03775421|62783438|FG000|Overall Study|Death|1|||
33404721|NCT03775421|62783438|FG000|Overall Study|Study Terminated by Sponsor|94|||
33404722|NCT00532155|62783444|FG000|Overall Study|Adverse Event|66|||
33404723|NCT00532155|62783445|FG001|Overall Study|Adverse Event|123|||
33404724|NCT00532155|62783444|FG000|Overall Study|Lack of Efficacy|332|||
33404725|NCT00532155|62783445|FG001|Overall Study|Lack of Efficacy|255|||
33404726|NCT00532155|62783444|FG000|Overall Study|Protocol Violation|1|||
33404727|NCT00532155|62783445|FG001|Overall Study|Protocol Violation|3|||
33404728|NCT00532155|62783444|FG000|Overall Study|Lost to Follow-up|2|||
33404729|NCT00532155|62783445|FG001|Overall Study|Lost to Follow-up|0|||
33404730|NCT00532155|62783444|FG000|Overall Study|Physician Decision|16|||
33404731|NCT00532155|62783445|FG001|Overall Study|Physician Decision|15|||
33404732|NCT00532155|62783444|FG000|Overall Study|Withdrawal by Subject|23|||
33404733|NCT00532155|62783445|FG001|Overall Study|Withdrawal by Subject|44|||
33404734|NCT00532155|62783444|FG000|Overall Study|Consent withdrawn|5|||
33404735|NCT00532155|62783445|FG001|Overall Study|Consent withdrawn|7|||
33404736|NCT00532155|62783444|FG000|Overall Study|Moved|1|||
33404737|NCT00532155|62783445|FG001|Overall Study|Moved|0|||
33404738|NCT00532155|62783444|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
33404739|NCT00532155|62783445|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
33404740|NCT00532155|62783444|FG000|Overall Study|Occurence of a second cancer|0|||
33404741|NCT00532155|62783445|FG001|Overall Study|Occurence of a second cancer|1|||
33404742|NCT00532155|62783444|FG000|Overall Study|Occurence of a secondary cancer|0|||
33404743|NCT00532155|62783445|FG001|Overall Study|Occurence of a secondary cancer|1|||
33404744|NCT00532155|62783444|FG000|Overall Study|Promotor ended study|1|||
33404745|NCT00532155|62783445|FG001|Overall Study|Promotor ended study|0|||
33404746|NCT00532155|62783444|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
33404747|NCT00532155|62783445|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
33404748|NCT00532155|62783444|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
33404749|NCT00532155|62783445|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
33404750|NCT00532155|62783444|FG000|Overall Study|Study stopped|1|||
33404751|NCT00532155|62783445|FG001|Overall Study|Study stopped|0|||
33404752|NCT00532155|62783444|FG000|Overall Study|Study terminated by sponsor|1|||
33404753|NCT00532155|62783445|FG001|Overall Study|Study terminated by sponsor|0|||
33404754|NCT00532155|62783444|FG000|Overall Study|Study termination stop further treatment|4|||
33404755|NCT00532155|62783445|FG001|Overall Study|Study termination stop further treatment|0|||
33404756|NCT00532155|62783444|FG000|Overall Study|Did not receive study medication|2|||
33404757|NCT00532155|62783445|FG001|Overall Study|Did not receive study medication|6|||
33404758|NCT00205777|62783455|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
33404759|NCT00205777|62783456|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
33404760|NCT00205777|62783457|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
33404761|NCT00205777|62783458|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
33404762|NCT00205777|62783459|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
33404763|NCT00205777|62783460|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
33404764|NCT00205777|62783455|FG000|Core Study (Up to 3 Years)|Death|9|||
33404765|NCT00205777|62783456|FG001|Core Study (Up to 3 Years)|Death|7|||
33404766|NCT00205777|62783457|FG002|Core Study (Up to 3 Years)|Death|14|||
33404767|NCT00205777|62783458|FG003|Core Study (Up to 3 Years)|Death|7|||
33404768|NCT00205777|62783459|FG004|Core Study (Up to 3 Years)|Death|0|||
33404769|NCT00205777|62783460|FG005|Core Study (Up to 3 Years)|Death|0|||
33404770|NCT00205777|62783455|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
33404771|NCT00205777|62783456|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
33404772|NCT00205777|62783457|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
33404773|NCT00205777|62783458|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
33404774|NCT00205777|62783459|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
33404775|NCT00205777|62783460|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
33404776|NCT00205777|62783455|FG000|Core Study (Up to 3 Years)|Other Event|49|||
33404777|NCT00205777|62783456|FG001|Core Study (Up to 3 Years)|Other Event|52|||
33404778|NCT00205777|62783457|FG002|Core Study (Up to 3 Years)|Other Event|41|||
33404779|NCT00205777|62783458|FG003|Core Study (Up to 3 Years)|Other Event|58|||
33404780|NCT00205777|62783459|FG004|Core Study (Up to 3 Years)|Other Event|0|||
33404781|NCT00205777|62783460|FG005|Core Study (Up to 3 Years)|Other Event|0|||
33404782|NCT00205777|62783455|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
33404783|NCT00205777|62783456|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
33404784|NCT00205777|62783457|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
33404785|NCT00205777|62783458|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
33404786|NCT00205777|62783459|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
33404787|NCT00205777|62783460|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
33404788|NCT00205777|62783455|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
33404789|NCT00205777|62783456|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
33404790|NCT00205777|62783457|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
33404791|NCT00205777|62783458|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
33404792|NCT00205777|62783459|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
33404793|NCT00205777|62783460|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
33404794|NCT00205777|62783455|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
33404795|NCT00205777|62783456|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
33404796|NCT00205777|62783457|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
33404797|NCT00205777|62783458|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
33404798|NCT00205777|62783459|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
33404799|NCT00205777|62783460|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
33404800|NCT00205777|62783455|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
33404801|NCT00205777|62783456|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
33404802|NCT00205777|62783457|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
33404803|NCT00205777|62783458|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
33404804|NCT00205777|62783459|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
33404805|NCT00205777|62783460|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
33404806|NCT00205777|62783455|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
33404807|NCT00205777|62783456|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
33404808|NCT00205777|62783457|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
33404809|NCT00205777|62783458|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
33404810|NCT00205777|62783459|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
33404811|NCT00205777|62783460|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
33404812|NCT00205777|62783455|FG000|Completed Core Study, Entered SE I|Other Event|52|||
33404813|NCT00205777|62783456|FG001|Completed Core Study, Entered SE I|Other Event|46|||
33404814|NCT00205777|62783457|FG002|Completed Core Study, Entered SE I|Other Event|47|||
33404815|NCT00205777|62783458|FG003|Completed Core Study, Entered SE I|Other Event|50|||
33404816|NCT00205777|62783459|FG004|Completed Core Study, Entered SE I|Other Event|0|||
33404817|NCT00205777|62783460|FG005|Completed Core Study, Entered SE I|Other Event|0|||
33404818|NCT00205777|62783455|FG000|Study Extension I|Adverse Event|57|||
33404819|NCT00205777|62783456|FG001|Study Extension I|Adverse Event|0|||
33404820|NCT00205777|62783457|FG002|Study Extension I|Adverse Event|0|||
33404821|NCT00205777|62783458|FG003|Study Extension I|Adverse Event|61|||
33404822|NCT00205777|62783459|FG004|Study Extension I|Adverse Event|58|||
33404823|NCT00205777|62783460|FG005|Study Extension I|Adverse Event|0|||
33404824|NCT00205777|62783455|FG000|Study Extension I|Death|5|||
33404825|NCT00205777|62783456|FG001|Study Extension I|Death|0|||
33404826|NCT00205777|62783457|FG002|Study Extension I|Death|0|||
33404827|NCT00205777|62783458|FG003|Study Extension I|Death|1|||
33404828|NCT00205777|62783459|FG004|Study Extension I|Death|2|||
33404829|NCT00205777|62783460|FG005|Study Extension I|Death|0|||
33404830|NCT00205777|62783455|FG000|Study Extension I|Withdrawal by Subject|99|||
33404831|NCT00205777|62783456|FG001|Study Extension I|Withdrawal by Subject|0|||
33404832|NCT00205777|62783457|FG002|Study Extension I|Withdrawal by Subject|0|||
33404833|NCT00205777|62783458|FG003|Study Extension I|Withdrawal by Subject|106|||
33404834|NCT00205777|62783459|FG004|Study Extension I|Withdrawal by Subject|89|||
33404835|NCT00205777|62783460|FG005|Study Extension I|Withdrawal by Subject|0|||
33404836|NCT00205777|62783455|FG000|Study Extension I|Protocol Violation|4|||
33404837|NCT00205777|62783456|FG001|Study Extension I|Protocol Violation|0|||
33404838|NCT00205777|62783457|FG002|Study Extension I|Protocol Violation|0|||
33404839|NCT00205777|62783458|FG003|Study Extension I|Protocol Violation|8|||
33404840|NCT00205777|62783459|FG004|Study Extension I|Protocol Violation|8|||
33404841|NCT00205777|62783460|FG005|Study Extension I|Protocol Violation|0|||
33404842|NCT00205777|62783455|FG000|Study Extension I|Lack of Efficacy|0|||
33404843|NCT00205777|62783456|FG001|Study Extension I|Lack of Efficacy|0|||
33404844|NCT00205777|62783457|FG002|Study Extension I|Lack of Efficacy|0|||
33404845|NCT00205777|62783458|FG003|Study Extension I|Lack of Efficacy|1|||
33404846|NCT00205777|62783459|FG004|Study Extension I|Lack of Efficacy|2|||
33404847|NCT00205777|62783460|FG005|Study Extension I|Lack of Efficacy|0|||
33404848|NCT00205777|62783455|FG000|Study Extension I|Failed to return|15|||
33404849|NCT00205777|62783456|FG001|Study Extension I|Failed to return|0|||
33404850|NCT00205777|62783457|FG002|Study Extension I|Failed to return|0|||
33404851|NCT00205777|62783458|FG003|Study Extension I|Failed to return|17|||
33404852|NCT00205777|62783459|FG004|Study Extension I|Failed to return|13|||
33404853|NCT00205777|62783460|FG005|Study Extension I|Failed to return|0|||
33404854|NCT00205777|62783455|FG000|Study Extension I|Other Event|34|||
33404855|NCT00205777|62783456|FG001|Study Extension I|Other Event|0|||
33404856|NCT00205777|62783457|FG002|Study Extension I|Other Event|0|||
33404857|NCT00205777|62783458|FG003|Study Extension I|Other Event|34|||
33404858|NCT00205777|62783459|FG004|Study Extension I|Other Event|29|||
33404859|NCT00205777|62783460|FG005|Study Extension I|Other Event|0|||
33404860|NCT00205777|62783455|FG000|Study Extension I|Withdrawn as per protocol|0|||
33404861|NCT00205777|62783456|FG001|Study Extension I|Withdrawn as per protocol|0|||
33404862|NCT00205777|62783457|FG002|Study Extension I|Withdrawn as per protocol|1070|||
33404863|NCT00205777|62783458|FG003|Study Extension I|Withdrawn as per protocol|0|||
33404864|NCT00205777|62783459|FG004|Study Extension I|Withdrawn as per protocol|0|||
33404865|NCT00205777|62783460|FG005|Study Extension I|Withdrawn as per protocol|0|||
33404866|NCT00205777|62783455|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
33404867|NCT00205777|62783456|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
33404868|NCT00205777|62783457|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
33404869|NCT00205777|62783458|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
33404870|NCT00205777|62783459|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
33404871|NCT00205777|62783460|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
33404872|NCT00205777|62783455|FG000|Study Extension II|Adverse Event|0|||
33404873|NCT00205777|62783456|FG001|Study Extension II|Adverse Event|0|||
33404874|NCT00205777|62783457|FG002|Study Extension II|Adverse Event|0|||
33404875|NCT00205777|62783458|FG003|Study Extension II|Adverse Event|14|||
33404876|NCT00205777|62783459|FG004|Study Extension II|Adverse Event|0|||
33404877|NCT00205777|62783460|FG005|Study Extension II|Adverse Event|30|||
33404878|NCT00205777|62783455|FG000|Study Extension II|Death|0|||
33404879|NCT00205777|62783456|FG001|Study Extension II|Death|0|||
33404880|NCT00205777|62783457|FG002|Study Extension II|Death|0|||
33404881|NCT00205777|62783458|FG003|Study Extension II|Death|2|||
33404882|NCT00205777|62783459|FG004|Study Extension II|Death|0|||
33404883|NCT00205777|62783460|FG005|Study Extension II|Death|5|||
33493956|NCT00089791|62872551|FG001|Overall Study|Physician Decision|3|||
33404884|NCT00205777|62783455|FG000|Study Extension II|Withdrawal by Subject|0|||
33404885|NCT00205777|62783456|FG001|Study Extension II|Withdrawal by Subject|0|||
33404886|NCT00205777|62783457|FG002|Study Extension II|Withdrawal by Subject|0|||
33404887|NCT00205777|62783458|FG003|Study Extension II|Withdrawal by Subject|35|||
33404888|NCT00205777|62783459|FG004|Study Extension II|Withdrawal by Subject|0|||
33404889|NCT00205777|62783460|FG005|Study Extension II|Withdrawal by Subject|59|||
33404890|NCT00205777|62783455|FG000|Study Extension II|Protocol Violation|0|||
33404891|NCT00205777|62783456|FG001|Study Extension II|Protocol Violation|0|||
33404892|NCT00205777|62783457|FG002|Study Extension II|Protocol Violation|0|||
33404893|NCT00205777|62783458|FG003|Study Extension II|Protocol Violation|1|||
33404894|NCT00205777|62783459|FG004|Study Extension II|Protocol Violation|0|||
33404895|NCT00205777|62783460|FG005|Study Extension II|Protocol Violation|10|||
33404896|NCT00205777|62783455|FG000|Study Extension II|Lack of Efficacy|0|||
33404897|NCT00205777|62783456|FG001|Study Extension II|Lack of Efficacy|0|||
33404898|NCT00205777|62783457|FG002|Study Extension II|Lack of Efficacy|0|||
33404899|NCT00205777|62783458|FG003|Study Extension II|Lack of Efficacy|0|||
33404900|NCT00205777|62783459|FG004|Study Extension II|Lack of Efficacy|0|||
33404901|NCT00205777|62783460|FG005|Study Extension II|Lack of Efficacy|1|||
33404902|NCT00205777|62783455|FG000|Study Extension II|Failed to return|0|||
33404903|NCT00205777|62783456|FG001|Study Extension II|Failed to return|0|||
33404904|NCT00205777|62783457|FG002|Study Extension II|Failed to return|0|||
33404905|NCT00205777|62783458|FG003|Study Extension II|Failed to return|14|||
33404906|NCT00205777|62783459|FG004|Study Extension II|Failed to return|0|||
33404907|NCT00205777|62783460|FG005|Study Extension II|Failed to return|26|||
33404908|NCT00205777|62783455|FG000|Study Extension II|Other Event|0|||
33404909|NCT00205777|62783456|FG001|Study Extension II|Other Event|0|||
33404910|NCT00205777|62783457|FG002|Study Extension II|Other Event|0|||
33404911|NCT00205777|62783458|FG003|Study Extension II|Other Event|12|||
33404912|NCT00205777|62783459|FG004|Study Extension II|Other Event|0|||
33404913|NCT00205777|62783460|FG005|Study Extension II|Other Event|20|||
33404914|NCT00205777|62783455|FG000|Study Extension II|Enrolled but not treated|0|||
33404915|NCT00205777|62783456|FG001|Study Extension II|Enrolled but not treated|0|||
33404916|NCT00205777|62783457|FG002|Study Extension II|Enrolled but not treated|0|||
33404917|NCT00205777|62783458|FG003|Study Extension II|Enrolled but not treated|71|||
33404918|NCT00205777|62783459|FG004|Study Extension II|Enrolled but not treated|0|||
33404919|NCT00205777|62783460|FG005|Study Extension II|Enrolled but not treated|131|||
33404920|NCT00483652|62783477|FG000|Double-blind Treatment Period|Protocol Violation|2|||
33404921|NCT00483652|62783478|FG001|Double-blind Treatment Period|Protocol Violation|1|||
33404922|NCT00483652|62783477|FG000|Double-blind Treatment Period|Adverse Event|3|||
33404923|NCT00483652|62783478|FG001|Double-blind Treatment Period|Adverse Event|4|||
33404924|NCT00483652|62783477|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
33404925|NCT00483652|62783478|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
33404926|NCT00483652|62783477|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
33404927|NCT00483652|62783478|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
33404928|NCT00483574|62783486|FG000|Overall Study|Adverse Event|6|||
33404929|NCT00483574|62783487|FG001|Overall Study|Adverse Event|0|||
33404930|NCT00483574|62783486|FG000|Overall Study|Protocol Violation|28|||
33404931|NCT00483574|62783487|FG001|Overall Study|Protocol Violation|9|||
33404932|NCT00483574|62783486|FG000|Overall Study|Lost to Follow-up|16|||
33404933|NCT00483574|62783487|FG001|Overall Study|Lost to Follow-up|4|||
33404934|NCT00483574|62783486|FG000|Overall Study|Withdrawal by Subject|52|||
33404935|NCT00483574|62783487|FG001|Overall Study|Withdrawal by Subject|0|||
33404936|NCT00483184|62783498|FG000|Overall Study|Withdrawal by Subject|2|||
33404937|NCT00483184|62783499|FG001|Overall Study|Withdrawal by Subject|2|||
33404938|NCT00483184|62783500|FG002|Overall Study|Withdrawal by Subject|0|||
33404939|NCT00483184|62783498|FG000|Overall Study|Lost to Follow-up|1|||
33404940|NCT00483184|62783499|FG001|Overall Study|Lost to Follow-up|0|||
33404941|NCT00483184|62783500|FG002|Overall Study|Lost to Follow-up|0|||
33404942|NCT00483184|62783498|FG000|Overall Study|Adverse Event|1|||
33404943|NCT00483184|62783499|FG001|Overall Study|Adverse Event|2|||
33404944|NCT00483184|62783500|FG002|Overall Study|Adverse Event|2|||
33404945|NCT00483184|62783498|FG000|Overall Study|Protocol Violation|1|||
33404946|NCT00483184|62783499|FG001|Overall Study|Protocol Violation|0|||
33404947|NCT00483184|62783500|FG002|Overall Study|Protocol Violation|1|||
33404948|NCT00482170|62783510|FG000|Overall Study|Adverse Event|5|||
33404949|NCT00482170|62783511|FG001|Overall Study|Adverse Event|14|||
33404950|NCT00482170|62783510|FG000|Overall Study|Withdrawal by Subject|6|||
33404951|NCT00482170|62783511|FG001|Overall Study|Withdrawal by Subject|1|||
33404952|NCT00482170|62783510|FG000|Overall Study|Protocol Violation|2|||
33404953|NCT00482170|62783511|FG001|Overall Study|Protocol Violation|3|||
33404954|NCT00482170|62783510|FG000|Overall Study|Lost to Follow-up|2|||
33404955|NCT00482170|62783511|FG001|Overall Study|Lost to Follow-up|0|||
33404956|NCT00482170|62783510|FG000|Overall Study|Unspecified reason|0|||
33404957|NCT00482170|62783511|FG001|Overall Study|Unspecified reason|2|||
33404958|NCT03883113|62783519|FG000|Overall Study|Physician Decision|4|||
33404959|NCT03883113|62783520|FG001|Overall Study|Physician Decision|2|||
33404960|NCT03883113|62783519|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
33404961|NCT03883113|62783520|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
33404962|NCT03883113|62783519|FG000|Overall Study|Pregnancy|1|||
33404963|NCT03883113|62783520|FG001|Overall Study|Pregnancy|0|||
33404964|NCT03883113|62783519|FG000|Overall Study|Adverse Event|0|||
33404965|NCT03883113|62783520|FG001|Overall Study|Adverse Event|1|||
33404966|NCT03883113|62783519|FG000|Overall Study|Withdrawal by Subject|1|||
33404967|NCT03883113|62783520|FG001|Overall Study|Withdrawal by Subject|2|||
33404968|NCT03883113|62783519|FG000|Overall Study|Lost to Follow-up|1|||
33404969|NCT03883113|62783520|FG001|Overall Study|Lost to Follow-up|0|||
33404970|NCT04218695|62783542|FG000|Overall Study|Adverse Event|1|||
33404971|NCT04218695|62783543|FG001|Overall Study|Adverse Event|0|||
33404972|NCT00490282|62783549|FG000|Overall Study|Withdrawal by Subject|3|||
33404973|NCT00615056|62783558|FG000|Overall Study|Death|31|||
33404974|NCT00615056|62783559|FG001|Overall Study|Death|31|||
33404975|NCT00615056|62783560|FG002|Overall Study|Death|21|||
33404976|NCT00615056|62783561|FG003|Overall Study|Death|23|||
33404977|NCT00615056|62783558|FG000|Overall Study|Lost to Follow-up|1|||
33404978|NCT00615056|62783559|FG001|Overall Study|Lost to Follow-up|2|||
33404979|NCT00615056|62783560|FG002|Overall Study|Lost to Follow-up|4|||
33404980|NCT00615056|62783561|FG003|Overall Study|Lost to Follow-up|5|||
33404981|NCT00615056|62783558|FG000|Overall Study|Other|13|||
33404982|NCT00615056|62783559|FG001|Overall Study|Other|15|||
33404983|NCT00615056|62783560|FG002|Overall Study|Other|10|||
33404984|NCT00615056|62783561|FG003|Overall Study|Other|7|||
33404985|NCT00615056|62783558|FG000|Overall Study|Objective progression or relapse|0|||
33404986|NCT00615056|62783559|FG001|Overall Study|Objective progression or relapse|2|||
33404987|NCT00615056|62783560|FG002|Overall Study|Objective progression or relapse|0|||
33404988|NCT00615056|62783561|FG003|Overall Study|Objective progression or relapse|0|||
33404989|NCT00615056|62783558|FG000|Overall Study|Withdrawal by Subject|0|||
33404990|NCT00615056|62783559|FG001|Overall Study|Withdrawal by Subject|1|||
33404991|NCT00615056|62783560|FG002|Overall Study|Withdrawal by Subject|1|||
33404992|NCT00615056|62783561|FG003|Overall Study|Withdrawal by Subject|0|||
33404993|NCT00615056|62783558|FG000|Overall Study|Discontinued by Sponsor|1|||
33404994|NCT00615056|62783559|FG001|Overall Study|Discontinued by Sponsor|0|||
33404995|NCT00615056|62783560|FG002|Overall Study|Discontinued by Sponsor|0|||
33404996|NCT00615056|62783561|FG003|Overall Study|Discontinued by Sponsor|0|||
33404997|NCT00615056|62783558|FG000|Overall Study|Randomized but not treated|3|||
33404998|NCT00615056|62783559|FG001|Overall Study|Randomized but not treated|0|||
33404999|NCT00615056|62783560|FG002|Overall Study|Randomized but not treated|0|||
33405000|NCT00615056|62783561|FG003|Overall Study|Randomized but not treated|0|||
33405001|NCT00482014|62783575|FG000|Overall Study|Withdrawal by Subject|1|||
33405002|NCT00482014|62783576|FG001|Overall Study|Withdrawal by Subject|2|||
33493957|NCT00089791|62872550|FG000|Overall Study|Adverse Event|81|||
33405003|NCT00482014|62783577|FG002|Overall Study|Withdrawal by Subject|3|||
33405004|NCT00482014|62783578|FG003|Overall Study|Withdrawal by Subject|4|||
33405005|NCT00482014|62783575|FG000|Overall Study|Adverse Event|3|||
33405006|NCT00482014|62783576|FG001|Overall Study|Adverse Event|0|||
33405007|NCT00482014|62783577|FG002|Overall Study|Adverse Event|2|||
33405008|NCT00482014|62783578|FG003|Overall Study|Adverse Event|8|||
33405009|NCT00482014|62783575|FG000|Overall Study|Death|1|||
33405010|NCT00482014|62783576|FG001|Overall Study|Death|2|||
33405011|NCT00482014|62783577|FG002|Overall Study|Death|1|||
33405012|NCT00482014|62783578|FG003|Overall Study|Death|4|||
33405013|NCT00482014|62783575|FG000|Overall Study|Lack of Efficacy|1|||
33405014|NCT00482014|62783576|FG001|Overall Study|Lack of Efficacy|0|||
33405015|NCT00482014|62783577|FG002|Overall Study|Lack of Efficacy|4|||
33405016|NCT00482014|62783578|FG003|Overall Study|Lack of Efficacy|6|||
33405017|NCT00482014|62783575|FG000|Overall Study|Sponsor Decision|1|||
33405018|NCT00482014|62783576|FG001|Overall Study|Sponsor Decision|2|||
33405019|NCT00482014|62783577|FG002|Overall Study|Sponsor Decision|1|||
33405020|NCT00482014|62783578|FG003|Overall Study|Sponsor Decision|1|||
33405021|NCT03595553|62783592|FG000|Overall Study|Withdrawal by Subject|20|||
33405022|NCT03595553|62783593|FG001|Overall Study|Withdrawal by Subject|8|||
33405023|NCT03595553|62783592|FG000|Overall Study|Physician Decision|3|||
33405024|NCT03595553|62783593|FG001|Overall Study|Physician Decision|2|||
33405025|NCT03595553|62783592|FG000|Overall Study|Adverse Event|2|||
33405026|NCT03595553|62783593|FG001|Overall Study|Adverse Event|5|||
33405027|NCT03595553|62783592|FG000|Overall Study|Death|24|||
33405028|NCT03595553|62783593|FG001|Overall Study|Death|22|||
33405029|NCT03595553|62783592|FG000|Overall Study|Lost to Follow-up|6|||
33405030|NCT03595553|62783593|FG001|Overall Study|Lost to Follow-up|7|||
33405031|NCT03595553|62783592|FG000|Overall Study|Other as indicated in CSR|3|||
33405032|NCT03595553|62783593|FG001|Overall Study|Other as indicated in CSR|3|||
33405033|NCT03595553|62783592|FG000|Overall Study|Sponsor Decision|0|||
33405034|NCT03595553|62783593|FG001|Overall Study|Sponsor Decision|1|||
33405035|NCT00614822|62783599|FG000|Overall Study|Adverse Event|3|||
33405036|NCT00529659|62783606|FG000|Overall Study|Adverse Event|8|||
33405037|NCT00529659|62783607|FG001|Overall Study|Adverse Event|7|||
33405038|NCT00529659|62783606|FG000|Overall Study|Lost to Follow-up|0|||
33405039|NCT00529659|62783607|FG001|Overall Study|Lost to Follow-up|2|||
33405040|NCT00529659|62783606|FG000|Overall Study|Physician Decision|0|||
33405041|NCT00529659|62783607|FG001|Overall Study|Physician Decision|2|||
33405042|NCT00529659|62783606|FG000|Overall Study|Protocol Violation|2|||
33405043|NCT00529659|62783607|FG001|Overall Study|Protocol Violation|6|||
33405044|NCT00529659|62783606|FG000|Overall Study|Withdrawal by Subject|1|||
33405045|NCT00529659|62783607|FG001|Overall Study|Withdrawal by Subject|6|||
33405046|NCT03569891|62783613|FG000|Lead-in|Ineligible during lead-in|8|||
33405047|NCT03569891|62783613|FG000|Lead-in|Withdrawal by Subject|3|||
33405048|NCT03569891|62783613|FG000|Lead-in|Risks related to COVID-19|2|||
33405049|NCT03569891|62783613|FG000|AMT-061|Adverse Event|1|||
33405050|NCT00143455|62783626|FG000|Cohort 1|Adverse Event|8|||
33405051|NCT00143455|62783627|FG001|Cohort 1|Adverse Event|4|||
33405052|NCT00143455|62783628|FG002|Cohort 1|Adverse Event|0|||
33405053|NCT00143455|62783629|FG003|Cohort 1|Adverse Event|0|||
33405054|NCT00143455|62783626|FG000|Cohort 1|Death|5|||
33405055|NCT00143455|62783627|FG001|Cohort 1|Death|2|||
33405056|NCT00143455|62783628|FG002|Cohort 1|Death|0|||
33405057|NCT00143455|62783629|FG003|Cohort 1|Death|0|||
33405058|NCT00143455|62783626|FG000|Cohort 1|Progressive Disease|0|||
33405059|NCT00143455|62783627|FG001|Cohort 1|Progressive Disease|6|||
33405060|NCT00143455|62783628|FG002|Cohort 1|Progressive Disease|0|||
33405061|NCT00143455|62783629|FG003|Cohort 1|Progressive Disease|0|||
33405062|NCT00143455|62783626|FG000|Cohort 1|Withdrawal by Subject|1|||
33405063|NCT00143455|62783627|FG001|Cohort 1|Withdrawal by Subject|4|||
33405064|NCT00143455|62783628|FG002|Cohort 1|Withdrawal by Subject|0|||
33405065|NCT00143455|62783629|FG003|Cohort 1|Withdrawal by Subject|0|||
33405066|NCT00143455|62783626|FG000|Cohort 1|Randomized But Not Treated|0|||
33405067|NCT00143455|62783627|FG001|Cohort 1|Randomized But Not Treated|1|||
33405068|NCT00143455|62783628|FG002|Cohort 1|Randomized But Not Treated|0|||
33405069|NCT00143455|62783629|FG003|Cohort 1|Randomized But Not Treated|0|||
33405070|NCT00143455|62783626|FG000|Cohort 2|Adverse Event|0|||
33405071|NCT00143455|62783627|FG001|Cohort 2|Adverse Event|0|||
33405072|NCT00143455|62783628|FG002|Cohort 2|Adverse Event|42|||
33405073|NCT00143455|62783629|FG003|Cohort 2|Adverse Event|30|||
33405074|NCT00143455|62783626|FG000|Cohort 2|No Longer Required Study Treatment|0|||
33405075|NCT00143455|62783627|FG001|Cohort 2|No Longer Required Study Treatment|0|||
33405076|NCT00143455|62783628|FG002|Cohort 2|No Longer Required Study Treatment|1|||
33405077|NCT00143455|62783629|FG003|Cohort 2|No Longer Required Study Treatment|0|||
33405078|NCT00143455|62783626|FG000|Cohort 2|Protocol Violation|0|||
33405079|NCT00143455|62783627|FG001|Cohort 2|Protocol Violation|0|||
33405080|NCT00143455|62783628|FG002|Cohort 2|Protocol Violation|1|||
33405081|NCT00143455|62783629|FG003|Cohort 2|Protocol Violation|1|||
33405082|NCT00143455|62783626|FG000|Cohort 2|Lost to Follow-up|0|||
33405083|NCT00143455|62783627|FG001|Cohort 2|Lost to Follow-up|0|||
33405084|NCT00143455|62783628|FG002|Cohort 2|Lost to Follow-up|1|||
33405085|NCT00143455|62783629|FG003|Cohort 2|Lost to Follow-up|4|||
33405086|NCT00143455|62783626|FG000|Cohort 2|Death|0|||
33405087|NCT00143455|62783627|FG001|Cohort 2|Death|0|||
33405088|NCT00143455|62783628|FG002|Cohort 2|Death|20|||
33405089|NCT00143455|62783629|FG003|Cohort 2|Death|12|||
33405090|NCT00143455|62783626|FG000|Cohort 2|Progressive Disease|0|||
33598387|NCT02293993|62997211|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
33405091|NCT00143455|62783627|FG001|Cohort 2|Progressive Disease|0|||
33405092|NCT00143455|62783628|FG002|Cohort 2|Progressive Disease|20|||
33598388|NCT02293993|62997212|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
33405093|NCT00143455|62783629|FG003|Cohort 2|Progressive Disease|27|||
33405094|NCT00143455|62783626|FG000|Cohort 2|Withdrawal by Subject|0|||
33405095|NCT00143455|62783627|FG001|Cohort 2|Withdrawal by Subject|0|||
33405096|NCT00143455|62783628|FG002|Cohort 2|Withdrawal by Subject|13|||
33405097|NCT00143455|62783629|FG003|Cohort 2|Withdrawal by Subject|12|||
33405098|NCT00143455|62783626|FG000|Cohort 2|Other|0|||
33405099|NCT00143455|62783627|FG001|Cohort 2|Other|0|||
33405100|NCT00143455|62783628|FG002|Cohort 2|Other|7|||
33405101|NCT00143455|62783629|FG003|Cohort 2|Other|6|||
33405102|NCT00143455|62783626|FG000|Cohort 2|Randomized But Not Treated|0|||
33405103|NCT00143455|62783627|FG001|Cohort 2|Randomized But Not Treated|0|||
33405104|NCT00143455|62783628|FG002|Cohort 2|Randomized But Not Treated|1|||
33405105|NCT00143455|62783629|FG003|Cohort 2|Randomized But Not Treated|1|||
33405106|NCT03529955|62783641|FG000|Overall Study|Adverse Event|1|||
33405107|NCT03529955|62783641|FG000|Overall Study|Lack of Efficacy|1|||
33405108|NCT00142909|62783657|FG000|Randomization|Various Reasons|7|||
33405109|NCT00142909|62783658|FG001|Randomization|Various Reasons|10|||
33405110|NCT00142909|62783657|FG000|Medications Begin|Protocol Violation|2|||
33405111|NCT00142909|62783658|FG001|Medications Begin|Protocol Violation|0|||
33405112|NCT00142909|62783657|FG000|Medications Begin|Withdrawal by Subject|5|||
33405113|NCT00142909|62783658|FG001|Medications Begin|Withdrawal by Subject|3|||
33405114|NCT00142909|62783657|FG000|Medications Begin|Withdrawal by Subject|2|||
33405115|NCT00142909|62783658|FG001|Medications Begin|Withdrawal by Subject|0|||
33405116|NCT00205699|62783667|FG000|Overall Study|Lost to Follow-up|1|||
33405117|NCT00205699|62783668|FG001|Overall Study|Lost to Follow-up|3|||
33405118|NCT00205699|62783669|FG002|Overall Study|Lost to Follow-up|5|||
33405119|NCT00205699|62783667|FG000|Overall Study|Adverse Event|1|||
33405120|NCT00205699|62783668|FG001|Overall Study|Adverse Event|0|||
33405121|NCT00205699|62783669|FG002|Overall Study|Adverse Event|0|||
33405122|NCT00205699|62783667|FG000|Overall Study|Withdrawal by Subject|1|||
33405123|NCT00205699|62783668|FG001|Overall Study|Withdrawal by Subject|2|||
33405124|NCT00205699|62783669|FG002|Overall Study|Withdrawal by Subject|1|||
33405125|NCT00205699|62783667|FG000|Overall Study|Lack of Efficacy|0|||
33405126|NCT00205699|62783668|FG001|Overall Study|Lack of Efficacy|1|||
33405127|NCT00205699|62783669|FG002|Overall Study|Lack of Efficacy|0|||
33405128|NCT03882801|62783682|FG000|Period 1|Adverse Event|0|||
33405129|NCT03882801|62783683|FG001|Period 1|Adverse Event|1|||
33405130|NCT03882801|62783682|FG000|Period 1|Non-compliance with study drug|1|||
33405131|NCT03882801|62783683|FG001|Period 1|Non-compliance with study drug|1|||
33405132|NCT03882801|62783682|FG000|Period 1|Never treated with study drug|1|||
33405133|NCT03882801|62783683|FG001|Period 1|Never treated with study drug|0|||
33405134|NCT03882801|62783682|FG000|Washout Period|Physician Decision|0|||
33405135|NCT03882801|62783683|FG001|Washout Period|Physician Decision|1|||
33405136|NCT03882801|62783682|FG000|Period 2|Non-compliance with study drug|0|||
33405137|NCT03882801|62783683|FG001|Period 2|Non-compliance with study drug|1|||
33405138|NCT03880227|62783693|FG000|First Visit|Withdrawal by Subject|1|||
33405139|NCT03880227|62783694|FG001|First Visit|Withdrawal by Subject|0|||
33405140|NCT03880227|62783695|FG002|First Visit|Withdrawal by Subject|0|||
33405141|NCT03880227|62783696|FG003|First Visit|Withdrawal by Subject|0|||
33405142|NCT03880227|62783693|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
33405143|NCT03880227|62783694|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
33405144|NCT03880227|62783695|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
33405145|NCT03880227|62783696|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
33405146|NCT03880227|62783693|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
33405147|NCT03880227|62783694|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
33405148|NCT03880227|62783695|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
33405149|NCT03880227|62783696|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
33405150|NCT03880227|62783693|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
33405151|NCT03880227|62783694|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
33405152|NCT03880227|62783695|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
33405153|NCT03880227|62783696|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
33405154|NCT00530439|62783720|FG000|Overall Study|GDM|9|||
33405155|NCT00530439|62783721|FG001|Overall Study|GDM|3|||
33405156|NCT00530439|62783720|FG000|Overall Study|Withdraw|18|||
33405157|NCT00530439|62783721|FG001|Overall Study|Withdraw|14|||
33493958|NCT00089791|62872551|FG001|Overall Study|Adverse Event|93|||
33493959|NCT00089791|62872550|FG000|Overall Study|Withdrawal by Subject|403|||
33405158|NCT00530439|62783720|FG000|Overall Study|Missed abortion|1|||
33405159|NCT00530439|62783721|FG001|Overall Study|Missed abortion|4|||
33405160|NCT00530439|62783720|FG000|Overall Study|Misclassification|2|||
33405161|NCT00530439|62783721|FG001|Overall Study|Misclassification|0|||
33405162|NCT00530439|62783720|FG000|Overall Study|Twin pregnancy|0|||
33405163|NCT00530439|62783721|FG001|Overall Study|Twin pregnancy|2|||
33405164|NCT00530439|62783720|FG000|Overall Study|Severe malformation/abortion|0|||
33493960|NCT00089791|62872551|FG001|Overall Study|Withdrawal by Subject|344|||
33405165|NCT00530439|62783721|FG001|Overall Study|Severe malformation/abortion|3|||
33405166|NCT00497146|62783729|FG000|Treatment Period|Adverse Event|6|||
33405167|NCT00497146|62783730|FG001|Treatment Period|Adverse Event|2|||
33405168|NCT00497146|62783729|FG000|Treatment Period|Withdrawal by Subject|5|||
33405169|NCT00497146|62783730|FG001|Treatment Period|Withdrawal by Subject|9|||
33405170|NCT00497146|62783729|FG000|Treatment Period|Lost to Follow-up|1|||
33405171|NCT00497146|62783730|FG001|Treatment Period|Lost to Follow-up|3|||
33405172|NCT00497146|62783729|FG000|Treatment Period|Required dialysis|4|||
33405173|NCT00497146|62783730|FG001|Treatment Period|Required dialysis|1|||
33405174|NCT00497146|62783729|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
33405175|NCT00497146|62783730|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
33405176|NCT00497146|62783729|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
33405177|NCT00497146|62783730|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
33405178|NCT00497146|62783729|FG000|Treatment Period|Other Reason|2|||
33405179|NCT00497146|62783730|FG001|Treatment Period|Other Reason|3|||
33405180|NCT00497146|62783729|FG000|Long-term Follow-up Period|Adverse Event|2|||
33405181|NCT00497146|62783730|FG001|Long-term Follow-up Period|Adverse Event|2|||
33405182|NCT00497146|62783729|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
33405183|NCT00497146|62783730|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
33405184|NCT00497146|62783729|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
33405185|NCT00497146|62783730|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
33405186|NCT00497146|62783729|FG000|Long-term Follow-up Period|Other|0|||
33405187|NCT00497146|62783730|FG001|Long-term Follow-up Period|Other|1|||
33405188|NCT00489970|62783741|FG000|Persistence Year 9|Lost to Follow-up|2|||
33405189|NCT00489970|62783742|FG001|Persistence Year 9|Lost to Follow-up|2|||
33405190|NCT00489970|62783743|FG002|Persistence Year 9|Lost to Follow-up|3|||
33405191|NCT00489970|62783741|FG000|Persistence Year 9|Other|1|||
33405192|NCT00489970|62783742|FG001|Persistence Year 9|Other|0|||
33405193|NCT00489970|62783743|FG002|Persistence Year 9|Other|2|||
33405194|NCT02798471|62783756|FG000|Overall Study|Adverse Event|7|||
33405195|NCT02798471|62783757|FG001|Overall Study|Adverse Event|2|||
33405196|NCT02798471|62783756|FG000|Overall Study|Physician Decision|3|||
33405197|NCT02798471|62783757|FG001|Overall Study|Physician Decision|7|||
33405198|NCT02798471|62783756|FG000|Overall Study|Death|2|||
33405199|NCT02798471|62783757|FG001|Overall Study|Death|3|||
33405200|NCT02798471|62783756|FG000|Overall Study|Lost to Follow-up|0|||
33405201|NCT02798471|62783757|FG001|Overall Study|Lost to Follow-up|1|||
33405202|NCT02798471|62783756|FG000|Overall Study|Other|5|||
33405203|NCT02798471|62783757|FG001|Overall Study|Other|3|||
33405204|NCT02798471|62783756|FG000|Overall Study|Subject withdrew consent|0|||
33405205|NCT02798471|62783757|FG001|Overall Study|Subject withdrew consent|6|||
33405206|NCT02798471|62783756|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
33405207|NCT02798471|62783757|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
33405208|NCT02798471|62783756|FG000|Overall Study|Randomized, but not treated|0|||
33405209|NCT02798471|62783757|FG001|Overall Study|Randomized, but not treated|2|||
33405210|NCT00489736|62783765|FG000|Overall Study|Lack of Efficacy|53|||
33405211|NCT00489736|62783766|FG001|Overall Study|Lack of Efficacy|14|||
33405212|NCT00489736|62783765|FG000|Overall Study|Adverse Event|32|||
33405213|NCT00489736|62783766|FG001|Overall Study|Adverse Event|45|||
33405214|NCT00489736|62783765|FG000|Overall Study|Poor compliance|6|||
33405215|NCT00489736|62783766|FG001|Overall Study|Poor compliance|2|||
33405216|NCT00489736|62783765|FG000|Overall Study|Not coded/ Not pre-specified|5|||
33405217|NCT00489736|62783766|FG001|Overall Study|Not coded/ Not pre-specified|8|||
33405218|NCT00617084|62783774|FG000|Overall Study|Withdrawal by Subject|5|||
33405219|NCT00617084|62783775|FG001|Overall Study|Withdrawal by Subject|7|||
33405220|NCT00617084|62783774|FG000|Overall Study|Missed 12 Months visit|16|||
33405221|NCT00617084|62783775|FG001|Overall Study|Missed 12 Months visit|19|||
33405222|NCT00489424|62783784|FG000|Overall Study|Adverse Event|3|||
33405223|NCT00489424|62783785|FG001|Overall Study|Adverse Event|3|||
33405224|NCT00489424|62783786|FG002|Overall Study|Adverse Event|4|||
33405225|NCT00489424|62783784|FG000|Overall Study|Lack of Efficacy|1|||
33405226|NCT00489424|62783785|FG001|Overall Study|Lack of Efficacy|0|||
33405227|NCT00489424|62783786|FG002|Overall Study|Lack of Efficacy|0|||
33405228|NCT00489424|62783784|FG000|Overall Study|Administrative problems|0|||
33405229|NCT00489424|62783785|FG001|Overall Study|Administrative problems|2|||
33405230|NCT00489424|62783786|FG002|Overall Study|Administrative problems|1|||
33405231|NCT00614744|62783796|FG000|Overall Study|Lost to Follow-up|5|||
33405232|NCT00614744|62783797|FG001|Overall Study|Lost to Follow-up|4|||
33405233|NCT00614744|62783796|FG000|Overall Study|Incomplete for Behavior Issues|0|||
33405234|NCT00614744|62783797|FG001|Overall Study|Incomplete for Behavior Issues|2|||
33405235|NCT00565812|62783806|FG000|Overall Study|Death|2|||
33405236|NCT00565812|62783807|FG001|Overall Study|Death|1|||
33405237|NCT00565812|62783808|FG002|Overall Study|Death|3|||
33405238|NCT00565812|62783806|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
33405239|NCT00565812|62783807|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
33405240|NCT00565812|62783808|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
33405241|NCT00565812|62783806|FG000|Overall Study|Lost to Follow-up|10|||
33405242|NCT00565812|62783807|FG001|Overall Study|Lost to Follow-up|8|||
33405243|NCT00565812|62783808|FG002|Overall Study|Lost to Follow-up|8|||
33405244|NCT00565812|62783806|FG000|Overall Study|Withdrawal by Subject|58|||
33405245|NCT00565812|62783807|FG001|Overall Study|Withdrawal by Subject|47|||
33405246|NCT00565812|62783808|FG002|Overall Study|Withdrawal by Subject|48|||
33405247|NCT00565812|62783806|FG000|Overall Study|Work Schedule|5|||
33405248|NCT00565812|62783807|FG001|Overall Study|Work Schedule|3|||
33405249|NCT00565812|62783808|FG002|Overall Study|Work Schedule|1|||
33405250|NCT00565812|62783806|FG000|Overall Study|Protocol Violation|2|||
33405251|NCT00565812|62783807|FG001|Overall Study|Protocol Violation|6|||
33405252|NCT00565812|62783808|FG002|Overall Study|Protocol Violation|4|||
33405253|NCT00565812|62783806|FG000|Overall Study|Adverse Event|41|||
33405254|NCT00565812|62783807|FG001|Overall Study|Adverse Event|54|||
33405255|NCT00565812|62783808|FG002|Overall Study|Adverse Event|40|||
33405256|NCT00565812|62783806|FG000|Overall Study|Jury Duty|1|||
33405257|NCT00565812|62783807|FG001|Overall Study|Jury Duty|0|||
33405258|NCT00565812|62783808|FG002|Overall Study|Jury Duty|0|||
33405259|NCT00565812|62783806|FG000|Overall Study|Relocated Out of Area|5|||
33405260|NCT00565812|62783807|FG001|Overall Study|Relocated Out of Area|8|||
33405261|NCT00565812|62783808|FG002|Overall Study|Relocated Out of Area|9|||
33405262|NCT00565812|62783806|FG000|Overall Study|Sponsor Decision|1|||
33405263|NCT00565812|62783807|FG001|Overall Study|Sponsor Decision|5|||
33405264|NCT00565812|62783808|FG002|Overall Study|Sponsor Decision|1|||
33405265|NCT00565812|62783806|FG000|Overall Study|Domestic Reasons|7|||
33405266|NCT00565812|62783807|FG001|Overall Study|Domestic Reasons|1|||
33405267|NCT00565812|62783808|FG002|Overall Study|Domestic Reasons|3|||
33405268|NCT00565812|62783806|FG000|Overall Study|Research Site Closure|6|||
33405269|NCT00565812|62783807|FG001|Overall Study|Research Site Closure|1|||
33405270|NCT00565812|62783808|FG002|Overall Study|Research Site Closure|8|||
33405271|NCT00565812|62783806|FG000|Overall Study|Surgical Intervention|0|||
33405272|NCT00565812|62783807|FG001|Overall Study|Surgical Intervention|1|||
33405273|NCT00565812|62783808|FG002|Overall Study|Surgical Intervention|2|||
33405274|NCT00565812|62783806|FG000|Overall Study|Low Compliance|1|||
33405275|NCT00565812|62783807|FG001|Overall Study|Low Compliance|0|||
33405276|NCT00565812|62783808|FG002|Overall Study|Low Compliance|1|||
33405277|NCT00565812|62783806|FG000|Overall Study|Follow-up Visit Not Completed|2|||
33405278|NCT00565812|62783807|FG001|Overall Study|Follow-up Visit Not Completed|0|||
33405279|NCT00565812|62783808|FG002|Overall Study|Follow-up Visit Not Completed|1|||
33405280|NCT00565812|62783806|FG000|Overall Study|Physician Decision|2|||
33405281|NCT00565812|62783807|FG001|Overall Study|Physician Decision|0|||
33405282|NCT00565812|62783808|FG002|Overall Study|Physician Decision|0|||
33405283|NCT03974334|62783816|FG000|Overall Study|Lost to Follow-up|1|||
33405284|NCT03970824|62783823|FG000|Overall Study|Withdrawal by Subject|1|||
33405285|NCT03970824|62783824|FG001|Overall Study|Withdrawal by Subject|1|||
33405286|NCT03970824|62783825|FG002|Overall Study|Withdrawal by Subject|3|||
33405287|NCT03970824|62783823|FG000|Overall Study|Lost to Follow-up|0|||
33405288|NCT03970824|62783824|FG001|Overall Study|Lost to Follow-up|2|||
33405289|NCT03970824|62783825|FG002|Overall Study|Lost to Follow-up|1|||
33405290|NCT03970824|62783823|FG000|Overall Study|Adverse Event|1|||
33405291|NCT03970824|62783824|FG001|Overall Study|Adverse Event|0|||
33405292|NCT03970824|62783825|FG002|Overall Study|Adverse Event|0|||
33405293|NCT00564486|62783836|FG000|Overall Study|Adverse Event|0|||
33405294|NCT00564486|62783837|FG001|Overall Study|Adverse Event|1|||
33405295|NCT00564486|62783838|FG002|Overall Study|Adverse Event|0|||
33405296|NCT00564486|62783839|FG003|Overall Study|Adverse Event|0|||
33405297|NCT00564486|62783836|FG000|Overall Study|Withdrawal by Subject|4|||
33405298|NCT00564486|62783837|FG001|Overall Study|Withdrawal by Subject|0|||
33405299|NCT00564486|62783838|FG002|Overall Study|Withdrawal by Subject|0|||
33405300|NCT00564486|62783839|FG003|Overall Study|Withdrawal by Subject|5|||
33405301|NCT00564486|62783836|FG000|Overall Study|Subject refused to have blood drawn|0|||
33493961|NCT00089791|62872550|FG000|Overall Study|Death|78|||
33405302|NCT00564486|62783837|FG001|Overall Study|Subject refused to have blood drawn|0|||
33405303|NCT00564486|62783838|FG002|Overall Study|Subject refused to have blood drawn|1|||
33405304|NCT00564486|62783839|FG003|Overall Study|Subject refused to have blood drawn|0|||
33405305|NCT00564486|62783836|FG000|Overall Study|Lost to Follow-up|3|||
33405306|NCT00564486|62783837|FG001|Overall Study|Lost to Follow-up|0|||
33405307|NCT00564486|62783838|FG002|Overall Study|Lost to Follow-up|2|||
33405308|NCT00564486|62783839|FG003|Overall Study|Lost to Follow-up|2|||
33405309|NCT00481078|62783855|FG000|Overall Study|Progression of disease|11|||
33405310|NCT00481078|62783856|FG001|Overall Study|Progression of disease|11|||
33405311|NCT00481078|62783855|FG000|Overall Study|Adverse Event|15|||
33405312|NCT00481078|62783856|FG001|Overall Study|Adverse Event|3|||
33405313|NCT00481078|62783855|FG000|Overall Study|Death|5|||
33405314|NCT00481078|62783856|FG001|Overall Study|Death|3|||
33405315|NCT00481078|62783855|FG000|Overall Study|Intercurrent illness|1|||
33405316|NCT00481078|62783856|FG001|Overall Study|Intercurrent illness|0|||
33405317|NCT00481078|62783855|FG000|Overall Study|Withdrawal by Subject|7|||
33405318|NCT00481078|62783856|FG001|Overall Study|Withdrawal by Subject|1|||
33405319|NCT00481078|62783855|FG000|Overall Study|Information not available|1|||
33405320|NCT00481078|62783856|FG001|Overall Study|Information not available|0|||
33405321|NCT00481078|62783855|FG000|Overall Study|Received other treatment|2|||
33405322|NCT00481078|62783856|FG001|Overall Study|Received other treatment|1|||
33405323|NCT00481078|62783855|FG000|Overall Study|Brain metastasis|0|||
33405324|NCT00481078|62783856|FG001|Overall Study|Brain metastasis|1|||
33405325|NCT00480532|62783866|FG000|Overall Study|Withdrawal by Subject|2|||
33405326|NCT00480532|62783867|FG001|Overall Study|Withdrawal by Subject|4|||
33405327|NCT00480532|62783868|FG002|Overall Study|Withdrawal by Subject|3|||
33405328|NCT00480532|62783869|FG003|Overall Study|Withdrawal by Subject|1|||
33405329|NCT00480532|62783866|FG000|Overall Study|Protocol Violation|0|||
33405330|NCT00480532|62783867|FG001|Overall Study|Protocol Violation|0|||
33405331|NCT00480532|62783868|FG002|Overall Study|Protocol Violation|1|||
33405332|NCT00480532|62783869|FG003|Overall Study|Protocol Violation|0|||
33405333|NCT00496366|62783879|FG000|Overall Study|Death|1|||
33405334|NCT00488644|62783883|FG000|Overall Study|Not Eligible|1|||
33405335|NCT00488644|62783883|FG000|Overall Study|Not Evaluable|1|||
33405336|NCT00564018|62783890|FG000|Overall Study|Withdrawal by Subject|2|||
33405337|NCT00564018|62783891|FG001|Overall Study|Withdrawal by Subject|3|||
33405338|NCT00564018|62783892|FG002|Overall Study|Withdrawal by Subject|1|||
33405339|NCT03381287|62783904|FG000|Overall Study|Withdrawal by Subject|0|||
33405340|NCT03381287|62783905|FG001|Overall Study|Withdrawal by Subject|1|||
33405341|NCT03381287|62783906|FG002|Overall Study|Withdrawal by Subject|0|||
33405342|NCT03381287|62783907|FG003|Overall Study|Withdrawal by Subject|0|||
33405343|NCT03381287|62783904|FG000|Overall Study|Adverse Event|0|||
33405344|NCT03381287|62783905|FG001|Overall Study|Adverse Event|0|||
33405345|NCT03381287|62783906|FG002|Overall Study|Adverse Event|0|||
33405346|NCT03381287|62783907|FG003|Overall Study|Adverse Event|1|||
33320988|NCT01995175|62696760|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
33320989|NCT01995175|62696760|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
33320990|NCT01995175|62696760|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
33320991|NCT01995175|62696760|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
33320992|NCT01995175|62696760|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
33320993|NCT01995175|62696760|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
33320994|NCT01752907|62696849|FG000|Overall Study|Withdrawal by Subject|4|||
33320995|NCT01752907|62696850|FG001|Overall Study|Withdrawal by Subject|10|||
33320996|NCT01752907|62696849|FG000|Overall Study|Lost to Follow-up|2|||
33320997|NCT01752907|62696850|FG001|Overall Study|Lost to Follow-up|1|||
33320998|NCT01752907|62696849|FG000|Overall Study|Decision by Sponsor|6|||
33320999|NCT01752907|62696850|FG001|Overall Study|Decision by Sponsor|9|||
33321000|NCT03439189|62696856|FG000|Overall Study|Protocol Violation|19|||
33321001|NCT03439189|62696856|FG000|Overall Study|Lack of Efficacy|63|||
33321002|NCT01211483|62696865|FG000|Phase 1b|Death|6|||
33321003|NCT01211483|62696866|FG001|Phase 1b|Death|0|||
33321004|NCT01211483|62696867|FG002|Phase 1b|Death|0|||
33321005|NCT01211483|62696868|FG003|Phase 1b|Death|0|||
33321006|NCT01211483|62696865|FG000|Phase 1b|Withdrawal by Subject|1|||
33321007|NCT01211483|62696866|FG001|Phase 1b|Withdrawal by Subject|0|||
33321008|NCT01211483|62696867|FG002|Phase 1b|Withdrawal by Subject|0|||
33321009|NCT01211483|62696868|FG003|Phase 1b|Withdrawal by Subject|0|||
33321010|NCT01211483|62696865|FG000|Phase 2|Lost to Follow-up|0|||
33321011|NCT01211483|62696866|FG001|Phase 2|Lost to Follow-up|1|||
33321012|NCT01211483|62696867|FG002|Phase 2|Lost to Follow-up|1|||
33321013|NCT01211483|62696868|FG003|Phase 2|Lost to Follow-up|2|||
33321014|NCT01211483|62696865|FG000|Phase 2|Death|0|||
33321015|NCT01211483|62696866|FG001|Phase 2|Death|64|||
33321016|NCT01211483|62696867|FG002|Phase 2|Death|53|||
33405347|NCT03381287|62783904|FG000|Overall Study|Physician Decision|0|||
33405348|NCT03381287|62783905|FG001|Overall Study|Physician Decision|0|||
33405349|NCT03381287|62783906|FG002|Overall Study|Physician Decision|0|||
33405350|NCT03381287|62783907|FG003|Overall Study|Physician Decision|1|||
33405351|NCT00616928|62783931|FG000|Overall Study|Adverse Event|6|||
33405352|NCT00616928|62783932|FG001|Overall Study|Adverse Event|3|||
33405353|NCT00616928|62783933|FG002|Overall Study|Adverse Event|2|||
33405354|NCT00616928|62783934|FG003|Overall Study|Adverse Event|2|||
33405355|NCT00616928|62783931|FG000|Overall Study|Other|51|||
33405356|NCT00616928|62783932|FG001|Overall Study|Other|8|||
33405357|NCT00616928|62783933|FG002|Overall Study|Other|15|||
33405358|NCT00616928|62783934|FG003|Overall Study|Other|5|||
33405359|NCT00616928|62783931|FG000|Overall Study|Lost to Follow-up|5|||
33405360|NCT00616928|62783932|FG001|Overall Study|Lost to Follow-up|7|||
33405361|NCT00616928|62783933|FG002|Overall Study|Lost to Follow-up|0|||
33405362|NCT00616928|62783934|FG003|Overall Study|Lost to Follow-up|0|||
33405363|NCT00563784|62783956|FG000|Overall Study|Withdrawal by Subject|2|||
33405364|NCT00563784|62783956|FG000|Overall Study|Screen Failures|20|||
33405365|NCT00203047|62783971|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
33405366|NCT00203047|62783972|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
33405367|NCT00203047|62783971|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
33405368|NCT00203047|62783972|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
33405369|NCT00203047|62783971|FG000|Overall Study|Withdrawal by Subject|13|||
33405370|NCT00203047|62783972|FG001|Overall Study|Withdrawal by Subject|47|||
33405371|NCT00203047|62783971|FG000|Overall Study|Teva requested participant withdrawal|1|||
33405372|NCT00203047|62783972|FG001|Overall Study|Teva requested participant withdrawal|1|||
33405373|NCT00203047|62783971|FG000|Overall Study|Physician Decision|8|||
33405374|NCT00203047|62783972|FG001|Overall Study|Physician Decision|7|||
33405375|NCT00203047|62783971|FG000|Overall Study|Non-compliance|4|||
33405376|NCT00203047|62783972|FG001|Overall Study|Non-compliance|8|||
33405377|NCT00203047|62783971|FG000|Overall Study|Protocol Violation|1|||
33405378|NCT00203047|62783972|FG001|Overall Study|Protocol Violation|0|||
33405379|NCT00203047|62783971|FG000|Overall Study|Lost to Follow-up|11|||
33405380|NCT00203047|62783972|FG001|Overall Study|Lost to Follow-up|5|||
33405381|NCT00203047|62783971|FG000|Overall Study|Adverse Event|8|||
33405382|NCT00203047|62783972|FG001|Overall Study|Adverse Event|18|||
33405383|NCT00203047|62783971|FG000|Overall Study|Death|1|||
33405384|NCT00203047|62783972|FG001|Overall Study|Death|2|||
33405385|NCT00203047|62783971|FG000|Overall Study|Pregnancy|3|||
33405386|NCT00203047|62783972|FG001|Overall Study|Pregnancy|0|||
33405387|NCT00203047|62783971|FG000|Overall Study|Other|5|||
33405388|NCT00203047|62783972|FG001|Overall Study|Other|5|||
33405389|NCT00142519|62783980|FG000|Overall Study|Not Treated|7|||
33405390|NCT00142519|62783981|FG001|Overall Study|Not Treated|9|||
33405391|NCT00142519|62783980|FG000|Overall Study|Protocol Violation|1|||
33405392|NCT00142519|62783981|FG001|Overall Study|Protocol Violation|0|||
33405393|NCT00142519|62783980|FG000|Overall Study|Withdrawal by Subject|10|||
33405394|NCT00142519|62783981|FG001|Overall Study|Withdrawal by Subject|7|||
33405395|NCT00141817|62784000|FG000|Overall Study|Protocol Violation|0|||
33405396|NCT00141817|62784001|FG001|Overall Study|Protocol Violation|0|||
33405397|NCT00141817|62784002|FG002|Overall Study|Protocol Violation|1|||
33405398|NCT00141817|62784003|FG003|Overall Study|Protocol Violation|0|||
33405399|NCT00141817|62784000|FG000|Overall Study|Parent request|1|||
33405400|NCT00141817|62784001|FG001|Overall Study|Parent request|0|||
33405401|NCT00141817|62784002|FG002|Overall Study|Parent request|0|||
33405402|NCT00141817|62784003|FG003|Overall Study|Parent request|0|||
33405403|NCT00573170|62784013|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
33405404|NCT00573170|62784014|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
33405405|NCT00573170|62784015|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
33405406|NCT00573170|62784016|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
33405407|NCT00573170|62784017|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
33405408|NCT00573170|62784018|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
33405409|NCT00573170|62784013|FG000|First Washout Period|Adverse Event|1|||
33598389|NCT02293993|62997209|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
33405410|NCT00573170|62784014|FG001|First Washout Period|Adverse Event|1|||
33405411|NCT00573170|62784015|FG002|First Washout Period|Adverse Event|0|||
33405412|NCT00573170|62784016|FG003|First Washout Period|Adverse Event|0|||
33405413|NCT00573170|62784017|FG004|First Washout Period|Adverse Event|0|||
33405414|NCT00573170|62784018|FG005|First Washout Period|Adverse Event|1|||
33405415|NCT00573170|62784013|FG000|First Washout Period|Lack of Efficacy|0|||
33405416|NCT00573170|62784014|FG001|First Washout Period|Lack of Efficacy|0|||
33405417|NCT00573170|62784015|FG002|First Washout Period|Lack of Efficacy|0|||
33405418|NCT00573170|62784016|FG003|First Washout Period|Lack of Efficacy|0|||
33405419|NCT00573170|62784017|FG004|First Washout Period|Lack of Efficacy|0|||
33405420|NCT00573170|62784018|FG005|First Washout Period|Lack of Efficacy|1|||
33405421|NCT00573170|62784013|FG000|First Washout Period|Lost to Follow-up|1|||
33405422|NCT00573170|62784014|FG001|First Washout Period|Lost to Follow-up|1|||
33405423|NCT00573170|62784015|FG002|First Washout Period|Lost to Follow-up|0|||
33405424|NCT00573170|62784016|FG003|First Washout Period|Lost to Follow-up|2|||
33405425|NCT00573170|62784017|FG004|First Washout Period|Lost to Follow-up|0|||
33405426|NCT00573170|62784018|FG005|First Washout Period|Lost to Follow-up|2|||
33405427|NCT00573170|62784013|FG000|First Washout Period|Withdrawal by Subject|2|||
33405428|NCT00573170|62784014|FG001|First Washout Period|Withdrawal by Subject|0|||
33405429|NCT00573170|62784015|FG002|First Washout Period|Withdrawal by Subject|0|||
33405430|NCT00573170|62784016|FG003|First Washout Period|Withdrawal by Subject|2|||
33405431|NCT00573170|62784017|FG004|First Washout Period|Withdrawal by Subject|3|||
33405432|NCT00573170|62784018|FG005|First Washout Period|Withdrawal by Subject|3|||
33405433|NCT00573170|62784013|FG000|First Washout Period|Other|4|||
33405434|NCT00573170|62784014|FG001|First Washout Period|Other|0|||
33405435|NCT00573170|62784015|FG002|First Washout Period|Other|1|||
33405436|NCT00573170|62784016|FG003|First Washout Period|Other|1|||
33405437|NCT00573170|62784017|FG004|First Washout Period|Other|0|||
33405438|NCT00573170|62784018|FG005|First Washout Period|Other|0|||
33405439|NCT00573170|62784013|FG000|Second Washout Period|Adverse Event|1|||
33405440|NCT00573170|62784014|FG001|Second Washout Period|Adverse Event|0|||
33405441|NCT00573170|62784015|FG002|Second Washout Period|Adverse Event|0|||
33405442|NCT00573170|62784016|FG003|Second Washout Period|Adverse Event|0|||
33405443|NCT00573170|62784017|FG004|Second Washout Period|Adverse Event|1|||
33405444|NCT00573170|62784018|FG005|Second Washout Period|Adverse Event|0|||
33405445|NCT00573170|62784013|FG000|Second Washout Period|Protocol Violation|2|||
33405446|NCT00573170|62784014|FG001|Second Washout Period|Protocol Violation|1|||
33405447|NCT00573170|62784015|FG002|Second Washout Period|Protocol Violation|1|||
33405448|NCT00573170|62784016|FG003|Second Washout Period|Protocol Violation|0|||
33405449|NCT00573170|62784017|FG004|Second Washout Period|Protocol Violation|0|||
33405450|NCT00573170|62784018|FG005|Second Washout Period|Protocol Violation|0|||
33405451|NCT00573170|62784013|FG000|Second Washout Period|Withdrawal by Subject|1|||
33405452|NCT00573170|62784014|FG001|Second Washout Period|Withdrawal by Subject|1|||
33405453|NCT00573170|62784015|FG002|Second Washout Period|Withdrawal by Subject|2|||
33405454|NCT00573170|62784016|FG003|Second Washout Period|Withdrawal by Subject|0|||
33405455|NCT00573170|62784017|FG004|Second Washout Period|Withdrawal by Subject|1|||
33405456|NCT00573170|62784018|FG005|Second Washout Period|Withdrawal by Subject|0|||
33405457|NCT00573170|62784013|FG000|Second Washout Period|Lost to Follow-up|0|||
33405458|NCT00573170|62784014|FG001|Second Washout Period|Lost to Follow-up|0|||
33405459|NCT00573170|62784015|FG002|Second Washout Period|Lost to Follow-up|0|||
33405460|NCT00573170|62784016|FG003|Second Washout Period|Lost to Follow-up|1|||
33405461|NCT00573170|62784017|FG004|Second Washout Period|Lost to Follow-up|0|||
33405462|NCT00573170|62784018|FG005|Second Washout Period|Lost to Follow-up|0|||
33405463|NCT00573170|62784013|FG000|Second Washout Period|Other|1|||
33405464|NCT00573170|62784014|FG001|Second Washout Period|Other|2|||
33405465|NCT00573170|62784015|FG002|Second Washout Period|Other|1|||
33405466|NCT00573170|62784016|FG003|Second Washout Period|Other|4|||
33405467|NCT00573170|62784017|FG004|Second Washout Period|Other|6|||
33405468|NCT00573170|62784018|FG005|Second Washout Period|Other|2|||
33405469|NCT00573170|62784013|FG000|Third Treatment Period|Withdrawal by Subject|1|||
33405470|NCT00573170|62784014|FG001|Third Treatment Period|Withdrawal by Subject|0|||
33405471|NCT00573170|62784015|FG002|Third Treatment Period|Withdrawal by Subject|0|||
33405472|NCT00573170|62784016|FG003|Third Treatment Period|Withdrawal by Subject|0|||
33405473|NCT00573170|62784017|FG004|Third Treatment Period|Withdrawal by Subject|0|||
33405474|NCT00573170|62784018|FG005|Third Treatment Period|Withdrawal by Subject|0|||
33405475|NCT00573170|62784013|FG000|Third Treatment Period|Lost to Follow-up|0|||
33405476|NCT00573170|62784014|FG001|Third Treatment Period|Lost to Follow-up|0|||
33405477|NCT00573170|62784015|FG002|Third Treatment Period|Lost to Follow-up|0|||
33405478|NCT00573170|62784016|FG003|Third Treatment Period|Lost to Follow-up|0|||
33405479|NCT00573170|62784017|FG004|Third Treatment Period|Lost to Follow-up|0|||
33405480|NCT00573170|62784018|FG005|Third Treatment Period|Lost to Follow-up|2|||
33405481|NCT00201643|62784037|FG000|Overall Study|Withdrawal by Subject|5|||
33405482|NCT00201643|62784038|FG001|Overall Study|Withdrawal by Subject|4|||
33405483|NCT00130039|62784046|FG000|Overall Study|Withdrawal by Subject|15|||
33405484|NCT00130039|62784047|FG001|Overall Study|Withdrawal by Subject|11|||
33405485|NCT00130039|62784046|FG000|Overall Study|Lost to Follow-up|3|||
33405486|NCT00130039|62784047|FG001|Overall Study|Lost to Follow-up|1|||
33405487|NCT00130039|62784046|FG000|Overall Study|Adverse Event|4|||
33405488|NCT00130039|62784047|FG001|Overall Study|Adverse Event|2|||
33598390|NCT02293993|62997210|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
33598391|NCT02293993|62997211|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
33405489|NCT00130039|62784046|FG000|Overall Study|Physician Decision|3|||
33405490|NCT00130039|62784047|FG001|Overall Study|Physician Decision|0|||
33405491|NCT00130039|62784046|FG000|Overall Study|clinical events without follow up MRI|5|||
33405492|NCT00130039|62784047|FG001|Overall Study|clinical events without follow up MRI|4|||
33405493|NCT00475852|62784055|FG000|Overall Study|Death|444|||
33405494|NCT00475852|62784056|FG001|Overall Study|Death|456|||
33405495|NCT00475852|62784055|FG000|Overall Study|Withdrawal by Subject|19|||
33405496|NCT00475852|62784056|FG001|Overall Study|Withdrawal by Subject|24|||
33405497|NCT00475852|62784055|FG000|Overall Study|Lost to Follow-up|54|||
33405498|NCT00475852|62784056|FG001|Overall Study|Lost to Follow-up|68|||
33405499|NCT00141271|62784065|FG000|Overall Study|Adverse Event|31|||
33405500|NCT00141271|62784066|FG001|Overall Study|Adverse Event|19|||
33405501|NCT00141271|62784067|FG002|Overall Study|Adverse Event|17|||
33405502|NCT00141271|62784065|FG000|Overall Study|Laboratory Abnormality|2|||
33405503|NCT00141271|62784066|FG001|Overall Study|Laboratory Abnormality|1|||
33405504|NCT00141271|62784067|FG002|Overall Study|Laboratory Abnormality|1|||
33405505|NCT00141271|62784065|FG000|Overall Study|Lack of Efficacy|7|||
33405506|NCT00141271|62784066|FG001|Overall Study|Lack of Efficacy|7|||
33405507|NCT00141271|62784067|FG002|Overall Study|Lack of Efficacy|3|||
33405508|NCT00141271|62784065|FG000|Overall Study|Lost to Follow-up|15|||
33405509|NCT00141271|62784066|FG001|Overall Study|Lost to Follow-up|15|||
33405510|NCT00141271|62784067|FG002|Overall Study|Lost to Follow-up|21|||
33405511|NCT00141271|62784065|FG000|Overall Study|Withdrawal by Subject|14|||
33405512|NCT00141271|62784066|FG001|Overall Study|Withdrawal by Subject|9|||
33405513|NCT00141271|62784067|FG002|Overall Study|Withdrawal by Subject|10|||
33405514|NCT00141271|62784065|FG000|Overall Study|Other|11|||
33405515|NCT00141271|62784066|FG001|Overall Study|Other|12|||
33405516|NCT00141271|62784067|FG002|Overall Study|Other|5|||
33405517|NCT00614120|62784079|FG000|Overall Study|Adverse Event|9|||
33405518|NCT00614120|62784080|FG001|Overall Study|Adverse Event|22|||
33405519|NCT00614120|62784081|FG002|Overall Study|Adverse Event|30|||
33405520|NCT00614120|62784082|FG003|Overall Study|Adverse Event|3|||
33405521|NCT00614120|62784079|FG000|Overall Study|Lack of Efficacy|3|||
33405522|NCT00614120|62784080|FG001|Overall Study|Lack of Efficacy|3|||
33405523|NCT00614120|62784081|FG002|Overall Study|Lack of Efficacy|2|||
33405524|NCT00614120|62784082|FG003|Overall Study|Lack of Efficacy|2|||
33405525|NCT00614120|62784079|FG000|Overall Study|Protocol Violation|2|||
33405526|NCT00614120|62784080|FG001|Overall Study|Protocol Violation|5|||
33405527|NCT00614120|62784081|FG002|Overall Study|Protocol Violation|3|||
33405528|NCT00614120|62784082|FG003|Overall Study|Protocol Violation|1|||
33405529|NCT00614120|62784079|FG000|Overall Study|Withdrawal criteria|1|||
33405530|NCT00614120|62784080|FG001|Overall Study|Withdrawal criteria|0|||
33405531|NCT00614120|62784081|FG002|Overall Study|Withdrawal criteria|0|||
33405532|NCT00614120|62784082|FG003|Overall Study|Withdrawal criteria|0|||
33405533|NCT00614120|62784079|FG000|Overall Study|Withdrawal by Subject|9|||
33405534|NCT00614120|62784080|FG001|Overall Study|Withdrawal by Subject|10|||
33405535|NCT00614120|62784081|FG002|Overall Study|Withdrawal by Subject|16|||
33405536|NCT00614120|62784082|FG003|Overall Study|Withdrawal by Subject|3|||
33405537|NCT00614120|62784079|FG000|Overall Study|Did not meet trial criteria|0|||
33405538|NCT00614120|62784080|FG001|Overall Study|Did not meet trial criteria|1|||
33405539|NCT00614120|62784081|FG002|Overall Study|Did not meet trial criteria|1|||
33405540|NCT00614120|62784082|FG003|Overall Study|Did not meet trial criteria|1|||
33405541|NCT00614120|62784079|FG000|Overall Study|hCG positive (not pregnant)|0|||
33405542|NCT00614120|62784080|FG001|Overall Study|hCG positive (not pregnant)|0|||
33405543|NCT00614120|62784081|FG002|Overall Study|hCG positive (not pregnant)|1|||
33405544|NCT00614120|62784082|FG003|Overall Study|hCG positive (not pregnant)|0|||
33405545|NCT00614120|62784079|FG000|Overall Study|Hypoglycaemia|0|||
33405546|NCT00614120|62784080|FG001|Overall Study|Hypoglycaemia|0|||
33405547|NCT00614120|62784081|FG002|Overall Study|Hypoglycaemia|0|||
33405548|NCT00614120|62784082|FG003|Overall Study|Hypoglycaemia|1|||
33405549|NCT00614120|62784079|FG000|Overall Study|Lack of trial product|3|||
33405550|NCT00614120|62784080|FG001|Overall Study|Lack of trial product|3|||
33405551|NCT00614120|62784081|FG002|Overall Study|Lack of trial product|2|||
33405552|NCT00614120|62784082|FG003|Overall Study|Lack of trial product|0|||
33405553|NCT00614120|62784079|FG000|Overall Study|Late syphilis, latent|1|||
33405554|NCT00614120|62784080|FG001|Overall Study|Late syphilis, latent|0|||
33405555|NCT00614120|62784081|FG002|Overall Study|Late syphilis, latent|0|||
33405556|NCT00614120|62784082|FG003|Overall Study|Late syphilis, latent|0|||
33598392|NCT02293993|62997212|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
33598393|NCT02293993|62997209|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
33598394|NCT02293993|62997210|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
33651385|NCT01969721|63062834|FG000|Overall Study|Other not defined above|0|||
33405557|NCT00614120|62784079|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
33405558|NCT00614120|62784080|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
33493962|NCT00089791|62872551|FG001|Overall Study|Death|62|||
33405559|NCT00614120|62784081|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
33405560|NCT00614120|62784082|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
33405561|NCT00614120|62784079|FG000|Overall Study|Lost to Follow-up|1|||
33493963|NCT00089791|62872550|FG000|Overall Study|Disease progression|7|||
33405562|NCT00614120|62784080|FG001|Overall Study|Lost to Follow-up|2|||
33405563|NCT00614120|62784081|FG002|Overall Study|Lost to Follow-up|3|||
33405564|NCT00614120|62784082|FG003|Overall Study|Lost to Follow-up|4|||
33405565|NCT00496054|62784092|FG000|Overall Study|Adverse Event|1|||
33405566|NCT00496054|62784092|FG000|Overall Study|Lost to Follow-up|7|||
33405567|NCT00495820|62784098|FG000|Overall Study|Adverse Event|1|||
33405568|NCT00495820|62784099|FG001|Overall Study|Adverse Event|1|||
33405569|NCT00495586|62784107|FG000|Overall Study|Withdrawal by Subject|4|||
33405570|NCT00495586|62784108|FG001|Overall Study|Withdrawal by Subject|4|||
33405571|NCT00613730|62784116|FG000|Overall Study|Disease progression|2|||
33405572|NCT00613730|62784116|FG000|Overall Study|Administrative decision|1|||
33405573|NCT00613574|62784120|FG000|Overall Study|Adverse Event|3|||
33405574|NCT00613574|62784120|FG000|Overall Study|Lost to Follow-up|2|||
33405575|NCT00613574|62784120|FG000|Overall Study|Other|1|||
33405576|NCT00613106|62784126|FG000|Overall Study|Adverse Event|3|||
33405577|NCT00613106|62784127|FG001|Overall Study|Adverse Event|1|||
33405578|NCT00613106|62784126|FG000|Overall Study|Withdrawal by Subject|6|||
33405579|NCT00613106|62784127|FG001|Overall Study|Withdrawal by Subject|3|||
33405580|NCT00613106|62784126|FG000|Overall Study|Lost to Follow-up|7|||
33405581|NCT00613106|62784127|FG001|Overall Study|Lost to Follow-up|2|||
33405582|NCT00613106|62784126|FG000|Overall Study|misc|4|||
33405583|NCT00613106|62784127|FG001|Overall Study|misc|3|||
33405584|NCT00141037|62784135|FG000|Overall Study|Physician Decision|1|||
33405585|NCT00141037|62784136|FG001|Overall Study|Physician Decision|2|||
33405586|NCT00141037|62784135|FG000|Overall Study|Lost to Follow-up|3|||
33405587|NCT00141037|62784136|FG001|Overall Study|Lost to Follow-up|1|||
33405588|NCT00141037|62784135|FG000|Overall Study|Protocol Violation|0|||
33405589|NCT00141037|62784136|FG001|Overall Study|Protocol Violation|2|||
33405590|NCT00141037|62784135|FG000|Overall Study|Withdrawal by Subject|2|||
33405591|NCT00141037|62784136|FG001|Overall Study|Withdrawal by Subject|1|||
33405592|NCT00141037|62784135|FG000|Overall Study|Other|0|||
33405593|NCT00141037|62784136|FG001|Overall Study|Other|1|||
33405594|NCT00141037|62784135|FG000|Overall Study|Moved from area|1|||
33405595|NCT00141037|62784136|FG001|Overall Study|Moved from area|7|||
33405596|NCT00141037|62784135|FG000|Overall Study|Graft Failure|3|||
33405597|NCT00141037|62784136|FG001|Overall Study|Graft Failure|4|||
33405598|NCT00140413|62784145|FG000|Overall Study|Lost to Follow-up|1|||
33405599|NCT00140413|62784146|FG001|Overall Study|Lost to Follow-up|0|||
33405600|NCT00140413|62784145|FG000|Overall Study|Withdrawal by Subject|2|||
33405601|NCT00140413|62784146|FG001|Overall Study|Withdrawal by Subject|0|||
33405602|NCT00563706|62784162|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
33405603|NCT00563706|62784163|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
33405604|NCT00563706|62784164|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
33405605|NCT00563706|62784165|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
33405606|NCT00563706|62784166|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
33405607|NCT00563706|62784167|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
33405608|NCT00563706|62784168|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
33405609|NCT00563706|62784169|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
33405610|NCT00563706|62784170|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
33405611|NCT00563706|62784162|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
33405612|NCT00563706|62784163|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
33405613|NCT00563706|62784164|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
33405614|NCT00563706|62784165|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
33405615|NCT00563706|62784166|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
33405616|NCT00563706|62784167|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
33405617|NCT00563706|62784168|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
33405618|NCT00563706|62784169|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
33405619|NCT00563706|62784170|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
33405620|NCT00563706|62784162|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
33405621|NCT00563706|62784163|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
33405622|NCT00563706|62784164|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
33405623|NCT00563706|62784165|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
33405624|NCT00563706|62784166|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
33405625|NCT00563706|62784167|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
33405626|NCT00563706|62784168|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
33405627|NCT00563706|62784169|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
33405628|NCT00563706|62784170|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
33405629|NCT00563706|62784162|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
33405630|NCT00563706|62784163|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
33405631|NCT00563706|62784164|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
33405632|NCT00563706|62784165|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
33405633|NCT00563706|62784166|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
33405634|NCT00563706|62784167|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
33493964|NCT00089791|62872551|FG001|Overall Study|Disease progression|3|||
33405635|NCT00563706|62784168|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
33405636|NCT00563706|62784169|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
33405637|NCT00563706|62784170|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
33405638|NCT00563706|62784162|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
33405639|NCT00563706|62784163|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
33405640|NCT00563706|62784164|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
33405641|NCT00563706|62784165|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
33405642|NCT00563706|62784166|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
33405643|NCT00563706|62784167|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
33405644|NCT00563706|62784168|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
33405645|NCT00563706|62784169|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
33405646|NCT00563706|62784170|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
33405647|NCT00129961|62784192|FG000|Overall Study|Adverse Event|1|||
33405648|NCT00129961|62784193|FG001|Overall Study|Adverse Event|0|||
33405649|NCT00129961|62784192|FG000|Overall Study|Death|1|||
33405650|NCT00129961|62784193|FG001|Overall Study|Death|1|||
33405651|NCT00129961|62784192|FG000|Overall Study|Withdrawal by Sponsor|14|||
33405652|NCT00129961|62784193|FG001|Overall Study|Withdrawal by Sponsor|20|||
33405653|NCT00129961|62784192|FG000|Overall Study|Physician Decision|1|||
33405654|NCT00129961|62784193|FG001|Overall Study|Physician Decision|0|||
33405655|NCT00129961|62784192|FG000|Overall Study|Withdrawal by Subject|2|||
33405656|NCT00129961|62784193|FG001|Overall Study|Withdrawal by Subject|1|||
33405657|NCT00129961|62784192|FG000|Overall Study|Missing Record|0|||
33405658|NCT00129961|62784193|FG001|Overall Study|Missing Record|1|||
33405659|NCT00528567|62784201|FG000|Overall Study|Death|4|||
33405660|NCT00528567|62784202|FG001|Overall Study|Death|5|||
33405661|NCT00528567|62784201|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
33405662|NCT00528567|62784202|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
33405663|NCT00528567|62784201|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
33405664|NCT00528567|62784202|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
33405665|NCT00528567|62784201|FG000|Overall Study|Violation Criteria at Entry|3|||
33405666|NCT00528567|62784202|FG001|Overall Study|Violation Criteria at Entry|17|||
33405667|NCT00528567|62784201|FG000|Overall Study|Withdrew Consent|59|||
33405668|NCT00528567|62784202|FG001|Overall Study|Withdrew Consent|55|||
33405669|NCT00528567|62784201|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
33405670|NCT00528567|62784202|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
33405671|NCT00528567|62784201|FG000|Overall Study|Failure to Return|1|||
33405672|NCT00528567|62784202|FG001|Overall Study|Failure to Return|4|||
33405673|NCT00528567|62784201|FG000|Overall Study|Other Protocol Violation|5|||
33405674|NCT00528567|62784202|FG001|Overall Study|Other Protocol Violation|21|||
33405675|NCT00528567|62784201|FG000|Overall Study|Administrative/Other|22|||
33405676|NCT00528567|62784202|FG001|Overall Study|Administrative/Other|75|||
33405677|NCT00138151|62784215|FG000|Overall Study|Withdrawal by Subject|3|||
33405678|NCT00138151|62784215|FG000|Overall Study|Physician Decision|1|||
33405679|NCT00138073|62784219|FG000|Overall Study|lack of resources|55|||
33405680|NCT02581631|62784228|FG000|Overall Study|Disease progression|29|||
33405681|NCT02581631|62784229|FG001|Overall Study|Disease progression|19|||
33405682|NCT02581631|62784230|FG002|Overall Study|Disease progression|13|||
33405683|NCT02581631|62784231|FG003|Overall Study|Disease progression|5|||
33405684|NCT02581631|62784232|FG004|Overall Study|Disease progression|8|||
33405685|NCT02581631|62784228|FG000|Overall Study|Study drug toxicity|4|||
33405686|NCT02581631|62784229|FG001|Overall Study|Study drug toxicity|6|||
33405687|NCT02581631|62784230|FG002|Overall Study|Study drug toxicity|7|||
33321017|NCT01211483|62696868|FG003|Phase 2|Death|53|||
33321018|NCT01211483|62696865|FG000|Phase 2|Withdrawal by Subject|0|||
33321019|NCT01211483|62696866|FG001|Phase 2|Withdrawal by Subject|1|||
33321020|NCT01211483|62696867|FG002|Phase 2|Withdrawal by Subject|10|||
33321021|NCT01211483|62696868|FG003|Phase 2|Withdrawal by Subject|5|||
33321022|NCT01211483|62696865|FG000|Phase 2|Study terminated by Sponsor|0|||
33321023|NCT01211483|62696866|FG001|Phase 2|Study terminated by Sponsor|6|||
33321024|NCT01211483|62696867|FG002|Phase 2|Study terminated by Sponsor|8|||
33321025|NCT01211483|62696868|FG003|Phase 2|Study terminated by Sponsor|11|||
33405688|NCT02581631|62784231|FG003|Overall Study|Study drug toxicity|0|||
33405689|NCT02581631|62784232|FG004|Overall Study|Study drug toxicity|3|||
33405690|NCT02581631|62784228|FG000|Overall Study|AE unrelated to study drug|3|||
33321026|NCT01210001|62696885|FG000|Overall Study|Not treated|1|||
33321027|NCT01210001|62696886|FG001|Overall Study|Not treated|0|||
33321028|NCT01210001|62696887|FG002|Overall Study|Not treated|0|||
33321029|NCT01210001|62696885|FG000|Overall Study|Adverse Event|4|||
33321030|NCT01210001|62696886|FG001|Overall Study|Adverse Event|2|||
33321031|NCT01210001|62696887|FG002|Overall Study|Adverse Event|5|||
33405691|NCT02581631|62784229|FG001|Overall Study|AE unrelated to study drug|1|||
33405692|NCT02581631|62784230|FG002|Overall Study|AE unrelated to study drug|1|||
33405693|NCT02581631|62784231|FG003|Overall Study|AE unrelated to study drug|0|||
33405694|NCT02581631|62784232|FG004|Overall Study|AE unrelated to study drug|2|||
33405695|NCT02581631|62784228|FG000|Overall Study|Request to discontinue|1|||
33405696|NCT02581631|62784229|FG001|Overall Study|Request to discontinue|0|||
33405697|NCT02581631|62784230|FG002|Overall Study|Request to discontinue|3|||
33405698|NCT02581631|62784231|FG003|Overall Study|Request to discontinue|0|||
33405699|NCT02581631|62784232|FG004|Overall Study|Request to discontinue|1|||
33405700|NCT02581631|62784228|FG000|Overall Study|participant withdrew consent|3|||
33405701|NCT02581631|62784229|FG001|Overall Study|participant withdrew consent|0|||
33405702|NCT02581631|62784230|FG002|Overall Study|participant withdrew consent|1|||
33405703|NCT02581631|62784231|FG003|Overall Study|participant withdrew consent|0|||
33405704|NCT02581631|62784232|FG004|Overall Study|participant withdrew consent|0|||
33405705|NCT02581631|62784228|FG000|Overall Study|Maximum clinical benefit|1|||
33405706|NCT02581631|62784229|FG001|Overall Study|Maximum clinical benefit|7|||
33405707|NCT02581631|62784230|FG002|Overall Study|Maximum clinical benefit|1|||
33405708|NCT02581631|62784231|FG003|Overall Study|Maximum clinical benefit|3|||
33405709|NCT02581631|62784232|FG004|Overall Study|Maximum clinical benefit|13|||
33405710|NCT02581631|62784228|FG000|Overall Study|Other Reasons|1|||
33405711|NCT02581631|62784229|FG001|Overall Study|Other Reasons|0|||
33405712|NCT02581631|62784230|FG002|Overall Study|Other Reasons|2|||
33405713|NCT02581631|62784231|FG003|Overall Study|Other Reasons|2|||
33405714|NCT02581631|62784232|FG004|Overall Study|Other Reasons|3|||
33405715|NCT02581631|62784228|FG000|Overall Study|Poor/Non-Compliance|0|||
33405716|NCT02581631|62784229|FG001|Overall Study|Poor/Non-Compliance|0|||
33405717|NCT02581631|62784230|FG002|Overall Study|Poor/Non-Compliance|1|||
33405718|NCT02581631|62784231|FG003|Overall Study|Poor/Non-Compliance|0|||
33405719|NCT02581631|62784232|FG004|Overall Study|Poor/Non-Compliance|0|||
33405720|NCT00529035|62784244|FG000|Overall Study|Withdrawal by Subject|1|||
33405721|NCT00609674|62784257|FG000|Overall Study|Adverse Event|1|||
33405722|NCT00609674|62784258|FG001|Overall Study|Adverse Event|1|||
33405723|NCT00609674|62784257|FG000|Overall Study|Protocol Violation|3|||
33405724|NCT00609674|62784258|FG001|Overall Study|Protocol Violation|5|||
33405725|NCT00609674|62784257|FG000|Overall Study|Lost to Follow-up|1|||
33405726|NCT00609674|62784258|FG001|Overall Study|Lost to Follow-up|0|||
33405727|NCT00609674|62784257|FG000|Overall Study|Withdrew consent|2|||
33405728|NCT00609674|62784258|FG001|Overall Study|Withdrew consent|1|||
33405729|NCT00137839|62784264|FG000|Overall Study|Adverse Event|7|||
33405730|NCT00137839|62784264|FG000|Overall Study|Physician Decision|7|||
33405731|NCT00137839|62784264|FG000|Overall Study|Death|8|||
33405732|NCT00137839|62784264|FG000|Overall Study|Disease Progression|60|||
33405733|NCT00137839|62784264|FG000|Overall Study|Not Start Treatment|1|||
33405734|NCT00137839|62784264|FG000|Overall Study|Prolonged Treatment Delay|1|||
33405735|NCT00563316|62784271|FG000|Overall Study|Adverse Event|2|||
33405736|NCT00563316|62784271|FG000|Overall Study|Physician Decision|1|||
33405737|NCT00563316|62784271|FG000|Overall Study|Lost to Follow-up|2|||
33405738|NCT00563316|62784271|FG000|Overall Study|Death|1|||
33405739|NCT00563316|62784271|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
33405740|NCT00563316|62784271|FG000|Overall Study|Other|1|||
33405741|NCT03178487|62784281|FG000|Period 1|Adverse Event|1|||
33405742|NCT03178487|62784282|FG001|Period 1|Adverse Event|2|||
33405743|NCT03178487|62784281|FG000|Period 1|Withdrawal by Subject|2|||
33405744|NCT03178487|62784282|FG001|Period 1|Withdrawal by Subject|1|||
33405745|NCT03178487|62784281|FG000|Period 1|Lost to Follow-up|1|||
33405746|NCT03178487|62784282|FG001|Period 1|Lost to Follow-up|0|||
33405747|NCT03178487|62784281|FG000|Period 1|Other|0|||
33405748|NCT03178487|62784282|FG001|Period 1|Other|1|||
33405749|NCT03178487|62784281|FG000|Period 2|Adverse Event|4|||
33321032|NCT01210001|62696885|FG000|Overall Study|Non compliant with protocol|2|||
33321033|NCT01210001|62696886|FG001|Overall Study|Non compliant with protocol|2|||
33321034|NCT01210001|62696887|FG002|Overall Study|Non compliant with protocol|3|||
33321035|NCT01210001|62696885|FG000|Overall Study|Lost to Follow-up|4|||
33321036|NCT01210001|62696886|FG001|Overall Study|Lost to Follow-up|3|||
33321037|NCT01210001|62696887|FG002|Overall Study|Lost to Follow-up|2|||
33321038|NCT01210001|62696885|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
33321039|NCT01210001|62696886|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
33321040|NCT01210001|62696887|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
33321041|NCT01210001|62696885|FG000|Overall Study|Other reason not defined above|2|||
33321042|NCT01210001|62696886|FG001|Overall Study|Other reason not defined above|2|||
33405750|NCT03178487|62784282|FG001|Period 2|Adverse Event|4|||
33405751|NCT03178487|62784281|FG000|Period 2|Withdrawal by Subject|6|||
33405752|NCT03178487|62784282|FG001|Period 2|Withdrawal by Subject|6|||
33405753|NCT03178487|62784281|FG000|Period 2|Lost to Follow-up|2|||
33405754|NCT03178487|62784282|FG001|Period 2|Lost to Follow-up|2|||
33405755|NCT03178487|62784281|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
33405756|NCT03178487|62784282|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
33405757|NCT03178487|62784281|FG000|Period 2|Other|8|||
33405758|NCT03178487|62784282|FG001|Period 2|Other|7|||
33405759|NCT00528957|62784291|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
33405760|NCT00528957|62784292|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
33405761|NCT00528957|62784291|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
33405762|NCT00528957|62784292|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
33405763|NCT00528957|62784291|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
33405764|NCT00528957|62784292|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
33405765|NCT00528957|62784291|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
33405766|NCT00528957|62784292|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
33405767|NCT00528957|62784291|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
33405768|NCT00528957|62784292|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
33405769|NCT00528957|62784291|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
33405770|NCT00528957|62784292|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
33405771|NCT00528957|62784291|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
33405772|NCT00528957|62784292|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
33405773|NCT00528957|62784291|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
33405774|NCT00528957|62784292|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
33405775|NCT00528957|62784291|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
33405776|NCT00528957|62784292|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
33405777|NCT00528957|62784291|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
33405778|NCT00528957|62784292|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
33405779|NCT00528957|62784291|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
33405780|NCT00528957|62784292|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
33405781|NCT00528957|62784291|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
33405782|NCT00528957|62784292|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
33405783|NCT00528957|62784291|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
33405784|NCT00528957|62784292|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
33405785|NCT00528957|62784291|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
33405786|NCT00528957|62784292|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
33405787|NCT00528957|62784291|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
33405788|NCT00528957|62784292|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
33405789|NCT00528957|62784291|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
33405790|NCT00528957|62784292|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
33405791|NCT00560508|62784310|FG000|12 Week Double-blind Period|Adverse Event|3|||
33405792|NCT00560508|62784311|FG001|12 Week Double-blind Period|Adverse Event|2|||
33405793|NCT00560508|62784310|FG000|12 Week Double-blind Period|Protocol Violation|1|||
33405794|NCT00560508|62784311|FG001|12 Week Double-blind Period|Protocol Violation|0|||
33405795|NCT00560508|62784310|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
33405796|NCT00560508|62784311|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
33405797|NCT00560508|62784310|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
33405798|NCT00560508|62784311|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
33405799|NCT00560508|62784310|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
33405800|NCT00560508|62784311|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
33405801|NCT00560508|62784310|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
33405802|NCT00560508|62784311|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
33405803|NCT00560508|62784310|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
33405804|NCT00560508|62784311|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
33405805|NCT03962790|62784322|FG000|Period 1|Adverse Event|0|||
33405806|NCT03962790|62784323|FG001|Period 1|Adverse Event|1|||
33405807|NCT03962790|62784322|FG000|Period 1|Failed to meet all eligibility criteria|1|||
33405808|NCT03962790|62784323|FG001|Period 1|Failed to meet all eligibility criteria|1|||
33405809|NCT03962790|62784322|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
33405810|NCT03962790|62784323|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
33405811|NCT03962790|62784322|FG000|Period 1|Withdrawal by Subject|1|||
33405812|NCT03962790|62784323|FG001|Period 1|Withdrawal by Subject|0|||
33405813|NCT00609518|62784331|FG000|Overall Study|Death from Study Disease|32|||
33405814|NCT00609518|62784332|FG001|Overall Study|Death from Study Disease|32|||
33405815|NCT00609518|62784331|FG000|Overall Study|Withdrawal by Subject|5|||
33405816|NCT00609518|62784332|FG001|Overall Study|Withdrawal by Subject|3|||
33405817|NCT00609518|62784331|FG000|Overall Study|Lost to Follow-up|3|||
33405818|NCT00609518|62784332|FG001|Overall Study|Lost to Follow-up|0|||
33405819|NCT00609518|62784331|FG000|Overall Study|Physician Decision|1|||
33405820|NCT00609518|62784332|FG001|Overall Study|Physician Decision|3|||
33405821|NCT00609518|62784331|FG000|Overall Study|Death from Adverse Event|2|||
33405822|NCT00609518|62784332|FG001|Overall Study|Death from Adverse Event|2|||
33405823|NCT00609362|62784340|FG000|Overall Study|Withdrawal by Subject|2|||
33405824|NCT00609362|62784341|FG001|Overall Study|Withdrawal by Subject|1|||
33405825|NCT00609362|62784340|FG000|Overall Study|Adverse Event|1|||
33405826|NCT00609362|62784341|FG001|Overall Study|Adverse Event|0|||
33405827|NCT00611858|62784347|FG000|Overall Study|Adverse Event|2|||
33405828|NCT00611858|62784347|FG000|Overall Study|Withdrawal by Subject|2|||
33405829|NCT00137449|62784355|FG000|Overall Study|Disease Progression|8|||
33405830|NCT00137449|62784356|FG001|Overall Study|Disease Progression|13|||
33405831|NCT00137449|62784355|FG000|Overall Study|Death|4|||
33405832|NCT00137449|62784356|FG001|Overall Study|Death|3|||
33405833|NCT00137449|62784355|FG000|Overall Study|Adverse Event|3|||
33405834|NCT00137449|62784356|FG001|Overall Study|Adverse Event|1|||
33405835|NCT00137449|62784355|FG000|Overall Study|Withdrawal by Subject|1|||
33405836|NCT00137449|62784356|FG001|Overall Study|Withdrawal by Subject|1|||
33405837|NCT00528879|62784367|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
33405838|NCT00528879|62784368|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
33405839|NCT00528879|62784369|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
33405840|NCT00528879|62784370|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
33405841|NCT00528879|62784367|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
33405842|NCT00528879|62784368|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
33405843|NCT00528879|62784369|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
33405844|NCT00528879|62784370|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
33405845|NCT00528879|62784367|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
33405846|NCT00528879|62784368|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
33405847|NCT00528879|62784369|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
33405848|NCT00528879|62784370|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
33405849|NCT00528879|62784367|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
33405850|NCT00528879|62784368|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
33405851|NCT00528879|62784369|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
33405852|NCT00528879|62784370|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
33405853|NCT00528879|62784367|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
33405854|NCT00528879|62784368|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
33405855|NCT00528879|62784369|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
33405856|NCT00528879|62784370|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
33405857|NCT00528879|62784367|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
33405858|NCT00528879|62784368|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
33405859|NCT00528879|62784369|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
33405860|NCT00528879|62784370|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
33405861|NCT00528879|62784367|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
33405862|NCT00528879|62784368|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
33405863|NCT00528879|62784369|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
33405864|NCT00528879|62784370|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
33405865|NCT00528879|62784367|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
33405866|NCT00528879|62784368|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
33405867|NCT00528879|62784369|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
33405868|NCT00528879|62784370|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
33405869|NCT00528879|62784367|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
33405870|NCT00528879|62784368|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
33405871|NCT00528879|62784369|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
33405872|NCT00528879|62784370|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
33405873|NCT00528879|62784367|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
33405874|NCT00528879|62784368|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
33405875|NCT00528879|62784369|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
33405876|NCT00528879|62784370|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
33405877|NCT00528879|62784367|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
33405878|NCT00528879|62784368|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
33405879|NCT00528879|62784369|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
33405880|NCT00528879|62784370|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
33405881|NCT00528879|62784367|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
33405882|NCT00528879|62784368|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
33405883|NCT00528879|62784369|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
33405884|NCT00528879|62784370|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
33405885|NCT00528879|62784367|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
33405886|NCT00528879|62784368|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
33405887|NCT00528879|62784369|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
33405888|NCT00528879|62784370|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
33405889|NCT00528879|62784367|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
33405890|NCT00528879|62784368|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
33405891|NCT00528879|62784369|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
33405892|NCT00528879|62784370|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
33405893|NCT00528879|62784367|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
33405894|NCT00528879|62784368|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
33405895|NCT00528879|62784369|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
33405896|NCT00528879|62784370|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
33405897|NCT00528879|62784367|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
33405898|NCT00528879|62784368|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
33405899|NCT00528879|62784369|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
33405900|NCT00528879|62784370|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
33405901|NCT00608894|62784382|FG000|Overall Study|Withdrawal by Subject|0|||
33405902|NCT00608894|62784383|FG001|Overall Study|Withdrawal by Subject|2|||
33405903|NCT00557856|62784391|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
33405904|NCT00557856|62784392|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
33405905|NCT00557856|62784393|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
33405906|NCT00557856|62784394|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
33405907|NCT00557856|62784395|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
33405908|NCT00557856|62784396|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
33405909|NCT00557856|62784397|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
33405910|NCT00557856|62784398|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
33405911|NCT00557856|62784399|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
33405912|NCT00557856|62784391|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
33405913|NCT00557856|62784392|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
33405914|NCT00557856|62784393|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
33405915|NCT00557856|62784394|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
33405916|NCT00557856|62784395|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
33405917|NCT00557856|62784396|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
33405918|NCT00557856|62784397|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
33405919|NCT00557856|62784398|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
33405920|NCT00557856|62784399|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
33405921|NCT00557856|62784391|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
33405922|NCT00557856|62784392|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
33405923|NCT00557856|62784393|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
33405924|NCT00557856|62784394|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
33405925|NCT00557856|62784395|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
33405926|NCT00557856|62784396|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
33405927|NCT00557856|62784397|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
33405928|NCT00557856|62784398|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
33405929|NCT00557856|62784399|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
33405930|NCT00557856|62784391|FG000|Part 1: Dose Escalation Phase|Other|0|||
33405931|NCT00557856|62784392|FG001|Part 1: Dose Escalation Phase|Other|0|||
33405932|NCT00557856|62784393|FG002|Part 1: Dose Escalation Phase|Other|1|||
33405933|NCT00557856|62784394|FG003|Part 1: Dose Escalation Phase|Other|1|||
33405934|NCT00557856|62784395|FG004|Part 1: Dose Escalation Phase|Other|0|||
33405935|NCT00557856|62784396|FG005|Part 1: Dose Escalation Phase|Other|0|||
33405936|NCT00557856|62784397|FG006|Part 1: Dose Escalation Phase|Other|0|||
33405937|NCT00557856|62784398|FG007|Part 1: Dose Escalation Phase|Other|1|||
33405938|NCT00557856|62784399|FG008|Part 1: Dose Escalation Phase|Other|0|||
33405939|NCT00557856|62784391|FG000|Part 1: Dose Escalation Phase|Death|0|||
33405940|NCT00557856|62784392|FG001|Part 1: Dose Escalation Phase|Death|0|||
33405941|NCT00557856|62784393|FG002|Part 1: Dose Escalation Phase|Death|0|||
33405942|NCT00557856|62784394|FG003|Part 1: Dose Escalation Phase|Death|0|||
33405943|NCT00557856|62784395|FG004|Part 1: Dose Escalation Phase|Death|0|||
33405944|NCT00557856|62784396|FG005|Part 1: Dose Escalation Phase|Death|1|||
33405945|NCT00557856|62784397|FG006|Part 1: Dose Escalation Phase|Death|0|||
33405946|NCT00557856|62784398|FG007|Part 1: Dose Escalation Phase|Death|0|||
33405947|NCT00557856|62784399|FG008|Part 1: Dose Escalation Phase|Death|0|||
33405948|NCT00557856|62784391|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
33405949|NCT00557856|62784392|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
33405950|NCT00557856|62784393|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
33405951|NCT00557856|62784394|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
33405952|NCT00557856|62784395|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
33405953|NCT00557856|62784396|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
33405954|NCT00557856|62784397|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
33405955|NCT00557856|62784398|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
33405956|NCT00557856|62784399|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
33405957|NCT00557856|62784391|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
33405958|NCT00557856|62784392|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33405959|NCT00557856|62784393|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33405960|NCT00557856|62784394|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33405961|NCT00557856|62784395|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33405962|NCT00557856|62784396|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33405963|NCT00557856|62784397|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33405964|NCT00557856|62784398|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33405965|NCT00557856|62784399|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33405966|NCT00557856|62784391|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
33405967|NCT00557856|62784392|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
33405968|NCT00557856|62784393|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
33405969|NCT00557856|62784394|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
33405970|NCT00557856|62784395|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
33405971|NCT00557856|62784396|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
33405972|NCT00557856|62784397|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
33405973|NCT00557856|62784398|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
33405974|NCT00557856|62784399|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
33405975|NCT00557856|62784391|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33405976|NCT00557856|62784392|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33405977|NCT00557856|62784393|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33405978|NCT00557856|62784394|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33405979|NCT00557856|62784395|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33405980|NCT00557856|62784396|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33405981|NCT00557856|62784397|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33405982|NCT00557856|62784398|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33405983|NCT00557856|62784399|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
33405984|NCT00557856|62784391|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
33405985|NCT00557856|62784392|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
33405986|NCT00557856|62784393|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
33405987|NCT00557856|62784394|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
33405988|NCT00557856|62784395|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
33405989|NCT00557856|62784396|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
33405990|NCT00557856|62784397|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
33405991|NCT00557856|62784398|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
33405992|NCT00557856|62784399|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
33405993|NCT00557856|62784391|FG000|Part 2: Exploratory Phase|Other|0|||
33405994|NCT00557856|62784392|FG001|Part 2: Exploratory Phase|Other|0|||
33405995|NCT00557856|62784393|FG002|Part 2: Exploratory Phase|Other|0|||
33405996|NCT00557856|62784394|FG003|Part 2: Exploratory Phase|Other|0|||
33405997|NCT00557856|62784395|FG004|Part 2: Exploratory Phase|Other|0|||
33405998|NCT00557856|62784396|FG005|Part 2: Exploratory Phase|Other|0|||
33405999|NCT00557856|62784397|FG006|Part 2: Exploratory Phase|Other|0|||
33406000|NCT00557856|62784398|FG007|Part 2: Exploratory Phase|Other|0|||
33406001|NCT00557856|62784399|FG008|Part 2: Exploratory Phase|Other|1|||
33406002|NCT00557856|62784391|FG000|Part 2: Exploratory Phase|Death|0|||
33406003|NCT00557856|62784392|FG001|Part 2: Exploratory Phase|Death|0|||
33406004|NCT00557856|62784393|FG002|Part 2: Exploratory Phase|Death|0|||
33406005|NCT00557856|62784394|FG003|Part 2: Exploratory Phase|Death|0|||
33406006|NCT00557856|62784395|FG004|Part 2: Exploratory Phase|Death|0|||
33406007|NCT00557856|62784396|FG005|Part 2: Exploratory Phase|Death|0|||
33406008|NCT00557856|62784397|FG006|Part 2: Exploratory Phase|Death|0|||
33406009|NCT00557856|62784398|FG007|Part 2: Exploratory Phase|Death|0|||
33406010|NCT00557856|62784399|FG008|Part 2: Exploratory Phase|Death|2|||
33406011|NCT00557856|62784391|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
33406012|NCT00557856|62784392|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
33406013|NCT00557856|62784393|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
33406014|NCT00557856|62784394|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
33406015|NCT00557856|62784395|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
33406016|NCT00557856|62784396|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
33406017|NCT00557856|62784397|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
33406018|NCT00557856|62784398|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
33406019|NCT00557856|62784399|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
33598395|NCT02293993|62997211|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
33598396|NCT02293993|62997212|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
33598397|NCT02322775|62997232|FG000|Overall Study|Adverse Event|1|||
33598398|NCT02322775|62997233|FG001|Overall Study|Adverse Event|0|||
33598399|NCT02322775|62997232|FG000|Overall Study|Lost to Follow-up|0|||
33598400|NCT02322775|62997233|FG001|Overall Study|Lost to Follow-up|1|||
33598401|NCT02322775|62997232|FG000|Overall Study|Protocol Violation|1|||
33598402|NCT02322775|62997233|FG001|Overall Study|Protocol Violation|0|||
33598403|NCT02322775|62997232|FG000|Overall Study|Withdrawal by Subject|3|||
33598404|NCT02322775|62997233|FG001|Overall Study|Withdrawal by Subject|4|||
33406020|NCT00191113|62784416|FG000|Core Study|Withdrawal by Subject|25|||
33321043|NCT01210001|62696887|FG002|Overall Study|Other reason not defined above|1|||
33406021|NCT00191113|62784417|FG001|Core Study|Withdrawal by Subject|9|||
33406022|NCT00191113|62784416|FG000|Core Study|Protocol Violation|6|||
33406023|NCT00191113|62784417|FG001|Core Study|Protocol Violation|2|||
33598405|NCT02322775|62997232|FG000|Overall Study|Not willing to perform all FU visits|0|||
33321044|NCT01209689|62696928|FG000|Overall Study|Insufficient Therapeutic Response|7|||
33321045|NCT01209689|62696929|FG001|Overall Study|Insufficient Therapeutic Response|2|||
33321046|NCT01209689|62696928|FG000|Overall Study|Refused Treatment|8|||
33321047|NCT01209689|62696929|FG001|Overall Study|Refused Treatment|3|||
33321048|NCT01209689|62696928|FG000|Overall Study|Adverse Event|4|||
33321049|NCT01209689|62696929|FG001|Overall Study|Adverse Event|0|||
33321050|NCT01209689|62696928|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
33321051|NCT01209689|62696929|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
33406024|NCT00191113|62784416|FG000|Core Study|Lost to Follow-up|3|||
33406025|NCT00191113|62784417|FG001|Core Study|Lost to Follow-up|0|||
33406026|NCT00191113|62784416|FG000|Core Study|Adverse Event|0|||
33406027|NCT00191113|62784417|FG001|Core Study|Adverse Event|2|||
33406028|NCT00191113|62784416|FG000|Core Study|Lack of Efficacy|0|||
33406029|NCT00191113|62784417|FG001|Core Study|Lack of Efficacy|2|||
33406030|NCT00191113|62784416|FG000|Core Study|Death|1|||
33406031|NCT00191113|62784417|FG001|Core Study|Death|0|||
33406032|NCT00608582|62784431|FG000|Overall Study|Lost to Follow-up|2|||
33406033|NCT00608582|62784432|FG001|Overall Study|Lost to Follow-up|0|||
33406034|NCT00608582|62784431|FG000|Overall Study|No Best Response in Phase 1 located|1|||
33406035|NCT00608582|62784432|FG001|Overall Study|No Best Response in Phase 1 located|1|||
33406036|NCT00608582|62784431|FG000|Overall Study|Illicit Drug Use|1|||
33406037|NCT00608582|62784432|FG001|Overall Study|Illicit Drug Use|0|||
33406038|NCT00608582|62784431|FG000|Overall Study|Early stage Design Change|0|||
33406039|NCT00608582|62784432|FG001|Overall Study|Early stage Design Change|3|||
33406040|NCT03965052|62784442|FG000|Overall Study|Protocol Violation|1|||
33406041|NCT03965052|62784443|FG001|Overall Study|Protocol Violation|0|||
33406042|NCT03964974|62784451|FG000|Overall Study|Lost to Follow-up|3|||
33406043|NCT03964974|62784452|FG001|Overall Study|Lost to Follow-up|2|||
33406044|NCT03964974|62784451|FG000|Overall Study|Withdrawal by Subject|0|||
33406045|NCT03964974|62784452|FG001|Overall Study|Withdrawal by Subject|3|||
33406046|NCT00606320|62784458|FG000|Overall Study|Adverse Event|3|||
33406047|NCT00606320|62784458|FG000|Overall Study|Lack of Efficacy|5|||
33406048|NCT00606320|62784458|FG000|Overall Study|Physician Decision|7|||
33406049|NCT00606320|62784458|FG000|Overall Study|Protocol Violation|8|||
33406050|NCT00606320|62784458|FG000|Overall Study|Withdrawal by Subject|10|||
33406051|NCT00606320|62784458|FG000|Overall Study|Progression to depressive phase|4|||
33406052|NCT00528411|62784465|FG000|Overall Study|Adverse Event|4|||
33406053|NCT00528411|62784466|FG001|Overall Study|Adverse Event|0|||
33406054|NCT00528411|62784467|FG002|Overall Study|Adverse Event|1|||
33406055|NCT00528411|62784465|FG000|Overall Study|Incorrect Enrolment|1|||
33406056|NCT00528411|62784466|FG001|Overall Study|Incorrect Enrolment|1|||
33406057|NCT00528411|62784467|FG002|Overall Study|Incorrect Enrolment|0|||
33406058|NCT00528411|62784465|FG000|Overall Study|Severe non-compliance to protocol|0|||
33406059|NCT00528411|62784466|FG001|Overall Study|Severe non-compliance to protocol|1|||
33406060|NCT00528411|62784467|FG002|Overall Study|Severe non-compliance to protocol|0|||
33406061|NCT00528411|62784465|FG000|Overall Study|Prior commitment medication|0|||
33406062|NCT00528411|62784466|FG001|Overall Study|Prior commitment medication|1|||
33406063|NCT00528411|62784467|FG002|Overall Study|Prior commitment medication|0|||
33406064|NCT00136357|62784477|FG000|Overall Study|Withdrawal by Subject|3|||
33406065|NCT00136357|62784478|FG001|Overall Study|Withdrawal by Subject|2|||
33406066|NCT00129649|62784486|FG000|Overall Study|Withdrawal by Subject|76|||
33406067|NCT00129649|62784487|FG001|Overall Study|Withdrawal by Subject|65|||
33406068|NCT00187135|62784499|FG000|Visit One|Withdrawal by Subject|1|||
33406069|NCT00187135|62784500|FG001|Visit One|Withdrawal by Subject|0|||
33406070|NCT00187135|62784501|FG002|Visit One|Withdrawal by Subject|0|||
33406071|NCT00187135|62784502|FG003|Visit One|Withdrawal by Subject|0|||
33406072|NCT00187135|62784503|FG004|Visit One|Withdrawal by Subject|0|||
33406073|NCT00187135|62784504|FG005|Visit One|Withdrawal by Subject|1|||
33406074|NCT00187135|62784499|FG000|Visit One|Physician Decision|3|||
33406075|NCT00187135|62784500|FG001|Visit One|Physician Decision|1|||
33406076|NCT00187135|62784501|FG002|Visit One|Physician Decision|0|||
33406077|NCT00187135|62784502|FG003|Visit One|Physician Decision|0|||
33406078|NCT00187135|62784503|FG004|Visit One|Physician Decision|0|||
33406079|NCT00187135|62784504|FG005|Visit One|Physician Decision|1|||
33406080|NCT00187135|62784499|FG000|Visit Two|Death|0|||
33406081|NCT00187135|62784500|FG001|Visit Two|Death|0|||
33406082|NCT00187135|62784501|FG002|Visit Two|Death|0|||
33406083|NCT00187135|62784502|FG003|Visit Two|Death|1|||
33406084|NCT00187135|62784503|FG004|Visit Two|Death|0|||
33406085|NCT00187135|62784504|FG005|Visit Two|Death|1|||
33406086|NCT00187135|62784499|FG000|Visit Two|Physician Decision|1|||
33406087|NCT00187135|62784500|FG001|Visit Two|Physician Decision|0|||
33406088|NCT00187135|62784501|FG002|Visit Two|Physician Decision|0|||
33406089|NCT00187135|62784502|FG003|Visit Two|Physician Decision|0|||
33406090|NCT00187135|62784503|FG004|Visit Two|Physician Decision|0|||
33406091|NCT00187135|62784504|FG005|Visit Two|Physician Decision|0|||
33406092|NCT00187135|62784499|FG000|Visit Two|Withdrawal by Subject|1|||
33406093|NCT00187135|62784500|FG001|Visit Two|Withdrawal by Subject|1|||
33406094|NCT00187135|62784501|FG002|Visit Two|Withdrawal by Subject|1|||
33406095|NCT00187135|62784502|FG003|Visit Two|Withdrawal by Subject|0|||
33406096|NCT00187135|62784503|FG004|Visit Two|Withdrawal by Subject|1|||
33406097|NCT00187135|62784504|FG005|Visit Two|Withdrawal by Subject|1|||
33406098|NCT00187135|62784499|FG000|Visit Two|Study Discontinued|3|||
33406099|NCT00187135|62784500|FG001|Visit Two|Study Discontinued|2|||
33406100|NCT00187135|62784501|FG002|Visit Two|Study Discontinued|1|||
33406101|NCT00187135|62784502|FG003|Visit Two|Study Discontinued|7|||
33406102|NCT00187135|62784503|FG004|Visit Two|Study Discontinued|5|||
33406103|NCT00187135|62784504|FG005|Visit Two|Study Discontinued|6|||
33406104|NCT00187135|62784499|FG000|Visit Three|Death|0|||
33406105|NCT00187135|62784500|FG001|Visit Three|Death|0|||
33406106|NCT00187135|62784501|FG002|Visit Three|Death|1|||
33406107|NCT00187135|62784502|FG003|Visit Three|Death|0|||
33406108|NCT00187135|62784503|FG004|Visit Three|Death|1|||
33406109|NCT00187135|62784504|FG005|Visit Three|Death|0|||
33406110|NCT00187135|62784499|FG000|Visit Three|Withdrawal by Subject|0|||
33406111|NCT00187135|62784500|FG001|Visit Three|Withdrawal by Subject|1|||
33406112|NCT00187135|62784501|FG002|Visit Three|Withdrawal by Subject|1|||
33406113|NCT00187135|62784502|FG003|Visit Three|Withdrawal by Subject|2|||
33406114|NCT00187135|62784503|FG004|Visit Three|Withdrawal by Subject|0|||
33406115|NCT00187135|62784504|FG005|Visit Three|Withdrawal by Subject|0|||
33406116|NCT00187135|62784499|FG000|Visit Three|Study Discontinued|7|||
33406117|NCT00187135|62784500|FG001|Visit Three|Study Discontinued|6|||
33406118|NCT00187135|62784501|FG002|Visit Three|Study Discontinued|7|||
33406119|NCT00187135|62784502|FG003|Visit Three|Study Discontinued|7|||
33406120|NCT00187135|62784503|FG004|Visit Three|Study Discontinued|7|||
33406121|NCT00187135|62784504|FG005|Visit Three|Study Discontinued|6|||
33406122|NCT00528021|62784520|FG000|Overall Study|Lack of Efficacy|17|||
33406123|NCT00528021|62784521|FG001|Overall Study|Lack of Efficacy|13|||
33406124|NCT00528021|62784522|FG002|Overall Study|Lack of Efficacy|7|||
33406125|NCT00528021|62784523|FG003|Overall Study|Lack of Efficacy|9|||
33406126|NCT00560352|62784536|FG000|Overall Study|Adverse event unrelated to study drug|2|||
33406127|NCT00560352|62784537|FG001|Overall Study|Adverse event unrelated to study drug|1|||
33406128|NCT00560352|62784538|FG002|Overall Study|Adverse event unrelated to study drug|1|||
33406129|NCT00560352|62784536|FG000|Overall Study|Study drug toxicity|3|||
33406130|NCT00560352|62784537|FG001|Overall Study|Study drug toxicity|0|||
33406131|NCT00560352|62784538|FG002|Overall Study|Study drug toxicity|1|||
33406132|NCT00560352|62784536|FG000|Overall Study|Disease progression|0|||
33406133|NCT00560352|62784537|FG001|Overall Study|Disease progression|1|||
33406134|NCT00560352|62784538|FG002|Overall Study|Disease progression|1|||
33406135|NCT00560352|62784536|FG000|Overall Study|Withdrawal by Subject|1|||
33406136|NCT00560352|62784537|FG001|Overall Study|Withdrawal by Subject|1|||
33406137|NCT00560352|62784538|FG002|Overall Study|Withdrawal by Subject|1|||
33406138|NCT00560352|62784536|FG000|Overall Study|Maximum clinical benefit|1|||
33406139|NCT00560352|62784537|FG001|Overall Study|Maximum clinical benefit|0|||
33406140|NCT00560352|62784538|FG002|Overall Study|Maximum clinical benefit|0|||
33406141|NCT00527787|62784552|FG000|Overall Study|Adverse Event|14|||
33406142|NCT00527787|62784553|FG001|Overall Study|Adverse Event|24|||
33406143|NCT00527787|62784552|FG000|Overall Study|Withdrawal by Subject|13|||
33406144|NCT00527787|62784553|FG001|Overall Study|Withdrawal by Subject|25|||
33406145|NCT00527787|62784552|FG000|Overall Study|Lost to Follow-up|5|||
33406146|NCT00527787|62784553|FG001|Overall Study|Lost to Follow-up|2|||
33406147|NCT00527787|62784552|FG000|Overall Study|Duodenal Ulcer|1|||
33406148|NCT00527787|62784553|FG001|Overall Study|Duodenal Ulcer|10|||
33406149|NCT00527787|62784552|FG000|Overall Study|misc|5|||
33406150|NCT00527787|62784553|FG001|Overall Study|misc|2|||
33406151|NCT00608426|62784561|FG000|Overall Study|Death|32|||
33406152|NCT00608426|62784562|FG001|Overall Study|Death|36|||
33406153|NCT00608426|62784561|FG000|Overall Study|Lost to Follow-up|485|||
33406154|NCT00608426|62784562|FG001|Overall Study|Lost to Follow-up|521|||
33406155|NCT00608426|62784561|FG000|Overall Study|refused, health issues, wrong address|319|||
33406156|NCT00608426|62784562|FG001|Overall Study|refused, health issues, wrong address|348|||
33406157|NCT00557076|62784570|FG000|Overall Study|Unblinding|0|||
33406158|NCT00557076|62784571|FG001|Overall Study|Unblinding|1|||
33406159|NCT00129259|62784579|FG000|Overall Study|Lost to Follow-up|1|||
33406160|NCT00129259|62784580|FG001|Overall Study|Lost to Follow-up|1|||
33406161|NCT00129259|62784579|FG000|Overall Study|Withdrawal by Subject|2|||
33406162|NCT00129259|62784580|FG001|Overall Study|Withdrawal by Subject|1|||
33406163|NCT00129259|62784579|FG000|Overall Study|Only available minimal phone assessments|0|||
33406164|NCT00129259|62784580|FG001|Overall Study|Only available minimal phone assessments|1|||
33406165|NCT00186901|62784589|FG000|Overall Study|Pregnancy|6|||
33406166|NCT00186901|62784590|FG001|Overall Study|Pregnancy|3|||
33406167|NCT00186901|62784591|FG002|Overall Study|Pregnancy|0|||
33406168|NCT00186901|62784589|FG000|Overall Study|Lost to Follow-up|6|||
33406169|NCT00186901|62784590|FG001|Overall Study|Lost to Follow-up|3|||
33406170|NCT00186901|62784591|FG002|Overall Study|Lost to Follow-up|0|||
33406171|NCT00186901|62784589|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
33406172|NCT00186901|62784590|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
33406173|NCT00186901|62784591|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
33406174|NCT00186901|62784589|FG000|Overall Study|ALL relapse or second malignancy|1|||
33406175|NCT00186901|62784590|FG001|Overall Study|ALL relapse or second malignancy|2|||
33406176|NCT00186901|62784591|FG002|Overall Study|ALL relapse or second malignancy|0|||
33406177|NCT00186901|62784589|FG000|Overall Study|Withdrawal by Subject|4|||
33406178|NCT00186901|62784590|FG001|Overall Study|Withdrawal by Subject|5|||
33406179|NCT00186901|62784591|FG002|Overall Study|Withdrawal by Subject|0|||
33406180|NCT00186901|62784589|FG000|Overall Study|Open label|3|||
33406181|NCT00186901|62784590|FG001|Overall Study|Open label|2|||
33406182|NCT00186901|62784591|FG002|Overall Study|Open label|0|||
33406183|NCT00186901|62784589|FG000|Overall Study|Limited adherence to study requirements|20|||
33406184|NCT00186901|62784590|FG001|Overall Study|Limited adherence to study requirements|23|||
33406185|NCT00186901|62784591|FG002|Overall Study|Limited adherence to study requirements|0|||
33406186|NCT00186901|62784589|FG000|Overall Study|Bone Mineral Density > 0|0|||
33406187|NCT00186901|62784590|FG001|Overall Study|Bone Mineral Density > 0|0|||
33406188|NCT00186901|62784591|FG002|Overall Study|Bone Mineral Density > 0|149|||
33406189|NCT00186121|62784628|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
33406190|NCT00186121|62784628|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
33406191|NCT00186121|62784628|FG000|Overall Study|Not eligible (no treatment)|1|||
33406192|NCT00186043|62784634|FG000|Overall Study|Lack of Efficacy|1|||
33406193|NCT00186043|62784635|FG001|Overall Study|Lack of Efficacy|3|||
33406194|NCT00186043|62784634|FG000|Overall Study|Lost to Follow-up|4|||
33406195|NCT00186043|62784635|FG001|Overall Study|Lost to Follow-up|6|||
33406196|NCT00186043|62784634|FG000|Overall Study|Withdrawal by Subject|1|||
33406197|NCT00186043|62784635|FG001|Overall Study|Withdrawal by Subject|0|||
33406198|NCT00186043|62784634|FG000|Overall Study|Adverse Event|7|||
33406199|NCT00186043|62784635|FG001|Overall Study|Adverse Event|3|||
33406200|NCT00186043|62784634|FG000|Overall Study|Protocol Violation|2|||
33406201|NCT00186043|62784635|FG001|Overall Study|Protocol Violation|1|||
33406202|NCT00185965|62784643|FG000|Overall Study|Adverse Event|0|||
33406203|NCT00185965|62784644|FG001|Overall Study|Adverse Event|1|||
33406204|NCT00607880|62784652|FG000|Overall Study|Unable to place port due to occlusion|1|||
33406205|NCT00607880|62784653|FG001|Overall Study|Unable to place port due to occlusion|0|||
33406206|NCT00127933|62784661|FG000|Overall Study|Randomized but not dosed|1|||
33406207|NCT00127933|62784662|FG001|Overall Study|Randomized but not dosed|0|||
33406208|NCT03875313|62784673|FG000|Overall Study|Withdrawal by Subject|1|||
33406209|NCT03875313|62784674|FG001|Overall Study|Withdrawal by Subject|3|||
33406210|NCT03875313|62784675|FG002|Overall Study|Withdrawal by Subject|0|||
33406211|NCT03875313|62784676|FG003|Overall Study|Withdrawal by Subject|0|||
33406212|NCT03875313|62784677|FG004|Overall Study|Withdrawal by Subject|0|||
33406213|NCT03875313|62784673|FG000|Overall Study|Death|0|||
33406214|NCT03875313|62784674|FG001|Overall Study|Death|0|||
33406215|NCT03875313|62784675|FG002|Overall Study|Death|0|||
33406216|NCT03875313|62784676|FG003|Overall Study|Death|0|||
33406217|NCT03875313|62784677|FG004|Overall Study|Death|1|||
33406218|NCT03875313|62784673|FG000|Overall Study|Lost to Follow-up|0|||
33406219|NCT03875313|62784674|FG001|Overall Study|Lost to Follow-up|0|||
33406220|NCT03875313|62784675|FG002|Overall Study|Lost to Follow-up|0|||
33598406|NCT02322775|62997233|FG001|Overall Study|Not willing to perform all FU visits|1|||
33598407|NCT02322229|62997239|FG000|Overall Study|Physician Decision|2|||
33598408|NCT02363959|62997246|FG000|Overall Study|Medical instability|1|||
33598409|NCT02363959|62997247|FG001|Overall Study|Medical instability|0|||
33598410|NCT02362789|62997255|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
33598411|NCT02362789|62997256|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
33598412|NCT02362789|62997257|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
33598413|NCT02362789|62997255|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
33598414|NCT02362789|62997256|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
33598415|NCT02362789|62997257|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
33598416|NCT02362789|62997255|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
33598417|NCT02362789|62997256|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
33598418|NCT02362789|62997257|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
33598419|NCT02362789|62997255|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
33598420|NCT02362789|62997256|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
33598421|NCT02362789|62997257|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
33598422|NCT02362789|62997255|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
33598423|NCT02362789|62997256|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
33406221|NCT03875313|62784676|FG003|Overall Study|Lost to Follow-up|0|||
33406222|NCT03875313|62784677|FG004|Overall Study|Lost to Follow-up|1|||
33406223|NCT03875313|62784673|FG000|Overall Study|Study Termination by Sponsor|0|||
33406224|NCT03875313|62784674|FG001|Overall Study|Study Termination by Sponsor|1|||
33598424|NCT02362789|62997257|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
33406225|NCT03875313|62784675|FG002|Overall Study|Study Termination by Sponsor|1|||
33406226|NCT03875313|62784676|FG003|Overall Study|Study Termination by Sponsor|0|||
33406227|NCT03875313|62784677|FG004|Overall Study|Study Termination by Sponsor|1|||
33406228|NCT03875313|62784673|FG000|Overall Study|New Anticancer Treatment|0|||
33406229|NCT03875313|62784674|FG001|Overall Study|New Anticancer Treatment|1|||
33406230|NCT03875313|62784675|FG002|Overall Study|New Anticancer Treatment|2|||
33406231|NCT03875313|62784676|FG003|Overall Study|New Anticancer Treatment|1|||
33406232|NCT03875313|62784677|FG004|Overall Study|New Anticancer Treatment|0|||
33406233|NCT03875313|62784673|FG000|Overall Study|Other, Not Specified|2|||
33406234|NCT03875313|62784674|FG001|Overall Study|Other, Not Specified|11|||
33406235|NCT03875313|62784675|FG002|Overall Study|Other, Not Specified|3|||
33406236|NCT03875313|62784676|FG003|Overall Study|Other, Not Specified|3|||
33406237|NCT03875313|62784677|FG004|Overall Study|Other, Not Specified|1|||
33406238|NCT00556998|62784689|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
33406239|NCT00556998|62784689|FG000|Voriconazole Intravenous (IV)|Other|4|||
33406240|NCT00556998|62784689|FG000|Voriconazole Oral|Adverse Event|1|||
33406241|NCT00556998|62784689|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
33406242|NCT00528801|62784699|FG000|Overall Study|Withdrawal by Subject|1|||
33406243|NCT00528801|62784700|FG001|Overall Study|Withdrawal by Subject|1|||
33406244|NCT00528801|62784699|FG000|Overall Study|Protocol Violation|11|||
33406245|NCT00528801|62784700|FG001|Overall Study|Protocol Violation|5|||
33406246|NCT00528801|62784699|FG000|Overall Study|Lost to Follow-up|15|||
33406247|NCT00528801|62784700|FG001|Overall Study|Lost to Follow-up|4|||
33406248|NCT00528801|62784699|FG000|Overall Study|Administrative Reasons|0|||
33406249|NCT00528801|62784700|FG001|Overall Study|Administrative Reasons|1|||
33406250|NCT00527397|62784706|FG000|Overall Study|Adverse Event|3|||
33406251|NCT00527397|62784706|FG000|Overall Study|Lack of Efficacy|1|||
33406252|NCT00527397|62784706|FG000|Overall Study|Protocol Violation|1|||
33406253|NCT00527397|62784706|FG000|Overall Study|Withdrawal by Subject|6|||
33406254|NCT00527397|62784706|FG000|Overall Study|Study terminated by sponsor|13|||
33406255|NCT00527319|62784716|FG000|Overall Study|Withdrawal by Subject|5|||
33406256|NCT00527319|62784717|FG001|Overall Study|Withdrawal by Subject|0|||
33406257|NCT00527319|62784718|FG002|Overall Study|Withdrawal by Subject|1|||
33406258|NCT00527319|62784716|FG000|Overall Study|Lost to Follow-up|1|||
33406259|NCT00527319|62784717|FG001|Overall Study|Lost to Follow-up|0|||
33406260|NCT00527319|62784718|FG002|Overall Study|Lost to Follow-up|0|||
33406261|NCT00527319|62784716|FG000|Overall Study|Death|0|||
33406262|NCT00527319|62784717|FG001|Overall Study|Death|3|||
33406263|NCT00527319|62784718|FG002|Overall Study|Death|1|||
33406264|NCT00527319|62784716|FG000|Overall Study|Intercurrent Medical Illness|0|||
33406265|NCT00527319|62784717|FG001|Overall Study|Intercurrent Medical Illness|1|||
33406266|NCT00527319|62784718|FG002|Overall Study|Intercurrent Medical Illness|3|||
33406267|NCT00527319|62784716|FG000|Overall Study|Adverse Event|0|||
33406268|NCT00527319|62784717|FG001|Overall Study|Adverse Event|0|||
33406269|NCT00527319|62784718|FG002|Overall Study|Adverse Event|1|||
33406270|NCT00562302|62784728|FG000|Overall Study|Lost to Follow-up|3|||
33406271|NCT00562302|62784729|FG001|Overall Study|Lost to Follow-up|3|||
33406272|NCT00562302|62784728|FG000|Overall Study|Adverse Event|0|||
33406273|NCT00562302|62784729|FG001|Overall Study|Adverse Event|6|||
33406274|NCT00562302|62784728|FG000|Overall Study|Non-compliance|1|||
33406275|NCT00562302|62784729|FG001|Overall Study|Non-compliance|2|||
33406276|NCT00562302|62784728|FG000|Overall Study|Withdrawal by Subject|7|||
33406277|NCT00562302|62784729|FG001|Overall Study|Withdrawal by Subject|8|||
33406278|NCT00562302|62784728|FG000|Overall Study|Death|1|||
33406279|NCT00562302|62784729|FG001|Overall Study|Death|2|||
33406280|NCT00562302|62784728|FG000|Overall Study|Lung resection prior to study completion|7|||
33406281|NCT00562302|62784729|FG001|Overall Study|Lung resection prior to study completion|7|||
33406282|NCT00562302|62784728|FG000|Overall Study|Not stated|1|||
33406283|NCT00562302|62784729|FG001|Overall Study|Not stated|4|||
33406284|NCT00134719|62784738|FG000|Primary Vaccination Phase|Adverse Event|4|||
33406285|NCT00134719|62784739|FG001|Primary Vaccination Phase|Adverse Event|0|||
33406286|NCT00134719|62784740|FG002|Primary Vaccination Phase|Adverse Event|0|||
33406287|NCT00134719|62784738|FG000|Primary Vaccination Phase|Protocol Violation|1|||
33406288|NCT00134719|62784739|FG001|Primary Vaccination Phase|Protocol Violation|0|||
33406289|NCT00134719|62784740|FG002|Primary Vaccination Phase|Protocol Violation|0|||
33406290|NCT00134719|62784738|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
33406291|NCT00134719|62784739|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
33406292|NCT00134719|62784740|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
33406293|NCT00134719|62784738|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
33406294|NCT00134719|62784739|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
33406295|NCT00134719|62784740|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
33406296|NCT00134719|62784738|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
33406297|NCT00134719|62784739|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
33406298|NCT00134719|62784740|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
33406299|NCT00134719|62784738|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
33406300|NCT00134719|62784739|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
33406301|NCT00134719|62784740|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
33406302|NCT00526071|62784748|FG000|Overall Study|Adverse Event|1|||
33406303|NCT00526071|62784748|FG000|Overall Study|Withdrawal by Subject|1|||
33406304|NCT00526071|62784748|FG000|Overall Study|Lack of Response to Study Drug|4|||
33406305|NCT00525915|62784758|FG000|Overall Study|Non-Compliance|0|||
33406306|NCT00525915|62784759|FG001|Overall Study|Non-Compliance|1|||
33406307|NCT00525915|62784758|FG000|Overall Study|Disease Progression|5|||
33406308|NCT00525915|62784759|FG001|Overall Study|Disease Progression|6|||
33406309|NCT00525915|62784758|FG000|Overall Study|Withdrawal by Subject|1|||
33406310|NCT00525915|62784759|FG001|Overall Study|Withdrawal by Subject|0|||
33406311|NCT00525915|62784758|FG000|Overall Study|Refused Surgery|1|||
33406312|NCT00525915|62784759|FG001|Overall Study|Refused Surgery|2|||
33406313|NCT00525915|62784758|FG000|Overall Study|Unrelated illness|1|||
33406314|NCT00525915|62784759|FG001|Overall Study|Unrelated illness|0|||
33406315|NCT00521079|62784767|FG000|Overall Study|Adverse Event|7|||
33406316|NCT00521079|62784768|FG001|Overall Study|Adverse Event|1|||
33406317|NCT00521079|62784767|FG000|Overall Study|Lost to Follow-up|2|||
33406318|NCT00521079|62784768|FG001|Overall Study|Lost to Follow-up|1|||
33406319|NCT00521079|62784767|FG000|Overall Study|Withdrawal by Subject|5|||
33406320|NCT00521079|62784768|FG001|Overall Study|Withdrawal by Subject|3|||
33406321|NCT00521001|62784774|FG000|Overall Study|Ineligible|1|||
33406322|NCT00134563|62784781|FG000|Overall Study|Not treated due to protocol violation|0|||
33406323|NCT00134563|62784782|FG001|Overall Study|Not treated due to protocol violation|1|||
33406324|NCT00134563|62784783|FG002|Overall Study|Not treated due to protocol violation|1|||
33406325|NCT00134563|62784781|FG000|Overall Study|Adverse Event|29|||
33406326|NCT00134563|62784782|FG001|Overall Study|Adverse Event|37|||
33406327|NCT00134563|62784783|FG002|Overall Study|Adverse Event|38|||
33406328|NCT00134563|62784781|FG000|Overall Study|Lack of Efficacy|24|||
33406329|NCT00134563|62784782|FG001|Overall Study|Lack of Efficacy|14|||
33406330|NCT00134563|62784783|FG002|Overall Study|Lack of Efficacy|17|||
33406331|NCT00134563|62784781|FG000|Overall Study|Protocol Violation|3|||
33406332|NCT00134563|62784782|FG001|Overall Study|Protocol Violation|2|||
33406333|NCT00134563|62784783|FG002|Overall Study|Protocol Violation|5|||
33406334|NCT00134563|62784781|FG000|Overall Study|Lost to Follow-up|4|||
33406335|NCT00134563|62784782|FG001|Overall Study|Lost to Follow-up|0|||
33406336|NCT00134563|62784783|FG002|Overall Study|Lost to Follow-up|2|||
33406337|NCT00134563|62784781|FG000|Overall Study|progressive disease|11|||
33406338|NCT00134563|62784782|FG001|Overall Study|progressive disease|4|||
33406339|NCT00134563|62784783|FG002|Overall Study|progressive disease|2|||
33406340|NCT00134563|62784781|FG000|Overall Study|did not wish to continue|33|||
33406341|NCT00134563|62784782|FG001|Overall Study|did not wish to continue|32|||
33406342|NCT00134563|62784783|FG002|Overall Study|did not wish to continue|26|||
33406343|NCT00134563|62784781|FG000|Overall Study|Reason other than above|0|||
33406344|NCT00134563|62784782|FG001|Overall Study|Reason other than above|2|||
33406345|NCT00134563|62784783|FG002|Overall Study|Reason other than above|5|||
33406346|NCT00520845|62784791|FG000|Overall Study|Death|3|||
33406347|NCT00520845|62784791|FG000|Overall Study|Adverse Event|4|||
33406348|NCT00520845|62784791|FG000|Overall Study|Disease Progression, relapse|13|||
33406349|NCT00520845|62784791|FG000|Overall Study|Withdrawal by Subject|1|||
33406350|NCT00520845|62784791|FG000|Overall Study|Alternative Therapy|1|||
33406351|NCT00185731|62784795|FG000|Overall Study|Withdrawal by Subject|1|||
33406352|NCT00185731|62784795|FG000|Overall Study|Not Eligible|1|||
33406353|NCT00582491|62784803|FG000|Overall Study|Withdrawal by Subject|1|||
33406354|NCT00582491|62784804|FG001|Overall Study|Withdrawal by Subject|0|||
33406355|NCT00520767|62784810|FG000|Overall Study|Death|2|||
33406356|NCT04679051|62784816|FG000|Overall Study|felt tired after restricted time in bed|3|||
33406357|NCT04679051|62784817|FG001|Overall Study|felt tired after restricted time in bed|0|||
33406358|NCT04679051|62784816|FG000|Overall Study|discomfort with blood pressure cuff|2|||
33406359|NCT04679051|62784817|FG001|Overall Study|discomfort with blood pressure cuff|0|||
33406360|NCT04679051|62784816|FG000|Overall Study|scheduling conflict|1|||
33406361|NCT04679051|62784817|FG001|Overall Study|scheduling conflict|1|||
33406362|NCT04679051|62784816|FG000|Overall Study|Protocol Violation|0|||
33406363|NCT04679051|62784817|FG001|Overall Study|Protocol Violation|4|||
33406364|NCT03873987|62784828|FG000|Overall Study|Adverse Event|1|||
33406365|NCT03873987|62784829|FG001|Overall Study|Adverse Event|0|||
33406366|NCT03873987|62784828|FG000|Overall Study|staff was unable to start a new IV line|1|||
33406367|NCT03873987|62784829|FG001|Overall Study|staff was unable to start a new IV line|0|||
33406368|NCT03873987|62784828|FG000|Overall Study|Lost to Follow-up|0|||
33406369|NCT03873987|62784829|FG001|Overall Study|Lost to Follow-up|1|||
33406370|NCT00474760|62784847|FG000|Overall Study|Death|0|||
33406371|NCT00474760|62784848|FG001|Overall Study|Death|0|||
33406372|NCT00474760|62784849|FG002|Overall Study|Death|0|||
33406373|NCT00474760|62784850|FG003|Overall Study|Death|0|||
33321052|NCT01209689|62696928|FG000|Overall Study|Failure to Return|3|||
33321053|NCT01209689|62696929|FG001|Overall Study|Failure to Return|0|||
33321054|NCT01209689|62696928|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
33321055|NCT01209689|62696929|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
33321056|NCT01209143|62696937|FG000|Overall Study|Adverse Event|2|||
33321057|NCT01209143|62696938|FG001|Overall Study|Adverse Event|1|||
33321058|NCT01209143|62696937|FG000|Overall Study|Death|0|||
33321059|NCT01209143|62696938|FG001|Overall Study|Death|1|||
33321060|NCT01209143|62696937|FG000|Overall Study|Physician Decision|3|||
33321061|NCT01209143|62696938|FG001|Overall Study|Physician Decision|1|||
33321062|NCT01209143|62696937|FG000|Overall Study|Lost to Follow-up|1|||
33321063|NCT01209143|62696938|FG001|Overall Study|Lost to Follow-up|0|||
33321064|NCT01209143|62696937|FG000|Overall Study|Withdrawal by Subject|2|||
33321065|NCT01209143|62696938|FG001|Overall Study|Withdrawal by Subject|1|||
33321066|NCT01209143|62696937|FG000|Overall Study|Disease progression|11|||
33321067|NCT01209143|62696938|FG001|Overall Study|Disease progression|16|||
33321068|NCT01023789|62696944|FG000|3 - Year Visit|Death|29|||
33321069|NCT01023789|62696944|FG000|3 - Year Visit|Withdrawal of consent|1|||
33321070|NCT01023789|62696944|FG000|3 - Year Visit|Lost to Follow-up|13|||
33321071|NCT01208207|62696951|FG000|Part I|Adverse Event|19|||
33321072|NCT01208207|62696952|FG001|Part I|Adverse Event|2|||
33321073|NCT01208207|62696953|FG002|Part I|Adverse Event|6|||
33321074|NCT01208207|62696954|FG003|Part I|Adverse Event|0|||
33321075|NCT01208207|62696955|FG004|Part I|Adverse Event|0|||
33321076|NCT01208207|62696956|FG005|Part I|Adverse Event|0|||
33321077|NCT01208207|62696957|FG006|Part I|Adverse Event|0|||
33321078|NCT01208207|62696951|FG000|Part I|Lack of Efficacy|21|||
33406374|NCT00474760|62784851|FG004|Overall Study|Death|2|||
33406375|NCT00474760|62784852|FG005|Overall Study|Death|0|||
33406376|NCT00474760|62784853|FG006|Overall Study|Death|0|||
33406377|NCT00474760|62784847|FG000|Overall Study|Adverse Event|0|||
33406378|NCT00474760|62784848|FG001|Overall Study|Adverse Event|0|||
33406379|NCT00474760|62784849|FG002|Overall Study|Adverse Event|0|||
33406380|NCT00474760|62784850|FG003|Overall Study|Adverse Event|0|||
33406381|NCT00474760|62784851|FG004|Overall Study|Adverse Event|1|||
33406382|NCT00474760|62784852|FG005|Overall Study|Adverse Event|7|||
33406383|NCT00474760|62784853|FG006|Overall Study|Adverse Event|0|||
33406384|NCT00474760|62784847|FG000|Overall Study|Laboratory abnormality|0|||
33406385|NCT00474760|62784848|FG001|Overall Study|Laboratory abnormality|0|||
33406386|NCT00474760|62784849|FG002|Overall Study|Laboratory abnormality|0|||
33406387|NCT00474760|62784850|FG003|Overall Study|Laboratory abnormality|0|||
33406388|NCT00474760|62784851|FG004|Overall Study|Laboratory abnormality|0|||
33406389|NCT00474760|62784852|FG005|Overall Study|Laboratory abnormality|1|||
33406390|NCT00474760|62784853|FG006|Overall Study|Laboratory abnormality|0|||
33406391|NCT00474760|62784847|FG000|Overall Study|Withdrawal by Subject|0|||
33406392|NCT00474760|62784848|FG001|Overall Study|Withdrawal by Subject|0|||
33406393|NCT00474760|62784849|FG002|Overall Study|Withdrawal by Subject|0|||
33406394|NCT00474760|62784850|FG003|Overall Study|Withdrawal by Subject|1|||
33406395|NCT00474760|62784851|FG004|Overall Study|Withdrawal by Subject|0|||
33406396|NCT00474760|62784852|FG005|Overall Study|Withdrawal by Subject|1|||
33406397|NCT00474760|62784853|FG006|Overall Study|Withdrawal by Subject|1|||
33406398|NCT00474760|62784847|FG000|Overall Study|Other|0|||
33406399|NCT00474760|62784848|FG001|Overall Study|Other|1|||
33406400|NCT00474760|62784849|FG002|Overall Study|Other|0|||
33406401|NCT00474760|62784850|FG003|Overall Study|Other|0|||
33406402|NCT00474760|62784851|FG004|Overall Study|Other|1|||
33406403|NCT00474760|62784852|FG005|Overall Study|Other|0|||
33406404|NCT00474760|62784853|FG006|Overall Study|Other|0|||
33406405|NCT00474760|62784847|FG000|Overall Study|Progressive disease|3|||
33406406|NCT00474760|62784848|FG001|Overall Study|Progressive disease|2|||
33406407|NCT00474760|62784849|FG002|Overall Study|Progressive disease|3|||
33406408|NCT00474760|62784850|FG003|Overall Study|Progressive disease|2|||
33406409|NCT00474760|62784851|FG004|Overall Study|Progressive disease|8|||
33406410|NCT00474760|62784852|FG005|Overall Study|Progressive disease|20|||
33406411|NCT00474760|62784853|FG006|Overall Study|Progressive disease|7|||
33406412|NCT00474760|62784847|FG000|Overall Study|Terminated by sponsor|0|||
33406413|NCT00474760|62784848|FG001|Overall Study|Terminated by sponsor|0|||
33406414|NCT00474760|62784849|FG002|Overall Study|Terminated by sponsor|0|||
33406415|NCT00474760|62784850|FG003|Overall Study|Terminated by sponsor|0|||
33406416|NCT00474760|62784851|FG004|Overall Study|Terminated by sponsor|0|||
33406417|NCT00474760|62784852|FG005|Overall Study|Terminated by sponsor|0|||
33406418|NCT00474760|62784853|FG006|Overall Study|Terminated by sponsor|2|||
33406419|NCT00528645|62784876|FG000|Overall Study|Adverse Event|3|||
33406420|NCT00524745|62784885|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
33406421|NCT00524745|62784886|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
33406422|NCT00524745|62784887|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
33406423|NCT00524745|62784888|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
33406424|NCT00495040|62784898|FG000|Overall Study|Withdrawal by Subject|3|||
33406425|NCT00494026|62784906|FG000|Overall Study|Sponsor Decision|4|||
33406426|NCT00524589|62784910|FG000|Overall Study|Withdrawal by Subject|2|||
33406427|NCT00524589|62784910|FG000|Overall Study|Disease Progression|16|||
33406428|NCT00472030|62784916|FG000|Overall Study|Physician Decision|1|||
33406429|NCT00472030|62784917|FG001|Overall Study|Physician Decision|0|||
33406430|NCT00127855|62784932|FG000|Primary Vaccination Course|Adverse Event|0|||
33406431|NCT00127855|62784933|FG001|Primary Vaccination Course|Adverse Event|0|||
33598425|NCT01646827|62997266|FG000|Overall Study|Lost to Follow-up|0|||
33406432|NCT00127855|62784934|FG002|Primary Vaccination Course|Adverse Event|1|||
33406433|NCT00127855|62784935|FG003|Primary Vaccination Course|Adverse Event|0|||
33406434|NCT00127855|62784936|FG004|Primary Vaccination Course|Adverse Event|0|||
33406435|NCT00127855|62784932|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
33406436|NCT00127855|62784933|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
33406437|NCT00127855|62784934|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
33406438|NCT00127855|62784935|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
33406439|NCT00127855|62784936|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
33406440|NCT00127855|62784932|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
33406441|NCT00127855|62784933|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
33406442|NCT00127855|62784934|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
33406443|NCT00127855|62784935|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
33406444|NCT00127855|62784936|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
33406445|NCT00127855|62784932|FG000|Primary Vaccination Course|Other|0|||
33406446|NCT00127855|62784933|FG001|Primary Vaccination Course|Other|0|||
33406447|NCT00127855|62784934|FG002|Primary Vaccination Course|Other|0|||
33406448|NCT00127855|62784935|FG003|Primary Vaccination Course|Other|0|||
33406449|NCT00127855|62784936|FG004|Primary Vaccination Course|Other|1|||
33406450|NCT00493636|62784950|FG000|Overall Study|Withdrawal by Subject|1|||
33406451|NCT00493636|62784951|FG001|Overall Study|Withdrawal by Subject|0|||
33406452|NCT00493636|62784950|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
33406453|NCT00493636|62784951|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
33406454|NCT00493636|62784950|FG000|Overall Study|Mis-randomization|1|||
33406455|NCT00493636|62784951|FG001|Overall Study|Mis-randomization|1|||
33406456|NCT00524121|62784957|FG000|Overall Study|Disease progression|6|||
33406457|NCT00524121|62784957|FG000|Overall Study|Adverse Event|4|||
33406458|NCT00524121|62784957|FG000|Overall Study|Patient refused|2|||
33406459|NCT00524121|62784957|FG000|Overall Study|Other|1|||
33406460|NCT00524121|62784957|FG000|Overall Study|Death|1|||
33406461|NCT00524121|62784957|FG000|Overall Study|Not treated (became ineligible)|4|||
33406462|NCT00524121|62784957|FG000|Overall Study|Not treated (changed mind)|1|||
33406463|NCT00470626|62784972|FG000|Overall Study|Lost to Follow-up|10|||
33406464|NCT00470626|62784972|FG000|Overall Study|Withdrawal by Subject|7|||
33406465|NCT00132769|62784978|FG000|Overall Study|Withdrawal by Subject|1|||
33406466|NCT00132769|62784979|FG001|Overall Study|Withdrawal by Subject|3|||
33406467|NCT00132769|62784978|FG000|Overall Study|Lack of Efficacy|7|||
33406468|NCT00132769|62784979|FG001|Overall Study|Lack of Efficacy|6|||
33406469|NCT00132769|62784978|FG000|Overall Study|Adverse Event|2|||
33406470|NCT00132769|62784979|FG001|Overall Study|Adverse Event|1|||
33406471|NCT00132769|62784978|FG000|Overall Study|Protocol Violation|1|||
33406472|NCT00132769|62784979|FG001|Overall Study|Protocol Violation|1|||
33406473|NCT00520299|62784988|FG000|Overall Study|Withdrawal by Subject|0|||
33406474|NCT00520299|62784989|FG001|Overall Study|Withdrawal by Subject|0|||
33406475|NCT00520299|62784990|FG002|Overall Study|Withdrawal by Subject|2|||
33406476|NCT00520299|62784988|FG000|Overall Study|Progressive disease|0|||
33406477|NCT00520299|62784989|FG001|Overall Study|Progressive disease|3|||
33406478|NCT00520299|62784990|FG002|Overall Study|Progressive disease|4|||
33406479|NCT02478255|62785000|FG000|Overall Study|Physician Decision|6|||
33406480|NCT02478255|62785001|FG001|Overall Study|Physician Decision|0|||
33406481|NCT02478255|62785000|FG000|Overall Study|Withdrawal by Subject|2|||
33406482|NCT02478255|62785001|FG001|Overall Study|Withdrawal by Subject|0|||
33406483|NCT00132691|62785009|FG000|Overall Study|Lost to Follow-up|5|||
33406484|NCT00132691|62785010|FG001|Overall Study|Lost to Follow-up|8|||
33406485|NCT00132691|62785009|FG000|Overall Study|Missed 2-year visit|4|||
33406486|NCT00132691|62785010|FG001|Overall Study|Missed 2-year visit|4|||
33406487|NCT00132691|62785009|FG000|Overall Study|Death|2|||
33406488|NCT00132691|62785010|FG001|Overall Study|Death|0|||
33406489|NCT00125359|62785021|FG000|Overall Study|Death|4|||
33406490|NCT00125359|62785021|FG000|Overall Study|Adverse Event|5|||
33406491|NCT00125359|62785021|FG000|Overall Study|Physician Decision|14|||
33406492|NCT00524043|62785028|FG000|Overall Study|Lack of Efficacy|15|||
33406493|NCT00524043|62785029|FG001|Overall Study|Lack of Efficacy|13|||
33406494|NCT00524043|62785030|FG002|Overall Study|Lack of Efficacy|14|||
33406495|NCT00524043|62785028|FG000|Overall Study|Withdrawal by Subject|5|||
33406496|NCT00524043|62785029|FG001|Overall Study|Withdrawal by Subject|7|||
33406497|NCT00524043|62785030|FG002|Overall Study|Withdrawal by Subject|7|||
33406498|NCT00524043|62785028|FG000|Overall Study|Adverse Event|5|||
33406499|NCT00524043|62785029|FG001|Overall Study|Adverse Event|2|||
33406500|NCT00524043|62785030|FG002|Overall Study|Adverse Event|7|||
33406501|NCT00524043|62785028|FG000|Overall Study|Lost to Follow-up|3|||
33406502|NCT00524043|62785029|FG001|Overall Study|Lost to Follow-up|5|||
33406503|NCT00524043|62785030|FG002|Overall Study|Lost to Follow-up|3|||
33406504|NCT00524043|62785028|FG000|Overall Study|Various (eg, incarceration)|2|||
33406505|NCT00524043|62785029|FG001|Overall Study|Various (eg, incarceration)|1|||
33406506|NCT00524043|62785030|FG002|Overall Study|Various (eg, incarceration)|0|||
33406507|NCT00523419|62785038|FG000|Overall Study|Adverse Event|1|||
33406508|NCT00523419|62785038|FG000|Overall Study|Withdrawal by Subject|1|||
33406509|NCT00523419|62785038|FG000|Overall Study|Physician Decision|2|||
33406510|NCT00523419|62785038|FG000|Overall Study|Progressive Disease|22|||
33406511|NCT00523419|62785038|FG000|Overall Study|Death due to Study Disease|4|||
33406512|NCT00523419|62785038|FG000|Overall Study|Death due to Adverse Event|2|||
33406513|NCT03868059|62785042|FG000|Overall Study|Adverse Event|3|||
33406514|NCT03868059|62785042|FG000|Overall Study|Lost to Follow-up|3|||
33406515|NCT03868059|62785042|FG000|Overall Study|Withdrawal by Subject|6|||
33406516|NCT00522951|62785046|FG000|Period 1|body motion|0|||
33406517|NCT00522951|62785047|FG001|Period 1|body motion|1|||
33406518|NCT00522951|62785046|FG000|Washout Period|Adverse Event|0|||
33406519|NCT00522951|62785047|FG001|Washout Period|Adverse Event|1|||
33406520|NCT00522951|62785046|FG000|Washout Period|Death|0|||
33406521|NCT00522951|62785047|FG001|Washout Period|Death|1|||
33406522|NCT00522951|62785046|FG000|Period 2|Withdrawal by Subject|1|||
33406523|NCT00522951|62785047|FG001|Period 2|Withdrawal by Subject|0|||
33406524|NCT00522951|62785046|FG000|Period 2|residual contrast medium|1|||
33321079|NCT01208207|62696952|FG001|Part I|Lack of Efficacy|3|||
33321080|NCT01208207|62696953|FG002|Part I|Lack of Efficacy|2|||
33321081|NCT01208207|62696954|FG003|Part I|Lack of Efficacy|0|||
33321082|NCT01208207|62696955|FG004|Part I|Lack of Efficacy|0|||
33321083|NCT01208207|62696956|FG005|Part I|Lack of Efficacy|0|||
33321084|NCT01208207|62696957|FG006|Part I|Lack of Efficacy|0|||
33321085|NCT01208207|62696951|FG000|Part I|Lost to Follow-up|6|||
33321086|NCT01208207|62696952|FG001|Part I|Lost to Follow-up|1|||
33321087|NCT01208207|62696953|FG002|Part I|Lost to Follow-up|0|||
33321088|NCT01208207|62696954|FG003|Part I|Lost to Follow-up|0|||
33321089|NCT01208207|62696955|FG004|Part I|Lost to Follow-up|0|||
33321090|NCT01208207|62696956|FG005|Part I|Lost to Follow-up|0|||
33321091|NCT01208207|62696957|FG006|Part I|Lost to Follow-up|0|||
33321092|NCT01208207|62696951|FG000|Part I|Non-Compliance With Study Drug|1|||
33321093|NCT01208207|62696952|FG001|Part I|Non-Compliance With Study Drug|0|||
33406525|NCT00522951|62785047|FG001|Period 2|residual contrast medium|1|||
33406526|NCT03865953|62785059|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
33321094|NCT01208207|62696953|FG002|Part I|Non-Compliance With Study Drug|1|||
33598426|NCT01646827|62997267|FG001|Overall Study|Lost to Follow-up|3|||
33406527|NCT03865953|62785060|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
33406528|NCT03865953|62785059|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
33406529|NCT03865953|62785060|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
33406530|NCT03865953|62785059|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
33406531|NCT03865953|62785060|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
33406532|NCT05439941|62785069|FG000|Overall Study|Lack of Efficacy|8|||
33406533|NCT05439941|62785070|FG001|Overall Study|Lack of Efficacy|5|||
33406534|NCT05439941|62785071|FG002|Overall Study|Lack of Efficacy|3|||
33406535|NCT05439941|62785069|FG000|Overall Study|Treatment Failure|0|||
33406536|NCT05439941|62785070|FG001|Overall Study|Treatment Failure|1|||
33406537|NCT05439941|62785071|FG002|Overall Study|Treatment Failure|0|||
33406538|NCT05439941|62785069|FG000|Overall Study|Adverse Event|1|||
33406539|NCT05439941|62785070|FG001|Overall Study|Adverse Event|3|||
33406540|NCT05439941|62785071|FG002|Overall Study|Adverse Event|0|||
33406541|NCT05439941|62785069|FG000|Overall Study|Adverse Event - Parent Study|1|||
33406542|NCT05439941|62785070|FG001|Overall Study|Adverse Event - Parent Study|0|||
33406543|NCT05439941|62785071|FG002|Overall Study|Adverse Event - Parent Study|0|||
33406544|NCT05439941|62785069|FG000|Overall Study|Pregnancy|1|||
33406545|NCT05439941|62785070|FG001|Overall Study|Pregnancy|0|||
33406546|NCT05439941|62785071|FG002|Overall Study|Pregnancy|0|||
33406547|NCT05439941|62785069|FG000|Overall Study|Withdrawal by Subject|9|||
33406548|NCT05439941|62785070|FG001|Overall Study|Withdrawal by Subject|6|||
33406549|NCT05439941|62785071|FG002|Overall Study|Withdrawal by Subject|10|||
33406550|NCT05439941|62785069|FG000|Overall Study|Non-Compliance|1|||
33406551|NCT05439941|62785070|FG001|Overall Study|Non-Compliance|1|||
33406552|NCT05439941|62785071|FG002|Overall Study|Non-Compliance|1|||
33406553|NCT05439941|62785069|FG000|Overall Study|Lost to Follow-up|2|||
33406554|NCT05439941|62785070|FG001|Overall Study|Lost to Follow-up|2|||
33406555|NCT05439941|62785071|FG002|Overall Study|Lost to Follow-up|0|||
33406556|NCT05439941|62785069|FG000|Overall Study|Physician Decision|1|||
33406557|NCT05439941|62785070|FG001|Overall Study|Physician Decision|0|||
33406558|NCT05439941|62785071|FG002|Overall Study|Physician Decision|0|||
33406559|NCT05439941|62785069|FG000|Overall Study|Trial Termination by Sponsor|78|||
33406560|NCT05439941|62785070|FG001|Overall Study|Trial Termination by Sponsor|83|||
33406561|NCT05439941|62785071|FG002|Overall Study|Trial Termination by Sponsor|65|||
33406562|NCT05439941|62785069|FG000|Overall Study|Other than Reasons Listed|2|||
33406563|NCT05439941|62785070|FG001|Overall Study|Other than Reasons Listed|1|||
33406564|NCT05439941|62785071|FG002|Overall Study|Other than Reasons Listed|0|||
33406565|NCT05091918|62785079|FG000|Overall Study|Adverse Event|1|||
33406566|NCT05091918|62785079|FG000|Overall Study|Withdrawal by Subject|81|||
33406567|NCT04912895|62785086|FG000|Overall Study|Unable to provide specimen|2|||
33406568|NCT04912895|62785087|FG001|Overall Study|Unable to provide specimen|0|||
33406569|NCT04912895|62785088|FG002|Overall Study|Unable to provide specimen|0|||
33406570|NCT04776720|62785096|FG000|Overall Study|COVID Related|4|||
33406571|NCT04776720|62785097|FG001|Overall Study|COVID Related|2|||
33406572|NCT04776720|62785096|FG000|Overall Study|Adverse Event|2|||
33406573|NCT04776720|62785097|FG001|Overall Study|Adverse Event|0|||
33406574|NCT04776720|62785096|FG000|Overall Study|Serious Adverse Event|0|||
33406575|NCT04776720|62785097|FG001|Overall Study|Serious Adverse Event|1|||
33406576|NCT04776720|62785096|FG000|Overall Study|Too Busy|3|||
33406577|NCT04776720|62785097|FG001|Overall Study|Too Busy|1|||
33406578|NCT04776720|62785096|FG000|Overall Study|Lost to Follow-up|1|||
33406579|NCT04776720|62785097|FG001|Overall Study|Lost to Follow-up|2|||
33406580|NCT04776720|62785096|FG000|Overall Study|Family|2|||
33406581|NCT04776720|62785097|FG001|Overall Study|Family|2|||
33406582|NCT04776720|62785096|FG000|Overall Study|No remote technology access|0|||
33406583|NCT04776720|62785097|FG001|Overall Study|No remote technology access|1|||
33406584|NCT04776720|62785096|FG000|Overall Study|Withdrawal by Subject|1|||
33406585|NCT04776720|62785097|FG001|Overall Study|Withdrawal by Subject|0|||
33406586|NCT04776720|62785096|FG000|Overall Study|Cannot tolerate intervention|1|||
33406587|NCT04776720|62785097|FG001|Overall Study|Cannot tolerate intervention|0|||
33406588|NCT04776720|62785096|FG000|Overall Study|Incomplete outcome data|6|||
33406589|NCT04776720|62785097|FG001|Overall Study|Incomplete outcome data|1|||
33406590|NCT04675151|62785116|FG000|Overall Study|Protocol Violation|1|||
33406591|NCT04675151|62785117|FG001|Overall Study|Protocol Violation|0|||
33406592|NCT04675151|62785118|FG002|Overall Study|Protocol Violation|0|||
33406593|NCT04675151|62785119|FG003|Overall Study|Protocol Violation|1|||
33406594|NCT04599907|62785132|FG000|Overall Study|Withdrawal by Subject|1|||
33406595|NCT04599907|62785133|FG001|Overall Study|Withdrawal by Subject|7|||
33406596|NCT04599907|62785134|FG002|Overall Study|Withdrawal by Subject|6|||
33406597|NCT04599907|62785132|FG000|Overall Study|Lost to Follow-up|0|||
33406598|NCT04599907|62785133|FG001|Overall Study|Lost to Follow-up|1|||
33406599|NCT04599907|62785134|FG002|Overall Study|Lost to Follow-up|0|||
33406600|NCT04503096|62785157|FG000|Overall Study|Withdrawal by Subject|3|||
33406601|NCT04270760|62785166|FG000|Overall Study|Withdrawal by Subject|0|||
33406602|NCT04270760|62785167|FG001|Overall Study|Withdrawal by Subject|1|||
33406603|NCT04270760|62785168|FG002|Overall Study|Withdrawal by Subject|3|||
33406604|NCT04270760|62785169|FG003|Overall Study|Withdrawal by Subject|0|||
33406605|NCT04270760|62785170|FG004|Overall Study|Withdrawal by Subject|0|||
33406606|NCT04270760|62785166|FG000|Overall Study|Lost to Follow-up|1|||
33406607|NCT04270760|62785167|FG001|Overall Study|Lost to Follow-up|2|||
33406608|NCT04270760|62785168|FG002|Overall Study|Lost to Follow-up|1|||
33406609|NCT04270760|62785169|FG003|Overall Study|Lost to Follow-up|0|||
33406610|NCT04270760|62785170|FG004|Overall Study|Lost to Follow-up|0|||
33406611|NCT04270760|62785166|FG000|Overall Study|Death|0|||
33406612|NCT04270760|62785167|FG001|Overall Study|Death|0|||
33406613|NCT04270760|62785168|FG002|Overall Study|Death|0|||
33406614|NCT04270760|62785169|FG003|Overall Study|Death|0|||
33406615|NCT04270760|62785170|FG004|Overall Study|Death|1|||
33406616|NCT04198363|62785189|FG000|Overall Study|Adverse Event|1|||
33406617|NCT04198363|62785190|FG001|Overall Study|Adverse Event|1|||
33406618|NCT04198363|62785189|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
33406619|NCT04198363|62785190|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
33493965|NCT00089791|62872550|FG000|Overall Study|Ineligibility determined|12|||
33493966|NCT00089791|62872551|FG001|Overall Study|Ineligibility determined|9|||
33406620|NCT04198363|62785189|FG000|Overall Study|Reason not Specified|1|||
33406621|NCT04198363|62785190|FG001|Overall Study|Reason not Specified|0|||
33406622|NCT04173247|62785198|FG000|Overall Study|Withdrawal by Subject|0|||
33406623|NCT04173247|62785199|FG001|Overall Study|Withdrawal by Subject|2|||
33406624|NCT04173247|62785198|FG000|Overall Study|Death|1|||
33406625|NCT04173247|62785199|FG001|Overall Study|Death|0|||
33406626|NCT04173247|62785198|FG000|Overall Study|Physician Decision|1|||
33406627|NCT04173247|62785199|FG001|Overall Study|Physician Decision|0|||
33406628|NCT04099251|62785207|FG000|Pre-Treatment|Other reasons|1|||
33406629|NCT04099251|62785208|FG001|Pre-Treatment|Other reasons|0|||
33406630|NCT04099251|62785207|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
33406631|NCT04099251|62785208|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
33406632|NCT04099251|62785207|FG000|Blinded Treatment Phase|Other reasons|16|||
33406633|NCT04099251|62785208|FG001|Blinded Treatment Phase|Other reasons|7|||
33406634|NCT04099251|62785207|FG000|Blinded Treatment Phase|Disease recurrence|26|||
33406635|NCT04099251|62785208|FG001|Blinded Treatment Phase|Disease recurrence|41|||
33406636|NCT04099251|62785207|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
33406637|NCT04099251|62785208|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
33406638|NCT04099251|62785207|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
33406639|NCT04099251|62785208|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
33406640|NCT04099251|62785207|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
33406641|NCT04099251|62785208|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
33406642|NCT04099251|62785207|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
33406643|NCT04099251|62785208|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
33406644|NCT04099251|62785207|FG000|Blinded Treatment Phase|Death|6|||
33406645|NCT04099251|62785208|FG001|Blinded Treatment Phase|Death|2|||
33406646|NCT04099251|62785207|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
33406647|NCT04099251|62785208|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
33406648|NCT04099251|62785207|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
33406649|NCT04099251|62785208|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
33406650|NCT04099251|62785207|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
33406651|NCT04099251|62785208|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
33406652|NCT04099251|62785207|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
33406653|NCT04099251|62785208|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
33406654|NCT04099251|62785207|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
33406655|NCT04099251|62785208|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
33406656|NCT04099251|62785207|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
33406657|NCT04099251|62785208|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
33406658|NCT04099251|62785207|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
33406659|NCT04099251|62785208|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
33406660|NCT04099251|62785207|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
33406661|NCT04099251|62785208|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
33406662|NCT04099251|62785207|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
33406663|NCT04099251|62785208|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
33406664|NCT03943446|62785222|FG000|Overall Study|Lost to Follow-up|0|||
33406665|NCT03943446|62785223|FG001|Overall Study|Lost to Follow-up|0|||
33406666|NCT03943446|62785224|FG002|Overall Study|Lost to Follow-up|1|||
33406667|NCT03943446|62785222|FG000|Overall Study|Withdrawal by Subject|1|||
33406668|NCT03943446|62785223|FG001|Overall Study|Withdrawal by Subject|1|||
33406669|NCT03943446|62785224|FG002|Overall Study|Withdrawal by Subject|2|||
33406670|NCT03943446|62785222|FG000|Overall Study|Study Terminated by Sponsor|1|||
33406671|NCT03943446|62785223|FG001|Overall Study|Study Terminated by Sponsor|2|||
33406672|NCT03943446|62785224|FG002|Overall Study|Study Terminated by Sponsor|1|||
33406673|NCT03943446|62785222|FG000|Overall Study|Reason not Specified|5|||
33406674|NCT03943446|62785223|FG001|Overall Study|Reason not Specified|1|||
33406675|NCT03943446|62785224|FG002|Overall Study|Reason not Specified|3|||
33406676|NCT03875235|62785293|FG000|Overall Study|Ongoing study treatment|63|||
33406677|NCT03875235|62785294|FG001|Overall Study|Ongoing study treatment|20|||
33406678|NCT03875235|62785293|FG000|Overall Study|Off treatment|77|||
33406679|NCT03875235|62785294|FG001|Overall Study|Off treatment|91|||
33406680|NCT03875235|62785293|FG000|Overall Study|Withdrawal by Subject|3|||
33406681|NCT03875235|62785294|FG001|Overall Study|Withdrawal by Subject|10|||
33406682|NCT03875235|62785293|FG000|Overall Study|Death|198|||
33406683|NCT03875235|62785294|FG001|Overall Study|Death|223|||
33406684|NCT03710161|62785302|FG000|Overall Study|Study halted due to COVID pandemic|3|||
33406685|NCT03710161|62785303|FG001|Overall Study|Study halted due to COVID pandemic|2|||
33406686|NCT03632993|62785319|FG000|Overall Study|Withdrawal by Subject|1|||
33406687|NCT03632993|62785320|FG001|Overall Study|Withdrawal by Subject|0|||
33406688|NCT03632993|62785321|FG002|Overall Study|Withdrawal by Subject|0|||
33406689|NCT03632993|62785322|FG003|Overall Study|Withdrawal by Subject|0|||
33406690|NCT03632993|62785323|FG004|Overall Study|Withdrawal by Subject|0|||
33406691|NCT03632993|62785324|FG005|Overall Study|Withdrawal by Subject|0|||
33406692|NCT03632993|62785325|FG006|Overall Study|Withdrawal by Subject|0|||
33406693|NCT03632993|62785326|FG007|Overall Study|Withdrawal by Subject|0|||
33321095|NCT01208207|62696954|FG003|Part I|Non-Compliance With Study Drug|0|||
33321096|NCT01208207|62696955|FG004|Part I|Non-Compliance With Study Drug|0|||
33321097|NCT01208207|62696956|FG005|Part I|Non-Compliance With Study Drug|0|||
33321098|NCT01208207|62696957|FG006|Part I|Non-Compliance With Study Drug|0|||
33321099|NCT01208207|62696951|FG000|Part I|Physician Decision|0|||
33321100|NCT01208207|62696952|FG001|Part I|Physician Decision|1|||
33321101|NCT01208207|62696953|FG002|Part I|Physician Decision|0|||
33321102|NCT01208207|62696954|FG003|Part I|Physician Decision|0|||
33321103|NCT01208207|62696955|FG004|Part I|Physician Decision|0|||
33321104|NCT01208207|62696956|FG005|Part I|Physician Decision|0|||
33406694|NCT03632993|62785327|FG008|Overall Study|Withdrawal by Subject|0|||
33406695|NCT03632993|62785328|FG009|Overall Study|Withdrawal by Subject|1|||
33406696|NCT03632993|62785319|FG000|Overall Study|Protocol Non-compliance|0|||
33493967|NCT00089791|62872550|FG000|Overall Study|Lost to Follow-up|57|||
33493968|NCT00089791|62872551|FG001|Overall Study|Lost to Follow-up|57|||
33321105|NCT01208207|62696957|FG006|Part I|Physician Decision|0|||
33406697|NCT03632993|62785320|FG001|Overall Study|Protocol Non-compliance|1|||
33493969|NCT00089791|62872550|FG000|Overall Study|Noncompliance|17|||
33406698|NCT03632993|62785321|FG002|Overall Study|Protocol Non-compliance|0|||
33406699|NCT03632993|62785322|FG003|Overall Study|Protocol Non-compliance|0|||
33406700|NCT03632993|62785323|FG004|Overall Study|Protocol Non-compliance|0|||
33406701|NCT03632993|62785324|FG005|Overall Study|Protocol Non-compliance|0|||
33406702|NCT03632993|62785325|FG006|Overall Study|Protocol Non-compliance|0|||
33406703|NCT03632993|62785326|FG007|Overall Study|Protocol Non-compliance|0|||
33406704|NCT03632993|62785327|FG008|Overall Study|Protocol Non-compliance|0|||
33406705|NCT03632993|62785328|FG009|Overall Study|Protocol Non-compliance|0|||
33406706|NCT03632993|62785319|FG000|Overall Study|Lost to Follow-up|0|||
33406707|NCT03632993|62785320|FG001|Overall Study|Lost to Follow-up|0|||
33406708|NCT03632993|62785321|FG002|Overall Study|Lost to Follow-up|0|||
33406709|NCT03632993|62785322|FG003|Overall Study|Lost to Follow-up|0|||
33406710|NCT03632993|62785323|FG004|Overall Study|Lost to Follow-up|0|||
33406711|NCT03632993|62785324|FG005|Overall Study|Lost to Follow-up|1|||
33406712|NCT03632993|62785325|FG006|Overall Study|Lost to Follow-up|0|||
33406713|NCT03632993|62785326|FG007|Overall Study|Lost to Follow-up|1|||
33406714|NCT03632993|62785327|FG008|Overall Study|Lost to Follow-up|0|||
33406715|NCT03632993|62785328|FG009|Overall Study|Lost to Follow-up|0|||
33406716|NCT03632993|62785319|FG000|Overall Study|Adverse Event|0|||
33406717|NCT03632993|62785320|FG001|Overall Study|Adverse Event|0|||
33406718|NCT03632993|62785321|FG002|Overall Study|Adverse Event|0|||
33406719|NCT03632993|62785322|FG003|Overall Study|Adverse Event|0|||
33406720|NCT03632993|62785323|FG004|Overall Study|Adverse Event|0|||
33406721|NCT03632993|62785324|FG005|Overall Study|Adverse Event|1|||
33406722|NCT03632993|62785325|FG006|Overall Study|Adverse Event|0|||
33406723|NCT03632993|62785326|FG007|Overall Study|Adverse Event|1|||
33406724|NCT03632993|62785327|FG008|Overall Study|Adverse Event|0|||
33406725|NCT03632993|62785328|FG009|Overall Study|Adverse Event|0|||
33406726|NCT03568461|62785350|FG000|Overall Study|Death|7|||
33406727|NCT03568461|62785350|FG000|Overall Study|Physician Decision|5|||
33406728|NCT03568461|62785350|FG000|Overall Study|Subject decision|5|||
33406729|NCT03568461|62785350|FG000|Overall Study|Lost to Follow-up|1|||
33406730|NCT03511664|62785356|FG000|Overall Study|Treatment ongoing|49|||
33406731|NCT03511664|62785357|FG001|Overall Study|Treatment ongoing|5|||
33406732|NCT03511664|62785356|FG000|Overall Study|Entered long-term follow-up|140|||
33406733|NCT03511664|62785357|FG001|Overall Study|Entered long-term follow-up|50|||
33406734|NCT03511664|62785356|FG000|Overall Study|Withdrawal by Subject|29|||
33406735|NCT03511664|62785357|FG001|Overall Study|Withdrawal by Subject|53|||
33406736|NCT03511664|62785356|FG000|Overall Study|Lost to Follow-up|4|||
33406737|NCT03511664|62785357|FG001|Overall Study|Lost to Follow-up|4|||
33406738|NCT03511664|62785356|FG000|Overall Study|Physician Decision|0|||
33406739|NCT03511664|62785357|FG001|Overall Study|Physician Decision|1|||
33406740|NCT03493282|62785366|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
33406741|NCT03493282|62785367|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
33406742|NCT03493282|62785368|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
33406743|NCT03493282|62785366|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
33406744|NCT03493282|62785367|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
33406745|NCT03493282|62785368|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
33598427|NCT01646827|62997266|FG000|Overall Study|Physician Decision|1|||
33598428|NCT01646827|62997267|FG001|Overall Study|Physician Decision|2|||
33598429|NCT01646827|62997266|FG000|Overall Study|Withdrawal by Subject|1|||
33598430|NCT01646827|62997267|FG001|Overall Study|Withdrawal by Subject|0|||
33598431|NCT02293837|62997277|FG000|Overall Study|Lost to Follow-up|0|||
33598432|NCT02293837|62997278|FG001|Overall Study|Lost to Follow-up|2|||
33598433|NCT02293837|62997279|FG002|Overall Study|Lost to Follow-up|1|||
33598434|NCT02293837|62997280|FG003|Overall Study|Lost to Follow-up|0|||
33598435|NCT02293837|62997277|FG000|Overall Study|Withdrawal by Subject|2|||
33598436|NCT02293837|62997278|FG001|Overall Study|Withdrawal by Subject|1|||
33598437|NCT02293837|62997279|FG002|Overall Study|Withdrawal by Subject|2|||
33598438|NCT02293837|62997280|FG003|Overall Study|Withdrawal by Subject|1|||
33598439|NCT02293837|62997277|FG000|Overall Study|COVID-19 Related|1|||
33598440|NCT02293837|62997278|FG001|Overall Study|COVID-19 Related|1|||
33598441|NCT02293837|62997279|FG002|Overall Study|COVID-19 Related|0|||
33598442|NCT02293837|62997280|FG003|Overall Study|COVID-19 Related|0|||
33598443|NCT02293837|62997277|FG000|Overall Study|Participant ill and could not be infused|0|||
33598444|NCT02293837|62997278|FG001|Overall Study|Participant ill and could not be infused|0|||
33598445|NCT02293837|62997279|FG002|Overall Study|Participant ill and could not be infused|1|||
33598446|NCT02293837|62997280|FG003|Overall Study|Participant ill and could not be infused|0|||
33598447|NCT02361307|62997296|FG000|Overall Study|Unstable medical condition.|0|||
33598448|NCT02361307|62997297|FG001|Overall Study|Unstable medical condition.|1|||
33598449|NCT02320903|62997306|FG000|Overall Study|Withdrawal by Subject|0|||
33598450|NCT02320903|62997307|FG001|Overall Study|Withdrawal by Subject|9|||
33598451|NCT02320903|62997308|FG002|Overall Study|Withdrawal by Subject|9|||
33598452|NCT02320903|62997306|FG000|Overall Study|Exited therapy; no longer eligible|8|||
33598453|NCT02320903|62997307|FG001|Overall Study|Exited therapy; no longer eligible|2|||
33598454|NCT02320903|62997308|FG002|Overall Study|Exited therapy; no longer eligible|2|||
33598455|NCT02320903|62997306|FG000|Overall Study|Lost to Follow-up|0|||
33598456|NCT02320903|62997307|FG001|Overall Study|Lost to Follow-up|5|||
33598457|NCT02320903|62997308|FG002|Overall Study|Lost to Follow-up|5|||
33598458|NCT02320123|62997319|FG000|Overall Study|Lost to Follow-up|4|||
33598459|NCT02320123|62997320|FG001|Overall Study|Lost to Follow-up|6|||
33598460|NCT02320123|62997319|FG000|Overall Study|Death|6|||
33598461|NCT02320123|62997320|FG001|Overall Study|Death|5|||
33598462|NCT02360995|62997333|FG000|Overall Study|Lost to Follow-up|2|||
33598463|NCT02360995|62997334|FG001|Overall Study|Lost to Follow-up|0|||
33598464|NCT02360995|62997335|FG002|Overall Study|Lost to Follow-up|2|||
33598465|NCT02360995|62997333|FG000|Overall Study|Withdrawal by Subject|0|||
33598466|NCT02360995|62997334|FG001|Overall Study|Withdrawal by Subject|1|||
33598467|NCT02360995|62997335|FG002|Overall Study|Withdrawal by Subject|0|||
33598468|NCT02360605|62997345|FG000|Overall Study|Withdrawal by Subject|4|||
33598469|NCT02360605|62997346|FG001|Overall Study|Withdrawal by Subject|9|||
33598470|NCT02360605|62997345|FG000|Overall Study|Lost to Follow-up|7|||
33598471|NCT02360605|62997346|FG001|Overall Study|Lost to Follow-up|8|||
33598472|NCT02360605|62997345|FG000|Overall Study|Death|0|||
33598473|NCT02360605|62997346|FG001|Overall Study|Death|1|||
33598474|NCT02360293|62997356|FG000|Overall Study|Lost to Follow-up|73|||
33598475|NCT02360293|62997357|FG001|Overall Study|Lost to Follow-up|95|||
33598476|NCT02360293|62997356|FG000|Overall Study|Withdrawal by Subject|2|||
33598477|NCT02360293|62997357|FG001|Overall Study|Withdrawal by Subject|1|||
33598478|NCT02360293|62997356|FG000|Overall Study|Excluded|1|||
33406797|NCT02998528|62785435|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
33406798|NCT02998528|62785436|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
33406799|NCT02998528|62785437|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
33406800|NCT02998528|62785435|FG000|Randomization Period|Participant withdrew consent|0|||
33406801|NCT02998528|62785436|FG001|Randomization Period|Participant withdrew consent|3|||
33406802|NCT02998528|62785437|FG002|Randomization Period|Participant withdrew consent|0|||
33406803|NCT02998528|62785435|FG000|Randomization Period|Participant no longer meets study criteria|1|||
33406804|NCT02998528|62785436|FG001|Randomization Period|Participant no longer meets study criteria|3|||
33406805|NCT02998528|62785437|FG002|Randomization Period|Participant no longer meets study criteria|2|||
33406806|NCT02998528|62785435|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
33406807|NCT02998528|62785436|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
33406808|NCT02998528|62785437|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
33406809|NCT02998528|62785435|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
33406810|NCT02998528|62785436|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
33406811|NCT02998528|62785437|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
33406812|NCT02998528|62785435|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
33406813|NCT02998528|62785436|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
33406814|NCT02998528|62785437|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
33406815|NCT02998528|62785435|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
33406816|NCT02998528|62785436|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
33406817|NCT02998528|62785437|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
33406818|NCT02998528|62785435|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
33406819|NCT02998528|62785436|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
33406820|NCT02998528|62785437|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
33406821|NCT02998528|62785435|FG000|Neoadjuvant Treatment Period|Death|1|||
33406822|NCT02998528|62785436|FG001|Neoadjuvant Treatment Period|Death|0|||
33406823|NCT02998528|62785437|FG002|Neoadjuvant Treatment Period|Death|0|||
33598479|NCT02360293|62997357|FG001|Overall Study|Excluded|0|||
33321106|NCT01208207|62696951|FG000|Part I|Progressive Disease|1|||
33321107|NCT01208207|62696952|FG001|Part I|Progressive Disease|0|||
33321108|NCT01208207|62696953|FG002|Part I|Progressive Disease|0|||
33321109|NCT01208207|62696954|FG003|Part I|Progressive Disease|0|||
33321110|NCT01208207|62696955|FG004|Part I|Progressive Disease|0|||
33321111|NCT01208207|62696956|FG005|Part I|Progressive Disease|0|||
33321112|NCT01208207|62696957|FG006|Part I|Progressive Disease|0|||
33406824|NCT02998528|62785435|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
33406825|NCT02998528|62785436|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
33321113|NCT01208207|62696951|FG000|Part I|Protocol Violation|8|||
33321114|NCT01208207|62696952|FG001|Part I|Protocol Violation|0|||
33321115|NCT01208207|62696953|FG002|Part I|Protocol Violation|2|||
33321116|NCT01208207|62696954|FG003|Part I|Protocol Violation|0|||
33406826|NCT02998528|62785437|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
33321117|NCT01208207|62696955|FG004|Part I|Protocol Violation|0|||
33406827|NCT02998528|62785435|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
33406828|NCT02998528|62785436|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
33406829|NCT02998528|62785437|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
33406830|NCT02998528|62785435|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
33406831|NCT02998528|62785436|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
33406832|NCT02998528|62785437|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
33406833|NCT02998528|62785435|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
33406834|NCT02998528|62785436|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
33406835|NCT02998528|62785437|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
33406836|NCT02998528|62785435|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
33406837|NCT02998528|62785436|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
33406838|NCT02998528|62785437|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
33406839|NCT02998528|62785435|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
33406840|NCT02998528|62785436|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
33406841|NCT02998528|62785437|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
33406842|NCT02998203|62785446|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
33406843|NCT02998203|62785447|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
33406844|NCT02998203|62785446|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
33406845|NCT02998203|62785447|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
33406846|NCT02994927|62785472|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33406847|NCT02994927|62785473|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33406848|NCT02994927|62785472|FG000|Overall Study|Did not meet eligibility criteria|0|||
33406849|NCT02994927|62785473|FG001|Overall Study|Did not meet eligibility criteria|1|||
33406850|NCT02994927|62785472|FG000|Overall Study|Physician Decision|4|||
33406851|NCT02994927|62785473|FG001|Overall Study|Physician Decision|3|||
33406852|NCT02994927|62785472|FG000|Overall Study|Death|4|||
33406853|NCT02994927|62785473|FG001|Overall Study|Death|2|||
33406854|NCT02994927|62785472|FG000|Overall Study|Adverse Event|2|||
33406855|NCT02994927|62785473|FG001|Overall Study|Adverse Event|1|||
33406856|NCT02994927|62785472|FG000|Overall Study|Withdrawal by Subject|3|||
33406857|NCT02994927|62785473|FG001|Overall Study|Withdrawal by Subject|6|||
33406858|NCT02994927|62785472|FG000|Overall Study|Lost to Follow-up|2|||
33406859|NCT02994927|62785473|FG001|Overall Study|Lost to Follow-up|1|||
33598480|NCT02359903|62997365|FG000|Overall Study|Adverse Event|0|||
33598481|NCT02359903|62997366|FG001|Overall Study|Adverse Event|2|||
33598482|NCT02291419|62997374|FG000|Overall Study|Early study termination|1|||
33598483|NCT02291419|62997375|FG001|Overall Study|Early study termination|5|||
33598484|NCT02319031|62997383|FG000|Treatment Period|Death|1|||
33598485|NCT02319031|62997384|FG001|Treatment Period|Death|0|||
33598486|NCT02318797|62997392|FG000|Overall Study|Death|3|||
33598487|NCT02318797|62997393|FG001|Overall Study|Death|6|||
33598488|NCT02318797|62997392|FG000|Overall Study|Lost to Follow-up|85|||
33598489|NCT02318797|62997393|FG001|Overall Study|Lost to Follow-up|96|||
33598490|NCT02359435|62997401|FG000|Overall Study|Lost to Follow-up|4|||
33598491|NCT02359435|62997402|FG001|Overall Study|Lost to Follow-up|4|||
33598492|NCT02318719|62997412|FG000|Double-blind Phase|Adverse Event|7|||
33598493|NCT02318719|62997413|FG001|Double-blind Phase|Adverse Event|6|||
33598494|NCT02318719|62997414|FG002|Double-blind Phase|Adverse Event|12|||
33598495|NCT02318719|62997415|FG003|Double-blind Phase|Adverse Event|4|||
33598496|NCT02318719|62997416|FG004|Double-blind Phase|Adverse Event|0|||
33598497|NCT02318719|62997412|FG000|Double-blind Phase|Lack of Efficacy|5|||
33598498|NCT02318719|62997413|FG001|Double-blind Phase|Lack of Efficacy|0|||
33598499|NCT02318719|62997414|FG002|Double-blind Phase|Lack of Efficacy|1|||
33598500|NCT02318719|62997415|FG003|Double-blind Phase|Lack of Efficacy|1|||
33598501|NCT02318719|62997416|FG004|Double-blind Phase|Lack of Efficacy|0|||
33598502|NCT02318719|62997412|FG000|Double-blind Phase|Protocol Violation|0|||
33598503|NCT02318719|62997413|FG001|Double-blind Phase|Protocol Violation|1|||
33598504|NCT02318719|62997414|FG002|Double-blind Phase|Protocol Violation|3|||
33598505|NCT02318719|62997415|FG003|Double-blind Phase|Protocol Violation|0|||
33598506|NCT02318719|62997416|FG004|Double-blind Phase|Protocol Violation|0|||
33598507|NCT02318719|62997412|FG000|Double-blind Phase|Withdrawal by Subject|25|||
33598508|NCT02318719|62997413|FG001|Double-blind Phase|Withdrawal by Subject|7|||
33598509|NCT02318719|62997414|FG002|Double-blind Phase|Withdrawal by Subject|9|||
33598510|NCT02318719|62997415|FG003|Double-blind Phase|Withdrawal by Subject|10|||
33598511|NCT02318719|62997416|FG004|Double-blind Phase|Withdrawal by Subject|0|||
33598512|NCT02318719|62997412|FG000|Double-blind Phase|Other|1|||
33598513|NCT02318719|62997413|FG001|Double-blind Phase|Other|2|||
33598514|NCT02318719|62997414|FG002|Double-blind Phase|Other|0|||
33598515|NCT02318719|62997415|FG003|Double-blind Phase|Other|0|||
33598516|NCT02318719|62997416|FG004|Double-blind Phase|Other|0|||
33598517|NCT02318719|62997412|FG000|Open-label Extension Phase|Adverse Event|0|||
33598518|NCT02318719|62997413|FG001|Open-label Extension Phase|Adverse Event|0|||
33598519|NCT02318719|62997414|FG002|Open-label Extension Phase|Adverse Event|0|||
33598520|NCT02318719|62997415|FG003|Open-label Extension Phase|Adverse Event|0|||
33598521|NCT02318719|62997416|FG004|Open-label Extension Phase|Adverse Event|15|||
33598522|NCT02318719|62997412|FG000|Open-label Extension Phase|Death|0|||
33598523|NCT02318719|62997413|FG001|Open-label Extension Phase|Death|0|||
33598524|NCT02318719|62997414|FG002|Open-label Extension Phase|Death|0|||
33321118|NCT01208207|62696956|FG005|Part I|Protocol Violation|0|||
33321119|NCT01208207|62696957|FG006|Part I|Protocol Violation|0|||
33321120|NCT01208207|62696951|FG000|Part I|Withdrawal by Subject|14|||
33321121|NCT01208207|62696952|FG001|Part I|Withdrawal by Subject|4|||
33321122|NCT01208207|62696953|FG002|Part I|Withdrawal by Subject|4|||
33321123|NCT01208207|62696954|FG003|Part I|Withdrawal by Subject|0|||
33321124|NCT01208207|62696955|FG004|Part I|Withdrawal by Subject|0|||
33321125|NCT01208207|62696956|FG005|Part I|Withdrawal by Subject|0|||
33321126|NCT01208207|62696957|FG006|Part I|Withdrawal by Subject|0|||
33321127|NCT01208207|62696951|FG000|Part II|Withdrawal by Subject|0|||
33321128|NCT01208207|62696952|FG001|Part II|Withdrawal by Subject|0|||
33321129|NCT01208207|62696953|FG002|Part II|Withdrawal by Subject|0|||
33321130|NCT01208207|62696954|FG003|Part II|Withdrawal by Subject|10|||
33321131|NCT01208207|62696955|FG004|Part II|Withdrawal by Subject|9|||
33321132|NCT01208207|62696956|FG005|Part II|Withdrawal by Subject|3|||
33321133|NCT01208207|62696957|FG006|Part II|Withdrawal by Subject|5|||
33321134|NCT01208207|62696951|FG000|Part II|Adverse Event|0|||
33321135|NCT01208207|62696952|FG001|Part II|Adverse Event|0|||
33321136|NCT01208207|62696953|FG002|Part II|Adverse Event|0|||
33321137|NCT01208207|62696954|FG003|Part II|Adverse Event|5|||
33321138|NCT01208207|62696955|FG004|Part II|Adverse Event|9|||
33321139|NCT01208207|62696956|FG005|Part II|Adverse Event|4|||
33321140|NCT01208207|62696957|FG006|Part II|Adverse Event|2|||
33321141|NCT01208207|62696951|FG000|Part II|Lack of Efficacy|0|||
33321142|NCT01208207|62696952|FG001|Part II|Lack of Efficacy|0|||
33321143|NCT01208207|62696953|FG002|Part II|Lack of Efficacy|0|||
33321144|NCT01208207|62696954|FG003|Part II|Lack of Efficacy|6|||
33321145|NCT01208207|62696955|FG004|Part II|Lack of Efficacy|4|||
33321146|NCT01208207|62696956|FG005|Part II|Lack of Efficacy|3|||
33321147|NCT01208207|62696957|FG006|Part II|Lack of Efficacy|3|||
33321148|NCT01208207|62696951|FG000|Part II|Lost to Follow-up|0|||
33321149|NCT01208207|62696952|FG001|Part II|Lost to Follow-up|0|||
33321150|NCT01208207|62696953|FG002|Part II|Lost to Follow-up|0|||
33321151|NCT01208207|62696954|FG003|Part II|Lost to Follow-up|4|||
33321152|NCT01208207|62696955|FG004|Part II|Lost to Follow-up|0|||
33321153|NCT01208207|62696956|FG005|Part II|Lost to Follow-up|2|||
33321154|NCT01208207|62696957|FG006|Part II|Lost to Follow-up|1|||
33321155|NCT01208207|62696951|FG000|Part II|Non-Compliance With Study Drug|0|||
33321156|NCT01208207|62696952|FG001|Part II|Non-Compliance With Study Drug|0|||
33321157|NCT01208207|62696953|FG002|Part II|Non-Compliance With Study Drug|0|||
33598525|NCT02318719|62997415|FG003|Open-label Extension Phase|Death|0|||
33598526|NCT02318719|62997416|FG004|Open-label Extension Phase|Death|1|||
33321158|NCT01208207|62696954|FG003|Part II|Non-Compliance With Study Drug|4|||
33321159|NCT01208207|62696955|FG004|Part II|Non-Compliance With Study Drug|1|||
33321160|NCT01208207|62696956|FG005|Part II|Non-Compliance With Study Drug|1|||
33321161|NCT01208207|62696957|FG006|Part II|Non-Compliance With Study Drug|0|||
33598527|NCT02318719|62997412|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
33493970|NCT00089791|62872551|FG001|Overall Study|Noncompliance|13|||
33493971|NCT00089791|62872550|FG000|Overall Study|Other|20|||
33321162|NCT01208207|62696951|FG000|Part II|Physician Decision|0|||
33321163|NCT01208207|62696952|FG001|Part II|Physician Decision|0|||
33321164|NCT01208207|62696953|FG002|Part II|Physician Decision|0|||
33493972|NCT00089791|62872551|FG001|Overall Study|Other|32|||
33321165|NCT01208207|62696954|FG003|Part II|Physician Decision|1|||
33321166|NCT01208207|62696955|FG004|Part II|Physician Decision|0|||
33321167|NCT01208207|62696956|FG005|Part II|Physician Decision|2|||
33321168|NCT01208207|62696957|FG006|Part II|Physician Decision|0|||
33321169|NCT01208207|62696951|FG000|Part II|Protocol Violation|0|||
33321170|NCT01208207|62696952|FG001|Part II|Protocol Violation|0|||
33321171|NCT01208207|62696953|FG002|Part II|Protocol Violation|0|||
33598528|NCT02318719|62997413|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
33321172|NCT01208207|62696954|FG003|Part II|Protocol Violation|1|||
33493973|NCT00089791|62872550|FG000|Overall Study|Protocol deviation|12|||
33598529|NCT02318719|62997414|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
33321173|NCT01208207|62696955|FG004|Part II|Protocol Violation|0|||
33321174|NCT01208207|62696956|FG005|Part II|Protocol Violation|0|||
33321175|NCT01208207|62696957|FG006|Part II|Protocol Violation|0|||
33321176|NCT01208207|62696951|FG000|Part II|Technical Problems|0|||
33321177|NCT01208207|62696952|FG001|Part II|Technical Problems|0|||
33321178|NCT01208207|62696953|FG002|Part II|Technical Problems|0|||
33321179|NCT01208207|62696954|FG003|Part II|Technical Problems|1|||
33321180|NCT01208207|62696955|FG004|Part II|Technical Problems|0|||
33321181|NCT01208207|62696956|FG005|Part II|Technical Problems|1|||
33321182|NCT01208207|62696957|FG006|Part II|Technical Problems|0|||
33321183|NCT01012713|62696988|FG000|Overall Study|Lack of Efficacy|3|||
33321184|NCT01007253|62696993|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
33321185|NCT01007253|62696994|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
33321186|NCT01007253|62696995|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
33321187|NCT01007253|62696996|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
33321188|NCT01006707|62697006|FG000|Study Session 1|Lost to Follow-up|2|||
33321189|NCT01006707|62697007|FG001|Study Session 1|Lost to Follow-up|0|||
33321190|NCT01006707|62697008|FG002|Study Session 1|Lost to Follow-up|0|||
33321191|NCT01006707|62697006|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
33321192|NCT01006707|62697007|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
33321193|NCT01006707|62697008|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
33598530|NCT02318719|62997415|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
33598531|NCT02318719|62997416|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
33598532|NCT02318719|62997412|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
33598533|NCT02318719|62997413|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
33598534|NCT02318719|62997414|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
33598535|NCT02318719|62997415|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
33598536|NCT02318719|62997416|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
33598537|NCT02318719|62997412|FG000|Open-label Extension Phase|Other|0|||
33598538|NCT02318719|62997413|FG001|Open-label Extension Phase|Other|0|||
33598539|NCT02318719|62997414|FG002|Open-label Extension Phase|Other|0|||
33598540|NCT02318719|62997415|FG003|Open-label Extension Phase|Other|0|||
33598541|NCT02318719|62997416|FG004|Open-label Extension Phase|Other|7|||
33598542|NCT01870726|62997435|FG000|Overall Study|Withdrawal of informed consent|0|||
33598543|NCT01870726|62997436|FG001|Overall Study|Withdrawal of informed consent|0|||
33598544|NCT01870726|62997437|FG002|Overall Study|Withdrawal of informed consent|0|||
33598545|NCT01870726|62997438|FG003|Overall Study|Withdrawal of informed consent|1|||
33598546|NCT01870726|62997439|FG004|Overall Study|Withdrawal of informed consent|0|||
33598547|NCT01870726|62997440|FG005|Overall Study|Withdrawal of informed consent|0|||
33598548|NCT01870726|62997441|FG006|Overall Study|Withdrawal of informed consent|0|||
33598549|NCT01870726|62997435|FG000|Overall Study|Withdrawal by Subject|0|||
33598550|NCT01870726|62997436|FG001|Overall Study|Withdrawal by Subject|1|||
33598551|NCT01870726|62997437|FG002|Overall Study|Withdrawal by Subject|0|||
33598552|NCT01870726|62997438|FG003|Overall Study|Withdrawal by Subject|0|||
33598553|NCT01870726|62997439|FG004|Overall Study|Withdrawal by Subject|0|||
33598554|NCT01870726|62997440|FG005|Overall Study|Withdrawal by Subject|0|||
33598555|NCT01870726|62997441|FG006|Overall Study|Withdrawal by Subject|0|||
33598556|NCT01870726|62997435|FG000|Overall Study|Adverse Event|0|||
33598557|NCT01870726|62997436|FG001|Overall Study|Adverse Event|0|||
33598558|NCT01870726|62997437|FG002|Overall Study|Adverse Event|0|||
33598559|NCT01870726|62997438|FG003|Overall Study|Adverse Event|0|||
33598560|NCT01870726|62997439|FG004|Overall Study|Adverse Event|1|||
33321194|NCT01006629|62697016|FG000|Overall Study|Adverse Event|1|||
33598561|NCT01870726|62997440|FG005|Overall Study|Adverse Event|1|||
33598562|NCT01870726|62997441|FG006|Overall Study|Adverse Event|0|||
33598563|NCT01870726|62997435|FG000|Overall Study|Progressive disease|5|||
33598564|NCT01870726|62997436|FG001|Overall Study|Progressive disease|5|||
33598565|NCT01870726|62997437|FG002|Overall Study|Progressive disease|4|||
33598566|NCT01870726|62997438|FG003|Overall Study|Progressive disease|5|||
33598567|NCT01870726|62997439|FG004|Overall Study|Progressive disease|6|||
33598568|NCT01870726|62997440|FG005|Overall Study|Progressive disease|4|||
33598569|NCT01870726|62997441|FG006|Overall Study|Progressive disease|10|||
33598570|NCT01900054|62997466|FG000|Overall Study|Physician Decision|1|||
33598571|NCT01900054|62997466|FG000|Overall Study|Withdrawal by Subject|1|||
33598572|NCT01612156|62997472|FG000|Overall Study|Protocol Violation|2|||
33598573|NCT01612156|62997473|FG001|Overall Study|Protocol Violation|0|||
33598574|NCT01899742|62997481|FG000|Overall Study|Adverse Event|5|||
33598575|NCT01899742|62997482|FG001|Overall Study|Adverse Event|4|||
33598576|NCT01899742|62997481|FG000|Overall Study|Lack of Efficacy|1|||
33598577|NCT01899742|62997482|FG001|Overall Study|Lack of Efficacy|5|||
33598578|NCT01899742|62997481|FG000|Overall Study|Protocol Violation|2|||
33598579|NCT01899742|62997482|FG001|Overall Study|Protocol Violation|2|||
33598580|NCT01899742|62997481|FG000|Overall Study|Withdrawal by Subject|9|||
33598581|NCT01899742|62997482|FG001|Overall Study|Withdrawal by Subject|5|||
33598582|NCT01615822|62997491|FG000|Period 1|Withdrawal by Subject|0|||
33598583|NCT01615822|62997492|FG001|Period 1|Withdrawal by Subject|1|||
33598584|NCT01615822|62997493|FG002|Period 1|Withdrawal by Subject|0|||
33598585|NCT01615822|62997491|FG000|Period 1|Adverse Event|1|||
33598586|NCT01615822|62997492|FG001|Period 1|Adverse Event|1|||
33598587|NCT01615822|62997493|FG002|Period 1|Adverse Event|0|||
33598588|NCT01615822|62997491|FG000|Period 2|Lost to Follow-up|0|||
33321195|NCT01006629|62697016|FG000|Overall Study|Parent refused to continue participation|1|||
33321196|NCT01006629|62697016|FG000|Overall Study|Parent unable to perform site visit|4|||
33321197|NCT01012323|62697020|FG000|Overall Study|Investigator Judgment|1|||
33321198|NCT01011933|62697024|FG000|Overall Study|Wrong cell type|1|||
33598589|NCT01615822|62997492|FG001|Period 2|Lost to Follow-up|1|||
33598590|NCT01615822|62997493|FG002|Period 2|Lost to Follow-up|2|||
33598591|NCT01898884|62997509|FG000|Multiple Dose Period|Adverse Event|0|||
33598592|NCT01898884|62997510|FG001|Multiple Dose Period|Adverse Event|0|||
33598593|NCT01898884|62997511|FG002|Multiple Dose Period|Adverse Event|0|||
33598594|NCT01898884|62997512|FG003|Multiple Dose Period|Adverse Event|0|||
33598595|NCT01898884|62997513|FG004|Multiple Dose Period|Adverse Event|0|||
33598596|NCT01898884|62997514|FG005|Multiple Dose Period|Adverse Event|0|||
33598597|NCT01898884|62997515|FG006|Multiple Dose Period|Adverse Event|1|||
33598598|NCT01898884|62997516|FG007|Multiple Dose Period|Adverse Event|0|||
33598599|NCT01898884|62997517|FG008|Multiple Dose Period|Adverse Event|0|||
33598600|NCT01898884|62997509|FG000|Multiple Dose Period|Randomized Not Treated|0|||
33598601|NCT01898884|62997510|FG001|Multiple Dose Period|Randomized Not Treated|0|||
33598602|NCT01898884|62997511|FG002|Multiple Dose Period|Randomized Not Treated|0|||
33598603|NCT01898884|62997512|FG003|Multiple Dose Period|Randomized Not Treated|0|||
33598604|NCT01898884|62997513|FG004|Multiple Dose Period|Randomized Not Treated|0|||
33321199|NCT01011933|62697024|FG000|Overall Study|Improper pre-protocol Rx|1|||
33321200|NCT01011933|62697024|FG000|Overall Study|Inadequate pathology|1|||
33321201|NCT01011933|62697024|FG000|Overall Study|Never treated|1|||
33321202|NCT01011465|62697046|FG000|Overall Study|Withdrawal by Subject|2|||
33321203|NCT01011465|62697047|FG001|Overall Study|Withdrawal by Subject|1|||
33321204|NCT01011465|62697048|FG002|Overall Study|Withdrawal by Subject|0|||
33321205|NCT01011465|62697049|FG003|Overall Study|Withdrawal by Subject|0|||
33321206|NCT01011465|62697050|FG004|Overall Study|Withdrawal by Subject|1|||
33321207|NCT01011465|62697051|FG005|Overall Study|Withdrawal by Subject|0|||
33321208|NCT01011465|62697052|FG006|Overall Study|Withdrawal by Subject|1|||
33321209|NCT01011465|62697053|FG007|Overall Study|Withdrawal by Subject|0|||
33321210|NCT01011387|62697078|FG000|Overall Study|Withdrawal by Subject|3|||
33321211|NCT01011387|62697078|FG000|Overall Study|Adverse Event|2|||
33321212|NCT01011387|62697078|FG000|Overall Study|Protocol Violation|1|||
33321213|NCT01011309|62697085|FG000|Overall Study|Adverse Event|2|||
33321214|NCT01011309|62697086|FG001|Overall Study|Adverse Event|1|||
33321215|NCT01011309|62697087|FG002|Overall Study|Adverse Event|2|||
33321216|NCT01011309|62697085|FG000|Overall Study|Lack of Efficacy|0|||
33321217|NCT01011309|62697086|FG001|Overall Study|Lack of Efficacy|1|||
33321218|NCT01011309|62697087|FG002|Overall Study|Lack of Efficacy|0|||
33321219|NCT01011309|62697085|FG000|Overall Study|Protocol Violation|0|||
33598605|NCT01898884|62997514|FG005|Multiple Dose Period|Randomized Not Treated|0|||
33598606|NCT01898884|62997515|FG006|Multiple Dose Period|Randomized Not Treated|0|||
33598607|NCT01898884|62997516|FG007|Multiple Dose Period|Randomized Not Treated|0|||
33598608|NCT01898884|62997517|FG008|Multiple Dose Period|Randomized Not Treated|1|||
33598609|NCT01613326|62997555|FG000|Overall Study|Adverse Event|7|||
33321220|NCT01011309|62697086|FG001|Overall Study|Protocol Violation|1|||
33321221|NCT01011309|62697087|FG002|Overall Study|Protocol Violation|3|||
33598610|NCT01613326|62997556|FG001|Overall Study|Adverse Event|5|||
33598611|NCT01613326|62997555|FG000|Overall Study|Withdrawal by Subject|3|||
33598612|NCT01613326|62997556|FG001|Overall Study|Withdrawal by Subject|4|||
33598613|NCT01613326|62997555|FG000|Overall Study|Abnormal test procedure result(s)|2|||
33598614|NCT01613326|62997556|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33598615|NCT01613326|62997555|FG000|Overall Study|inability to use device|1|||
33598616|NCT01613326|62997556|FG001|Overall Study|inability to use device|0|||
33598617|NCT01613326|62997555|FG000|Overall Study|Lack of Efficacy|0|||
33598618|NCT01613326|62997556|FG001|Overall Study|Lack of Efficacy|1|||
33598619|NCT01613326|62997555|FG000|Overall Study|Lost to Follow-up|0|||
33598620|NCT01613326|62997556|FG001|Overall Study|Lost to Follow-up|1|||
33598621|NCT01613326|62997555|FG000|Overall Study|Administrative|0|||
33598622|NCT01613326|62997556|FG001|Overall Study|Administrative|2|||
33598623|NCT01613326|62997555|FG000|Overall Study|Protocol Violation|0|||
33598624|NCT01613326|62997556|FG001|Overall Study|Protocol Violation|1|||
33598625|NCT01613248|62997568|FG000|Overall Study|Adverse Event|0|||
33598626|NCT01613248|62997569|FG001|Overall Study|Adverse Event|0|||
33598627|NCT01613248|62997570|FG002|Overall Study|Adverse Event|0|||
33598628|NCT01613248|62997571|FG003|Overall Study|Adverse Event|1|||
33598629|NCT01613248|62997572|FG004|Overall Study|Adverse Event|0|||
33598630|NCT01613248|62997573|FG005|Overall Study|Adverse Event|0|||
33598631|NCT01613248|62997568|FG000|Overall Study|Withdrawal by Subject|3|||
33598632|NCT01613248|62997569|FG001|Overall Study|Withdrawal by Subject|2|||
33598633|NCT01613248|62997570|FG002|Overall Study|Withdrawal by Subject|2|||
33598634|NCT01613248|62997571|FG003|Overall Study|Withdrawal by Subject|5|||
33598635|NCT01613248|62997572|FG004|Overall Study|Withdrawal by Subject|0|||
33598636|NCT01613248|62997573|FG005|Overall Study|Withdrawal by Subject|1|||
33598637|NCT01613248|62997568|FG000|Overall Study|Lost to Follow-up|5|||
33598638|NCT01613248|62997569|FG001|Overall Study|Lost to Follow-up|7|||
33406965|NCT02873338|62785517|FG000|Overall Study|Adverse Event|0|||
33406966|NCT02873338|62785518|FG001|Overall Study|Adverse Event|2|||
33406967|NCT02873338|62785519|FG002|Overall Study|Adverse Event|1|||
33406968|NCT02873338|62785517|FG000|Overall Study|Death|2|||
33406969|NCT02873338|62785518|FG001|Overall Study|Death|1|||
33406970|NCT02873338|62785519|FG002|Overall Study|Death|1|||
33406971|NCT02873338|62785517|FG000|Overall Study|Withdrawal by Subject|2|||
33406972|NCT02873338|62785518|FG001|Overall Study|Withdrawal by Subject|1|||
33406973|NCT02873338|62785519|FG002|Overall Study|Withdrawal by Subject|3|||
33406974|NCT02873338|62785517|FG000|Overall Study|Lack of Efficacy|0|||
33406975|NCT02873338|62785518|FG001|Overall Study|Lack of Efficacy|2|||
33406976|NCT02873338|62785519|FG002|Overall Study|Lack of Efficacy|0|||
33406977|NCT02873338|62785517|FG000|Overall Study|Other or Missing|14|||
33406978|NCT02873338|62785518|FG001|Overall Study|Other or Missing|15|||
33406979|NCT02873338|62785519|FG002|Overall Study|Other or Missing|13|||
33406980|NCT02725567|62785543|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
33406981|NCT02725567|62785544|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
33406982|NCT02725567|62785543|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
33406983|NCT02725567|62785544|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
33406984|NCT02725567|62785543|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
33406985|NCT02725567|62785544|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
33598639|NCT01613248|62997570|FG002|Overall Study|Lost to Follow-up|4|||
33598640|NCT01613248|62997571|FG003|Overall Study|Lost to Follow-up|8|||
33598641|NCT01613248|62997572|FG004|Overall Study|Lost to Follow-up|4|||
33598642|NCT01613248|62997573|FG005|Overall Study|Lost to Follow-up|2|||
33598643|NCT01613248|62997568|FG000|Overall Study|Study Terminated by Sponsor|4|||
33598644|NCT01613248|62997569|FG001|Overall Study|Study Terminated by Sponsor|6|||
33598645|NCT01613248|62997570|FG002|Overall Study|Study Terminated by Sponsor|8|||
33598646|NCT01613248|62997571|FG003|Overall Study|Study Terminated by Sponsor|8|||
33598647|NCT01613248|62997572|FG004|Overall Study|Study Terminated by Sponsor|9|||
33598648|NCT01613248|62997573|FG005|Overall Study|Study Terminated by Sponsor|11|||
33598649|NCT01613248|62997568|FG000|Overall Study|Physician Decision|8|||
33598650|NCT01613248|62997569|FG001|Overall Study|Physician Decision|8|||
33598651|NCT01613248|62997570|FG002|Overall Study|Physician Decision|9|||
33598652|NCT01613248|62997571|FG003|Overall Study|Physician Decision|4|||
33598653|NCT01613248|62997572|FG004|Overall Study|Physician Decision|7|||
33598654|NCT01613248|62997573|FG005|Overall Study|Physician Decision|6|||
33598655|NCT01613248|62997568|FG000|Overall Study|Lack of Qualifying Event|9|||
33598656|NCT01613248|62997569|FG001|Overall Study|Lack of Qualifying Event|11|||
33598657|NCT01613248|62997570|FG002|Overall Study|Lack of Qualifying Event|10|||
33598658|NCT01613248|62997571|FG003|Overall Study|Lack of Qualifying Event|11|||
33598659|NCT01613248|62997572|FG004|Overall Study|Lack of Qualifying Event|15|||
33598660|NCT01613248|62997573|FG005|Overall Study|Lack of Qualifying Event|18|||
33598661|NCT01613248|62997568|FG000|Overall Study|Pregnancy|0|||
33598662|NCT01613248|62997569|FG001|Overall Study|Pregnancy|0|||
33598663|NCT01613248|62997570|FG002|Overall Study|Pregnancy|0|||
33598664|NCT01613248|62997571|FG003|Overall Study|Pregnancy|1|||
33598665|NCT01613248|62997572|FG004|Overall Study|Pregnancy|0|||
33598666|NCT01613248|62997573|FG005|Overall Study|Pregnancy|0|||
33598667|NCT01898806|62997587|FG000|Overall Study|Withdrawal by Subject|2|||
33598668|NCT01898806|62997587|FG000|Overall Study|Physician Decision|1|||
33598669|NCT02291029|62997597|FG000|Overall Study|Withdrawal by Subject|0|||
33598670|NCT02291029|62997598|FG001|Overall Study|Withdrawal by Subject|0|||
33598671|NCT02291029|62997599|FG002|Overall Study|Withdrawal by Subject|1|||
33598672|NCT02291029|62997600|FG003|Overall Study|Withdrawal by Subject|0|||
33598673|NCT02291029|62997601|FG004|Overall Study|Withdrawal by Subject|0|||
33598674|NCT02291029|62997602|FG005|Overall Study|Withdrawal by Subject|0|||
33598675|NCT02291029|62997597|FG000|Overall Study|Adverse Event|0|||
33598676|NCT02291029|62997598|FG001|Overall Study|Adverse Event|1|||
33598677|NCT02291029|62997599|FG002|Overall Study|Adverse Event|0|||
33407017|NCT02337686|62785571|FG000|Overall Study|Adverse Event|1|||
33407018|NCT02231749|62785577|FG000|Overall Study|Disease progression|229|||
33407019|NCT02231749|62785578|FG001|Overall Study|Disease progression|297|||
33407020|NCT02231749|62785577|FG000|Overall Study|Study Drug Toxicity|134|||
33407021|NCT02231749|62785578|FG001|Overall Study|Study Drug Toxicity|63|||
33407022|NCT02231749|62785577|FG000|Overall Study|Death|1|||
33407023|NCT02231749|62785578|FG001|Overall Study|Death|1|||
33407024|NCT02231749|62785577|FG000|Overall Study|AE unrelated to Study drug|32|||
33407025|NCT02231749|62785578|FG001|Overall Study|AE unrelated to Study drug|31|||
33407026|NCT02231749|62785577|FG000|Overall Study|Participant's request to discontinue|10|||
33407027|NCT02231749|62785578|FG001|Overall Study|Participant's request to discontinue|21|||
33407028|NCT02231749|62785577|FG000|Overall Study|Participant withdrew Consent|8|||
33407029|NCT02231749|62785578|FG001|Overall Study|Participant withdrew Consent|15|||
33407030|NCT02231749|62785577|FG000|Overall Study|Lost to Follow-up|1|||
33407031|NCT02231749|62785578|FG001|Overall Study|Lost to Follow-up|2|||
33407032|NCT02231749|62785577|FG000|Overall Study|Maximum Clinical Benefit|5|||
33407033|NCT02231749|62785578|FG001|Overall Study|Maximum Clinical Benefit|8|||
33407034|NCT02231749|62785577|FG000|Overall Study|Poor/Non-Compliance|0|||
33407035|NCT02231749|62785578|FG001|Overall Study|Poor/Non-Compliance|3|||
33407036|NCT02231749|62785577|FG000|Overall Study|Pregnancy|1|||
33407037|NCT02231749|62785578|FG001|Overall Study|Pregnancy|0|||
33407038|NCT02231749|62785577|FG000|Overall Study|other|0|||
33407039|NCT02231749|62785578|FG001|Overall Study|other|8|||
33407040|NCT02231749|62785577|FG000|Overall Study|No longer meets Study Criteria|1|||
33407041|NCT02231749|62785578|FG001|Overall Study|No longer meets Study Criteria|0|||
33407042|NCT02108964|62785607|FG000|Overall Study|Progressive disease|12|||
33407043|NCT02108964|62785608|FG001|Overall Study|Progressive disease|25|||
33407044|NCT02108964|62785609|FG002|Overall Study|Progressive disease|50|||
33407045|NCT02108964|62785610|FG003|Overall Study|Progressive disease|6|||
33407046|NCT02108964|62785611|FG004|Overall Study|Progressive disease|18|||
33407047|NCT02108964|62785612|FG005|Overall Study|Progressive disease|5|||
33407048|NCT02108964|62785613|FG006|Overall Study|Progressive disease|7|||
33407049|NCT02108964|62785614|FG007|Overall Study|Progressive disease|9|||
33407050|NCT02108964|62785607|FG000|Overall Study|Physician Decision|1|||
33407051|NCT02108964|62785608|FG001|Overall Study|Physician Decision|5|||
33407052|NCT02108964|62785609|FG002|Overall Study|Physician Decision|6|||
33407053|NCT02108964|62785610|FG003|Overall Study|Physician Decision|0|||
33407054|NCT02108964|62785611|FG004|Overall Study|Physician Decision|1|||
33407055|NCT02108964|62785612|FG005|Overall Study|Physician Decision|0|||
33407056|NCT02108964|62785613|FG006|Overall Study|Physician Decision|0|||
33407057|NCT02108964|62785614|FG007|Overall Study|Physician Decision|0|||
33407058|NCT02108964|62785607|FG000|Overall Study|Adverse Event|0|||
33407059|NCT02108964|62785608|FG001|Overall Study|Adverse Event|0|||
33407060|NCT02108964|62785609|FG002|Overall Study|Adverse Event|4|||
33407061|NCT02108964|62785610|FG003|Overall Study|Adverse Event|0|||
33407062|NCT02108964|62785611|FG004|Overall Study|Adverse Event|1|||
33407063|NCT02108964|62785612|FG005|Overall Study|Adverse Event|0|||
33407064|NCT02108964|62785613|FG006|Overall Study|Adverse Event|3|||
33407065|NCT02108964|62785614|FG007|Overall Study|Adverse Event|1|||
33407066|NCT02108964|62785607|FG000|Overall Study|Death|1|||
33407067|NCT02108964|62785608|FG001|Overall Study|Death|1|||
33407068|NCT02108964|62785609|FG002|Overall Study|Death|2|||
33407069|NCT02108964|62785610|FG003|Overall Study|Death|0|||
33407070|NCT02108964|62785611|FG004|Overall Study|Death|3|||
33407071|NCT02108964|62785612|FG005|Overall Study|Death|0|||
33407072|NCT02108964|62785613|FG006|Overall Study|Death|0|||
33407073|NCT02108964|62785614|FG007|Overall Study|Death|1|||
33407074|NCT02108964|62785607|FG000|Overall Study|Subject/Guardian decision|0|||
33407075|NCT02108964|62785608|FG001|Overall Study|Subject/Guardian decision|1|||
33407076|NCT02108964|62785609|FG002|Overall Study|Subject/Guardian decision|3|||
33407077|NCT02108964|62785610|FG003|Overall Study|Subject/Guardian decision|0|||
33407078|NCT02108964|62785611|FG004|Overall Study|Subject/Guardian decision|2|||
33407079|NCT02108964|62785612|FG005|Overall Study|Subject/Guardian decision|0|||
33407080|NCT02108964|62785613|FG006|Overall Study|Subject/Guardian decision|1|||
33407081|NCT02108964|62785614|FG007|Overall Study|Subject/Guardian decision|1|||
33407082|NCT01928394|62785656|FG000|Treatment Period|Disease progression|17|||
33407083|NCT01928394|62785657|FG001|Treatment Period|Disease progression|2|||
33407084|NCT01928394|62785658|FG002|Treatment Period|Disease progression|12|||
33407085|NCT01928394|62785659|FG003|Treatment Period|Disease progression|48|||
33407086|NCT01928394|62785660|FG004|Treatment Period|Disease progression|3|||
33407087|NCT01928394|62785661|FG005|Treatment Period|Disease progression|25|||
33598678|NCT02291029|62997600|FG003|Overall Study|Adverse Event|0|||
33598679|NCT02291029|62997601|FG004|Overall Study|Adverse Event|0|||
33598680|NCT02291029|62997602|FG005|Overall Study|Adverse Event|0|||
33598681|NCT02290873|62997619|FG000|Overall Study|Withdrawal by Subject|0|||
33598682|NCT02290873|62997620|FG001|Overall Study|Withdrawal by Subject|1|||
33598683|NCT02290873|62997621|FG002|Overall Study|Withdrawal by Subject|1|||
33598684|NCT02290873|62997619|FG000|Overall Study|Nellcor device error|1|||
33598685|NCT02290873|62997620|FG001|Overall Study|Nellcor device error|0|||
33598686|NCT02290873|62997621|FG002|Overall Study|Nellcor device error|0|||
33598687|NCT02290873|62997619|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
33407088|NCT01928394|62785662|FG006|Treatment Period|Disease progression|38|||
33407089|NCT01928394|62785663|FG007|Treatment Period|Disease progression|16|||
33407090|NCT01928394|62785664|FG008|Treatment Period|Disease progression|3|||
33407091|NCT01928394|62785665|FG009|Treatment Period|Disease progression|11|||
33407092|NCT01928394|62785666|FG010|Treatment Period|Disease progression|22|||
33407093|NCT01928394|62785667|FG011|Treatment Period|Disease progression|73|||
33407094|NCT01928394|62785668|FG012|Treatment Period|Disease progression|38|||
33407095|NCT01928394|62785669|FG013|Treatment Period|Disease progression|118|||
33407096|NCT01928394|62785670|FG014|Treatment Period|Disease progression|59|||
33407097|NCT01928394|62785671|FG015|Treatment Period|Disease progression|1|||
33407098|NCT01928394|62785672|FG016|Treatment Period|Disease progression|43|||
33407099|NCT01928394|62785673|FG017|Treatment Period|Disease progression|56|||
33407100|NCT01928394|62785674|FG018|Treatment Period|Disease progression|50|||
33407101|NCT01928394|62785675|FG019|Treatment Period|Disease progression|71|||
33407102|NCT01928394|62785676|FG020|Treatment Period|Disease progression|30|||
33407103|NCT01928394|62785677|FG021|Treatment Period|Disease progression|31|||
33407104|NCT01928394|62785678|FG022|Treatment Period|Disease progression|31|||
33407105|NCT01928394|62785656|FG000|Treatment Period|Study drug toxicity|1|||
33407106|NCT01928394|62785657|FG001|Treatment Period|Study drug toxicity|1|||
33407107|NCT01928394|62785658|FG002|Treatment Period|Study drug toxicity|3|||
33407108|NCT01928394|62785659|FG003|Treatment Period|Study drug toxicity|3|||
33407109|NCT01928394|62785660|FG004|Treatment Period|Study drug toxicity|0|||
33407110|NCT01928394|62785661|FG005|Treatment Period|Study drug toxicity|9|||
33407111|NCT01928394|62785662|FG006|Treatment Period|Study drug toxicity|7|||
33407112|NCT01928394|62785663|FG007|Treatment Period|Study drug toxicity|1|||
33407113|NCT01928394|62785664|FG008|Treatment Period|Study drug toxicity|0|||
33407114|NCT01928394|62785665|FG009|Treatment Period|Study drug toxicity|5|||
33407115|NCT01928394|62785666|FG010|Treatment Period|Study drug toxicity|2|||
33407116|NCT01928394|62785667|FG011|Treatment Period|Study drug toxicity|3|||
33407117|NCT01928394|62785668|FG012|Treatment Period|Study drug toxicity|7|||
33407118|NCT01928394|62785669|FG013|Treatment Period|Study drug toxicity|5|||
33407119|NCT01928394|62785670|FG014|Treatment Period|Study drug toxicity|12|||
33407120|NCT01928394|62785671|FG015|Treatment Period|Study drug toxicity|0|||
33407121|NCT01928394|62785672|FG016|Treatment Period|Study drug toxicity|3|||
33407122|NCT01928394|62785673|FG017|Treatment Period|Study drug toxicity|3|||
33407123|NCT01928394|62785674|FG018|Treatment Period|Study drug toxicity|12|||
33407124|NCT01928394|62785675|FG019|Treatment Period|Study drug toxicity|15|||
33407125|NCT01928394|62785676|FG020|Treatment Period|Study drug toxicity|4|||
33407126|NCT01928394|62785677|FG021|Treatment Period|Study drug toxicity|7|||
33407127|NCT01928394|62785678|FG022|Treatment Period|Study drug toxicity|4|||
33407128|NCT01928394|62785656|FG000|Treatment Period|AE unrelated to study drug|0|||
33407129|NCT01928394|62785657|FG001|Treatment Period|AE unrelated to study drug|0|||
33407130|NCT01928394|62785658|FG002|Treatment Period|AE unrelated to study drug|2|||
33407131|NCT01928394|62785659|FG003|Treatment Period|AE unrelated to study drug|3|||
33407132|NCT01928394|62785660|FG004|Treatment Period|AE unrelated to study drug|0|||
33407133|NCT01928394|62785661|FG005|Treatment Period|AE unrelated to study drug|5|||
33407134|NCT01928394|62785662|FG006|Treatment Period|AE unrelated to study drug|1|||
33407135|NCT01928394|62785663|FG007|Treatment Period|AE unrelated to study drug|0|||
33407136|NCT01928394|62785664|FG008|Treatment Period|AE unrelated to study drug|0|||
33407137|NCT01928394|62785665|FG009|Treatment Period|AE unrelated to study drug|2|||
33407138|NCT01928394|62785666|FG010|Treatment Period|AE unrelated to study drug|0|||
33598688|NCT02290873|62997620|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
33598689|NCT02290873|62997621|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
33598690|NCT02290873|62997619|FG000|Overall Study|Protocol Violation|0|||
33598691|NCT02290873|62997620|FG001|Overall Study|Protocol Violation|0|||
33598692|NCT02290873|62997621|FG002|Overall Study|Protocol Violation|1|||
33407139|NCT01928394|62785667|FG011|Treatment Period|AE unrelated to study drug|12|||
33407140|NCT01928394|62785668|FG012|Treatment Period|AE unrelated to study drug|6|||
33407141|NCT01928394|62785669|FG013|Treatment Period|AE unrelated to study drug|13|||
33407142|NCT01928394|62785670|FG014|Treatment Period|AE unrelated to study drug|6|||
33407143|NCT01928394|62785671|FG015|Treatment Period|AE unrelated to study drug|1|||
33407144|NCT01928394|62785672|FG016|Treatment Period|AE unrelated to study drug|1|||
33407145|NCT01928394|62785673|FG017|Treatment Period|AE unrelated to study drug|6|||
33407146|NCT01928394|62785674|FG018|Treatment Period|AE unrelated to study drug|3|||
33407147|NCT01928394|62785675|FG019|Treatment Period|AE unrelated to study drug|5|||
33407148|NCT01928394|62785676|FG020|Treatment Period|AE unrelated to study drug|1|||
33407149|NCT01928394|62785677|FG021|Treatment Period|AE unrelated to study drug|1|||
33407150|NCT01928394|62785678|FG022|Treatment Period|AE unrelated to study drug|0|||
33407151|NCT01928394|62785656|FG000|Treatment Period|Participant request to stop therapy|0|||
33407152|NCT01928394|62785657|FG001|Treatment Period|Participant request to stop therapy|0|||
33407153|NCT01928394|62785658|FG002|Treatment Period|Participant request to stop therapy|0|||
33407154|NCT01928394|62785659|FG003|Treatment Period|Participant request to stop therapy|0|||
33407155|NCT01928394|62785660|FG004|Treatment Period|Participant request to stop therapy|0|||
33407156|NCT01928394|62785661|FG005|Treatment Period|Participant request to stop therapy|3|||
33407157|NCT01928394|62785662|FG006|Treatment Period|Participant request to stop therapy|3|||
33407158|NCT01928394|62785663|FG007|Treatment Period|Participant request to stop therapy|0|||
33407159|NCT01928394|62785664|FG008|Treatment Period|Participant request to stop therapy|0|||
33407160|NCT01928394|62785665|FG009|Treatment Period|Participant request to stop therapy|0|||
33407161|NCT01928394|62785666|FG010|Treatment Period|Participant request to stop therapy|3|||
33407162|NCT01928394|62785667|FG011|Treatment Period|Participant request to stop therapy|2|||
33407163|NCT01928394|62785668|FG012|Treatment Period|Participant request to stop therapy|1|||
33407164|NCT01928394|62785669|FG013|Treatment Period|Participant request to stop therapy|2|||
33407165|NCT01928394|62785670|FG014|Treatment Period|Participant request to stop therapy|4|||
33407166|NCT01928394|62785671|FG015|Treatment Period|Participant request to stop therapy|0|||
33407167|NCT01928394|62785672|FG016|Treatment Period|Participant request to stop therapy|1|||
33407168|NCT01928394|62785673|FG017|Treatment Period|Participant request to stop therapy|3|||
33407169|NCT01928394|62785674|FG018|Treatment Period|Participant request to stop therapy|1|||
33321222|NCT01011153|62697098|FG000|Overall Study|Less than 78 cases completed|8|||
33321223|NCT01011153|62697099|FG001|Overall Study|Less than 78 cases completed|11|||
33321224|NCT01011153|62697100|FG002|Overall Study|Less than 78 cases completed|9|||
33407170|NCT01928394|62785675|FG019|Treatment Period|Participant request to stop therapy|1|||
33407171|NCT01928394|62785676|FG020|Treatment Period|Participant request to stop therapy|3|||
33407172|NCT01928394|62785677|FG021|Treatment Period|Participant request to stop therapy|1|||
33407173|NCT01928394|62785678|FG022|Treatment Period|Participant request to stop therapy|3|||
33407174|NCT01928394|62785656|FG000|Treatment Period|Participant withdrew consent|0|||
33407175|NCT01928394|62785657|FG001|Treatment Period|Participant withdrew consent|0|||
33407176|NCT01928394|62785658|FG002|Treatment Period|Participant withdrew consent|1|||
33407177|NCT01928394|62785659|FG003|Treatment Period|Participant withdrew consent|1|||
33407178|NCT01928394|62785660|FG004|Treatment Period|Participant withdrew consent|0|||
33407179|NCT01928394|62785661|FG005|Treatment Period|Participant withdrew consent|1|||
33407180|NCT01928394|62785662|FG006|Treatment Period|Participant withdrew consent|0|||
33407181|NCT01928394|62785663|FG007|Treatment Period|Participant withdrew consent|1|||
33407182|NCT01928394|62785664|FG008|Treatment Period|Participant withdrew consent|0|||
33407183|NCT01928394|62785665|FG009|Treatment Period|Participant withdrew consent|0|||
33407184|NCT01928394|62785666|FG010|Treatment Period|Participant withdrew consent|1|||
33407185|NCT01928394|62785667|FG011|Treatment Period|Participant withdrew consent|1|||
33407186|NCT01928394|62785668|FG012|Treatment Period|Participant withdrew consent|1|||
33407187|NCT01928394|62785669|FG013|Treatment Period|Participant withdrew consent|0|||
33321225|NCT00997893|62697132|FG000|Overall Study|Adverse Event|1|||
33321226|NCT00997893|62697133|FG001|Overall Study|Adverse Event|0|||
33321227|NCT00997893|62697134|FG002|Overall Study|Adverse Event|0|||
33407188|NCT01928394|62785670|FG014|Treatment Period|Participant withdrew consent|2|||
33321228|NCT00997893|62697132|FG000|Overall Study|Unable to meet study timelines|1|||
33321229|NCT00997893|62697133|FG001|Overall Study|Unable to meet study timelines|0|||
33321230|NCT00997893|62697134|FG002|Overall Study|Unable to meet study timelines|0|||
33407189|NCT01928394|62785671|FG015|Treatment Period|Participant withdrew consent|0|||
33407190|NCT01928394|62785672|FG016|Treatment Period|Participant withdrew consent|2|||
33407191|NCT01928394|62785673|FG017|Treatment Period|Participant withdrew consent|1|||
33407192|NCT01928394|62785674|FG018|Treatment Period|Participant withdrew consent|1|||
33407193|NCT01928394|62785675|FG019|Treatment Period|Participant withdrew consent|1|||
33407194|NCT01928394|62785676|FG020|Treatment Period|Participant withdrew consent|0|||
33407195|NCT01928394|62785677|FG021|Treatment Period|Participant withdrew consent|2|||
33407196|NCT01928394|62785678|FG022|Treatment Period|Participant withdrew consent|0|||
33407197|NCT01928394|62785656|FG000|Treatment Period|Poor/non-compliance|0|||
33407198|NCT01928394|62785657|FG001|Treatment Period|Poor/non-compliance|0|||
33407199|NCT01928394|62785658|FG002|Treatment Period|Poor/non-compliance|0|||
33407200|NCT01928394|62785659|FG003|Treatment Period|Poor/non-compliance|1|||
33407201|NCT01928394|62785660|FG004|Treatment Period|Poor/non-compliance|0|||
33407202|NCT01928394|62785661|FG005|Treatment Period|Poor/non-compliance|0|||
33407203|NCT01928394|62785662|FG006|Treatment Period|Poor/non-compliance|0|||
33407204|NCT01928394|62785663|FG007|Treatment Period|Poor/non-compliance|0|||
33407205|NCT01928394|62785664|FG008|Treatment Period|Poor/non-compliance|0|||
33407206|NCT01928394|62785665|FG009|Treatment Period|Poor/non-compliance|0|||
33407207|NCT01928394|62785666|FG010|Treatment Period|Poor/non-compliance|0|||
33407208|NCT01928394|62785667|FG011|Treatment Period|Poor/non-compliance|0|||
33407209|NCT01928394|62785668|FG012|Treatment Period|Poor/non-compliance|1|||
33407210|NCT01928394|62785669|FG013|Treatment Period|Poor/non-compliance|0|||
33407211|NCT01928394|62785670|FG014|Treatment Period|Poor/non-compliance|1|||
33407212|NCT01928394|62785671|FG015|Treatment Period|Poor/non-compliance|0|||
33407213|NCT01928394|62785672|FG016|Treatment Period|Poor/non-compliance|0|||
33407214|NCT01928394|62785673|FG017|Treatment Period|Poor/non-compliance|1|||
33407215|NCT01928394|62785674|FG018|Treatment Period|Poor/non-compliance|0|||
33407216|NCT01928394|62785675|FG019|Treatment Period|Poor/non-compliance|1|||
33407217|NCT01928394|62785676|FG020|Treatment Period|Poor/non-compliance|0|||
33407218|NCT01928394|62785677|FG021|Treatment Period|Poor/non-compliance|0|||
33407219|NCT01928394|62785678|FG022|Treatment Period|Poor/non-compliance|0|||
33407220|NCT01928394|62785656|FG000|Treatment Period|other reason|0|||
33407221|NCT01928394|62785657|FG001|Treatment Period|other reason|0|||
33407222|NCT01928394|62785658|FG002|Treatment Period|other reason|0|||
33407223|NCT01928394|62785659|FG003|Treatment Period|other reason|0|||
33407224|NCT01928394|62785660|FG004|Treatment Period|other reason|0|||
33407225|NCT01928394|62785661|FG005|Treatment Period|other reason|0|||
33407226|NCT01928394|62785662|FG006|Treatment Period|other reason|0|||
33407227|NCT01928394|62785663|FG007|Treatment Period|other reason|0|||
33407228|NCT01928394|62785664|FG008|Treatment Period|other reason|0|||
33407229|NCT01928394|62785665|FG009|Treatment Period|other reason|0|||
33407230|NCT01928394|62785666|FG010|Treatment Period|other reason|1|||
33407231|NCT01928394|62785667|FG011|Treatment Period|other reason|1|||
33407232|NCT01928394|62785668|FG012|Treatment Period|other reason|1|||
33407233|NCT01928394|62785669|FG013|Treatment Period|other reason|0|||
33407234|NCT01928394|62785670|FG014|Treatment Period|other reason|1|||
33407235|NCT01928394|62785671|FG015|Treatment Period|other reason|0|||
33407236|NCT01928394|62785672|FG016|Treatment Period|other reason|0|||
33407237|NCT01928394|62785673|FG017|Treatment Period|other reason|0|||
33407238|NCT01928394|62785674|FG018|Treatment Period|other reason|2|||
33407239|NCT01928394|62785675|FG019|Treatment Period|other reason|2|||
33407240|NCT01928394|62785676|FG020|Treatment Period|other reason|0|||
33407241|NCT01928394|62785677|FG021|Treatment Period|other reason|0|||
33407242|NCT01928394|62785678|FG022|Treatment Period|other reason|0|||
33407243|NCT01928394|62785656|FG000|Treatment Period|Maximum clinical benefit|0|||
33407244|NCT01928394|62785657|FG001|Treatment Period|Maximum clinical benefit|0|||
33407245|NCT01928394|62785658|FG002|Treatment Period|Maximum clinical benefit|0|||
33407246|NCT01928394|62785659|FG003|Treatment Period|Maximum clinical benefit|0|||
33407247|NCT01928394|62785660|FG004|Treatment Period|Maximum clinical benefit|0|||
33493974|NCT00089791|62872551|FG001|Overall Study|Protocol deviation|10|||
33493975|NCT00089791|62872550|FG000|Overall Study|Requirement for alternative therapy|7|||
33493976|NCT00089791|62872551|FG001|Overall Study|Requirement for alternative therapy|4|||
33493977|NCT03558672|62872557|FG000|Overall Study|Study Early Termination|10|||
33407248|NCT01928394|62785661|FG005|Treatment Period|Maximum clinical benefit|0|||
33407249|NCT01928394|62785662|FG006|Treatment Period|Maximum clinical benefit|0|||
33407250|NCT01928394|62785663|FG007|Treatment Period|Maximum clinical benefit|0|||
33407251|NCT01928394|62785664|FG008|Treatment Period|Maximum clinical benefit|0|||
33407252|NCT01928394|62785665|FG009|Treatment Period|Maximum clinical benefit|0|||
33407253|NCT01928394|62785666|FG010|Treatment Period|Maximum clinical benefit|1|||
33407254|NCT01928394|62785667|FG011|Treatment Period|Maximum clinical benefit|1|||
33407255|NCT01928394|62785668|FG012|Treatment Period|Maximum clinical benefit|0|||
33407256|NCT01928394|62785669|FG013|Treatment Period|Maximum clinical benefit|0|||
33407257|NCT01928394|62785670|FG014|Treatment Period|Maximum clinical benefit|1|||
33407258|NCT01928394|62785671|FG015|Treatment Period|Maximum clinical benefit|0|||
33407259|NCT01928394|62785672|FG016|Treatment Period|Maximum clinical benefit|0|||
33407260|NCT01928394|62785673|FG017|Treatment Period|Maximum clinical benefit|1|||
33407261|NCT01928394|62785674|FG018|Treatment Period|Maximum clinical benefit|1|||
33407262|NCT01928394|62785675|FG019|Treatment Period|Maximum clinical benefit|0|||
33407263|NCT01928394|62785676|FG020|Treatment Period|Maximum clinical benefit|2|||
33407264|NCT01928394|62785677|FG021|Treatment Period|Maximum clinical benefit|0|||
33598693|NCT02290405|62997632|FG000|Overall Study|Withdrawal by Subject|1|||
33598694|NCT02290405|62997633|FG001|Overall Study|Withdrawal by Subject|0|||
33598695|NCT02359045|62997641|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
33598696|NCT02359045|62997642|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33598697|NCT02359045|62997641|FG000|Overall Study|Lost to Follow-up|1|||
33407265|NCT01928394|62785678|FG022|Treatment Period|Maximum clinical benefit|0|||
33407266|NCT01928394|62785656|FG000|Treatment Period|Lost to Follow-up|0|||
33407267|NCT01928394|62785657|FG001|Treatment Period|Lost to Follow-up|0|||
33407268|NCT01928394|62785658|FG002|Treatment Period|Lost to Follow-up|0|||
33407269|NCT01928394|62785659|FG003|Treatment Period|Lost to Follow-up|0|||
33407270|NCT01928394|62785660|FG004|Treatment Period|Lost to Follow-up|0|||
33407271|NCT01928394|62785661|FG005|Treatment Period|Lost to Follow-up|0|||
33407272|NCT01928394|62785662|FG006|Treatment Period|Lost to Follow-up|0|||
33407273|NCT01928394|62785663|FG007|Treatment Period|Lost to Follow-up|0|||
33407274|NCT01928394|62785664|FG008|Treatment Period|Lost to Follow-up|0|||
33407275|NCT01928394|62785665|FG009|Treatment Period|Lost to Follow-up|0|||
33598698|NCT02359045|62997642|FG001|Overall Study|Lost to Follow-up|1|||
33598699|NCT02359045|62997641|FG000|Overall Study|Adverse Event|0|||
33598700|NCT02359045|62997642|FG001|Overall Study|Adverse Event|1|||
33407276|NCT01928394|62785666|FG010|Treatment Period|Lost to Follow-up|0|||
33407277|NCT01928394|62785667|FG011|Treatment Period|Lost to Follow-up|0|||
33598701|NCT02358343|62997663|FG000|Screening Intervention|Death|0|||
33407278|NCT01928394|62785668|FG012|Treatment Period|Lost to Follow-up|0|||
33407279|NCT01928394|62785669|FG013|Treatment Period|Lost to Follow-up|0|||
33407280|NCT01928394|62785670|FG014|Treatment Period|Lost to Follow-up|0|||
33407281|NCT01928394|62785671|FG015|Treatment Period|Lost to Follow-up|0|||
33407282|NCT01928394|62785672|FG016|Treatment Period|Lost to Follow-up|0|||
33407283|NCT01928394|62785673|FG017|Treatment Period|Lost to Follow-up|0|||
33407284|NCT01928394|62785674|FG018|Treatment Period|Lost to Follow-up|0|||
33407285|NCT01928394|62785675|FG019|Treatment Period|Lost to Follow-up|0|||
33407286|NCT01928394|62785676|FG020|Treatment Period|Lost to Follow-up|0|||
33407287|NCT01928394|62785677|FG021|Treatment Period|Lost to Follow-up|0|||
33407288|NCT01928394|62785678|FG022|Treatment Period|Lost to Follow-up|1|||
33407289|NCT01928394|62785656|FG000|Treatment Period|Death|0|||
33407290|NCT01928394|62785657|FG001|Treatment Period|Death|0|||
33407291|NCT01928394|62785658|FG002|Treatment Period|Death|0|||
33407292|NCT01928394|62785659|FG003|Treatment Period|Death|0|||
33407293|NCT01928394|62785660|FG004|Treatment Period|Death|0|||
33407294|NCT01928394|62785661|FG005|Treatment Period|Death|0|||
33407295|NCT01928394|62785662|FG006|Treatment Period|Death|0|||
33407296|NCT01928394|62785663|FG007|Treatment Period|Death|0|||
33407297|NCT01928394|62785664|FG008|Treatment Period|Death|0|||
33407298|NCT01928394|62785665|FG009|Treatment Period|Death|0|||
33407299|NCT01928394|62785666|FG010|Treatment Period|Death|0|||
33407300|NCT01928394|62785667|FG011|Treatment Period|Death|0|||
33407301|NCT01928394|62785668|FG012|Treatment Period|Death|0|||
33407302|NCT01928394|62785669|FG013|Treatment Period|Death|1|||
33407303|NCT01928394|62785670|FG014|Treatment Period|Death|2|||
33407304|NCT01928394|62785671|FG015|Treatment Period|Death|0|||
33407305|NCT01928394|62785672|FG016|Treatment Period|Death|0|||
33407306|NCT01928394|62785673|FG017|Treatment Period|Death|0|||
33407307|NCT01928394|62785674|FG018|Treatment Period|Death|0|||
33407308|NCT01928394|62785675|FG019|Treatment Period|Death|0|||
33598702|NCT02358343|62997664|FG001|Screening Intervention|Death|2|||
33598703|NCT02358343|62997665|FG002|Screening Intervention|Death|0|||
33407309|NCT01928394|62785676|FG020|Treatment Period|Death|0|||
33407310|NCT01928394|62785677|FG021|Treatment Period|Death|0|||
33407311|NCT01928394|62785678|FG022|Treatment Period|Death|0|||
33407312|NCT01928394|62785656|FG000|Follow-up Period|Participant withdrew consent|3|||
33407313|NCT01928394|62785657|FG001|Follow-up Period|Participant withdrew consent|0|||
33407314|NCT01928394|62785658|FG002|Follow-up Period|Participant withdrew consent|1|||
33407315|NCT01928394|62785659|FG003|Follow-up Period|Participant withdrew consent|4|||
33407316|NCT01928394|62785660|FG004|Follow-up Period|Participant withdrew consent|0|||
33407317|NCT01928394|62785661|FG005|Follow-up Period|Participant withdrew consent|2|||
33407318|NCT01928394|62785662|FG006|Follow-up Period|Participant withdrew consent|5|||
33407319|NCT01928394|62785663|FG007|Follow-up Period|Participant withdrew consent|1|||
33407320|NCT01928394|62785664|FG008|Follow-up Period|Participant withdrew consent|0|||
33407321|NCT01928394|62785665|FG009|Follow-up Period|Participant withdrew consent|0|||
33407322|NCT01928394|62785666|FG010|Follow-up Period|Participant withdrew consent|5|||
33407323|NCT01928394|62785667|FG011|Follow-up Period|Participant withdrew consent|8|||
33407324|NCT01928394|62785668|FG012|Follow-up Period|Participant withdrew consent|2|||
33407325|NCT01928394|62785669|FG013|Follow-up Period|Participant withdrew consent|12|||
33407326|NCT01928394|62785670|FG014|Follow-up Period|Participant withdrew consent|7|||
33407327|NCT01928394|62785671|FG015|Follow-up Period|Participant withdrew consent|0|||
33407328|NCT01928394|62785672|FG016|Follow-up Period|Participant withdrew consent|5|||
33407329|NCT01928394|62785673|FG017|Follow-up Period|Participant withdrew consent|3|||
33407330|NCT01928394|62785674|FG018|Follow-up Period|Participant withdrew consent|2|||
33407331|NCT01928394|62785675|FG019|Follow-up Period|Participant withdrew consent|7|||
33407332|NCT01928394|62785676|FG020|Follow-up Period|Participant withdrew consent|4|||
33407333|NCT01928394|62785677|FG021|Follow-up Period|Participant withdrew consent|6|||
33407334|NCT01928394|62785678|FG022|Follow-up Period|Participant withdrew consent|2|||
33407335|NCT01928394|62785656|FG000|Follow-up Period|Death|0|||
33407336|NCT01928394|62785657|FG001|Follow-up Period|Death|0|||
33407337|NCT01928394|62785658|FG002|Follow-up Period|Death|2|||
33407338|NCT01928394|62785659|FG003|Follow-up Period|Death|6|||
33407339|NCT01928394|62785660|FG004|Follow-up Period|Death|0|||
33407340|NCT01928394|62785661|FG005|Follow-up Period|Death|6|||
33598704|NCT02358343|62997666|FG003|Screening Intervention|Death|0|||
33407341|NCT01928394|62785662|FG006|Follow-up Period|Death|6|||
33407342|NCT01928394|62785663|FG007|Follow-up Period|Death|2|||
33407343|NCT01928394|62785664|FG008|Follow-up Period|Death|1|||
33407344|NCT01928394|62785665|FG009|Follow-up Period|Death|2|||
33407345|NCT01928394|62785666|FG010|Follow-up Period|Death|4|||
33407346|NCT01928394|62785667|FG011|Follow-up Period|Death|12|||
33407347|NCT01928394|62785668|FG012|Follow-up Period|Death|11|||
33407348|NCT01928394|62785669|FG013|Follow-up Period|Death|25|||
33407349|NCT01928394|62785670|FG014|Follow-up Period|Death|18|||
33407350|NCT01928394|62785671|FG015|Follow-up Period|Death|0|||
33407351|NCT01928394|62785672|FG016|Follow-up Period|Death|6|||
33407352|NCT01928394|62785673|FG017|Follow-up Period|Death|5|||
33598705|NCT02358343|62997667|FG004|Screening Intervention|Death|0|||
33407353|NCT01928394|62785674|FG018|Follow-up Period|Death|13|||
33407354|NCT01928394|62785675|FG019|Follow-up Period|Death|13|||
33407355|NCT01928394|62785676|FG020|Follow-up Period|Death|5|||
33407356|NCT01928394|62785677|FG021|Follow-up Period|Death|3|||
33407357|NCT01928394|62785678|FG022|Follow-up Period|Death|2|||
33407358|NCT01928394|62785656|FG000|Follow-up Period|other reason|0|||
33407359|NCT01928394|62785657|FG001|Follow-up Period|other reason|0|||
33407360|NCT01928394|62785658|FG002|Follow-up Period|other reason|0|||
33407361|NCT01928394|62785659|FG003|Follow-up Period|other reason|0|||
33407362|NCT01928394|62785660|FG004|Follow-up Period|other reason|0|||
33407363|NCT01928394|62785661|FG005|Follow-up Period|other reason|0|||
33407364|NCT01928394|62785662|FG006|Follow-up Period|other reason|1|||
33407365|NCT01928394|62785663|FG007|Follow-up Period|other reason|3|||
33407366|NCT01928394|62785664|FG008|Follow-up Period|other reason|0|||
33407367|NCT01928394|62785665|FG009|Follow-up Period|other reason|0|||
33407368|NCT01928394|62785666|FG010|Follow-up Period|other reason|2|||
33407369|NCT01928394|62785667|FG011|Follow-up Period|other reason|1|||
33407370|NCT01928394|62785668|FG012|Follow-up Period|other reason|0|||
33407371|NCT01928394|62785669|FG013|Follow-up Period|other reason|1|||
33407372|NCT01928394|62785670|FG014|Follow-up Period|other reason|4|||
33407373|NCT01928394|62785671|FG015|Follow-up Period|other reason|0|||
33407374|NCT01928394|62785672|FG016|Follow-up Period|other reason|2|||
33407375|NCT01928394|62785673|FG017|Follow-up Period|other reason|0|||
33407376|NCT01928394|62785674|FG018|Follow-up Period|other reason|1|||
33407377|NCT01928394|62785675|FG019|Follow-up Period|other reason|1|||
33407378|NCT01928394|62785676|FG020|Follow-up Period|other reason|0|||
33407379|NCT01928394|62785677|FG021|Follow-up Period|other reason|0|||
33598706|NCT02358343|62997663|FG000|Screening Intervention|Withdrawal by Subject|1|||
33598707|NCT02358343|62997664|FG001|Screening Intervention|Withdrawal by Subject|0|||
33598708|NCT02358343|62997665|FG002|Screening Intervention|Withdrawal by Subject|0|||
33598709|NCT02358343|62997666|FG003|Screening Intervention|Withdrawal by Subject|0|||
33598710|NCT02358343|62997667|FG004|Screening Intervention|Withdrawal by Subject|0|||
33598711|NCT02358343|62997663|FG000|Screening Intervention|Determined Ineligible|5|||
33598712|NCT02358343|62997664|FG001|Screening Intervention|Determined Ineligible|6|||
33598713|NCT02358343|62997665|FG002|Screening Intervention|Determined Ineligible|0|||
33598714|NCT02358343|62997666|FG003|Screening Intervention|Determined Ineligible|0|||
33598715|NCT02358343|62997667|FG004|Screening Intervention|Determined Ineligible|0|||
33598716|NCT02358343|62997663|FG000|Comparative Efficacy Trial / Observation|Death|0|||
33598717|NCT02358343|62997664|FG001|Comparative Efficacy Trial / Observation|Death|0|||
33598718|NCT02358343|62997665|FG002|Comparative Efficacy Trial / Observation|Death|2|||
33598719|NCT02358343|62997666|FG003|Comparative Efficacy Trial / Observation|Death|0|||
33598720|NCT02358343|62997667|FG004|Comparative Efficacy Trial / Observation|Death|0|||
33598721|NCT02358343|62997663|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
33598722|NCT02358343|62997664|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
33598723|NCT02358343|62997665|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
33598724|NCT02358343|62997666|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
33598725|NCT02358343|62997667|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
33598726|NCT02358343|62997663|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
33598727|NCT02358343|62997664|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
33598728|NCT02358343|62997665|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
33598729|NCT02358343|62997666|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
33598730|NCT02358343|62997667|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
33598731|NCT02356783|62997680|FG000|Overall Study|Lost to Follow-up|1|||
33598732|NCT02356783|62997681|FG001|Overall Study|Lost to Follow-up|3|||
33598733|NCT02289469|62997689|FG000|Overall Study|Unable to match a control|6|||
33598734|NCT02289469|62997690|FG001|Overall Study|Unable to match a control|0|||
33598735|NCT02318095|62997696|FG000|Overall Study|Adverse Event|1|||
33407380|NCT01928394|62785678|FG022|Follow-up Period|other reason|1|||
33407381|NCT01928394|62785656|FG000|Follow-up Period|Lost to Follow-up|0|||
33407382|NCT01928394|62785657|FG001|Follow-up Period|Lost to Follow-up|0|||
33407383|NCT01928394|62785658|FG002|Follow-up Period|Lost to Follow-up|0|||
33407384|NCT01928394|62785659|FG003|Follow-up Period|Lost to Follow-up|0|||
33407385|NCT01928394|62785660|FG004|Follow-up Period|Lost to Follow-up|0|||
33407386|NCT01928394|62785661|FG005|Follow-up Period|Lost to Follow-up|0|||
33407387|NCT01928394|62785662|FG006|Follow-up Period|Lost to Follow-up|0|||
33407388|NCT01928394|62785663|FG007|Follow-up Period|Lost to Follow-up|0|||
33407389|NCT01928394|62785664|FG008|Follow-up Period|Lost to Follow-up|0|||
33407390|NCT01928394|62785665|FG009|Follow-up Period|Lost to Follow-up|0|||
33407391|NCT01928394|62785666|FG010|Follow-up Period|Lost to Follow-up|0|||
33407392|NCT01928394|62785667|FG011|Follow-up Period|Lost to Follow-up|1|||
33407393|NCT01928394|62785668|FG012|Follow-up Period|Lost to Follow-up|1|||
33407394|NCT01928394|62785669|FG013|Follow-up Period|Lost to Follow-up|0|||
33407395|NCT01928394|62785670|FG014|Follow-up Period|Lost to Follow-up|1|||
33407396|NCT01928394|62785671|FG015|Follow-up Period|Lost to Follow-up|0|||
33407397|NCT01928394|62785672|FG016|Follow-up Period|Lost to Follow-up|1|||
33407398|NCT01928394|62785673|FG017|Follow-up Period|Lost to Follow-up|0|||
33407399|NCT01928394|62785674|FG018|Follow-up Period|Lost to Follow-up|0|||
33407400|NCT01928394|62785675|FG019|Follow-up Period|Lost to Follow-up|0|||
33407401|NCT01928394|62785676|FG020|Follow-up Period|Lost to Follow-up|0|||
33407402|NCT01928394|62785677|FG021|Follow-up Period|Lost to Follow-up|0|||
33407403|NCT01928394|62785678|FG022|Follow-up Period|Lost to Follow-up|1|||
33407404|NCT01909453|62785731|FG000|Overall Study|Ongoing|118|||
33407405|NCT01909453|62785732|FG001|Overall Study|Ongoing|103|||
33407406|NCT01909453|62785733|FG002|Overall Study|Ongoing|83|||
33407407|NCT01909453|62785734|FG003|Overall Study|Ongoing|164|||
33407408|NCT01909453|62785735|FG004|Overall Study|Ongoing|50|||
33407409|NCT01909453|62785731|FG000|Overall Study|Death|69|||
33407410|NCT01909453|62785732|FG001|Overall Study|Death|74|||
33407411|NCT01909453|62785733|FG002|Overall Study|Death|88|||
33407412|NCT01909453|62785734|FG003|Overall Study|Death|86|||
33407413|NCT01909453|62785735|FG004|Overall Study|Death|29|||
33407414|NCT01909453|62785731|FG000|Overall Study|Lost to Follow-up|3|||
33407415|NCT01909453|62785732|FG001|Overall Study|Lost to Follow-up|4|||
33407416|NCT01909453|62785733|FG002|Overall Study|Lost to Follow-up|4|||
33407417|NCT01909453|62785734|FG003|Overall Study|Lost to Follow-up|3|||
33407418|NCT01909453|62785735|FG004|Overall Study|Lost to Follow-up|3|||
33407419|NCT01909453|62785731|FG000|Overall Study|Withdrawal by Subject|2|||
33407420|NCT01909453|62785732|FG001|Overall Study|Withdrawal by Subject|13|||
33407421|NCT01909453|62785733|FG002|Overall Study|Withdrawal by Subject|16|||
33407422|NCT01909453|62785734|FG003|Overall Study|Withdrawal by Subject|5|||
33407423|NCT01909453|62785735|FG004|Overall Study|Withdrawal by Subject|4|||
33407424|NCT01882803|62785753|FG000|Overall Study|Disease Progression|1|||
33407425|NCT01882803|62785753|FG000|Overall Study|Withdrawal by Subject|9|||
33407426|NCT01882803|62785753|FG000|Overall Study|Death|68|||
33407427|NCT01882803|62785753|FG000|Overall Study|Physician Decision|3|||
33407428|NCT01882803|62785753|FG000|Overall Study|Lost to Follow-up|3|||
33407429|NCT01882803|62785753|FG000|Overall Study|Follow-up Completed|39|||
33407430|NCT01882803|62785753|FG000|Overall Study|Study Terminated by the Sponsor|6|||
33407431|NCT01844986|62785760|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
33407432|NCT01844986|62785761|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
33407433|NCT01844986|62785760|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
33407434|NCT01844986|62785761|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
33407435|NCT01844986|62785760|FG000|Overall Study (Global Cohort)|Death|55|||
33407436|NCT01844986|62785761|FG001|Overall Study (Global Cohort)|Death|26|||
33407437|NCT01844986|62785760|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
33407438|NCT01844986|62785761|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
33407439|NCT01844986|62785760|FG000|Overall Study (China Cohort)|Death|10|||
33407440|NCT01844986|62785761|FG001|Overall Study (China Cohort)|Death|6|||
33407441|NCT01196390|62785781|FG000|Overall Study|Protocol Violation|4|||
33407442|NCT01196390|62785782|FG001|Overall Study|Protocol Violation|5|||
33407443|NCT00659126|62785805|FG000|Overall Study|Adverse Event|2|||
33407444|NCT00659126|62785806|FG001|Overall Study|Adverse Event|2|||
33407445|NCT00659126|62785805|FG000|Overall Study|Screen failure|1|||
33407446|NCT00659126|62785806|FG001|Overall Study|Screen failure|1|||
33407447|NCT00659126|62785805|FG000|Overall Study|Technical problems with MRI|0|||
33407448|NCT00659126|62785806|FG001|Overall Study|Technical problems with MRI|1|||
33407449|NCT00152503|62785837|FG000|Overall Study|Adverse Event|4|||
33321231|NCT00997893|62697132|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
33321232|NCT00997893|62697133|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
33321233|NCT00997893|62697134|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
33321234|NCT02905825|62697151|FG000|Overall Study|Protocol Violation|11|||
33321235|NCT02905825|62697151|FG000|Overall Study|Device Malfunction|1|||
33321236|NCT01208051|62697160|FG000|Total Enrollment|Withdrawal by Subject|0|||
33407450|NCT03865407|62785843|FG000|Overall Study|Adverse Event|1|||
33407451|NCT03865407|62785844|FG001|Overall Study|Adverse Event|0|||
33407452|NCT03865407|62785843|FG000|Overall Study|Withdrawal by Subject|1|||
33407453|NCT03865407|62785844|FG001|Overall Study|Withdrawal by Subject|0|||
33407454|NCT03865407|62785843|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
33407455|NCT03865407|62785844|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
33407456|NCT00487942|62785854|FG000|Overall Study|Adverse Event|1|||
33407457|NCT00487942|62785855|FG001|Overall Study|Adverse Event|1|||
33407458|NCT00487942|62785856|FG002|Overall Study|Adverse Event|1|||
33407459|NCT00487942|62785857|FG003|Overall Study|Adverse Event|1|||
33407460|NCT00487942|62785854|FG000|Overall Study|Lost to Follow-up|1|||
33407461|NCT00487942|62785855|FG001|Overall Study|Lost to Follow-up|0|||
33407462|NCT00487942|62785856|FG002|Overall Study|Lost to Follow-up|0|||
33407463|NCT00487942|62785857|FG003|Overall Study|Lost to Follow-up|1|||
33407464|NCT00487942|62785854|FG000|Overall Study|Protocol Violation|1|||
33407465|NCT00487942|62785855|FG001|Overall Study|Protocol Violation|1|||
33407466|NCT00487942|62785856|FG002|Overall Study|Protocol Violation|0|||
33407467|NCT00487942|62785857|FG003|Overall Study|Protocol Violation|0|||
33407468|NCT00487942|62785854|FG000|Overall Study|Withdrawal by Subject|0|||
33598736|NCT02317705|62997701|FG000|Overall Study|Withdrawal by Subject|3|||
33598737|NCT02317705|62997701|FG000|Overall Study|Physician Decision|1|||
33598738|NCT02317705|62997701|FG000|Overall Study|Drug not usable|1|||
33598739|NCT02474069|62997705|FG000|Selection Phase (SP)|Adverse Event|8|||
33598740|NCT02474069|62997706|FG001|Selection Phase (SP)|Adverse Event|0|||
33321237|NCT01208051|62697161|FG001|Total Enrollment|Withdrawal by Subject|1|||
33321238|NCT01208051|62697162|FG002|Total Enrollment|Withdrawal by Subject|0|||
33321239|NCT01208051|62697163|FG003|Total Enrollment|Withdrawal by Subject|0|||
33321240|NCT01208051|62697164|FG004|Total Enrollment|Withdrawal by Subject|2|||
33321241|NCT01208051|62697160|FG000|Total Enrollment|Brain metastases|0|||
33321242|NCT01208051|62697161|FG001|Total Enrollment|Brain metastases|0|||
33321243|NCT01208051|62697162|FG002|Total Enrollment|Brain metastases|1|||
33407469|NCT00487942|62785855|FG001|Overall Study|Withdrawal by Subject|1|||
33407470|NCT00487942|62785856|FG002|Overall Study|Withdrawal by Subject|2|||
33321244|NCT01208051|62697163|FG003|Total Enrollment|Brain metastases|0|||
33321245|NCT01208051|62697164|FG004|Total Enrollment|Brain metastases|0|||
33321246|NCT01207583|62697183|FG000|Overall Study|Withdrawal by Subject|0|||
33407471|NCT00487942|62785857|FG003|Overall Study|Withdrawal by Subject|0|||
33407472|NCT00132301|62785869|FG000|Overall Study|Death|7|||
33407473|NCT00132301|62785870|FG001|Overall Study|Death|6|||
33407474|NCT00132301|62785869|FG000|Overall Study|Withdrawal by Subject|5|||
33598741|NCT02474069|62997707|FG002|Selection Phase (SP)|Adverse Event|0|||
33598742|NCT02474069|62997705|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
33598743|NCT02474069|62997706|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
33598744|NCT02474069|62997707|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
33598745|NCT02474069|62997705|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
33598746|NCT02474069|62997706|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
33598747|NCT02474069|62997707|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
33598748|NCT02474069|62997705|FG000|Selection Phase (SP)|Physician Decision|1|||
33598749|NCT02474069|62997706|FG001|Selection Phase (SP)|Physician Decision|0|||
33598750|NCT02474069|62997707|FG002|Selection Phase (SP)|Physician Decision|0|||
33598751|NCT02474069|62997705|FG000|Selection Phase (SP)|Protocol Violation|1|||
33598752|NCT02474069|62997706|FG001|Selection Phase (SP)|Protocol Violation|0|||
33598753|NCT02474069|62997707|FG002|Selection Phase (SP)|Protocol Violation|0|||
33598754|NCT02474069|62997705|FG000|Selection Phase (SP)|No longer requires treatment|1|||
33598755|NCT02474069|62997706|FG001|Selection Phase (SP)|No longer requires treatment|0|||
33598756|NCT02474069|62997707|FG002|Selection Phase (SP)|No longer requires treatment|0|||
33598757|NCT02474069|62997705|FG000|Selection Phase (SP)|Technical Problem|1|||
33598758|NCT02474069|62997706|FG001|Selection Phase (SP)|Technical Problem|0|||
33598759|NCT02474069|62997707|FG002|Selection Phase (SP)|Technical Problem|0|||
33598760|NCT02474069|62997705|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
33598761|NCT02474069|62997706|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
33598762|NCT02474069|62997707|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
33598763|NCT02474069|62997705|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
33598764|NCT02474069|62997706|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
33598765|NCT02474069|62997707|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
33598766|NCT02474069|62997705|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
33598767|NCT02474069|62997706|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
33598768|NCT02474069|62997707|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
33598769|NCT02474069|62997705|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
33598770|NCT02474069|62997706|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
33598771|NCT02474069|62997707|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
33598772|NCT02474069|62997705|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
33407475|NCT00132301|62785870|FG001|Overall Study|Withdrawal by Subject|2|||
33407476|NCT00132301|62785869|FG000|Overall Study|Physician Decision|1|||
33407477|NCT00132301|62785870|FG001|Overall Study|Physician Decision|1|||
33407478|NCT00132301|62785869|FG000|Overall Study|Lost to Follow-up|5|||
33407479|NCT00132301|62785870|FG001|Overall Study|Lost to Follow-up|3|||
33407480|NCT00132301|62785869|FG000|Overall Study|Other|1|||
33407481|NCT00132301|62785870|FG001|Overall Study|Other|1|||
33407482|NCT00132301|62785869|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
33407483|NCT00132301|62785870|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
33407484|NCT00522873|62785878|FG000|Overall Study|Adverse Event|41|||
33407485|NCT00522873|62785879|FG001|Overall Study|Adverse Event|26|||
33407486|NCT00522873|62785878|FG000|Overall Study|Withdrawal by Subject|20|||
33407487|NCT00522873|62785879|FG001|Overall Study|Withdrawal by Subject|9|||
33407488|NCT00522873|62785878|FG000|Overall Study|Protocol Violation|14|||
33407489|NCT00522873|62785879|FG001|Overall Study|Protocol Violation|4|||
33407490|NCT00522873|62785878|FG000|Overall Study|Lost to Follow-up|11|||
33407491|NCT00522873|62785879|FG001|Overall Study|Lost to Follow-up|3|||
33407492|NCT00522873|62785878|FG000|Overall Study|Personal Reasons|8|||
33407493|NCT00522873|62785879|FG001|Overall Study|Personal Reasons|1|||
33407494|NCT00522873|62785878|FG000|Overall Study|Medication Errors|1|||
33407495|NCT00522873|62785879|FG001|Overall Study|Medication Errors|1|||
33407496|NCT00522873|62785878|FG000|Overall Study|Never Received Medication|1|||
33407497|NCT00522873|62785879|FG001|Overall Study|Never Received Medication|0|||
33407498|NCT03684057|62785887|FG000|Overall Study|Withdrawal by Subject|4|||
33407499|NCT03684057|62785888|FG001|Overall Study|Withdrawal by Subject|5|||
33407500|NCT03864627|62785897|FG000|Overall Study|Adverse Event|0|||
33407501|NCT03864627|62785898|FG001|Overall Study|Adverse Event|1|||
33598773|NCT02474069|62997706|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
33598774|NCT02474069|62997707|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
33598775|NCT02474069|62997705|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
33598776|NCT02474069|62997706|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
33598777|NCT02474069|62997707|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
33407502|NCT03864627|62785897|FG000|Overall Study|Lack of Efficacy|0|||
33407503|NCT03864627|62785898|FG001|Overall Study|Lack of Efficacy|1|||
33407504|NCT03864627|62785897|FG000|Overall Study|Lost to Follow-up|0|||
33407505|NCT03864627|62785898|FG001|Overall Study|Lost to Follow-up|1|||
33407506|NCT03864627|62785897|FG000|Overall Study|Withdrawal by Subject|4|||
33407507|NCT03864627|62785898|FG001|Overall Study|Withdrawal by Subject|8|||
33407508|NCT03864627|62785897|FG000|Overall Study|Study terminated by sponsor|0|||
33598778|NCT02317627|62997720|FG000|Overall Study|Withdrawal by Subject|0|||
33598779|NCT02317627|62997721|FG001|Overall Study|Withdrawal by Subject|1|||
33598780|NCT02317627|62997722|FG002|Overall Study|Withdrawal by Subject|1|||
33598781|NCT02317627|62997720|FG000|Overall Study|Lost to Follow-up|2|||
33598782|NCT02317627|62997721|FG001|Overall Study|Lost to Follow-up|0|||
33598783|NCT02317627|62997722|FG002|Overall Study|Lost to Follow-up|0|||
33598784|NCT02317627|62997720|FG000|Overall Study|Stopped by Investigator|0|||
33598785|NCT02317627|62997721|FG001|Overall Study|Stopped by Investigator|1|||
33598786|NCT02317627|62997722|FG002|Overall Study|Stopped by Investigator|0|||
33598787|NCT02317627|62997720|FG000|Overall Study|Adverse Event|0|||
33598788|NCT02317627|62997721|FG001|Overall Study|Adverse Event|2|||
33598789|NCT02317627|62997722|FG002|Overall Study|Adverse Event|3|||
33598790|NCT02317627|62997720|FG000|Overall Study|Non-compliance with study drug|0|||
33598791|NCT02317627|62997721|FG001|Overall Study|Non-compliance with study drug|1|||
33598792|NCT02317627|62997722|FG002|Overall Study|Non-compliance with study drug|0|||
33598793|NCT02517905|62997738|FG000|Overall Study|Lost to Follow-up|4|||
33598794|NCT02517905|62997739|FG001|Overall Study|Lost to Follow-up|0|||
33598795|NCT02517905|62997738|FG000|Overall Study|Withdrawal by Subject|4|||
33598796|NCT02517905|62997739|FG001|Overall Study|Withdrawal by Subject|0|||
33598797|NCT02517905|62997738|FG000|Overall Study|Screen failure|2|||
33598798|NCT02517905|62997739|FG001|Overall Study|Screen failure|2|||
33598799|NCT02473913|62997747|FG000|Overall Study|Lost to Follow-up|3|||
33598800|NCT02473913|62997748|FG001|Overall Study|Lost to Follow-up|3|||
33598801|NCT02316847|62997756|FG000|Overall Study|Adverse Event|0|||
33598802|NCT02316847|62997757|FG001|Overall Study|Adverse Event|3|||
33598803|NCT02316847|62997756|FG000|Overall Study|Lost to Follow-up|0|||
33598804|NCT02316847|62997757|FG001|Overall Study|Lost to Follow-up|2|||
33598805|NCT02316847|62997756|FG000|Overall Study|Physician Decision|0|||
33598806|NCT02316847|62997757|FG001|Overall Study|Physician Decision|1|||
33598807|NCT02316847|62997756|FG000|Overall Study|Pregnancy|0|||
33598808|NCT02316847|62997757|FG001|Overall Study|Pregnancy|1|||
33598809|NCT02316847|62997756|FG000|Overall Study|Withdrawal by Subject|2|||
33598810|NCT02316847|62997757|FG001|Overall Study|Withdrawal by Subject|9|||
33598811|NCT02316847|62997756|FG000|Overall Study|Noncompliance with study drug|0|||
33598812|NCT02316847|62997757|FG001|Overall Study|Noncompliance with study drug|3|||
33598813|NCT02316847|62997756|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
33598814|NCT02316847|62997757|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
33598815|NCT02473523|62997765|FG000|Overall Study|Death|1|||
33598816|NCT02473523|62997765|FG000|Overall Study|Lost to Follow-up|1|||
33598817|NCT02316769|62997771|FG000|Overall Study|Physician Decision|1|||
33598818|NCT02316769|62997772|FG001|Overall Study|Physician Decision|0|||
33598819|NCT02316769|62997771|FG000|Overall Study|Withdrawal by Subject|1|||
33598820|NCT02316769|62997772|FG001|Overall Study|Withdrawal by Subject|0|||
33598821|NCT02473445|62997778|FG000|Overall Study|Withdrawal by Subject|2|||
33598822|NCT02473445|62997778|FG000|Overall Study|Sponsor Decision|20|||
33598823|NCT02473367|62997782|FG000|Wait 1|Withdrawal by Subject|1|||
33598824|NCT02473367|62997782|FG000|Period 4|Lost to Follow-up|1|||
33598825|NCT02316613|62997792|FG000|Overall Study|Death|63|||
33598826|NCT02316613|62997792|FG000|Overall Study|Lost to Follow-up|9|||
33598827|NCT02316613|62997792|FG000|Overall Study|Lymphoma transformation|2|||
33598828|NCT02316613|62997792|FG000|Overall Study|Participant moved/changed medical team|11|||
33598829|NCT02316613|62997792|FG000|Overall Study|No data and duplicate cases|5|||
33321247|NCT01207583|62697184|FG001|Overall Study|Withdrawal by Subject|3|||
33321248|NCT01207583|62697185|FG002|Overall Study|Withdrawal by Subject|1|||
33321249|NCT01207583|62697183|FG000|Overall Study|Participant failed to return|1|||
33407509|NCT03864627|62785898|FG001|Overall Study|Study terminated by sponsor|1|||
33407510|NCT00519831|62785905|FG000|Overall Study|Adverse Event|3|||
33407511|NCT00131911|62785915|FG000|Overall Study|Withdrawal by Subject|1|||
33407512|NCT00131911|62785916|FG001|Overall Study|Withdrawal by Subject|0|||
33407513|NCT00184093|62785921|FG000|Overall Study|Adverse Event|3|||
33407514|NCT00184093|62785921|FG000|Overall Study|Lost to Follow-up|3|||
33407515|NCT00184093|62785921|FG000|Overall Study|Physician Decision|1|||
33598830|NCT02316613|62997792|FG000|Overall Study|Did not met selection criteria|14|||
33321250|NCT01207583|62697184|FG001|Overall Study|Participant failed to return|0|||
33598831|NCT02492165|62997811|FG000|Overall Study|Withdrawal by Subject|0|||
33598832|NCT02492165|62997812|FG001|Overall Study|Withdrawal by Subject|1|||
33598833|NCT02492165|62997813|FG002|Overall Study|Withdrawal by Subject|0|||
33598834|NCT02492165|62997814|FG003|Overall Study|Withdrawal by Subject|0|||
33598835|NCT02355691|62997826|FG000|Overall Study|Loss of Research Personnel|7|||
33598836|NCT02355691|62997827|FG001|Overall Study|Loss of Research Personnel|9|||
33598837|NCT02473289|62997835|FG000|Overall Study|Adverse Event|2|||
33321251|NCT01207583|62697185|FG002|Overall Study|Participant failed to return|0|||
33321252|NCT01207583|62697183|FG000|Overall Study|Lost to Follow-up|0|||
33321253|NCT01207583|62697184|FG001|Overall Study|Lost to Follow-up|2|||
33598838|NCT02473289|62997836|FG001|Overall Study|Adverse Event|3|||
33407516|NCT00184093|62785921|FG000|Overall Study|Withdrawal by Subject|2|||
33407517|NCT00183625|62785927|FG000|Overall Study|Withdrawal by Subject|18|||
33407518|NCT00183625|62785928|FG001|Overall Study|Withdrawal by Subject|18|||
33407519|NCT00183625|62785929|FG002|Overall Study|Withdrawal by Subject|19|||
33407520|NCT00183625|62785930|FG003|Overall Study|Withdrawal by Subject|14|||
33407521|NCT00511875|62785940|FG000|Overall Study|Lost to Follow-up|4|||
33407522|NCT00511875|62785941|FG001|Overall Study|Lost to Follow-up|0|||
33407523|NCT00511875|62785940|FG000|Overall Study|Missing variables|1|||
33407524|NCT00511875|62785941|FG001|Overall Study|Missing variables|0|||
33407525|NCT00183391|62785949|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
33407526|NCT00183391|62785950|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
33407527|NCT00183391|62785949|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
33407528|NCT00183391|62785950|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
33407529|NCT00493246|62785966|FG000|Overall Study|Withdrawal by Subject|0|||
33407530|NCT00493246|62785967|FG001|Overall Study|Withdrawal by Subject|0|||
33407531|NCT00493246|62785968|FG002|Overall Study|Withdrawal by Subject|0|||
33407532|NCT00493246|62785969|FG003|Overall Study|Withdrawal by Subject|0|||
33407533|NCT00493246|62785970|FG004|Overall Study|Withdrawal by Subject|1|||
33407534|NCT00493246|62785971|FG005|Overall Study|Withdrawal by Subject|0|||
33407535|NCT00493246|62785972|FG006|Overall Study|Withdrawal by Subject|0|||
33407536|NCT00493246|62785973|FG007|Overall Study|Withdrawal by Subject|0|||
33407537|NCT00493246|62785966|FG000|Overall Study|No access to draw blood|0|||
33407538|NCT00493246|62785967|FG001|Overall Study|No access to draw blood|0|||
33407539|NCT00493246|62785968|FG002|Overall Study|No access to draw blood|0|||
33407540|NCT00493246|62785969|FG003|Overall Study|No access to draw blood|0|||
33407541|NCT00493246|62785970|FG004|Overall Study|No access to draw blood|0|||
33407542|NCT00493246|62785971|FG005|Overall Study|No access to draw blood|1|||
33407543|NCT00493246|62785972|FG006|Overall Study|No access to draw blood|0|||
33407544|NCT00493246|62785973|FG007|Overall Study|No access to draw blood|0|||
33407545|NCT00493246|62785966|FG000|Overall Study|Lost to Follow-up|0|||
33407546|NCT00493246|62785967|FG001|Overall Study|Lost to Follow-up|0|||
33407547|NCT00493246|62785968|FG002|Overall Study|Lost to Follow-up|0|||
33407548|NCT00493246|62785969|FG003|Overall Study|Lost to Follow-up|0|||
33407549|NCT00493246|62785970|FG004|Overall Study|Lost to Follow-up|0|||
33407550|NCT00493246|62785971|FG005|Overall Study|Lost to Follow-up|0|||
33407551|NCT00493246|62785972|FG006|Overall Study|Lost to Follow-up|1|||
33407552|NCT00493246|62785973|FG007|Overall Study|Lost to Follow-up|0|||
33407553|NCT02281955|62785991|FG000|Overall Study|Death|1|||
33407554|NCT00511797|62785999|FG000|Overall Study|Adverse Event|1|||
33407555|NCT00511797|62786000|FG001|Overall Study|Adverse Event|2|||
33407556|NCT00511797|62786001|FG002|Overall Study|Adverse Event|2|||
33407557|NCT00511797|62786002|FG003|Overall Study|Adverse Event|2|||
33407558|NCT00511797|62785999|FG000|Overall Study|Lost to Follow-up|1|||
33407559|NCT00511797|62786000|FG001|Overall Study|Lost to Follow-up|0|||
33407560|NCT00511797|62786001|FG002|Overall Study|Lost to Follow-up|0|||
33407561|NCT00511797|62786002|FG003|Overall Study|Lost to Follow-up|1|||
33321254|NCT01207583|62697185|FG002|Overall Study|Lost to Follow-up|0|||
33321255|NCT01207427|62697209|FG000|Double-blind Treatment Period|Adverse Event|0|||
33321256|NCT01207427|62697210|FG001|Double-blind Treatment Period|Adverse Event|1|||
33321257|NCT01207427|62697211|FG002|Double-blind Treatment Period|Adverse Event|0|||
33321258|NCT01207427|62697209|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
33321259|NCT01207427|62697210|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
33321260|NCT01207427|62697211|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
33321261|NCT01207427|62697209|FG000|Double-blind Treatment Period|Protocol Violation|2|||
33321262|NCT01207427|62697210|FG001|Double-blind Treatment Period|Protocol Violation|1|||
33321263|NCT01207427|62697211|FG002|Double-blind Treatment Period|Protocol Violation|1|||
33321264|NCT01207427|62697209|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
33321265|NCT01207427|62697210|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
33321266|NCT01207427|62697211|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33321267|NCT04713553|62697224|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
33321268|NCT04713553|62697225|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
33321269|NCT04713553|62697226|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
33321270|NCT04713553|62697227|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
33321271|NCT04713553|62697228|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
33407562|NCT00511797|62785999|FG000|Overall Study|Pregnancy|0|||
33407563|NCT00511797|62786000|FG001|Overall Study|Pregnancy|0|||
33407564|NCT00511797|62786001|FG002|Overall Study|Pregnancy|0|||
33407565|NCT00511797|62786002|FG003|Overall Study|Pregnancy|1|||
33407566|NCT00511797|62785999|FG000|Overall Study|Protocol Violation|0|||
33407567|NCT00511797|62786000|FG001|Overall Study|Protocol Violation|2|||
33407568|NCT00511797|62786001|FG002|Overall Study|Protocol Violation|2|||
33407569|NCT00511797|62786002|FG003|Overall Study|Protocol Violation|3|||
33407570|NCT00511797|62785999|FG000|Overall Study|Withdrawal by Subject|3|||
33407571|NCT00511797|62786000|FG001|Overall Study|Withdrawal by Subject|3|||
33321272|NCT04713553|62697229|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
33407572|NCT00511797|62786001|FG002|Overall Study|Withdrawal by Subject|4|||
33407573|NCT00511797|62786002|FG003|Overall Study|Withdrawal by Subject|2|||
33407574|NCT00511797|62785999|FG000|Overall Study|Never dispensed|1|||
33407575|NCT00511797|62786000|FG001|Overall Study|Never dispensed|0|||
33407576|NCT00511797|62786001|FG002|Overall Study|Never dispensed|1|||
33407577|NCT00511797|62786002|FG003|Overall Study|Never dispensed|3|||
33407578|NCT00511797|62785999|FG000|Overall Study|Study drug not taken|0|||
33407579|NCT00511797|62786000|FG001|Overall Study|Study drug not taken|1|||
33407580|NCT00511797|62786001|FG002|Overall Study|Study drug not taken|0|||
33407581|NCT00511797|62786002|FG003|Overall Study|Study drug not taken|1|||
33407582|NCT00511797|62785999|FG000|Overall Study|Partially missing diary|0|||
33407583|NCT00511797|62786000|FG001|Overall Study|Partially missing diary|0|||
33407584|NCT00511797|62786001|FG002|Overall Study|Partially missing diary|1|||
33407585|NCT00511797|62786002|FG003|Overall Study|Partially missing diary|0|||
33407586|NCT00511797|62785999|FG000|Overall Study|Other (moving etc)|1|||
33407587|NCT00511797|62786000|FG001|Overall Study|Other (moving etc)|0|||
33407588|NCT00511797|62786001|FG002|Overall Study|Other (moving etc)|1|||
33407589|NCT00511797|62786002|FG003|Overall Study|Other (moving etc)|2|||
33407590|NCT00487552|62786012|FG000|Overall Study|Unsuccessful magnet placements|3|||
33407591|NCT00487552|62786012|FG000|Overall Study|Death due to progressive malignancy|2|||
33407592|NCT00487552|62786012|FG000|Overall Study|Stent not placed|1|||
33407593|NCT00182689|62786019|FG000|Overall Study|Adverse Event|8|||
33407594|NCT00182689|62786020|FG001|Overall Study|Adverse Event|11|||
33407595|NCT00182689|62786019|FG000|Overall Study|Withdrawal by Subject|2|||
33407596|NCT00182689|62786020|FG001|Overall Study|Withdrawal by Subject|2|||
33407597|NCT00182689|62786019|FG000|Overall Study|Progression|27|||
33407598|NCT00182689|62786020|FG001|Overall Study|Progression|29|||
33407599|NCT00182689|62786019|FG000|Overall Study|Death|1|||
33407600|NCT00182689|62786020|FG001|Overall Study|Death|0|||
33407601|NCT00182689|62786019|FG000|Overall Study|not protocol specified|0|||
33407602|NCT00182689|62786020|FG001|Overall Study|not protocol specified|3|||
33407603|NCT00182689|62786019|FG000|Overall Study|Ineligible|1|||
33407604|NCT00182689|62786020|FG001|Overall Study|Ineligible|4|||
33407605|NCT00182689|62786019|FG000|Overall Study|Never received treatment|1|||
33407606|NCT00182689|62786020|FG001|Overall Study|Never received treatment|0|||
33407607|NCT03860259|62786032|FG000|Overall Study|Lost to Follow-up|5|||
33407608|NCT03860259|62786033|FG001|Overall Study|Lost to Follow-up|5|||
33407609|NCT03860259|62786032|FG000|Overall Study|Protocol Violation|1|||
33407610|NCT03860259|62786033|FG001|Overall Study|Protocol Violation|0|||
33407611|NCT00131365|62786039|FG000|Overall Study|Withdrawal by Subject|1|||
33407612|NCT00131365|62786039|FG000|Overall Study|Alternative treatment|3|||
33407613|NCT00487240|62786046|FG000|Overall Study|Withdrawal by Subject|12|||
33407614|NCT00487240|62786047|FG001|Overall Study|Withdrawal by Subject|6|||
33407615|NCT00487240|62786046|FG000|Overall Study|Lost to Follow-up|7|||
33598839|NCT02473289|62997835|FG000|Overall Study|Lost to Follow-up|1|||
33598840|NCT02473289|62997836|FG001|Overall Study|Lost to Follow-up|1|||
33598841|NCT02473289|62997835|FG000|Overall Study|Protocol Violation|0|||
33598842|NCT02473289|62997836|FG001|Overall Study|Protocol Violation|1|||
33598843|NCT02473289|62997835|FG000|Overall Study|Withdrawal of consent|6|||
33321273|NCT04713553|62697230|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
33321274|NCT04713553|62697224|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
33321275|NCT04713553|62697225|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
33321276|NCT04713553|62697226|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
33321277|NCT04713553|62697227|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
33321278|NCT04713553|62697228|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
33321279|NCT04713553|62697229|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
33321280|NCT04713553|62697230|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
33321281|NCT04713553|62697224|FG000|Primary Study (2 Months)|Other|1|||
33407616|NCT00487240|62786047|FG001|Overall Study|Lost to Follow-up|6|||
33407617|NCT00487240|62786046|FG000|Overall Study|Adverse Event|0|||
33407618|NCT00487240|62786047|FG001|Overall Study|Adverse Event|4|||
33407619|NCT00487240|62786046|FG000|Overall Study|Protocol Violation|5|||
33407620|NCT00487240|62786047|FG001|Overall Study|Protocol Violation|5|||
33407621|NCT00487240|62786046|FG000|Overall Study|Entry Criteria Not Met|3|||
33407622|NCT00487240|62786047|FG001|Overall Study|Entry Criteria Not Met|4|||
33407623|NCT00487240|62786046|FG000|Overall Study|Sponsor Decision|2|||
33407624|NCT00487240|62786047|FG001|Overall Study|Sponsor Decision|1|||
33407625|NCT00487240|62786046|FG000|Overall Study|Physician Decision|2|||
33407626|NCT00487240|62786047|FG001|Overall Study|Physician Decision|0|||
33407627|NCT02224391|62786055|FG000|Overall Study|Lost to Follow-up|26|||
33407628|NCT02224391|62786056|FG001|Overall Study|Lost to Follow-up|19|||
33407629|NCT02224391|62786055|FG000|Overall Study|Withdrawal by Subject|6|||
33407630|NCT02224391|62786056|FG001|Overall Study|Withdrawal by Subject|5|||
33407631|NCT00487162|62786064|FG000|Overall Study|Adverse Event|0|||
33407632|NCT00487162|62786065|FG001|Overall Study|Adverse Event|1|||
33407633|NCT00487162|62786064|FG000|Overall Study|Physician Decision|0|||
33407634|NCT00487162|62786065|FG001|Overall Study|Physician Decision|1|||
33407635|NCT00487162|62786064|FG000|Overall Study|Withdrawal by Subject|2|||
33321282|NCT04713553|62697225|FG001|Primary Study (2 Months)|Other|2|||
33321283|NCT04713553|62697226|FG002|Primary Study (2 Months)|Other|0|||
33321284|NCT04713553|62697227|FG003|Primary Study (2 Months)|Other|0|||
33321285|NCT04713553|62697228|FG004|Primary Study (2 Months)|Other|1|||
33321286|NCT04713553|62697229|FG005|Primary Study (2 Months)|Other|0|||
33321287|NCT04713553|62697230|FG006|Primary Study (2 Months)|Other|0|||
33321288|NCT04713553|62697224|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
33321289|NCT04713553|62697225|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
33321290|NCT04713553|62697226|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
33321291|NCT04713553|62697227|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
33321292|NCT04713553|62697228|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
33321293|NCT04713553|62697229|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
33321294|NCT04713553|62697230|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
33321295|NCT04713553|62697224|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
33321296|NCT04713553|62697225|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
33321297|NCT04713553|62697226|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
33321298|NCT04713553|62697227|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
33321299|NCT04713553|62697228|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
33321300|NCT04713553|62697229|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
33321301|NCT04713553|62697230|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
33321302|NCT01206101|62697253|FG000|Overall Study|Adverse Event|1|||
33321303|NCT01206101|62697254|FG001|Overall Study|Adverse Event|0|||
33321304|NCT01206101|62697253|FG000|Overall Study|Physician Decision|0|||
33321305|NCT01206101|62697254|FG001|Overall Study|Physician Decision|1|||
33321306|NCT01206101|62697253|FG000|Overall Study|Unclassified|1|||
33321307|NCT01206101|62697254|FG001|Overall Study|Unclassified|0|||
33321308|NCT01205165|62697260|FG000|Overall Study|Lost to Follow-up|2|||
33321309|NCT00997503|62697265|FG000|Overall Study|Death|53|||
33321310|NCT00997503|62697265|FG000|Overall Study|Withdrawal by Subject|76|||
33321311|NCT00997503|62697265|FG000|Overall Study|Lost to Follow-up|33|||
33321312|NCT00997503|62697265|FG000|Overall Study|Adverse Event|3|||
33321313|NCT00997503|62697265|FG000|Overall Study|Physician Decision|10|||
33321314|NCT00997503|62697265|FG000|Overall Study|Missed 12-month follow-up|85|||
33321315|NCT00997503|62697265|FG000|Overall Study|Other reason|13|||
33321316|NCT01204775|62697274|FG000|Overall Study|Poor/non-compliance|0|||
33321317|NCT01204775|62697275|FG001|Overall Study|Poor/non-compliance|1|||
33321318|NCT01204775|62697274|FG000|Overall Study|Withdrawal by Subject|1|||
33407636|NCT00487162|62786065|FG001|Overall Study|Withdrawal by Subject|3|||
33407637|NCT00487084|62786074|FG000|Overall Study|Did not receive intervention|4|||
33407638|NCT00487084|62786075|FG001|Overall Study|Did not receive intervention|3|||
33407639|NCT00487084|62786076|FG002|Overall Study|Did not receive intervention|5|||
33407640|NCT00466726|62786084|FG000|Overall Study|Not evaluable for response|14|||
33407641|NCT01721291|62786090|FG000|Overall Study|Withdrawal by Subject|1|||
33407642|NCT01721291|62786091|FG001|Overall Study|Withdrawal by Subject|0|||
33407643|NCT01721291|62786090|FG000|Overall Study|did not like the treatment|1|||
33598844|NCT02473289|62997836|FG001|Overall Study|Withdrawal of consent|7|||
33598845|NCT02473289|62997835|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
33321319|NCT01204775|62697275|FG001|Overall Study|Withdrawal by Subject|0|||
33407644|NCT01721291|62786091|FG001|Overall Study|did not like the treatment|0|||
33407645|NCT00486226|62786117|FG000|Overall Study|Death|3|||
33407646|NCT00486226|62786117|FG000|Overall Study|Adverse Event|1|||
33407647|NCT00486226|62786117|FG000|Overall Study|Withdrawal by Subject|1|||
33407648|NCT00486226|62786117|FG000|Overall Study|Lost to Follow-up|8|||
33407649|NCT00485758|62786126|FG000|Overall Study|Adverse Event|102|||
33407650|NCT00485758|62786127|FG001|Overall Study|Adverse Event|31|||
33598846|NCT02473289|62997836|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
33598847|NCT02473289|62997835|FG000|Overall Study|Other|2|||
33321320|NCT00997035|62697283|FG000|3-week Followup Visit|Lost to Follow-up|9|||
33407651|NCT00485758|62786126|FG000|Overall Study|Death|0|||
33407652|NCT00485758|62786127|FG001|Overall Study|Death|1|||
33407653|NCT00485758|62786126|FG000|Overall Study|Lost to Follow-up|5|||
33407654|NCT00485758|62786127|FG001|Overall Study|Lost to Follow-up|1|||
33321321|NCT00997035|62697284|FG001|3-week Followup Visit|Lost to Follow-up|6|||
33321322|NCT00997035|62697283|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
33321323|NCT00997035|62697284|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
33321324|NCT01204697|62697302|FG000|Overall Study|Death|26|||
33407655|NCT00485758|62786126|FG000|Overall Study|Physician Decision|3|||
33407656|NCT00485758|62786127|FG001|Overall Study|Physician Decision|3|||
33407657|NCT00485758|62786126|FG000|Overall Study|Protocol Violation|11|||
33407658|NCT00485758|62786127|FG001|Overall Study|Protocol Violation|2|||
33407659|NCT00485758|62786126|FG000|Overall Study|Withdrawal by Subject|32|||
33407660|NCT00485758|62786127|FG001|Overall Study|Withdrawal by Subject|27|||
33407661|NCT00485758|62786126|FG000|Overall Study|Study Terminated by Sponsor|3|||
33407662|NCT00485758|62786127|FG001|Overall Study|Study Terminated by Sponsor|0|||
33407663|NCT00469612|62786135|FG000|Overall Study|Study terminated before data collected|2|||
33407664|NCT00469612|62786136|FG001|Overall Study|Study terminated before data collected|0|||
33407665|NCT00469456|62786144|FG000|Overall Study|Adverse Event|4|||
33407666|NCT00469456|62786145|FG001|Overall Study|Adverse Event|3|||
33407667|NCT00469456|62786144|FG000|Overall Study|Protocol Violation|1|||
33407668|NCT00469456|62786145|FG001|Overall Study|Protocol Violation|0|||
33407669|NCT00469456|62786144|FG000|Overall Study|Withdrawal by Subject|4|||
33407670|NCT00469456|62786145|FG001|Overall Study|Withdrawal by Subject|1|||
33407671|NCT00581555|62786153|FG000|Overall Study|Adverse Event|4|||
33321325|NCT01204697|62697303|FG001|Overall Study|Death|27|||
33321326|NCT01204697|62697302|FG000|Overall Study|Lost to Follow-up|3|||
33321327|NCT01204697|62697303|FG001|Overall Study|Lost to Follow-up|4|||
33321328|NCT01204697|62697302|FG000|Overall Study|Withdrawal by Subject|2|||
33321329|NCT01204697|62697303|FG001|Overall Study|Withdrawal by Subject|4|||
33407672|NCT00581555|62786154|FG001|Overall Study|Adverse Event|3|||
33407673|NCT00581555|62786153|FG000|Overall Study|Physician Decision|3|||
33407674|NCT00581555|62786154|FG001|Overall Study|Physician Decision|2|||
33407675|NCT00581555|62786153|FG000|Overall Study|Withdrawal by Subject|18|||
33407676|NCT00581555|62786154|FG001|Overall Study|Withdrawal by Subject|9|||
33407677|NCT00581555|62786153|FG000|Overall Study|Lost to Follow-up|2|||
33407678|NCT00581555|62786154|FG001|Overall Study|Lost to Follow-up|2|||
33407679|NCT00581555|62786153|FG000|Overall Study|Other reasons|16|||
33407680|NCT00581555|62786154|FG001|Overall Study|Other reasons|4|||
33407681|NCT00469144|62786162|FG000|Overall Study|Death|0|||
33407682|NCT00469144|62786163|FG001|Overall Study|Death|1|||
33407683|NCT00469144|62786162|FG000|Overall Study|No Response|5|||
33407684|NCT00469144|62786163|FG001|Overall Study|No Response|5|||
33407685|NCT00469144|62786162|FG000|Overall Study|Progressive Disease|1|||
33407686|NCT00469144|62786163|FG001|Overall Study|Progressive Disease|0|||
33407687|NCT00468910|62786175|FG000|Overall Study|Lost to Follow-up|2|||
33407688|NCT00468910|62786176|FG001|Overall Study|Lost to Follow-up|1|||
33407689|NCT00468910|62786175|FG000|Overall Study|Withdrawal by Subject|2|||
33407690|NCT00468910|62786176|FG001|Overall Study|Withdrawal by Subject|1|||
33407691|NCT00468910|62786175|FG000|Overall Study|Medical Contraindication|0|||
33407692|NCT00468910|62786176|FG001|Overall Study|Medical Contraindication|1|||
33407693|NCT01412333|62786185|FG000|Overall Study|Death|1|||
33407694|NCT01412333|62786186|FG001|Overall Study|Death|1|||
33407695|NCT01412333|62786185|FG000|Overall Study|Physician Decision|0|||
33407696|NCT01412333|62786186|FG001|Overall Study|Physician Decision|1|||
33321330|NCT01204697|62697302|FG000|Overall Study|Randomized, but not treated|0|||
33321331|NCT01204697|62697303|FG001|Overall Study|Randomized, but not treated|1|||
33321332|NCT01001325|62697311|FG000|Overall Study|Lost to Follow-up|16|||
33321333|NCT01001325|62697312|FG001|Overall Study|Lost to Follow-up|10|||
33321334|NCT01001325|62697311|FG000|Overall Study|Protocol Violation|2|||
33321335|NCT01001325|62697312|FG001|Overall Study|Protocol Violation|0|||
33407697|NCT01412333|62786185|FG000|Overall Study|Reason not specified|16|||
33321336|NCT01203917|62697318|FG000|Overall Study|Death|29|||
33407698|NCT01412333|62786186|FG001|Overall Study|Reason not specified|10|||
33407699|NCT01412333|62786185|FG000|Overall Study|Non-compliance with study drug|1|||
33407700|NCT01412333|62786186|FG001|Overall Study|Non-compliance with study drug|1|||
33407701|NCT01412333|62786185|FG000|Overall Study|Protocol Violation|1|||
33407702|NCT01412333|62786186|FG001|Overall Study|Protocol Violation|1|||
33407703|NCT01412333|62786185|FG000|Overall Study|Non-compliance|1|||
33321337|NCT01203917|62697318|FG000|Overall Study|Lost to Follow-up|2|||
33407704|NCT01412333|62786186|FG001|Overall Study|Non-compliance|3|||
33407705|NCT01412333|62786185|FG000|Overall Study|Lack of Efficacy|15|||
33407706|NCT01412333|62786186|FG001|Overall Study|Lack of Efficacy|6|||
33407707|NCT01412333|62786185|FG000|Overall Study|Pregnancy|3|||
33407708|NCT01412333|62786186|FG001|Overall Study|Pregnancy|0|||
33407709|NCT01412333|62786185|FG000|Overall Study|Consent withdrawn by participant|25|||
33407710|NCT01412333|62786186|FG001|Overall Study|Consent withdrawn by participant|12|||
33407711|NCT01412333|62786185|FG000|Overall Study|Adverse Event|25|||
33407712|NCT01412333|62786186|FG001|Overall Study|Adverse Event|16|||
33407713|NCT01412333|62786185|FG000|Overall Study|Lost to Follow-up|10|||
33407714|NCT01412333|62786186|FG001|Overall Study|Lost to Follow-up|6|||
33407715|NCT00519285|62786195|FG000|Overall Study|Adverse Event|127|||
33407716|NCT00519285|62786196|FG001|Overall Study|Adverse Event|266|||
33407717|NCT00519285|62786195|FG000|Overall Study|Disease progression|334|||
33407718|NCT00519285|62786196|FG001|Overall Study|Disease progression|186|||
33407719|NCT00519285|62786195|FG000|Overall Study|Physician Decision|75|||
33407720|NCT00519285|62786196|FG001|Overall Study|Physician Decision|47|||
33407721|NCT00519285|62786195|FG000|Overall Study|Participant's request|53|||
33407722|NCT00519285|62786196|FG001|Overall Study|Participant's request|84|||
33407723|NCT00519285|62786195|FG000|Overall Study|Consent withdrawn|4|||
33407724|NCT00519285|62786196|FG001|Overall Study|Consent withdrawn|5|||
33407725|NCT00519285|62786195|FG000|Overall Study|Poor compliance to protocol|5|||
33407726|NCT00519285|62786196|FG001|Overall Study|Poor compliance to protocol|7|||
33407727|NCT00519285|62786195|FG000|Overall Study|Reason unspecified|5|||
33407728|NCT00519285|62786196|FG001|Overall Study|Reason unspecified|8|||
33407729|NCT00519285|62786195|FG000|Overall Study|Not treated|8|||
33407730|NCT00519285|62786196|FG001|Overall Study|Not treated|7|||
33407731|NCT00519285|62786195|FG000|Overall Study|Treatment ongoing|1|||
33407732|NCT00519285|62786196|FG001|Overall Study|Treatment ongoing|2|||
33407733|NCT00464620|62786202|FG000|Overall Study|Physician Decision|1|||
33407734|NCT00464620|62786203|FG001|Overall Study|Physician Decision|0|||
33407735|NCT00464620|62786204|FG002|Overall Study|Physician Decision|0|||
33407736|NCT00464620|62786202|FG000|Overall Study|Withdrawal by Subject|1|||
33407737|NCT00464620|62786203|FG001|Overall Study|Withdrawal by Subject|0|||
33407738|NCT00464620|62786204|FG002|Overall Study|Withdrawal by Subject|3|||
33407739|NCT00464620|62786202|FG000|Overall Study|Ineligible sarcoma subtype|0|||
33407740|NCT00464620|62786203|FG001|Overall Study|Ineligible sarcoma subtype|2|||
33407741|NCT00464620|62786204|FG002|Overall Study|Ineligible sarcoma subtype|2|||
33407742|NCT00464620|62786202|FG000|Overall Study|Use of prohibited concomitant medication|0|||
33407743|NCT00464620|62786203|FG001|Overall Study|Use of prohibited concomitant medication|0|||
33407744|NCT00464620|62786204|FG002|Overall Study|Use of prohibited concomitant medication|2|||
33407745|NCT00464542|62786217|FG000|Pre-treatment|Withdrawal by Subject|2|||
33598848|NCT02473289|62997836|FG001|Overall Study|Other|0|||
33407746|NCT00468676|62786223|FG000|Overall Study|Lost to Follow-up|14|||
33407747|NCT00468676|62786224|FG001|Overall Study|Lost to Follow-up|11|||
33407748|NCT00468676|62786223|FG000|Overall Study|Death|2|||
33407749|NCT00468676|62786224|FG001|Overall Study|Death|1|||
33407750|NCT00464308|62786235|FG000|Overall Study|Adverse Event|22|||
33407751|NCT00464308|62786236|FG001|Overall Study|Adverse Event|27|||
33407752|NCT00464308|62786237|FG002|Overall Study|Adverse Event|16|||
33407753|NCT00464308|62786235|FG000|Overall Study|Lost to Follow-up|29|||
33407754|NCT00464308|62786236|FG001|Overall Study|Lost to Follow-up|19|||
33407755|NCT00464308|62786237|FG002|Overall Study|Lost to Follow-up|20|||
33407756|NCT00464308|62786235|FG000|Overall Study|Patient discontinued and other reasons|17|||
33407757|NCT00464308|62786236|FG001|Overall Study|Patient discontinued and other reasons|17|||
33598849|NCT02354599|62997848|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33598850|NCT02354599|62997849|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
33598851|NCT02354599|62997850|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
33598852|NCT02354599|62997851|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
33598853|NCT02354599|62997852|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
33598854|NCT02354599|62997853|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
33598855|NCT02354599|62997848|FG000|Overall Study|Withdrawal by Subject|1|||
33407758|NCT00464308|62786237|FG002|Overall Study|Patient discontinued and other reasons|23|||
33407759|NCT00464308|62786235|FG000|Overall Study|Physician Decision|1|||
33407760|NCT00464308|62786236|FG001|Overall Study|Physician Decision|0|||
33407761|NCT00464308|62786237|FG002|Overall Study|Physician Decision|0|||
33407762|NCT00468286|62786247|FG000|Overall Study|Adverse Event|1|||
33407763|NCT00468286|62786248|FG001|Overall Study|Adverse Event|6|||
33598856|NCT02354599|62997849|FG001|Overall Study|Withdrawal by Subject|1|||
33598857|NCT02354599|62997850|FG002|Overall Study|Withdrawal by Subject|0|||
33598858|NCT02354599|62997851|FG003|Overall Study|Withdrawal by Subject|0|||
33598859|NCT02354599|62997852|FG004|Overall Study|Withdrawal by Subject|0|||
33407764|NCT00468286|62786247|FG000|Overall Study|Protocol Violation|2|||
33407765|NCT00468286|62786248|FG001|Overall Study|Protocol Violation|2|||
33407766|NCT00468286|62786247|FG000|Overall Study|Withdrawal by Subject|4|||
33407767|NCT00468286|62786248|FG001|Overall Study|Withdrawal by Subject|3|||
33407768|NCT00468286|62786247|FG000|Overall Study|Physician Decision|0|||
33407769|NCT00468286|62786248|FG001|Overall Study|Physician Decision|1|||
33407770|NCT00463840|62786254|FG000|Overall Study|Disease progression|7|||
33407771|NCT00463840|62786254|FG000|Overall Study|Withdrawal by Subject|2|||
33407772|NCT00463840|62786254|FG000|Overall Study|Adverse Event|3|||
33407773|NCT00129389|62786260|FG000|Overall Study|Adverse Event|19|||
33407774|NCT00129389|62786261|FG001|Overall Study|Adverse Event|87|||
33407775|NCT00129389|62786260|FG000|Overall Study|Death|0|||
33407776|NCT00129389|62786261|FG001|Overall Study|Death|1|||
33407777|NCT00129389|62786260|FG000|Overall Study|Lost to Follow-up|2|||
33407778|NCT00129389|62786261|FG001|Overall Study|Lost to Follow-up|1|||
33407779|NCT00129389|62786260|FG000|Overall Study|Physician Decision|0|||
33407780|NCT00129389|62786261|FG001|Overall Study|Physician Decision|4|||
33407781|NCT00129389|62786260|FG000|Overall Study|Protocol Violation|0|||
33407782|NCT00129389|62786261|FG001|Overall Study|Protocol Violation|6|||
33407783|NCT00129389|62786260|FG000|Overall Study|Withdrawal by Subject|9|||
33407784|NCT00129389|62786261|FG001|Overall Study|Withdrawal by Subject|23|||
33407785|NCT00129389|62786260|FG000|Overall Study|Relapse|1|||
33407786|NCT00129389|62786261|FG001|Overall Study|Relapse|0|||
33407787|NCT00129389|62786260|FG000|Overall Study|Not eligible|1|||
33407788|NCT00129389|62786261|FG001|Overall Study|Not eligible|2|||
33407789|NCT00129389|62786260|FG000|Overall Study|Crossed to the other arm|1|||
33407790|NCT00129389|62786261|FG001|Overall Study|Crossed to the other arm|16|||
33407791|NCT00468052|62786269|FG000|Overall Study|Protocol Violation|7|||
33407792|NCT00468052|62786270|FG001|Overall Study|Protocol Violation|8|||
33407793|NCT00453310|62786278|FG000|Overall Study|Progression of Disease|10|||
33407794|NCT00124657|62786285|FG000|Overall Study|Toxicity|0|||
33407795|NCT00124657|62786286|FG001|Overall Study|Toxicity|0|||
33407796|NCT00124657|62786287|FG002|Overall Study|Toxicity|1|||
33407797|NCT00124657|62786285|FG000|Overall Study|Non-compliance|1|||
33407798|NCT00124657|62786286|FG001|Overall Study|Non-compliance|0|||
33407799|NCT00124657|62786287|FG002|Overall Study|Non-compliance|4|||
33407800|NCT00124657|62786285|FG000|Overall Study|Progressive disease|14|||
33407801|NCT00124657|62786286|FG001|Overall Study|Progressive disease|5|||
33407802|NCT00124657|62786287|FG002|Overall Study|Progressive disease|27|||
33407803|NCT00124657|62786285|FG000|Overall Study|Intercurrent illness|1|||
33407804|NCT00124657|62786286|FG001|Overall Study|Intercurrent illness|0|||
33407805|NCT00124657|62786287|FG002|Overall Study|Intercurrent illness|0|||
33407806|NCT00581945|62786310|FG000|Overall Study|Adverse Event|4|||
33407807|NCT00581945|62786311|FG001|Overall Study|Adverse Event|4|||
33407808|NCT00581945|62786310|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33407809|NCT00581945|62786311|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33407810|NCT00581945|62786310|FG000|Overall Study|Withdrawal by Subject|2|||
33407811|NCT00581945|62786311|FG001|Overall Study|Withdrawal by Subject|6|||
33407812|NCT00581945|62786310|FG000|Overall Study|Death|1|||
33407813|NCT00581945|62786311|FG001|Overall Study|Death|0|||
33407814|NCT00555906|62786320|FG000|Phase 1|Objective Progression or Relapse|3|||
33407815|NCT00555906|62786321|FG001|Phase 1|Objective Progression or Relapse|5|||
33407816|NCT00555906|62786322|FG002|Phase 1|Objective Progression or Relapse|3|||
33493978|NCT03558516|62872563|FG000|Overall Study|Protocol Violation|2|||
33407817|NCT00555906|62786323|FG003|Phase 1|Objective Progression or Relapse|1|||
33407818|NCT00555906|62786324|FG004|Phase 1|Objective Progression or Relapse|0|||
33407819|NCT00555906|62786320|FG000|Phase 1|Global Deterioration of Health Status|0|||
33407820|NCT00555906|62786321|FG001|Phase 1|Global Deterioration of Health Status|1|||
33407821|NCT00555906|62786322|FG002|Phase 1|Global Deterioration of Health Status|1|||
33407822|NCT00555906|62786323|FG003|Phase 1|Global Deterioration of Health Status|1|||
33407823|NCT00555906|62786324|FG004|Phase 1|Global Deterioration of Health Status|0|||
33407824|NCT00555906|62786320|FG000|Phase 1|Adverse Event|0|||
33407825|NCT00555906|62786321|FG001|Phase 1|Adverse Event|0|||
33407826|NCT00555906|62786322|FG002|Phase 1|Adverse Event|3|||
33407827|NCT00555906|62786323|FG003|Phase 1|Adverse Event|2|||
33407828|NCT00555906|62786324|FG004|Phase 1|Adverse Event|0|||
33407829|NCT00555906|62786320|FG000|Phase 1|Withdrawal by Subject|0|||
33407830|NCT00555906|62786321|FG001|Phase 1|Withdrawal by Subject|0|||
33407831|NCT00555906|62786322|FG002|Phase 1|Withdrawal by Subject|0|||
33407832|NCT00555906|62786323|FG003|Phase 1|Withdrawal by Subject|1|||
33407833|NCT00555906|62786324|FG004|Phase 1|Withdrawal by Subject|0|||
33407834|NCT00555906|62786320|FG000|Phase 2|Adverse Event|0|||
33407835|NCT00555906|62786321|FG001|Phase 2|Adverse Event|0|||
33407836|NCT00555906|62786322|FG002|Phase 2|Adverse Event|0|||
33407837|NCT00555906|62786323|FG003|Phase 2|Adverse Event|0|||
33407838|NCT00555906|62786324|FG004|Phase 2|Adverse Event|4|||
33598860|NCT02354599|62997853|FG005|Overall Study|Withdrawal by Subject|0|||
33598861|NCT02316223|62997876|FG000|Overall Study|Lack of Efficacy|0|||
33598862|NCT02316223|62997877|FG001|Overall Study|Lack of Efficacy|1|||
33598863|NCT02316223|62997878|FG002|Overall Study|Lack of Efficacy|1|||
33598864|NCT02316223|62997876|FG000|Overall Study|Lost to Follow-up|27|||
33598865|NCT02316223|62997877|FG001|Overall Study|Lost to Follow-up|34|||
33598866|NCT02316223|62997878|FG002|Overall Study|Lost to Follow-up|36|||
33598867|NCT02316223|62997876|FG000|Overall Study|COPD Diagnosis|3|||
33598868|NCT02316223|62997877|FG001|Overall Study|COPD Diagnosis|2|||
33407839|NCT00555906|62786320|FG000|Phase 2|Global Deterioration of Health Status|0|||
33598869|NCT02316223|62997878|FG002|Overall Study|COPD Diagnosis|3|||
33598870|NCT02316223|62997876|FG000|Overall Study|Reside outside study area|1|||
33598871|NCT02316223|62997877|FG001|Overall Study|Reside outside study area|1|||
33407840|NCT00555906|62786321|FG001|Phase 2|Global Deterioration of Health Status|0|||
33407841|NCT00555906|62786322|FG002|Phase 2|Global Deterioration of Health Status|0|||
33407842|NCT00555906|62786323|FG003|Phase 2|Global Deterioration of Health Status|0|||
33407843|NCT00555906|62786324|FG004|Phase 2|Global Deterioration of Health Status|2|||
33407844|NCT00555906|62786320|FG000|Phase 2|Objective Progression or Relapse|0|||
33407845|NCT00555906|62786321|FG001|Phase 2|Objective Progression or Relapse|0|||
33407846|NCT00555906|62786322|FG002|Phase 2|Objective Progression or Relapse|0|||
33407847|NCT00555906|62786323|FG003|Phase 2|Objective Progression or Relapse|0|||
33407848|NCT00555906|62786324|FG004|Phase 2|Objective Progression or Relapse|16|||
33407849|NCT00555906|62786320|FG000|Phase 2|Withdrawal by Subject|0|||
33407850|NCT00555906|62786321|FG001|Phase 2|Withdrawal by Subject|0|||
33407851|NCT00555906|62786322|FG002|Phase 2|Withdrawal by Subject|0|||
33407852|NCT00555906|62786323|FG003|Phase 2|Withdrawal by Subject|0|||
33407853|NCT00555906|62786324|FG004|Phase 2|Withdrawal by Subject|2|||
33407854|NCT00555906|62786320|FG000|Phase 2|Other|0|||
33407855|NCT00555906|62786321|FG001|Phase 2|Other|0|||
33407856|NCT00555906|62786322|FG002|Phase 2|Other|0|||
33407857|NCT00555906|62786323|FG003|Phase 2|Other|0|||
33407858|NCT00555906|62786324|FG004|Phase 2|Other|6|||
33407859|NCT00555906|62786320|FG000|Phase 2|Randomized but not Treated|0|||
33407860|NCT00555906|62786321|FG001|Phase 2|Randomized but not Treated|0|||
33407861|NCT00555906|62786322|FG002|Phase 2|Randomized but not Treated|0|||
33407862|NCT00555906|62786323|FG003|Phase 2|Randomized but not Treated|0|||
33407863|NCT00555906|62786324|FG004|Phase 2|Randomized but not Treated|2|||
33407864|NCT03817879|62786341|FG000|Overall Study|Drop out|5|||
33407865|NCT03817879|62786342|FG001|Overall Study|Drop out|12|||
33407866|NCT03817879|62786341|FG000|Overall Study|Withdrawal by Subject|0|||
33407867|NCT03817879|62786342|FG001|Overall Study|Withdrawal by Subject|1|||
33407868|NCT00555672|62786350|FG000|Overall Study|Death|0|||
33407869|NCT00555672|62786351|FG001|Overall Study|Death|2|||
33407870|NCT00555672|62786350|FG000|Overall Study|Adverse Event|8|||
33407871|NCT00555672|62786351|FG001|Overall Study|Adverse Event|2|||
33407872|NCT00555672|62786350|FG000|Overall Study|Objective progression or relapse|11|||
33598872|NCT02316223|62997878|FG002|Overall Study|Reside outside study area|1|||
33598873|NCT02316223|62997876|FG000|Overall Study|No asthma|2|||
33598874|NCT02316223|62997877|FG001|Overall Study|No asthma|0|||
33598875|NCT02316223|62997878|FG002|Overall Study|No asthma|0|||
33407873|NCT00555672|62786351|FG001|Overall Study|Objective progression or relapse|5|||
33407874|NCT00555672|62786350|FG000|Overall Study|Other|3|||
33407875|NCT00555672|62786351|FG001|Overall Study|Other|1|||
33407876|NCT00555672|62786350|FG000|Overall Study|Participant refused|2|||
33407877|NCT00555672|62786351|FG001|Overall Study|Participant refused|0|||
33407878|NCT03958656|62786361|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
33407879|NCT03958656|62786362|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
33407880|NCT03958656|62786363|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
33493979|NCT03558516|62872564|FG001|Overall Study|Protocol Violation|2|||
33598876|NCT02316223|62997876|FG000|Overall Study|Discontinued by PI|11|||
33407881|NCT03958656|62786364|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
33407882|NCT03958656|62786361|FG000|Overall Study|No longer meets eligibility criteria|0|||
33407883|NCT03958656|62786362|FG001|Overall Study|No longer meets eligibility criteria|0|||
33407884|NCT03958656|62786363|FG002|Overall Study|No longer meets eligibility criteria|1|||
33407885|NCT03958656|62786364|FG003|Overall Study|No longer meets eligibility criteria|0|||
33407886|NCT03958656|62786361|FG000|Overall Study|Started anti-cancer treatment|0|||
33407887|NCT03958656|62786362|FG001|Overall Study|Started anti-cancer treatment|0|||
33321338|NCT01203917|62697318|FG000|Overall Study|Withdrawal by Subject|3|||
33407888|NCT03958656|62786363|FG002|Overall Study|Started anti-cancer treatment|1|||
33407889|NCT03958656|62786364|FG003|Overall Study|Started anti-cancer treatment|0|||
33407890|NCT00561912|62786374|FG000|Overall Study|ineligible|1|||
33407891|NCT00561678|62786380|FG000|Overall Study|Withdrawal by Subject|4|||
33407892|NCT00561678|62786381|FG001|Overall Study|Withdrawal by Subject|3|||
33407893|NCT00561678|62786380|FG000|Overall Study|surgery cancelled|1|||
33407894|NCT00561678|62786381|FG001|Overall Study|surgery cancelled|1|||
33407895|NCT00561678|62786380|FG000|Overall Study|surgery rescheduled to different site|2|||
33407896|NCT00561678|62786381|FG001|Overall Study|surgery rescheduled to different site|2|||
33407897|NCT00561678|62786380|FG000|Overall Study|anesthesia provider refusal|1|||
33407898|NCT00561678|62786381|FG001|Overall Study|anesthesia provider refusal|0|||
33407899|NCT00463684|62786387|FG000|Overall Study|Withdrawal by Subject|1|||
33407900|NCT00463684|62786387|FG000|Overall Study|Lost to Follow-up|3|||
33407901|NCT00463606|62786394|FG000|Overall Study|Adverse Event|21|||
33407902|NCT00463606|62786395|FG001|Overall Study|Adverse Event|18|||
33407903|NCT00463606|62786396|FG002|Overall Study|Adverse Event|11|||
33407904|NCT00463606|62786394|FG000|Overall Study|Withdrawal by Subject|11|||
33407905|NCT00463606|62786395|FG001|Overall Study|Withdrawal by Subject|11|||
33321339|NCT01203917|62697318|FG000|Overall Study|Due to objective disease progression|1|||
33321340|NCT01203917|62697318|FG000|Overall Study|Due to EGFR M+I patient|1|||
33321341|NCT01202903|62697324|FG000|Overall Study|Administrative Probelms|1|||
33407906|NCT00463606|62786396|FG002|Overall Study|Withdrawal by Subject|5|||
33407907|NCT00463606|62786394|FG000|Overall Study|Lost to Follow-up|2|||
33407908|NCT00463606|62786395|FG001|Overall Study|Lost to Follow-up|2|||
33407909|NCT00463606|62786396|FG002|Overall Study|Lost to Follow-up|3|||
33407910|NCT00463606|62786394|FG000|Overall Study|Subject noncompliance|1|||
33407911|NCT00463606|62786395|FG001|Overall Study|Subject noncompliance|1|||
33407912|NCT00463606|62786396|FG002|Overall Study|Subject noncompliance|0|||
33407913|NCT00463606|62786394|FG000|Overall Study|Subject moved out of town|1|||
33407914|NCT00463606|62786395|FG001|Overall Study|Subject moved out of town|0|||
33598877|NCT02316223|62997877|FG001|Overall Study|Discontinued by PI|19|||
33598878|NCT02316223|62997878|FG002|Overall Study|Discontinued by PI|3|||
33321342|NCT01202903|62697325|FG001|Overall Study|Administrative Probelms|4|||
33321343|NCT01202903|62697324|FG000|Overall Study|Protocol Violation|0|||
33321344|NCT01202903|62697325|FG001|Overall Study|Protocol Violation|1|||
33321345|NCT01202903|62697324|FG000|Overall Study|Death|1|||
33321346|NCT01202903|62697325|FG001|Overall Study|Death|0|||
33321347|NCT01202903|62697324|FG000|Overall Study|Lost to Follow-up|1|||
33321348|NCT01202903|62697325|FG001|Overall Study|Lost to Follow-up|1|||
33321349|NCT01202903|62697324|FG000|Overall Study|Lack of Efficacy|1|||
33321350|NCT01202903|62697325|FG001|Overall Study|Lack of Efficacy|3|||
33321351|NCT01202903|62697324|FG000|Overall Study|Adverse Event|3|||
33321352|NCT01202903|62697325|FG001|Overall Study|Adverse Event|3|||
33321353|NCT01202903|62697324|FG000|Overall Study|Withdrawal by Subject|4|||
33321354|NCT01202903|62697325|FG001|Overall Study|Withdrawal by Subject|4|||
33321355|NCT01001169|62697333|FG000|Overall Study|Withdrawal by Subject|2|||
33321356|NCT01001169|62697334|FG001|Overall Study|Withdrawal by Subject|1|||
33321357|NCT01202747|62697348|FG000|Overall Study|Withdrawal by Subject|1|||
33321358|NCT00996801|62697358|FG000|Overall Study|Adverse Event|6|||
33321359|NCT00996801|62697359|FG001|Overall Study|Adverse Event|4|||
33321360|NCT00996801|62697360|FG002|Overall Study|Adverse Event|12|||
33321361|NCT00996801|62697361|FG003|Overall Study|Adverse Event|17|||
33598879|NCT02286895|62997888|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
33321362|NCT00996801|62697362|FG004|Overall Study|Adverse Event|31|||
33321363|NCT00996801|62697363|FG005|Overall Study|Adverse Event|3|||
33407915|NCT00463606|62786396|FG002|Overall Study|Subject moved out of town|0|||
33407916|NCT00463606|62786394|FG000|Overall Study|Physician Decision|0|||
33407917|NCT00463606|62786395|FG001|Overall Study|Physician Decision|1|||
33407918|NCT00463606|62786396|FG002|Overall Study|Physician Decision|0|||
33321364|NCT00996801|62697358|FG000|Overall Study|Lack of Efficacy|3|||
33321365|NCT00996801|62697359|FG001|Overall Study|Lack of Efficacy|0|||
33407919|NCT00463606|62786394|FG000|Overall Study|Sponsor request|0|||
33407920|NCT00463606|62786395|FG001|Overall Study|Sponsor request|1|||
33407921|NCT00463606|62786396|FG002|Overall Study|Sponsor request|0|||
33407922|NCT00463606|62786394|FG000|Overall Study|Exclusion criteria violation|2|||
33407923|NCT00463606|62786395|FG001|Overall Study|Exclusion criteria violation|0|||
33407924|NCT00463606|62786396|FG002|Overall Study|Exclusion criteria violation|0|||
33407925|NCT00463606|62786394|FG000|Overall Study|Coordinator error|1|||
33407926|NCT00463606|62786395|FG001|Overall Study|Coordinator error|0|||
33407927|NCT00463606|62786396|FG002|Overall Study|Coordinator error|0|||
33407928|NCT00463606|62786394|FG000|Overall Study|Patient randomized in error|1|||
33407929|NCT00463606|62786395|FG001|Overall Study|Patient randomized in error|0|||
33407930|NCT00463606|62786396|FG002|Overall Study|Patient randomized in error|0|||
33407931|NCT00463606|62786394|FG000|Overall Study|Participation in another ABT-335 trial|1|||
33407932|NCT00463606|62786395|FG001|Overall Study|Participation in another ABT-335 trial|0|||
33407933|NCT00463606|62786396|FG002|Overall Study|Participation in another ABT-335 trial|0|||
33407934|NCT00463606|62786394|FG000|Overall Study|Protocol Violation|0|||
33407935|NCT00463606|62786395|FG001|Overall Study|Protocol Violation|0|||
33407936|NCT00463606|62786396|FG002|Overall Study|Protocol Violation|1|||
33407937|NCT03961308|62786406|FG000|Overall Study|Withdrawal by Subject|1|||
33407938|NCT03961308|62786407|FG001|Overall Study|Withdrawal by Subject|0|||
33407939|NCT03961308|62786406|FG000|Overall Study|Other|1|||
33407940|NCT03961308|62786407|FG001|Overall Study|Other|0|||
33407941|NCT03961308|62786406|FG000|Overall Study|Lost to Follow-up|0|||
33407942|NCT03961308|62786407|FG001|Overall Study|Lost to Follow-up|1|||
33407943|NCT03961308|62786406|FG000|Overall Study|Adverse Event|0|||
33407944|NCT03961308|62786407|FG001|Overall Study|Adverse Event|1|||
33407945|NCT00174187|62786415|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
33407946|NCT00174187|62786416|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
33407947|NCT00174187|62786417|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
33407948|NCT00174187|62786415|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
33407949|NCT00174187|62786416|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
33407950|NCT00174187|62786417|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
33407951|NCT00174187|62786415|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
33407952|NCT00174187|62786416|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
33407953|NCT00174187|62786417|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
33407954|NCT00174187|62786415|FG000|Period 1 (up to 3 Years)|Other|0|||
33407955|NCT00174187|62786416|FG001|Period 1 (up to 3 Years)|Other|1|||
33407956|NCT00174187|62786417|FG002|Period 1 (up to 3 Years)|Other|0|||
33407957|NCT00174187|62786415|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
33407958|NCT00174187|62786416|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
33407959|NCT00174187|62786417|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
33407960|NCT00174187|62786415|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
33407961|NCT00174187|62786416|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
33321366|NCT00996801|62697360|FG002|Overall Study|Lack of Efficacy|1|||
33321367|NCT00996801|62697361|FG003|Overall Study|Lack of Efficacy|3|||
33321368|NCT00996801|62697362|FG004|Overall Study|Lack of Efficacy|0|||
33321369|NCT00996801|62697363|FG005|Overall Study|Lack of Efficacy|1|||
33321370|NCT00996801|62697358|FG000|Overall Study|Lost to Follow-up|0|||
33321371|NCT00996801|62697359|FG001|Overall Study|Lost to Follow-up|0|||
33321372|NCT00996801|62697360|FG002|Overall Study|Lost to Follow-up|0|||
33321373|NCT00996801|62697361|FG003|Overall Study|Lost to Follow-up|3|||
33321374|NCT00996801|62697362|FG004|Overall Study|Lost to Follow-up|3|||
33321375|NCT00996801|62697363|FG005|Overall Study|Lost to Follow-up|2|||
33321376|NCT00996801|62697358|FG000|Overall Study|Physician Decision|0|||
33321377|NCT00996801|62697359|FG001|Overall Study|Physician Decision|0|||
33321378|NCT00996801|62697360|FG002|Overall Study|Physician Decision|0|||
33321379|NCT00996801|62697361|FG003|Overall Study|Physician Decision|1|||
33321380|NCT00996801|62697362|FG004|Overall Study|Physician Decision|0|||
33321381|NCT00996801|62697363|FG005|Overall Study|Physician Decision|0|||
33407962|NCT00174187|62786417|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
33407963|NCT00174187|62786415|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
33407964|NCT00174187|62786416|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
33493980|NCT03557970|62872572|FG000|Overall Study|Study closure|1|||
33321382|NCT00996801|62697358|FG000|Overall Study|Progressive Disease|0|||
33407965|NCT00174187|62786417|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
33407966|NCT00174187|62786415|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
33407967|NCT00174187|62786416|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
33407968|NCT00174187|62786417|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
33407969|NCT00174187|62786415|FG000|Period 2 (After 3 Years)|Other|0|||
33407970|NCT00174187|62786416|FG001|Period 2 (After 3 Years)|Other|0|||
33407971|NCT00174187|62786417|FG002|Period 2 (After 3 Years)|Other|5|||
33407972|NCT01011335|62786429|FG000|Overall Study|Lost to Follow-up|0|||
33407973|NCT01011335|62786430|FG001|Overall Study|Lost to Follow-up|0|||
33407974|NCT01011335|62786431|FG002|Overall Study|Lost to Follow-up|1|||
33407975|NCT01011335|62786432|FG003|Overall Study|Lost to Follow-up|1|||
33407976|NCT01011335|62786433|FG004|Overall Study|Lost to Follow-up|1|||
33407977|NCT01011335|62786434|FG005|Overall Study|Lost to Follow-up|1|||
33407978|NCT01011335|62786435|FG006|Overall Study|Lost to Follow-up|2|||
33407979|NCT01011335|62786436|FG007|Overall Study|Lost to Follow-up|2|||
33407980|NCT01011335|62786437|FG008|Overall Study|Lost to Follow-up|1|||
33407981|NCT01011335|62786438|FG009|Overall Study|Lost to Follow-up|0|||
33407982|NCT01011335|62786439|FG010|Overall Study|Lost to Follow-up|0|||
33407983|NCT01011335|62786440|FG011|Overall Study|Lost to Follow-up|1|||
33407984|NCT01011335|62786441|FG012|Overall Study|Lost to Follow-up|2|||
33407985|NCT01011335|62786429|FG000|Overall Study|Protocol Violation|0|||
33407986|NCT01011335|62786430|FG001|Overall Study|Protocol Violation|1|||
33407987|NCT01011335|62786431|FG002|Overall Study|Protocol Violation|0|||
33407988|NCT01011335|62786432|FG003|Overall Study|Protocol Violation|0|||
33407989|NCT01011335|62786433|FG004|Overall Study|Protocol Violation|0|||
33407990|NCT01011335|62786434|FG005|Overall Study|Protocol Violation|0|||
33407991|NCT01011335|62786435|FG006|Overall Study|Protocol Violation|0|||
33407992|NCT01011335|62786436|FG007|Overall Study|Protocol Violation|0|||
33407993|NCT01011335|62786437|FG008|Overall Study|Protocol Violation|0|||
33407994|NCT01011335|62786438|FG009|Overall Study|Protocol Violation|0|||
33407995|NCT01011335|62786439|FG010|Overall Study|Protocol Violation|0|||
33407996|NCT01011335|62786440|FG011|Overall Study|Protocol Violation|0|||
33407997|NCT01011335|62786441|FG012|Overall Study|Protocol Violation|0|||
33407998|NCT01011335|62786429|FG000|Overall Study|Moved/deployed or no booster|1|||
33407999|NCT01011335|62786430|FG001|Overall Study|Moved/deployed or no booster|0|||
33598880|NCT02286895|62997889|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
33598881|NCT02286895|62997888|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
33598882|NCT02286895|62997889|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
33598883|NCT02286895|62997888|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
33598884|NCT02286895|62997889|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
33598885|NCT02472977|62997898|FG000|Overall Study|Disease progression|4|||
33598886|NCT02472977|62997899|FG001|Overall Study|Disease progression|25|||
33598887|NCT02472977|62997900|FG002|Overall Study|Disease progression|6|||
33598888|NCT02472977|62997898|FG000|Overall Study|Withdrawal by Subject|0|||
33598889|NCT02472977|62997899|FG001|Overall Study|Withdrawal by Subject|1|||
33598890|NCT02472977|62997900|FG002|Overall Study|Withdrawal by Subject|0|||
33598891|NCT02472977|62997898|FG000|Overall Study|Study drug toxicity|2|||
33598892|NCT02472977|62997899|FG001|Overall Study|Study drug toxicity|0|||
33598893|NCT02472977|62997900|FG002|Overall Study|Study drug toxicity|2|||
33598894|NCT02472977|62997898|FG000|Overall Study|Subject request to discontinue treatment|0|||
33598895|NCT02472977|62997899|FG001|Overall Study|Subject request to discontinue treatment|1|||
33598896|NCT02472977|62997900|FG002|Overall Study|Subject request to discontinue treatment|0|||
33598897|NCT02060487|62997911|FG000|Overall Study|Other|1|||
33598898|NCT02060487|62997912|FG001|Overall Study|Other|2|||
33598899|NCT02060487|62997913|FG002|Overall Study|Other|1|||
33598900|NCT02060487|62997911|FG000|Overall Study|Lack of Efficacy|0|||
33598901|NCT02060487|62997912|FG001|Overall Study|Lack of Efficacy|1|||
33598902|NCT02060487|62997913|FG002|Overall Study|Lack of Efficacy|0|||
33598903|NCT02060487|62997911|FG000|Overall Study|Withdrawal by Subject|3|||
33598904|NCT02060487|62997912|FG001|Overall Study|Withdrawal by Subject|10|||
33598905|NCT02060487|62997913|FG002|Overall Study|Withdrawal by Subject|4|||
33598906|NCT02060487|62997911|FG000|Overall Study|Study Terminated By Sponsor|87|||
33598907|NCT02060487|62997912|FG001|Overall Study|Study Terminated By Sponsor|89|||
33408000|NCT01011335|62786431|FG002|Overall Study|Moved/deployed or no booster|0|||
33408001|NCT01011335|62786432|FG003|Overall Study|Moved/deployed or no booster|1|||
33408002|NCT01011335|62786433|FG004|Overall Study|Moved/deployed or no booster|0|||
33408003|NCT01011335|62786434|FG005|Overall Study|Moved/deployed or no booster|0|||
33408004|NCT01011335|62786435|FG006|Overall Study|Moved/deployed or no booster|1|||
33408005|NCT01011335|62786436|FG007|Overall Study|Moved/deployed or no booster|0|||
33408006|NCT01011335|62786437|FG008|Overall Study|Moved/deployed or no booster|1|||
33493981|NCT03557970|62872573|FG001|Overall Study|Study closure|0|||
33493982|NCT03557970|62872572|FG000|Overall Study|Physician Decision|0|||
33493983|NCT03557970|62872573|FG001|Overall Study|Physician Decision|1|||
33493984|NCT03557970|62872572|FG000|Overall Study|Death|0|||
33493985|NCT03557970|62872573|FG001|Overall Study|Death|1|||
33493986|NCT02815280|62872581|FG000|Double-Blind Phase|Adverse Event|1|||
33493987|NCT02815280|62872582|FG001|Double-Blind Phase|Adverse Event|1|||
33493988|NCT02815280|62872581|FG000|Double-Blind Phase|Lost to Follow-up|10|||
33493989|NCT02815280|62872582|FG001|Double-Blind Phase|Lost to Follow-up|9|||
33598908|NCT02060487|62997913|FG002|Overall Study|Study Terminated By Sponsor|100|||
33408007|NCT01011335|62786438|FG009|Overall Study|Moved/deployed or no booster|0|||
33408008|NCT01011335|62786439|FG010|Overall Study|Moved/deployed or no booster|2|||
33408009|NCT01011335|62786440|FG011|Overall Study|Moved/deployed or no booster|0|||
33408010|NCT01011335|62786441|FG012|Overall Study|Moved/deployed or no booster|0|||
33408011|NCT01011335|62786429|FG000|Overall Study|Adverse Event|0|||
33408012|NCT01011335|62786430|FG001|Overall Study|Adverse Event|0|||
33598909|NCT02060487|62997911|FG000|Overall Study|Randomized in error|1|||
33598910|NCT02060487|62997912|FG001|Overall Study|Randomized in error|0|||
33598911|NCT02060487|62997913|FG002|Overall Study|Randomized in error|0|||
33598912|NCT02060487|62997911|FG000|Overall Study|Protocol Violation|0|||
33598913|NCT02060487|62997912|FG001|Overall Study|Protocol Violation|1|||
33598914|NCT02060487|62997913|FG002|Overall Study|Protocol Violation|1|||
33408013|NCT01011335|62786431|FG002|Overall Study|Adverse Event|0|||
33408014|NCT01011335|62786432|FG003|Overall Study|Adverse Event|0|||
33408015|NCT01011335|62786433|FG004|Overall Study|Adverse Event|0|||
33408016|NCT01011335|62786434|FG005|Overall Study|Adverse Event|0|||
33408017|NCT01011335|62786435|FG006|Overall Study|Adverse Event|0|||
33598915|NCT02060487|62997911|FG000|Overall Study|Lost to Follow-up|3|||
33408018|NCT01011335|62786436|FG007|Overall Study|Adverse Event|0|||
33408019|NCT01011335|62786437|FG008|Overall Study|Adverse Event|0|||
33408020|NCT01011335|62786438|FG009|Overall Study|Adverse Event|0|||
33408021|NCT01011335|62786439|FG010|Overall Study|Adverse Event|4|||
33408022|NCT01011335|62786440|FG011|Overall Study|Adverse Event|0|||
33408023|NCT01011335|62786441|FG012|Overall Study|Adverse Event|1|||
33408024|NCT00467896|62786478|FG000|Overall Study|Consent Withdrawal|18|||
33408025|NCT00467896|62786478|FG000|Overall Study|Adverse Event|7|||
33408026|NCT00467896|62786478|FG000|Overall Study|Serious Adverse Event|13|||
33408027|NCT00467896|62786478|FG000|Overall Study|Non-compliance|3|||
33408028|NCT00467896|62786478|FG000|Overall Study|Changed therapy|2|||
33408029|NCT00467896|62786478|FG000|Overall Study|Patient received transplant|2|||
33408030|NCT00467896|62786478|FG000|Overall Study|Patient had atrial septostomy|1|||
33408031|NCT00467896|62786478|FG000|Overall Study|Patient weaned off iloprost|1|||
33408032|NCT00467896|62786478|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
33408033|NCT00467896|62786478|FG000|Overall Study|Started intravenous prostacyclin|1|||
33408034|NCT00467896|62786478|FG000|Overall Study|Started inhaled Remodulin|1|||
33408035|NCT00467896|62786478|FG000|Overall Study|Patient had no improvement|1|||
33408036|NCT00579059|62786486|FG000|Overall Study|Study Canceled at 1 Year|21|||
33408037|NCT00579059|62786487|FG001|Overall Study|Study Canceled at 1 Year|10|||
33408038|NCT00467818|62786495|FG000|Overall Study|Adverse Event|1|||
33408039|NCT00467818|62786496|FG001|Overall Study|Adverse Event|0|||
33408040|NCT00467818|62786495|FG000|Overall Study|Lost to Follow-up|2|||
33408041|NCT00467818|62786496|FG001|Overall Study|Lost to Follow-up|2|||
33493990|NCT02815280|62872581|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
33408042|NCT00467740|62786509|FG000|Overall Study|Adverse Event|0|||
33408043|NCT00467740|62786510|FG001|Overall Study|Adverse Event|0|||
33493991|NCT02815280|62872582|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
33493992|NCT02815280|62872581|FG000|Double-Blind Phase|Protocol Violation|2|||
33493993|NCT02815280|62872582|FG001|Double-Blind Phase|Protocol Violation|2|||
33493994|NCT02815280|62872581|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
33493995|NCT02815280|62872582|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
33493996|NCT02815280|62872581|FG000|Open-Label Phase|Adverse Event|2|||
33493997|NCT02815280|62872582|FG001|Open-Label Phase|Adverse Event|3|||
33493998|NCT02815280|62872581|FG000|Open-Label Phase|Lost to Follow-up|18|||
33493999|NCT02815280|62872582|FG001|Open-Label Phase|Lost to Follow-up|9|||
33598916|NCT02060487|62997912|FG001|Overall Study|Lost to Follow-up|0|||
33408044|NCT00467740|62786511|FG002|Overall Study|Adverse Event|1|||
33408045|NCT00467740|62786512|FG003|Overall Study|Adverse Event|0|||
33408046|NCT00467740|62786513|FG004|Overall Study|Adverse Event|0|||
33408047|NCT00467740|62786509|FG000|Overall Study|Protocol Violation|0|||
33408048|NCT00467740|62786510|FG001|Overall Study|Protocol Violation|0|||
33408049|NCT00467740|62786511|FG002|Overall Study|Protocol Violation|1|||
33408050|NCT00467740|62786512|FG003|Overall Study|Protocol Violation|0|||
33408051|NCT00467740|62786513|FG004|Overall Study|Protocol Violation|0|||
33408052|NCT00467740|62786509|FG000|Overall Study|Lost to Follow-up|0|||
33408053|NCT00467740|62786510|FG001|Overall Study|Lost to Follow-up|1|||
33408054|NCT00467740|62786511|FG002|Overall Study|Lost to Follow-up|0|||
33408055|NCT00467740|62786512|FG003|Overall Study|Lost to Follow-up|0|||
33408056|NCT00467740|62786513|FG004|Overall Study|Lost to Follow-up|0|||
33408057|NCT00467740|62786509|FG000|Overall Study|Withdrawal by Subject|1|||
33408058|NCT00467740|62786510|FG001|Overall Study|Withdrawal by Subject|1|||
33408059|NCT00467740|62786511|FG002|Overall Study|Withdrawal by Subject|0|||
33408060|NCT00467740|62786512|FG003|Overall Study|Withdrawal by Subject|1|||
33408061|NCT00467740|62786513|FG004|Overall Study|Withdrawal by Subject|0|||
33408062|NCT00467740|62786509|FG000|Overall Study|Lack of Efficacy|0|||
33408063|NCT00467740|62786510|FG001|Overall Study|Lack of Efficacy|1|||
33408064|NCT00467740|62786511|FG002|Overall Study|Lack of Efficacy|0|||
33408065|NCT00467740|62786512|FG003|Overall Study|Lack of Efficacy|0|||
33408066|NCT00467740|62786513|FG004|Overall Study|Lack of Efficacy|0|||
33408067|NCT00553254|62786527|FG000|Overall Study|Death|3|||
33408068|NCT00553254|62786528|FG001|Overall Study|Death|6|||
33408069|NCT00553254|62786529|FG002|Overall Study|Death|25|||
33408070|NCT00553254|62786527|FG000|Overall Study|Lost to Follow-up|0|||
33408071|NCT00553254|62786528|FG001|Overall Study|Lost to Follow-up|0|||
33408072|NCT00553254|62786529|FG002|Overall Study|Lost to Follow-up|2|||
33408073|NCT00553254|62786527|FG000|Overall Study|Withdrawal by Subject|2|||
33408074|NCT00553254|62786528|FG001|Overall Study|Withdrawal by Subject|0|||
33408075|NCT00553254|62786529|FG002|Overall Study|Withdrawal by Subject|2|||
33408076|NCT00553254|62786527|FG000|Overall Study|Study terminated by Sponsor|0|||
33408077|NCT00553254|62786528|FG001|Overall Study|Study terminated by Sponsor|0|||
33408078|NCT00553254|62786529|FG002|Overall Study|Study terminated by Sponsor|1|||
33408079|NCT00553254|62786527|FG000|Overall Study|Other|1|||
33408080|NCT00553254|62786528|FG001|Overall Study|Other|0|||
33408081|NCT00553254|62786529|FG002|Overall Study|Other|13|||
33408082|NCT00168805|62786544|FG000|Overall Study|Adverse Event|7|||
33408083|NCT00168805|62786545|FG001|Overall Study|Adverse Event|11|||
33408084|NCT00168805|62786546|FG002|Overall Study|Adverse Event|16|||
33408085|NCT00168805|62786544|FG000|Overall Study|Protocol Violation|12|||
33408086|NCT00168805|62786545|FG001|Overall Study|Protocol Violation|11|||
33408087|NCT00168805|62786546|FG002|Overall Study|Protocol Violation|8|||
33408088|NCT00168805|62786544|FG000|Overall Study|Lost to Follow-up|12|||
33408089|NCT00168805|62786545|FG001|Overall Study|Lost to Follow-up|17|||
33408090|NCT00168805|62786546|FG002|Overall Study|Lost to Follow-up|11|||
33408091|NCT00168805|62786544|FG000|Overall Study|Withdrawal by Subject|16|||
33408092|NCT00168805|62786545|FG001|Overall Study|Withdrawal by Subject|18|||
33408093|NCT00168805|62786546|FG002|Overall Study|Withdrawal by Subject|21|||
33408094|NCT00168805|62786544|FG000|Overall Study|Other|24|||
33408095|NCT00168805|62786545|FG001|Overall Study|Other|21|||
33408096|NCT00168805|62786546|FG002|Overall Study|Other|22|||
33408097|NCT00168805|62786544|FG000|Treatment|Adverse Event|25|||
33408098|NCT00168805|62786545|FG001|Treatment|Adverse Event|26|||
33408099|NCT00168805|62786546|FG002|Treatment|Adverse Event|32|||
33408100|NCT00168805|62786544|FG000|Treatment|Protocol Violation|3|||
33408101|NCT00168805|62786545|FG001|Treatment|Protocol Violation|5|||
33408102|NCT00168805|62786546|FG002|Treatment|Protocol Violation|5|||
33408103|NCT00168805|62786544|FG000|Treatment|Withdrawal by Subject|3|||
33408104|NCT00168805|62786545|FG001|Treatment|Withdrawal by Subject|7|||
33408105|NCT00168805|62786546|FG002|Treatment|Withdrawal by Subject|8|||
33408106|NCT00168805|62786544|FG000|Treatment|Other|18|||
33408107|NCT00168805|62786545|FG001|Treatment|Other|18|||
33408108|NCT00168805|62786546|FG002|Treatment|Other|17|||
33408109|NCT00467584|62786557|FG000|Overall Study|Withdrawal by Subject|4|||
33408110|NCT00467584|62786558|FG001|Overall Study|Withdrawal by Subject|5|||
33598917|NCT02060487|62997913|FG002|Overall Study|Lost to Follow-up|2|||
33408111|NCT00467584|62786559|FG002|Overall Study|Withdrawal by Subject|1|||
33408112|NCT03839212|62786567|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
33408113|NCT00168103|62786574|FG000|Overall Study|Withdrawal by Subject|1|||
33408114|NCT00168103|62786575|FG001|Overall Study|Withdrawal by Subject|2|||
33408115|NCT00168103|62786576|FG002|Overall Study|Withdrawal by Subject|1|||
33408116|NCT00168103|62786577|FG003|Overall Study|Withdrawal by Subject|0|||
33408117|NCT00168103|62786574|FG000|Overall Study|Lost to Follow-up|1|||
33408118|NCT00168103|62786575|FG001|Overall Study|Lost to Follow-up|3|||
33408119|NCT00168103|62786576|FG002|Overall Study|Lost to Follow-up|0|||
33408120|NCT00168103|62786577|FG003|Overall Study|Lost to Follow-up|0|||
33408121|NCT00463060|62786587|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
33408122|NCT00463060|62786587|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
33408123|NCT00462982|62786596|FG000|Overall Study|Adverse Event|1|||
33408124|NCT00462982|62786596|FG000|Overall Study|Patient Not Treated|2|||
33408125|NCT00462904|62786617|FG000|Overall Study|Lost to Follow-up|1|||
33408126|NCT00467272|62786621|FG000|Overall Study|Pneumonia|2|||
33408127|NCT00467272|62786621|FG000|Overall Study|Thrombophlebitis|1|||
33408128|NCT00462826|62786625|FG000|Overall Study|Ineligible - second primary|1|||
33408129|NCT00462826|62786625|FG000|Overall Study|Ineligible - wrong cell type|1|||
33408130|NCT00462826|62786625|FG000|Overall Study|Ineligible - wrong primary|2|||
33408131|NCT00462826|62786625|FG000|Overall Study|Never treated|1|||
33408132|NCT00551616|62786637|FG000|Overall Study|Lost to Follow-up|48|||
33408133|NCT00551616|62786638|FG001|Overall Study|Lost to Follow-up|40|||
33408134|NCT00452530|62786646|FG000|Overall Study|Death|1|||
33408135|NCT00452530|62786647|FG001|Overall Study|Death|0|||
33408136|NCT00452530|62786646|FG000|Overall Study|Adverse Event|40|||
33408137|NCT00452530|62786647|FG001|Overall Study|Adverse Event|44|||
33408138|NCT00452530|62786646|FG000|Overall Study|Withdrawal by Subject|68|||
33598918|NCT02060487|62997911|FG000|Overall Study|Death|34|||
33598919|NCT02060487|62997912|FG001|Overall Study|Death|25|||
33598920|NCT02060487|62997913|FG002|Overall Study|Death|19|||
33598921|NCT02060487|62997911|FG000|Overall Study|Adverse Event|0|||
33598922|NCT02060487|62997912|FG001|Overall Study|Adverse Event|0|||
33598923|NCT02060487|62997913|FG002|Overall Study|Adverse Event|1|||
33598924|NCT02059395|62997923|FG000|Overall Study|Lost to Follow-up|2|||
33598925|NCT02059395|62997924|FG001|Overall Study|Lost to Follow-up|4|||
33598926|NCT02059239|62997932|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
33598927|NCT02059239|62997933|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
33598928|NCT02059239|62997932|FG000|Overall Study|Physician Decision|1|||
33408139|NCT00452530|62786647|FG001|Overall Study|Withdrawal by Subject|57|||
33408140|NCT00452530|62786646|FG000|Overall Study|Lost to Follow-up|1|||
33408141|NCT00452530|62786647|FG001|Overall Study|Lost to Follow-up|0|||
33408142|NCT00452530|62786646|FG000|Overall Study|Poor compliance/noncompliance|1|||
33408143|NCT00452530|62786647|FG001|Overall Study|Poor compliance/noncompliance|2|||
33408144|NCT00452530|62786646|FG000|Overall Study|No longer met study criteria|18|||
33408145|NCT00452530|62786647|FG001|Overall Study|No longer met study criteria|22|||
33408146|NCT00452530|62786646|FG000|Overall Study|Other|7|||
33408147|NCT00452530|62786647|FG001|Overall Study|Other|11|||
33408148|NCT00549198|62786659|FG000|Overall Study|Adverse Event|28|||
33408149|NCT00549198|62786660|FG001|Overall Study|Adverse Event|26|||
33408150|NCT00549198|62786659|FG000|Overall Study|Insufficient Viral Load Response|4|||
33408151|NCT00549198|62786660|FG001|Overall Study|Insufficient Viral Load Response|2|||
33408152|NCT00549198|62786659|FG000|Overall Study|Protocol-defined Virological Failure|7|||
33408153|NCT00549198|62786660|FG001|Overall Study|Protocol-defined Virological Failure|0|||
33408154|NCT00549198|62786659|FG000|Overall Study|Non-compliance|2|||
33408155|NCT00549198|62786660|FG001|Overall Study|Non-compliance|4|||
33408156|NCT00549198|62786659|FG000|Overall Study|Lost to Follow-up|7|||
33408157|NCT00549198|62786660|FG001|Overall Study|Lost to Follow-up|8|||
33408158|NCT00549198|62786659|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
33408159|NCT00549198|62786660|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33408160|NCT00549198|62786659|FG000|Overall Study|Protocol Violation|7|||
33408161|NCT00549198|62786660|FG001|Overall Study|Protocol Violation|2|||
33408162|NCT00549198|62786659|FG000|Overall Study|Investigator Decision|4|||
33408163|NCT00549198|62786660|FG001|Overall Study|Investigator Decision|3|||
33408164|NCT00549198|62786659|FG000|Overall Study|Withdrawal by Subject|7|||
33408165|NCT00549198|62786660|FG001|Overall Study|Withdrawal by Subject|7|||
33408166|NCT00549198|62786659|FG000|Overall Study|Disease Progression|1|||
33598929|NCT02059239|62997933|FG001|Overall Study|Physician Decision|0|||
33408167|NCT00549198|62786660|FG001|Overall Study|Disease Progression|0|||
33408168|NCT00549198|62786659|FG000|Overall Study|Participant Moved|2|||
33598930|NCT02059161|62997942|FG000|Overall Study|Pregnancy|0|||
33408169|NCT00549198|62786660|FG001|Overall Study|Participant Moved|0|||
33408170|NCT00549198|62786659|FG000|Overall Study|Participant not able to perform Week 96|1|||
33408171|NCT00549198|62786660|FG001|Overall Study|Participant not able to perform Week 96|0|||
33408172|NCT00549198|62786659|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
33598931|NCT02059161|62997943|FG001|Overall Study|Pregnancy|2|||
33598932|NCT02059161|62997942|FG000|Overall Study|Adverse Event|2|||
33598933|NCT02059161|62997943|FG001|Overall Study|Adverse Event|6|||
33408173|NCT00549198|62786660|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
33408174|NCT00549198|62786659|FG000|Overall Study|Prohibited Medication|1|||
33408175|NCT00549198|62786660|FG001|Overall Study|Prohibited Medication|2|||
33408176|NCT00549198|62786659|FG000|Overall Study|Participant planning pregnancy|1|||
33408177|NCT00549198|62786660|FG001|Overall Study|Participant planning pregnancy|0|||
33408178|NCT00549198|62786659|FG000|Overall Study|Participant overweight, no scan possible|1|||
33408179|NCT00549198|62786660|FG001|Overall Study|Participant overweight, no scan possible|0|||
33408180|NCT00549198|62786659|FG000|Overall Study|No scan facilities|0|||
33408181|NCT00549198|62786660|FG001|Overall Study|No scan facilities|2|||
33408182|NCT00549198|62786659|FG000|Overall Study|Pregnancy|0|||
33408183|NCT00549198|62786660|FG001|Overall Study|Pregnancy|3|||
33408184|NCT00549198|62786659|FG000|Overall Study|Not Exposed to Study Drug|3|||
33408185|NCT00549198|62786660|FG001|Overall Study|Not Exposed to Study Drug|4|||
33408186|NCT00607724|62786673|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
33408187|NCT00607724|62786674|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
33408188|NCT00607724|62786675|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
33408189|NCT00607724|62786676|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
33408190|NCT00607724|62786677|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
33408191|NCT00607724|62786678|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
33408192|NCT00607724|62786679|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
33321383|NCT00996801|62697359|FG001|Overall Study|Progressive Disease|1|||
33321384|NCT00996801|62697360|FG002|Overall Study|Progressive Disease|0|||
33321385|NCT00996801|62697361|FG003|Overall Study|Progressive Disease|0|||
33321386|NCT00996801|62697362|FG004|Overall Study|Progressive Disease|0|||
33321387|NCT00996801|62697363|FG005|Overall Study|Progressive Disease|0|||
33321388|NCT00996801|62697358|FG000|Overall Study|Protocol Violation|3|||
33321389|NCT00996801|62697359|FG001|Overall Study|Protocol Violation|4|||
33321390|NCT00996801|62697360|FG002|Overall Study|Protocol Violation|1|||
33408193|NCT00607724|62786673|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
33321391|NCT00996801|62697361|FG003|Overall Study|Protocol Violation|2|||
33321392|NCT00996801|62697362|FG004|Overall Study|Protocol Violation|3|||
33321393|NCT00996801|62697363|FG005|Overall Study|Protocol Violation|4|||
33321394|NCT00996801|62697358|FG000|Overall Study|Study Terminated by Sponsor|0|||
33408194|NCT00607724|62786674|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
33494000|NCT02815280|62872581|FG000|Open-Label Phase|Withdrawal by Subject|33|||
33321395|NCT00996801|62697359|FG001|Overall Study|Study Terminated by Sponsor|1|||
33321396|NCT00996801|62697360|FG002|Overall Study|Study Terminated by Sponsor|0|||
33408195|NCT00607724|62786675|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
33408196|NCT00607724|62786676|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
33408197|NCT00607724|62786677|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
33408198|NCT00607724|62786678|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
33408199|NCT00607724|62786679|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
33408200|NCT00607724|62786673|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
33408201|NCT00607724|62786674|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
33408202|NCT00607724|62786675|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
33408203|NCT00607724|62786676|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
33408204|NCT00607724|62786677|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
33408205|NCT00607724|62786678|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
33408206|NCT00607724|62786679|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
33408207|NCT00607724|62786673|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
33408208|NCT00607724|62786674|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
33408209|NCT00607724|62786675|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
33408210|NCT00607724|62786676|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
33408211|NCT00607724|62786677|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
33408212|NCT00607724|62786678|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
33408213|NCT00607724|62786679|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
33408214|NCT00607724|62786673|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
33408215|NCT00607724|62786674|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
33408216|NCT00607724|62786675|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
33408217|NCT00607724|62786676|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
33408218|NCT00607724|62786677|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
33408219|NCT00607724|62786678|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
33408220|NCT00607724|62786679|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
33408221|NCT00506415|62786703|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
33408222|NCT00506415|62786704|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
33408223|NCT00506415|62786705|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
33408224|NCT00506415|62786706|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
33408225|NCT00506415|62786703|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
33408226|NCT00506415|62786704|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
33408227|NCT00506415|62786705|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
33408228|NCT00506415|62786706|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
33408229|NCT00506415|62786703|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
33408230|NCT00506415|62786704|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
33408231|NCT00506415|62786705|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
33408232|NCT00506415|62786706|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
33408233|NCT00506415|62786703|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
33408234|NCT00506415|62786704|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
33408235|NCT00506415|62786705|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
33408236|NCT00506415|62786706|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
33408237|NCT00506415|62786703|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
33408238|NCT00506415|62786704|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
33408239|NCT00506415|62786705|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
33408240|NCT00506415|62786706|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
33408241|NCT00506415|62786703|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
33408242|NCT00506415|62786704|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
33408243|NCT00506415|62786705|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
33408244|NCT00506415|62786706|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
33408245|NCT00506415|62786703|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
33408246|NCT00506415|62786704|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
33408247|NCT00506415|62786705|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
33408248|NCT00506415|62786706|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
33408249|NCT00506415|62786703|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
33408250|NCT00506415|62786704|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
33408251|NCT00506415|62786705|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
33408252|NCT00506415|62786706|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
33408253|NCT00506415|62786703|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
33408254|NCT00506415|62786704|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
33408255|NCT00506415|62786705|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
33408256|NCT00506415|62786706|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
33408257|NCT00506415|62786703|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
33408258|NCT00506415|62786704|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
33408259|NCT00506415|62786705|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
33408260|NCT00506415|62786706|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
33408261|NCT00506415|62786703|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
33408262|NCT00506415|62786704|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
33408263|NCT00506415|62786705|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
33408264|NCT00506415|62786706|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
33408265|NCT00506415|62786703|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
33408266|NCT00506415|62786704|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
33408267|NCT00506415|62786705|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
33408268|NCT00506415|62786706|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
33408269|NCT00506415|62786703|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
33408270|NCT00506415|62786704|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
33408271|NCT00506415|62786705|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
33408272|NCT00506415|62786706|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
33408273|NCT00506415|62786703|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
33408274|NCT00506415|62786704|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
33408275|NCT00506415|62786705|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
33408276|NCT00506415|62786706|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
33408277|NCT00506415|62786703|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
33408278|NCT00506415|62786704|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
33408279|NCT00506415|62786705|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
33408280|NCT00506415|62786706|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
33408281|NCT00506415|62786703|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
33408282|NCT00506415|62786704|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
33408283|NCT00506415|62786705|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
33408284|NCT00506415|62786706|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
33408285|NCT00506415|62786703|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
33408286|NCT00506415|62786704|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
33408287|NCT00506415|62786705|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
33408288|NCT00506415|62786706|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
33408289|NCT00506415|62786703|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
33408290|NCT00506415|62786704|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
33408291|NCT00506415|62786705|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
33408292|NCT00506415|62786706|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
33408293|NCT00506415|62786703|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
33408294|NCT00506415|62786704|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
33408295|NCT00506415|62786705|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
33408296|NCT00506415|62786706|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
33408297|NCT00506415|62786703|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
33408298|NCT00506415|62786704|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
33408299|NCT00506415|62786705|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
33408300|NCT00506415|62786706|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
33408301|NCT00506415|62786703|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
33408302|NCT00506415|62786704|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
33408303|NCT00506415|62786705|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
33408304|NCT00506415|62786706|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
33408305|NCT00506415|62786703|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
33408306|NCT00506415|62786704|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
33408307|NCT00506415|62786705|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
33408308|NCT00506415|62786706|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
33408309|NCT00506415|62786703|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
33408310|NCT00506415|62786704|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
33408311|NCT00506415|62786705|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
33408312|NCT00506415|62786706|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
33408313|NCT00506415|62786703|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
33408314|NCT00506415|62786704|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
33408315|NCT00506415|62786705|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
33598934|NCT02059161|62997942|FG000|Overall Study|Lost to Follow-up|20|||
33408316|NCT00506415|62786706|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
33408317|NCT00452452|62786722|FG000|Overall Study|Protocol Violation|0|||
33408318|NCT00452452|62786723|FG001|Overall Study|Protocol Violation|0|||
33408319|NCT00452452|62786724|FG002|Overall Study|Protocol Violation|1|||
33408320|NCT00452452|62786722|FG000|Overall Study|Withdrawal by Subject|1|||
33408321|NCT00452452|62786723|FG001|Overall Study|Withdrawal by Subject|0|||
33408322|NCT00452452|62786724|FG002|Overall Study|Withdrawal by Subject|0|||
33408323|NCT00452452|62786722|FG000|Overall Study|Lost to Follow-up|1|||
33408324|NCT00452452|62786723|FG001|Overall Study|Lost to Follow-up|0|||
33408325|NCT00452452|62786724|FG002|Overall Study|Lost to Follow-up|0|||
33408326|NCT00510783|62786740|FG000|Overall Study|Lost to Follow-up|29|||
33408327|NCT00510783|62786741|FG001|Overall Study|Lost to Follow-up|25|||
33408328|NCT00510783|62786740|FG000|Overall Study|Withdrawal by Subject|2|||
33408329|NCT00510783|62786741|FG001|Overall Study|Withdrawal by Subject|3|||
33408330|NCT00510783|62786740|FG000|Overall Study|Protocol Violation|0|||
33408331|NCT00510783|62786741|FG001|Overall Study|Protocol Violation|1|||
33408332|NCT00518973|62786749|FG000|Overall Study|Withdrawal by Subject|3|||
33408333|NCT00518973|62786750|FG001|Overall Study|Withdrawal by Subject|2|||
33408334|NCT00462670|62786758|FG000|Overall Study|Adverse Event|3|||
33408335|NCT00462670|62786759|FG001|Overall Study|Adverse Event|5|||
33408336|NCT00462670|62786758|FG000|Overall Study|Lack of Efficacy|1|||
33408337|NCT00462670|62786759|FG001|Overall Study|Lack of Efficacy|0|||
33408338|NCT00462670|62786758|FG000|Overall Study|Protocol Violation|1|||
33408339|NCT00462670|62786759|FG001|Overall Study|Protocol Violation|0|||
33408340|NCT00462670|62786758|FG000|Overall Study|Resolution of signs and symptoms|0|||
33408341|NCT00462670|62786759|FG001|Overall Study|Resolution of signs and symptoms|2|||
33408342|NCT00606086|62786767|FG000|Overall Study|Adverse Event|1|||
33408343|NCT00606086|62786768|FG001|Overall Study|Adverse Event|1|||
33408344|NCT00606086|62786767|FG000|Overall Study|Lost to Follow-up|4|||
33408345|NCT00606086|62786768|FG001|Overall Study|Lost to Follow-up|8|||
33408346|NCT00606086|62786767|FG000|Overall Study|Protocol Violation|1|||
33408347|NCT00606086|62786768|FG001|Overall Study|Protocol Violation|0|||
33408348|NCT00606086|62786767|FG000|Overall Study|Withdrawal by Subject|5|||
33408349|NCT00606086|62786768|FG001|Overall Study|Withdrawal by Subject|3|||
33408350|NCT00606086|62786767|FG000|Overall Study|Non-compliance|0|||
33408351|NCT00606086|62786768|FG001|Overall Study|Non-compliance|1|||
33408352|NCT00606086|62786767|FG000|Overall Study|Randomized, not treated|1|||
33408353|NCT00606086|62786768|FG001|Overall Study|Randomized, not treated|2|||
33408354|NCT00609986|62786776|FG000|Overall Study|Did not receive transplant or treatment|8|||
33408355|NCT00609986|62786777|FG001|Overall Study|Did not receive transplant or treatment|3|||
33408356|NCT00451906|62786783|FG000|Overall Study|Adverse Event|515|||
33408357|NCT00451906|62786783|FG000|Overall Study|Lost to Follow-up|31|||
33408358|NCT00451906|62786783|FG000|Overall Study|Withdrawal by Subject|111|||
33408359|NCT00451906|62786783|FG000|Overall Study|Protocol Violation|21|||
33408360|NCT00451906|62786783|FG000|Overall Study|Progressive disease|1328|||
33408361|NCT00451906|62786783|FG000|Overall Study|Termination of the study|108|||
33408362|NCT00451906|62786783|FG000|Overall Study|Other Reasons|121|||
33408363|NCT00451906|62786783|FG000|Overall Study|Did not complete final visit|4|||
33408364|NCT00451282|62786789|FG000|Overall Study|Lost to Follow-up|6|||
33408365|NCT00451282|62786790|FG001|Overall Study|Lost to Follow-up|5|||
33408366|NCT03838198|62786798|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
33408367|NCT03838198|62786799|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
33408368|NCT03838198|62786800|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
33408369|NCT03838198|62786801|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
33408370|NCT03838198|62786798|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
33408371|NCT03838198|62786799|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
33408372|NCT03838198|62786800|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
33408373|NCT03838198|62786801|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
33408374|NCT00115765|62786816|FG000|Overall Study|Withdrawal by Subject|22|||
33408375|NCT00115765|62786817|FG001|Overall Study|Withdrawal by Subject|53|||
33408376|NCT00115765|62786818|FG002|Overall Study|Withdrawal by Subject|76|||
33408377|NCT00115765|62786819|FG003|Overall Study|Withdrawal by Subject|15|||
33408378|NCT00115765|62786816|FG000|Overall Study|Physician Decision|4|||
33408379|NCT00115765|62786817|FG001|Overall Study|Physician Decision|15|||
33408380|NCT00115765|62786818|FG002|Overall Study|Physician Decision|18|||
33408381|NCT00115765|62786819|FG003|Overall Study|Physician Decision|13|||
33408382|NCT00115765|62786816|FG000|Overall Study|Lost to Follow-up|3|||
33408383|NCT00115765|62786817|FG001|Overall Study|Lost to Follow-up|20|||
33408384|NCT00115765|62786818|FG002|Overall Study|Lost to Follow-up|18|||
33408385|NCT00115765|62786819|FG003|Overall Study|Lost to Follow-up|1|||
33408386|NCT00115765|62786816|FG000|Overall Study|Other|6|||
33408387|NCT00115765|62786817|FG001|Overall Study|Other|12|||
33408388|NCT00115765|62786818|FG002|Overall Study|Other|9|||
33408389|NCT00115765|62786819|FG003|Overall Study|Other|2|||
33408390|NCT00606008|62786827|FG000|Overall Study|Adverse Event|1|||
33408391|NCT00606008|62786827|FG000|Overall Study|Withdrawal by Subject|4|||
33408392|NCT00461812|62786839|FG000|Overall Study|study terminated|10|||
33408393|NCT00123955|62786846|FG000|Overall Study|Adverse Event|1|||
33408394|NCT00123955|62786847|FG001|Overall Study|Adverse Event|0|||
33408395|NCT00123955|62786846|FG000|Overall Study|Withdrawal by Subject|4|||
33408396|NCT00123955|62786847|FG001|Overall Study|Withdrawal by Subject|3|||
33408397|NCT00123955|62786846|FG000|Overall Study|Death|0|||
33408398|NCT00123955|62786847|FG001|Overall Study|Death|1|||
33408399|NCT03837028|62786857|FG000|Overall Study|Lost to Follow-up|4|||
33408400|NCT03837028|62786858|FG001|Overall Study|Lost to Follow-up|0|||
33408401|NCT03837028|62786859|FG002|Overall Study|Lost to Follow-up|2|||
33408402|NCT03837028|62786860|FG003|Overall Study|Lost to Follow-up|0|||
33408403|NCT03837028|62786857|FG000|Overall Study|Withdrawal by Subject|12|||
33408404|NCT03837028|62786858|FG001|Overall Study|Withdrawal by Subject|11|||
33408405|NCT03837028|62786859|FG002|Overall Study|Withdrawal by Subject|11|||
33408406|NCT03837028|62786860|FG003|Overall Study|Withdrawal by Subject|7|||
33408407|NCT00115063|62786872|FG000|Overall Study|Lost to Follow-up|98|||
33408408|NCT00115063|62786873|FG001|Overall Study|Lost to Follow-up|104|||
33408409|NCT00115063|62786872|FG000|Overall Study|Death|1|||
33408410|NCT00115063|62786873|FG001|Overall Study|Death|0|||
33408411|NCT00461500|62786881|FG000|Overall Study|Adverse Event|1|||
33408412|NCT00461500|62786882|FG001|Overall Study|Adverse Event|0|||
33408413|NCT00461500|62786881|FG000|Overall Study|Lack of Efficacy|0|||
33408414|NCT00461500|62786882|FG001|Overall Study|Lack of Efficacy|1|||
33408415|NCT00461500|62786881|FG000|Overall Study|Expired Drug Treatment|1|||
33408416|NCT00461500|62786882|FG001|Overall Study|Expired Drug Treatment|1|||
33408417|NCT00461500|62786881|FG000|Overall Study|Study Stopped|1|||
33408418|NCT00461500|62786882|FG001|Overall Study|Study Stopped|2|||
33408419|NCT00461500|62786881|FG000|Overall Study|Drug Treatment Misuse|1|||
33408420|NCT00461500|62786882|FG001|Overall Study|Drug Treatment Misuse|0|||
33408421|NCT00461500|62786881|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
33408422|NCT00461500|62786882|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
33408423|NCT00461500|62786881|FG000|Overall Study|Lost to Follow-up|2|||
33408424|NCT00461500|62786882|FG001|Overall Study|Lost to Follow-up|2|||
33408425|NCT00167245|62786890|FG000|Overall Study|Lost to Follow-up|20|||
33408426|NCT00167245|62786891|FG001|Overall Study|Lost to Follow-up|31|||
33408427|NCT00167245|62786890|FG000|Overall Study|Withdrawal by Subject|5|||
33408428|NCT00167245|62786891|FG001|Overall Study|Withdrawal by Subject|8|||
33408429|NCT00167245|62786890|FG000|Overall Study|Incarcerated|3|||
33408430|NCT00167245|62786891|FG001|Overall Study|Incarcerated|2|||
33408431|NCT00167245|62786890|FG000|Overall Study|Drowsy|1|||
33408432|NCT00167245|62786891|FG001|Overall Study|Drowsy|0|||
33408433|NCT00443560|62786902|FG000|Overall Study|No intrathecal dose|58|||
33408434|NCT00443560|62786903|FG001|Overall Study|No intrathecal dose|26|||
33408435|NCT00443560|62786902|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
33408436|NCT00443560|62786903|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
33408437|NCT00451204|62786911|FG000|Overall Study|Adverse Event|4|||
33408438|NCT00451204|62786912|FG001|Overall Study|Adverse Event|6|||
33408439|NCT00451204|62786911|FG000|Overall Study|Lack of Efficacy|4|||
33408440|NCT00451204|62786912|FG001|Overall Study|Lack of Efficacy|4|||
33408441|NCT00451204|62786911|FG000|Overall Study|Lost to Follow-up|4|||
33408442|NCT00451204|62786912|FG001|Overall Study|Lost to Follow-up|4|||
33408443|NCT00451204|62786911|FG000|Overall Study|Protocol Violation|1|||
33408444|NCT00451204|62786912|FG001|Overall Study|Protocol Violation|0|||
33408445|NCT00451204|62786911|FG000|Overall Study|Patient refusal|8|||
33408446|NCT00451204|62786912|FG001|Overall Study|Patient refusal|4|||
33408447|NCT00451204|62786911|FG000|Overall Study|Other|1|||
33408448|NCT00451204|62786912|FG001|Overall Study|Other|2|||
33408449|NCT00605540|62786921|FG000|Overall Study|Death|15|||
33408450|NCT00605540|62786921|FG000|Overall Study|Lost to Follow-up|23|||
33408451|NCT00605306|62786927|FG000|Overall Study|Adverse Event|0|||
33408452|NCT00605306|62786928|FG001|Overall Study|Adverse Event|1|||
33408453|NCT00607022|62786937|FG000|Overall Study|Withdrawal by Subject|1|||
33408454|NCT00607022|62786938|FG001|Overall Study|Withdrawal by Subject|0|||
33408455|NCT00607022|62786939|FG002|Overall Study|Withdrawal by Subject|0|||
33408456|NCT00606632|62786947|FG000|Overall Study|Withdrawal by Subject|13|||
33408457|NCT00606632|62786947|FG000|Overall Study|Miscellaneous reasons|9|||
33408458|NCT00450814|62786966|FG000|Overall Study|Failed to complete the initial therapy|0|||
33408459|NCT00450814|62786967|FG001|Overall Study|Failed to complete the initial therapy|0|||
33408460|NCT00450814|62786968|FG002|Overall Study|Failed to complete the initial therapy|0|||
33408461|NCT00450814|62786969|FG003|Overall Study|Failed to complete the initial therapy|1|||
33408462|NCT00450814|62786970|FG004|Overall Study|Failed to complete the initial therapy|1|||
33408463|NCT00450814|62786971|FG005|Overall Study|Failed to complete the initial therapy|1|||
33408464|NCT00450814|62786972|FG006|Overall Study|Failed to complete the initial therapy|0|||
33408465|NCT00450814|62786973|FG007|Overall Study|Failed to complete the initial therapy|0|||
33408466|NCT00450814|62786974|FG008|Overall Study|Failed to complete the initial therapy|0|||
33408467|NCT00450814|62786975|FG009|Overall Study|Failed to complete the initial therapy|0|||
33408468|NCT00450814|62786976|FG010|Overall Study|Failed to complete the initial therapy|0|||
33408469|NCT00450814|62786966|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
33408470|NCT00450814|62786967|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
33408471|NCT00450814|62786968|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
33408472|NCT00450814|62786969|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
33408473|NCT00450814|62786970|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
33408474|NCT00450814|62786971|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
33408475|NCT00450814|62786972|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
33408476|NCT00450814|62786973|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
33408477|NCT00450814|62786974|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
33408478|NCT00450814|62786975|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
33408479|NCT00450814|62786976|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
33408480|NCT00518115|62787011|FG000|Overall Study|Adverse Event|6|||
33408481|NCT00518115|62787012|FG001|Overall Study|Adverse Event|1|||
33408482|NCT00518115|62787013|FG002|Overall Study|Adverse Event|5|||
33408483|NCT00518115|62787014|FG003|Overall Study|Adverse Event|6|||
33408484|NCT00518115|62787015|FG004|Overall Study|Adverse Event|5|||
33408485|NCT00518115|62787016|FG005|Overall Study|Adverse Event|5|||
33408486|NCT00518115|62787017|FG006|Overall Study|Adverse Event|5|||
33408487|NCT00518115|62787018|FG007|Overall Study|Adverse Event|10|||
33408488|NCT00518115|62787019|FG008|Overall Study|Adverse Event|2|||
33408489|NCT00518115|62787020|FG009|Overall Study|Adverse Event|9|||
33408490|NCT00518115|62787011|FG000|Overall Study|Lost to Follow-up|0|||
33408491|NCT00518115|62787012|FG001|Overall Study|Lost to Follow-up|0|||
33408492|NCT00518115|62787013|FG002|Overall Study|Lost to Follow-up|2|||
33408493|NCT00518115|62787014|FG003|Overall Study|Lost to Follow-up|3|||
33408494|NCT00518115|62787015|FG004|Overall Study|Lost to Follow-up|1|||
33408495|NCT00518115|62787016|FG005|Overall Study|Lost to Follow-up|3|||
33408496|NCT00518115|62787017|FG006|Overall Study|Lost to Follow-up|0|||
33408497|NCT00518115|62787018|FG007|Overall Study|Lost to Follow-up|1|||
33408498|NCT00518115|62787019|FG008|Overall Study|Lost to Follow-up|1|||
33408499|NCT00518115|62787020|FG009|Overall Study|Lost to Follow-up|1|||
33408500|NCT00518115|62787011|FG000|Overall Study|Protocol Violation|1|||
33408501|NCT00518115|62787012|FG001|Overall Study|Protocol Violation|3|||
33408502|NCT00518115|62787013|FG002|Overall Study|Protocol Violation|1|||
33408503|NCT00518115|62787014|FG003|Overall Study|Protocol Violation|0|||
33408504|NCT00518115|62787015|FG004|Overall Study|Protocol Violation|0|||
33408505|NCT00518115|62787016|FG005|Overall Study|Protocol Violation|0|||
33408506|NCT00518115|62787017|FG006|Overall Study|Protocol Violation|0|||
33408507|NCT00518115|62787018|FG007|Overall Study|Protocol Violation|0|||
33408508|NCT00518115|62787019|FG008|Overall Study|Protocol Violation|0|||
33408509|NCT00518115|62787020|FG009|Overall Study|Protocol Violation|0|||
33408510|NCT00518115|62787011|FG000|Overall Study|Withdrawal by Subject|1|||
33408511|NCT00518115|62787012|FG001|Overall Study|Withdrawal by Subject|1|||
33598935|NCT02059161|62997943|FG001|Overall Study|Lost to Follow-up|12|||
33598936|NCT02059161|62997942|FG000|Overall Study|Physician Decision|4|||
33598937|NCT02059161|62997943|FG001|Overall Study|Physician Decision|4|||
33598938|NCT02059161|62997942|FG000|Overall Study|Protocol Violation|1|||
33598939|NCT02059161|62997943|FG001|Overall Study|Protocol Violation|1|||
33598940|NCT02059161|62997942|FG000|Overall Study|Withdrawal by Subject|16|||
33598941|NCT02059161|62997943|FG001|Overall Study|Withdrawal by Subject|13|||
33598942|NCT02059161|62997942|FG000|Overall Study|Randomized in error, no study drug|0|||
33598943|NCT02059161|62997943|FG001|Overall Study|Randomized in error, no study drug|1|||
33598944|NCT02059161|62997942|FG000|Overall Study|Non-compliance with study drug|6|||
33598945|NCT02059161|62997943|FG001|Overall Study|Non-compliance with study drug|2|||
33598946|NCT01897714|62997955|FG000|Phase I (Dose Escalation)|Disease progression|3|||
33598947|NCT01897714|62997956|FG001|Phase I (Dose Escalation)|Disease progression|5|||
33598948|NCT01897714|62997957|FG002|Phase I (Dose Escalation)|Disease progression|1|||
33598949|NCT01897714|62997958|FG003|Phase I (Dose Escalation)|Disease progression|3|||
33598950|NCT01897714|62997959|FG004|Phase I (Dose Escalation)|Disease progression|0|||
33598951|NCT01897714|62997960|FG005|Phase I (Dose Escalation)|Disease progression|0|||
33598952|NCT01897714|62997955|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
33598953|NCT01897714|62997956|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
33598954|NCT01897714|62997957|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
33598955|NCT01897714|62997958|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
33598956|NCT01897714|62997959|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
33598957|NCT01897714|62997960|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
33598958|NCT01897714|62997955|FG000|Phase I (Dose Escalation)|Other|0|||
33598959|NCT01897714|62997956|FG001|Phase I (Dose Escalation)|Other|1|||
33598960|NCT01897714|62997957|FG002|Phase I (Dose Escalation)|Other|0|||
33598961|NCT01897714|62997958|FG003|Phase I (Dose Escalation)|Other|0|||
33598962|NCT01897714|62997959|FG004|Phase I (Dose Escalation)|Other|0|||
33598963|NCT01897714|62997960|FG005|Phase I (Dose Escalation)|Other|0|||
33598964|NCT01897714|62997955|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
33598965|NCT01897714|62997956|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
33598966|NCT01897714|62997957|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
33598967|NCT01897714|62997958|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
33598968|NCT01897714|62997959|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
33598969|NCT01897714|62997960|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
33598970|NCT01897714|62997955|FG000|Phase II (MTD)|Lost to Follow-up|0|||
33598971|NCT01897714|62997956|FG001|Phase II (MTD)|Lost to Follow-up|0|||
33598972|NCT01897714|62997957|FG002|Phase II (MTD)|Lost to Follow-up|0|||
33408512|NCT00518115|62787013|FG002|Overall Study|Withdrawal by Subject|5|||
33408513|NCT00518115|62787014|FG003|Overall Study|Withdrawal by Subject|0|||
33408514|NCT00518115|62787015|FG004|Overall Study|Withdrawal by Subject|2|||
33408515|NCT00518115|62787016|FG005|Overall Study|Withdrawal by Subject|1|||
33408516|NCT00518115|62787017|FG006|Overall Study|Withdrawal by Subject|0|||
33408517|NCT00518115|62787018|FG007|Overall Study|Withdrawal by Subject|2|||
33408518|NCT00518115|62787019|FG008|Overall Study|Withdrawal by Subject|1|||
33408519|NCT00518115|62787020|FG009|Overall Study|Withdrawal by Subject|3|||
33408520|NCT00518115|62787011|FG000|Overall Study|Lack of Efficacy|1|||
33408521|NCT00518115|62787012|FG001|Overall Study|Lack of Efficacy|0|||
33408522|NCT00518115|62787013|FG002|Overall Study|Lack of Efficacy|1|||
33408523|NCT00518115|62787014|FG003|Overall Study|Lack of Efficacy|1|||
33408524|NCT00518115|62787015|FG004|Overall Study|Lack of Efficacy|0|||
33408525|NCT00518115|62787016|FG005|Overall Study|Lack of Efficacy|0|||
33408526|NCT00518115|62787017|FG006|Overall Study|Lack of Efficacy|0|||
33408527|NCT00518115|62787018|FG007|Overall Study|Lack of Efficacy|1|||
33408528|NCT00518115|62787019|FG008|Overall Study|Lack of Efficacy|0|||
33408529|NCT00518115|62787020|FG009|Overall Study|Lack of Efficacy|0|||
33408530|NCT00518115|62787011|FG000|Overall Study|Non-Compliance|1|||
33408531|NCT00518115|62787012|FG001|Overall Study|Non-Compliance|0|||
33408532|NCT00518115|62787013|FG002|Overall Study|Non-Compliance|1|||
33408533|NCT00518115|62787014|FG003|Overall Study|Non-Compliance|0|||
33408534|NCT00518115|62787015|FG004|Overall Study|Non-Compliance|1|||
33598973|NCT01897714|62997958|FG003|Phase II (MTD)|Lost to Follow-up|0|||
33598974|NCT01897714|62997959|FG004|Phase II (MTD)|Lost to Follow-up|1|||
33408535|NCT00518115|62787016|FG005|Overall Study|Non-Compliance|1|||
33598975|NCT01897714|62997960|FG005|Phase II (MTD)|Lost to Follow-up|0|||
33598976|NCT01897714|62997955|FG000|Phase II (MTD)|Death|0|||
33598977|NCT01897714|62997956|FG001|Phase II (MTD)|Death|0|||
33598978|NCT01897714|62997957|FG002|Phase II (MTD)|Death|0|||
33408536|NCT00518115|62787017|FG006|Overall Study|Non-Compliance|1|||
33408537|NCT00518115|62787018|FG007|Overall Study|Non-Compliance|1|||
33408538|NCT00518115|62787019|FG008|Overall Study|Non-Compliance|0|||
33408539|NCT00518115|62787020|FG009|Overall Study|Non-Compliance|1|||
33598979|NCT01897714|62997958|FG003|Phase II (MTD)|Death|0|||
33598980|NCT01897714|62997959|FG004|Phase II (MTD)|Death|25|||
33408540|NCT00518115|62787011|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
33408541|NCT00518115|62787012|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
33408542|NCT00518115|62787013|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33408543|NCT00518115|62787014|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33408544|NCT00518115|62787015|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33408545|NCT00518115|62787016|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
33408546|NCT00518115|62787017|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33408547|NCT00518115|62787018|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33408548|NCT00518115|62787019|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33408549|NCT00518115|62787020|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33408550|NCT00518115|62787011|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
33408551|NCT00518115|62787012|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33408552|NCT00518115|62787013|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33408553|NCT00518115|62787014|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33408554|NCT00518115|62787015|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33408555|NCT00518115|62787016|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33408556|NCT00518115|62787017|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33408557|NCT00518115|62787018|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33408558|NCT00518115|62787019|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33408559|NCT00518115|62787020|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33408560|NCT00518115|62787011|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
33408561|NCT00518115|62787012|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
33408562|NCT00518115|62787013|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
33408563|NCT00518115|62787014|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
33408564|NCT00518115|62787015|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
33408565|NCT00518115|62787016|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
33408566|NCT00518115|62787017|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
33408567|NCT00518115|62787018|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
33408568|NCT00518115|62787019|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
33408569|NCT00518115|62787020|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
33408570|NCT00518115|62787011|FG000|Overall Study|Wrong Monotherapy Administered|0|||
33408571|NCT00518115|62787012|FG001|Overall Study|Wrong Monotherapy Administered|0|||
33408572|NCT00518115|62787013|FG002|Overall Study|Wrong Monotherapy Administered|1|||
33408573|NCT00518115|62787014|FG003|Overall Study|Wrong Monotherapy Administered|0|||
33408574|NCT00518115|62787015|FG004|Overall Study|Wrong Monotherapy Administered|0|||
33408575|NCT00518115|62787016|FG005|Overall Study|Wrong Monotherapy Administered|0|||
33408576|NCT00518115|62787017|FG006|Overall Study|Wrong Monotherapy Administered|1|||
33408577|NCT00518115|62787018|FG007|Overall Study|Wrong Monotherapy Administered|0|||
33408578|NCT00518115|62787019|FG008|Overall Study|Wrong Monotherapy Administered|0|||
33408579|NCT00518115|62787020|FG009|Overall Study|Wrong Monotherapy Administered|0|||
33408580|NCT00518115|62787011|FG000|Overall Study|Violation of Exclusion Criteria|0|||
33408581|NCT00518115|62787012|FG001|Overall Study|Violation of Exclusion Criteria|0|||
33408582|NCT00518115|62787013|FG002|Overall Study|Violation of Exclusion Criteria|0|||
33408583|NCT00518115|62787014|FG003|Overall Study|Violation of Exclusion Criteria|1|||
33408584|NCT00518115|62787015|FG004|Overall Study|Violation of Exclusion Criteria|0|||
33408585|NCT00518115|62787016|FG005|Overall Study|Violation of Exclusion Criteria|0|||
33408586|NCT00518115|62787017|FG006|Overall Study|Violation of Exclusion Criteria|1|||
33408587|NCT00518115|62787018|FG007|Overall Study|Violation of Exclusion Criteria|0|||
33408588|NCT00518115|62787019|FG008|Overall Study|Violation of Exclusion Criteria|0|||
33408589|NCT00518115|62787020|FG009|Overall Study|Violation of Exclusion Criteria|0|||
33408590|NCT00518115|62787011|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
33408591|NCT00518115|62787012|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
33408592|NCT00518115|62787013|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
33408593|NCT00518115|62787014|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
33408594|NCT00518115|62787015|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
33408595|NCT00518115|62787016|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
33408596|NCT00518115|62787017|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
33408597|NCT00518115|62787018|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
33408598|NCT00518115|62787019|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
33408599|NCT00518115|62787020|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
33408600|NCT00518115|62787011|FG000|Overall Study|Withdrew Consent|0|||
33408601|NCT00518115|62787012|FG001|Overall Study|Withdrew Consent|0|||
33598981|NCT01897714|62997960|FG005|Phase II (MTD)|Death|10|||
33598982|NCT01897714|62997955|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
33408602|NCT00518115|62787013|FG002|Overall Study|Withdrew Consent|0|||
33408603|NCT00518115|62787014|FG003|Overall Study|Withdrew Consent|0|||
33408604|NCT00518115|62787015|FG004|Overall Study|Withdrew Consent|0|||
33408605|NCT00518115|62787016|FG005|Overall Study|Withdrew Consent|1|||
33598983|NCT01897714|62997956|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
33408606|NCT00518115|62787017|FG006|Overall Study|Withdrew Consent|0|||
33408607|NCT00518115|62787018|FG007|Overall Study|Withdrew Consent|0|||
33408608|NCT00518115|62787019|FG008|Overall Study|Withdrew Consent|0|||
33408609|NCT00518115|62787020|FG009|Overall Study|Withdrew Consent|0|||
33408610|NCT00518115|62787011|FG000|Overall Study|Moved Out of State|0|||
33408611|NCT00518115|62787012|FG001|Overall Study|Moved Out of State|0|||
33408612|NCT00518115|62787013|FG002|Overall Study|Moved Out of State|0|||
33408613|NCT00518115|62787014|FG003|Overall Study|Moved Out of State|0|||
33408614|NCT00518115|62787015|FG004|Overall Study|Moved Out of State|0|||
33408615|NCT00518115|62787016|FG005|Overall Study|Moved Out of State|0|||
33408616|NCT00518115|62787017|FG006|Overall Study|Moved Out of State|0|||
33408617|NCT00518115|62787018|FG007|Overall Study|Moved Out of State|0|||
33598984|NCT01897714|62997957|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
33598985|NCT01897714|62997958|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
33598986|NCT01897714|62997959|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
33408618|NCT00518115|62787019|FG008|Overall Study|Moved Out of State|0|||
33408619|NCT00518115|62787020|FG009|Overall Study|Moved Out of State|1|||
33408620|NCT00450658|62787045|FG000|Overall Study|Adverse Event|24|||
33408621|NCT00450658|62787046|FG001|Overall Study|Adverse Event|15|||
33408622|NCT00450658|62787045|FG000|Overall Study|Withdrawal by Subject|43|||
33408623|NCT00450658|62787046|FG001|Overall Study|Withdrawal by Subject|26|||
33408624|NCT00450658|62787045|FG000|Overall Study|Lost to Follow-up|22|||
33408625|NCT00450658|62787046|FG001|Overall Study|Lost to Follow-up|5|||
33408626|NCT00450658|62787045|FG000|Overall Study|UGI ulcer|33|||
33408627|NCT00450658|62787046|FG001|Overall Study|UGI ulcer|34|||
33408628|NCT00450658|62787045|FG000|Overall Study|misc|21|||
33408629|NCT00450658|62787046|FG001|Overall Study|misc|10|||
33408630|NCT00517881|62787052|FG000|Overall Study|Protocol Violation|2|||
33408631|NCT00517881|62787052|FG000|Overall Study|Adverse Event|1|||
33408632|NCT00517881|62787052|FG000|Overall Study|Renal transplantation|2|||
33408633|NCT00517413|62787073|FG000|Overall Study|Adverse Event|7|||
33408634|NCT00517413|62787073|FG000|Overall Study|Death|13|||
33408635|NCT00517413|62787073|FG000|Overall Study|Protocol Violation|15|||
33408636|NCT00517413|62787073|FG000|Overall Study|Withdrawal by Subject|2|||
33408637|NCT00517413|62787073|FG000|Overall Study|Failure to return|1|||
33408638|NCT00517413|62787073|FG000|Overall Study|Other-Reasons|23|||
33408639|NCT00604214|62787087|FG000|Baseline to Day 28|Death|223|||
33408640|NCT00604214|62787088|FG001|Baseline to Day 28|Death|202|||
33408641|NCT00604214|62787087|FG000|Baseline to Day 28|Lost to Follow-up|2|||
33408642|NCT00604214|62787088|FG001|Baseline to Day 28|Lost to Follow-up|4|||
33408643|NCT00604214|62787087|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
33408644|NCT00604214|62787088|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
33408645|NCT00604214|62787087|FG000|Day 29 to Day 90|Death|64|||
33408646|NCT00604214|62787088|FG001|Day 29 to Day 90|Death|67|||
33408647|NCT00604214|62787087|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
33408648|NCT00604214|62787088|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
33408649|NCT00604214|62787087|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
33408650|NCT00604214|62787088|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
33408651|NCT00604214|62787087|FG000|Day 91 to Day 180|Death|19|||
33408652|NCT00604214|62787088|FG001|Day 91 to Day 180|Death|23|||
33408653|NCT00604214|62787087|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
33408654|NCT00604214|62787088|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
33408655|NCT00604214|62787087|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
33408656|NCT00604214|62787088|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
33408657|NCT00450580|62787096|FG000|Overall Study|Adverse Event|5|||
33408658|NCT00450580|62787097|FG001|Overall Study|Adverse Event|7|||
33408659|NCT00450580|62787096|FG000|Overall Study|Lost to Follow-up|4|||
33408660|NCT00450580|62787097|FG001|Overall Study|Lost to Follow-up|5|||
33408661|NCT00450580|62787096|FG000|Overall Study|Withdrawal by Subject|2|||
33408662|NCT00450580|62787097|FG001|Overall Study|Withdrawal by Subject|2|||
33598987|NCT01897714|62997960|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
33598988|NCT01897714|62997955|FG000|Phase II (MTD)|Other|0|||
33408663|NCT00450580|62787096|FG000|Overall Study|Protocol Violation|1|||
33408664|NCT00450580|62787097|FG001|Overall Study|Protocol Violation|1|||
33408665|NCT00450580|62787096|FG000|Overall Study|Protocol-defined virologic failure|1|||
33408666|NCT00450580|62787097|FG001|Overall Study|Protocol-defined virologic failure|0|||
33408667|NCT00450580|62787096|FG000|Overall Study|Could not comply with scheduled visits|1|||
33408668|NCT00450580|62787097|FG001|Overall Study|Could not comply with scheduled visits|0|||
33408669|NCT00450580|62787096|FG000|Overall Study|Patient went to Brazil|1|||
33408670|NCT00450580|62787097|FG001|Overall Study|Patient went to Brazil|0|||
33408671|NCT00450580|62787096|FG000|Overall Study|Patient could not swallow Norvir|1|||
33598989|NCT01897714|62997956|FG001|Phase II (MTD)|Other|0|||
33598990|NCT01897714|62997957|FG002|Phase II (MTD)|Other|0|||
33598991|NCT01897714|62997958|FG003|Phase II (MTD)|Other|0|||
33598992|NCT01897714|62997959|FG004|Phase II (MTD)|Other|3|||
33598993|NCT01897714|62997960|FG005|Phase II (MTD)|Other|0|||
33598994|NCT01861522|62997978|FG000|Overall Study|Adverse Event|1|||
33408672|NCT00450580|62787097|FG001|Overall Study|Patient could not swallow Norvir|0|||
33408673|NCT00450580|62787096|FG000|Overall Study|Withdrawal due to pregnancy|0|||
33408674|NCT00450580|62787097|FG001|Overall Study|Withdrawal due to pregnancy|1|||
33408675|NCT00123487|62787105|FG000|Randomized|Death prior to starting treatment|0|||
33408676|NCT00123487|62787106|FG001|Randomized|Death prior to starting treatment|1|||
33408677|NCT00123487|62787105|FG000|Randomized|SAE prior to starting treatment|1|||
33408678|NCT00123487|62787106|FG001|Randomized|SAE prior to starting treatment|0|||
33408679|NCT00123487|62787105|FG000|Treated With Study Drug|Adverse Event|23|||
33408680|NCT00123487|62787106|FG001|Treated With Study Drug|Adverse Event|22|||
33408681|NCT00123487|62787105|FG000|Treated With Study Drug|Disease Progression|141|||
33408682|NCT00123487|62787106|FG001|Treated With Study Drug|Disease Progression|122|||
33408683|NCT00123487|62787105|FG000|Treated With Study Drug|Physician Decision|8|||
33408684|NCT00123487|62787106|FG001|Treated With Study Drug|Physician Decision|9|||
33408685|NCT00123487|62787105|FG000|Treated With Study Drug|Other|59|||
33408686|NCT00123487|62787106|FG001|Treated With Study Drug|Other|58|||
33408687|NCT00123487|62787105|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
33408688|NCT00123487|62787106|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
33408689|NCT00123487|62787105|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
33408690|NCT00123487|62787106|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
33408691|NCT00123487|62787105|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
33408692|NCT00123487|62787106|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
33408693|NCT00509925|62787113|FG000|Overall Study|Personal reasons|0|||
33408694|NCT00509925|62787114|FG001|Overall Study|Personal reasons|1|||
33408695|NCT00504777|62787122|FG000|Overall Study|Adverse Event|1|||
33408696|NCT00509769|62787126|FG000|Overall Study|Progressive disease|77|||
33408697|NCT00509769|62787126|FG000|Overall Study|Adverse Event|4|||
33408698|NCT00509769|62787126|FG000|Overall Study|Patient's decision|1|||
33408699|NCT00509769|62787126|FG000|Overall Study|Physician Decision|8|||
33408700|NCT00509769|62787126|FG000|Overall Study|Use of prohibited therapies during study|1|||
33408701|NCT00114127|62787132|FG000|Overall Study|Adverse Event|2|||
33408702|NCT00114127|62787133|FG001|Overall Study|Adverse Event|1|||
33408703|NCT00114127|62787132|FG000|Overall Study|Lost to Follow-up|1|||
33408704|NCT00114127|62787133|FG001|Overall Study|Lost to Follow-up|0|||
33408705|NCT00114127|62787132|FG000|Overall Study|Withdrawal by Subject|1|||
33408706|NCT00114127|62787133|FG001|Overall Study|Withdrawal by Subject|3|||
33408707|NCT00572624|62787141|FG000|Overall Study|Lost to Follow-up|10|||
33408708|NCT00572624|62787142|FG001|Overall Study|Lost to Follow-up|4|||
33408709|NCT00572624|62787141|FG000|Overall Study|Wanted to do a different diet program|1|||
33408710|NCT00572624|62787142|FG001|Overall Study|Wanted to do a different diet program|0|||
33408711|NCT00572624|62787141|FG000|Overall Study|Medication change|1|||
33408712|NCT00572624|62787142|FG001|Overall Study|Medication change|0|||
33408713|NCT00572624|62787141|FG000|Overall Study|Started a new job-- no time for study|1|||
33408714|NCT00572624|62787142|FG001|Overall Study|Started a new job-- no time for study|0|||
33408715|NCT00572624|62787141|FG000|Overall Study|Admitted to being a smoker|1|||
33408716|NCT00572624|62787142|FG001|Overall Study|Admitted to being a smoker|0|||
33408717|NCT00572624|62787141|FG000|Overall Study|Refused to do the stress test|1|||
33408718|NCT00572624|62787142|FG001|Overall Study|Refused to do the stress test|0|||
33408719|NCT00572624|62787141|FG000|Overall Study|Problem with vascular access|1|||
33408720|NCT00572624|62787142|FG001|Overall Study|Problem with vascular access|0|||
33598995|NCT01861522|62997979|FG001|Overall Study|Adverse Event|0|||
33598996|NCT01861522|62997978|FG000|Overall Study|Withdrawal by Subject|2|||
33598997|NCT01861522|62997979|FG001|Overall Study|Withdrawal by Subject|0|||
33598998|NCT01860976|62997987|FG000|Blinded Treatment|Adverse Event|1|||
33598999|NCT01860976|62997988|FG001|Blinded Treatment|Adverse Event|3|||
33599000|NCT01860976|62997987|FG000|Blinded Treatment|Lack of Efficacy|5|||
33599001|NCT01860976|62997988|FG001|Blinded Treatment|Lack of Efficacy|12|||
33599002|NCT01860976|62997987|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
33408721|NCT00572624|62787141|FG000|Overall Study|Health issues unrelated to the study|1|||
33408722|NCT00572624|62787142|FG001|Overall Study|Health issues unrelated to the study|0|||
33408723|NCT00122317|62787148|FG000|Overall Study|Death|3|||
33599003|NCT01860976|62997988|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
33408724|NCT00122317|62787148|FG000|Overall Study|Adverse Event|4|||
33408725|NCT00122317|62787148|FG000|Overall Study|Physician Decision|2|||
33408726|NCT00122317|62787148|FG000|Overall Study|patient non-compliance|1|||
33408727|NCT00122317|62787148|FG000|Overall Study|Withdrawal by Subject|1|||
33408728|NCT03870555|62787155|FG000|Period 3 (2 Days)|Adverse Event|1|||
33408729|NCT03870555|62787156|FG001|Period 3 (2 Days)|Adverse Event|0|||
33599004|NCT01860976|62997987|FG000|Blinded Treatment|Withdrawal by Subject|3|||
33408730|NCT03870555|62787157|FG002|Period 3 (2 Days)|Adverse Event|0|||
33408731|NCT03870477|62787168|FG000|Overall Study|Early Study Termination|1|||
33408732|NCT00165841|62787174|FG000|Overall Study|Adverse Event|2|||
33408733|NCT00165841|62787175|FG001|Overall Study|Adverse Event|3|||
33408734|NCT00165841|62787174|FG000|Overall Study|Lack of Efficacy|6|||
33408735|NCT00165841|62787175|FG001|Overall Study|Lack of Efficacy|33|||
33408736|NCT00165841|62787174|FG000|Overall Study|Lost to Follow-up|4|||
33408737|NCT00165841|62787175|FG001|Overall Study|Lost to Follow-up|4|||
33408738|NCT00165841|62787174|FG000|Overall Study|Withdrawal by Subject|7|||
33408739|NCT00165841|62787175|FG001|Overall Study|Withdrawal by Subject|8|||
33408740|NCT00165841|62787174|FG000|Overall Study|Physician Decision|1|||
33408741|NCT00165841|62787175|FG001|Overall Study|Physician Decision|0|||
33408742|NCT00165841|62787174|FG000|Overall Study|Protocol Violation|6|||
33408743|NCT00165841|62787175|FG001|Overall Study|Protocol Violation|8|||
33408744|NCT00165841|62787174|FG000|Overall Study|Other|3|||
33408745|NCT00165841|62787175|FG001|Overall Study|Other|5|||
33599005|NCT01860976|62997988|FG001|Blinded Treatment|Withdrawal by Subject|5|||
33599006|NCT01860976|62997987|FG000|Blinded Treatment|Subject no longer met criteria|1|||
33408746|NCT00165841|62787174|FG000|Overall Study|Medication Noncompliance|1|||
33408747|NCT00165841|62787175|FG001|Overall Study|Medication Noncompliance|1|||
33408748|NCT00509223|62787183|FG000|Overall Study|Lost to Follow-up|1|||
33408749|NCT00509223|62787184|FG001|Overall Study|Lost to Follow-up|1|||
33408750|NCT00509223|62787183|FG000|Overall Study|Adverse Event|1|||
33408751|NCT00509223|62787184|FG001|Overall Study|Adverse Event|1|||
33408752|NCT00509223|62787183|FG000|Overall Study|Withdrawal by Subject|25|||
33408753|NCT00509223|62787184|FG001|Overall Study|Withdrawal by Subject|6|||
33408754|NCT00509223|62787183|FG000|Overall Study|Including: subject change of address|5|||
33408755|NCT00509223|62787184|FG001|Overall Study|Including: subject change of address|2|||
33408756|NCT00509223|62787183|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
33408757|NCT00509223|62787184|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
33408758|NCT00460798|62787190|FG000|Overall Study|Death|59|||
33408759|NCT00460798|62787190|FG000|Overall Study|Adverse Event|27|||
33408760|NCT00460798|62787190|FG000|Overall Study|Lost to Follow-up|19|||
33408761|NCT00460798|62787190|FG000|Overall Study|Progressive Disease|99|||
33408762|NCT00460798|62787190|FG000|Overall Study|Other|27|||
33408763|NCT00460798|62787190|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
33408764|NCT00460798|62787190|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
33408765|NCT00603980|62787194|FG000|Study Qualification|Protocol Violation|3|||
33408766|NCT00603980|62787194|FG000|Study Qualification|Inconsistent data reporting|13|||
33408767|NCT00603980|62787194|FG000|Main Study|14th subject completed trial|1|||
33408768|NCT00450190|62787214|FG000|Overall Study|Withdrawal by Subject|2|||
33408769|NCT00450112|62787220|FG000|Overall Study|Other Treatment Required|5|||
33408770|NCT00450112|62787221|FG001|Overall Study|Other Treatment Required|1|||
33408771|NCT00450112|62787220|FG000|Overall Study|Withdrawal by Subject|4|||
33408772|NCT00450112|62787221|FG001|Overall Study|Withdrawal by Subject|1|||
33408773|NCT00450112|62787220|FG000|Overall Study|Lost to Follow-up|2|||
33408774|NCT00450112|62787221|FG001|Overall Study|Lost to Follow-up|1|||
33408775|NCT00450112|62787220|FG000|Overall Study|Others|2|||
33408776|NCT00450112|62787221|FG001|Overall Study|Others|3|||
33408777|NCT00449956|62787230|FG000|Overall Study|Adverse Event|7|||
33408778|NCT00449956|62787231|FG001|Overall Study|Adverse Event|1|||
33408779|NCT00449956|62787232|FG002|Overall Study|Adverse Event|6|||
33408780|NCT00449956|62787230|FG000|Overall Study|Lack of Efficacy|0|||
33408781|NCT00449956|62787231|FG001|Overall Study|Lack of Efficacy|0|||
33408782|NCT00449956|62787232|FG002|Overall Study|Lack of Efficacy|1|||
33408783|NCT00449956|62787230|FG000|Overall Study|Protocol Violation|1|||
33408784|NCT00449956|62787231|FG001|Overall Study|Protocol Violation|1|||
33408785|NCT00449956|62787232|FG002|Overall Study|Protocol Violation|1|||
33408786|NCT00449956|62787230|FG000|Overall Study|Withdrawal by Subject|0|||
33408787|NCT00449956|62787231|FG001|Overall Study|Withdrawal by Subject|1|||
33408788|NCT00449956|62787232|FG002|Overall Study|Withdrawal by Subject|0|||
33408789|NCT00449956|62787230|FG000|Overall Study|Physician Decision|2|||
33408790|NCT00449956|62787231|FG001|Overall Study|Physician Decision|1|||
33408791|NCT00449956|62787232|FG002|Overall Study|Physician Decision|1|||
33408792|NCT00509145|62787242|FG000|Overall Study|Death|0|||
33408793|NCT00509145|62787243|FG001|Overall Study|Death|2|||
33408794|NCT00509145|62787242|FG000|Overall Study|Adverse Event|42|||
33408795|NCT00509145|62787243|FG001|Overall Study|Adverse Event|28|||
33408796|NCT00509145|62787242|FG000|Overall Study|Withdrawal by Subject|32|||
33408797|NCT00509145|62787243|FG001|Overall Study|Withdrawal by Subject|38|||
33408798|NCT00509145|62787242|FG000|Overall Study|Physician Decision|11|||
33408799|NCT00509145|62787243|FG001|Overall Study|Physician Decision|14|||
33408800|NCT00509145|62787242|FG000|Overall Study|Protocol Violation|1|||
33408801|NCT00509145|62787243|FG001|Overall Study|Protocol Violation|6|||
33408802|NCT00509145|62787242|FG000|Overall Study|Pregnancy|3|||
33408803|NCT00509145|62787243|FG001|Overall Study|Pregnancy|8|||
33408804|NCT00509145|62787242|FG000|Overall Study|Lost to Follow-up|6|||
33408805|NCT00509145|62787243|FG001|Overall Study|Lost to Follow-up|5|||
33408806|NCT00509145|62787242|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
33408807|NCT00509145|62787243|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
33408808|NCT00509145|62787242|FG000|Overall Study|Other|6|||
33408809|NCT00509145|62787243|FG001|Overall Study|Other|6|||
33408810|NCT00509067|62787251|FG000|Overall Study|Lost to Follow-up|1|||
33408811|NCT00509067|62787252|FG001|Overall Study|Lost to Follow-up|1|||
33408812|NCT00509067|62787251|FG000|Overall Study|Adverse Event|3|||
33408813|NCT00509067|62787252|FG001|Overall Study|Adverse Event|1|||
33408814|NCT00509067|62787251|FG000|Overall Study|Protocol Violation|0|||
33408815|NCT00509067|62787252|FG001|Overall Study|Protocol Violation|3|||
33408816|NCT00504309|62787268|FG000|Overall Study|Death|0|||
33408817|NCT00504309|62787269|FG001|Overall Study|Death|0|||
33408818|NCT00504309|62787270|FG002|Overall Study|Death|0|||
33408819|NCT00504309|62787271|FG003|Overall Study|Death|0|||
33408820|NCT00504309|62787272|FG004|Overall Study|Death|1|||
33408821|NCT00504309|62787273|FG005|Overall Study|Death|0|||
33408822|NCT00504309|62787268|FG000|Overall Study|Withdrawal by Subject|0|||
33408823|NCT00504309|62787269|FG001|Overall Study|Withdrawal by Subject|0|||
33408824|NCT00504309|62787270|FG002|Overall Study|Withdrawal by Subject|1|||
33408825|NCT00504309|62787271|FG003|Overall Study|Withdrawal by Subject|0|||
33408826|NCT00504309|62787272|FG004|Overall Study|Withdrawal by Subject|0|||
33408827|NCT00504309|62787273|FG005|Overall Study|Withdrawal by Subject|0|||
33408828|NCT00508755|62787285|FG000|Overall Study|Withdrawal by Subject|1|||
33408829|NCT00504231|62787295|FG000|Overall Study|Discrepant chart documentation re route|0|||
33408830|NCT00504231|62787296|FG001|Overall Study|Discrepant chart documentation re route|0|||
33408831|NCT00504231|62787297|FG002|Overall Study|Discrepant chart documentation re route|1|||
33408832|NCT00504231|62787298|FG003|Overall Study|Discrepant chart documentation re route|0|||
33408833|NCT00568178|62787350|FG000|Double Blind Base Study|Adverse Event|0|||
33408834|NCT00568178|62787351|FG001|Double Blind Base Study|Adverse Event|2|||
33408835|NCT00568178|62787352|FG002|Double Blind Base Study|Adverse Event|1|||
33408836|NCT00568178|62787353|FG003|Double Blind Base Study|Adverse Event|2|||
33408837|NCT00568178|62787354|FG004|Double Blind Base Study|Adverse Event|0|||
33408838|NCT00568178|62787355|FG005|Double Blind Base Study|Adverse Event|0|||
33408839|NCT00568178|62787350|FG000|Double Blind Base Study|Lost to Follow-up|1|||
33408840|NCT00568178|62787351|FG001|Double Blind Base Study|Lost to Follow-up|0|||
33408841|NCT00568178|62787352|FG002|Double Blind Base Study|Lost to Follow-up|0|||
33408842|NCT00568178|62787353|FG003|Double Blind Base Study|Lost to Follow-up|1|||
33408843|NCT00568178|62787354|FG004|Double Blind Base Study|Lost to Follow-up|0|||
33408844|NCT00568178|62787355|FG005|Double Blind Base Study|Lost to Follow-up|0|||
33408845|NCT00568178|62787350|FG000|Double Blind Base Study|Physician Decision|1|||
33408846|NCT00568178|62787351|FG001|Double Blind Base Study|Physician Decision|1|||
33408847|NCT00568178|62787352|FG002|Double Blind Base Study|Physician Decision|0|||
33408848|NCT00568178|62787353|FG003|Double Blind Base Study|Physician Decision|1|||
33408849|NCT00568178|62787354|FG004|Double Blind Base Study|Physician Decision|0|||
33408850|NCT00568178|62787355|FG005|Double Blind Base Study|Physician Decision|0|||
33408851|NCT00568178|62787350|FG000|Double Blind Base Study|Protocol Violation|3|||
33408852|NCT00568178|62787351|FG001|Double Blind Base Study|Protocol Violation|2|||
33408853|NCT00568178|62787352|FG002|Double Blind Base Study|Protocol Violation|0|||
33408854|NCT00568178|62787353|FG003|Double Blind Base Study|Protocol Violation|0|||
33408855|NCT00568178|62787354|FG004|Double Blind Base Study|Protocol Violation|0|||
33408856|NCT00568178|62787355|FG005|Double Blind Base Study|Protocol Violation|0|||
33408857|NCT00568178|62787350|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
33408858|NCT00568178|62787351|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
33408859|NCT00568178|62787352|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
33408860|NCT00568178|62787353|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
33408861|NCT00568178|62787354|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
33408862|NCT00568178|62787355|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
33408863|NCT00568178|62787350|FG000|Double Blind Base Study|Progressive Disease|0|||
33408864|NCT00568178|62787351|FG001|Double Blind Base Study|Progressive Disease|0|||
33408865|NCT00568178|62787352|FG002|Double Blind Base Study|Progressive Disease|0|||
33408866|NCT00568178|62787353|FG003|Double Blind Base Study|Progressive Disease|1|||
33408867|NCT00568178|62787354|FG004|Double Blind Base Study|Progressive Disease|0|||
33408868|NCT00568178|62787355|FG005|Double Blind Base Study|Progressive Disease|0|||
33408869|NCT00568178|62787350|FG000|Open Label Extension|Adverse Event|0|||
33408870|NCT00568178|62787351|FG001|Open Label Extension|Adverse Event|0|||
33408871|NCT00568178|62787352|FG002|Open Label Extension|Adverse Event|0|||
33408872|NCT00568178|62787353|FG003|Open Label Extension|Adverse Event|0|||
33408873|NCT00568178|62787354|FG004|Open Label Extension|Adverse Event|11|||
33408874|NCT00568178|62787355|FG005|Open Label Extension|Adverse Event|8|||
33408875|NCT00568178|62787350|FG000|Open Label Extension|Protocol Violation|0|||
33408876|NCT00568178|62787351|FG001|Open Label Extension|Protocol Violation|0|||
33408877|NCT00568178|62787352|FG002|Open Label Extension|Protocol Violation|0|||
33408878|NCT00568178|62787353|FG003|Open Label Extension|Protocol Violation|0|||
33408879|NCT00568178|62787354|FG004|Open Label Extension|Protocol Violation|1|||
33408880|NCT00568178|62787355|FG005|Open Label Extension|Protocol Violation|0|||
33408881|NCT00568178|62787350|FG000|Open Label Extension|Lost to Follow-up|0|||
33408882|NCT00568178|62787351|FG001|Open Label Extension|Lost to Follow-up|0|||
33408883|NCT00568178|62787352|FG002|Open Label Extension|Lost to Follow-up|0|||
33408884|NCT00568178|62787353|FG003|Open Label Extension|Lost to Follow-up|0|||
33408885|NCT00568178|62787354|FG004|Open Label Extension|Lost to Follow-up|6|||
33408886|NCT00568178|62787355|FG005|Open Label Extension|Lost to Follow-up|11|||
33408887|NCT00568178|62787350|FG000|Open Label Extension|Physician Decision|0|||
33408888|NCT00568178|62787351|FG001|Open Label Extension|Physician Decision|0|||
33408889|NCT00568178|62787352|FG002|Open Label Extension|Physician Decision|0|||
33408890|NCT00568178|62787353|FG003|Open Label Extension|Physician Decision|0|||
33408891|NCT00568178|62787354|FG004|Open Label Extension|Physician Decision|9|||
33408892|NCT00568178|62787355|FG005|Open Label Extension|Physician Decision|8|||
33408893|NCT00568178|62787350|FG000|Open Label Extension|Pregnancy|0|||
33408894|NCT00568178|62787351|FG001|Open Label Extension|Pregnancy|0|||
33408895|NCT00568178|62787352|FG002|Open Label Extension|Pregnancy|0|||
33408896|NCT00568178|62787353|FG003|Open Label Extension|Pregnancy|0|||
33408897|NCT00568178|62787354|FG004|Open Label Extension|Pregnancy|0|||
33408898|NCT00568178|62787355|FG005|Open Label Extension|Pregnancy|1|||
33408899|NCT00568178|62787350|FG000|Open Label Extension|Progressive Disease|0|||
33408900|NCT00568178|62787351|FG001|Open Label Extension|Progressive Disease|0|||
33408901|NCT00568178|62787352|FG002|Open Label Extension|Progressive Disease|0|||
33408902|NCT00568178|62787353|FG003|Open Label Extension|Progressive Disease|0|||
33408903|NCT00568178|62787354|FG004|Open Label Extension|Progressive Disease|3|||
33408904|NCT00568178|62787355|FG005|Open Label Extension|Progressive Disease|1|||
33408905|NCT00568178|62787350|FG000|Open Label Extension|Termination of Trial|0|||
33408906|NCT00568178|62787351|FG001|Open Label Extension|Termination of Trial|0|||
33408907|NCT00568178|62787352|FG002|Open Label Extension|Termination of Trial|0|||
33408908|NCT00568178|62787353|FG003|Open Label Extension|Termination of Trial|0|||
33408909|NCT00568178|62787354|FG004|Open Label Extension|Termination of Trial|45|||
33408910|NCT00568178|62787355|FG005|Open Label Extension|Termination of Trial|47|||
33408911|NCT00568178|62787350|FG000|Open Label Extension|Withdrawal by Subject|0|||
33408912|NCT00568178|62787351|FG001|Open Label Extension|Withdrawal by Subject|0|||
33408913|NCT00568178|62787352|FG002|Open Label Extension|Withdrawal by Subject|0|||
33408914|NCT00568178|62787353|FG003|Open Label Extension|Withdrawal by Subject|0|||
33408915|NCT00568178|62787354|FG004|Open Label Extension|Withdrawal by Subject|4|||
33408916|NCT00568178|62787355|FG005|Open Label Extension|Withdrawal by Subject|4|||
33408917|NCT00577889|62787372|FG000|Overall Study|Withdrawal by Subject|1|||
33599007|NCT01860976|62997988|FG001|Blinded Treatment|Subject no longer met criteria|0|||
33599008|NCT01860976|62997987|FG000|Blinded Treatment|Entered Open-Label in error|0|||
33599009|NCT01860976|62997988|FG001|Blinded Treatment|Entered Open-Label in error|1|||
33599010|NCT01860976|62997987|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
33599011|NCT01860976|62997988|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
33599012|NCT01860976|62997987|FG000|Open-Label|Adverse Event|2|||
33408918|NCT00577889|62787373|FG001|Overall Study|Withdrawal by Subject|0|||
33408919|NCT00577889|62787374|FG002|Overall Study|Withdrawal by Subject|0|||
33408920|NCT00460564|62787386|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
33408921|NCT00460564|62787387|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
33408922|NCT00460564|62787388|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33408923|NCT00460564|62787389|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33408924|NCT00460564|62787390|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33408925|NCT00460564|62787391|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33408926|NCT00460564|62787392|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33408927|NCT00460564|62787393|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33408928|NCT00460564|62787386|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
33408929|NCT00460564|62787387|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33408930|NCT00460564|62787388|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33408931|NCT00460564|62787389|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33408932|NCT00460564|62787390|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33408933|NCT00460564|62787391|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33408934|NCT00460564|62787392|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33408935|NCT00460564|62787393|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33408936|NCT00460564|62787386|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
33408937|NCT00460564|62787387|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
33408938|NCT00460564|62787388|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
33408939|NCT00460564|62787389|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
33408940|NCT00460564|62787390|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
33408941|NCT00460564|62787391|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
33408942|NCT00460564|62787392|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
33408943|NCT00460564|62787393|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
33408944|NCT00460564|62787386|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33408945|NCT00460564|62787387|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33408946|NCT00460564|62787388|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33408947|NCT00460564|62787389|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33408948|NCT00460564|62787390|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
33408949|NCT00460564|62787391|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
33408950|NCT00460564|62787392|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33408951|NCT00460564|62787393|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33408952|NCT00460564|62787386|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
33408953|NCT00460564|62787387|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
33408954|NCT00460564|62787388|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
33408955|NCT00460564|62787389|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
33408956|NCT00460564|62787390|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
33408957|NCT00460564|62787391|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
33408958|NCT00460564|62787392|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
33408959|NCT00460564|62787393|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
33408960|NCT00567476|62787415|FG000|Overall Study|Adverse Event|2|||
33408961|NCT00567476|62787416|FG001|Overall Study|Adverse Event|0|||
33408962|NCT00567476|62787415|FG000|Overall Study|Pregnancy|1|||
33408963|NCT00567476|62787416|FG001|Overall Study|Pregnancy|0|||
33408964|NCT00567476|62787415|FG000|Overall Study|Protocol Violation|4|||
33408965|NCT00567476|62787416|FG001|Overall Study|Protocol Violation|1|||
33408966|NCT00567476|62787415|FG000|Overall Study|Lost to Follow-up|0|||
33408967|NCT00567476|62787416|FG001|Overall Study|Lost to Follow-up|1|||
33408968|NCT00567476|62787415|FG000|Overall Study|Administrative issues|1|||
33408969|NCT00567476|62787416|FG001|Overall Study|Administrative issues|0|||
33408970|NCT00567476|62787415|FG000|Overall Study|Medical Decision|0|||
33408971|NCT00567476|62787416|FG001|Overall Study|Medical Decision|1|||
33408972|NCT00567476|62787415|FG000|Overall Study|Non-adherence to protocol|0|||
33408973|NCT00567476|62787416|FG001|Overall Study|Non-adherence to protocol|1|||
33408974|NCT00516321|62787424|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
33408975|NCT00516321|62787425|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
33408976|NCT00516321|62787426|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
33408977|NCT00516321|62787424|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
33321397|NCT00996801|62697361|FG003|Overall Study|Study Terminated by Sponsor|0|||
33321398|NCT00996801|62697362|FG004|Overall Study|Study Terminated by Sponsor|46|||
33321399|NCT00996801|62697363|FG005|Overall Study|Study Terminated by Sponsor|0|||
33321400|NCT00996801|62697358|FG000|Overall Study|Withdrawal by Subject|8|||
33321401|NCT00996801|62697359|FG001|Overall Study|Withdrawal by Subject|6|||
33321402|NCT00996801|62697360|FG002|Overall Study|Withdrawal by Subject|9|||
33321403|NCT00996801|62697361|FG003|Overall Study|Withdrawal by Subject|5|||
33321404|NCT00996801|62697362|FG004|Overall Study|Withdrawal by Subject|5|||
33321405|NCT00996801|62697363|FG005|Overall Study|Withdrawal by Subject|9|||
33408978|NCT00516321|62787425|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
33408979|NCT00516321|62787426|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
33408980|NCT00516321|62787424|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
33408981|NCT00516321|62787425|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
33408982|NCT00516321|62787426|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
33408983|NCT00516321|62787424|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
33408984|NCT00516321|62787425|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
33408985|NCT00516321|62787426|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
33408986|NCT00516321|62787424|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
33408987|NCT00516321|62787425|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
33408988|NCT00516321|62787426|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
33408989|NCT00516321|62787424|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
33408990|NCT00516321|62787425|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
33408991|NCT00516321|62787426|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
33408992|NCT00516321|62787424|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
33408993|NCT00516321|62787425|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
33408994|NCT00516321|62787426|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
33408995|NCT00516321|62787424|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
33408996|NCT00516321|62787425|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
33408997|NCT00516321|62787426|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
33408998|NCT00516321|62787424|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
33408999|NCT00516321|62787425|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
33409000|NCT00516321|62787426|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
33409001|NCT00516321|62787424|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
33409002|NCT00516321|62787425|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
33409003|NCT00516321|62787426|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
33409004|NCT00516321|62787424|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
33409005|NCT00516321|62787425|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
33409006|NCT00516321|62787426|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
33409007|NCT00460408|62787438|FG000|Overall Study|Adverse Event|1|||
33409008|NCT00460408|62787439|FG001|Overall Study|Adverse Event|0|||
33409009|NCT00460408|62787440|FG002|Overall Study|Adverse Event|0|||
33409010|NCT00460408|62787441|FG003|Overall Study|Adverse Event|0|||
33409011|NCT00460408|62787438|FG000|Overall Study|Death|7|||
33409012|NCT00460408|62787439|FG001|Overall Study|Death|0|||
33409013|NCT00460408|62787440|FG002|Overall Study|Death|0|||
33409014|NCT00460408|62787441|FG003|Overall Study|Death|0|||
33409015|NCT00460408|62787438|FG000|Overall Study|Lost to Follow-up|11|||
33409016|NCT00460408|62787439|FG001|Overall Study|Lost to Follow-up|0|||
33409017|NCT00460408|62787440|FG002|Overall Study|Lost to Follow-up|1|||
33409018|NCT00460408|62787441|FG003|Overall Study|Lost to Follow-up|0|||
33409019|NCT00460408|62787438|FG000|Overall Study|Withdrawal by Subject|31|||
33409020|NCT00460408|62787439|FG001|Overall Study|Withdrawal by Subject|0|||
33409021|NCT00460408|62787440|FG002|Overall Study|Withdrawal by Subject|0|||
33409022|NCT00460408|62787441|FG003|Overall Study|Withdrawal by Subject|0|||
33409023|NCT00460408|62787438|FG000|Overall Study|Insufficient clinical response|5|||
33409024|NCT00460408|62787439|FG001|Overall Study|Insufficient clinical response|1|||
33409025|NCT00460408|62787440|FG002|Overall Study|Insufficient clinical response|5|||
33409026|NCT00460408|62787441|FG003|Overall Study|Insufficient clinical response|0|||
33409027|NCT00460408|62787438|FG000|Overall Study|Other|12|||
33409028|NCT00460408|62787439|FG001|Overall Study|Other|2|||
33599013|NCT01860976|62997988|FG001|Open-Label|Adverse Event|4|||
33599014|NCT01860976|62997987|FG000|Open-Label|Lack of Efficacy|16|||
33599015|NCT01860976|62997988|FG001|Open-Label|Lack of Efficacy|8|||
33599016|NCT01860976|62997987|FG000|Open-Label|Lost to Follow-up|1|||
33599017|NCT01860976|62997988|FG001|Open-Label|Lost to Follow-up|2|||
33599018|NCT01860976|62997987|FG000|Open-Label|Subject request discontinue treatment|4|||
33599019|NCT01860976|62997988|FG001|Open-Label|Subject request discontinue treatment|3|||
33599020|NCT01860976|62997987|FG000|Open-Label|Withdrawal by Subject|4|||
33409029|NCT00460408|62787440|FG002|Overall Study|Other|0|||
33599021|NCT01860976|62997988|FG001|Open-Label|Withdrawal by Subject|1|||
33599022|NCT01860976|62997987|FG000|Open-Label|Other Reasons|1|||
33409030|NCT00460408|62787441|FG003|Overall Study|Other|0|||
33409031|NCT00507819|62787451|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
33409032|NCT00507819|62787452|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
33409033|NCT00442936|62787482|FG000|Overall Study|Protocol Violation|1|||
33409034|NCT00442936|62787483|FG001|Overall Study|Protocol Violation|0|||
33409035|NCT00442936|62787484|FG002|Overall Study|Protocol Violation|1|||
33409036|NCT00442936|62787485|FG003|Overall Study|Protocol Violation|1|||
33409037|NCT00577655|62787497|FG000|Overall Study|Patient Request|0|||
33409038|NCT00577655|62787498|FG001|Overall Study|Patient Request|2|||
33409039|NCT00577655|62787497|FG000|Overall Study|Protocol Violation|0|||
33409040|NCT00577655|62787498|FG001|Overall Study|Protocol Violation|1|||
33409041|NCT00577655|62787497|FG000|Overall Study|Lost to Follow-up|1|||
33409042|NCT00577655|62787498|FG001|Overall Study|Lost to Follow-up|1|||
33409043|NCT00113269|62787509|FG000|Overall Study|Not transplanted, donor issues|4|||
33409044|NCT00113269|62787510|FG001|Overall Study|Not transplanted, donor issues|0|||
33409045|NCT00113269|62787511|FG002|Overall Study|Not transplanted, donor issues|2|||
33409046|NCT00113269|62787512|FG003|Overall Study|Not transplanted, donor issues|2|||
33409047|NCT00113269|62787509|FG000|Overall Study|Not transplanted, recipient issues|2|||
33409048|NCT00113269|62787510|FG001|Overall Study|Not transplanted, recipient issues|1|||
33409049|NCT00113269|62787511|FG002|Overall Study|Not transplanted, recipient issues|7|||
33409050|NCT00113269|62787512|FG003|Overall Study|Not transplanted, recipient issues|4|||
33409051|NCT00113269|62787509|FG000|Overall Study|Early graft loss, technical|0|||
33409052|NCT00113269|62787510|FG001|Overall Study|Early graft loss, technical|0|||
33409053|NCT00113269|62787511|FG002|Overall Study|Early graft loss, technical|2|||
33409054|NCT00113269|62787512|FG003|Overall Study|Early graft loss, technical|0|||
33409055|NCT00113269|62787509|FG000|Overall Study|Death in operating room|0|||
33409056|NCT00113269|62787510|FG001|Overall Study|Death in operating room|0|||
33409057|NCT00113269|62787511|FG002|Overall Study|Death in operating room|0|||
33409058|NCT00113269|62787512|FG003|Overall Study|Death in operating room|1|||
33409059|NCT00113269|62787509|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
33409060|NCT00113269|62787510|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
33409061|NCT00113269|62787511|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
33409062|NCT00113269|62787512|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
33409063|NCT00113269|62787509|FG000|Overall Study|Adverse Event|2|||
33409064|NCT00113269|62787510|FG001|Overall Study|Adverse Event|7|||
33409065|NCT00113269|62787511|FG002|Overall Study|Adverse Event|11|||
33409066|NCT00113269|62787512|FG003|Overall Study|Adverse Event|7|||
33409067|NCT00113269|62787509|FG000|Overall Study|Withdrawal by Subject|4|||
33409068|NCT00113269|62787510|FG001|Overall Study|Withdrawal by Subject|3|||
33409069|NCT00113269|62787511|FG002|Overall Study|Withdrawal by Subject|4|||
33599023|NCT01860976|62997988|FG001|Open-Label|Other Reasons|1|||
33599024|NCT01860976|62997987|FG000|Long Term Extension|Adverse Event|4|||
33599025|NCT01860976|62997988|FG001|Long Term Extension|Adverse Event|0|||
33321406|NCT00996489|62697379|FG000|Overall Study|Device failure|45|||
33321407|NCT00996489|62697379|FG000|Overall Study|Discontinued|116|||
33321408|NCT01000311|62697385|FG000|Overall Study|Adverse Event|2|||
33321409|NCT01000311|62697386|FG001|Overall Study|Adverse Event|5|||
33321410|NCT01000311|62697385|FG000|Overall Study|Withdrawal by Subject|16|||
33321411|NCT01000311|62697386|FG001|Overall Study|Withdrawal by Subject|24|||
33321412|NCT01000311|62697385|FG000|Overall Study|Lost to Follow-up|15|||
33321413|NCT01000311|62697386|FG001|Overall Study|Lost to Follow-up|24|||
33321414|NCT01000311|62697385|FG000|Overall Study|Protocol Violation|1|||
33321415|NCT01000311|62697386|FG001|Overall Study|Protocol Violation|2|||
33321416|NCT01000311|62697385|FG000|Overall Study|Inappropriate enrollment|2|||
33321417|NCT01000311|62697386|FG001|Overall Study|Inappropriate enrollment|0|||
33409070|NCT00113269|62787512|FG003|Overall Study|Withdrawal by Subject|2|||
33409071|NCT00113269|62787509|FG000|Overall Study|Graft loss|6|||
33409072|NCT00113269|62787510|FG001|Overall Study|Graft loss|6|||
33409073|NCT00113269|62787511|FG002|Overall Study|Graft loss|4|||
33321418|NCT01000311|62697385|FG000|Overall Study|Administrative reason|9|||
33321419|NCT01000311|62697386|FG001|Overall Study|Administrative reason|15|||
33321420|NCT01003899|62697392|FG000|Overall Study|Other Adverse Event|8|||
33321421|NCT01003899|62697392|FG000|Overall Study|Not entered|4|||
33599026|NCT01860976|62997987|FG000|Long Term Extension|Lack of Efficacy|2|||
33599027|NCT01860976|62997988|FG001|Long Term Extension|Lack of Efficacy|0|||
33599028|NCT01860976|62997987|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
33599029|NCT01860976|62997988|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
33599030|NCT01860976|62997987|FG000|Long Term Extension|Lost to Follow-up|2|||
33599031|NCT01860976|62997988|FG001|Long Term Extension|Lost to Follow-up|0|||
33599032|NCT01860976|62997987|FG000|Long Term Extension|subject withdrew consent|7|||
33599033|NCT01860976|62997988|FG001|Long Term Extension|subject withdrew consent|0|||
33599034|NCT01860040|62997999|FG000|Overall Study|Withdrawal by Subject|1|||
33599035|NCT01860040|62998000|FG001|Overall Study|Withdrawal by Subject|0|||
33599036|NCT01896934|62998005|FG000|Overall Study|Adverse Event|1|||
33599037|NCT01896934|62998005|FG000|Overall Study|Withdrawal by Subject|1|||
33599038|NCT02039505|62998012|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
33599039|NCT02039505|62998013|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
33599040|NCT02039505|62998014|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
33599041|NCT02039505|62998015|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
33599042|NCT02039505|62998016|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
33599043|NCT02039505|62998017|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
33599044|NCT02039505|62998018|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
33599045|NCT02039505|62998012|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
33599046|NCT02039505|62998013|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
33599047|NCT02039505|62998014|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
33409074|NCT00113269|62787512|FG003|Overall Study|Graft loss|9|||
33409075|NCT00113269|62787509|FG000|Overall Study|Protocol Violation|1|||
33409076|NCT00113269|62787510|FG001|Overall Study|Protocol Violation|0|||
33409077|NCT00113269|62787511|FG002|Overall Study|Protocol Violation|4|||
33409078|NCT00113269|62787512|FG003|Overall Study|Protocol Violation|2|||
33409079|NCT00113269|62787509|FG000|Overall Study|Lost to Follow-up|2|||
33409080|NCT00113269|62787510|FG001|Overall Study|Lost to Follow-up|3|||
33409081|NCT00113269|62787511|FG002|Overall Study|Lost to Follow-up|6|||
33409082|NCT00113269|62787512|FG003|Overall Study|Lost to Follow-up|3|||
33409083|NCT00113269|62787509|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
33409084|NCT00113269|62787510|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
33409085|NCT00113269|62787511|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
33409086|NCT00113269|62787512|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
33409087|NCT00113269|62787509|FG000|Overall Study|Discontinued due to rejection|0|||
33409088|NCT00113269|62787510|FG001|Overall Study|Discontinued due to rejection|0|||
33409089|NCT00113269|62787511|FG002|Overall Study|Discontinued due to rejection|1|||
33409090|NCT00113269|62787512|FG003|Overall Study|Discontinued due to rejection|0|||
33409091|NCT00113269|62787509|FG000|Overall Study|Moved|0|||
33409092|NCT00113269|62787510|FG001|Overall Study|Moved|1|||
33409093|NCT00113269|62787511|FG002|Overall Study|Moved|0|||
33409094|NCT00113269|62787512|FG003|Overall Study|Moved|3|||
33409095|NCT00113269|62787509|FG000|Overall Study|Received pancreas transplant|0|||
33409096|NCT00113269|62787510|FG001|Overall Study|Received pancreas transplant|0|||
33409097|NCT00113269|62787511|FG002|Overall Study|Received pancreas transplant|0|||
33409098|NCT00113269|62787512|FG003|Overall Study|Received pancreas transplant|2|||
33599048|NCT02039505|62998015|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
33599049|NCT02039505|62998016|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
33599050|NCT02039505|62998017|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
33599051|NCT02039505|62998018|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
33599052|NCT02039505|62998012|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
33599053|NCT02039505|62998013|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
33599054|NCT02039505|62998014|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
33599055|NCT02039505|62998015|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
33409099|NCT00113269|62787509|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
33409100|NCT00113269|62787510|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
33409101|NCT00113269|62787511|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
33409102|NCT00113269|62787512|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
33409103|NCT00113269|62787509|FG000|Overall Study|Did not meet eligibility criteria|1|||
33409104|NCT00113269|62787510|FG001|Overall Study|Did not meet eligibility criteria|0|||
33409105|NCT00113269|62787511|FG002|Overall Study|Did not meet eligibility criteria|0|||
33409106|NCT00113269|62787512|FG003|Overall Study|Did not meet eligibility criteria|1|||
33409107|NCT00113269|62787509|FG000|Overall Study|Unable to return for follow up|2|||
33409108|NCT00113269|62787510|FG001|Overall Study|Unable to return for follow up|1|||
33409109|NCT00113269|62787511|FG002|Overall Study|Unable to return for follow up|0|||
33409110|NCT00113269|62787512|FG003|Overall Study|Unable to return for follow up|0|||
33409111|NCT00515619|62787522|FG000|Overall Study|Adverse Event|34|||
33409112|NCT00515619|62787522|FG000|Overall Study|Lack of Efficacy|92|||
33409113|NCT00515619|62787522|FG000|Overall Study|Withdrawal by Subject|66|||
33409114|NCT00515619|62787522|FG000|Overall Study|Protocol Violation|3|||
33409115|NCT00515619|62787522|FG000|Overall Study|Lost to Follow-up|4|||
33409116|NCT00515619|62787522|FG000|Overall Study|Unsatisfactory compliance|6|||
33409117|NCT00515619|62787522|FG000|Overall Study|Other: Site discontinuing trials|2|||
33409118|NCT00515619|62787522|FG000|Overall Study|Other: Subject cannot attend visits|2|||
33321422|NCT01003899|62697392|FG000|Overall Study|Not treated|1|||
33321423|NCT01003899|62697392|FG000|Overall Study|Progressive disease|34|||
33321424|NCT01000155|62697396|FG000|Overall Study|Withdrawal by Subject|1|||
33321425|NCT01000155|62697396|FG000|Overall Study|Adverse Event|1|||
33321426|NCT00999921|62697402|FG000|Overall Study|Lost to Follow-up|10|||
33321427|NCT00999921|62697403|FG001|Overall Study|Lost to Follow-up|19|||
33321428|NCT01002573|62697414|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
33321429|NCT01002573|62697415|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
33321430|NCT00999687|62697421|FG000|First Intervention|Withdrawal by Subject|1|||
33321431|NCT00999687|62697421|FG000|Second Intervention|Withdrawal by Subject|2|||
33321432|NCT00999687|62697421|FG000|Second Intervention|Lack of Efficacy|1|||
33321433|NCT00996333|62697427|FG000|Overall Study|Screen failure|1|||
33321434|NCT00996333|62697427|FG000|Overall Study|Withdrawal by Subject|1|||
33321435|NCT00996333|62697427|FG000|Overall Study|Death|4|||
33321436|NCT00996333|62697427|FG000|Overall Study|Adverse Event|1|||
33321437|NCT00996333|62697427|FG000|Overall Study|Physician Decision|1|||
33321438|NCT00996333|62697427|FG000|Overall Study|Other|5|||
33321439|NCT00995865|62697434|FG000|Overall Study|Protocol Violation|2|||
33321440|NCT00995865|62697435|FG001|Overall Study|Protocol Violation|0|||
33321441|NCT00995865|62697436|FG002|Overall Study|Protocol Violation|0|||
33409119|NCT00515619|62787522|FG000|Overall Study|Other: Subject required surgery|1|||
33321442|NCT00995865|62697434|FG000|Overall Study|Lost to Follow-up|0|||
33409120|NCT00515619|62787522|FG000|Overall Study|Other: Subject moved to another country|1|||
33409121|NCT00515619|62787522|FG000|Overall Study|Other: Investigator decision|1|||
33409122|NCT00515619|62787522|FG000|Overall Study|Other: Subject became pregnant|1|||
33409123|NCT00515619|62787522|FG000|Overall Study|Other: Request from sponsor|1|||
33409124|NCT00515619|62787522|FG000|Overall Study|Other: Drug available on license|1|||
33599056|NCT02039505|62998016|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
33599057|NCT02039505|62998017|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
33599058|NCT02039505|62998018|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
33599059|NCT02039505|62998012|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
33599060|NCT02039505|62998013|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
33599061|NCT02039505|62998014|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
33409125|NCT00515619|62787522|FG000|Overall Study|Other: Subject interested in other AED|1|||
33409126|NCT00449644|62787530|FG000|Overall Study|Adverse Event|0|||
33409127|NCT00449644|62787531|FG001|Overall Study|Adverse Event|0|||
33409128|NCT00449644|62787532|FG002|Overall Study|Adverse Event|3|||
33409129|NCT00449644|62787533|FG003|Overall Study|Adverse Event|5|||
33409130|NCT00449644|62787530|FG000|Overall Study|Death|1|||
33409131|NCT00449644|62787531|FG001|Overall Study|Death|0|||
33409132|NCT00449644|62787532|FG002|Overall Study|Death|6|||
33409133|NCT00449644|62787533|FG003|Overall Study|Death|1|||
33409134|NCT00449644|62787530|FG000|Overall Study|Lost to Follow-up|1|||
33409135|NCT00449644|62787531|FG001|Overall Study|Lost to Follow-up|1|||
33409136|NCT00449644|62787532|FG002|Overall Study|Lost to Follow-up|5|||
33409137|NCT00449644|62787533|FG003|Overall Study|Lost to Follow-up|3|||
33409138|NCT00449644|62787530|FG000|Overall Study|Pregnancy|0|||
33409139|NCT00449644|62787531|FG001|Overall Study|Pregnancy|0|||
33409140|NCT00449644|62787532|FG002|Overall Study|Pregnancy|3|||
33409141|NCT00449644|62787533|FG003|Overall Study|Pregnancy|2|||
33409142|NCT00449644|62787530|FG000|Overall Study|Protocol Violation|4|||
33409143|NCT00449644|62787531|FG001|Overall Study|Protocol Violation|4|||
33409144|NCT00449644|62787532|FG002|Overall Study|Protocol Violation|3|||
33409145|NCT00449644|62787533|FG003|Overall Study|Protocol Violation|7|||
33409146|NCT00449644|62787530|FG000|Overall Study|Withdrawal by Subject|3|||
33409147|NCT00449644|62787531|FG001|Overall Study|Withdrawal by Subject|4|||
33409148|NCT00449644|62787532|FG002|Overall Study|Withdrawal by Subject|6|||
33409149|NCT00449644|62787533|FG003|Overall Study|Withdrawal by Subject|7|||
33409150|NCT00449644|62787530|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
33409151|NCT00449644|62787531|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
33409152|NCT00449644|62787532|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
33409153|NCT00449644|62787533|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
33409154|NCT00449644|62787530|FG000|Overall Study|Other|1|||
33409155|NCT00449644|62787531|FG001|Overall Study|Other|4|||
33409156|NCT00449644|62787532|FG002|Overall Study|Other|1|||
33409157|NCT00449644|62787533|FG003|Overall Study|Other|0|||
33409158|NCT00449644|62787530|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
33409159|NCT00449644|62787531|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
33409160|NCT00449644|62787532|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
33409161|NCT00449644|62787533|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
33409162|NCT00515541|62787550|FG000|Overall Study|Physician Decision|0|||
33409163|NCT00515541|62787551|FG001|Overall Study|Physician Decision|2|||
33409164|NCT00515541|62787552|FG002|Overall Study|Physician Decision|0|||
33409165|NCT00515541|62787553|FG003|Overall Study|Physician Decision|1|||
33409166|NCT00515541|62787550|FG000|Overall Study|No show for appointments|0|||
33599062|NCT02039505|62998015|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
33599063|NCT02039505|62998016|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
33599064|NCT02039505|62998017|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
33599065|NCT02039505|62998018|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
33599066|NCT02039505|62998012|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
33409167|NCT00515541|62787551|FG001|Overall Study|No show for appointments|1|||
33409168|NCT00515541|62787552|FG002|Overall Study|No show for appointments|0|||
33409169|NCT00515541|62787553|FG003|Overall Study|No show for appointments|2|||
33409170|NCT00515541|62787550|FG000|Overall Study|Withdrawal by Subject|0|||
33494001|NCT02815280|62872582|FG001|Open-Label Phase|Withdrawal by Subject|18|||
33599067|NCT02039505|62998013|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
33599068|NCT02039505|62998014|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
33599069|NCT02039505|62998015|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
33599070|NCT02039505|62998016|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
33494002|NCT02815280|62872581|FG000|Open-Label Phase|Protocol Violation|3|||
33494003|NCT02815280|62872582|FG001|Open-Label Phase|Protocol Violation|0|||
33494004|NCT02815280|62872581|FG000|Open-Label Phase|Administrative|26|||
33494005|NCT02815280|62872582|FG001|Open-Label Phase|Administrative|12|||
33494006|NCT02815280|62872581|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
33599071|NCT02039505|62998017|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
33599072|NCT02039505|62998018|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
33599073|NCT02039505|62998012|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
33599074|NCT02039505|62998013|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
33599075|NCT02039505|62998014|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
33599076|NCT02039505|62998015|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
33599077|NCT02039505|62998016|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
33599078|NCT02039505|62998017|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
33599079|NCT02039505|62998018|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
33599080|NCT02039505|62998012|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
33599081|NCT02039505|62998013|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
33599082|NCT02039505|62998014|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
33409171|NCT00515541|62787551|FG001|Overall Study|Withdrawal by Subject|2|||
33409172|NCT00515541|62787552|FG002|Overall Study|Withdrawal by Subject|0|||
33409173|NCT00515541|62787553|FG003|Overall Study|Withdrawal by Subject|2|||
33409174|NCT00112489|62787563|FG000|Overall Study|Refused further treatment|8|||
33409175|NCT00112489|62787563|FG000|Overall Study|Adverse Event|12|||
33409176|NCT00112489|62787563|FG000|Overall Study|Death|2|||
33409177|NCT00112489|62787563|FG000|Overall Study|Other, Not Specified|9|||
33409178|NCT00112489|62787563|FG000|Overall Study|Patient never treated|2|||
33409179|NCT00112489|62787563|FG000|Overall Study|Ineligible|7|||
33409180|NCT00711971|62787576|FG000|Overall Study|Lost to Follow-up|3|||
33409181|NCT00711971|62787577|FG001|Overall Study|Lost to Follow-up|4|||
33409182|NCT00711971|62787578|FG002|Overall Study|Lost to Follow-up|1|||
33409183|NCT00515463|62787592|FG000|Overall Study|Physician Decision|4|||
33409184|NCT00515463|62787593|FG001|Overall Study|Physician Decision|2|||
33409185|NCT00515463|62787592|FG000|Overall Study|Adverse Event|1|||
33409186|NCT00515463|62787593|FG001|Overall Study|Adverse Event|2|||
33409187|NCT00515463|62787592|FG000|Overall Study|Withdrawal by Subject|3|||
33409188|NCT00515463|62787593|FG001|Overall Study|Withdrawal by Subject|4|||
33409189|NCT00515463|62787592|FG000|Overall Study|Lost to Follow-up|6|||
33409190|NCT00515463|62787593|FG001|Overall Study|Lost to Follow-up|5|||
33409191|NCT00515463|62787592|FG000|Overall Study|Other|0|||
33409192|NCT00515463|62787593|FG001|Overall Study|Other|1|||
33409193|NCT00507507|62787602|FG000|Treatment Period|Lost to Follow-up|0|||
33409194|NCT00507507|62787603|FG001|Treatment Period|Lost to Follow-up|2|||
33409195|NCT00507507|62787602|FG000|Treatment Period|Physician Decision|4|||
33409196|NCT00507507|62787603|FG001|Treatment Period|Physician Decision|1|||
33409197|NCT00507507|62787602|FG000|Treatment Period|Protocol Violation|1|||
33409198|NCT00507507|62787603|FG001|Treatment Period|Protocol Violation|2|||
33409199|NCT00507507|62787602|FG000|Treatment Period|Adverse Event|1|||
33409200|NCT00507507|62787603|FG001|Treatment Period|Adverse Event|1|||
33409201|NCT00507507|62787602|FG000|Treatment Period|Withdrawal by Subject|46|||
33409202|NCT00507507|62787603|FG001|Treatment Period|Withdrawal by Subject|47|||
33543979|NCT03034967|62934797|FG003|Overall Study|Liver function test abnormality|0|||
33543980|NCT03034967|62934798|FG004|Overall Study|Liver function test abnormality|0|||
33543981|NCT03034967|62934799|FG005|Overall Study|Liver function test abnormality|0|||
33543982|NCT03034967|62934794|FG000|Overall Study|Protocol Violation|1|||
33543983|NCT03034967|62934795|FG001|Overall Study|Protocol Violation|0|||
33543984|NCT03034967|62934796|FG002|Overall Study|Protocol Violation|0|||
33543985|NCT03034967|62934797|FG003|Overall Study|Protocol Violation|0|||
33543986|NCT03034967|62934798|FG004|Overall Study|Protocol Violation|0|||
33543987|NCT03034967|62934799|FG005|Overall Study|Protocol Violation|2|||
33543988|NCT03034967|62934794|FG000|Overall Study|Lack of Efficacy|0|||
33409203|NCT00507507|62787602|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
33409204|NCT00507507|62787603|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
33409205|NCT00507507|62787602|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
33409206|NCT00507507|62787603|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
33409207|NCT00507507|62787602|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
33409208|NCT00507507|62787603|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
33409209|NCT00459706|62787613|FG000|Overall Study|Adverse Event|19|||
33409210|NCT00459706|62787614|FG001|Overall Study|Adverse Event|13|||
33409211|NCT00459706|62787613|FG000|Overall Study|Withdrawal by Subject|1|||
33409212|NCT00459706|62787614|FG001|Overall Study|Withdrawal by Subject|6|||
33409213|NCT00459706|62787613|FG000|Overall Study|Physician Decision|2|||
33409214|NCT00459706|62787614|FG001|Overall Study|Physician Decision|0|||
33409215|NCT00459706|62787613|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
33409216|NCT00459706|62787614|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
33409217|NCT00459706|62787613|FG000|Overall Study|Protocol Violation|2|||
33409218|NCT00459706|62787614|FG001|Overall Study|Protocol Violation|1|||
33409219|NCT00459706|62787613|FG000|Overall Study|Failed to Return|1|||
33409220|NCT00459706|62787614|FG001|Overall Study|Failed to Return|0|||
33409221|NCT00459706|62787613|FG000|Overall Study|Other|0|||
33409222|NCT00459706|62787614|FG001|Overall Study|Other|1|||
33409223|NCT00507429|62787622|FG000|Treatment Phase|Disease Progression|12|||
33409224|NCT00507429|62787623|FG001|Treatment Phase|Disease Progression|5|||
33409225|NCT00507429|62787622|FG000|Treatment Phase|Adverse Event|12|||
33409226|NCT00507429|62787623|FG001|Treatment Phase|Adverse Event|5|||
33409227|NCT00507429|62787622|FG000|Treatment Phase|Withdrawal by Subject|3|||
33409228|NCT00507429|62787623|FG001|Treatment Phase|Withdrawal by Subject|3|||
33409229|NCT00507429|62787622|FG000|Treatment Phase|Physician Decision|4|||
33409230|NCT00507429|62787623|FG001|Treatment Phase|Physician Decision|2|||
33409231|NCT00507429|62787622|FG000|Treatment Phase|Other|6|||
33409232|NCT00507429|62787623|FG001|Treatment Phase|Other|3|||
33409233|NCT00507429|62787622|FG000|Maintenance Phase|Progressive Disease|14|||
33409234|NCT00507429|62787623|FG001|Maintenance Phase|Progressive Disease|0|||
33409235|NCT00449176|62787634|FG000|Overall Study|Withdrawal by Subject|39|||
33409236|NCT00449176|62787635|FG001|Overall Study|Withdrawal by Subject|43|||
33409237|NCT00449176|62787636|FG002|Overall Study|Withdrawal by Subject|59|||
33599083|NCT02039505|62998015|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
33599084|NCT02039505|62998016|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
33599085|NCT02039505|62998017|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
33599086|NCT02039505|62998018|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
33599087|NCT02039505|62998012|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
33409238|NCT00449176|62787634|FG000|Overall Study|Lost to Follow-up|13|||
33409239|NCT00449176|62787635|FG001|Overall Study|Lost to Follow-up|8|||
33409240|NCT00449176|62787636|FG002|Overall Study|Lost to Follow-up|12|||
33409241|NCT00449176|62787634|FG000|Overall Study|Adverse Event|51|||
33599088|NCT02039505|62998013|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
33599089|NCT02039505|62998014|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
33599090|NCT02039505|62998015|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
33599091|NCT02039505|62998016|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
33599092|NCT02039505|62998017|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
33599093|NCT02039505|62998018|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
33599094|NCT02039505|62998012|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
33599095|NCT02039505|62998013|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
33599096|NCT02039505|62998014|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
33599097|NCT02039505|62998015|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
33599098|NCT02039505|62998016|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
33599099|NCT02039505|62998017|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
33599100|NCT02039505|62998018|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
33599101|NCT02039505|62998012|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
33599102|NCT02039505|62998013|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
33599103|NCT02039505|62998014|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
33599104|NCT02039505|62998015|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
33599105|NCT02039505|62998016|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
33599106|NCT02039505|62998017|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
33599107|NCT02039505|62998018|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
33599108|NCT02039505|62998012|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
33599109|NCT02039505|62998013|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
33321443|NCT00995865|62697435|FG001|Overall Study|Lost to Follow-up|0|||
33409242|NCT00449176|62787635|FG001|Overall Study|Adverse Event|107|||
33321444|NCT00995865|62697436|FG002|Overall Study|Lost to Follow-up|1|||
33321445|NCT00995709|62697452|FG000|Overall Study|Adverse Event|4|||
33409243|NCT00449176|62787636|FG002|Overall Study|Adverse Event|15|||
33409244|NCT00449176|62787634|FG000|Overall Study|Lack of Efficacy|13|||
33409245|NCT00449176|62787635|FG001|Overall Study|Lack of Efficacy|7|||
33409246|NCT00449176|62787636|FG002|Overall Study|Lack of Efficacy|50|||
33409247|NCT00449176|62787634|FG000|Overall Study|Study drug non-compliant|14|||
33409248|NCT00449176|62787635|FG001|Overall Study|Study drug non-compliant|11|||
33409249|NCT00449176|62787636|FG002|Overall Study|Study drug non-compliant|11|||
33409250|NCT00449176|62787634|FG000|Overall Study|all other|22|||
33409251|NCT00449176|62787635|FG001|Overall Study|all other|19|||
33409252|NCT00449176|62787636|FG002|Overall Study|all other|20|||
33409253|NCT00515073|62787644|FG000|Overall Study|Withdrawal by Subject|1|||
33409254|NCT00515073|62787644|FG000|Overall Study|Physician Decision|1|||
33409255|NCT00710021|62787651|FG000|Overall Study|Lost to Follow-up|1|||
33409256|NCT00710021|62787652|FG001|Overall Study|Lost to Follow-up|0|||
33409257|NCT00710021|62787653|FG002|Overall Study|Lost to Follow-up|0|||
33409258|NCT00710021|62787651|FG000|Overall Study|Subject's Decision|0|||
33409259|NCT00710021|62787652|FG001|Overall Study|Subject's Decision|1|||
33409260|NCT00710021|62787653|FG002|Overall Study|Subject's Decision|0|||
33409261|NCT00710021|62787651|FG000|Overall Study|Subject misrandomized|0|||
33409262|NCT00710021|62787652|FG001|Overall Study|Subject misrandomized|1|||
33409263|NCT00710021|62787653|FG002|Overall Study|Subject misrandomized|1|||
33409264|NCT00710021|62787651|FG000|Overall Study|Physician Decision|0|||
33599110|NCT02039505|62998014|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
33599111|NCT02039505|62998015|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
33321446|NCT00995709|62697453|FG001|Overall Study|Adverse Event|2|||
33321447|NCT00995709|62697454|FG002|Overall Study|Adverse Event|0|||
33321448|NCT00995709|62697452|FG000|Overall Study|Lack of Efficacy|0|||
33321449|NCT00995709|62697453|FG001|Overall Study|Lack of Efficacy|1|||
33321450|NCT00995709|62697454|FG002|Overall Study|Lack of Efficacy|4|||
33321451|NCT00995709|62697452|FG000|Overall Study|Withdrawal by Subject|0|||
33321452|NCT00995709|62697453|FG001|Overall Study|Withdrawal by Subject|4|||
33321453|NCT00995709|62697454|FG002|Overall Study|Withdrawal by Subject|1|||
33321454|NCT00995709|62697452|FG000|Overall Study|Lost to Follow-up|1|||
33321455|NCT00995709|62697453|FG001|Overall Study|Lost to Follow-up|0|||
33409265|NCT00710021|62787652|FG001|Overall Study|Physician Decision|1|||
33409266|NCT00710021|62787653|FG002|Overall Study|Physician Decision|0|||
33409267|NCT00504153|62787662|FG000|Overall Study|Withdrawal by Subject|1|||
33409268|NCT00504153|62787662|FG000|Overall Study|Adverse Event|4|||
33409269|NCT00504153|62787662|FG000|Overall Study|Death|1|||
33409270|NCT00442702|62787668|FG000|Titration Period|Adverse Event|2|||
33409271|NCT00442702|62787669|FG001|Titration Period|Adverse Event|0|||
33409272|NCT00442702|62787668|FG000|Titration Period|Death|3|||
33409273|NCT00442702|62787669|FG001|Titration Period|Death|2|||
33409274|NCT00442702|62787668|FG000|Titration Period|Insufficient Therapeutic Response|1|||
33409275|NCT00442702|62787669|FG001|Titration Period|Insufficient Therapeutic Response|0|||
33409276|NCT00442702|62787668|FG000|Titration Period|Refused Treatment|4|||
33409277|NCT00442702|62787669|FG001|Titration Period|Refused Treatment|1|||
33409278|NCT00442702|62787668|FG000|Titration Period|Failure to return|1|||
33409279|NCT00442702|62787669|FG001|Titration Period|Failure to return|0|||
33409280|NCT00442702|62787668|FG000|Titration Period|Hospitalized in another hospital|1|||
33409281|NCT00442702|62787669|FG001|Titration Period|Hospitalized in another hospital|0|||
33409282|NCT00442702|62787668|FG000|Evaluation Period|Adverse Event|1|||
33409283|NCT00442702|62787669|FG001|Evaluation Period|Adverse Event|0|||
33409284|NCT00442702|62787668|FG000|Evaluation Period|Death|1|||
33409285|NCT00442702|62787669|FG001|Evaluation Period|Death|1|||
33409286|NCT00442702|62787668|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
33409287|NCT00442702|62787669|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
33409288|NCT00442702|62787668|FG000|Evaluation Period|Refused treatment|1|||
33409289|NCT00442702|62787669|FG001|Evaluation Period|Refused treatment|1|||
33409290|NCT00442702|62787668|FG000|Evaluation Period|Renal transplant|0|||
33409291|NCT00442702|62787669|FG001|Evaluation Period|Renal transplant|1|||
33409292|NCT00442702|62787668|FG000|Evaluation Period|Failure to return|1|||
33409293|NCT00442702|62787669|FG001|Evaluation Period|Failure to return|0|||
33409294|NCT00442702|62787668|FG000|Evaluation Period|Site closure|0|||
33409295|NCT00442702|62787669|FG001|Evaluation Period|Site closure|1|||
33409296|NCT00514917|62787677|FG000|Overall Study|Death|4|||
33409297|NCT00514917|62787678|FG001|Overall Study|Death|10|||
33409298|NCT00514917|62787677|FG000|Overall Study|Protocol Violation|1|||
33599112|NCT02039505|62998016|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
33599113|NCT02039505|62998017|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
33599114|NCT02039505|62998018|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
33599115|NCT02095197|62998040|FG000|Overall Study|Lost to Follow-up|0|||
33599116|NCT02095197|62998041|FG001|Overall Study|Lost to Follow-up|3|||
33599117|NCT02039427|62998051|FG000|Overall Study|Duration of surgery > 3h|1|||
33599118|NCT02039427|62998052|FG001|Overall Study|Duration of surgery > 3h|1|||
33599119|NCT02039427|62998053|FG002|Overall Study|Duration of surgery > 3h|0|||
33321456|NCT00995709|62697454|FG002|Overall Study|Lost to Follow-up|0|||
33321457|NCT00995709|62697452|FG000|Overall Study|Death|0|||
33321458|NCT00995709|62697453|FG001|Overall Study|Death|1|||
33409299|NCT00514917|62787678|FG001|Overall Study|Protocol Violation|0|||
33409300|NCT00514917|62787677|FG000|Overall Study|Lost to Follow-up|4|||
33409301|NCT00514917|62787678|FG001|Overall Study|Lost to Follow-up|3|||
33409302|NCT00514917|62787677|FG000|Overall Study|Withdrawal by Subject|18|||
33321459|NCT00995709|62697454|FG002|Overall Study|Death|0|||
33321460|NCT00995709|62697452|FG000|Overall Study|Protocol Violation|2|||
33321461|NCT00995709|62697453|FG001|Overall Study|Protocol Violation|1|||
33321462|NCT00995709|62697454|FG002|Overall Study|Protocol Violation|0|||
33321463|NCT00998985|62697476|FG000|Overall Study|Withdrawal by Subject|0|||
33321464|NCT00998985|62697477|FG001|Overall Study|Withdrawal by Subject|0|||
33321465|NCT00998985|62697478|FG002|Overall Study|Withdrawal by Subject|0|||
33321466|NCT00998985|62697479|FG003|Overall Study|Withdrawal by Subject|0|||
33321467|NCT00998985|62697480|FG004|Overall Study|Withdrawal by Subject|0|||
33321468|NCT00998985|62697481|FG005|Overall Study|Withdrawal by Subject|0|||
33321469|NCT00998985|62697482|FG006|Overall Study|Withdrawal by Subject|0|||
33409303|NCT00514917|62787678|FG001|Overall Study|Withdrawal by Subject|16|||
33409304|NCT00514917|62787677|FG000|Overall Study|Discontinued due to study closure|88|||
33409305|NCT00514917|62787678|FG001|Overall Study|Discontinued due to study closure|81|||
33409306|NCT00514917|62787677|FG000|Overall Study|Undefined|11|||
33409307|NCT00514917|62787678|FG001|Overall Study|Undefined|5|||
33409308|NCT00711425|62787686|FG000|Overall Study|Protocol Violation|1|||
33409309|NCT00711425|62787686|FG000|Overall Study|Death|2|||
33409310|NCT00711425|62787686|FG000|Overall Study|Lost to Follow-up|1|||
33409311|NCT00504075|62787690|FG000|Overall Study|Adverse Event|1|||
33409312|NCT00504075|62787690|FG000|Overall Study|Lost to Follow-up|5|||
33409313|NCT00504075|62787690|FG000|Overall Study|Withdrawal by Subject|1|||
33599120|NCT02039427|62998054|FG003|Overall Study|Duration of surgery > 3h|0|||
33409314|NCT00504075|62787690|FG000|Overall Study|Required other therapeutic intervention|1|||
33409315|NCT00503997|62787695|FG000|Overall Study|disease progression|1|||
33409316|NCT00503997|62787695|FG000|Overall Study|Adverse Event|5|||
33409317|NCT00503997|62787695|FG000|Overall Study|Death|1|||
33409318|NCT00503997|62787695|FG000|Overall Study|Withdrawal by Subject|1|||
33409319|NCT00096265|62787702|FG000|Overall Study|Ineligible|1|||
33409320|NCT00096265|62787703|FG001|Overall Study|Ineligible|0|||
33409321|NCT00096265|62787704|FG002|Overall Study|Ineligible|0|||
33409322|NCT00711191|62787716|FG000|Overall Study|Adverse Event|1|||
33409323|NCT00711191|62787717|FG001|Overall Study|Adverse Event|1|||
33409324|NCT00711191|62787718|FG002|Overall Study|Adverse Event|2|||
33409325|NCT00711191|62787716|FG000|Overall Study|Objective progression or relapse|2|||
33409326|NCT00711191|62787717|FG001|Overall Study|Objective progression or relapse|3|||
33409327|NCT00711191|62787718|FG002|Overall Study|Objective progression or relapse|7|||
33409328|NCT00711191|62787716|FG000|Overall Study|Withdrawal by Subject|0|||
33409329|NCT00711191|62787717|FG001|Overall Study|Withdrawal by Subject|1|||
33409330|NCT00711191|62787718|FG002|Overall Study|Withdrawal by Subject|3|||
33409331|NCT00706511|62787733|FG000|Overall Study|Withdrawal by Subject|1|||
33409332|NCT00706511|62787734|FG001|Overall Study|Withdrawal by Subject|0|||
33409333|NCT00706511|62787735|FG002|Overall Study|Withdrawal by Subject|0|||
33409334|NCT00706511|62787736|FG003|Overall Study|Withdrawal by Subject|0|||
33409335|NCT00448864|62787747|FG000|Overall Study|Death|1|||
33409336|NCT00448864|62787748|FG001|Overall Study|Death|0|||
33409337|NCT00448864|62787749|FG002|Overall Study|Death|0|||
33409338|NCT00448864|62787747|FG000|Overall Study|Lost to Follow-up|3|||
33409339|NCT00448864|62787748|FG001|Overall Study|Lost to Follow-up|1|||
33409340|NCT00448864|62787749|FG002|Overall Study|Lost to Follow-up|0|||
33321470|NCT00998985|62697483|FG007|Overall Study|Withdrawal by Subject|0|||
33321471|NCT00998985|62697484|FG008|Overall Study|Withdrawal by Subject|1|||
33321472|NCT00998985|62697485|FG009|Overall Study|Withdrawal by Subject|0|||
33409341|NCT00448864|62787747|FG000|Overall Study|Physician Decision|1|||
33409342|NCT00448864|62787748|FG001|Overall Study|Physician Decision|0|||
33409343|NCT00448864|62787749|FG002|Overall Study|Physician Decision|1|||
33409344|NCT00448864|62787747|FG000|Overall Study|Withdrawal by Subject|0|||
33409345|NCT00448864|62787748|FG001|Overall Study|Withdrawal by Subject|2|||
33409346|NCT00448864|62787749|FG002|Overall Study|Withdrawal by Subject|0|||
33409347|NCT00448864|62787747|FG000|Overall Study|Protocol Violation|0|||
33409348|NCT00448864|62787748|FG001|Overall Study|Protocol Violation|2|||
33409349|NCT00448864|62787749|FG002|Overall Study|Protocol Violation|0|||
33409350|NCT00567398|62787761|FG000|Overall Study|Adverse Event|6|||
33409351|NCT00567398|62787762|FG001|Overall Study|Adverse Event|14|||
33409352|NCT00567398|62787761|FG000|Overall Study|Physician Decision|0|||
33409353|NCT00567398|62787762|FG001|Overall Study|Physician Decision|4|||
33409354|NCT00567398|62787761|FG000|Overall Study|Withdrawal by Subject|0|||
33409355|NCT00567398|62787762|FG001|Overall Study|Withdrawal by Subject|2|||
33409356|NCT00567398|62787761|FG000|Overall Study|Renal Transplantation|0|||
33409357|NCT00567398|62787762|FG001|Overall Study|Renal Transplantation|3|||
33409358|NCT00567398|62787761|FG000|Overall Study|Other|1|||
33409359|NCT00567398|62787762|FG001|Overall Study|Other|0|||
33409360|NCT00448708|62787770|FG000|Overall Study|Death|21|||
33409361|NCT00448708|62787771|FG001|Overall Study|Death|17|||
33321473|NCT00998985|62697486|FG010|Overall Study|Withdrawal by Subject|0|||
33321474|NCT00998985|62697487|FG011|Overall Study|Withdrawal by Subject|0|||
33321475|NCT00998985|62697488|FG012|Overall Study|Withdrawal by Subject|0|||
33321476|NCT00998985|62697489|FG013|Overall Study|Withdrawal by Subject|0|||
33321477|NCT00998985|62697476|FG000|Overall Study|Protocol Violation|0|||
33321478|NCT00998985|62697477|FG001|Overall Study|Protocol Violation|0|||
33321479|NCT00998985|62697478|FG002|Overall Study|Protocol Violation|0|||
33321480|NCT00998985|62697479|FG003|Overall Study|Protocol Violation|0|||
33321481|NCT00998985|62697480|FG004|Overall Study|Protocol Violation|0|||
33321482|NCT00998985|62697481|FG005|Overall Study|Protocol Violation|1|||
33321483|NCT00998985|62697482|FG006|Overall Study|Protocol Violation|0|||
33409362|NCT00448708|62787770|FG000|Overall Study|Withdrawal by Subject|8|||
33409363|NCT00448708|62787771|FG001|Overall Study|Withdrawal by Subject|4|||
33409364|NCT00448708|62787770|FG000|Overall Study|Lost to Follow-up|6|||
33409365|NCT00448708|62787771|FG001|Overall Study|Lost to Follow-up|8|||
33409366|NCT00448708|62787770|FG000|Overall Study|not listed|0|||
33321484|NCT00998985|62697483|FG007|Overall Study|Protocol Violation|0|||
33321485|NCT00998985|62697484|FG008|Overall Study|Protocol Violation|0|||
33321486|NCT00998985|62697485|FG009|Overall Study|Protocol Violation|0|||
33599121|NCT02039427|62998051|FG000|Overall Study|Withdrawal on concent|0|||
33599122|NCT02039427|62998052|FG001|Overall Study|Withdrawal on concent|0|||
33599123|NCT02039427|62998053|FG002|Overall Study|Withdrawal on concent|0|||
33599124|NCT02039427|62998054|FG003|Overall Study|Withdrawal on concent|1|||
33599125|NCT02039427|62998051|FG000|Overall Study|Cancellation of surgery|0|||
33599126|NCT02039427|62998052|FG001|Overall Study|Cancellation of surgery|0|||
33599127|NCT02039427|62998053|FG002|Overall Study|Cancellation of surgery|1|||
33599128|NCT02039427|62998054|FG003|Overall Study|Cancellation of surgery|0|||
33599129|NCT02039427|62998051|FG000|Overall Study|Loss of follow - up|1|||
33599130|NCT02039427|62998052|FG001|Overall Study|Loss of follow - up|0|||
33599131|NCT02039427|62998053|FG002|Overall Study|Loss of follow - up|2|||
33599132|NCT02039427|62998054|FG003|Overall Study|Loss of follow - up|4|||
33599133|NCT02039427|62998051|FG000|Overall Study|Steroid Use|1|||
33599134|NCT02039427|62998052|FG001|Overall Study|Steroid Use|0|||
33599135|NCT02039427|62998053|FG002|Overall Study|Steroid Use|0|||
33599136|NCT02039427|62998054|FG003|Overall Study|Steroid Use|0|||
33599137|NCT02094885|62998070|FG000|Overall Study|Death|1|||
33599138|NCT02094885|62998071|FG001|Overall Study|Death|5|||
33599139|NCT02094885|62998070|FG000|Overall Study|Withdrawn due to age|1|||
33599140|NCT02094885|62998071|FG001|Overall Study|Withdrawn due to age|0|||
33599141|NCT01896856|62998083|FG000|Overall Study|Transportation issues / Non-compliance|0|||
33321487|NCT00998985|62697486|FG010|Overall Study|Protocol Violation|0|||
33321488|NCT00998985|62697487|FG011|Overall Study|Protocol Violation|0|||
33321489|NCT00998985|62697488|FG012|Overall Study|Protocol Violation|0|||
33321490|NCT00998985|62697489|FG013|Overall Study|Protocol Violation|0|||
33321491|NCT00995553|62697536|FG000|Overall Study|Withdrawal by Subject|2|||
33321492|NCT00995553|62697537|FG001|Overall Study|Withdrawal by Subject|6|||
33321493|NCT00991887|62697545|FG000|Overall Study|Lost to Follow-up|2|||
33494007|NCT02815280|62872582|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
33599142|NCT01896856|62998084|FG001|Overall Study|Transportation issues / Non-compliance|0|||
33599143|NCT01896856|62998085|FG002|Overall Study|Transportation issues / Non-compliance|1|||
33599144|NCT01896856|62998086|FG003|Overall Study|Transportation issues / Non-compliance|0|||
33409367|NCT00448708|62787771|FG001|Overall Study|not listed|2|||
33409368|NCT00706355|62787781|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
33409369|NCT00706355|62787782|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
33409370|NCT00706355|62787783|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
33409371|NCT00706355|62787784|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
33409372|NCT00706355|62787781|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
33409373|NCT00706355|62787782|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
33409374|NCT00706355|62787783|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
33409375|NCT00706355|62787784|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
33409376|NCT00706355|62787781|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
33409377|NCT00706355|62787782|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
33409378|NCT00706355|62787783|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
33409379|NCT00706355|62787784|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
33409380|NCT00706355|62787781|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
33409381|NCT00706355|62787782|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
33409382|NCT00706355|62787783|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
33409383|NCT00706355|62787784|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
33409384|NCT00706355|62787781|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
33409385|NCT00706355|62787782|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
33409386|NCT00706355|62787783|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
33409387|NCT00706355|62787784|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
33409388|NCT00706355|62787781|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
33409389|NCT00706355|62787782|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
33409390|NCT00706355|62787783|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
33409391|NCT00706355|62787784|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
33409392|NCT00706355|62787781|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
33409393|NCT00706355|62787782|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
33409394|NCT00706355|62787783|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
33409395|NCT00706355|62787784|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
33409396|NCT00706355|62787781|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
33409397|NCT00706355|62787782|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
33409398|NCT00706355|62787783|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
33409399|NCT00706355|62787784|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
33599145|NCT01896856|62998087|FG004|Overall Study|Transportation issues / Non-compliance|0|||
33599146|NCT01896856|62998088|FG005|Overall Study|Transportation issues / Non-compliance|0|||
33409400|NCT00706355|62787781|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
33409401|NCT00706355|62787782|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
33409402|NCT00706355|62787783|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
33409403|NCT00706355|62787784|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
33409404|NCT00711113|62787796|FG000|Overall Study|Lost to Follow-up|9|||
33409405|NCT00711113|62787796|FG000|Overall Study|Implant lost|2|||
33409406|NCT00710879|62787806|FG000|Overall Study|Lost to Follow-up|2|||
33409407|NCT00710879|62787807|FG001|Overall Study|Lost to Follow-up|1|||
33409408|NCT00710879|62787806|FG000|Overall Study|Protocol Violation|0|||
33409409|NCT00710879|62787807|FG001|Overall Study|Protocol Violation|3|||
33409410|NCT03979274|62787813|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33409411|NCT03979274|62787814|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33409412|NCT00459316|62787824|FG000|Steps 1 & 2|Other eligibility failure|1|||
33409413|NCT00459316|62787825|FG001|Steps 1 & 2|Other eligibility failure|1|||
33409414|NCT00459316|62787826|FG002|Steps 1 & 2|Other eligibility failure|0|||
33409415|NCT00459316|62787824|FG000|Steps 1 & 2|Death|1|||
33409416|NCT00459316|62787825|FG001|Steps 1 & 2|Death|1|||
33409417|NCT00459316|62787826|FG002|Steps 1 & 2|Death|0|||
33409418|NCT00459316|62787824|FG000|Steps 1 & 2|Not able to get to clinic|7|||
33409419|NCT00459316|62787825|FG001|Steps 1 & 2|Not able to get to clinic|4|||
33409420|NCT00459316|62787826|FG002|Steps 1 & 2|Not able to get to clinic|0|||
33409421|NCT00459316|62787824|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
33409422|NCT00459316|62787825|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
33599147|NCT02038959|62998105|FG000|Overall Study|Withdrawal by Subject|6|||
33599148|NCT02038959|62998106|FG001|Overall Study|Withdrawal by Subject|8|||
33599149|NCT01896700|62998114|FG000|Overall Study|Adverse Event|4|||
33321494|NCT00991887|62697546|FG001|Overall Study|Lost to Follow-up|1|||
33599150|NCT01896700|62998115|FG001|Overall Study|Adverse Event|5|||
33409423|NCT00459316|62787826|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
33409424|NCT00459316|62787824|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
33409425|NCT00459316|62787825|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
33409426|NCT00459316|62787826|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
33409427|NCT00459316|62787824|FG000|Steps 1 & 2|Lost to Follow-up|5|||
33409428|NCT00459316|62787825|FG001|Steps 1 & 2|Lost to Follow-up|0|||
33409429|NCT00459316|62787826|FG002|Steps 1 & 2|Lost to Follow-up|2|||
33409430|NCT00459316|62787824|FG000|Step 3|Withdrawal by Subject|3|||
33409431|NCT00459316|62787825|FG001|Step 3|Withdrawal by Subject|0|||
33409432|NCT00459316|62787826|FG002|Step 3|Withdrawal by Subject|1|||
33409433|NCT00567164|62787852|FG000|Overall Study|Withdrawal by Subject|171|||
33409434|NCT00567164|62787853|FG001|Overall Study|Withdrawal by Subject|21|||
33409435|NCT00567164|62787854|FG002|Overall Study|Withdrawal by Subject|17|||
33409436|NCT00567164|62787852|FG000|Overall Study|Protocol Violation|23|||
33409437|NCT00567164|62787853|FG001|Overall Study|Protocol Violation|4|||
33409438|NCT00567164|62787854|FG002|Overall Study|Protocol Violation|2|||
33409439|NCT00567164|62787852|FG000|Overall Study|Adverse Event|92|||
33409440|NCT00567164|62787853|FG001|Overall Study|Adverse Event|13|||
33409441|NCT00567164|62787854|FG002|Overall Study|Adverse Event|9|||
33409442|NCT00567164|62787852|FG000|Overall Study|Death|0|||
33599151|NCT01896700|62998114|FG000|Overall Study|Withdrawal by Subject|0|||
33599152|NCT01896700|62998115|FG001|Overall Study|Withdrawal by Subject|1|||
33599153|NCT02352493|62998139|FG000|Overall Study|Pregnancy|0|||
33599154|NCT02352493|62998140|FG001|Overall Study|Pregnancy|0|||
33599155|NCT02352493|62998141|FG002|Overall Study|Pregnancy|0|||
33599156|NCT02352493|62998142|FG003|Overall Study|Pregnancy|0|||
33599157|NCT02352493|62998143|FG004|Overall Study|Pregnancy|0|||
33599158|NCT02352493|62998144|FG005|Overall Study|Pregnancy|0|||
33599159|NCT02352493|62998145|FG006|Overall Study|Pregnancy|1|||
33599160|NCT02352493|62998146|FG007|Overall Study|Pregnancy|0|||
33599161|NCT02352493|62998147|FG008|Overall Study|Pregnancy|1|||
33599162|NCT02352493|62998148|FG009|Overall Study|Pregnancy|0|||
33599163|NCT02352493|62998149|FG010|Overall Study|Pregnancy|0|||
33599164|NCT02352493|62998150|FG011|Overall Study|Pregnancy|0|||
33599165|NCT02352493|62998151|FG012|Overall Study|Pregnancy|0|||
33599166|NCT02352493|62998152|FG013|Overall Study|Pregnancy|0|||
33599167|NCT02352493|62998153|FG014|Overall Study|Pregnancy|0|||
33599168|NCT02352493|62998154|FG015|Overall Study|Pregnancy|0|||
33599169|NCT02352493|62998155|FG016|Overall Study|Pregnancy|0|||
33599170|NCT02352493|62998156|FG017|Overall Study|Pregnancy|0|||
33599171|NCT02352493|62998139|FG000|Overall Study|Withdrawal by Subject|0|||
33599172|NCT02352493|62998140|FG001|Overall Study|Withdrawal by Subject|0|||
33599173|NCT02352493|62998141|FG002|Overall Study|Withdrawal by Subject|0|||
33599174|NCT02352493|62998142|FG003|Overall Study|Withdrawal by Subject|0|||
33599175|NCT02352493|62998143|FG004|Overall Study|Withdrawal by Subject|0|||
33599176|NCT02352493|62998144|FG005|Overall Study|Withdrawal by Subject|0|||
33599177|NCT02352493|62998145|FG006|Overall Study|Withdrawal by Subject|0|||
33599178|NCT02352493|62998146|FG007|Overall Study|Withdrawal by Subject|0|||
33599179|NCT02352493|62998147|FG008|Overall Study|Withdrawal by Subject|1|||
33599180|NCT02352493|62998148|FG009|Overall Study|Withdrawal by Subject|0|||
33599181|NCT02352493|62998149|FG010|Overall Study|Withdrawal by Subject|0|||
33599182|NCT02352493|62998150|FG011|Overall Study|Withdrawal by Subject|0|||
33599183|NCT02352493|62998151|FG012|Overall Study|Withdrawal by Subject|0|||
33599184|NCT02352493|62998152|FG013|Overall Study|Withdrawal by Subject|0|||
33599185|NCT02352493|62998153|FG014|Overall Study|Withdrawal by Subject|1|||
33599186|NCT02352493|62998154|FG015|Overall Study|Withdrawal by Subject|0|||
33599187|NCT02352493|62998155|FG016|Overall Study|Withdrawal by Subject|0|||
33599188|NCT02352493|62998156|FG017|Overall Study|Withdrawal by Subject|0|||
33599189|NCT02352493|62998139|FG000|Overall Study|Lost to Follow-up|0|||
33599190|NCT02352493|62998140|FG001|Overall Study|Lost to Follow-up|0|||
33599191|NCT02352493|62998141|FG002|Overall Study|Lost to Follow-up|0|||
33599192|NCT02352493|62998142|FG003|Overall Study|Lost to Follow-up|0|||
33599193|NCT02352493|62998143|FG004|Overall Study|Lost to Follow-up|0|||
33599194|NCT02352493|62998144|FG005|Overall Study|Lost to Follow-up|0|||
33599195|NCT02352493|62998145|FG006|Overall Study|Lost to Follow-up|0|||
33599196|NCT02352493|62998146|FG007|Overall Study|Lost to Follow-up|0|||
33409443|NCT00567164|62787853|FG001|Overall Study|Death|0|||
33409444|NCT00567164|62787854|FG002|Overall Study|Death|1|||
33409445|NCT00567164|62787852|FG000|Overall Study|Lost to Follow-up|202|||
33409446|NCT00567164|62787853|FG001|Overall Study|Lost to Follow-up|23|||
33494008|NCT02737930|62872594|FG000|Overall Study|Withdrawal by Subject|0|||
33599197|NCT02352493|62998147|FG008|Overall Study|Lost to Follow-up|0|||
33599198|NCT02352493|62998148|FG009|Overall Study|Lost to Follow-up|1|||
33599199|NCT02352493|62998149|FG010|Overall Study|Lost to Follow-up|0|||
33599200|NCT02352493|62998150|FG011|Overall Study|Lost to Follow-up|0|||
33599201|NCT02352493|62998151|FG012|Overall Study|Lost to Follow-up|1|||
33599202|NCT02352493|62998152|FG013|Overall Study|Lost to Follow-up|2|||
33409447|NCT00567164|62787854|FG002|Overall Study|Lost to Follow-up|21|||
33409448|NCT00567164|62787852|FG000|Overall Study|Pregnancy|20|||
33599203|NCT02352493|62998153|FG014|Overall Study|Lost to Follow-up|0|||
33599204|NCT02352493|62998154|FG015|Overall Study|Lost to Follow-up|0|||
33599205|NCT02352493|62998155|FG016|Overall Study|Lost to Follow-up|0|||
33599206|NCT02352493|62998156|FG017|Overall Study|Lost to Follow-up|0|||
33599207|NCT02286193|62998211|FG000|Overall Study|Referred: CRS unable to make contact|62|||
33599208|NCT02286193|62998211|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
33599209|NCT02286193|62998211|FG000|Overall Study|Referred: Declined service|38|||
33599210|NCT01896232|62998218|FG000|Overall Study|Death|6|||
33409449|NCT00567164|62787853|FG001|Overall Study|Pregnancy|4|||
33409450|NCT00567164|62787854|FG002|Overall Study|Pregnancy|6|||
33409451|NCT00567164|62787852|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
33409452|NCT00567164|62787853|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
33409453|NCT00567164|62787854|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
33409454|NCT00567164|62787852|FG000|Overall Study|Missing|1|||
33409455|NCT00567164|62787853|FG001|Overall Study|Missing|0|||
33409456|NCT00567164|62787854|FG002|Overall Study|Missing|0|||
33409457|NCT00713219|62787866|FG000|Overall Study|Death|1|||
33409458|NCT00713219|62787866|FG000|Overall Study|Protocol Violation|1|||
33409459|NCT00712985|62787870|FG000|Overall Study|1 withdrew prior to start of drug|1|||
33409460|NCT00712985|62787870|FG000|Overall Study|1 patient moved out of state|1|||
33409461|NCT00712985|62787870|FG000|Overall Study|Lack of Efficacy|3|||
33409462|NCT00700115|62787876|FG000|Overall Study|Withdrawal by Subject|1|||
33409463|NCT00700115|62787877|FG001|Overall Study|Withdrawal by Subject|0|||
33409464|NCT00700115|62787876|FG000|Overall Study|Lost to Follow-up|0|||
33409465|NCT00700115|62787877|FG001|Overall Study|Lost to Follow-up|1|||
33409466|NCT00566852|62787885|FG000|Overall Study|Protocol Violation|22|||
33409467|NCT00566852|62787886|FG001|Overall Study|Protocol Violation|24|||
33409468|NCT00566852|62787885|FG000|Overall Study|Death|95|||
33409469|NCT00566852|62787886|FG001|Overall Study|Death|78|||
33409470|NCT00566852|62787885|FG000|Overall Study|Withdrawal by Subject|30|||
33409471|NCT00566852|62787886|FG001|Overall Study|Withdrawal by Subject|25|||
33409472|NCT00566852|62787885|FG000|Overall Study|Patient refusal|37|||
33409473|NCT00566852|62787886|FG001|Overall Study|Patient refusal|37|||
33409474|NCT00566852|62787885|FG000|Overall Study|Not tested due to disability|6|||
33409475|NCT00566852|62787886|FG001|Overall Study|Not tested due to disability|12|||
33409476|NCT00566852|62787885|FG000|Overall Study|Missing reason not specified|1|||
33409477|NCT00566852|62787886|FG001|Overall Study|Missing reason not specified|2|||
33409478|NCT00566852|62787885|FG000|Overall Study|Missing reason not reported|16|||
33409479|NCT00566852|62787886|FG001|Overall Study|Missing reason not reported|20|||
33409480|NCT00442546|62787895|FG000|Overall Study|Adverse Event|11|||
33409481|NCT00442546|62787896|FG001|Overall Study|Adverse Event|17|||
33409482|NCT00442546|62787897|FG002|Overall Study|Adverse Event|13|||
33409483|NCT00442546|62787895|FG000|Overall Study|Lost to Follow-up|1|||
33409484|NCT00442546|62787896|FG001|Overall Study|Lost to Follow-up|2|||
33409485|NCT00442546|62787897|FG002|Overall Study|Lost to Follow-up|1|||
33409486|NCT00442546|62787895|FG000|Overall Study|Other|4|||
33494009|NCT02737930|62872595|FG001|Overall Study|Withdrawal by Subject|1|||
33494010|NCT03493698|62872601|FG000|Treatment Period C|Adverse Event|1|||
33494011|NCT03493698|62872601|FG000|Treatment Period C|Withdrawal by Subject|1|||
33494012|NCT02737852|62872615|FG000|Overall Study|Withdrawal by Subject|2|||
33494013|NCT03528174|62872619|FG000|Overall Study|Adverse Event|1|||
33494014|NCT03528174|62872619|FG000|Overall Study|sensors dislodged|1|||
33494015|NCT03109184|62872629|FG000|Overall Study|Lost to Follow-up|6|||
33494016|NCT03109184|62872630|FG001|Overall Study|Lost to Follow-up|6|||
33494017|NCT03109184|62872629|FG000|Overall Study|Withdrawal by Subject|1|||
33494018|NCT03109184|62872630|FG001|Overall Study|Withdrawal by Subject|1|||
33494019|NCT03493542|62872648|FG000|Overall Study|Ongoing|2|||
33494020|NCT03493542|62872649|FG001|Overall Study|Ongoing|3|||
33494021|NCT03493542|62872648|FG000|Overall Study|Withdrawal by parent or guardian|3|||
33494022|NCT03493542|62872649|FG001|Overall Study|Withdrawal by parent or guardian|0|||
33494023|NCT03493542|62872648|FG000|Overall Study|Withdrawal by Subject|2|||
33494024|NCT03493542|62872649|FG001|Overall Study|Withdrawal by Subject|6|||
33409487|NCT00442546|62787896|FG001|Overall Study|Other|9|||
33494025|NCT03493386|62872657|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33409488|NCT00442546|62787897|FG002|Overall Study|Other|6|||
33409489|NCT00442546|62787895|FG000|Overall Study|Withdrawal by Subject|5|||
33409490|NCT00442546|62787896|FG001|Overall Study|Withdrawal by Subject|5|||
33409491|NCT00442546|62787897|FG002|Overall Study|Withdrawal by Subject|7|||
33409492|NCT00442546|62787895|FG000|Overall Study|Randomized But Not Treated|5|||
33409493|NCT00442546|62787896|FG001|Overall Study|Randomized But Not Treated|4|||
33409494|NCT00442546|62787897|FG002|Overall Study|Randomized But Not Treated|6|||
33409495|NCT00514683|62787912|FG000|Overall Study|Not treated|2|||
33409496|NCT00514683|62787913|FG001|Overall Study|Not treated|1|||
33409497|NCT00514683|62787914|FG002|Overall Study|Not treated|0|||
33409498|NCT00514683|62787915|FG003|Overall Study|Not treated|0|||
33409499|NCT00514683|62787916|FG004|Overall Study|Not treated|1|||
33409500|NCT00514683|62787912|FG000|Overall Study|Adverse Event|21|||
33409501|NCT00514683|62787913|FG001|Overall Study|Adverse Event|20|||
33409502|NCT00514683|62787914|FG002|Overall Study|Adverse Event|15|||
33409503|NCT00514683|62787915|FG003|Overall Study|Adverse Event|13|||
33409504|NCT00514683|62787916|FG004|Overall Study|Adverse Event|27|||
33409505|NCT00514683|62787912|FG000|Overall Study|Protocol Violation|1|||
33409506|NCT00514683|62787913|FG001|Overall Study|Protocol Violation|1|||
33409507|NCT00514683|62787914|FG002|Overall Study|Protocol Violation|0|||
33409508|NCT00514683|62787915|FG003|Overall Study|Protocol Violation|1|||
33409509|NCT00514683|62787916|FG004|Overall Study|Protocol Violation|0|||
33409510|NCT00514683|62787912|FG000|Overall Study|Withdrawal by Subject|2|||
33599211|NCT01896232|62998219|FG001|Overall Study|Death|10|||
33599212|NCT01896232|62998218|FG000|Overall Study|Withdrawal by Subject|32|||
33599213|NCT01896232|62998219|FG001|Overall Study|Withdrawal by Subject|31|||
33409511|NCT00514683|62787913|FG001|Overall Study|Withdrawal by Subject|2|||
33409512|NCT00514683|62787914|FG002|Overall Study|Withdrawal by Subject|1|||
33409513|NCT00514683|62787915|FG003|Overall Study|Withdrawal by Subject|0|||
33409514|NCT00514683|62787916|FG004|Overall Study|Withdrawal by Subject|4|||
33543989|NCT03034967|62934795|FG001|Overall Study|Lack of Efficacy|1|||
33543990|NCT03034967|62934796|FG002|Overall Study|Lack of Efficacy|2|||
33543991|NCT03034967|62934797|FG003|Overall Study|Lack of Efficacy|1|||
33543992|NCT03034967|62934798|FG004|Overall Study|Lack of Efficacy|1|||
33543993|NCT03034967|62934799|FG005|Overall Study|Lack of Efficacy|0|||
33543994|NCT03034967|62934794|FG000|Overall Study|Adverse Event, non-fatal|3|||
33543995|NCT03034967|62934795|FG001|Overall Study|Adverse Event, non-fatal|1|||
33543996|NCT03034967|62934796|FG002|Overall Study|Adverse Event, non-fatal|2|||
33543997|NCT03034967|62934797|FG003|Overall Study|Adverse Event, non-fatal|0|||
33543998|NCT03034967|62934798|FG004|Overall Study|Adverse Event, non-fatal|2|||
33543999|NCT03034967|62934799|FG005|Overall Study|Adverse Event, non-fatal|8|||
33544000|NCT03034967|62934794|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
33544001|NCT03034967|62934795|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
33544002|NCT03034967|62934796|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
33544003|NCT03034967|62934797|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
33544004|NCT03034967|62934798|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
33599214|NCT01896232|62998218|FG000|Overall Study|Sponsor Decision|2|||
33409515|NCT00514683|62787912|FG000|Overall Study|Reason other than listed above|0|||
33409516|NCT00514683|62787913|FG001|Overall Study|Reason other than listed above|1|||
33599215|NCT01896232|62998219|FG001|Overall Study|Sponsor Decision|0|||
33599216|NCT01896232|62998218|FG000|Overall Study|Lost to Follow-up|9|||
33599217|NCT01896232|62998219|FG001|Overall Study|Lost to Follow-up|12|||
33599218|NCT02460224|62998254|FG000|Overall Study|Adverse Event|0|||
33599219|NCT02460224|62998255|FG001|Overall Study|Adverse Event|0|||
33599220|NCT02460224|62998256|FG002|Overall Study|Adverse Event|0|||
33599221|NCT02460224|62998257|FG003|Overall Study|Adverse Event|0|||
33599222|NCT02460224|62998258|FG004|Overall Study|Adverse Event|0|||
33599223|NCT02460224|62998259|FG005|Overall Study|Adverse Event|0|||
33599224|NCT02460224|62998260|FG006|Overall Study|Adverse Event|1|||
33599225|NCT02460224|62998261|FG007|Overall Study|Adverse Event|0|||
33599226|NCT02460224|62998262|FG008|Overall Study|Adverse Event|0|||
33599227|NCT02460224|62998263|FG009|Overall Study|Adverse Event|0|||
33599228|NCT02460224|62998264|FG010|Overall Study|Adverse Event|0|||
33599229|NCT02460224|62998265|FG011|Overall Study|Adverse Event|0|||
33599230|NCT02460224|62998266|FG012|Overall Study|Adverse Event|1|||
33599231|NCT02460224|62998267|FG013|Overall Study|Adverse Event|0|||
33599232|NCT02460224|62998268|FG014|Overall Study|Adverse Event|0|||
33599233|NCT02460224|62998269|FG015|Overall Study|Adverse Event|0|||
33409517|NCT00514683|62787914|FG002|Overall Study|Reason other than listed above|2|||
33409518|NCT00514683|62787915|FG003|Overall Study|Reason other than listed above|0|||
33409519|NCT00514683|62787916|FG004|Overall Study|Reason other than listed above|1|||
33409520|NCT00566696|62787932|FG000|Overall Study|Met Exclusion Criteria|2|||
33409521|NCT00566696|62787932|FG000|Overall Study|Muromonab not available|1|||
33409522|NCT00566696|62787932|FG000|Overall Study|Health Status Change|1|||
33409523|NCT00566696|62787932|FG000|Overall Study|Physician Decision|1|||
33409524|NCT00566696|62787932|FG000|Overall Study|Non-Patient Donors|37|||
33409525|NCT00503841|62787936|FG000|Overall Study|All screen failures|44|||
33409526|NCT00442468|62787942|FG000|Overall Study|Adverse Event|4|||
33409527|NCT00442468|62787942|FG000|Overall Study|Withdrawal by Subject|91|||
33409528|NCT00442468|62787942|FG000|Overall Study|Did not complete all study procedures|88|||
33409529|NCT00506883|62787949|FG000|Overall Study|Lost to Follow-up|1|||
33409530|NCT00506883|62787950|FG001|Overall Study|Lost to Follow-up|1|||
33409531|NCT00506883|62787951|FG002|Overall Study|Lost to Follow-up|1|||
33409532|NCT00506883|62787949|FG000|Overall Study|Withdrawal by Subject|1|||
33409533|NCT00506883|62787950|FG001|Overall Study|Withdrawal by Subject|0|||
33409534|NCT00506883|62787951|FG002|Overall Study|Withdrawal by Subject|1|||
33409535|NCT00506883|62787949|FG000|Overall Study|Lack of Efficacy|0|||
33409536|NCT00506883|62787950|FG001|Overall Study|Lack of Efficacy|1|||
33409537|NCT00506883|62787951|FG002|Overall Study|Lack of Efficacy|1|||
33409538|NCT00506883|62787949|FG000|Overall Study|Other|5|||
33409539|NCT00506883|62787950|FG001|Overall Study|Other|1|||
33409540|NCT00506883|62787951|FG002|Overall Study|Other|1|||
33409541|NCT00503685|62787962|FG000|Overall Study|Adverse Event|0|||
33409542|NCT00503685|62787963|FG001|Overall Study|Adverse Event|0|||
33409543|NCT00503685|62787964|FG002|Overall Study|Adverse Event|2|||
33409544|NCT00503685|62787962|FG000|Overall Study|Withdrawal by Subject|0|||
33409545|NCT00503685|62787963|FG001|Overall Study|Withdrawal by Subject|1|||
33599234|NCT02460224|62998270|FG016|Overall Study|Adverse Event|1|||
33599235|NCT02460224|62998271|FG017|Overall Study|Adverse Event|0|||
33599236|NCT02460224|62998272|FG018|Overall Study|Adverse Event|1|||
33599237|NCT02460224|62998273|FG019|Overall Study|Adverse Event|0|||
33599238|NCT02460224|62998274|FG020|Overall Study|Adverse Event|1|||
33409546|NCT00503685|62787964|FG002|Overall Study|Withdrawal by Subject|0|||
33409547|NCT00503685|62787962|FG000|Overall Study|Protocol Violation|0|||
33409548|NCT00503685|62787963|FG001|Overall Study|Protocol Violation|1|||
33409549|NCT00503685|62787964|FG002|Overall Study|Protocol Violation|0|||
33599239|NCT02460224|62998275|FG021|Overall Study|Adverse Event|1|||
33599240|NCT02460224|62998276|FG022|Overall Study|Adverse Event|1|||
33409550|NCT00503685|62787962|FG000|Overall Study|Eligibility Criteria Not Met|0|||
33599241|NCT02460224|62998277|FG023|Overall Study|Adverse Event|0|||
33599242|NCT02460224|62998278|FG024|Overall Study|Adverse Event|0|||
33599243|NCT02460224|62998279|FG025|Overall Study|Adverse Event|0|||
33599244|NCT02460224|62998280|FG026|Overall Study|Adverse Event|11|||
33599245|NCT02460224|62998281|FG027|Overall Study|Adverse Event|1|||
33599246|NCT02460224|62998282|FG028|Overall Study|Adverse Event|6|||
33409551|NCT00503685|62787963|FG001|Overall Study|Eligibility Criteria Not Met|1|||
33409552|NCT00503685|62787964|FG002|Overall Study|Eligibility Criteria Not Met|0|||
33409553|NCT00712673|62787976|FG000|Overall Study|Adverse Event|3|||
33409554|NCT00712673|62787977|FG001|Overall Study|Adverse Event|3|||
33409555|NCT00712673|62787978|FG002|Overall Study|Adverse Event|21|||
33409556|NCT00712673|62787979|FG003|Overall Study|Adverse Event|26|||
33409557|NCT00712673|62787976|FG000|Overall Study|Lack of Efficacy|2|||
33409558|NCT00712673|62787977|FG001|Overall Study|Lack of Efficacy|8|||
33409559|NCT00712673|62787978|FG002|Overall Study|Lack of Efficacy|8|||
33409560|NCT00712673|62787979|FG003|Overall Study|Lack of Efficacy|6|||
33409561|NCT00712673|62787976|FG000|Overall Study|Poor Compliance to Protocol|3|||
33409562|NCT00712673|62787977|FG001|Overall Study|Poor Compliance to Protocol|3|||
33409563|NCT00712673|62787978|FG002|Overall Study|Poor Compliance to Protocol|4|||
33409564|NCT00712673|62787979|FG003|Overall Study|Poor Compliance to Protocol|16|||
33409565|NCT00712673|62787976|FG000|Overall Study|Lost to Follow-up|1|||
33409566|NCT00712673|62787977|FG001|Overall Study|Lost to Follow-up|0|||
33409567|NCT00712673|62787978|FG002|Overall Study|Lost to Follow-up|2|||
33409568|NCT00712673|62787979|FG003|Overall Study|Lost to Follow-up|0|||
33409569|NCT00712673|62787976|FG000|Overall Study|Withdrawal by Subject|6|||
33409570|NCT00712673|62787977|FG001|Overall Study|Withdrawal by Subject|7|||
33409571|NCT00712673|62787978|FG002|Overall Study|Withdrawal by Subject|15|||
33409572|NCT00712673|62787979|FG003|Overall Study|Withdrawal by Subject|20|||
33409573|NCT00712673|62787976|FG000|Overall Study|Familial and Personal Reasons|5|||
33409574|NCT00712673|62787977|FG001|Overall Study|Familial and Personal Reasons|0|||
33409575|NCT00712673|62787978|FG002|Overall Study|Familial and Personal Reasons|5|||
33409576|NCT00712673|62787979|FG003|Overall Study|Familial and Personal Reasons|2|||
33409577|NCT00712673|62787976|FG000|Overall Study|Investigator's Decision|1|||
33409578|NCT00712673|62787977|FG001|Overall Study|Investigator's Decision|0|||
33409579|NCT00712673|62787978|FG002|Overall Study|Investigator's Decision|0|||
33409580|NCT00712673|62787979|FG003|Overall Study|Investigator's Decision|0|||
33409581|NCT00712673|62787976|FG000|Overall Study|Protocol Violation|0|||
33409582|NCT00712673|62787977|FG001|Overall Study|Protocol Violation|0|||
33409583|NCT00712673|62787978|FG002|Overall Study|Protocol Violation|2|||
33409584|NCT00712673|62787979|FG003|Overall Study|Protocol Violation|0|||
33409585|NCT03976466|62788000|FG000|Overall Study|Lost to Follow-up|1|||
33409586|NCT03976466|62788001|FG001|Overall Study|Lost to Follow-up|3|||
33409587|NCT02536755|62788009|FG000|Overall Study|Adverse Event|4|||
33409588|NCT03303105|62788018|FG000|Overall Study|Adverse Event|0|||
33409589|NCT03303105|62788019|FG001|Overall Study|Adverse Event|2|||
33409590|NCT03303105|62788018|FG000|Overall Study|Lack of Efficacy|1|||
33409591|NCT03303105|62788019|FG001|Overall Study|Lack of Efficacy|0|||
33409592|NCT03303105|62788018|FG000|Overall Study|Protocol Violation|1|||
33409593|NCT03303105|62788019|FG001|Overall Study|Protocol Violation|0|||
33409594|NCT03303105|62788018|FG000|Overall Study|Withdrawal by Subject|0|||
33599247|NCT02460224|62998254|FG000|Overall Study|Death|0|||
33599248|NCT02460224|62998255|FG001|Overall Study|Death|0|||
33409595|NCT03303105|62788019|FG001|Overall Study|Withdrawal by Subject|2|||
33409596|NCT00447694|62788025|FG000|Overall Study|Adverse Event|2|||
33409597|NCT00447694|62788025|FG000|Overall Study|Abnormal laboratory value|1|||
33599249|NCT02460224|62998256|FG002|Overall Study|Death|0|||
33599250|NCT02460224|62998257|FG003|Overall Study|Death|0|||
33409598|NCT00447694|62788025|FG000|Overall Study|Abnormal test procedure result|1|||
33409599|NCT00447694|62788025|FG000|Overall Study|Withdrawal by Subject|2|||
33409600|NCT00564278|62788031|FG000|Overall Study|Lost to Follow-up|35|||
33409601|NCT00564278|62788032|FG001|Overall Study|Lost to Follow-up|33|||
33599251|NCT02460224|62998258|FG004|Overall Study|Death|0|||
33409602|NCT00564278|62788031|FG000|Overall Study|Physician Decision|1|||
33409603|NCT00564278|62788032|FG001|Overall Study|Physician Decision|2|||
33409604|NCT00564278|62788031|FG000|Overall Study|Withdrawal by Subject|11|||
33409605|NCT00564278|62788032|FG001|Overall Study|Withdrawal by Subject|7|||
33409606|NCT00565604|62788038|FG000|Overall Study|Failure to treat|2|||
33409607|NCT00565604|62788038|FG000|Overall Study|Lost to Follow-up|2|||
33409608|NCT00447382|62788044|FG000|Overall Study|Adverse Event|1|||
33409609|NCT00447382|62788045|FG001|Overall Study|Adverse Event|1|||
33409610|NCT00447382|62788044|FG000|Overall Study|Lack of Efficacy|1|||
33409611|NCT00447382|62788045|FG001|Overall Study|Lack of Efficacy|0|||
33409612|NCT00447382|62788044|FG000|Overall Study|Protocol Violation|2|||
33409613|NCT00447382|62788045|FG001|Overall Study|Protocol Violation|0|||
33409614|NCT00447382|62788044|FG000|Overall Study|Unclassified|2|||
33409615|NCT00447382|62788045|FG001|Overall Study|Unclassified|5|||
33409616|NCT00447226|62788051|FG000|12-Week Open-label Phase|Adverse Event|0|||
33409617|NCT00447226|62788052|FG001|12-Week Open-label Phase|Adverse Event|3|||
33409618|NCT00447226|62788051|FG000|12-Week Open-label Phase|Protocol Violation|0|||
33409619|NCT00447226|62788052|FG001|12-Week Open-label Phase|Protocol Violation|1|||
33409620|NCT00447226|62788051|FG000|12-Week Open-label Phase|Disease Progression|0|||
33409621|NCT00447226|62788052|FG001|12-Week Open-label Phase|Disease Progression|20|||
33409622|NCT00447226|62788051|FG000|12-Week Open-label Phase|Physician Decision|0|||
33409623|NCT00447226|62788052|FG001|12-Week Open-label Phase|Physician Decision|1|||
33409624|NCT00447226|62788051|FG000|Double-blind Phase|Disease Progression|4|||
33409625|NCT00447226|62788052|FG001|Double-blind Phase|Disease Progression|3|||
33409626|NCT00446992|62788067|FG000|Overall Study|Adverse Event|11|||
33409627|NCT00446992|62788067|FG000|Overall Study|Lost to Follow-up|5|||
33409628|NCT00503139|62788071|FG000|Overall Study|Case Report Forms were not collected|4|||
33409629|NCT00503139|62788071|FG000|Overall Study|Protocol Violation|4|||
33409630|NCT00577031|62788075|FG000|Overall Study|Adverse Event|52|||
33409631|NCT00577031|62788075|FG000|Overall Study|Progression of disease|93|||
33409632|NCT00577031|62788075|FG000|Overall Study|Protocol Violation|5|||
33409633|NCT00577031|62788075|FG000|Overall Study|Participant withdrew consent|13|||
33409634|NCT00577031|62788075|FG000|Overall Study|Participant non-compliance|5|||
33409635|NCT00577031|62788075|FG000|Overall Study|Need for surgery|17|||
33409636|NCT00577031|62788075|FG000|Overall Study|Medical decision|14|||
33409637|NCT00577031|62788075|FG000|Overall Study|Death|6|||
33409638|NCT00565448|62788084|FG000|Overall Study|Adverse Event|1|||
33409639|NCT00565448|62788085|FG001|Overall Study|Adverse Event|2|||
33409640|NCT00565448|62788084|FG000|Overall Study|Disease progression|1|||
33409641|NCT00565448|62788085|FG001|Overall Study|Disease progression|0|||
33409642|NCT00565448|62788084|FG000|Overall Study|Withdrawal by Subject|1|||
33409643|NCT00565448|62788085|FG001|Overall Study|Withdrawal by Subject|0|||
33409644|NCT00446446|62788094|FG000|Overall Study|Death|10|||
33409645|NCT00446446|62788094|FG000|Overall Study|Withdrawal by Subject|6|||
33409646|NCT00446446|62788094|FG000|Overall Study|Other|4|||
33409647|NCT00446446|62788094|FG000|Overall Study|Disease Progession|2|||
33409648|NCT00446446|62788094|FG000|Overall Study|Adverse Event|1|||
33409649|NCT00446446|62788094|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
33409650|NCT00506493|62788098|FG000|Overall Study|Death|6|||
33409651|NCT00506493|62788098|FG000|Overall Study|Withdrawal by Subject|5|||
33409652|NCT00514449|62788106|FG000|Overall Study|Withdrawal by Subject|1|||
33409653|NCT00514449|62788107|FG001|Overall Study|Withdrawal by Subject|2|||
33409654|NCT00514449|62788106|FG000|Overall Study|Protocol Violation|1|||
33409655|NCT00514449|62788107|FG001|Overall Study|Protocol Violation|2|||
33409656|NCT00514449|62788106|FG000|Overall Study|Lost to Follow-up|1|||
33409657|NCT00514449|62788107|FG001|Overall Study|Lost to Follow-up|0|||
33409658|NCT00565136|62788116|FG000|Overall Study|Lost to Follow-up|1|||
33409659|NCT00565136|62788116|FG000|Overall Study|Withdrawal by Subject|1|||
33409660|NCT00565136|62788116|FG000|Overall Study|Protocol Violation|1|||
33409661|NCT00492921|62788120|FG000|Overall Study|Death|1|||
33409662|NCT00492921|62788121|FG001|Overall Study|Death|0|||
33409663|NCT00492921|62788122|FG002|Overall Study|Death|1|||
33409664|NCT00502671|62788130|FG000|Overall Study|Disease Progression|13|||
33321495|NCT01002339|62697555|FG000|Overall Study|Withdrawal by Subject|0|||
33321496|NCT01002339|62697556|FG001|Overall Study|Withdrawal by Subject|1|||
33321497|NCT01002339|62697557|FG002|Overall Study|Withdrawal by Subject|0|||
33409665|NCT00502671|62788130|FG000|Overall Study|Personal Reasons|22|||
33409666|NCT00502671|62788130|FG000|Overall Study|Lost to Follow-up|7|||
33409667|NCT00502671|62788130|FG000|Overall Study|Protocol Violation|16|||
33409668|NCT00502671|62788130|FG000|Overall Study|Adverse Event|19|||
33409669|NCT00697463|62788134|FG000|Overall Study|Withdrawal by Subject|1|||
33409670|NCT00492531|62788140|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
33409671|NCT00492531|62788141|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
33409672|NCT00111475|62788157|FG000|Overall Study|Lost to Follow-up|0|||
33409673|NCT00111475|62788158|FG001|Overall Study|Lost to Follow-up|0|||
33409674|NCT00111475|62788159|FG002|Overall Study|Lost to Follow-up|0|||
33409675|NCT00111475|62788160|FG003|Overall Study|Lost to Follow-up|0|||
33409676|NCT00111475|62788161|FG004|Overall Study|Lost to Follow-up|0|||
33409677|NCT00111475|62788162|FG005|Overall Study|Lost to Follow-up|1|||
33409678|NCT00111475|62788163|FG006|Overall Study|Lost to Follow-up|0|||
33409679|NCT00111475|62788164|FG007|Overall Study|Lost to Follow-up|0|||
33409680|NCT00111475|62788165|FG008|Overall Study|Lost to Follow-up|0|||
33409681|NCT00111475|62788166|FG009|Overall Study|Lost to Follow-up|0|||
33409682|NCT00111241|62788195|FG000|Overall Study|Lost to Follow-up|1|||
33409683|NCT00111241|62788196|FG001|Overall Study|Lost to Follow-up|0|||
33409684|NCT00111241|62788195|FG000|Overall Study|Withdrawal by Subject|4|||
33321498|NCT01002339|62697555|FG000|Overall Study|Incorrect treatment assignment|0|||
33321499|NCT01002339|62697556|FG001|Overall Study|Incorrect treatment assignment|0|||
33321500|NCT01002339|62697557|FG002|Overall Study|Incorrect treatment assignment|1|||
33321501|NCT01002339|62697555|FG000|Overall Study|Protocol Violation|0|||
33321502|NCT01002339|62697556|FG001|Overall Study|Protocol Violation|0|||
33321503|NCT01002339|62697557|FG002|Overall Study|Protocol Violation|2|||
33321504|NCT01002339|62697555|FG000|Overall Study|Lung cancer detected before transplant|0|||
33321505|NCT01002339|62697556|FG001|Overall Study|Lung cancer detected before transplant|0|||
33321506|NCT01002339|62697557|FG002|Overall Study|Lung cancer detected before transplant|1|||
33321507|NCT01002339|62697555|FG000|Overall Study|Randomized. Not transplanted|0|||
33321508|NCT01002339|62697556|FG001|Overall Study|Randomized. Not transplanted|0|||
33321509|NCT01002339|62697557|FG002|Overall Study|Randomized. Not transplanted|1|||
33321510|NCT01002105|62697567|FG000|Overall Study|Lost to Follow-up|10|||
33409685|NCT00111241|62788196|FG001|Overall Study|Withdrawal by Subject|0|||
33409686|NCT00111241|62788195|FG000|Overall Study|Protocol Violation|9|||
33409687|NCT00111241|62788196|FG001|Overall Study|Protocol Violation|8|||
33409688|NCT00111241|62788195|FG000|Overall Study|Adverse Event|1|||
33409689|NCT00111241|62788196|FG001|Overall Study|Adverse Event|0|||
33409690|NCT00492297|62788204|FG000|Treatment|Death|2|||
33409691|NCT00492297|62788204|FG000|Treatment|Study terminated by sponsor|3|||
33409692|NCT00492297|62788204|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
33409693|NCT00492297|62788204|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
33494026|NCT03493386|62872658|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
33321511|NCT01002105|62697568|FG001|Overall Study|Lost to Follow-up|16|||
33321512|NCT01002105|62697567|FG000|Overall Study|non compliance|5|||
33321513|NCT01002105|62697568|FG001|Overall Study|non compliance|3|||
33321514|NCT01002105|62697567|FG000|Overall Study|condition worsened|4|||
33321515|NCT01002105|62697568|FG001|Overall Study|condition worsened|2|||
33321516|NCT02605993|62697581|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
33321517|NCT02605993|62697582|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
33321518|NCT02605993|62697583|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
33321519|NCT02605993|62697584|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
33321520|NCT00995085|62697594|FG000|Overall Study|Withdrawal by Subject|5|||
33321521|NCT00603733|62697600|FG000|Active Phase ITT|Adverse Event|8|||
33321522|NCT00603733|62697601|FG001|Active Phase ITT|Adverse Event|7|||
33321523|NCT00603733|62697600|FG000|Active Phase ITT|Withdrawal by Subject|0|||
33321524|NCT00603733|62697601|FG001|Active Phase ITT|Withdrawal by Subject|3|||
33321525|NCT00603733|62697600|FG000|Active Phase ITT|Lost to Follow-up|0|||
33321526|NCT00603733|62697601|FG001|Active Phase ITT|Lost to Follow-up|1|||
33321527|NCT00603733|62697600|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
33321528|NCT00603733|62697601|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
33321529|NCT00603733|62697600|FG000|Active Phase ITT|Lack of Efficacy|1|||
33321530|NCT00603733|62697601|FG001|Active Phase ITT|Lack of Efficacy|2|||
33321531|NCT00603733|62697600|FG000|Active Phase ITT|Subject moved, site closed|1|||
33321532|NCT00603733|62697601|FG001|Active Phase ITT|Subject moved, site closed|1|||
33321533|NCT00603733|62697600|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
33321534|NCT00603733|62697601|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
33321535|NCT00603733|62697600|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
33321536|NCT00603733|62697601|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
33321537|NCT00603733|62697600|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
33321538|NCT00603733|62697601|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
33321539|NCT00603733|62697600|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
33321540|NCT00603733|62697601|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
33321541|NCT00603733|62697600|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
33321542|NCT00603733|62697601|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
33321543|NCT00603733|62697600|FG000|Maintenance Phase ITT|Adverse Event|3|||
33321544|NCT00603733|62697601|FG001|Maintenance Phase ITT|Adverse Event|6|||
33321545|NCT00603733|62697600|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
33321546|NCT00603733|62697601|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
33321547|NCT00603733|62697600|FG000|Maintenance Phase ITT|Protocol Violation|1|||
33321548|NCT00603733|62697601|FG001|Maintenance Phase ITT|Protocol Violation|1|||
33321549|NCT00603733|62697600|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
33321550|NCT00603733|62697601|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
33321551|NCT00603733|62697600|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
33409694|NCT00492297|62788204|FG000|Survival Only Follow-up|Death|46|||
33409695|NCT00492297|62788204|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
33409696|NCT00492297|62788204|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
33409697|NCT00565058|62788210|FG000|Overall Study|Adverse Event|1|||
33409698|NCT00565058|62788211|FG001|Overall Study|Adverse Event|0|||
33409699|NCT00564902|62788220|FG000|Overall Study|Withdrawal by Subject|0|||
33409700|NCT00564902|62788221|FG001|Overall Study|Withdrawal by Subject|3|||
33409701|NCT00564902|62788222|FG002|Overall Study|Withdrawal by Subject|4|||
33409702|NCT00564902|62788220|FG000|Overall Study|Death|1|||
33409703|NCT00564902|62788221|FG001|Overall Study|Death|1|||
33409704|NCT00564902|62788222|FG002|Overall Study|Death|0|||
33409705|NCT00446134|62788234|FG000|Overall Study|Adverse Event|7|||
33409706|NCT00446134|62788235|FG001|Overall Study|Adverse Event|17|||
33409707|NCT00446134|62788236|FG002|Overall Study|Adverse Event|13|||
33409708|NCT00446134|62788237|FG003|Overall Study|Adverse Event|18|||
33409709|NCT00446134|62788234|FG000|Overall Study|Lack of Efficacy|19|||
33409710|NCT00446134|62788235|FG001|Overall Study|Lack of Efficacy|19|||
33409711|NCT00446134|62788236|FG002|Overall Study|Lack of Efficacy|24|||
33409712|NCT00446134|62788237|FG003|Overall Study|Lack of Efficacy|19|||
33409713|NCT00446134|62788234|FG000|Overall Study|Protocol Violation|0|||
33409714|NCT00446134|62788235|FG001|Overall Study|Protocol Violation|2|||
33409715|NCT00446134|62788236|FG002|Overall Study|Protocol Violation|1|||
33409716|NCT00446134|62788237|FG003|Overall Study|Protocol Violation|0|||
33409717|NCT00446134|62788234|FG000|Overall Study|Lost to Follow-up|1|||
33409718|NCT00446134|62788235|FG001|Overall Study|Lost to Follow-up|3|||
33409719|NCT00446134|62788236|FG002|Overall Study|Lost to Follow-up|1|||
33409720|NCT00446134|62788237|FG003|Overall Study|Lost to Follow-up|1|||
33409721|NCT00446134|62788234|FG000|Overall Study|Withdrawal by Subject|3|||
33409722|NCT00446134|62788235|FG001|Overall Study|Withdrawal by Subject|3|||
33409723|NCT00446134|62788236|FG002|Overall Study|Withdrawal by Subject|1|||
33409724|NCT00446134|62788237|FG003|Overall Study|Withdrawal by Subject|3|||
33409725|NCT00446134|62788234|FG000|Overall Study|Physician Decision|0|||
33409726|NCT00446134|62788235|FG001|Overall Study|Physician Decision|0|||
33409727|NCT00446134|62788236|FG002|Overall Study|Physician Decision|0|||
33409728|NCT00446134|62788237|FG003|Overall Study|Physician Decision|2|||
33409729|NCT00446134|62788234|FG000|Overall Study|Adverse Event-Diarrhea|1|||
33409730|NCT00446134|62788235|FG001|Overall Study|Adverse Event-Diarrhea|1|||
33409731|NCT00446134|62788236|FG002|Overall Study|Adverse Event-Diarrhea|2|||
33409732|NCT00446134|62788237|FG003|Overall Study|Adverse Event-Diarrhea|0|||
33409733|NCT00446134|62788234|FG000|Overall Study|Reason Not Completed|3|||
33409734|NCT00446134|62788235|FG001|Overall Study|Reason Not Completed|0|||
33409735|NCT00446134|62788236|FG002|Overall Study|Reason Not Completed|1|||
33409736|NCT00446134|62788237|FG003|Overall Study|Reason Not Completed|2|||
33409737|NCT00563186|62788249|FG000|Overall Study|LOS<48 hours|97|||
33409738|NCT00563186|62788250|FG001|Overall Study|LOS<48 hours|74|||
33409739|NCT00563186|62788249|FG000|Overall Study|Incomplete data|1|||
33409740|NCT00563186|62788250|FG001|Overall Study|Incomplete data|1|||
33409741|NCT00699413|62788261|FG000|Overall Study|Withdrawal by Subject|0|||
33409742|NCT00699413|62788262|FG001|Overall Study|Withdrawal by Subject|2|||
33409743|NCT00699413|62788261|FG000|Overall Study|Study terminated by sponsor|4|||
33409744|NCT00699413|62788262|FG001|Overall Study|Study terminated by sponsor|2|||
33409745|NCT04808609|62788270|FG000|Overall Study|Lost to Follow-up|0|||
33409746|NCT04808609|62788271|FG001|Overall Study|Lost to Follow-up|2|||
33409747|NCT04808609|62788270|FG000|Overall Study|Administrative Withdrawal|0|||
33409748|NCT04808609|62788271|FG001|Overall Study|Administrative Withdrawal|1|||
33409749|NCT00111007|62788279|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
33409750|NCT00111007|62788280|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
33409751|NCT00111007|62788279|FG000|Double-blind (DB) Treatment|Death|5|||
33409752|NCT00111007|62788280|FG001|Double-blind (DB) Treatment|Death|2|||
33409753|NCT00111007|62788279|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
33409754|NCT00111007|62788280|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
33409755|NCT00111007|62788279|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
33409756|NCT00111007|62788280|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
33409757|NCT00111007|62788279|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
33409758|NCT00111007|62788280|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
33409759|NCT00111007|62788279|FG000|Double-blind (DB) Treatment|Relapse|1|||
33409760|NCT00111007|62788280|FG001|Double-blind (DB) Treatment|Relapse|0|||
33409761|NCT00111007|62788279|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
33409762|NCT00111007|62788280|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
33409763|NCT00111007|62788279|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
33409764|NCT00111007|62788280|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
33409765|NCT00111007|62788279|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
33409766|NCT00111007|62788280|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
33409767|NCT00111007|62788279|FG000|Active Follow-up|Adverse Event|1|||
33409768|NCT00111007|62788280|FG001|Active Follow-up|Adverse Event|0|||
33409769|NCT00111007|62788279|FG000|Active Follow-up|Death|2|||
33409770|NCT00111007|62788280|FG001|Active Follow-up|Death|0|||
33409771|NCT00111007|62788279|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
33409772|NCT00111007|62788280|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
33409773|NCT00111007|62788279|FG000|Long Term Follow-up|Death|34|||
33409774|NCT00111007|62788280|FG001|Long Term Follow-up|Death|39|||
33409775|NCT00111007|62788279|FG000|Long Term Follow-up|Lost to Follow-up|1|||
33409776|NCT00111007|62788280|FG001|Long Term Follow-up|Lost to Follow-up|1|||
33409777|NCT00111007|62788279|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
33409778|NCT00111007|62788280|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
33409779|NCT00111007|62788279|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
33409780|NCT00111007|62788280|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
33409781|NCT00111007|62788279|FG000|Long Term Follow-up|Missing|10|||
33409782|NCT00111007|62788280|FG001|Long Term Follow-up|Missing|3|||
33409783|NCT03975920|62788288|FG000|Overall Study|Lost to Follow-up|1|||
33409784|NCT03975920|62788289|FG001|Overall Study|Lost to Follow-up|2|||
33409785|NCT03975920|62788288|FG000|Overall Study|Protocol Violation|1|||
33409786|NCT03975920|62788289|FG001|Overall Study|Protocol Violation|1|||
33409787|NCT03975920|62788288|FG000|Overall Study|Did not complete survey|2|||
33409788|NCT03975920|62788289|FG001|Overall Study|Did not complete survey|1|||
33409789|NCT00699335|62788295|FG000|Overall Study|Combination of multiple reasons|176|||
33409790|NCT00699335|62788295|FG000|Overall Study|Missing data|52|||
33409791|NCT00445978|62788302|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
33409792|NCT00445978|62788302|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
33409793|NCT00445978|62788302|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
33409794|NCT00445978|62788302|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
33409795|NCT00445978|62788302|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
33409796|NCT00445978|62788302|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
33409797|NCT00445978|62788302|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
33409798|NCT00445978|62788302|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
33409799|NCT00445978|62788302|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
33409800|NCT00566228|62788315|FG000|Overall Study|Withdrawal by Subject|1|||
33409801|NCT00566228|62788316|FG001|Overall Study|Withdrawal by Subject|0|||
33409802|NCT00566228|62788315|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
33409803|NCT00566228|62788316|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
33409804|NCT00566228|62788315|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
33409805|NCT00566228|62788316|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
33494027|NCT03493386|62872659|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33409806|NCT00566228|62788315|FG000|Overall Study|progressed before infusion could occur|0|||
33409807|NCT00566228|62788316|FG001|Overall Study|progressed before infusion could occur|1|||
33409808|NCT00698009|62788322|FG000|Overall Study|Withdrawal by Subject|1|||
33409809|NCT03968978|62788328|FG000|Overall Study|Adverse Event|1|||
33409810|NCT03968978|62788329|FG001|Overall Study|Adverse Event|0|||
33409811|NCT00562718|62788335|FG000|Overall Study|Death|1|||
33409812|NCT00562718|62788335|FG000|Overall Study|Withdrawal by Subject|3|||
33409813|NCT00562718|62788335|FG000|Overall Study|Adverse Event|4|||
33409814|NCT00562718|62788335|FG000|Overall Study|Lack of Efficacy|2|||
33409815|NCT00562718|62788335|FG000|Overall Study|not stated|1|||
33409816|NCT00697619|62788341|FG000|Overall Study|Lack of Efficacy|2|||
33409817|NCT00697619|62788342|FG001|Overall Study|Lack of Efficacy|2|||
33409818|NCT00697619|62788341|FG000|Overall Study|Adverse Event|4|||
33409819|NCT00697619|62788342|FG001|Overall Study|Adverse Event|6|||
33409820|NCT00445432|62788351|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
33409821|NCT00445432|62788352|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
33409822|NCT00445432|62788353|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
33409823|NCT00445432|62788354|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
33409824|NCT00445432|62788351|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
33409825|NCT00445432|62788352|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
33409826|NCT00445432|62788353|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
33409827|NCT00445432|62788354|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
33409828|NCT00445432|62788351|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
33409829|NCT00445432|62788352|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
33409830|NCT00445432|62788353|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
33409831|NCT00445432|62788354|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
33409832|NCT00445432|62788351|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
33409833|NCT00445432|62788352|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
33409834|NCT00445432|62788353|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
33409835|NCT00445432|62788354|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
33409836|NCT00445432|62788351|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
33409837|NCT00445432|62788352|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
33409838|NCT00445432|62788353|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
33409839|NCT00445432|62788354|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
33409840|NCT00445432|62788351|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
33409841|NCT00445432|62788352|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
33409842|NCT00445432|62788353|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
33409843|NCT00445432|62788354|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
33409844|NCT00445432|62788351|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
33409845|NCT00445432|62788352|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
33409846|NCT00445432|62788353|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
33409847|NCT00445432|62788354|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
33409848|NCT03370133|62788368|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
33409849|NCT03370133|62788369|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
33409850|NCT03370133|62788370|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
33409851|NCT03370133|62788371|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
33409852|NCT03370133|62788372|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
33409853|NCT03370133|62788373|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
33409854|NCT03370133|62788368|FG000|Initial Treatment Period (WK 16)|Death|1|||
33409855|NCT03370133|62788369|FG001|Initial Treatment Period (WK 16)|Death|1|||
33409856|NCT03370133|62788370|FG002|Initial Treatment Period (WK 16)|Death|1|||
33409857|NCT03370133|62788371|FG003|Initial Treatment Period (WK 16)|Death|0|||
33409858|NCT03370133|62788372|FG004|Initial Treatment Period (WK 16)|Death|0|||
33409859|NCT03370133|62788373|FG005|Initial Treatment Period (WK 16)|Death|0|||
33409860|NCT03370133|62788368|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
33409861|NCT03370133|62788369|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
33409862|NCT03370133|62788370|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
33409863|NCT03370133|62788371|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
33409864|NCT03370133|62788372|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
33409865|NCT03370133|62788373|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
33409866|NCT03370133|62788368|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
33409867|NCT03370133|62788369|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
33409868|NCT03370133|62788370|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
33409869|NCT03370133|62788371|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
33409870|NCT03370133|62788372|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
33321552|NCT00603733|62697601|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
33321553|NCT00603733|62697600|FG000|Maintenance Phase ITT|Physician Decision|0|||
33321554|NCT00603733|62697601|FG001|Maintenance Phase ITT|Physician Decision|1|||
33321555|NCT00603733|62697600|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
33321556|NCT00603733|62697601|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
33321557|NCT04631107|62697607|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
33321558|NCT04631107|62697607|FG000|Second Intervention (1 Night)|Adverse Event|1|||
33321559|NCT04631107|62697607|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
33321560|NCT04631107|62697607|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
33409871|NCT03370133|62788373|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
33409872|NCT03370133|62788368|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
33599252|NCT02460224|62998259|FG005|Overall Study|Death|2|||
33409873|NCT03370133|62788369|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
33409874|NCT03370133|62788370|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
33409875|NCT03370133|62788371|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
33321561|NCT00995007|62697617|FG000|Overall Study|Withdrew consent|1|||
33321562|NCT00995007|62697618|FG001|Overall Study|Withdrew consent|0|||
33321563|NCT00995007|62697617|FG000|Overall Study|Refused further treatment|8|||
33321564|NCT00995007|62697618|FG001|Overall Study|Refused further treatment|2|||
33321565|NCT00995007|62697617|FG000|Overall Study|Toxicity|8|||
33321566|NCT00995007|62697618|FG001|Overall Study|Toxicity|0|||
33321567|NCT00994461|62697636|FG000|Overall Study|Adverse Event|2|||
33321568|NCT00994461|62697637|FG001|Overall Study|Adverse Event|1|||
33321569|NCT00994461|62697638|FG002|Overall Study|Adverse Event|0|||
33321570|NCT00993915|62697646|FG000|Overall Study|Insufficient clinical response|3|||
33409876|NCT03370133|62788372|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
33409877|NCT03370133|62788373|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
33409878|NCT03370133|62788368|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
33409879|NCT03370133|62788369|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
33409880|NCT03370133|62788370|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
33409881|NCT03370133|62788371|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
33409882|NCT03370133|62788372|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
33409883|NCT03370133|62788373|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
33409884|NCT03370133|62788368|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
33409885|NCT03370133|62788369|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
33409886|NCT03370133|62788370|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
33409887|NCT03370133|62788371|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
33409888|NCT03370133|62788372|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
33409889|NCT03370133|62788373|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
33409890|NCT03370133|62788368|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
33409891|NCT03370133|62788369|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
33409892|NCT03370133|62788370|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
33409893|NCT03370133|62788371|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
33409894|NCT03370133|62788372|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
33409895|NCT03370133|62788373|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
33409896|NCT03370133|62788368|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
33409897|NCT03370133|62788369|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
33409898|NCT03370133|62788370|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
33409899|NCT03370133|62788371|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
33409900|NCT03370133|62788372|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
33409901|NCT03370133|62788373|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
33409902|NCT03370133|62788368|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
33409903|NCT03370133|62788369|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
33409904|NCT03370133|62788370|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
33409905|NCT03370133|62788371|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
33409906|NCT03370133|62788372|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
33409907|NCT03370133|62788373|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
33409908|NCT03370133|62788368|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
33409909|NCT03370133|62788369|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
33409910|NCT03370133|62788370|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
33409911|NCT03370133|62788371|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
33409912|NCT03370133|62788372|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
33409913|NCT03370133|62788373|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
33409914|NCT03370133|62788368|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
33409915|NCT03370133|62788369|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
33409916|NCT03370133|62788370|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
33409917|NCT03370133|62788371|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
33409918|NCT03370133|62788372|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
33494028|NCT03493386|62872660|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33409919|NCT03370133|62788373|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
33409920|NCT03370133|62788368|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
33409921|NCT03370133|62788369|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
33409922|NCT03370133|62788370|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
33409923|NCT03370133|62788371|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
33409924|NCT03370133|62788372|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
33409925|NCT03370133|62788373|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
33409926|NCT03370133|62788368|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
33409927|NCT03370133|62788369|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
33409928|NCT03370133|62788370|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
33409929|NCT03370133|62788371|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
33409930|NCT03370133|62788372|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
33409931|NCT03370133|62788373|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
33409932|NCT03370133|62788368|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
33409933|NCT03370133|62788369|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
33409934|NCT03370133|62788370|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
33409935|NCT03370133|62788371|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
33409936|NCT03370133|62788372|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
33409937|NCT03370133|62788373|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
33409938|NCT00696137|62788391|FG000|Overall Study|Withdrawal by Subject|2|||
33409939|NCT00441142|62788399|FG000|Overall Study|Adverse Event|2|||
33409940|NCT00441142|62788400|FG001|Overall Study|Adverse Event|3|||
33409941|NCT00441142|62788401|FG002|Overall Study|Adverse Event|3|||
33409942|NCT00441142|62788402|FG003|Overall Study|Adverse Event|22|||
33409943|NCT00441142|62788399|FG000|Overall Study|Lack of Efficacy|3|||
33409944|NCT00441142|62788400|FG001|Overall Study|Lack of Efficacy|3|||
33409945|NCT00441142|62788401|FG002|Overall Study|Lack of Efficacy|17|||
33409946|NCT00441142|62788402|FG003|Overall Study|Lack of Efficacy|32|||
33409947|NCT00441142|62788399|FG000|Overall Study|Withdrawal by Subject|0|||
33409948|NCT00441142|62788400|FG001|Overall Study|Withdrawal by Subject|0|||
33409949|NCT00441142|62788401|FG002|Overall Study|Withdrawal by Subject|2|||
33409950|NCT00441142|62788402|FG003|Overall Study|Withdrawal by Subject|10|||
33409951|NCT00441142|62788399|FG000|Overall Study|Patient still receiving active study tx|1|||
33409952|NCT00441142|62788400|FG001|Overall Study|Patient still receiving active study tx|0|||
33409953|NCT00441142|62788401|FG002|Overall Study|Patient still receiving active study tx|0|||
33409954|NCT00441142|62788402|FG003|Overall Study|Patient still receiving active study tx|2|||
33409955|NCT00441142|62788399|FG000|Overall Study|Physician Decision|0|||
33409956|NCT00441142|62788400|FG001|Overall Study|Physician Decision|1|||
33409957|NCT00441142|62788401|FG002|Overall Study|Physician Decision|0|||
33409958|NCT00441142|62788402|FG003|Overall Study|Physician Decision|1|||
33409959|NCT00441142|62788399|FG000|Overall Study|Death|0|||
33409960|NCT00441142|62788400|FG001|Overall Study|Death|0|||
33409961|NCT00441142|62788401|FG002|Overall Study|Death|0|||
33409962|NCT00441142|62788402|FG003|Overall Study|Death|1|||
33409963|NCT04025021|62788416|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
33409964|NCT04025021|62788417|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
33409965|NCT03848416|62788427|FG000|Overall Study|Withdrawal by Subject|1|||
33409966|NCT03848416|62788428|FG001|Overall Study|Withdrawal by Subject|0|||
33409967|NCT03848416|62788429|FG002|Overall Study|Withdrawal by Subject|0|||
33409968|NCT03848416|62788427|FG000|Overall Study|Death|0|||
33409969|NCT03848416|62788428|FG001|Overall Study|Death|0|||
33409970|NCT03848416|62788429|FG002|Overall Study|Death|1|||
33409971|NCT00458302|62788439|FG000|Overall Study|Adverse Event|4|||
33409972|NCT00458302|62788440|FG001|Overall Study|Adverse Event|14|||
33409973|NCT00458302|62788439|FG000|Overall Study|Pregnancy|2|||
33409974|NCT00458302|62788440|FG001|Overall Study|Pregnancy|1|||
33409975|NCT00458302|62788439|FG000|Overall Study|Protocol Violation|0|||
33409976|NCT00458302|62788440|FG001|Overall Study|Protocol Violation|2|||
33409977|NCT00458302|62788439|FG000|Overall Study|Withdrawal by Subject|6|||
33409978|NCT00458302|62788440|FG001|Overall Study|Withdrawal by Subject|4|||
33409979|NCT00458302|62788439|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
33409980|NCT00458302|62788440|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
33409981|NCT00458302|62788439|FG000|Overall Study|Study Termination By Sponsor|1|||
33409982|NCT00458302|62788440|FG001|Overall Study|Study Termination By Sponsor|0|||
33409983|NCT00458302|62788439|FG000|Overall Study|Lost to Follow-up|2|||
33409984|NCT00458302|62788440|FG001|Overall Study|Lost to Follow-up|0|||
33409985|NCT00458302|62788439|FG000|Overall Study|Other|4|||
33409986|NCT00458302|62788440|FG001|Overall Study|Other|2|||
33409987|NCT00444106|62788450|FG000|Overall Study|Lost to Follow-up|2|||
33409988|NCT00444106|62788451|FG001|Overall Study|Lost to Follow-up|1|||
33409989|NCT00444106|62788452|FG002|Overall Study|Lost to Follow-up|0|||
33409990|NCT00444106|62788450|FG000|Overall Study|Abnormal Test Procedure Results|0|||
33409991|NCT00444106|62788451|FG001|Overall Study|Abnormal Test Procedure Results|0|||
33409992|NCT00444106|62788452|FG002|Overall Study|Abnormal Test Procedure Results|1|||
33409993|NCT00561470|62788465|FG000|Overall Study|Adverse Event|74|||
33409994|NCT00561470|62788466|FG001|Overall Study|Adverse Event|163|||
33409995|NCT00561470|62788465|FG000|Overall Study|Disease progression|437|||
33409996|NCT00561470|62788466|FG001|Overall Study|Disease progression|305|||
33409997|NCT00561470|62788465|FG000|Overall Study|poor compliance to protocol|4|||
33409998|NCT00561470|62788466|FG001|Overall Study|poor compliance to protocol|4|||
33409999|NCT00561470|62788465|FG000|Overall Study|Lost to Follow-up|2|||
33410000|NCT00561470|62788466|FG001|Overall Study|Lost to Follow-up|0|||
33410001|NCT00561470|62788465|FG000|Overall Study|Physician Decision|21|||
33410002|NCT00561470|62788466|FG001|Overall Study|Physician Decision|20|||
33410003|NCT00561470|62788465|FG000|Overall Study|Consent Withdrawn|2|||
33410004|NCT00561470|62788466|FG001|Overall Study|Consent Withdrawn|6|||
33410005|NCT00561470|62788465|FG000|Overall Study|Subject request|43|||
33410006|NCT00561470|62788466|FG001|Overall Study|Subject request|77|||
33410007|NCT00561470|62788465|FG000|Overall Study|Metastatic surgery|10|||
33410008|NCT00561470|62788466|FG001|Overall Study|Metastatic surgery|12|||
33410009|NCT00561470|62788465|FG000|Overall Study|Unauthorized procedure|3|||
33410010|NCT00561470|62788466|FG001|Overall Study|Unauthorized procedure|1|||
33410011|NCT00561470|62788465|FG000|Overall Study|Randomized but not treated|5|||
33410012|NCT00561470|62788466|FG001|Overall Study|Randomized but not treated|5|||
33410013|NCT00561470|62788465|FG000|Overall Study|Missed visit window|1|||
33410014|NCT00561470|62788466|FG001|Overall Study|Missed visit window|4|||
33410015|NCT00561470|62788465|FG000|Overall Study|Planning surgery|1|||
33410016|NCT00561470|62788466|FG001|Overall Study|Planning surgery|1|||
33410017|NCT00561470|62788465|FG000|Overall Study|Ongoing Treatment|11|||
33410018|NCT00561470|62788466|FG001|Overall Study|Ongoing Treatment|14|||
33410019|NCT00443872|62788474|FG000|Overall Study|Protocol Violation|7|||
33410020|NCT00443872|62788474|FG000|Overall Study|Lost to Follow-up|2|||
33410021|NCT00443872|62788474|FG000|Overall Study|Adverse Event|8|||
33410022|NCT00441064|62788489|FG000|Overall Study|Adverse Event|1|||
33410023|NCT00441064|62788490|FG001|Overall Study|Adverse Event|0|||
33410024|NCT00441064|62788489|FG000|Overall Study|Abnormal laboratory values|0|||
33410025|NCT00441064|62788490|FG001|Overall Study|Abnormal laboratory values|2|||
33410026|NCT00441064|62788489|FG000|Overall Study|Abnormal test procedure results|0|||
33410027|NCT00441064|62788490|FG001|Overall Study|Abnormal test procedure results|1|||
33410028|NCT00441064|62788489|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33410029|NCT00441064|62788490|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33410030|NCT00441064|62788489|FG000|Overall Study|Protocol Deviation|3|||
33410031|NCT00441064|62788490|FG001|Overall Study|Protocol Deviation|2|||
33410032|NCT00441064|62788489|FG000|Overall Study|Patient withdrew consent|5|||
33410033|NCT00441064|62788490|FG001|Overall Study|Patient withdrew consent|2|||
33410034|NCT03962738|62788500|FG000|Overall Study|Protocol Deviation|3|||
33410035|NCT03962738|62788501|FG001|Overall Study|Protocol Deviation|0|||
33410036|NCT03962738|62788502|FG002|Overall Study|Protocol Deviation|1|||
33410037|NCT03962738|62788503|FG003|Overall Study|Protocol Deviation|1|||
33410038|NCT03962738|62788500|FG000|Overall Study|Withdrawal by Subject|4|||
33410039|NCT03962738|62788501|FG001|Overall Study|Withdrawal by Subject|0|||
33410040|NCT03962738|62788502|FG002|Overall Study|Withdrawal by Subject|0|||
33410041|NCT03962738|62788503|FG003|Overall Study|Withdrawal by Subject|0|||
33410042|NCT03962738|62788500|FG000|Overall Study|Lost to Follow-up|0|||
33410043|NCT03962738|62788501|FG001|Overall Study|Lost to Follow-up|0|||
33410044|NCT03962738|62788502|FG002|Overall Study|Lost to Follow-up|1|||
33410045|NCT03962738|62788503|FG003|Overall Study|Lost to Follow-up|0|||
33410046|NCT00561392|62788521|FG000|Overall Study|Adverse Event|38|||
33410047|NCT00561392|62788521|FG000|Overall Study|Lack of Efficacy|2|||
33410048|NCT00561392|62788521|FG000|Overall Study|Protocol Violation|1|||
33410049|NCT00561392|62788521|FG000|Overall Study|Withdrawal by Subject|8|||
33410050|NCT00561392|62788521|FG000|Overall Study|Administrative problems|4|||
33410051|NCT00694109|62788525|FG000|Overall Study|Physician Decision|3|||
33410052|NCT00694109|62788525|FG000|Overall Study|Adverse Event|74|||
33410053|NCT00694109|62788525|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
33410054|NCT00694109|62788525|FG000|Overall Study|Lack of Efficacy|2|||
33410055|NCT00694109|62788525|FG000|Overall Study|Withdrawal by Subject|13|||
33410056|NCT00694109|62788525|FG000|Overall Study|Pregnancy|1|||
33410057|NCT00694109|62788525|FG000|Overall Study|Enrolled but not treated|1|||
33410058|NCT00694109|62788525|FG000|Overall Study|Other|2|||
33410059|NCT00694109|62788525|FG000|Overall Study|Consented but no additional treatment|3|||
33410060|NCT00562484|62788536|FG000|Overall Study|Adverse Event|6|||
33410061|NCT00562484|62788537|FG001|Overall Study|Adverse Event|1|||
33410062|NCT00562484|62788536|FG000|Overall Study|Protocol Violation|11|||
33410063|NCT00562484|62788537|FG001|Overall Study|Protocol Violation|2|||
33410064|NCT00562484|62788536|FG000|Overall Study|Withdrawal by Subject|12|||
33410065|NCT00562484|62788537|FG001|Overall Study|Withdrawal by Subject|9|||
33410066|NCT00562484|62788536|FG000|Overall Study|Moved away from the study area|20|||
33410067|NCT00562484|62788537|FG001|Overall Study|Moved away from the study area|9|||
33410068|NCT00562484|62788536|FG000|Overall Study|Lost to Follow-up|132|||
33410069|NCT00562484|62788537|FG001|Overall Study|Lost to Follow-up|71|||
33410070|NCT00562484|62788536|FG000|Overall Study|Reason not provided or not specified|25|||
33410071|NCT00562484|62788537|FG001|Overall Study|Reason not provided or not specified|12|||
33410072|NCT00561080|62788546|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
33410073|NCT00561080|62788547|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
33410074|NCT00561080|62788548|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
33410075|NCT00561080|62788546|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
33410076|NCT00561080|62788547|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
33410077|NCT00561080|62788548|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
33410078|NCT00561080|62788546|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
33410079|NCT00561080|62788547|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
33410080|NCT00561080|62788548|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
33410081|NCT00561080|62788546|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
33494029|NCT03478644|62872679|FG000|Phase 2|Withdrawal by Subject|2|||
33410082|NCT00561080|62788547|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
33410083|NCT00561080|62788548|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
33410084|NCT00561080|62788546|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
33410085|NCT00561080|62788547|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
33410086|NCT00561080|62788548|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
33410087|NCT00561080|62788546|FG000|Vaccination Period (up to Month 4)|Other|0|||
33410088|NCT00561080|62788547|FG001|Vaccination Period (up to Month 4)|Other|2|||
33410089|NCT00561080|62788548|FG002|Vaccination Period (up to Month 4)|Other|1|||
33410090|NCT00561080|62788546|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
33410091|NCT00561080|62788547|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
33410092|NCT00561080|62788548|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
33410093|NCT00561080|62788546|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
33410094|NCT00561080|62788547|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
33410095|NCT00561080|62788548|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
33410096|NCT00561080|62788546|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
33410097|NCT00561080|62788547|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
33410098|NCT00561080|62788548|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
33410099|NCT00561080|62788546|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
33410100|NCT00561080|62788547|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
33410101|NCT00561080|62788548|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
33410102|NCT00562094|62788558|FG000|Overall Study|Lost to Follow-up|62|||
33410103|NCT03817853|62788566|FG000|Induction Phase|Adverse Event|5|||
33410104|NCT03817853|62788567|FG001|Induction Phase|Adverse Event|0|||
33410105|NCT03817853|62788568|FG002|Induction Phase|Adverse Event|0|||
33410106|NCT03817853|62788566|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
33494030|NCT03478644|62872680|FG001|Phase 2|Withdrawal by Subject|1|||
33494031|NCT03478644|62872679|FG000|Phase 2|Lost to Follow-up|1|||
33410107|NCT03817853|62788567|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
33410108|NCT03817853|62788568|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
33410109|NCT03817853|62788566|FG000|Induction Phase|Physician Decision|2|||
33410110|NCT03817853|62788567|FG001|Induction Phase|Physician Decision|0|||
33410111|NCT03817853|62788568|FG002|Induction Phase|Physician Decision|0|||
33410112|NCT03817853|62788566|FG000|Induction Phase|Progressive Disease|4|||
33410113|NCT03817853|62788567|FG001|Induction Phase|Progressive Disease|0|||
33410114|NCT03817853|62788568|FG002|Induction Phase|Progressive Disease|0|||
33410115|NCT03817853|62788566|FG000|Induction Phase|Withdrawal by Subject|3|||
33410116|NCT03817853|62788567|FG001|Induction Phase|Withdrawal by Subject|0|||
33410117|NCT03817853|62788568|FG002|Induction Phase|Withdrawal by Subject|0|||
33410118|NCT03817853|62788566|FG000|Induction Phase|Continuing on Study|34|||
33410119|NCT03817853|62788567|FG001|Induction Phase|Continuing on Study|0|||
33410120|NCT03817853|62788568|FG002|Induction Phase|Continuing on Study|0|||
33410121|NCT03817853|62788566|FG000|Maintenance/ Follow-up Phase|Adverse Event|0|||
33410122|NCT03817853|62788567|FG001|Maintenance/ Follow-up Phase|Adverse Event|1|||
33410123|NCT03817853|62788568|FG002|Maintenance/ Follow-up Phase|Adverse Event|0|||
33410124|NCT03817853|62788566|FG000|Maintenance/ Follow-up Phase|Death|0|||
33410125|NCT03817853|62788567|FG001|Maintenance/ Follow-up Phase|Death|1|||
33410126|NCT03817853|62788568|FG002|Maintenance/ Follow-up Phase|Death|1|||
33410127|NCT03817853|62788566|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0|||
33410128|NCT03817853|62788567|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1|||
33410129|NCT03817853|62788568|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3|||
33410130|NCT03817853|62788566|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
33410131|NCT03817853|62788567|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1|||
33410132|NCT03817853|62788568|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
33410133|NCT03817853|62788566|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0|||
33410134|NCT03817853|62788567|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52|||
33410135|NCT03817853|62788568|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2|||
33410136|NCT00439270|62788581|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
33410137|NCT00439270|62788582|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
33410138|NCT00439270|62788583|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
33410139|NCT00439270|62788584|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
33410140|NCT00439270|62788585|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
33410141|NCT00439270|62788581|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
33410142|NCT00439270|62788582|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
33410143|NCT00439270|62788583|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
33410144|NCT00439270|62788584|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
33410145|NCT00439270|62788585|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
33410146|NCT00439270|62788581|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
33410147|NCT00439270|62788582|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
33410148|NCT00439270|62788583|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
33410149|NCT00439270|62788584|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
33321571|NCT00993915|62697646|FG000|Overall Study|Withdrawal by Subject|2|||
33321572|NCT00993915|62697646|FG000|Overall Study|Other|1|||
33321573|NCT00993915|62697646|FG000|Overall Study|Ongoing|3|||
33321574|NCT01202591|62697656|FG000|Overall Study|Adverse Event|2|||
33321575|NCT01202591|62697657|FG001|Overall Study|Adverse Event|1|||
33321576|NCT01202591|62697658|FG002|Overall Study|Adverse Event|4|||
33321577|NCT01202591|62697659|FG003|Overall Study|Adverse Event|4|||
33321578|NCT01202591|62697660|FG004|Overall Study|Adverse Event|0|||
33321579|NCT01202591|62697661|FG005|Overall Study|Adverse Event|0|||
33321580|NCT01202591|62697656|FG000|Overall Study|Other reason as per investigator|3|||
33321581|NCT01202591|62697657|FG001|Overall Study|Other reason as per investigator|4|||
33321582|NCT01202591|62697658|FG002|Overall Study|Other reason as per investigator|7|||
33321583|NCT01202591|62697659|FG003|Overall Study|Other reason as per investigator|3|||
33410150|NCT00439270|62788585|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
33410151|NCT00439270|62788581|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
33410152|NCT00439270|62788582|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
33410153|NCT00439270|62788583|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
33410154|NCT00439270|62788584|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
33410155|NCT00439270|62788585|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
33410156|NCT00439270|62788581|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
33410157|NCT00439270|62788582|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
33410158|NCT00439270|62788583|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
33410159|NCT00439270|62788584|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
33410160|NCT00439270|62788585|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
33410161|NCT00439270|62788581|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
33410162|NCT00439270|62788582|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
33410163|NCT00439270|62788583|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
33410164|NCT00439270|62788584|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
33410165|NCT00439270|62788585|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
33410166|NCT00439270|62788581|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
33410167|NCT00439270|62788582|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
33410168|NCT00439270|62788583|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
33410169|NCT00439270|62788584|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
33410170|NCT00439270|62788585|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
33410171|NCT00439270|62788581|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
33410172|NCT00439270|62788582|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
33410173|NCT00439270|62788583|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
33410174|NCT00439270|62788584|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
33410175|NCT00439270|62788585|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
33410176|NCT00439270|62788581|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
33410177|NCT00439270|62788582|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
33410178|NCT00439270|62788583|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
33410179|NCT00439270|62788584|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
33410180|NCT00439270|62788585|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
33410181|NCT00439270|62788581|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
33410182|NCT00439270|62788582|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
33410183|NCT00439270|62788583|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
33410184|NCT00439270|62788584|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
33410185|NCT00439270|62788585|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
33410186|NCT00553280|62788604|FG000|Overall Study|Adverse Event|19|||
33410187|NCT00553280|62788604|FG000|Overall Study|Lack of Efficacy|3|||
33494032|NCT03478644|62872680|FG001|Phase 2|Lost to Follow-up|0|||
33494033|NCT03527550|62872688|FG000|Overall Study|Lost to Follow-up|4|||
33494034|NCT03527550|62872689|FG001|Overall Study|Lost to Follow-up|2|||
33410188|NCT00553280|62788604|FG000|Overall Study|Withdrawal by Subject|3|||
33410189|NCT00553280|62788604|FG000|Overall Study|Physician Decision|1|||
33410190|NCT00440518|62788611|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
33410191|NCT00440518|62788612|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
33410192|NCT00440518|62788613|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
33410193|NCT00440518|62788611|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
33410194|NCT00440518|62788612|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
33410195|NCT00440518|62788613|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
33410196|NCT00440518|62788611|FG000|Randomized /Titration Period|Protocol Deviation|1|||
33410197|NCT00440518|62788612|FG001|Randomized /Titration Period|Protocol Deviation|0|||
33410198|NCT00440518|62788613|FG002|Randomized /Titration Period|Protocol Deviation|0|||
33410199|NCT00440518|62788611|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
33410200|NCT00440518|62788612|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
33410201|NCT00440518|62788613|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
33410202|NCT00440518|62788611|FG000|Randomized /Titration Period|Other|1|||
33410203|NCT00440518|62788612|FG001|Randomized /Titration Period|Other|0|||
33410204|NCT00440518|62788613|FG002|Randomized /Titration Period|Other|0|||
33410205|NCT00440518|62788611|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
33410206|NCT00440518|62788612|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
33410207|NCT00440518|62788613|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
33410208|NCT00440518|62788611|FG000|Randomized /Titration Period|Adverse Event|2|||
33410209|NCT00440518|62788612|FG001|Randomized /Titration Period|Adverse Event|3|||
33410210|NCT00440518|62788613|FG002|Randomized /Titration Period|Adverse Event|0|||
33410211|NCT00440518|62788611|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
33410212|NCT00440518|62788612|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
33410213|NCT00440518|62788613|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
33410214|NCT00440518|62788611|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
33410215|NCT00440518|62788612|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
33410216|NCT00440518|62788613|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
33410217|NCT00440518|62788611|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
33410218|NCT00440518|62788612|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
33410219|NCT00440518|62788613|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
33410220|NCT00440518|62788611|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
33410221|NCT00440518|62788612|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
33410222|NCT00440518|62788613|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
33410223|NCT00440518|62788611|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
33410224|NCT00440518|62788612|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
33410225|NCT00440518|62788613|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
33410226|NCT00440518|62788611|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
33410227|NCT00440518|62788612|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
33410228|NCT00440518|62788613|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
33410229|NCT00438256|62788621|FG000|Overall Study|Ineligible for Resection|2|||
33410230|NCT00438256|62788622|FG001|Overall Study|Ineligible for Resection|1|||
33410231|NCT00438256|62788623|FG002|Overall Study|Ineligible for Resection|1|||
33410232|NCT00438256|62788624|FG003|Overall Study|Ineligible for Resection|7|||
33410233|NCT00438256|62788621|FG000|Overall Study|Excluded final Diagnosis|0|||
33410234|NCT00438256|62788622|FG001|Overall Study|Excluded final Diagnosis|0|||
33410235|NCT00438256|62788623|FG002|Overall Study|Excluded final Diagnosis|0|||
33410236|NCT00438256|62788624|FG003|Overall Study|Excluded final Diagnosis|2|||
33410237|NCT00436852|62788643|FG000|Overall Study|Death|23|||
33410238|NCT00436852|62788644|FG001|Overall Study|Death|34|||
33410239|NCT00436852|62788643|FG000|Overall Study|Lack of Efficacy|9|||
33410240|NCT00436852|62788644|FG001|Overall Study|Lack of Efficacy|7|||
33410241|NCT00436852|62788643|FG000|Overall Study|Withdrawal by Subject|2|||
33321584|NCT01202591|62697660|FG004|Overall Study|Other reason as per investigator|1|||
33321585|NCT01202591|62697661|FG005|Overall Study|Other reason as per investigator|3|||
33321586|NCT01202591|62697656|FG000|Overall Study|Withdrawal by Subject|0|||
33321587|NCT01202591|62697657|FG001|Overall Study|Withdrawal by Subject|0|||
33321588|NCT01202591|62697658|FG002|Overall Study|Withdrawal by Subject|0|||
33321589|NCT01202591|62697659|FG003|Overall Study|Withdrawal by Subject|0|||
33321590|NCT01202591|62697660|FG004|Overall Study|Withdrawal by Subject|2|||
33321591|NCT01202591|62697661|FG005|Overall Study|Withdrawal by Subject|1|||
33321592|NCT01202591|62697656|FG000|Overall Study|Objective Disease Progression|0|||
33321593|NCT01202591|62697657|FG001|Overall Study|Objective Disease Progression|0|||
33410242|NCT00436852|62788644|FG001|Overall Study|Withdrawal by Subject|4|||
33410243|NCT00436852|62788643|FG000|Overall Study|Ineligible|1|||
33410244|NCT00436852|62788644|FG001|Overall Study|Ineligible|0|||
33410245|NCT00120289|62788655|FG000|Overall Study|Death|96|||
33410246|NCT00120289|62788656|FG001|Overall Study|Death|82|||
33410247|NCT00120289|62788655|FG000|Overall Study|Lost to Follow-up|11|||
33321594|NCT01202591|62697658|FG002|Overall Study|Objective Disease Progression|0|||
33410248|NCT00120289|62788656|FG001|Overall Study|Lost to Follow-up|14|||
33410249|NCT00120289|62788655|FG000|Overall Study|Withdrawal by Subject|14|||
33410250|NCT00120289|62788656|FG001|Overall Study|Withdrawal by Subject|13|||
33410251|NCT00550446|62788669|FG000|Up To Week 12|Adverse Event|2|||
33410252|NCT00550446|62788670|FG001|Up To Week 12|Adverse Event|2|||
33410253|NCT00550446|62788671|FG002|Up To Week 12|Adverse Event|0|||
33410254|NCT00550446|62788672|FG003|Up To Week 12|Adverse Event|0|||
33410255|NCT00550446|62788673|FG004|Up To Week 12|Adverse Event|2|||
33410256|NCT00550446|62788674|FG005|Up To Week 12|Adverse Event|2|||
33410257|NCT00550446|62788675|FG006|Up To Week 12|Adverse Event|1|||
33410258|NCT00550446|62788676|FG007|Up To Week 12|Adverse Event|0|||
33410259|NCT00550446|62788677|FG008|Up To Week 12|Adverse Event|0|||
33410260|NCT00550446|62788678|FG009|Up To Week 12|Adverse Event|0|||
33410261|NCT00550446|62788679|FG010|Up To Week 12|Adverse Event|0|||
33410262|NCT00550446|62788669|FG000|Up To Week 12|Lack of Efficacy|3|||
33410263|NCT00550446|62788670|FG001|Up To Week 12|Lack of Efficacy|1|||
33410264|NCT00550446|62788671|FG002|Up To Week 12|Lack of Efficacy|0|||
33410265|NCT00550446|62788672|FG003|Up To Week 12|Lack of Efficacy|1|||
33321595|NCT01202591|62697659|FG003|Overall Study|Objective Disease Progression|0|||
33321596|NCT01202591|62697660|FG004|Overall Study|Objective Disease Progression|2|||
33321597|NCT01202591|62697661|FG005|Overall Study|Objective Disease Progression|0|||
33321598|NCT01202279|62697677|FG000|Overall Study|Adverse Event|8|||
33321599|NCT01202279|62697678|FG001|Overall Study|Adverse Event|6|||
33321600|NCT01202279|62697677|FG000|Overall Study|Withdrawal by Subject|13|||
33321601|NCT01202279|62697678|FG001|Overall Study|Withdrawal by Subject|10|||
33321602|NCT01202279|62697677|FG000|Overall Study|Physician Decision|0|||
33321603|NCT01202279|62697678|FG001|Overall Study|Physician Decision|1|||
33321604|NCT01202279|62697677|FG000|Overall Study|Lost to Follow-up|10|||
33321605|NCT01202279|62697678|FG001|Overall Study|Lost to Follow-up|7|||
33321606|NCT01202279|62697677|FG000|Overall Study|Protocol Violation|1|||
33321607|NCT01202279|62697678|FG001|Overall Study|Protocol Violation|1|||
33321608|NCT01202279|62697677|FG000|Overall Study|study compliance|5|||
33321609|NCT01202279|62697678|FG001|Overall Study|study compliance|2|||
33321610|NCT01201967|62697686|FG000|Overall Study|Lost to Follow-up|6|||
33321611|NCT01201967|62697687|FG001|Overall Study|Lost to Follow-up|5|||
33321612|NCT01201811|62697703|FG000|Overall Study|Adverse Event|6|||
33321613|NCT01201811|62697703|FG000|Overall Study|Disease progression|3|||
33321614|NCT01201811|62697703|FG000|Overall Study|Withdrawal by Subject|3|||
33321615|NCT01201811|62697703|FG000|Overall Study|Death|4|||
33321616|NCT01201811|62697703|FG000|Overall Study|Treatment Failure|2|||
33321617|NCT01201811|62697703|FG000|Overall Study|Physician Decision|1|||
33321618|NCT01201343|62697707|FG000|Overall Study|Adverse Event|6|||
33321619|NCT01201343|62697707|FG000|Overall Study|Withdrawal by Subject|5|||
33321620|NCT01201343|62697707|FG000|Overall Study|Lost to Follow-up|2|||
33321621|NCT01201343|62697707|FG000|Overall Study|Lack of Efficacy|2|||
33321622|NCT01201343|62697707|FG000|Overall Study|Participant wrongly included in trial|1|||
33321623|NCT01201343|62697707|FG000|Overall Study|Randomized, not treated|3|||
33321624|NCT01201265|62697711|FG000|Overall Study|Death|14|||
33321625|NCT01201265|62697711|FG000|Overall Study|Insufficient Therapeutic Response|3|||
33321626|NCT01201265|62697711|FG000|Overall Study|Lost to Follow-up|10|||
33321627|NCT01201265|62697711|FG000|Overall Study|Withdrawal by Subject|7|||
33321628|NCT01201265|62697711|FG000|Overall Study|Disease Progression|4|||
33321629|NCT04246801|62697717|FG000|Overall Study|Adverse Event|1|||
33410266|NCT00550446|62788673|FG004|Up To Week 12|Lack of Efficacy|0|||
33410267|NCT00550446|62788674|FG005|Up To Week 12|Lack of Efficacy|3|||
33410268|NCT00550446|62788675|FG006|Up To Week 12|Lack of Efficacy|3|||
33410269|NCT00550446|62788676|FG007|Up To Week 12|Lack of Efficacy|0|||
33410270|NCT00550446|62788677|FG008|Up To Week 12|Lack of Efficacy|0|||
33410271|NCT00550446|62788678|FG009|Up To Week 12|Lack of Efficacy|0|||
33410272|NCT00550446|62788679|FG010|Up To Week 12|Lack of Efficacy|0|||
33321630|NCT04246801|62697718|FG001|Overall Study|Adverse Event|1|||
33321631|NCT04246801|62697717|FG000|Overall Study|Protocol Violation|1|||
33321632|NCT04246801|62697718|FG001|Overall Study|Protocol Violation|1|||
33321633|NCT04246801|62697717|FG000|Overall Study|Lack of Efficacy|0|||
33321634|NCT04246801|62697718|FG001|Overall Study|Lack of Efficacy|2|||
33410273|NCT00550446|62788669|FG000|Up To Week 12|Lost to Follow-up|0|||
33410274|NCT00550446|62788670|FG001|Up To Week 12|Lost to Follow-up|1|||
33410275|NCT00550446|62788671|FG002|Up To Week 12|Lost to Follow-up|0|||
33410276|NCT00550446|62788672|FG003|Up To Week 12|Lost to Follow-up|0|||
33410277|NCT00550446|62788673|FG004|Up To Week 12|Lost to Follow-up|1|||
33410278|NCT00550446|62788674|FG005|Up To Week 12|Lost to Follow-up|1|||
33410279|NCT00550446|62788675|FG006|Up To Week 12|Lost to Follow-up|2|||
33410280|NCT00550446|62788676|FG007|Up To Week 12|Lost to Follow-up|0|||
33410281|NCT00550446|62788677|FG008|Up To Week 12|Lost to Follow-up|0|||
33410282|NCT00550446|62788678|FG009|Up To Week 12|Lost to Follow-up|0|||
33410283|NCT00550446|62788679|FG010|Up To Week 12|Lost to Follow-up|0|||
33410284|NCT00550446|62788669|FG000|Up To Week 12|Withdrawal by Subject|2|||
33410285|NCT00550446|62788670|FG001|Up To Week 12|Withdrawal by Subject|0|||
33410286|NCT00550446|62788671|FG002|Up To Week 12|Withdrawal by Subject|3|||
33410287|NCT00550446|62788672|FG003|Up To Week 12|Withdrawal by Subject|2|||
33410288|NCT00550446|62788673|FG004|Up To Week 12|Withdrawal by Subject|0|||
33410289|NCT00550446|62788674|FG005|Up To Week 12|Withdrawal by Subject|1|||
33410290|NCT00550446|62788675|FG006|Up To Week 12|Withdrawal by Subject|3|||
33410291|NCT00550446|62788676|FG007|Up To Week 12|Withdrawal by Subject|0|||
33410292|NCT00550446|62788677|FG008|Up To Week 12|Withdrawal by Subject|0|||
33410293|NCT00550446|62788678|FG009|Up To Week 12|Withdrawal by Subject|0|||
33410294|NCT00550446|62788679|FG010|Up To Week 12|Withdrawal by Subject|0|||
33410295|NCT00550446|62788669|FG000|Up To Week 12|Other|3|||
33410296|NCT00550446|62788670|FG001|Up To Week 12|Other|0|||
33410297|NCT00550446|62788671|FG002|Up To Week 12|Other|0|||
33410298|NCT00550446|62788672|FG003|Up To Week 12|Other|0|||
33410299|NCT00550446|62788673|FG004|Up To Week 12|Other|0|||
33410300|NCT00550446|62788674|FG005|Up To Week 12|Other|1|||
33410301|NCT00550446|62788675|FG006|Up To Week 12|Other|4|||
33410302|NCT00550446|62788676|FG007|Up To Week 12|Other|0|||
33410303|NCT00550446|62788677|FG008|Up To Week 12|Other|0|||
33410304|NCT00550446|62788678|FG009|Up To Week 12|Other|0|||
33410305|NCT00550446|62788679|FG010|Up To Week 12|Other|0|||
33410306|NCT00550446|62788669|FG000|Up To Week 12|Randomized not treated|0|||
33410307|NCT00550446|62788670|FG001|Up To Week 12|Randomized not treated|1|||
33410308|NCT00550446|62788671|FG002|Up To Week 12|Randomized not treated|1|||
33410309|NCT00550446|62788672|FG003|Up To Week 12|Randomized not treated|0|||
33321635|NCT04246801|62697717|FG000|Overall Study|Lost to Follow-up|1|||
33321636|NCT04246801|62697718|FG001|Overall Study|Lost to Follow-up|1|||
33321637|NCT04246801|62697717|FG000|Overall Study|Withdrawal by Subject|2|||
33321638|NCT04246801|62697718|FG001|Overall Study|Withdrawal by Subject|1|||
33321639|NCT01200797|62697724|FG000|Overall Study|symptomatic deterioration|2|||
33321640|NCT01200797|62697724|FG000|Overall Study|Adverse Event|4|||
33321641|NCT01200797|62697724|FG000|Overall Study|Disease Progression|13|||
33321642|NCT01200485|62697729|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
33321643|NCT01200485|62697730|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
33321644|NCT01200485|62697731|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
33321645|NCT01200485|62697729|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
33321646|NCT01200485|62697730|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
33321647|NCT01200485|62697731|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
33321648|NCT01200407|62697738|FG000|Overall Study|Lost to Follow-up|56|||
33410310|NCT00550446|62788673|FG004|Up To Week 12|Randomized not treated|0|||
33410311|NCT00550446|62788674|FG005|Up To Week 12|Randomized not treated|0|||
33410312|NCT00550446|62788675|FG006|Up To Week 12|Randomized not treated|0|||
33410313|NCT00550446|62788676|FG007|Up To Week 12|Randomized not treated|0|||
33410314|NCT00550446|62788677|FG008|Up To Week 12|Randomized not treated|0|||
33410315|NCT00550446|62788678|FG009|Up To Week 12|Randomized not treated|0|||
33410316|NCT00550446|62788679|FG010|Up To Week 12|Randomized not treated|0|||
33410317|NCT00550446|62788669|FG000|Post Week 12|Adverse Event|2|||
33410318|NCT00550446|62788670|FG001|Post Week 12|Adverse Event|1|||
33410319|NCT00550446|62788671|FG002|Post Week 12|Adverse Event|1|||
33410320|NCT00550446|62788672|FG003|Post Week 12|Adverse Event|1|||
33410321|NCT00550446|62788673|FG004|Post Week 12|Adverse Event|1|||
33410322|NCT00550446|62788674|FG005|Post Week 12|Adverse Event|1|||
33410323|NCT00550446|62788675|FG006|Post Week 12|Adverse Event|0|||
33410324|NCT00550446|62788676|FG007|Post Week 12|Adverse Event|0|||
33410325|NCT00550446|62788677|FG008|Post Week 12|Adverse Event|0|||
33410326|NCT00550446|62788678|FG009|Post Week 12|Adverse Event|4|||
33410327|NCT00550446|62788679|FG010|Post Week 12|Adverse Event|0|||
33410328|NCT00550446|62788669|FG000|Post Week 12|Lack of Efficacy|0|||
33410329|NCT00550446|62788670|FG001|Post Week 12|Lack of Efficacy|0|||
33410330|NCT00550446|62788671|FG002|Post Week 12|Lack of Efficacy|1|||
33410331|NCT00550446|62788672|FG003|Post Week 12|Lack of Efficacy|0|||
33410332|NCT00550446|62788673|FG004|Post Week 12|Lack of Efficacy|0|||
33410333|NCT00550446|62788674|FG005|Post Week 12|Lack of Efficacy|0|||
33410334|NCT00550446|62788675|FG006|Post Week 12|Lack of Efficacy|0|||
33410335|NCT00550446|62788676|FG007|Post Week 12|Lack of Efficacy|1|||
33410336|NCT00550446|62788677|FG008|Post Week 12|Lack of Efficacy|1|||
33410337|NCT00550446|62788678|FG009|Post Week 12|Lack of Efficacy|2|||
33410338|NCT00550446|62788679|FG010|Post Week 12|Lack of Efficacy|1|||
33410339|NCT00550446|62788669|FG000|Post Week 12|Lost to Follow-up|0|||
33410340|NCT00550446|62788670|FG001|Post Week 12|Lost to Follow-up|0|||
33410341|NCT00550446|62788671|FG002|Post Week 12|Lost to Follow-up|1|||
33410342|NCT00550446|62788672|FG003|Post Week 12|Lost to Follow-up|1|||
33410343|NCT00550446|62788673|FG004|Post Week 12|Lost to Follow-up|0|||
33410344|NCT00550446|62788674|FG005|Post Week 12|Lost to Follow-up|0|||
33410345|NCT00550446|62788675|FG006|Post Week 12|Lost to Follow-up|1|||
33410346|NCT00550446|62788676|FG007|Post Week 12|Lost to Follow-up|0|||
33410347|NCT00550446|62788677|FG008|Post Week 12|Lost to Follow-up|0|||
33410348|NCT00550446|62788678|FG009|Post Week 12|Lost to Follow-up|0|||
33410349|NCT00550446|62788679|FG010|Post Week 12|Lost to Follow-up|0|||
33410350|NCT00550446|62788669|FG000|Post Week 12|Withdrawal by Subject|0|||
33410351|NCT00550446|62788670|FG001|Post Week 12|Withdrawal by Subject|0|||
33410352|NCT00550446|62788671|FG002|Post Week 12|Withdrawal by Subject|0|||
33410353|NCT00550446|62788672|FG003|Post Week 12|Withdrawal by Subject|0|||
33410354|NCT00550446|62788673|FG004|Post Week 12|Withdrawal by Subject|1|||
33410355|NCT00550446|62788674|FG005|Post Week 12|Withdrawal by Subject|0|||
33410356|NCT00550446|62788675|FG006|Post Week 12|Withdrawal by Subject|0|||
33410357|NCT00550446|62788676|FG007|Post Week 12|Withdrawal by Subject|0|||
33410358|NCT00550446|62788677|FG008|Post Week 12|Withdrawal by Subject|0|||
33410359|NCT00550446|62788678|FG009|Post Week 12|Withdrawal by Subject|0|||
33410360|NCT00550446|62788679|FG010|Post Week 12|Withdrawal by Subject|0|||
33410361|NCT00550446|62788669|FG000|Post Week 12|Other|1|||
33410362|NCT00550446|62788670|FG001|Post Week 12|Other|1|||
33410363|NCT00550446|62788671|FG002|Post Week 12|Other|0|||
33410364|NCT00550446|62788672|FG003|Post Week 12|Other|1|||
33410365|NCT00550446|62788673|FG004|Post Week 12|Other|0|||
33410366|NCT00550446|62788674|FG005|Post Week 12|Other|0|||
33410367|NCT00550446|62788675|FG006|Post Week 12|Other|1|||
33410368|NCT00550446|62788676|FG007|Post Week 12|Other|0|||
33494035|NCT03527550|62872688|FG000|Overall Study|Withdrawal by Subject|4|||
33410369|NCT00550446|62788677|FG008|Post Week 12|Other|1|||
33410370|NCT00550446|62788678|FG009|Post Week 12|Other|1|||
33410371|NCT00550446|62788679|FG010|Post Week 12|Other|0|||
33410372|NCT00436618|62788720|FG000|Overall Study|Withdrawal by Subject|5|||
33410373|NCT00436618|62788721|FG001|Overall Study|Withdrawal by Subject|8|||
33410374|NCT00436618|62788722|FG002|Overall Study|Withdrawal by Subject|11|||
33410375|NCT00436618|62788720|FG000|Overall Study|Adverse Event|8|||
33410376|NCT00436618|62788721|FG001|Overall Study|Adverse Event|8|||
33410377|NCT00436618|62788722|FG002|Overall Study|Adverse Event|9|||
33410378|NCT00436618|62788720|FG000|Overall Study|Alternate Treatment|3|||
33410379|NCT00436618|62788721|FG001|Overall Study|Alternate Treatment|4|||
33410380|NCT00436618|62788722|FG002|Overall Study|Alternate Treatment|12|||
33410381|NCT00436618|62788720|FG000|Overall Study|Other Medical Problems|3|||
33410382|NCT00436618|62788721|FG001|Overall Study|Other Medical Problems|1|||
33410383|NCT00436618|62788722|FG002|Overall Study|Other Medical Problems|7|||
33410384|NCT00436618|62788720|FG000|Overall Study|Death|4|||
33410385|NCT00436618|62788721|FG001|Overall Study|Death|2|||
33410386|NCT00436618|62788722|FG002|Overall Study|Death|3|||
33410387|NCT00436618|62788720|FG000|Overall Study|New Primary or Other Reasons|6|||
33410388|NCT00436618|62788721|FG001|Overall Study|New Primary or Other Reasons|2|||
33410389|NCT00436618|62788722|FG002|Overall Study|New Primary or Other Reasons|12|||
33410390|NCT00436618|62788720|FG000|Overall Study|Still on treatment|1|||
33410391|NCT00436618|62788721|FG001|Overall Study|Still on treatment|2|||
33410392|NCT00436618|62788722|FG002|Overall Study|Still on treatment|7|||
33410393|NCT00548808|62788759|FG000|Overall Study|Lost to Follow-up|9|||
33410394|NCT00548808|62788760|FG001|Overall Study|Lost to Follow-up|3|||
33410395|NCT00548808|62788759|FG000|Overall Study|Protocol Violation|8|||
33410396|NCT00548808|62788760|FG001|Overall Study|Protocol Violation|8|||
33410397|NCT00548808|62788759|FG000|Overall Study|Withdrawal by Subject|8|||
33410398|NCT00548808|62788760|FG001|Overall Study|Withdrawal by Subject|4|||
33410399|NCT00548808|62788759|FG000|Overall Study|Physician Decision|6|||
33410400|NCT00548808|62788760|FG001|Overall Study|Physician Decision|3|||
33410401|NCT00548808|62788759|FG000|Overall Study|Adverse Event|4|||
33410402|NCT00548808|62788760|FG001|Overall Study|Adverse Event|5|||
33410403|NCT00548808|62788759|FG000|Overall Study|Death|2|||
33410404|NCT00548808|62788760|FG001|Overall Study|Death|0|||
33410405|NCT00548808|62788759|FG000|Overall Study|Entry Criteria Not Met|2|||
33410406|NCT00548808|62788760|FG001|Overall Study|Entry Criteria Not Met|2|||
33410407|NCT00548808|62788759|FG000|Overall Study|Lack of Efficacy|2|||
33410408|NCT00548808|62788760|FG001|Overall Study|Lack of Efficacy|0|||
33410409|NCT00548808|62788759|FG000|Overall Study|Sponsor Decision|1|||
33410410|NCT00548808|62788760|FG001|Overall Study|Sponsor Decision|1|||
33410411|NCT00110617|62788768|FG000|Overall Study|Adverse Event|2|||
33410412|NCT00110617|62788769|FG001|Overall Study|Adverse Event|4|||
33410413|NCT00110617|62788768|FG000|Overall Study|Abnormal Laboratory Value|4|||
33410414|NCT00110617|62788769|FG001|Overall Study|Abnormal Laboratory Value|2|||
33410415|NCT00110617|62788768|FG000|Overall Study|Lack of Efficacy|1|||
33410416|NCT00110617|62788769|FG001|Overall Study|Lack of Efficacy|0|||
33410417|NCT00110617|62788768|FG000|Overall Study|Patient no longer requires study drug|1|||
33410418|NCT00110617|62788769|FG001|Overall Study|Patient no longer requires study drug|0|||
33410419|NCT00110617|62788768|FG000|Overall Study|Protocol Violation|5|||
33410420|NCT00110617|62788769|FG001|Overall Study|Protocol Violation|0|||
33410421|NCT00110617|62788768|FG000|Overall Study|Withdrawal by Subject|10|||
33410422|NCT00110617|62788769|FG001|Overall Study|Withdrawal by Subject|4|||
33410423|NCT00110617|62788768|FG000|Overall Study|Lost to Follow-up|9|||
33410424|NCT00110617|62788769|FG001|Overall Study|Lost to Follow-up|1|||
33410425|NCT00110617|62788768|FG000|Overall Study|Administrative problems|6|||
33410426|NCT00110617|62788769|FG001|Overall Study|Administrative problems|5|||
33410427|NCT00110617|62788768|FG000|Overall Study|Death|1|||
33410428|NCT00110617|62788769|FG001|Overall Study|Death|1|||
33410429|NCT00110617|62788768|FG000|Overall Study|Did not receive study drug|0|||
33410430|NCT00110617|62788769|FG001|Overall Study|Did not receive study drug|12|||
33410431|NCT03956862|62788779|FG000|Overall Study|Lost to Follow-up|1|||
33410432|NCT03956862|62788780|FG001|Overall Study|Lost to Follow-up|1|||
33410433|NCT03956862|62788779|FG000|Overall Study|Withdrawal by Subject|1|||
33410434|NCT03956862|62788780|FG001|Overall Study|Withdrawal by Subject|1|||
33410435|NCT00550238|62788786|FG000|Overall Study|Adverse Event|88|||
33410436|NCT00550238|62788786|FG000|Overall Study|Death|34|||
33494036|NCT03527550|62872689|FG001|Overall Study|Withdrawal by Subject|1|||
33410437|NCT00550238|62788786|FG000|Overall Study|Disease progression|46|||
33410438|NCT00550238|62788786|FG000|Overall Study|Withdrawal by Subject|167|||
33410439|NCT00550238|62788786|FG000|Overall Study|Physician Decision|31|||
33410440|NCT00550238|62788786|FG000|Overall Study|Patient noncompliance|25|||
33410441|NCT00550238|62788786|FG000|Overall Study|Lost to Follow-up|13|||
33410442|NCT00550238|62788786|FG000|Overall Study|Sponsor decision|55|||
33410443|NCT03956550|62788793|FG000|Overall Study|Sponsor decision|65|||
33410444|NCT03956550|62788794|FG001|Overall Study|Sponsor decision|66|||
33410445|NCT03956550|62788795|FG002|Overall Study|Sponsor decision|64|||
33410446|NCT03956550|62788793|FG000|Overall Study|Adverse Event|0|||
33410447|NCT03956550|62788794|FG001|Overall Study|Adverse Event|1|||
33410448|NCT03956550|62788795|FG002|Overall Study|Adverse Event|0|||
33410449|NCT03956550|62788793|FG000|Overall Study|Withdrawal by Subject|5|||
33410450|NCT03956550|62788794|FG001|Overall Study|Withdrawal by Subject|5|||
33410451|NCT03956550|62788795|FG002|Overall Study|Withdrawal by Subject|6|||
33410452|NCT00110305|62788807|FG000|Overall Study|Adverse Event|46|||
33410453|NCT00110305|62788808|FG001|Overall Study|Adverse Event|13|||
33410454|NCT00110305|62788807|FG000|Overall Study|Sponsors Decision|1|||
33410455|NCT00110305|62788808|FG001|Overall Study|Sponsors Decision|0|||
33410456|NCT00110305|62788807|FG000|Overall Study|Subject Non-Compliant|9|||
33410457|NCT00110305|62788808|FG001|Overall Study|Subject Non-Compliant|2|||
33410458|NCT00110305|62788807|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
33410459|NCT00110305|62788808|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
33410460|NCT00110305|62788807|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
33410461|NCT00110305|62788808|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
33410462|NCT00110305|62788807|FG000|Overall Study|Protocol Violation|0|||
33410463|NCT00110305|62788808|FG001|Overall Study|Protocol Violation|1|||
33410464|NCT00110305|62788807|FG000|Overall Study|Withdrawal by Subject|7|||
33410465|NCT00110305|62788808|FG001|Overall Study|Withdrawal by Subject|7|||
33410466|NCT00110305|62788807|FG000|Overall Study|Lost to Follow-up|20|||
33410467|NCT00110305|62788808|FG001|Overall Study|Lost to Follow-up|3|||
33410468|NCT00110305|62788807|FG000|Overall Study|Other|8|||
33410469|NCT00110305|62788808|FG001|Overall Study|Other|2|||
33410470|NCT00428116|62788827|FG000|Overall Study|Death|1|||
33410471|NCT00428116|62788828|FG001|Overall Study|Death|0|||
33410472|NCT00428116|62788827|FG000|Overall Study|Withdrawal by Subject|1|||
33410473|NCT00428116|62788828|FG001|Overall Study|Withdrawal by Subject|0|||
33410474|NCT00428116|62788827|FG000|Overall Study|Lost to Follow-up|1|||
33410475|NCT00428116|62788828|FG001|Overall Study|Lost to Follow-up|0|||
33410476|NCT00560066|62788837|FG000|Overall Study|Death|2|||
33410477|NCT00560066|62788838|FG001|Overall Study|Death|1|||
33410478|NCT00560066|62788837|FG000|Overall Study|Withdrawal by Subject|0|||
33410479|NCT00560066|62788838|FG001|Overall Study|Withdrawal by Subject|3|||
33410480|NCT00560066|62788837|FG000|Overall Study|Lost to Follow-up|4|||
33410481|NCT00560066|62788838|FG001|Overall Study|Lost to Follow-up|10|||
33410482|NCT00560066|62788837|FG000|Overall Study|Protocol Violation|0|||
33321649|NCT01200407|62697738|FG000|Overall Study|Adverse Event|3|||
33321650|NCT01200407|62697738|FG000|Overall Study|Withdrawal by Subject|4|||
33321651|NCT01200407|62697738|FG000|Overall Study|Other|19|||
33321652|NCT01200329|62697742|FG000|Overall Study|Lack of financial coverage|2|||
33321653|NCT01200329|62697742|FG000|Overall Study|Progressive disease|1|||
33321654|NCT01199939|62697746|FG000|Overall Study|Adverse Event|4|||
33321655|NCT01199939|62697746|FG000|Overall Study|Protocol Violation|3|||
33321656|NCT01199939|62697746|FG000|Overall Study|Lost to Follow-up|2|||
33321657|NCT01199939|62697746|FG000|Overall Study|Reached a virologic endpoint|4|||
33321658|NCT01199861|62697752|FG000|Overall Study|Administrative problems|1|||
33321659|NCT01199861|62697753|FG001|Overall Study|Administrative problems|0|||
33321660|NCT01199861|62697752|FG000|Overall Study|Adverse Event|1|||
33321661|NCT01199861|62697753|FG001|Overall Study|Adverse Event|0|||
33321662|NCT01199705|62697773|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
33321663|NCT01199471|62697788|FG000|Overall Study|Protocol Violation|4|||
33321664|NCT01199471|62697788|FG000|Overall Study|Withdrawal by Subject|1|||
33321665|NCT01199471|62697788|FG000|Overall Study|Physician Decision|1|||
33321666|NCT01198145|62697795|FG000|Overall Study|Withdrawal by Subject|1|||
33321667|NCT01198145|62697796|FG001|Overall Study|Withdrawal by Subject|1|||
33321668|NCT01197911|62697806|FG000|Overall Study|Adverse Event|0|||
33321669|NCT01197911|62697807|FG001|Overall Study|Adverse Event|0|||
33321670|NCT01197911|62697808|FG002|Overall Study|Adverse Event|1|||
33410483|NCT00560066|62788838|FG001|Overall Study|Protocol Violation|1|||
33410484|NCT00560066|62788837|FG000|Overall Study|Administrative reason|0|||
33410485|NCT00560066|62788838|FG001|Overall Study|Administrative reason|5|||
33410486|NCT00560066|62788837|FG000|Overall Study|Missing primary reason|0|||
33410487|NCT00560066|62788838|FG001|Overall Study|Missing primary reason|2|||
33410488|NCT00549900|62788849|FG000|Overall Study|Adverse Event|1|||
33410489|NCT00435994|62788856|FG000|Overall Study|Lost to Follow-up|7|||
33410490|NCT00435994|62788857|FG001|Overall Study|Lost to Follow-up|0|||
33321671|NCT01197755|62697820|FG000|Overall Study|Adverse Event|8|||
33410491|NCT00435994|62788858|FG002|Overall Study|Lost to Follow-up|0|||
33410492|NCT00435370|62788869|FG000|Overall Study|Adverse Event|8|||
33410493|NCT00435370|62788870|FG001|Overall Study|Adverse Event|8|||
33410494|NCT00435370|62788869|FG000|Overall Study|Withdrawal by Subject|10|||
33410495|NCT00435370|62788870|FG001|Overall Study|Withdrawal by Subject|10|||
33410496|NCT00435370|62788869|FG000|Overall Study|Antipsychotic medication changed|4|||
33410497|NCT00435370|62788870|FG001|Overall Study|Antipsychotic medication changed|2|||
33410498|NCT00096031|62788876|FG000|Overall Study|Adverse Event|3|||
33410499|NCT00096031|62788876|FG000|Overall Study|Lack of Efficacy|42|||
33410500|NCT00096031|62788876|FG000|Overall Study|Death|4|||
33410501|NCT00096031|62788876|FG000|Overall Study|Withdrawal by Subject|1|||
33410502|NCT00096031|62788876|FG000|Overall Study|Ineligible|8|||
33410503|NCT00096031|62788876|FG000|Overall Study|Not protocol specified|5|||
33410504|NCT00118417|62788880|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
33410505|NCT00118417|62788881|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
33410506|NCT00118417|62788880|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
33410507|NCT00118417|62788881|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
33410508|NCT00118417|62788880|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
33410509|NCT00118417|62788881|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
33410510|NCT00118417|62788880|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
33410511|NCT00118417|62788881|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
33410512|NCT00118417|62788880|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
33410513|NCT00118417|62788881|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
33410514|NCT00549848|62788894|FG000|Overall Study|Death|1|||
33410515|NCT00549848|62788895|FG001|Overall Study|Death|4|||
33410516|NCT00549848|62788896|FG002|Overall Study|Death|13|||
33410517|NCT00549848|62788894|FG000|Overall Study|Physician Decision|0|||
33410518|NCT00549848|62788895|FG001|Overall Study|Physician Decision|0|||
33410519|NCT00549848|62788896|FG002|Overall Study|Physician Decision|4|||
33410520|NCT00549848|62788894|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
33410521|NCT00549848|62788895|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
33410522|NCT00549848|62788896|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
33410523|NCT00549848|62788894|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
33410524|NCT00549848|62788895|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
33410525|NCT00549848|62788896|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
33599253|NCT02460224|62998260|FG006|Overall Study|Death|1|||
33599254|NCT02460224|62998261|FG007|Overall Study|Death|0|||
33599255|NCT02460224|62998262|FG008|Overall Study|Death|0|||
33599256|NCT02460224|62998263|FG009|Overall Study|Death|1|||
33599257|NCT02460224|62998264|FG010|Overall Study|Death|0|||
33599258|NCT02460224|62998265|FG011|Overall Study|Death|0|||
33599259|NCT02460224|62998266|FG012|Overall Study|Death|0|||
33599260|NCT02460224|62998267|FG013|Overall Study|Death|1|||
33599261|NCT02460224|62998268|FG014|Overall Study|Death|0|||
33599262|NCT02460224|62998269|FG015|Overall Study|Death|0|||
33599263|NCT02460224|62998270|FG016|Overall Study|Death|2|||
33599264|NCT02460224|62998271|FG017|Overall Study|Death|1|||
33599265|NCT02460224|62998272|FG018|Overall Study|Death|0|||
33599266|NCT02460224|62998273|FG019|Overall Study|Death|2|||
33599267|NCT02460224|62998274|FG020|Overall Study|Death|0|||
33599268|NCT02460224|62998275|FG021|Overall Study|Death|0|||
33599269|NCT02460224|62998276|FG022|Overall Study|Death|0|||
33599270|NCT02460224|62998277|FG023|Overall Study|Death|0|||
33599271|NCT02460224|62998278|FG024|Overall Study|Death|1|||
33321672|NCT01197755|62697821|FG001|Overall Study|Adverse Event|10|||
33321673|NCT01197755|62697822|FG002|Overall Study|Adverse Event|10|||
33321674|NCT01197755|62697820|FG000|Overall Study|Study-specific discontinuation criteria|2|||
33321675|NCT01197755|62697821|FG001|Overall Study|Study-specific discontinuation criteria|1|||
33321676|NCT01197755|62697822|FG002|Overall Study|Study-specific discontinuation criteria|0|||
33321677|NCT01197755|62697820|FG000|Overall Study|Entered the long-term extension study|18|||
33321678|NCT01197755|62697821|FG001|Overall Study|Entered the long-term extension study|21|||
33321679|NCT01197755|62697822|FG002|Overall Study|Entered the long-term extension study|35|||
33321680|NCT01197755|62697820|FG000|Overall Study|Lack of therapeutic response|0|||
33321681|NCT01197755|62697821|FG001|Overall Study|Lack of therapeutic response|7|||
33321682|NCT01197755|62697822|FG002|Overall Study|Lack of therapeutic response|4|||
33410526|NCT00549848|62788894|FG000|Overall Study|Participant/Family Withdraw|2|||
33410527|NCT00549848|62788895|FG001|Overall Study|Participant/Family Withdraw|3|||
33410528|NCT00549848|62788896|FG002|Overall Study|Participant/Family Withdraw|5|||
33410529|NCT00549848|62788894|FG000|Overall Study|Second Malignancy|1|||
33410530|NCT00549848|62788895|FG001|Overall Study|Second Malignancy|0|||
33410531|NCT00549848|62788896|FG002|Overall Study|Second Malignancy|0|||
33599272|NCT02460224|62998279|FG025|Overall Study|Death|1|||
33599273|NCT02460224|62998280|FG026|Overall Study|Death|5|||
33599274|NCT02460224|62998281|FG027|Overall Study|Death|0|||
33599275|NCT02460224|62998282|FG028|Overall Study|Death|1|||
33599276|NCT02460224|62998254|FG000|Overall Study|Lost to Follow-up|0|||
33599277|NCT02460224|62998255|FG001|Overall Study|Lost to Follow-up|0|||
33599278|NCT02460224|62998256|FG002|Overall Study|Lost to Follow-up|0|||
33599279|NCT02460224|62998257|FG003|Overall Study|Lost to Follow-up|0|||
33599280|NCT02460224|62998258|FG004|Overall Study|Lost to Follow-up|0|||
33599281|NCT02460224|62998259|FG005|Overall Study|Lost to Follow-up|0|||
33599282|NCT02460224|62998260|FG006|Overall Study|Lost to Follow-up|0|||
33599283|NCT02460224|62998261|FG007|Overall Study|Lost to Follow-up|0|||
33599284|NCT02460224|62998262|FG008|Overall Study|Lost to Follow-up|0|||
33599285|NCT02460224|62998263|FG009|Overall Study|Lost to Follow-up|0|||
33599286|NCT02460224|62998264|FG010|Overall Study|Lost to Follow-up|0|||
33599287|NCT02460224|62998265|FG011|Overall Study|Lost to Follow-up|0|||
33599288|NCT02460224|62998266|FG012|Overall Study|Lost to Follow-up|0|||
33599289|NCT02460224|62998267|FG013|Overall Study|Lost to Follow-up|0|||
33599290|NCT02460224|62998268|FG014|Overall Study|Lost to Follow-up|0|||
33599291|NCT02460224|62998269|FG015|Overall Study|Lost to Follow-up|0|||
33599292|NCT02460224|62998270|FG016|Overall Study|Lost to Follow-up|0|||
33599293|NCT02460224|62998271|FG017|Overall Study|Lost to Follow-up|0|||
33599294|NCT02460224|62998272|FG018|Overall Study|Lost to Follow-up|0|||
33599295|NCT02460224|62998273|FG019|Overall Study|Lost to Follow-up|0|||
33599296|NCT02460224|62998274|FG020|Overall Study|Lost to Follow-up|0|||
33599297|NCT02460224|62998275|FG021|Overall Study|Lost to Follow-up|0|||
33599298|NCT02460224|62998276|FG022|Overall Study|Lost to Follow-up|1|||
33599299|NCT02460224|62998277|FG023|Overall Study|Lost to Follow-up|0|||
33599300|NCT02460224|62998278|FG024|Overall Study|Lost to Follow-up|0|||
33599301|NCT02460224|62998279|FG025|Overall Study|Lost to Follow-up|0|||
33410532|NCT00549848|62788894|FG000|Overall Study|Transplant|3|||
33410533|NCT00549848|62788895|FG001|Overall Study|Transplant|3|||
33410534|NCT00549848|62788896|FG002|Overall Study|Transplant|18|||
33410535|NCT00549848|62788894|FG000|Overall Study|Unacceptable Toxicity|1|||
33410536|NCT00549848|62788895|FG001|Overall Study|Unacceptable Toxicity|6|||
33410537|NCT00549848|62788896|FG002|Overall Study|Unacceptable Toxicity|6|||
33599302|NCT02460224|62998280|FG026|Overall Study|Lost to Follow-up|0|||
33599303|NCT02460224|62998281|FG027|Overall Study|Lost to Follow-up|0|||
33599304|NCT02460224|62998282|FG028|Overall Study|Lost to Follow-up|0|||
33599305|NCT02460224|62998254|FG000|Overall Study|Physician Decision|0|||
33599306|NCT02460224|62998255|FG001|Overall Study|Physician Decision|1|||
33599307|NCT02460224|62998256|FG002|Overall Study|Physician Decision|0|||
33599308|NCT02460224|62998257|FG003|Overall Study|Physician Decision|0|||
33599309|NCT02460224|62998258|FG004|Overall Study|Physician Decision|1|||
33599310|NCT02460224|62998259|FG005|Overall Study|Physician Decision|0|||
33599311|NCT02460224|62998260|FG006|Overall Study|Physician Decision|0|||
33599312|NCT02460224|62998261|FG007|Overall Study|Physician Decision|1|||
33321683|NCT01197755|62697820|FG000|Overall Study|Severe non-compliance to the protocol|2|||
33321684|NCT01197755|62697821|FG001|Overall Study|Severe non-compliance to the protocol|1|||
33321685|NCT01197755|62697822|FG002|Overall Study|Severe non-compliance to the protocol|2|||
33321686|NCT01197755|62697820|FG000|Overall Study|Withdrawal by Subject|1|||
33321687|NCT01197755|62697821|FG001|Overall Study|Withdrawal by Subject|0|||
33321688|NCT01197755|62697822|FG002|Overall Study|Withdrawal by Subject|0|||
33321689|NCT01197755|62697820|FG000|Overall Study|Lost to Follow-up|0|||
33321690|NCT01197755|62697821|FG001|Overall Study|Lost to Follow-up|0|||
33321691|NCT01197755|62697822|FG002|Overall Study|Lost to Follow-up|1|||
33321692|NCT01197755|62697820|FG000|Overall Study|eg, change in circumstances|7|||
33321693|NCT01197755|62697821|FG001|Overall Study|eg, change in circumstances|3|||
33410538|NCT00549770|62788920|FG000|Overall Study|Protocol deviation|1|||
33410539|NCT00549770|62788921|FG001|Overall Study|Protocol deviation|1|||
33410540|NCT00549770|62788922|FG002|Overall Study|Protocol deviation|1|||
33410541|NCT00549770|62788923|FG003|Overall Study|Protocol deviation|2|||
33599313|NCT02460224|62998262|FG008|Overall Study|Physician Decision|0|||
33599314|NCT02460224|62998263|FG009|Overall Study|Physician Decision|0|||
33599315|NCT02460224|62998264|FG010|Overall Study|Physician Decision|0|||
33599316|NCT02460224|62998265|FG011|Overall Study|Physician Decision|1|||
33321694|NCT01197755|62697822|FG002|Overall Study|eg, change in circumstances|2|||
33410542|NCT00549770|62788924|FG004|Overall Study|Protocol deviation|2|||
33410543|NCT00549770|62788925|FG005|Overall Study|Protocol deviation|2|||
33599317|NCT02460224|62998266|FG012|Overall Study|Physician Decision|0|||
33599318|NCT02460224|62998267|FG013|Overall Study|Physician Decision|1|||
33599319|NCT02460224|62998268|FG014|Overall Study|Physician Decision|0|||
33599320|NCT02460224|62998269|FG015|Overall Study|Physician Decision|0|||
33410544|NCT00549770|62788926|FG006|Overall Study|Protocol deviation|1|||
33410545|NCT00549770|62788927|FG007|Overall Study|Protocol deviation|2|||
33410546|NCT00549770|62788920|FG000|Overall Study|Administrative problems|0|||
33410547|NCT00549770|62788921|FG001|Overall Study|Administrative problems|1|||
33410548|NCT00549770|62788922|FG002|Overall Study|Administrative problems|0|||
33410549|NCT00549770|62788923|FG003|Overall Study|Administrative problems|0|||
33410550|NCT00549770|62788924|FG004|Overall Study|Administrative problems|0|||
33410551|NCT00549770|62788925|FG005|Overall Study|Administrative problems|0|||
33410552|NCT00549770|62788926|FG006|Overall Study|Administrative problems|0|||
33410553|NCT00549770|62788927|FG007|Overall Study|Administrative problems|1|||
33410554|NCT00549770|62788920|FG000|Overall Study|Lost to Follow-up|0|||
33410555|NCT00549770|62788921|FG001|Overall Study|Lost to Follow-up|0|||
33410556|NCT00549770|62788922|FG002|Overall Study|Lost to Follow-up|2|||
33410557|NCT00549770|62788923|FG003|Overall Study|Lost to Follow-up|2|||
33410558|NCT00549770|62788924|FG004|Overall Study|Lost to Follow-up|3|||
33410559|NCT00549770|62788925|FG005|Overall Study|Lost to Follow-up|2|||
33410560|NCT00549770|62788926|FG006|Overall Study|Lost to Follow-up|0|||
33410561|NCT00549770|62788927|FG007|Overall Study|Lost to Follow-up|0|||
33410562|NCT00549770|62788920|FG000|Overall Study|Withdrawal by Subject|4|||
33410563|NCT00549770|62788921|FG001|Overall Study|Withdrawal by Subject|6|||
33410564|NCT00549770|62788922|FG002|Overall Study|Withdrawal by Subject|4|||
33410565|NCT00549770|62788923|FG003|Overall Study|Withdrawal by Subject|5|||
33410566|NCT00549770|62788924|FG004|Overall Study|Withdrawal by Subject|6|||
33410567|NCT00549770|62788925|FG005|Overall Study|Withdrawal by Subject|6|||
33410568|NCT00549770|62788926|FG006|Overall Study|Withdrawal by Subject|4|||
33410569|NCT00549770|62788927|FG007|Overall Study|Withdrawal by Subject|9|||
33410570|NCT00549770|62788920|FG000|Overall Study|Lack of Efficacy|1|||
33410571|NCT00549770|62788921|FG001|Overall Study|Lack of Efficacy|0|||
33410572|NCT00549770|62788922|FG002|Overall Study|Lack of Efficacy|2|||
33410573|NCT00549770|62788923|FG003|Overall Study|Lack of Efficacy|3|||
33410574|NCT00549770|62788924|FG004|Overall Study|Lack of Efficacy|5|||
33410575|NCT00549770|62788925|FG005|Overall Study|Lack of Efficacy|1|||
33410576|NCT00549770|62788926|FG006|Overall Study|Lack of Efficacy|3|||
33410577|NCT00549770|62788927|FG007|Overall Study|Lack of Efficacy|8|||
33410578|NCT00549770|62788920|FG000|Overall Study|Abnormal test procedure results|0|||
33410579|NCT00549770|62788921|FG001|Overall Study|Abnormal test procedure results|0|||
33410580|NCT00549770|62788922|FG002|Overall Study|Abnormal test procedure results|0|||
33410581|NCT00549770|62788923|FG003|Overall Study|Abnormal test procedure results|2|||
33410582|NCT00549770|62788924|FG004|Overall Study|Abnormal test procedure results|0|||
33410583|NCT00549770|62788925|FG005|Overall Study|Abnormal test procedure results|1|||
33410584|NCT00549770|62788926|FG006|Overall Study|Abnormal test procedure results|1|||
33410585|NCT00549770|62788927|FG007|Overall Study|Abnormal test procedure results|1|||
33410586|NCT00549770|62788920|FG000|Overall Study|Abnormal laboratory values|0|||
33410587|NCT00549770|62788921|FG001|Overall Study|Abnormal laboratory values|0|||
33410588|NCT00549770|62788922|FG002|Overall Study|Abnormal laboratory values|0|||
33410589|NCT00549770|62788923|FG003|Overall Study|Abnormal laboratory values|0|||
33410590|NCT00549770|62788924|FG004|Overall Study|Abnormal laboratory values|0|||
33410591|NCT00549770|62788925|FG005|Overall Study|Abnormal laboratory values|1|||
33410592|NCT00549770|62788926|FG006|Overall Study|Abnormal laboratory values|0|||
33410593|NCT00549770|62788927|FG007|Overall Study|Abnormal laboratory values|0|||
33410594|NCT00549770|62788920|FG000|Overall Study|Adverse Event|1|||
33410595|NCT00549770|62788921|FG001|Overall Study|Adverse Event|3|||
33410596|NCT00549770|62788922|FG002|Overall Study|Adverse Event|1|||
33410597|NCT00549770|62788923|FG003|Overall Study|Adverse Event|2|||
33410598|NCT00549770|62788924|FG004|Overall Study|Adverse Event|1|||
33410599|NCT00549770|62788925|FG005|Overall Study|Adverse Event|0|||
33410600|NCT00549770|62788926|FG006|Overall Study|Adverse Event|5|||
33410601|NCT00549770|62788927|FG007|Overall Study|Adverse Event|4|||
33410602|NCT00548184|62788945|FG000|Overall Study|Adverse Event|3|||
33410603|NCT00548184|62788945|FG000|Overall Study|took other drug|1|||
33410604|NCT00548184|62788945|FG000|Overall Study|Found Her2 negative|1|||
33410605|NCT00454636|62788953|FG000|Overall Study|Adverse Event|10|||
33410606|NCT00454636|62788954|FG001|Overall Study|Adverse Event|6|||
33410607|NCT00454636|62788955|FG002|Overall Study|Adverse Event|9|||
33410608|NCT00454636|62788956|FG003|Overall Study|Adverse Event|15|||
33410609|NCT00454636|62788953|FG000|Overall Study|Disease Progression|11|||
33410610|NCT00454636|62788954|FG001|Overall Study|Disease Progression|12|||
33410611|NCT00454636|62788955|FG002|Overall Study|Disease Progression|4|||
33410612|NCT00454636|62788956|FG003|Overall Study|Disease Progression|11|||
33410613|NCT00454636|62788953|FG000|Overall Study|Protocol Violation|3|||
33410614|NCT00454636|62788954|FG001|Overall Study|Protocol Violation|2|||
33410615|NCT00454636|62788955|FG002|Overall Study|Protocol Violation|3|||
33410616|NCT00454636|62788956|FG003|Overall Study|Protocol Violation|3|||
33410617|NCT00454636|62788953|FG000|Overall Study|Death|6|||
33599321|NCT02460224|62998270|FG016|Overall Study|Physician Decision|2|||
33599322|NCT02460224|62998271|FG017|Overall Study|Physician Decision|1|||
33599323|NCT02460224|62998272|FG018|Overall Study|Physician Decision|1|||
33599324|NCT02460224|62998273|FG019|Overall Study|Physician Decision|2|||
33599325|NCT02460224|62998274|FG020|Overall Study|Physician Decision|1|||
33599326|NCT02460224|62998275|FG021|Overall Study|Physician Decision|1|||
33410618|NCT00454636|62788954|FG001|Overall Study|Death|1|||
33410619|NCT00454636|62788955|FG002|Overall Study|Death|1|||
33410620|NCT00454636|62788956|FG003|Overall Study|Death|1|||
33410621|NCT00454636|62788953|FG000|Overall Study|Patient refusal|1|||
33410622|NCT00454636|62788954|FG001|Overall Study|Patient refusal|1|||
33410623|NCT00454636|62788955|FG002|Overall Study|Patient refusal|3|||
33410624|NCT00454636|62788956|FG003|Overall Study|Patient refusal|2|||
33410625|NCT00454636|62788953|FG000|Overall Study|Lost to Follow-up|0|||
33410626|NCT00454636|62788954|FG001|Overall Study|Lost to Follow-up|1|||
33410627|NCT00454636|62788955|FG002|Overall Study|Lost to Follow-up|0|||
33410628|NCT00454636|62788956|FG003|Overall Study|Lost to Follow-up|0|||
33410629|NCT00427960|62788968|FG000|Overall Study|Adverse Event|2|||
33410630|NCT00427960|62788969|FG001|Overall Study|Adverse Event|0|||
33410631|NCT00427960|62788968|FG000|Overall Study|Withdrawal by Subject|0|||
33410632|NCT00427960|62788969|FG001|Overall Study|Withdrawal by Subject|3|||
33410633|NCT00427960|62788968|FG000|Overall Study|Other|0|||
33410634|NCT00427960|62788969|FG001|Overall Study|Other|1|||
33410635|NCT00548340|62788978|FG000|Overall Study|Protocol Violation|2|||
33410636|NCT00548340|62788979|FG001|Overall Study|Protocol Violation|3|||
33410637|NCT00548340|62788980|FG002|Overall Study|Protocol Violation|3|||
33410638|NCT00548340|62788978|FG000|Overall Study|Adverse Event|2|||
33410639|NCT00548340|62788979|FG001|Overall Study|Adverse Event|2|||
33410640|NCT00548340|62788980|FG002|Overall Study|Adverse Event|2|||
33410641|NCT00548340|62788978|FG000|Overall Study|Lost to Follow-up|1|||
33410642|NCT00548340|62788979|FG001|Overall Study|Lost to Follow-up|1|||
33410643|NCT00548340|62788980|FG002|Overall Study|Lost to Follow-up|0|||
33410644|NCT00548340|62788978|FG000|Overall Study|Withdrawal by Subject|2|||
33410645|NCT00548340|62788979|FG001|Overall Study|Withdrawal by Subject|4|||
33410646|NCT00548340|62788980|FG002|Overall Study|Withdrawal by Subject|3|||
33410647|NCT00548340|62788978|FG000|Overall Study|Other|1|||
33410648|NCT00548340|62788979|FG001|Overall Study|Other|1|||
33410649|NCT00548340|62788980|FG002|Overall Study|Other|1|||
33410650|NCT00454246|62788991|FG000|Overall Study|Adverse Event|2|||
33410651|NCT00454246|62788992|FG001|Overall Study|Adverse Event|2|||
33410652|NCT00454246|62788993|FG002|Overall Study|Adverse Event|0|||
33410653|NCT00454246|62788991|FG000|Overall Study|Violation of selection criteria at entry|6|||
33410654|NCT00454246|62788992|FG001|Overall Study|Violation of selection criteria at entry|0|||
33410655|NCT00454246|62788993|FG002|Overall Study|Violation of selection criteria at entry|0|||
33410656|NCT00454246|62788991|FG000|Overall Study|Protocol Violation|1|||
33410657|NCT00454246|62788992|FG001|Overall Study|Protocol Violation|0|||
33410658|NCT00454246|62788993|FG002|Overall Study|Protocol Violation|0|||
33410659|NCT00454246|62788991|FG000|Overall Study|Refused Treatment|1|||
33410660|NCT00454246|62788992|FG001|Overall Study|Refused Treatment|1|||
33410661|NCT00454246|62788993|FG002|Overall Study|Refused Treatment|0|||
33410662|NCT00454246|62788991|FG000|Overall Study|Failure to return|1|||
33410663|NCT00454246|62788992|FG001|Overall Study|Failure to return|0|||
33410664|NCT00454246|62788993|FG002|Overall Study|Failure to return|0|||
33410665|NCT00454246|62788991|FG000|Overall Study|Early termination of study|62|||
33410666|NCT00454246|62788992|FG001|Overall Study|Early termination of study|26|||
33410667|NCT00454246|62788993|FG002|Overall Study|Early termination of study|9|||
33410668|NCT00434590|62789003|FG000|Overall Study|Administrative problems|5|||
33410669|NCT00434590|62789004|FG001|Overall Study|Administrative problems|5|||
33410670|NCT02891837|62789012|FG000|Overall Study|Lost to Follow-up|2|||
33410671|NCT02891837|62789013|FG001|Overall Study|Lost to Follow-up|0|||
33599327|NCT02460224|62998276|FG022|Overall Study|Physician Decision|0|||
33599328|NCT02460224|62998277|FG023|Overall Study|Physician Decision|0|||
33599329|NCT02460224|62998278|FG024|Overall Study|Physician Decision|1|||
33599330|NCT02460224|62998279|FG025|Overall Study|Physician Decision|0|||
33599331|NCT02460224|62998280|FG026|Overall Study|Physician Decision|14|||
33599332|NCT02460224|62998281|FG027|Overall Study|Physician Decision|1|||
33410672|NCT02891837|62789012|FG000|Overall Study|Withdrawal by Subject|1|||
33410673|NCT02891837|62789013|FG001|Overall Study|Withdrawal by Subject|0|||
33410674|NCT00695903|62789037|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
33410675|NCT00695903|62789038|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
33410676|NCT00695903|62789037|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
33410677|NCT00695903|62789038|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
33410678|NCT00695903|62789037|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
33410679|NCT00695903|62789038|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
33410680|NCT00695903|62789037|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
33599333|NCT02460224|62998282|FG028|Overall Study|Physician Decision|6|||
33410681|NCT00695903|62789038|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
33410682|NCT00695903|62789037|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
33410683|NCT00695903|62789038|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
33410684|NCT00695903|62789037|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
33410685|NCT00695903|62789038|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
33410686|NCT00695903|62789037|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
33321695|NCT01179048|62697834|FG000|Overall Study|Withdrawn - does not allow contact|4|||
33321696|NCT01179048|62697835|FG001|Overall Study|Withdrawn - does not allow contact|8|||
33321697|NCT01179048|62697834|FG000|Overall Study|Lost to Follow-up|8|||
33321698|NCT01179048|62697835|FG001|Overall Study|Lost to Follow-up|9|||
33321699|NCT01179048|62697834|FG000|Overall Study|Alive|127|||
33321700|NCT01179048|62697835|FG001|Overall Study|Alive|142|||
33410687|NCT00695903|62789038|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
33410688|NCT00695903|62789037|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
33410689|NCT00695903|62789038|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
33410690|NCT00695903|62789037|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
33410691|NCT00695903|62789038|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
33410692|NCT02759861|62789044|FG000|Overall Study|Death|1|||
33410693|NCT00548262|62789049|FG000|Overall Study|Death|21|||
33410694|NCT00548262|62789049|FG000|Overall Study|Adverse Event|2|||
33410695|NCT00548262|62789049|FG000|Overall Study|Lack of Efficacy|4|||
33410696|NCT00548262|62789049|FG000|Overall Study|Lost to Follow-up|1|||
33410697|NCT00548262|62789049|FG000|Overall Study|Other|3|||
33410698|NCT00548262|62789049|FG000|Overall Study|Withdrawal by Subject|1|||
33410699|NCT00095173|62789053|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
33410700|NCT00095173|62789054|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
33410701|NCT00095173|62789055|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
33410702|NCT00095173|62789056|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
33410703|NCT00095173|62789057|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
33410704|NCT00095173|62789058|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
33410705|NCT00095173|62789053|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
33410706|NCT00095173|62789054|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
33410707|NCT00095173|62789055|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
33410708|NCT00095173|62789056|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
33410709|NCT00095173|62789057|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
33410710|NCT00095173|62789058|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
33410711|NCT00095173|62789053|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
33410712|NCT00095173|62789054|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
33410713|NCT00095173|62789055|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
33410714|NCT00095173|62789056|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
33410715|NCT00095173|62789057|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
33410716|NCT00095173|62789058|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
33410717|NCT00095173|62789053|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
33410718|NCT00095173|62789054|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
33410719|NCT00095173|62789055|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
33410720|NCT00095173|62789056|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
33410721|NCT00095173|62789057|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
33410722|NCT00095173|62789058|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
33410723|NCT00095173|62789053|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
33410724|NCT00095173|62789054|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
33410725|NCT00095173|62789055|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
33410726|NCT00095173|62789056|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
33410727|NCT00095173|62789057|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
33410728|NCT00095173|62789058|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
33410729|NCT00095173|62789053|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
33410730|NCT00095173|62789054|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
33410731|NCT00095173|62789055|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
33410732|NCT00095173|62789056|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
33410733|NCT00095173|62789057|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
33410734|NCT00095173|62789058|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
33410735|NCT00095173|62789053|FG000|Open-Label Extension Phase (Period C)|Death|0|||
33321701|NCT00603265|62697844|FG000|Overall Study|Adverse Event|2|||
33321702|NCT00603265|62697845|FG001|Overall Study|Adverse Event|11|||
33321703|NCT00603265|62697846|FG002|Overall Study|Adverse Event|1|||
33410736|NCT00095173|62789054|FG001|Open-Label Extension Phase (Period C)|Death|0|||
33410737|NCT00095173|62789055|FG002|Open-Label Extension Phase (Period C)|Death|0|||
33410738|NCT00095173|62789056|FG003|Open-Label Extension Phase (Period C)|Death|0|||
33410739|NCT00095173|62789057|FG004|Open-Label Extension Phase (Period C)|Death|0|||
33410740|NCT00095173|62789058|FG005|Open-Label Extension Phase (Period C)|Death|1|||
33410741|NCT00095173|62789053|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
33410742|NCT00095173|62789054|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
33599334|NCT02460224|62998254|FG000|Overall Study|Progressive disease|15|||
33321704|NCT00603265|62697844|FG000|Overall Study|Withdrawal by Subject|1|||
33599335|NCT02460224|62998255|FG001|Overall Study|Progressive disease|11|||
33599336|NCT02460224|62998256|FG002|Overall Study|Progressive disease|5|||
33599337|NCT02460224|62998257|FG003|Overall Study|Progressive disease|6|||
33599338|NCT02460224|62998258|FG004|Overall Study|Progressive disease|3|||
33410743|NCT00095173|62789055|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
33410744|NCT00095173|62789056|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
33410745|NCT00095173|62789057|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
33410746|NCT00095173|62789058|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
33410747|NCT00095173|62789053|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
33410748|NCT00095173|62789054|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
33410749|NCT00095173|62789055|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
33410750|NCT00095173|62789056|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
33410751|NCT00095173|62789057|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
33410752|NCT00095173|62789058|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
33410753|NCT00095173|62789053|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
33410754|NCT00095173|62789054|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
33410755|NCT00095173|62789055|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
33410756|NCT00095173|62789056|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
33410757|NCT00095173|62789057|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
33410758|NCT00095173|62789058|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
33410759|NCT00095173|62789053|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
33410760|NCT00095173|62789054|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
33410761|NCT00095173|62789055|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
33410762|NCT00095173|62789056|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
33410763|NCT00095173|62789057|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
33410764|NCT00095173|62789058|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
33410765|NCT00095173|62789053|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
33410766|NCT00095173|62789054|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
33410767|NCT00095173|62789055|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
33410768|NCT00095173|62789056|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
33410769|NCT00095173|62789057|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
33410770|NCT00095173|62789058|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
33410771|NCT00095173|62789053|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
33410772|NCT00095173|62789054|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
33410773|NCT00095173|62789055|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
33410774|NCT00095173|62789056|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
33410775|NCT00095173|62789057|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
33410776|NCT00095173|62789058|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
33410777|NCT00095173|62789053|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
33410778|NCT00095173|62789054|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
33410779|NCT00095173|62789055|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
33410780|NCT00095173|62789056|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
33410781|NCT00095173|62789057|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
33410782|NCT00095173|62789058|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
33410783|NCT00095173|62789053|FG000|Open-Label Extension Phase (Period C)|Other|0|||
33410784|NCT00095173|62789054|FG001|Open-Label Extension Phase (Period C)|Other|0|||
33410785|NCT00095173|62789055|FG002|Open-Label Extension Phase (Period C)|Other|0|||
33410786|NCT00095173|62789056|FG003|Open-Label Extension Phase (Period C)|Other|4|||
33410787|NCT00095173|62789057|FG004|Open-Label Extension Phase (Period C)|Other|6|||
33410788|NCT00095173|62789058|FG005|Open-Label Extension Phase (Period C)|Other|8|||
33410789|NCT00690443|62789074|FG000|Overall Study|Adverse Event|1|||
33410790|NCT00690443|62789075|FG001|Overall Study|Adverse Event|2|||
33410791|NCT03954834|62789085|FG000|Overall Study|Adverse Event|1|||
33410792|NCT03954834|62789086|FG001|Overall Study|Adverse Event|3|||
33410793|NCT03954834|62789087|FG002|Overall Study|Adverse Event|1|||
33410794|NCT03954834|62789088|FG003|Overall Study|Adverse Event|1|||
33410795|NCT03954834|62789085|FG000|Overall Study|Death|0|||
33410796|NCT03954834|62789086|FG001|Overall Study|Death|0|||
33410797|NCT03954834|62789087|FG002|Overall Study|Death|0|||
33599339|NCT02460224|62998259|FG005|Overall Study|Progressive disease|26|||
33599340|NCT02460224|62998260|FG006|Overall Study|Progressive disease|28|||
33599341|NCT02460224|62998261|FG007|Overall Study|Progressive disease|4|||
33410798|NCT03954834|62789088|FG003|Overall Study|Death|1|||
33410799|NCT03954834|62789085|FG000|Overall Study|Physician Decision|0|||
33410800|NCT03954834|62789086|FG001|Overall Study|Physician Decision|1|||
33599342|NCT02460224|62998262|FG008|Overall Study|Progressive disease|5|||
33599343|NCT02460224|62998263|FG009|Overall Study|Progressive disease|9|||
33599344|NCT02460224|62998264|FG010|Overall Study|Progressive disease|5|||
33599345|NCT02460224|62998265|FG011|Overall Study|Progressive disease|4|||
33599346|NCT02460224|62998266|FG012|Overall Study|Progressive disease|5|||
33410801|NCT03954834|62789087|FG002|Overall Study|Physician Decision|0|||
33321705|NCT00603265|62697845|FG001|Overall Study|Withdrawal by Subject|2|||
33321706|NCT00603265|62697846|FG002|Overall Study|Withdrawal by Subject|1|||
33321707|NCT00603265|62697844|FG000|Overall Study|Lack of Efficacy|3|||
33321708|NCT00603265|62697845|FG001|Overall Study|Lack of Efficacy|0|||
33321709|NCT00603265|62697846|FG002|Overall Study|Lack of Efficacy|3|||
33321710|NCT00603265|62697844|FG000|Overall Study|Lost to Follow-up|0|||
33321711|NCT00603265|62697845|FG001|Overall Study|Lost to Follow-up|1|||
33321712|NCT00603265|62697846|FG002|Overall Study|Lost to Follow-up|0|||
33321713|NCT00603265|62697844|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
33321714|NCT00603265|62697845|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
33321715|NCT00603265|62697846|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
33321716|NCT00603265|62697844|FG000|Overall Study|Participant Left Country, No Responses|0|||
33321717|NCT00603265|62697845|FG001|Overall Study|Participant Left Country, No Responses|1|||
33321718|NCT00603265|62697846|FG002|Overall Study|Participant Left Country, No Responses|0|||
33321719|NCT00603265|62697844|FG000|Overall Study|Protocol Violation|1|||
33321720|NCT00603265|62697845|FG001|Overall Study|Protocol Violation|0|||
33321721|NCT00603265|62697846|FG002|Overall Study|Protocol Violation|0|||
33321722|NCT04010227|62697856|FG000|Overall Study|Death|1|||
33321723|NCT04010227|62697857|FG001|Overall Study|Death|2|||
33321724|NCT04010227|62697856|FG000|Overall Study|Medical Reasons|4|||
33321725|NCT04010227|62697857|FG001|Overall Study|Medical Reasons|3|||
33321726|NCT04010227|62697856|FG000|Overall Study|Withdrawal by Subject|2|||
33321727|NCT04010227|62697857|FG001|Overall Study|Withdrawal by Subject|0|||
33321728|NCT04010227|62697856|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
33321729|NCT04010227|62697857|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
33321730|NCT01158534|62697864|FG000|Overall Study|Withdrawal by Subject|1|||
33321731|NCT01158534|62697864|FG000|Overall Study|Death|1|||
33321732|NCT01158534|62697864|FG000|Overall Study|Other|1|||
33321733|NCT01158378|62697870|FG000|Overall Study|Death|4|||
33321734|NCT01158378|62697871|FG001|Overall Study|Death|5|||
33321735|NCT01158378|62697870|FG000|Overall Study|Lost to Follow-up|2|||
33321736|NCT01158378|62697871|FG001|Overall Study|Lost to Follow-up|4|||
33321737|NCT01158378|62697870|FG000|Overall Study|Withdrawal by Subject|4|||
33321738|NCT01158378|62697871|FG001|Overall Study|Withdrawal by Subject|0|||
33321739|NCT01158222|62697878|FG000|Overall Study|Not eligible for intermediate phase|17|||
33321740|NCT01197521|62697885|FG000|Overall Study|Not reported|24|||
33321741|NCT01197521|62697886|FG001|Overall Study|Not reported|25|||
33321742|NCT01197521|62697887|FG002|Overall Study|Not reported|21|||
33321743|NCT01197521|62697885|FG000|Overall Study|Enrolment in long term extension|42|||
33321744|NCT01197521|62697886|FG001|Overall Study|Enrolment in long term extension|36|||
33321745|NCT01197521|62697887|FG002|Overall Study|Enrolment in long term extension|87|||
33321746|NCT01197521|62697885|FG000|Overall Study|Severe non-compliance to protocol|1|||
33321747|NCT01197521|62697886|FG001|Overall Study|Severe non-compliance to protocol|3|||
33321748|NCT01197521|62697887|FG002|Overall Study|Severe non-compliance to protocol|3|||
33321749|NCT01197521|62697885|FG000|Overall Study|Lack of therapeutic response|2|||
33321750|NCT01197521|62697886|FG001|Overall Study|Lack of therapeutic response|3|||
33321751|NCT01197521|62697887|FG002|Overall Study|Lack of therapeutic response|4|||
33321752|NCT01197521|62697885|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
33321753|NCT01197521|62697886|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
33321754|NCT01197521|62697887|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
33321755|NCT01197521|62697885|FG000|Overall Study|Lost to Follow-up|3|||
33321756|NCT01197521|62697886|FG001|Overall Study|Lost to Follow-up|2|||
33321757|NCT01197521|62697887|FG002|Overall Study|Lost to Follow-up|2|||
33321758|NCT01197521|62697885|FG000|Overall Study|Adverse Event|25|||
33321759|NCT01197521|62697886|FG001|Overall Study|Adverse Event|28|||
33321760|NCT01197521|62697887|FG002|Overall Study|Adverse Event|24|||
33321761|NCT01157676|62697900|FG000|Randomization|Death|1|||
33321762|NCT01157676|62697901|FG001|Randomization|Death|1|||
33321763|NCT01157676|62697900|FG000|Randomization|unresectable|2|||
33321764|NCT01157676|62697901|FG001|Randomization|unresectable|3|||
33321765|NCT01157676|62697900|FG000|Randomization|Withdrawal by Subject|17|||
33321766|NCT01157676|62697901|FG001|Randomization|Withdrawal by Subject|13|||
33321767|NCT01157676|62697900|FG000|Randomization|Physician Decision|1|||
33321768|NCT01157676|62697901|FG001|Randomization|Physician Decision|0|||
33410802|NCT03954834|62789088|FG003|Overall Study|Physician Decision|2|||
33410803|NCT03954834|62789085|FG000|Overall Study|Protocol Violation|1|||
33410804|NCT03954834|62789086|FG001|Overall Study|Protocol Violation|0|||
33321769|NCT01157676|62697900|FG000|Surgery|underwent open cystectomy|0|||
33321770|NCT01157676|62697901|FG001|Surgery|underwent open cystectomy|4|||
33321771|NCT01157676|62697900|FG000|Surgery|converted to open procedure|0|||
33321772|NCT01157676|62697901|FG001|Surgery|converted to open procedure|5|||
33321773|NCT01157676|62697900|FG000|Surgery|underwent robotic cystectomy|1|||
33321774|NCT01157676|62697901|FG001|Surgery|underwent robotic cystectomy|0|||
33410805|NCT03954834|62789087|FG002|Overall Study|Protocol Violation|0|||
33410806|NCT03954834|62789088|FG003|Overall Study|Protocol Violation|1|||
33410807|NCT03954834|62789085|FG000|Overall Study|Withdrawal by Subject|2|||
33410808|NCT03954834|62789086|FG001|Overall Study|Withdrawal by Subject|3|||
33410809|NCT03954834|62789087|FG002|Overall Study|Withdrawal by Subject|13|||
33410810|NCT03954834|62789088|FG003|Overall Study|Withdrawal by Subject|6|||
33410811|NCT03954834|62789085|FG000|Overall Study|Participant left the country|0|||
33410812|NCT03954834|62789086|FG001|Overall Study|Participant left the country|0|||
33410813|NCT03954834|62789087|FG002|Overall Study|Participant left the country|1|||
33410814|NCT03954834|62789088|FG003|Overall Study|Participant left the country|0|||
33410815|NCT03954834|62789085|FG000|Overall Study|Lost to Follow-up|3|||
33410816|NCT03954834|62789086|FG001|Overall Study|Lost to Follow-up|2|||
33410817|NCT03954834|62789087|FG002|Overall Study|Lost to Follow-up|3|||
33410818|NCT03954834|62789088|FG003|Overall Study|Lost to Follow-up|5|||
33410819|NCT00693017|62789100|FG000|Overall Study|Sponsor Decision|2|||
33410820|NCT00693017|62789101|FG001|Overall Study|Sponsor Decision|1|||
33410821|NCT00693017|62789100|FG000|Overall Study|Death|0|||
33410822|NCT00693017|62789101|FG001|Overall Study|Death|1|||
33410823|NCT00692237|62789109|FG000|Overall Study|Withdrawal by Subject|1|||
33410824|NCT00692237|62789110|FG001|Overall Study|Withdrawal by Subject|3|||
33410825|NCT00692237|62789109|FG000|Overall Study|Adverse Event|0|||
33410826|NCT00692237|62789110|FG001|Overall Study|Adverse Event|1|||
33410827|NCT00110149|62789116|FG000|Overall Study|Physician Decision|3|||
33410828|NCT03954444|62789124|FG000|Overall Study|Withdrawal by Subject|5|||
33410829|NCT03954444|62789125|FG001|Overall Study|Withdrawal by Subject|5|||
33410830|NCT03954444|62789126|FG002|Overall Study|Withdrawal by Subject|5|||
33410831|NCT03954444|62789124|FG000|Overall Study|Adverse Event|1|||
33410832|NCT03954444|62789125|FG001|Overall Study|Adverse Event|3|||
33410833|NCT03954444|62789126|FG002|Overall Study|Adverse Event|2|||
33410834|NCT03954444|62789124|FG000|Overall Study|Protocol Violation|0|||
33410835|NCT03954444|62789125|FG001|Overall Study|Protocol Violation|3|||
33410836|NCT03954444|62789126|FG002|Overall Study|Protocol Violation|5|||
33410837|NCT03954444|62789124|FG000|Overall Study|Use of prohibited therapy|1|||
33410838|NCT03954444|62789125|FG001|Overall Study|Use of prohibited therapy|1|||
33410839|NCT03954444|62789126|FG002|Overall Study|Use of prohibited therapy|2|||
33410840|NCT03954444|62789124|FG000|Overall Study|Lost to Follow-up|1|||
33410841|NCT03954444|62789125|FG001|Overall Study|Lost to Follow-up|0|||
33410842|NCT03954444|62789126|FG002|Overall Study|Lost to Follow-up|1|||
33410843|NCT03954444|62789124|FG000|Overall Study|Non-compliant with study drug application|2|||
33410844|NCT03954444|62789125|FG001|Overall Study|Non-compliant with study drug application|2|||
33410845|NCT03954444|62789126|FG002|Overall Study|Non-compliant with study drug application|0|||
33599347|NCT02460224|62998267|FG013|Overall Study|Progressive disease|4|||
33599348|NCT02460224|62998268|FG014|Overall Study|Progressive disease|5|||
33599349|NCT02460224|62998269|FG015|Overall Study|Progressive disease|5|||
33410846|NCT03954444|62789124|FG000|Overall Study|Administrative reasons|0|||
33410847|NCT03954444|62789125|FG001|Overall Study|Administrative reasons|0|||
33410848|NCT03954444|62789126|FG002|Overall Study|Administrative reasons|1|||
33599350|NCT02460224|62998270|FG016|Overall Study|Progressive disease|15|||
33599351|NCT02460224|62998271|FG017|Overall Study|Progressive disease|3|||
33599352|NCT02460224|62998272|FG018|Overall Study|Progressive disease|8|||
33599353|NCT02460224|62998273|FG019|Overall Study|Progressive disease|3|||
33599354|NCT02460224|62998274|FG020|Overall Study|Progressive disease|4|||
33599355|NCT02460224|62998275|FG021|Overall Study|Progressive disease|9|||
33599356|NCT02460224|62998276|FG022|Overall Study|Progressive disease|4|||
33599357|NCT02460224|62998277|FG023|Overall Study|Progressive disease|11|||
33599358|NCT02460224|62998278|FG024|Overall Study|Progressive disease|4|||
33599359|NCT02460224|62998279|FG025|Overall Study|Progressive disease|5|||
33599360|NCT02460224|62998280|FG026|Overall Study|Progressive disease|85|||
33599361|NCT02460224|62998281|FG027|Overall Study|Progressive disease|17|||
33599362|NCT02460224|62998282|FG028|Overall Study|Progressive disease|77|||
33599363|NCT02460224|62998254|FG000|Overall Study|Subject/guardian decision|2|||
33599364|NCT02460224|62998255|FG001|Overall Study|Subject/guardian decision|0|||
33599365|NCT02460224|62998256|FG002|Overall Study|Subject/guardian decision|1|||
33599366|NCT02460224|62998257|FG003|Overall Study|Subject/guardian decision|0|||
33410849|NCT03954444|62789124|FG000|Overall Study|Miscellaneous|3|||
33410850|NCT03954444|62789125|FG001|Overall Study|Miscellaneous|2|||
33410851|NCT03954444|62789126|FG002|Overall Study|Miscellaneous|1|||
33410852|NCT03953820|62789134|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
33599367|NCT02460224|62998258|FG004|Overall Study|Subject/guardian decision|2|||
33599368|NCT02460224|62998259|FG005|Overall Study|Subject/guardian decision|2|||
33599369|NCT02460224|62998260|FG006|Overall Study|Subject/guardian decision|0|||
33410853|NCT03953820|62789135|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
33599370|NCT02460224|62998261|FG007|Overall Study|Subject/guardian decision|0|||
33410854|NCT03953820|62789136|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
33410855|NCT03953820|62789134|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
33410856|NCT03953820|62789135|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
33410857|NCT03953820|62789136|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
33410858|NCT00117949|62789153|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
33410859|NCT00117949|62789154|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
33410860|NCT00117949|62789155|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
33410861|NCT00117949|62789156|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
33410862|NCT00117949|62789153|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
33410863|NCT00117949|62789154|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
33410864|NCT00117949|62789155|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
33410865|NCT00117949|62789156|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
33410866|NCT00117949|62789153|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
33410867|NCT00117949|62789154|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
33410868|NCT00117949|62789155|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
33410869|NCT00117949|62789156|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
33410870|NCT00117949|62789153|FG000|Overall Study|PSA increase >=10ng/mL|0|||
33410871|NCT00117949|62789154|FG001|Overall Study|PSA increase >=10ng/mL|1|||
33410872|NCT00117949|62789155|FG002|Overall Study|PSA increase >=10ng/mL|1|||
33410873|NCT00117949|62789156|FG003|Overall Study|PSA increase >=10ng/mL|0|||
33410874|NCT00117949|62789153|FG000|Overall Study|PSA reduction <=50%|0|||
33410875|NCT00117949|62789154|FG001|Overall Study|PSA reduction <=50%|2|||
33410876|NCT00117949|62789155|FG002|Overall Study|PSA reduction <=50%|2|||
33410877|NCT00117949|62789156|FG003|Overall Study|PSA reduction <=50%|4|||
33410878|NCT00117949|62789153|FG000|Overall Study|Hepatic abnormalities|0|||
33410879|NCT00117949|62789154|FG001|Overall Study|Hepatic abnormalities|1|||
33410880|NCT00117949|62789155|FG002|Overall Study|Hepatic abnormalities|0|||
33410881|NCT00117949|62789156|FG003|Overall Study|Hepatic abnormalities|1|||
33410882|NCT02611037|62789166|FG000|Overall Study|Withdrawal prior to treatment|2|||
33410883|NCT02611037|62789167|FG001|Overall Study|Withdrawal prior to treatment|0|||
33410884|NCT00117793|62789172|FG000|Overall Study|Withdrawal by Subject|12|||
33410885|NCT00695669|62789181|FG000|Overall Study|Adverse Event|0|||
33410886|NCT00695669|62789182|FG001|Overall Study|Adverse Event|0|||
33410887|NCT00695669|62789183|FG002|Overall Study|Adverse Event|2|||
33410888|NCT00695669|62789184|FG003|Overall Study|Adverse Event|0|||
33410889|NCT00695669|62789181|FG000|Overall Study|Lost to Follow-up|4|||
33410890|NCT00695669|62789182|FG001|Overall Study|Lost to Follow-up|4|||
33410891|NCT00695669|62789183|FG002|Overall Study|Lost to Follow-up|1|||
33410892|NCT00695669|62789184|FG003|Overall Study|Lost to Follow-up|4|||
33599371|NCT02460224|62998262|FG008|Overall Study|Subject/guardian decision|1|||
33321775|NCT00991341|62697915|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
33321776|NCT00991341|62697916|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
33321777|NCT00991341|62697915|FG000|Overall Study|Death|3|||
33321778|NCT00991341|62697916|FG001|Overall Study|Death|0|||
33321779|NCT00991341|62697915|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
33321780|NCT00991341|62697916|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
33321781|NCT00991341|62697915|FG000|Overall Study|Physician Decision|1|||
33410893|NCT03671369|62789197|FG000|Overall Study|Other|1|||
33410894|NCT03671369|62789197|FG000|Overall Study|Withdrawal by Subject|289|||
33410895|NCT03671369|62789197|FG000|Overall Study|Not willing to be vaccinated|1|||
33410896|NCT00692003|62789203|FG000|Overall Study|Sponsor Decision|5|||
33321782|NCT00991341|62697916|FG001|Overall Study|Physician Decision|2|||
33321783|NCT00991341|62697915|FG000|Overall Study|Withdrawal by Subject|3|||
33410897|NCT00692003|62789204|FG001|Overall Study|Sponsor Decision|1|||
33410898|NCT00434512|62789216|FG000|Overall Study|Migrated/moved from study area|0|||
33410899|NCT00434512|62789217|FG001|Overall Study|Migrated/moved from study area|0|||
33410900|NCT00434512|62789218|FG002|Overall Study|Migrated/moved from study area|0|||
33410901|NCT00434512|62789219|FG003|Overall Study|Migrated/moved from study area|1|||
33410902|NCT00434512|62789220|FG004|Overall Study|Migrated/moved from study area|1|||
33410903|NCT00434512|62789221|FG005|Overall Study|Migrated/moved from study area|1|||
33410904|NCT00434512|62789216|FG000|Overall Study|Other|0|||
33410905|NCT00434512|62789217|FG001|Overall Study|Other|1|||
33410906|NCT00434512|62789218|FG002|Overall Study|Other|0|||
33410907|NCT00434512|62789219|FG003|Overall Study|Other|0|||
33410908|NCT00434512|62789220|FG004|Overall Study|Other|0|||
33410909|NCT00434512|62789221|FG005|Overall Study|Other|0|||
33410910|NCT00427648|62789241|FG000|Overall Study|Protocol Violation|1|||
33410911|NCT00427648|62789242|FG001|Overall Study|Protocol Violation|2|||
33410912|NCT00427648|62789241|FG000|Overall Study|Adverse Event|0|||
33410913|NCT00427648|62789242|FG001|Overall Study|Adverse Event|1|||
33410914|NCT00416884|62789250|FG000|Overall Study|Study terminated due to low accrual|1|||
33410915|NCT00434122|62789256|FG000|Overall Study|Non-compliance with protocol|0|||
33410916|NCT00434122|62789257|FG001|Overall Study|Non-compliance with protocol|1|||
33410917|NCT00434122|62789256|FG000|Overall Study|loss of subject contact|1|||
33410918|NCT00434122|62789257|FG001|Overall Study|loss of subject contact|1|||
33410919|NCT00434122|62789256|FG000|Overall Study|Personal reasons|1|||
33410920|NCT00434122|62789257|FG001|Overall Study|Personal reasons|1|||
33410921|NCT00434122|62789256|FG000|Overall Study|Large follicle size|2|||
33410922|NCT00434122|62789257|FG001|Overall Study|Large follicle size|2|||
33410923|NCT00434122|62789256|FG000|Overall Study|Low follicular response.|1|||
33410924|NCT00434122|62789257|FG001|Overall Study|Low follicular response.|2|||
33410925|NCT00434122|62789256|FG000|Overall Study|Travelling of subject.|1|||
33410926|NCT00434122|62789257|FG001|Overall Study|Travelling of subject.|0|||
33410927|NCT00555620|62789271|FG000|Overall Study|Death|0|||
33410928|NCT00555620|62789272|FG001|Overall Study|Death|1|||
33410929|NCT00555620|62789273|FG002|Overall Study|Death|0|||
33410930|NCT00555620|62789274|FG003|Overall Study|Death|0|||
33410931|NCT00555620|62789275|FG004|Overall Study|Death|0|||
33410932|NCT00555620|62789276|FG005|Overall Study|Death|1|||
33410933|NCT00555620|62789271|FG000|Overall Study|Study terminated by sponsor|0|||
33410934|NCT00555620|62789272|FG001|Overall Study|Study terminated by sponsor|0|||
33410935|NCT00555620|62789273|FG002|Overall Study|Study terminated by sponsor|1|||
33410936|NCT00555620|62789274|FG003|Overall Study|Study terminated by sponsor|0|||
33410937|NCT00555620|62789275|FG004|Overall Study|Study terminated by sponsor|0|||
33410938|NCT00555620|62789276|FG005|Overall Study|Study terminated by sponsor|0|||
33410939|NCT00555620|62789271|FG000|Overall Study|Adverse Event|0|||
33410940|NCT00555620|62789272|FG001|Overall Study|Adverse Event|0|||
33410941|NCT00555620|62789273|FG002|Overall Study|Adverse Event|1|||
33410942|NCT00555620|62789274|FG003|Overall Study|Adverse Event|5|||
33494037|NCT03527550|62872688|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
33494038|NCT03527550|62872689|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
33410943|NCT00555620|62789275|FG004|Overall Study|Adverse Event|0|||
33410944|NCT00555620|62789276|FG005|Overall Study|Adverse Event|1|||
33410945|NCT00555620|62789271|FG000|Overall Study|Objective progression or relapse|6|||
33410946|NCT00555620|62789272|FG001|Overall Study|Objective progression or relapse|5|||
33410947|NCT00555620|62789273|FG002|Overall Study|Objective progression or relapse|12|||
33410948|NCT00555620|62789274|FG003|Overall Study|Objective progression or relapse|17|||
33494039|NCT03475056|62872699|FG000|Overall Study|Lost to Follow-up|0|||
33410949|NCT00555620|62789275|FG004|Overall Study|Objective progression or relapse|3|||
33410950|NCT00555620|62789276|FG005|Overall Study|Objective progression or relapse|16|||
33410951|NCT00555620|62789271|FG000|Overall Study|Participant refused treatment|0|||
33410952|NCT00555620|62789272|FG001|Overall Study|Participant refused treatment|1|||
33410953|NCT00555620|62789273|FG002|Overall Study|Participant refused treatment|1|||
33410954|NCT00555620|62789274|FG003|Overall Study|Participant refused treatment|0|||
33410955|NCT00555620|62789275|FG004|Overall Study|Participant refused treatment|0|||
33410956|NCT00555620|62789276|FG005|Overall Study|Participant refused treatment|1|||
33410957|NCT00555620|62789271|FG000|Overall Study|Other|0|||
33410958|NCT00555620|62789272|FG001|Overall Study|Other|0|||
33410959|NCT00555620|62789273|FG002|Overall Study|Other|0|||
33410960|NCT00555620|62789274|FG003|Overall Study|Other|1|||
33410961|NCT00555620|62789275|FG004|Overall Study|Other|0|||
33410962|NCT00555620|62789276|FG005|Overall Study|Other|3|||
33410963|NCT00433966|62789296|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
33410964|NCT00433966|62789297|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
33410965|NCT00433966|62789298|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
33410966|NCT00433966|62789299|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
33410967|NCT00433966|62789296|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
33410968|NCT00433966|62789297|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
33410969|NCT00433966|62789298|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
33410970|NCT00433966|62789299|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
33410971|NCT00433966|62789296|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
33410972|NCT00433966|62789297|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
33410973|NCT00433966|62789298|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
33410974|NCT00433966|62789299|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
33410975|NCT00433966|62789296|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
33410976|NCT00433966|62789297|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
33410977|NCT00433966|62789298|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
33410978|NCT00433966|62789299|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
33410979|NCT00433966|62789296|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
33410980|NCT00433966|62789297|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
33410981|NCT00433966|62789298|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
33410982|NCT00433966|62789299|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
33410983|NCT03952650|62789316|FG000|Overall Study|TRAVEL|0|||
33410984|NCT03952650|62789317|FG001|Overall Study|TRAVEL|4|||
33410985|NCT03952650|62789318|FG002|Overall Study|TRAVEL|0|||
33410986|NCT03952650|62789319|FG003|Overall Study|TRAVEL|4|||
33410987|NCT03952650|62789320|FG004|Overall Study|TRAVEL|0|||
33410988|NCT03952650|62789321|FG005|Overall Study|TRAVEL|3|||
33410989|NCT03952650|62789322|FG006|Overall Study|TRAVEL|2|||
33410990|NCT03952650|62789316|FG000|Overall Study|Withdrawal by Subject|0|||
33410991|NCT03952650|62789317|FG001|Overall Study|Withdrawal by Subject|2|||
33410992|NCT03952650|62789318|FG002|Overall Study|Withdrawal by Subject|0|||
33410993|NCT03952650|62789319|FG003|Overall Study|Withdrawal by Subject|3|||
33410994|NCT03952650|62789320|FG004|Overall Study|Withdrawal by Subject|0|||
33410995|NCT03952650|62789321|FG005|Overall Study|Withdrawal by Subject|1|||
33410996|NCT03952650|62789322|FG006|Overall Study|Withdrawal by Subject|1|||
33410997|NCT03952650|62789316|FG000|Overall Study|Lost to Follow-up|0|||
33410998|NCT03952650|62789317|FG001|Overall Study|Lost to Follow-up|1|||
33410999|NCT03952650|62789318|FG002|Overall Study|Lost to Follow-up|0|||
33411000|NCT03952650|62789319|FG003|Overall Study|Lost to Follow-up|0|||
33411001|NCT03952650|62789320|FG004|Overall Study|Lost to Follow-up|0|||
33411002|NCT03952650|62789321|FG005|Overall Study|Lost to Follow-up|1|||
33411003|NCT03952650|62789322|FG006|Overall Study|Lost to Follow-up|1|||
33411004|NCT03952650|62789316|FG000|Overall Study|Received wrong vaccine and travelled|0|||
33411005|NCT03952650|62789317|FG001|Overall Study|Received wrong vaccine and travelled|0|||
33411006|NCT03952650|62789318|FG002|Overall Study|Received wrong vaccine and travelled|0|||
33411007|NCT03952650|62789319|FG003|Overall Study|Received wrong vaccine and travelled|0|||
33411008|NCT03952650|62789320|FG004|Overall Study|Received wrong vaccine and travelled|0|||
33411009|NCT03952650|62789321|FG005|Overall Study|Received wrong vaccine and travelled|1|||
33411010|NCT03952650|62789322|FG006|Overall Study|Received wrong vaccine and travelled|0|||
33411011|NCT03952650|62789316|FG000|Overall Study|Unable to make study visit|0|||
33599372|NCT02460224|62998263|FG009|Overall Study|Subject/guardian decision|1|||
33599373|NCT02460224|62998264|FG010|Overall Study|Subject/guardian decision|0|||
33599374|NCT02460224|62998265|FG011|Overall Study|Subject/guardian decision|1|||
33599375|NCT02460224|62998266|FG012|Overall Study|Subject/guardian decision|0|||
33411012|NCT03952650|62789317|FG001|Overall Study|Unable to make study visit|0|||
33411013|NCT03952650|62789318|FG002|Overall Study|Unable to make study visit|0|||
33411014|NCT03952650|62789319|FG003|Overall Study|Unable to make study visit|0|||
33411015|NCT03952650|62789320|FG004|Overall Study|Unable to make study visit|0|||
33411016|NCT03952650|62789321|FG005|Overall Study|Unable to make study visit|1|||
33411017|NCT03952650|62789322|FG006|Overall Study|Unable to make study visit|0|||
33599376|NCT02460224|62998267|FG013|Overall Study|Subject/guardian decision|0|||
33411018|NCT00691301|62789338|FG000|Overall Study|Adverse Event|10|||
33411019|NCT00691301|62789338|FG000|Overall Study|Death|2|||
33411020|NCT00691301|62789338|FG000|Overall Study|Lack of Efficacy|32|||
33411021|NCT00691301|62789338|FG000|Overall Study|Withdrawal by Subject|4|||
33411022|NCT00691301|62789338|FG000|Overall Study|Concurrent illness|2|||
33411023|NCT00691301|62789338|FG000|Overall Study|other reason|3|||
33411024|NCT00691301|62789338|FG000|Overall Study|Did not initiate study treatment|1|||
33411025|NCT00927563|62789348|FG000|Overall Study|Lost to Follow-up|1|||
33411026|NCT00927563|62789348|FG000|Overall Study|Withdrawal by Subject|1|||
33411027|NCT00653159|62789363|FG000|Overall Study|Adverse Event|4|||
33411028|NCT00653159|62789364|FG001|Overall Study|Adverse Event|1|||
33411029|NCT00653159|62789363|FG000|Overall Study|Lost to Follow-up|1|||
33411030|NCT00653159|62789364|FG001|Overall Study|Lost to Follow-up|2|||
33411031|NCT00117637|62789372|FG000|First Intervention (Period 1)|Adverse Event|11|||
33411032|NCT00117637|62789373|FG001|First Intervention (Period 1)|Adverse Event|16|||
33411033|NCT00117637|62789372|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
33411034|NCT00117637|62789373|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
33411035|NCT00117637|62789372|FG000|First Intervention (Period 1)|Protocol Violation|1|||
33411036|NCT00117637|62789373|FG001|First Intervention (Period 1)|Protocol Violation|0|||
33411037|NCT00117637|62789372|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
33411038|NCT00117637|62789373|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
33411039|NCT00117637|62789372|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
33411040|NCT00117637|62789373|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
33411041|NCT00117637|62789372|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
33411042|NCT00117637|62789373|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
33411043|NCT00117637|62789372|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
33411044|NCT00117637|62789373|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
33411045|NCT00117637|62789372|FG000|First Intervention (Period 1)|reason not reported|0|||
33411046|NCT00117637|62789373|FG001|First Intervention (Period 1)|reason not reported|1|||
33411047|NCT00117637|62789372|FG000|Second Intervention (Period 2)|Adverse Event|0|||
33411048|NCT00117637|62789373|FG001|Second Intervention (Period 2)|Adverse Event|9|||
33411049|NCT00117637|62789372|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
33411050|NCT00117637|62789373|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
33411051|NCT00117637|62789372|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
33411052|NCT00117637|62789373|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
33411053|NCT00117637|62789372|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
33411054|NCT00117637|62789373|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
33411055|NCT00117637|62789372|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
33411056|NCT00117637|62789373|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
33411057|NCT00117637|62789372|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
33411058|NCT00117637|62789373|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
33411059|NCT00117637|62789372|FG000|Second Intervention (Period 2)|reason not reported|1|||
33411060|NCT00117637|62789373|FG001|Second Intervention (Period 2)|reason not reported|0|||
33411061|NCT00690755|62789393|FG000|Overall Study|Physician Decision|2|||
33411062|NCT00690755|62789394|FG001|Overall Study|Physician Decision|0|||
33411063|NCT00690755|62789395|FG002|Overall Study|Physician Decision|46|||
33411064|NCT00690755|62789396|FG003|Overall Study|Physician Decision|5|||
33411065|NCT00690755|62789397|FG004|Overall Study|Physician Decision|0|||
33411066|NCT00690755|62789398|FG005|Overall Study|Physician Decision|4|||
33411067|NCT00690755|62789399|FG006|Overall Study|Physician Decision|0|||
33411068|NCT00549302|62789417|FG000|Double-Blind|Death|2|||
33411069|NCT00549302|62789418|FG001|Double-Blind|Death|9|||
33411070|NCT00549302|62789419|FG002|Double-Blind|Death|0|||
33411071|NCT00549302|62789417|FG000|Double-Blind|Adverse Event|3|||
33411072|NCT00549302|62789418|FG001|Double-Blind|Adverse Event|16|||
33411073|NCT00549302|62789419|FG002|Double-Blind|Adverse Event|0|||
33411074|NCT00549302|62789417|FG000|Double-Blind|Withdrawal by Subject|3|||
33411075|NCT00549302|62789418|FG001|Double-Blind|Withdrawal by Subject|8|||
33411076|NCT00549302|62789419|FG002|Double-Blind|Withdrawal by Subject|0|||
33411077|NCT00549302|62789417|FG000|Double-Blind|Investigator Decision|1|||
33411078|NCT00549302|62789418|FG001|Double-Blind|Investigator Decision|5|||
33411079|NCT00549302|62789419|FG002|Double-Blind|Investigator Decision|0|||
33411080|NCT00549302|62789417|FG000|Double-Blind|Sponsor Decision|0|||
33411081|NCT00549302|62789418|FG001|Double-Blind|Sponsor Decision|1|||
33411082|NCT00549302|62789419|FG002|Double-Blind|Sponsor Decision|0|||
33411083|NCT00549302|62789417|FG000|Double-Blind|Lost to Follow-up|1|||
33411084|NCT00549302|62789418|FG001|Double-Blind|Lost to Follow-up|2|||
33411085|NCT00549302|62789419|FG002|Double-Blind|Lost to Follow-up|0|||
33411086|NCT00549302|62789417|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
33411087|NCT00549302|62789418|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
33411088|NCT00549302|62789419|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
33411089|NCT00549302|62789417|FG000|Double-Blind|New condition or starts new therapy|0|||
33411090|NCT00549302|62789418|FG001|Double-Blind|New condition or starts new therapy|2|||
33411091|NCT00549302|62789419|FG002|Double-Blind|New condition or starts new therapy|0|||
33411092|NCT00549302|62789417|FG000|Open-Label|Adverse Event|0|||
33411093|NCT00549302|62789418|FG001|Open-Label|Adverse Event|0|||
33411094|NCT00549302|62789419|FG002|Open-Label|Adverse Event|11|||
33411095|NCT00549302|62789417|FG000|Open-Label|Death|0|||
33411096|NCT00549302|62789418|FG001|Open-Label|Death|0|||
33411097|NCT00549302|62789419|FG002|Open-Label|Death|40|||
33411098|NCT00549302|62789417|FG000|Open-Label|Investigator Decision|0|||
33411099|NCT00549302|62789418|FG001|Open-Label|Investigator Decision|0|||
33411100|NCT00549302|62789419|FG002|Open-Label|Investigator Decision|5|||
33411101|NCT00549302|62789417|FG000|Open-Label|Lost to Follow-up|0|||
33411102|NCT00549302|62789418|FG001|Open-Label|Lost to Follow-up|0|||
33411103|NCT00549302|62789419|FG002|Open-Label|Lost to Follow-up|2|||
33411104|NCT00549302|62789417|FG000|Open-Label|Other|0|||
33411105|NCT00549302|62789418|FG001|Open-Label|Other|0|||
33411106|NCT00549302|62789419|FG002|Open-Label|Other|3|||
33411107|NCT00549302|62789417|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
33411108|NCT00549302|62789418|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
33411109|NCT00549302|62789419|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
33411110|NCT00549302|62789417|FG000|Open-Label|Withdrawal by Subject|0|||
33411111|NCT00549302|62789418|FG001|Open-Label|Withdrawal by Subject|0|||
33411112|NCT00549302|62789419|FG002|Open-Label|Withdrawal by Subject|6|||
33411113|NCT00117325|62789429|FG000|Overall Study|Adverse Event|3|||
33411114|NCT00117325|62789430|FG001|Overall Study|Adverse Event|3|||
33411115|NCT00117325|62789429|FG000|Overall Study|Lost to Follow-up|1|||
33411116|NCT00117325|62789430|FG001|Overall Study|Lost to Follow-up|1|||
33411117|NCT00117325|62789429|FG000|Overall Study|Protocol Violation|2|||
33411118|NCT00117325|62789430|FG001|Overall Study|Protocol Violation|3|||
33411119|NCT00117325|62789429|FG000|Overall Study|Withdrawal by Subject|3|||
33411120|NCT00117325|62789430|FG001|Overall Study|Withdrawal by Subject|2|||
33411121|NCT00117325|62789429|FG000|Overall Study|Lack of Efficacy|1|||
33411122|NCT00117325|62789430|FG001|Overall Study|Lack of Efficacy|0|||
33411123|NCT00117325|62789429|FG000|Overall Study|Use of prohibited medicine|1|||
33411124|NCT00117325|62789430|FG001|Overall Study|Use of prohibited medicine|2|||
33411125|NCT00117325|62789429|FG000|Overall Study|Early termination|1|||
33411126|NCT00117325|62789430|FG001|Overall Study|Early termination|1|||
33411127|NCT00117325|62789429|FG000|Overall Study|Admisnitrative|1|||
33411128|NCT00117325|62789430|FG001|Overall Study|Admisnitrative|0|||
33411129|NCT00108433|62789439|FG000|Overall Study|Lack of Efficacy|1|||
33411130|NCT00108433|62789440|FG001|Overall Study|Lack of Efficacy|2|||
33411131|NCT00108433|62789439|FG000|Overall Study|Death|3|||
33411132|NCT00108433|62789440|FG001|Overall Study|Death|0|||
33411133|NCT00108433|62789439|FG000|Overall Study|Adverse Event|3|||
33411134|NCT00108433|62789440|FG001|Overall Study|Adverse Event|1|||
33411135|NCT00108433|62789439|FG000|Overall Study|Other|14|||
33411136|NCT00108433|62789440|FG001|Overall Study|Other|14|||
33411137|NCT00116779|62789448|FG000|Overall Study|Adverse Event|4|||
33411138|NCT00116779|62789449|FG001|Overall Study|Adverse Event|2|||
33411139|NCT00116779|62789448|FG000|Overall Study|Protocol Violation|1|||
33411140|NCT00116779|62789449|FG001|Overall Study|Protocol Violation|4|||
33411141|NCT00116779|62789448|FG000|Overall Study|Withdrawal by Subject|4|||
33411142|NCT00116779|62789449|FG001|Overall Study|Withdrawal by Subject|1|||
33411143|NCT00116779|62789448|FG000|Overall Study|Inadequate testosterone suppression|7|||
33411144|NCT00116779|62789449|FG001|Overall Study|Inadequate testosterone suppression|9|||
33411145|NCT00116779|62789448|FG000|Overall Study|Physician Decision|3|||
33411146|NCT00116779|62789449|FG001|Overall Study|Physician Decision|1|||
33411147|NCT00116779|62789448|FG000|Overall Study|Elevated PSA levels|2|||
33411148|NCT00116779|62789449|FG001|Overall Study|Elevated PSA levels|2|||
33411149|NCT03943290|62789464|FG000|Overall Study|Sponsor Terminated Study|6|||
33411150|NCT03943290|62789465|FG001|Overall Study|Sponsor Terminated Study|1|||
33411151|NCT03943290|62789466|FG002|Overall Study|Sponsor Terminated Study|11|||
33321784|NCT00991341|62697916|FG001|Overall Study|Withdrawal by Subject|4|||
33321785|NCT00990249|62697922|FG000|Overall Study|Disease Progression|8|||
33321786|NCT00990249|62697922|FG000|Overall Study|Non-Compliance|1|||
33321787|NCT00990249|62697922|FG000|Overall Study|Death|2|||
33321788|NCT00990249|62697922|FG000|Overall Study|Not treated|2|||
33321789|NCT02846545|62697928|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
33321790|NCT02846545|62697929|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
33321791|NCT02846545|62697928|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
33321792|NCT02846545|62697929|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
33321793|NCT02846545|62697928|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
33321794|NCT02846545|62697929|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
33321795|NCT02846545|62697928|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
33321796|NCT02846545|62697929|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
33321797|NCT02846545|62697928|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
33321798|NCT02846545|62697929|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
33321799|NCT00990093|62697939|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
33321800|NCT00990093|62697940|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
33599377|NCT02460224|62998268|FG014|Overall Study|Subject/guardian decision|0|||
33411152|NCT03943290|62789467|FG003|Overall Study|Sponsor Terminated Study|6|||
33411153|NCT03943290|62789468|FG004|Overall Study|Sponsor Terminated Study|7|||
33411154|NCT03943290|62789469|FG005|Overall Study|Sponsor Terminated Study|6|||
33411155|NCT03943290|62789470|FG006|Overall Study|Sponsor Terminated Study|6|||
33411156|NCT03943290|62789471|FG007|Overall Study|Sponsor Terminated Study|7|||
33411157|NCT03943290|62789472|FG008|Overall Study|Sponsor Terminated Study|8|||
33411158|NCT03943290|62789464|FG000|Overall Study|Lost to Follow-up|1|||
33411159|NCT03943290|62789465|FG001|Overall Study|Lost to Follow-up|0|||
33411160|NCT03943290|62789466|FG002|Overall Study|Lost to Follow-up|1|||
33411161|NCT03943290|62789467|FG003|Overall Study|Lost to Follow-up|0|||
33411162|NCT03943290|62789468|FG004|Overall Study|Lost to Follow-up|0|||
33411163|NCT03943290|62789469|FG005|Overall Study|Lost to Follow-up|0|||
33411164|NCT03943290|62789470|FG006|Overall Study|Lost to Follow-up|0|||
33411165|NCT03943290|62789471|FG007|Overall Study|Lost to Follow-up|1|||
33411166|NCT03943290|62789472|FG008|Overall Study|Lost to Follow-up|0|||
33411167|NCT03943290|62789464|FG000|Overall Study|Withdrawal by Subject|0|||
33411168|NCT03943290|62789465|FG001|Overall Study|Withdrawal by Subject|0|||
33411169|NCT03943290|62789466|FG002|Overall Study|Withdrawal by Subject|1|||
33411170|NCT03943290|62789467|FG003|Overall Study|Withdrawal by Subject|0|||
33411171|NCT03943290|62789468|FG004|Overall Study|Withdrawal by Subject|0|||
33411172|NCT03943290|62789469|FG005|Overall Study|Withdrawal by Subject|0|||
33411173|NCT03943290|62789470|FG006|Overall Study|Withdrawal by Subject|0|||
33411174|NCT03943290|62789471|FG007|Overall Study|Withdrawal by Subject|0|||
33411175|NCT03943290|62789472|FG008|Overall Study|Withdrawal by Subject|0|||
33411176|NCT00108355|62789507|FG000|Overall Study|Peritonitis at index paracentesis|1|||
33411177|NCT00108355|62789508|FG001|Overall Study|Peritonitis at index paracentesis|1|||
33411178|NCT00108355|62789507|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
33411179|NCT00108355|62789508|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
33411180|NCT00094861|62789529|FG000|Overall Study|Adverse Event|5|||
33411181|NCT00094861|62789530|FG001|Overall Study|Adverse Event|2|||
33411182|NCT00094861|62789529|FG000|Overall Study|Withdrawal by Subject|5|||
33411183|NCT00094861|62789530|FG001|Overall Study|Withdrawal by Subject|3|||
33411184|NCT00094861|62789529|FG000|Overall Study|Physician Decision|1|||
33411185|NCT00094861|62789530|FG001|Overall Study|Physician Decision|1|||
33411186|NCT00094861|62789529|FG000|Overall Study|Lost to Follow-up|0|||
33411187|NCT00094861|62789530|FG001|Overall Study|Lost to Follow-up|1|||
33411188|NCT00094861|62789529|FG000|Overall Study|Death|4|||
33411189|NCT00094861|62789530|FG001|Overall Study|Death|2|||
33411190|NCT00094861|62789529|FG000|Overall Study|Other|3|||
33411191|NCT00094861|62789530|FG001|Overall Study|Other|0|||
33411192|NCT00426556|62789540|FG000|Phase I - Core Phase|Disease Progression|0|||
33411193|NCT00426556|62789541|FG001|Phase I - Core Phase|Disease Progression|6|||
33411194|NCT00426556|62789542|FG002|Phase I - Core Phase|Disease Progression|2|||
33411195|NCT00426556|62789543|FG003|Phase I - Core Phase|Disease Progression|0|||
33411196|NCT00426556|62789540|FG000|Phase I - Core Phase|Adverse Event|1|||
33411197|NCT00426556|62789541|FG001|Phase I - Core Phase|Adverse Event|3|||
33411198|NCT00426556|62789542|FG002|Phase I - Core Phase|Adverse Event|1|||
33411199|NCT00426556|62789543|FG003|Phase I - Core Phase|Adverse Event|0|||
33411200|NCT00426556|62789540|FG000|Phase I - Core Phase|Death|0|||
33411201|NCT00426556|62789541|FG001|Phase I - Core Phase|Death|1|||
33411202|NCT00426556|62789542|FG002|Phase I - Core Phase|Death|0|||
33411203|NCT00426556|62789543|FG003|Phase I - Core Phase|Death|0|||
33411204|NCT00426556|62789540|FG000|Phase I - Extension Phase|Adverse Event|0|||
33411205|NCT00426556|62789541|FG001|Phase I - Extension Phase|Adverse Event|1|||
33411206|NCT00426556|62789542|FG002|Phase I - Extension Phase|Adverse Event|1|||
33411207|NCT00426556|62789543|FG003|Phase I - Extension Phase|Adverse Event|0|||
33411208|NCT00426556|62789540|FG000|Phase I - Extension Phase|Disease Progression|5|||
33411209|NCT00426556|62789541|FG001|Phase I - Extension Phase|Disease Progression|5|||
33411210|NCT00426556|62789542|FG002|Phase I - Extension Phase|Disease Progression|6|||
33411211|NCT00426556|62789543|FG003|Phase I - Extension Phase|Disease Progression|0|||
33411212|NCT00426556|62789540|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
33411213|NCT00426556|62789541|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
33321801|NCT00990093|62697939|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
33411214|NCT00426556|62789542|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
33411215|NCT00426556|62789543|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
33321802|NCT00990093|62697940|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
33321803|NCT00990093|62697939|FG000|Test Period 1 (1-14 Days)|Other|1|||
33321804|NCT00990093|62697940|FG001|Test Period 1 (1-14 Days)|Other|0|||
33321805|NCT00990093|62697939|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
33321806|NCT00990093|62697940|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
33321807|NCT00990093|62697939|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
33321808|NCT00990093|62697940|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
33321809|NCT00990093|62697939|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
33411216|NCT00426556|62789540|FG000|Phase II - Core Phase|Disease Progression|0|||
33411217|NCT00426556|62789541|FG001|Phase II - Core Phase|Disease Progression|0|||
33411218|NCT00426556|62789542|FG002|Phase II - Core Phase|Disease Progression|0|||
33411219|NCT00426556|62789543|FG003|Phase II - Core Phase|Disease Progression|16|||
33411220|NCT00426556|62789540|FG000|Phase II - Core Phase|Adverse Event|0|||
33411221|NCT00426556|62789541|FG001|Phase II - Core Phase|Adverse Event|0|||
33411222|NCT00426556|62789542|FG002|Phase II - Core Phase|Adverse Event|0|||
33411223|NCT00426556|62789543|FG003|Phase II - Core Phase|Adverse Event|8|||
33411224|NCT00426556|62789540|FG000|Phase II - Extension Phase|Disease Progression|0|||
33411225|NCT00426556|62789541|FG001|Phase II - Extension Phase|Disease Progression|0|||
33411226|NCT00426556|62789542|FG002|Phase II - Extension Phase|Disease Progression|0|||
33411227|NCT00426556|62789543|FG003|Phase II - Extension Phase|Disease Progression|21|||
33411228|NCT00426556|62789540|FG000|Phase II - Extension Phase|Adverse Event|0|||
33411229|NCT00426556|62789541|FG001|Phase II - Extension Phase|Adverse Event|0|||
33411230|NCT00426556|62789542|FG002|Phase II - Extension Phase|Adverse Event|0|||
33411231|NCT00426556|62789543|FG003|Phase II - Extension Phase|Adverse Event|2|||
33411232|NCT00107653|62789555|FG000|Overall Study|Adverse Event|24|||
33411233|NCT00107653|62789556|FG001|Overall Study|Adverse Event|43|||
33411234|NCT00107653|62789555|FG000|Overall Study|Insufficient Therapeutic Response|25|||
33411235|NCT00107653|62789556|FG001|Overall Study|Insufficient Therapeutic Response|11|||
33411236|NCT00107653|62789555|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
33411237|NCT00107653|62789556|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
33411238|NCT00107653|62789555|FG000|Overall Study|Protocol Violation|1|||
33411239|NCT00107653|62789556|FG001|Overall Study|Protocol Violation|0|||
33411240|NCT00107653|62789555|FG000|Overall Study|Withdrawal by Subject|12|||
33411241|NCT00107653|62789556|FG001|Overall Study|Withdrawal by Subject|13|||
33411242|NCT00107653|62789555|FG000|Overall Study|Lost to Follow-up|13|||
33411243|NCT00107653|62789556|FG001|Overall Study|Lost to Follow-up|5|||
33411244|NCT00107653|62789555|FG000|Overall Study|Administrative Reasons|3|||
33411245|NCT00107653|62789556|FG001|Overall Study|Administrative Reasons|3|||
33411246|NCT03950856|62789566|FG000|Overall Study|Death|1|||
33411247|NCT03950856|62789567|FG001|Overall Study|Death|2|||
33411248|NCT03950856|62789568|FG002|Overall Study|Death|0|||
33411249|NCT03950856|62789569|FG003|Overall Study|Death|0|||
33411250|NCT03950856|62789566|FG000|Overall Study|Lost to Follow-up|5|||
33411251|NCT03950856|62789567|FG001|Overall Study|Lost to Follow-up|6|||
33411252|NCT03950856|62789568|FG002|Overall Study|Lost to Follow-up|8|||
33411253|NCT03950856|62789569|FG003|Overall Study|Lost to Follow-up|2|||
33411254|NCT03950856|62789566|FG000|Overall Study|Protocol Violation|2|||
33411255|NCT03950856|62789567|FG001|Overall Study|Protocol Violation|0|||
33411256|NCT03950856|62789568|FG002|Overall Study|Protocol Violation|0|||
33411257|NCT03950856|62789569|FG003|Overall Study|Protocol Violation|1|||
33411258|NCT03950856|62789566|FG000|Overall Study|Withdrawal by Subject|4|||
33411259|NCT03950856|62789567|FG001|Overall Study|Withdrawal by Subject|1|||
33411260|NCT03950856|62789568|FG002|Overall Study|Withdrawal by Subject|3|||
33411261|NCT03950856|62789569|FG003|Overall Study|Withdrawal by Subject|1|||
33411262|NCT03950856|62789566|FG000|Overall Study|Unable to phone|7|||
33411263|NCT03950856|62789567|FG001|Overall Study|Unable to phone|6|||
33494040|NCT03475056|62872700|FG001|Overall Study|Lost to Follow-up|1|||
33411264|NCT03950856|62789568|FG002|Overall Study|Unable to phone|7|||
33411265|NCT03950856|62789569|FG003|Overall Study|Unable to phone|2|||
33411266|NCT00433654|62789583|FG000|Overall Study|Death|4|||
33411267|NCT00433654|62789584|FG001|Overall Study|Death|0|||
33411268|NCT00433654|62789583|FG000|Overall Study|Missed visit|6|||
33411269|NCT00433654|62789584|FG001|Overall Study|Missed visit|3|||
33494041|NCT03475056|62872699|FG000|Overall Study|Moved from Area|0|||
33411270|NCT00433654|62789583|FG000|Overall Study|Subject not yet due for visit|4|||
33411271|NCT00433654|62789584|FG001|Overall Study|Subject not yet due for visit|0|||
33411272|NCT00433654|62789583|FG000|Overall Study|Withdrawal by Subject|1|||
33411273|NCT00433654|62789584|FG001|Overall Study|Withdrawal by Subject|2|||
33411274|NCT00689351|62789598|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
33411275|NCT00689351|62789599|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
33411276|NCT00689351|62789598|FG000|Infant Series of Dosing|Adverse Event|1|||
33411277|NCT00689351|62789599|FG001|Infant Series of Dosing|Adverse Event|0|||
33411278|NCT00689351|62789598|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
33411279|NCT00689351|62789599|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
33411280|NCT00689351|62789598|FG000|After Infant Series|Parent/legal guardian request|1|||
33411281|NCT00689351|62789599|FG001|After Infant Series|Parent/legal guardian request|0|||
33411282|NCT03950622|62789611|FG000|Overall Study|Withdrawal by Subject|1|||
33411283|NCT03950622|62789612|FG001|Overall Study|Withdrawal by Subject|0|||
33411284|NCT03950622|62789611|FG000|Overall Study|Protocol Deviation|0|||
33411285|NCT03950622|62789612|FG001|Overall Study|Protocol Deviation|1|||
33411286|NCT03950622|62789611|FG000|Overall Study|Physician Decision|1|||
33411287|NCT03950622|62789612|FG001|Overall Study|Physician Decision|0|||
33411288|NCT03950622|62789611|FG000|Overall Study|Lost to Follow-up|5|||
33411289|NCT03950622|62789612|FG001|Overall Study|Lost to Follow-up|5|||
33411290|NCT03950622|62789611|FG000|Overall Study|Death|1|||
33411291|NCT03950622|62789612|FG001|Overall Study|Death|1|||
33411292|NCT03937908|62789618|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
33411293|NCT03937908|62789619|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
33411294|NCT00689273|62789627|FG000|Overall Study|Adverse Event|3|||
33411295|NCT00689273|62789628|FG001|Overall Study|Adverse Event|1|||
33411296|NCT00689273|62789627|FG000|Overall Study|Lack of Efficacy|3|||
33411297|NCT00689273|62789628|FG001|Overall Study|Lack of Efficacy|0|||
33411298|NCT00689273|62789627|FG000|Overall Study|Lost to Follow-up|0|||
33411299|NCT00689273|62789628|FG001|Overall Study|Lost to Follow-up|2|||
33599378|NCT02460224|62998269|FG015|Overall Study|Subject/guardian decision|1|||
33599379|NCT02460224|62998270|FG016|Overall Study|Subject/guardian decision|0|||
33599380|NCT02460224|62998271|FG017|Overall Study|Subject/guardian decision|1|||
33599381|NCT02460224|62998272|FG018|Overall Study|Subject/guardian decision|2|||
33599382|NCT02460224|62998273|FG019|Overall Study|Subject/guardian decision|0|||
33599383|NCT02460224|62998274|FG020|Overall Study|Subject/guardian decision|0|||
33599384|NCT02460224|62998275|FG021|Overall Study|Subject/guardian decision|1|||
33599385|NCT02460224|62998276|FG022|Overall Study|Subject/guardian decision|0|||
33321810|NCT00990093|62697940|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
33321811|NCT00990093|62697939|FG000|Test Period 2 (15-28 Days)|Other|0|||
33321812|NCT00990093|62697940|FG001|Test Period 2 (15-28 Days)|Other|1|||
33321813|NCT00984165|62697950|FG000|Overall Study|Death on study|2|||
33321814|NCT00984165|62697951|FG001|Overall Study|Death on study|0|||
33321815|NCT00984165|62697952|FG002|Overall Study|Death on study|0|||
33321816|NCT00984165|62697953|FG003|Overall Study|Death on study|0|||
33321817|NCT00984165|62697950|FG000|Overall Study|Disease progression on study|5|||
33321818|NCT00984165|62697951|FG001|Overall Study|Disease progression on study|1|||
33321819|NCT00984165|62697952|FG002|Overall Study|Disease progression on study|0|||
33321820|NCT00984165|62697953|FG003|Overall Study|Disease progression on study|0|||
33321821|NCT00984165|62697950|FG000|Overall Study|Death of recipient|0|||
33321822|NCT00984165|62697951|FG001|Overall Study|Death of recipient|0|||
33321823|NCT00984165|62697952|FG002|Overall Study|Death of recipient|0|||
33321824|NCT00984165|62697953|FG003|Overall Study|Death of recipient|1|||
33321825|NCT00984165|62697950|FG000|Overall Study|New protocol|0|||
33321826|NCT00984165|62697951|FG001|Overall Study|New protocol|0|||
33321827|NCT00984165|62697952|FG002|Overall Study|New protocol|0|||
33321828|NCT00984165|62697953|FG003|Overall Study|New protocol|1|||
33321829|NCT00984165|62697950|FG000|Overall Study|P+/donor pair removed from protocol|0|||
33321830|NCT00984165|62697951|FG001|Overall Study|P+/donor pair removed from protocol|0|||
33321831|NCT00984165|62697952|FG002|Overall Study|P+/donor pair removed from protocol|0|||
33321832|NCT00984165|62697953|FG003|Overall Study|P+/donor pair removed from protocol|1|||
33321833|NCT00984165|62697950|FG000|Overall Study|removed with a pair recipient|0|||
33321834|NCT00984165|62697951|FG001|Overall Study|removed with a pair recipient|0|||
33321835|NCT00984165|62697952|FG002|Overall Study|removed with a pair recipient|0|||
33321836|NCT00984165|62697953|FG003|Overall Study|removed with a pair recipient|1|||
33321837|NCT00993291|62697964|FG000|Overall Study|Withdrawal by Subject|1|||
33321838|NCT01196975|62697973|FG000|Overall Study|Adverse Event|2|||
33321839|NCT01196975|62697974|FG001|Overall Study|Adverse Event|2|||
33321840|NCT01196975|62697975|FG002|Overall Study|Adverse Event|0|||
33321841|NCT01196975|62697976|FG003|Overall Study|Adverse Event|0|||
33321842|NCT01196975|62697977|FG004|Overall Study|Adverse Event|2|||
33321843|NCT01196975|62697973|FG000|Overall Study|Withdrawal by Subject|2|||
33321844|NCT01196975|62697974|FG001|Overall Study|Withdrawal by Subject|1|||
33321845|NCT01196975|62697975|FG002|Overall Study|Withdrawal by Subject|0|||
33321846|NCT01196975|62697976|FG003|Overall Study|Withdrawal by Subject|1|||
33321847|NCT01196975|62697977|FG004|Overall Study|Withdrawal by Subject|0|||
33411300|NCT00689273|62789627|FG000|Overall Study|Other|6|||
33411301|NCT00689273|62789628|FG001|Overall Study|Other|2|||
33411302|NCT00689273|62789627|FG000|Overall Study|Randomized but not Treated|1|||
33411303|NCT00689273|62789628|FG001|Overall Study|Randomized but not Treated|0|||
33411304|NCT00553358|62789637|FG000|Overall Study|Randomized but did not receive treatment|3|||
33411305|NCT00553358|62789638|FG001|Overall Study|Randomized but did not receive treatment|3|||
33411306|NCT00553358|62789639|FG002|Overall Study|Randomized but did not receive treatment|1|||
33411307|NCT00553358|62789637|FG000|Overall Study|Lost to Follow-up|22|||
33411308|NCT00553358|62789638|FG001|Overall Study|Lost to Follow-up|26|||
33411309|NCT00553358|62789639|FG002|Overall Study|Lost to Follow-up|18|||
33411310|NCT00553358|62789637|FG000|Overall Study|Withdrew completely|23|||
33411311|NCT00553358|62789638|FG001|Overall Study|Withdrew completely|33|||
33411312|NCT00553358|62789639|FG002|Overall Study|Withdrew completely|34|||
33411313|NCT00553358|62789637|FG000|Overall Study|Died during clinical follow-up|25|||
33411314|NCT00553358|62789638|FG001|Overall Study|Died during clinical follow-up|29|||
33411315|NCT00553358|62789639|FG002|Overall Study|Died during clinical follow-up|32|||
33411316|NCT00553358|62789637|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
33411317|NCT00553358|62789638|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
33411318|NCT00553358|62789639|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
33411319|NCT00553358|62789637|FG000|Overall Study|Died after clinical follow-up ended|1|||
33411320|NCT00553358|62789638|FG001|Overall Study|Died after clinical follow-up ended|2|||
33411321|NCT00553358|62789639|FG002|Overall Study|Died after clinical follow-up ended|0|||
33411322|NCT00553358|62789637|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
33411323|NCT00553358|62789638|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
33321848|NCT01196975|62697973|FG000|Overall Study|Lost to Follow-up|11|||
33321849|NCT01196975|62697974|FG001|Overall Study|Lost to Follow-up|6|||
33321850|NCT01196975|62697975|FG002|Overall Study|Lost to Follow-up|5|||
33321851|NCT01196975|62697976|FG003|Overall Study|Lost to Follow-up|5|||
33321852|NCT01196975|62697977|FG004|Overall Study|Lost to Follow-up|11|||
33321853|NCT00992589|62698012|FG000|Open-Label Phase|Adverse Event|4|||
33321854|NCT00992589|62698013|FG001|Open-Label Phase|Adverse Event|0|||
33321855|NCT00992589|62698014|FG002|Open-Label Phase|Adverse Event|0|||
33321856|NCT00992589|62698015|FG003|Open-Label Phase|Adverse Event|0|||
33321857|NCT00992589|62698012|FG000|Open-Label Phase|Withdrawal by Subject|20|||
33321858|NCT00992589|62698013|FG001|Open-Label Phase|Withdrawal by Subject|0|||
33321859|NCT00992589|62698014|FG002|Open-Label Phase|Withdrawal by Subject|0|||
33321860|NCT00992589|62698015|FG003|Open-Label Phase|Withdrawal by Subject|0|||
33321861|NCT00992589|62698012|FG000|Open-Label Phase|Lost to Follow-up|1|||
33321862|NCT00992589|62698013|FG001|Open-Label Phase|Lost to Follow-up|0|||
33321863|NCT00992589|62698014|FG002|Open-Label Phase|Lost to Follow-up|0|||
33321864|NCT00992589|62698015|FG003|Open-Label Phase|Lost to Follow-up|0|||
33321865|NCT00992589|62698012|FG000|Open-Label Phase|Protocol Violation|3|||
33321866|NCT00992589|62698013|FG001|Open-Label Phase|Protocol Violation|0|||
33321867|NCT00992589|62698014|FG002|Open-Label Phase|Protocol Violation|0|||
33321868|NCT00992589|62698015|FG003|Open-Label Phase|Protocol Violation|0|||
33321869|NCT00992589|62698012|FG000|Open-Label Phase|Physician Decision|4|||
33321870|NCT00992589|62698013|FG001|Open-Label Phase|Physician Decision|0|||
33321871|NCT00992589|62698014|FG002|Open-Label Phase|Physician Decision|0|||
33321872|NCT00992589|62698015|FG003|Open-Label Phase|Physician Decision|0|||
33321873|NCT00992589|62698012|FG000|Open-Label Phase|Other|45|||
33321874|NCT00992589|62698013|FG001|Open-Label Phase|Other|0|||
33321875|NCT00992589|62698014|FG002|Open-Label Phase|Other|0|||
33321876|NCT00992589|62698015|FG003|Open-Label Phase|Other|0|||
33321877|NCT00992589|62698012|FG000|Double-Blind Phase|Adverse Event|0|||
33321878|NCT00992589|62698013|FG001|Double-Blind Phase|Adverse Event|6|||
33321879|NCT00992589|62698014|FG002|Double-Blind Phase|Adverse Event|2|||
33321880|NCT00992589|62698015|FG003|Double-Blind Phase|Adverse Event|3|||
33411324|NCT00553358|62789639|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
33321881|NCT00992589|62698012|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
33321882|NCT00992589|62698013|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
33321883|NCT00992589|62698014|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
33321884|NCT00992589|62698015|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
33411325|NCT00688259|62789655|FG000|Overall Study|Lost to Follow-up|2|||
33411326|NCT00688259|62789656|FG001|Overall Study|Lost to Follow-up|4|||
33411327|NCT00688259|62789655|FG000|Overall Study|Physician Decision|1|||
33411328|NCT00688259|62789656|FG001|Overall Study|Physician Decision|0|||
33411329|NCT00688259|62789655|FG000|Overall Study|Withdrawal by Subject|2|||
33411330|NCT00688259|62789656|FG001|Overall Study|Withdrawal by Subject|0|||
33411331|NCT00688259|62789655|FG000|Overall Study|Declined Interview|2|||
33411332|NCT00688259|62789656|FG001|Overall Study|Declined Interview|3|||
33411333|NCT00688259|62789655|FG000|Overall Study|Hospitalized at Follow-up|0|||
33411334|NCT00688259|62789656|FG001|Overall Study|Hospitalized at Follow-up|1|||
33411335|NCT00688181|62789662|FG000|Overall Study|Lost to Follow-up|17|||
33411336|NCT00688181|62789662|FG000|Overall Study|Unknown Reason|4|||
33411337|NCT00688181|62789662|FG000|Overall Study|Non-clinical Reason|2|||
33411338|NCT00689117|62789681|FG000|Overall Study|Adverse Event|6|||
33411339|NCT00689117|62789682|FG001|Overall Study|Adverse Event|0|||
33411340|NCT00689117|62789683|FG002|Overall Study|Adverse Event|5|||
33411341|NCT00689117|62789684|FG003|Overall Study|Adverse Event|0|||
33411342|NCT00689117|62789681|FG000|Overall Study|Lost to Follow-up|26|||
33411343|NCT00689117|62789682|FG001|Overall Study|Lost to Follow-up|19|||
33411344|NCT00689117|62789683|FG002|Overall Study|Lost to Follow-up|17|||
33411345|NCT00689117|62789684|FG003|Overall Study|Lost to Follow-up|11|||
33411346|NCT00689117|62789681|FG000|Overall Study|Lack of Efficacy|1|||
33411347|NCT00689117|62789682|FG001|Overall Study|Lack of Efficacy|2|||
33411348|NCT00689117|62789683|FG002|Overall Study|Lack of Efficacy|2|||
33411349|NCT00689117|62789684|FG003|Overall Study|Lack of Efficacy|2|||
33411350|NCT00689117|62789681|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
33411351|NCT00689117|62789682|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
33411352|NCT00689117|62789683|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
33411353|NCT00689117|62789684|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
33411354|NCT00689117|62789681|FG000|Overall Study|Withdrawal by Subject|19|||
33411355|NCT00689117|62789682|FG001|Overall Study|Withdrawal by Subject|18|||
33411356|NCT00689117|62789683|FG002|Overall Study|Withdrawal by Subject|26|||
33411357|NCT00689117|62789684|FG003|Overall Study|Withdrawal by Subject|13|||
33411358|NCT00689117|62789681|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
33411359|NCT00689117|62789682|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
33411360|NCT00689117|62789683|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
33411361|NCT00689117|62789684|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
33411362|NCT00689117|62789681|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
33411363|NCT00689117|62789682|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
33411364|NCT00689117|62789683|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33411365|NCT00689117|62789684|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33411366|NCT00689117|62789681|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
33411367|NCT00689117|62789682|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
33411368|NCT00689117|62789683|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
33411369|NCT00689117|62789684|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
33411370|NCT00689117|62789681|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
33411371|NCT00689117|62789682|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
33411372|NCT00689117|62789683|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
33411373|NCT00689117|62789684|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
33411374|NCT00689117|62789681|FG000|Overall Study|Use of Prohibitive Medication|2|||
33411375|NCT00689117|62789682|FG001|Overall Study|Use of Prohibitive Medication|1|||
33411376|NCT00689117|62789683|FG002|Overall Study|Use of Prohibitive Medication|3|||
33411377|NCT00689117|62789684|FG003|Overall Study|Use of Prohibitive Medication|0|||
33411378|NCT00689117|62789681|FG000|Overall Study|Pregnancy|0|||
33411379|NCT00689117|62789682|FG001|Overall Study|Pregnancy|2|||
33411380|NCT00689117|62789683|FG002|Overall Study|Pregnancy|0|||
33411381|NCT00689117|62789684|FG003|Overall Study|Pregnancy|2|||
33411382|NCT00689117|62789681|FG000|Overall Study|Incarceration|2|||
33411383|NCT00689117|62789682|FG001|Overall Study|Incarceration|0|||
33411384|NCT00689117|62789683|FG002|Overall Study|Incarceration|0|||
33411385|NCT00689117|62789684|FG003|Overall Study|Incarceration|0|||
33411386|NCT00689117|62789681|FG000|Overall Study|Fear of Birth Defects|0|||
33411387|NCT00689117|62789682|FG001|Overall Study|Fear of Birth Defects|0|||
33411388|NCT00689117|62789683|FG002|Overall Study|Fear of Birth Defects|1|||
33411389|NCT00689117|62789684|FG003|Overall Study|Fear of Birth Defects|0|||
33411390|NCT00689117|62789681|FG000|Overall Study|Transportation|1|||
33411391|NCT00689117|62789682|FG001|Overall Study|Transportation|0|||
33411392|NCT00689117|62789683|FG002|Overall Study|Transportation|0|||
33411393|NCT00689117|62789684|FG003|Overall Study|Transportation|0|||
33411394|NCT00689117|62789681|FG000|Overall Study|Patient Withdrew from Study|0|||
33411395|NCT00689117|62789682|FG001|Overall Study|Patient Withdrew from Study|0|||
33411396|NCT00689117|62789683|FG002|Overall Study|Patient Withdrew from Study|0|||
33411397|NCT00689117|62789684|FG003|Overall Study|Patient Withdrew from Study|1|||
33411398|NCT00689117|62789681|FG000|Overall Study|Personal Reason|0|||
33599386|NCT02460224|62998277|FG023|Overall Study|Subject/guardian decision|0|||
33599387|NCT02460224|62998278|FG024|Overall Study|Subject/guardian decision|0|||
33599388|NCT02460224|62998279|FG025|Overall Study|Subject/guardian decision|0|||
33599389|NCT02460224|62998280|FG026|Overall Study|Subject/guardian decision|6|||
33599390|NCT02460224|62998281|FG027|Overall Study|Subject/guardian decision|2|||
33599391|NCT02460224|62998282|FG028|Overall Study|Subject/guardian decision|3|||
33599392|NCT02094573|62998356|FG000|Overall Study|Adverse Event|4|||
33599393|NCT02094573|62998357|FG001|Overall Study|Adverse Event|14|||
33599394|NCT02094573|62998356|FG000|Overall Study|Clinical Progressive Disease|9|||
33599395|NCT02094573|62998357|FG001|Overall Study|Clinical Progressive Disease|13|||
33599396|NCT02094573|62998356|FG000|Overall Study|Death|11|||
33599397|NCT02094573|62998357|FG001|Overall Study|Death|3|||
33599398|NCT02094573|62998356|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
33599399|NCT02094573|62998357|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
33599400|NCT02094573|62998356|FG000|Overall Study|Non-compliance with Study Drug|1|||
33599401|NCT02094573|62998357|FG001|Overall Study|Non-compliance with Study Drug|1|||
33599402|NCT02094573|62998356|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
33599403|NCT02094573|62998357|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
33599404|NCT02094573|62998356|FG000|Overall Study|Physician Decision|4|||
33599405|NCT02094573|62998357|FG001|Overall Study|Physician Decision|4|||
33599406|NCT02094573|62998356|FG000|Overall Study|Site Terminated by Sponsor|10|||
33599407|NCT02094573|62998357|FG001|Overall Study|Site Terminated by Sponsor|17|||
33599408|NCT02094573|62998356|FG000|Overall Study|Withdrawal by Subject|6|||
33599409|NCT02094573|62998357|FG001|Overall Study|Withdrawal by Subject|8|||
33599410|NCT02094573|62998356|FG000|Overall Study|Randomized but not Treated|3|||
33599411|NCT02094573|62998357|FG001|Overall Study|Randomized but not Treated|0|||
33599412|NCT01859494|62998363|FG000|Overall Study|Adverse Event|1|||
33599413|NCT01858636|62998367|FG000|Overall Study|No Device Deployment Attempted|24|||
33599414|NCT01858636|62998367|FG000|Overall Study|Physician Decision|1|||
33599415|NCT01858636|62998367|FG000|Overall Study|Death|1|||
33599416|NCT01858636|62998367|FG000|Overall Study|Lost to Follow-up|1|||
33599417|NCT01858636|62998367|FG000|Overall Study|Withdrawal by Subject|1|||
33411399|NCT00689117|62789682|FG001|Overall Study|Personal Reason|1|||
33411400|NCT00689117|62789683|FG002|Overall Study|Personal Reason|0|||
33411401|NCT00689117|62789684|FG003|Overall Study|Personal Reason|0|||
33411402|NCT00689117|62789681|FG000|Overall Study|Dispensing Error|0|||
33411403|NCT00689117|62789682|FG001|Overall Study|Dispensing Error|1|||
33411404|NCT00689117|62789683|FG002|Overall Study|Dispensing Error|0|||
33411405|NCT00689117|62789684|FG003|Overall Study|Dispensing Error|0|||
33411406|NCT00547248|62789698|FG000|Overall Study|Protocol Violation|0|||
33411407|NCT00547248|62789699|FG001|Overall Study|Protocol Violation|0|||
33411408|NCT00547248|62789700|FG002|Overall Study|Protocol Violation|1|||
33411409|NCT00547248|62789701|FG003|Overall Study|Protocol Violation|1|||
33411410|NCT00547248|62789698|FG000|Overall Study|Migrated/moved from study area|0|||
33411411|NCT00547248|62789699|FG001|Overall Study|Migrated/moved from study area|0|||
33411412|NCT00547248|62789700|FG002|Overall Study|Migrated/moved from study area|2|||
33411413|NCT00547248|62789701|FG003|Overall Study|Migrated/moved from study area|0|||
33411414|NCT00547248|62789698|FG000|Overall Study|Withdrawal by Subject|0|||
33411415|NCT00547248|62789699|FG001|Overall Study|Withdrawal by Subject|0|||
33411416|NCT00547248|62789700|FG002|Overall Study|Withdrawal by Subject|7|||
33411417|NCT00547248|62789701|FG003|Overall Study|Withdrawal by Subject|1|||
33411418|NCT00688103|62789716|FG000|Overall Study|Adverse Event|4|||
33411419|NCT00688103|62789717|FG001|Overall Study|Adverse Event|1|||
33411420|NCT00688103|62789716|FG000|Overall Study|Lack of Efficacy|11|||
33411421|NCT00688103|62789717|FG001|Overall Study|Lack of Efficacy|1|||
33411422|NCT00688103|62789716|FG000|Overall Study|Withdrawal by Subject|4|||
33599418|NCT02058849|62998374|FG000|Overall Study|Hospitalization|1|||
33599419|NCT02058849|62998375|FG001|Overall Study|Hospitalization|1|||
33599420|NCT02058849|62998374|FG000|Overall Study|Death|1|||
33599421|NCT02058849|62998375|FG001|Overall Study|Death|0|||
33599422|NCT02058849|62998374|FG000|Overall Study|Lost to Follow-up|1|||
33599423|NCT02058849|62998375|FG001|Overall Study|Lost to Follow-up|0|||
33599424|NCT02058849|62998374|FG000|Overall Study|Withdrawal by Subject|4|||
33411423|NCT00688103|62789717|FG001|Overall Study|Withdrawal by Subject|2|||
33411424|NCT00688103|62789716|FG000|Overall Study|complex reasons|11|||
33411425|NCT00688103|62789717|FG001|Overall Study|complex reasons|9|||
33411426|NCT00686855|62789727|FG000|Overall Study|Lost to Follow-up|1|||
33411427|NCT00686855|62789728|FG001|Overall Study|Lost to Follow-up|0|||
33411428|NCT00686855|62789727|FG000|Overall Study|Progressive GVHD|0|||
33411429|NCT00686855|62789728|FG001|Overall Study|Progressive GVHD|1|||
33599425|NCT02058849|62998375|FG001|Overall Study|Withdrawal by Subject|0|||
33599426|NCT01858558|62998383|FG000|Overall Study|Death|1|||
33599427|NCT01858558|62998384|FG001|Overall Study|Death|1|||
33599428|NCT01858558|62998383|FG000|Overall Study|Lost to Follow-up|1|||
33599429|NCT01858558|62998384|FG001|Overall Study|Lost to Follow-up|0|||
33599430|NCT01858558|62998383|FG000|Overall Study|Disease progression|3|||
33411430|NCT00686777|62789734|FG000|Overall Study|Adverse Event|2|||
33411431|NCT00686777|62789734|FG000|Overall Study|Pregnancy|1|||
33411432|NCT00686777|62789734|FG000|Overall Study|Withdrawal by Subject|2|||
33411433|NCT00686777|62789734|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
33411434|NCT00686777|62789734|FG000|Overall Study|No Visit|1|||
33411435|NCT00686699|62789740|FG000|Treatment Period 1|Adverse Event|0|||
33411436|NCT00686699|62789741|FG001|Treatment Period 1|Adverse Event|2|||
33411437|NCT00106639|62789750|FG000|Overall Study|Adverse Event|3|||
33411438|NCT00106639|62789751|FG001|Overall Study|Adverse Event|4|||
33411439|NCT00106639|62789752|FG002|Overall Study|Adverse Event|1|||
33411440|NCT00106639|62789750|FG000|Overall Study|Protocol Violation|0|||
33411441|NCT00106639|62789751|FG001|Overall Study|Protocol Violation|1|||
33411442|NCT00106639|62789752|FG002|Overall Study|Protocol Violation|0|||
33411443|NCT00106639|62789750|FG000|Overall Study|Withdrawal by Subject|0|||
33411444|NCT00106639|62789751|FG001|Overall Study|Withdrawal by Subject|1|||
33411445|NCT00106639|62789752|FG002|Overall Study|Withdrawal by Subject|0|||
33411446|NCT00106639|62789750|FG000|Overall Study|Participant defaulted|0|||
33411447|NCT00106639|62789751|FG001|Overall Study|Participant defaulted|1|||
33411448|NCT00106639|62789752|FG002|Overall Study|Participant defaulted|1|||
33411449|NCT00106249|62789763|FG000|Overall Study|Lost to Follow-up|3|||
33411450|NCT00106249|62789764|FG001|Overall Study|Lost to Follow-up|2|||
33411451|NCT00105469|62789772|FG000|Overall Study|Adverse Event|9|||
33411452|NCT00105469|62789773|FG001|Overall Study|Adverse Event|8|||
33411453|NCT00105469|62789772|FG000|Overall Study|Protocol Violation|4|||
33411454|NCT00105469|62789773|FG001|Overall Study|Protocol Violation|0|||
33411455|NCT00105469|62789772|FG000|Overall Study|Withdrawal by Subject|2|||
33411456|NCT00105469|62789773|FG001|Overall Study|Withdrawal by Subject|3|||
33411457|NCT00105469|62789772|FG000|Overall Study|Lost to Follow-up|1|||
33411458|NCT00105469|62789773|FG001|Overall Study|Lost to Follow-up|0|||
33411459|NCT00105469|62789772|FG000|Overall Study|Lack of Efficacy|2|||
33411460|NCT00105469|62789773|FG001|Overall Study|Lack of Efficacy|0|||
33411461|NCT00105469|62789772|FG000|Overall Study|Other Reason|4|||
33411462|NCT00105469|62789773|FG001|Overall Study|Other Reason|0|||
33411463|NCT00105235|62789779|FG000|Overall Study|Death|4|||
33411464|NCT00105235|62789779|FG000|Overall Study|Physician Decision|1|||
33599431|NCT01858558|62998384|FG001|Overall Study|Disease progression|1|||
33599432|NCT01858558|62998383|FG000|Overall Study|Product contamination|2|||
33599433|NCT01858558|62998384|FG001|Overall Study|Product contamination|0|||
33599434|NCT01858558|62998383|FG000|Overall Study|Failed expansion of cell product|2|||
33599435|NCT01858558|62998384|FG001|Overall Study|Failed expansion of cell product|0|||
33599436|NCT02058537|62998390|FG000|Overall Study|Withdrawal by Subject|1|||
33599437|NCT01612000|62998398|FG000|Overall Study|Lost to Follow-up|6|||
33599438|NCT01612000|62998399|FG001|Overall Study|Lost to Follow-up|4|||
33411465|NCT00105235|62789779|FG000|Overall Study|Withdrawal by Subject|2|||
33411466|NCT00547118|62789789|FG000|Overall Study|Did not qualify prior to starting drug|1|||
33411467|NCT00547118|62789790|FG001|Overall Study|Did not qualify prior to starting drug|1|||
33599439|NCT01612000|62998400|FG002|Overall Study|Lost to Follow-up|4|||
33599440|NCT01612000|62998401|FG003|Overall Study|Lost to Follow-up|8|||
33321885|NCT00992589|62698012|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33321886|NCT00992589|62698013|FG001|Double-Blind Phase|Lost to Follow-up|0|||
33321887|NCT00992589|62698014|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33321888|NCT00992589|62698015|FG003|Double-Blind Phase|Lost to Follow-up|2|||
33321889|NCT00992589|62698012|FG000|Double-Blind Phase|Other|0|||
33321890|NCT00992589|62698013|FG001|Double-Blind Phase|Other|1|||
33321891|NCT00992589|62698014|FG002|Double-Blind Phase|Other|6|||
33321892|NCT00992589|62698015|FG003|Double-Blind Phase|Other|3|||
33411468|NCT00547118|62789789|FG000|Overall Study|Study suspended|7|||
33411469|NCT00547118|62789790|FG001|Overall Study|Study suspended|8|||
33411470|NCT00502593|62789810|FG000|Overall Study|Withdrawn unspecified reason|1|||
33411471|NCT00502593|62789811|FG001|Overall Study|Withdrawn unspecified reason|1|||
33411472|NCT00502593|62789812|FG002|Overall Study|Withdrawn unspecified reason|3|||
33599441|NCT01612000|62998398|FG000|Overall Study|Physician Decision|0|||
33599442|NCT01612000|62998399|FG001|Overall Study|Physician Decision|0|||
33599443|NCT01612000|62998400|FG002|Overall Study|Physician Decision|1|||
33599444|NCT01612000|62998401|FG003|Overall Study|Physician Decision|0|||
33599445|NCT01612000|62998398|FG000|Overall Study|Withdrawal by Subject|3|||
33321893|NCT01196741|62698035|FG000|Overall Study|Disease progression|34|||
33411473|NCT00502593|62789813|FG003|Overall Study|Withdrawn unspecified reason|1|||
33411474|NCT00502593|62789814|FG004|Overall Study|Withdrawn unspecified reason|2|||
33411475|NCT00502593|62789815|FG005|Overall Study|Withdrawn unspecified reason|0|||
33411476|NCT00502593|62789816|FG006|Overall Study|Withdrawn unspecified reason|2|||
33599446|NCT01612000|62998399|FG001|Overall Study|Withdrawal by Subject|1|||
33599447|NCT01612000|62998400|FG002|Overall Study|Withdrawal by Subject|2|||
33411477|NCT00502593|62789817|FG007|Overall Study|Withdrawn unspecified reason|0|||
33411478|NCT00502593|62789818|FG008|Overall Study|Withdrawn unspecified reason|0|||
33411479|NCT00502593|62789819|FG009|Overall Study|Withdrawn unspecified reason|0|||
33411480|NCT00502593|62789820|FG010|Overall Study|Withdrawn unspecified reason|0|||
33411481|NCT00502593|62789821|FG011|Overall Study|Withdrawn unspecified reason|0|||
33411482|NCT00502593|62789810|FG000|Overall Study|Withdrawal by Subject|0|||
33411483|NCT00502593|62789811|FG001|Overall Study|Withdrawal by Subject|0|||
33411484|NCT00502593|62789812|FG002|Overall Study|Withdrawal by Subject|6|||
33411485|NCT00502593|62789813|FG003|Overall Study|Withdrawal by Subject|2|||
33411486|NCT00502593|62789814|FG004|Overall Study|Withdrawal by Subject|2|||
33411487|NCT00502593|62789815|FG005|Overall Study|Withdrawal by Subject|0|||
33599448|NCT01612000|62998401|FG003|Overall Study|Withdrawal by Subject|2|||
33599449|NCT01895608|62998415|FG000|Overall Study|change in health status|0|||
33599450|NCT01895608|62998416|FG001|Overall Study|change in health status|1|||
33599451|NCT01895608|62998417|FG002|Overall Study|change in health status|1|||
33599452|NCT01895608|62998418|FG003|Overall Study|change in health status|0|||
33599453|NCT01895608|62998415|FG000|Overall Study|Withdrawal by Subject|0|||
33599454|NCT01895608|62998416|FG001|Overall Study|Withdrawal by Subject|0|||
33599455|NCT01895608|62998417|FG002|Overall Study|Withdrawal by Subject|2|||
33599456|NCT01895608|62998418|FG003|Overall Study|Withdrawal by Subject|0|||
33599457|NCT02409680|62998430|FG000|Overall Study|Lost to Follow-up|15|||
33599458|NCT02409680|62998431|FG001|Overall Study|Lost to Follow-up|30|||
33599459|NCT01895452|62998439|FG000|Overall Study|Adverse Event|1|||
33599460|NCT01895452|62998440|FG001|Overall Study|Adverse Event|4|||
33599461|NCT01895452|62998439|FG000|Overall Study|Lost to Follow-up|1|||
33599462|NCT01895452|62998440|FG001|Overall Study|Lost to Follow-up|5|||
33599463|NCT01895452|62998439|FG000|Overall Study|Pregnancy|0|||
33599464|NCT01895452|62998440|FG001|Overall Study|Pregnancy|1|||
33599465|NCT01895452|62998439|FG000|Overall Study|Withdrawal by Subject|2|||
33599466|NCT01895452|62998440|FG001|Overall Study|Withdrawal by Subject|14|||
33599467|NCT01895452|62998439|FG000|Overall Study|Underlying disease|0|||
33599468|NCT01895452|62998440|FG001|Overall Study|Underlying disease|3|||
33321894|NCT01196741|62698036|FG001|Overall Study|Disease progression|14|||
33321895|NCT01196741|62698035|FG000|Overall Study|Adverse Event|10|||
33321896|NCT01196741|62698036|FG001|Overall Study|Adverse Event|6|||
33321897|NCT01196741|62698035|FG000|Overall Study|Serious Adverse Event|3|||
33321898|NCT01196741|62698036|FG001|Overall Study|Serious Adverse Event|1|||
33321899|NCT01196741|62698035|FG000|Overall Study|Dose limiting Adverse Event|2|||
33321900|NCT01196741|62698036|FG001|Overall Study|Dose limiting Adverse Event|1|||
33321901|NCT01196741|62698035|FG000|Overall Study|Withdrawal by Subject|3|||
33321902|NCT01196741|62698036|FG001|Overall Study|Withdrawal by Subject|0|||
33321903|NCT01196741|62698035|FG000|Overall Study|Other reason|3|||
33321904|NCT01196741|62698036|FG001|Overall Study|Other reason|3|||
33321905|NCT01196741|62698035|FG000|Overall Study|Other|3|||
33321906|NCT01196741|62698036|FG001|Overall Study|Other|2|||
33321907|NCT01196741|62698035|FG000|Overall Study|Protocol Violation|2|||
33321908|NCT01196741|62698036|FG001|Overall Study|Protocol Violation|1|||
33321909|NCT00983385|62698042|FG000|Observation Period|Not eligible to be dosed|20|||
33321910|NCT00983385|62698042|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
33321911|NCT00992511|62698065|FG000|Overall Study|Migrated/moved from study area|1|||
33321912|NCT00992511|62698066|FG001|Overall Study|Migrated/moved from study area|0|||
33321913|NCT00992511|62698067|FG002|Overall Study|Migrated/moved from study area|1|||
33321914|NCT00992511|62698068|FG003|Overall Study|Migrated/moved from study area|2|||
33321915|NCT00992511|62698065|FG000|Overall Study|Lost to Follow-up|1|||
33321916|NCT00992511|62698066|FG001|Overall Study|Lost to Follow-up|0|||
33321917|NCT00992511|62698067|FG002|Overall Study|Lost to Follow-up|0|||
33321918|NCT00992511|62698068|FG003|Overall Study|Lost to Follow-up|2|||
33321919|NCT00992511|62698065|FG000|Overall Study|Withdrawal by Subject|0|||
33321920|NCT00992511|62698066|FG001|Overall Study|Withdrawal by Subject|0|||
33321921|NCT00992511|62698067|FG002|Overall Study|Withdrawal by Subject|1|||
33321922|NCT00992511|62698068|FG003|Overall Study|Withdrawal by Subject|1|||
33411488|NCT00502593|62789816|FG006|Overall Study|Withdrawal by Subject|3|||
33599469|NCT01895452|62998439|FG000|Overall Study|Noncompliance with study drug|0|||
33599470|NCT01895452|62998440|FG001|Overall Study|Noncompliance with study drug|1|||
33599471|NCT02094417|62998450|FG000|Overall Study|Adverse Event|0|||
33599472|NCT02094417|62998451|FG001|Overall Study|Adverse Event|0|||
33599473|NCT02094417|62998452|FG002|Overall Study|Adverse Event|0|||
33599474|NCT02094417|62998453|FG003|Overall Study|Adverse Event|1|||
33321923|NCT01196429|62698080|FG000|Overall Study|Ineligible - inadequate pathology|1|||
33599475|NCT02094417|62998450|FG000|Overall Study|Eligibility criteria|0|||
33321924|NCT01196429|62698081|FG001|Overall Study|Ineligible - inadequate pathology|0|||
33321925|NCT01196429|62698080|FG000|Overall Study|Ineligible - wrong cell type|1|||
33321926|NCT01196429|62698081|FG001|Overall Study|Ineligible - wrong cell type|0|||
33321927|NCT01196429|62698080|FG000|Overall Study|Refused - Never Treated|1|||
33599476|NCT02094417|62998451|FG001|Overall Study|Eligibility criteria|1|||
33599477|NCT02094417|62998452|FG002|Overall Study|Eligibility criteria|0|||
33599478|NCT02094417|62998453|FG003|Overall Study|Eligibility criteria|0|||
33599479|NCT02094417|62998450|FG000|Overall Study|No responder|4|||
33599480|NCT02094417|62998451|FG001|Overall Study|No responder|4|||
33599481|NCT02094417|62998452|FG002|Overall Study|No responder|4|||
33599482|NCT02094417|62998453|FG003|Overall Study|No responder|3|||
33599483|NCT02094417|62998450|FG000|Overall Study|Unable to conduct observations or assess|0|||
33599484|NCT02094417|62998451|FG001|Overall Study|Unable to conduct observations or assess|1|||
33599485|NCT02094417|62998452|FG002|Overall Study|Unable to conduct observations or assess|0|||
33599486|NCT02094417|62998453|FG003|Overall Study|Unable to conduct observations or assess|0|||
33599487|NCT02094417|62998450|FG000|Overall Study|Withdrawal by Subject|1|||
33599488|NCT02094417|62998451|FG001|Overall Study|Withdrawal by Subject|2|||
33599489|NCT02094417|62998452|FG002|Overall Study|Withdrawal by Subject|1|||
33599490|NCT02094417|62998453|FG003|Overall Study|Withdrawal by Subject|3|||
33599491|NCT01894984|62998465|FG000|Overall Study|Other|314|||
33411489|NCT00502593|62789817|FG007|Overall Study|Withdrawal by Subject|0|||
33411490|NCT00502593|62789818|FG008|Overall Study|Withdrawal by Subject|3|||
33411491|NCT00502593|62789819|FG009|Overall Study|Withdrawal by Subject|0|||
33411492|NCT00502593|62789820|FG010|Overall Study|Withdrawal by Subject|1|||
33411493|NCT00502593|62789821|FG011|Overall Study|Withdrawal by Subject|0|||
33411494|NCT00502593|62789810|FG000|Overall Study|Lost to Follow-up|2|||
33411495|NCT00502593|62789811|FG001|Overall Study|Lost to Follow-up|1|||
33411496|NCT00502593|62789812|FG002|Overall Study|Lost to Follow-up|1|||
33411497|NCT00502593|62789813|FG003|Overall Study|Lost to Follow-up|1|||
33411498|NCT00502593|62789814|FG004|Overall Study|Lost to Follow-up|0|||
33411499|NCT00502593|62789815|FG005|Overall Study|Lost to Follow-up|0|||
33411500|NCT00502593|62789816|FG006|Overall Study|Lost to Follow-up|0|||
33411501|NCT00502593|62789817|FG007|Overall Study|Lost to Follow-up|0|||
33411502|NCT00502593|62789818|FG008|Overall Study|Lost to Follow-up|3|||
33411503|NCT00502593|62789819|FG009|Overall Study|Lost to Follow-up|0|||
33411504|NCT00502593|62789820|FG010|Overall Study|Lost to Follow-up|1|||
33411505|NCT00502593|62789821|FG011|Overall Study|Lost to Follow-up|0|||
33411506|NCT00686543|62789874|FG000|Overall Study|Adverse Event|9|||
33411507|NCT00686543|62789875|FG001|Overall Study|Adverse Event|1|||
33411508|NCT00686543|62789876|FG002|Overall Study|Adverse Event|3|||
33411509|NCT00686543|62789877|FG003|Overall Study|Adverse Event|2|||
33411510|NCT00686543|62789874|FG000|Overall Study|Withdrawal by Subject|2|||
33411511|NCT00686543|62789875|FG001|Overall Study|Withdrawal by Subject|0|||
33411512|NCT00686543|62789876|FG002|Overall Study|Withdrawal by Subject|0|||
33411513|NCT00686543|62789877|FG003|Overall Study|Withdrawal by Subject|0|||
33411514|NCT00686543|62789874|FG000|Overall Study|Protocol Violation|3|||
33411515|NCT00686543|62789875|FG001|Overall Study|Protocol Violation|0|||
33411516|NCT00686543|62789876|FG002|Overall Study|Protocol Violation|2|||
33411517|NCT00686543|62789877|FG003|Overall Study|Protocol Violation|1|||
33411518|NCT00545688|62789891|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
33411519|NCT00545688|62789892|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
33411520|NCT00545688|62789893|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
33411521|NCT00545688|62789894|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
33411522|NCT00545688|62789891|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
33411523|NCT00545688|62789892|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
33411524|NCT00545688|62789893|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
33411525|NCT00545688|62789894|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
33411526|NCT00545688|62789891|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
33411527|NCT00545688|62789892|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
33494042|NCT03475056|62872700|FG001|Overall Study|Moved from Area|2|||
33494043|NCT00938912|62872707|FG000|Overall Study|Withdrawal by Subject|28|||
33494044|NCT00938912|62872707|FG000|Overall Study|Lost to Follow-up|4|||
33494045|NCT00938912|62872707|FG000|Overall Study|Lack of Efficacy|43|||
33494046|NCT00938912|62872707|FG000|Overall Study|Adverse event, non-fatal|24|||
33494047|NCT00938912|62872707|FG000|Overall Study|Adverse event, fatal|1|||
33494048|NCT00938912|62872707|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
33494049|NCT00938912|62872707|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
33494050|NCT00938912|62872707|FG000|Overall Study|Participant needed prohibit medication|1|||
33494051|NCT00938912|62872707|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
33494052|NCT00938912|62872707|FG000|Overall Study|Did not meet Eligibility criteria|1|||
33411528|NCT00545688|62789893|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
33411529|NCT00545688|62789894|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
33411530|NCT00545688|62789891|FG000|Neo-Adjuvant Treatment Period|Death|0|||
33411531|NCT00545688|62789892|FG001|Neo-Adjuvant Treatment Period|Death|1|||
33411532|NCT00545688|62789893|FG002|Neo-Adjuvant Treatment Period|Death|0|||
33411533|NCT00545688|62789894|FG003|Neo-Adjuvant Treatment Period|Death|0|||
33411534|NCT00545688|62789891|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
33599492|NCT01894984|62998466|FG001|Overall Study|Other|175|||
33599493|NCT02375672|62998472|FG000|Overall Study|remain on follow up|20|||
33599494|NCT01894516|62998480|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
33599495|NCT01894516|62998481|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
33599496|NCT01894516|62998482|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
33599497|NCT01894516|62998483|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
33599498|NCT01894516|62998480|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
33599499|NCT01894516|62998481|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33599500|NCT01894516|62998482|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33599501|NCT01894516|62998483|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33599502|NCT01894516|62998480|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
33599503|NCT01894516|62998481|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
33599504|NCT01894516|62998482|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
33599505|NCT01894516|62998483|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
33599506|NCT01894516|62998480|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
33599507|NCT01894516|62998481|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
33599508|NCT01894516|62998482|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
33599509|NCT01894516|62998483|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
33599510|NCT01894516|62998480|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
33599511|NCT01894516|62998481|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
33599512|NCT01894516|62998482|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
33599513|NCT01894516|62998483|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
33599514|NCT01894516|62998480|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
33599515|NCT01894516|62998481|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
33599516|NCT01894516|62998482|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
33599517|NCT01894516|62998483|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
33599518|NCT01894516|62998480|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
33599519|NCT01894516|62998481|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
33599520|NCT01894516|62998482|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
33599521|NCT01894516|62998483|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
33599522|NCT01894516|62998480|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
33599523|NCT01894516|62998481|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
33599524|NCT01894516|62998482|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
33599525|NCT01894516|62998483|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
33599526|NCT02491463|62998501|FG000|Overall Study|Withdrawal by Subject|1|||
33599527|NCT02491463|62998502|FG001|Overall Study|Withdrawal by Subject|2|||
33599528|NCT02491463|62998503|FG002|Overall Study|Withdrawal by Subject|0|||
33599529|NCT02491463|62998504|FG003|Overall Study|Withdrawal by Subject|0|||
33599530|NCT02491463|62998501|FG000|Overall Study|Migrated/moved from study area|1|||
33599531|NCT02491463|62998502|FG001|Overall Study|Migrated/moved from study area|5|||
33599532|NCT02491463|62998503|FG002|Overall Study|Migrated/moved from study area|1|||
33599533|NCT02491463|62998504|FG003|Overall Study|Migrated/moved from study area|1|||
33599534|NCT02491463|62998501|FG000|Overall Study|Lost to Follow-up|0|||
33599535|NCT02491463|62998502|FG001|Overall Study|Lost to Follow-up|3|||
33599536|NCT02491463|62998503|FG002|Overall Study|Lost to Follow-up|3|||
33599537|NCT02491463|62998504|FG003|Overall Study|Lost to Follow-up|0|||
33599538|NCT02038881|62998517|FG000|Overall Study|Withdrawal by Subject|0|||
33599539|NCT02038881|62998518|FG001|Overall Study|Withdrawal by Subject|0|||
33599540|NCT02038881|62998519|FG002|Overall Study|Withdrawal by Subject|1|||
33599541|NCT02038881|62998517|FG000|Overall Study|Lost to Follow-up|2|||
33599542|NCT02038881|62998518|FG001|Overall Study|Lost to Follow-up|0|||
33599543|NCT02038881|62998519|FG002|Overall Study|Lost to Follow-up|0|||
33599544|NCT02038881|62998517|FG000|Overall Study|incarcerated|1|||
33599545|NCT02038881|62998518|FG001|Overall Study|incarcerated|0|||
33599546|NCT02038881|62998519|FG002|Overall Study|incarcerated|0|||
33599547|NCT01857622|62998532|FG000|Overall Study|Adverse Event|5|||
33599548|NCT01857622|62998533|FG001|Overall Study|Adverse Event|0|||
33599549|NCT01857622|62998534|FG002|Overall Study|Adverse Event|2|||
33599550|NCT01857622|62998532|FG000|Overall Study|Physician Decision|1|||
33599551|NCT01857622|62998533|FG001|Overall Study|Physician Decision|0|||
33599552|NCT01857622|62998534|FG002|Overall Study|Physician Decision|0|||
33599553|NCT01857622|62998532|FG000|Overall Study|Protocol Violation|4|||
33599554|NCT01857622|62998533|FG001|Overall Study|Protocol Violation|1|||
33599555|NCT01857622|62998534|FG002|Overall Study|Protocol Violation|0|||
33599556|NCT01857622|62998532|FG000|Overall Study|Withdrawal by Subject|1|||
33599557|NCT01857622|62998533|FG001|Overall Study|Withdrawal by Subject|0|||
33599558|NCT01857622|62998534|FG002|Overall Study|Withdrawal by Subject|0|||
33599559|NCT01857310|62998544|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
33599560|NCT01857310|62998545|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
33599561|NCT02472353|62998553|FG000|Overall Study|Lost to Follow-up|1|||
33599562|NCT02472353|62998554|FG001|Overall Study|Lost to Follow-up|1|||
33599563|NCT02472353|62998553|FG000|Overall Study|Withdrawal by Subject|2|||
33599564|NCT02472353|62998554|FG001|Overall Study|Withdrawal by Subject|1|||
33599565|NCT02472353|62998553|FG000|Overall Study|Study Termination|1|||
33599566|NCT02472353|62998554|FG001|Overall Study|Study Termination|4|||
33599567|NCT02491073|62998562|FG000|Overall Study|screen failure|1|||
33599568|NCT02491073|62998563|FG001|Overall Study|screen failure|0|||
33599569|NCT02314117|62998587|FG000|Overall Study|Lost to Follow-up|9|||
33599570|NCT02314117|62998588|FG001|Overall Study|Lost to Follow-up|14|||
33599571|NCT02314117|62998587|FG000|Overall Study|Withdrawal by Subject|3|||
33599572|NCT02314117|62998588|FG001|Overall Study|Withdrawal by Subject|2|||
33599573|NCT01893346|62998599|FG000|Overall Study|Lost to Follow-up|0|||
33411535|NCT00545688|62789892|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
33599574|NCT01893346|62998600|FG001|Overall Study|Lost to Follow-up|1|||
33599575|NCT01893346|62998601|FG002|Overall Study|Lost to Follow-up|0|||
33599576|NCT01893346|62998602|FG003|Overall Study|Lost to Follow-up|0|||
33599577|NCT01893346|62998599|FG000|Overall Study|Protocol Violation|1|||
33599578|NCT01893346|62998600|FG001|Overall Study|Protocol Violation|0|||
33411536|NCT00545688|62789893|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
33599579|NCT01893346|62998601|FG002|Overall Study|Protocol Violation|0|||
33599580|NCT01893346|62998602|FG003|Overall Study|Protocol Violation|0|||
33599581|NCT01893346|62998599|FG000|Overall Study|Withdrawal by Subject|2|||
33599582|NCT01893346|62998600|FG001|Overall Study|Withdrawal by Subject|0|||
33599583|NCT01893346|62998601|FG002|Overall Study|Withdrawal by Subject|0|||
33599584|NCT01893346|62998602|FG003|Overall Study|Withdrawal by Subject|0|||
33599585|NCT02490371|62998614|FG000|Overall Study|Lost to Follow-up|1|||
33599586|NCT02490371|62998615|FG001|Overall Study|Lost to Follow-up|1|||
33599587|NCT02058147|62998624|FG000|Overall Study|Randomized but not treated|0|||
33599588|NCT02058147|62998625|FG001|Overall Study|Randomized but not treated|0|||
33599589|NCT02058147|62998626|FG002|Overall Study|Randomized but not treated|1|||
33599590|NCT02058147|62998624|FG000|Overall Study|Adverse Event|12|||
33599591|NCT02058147|62998625|FG001|Overall Study|Adverse Event|9|||
33599592|NCT02058147|62998626|FG002|Overall Study|Adverse Event|21|||
33599593|NCT02058147|62998624|FG000|Overall Study|Lack of Efficacy|1|||
33599594|NCT02058147|62998625|FG001|Overall Study|Lack of Efficacy|0|||
33599595|NCT02058147|62998626|FG002|Overall Study|Lack of Efficacy|3|||
33599596|NCT02058147|62998624|FG000|Overall Study|Poor compliance to protocol|8|||
33599597|NCT02058147|62998625|FG001|Overall Study|Poor compliance to protocol|9|||
33599598|NCT02058147|62998626|FG002|Overall Study|Poor compliance to protocol|4|||
33599599|NCT02058147|62998624|FG000|Overall Study|Other than specified|8|||
33599600|NCT02058147|62998625|FG001|Overall Study|Other than specified|9|||
33599601|NCT02058147|62998626|FG002|Overall Study|Other than specified|0|||
33599602|NCT02489981|62998634|FG000|Overall Study|Adverse Event|21|||
33599603|NCT02489981|62998634|FG000|Overall Study|Insufficient effectiveness|16|||
33599604|NCT02489981|62998634|FG000|Overall Study|Improved|31|||
33599605|NCT02489981|62998634|FG000|Overall Study|Lost to Follow-up|31|||
33599606|NCT02489981|62998634|FG000|Overall Study|Other than listed|28|||
33599607|NCT02471183|62998638|FG000|Main Treatment Period|Adverse Event|1|||
33599608|NCT02471183|62998638|FG000|Main Treatment Period|Withdrawal by Subject|1|||
33599609|NCT02471183|62998638|FG000|Extended Treatment Period|Lack of Efficacy|1|||
33599610|NCT01855828|62998642|FG000|Overall Study|Adverse Event|1|||
33599611|NCT01855828|62998642|FG000|Overall Study|Withdrawal by Subject|1|||
33599612|NCT02489279|62998653|FG000|Overall Study|Lost to Follow-up|12|||
33599613|NCT02489279|62998654|FG001|Overall Study|Lost to Follow-up|10|||
33599614|NCT02489045|62998660|FG000|Overall Study|unable to collect usable data|53|||
33599615|NCT02489045|62998660|FG000|Follow-up|Lost to Follow-up|10|||
33599616|NCT02488109|62998666|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
33599617|NCT02488109|62998667|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
33599618|NCT02488109|62998666|FG000|12-month Follow-Up|Lost to Follow-up|4|||
33599619|NCT02488109|62998667|FG001|12-month Follow-Up|Lost to Follow-up|7|||
33599620|NCT02351167|62998678|FG000|Overall Study|Withdrawal by Subject|19|||
33599621|NCT02351167|62998679|FG001|Overall Study|Withdrawal by Subject|18|||
33599622|NCT02351167|62998680|FG002|Overall Study|Withdrawal by Subject|21|||
33599623|NCT02350309|62998695|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
33599624|NCT02350309|62998696|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
33599625|NCT02350309|62998697|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
33599626|NCT02350309|62998698|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
33599627|NCT02350309|62998699|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
33599628|NCT02350309|62998700|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
33599629|NCT02350309|62998695|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
33599630|NCT02350309|62998696|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
33599631|NCT02350309|62998697|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
33599632|NCT02350309|62998698|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
33599633|NCT02350309|62998699|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
33599634|NCT02350309|62998700|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
33599635|NCT02038647|62998717|FG000|Overall Study|Progressive Disease|50|||
33599636|NCT02038647|62998718|FG001|Overall Study|Progressive Disease|59|||
33599637|NCT02038647|62998717|FG000|Overall Study|Adverse Event|18|||
33599638|NCT02038647|62998718|FG001|Overall Study|Adverse Event|10|||
33599639|NCT02038647|62998717|FG000|Overall Study|Symptomatic Deterioration|7|||
33599640|NCT02038647|62998718|FG001|Overall Study|Symptomatic Deterioration|7|||
33599641|NCT02038647|62998717|FG000|Overall Study|Withdrawal by Subject|5|||
33599642|NCT02038647|62998718|FG001|Overall Study|Withdrawal by Subject|2|||
33599643|NCT02038647|62998717|FG000|Overall Study|Not Reported|0|||
33599644|NCT02038647|62998718|FG001|Overall Study|Not Reported|1|||
33599645|NCT02038647|62998717|FG000|Overall Study|Ongoing at Datacut|9|||
33599646|NCT02038647|62998718|FG001|Overall Study|Ongoing at Datacut|10|||
33599647|NCT02058069|62998724|FG000|Overall Study|Exclusion due to implant size|5|||
33599648|NCT02058069|62998724|FG000|Overall Study|Withdrawal by Subject|6|||
33599649|NCT02057835|62998738|FG000|Overall Study|Withdrawal by Subject|0|||
33599650|NCT02057835|62998739|FG001|Overall Study|Withdrawal by Subject|2|||
33599651|NCT02057835|62998740|FG002|Overall Study|Withdrawal by Subject|0|||
33411537|NCT00545688|62789894|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
33411538|NCT00545688|62789891|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
33411539|NCT00545688|62789892|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
33411540|NCT00545688|62789893|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
33411541|NCT00545688|62789894|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
33411542|NCT00545688|62789891|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
33411543|NCT00545688|62789892|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
33411544|NCT00545688|62789893|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
33411545|NCT00545688|62789894|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
33411546|NCT00545688|62789891|FG000|Adjuvant Treatment Period|Disease Progression|3|||
33411547|NCT00545688|62789892|FG001|Adjuvant Treatment Period|Disease Progression|3|||
33411548|NCT00545688|62789893|FG002|Adjuvant Treatment Period|Disease Progression|0|||
33411549|NCT00545688|62789894|FG003|Adjuvant Treatment Period|Disease Progression|7|||
33411550|NCT00545688|62789891|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
33411551|NCT00545688|62789892|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
33411552|NCT00545688|62789893|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
33411553|NCT00545688|62789894|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
33411554|NCT00545688|62789891|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
33411555|NCT00545688|62789892|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
33411556|NCT00545688|62789893|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
33411557|NCT00545688|62789894|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
33411558|NCT00545688|62789891|FG000|Adjuvant Treatment Period|Adverse Event|0|||
33411559|NCT00545688|62789892|FG001|Adjuvant Treatment Period|Adverse Event|3|||
33411560|NCT00545688|62789893|FG002|Adjuvant Treatment Period|Adverse Event|2|||
33411561|NCT00545688|62789894|FG003|Adjuvant Treatment Period|Adverse Event|2|||
33411562|NCT00545688|62789891|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
33411563|NCT00545688|62789892|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
33411564|NCT00545688|62789893|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
33411565|NCT00545688|62789894|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
33411566|NCT00545688|62789891|FG000|Follow-Up Period|Death|4|||
33411567|NCT00545688|62789892|FG001|Follow-Up Period|Death|2|||
33411568|NCT00545688|62789893|FG002|Follow-Up Period|Death|2|||
33411569|NCT00545688|62789894|FG003|Follow-Up Period|Death|6|||
33411570|NCT00545688|62789891|FG000|Follow-Up Period|Disease Progression|6|||
33411571|NCT00545688|62789892|FG001|Follow-Up Period|Disease Progression|5|||
33411572|NCT00545688|62789893|FG002|Follow-Up Period|Disease Progression|9|||
33411573|NCT00545688|62789894|FG003|Follow-Up Period|Disease Progression|9|||
33411574|NCT00545688|62789891|FG000|Follow-Up Period|Refused Treatment|6|||
33411575|NCT00545688|62789892|FG001|Follow-Up Period|Refused Treatment|2|||
33411576|NCT00545688|62789893|FG002|Follow-Up Period|Refused Treatment|0|||
33411577|NCT00545688|62789894|FG003|Follow-Up Period|Refused Treatment|2|||
33411578|NCT00545688|62789891|FG000|Follow-Up Period|Lost to Follow-up|3|||
33411579|NCT00545688|62789892|FG001|Follow-Up Period|Lost to Follow-up|3|||
33411580|NCT00545688|62789893|FG002|Follow-Up Period|Lost to Follow-up|3|||
33411581|NCT00545688|62789894|FG003|Follow-Up Period|Lost to Follow-up|1|||
33411582|NCT00545688|62789891|FG000|Follow-Up Period|Unspecified Reason|2|||
33411583|NCT00545688|62789892|FG001|Follow-Up Period|Unspecified Reason|5|||
33411584|NCT00545688|62789893|FG002|Follow-Up Period|Unspecified Reason|6|||
33411585|NCT00545688|62789894|FG003|Follow-Up Period|Unspecified Reason|8|||
33411586|NCT00545688|62789891|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
33411587|NCT00545688|62789892|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
33411588|NCT00545688|62789893|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
33411589|NCT00545688|62789894|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
33411590|NCT00502203|62789907|FG000|Overall Study|Inevaluable|1|||
33411591|NCT00546078|62789913|FG000|Overall Study|Lost to Follow-up|1|||
33411592|NCT00546078|62789914|FG001|Overall Study|Lost to Follow-up|3|||
33411593|NCT00546078|62789913|FG000|Overall Study|Withdrawal by Subject|2|||
33411594|NCT00546078|62789914|FG001|Overall Study|Withdrawal by Subject|3|||
33411595|NCT00546078|62789913|FG000|Overall Study|Other reason|1|||
33411596|NCT00546078|62789914|FG001|Overall Study|Other reason|1|||
33411597|NCT00546000|62789920|FG000|Overall Study|Adverse Event|1|||
33411598|NCT00546000|62789920|FG000|Overall Study|Lost to Follow-up|1|||
33411599|NCT00546000|62789920|FG000|Overall Study|Baseline HPA Axis Supression|2|||
33411600|NCT00501969|62789924|FG000|Overall Study|Major Protocol Violation|4|||
33411601|NCT00501969|62789924|FG000|Overall Study|Lack of Efficacy|29|||
33411602|NCT00501969|62789924|FG000|Overall Study|Adverse Event|76|||
33411603|NCT00501969|62789924|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
33411604|NCT00501969|62789924|FG000|Overall Study|Subject withdrew consent|51|||
33411605|NCT00501969|62789924|FG000|Overall Study|Lost to Follow-up|4|||
33411606|NCT00501969|62789924|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
33411607|NCT00501969|62789924|FG000|Overall Study|Other: Sponsors Request|10|||
33411608|NCT00501969|62789924|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
33411609|NCT00501969|62789924|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
33411610|NCT00501969|62789924|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
33411611|NCT00501969|62789924|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
33411612|NCT00501969|62789924|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
33411613|NCT00501969|62789924|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
33411614|NCT00501969|62789924|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
33411615|NCT00501969|62789924|FG000|Overall Study|Other: As Required by Local EC|2|||
33411616|NCT00501969|62789924|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
33411617|NCT00501969|62789924|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
33411618|NCT03942042|62789930|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
33411619|NCT03942042|62789931|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
33411620|NCT03942042|62789930|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
33411621|NCT03942042|62789931|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
33411622|NCT00104299|62789943|FG000|Overall Study|Adverse Event|3|||
33411623|NCT00104299|62789944|FG001|Overall Study|Adverse Event|1|||
33411624|NCT00104299|62789943|FG000|Overall Study|Death|2|||
33321928|NCT01196429|62698081|FG001|Overall Study|Refused - Never Treated|0|||
33321929|NCT01157364|62698095|FG000|Overall Study|Other Reasons|1|||
33411625|NCT00104299|62789944|FG001|Overall Study|Death|2|||
33411626|NCT00104299|62789943|FG000|Overall Study|Withdrawal by Subject|2|||
33411627|NCT00104299|62789944|FG001|Overall Study|Withdrawal by Subject|6|||
33411628|NCT00104299|62789943|FG000|Overall Study|Physician Decision|1|||
33411629|NCT00104299|62789944|FG001|Overall Study|Physician Decision|1|||
33411630|NCT00104299|62789943|FG000|Overall Study|To have renal transplant|1|||
33411631|NCT00104299|62789944|FG001|Overall Study|To have renal transplant|0|||
33411632|NCT03939312|62789950|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
33411633|NCT03939312|62789950|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
33411634|NCT03939312|62789950|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
33411635|NCT03939312|62789950|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
33411636|NCT03939312|62789950|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
33411637|NCT03939312|62789950|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
33411638|NCT03939312|62789950|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
33411639|NCT03939312|62789950|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
33411640|NCT03939312|62789950|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
33411641|NCT03939312|62789950|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
33411642|NCT03939312|62789950|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
33411643|NCT03939312|62789950|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
33411644|NCT00082381|62789958|FG000|Overall Study|Adverse Event|27|||
33411645|NCT00082381|62789959|FG001|Overall Study|Adverse Event|2|||
33411646|NCT00082381|62789958|FG000|Overall Study|Lost to Follow-up|5|||
33411647|NCT00082381|62789959|FG001|Overall Study|Lost to Follow-up|7|||
33411648|NCT00082381|62789958|FG000|Overall Study|Patient Decision|8|||
33411649|NCT00082381|62789959|FG001|Overall Study|Patient Decision|4|||
33411650|NCT00082381|62789958|FG000|Overall Study|Physician Decision|1|||
33411651|NCT00082381|62789959|FG001|Overall Study|Physician Decision|2|||
33411652|NCT00082381|62789958|FG000|Overall Study|Protocol Violation|10|||
33411653|NCT00082381|62789959|FG001|Overall Study|Protocol Violation|11|||
33411654|NCT00082381|62789958|FG000|Overall Study|Loss of Glucose Control|4|||
33411655|NCT00082381|62789959|FG001|Overall Study|Loss of Glucose Control|0|||
33411656|NCT00545844|62789965|FG000|Overall Study|Lost to Follow-up|9|||
33411657|NCT00545844|62789965|FG000|Overall Study|Protocol Violation|1|||
33411658|NCT00545844|62789965|FG000|Overall Study|Withdrawal by Subject|2|||
33321930|NCT01157364|62698096|FG001|Overall Study|Other Reasons|1|||
33321931|NCT01157364|62698097|FG002|Overall Study|Other Reasons|2|||
33321932|NCT01157364|62698098|FG003|Overall Study|Other Reasons|1|||
33321933|NCT01157364|62698099|FG004|Overall Study|Other Reasons|0|||
33321934|NCT01157364|62698100|FG005|Overall Study|Other Reasons|0|||
33321935|NCT01157364|62698095|FG000|Overall Study|Personal Reasons|0|||
33321936|NCT01157364|62698096|FG001|Overall Study|Personal Reasons|2|||
33411659|NCT00492063|62789975|FG000|Overall Study|Death|0|||
33411660|NCT00492063|62789976|FG001|Overall Study|Death|0|||
33411661|NCT00492063|62789977|FG002|Overall Study|Death|1|||
33411662|NCT00492063|62789978|FG003|Overall Study|Death|2|||
33411663|NCT00492063|62789975|FG000|Overall Study|Withdrawal by Subject|4|||
33411664|NCT00492063|62789976|FG001|Overall Study|Withdrawal by Subject|3|||
33411665|NCT00492063|62789977|FG002|Overall Study|Withdrawal by Subject|5|||
33411666|NCT00492063|62789978|FG003|Overall Study|Withdrawal by Subject|4|||
33321937|NCT01157364|62698097|FG002|Overall Study|Personal Reasons|0|||
33411667|NCT00492063|62789975|FG000|Overall Study|Lost to Follow-up|6|||
33321938|NCT01157364|62698098|FG003|Overall Study|Personal Reasons|0|||
33411668|NCT00492063|62789976|FG001|Overall Study|Lost to Follow-up|11|||
33411669|NCT00492063|62789977|FG002|Overall Study|Lost to Follow-up|5|||
33411670|NCT00492063|62789978|FG003|Overall Study|Lost to Follow-up|3|||
33411671|NCT00492063|62789975|FG000|Overall Study|Protocol Violation|0|||
33411672|NCT00492063|62789976|FG001|Overall Study|Protocol Violation|0|||
33411673|NCT00492063|62789977|FG002|Overall Study|Protocol Violation|0|||
33411674|NCT00492063|62789978|FG003|Overall Study|Protocol Violation|1|||
33411675|NCT00093145|62789988|FG000|Overall Study|Unacceptable Toxicity Only|2|||
33411676|NCT00093145|62789988|FG000|Overall Study|Physician Decision|5|||
33411677|NCT00093145|62789988|FG000|Overall Study|Withdrawal by Subject|9|||
33411678|NCT00093145|62789988|FG000|Overall Study|Other|1|||
33411679|NCT00513357|62789994|FG000|Overall Study|did not receive allocated placebo|2|||
33411680|NCT00513357|62789995|FG001|Overall Study|did not receive allocated placebo|3|||
33411681|NCT00513357|62789994|FG000|Overall Study|Adverse Event|4|||
33411682|NCT00513357|62789995|FG001|Overall Study|Adverse Event|2|||
33411683|NCT00513357|62789994|FG000|Overall Study|Death|2|||
33411684|NCT00513357|62789995|FG001|Overall Study|Death|0|||
33411685|NCT00513357|62789994|FG000|Overall Study|Withdrawal by Subject|5|||
33411686|NCT00513357|62789995|FG001|Overall Study|Withdrawal by Subject|4|||
33411687|NCT00513357|62789994|FG000|Overall Study|Disease Progression|2|||
33411688|NCT00513357|62789995|FG001|Overall Study|Disease Progression|1|||
33411689|NCT03933462|62790001|FG000|Overall Study|Adverse Event|2|||
33411690|NCT03933462|62790002|FG001|Overall Study|Adverse Event|0|||
33411691|NCT03929562|62790010|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
33411692|NCT03929562|62790011|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
33411693|NCT03929562|62790010|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
33411694|NCT03929562|62790011|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
33411695|NCT03929562|62790010|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
33411696|NCT03929562|62790011|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
33411697|NCT00415636|62790025|FG000|Overall Study|Symptomatic deterioration|1|||
33411698|NCT00415636|62790026|FG001|Overall Study|Symptomatic deterioration|0|||
33411699|NCT00415636|62790027|FG002|Overall Study|Symptomatic deterioration|1|||
33411700|NCT00415636|62790028|FG003|Overall Study|Symptomatic deterioration|2|||
33411701|NCT00415636|62790029|FG004|Overall Study|Symptomatic deterioration|0|||
33411702|NCT00415636|62790030|FG005|Overall Study|Symptomatic deterioration|1|||
33411703|NCT00415636|62790025|FG000|Overall Study|Adverse Event|0|||
33411704|NCT00415636|62790026|FG001|Overall Study|Adverse Event|0|||
33411705|NCT00415636|62790027|FG002|Overall Study|Adverse Event|0|||
33411706|NCT00415636|62790028|FG003|Overall Study|Adverse Event|1|||
33411707|NCT00415636|62790029|FG004|Overall Study|Adverse Event|1|||
33411708|NCT00415636|62790030|FG005|Overall Study|Adverse Event|0|||
33411709|NCT00415636|62790025|FG000|Overall Study|Withdrawal by Subject|0|||
33411710|NCT00415636|62790026|FG001|Overall Study|Withdrawal by Subject|0|||
33411711|NCT00415636|62790027|FG002|Overall Study|Withdrawal by Subject|0|||
33411712|NCT00415636|62790028|FG003|Overall Study|Withdrawal by Subject|0|||
33411713|NCT00415636|62790029|FG004|Overall Study|Withdrawal by Subject|1|||
33411714|NCT00415636|62790030|FG005|Overall Study|Withdrawal by Subject|0|||
33411715|NCT00415636|62790025|FG000|Overall Study|Disease progression|0|||
33599652|NCT02057835|62998741|FG003|Overall Study|Withdrawal by Subject|0|||
33599653|NCT02057835|62998742|FG004|Overall Study|Withdrawal by Subject|0|||
33599654|NCT02057835|62998743|FG005|Overall Study|Withdrawal by Subject|0|||
33599655|NCT02057835|62998744|FG006|Overall Study|Withdrawal by Subject|0|||
33599656|NCT02057835|62998745|FG007|Overall Study|Withdrawal by Subject|0|||
33599657|NCT02057835|62998746|FG008|Overall Study|Withdrawal by Subject|0|||
33411716|NCT00415636|62790026|FG001|Overall Study|Disease progression|0|||
33411717|NCT00415636|62790027|FG002|Overall Study|Disease progression|0|||
33411718|NCT00415636|62790028|FG003|Overall Study|Disease progression|3|||
33599658|NCT02057835|62998747|FG009|Overall Study|Withdrawal by Subject|0|||
33599659|NCT02057757|62998778|FG000|Overall Study|Withdrawal by Subject|3|||
33599660|NCT02057757|62998779|FG001|Overall Study|Withdrawal by Subject|5|||
33599661|NCT02057757|62998778|FG000|Overall Study|Death|2|||
33411719|NCT00415636|62790029|FG004|Overall Study|Disease progression|0|||
33599662|NCT02057757|62998779|FG001|Overall Study|Death|0|||
33599663|NCT02057757|62998778|FG000|Overall Study|Lost to Follow-up|8|||
33599664|NCT02057757|62998779|FG001|Overall Study|Lost to Follow-up|3|||
33599665|NCT02057757|62998778|FG000|Overall Study|Non-compliance|1|||
33599666|NCT02057757|62998779|FG001|Overall Study|Non-compliance|0|||
33411720|NCT00415636|62790030|FG005|Overall Study|Disease progression|1|||
33411721|NCT00425854|62790054|FG000|Overall Study|Progressive Disease|19|||
33411722|NCT00425854|62790055|FG001|Overall Study|Progressive Disease|12|||
33411723|NCT00425854|62790054|FG000|Overall Study|Dose reduction toxicity AE|8|||
33411724|NCT00425854|62790055|FG001|Overall Study|Dose reduction toxicity AE|7|||
33411725|NCT00425854|62790054|FG000|Overall Study|Other Adverse Event|2|||
33411726|NCT00425854|62790055|FG001|Overall Study|Other Adverse Event|2|||
33411727|NCT00425698|62790064|FG000|Overall Study|Adverse Event|3|||
33411728|NCT00425698|62790065|FG001|Overall Study|Adverse Event|1|||
33411729|NCT00425698|62790064|FG000|Overall Study|Withdrawal by Subject|0|||
33411730|NCT00425698|62790065|FG001|Overall Study|Withdrawal by Subject|1|||
33411731|NCT00425308|62790073|FG000|Overall Study|Adverse Event|2|||
33411732|NCT00425308|62790074|FG001|Overall Study|Adverse Event|1|||
33411733|NCT00425308|62790073|FG000|Overall Study|Withdrawal by Subject|1|||
33411734|NCT00425308|62790074|FG001|Overall Study|Withdrawal by Subject|0|||
33411735|NCT00425308|62790073|FG000|Overall Study|Death|1|||
33411736|NCT00425308|62790074|FG001|Overall Study|Death|0|||
33411737|NCT00545064|62790080|FG000|Overall Study|Lost to Follow-up|3|||
33411738|NCT00545064|62790080|FG000|Overall Study|Withdrawal by Subject|2|||
33411739|NCT00545064|62790080|FG000|Overall Study|did not complete course of treatment|1|||
33411740|NCT00545064|62790080|FG000|Overall Study|cancel all appointments, no rebooking|1|||
33321939|NCT01157364|62698099|FG004|Overall Study|Personal Reasons|1|||
33321940|NCT01157364|62698100|FG005|Overall Study|Personal Reasons|1|||
33321941|NCT01157364|62698095|FG000|Overall Study|Lost to Follow-up|1|||
33321942|NCT01157364|62698096|FG001|Overall Study|Lost to Follow-up|0|||
33321943|NCT01157364|62698097|FG002|Overall Study|Lost to Follow-up|1|||
33321944|NCT01157364|62698098|FG003|Overall Study|Lost to Follow-up|0|||
33321945|NCT01157364|62698099|FG004|Overall Study|Lost to Follow-up|0|||
33321946|NCT01157364|62698100|FG005|Overall Study|Lost to Follow-up|0|||
33321947|NCT01157364|62698095|FG000|Overall Study|Lack of Efficacy|0|||
33321948|NCT01157364|62698096|FG001|Overall Study|Lack of Efficacy|0|||
33321949|NCT01157364|62698097|FG002|Overall Study|Lack of Efficacy|0|||
33321950|NCT01157364|62698098|FG003|Overall Study|Lack of Efficacy|1|||
33411741|NCT00545064|62790080|FG000|Overall Study|inclement weather|1|||
33321951|NCT01157364|62698099|FG004|Overall Study|Lack of Efficacy|0|||
33411742|NCT00432562|62790088|FG000|Overall Study|Death|3|||
33411743|NCT00432562|62790089|FG001|Overall Study|Death|0|||
33411744|NCT00432172|62790099|FG000|Overall Study|Physician Decision|0|||
33321952|NCT01157364|62698100|FG005|Overall Study|Lack of Efficacy|0|||
33321953|NCT01157364|62698095|FG000|Overall Study|Adverse Event|0|||
33321954|NCT01157364|62698096|FG001|Overall Study|Adverse Event|1|||
33321955|NCT01157364|62698097|FG002|Overall Study|Adverse Event|1|||
33411745|NCT00432172|62790100|FG001|Overall Study|Physician Decision|0|||
33411746|NCT00432172|62790101|FG002|Overall Study|Physician Decision|2|||
33411747|NCT00432172|62790102|FG003|Overall Study|Physician Decision|0|||
33411748|NCT00432172|62790099|FG000|Overall Study|Adverse Event|4|||
33411749|NCT00432172|62790100|FG001|Overall Study|Adverse Event|2|||
33411750|NCT00432172|62790101|FG002|Overall Study|Adverse Event|4|||
33411751|NCT00432172|62790102|FG003|Overall Study|Adverse Event|3|||
33411752|NCT00432172|62790099|FG000|Overall Study|Disease progression|0|||
33411753|NCT00432172|62790100|FG001|Overall Study|Disease progression|2|||
33411754|NCT00432172|62790101|FG002|Overall Study|Disease progression|5|||
33411755|NCT00432172|62790102|FG003|Overall Study|Disease progression|1|||
33411756|NCT00432172|62790099|FG000|Overall Study|Withdrawal by Subject|0|||
33411757|NCT00432172|62790100|FG001|Overall Study|Withdrawal by Subject|1|||
33411758|NCT00432172|62790101|FG002|Overall Study|Withdrawal by Subject|0|||
33411759|NCT00432172|62790102|FG003|Overall Study|Withdrawal by Subject|2|||
33411760|NCT00432172|62790099|FG000|Overall Study|No treatment received|2|||
33411761|NCT00432172|62790100|FG001|Overall Study|No treatment received|2|||
33411762|NCT00432172|62790101|FG002|Overall Study|No treatment received|0|||
33411763|NCT00432172|62790102|FG003|Overall Study|No treatment received|1|||
33411764|NCT00415168|62790114|FG000|Overall Study|Death|26|||
33411765|NCT00415168|62790114|FG000|Overall Study|Lost to Follow-up|3|||
33411766|NCT00415168|62790114|FG000|Overall Study|Physician Decision|13|||
33411767|NCT00415168|62790114|FG000|Overall Study|Sponsor Decision|4|||
33411768|NCT00415168|62790114|FG000|Overall Study|Withdrawal by Subject|6|||
33411769|NCT00424762|62790120|FG000|Overall Study|Withdrawal by Subject|18|||
33411770|NCT00424762|62790121|FG001|Overall Study|Withdrawal by Subject|19|||
33411771|NCT00424762|62790120|FG000|Overall Study|Lost to Follow-up|2|||
33411772|NCT00424762|62790121|FG001|Overall Study|Lost to Follow-up|3|||
33411773|NCT00414544|62790127|FG000|Overall Study|Lost to Follow-up|14|||
33411774|NCT00414466|62790137|FG000|Overall Study|Adverse Event|0|||
33321956|NCT01157364|62698098|FG003|Overall Study|Adverse Event|0|||
33321957|NCT01157364|62698099|FG004|Overall Study|Adverse Event|1|||
33321958|NCT01157364|62698100|FG005|Overall Study|Adverse Event|0|||
33321959|NCT01195415|62698114|FG000|Overall Study|No repeat biopsy due to progression|2|||
33321960|NCT01195103|62698121|FG000|Overall Study|Withdrawal by Subject|1|||
33321961|NCT01195103|62698122|FG001|Overall Study|Withdrawal by Subject|0|||
33321962|NCT01195103|62698123|FG002|Overall Study|Withdrawal by Subject|0|||
33321963|NCT01194869|62698131|FG000|Overall Study|Disease Progression|2|||
33321964|NCT01194869|62698131|FG000|Overall Study|Toxicity|2|||
33411775|NCT00414466|62790138|FG001|Overall Study|Adverse Event|0|||
33411776|NCT00414466|62790139|FG002|Overall Study|Adverse Event|1|||
33411777|NCT00414466|62790140|FG003|Overall Study|Adverse Event|1|||
33411778|NCT00414466|62790137|FG000|Overall Study|Lack of Efficacy|1|||
33411779|NCT00414466|62790138|FG001|Overall Study|Lack of Efficacy|0|||
33321965|NCT01177800|62698137|FG000|Overall Study|Adverse Event|9|||
33321966|NCT01177800|62698138|FG001|Overall Study|Adverse Event|3|||
33411780|NCT00414466|62790139|FG002|Overall Study|Lack of Efficacy|0|||
33411781|NCT00414466|62790140|FG003|Overall Study|Lack of Efficacy|0|||
33411782|NCT00414466|62790137|FG000|Overall Study|Withdrawn by Sponsor|1|||
33599667|NCT02037477|62998793|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
33599668|NCT02037477|62998794|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
33599669|NCT02037477|62998795|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
33599670|NCT02037477|62998796|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
33599671|NCT02057523|62998806|FG000|Overall Study|Withdrawal by Subject|1|||
33599672|NCT02057523|62998806|FG000|Overall Study|Lack of Efficacy|1|||
33599673|NCT02037165|62998815|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
33599674|NCT02037165|62998816|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
33599675|NCT02037165|62998817|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
33599676|NCT02037165|62998818|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
33599677|NCT02037165|62998819|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
33599678|NCT02470403|62998840|FG000|Overall Study|Adverse Event|1|||
33599679|NCT02470403|62998841|FG001|Overall Study|Adverse Event|0|||
33599680|NCT02470403|62998842|FG002|Overall Study|Adverse Event|0|||
33599681|NCT02470403|62998843|FG003|Overall Study|Adverse Event|0|||
33599682|NCT02470403|62998844|FG004|Overall Study|Adverse Event|0|||
33599683|NCT02470403|62998840|FG000|Overall Study|Lost to Follow-up|0|||
33599684|NCT02470403|62998841|FG001|Overall Study|Lost to Follow-up|1|||
33599685|NCT02470403|62998842|FG002|Overall Study|Lost to Follow-up|0|||
33599686|NCT02470403|62998843|FG003|Overall Study|Lost to Follow-up|0|||
33599687|NCT02470403|62998844|FG004|Overall Study|Lost to Follow-up|0|||
33599688|NCT02470403|62998840|FG000|Overall Study|Subject/guardian decision|1|||
33599689|NCT02470403|62998841|FG001|Overall Study|Subject/guardian decision|0|||
33599690|NCT02470403|62998842|FG002|Overall Study|Subject/guardian decision|0|||
33599691|NCT02470403|62998843|FG003|Overall Study|Subject/guardian decision|4|||
33599692|NCT02470403|62998844|FG004|Overall Study|Subject/guardian decision|0|||
33599693|NCT01855750|62998861|FG000|Overall Study|Death|78|||
33599694|NCT01855750|62998862|FG001|Overall Study|Death|78|||
33599695|NCT01855750|62998861|FG000|Overall Study|Lost to Follow-up|9|||
33599696|NCT01855750|62998862|FG001|Overall Study|Lost to Follow-up|23|||
33599697|NCT01855750|62998861|FG000|Overall Study|Withdrawal by Subject|35|||
33599698|NCT01855750|62998862|FG001|Overall Study|Withdrawal by Subject|28|||
33599699|NCT01855750|62998861|FG000|Overall Study|Sponsor ends the study|297|||
33599700|NCT01855750|62998862|FG001|Overall Study|Sponsor ends the study|290|||
33599701|NCT01855126|62998870|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
33321967|NCT01177800|62698137|FG000|Overall Study|Protocol Violation|0|||
33321968|NCT01177800|62698138|FG001|Overall Study|Protocol Violation|1|||
33321969|NCT01177800|62698137|FG000|Overall Study|Physician Decision|1|||
33321970|NCT01177800|62698138|FG001|Overall Study|Physician Decision|0|||
33321971|NCT01177800|62698137|FG000|Overall Study|Withdrawal of informed consent|0|||
33599702|NCT01855126|62998871|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
33599703|NCT01855126|62998870|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
33599704|NCT01855126|62998871|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
33321972|NCT01177800|62698138|FG001|Overall Study|Withdrawal of informed consent|1|||
33321973|NCT01177722|62698148|FG000|Overall Study|Serious Adverse Event|0|||
33321974|NCT01177722|62698149|FG001|Overall Study|Serious Adverse Event|0|||
33599705|NCT01622673|62998887|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33599706|NCT01622673|62998888|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33599707|NCT01622673|62998889|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33599708|NCT01622673|62998890|FG003|Treatment Period 1|Withdrawal by Subject|1|||
33599709|NCT01622673|62998891|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33599710|NCT01622673|62998892|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33599711|NCT01622673|62998887|FG000|Treatment Period 1|Protocol Violation|0|||
33599712|NCT01622673|62998888|FG001|Treatment Period 1|Protocol Violation|1|||
33599713|NCT01622673|62998889|FG002|Treatment Period 1|Protocol Violation|0|||
33599714|NCT01622673|62998890|FG003|Treatment Period 1|Protocol Violation|0|||
33411783|NCT00414466|62790138|FG001|Overall Study|Withdrawn by Sponsor|0|||
33411784|NCT00414466|62790139|FG002|Overall Study|Withdrawn by Sponsor|0|||
33599715|NCT01622673|62998891|FG004|Treatment Period 1|Protocol Violation|0|||
33599716|NCT01622673|62998892|FG005|Treatment Period 1|Protocol Violation|0|||
33599717|NCT01622673|62998887|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33599718|NCT01622673|62998888|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33599719|NCT01622673|62998889|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33599720|NCT01622673|62998890|FG003|Treatment Period 2|Withdrawal by Subject|1|||
33599721|NCT01622673|62998891|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33599722|NCT01622673|62998892|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33599723|NCT01622673|62998887|FG000|Treatment Period 3|Protocol Violation|0|||
33599724|NCT01622673|62998888|FG001|Treatment Period 3|Protocol Violation|1|||
33599725|NCT01622673|62998889|FG002|Treatment Period 3|Protocol Violation|0|||
33599726|NCT01622673|62998890|FG003|Treatment Period 3|Protocol Violation|0|||
33599727|NCT01622673|62998891|FG004|Treatment Period 3|Protocol Violation|0|||
33599728|NCT01622673|62998892|FG005|Treatment Period 3|Protocol Violation|0|||
33599729|NCT01855048|62998917|FG000|Overall Study|Withdrawal by Subject|0|||
33599730|NCT01855048|62998918|FG001|Overall Study|Withdrawal by Subject|1|||
33599731|NCT01855048|62998919|FG002|Overall Study|Withdrawal by Subject|0|||
33599732|NCT01855048|62998920|FG003|Overall Study|Withdrawal by Subject|0|||
33599733|NCT01855048|62998921|FG004|Overall Study|Withdrawal by Subject|1|||
33599734|NCT01855048|62998922|FG005|Overall Study|Withdrawal by Subject|0|||
33599735|NCT02469857|62998948|FG000|Overall Study|Death|24|||
33599736|NCT02469857|62998949|FG001|Overall Study|Death|29|||
33599737|NCT02469857|62998948|FG000|Overall Study|Discontinuation|1|||
33599738|NCT02469857|62998949|FG001|Overall Study|Discontinuation|3|||
33599739|NCT02036853|62998959|FG000|Overall Study|Adverse Event|0|||
33599740|NCT02036853|62998960|FG001|Overall Study|Adverse Event|2|||
33599741|NCT02036853|62998959|FG000|Overall Study|Lack of Efficacy|0|||
33599742|NCT02036853|62998960|FG001|Overall Study|Lack of Efficacy|2|||
33599743|NCT02036853|62998959|FG000|Overall Study|Physician Decision|0|||
33599744|NCT02036853|62998960|FG001|Overall Study|Physician Decision|1|||
33599745|NCT02036853|62998959|FG000|Overall Study|Withdrawal by Subject|0|||
33599746|NCT02036853|62998960|FG001|Overall Study|Withdrawal by Subject|1|||
33599747|NCT02469623|62998966|FG000|Overall Study|Not consented for long-term follow-up|4|||
33599748|NCT02469623|62998966|FG000|Overall Study|Lost to Follow-up|4|||
33599749|NCT02469623|62998966|FG000|Overall Study|Withdrawal by Subject|2|||
33599750|NCT02469623|62998966|FG000|Overall Study|Death|3|||
33599751|NCT02469077|62998973|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
33599752|NCT02469077|62998974|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
33599753|NCT02469077|62998973|FG000|Post Randomization/Intervention Period|Relocated|1|||
33599754|NCT02469077|62998974|FG001|Post Randomization/Intervention Period|Relocated|1|||
33599755|NCT02469077|62998973|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
33599756|NCT02469077|62998974|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
33599757|NCT02469077|62998973|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
33599758|NCT02469077|62998974|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
33599759|NCT02486627|62998986|FG000|Overall Study|Death|1|||
33599760|NCT02486627|62998987|FG001|Overall Study|Death|0|||
33599761|NCT02486627|62998986|FG000|Overall Study|Other Unspecified|0|||
33599762|NCT02486627|62998987|FG001|Overall Study|Other Unspecified|2|||
33599763|NCT02486627|62998986|FG000|Overall Study|Consent Withdrawn by Participant|4|||
33599764|NCT02486627|62998987|FG001|Overall Study|Consent Withdrawn by Participant|3|||
33599765|NCT02486627|62998986|FG000|Overall Study|Significant Participant Noncompliance|1|||
33599766|NCT02486627|62998987|FG001|Overall Study|Significant Participant Noncompliance|1|||
33599767|NCT02486627|62998986|FG000|Overall Study|Lost to Follow-up|1|||
33599768|NCT02486627|62998987|FG001|Overall Study|Lost to Follow-up|3|||
33599769|NCT01644565|62998993|FG000|Overall Study|Undisclosed Medical History|1|||
33599770|NCT01644565|62998994|FG001|Overall Study|Undisclosed Medical History|0|||
33599771|NCT01644565|62998995|FG002|Overall Study|Undisclosed Medical History|0|||
33599772|NCT01644565|62998996|FG003|Overall Study|Undisclosed Medical History|0|||
33411785|NCT00414466|62790140|FG003|Overall Study|Withdrawn by Sponsor|0|||
33599773|NCT01644565|62998997|FG004|Overall Study|Undisclosed Medical History|0|||
33599774|NCT01644565|62998998|FG005|Overall Study|Undisclosed Medical History|0|||
33599775|NCT01644565|62998999|FG006|Overall Study|Undisclosed Medical History|0|||
33599776|NCT01644565|62999000|FG007|Overall Study|Undisclosed Medical History|0|||
33599777|NCT01644565|62999001|FG008|Overall Study|Undisclosed Medical History|0|||
33599778|NCT01644565|62998993|FG000|Overall Study|Lost to Follow-up|0|||
33494053|NCT00938912|62872707|FG000|Overall Study|Participant relocated not related to AE|1|||
33494054|NCT00938912|62872707|FG000|Overall Study|Participant moved to another city|1|||
33599779|NCT01644565|62998994|FG001|Overall Study|Lost to Follow-up|0|||
33599780|NCT01644565|62998995|FG002|Overall Study|Lost to Follow-up|0|||
33599781|NCT01644565|62998996|FG003|Overall Study|Lost to Follow-up|1|||
33599782|NCT01644565|62998997|FG004|Overall Study|Lost to Follow-up|0|||
33599783|NCT01644565|62998998|FG005|Overall Study|Lost to Follow-up|0|||
33599784|NCT01644565|62998999|FG006|Overall Study|Lost to Follow-up|0|||
33599785|NCT01644565|62999000|FG007|Overall Study|Lost to Follow-up|2|||
33599786|NCT01644565|62999001|FG008|Overall Study|Lost to Follow-up|0|||
33599787|NCT01644565|62998993|FG000|Overall Study|Family emergency|0|||
33599788|NCT01644565|62998994|FG001|Overall Study|Family emergency|0|||
33599789|NCT01644565|62998995|FG002|Overall Study|Family emergency|0|||
33599790|NCT01644565|62998996|FG003|Overall Study|Family emergency|0|||
33599791|NCT01644565|62998997|FG004|Overall Study|Family emergency|1|||
33599792|NCT01644565|62998998|FG005|Overall Study|Family emergency|0|||
33599793|NCT01644565|62998999|FG006|Overall Study|Family emergency|0|||
33599794|NCT01644565|62999000|FG007|Overall Study|Family emergency|0|||
33599795|NCT01644565|62999001|FG008|Overall Study|Family emergency|0|||
33599796|NCT01644565|62998993|FG000|Overall Study|Relocation|0|||
33599797|NCT01644565|62998994|FG001|Overall Study|Relocation|0|||
33599798|NCT01644565|62998995|FG002|Overall Study|Relocation|0|||
33599799|NCT01644565|62998996|FG003|Overall Study|Relocation|0|||
33599800|NCT01644565|62998997|FG004|Overall Study|Relocation|0|||
33599801|NCT01644565|62998998|FG005|Overall Study|Relocation|0|||
33599802|NCT01644565|62998999|FG006|Overall Study|Relocation|0|||
33599803|NCT01644565|62999000|FG007|Overall Study|Relocation|0|||
33599804|NCT01644565|62999001|FG008|Overall Study|Relocation|1|||
33599805|NCT02485925|62999021|FG000|Overall Study|Withdrawal by Subject|3|||
33599806|NCT02485925|62999021|FG000|Overall Study|Death|1|||
33599807|NCT02485925|62999021|FG000|Overall Study|Lost to Follow-up|11|||
33599808|NCT02282293|62999027|FG000|Overall Study|Lost to Follow-up|2|||
33599809|NCT02282293|62999028|FG001|Overall Study|Lost to Follow-up|2|||
33599810|NCT02282293|62999027|FG000|Overall Study|Unable to comply with study procedures|1|||
33599811|NCT02282293|62999028|FG001|Overall Study|Unable to comply with study procedures|0|||
33599812|NCT02282293|62999027|FG000|Overall Study|Moved out of study area|0|||
33599813|NCT02282293|62999028|FG001|Overall Study|Moved out of study area|1|||
33599814|NCT01854658|62999038|FG000|Overall Study|Protocol Violation|6|||
33599815|NCT01854658|62999039|FG001|Overall Study|Protocol Violation|2|||
33599816|NCT01854658|62999040|FG002|Overall Study|Protocol Violation|2|||
33599817|NCT01854658|62999041|FG003|Overall Study|Protocol Violation|1|||
33599818|NCT01854658|62999038|FG000|Overall Study|Physician Decision|7|||
33321975|NCT01177722|62698150|FG002|Overall Study|Serious Adverse Event|1|||
33411786|NCT00424528|62790156|FG000|Overall Study|Adverse Event|2|||
33411787|NCT00424528|62790157|FG001|Overall Study|Adverse Event|1|||
33599819|NCT01854658|62999039|FG001|Overall Study|Physician Decision|5|||
33599820|NCT01854658|62999040|FG002|Overall Study|Physician Decision|2|||
33599821|NCT01854658|62999041|FG003|Overall Study|Physician Decision|4|||
33599822|NCT01854658|62999038|FG000|Overall Study|Lost to Follow-up|8|||
33599823|NCT01854658|62999039|FG001|Overall Study|Lost to Follow-up|9|||
33599824|NCT01854658|62999040|FG002|Overall Study|Lost to Follow-up|8|||
33599825|NCT01854658|62999041|FG003|Overall Study|Lost to Follow-up|4|||
33599826|NCT01854658|62999038|FG000|Overall Study|Withdrawal by Subject|28|||
33599827|NCT01854658|62999039|FG001|Overall Study|Withdrawal by Subject|21|||
33599828|NCT01854658|62999040|FG002|Overall Study|Withdrawal by Subject|29|||
33599829|NCT01854658|62999041|FG003|Overall Study|Withdrawal by Subject|15|||
33599830|NCT01854658|62999038|FG000|Overall Study|Protocol-specified criteria|15|||
33599831|NCT01854658|62999039|FG001|Overall Study|Protocol-specified criteria|15|||
33411788|NCT00424528|62790158|FG002|Overall Study|Adverse Event|2|||
33411789|NCT00424528|62790156|FG000|Overall Study|Protocol Violation|1|||
33411790|NCT00424528|62790157|FG001|Overall Study|Protocol Violation|1|||
33411791|NCT00424528|62790158|FG002|Overall Study|Protocol Violation|0|||
33411792|NCT00424528|62790156|FG000|Overall Study|Lost to Follow-up|0|||
33411793|NCT00424528|62790157|FG001|Overall Study|Lost to Follow-up|1|||
33411794|NCT00424528|62790158|FG002|Overall Study|Lost to Follow-up|0|||
33411795|NCT00424528|62790156|FG000|Overall Study|noncompliance with study requirements|2|||
33411796|NCT00424528|62790157|FG001|Overall Study|noncompliance with study requirements|1|||
33411797|NCT00424528|62790158|FG002|Overall Study|noncompliance with study requirements|2|||
33411798|NCT00545532|62790168|FG000|Overall Study|Withdrawal by Subject|1|||
33411799|NCT00545532|62790169|FG001|Overall Study|Withdrawal by Subject|3|||
33411800|NCT00545532|62790168|FG000|Overall Study|Lost to Follow-up|5|||
33599832|NCT01854658|62999040|FG002|Overall Study|Protocol-specified criteria|10|||
33599833|NCT01854658|62999041|FG003|Overall Study|Protocol-specified criteria|7|||
33599834|NCT01854658|62999038|FG000|Overall Study|Lack of Efficacy|3|||
33599835|NCT01854658|62999039|FG001|Overall Study|Lack of Efficacy|8|||
33599836|NCT01854658|62999040|FG002|Overall Study|Lack of Efficacy|4|||
33599837|NCT01854658|62999041|FG003|Overall Study|Lack of Efficacy|7|||
33599838|NCT01854658|62999038|FG000|Overall Study|Adverse Event|21|||
33599839|NCT01854658|62999039|FG001|Overall Study|Adverse Event|14|||
33599840|NCT01854658|62999040|FG002|Overall Study|Adverse Event|23|||
33599841|NCT01854658|62999041|FG003|Overall Study|Adverse Event|19|||
33599842|NCT01854658|62999038|FG000|Overall Study|Administrative reasons|5|||
33321976|NCT01177722|62698151|FG003|Overall Study|Serious Adverse Event|0|||
33321977|NCT01177722|62698148|FG000|Overall Study|Protocol Violation|0|||
33321978|NCT01177722|62698149|FG001|Overall Study|Protocol Violation|0|||
33321979|NCT01177722|62698150|FG002|Overall Study|Protocol Violation|1|||
33321980|NCT01177722|62698151|FG003|Overall Study|Protocol Violation|0|||
33321981|NCT01177722|62698148|FG000|Overall Study|Lost to Follow-up|3|||
33321982|NCT01177722|62698149|FG001|Overall Study|Lost to Follow-up|4|||
33321983|NCT01177722|62698150|FG002|Overall Study|Lost to Follow-up|3|||
33321984|NCT01177722|62698151|FG003|Overall Study|Lost to Follow-up|1|||
33321985|NCT01177722|62698148|FG000|Overall Study|Withdrawal by Subject|10|||
33321986|NCT01177722|62698149|FG001|Overall Study|Withdrawal by Subject|6|||
33599843|NCT01854658|62999039|FG001|Overall Study|Administrative reasons|1|||
33599844|NCT01854658|62999040|FG002|Overall Study|Administrative reasons|2|||
33599845|NCT01854658|62999041|FG003|Overall Study|Administrative reasons|2|||
33599846|NCT01892020|62999051|FG000|Period 1|Adverse Event|1|||
33599847|NCT01892020|62999052|FG001|Period 1|Adverse Event|1|||
33599848|NCT01892020|62999051|FG000|Period 1|Protocol Violation|2|||
33599849|NCT01892020|62999052|FG001|Period 1|Protocol Violation|4|||
33599850|NCT01892020|62999051|FG000|Period 1|Unclassified|0|||
33599851|NCT01892020|62999052|FG001|Period 1|Unclassified|1|||
33599852|NCT01892020|62999051|FG000|Period 2|Protocol Violation|1|||
33599853|NCT01892020|62999052|FG001|Period 2|Protocol Violation|0|||
33599854|NCT02485691|62999060|FG000|Overall Study|Adverse Event|25|||
33599855|NCT02485691|62999061|FG001|Overall Study|Adverse Event|11|||
33599856|NCT02485691|62999060|FG000|Overall Study|Poor compliance to protocol|0|||
33599857|NCT02485691|62999061|FG001|Overall Study|Poor compliance to protocol|1|||
33599858|NCT02485691|62999060|FG000|Overall Study|Disease progression|57|||
33599859|NCT02485691|62999061|FG001|Overall Study|Disease progression|92|||
33599860|NCT02485691|62999060|FG000|Overall Study|Investigator's decision|23|||
33599861|NCT02485691|62999061|FG001|Overall Study|Investigator's decision|5|||
33599862|NCT02485691|62999060|FG000|Overall Study|Participant's request|13|||
33599863|NCT02485691|62999061|FG001|Overall Study|Participant's request|6|||
33599864|NCT02485691|62999060|FG000|Overall Study|Other reason|8|||
33599865|NCT02485691|62999061|FG001|Overall Study|Other reason|9|||
33599866|NCT02485691|62999060|FG000|Overall Study|Randomized and not treated|3|||
33599867|NCT02485691|62999061|FG001|Overall Study|Randomized and not treated|2|||
33599868|NCT02517515|62999070|FG000|Overall Study|Adverse Event|0|||
33599869|NCT02517515|62999071|FG001|Overall Study|Adverse Event|1|||
33599870|NCT02517515|62999070|FG000|Overall Study|Withdrew Consent|0|||
33599871|NCT02517515|62999071|FG001|Overall Study|Withdrew Consent|1|||
33599872|NCT02517515|62999070|FG000|Overall Study|Lost to Follow-up|1|||
33599873|NCT02517515|62999071|FG001|Overall Study|Lost to Follow-up|0|||
33599874|NCT02517515|62999070|FG000|Overall Study|Other|1|||
33599875|NCT02517515|62999071|FG001|Overall Study|Other|0|||
33599876|NCT02466659|62999080|FG000|Overall Study|Lost to Follow-up|5|||
33599877|NCT02466659|62999081|FG001|Overall Study|Lost to Follow-up|2|||
33599878|NCT01891864|62999089|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
33599879|NCT01891864|62999090|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
33599880|NCT01891864|62999091|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
33599881|NCT01891864|62999092|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
33599882|NCT01891864|62999093|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
33599883|NCT01891864|62999094|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
33599884|NCT01891864|62999089|FG000|Treatment Period 1|Physician Decision|0|||
33599885|NCT01891864|62999090|FG001|Treatment Period 1|Physician Decision|1|||
33599886|NCT01891864|62999091|FG002|Treatment Period 1|Physician Decision|0|||
33599887|NCT01891864|62999092|FG003|Treatment Period 1|Physician Decision|0|||
33599888|NCT01891864|62999093|FG004|Treatment Period 1|Physician Decision|0|||
33599889|NCT01891864|62999094|FG005|Treatment Period 1|Physician Decision|0|||
33411801|NCT00545532|62790169|FG001|Overall Study|Lost to Follow-up|6|||
33411802|NCT00545532|62790168|FG000|Overall Study|Death|0|||
33599890|NCT01891864|62999089|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
33599891|NCT01891864|62999090|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
33599892|NCT01891864|62999091|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
33599893|NCT01891864|62999092|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
33599894|NCT01891864|62999093|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
33599895|NCT01891864|62999094|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
33599896|NCT01891864|62999089|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
33599897|NCT01891864|62999090|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
33599898|NCT01891864|62999091|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
33599899|NCT01891864|62999092|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
33599900|NCT01891864|62999093|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
33599901|NCT01891864|62999094|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
33599902|NCT01891864|62999089|FG000|Treatment Period 1|Withdrawal by Subject|2|||
33599903|NCT01891864|62999090|FG001|Treatment Period 1|Withdrawal by Subject|5|||
33599904|NCT01891864|62999091|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33599905|NCT01891864|62999092|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33599906|NCT01891864|62999093|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33599907|NCT01891864|62999094|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33599908|NCT01891864|62999089|FG000|Treatment Period 1|Lost to Follow-up|1|||
33599909|NCT01891864|62999090|FG001|Treatment Period 1|Lost to Follow-up|0|||
33599910|NCT01891864|62999091|FG002|Treatment Period 1|Lost to Follow-up|0|||
33599911|NCT01891864|62999092|FG003|Treatment Period 1|Lost to Follow-up|0|||
33411803|NCT00545532|62790169|FG001|Overall Study|Death|1|||
33411804|NCT00544440|62790177|FG000|Overall Study|Other|1|||
33411805|NCT00544440|62790177|FG000|Overall Study|Adverse Event|1|||
33411806|NCT00544440|62790177|FG000|Overall Study|Withdrawal by Subject|2|||
33411807|NCT00544440|62790177|FG000|Overall Study|Subject Non-compliance|1|||
33411808|NCT00544440|62790177|FG000|Overall Study|Progressive Disease|47|||
33411809|NCT00544440|62790177|FG000|Overall Study|Other|5|||
33599912|NCT01891864|62999093|FG004|Treatment Period 1|Lost to Follow-up|0|||
33599913|NCT01891864|62999094|FG005|Treatment Period 1|Lost to Follow-up|0|||
33599914|NCT01891864|62999089|FG000|Treatment Period 2|Protocol Violation|0|||
33599915|NCT01891864|62999090|FG001|Treatment Period 2|Protocol Violation|0|||
33599916|NCT01891864|62999091|FG002|Treatment Period 2|Protocol Violation|0|||
33599917|NCT01891864|62999092|FG003|Treatment Period 2|Protocol Violation|1|||
33599918|NCT01891864|62999093|FG004|Treatment Period 2|Protocol Violation|0|||
33599919|NCT01891864|62999094|FG005|Treatment Period 2|Protocol Violation|0|||
33599920|NCT01891864|62999089|FG000|Treatment Period 2|Physician Decision|0|||
33599921|NCT01891864|62999090|FG001|Treatment Period 2|Physician Decision|0|||
33599922|NCT01891864|62999091|FG002|Treatment Period 2|Physician Decision|1|||
33599923|NCT01891864|62999092|FG003|Treatment Period 2|Physician Decision|0|||
33599924|NCT01891864|62999093|FG004|Treatment Period 2|Physician Decision|0|||
33599925|NCT01891864|62999094|FG005|Treatment Period 2|Physician Decision|0|||
33599926|NCT01891864|62999089|FG000|Treatment Period 2|Site Termination|0|||
33599927|NCT01891864|62999090|FG001|Treatment Period 2|Site Termination|0|||
33599928|NCT01891864|62999091|FG002|Treatment Period 2|Site Termination|1|||
33599929|NCT01891864|62999092|FG003|Treatment Period 2|Site Termination|2|||
33599930|NCT01891864|62999093|FG004|Treatment Period 2|Site Termination|0|||
33599931|NCT01891864|62999094|FG005|Treatment Period 2|Site Termination|0|||
33599932|NCT01891864|62999089|FG000|Treatment Period 2|Lack of Efficacy|0|||
33599933|NCT01891864|62999090|FG001|Treatment Period 2|Lack of Efficacy|0|||
33599934|NCT01891864|62999091|FG002|Treatment Period 2|Lack of Efficacy|1|||
33599935|NCT01891864|62999092|FG003|Treatment Period 2|Lack of Efficacy|0|||
33599936|NCT01891864|62999093|FG004|Treatment Period 2|Lack of Efficacy|1|||
33599937|NCT01891864|62999094|FG005|Treatment Period 2|Lack of Efficacy|0|||
33599938|NCT01891864|62999089|FG000|Treatment Period 2|Adverse Event|0|||
33599939|NCT01891864|62999090|FG001|Treatment Period 2|Adverse Event|0|||
33599940|NCT01891864|62999091|FG002|Treatment Period 2|Adverse Event|1|||
33599941|NCT01891864|62999092|FG003|Treatment Period 2|Adverse Event|2|||
33599942|NCT01891864|62999093|FG004|Treatment Period 2|Adverse Event|0|||
33599943|NCT01891864|62999094|FG005|Treatment Period 2|Adverse Event|4|||
33599944|NCT01891864|62999089|FG000|Treatment Period 2|Termination of Site|0|||
33599945|NCT01891864|62999090|FG001|Treatment Period 2|Termination of Site|0|||
33599946|NCT01891864|62999091|FG002|Treatment Period 2|Termination of Site|0|||
33599947|NCT01891864|62999092|FG003|Treatment Period 2|Termination of Site|0|||
33411810|NCT03920670|62790183|FG000|Overall Study|Protocol Violation|2|||
33599948|NCT01891864|62999093|FG004|Treatment Period 2|Termination of Site|2|||
33599949|NCT01891864|62999094|FG005|Treatment Period 2|Termination of Site|0|||
33599950|NCT01891864|62999089|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33599951|NCT01891864|62999090|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33599952|NCT01891864|62999091|FG002|Treatment Period 2|Withdrawal by Subject|3|||
33599953|NCT01891864|62999092|FG003|Treatment Period 2|Withdrawal by Subject|4|||
33599954|NCT01891864|62999093|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33411811|NCT03920670|62790184|FG001|Overall Study|Protocol Violation|2|||
33411812|NCT03920670|62790183|FG000|Overall Study|Adverse Event|1|||
33599955|NCT01891864|62999094|FG005|Treatment Period 2|Withdrawal by Subject|1|||
33599956|NCT01891864|62999089|FG000|Extension Period|Lack of Efficacy|0|||
33599957|NCT01891864|62999090|FG001|Extension Period|Lack of Efficacy|0|||
33599958|NCT01891864|62999091|FG002|Extension Period|Lack of Efficacy|0|||
33599959|NCT01891864|62999092|FG003|Extension Period|Lack of Efficacy|1|||
33599960|NCT01891864|62999093|FG004|Extension Period|Lack of Efficacy|1|||
33599961|NCT01891864|62999094|FG005|Extension Period|Lack of Efficacy|0|||
33599962|NCT01891864|62999089|FG000|Extension Period|Pregnancy|0|||
33599963|NCT01891864|62999090|FG001|Extension Period|Pregnancy|0|||
33599964|NCT01891864|62999091|FG002|Extension Period|Pregnancy|1|||
33599965|NCT01891864|62999092|FG003|Extension Period|Pregnancy|0|||
33599966|NCT01891864|62999093|FG004|Extension Period|Pregnancy|0|||
33599967|NCT01891864|62999094|FG005|Extension Period|Pregnancy|0|||
33599968|NCT01891864|62999089|FG000|Extension Period|Adverse Event|0|||
33599969|NCT01891864|62999090|FG001|Extension Period|Adverse Event|0|||
33599970|NCT01891864|62999091|FG002|Extension Period|Adverse Event|4|||
33599971|NCT01891864|62999092|FG003|Extension Period|Adverse Event|2|||
33599972|NCT01891864|62999093|FG004|Extension Period|Adverse Event|2|||
33599973|NCT01891864|62999094|FG005|Extension Period|Adverse Event|0|||
33599974|NCT01891864|62999089|FG000|Extension Period|Withdrawal by Subject|0|||
33599975|NCT01891864|62999090|FG001|Extension Period|Withdrawal by Subject|0|||
33599976|NCT01891864|62999091|FG002|Extension Period|Withdrawal by Subject|1|||
33599977|NCT01891864|62999092|FG003|Extension Period|Withdrawal by Subject|2|||
33599978|NCT01891864|62999093|FG004|Extension Period|Withdrawal by Subject|4|||
33321987|NCT01177722|62698150|FG002|Overall Study|Withdrawal by Subject|4|||
33599979|NCT01891864|62999094|FG005|Extension Period|Withdrawal by Subject|0|||
33599980|NCT01891864|62999089|FG000|Extension Period|Lost to Follow-up|0|||
33599981|NCT01891864|62999090|FG001|Extension Period|Lost to Follow-up|0|||
33599982|NCT01891864|62999091|FG002|Extension Period|Lost to Follow-up|2|||
33599983|NCT01891864|62999092|FG003|Extension Period|Lost to Follow-up|0|||
33599984|NCT01891864|62999093|FG004|Extension Period|Lost to Follow-up|0|||
33599985|NCT01891864|62999094|FG005|Extension Period|Lost to Follow-up|0|||
33599986|NCT02485301|62999108|FG000|Overall Study|Serious Adverse Events|2|||
33599987|NCT02485301|62999109|FG001|Overall Study|Serious Adverse Events|1|||
33599988|NCT02485301|62999108|FG000|Overall Study|Protocol Violation|0|||
33599989|NCT02485301|62999109|FG001|Overall Study|Protocol Violation|1|||
33599990|NCT02485301|62999108|FG000|Overall Study|Withdrawal by Subject|6|||
33599991|NCT02485301|62999109|FG001|Overall Study|Withdrawal by Subject|7|||
33599992|NCT02485301|62999108|FG000|Overall Study|Migrated/moved from study area|10|||
33599993|NCT02485301|62999109|FG001|Overall Study|Migrated/moved from study area|19|||
33599994|NCT02485301|62999108|FG000|Overall Study|Lost to Follow-up|17|||
33599995|NCT02485301|62999109|FG001|Overall Study|Lost to Follow-up|17|||
33321988|NCT01177722|62698151|FG003|Overall Study|Withdrawal by Subject|6|||
33321989|NCT01177410|62698165|FG000|Overall Study|Adverse Event|0|||
33599996|NCT02485301|62999108|FG000|Overall Study|Other|3|||
33599997|NCT02485301|62999109|FG001|Overall Study|Other|4|||
33599998|NCT02484911|62999117|FG000|Overall Study|Withdrawal by Subject|2|||
33599999|NCT02484911|62999118|FG001|Overall Study|Withdrawal by Subject|1|||
33600000|NCT02484911|62999117|FG000|Overall Study|Protocol Violation|2|||
33600001|NCT02484911|62999118|FG001|Overall Study|Protocol Violation|1|||
33600002|NCT02466425|62999127|FG000|Overall Study|Adverse Event|3|||
33600003|NCT02466425|62999128|FG001|Overall Study|Adverse Event|11|||
33600004|NCT02466425|62999127|FG000|Overall Study|Lack of Efficacy|4|||
33600005|NCT02466425|62999128|FG001|Overall Study|Lack of Efficacy|1|||
33600006|NCT02466425|62999127|FG000|Overall Study|Lost to Follow-up|3|||
33411813|NCT03920670|62790184|FG001|Overall Study|Adverse Event|0|||
33411814|NCT00430300|62790194|FG000|Overall Study|Adverse Event|0|||
33411815|NCT00430300|62790195|FG001|Overall Study|Adverse Event|2|||
33600007|NCT02466425|62999128|FG001|Overall Study|Lost to Follow-up|0|||
33600008|NCT02466425|62999127|FG000|Overall Study|Protocol Violation|1|||
33600009|NCT02466425|62999128|FG001|Overall Study|Protocol Violation|0|||
33600010|NCT02466425|62999127|FG000|Overall Study|Withdrawal by Subject|0|||
33600011|NCT02466425|62999128|FG001|Overall Study|Withdrawal by Subject|1|||
33600012|NCT02466425|62999127|FG000|Overall Study|Other|1|||
33600013|NCT02466425|62999128|FG001|Overall Study|Other|3|||
33600014|NCT02466425|62999127|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
33600015|NCT02466425|62999128|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33600016|NCT02451917|62999136|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
33321990|NCT01177410|62698166|FG001|Overall Study|Adverse Event|2|||
33600017|NCT02451917|62999137|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
33600018|NCT02451917|62999136|FG000|First Intervention (24 Weeks)|Death|0|||
33600019|NCT02451917|62999137|FG001|First Intervention (24 Weeks)|Death|1|||
33600020|NCT02451917|62999136|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
33600021|NCT02451917|62999137|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
33600022|NCT02349451|62999150|FG000|Overall Study|Withdrawal by Subject|0|||
33600023|NCT02349451|62999151|FG001|Overall Study|Withdrawal by Subject|1|||
33600024|NCT02349451|62999152|FG002|Overall Study|Withdrawal by Subject|2|||
33600025|NCT02349451|62999153|FG003|Overall Study|Withdrawal by Subject|1|||
33600026|NCT02409368|62999170|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
33600027|NCT02409368|62999171|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
33600028|NCT02409368|62999172|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
33600029|NCT02409368|62999173|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
33600030|NCT02409368|62999170|FG000|ECOG Reclassification|Death|1|||
33600031|NCT02409368|62999171|FG001|ECOG Reclassification|Death|5|||
33600032|NCT02409368|62999172|FG002|ECOG Reclassification|Death|0|||
33600033|NCT02409368|62999173|FG003|ECOG Reclassification|Death|0|||
33600034|NCT02409368|62999170|FG000|ECOG Reclassification|Disease Progression|113|||
33600035|NCT02409368|62999171|FG001|ECOG Reclassification|Disease Progression|382|||
33600036|NCT02409368|62999172|FG002|ECOG Reclassification|Disease Progression|70|||
33600037|NCT02409368|62999173|FG003|ECOG Reclassification|Disease Progression|1|||
33600038|NCT02409368|62999170|FG000|ECOG Reclassification|Lost to Follow-up|1|||
33600039|NCT02409368|62999171|FG001|ECOG Reclassification|Lost to Follow-up|5|||
33600040|NCT02409368|62999172|FG002|ECOG Reclassification|Lost to Follow-up|0|||
33600041|NCT02409368|62999173|FG003|ECOG Reclassification|Lost to Follow-up|0|||
33600042|NCT02409368|62999170|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
33600043|NCT02409368|62999171|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
33600044|NCT02409368|62999172|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
33600045|NCT02409368|62999173|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
33600046|NCT02409368|62999170|FG000|ECOG Reclassification|Poor/non-compliance|0|||
33600047|NCT02409368|62999171|FG001|ECOG Reclassification|Poor/non-compliance|3|||
33600048|NCT02409368|62999172|FG002|ECOG Reclassification|Poor/non-compliance|2|||
33600049|NCT02409368|62999173|FG003|ECOG Reclassification|Poor/non-compliance|0|||
33600050|NCT02409368|62999170|FG000|ECOG Reclassification|Study drug toxicity|17|||
33600051|NCT02409368|62999171|FG001|ECOG Reclassification|Study drug toxicity|42|||
33600052|NCT02409368|62999172|FG002|ECOG Reclassification|Study drug toxicity|7|||
33600053|NCT02409368|62999173|FG003|ECOG Reclassification|Study drug toxicity|0|||
33600054|NCT02409368|62999170|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
33600055|NCT02409368|62999171|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
33600056|NCT02409368|62999172|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
33600057|NCT02409368|62999173|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
33600058|NCT02409368|62999170|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
33600059|NCT02409368|62999171|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
33600060|NCT02409368|62999172|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
33600061|NCT02409368|62999173|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
33600062|NCT02409368|62999170|FG000|ECOG Reclassification|Participant withdrew consent|2|||
33600063|NCT02409368|62999171|FG001|ECOG Reclassification|Participant withdrew consent|3|||
33600064|NCT02409368|62999172|FG002|ECOG Reclassification|Participant withdrew consent|4|||
33600065|NCT02409368|62999173|FG003|ECOG Reclassification|Participant withdrew consent|0|||
33600066|NCT02409368|62999170|FG000|ECOG Reclassification|Other Reasons|5|||
33600067|NCT02409368|62999171|FG001|ECOG Reclassification|Other Reasons|26|||
33600068|NCT02409368|62999172|FG002|ECOG Reclassification|Other Reasons|2|||
33600069|NCT02409368|62999173|FG003|ECOG Reclassification|Other Reasons|0|||
33600070|NCT02409368|62999170|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
33600071|NCT02409368|62999171|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
33600072|NCT02409368|62999172|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
33600073|NCT02409368|62999173|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
33411816|NCT00430300|62790196|FG002|Overall Study|Adverse Event|1|||
33411817|NCT00430300|62790197|FG003|Overall Study|Adverse Event|1|||
33411818|NCT00430300|62790194|FG000|Overall Study|Withdrawal by Subject|1|||
33411819|NCT00430300|62790195|FG001|Overall Study|Withdrawal by Subject|0|||
33411820|NCT00430300|62790196|FG002|Overall Study|Withdrawal by Subject|5|||
33411821|NCT00430300|62790197|FG003|Overall Study|Withdrawal by Subject|0|||
33411822|NCT00430300|62790194|FG000|Overall Study|Laboratory abnormality|1|||
33600074|NCT01853878|62999186|FG000|Overall Study|Recurrence|2|||
33600075|NCT01853878|62999187|FG001|Overall Study|Recurrence|0|||
33600076|NCT01853878|62999186|FG000|Overall Study|Adverse Event|2|||
33600077|NCT01853878|62999187|FG001|Overall Study|Adverse Event|0|||
33600078|NCT01853878|62999186|FG000|Overall Study|Withdrawal by Subject|3|||
33600079|NCT01853878|62999187|FG001|Overall Study|Withdrawal by Subject|1|||
33321991|NCT01177410|62698167|FG002|Overall Study|Adverse Event|2|||
33321992|NCT01177410|62698165|FG000|Overall Study|Withdrawal by Subject|1|||
33321993|NCT01177410|62698166|FG001|Overall Study|Withdrawal by Subject|4|||
33321994|NCT01177410|62698167|FG002|Overall Study|Withdrawal by Subject|3|||
33321995|NCT01177410|62698165|FG000|Overall Study|Lost to Follow-up|0|||
33321996|NCT01177410|62698166|FG001|Overall Study|Lost to Follow-up|1|||
33321997|NCT01177410|62698167|FG002|Overall Study|Lost to Follow-up|0|||
33321998|NCT01156116|62698177|FG000|Overall Study|Withdrawal by Subject|3|||
33321999|NCT01156116|62698178|FG001|Overall Study|Withdrawal by Subject|1|||
33322000|NCT01156116|62698177|FG000|Overall Study|CPAP intolerance|2|||
33322001|NCT01156116|62698178|FG001|Overall Study|CPAP intolerance|0|||
33322002|NCT01155726|62698184|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
33322003|NCT01155726|62698185|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
33322004|NCT01155726|62698186|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
33322005|NCT01155726|62698187|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
33322006|NCT01155570|62698209|FG000|Overall Study|Adverse Event|39|||
33600080|NCT01853878|62999186|FG000|Overall Study|Migrated/moved from the study area|1|||
33600081|NCT01853878|62999187|FG001|Overall Study|Migrated/moved from the study area|0|||
33600082|NCT01853878|62999186|FG000|Overall Study|Other|55|||
33600083|NCT01853878|62999187|FG001|Overall Study|Other|43|||
33600084|NCT02342678|62999195|FG000|Overall Study|Lost to Follow-up|0|||
33600085|NCT02342678|62999196|FG001|Overall Study|Lost to Follow-up|1|||
33600086|NCT02342678|62999195|FG000|Overall Study|Too busy to complete study|0|||
33600087|NCT02342678|62999196|FG001|Overall Study|Too busy to complete study|2|||
33600088|NCT02342678|62999195|FG000|Overall Study|Family illness/emergency|0|||
33600089|NCT02342678|62999196|FG001|Overall Study|Family illness/emergency|1|||
33600090|NCT02342678|62999195|FG000|Overall Study|Illness/medical reason|1|||
33600091|NCT02342678|62999196|FG001|Overall Study|Illness/medical reason|1|||
33600092|NCT02342288|62999204|FG000|Overall Study|no protocol anesthesiologist available|3|||
33600093|NCT02342288|62999205|FG001|Overall Study|no protocol anesthesiologist available|2|||
33600094|NCT02342288|62999204|FG000|Overall Study|anesthesia leak in system|1|||
33600095|NCT02342288|62999205|FG001|Overall Study|anesthesia leak in system|0|||
33600096|NCT02342288|62999204|FG000|Overall Study|Withdrawal by Subject|1|||
33600097|NCT02342288|62999205|FG001|Overall Study|Withdrawal by Subject|0|||
33600098|NCT02342288|62999204|FG000|Overall Study|coordinator contaminated with blood|0|||
33322007|NCT01155570|62698209|FG000|Overall Study|Lack of Efficacy|46|||
33322008|NCT01155570|62698209|FG000|Overall Study|Participant's Economic Reasons|17|||
33322009|NCT01155570|62698209|FG000|Overall Study|No Hospital Visits|7|||
33322010|NCT01155570|62698209|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
33322011|NCT01155570|62698209|FG000|Overall Study|Adverse Event + Other Reasons|7|||
33322012|NCT01155570|62698209|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
33322013|NCT01155570|62698209|FG000|Overall Study|Other Reasons|23|||
33322014|NCT01155024|62698215|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
33322015|NCT01155024|62698216|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
33322016|NCT01155024|62698215|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
33600099|NCT02342288|62999205|FG001|Overall Study|coordinator contaminated with blood|1|||
33600100|NCT02342288|62999204|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
33600101|NCT02342288|62999205|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
33600102|NCT02342288|62999204|FG000|Overall Study|coordinator not available|0|||
33600103|NCT02342288|62999205|FG001|Overall Study|coordinator not available|2|||
33600104|NCT01853644|62999211|FG000|Registration and Treatment Start|Did not start treatment|1|||
33322017|NCT01155024|62698216|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
33322018|NCT01155024|62698215|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
33322019|NCT01155024|62698216|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
33322020|NCT01176240|62698227|FG000|Study 306A|Lack of Efficacy|2|||
33322021|NCT01176240|62698228|FG001|Study 306A|Lack of Efficacy|1|||
33322022|NCT01176240|62698227|FG000|Study 306A|Protocol Violation|0|||
33322023|NCT01176240|62698228|FG001|Study 306A|Protocol Violation|1|||
33322024|NCT01176240|62698227|FG000|Study 306A|Withdrawal by Subject|0|||
33322025|NCT01176240|62698228|FG001|Study 306A|Withdrawal by Subject|1|||
33322026|NCT01176240|62698227|FG000|Study 306A|Stop due to diverse problems|1|||
33322027|NCT01176240|62698228|FG001|Study 306A|Stop due to diverse problems|0|||
33322028|NCT01176240|62698227|FG000|Study 306B|Lack of Efficacy|5|||
33322029|NCT01176240|62698228|FG001|Study 306B|Lack of Efficacy|3|||
33322030|NCT01176240|62698227|FG000|Study 306B|Adverse Event|10|||
33600105|NCT01853644|62999211|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
33600106|NCT01853644|62999211|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
33411823|NCT00430300|62790195|FG001|Overall Study|Laboratory abnormality|0|||
33411824|NCT00430300|62790196|FG002|Overall Study|Laboratory abnormality|0|||
33411825|NCT00430300|62790197|FG003|Overall Study|Laboratory abnormality|0|||
33411826|NCT00430300|62790194|FG000|Overall Study|Other|0|||
33411827|NCT00430300|62790195|FG001|Overall Study|Other|0|||
33411828|NCT00430300|62790196|FG002|Overall Study|Other|0|||
33411829|NCT00430300|62790197|FG003|Overall Study|Other|1|||
33411830|NCT03927846|62790209|FG000|Overall Study|Lost to Follow-up|10|||
33411831|NCT03927846|62790210|FG001|Overall Study|Lost to Follow-up|11|||
33411832|NCT03927144|62790218|FG000|Overall Study|Adverse Event|9|||
33411833|NCT03927144|62790219|FG001|Overall Study|Adverse Event|5|||
33411834|NCT03927144|62790218|FG000|Overall Study|Lost to Follow-up|3|||
33411835|NCT03927144|62790219|FG001|Overall Study|Lost to Follow-up|2|||
33411836|NCT03927144|62790218|FG000|Overall Study|New Therapy for Study Indication|0|||
33411837|NCT03927144|62790219|FG001|Overall Study|New Therapy for Study Indication|1|||
33411838|NCT03927144|62790218|FG000|Overall Study|No Longer Clinically Benefiting|4|||
33411839|NCT03927144|62790219|FG001|Overall Study|No Longer Clinically Benefiting|4|||
33411840|NCT03927144|62790218|FG000|Overall Study|Physician Decision|2|||
33411841|NCT03927144|62790219|FG001|Overall Study|Physician Decision|8|||
33411842|NCT03927144|62790218|FG000|Overall Study|Protocol Violation|2|||
33411843|NCT03927144|62790219|FG001|Overall Study|Protocol Violation|2|||
33411844|NCT03927144|62790218|FG000|Overall Study|Withdrawal by Subject|16|||
33411845|NCT03927144|62790219|FG001|Overall Study|Withdrawal by Subject|40|||
33411846|NCT00545298|62790228|FG000|Overall Study|Issues with Standard of Care|2|||
33411847|NCT00545298|62790229|FG001|Overall Study|Issues with Standard of Care|0|||
33411848|NCT00545298|62790230|FG002|Overall Study|Issues with Standard of Care|1|||
33411849|NCT00429364|62790243|FG000|Overall Study|Withdrawal by Subject|11|||
33411850|NCT00429364|62790244|FG001|Overall Study|Withdrawal by Subject|5|||
33411851|NCT00429364|62790243|FG000|Overall Study|Physician Decision|4|||
33411852|NCT00429364|62790244|FG001|Overall Study|Physician Decision|2|||
33411853|NCT00429364|62790243|FG000|Overall Study|Lost to Follow-up|7|||
33411854|NCT00429364|62790244|FG001|Overall Study|Lost to Follow-up|6|||
33411855|NCT00429364|62790243|FG000|Overall Study|Death|0|||
33411856|NCT00429364|62790244|FG001|Overall Study|Death|1|||
33411857|NCT00429364|62790243|FG000|Overall Study|Underwent aortic root surgery|10|||
33411858|NCT00429364|62790244|FG001|Overall Study|Underwent aortic root surgery|18|||
33411859|NCT00429364|62790243|FG000|Overall Study|Pregnancy|0|||
33411860|NCT00429364|62790244|FG001|Overall Study|Pregnancy|1|||
33411861|NCT00414388|62790250|FG000|Overall Study|Adverse Event|1|||
33411862|NCT03920280|62790257|FG000|Overall Study|Adverse Event|2|||
33411863|NCT03920280|62790258|FG001|Overall Study|Adverse Event|3|||
33411864|NCT03920280|62790257|FG000|Overall Study|Lost to Follow-up|0|||
33411865|NCT03920280|62790258|FG001|Overall Study|Lost to Follow-up|1|||
33411866|NCT03920280|62790257|FG000|Overall Study|Withdrawal by Subject|1|||
33322031|NCT01176240|62698228|FG001|Study 306B|Adverse Event|5|||
33322032|NCT01176240|62698227|FG000|Study 306B|Protocol Violation|2|||
33322033|NCT01176240|62698228|FG001|Study 306B|Protocol Violation|3|||
33322034|NCT01176240|62698227|FG000|Study 306B|Withdrawal by Subject|4|||
33322035|NCT01176240|62698228|FG001|Study 306B|Withdrawal by Subject|1|||
33322036|NCT01176240|62698227|FG000|Study 306B|Physician Decision|2|||
33411867|NCT03920280|62790258|FG001|Overall Study|Withdrawal by Subject|1|||
33411868|NCT03920280|62790257|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
33411869|NCT03920280|62790258|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
33411870|NCT00424372|62790267|FG000|Overall Study|Death|1|||
33411871|NCT00424372|62790267|FG000|Overall Study|Adverse Event|18|||
33411872|NCT00424372|62790267|FG000|Overall Study|Lack of Efficacy|6|||
33600107|NCT01853644|62999211|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
33600108|NCT01853644|62999211|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
33322037|NCT01176240|62698228|FG001|Study 306B|Physician Decision|1|||
33411873|NCT00424372|62790267|FG000|Overall Study|Withdrawal by Subject|4|||
33411874|NCT00424372|62790267|FG000|Overall Study|Protocol Violation|1|||
33411875|NCT00424372|62790267|FG000|Overall Study|Health deterioration|1|||
33411876|NCT00414310|62790273|FG000|Overall Study|Not treated|1|||
33411877|NCT00414310|62790274|FG001|Overall Study|Not treated|0|||
33411878|NCT00542880|62790284|FG000|Period 1|Eligibility criteria not fulfilled|2|||
33411879|NCT00542880|62790285|FG001|Period 1|Eligibility criteria not fulfilled|6|||
33411880|NCT00542880|62790284|FG000|Period 1|Adverse Event|2|||
33411881|NCT00542880|62790285|FG001|Period 1|Adverse Event|2|||
33411882|NCT00542880|62790284|FG000|Period 1|Development of study-specific criteria|1|||
33411883|NCT00542880|62790285|FG001|Period 1|Development of study-specific criteria|2|||
33411884|NCT00542880|62790284|FG000|Period 1|Withdrawal by Subject|1|||
33411885|NCT00542880|62790285|FG001|Period 1|Withdrawal by Subject|1|||
33411886|NCT00542880|62790284|FG000|Period 1|Protocol Violation|0|||
33411887|NCT00542880|62790285|FG001|Period 1|Protocol Violation|1|||
33411888|NCT00542880|62790284|FG000|Period 2|Adverse Event|5|||
33411889|NCT00542880|62790285|FG001|Period 2|Adverse Event|7|||
33600109|NCT01853644|62999211|FG000|Continued Treatment After First Response|Adverse Event|2|||
33600110|NCT01853644|62999211|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
33600111|NCT02374346|62999215|FG000|Overall Study|operated or discharged during weekend|48|||
33600112|NCT01853254|62999221|FG000|Overall Study|Abnormal Laboratory Test|1|||
33600113|NCT01853254|62999221|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
33600114|NCT01853254|62999221|FG000|Overall Study|Death|1|||
33600115|NCT01853254|62999221|FG000|Overall Study|Failure to Return|43|||
33600116|NCT01853254|62999221|FG000|Overall Study|Insufficient Therapeutic Response|22|||
33600117|NCT01853254|62999221|FG000|Overall Study|Refusal of Treatment|1|||
33600118|NCT01853254|62999221|FG000|Overall Study|Other Protocol Violation|1|||
33600119|NCT01853254|62999221|FG000|Overall Study|Withdrawal of Consent|16|||
33600120|NCT01853254|62999221|FG000|Overall Study|Administrative/Other|16|||
33600121|NCT02373098|62999227|FG000|Overall Study|Lost to Follow-up|1|||
33600122|NCT02373098|62999228|FG001|Overall Study|Lost to Follow-up|0|||
33600123|NCT02373098|62999227|FG000|Overall Study|Protocol Violation|3|||
33600124|NCT02373098|62999228|FG001|Overall Study|Protocol Violation|0|||
33600125|NCT02373098|62999227|FG000|Overall Study|Withdrawal by Subject|5|||
33600126|NCT02373098|62999228|FG001|Overall Study|Withdrawal by Subject|0|||
33600127|NCT02373098|62999227|FG000|Overall Study|Adverse Event|3|||
33600128|NCT02373098|62999228|FG001|Overall Study|Adverse Event|0|||
33600129|NCT01853176|62999242|FG000|Overall Study|Study terminated|4|||
33600130|NCT01853176|62999243|FG001|Overall Study|Study terminated|0|||
33600131|NCT02372396|62999251|FG000|Overall Study|Lost to Follow-up|7|||
33600132|NCT02372396|62999252|FG001|Overall Study|Lost to Follow-up|9|||
33600133|NCT01835548|62999260|FG000|Dose Optimization Period|Adverse Event|0|||
33600134|NCT01835548|62999261|FG001|Dose Optimization Period|Adverse Event|0|||
33600135|NCT01835548|62999262|FG002|Dose Optimization Period|Adverse Event|1|||
33600136|NCT01835548|62999260|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
33600137|NCT01835548|62999261|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
33600138|NCT01835548|62999262|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
33600139|NCT01835548|62999260|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33600140|NCT01835548|62999261|FG001|Double-Blind Treatment Period|Adverse Event|1|||
33600141|NCT01835548|62999262|FG002|Double-Blind Treatment Period|Adverse Event|0|||
33600142|NCT01835548|62999260|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33600143|NCT01835548|62999261|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33600144|NCT01835548|62999262|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33600145|NCT01852942|62999276|FG000|Overall Study|Physician Decision|1|||
33600146|NCT01852942|62999277|FG001|Overall Study|Physician Decision|0|||
33600147|NCT01852942|62999276|FG000|Overall Study|Death|1|||
33600148|NCT01852942|62999277|FG001|Overall Study|Death|1|||
33600149|NCT01852942|62999276|FG000|Overall Study|Withdrawal by Subject|2|||
33600150|NCT01852942|62999277|FG001|Overall Study|Withdrawal by Subject|3|||
33600151|NCT01852942|62999276|FG000|Overall Study|Lost to Follow-up|1|||
33600152|NCT01852942|62999277|FG001|Overall Study|Lost to Follow-up|2|||
33600153|NCT01852162|62999286|FG000|Overall Study|Adverse Event|1|||
33600154|NCT01852162|62999287|FG001|Overall Study|Adverse Event|0|||
33600155|NCT01852162|62999286|FG000|Overall Study|Withdrawal by Subject|3|||
33600156|NCT01852162|62999287|FG001|Overall Study|Withdrawal by Subject|1|||
33600157|NCT01835470|62999293|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
33600158|NCT01835470|62999293|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
33600159|NCT02451137|62999300|FG000|Overall Study|Randomized but not treated|19|||
33411890|NCT00542880|62790284|FG000|Period 2|Eligibility not fulfilled|0|||
33411891|NCT00542880|62790285|FG001|Period 2|Eligibility not fulfilled|1|||
33600160|NCT02451137|62999301|FG001|Overall Study|Randomized but not treated|27|||
33600161|NCT02451137|62999300|FG000|Overall Study|Adverse Event|43|||
33600162|NCT02451137|62999301|FG001|Overall Study|Adverse Event|42|||
33600163|NCT02451137|62999300|FG000|Overall Study|Lack of Efficacy|4|||
33600164|NCT02451137|62999301|FG001|Overall Study|Lack of Efficacy|9|||
33411892|NCT00542880|62790284|FG000|Period 2|Discontinuation criteria|2|||
33411893|NCT00542880|62790285|FG001|Period 2|Discontinuation criteria|0|||
33600165|NCT02451137|62999300|FG000|Overall Study|Participant decision:discontinue insulin|41|||
33600166|NCT02451137|62999301|FG001|Overall Study|Participant decision:discontinue insulin|43|||
33600167|NCT02451137|62999300|FG000|Overall Study|Hypoglycemia|2|||
33600168|NCT02451137|62999301|FG001|Overall Study|Hypoglycemia|1|||
33600169|NCT02451137|62999300|FG000|Overall Study|Investigator's decision|23|||
33600170|NCT02451137|62999301|FG001|Overall Study|Investigator's decision|19|||
33600171|NCT02451137|62999300|FG000|Overall Study|Lost to Follow-up|53|||
33600172|NCT02451137|62999301|FG001|Overall Study|Lost to Follow-up|61|||
33600173|NCT02451137|62999300|FG000|Overall Study|Physician Decision|6|||
33600174|NCT02451137|62999301|FG001|Overall Study|Physician Decision|5|||
33600175|NCT02451137|62999300|FG000|Overall Study|Sponsor decision|13|||
33600176|NCT02451137|62999301|FG001|Overall Study|Sponsor decision|25|||
33600177|NCT02451137|62999300|FG000|Overall Study|Withdrawal by Subject|40|||
33600178|NCT02451137|62999301|FG001|Overall Study|Withdrawal by Subject|63|||
33600179|NCT02451137|62999300|FG000|Overall Study|Other than specified above|2|||
33600180|NCT02451137|62999301|FG001|Overall Study|Other than specified above|3|||
33600181|NCT02372006|62999310|FG000|Overall Study|Progressive disease|8|||
33600182|NCT02372006|62999311|FG001|Overall Study|Progressive disease|7|||
33600183|NCT02372006|62999312|FG002|Overall Study|Progressive disease|34|||
33600184|NCT02372006|62999310|FG000|Overall Study|Dose limiting toxicity|0|||
33600185|NCT02372006|62999311|FG001|Overall Study|Dose limiting toxicity|1|||
33600186|NCT02372006|62999312|FG002|Overall Study|Dose limiting toxicity|0|||
33600187|NCT02372006|62999310|FG000|Overall Study|Adverse Event|0|||
33600188|NCT02372006|62999311|FG001|Overall Study|Adverse Event|0|||
33600189|NCT02372006|62999312|FG002|Overall Study|Adverse Event|3|||
33600190|NCT02372006|62999310|FG000|Overall Study|Withdrawal by Subject|0|||
33600191|NCT02372006|62999311|FG001|Overall Study|Withdrawal by Subject|1|||
33600192|NCT02372006|62999312|FG002|Overall Study|Withdrawal by Subject|1|||
33600193|NCT02372006|62999310|FG000|Overall Study|Other reason for not completing|0|||
33600194|NCT02372006|62999311|FG001|Overall Study|Other reason for not completing|0|||
33600195|NCT02372006|62999312|FG002|Overall Study|Other reason for not completing|1|||
33600196|NCT02406248|62999321|FG000|Overall Study|Death|7|||
33600197|NCT02406248|62999321|FG000|Overall Study|Withdrawal by Subject|2|||
33600198|NCT02450903|62999325|FG000|Overall Study|Adverse Event|3|||
33600199|NCT02450903|62999325|FG000|Overall Study|Progressive disease|15|||
33600200|NCT02450903|62999325|FG000|Overall Study|Switched to commercial drug|1|||
33600201|NCT02450903|62999325|FG000|Overall Study|Subject/guardian decision|1|||
33600202|NCT02371616|62999331|FG000|Overall Study|Protocol Violation|2|||
33600203|NCT02371616|62999332|FG001|Overall Study|Protocol Violation|1|||
33600204|NCT02371616|62999331|FG000|Overall Study|Adverse Event|0|||
33600205|NCT02371616|62999332|FG001|Overall Study|Adverse Event|1|||
33600206|NCT02371616|62999331|FG000|Overall Study|Withdrawal of Consent|1|||
33600207|NCT02371616|62999332|FG001|Overall Study|Withdrawal of Consent|0|||
33600208|NCT02371616|62999331|FG000|Overall Study|Other (Not specified)|1|||
33600209|NCT02371616|62999332|FG001|Overall Study|Other (Not specified)|5|||
33600210|NCT02370914|62999338|FG000|Overall Study|Protocol Violation|2|||
33600211|NCT02370602|62999348|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
33600212|NCT02370602|62999349|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
33600213|NCT02370602|62999350|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
33600214|NCT02370602|62999351|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
33600215|NCT02370602|62999352|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
33600216|NCT02370602|62999353|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
33600217|NCT02370368|62999372|FG000|Overall Study|Adverse Event|1|||
33600218|NCT02370368|62999373|FG001|Overall Study|Adverse Event|2|||
33600219|NCT02370368|62999372|FG000|Overall Study|Withdrawal by Subject|5|||
33600220|NCT02370368|62999373|FG001|Overall Study|Withdrawal by Subject|4|||
33600221|NCT02340806|62999381|FG000|Overall Study|Protocol Violation|2|||
33600222|NCT02340806|62999382|FG001|Overall Study|Protocol Violation|0|||
33600223|NCT02340806|62999381|FG000|Overall Study|epidural catheter replaced|2|||
33600224|NCT02340806|62999382|FG001|Overall Study|epidural catheter replaced|1|||
33600225|NCT02340806|62999381|FG000|Overall Study|history of chronic pain medication|1|||
33600226|NCT02340806|62999382|FG001|Overall Study|history of chronic pain medication|0|||
33600227|NCT02340806|62999381|FG000|Overall Study|re-dose < 90 min of CSE|1|||
33600228|NCT02340806|62999382|FG001|Overall Study|re-dose < 90 min of CSE|3|||
33600229|NCT02338154|62999388|FG000|Overall Study|Death|46|||
33322038|NCT01176240|62698227|FG000|Study 306B|Supine Hypertension|1|||
33411894|NCT00542880|62790284|FG000|Period 2|Severe non-compliance|0|||
33600230|NCT02338154|62999388|FG000|Overall Study|Valve Implant Failure|17|||
33600231|NCT02338154|62999388|FG000|Overall Study|Valve Explant|11|||
33600232|NCT02338154|62999388|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
33411895|NCT00542880|62790285|FG001|Period 2|Severe non-compliance|1|||
33600233|NCT02338154|62999388|FG000|Overall Study|Lost to Follow-up|8|||
33600234|NCT02338154|62999388|FG000|Overall Study|Other Reason|3|||
33600235|NCT02338154|62999388|FG000|Overall Study|Patients Without Exit Form|47|||
33600236|NCT02338154|62999388|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
33600237|NCT01835158|62999402|FG000|Overall Study|Withdrawal by Subject|1|||
33600238|NCT01835158|62999403|FG001|Overall Study|Withdrawal by Subject|6|||
33411896|NCT00542880|62790284|FG000|Period 2|Other|0|||
33411897|NCT00542880|62790285|FG001|Period 2|Other|1|||
33411898|NCT00542880|62790284|FG000|Period 3|Adverse Event|0|||
33411899|NCT00542880|62790285|FG001|Period 3|Adverse Event|2|||
33411900|NCT00414076|62790294|FG000|Overall Study|Progression|1|||
33411901|NCT00414076|62790295|FG001|Overall Study|Progression|2|||
33411902|NCT00414076|62790294|FG000|Overall Study|Withdrawal by Subject|1|||
33411903|NCT00414076|62790295|FG001|Overall Study|Withdrawal by Subject|3|||
33411904|NCT00414076|62790294|FG000|Overall Study|Adverse Event|1|||
33411905|NCT00414076|62790295|FG001|Overall Study|Adverse Event|0|||
33411906|NCT00092677|62790303|FG000|Overall Study|Lost to Follow-up|0|||
33411907|NCT00092677|62790304|FG001|Overall Study|Lost to Follow-up|2|||
33411908|NCT00092677|62790303|FG000|Overall Study|Adminstrative|5|||
33411909|NCT00092677|62790304|FG001|Overall Study|Adminstrative|9|||
33411910|NCT00542178|62790316|FG000|Overall Study|did not complete year 4 follow-up|75|||
33411911|NCT00542178|62790317|FG001|Overall Study|did not complete year 4 follow-up|80|||
33411912|NCT00542178|62790318|FG002|Overall Study|did not complete year 4 follow-up|74|||
33411913|NCT00542178|62790319|FG003|Overall Study|did not complete year 4 follow-up|62|||
33411914|NCT00542178|62790320|FG004|Overall Study|did not complete year 4 follow-up|64|||
33411915|NCT00542178|62790321|FG005|Overall Study|did not complete year 4 follow-up|89|||
33322039|NCT01176240|62698228|FG001|Study 306B|Supine Hypertension|2|||
33322040|NCT01176240|62698227|FG000|Study 306B|Lost to Follow-up|0|||
33322041|NCT01176240|62698228|FG001|Study 306B|Lost to Follow-up|1|||
33322042|NCT01176240|62698227|FG000|Study 306B|withdrew prior to dosing|2|||
33322043|NCT01176240|62698228|FG001|Study 306B|withdrew prior to dosing|1|||
33322044|NCT00988221|62698237|FG000|Part I|Adverse Event|0|||
33322045|NCT00988221|62698238|FG001|Part I|Adverse Event|1|||
33411916|NCT00542178|62790322|FG006|Overall Study|did not complete year 4 follow-up|87|||
33411917|NCT00542178|62790323|FG007|Overall Study|did not complete year 4 follow-up|85|||
33411918|NCT00424294|62790339|FG000|Overall Study|Adverse Event|4|||
33411919|NCT00424294|62790340|FG001|Overall Study|Adverse Event|10|||
33322046|NCT00988221|62698239|FG002|Part I|Adverse Event|2|||
33322047|NCT00988221|62698240|FG003|Part I|Adverse Event|0|||
33322048|NCT00988221|62698237|FG000|Part I|Insufficient Therapeutic Response|4|||
33411920|NCT00424294|62790339|FG000|Overall Study|Lack of Efficacy|2|||
33411921|NCT00424294|62790340|FG001|Overall Study|Lack of Efficacy|1|||
33411922|NCT00424294|62790339|FG000|Overall Study|Withdrawal by Subject|1|||
33411923|NCT00424294|62790340|FG001|Overall Study|Withdrawal by Subject|2|||
33411924|NCT00424294|62790339|FG000|Overall Study|Other|0|||
33411925|NCT00424294|62790340|FG001|Overall Study|Other|2|||
33322049|NCT00988221|62698238|FG001|Part I|Insufficient Therapeutic Response|6|||
33322050|NCT00988221|62698239|FG002|Part I|Insufficient Therapeutic Response|5|||
33322051|NCT00988221|62698240|FG003|Part I|Insufficient Therapeutic Response|0|||
33322052|NCT00988221|62698237|FG000|Part I|Refused Treatment|0|||
33322053|NCT00988221|62698238|FG001|Part I|Refused Treatment|2|||
33322054|NCT00988221|62698239|FG002|Part I|Refused Treatment|1|||
33322055|NCT00988221|62698240|FG003|Part I|Refused Treatment|0|||
33322056|NCT00988221|62698237|FG000|Part I|Lost to Follow-up|0|||
33322057|NCT00988221|62698238|FG001|Part I|Lost to Follow-up|1|||
33322058|NCT00988221|62698239|FG002|Part I|Lost to Follow-up|0|||
33322059|NCT00988221|62698240|FG003|Part I|Lost to Follow-up|0|||
33411926|NCT00424294|62790339|FG000|Overall Study|Randomized but not Treated|1|||
33411927|NCT00424294|62790340|FG001|Overall Study|Randomized but not Treated|0|||
33494055|NCT00938912|62872707|FG000|Overall Study|Participant experienced break through seizures|1|||
33600239|NCT02337764|62999409|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
33600240|NCT02337764|62999409|FG000|Overall Study|Voluntary Withdrawal|12|||
33600241|NCT02337764|62999409|FG000|Overall Study|Lack of Efficacy|2|||
33600242|NCT01834222|62999413|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
33600243|NCT01833832|62999417|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
33600244|NCT01833520|62999423|FG000|Overall Study|Lack of Efficacy|3|||
33600245|NCT01833520|62999424|FG001|Overall Study|Lack of Efficacy|3|||
33600246|NCT01833520|62999425|FG002|Overall Study|Lack of Efficacy|8|||
33600247|NCT01833520|62999426|FG003|Overall Study|Lack of Efficacy|3|||
33600248|NCT01850602|62999440|FG000|Overall Study|Adverse Event|7|||
33600249|NCT01850602|62999441|FG001|Overall Study|Adverse Event|10|||
33600250|NCT01850602|62999440|FG000|Overall Study|Physician Decision|2|||
33600251|NCT01850602|62999441|FG001|Overall Study|Physician Decision|1|||
33600252|NCT01850602|62999440|FG000|Overall Study|Withdrawal by Subject|2|||
33600253|NCT01850602|62999441|FG001|Overall Study|Withdrawal by Subject|4|||
33600254|NCT01850602|62999440|FG000|Overall Study|Decrease in serum calcium|2|||
33600255|NCT01850602|62999441|FG001|Overall Study|Decrease in serum calcium|3|||
33600256|NCT01850602|62999440|FG000|Overall Study|Increase in serum ferritin|1|||
33600257|NCT01850602|62999441|FG001|Overall Study|Increase in serum ferritin|0|||
33600258|NCT01832818|62999447|FG000|Overall Study|Lost to Follow-up|6|||
33600259|NCT02405780|62999455|FG000|Period I|Adverse Event|8|||
33600260|NCT02405780|62999456|FG001|Period I|Adverse Event|0|||
33600261|NCT02405780|62999457|FG002|Period I|Adverse Event|3|||
33600262|NCT02405780|62999458|FG003|Period I|Adverse Event|7|||
33600263|NCT02405780|62999455|FG000|Period I|Medical reasons|1|||
33600264|NCT02405780|62999456|FG001|Period I|Medical reasons|1|||
33600265|NCT02405780|62999457|FG002|Period I|Medical reasons|0|||
33600266|NCT02405780|62999458|FG003|Period I|Medical reasons|1|||
33600267|NCT02405780|62999455|FG000|Period I|Screening Failure|1|||
33600268|NCT02405780|62999456|FG001|Period I|Screening Failure|0|||
33600269|NCT02405780|62999457|FG002|Period I|Screening Failure|1|||
33600270|NCT02405780|62999458|FG003|Period I|Screening Failure|0|||
33600271|NCT02405780|62999455|FG000|Period I|Withdrawal by Subject|9|||
33600272|NCT02405780|62999456|FG001|Period I|Withdrawal by Subject|1|||
33600273|NCT02405780|62999457|FG002|Period I|Withdrawal by Subject|3|||
33600274|NCT02405780|62999458|FG003|Period I|Withdrawal by Subject|4|||
33600275|NCT02405780|62999455|FG000|Period I|Non-compliance with study procedures|8|||
33600276|NCT02405780|62999456|FG001|Period I|Non-compliance with study procedures|6|||
33600277|NCT02405780|62999457|FG002|Period I|Non-compliance with study procedures|8|||
33600278|NCT02405780|62999458|FG003|Period I|Non-compliance with study procedures|11|||
33600279|NCT02405780|62999455|FG000|Period II|Adverse Event|3|||
33600280|NCT02405780|62999456|FG001|Period II|Adverse Event|5|||
33600281|NCT02405780|62999457|FG002|Period II|Adverse Event|4|||
33600282|NCT02405780|62999458|FG003|Period II|Adverse Event|11|||
33600283|NCT02405780|62999455|FG000|Period II|Medical reason|0|||
33600284|NCT02405780|62999456|FG001|Period II|Medical reason|1|||
33600285|NCT02405780|62999457|FG002|Period II|Medical reason|0|||
33600286|NCT02405780|62999458|FG003|Period II|Medical reason|0|||
33322060|NCT00988221|62698237|FG000|Part II|Adverse Event|1|||
33322061|NCT00988221|62698238|FG001|Part II|Adverse Event|0|||
33322062|NCT00988221|62698239|FG002|Part II|Adverse Event|0|||
33322063|NCT00988221|62698240|FG003|Part II|Adverse Event|1|||
33411928|NCT00092521|62790349|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
33411929|NCT00092521|62790350|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
33411930|NCT00092521|62790351|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
33411931|NCT00092521|62790352|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
33494056|NCT00938912|62872707|FG000|Overall Study|No longer wished to participate in the study|1|||
33494057|NCT00938912|62872707|FG000|Overall Study|Protocol Deviation|2|||
33411932|NCT00092521|62790349|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
33600287|NCT02405780|62999455|FG000|Period II|Pregnancy|0|||
33600288|NCT02405780|62999456|FG001|Period II|Pregnancy|0|||
33600289|NCT02405780|62999457|FG002|Period II|Pregnancy|1|||
33600290|NCT02405780|62999458|FG003|Period II|Pregnancy|0|||
33600291|NCT02405780|62999455|FG000|Period II|Withdrawal by Subject|7|||
33600292|NCT02405780|62999456|FG001|Period II|Withdrawal by Subject|4|||
33600293|NCT02405780|62999457|FG002|Period II|Withdrawal by Subject|0|||
33600294|NCT02405780|62999458|FG003|Period II|Withdrawal by Subject|3|||
33600295|NCT02405780|62999455|FG000|Period II|Non-compliance with study procedures|5|||
33600296|NCT02405780|62999456|FG001|Period II|Non-compliance with study procedures|2|||
33600297|NCT02405780|62999457|FG002|Period II|Non-compliance with study procedures|7|||
33600298|NCT02405780|62999458|FG003|Period II|Non-compliance with study procedures|4|||
33600299|NCT02369510|62999486|FG000|Overall Study|Spilled Medication|1|||
33600300|NCT02369510|62999487|FG001|Overall Study|Spilled Medication|2|||
33600301|NCT02369510|62999488|FG002|Overall Study|Spilled Medication|1|||
33322064|NCT00988221|62698237|FG000|Part II|Withdrawal by Subject|0|||
33322065|NCT00988221|62698238|FG001|Part II|Withdrawal by Subject|0|||
33322066|NCT00988221|62698239|FG002|Part II|Withdrawal by Subject|2|||
33322067|NCT00988221|62698240|FG003|Part II|Withdrawal by Subject|2|||
33322068|NCT00988221|62698237|FG000|Part II|Reason not Specified|0|||
33322069|NCT00988221|62698238|FG001|Part II|Reason not Specified|0|||
33322070|NCT00988221|62698239|FG002|Part II|Reason not Specified|1|||
33322071|NCT00988221|62698240|FG003|Part II|Reason not Specified|0|||
33322072|NCT00988221|62698237|FG000|Part III|Adverse Event|1|||
33322073|NCT00988221|62698238|FG001|Part III|Adverse Event|0|||
33322074|NCT00988221|62698239|FG002|Part III|Adverse Event|1|||
33322075|NCT00988221|62698240|FG003|Part III|Adverse Event|0|||
33322076|NCT00988221|62698237|FG000|Part III|Insufficient Therapeutic Response|0|||
33322077|NCT00988221|62698238|FG001|Part III|Insufficient Therapeutic Response|1|||
33322078|NCT00988221|62698239|FG002|Part III|Insufficient Therapeutic Response|1|||
33411933|NCT00092521|62790350|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
33411934|NCT00092521|62790351|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
33411935|NCT00092521|62790352|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
33411936|NCT00092521|62790349|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
33600302|NCT02369510|62999486|FG000|Overall Study|Epidural Activation|1|||
33600303|NCT02369510|62999487|FG001|Overall Study|Epidural Activation|1|||
33600304|NCT02369510|62999488|FG002|Overall Study|Epidural Activation|5|||
33600305|NCT01650194|62999496|FG000|Overall Study|Progressive Disease (PD)|35|||
33600306|NCT01650194|62999496|FG000|Overall Study|Withdrawal by Subject|2|||
33600307|NCT01650194|62999496|FG000|Overall Study|Miscellaneous|10|||
33600308|NCT02367716|62999501|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
33600309|NCT02366936|62999506|FG000|Overall Study|Withdrawal by Subject|2|||
33600310|NCT02366936|62999506|FG000|Overall Study|Lost to Follow-up|4|||
33600311|NCT02366936|62999506|FG000|Overall Study|Physician Decision|2|||
33600312|NCT01648166|62999512|FG000|Overall Study|inadequate toenail samples|53|||
33600313|NCT01648166|62999513|FG001|Overall Study|inadequate toenail samples|100|||
33600314|NCT02404220|62999523|FG000|Overall Study|Adverse Event|0|||
33600315|NCT02404220|62999524|FG001|Overall Study|Adverse Event|0|||
33600316|NCT02404220|62999525|FG002|Overall Study|Adverse Event|1|||
33600317|NCT02404220|62999526|FG003|Overall Study|Adverse Event|0|||
33600318|NCT02404220|62999523|FG000|Overall Study|Death|5|||
33600319|NCT02404220|62999524|FG001|Overall Study|Death|5|||
33600320|NCT02404220|62999525|FG002|Overall Study|Death|3|||
33600321|NCT02404220|62999526|FG003|Overall Study|Death|8|||
33600322|NCT02404220|62999523|FG000|Overall Study|Progressive Disease|0|||
33600323|NCT02404220|62999524|FG001|Overall Study|Progressive Disease|0|||
33600324|NCT02404220|62999525|FG002|Overall Study|Progressive Disease|1|||
33600325|NCT02404220|62999526|FG003|Overall Study|Progressive Disease|1|||
33600326|NCT02404220|62999523|FG000|Overall Study|Study Terminated by Sponsor|0|||
33600327|NCT02404220|62999524|FG001|Overall Study|Study Terminated by Sponsor|0|||
33600328|NCT02404220|62999525|FG002|Overall Study|Study Terminated by Sponsor|2|||
33600329|NCT02404220|62999526|FG003|Overall Study|Study Terminated by Sponsor|1|||
33600330|NCT02404220|62999523|FG000|Overall Study|Withdrawal by Subject|0|||
33600331|NCT02404220|62999524|FG001|Overall Study|Withdrawal by Subject|1|||
33600332|NCT02404220|62999525|FG002|Overall Study|Withdrawal by Subject|0|||
33600333|NCT02404220|62999526|FG003|Overall Study|Withdrawal by Subject|0|||
33600334|NCT02404220|62999523|FG000|Overall Study|Enrolled but Never Treated|0|||
33600335|NCT02404220|62999524|FG001|Overall Study|Enrolled but Never Treated|2|||
33600336|NCT02404220|62999525|FG002|Overall Study|Enrolled but Never Treated|0|||
33600337|NCT02404220|62999526|FG003|Overall Study|Enrolled but Never Treated|0|||
33600338|NCT02335658|62999538|FG000|Overall Study|Adverse Event|18|||
33600339|NCT02335658|62999539|FG001|Overall Study|Adverse Event|12|||
33600340|NCT02335658|62999538|FG000|Overall Study|Lack of Efficacy|4|||
33600341|NCT02335658|62999539|FG001|Overall Study|Lack of Efficacy|5|||
33322079|NCT00988221|62698240|FG003|Part III|Insufficient Therapeutic Response|0|||
33411937|NCT00092521|62790350|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
33411938|NCT00092521|62790351|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
33411939|NCT00092521|62790352|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
33600342|NCT02335658|62999538|FG000|Overall Study|Pregnancy|1|||
33600343|NCT02335658|62999539|FG001|Overall Study|Pregnancy|0|||
33600344|NCT02335658|62999538|FG000|Overall Study|Withdrawal by Subject|13|||
33600345|NCT02335658|62999539|FG001|Overall Study|Withdrawal by Subject|21|||
33322080|NCT00988221|62698237|FG000|Part III|Refused Treatment|0|||
33322081|NCT00988221|62698238|FG001|Part III|Refused Treatment|0|||
33322082|NCT00988221|62698239|FG002|Part III|Refused Treatment|1|||
33322083|NCT00988221|62698240|FG003|Part III|Refused Treatment|0|||
33322084|NCT01149096|62698261|FG000|Overall Study|Lost to Follow-up|0|||
33600346|NCT02335658|62999538|FG000|Overall Study|non-compliance|2|||
33600347|NCT02335658|62999539|FG001|Overall Study|non-compliance|3|||
33600348|NCT02335658|62999538|FG000|Overall Study|other reason|2|||
33600349|NCT02335658|62999539|FG001|Overall Study|other reason|3|||
33600350|NCT02366468|62999549|FG000|Overall Study|Adverse Event|2|||
33600351|NCT02366468|62999550|FG001|Overall Study|Adverse Event|0|||
33600352|NCT02366468|62999549|FG000|Overall Study|Withdrawal by Subject|1|||
33600353|NCT02366468|62999550|FG001|Overall Study|Withdrawal by Subject|5|||
33600354|NCT02366468|62999549|FG000|Overall Study|Lost to Follow-up|2|||
33600355|NCT02366468|62999550|FG001|Overall Study|Lost to Follow-up|0|||
33600356|NCT02366468|62999549|FG000|Overall Study|Death|1|||
33600357|NCT02366468|62999550|FG001|Overall Study|Death|2|||
33600358|NCT02366468|62999549|FG000|Overall Study|Other|0|||
33600359|NCT02366468|62999550|FG001|Overall Study|Other|2|||
33600360|NCT02366312|62999558|FG000|Overall Study|Lost to Follow-up|0|||
33600361|NCT02366312|62999559|FG001|Overall Study|Lost to Follow-up|1|||
33600362|NCT02335346|62999565|FG000|Overall Study|Adverse Event|11|||
33600363|NCT02335346|62999565|FG000|Overall Study|Withdrawal by Subject|1|||
33600364|NCT02403674|62999571|FG000|Overall Study|Adverse Event|10|||
33600365|NCT02403674|62999572|FG001|Overall Study|Adverse Event|23|||
33600366|NCT02403674|62999571|FG000|Overall Study|Death|1|||
33600367|NCT02403674|62999572|FG001|Overall Study|Death|3|||
33600368|NCT02403674|62999571|FG000|Overall Study|Lack of Efficacy|18|||
33600369|NCT02403674|62999572|FG001|Overall Study|Lack of Efficacy|10|||
33600370|NCT02403674|62999571|FG000|Overall Study|Lost to Follow-up|6|||
33600371|NCT02403674|62999572|FG001|Overall Study|Lost to Follow-up|7|||
33600372|NCT02403674|62999571|FG000|Overall Study|Noncompliance with study drug|1|||
33600373|NCT02403674|62999572|FG001|Overall Study|Noncompliance with study drug|2|||
33600374|NCT02403674|62999571|FG000|Overall Study|Withdrawal by Subject|8|||
33600375|NCT02403674|62999572|FG001|Overall Study|Withdrawal by Subject|11|||
33600376|NCT02403674|62999571|FG000|Overall Study|Physician Decision|2|||
33600377|NCT02403674|62999572|FG001|Overall Study|Physician Decision|2|||
33600378|NCT02403674|62999571|FG000|Overall Study|Not treated with study drug|4|||
33600379|NCT02403674|62999572|FG001|Overall Study|Not treated with study drug|2|||
33600380|NCT02403674|62999571|FG000|Overall Study|Pregnancy|1|||
33600381|NCT02403674|62999572|FG001|Overall Study|Pregnancy|1|||
33600382|NCT02403674|62999571|FG000|Overall Study|Protocol Violation|4|||
33600383|NCT02403674|62999572|FG001|Overall Study|Protocol Violation|2|||
33600384|NCT02403206|62999580|FG000|Overall Study|Lost to Follow-up|4|||
33600385|NCT02403206|62999581|FG001|Overall Study|Lost to Follow-up|3|||
33600386|NCT02403206|62999580|FG000|Overall Study|Physician Decision|2|||
33600387|NCT02403206|62999581|FG001|Overall Study|Physician Decision|0|||
33600388|NCT02403206|62999580|FG000|Overall Study|Withdrawal by Subject|3|||
33600389|NCT02403206|62999581|FG001|Overall Study|Withdrawal by Subject|3|||
33600390|NCT02403206|62999580|FG000|Overall Study|Reason not given|2|||
33600391|NCT02403206|62999581|FG001|Overall Study|Reason not given|4|||
33600392|NCT02333630|62999590|FG000|Overall Study|Lost to Follow-up|5|||
33600393|NCT02333630|62999591|FG001|Overall Study|Lost to Follow-up|2|||
33411940|NCT00092521|62790349|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
33411941|NCT00092521|62790350|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
33411942|NCT00092521|62790351|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
33411943|NCT00092521|62790352|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
33411944|NCT00092521|62790349|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
33411945|NCT00092521|62790350|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
33411946|NCT00092521|62790351|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
33411947|NCT00092521|62790352|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
33411948|NCT00092521|62790349|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
33411949|NCT00092521|62790350|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
33411950|NCT00092521|62790351|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
33411951|NCT00092521|62790352|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
33411952|NCT00092521|62790349|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
33411953|NCT00092521|62790350|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
33411954|NCT00092521|62790351|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
33411955|NCT00092521|62790352|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
33411956|NCT00092521|62790349|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
33600394|NCT02401412|62999603|FG000|Overall Study|Lost to Follow-up|1|||
33600395|NCT02401412|62999604|FG001|Overall Study|Lost to Follow-up|0|||
33600396|NCT02401412|62999603|FG000|Overall Study|Discontinued Intervention|15|||
33600397|NCT02401412|62999604|FG001|Overall Study|Discontinued Intervention|21|||
33322085|NCT01149096|62698262|FG001|Overall Study|Lost to Follow-up|1|||
33322086|NCT01175382|62698272|FG000|Overall Study|Lost to Follow-up|4|||
33322087|NCT01175382|62698273|FG001|Overall Study|Lost to Follow-up|3|||
33322088|NCT01175382|62698274|FG002|Overall Study|Lost to Follow-up|1|||
33322089|NCT01175382|62698272|FG000|Overall Study|Physician Decision|0|||
33322090|NCT01175382|62698273|FG001|Overall Study|Physician Decision|1|||
33322091|NCT01175382|62698274|FG002|Overall Study|Physician Decision|0|||
33322092|NCT01175382|62698272|FG000|Overall Study|Withdrawal by Subject|0|||
33322093|NCT01175382|62698273|FG001|Overall Study|Withdrawal by Subject|0|||
33322094|NCT01175382|62698274|FG002|Overall Study|Withdrawal by Subject|1|||
33600398|NCT02401412|62999603|FG000|Overall Study|Withdrawal by Subject|4|||
33600399|NCT02401412|62999604|FG001|Overall Study|Withdrawal by Subject|4|||
33600400|NCT02401412|62999603|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
33600401|NCT02401412|62999604|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
33600402|NCT02401412|62999603|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
33600403|NCT02401412|62999604|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
33600404|NCT02365298|62999610|FG000|Period 2|incorrect Rx dispensed|1|||
33600405|NCT02365298|62999611|FG001|Period 2|incorrect Rx dispensed|0|||
33600406|NCT02365298|62999610|FG000|Period 2|Discontinued at request of Sponsor|1|||
33600407|NCT02365298|62999611|FG001|Period 2|Discontinued at request of Sponsor|0|||
33600408|NCT02365298|62999610|FG000|Period 2|Test Article longer available|0|||
33600409|NCT02365298|62999611|FG001|Period 2|Test Article longer available|1|||
33600410|NCT02365298|62999610|FG000|Period 2|Protocol Violation|0|||
33600411|NCT02365298|62999611|FG001|Period 2|Protocol Violation|1|||
33600412|NCT02365064|62999619|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
33600413|NCT02365064|62999620|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
33600414|NCT02365064|62999619|FG000|Overall Study|Withdrawal by Subject|6|||
33600415|NCT02365064|62999620|FG001|Overall Study|Withdrawal by Subject|9|||
33600416|NCT02365064|62999619|FG000|Overall Study|Treatment intolerance|2|||
33600417|NCT02365064|62999620|FG001|Overall Study|Treatment intolerance|4|||
33600418|NCT02401256|62999626|FG000|Overall Study|Adverse Event|5|||
33600419|NCT02401256|62999626|FG000|Overall Study|Withdrawal by Subject|12|||
33600420|NCT02349295|62999635|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
33600421|NCT02349295|62999636|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
33411957|NCT00092521|62790350|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
33600422|NCT02349295|62999637|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
33600423|NCT02349295|62999638|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33600424|NCT02349295|62999639|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33600425|NCT02349295|62999640|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33600426|NCT02349295|62999641|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33411958|NCT00092521|62790351|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
33411959|NCT00092521|62790352|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
33411960|NCT00092521|62790349|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
33411961|NCT00092521|62790350|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
33411962|NCT00092521|62790351|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
33411963|NCT00092521|62790352|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
33411964|NCT00092521|62790349|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
33411965|NCT00092521|62790350|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
33411966|NCT00092521|62790351|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
33411967|NCT00092521|62790352|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
33411968|NCT00092521|62790349|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
33411969|NCT00092521|62790350|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
33411970|NCT00092521|62790351|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
33411971|NCT00092521|62790352|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
33411972|NCT00092521|62790349|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
33411973|NCT00092521|62790350|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
33411974|NCT00092521|62790351|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
33411975|NCT00092521|62790352|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
33411976|NCT00092521|62790349|FG000|Follow-Up (After Month 7)|Death|2|||
33411977|NCT00092521|62790350|FG001|Follow-Up (After Month 7)|Death|0|||
33411978|NCT00092521|62790351|FG002|Follow-Up (After Month 7)|Death|1|||
33411979|NCT00092521|62790352|FG003|Follow-Up (After Month 7)|Death|0|||
33411980|NCT00092521|62790349|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
33411981|NCT00092521|62790350|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
33411982|NCT00092521|62790351|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
33411983|NCT00092521|62790352|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
33411984|NCT00092521|62790349|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
33411985|NCT00092521|62790350|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
33411986|NCT00092521|62790351|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
33411987|NCT00092521|62790352|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
33411988|NCT00092521|62790349|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
33411989|NCT00092521|62790350|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
33322095|NCT01175382|62698272|FG000|Overall Study|No longer having problem|1|||
33322096|NCT01175382|62698273|FG001|Overall Study|No longer having problem|0|||
33322097|NCT01175382|62698274|FG002|Overall Study|No longer having problem|1|||
33322098|NCT01175382|62698272|FG000|Overall Study|Unable/unwilling to attend visits|3|||
33322099|NCT01175382|62698273|FG001|Overall Study|Unable/unwilling to attend visits|1|||
33322100|NCT01175382|62698274|FG002|Overall Study|Unable/unwilling to attend visits|2|||
33322101|NCT01175382|62698272|FG000|Overall Study|Unwilling to follow protocol|0|||
33322102|NCT01175382|62698273|FG001|Overall Study|Unwilling to follow protocol|1|||
33322103|NCT01175382|62698274|FG002|Overall Study|Unwilling to follow protocol|0|||
33411990|NCT00092521|62790351|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
33411991|NCT00092521|62790352|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
33411992|NCT00092521|62790349|FG000|Follow-Up (After Month 7)|Moved|32|||
33411993|NCT00092521|62790350|FG001|Follow-Up (After Month 7)|Moved|2|||
33411994|NCT00092521|62790351|FG002|Follow-Up (After Month 7)|Moved|28|||
33411995|NCT00092521|62790352|FG003|Follow-Up (After Month 7)|Moved|0|||
33411996|NCT00092521|62790349|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
33411997|NCT00092521|62790350|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
33411998|NCT00092521|62790351|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
33411999|NCT00092521|62790352|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
33412000|NCT00092521|62790349|FG000|Follow-Up (After Month 7)|Travel|2|||
33412001|NCT00092521|62790350|FG001|Follow-Up (After Month 7)|Travel|0|||
33412002|NCT00092521|62790351|FG002|Follow-Up (After Month 7)|Travel|0|||
33600427|NCT02349295|62999642|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33600428|NCT02349295|62999643|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33600429|NCT02349295|62999644|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33600430|NCT02349295|62999645|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33600431|NCT02349295|62999646|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33600432|NCT02349295|62999647|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33600433|NCT02349295|62999648|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33600434|NCT02349295|62999635|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
33600435|NCT02349295|62999636|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
33600436|NCT02349295|62999637|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
33600437|NCT02349295|62999638|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33600438|NCT02349295|62999639|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33600439|NCT02349295|62999640|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33600440|NCT02349295|62999641|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33600441|NCT02349295|62999642|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33600442|NCT02349295|62999643|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33600443|NCT02349295|62999644|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33600444|NCT02349295|62999645|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33600445|NCT02349295|62999646|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33600446|NCT02349295|62999647|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33600447|NCT02349295|62999648|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33600448|NCT02349295|62999635|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
33600449|NCT02349295|62999636|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
33600450|NCT02349295|62999637|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
33600451|NCT02349295|62999638|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33600452|NCT02349295|62999639|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33600453|NCT02349295|62999640|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33600454|NCT02349295|62999641|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33600455|NCT02349295|62999642|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33600456|NCT02349295|62999643|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33600457|NCT02349295|62999644|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33600458|NCT02349295|62999645|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33600459|NCT02349295|62999646|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33600460|NCT02349295|62999647|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33600461|NCT02349295|62999648|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33600462|NCT02349295|62999635|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
33600463|NCT02349295|62999636|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
33600464|NCT02349295|62999637|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
33600465|NCT02349295|62999638|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33600466|NCT02349295|62999639|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33600467|NCT02349295|62999640|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33600468|NCT02349295|62999641|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33600469|NCT02349295|62999642|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33600470|NCT02349295|62999643|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33600471|NCT02349295|62999644|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33600472|NCT02349295|62999645|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33600473|NCT02349295|62999646|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33600474|NCT02349295|62999647|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33600475|NCT02349295|62999648|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33600476|NCT02349295|62999635|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33600477|NCT02349295|62999636|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
33600478|NCT02349295|62999637|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
33600479|NCT02349295|62999638|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33600480|NCT02349295|62999639|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33600481|NCT02349295|62999640|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33600482|NCT02349295|62999641|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33600483|NCT02349295|62999642|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33600484|NCT02349295|62999643|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33600485|NCT02349295|62999644|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33600486|NCT02349295|62999645|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33600487|NCT02349295|62999646|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33600488|NCT02349295|62999647|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33322104|NCT01175382|62698272|FG000|Overall Study|Unable to tolerate study meds|0|||
33322105|NCT01175382|62698273|FG001|Overall Study|Unable to tolerate study meds|1|||
33600489|NCT02349295|62999648|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33600490|NCT02349295|62999635|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
33600491|NCT02349295|62999636|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
33600492|NCT02349295|62999637|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
33600493|NCT02349295|62999638|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
33600494|NCT02349295|62999639|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
33600495|NCT02349295|62999640|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
33600496|NCT02349295|62999641|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
33412003|NCT00092521|62790352|FG003|Follow-Up (After Month 7)|Travel|0|||
33412004|NCT00092521|62790349|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
33412005|NCT00092521|62790350|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
33412006|NCT00092521|62790351|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
33412007|NCT00092521|62790352|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
33412008|NCT00092521|62790349|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
33412009|NCT00092521|62790350|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
33412010|NCT00092521|62790351|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
33412011|NCT00092521|62790352|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
33412012|NCT00092521|62790349|FG000|Extension Study (Group 4)|Adverse Event|0|||
33412013|NCT00092521|62790350|FG001|Extension Study (Group 4)|Adverse Event|0|||
33412014|NCT00092521|62790351|FG002|Extension Study (Group 4)|Adverse Event|0|||
33412015|NCT00092521|62790352|FG003|Extension Study (Group 4)|Adverse Event|2|||
33412016|NCT00092521|62790349|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
33412017|NCT00092521|62790350|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
33412018|NCT00092521|62790351|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
33412019|NCT00092521|62790352|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
33412020|NCT00092521|62790349|FG000|Extension Study (Group 4)|Pregnancy|0|||
33412021|NCT00092521|62790350|FG001|Extension Study (Group 4)|Pregnancy|0|||
33412022|NCT00092521|62790351|FG002|Extension Study (Group 4)|Pregnancy|0|||
33412023|NCT00092521|62790352|FG003|Extension Study (Group 4)|Pregnancy|4|||
33412024|NCT00092521|62790349|FG000|Extension Study (Group 4)|Protocol Violation|0|||
33412025|NCT00092521|62790350|FG001|Extension Study (Group 4)|Protocol Violation|0|||
33412026|NCT00092521|62790351|FG002|Extension Study (Group 4)|Protocol Violation|0|||
33412027|NCT00092521|62790352|FG003|Extension Study (Group 4)|Protocol Violation|2|||
33412028|NCT00092521|62790349|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
33412029|NCT00092521|62790350|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
33412030|NCT00092521|62790351|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
33412031|NCT00092521|62790352|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
33412032|NCT00092521|62790349|FG000|Extension Study (Group 4)|Moved|0|||
33412033|NCT00092521|62790350|FG001|Extension Study (Group 4)|Moved|0|||
33412034|NCT00092521|62790351|FG002|Extension Study (Group 4)|Moved|0|||
33412035|NCT00092521|62790352|FG003|Extension Study (Group 4)|Moved|16|||
33412036|NCT00092521|62790349|FG000|Extension Study (Group 4)|Site Terminated|0|||
33412037|NCT00092521|62790350|FG001|Extension Study (Group 4)|Site Terminated|0|||
33412038|NCT00092521|62790351|FG002|Extension Study (Group 4)|Site Terminated|0|||
33412039|NCT00092521|62790352|FG003|Extension Study (Group 4)|Site Terminated|4|||
33412040|NCT00092521|62790349|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
33412041|NCT00092521|62790350|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
33412042|NCT00092521|62790351|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
33412043|NCT00092521|62790352|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
33412044|NCT03908970|62790362|FG000|Overall Study|Adverse Event|7|||
33412045|NCT03908970|62790363|FG001|Overall Study|Adverse Event|21|||
33412046|NCT03908970|62790362|FG000|Overall Study|Physician Decision|1|||
33412047|NCT03908970|62790363|FG001|Overall Study|Physician Decision|4|||
33412048|NCT03908970|62790362|FG000|Overall Study|Withdrawal by Subject|9|||
33600497|NCT02349295|62999642|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
33600498|NCT02349295|62999643|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
33600499|NCT02349295|62999644|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
33600500|NCT02349295|62999645|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
33600501|NCT02349295|62999646|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
33600502|NCT02349295|62999647|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
33600503|NCT02349295|62999648|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
33600504|NCT02349295|62999635|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33600505|NCT02349295|62999636|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33600506|NCT02349295|62999637|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33600507|NCT02349295|62999638|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33600508|NCT02349295|62999639|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33600509|NCT02349295|62999640|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33600510|NCT02349295|62999641|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33600511|NCT02349295|62999642|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
33600512|NCT02349295|62999643|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
33600513|NCT02349295|62999644|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
33600514|NCT02349295|62999645|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
33600515|NCT02349295|62999646|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33600516|NCT02349295|62999647|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33600517|NCT02349295|62999648|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33600518|NCT02349295|62999635|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33600519|NCT02349295|62999636|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33600520|NCT02349295|62999637|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33600521|NCT02349295|62999638|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33600522|NCT02349295|62999639|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33600523|NCT02349295|62999640|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33600524|NCT02349295|62999641|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33600525|NCT02349295|62999642|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
33600526|NCT02349295|62999643|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
33600527|NCT02349295|62999644|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
33600528|NCT02349295|62999645|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
33600529|NCT02349295|62999646|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33600530|NCT02349295|62999647|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33600531|NCT02349295|62999648|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33600532|NCT02349295|62999635|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33600533|NCT02349295|62999636|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33600534|NCT02349295|62999637|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33600535|NCT02349295|62999638|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33600536|NCT02349295|62999639|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33600537|NCT02349295|62999640|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33600538|NCT02349295|62999641|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33600539|NCT02349295|62999642|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
33600540|NCT02349295|62999643|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33600541|NCT02349295|62999644|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
33600542|NCT02349295|62999645|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33600543|NCT02349295|62999646|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33600544|NCT02349295|62999647|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33600545|NCT02349295|62999648|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33600546|NCT02349295|62999635|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
33600547|NCT02349295|62999636|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
33600548|NCT02349295|62999637|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
33600549|NCT02349295|62999638|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
33600550|NCT02349295|62999639|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
33600551|NCT02349295|62999640|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
33600552|NCT02349295|62999641|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
33600553|NCT02349295|62999642|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
33600554|NCT02349295|62999643|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
33600555|NCT02349295|62999644|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
33600556|NCT02349295|62999645|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
33600557|NCT02349295|62999646|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
33600558|NCT02349295|62999647|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
33600559|NCT02349295|62999648|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
33600560|NCT02349295|62999635|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33600561|NCT02349295|62999636|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33600562|NCT02349295|62999637|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33600563|NCT02349295|62999638|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33600564|NCT02349295|62999639|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33600565|NCT02349295|62999640|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33600566|NCT02349295|62999641|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33600567|NCT02349295|62999642|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
33600568|NCT02349295|62999643|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
33600569|NCT02349295|62999644|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
33600570|NCT02349295|62999645|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
33600571|NCT02349295|62999646|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33600572|NCT02349295|62999647|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33600573|NCT02349295|62999648|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33600574|NCT02349295|62999635|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33600575|NCT02349295|62999636|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33600576|NCT02349295|62999637|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33600577|NCT02349295|62999638|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33600578|NCT02349295|62999639|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33600579|NCT02349295|62999640|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33600580|NCT02349295|62999641|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33600581|NCT02349295|62999642|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
33600582|NCT02349295|62999643|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
33600583|NCT02349295|62999644|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33600584|NCT02349295|62999645|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33600585|NCT02349295|62999646|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33600586|NCT02349295|62999647|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33600587|NCT02349295|62999648|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33600588|NCT02349295|62999635|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33600589|NCT02349295|62999636|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33600590|NCT02349295|62999637|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33600591|NCT02349295|62999638|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33600592|NCT02349295|62999639|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33600593|NCT02349295|62999640|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33600594|NCT02349295|62999641|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33600595|NCT02349295|62999642|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
33600596|NCT02349295|62999643|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
33600597|NCT02349295|62999644|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33600598|NCT02349295|62999645|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33600599|NCT02349295|62999646|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33600600|NCT02349295|62999647|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33600601|NCT02349295|62999648|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33600602|NCT02349295|62999635|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33600603|NCT02349295|62999636|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33600604|NCT02349295|62999637|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33600605|NCT02349295|62999638|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33600606|NCT02349295|62999639|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33600607|NCT02349295|62999640|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33600608|NCT02349295|62999641|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33600609|NCT02349295|62999642|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33600610|NCT02349295|62999643|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33600611|NCT02349295|62999644|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33600612|NCT02349295|62999645|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33600613|NCT02349295|62999646|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
33600614|NCT02349295|62999647|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
33600615|NCT02349295|62999648|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
33600616|NCT02349295|62999635|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33600617|NCT02349295|62999636|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33600618|NCT02349295|62999637|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33600619|NCT02349295|62999638|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33600620|NCT02349295|62999639|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33600621|NCT02349295|62999640|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33600622|NCT02349295|62999641|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33600623|NCT02349295|62999642|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33600624|NCT02349295|62999643|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33600625|NCT02349295|62999644|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33600626|NCT02349295|62999645|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33600627|NCT02349295|62999646|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
33600628|NCT02349295|62999647|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
33600629|NCT02349295|62999648|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33600630|NCT02349295|62999635|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33600631|NCT02349295|62999636|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33600632|NCT02349295|62999637|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33600633|NCT02349295|62999638|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33600634|NCT02349295|62999639|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33600635|NCT02349295|62999640|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33600636|NCT02349295|62999641|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33412049|NCT03908970|62790363|FG001|Overall Study|Withdrawal by Subject|22|||
33412050|NCT00092443|62790371|FG000|Overall Study|Adverse Event|9|||
33600637|NCT02349295|62999642|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33600638|NCT02349295|62999643|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33412051|NCT00092443|62790372|FG001|Overall Study|Adverse Event|13|||
33600639|NCT02349295|62999644|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33322106|NCT01175382|62698274|FG002|Overall Study|Unable to tolerate study meds|1|||
33412052|NCT00092443|62790371|FG000|Overall Study|Lost to Follow-up|7|||
33412053|NCT00092443|62790372|FG001|Overall Study|Lost to Follow-up|3|||
33412054|NCT00092443|62790371|FG000|Overall Study|Protocol Violation|11|||
33412055|NCT00092443|62790372|FG001|Overall Study|Protocol Violation|9|||
33412056|NCT00092443|62790371|FG000|Overall Study|Withdrawal by Subject|9|||
33412057|NCT00092443|62790372|FG001|Overall Study|Withdrawal by Subject|11|||
33412058|NCT00092443|62790371|FG000|Overall Study|Moved|5|||
33412059|NCT00092443|62790372|FG001|Overall Study|Moved|5|||
33412060|NCT00092443|62790371|FG000|Overall Study|Other|17|||
33412061|NCT00092443|62790372|FG001|Overall Study|Other|13|||
33412062|NCT00413920|62790390|FG000|Overall Study|Adverse Event|9|||
33412063|NCT00413920|62790391|FG001|Overall Study|Adverse Event|11|||
33412064|NCT00413920|62790390|FG000|Overall Study|Lack of Efficacy|11|||
33412065|NCT00413920|62790391|FG001|Overall Study|Lack of Efficacy|9|||
33412066|NCT00413920|62790390|FG000|Overall Study|Death|3|||
33412067|NCT00413920|62790391|FG001|Overall Study|Death|5|||
33412068|NCT00413920|62790390|FG000|Overall Study|Graft Loss|5|||
33412069|NCT00413920|62790391|FG001|Overall Study|Graft Loss|3|||
33412070|NCT00091819|62790399|FG000|Overall Study|Adverse Event|1|||
33412071|NCT00091819|62790400|FG001|Overall Study|Adverse Event|1|||
33412072|NCT00091819|62790399|FG000|Overall Study|Death|4|||
33412073|NCT00091819|62790400|FG001|Overall Study|Death|5|||
33412074|NCT00091819|62790399|FG000|Overall Study|Lost to Follow-up|26|||
33412075|NCT00091819|62790400|FG001|Overall Study|Lost to Follow-up|23|||
33412076|NCT00091819|62790399|FG000|Overall Study|Withdrawal by Subject|5|||
33412077|NCT00091819|62790400|FG001|Overall Study|Withdrawal by Subject|8|||
33600640|NCT02349295|62999645|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33600641|NCT02349295|62999646|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
33600642|NCT02349295|62999647|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
33600643|NCT02349295|62999648|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33322107|NCT01194245|62698287|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
33322108|NCT01194245|62698288|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
33322109|NCT01194245|62698289|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
33322110|NCT01194245|62698290|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
33322111|NCT01194245|62698291|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
33322112|NCT01194245|62698287|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
33322113|NCT01194245|62698288|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
33322114|NCT01194245|62698289|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
33322115|NCT01194245|62698290|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
33322116|NCT01194245|62698291|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
33322117|NCT01194245|62698287|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
33322118|NCT01194245|62698288|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
33322119|NCT01194245|62698289|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
33322120|NCT01194245|62698290|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
33322121|NCT01194245|62698291|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
33322122|NCT01194245|62698287|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
33322123|NCT01194245|62698288|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
33322124|NCT01194245|62698289|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
33322125|NCT01194245|62698290|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
33322126|NCT01194245|62698291|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
33322127|NCT01194245|62698287|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33322128|NCT01194245|62698288|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33322129|NCT01194245|62698289|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33322130|NCT01194245|62698290|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33322131|NCT01194245|62698291|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
33322132|NCT01194245|62698287|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33322133|NCT01194245|62698288|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33322134|NCT01194245|62698289|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
33412078|NCT00091819|62790399|FG000|Overall Study|Protocol Violation|1|||
33412079|NCT00091819|62790400|FG001|Overall Study|Protocol Violation|2|||
33412080|NCT00091819|62790399|FG000|Overall Study|Other|2|||
33412081|NCT00091819|62790400|FG001|Overall Study|Other|3|||
33412082|NCT00091819|62790399|FG000|Overall Study|Never received study treatment|3|||
33412083|NCT00091819|62790400|FG001|Overall Study|Never received study treatment|4|||
33412084|NCT00540228|62790411|FG000|Overall Study|Adverse Event|2|||
33412085|NCT00540228|62790412|FG001|Overall Study|Adverse Event|0|||
33412086|NCT00540228|62790413|FG002|Overall Study|Adverse Event|0|||
33412087|NCT00540228|62790414|FG003|Overall Study|Adverse Event|0|||
33412088|NCT00540228|62790415|FG004|Overall Study|Adverse Event|0|||
33412089|NCT00540228|62790411|FG000|Overall Study|Lost to Follow-up|1|||
33412090|NCT00540228|62790412|FG001|Overall Study|Lost to Follow-up|1|||
33600644|NCT02349295|62999635|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33600645|NCT02349295|62999636|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33600646|NCT02349295|62999637|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33600647|NCT02349295|62999638|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33600648|NCT02349295|62999639|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33600649|NCT02349295|62999640|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33600650|NCT02349295|62999641|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33600651|NCT02349295|62999642|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33600652|NCT02349295|62999643|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33600653|NCT02349295|62999644|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33600654|NCT02349295|62999645|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33600655|NCT02349295|62999646|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
33600656|NCT02349295|62999647|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33600657|NCT02349295|62999648|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33600658|NCT02349295|62999635|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33600659|NCT02349295|62999636|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33600660|NCT02349295|62999637|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33600661|NCT02349295|62999638|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33600662|NCT02349295|62999639|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33600663|NCT02349295|62999640|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33600664|NCT02349295|62999641|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33600665|NCT02349295|62999642|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33600666|NCT02349295|62999643|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33600667|NCT02349295|62999644|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33600668|NCT02349295|62999645|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33600669|NCT02349295|62999646|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
33600670|NCT02349295|62999647|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33600671|NCT02349295|62999648|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33600672|NCT02281357|62999675|FG000|Overall Study|Adverse Event|2|||
33600673|NCT02281357|62999676|FG001|Overall Study|Adverse Event|1|||
33600674|NCT02281357|62999675|FG000|Overall Study|Lost to Follow-up|1|||
33600675|NCT02281357|62999676|FG001|Overall Study|Lost to Follow-up|0|||
33600676|NCT02281357|62999675|FG000|Overall Study|Withdrawal by Subject|4|||
33600677|NCT02281357|62999676|FG001|Overall Study|Withdrawal by Subject|3|||
33600678|NCT02284243|62999684|FG000|Overall Study|Lack of Efficacy|3|||
33600679|NCT02284243|62999685|FG001|Overall Study|Lack of Efficacy|3|||
33600680|NCT02284243|62999684|FG000|Overall Study|Adverse Event|1|||
33600681|NCT02284243|62999685|FG001|Overall Study|Adverse Event|0|||
33600682|NCT02284009|62999693|FG000|Overall Study|Adverse Event|3|||
33600683|NCT02284009|62999694|FG001|Overall Study|Adverse Event|0|||
33600684|NCT02284009|62999693|FG000|Overall Study|Lost to Follow-up|1|||
33600685|NCT02284009|62999694|FG001|Overall Study|Lost to Follow-up|3|||
33600686|NCT02284009|62999693|FG000|Overall Study|Physician Decision|0|||
33600687|NCT02284009|62999694|FG001|Overall Study|Physician Decision|2|||
33600688|NCT02284009|62999693|FG000|Overall Study|Withdrawal by Subject|2|||
33600689|NCT02284009|62999694|FG001|Overall Study|Withdrawal by Subject|5|||
33600690|NCT02280499|62999702|FG000|Overall Study|Death|14|||
33600691|NCT02280499|62999702|FG000|Overall Study|Lost to Follow-up|42|||
33600692|NCT02280499|62999702|FG000|Overall Study|Adverse Event|5|||
33600693|NCT02400476|62999712|FG000|Overall Study|Adverse Event|57|||
33600694|NCT02400476|62999713|FG001|Overall Study|Adverse Event|10|||
33322135|NCT01194245|62698290|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
33322136|NCT01194245|62698291|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
33600695|NCT02400476|62999714|FG002|Overall Study|Adverse Event|22|||
33600696|NCT02400476|62999715|FG003|Overall Study|Adverse Event|19|||
33600697|NCT02400476|62999716|FG004|Overall Study|Adverse Event|5|||
33600698|NCT02400476|62999717|FG005|Overall Study|Adverse Event|8|||
33600699|NCT02400476|62999712|FG000|Overall Study|Withdrawal by Subject|4|||
33600700|NCT02400476|62999713|FG001|Overall Study|Withdrawal by Subject|1|||
33600701|NCT02400476|62999714|FG002|Overall Study|Withdrawal by Subject|12|||
33600702|NCT02400476|62999715|FG003|Overall Study|Withdrawal by Subject|7|||
33600703|NCT02400476|62999716|FG004|Overall Study|Withdrawal by Subject|5|||
33600704|NCT02400476|62999717|FG005|Overall Study|Withdrawal by Subject|5|||
33600705|NCT02400476|62999712|FG000|Overall Study|Lost to Follow-up|0|||
33600706|NCT02400476|62999713|FG001|Overall Study|Lost to Follow-up|0|||
33600707|NCT02400476|62999714|FG002|Overall Study|Lost to Follow-up|0|||
33600708|NCT02400476|62999715|FG003|Overall Study|Lost to Follow-up|1|||
33600709|NCT02400476|62999716|FG004|Overall Study|Lost to Follow-up|3|||
33600710|NCT02400476|62999717|FG005|Overall Study|Lost to Follow-up|1|||
33600711|NCT02400476|62999712|FG000|Overall Study|Physician Decision|0|||
33600712|NCT02400476|62999713|FG001|Overall Study|Physician Decision|0|||
33600713|NCT02400476|62999714|FG002|Overall Study|Physician Decision|1|||
33600714|NCT02400476|62999715|FG003|Overall Study|Physician Decision|1|||
33600715|NCT02400476|62999716|FG004|Overall Study|Physician Decision|0|||
33600716|NCT02400476|62999717|FG005|Overall Study|Physician Decision|1|||
33600717|NCT02400476|62999712|FG000|Overall Study|Other, Disease Progression|0|||
33600718|NCT02400476|62999713|FG001|Overall Study|Other, Disease Progression|1|||
33600719|NCT02400476|62999714|FG002|Overall Study|Other, Disease Progression|2|||
33600720|NCT02400476|62999715|FG003|Overall Study|Other, Disease Progression|1|||
33600721|NCT02400476|62999716|FG004|Overall Study|Other, Disease Progression|2|||
33600722|NCT02400476|62999717|FG005|Overall Study|Other, Disease Progression|1|||
33600723|NCT02400476|62999712|FG000|Overall Study|Other, Decreased Quality of Life|0|||
33600724|NCT02400476|62999713|FG001|Overall Study|Other, Decreased Quality of Life|0|||
33600725|NCT02400476|62999714|FG002|Overall Study|Other, Decreased Quality of Life|2|||
33600726|NCT02400476|62999715|FG003|Overall Study|Other, Decreased Quality of Life|0|||
33600727|NCT02400476|62999716|FG004|Overall Study|Other, Decreased Quality of Life|0|||
33600728|NCT02400476|62999717|FG005|Overall Study|Other, Decreased Quality of Life|0|||
33600729|NCT02400476|62999712|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
33600730|NCT02400476|62999713|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
33600731|NCT02400476|62999714|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
33600732|NCT02400476|62999715|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
33600733|NCT02400476|62999716|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
33600734|NCT02400476|62999717|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
33600735|NCT02363738|62999733|FG000|Overall Study|Adverse Event|5|||
33600736|NCT02363738|62999734|FG001|Overall Study|Adverse Event|2|||
33600737|NCT02363738|62999733|FG000|Overall Study|Lack of Efficacy|1|||
33600738|NCT02363738|62999734|FG001|Overall Study|Lack of Efficacy|2|||
33600739|NCT02363738|62999733|FG000|Overall Study|Lost to Follow-up|2|||
33600740|NCT02363738|62999734|FG001|Overall Study|Lost to Follow-up|1|||
33600741|NCT02331680|62999743|FG000|Overall Study|Adverse Event|3|||
33600742|NCT02331680|62999744|FG001|Overall Study|Adverse Event|0|||
33600743|NCT02331680|62999745|FG002|Overall Study|Adverse Event|2|||
33600744|NCT02331680|62999743|FG000|Overall Study|Physician Decision|1|||
33600745|NCT02331680|62999744|FG001|Overall Study|Physician Decision|1|||
33600746|NCT02331680|62999745|FG002|Overall Study|Physician Decision|2|||
33600747|NCT02331680|62999743|FG000|Overall Study|Withdrawal by Subject|0|||
33600748|NCT02331680|62999744|FG001|Overall Study|Withdrawal by Subject|1|||
33600749|NCT02331680|62999745|FG002|Overall Study|Withdrawal by Subject|2|||
33600750|NCT02331680|62999743|FG000|Overall Study|Met withdrawal criteria|2|||
33600751|NCT02331680|62999744|FG001|Overall Study|Met withdrawal criteria|2|||
33600752|NCT02331680|62999745|FG002|Overall Study|Met withdrawal criteria|5|||
33600753|NCT02331680|62999743|FG000|Overall Study|Non-compliance with study drug|0|||
33600754|NCT02331680|62999744|FG001|Overall Study|Non-compliance with study drug|0|||
33600755|NCT02331680|62999745|FG002|Overall Study|Non-compliance with study drug|1|||
33600756|NCT02331680|62999743|FG000|Overall Study|Protocol Violation|0|||
33600757|NCT02331680|62999744|FG001|Overall Study|Protocol Violation|0|||
33600758|NCT02331680|62999745|FG002|Overall Study|Protocol Violation|3|||
33600759|NCT02331446|62999757|FG000|Overall Study|Lost to Follow-up|2|||
33600760|NCT02331446|62999758|FG001|Overall Study|Lost to Follow-up|1|||
33600761|NCT02331446|62999759|FG002|Overall Study|Lost to Follow-up|0|||
33600762|NCT02331446|62999760|FG003|Overall Study|Lost to Follow-up|1|||
33600763|NCT02331446|62999757|FG000|Overall Study|Personal Problem|2|||
33600764|NCT02331446|62999758|FG001|Overall Study|Personal Problem|0|||
33600765|NCT02331446|62999759|FG002|Overall Study|Personal Problem|0|||
33600766|NCT02331446|62999760|FG003|Overall Study|Personal Problem|0|||
33322137|NCT00979407|62698302|FG000|Overall Study|Withdrawal by Subject|3|||
33412091|NCT00540228|62790413|FG002|Overall Study|Lost to Follow-up|0|||
33600767|NCT02331446|62999757|FG000|Overall Study|Disease|0|||
33600768|NCT02331446|62999758|FG001|Overall Study|Disease|2|||
33600769|NCT02331446|62999759|FG002|Overall Study|Disease|2|||
33600770|NCT02331446|62999760|FG003|Overall Study|Disease|1|||
33600771|NCT02331446|62999757|FG000|Overall Study|Physician Decision|0|||
33600772|NCT02331446|62999758|FG001|Overall Study|Physician Decision|1|||
33600773|NCT02331446|62999759|FG002|Overall Study|Physician Decision|0|||
33600774|NCT02331446|62999760|FG003|Overall Study|Physician Decision|1|||
33600775|NCT02331446|62999757|FG000|Overall Study|Lost before baseline analysis|0|||
33600776|NCT02331446|62999758|FG001|Overall Study|Lost before baseline analysis|1|||
33600777|NCT02331446|62999759|FG002|Overall Study|Lost before baseline analysis|1|||
33600778|NCT02331446|62999760|FG003|Overall Study|Lost before baseline analysis|0|||
33600779|NCT02349061|62999772|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
33600780|NCT02349061|62999773|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
33600781|NCT02349061|62999774|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
33412092|NCT00540228|62790414|FG003|Overall Study|Lost to Follow-up|0|||
33600782|NCT02349061|62999772|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
33600783|NCT02349061|62999773|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
33600784|NCT02349061|62999774|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
33600785|NCT02349061|62999772|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
33600786|NCT02349061|62999773|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
33600787|NCT02349061|62999774|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
33600788|NCT02349061|62999772|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
33600789|NCT02349061|62999773|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
33600790|NCT02349061|62999774|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
33600791|NCT02349061|62999772|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
33600792|NCT02349061|62999773|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
33600793|NCT02349061|62999774|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
33600794|NCT02349061|62999772|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
33600795|NCT02349061|62999773|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
33600796|NCT02349061|62999774|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
33600797|NCT02349061|62999772|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
33600798|NCT02349061|62999773|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
33600799|NCT02349061|62999774|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
33600800|NCT02349061|62999772|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
33600801|NCT02349061|62999773|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
33600802|NCT02349061|62999774|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
33600803|NCT02349061|62999772|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
33600804|NCT02349061|62999773|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
33600805|NCT02349061|62999774|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
33600806|NCT02349061|62999772|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
33600807|NCT02349061|62999773|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
33600808|NCT02349061|62999774|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
33600809|NCT02349061|62999772|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
33600810|NCT02349061|62999773|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
33600811|NCT02349061|62999774|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
33600812|NCT02349061|62999772|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
33600813|NCT02349061|62999773|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
33600814|NCT02349061|62999774|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
33600815|NCT02349061|62999772|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
33600816|NCT02349061|62999773|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
33600817|NCT02349061|62999774|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
33600818|NCT02331368|62999784|FG000|Overall Study|Withdrawal by Subject|3|||
33600819|NCT02362724|62999790|FG000|Overall Study|Withdrawal by Subject|3|||
33600820|NCT02362724|62999791|FG001|Overall Study|Withdrawal by Subject|1|||
33600821|NCT02362724|62999790|FG000|Overall Study|Adverse Event|3|||
33600822|NCT02362724|62999791|FG001|Overall Study|Adverse Event|0|||
33600823|NCT02362646|62999799|FG000|Overall Study|Death|15|||
33600824|NCT02362646|62999800|FG001|Overall Study|Death|8|||
33600825|NCT02362646|62999799|FG000|Overall Study|Withdrawal by Subject|2|||
33600826|NCT02362646|62999800|FG001|Overall Study|Withdrawal by Subject|2|||
33600827|NCT02362646|62999799|FG000|Overall Study|received transplant|21|||
33600828|NCT02362646|62999800|FG001|Overall Study|received transplant|14|||
33600829|NCT02280421|62999810|FG000|Washout (2 Weeks)|Adverse Event|0|||
33600830|NCT02280421|62999811|FG001|Washout (2 Weeks)|Adverse Event|1|||
33600831|NCT02280421|62999810|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
33600832|NCT02280421|62999811|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
33600833|NCT02362412|62999829|FG000|Treatment Period III|Lost to Follow-up|0|||
33600834|NCT02362412|62999830|FG001|Treatment Period III|Lost to Follow-up|1|||
33600835|NCT02280187|62999842|FG000|Overall Study|Lost to Follow-up|218|||
33600836|NCT02347813|62999848|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
33600837|NCT02347813|62999849|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
33600838|NCT02347813|62999848|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
33600839|NCT02347813|62999849|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
33600840|NCT02329730|62999859|FG000|Overall Study|Protocol Violation|0|||
33412093|NCT00540228|62790415|FG004|Overall Study|Lost to Follow-up|0|||
33412094|NCT05013385|62790440|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
33412095|NCT04250636|62790463|FG000|Overall Study|Lost to Follow-up|2|||
33412096|NCT03989115|62790475|FG000|Overall Study|Withdrawal by Subject|2|||
33412097|NCT03989115|62790476|FG001|Overall Study|Withdrawal by Subject|1|||
33412098|NCT03989115|62790477|FG002|Overall Study|Withdrawal by Subject|3|||
33600841|NCT02329730|62999860|FG001|Overall Study|Protocol Violation|0|||
33412099|NCT03989115|62790478|FG003|Overall Study|Withdrawal by Subject|0|||
33412100|NCT03989115|62790479|FG004|Overall Study|Withdrawal by Subject|17|||
33412101|NCT03989115|62790480|FG005|Overall Study|Withdrawal by Subject|1|||
33600842|NCT02329730|62999861|FG002|Overall Study|Protocol Violation|0|||
33600843|NCT02329730|62999862|FG003|Overall Study|Protocol Violation|0|||
33600844|NCT02329730|62999863|FG004|Overall Study|Protocol Violation|2|||
33600845|NCT02329730|62999864|FG005|Overall Study|Protocol Violation|2|||
33600846|NCT02329730|62999865|FG006|Overall Study|Protocol Violation|0|||
33600847|NCT02329730|62999866|FG007|Overall Study|Protocol Violation|0|||
33600848|NCT02329730|62999867|FG008|Overall Study|Protocol Violation|0|||
33600849|NCT02329730|62999868|FG009|Overall Study|Protocol Violation|0|||
33600850|NCT02329730|62999869|FG010|Overall Study|Protocol Violation|0|||
33600851|NCT02329730|62999870|FG011|Overall Study|Protocol Violation|0|||
33600852|NCT02329730|62999859|FG000|Overall Study|Withdrawal by Subject|0|||
33600853|NCT02329730|62999860|FG001|Overall Study|Withdrawal by Subject|0|||
33600854|NCT02329730|62999861|FG002|Overall Study|Withdrawal by Subject|0|||
33600855|NCT02329730|62999862|FG003|Overall Study|Withdrawal by Subject|0|||
33600856|NCT02329730|62999863|FG004|Overall Study|Withdrawal by Subject|1|||
33600857|NCT02329730|62999864|FG005|Overall Study|Withdrawal by Subject|0|||
33600858|NCT02329730|62999865|FG006|Overall Study|Withdrawal by Subject|1|||
33600859|NCT02329730|62999866|FG007|Overall Study|Withdrawal by Subject|1|||
33600860|NCT02329730|62999867|FG008|Overall Study|Withdrawal by Subject|1|||
33600861|NCT02329730|62999868|FG009|Overall Study|Withdrawal by Subject|1|||
33600862|NCT02329730|62999869|FG010|Overall Study|Withdrawal by Subject|0|||
33600863|NCT02329730|62999870|FG011|Overall Study|Withdrawal by Subject|0|||
33600864|NCT02328326|62999890|FG000|Overall Study|Withdrawal by Subject|10|||
33600865|NCT02328326|62999891|FG001|Overall Study|Withdrawal by Subject|3|||
33600866|NCT02328326|62999890|FG000|Overall Study|Death|2|||
33322138|NCT00979407|62698303|FG001|Overall Study|Withdrawal by Subject|4|||
33322139|NCT00979407|62698302|FG000|Overall Study|Lost to Follow-up|3|||
33322140|NCT00979407|62698303|FG001|Overall Study|Lost to Follow-up|3|||
33600867|NCT02328326|62999891|FG001|Overall Study|Death|1|||
33600868|NCT02328326|62999890|FG000|Overall Study|Lost to Follow-up|10|||
33600869|NCT02328326|62999891|FG001|Overall Study|Lost to Follow-up|4|||
33600870|NCT01649804|62999899|FG000|Overall Study|Administrative/Other|8|||
33600871|NCT02397278|62999905|FG000|Overall Study|Withdrawal by Subject|0|||
33600872|NCT02397278|62999906|FG001|Overall Study|Withdrawal by Subject|2|||
33600873|NCT02397278|62999905|FG000|Overall Study|Deemed ineligible following surgery|1|||
33600874|NCT02397278|62999906|FG001|Overall Study|Deemed ineligible following surgery|1|||
33600875|NCT02360228|62999915|FG000|Overall Study|Withdrawal by Subject|1|||
33600876|NCT02360228|62999916|FG001|Overall Study|Withdrawal by Subject|0|||
33600877|NCT02360228|62999917|FG002|Overall Study|Withdrawal by Subject|0|||
33600878|NCT02360228|62999915|FG000|Overall Study|Self-discontinued medication|0|||
33600879|NCT02360228|62999916|FG001|Overall Study|Self-discontinued medication|1|||
33600880|NCT02360228|62999917|FG002|Overall Study|Self-discontinued medication|0|||
33600881|NCT02360228|62999915|FG000|Overall Study|Unstable symptoms during screening|0|||
33600882|NCT02360228|62999916|FG001|Overall Study|Unstable symptoms during screening|0|||
33600883|NCT02360228|62999917|FG002|Overall Study|Unstable symptoms during screening|1|||
33600884|NCT02359994|62999927|FG000|Overall Population Study|Adverse Event|1|||
33600885|NCT02359994|62999928|FG001|Overall Population Study|Adverse Event|1|||
33600886|NCT02359994|62999927|FG000|Overall Population Study|Death|1|||
33600887|NCT02359994|62999928|FG001|Overall Population Study|Death|5|||
33600888|NCT02359994|62999927|FG000|Overall Population Study|Lost to Follow-up|1|||
33600889|NCT02359994|62999928|FG001|Overall Population Study|Lost to Follow-up|1|||
33600890|NCT02359994|62999927|FG000|Overall Population Study|Withdrawal by Subject|1|||
33600891|NCT02359994|62999928|FG001|Overall Population Study|Withdrawal by Subject|0|||
33600892|NCT02359994|62999927|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
33600893|NCT02359994|62999928|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
33600894|NCT02359994|62999927|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
33600895|NCT02359994|62999928|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
33600896|NCT02359994|62999927|FG000|Extended Oncology 24-Month Survival|Death|19|||
33600897|NCT02359994|62999928|FG001|Extended Oncology 24-Month Survival|Death|21|||
33600898|NCT02359994|62999927|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
33600899|NCT02359994|62999928|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
33600900|NCT02326298|62999937|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33600901|NCT02326298|62999938|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33600902|NCT02326298|62999939|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
33600903|NCT02326298|62999940|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33600904|NCT02326298|62999941|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33600905|NCT02326298|62999942|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33600906|NCT02326298|62999943|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33600907|NCT02326298|62999944|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33600908|NCT02326298|62999945|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33600909|NCT02326298|62999946|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33600910|NCT02326298|62999947|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33600911|NCT02326298|62999948|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33600912|NCT02326298|62999949|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33600913|NCT02326298|62999950|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33600914|NCT02326298|62999937|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
33322141|NCT01148862|62698311|FG000|Second Intervention|Withdrawal by Subject|0|||
33600915|NCT02326298|62999938|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33600916|NCT02326298|62999939|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33600917|NCT02326298|62999940|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33600918|NCT02326298|62999941|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33600919|NCT02326298|62999942|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33600920|NCT02326298|62999943|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33600921|NCT02326298|62999944|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33600922|NCT02326298|62999945|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33600923|NCT02326298|62999946|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33600924|NCT02326298|62999947|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33600925|NCT02326298|62999948|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33412102|NCT03989115|62790481|FG006|Overall Study|Withdrawal by Subject|0|||
33412103|NCT03989115|62790482|FG007|Overall Study|Withdrawal by Subject|0|||
33412104|NCT03989115|62790475|FG000|Overall Study|Sponsor decision to terminate the study|1|||
33412105|NCT03989115|62790476|FG001|Overall Study|Sponsor decision to terminate the study|1|||
33412106|NCT03989115|62790477|FG002|Overall Study|Sponsor decision to terminate the study|0|||
33412107|NCT03989115|62790478|FG003|Overall Study|Sponsor decision to terminate the study|1|||
33412108|NCT03989115|62790479|FG004|Overall Study|Sponsor decision to terminate the study|11|||
33412109|NCT03989115|62790480|FG005|Overall Study|Sponsor decision to terminate the study|0|||
33412110|NCT03989115|62790481|FG006|Overall Study|Sponsor decision to terminate the study|2|||
33412111|NCT03989115|62790482|FG007|Overall Study|Sponsor decision to terminate the study|1|||
33412112|NCT03989115|62790475|FG000|Overall Study|Lost to Follow-up|2|||
33412113|NCT03989115|62790476|FG001|Overall Study|Lost to Follow-up|0|||
33412114|NCT03989115|62790477|FG002|Overall Study|Lost to Follow-up|0|||
33412115|NCT03989115|62790478|FG003|Overall Study|Lost to Follow-up|0|||
33412116|NCT03989115|62790479|FG004|Overall Study|Lost to Follow-up|1|||
33412117|NCT03989115|62790480|FG005|Overall Study|Lost to Follow-up|0|||
33412118|NCT03989115|62790481|FG006|Overall Study|Lost to Follow-up|0|||
33412119|NCT03989115|62790482|FG007|Overall Study|Lost to Follow-up|0|||
33412120|NCT03989115|62790475|FG000|Overall Study|Death|2|||
33412121|NCT03989115|62790476|FG001|Overall Study|Death|2|||
33412122|NCT03989115|62790477|FG002|Overall Study|Death|9|||
33412123|NCT03989115|62790478|FG003|Overall Study|Death|6|||
33412124|NCT03989115|62790479|FG004|Overall Study|Death|31|||
33412125|NCT03989115|62790480|FG005|Overall Study|Death|6|||
33412126|NCT03989115|62790481|FG006|Overall Study|Death|2|||
33412127|NCT03989115|62790482|FG007|Overall Study|Death|3|||
33412128|NCT03989115|62790475|FG000|Overall Study|Other|1|||
33412129|NCT03989115|62790476|FG001|Overall Study|Other|2|||
33412130|NCT03989115|62790477|FG002|Overall Study|Other|0|||
33600926|NCT02326298|62999949|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33412131|NCT03989115|62790478|FG003|Overall Study|Other|0|||
33412132|NCT03989115|62790479|FG004|Overall Study|Other|5|||
33412133|NCT03989115|62790480|FG005|Overall Study|Other|0|||
33412134|NCT03989115|62790481|FG006|Overall Study|Other|0|||
33412135|NCT03989115|62790482|FG007|Overall Study|Other|0|||
33412136|NCT03797898|62790511|FG000|Overall Study|Lost to Follow-up|60|||
33412137|NCT03797898|62790512|FG001|Overall Study|Lost to Follow-up|69|||
33412138|NCT03797898|62790511|FG000|Overall Study|Withdrawal by Subject|9|||
33412139|NCT03797898|62790512|FG001|Overall Study|Withdrawal by Subject|7|||
33412140|NCT03797898|62790511|FG000|Overall Study|Became ineligible|5|||
33494058|NCT03473808|62872714|FG000|Overall Study|Withdrawal by Subject|1|||
33412141|NCT03797898|62790512|FG001|Overall Study|Became ineligible|2|||
33412142|NCT03559192|62790534|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
33600927|NCT02326298|62999950|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33600928|NCT02326298|62999937|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
33600929|NCT02326298|62999938|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
33600930|NCT02326298|62999939|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33600931|NCT02326298|62999940|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33600932|NCT02326298|62999941|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33600933|NCT02326298|62999942|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33600934|NCT02326298|62999943|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33600935|NCT02326298|62999944|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33600936|NCT02326298|62999945|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33600937|NCT02326298|62999946|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33600938|NCT02326298|62999947|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33600939|NCT02326298|62999948|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33600940|NCT02326298|62999949|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33600941|NCT02326298|62999950|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33600942|NCT02326298|62999937|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
33600943|NCT02326298|62999938|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
33600944|NCT02326298|62999939|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33600945|NCT02326298|62999940|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33600946|NCT02326298|62999941|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33600947|NCT02326298|62999942|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33600948|NCT02326298|62999943|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33600949|NCT02326298|62999944|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33600950|NCT02326298|62999945|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33600951|NCT02326298|62999946|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33600952|NCT02326298|62999947|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33600953|NCT02326298|62999948|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33600954|NCT02326298|62999949|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33600955|NCT02326298|62999950|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33600956|NCT02326298|62999937|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33600957|NCT02326298|62999938|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33600958|NCT02326298|62999939|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
33412143|NCT03559192|62790535|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
33412144|NCT03559192|62790536|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
33412145|NCT03559192|62790534|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
33412146|NCT03559192|62790535|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
33412147|NCT03559192|62790536|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
33412148|NCT03559192|62790534|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
33412149|NCT03559192|62790535|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
33412150|NCT03559192|62790536|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
33412151|NCT03559192|62790534|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
33412152|NCT03559192|62790535|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
33412153|NCT03559192|62790536|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
33412154|NCT03559192|62790534|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
33322142|NCT01148862|62698312|FG001|Second Intervention|Withdrawal by Subject|2|||
33322143|NCT00975975|62698318|FG000|Overall Study|Death|6|||
33322144|NCT01193153|62698322|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
33322145|NCT01193153|62698323|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
33322146|NCT01193153|62698322|FG000|Open-label Lead in Period|Pregnancy|1|||
33322147|NCT01193153|62698323|FG001|Open-label Lead in Period|Pregnancy|0|||
33322148|NCT01193153|62698322|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
33322149|NCT01193153|62698323|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
33322150|NCT01193153|62698322|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
33322151|NCT01193153|62698323|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
33322152|NCT01193153|62698322|FG000|Open-label Lead in Period|Other|14|||
33322153|NCT01193153|62698323|FG001|Open-label Lead in Period|Other|0|||
33322154|NCT01193153|62698322|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
33322155|NCT01193153|62698323|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
33412155|NCT03559192|62790535|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
33494059|NCT03473340|62872720|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
33600959|NCT02326298|62999940|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33600960|NCT02326298|62999941|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33600961|NCT02326298|62999942|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33600962|NCT02326298|62999943|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33600963|NCT02326298|62999944|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33600964|NCT02326298|62999945|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33600965|NCT02326298|62999946|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33600966|NCT02326298|62999947|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33600967|NCT02326298|62999948|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33600968|NCT02326298|62999949|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33600969|NCT02326298|62999950|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33600970|NCT02326298|62999937|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33600971|NCT02326298|62999938|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33600972|NCT02326298|62999939|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33600973|NCT02326298|62999940|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33600974|NCT02326298|62999941|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33600975|NCT02326298|62999942|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33600976|NCT02326298|62999943|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
33600977|NCT02326298|62999944|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33600978|NCT02326298|62999945|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33600979|NCT02326298|62999946|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33600980|NCT02326298|62999947|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33600981|NCT02326298|62999948|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33600982|NCT02326298|62999949|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33600983|NCT02326298|62999950|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33600984|NCT02326298|62999937|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33600985|NCT02326298|62999938|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33600986|NCT02326298|62999939|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33600987|NCT02326298|62999940|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33600988|NCT02326298|62999941|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33600989|NCT02326298|62999942|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
33600990|NCT02326298|62999943|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
33600991|NCT02326298|62999944|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33600992|NCT02326298|62999945|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
33600993|NCT02326298|62999946|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33600994|NCT02326298|62999947|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33600995|NCT02326298|62999948|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33600996|NCT02326298|62999949|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33600997|NCT02326298|62999950|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33600998|NCT02326298|62999937|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33600999|NCT02326298|62999938|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33601000|NCT02326298|62999939|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33601001|NCT02326298|62999940|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33601002|NCT02326298|62999941|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33601003|NCT02326298|62999942|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
33601004|NCT02326298|62999943|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33601005|NCT02326298|62999944|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33412156|NCT03559192|62790536|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
33412157|NCT03559192|62790534|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
33412158|NCT03559192|62790535|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
33651386|NCT01969721|63062835|FG001|Overall Study|Other not defined above|2|||
33651387|NCT01969721|63062836|FG002|Overall Study|Other not defined above|0|||
33651388|NCT01969721|63062837|FG003|Overall Study|Other not defined above|0|||
33651389|NCT01969721|63062834|FG000|Overall Study|Discontinued during washout periods.|0|||
33651390|NCT01969721|63062835|FG001|Overall Study|Discontinued during washout periods.|1|||
33651391|NCT01969721|63062836|FG002|Overall Study|Discontinued during washout periods.|1|||
33651392|NCT01969721|63062837|FG003|Overall Study|Discontinued during washout periods.|2|||
33651393|NCT01969565|63062847|FG000|Overall Study|Withdrawal by Subject|1|||
33651394|NCT01968707|63062860|FG000|Overall Study|Did not meet treatment day baseline|49|||
33651395|NCT01968707|63062861|FG001|Overall Study|Did not meet treatment day baseline|12|||
33651396|NCT01968707|63062862|FG002|Overall Study|Did not meet treatment day baseline|41|||
33651397|NCT01968707|63062863|FG003|Overall Study|Did not meet treatment day baseline|44|||
33651398|NCT01968707|63062864|FG004|Overall Study|Did not meet treatment day baseline|36|||
33651399|NCT01968707|63062865|FG005|Overall Study|Did not meet treatment day baseline|11|||
33651400|NCT01968707|63062866|FG006|Overall Study|Did not meet treatment day baseline|34|||
33651401|NCT01968707|63062867|FG007|Overall Study|Did not meet treatment day baseline|35|||
33651402|NCT01959581|63062900|FG000|Overall Study|Lost to Follow-up|5|||
33651403|NCT01746901|63062904|FG000|Naloxone Challenge Phase|Adverse Event|2|||
33651404|NCT01746901|63062905|FG001|Naloxone Challenge Phase|Adverse Event|0|||
33651405|NCT01746901|63062906|FG002|Naloxone Challenge Phase|Adverse Event|0|||
33651406|NCT01746901|63062907|FG003|Naloxone Challenge Phase|Adverse Event|0|||
33651407|NCT01746901|63062908|FG004|Naloxone Challenge Phase|Adverse Event|0|||
33651408|NCT01746901|63062909|FG005|Naloxone Challenge Phase|Adverse Event|0|||
33651409|NCT01746901|63062910|FG006|Naloxone Challenge Phase|Adverse Event|0|||
33651410|NCT01746901|63062911|FG007|Naloxone Challenge Phase|Adverse Event|0|||
33651411|NCT01746901|63062912|FG008|Naloxone Challenge Phase|Adverse Event|0|||
33651412|NCT01746901|63062904|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
33651413|NCT01746901|63062905|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33651414|NCT01746901|63062906|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33651415|NCT01746901|63062907|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33651416|NCT01746901|63062908|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33651417|NCT01746901|63062909|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33651418|NCT01746901|63062910|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33651419|NCT01746901|63062911|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33651420|NCT01746901|63062912|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33651421|NCT01746901|63062904|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33651422|NCT01746901|63062905|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
33601006|NCT02326298|62999945|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33601007|NCT02326298|62999946|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33601008|NCT02326298|62999947|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33601009|NCT02326298|62999948|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33601010|NCT02326298|62999949|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33601011|NCT02326298|62999950|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33601012|NCT02326298|62999937|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33601013|NCT02326298|62999938|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33601014|NCT02326298|62999939|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33601015|NCT02326298|62999940|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33601016|NCT02326298|62999941|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33601017|NCT02326298|62999942|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33601018|NCT02326298|62999943|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
33601019|NCT02326298|62999944|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33601020|NCT02326298|62999945|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33601021|NCT02326298|62999946|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33601022|NCT02326298|62999947|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33601023|NCT02326298|62999948|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33601024|NCT02326298|62999949|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33601025|NCT02326298|62999950|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33601026|NCT02326298|62999937|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33601027|NCT02326298|62999938|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33601028|NCT02326298|62999939|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33601029|NCT02326298|62999940|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33601030|NCT02326298|62999941|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33601031|NCT02326298|62999942|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33601032|NCT02326298|62999943|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33601033|NCT02326298|62999944|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
33601034|NCT02326298|62999945|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33601035|NCT02326298|62999946|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33601036|NCT02326298|62999947|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33601037|NCT02326298|62999948|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33601038|NCT02326298|62999949|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33601039|NCT02326298|62999950|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33601040|NCT02326298|62999937|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33601041|NCT02326298|62999938|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33601042|NCT02326298|62999939|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33601043|NCT02326298|62999940|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33601044|NCT02326298|62999941|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33601045|NCT02326298|62999942|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33601046|NCT02326298|62999943|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
33601047|NCT02326298|62999944|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
33412159|NCT03559192|62790536|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
33412160|NCT03559192|62790534|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
33412161|NCT03559192|62790535|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
33412162|NCT03559192|62790536|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
33412163|NCT03559192|62790534|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
33412164|NCT03559192|62790535|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
33412165|NCT03559192|62790536|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
33412166|NCT03559192|62790534|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
33412167|NCT03559192|62790535|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
33412168|NCT03559192|62790536|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
33412169|NCT03523585|62790547|FG000|Overall Study|Progressive Disease|174|||
33412170|NCT03523585|62790548|FG001|Overall Study|Progressive Disease|64|||
33412171|NCT03523585|62790549|FG002|Overall Study|Progressive Disease|77|||
33412172|NCT03523585|62790547|FG000|Overall Study|Adverse Event|74|||
33412173|NCT03523585|62790548|FG001|Overall Study|Adverse Event|5|||
33412174|NCT03523585|62790549|FG002|Overall Study|Adverse Event|9|||
33412175|NCT03523585|62790547|FG000|Overall Study|Withdrawal by Subject|30|||
33412176|NCT03523585|62790548|FG001|Overall Study|Withdrawal by Subject|11|||
33412177|NCT03523585|62790549|FG002|Overall Study|Withdrawal by Subject|6|||
33412178|NCT03523585|62790547|FG000|Overall Study|Clinical Progression|23|||
33412179|NCT03523585|62790548|FG001|Overall Study|Clinical Progression|5|||
33412180|NCT03523585|62790549|FG002|Overall Study|Clinical Progression|10|||
33412181|NCT03523585|62790547|FG000|Overall Study|Death|4|||
33412182|NCT03523585|62790548|FG001|Overall Study|Death|0|||
33412183|NCT03523585|62790549|FG002|Overall Study|Death|1|||
33412184|NCT03523585|62790547|FG000|Overall Study|Physician Decision|2|||
33412185|NCT03523585|62790548|FG001|Overall Study|Physician Decision|1|||
33412186|NCT03523585|62790549|FG002|Overall Study|Physician Decision|0|||
33412187|NCT03523585|62790547|FG000|Overall Study|Lost to Follow-up|1|||
33412188|NCT03523585|62790548|FG001|Overall Study|Lost to Follow-up|0|||
33412189|NCT03523585|62790549|FG002|Overall Study|Lost to Follow-up|0|||
33412190|NCT03523585|62790547|FG000|Overall Study|Miscellaneous|1|||
33412191|NCT03523585|62790548|FG001|Overall Study|Miscellaneous|0|||
33412192|NCT03523585|62790549|FG002|Overall Study|Miscellaneous|0|||
33412193|NCT03523585|62790547|FG000|Overall Study|Protocol Deviation|1|||
33412194|NCT03523585|62790548|FG001|Overall Study|Protocol Deviation|0|||
33412195|NCT03523585|62790549|FG002|Overall Study|Protocol Deviation|1|||
33412196|NCT03523585|62790547|FG000|Overall Study|Randomized But Not Treated|2|||
33412197|NCT03523585|62790548|FG001|Overall Study|Randomized But Not Treated|4|||
33412198|NCT03523585|62790549|FG002|Overall Study|Randomized But Not Treated|3|||
33412199|NCT03485911|62790559|FG000|Part 1|Perceived lack of efficacy|1|||
33412200|NCT03485911|62790560|FG001|Part 1|Perceived lack of efficacy|1|||
33412201|NCT03485911|62790561|FG002|Part 1|Perceived lack of efficacy|2|||
33412202|NCT03485911|62790562|FG003|Part 1|Perceived lack of efficacy|0|||
33412203|NCT03485911|62790559|FG000|Part 1|Subject withdrew consent|0|||
33412204|NCT03485911|62790560|FG001|Part 1|Subject withdrew consent|1|||
33412205|NCT03485911|62790561|FG002|Part 1|Subject withdrew consent|0|||
33412206|NCT03485911|62790562|FG003|Part 1|Subject withdrew consent|1|||
33412207|NCT03485911|62790559|FG000|Part 1|Lab abnormalities/AEs|3|||
33412208|NCT03485911|62790560|FG001|Part 1|Lab abnormalities/AEs|1|||
33412209|NCT03485911|62790561|FG002|Part 1|Lab abnormalities/AEs|1|||
33412210|NCT03485911|62790562|FG003|Part 1|Lab abnormalities/AEs|0|||
33412211|NCT03485911|62790559|FG000|Part 1|Withdrew Consent prior to dosing|0|||
33412212|NCT03485911|62790560|FG001|Part 1|Withdrew Consent prior to dosing|0|||
33412213|NCT03485911|62790561|FG002|Part 1|Withdrew Consent prior to dosing|0|||
33412214|NCT03485911|62790562|FG003|Part 1|Withdrew Consent prior to dosing|1|||
33601048|NCT02326298|62999945|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33412215|NCT03485911|62790559|FG000|Part 1|Other NOS|0|||
33412216|NCT03485911|62790560|FG001|Part 1|Other NOS|0|||
33412217|NCT03485911|62790561|FG002|Part 1|Other NOS|0|||
33412218|NCT03485911|62790562|FG003|Part 1|Other NOS|1|||
33412219|NCT03485911|62790559|FG000|Part 2|Perceived lack of efficacy|5|||
33412220|NCT03485911|62790560|FG001|Part 2|Perceived lack of efficacy|3|||
33412221|NCT03485911|62790561|FG002|Part 2|Perceived lack of efficacy|0|||
33412222|NCT03485911|62790562|FG003|Part 2|Perceived lack of efficacy|2|||
33412223|NCT03485911|62790559|FG000|Part 2|Subject withdrew consent|1|||
33412224|NCT03485911|62790560|FG001|Part 2|Subject withdrew consent|0|||
33412225|NCT03485911|62790561|FG002|Part 2|Subject withdrew consent|2|||
33412226|NCT03485911|62790562|FG003|Part 2|Subject withdrew consent|1|||
33412227|NCT03485911|62790559|FG000|Part 2|Lab abnormalities/AEs|1|||
33412228|NCT03485911|62790560|FG001|Part 2|Lab abnormalities/AEs|2|||
33412229|NCT03485911|62790561|FG002|Part 2|Lab abnormalities/AEs|0|||
33412230|NCT03485911|62790562|FG003|Part 2|Lab abnormalities/AEs|0|||
33601049|NCT02326298|62999946|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33601050|NCT02326298|62999947|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33601051|NCT02326298|62999948|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33601052|NCT02326298|62999949|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33601053|NCT02326298|62999950|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33601054|NCT02326298|62999937|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33601055|NCT02326298|62999938|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33601056|NCT02326298|62999939|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33601057|NCT02326298|62999940|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33601058|NCT02326298|62999941|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33601059|NCT02326298|62999942|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33601060|NCT02326298|62999943|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33601061|NCT02326298|62999944|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
33601062|NCT02326298|62999945|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33601063|NCT02326298|62999946|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33601064|NCT02326298|62999947|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33601065|NCT02326298|62999948|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33601066|NCT02326298|62999949|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33601067|NCT02326298|62999950|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33601068|NCT02326298|62999937|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33601069|NCT02326298|62999938|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33601070|NCT02326298|62999939|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33601071|NCT02326298|62999940|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33601072|NCT02326298|62999941|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33601073|NCT02326298|62999942|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
33601074|NCT02326298|62999943|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33601075|NCT02326298|62999944|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33601076|NCT02326298|62999945|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33601077|NCT02326298|62999946|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33601078|NCT02326298|62999947|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33601079|NCT02326298|62999948|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33601080|NCT02326298|62999949|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33601081|NCT02326298|62999950|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33601082|NCT02326298|62999937|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
33601083|NCT02326298|62999938|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
33601084|NCT02326298|62999939|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
33601085|NCT02326298|62999940|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
33601086|NCT02326298|62999941|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
33601087|NCT02326298|62999942|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
33601088|NCT02326298|62999943|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
33601089|NCT02326298|62999944|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
33601090|NCT02326298|62999945|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
33601091|NCT02326298|62999946|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
33601092|NCT02326298|62999947|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
33601093|NCT02326298|62999948|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
33601094|NCT02326298|62999949|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
33601095|NCT02326298|62999950|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
33601096|NCT02326298|62999937|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33601097|NCT02326298|62999938|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33601098|NCT02326298|62999939|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33601099|NCT02326298|62999940|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33601100|NCT02326298|62999941|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33601101|NCT02326298|62999942|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33601102|NCT02326298|62999943|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33601103|NCT02326298|62999944|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33601104|NCT02326298|62999945|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33322156|NCT01193153|62698322|FG000|Open-label Lead in Period|Adverse Event|41|||
33412231|NCT03485911|62790559|FG000|Part 2|Other NOS|0|||
33322157|NCT01193153|62698323|FG001|Open-label Lead in Period|Adverse Event|0|||
33322158|NCT01193153|62698322|FG000|Open-label Lead in Period|Death|1|||
33322159|NCT01193153|62698323|FG001|Open-label Lead in Period|Death|0|||
33322160|NCT01193153|62698322|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
33412232|NCT03485911|62790560|FG001|Part 2|Other NOS|1|||
33412233|NCT03485911|62790561|FG002|Part 2|Other NOS|0|||
33412234|NCT03485911|62790562|FG003|Part 2|Other NOS|0|||
33601105|NCT02326298|62999946|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33601106|NCT02326298|62999947|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33601107|NCT02326298|62999948|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
33601108|NCT02326298|62999949|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
33601109|NCT02326298|62999950|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33601110|NCT02326298|62999937|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33601111|NCT02326298|62999938|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33601112|NCT02326298|62999939|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33601113|NCT02326298|62999940|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33601114|NCT02326298|62999941|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33601115|NCT02326298|62999942|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33601116|NCT02326298|62999943|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33601117|NCT02326298|62999944|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33601118|NCT02326298|62999945|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33601119|NCT02326298|62999946|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33601120|NCT02326298|62999947|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33601121|NCT02326298|62999948|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
33601122|NCT02326298|62999949|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
33601123|NCT02326298|62999950|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33601124|NCT02326298|62999937|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33601125|NCT02326298|62999938|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33601126|NCT02326298|62999939|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33601127|NCT02326298|62999940|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33601128|NCT02326298|62999941|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33601129|NCT02326298|62999942|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33601130|NCT02326298|62999943|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33601131|NCT02326298|62999944|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33601132|NCT02326298|62999945|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33601133|NCT02326298|62999946|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33601134|NCT02326298|62999947|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33601135|NCT02326298|62999948|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33601136|NCT02326298|62999949|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33601137|NCT02326298|62999950|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
33601138|NCT02326298|62999937|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33601139|NCT02326298|62999938|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33601140|NCT02326298|62999939|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33601141|NCT02326298|62999940|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33601142|NCT02326298|62999941|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33601143|NCT02326298|62999942|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33601144|NCT02326298|62999943|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33601145|NCT02326298|62999944|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33601146|NCT02326298|62999945|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33601147|NCT02326298|62999946|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33601148|NCT02326298|62999947|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33601149|NCT02326298|62999948|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
33412235|NCT03485911|62790559|FG000|Part 2|Intercurrent illness/new medical condition|1|||
33412236|NCT03485911|62790560|FG001|Part 2|Intercurrent illness/new medical condition|0|||
33412237|NCT03485911|62790561|FG002|Part 2|Intercurrent illness/new medical condition|0|||
33412238|NCT03485911|62790562|FG003|Part 2|Intercurrent illness/new medical condition|0|||
33412239|NCT03485911|62790559|FG000|Part 2|Investigator judgement|1|||
33412240|NCT03485911|62790560|FG001|Part 2|Investigator judgement|0|||
33412241|NCT03485911|62790561|FG002|Part 2|Investigator judgement|0|||
33412242|NCT03485911|62790562|FG003|Part 2|Investigator judgement|0|||
33412243|NCT03485911|62790559|FG000|Part 3|Perceived lack of efficacy|2|||
33412244|NCT03485911|62790560|FG001|Part 3|Perceived lack of efficacy|2|||
33412245|NCT03485911|62790561|FG002|Part 3|Perceived lack of efficacy|2|||
33412246|NCT03485911|62790562|FG003|Part 3|Perceived lack of efficacy|0|||
33412247|NCT03485911|62790559|FG000|Part 3|Subject withdrew consent|1|||
33322161|NCT01193153|62698323|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
33322162|NCT01193153|62698322|FG000|Open-label Stabilization Period|Adverse Event|9|||
33322163|NCT01193153|62698323|FG001|Open-label Stabilization Period|Adverse Event|0|||
33322164|NCT01193153|62698322|FG000|Open-label Stabilization Period|Death|2|||
33322165|NCT01193153|62698323|FG001|Open-label Stabilization Period|Death|0|||
33322166|NCT01193153|62698322|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
33322167|NCT01193153|62698323|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
33322168|NCT01193153|62698322|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
33412248|NCT03485911|62790560|FG001|Part 3|Subject withdrew consent|4|||
33412249|NCT03485911|62790561|FG002|Part 3|Subject withdrew consent|0|||
33412250|NCT03485911|62790562|FG003|Part 3|Subject withdrew consent|1|||
33412251|NCT03485911|62790559|FG000|Part 3|Lab abnormalities/AEs|1|||
33412252|NCT03485911|62790560|FG001|Part 3|Lab abnormalities/AEs|1|||
33412253|NCT03485911|62790561|FG002|Part 3|Lab abnormalities/AEs|0|||
33412254|NCT03485911|62790562|FG003|Part 3|Lab abnormalities/AEs|2|||
33412255|NCT03485911|62790559|FG000|Part 3|Other NOS|1|||
33412256|NCT03485911|62790560|FG001|Part 3|Other NOS|1|||
33412257|NCT03485911|62790561|FG002|Part 3|Other NOS|0|||
33412258|NCT03485911|62790562|FG003|Part 3|Other NOS|0|||
33412259|NCT03485911|62790559|FG000|Part 3|Intercurrent illness/new medical condition|0|||
33412260|NCT03485911|62790560|FG001|Part 3|Intercurrent illness/new medical condition|1|||
33412261|NCT03485911|62790561|FG002|Part 3|Intercurrent illness/new medical condition|1|||
33412262|NCT03485911|62790562|FG003|Part 3|Intercurrent illness/new medical condition|0|||
33412263|NCT03485911|62790559|FG000|Part 3|Sponsor discontinuation|1|||
33412264|NCT03485911|62790560|FG001|Part 3|Sponsor discontinuation|0|||
33412265|NCT03485911|62790561|FG002|Part 3|Sponsor discontinuation|0|||
33412266|NCT03485911|62790562|FG003|Part 3|Sponsor discontinuation|0|||
33412267|NCT03485911|62790559|FG000|Part 3|Berotralstat provided by alternative means|13|||
33412268|NCT03485911|62790560|FG001|Part 3|Berotralstat provided by alternative means|13|||
33412269|NCT03485911|62790561|FG002|Part 3|Berotralstat provided by alternative means|7|||
33412270|NCT03485911|62790562|FG003|Part 3|Berotralstat provided by alternative means|7|||
33412271|NCT02933489|62790621|FG000|Overall Study|Ineligible|3|||
33412272|NCT02933489|62790622|FG001|Overall Study|Ineligible|3|||
33412273|NCT02933489|62790621|FG000|Overall Study|Withdrawal by Subject|27|||
33412274|NCT02933489|62790622|FG001|Overall Study|Withdrawal by Subject|18|||
33412275|NCT02933489|62790621|FG000|Overall Study|Unable to complete exams (other)|14|||
33412276|NCT02933489|62790622|FG001|Overall Study|Unable to complete exams (other)|7|||
33412277|NCT02886936|62790658|FG000|Overall Study|Lost to Follow-up|4|||
33412278|NCT02886936|62790659|FG001|Overall Study|Lost to Follow-up|3|||
33412279|NCT02886936|62790660|FG002|Overall Study|Lost to Follow-up|0|||
33412280|NCT02589522|62790673|FG000|Overall Study|Physician Decision|1|||
33412281|NCT02589522|62790674|FG001|Overall Study|Physician Decision|2|||
33412282|NCT02589522|62790675|FG002|Overall Study|Physician Decision|0|||
33412283|NCT02589522|62790673|FG000|Overall Study|Did not start treatment|1|||
33412284|NCT02589522|62790674|FG001|Overall Study|Did not start treatment|0|||
33412285|NCT02589522|62790675|FG002|Overall Study|Did not start treatment|0|||
33412286|NCT02162511|62790708|FG000|Overall Study|Lack of Efficacy|0|||
33412287|NCT02162511|62790709|FG001|Overall Study|Lack of Efficacy|0|||
33412288|NCT02162511|62790710|FG002|Overall Study|Lack of Efficacy|2|||
33601150|NCT02326298|62999949|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
33601151|NCT02326298|62999950|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
33601152|NCT02326298|62999937|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33601153|NCT02326298|62999938|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33601154|NCT02326298|62999939|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33601155|NCT02326298|62999940|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33601156|NCT02326298|62999941|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33601157|NCT02326298|62999942|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33601158|NCT02326298|62999943|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33601159|NCT02326298|62999944|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33601160|NCT02326298|62999945|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33601161|NCT02326298|62999946|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33601162|NCT02326298|62999947|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33412294|NCT00539994|62790779|FG000|Overall Study|Lost to Follow-up|2|||
33412295|NCT00539994|62790780|FG001|Overall Study|Lost to Follow-up|1|||
33412296|NCT00539994|62790781|FG002|Overall Study|Lost to Follow-up|0|||
33412297|NCT00539994|62790779|FG000|Overall Study|Withdrawal by Subject|1|||
33412298|NCT00539994|62790780|FG001|Overall Study|Withdrawal by Subject|0|||
33412299|NCT00539994|62790781|FG002|Overall Study|Withdrawal by Subject|1|||
33412300|NCT00539994|62790779|FG000|Overall Study|Physician Decision|0|||
33412301|NCT00539994|62790780|FG001|Overall Study|Physician Decision|0|||
33412302|NCT00539994|62790781|FG002|Overall Study|Physician Decision|1|||
33412303|NCT00098839|62790798|FG000|Overall Study|Adverse Event|5|||
33412304|NCT00098839|62790799|FG001|Overall Study|Adverse Event|2|||
33412305|NCT00098839|62790798|FG000|Overall Study|Death|1|||
33412306|NCT00098839|62790799|FG001|Overall Study|Death|2|||
33412307|NCT00098839|62790798|FG000|Overall Study|Physician Decision|4|||
33412308|NCT00098839|62790799|FG001|Overall Study|Physician Decision|14|||
33494060|NCT03473340|62872721|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
33601163|NCT02326298|62999948|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
33601164|NCT02326298|62999949|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
33601165|NCT02326298|62999950|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
33601166|NCT02326298|62999937|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33601167|NCT02326298|62999938|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33601168|NCT02326298|62999939|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33601169|NCT02326298|62999940|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33601170|NCT02326298|62999941|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33601171|NCT02326298|62999942|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33601172|NCT02326298|62999943|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33601173|NCT02326298|62999944|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33601174|NCT02326298|62999945|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33601175|NCT02326298|62999946|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33601176|NCT02326298|62999947|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33601177|NCT02326298|62999948|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
33322169|NCT01193153|62698323|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
33322170|NCT01193153|62698322|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
33322171|NCT01193153|62698323|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
33322172|NCT01193153|62698322|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
33322173|NCT01193153|62698323|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
33322174|NCT01193153|62698322|FG000|Open-label Stabilization Period|Other|8|||
33322175|NCT01193153|62698323|FG001|Open-label Stabilization Period|Other|0|||
33322176|NCT01193153|62698322|FG000|Double Blind Relapse Prevention Period|Other|2|||
33322177|NCT01193153|62698323|FG001|Double Blind Relapse Prevention Period|Other|3|||
33322178|NCT01193153|62698322|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
33322179|NCT01193153|62698323|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
33322180|NCT01193153|62698322|FG000|Double Blind Relapse Prevention Period|Death|2|||
33322181|NCT01193153|62698323|FG001|Double Blind Relapse Prevention Period|Death|0|||
33412309|NCT00098839|62790798|FG000|Overall Study|Withdrawal by Subject|1|||
33412310|NCT00098839|62790799|FG001|Overall Study|Withdrawal by Subject|0|||
33412311|NCT00098839|62790798|FG000|Overall Study|Refusal of further protocol therapy|3|||
33412312|NCT00098839|62790799|FG001|Overall Study|Refusal of further protocol therapy|1|||
33412313|NCT00098839|62790798|FG000|Overall Study|Relapse|6|||
33412314|NCT00098839|62790799|FG001|Overall Study|Relapse|3|||
33412315|NCT00098839|62790798|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
33412316|NCT00098839|62790799|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
33412317|NCT00098839|62790798|FG000|Overall Study|Ineligible|2|||
33412318|NCT00098839|62790799|FG001|Overall Study|Ineligible|0|||
33412319|NCT03811093|62790808|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
33412320|NCT03811093|62790809|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
33412321|NCT03811093|62790808|FG000|Overall Study|Unable to measure body fat percentage|2|||
33412322|NCT03811093|62790809|FG001|Overall Study|Unable to measure body fat percentage|0|||
33412323|NCT00485589|62790821|FG000|Overall Study|Death|2|||
33412324|NCT00485589|62790822|FG001|Overall Study|Death|2|||
33412325|NCT00485589|62790823|FG002|Overall Study|Death|0|||
33412326|NCT00485589|62790821|FG000|Overall Study|Failure to return|6|||
33412327|NCT00485589|62790822|FG001|Overall Study|Failure to return|5|||
33412328|NCT00485589|62790823|FG002|Overall Study|Failure to return|1|||
33412329|NCT00485589|62790821|FG000|Overall Study|Protocol Violation|1|||
33601178|NCT02326298|62999949|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
33601179|NCT02326298|62999950|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
33601180|NCT02396420|62999959|FG000|Overall Study|Death|1|||
33601181|NCT02279719|62999971|FG000|Overall Study|Patients randomized but never treated|0|||
33601182|NCT02279719|62999972|FG001|Overall Study|Patients randomized but never treated|0|||
33601183|NCT02279719|62999973|FG002|Overall Study|Patients randomized but never treated|0|||
33412330|NCT00485589|62790822|FG001|Overall Study|Protocol Violation|0|||
33412331|NCT00485589|62790823|FG002|Overall Study|Protocol Violation|0|||
33412332|NCT00485589|62790821|FG000|Overall Study|Violation of selection criteria at entry|0|||
33412333|NCT00485589|62790822|FG001|Overall Study|Violation of selection criteria at entry|3|||
33412334|NCT00485589|62790823|FG002|Overall Study|Violation of selection criteria at entry|1|||
33601184|NCT02279719|62999974|FG003|Overall Study|Patients randomized but never treated|0|||
33601185|NCT02279719|62999975|FG004|Overall Study|Patients randomized but never treated|3|||
33601186|NCT02279719|62999976|FG005|Overall Study|Patients randomized but never treated|0|||
33601187|NCT02279719|62999977|FG006|Overall Study|Patients randomized but never treated|3|||
33601188|NCT02279407|63000014|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
33601189|NCT02279407|63000015|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
33601190|NCT02279407|63000016|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
33601191|NCT02279407|63000017|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
33601192|NCT02279407|63000014|FG000|Overall Study|Withdrawal by Subject|1|||
33601193|NCT02279407|63000015|FG001|Overall Study|Withdrawal by Subject|0|||
33601194|NCT02279407|63000016|FG002|Overall Study|Withdrawal by Subject|1|||
33601195|NCT02279407|63000017|FG003|Overall Study|Withdrawal by Subject|1|||
33601196|NCT02279407|63000014|FG000|Overall Study|Adverse Event|1|||
33601197|NCT02279407|63000015|FG001|Overall Study|Adverse Event|1|||
33601198|NCT02279407|63000016|FG002|Overall Study|Adverse Event|2|||
33601199|NCT02279407|63000017|FG003|Overall Study|Adverse Event|0|||
33601200|NCT02326220|63000029|FG000|Double-blind Treatment Period|Adverse Event|1|||
33601201|NCT02326220|63000030|FG001|Double-blind Treatment Period|Adverse Event|2|||
33601202|NCT02326220|63000031|FG002|Double-blind Treatment Period|Adverse Event|0|||
33601203|NCT02326220|63000029|FG000|Double-blind Treatment Period|Protocol Violation|0|||
33601204|NCT02326220|63000030|FG001|Double-blind Treatment Period|Protocol Violation|1|||
33601205|NCT02326220|63000031|FG002|Double-blind Treatment Period|Protocol Violation|0|||
33601206|NCT02326220|63000029|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
33601207|NCT02326220|63000030|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
33601208|NCT02326220|63000031|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33601209|NCT02326220|63000029|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
33601210|NCT02326220|63000030|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
33601211|NCT02326220|63000031|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
33601212|NCT02326220|63000029|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
33601213|NCT02326220|63000030|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
33601214|NCT02326220|63000031|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
33601215|NCT02279173|63000041|FG000|Overall Study|Protocol-specified Criteria|67|||
33601216|NCT02279173|63000041|FG000|Overall Study|Withdrawal by Subject|20|||
33601217|NCT02279173|63000041|FG000|Overall Study|Decision by Sponsor|4|||
33601218|NCT02279173|63000041|FG000|Overall Study|Lost to Follow-up|3|||
33601219|NCT02282917|63000047|FG000|Overall Study|Withdrawal by Subject|1|||
33601220|NCT02282917|63000047|FG000|Overall Study|Screen Failure/Not Eligible|1|||
33601221|NCT02358668|63000054|FG000|Overall Study|Adverse Event|2|||
33601222|NCT02358668|63000055|FG001|Overall Study|Adverse Event|0|||
33601223|NCT02358668|63000056|FG002|Overall Study|Adverse Event|0|||
33601224|NCT02358668|63000054|FG000|Overall Study|Withdrawal by Subject|0|||
33601225|NCT02358668|63000055|FG001|Overall Study|Withdrawal by Subject|1|||
33601226|NCT02358668|63000056|FG002|Overall Study|Withdrawal by Subject|0|||
33601227|NCT02282605|63000067|FG000|Overall Study|negative SA result on Day -1|3|||
33601228|NCT02282605|63000068|FG001|Overall Study|negative SA result on Day -1|0|||
33601229|NCT02282605|63000069|FG002|Overall Study|negative SA result on Day -1|0|||
33601230|NCT02282527|63000079|FG000|Overall Study|Lost to Follow-up|0|||
33601231|NCT02282527|63000080|FG001|Overall Study|Lost to Follow-up|1|||
33601232|NCT02282527|63000079|FG000|Overall Study|Lack of home health aid|1|||
33601233|NCT02282527|63000080|FG001|Overall Study|Lack of home health aid|0|||
33601234|NCT02278939|63000091|FG000|Overall Study|lack of time|1|||
33601235|NCT02278939|63000092|FG001|Overall Study|lack of time|0|||
33601236|NCT02278939|63000091|FG000|Overall Study|Lost to Follow-up|1|||
33601237|NCT02278939|63000092|FG001|Overall Study|Lost to Follow-up|1|||
33601238|NCT02278939|63000091|FG000|Overall Study|death in family|1|||
33601239|NCT02278939|63000092|FG001|Overall Study|death in family|0|||
33601240|NCT02278939|63000091|FG000|Overall Study|family emergency unable to commit|2|||
33601241|NCT02278939|63000092|FG001|Overall Study|family emergency unable to commit|0|||
33601242|NCT02278471|63000100|FG000|Overall Study|Lost to Follow-up|6|||
33601243|NCT02278471|63000101|FG001|Overall Study|Lost to Follow-up|15|||
33601244|NCT02278471|63000100|FG000|Overall Study|Death|2|||
33601245|NCT02278471|63000101|FG001|Overall Study|Death|2|||
33601246|NCT02278471|63000100|FG000|Overall Study|Withdrawal by Subject|0|||
33601247|NCT02278471|63000101|FG001|Overall Study|Withdrawal by Subject|3|||
33601248|NCT02278003|63000110|FG000|Overall Study|Withdrawal by Subject|11|||
33601249|NCT02278003|63000111|FG001|Overall Study|Withdrawal by Subject|0|||
33601250|NCT02278003|63000110|FG000|Overall Study|Not Treated|1|||
33601251|NCT02278003|63000111|FG001|Overall Study|Not Treated|0|||
33601252|NCT02278003|63000110|FG000|Overall Study|Recognition task improperly completed|7|||
33601253|NCT02278003|63000111|FG001|Overall Study|Recognition task improperly completed|0|||
33601254|NCT02277769|63000120|FG000|Overall Study|Protocol Violation|3|||
33601255|NCT02277769|63000121|FG001|Overall Study|Protocol Violation|3|||
33601256|NCT02277769|63000122|FG002|Overall Study|Protocol Violation|5|||
33601257|NCT02277769|63000120|FG000|Overall Study|Lack of Efficacy|17|||
33601258|NCT02277769|63000121|FG001|Overall Study|Lack of Efficacy|0|||
33601259|NCT02277769|63000122|FG002|Overall Study|Lack of Efficacy|4|||
33601260|NCT02277769|63000120|FG000|Overall Study|Adverse Event|14|||
33601261|NCT02277769|63000121|FG001|Overall Study|Adverse Event|2|||
33601262|NCT02277769|63000122|FG002|Overall Study|Adverse Event|4|||
33601263|NCT02277769|63000120|FG000|Overall Study|Other than specified above|12|||
33601264|NCT02277769|63000121|FG001|Overall Study|Other than specified above|8|||
33601265|NCT02277769|63000122|FG002|Overall Study|Other than specified above|5|||
33601266|NCT01641991|63000134|FG000|Overall Study|Physician Decision|0|||
33601267|NCT01641991|63000135|FG001|Overall Study|Physician Decision|1|||
33601268|NCT01641991|63000136|FG002|Overall Study|Physician Decision|7|||
33601269|NCT01641991|63000137|FG003|Overall Study|Physician Decision|5|||
33601270|NCT01641991|63000134|FG000|Overall Study|Withdrawal by Subject|4|||
33601271|NCT01641991|63000135|FG001|Overall Study|Withdrawal by Subject|2|||
33601272|NCT01641991|63000136|FG002|Overall Study|Withdrawal by Subject|1|||
33601273|NCT01641991|63000137|FG003|Overall Study|Withdrawal by Subject|5|||
33601274|NCT01641991|63000134|FG000|Overall Study|Adverse Event|2|||
33601275|NCT01641991|63000135|FG001|Overall Study|Adverse Event|1|||
33601276|NCT01641991|63000136|FG002|Overall Study|Adverse Event|2|||
33601277|NCT01641991|63000137|FG003|Overall Study|Adverse Event|1|||
33601278|NCT01641991|63000134|FG000|Overall Study|Lost to Follow-up|0|||
33601279|NCT01641991|63000135|FG001|Overall Study|Lost to Follow-up|2|||
33601280|NCT01641991|63000136|FG002|Overall Study|Lost to Follow-up|3|||
33601281|NCT01641991|63000137|FG003|Overall Study|Lost to Follow-up|1|||
33601282|NCT01641991|63000134|FG000|Overall Study|Protocol Violation|1|||
33601283|NCT01641991|63000135|FG001|Overall Study|Protocol Violation|1|||
33601284|NCT01641991|63000136|FG002|Overall Study|Protocol Violation|3|||
33601285|NCT01641991|63000137|FG003|Overall Study|Protocol Violation|0|||
33601286|NCT01641991|63000134|FG000|Overall Study|Pregnancy|0|||
33601287|NCT01641991|63000135|FG001|Overall Study|Pregnancy|0|||
33601288|NCT01641991|63000136|FG002|Overall Study|Pregnancy|1|||
33601289|NCT01641991|63000137|FG003|Overall Study|Pregnancy|0|||
33601290|NCT01641991|63000134|FG000|Overall Study|no longer eligible|2|||
33601291|NCT01641991|63000135|FG001|Overall Study|no longer eligible|1|||
33601292|NCT01641991|63000136|FG002|Overall Study|no longer eligible|0|||
33601293|NCT01641991|63000137|FG003|Overall Study|no longer eligible|4|||
33601294|NCT02277691|63000150|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
33601295|NCT02277691|63000150|FG000|Overall Study|Voluntary Withdrawal|7|||
33601296|NCT02277691|63000150|FG000|Overall Study|Lack of Efficacy|5|||
33601297|NCT02277691|63000150|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
33601298|NCT02395172|63000156|FG000|Overall Study|Participants randomized but not treated|3|||
33601299|NCT02395172|63000157|FG001|Overall Study|Participants randomized but not treated|31|||
33601300|NCT02276053|63000163|FG000|Overall Study|Death|2|||
33601301|NCT02276053|63000163|FG000|Overall Study|Adverse Event|5|||
33601302|NCT02276053|63000163|FG000|Overall Study|Lack of Efficacy|2|||
33601303|NCT02276053|63000163|FG000|Overall Study|Withdrawal by Subject|1|||
33601304|NCT02276053|63000163|FG000|Overall Study|Patient does not meet selection criteria|3|||
33601305|NCT02276053|63000163|FG000|Overall Study|Patient needs to increase baseline AED|1|||
33601306|NCT02275819|63000170|FG000|Overall Study|Adverse Event|0|||
33601307|NCT02275819|63000171|FG001|Overall Study|Adverse Event|1|||
33601308|NCT02358044|63000179|FG000|Overall Study|Adverse Event|0|||
33601309|NCT02358044|63000180|FG001|Overall Study|Adverse Event|1|||
33601310|NCT02358044|63000179|FG000|Overall Study|Lost to Follow-up|2|||
33601311|NCT02358044|63000180|FG001|Overall Study|Lost to Follow-up|1|||
33601312|NCT02358044|63000179|FG000|Overall Study|Physician Decision|0|||
33601313|NCT02358044|63000180|FG001|Overall Study|Physician Decision|1|||
33601314|NCT02358044|63000179|FG000|Overall Study|Withdrawal by Subject|0|||
33601315|NCT02358044|63000180|FG001|Overall Study|Withdrawal by Subject|4|||
33601316|NCT02275117|63000191|FG000|Overall Study|Adverse Event|0|||
33601317|NCT02275117|63000192|FG001|Overall Study|Adverse Event|0|||
33601318|NCT02275117|63000193|FG002|Overall Study|Adverse Event|0|||
33601319|NCT02275117|63000194|FG003|Overall Study|Adverse Event|0|||
33601320|NCT02275117|63000195|FG004|Overall Study|Adverse Event|1|||
33601321|NCT02275117|63000191|FG000|Overall Study|Lack of Efficacy|6|||
33601322|NCT02275117|63000192|FG001|Overall Study|Lack of Efficacy|7|||
33601323|NCT02275117|63000193|FG002|Overall Study|Lack of Efficacy|5|||
33601324|NCT02275117|63000194|FG003|Overall Study|Lack of Efficacy|2|||
33601325|NCT02275117|63000195|FG004|Overall Study|Lack of Efficacy|10|||
33601326|NCT02275117|63000191|FG000|Overall Study|Lost to Follow-up|11|||
33601327|NCT02275117|63000192|FG001|Overall Study|Lost to Follow-up|16|||
33601328|NCT02275117|63000193|FG002|Overall Study|Lost to Follow-up|15|||
33601329|NCT02275117|63000194|FG003|Overall Study|Lost to Follow-up|16|||
33601330|NCT02275117|63000195|FG004|Overall Study|Lost to Follow-up|8|||
33601331|NCT02275117|63000191|FG000|Overall Study|Physician Decision|0|||
33601332|NCT02275117|63000192|FG001|Overall Study|Physician Decision|1|||
33601333|NCT02275117|63000193|FG002|Overall Study|Physician Decision|1|||
33601334|NCT02275117|63000194|FG003|Overall Study|Physician Decision|0|||
33601335|NCT02275117|63000195|FG004|Overall Study|Physician Decision|1|||
33601336|NCT02275117|63000191|FG000|Overall Study|Protocol Violation|1|||
33601337|NCT02275117|63000192|FG001|Overall Study|Protocol Violation|0|||
33601338|NCT02275117|63000193|FG002|Overall Study|Protocol Violation|1|||
33601339|NCT02275117|63000194|FG003|Overall Study|Protocol Violation|1|||
33601340|NCT02275117|63000195|FG004|Overall Study|Protocol Violation|0|||
33601341|NCT02275117|63000191|FG000|Overall Study|Withdrawal by Subject|6|||
33601342|NCT02275117|63000192|FG001|Overall Study|Withdrawal by Subject|4|||
33601343|NCT02275117|63000193|FG002|Overall Study|Withdrawal by Subject|7|||
33601344|NCT02275117|63000194|FG003|Overall Study|Withdrawal by Subject|3|||
33601345|NCT02275117|63000195|FG004|Overall Study|Withdrawal by Subject|3|||
33601346|NCT02275117|63000191|FG000|Overall Study|Terminated by Sponsor|4|||
33601347|NCT02275117|63000192|FG001|Overall Study|Terminated by Sponsor|4|||
33601348|NCT02275117|63000193|FG002|Overall Study|Terminated by Sponsor|4|||
33601349|NCT02275117|63000194|FG003|Overall Study|Terminated by Sponsor|6|||
33601350|NCT02275117|63000195|FG004|Overall Study|Terminated by Sponsor|4|||
33601351|NCT02275117|63000191|FG000|Overall Study|Worsening of Study Indication|0|||
33601352|NCT02275117|63000192|FG001|Overall Study|Worsening of Study Indication|1|||
33601353|NCT02275117|63000193|FG002|Overall Study|Worsening of Study Indication|2|||
33601354|NCT02275117|63000194|FG003|Overall Study|Worsening of Study Indication|0|||
33601355|NCT02275117|63000195|FG004|Overall Study|Worsening of Study Indication|0|||
33601356|NCT02275117|63000191|FG000|Overall Study|Study Burden|5|||
33601357|NCT02275117|63000192|FG001|Overall Study|Study Burden|4|||
33601358|NCT02275117|63000193|FG002|Overall Study|Study Burden|7|||
33601359|NCT02275117|63000194|FG003|Overall Study|Study Burden|5|||
33601360|NCT02275117|63000195|FG004|Overall Study|Study Burden|7|||
33601361|NCT02275117|63000191|FG000|Overall Study|Other|1|||
33601362|NCT02275117|63000192|FG001|Overall Study|Other|0|||
33601363|NCT02275117|63000193|FG002|Overall Study|Other|0|||
33601364|NCT02275117|63000194|FG003|Overall Study|Other|0|||
33601365|NCT02275117|63000195|FG004|Overall Study|Other|2|||
33601366|NCT02274493|63000207|FG000|Overall Study|Withdrawal by Subject|1|||
33601367|NCT02273167|63000214|FG000|Overall Study|Adverse Event|1|||
33601368|NCT02273167|63000215|FG001|Overall Study|Adverse Event|0|||
33601369|NCT02273167|63000216|FG002|Overall Study|Adverse Event|0|||
33601370|NCT02273167|63000214|FG000|Overall Study|Protocol Violation|3|||
33601371|NCT02273167|63000215|FG001|Overall Study|Protocol Violation|1|||
33601372|NCT02273167|63000216|FG002|Overall Study|Protocol Violation|1|||
33601373|NCT02273167|63000214|FG000|Overall Study|Lost to Follow-up|0|||
33601374|NCT02273167|63000215|FG001|Overall Study|Lost to Follow-up|1|||
33601375|NCT02273167|63000216|FG002|Overall Study|Lost to Follow-up|1|||
33601376|NCT02273167|63000214|FG000|Overall Study|Withdrawal by Subject|10|||
33601377|NCT02273167|63000215|FG001|Overall Study|Withdrawal by Subject|12|||
33601378|NCT02273167|63000216|FG002|Overall Study|Withdrawal by Subject|11|||
33601379|NCT02273167|63000214|FG000|Overall Study|Various|10|||
33601380|NCT02273167|63000215|FG001|Overall Study|Various|9|||
33601381|NCT02273167|63000216|FG002|Overall Study|Various|8|||
33601382|NCT02272777|63000227|FG000|Overall Study|Adverse Event|0|||
33601383|NCT02272777|63000228|FG001|Overall Study|Adverse Event|1|||
33601384|NCT02272777|63000227|FG000|Overall Study|Withdrawal by Subject|0|||
33601385|NCT02272777|63000228|FG001|Overall Study|Withdrawal by Subject|3|||
33601386|NCT02272777|63000227|FG000|Overall Study|Lost to Follow-up|2|||
33601387|NCT02272777|63000228|FG001|Overall Study|Lost to Follow-up|0|||
33601388|NCT02272777|63000227|FG000|Overall Study|Other|2|||
33601389|NCT02272777|63000228|FG001|Overall Study|Other|0|||
33601390|NCT02357810|63000234|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
33601391|NCT02357810|63000234|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
33601392|NCT02357810|63000234|FG000|Reached 12 Weeks Response|Adverse Event|5|||
33601393|NCT02357810|63000234|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
33601394|NCT02357810|63000234|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
33601395|NCT02357810|63000234|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
33601396|NCT02357810|63000234|FG000|Reached 12 Weeks Response|Death|1|||
33601397|NCT02357810|63000234|FG000|Reached 12 Weeks Response|Physician Decision|1|||
33601398|NCT02357810|63000234|FG000|Reached 12 Weeks Response|Other|1|||
33601399|NCT02357810|63000234|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
33601400|NCT02357810|63000234|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
33601401|NCT02357810|63000234|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
33601402|NCT02357810|63000234|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
33601403|NCT02357810|63000234|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
33601404|NCT02357810|63000234|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
33601405|NCT02357576|63000240|FG000|Treatment Period|Withdrawal by Subject|0|||
33601406|NCT02357576|63000241|FG001|Treatment Period|Withdrawal by Subject|1|||
33601407|NCT02357576|63000240|FG000|Treatment Period|Physician Decision|0|||
33601408|NCT02357576|63000241|FG001|Treatment Period|Physician Decision|1|||
33601409|NCT02357576|63000240|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
33601410|NCT02357576|63000241|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
33601411|NCT02357576|63000240|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
33601412|NCT02357576|63000241|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
33601413|NCT02357576|63000240|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
33601414|NCT02357576|63000241|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
33601415|NCT02357576|63000240|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
33601416|NCT02357576|63000241|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
33601417|NCT01850446|63000249|FG000|Overall Study|Lack of Efficacy|1|||
33601418|NCT01850446|63000250|FG001|Overall Study|Lack of Efficacy|0|||
33601419|NCT01850446|63000249|FG000|Overall Study|Withdrawal by Subject|4|||
33601420|NCT01850446|63000250|FG001|Overall Study|Withdrawal by Subject|0|||
33601421|NCT01850446|63000249|FG000|Overall Study|Protocol Violation|0|||
33601422|NCT01850446|63000250|FG001|Overall Study|Protocol Violation|2|||
33601423|NCT02465567|63000260|FG000|Overall Study|Adverse Event|118|||
33601424|NCT02465567|63000261|FG001|Overall Study|Adverse Event|113|||
33601425|NCT02465567|63000262|FG002|Overall Study|Adverse Event|147|||
33601426|NCT02465567|63000263|FG003|Overall Study|Adverse Event|138|||
33601427|NCT02465567|63000260|FG000|Overall Study|Lack of Efficacy|103|||
33601428|NCT02465567|63000261|FG001|Overall Study|Lack of Efficacy|102|||
33601429|NCT02465567|63000262|FG002|Overall Study|Lack of Efficacy|171|||
33601430|NCT02465567|63000263|FG003|Overall Study|Lack of Efficacy|135|||
33601431|NCT02465567|63000260|FG000|Overall Study|Withdrawal by Subject|104|||
33601432|NCT02465567|63000261|FG001|Overall Study|Withdrawal by Subject|94|||
33601433|NCT02465567|63000262|FG002|Overall Study|Withdrawal by Subject|123|||
33601434|NCT02465567|63000263|FG003|Overall Study|Withdrawal by Subject|130|||
33601435|NCT02465567|63000260|FG000|Overall Study|Physician Decision|23|||
33601436|NCT02465567|63000261|FG001|Overall Study|Physician Decision|33|||
33601437|NCT02465567|63000262|FG002|Overall Study|Physician Decision|38|||
33601438|NCT02465567|63000263|FG003|Overall Study|Physician Decision|28|||
33601439|NCT02465567|63000260|FG000|Overall Study|Major Protocol Deviation|24|||
33601440|NCT02465567|63000261|FG001|Overall Study|Major Protocol Deviation|26|||
33601441|NCT02465567|63000262|FG002|Overall Study|Major Protocol Deviation|22|||
33601442|NCT02465567|63000263|FG003|Overall Study|Major Protocol Deviation|25|||
33601443|NCT02465567|63000260|FG000|Overall Study|Lost to Follow-up|25|||
33601444|NCT02465567|63000261|FG001|Overall Study|Lost to Follow-up|21|||
33601445|NCT02465567|63000262|FG002|Overall Study|Lost to Follow-up|19|||
33601446|NCT02465567|63000263|FG003|Overall Study|Lost to Follow-up|15|||
33601447|NCT02465567|63000260|FG000|Overall Study|Protocol Specified Criteria|20|||
33601448|NCT02465567|63000261|FG001|Overall Study|Protocol Specified Criteria|10|||
33601449|NCT02465567|63000262|FG002|Overall Study|Protocol Specified Criteria|9|||
33601450|NCT02465567|63000263|FG003|Overall Study|Protocol Specified Criteria|12|||
33601451|NCT02465567|63000260|FG000|Overall Study|Administrative Reasons|12|||
33601452|NCT02465567|63000261|FG001|Overall Study|Administrative Reasons|9|||
33601453|NCT02465567|63000262|FG002|Overall Study|Administrative Reasons|11|||
33601454|NCT02465567|63000263|FG003|Overall Study|Administrative Reasons|5|||
33601455|NCT02465567|63000260|FG000|Overall Study|Randomized but not treated|1|||
33601456|NCT02465567|63000261|FG001|Overall Study|Randomized but not treated|5|||
33601457|NCT02465567|63000262|FG002|Overall Study|Randomized but not treated|4|||
33601458|NCT02465567|63000263|FG003|Overall Study|Randomized but not treated|5|||
33601459|NCT02465567|63000260|FG000|Overall Study|enrolled in >1 studies|18|||
33601460|NCT02465567|63000261|FG001|Overall Study|enrolled in >1 studies|11|||
33601461|NCT02465567|63000262|FG002|Overall Study|enrolled in >1 studies|19|||
33601462|NCT02465567|63000263|FG003|Overall Study|enrolled in >1 studies|15|||
33601463|NCT02465567|63000260|FG000|Overall Study|missing PI Signature|1|||
33601464|NCT02465567|63000261|FG001|Overall Study|missing PI Signature|0|||
33601465|NCT02465567|63000262|FG002|Overall Study|missing PI Signature|0|||
33601466|NCT02465567|63000263|FG003|Overall Study|missing PI Signature|0|||
33601467|NCT01644175|63000275|FG000|Overall Study|Randomized But Not Treated|0|||
33601468|NCT01644175|63000276|FG001|Overall Study|Randomized But Not Treated|2|||
33601469|NCT01644175|63000275|FG000|Overall Study|Adverse Event|8|||
33601470|NCT01644175|63000276|FG001|Overall Study|Adverse Event|13|||
33601471|NCT01644175|63000275|FG000|Overall Study|Death|1|||
33601472|NCT01644175|63000276|FG001|Overall Study|Death|2|||
33601473|NCT01644175|63000275|FG000|Overall Study|Poor compliance to protocol|9|||
33601474|NCT01644175|63000276|FG001|Overall Study|Poor compliance to protocol|10|||
33601475|NCT01644175|63000275|FG000|Overall Study|Physician Decision|1|||
33601476|NCT01644175|63000276|FG001|Overall Study|Physician Decision|2|||
33601477|NCT01644175|63000275|FG000|Overall Study|Participant Moved|1|||
33601478|NCT01644175|63000276|FG001|Overall Study|Participant Moved|2|||
33601479|NCT01644175|63000275|FG000|Overall Study|Consent withdrawn by participant|3|||
33601480|NCT01644175|63000276|FG001|Overall Study|Consent withdrawn by participant|4|||
33601481|NCT01644175|63000275|FG000|Overall Study|Related to Autoinjector Administration|2|||
33601482|NCT01644175|63000276|FG001|Overall Study|Related to Autoinjector Administration|1|||
33601483|NCT01644175|63000275|FG000|Overall Study|Last visit outside protocol visit window|4|||
33601484|NCT01644175|63000276|FG001|Overall Study|Last visit outside protocol visit window|11|||
33601485|NCT01644175|63000275|FG000|Overall Study|Selection criteria finally not met|0|||
33601486|NCT01644175|63000276|FG001|Overall Study|Selection criteria finally not met|1|||
33601487|NCT01644175|63000275|FG000|Overall Study|Site closure|2|||
33601488|NCT01644175|63000276|FG001|Overall Study|Site closure|2|||
33601489|NCT01644175|63000275|FG000|Overall Study|Lost to Follow-up|1|||
33601490|NCT01644175|63000276|FG001|Overall Study|Lost to Follow-up|0|||
33601491|NCT01644175|63000275|FG000|Overall Study|Other than specified above|0|||
33601492|NCT01644175|63000276|FG001|Overall Study|Other than specified above|3|||
33601493|NCT02357420|63000286|FG000|Overall Study|Adverse Event|3|||
33601494|NCT02357420|63000287|FG001|Overall Study|Adverse Event|3|||
33601495|NCT02357420|63000288|FG002|Overall Study|Adverse Event|8|||
33601496|NCT02357420|63000289|FG003|Overall Study|Adverse Event|9|||
33601497|NCT02357420|63000286|FG000|Overall Study|Investigator Decision|1|||
33601498|NCT02357420|63000287|FG001|Overall Study|Investigator Decision|0|||
33601499|NCT02357420|63000288|FG002|Overall Study|Investigator Decision|0|||
33601500|NCT02357420|63000289|FG003|Overall Study|Investigator Decision|0|||
33412335|NCT00485589|62790821|FG000|Overall Study|Administrative/Other|1|||
33412336|NCT00485589|62790822|FG001|Overall Study|Administrative/Other|2|||
33412337|NCT00485589|62790823|FG002|Overall Study|Administrative/Other|1|||
33412338|NCT00485589|62790821|FG000|Overall Study|Insufficient therapeutic response|10|||
33601501|NCT02357420|63000286|FG000|Overall Study|Prohibited Medication|1|||
33601502|NCT02357420|63000287|FG001|Overall Study|Prohibited Medication|1|||
33601503|NCT02357420|63000288|FG002|Overall Study|Prohibited Medication|0|||
33601504|NCT02357420|63000289|FG003|Overall Study|Prohibited Medication|0|||
33601505|NCT02357420|63000286|FG000|Overall Study|Protocol Non-compliance|0|||
33601506|NCT02357420|63000287|FG001|Overall Study|Protocol Non-compliance|0|||
33601507|NCT02357420|63000288|FG002|Overall Study|Protocol Non-compliance|0|||
33601508|NCT02357420|63000289|FG003|Overall Study|Protocol Non-compliance|1|||
33601509|NCT02357420|63000286|FG000|Overall Study|Withdrawn Consent|4|||
33601510|NCT02357420|63000287|FG001|Overall Study|Withdrawn Consent|8|||
33601511|NCT02357420|63000288|FG002|Overall Study|Withdrawn Consent|6|||
33601512|NCT02357420|63000289|FG003|Overall Study|Withdrawn Consent|6|||
33412339|NCT00485589|62790822|FG001|Overall Study|Insufficient therapeutic response|3|||
33601513|NCT02357420|63000286|FG000|Overall Study|Lost to Follow-up|3|||
33601514|NCT02357420|63000287|FG001|Overall Study|Lost to Follow-up|0|||
33601515|NCT02357420|63000288|FG002|Overall Study|Lost to Follow-up|2|||
33601516|NCT02357420|63000289|FG003|Overall Study|Lost to Follow-up|3|||
33601517|NCT01832038|63000299|FG000|Overall Study|Death|5|||
33601518|NCT01832038|63000299|FG000|Overall Study|Adverse Event|50|||
33601519|NCT01832038|63000299|FG000|Overall Study|Lack of Efficacy|81|||
33601520|NCT01832038|63000299|FG000|Overall Study|Protocol Violation|7|||
33601521|NCT01832038|63000299|FG000|Overall Study|Lost to Follow-up|10|||
33601522|NCT01832038|63000299|FG000|Overall Study|Withdrawal by Subject|49|||
33601523|NCT01832038|63000299|FG000|Overall Study|Visit non-compliance|2|||
33601524|NCT01832038|63000299|FG000|Overall Study|Subject refused to return visit|2|||
33601525|NCT01832038|63000299|FG000|Overall Study|Not convenient to come back to site|2|||
33601526|NCT01832038|63000299|FG000|Overall Study|Participant was asked to quit|5|||
33601527|NCT01832038|63000299|FG000|Overall Study|Back home|1|||
33601528|NCT01832038|63000299|FG000|Overall Study|Pregnancy|1|||
33601529|NCT01832038|63000299|FG000|Overall Study|Low compliance|3|||
33601530|NCT01832038|63000299|FG000|Overall Study|Prohibit procedure|2|||
33601531|NCT01832038|63000299|FG000|Overall Study|Not possible to visit the hospital|1|||
33601532|NCT01832038|63000299|FG000|Overall Study|Changes of implementation system|3|||
33601533|NCT01832038|63000299|FG000|Overall Study|Plan to pregnancy|7|||
33601534|NCT01832038|63000299|FG000|Overall Study|Bad mood and has suicidal thought|1|||
33601535|NCT01832038|63000299|FG000|Overall Study|Prohibited concomitant medication|1|||
33601536|NCT01832038|63000299|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
33601537|NCT01832038|63000299|FG000|Overall Study|Subject considered the efficacy was poor|1|||
33601538|NCT01849588|63000304|FG000|Overall Study|Lack of Efficacy|3|||
33601539|NCT02357342|63000310|FG000|First 6 Months|Death|2|||
33601540|NCT02357342|63000311|FG001|First 6 Months|Death|0|||
33601541|NCT02271529|63000317|FG000|Overall Study|Withdrawal by Subject|1|||
33601542|NCT02325518|63000323|FG000|Overall Study|Adverse Event|4|||
33601543|NCT02325518|63000324|FG001|Overall Study|Adverse Event|1|||
33601544|NCT02325518|63000323|FG000|Overall Study|Physician Decision|0|||
33601545|NCT02325518|63000324|FG001|Overall Study|Physician Decision|1|||
33601546|NCT02325518|63000323|FG000|Overall Study|Withdrawal by Subject|0|||
33601547|NCT02325518|63000324|FG001|Overall Study|Withdrawal by Subject|1|||
33601548|NCT02270983|63000334|FG000|Overall Study|Adverse Event|3|||
33601549|NCT02270983|63000335|FG001|Overall Study|Adverse Event|2|||
33601550|NCT02270983|63000336|FG002|Overall Study|Adverse Event|6|||
33601551|NCT02270983|63000334|FG000|Overall Study|Lack of Efficacy|2|||
33601552|NCT02270983|63000335|FG001|Overall Study|Lack of Efficacy|1|||
33601553|NCT02270983|63000336|FG002|Overall Study|Lack of Efficacy|1|||
33601554|NCT02270983|63000334|FG000|Overall Study|Withdrawal by Subject|1|||
33601555|NCT02270983|63000335|FG001|Overall Study|Withdrawal by Subject|0|||
33601556|NCT02270983|63000336|FG002|Overall Study|Withdrawal by Subject|2|||
33601557|NCT02270983|63000334|FG000|Overall Study|Lost to Follow-up|1|||
33601558|NCT02270983|63000335|FG001|Overall Study|Lost to Follow-up|1|||
33601559|NCT02270983|63000336|FG002|Overall Study|Lost to Follow-up|2|||
33601560|NCT02270983|63000334|FG000|Overall Study|Protocol Violation|1|||
33601561|NCT02270983|63000335|FG001|Overall Study|Protocol Violation|1|||
33601562|NCT02270983|63000336|FG002|Overall Study|Protocol Violation|1|||
33601563|NCT02270983|63000334|FG000|Overall Study|family emergency|0|||
33601564|NCT02270983|63000335|FG001|Overall Study|family emergency|1|||
33601565|NCT02270983|63000336|FG002|Overall Study|family emergency|0|||
33601566|NCT02270983|63000334|FG000|Overall Study|study procedure non-compliance|1|||
33601567|NCT02270983|63000335|FG001|Overall Study|study procedure non-compliance|0|||
33601568|NCT02270983|63000336|FG002|Overall Study|study procedure non-compliance|0|||
33601569|NCT02270983|63000334|FG000|Overall Study|moved away from study site|0|||
33601570|NCT02270983|63000335|FG001|Overall Study|moved away from study site|1|||
33601571|NCT02270983|63000336|FG002|Overall Study|moved away from study site|0|||
33601572|NCT02449889|63000347|FG000|Overall Study|Adverse Event|1|||
33601573|NCT02449889|63000348|FG001|Overall Study|Adverse Event|2|||
33601574|NCT02449889|63000349|FG002|Overall Study|Adverse Event|0|||
33601575|NCT02449889|63000347|FG000|Overall Study|Protocol Violation|0|||
33601576|NCT02449889|63000348|FG001|Overall Study|Protocol Violation|4|||
33601577|NCT02449889|63000349|FG002|Overall Study|Protocol Violation|1|||
33601578|NCT01831804|63000366|FG000|Overall Study|Adverse Event|0|||
33601579|NCT01831804|63000367|FG001|Overall Study|Adverse Event|0|||
33601580|NCT01831804|63000368|FG002|Overall Study|Adverse Event|0|||
33601581|NCT01831804|63000369|FG003|Overall Study|Adverse Event|0|||
33601582|NCT01831804|63000370|FG004|Overall Study|Adverse Event|0|||
33412340|NCT00485589|62790823|FG002|Overall Study|Insufficient therapeutic response|1|||
33412341|NCT00485589|62790821|FG000|Overall Study|Refused treatment/did not cooperate|1|||
33601583|NCT01831804|63000371|FG005|Overall Study|Adverse Event|0|||
33601584|NCT01831804|63000372|FG006|Overall Study|Adverse Event|1|||
33412342|NCT00485589|62790822|FG001|Overall Study|Refused treatment/did not cooperate|0|||
33412343|NCT00485589|62790823|FG002|Overall Study|Refused treatment/did not cooperate|2|||
33601585|NCT01831804|63000373|FG007|Overall Study|Adverse Event|0|||
33601586|NCT01831804|63000374|FG008|Overall Study|Adverse Event|1|||
33601587|NCT01831804|63000366|FG000|Overall Study|Protocol Violation|0|||
33601588|NCT01831804|63000367|FG001|Overall Study|Protocol Violation|0|||
33601589|NCT01831804|63000368|FG002|Overall Study|Protocol Violation|2|||
33601590|NCT01831804|63000369|FG003|Overall Study|Protocol Violation|0|||
33601591|NCT01831804|63000370|FG004|Overall Study|Protocol Violation|0|||
33601592|NCT01831804|63000371|FG005|Overall Study|Protocol Violation|0|||
33601593|NCT01831804|63000372|FG006|Overall Study|Protocol Violation|0|||
33601594|NCT01831804|63000373|FG007|Overall Study|Protocol Violation|0|||
33601595|NCT01831804|63000374|FG008|Overall Study|Protocol Violation|0|||
33601596|NCT01831804|63000366|FG000|Overall Study|Protocol defined stopping criteria|1|||
33601597|NCT01831804|63000367|FG001|Overall Study|Protocol defined stopping criteria|1|||
33601598|NCT01831804|63000368|FG002|Overall Study|Protocol defined stopping criteria|3|||
33601599|NCT01831804|63000369|FG003|Overall Study|Protocol defined stopping criteria|0|||
33601600|NCT01831804|63000370|FG004|Overall Study|Protocol defined stopping criteria|1|||
33601601|NCT01831804|63000371|FG005|Overall Study|Protocol defined stopping criteria|0|||
33412344|NCT00485589|62790821|FG000|Overall Study|Withdrawal by Subject|3|||
33412345|NCT00485589|62790822|FG001|Overall Study|Withdrawal by Subject|2|||
33412346|NCT00485589|62790823|FG002|Overall Study|Withdrawal by Subject|2|||
33412347|NCT00485589|62790821|FG000|Overall Study|Adverse Event|3|||
33412348|NCT00485589|62790822|FG001|Overall Study|Adverse Event|3|||
33412349|NCT00485589|62790823|FG002|Overall Study|Adverse Event|10|||
33412350|NCT00490971|62790842|FG000|Acute/Continuation|Adverse Event|62|||
33412351|NCT00490971|62790843|FG001|Acute/Continuation|Adverse Event|13|||
33412352|NCT00490971|62790844|FG002|Acute/Continuation|Adverse Event|0|||
33412353|NCT00490971|62790845|FG003|Acute/Continuation|Adverse Event|0|||
33412354|NCT00490971|62790846|FG004|Acute/Continuation|Adverse Event|0|||
33412355|NCT00490971|62790842|FG000|Acute/Continuation|Death|2|||
33412356|NCT00490971|62790843|FG001|Acute/Continuation|Death|0|||
33412357|NCT00490971|62790844|FG002|Acute/Continuation|Death|0|||
33412358|NCT00490971|62790845|FG003|Acute/Continuation|Death|0|||
33412359|NCT00490971|62790846|FG004|Acute/Continuation|Death|0|||
33412360|NCT00490971|62790842|FG000|Acute/Continuation|Lack of Efficacy|106|||
33412361|NCT00490971|62790843|FG001|Acute/Continuation|Lack of Efficacy|12|||
33412362|NCT00490971|62790844|FG002|Acute/Continuation|Lack of Efficacy|0|||
33412363|NCT00490971|62790845|FG003|Acute/Continuation|Lack of Efficacy|0|||
33412364|NCT00490971|62790846|FG004|Acute/Continuation|Lack of Efficacy|0|||
33412365|NCT00490971|62790842|FG000|Acute/Continuation|Lost to Follow-up|23|||
33412366|NCT00490971|62790843|FG001|Acute/Continuation|Lost to Follow-up|7|||
33412367|NCT00490971|62790844|FG002|Acute/Continuation|Lost to Follow-up|0|||
33412368|NCT00490971|62790845|FG003|Acute/Continuation|Lost to Follow-up|0|||
33412369|NCT00490971|62790846|FG004|Acute/Continuation|Lost to Follow-up|0|||
33412370|NCT00490971|62790842|FG000|Acute/Continuation|Protocol Violation|10|||
33412371|NCT00490971|62790843|FG001|Acute/Continuation|Protocol Violation|2|||
33412372|NCT00490971|62790844|FG002|Acute/Continuation|Protocol Violation|0|||
33412373|NCT00490971|62790845|FG003|Acute/Continuation|Protocol Violation|0|||
33412374|NCT00490971|62790846|FG004|Acute/Continuation|Protocol Violation|0|||
33412375|NCT00490971|62790842|FG000|Acute/Continuation|Withdrawal by Subject|92|||
33412376|NCT00490971|62790843|FG001|Acute/Continuation|Withdrawal by Subject|24|||
33412377|NCT00490971|62790844|FG002|Acute/Continuation|Withdrawal by Subject|0|||
33412378|NCT00490971|62790845|FG003|Acute/Continuation|Withdrawal by Subject|0|||
33412379|NCT00490971|62790846|FG004|Acute/Continuation|Withdrawal by Subject|0|||
33412380|NCT00490971|62790842|FG000|Acute/Continuation|Other|11|||
33412381|NCT00490971|62790843|FG001|Acute/Continuation|Other|4|||
33412382|NCT00490971|62790844|FG002|Acute/Continuation|Other|0|||
33412383|NCT00490971|62790845|FG003|Acute/Continuation|Other|0|||
33412384|NCT00490971|62790846|FG004|Acute/Continuation|Other|0|||
33412385|NCT00490971|62790842|FG000|Maintenance|Adverse Event|0|||
33412386|NCT00490971|62790843|FG001|Maintenance|Adverse Event|0|||
33412387|NCT00490971|62790844|FG002|Maintenance|Adverse Event|4|||
33412388|NCT00490971|62790845|FG003|Maintenance|Adverse Event|5|||
33412389|NCT00490971|62790846|FG004|Maintenance|Adverse Event|7|||
33412390|NCT00490971|62790842|FG000|Maintenance|Death|0|||
33412391|NCT00490971|62790843|FG001|Maintenance|Death|0|||
33412392|NCT00490971|62790844|FG002|Maintenance|Death|0|||
33412393|NCT00490971|62790845|FG003|Maintenance|Death|2|||
33412394|NCT00490971|62790846|FG004|Maintenance|Death|0|||
33412395|NCT00490971|62790842|FG000|Maintenance|Lost to Follow-up|0|||
33412396|NCT00490971|62790843|FG001|Maintenance|Lost to Follow-up|0|||
33412397|NCT00490971|62790844|FG002|Maintenance|Lost to Follow-up|5|||
33412398|NCT00490971|62790845|FG003|Maintenance|Lost to Follow-up|8|||
33412399|NCT00490971|62790846|FG004|Maintenance|Lost to Follow-up|10|||
33412400|NCT00490971|62790842|FG000|Maintenance|Pregnancy|0|||
33412401|NCT00490971|62790843|FG001|Maintenance|Pregnancy|0|||
33412402|NCT00490971|62790844|FG002|Maintenance|Pregnancy|1|||
33412403|NCT00490971|62790845|FG003|Maintenance|Pregnancy|0|||
33412404|NCT00490971|62790846|FG004|Maintenance|Pregnancy|0|||
33412405|NCT00490971|62790842|FG000|Maintenance|Protocol Violation|0|||
33412406|NCT00490971|62790843|FG001|Maintenance|Protocol Violation|0|||
33412407|NCT00490971|62790844|FG002|Maintenance|Protocol Violation|4|||
33412408|NCT00490971|62790845|FG003|Maintenance|Protocol Violation|1|||
33412409|NCT00490971|62790846|FG004|Maintenance|Protocol Violation|1|||
33412410|NCT00490971|62790842|FG000|Maintenance|Withdrawal by Subject|0|||
33412411|NCT00490971|62790843|FG001|Maintenance|Withdrawal by Subject|0|||
33412412|NCT00490971|62790844|FG002|Maintenance|Withdrawal by Subject|26|||
33412413|NCT00490971|62790845|FG003|Maintenance|Withdrawal by Subject|28|||
33412414|NCT00490971|62790846|FG004|Maintenance|Withdrawal by Subject|18|||
33412415|NCT00490971|62790842|FG000|Maintenance|Other|0|||
33412416|NCT00490971|62790843|FG001|Maintenance|Other|0|||
33601602|NCT01831804|63000372|FG006|Overall Study|Protocol defined stopping criteria|0|||
33412417|NCT00490971|62790844|FG002|Maintenance|Other|11|||
33601603|NCT01831804|63000373|FG007|Overall Study|Protocol defined stopping criteria|0|||
33601604|NCT01831804|63000374|FG008|Overall Study|Protocol defined stopping criteria|0|||
33601605|NCT01831804|63000366|FG000|Overall Study|Lost to Follow-up|0|||
33601606|NCT01831804|63000367|FG001|Overall Study|Lost to Follow-up|0|||
33601607|NCT01831804|63000368|FG002|Overall Study|Lost to Follow-up|1|||
33601608|NCT01831804|63000369|FG003|Overall Study|Lost to Follow-up|0|||
33601609|NCT01831804|63000370|FG004|Overall Study|Lost to Follow-up|0|||
33601610|NCT01831804|63000371|FG005|Overall Study|Lost to Follow-up|0|||
33601611|NCT01831804|63000372|FG006|Overall Study|Lost to Follow-up|0|||
33601612|NCT01831804|63000373|FG007|Overall Study|Lost to Follow-up|0|||
33601613|NCT01831804|63000374|FG008|Overall Study|Lost to Follow-up|1|||
33601614|NCT01831804|63000366|FG000|Overall Study|Investigator discretion|0|||
33601615|NCT01831804|63000367|FG001|Overall Study|Investigator discretion|0|||
33601616|NCT01831804|63000368|FG002|Overall Study|Investigator discretion|0|||
33601617|NCT01831804|63000369|FG003|Overall Study|Investigator discretion|0|||
33601618|NCT01831804|63000370|FG004|Overall Study|Investigator discretion|1|||
33601619|NCT01831804|63000371|FG005|Overall Study|Investigator discretion|0|||
33601620|NCT01831804|63000372|FG006|Overall Study|Investigator discretion|0|||
33601621|NCT01831804|63000373|FG007|Overall Study|Investigator discretion|1|||
33601622|NCT01831804|63000374|FG008|Overall Study|Investigator discretion|0|||
33601623|NCT01831804|63000366|FG000|Overall Study|Withdrew Consent|0|||
33601624|NCT01831804|63000367|FG001|Overall Study|Withdrew Consent|1|||
33601625|NCT01831804|63000368|FG002|Overall Study|Withdrew Consent|0|||
33601626|NCT01831804|63000369|FG003|Overall Study|Withdrew Consent|0|||
33601627|NCT01831804|63000370|FG004|Overall Study|Withdrew Consent|0|||
33601628|NCT01831804|63000371|FG005|Overall Study|Withdrew Consent|0|||
33601629|NCT01831804|63000372|FG006|Overall Study|Withdrew Consent|0|||
33601630|NCT01831804|63000373|FG007|Overall Study|Withdrew Consent|2|||
33601631|NCT01831804|63000374|FG008|Overall Study|Withdrew Consent|0|||
33601632|NCT02270671|63000405|FG000|Overall Study|Withdrawal by Subject|1|||
33601633|NCT02270671|63000406|FG001|Overall Study|Withdrawal by Subject|1|||
33601634|NCT02270671|63000405|FG000|Overall Study|Protocol Violation|0|||
33601635|NCT02270671|63000406|FG001|Overall Study|Protocol Violation|1|||
33601636|NCT02270671|63000405|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
33601637|NCT02270671|63000406|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
33601638|NCT02270671|63000405|FG000|Overall Study|Lost to Follow-up|2|||
33601639|NCT02270671|63000406|FG001|Overall Study|Lost to Follow-up|1|||
33601640|NCT02324270|63000415|FG000|Overall Study|Withdrawal by Subject|0|||
33601641|NCT02324270|63000416|FG001|Overall Study|Withdrawal by Subject|1|||
33601642|NCT02324270|63000417|FG002|Overall Study|Withdrawal by Subject|0|||
33601643|NCT02324270|63000415|FG000|Overall Study|Lost to Follow-up|4|||
33601644|NCT02324270|63000416|FG001|Overall Study|Lost to Follow-up|3|||
33601645|NCT02324270|63000417|FG002|Overall Study|Lost to Follow-up|4|||
33412418|NCT00490971|62790845|FG003|Maintenance|Other|9|||
33412419|NCT00490971|62790846|FG004|Maintenance|Other|3|||
33412420|NCT00686075|62790868|FG000|Overall Study|Withdrawal by Subject|4|||
33601646|NCT02324270|63000415|FG000|Overall Study|Protocol Violation|0|||
33601647|NCT02324270|63000416|FG001|Overall Study|Protocol Violation|1|||
33601648|NCT02324270|63000417|FG002|Overall Study|Protocol Violation|1|||
33601649|NCT02324270|63000415|FG000|Overall Study|Non Compliance with Study Drug|1|||
33601650|NCT02324270|63000416|FG001|Overall Study|Non Compliance with Study Drug|2|||
33601651|NCT02324270|63000417|FG002|Overall Study|Non Compliance with Study Drug|0|||
33601652|NCT02270515|63000425|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
33601653|NCT02270515|63000425|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
33601654|NCT02270515|63000425|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
33601655|NCT02270515|63000425|FG000|Intervention Period 1: 0-6 Months|Death|7|||
33601656|NCT02270515|63000425|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
33601657|NCT02270515|63000425|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
33601658|NCT02270515|63000425|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
33601659|NCT02270515|63000425|FG000|Intervention Period 2: 6-12 Months|Death|5|||
33601660|NCT02270515|63000425|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
33601661|NCT02270515|63000425|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
33601662|NCT02270515|63000425|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
33601663|NCT02270515|63000425|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
33601664|NCT02270515|63000425|FG000|Intervention Period 3: 12-18 Months|Death|3|||
33601665|NCT02270515|63000425|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
33601666|NCT02448875|63000439|FG000|Overall Study|Adverse Event|2|||
33601667|NCT02448875|63000440|FG001|Overall Study|Adverse Event|1|||
33601668|NCT02448875|63000441|FG002|Overall Study|Adverse Event|0|||
33601669|NCT02448875|63000439|FG000|Overall Study|Lost to Follow-up|1|||
33601670|NCT02448875|63000440|FG001|Overall Study|Lost to Follow-up|0|||
33601671|NCT02448875|63000441|FG002|Overall Study|Lost to Follow-up|0|||
33601672|NCT02448875|63000439|FG000|Overall Study|Investigator Decision|3|||
33601673|NCT02448875|63000440|FG001|Overall Study|Investigator Decision|0|||
33601674|NCT02448875|63000441|FG002|Overall Study|Investigator Decision|1|||
33601675|NCT02448875|63000439|FG000|Overall Study|Withdrawal by Subject|1|||
33601676|NCT02448875|63000440|FG001|Overall Study|Withdrawal by Subject|0|||
33601677|NCT02448875|63000441|FG002|Overall Study|Withdrawal by Subject|0|||
33601678|NCT01831726|63000452|FG000|Overall Study|Adverse Event|16|||
33601679|NCT01831726|63000452|FG000|Overall Study|Death|7|||
33601680|NCT01831726|63000452|FG000|Overall Study|Disease Progression|49|||
33601681|NCT01831726|63000452|FG000|Overall Study|Physician Decision|1|||
33601682|NCT01831726|63000452|FG000|Overall Study|Subject/guardian decision|7|||
33601683|NCT01831258|63000456|FG000|Overall Study|Withdrawal by Subject|2|||
33601684|NCT01831258|63000457|FG001|Overall Study|Withdrawal by Subject|1|||
33601685|NCT01831258|63000456|FG000|Overall Study|Lost to Follow-up|3|||
33601686|NCT01831258|63000457|FG001|Overall Study|Lost to Follow-up|2|||
33601687|NCT01849276|63000465|FG000|Followed for Survival for 5 Years|Death|1|||
33601688|NCT01849276|63000465|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
33601689|NCT02465489|63000469|FG000|Overall Study|Adverse Event|5|||
33601690|NCT01829464|63000484|FG000|Overall Study|Adverse Event|1|||
33601691|NCT01829464|63000485|FG001|Overall Study|Adverse Event|0|||
33601692|NCT01829464|63000486|FG002|Overall Study|Adverse Event|0|||
33601693|NCT01829464|63000484|FG000|Overall Study|Lost to Follow-up|0|||
33601694|NCT01829464|63000485|FG001|Overall Study|Lost to Follow-up|0|||
33601695|NCT01829464|63000486|FG002|Overall Study|Lost to Follow-up|1|||
33601696|NCT01829464|63000484|FG000|Overall Study|Withdrawal by Subject|2|||
33601697|NCT01829464|63000485|FG001|Overall Study|Withdrawal by Subject|0|||
33601698|NCT01829464|63000486|FG002|Overall Study|Withdrawal by Subject|0|||
33601699|NCT01829464|63000484|FG000|Overall Study|Study terminated by sponsor|25|||
33601700|NCT01829464|63000485|FG001|Overall Study|Study terminated by sponsor|28|||
33601701|NCT01829464|63000486|FG002|Overall Study|Study terminated by sponsor|25|||
33601702|NCT01829464|63000484|FG000|Overall Study|Lack of Efficacy|0|||
33601703|NCT01829464|63000485|FG001|Overall Study|Lack of Efficacy|1|||
33601704|NCT01829464|63000486|FG002|Overall Study|Lack of Efficacy|0|||
33601705|NCT01847092|63000496|FG000|Overall Study|Adverse Event|12|||
33601706|NCT01847092|63000497|FG001|Overall Study|Adverse Event|3|||
33601707|NCT01847092|63000496|FG000|Overall Study|Withdrawal by Subject|5|||
33601708|NCT01847092|63000497|FG001|Overall Study|Withdrawal by Subject|5|||
33601709|NCT01847092|63000496|FG000|Overall Study|Protocol Specified|8|||
33601710|NCT01847092|63000497|FG001|Overall Study|Protocol Specified|0|||
33601711|NCT01847092|63000496|FG000|Overall Study|Physician Decision|1|||
33601712|NCT01847092|63000497|FG001|Overall Study|Physician Decision|1|||
33601713|NCT01847092|63000496|FG000|Overall Study|Protocol Violation|0|||
33601714|NCT01847092|63000497|FG001|Overall Study|Protocol Violation|2|||
33601715|NCT01601821|63000505|FG000|Overall Study|Death|2|||
33601716|NCT01601821|63000506|FG001|Overall Study|Death|5|||
33601717|NCT01601821|63000505|FG000|Overall Study|Protocol Violation|2|||
33601718|NCT01601821|63000506|FG001|Overall Study|Protocol Violation|2|||
33601719|NCT01601821|63000505|FG000|Overall Study|Lost to Follow-up|6|||
33601720|NCT01601821|63000506|FG001|Overall Study|Lost to Follow-up|14|||
33601721|NCT01601821|63000505|FG000|Overall Study|Withdrawal by Subject|1|||
33601722|NCT01601821|63000506|FG001|Overall Study|Withdrawal by Subject|0|||
33601723|NCT01601821|63000505|FG000|Overall Study|Graft Loss|6|||
33601724|NCT01601821|63000506|FG001|Overall Study|Graft Loss|6|||
33601725|NCT01601821|63000505|FG000|Overall Study|Study Events|7|||
33601726|NCT01601821|63000506|FG001|Overall Study|Study Events|1|||
33601727|NCT01601821|63000505|FG000|Overall Study|Other|5|||
33601728|NCT01601821|63000506|FG001|Overall Study|Other|1|||
33601729|NCT02323646|63000515|FG000|Treatment Course 1|Adverse Event|1|||
33601730|NCT02323646|63000516|FG001|Treatment Course 1|Adverse Event|0|||
33601731|NCT02323646|63000517|FG002|Treatment Course 1|Adverse Event|1|||
33601732|NCT02323646|63000515|FG000|Treatment Course 1|Heavy Bleeding|1|||
33601733|NCT02323646|63000516|FG001|Treatment Course 1|Heavy Bleeding|1|||
33601734|NCT02323646|63000517|FG002|Treatment Course 1|Heavy Bleeding|0|||
33601735|NCT02323646|63000515|FG000|Treatment Course 1|Lost to Follow-up|1|||
33601736|NCT02323646|63000516|FG001|Treatment Course 1|Lost to Follow-up|0|||
33601737|NCT02323646|63000517|FG002|Treatment Course 1|Lost to Follow-up|2|||
33601738|NCT02323646|63000515|FG000|Treatment Course 1|Withdrawal by Subject|0|||
33601739|NCT02323646|63000516|FG001|Treatment Course 1|Withdrawal by Subject|2|||
33601740|NCT02323646|63000517|FG002|Treatment Course 1|Withdrawal by Subject|0|||
33601741|NCT02323646|63000515|FG000|Treatment Course 2|Adverse Event|1|||
33601742|NCT02323646|63000516|FG001|Treatment Course 2|Adverse Event|0|||
33601743|NCT02323646|63000517|FG002|Treatment Course 2|Adverse Event|1|||
33601744|NCT02323646|63000515|FG000|Treatment Course 2|Lost to Follow-up|0|||
33601745|NCT02323646|63000516|FG001|Treatment Course 2|Lost to Follow-up|0|||
33601746|NCT02323646|63000517|FG002|Treatment Course 2|Lost to Follow-up|1|||
33601747|NCT02323646|63000515|FG000|Treatment Course 2|Non-compliance|0|||
33601748|NCT02323646|63000516|FG001|Treatment Course 2|Non-compliance|1|||
33601749|NCT02323646|63000517|FG002|Treatment Course 2|Non-compliance|1|||
33601750|NCT01846624|63000525|FG000|Overall Study|Died during induction, no midostaurin|1|||
33601751|NCT01829230|63000531|FG000|Overall Study|Protocol Violation|0|||
33601752|NCT01829230|63000532|FG001|Overall Study|Protocol Violation|2|||
33601753|NCT01829230|63000531|FG000|Overall Study|Withdrawal by Subject|0|||
33601754|NCT01829230|63000532|FG001|Overall Study|Withdrawal by Subject|1|||
33601755|NCT01829230|63000531|FG000|Overall Study|Lost to Follow-up|1|||
33601756|NCT01829230|63000532|FG001|Overall Study|Lost to Follow-up|1|||
33601757|NCT02269657|63000538|FG000|Overall Study|Protocol Violation|3|||
33601758|NCT02269423|63000548|FG000|Overall Study|Discontinued due to change in residence|0|||
33601759|NCT02269423|63000549|FG001|Overall Study|Discontinued due to change in residence|1|||
33601760|NCT02269423|63000550|FG002|Overall Study|Discontinued due to change in residence|0|||
33601761|NCT02269423|63000551|FG003|Overall Study|Discontinued due to change in residence|1|||
33601762|NCT01827670|63000563|FG000|Overall Study|Withdrawal of Consent|3|||
33601763|NCT01827670|63000564|FG001|Overall Study|Withdrawal of Consent|2|||
33601764|NCT01827670|63000563|FG000|Overall Study|Lost to Follow-up|0|||
33601765|NCT01827670|63000564|FG001|Overall Study|Lost to Follow-up|1|||
33601766|NCT02267317|63000578|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
33601767|NCT02267317|63000579|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
33601768|NCT02267317|63000580|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
33601769|NCT02267317|63000581|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
33601770|NCT02267317|63000582|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
33601771|NCT02267317|63000583|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
33601772|NCT02267317|63000578|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
33601773|NCT02267317|63000579|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
33601774|NCT02267317|63000580|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
33601775|NCT02267317|63000581|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
33601776|NCT02267317|63000582|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
33601777|NCT02267317|63000583|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
33601778|NCT01844830|63000599|FG000|Overall Study|Withdrawal by Subject|1|||
33601779|NCT01844830|63000600|FG001|Overall Study|Withdrawal by Subject|0|||
33601780|NCT01827592|63000609|FG000|Overall Study|Adverse Event|11|||
33601781|NCT01827592|63000610|FG001|Overall Study|Adverse Event|9|||
33601782|NCT01827592|63000611|FG002|Overall Study|Adverse Event|2|||
33601783|NCT01827592|63000609|FG000|Overall Study|Physician Decision|0|||
33601784|NCT01827592|63000610|FG001|Overall Study|Physician Decision|2|||
33601785|NCT01827592|63000611|FG002|Overall Study|Physician Decision|1|||
33601786|NCT01827592|63000609|FG000|Overall Study|Protocol Violation|2|||
33601787|NCT01827592|63000610|FG001|Overall Study|Protocol Violation|1|||
33601788|NCT01827592|63000611|FG002|Overall Study|Protocol Violation|0|||
33601789|NCT01827592|63000609|FG000|Overall Study|Lost to Follow-up|1|||
33601790|NCT01827592|63000610|FG001|Overall Study|Lost to Follow-up|2|||
33601791|NCT01827592|63000611|FG002|Overall Study|Lost to Follow-up|2|||
33601792|NCT01827592|63000609|FG000|Overall Study|Withdrawal by Subject|12|||
33601793|NCT01827592|63000610|FG001|Overall Study|Withdrawal by Subject|11|||
33601794|NCT01827592|63000611|FG002|Overall Study|Withdrawal by Subject|11|||
33601795|NCT01827592|63000609|FG000|Overall Study|Patient's substantial non-compliance|1|||
33601796|NCT01827592|63000610|FG001|Overall Study|Patient's substantial non-compliance|1|||
33601797|NCT01827592|63000611|FG002|Overall Study|Patient's substantial non-compliance|6|||
33601798|NCT01827592|63000609|FG000|Overall Study|Trial terminated by Sponsor|47|||
33601799|NCT01827592|63000610|FG001|Overall Study|Trial terminated by Sponsor|53|||
33601800|NCT01827592|63000611|FG002|Overall Study|Trial terminated by Sponsor|51|||
33601801|NCT01827592|63000609|FG000|Overall Study|Others|0|||
33601802|NCT01827592|63000610|FG001|Overall Study|Others|1|||
33601803|NCT01827592|63000611|FG002|Overall Study|Others|3|||
33601804|NCT02323334|63000629|FG000|Period 3|Lost to Follow-up|0|||
33601805|NCT02323334|63000630|FG001|Period 3|Lost to Follow-up|0|||
33601806|NCT02323334|63000631|FG002|Period 3|Lost to Follow-up|1|||
33601807|NCT02323334|63000632|FG003|Period 3|Lost to Follow-up|0|||
33601808|NCT02323334|63000633|FG004|Period 3|Lost to Follow-up|0|||
33601809|NCT02323334|63000634|FG005|Period 3|Lost to Follow-up|0|||
33601810|NCT02323334|63000635|FG006|Period 3|Lost to Follow-up|0|||
33601811|NCT02323334|63000636|FG007|Period 3|Lost to Follow-up|0|||
33601812|NCT02323334|63000637|FG008|Period 3|Lost to Follow-up|0|||
33601813|NCT02323334|63000638|FG009|Period 3|Lost to Follow-up|0|||
33601814|NCT02323334|63000639|FG010|Period 3|Lost to Follow-up|0|||
33601815|NCT02323334|63000640|FG011|Period 3|Lost to Follow-up|0|||
33601816|NCT02323334|63000641|FG012|Period 3|Lost to Follow-up|0|||
33601817|NCT02323334|63000642|FG013|Period 3|Lost to Follow-up|0|||
33601818|NCT02323334|63000643|FG014|Period 3|Lost to Follow-up|0|||
33601819|NCT02323334|63000644|FG015|Period 3|Lost to Follow-up|0|||
33601820|NCT02323334|63000645|FG016|Period 3|Lost to Follow-up|0|||
33601821|NCT02323334|63000629|FG000|Period 3|Withdrawal by Subject|1|||
33601822|NCT02323334|63000630|FG001|Period 3|Withdrawal by Subject|0|||
33601823|NCT02323334|63000631|FG002|Period 3|Withdrawal by Subject|0|||
33601824|NCT02323334|63000632|FG003|Period 3|Withdrawal by Subject|0|||
33601825|NCT02323334|63000633|FG004|Period 3|Withdrawal by Subject|0|||
33601826|NCT02323334|63000634|FG005|Period 3|Withdrawal by Subject|0|||
33601827|NCT02323334|63000635|FG006|Period 3|Withdrawal by Subject|0|||
33601828|NCT02323334|63000636|FG007|Period 3|Withdrawal by Subject|0|||
33601829|NCT02323334|63000637|FG008|Period 3|Withdrawal by Subject|0|||
33601830|NCT02323334|63000638|FG009|Period 3|Withdrawal by Subject|0|||
33601831|NCT02323334|63000639|FG010|Period 3|Withdrawal by Subject|0|||
33601832|NCT02323334|63000640|FG011|Period 3|Withdrawal by Subject|0|||
33601833|NCT02323334|63000641|FG012|Period 3|Withdrawal by Subject|0|||
33601834|NCT02323334|63000642|FG013|Period 3|Withdrawal by Subject|0|||
33601835|NCT02323334|63000643|FG014|Period 3|Withdrawal by Subject|0|||
33601836|NCT02323334|63000644|FG015|Period 3|Withdrawal by Subject|0|||
33601837|NCT02323334|63000645|FG016|Period 3|Withdrawal by Subject|0|||
33601838|NCT02448719|63000718|FG000|Overall Study|Withdrawal by Subject|0|||
33601839|NCT02448719|63000719|FG001|Overall Study|Withdrawal by Subject|0|||
33601840|NCT02448719|63000720|FG002|Overall Study|Withdrawal by Subject|0|||
33601841|NCT02448719|63000721|FG003|Overall Study|Withdrawal by Subject|0|||
33601842|NCT02448719|63000722|FG004|Overall Study|Withdrawal by Subject|1|||
33601843|NCT02448719|63000723|FG005|Overall Study|Withdrawal by Subject|0|||
33601844|NCT02448719|63000724|FG006|Overall Study|Withdrawal by Subject|0|||
33601845|NCT02448719|63000725|FG007|Overall Study|Withdrawal by Subject|0|||
33601846|NCT02448719|63000726|FG008|Overall Study|Withdrawal by Subject|0|||
33601847|NCT02448719|63000727|FG009|Overall Study|Withdrawal by Subject|0|||
33412421|NCT00686075|62790869|FG001|Overall Study|Withdrawal by Subject|3|||
33412422|NCT00686075|62790870|FG002|Overall Study|Withdrawal by Subject|3|||
33601848|NCT02448719|63000728|FG010|Overall Study|Withdrawal by Subject|0|||
33601849|NCT02322866|63000791|FG000|Overall Study|Adverse Event|6|||
33601850|NCT02322866|63000792|FG001|Overall Study|Adverse Event|11|||
33601851|NCT02322866|63000791|FG000|Overall Study|Withdrawal of Consent|16|||
33601852|NCT02322866|63000792|FG001|Overall Study|Withdrawal of Consent|25|||
33601853|NCT02322866|63000791|FG000|Overall Study|Lost to Follow-up|36|||
33601854|NCT02322866|63000792|FG001|Overall Study|Lost to Follow-up|39|||
33601855|NCT02322866|63000791|FG000|Overall Study|Protocol Violation|1|||
33601856|NCT02322866|63000792|FG001|Overall Study|Protocol Violation|0|||
33601857|NCT02322866|63000791|FG000|Overall Study|Noncompliance with Treatment|3|||
33601858|NCT02322866|63000792|FG001|Overall Study|Noncompliance with Treatment|4|||
33601859|NCT02322866|63000791|FG000|Overall Study|Lack of Efficacy|3|||
33601860|NCT02322866|63000792|FG001|Overall Study|Lack of Efficacy|1|||
33412423|NCT00686075|62790871|FG003|Overall Study|Withdrawal by Subject|7|||
33412424|NCT00686075|62790872|FG004|Overall Study|Withdrawal by Subject|1|||
33412425|NCT00686075|62790873|FG005|Overall Study|Withdrawal by Subject|0|||
33601861|NCT02322866|63000791|FG000|Overall Study|Other Miscellaneous Reasons|6|||
33601862|NCT02322866|63000792|FG001|Overall Study|Other Miscellaneous Reasons|6|||
33601863|NCT01640353|63000798|FG000|Overall Study|Withdrew prior to treatment|10|||
33601864|NCT01640353|63000798|FG000|Overall Study|Withdrawn from analysis at term site|12|||
33601865|NCT01640353|63000798|FG000|Overall Study|Withdrawal by Subject|5|||
33601866|NCT01640353|63000798|FG000|Overall Study|Death|2|||
33601867|NCT01640353|63000798|FG000|Overall Study|Early site termination|3|||
33601868|NCT01640353|63000798|FG000|Overall Study|Lost to Follow-up|12|||
33601869|NCT01640353|63000798|FG000|Overall Study|Physician Decision|1|||
33601870|NCT02463071|63000805|FG000|Overall Study|Adverse Event|3|||
33601871|NCT02463071|63000806|FG001|Overall Study|Adverse Event|5|||
33601872|NCT02463071|63000807|FG002|Overall Study|Adverse Event|1|||
33601873|NCT02463071|63000805|FG000|Overall Study|Death|1|||
33601874|NCT02463071|63000806|FG001|Overall Study|Death|0|||
33601875|NCT02463071|63000807|FG002|Overall Study|Death|0|||
33601876|NCT02463071|63000805|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
33601877|NCT02463071|63000806|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33601878|NCT02463071|63000807|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
33412426|NCT00686075|62790874|FG006|Overall Study|Withdrawal by Subject|0|||
33412427|NCT00686075|62790875|FG007|Overall Study|Withdrawal by Subject|2|||
33412428|NCT00686075|62790876|FG008|Overall Study|Withdrawal by Subject|4|||
33412429|NCT00686075|62790877|FG009|Overall Study|Withdrawal by Subject|6|||
33412430|NCT00686075|62790868|FG000|Overall Study|Lost to Follow-up|3|||
33412431|NCT00686075|62790869|FG001|Overall Study|Lost to Follow-up|6|||
33412432|NCT00686075|62790870|FG002|Overall Study|Lost to Follow-up|3|||
33412433|NCT00686075|62790871|FG003|Overall Study|Lost to Follow-up|2|||
33412434|NCT00686075|62790872|FG004|Overall Study|Lost to Follow-up|3|||
33412435|NCT00686075|62790873|FG005|Overall Study|Lost to Follow-up|3|||
33412436|NCT00686075|62790874|FG006|Overall Study|Lost to Follow-up|0|||
33412437|NCT00686075|62790875|FG007|Overall Study|Lost to Follow-up|0|||
33412438|NCT00686075|62790876|FG008|Overall Study|Lost to Follow-up|2|||
33412439|NCT00686075|62790877|FG009|Overall Study|Lost to Follow-up|3|||
33412440|NCT00686075|62790868|FG000|Overall Study|Other|1|||
33412441|NCT00686075|62790869|FG001|Overall Study|Other|1|||
33412442|NCT00686075|62790870|FG002|Overall Study|Other|0|||
33412443|NCT00686075|62790871|FG003|Overall Study|Other|0|||
33412444|NCT00686075|62790872|FG004|Overall Study|Other|0|||
33412445|NCT00686075|62790873|FG005|Overall Study|Other|0|||
33412446|NCT00686075|62790874|FG006|Overall Study|Other|0|||
33412447|NCT00686075|62790875|FG007|Overall Study|Other|0|||
33412448|NCT00686075|62790876|FG008|Overall Study|Other|0|||
33412449|NCT00686075|62790877|FG009|Overall Study|Other|1|||
33412450|NCT00685763|62790899|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
33412451|NCT00685763|62790899|FG000|Overall Study|Protocol Violation|1|||
33412452|NCT00098293|62790906|FG000|Double-blind (DB) Phase|Adverse Event|14|||
33412453|NCT00098293|62790907|FG001|Double-blind (DB) Phase|Adverse Event|27|||
33412454|NCT00098293|62790908|FG002|Double-blind (DB) Phase|Adverse Event|60|||
33412455|NCT00098293|62790909|FG003|Double-blind (DB) Phase|Adverse Event|0|||
33412456|NCT00098293|62790910|FG004|Double-blind (DB) Phase|Adverse Event|0|||
33412457|NCT00098293|62790906|FG000|Double-blind (DB) Phase|Pregnancy|0|||
33412458|NCT00098293|62790907|FG001|Double-blind (DB) Phase|Pregnancy|7|||
33412459|NCT00098293|62790908|FG002|Double-blind (DB) Phase|Pregnancy|9|||
33601879|NCT02463071|63000805|FG000|Overall Study|Reason not specified|7|||
33601880|NCT02463071|63000806|FG001|Overall Study|Reason not specified|9|||
33601881|NCT02463071|63000807|FG002|Overall Study|Reason not specified|4|||
33412460|NCT00098293|62790909|FG003|Double-blind (DB) Phase|Pregnancy|0|||
33412461|NCT00098293|62790910|FG004|Double-blind (DB) Phase|Pregnancy|0|||
33412462|NCT00098293|62790906|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
33412463|NCT00098293|62790907|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
33412464|NCT00098293|62790908|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
33412465|NCT00098293|62790909|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
33601882|NCT02463071|63000805|FG000|Overall Study|Protocol Violation|0|||
33601883|NCT02463071|63000806|FG001|Overall Study|Protocol Violation|2|||
33412466|NCT00098293|62790910|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
33412467|NCT00098293|62790906|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
33601884|NCT02463071|63000807|FG002|Overall Study|Protocol Violation|0|||
33601885|NCT02463071|63000805|FG000|Overall Study|Lost to Follow-up|0|||
33601886|NCT02463071|63000806|FG001|Overall Study|Lost to Follow-up|0|||
33601887|NCT02463071|63000807|FG002|Overall Study|Lost to Follow-up|1|||
33601888|NCT02266381|63000818|FG000|Overall Study|Physician Decision|3|||
33601889|NCT02266381|63000819|FG001|Overall Study|Physician Decision|5|||
33601890|NCT02266381|63000820|FG002|Overall Study|Physician Decision|4|||
33601891|NCT01827046|63000832|FG000|Overall Study|Lost to Follow-up|1|||
33601892|NCT01827046|63000833|FG001|Overall Study|Lost to Follow-up|5|||
33601893|NCT01827046|63000832|FG000|Overall Study|Withdrawal by Subject|0|||
33601894|NCT01827046|63000833|FG001|Overall Study|Withdrawal by Subject|4|||
33601895|NCT02356562|63000841|FG000|Overall Study|Withdrawal by Subject|0|||
33601896|NCT02356562|63000842|FG001|Overall Study|Withdrawal by Subject|1|||
33601897|NCT02356562|63000841|FG000|Overall Study|Re-entered treatment in a previous study|1|||
33601898|NCT02356562|63000842|FG001|Overall Study|Re-entered treatment in a previous study|0|||
33601899|NCT02356562|63000841|FG000|Overall Study|site closure|1|||
33601900|NCT02356562|63000842|FG001|Overall Study|site closure|0|||
33601901|NCT02448563|63000853|FG000|Overall Study|Lost to Follow-up|16|||
33601902|NCT02448563|63000854|FG001|Overall Study|Lost to Follow-up|10|||
33601903|NCT02448563|63000853|FG000|Overall Study|Withdrawal by Subject|0|||
33601904|NCT02448563|63000854|FG001|Overall Study|Withdrawal by Subject|1|||
33601905|NCT02266225|63000864|FG000|Overall Study|Lost to Follow-up|2|||
33601906|NCT02266225|63000864|FG000|Overall Study|Death|1|||
33601907|NCT02266225|63000864|FG000|Overall Study|Withdrawal by Subject|13|||
33601908|NCT02354690|63000869|FG000|Overall Study|Physician Decision|1|||
33601909|NCT02354222|63000875|FG000|Overall Study|Adverse Event|0|||
33601910|NCT02354222|63000876|FG001|Overall Study|Adverse Event|3|||
33601911|NCT02354222|63000875|FG000|Overall Study|Physician Decision|1|||
33601912|NCT02354222|63000876|FG001|Overall Study|Physician Decision|1|||
33601913|NCT02354222|63000875|FG000|Overall Study|Pregnancy|1|||
33601914|NCT02354222|63000876|FG001|Overall Study|Pregnancy|0|||
33601915|NCT02354222|63000875|FG000|Overall Study|Withdrawal by Subject|2|||
33601916|NCT02354222|63000876|FG001|Overall Study|Withdrawal by Subject|3|||
33601917|NCT02354222|63000875|FG000|Overall Study|Conflict with the stopping criteria|0|||
33601918|NCT02354222|63000876|FG001|Overall Study|Conflict with the stopping criteria|4|||
33601919|NCT02353442|63000884|FG000|Overall Study|Withdrawal by Subject|3|||
33601920|NCT02353442|63000885|FG001|Overall Study|Withdrawal by Subject|4|||
33601921|NCT02351960|63000893|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
33601922|NCT02351960|63000894|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
33601923|NCT02351960|63000893|FG000|Overall Study|Voluntary Withdrawal|5|||
33601924|NCT02351960|63000894|FG001|Overall Study|Voluntary Withdrawal|4|||
33601925|NCT02351960|63000893|FG000|Overall Study|Significant Protocol Deviation|0|||
33601926|NCT02351960|63000894|FG001|Overall Study|Significant Protocol Deviation|5|||
33601927|NCT02351180|63000903|FG000|Overall Study|Withdrawal by Subject|1|||
33601928|NCT02351180|63000904|FG001|Overall Study|Withdrawal by Subject|0|||
33601929|NCT02350478|63000912|FG000|Overall Study|Lost to Follow-up|5|||
33601930|NCT02350478|63000913|FG001|Overall Study|Lost to Follow-up|1|||
33601931|NCT02349542|63000919|FG000|Overall Study|Withdrawal by Subject|5|||
33601932|NCT02321930|63000923|FG000|Overall Study|Lost to Follow-up|1|||
33601933|NCT01647542|63000930|FG000|Overall Study|Major Protocol Deviation|1|||
33412468|NCT00098293|62790907|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
33412469|NCT00098293|62790908|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
33412470|NCT00098293|62790909|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
33601934|NCT01647542|63000931|FG001|Overall Study|Major Protocol Deviation|0|||
33601935|NCT01647542|63000932|FG002|Overall Study|Major Protocol Deviation|0|||
33601936|NCT01647542|63000930|FG000|Overall Study|Adverse Event|4|||
33601937|NCT01647542|63000931|FG001|Overall Study|Adverse Event|5|||
33412471|NCT00098293|62790910|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
33412472|NCT00098293|62790906|FG000|Double-blind (DB) Phase|Death|1|||
33412473|NCT00098293|62790907|FG001|Double-blind (DB) Phase|Death|2|||
33412474|NCT00098293|62790908|FG002|Double-blind (DB) Phase|Death|2|||
33412475|NCT00098293|62790909|FG003|Double-blind (DB) Phase|Death|0|||
33412476|NCT00098293|62790910|FG004|Double-blind (DB) Phase|Death|0|||
33412477|NCT00098293|62790906|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
33412478|NCT00098293|62790907|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
33412479|NCT00098293|62790908|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
33412480|NCT00098293|62790909|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
33412481|NCT00098293|62790910|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
33412482|NCT00098293|62790906|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
33412483|NCT00098293|62790907|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
33412484|NCT00098293|62790908|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
33412485|NCT00098293|62790909|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
33412486|NCT00098293|62790910|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
33412487|NCT00098293|62790906|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
33412488|NCT00098293|62790907|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
33412489|NCT00098293|62790908|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
33412490|NCT00098293|62790909|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
33412491|NCT00098293|62790910|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
33412492|NCT00098293|62790906|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
33412493|NCT00098293|62790907|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
33412494|NCT00098293|62790908|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
33412495|NCT00098293|62790909|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
33412496|NCT00098293|62790910|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
33412497|NCT00098293|62790906|FG000|Open-label (OL) Phase|Adverse Event|0|||
33412498|NCT00098293|62790907|FG001|Open-label (OL) Phase|Adverse Event|3|||
33412499|NCT00098293|62790908|FG002|Open-label (OL) Phase|Adverse Event|7|||
33412500|NCT00098293|62790909|FG003|Open-label (OL) Phase|Adverse Event|6|||
33412501|NCT00098293|62790910|FG004|Open-label (OL) Phase|Adverse Event|0|||
33412502|NCT00098293|62790906|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
33412503|NCT00098293|62790907|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
33322182|NCT01193153|62698322|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
33322183|NCT01193153|62698323|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
33322184|NCT01193153|62698322|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
33322185|NCT01193153|62698323|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
33322186|NCT01193153|62698322|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
33322187|NCT01193153|62698323|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
33322188|NCT01193153|62698322|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
33322189|NCT01193153|62698323|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
33412504|NCT00098293|62790908|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
33412505|NCT00098293|62790909|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
33412506|NCT00098293|62790910|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
33412507|NCT00098293|62790906|FG000|Open-label (OL) Phase|Pregnancy|0|||
33412508|NCT00098293|62790907|FG001|Open-label (OL) Phase|Pregnancy|1|||
33601938|NCT01647542|63000932|FG002|Overall Study|Adverse Event|4|||
33601939|NCT01647542|63000930|FG000|Overall Study|Lost to Follow-up|0|||
33601940|NCT01647542|63000931|FG001|Overall Study|Lost to Follow-up|2|||
33412509|NCT00098293|62790908|FG002|Open-label (OL) Phase|Pregnancy|0|||
33412510|NCT00098293|62790909|FG003|Open-label (OL) Phase|Pregnancy|3|||
33494061|NCT03473340|62872720|FG000|Overall Study|Withdrawal by Subject|1|||
33601941|NCT01647542|63000932|FG002|Overall Study|Lost to Follow-up|2|||
33601942|NCT01647542|63000930|FG000|Overall Study|Withdrawal by Subject|6|||
33601943|NCT01647542|63000931|FG001|Overall Study|Withdrawal by Subject|4|||
33601944|NCT01647542|63000932|FG002|Overall Study|Withdrawal by Subject|0|||
33601945|NCT01647542|63000930|FG000|Overall Study|Study Termination|64|||
33601946|NCT01647542|63000931|FG001|Overall Study|Study Termination|61|||
33601947|NCT01647542|63000932|FG002|Overall Study|Study Termination|65|||
33601948|NCT01647542|63000930|FG000|Overall Study|Lack of Efficacy|1|||
33601949|NCT01647542|63000931|FG001|Overall Study|Lack of Efficacy|1|||
33601950|NCT01647542|63000932|FG002|Overall Study|Lack of Efficacy|0|||
33601951|NCT01647542|63000930|FG000|Overall Study|Death|0|||
33601952|NCT01647542|63000931|FG001|Overall Study|Death|0|||
33601953|NCT01647542|63000932|FG002|Overall Study|Death|1|||
33601954|NCT02321462|63000942|FG000|Overall Study|Withdrawal by Subject|5|||
33601955|NCT02321462|63000943|FG001|Overall Study|Withdrawal by Subject|2|||
33601956|NCT02321462|63000942|FG000|Overall Study|Subject withdrawn before any treatment|1|||
33601957|NCT02321462|63000943|FG001|Overall Study|Subject withdrawn before any treatment|1|||
33601958|NCT02391584|63000952|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
33601959|NCT02391584|63000953|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
33601960|NCT02391584|63000952|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
33601961|NCT02391584|63000953|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
33601962|NCT02391584|63000952|FG000|3 Month|Lost to Follow-up|1|||
33601963|NCT02391584|63000953|FG001|3 Month|Lost to Follow-up|0|||
33601964|NCT02391584|63000952|FG000|6 Month|Withdrawal by Subject|1|||
33601965|NCT02391584|63000953|FG001|6 Month|Withdrawal by Subject|0|||
33601966|NCT02391584|63000952|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
33601967|NCT02391584|63000953|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
33601968|NCT02266147|63000966|FG000|PART 1: Dose Escalation|Physician Decision|0|||
33601969|NCT02266147|63000967|FG001|PART 1: Dose Escalation|Physician Decision|0|||
33601970|NCT02266147|63000968|FG002|PART 1: Dose Escalation|Physician Decision|1|||
33601971|NCT02266147|63000969|FG003|PART 1: Dose Escalation|Physician Decision|0|||
33601972|NCT02266147|63000966|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
33601973|NCT02266147|63000967|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
33601974|NCT02266147|63000968|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
33601975|NCT02266147|63000969|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
33601976|NCT02266147|63000966|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
33601977|NCT02266147|63000967|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
33601978|NCT02266147|63000968|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
33601979|NCT02266147|63000969|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
33601980|NCT02266147|63000966|FG000|PART 1: Dose Escalation|Other|1|||
33601981|NCT02266147|63000967|FG001|PART 1: Dose Escalation|Other|1|||
33601982|NCT02266147|63000968|FG002|PART 1: Dose Escalation|Other|0|||
33601983|NCT02266147|63000969|FG003|PART 1: Dose Escalation|Other|0|||
33601984|NCT02266147|63000966|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
33601985|NCT02266147|63000967|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
33601986|NCT02266147|63000968|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
33601987|NCT02266147|63000969|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
33601988|NCT02266147|63000966|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
33601989|NCT02266147|63000967|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
33601990|NCT02266147|63000968|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
33601991|NCT02266147|63000969|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
33601992|NCT02264977|63000981|FG000|Overall Study|Death|3|||
33601993|NCT02264977|63000981|FG000|Overall Study|Physician Decision|1|||
33412511|NCT00098293|62790910|FG004|Open-label (OL) Phase|Pregnancy|0|||
33412512|NCT00098293|62790906|FG000|Open-label (OL) Phase|Protocol Violation|0|||
33601994|NCT02264977|63000981|FG000|Overall Study|Refuse to return|1|||
33601995|NCT02264821|63000988|FG000|Overall Study|Protocol Violation|1|||
33601996|NCT02264821|63000989|FG001|Overall Study|Protocol Violation|3|||
33601997|NCT02264821|63000990|FG002|Overall Study|Protocol Violation|6|||
33601998|NCT02261467|63001000|FG000|Overall Study|Enrolled in Error|1|||
33601999|NCT02261467|63001001|FG001|Overall Study|Enrolled in Error|0|||
33602000|NCT02261467|63001000|FG000|Overall Study|Protocol Violation|0|||
33602001|NCT02261467|63001001|FG001|Overall Study|Protocol Violation|1|||
33602002|NCT02261467|63001000|FG000|Overall Study|Personal Reasons|17|||
33602003|NCT02261467|63001001|FG001|Overall Study|Personal Reasons|22|||
33602004|NCT02261467|63001000|FG000|Overall Study|Lost to Follow-up|2|||
33602005|NCT02261467|63001001|FG001|Overall Study|Lost to Follow-up|13|||
33602006|NCT02261467|63001000|FG000|Overall Study|Adverse Event|1|||
33602007|NCT02261467|63001001|FG001|Overall Study|Adverse Event|1|||
33602008|NCT01643473|63001009|FG000|Overall Study|Lost to Follow-up|1|||
33602009|NCT01643473|63001010|FG001|Overall Study|Lost to Follow-up|0|||
33602010|NCT02320058|63001018|FG000|Overall Study|Death|25|||
33602011|NCT02320058|63001019|FG001|Overall Study|Death|10|||
33602012|NCT02320058|63001018|FG000|Overall Study|Lost to Follow-up|4|||
33602013|NCT02320058|63001019|FG001|Overall Study|Lost to Follow-up|0|||
33602014|NCT02320058|63001018|FG000|Overall Study|Other reasons|4|||
33602015|NCT02320058|63001019|FG001|Overall Study|Other reasons|1|||
33602016|NCT02320058|63001018|FG000|Overall Study|Withdrawal by Subject|8|||
33602017|NCT02320058|63001019|FG001|Overall Study|Withdrawal by Subject|2|||
33602018|NCT02320058|63001018|FG000|Overall Study|Not reported|1|||
33602019|NCT02320058|63001019|FG001|Overall Study|Not reported|0|||
33602020|NCT02319668|63001027|FG000|Overall Study|Other (Not specified)|0|||
33602021|NCT02319668|63001028|FG001|Overall Study|Other (Not specified)|2|||
33602022|NCT02092467|63001040|FG000|Overall Study|Death|49|||
33602023|NCT02092467|63001041|FG001|Overall Study|Death|66|||
33602024|NCT02092467|63001042|FG002|Overall Study|Death|38|||
33602025|NCT02092467|63001040|FG000|Overall Study|Lost to Follow-up|38|||
33602026|NCT02092467|63001041|FG001|Overall Study|Lost to Follow-up|35|||
33602027|NCT02092467|63001042|FG002|Overall Study|Lost to Follow-up|40|||
33602028|NCT02092467|63001040|FG000|Overall Study|Global Deterioration of Health Status|1|||
33602029|NCT02092467|63001041|FG001|Overall Study|Global Deterioration of Health Status|0|||
33602030|NCT02092467|63001042|FG002|Overall Study|Global Deterioration of Health Status|0|||
33602031|NCT02092467|63001040|FG000|Overall Study|Other|32|||
33602032|NCT02092467|63001041|FG001|Overall Study|Other|30|||
33602033|NCT02092467|63001042|FG002|Overall Study|Other|24|||
33602034|NCT02092467|63001040|FG000|Overall Study|Withdrawal by Subject|282|||
33602035|NCT02092467|63001041|FG001|Overall Study|Withdrawal by Subject|327|||
33602036|NCT02092467|63001042|FG002|Overall Study|Withdrawal by Subject|289|||
33602037|NCT02092467|63001040|FG000|Overall Study|Randomized but not treated|2|||
33602038|NCT02092467|63001041|FG001|Overall Study|Randomized but not treated|1|||
33602039|NCT02092467|63001042|FG002|Overall Study|Randomized but not treated|7|||
33602040|NCT02462759|63001054|FG000|Part 1: Double Blind|Death|1|||
33602041|NCT02462759|63001055|FG001|Part 1: Double Blind|Death|0|||
33602042|NCT02462759|63001056|FG002|Part 1: Double Blind|Death|0|||
33602043|NCT02349386|63001071|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
33602044|NCT02349386|63001072|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
33602045|NCT02349386|63001073|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
33602046|NCT02349386|63001074|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
33602047|NCT02349386|63001071|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
33602048|NCT02349386|63001072|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
33602049|NCT02349386|63001073|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
33602050|NCT02349386|63001074|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
33602051|NCT02349386|63001071|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
33412513|NCT00098293|62790907|FG001|Open-label (OL) Phase|Protocol Violation|6|||
33412514|NCT00098293|62790908|FG002|Open-label (OL) Phase|Protocol Violation|13|||
33412515|NCT00098293|62790909|FG003|Open-label (OL) Phase|Protocol Violation|16|||
33602052|NCT02349386|63001072|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
33602053|NCT02349386|63001073|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
33602054|NCT02349386|63001074|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
33602055|NCT02349386|63001071|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
33602056|NCT02349386|63001072|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
33602057|NCT02349386|63001073|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
33602058|NCT02349386|63001074|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
33322190|NCT01193153|62698322|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
33322191|NCT01193153|62698323|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
33322192|NCT01192295|62698334|FG000|Overall Study|Adverse Event|3|||
33322193|NCT01192295|62698335|FG001|Overall Study|Adverse Event|7|||
33322194|NCT01192295|62698334|FG000|Overall Study|Withdrawal by Subject|3|||
33322195|NCT01192295|62698335|FG001|Overall Study|Withdrawal by Subject|4|||
33322196|NCT01192295|62698334|FG000|Overall Study|Lost to Follow-up|0|||
33322197|NCT01192295|62698335|FG001|Overall Study|Lost to Follow-up|1|||
33322198|NCT01192295|62698334|FG000|Overall Study|Lack of Efficacy|0|||
33322199|NCT01192295|62698335|FG001|Overall Study|Lack of Efficacy|5|||
33322200|NCT01192295|62698334|FG000|Overall Study|Administrative|4|||
33322201|NCT01192295|62698335|FG001|Overall Study|Administrative|6|||
33412516|NCT00098293|62790910|FG004|Open-label (OL) Phase|Protocol Violation|0|||
33602059|NCT02349386|63001071|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
33602060|NCT02349386|63001072|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
33602061|NCT02349386|63001073|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
33602062|NCT02349386|63001074|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
33602063|NCT02349386|63001071|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
33602064|NCT02349386|63001072|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
33602065|NCT02349386|63001073|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
33602066|NCT02349386|63001074|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
33602067|NCT02036775|63001084|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
33412517|NCT00098293|62790906|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
33602068|NCT02036775|63001085|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
33602069|NCT02036775|63001086|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
33602070|NCT02036775|63001087|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
33602071|NCT02036775|63001088|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
33602072|NCT02036775|63001089|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
33602073|NCT02092389|63001097|FG000|Overall Study|Adverse Event|1|||
33602074|NCT02092389|63001097|FG000|Overall Study|Other|5|||
33602075|NCT02034591|63001101|FG000|Overall Study|Withdrawal by Subject|0|||
33602076|NCT02034591|63001102|FG001|Overall Study|Withdrawal by Subject|0|||
33602077|NCT02034591|63001103|FG002|Overall Study|Withdrawal by Subject|0|||
33602078|NCT02034591|63001104|FG003|Overall Study|Withdrawal by Subject|0|||
33602079|NCT02034591|63001105|FG004|Overall Study|Withdrawal by Subject|1|||
33602080|NCT02034591|63001106|FG005|Overall Study|Withdrawal by Subject|0|||
33412518|NCT00098293|62790907|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
33412519|NCT00098293|62790908|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
33412520|NCT00098293|62790909|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
33412521|NCT00098293|62790910|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
33602081|NCT02391116|63001115|FG000|Treatment|Withdrawal by Subject|1|||
33602082|NCT02391116|63001115|FG000|Treatment|Protocol Violation|1|||
33602083|NCT02391116|63001115|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
33602084|NCT02391116|63001115|FG000|Treatment|AE with Clinical PD|3|||
33602085|NCT02391116|63001115|FG000|Safety Follow-up|Adverse Event|1|||
33602086|NCT02391116|63001115|FG000|Safety Follow-up|Withdrawal by Subject|4|||
33602087|NCT02391116|63001115|FG000|Safety Follow-up|Switching to Other Therapy|4|||
33602088|NCT02391116|63001115|FG000|Safety Follow-up|No Follow Up|1|||
33602089|NCT02391116|63001115|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
33602090|NCT02391116|63001115|FG000|Active Follow-up|Withdrawal by Subject|1|||
33602091|NCT02391116|63001115|FG000|Active Follow-up|Switching to Other Therapy|2|||
33602092|NCT02391116|63001115|FG000|Survival Follow-up|Withdrawal by Subject|3|||
33602093|NCT02391116|63001115|FG000|Survival Follow-up|Switching to Other Therapy|1|||
33602094|NCT02091921|63001126|FG000|Overall Study|Adverse Event|3|||
33602095|NCT02447081|63001133|FG000|Overall Study|Death|161|||
33602096|NCT02447081|63001133|FG000|Overall Study|Lost to Follow-up|36|||
33602097|NCT02447081|63001133|FG000|Overall Study|Visit not completed|17|||
33602098|NCT02447081|63001133|FG000|Overall Study|unsuccessful implant procedure|10|||
33602099|NCT02391038|63001137|FG000|Overall Study|Progressive disease|3|||
33602100|NCT02391038|63001138|FG001|Overall Study|Progressive disease|3|||
33602101|NCT02391038|63001139|FG002|Overall Study|Progressive disease|6|||
33602102|NCT02260921|63001150|FG000|Overall Study|Adverse Event|1|||
33602103|NCT02260921|63001151|FG001|Overall Study|Adverse Event|0|||
33602104|NCT02260921|63001150|FG000|Overall Study|Lost to Follow-up|4|||
33602105|NCT02260921|63001151|FG001|Overall Study|Lost to Follow-up|3|||
33602106|NCT02260921|63001150|FG000|Overall Study|Withdraw Consent|4|||
33602107|NCT02260921|63001151|FG001|Overall Study|Withdraw Consent|1|||
33412522|NCT00098293|62790906|FG000|Open-label (OL) Phase|Death|0|||
33412523|NCT00098293|62790907|FG001|Open-label (OL) Phase|Death|2|||
33412524|NCT00098293|62790908|FG002|Open-label (OL) Phase|Death|3|||
33602108|NCT02260921|63001150|FG000|Overall Study|Death|1|||
33602109|NCT02260921|63001151|FG001|Overall Study|Death|0|||
33412525|NCT00098293|62790909|FG003|Open-label (OL) Phase|Death|0|||
33602110|NCT02260921|63001150|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
33602111|NCT02260921|63001151|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
33602112|NCT02462603|63001157|FG000|Overall Study|Investigator Decision|1|||
33602113|NCT02462603|63001157|FG000|Overall Study|Non-Compliance|1|||
33602114|NCT02462603|63001157|FG000|Overall Study|Withdrawal by Subject|2|||
33602115|NCT02034513|63001163|FG000|Overall Study|Adverse Event|11|||
33602116|NCT02034513|63001164|FG001|Overall Study|Adverse Event|10|||
33602117|NCT02034513|63001163|FG000|Overall Study|Lack of Efficacy|0|||
33602118|NCT02034513|63001164|FG001|Overall Study|Lack of Efficacy|1|||
33602119|NCT02034513|63001163|FG000|Overall Study|Lost to Follow-up|6|||
33602120|NCT02034513|63001164|FG001|Overall Study|Lost to Follow-up|7|||
33412526|NCT00098293|62790910|FG004|Open-label (OL) Phase|Death|0|||
33412527|NCT00098293|62790906|FG000|Supplemental Phase (SP)|Death|0|||
33412528|NCT00098293|62790907|FG001|Supplemental Phase (SP)|Death|0|||
33412529|NCT00098293|62790908|FG002|Supplemental Phase (SP)|Death|0|||
33412530|NCT00098293|62790909|FG003|Supplemental Phase (SP)|Death|0|||
33412531|NCT00098293|62790910|FG004|Supplemental Phase (SP)|Death|1|||
33412532|NCT00098293|62790906|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
33412533|NCT00098293|62790907|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
33412534|NCT00098293|62790908|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
33412535|NCT00098293|62790909|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
33412536|NCT00098293|62790910|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
33412537|NCT00098293|62790906|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
33412538|NCT00098293|62790907|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
33412539|NCT00098293|62790908|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
33412540|NCT00098293|62790909|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
33412541|NCT00098293|62790910|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
33412542|NCT00098293|62790906|FG000|Supplemental Phase (SP)|Other|0|||
33412543|NCT00098293|62790907|FG001|Supplemental Phase (SP)|Other|0|||
33412544|NCT00098293|62790908|FG002|Supplemental Phase (SP)|Other|0|||
33412545|NCT00098293|62790909|FG003|Supplemental Phase (SP)|Other|0|||
33412546|NCT00098293|62790910|FG004|Supplemental Phase (SP)|Other|22|||
33602121|NCT02034513|63001163|FG000|Overall Study|Pregnancy|0|||
33602122|NCT02034513|63001164|FG001|Overall Study|Pregnancy|3|||
33322202|NCT01154166|62698345|FG000|Overall Study|Adverse Event|14|||
33322203|NCT01154166|62698346|FG001|Overall Study|Adverse Event|9|||
33322204|NCT01154166|62698345|FG000|Overall Study|Lost to Follow-up|1|||
33322205|NCT01154166|62698346|FG001|Overall Study|Lost to Follow-up|1|||
33322206|NCT01154166|62698345|FG000|Overall Study|Protocol Violation|4|||
33322207|NCT01154166|62698346|FG001|Overall Study|Protocol Violation|1|||
33322208|NCT01154166|62698345|FG000|Overall Study|Withdrawal by Subject|10|||
33322209|NCT01154166|62698346|FG001|Overall Study|Withdrawal by Subject|1|||
33322210|NCT01154166|62698345|FG000|Overall Study|Lack of Efficacy|3|||
33322211|NCT01154166|62698346|FG001|Overall Study|Lack of Efficacy|0|||
33322212|NCT01154166|62698345|FG000|Overall Study|Disease Progression|1|||
33322213|NCT01154166|62698346|FG001|Overall Study|Disease Progression|0|||
33322214|NCT01154166|62698345|FG000|Overall Study|Poor Compliance|1|||
33322215|NCT01154166|62698346|FG001|Overall Study|Poor Compliance|0|||
33322216|NCT00975585|62698354|FG000|Overall Study|Adverse Event|0|||
33322217|NCT00975585|62698355|FG001|Overall Study|Adverse Event|4|||
33322218|NCT00975585|62698354|FG000|Overall Study|Lost to Follow-up|3|||
33322219|NCT00975585|62698355|FG001|Overall Study|Lost to Follow-up|5|||
33322220|NCT00975585|62698354|FG000|Overall Study|Withdrawal by Subject|2|||
33322221|NCT00975585|62698355|FG001|Overall Study|Withdrawal by Subject|1|||
33322222|NCT00975585|62698354|FG000|Overall Study|Lens issue|2|||
33322223|NCT00975585|62698355|FG001|Overall Study|Lens issue|2|||
33322224|NCT01181921|62698363|FG000|Overall Study|Lost to Follow-up|1|||
33322225|NCT01174446|62698367|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
33322226|NCT01174446|62698368|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
33322227|NCT01174446|62698369|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
33322228|NCT01174446|62698370|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
33412547|NCT00685685|62790921|FG000|Washout Period of 7 Days|Adverse Event|2|||
33412548|NCT00685685|62790922|FG001|Washout Period of 7 Days|Adverse Event|0|||
33602123|NCT02034513|63001163|FG000|Overall Study|Protocol Violation|7|||
33602124|NCT02034513|63001164|FG001|Overall Study|Protocol Violation|10|||
33602125|NCT02034513|63001163|FG000|Overall Study|Withdrawal by Subject|25|||
33602126|NCT02034513|63001164|FG001|Overall Study|Withdrawal by Subject|25|||
33602127|NCT02034513|63001163|FG000|Overall Study|Unclassified|0|||
33602128|NCT02034513|63001164|FG001|Overall Study|Unclassified|1|||
33602129|NCT02348840|63001176|FG000|Overall Study|Withdrawal by Subject|2|||
33602130|NCT02348840|63001177|FG001|Overall Study|Withdrawal by Subject|1|||
33602131|NCT02348840|63001178|FG002|Overall Study|Withdrawal by Subject|0|||
33602132|NCT02348840|63001179|FG003|Overall Study|Withdrawal by Subject|0|||
33602133|NCT02462057|63001194|FG000|Overall Study|Left Vitality|32|||
33602134|NCT02462057|63001195|FG001|Overall Study|Left Vitality|27|||
33602135|NCT02462057|63001196|FG002|Overall Study|Left Vitality|23|||
33602136|NCT02462057|63001197|FG003|Overall Study|Left Vitality|35|||
33602137|NCT02462057|63001198|FG004|Overall Study|Left Vitality|33|||
33602138|NCT02462057|63001194|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
33602139|NCT02462057|63001195|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
33602140|NCT02462057|63001196|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
33602141|NCT02462057|63001197|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
33602142|NCT02462057|63001198|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
33602143|NCT02461745|63001212|FG000|Overall Study|Lack of Efficacy|9|||
33602144|NCT02461745|63001213|FG001|Overall Study|Lack of Efficacy|1|||
33602145|NCT02461745|63001212|FG000|Overall Study|Lost to Follow-up|2|||
33602146|NCT02461745|63001213|FG001|Overall Study|Lost to Follow-up|2|||
33602147|NCT02461745|63001212|FG000|Overall Study|Withdrawal by Subject|3|||
33602148|NCT02461745|63001213|FG001|Overall Study|Withdrawal by Subject|1|||
33602149|NCT02034435|63001223|FG000|Overall Study|Withdrawal by Subject|1|||
33602150|NCT02034435|63001224|FG001|Overall Study|Withdrawal by Subject|0|||
33602151|NCT02034435|63001225|FG002|Overall Study|Withdrawal by Subject|0|||
33602152|NCT02034435|63001226|FG003|Overall Study|Withdrawal by Subject|0|||
33602153|NCT02034435|63001223|FG000|Overall Study|Illness|0|||
33602154|NCT02034435|63001224|FG001|Overall Study|Illness|2|||
33602155|NCT02034435|63001225|FG002|Overall Study|Illness|0|||
33602156|NCT02034435|63001226|FG003|Overall Study|Illness|0|||
33602157|NCT02034435|63001223|FG000|Overall Study|Inadequate IV access|1|||
33602158|NCT02034435|63001224|FG001|Overall Study|Inadequate IV access|0|||
33602159|NCT02034435|63001225|FG002|Overall Study|Inadequate IV access|0|||
33602160|NCT02034435|63001226|FG003|Overall Study|Inadequate IV access|1|||
33602161|NCT02033889|63001239|FG000|Overall Study|Adverse Event|3|||
33602162|NCT02033889|63001240|FG001|Overall Study|Adverse Event|1|||
33602163|NCT02033889|63001241|FG002|Overall Study|Adverse Event|3|||
33602164|NCT02033889|63001239|FG000|Overall Study|Death|3|||
33602165|NCT02033889|63001240|FG001|Overall Study|Death|1|||
33602166|NCT02033889|63001241|FG002|Overall Study|Death|2|||
33602167|NCT02033889|63001239|FG000|Overall Study|Excluded Medication|1|||
33602168|NCT02033889|63001240|FG001|Overall Study|Excluded Medication|1|||
33602169|NCT02033889|63001241|FG002|Overall Study|Excluded Medication|0|||
33602170|NCT02033889|63001239|FG000|Overall Study|Lost to Follow-up|8|||
33602171|NCT02033889|63001240|FG001|Overall Study|Lost to Follow-up|5|||
33602172|NCT02033889|63001241|FG002|Overall Study|Lost to Follow-up|6|||
33602173|NCT02033889|63001239|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33602174|NCT02033889|63001240|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33602175|NCT02033889|63001241|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33602176|NCT02033889|63001239|FG000|Overall Study|Physician Decision|0|||
33602177|NCT02033889|63001240|FG001|Overall Study|Physician Decision|1|||
33602178|NCT02033889|63001241|FG002|Overall Study|Physician Decision|1|||
33602179|NCT02033889|63001239|FG000|Overall Study|Participant moved|0|||
33602180|NCT02033889|63001240|FG001|Overall Study|Participant moved|1|||
33602181|NCT02033889|63001241|FG002|Overall Study|Participant moved|0|||
33602182|NCT02033889|63001239|FG000|Overall Study|Withdrawal by Subject|18|||
33602183|NCT02033889|63001240|FG001|Overall Study|Withdrawal by Subject|10|||
33602184|NCT02033889|63001241|FG002|Overall Study|Withdrawal by Subject|13|||
33602185|NCT02447003|63001251|FG000|Overall Study|Other|0|||
33602186|NCT02447003|63001252|FG001|Overall Study|Other|4|||
33602187|NCT02447003|63001251|FG000|Overall Study|Site discontinued|0|||
33602188|NCT02447003|63001252|FG001|Overall Study|Site discontinued|2|||
33602189|NCT02447003|63001251|FG000|Overall Study|Physician Decision|0|||
33602190|NCT02447003|63001252|FG001|Overall Study|Physician Decision|1|||
33602191|NCT02447003|63001251|FG000|Overall Study|Withdrawal by Subject|4|||
33412549|NCT00685685|62790921|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
33412550|NCT00685685|62790922|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33412551|NCT00684671|62790931|FG000|Overall Study|Adverse Event|1|||
33412552|NCT00684671|62790932|FG001|Overall Study|Adverse Event|0|||
33412553|NCT00684671|62790933|FG002|Overall Study|Adverse Event|0|||
33412554|NCT00684671|62790931|FG000|Overall Study|Lost to Follow-up|1|||
33412555|NCT00684671|62790932|FG001|Overall Study|Lost to Follow-up|0|||
33412556|NCT00684671|62790933|FG002|Overall Study|Lost to Follow-up|0|||
33412557|NCT00684671|62790931|FG000|Overall Study|Alcoholic dependance|1|||
33412558|NCT00684671|62790932|FG001|Overall Study|Alcoholic dependance|0|||
33412559|NCT00684671|62790933|FG002|Overall Study|Alcoholic dependance|0|||
33412560|NCT03859323|62790954|FG000|Overall Study|Lost to Follow-up|0|||
33412561|NCT03859323|62790955|FG001|Overall Study|Lost to Follow-up|0|||
33412562|NCT03859323|62790956|FG002|Overall Study|Lost to Follow-up|0|||
33412563|NCT03859323|62790957|FG003|Overall Study|Lost to Follow-up|0|||
33412564|NCT03859323|62790958|FG004|Overall Study|Lost to Follow-up|0|||
33412565|NCT03859323|62790959|FG005|Overall Study|Lost to Follow-up|0|||
33412566|NCT03859323|62790960|FG006|Overall Study|Lost to Follow-up|1|||
33412567|NCT03859323|62790961|FG007|Overall Study|Lost to Follow-up|0|||
33412568|NCT03859323|62790962|FG008|Overall Study|Lost to Follow-up|0|||
33412569|NCT03859323|62790963|FG009|Overall Study|Lost to Follow-up|0|||
33412570|NCT03859323|62790964|FG010|Overall Study|Lost to Follow-up|0|||
33412571|NCT03859323|62790965|FG011|Overall Study|Lost to Follow-up|0|||
33412572|NCT03859323|62790966|FG012|Overall Study|Lost to Follow-up|0|||
33412573|NCT03859323|62790954|FG000|Overall Study|Withdrawal by Subject|0|||
33412574|NCT03859323|62790955|FG001|Overall Study|Withdrawal by Subject|0|||
33412575|NCT03859323|62790956|FG002|Overall Study|Withdrawal by Subject|1|||
33412576|NCT03859323|62790957|FG003|Overall Study|Withdrawal by Subject|0|||
33412577|NCT03859323|62790958|FG004|Overall Study|Withdrawal by Subject|0|||
33412578|NCT03859323|62790959|FG005|Overall Study|Withdrawal by Subject|1|||
33412579|NCT03859323|62790960|FG006|Overall Study|Withdrawal by Subject|0|||
33412580|NCT03859323|62790961|FG007|Overall Study|Withdrawal by Subject|0|||
33412581|NCT03859323|62790962|FG008|Overall Study|Withdrawal by Subject|0|||
33412582|NCT03859323|62790963|FG009|Overall Study|Withdrawal by Subject|1|||
33412583|NCT03859323|62790964|FG010|Overall Study|Withdrawal by Subject|1|||
33412584|NCT03859323|62790965|FG011|Overall Study|Withdrawal by Subject|2|||
33412585|NCT03859323|62790966|FG012|Overall Study|Withdrawal by Subject|1|||
33412586|NCT03859323|62790954|FG000|Overall Study|Pregnancy|0|||
33412587|NCT03859323|62790955|FG001|Overall Study|Pregnancy|0|||
33412588|NCT03859323|62790956|FG002|Overall Study|Pregnancy|0|||
33412589|NCT03859323|62790957|FG003|Overall Study|Pregnancy|0|||
33412590|NCT03859323|62790958|FG004|Overall Study|Pregnancy|0|||
33412591|NCT03859323|62790959|FG005|Overall Study|Pregnancy|0|||
33412592|NCT03859323|62790960|FG006|Overall Study|Pregnancy|0|||
33412593|NCT03859323|62790961|FG007|Overall Study|Pregnancy|0|||
33412594|NCT03859323|62790962|FG008|Overall Study|Pregnancy|0|||
33412595|NCT03859323|62790963|FG009|Overall Study|Pregnancy|1|||
33412596|NCT03859323|62790964|FG010|Overall Study|Pregnancy|0|||
33412597|NCT03859323|62790965|FG011|Overall Study|Pregnancy|0|||
33412598|NCT03859323|62790966|FG012|Overall Study|Pregnancy|0|||
33412599|NCT03857841|62791009|FG000|Overall Study|Death|1|||
33602192|NCT02447003|63001252|FG001|Overall Study|Withdrawal by Subject|3|||
33602193|NCT02447003|63001251|FG000|Overall Study|Sponsor Decision|6|||
33602194|NCT02447003|63001252|FG001|Overall Study|Sponsor Decision|11|||
33602195|NCT02447003|63001251|FG000|Overall Study|Progressive Disease|1|||
33602196|NCT02447003|63001252|FG001|Overall Study|Progressive Disease|0|||
33412600|NCT03857841|62791010|FG001|Overall Study|Death|0|||
33412601|NCT03857841|62791011|FG002|Overall Study|Death|0|||
33412602|NCT03857841|62791012|FG003|Overall Study|Death|0|||
33412603|NCT03857841|62791009|FG000|Overall Study|Study Terminated by Sponsor|1|||
33602197|NCT02447003|63001251|FG000|Overall Study|Lost to Follow-up|5|||
33602198|NCT02447003|63001252|FG001|Overall Study|Lost to Follow-up|0|||
33602199|NCT02447003|63001251|FG000|Overall Study|Death|154|||
33602200|NCT02447003|63001252|FG001|Overall Study|Death|63|||
33602201|NCT01844284|63001262|FG000|Overall Study|Lost to Follow-up|12|||
33602202|NCT01844284|63001263|FG001|Overall Study|Lost to Follow-up|7|||
33602203|NCT02054715|63001271|FG000|Baseline/Follow-up 1|Refused|1|||
33602204|NCT02054715|63001272|FG001|Baseline/Follow-up 1|Refused|3|||
33602205|NCT02054715|63001271|FG000|Baseline/Follow-up 1|Medical|0|||
33602206|NCT02054715|63001272|FG001|Baseline/Follow-up 1|Medical|1|||
33602207|NCT02054715|63001271|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
33602208|NCT02054715|63001272|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
33602209|NCT02054715|63001271|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
33602210|NCT02054715|63001272|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
33602211|NCT02054715|63001271|FG000|Baseline/Follow-up 1|No Reason|0|||
33602212|NCT02054715|63001272|FG001|Baseline/Follow-up 1|No Reason|1|||
33602213|NCT02054715|63001271|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
33602214|NCT02054715|63001272|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
33602215|NCT02054715|63001271|FG000|Baseline/Follow-up 1|Ineligible|3|||
33602216|NCT02054715|63001272|FG001|Baseline/Follow-up 1|Ineligible|0|||
33602217|NCT02054715|63001271|FG000|Baseline/Follow-up 1|Hospitalization|1|||
33602218|NCT02054715|63001272|FG001|Baseline/Follow-up 1|Hospitalization|0|||
33602219|NCT02054715|63001271|FG000|Baseline/Follow-up 1|Changed Mind|1|||
33602220|NCT02054715|63001272|FG001|Baseline/Follow-up 1|Changed Mind|0|||
33602221|NCT02054715|63001271|FG000|Follow-up 2|Lost to Followup|3|||
33602222|NCT02054715|63001272|FG001|Follow-up 2|Lost to Followup|1|||
33602223|NCT02054715|63001271|FG000|Follow-up 2|Refused|3|||
33602224|NCT02054715|63001272|FG001|Follow-up 2|Refused|2|||
33602225|NCT02054715|63001271|FG000|Follow-up 2|Followup Not Completed|3|||
33602226|NCT02054715|63001272|FG001|Follow-up 2|Followup Not Completed|4|||
33602227|NCT02054715|63001271|FG000|Follow-up 2|Ineligible|4|||
33602228|NCT02054715|63001272|FG001|Follow-up 2|Ineligible|5|||
33602229|NCT02054715|63001271|FG000|Follow-up 2|Death|3|||
33602230|NCT02054715|63001272|FG001|Follow-up 2|Death|3|||
33602231|NCT02054715|63001271|FG000|Follow-up 2|Hospitalization|0|||
33602232|NCT02054715|63001272|FG001|Follow-up 2|Hospitalization|2|||
33602233|NCT02054715|63001271|FG000|Follow-up 2|Changed MD/Facility|0|||
33602234|NCT02054715|63001272|FG001|Follow-up 2|Changed MD/Facility|1|||
33602235|NCT02054715|63001271|FG000|Follow-up 2|Changed Mind|0|||
33602236|NCT02054715|63001272|FG001|Follow-up 2|Changed Mind|1|||
33602237|NCT02054715|63001271|FG000|Follow-up 2|No Reason|2|||
33602238|NCT02054715|63001272|FG001|Follow-up 2|No Reason|0|||
33602239|NCT02054715|63001271|FG000|Follow-up 2|Treatment Change or Delay|1|||
33602240|NCT02054715|63001272|FG001|Follow-up 2|Treatment Change or Delay|0|||
33602241|NCT02446769|63001278|FG000|Screening Period|Screen Failure|11|||
33602242|NCT02446769|63001279|FG001|Screening Period|Screen Failure|0|||
33602243|NCT02446769|63001280|FG002|Screening Period|Screen Failure|0|||
33602244|NCT02446769|63001278|FG000|Study Period|Randomized in Error|0|||
33602245|NCT02446769|63001279|FG001|Study Period|Randomized in Error|2|||
33602246|NCT02446769|63001280|FG002|Study Period|Randomized in Error|0|||
33602247|NCT02420093|63001289|FG000|Overall Study|Withdrawal by Subject|1|||
33602248|NCT02420093|63001290|FG001|Overall Study|Withdrawal by Subject|1|||
33602249|NCT02419937|63001298|FG000|Overall Study|Lost to Follow-up|1|||
33602250|NCT02419937|63001299|FG001|Overall Study|Lost to Follow-up|0|||
33602251|NCT02054481|63001309|FG000|Overall Study|Adverse Event|1|||
33602252|NCT02054481|63001310|FG001|Overall Study|Adverse Event|1|||
33602253|NCT02054481|63001311|FG002|Overall Study|Adverse Event|0|||
33602254|NCT02054481|63001312|FG003|Overall Study|Adverse Event|1|||
33602255|NCT02054481|63001309|FG000|Overall Study|Lost to Follow-up|1|||
33602256|NCT02054481|63001310|FG001|Overall Study|Lost to Follow-up|0|||
33602257|NCT02054481|63001311|FG002|Overall Study|Lost to Follow-up|0|||
33602258|NCT02054481|63001312|FG003|Overall Study|Lost to Follow-up|0|||
33602259|NCT02054481|63001309|FG000|Overall Study|Other reason|2|||
33602260|NCT02054481|63001310|FG001|Overall Study|Other reason|1|||
33602261|NCT02054481|63001311|FG002|Overall Study|Other reason|2|||
33602262|NCT02054481|63001312|FG003|Overall Study|Other reason|0|||
33602263|NCT01610752|63001326|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
33602264|NCT01610752|63001327|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
33602265|NCT01610752|63001328|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
33602266|NCT02054325|63001338|FG000|Overall Study|Lost to Follow-up|8|||
33602267|NCT02054325|63001339|FG001|Overall Study|Lost to Follow-up|5|||
33602268|NCT02446691|63001345|FG000|Overall Study|Withdrawal by Subject|2|||
33602269|NCT02446691|63001345|FG000|Overall Study|Lost to Follow-up|8|||
33602270|NCT02446691|63001345|FG000|Overall Study|Protocol Violation|1|||
33602271|NCT02091375|63001351|FG000|Overall Study|Adverse Event|8|||
33602272|NCT02091375|63001352|FG001|Overall Study|Adverse Event|1|||
33602273|NCT02091375|63001351|FG000|Overall Study|Lost to Follow-up|0|||
33602274|NCT02091375|63001352|FG001|Overall Study|Lost to Follow-up|1|||
33602275|NCT02091375|63001351|FG000|Overall Study|Withdrawal by Subject|0|||
33602276|NCT02091375|63001352|FG001|Overall Study|Withdrawal by Subject|1|||
33602277|NCT02091375|63001351|FG000|Overall Study|Withdrawn by the investigator|1|||
33602278|NCT02091375|63001352|FG001|Overall Study|Withdrawn by the investigator|0|||
33602279|NCT02032875|63001360|FG000|Treatment Period|Adverse Event|1|||
33602280|NCT02032875|63001361|FG001|Treatment Period|Adverse Event|0|||
33602281|NCT02032875|63001360|FG000|Treatment Period|Liver transplant, No extension needed|0|||
33602282|NCT02032875|63001361|FG001|Treatment Period|Liver transplant, No extension needed|1|||
33602283|NCT02032875|63001360|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
33602284|NCT02032875|63001361|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
33602285|NCT02032875|63001360|FG000|Follow-up Period|Death|0|||
33602286|NCT02032875|63001361|FG001|Follow-up Period|Death|1|||
33602287|NCT02032875|63001360|FG000|Follow-up Period|Virologic Relapse|3|||
33602288|NCT02032875|63001361|FG001|Follow-up Period|Virologic Relapse|10|||
33602289|NCT02032407|63001368|FG000|Overall Study|Lost to Follow-up|2|||
33602290|NCT02032407|63001368|FG000|Overall Study|Pregnancy|1|||
33602291|NCT02032407|63001368|FG000|Overall Study|Other Miscellaneous Reasons|2|||
33602292|NCT01843972|63001386|FG000|Overall Study|Withdrawal by Subject|0|||
33602293|NCT01843972|63001387|FG001|Overall Study|Withdrawal by Subject|0|||
33602294|NCT01843972|63001388|FG002|Overall Study|Withdrawal by Subject|0|||
33602295|NCT01843972|63001389|FG003|Overall Study|Withdrawal by Subject|0|||
33602296|NCT01843972|63001390|FG004|Overall Study|Withdrawal by Subject|1|||
33602297|NCT01843972|63001391|FG005|Overall Study|Withdrawal by Subject|0|||
33602298|NCT01843972|63001392|FG006|Overall Study|Withdrawal by Subject|0|||
33602299|NCT01843972|63001393|FG007|Overall Study|Withdrawal by Subject|0|||
33602300|NCT01843972|63001394|FG008|Overall Study|Withdrawal by Subject|0|||
33602301|NCT01843972|63001395|FG009|Overall Study|Withdrawal by Subject|0|||
33602302|NCT01826422|63001433|FG000|Overall Study|Withdrawal by Subject|1|||
33602303|NCT01826422|63001434|FG001|Overall Study|Withdrawal by Subject|3|||
33602304|NCT01843660|63001440|FG000|Overall Study|Other|30|||
33602305|NCT02090283|63001447|FG000|Overall Study|Withdrawal by Subject|6|||
33602306|NCT02090283|63001448|FG001|Overall Study|Withdrawal by Subject|6|||
33602307|NCT02090283|63001449|FG002|Overall Study|Withdrawal by Subject|6|||
33602308|NCT02090283|63001447|FG000|Overall Study|Sponsor Terminated Study|6|||
33602309|NCT02090283|63001448|FG001|Overall Study|Sponsor Terminated Study|6|||
33602310|NCT02090283|63001449|FG002|Overall Study|Sponsor Terminated Study|1|||
33602311|NCT02090283|63001447|FG000|Overall Study|Lost to Follow-up|2|||
33602312|NCT02090283|63001448|FG001|Overall Study|Lost to Follow-up|2|||
33602313|NCT02090283|63001449|FG002|Overall Study|Lost to Follow-up|3|||
33602314|NCT02090283|63001447|FG000|Overall Study|Adverse Event|1|||
33602315|NCT02090283|63001448|FG001|Overall Study|Adverse Event|1|||
33602316|NCT02090283|63001449|FG002|Overall Study|Adverse Event|0|||
33602317|NCT02090283|63001447|FG000|Overall Study|Protocol Violation|2|||
33602318|NCT02090283|63001448|FG001|Overall Study|Protocol Violation|0|||
33602319|NCT02090283|63001449|FG002|Overall Study|Protocol Violation|0|||
33602320|NCT02032173|63001457|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
33602321|NCT02031471|63001461|FG000|24 Week Treatment Period|Adverse Event|6|||
33602322|NCT02031471|63001461|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
33602323|NCT02031471|63001461|FG000|24 Week Treatment Period|Protocol Violation|1|||
33602324|NCT02031471|63001461|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
33602325|NCT02031471|63001461|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
33602326|NCT02031471|63001461|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
33602327|NCT02031471|63001461|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
33602328|NCT02461589|63001475|FG000|Overall Study|Withdrawal by Subject|5|||
33602329|NCT02461589|63001476|FG001|Overall Study|Withdrawal by Subject|1|||
33602330|NCT02461589|63001477|FG002|Overall Study|Withdrawal by Subject|3|||
33602331|NCT02461589|63001478|FG003|Overall Study|Withdrawal by Subject|2|||
33602332|NCT02461589|63001479|FG004|Overall Study|Withdrawal by Subject|1|||
33602333|NCT02461589|63001480|FG005|Overall Study|Withdrawal by Subject|2|||
33602334|NCT02461589|63001481|FG006|Overall Study|Withdrawal by Subject|1|||
33602335|NCT02461589|63001482|FG007|Overall Study|Withdrawal by Subject|3|||
33602336|NCT02461589|63001483|FG008|Overall Study|Withdrawal by Subject|3|||
33602337|NCT02461589|63001484|FG009|Overall Study|Withdrawal by Subject|1|||
33602338|NCT02461589|63001475|FG000|Overall Study|Lost to Follow-up|0|||
33602339|NCT02461589|63001476|FG001|Overall Study|Lost to Follow-up|0|||
33602340|NCT02461589|63001477|FG002|Overall Study|Lost to Follow-up|2|||
33602341|NCT02461589|63001478|FG003|Overall Study|Lost to Follow-up|3|||
33602342|NCT02461589|63001479|FG004|Overall Study|Lost to Follow-up|1|||
33602343|NCT02461589|63001480|FG005|Overall Study|Lost to Follow-up|1|||
33602344|NCT02461589|63001481|FG006|Overall Study|Lost to Follow-up|3|||
33602345|NCT02461589|63001482|FG007|Overall Study|Lost to Follow-up|1|||
33602346|NCT02461589|63001483|FG008|Overall Study|Lost to Follow-up|3|||
33602347|NCT02461589|63001484|FG009|Overall Study|Lost to Follow-up|1|||
33602348|NCT02461589|63001475|FG000|Overall Study|Death|0|||
33602349|NCT02461589|63001476|FG001|Overall Study|Death|0|||
33602350|NCT02461589|63001477|FG002|Overall Study|Death|0|||
33602351|NCT02461589|63001478|FG003|Overall Study|Death|0|||
33602352|NCT02461589|63001479|FG004|Overall Study|Death|0|||
33602353|NCT02461589|63001480|FG005|Overall Study|Death|0|||
33602354|NCT02461589|63001481|FG006|Overall Study|Death|0|||
33602355|NCT02461589|63001482|FG007|Overall Study|Death|1|||
33602356|NCT02461589|63001483|FG008|Overall Study|Death|0|||
33602357|NCT02461589|63001484|FG009|Overall Study|Death|0|||
33602358|NCT02461589|63001475|FG000|Overall Study|Unclassified|0|||
33602359|NCT02461589|63001476|FG001|Overall Study|Unclassified|0|||
33602360|NCT02461589|63001477|FG002|Overall Study|Unclassified|0|||
33602361|NCT02461589|63001478|FG003|Overall Study|Unclassified|0|||
33602362|NCT02461589|63001479|FG004|Overall Study|Unclassified|0|||
33602363|NCT02461589|63001480|FG005|Overall Study|Unclassified|0|||
33602364|NCT02461589|63001481|FG006|Overall Study|Unclassified|1|||
33602365|NCT02461589|63001482|FG007|Overall Study|Unclassified|0|||
33602366|NCT02461589|63001483|FG008|Overall Study|Unclassified|0|||
33602367|NCT02461589|63001484|FG009|Overall Study|Unclassified|2|||
33602368|NCT02461589|63001475|FG000|Overall Study|Missing follow-up information|1|||
33602369|NCT02461589|63001476|FG001|Overall Study|Missing follow-up information|1|||
33602370|NCT02461589|63001477|FG002|Overall Study|Missing follow-up information|0|||
33602371|NCT02461589|63001478|FG003|Overall Study|Missing follow-up information|0|||
33602372|NCT02461589|63001479|FG004|Overall Study|Missing follow-up information|0|||
33602373|NCT02461589|63001480|FG005|Overall Study|Missing follow-up information|0|||
33602374|NCT02461589|63001481|FG006|Overall Study|Missing follow-up information|1|||
33602375|NCT02461589|63001482|FG007|Overall Study|Missing follow-up information|0|||
33602376|NCT02461589|63001483|FG008|Overall Study|Missing follow-up information|0|||
33602377|NCT02461589|63001484|FG009|Overall Study|Missing follow-up information|0|||
33602378|NCT02461589|63001475|FG000|Overall Study|Withdrawal from trial before exposure|0|||
33602379|NCT02461589|63001476|FG001|Overall Study|Withdrawal from trial before exposure|0|||
33602380|NCT02461589|63001477|FG002|Overall Study|Withdrawal from trial before exposure|0|||
33602381|NCT02461589|63001478|FG003|Overall Study|Withdrawal from trial before exposure|0|||
33602382|NCT02461589|63001479|FG004|Overall Study|Withdrawal from trial before exposure|0|||
33602383|NCT02461589|63001480|FG005|Overall Study|Withdrawal from trial before exposure|0|||
33602384|NCT02461589|63001481|FG006|Overall Study|Withdrawal from trial before exposure|0|||
33602385|NCT02461589|63001482|FG007|Overall Study|Withdrawal from trial before exposure|0|||
33602386|NCT02461589|63001483|FG008|Overall Study|Withdrawal from trial before exposure|0|||
33602387|NCT02461589|63001484|FG009|Overall Study|Withdrawal from trial before exposure|1|||
33602388|NCT02089737|63001506|FG000|Overall Study|Survey form not completed|5|||
33602389|NCT02089737|63001506|FG000|Overall Study|Not treated|1|||
33602390|NCT02460575|63001513|FG000|Overall Study|Lost to Follow-up|1|||
33602391|NCT02460575|63001514|FG001|Overall Study|Lost to Follow-up|0|||
33602392|NCT02089347|63001522|FG000|Overall Study|Protocol Violation|1|||
33602393|NCT02089347|63001523|FG001|Overall Study|Protocol Violation|0|||
33602394|NCT02445755|63001529|FG000|Overall Study|Withdrawal by Subject|2|||
33602395|NCT02445755|63001529|FG000|Overall Study|Protocol Violation|6|||
33602396|NCT02445755|63001529|FG000|Overall Study|Screen Failure|5|||
33602397|NCT02419469|63001536|FG000|Overall Study|Withdrawal by Subject|1|||
33602398|NCT02419313|63001540|FG000|First Intervention|Lost to Follow-up|2|||
33602399|NCT02419313|63001541|FG001|First Intervention|Lost to Follow-up|0|||
33602400|NCT02419313|63001540|FG000|Second Intervention|Lost to Follow-up|1|||
33602401|NCT02419313|63001541|FG001|Second Intervention|Lost to Follow-up|0|||
33602402|NCT02419001|63001549|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
33602403|NCT02419001|63001550|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
33602404|NCT02031237|63001558|FG000|Overall Study|Death|1|||
33602405|NCT02031237|63001559|FG001|Overall Study|Death|5|||
33602406|NCT02031237|63001560|FG002|Overall Study|Death|0|||
33602407|NCT02031237|63001558|FG000|Overall Study|Physician Decision|0|||
33412604|NCT03857841|62791010|FG001|Overall Study|Study Terminated by Sponsor|0|||
33412605|NCT03857841|62791011|FG002|Overall Study|Study Terminated by Sponsor|0|||
33412606|NCT03857841|62791012|FG003|Overall Study|Study Terminated by Sponsor|0|||
33412607|NCT00500331|62791029|FG000|Overall Study|Adverse Event|0|||
33412608|NCT00500331|62791030|FG001|Overall Study|Adverse Event|2|||
33412609|NCT00500331|62791031|FG002|Overall Study|Adverse Event|0|||
33412610|NCT00500331|62791032|FG003|Overall Study|Adverse Event|1|||
33412611|NCT00500331|62791033|FG004|Overall Study|Adverse Event|2|||
33412612|NCT00500331|62791034|FG005|Overall Study|Adverse Event|2|||
33412613|NCT00500331|62791035|FG006|Overall Study|Adverse Event|0|||
33412614|NCT00500331|62791029|FG000|Overall Study|Lost to Follow-up|1|||
33412615|NCT00500331|62791030|FG001|Overall Study|Lost to Follow-up|1|||
33412616|NCT00500331|62791031|FG002|Overall Study|Lost to Follow-up|1|||
33412617|NCT00500331|62791032|FG003|Overall Study|Lost to Follow-up|2|||
33412618|NCT00500331|62791033|FG004|Overall Study|Lost to Follow-up|1|||
33412619|NCT00500331|62791034|FG005|Overall Study|Lost to Follow-up|0|||
33412620|NCT00500331|62791035|FG006|Overall Study|Lost to Follow-up|0|||
33412621|NCT00500331|62791029|FG000|Overall Study|Protocol Violation|3|||
33412622|NCT00500331|62791030|FG001|Overall Study|Protocol Violation|1|||
33412623|NCT00500331|62791031|FG002|Overall Study|Protocol Violation|1|||
33412624|NCT00500331|62791032|FG003|Overall Study|Protocol Violation|0|||
33412625|NCT00500331|62791033|FG004|Overall Study|Protocol Violation|1|||
33412626|NCT00500331|62791034|FG005|Overall Study|Protocol Violation|1|||
33412627|NCT00500331|62791035|FG006|Overall Study|Protocol Violation|1|||
33412628|NCT00500331|62791029|FG000|Overall Study|Withdrawal by Subject|4|||
33412629|NCT00500331|62791030|FG001|Overall Study|Withdrawal by Subject|0|||
33412630|NCT00500331|62791031|FG002|Overall Study|Withdrawal by Subject|1|||
33412631|NCT00500331|62791032|FG003|Overall Study|Withdrawal by Subject|5|||
33412632|NCT00500331|62791033|FG004|Overall Study|Withdrawal by Subject|0|||
33412633|NCT00500331|62791034|FG005|Overall Study|Withdrawal by Subject|1|||
33412634|NCT00500331|62791035|FG006|Overall Study|Withdrawal by Subject|1|||
33412635|NCT00500331|62791029|FG000|Overall Study|Lack of Efficacy|3|||
33412636|NCT00500331|62791030|FG001|Overall Study|Lack of Efficacy|1|||
33412637|NCT00500331|62791031|FG002|Overall Study|Lack of Efficacy|0|||
33412638|NCT00500331|62791032|FG003|Overall Study|Lack of Efficacy|0|||
33412639|NCT00500331|62791033|FG004|Overall Study|Lack of Efficacy|0|||
33602408|NCT02031237|63001559|FG001|Overall Study|Physician Decision|1|||
33412640|NCT00500331|62791034|FG005|Overall Study|Lack of Efficacy|0|||
33412641|NCT00500331|62791035|FG006|Overall Study|Lack of Efficacy|0|||
33412642|NCT00500331|62791029|FG000|Overall Study|Liver function test abnormality|0|||
33412643|NCT00500331|62791030|FG001|Overall Study|Liver function test abnormality|0|||
33412644|NCT00500331|62791031|FG002|Overall Study|Liver function test abnormality|1|||
33602409|NCT02031237|63001560|FG002|Overall Study|Physician Decision|0|||
33602410|NCT02031237|63001558|FG000|Overall Study|Withdrawal by Subject|2|||
33602411|NCT02031237|63001559|FG001|Overall Study|Withdrawal by Subject|2|||
33602412|NCT02031237|63001560|FG002|Overall Study|Withdrawal by Subject|0|||
33412645|NCT00500331|62791032|FG003|Overall Study|Liver function test abnormality|0|||
33412646|NCT00500331|62791033|FG004|Overall Study|Liver function test abnormality|0|||
33412647|NCT00500331|62791034|FG005|Overall Study|Liver function test abnormality|0|||
33412648|NCT00500331|62791035|FG006|Overall Study|Liver function test abnormality|0|||
33602413|NCT02031237|63001558|FG000|Overall Study|Protocol Violation|2|||
33602414|NCT02031237|63001559|FG001|Overall Study|Protocol Violation|6|||
33602415|NCT02031237|63001560|FG002|Overall Study|Protocol Violation|0|||
33602416|NCT02031237|63001558|FG000|Overall Study|Alternate Treatment Given|0|||
33602417|NCT02031237|63001559|FG001|Overall Study|Alternate Treatment Given|0|||
33602418|NCT02031237|63001560|FG002|Overall Study|Alternate Treatment Given|3|||
33602419|NCT02088957|63001567|FG000|Overall Study|Lack of Efficacy|1|||
33602420|NCT02088957|63001568|FG001|Overall Study|Lack of Efficacy|0|||
33602421|NCT02418845|63001576|FG000|Overall Study|Lost to Follow-up|7|||
33602422|NCT02418845|63001577|FG001|Overall Study|Lost to Follow-up|2|||
33602423|NCT02418845|63001576|FG000|Overall Study|Lack of Efficacy|0|||
33602424|NCT02418845|63001577|FG001|Overall Study|Lack of Efficacy|3|||
33602425|NCT02418845|63001576|FG000|Overall Study|Physician Decision|5|||
33602426|NCT02418845|63001577|FG001|Overall Study|Physician Decision|5|||
33602427|NCT02418845|63001576|FG000|Overall Study|Protocol Violation|1|||
33602428|NCT02418845|63001577|FG001|Overall Study|Protocol Violation|0|||
33602429|NCT02418845|63001576|FG000|Overall Study|Withdrawal by Subject|3|||
33602430|NCT02418845|63001577|FG001|Overall Study|Withdrawal by Subject|2|||
33602431|NCT02088177|63001583|FG000|Overall Study|Lost to Follow-up|3|||
33602432|NCT02030535|63001587|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
33602433|NCT02029989|63001603|FG000|Overall Study|Withdrawal by Subject|1|||
33602434|NCT02029989|63001604|FG001|Overall Study|Withdrawal by Subject|0|||
33602435|NCT02029989|63001603|FG000|Overall Study|Withdrawal: Fear of needles|1|||
33602436|NCT02029989|63001604|FG001|Overall Study|Withdrawal: Fear of needles|0|||
33602437|NCT02029989|63001603|FG000|Overall Study|Change of location|2|||
33602438|NCT02029989|63001604|FG001|Overall Study|Change of location|3|||
33602439|NCT02029989|63001603|FG000|Overall Study|Physician Decision|2|||
33602440|NCT02029989|63001604|FG001|Overall Study|Physician Decision|0|||
33602441|NCT02029989|63001603|FG000|Overall Study|Lost to Follow-up|9|||
33602442|NCT02029989|63001604|FG001|Overall Study|Lost to Follow-up|7|||
33602443|NCT02029989|63001603|FG000|Overall Study|Death|0|||
33602444|NCT02029989|63001604|FG001|Overall Study|Death|1|||
33602445|NCT02029989|63001603|FG000|Overall Study|Protocol Violation|1|||
33602446|NCT02029989|63001604|FG001|Overall Study|Protocol Violation|0|||
33602447|NCT02048241|63001612|FG000|Overall Study|Withdrawal by Subject|0|||
33602448|NCT02048241|63001613|FG001|Overall Study|Withdrawal by Subject|1|||
33602449|NCT02087943|63001622|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
33602450|NCT02087943|63001623|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
33602451|NCT02087943|63001624|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
33602452|NCT02087943|63001625|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
33602453|NCT02087943|63001626|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
33602454|NCT02087943|63001622|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
33602455|NCT02087943|63001623|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
33602456|NCT02087943|63001624|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
33602457|NCT02087943|63001625|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
33602458|NCT02087943|63001626|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
33602459|NCT02087943|63001622|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
33602460|NCT02087943|63001623|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
33602461|NCT02087943|63001624|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
33602462|NCT02087943|63001625|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
33602463|NCT02087943|63001626|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
33602464|NCT02087943|63001622|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
33602465|NCT02087943|63001623|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
33602466|NCT02087943|63001624|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
33602467|NCT02087943|63001625|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
33602468|NCT02087943|63001626|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
33602469|NCT02087943|63001622|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
33602470|NCT02087943|63001623|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
33602471|NCT02087943|63001624|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
33602472|NCT02087943|63001625|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
33602473|NCT02087943|63001626|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
33602474|NCT02087943|63001622|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
33602475|NCT02087943|63001623|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
33602476|NCT02087943|63001624|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
33602477|NCT02087943|63001625|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
33602478|NCT02087943|63001626|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
33602479|NCT02087943|63001622|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
33602480|NCT02087943|63001623|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
33602481|NCT02087943|63001624|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
33602482|NCT02087943|63001625|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
33602483|NCT02087943|63001626|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
33602484|NCT02087943|63001622|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
33602485|NCT02087943|63001623|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
33602486|NCT02087943|63001624|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
33602487|NCT02087943|63001625|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
33602488|NCT02087943|63001626|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
33602489|NCT02087943|63001622|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
33602490|NCT02087943|63001623|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
33602491|NCT02087943|63001624|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
33602492|NCT02087943|63001625|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
33602493|NCT02087943|63001626|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
33602494|NCT02087943|63001622|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
33602495|NCT02087943|63001623|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
33602496|NCT02087943|63001624|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
33602497|NCT02087943|63001625|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
33602498|NCT02087943|63001626|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
33602499|NCT02029521|63001640|FG000|Overall Study|Protocol Violation|1|||
33602500|NCT02029521|63001641|FG001|Overall Study|Protocol Violation|0|||
33602501|NCT02029521|63001640|FG000|Overall Study|Withdrawal by Subject|1|||
33602502|NCT02029521|63001641|FG001|Overall Study|Withdrawal by Subject|1|||
33602503|NCT02443883|63001662|FG000|Overall Study|Adverse Event|0|||
33602504|NCT02443883|63001663|FG001|Overall Study|Adverse Event|1|||
33602505|NCT02443883|63001664|FG002|Overall Study|Adverse Event|0|||
33602506|NCT02443883|63001665|FG003|Overall Study|Adverse Event|0|||
33602507|NCT02443883|63001662|FG000|Overall Study|Lost to Follow-up|3|||
33602508|NCT02443883|63001663|FG001|Overall Study|Lost to Follow-up|2|||
33602509|NCT02443883|63001664|FG002|Overall Study|Lost to Follow-up|1|||
33602510|NCT02443883|63001665|FG003|Overall Study|Lost to Follow-up|0|||
33602511|NCT02443883|63001662|FG000|Overall Study|Physician Decision|1|||
33602512|NCT02443883|63001663|FG001|Overall Study|Physician Decision|1|||
33602513|NCT02443883|63001664|FG002|Overall Study|Physician Decision|0|||
33602514|NCT02443883|63001665|FG003|Overall Study|Physician Decision|3|||
33602515|NCT02443883|63001662|FG000|Overall Study|Withdrawal by Subject|1|||
33602516|NCT02443883|63001663|FG001|Overall Study|Withdrawal by Subject|0|||
33602517|NCT02443883|63001664|FG002|Overall Study|Withdrawal by Subject|0|||
33602518|NCT02443883|63001665|FG003|Overall Study|Withdrawal by Subject|2|||
33602519|NCT02443883|63001662|FG000|Overall Study|Randomized, but never treated|1|||
33602520|NCT02443883|63001663|FG001|Overall Study|Randomized, but never treated|0|||
33602521|NCT02443883|63001664|FG002|Overall Study|Randomized, but never treated|0|||
33602522|NCT02443883|63001665|FG003|Overall Study|Randomized, but never treated|0|||
33602523|NCT02460263|63001675|FG000|Transition Period|Withdrawal by Subject|1|||
33602524|NCT02460263|63001675|FG000|Transition Period|Death|1|||
33602525|NCT02443805|63001685|FG000|Overall Study|Adverse Event|100|||
33602526|NCT02443805|63001686|FG001|Overall Study|Adverse Event|18|||
33602527|NCT02443805|63001685|FG000|Overall Study|Withdrawal by Subject|73|||
33602528|NCT02443805|63001686|FG001|Overall Study|Withdrawal by Subject|74|||
33602529|NCT02443805|63001685|FG000|Overall Study|Lost to Follow-up|19|||
33602530|NCT02443805|63001686|FG001|Overall Study|Lost to Follow-up|14|||
33602531|NCT02443805|63001685|FG000|Overall Study|Pregnancy|6|||
33602532|NCT02443805|63001686|FG001|Overall Study|Pregnancy|5|||
33602533|NCT02443805|63001685|FG000|Overall Study|Protocol Violation|2|||
33602534|NCT02443805|63001686|FG001|Overall Study|Protocol Violation|4|||
33602535|NCT02443805|63001685|FG000|Overall Study|Lack of Efficacy|1|||
33602536|NCT02443805|63001686|FG001|Overall Study|Lack of Efficacy|1|||
33602537|NCT02443805|63001685|FG000|Overall Study|Non-compliance with study drug|6|||
33602538|NCT02443805|63001686|FG001|Overall Study|Non-compliance with study drug|4|||
33602539|NCT02443805|63001685|FG000|Overall Study|Withdrawal by parent/guardian|3|||
33602540|NCT02443805|63001686|FG001|Overall Study|Withdrawal by parent/guardian|5|||
33602541|NCT02443805|63001685|FG000|Overall Study|Any other reason not above-mentioned|3|||
33602542|NCT02443805|63001686|FG001|Overall Study|Any other reason not above-mentioned|2|||
33602543|NCT01652885|63001692|FG000|Overall Study|Adverse Event|1|||
33602544|NCT02459951|63001696|FG000|Overall Study|Unable to meet holding requirement|1|||
33602545|NCT02087241|63001705|FG000|Overall Study|Death|2|||
33602546|NCT02087241|63001706|FG001|Overall Study|Death|1|||
33602547|NCT02087241|63001707|FG002|Overall Study|Death|1|||
33602548|NCT02087241|63001708|FG003|Overall Study|Death|1|||
33602549|NCT02087241|63001705|FG000|Overall Study|Withdrawal by Subject|1|||
33602550|NCT02087241|63001706|FG001|Overall Study|Withdrawal by Subject|0|||
33602551|NCT02087241|63001707|FG002|Overall Study|Withdrawal by Subject|0|||
33602552|NCT02087241|63001708|FG003|Overall Study|Withdrawal by Subject|1|||
33602553|NCT02087241|63001705|FG000|Overall Study|Progressive Disease|0|||
33602554|NCT02087241|63001706|FG001|Overall Study|Progressive Disease|0|||
33602555|NCT02087241|63001707|FG002|Overall Study|Progressive Disease|0|||
33602556|NCT02087241|63001708|FG003|Overall Study|Progressive Disease|1|||
33602557|NCT02087241|63001705|FG000|Overall Study|Study Terminated by Sponsor|0|||
33602558|NCT02087241|63001706|FG001|Overall Study|Study Terminated by Sponsor|2|||
33602559|NCT02087241|63001707|FG002|Overall Study|Study Terminated by Sponsor|0|||
33602560|NCT02087241|63001708|FG003|Overall Study|Study Terminated by Sponsor|4|||
33602561|NCT02087085|63001724|FG000|Overall Study|Adverse Event|10|||
33602562|NCT02087085|63001725|FG001|Overall Study|Adverse Event|14|||
33602563|NCT02087085|63001724|FG000|Overall Study|Lack of Efficacy|4|||
33602564|NCT02087085|63001725|FG001|Overall Study|Lack of Efficacy|3|||
33602565|NCT02087085|63001724|FG000|Overall Study|Lost to Follow-up|6|||
33602566|NCT02087085|63001725|FG001|Overall Study|Lost to Follow-up|4|||
33602567|NCT02087085|63001724|FG000|Overall Study|Withdrawal by Subject|9|||
33602568|NCT02087085|63001725|FG001|Overall Study|Withdrawal by Subject|11|||
33602569|NCT02087085|63001724|FG000|Overall Study|Protocol Violation|1|||
33602570|NCT02087085|63001725|FG001|Overall Study|Protocol Violation|0|||
33602571|NCT02087085|63001724|FG000|Overall Study|Study Terminated by Sponsor|87|||
33602572|NCT02087085|63001725|FG001|Overall Study|Study Terminated by Sponsor|80|||
33602573|NCT02087085|63001724|FG000|Overall Study|Other Miscellaneous Reasons|3|||
33602574|NCT02087085|63001725|FG001|Overall Study|Other Miscellaneous Reasons|4|||
33602575|NCT02443337|63001733|FG000|Overall Study|Adverse Event|0|||
33602576|NCT02443337|63001734|FG001|Overall Study|Adverse Event|1|||
33602577|NCT02443337|63001733|FG000|Overall Study|Clinical Progressive Disease|3|||
33602578|NCT02443337|63001734|FG001|Overall Study|Clinical Progressive Disease|0|||
33602579|NCT02443337|63001733|FG000|Overall Study|Withdrawal by Subject|2|||
33602580|NCT02443337|63001734|FG001|Overall Study|Withdrawal by Subject|1|||
33602581|NCT02443103|63001745|FG000|Overall Study|Adverse Event|2|||
33602582|NCT02443103|63001745|FG000|Overall Study|Noncompliance|1|||
33602583|NCT02022657|63001749|FG000|Overall Study|Withdrawal by Subject|2|||
33602584|NCT02022657|63001750|FG001|Overall Study|Withdrawal by Subject|0|||
33412649|NCT00500331|62791029|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
33412650|NCT00500331|62791030|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
33412651|NCT00500331|62791031|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
33602585|NCT02022657|63001751|FG002|Overall Study|Withdrawal by Subject|1|||
33602586|NCT02022657|63001752|FG003|Overall Study|Withdrawal by Subject|0|||
33602587|NCT02022657|63001753|FG004|Overall Study|Withdrawal by Subject|0|||
33602588|NCT02022657|63001754|FG005|Overall Study|Withdrawal by Subject|0|||
33602589|NCT02022657|63001749|FG000|Overall Study|Physician Decision|0|||
33602590|NCT02022657|63001750|FG001|Overall Study|Physician Decision|0|||
33602591|NCT02022657|63001751|FG002|Overall Study|Physician Decision|0|||
33412652|NCT00500331|62791032|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
33602592|NCT02022657|63001752|FG003|Overall Study|Physician Decision|0|||
33602593|NCT02022657|63001753|FG004|Overall Study|Physician Decision|0|||
33602594|NCT02022657|63001754|FG005|Overall Study|Physician Decision|1|||
33602595|NCT02418455|63001760|FG000|48-Week Treatment Period|Other- Not Specified|1|||
33602596|NCT02418455|63001760|FG000|Continuation Period|Sponsor Decision|7|||
33602597|NCT02417753|63001766|FG000|Overall Study|Death|1|||
33412653|NCT00500331|62791033|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
33412654|NCT00500331|62791034|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
33412655|NCT00500331|62791035|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
33412656|NCT00500331|62791029|FG000|Overall Study|Didn't return for continuation of study|1|||
33412657|NCT00500331|62791030|FG001|Overall Study|Didn't return for continuation of study|0|||
33412658|NCT00500331|62791031|FG002|Overall Study|Didn't return for continuation of study|0|||
33412659|NCT00500331|62791032|FG003|Overall Study|Didn't return for continuation of study|0|||
33412660|NCT00500331|62791033|FG004|Overall Study|Didn't return for continuation of study|0|||
33412661|NCT00500331|62791034|FG005|Overall Study|Didn't return for continuation of study|0|||
33412662|NCT00500331|62791035|FG006|Overall Study|Didn't return for continuation of study|0|||
33412663|NCT00500331|62791029|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
33412664|NCT00500331|62791030|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
33412665|NCT00500331|62791031|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
33412666|NCT00500331|62791032|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
33412667|NCT00500331|62791033|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
33412668|NCT00500331|62791034|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
33412669|NCT00500331|62791035|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
33412670|NCT00500331|62791029|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
33412671|NCT00500331|62791030|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
33412672|NCT00500331|62791031|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
33412673|NCT00500331|62791032|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
33412674|NCT00500331|62791033|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
33412675|NCT00500331|62791034|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
33412676|NCT00500331|62791035|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
33412677|NCT00500331|62791029|FG000|Overall Study|Participant was randomized by mistake|1|||
33412678|NCT00500331|62791030|FG001|Overall Study|Participant was randomized by mistake|0|||
33412679|NCT00500331|62791031|FG002|Overall Study|Participant was randomized by mistake|0|||
33412680|NCT00500331|62791032|FG003|Overall Study|Participant was randomized by mistake|0|||
33412681|NCT00500331|62791033|FG004|Overall Study|Participant was randomized by mistake|0|||
33412682|NCT00500331|62791034|FG005|Overall Study|Participant was randomized by mistake|0|||
33412683|NCT00500331|62791035|FG006|Overall Study|Participant was randomized by mistake|0|||
33412684|NCT00500331|62791029|FG000|Overall Study|Diabetologist nurse in the study|0|||
33412685|NCT00500331|62791030|FG001|Overall Study|Diabetologist nurse in the study|0|||
33412686|NCT00500331|62791031|FG002|Overall Study|Diabetologist nurse in the study|1|||
33412687|NCT00500331|62791032|FG003|Overall Study|Diabetologist nurse in the study|0|||
33412688|NCT00500331|62791033|FG004|Overall Study|Diabetologist nurse in the study|0|||
33412689|NCT00500331|62791034|FG005|Overall Study|Diabetologist nurse in the study|0|||
33412690|NCT00500331|62791035|FG006|Overall Study|Diabetologist nurse in the study|0|||
33412691|NCT00500331|62791029|FG000|Overall Study|State ban of biological samples export|0|||
33412692|NCT00500331|62791030|FG001|Overall Study|State ban of biological samples export|0|||
33412693|NCT00500331|62791031|FG002|Overall Study|State ban of biological samples export|0|||
33602598|NCT02417441|63001772|FG000|Overall Study|Inconclusive due to missing data|52|||
33602599|NCT02417441|63001773|FG001|Overall Study|Inconclusive due to missing data|19|||
33602600|NCT02021643|63001786|FG000|Overall Study|Enrolled but Never Treated|1|||
33602601|NCT02021643|63001787|FG001|Overall Study|Enrolled but Never Treated|0|||
33322229|NCT01174446|62698367|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
33322230|NCT01174446|62698368|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
33322231|NCT01174446|62698369|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
33322232|NCT01174446|62698370|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
33322233|NCT01174446|62698367|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
33322234|NCT01174446|62698368|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
33322235|NCT01174446|62698369|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
33322236|NCT01174446|62698370|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
33322237|NCT01174446|62698367|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
33322238|NCT01174446|62698368|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
33322239|NCT01174446|62698369|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
33412694|NCT00500331|62791032|FG003|Overall Study|State ban of biological samples export|1|||
33412695|NCT00500331|62791033|FG004|Overall Study|State ban of biological samples export|0|||
33602602|NCT02021643|63001788|FG002|Overall Study|Enrolled but Never Treated|0|||
33602603|NCT02021643|63001789|FG003|Overall Study|Enrolled but Never Treated|0|||
33602604|NCT02021643|63001786|FG000|Overall Study|Adverse Event|0|||
33602605|NCT02021643|63001787|FG001|Overall Study|Adverse Event|1|||
33602606|NCT02021643|63001788|FG002|Overall Study|Adverse Event|0|||
33602607|NCT02021643|63001789|FG003|Overall Study|Adverse Event|0|||
33602608|NCT02021643|63001786|FG000|Overall Study|Death|0|||
33602609|NCT02021643|63001787|FG001|Overall Study|Death|1|||
33602610|NCT02021643|63001788|FG002|Overall Study|Death|0|||
33602611|NCT02021643|63001789|FG003|Overall Study|Death|0|||
33602612|NCT02021643|63001786|FG000|Overall Study|Investigator's Discretion|1|||
33602613|NCT02021643|63001787|FG001|Overall Study|Investigator's Discretion|0|||
33602614|NCT02021643|63001788|FG002|Overall Study|Investigator's Discretion|0|||
33602615|NCT02021643|63001789|FG003|Overall Study|Investigator's Discretion|0|||
33602616|NCT02021643|63001786|FG000|Overall Study|Lack of Efficacy|7|||
33602617|NCT02021643|63001787|FG001|Overall Study|Lack of Efficacy|6|||
33602618|NCT02021643|63001788|FG002|Overall Study|Lack of Efficacy|0|||
33602619|NCT02021643|63001789|FG003|Overall Study|Lack of Efficacy|12|||
33602620|NCT02021643|63001786|FG000|Overall Study|Lost to Follow-up|0|||
33602621|NCT02021643|63001787|FG001|Overall Study|Lost to Follow-up|1|||
33602622|NCT02021643|63001788|FG002|Overall Study|Lost to Follow-up|0|||
33602623|NCT02021643|63001789|FG003|Overall Study|Lost to Follow-up|0|||
33602624|NCT02021643|63001786|FG000|Overall Study|Withdrew Consent|0|||
33602625|NCT02021643|63001787|FG001|Overall Study|Withdrew Consent|1|||
33602626|NCT02021643|63001788|FG002|Overall Study|Withdrew Consent|0|||
33602627|NCT02021643|63001789|FG003|Overall Study|Withdrew Consent|0|||
33602628|NCT02415959|63001810|FG000|Overall Study|Adverse Event|0|||
33602629|NCT02415959|63001811|FG001|Overall Study|Adverse Event|1|||
33602630|NCT02415959|63001812|FG002|Overall Study|Adverse Event|0|||
33602631|NCT02415959|63001813|FG003|Overall Study|Adverse Event|0|||
33602632|NCT02415959|63001814|FG004|Overall Study|Adverse Event|0|||
33602633|NCT02415959|63001810|FG000|Overall Study|Protocol Violation|0|||
33602634|NCT02415959|63001811|FG001|Overall Study|Protocol Violation|0|||
33602635|NCT02415959|63001812|FG002|Overall Study|Protocol Violation|0|||
33602636|NCT02415959|63001813|FG003|Overall Study|Protocol Violation|1|||
33602637|NCT02415959|63001814|FG004|Overall Study|Protocol Violation|0|||
33602638|NCT02021565|63001828|FG000|Baseline Through Intervention|Death|0|||
33602639|NCT02021565|63001829|FG001|Baseline Through Intervention|Death|1|||
33602640|NCT02021565|63001828|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
33602641|NCT02021565|63001829|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
33602642|NCT02021565|63001828|FG000|Baseline Through Intervention|Protocol Violation|0|||
33602643|NCT02021565|63001829|FG001|Baseline Through Intervention|Protocol Violation|7|||
33602644|NCT02021565|63001828|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
33602645|NCT02021565|63001829|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
33602646|NCT02021565|63001828|FG000|3-month Follow-up|Death|3|||
33602647|NCT02021565|63001829|FG001|3-month Follow-up|Death|0|||
33602648|NCT02021565|63001828|FG000|3-month Follow-up|Withdrawal by Subject|4|||
33602649|NCT02021565|63001829|FG001|3-month Follow-up|Withdrawal by Subject|0|||
33602650|NCT02021565|63001828|FG000|3-month Follow-up|Protocol Violation|3|||
33602651|NCT02021565|63001829|FG001|3-month Follow-up|Protocol Violation|2|||
33602652|NCT02021331|63001839|FG000|Overall Study|Adverse Event|0|||
33602653|NCT02021331|63001840|FG001|Overall Study|Adverse Event|2|||
33602654|NCT02085135|63001848|FG000|Overall Study|Adverse Event|4|||
33602655|NCT02085135|63001849|FG001|Overall Study|Adverse Event|7|||
33602656|NCT02085135|63001848|FG000|Overall Study|Lost to Follow-up|2|||
33602657|NCT02085135|63001849|FG001|Overall Study|Lost to Follow-up|2|||
33602658|NCT02085135|63001848|FG000|Overall Study|Withdrawal by Subject|3|||
33602659|NCT02085135|63001849|FG001|Overall Study|Withdrawal by Subject|0|||
33602660|NCT02085135|63001848|FG000|Overall Study|Lack of Efficacy|2|||
33602661|NCT02085135|63001849|FG001|Overall Study|Lack of Efficacy|0|||
33602662|NCT02441309|63001858|FG000|Overall Study|Disease progression|2|||
33602663|NCT02441309|63001859|FG001|Overall Study|Disease progression|1|||
33602664|NCT02441309|63001860|FG002|Overall Study|Disease progression|2|||
33602665|NCT02441309|63001858|FG000|Overall Study|Adverse Event|0|||
33602666|NCT02441309|63001859|FG001|Overall Study|Adverse Event|1|||
33602667|NCT02441309|63001860|FG002|Overall Study|Adverse Event|0|||
33602668|NCT02441309|63001858|FG000|Overall Study|Withdrawal by Subject|1|||
33602669|NCT02441309|63001859|FG001|Overall Study|Withdrawal by Subject|0|||
33602670|NCT02441309|63001860|FG002|Overall Study|Withdrawal by Subject|1|||
33602671|NCT02027025|63001874|FG000|Overall Study|Adverse Event|0|||
33602672|NCT02027025|63001875|FG001|Overall Study|Adverse Event|1|||
33602673|NCT02027025|63001876|FG002|Overall Study|Adverse Event|1|||
33602674|NCT02027025|63001874|FG000|Overall Study|Protocol Violation|1|||
33602675|NCT02027025|63001875|FG001|Overall Study|Protocol Violation|0|||
33412696|NCT00500331|62791034|FG005|Overall Study|State ban of biological samples export|0|||
33412697|NCT00500331|62791035|FG006|Overall Study|State ban of biological samples export|0|||
33602676|NCT02027025|63001876|FG002|Overall Study|Protocol Violation|0|||
33602677|NCT02027025|63001874|FG000|Overall Study|Lost to Follow-up|0|||
33602678|NCT02027025|63001875|FG001|Overall Study|Lost to Follow-up|2|||
33602679|NCT02027025|63001876|FG002|Overall Study|Lost to Follow-up|0|||
33602680|NCT02027025|63001874|FG000|Overall Study|Withdrawal by Subject|0|||
33602681|NCT02027025|63001875|FG001|Overall Study|Withdrawal by Subject|1|||
33602682|NCT02027025|63001876|FG002|Overall Study|Withdrawal by Subject|0|||
33602683|NCT02027025|63001874|FG000|Overall Study|Sponsor's decision|0|||
33602684|NCT02027025|63001875|FG001|Overall Study|Sponsor's decision|1|||
33602685|NCT02027025|63001876|FG002|Overall Study|Sponsor's decision|0|||
33602686|NCT01652729|63001898|FG000|Overall Study|Withdrawal by Subject|14|||
33602687|NCT01652729|63001899|FG001|Overall Study|Withdrawal by Subject|7|||
33602688|NCT01652729|63001900|FG002|Overall Study|Withdrawal by Subject|7|||
33602689|NCT01652729|63001898|FG000|Overall Study|Adverse Event|4|||
33602690|NCT01652729|63001899|FG001|Overall Study|Adverse Event|0|||
33602691|NCT01652729|63001900|FG002|Overall Study|Adverse Event|3|||
33602692|NCT01652729|63001898|FG000|Overall Study|Physician Decision|1|||
33602693|NCT01652729|63001899|FG001|Overall Study|Physician Decision|0|||
33602694|NCT01652729|63001900|FG002|Overall Study|Physician Decision|1|||
33602695|NCT01652729|63001898|FG000|Overall Study|Protocol Violation|1|||
33602696|NCT01652729|63001899|FG001|Overall Study|Protocol Violation|0|||
33602697|NCT01652729|63001900|FG002|Overall Study|Protocol Violation|0|||
33602698|NCT01652729|63001898|FG000|Overall Study|Lost to Follow-up|6|||
33602699|NCT01652729|63001899|FG001|Overall Study|Lost to Follow-up|6|||
33602700|NCT01652729|63001900|FG002|Overall Study|Lost to Follow-up|3|||
33602701|NCT01652729|63001898|FG000|Overall Study|Administrative|1|||
33602702|NCT01652729|63001899|FG001|Overall Study|Administrative|0|||
33602703|NCT01652729|63001900|FG002|Overall Study|Administrative|0|||
33602704|NCT02083965|63001910|FG000|Treatment Period|Other|1|||
33602705|NCT02083965|63001911|FG001|Treatment Period|Other|0|||
33602706|NCT02438813|63001919|FG000|Overall Study|Patient Decision|59|||
33602707|NCT02438813|63001919|FG000|Overall Study|Patient Lost to Follow-Up|137|||
33602708|NCT02438813|63001919|FG000|Overall Study|Study Ended by Sponsor|80|||
33602709|NCT02438813|63001919|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
33602710|NCT02437409|63001933|FG000|Overall Study|Withdrawal by Subject|3|||
33602711|NCT02437409|63001933|FG000|Overall Study|Screening failure|12|||
33602712|NCT02459093|63001940|FG000|Overall Study|Protocol Violation|6|||
33602713|NCT02459093|63001941|FG001|Overall Study|Protocol Violation|11|||
33602714|NCT02459093|63001940|FG000|Overall Study|Lost to Follow-up|6|||
33602715|NCT02459093|63001941|FG001|Overall Study|Lost to Follow-up|7|||
33602716|NCT02458469|63001947|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
33602717|NCT02458469|63001948|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
33602718|NCT02458469|63001949|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
33602719|NCT02458469|63001950|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
33602720|NCT02458469|63001951|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
33602721|NCT02458469|63001952|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
33602722|NCT02458469|63001947|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
33602723|NCT02458469|63001948|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
33602724|NCT02458469|63001949|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
33602725|NCT02458469|63001950|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
33602726|NCT02458469|63001951|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
33602727|NCT02458469|63001952|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
33602728|NCT02458469|63001947|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
33602729|NCT02458469|63001948|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
33602730|NCT02458469|63001949|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
33602731|NCT02458469|63001950|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
33602732|NCT02458469|63001951|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
33602733|NCT02458469|63001952|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
33602734|NCT01843348|63001963|FG000|Overall Study|Withdrawal by Subject|4|||
33602735|NCT01843348|63001964|FG001|Overall Study|Withdrawal by Subject|16|||
33602736|NCT01843348|63001965|FG002|Overall Study|Withdrawal by Subject|18|||
33602737|NCT01843348|63001963|FG000|Overall Study|Lost to Follow-up|5|||
33602738|NCT01843348|63001964|FG001|Overall Study|Lost to Follow-up|4|||
33602739|NCT01843348|63001965|FG002|Overall Study|Lost to Follow-up|2|||
33602740|NCT01843348|63001963|FG000|Overall Study|Death|5|||
33602741|NCT01843348|63001964|FG001|Overall Study|Death|3|||
33602742|NCT01843348|63001965|FG002|Overall Study|Death|4|||
33602743|NCT01843348|63001963|FG000|Overall Study|Graft loss/retransplantation|5|||
33602744|NCT01843348|63001964|FG001|Overall Study|Graft loss/retransplantation|8|||
33602745|NCT01843348|63001965|FG002|Overall Study|Graft loss/retransplantation|11|||
33602746|NCT01843348|63001963|FG000|Overall Study|Various reasons|4|||
33602747|NCT01843348|63001964|FG001|Overall Study|Various reasons|9|||
33602748|NCT01843348|63001965|FG002|Overall Study|Various reasons|6|||
33602749|NCT01843192|63001978|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
33602750|NCT01843192|63001979|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
33602751|NCT01843192|63001980|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
33602752|NCT01825876|63001988|FG000|Period 2|Withdrawal by Subject|0|||
33602753|NCT01825876|63001989|FG001|Period 2|Withdrawal by Subject|1|||
33602754|NCT01842958|63002000|FG000|Overall Study|Lost to Follow-up|1|||
33602755|NCT01842958|63002001|FG001|Overall Study|Lost to Follow-up|1|||
33602756|NCT02413229|63002015|FG000|Overall Study|Adverse Event|0|||
33602757|NCT02413229|63002016|FG001|Overall Study|Adverse Event|0|||
33602758|NCT02413229|63002017|FG002|Overall Study|Adverse Event|0|||
33602759|NCT02413229|63002018|FG003|Overall Study|Adverse Event|1|||
33602760|NCT02413229|63002019|FG004|Overall Study|Adverse Event|0|||
33602761|NCT02413229|63002020|FG005|Overall Study|Adverse Event|0|||
33602762|NCT02413229|63002021|FG006|Overall Study|Adverse Event|0|||
33602763|NCT02413229|63002022|FG007|Overall Study|Adverse Event|1|||
33602764|NCT02413229|63002015|FG000|Overall Study|Lost to Follow-up|0|||
33602765|NCT02413229|63002016|FG001|Overall Study|Lost to Follow-up|0|||
33602766|NCT02413229|63002017|FG002|Overall Study|Lost to Follow-up|1|||
33602767|NCT02413229|63002018|FG003|Overall Study|Lost to Follow-up|0|||
33602768|NCT02413229|63002019|FG004|Overall Study|Lost to Follow-up|2|||
33602769|NCT02413229|63002020|FG005|Overall Study|Lost to Follow-up|0|||
33602770|NCT02413229|63002021|FG006|Overall Study|Lost to Follow-up|0|||
33602771|NCT02413229|63002022|FG007|Overall Study|Lost to Follow-up|0|||
33602772|NCT02413229|63002015|FG000|Overall Study|Withdrawal by Subject|1|||
33602773|NCT02413229|63002016|FG001|Overall Study|Withdrawal by Subject|1|||
33602774|NCT02413229|63002017|FG002|Overall Study|Withdrawal by Subject|0|||
33602775|NCT02413229|63002018|FG003|Overall Study|Withdrawal by Subject|0|||
33602776|NCT02413229|63002019|FG004|Overall Study|Withdrawal by Subject|1|||
33602777|NCT02413229|63002020|FG005|Overall Study|Withdrawal by Subject|0|||
33602778|NCT02413229|63002021|FG006|Overall Study|Withdrawal by Subject|0|||
33602779|NCT02413229|63002022|FG007|Overall Study|Withdrawal by Subject|2|||
33602780|NCT02413229|63002015|FG000|Overall Study|Progressive Disease|0|||
33602781|NCT02413229|63002016|FG001|Overall Study|Progressive Disease|0|||
33602782|NCT02413229|63002017|FG002|Overall Study|Progressive Disease|0|||
33602783|NCT02413229|63002018|FG003|Overall Study|Progressive Disease|0|||
33602784|NCT02413229|63002019|FG004|Overall Study|Progressive Disease|0|||
33602785|NCT02413229|63002020|FG005|Overall Study|Progressive Disease|0|||
33602786|NCT02413229|63002021|FG006|Overall Study|Progressive Disease|0|||
33602787|NCT02413229|63002022|FG007|Overall Study|Progressive Disease|1|||
33602788|NCT01825798|63002042|FG000|Overall Study|Adverse Event|1|||
33602789|NCT01825798|63002043|FG001|Overall Study|Adverse Event|5|||
33602790|NCT01825798|63002042|FG000|Overall Study|Lost to Follow-up|1|||
33602791|NCT01825798|63002043|FG001|Overall Study|Lost to Follow-up|0|||
33602792|NCT01824472|63002052|FG000|Overall Study|Lost to Follow-up|0|||
33602793|NCT01824472|63002053|FG001|Overall Study|Lost to Follow-up|0|||
33602794|NCT01824472|63002054|FG002|Overall Study|Lost to Follow-up|1|||
33602795|NCT01824472|63002052|FG000|Overall Study|Withdrawal by Subject|1|||
33602796|NCT01824472|63002053|FG001|Overall Study|Withdrawal by Subject|5|||
33602797|NCT01824472|63002054|FG002|Overall Study|Withdrawal by Subject|3|||
33602798|NCT01824472|63002052|FG000|Overall Study|Ineligible post randomization&screening|0|||
33602799|NCT01824472|63002053|FG001|Overall Study|Ineligible post randomization&screening|2|||
33602800|NCT01824472|63002054|FG002|Overall Study|Ineligible post randomization&screening|0|||
33602801|NCT02412761|63002062|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33602802|NCT02412761|63002063|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
33602803|NCT02412761|63002064|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
33602804|NCT02412761|63002065|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33602805|NCT02412761|63002066|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33602806|NCT02412761|63002067|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
33602807|NCT01842334|63002077|FG000|Overall Study|Withdrawal by Subject|3|||
33602808|NCT01842334|63002078|FG001|Overall Study|Withdrawal by Subject|3|||
33602809|NCT01842334|63002077|FG000|Overall Study|Moved away mid-study|0|||
33602810|NCT01842334|63002078|FG001|Overall Study|Moved away mid-study|1|||
33602811|NCT02457611|63002084|FG000|Overall Study|Lost to Follow-up|3|||
33602812|NCT02457065|63002090|FG000|Overall Study|Lost to Follow-up|9|||
33602813|NCT02457065|63002091|FG001|Overall Study|Lost to Follow-up|11|||
33602814|NCT02083653|63002100|FG000|Overall Study|Randomized but not Treated|0|||
33602815|NCT02083653|63002101|FG001|Overall Study|Randomized but not Treated|2|||
33602816|NCT02083653|63002102|FG002|Overall Study|Randomized but not Treated|7|||
33412698|NCT00500331|62791029|FG000|Overall Study|Protocol violated|0|||
33602817|NCT02083653|63002100|FG000|Overall Study|Adverse Event|12|||
33602818|NCT02083653|63002101|FG001|Overall Study|Adverse Event|5|||
33602819|NCT02083653|63002102|FG002|Overall Study|Adverse Event|4|||
33602820|NCT02083653|63002100|FG000|Overall Study|Lost to Follow-up|1|||
33602821|NCT02083653|63002101|FG001|Overall Study|Lost to Follow-up|0|||
33602822|NCT02083653|63002102|FG002|Overall Study|Lost to Follow-up|0|||
33602823|NCT02083653|63002100|FG000|Overall Study|Death|2|||
33602824|NCT02083653|63002101|FG001|Overall Study|Death|2|||
33602825|NCT02083653|63002102|FG002|Overall Study|Death|2|||
33602826|NCT02083653|63002100|FG000|Overall Study|Progressive Disease|65|||
33602827|NCT02083653|63002101|FG001|Overall Study|Progressive Disease|73|||
33602828|NCT02083653|63002102|FG002|Overall Study|Progressive Disease|63|||
33602829|NCT02083653|63002100|FG000|Overall Study|Withdrawal by Subject|2|||
33602830|NCT02083653|63002101|FG001|Overall Study|Withdrawal by Subject|1|||
33602831|NCT02083653|63002102|FG002|Overall Study|Withdrawal by Subject|2|||
33602832|NCT02083653|63002100|FG000|Overall Study|Other Events|0|||
33602833|NCT02083653|63002101|FG001|Overall Study|Other Events|2|||
33602834|NCT02083653|63002102|FG002|Overall Study|Other Events|2|||
33602835|NCT02083653|63002100|FG000|Overall Study|Reason Missing|0|||
33602836|NCT02083653|63002101|FG001|Overall Study|Reason Missing|0|||
33602837|NCT02083653|63002102|FG002|Overall Study|Reason Missing|4|||
33602838|NCT02436239|63002114|FG000|Open-Lable Treatment Period|Adverse Event|12|||
33602839|NCT02436239|63002115|FG001|Open-Lable Treatment Period|Adverse Event|3|||
33602840|NCT02436239|63002116|FG002|Open-Lable Treatment Period|Adverse Event|4|||
33602841|NCT02436239|63002117|FG003|Open-Lable Treatment Period|Adverse Event|2|||
33602842|NCT02436239|63002114|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
33602843|NCT02436239|63002115|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
33602844|NCT02436239|63002116|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
33602845|NCT02436239|63002117|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
33602846|NCT02436239|63002114|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
33602847|NCT02436239|63002115|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
33602848|NCT02436239|63002116|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
33602849|NCT02436239|63002117|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
33602850|NCT02436239|63002114|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
33602851|NCT02436239|63002115|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
33602852|NCT02436239|63002116|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
33602853|NCT02436239|63002117|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
33602854|NCT02436239|63002114|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
33602855|NCT02436239|63002115|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
33602856|NCT02436239|63002116|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
33602857|NCT02436239|63002117|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
33602858|NCT02436239|63002114|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
33602859|NCT02436239|63002115|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
33412699|NCT00500331|62791030|FG001|Overall Study|Protocol violated|0|||
33412700|NCT00500331|62791031|FG002|Overall Study|Protocol violated|0|||
33412701|NCT00500331|62791032|FG003|Overall Study|Protocol violated|1|||
33412702|NCT00500331|62791033|FG004|Overall Study|Protocol violated|0|||
33412703|NCT00500331|62791034|FG005|Overall Study|Protocol violated|0|||
33412704|NCT00500331|62791035|FG006|Overall Study|Protocol violated|0|||
33412705|NCT00499863|62791054|FG000|Overall Study|Lack of Efficacy|21|||
33412706|NCT00499863|62791055|FG001|Overall Study|Lack of Efficacy|27|||
33412707|NCT00499863|62791054|FG000|Overall Study|Protocol Violation|12|||
33412708|NCT00499863|62791055|FG001|Overall Study|Protocol Violation|7|||
33412709|NCT00499863|62791054|FG000|Overall Study|Withdrawal by Subject|6|||
33412710|NCT00499863|62791055|FG001|Overall Study|Withdrawal by Subject|4|||
33412711|NCT00499863|62791054|FG000|Overall Study|Adverse Event|8|||
33412712|NCT00499863|62791055|FG001|Overall Study|Adverse Event|2|||
33412713|NCT00499863|62791054|FG000|Overall Study|Sponsor decision|2|||
33412714|NCT00499863|62791055|FG001|Overall Study|Sponsor decision|2|||
33412715|NCT00499863|62791054|FG000|Overall Study|Lost to Follow-up|1|||
33412716|NCT00499863|62791055|FG001|Overall Study|Lost to Follow-up|1|||
33412717|NCT00484185|62791061|FG000|Overall Study|Lost to Follow-up|44|||
33412718|NCT00484185|62791061|FG000|Overall Study|Other|20|||
33412719|NCT00484185|62791061|FG000|Overall Study|Randomized but not treated|5|||
33602860|NCT02436239|63002116|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
33412720|NCT00484185|62791061|FG000|Overall Study|Death|2|||
33412721|NCT00097981|62791067|FG000|Overall Study|Adverse Event|31|||
33412722|NCT00097981|62791068|FG001|Overall Study|Adverse Event|44|||
33412723|NCT00097981|62791067|FG000|Overall Study|Withdrawal by Subject|10|||
33412724|NCT00097981|62791068|FG001|Overall Study|Withdrawal by Subject|8|||
33602861|NCT02436239|63002117|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
33602862|NCT02436239|63002114|FG000|Open-Lable Treatment Period|Other Reason|1|||
33412725|NCT00097981|62791067|FG000|Overall Study|Protocol Violation|1|||
33412726|NCT00097981|62791068|FG001|Overall Study|Protocol Violation|1|||
33412727|NCT00097981|62791067|FG000|Overall Study|Death|2|||
33412728|NCT00097981|62791068|FG001|Overall Study|Death|4|||
33412729|NCT00097981|62791067|FG000|Overall Study|Physician Decision|7|||
33602863|NCT02436239|63002115|FG001|Open-Lable Treatment Period|Other Reason|1|||
33602864|NCT02436239|63002116|FG002|Open-Lable Treatment Period|Other Reason|0|||
33602865|NCT02436239|63002117|FG003|Open-Lable Treatment Period|Other Reason|0|||
33602866|NCT02436239|63002114|FG000|Down-Taper Period|Withdrawal by Subject|4|||
33602867|NCT02436239|63002115|FG001|Down-Taper Period|Withdrawal by Subject|4|||
33602868|NCT02436239|63002116|FG002|Down-Taper Period|Withdrawal by Subject|1|||
33602869|NCT02436239|63002117|FG003|Down-Taper Period|Withdrawal by Subject|2|||
33602870|NCT02026011|63002129|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
33602871|NCT02026011|63002130|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
33602872|NCT02026011|63002129|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
33602873|NCT02026011|63002130|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
33602874|NCT02026011|63002129|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
33602875|NCT02026011|63002130|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
33602876|NCT02026011|63002129|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
33602877|NCT02026011|63002130|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
33602878|NCT02436005|63002139|FG000|Second Intervention|Adverse Event|0|||
33602879|NCT02436005|63002140|FG001|Second Intervention|Adverse Event|1|||
33602880|NCT02456909|63002148|FG000|Overall Study|Did not receive allocated intervention|24|||
33602881|NCT02456909|63002149|FG001|Overall Study|Did not receive allocated intervention|26|||
33602882|NCT02456909|63002148|FG000|Overall Study|Did not complete the primary outcome|0|||
33602883|NCT02456909|63002149|FG001|Overall Study|Did not complete the primary outcome|1|||
33602884|NCT02025621|63002157|FG000|Overall Study|Withdrawal by Subject|1|||
33602885|NCT02025621|63002158|FG001|Overall Study|Withdrawal by Subject|0|||
33602886|NCT02025621|63002157|FG000|Overall Study|Death|0|||
33602887|NCT02025621|63002158|FG001|Overall Study|Death|1|||
33602888|NCT02025621|63002157|FG000|Overall Study|No longer eligible|10|||
33602889|NCT02025621|63002158|FG001|Overall Study|No longer eligible|15|||
33602890|NCT02025621|63002157|FG000|Overall Study|Surgery initiated before infusion|3|||
33602891|NCT02025621|63002158|FG001|Overall Study|Surgery initiated before infusion|3|||
33602892|NCT02020941|63002164|FG000|Overall Study|Adverse Event|1|||
33602893|NCT02020941|63002164|FG000|Overall Study|Physician Decision|2|||
33602894|NCT02020941|63002164|FG000|Overall Study|Withdrawal by Subject|1|||
33602895|NCT02020941|63002164|FG000|Overall Study|Disease Progression|4|||
33602896|NCT02024529|63002170|FG000|Overall Study|Withdrawal by Subject|11|||
33602897|NCT02024529|63002171|FG001|Overall Study|Withdrawal by Subject|21|||
33602898|NCT02024529|63002170|FG000|Overall Study|Lost to Follow-up|2|||
33602899|NCT02024529|63002171|FG001|Overall Study|Lost to Follow-up|4|||
33602900|NCT02020863|63002179|FG000|Overall Study|Discovery of Metastatic disease|4|||
33602901|NCT02020863|63002179|FG000|Overall Study|Team chose not to place an a line|1|||
33602902|NCT01824394|63002186|FG000|Overall Study|Early Termination|1|||
33602903|NCT01824394|63002187|FG001|Overall Study|Early Termination|1|||
33602904|NCT01824394|63002188|FG002|Overall Study|Early Termination|3|||
33602905|NCT01824394|63002186|FG000|Overall Study|Withdrawn due to Study Termination|91|||
33602906|NCT01824394|63002187|FG001|Overall Study|Withdrawn due to Study Termination|83|||
33602907|NCT01824394|63002188|FG002|Overall Study|Withdrawn due to Study Termination|41|||
33602908|NCT01824394|63002186|FG000|Overall Study|Lost to Follow-up|0|||
33602909|NCT01824394|63002187|FG001|Overall Study|Lost to Follow-up|9|||
33602910|NCT01824394|63002188|FG002|Overall Study|Lost to Follow-up|3|||
33602911|NCT01824394|63002186|FG000|Overall Study|Death|3|||
33602912|NCT01824394|63002187|FG001|Overall Study|Death|2|||
33602913|NCT01824394|63002188|FG002|Overall Study|Death|4|||
33602914|NCT01824394|63002186|FG000|Overall Study|Discontinued Subjects|1|||
33602915|NCT01824394|63002187|FG001|Overall Study|Discontinued Subjects|1|||
33602916|NCT01824394|63002188|FG002|Overall Study|Discontinued Subjects|2|||
33602917|NCT01824394|63002186|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
33602918|NCT01824394|63002187|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
33602919|NCT01824394|63002188|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
33602920|NCT01823536|63002202|FG000|Overall Study|Lost to Follow-up|1|||
33602921|NCT01823536|63002203|FG001|Overall Study|Lost to Follow-up|0|||
33602922|NCT01823536|63002204|FG002|Overall Study|Lost to Follow-up|0|||
33602923|NCT01823536|63002205|FG003|Overall Study|Lost to Follow-up|1|||
33602924|NCT01823536|63002206|FG004|Overall Study|Lost to Follow-up|1|||
33602925|NCT01823536|63002207|FG005|Overall Study|Lost to Follow-up|0|||
33602926|NCT01823536|63002202|FG000|Overall Study|Protocol Violation|0|||
33602927|NCT01823536|63002203|FG001|Overall Study|Protocol Violation|1|||
33602928|NCT01823536|63002204|FG002|Overall Study|Protocol Violation|0|||
33602929|NCT01823536|63002205|FG003|Overall Study|Protocol Violation|0|||
33602930|NCT01823536|63002206|FG004|Overall Study|Protocol Violation|0|||
33602931|NCT01823536|63002207|FG005|Overall Study|Protocol Violation|0|||
33602932|NCT01823536|63002202|FG000|Overall Study|Withdrawal by Subject|1|||
33602933|NCT01823536|63002203|FG001|Overall Study|Withdrawal by Subject|1|||
33494062|NCT03473340|62872721|FG001|Overall Study|Withdrawal by Subject|0|||
33602934|NCT01823536|63002204|FG002|Overall Study|Withdrawal by Subject|0|||
33602935|NCT01823536|63002205|FG003|Overall Study|Withdrawal by Subject|0|||
33602936|NCT01823536|63002206|FG004|Overall Study|Withdrawal by Subject|0|||
33602937|NCT01823536|63002207|FG005|Overall Study|Withdrawal by Subject|0|||
33602938|NCT01823536|63002202|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
33602939|NCT01823536|63002203|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
33602940|NCT01823536|63002204|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
33602941|NCT01823536|63002205|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
33602942|NCT01823536|63002206|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
33602943|NCT01823536|63002207|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
33602944|NCT01823536|63002202|FG000|Overall Study|Met exclusion criterion No 6|0|||
33602945|NCT01823536|63002203|FG001|Overall Study|Met exclusion criterion No 6|0|||
33602946|NCT01823536|63002204|FG002|Overall Study|Met exclusion criterion No 6|0|||
33602947|NCT01823536|63002205|FG003|Overall Study|Met exclusion criterion No 6|1|||
33602948|NCT01823536|63002206|FG004|Overall Study|Met exclusion criterion No 6|0|||
33602949|NCT01823536|63002207|FG005|Overall Study|Met exclusion criterion No 6|0|||
33602950|NCT01823536|63002202|FG000|Overall Study|Subject moved out of the state|0|||
33602951|NCT01823536|63002203|FG001|Overall Study|Subject moved out of the state|0|||
33602952|NCT01823536|63002204|FG002|Overall Study|Subject moved out of the state|0|||
33602953|NCT01823536|63002205|FG003|Overall Study|Subject moved out of the state|0|||
33602954|NCT01823536|63002206|FG004|Overall Study|Subject moved out of the state|1|||
33602955|NCT01823536|63002207|FG005|Overall Study|Subject moved out of the state|0|||
33602956|NCT01841554|63002220|FG000|Overall Study|Death|7|||
33602957|NCT01841554|63002220|FG000|Overall Study|No Implantation|1|||
33602958|NCT01841554|63002220|FG000|Overall Study|Discontinued Follow Up|5|||
33602959|NCT01841554|63002220|FG000|Overall Study|Study exit due to secondary intervention|6|||
33602960|NCT01823224|63002226|FG000|Overall Study|Lost to Follow-up|5|||
33602961|NCT01823224|63002227|FG001|Overall Study|Lost to Follow-up|6|||
33602962|NCT01823224|63002226|FG000|Overall Study|didn't qualify|1|||
33602963|NCT01823224|63002227|FG001|Overall Study|didn't qualify|2|||
33602964|NCT01823224|63002226|FG000|Overall Study|pharmacy error|0|||
33602965|NCT01823224|63002227|FG001|Overall Study|pharmacy error|1|||
33602966|NCT01823224|63002226|FG000|Overall Study|missed med dose|0|||
33602967|NCT01823224|63002227|FG001|Overall Study|missed med dose|1|||
33602968|NCT01823224|63002226|FG000|Overall Study|Withdrawal by Subject|0|||
33602969|NCT01823224|63002227|FG001|Overall Study|Withdrawal by Subject|1|||
33602970|NCT01840228|63002237|FG000|Overall Study|Lost to Follow-up|1|||
33602971|NCT01840228|63002238|FG001|Overall Study|Lost to Follow-up|1|||
33602972|NCT01839916|63002248|FG000|Overall Study|Death|9|||
33602973|NCT01839916|63002248|FG000|Overall Study|Physician Decision|17|||
33602974|NCT01839916|63002248|FG000|Overall Study|Relapse|12|||
33602975|NCT01839916|63002248|FG000|Overall Study|GVHD|2|||
33602976|NCT01839916|63002248|FG000|Overall Study|Graft Failure|1|||
33602977|NCT01823146|63002254|FG000|Overall Study|Withdrawal by Subject|0|||
33602978|NCT01823146|63002255|FG001|Overall Study|Withdrawal by Subject|1|||
33602979|NCT01823146|63002254|FG000|Overall Study|Lost to Follow-up|2|||
33602980|NCT01823146|63002255|FG001|Overall Study|Lost to Follow-up|1|||
33602981|NCT02083185|63002264|FG000|Overall Study|Lost to Follow-up|0|||
33602982|NCT02083185|63002265|FG001|Overall Study|Lost to Follow-up|3|||
33602983|NCT02083185|63002266|FG002|Overall Study|Lost to Follow-up|0|||
33602984|NCT02083185|63002264|FG000|Overall Study|Withdrawal by Subject|9|||
33602985|NCT02083185|63002265|FG001|Overall Study|Withdrawal by Subject|15|||
33602986|NCT02083185|63002266|FG002|Overall Study|Withdrawal by Subject|1|||
33602987|NCT02083185|63002264|FG000|Overall Study|Death|2|||
33602988|NCT02083185|63002265|FG001|Overall Study|Death|2|||
33602989|NCT02083185|63002266|FG002|Overall Study|Death|1|||
33602990|NCT02083185|63002264|FG000|Overall Study|Reason not Specified|9|||
33602991|NCT02083185|63002265|FG001|Overall Study|Reason not Specified|6|||
33602992|NCT02083185|63002266|FG002|Overall Study|Reason not Specified|5|||
33602993|NCT02083185|63002264|FG000|Overall Study|Study Terminated by Sponsor|0|||
33602994|NCT02083185|63002265|FG001|Overall Study|Study Terminated by Sponsor|1|||
33602995|NCT02083185|63002266|FG002|Overall Study|Study Terminated by Sponsor|0|||
33602996|NCT02083185|63002264|FG000|Overall Study|Did not Receive Study Drug|0|||
33602997|NCT02083185|63002265|FG001|Overall Study|Did not Receive Study Drug|2|||
33602998|NCT02083185|63002266|FG002|Overall Study|Did not Receive Study Drug|0|||
33602999|NCT02019927|63002280|FG000|Overall Study|Lost to Follow-up|2|||
33603000|NCT02019927|63002281|FG001|Overall Study|Lost to Follow-up|4|||
33603001|NCT02019927|63002282|FG002|Overall Study|Lost to Follow-up|1|||
33603002|NCT02019927|63002283|FG003|Overall Study|Lost to Follow-up|2|||
33603003|NCT02019927|63002284|FG004|Overall Study|Lost to Follow-up|3|||
33603004|NCT02019927|63002285|FG005|Overall Study|Lost to Follow-up|1|||
33603005|NCT02412371|63002309|FG000|Overall Study|Withdrawal by Subject|0|||
33603006|NCT02412371|63002310|FG001|Overall Study|Withdrawal by Subject|2|||
33603007|NCT02412371|63002311|FG002|Overall Study|Withdrawal by Subject|0|||
33603008|NCT02412371|63002312|FG003|Overall Study|Withdrawal by Subject|1|||
33603009|NCT02412371|63002313|FG004|Overall Study|Withdrawal by Subject|1|||
33603010|NCT02412371|63002314|FG005|Overall Study|Withdrawal by Subject|0|||
33603011|NCT02412371|63002309|FG000|Overall Study|Sponsor Discontinued Study|1|||
33603012|NCT02412371|63002310|FG001|Overall Study|Sponsor Discontinued Study|4|||
33603013|NCT02412371|63002311|FG002|Overall Study|Sponsor Discontinued Study|6|||
33603014|NCT02412371|63002312|FG003|Overall Study|Sponsor Discontinued Study|4|||
33603015|NCT02412371|63002313|FG004|Overall Study|Sponsor Discontinued Study|5|||
33603016|NCT02412371|63002314|FG005|Overall Study|Sponsor Discontinued Study|0|||
33603017|NCT02412371|63002309|FG000|Overall Study|Death|4|||
33603018|NCT02412371|63002310|FG001|Overall Study|Death|2|||
33603019|NCT02412371|63002311|FG002|Overall Study|Death|1|||
33603020|NCT02412371|63002312|FG003|Overall Study|Death|3|||
33603021|NCT02412371|63002313|FG004|Overall Study|Death|5|||
33603022|NCT02412371|63002314|FG005|Overall Study|Death|2|||
33603023|NCT02412371|63002309|FG000|Overall Study|Other|2|||
33603024|NCT02412371|63002310|FG001|Overall Study|Other|1|||
33603025|NCT02412371|63002311|FG002|Overall Study|Other|0|||
33603026|NCT02412371|63002312|FG003|Overall Study|Other|0|||
33603027|NCT02412371|63002313|FG004|Overall Study|Other|1|||
33603028|NCT02412371|63002314|FG005|Overall Study|Other|3|||
33603029|NCT02411747|63002331|FG000|Overall Study|Withdrawal by Subject|1|||
33603030|NCT02411747|63002332|FG001|Overall Study|Withdrawal by Subject|0|||
33603031|NCT02411747|63002331|FG000|Overall Study|Protocol Violation|2|||
33603032|NCT02411747|63002332|FG001|Overall Study|Protocol Violation|4|||
33603033|NCT01822756|63002343|FG000|Overall Study|Adverse Event|0|||
33603034|NCT01822756|63002344|FG001|Overall Study|Adverse Event|0|||
33603035|NCT01822756|63002345|FG002|Overall Study|Adverse Event|0|||
33603036|NCT01822756|63002346|FG003|Overall Study|Adverse Event|2|||
33603037|NCT01822756|63002347|FG004|Overall Study|Adverse Event|0|||
33603038|NCT01822756|63002343|FG000|Overall Study|Disease progression|11|||
33603039|NCT01822756|63002344|FG001|Overall Study|Disease progression|1|||
33603040|NCT01822756|63002345|FG002|Overall Study|Disease progression|7|||
33603041|NCT01822756|63002346|FG003|Overall Study|Disease progression|2|||
33603042|NCT01822756|63002347|FG004|Overall Study|Disease progression|6|||
33603043|NCT01822756|63002343|FG000|Overall Study|Death|2|||
33603044|NCT01822756|63002344|FG001|Overall Study|Death|2|||
33603045|NCT01822756|63002345|FG002|Overall Study|Death|1|||
33603046|NCT01822756|63002346|FG003|Overall Study|Death|0|||
33603047|NCT01822756|63002347|FG004|Overall Study|Death|0|||
33603048|NCT01822756|63002343|FG000|Overall Study|Lost to Follow-up|1|||
33603049|NCT01822756|63002344|FG001|Overall Study|Lost to Follow-up|0|||
33603050|NCT01822756|63002345|FG002|Overall Study|Lost to Follow-up|1|||
33603051|NCT01822756|63002346|FG003|Overall Study|Lost to Follow-up|0|||
33603052|NCT01822756|63002347|FG004|Overall Study|Lost to Follow-up|1|||
33603053|NCT01822756|63002343|FG000|Overall Study|Physician Decision|0|||
33603054|NCT01822756|63002344|FG001|Overall Study|Physician Decision|1|||
33603055|NCT01822756|63002345|FG002|Overall Study|Physician Decision|0|||
33603056|NCT01822756|63002346|FG003|Overall Study|Physician Decision|0|||
33603057|NCT01822756|63002347|FG004|Overall Study|Physician Decision|0|||
33603058|NCT01822756|63002343|FG000|Overall Study|disease progression & patient preference|2|||
33603059|NCT01822756|63002344|FG001|Overall Study|disease progression & patient preference|0|||
33603060|NCT01822756|63002345|FG002|Overall Study|disease progression & patient preference|1|||
33603061|NCT01822756|63002346|FG003|Overall Study|disease progression & patient preference|0|||
33603062|NCT01822756|63002347|FG004|Overall Study|disease progression & patient preference|0|||
33603063|NCT01822678|63002362|FG000|Overall Study|Withdrawal by Subject|5|||
33603064|NCT01822678|63002363|FG001|Overall Study|Withdrawal by Subject|4|||
33603065|NCT01822678|63002364|FG002|Overall Study|Withdrawal by Subject|4|||
33603066|NCT01822678|63002362|FG000|Overall Study|Adverse Event|4|||
33603067|NCT01822678|63002363|FG001|Overall Study|Adverse Event|3|||
33603068|NCT01822678|63002364|FG002|Overall Study|Adverse Event|1|||
33603069|NCT01822678|63002362|FG000|Overall Study|Lack of Efficacy|3|||
33603070|NCT01822678|63002363|FG001|Overall Study|Lack of Efficacy|6|||
33603071|NCT01822678|63002364|FG002|Overall Study|Lack of Efficacy|5|||
33603072|NCT01822678|63002362|FG000|Overall Study|Lost to Follow-up|0|||
33603073|NCT01822678|63002363|FG001|Overall Study|Lost to Follow-up|2|||
33603074|NCT01822678|63002364|FG002|Overall Study|Lost to Follow-up|1|||
33603075|NCT01822366|63002376|FG000|Overall Study|Lost to Follow-up|5|||
33603076|NCT01822366|63002377|FG001|Overall Study|Lost to Follow-up|1|||
33603077|NCT01822366|63002378|FG002|Overall Study|Lost to Follow-up|5|||
33603078|NCT01822366|63002379|FG003|Overall Study|Lost to Follow-up|1|||
33603079|NCT01822366|63002376|FG000|Overall Study|Withdrawal by Subject|0|||
33603080|NCT01822366|63002377|FG001|Overall Study|Withdrawal by Subject|6|||
33603081|NCT01822366|63002378|FG002|Overall Study|Withdrawal by Subject|0|||
33603082|NCT01822366|63002379|FG003|Overall Study|Withdrawal by Subject|6|||
33603083|NCT01822366|63002376|FG000|Overall Study|Partial Intervention Completion|0|||
33603084|NCT01822366|63002377|FG001|Overall Study|Partial Intervention Completion|15|||
33603085|NCT01822366|63002378|FG002|Overall Study|Partial Intervention Completion|0|||
33603086|NCT01822366|63002379|FG003|Overall Study|Partial Intervention Completion|15|||
33603087|NCT01838590|63002411|FG000|Overall Study|Lack of Efficacy|12|||
33603088|NCT01838590|63002412|FG001|Overall Study|Lack of Efficacy|4|||
33603089|NCT01838590|63002411|FG000|Overall Study|Lost to Follow-up|0|||
33603090|NCT01838590|63002412|FG001|Overall Study|Lost to Follow-up|1|||
33603091|NCT01611454|63002424|FG000|Overall Study|Lack of Efficacy|18|||
33603092|NCT01611454|63002425|FG001|Overall Study|Lack of Efficacy|10|||
33603093|NCT01611298|63002435|FG000|Overall Study|Relapsed|2|||
33603094|NCT01822132|63002441|FG000|Overall Study|Lost to Follow-up|4|||
33603095|NCT01822132|63002442|FG001|Overall Study|Lost to Follow-up|2|||
33603096|NCT01821898|63002456|FG000|Overall Study|Withdrawal by Subject|2|||
33603097|NCT01821898|63002457|FG001|Overall Study|Withdrawal by Subject|1|||
33603098|NCT02411591|63002467|FG000|Overall Study|Adverse Event|0|||
33603099|NCT02411591|63002468|FG001|Overall Study|Adverse Event|4|||
33603100|NCT02411591|63002469|FG002|Overall Study|Adverse Event|2|||
33603101|NCT02411591|63002467|FG000|Overall Study|Withdrawal by Subject|0|||
33603102|NCT02411591|63002468|FG001|Overall Study|Withdrawal by Subject|3|||
33603103|NCT02411591|63002469|FG002|Overall Study|Withdrawal by Subject|0|||
33603104|NCT02411591|63002467|FG000|Overall Study|Physician Decision|0|||
33603105|NCT02411591|63002468|FG001|Overall Study|Physician Decision|3|||
33603106|NCT02411591|63002469|FG002|Overall Study|Physician Decision|1|||
33603107|NCT02454959|63002485|FG000|Overall Study|Protocol-Specified Criteria|3|||
33603108|NCT02454959|63002485|FG000|Overall Study|Physician Decision|1|||
33603109|NCT02454959|63002485|FG000|Overall Study|Withdrawal by Subject|3|||
33603110|NCT02454959|63002485|FG000|Overall Study|Adverse Event|2|||
33603111|NCT01821118|63002493|FG000|Overall Study|Death|0|||
33603112|NCT01821118|63002494|FG001|Overall Study|Death|1|||
33603113|NCT01650779|63002500|FG000|Overall Study|Withdrawal by Subject|1|||
33603114|NCT02411201|63002504|FG000|Overall Study|Adverse Event|2|||
33603115|NCT02411201|63002504|FG000|Overall Study|Withdrawal by Subject|2|||
33603116|NCT02411201|63002504|FG000|Overall Study|Age group completed|2|||
33603117|NCT01838044|63002512|FG000|Overall Study|Adverse Event|4|||
33603118|NCT01838044|63002513|FG001|Overall Study|Adverse Event|6|||
33603119|NCT01838044|63002512|FG000|Overall Study|Protocol Violation|3|||
33603120|NCT01838044|63002513|FG001|Overall Study|Protocol Violation|3|||
33322240|NCT01174446|62698370|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
33412730|NCT00097981|62791068|FG001|Overall Study|Physician Decision|1|||
33412731|NCT00097981|62791067|FG000|Overall Study|Disease Progression|8|||
33412732|NCT00097981|62791068|FG001|Overall Study|Disease Progression|2|||
33603121|NCT01838044|63002512|FG000|Overall Study|Withdrawal by Subject|0|||
33603122|NCT01838044|63002513|FG001|Overall Study|Withdrawal by Subject|2|||
33603123|NCT01838044|63002512|FG000|Overall Study|Insufficient clinical response|1|||
33603124|NCT01838044|63002513|FG001|Overall Study|Insufficient clinical response|2|||
33603125|NCT01838044|63002512|FG000|Overall Study|Medication error without associated AE|0|||
33603126|NCT01838044|63002513|FG001|Overall Study|Medication error without associated AE|1|||
33603127|NCT01838044|63002512|FG000|Overall Study|Lost to Follow-up|0|||
33603128|NCT01838044|63002513|FG001|Overall Study|Lost to Follow-up|2|||
33603129|NCT02410811|63002524|FG000|Overall Study|Withdrawal by Subject|0|||
33603130|NCT02410811|63002525|FG001|Overall Study|Withdrawal by Subject|0|||
33603131|NCT02410811|63002526|FG002|Overall Study|Withdrawal by Subject|1|||
33603132|NCT02410811|63002527|FG003|Overall Study|Withdrawal by Subject|0|||
33603133|NCT02435381|63002537|FG000|Overall Study|Lost to Follow-up|2|||
33603134|NCT02435381|63002538|FG001|Overall Study|Lost to Follow-up|1|||
33603135|NCT01837966|63002554|FG000|Overall Study|Withdrawal by Subject|2|||
33603136|NCT01837966|63002555|FG001|Overall Study|Withdrawal by Subject|1|||
33603137|NCT02435147|63002561|FG000|Overall Study|non-evaluable DXA scan|11|||
33603138|NCT02435069|63002565|FG000|Dose Response - First Intervention|Adverse Event|0|||
33603139|NCT02435069|63002566|FG001|Dose Response - First Intervention|Adverse Event|1|||
33603140|NCT02435069|63002567|FG002|Dose Response - First Intervention|Adverse Event|1|||
33603141|NCT02435069|63002568|FG003|Dose Response - First Intervention|Adverse Event|0|||
33603142|NCT02435069|63002569|FG004|Dose Response - First Intervention|Adverse Event|0|||
33603143|NCT02435069|63002565|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
33603144|NCT02435069|63002566|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
33603145|NCT02435069|63002567|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
33603146|NCT02435069|63002568|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
33603147|NCT02435069|63002569|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
33603148|NCT02454101|63002591|FG000|Overall Study|Adverse Event|2|||
33603149|NCT02454101|63002592|FG001|Overall Study|Adverse Event|3|||
33603150|NCT02454101|63002591|FG000|Overall Study|Lost to Follow-up|3|||
33603151|NCT02454101|63002592|FG001|Overall Study|Lost to Follow-up|4|||
33603152|NCT02409719|63002600|FG000|Overall Study|Lost to Follow-up|3|||
33603153|NCT02409719|63002601|FG001|Overall Study|Lost to Follow-up|3|||
33603154|NCT01820572|63002609|FG000|Randomization|Not Treated|2|||
33603155|NCT01820572|63002610|FG001|Randomization|Not Treated|1|||
33603156|NCT01820572|63002609|FG000|Treatment Period|Adverse Event|12|||
33603157|NCT01820572|63002610|FG001|Treatment Period|Adverse Event|7|||
33603158|NCT01820572|63002609|FG000|Treatment Period|Death|3|||
33603159|NCT01820572|63002610|FG001|Treatment Period|Death|3|||
33603160|NCT01820572|63002609|FG000|Treatment Period|Lack of Efficacy|1|||
33603161|NCT01820572|63002610|FG001|Treatment Period|Lack of Efficacy|0|||
33603162|NCT01820572|63002609|FG000|Treatment Period|poor/non compliance|0|||
33603163|NCT01820572|63002610|FG001|Treatment Period|poor/non compliance|3|||
33603164|NCT01820572|63002609|FG000|Treatment Period|request to discontinue|6|||
33603165|NCT01820572|63002610|FG001|Treatment Period|request to discontinue|11|||
33603166|NCT01820572|63002609|FG000|Treatment Period|No longer meets study criteria|3|||
33603167|NCT01820572|63002610|FG001|Treatment Period|No longer meets study criteria|10|||
33603168|NCT01820572|63002609|FG000|Treatment Period|withdrew consent|1|||
33603169|NCT01820572|63002610|FG001|Treatment Period|withdrew consent|2|||
33603170|NCT01820260|63002630|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33603171|NCT01820260|63002631|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33603172|NCT01820260|63002632|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33603173|NCT01820260|63002633|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33603174|NCT01820260|63002634|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33603175|NCT01820260|63002635|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33603176|NCT01820260|63002636|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
33322241|NCT00932698|62698428|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
33412733|NCT00097981|62791067|FG000|Overall Study|Transplant planned|28|||
33412734|NCT00097981|62791068|FG001|Overall Study|Transplant planned|27|||
33322242|NCT00932698|62698429|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
33322243|NCT00932698|62698430|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
33322244|NCT00932698|62698431|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
33322245|NCT00932698|62698432|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
33322246|NCT00932698|62698433|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
33322247|NCT00932698|62698434|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
33322248|NCT00932698|62698435|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
33322249|NCT00932698|62698436|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
33322250|NCT00932698|62698437|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
33322251|NCT00932698|62698438|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
33322252|NCT00932698|62698428|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
33412735|NCT00097981|62791067|FG000|Overall Study|Other|19|||
33603177|NCT01820260|63002637|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33603178|NCT01820260|63002638|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33603179|NCT01820260|63002639|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33603180|NCT01820260|63002640|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33603181|NCT01820260|63002641|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33603182|NCT01820260|63002642|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33603183|NCT01820260|63002643|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33603184|NCT01820260|63002630|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33603185|NCT01820260|63002631|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33603186|NCT01820260|63002632|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33603187|NCT01820260|63002633|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33603188|NCT01820260|63002634|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33603189|NCT01820260|63002635|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33603190|NCT01820260|63002636|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33603191|NCT01820260|63002637|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33603192|NCT01820260|63002638|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33603193|NCT01820260|63002639|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
33603194|NCT01820260|63002640|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33603195|NCT01820260|63002641|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33603196|NCT01820260|63002642|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33603197|NCT01820260|63002643|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33603198|NCT01610596|63002681|FG000|Overall Study|Lost to Follow-up|0|||
33603199|NCT01610596|63002682|FG001|Overall Study|Lost to Follow-up|1|||
33603200|NCT01818700|63002688|FG000|Overall Study|Adverse Event|67|||
33603201|NCT01818700|63002688|FG000|Overall Study|Lack of Efficacy|2|||
33603202|NCT01818700|63002688|FG000|Overall Study|Lost to Follow-up|5|||
33603203|NCT01818700|63002688|FG000|Overall Study|Withdrawal by Subject|27|||
33603204|NCT01818700|63002688|FG000|Overall Study|Protocol Violation|2|||
33603205|NCT01818700|63002688|FG000|Overall Study|Other|1|||
33603206|NCT01817764|63002696|FG000|Overall Study|Adverse Event|7|||
33603207|NCT01817764|63002697|FG001|Overall Study|Adverse Event|10|||
33603208|NCT01817764|63002696|FG000|Overall Study|Lack of Efficacy|9|||
33603209|NCT01817764|63002697|FG001|Overall Study|Lack of Efficacy|7|||
33603210|NCT01817764|63002696|FG000|Overall Study|Protocol Violation|7|||
33603211|NCT01817764|63002697|FG001|Overall Study|Protocol Violation|5|||
33603212|NCT01817764|63002696|FG000|Overall Study|Lost to Follow-up|1|||
33603213|NCT01817764|63002697|FG001|Overall Study|Lost to Follow-up|4|||
33603214|NCT01817764|63002696|FG000|Overall Study|Withdrawal by Subject|10|||
33603215|NCT01817764|63002697|FG001|Overall Study|Withdrawal by Subject|12|||
33603216|NCT01803880|63002706|FG000|Overall Study|Adverse Event|1|||
33603217|NCT01803880|63002707|FG001|Overall Study|Adverse Event|0|||
33603218|NCT01803880|63002708|FG002|Overall Study|Adverse Event|0|||
33603219|NCT01803880|63002706|FG000|Overall Study|Withdrawal by Subject|1|||
33603220|NCT01803880|63002707|FG001|Overall Study|Withdrawal by Subject|1|||
33603221|NCT01803880|63002708|FG002|Overall Study|Withdrawal by Subject|4|||
33603222|NCT01803880|63002706|FG000|Overall Study|Physician Decision|0|||
33603223|NCT01803880|63002707|FG001|Overall Study|Physician Decision|0|||
33603224|NCT01803880|63002708|FG002|Overall Study|Physician Decision|1|||
33603225|NCT01803880|63002706|FG000|Overall Study|Unable to return for follow-up visits|0|||
33603226|NCT01803880|63002707|FG001|Overall Study|Unable to return for follow-up visits|1|||
33603227|NCT01803880|63002708|FG002|Overall Study|Unable to return for follow-up visits|2|||
33603228|NCT01803880|63002706|FG000|Overall Study|Lost to Follow-up|1|||
33603229|NCT01803880|63002707|FG001|Overall Study|Lost to Follow-up|2|||
33603230|NCT01803880|63002708|FG002|Overall Study|Lost to Follow-up|3|||
33603231|NCT01803880|63002706|FG000|Overall Study|Protocol Violation|1|||
33603232|NCT01803880|63002707|FG001|Overall Study|Protocol Violation|0|||
33603233|NCT01803880|63002708|FG002|Overall Study|Protocol Violation|0|||
33603234|NCT01803880|63002706|FG000|Overall Study|Early study termination|0|||
33603235|NCT01803880|63002707|FG001|Overall Study|Early study termination|6|||
33603236|NCT01803880|63002708|FG002|Overall Study|Early study termination|5|||
33603237|NCT01803880|63002706|FG000|Overall Study|Incomplete data entry by sites|2|||
33322253|NCT00932698|62698429|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
33603238|NCT01803880|63002707|FG001|Overall Study|Incomplete data entry by sites|0|||
33603239|NCT01803880|63002708|FG002|Overall Study|Incomplete data entry by sites|0|||
33603240|NCT01803646|63002720|FG000|Overall Study|Protocol Violation|1|||
33603241|NCT01803646|63002721|FG001|Overall Study|Protocol Violation|0|||
33603242|NCT01803646|63002720|FG000|Overall Study|Adverse Event|1|||
33603243|NCT01803646|63002721|FG001|Overall Study|Adverse Event|1|||
33603244|NCT01803646|63002720|FG000|Overall Study|Withdrawal by Subject|9|||
33603245|NCT01803646|63002721|FG001|Overall Study|Withdrawal by Subject|6|||
33603246|NCT01803646|63002720|FG000|Overall Study|Randomization error|1|||
33603247|NCT01803646|63002721|FG001|Overall Study|Randomization error|2|||
33603248|NCT01803646|63002720|FG000|Overall Study|Lost to Follow-up|5|||
33603249|NCT01803646|63002721|FG001|Overall Study|Lost to Follow-up|1|||
33603250|NCT01817530|63002735|FG000|Overall Study|Exclusionary Medication Received|0|||
33603251|NCT01817530|63002736|FG001|Overall Study|Exclusionary Medication Received|0|||
33603252|NCT01817530|63002737|FG002|Overall Study|Exclusionary Medication Received|0|||
33603253|NCT01817530|63002738|FG003|Overall Study|Exclusionary Medication Received|0|||
33603254|NCT01817530|63002739|FG004|Overall Study|Exclusionary Medication Received|1|||
33603255|NCT01817530|63002740|FG005|Overall Study|Exclusionary Medication Received|0|||
33603256|NCT01817530|63002741|FG006|Overall Study|Exclusionary Medication Received|0|||
33603257|NCT01817530|63002742|FG007|Overall Study|Exclusionary Medication Received|0|||
33603258|NCT01817530|63002735|FG000|Overall Study|Adverse Event|6|||
33603259|NCT01817530|63002736|FG001|Overall Study|Adverse Event|3|||
33412736|NCT00097981|62791068|FG001|Overall Study|Other|13|||
33412738|NCT00572195|62791078|FG000|Overall Study|Withdrawal by Subject|50|||
33412739|NCT00572195|62791078|FG000|Overall Study|Death|9|||
33412740|NCT00572195|62791078|FG000|Overall Study|Adverse Event|4|||
33412741|NCT00572195|62791078|FG000|Overall Study|Lost to Follow-up|5|||
33412742|NCT00572039|62791084|FG000|Overall Study|Withdrawal by Subject|9|||
33412743|NCT00572039|62791085|FG001|Overall Study|Withdrawal by Subject|6|||
33412744|NCT00572039|62791084|FG000|Overall Study|Death|2|||
33412745|NCT00572039|62791085|FG001|Overall Study|Death|3|||
33412746|NCT00572039|62791084|FG000|Overall Study|Ill|5|||
33412747|NCT00572039|62791085|FG001|Overall Study|Ill|1|||
33412748|NCT00684593|62791095|FG000|Overall Study|Adverse Event|0|||
33412749|NCT00684593|62791096|FG001|Overall Study|Adverse Event|2|||
33412750|NCT00685373|62791102|FG000|Overall Study|Adverse Event|3|||
33412751|NCT00685373|62791102|FG000|Overall Study|Withdrawal by Subject|5|||
33412752|NCT00685373|62791102|FG000|Overall Study|Lack of Efficacy|3|||
33412753|NCT00685373|62791102|FG000|Overall Study|Condition no longer requires study drug|1|||
33412754|NCT00685373|62791102|FG000|Overall Study|Lost to Follow-up|2|||
33412755|NCT00685373|62791102|FG000|Overall Study|Protocol Violation|1|||
33412756|NCT00684515|62791109|FG000|Overall Study|Adverse Event|3|||
33412757|NCT00684515|62791110|FG001|Overall Study|Adverse Event|3|||
33412758|NCT00684515|62791111|FG002|Overall Study|Adverse Event|1|||
33412759|NCT00684515|62791109|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
33412760|NCT00684515|62791110|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
33412761|NCT00684515|62791111|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
33412762|NCT00490815|62791121|FG000|Overall Study|Adverse Event|2|||
33412763|NCT00490815|62791122|FG001|Overall Study|Adverse Event|3|||
33412764|NCT00490815|62791121|FG000|Overall Study|Withdrawal by Subject|4|||
33412765|NCT00490815|62791122|FG001|Overall Study|Withdrawal by Subject|0|||
33412766|NCT00490815|62791121|FG000|Overall Study|Lost to Follow-up|1|||
33412767|NCT00490815|62791122|FG001|Overall Study|Lost to Follow-up|3|||
33412768|NCT00490815|62791121|FG000|Overall Study|Death|1|||
33603260|NCT01817530|63002737|FG002|Overall Study|Adverse Event|2|||
33603261|NCT01817530|63002738|FG003|Overall Study|Adverse Event|5|||
33603262|NCT01817530|63002739|FG004|Overall Study|Adverse Event|0|||
33603263|NCT01817530|63002740|FG005|Overall Study|Adverse Event|10|||
33603264|NCT01817530|63002741|FG006|Overall Study|Adverse Event|5|||
33603265|NCT01817530|63002742|FG007|Overall Study|Adverse Event|8|||
33603266|NCT01817530|63002735|FG000|Overall Study|Subject Noncompliant|3|||
33603267|NCT01817530|63002736|FG001|Overall Study|Subject Noncompliant|1|||
33603268|NCT01817530|63002737|FG002|Overall Study|Subject Noncompliant|0|||
33603269|NCT01817530|63002738|FG003|Overall Study|Subject Noncompliant|4|||
33412769|NCT00490815|62791122|FG001|Overall Study|Death|3|||
33603270|NCT01817530|63002739|FG004|Overall Study|Subject Noncompliant|0|||
33412770|NCT03855189|62791131|FG000|Overall Study|Adverse Event|5|||
33412771|NCT03855189|62791132|FG001|Overall Study|Adverse Event|2|||
33603271|NCT01817530|63002740|FG005|Overall Study|Subject Noncompliant|1|||
33603272|NCT01817530|63002741|FG006|Overall Study|Subject Noncompliant|1|||
33603273|NCT01817530|63002742|FG007|Overall Study|Subject Noncompliant|1|||
33603274|NCT01817530|63002735|FG000|Overall Study|Lack of Efficacy|1|||
33412772|NCT03855189|62791133|FG002|Overall Study|Adverse Event|4|||
33412773|NCT03855189|62791131|FG000|Overall Study|Treatment Failure|1|||
33412774|NCT03855189|62791132|FG001|Overall Study|Treatment Failure|1|||
33412775|NCT03855189|62791133|FG002|Overall Study|Treatment Failure|2|||
33603275|NCT01817530|63002736|FG001|Overall Study|Lack of Efficacy|0|||
33603276|NCT01817530|63002737|FG002|Overall Study|Lack of Efficacy|0|||
33603277|NCT01817530|63002738|FG003|Overall Study|Lack of Efficacy|0|||
33603278|NCT01817530|63002739|FG004|Overall Study|Lack of Efficacy|0|||
33603279|NCT01817530|63002740|FG005|Overall Study|Lack of Efficacy|1|||
33603280|NCT01817530|63002741|FG006|Overall Study|Lack of Efficacy|0|||
33603281|NCT01817530|63002742|FG007|Overall Study|Lack of Efficacy|1|||
33603282|NCT01817530|63002735|FG000|Overall Study|Pregnancy|0|||
33603283|NCT01817530|63002736|FG001|Overall Study|Pregnancy|0|||
33603284|NCT01817530|63002737|FG002|Overall Study|Pregnancy|0|||
33603285|NCT01817530|63002738|FG003|Overall Study|Pregnancy|0|||
33603286|NCT01817530|63002739|FG004|Overall Study|Pregnancy|0|||
33603287|NCT01817530|63002740|FG005|Overall Study|Pregnancy|1|||
33603288|NCT01817530|63002741|FG006|Overall Study|Pregnancy|0|||
33603289|NCT01817530|63002742|FG007|Overall Study|Pregnancy|0|||
33603290|NCT01817530|63002735|FG000|Overall Study|Other|0|||
33603291|NCT01817530|63002736|FG001|Overall Study|Other|1|||
33603292|NCT01817530|63002737|FG002|Overall Study|Other|0|||
33603293|NCT01817530|63002738|FG003|Overall Study|Other|0|||
33603294|NCT01817530|63002739|FG004|Overall Study|Other|1|||
33603295|NCT01817530|63002740|FG005|Overall Study|Other|0|||
33603296|NCT01817530|63002741|FG006|Overall Study|Other|5|||
33603297|NCT01817530|63002742|FG007|Overall Study|Other|0|||
33603298|NCT01817530|63002735|FG000|Overall Study|Surgery or Invasive Intervention|1|||
33603299|NCT01817530|63002736|FG001|Overall Study|Surgery or Invasive Intervention|0|||
33603300|NCT01817530|63002737|FG002|Overall Study|Surgery or Invasive Intervention|0|||
33603301|NCT01817530|63002738|FG003|Overall Study|Surgery or Invasive Intervention|0|||
33603302|NCT01817530|63002739|FG004|Overall Study|Surgery or Invasive Intervention|1|||
33603303|NCT01817530|63002740|FG005|Overall Study|Surgery or Invasive Intervention|1|||
33603304|NCT01817530|63002741|FG006|Overall Study|Surgery or Invasive Intervention|1|||
33603305|NCT01817530|63002742|FG007|Overall Study|Surgery or Invasive Intervention|0|||
33603306|NCT01817530|63002735|FG000|Overall Study|Consent Withdrawn by Subject|3|||
33603307|NCT01817530|63002736|FG001|Overall Study|Consent Withdrawn by Subject|4|||
33603308|NCT01817530|63002737|FG002|Overall Study|Consent Withdrawn by Subject|7|||
33603309|NCT01817530|63002738|FG003|Overall Study|Consent Withdrawn by Subject|3|||
33603310|NCT01817530|63002739|FG004|Overall Study|Consent Withdrawn by Subject|5|||
33603311|NCT01817530|63002740|FG005|Overall Study|Consent Withdrawn by Subject|3|||
33603312|NCT01817530|63002741|FG006|Overall Study|Consent Withdrawn by Subject|3|||
33603313|NCT01817530|63002742|FG007|Overall Study|Consent Withdrawn by Subject|10|||
33603314|NCT01817530|63002735|FG000|Overall Study|Lost to Follow-up|1|||
33603315|NCT01817530|63002736|FG001|Overall Study|Lost to Follow-up|4|||
33603316|NCT01817530|63002737|FG002|Overall Study|Lost to Follow-up|2|||
33603317|NCT01817530|63002738|FG003|Overall Study|Lost to Follow-up|1|||
33603318|NCT01817530|63002739|FG004|Overall Study|Lost to Follow-up|3|||
33603319|NCT01817530|63002740|FG005|Overall Study|Lost to Follow-up|2|||
33603320|NCT01817530|63002741|FG006|Overall Study|Lost to Follow-up|8|||
33603321|NCT01817530|63002742|FG007|Overall Study|Lost to Follow-up|4|||
33603322|NCT01816984|63002760|FG000|Overall Study|declining health status|1|||
33603323|NCT01816906|63002766|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
33603324|NCT01816906|63002767|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
33322254|NCT00932698|62698430|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
33322255|NCT00932698|62698431|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
33603325|NCT01816906|63002766|FG000|Six Months|Lost to Follow-up|14|||
33603326|NCT01816906|63002767|FG001|Six Months|Lost to Follow-up|16|||
33603327|NCT01816906|63002766|FG000|12 Months|Adverse Event|2|||
33603328|NCT01816906|63002767|FG001|12 Months|Adverse Event|2|||
33603329|NCT01816906|63002766|FG000|12 Months|Death|0|||
33603330|NCT01816906|63002767|FG001|12 Months|Death|2|||
33603331|NCT01816906|63002766|FG000|12 Months|Lost to Follow-up|2|||
33603332|NCT01816906|63002767|FG001|12 Months|Lost to Follow-up|1|||
33603333|NCT01816594|63002776|FG000|Overall Study|Local Progress|0|||
33603334|NCT01816594|63002777|FG001|Overall Study|Local Progress|2|||
33603335|NCT01816594|63002776|FG000|Overall Study|Adverse Event|9|||
33603336|NCT01816594|63002777|FG001|Overall Study|Adverse Event|0|||
33603337|NCT01816594|63002776|FG000|Overall Study|Withdrawal by Subject|1|||
33603338|NCT01816594|63002777|FG001|Overall Study|Withdrawal by Subject|0|||
33603339|NCT01816594|63002776|FG000|Overall Study|Physician Decision|1|||
33603340|NCT01816594|63002777|FG001|Overall Study|Physician Decision|0|||
33603341|NCT01802320|63002789|FG000|Overall Study|Death|1|||
33603342|NCT01802320|63002789|FG000|Overall Study|Withdrawal by Subject|1|||
33603343|NCT02453711|63002802|FG000|Overall Study|Withdrawal by Subject|5|||
33603344|NCT02453711|63002803|FG001|Overall Study|Withdrawal by Subject|4|||
33603345|NCT02453711|63002804|FG002|Overall Study|Withdrawal by Subject|6|||
33603346|NCT02453711|63002805|FG003|Overall Study|Withdrawal by Subject|4|||
33603347|NCT02453711|63002806|FG004|Overall Study|Withdrawal by Subject|1|||
33603348|NCT02453711|63002807|FG005|Overall Study|Withdrawal by Subject|1|||
33603349|NCT02453711|63002808|FG006|Overall Study|Withdrawal by Subject|0|||
33603350|NCT02453711|63002809|FG007|Overall Study|Withdrawal by Subject|1|||
33603351|NCT02453711|63002810|FG008|Overall Study|Withdrawal by Subject|7|||
33603352|NCT02453711|63002802|FG000|Overall Study|Lost to Follow-up|5|||
33603353|NCT02453711|63002803|FG001|Overall Study|Lost to Follow-up|3|||
33603354|NCT02453711|63002804|FG002|Overall Study|Lost to Follow-up|2|||
33603355|NCT02453711|63002805|FG003|Overall Study|Lost to Follow-up|3|||
33603356|NCT02453711|63002806|FG004|Overall Study|Lost to Follow-up|1|||
33603357|NCT02453711|63002807|FG005|Overall Study|Lost to Follow-up|5|||
33603358|NCT02453711|63002808|FG006|Overall Study|Lost to Follow-up|2|||
33603359|NCT02453711|63002809|FG007|Overall Study|Lost to Follow-up|6|||
33603360|NCT02453711|63002810|FG008|Overall Study|Lost to Follow-up|6|||
33603361|NCT02453711|63002802|FG000|Overall Study|Death|0|||
33603362|NCT02453711|63002803|FG001|Overall Study|Death|0|||
33603363|NCT02453711|63002804|FG002|Overall Study|Death|0|||
33603364|NCT02453711|63002805|FG003|Overall Study|Death|0|||
33603365|NCT02453711|63002806|FG004|Overall Study|Death|0|||
33603366|NCT02453711|63002807|FG005|Overall Study|Death|0|||
33603367|NCT02453711|63002808|FG006|Overall Study|Death|1|||
33603368|NCT02453711|63002809|FG007|Overall Study|Death|0|||
33603369|NCT02453711|63002810|FG008|Overall Study|Death|0|||
33603370|NCT02453711|63002802|FG000|Overall Study|Unclassified|1|||
33603371|NCT02453711|63002803|FG001|Overall Study|Unclassified|0|||
33603372|NCT02453711|63002804|FG002|Overall Study|Unclassified|1|||
33603373|NCT02453711|63002805|FG003|Overall Study|Unclassified|0|||
33603374|NCT02453711|63002806|FG004|Overall Study|Unclassified|0|||
33603375|NCT02453711|63002807|FG005|Overall Study|Unclassified|0|||
33603376|NCT02453711|63002808|FG006|Overall Study|Unclassified|0|||
33603377|NCT02453711|63002809|FG007|Overall Study|Unclassified|0|||
33603378|NCT02453711|63002810|FG008|Overall Study|Unclassified|0|||
33603379|NCT02453555|63002832|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
33603380|NCT02453555|63002833|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
33603381|NCT02453555|63002834|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
33603382|NCT02453555|63002835|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
33603383|NCT02453555|63002836|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
33603384|NCT02453555|63002837|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
33603385|NCT02453555|63002832|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
33603386|NCT02453555|63002833|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
33603387|NCT02453555|63002834|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
33603388|NCT02453555|63002835|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
33603389|NCT02453555|63002836|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
33603390|NCT02453555|63002837|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
33603391|NCT02453555|63002832|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
33603392|NCT02453555|63002833|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
33603393|NCT02453555|63002834|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33603394|NCT02453555|63002835|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33603395|NCT02453555|63002836|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33603396|NCT02453555|63002837|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33603397|NCT02453555|63002832|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
33603398|NCT02453555|63002833|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
33603399|NCT02453555|63002834|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
33603400|NCT02453555|63002835|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
33603401|NCT02453555|63002836|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
33603402|NCT02453555|63002837|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
33603403|NCT02453555|63002832|FG000|Extension Period|Adverse Event|0|||
33603404|NCT02453555|63002833|FG001|Extension Period|Adverse Event|0|||
33603405|NCT02453555|63002834|FG002|Extension Period|Adverse Event|1|||
33603406|NCT02453555|63002835|FG003|Extension Period|Adverse Event|2|||
33603407|NCT02453555|63002836|FG004|Extension Period|Adverse Event|1|||
33603408|NCT02453555|63002837|FG005|Extension Period|Adverse Event|1|||
33603409|NCT02453555|63002832|FG000|Extension Period|Protocol Violation|0|||
33603410|NCT02453555|63002833|FG001|Extension Period|Protocol Violation|0|||
33603411|NCT02453555|63002834|FG002|Extension Period|Protocol Violation|1|||
33603412|NCT02453555|63002835|FG003|Extension Period|Protocol Violation|0|||
33603413|NCT02453555|63002836|FG004|Extension Period|Protocol Violation|0|||
33603414|NCT02453555|63002837|FG005|Extension Period|Protocol Violation|0|||
33603415|NCT02453555|63002832|FG000|Extension Period|Withdrawal by Subject|0|||
33603416|NCT02453555|63002833|FG001|Extension Period|Withdrawal by Subject|0|||
33603417|NCT02453555|63002834|FG002|Extension Period|Withdrawal by Subject|1|||
33412776|NCT03855189|62791131|FG000|Overall Study|Noncompliance with Protocol|0|||
33412777|NCT03855189|62791132|FG001|Overall Study|Noncompliance with Protocol|1|||
33412778|NCT03855189|62791133|FG002|Overall Study|Noncompliance with Protocol|0|||
33412779|NCT03855189|62791131|FG000|Overall Study|Did Not Return|4|||
33412780|NCT03855189|62791132|FG001|Overall Study|Did Not Return|3|||
33412781|NCT03855189|62791133|FG002|Overall Study|Did Not Return|0|||
33412782|NCT03853551|62791141|FG000|Overall Study|Death|2|||
33412783|NCT03853551|62791141|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
33412784|NCT00423670|62791152|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
33412785|NCT00423670|62791153|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
33412786|NCT00423670|62791154|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
33412787|NCT00423670|62791155|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
33412788|NCT00423670|62791156|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
33412789|NCT00423670|62791157|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
33412790|NCT00423670|62791158|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
33412791|NCT00423670|62791159|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
33412792|NCT00423670|62791152|FG000|Treatment Period|Adverse Event|8|||
33412793|NCT00423670|62791153|FG001|Treatment Period|Adverse Event|12|||
33412794|NCT00423670|62791154|FG002|Treatment Period|Adverse Event|15|||
33412795|NCT00423670|62791155|FG003|Treatment Period|Adverse Event|20|||
33412796|NCT00423670|62791156|FG004|Treatment Period|Adverse Event|9|||
33412797|NCT00423670|62791157|FG005|Treatment Period|Adverse Event|4|||
33412798|NCT00423670|62791158|FG006|Treatment Period|Adverse Event|7|||
33412799|NCT00423670|62791159|FG007|Treatment Period|Adverse Event|2|||
33412800|NCT00423670|62791152|FG000|Treatment Period|Protocol-defined clinical event|0|||
33412801|NCT00423670|62791153|FG001|Treatment Period|Protocol-defined clinical event|7|||
33412802|NCT00423670|62791154|FG002|Treatment Period|Protocol-defined clinical event|4|||
33412803|NCT00423670|62791155|FG003|Treatment Period|Protocol-defined clinical event|12|||
33412804|NCT00423670|62791156|FG004|Treatment Period|Protocol-defined clinical event|5|||
33412805|NCT00423670|62791157|FG005|Treatment Period|Protocol-defined clinical event|4|||
33412806|NCT00423670|62791158|FG006|Treatment Period|Protocol-defined clinical event|16|||
33412807|NCT00423670|62791159|FG007|Treatment Period|Protocol-defined clinical event|15|||
33412808|NCT00423670|62791152|FG000|Treatment Period|Lost to Follow-up|2|||
33412809|NCT00423670|62791153|FG001|Treatment Period|Lost to Follow-up|1|||
33412810|NCT00423670|62791154|FG002|Treatment Period|Lost to Follow-up|3|||
33412811|NCT00423670|62791155|FG003|Treatment Period|Lost to Follow-up|1|||
33412812|NCT00423670|62791156|FG004|Treatment Period|Lost to Follow-up|6|||
33412813|NCT00423670|62791157|FG005|Treatment Period|Lost to Follow-up|0|||
33412814|NCT00423670|62791158|FG006|Treatment Period|Lost to Follow-up|3|||
33412815|NCT00423670|62791159|FG007|Treatment Period|Lost to Follow-up|1|||
33412816|NCT00423670|62791152|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
33412817|NCT00423670|62791153|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
33412818|NCT00423670|62791154|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
33412819|NCT00423670|62791155|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
33412820|NCT00423670|62791156|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
33412821|NCT00423670|62791157|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
33412822|NCT00423670|62791158|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
33412823|NCT00423670|62791159|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
33412824|NCT00423670|62791152|FG000|Treatment Period|Investigator decision|0|||
33412825|NCT00423670|62791153|FG001|Treatment Period|Investigator decision|0|||
33412826|NCT00423670|62791154|FG002|Treatment Period|Investigator decision|0|||
33412827|NCT00423670|62791155|FG003|Treatment Period|Investigator decision|0|||
33412828|NCT00423670|62791156|FG004|Treatment Period|Investigator decision|0|||
33412829|NCT00423670|62791157|FG005|Treatment Period|Investigator decision|0|||
33412830|NCT00423670|62791158|FG006|Treatment Period|Investigator decision|0|||
33412831|NCT00423670|62791159|FG007|Treatment Period|Investigator decision|1|||
33412832|NCT00423670|62791152|FG000|Treatment Period|Non-compliance with protocol|3|||
33412833|NCT00423670|62791153|FG001|Treatment Period|Non-compliance with protocol|1|||
33412834|NCT00423670|62791154|FG002|Treatment Period|Non-compliance with protocol|1|||
33412835|NCT00423670|62791155|FG003|Treatment Period|Non-compliance with protocol|3|||
33603418|NCT02453555|63002835|FG003|Extension Period|Withdrawal by Subject|0|||
33603419|NCT02453555|63002836|FG004|Extension Period|Withdrawal by Subject|0|||
33412836|NCT00423670|62791156|FG004|Treatment Period|Non-compliance with protocol|2|||
33412837|NCT00423670|62791157|FG005|Treatment Period|Non-compliance with protocol|0|||
33412838|NCT00423670|62791158|FG006|Treatment Period|Non-compliance with protocol|2|||
33412839|NCT00423670|62791159|FG007|Treatment Period|Non-compliance with protocol|2|||
33412840|NCT00423670|62791152|FG000|Follow-up Period|Lost to Follow-up|0|||
33603420|NCT02453555|63002837|FG005|Extension Period|Withdrawal by Subject|0|||
33603421|NCT02453321|63002850|FG000|Overall Study|Weakness|1|||
33603422|NCT02453321|63002851|FG001|Overall Study|Weakness|1|||
33603423|NCT02453321|63002852|FG002|Overall Study|Weakness|2|||
33603424|NCT02453321|63002850|FG000|Overall Study|Deep Venous Thrombosis|0|||
33603425|NCT02453321|63002851|FG001|Overall Study|Deep Venous Thrombosis|1|||
33603426|NCT02453321|63002852|FG002|Overall Study|Deep Venous Thrombosis|0|||
33603427|NCT01610284|63002865|FG000|Randomization Phase|Adverse Event|1|||
33603428|NCT01610284|63002866|FG001|Randomization Phase|Adverse Event|0|||
33603429|NCT01610284|63002865|FG000|Randomization Phase|Physician Decision|1|||
33603430|NCT01610284|63002866|FG001|Randomization Phase|Physician Decision|1|||
33603431|NCT01610284|63002865|FG000|Randomization Phase|Death|0|||
33603432|NCT01610284|63002866|FG001|Randomization Phase|Death|1|||
33603433|NCT01610284|63002865|FG000|Treatment Phase|Adverse Event|80|||
33603434|NCT01610284|63002866|FG001|Treatment Phase|Adverse Event|12|||
33603435|NCT01610284|63002865|FG000|Treatment Phase|Lost to Follow-up|1|||
33603436|NCT01610284|63002866|FG001|Treatment Phase|Lost to Follow-up|0|||
33603437|NCT01610284|63002865|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
33603438|NCT01610284|63002866|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
33603439|NCT01610284|63002865|FG000|Treatment Phase|Physician Decision|27|||
33603440|NCT01610284|63002866|FG001|Treatment Phase|Physician Decision|24|||
33603441|NCT01610284|63002865|FG000|Treatment Phase|Progressive Disease|377|||
33603442|NCT01610284|63002866|FG001|Treatment Phase|Progressive Disease|486|||
33603443|NCT01610284|63002865|FG000|Treatment Phase|Protocol Deviation|2|||
33603444|NCT01610284|63002866|FG001|Treatment Phase|Protocol Deviation|3|||
33603445|NCT01610284|63002865|FG000|Treatment Phase|Study terminated by Sponsor|18|||
33603446|NCT01610284|63002866|FG001|Treatment Phase|Study terminated by Sponsor|15|||
33603447|NCT01610284|63002865|FG000|Treatment Phase|Subject/Guardian Decision|55|||
33603448|NCT01610284|63002866|FG001|Treatment Phase|Subject/Guardian Decision|23|||
33603449|NCT01610284|63002865|FG000|Treatment Phase|Death|6|||
33603450|NCT01610284|63002866|FG001|Treatment Phase|Death|5|||
33603451|NCT01610284|63002865|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
33603452|NCT01610284|63002866|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33603453|NCT01610284|63002865|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
33603454|NCT01610284|63002866|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
33603455|NCT01610284|63002865|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
33603456|NCT01610284|63002866|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
33603457|NCT01610284|63002865|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
33603458|NCT01610284|63002866|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
33603459|NCT01610284|63002865|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
33603460|NCT01610284|63002866|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
33603461|NCT01610284|63002865|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
33603462|NCT01610284|63002866|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
33603463|NCT02452463|63002875|FG000|Overall Study|Death|1|||
33603464|NCT02452463|63002876|FG001|Overall Study|Death|0|||
33603465|NCT02452463|63002877|FG002|Overall Study|Death|0|||
33603466|NCT02452463|63002875|FG000|Overall Study|Study Suspended|1|||
33603467|NCT02452463|63002876|FG001|Overall Study|Study Suspended|0|||
33603468|NCT02452463|63002877|FG002|Overall Study|Study Suspended|0|||
33603469|NCT02452463|63002875|FG000|Overall Study|Recommended by DSMB|0|||
33603470|NCT02452463|63002876|FG001|Overall Study|Recommended by DSMB|1|||
33603471|NCT02452463|63002877|FG002|Overall Study|Recommended by DSMB|0|||
33603472|NCT02452463|63002875|FG000|Overall Study|Withdrawal by Subject|0|||
33603473|NCT02452463|63002876|FG001|Overall Study|Withdrawal by Subject|1|||
33603474|NCT02452463|63002877|FG002|Overall Study|Withdrawal by Subject|0|||
33603475|NCT02432105|63002888|FG000|Overall Study|Lost to Follow-up|1|||
33603476|NCT02432105|63002889|FG001|Overall Study|Lost to Follow-up|1|||
33603477|NCT02432105|63002890|FG002|Overall Study|Lost to Follow-up|0|||
33603478|NCT02432105|63002888|FG000|Overall Study|Withdrawal by Subject|1|||
33603479|NCT02432105|63002889|FG001|Overall Study|Withdrawal by Subject|0|||
33603480|NCT02432105|63002890|FG002|Overall Study|Withdrawal by Subject|1|||
33603481|NCT02432105|63002888|FG000|Overall Study|Culture positive for yeast|0|||
33603482|NCT02432105|63002889|FG001|Overall Study|Culture positive for yeast|1|||
33603483|NCT02432105|63002890|FG002|Overall Study|Culture positive for yeast|0|||
33603484|NCT02432105|63002888|FG000|Overall Study|Randomized in error|0|||
33603485|NCT02432105|63002889|FG001|Overall Study|Randomized in error|0|||
33412841|NCT00423670|62791153|FG001|Follow-up Period|Lost to Follow-up|12|||
33603486|NCT02432105|63002890|FG002|Overall Study|Randomized in error|2|||
33603487|NCT02431793|63002902|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
33603488|NCT02431793|63002903|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
33603489|NCT02431793|63002904|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
33603490|NCT02431793|63002902|FG000|Overall Study|Withdrawal by Subject|7|||
33603491|NCT02431793|63002903|FG001|Overall Study|Withdrawal by Subject|5|||
33603492|NCT02431793|63002904|FG002|Overall Study|Withdrawal by Subject|5|||
33603493|NCT02431793|63002902|FG000|Overall Study|Lost to Follow-up|101|||
33603494|NCT02431793|63002903|FG001|Overall Study|Lost to Follow-up|122|||
33603495|NCT02431793|63002904|FG002|Overall Study|Lost to Follow-up|104|||
33603496|NCT01801930|63002916|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
33603497|NCT01801930|63002917|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
33603498|NCT01801930|63002918|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
33603499|NCT01801930|63002919|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
33603500|NCT01801930|63002916|FG000|Overall Study|DLT occurs|0|||
33603501|NCT01801930|63002917|FG001|Overall Study|DLT occurs|1|||
33603502|NCT01801930|63002918|FG002|Overall Study|DLT occurs|0|||
33603503|NCT01801930|63002919|FG003|Overall Study|DLT occurs|0|||
33603504|NCT01610206|63002931|FG000|Overall Study|Adverse Event|10|||
33603505|NCT01610206|63002932|FG001|Overall Study|Adverse Event|30|||
33603506|NCT01816048|63002938|FG000|Overall Study|Adverse Event|1|||
33603507|NCT01816048|63002938|FG000|Overall Study|Death|1|||
33603508|NCT01816048|63002938|FG000|Overall Study|Withdrawal by Subject|1|||
33603509|NCT01816048|63002938|FG000|Overall Study|Disease Progression|3|||
33603510|NCT01612858|63002945|FG000|Overall Study|Withdrawal by Subject|5|||
33603511|NCT01612858|63002946|FG001|Overall Study|Withdrawal by Subject|1|||
33603512|NCT01612780|63002952|FG000|Overall Study|Treatment not completed|1|||
33603513|NCT01612780|63002952|FG000|Overall Study|Withdrawal by Subject|5|||
33603514|NCT01612702|63002958|FG000|Overall Study|Protocol Violation|11|||
33603515|NCT01612702|63002959|FG001|Overall Study|Protocol Violation|11|||
33603516|NCT02431559|63002969|FG000|Overall Study|Adverse Event|0|||
33603517|NCT02431559|63002970|FG001|Overall Study|Adverse Event|1|||
33603518|NCT02431559|63002971|FG002|Overall Study|Adverse Event|0|||
33603519|NCT02431559|63002972|FG003|Overall Study|Adverse Event|4|||
33603520|NCT02431559|63002969|FG000|Overall Study|Progressive disease|2|||
33603521|NCT02431559|63002970|FG001|Overall Study|Progressive disease|1|||
33603522|NCT02431559|63002971|FG002|Overall Study|Progressive disease|4|||
33603523|NCT02431559|63002972|FG003|Overall Study|Progressive disease|22|||
33603524|NCT02431559|63002969|FG000|Overall Study|Withdrawal by Subject|0|||
33603525|NCT02431559|63002970|FG001|Overall Study|Withdrawal by Subject|1|||
33603526|NCT02431559|63002971|FG002|Overall Study|Withdrawal by Subject|0|||
33603527|NCT02431559|63002972|FG003|Overall Study|Withdrawal by Subject|4|||
33603528|NCT02431559|63002969|FG000|Overall Study|Physician Decision|0|||
33603529|NCT02431559|63002970|FG001|Overall Study|Physician Decision|0|||
33603530|NCT02431559|63002971|FG002|Overall Study|Physician Decision|0|||
33603531|NCT02431559|63002972|FG003|Overall Study|Physician Decision|1|||
33412842|NCT00423670|62791154|FG002|Follow-up Period|Lost to Follow-up|8|||
33412843|NCT00423670|62791155|FG003|Follow-up Period|Lost to Follow-up|3|||
33412844|NCT00423670|62791156|FG004|Follow-up Period|Lost to Follow-up|1|||
33412845|NCT00423670|62791157|FG005|Follow-up Period|Lost to Follow-up|0|||
33412846|NCT00423670|62791158|FG006|Follow-up Period|Lost to Follow-up|5|||
33412847|NCT00423670|62791159|FG007|Follow-up Period|Lost to Follow-up|0|||
33412848|NCT00423670|62791152|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
33412849|NCT00423670|62791153|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
33412850|NCT00423670|62791154|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
33412851|NCT00423670|62791155|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
33412852|NCT00423670|62791156|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
33412853|NCT00423670|62791157|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
33412854|NCT00423670|62791158|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
33412855|NCT00423670|62791159|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
33412856|NCT00423670|62791152|FG000|Follow-up Period|Non-compliance with protocol|2|||
33412857|NCT00423670|62791153|FG001|Follow-up Period|Non-compliance with protocol|0|||
33412858|NCT00423670|62791154|FG002|Follow-up Period|Non-compliance with protocol|1|||
33412859|NCT00423670|62791155|FG003|Follow-up Period|Non-compliance with protocol|1|||
33412860|NCT00423670|62791156|FG004|Follow-up Period|Non-compliance with protocol|0|||
33412861|NCT00423670|62791157|FG005|Follow-up Period|Non-compliance with protocol|0|||
33412862|NCT00423670|62791158|FG006|Follow-up Period|Non-compliance with protocol|3|||
33412863|NCT00423670|62791159|FG007|Follow-up Period|Non-compliance with protocol|2|||
33412864|NCT00483717|62791182|FG000|Overall Study|Protocol Violation|5|||
33412865|NCT00483717|62791183|FG001|Overall Study|Protocol Violation|7|||
33412866|NCT00483717|62791182|FG000|Overall Study|Time of dosing missing|1|||
33412867|NCT00483717|62791183|FG001|Overall Study|Time of dosing missing|1|||
33412868|NCT00483717|62791182|FG000|Overall Study|No treatment for migraine|16|||
33412869|NCT00483717|62791183|FG001|Overall Study|No treatment for migraine|13|||
33494063|NCT03473340|62872720|FG000|Overall Study|Lost to Follow-up|1|||
33412870|NCT00483717|62791182|FG000|Overall Study|Lost to Follow-up|1|||
33603532|NCT02388269|63002986|FG000|Overall Study|Adverse Event|2|||
33603533|NCT02388269|63002987|FG001|Overall Study|Adverse Event|0|||
33603534|NCT02388269|63002988|FG002|Overall Study|Adverse Event|0|||
33603535|NCT02388269|63002986|FG000|Overall Study|Withdrawal by Subject|1|||
33603536|NCT02388269|63002987|FG001|Overall Study|Withdrawal by Subject|2|||
33603537|NCT02388269|63002988|FG002|Overall Study|Withdrawal by Subject|0|||
33603538|NCT02388269|63002986|FG000|Overall Study|less than 50% stimulations|1|||
33603539|NCT02388269|63002987|FG001|Overall Study|less than 50% stimulations|0|||
33603540|NCT02388269|63002988|FG002|Overall Study|less than 50% stimulations|0|||
33603541|NCT02388269|63002986|FG000|Overall Study|no diary data|3|||
33603542|NCT02388269|63002987|FG001|Overall Study|no diary data|0|||
33603543|NCT02388269|63002988|FG002|Overall Study|no diary data|0|||
33603544|NCT02388269|63002986|FG000|Overall Study|Protocol Violation|2|||
33603545|NCT02388269|63002987|FG001|Overall Study|Protocol Violation|0|||
33603546|NCT02388269|63002988|FG002|Overall Study|Protocol Violation|0|||
33603547|NCT02388269|63002986|FG000|Overall Study|Screen Failure|0|||
33603548|NCT02388269|63002987|FG001|Overall Study|Screen Failure|0|||
33603549|NCT02388269|63002988|FG002|Overall Study|Screen Failure|10|||
33603550|NCT01652573|63003014|FG000|Overall Study|Adverse Event|0|||
33603551|NCT01652573|63003015|FG001|Overall Study|Adverse Event|1|||
33603552|NCT02388191|63003023|FG000|Overall Study|Patient did not receive IUD|1|||
33603553|NCT02388191|63003024|FG001|Overall Study|Patient did not receive IUD|0|||
33603554|NCT01815736|63003032|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
33603555|NCT01815736|63003033|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
33603556|NCT01815736|63003032|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
33603557|NCT01815736|63003033|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
33603558|NCT01815736|63003032|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
33603559|NCT01815736|63003033|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
33603560|NCT01815736|63003032|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
33603561|NCT01815736|63003033|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
33603562|NCT01815736|63003032|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
33603563|NCT01815736|63003033|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
33603564|NCT01815736|63003032|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
33603565|NCT01815736|63003033|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
33603566|NCT01815736|63003032|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
33603567|NCT01815736|63003033|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
33603568|NCT01815736|63003032|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
33603569|NCT01815736|63003033|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
33603570|NCT01815736|63003032|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
33603571|NCT01815736|63003033|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
33603572|NCT01815736|63003032|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
33603573|NCT01815736|63003033|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
33603574|NCT01815736|63003032|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
33603575|NCT01815736|63003033|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
33603576|NCT01815736|63003032|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
33603577|NCT01815736|63003033|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
33603578|NCT01815736|63003032|FG000|Extension Treatment Phase- After Week 96|Death|1|||
33603579|NCT01815736|63003033|FG001|Extension Treatment Phase- After Week 96|Death|0|||
33603580|NCT01651949|63003044|FG000|Overall Study|Unknown status|4|||
33603581|NCT01651949|63003045|FG001|Overall Study|Unknown status|4|||
33603582|NCT01651949|63003046|FG002|Overall Study|Unknown status|0|||
33603583|NCT01651949|63003044|FG000|Overall Study|Lost to Follow-up|30|||
33603584|NCT01651949|63003045|FG001|Overall Study|Lost to Follow-up|56|||
33603585|NCT01651949|63003046|FG002|Overall Study|Lost to Follow-up|20|||
33603586|NCT01651949|63003044|FG000|Overall Study|Protocol Violation|0|||
33603587|NCT01651949|63003045|FG001|Overall Study|Protocol Violation|2|||
33603588|NCT01651949|63003046|FG002|Overall Study|Protocol Violation|1|||
33603589|NCT01651949|63003044|FG000|Overall Study|Physician Decision|0|||
33603590|NCT01651949|63003045|FG001|Overall Study|Physician Decision|2|||
33603591|NCT01651949|63003046|FG002|Overall Study|Physician Decision|0|||
33603592|NCT01651949|63003044|FG000|Overall Study|Adverse Event|0|||
33603593|NCT01651949|63003045|FG001|Overall Study|Adverse Event|2|||
33603594|NCT01651949|63003046|FG002|Overall Study|Adverse Event|1|||
33603595|NCT01651949|63003044|FG000|Overall Study|Screen failure|2|||
33603596|NCT01651949|63003045|FG001|Overall Study|Screen failure|2|||
33603597|NCT01651949|63003046|FG002|Overall Study|Screen failure|0|||
33603598|NCT01651949|63003044|FG000|Overall Study|Withdrawal by Subject|17|||
33603599|NCT01651949|63003045|FG001|Overall Study|Withdrawal by Subject|18|||
33603600|NCT01651949|63003046|FG002|Overall Study|Withdrawal by Subject|9|||
33603601|NCT02387957|63003057|FG000|Overall Study|The study was discontinued|21|||
33603602|NCT02387957|63003058|FG001|Overall Study|The study was discontinued|21|||
33603603|NCT02387957|63003059|FG002|Overall Study|The study was discontinued|20|||
33603604|NCT01800916|63003067|FG000|Test Period 1 (1 Week)|Convex product user|0|||
33603605|NCT01800916|63003068|FG001|Test Period 1 (1 Week)|Convex product user|0|||
33603606|NCT01800916|63003069|FG002|Test Period 1 (1 Week)|Convex product user|0|||
33603607|NCT01800916|63003070|FG003|Test Period 1 (1 Week)|Convex product user|1|||
33603608|NCT01800916|63003071|FG004|Test Period 1 (1 Week)|Convex product user|0|||
33603609|NCT01800916|63003072|FG005|Test Period 1 (1 Week)|Convex product user|0|||
33603610|NCT01800916|63003073|FG006|Test Period 1 (1 Week)|Convex product user|0|||
33603611|NCT01800916|63003074|FG007|Test Period 1 (1 Week)|Convex product user|0|||
33603612|NCT01800916|63003075|FG008|Test Period 1 (1 Week)|Convex product user|0|||
33603613|NCT01800916|63003067|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
33603614|NCT01800916|63003068|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
33603615|NCT01800916|63003069|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
33603616|NCT01800916|63003070|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
33603617|NCT01800916|63003071|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
33603618|NCT01800916|63003072|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
33603619|NCT01800916|63003073|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
33603620|NCT01800916|63003074|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
33603621|NCT01800916|63003075|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
33603622|NCT01800058|63003085|FG000|Overall Study|Lost to Follow-up|1|||
33603623|NCT01815580|63003092|FG000|Overall Study|Lost to Follow-up|4|||
33603624|NCT01815580|63003093|FG001|Overall Study|Lost to Follow-up|7|||
33603625|NCT01815580|63003092|FG000|Overall Study|Withdrawal by Subject|3|||
33603626|NCT01815580|63003093|FG001|Overall Study|Withdrawal by Subject|4|||
33603627|NCT01815580|63003092|FG000|Overall Study|Excluded from analysis|5|||
33603628|NCT01815580|63003093|FG001|Overall Study|Excluded from analysis|4|||
33603629|NCT01799590|63003107|FG000|Overall Study|Adverse Event|13|||
33603630|NCT01799590|63003108|FG001|Overall Study|Adverse Event|7|||
33603631|NCT01799590|63003109|FG002|Overall Study|Adverse Event|5|||
33603632|NCT01799590|63003107|FG000|Overall Study|Pregnancy|2|||
33603633|NCT01799590|63003108|FG001|Overall Study|Pregnancy|0|||
33603634|NCT01799590|63003109|FG002|Overall Study|Pregnancy|0|||
33603635|NCT01799590|63003107|FG000|Overall Study|Lack of Efficacy|3|||
33603636|NCT01799590|63003108|FG001|Overall Study|Lack of Efficacy|1|||
33603637|NCT01799590|63003109|FG002|Overall Study|Lack of Efficacy|3|||
33603638|NCT01799590|63003107|FG000|Overall Study|Participants convenience|4|||
33603639|NCT01799590|63003108|FG001|Overall Study|Participants convenience|4|||
33603640|NCT01799590|63003109|FG002|Overall Study|Participants convenience|2|||
33603641|NCT01799590|63003107|FG000|Overall Study|Aggravation of complications|0|||
33603642|NCT01799590|63003108|FG001|Overall Study|Aggravation of complications|1|||
33603643|NCT01799590|63003109|FG002|Overall Study|Aggravation of complications|1|||
33603644|NCT01799590|63003107|FG000|Overall Study|Using drugs with restricted days of use|0|||
33603645|NCT01799590|63003108|FG001|Overall Study|Using drugs with restricted days of use|3|||
33603646|NCT01799590|63003109|FG002|Overall Study|Using drugs with restricted days of use|2|||
33603647|NCT01799590|63003107|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
33603648|NCT01799590|63003108|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
33603649|NCT01799590|63003109|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
33603650|NCT01799590|63003107|FG000|Overall Study|Other|3|||
33603651|NCT01799590|63003108|FG001|Overall Study|Other|0|||
33603652|NCT01799590|63003109|FG002|Overall Study|Other|1|||
33603653|NCT01815424|63003120|FG000|Week 0 to 16|Adverse Event|1|||
33603654|NCT01815424|63003121|FG001|Week 0 to 16|Adverse Event|3|||
33603655|NCT01815424|63003122|FG002|Week 0 to 16|Adverse Event|3|||
33603656|NCT01815424|63003123|FG003|Week 0 to 16|Adverse Event|0|||
33603657|NCT01815424|63003124|FG004|Week 0 to 16|Adverse Event|0|||
33603658|NCT01815424|63003120|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
33603659|NCT01815424|63003121|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
33603660|NCT01815424|63003122|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
33603661|NCT01815424|63003123|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
33603662|NCT01815424|63003124|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
33603663|NCT01815424|63003120|FG000|Week 0 to 16|Lost to Follow-up|0|||
33603664|NCT01815424|63003121|FG001|Week 0 to 16|Lost to Follow-up|1|||
33603665|NCT01815424|63003122|FG002|Week 0 to 16|Lost to Follow-up|0|||
33603666|NCT01815424|63003123|FG003|Week 0 to 16|Lost to Follow-up|0|||
33603667|NCT01815424|63003124|FG004|Week 0 to 16|Lost to Follow-up|0|||
33603668|NCT01815424|63003120|FG000|Week 0 to 16|Withdrawal by Subject|0|||
33603669|NCT01815424|63003121|FG001|Week 0 to 16|Withdrawal by Subject|0|||
33603670|NCT01815424|63003122|FG002|Week 0 to 16|Withdrawal by Subject|1|||
33603671|NCT01815424|63003123|FG003|Week 0 to 16|Withdrawal by Subject|0|||
33603672|NCT01815424|63003124|FG004|Week 0 to 16|Withdrawal by Subject|0|||
33603673|NCT01815424|63003120|FG000|Week 0 to 16|Other|1|||
33603674|NCT01815424|63003121|FG001|Week 0 to 16|Other|0|||
33603675|NCT01815424|63003122|FG002|Week 0 to 16|Other|3|||
33603676|NCT01815424|63003123|FG003|Week 0 to 16|Other|0|||
33603677|NCT01815424|63003124|FG004|Week 0 to 16|Other|0|||
33603678|NCT01815424|63003120|FG000|Week 0 to 16|Protocol Violation|1|||
33322256|NCT00932698|62698432|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
33603679|NCT01815424|63003121|FG001|Week 0 to 16|Protocol Violation|0|||
33603680|NCT01815424|63003122|FG002|Week 0 to 16|Protocol Violation|0|||
33603681|NCT01815424|63003123|FG003|Week 0 to 16|Protocol Violation|0|||
33603682|NCT01815424|63003124|FG004|Week 0 to 16|Protocol Violation|0|||
33603683|NCT01815424|63003120|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
33322257|NCT00932698|62698433|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
33603684|NCT01815424|63003121|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
33603685|NCT01815424|63003122|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
33603686|NCT01815424|63003123|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
33603687|NCT01815424|63003124|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
33603688|NCT01815424|63003120|FG000|Week 16 to 52|Other|0|||
33603689|NCT01815424|63003121|FG001|Week 16 to 52|Other|1|||
33603690|NCT01815424|63003122|FG002|Week 16 to 52|Other|0|||
33603691|NCT01815424|63003123|FG003|Week 16 to 52|Other|0|||
33603692|NCT01815424|63003124|FG004|Week 16 to 52|Other|0|||
33603693|NCT01815424|63003120|FG000|Week 16 to 52|Adverse Event|0|||
33603694|NCT01815424|63003121|FG001|Week 16 to 52|Adverse Event|0|||
33603695|NCT01815424|63003122|FG002|Week 16 to 52|Adverse Event|0|||
33603696|NCT01815424|63003123|FG003|Week 16 to 52|Adverse Event|0|||
33603697|NCT01815424|63003124|FG004|Week 16 to 52|Adverse Event|1|||
33603698|NCT01815424|63003120|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
33603699|NCT01815424|63003121|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
33603700|NCT01815424|63003122|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
33603701|NCT01815424|63003123|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
33603702|NCT01815424|63003124|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
33603703|NCT01815424|63003120|FG000|Week 16 to 52|Lost to Follow-up|0|||
33603704|NCT01815424|63003121|FG001|Week 16 to 52|Lost to Follow-up|2|||
33603705|NCT01815424|63003122|FG002|Week 16 to 52|Lost to Follow-up|0|||
33603706|NCT01815424|63003123|FG003|Week 16 to 52|Lost to Follow-up|2|||
33603707|NCT01815424|63003124|FG004|Week 16 to 52|Lost to Follow-up|1|||
33603708|NCT01815424|63003120|FG000|Week 16 to 52|Withdrawal by Subject|1|||
33603709|NCT01815424|63003121|FG001|Week 16 to 52|Withdrawal by Subject|2|||
33603710|NCT01815424|63003122|FG002|Week 16 to 52|Withdrawal by Subject|0|||
33603711|NCT01815424|63003123|FG003|Week 16 to 52|Withdrawal by Subject|0|||
33603712|NCT01815424|63003124|FG004|Week 16 to 52|Withdrawal by Subject|0|||
33603713|NCT02431247|63003139|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
33603714|NCT02431247|63003140|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
33603715|NCT02431247|63003141|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
33603716|NCT02431247|63003139|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
33603717|NCT02431247|63003140|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
33603718|NCT02431247|63003141|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
33603719|NCT02431247|63003139|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
33603720|NCT02431247|63003140|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
33603721|NCT02431247|63003141|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
33603722|NCT02431247|63003139|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
33603723|NCT02431247|63003140|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
33603724|NCT02431247|63003141|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
33603725|NCT02431247|63003139|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
33603726|NCT02431247|63003140|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
33603727|NCT02431247|63003141|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
33603728|NCT02431247|63003139|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
33603729|NCT02431247|63003140|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
33603730|NCT02431247|63003141|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
33603731|NCT02431247|63003139|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
33603732|NCT02431247|63003140|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
33603733|NCT02431247|63003141|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
33603734|NCT02431247|63003139|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
33603735|NCT02431247|63003140|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
33603736|NCT02431247|63003141|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
33603737|NCT02431247|63003139|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
33603738|NCT02431247|63003140|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
33603739|NCT02431247|63003141|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
33603740|NCT02431247|63003139|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
33603741|NCT02431247|63003140|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
33603742|NCT02431247|63003141|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
33603743|NCT02431247|63003139|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
33603744|NCT02431247|63003140|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
33603745|NCT02431247|63003141|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
33603746|NCT02431247|63003139|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
33603747|NCT02431247|63003140|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
33603748|NCT02431247|63003141|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
33603749|NCT02431247|63003139|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
33603750|NCT02431247|63003140|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
33603751|NCT02431247|63003141|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
33603752|NCT02431247|63003139|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
33603753|NCT02431247|63003140|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
33603754|NCT02431247|63003141|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
33603755|NCT01814878|63003155|FG000|Overall Study|Adverse Event|16|||
33603756|NCT01814878|63003156|FG001|Overall Study|Adverse Event|5|||
33603757|NCT01814878|63003155|FG000|Overall Study|Withdrawal by Subject|20|||
33603758|NCT01814878|63003156|FG001|Overall Study|Withdrawal by Subject|16|||
33603759|NCT01814878|63003155|FG000|Overall Study|Protocol Violation|5|||
33603760|NCT01814878|63003156|FG001|Overall Study|Protocol Violation|5|||
33603761|NCT01814878|63003155|FG000|Overall Study|Physician Decision|3|||
33603762|NCT01814878|63003156|FG001|Overall Study|Physician Decision|1|||
33603763|NCT01814878|63003155|FG000|Overall Study|Screening failure (drop-out)|0|||
33603764|NCT01814878|63003156|FG001|Overall Study|Screening failure (drop-out)|3|||
33603765|NCT01814878|63003155|FG000|Overall Study|Other|2|||
33603766|NCT01814878|63003156|FG001|Overall Study|Other|0|||
33603767|NCT02407457|63003164|FG000|1 Month|Death|3|||
33603768|NCT02407457|63003165|FG001|1 Month|Death|0|||
33603769|NCT02407457|63003164|FG000|1 Month|Lost to Follow-up|1|||
33603770|NCT02407457|63003165|FG001|1 Month|Lost to Follow-up|1|||
33603771|NCT02407457|63003164|FG000|1 Month|missed visit|2|||
33603772|NCT02407457|63003165|FG001|1 Month|missed visit|6|||
33603773|NCT02407457|63003164|FG000|6-Month|Death|2|||
33603774|NCT02407457|63003165|FG001|6-Month|Death|8|||
33603775|NCT02407457|63003164|FG000|6-Month|Lost to Follow-up|2|||
33603776|NCT02407457|63003165|FG001|6-Month|Lost to Follow-up|2|||
33603777|NCT02407457|63003164|FG000|6-Month|missed visit|15|||
33603778|NCT02407457|63003165|FG001|6-Month|missed visit|12|||
33603779|NCT02407457|63003164|FG000|6-Month|Over Due|1|||
33603780|NCT02407457|63003165|FG001|6-Month|Over Due|2|||
33603781|NCT02407457|63003164|FG000|6-Month|Open Repair|0|||
33603782|NCT02407457|63003165|FG001|6-Month|Open Repair|1|||
33603783|NCT02407457|63003164|FG000|1 Year|Death|6|||
33603784|NCT02407457|63003165|FG001|1 Year|Death|11|||
33603785|NCT02407457|63003164|FG000|1 Year|Lost to Follow-up|3|||
33603786|NCT02407457|63003165|FG001|1 Year|Lost to Follow-up|2|||
33603787|NCT02407457|63003164|FG000|1 Year|Missed Visit|18|||
33603788|NCT02407457|63003165|FG001|1 Year|Missed Visit|10|||
33603789|NCT02407457|63003164|FG000|1 Year|Over Due|6|||
33603790|NCT02407457|63003165|FG001|1 Year|Over Due|4|||
33603791|NCT02407457|63003164|FG000|1 Year|Open Repair|0|||
33603792|NCT02407457|63003165|FG001|1 Year|Open Repair|1|||
33603793|NCT02407457|63003164|FG000|2-year|Death|14|||
33603794|NCT02407457|63003165|FG001|2-year|Death|8|||
33603795|NCT02407457|63003164|FG000|2-year|Lost to Follow-up|6|||
33603796|NCT02407457|63003165|FG001|2-year|Lost to Follow-up|9|||
33603797|NCT02407457|63003164|FG000|2-year|Missed Visit|13|||
33322258|NCT00932698|62698434|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
33603798|NCT02407457|63003165|FG001|2-year|Missed Visit|11|||
33603799|NCT02407457|63003164|FG000|2-year|Over Due|1|||
33603800|NCT02407457|63003165|FG001|2-year|Over Due|5|||
33603801|NCT02407457|63003164|FG000|2-year|Open Repair|0|||
33603802|NCT02407457|63003165|FG001|2-year|Open Repair|2|||
33603803|NCT02407457|63003164|FG000|3-year|Death|11|||
33603804|NCT02407457|63003165|FG001|3-year|Death|10|||
33603805|NCT02407457|63003164|FG000|3-year|Lost to Follow-up|6|||
33603806|NCT02407457|63003165|FG001|3-year|Lost to Follow-up|9|||
33603807|NCT02407457|63003164|FG000|3-year|Missed Visit|21|||
33603808|NCT02407457|63003165|FG001|3-year|Missed Visit|16|||
33603809|NCT02407457|63003164|FG000|3-year|Over Due|4|||
33603810|NCT02407457|63003165|FG001|3-year|Over Due|3|||
33603811|NCT02407457|63003164|FG000|4-year|Death|14|||
33603812|NCT02407457|63003165|FG001|4-year|Death|7|||
33603813|NCT02407457|63003164|FG000|4-year|Lost to Follow-up|9|||
33603814|NCT02407457|63003165|FG001|4-year|Lost to Follow-up|12|||
33603815|NCT02407457|63003164|FG000|4-year|Over Due|10|||
33603816|NCT02407457|63003165|FG001|4-year|Over Due|5|||
33603817|NCT02407457|63003164|FG000|4-year|Missed Visit|13|||
33603818|NCT02407457|63003165|FG001|4-year|Missed Visit|13|||
33603819|NCT02407457|63003164|FG000|4-year|Pending visit|19|||
33603820|NCT02407457|63003165|FG001|4-year|Pending visit|14|||
33412871|NCT00483717|62791183|FG001|Overall Study|Lost to Follow-up|0|||
33412872|NCT00483717|62791182|FG000|Overall Study|Withdrawal by Subject|1|||
33412873|NCT00483717|62791183|FG001|Overall Study|Withdrawal by Subject|0|||
33412874|NCT00406354|62791192|FG000|All Randomized Patients|Protocol Violation|0|||
33412875|NCT00406354|62791193|FG001|All Randomized Patients|Protocol Violation|0|||
33412876|NCT00406354|62791194|FG002|All Randomized Patients|Protocol Violation|1|||
33412877|NCT00406354|62791192|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
33412878|NCT00406354|62791193|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
33412879|NCT00406354|62791194|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
33412880|NCT00406354|62791192|FG000|All Randomized and Treated Patients|Adverse Event|6|||
33412881|NCT00406354|62791193|FG001|All Randomized and Treated Patients|Adverse Event|2|||
33412882|NCT00406354|62791194|FG002|All Randomized and Treated Patients|Adverse Event|1|||
33412883|NCT00406354|62791192|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
33412884|NCT00406354|62791193|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
33412885|NCT00406354|62791194|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
33412886|NCT00406354|62791192|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
33412887|NCT00406354|62791193|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
33412888|NCT00406354|62791194|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
33412889|NCT00406354|62791192|FG000|All Randomized and Treated Patients|Physician Decision|0|||
33412890|NCT00406354|62791193|FG001|All Randomized and Treated Patients|Physician Decision|0|||
33412891|NCT00406354|62791194|FG002|All Randomized and Treated Patients|Physician Decision|1|||
33412892|NCT00483405|62791202|FG000|Overall Study|Adverse Event|8|||
33412893|NCT00483405|62791202|FG000|Overall Study|Lack of Efficacy|14|||
33322259|NCT00932698|62698435|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
33322260|NCT00932698|62698436|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
33322261|NCT00932698|62698437|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
33412894|NCT00483405|62791202|FG000|Overall Study|Death|3|||
33412895|NCT00483405|62791202|FG000|Overall Study|Withdrawal by Subject|2|||
33412896|NCT00483405|62791202|FG000|Overall Study|Other complicating disease|1|||
33412897|NCT00483327|62791210|FG000|Overall Study|Adverse Event|1|||
33412898|NCT00483327|62791210|FG000|Overall Study|Withdrawal by Subject|3|||
33412899|NCT00483327|62791210|FG000|Overall Study|Lost to Follow-up|4|||
33412900|NCT00483327|62791210|FG000|Overall Study|Patient Non Compliance|2|||
33412901|NCT00684203|62791222|FG000|Overall Study|Adverse Event|6|||
33412902|NCT00684203|62791223|FG001|Overall Study|Adverse Event|4|||
33322262|NCT00932698|62698438|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
33322263|NCT00932698|62698428|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
33322264|NCT00932698|62698429|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
33322265|NCT00932698|62698430|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
33322266|NCT00932698|62698431|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
33322267|NCT00932698|62698432|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
33322268|NCT00932698|62698433|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
33322269|NCT00932698|62698434|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
33322270|NCT00932698|62698435|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
33322271|NCT00932698|62698436|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
33322272|NCT00932698|62698437|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
33322273|NCT00932698|62698438|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
33412903|NCT00684203|62791224|FG002|Overall Study|Adverse Event|8|||
33412904|NCT00684203|62791225|FG003|Overall Study|Adverse Event|0|||
33603821|NCT02407457|63003164|FG000|4-year|Not Due|16|||
33603822|NCT02407457|63003165|FG001|4-year|Not Due|10|||
33603823|NCT02407457|63003164|FG000|5-year|Death|6|||
33603824|NCT02407457|63003165|FG001|5-year|Death|1|||
33603825|NCT02407457|63003164|FG000|5-year|Lost to Follow-up|4|||
33603826|NCT02407457|63003165|FG001|5-year|Lost to Follow-up|4|||
33603827|NCT02407457|63003164|FG000|5-year|Missed Visit|10|||
33603828|NCT02407457|63003165|FG001|5-year|Missed Visit|9|||
33603829|NCT02407457|63003164|FG000|5-year|Pending Visit|18|||
33603830|NCT02407457|63003165|FG001|5-year|Pending Visit|17|||
33603831|NCT02407457|63003164|FG000|5-year|Not Due|54|||
33603832|NCT02407457|63003165|FG001|5-year|Not Due|46|||
33603833|NCT01814800|63003171|FG000|Overall Study|Adverse Event|2|||
33603834|NCT01814800|63003171|FG000|Overall Study|Pregnancy|1|||
33603835|NCT01814800|63003171|FG000|Overall Study|Sponsor decision|1|||
33603836|NCT01814800|63003171|FG000|Overall Study|Subject relocation|1|||
33603837|NCT01814332|63003177|FG000|Overall Study|Adverse Event|8|||
33603838|NCT01814332|63003178|FG001|Overall Study|Adverse Event|3|||
33603839|NCT01814332|63003177|FG000|Overall Study|Withdrawal by Subject|3|||
33412905|NCT00684203|62791226|FG004|Overall Study|Adverse Event|0|||
33412906|NCT00684203|62791227|FG005|Overall Study|Adverse Event|0|||
33603840|NCT01814332|63003178|FG001|Overall Study|Withdrawal by Subject|8|||
33412907|NCT00684203|62791222|FG000|Overall Study|Protocol-defined clinical event|3|||
33412908|NCT00684203|62791223|FG001|Overall Study|Protocol-defined clinical event|1|||
33412909|NCT00684203|62791224|FG002|Overall Study|Protocol-defined clinical event|0|||
33412910|NCT00684203|62791225|FG003|Overall Study|Protocol-defined clinical event|0|||
33412911|NCT00684203|62791226|FG004|Overall Study|Protocol-defined clinical event|0|||
33412912|NCT00684203|62791227|FG005|Overall Study|Protocol-defined clinical event|0|||
33412913|NCT00684203|62791222|FG000|Overall Study|Withdrawal by Subject|0|||
33412914|NCT00684203|62791223|FG001|Overall Study|Withdrawal by Subject|2|||
33412915|NCT00684203|62791224|FG002|Overall Study|Withdrawal by Subject|1|||
33412916|NCT00684203|62791225|FG003|Overall Study|Withdrawal by Subject|0|||
33412917|NCT00684203|62791226|FG004|Overall Study|Withdrawal by Subject|0|||
33412918|NCT00684203|62791227|FG005|Overall Study|Withdrawal by Subject|0|||
33412919|NCT00684203|62791222|FG000|Overall Study|Did not meet protocol eligibility|0|||
33412920|NCT00684203|62791223|FG001|Overall Study|Did not meet protocol eligibility|1|||
33412921|NCT00684203|62791224|FG002|Overall Study|Did not meet protocol eligibility|0|||
33412922|NCT00684203|62791225|FG003|Overall Study|Did not meet protocol eligibility|0|||
33412923|NCT00684203|62791226|FG004|Overall Study|Did not meet protocol eligibility|0|||
33412924|NCT00684203|62791227|FG005|Overall Study|Did not meet protocol eligibility|0|||
33412925|NCT00423592|62791248|FG000|Overall Study|Adverse Event (through Week 12)|2|||
33412926|NCT00423592|62791248|FG000|Overall Study|Adverse Event (post Week 12)|5|||
33494064|NCT03473340|62872721|FG001|Overall Study|Lost to Follow-up|2|||
33603841|NCT01814332|63003177|FG000|Overall Study|Protocol Violation|0|||
33603842|NCT01814332|63003178|FG001|Overall Study|Protocol Violation|4|||
33603843|NCT01814332|63003177|FG000|Overall Study|Lost to Follow-up|5|||
33412927|NCT00683657|62791254|FG000|Overall Study|Adverse Event|0|||
33412928|NCT00683657|62791255|FG001|Overall Study|Adverse Event|1|||
33412929|NCT00683657|62791254|FG000|Overall Study|Subject Withdrew Consent|1|||
33412930|NCT00683657|62791255|FG001|Overall Study|Subject Withdrew Consent|0|||
33603844|NCT01814332|63003178|FG001|Overall Study|Lost to Follow-up|1|||
33603845|NCT02407223|63003187|FG000|Overall Study|Adverse Event|1|||
33603846|NCT02407223|63003188|FG001|Overall Study|Adverse Event|0|||
33603847|NCT02407223|63003189|FG002|Overall Study|Adverse Event|1|||
33603848|NCT02407223|63003187|FG000|Overall Study|Lack of Efficacy|6|||
33603849|NCT02407223|63003188|FG001|Overall Study|Lack of Efficacy|6|||
33603850|NCT02407223|63003189|FG002|Overall Study|Lack of Efficacy|4|||
33603851|NCT02407223|63003187|FG000|Overall Study|Lost to Follow-up|1|||
33603852|NCT02407223|63003188|FG001|Overall Study|Lost to Follow-up|0|||
33603853|NCT02407223|63003189|FG002|Overall Study|Lost to Follow-up|2|||
33603854|NCT02407223|63003187|FG000|Overall Study|Withdrawal by Subject|2|||
33603855|NCT02407223|63003188|FG001|Overall Study|Withdrawal by Subject|4|||
33603856|NCT02407223|63003189|FG002|Overall Study|Withdrawal by Subject|4|||
33603857|NCT02407223|63003187|FG000|Overall Study|Study Terminated by Sponsor|77|||
33603858|NCT02407223|63003188|FG001|Overall Study|Study Terminated by Sponsor|80|||
33603859|NCT02407223|63003189|FG002|Overall Study|Study Terminated by Sponsor|86|||
33603860|NCT02407223|63003187|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
33603861|NCT02407223|63003188|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
33603862|NCT02407223|63003189|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
33603863|NCT02407223|63003187|FG000|Overall Study|Other|29|||
33603864|NCT02407223|63003188|FG001|Overall Study|Other|27|||
33603865|NCT02407223|63003189|FG002|Overall Study|Other|25|||
33603866|NCT01797562|63003199|FG000|Overall Study|Protocol Violation|5|||
33603867|NCT01813474|63003207|FG000|Overall Study|Withdrawal by Subject|0|||
33603868|NCT01813474|63003208|FG001|Overall Study|Withdrawal by Subject|0|||
33603869|NCT01813474|63003209|FG002|Overall Study|Withdrawal by Subject|1|||
33603870|NCT01813474|63003207|FG000|Overall Study|Adverse Event|1|||
33603871|NCT01813474|63003208|FG001|Overall Study|Adverse Event|1|||
33603872|NCT01813474|63003209|FG002|Overall Study|Adverse Event|0|||
33603873|NCT01813474|63003207|FG000|Overall Study|Lack of Efficacy|2|||
33603874|NCT01813474|63003208|FG001|Overall Study|Lack of Efficacy|6|||
33603875|NCT01813474|63003209|FG002|Overall Study|Lack of Efficacy|9|||
33603876|NCT01813474|63003207|FG000|Overall Study|Death|0|||
33603877|NCT01813474|63003208|FG001|Overall Study|Death|0|||
33603878|NCT01813474|63003209|FG002|Overall Study|Death|1|||
33603879|NCT01868542|63003220|FG000|Overall Study|Protocol Violation|0|||
33603880|NCT01868542|63003221|FG001|Overall Study|Protocol Violation|1|||
33603881|NCT01868542|63003220|FG000|Overall Study|Unclassified|0|||
33603882|NCT01868542|63003221|FG001|Overall Study|Unclassified|1|||
33603883|NCT01797094|63003229|FG000|Overall Study|Adverse Event|1|||
33603884|NCT01797094|63003230|FG001|Overall Study|Adverse Event|1|||
33603885|NCT01797094|63003229|FG000|Overall Study|Personal Reasons|4|||
33603886|NCT01797094|63003230|FG001|Overall Study|Personal Reasons|0|||
33322274|NCT00932698|62698428|FG000|Part 1 (Dose Escalation)|Other|0|||
33322275|NCT00932698|62698429|FG001|Part 1 (Dose Escalation)|Other|0|||
33322276|NCT00932698|62698430|FG002|Part 1 (Dose Escalation)|Other|1|||
33603887|NCT01797094|63003229|FG000|Overall Study|Protocol Violation|0|||
33603888|NCT01797094|63003230|FG001|Overall Study|Protocol Violation|1|||
33603889|NCT01797094|63003229|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33603890|NCT01797094|63003230|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33603891|NCT02383589|63003238|FG000|Treatment Period|Adverse Event|1|||
33603892|NCT02383589|63003239|FG001|Treatment Period|Adverse Event|3|||
33603893|NCT02383589|63003238|FG000|Treatment Period|Lost to Follow-up|0|||
33603894|NCT02383589|63003239|FG001|Treatment Period|Lost to Follow-up|1|||
33603895|NCT02383589|63003238|FG000|Treatment Period|Withdrawal by Subject|0|||
33603896|NCT02383589|63003239|FG001|Treatment Period|Withdrawal by Subject|5|||
33603897|NCT02383589|63003238|FG000|Treatment Period|Non-compliance with study drug|0|||
33603898|NCT02383589|63003239|FG001|Treatment Period|Non-compliance with study drug|1|||
33603899|NCT02383589|63003238|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
33603900|NCT02383589|63003239|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
33603901|NCT02383589|63003238|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
33603902|NCT02383589|63003239|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
33603903|NCT02383589|63003238|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
33603904|NCT02383589|63003239|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
33603905|NCT01810432|63003247|FG000|Washout|Protocol Violation|0|||
33603906|NCT01810432|63003248|FG001|Washout|Protocol Violation|1|||
33603907|NCT01810432|63003247|FG000|Washout|Adverse Event|1|||
33603908|NCT01810432|63003248|FG001|Washout|Adverse Event|0|||
33603909|NCT01810432|63003247|FG000|Period 2|Withdrawal by Subject|2|||
33603910|NCT01810432|63003248|FG001|Period 2|Withdrawal by Subject|1|||
33603911|NCT01810432|63003247|FG000|Period 2|Physician Decision|1|||
33603912|NCT01810432|63003248|FG001|Period 2|Physician Decision|0|||
33603913|NCT01810432|63003247|FG000|Period 2|Lost to Follow-up|1|||
33603914|NCT01810432|63003248|FG001|Period 2|Lost to Follow-up|1|||
33603915|NCT01796860|63003254|FG000|Overall Study|Withdrawal by Subject|3|||
33603916|NCT01796548|63003258|FG000|Overall Study|Lost to Follow-up|1|||
33603917|NCT01796548|63003258|FG000|Overall Study|Other|2|||
33603918|NCT02406677|63003264|FG000|Overall Study|Death|16|||
33603919|NCT02406677|63003265|FG001|Overall Study|Death|8|||
33603920|NCT02406677|63003264|FG000|Overall Study|Discharged without P2Y12|1|||
33603921|NCT02406677|63003265|FG001|Overall Study|Discharged without P2Y12|3|||
33603922|NCT02406677|63003264|FG000|Overall Study|Discharged on prasugrel|283|||
33603923|NCT02406677|63003265|FG001|Overall Study|Discharged on prasugrel|587|||
33603924|NCT02406677|63003264|FG000|Overall Study|Withdrawal by Subject|1|||
33603925|NCT02406677|63003265|FG001|Overall Study|Withdrawal by Subject|0|||
33603926|NCT02404805|63003281|FG000|Overall Study|Withdrawal by Subject|1|||
33603927|NCT02404805|63003282|FG001|Overall Study|Withdrawal by Subject|0|||
33603928|NCT02404805|63003283|FG002|Overall Study|Withdrawal by Subject|0|||
33603929|NCT02404805|63003284|FG003|Overall Study|Withdrawal by Subject|0|||
33603930|NCT02404805|63003285|FG004|Overall Study|Withdrawal by Subject|0|||
33603931|NCT02404805|63003286|FG005|Overall Study|Withdrawal by Subject|0|||
33603932|NCT02430311|63003297|FG000|Part A|Adverse Event|0|||
33603933|NCT02430311|63003298|FG001|Part A|Adverse Event|1|||
33603934|NCT02430311|63003297|FG000|Part A|Withdrawal by Subject|1|||
33603935|NCT02430311|63003298|FG001|Part A|Withdrawal by Subject|0|||
33603936|NCT02430311|63003297|FG000|Part B|Meet study-specific withdrawal criteria|6|||
33603937|NCT02430311|63003298|FG001|Part B|Meet study-specific withdrawal criteria|6|||
33603938|NCT02430311|63003297|FG000|Part B|Withdrawal by Subject|2|||
33603939|NCT02430311|63003298|FG001|Part B|Withdrawal by Subject|2|||
33603940|NCT02430311|63003297|FG000|Part B|Adverse Event|1|||
33603941|NCT02430311|63003298|FG001|Part B|Adverse Event|0|||
33603942|NCT02430311|63003297|FG000|Part B|Death|1|||
33603943|NCT02430311|63003298|FG001|Part B|Death|0|||
33603944|NCT02383433|63003313|FG000|Overall Study|Disease progression|2|||
33603945|NCT02404649|63003319|FG000|Overall Study|Adverse Event|1|||
33603946|NCT02404649|63003320|FG001|Overall Study|Adverse Event|2|||
33603947|NCT02383355|63003328|FG000|Overall Study|Adverse Event|2|||
33603948|NCT02383355|63003329|FG001|Overall Study|Adverse Event|0|||
33603949|NCT02381795|63003335|FG000|Overall Study|Withdrawal by Subject|1|||
33603950|NCT02381795|63003335|FG000|Overall Study|Study Terminated|2|||
33603951|NCT02404493|63003341|FG000|Overall Study|Adverse Event|1|||
33603952|NCT02404493|63003342|FG001|Overall Study|Adverse Event|1|||
33603953|NCT02380859|63003350|FG000|Overall Study|Withdrawal by Subject|2|||
33603954|NCT02380859|63003351|FG001|Overall Study|Withdrawal by Subject|0|||
33603955|NCT02380703|63003359|FG000|Overall Study|Withdrawal by Subject|12|||
33603956|NCT02380703|63003360|FG001|Overall Study|Withdrawal by Subject|9|||
33603957|NCT02380703|63003359|FG000|Overall Study|Lost to Follow-up|12|||
33603958|NCT02380703|63003360|FG001|Overall Study|Lost to Follow-up|12|||
33603959|NCT02380703|63003359|FG000|Overall Study|Caregiver death|1|||
33603960|NCT02380703|63003360|FG001|Overall Study|Caregiver death|0|||
33603961|NCT02380703|63003359|FG000|Overall Study|Person with dementia (PWD) death|7|||
33603962|NCT02380703|63003360|FG001|Overall Study|Person with dementia (PWD) death|8|||
33603963|NCT02380703|63003359|FG000|Overall Study|Entered Long-term Care|4|||
33603964|NCT02380703|63003360|FG001|Overall Study|Entered Long-term Care|7|||
33603965|NCT02379923|63003366|FG000|Overall Study|Death|5|||
33603966|NCT02379221|63003373|FG000|Overall Study|Lost to Follow-up|1|||
33603967|NCT02404103|63003384|FG000|Overall Study|Adverse Event|1|||
33603968|NCT02404103|63003385|FG001|Overall Study|Adverse Event|0|||
33603969|NCT02404103|63003384|FG000|Overall Study|Lost to Follow-up|3|||
33603970|NCT02404103|63003385|FG001|Overall Study|Lost to Follow-up|3|||
33603971|NCT02404025|63003401|FG000|Overall Study|Adverse Event|1|||
33603972|NCT02404025|63003401|FG000|Overall Study|Lack of Efficacy|3|||
33603973|NCT02377817|63003407|FG000|Overall Study|Transportation/childcare barriers.|2|||
33603974|NCT02377817|63003408|FG001|Overall Study|Transportation/childcare barriers.|0|||
33603975|NCT02377817|63003407|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
33603976|NCT02377817|63003408|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
33603977|NCT02403635|63003416|FG000|Overall Study|Not eligible|9|||
33603978|NCT02402933|63003436|FG000|Overall Study|Withdrawal by Subject|4|||
33603979|NCT02402933|63003436|FG000|Overall Study|Discontinued; Site Termination|10|||
33603980|NCT01796470|63003445|FG000|Overall Study|Adverse Event|4|||
33603981|NCT01796470|63003446|FG001|Overall Study|Adverse Event|2|||
33603982|NCT01796470|63003447|FG002|Overall Study|Adverse Event|2|||
33603983|NCT01796470|63003448|FG003|Overall Study|Adverse Event|1|||
33603984|NCT01796470|63003449|FG004|Overall Study|Adverse Event|3|||
33603985|NCT01796470|63003445|FG000|Overall Study|Death|2|||
33603986|NCT01796470|63003446|FG001|Overall Study|Death|0|||
33603987|NCT01796470|63003447|FG002|Overall Study|Death|0|||
33603988|NCT01796470|63003448|FG003|Overall Study|Death|0|||
33603989|NCT01796470|63003449|FG004|Overall Study|Death|1|||
33603990|NCT01796470|63003445|FG000|Overall Study|Initiated New Therapy|9|||
33603991|NCT01796470|63003446|FG001|Overall Study|Initiated New Therapy|0|||
33603992|NCT01796470|63003447|FG002|Overall Study|Initiated New Therapy|0|||
33603993|NCT01796470|63003448|FG003|Overall Study|Initiated New Therapy|0|||
33603994|NCT01796470|63003449|FG004|Overall Study|Initiated New Therapy|2|||
33603995|NCT01796470|63003445|FG000|Overall Study|Lost to Follow-up|0|||
33603996|NCT01796470|63003446|FG001|Overall Study|Lost to Follow-up|1|||
33603997|NCT01796470|63003447|FG002|Overall Study|Lost to Follow-up|0|||
33603998|NCT01796470|63003448|FG003|Overall Study|Lost to Follow-up|0|||
33603999|NCT01796470|63003449|FG004|Overall Study|Lost to Follow-up|0|||
33604000|NCT01796470|63003445|FG000|Overall Study|Physician Decision|5|||
33604001|NCT01796470|63003446|FG001|Overall Study|Physician Decision|4|||
33604002|NCT01796470|63003447|FG002|Overall Study|Physician Decision|1|||
33604003|NCT01796470|63003448|FG003|Overall Study|Physician Decision|0|||
33604004|NCT01796470|63003449|FG004|Overall Study|Physician Decision|1|||
33604005|NCT01796470|63003445|FG000|Overall Study|Progressive Disease|7|||
33604006|NCT01796470|63003446|FG001|Overall Study|Progressive Disease|7|||
33604007|NCT01796470|63003447|FG002|Overall Study|Progressive Disease|3|||
33604008|NCT01796470|63003448|FG003|Overall Study|Progressive Disease|2|||
33604009|NCT01796470|63003449|FG004|Overall Study|Progressive Disease|0|||
33604010|NCT01796470|63003445|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
33604011|NCT01796470|63003446|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
33604012|NCT01796470|63003447|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
33604013|NCT01796470|63003448|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
33604014|NCT01796470|63003449|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
33604015|NCT01796470|63003445|FG000|Overall Study|Withdrawal by Subject|7|||
33604016|NCT01796470|63003446|FG001|Overall Study|Withdrawal by Subject|0|||
33604017|NCT01796470|63003447|FG002|Overall Study|Withdrawal by Subject|0|||
33604018|NCT01796470|63003448|FG003|Overall Study|Withdrawal by Subject|0|||
33604019|NCT01796470|63003449|FG004|Overall Study|Withdrawal by Subject|1|||
33604020|NCT01868074|63003467|FG000|Overall Study|Lost to Follow-up|3|||
33604021|NCT01868074|63003468|FG001|Overall Study|Lost to Follow-up|2|||
33604022|NCT01868074|63003467|FG000|Overall Study|Withdrawal by Subject|4|||
33604023|NCT01868074|63003468|FG001|Overall Study|Withdrawal by Subject|2|||
33604024|NCT01810042|63003474|FG000|Overall Study|Lost to Follow-up|10|||
33604025|NCT02424539|63003481|FG000|Overall Study|Adverse Event|0|||
33604026|NCT02424539|63003482|FG001|Overall Study|Adverse Event|0|||
33604027|NCT02424539|63003483|FG002|Overall Study|Adverse Event|1|||
33604028|NCT02424539|63003481|FG000|Overall Study|Physician Decision|0|||
33604029|NCT02424539|63003482|FG001|Overall Study|Physician Decision|0|||
33604030|NCT02424539|63003483|FG002|Overall Study|Physician Decision|1|||
33604031|NCT02424539|63003481|FG000|Overall Study|Withdrawal by Subject|3|||
33604032|NCT02424539|63003482|FG001|Overall Study|Withdrawal by Subject|1|||
33604033|NCT02424539|63003483|FG002|Overall Study|Withdrawal by Subject|0|||
33604034|NCT02424539|63003481|FG000|Overall Study|Other: Reached stopping criteria|11|||
33604035|NCT02424539|63003482|FG001|Overall Study|Other: Reached stopping criteria|7|||
33604036|NCT02424539|63003483|FG002|Overall Study|Other: Reached stopping criteria|6|||
33604037|NCT01809262|63003491|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
33604038|NCT01809262|63003492|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
33604039|NCT01809262|63003493|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
33604040|NCT01809262|63003494|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
33604041|NCT01809262|63003495|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
33604042|NCT01809262|63003496|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
33604043|NCT01809262|63003497|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
33604044|NCT01809262|63003498|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
33604045|NCT01809262|63003499|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
33604046|NCT01809262|63003500|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
33604047|NCT01809262|63003491|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33604048|NCT01809262|63003492|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
33604049|NCT01809262|63003493|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33604050|NCT01809262|63003494|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33604051|NCT01809262|63003495|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33604052|NCT01809262|63003496|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33604053|NCT01809262|63003497|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33604054|NCT01809262|63003498|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33604055|NCT01809262|63003499|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33604056|NCT01809262|63003500|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33604057|NCT01808248|63003514|FG000|Overall Study|Lack of Efficacy|3|||
33604058|NCT01808248|63003514|FG000|Overall Study|Withdrawal by Subject|1|||
33604059|NCT01808248|63003514|FG000|Overall Study|Lost to Follow-up|1|||
33604060|NCT02424383|63003520|FG000|Overall Study|Withdrawal by Subject|32|||
33604061|NCT02424383|63003520|FG000|Overall Study|Death|170|||
33604062|NCT02424383|63003520|FG000|Overall Study|Sponsor's decision|3|||
33604063|NCT02424383|63003520|FG000|Overall Study|Investigator's decision|44|||
33604064|NCT02424383|63003520|FG000|Overall Study|Lost to Follow-up|81|||
33604065|NCT02424383|63003520|FG000|Overall Study|Other|7|||
33604066|NCT02424383|63003520|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
33604067|NCT01867294|63003528|FG000|Overall Study|Withdrawal by Subject|1|||
33604068|NCT01867294|63003529|FG001|Overall Study|Withdrawal by Subject|1|||
33604069|NCT01867294|63003530|FG002|Overall Study|Withdrawal by Subject|0|||
33604070|NCT01867294|63003531|FG003|Overall Study|Withdrawal by Subject|0|||
33604071|NCT02424149|63003541|FG000|Overall Study|surgery cancelled|2|||
33604072|NCT02424149|63003542|FG001|Overall Study|surgery cancelled|0|||
33604073|NCT02424149|63003541|FG000|Overall Study|Withdrawal by Subject|0|||
33604074|NCT02424149|63003542|FG001|Overall Study|Withdrawal by Subject|1|||
33604075|NCT02423291|63003548|FG000|Overall Study|Lack of Efficacy|14|||
33604076|NCT02423291|63003548|FG000|Overall Study|Adverse Event|1|||
33604077|NCT02401529|63003554|FG000|Overall Study|Lost to Follow-up|2|||
33604078|NCT02401529|63003555|FG001|Overall Study|Lost to Follow-up|1|||
33604079|NCT02401529|63003554|FG000|Overall Study|Physician Decision|2|||
33604080|NCT02401529|63003555|FG001|Overall Study|Physician Decision|6|||
33604081|NCT02401529|63003554|FG000|Overall Study|Protocol Violation|5|||
33604082|NCT02401529|63003555|FG001|Overall Study|Protocol Violation|0|||
33604083|NCT01867216|63003569|FG000|Overall Study|Withdrawal by Subject|2|||
33604084|NCT01867216|63003570|FG001|Overall Study|Withdrawal by Subject|0|||
33604085|NCT01867216|63003571|FG002|Overall Study|Withdrawal by Subject|0|||
33604086|NCT01867216|63003572|FG003|Overall Study|Withdrawal by Subject|0|||
33604087|NCT01867216|63003573|FG004|Overall Study|Withdrawal by Subject|1|||
33604088|NCT01867216|63003574|FG005|Overall Study|Withdrawal by Subject|0|||
33604089|NCT01867216|63003575|FG006|Overall Study|Withdrawal by Subject|1|||
33604090|NCT01867216|63003569|FG000|Overall Study|Physician Decision|1|||
33604091|NCT01867216|63003570|FG001|Overall Study|Physician Decision|0|||
33604092|NCT01867216|63003571|FG002|Overall Study|Physician Decision|0|||
33494065|NCT03490032|62872730|FG000|Overall Study|family issue (child custody)|1|||
33604093|NCT01867216|63003572|FG003|Overall Study|Physician Decision|0|||
33494066|NCT03490032|62872731|FG001|Overall Study|family issue (child custody)|0|||
33604094|NCT01867216|63003573|FG004|Overall Study|Physician Decision|0|||
33604095|NCT01867216|63003574|FG005|Overall Study|Physician Decision|0|||
33604096|NCT01867216|63003575|FG006|Overall Study|Physician Decision|0|||
33604097|NCT01867216|63003569|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
33604098|NCT01867216|63003570|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
33604099|NCT01867216|63003571|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
33604100|NCT01867216|63003572|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
33604101|NCT01867216|63003573|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
33604102|NCT01867216|63003574|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
33604103|NCT01867216|63003575|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
33604104|NCT01866826|63003597|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
33604105|NCT01866826|63003598|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
33604106|NCT01866826|63003597|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
33604107|NCT01866826|63003598|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
33604108|NCT01866826|63003597|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
33604109|NCT01866826|63003598|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
33604110|NCT01791244|63003615|FG000|Overall Study|Adverse Event|5|||
33604111|NCT01791244|63003616|FG001|Overall Study|Adverse Event|7|||
33604112|NCT01791244|63003615|FG000|Overall Study|Insufficient clinical response|10|||
33604113|NCT01791244|63003616|FG001|Overall Study|Insufficient clinical response|10|||
33604114|NCT01791244|63003615|FG000|Overall Study|Laboratory Abnormality|0|||
33604115|NCT01791244|63003616|FG001|Overall Study|Laboratory Abnormality|1|||
33604116|NCT01865812|63003624|FG000|Primary Treatment Phase|Adverse Event|2|||
33604117|NCT01865812|63003625|FG001|Primary Treatment Phase|Adverse Event|0|||
33604118|NCT01865812|63003624|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
33604119|NCT01865812|63003625|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
33604120|NCT01865812|63003624|FG000|Long-term Safety Extension Phase|Pruritus|0|||
33604121|NCT01865812|63003625|FG001|Long-term Safety Extension Phase|Pruritus|3|||
33604122|NCT01865812|63003624|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
33604123|NCT01865812|63003625|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
33604124|NCT01865812|63003624|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
33604125|NCT01865812|63003625|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
33604126|NCT01808092|63003634|FG000|Overall Study|Death|39|||
33604127|NCT01808092|63003635|FG001|Overall Study|Death|29|||
33604128|NCT01808092|63003634|FG000|Overall Study|Lost to Follow-up|3|||
33604129|NCT01808092|63003635|FG001|Overall Study|Lost to Follow-up|7|||
33604130|NCT01808092|63003634|FG000|Overall Study|Withdrawal by Subject|9|||
33604131|NCT01808092|63003635|FG001|Overall Study|Withdrawal by Subject|4|||
33604132|NCT01808092|63003634|FG000|Overall Study|Other Eligibility criteria|3|||
33604133|NCT01808092|63003635|FG001|Overall Study|Other Eligibility criteria|5|||
33604134|NCT01774084|63003643|FG000|Overall Study|Personal reasons|1|||
33604135|NCT01774084|63003644|FG001|Overall Study|Personal reasons|0|||
33604136|NCT01807234|63003656|FG000|Overall Study|Lost to Follow-up|2|||
33604137|NCT01807234|63003657|FG001|Overall Study|Lost to Follow-up|5|||
33604138|NCT01807234|63003658|FG002|Overall Study|Lost to Follow-up|1|||
33604139|NCT01807234|63003659|FG003|Overall Study|Lost to Follow-up|1|||
33604140|NCT01807234|63003660|FG004|Overall Study|Lost to Follow-up|1|||
33604141|NCT01807234|63003661|FG005|Overall Study|Lost to Follow-up|2|||
33604142|NCT01807234|63003656|FG000|Overall Study|Withdrawal by Subject|3|||
33604143|NCT01807234|63003657|FG001|Overall Study|Withdrawal by Subject|1|||
33604144|NCT01807234|63003658|FG002|Overall Study|Withdrawal by Subject|1|||
33604145|NCT01807234|63003659|FG003|Overall Study|Withdrawal by Subject|1|||
33604146|NCT01807234|63003660|FG004|Overall Study|Withdrawal by Subject|2|||
33604147|NCT01807234|63003661|FG005|Overall Study|Withdrawal by Subject|1|||
33604148|NCT01807234|63003656|FG000|Overall Study|Lack of Efficacy|0|||
33604149|NCT01807234|63003657|FG001|Overall Study|Lack of Efficacy|0|||
33604150|NCT01807234|63003658|FG002|Overall Study|Lack of Efficacy|0|||
33604151|NCT01807234|63003659|FG003|Overall Study|Lack of Efficacy|0|||
33604152|NCT01807234|63003660|FG004|Overall Study|Lack of Efficacy|1|||
33604153|NCT01807234|63003661|FG005|Overall Study|Lack of Efficacy|1|||
33604154|NCT01790932|63003671|FG000|Overall Study|Disease Progression|41|||
33604155|NCT01790932|63003671|FG000|Overall Study|Adverse Event|7|||
33604156|NCT01790932|63003671|FG000|Overall Study|Physician Decision|1|||
33604157|NCT01790932|63003671|FG000|Overall Study|Withdrawal by Subject|1|||
33322277|NCT00932698|62698431|FG003|Part 1 (Dose Escalation)|Other|0|||
33604158|NCT02377427|63003677|FG000|Part A (Up to Week 20)|Physician Decision|1|||
33604159|NCT02377427|63003678|FG001|Part A (Up to Week 20)|Physician Decision|0|||
33604160|NCT02377427|63003679|FG002|Part A (Up to Week 20)|Physician Decision|0|||
33604161|NCT02377427|63003680|FG003|Part A (Up to Week 20)|Physician Decision|0|||
33604162|NCT02377427|63003681|FG004|Part A (Up to Week 20)|Physician Decision|0|||
33604163|NCT02377427|63003677|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
33604164|NCT02377427|63003678|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
33604165|NCT02377427|63003679|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
33604166|NCT02377427|63003680|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
33604167|NCT02377427|63003681|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
33604168|NCT02377427|63003677|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
33604169|NCT02377427|63003678|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
33604170|NCT02377427|63003679|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
33604171|NCT02377427|63003680|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
33604172|NCT02377427|63003681|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
33604173|NCT02377427|63003677|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
33604174|NCT02377427|63003678|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
33604175|NCT02377427|63003679|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
33604176|NCT02377427|63003680|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
33604177|NCT02377427|63003681|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
33322278|NCT00932698|62698432|FG004|Part 1 (Dose Escalation)|Other|0|||
33322279|NCT00932698|62698433|FG005|Part 1 (Dose Escalation)|Other|0|||
33604178|NCT02421887|63003696|FG000|Overall Study|Lost to Follow-up|5|||
33604179|NCT02421887|63003697|FG001|Overall Study|Lost to Follow-up|0|||
33604180|NCT02421887|63003696|FG000|Overall Study|Withdrawal by Subject|8|||
33322280|NCT00932698|62698434|FG006|Part 1 (Dose Escalation)|Other|1|||
33604181|NCT02421887|63003697|FG001|Overall Study|Withdrawal by Subject|5|||
33604182|NCT02421887|63003696|FG000|Overall Study|Physician Decision|2|||
33604183|NCT02421887|63003697|FG001|Overall Study|Physician Decision|4|||
33604184|NCT02421887|63003696|FG000|Overall Study|Adverse Event|2|||
33604185|NCT02421887|63003697|FG001|Overall Study|Adverse Event|0|||
33604186|NCT01609582|63003705|FG000|Overall Study|Adverse Event|20|||
33604187|NCT01609582|63003706|FG001|Overall Study|Adverse Event|18|||
33604188|NCT01609582|63003705|FG000|Overall Study|Lost to Follow-up|10|||
33604189|NCT01609582|63003706|FG001|Overall Study|Lost to Follow-up|10|||
33604190|NCT01609582|63003705|FG000|Overall Study|Withdrawal by Subject|21|||
33604191|NCT01609582|63003706|FG001|Overall Study|Withdrawal by Subject|15|||
33604192|NCT01609582|63003705|FG000|Overall Study|Study Terminated by Sponsor|1543|||
33604193|NCT01609582|63003706|FG001|Overall Study|Study Terminated by Sponsor|1548|||
33604194|NCT01609582|63003705|FG000|Overall Study|Other|9|||
33604195|NCT01609582|63003706|FG001|Overall Study|Other|10|||
33604196|NCT01609582|63003705|FG000|Overall Study|Randomized, but not treated|0|||
33604197|NCT01609582|63003706|FG001|Overall Study|Randomized, but not treated|3|||
33604198|NCT01789606|63003714|FG000|Overall Study|Participant not Purchased the Product|0|||
33604199|NCT01789606|63003715|FG001|Overall Study|Participant not Purchased the Product|20|||
33604200|NCT01789606|63003714|FG000|Overall Study|Withdrawal by Subject|0|||
33604201|NCT01789606|63003715|FG001|Overall Study|Withdrawal by Subject|1|||
33604202|NCT01789606|63003714|FG000|Overall Study|Ineligible|6|||
33412931|NCT00680771|62791263|FG000|Overall Study|Withdrawal by Subject|1|||
33604203|NCT01789606|63003715|FG001|Overall Study|Ineligible|2|||
33604204|NCT01789606|63003714|FG000|Overall Study|Administrative Reasons|17|||
33604205|NCT01789606|63003715|FG001|Overall Study|Administrative Reasons|6|||
33604206|NCT01789606|63003714|FG000|Overall Study|No Study Medication Taken|0|||
33604207|NCT01789606|63003715|FG001|Overall Study|No Study Medication Taken|1|||
33604208|NCT01789606|63003714|FG000|Overall Study|Protocol Violation|0|||
33604209|NCT01789606|63003715|FG001|Overall Study|Protocol Violation|55|||
33604210|NCT01789606|63003714|FG000|Overall Study|Adverse Event|0|||
33604211|NCT01789606|63003715|FG001|Overall Study|Adverse Event|3|||
33604212|NCT01789606|63003714|FG000|Overall Study|Lost to Follow-up|0|||
33604213|NCT01789606|63003715|FG001|Overall Study|Lost to Follow-up|14|||
33604214|NCT01789606|63003714|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
33604215|NCT01789606|63003715|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
33604216|NCT01788358|63003720|FG000|Overall Study|Other|11|||
33604217|NCT01788358|63003720|FG000|Overall Study|Logistical difficulties|1|||
33604218|NCT01788358|63003720|FG000|Overall Study|Lost to Follow-up|5|||
33604219|NCT01788358|63003720|FG000|Overall Study|Protocol Violation|3|||
33604220|NCT01788358|63003720|FG000|Overall Study|Withdrawal by Subject|26|||
33604221|NCT01788358|63003720|FG000|Overall Study|Lack of Efficacy|1|||
33604222|NCT01788358|63003720|FG000|Overall Study|Adverse Event|51|||
33604223|NCT01773226|63003724|FG000|Overall Study|Withdrawal by Subject|1|||
33604224|NCT01773070|63003728|FG000|Overall Study|Withdrawal by Subject|24|||
33604225|NCT01773070|63003728|FG000|Overall Study|Lost to Follow-up|39|||
33604226|NCT01773070|63003728|FG000|Overall Study|Other|15|||
33604227|NCT01773070|63003728|FG000|Overall Study|Death (unrelated to study procedures)|3|||
33604228|NCT01772368|63003732|FG000|Overall Study|Adverse Event|1|||
33604229|NCT01772368|63003732|FG000|Overall Study|Withdrawal by Subject|3|||
33604230|NCT01772368|63003732|FG000|Overall Study|Protocol Violation|2|||
33604231|NCT01772368|63003732|FG000|Overall Study|Other|1|||
33604232|NCT01788046|63003750|FG000|Overall Study|Withdrawal by Subject|12|||
33604233|NCT01788046|63003751|FG001|Overall Study|Withdrawal by Subject|12|||
33604234|NCT01788046|63003750|FG000|Overall Study|Lost to Follow-up|12|||
33604235|NCT01788046|63003751|FG001|Overall Study|Lost to Follow-up|19|||
33604236|NCT01788046|63003750|FG000|Overall Study|Death|7|||
33604237|NCT01788046|63003751|FG001|Overall Study|Death|5|||
33604238|NCT01788046|63003750|FG000|Overall Study|Protocol Specified Criteria|25|||
33604239|NCT01788046|63003751|FG001|Overall Study|Protocol Specified Criteria|1|||
33604240|NCT01806298|63003757|FG000|Overall Study|Adverse Event|3|||
33604241|NCT01806298|63003757|FG000|Overall Study|Protocol Non-compliance|1|||
33604242|NCT01806298|63003757|FG000|Overall Study|Withdrawal by Subject|1|||
33604243|NCT01806298|63003757|FG000|Overall Study|Other|5|||
33604244|NCT01772134|63003764|FG000|Overall Study|Adverse Event|6|||
33604245|NCT01772134|63003765|FG001|Overall Study|Adverse Event|5|||
33604246|NCT01772134|63003766|FG002|Overall Study|Adverse Event|10|||
33604247|NCT01772134|63003764|FG000|Overall Study|Withdrew Consent|3|||
33604248|NCT01772134|63003765|FG001|Overall Study|Withdrew Consent|1|||
33604249|NCT01772134|63003766|FG002|Overall Study|Withdrew Consent|5|||
33604250|NCT01772134|63003764|FG000|Overall Study|Lost to Follow-up|2|||
33604251|NCT01772134|63003765|FG001|Overall Study|Lost to Follow-up|0|||
33604252|NCT01772134|63003766|FG002|Overall Study|Lost to Follow-up|0|||
33604253|NCT01772134|63003764|FG000|Overall Study|Protocol Deviation|4|||
33604254|NCT01772134|63003765|FG001|Overall Study|Protocol Deviation|3|||
33604255|NCT01772134|63003766|FG002|Overall Study|Protocol Deviation|3|||
33604256|NCT01772134|63003764|FG000|Overall Study|Lack of Efficacy|11|||
33604257|NCT01772134|63003765|FG001|Overall Study|Lack of Efficacy|5|||
33604258|NCT01772134|63003766|FG002|Overall Study|Lack of Efficacy|3|||
33604259|NCT01772134|63003764|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
33604260|NCT01772134|63003765|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
33604261|NCT01772134|63003766|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
33604262|NCT01772134|63003764|FG000|Overall Study|Randomized Study Medication Not Received|2|||
33604263|NCT01772134|63003765|FG001|Overall Study|Randomized Study Medication Not Received|0|||
33604264|NCT01772134|63003766|FG002|Overall Study|Randomized Study Medication Not Received|1|||
33604265|NCT01994889|63003777|FG000|Overall Study|Adverse Event|5|||
33604266|NCT01994889|63003778|FG001|Overall Study|Adverse Event|12|||
33604267|NCT01994889|63003779|FG002|Overall Study|Adverse Event|11|||
33604268|NCT01994889|63003777|FG000|Overall Study|Cardiac Device Implantation|0|||
33604269|NCT01994889|63003778|FG001|Overall Study|Cardiac Device Implantation|2|||
33604270|NCT01994889|63003779|FG002|Overall Study|Cardiac Device Implantation|0|||
33604271|NCT01994889|63003777|FG000|Overall Study|Organ Transplantation|1|||
33604272|NCT01994889|63003778|FG001|Overall Study|Organ Transplantation|5|||
33604273|NCT01994889|63003779|FG002|Overall Study|Organ Transplantation|5|||
33604274|NCT01994889|63003777|FG000|Overall Study|No longer willing to participate|8|||
33604275|NCT01994889|63003778|FG001|Overall Study|No longer willing to participate|17|||
33604276|NCT01994889|63003779|FG002|Overall Study|No longer willing to participate|37|||
33604277|NCT01994889|63003777|FG000|Overall Study|Lost to Follow-up|0|||
33604278|NCT01994889|63003778|FG001|Overall Study|Lost to Follow-up|1|||
33604279|NCT01994889|63003779|FG002|Overall Study|Lost to Follow-up|0|||
33604280|NCT01994889|63003777|FG000|Overall Study|Protocol Violation|0|||
33604281|NCT01994889|63003778|FG001|Overall Study|Protocol Violation|1|||
33604282|NCT01994889|63003779|FG002|Overall Study|Protocol Violation|1|||
33604283|NCT01994889|63003777|FG000|Overall Study|Death|14|||
33604284|NCT01994889|63003778|FG001|Overall Study|Death|25|||
33604285|NCT01994889|63003779|FG002|Overall Study|Death|38|||
33604286|NCT02082483|63003788|FG000|Overall Study|Lost to Follow-up|1|||
33604287|NCT02082483|63003789|FG001|Overall Study|Lost to Follow-up|1|||
33604288|NCT02082483|63003788|FG000|Overall Study|Withdrawal by Subject|2|||
33604289|NCT02082483|63003789|FG001|Overall Study|Withdrawal by Subject|1|||
33604290|NCT02082483|63003788|FG000|Overall Study|Physician Decision|1|||
33604291|NCT02082483|63003789|FG001|Overall Study|Physician Decision|1|||
33604292|NCT02082483|63003788|FG000|Overall Study|Death|2|||
33604293|NCT02082483|63003789|FG001|Overall Study|Death|3|||
33604294|NCT02017899|63003802|FG000|Overall Study|Withdrawal by Subject|0|||
33604295|NCT02017899|63003803|FG001|Overall Study|Withdrawal by Subject|0|||
33604296|NCT02017899|63003804|FG002|Overall Study|Withdrawal by Subject|0|||
33604297|NCT02017899|63003805|FG003|Overall Study|Withdrawal by Subject|1|||
33604298|NCT02017899|63003806|FG004|Overall Study|Withdrawal by Subject|1|||
33604299|NCT02017899|63003807|FG005|Overall Study|Withdrawal by Subject|0|||
33604300|NCT01993329|63003827|FG000|Period 2|Adverse Event|0|||
33604301|NCT01993329|63003828|FG001|Period 2|Adverse Event|0|||
33604302|NCT01993329|63003829|FG002|Period 2|Adverse Event|0|||
33604303|NCT01993329|63003830|FG003|Period 2|Adverse Event|0|||
33604304|NCT01993329|63003831|FG004|Period 2|Adverse Event|0|||
33604305|NCT01993329|63003832|FG005|Period 2|Adverse Event|1|||
33604306|NCT01993329|63003827|FG000|Wash-out|Personal reasons|0|||
33604307|NCT01993329|63003828|FG001|Wash-out|Personal reasons|1|||
33604308|NCT01993329|63003829|FG002|Wash-out|Personal reasons|0|||
33604309|NCT01993329|63003830|FG003|Wash-out|Personal reasons|0|||
33604310|NCT01993329|63003831|FG004|Wash-out|Personal reasons|0|||
33604311|NCT01993329|63003832|FG005|Wash-out|Personal reasons|0|||
33604312|NCT02016183|63003844|FG000|Overall Study|Case Report Forms Uncollected|13|||
33604313|NCT02016183|63003844|FG000|Overall Study|Protocol Violation|52|||
33604314|NCT02377349|63003850|FG000|Overall Study|Serious Adverse Event|1|||
33604315|NCT02377349|63003851|FG001|Overall Study|Serious Adverse Event|0|||
33604316|NCT02377349|63003850|FG000|Overall Study|Protocol Violation|3|||
33604317|NCT02377349|63003851|FG001|Overall Study|Protocol Violation|2|||
33604318|NCT02377349|63003850|FG000|Overall Study|Withdrawal by Subject|5|||
33604319|NCT02377349|63003851|FG001|Overall Study|Withdrawal by Subject|3|||
33604320|NCT02377349|63003850|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
33604321|NCT02377349|63003851|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
33604322|NCT02377349|63003850|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
33604323|NCT02377349|63003851|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
33604324|NCT02377349|63003850|FG000|Overall Study|Other|0|||
33604325|NCT02377349|63003851|FG001|Overall Study|Other|1|||
33604326|NCT02421419|63003869|FG000|Overall Study|Physician Decision|0|||
33604327|NCT02421419|63003870|FG001|Overall Study|Physician Decision|0|||
33604328|NCT02421419|63003871|FG002|Overall Study|Physician Decision|1|||
33604329|NCT02420717|63003882|FG000|Overall Study|Did not receive all study medication|2|||
33604330|NCT02420717|63003883|FG001|Overall Study|Did not receive all study medication|0|||
33604331|NCT02420717|63003884|FG002|Overall Study|Did not receive all study medication|0|||
33604332|NCT02016105|63003894|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
33604333|NCT02016105|63003895|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
33604334|NCT02016105|63003896|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
33604335|NCT02016105|63003897|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
33604336|NCT02016105|63003898|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
33604337|NCT02016105|63003899|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
33604338|NCT02016105|63003894|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
33604339|NCT02016105|63003895|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
33604340|NCT02016105|63003896|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
33604341|NCT02016105|63003897|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
33604342|NCT02016105|63003898|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
33604343|NCT02016105|63003899|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
33604344|NCT02016105|63003894|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
33604345|NCT02016105|63003895|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
33604346|NCT02016105|63003896|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
33604347|NCT02016105|63003897|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
33604348|NCT02016105|63003898|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
33604349|NCT02016105|63003899|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
33604350|NCT02016105|63003894|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
33604351|NCT02016105|63003895|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
33604352|NCT02016105|63003896|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
33604353|NCT02016105|63003897|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
33604354|NCT02016105|63003898|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
33604355|NCT02016105|63003899|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
33604356|NCT02016105|63003894|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
33604357|NCT02016105|63003895|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
33604358|NCT02016105|63003896|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
33604359|NCT02016105|63003897|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
33604360|NCT02016105|63003898|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
33604361|NCT02016105|63003899|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
33604362|NCT02016105|63003894|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
33604363|NCT02016105|63003895|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
33604364|NCT02016105|63003896|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
33604365|NCT02016105|63003897|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
33604366|NCT02016105|63003898|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
33604367|NCT02016105|63003899|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
33604368|NCT02016105|63003894|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
33604369|NCT02016105|63003895|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
33604370|NCT02016105|63003896|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
33604371|NCT02016105|63003897|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
33494067|NCT03490032|62872732|FG002|Overall Study|family issue (child custody)|0|||
33604372|NCT02016105|63003898|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
33604373|NCT02016105|63003899|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
33604374|NCT02016105|63003894|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
33604375|NCT02016105|63003895|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
33604376|NCT02016105|63003896|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
33604377|NCT02016105|63003897|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
33604378|NCT02016105|63003898|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
33604379|NCT02016105|63003899|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
33604380|NCT02016105|63003894|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
33604381|NCT02016105|63003895|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
33604382|NCT02016105|63003896|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
33604383|NCT02016105|63003897|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
33604384|NCT02016105|63003898|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
33604385|NCT02016105|63003899|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
33604386|NCT02016105|63003894|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
33604387|NCT02016105|63003895|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
33604388|NCT02016105|63003896|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
33604389|NCT02016105|63003897|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
33604390|NCT02016105|63003898|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
33604391|NCT02016105|63003899|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
33604392|NCT02016105|63003894|FG000|TREATMENT PERIOD 2|Death|0|||
33604393|NCT02016105|63003895|FG001|TREATMENT PERIOD 2|Death|0|||
33604394|NCT02016105|63003896|FG002|TREATMENT PERIOD 2|Death|0|||
33604395|NCT02016105|63003897|FG003|TREATMENT PERIOD 2|Death|0|||
33604396|NCT02016105|63003898|FG004|TREATMENT PERIOD 2|Death|0|||
33604397|NCT02016105|63003899|FG005|TREATMENT PERIOD 2|Death|1|||
33604398|NCT02016105|63003894|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
33604399|NCT02016105|63003895|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
33604400|NCT02016105|63003896|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
33604401|NCT02016105|63003897|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
33604402|NCT02016105|63003898|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
33604403|NCT02016105|63003899|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
33604404|NCT02016105|63003894|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
33604405|NCT02016105|63003895|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
33604406|NCT02016105|63003896|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
33604407|NCT02016105|63003897|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
33604408|NCT02016105|63003898|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
33604409|NCT02016105|63003899|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
33604410|NCT02016105|63003894|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
33604411|NCT02016105|63003895|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
33604412|NCT02016105|63003896|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
33604413|NCT02016105|63003897|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
33604414|NCT02016105|63003898|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
33604415|NCT02016105|63003899|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
33604416|NCT02016105|63003894|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
33604417|NCT02016105|63003895|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
33604418|NCT02016105|63003896|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
33604419|NCT02016105|63003897|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
33604420|NCT02016105|63003898|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
33604421|NCT02016105|63003899|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
33604422|NCT02016105|63003894|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
33604423|NCT02016105|63003895|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
33604424|NCT02016105|63003896|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
33604425|NCT02016105|63003897|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
33604426|NCT02016105|63003898|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
33604427|NCT02016105|63003899|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
33604428|NCT02016105|63003894|FG000|EXTENSION PERIOD|Adverse Event|0|||
33604429|NCT02016105|63003895|FG001|EXTENSION PERIOD|Adverse Event|0|||
33604430|NCT02016105|63003896|FG002|EXTENSION PERIOD|Adverse Event|2|||
33322281|NCT00932698|62698435|FG007|Part 1 (Dose Escalation)|Other|0|||
33322282|NCT00932698|62698436|FG008|Part 1 (Dose Escalation)|Other|0|||
33322283|NCT00932698|62698437|FG009|Part 1 (Dose Escalation)|Other|0|||
33322284|NCT00932698|62698438|FG010|Part 1 (Dose Escalation)|Other|0|||
33604431|NCT02016105|63003897|FG003|EXTENSION PERIOD|Adverse Event|0|||
33604432|NCT02016105|63003898|FG004|EXTENSION PERIOD|Adverse Event|1|||
33604433|NCT02016105|63003899|FG005|EXTENSION PERIOD|Adverse Event|0|||
33604434|NCT02016105|63003894|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
33604435|NCT02016105|63003895|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
33604436|NCT02016105|63003896|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
33604437|NCT02016105|63003897|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
33604438|NCT02016105|63003898|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
33604439|NCT02016105|63003899|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
33604440|NCT02016105|63003894|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
33604441|NCT02016105|63003895|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
33604442|NCT02016105|63003896|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
33604443|NCT02016105|63003897|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
33604444|NCT02016105|63003898|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
33604445|NCT02016105|63003899|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
33494068|NCT03489720|62872752|FG000|Overall Study|Withdrawal by Subject|2|||
33604446|NCT02016105|63003894|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
33604447|NCT02016105|63003895|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
33604448|NCT02016105|63003896|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
33604449|NCT02016105|63003897|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
33604450|NCT02016105|63003898|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
33604451|NCT02016105|63003899|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
33604452|NCT02400905|63003913|FG000|Overall Study|Death|24|||
33604453|NCT02400905|63003913|FG000|Overall Study|Lost to Follow-up|18|||
33604454|NCT02400905|63003913|FG000|Overall Study|Withdrawal by Subject|16|||
33604455|NCT02400905|63003913|FG000|Overall Study|Physician Decision|4|||
33604456|NCT02400905|63003913|FG000|Overall Study|Other|1|||
33604457|NCT02400749|63003920|FG000|Week 0 -16|Withdrawal by Subject|5|||
33604458|NCT02400749|63003921|FG001|Week 0 -16|Withdrawal by Subject|5|||
33604459|NCT02400749|63003920|FG000|Week 0 -16|Adverse Event|3|||
33604460|NCT02400749|63003921|FG001|Week 0 -16|Adverse Event|1|||
33604461|NCT02400749|63003920|FG000|Week 0 -16|Lost to Follow-up|2|||
33604462|NCT02400749|63003921|FG001|Week 0 -16|Lost to Follow-up|0|||
33604463|NCT02400749|63003920|FG000|Week 0 -16|Protocol Violation|1|||
33604464|NCT02400749|63003921|FG001|Week 0 -16|Protocol Violation|0|||
33604465|NCT02400749|63003920|FG000|Week 17 - 32|Withdrawal by Subject|3|||
33604466|NCT02400749|63003921|FG001|Week 17 - 32|Withdrawal by Subject|2|||
33604467|NCT02400749|63003920|FG000|Week 17 - 32|Adverse Event|2|||
33604468|NCT02400749|63003921|FG001|Week 17 - 32|Adverse Event|1|||
33604469|NCT02420327|63003927|FG000|Overall Study|Adverse Event|7|||
33604470|NCT02420327|63003927|FG000|Overall Study|Pregnancy|1|||
33604471|NCT02420327|63003927|FG000|Overall Study|Withdrawal by Subject|6|||
33604472|NCT02420327|63003927|FG000|Overall Study|Lost to Follow-up|1|||
33604473|NCT02420327|63003927|FG000|Overall Study|Protocol Violation|1|||
33604474|NCT02374853|63003939|FG000|Overall Study|Surgery Cancelled|5|||
33604475|NCT02374853|63003940|FG001|Overall Study|Surgery Cancelled|11|||
33604476|NCT02015793|63003948|FG000|Overall Study|Adverse Event|3|||
33604477|NCT02015793|63003949|FG001|Overall Study|Adverse Event|3|||
33604478|NCT02015793|63003948|FG000|Overall Study|Withdrawal by Subject|1|||
33604479|NCT02015793|63003949|FG001|Overall Study|Withdrawal by Subject|1|||
33604480|NCT02347631|63003963|FG000|First Intervention (2 Months)|Adverse Event|1|||
33604481|NCT02347631|63003964|FG001|First Intervention (2 Months)|Adverse Event|1|||
33604482|NCT02347631|63003963|FG000|First Intervention (2 Months)|Pregnancy|1|||
33494069|NCT03489720|62872753|FG001|Overall Study|Withdrawal by Subject|0|||
33604483|NCT02347631|63003964|FG001|First Intervention (2 Months)|Pregnancy|0|||
33604484|NCT02347631|63003963|FG000|First Intervention (2 Months)|Moved out of area|0|||
33604485|NCT02347631|63003964|FG001|First Intervention (2 Months)|Moved out of area|2|||
33604486|NCT02347631|63003963|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
33604487|NCT02347631|63003964|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
33604488|NCT02347631|63003963|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
33604489|NCT02347631|63003964|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
33604490|NCT02347631|63003963|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
33604491|NCT02347631|63003964|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
33604492|NCT02347631|63003963|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
33604493|NCT02347631|63003964|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
33604494|NCT02347631|63003963|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
33604495|NCT02347631|63003964|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
33604496|NCT02015637|63003974|FG000|Overall Study|Lost to Follow-up|3|||
33604497|NCT02015637|63003975|FG001|Overall Study|Lost to Follow-up|5|||
33604498|NCT02015637|63003974|FG000|Overall Study|Adverse Event|3|||
33604499|NCT02015637|63003975|FG001|Overall Study|Adverse Event|0|||
33604500|NCT02015637|63003974|FG000|Overall Study|Did not take study drug|2|||
33604501|NCT02015637|63003975|FG001|Overall Study|Did not take study drug|0|||
33604502|NCT02347085|63003981|FG000|Overall Study|Adverse Event|2|||
33604503|NCT02347085|63003981|FG000|Overall Study|Lack of Efficacy|1|||
33604504|NCT02347085|63003981|FG000|Overall Study|Withdrawal by Subject|4|||
33604505|NCT02347085|63003981|FG000|Overall Study|Lost to Follow-up|1|||
33604506|NCT02347085|63003981|FG000|Overall Study|Protocol Criteria|2|||
33604507|NCT02374463|63003989|FG000|Overall Study|Withdrawal by Subject|3|||
33604508|NCT02374463|63003990|FG001|Overall Study|Withdrawal by Subject|3|||
33604509|NCT02015481|63003997|FG000|Overall Study|Death|1|||
33604510|NCT02374307|63004004|FG000|3-months Follow-up|Lost to Follow-up|1|||
33604511|NCT02374307|63004005|FG001|3-months Follow-up|Lost to Follow-up|2|||
33604512|NCT02374307|63004004|FG000|3-months Follow-up|Withdrawal by Subject|1|||
33604513|NCT02374307|63004005|FG001|3-months Follow-up|Withdrawal by Subject|4|||
33604514|NCT02374307|63004004|FG000|3-months Follow-up|Death|1|||
33604515|NCT02374307|63004005|FG001|3-months Follow-up|Death|2|||
33604516|NCT02374307|63004004|FG000|3-months Follow-up|Missed first follow-up|5|||
33604517|NCT02374307|63004005|FG001|3-months Follow-up|Missed first follow-up|1|||
33604518|NCT02374307|63004004|FG000|6-months Follow-up|Lost to Follow-up|1|||
33604519|NCT02374307|63004005|FG001|6-months Follow-up|Lost to Follow-up|2|||
33604520|NCT02374307|63004004|FG000|6-months Follow-up|Death|2|||
33604521|NCT02374307|63004005|FG001|6-months Follow-up|Death|1|||
33604522|NCT02374307|63004004|FG000|6-months Follow-up|Withdrawal by Subject|0|||
33604523|NCT02374307|63004005|FG001|6-months Follow-up|Withdrawal by Subject|3|||
33604524|NCT02397473|63004013|FG000|Treatment Phase|Adverse Event|1|||
33604525|NCT02397473|63004014|FG001|Treatment Phase|Adverse Event|2|||
33604526|NCT02397473|63004013|FG000|Treatment Phase|Lack of Efficacy|8|||
33604527|NCT02397473|63004014|FG001|Treatment Phase|Lack of Efficacy|1|||
33604528|NCT02397473|63004013|FG000|Treatment Phase|Lost to Follow-up|1|||
33604529|NCT02397473|63004014|FG001|Treatment Phase|Lost to Follow-up|0|||
33604530|NCT02397473|63004013|FG000|Treatment Phase|Withdrawal by Subject|2|||
33604531|NCT02397473|63004014|FG001|Treatment Phase|Withdrawal by Subject|1|||
33604532|NCT02397473|63004013|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
33604533|NCT02397473|63004014|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
33604534|NCT02397473|63004013|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
33604535|NCT02397473|63004014|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
33604536|NCT02397473|63004013|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
33604537|NCT02397473|63004014|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
33604538|NCT02397473|63004013|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
33604539|NCT02397473|63004014|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
33604540|NCT02397473|63004013|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
33604541|NCT02397473|63004014|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
33604542|NCT02344745|63004025|FG000|Overall Study|Data collection sheets were lost|2|||
33604543|NCT02344745|63004026|FG001|Overall Study|Data collection sheets were lost|0|||
33604544|NCT02370641|63004034|FG000|Overall Study|dropped study|4|||
33604545|NCT02370641|63004035|FG001|Overall Study|dropped study|2|||
33604546|NCT01621191|63004041|FG000|Overall Study|Adverse Event|9|||
33604547|NCT01621191|63004041|FG000|Overall Study|Withdrawal by Subject|8|||
33412932|NCT00680771|62791264|FG001|Overall Study|Withdrawal by Subject|0|||
33412933|NCT00680771|62791263|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
33604548|NCT01621191|63004041|FG000|Overall Study|Lack of Efficacy|6|||
33604549|NCT01621191|63004041|FG000|Overall Study|Lost to Follow-up|1|||
33604550|NCT01621191|63004041|FG000|Overall Study|Site Removed From Study|1|||
33604551|NCT02343263|63004049|FG000|Overall Study|Physician Decision|5|||
33604552|NCT02343263|63004050|FG001|Overall Study|Physician Decision|3|||
33604553|NCT02343263|63004051|FG002|Overall Study|Physician Decision|1|||
33604554|NCT02081859|63004065|FG000|Overall Study|No fertilization|2|||
33604555|NCT02081859|63004066|FG001|Overall Study|No fertilization|2|||
33604556|NCT02081859|63004065|FG000|Overall Study|No sperm|1|||
33604557|NCT02081859|63004066|FG001|Overall Study|No sperm|0|||
33604558|NCT02081859|63004065|FG000|Overall Study|Unanticipated freeze all cycle|2|||
33604559|NCT02081859|63004066|FG001|Overall Study|Unanticipated freeze all cycle|6|||
33604560|NCT02081859|63004065|FG000|Overall Study|< 4 embryos|27|||
33604561|NCT02081859|63004066|FG001|Overall Study|< 4 embryos|23|||
33604562|NCT02081859|63004065|FG000|Overall Study|Other reasons|2|||
33604563|NCT02081859|63004066|FG001|Overall Study|Other reasons|0|||
33604564|NCT02342639|63004074|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
33604565|NCT02342639|63004075|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
33604566|NCT02342639|63004074|FG000|Overall Study|Protocol Violation|0|||
33604567|NCT02342639|63004075|FG001|Overall Study|Protocol Violation|2|||
33604568|NCT01625091|63004085|FG000|Intervention|Death|1|||
33604569|NCT01625091|63004086|FG001|Intervention|Death|1|||
33604570|NCT01625091|63004085|FG000|Intervention|Withdrawal by Subject|4|||
33604571|NCT01625091|63004086|FG001|Intervention|Withdrawal by Subject|1|||
33604572|NCT01625091|63004085|FG000|Intervention|Adverse Event|0|||
33604573|NCT01625091|63004086|FG001|Intervention|Adverse Event|2|||
33604574|NCT01625091|63004085|FG000|Intervention|Lost to Follow-up|4|||
33604575|NCT01625091|63004086|FG001|Intervention|Lost to Follow-up|4|||
33604576|NCT01625091|63004085|FG000|Intervention|Study termination|2|||
33604577|NCT01625091|63004086|FG001|Intervention|Study termination|3|||
33604578|NCT01625091|63004085|FG000|Post-intervention|Death|0|||
33604579|NCT01625091|63004086|FG001|Post-intervention|Death|1|||
33604580|NCT01625091|63004085|FG000|Post-intervention|Lost to Follow-up|2|||
33604581|NCT01625091|63004086|FG001|Post-intervention|Lost to Follow-up|0|||
33604582|NCT01625091|63004085|FG000|Post-intervention|Study termination|2|||
33604583|NCT01625091|63004086|FG001|Post-intervention|Study termination|1|||
33604584|NCT02396849|63004094|FG000|Overall Study|Lost to Follow-up|1|||
33604585|NCT02396849|63004095|FG001|Overall Study|Lost to Follow-up|1|||
33604586|NCT02396849|63004094|FG000|Overall Study|Did not tolerate intervention|1|||
33604587|NCT02396849|63004095|FG001|Overall Study|Did not tolerate intervention|1|||
33604588|NCT02370251|63004103|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
33604589|NCT02370251|63004103|FG000|Overall Study|Death|4|||
33604590|NCT02396537|63004109|FG000|Overall Study|Protocol Violation|0|||
33604591|NCT02396537|63004110|FG001|Overall Study|Protocol Violation|1|||
33604592|NCT02342171|63004118|FG000|Overall Study|Death|4|||
33604593|NCT02342171|63004119|FG001|Overall Study|Death|87|||
33604594|NCT02342171|63004118|FG000|Overall Study|Received favipiravir|10|||
33604595|NCT02342171|63004119|FG001|Overall Study|Received favipiravir|0|||
33604596|NCT02342171|63004118|FG000|Overall Study|Missing cycle treshold value|1|||
33604597|NCT02342171|63004119|FG001|Overall Study|Missing cycle treshold value|0|||
33604598|NCT02342171|63004118|FG000|Overall Study|Unknown outcome|0|||
33604599|NCT02342171|63004119|FG001|Overall Study|Unknown outcome|1|||
33604600|NCT02342171|63004118|FG000|Overall Study|Missing age data|0|||
33604601|NCT02342171|63004119|FG001|Overall Study|Missing age data|1|||
33604602|NCT01624467|63004124|FG000|Overall Study|Withdrawal by Subject|2|||
33604603|NCT01624467|63004124|FG000|Overall Study|Lost to Follow-up|1|||
33604604|NCT01624467|63004124|FG000|Overall Study|Adverse Event|7|||
33604605|NCT01624467|63004124|FG000|Overall Study|Progressive Disease|19|||
33604606|NCT01624467|63004124|FG000|Overall Study|Per Sponsor Requirement|1|||
33604607|NCT01624467|63004124|FG000|Overall Study|Subject Withdrew from Treatment|1|||
33604608|NCT01624233|63004130|FG000|Period 2 - Induction|Adverse Event|1|||
33604609|NCT01624233|63004130|FG000|Period 3 - Maintenance|Adverse Event|2|||
33604610|NCT01624233|63004130|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
33604611|NCT01624233|63004130|FG000|Period 3 - Maintenance|Physician Decision|2|||
33604612|NCT01624233|63004130|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
33604613|NCT01624233|63004130|FG000|Period 4 - Drug Free Period|Relapsed|61|||
33604614|NCT01624233|63004130|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
33604615|NCT01624233|63004130|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
33604616|NCT01624233|63004130|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
33604617|NCT01624233|63004130|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
33604618|NCT01624233|63004130|FG000|Period 6: Follow-up|Adverse Event|3|||
33604619|NCT01624233|63004130|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
33604620|NCT01624233|63004130|FG000|Period 6: Follow-up|Physician Decision|1|||
33604621|NCT01624233|63004130|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
33604622|NCT01993017|63004141|FG000|Overall Study|Death|23|||
33604623|NCT01993017|63004142|FG001|Overall Study|Death|26|||
33604624|NCT01993017|63004143|FG002|Overall Study|Death|18|||
33604625|NCT01993017|63004141|FG000|Overall Study|Could not be contacted|43|||
33604626|NCT01993017|63004142|FG001|Overall Study|Could not be contacted|42|||
33604627|NCT01993017|63004143|FG002|Overall Study|Could not be contacted|38|||
33604628|NCT01993017|63004141|FG000|Overall Study|Dropped out|19|||
33604629|NCT01993017|63004142|FG001|Overall Study|Dropped out|6|||
33604630|NCT01993017|63004143|FG002|Overall Study|Dropped out|11|||
33604631|NCT01993017|63004141|FG000|Overall Study|Other reasons|17|||
33604632|NCT01993017|63004142|FG001|Overall Study|Other reasons|11|||
33604633|NCT01993017|63004143|FG002|Overall Study|Other reasons|7|||
33604634|NCT01993017|63004141|FG000|Overall Study|Ineligible after randomization|4|||
33604635|NCT01993017|63004142|FG001|Overall Study|Ineligible after randomization|5|||
33604636|NCT01993017|63004143|FG002|Overall Study|Ineligible after randomization|5|||
33604637|NCT01992549|63004152|FG000|Overall Study|Lost to Follow-up|2|||
33604638|NCT01992549|63004152|FG000|Overall Study|Serious Adverse Event|1|||
33604639|NCT01992549|63004152|FG000|Overall Study|Product Switch to Extend Half Life|1|||
33604640|NCT01992159|63004166|FG000|Overall Study|Withdrawal by Subject|4|||
33604641|NCT01992159|63004167|FG001|Overall Study|Withdrawal by Subject|7|||
33604642|NCT01992159|63004168|FG002|Overall Study|Withdrawal by Subject|0|||
33604643|NCT01992159|63004169|FG003|Overall Study|Withdrawal by Subject|3|||
33604644|NCT01992159|63004166|FG000|Overall Study|Adverse Event|0|||
33604645|NCT01992159|63004167|FG001|Overall Study|Adverse Event|1|||
33604646|NCT01992159|63004168|FG002|Overall Study|Adverse Event|0|||
33604647|NCT01992159|63004169|FG003|Overall Study|Adverse Event|1|||
33604648|NCT01992159|63004166|FG000|Overall Study|Death|0|||
33604649|NCT01992159|63004167|FG001|Overall Study|Death|0|||
33604650|NCT01992159|63004168|FG002|Overall Study|Death|1|||
33604651|NCT01992159|63004169|FG003|Overall Study|Death|0|||
33604652|NCT01988493|63004184|FG000|Overall Study|Randomized but not treated|0|||
33604653|NCT01988493|63004185|FG001|Overall Study|Randomized but not treated|0|||
33604654|NCT01988493|63004186|FG002|Overall Study|Randomized but not treated|0|||
33604655|NCT01988493|63004187|FG003|Overall Study|Randomized but not treated|0|||
33604656|NCT01988493|63004188|FG004|Overall Study|Randomized but not treated|1|||
33604657|NCT02081079|63004204|FG000|Overall Study|Lack of Efficacy|3|||
33604658|NCT02081079|63004205|FG001|Overall Study|Lack of Efficacy|2|||
33604659|NCT02081079|63004204|FG000|Overall Study|Lost to Follow-up|1|||
33604660|NCT02081079|63004205|FG001|Overall Study|Lost to Follow-up|0|||
33604661|NCT02081001|63004217|FG000|Overall Study|Adverse Event|0|||
33604662|NCT02081001|63004218|FG001|Overall Study|Adverse Event|0|||
33604663|NCT02081001|63004219|FG002|Overall Study|Adverse Event|0|||
33604664|NCT02081001|63004220|FG003|Overall Study|Adverse Event|0|||
33604665|NCT02081001|63004221|FG004|Overall Study|Adverse Event|1|||
33604666|NCT02081001|63004222|FG005|Overall Study|Adverse Event|0|||
33604667|NCT02081001|63004223|FG006|Overall Study|Adverse Event|0|||
33604668|NCT02081001|63004224|FG007|Overall Study|Adverse Event|0|||
33604669|NCT02081001|63004225|FG008|Overall Study|Adverse Event|0|||
33604670|NCT02081001|63004226|FG009|Overall Study|Adverse Event|0|||
33604671|NCT02081001|63004227|FG010|Overall Study|Adverse Event|0|||
33604672|NCT02081001|63004228|FG011|Overall Study|Adverse Event|0|||
33604673|NCT02080221|63004239|FG000|Overall Study|Withdrawal by Subject|1|||
33604674|NCT02080221|63004239|FG000|Overall Study|Clinical Progression of Disease|1|||
33604675|NCT02079909|63004246|FG000|Overall Study|Adverse Event|23|||
33604676|NCT02079909|63004247|FG001|Overall Study|Adverse Event|23|||
33604677|NCT02079909|63004248|FG002|Overall Study|Adverse Event|7|||
33604678|NCT02079909|63004246|FG000|Overall Study|Withdrawal by Subject|9|||
33604679|NCT02079909|63004247|FG001|Overall Study|Withdrawal by Subject|17|||
33604680|NCT02079909|63004248|FG002|Overall Study|Withdrawal by Subject|4|||
33604681|NCT02079909|63004246|FG000|Overall Study|Lost to Follow-up|2|||
33604682|NCT02079909|63004247|FG001|Overall Study|Lost to Follow-up|3|||
33604683|NCT02079909|63004248|FG002|Overall Study|Lost to Follow-up|1|||
33604684|NCT02079909|63004246|FG000|Overall Study|Death|2|||
33604685|NCT02079909|63004247|FG001|Overall Study|Death|2|||
33604686|NCT02079909|63004248|FG002|Overall Study|Death|0|||
33604687|NCT02079909|63004246|FG000|Overall Study|Lack of Efficacy|0|||
33604688|NCT02079909|63004247|FG001|Overall Study|Lack of Efficacy|0|||
33604689|NCT02079909|63004248|FG002|Overall Study|Lack of Efficacy|1|||
33604690|NCT02079909|63004246|FG000|Overall Study|Protocol Violation|0|||
33604691|NCT02079909|63004247|FG001|Overall Study|Protocol Violation|1|||
33604692|NCT02079909|63004248|FG002|Overall Study|Protocol Violation|1|||
33604693|NCT02079909|63004246|FG000|Overall Study|Physician Decision|0|||
33604694|NCT02079909|63004247|FG001|Overall Study|Physician Decision|1|||
33604695|NCT02079909|63004248|FG002|Overall Study|Physician Decision|1|||
33604696|NCT02079909|63004246|FG000|Overall Study|Relocation etc.|2|||
33604697|NCT02079909|63004247|FG001|Overall Study|Relocation etc.|2|||
33604698|NCT02079909|63004248|FG002|Overall Study|Relocation etc.|3|||
33604699|NCT02014467|63004258|FG000|Overall Study|Adverse Event|4|||
33604700|NCT02014467|63004259|FG001|Overall Study|Adverse Event|0|||
33604701|NCT02014467|63004258|FG000|Overall Study|Protocol Violation|3|||
33604702|NCT02014467|63004259|FG001|Overall Study|Protocol Violation|0|||
33604703|NCT02014467|63004258|FG000|Overall Study|Physician Decision|2|||
33604704|NCT02014467|63004259|FG001|Overall Study|Physician Decision|3|||
33604705|NCT02014467|63004258|FG000|Overall Study|Withdrawal by Subject|16|||
33604706|NCT02014467|63004259|FG001|Overall Study|Withdrawal by Subject|4|||
33604707|NCT02013765|63004265|FG000|Overall Study|Trial was terminated by sponsor|1|||
33604708|NCT02013687|63004273|FG000|Overall Study|Lost to Follow-up|0|||
33604709|NCT02013687|63004274|FG001|Overall Study|Lost to Follow-up|0|||
33604710|NCT02013687|63004275|FG002|Overall Study|Lost to Follow-up|1|||
33604711|NCT02013687|63004276|FG003|Overall Study|Lost to Follow-up|0|||
33604712|NCT02013687|63004273|FG000|Overall Study|Protocol Violation|0|||
33604713|NCT02013687|63004274|FG001|Overall Study|Protocol Violation|0|||
33604714|NCT02013687|63004275|FG002|Overall Study|Protocol Violation|0|||
33604715|NCT02013687|63004276|FG003|Overall Study|Protocol Violation|1|||
33604716|NCT02013687|63004273|FG000|Overall Study|Withdrawal by Subject|0|||
33604717|NCT02013687|63004274|FG001|Overall Study|Withdrawal by Subject|0|||
33604718|NCT02013687|63004275|FG002|Overall Study|Withdrawal by Subject|0|||
33604719|NCT02013687|63004276|FG003|Overall Study|Withdrawal by Subject|1|||
33604720|NCT02013687|63004273|FG000|Overall Study|Missed visits due to patient travel|0|||
33604721|NCT02013687|63004274|FG001|Overall Study|Missed visits due to patient travel|0|||
33604722|NCT02013687|63004275|FG002|Overall Study|Missed visits due to patient travel|1|||
33604723|NCT02013687|63004276|FG003|Overall Study|Missed visits due to patient travel|0|||
33604724|NCT02013609|63004290|FG000|Overall Study|Withdrawal by Subject|9|||
33604725|NCT02013609|63004290|FG000|Overall Study|Lost to Follow-up|3|||
33604726|NCT02013609|63004290|FG000|Overall Study|Adverse Event|3|||
33604727|NCT02013609|63004290|FG000|Overall Study|Met Withdrawal Criteria|3|||
33604728|NCT01988337|63004294|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
33604729|NCT02013531|63004300|FG000|Overall Study|Lost to Follow-up|3|||
33604730|NCT02013531|63004300|FG000|Overall Study|Met Withdrawal Criteria|1|||
33604731|NCT02013531|63004300|FG000|Overall Study|Withdrawal by Subject|1|||
33604732|NCT01988103|63004307|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
33604733|NCT01988103|63004308|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
33412934|NCT00680771|62791264|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
33412935|NCT00680771|62791263|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
33412936|NCT00680771|62791264|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
33412937|NCT00482703|62791272|FG000|Overall Study|Poor compliance|1|||
33322285|NCT00932698|62698428|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
33322286|NCT00932698|62698429|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
33322287|NCT00932698|62698430|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
33322288|NCT00932698|62698431|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
33322289|NCT00932698|62698432|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
33322290|NCT00932698|62698433|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
33322291|NCT00932698|62698434|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
33322292|NCT00932698|62698435|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
33322293|NCT00932698|62698436|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
33322294|NCT00932698|62698437|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
33322295|NCT00932698|62698438|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
33322296|NCT00932698|62698428|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33322297|NCT00932698|62698429|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33322298|NCT00932698|62698430|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33322299|NCT00932698|62698431|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33322300|NCT00932698|62698432|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33322301|NCT00932698|62698433|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33322302|NCT00932698|62698434|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33322303|NCT00932698|62698435|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
33322304|NCT00932698|62698436|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
33322305|NCT00932698|62698437|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
33322306|NCT00932698|62698438|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33322307|NCT00932698|62698428|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
33322308|NCT00932698|62698429|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
33322309|NCT00932698|62698430|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
33322310|NCT00932698|62698431|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
33322311|NCT00932698|62698432|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
33322312|NCT00932698|62698433|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
33322313|NCT00932698|62698434|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
33322314|NCT00932698|62698435|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
33322315|NCT00932698|62698436|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
33322316|NCT00932698|62698437|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
33322317|NCT00932698|62698438|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
33322318|NCT00978627|62698466|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
33322319|NCT00978627|62698467|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
33322320|NCT00978627|62698466|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
33322321|NCT00978627|62698467|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
33412938|NCT00482703|62791273|FG001|Overall Study|Poor compliance|0|||
33412939|NCT00482391|62791286|FG000|Overall Study|Withdrawal by Subject|1|||
33322322|NCT00978627|62698466|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
33322323|NCT00978627|62698467|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
33412940|NCT00482391|62791286|FG000|Overall Study|Adverse Event|1|||
33412941|NCT00482391|62791286|FG000|Overall Study|Death|1|||
33322324|NCT00978627|62698466|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
33604734|NCT01988103|63004309|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
33604735|NCT01988103|63004310|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
33322325|NCT00978627|62698467|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
33322326|NCT00978627|62698466|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
33322327|NCT00978627|62698467|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
33322328|NCT00978627|62698466|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
33322329|NCT00978627|62698467|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
33322330|NCT00978627|62698466|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
33322331|NCT00978627|62698467|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
33322332|NCT00978627|62698466|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
33322333|NCT00978627|62698467|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
33412942|NCT00423046|62791293|FG000|Overall Study|Other|340|||
33412943|NCT00423046|62791294|FG001|Overall Study|Other|345|||
33322334|NCT00978627|62698466|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
33412944|NCT00496587|62791302|FG000|Overall Study|Adverse Event|2|||
33412945|NCT00496587|62791302|FG000|Overall Study|Progressive Disease|24|||
33412946|NCT00496587|62791302|FG000|Overall Study|Withdrawal by Subject|2|||
33412947|NCT00496587|62791302|FG000|Overall Study|Death|1|||
33412948|NCT00496587|62791302|FG000|Overall Study|Complications unrelated|2|||
33412949|NCT00405652|62791306|FG000|Overall Study|Adverse Event|4|||
33412950|NCT00422734|62791312|FG000|Overall Study|Physician Decision|1|||
33412951|NCT00422734|62791313|FG001|Overall Study|Physician Decision|1|||
33412952|NCT00422734|62791312|FG000|Overall Study|Protocol Violation|1|||
33412953|NCT00422734|62791313|FG001|Overall Study|Protocol Violation|6|||
33412954|NCT00422734|62791312|FG000|Overall Study|Withdrawal by Subject|12|||
33412955|NCT00422734|62791313|FG001|Overall Study|Withdrawal by Subject|8|||
33412956|NCT00422734|62791312|FG000|Overall Study|Adverse Event|0|||
33412957|NCT00422734|62791313|FG001|Overall Study|Adverse Event|3|||
33412958|NCT00422734|62791312|FG000|Overall Study|Partner Decision|0|||
33412959|NCT00422734|62791313|FG001|Overall Study|Partner Decision|3|||
33412960|NCT00422422|62791319|FG000|Overall Study|Lack of Efficacy|1|||
33412961|NCT00422422|62791319|FG000|Overall Study|Protocol Violation|1|||
33412962|NCT00422422|62791319|FG000|Overall Study|Withdrawal by Subject|2|||
33412963|NCT00422422|62791319|FG000|Overall Study|SAE, non-fatal|1|||
33412964|NCT00422422|62791319|FG000|Overall Study|AE, non-serious non-fatal|5|||
33412965|NCT00413374|62791327|FG000|Overall Study|Ineligible due to screening criteria.|3|||
33412966|NCT00413374|62791328|FG001|Overall Study|Ineligible due to screening criteria.|0|||
33412967|NCT00413374|62791327|FG000|Overall Study|Adverse Event|1|||
33412968|NCT00413374|62791328|FG001|Overall Study|Adverse Event|0|||
33412969|NCT00413374|62791327|FG000|Overall Study|Lost to Follow-up|1|||
33412970|NCT00413374|62791328|FG001|Overall Study|Lost to Follow-up|0|||
33412971|NCT00413374|62791327|FG000|Overall Study|Surgery|1|||
33412972|NCT00413374|62791328|FG001|Overall Study|Surgery|0|||
33412973|NCT00682643|62791339|FG000|Overall Study|Adverse Event|12|||
33412974|NCT00682643|62791340|FG001|Overall Study|Adverse Event|23|||
33412975|NCT00682643|62791339|FG000|Overall Study|Lack of Efficacy|2|||
33412976|NCT00682643|62791340|FG001|Overall Study|Lack of Efficacy|0|||
33412977|NCT00682643|62791339|FG000|Overall Study|Protocol Violation|38|||
33412978|NCT00682643|62791340|FG001|Overall Study|Protocol Violation|76|||
33412979|NCT00682643|62791339|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
33322335|NCT00978627|62698467|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
33322336|NCT01181609|62698473|FG000|Overall Study|Adverse Event|1|||
33322337|NCT01181609|62698473|FG000|Overall Study|Withdrawal by Subject|1|||
33322338|NCT01181609|62698473|FG000|Overall Study|Lost to Follow-up|1|||
33322339|NCT01181609|62698473|FG000|Overall Study|Death|50|||
33322340|NCT01154010|62698479|FG000|Overall Study|Lost to Follow-up|0|||
33322341|NCT01154010|62698480|FG001|Overall Study|Lost to Follow-up|1|||
33322342|NCT01153698|62698486|FG000|Overall Study|Adverse Event|12|||
33412980|NCT00682643|62791340|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
33604736|NCT01988103|63004311|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
33322343|NCT01153698|62698486|FG000|Overall Study|Lost to Follow-up|4|||
33412981|NCT00682643|62791339|FG000|Overall Study|Lost to Follow-up|1|||
33412982|NCT00682643|62791340|FG001|Overall Study|Lost to Follow-up|6|||
33412983|NCT00682643|62791339|FG000|Overall Study|Physician Decision|2|||
33412984|NCT00682643|62791340|FG001|Overall Study|Physician Decision|6|||
33412985|NCT00682643|62791339|FG000|Overall Study|Withdrawal by Subject|19|||
33412986|NCT00682643|62791340|FG001|Overall Study|Withdrawal by Subject|53|||
33412987|NCT00682643|62791339|FG000|Overall Study|Did Not Receive Study Drug|1|||
33412988|NCT00682643|62791340|FG001|Overall Study|Did Not Receive Study Drug|1|||
33412989|NCT00421408|62791349|FG000|Overall Study|Lost to Follow-up|30|||
33412990|NCT00421408|62791350|FG001|Overall Study|Lost to Follow-up|20|||
33412991|NCT00421408|62791349|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
33412992|NCT00421408|62791350|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
33412993|NCT00679913|62791358|FG000|Overall Study|Protocol Violation|18|||
33412994|NCT00679913|62791359|FG001|Overall Study|Protocol Violation|13|||
33412995|NCT00482001|62791368|FG000|Overall Study|Protocol Violation|1|||
33412996|NCT00482001|62791369|FG001|Overall Study|Protocol Violation|1|||
33412997|NCT00490035|62791381|FG000|Overall Study|AE, non-serious non-fatal|3|||
33412998|NCT00490035|62791382|FG001|Overall Study|AE, non-serious non-fatal|4|||
33412999|NCT00490035|62791383|FG002|Overall Study|AE, non-serious non-fatal|4|||
33413000|NCT00490035|62791384|FG003|Overall Study|AE, non-serious non-fatal|5|||
33413001|NCT00490035|62791381|FG000|Overall Study|Lost to Follow-up|2|||
33413002|NCT00490035|62791382|FG001|Overall Study|Lost to Follow-up|0|||
33413003|NCT00490035|62791383|FG002|Overall Study|Lost to Follow-up|1|||
33413004|NCT00490035|62791384|FG003|Overall Study|Lost to Follow-up|0|||
33604737|NCT01988103|63004307|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
33604738|NCT01988103|63004308|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
33413005|NCT00490035|62791381|FG000|Overall Study|Withdrawal by Subject|2|||
33413006|NCT00490035|62791382|FG001|Overall Study|Withdrawal by Subject|1|||
33413007|NCT00490035|62791383|FG002|Overall Study|Withdrawal by Subject|1|||
33413008|NCT00490035|62791384|FG003|Overall Study|Withdrawal by Subject|0|||
33413009|NCT00490035|62791381|FG000|Overall Study|Other reason|0|||
33413010|NCT00490035|62791382|FG001|Overall Study|Other reason|1|||
33413011|NCT00490035|62791383|FG002|Overall Study|Other reason|3|||
33413012|NCT00490035|62791384|FG003|Overall Study|Other reason|1|||
33413013|NCT00490035|62791381|FG000|Overall Study|AE, serious fatal|1|||
33413014|NCT00490035|62791382|FG001|Overall Study|AE, serious fatal|0|||
33413015|NCT00490035|62791383|FG002|Overall Study|AE, serious fatal|0|||
33413016|NCT00490035|62791384|FG003|Overall Study|AE, serious fatal|0|||
33413017|NCT00490035|62791381|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
33413018|NCT00490035|62791382|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
33413019|NCT00490035|62791383|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
33494070|NCT03527160|62872765|FG000|Overall Study|No urine collected|13|||
33322344|NCT01153698|62698486|FG000|Overall Study|Withdrawal by Subject|2|||
33413020|NCT00490035|62791384|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
33413021|NCT00490035|62791381|FG000|Overall Study|AE of unknown type|0|||
33413022|NCT00490035|62791382|FG001|Overall Study|AE of unknown type|0|||
33413023|NCT00490035|62791383|FG002|Overall Study|AE of unknown type|2|||
33413024|NCT00490035|62791384|FG003|Overall Study|AE of unknown type|0|||
33413025|NCT00404248|62791397|FG000|Overall Study|pts declining status|0|||
33413026|NCT00404248|62791398|FG001|Overall Study|pts declining status|1|||
33413027|NCT00404248|62791399|FG002|Overall Study|pts declining status|0|||
33413028|NCT00404248|62791400|FG003|Overall Study|pts declining status|0|||
33413029|NCT00404248|62791401|FG004|Overall Study|pts declining status|0|||
33413030|NCT00404248|62791402|FG005|Overall Study|pts declining status|0|||
33413031|NCT00404248|62791403|FG006|Overall Study|pts declining status|0|||
33413032|NCT00404248|62791404|FG007|Overall Study|pts declining status|0|||
33413033|NCT00404248|62791405|FG008|Overall Study|pts declining status|0|||
33322345|NCT01153698|62698486|FG000|Overall Study|Switch to other anticoagulants|4|||
33322346|NCT01153698|62698486|FG000|Overall Study|Other|2|||
33322347|NCT01153698|62698486|FG000|Overall Study|Not treated with Pradaxa|5|||
33322348|NCT01174368|62698491|FG000|Overall Study|Withdrawal by Subject|1|||
33322349|NCT01147926|62698497|FG000|Overall Study|Subject Withdrew Consent|9|||
33322350|NCT01147926|62698498|FG001|Overall Study|Subject Withdrew Consent|10|||
33322351|NCT01147926|62698497|FG000|Overall Study|Adverse Event|7|||
33322352|NCT01147926|62698498|FG001|Overall Study|Adverse Event|6|||
33322353|NCT01147926|62698497|FG000|Overall Study|Subject Non-Compliant|5|||
33322354|NCT01147926|62698498|FG001|Overall Study|Subject Non-Compliant|4|||
33413034|NCT00421174|62791433|FG000|Overall Study|Withdrawal by Subject|0|||
33413035|NCT00421174|62791434|FG001|Overall Study|Withdrawal by Subject|1|||
33413036|NCT00421174|62791433|FG000|Overall Study|Ineligible due to infection|2|||
33413037|NCT00421174|62791434|FG001|Overall Study|Ineligible due to infection|0|||
33413038|NCT00496197|62791440|FG000|Overall Study|Discontinued study due to death|43|||
33413039|NCT00496197|62791440|FG000|Overall Study|Adverse Event|13|||
33413040|NCT00496197|62791440|FG000|Overall Study|Does not meet entrance criteria|5|||
33413041|NCT00496197|62791440|FG000|Overall Study|Insufficient clinical response|3|||
33413042|NCT00496197|62791440|FG000|Overall Study|Insufficient bacteriological response|10|||
33413043|NCT00496197|62791440|FG000|Overall Study|Lost to Follow-up|11|||
33413044|NCT00496197|62791440|FG000|Overall Study|Withdrawal by Subject|11|||
33413045|NCT00496197|62791440|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
33413046|NCT00496197|62791440|FG000|Overall Study|Other|14|||
33413047|NCT00496197|62791440|FG000|Overall Study|Protocol Violation|8|||
33413048|NCT00495495|62791444|FG000|Overall Study|Protocol Violation|99|||
33413049|NCT00404092|62791453|FG000|Overall Study|Death|1|||
33413050|NCT00404092|62791454|FG001|Overall Study|Death|0|||
33413051|NCT00404092|62791455|FG002|Overall Study|Death|0|||
33413052|NCT00404092|62791456|FG003|Overall Study|Death|0|||
33413053|NCT00404092|62791453|FG000|Overall Study|Adverse Event|0|||
33413054|NCT00404092|62791454|FG001|Overall Study|Adverse Event|0|||
33413055|NCT00404092|62791455|FG002|Overall Study|Adverse Event|1|||
33413056|NCT00404092|62791456|FG003|Overall Study|Adverse Event|0|||
33413057|NCT00481767|62791468|FG000|Overall Study|Withdrawal by Subject|16|||
33413058|NCT00481767|62791469|FG001|Overall Study|Withdrawal by Subject|11|||
33413059|NCT00481767|62791468|FG000|Overall Study|Lost to Follow-up|16|||
33413060|NCT00481767|62791469|FG001|Overall Study|Lost to Follow-up|10|||
33413061|NCT00489489|62791478|FG000|Overall Study|Not treated due to protocol violation|0|||
33413062|NCT00489489|62791479|FG001|Overall Study|Not treated due to protocol violation|1|||
33413063|NCT00489489|62791480|FG002|Overall Study|Not treated due to protocol violation|1|||
33413064|NCT00489489|62791478|FG000|Overall Study|Adverse Event|1|||
33413065|NCT00489489|62791479|FG001|Overall Study|Adverse Event|1|||
33413066|NCT00489489|62791480|FG002|Overall Study|Adverse Event|1|||
33413067|NCT00489489|62791478|FG000|Overall Study|Protocol Violation|1|||
33413068|NCT00489489|62791479|FG001|Overall Study|Protocol Violation|0|||
33413069|NCT00489489|62791480|FG002|Overall Study|Protocol Violation|1|||
33413070|NCT00489489|62791478|FG000|Overall Study|Progressive disease|0|||
33413071|NCT00489489|62791479|FG001|Overall Study|Progressive disease|1|||
33413072|NCT00489489|62791480|FG002|Overall Study|Progressive disease|0|||
33413073|NCT00489489|62791478|FG000|Overall Study|Participant did not wish to continue|1|||
33413074|NCT00489489|62791479|FG001|Overall Study|Participant did not wish to continue|1|||
33413075|NCT00489489|62791480|FG002|Overall Study|Participant did not wish to continue|0|||
33413076|NCT00489489|62791478|FG000|Overall Study|Other than above|0|||
33413077|NCT00489489|62791479|FG001|Overall Study|Other than above|1|||
33413078|NCT00489489|62791480|FG002|Overall Study|Other than above|0|||
33413079|NCT00489411|62791492|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
33413080|NCT00489411|62791493|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
33413081|NCT00489411|62791492|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
33413082|NCT00489411|62791493|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
33413083|NCT00489411|62791492|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
33413084|NCT00489411|62791493|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
33413085|NCT00489411|62791492|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
33413086|NCT00489411|62791493|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
33413087|NCT00489411|62791492|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
33413088|NCT00489411|62791493|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
33413089|NCT00420784|62791503|FG000|Overall Study|Adverse Event|11|||
33413090|NCT00420784|62791504|FG001|Overall Study|Adverse Event|29|||
33413091|NCT00420784|62791505|FG002|Overall Study|Adverse Event|10|||
33413092|NCT00420784|62791506|FG003|Overall Study|Adverse Event|5|||
33413093|NCT00420784|62791503|FG000|Overall Study|Withdrawal by Subject|0|||
33413094|NCT00420784|62791504|FG001|Overall Study|Withdrawal by Subject|1|||
33413095|NCT00420784|62791505|FG002|Overall Study|Withdrawal by Subject|0|||
33413096|NCT00420784|62791506|FG003|Overall Study|Withdrawal by Subject|0|||
33413097|NCT00420784|62791503|FG000|Overall Study|Lost to Follow-up|0|||
33413098|NCT00420784|62791504|FG001|Overall Study|Lost to Follow-up|0|||
33413099|NCT00420784|62791505|FG002|Overall Study|Lost to Follow-up|2|||
33413100|NCT00420784|62791506|FG003|Overall Study|Lost to Follow-up|1|||
33413101|NCT00420784|62791503|FG000|Overall Study|Virologic Stopping Rule|17|||
33413102|NCT00420784|62791504|FG001|Overall Study|Virologic Stopping Rule|26|||
33413103|NCT00420784|62791505|FG002|Overall Study|Virologic Stopping Rule|41|||
33413104|NCT00420784|62791506|FG003|Overall Study|Virologic Stopping Rule|67|||
33413105|NCT00420784|62791503|FG000|Overall Study|Other|1|||
33413106|NCT00420784|62791504|FG001|Overall Study|Other|2|||
33413107|NCT00420784|62791505|FG002|Overall Study|Other|0|||
33413108|NCT00420784|62791506|FG003|Overall Study|Other|5|||
33413109|NCT00420628|62791519|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
33413110|NCT00420628|62791520|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
33413111|NCT00420628|62791519|FG000|Overall Study|Lost to Follow-up|3|||
33413112|NCT00420628|62791520|FG001|Overall Study|Lost to Follow-up|2|||
33604739|NCT01988103|63004309|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
33604740|NCT01988103|63004310|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
33413113|NCT00420628|62791519|FG000|Overall Study|Adverse Event|1|||
33413114|NCT00420628|62791520|FG001|Overall Study|Adverse Event|0|||
33604741|NCT01988103|63004311|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
33413115|NCT00489255|62791528|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
33413116|NCT00489255|62791529|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
33413117|NCT00489255|62791528|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
33413118|NCT00489255|62791529|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
33413119|NCT00489255|62791528|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
33413120|NCT00489255|62791529|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
33413121|NCT00489255|62791528|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
33413122|NCT00489255|62791529|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
33413123|NCT00489255|62791528|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
33413124|NCT00489255|62791529|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
33413125|NCT00489255|62791528|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
33413126|NCT00489255|62791529|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
33413127|NCT00489255|62791528|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
33413128|NCT00489255|62791529|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
33413129|NCT00489255|62791528|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
33413130|NCT00489255|62791529|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
33413131|NCT00489255|62791528|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
33413132|NCT00489255|62791529|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
33413133|NCT00489255|62791528|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
33413134|NCT00489255|62791529|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
33413135|NCT00413218|62791537|FG000|Overall Study|Randomized but didn't receive study drug|2|||
33413136|NCT00413218|62791538|FG001|Overall Study|Randomized but didn't receive study drug|8|||
33413137|NCT00413218|62791537|FG000|Overall Study|Death|57|||
33413138|NCT00413218|62791538|FG001|Overall Study|Death|56|||
33413139|NCT00413218|62791537|FG000|Overall Study|Lost to Follow-up|14|||
33413140|NCT00413218|62791538|FG001|Overall Study|Lost to Follow-up|17|||
33413141|NCT00413218|62791537|FG000|Overall Study|Admin|20|||
33413142|NCT00413218|62791538|FG001|Overall Study|Admin|14|||
33413143|NCT00413218|62791537|FG000|Overall Study|Missing|1|||
33413144|NCT00413218|62791538|FG001|Overall Study|Missing|0|||
33413145|NCT00413218|62791537|FG000|Overall Study|Withdrawal by Subject|9|||
33413146|NCT00413218|62791538|FG001|Overall Study|Withdrawal by Subject|1|||
33413147|NCT00420316|62791547|FG000|Overall Study|Withdrawal by Subject|0|||
33413148|NCT00420316|62791548|FG001|Overall Study|Withdrawal by Subject|1|||
33413149|NCT00420316|62791547|FG000|Overall Study|Lost to Follow-up|12|||
33413150|NCT00420316|62791548|FG001|Overall Study|Lost to Follow-up|8|||
33413151|NCT00494871|62791556|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
33413152|NCT00494871|62791557|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
33413153|NCT00494871|62791556|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
33413154|NCT00494871|62791557|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
33413155|NCT00494871|62791556|FG000|Double-blind (DB) Treatment Period|Death|8|||
33413156|NCT00494871|62791557|FG001|Double-blind (DB) Treatment Period|Death|3|||
33413157|NCT00494871|62791556|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
33413158|NCT00494871|62791557|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
33413159|NCT00494871|62791556|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
33413160|NCT00494871|62791557|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
33413161|NCT00494871|62791556|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
33413162|NCT00494871|62791557|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
33413163|NCT00494871|62791556|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
33413164|NCT00494871|62791557|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
33413165|NCT00494871|62791556|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
33413166|NCT00494871|62791557|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
33413167|NCT00494871|62791556|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
33413168|NCT00494871|62791557|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
33413169|NCT00494871|62791556|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
33413170|NCT00494871|62791557|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
33413171|NCT00494871|62791556|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
33413172|NCT00494871|62791557|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
33413173|NCT00494871|62791556|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
33413174|NCT00494871|62791557|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
33413175|NCT00494871|62791556|FG000|Follow-up (FU) Period|Adverse Event|1|||
33494071|NCT03527160|62872765|FG000|Overall Study|No clinical serum creatinine collected|6|||
33604742|NCT01988103|63004307|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
33604743|NCT01988103|63004308|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
33413176|NCT00494871|62791557|FG001|Follow-up (FU) Period|Adverse Event|1|||
33413177|NCT00494871|62791556|FG000|Follow-up (FU) Period|Death|13|||
33413178|NCT00494871|62791557|FG001|Follow-up (FU) Period|Death|12|||
33413179|NCT00494871|62791556|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
33413180|NCT00494871|62791557|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
33413181|NCT00494871|62791556|FG000|Follow-up (FU) Period|Physician Decision|0|||
33413182|NCT00494871|62791557|FG001|Follow-up (FU) Period|Physician Decision|1|||
33413183|NCT00494871|62791556|FG000|Follow-up (FU) Period|Protocol Violation|1|||
33413184|NCT00494871|62791557|FG001|Follow-up (FU) Period|Protocol Violation|0|||
33413185|NCT00494871|62791556|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
33413186|NCT00494871|62791557|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
33413187|NCT00494871|62791556|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
33413188|NCT00494871|62791557|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
33413189|NCT00420238|62791567|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
33413190|NCT00420238|62791568|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
33413191|NCT00420238|62791567|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
33413192|NCT00420238|62791568|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
33413193|NCT00420238|62791567|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
33413194|NCT00420238|62791568|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
33413195|NCT00420238|62791567|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
33413196|NCT00420238|62791568|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
33413197|NCT00420238|62791567|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
33413198|NCT00420238|62791568|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
33413199|NCT00420238|62791567|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
33413200|NCT00420238|62791568|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
33413201|NCT00420004|62791583|FG000|Overall Study|Adverse Event|4|||
33413202|NCT00420004|62791584|FG001|Overall Study|Adverse Event|1|||
33413203|NCT00420004|62791585|FG002|Overall Study|Adverse Event|1|||
33413204|NCT00420004|62791583|FG000|Overall Study|Lack of Efficacy|5|||
33413205|NCT00420004|62791584|FG001|Overall Study|Lack of Efficacy|4|||
33413206|NCT00420004|62791585|FG002|Overall Study|Lack of Efficacy|1|||
33413207|NCT00420004|62791583|FG000|Overall Study|Lost to Follow-up|31|||
33413208|NCT00420004|62791584|FG001|Overall Study|Lost to Follow-up|12|||
33604744|NCT01988103|63004309|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
33413209|NCT00420004|62791585|FG002|Overall Study|Lost to Follow-up|10|||
33413210|NCT00420004|62791583|FG000|Overall Study|Entry Criteria Not Met|0|||
33413211|NCT00420004|62791584|FG001|Overall Study|Entry Criteria Not Met|1|||
33413212|NCT00420004|62791585|FG002|Overall Study|Entry Criteria Not Met|0|||
33413213|NCT00420004|62791583|FG000|Overall Study|Physician Decision|14|||
33413214|NCT00420004|62791584|FG001|Overall Study|Physician Decision|4|||
33413215|NCT00420004|62791585|FG002|Overall Study|Physician Decision|2|||
33413216|NCT00420004|62791583|FG000|Overall Study|Protocol Violation|5|||
33413217|NCT00420004|62791584|FG001|Overall Study|Protocol Violation|4|||
33413218|NCT00420004|62791585|FG002|Overall Study|Protocol Violation|3|||
33413219|NCT00420004|62791583|FG000|Overall Study|Withdrawal by Subject|67|||
33413220|NCT00420004|62791584|FG001|Overall Study|Withdrawal by Subject|42|||
33413221|NCT00420004|62791585|FG002|Overall Study|Withdrawal by Subject|14|||
33413222|NCT00420004|62791583|FG000|Overall Study|Sponsor Decision|3|||
33413223|NCT00420004|62791584|FG001|Overall Study|Sponsor Decision|3|||
33413224|NCT00420004|62791585|FG002|Overall Study|Sponsor Decision|1|||
33413225|NCT00494481|62791599|FG000|Overall Study|Condition under investigation worsened|11|||
33413226|NCT00494481|62791600|FG001|Overall Study|Condition under investigation worsened|13|||
33413227|NCT00494481|62791599|FG000|Overall Study|Adverse Event|15|||
33413228|NCT00494481|62791600|FG001|Overall Study|Adverse Event|11|||
33413229|NCT00494481|62791599|FG000|Overall Study|Other|1|||
33413230|NCT00494481|62791600|FG001|Overall Study|Other|0|||
33413231|NCT00494481|62791599|FG000|Overall Study|Never received IP|2|||
33413232|NCT00494481|62791600|FG001|Overall Study|Never received IP|0|||
33413233|NCT00097591|62791608|FG000|Overall Study|Withdrawal of consent|342|||
33413234|NCT00097591|62791609|FG001|Overall Study|Withdrawal of consent|323|||
33413235|NCT00097591|62791608|FG000|Overall Study|Less than 6 months on study drug|9|||
33413236|NCT00097591|62791609|FG001|Overall Study|Less than 6 months on study drug|7|||
33413237|NCT00097591|62791608|FG000|Overall Study|Unable to attend termination visit|53|||
33413238|NCT00097591|62791609|FG001|Overall Study|Unable to attend termination visit|51|||
33413239|NCT00097591|62791608|FG000|Overall Study|Lost to follow up|6|||
33413240|NCT00097591|62791609|FG001|Overall Study|Lost to follow up|10|||
33413241|NCT00097591|62791608|FG000|Overall Study|Other|0|||
33413242|NCT00097591|62791609|FG001|Overall Study|Other|3|||
33413243|NCT00419926|62791617|FG000|Overall Study|Withdrawal by Subject|7|||
33413244|NCT00419926|62791618|FG001|Overall Study|Withdrawal by Subject|3|||
33413245|NCT00419926|62791617|FG000|Overall Study|Administrative Problem|4|||
33413246|NCT00419926|62791618|FG001|Overall Study|Administrative Problem|4|||
33413247|NCT00419926|62791617|FG000|Overall Study|Lost to Follow-up|1|||
33413248|NCT00419926|62791618|FG001|Overall Study|Lost to Follow-up|2|||
33413249|NCT00419926|62791617|FG000|Overall Study|Death|2|||
33413250|NCT00419926|62791618|FG001|Overall Study|Death|1|||
33413251|NCT00419770|62791626|FG000|Overall Study|Withdrawal by Subject|5|||
33413252|NCT00419770|62791627|FG001|Overall Study|Withdrawal by Subject|1|||
33413253|NCT00080119|62791637|FG000|Overall Study|Discontinued because of study closure|0|||
33413254|NCT00080119|62791638|FG001|Overall Study|Discontinued because of study closure|0|||
33413255|NCT00080119|62791639|FG002|Overall Study|Discontinued because of study closure|130|||
33413256|NCT00080119|62791640|FG003|Overall Study|Discontinued because of study closure|141|||
33413257|NCT00080119|62791637|FG000|Overall Study|Unable to get to clinic|24|||
33413258|NCT00080119|62791638|FG001|Overall Study|Unable to get to clinic|24|||
33413259|NCT00080119|62791639|FG002|Overall Study|Unable to get to clinic|7|||
33413260|NCT00080119|62791640|FG003|Overall Study|Unable to get to clinic|1|||
33413261|NCT00080119|62791637|FG000|Overall Study|Consent withdrawn|13|||
33413262|NCT00080119|62791638|FG001|Overall Study|Consent withdrawn|17|||
33413263|NCT00080119|62791639|FG002|Overall Study|Consent withdrawn|4|||
33413264|NCT00080119|62791640|FG003|Overall Study|Consent withdrawn|6|||
33413265|NCT00080119|62791637|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
33413266|NCT00080119|62791638|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
33413267|NCT00080119|62791639|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
33413268|NCT00080119|62791640|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
33413269|NCT00080119|62791637|FG000|Overall Study|Lost to Follow-up|16|||
33413270|NCT00080119|62791638|FG001|Overall Study|Lost to Follow-up|19|||
33413271|NCT00080119|62791639|FG002|Overall Study|Lost to Follow-up|19|||
33413272|NCT00080119|62791640|FG003|Overall Study|Lost to Follow-up|14|||
33413273|NCT00419380|62791654|FG000|Overall Study|Lack of Efficacy|1|||
33604745|NCT01988103|63004310|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
33604746|NCT01988103|63004311|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
33604747|NCT01988103|63004307|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
33604748|NCT01988103|63004308|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
33604749|NCT01988103|63004309|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
33413274|NCT00419380|62791655|FG001|Overall Study|Lack of Efficacy|7|||
33413275|NCT00419380|62791654|FG000|Overall Study|Physician Decision|0|||
33413276|NCT00419380|62791655|FG001|Overall Study|Physician Decision|1|||
33413277|NCT00419380|62791654|FG000|Overall Study|Lost to Follow-up|0|||
33413278|NCT00419380|62791655|FG001|Overall Study|Lost to Follow-up|1|||
33413279|NCT00419380|62791654|FG000|Overall Study|Withdrawal by Subject|0|||
33413280|NCT00419380|62791655|FG001|Overall Study|Withdrawal by Subject|1|||
33413281|NCT00413062|62791663|FG000|Overall Study|Adverse event/serious adverse event|289|||
33413282|NCT00413062|62791664|FG001|Overall Study|Adverse event/serious adverse event|56|||
33413283|NCT00413062|62791663|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
33413284|NCT00413062|62791664|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
33413285|NCT00413062|62791663|FG000|Overall Study|Withdrawal of informed consent|111|||
33413286|NCT00413062|62791664|FG001|Overall Study|Withdrawal of informed consent|36|||
33413287|NCT00413062|62791663|FG000|Overall Study|Pregnancy|15|||
33413288|NCT00413062|62791664|FG001|Overall Study|Pregnancy|5|||
33413289|NCT00413062|62791663|FG000|Overall Study|Pregnancy wish|17|||
33413290|NCT00413062|62791664|FG001|Overall Study|Pregnancy wish|6|||
33413291|NCT00413062|62791663|FG000|Overall Study|Lost to Follow-up|175|||
33494072|NCT03527160|62872765|FG000|Overall Study|Did not meet inclusion|2|||
33413292|NCT00413062|62791664|FG001|Overall Study|Lost to Follow-up|73|||
33413293|NCT00413062|62791663|FG000|Overall Study|Other reason|70|||
33413294|NCT00413062|62791664|FG001|Overall Study|Other reason|34|||
33413295|NCT00494091|62791674|FG000|Overall Study|Death|5|||
33413296|NCT00494091|62791675|FG001|Overall Study|Death|54|||
33413297|NCT00494091|62791674|FG000|Overall Study|Lost to Follow-up|0|||
33413298|NCT00494091|62791675|FG001|Overall Study|Lost to Follow-up|4|||
33413299|NCT00494091|62791674|FG000|Overall Study|Other|1|||
33413300|NCT00494091|62791675|FG001|Overall Study|Other|11|||
33413301|NCT00494091|62791674|FG000|Overall Study|Withdrawal by Subject|0|||
33413302|NCT00494091|62791675|FG001|Overall Study|Withdrawal by Subject|7|||
33413303|NCT00494013|62791684|FG000|Overall Study|Adverse Event|0|||
33413304|NCT00494013|62791685|FG001|Overall Study|Adverse Event|1|||
33413305|NCT00494013|62791684|FG000|Overall Study|Entry Criteria Not Met|1|||
33413306|NCT00494013|62791685|FG001|Overall Study|Entry Criteria Not Met|4|||
33413307|NCT00494013|62791684|FG000|Overall Study|Lost to Follow-up|5|||
33413308|NCT00494013|62791685|FG001|Overall Study|Lost to Follow-up|6|||
33413309|NCT00494013|62791684|FG000|Overall Study|Physician Decision|3|||
33413310|NCT00494013|62791685|FG001|Overall Study|Physician Decision|5|||
33413311|NCT00494013|62791684|FG000|Overall Study|Protocol Violation|8|||
33413312|NCT00494013|62791685|FG001|Overall Study|Protocol Violation|5|||
33413313|NCT00494013|62791684|FG000|Overall Study|Withdrawal by Subject|13|||
33413314|NCT00494013|62791685|FG001|Overall Study|Withdrawal by Subject|14|||
33413315|NCT00494013|62791684|FG000|Overall Study|Sponsor Decision|0|||
33413316|NCT00494013|62791685|FG001|Overall Study|Sponsor Decision|1|||
33413317|NCT00079339|62791694|FG000|Overall Study|Adverse Event|1|||
33413318|NCT00079339|62791695|FG001|Overall Study|Adverse Event|7|||
33413319|NCT00079339|62791696|FG002|Overall Study|Adverse Event|2|||
33413320|NCT00079339|62791694|FG000|Overall Study|Death|1|||
33413321|NCT00079339|62791695|FG001|Overall Study|Death|0|||
33413322|NCT00079339|62791696|FG002|Overall Study|Death|0|||
33413323|NCT00079339|62791694|FG000|Overall Study|Non-compliance|0|||
33413324|NCT00079339|62791695|FG001|Overall Study|Non-compliance|0|||
33413325|NCT00079339|62791696|FG002|Overall Study|Non-compliance|1|||
33413326|NCT00079339|62791694|FG000|Overall Study|Withdrawal by Subject|0|||
33413327|NCT00079339|62791695|FG001|Overall Study|Withdrawal by Subject|4|||
33413328|NCT00079339|62791696|FG002|Overall Study|Withdrawal by Subject|1|||
33413329|NCT00079339|62791694|FG000|Overall Study|Disease progression|3|||
33413330|NCT00079339|62791695|FG001|Overall Study|Disease progression|28|||
33413331|NCT00079339|62791696|FG002|Overall Study|Disease progression|2|||
33413332|NCT00493779|62791709|FG000|Overall Study|Logistical issue at site|1|||
33413333|NCT00541866|62791719|FG000|Overall Study|Adverse Event|3|||
33413334|NCT00541866|62791720|FG001|Overall Study|Adverse Event|0|||
33413335|NCT00541866|62791721|FG002|Overall Study|Adverse Event|0|||
33413336|NCT00541866|62791722|FG003|Overall Study|Adverse Event|0|||
33413337|NCT00541866|62791723|FG004|Overall Study|Adverse Event|0|||
33413338|NCT00541866|62791719|FG000|Overall Study|Death|1|||
33413339|NCT00541866|62791720|FG001|Overall Study|Death|0|||
33413340|NCT00541866|62791721|FG002|Overall Study|Death|0|||
33413341|NCT00541866|62791722|FG003|Overall Study|Death|0|||
33604750|NCT01988103|63004310|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
33604751|NCT01988103|63004311|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
33604752|NCT01988103|63004307|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
33413342|NCT00541866|62791723|FG004|Overall Study|Death|0|||
33413343|NCT00541866|62791719|FG000|Overall Study|Lack of Efficacy|19|||
33413344|NCT00541866|62791720|FG001|Overall Study|Lack of Efficacy|15|||
33413345|NCT00541866|62791721|FG002|Overall Study|Lack of Efficacy|10|||
33413346|NCT00541866|62791722|FG003|Overall Study|Lack of Efficacy|12|||
33413347|NCT00541866|62791723|FG004|Overall Study|Lack of Efficacy|14|||
33413348|NCT00541866|62791719|FG000|Overall Study|Not Reported or Other|11|||
33413349|NCT00541866|62791720|FG001|Overall Study|Not Reported or Other|3|||
33413350|NCT00541866|62791721|FG002|Overall Study|Not Reported or Other|3|||
33413351|NCT00541866|62791722|FG003|Overall Study|Not Reported or Other|3|||
33494073|NCT03739138|62872775|FG000|Overall Study|Death|0|||
33604753|NCT01988103|63004308|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
33604754|NCT01988103|63004309|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
33604755|NCT01988103|63004310|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
33413352|NCT00541866|62791723|FG004|Overall Study|Not Reported or Other|1|||
33413353|NCT00541866|62791719|FG000|Overall Study|Physician Decision|0|||
33413354|NCT00541866|62791720|FG001|Overall Study|Physician Decision|0|||
33413355|NCT00541866|62791721|FG002|Overall Study|Physician Decision|2|||
33413356|NCT00541866|62791722|FG003|Overall Study|Physician Decision|1|||
33413357|NCT00541866|62791723|FG004|Overall Study|Physician Decision|0|||
33413358|NCT00493467|62791751|FG000|Overall Study|Death|1|||
33413359|NCT00090493|62791755|FG000|Overall Study|Physician Decision|2|||
33413360|NCT04329702|62791762|FG000|Overall Study|illness|3|||
33413361|NCT04329702|62791763|FG001|Overall Study|illness|4|||
33413362|NCT04329702|62791764|FG002|Overall Study|illness|0|||
33413363|NCT04329702|62791762|FG000|Overall Study|Lost to Follow-up|0|||
33413364|NCT04329702|62791763|FG001|Overall Study|Lost to Follow-up|0|||
33413365|NCT04329702|62791764|FG002|Overall Study|Lost to Follow-up|2|||
33413366|NCT04329702|62791762|FG000|Overall Study|Death|0|||
33413367|NCT04329702|62791763|FG001|Overall Study|Death|2|||
33413368|NCT04329702|62791764|FG002|Overall Study|Death|0|||
33413369|NCT00481065|62791785|FG000|Overall Study|Adverse event or death|1|||
33413370|NCT00481065|62791786|FG001|Overall Study|Adverse event or death|1|||
33413371|NCT00481065|62791787|FG002|Overall Study|Adverse event or death|3|||
33413372|NCT00481065|62791788|FG003|Overall Study|Adverse event or death|0|||
33413373|NCT00481065|62791789|FG004|Overall Study|Adverse event or death|2|||
33413374|NCT00481065|62791790|FG005|Overall Study|Adverse event or death|0|||
33413375|NCT00481065|62791791|FG006|Overall Study|Adverse event or death|1|||
33413376|NCT00481065|62791792|FG007|Overall Study|Adverse event or death|1|||
33413377|NCT00481065|62791785|FG000|Overall Study|Withdrawal by Subject|11|||
33413378|NCT00481065|62791786|FG001|Overall Study|Withdrawal by Subject|12|||
33413379|NCT00481065|62791787|FG002|Overall Study|Withdrawal by Subject|7|||
33413380|NCT00481065|62791788|FG003|Overall Study|Withdrawal by Subject|11|||
33413381|NCT00481065|62791789|FG004|Overall Study|Withdrawal by Subject|13|||
33413382|NCT00481065|62791790|FG005|Overall Study|Withdrawal by Subject|12|||
33413383|NCT00481065|62791791|FG006|Overall Study|Withdrawal by Subject|9|||
33413384|NCT00481065|62791792|FG007|Overall Study|Withdrawal by Subject|10|||
33413385|NCT00481065|62791785|FG000|Overall Study|Lost to Follow-up|4|||
33413386|NCT00481065|62791786|FG001|Overall Study|Lost to Follow-up|2|||
33413387|NCT00481065|62791787|FG002|Overall Study|Lost to Follow-up|4|||
33413388|NCT00481065|62791788|FG003|Overall Study|Lost to Follow-up|3|||
33413389|NCT00481065|62791789|FG004|Overall Study|Lost to Follow-up|3|||
33413390|NCT00481065|62791790|FG005|Overall Study|Lost to Follow-up|3|||
33413391|NCT00481065|62791791|FG006|Overall Study|Lost to Follow-up|2|||
33413392|NCT00481065|62791792|FG007|Overall Study|Lost to Follow-up|5|||
33413393|NCT00481065|62791785|FG000|Overall Study|Inappropriate enrollment|4|||
33413394|NCT00481065|62791786|FG001|Overall Study|Inappropriate enrollment|0|||
33413395|NCT00481065|62791787|FG002|Overall Study|Inappropriate enrollment|2|||
33413396|NCT00481065|62791788|FG003|Overall Study|Inappropriate enrollment|0|||
33413397|NCT00481065|62791789|FG004|Overall Study|Inappropriate enrollment|2|||
33413398|NCT00481065|62791790|FG005|Overall Study|Inappropriate enrollment|1|||
33413399|NCT00481065|62791791|FG006|Overall Study|Inappropriate enrollment|0|||
33413400|NCT00481065|62791792|FG007|Overall Study|Inappropriate enrollment|1|||
33413401|NCT00481065|62791785|FG000|Overall Study|Administrative reason|0|||
33413402|NCT00481065|62791786|FG001|Overall Study|Administrative reason|0|||
33413403|NCT00481065|62791787|FG002|Overall Study|Administrative reason|0|||
33413404|NCT00481065|62791788|FG003|Overall Study|Administrative reason|0|||
33413405|NCT00481065|62791789|FG004|Overall Study|Administrative reason|0|||
33413406|NCT00481065|62791790|FG005|Overall Study|Administrative reason|2|||
33413407|NCT00481065|62791791|FG006|Overall Study|Administrative reason|1|||
33413408|NCT00481065|62791792|FG007|Overall Study|Administrative reason|0|||
33413409|NCT00481065|62791785|FG000|Overall Study|Protocol Violation|2|||
33413410|NCT00481065|62791786|FG001|Overall Study|Protocol Violation|1|||
33413411|NCT00481065|62791787|FG002|Overall Study|Protocol Violation|1|||
33413412|NCT00481065|62791788|FG003|Overall Study|Protocol Violation|1|||
33413413|NCT00481065|62791789|FG004|Overall Study|Protocol Violation|2|||
33413414|NCT00481065|62791790|FG005|Overall Study|Protocol Violation|6|||
33413415|NCT00481065|62791791|FG006|Overall Study|Protocol Violation|3|||
33413416|NCT00481065|62791792|FG007|Overall Study|Protocol Violation|2|||
33413417|NCT00481065|62791785|FG000|Overall Study|Unable to classify|0|||
33413418|NCT00481065|62791786|FG001|Overall Study|Unable to classify|1|||
33413419|NCT00481065|62791787|FG002|Overall Study|Unable to classify|2|||
33413420|NCT00481065|62791788|FG003|Overall Study|Unable to classify|0|||
33604756|NCT01988103|63004311|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
33604757|NCT01988103|63004307|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
33413421|NCT00481065|62791789|FG004|Overall Study|Unable to classify|1|||
33413422|NCT00481065|62791790|FG005|Overall Study|Unable to classify|0|||
33413423|NCT00481065|62791791|FG006|Overall Study|Unable to classify|0|||
33413424|NCT00481065|62791792|FG007|Overall Study|Unable to classify|0|||
33413425|NCT00493311|62791814|FG000|Overall Study|Need for rescue medication|2|||
33413426|NCT00493311|62791815|FG001|Overall Study|Need for rescue medication|2|||
33413427|NCT00571649|62791823|FG000|Treatment Period|Adverse Event|438|||
33413428|NCT00571649|62791824|FG001|Treatment Period|Adverse Event|385|||
33494074|NCT03739138|62872776|FG001|Overall Study|Death|7|||
33604758|NCT01988103|63004308|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
33604759|NCT01988103|63004309|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
33604760|NCT01988103|63004310|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
33604761|NCT01988103|63004311|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
33604762|NCT01988103|63004307|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
33604763|NCT01988103|63004308|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
33604764|NCT01988103|63004309|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
33494075|NCT03739138|62872777|FG002|Overall Study|Death|4|||
33322355|NCT01147926|62698497|FG000|Overall Study|Principal investigator left hospital|1|||
33413429|NCT00571649|62791823|FG000|Treatment Period|Clinical endpoint reached|50|||
33413430|NCT00571649|62791824|FG001|Treatment Period|Clinical endpoint reached|56|||
33604765|NCT01988103|63004310|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
33604766|NCT01988103|63004311|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
33604767|NCT02013375|63004326|FG000|Overall Study|Did not engraft|1|||
33604768|NCT02013375|63004326|FG000|Overall Study|Did not engraft|1|||
33604769|NCT02079519|63004331|FG000|Overall Study|Disease Progression|9|||
33604770|NCT02079519|63004331|FG000|Overall Study|Adverse Event|1|||
33604771|NCT01987557|63004338|FG000|Overall Study|Protocol Violation|1|||
33604772|NCT01987557|63004339|FG001|Overall Study|Protocol Violation|0|||
33604773|NCT01987557|63004340|FG002|Overall Study|Protocol Violation|1|||
33604774|NCT01987557|63004338|FG000|Overall Study|Withdrawal by Subject|2|||
33604775|NCT01987557|63004339|FG001|Overall Study|Withdrawal by Subject|1|||
33604776|NCT01987557|63004340|FG002|Overall Study|Withdrawal by Subject|2|||
33604777|NCT01987557|63004338|FG000|Overall Study|Adverse Event|0|||
33604778|NCT01987557|63004339|FG001|Overall Study|Adverse Event|2|||
33604779|NCT01987557|63004340|FG002|Overall Study|Adverse Event|0|||
33604780|NCT02078817|63004348|FG000|Overall Study|Withdrawal by Subject|1|||
33604781|NCT02011893|63004352|FG000|Enrollment to Randomization|Adverse Event|2|||
33604782|NCT02011893|63004353|FG001|Enrollment to Randomization|Adverse Event|0|||
33604783|NCT02011893|63004354|FG002|Enrollment to Randomization|Adverse Event|0|||
33604784|NCT02011893|63004352|FG000|Enrollment to Randomization|Physician Decision|10|||
33604785|NCT02011893|63004353|FG001|Enrollment to Randomization|Physician Decision|0|||
33604786|NCT02011893|63004354|FG002|Enrollment to Randomization|Physician Decision|0|||
33604787|NCT02011893|63004352|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
33604788|NCT02011893|63004353|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
33604789|NCT02011893|63004354|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
33604790|NCT02011893|63004352|FG000|Enrollment to Randomization|Screening Failure|29|||
33604791|NCT02011893|63004353|FG001|Enrollment to Randomization|Screening Failure|0|||
33604792|NCT02011893|63004354|FG002|Enrollment to Randomization|Screening Failure|0|||
33604793|NCT02011893|63004352|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
33604794|NCT02011893|63004353|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
33604795|NCT02011893|63004354|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
33322356|NCT01147926|62698498|FG001|Overall Study|Principal investigator left hospital|3|||
33604796|NCT02011893|63004352|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
33604797|NCT02011893|63004353|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
33604798|NCT02011893|63004354|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
33604799|NCT02011893|63004352|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
33322357|NCT01147926|62698497|FG000|Overall Study|Selection criteria not met|3|||
33322358|NCT01147926|62698498|FG001|Overall Study|Selection criteria not met|1|||
33604800|NCT02011893|63004353|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
33604801|NCT02011893|63004354|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
33604802|NCT02011893|63004352|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
33604803|NCT02011893|63004353|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
33604804|NCT02011893|63004354|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
33604805|NCT02011893|63004352|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
33604806|NCT02011893|63004353|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
33604807|NCT02011893|63004354|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
33322359|NCT01147926|62698497|FG000|Overall Study|Lost to Follow-up|0|||
33604808|NCT02011113|63004359|FG000|Overall Study|Adverse Event|4|||
33604809|NCT02011113|63004359|FG000|Overall Study|Disease Progression (DP)|16|||
33322360|NCT01147926|62698498|FG001|Overall Study|Lost to Follow-up|2|||
33322361|NCT01147926|62698497|FG000|Overall Study|Sponsor's Decision|0|||
33413431|NCT00571649|62791823|FG000|Treatment Period|Withdrawal by Subject|285|||
33413432|NCT00571649|62791824|FG001|Treatment Period|Withdrawal by Subject|255|||
33413433|NCT00571649|62791823|FG000|Treatment Period|Death|76|||
33413434|NCT00571649|62791824|FG001|Treatment Period|Death|59|||
33413435|NCT00571649|62791823|FG000|Treatment Period|Physician Decision|8|||
33413436|NCT00571649|62791824|FG001|Treatment Period|Physician Decision|9|||
33413437|NCT00571649|62791823|FG000|Treatment Period|Lost to Follow-up|43|||
33413438|NCT00571649|62791824|FG001|Treatment Period|Lost to Follow-up|41|||
33413439|NCT00571649|62791823|FG000|Treatment Period|Non-compliant with study medication|88|||
33413440|NCT00571649|62791824|FG001|Treatment Period|Non-compliant with study medication|89|||
33413441|NCT00571649|62791823|FG000|Treatment Period|Patient convenience|11|||
33413442|NCT00571649|62791824|FG001|Treatment Period|Patient convenience|13|||
33413443|NCT00571649|62791823|FG000|Treatment Period|Protocol Violation|90|||
33413444|NCT00571649|62791824|FG001|Treatment Period|Protocol Violation|92|||
33413445|NCT00571649|62791823|FG000|Treatment Period|Technical problems|3|||
33413446|NCT00571649|62791824|FG001|Treatment Period|Technical problems|5|||
33413447|NCT00571649|62791823|FG000|Follow-up Period|Adverse Event|46|||
33413448|NCT00571649|62791824|FG001|Follow-up Period|Adverse Event|40|||
33413449|NCT00571649|62791823|FG000|Follow-up Period|Clinical endpoint reached|5|||
33413450|NCT00571649|62791824|FG001|Follow-up Period|Clinical endpoint reached|2|||
33413451|NCT00571649|62791823|FG000|Follow-up Period|Withdrawal by Subject|119|||
33413452|NCT00571649|62791824|FG001|Follow-up Period|Withdrawal by Subject|115|||
33413453|NCT00571649|62791823|FG000|Follow-up Period|Death|132|||
33413454|NCT00571649|62791824|FG001|Follow-up Period|Death|133|||
33413455|NCT00571649|62791823|FG000|Follow-up Period|Physician Decision|7|||
33413456|NCT00571649|62791824|FG001|Follow-up Period|Physician Decision|13|||
33413457|NCT00571649|62791823|FG000|Follow-up Period|Lost to Follow-up|95|||
33413458|NCT00571649|62791824|FG001|Follow-up Period|Lost to Follow-up|92|||
33413459|NCT00571649|62791823|FG000|Follow-up Period|Patient convenience|136|||
33413460|NCT00571649|62791824|FG001|Follow-up Period|Patient convenience|121|||
33413461|NCT00571649|62791823|FG000|Follow-up Period|Protocol Violation|5|||
33413462|NCT00571649|62791824|FG001|Follow-up Period|Protocol Violation|12|||
33413463|NCT00546572|62791832|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
33413464|NCT00546572|62791833|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
33413465|NCT00546572|62791832|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
33413466|NCT00546572|62791833|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
33413467|NCT00546572|62791832|FG000|Vax 1 / Year 0|Protocol Violation|3|||
33413468|NCT00546572|62791833|FG001|Vax 1 / Year 0|Protocol Violation|4|||
33413469|NCT00546572|62791832|FG000|Vax 1 / Year 0|Death|2|||
33413470|NCT00546572|62791833|FG001|Vax 1 / Year 0|Death|2|||
33413471|NCT00546572|62791832|FG000|Vax 1 / Year 0|Adverse Event|0|||
33413472|NCT00546572|62791833|FG001|Vax 1 / Year 0|Adverse Event|1|||
33413473|NCT00546572|62791832|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
33413474|NCT00546572|62791833|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
33413475|NCT00546572|62791832|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
33413476|NCT00546572|62791833|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
33413477|NCT00546572|62791832|FG000|Vax 2 / Year 1|Other|1|||
33413478|NCT00546572|62791833|FG001|Vax 2 / Year 1|Other|1|||
33413479|NCT00546572|62791832|FG000|Vax 2 / Year 1|Adverse Event|1|||
33413480|NCT00546572|62791833|FG001|Vax 2 / Year 1|Adverse Event|0|||
33413481|NCT00546572|62791832|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
33413482|NCT00546572|62791833|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
33413483|NCT03917472|62791852|FG000|Overall Study|Physician Decision|4|||
33413484|NCT03917472|62791853|FG001|Overall Study|Physician Decision|0|||
33413485|NCT03917472|62791852|FG000|Overall Study|Adverse Event|3|||
33413486|NCT03917472|62791853|FG001|Overall Study|Adverse Event|1|||
33413487|NCT03917472|62791852|FG000|Overall Study|Death|7|||
33413488|NCT03917472|62791853|FG001|Overall Study|Death|5|||
33413489|NCT03917472|62791852|FG000|Overall Study|Withdrawal by Subject|11|||
33413490|NCT03917472|62791853|FG001|Overall Study|Withdrawal by Subject|4|||
33413491|NCT03917472|62791852|FG000|Overall Study|Lost to Follow-up|10|||
33413492|NCT03917472|62791853|FG001|Overall Study|Lost to Follow-up|5|||
33413493|NCT00681863|62791860|FG000|Overall Study|Adverse Event|1|||
33413494|NCT00681863|62791860|FG000|Overall Study|Lost to Follow-up|2|||
33413495|NCT00681863|62791860|FG000|Overall Study|Lack of Efficacy|2|||
33413496|NCT00681863|62791860|FG000|Overall Study|Other|18|||
33413497|NCT00681629|62791866|FG000|Overall Study|Study termination|4|||
33413498|NCT00681629|62791867|FG001|Overall Study|Study termination|2|||
33413499|NCT00681629|62791866|FG000|Overall Study|Adverse Event|1|||
33413500|NCT00681629|62791867|FG001|Overall Study|Adverse Event|0|||
33413501|NCT00679367|62791873|FG000|Overall Study|Adverse Event|7|||
33413502|NCT00679367|62791873|FG000|Overall Study|inability to swallow oral drugs|1|||
33413503|NCT00679367|62791873|FG000|Overall Study|Lack of Efficacy|3|||
33413504|NCT00679367|62791873|FG000|Overall Study|Withdrawal by Subject|1|||
33413505|NCT03937778|62791878|FG000|Overall Study|Withdrawal by Subject|1|||
33413506|NCT03937778|62791878|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
33413507|NCT03935126|62791882|FG000|Overall Study|Study termination by sponsor|3|||
33413508|NCT00545714|62791886|FG000|Induction Phase (6 Months)|Physician Decision|3|||
33413509|NCT00545714|62791886|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
33413510|NCT00545714|62791886|FG000|Induction Phase (6 Months)|Disease Progression|1|||
33413511|NCT00545714|62791886|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
33413512|NCT00545714|62791886|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
33413513|NCT00545714|62791886|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
33413514|NCT00545714|62791886|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
33322362|NCT01147926|62698498|FG001|Overall Study|Sponsor's Decision|1|||
33413515|NCT00545714|62791886|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
33413516|NCT00545714|62791886|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
33413517|NCT00545714|62791886|FG000|Maintenance Phase (36 Months)|Death|2|||
33413518|NCT00539838|62791893|FG000|Overall Study|Fail to return|2|||
33413519|NCT00539838|62791894|FG001|Overall Study|Fail to return|0|||
33413520|NCT00539838|62791895|FG002|Overall Study|Fail to return|0|||
33413521|NCT00539838|62791893|FG000|Overall Study|Withdrawal by Subject|0|||
33322363|NCT01147926|62698497|FG000|Overall Study|Lack of Efficacy|1|||
33413522|NCT00539838|62791894|FG001|Overall Study|Withdrawal by Subject|4|||
33322364|NCT01147926|62698498|FG001|Overall Study|Lack of Efficacy|0|||
33322365|NCT01147926|62698497|FG000|Overall Study|Too busy, no time for study|1|||
33413523|NCT00539838|62791895|FG002|Overall Study|Withdrawal by Subject|0|||
33413524|NCT00539838|62791893|FG000|Overall Study|Death|0|||
33413525|NCT00539838|62791894|FG001|Overall Study|Death|2|||
33413526|NCT00539838|62791895|FG002|Overall Study|Death|0|||
33413527|NCT00539838|62791893|FG000|Overall Study|Did not cooperate|1|||
33413528|NCT00539838|62791894|FG001|Overall Study|Did not cooperate|0|||
33413529|NCT00539838|62791895|FG002|Overall Study|Did not cooperate|1|||
33413530|NCT00539838|62791893|FG000|Overall Study|Administrative|4|||
33413531|NCT00539838|62791894|FG001|Overall Study|Administrative|0|||
33413532|NCT00539838|62791895|FG002|Overall Study|Administrative|8|||
33413533|NCT00679289|62791908|FG000|Overall Study|Progressive disease|4|||
33413534|NCT00679289|62791909|FG001|Overall Study|Progressive disease|5|||
33322366|NCT01147926|62698498|FG001|Overall Study|Too busy, no time for study|0|||
33322367|NCT01147926|62698497|FG000|Overall Study|Went on holiday|0|||
33322368|NCT01147926|62698498|FG001|Overall Study|Went on holiday|1|||
33322369|NCT01147926|62698497|FG000|Overall Study|Colonoscopy result|0|||
33322370|NCT01147926|62698498|FG001|Overall Study|Colonoscopy result|1|||
33322371|NCT00975507|62698506|FG000|Overall Study|Adverse Event|1|||
33322372|NCT00975507|62698507|FG001|Overall Study|Adverse Event|0|||
33322373|NCT00975507|62698506|FG000|Overall Study|Lost to Follow-up|7|||
33413535|NCT00679289|62791910|FG002|Overall Study|Progressive disease|18|||
33322374|NCT00975507|62698507|FG001|Overall Study|Lost to Follow-up|1|||
33413536|NCT00679289|62791908|FG000|Overall Study|Withdrawal by Subject|0|||
33413537|NCT00679289|62791909|FG001|Overall Study|Withdrawal by Subject|1|||
33413538|NCT00679289|62791910|FG002|Overall Study|Withdrawal by Subject|1|||
33413539|NCT00679289|62791908|FG000|Overall Study|Adverse Event|0|||
33413540|NCT00679289|62791909|FG001|Overall Study|Adverse Event|0|||
33413541|NCT00679289|62791910|FG002|Overall Study|Adverse Event|3|||
33413542|NCT00679289|62791908|FG000|Overall Study|Physician Decision|1|||
33413543|NCT00679289|62791909|FG001|Overall Study|Physician Decision|0|||
33413544|NCT00679289|62791910|FG002|Overall Study|Physician Decision|1|||
33413545|NCT00679211|62791920|FG000|Overall Study|Progressive disease|82|||
33413546|NCT00679211|62791920|FG000|Overall Study|Adverse Event|7|||
33413547|NCT00679211|62791920|FG000|Overall Study|Withdrawal by Subject|2|||
33413548|NCT00679211|62791920|FG000|Overall Study|Physician Decision|5|||
33413549|NCT00679211|62791920|FG000|Overall Study|Refused to undergo protocol procedures|1|||
33413550|NCT00679211|62791920|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
33413551|NCT00679211|62791920|FG000|Overall Study|Other|1|||
33413552|NCT00545948|62791929|FG000|Overall Study|Not Treated|1|||
33413553|NCT00545948|62791930|FG001|Overall Study|Not Treated|1|||
33413554|NCT00545948|62791931|FG002|Overall Study|Not Treated|7|||
33413555|NCT00679055|62791942|FG000|Overall Study|Adverse Event|0|||
33413556|NCT00679055|62791943|FG001|Overall Study|Adverse Event|1|||
33413557|NCT00679055|62791942|FG000|Overall Study|Other|0|||
33413558|NCT00679055|62791943|FG001|Overall Study|Other|3|||
33413559|NCT00679055|62791942|FG000|Overall Study|Study Terminated|2|||
33322375|NCT00975507|62698506|FG000|Overall Study|Protocol Violation|2|||
33322376|NCT00975507|62698507|FG001|Overall Study|Protocol Violation|0|||
33322377|NCT00975507|62698506|FG000|Overall Study|Withdrawal by Subject|10|||
33322378|NCT00975507|62698507|FG001|Overall Study|Withdrawal by Subject|3|||
33322379|NCT01147848|62698517|FG000|Run-in Period|Screen Failure|623|||
33322380|NCT01147848|62698518|FG001|Run-in Period|Screen Failure|0|||
33322381|NCT01147848|62698519|FG002|Run-in Period|Screen Failure|0|||
33322382|NCT01147848|62698517|FG000|Run-in Period|Run-in Failure|135|||
33322383|NCT01147848|62698518|FG001|Run-in Period|Run-in Failure|0|||
33322384|NCT01147848|62698519|FG002|Run-in Period|Run-in Failure|0|||
33413560|NCT00679055|62791943|FG001|Overall Study|Study Terminated|1|||
33413561|NCT03927950|62791949|FG000|Overall Study|Adverse Event|9|||
33413562|NCT00678899|62791954|FG000|Overall Study|Adverse Event|1|||
33413563|NCT00678587|62791961|FG000|Overall Study|Adverse Event|3|||
33413564|NCT00678587|62791962|FG001|Overall Study|Adverse Event|3|||
33413565|NCT00678587|62791961|FG000|Overall Study|Lack of Efficacy|1|||
33413566|NCT00678587|62791962|FG001|Overall Study|Lack of Efficacy|0|||
33413567|NCT00678587|62791961|FG000|Overall Study|Protocol Violation|2|||
33413568|NCT00678587|62791962|FG001|Overall Study|Protocol Violation|1|||
33413569|NCT00678587|62791961|FG000|Overall Study|Study Closed/Terminated|1|||
33413570|NCT00678587|62791962|FG001|Overall Study|Study Closed/Terminated|0|||
33413571|NCT00678587|62791961|FG000|Overall Study|Lost to Follow-up|3|||
33413572|NCT00678587|62791962|FG001|Overall Study|Lost to Follow-up|5|||
33413573|NCT00678587|62791961|FG000|Overall Study|Investigator Discretion|2|||
33413574|NCT00678587|62791962|FG001|Overall Study|Investigator Discretion|6|||
33413575|NCT00678587|62791961|FG000|Overall Study|Withdrew Consent|8|||
33413576|NCT00678587|62791962|FG001|Overall Study|Withdrew Consent|3|||
33413577|NCT03523728|62791974|FG000|Stage 1 (24 Months)|Adverse Event|2|||
33413578|NCT03523728|62791975|FG001|Stage 1 (24 Months)|Adverse Event|2|||
33413579|NCT03523728|62791976|FG002|Stage 1 (24 Months)|Adverse Event|4|||
33413580|NCT03523728|62791977|FG003|Stage 1 (24 Months)|Adverse Event|0|||
33413581|NCT03523728|62791978|FG004|Stage 1 (24 Months)|Adverse Event|0|||
33413582|NCT03523728|62791974|FG000|Stage 1 (24 Months)|Progressive disease|0|||
33413583|NCT03523728|62791975|FG001|Stage 1 (24 Months)|Progressive disease|0|||
33413584|NCT03523728|62791976|FG002|Stage 1 (24 Months)|Progressive disease|1|||
33413585|NCT03523728|62791977|FG003|Stage 1 (24 Months)|Progressive disease|0|||
33413586|NCT03523728|62791978|FG004|Stage 1 (24 Months)|Progressive disease|0|||
33604810|NCT02011113|63004359|FG000|Overall Study|Death|1|||
33604811|NCT02011113|63004359|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
33322385|NCT01147848|62698517|FG000|Randomized Phase|Adverse Event|0|||
33322386|NCT01147848|62698518|FG001|Randomized Phase|Adverse Event|6|||
33322387|NCT01147848|62698519|FG002|Randomized Phase|Adverse Event|8|||
33322388|NCT01147848|62698517|FG000|Randomized Phase|Lack of Efficacy|0|||
33322389|NCT01147848|62698518|FG001|Randomized Phase|Lack of Efficacy|20|||
33322390|NCT01147848|62698519|FG002|Randomized Phase|Lack of Efficacy|11|||
33322391|NCT01147848|62698517|FG000|Randomized Phase|Protocol Violation|0|||
33322392|NCT01147848|62698518|FG001|Randomized Phase|Protocol Violation|7|||
33322393|NCT01147848|62698519|FG002|Randomized Phase|Protocol Violation|10|||
33322394|NCT01147848|62698517|FG000|Randomized Phase|Lost to Follow-up|0|||
33322395|NCT01147848|62698518|FG001|Randomized Phase|Lost to Follow-up|5|||
33322396|NCT01147848|62698519|FG002|Randomized Phase|Lost to Follow-up|7|||
33322397|NCT01147848|62698517|FG000|Randomized Phase|Physician Decision|0|||
33322398|NCT01147848|62698518|FG001|Randomized Phase|Physician Decision|0|||
33322399|NCT01147848|62698519|FG002|Randomized Phase|Physician Decision|1|||
33322400|NCT01147848|62698517|FG000|Randomized Phase|Withdrawal by Subject|0|||
33322401|NCT01147848|62698518|FG001|Randomized Phase|Withdrawal by Subject|7|||
33322402|NCT01147848|62698519|FG002|Randomized Phase|Withdrawal by Subject|9|||
33322403|NCT00929656|62698528|FG000|Overall Study|Lost to Follow-up|0|||
33322404|NCT00929656|62698529|FG001|Overall Study|Lost to Follow-up|1|||
33322405|NCT00977613|62698535|FG000|Overall Study|Lost to Follow-up|16|||
33322406|NCT01152996|62698539|FG000|Overall Study|Withdrawal by Subject|142|||
33322407|NCT01152996|62698539|FG000|Overall Study|Adverse Event|115|||
33322408|NCT01152996|62698539|FG000|Overall Study|Lost to Follow-up|112|||
33322409|NCT01152996|62698539|FG000|Overall Study|Lack of Efficacy|68|||
33322410|NCT01152996|62698539|FG000|Overall Study|Noncompliance|41|||
33322411|NCT01152996|62698539|FG000|Overall Study|Other|36|||
33322412|NCT01152996|62698539|FG000|Overall Study|Protocol Violation|22|||
33322413|NCT01152996|62698539|FG000|Overall Study|Elevated liver enzymes|1|||
33322414|NCT00979953|62698547|FG000|Overall Study|Adverse Event|5|||
33322415|NCT00979953|62698548|FG001|Overall Study|Adverse Event|2|||
33413587|NCT03523728|62791974|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
33413588|NCT03523728|62791975|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
33322416|NCT00979953|62698549|FG002|Overall Study|Adverse Event|17|||
33322417|NCT00979953|62698550|FG003|Overall Study|Adverse Event|4|||
33322418|NCT00979953|62698547|FG000|Overall Study|Lack of Efficacy|1|||
33322419|NCT00979953|62698548|FG001|Overall Study|Lack of Efficacy|2|||
33322420|NCT00979953|62698549|FG002|Overall Study|Lack of Efficacy|0|||
33322421|NCT00979953|62698550|FG003|Overall Study|Lack of Efficacy|0|||
33322422|NCT00979953|62698547|FG000|Overall Study|Lost to Follow-up|1|||
33322423|NCT00979953|62698548|FG001|Overall Study|Lost to Follow-up|1|||
33322424|NCT00979953|62698549|FG002|Overall Study|Lost to Follow-up|1|||
33413589|NCT03523728|62791976|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
33413590|NCT03523728|62791977|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
33413591|NCT03523728|62791978|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
33413592|NCT03523728|62791974|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
33413593|NCT03523728|62791975|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
33413594|NCT03523728|62791976|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
33413595|NCT03523728|62791977|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
33413596|NCT03523728|62791978|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
33413597|NCT03523728|62791974|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
33413598|NCT03523728|62791975|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
33413599|NCT03523728|62791976|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
33413600|NCT03523728|62791977|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
33413601|NCT03523728|62791978|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
33413602|NCT03523728|62791974|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
33413603|NCT03523728|62791975|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
33413604|NCT03523728|62791976|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
33413605|NCT03523728|62791977|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
33413606|NCT03523728|62791978|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
33413607|NCT03523728|62791974|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
33413608|NCT03523728|62791975|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
33413609|NCT03523728|62791976|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
33413610|NCT03523728|62791977|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
33413611|NCT03523728|62791978|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
33413612|NCT03523728|62791974|FG000|Stage 2 (24 Months)|Adverse Event|0|||
33413613|NCT03523728|62791975|FG001|Stage 2 (24 Months)|Adverse Event|0|||
33413614|NCT03523728|62791976|FG002|Stage 2 (24 Months)|Adverse Event|0|||
33413615|NCT03523728|62791977|FG003|Stage 2 (24 Months)|Adverse Event|1|||
33413616|NCT03523728|62791978|FG004|Stage 2 (24 Months)|Adverse Event|2|||
33413617|NCT03523728|62791974|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
33413618|NCT03523728|62791975|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
33413619|NCT03523728|62791976|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
33413620|NCT03523728|62791977|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
33413621|NCT03523728|62791978|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
33413622|NCT03523728|62791974|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
33413623|NCT03523728|62791975|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
33413624|NCT03523728|62791976|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
33413625|NCT03523728|62791977|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
33413626|NCT03523728|62791978|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
33413627|NCT03523728|62791974|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
33413628|NCT03523728|62791975|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
33413629|NCT03523728|62791976|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
33413630|NCT03523728|62791977|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
33413631|NCT03523728|62791978|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
33413632|NCT03523728|62791974|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
33413633|NCT03523728|62791975|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
33413634|NCT03523728|62791976|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
33413635|NCT03523728|62791977|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
33413636|NCT03523728|62791978|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
33413637|NCT00538590|62791997|FG000|Overall Study|Death|1|||
33413638|NCT00538590|62791998|FG001|Overall Study|Death|0|||
33413639|NCT00466947|62792006|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
33413640|NCT00466947|62792007|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
33413641|NCT00466947|62792006|FG000|Study End Analysis Period|Adverse Event|35|||
33413642|NCT00466947|62792007|FG001|Study End Analysis Period|Adverse Event|43|||
33413643|NCT00466947|62792006|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
33413644|NCT00466947|62792007|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
33413645|NCT00466947|62792006|FG000|Study End Analysis Period|Physician Decision|29|||
33413646|NCT00466947|62792007|FG001|Study End Analysis Period|Physician Decision|29|||
33413647|NCT00466947|62792006|FG000|Study End Analysis Period|Protocol Violation|9|||
33413648|NCT00466947|62792007|FG001|Study End Analysis Period|Protocol Violation|17|||
33413649|NCT00466947|62792006|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
33413650|NCT00466947|62792007|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
33413651|NCT00466947|62792006|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
33413652|NCT00466947|62792007|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
33413653|NCT00466947|62792006|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
33413654|NCT00466947|62792007|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
33413655|NCT00466947|62792006|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
33413656|NCT00466947|62792007|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
33413657|NCT00537810|62792018|FG000|Overall Study|Withdrawal by Subject|4|||
33413658|NCT00537810|62792019|FG001|Overall Study|Withdrawal by Subject|11|||
33413659|NCT00537810|62792020|FG002|Overall Study|Withdrawal by Subject|4|||
33413660|NCT00537810|62792021|FG003|Overall Study|Withdrawal by Subject|3|||
33413661|NCT00537810|62792018|FG000|Overall Study|Medically withdrawn|2|||
33413662|NCT00537810|62792019|FG001|Overall Study|Medically withdrawn|2|||
33413663|NCT00537810|62792020|FG002|Overall Study|Medically withdrawn|0|||
33413664|NCT00537810|62792021|FG003|Overall Study|Medically withdrawn|1|||
33413665|NCT01287936|62792034|FG000|Overall Study|Lost to Follow-up|0|||
33413666|NCT01287936|62792035|FG001|Overall Study|Lost to Follow-up|1|||
33413667|NCT01287936|62792036|FG002|Overall Study|Lost to Follow-up|1|||
33413668|NCT00090259|62792046|FG000|Overall Study|Lost to Follow-up|30|||
33413669|NCT00090259|62792047|FG001|Overall Study|Lost to Follow-up|26|||
33413670|NCT00090259|62792046|FG000|Overall Study|Withdrawal by Subject|21|||
33413671|NCT00090259|62792047|FG001|Overall Study|Withdrawal by Subject|15|||
33413672|NCT00090259|62792046|FG000|Overall Study|Investigator site closed|11|||
33413673|NCT00090259|62792047|FG001|Overall Study|Investigator site closed|7|||
33413674|NCT00079183|62792053|FG000|Overall Study|Withdrawal by Subject|4|||
33413675|NCT00079183|62792053|FG000|Overall Study|Study medication non-compliance|2|||
33413676|NCT00079183|62792053|FG000|Overall Study|Specimen collection non-compliance|1|||
33413677|NCT00676403|62792064|FG000|Overall Study|Adverse Event|1|||
33413678|NCT00676403|62792065|FG001|Overall Study|Adverse Event|2|||
33413679|NCT00676403|62792066|FG002|Overall Study|Adverse Event|0|||
33413680|NCT00676403|62792067|FG003|Overall Study|Adverse Event|5|||
33413681|NCT00676403|62792068|FG004|Overall Study|Adverse Event|1|||
33413682|NCT00676403|62792069|FG005|Overall Study|Adverse Event|2|||
33413683|NCT00676403|62792064|FG000|Overall Study|Lost to Follow-up|0|||
33413684|NCT00676403|62792065|FG001|Overall Study|Lost to Follow-up|0|||
33413685|NCT00676403|62792066|FG002|Overall Study|Lost to Follow-up|0|||
33413686|NCT00676403|62792067|FG003|Overall Study|Lost to Follow-up|0|||
33413687|NCT00676403|62792068|FG004|Overall Study|Lost to Follow-up|0|||
33413688|NCT00676403|62792069|FG005|Overall Study|Lost to Follow-up|1|||
33413689|NCT00676403|62792064|FG000|Overall Study|Reason Unspecified|1|||
33413690|NCT00676403|62792065|FG001|Overall Study|Reason Unspecified|0|||
33413691|NCT00676403|62792066|FG002|Overall Study|Reason Unspecified|1|||
33413692|NCT00676403|62792067|FG003|Overall Study|Reason Unspecified|0|||
33322425|NCT00979953|62698550|FG003|Overall Study|Lost to Follow-up|0|||
33322426|NCT00979953|62698547|FG000|Overall Study|Withdrawal by Subject|0|||
33322427|NCT00979953|62698548|FG001|Overall Study|Withdrawal by Subject|0|||
33322428|NCT00979953|62698549|FG002|Overall Study|Withdrawal by Subject|2|||
33322429|NCT00979953|62698550|FG003|Overall Study|Withdrawal by Subject|1|||
33322430|NCT00979953|62698547|FG000|Overall Study|Protocol Violation|1|||
33322431|NCT00979953|62698548|FG001|Overall Study|Protocol Violation|0|||
33322432|NCT00979953|62698549|FG002|Overall Study|Protocol Violation|2|||
33322433|NCT00979953|62698550|FG003|Overall Study|Protocol Violation|2|||
33322434|NCT01181531|62698562|FG000|Overall Study|Other|17|||
33322435|NCT01181531|62698563|FG001|Overall Study|Other|12|||
33322436|NCT01181531|62698562|FG000|Overall Study|Partial consent by subject withdrawn|0|||
33322437|NCT01181531|62698563|FG001|Overall Study|Partial consent by subject withdrawn|1|||
33322438|NCT01181531|62698562|FG000|Overall Study|Physician Decision|3|||
33322439|NCT01181531|62698563|FG001|Overall Study|Physician Decision|1|||
33322440|NCT01181531|62698562|FG000|Overall Study|Noncompliance|2|||
33322441|NCT01181531|62698563|FG001|Overall Study|Noncompliance|2|||
33322442|NCT01181531|62698562|FG000|Overall Study|Ineligibility determined|1|||
33413693|NCT00676403|62792068|FG004|Overall Study|Reason Unspecified|0|||
33413694|NCT00676403|62792069|FG005|Overall Study|Reason Unspecified|1|||
33413695|NCT00676403|62792064|FG000|Overall Study|Withdrawal by Subject|0|||
33413696|NCT00676403|62792065|FG001|Overall Study|Withdrawal by Subject|0|||
33413697|NCT00676403|62792066|FG002|Overall Study|Withdrawal by Subject|0|||
33413698|NCT00676403|62792067|FG003|Overall Study|Withdrawal by Subject|0|||
33413699|NCT00676403|62792068|FG004|Overall Study|Withdrawal by Subject|0|||
33322443|NCT01181531|62698563|FG001|Overall Study|Ineligibility determined|2|||
33322444|NCT01181531|62698562|FG000|Overall Study|Protocol Specified Criteria|15|||
33413700|NCT00676403|62792069|FG005|Overall Study|Withdrawal by Subject|1|||
33413701|NCT00078325|62792092|FG000|Overall Study|Adverse Event|15|||
33413702|NCT00078325|62792093|FG001|Overall Study|Adverse Event|10|||
33413703|NCT00078325|62792094|FG002|Overall Study|Adverse Event|5|||
33413704|NCT00078325|62792092|FG000|Overall Study|Protocol Violation|2|||
33413705|NCT00078325|62792093|FG001|Overall Study|Protocol Violation|2|||
33413706|NCT00078325|62792094|FG002|Overall Study|Protocol Violation|0|||
33413707|NCT00078325|62792092|FG000|Overall Study|Withdrawal by Subject|1|||
33413708|NCT00078325|62792093|FG001|Overall Study|Withdrawal by Subject|5|||
33413709|NCT00078325|62792094|FG002|Overall Study|Withdrawal by Subject|3|||
33413710|NCT00078325|62792092|FG000|Overall Study|Lost to Follow-up|0|||
33413711|NCT00078325|62792093|FG001|Overall Study|Lost to Follow-up|1|||
33413712|NCT00078325|62792094|FG002|Overall Study|Lost to Follow-up|1|||
33413713|NCT00078325|62792092|FG000|Overall Study|Physician Decision|2|||
33413714|NCT00078325|62792093|FG001|Overall Study|Physician Decision|0|||
33413715|NCT00078325|62792094|FG002|Overall Study|Physician Decision|1|||
33413716|NCT00078325|62792092|FG000|Overall Study|Miscellaneous|1|||
33413717|NCT00078325|62792093|FG001|Overall Study|Miscellaneous|1|||
33413718|NCT00078325|62792094|FG002|Overall Study|Miscellaneous|1|||
33413719|NCT00077857|62792104|FG000|Overall Study|Adverse Event|30|||
33413720|NCT00077857|62792105|FG001|Overall Study|Adverse Event|32|||
33413721|NCT00077857|62792104|FG000|Overall Study|Death|7|||
33413722|NCT00077857|62792105|FG001|Overall Study|Death|3|||
33413723|NCT00077857|62792104|FG000|Overall Study|Insufficient therapeutic response|112|||
33413724|NCT00077857|62792105|FG001|Overall Study|Insufficient therapeutic response|128|||
33413725|NCT00077857|62792104|FG000|Overall Study|Violation of selection criteria at entry|3|||
33413726|NCT00077857|62792105|FG001|Overall Study|Violation of selection criteria at entry|1|||
33413727|NCT00077857|62792104|FG000|Overall Study|Other protocol violation|0|||
33322445|NCT01181531|62698563|FG001|Overall Study|Protocol Specified Criteria|8|||
33322446|NCT01181531|62698562|FG000|Overall Study|Pregnancy|0|||
33322447|NCT01181531|62698563|FG001|Overall Study|Pregnancy|1|||
33322448|NCT01181531|62698562|FG000|Overall Study|Withdrawal by Subject|8|||
33322449|NCT01181531|62698563|FG001|Overall Study|Withdrawal by Subject|7|||
33322450|NCT01181531|62698562|FG000|Overall Study|Protocol Violation|6|||
33322451|NCT01181531|62698563|FG001|Overall Study|Protocol Violation|6|||
33322452|NCT01181531|62698562|FG000|Overall Study|Death|9|||
33322453|NCT01181531|62698563|FG001|Overall Study|Death|12|||
33322454|NCT01181531|62698562|FG000|Overall Study|Adverse Event|0|||
33322455|NCT01181531|62698563|FG001|Overall Study|Adverse Event|1|||
33322456|NCT01152450|62698569|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
33322457|NCT01152450|62698570|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
33322458|NCT01152450|62698571|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
33322459|NCT01152450|62698572|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
33322460|NCT01152450|62698573|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
33322461|NCT01152450|62698574|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
33322462|NCT01152450|62698569|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
33322463|NCT01152450|62698570|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
33413728|NCT00077857|62792105|FG001|Overall Study|Other protocol violation|1|||
33413729|NCT00077857|62792104|FG000|Overall Study|Refused treatment|29|||
33413730|NCT00077857|62792105|FG001|Overall Study|Refused treatment|21|||
33413731|NCT00077857|62792104|FG000|Overall Study|Failure to return|5|||
33413732|NCT00077857|62792105|FG001|Overall Study|Failure to return|5|||
33413733|NCT00077857|62792104|FG000|Overall Study|Other|15|||
33413734|NCT00077857|62792105|FG001|Overall Study|Other|13|||
33413735|NCT00545402|62792113|FG000|Overall Study|Discontinuation of treatment|17|||
33413736|NCT00545402|62792114|FG001|Overall Study|Discontinuation of treatment|9|||
33413737|NCT00545402|62792113|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
33413738|NCT00545402|62792114|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
33413739|NCT00545402|62792113|FG000|Overall Study|Death|5|||
33413740|NCT00545402|62792114|FG001|Overall Study|Death|7|||
33413741|NCT00545402|62792113|FG000|Overall Study|Graft loss|2|||
33413742|NCT00545402|62792114|FG001|Overall Study|Graft loss|4|||
33413743|NCT00545402|62792113|FG000|Overall Study|Withdrawal by Subject|0|||
33413744|NCT00545402|62792114|FG001|Overall Study|Withdrawal by Subject|1|||
33413745|NCT00545402|62792113|FG000|Overall Study|Protocol Violation|1|||
33413746|NCT00545402|62792114|FG001|Overall Study|Protocol Violation|0|||
33413747|NCT00545402|62792113|FG000|Overall Study|Reason not specified|1|||
33413748|NCT00545402|62792114|FG001|Overall Study|Reason not specified|1|||
33413749|NCT00545792|62792120|FG000|Overall Study|Withdrawal by Subject|1|||
33413750|NCT00545168|62792127|FG000|Overall Study|Lost to Follow-up|5|||
33413751|NCT00545168|62792128|FG001|Overall Study|Lost to Follow-up|5|||
33413752|NCT00545168|62792129|FG002|Overall Study|Lost to Follow-up|5|||
33413753|NCT00545168|62792127|FG000|Overall Study|Withdrawal by Subject|9|||
33413754|NCT00545168|62792128|FG001|Overall Study|Withdrawal by Subject|0|||
33413755|NCT00545168|62792129|FG002|Overall Study|Withdrawal by Subject|13|||
33413756|NCT00545168|62792127|FG000|Overall Study|Protocol Violation|1|||
33413757|NCT00545168|62792128|FG001|Overall Study|Protocol Violation|0|||
33413758|NCT00545168|62792129|FG002|Overall Study|Protocol Violation|1|||
33413759|NCT00545168|62792127|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
33413760|NCT00545168|62792128|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
33413761|NCT00545168|62792129|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
33413762|NCT00544544|62792138|FG000|Overall Study|Withdrawal by Subject|1|||
33413763|NCT00544544|62792138|FG000|Overall Study|Adverse Event|1|||
33413764|NCT00544544|62792138|FG000|Overall Study|Lost to Follow-up|1|||
33413765|NCT00541346|62792142|FG000|Follow-up|Adverse Event|1|||
33413766|NCT00077623|62792149|FG000|Overall Study|Adverse Event|1|||
33413767|NCT00077623|62792150|FG001|Overall Study|Adverse Event|0|||
33413768|NCT00077623|62792151|FG002|Overall Study|Adverse Event|1|||
33413769|NCT00077623|62792149|FG000|Overall Study|Withdrawal by Subject|2|||
33413770|NCT00077623|62792150|FG001|Overall Study|Withdrawal by Subject|10|||
33413771|NCT00077623|62792151|FG002|Overall Study|Withdrawal by Subject|1|||
33413772|NCT00077623|62792149|FG000|Overall Study|Other-Non safety reason|18|||
33322464|NCT01152450|62698571|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
33322465|NCT01152450|62698572|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
33322466|NCT01152450|62698573|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
33322467|NCT01152450|62698574|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
33322468|NCT01152450|62698569|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33322469|NCT01152450|62698570|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
33322470|NCT01152450|62698571|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
33413773|NCT00077623|62792150|FG001|Overall Study|Other-Non safety reason|15|||
33413774|NCT00077623|62792151|FG002|Overall Study|Other-Non safety reason|19|||
33413775|NCT00077623|62792149|FG000|Overall Study|Insufficient therapeutic response|2|||
33413776|NCT00077623|62792150|FG001|Overall Study|Insufficient therapeutic response|0|||
33413777|NCT00077623|62792151|FG002|Overall Study|Insufficient therapeutic response|0|||
33413778|NCT00077623|62792149|FG000|Overall Study|Death|12|||
33413779|NCT00077623|62792150|FG001|Overall Study|Death|18|||
33413780|NCT00077623|62792151|FG002|Overall Study|Death|11|||
33413781|NCT00077623|62792149|FG000|Overall Study|Failure to return|1|||
33413782|NCT00077623|62792150|FG001|Overall Study|Failure to return|0|||
33413783|NCT00077623|62792151|FG002|Overall Study|Failure to return|0|||
33413784|NCT00541034|62792159|FG000|Overall Study|Non-Compliance|3|||
33413785|NCT00540644|62792165|FG000|Overall Study|Adverse Event|3|||
33413786|NCT00540644|62792166|FG001|Overall Study|Adverse Event|1|||
33413787|NCT00540644|62792165|FG000|Overall Study|Disease Progression|3|||
33413788|NCT00540644|62792166|FG001|Overall Study|Disease Progression|1|||
33413789|NCT00540644|62792165|FG000|Overall Study|Physician Decision|0|||
33413790|NCT00540644|62792166|FG001|Overall Study|Physician Decision|5|||
33413791|NCT00540644|62792165|FG000|Overall Study|Withdrawal by Subject|2|||
33413792|NCT00540644|62792166|FG001|Overall Study|Withdrawal by Subject|2|||
33413793|NCT00540644|62792165|FG000|Overall Study|Noncomplilance|1|||
33413794|NCT00540644|62792166|FG001|Overall Study|Noncomplilance|0|||
33413795|NCT00543296|62792172|FG000|Overall Study|Physician Decision|7|||
33413796|NCT00543140|62792176|FG000|Overall Study|Lost to Follow-up|33|||
33413797|NCT00543140|62792176|FG000|Overall Study|Withdrawal by Subject|13|||
33413798|NCT00543140|62792176|FG000|Overall Study|Protocol Violation|10|||
33413799|NCT00543140|62792176|FG000|Overall Study|Insufficient weight loss|10|||
33413800|NCT00543140|62792176|FG000|Overall Study|SAE leading to explant of SAGB|3|||
33413801|NCT00543140|62792176|FG000|Overall Study|Death|1|||
33413802|NCT00543140|62792176|FG000|Overall Study|Subject moved|1|||
33413803|NCT00543140|62792176|FG000|Overall Study|Conversion to different procedure|1|||
33322471|NCT01152450|62698572|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33322472|NCT01152450|62698573|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33322473|NCT01152450|62698574|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33322474|NCT01181141|62698584|FG000|Overall Study|Adverse Event|2|||
33322475|NCT01181141|62698585|FG001|Overall Study|Adverse Event|1|||
33322476|NCT01181141|62698584|FG000|Overall Study|Lack of Efficacy|1|||
33322477|NCT01181141|62698585|FG001|Overall Study|Lack of Efficacy|0|||
33322478|NCT01181141|62698584|FG000|Overall Study|Lost to Follow-up|1|||
33322479|NCT01181141|62698585|FG001|Overall Study|Lost to Follow-up|1|||
33322480|NCT01181141|62698584|FG000|Overall Study|Physician Decision|2|||
33322481|NCT01181141|62698585|FG001|Overall Study|Physician Decision|0|||
33322482|NCT01181141|62698584|FG000|Overall Study|Protocol Violation|3|||
33322483|NCT01181141|62698585|FG001|Overall Study|Protocol Violation|1|||
33322484|NCT01181141|62698584|FG000|Overall Study|Withdrawal by Subject|3|||
33322485|NCT01181141|62698585|FG001|Overall Study|Withdrawal by Subject|1|||
33322486|NCT01173120|62698591|FG000|Overall Study|Lack of Efficacy|2|||
33322487|NCT01173120|62698591|FG000|Overall Study|Lost to Follow-up|1|||
33322488|NCT01173120|62698591|FG000|Overall Study|Participant Decision|2|||
33322489|NCT01173120|62698591|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
33322490|NCT01173120|62698591|FG000|Overall Study|Switch-Participant Decision|12|||
33322491|NCT01173120|62698591|FG000|Overall Study|Switch-Difficulty With Device|12|||
33322492|NCT00977379|62698599|FG000|Overall Study|Withdrawal by Subject|1|||
33322493|NCT00977379|62698600|FG001|Overall Study|Withdrawal by Subject|1|||
33322494|NCT00977379|62698599|FG000|Overall Study|Death|7|||
33322495|NCT00977379|62698600|FG001|Overall Study|Death|9|||
33322496|NCT00977379|62698599|FG000|Overall Study|Premature Study Termination|4|||
33322497|NCT00977379|62698600|FG001|Overall Study|Premature Study Termination|0|||
33322498|NCT00977379|62698599|FG000|Overall Study|Participant Moving House|0|||
33322499|NCT00977379|62698600|FG001|Overall Study|Participant Moving House|1|||
33322500|NCT00977379|62698599|FG000|Overall Study|Randomization Error|0|||
33322501|NCT00977379|62698600|FG001|Overall Study|Randomization Error|1|||
33322502|NCT01180985|62698606|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
33322503|NCT01180985|62698607|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
33322504|NCT01147536|62698614|FG000|Overall Study|Administrative study close|2|||
33322505|NCT01147536|62698614|FG000|Overall Study|Death|1|||
33322506|NCT01154088|62698621|FG000|Overall Study|Lost to Follow-up|4|||
33322507|NCT01154088|62698622|FG001|Overall Study|Lost to Follow-up|6|||
33322508|NCT01154088|62698623|FG002|Overall Study|Lost to Follow-up|7|||
33322509|NCT01180049|62698634|FG000|Overall Study|Other|9|||
33604812|NCT02011113|63004359|FG000|Overall Study|Investigator's judgement- DP|3|||
33604813|NCT02011113|63004359|FG000|Overall Study|Study terminated by sponsor|11|||
33604814|NCT01807156|63004364|FG000|Overall Study|Physician Decision|1|||
33604815|NCT01987479|63004368|FG000|Overall Study|Protocol Violation|1|||
33604816|NCT01987479|63004368|FG000|Overall Study|Physician Decision|2|||
33604817|NCT01987479|63004368|FG000|Overall Study|Participant/legal guardian decision|1|||
33604818|NCT01987479|63004368|FG000|Overall Study|Other|5|||
33604819|NCT01987479|63004368|FG000|Overall Study|Lost to Follow-up|1|||
33604820|NCT01987479|63004368|FG000|Overall Study|Adverse Event|7|||
33604821|NCT01620489|63004374|FG000|Overall Study|Adverse Event|17|||
33604822|NCT01620489|63004375|FG001|Overall Study|Adverse Event|4|||
33322510|NCT01180049|62698635|FG001|Overall Study|Other|7|||
33322511|NCT01180049|62698634|FG000|Overall Study|Lost to Follow-up|8|||
33322512|NCT01180049|62698635|FG001|Overall Study|Lost to Follow-up|6|||
33604823|NCT01620489|63004374|FG000|Overall Study|Protocol Violation|0|||
33604824|NCT01620489|63004375|FG001|Overall Study|Protocol Violation|3|||
33322513|NCT01180049|62698634|FG000|Overall Study|Death|36|||
33322514|NCT01180049|62698635|FG001|Overall Study|Death|35|||
33322515|NCT01147458|62698641|FG000|First Intervention|Study terminated by sponsor|8|||
33322516|NCT01147458|62698642|FG001|First Intervention|Study terminated by sponsor|8|||
33322517|NCT01147458|62698643|FG002|First Intervention|Study terminated by sponsor|7|||
33604825|NCT01620489|63004374|FG000|Overall Study|Withdrawal Criteria|17|||
33604826|NCT01620489|63004375|FG001|Overall Study|Withdrawal Criteria|25|||
33604827|NCT01620489|63004374|FG000|Overall Study|Unclassified|1|||
33604828|NCT01620489|63004375|FG001|Overall Study|Unclassified|2|||
33413804|NCT00543062|62792180|FG000|Overall Study|Withdrawal by Subject|1|||
33413805|NCT00543062|62792181|FG001|Overall Study|Withdrawal by Subject|0|||
33413806|NCT00543062|62792182|FG002|Overall Study|Withdrawal by Subject|2|||
33413807|NCT00543062|62792183|FG003|Overall Study|Withdrawal by Subject|0|||
33413808|NCT00543062|62792180|FG000|Overall Study|Adverse Event|0|||
33413809|NCT00543062|62792181|FG001|Overall Study|Adverse Event|1|||
33413810|NCT00543062|62792182|FG002|Overall Study|Adverse Event|1|||
33413811|NCT00543062|62792183|FG003|Overall Study|Adverse Event|1|||
33413812|NCT00543062|62792180|FG000|Overall Study|Protocol Violation|1|||
33413813|NCT00543062|62792181|FG001|Overall Study|Protocol Violation|0|||
33413814|NCT00543062|62792182|FG002|Overall Study|Protocol Violation|0|||
33413815|NCT00543062|62792183|FG003|Overall Study|Protocol Violation|0|||
33413816|NCT03911960|62792203|FG000|Overall Study|Lost to Follow-up|5|||
33413817|NCT03911960|62792204|FG001|Overall Study|Lost to Follow-up|3|||
33413818|NCT00676091|62792213|FG000|Infant Series|Parent or legal guardian request|10|||
33413819|NCT00676091|62792214|FG001|Infant Series|Parent or legal guardian request|8|||
33413820|NCT00676091|62792213|FG000|Infant Series|Protocol Violation|6|||
33413821|NCT00676091|62792214|FG001|Infant Series|Protocol Violation|3|||
33413822|NCT00676091|62792213|FG000|Infant Series|Adverse Event|2|||
33413823|NCT00676091|62792214|FG001|Infant Series|Adverse Event|3|||
33413824|NCT00676091|62792213|FG000|Infant Series|Failed to return|1|||
33413825|NCT00676091|62792214|FG001|Infant Series|Failed to return|3|||
33413826|NCT00676091|62792213|FG000|Infant Series|Lost to Follow-up|1|||
33413827|NCT00676091|62792214|FG001|Infant Series|Lost to Follow-up|0|||
33413828|NCT00676091|62792213|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
33413829|NCT00676091|62792214|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
33413830|NCT00676091|62792213|FG000|After Infant Series|Adverse Event|0|||
33413831|NCT00676091|62792214|FG001|After Infant Series|Adverse Event|1|||
33413832|NCT00676091|62792213|FG000|After Infant Series|Protocol Violation|0|||
33494076|NCT03739138|62872778|FG003|Overall Study|Death|13|||
33413833|NCT00676091|62792214|FG001|After Infant Series|Protocol Violation|1|||
33413834|NCT00676091|62792213|FG000|After Infant Series|Failed to return|1|||
33413835|NCT00676091|62792214|FG001|After Infant Series|Failed to return|1|||
33413836|NCT00676091|62792213|FG000|Toddler Dose|Failed to return|2|||
33413837|NCT00676091|62792214|FG001|Toddler Dose|Failed to return|0|||
33413838|NCT00676091|62792213|FG000|Toddler Dose|Parent or legal guardian request|1|||
33413839|NCT00676091|62792214|FG001|Toddler Dose|Parent or legal guardian request|0|||
33413840|NCT00678041|62792226|FG000|Overall Study|Physician Decision|5|||
33413841|NCT00678041|62792227|FG001|Overall Study|Physician Decision|5|||
33413842|NCT03903822|62792242|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
33413843|NCT03903822|62792243|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
33413844|NCT03903822|62792244|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
33413845|NCT03903822|62792245|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
33413846|NCT03903822|62792246|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
33413847|NCT03903822|62792247|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
33413848|NCT03903822|62792248|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
33413849|NCT03903822|62792249|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
33413850|NCT03903822|62792242|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
33413851|NCT03903822|62792243|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
33413852|NCT03903822|62792244|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
33413853|NCT03903822|62792245|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
33413854|NCT03903822|62792246|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
33413855|NCT03903822|62792247|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
33413856|NCT03903822|62792248|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
33413857|NCT03903822|62792249|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
33413858|NCT03903822|62792242|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
33413859|NCT03903822|62792243|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
33413860|NCT03903822|62792244|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
33413861|NCT03903822|62792245|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
33413862|NCT03903822|62792246|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
33413863|NCT03903822|62792247|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
33413864|NCT03903822|62792248|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
33604829|NCT02076165|63004383|FG000|Overall Study|Lost to Follow-up|7|||
33322518|NCT01147458|62698644|FG003|First Intervention|Study terminated by sponsor|8|||
33322519|NCT01147458|62698641|FG000|First Intervention|Protocol Violation|2|||
33322520|NCT01147458|62698642|FG001|First Intervention|Protocol Violation|3|||
33322521|NCT01147458|62698643|FG002|First Intervention|Protocol Violation|2|||
33322522|NCT01147458|62698644|FG003|First Intervention|Protocol Violation|3|||
33322523|NCT01147458|62698641|FG000|First Intervention|Withdrawal by Subject|3|||
33322524|NCT01147458|62698642|FG001|First Intervention|Withdrawal by Subject|0|||
33322525|NCT01147458|62698643|FG002|First Intervention|Withdrawal by Subject|1|||
33322526|NCT01147458|62698644|FG003|First Intervention|Withdrawal by Subject|0|||
33322527|NCT01147458|62698641|FG000|First Intervention|Adverse Event|0|||
33322528|NCT01147458|62698642|FG001|First Intervention|Adverse Event|3|||
33322529|NCT01147458|62698643|FG002|First Intervention|Adverse Event|2|||
33322530|NCT01147458|62698644|FG003|First Intervention|Adverse Event|3|||
33322531|NCT01147458|62698641|FG000|First Intervention|Other|1|||
33322532|NCT01147458|62698642|FG001|First Intervention|Other|2|||
33322533|NCT01147458|62698643|FG002|First Intervention|Other|0|||
33322534|NCT01147458|62698644|FG003|First Intervention|Other|0|||
33322535|NCT01147458|62698641|FG000|Second Intervention|Study terminated by sponsor|7|||
33322536|NCT01147458|62698642|FG001|Second Intervention|Study terminated by sponsor|5|||
33322537|NCT01147458|62698643|FG002|Second Intervention|Study terminated by sponsor|5|||
33322538|NCT01147458|62698644|FG003|Second Intervention|Study terminated by sponsor|3|||
33322539|NCT01147458|62698641|FG000|Second Intervention|Protocol Violation|0|||
33322540|NCT01147458|62698642|FG001|Second Intervention|Protocol Violation|1|||
33413865|NCT03903822|62792249|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
33604830|NCT02076165|63004384|FG001|Overall Study|Lost to Follow-up|5|||
33322541|NCT01147458|62698643|FG002|Second Intervention|Protocol Violation|1|||
33322542|NCT01147458|62698644|FG003|Second Intervention|Protocol Violation|0|||
33322543|NCT01147458|62698641|FG000|Second Intervention|Withdrawal by Subject|0|||
33604831|NCT02076165|63004383|FG000|Overall Study|Refused follow-up assessment|1|||
33604832|NCT02076165|63004384|FG001|Overall Study|Refused follow-up assessment|1|||
33604833|NCT01620255|63004395|FG000|Overall Study|Withdrawal by Subject|4|||
33604834|NCT01620255|63004396|FG001|Overall Study|Withdrawal by Subject|1|||
33604835|NCT01620255|63004397|FG002|Overall Study|Withdrawal by Subject|1|||
33604836|NCT01620255|63004398|FG003|Overall Study|Withdrawal by Subject|2|||
33494077|NCT03739138|62872779|FG004|Overall Study|Death|0|||
33604837|NCT01620255|63004399|FG004|Overall Study|Withdrawal by Subject|4|||
33604838|NCT01620255|63004395|FG000|Overall Study|Participant underwent fecal transplant|0|||
33322544|NCT01147458|62698642|FG001|Second Intervention|Withdrawal by Subject|1|||
33413866|NCT03903822|62792242|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
33413867|NCT03903822|62792243|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
33413868|NCT03903822|62792244|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
33413869|NCT03903822|62792245|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
33413870|NCT03903822|62792246|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
33413871|NCT03903822|62792247|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
33494078|NCT03739138|62872775|FG000|Overall Study|Lost to Follow-up|0|||
33604839|NCT01620255|63004396|FG001|Overall Study|Participant underwent fecal transplant|0|||
33604840|NCT01620255|63004397|FG002|Overall Study|Participant underwent fecal transplant|1|||
33604841|NCT01620255|63004398|FG003|Overall Study|Participant underwent fecal transplant|0|||
33604842|NCT01620255|63004399|FG004|Overall Study|Participant underwent fecal transplant|0|||
33604843|NCT01620255|63004395|FG000|Overall Study|Non-compliance|0|||
33604844|NCT01620255|63004396|FG001|Overall Study|Non-compliance|1|||
33604845|NCT01620255|63004397|FG002|Overall Study|Non-compliance|0|||
33604846|NCT01620255|63004398|FG003|Overall Study|Non-compliance|0|||
33604847|NCT01620255|63004399|FG004|Overall Study|Non-compliance|0|||
33604848|NCT01620255|63004395|FG000|Overall Study|Adverse Event|0|||
33604849|NCT01620255|63004396|FG001|Overall Study|Adverse Event|4|||
33604850|NCT01620255|63004397|FG002|Overall Study|Adverse Event|0|||
33604851|NCT01620255|63004398|FG003|Overall Study|Adverse Event|1|||
33604852|NCT01620255|63004399|FG004|Overall Study|Adverse Event|1|||
33413872|NCT03903822|62792248|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
33413873|NCT03903822|62792249|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
33413874|NCT03903822|62792242|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
33413875|NCT03903822|62792243|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
33413876|NCT03903822|62792244|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
33413877|NCT03903822|62792245|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
33413878|NCT03903822|62792246|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
33413879|NCT03903822|62792247|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
33413880|NCT03903822|62792248|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
33413881|NCT03903822|62792249|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
33413882|NCT03903822|62792242|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
33413883|NCT03903822|62792243|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
33413884|NCT03903822|62792244|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
33413885|NCT03903822|62792245|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
33413886|NCT03903822|62792246|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
33413887|NCT03903822|62792247|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
33413888|NCT03903822|62792248|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
33413889|NCT03903822|62792249|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
33604853|NCT01620255|63004395|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
33413890|NCT03903822|62792242|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
33413891|NCT03903822|62792243|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
33413892|NCT03903822|62792244|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
33413893|NCT03903822|62792245|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
33413894|NCT03903822|62792246|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
33413895|NCT03903822|62792247|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
33494079|NCT03739138|62872776|FG001|Overall Study|Lost to Follow-up|0|||
33413896|NCT03903822|62792248|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
33413897|NCT03903822|62792249|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
33604854|NCT01620255|63004396|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
33604855|NCT01620255|63004397|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
33604856|NCT01620255|63004398|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
33322545|NCT01147458|62698643|FG002|Second Intervention|Withdrawal by Subject|0|||
33322546|NCT01147458|62698644|FG003|Second Intervention|Withdrawal by Subject|0|||
33322547|NCT01147458|62698641|FG000|Second Intervention|Adverse Event|2|||
33322548|NCT01147458|62698642|FG001|Second Intervention|Adverse Event|0|||
33494080|NCT03739138|62872777|FG002|Overall Study|Lost to Follow-up|1|||
33322549|NCT01147458|62698643|FG002|Second Intervention|Adverse Event|1|||
33322550|NCT01147458|62698644|FG003|Second Intervention|Adverse Event|1|||
33413898|NCT03903822|62792242|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
33413899|NCT03903822|62792243|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
33413900|NCT03903822|62792244|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
33413901|NCT03903822|62792245|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
33413902|NCT03903822|62792246|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
33413903|NCT03903822|62792247|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
33413904|NCT03903822|62792248|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
33413905|NCT03903822|62792249|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
33413906|NCT03903822|62792242|FG000|Treatment Phase (6 Weeks)|Other|2|||
33413907|NCT03903822|62792243|FG001|Treatment Phase (6 Weeks)|Other|1|||
33413908|NCT03903822|62792244|FG002|Treatment Phase (6 Weeks)|Other|0|||
33413909|NCT03903822|62792245|FG003|Treatment Phase (6 Weeks)|Other|0|||
33413910|NCT03903822|62792246|FG004|Treatment Phase (6 Weeks)|Other|1|||
33413911|NCT03903822|62792247|FG005|Treatment Phase (6 Weeks)|Other|1|||
33413912|NCT03903822|62792248|FG006|Treatment Phase (6 Weeks)|Other|0|||
33413913|NCT03903822|62792249|FG007|Treatment Phase (6 Weeks)|Other|0|||
33413914|NCT03903822|62792242|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
33413915|NCT03903822|62792243|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
33413916|NCT03903822|62792244|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
33413917|NCT03903822|62792245|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
33413918|NCT03903822|62792246|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
33413919|NCT03903822|62792247|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
33413920|NCT03903822|62792248|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
33413921|NCT03903822|62792249|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
33413922|NCT03903822|62792242|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
33413923|NCT03903822|62792243|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
33413924|NCT03903822|62792244|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
33413925|NCT03903822|62792245|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
33413926|NCT03903822|62792246|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
33413927|NCT03903822|62792247|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
33413928|NCT03903822|62792248|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
33413929|NCT03903822|62792249|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
33413930|NCT03903822|62792242|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
33413931|NCT03903822|62792243|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
33413932|NCT03903822|62792244|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
33413933|NCT03903822|62792245|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
33413934|NCT03903822|62792246|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
33413935|NCT03903822|62792247|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
33413936|NCT03903822|62792248|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
33413937|NCT03903822|62792249|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
33413938|NCT03903822|62792242|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
33413939|NCT03903822|62792243|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
33413940|NCT03903822|62792244|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
33413941|NCT03903822|62792245|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
33413942|NCT03903822|62792246|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
33413943|NCT03903822|62792247|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
33413944|NCT03903822|62792248|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
33413945|NCT03903822|62792249|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
33413946|NCT03903822|62792242|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
33413947|NCT03903822|62792243|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
33413948|NCT03903822|62792244|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
33413949|NCT03903822|62792245|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
33322551|NCT01147458|62698641|FG000|Second Intervention|Other|0|||
33322552|NCT01147458|62698642|FG001|Second Intervention|Other|0|||
33322553|NCT01147458|62698643|FG002|Second Intervention|Other|1|||
33322554|NCT01147458|62698644|FG003|Second Intervention|Other|0|||
33322555|NCT01172808|62698660|FG000|Overall Study|Adverse Event|8|||
33322556|NCT01172808|62698661|FG001|Overall Study|Adverse Event|4|||
33322557|NCT01172808|62698662|FG002|Overall Study|Adverse Event|8|||
33322558|NCT01172808|62698663|FG003|Overall Study|Adverse Event|3|||
33322559|NCT01172808|62698660|FG000|Overall Study|Lack of Efficacy|1|||
33322560|NCT01172808|62698661|FG001|Overall Study|Lack of Efficacy|0|||
33322561|NCT01172808|62698662|FG002|Overall Study|Lack of Efficacy|0|||
33322562|NCT01172808|62698663|FG003|Overall Study|Lack of Efficacy|0|||
33322563|NCT01172808|62698660|FG000|Overall Study|Protocol Violation|2|||
33322564|NCT01172808|62698661|FG001|Overall Study|Protocol Violation|2|||
33322565|NCT01172808|62698662|FG002|Overall Study|Protocol Violation|2|||
33322566|NCT01172808|62698663|FG003|Overall Study|Protocol Violation|0|||
33322567|NCT01172808|62698660|FG000|Overall Study|Lost to Follow-up|0|||
33322568|NCT01172808|62698661|FG001|Overall Study|Lost to Follow-up|1|||
33322569|NCT01172808|62698662|FG002|Overall Study|Lost to Follow-up|1|||
33322570|NCT01172808|62698663|FG003|Overall Study|Lost to Follow-up|3|||
33322571|NCT01172808|62698660|FG000|Overall Study|Withdrawal by Subject|4|||
33413950|NCT03903822|62792246|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
33322572|NCT01172808|62698661|FG001|Overall Study|Withdrawal by Subject|1|||
33494081|NCT03739138|62872778|FG003|Overall Study|Lost to Follow-up|0|||
33322573|NCT01172808|62698662|FG002|Overall Study|Withdrawal by Subject|3|||
33322574|NCT01172808|62698663|FG003|Overall Study|Withdrawal by Subject|2|||
33322575|NCT01172808|62698660|FG000|Overall Study|Other|6|||
33322576|NCT01172808|62698661|FG001|Overall Study|Other|5|||
33322577|NCT01172808|62698662|FG002|Overall Study|Other|9|||
33494082|NCT03739138|62872779|FG004|Overall Study|Lost to Follow-up|0|||
33322578|NCT01172808|62698663|FG003|Overall Study|Other|7|||
33322579|NCT04066491|62698676|FG000|Overall Study|Treatment ongoing|2|||
33322580|NCT04066491|62698677|FG001|Overall Study|Treatment ongoing|72|||
33322581|NCT04066491|62698678|FG002|Overall Study|Treatment ongoing|66|||
33322582|NCT04066491|62698676|FG000|Overall Study|Treatment completed/discontinued and in follow-up,|2|||
33322583|NCT04066491|62698677|FG001|Overall Study|Treatment completed/discontinued and in follow-up,|39|||
33322584|NCT04066491|62698678|FG002|Overall Study|Treatment completed/discontinued and in follow-up,|41|||
33413951|NCT03903822|62792247|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
33413952|NCT03903822|62792248|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
33413953|NCT03903822|62792249|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
33413954|NCT03903822|62792242|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
33413955|NCT03903822|62792243|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
33413956|NCT03903822|62792244|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
33413957|NCT03903822|62792245|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
33413958|NCT03903822|62792246|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
33413959|NCT03903822|62792247|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
33494083|NCT03739138|62872775|FG000|Overall Study|Study Terminated By Sponsor|0|||
33322585|NCT04066491|62698676|FG000|Overall Study|Randomized, not treated|0|||
33322586|NCT04066491|62698677|FG001|Overall Study|Randomized, not treated|0|||
33322587|NCT04066491|62698678|FG002|Overall Study|Randomized, not treated|2|||
33322588|NCT01151280|62698687|FG000|Overall Study|Adverse Event|1|||
33413960|NCT03903822|62792248|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
33413961|NCT03903822|62792249|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
33413962|NCT03903822|62792242|FG000|Follow up Phase (4 Weeks)|Other|1|||
33413963|NCT03903822|62792243|FG001|Follow up Phase (4 Weeks)|Other|1|||
33413964|NCT03903822|62792244|FG002|Follow up Phase (4 Weeks)|Other|0|||
33413965|NCT03903822|62792245|FG003|Follow up Phase (4 Weeks)|Other|0|||
33413966|NCT03903822|62792246|FG004|Follow up Phase (4 Weeks)|Other|0|||
33413967|NCT03903822|62792247|FG005|Follow up Phase (4 Weeks)|Other|0|||
33413968|NCT03903822|62792248|FG006|Follow up Phase (4 Weeks)|Other|0|||
33413969|NCT03903822|62792249|FG007|Follow up Phase (4 Weeks)|Other|0|||
33413970|NCT00677807|62792270|FG000|Overall Study|Adverse Event|4|||
33413971|NCT00677807|62792271|FG001|Overall Study|Adverse Event|1|||
33413972|NCT00677807|62792272|FG002|Overall Study|Adverse Event|6|||
33413973|NCT00677807|62792270|FG000|Overall Study|Lack of Efficacy|0|||
33413974|NCT00677807|62792271|FG001|Overall Study|Lack of Efficacy|0|||
33413975|NCT00677807|62792272|FG002|Overall Study|Lack of Efficacy|2|||
33413976|NCT00677807|62792270|FG000|Overall Study|Participant no longer needs study drug|0|||
33413977|NCT00677807|62792271|FG001|Overall Study|Participant no longer needs study drug|0|||
33413978|NCT00677807|62792272|FG002|Overall Study|Participant no longer needs study drug|1|||
33413979|NCT00677807|62792270|FG000|Overall Study|Withdrawal by Subject|10|||
33413980|NCT00677807|62792271|FG001|Overall Study|Withdrawal by Subject|3|||
33413981|NCT00677807|62792272|FG002|Overall Study|Withdrawal by Subject|6|||
33413982|NCT00677807|62792270|FG000|Overall Study|Lost to Follow-up|2|||
33413983|NCT00677807|62792271|FG001|Overall Study|Lost to Follow-up|2|||
33413984|NCT00677807|62792272|FG002|Overall Study|Lost to Follow-up|2|||
33413985|NCT00677807|62792270|FG000|Overall Study|Administrative problems|1|||
33413986|NCT00677807|62792271|FG001|Overall Study|Administrative problems|1|||
33413987|NCT00677807|62792272|FG002|Overall Study|Administrative problems|2|||
33413988|NCT00677807|62792270|FG000|Overall Study|Death|0|||
33413989|NCT00677807|62792271|FG001|Overall Study|Death|1|||
33413990|NCT00677807|62792272|FG002|Overall Study|Death|1|||
33413991|NCT00677807|62792270|FG000|Overall Study|Protocol Deviation|1|||
33413992|NCT00677807|62792271|FG001|Overall Study|Protocol Deviation|3|||
33413993|NCT00677807|62792272|FG002|Overall Study|Protocol Deviation|0|||
33413994|NCT00687401|62792280|FG000|Overall Study|Protocol Violation|7|||
33413995|NCT00687401|62792280|FG000|Overall Study|Adverse Event|6|||
33413996|NCT00687401|62792280|FG000|Overall Study|Lack of Efficacy|6|||
33413997|NCT00687401|62792280|FG000|Overall Study|Withdrawal by Subject|4|||
33413998|NCT00687401|62792280|FG000|Overall Study|Did not return for visit|3|||
33413999|NCT00687401|62792280|FG000|Overall Study|For reasons different from those above|4|||
33414000|NCT00538902|62792300|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
33414001|NCT00538902|62792301|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
33414002|NCT00538902|62792302|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
33414003|NCT00538902|62792300|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
33414004|NCT00538902|62792301|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
33414005|NCT00538902|62792302|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
33414006|NCT00538902|62792300|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
33414007|NCT00538902|62792301|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
33414008|NCT00538902|62792302|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
33414009|NCT00538902|62792300|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
33414010|NCT00538902|62792301|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
33414011|NCT00538902|62792302|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
33414012|NCT00538902|62792300|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
33414013|NCT00538902|62792301|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
33414014|NCT00538902|62792302|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
33414015|NCT00538902|62792300|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
33414016|NCT00538902|62792301|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
33414017|NCT00538902|62792302|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
33414018|NCT00538902|62792300|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
33414019|NCT00538902|62792301|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
33414020|NCT00538902|62792302|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
33414021|NCT00538902|62792300|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
33494084|NCT03739138|62872776|FG001|Overall Study|Study Terminated By Sponsor|0|||
33322589|NCT01151280|62698687|FG000|Overall Study|Lack of Efficacy|3|||
33322590|NCT01149486|62698693|FG000|First Intervention|Adverse Event|0|||
33322591|NCT01149486|62698694|FG001|First Intervention|Adverse Event|1|||
33414022|NCT00538902|62792301|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
33414023|NCT00538902|62792302|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
33414024|NCT00541970|62792316|FG000|Month 7|Protocol Violation|9|||
33414025|NCT00541970|62792317|FG001|Month 7|Protocol Violation|13|||
33414026|NCT00541970|62792318|FG002|Month 7|Protocol Violation|11|||
33414027|NCT00541970|62792319|FG003|Month 7|Protocol Violation|5|||
33414028|NCT00541970|62792316|FG000|Month 12|Adverse Event|0|||
33414029|NCT00541970|62792317|FG001|Month 12|Adverse Event|1|||
33414030|NCT00541970|62792318|FG002|Month 12|Adverse Event|1|||
33414031|NCT00541970|62792319|FG003|Month 12|Adverse Event|1|||
33414032|NCT00541970|62792316|FG000|Month 12|Protocol Violation|12|||
33414033|NCT00541970|62792317|FG001|Month 12|Protocol Violation|21|||
33414034|NCT00541970|62792318|FG002|Month 12|Protocol Violation|20|||
33414035|NCT00541970|62792319|FG003|Month 12|Protocol Violation|15|||
33414036|NCT00541970|62792316|FG000|Month 18|Adverse Event|0|||
33414037|NCT00541970|62792317|FG001|Month 18|Adverse Event|1|||
33414038|NCT00541970|62792318|FG002|Month 18|Adverse Event|1|||
33414039|NCT00541970|62792319|FG003|Month 18|Adverse Event|1|||
33414040|NCT00541970|62792316|FG000|Month 18|Protocol Violation|14|||
33414041|NCT00541970|62792317|FG001|Month 18|Protocol Violation|23|||
33414042|NCT00541970|62792318|FG002|Month 18|Protocol Violation|24|||
33414043|NCT00541970|62792319|FG003|Month 18|Protocol Violation|16|||
33414044|NCT00541970|62792316|FG000|Month 24|Adverse Event|0|||
33414045|NCT00541970|62792317|FG001|Month 24|Adverse Event|1|||
33414046|NCT00541970|62792318|FG002|Month 24|Adverse Event|1|||
33414047|NCT00541970|62792319|FG003|Month 24|Adverse Event|1|||
33414048|NCT00541970|62792316|FG000|Month 24|Protocol Violation|29|||
33414049|NCT00541970|62792317|FG001|Month 24|Protocol Violation|31|||
33414050|NCT00541970|62792318|FG002|Month 24|Protocol Violation|31|||
33414051|NCT00541970|62792319|FG003|Month 24|Protocol Violation|21|||
33414052|NCT00541970|62792316|FG000|Month 36|Protocol Violation|61|||
33414053|NCT00541970|62792317|FG001|Month 36|Protocol Violation|66|||
33414054|NCT00541970|62792318|FG002|Month 36|Protocol Violation|66|||
33414055|NCT00541970|62792319|FG003|Month 36|Protocol Violation|60|||
33414056|NCT00541970|62792316|FG000|Month 48|Withdrawal by Subject|2|||
33414057|NCT00541970|62792317|FG001|Month 48|Withdrawal by Subject|4|||
33414058|NCT00541970|62792318|FG002|Month 48|Withdrawal by Subject|4|||
33414059|NCT00541970|62792319|FG003|Month 48|Withdrawal by Subject|2|||
33414060|NCT00541970|62792316|FG000|Month 48|Other|3|||
33322592|NCT00601705|62698700|FG000|Overall Study|Withdrawal by Subject|1|||
33322593|NCT01179737|62698709|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
33322594|NCT01179737|62698710|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
33322595|NCT01179737|62698711|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
33322596|NCT01179737|62698712|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
33322597|NCT01179737|62698709|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
33322598|NCT01179737|62698710|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
33322599|NCT01179737|62698711|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
33414061|NCT00541970|62792317|FG001|Month 48|Other|1|||
33414062|NCT00541970|62792318|FG002|Month 48|Other|1|||
33322600|NCT01179737|62698712|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
33414063|NCT00541970|62792319|FG003|Month 48|Other|0|||
33414064|NCT00541970|62792316|FG000|Month 48|Lost to Follow-up|66|||
33414065|NCT00541970|62792317|FG001|Month 48|Lost to Follow-up|68|||
33414066|NCT00541970|62792318|FG002|Month 48|Lost to Follow-up|68|||
33414067|NCT00541970|62792319|FG003|Month 48|Lost to Follow-up|73|||
33414068|NCT00541970|62792316|FG000|Month 60|Protocol Violation|78|||
33414069|NCT00541970|62792317|FG001|Month 60|Protocol Violation|77|||
33414070|NCT00541970|62792318|FG002|Month 60|Protocol Violation|82|||
33414071|NCT00541970|62792319|FG003|Month 60|Protocol Violation|72|||
33414072|NCT00687323|62792329|FG000|Overall Study|Death|25|||
33414073|NCT00687323|62792329|FG000|Overall Study|Withdrawal by Subject|1|||
33414074|NCT00687323|62792329|FG000|Overall Study|Excluded from efficacy evaluations|6|||
33414075|NCT00687323|62792329|FG000|Overall Study|Screen failure|148|||
33414076|NCT03899064|62792346|FG000|Overall Study|Lost to Follow-up|1|||
33414077|NCT03899064|62792346|FG000|Overall Study|Protocol Violation|2|||
33322601|NCT01179737|62698709|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
33322602|NCT01179737|62698710|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
33322603|NCT01179737|62698711|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
33414078|NCT03899064|62792346|FG000|Overall Study|Withdrawal by Subject|2|||
33414079|NCT03899064|62792346|FG000|Overall Study|Other|2|||
33414080|NCT03902574|62792353|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
33414081|NCT03902574|62792354|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
33414082|NCT03902574|62792355|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
33414083|NCT00542828|62792367|FG000|Overall Study|Physician Decision|1|||
33414084|NCT00542828|62792367|FG000|Overall Study|Need for Prohibited Treatment|3|||
33414085|NCT00542828|62792367|FG000|Overall Study|Study Prematurely Discontinued|7|||
33414086|NCT00542828|62792367|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
33414087|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
33414088|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
33414089|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
33414090|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
33414091|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
33414092|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
33414093|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
33414094|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
33414095|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
33414096|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
33414097|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
33414098|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
33414099|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
33414100|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
33414101|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
33414102|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
33414103|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
33414104|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
33414105|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
33322604|NCT01179737|62698712|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
33322605|NCT01179737|62698709|FG000|Cohort 1 & Cohort 2|Death|0|||
33322606|NCT01179737|62698710|FG001|Cohort 1 & Cohort 2|Death|0|||
33322607|NCT01179737|62698711|FG002|Cohort 1 & Cohort 2|Death|1|||
33322608|NCT01179737|62698712|FG003|Cohort 1 & Cohort 2|Death|0|||
33414106|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
33414107|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
33414108|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
33414109|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
33414110|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
33322609|NCT01179737|62698709|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
33322610|NCT01179737|62698710|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
33322611|NCT01179737|62698711|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
33322612|NCT01179737|62698712|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
33322613|NCT01179737|62698709|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
33322614|NCT01179737|62698710|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
33322615|NCT01179737|62698711|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
33322616|NCT01179737|62698712|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
33322617|NCT01179737|62698709|FG000|Extension|The study was terminated|3|||
33322618|NCT01179737|62698710|FG001|Extension|The study was terminated|0|||
33322619|NCT01179737|62698711|FG002|Extension|The study was terminated|0|||
33322620|NCT01179737|62698712|FG003|Extension|The study was terminated|0|||
33322621|NCT00929110|62698724|FG000|Overall Study|Adverse Event|40|||
33322622|NCT00929110|62698725|FG001|Overall Study|Adverse Event|29|||
33322623|NCT00929110|62698726|FG002|Overall Study|Adverse Event|18|||
33322624|NCT00929110|62698724|FG000|Overall Study|Subject withdrew consent|40|||
33322625|NCT00929110|62698725|FG001|Overall Study|Subject withdrew consent|23|||
33322626|NCT00929110|62698726|FG002|Overall Study|Subject withdrew consent|26|||
33322627|NCT00929110|62698724|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
33414111|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
33414112|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
33414113|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
33414114|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
33414115|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
33414116|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
33414117|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
33414118|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
33414119|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
33414120|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
33414121|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
33414122|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
33414123|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
33414124|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
33414125|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
33414126|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
33414127|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
33414128|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
33414129|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
33414130|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
33322628|NCT00929110|62698725|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
33322629|NCT00929110|62698726|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
33322630|NCT00929110|62698724|FG000|Overall Study|Lost to Follow-up|7|||
33414131|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
33414132|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
33414133|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
33414134|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
33414135|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
33414136|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
33414137|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
33414138|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
33414139|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
33414140|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
33414141|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
33414142|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
33414143|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
33414144|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
33414145|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
33414146|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
33414147|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
33414148|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
33414149|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
33414150|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
33414151|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
33414152|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
33414153|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
33414154|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
33414155|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
33414156|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
33414157|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
33414158|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
33414159|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
33414160|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
33414161|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
33414162|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
33414163|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
33414164|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
33414165|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
33414166|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
33414167|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
33414168|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
33414169|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
33414170|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
33414171|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
33414172|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
33414173|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
33414174|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
33414175|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
33604857|NCT01620255|63004399|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
33604858|NCT02010567|63004416|FG000|Overall Study|Adverse Event|0|||
33604859|NCT02010567|63004417|FG001|Overall Study|Adverse Event|0|||
33604860|NCT02010567|63004418|FG002|Overall Study|Adverse Event|1|||
33604861|NCT02010567|63004419|FG003|Overall Study|Adverse Event|0|||
33322631|NCT00929110|62698725|FG001|Overall Study|Lost to Follow-up|7|||
33322632|NCT00929110|62698726|FG002|Overall Study|Lost to Follow-up|3|||
33322633|NCT00929110|62698724|FG000|Overall Study|Protocol deviation|5|||
33322634|NCT00929110|62698725|FG001|Overall Study|Protocol deviation|2|||
33322635|NCT00929110|62698726|FG002|Overall Study|Protocol deviation|4|||
33322636|NCT00929110|62698724|FG000|Overall Study|Administrative problems|4|||
33322637|NCT00929110|62698725|FG001|Overall Study|Administrative problems|1|||
33322638|NCT00929110|62698726|FG002|Overall Study|Administrative problems|2|||
33322639|NCT00929110|62698724|FG000|Overall Study|Death|2|||
33322640|NCT00929110|62698725|FG001|Overall Study|Death|2|||
33322641|NCT00929110|62698726|FG002|Overall Study|Death|2|||
33322642|NCT00929110|62698724|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33322643|NCT00929110|62698725|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33322644|NCT00929110|62698726|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33322645|NCT00929110|62698724|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33322646|NCT00929110|62698725|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33322647|NCT00929110|62698726|FG002|Overall Study|Abnormal test procedure result(s)|1|||
33414176|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
33414177|NCT00090103|62792374|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
33414178|NCT00090103|62792375|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
33414179|NCT00090103|62792376|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
33322648|NCT00929110|62698724|FG000|Overall Study|Patient inability to use the device|0|||
33322649|NCT00929110|62698725|FG001|Overall Study|Patient inability to use the device|1|||
33322650|NCT00929110|62698726|FG002|Overall Study|Patient inability to use the device|0|||
33322651|NCT01147068|62698741|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
33322652|NCT01147068|62698742|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
33322653|NCT01147068|62698743|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
33322654|NCT01147068|62698744|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
33322655|NCT01147068|62698745|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
33322656|NCT01147068|62698746|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
33414180|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
33414181|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
33494085|NCT03739138|62872777|FG002|Overall Study|Study Terminated By Sponsor|0|||
33322657|NCT01147068|62698747|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
33322658|NCT01147068|62698741|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
33322659|NCT01147068|62698742|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
33322660|NCT01147068|62698743|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
33322661|NCT01147068|62698744|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
33322662|NCT01147068|62698745|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
33322663|NCT01147068|62698746|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
33322664|NCT01147068|62698747|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
33322665|NCT01147068|62698741|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
33322666|NCT01147068|62698742|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
33322667|NCT01147068|62698743|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
33414182|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
33414183|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
33414184|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
33414185|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
33414186|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
33414187|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
33414188|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
33414189|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
33414190|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
33414191|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
33414192|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
33414193|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
33414194|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
33414195|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
33414196|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
33414197|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
33414198|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
33414199|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
33414200|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
33414201|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
33414202|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
33414203|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
33414204|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
33414205|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
33414206|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
33414207|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
33414208|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
33414209|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
33414210|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
33414211|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
33414212|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
33414213|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
33414214|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
33414215|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
33414216|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
33414217|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
33414218|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
33414219|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
33414220|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
33414221|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
33414222|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
33414223|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
33414224|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
33414225|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
33414226|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
33414227|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
33322668|NCT01147068|62698744|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
33322669|NCT01147068|62698745|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
33322670|NCT01147068|62698746|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
33322671|NCT01147068|62698747|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
33322672|NCT01147068|62698741|FG000|Subjects That Received 2nd Dose|Other|0|||
33322673|NCT01147068|62698742|FG001|Subjects That Received 2nd Dose|Other|3|||
33322674|NCT01147068|62698743|FG002|Subjects That Received 2nd Dose|Other|3|||
33322675|NCT01147068|62698744|FG003|Subjects That Received 2nd Dose|Other|0|||
33322676|NCT01147068|62698745|FG004|Subjects That Received 2nd Dose|Other|1|||
33322677|NCT01147068|62698746|FG005|Subjects That Received 2nd Dose|Other|0|||
33322678|NCT01147068|62698747|FG006|Subjects That Received 2nd Dose|Other|0|||
33322679|NCT01147068|62698741|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
33414228|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Death|1|||
33414229|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Death|0|||
33414230|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Death|1|||
33414231|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
33414232|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
33414233|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
33414234|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
33414235|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
33414236|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
33414237|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
33414238|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
33414239|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
33414240|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
33414241|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
33414242|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
33414243|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
33414244|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
33414245|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
33414246|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
33414247|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
33414248|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
33414249|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
33414250|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
33414251|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
33414252|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Depression|0|||
33414253|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Depression|1|||
33414254|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Depression|0|||
33414255|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
33414256|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
33414257|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
33414258|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Jailed|0|||
33414259|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Jailed|1|||
33414260|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Jailed|0|||
33414261|NCT00090103|62792374|FG000|16-Week Safety Follow-up Period|Other|0|||
33414262|NCT00090103|62792375|FG001|16-Week Safety Follow-up Period|Other|1|||
33414263|NCT00090103|62792376|FG002|16-Week Safety Follow-up Period|Other|0|||
33414264|NCT00087607|62792386|FG000|Overall Study|Adverse Event|14|||
33414265|NCT00087607|62792387|FG001|Overall Study|Adverse Event|24|||
33414266|NCT00087607|62792386|FG000|Overall Study|Death|0|||
33414267|NCT00087607|62792387|FG001|Overall Study|Death|1|||
33414268|NCT00087607|62792386|FG000|Overall Study|Insufficient Therapeutic Response|53|||
33414269|NCT00087607|62792387|FG001|Overall Study|Insufficient Therapeutic Response|42|||
33414270|NCT00087607|62792386|FG000|Overall Study|Failure to return|21|||
33414271|NCT00087607|62792387|FG001|Overall Study|Failure to return|17|||
33414272|NCT00087607|62792386|FG000|Overall Study|Withdrew Consent|12|||
33414273|NCT00087607|62792387|FG001|Overall Study|Withdrew Consent|16|||
33414274|NCT00087607|62792386|FG000|Overall Study|Administrative|12|||
33414275|NCT00087607|62792387|FG001|Overall Study|Administrative|12|||
33414276|NCT00087607|62792386|FG000|Overall Study|Refused Treatment|5|||
33414277|NCT00087607|62792387|FG001|Overall Study|Refused Treatment|7|||
33414278|NCT00087607|62792386|FG000|Overall Study|Other Protocol Violation|5|||
33414279|NCT00087607|62792387|FG001|Overall Study|Other Protocol Violation|2|||
33414280|NCT00087607|62792386|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
33414281|NCT00087607|62792387|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
33414282|NCT00069823|62792399|FG000|Overall Study|Did not have follow-up diary cards|6|||
33414283|NCT00069823|62792400|FG001|Overall Study|Did not have follow-up diary cards|3|||
33414284|NCT00086515|62792412|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
33414285|NCT00086515|62792413|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
33414286|NCT00086515|62792412|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
33414287|NCT00086515|62792413|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
33414288|NCT00086515|62792412|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
33414289|NCT00086515|62792413|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
33414290|NCT00086515|62792412|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
33414291|NCT00086515|62792413|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
33414292|NCT00086515|62792412|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
33414293|NCT00086515|62792413|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
33414294|NCT00086515|62792412|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
33414295|NCT00086515|62792413|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
33414296|NCT00086515|62792412|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
33414297|NCT00086515|62792413|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
33414298|NCT00086515|62792412|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
33414299|NCT00086515|62792413|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
33414300|NCT00086515|62792412|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
33414301|NCT00086515|62792413|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
33414302|NCT00086515|62792412|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
33414303|NCT00086515|62792413|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
33414304|NCT00086515|62792412|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
33414305|NCT00086515|62792413|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
33414306|NCT00086515|62792412|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
33414307|NCT00086515|62792413|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
33414308|NCT00086515|62792412|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
33414309|NCT00086515|62792413|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
33414310|NCT00086515|62792412|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
33414311|NCT00086515|62792413|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
33414312|NCT00086515|62792412|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
33414313|NCT00086515|62792413|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
33414314|NCT00086515|62792412|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
33414315|NCT00086515|62792413|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
33414316|NCT00086515|62792412|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
33414317|NCT00086515|62792413|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
33414318|NCT00086515|62792412|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
33414319|NCT00086515|62792413|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
33414320|NCT00086515|62792412|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
33414321|NCT00086515|62792413|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
33414322|NCT00086515|62792412|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
33414323|NCT00086515|62792413|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
33414324|NCT00086515|62792412|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
33414325|NCT00086515|62792413|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
33414326|NCT00086515|62792412|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
33414327|NCT00086515|62792413|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
33414328|NCT00086515|62792412|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
33414329|NCT00086515|62792413|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
33414330|NCT00086515|62792412|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
33414331|NCT00086515|62792413|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
33414332|NCT00086515|62792412|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
33414333|NCT00086515|62792413|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
33414334|NCT00086515|62792412|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
33414335|NCT00086515|62792413|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
33414336|NCT00086515|62792412|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
33414337|NCT00086515|62792413|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
33414338|NCT00086515|62792412|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
33414339|NCT00086515|62792413|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
33414340|NCT00086515|62792412|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
33414341|NCT00086515|62792413|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
33414342|NCT00086515|62792412|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
33414343|NCT00086515|62792413|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
33414344|NCT00086515|62792412|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
33414345|NCT00086515|62792413|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
33414346|NCT00541658|62792422|FG000|Overall Study|Adverse Event|28|||
33414347|NCT00541658|62792423|FG001|Overall Study|Adverse Event|37|||
33414348|NCT00541658|62792424|FG002|Overall Study|Adverse Event|25|||
33414349|NCT00541658|62792422|FG000|Overall Study|Physician Decision|0|||
33414350|NCT00541658|62792423|FG001|Overall Study|Physician Decision|0|||
33414351|NCT00541658|62792424|FG002|Overall Study|Physician Decision|4|||
33414352|NCT00541658|62792422|FG000|Overall Study|Lost to Follow-up|3|||
33414353|NCT00541658|62792423|FG001|Overall Study|Lost to Follow-up|3|||
33414354|NCT00541658|62792424|FG002|Overall Study|Lost to Follow-up|6|||
33414355|NCT00541658|62792422|FG000|Overall Study|Protocol Violation|0|||
33414356|NCT00541658|62792423|FG001|Overall Study|Protocol Violation|1|||
33414357|NCT00541658|62792424|FG002|Overall Study|Protocol Violation|1|||
33414358|NCT00541658|62792422|FG000|Overall Study|Withdrawal by Subject|28|||
33414359|NCT00541658|62792423|FG001|Overall Study|Withdrawal by Subject|32|||
33414360|NCT00541658|62792424|FG002|Overall Study|Withdrawal by Subject|32|||
33414361|NCT00541658|62792422|FG000|Overall Study|Took No Study Drug|1|||
33414362|NCT00541658|62792423|FG001|Overall Study|Took No Study Drug|0|||
33414363|NCT00541658|62792424|FG002|Overall Study|Took No Study Drug|0|||
33414364|NCT03907280|62792448|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
33414365|NCT03907280|62792449|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
33414366|NCT03907280|62792450|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
33414367|NCT04120376|62792462|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
33494086|NCT03739138|62872778|FG003|Overall Study|Study Terminated By Sponsor|4|||
33494087|NCT03739138|62872779|FG004|Overall Study|Study Terminated By Sponsor|0|||
33494088|NCT03739138|62872775|FG000|Overall Study|Withdrawal by Subject|0|||
33322680|NCT01147068|62698742|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
33322681|NCT01147068|62698743|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
33322682|NCT01147068|62698744|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
33322683|NCT01147068|62698745|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
33322684|NCT01147068|62698746|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
33322685|NCT01147068|62698747|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
33322686|NCT01147068|62698741|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
33322687|NCT01147068|62698742|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
33322688|NCT01147068|62698743|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
33322689|NCT01147068|62698744|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
33322690|NCT01147068|62698745|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
33322691|NCT01147068|62698746|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
33322692|NCT01147068|62698747|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
33322693|NCT01147068|62698741|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
33322694|NCT01147068|62698742|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
33322695|NCT01147068|62698743|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
33322696|NCT01147068|62698744|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
33322697|NCT01147068|62698745|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
33322698|NCT01147068|62698746|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
33322699|NCT01147068|62698747|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
33322700|NCT01146912|62698770|FG000|Overall Study|Already received influenza vaccination|817|||
33322701|NCT01146912|62698771|FG001|Overall Study|Already received influenza vaccination|822|||
33322702|NCT01146912|62698772|FG002|Overall Study|Already received influenza vaccination|13|||
33322703|NCT01146912|62698773|FG003|Overall Study|Already received influenza vaccination|15|||
33322704|NCT01146912|62698774|FG004|Overall Study|Already received influenza vaccination|41|||
33322705|NCT01146912|62698775|FG005|Overall Study|Already received influenza vaccination|61|||
33322706|NCT01146912|62698776|FG006|Overall Study|Already received influenza vaccination|56|||
33322707|NCT01146912|62698777|FG007|Overall Study|Already received influenza vaccination|0|||
33322708|NCT01146912|62698770|FG000|Overall Study|< 14 weeks gestational age|0|||
33322709|NCT01146912|62698771|FG001|Overall Study|< 14 weeks gestational age|0|||
33414368|NCT04120376|62792463|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
33414369|NCT03905642|62792470|FG000|Overall Study|Withdrawal by Subject|3|||
33414370|NCT03905642|62792470|FG000|Overall Study|Pregnancy|1|||
33414371|NCT03905642|62792470|FG000|Overall Study|Adverse Event|1|||
33414372|NCT03905642|62792470|FG000|Overall Study|Lack of Efficacy|1|||
33414373|NCT03905642|62792470|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
33414374|NCT00412984|62792510|FG000|Overall Study|Death|331|||
33414375|NCT00412984|62792511|FG001|Overall Study|Death|349|||
33414376|NCT00412984|62792510|FG000|Overall Study|Adverse Event|679|||
33414377|NCT00412984|62792511|FG001|Overall Study|Adverse Event|738|||
33414378|NCT00412984|62792510|FG000|Overall Study|Withdrawal by Subject|921|||
33414379|NCT00412984|62792511|FG001|Overall Study|Withdrawal by Subject|989|||
33414380|NCT00412984|62792510|FG000|Overall Study|Lost to Follow-up|51|||
33414381|NCT00412984|62792511|FG001|Overall Study|Lost to Follow-up|39|||
33414382|NCT00412984|62792510|FG000|Overall Study|Poor/Noncompliance|57|||
33414383|NCT00412984|62792511|FG001|Overall Study|Poor/Noncompliance|77|||
33414384|NCT00412984|62792510|FG000|Overall Study|Pregnancy|1|||
33414385|NCT00412984|62792511|FG001|Overall Study|Pregnancy|0|||
33414386|NCT00412984|62792510|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
33414387|NCT00412984|62792511|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
33414388|NCT00412984|62792510|FG000|Overall Study|Administrative Reason by Sponsor|11|||
33414389|NCT00412984|62792511|FG001|Overall Study|Administrative Reason by Sponsor|8|||
33414390|NCT00412984|62792510|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
33414391|NCT00412984|62792511|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
33414392|NCT00412984|62792510|FG000|Overall Study|Other Reason|80|||
33414393|NCT00412984|62792511|FG001|Overall Study|Other Reason|92|||
33414394|NCT00412984|62792510|FG000|Overall Study|Not Reported|11|||
33414395|NCT00412984|62792511|FG001|Overall Study|Not Reported|12|||
33414396|NCT00539864|62792519|FG000|Overall Study|Lost to Follow-up|0|||
33414397|NCT00539864|62792520|FG001|Overall Study|Lost to Follow-up|1|||
33414398|NCT00539864|62792519|FG000|Overall Study|Withdrawal by Subject|1|||
33414399|NCT00539864|62792520|FG001|Overall Study|Withdrawal by Subject|1|||
33414400|NCT00673049|62792528|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
33414401|NCT00673049|62792529|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
33414402|NCT00673049|62792530|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
33414403|NCT00673049|62792531|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
33414404|NCT00673049|62792528|FG000|Before Progression on Erlotinib|Death|235|||
33414405|NCT00673049|62792529|FG001|Before Progression on Erlotinib|Death|167|||
33414406|NCT00673049|62792530|FG002|Before Progression on Erlotinib|Death|1|||
33414407|NCT00673049|62792531|FG003|Before Progression on Erlotinib|Death|0|||
33414408|NCT00673049|62792528|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
33414409|NCT00673049|62792529|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
33414410|NCT00673049|62792530|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
33414411|NCT00673049|62792531|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
33414412|NCT00673049|62792528|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
33414413|NCT00673049|62792529|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
33414414|NCT00673049|62792530|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
33414415|NCT00673049|62792531|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
33414416|NCT00673049|62792528|FG000|Before Progression on Erlotinib|Other|1|||
33414417|NCT00673049|62792529|FG001|Before Progression on Erlotinib|Other|2|||
33414418|NCT00673049|62792530|FG002|Before Progression on Erlotinib|Other|0|||
33414419|NCT00673049|62792531|FG003|Before Progression on Erlotinib|Other|0|||
33414420|NCT00673049|62792528|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
33414421|NCT00673049|62792529|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
33414422|NCT00673049|62792530|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
33414423|NCT00673049|62792531|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
33414424|NCT00673049|62792528|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
33414425|NCT00673049|62792529|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
33414426|NCT00673049|62792530|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
33414427|NCT00673049|62792531|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
33414428|NCT00673049|62792528|FG000|After Progression on Erlotinib|Death|0|||
33414429|NCT00673049|62792529|FG001|After Progression on Erlotinib|Death|0|||
33414430|NCT00673049|62792530|FG002|After Progression on Erlotinib|Death|0|||
33414431|NCT00673049|62792531|FG003|After Progression on Erlotinib|Death|71|||
33414432|NCT00673049|62792528|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
33414433|NCT00673049|62792529|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
33414434|NCT00673049|62792530|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
33414435|NCT00673049|62792531|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
33414436|NCT00673049|62792528|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
33414437|NCT00673049|62792529|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
33414438|NCT00673049|62792530|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
33604862|NCT02010567|63004420|FG004|Overall Study|Adverse Event|1|||
33414439|NCT00673049|62792531|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
33414440|NCT00673049|62792528|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
33414441|NCT00673049|62792529|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
33414442|NCT00673049|62792530|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
33414443|NCT00673049|62792531|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
33414444|NCT00412750|62792542|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33414445|NCT00412750|62792543|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33414446|NCT00412750|62792544|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33414447|NCT00412750|62792542|FG000|Overall Study|Administrative problems|21|||
33414448|NCT00412750|62792543|FG001|Overall Study|Administrative problems|17|||
33414449|NCT00412750|62792544|FG002|Overall Study|Administrative problems|14|||
33414450|NCT00412750|62792542|FG000|Overall Study|Adverse Event|8|||
33414451|NCT00412750|62792543|FG001|Overall Study|Adverse Event|3|||
33414452|NCT00412750|62792544|FG002|Overall Study|Adverse Event|3|||
33414453|NCT00412750|62792542|FG000|Overall Study|Lost to Follow-up|1|||
33414454|NCT00412750|62792543|FG001|Overall Study|Lost to Follow-up|0|||
33414455|NCT00412750|62792544|FG002|Overall Study|Lost to Follow-up|1|||
33414456|NCT00412750|62792542|FG000|Overall Study|Withdrawal by Subject|0|||
33414457|NCT00412750|62792543|FG001|Overall Study|Withdrawal by Subject|1|||
33414458|NCT00412750|62792544|FG002|Overall Study|Withdrawal by Subject|2|||
33414459|NCT00412750|62792542|FG000|Overall Study|Lack of Efficacy|0|||
33414460|NCT00412750|62792543|FG001|Overall Study|Lack of Efficacy|0|||
33414461|NCT00412750|62792544|FG002|Overall Study|Lack of Efficacy|3|||
33414462|NCT00076999|62792558|FG000|Overall Study|Adverse Event|2|||
33414463|NCT00076999|62792559|FG001|Overall Study|Adverse Event|8|||
33414464|NCT00076999|62792560|FG002|Overall Study|Adverse Event|6|||
33414465|NCT00076999|62792561|FG003|Overall Study|Adverse Event|0|||
33414466|NCT00076999|62792562|FG004|Overall Study|Adverse Event|2|||
33414467|NCT00076999|62792558|FG000|Overall Study|Protocol Violation|0|||
33414468|NCT00076999|62792559|FG001|Overall Study|Protocol Violation|3|||
33414469|NCT00076999|62792560|FG002|Overall Study|Protocol Violation|4|||
33414470|NCT00076999|62792561|FG003|Overall Study|Protocol Violation|0|||
33414471|NCT00076999|62792562|FG004|Overall Study|Protocol Violation|9|||
33414472|NCT00076999|62792558|FG000|Overall Study|Lost to Follow-up|2|||
33414473|NCT00076999|62792559|FG001|Overall Study|Lost to Follow-up|1|||
33414474|NCT00076999|62792560|FG002|Overall Study|Lost to Follow-up|0|||
33414475|NCT00076999|62792561|FG003|Overall Study|Lost to Follow-up|0|||
33414476|NCT00076999|62792562|FG004|Overall Study|Lost to Follow-up|0|||
33414477|NCT00076999|62792558|FG000|Overall Study|Withdrawal by Subject|0|||
33414478|NCT00076999|62792559|FG001|Overall Study|Withdrawal by Subject|4|||
33414479|NCT00076999|62792560|FG002|Overall Study|Withdrawal by Subject|3|||
33414480|NCT00076999|62792561|FG003|Overall Study|Withdrawal by Subject|0|||
33414481|NCT00076999|62792562|FG004|Overall Study|Withdrawal by Subject|1|||
33414482|NCT00076999|62792558|FG000|Overall Study|Other reason (not specified)|8|||
33414483|NCT00076999|62792559|FG001|Overall Study|Other reason (not specified)|8|||
33414484|NCT00076999|62792560|FG002|Overall Study|Other reason (not specified)|4|||
33414485|NCT00076999|62792561|FG003|Overall Study|Other reason (not specified)|1|||
33414486|NCT00076999|62792562|FG004|Overall Study|Other reason (not specified)|13|||
33414487|NCT03905096|62792577|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
33414488|NCT03905096|62792578|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
33414489|NCT00412360|62792593|FG000|Overall Study|Lost to Follow-up|0|||
33414490|NCT00412360|62792594|FG001|Overall Study|Lost to Follow-up|1|||
33414491|NCT00412360|62792593|FG000|Overall Study|Not Transplanted|1|||
33414492|NCT00412360|62792594|FG001|Overall Study|Not Transplanted|2|||
33494089|NCT03739138|62872776|FG001|Overall Study|Withdrawal by Subject|0|||
33414493|NCT00571103|62792600|FG000|Overall Study|Withdrawal by Subject|1|||
33414494|NCT00571103|62792600|FG000|Overall Study|Lost to Follow-up|1|||
33414495|NCT00084799|62792606|FG000|Overall Study|Disease Progression|1|||
33414496|NCT00084799|62792607|FG001|Overall Study|Disease Progression|0|||
33414497|NCT00069277|62792613|FG000|Overall Study|Adverse Event|3|||
33414498|NCT00069277|62792613|FG000|Overall Study|Withdrawal by Subject|1|||
33414499|NCT00069277|62792613|FG000|Overall Study|Progressive Disease|15|||
33414500|NCT00069277|62792613|FG000|Overall Study|Physician Decision|2|||
33414501|NCT00418522|62792619|FG000|Overall Study|Adverse Event|7|||
33414502|NCT00418522|62792620|FG001|Overall Study|Adverse Event|1|||
33414503|NCT00418522|62792619|FG000|Overall Study|Lack of Efficacy|1|||
33414504|NCT00418522|62792620|FG001|Overall Study|Lack of Efficacy|3|||
33414505|NCT00418522|62792619|FG000|Overall Study|Lost to Follow-up|10|||
33414506|NCT00418522|62792620|FG001|Overall Study|Lost to Follow-up|4|||
33414507|NCT00418522|62792619|FG000|Overall Study|Withdrawal by Subject|31|||
33414508|NCT00418522|62792620|FG001|Overall Study|Withdrawal by Subject|7|||
33414509|NCT00418522|62792619|FG000|Overall Study|Other|27|||
33414510|NCT00418522|62792620|FG001|Overall Study|Other|23|||
33414511|NCT00418522|62792619|FG000|Overall Study|Randomized but did not receive treatment|7|||
33414512|NCT00418522|62792620|FG001|Overall Study|Randomized but did not receive treatment|4|||
33414513|NCT00403546|62792628|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
33414514|NCT00403546|62792629|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
33414515|NCT00403546|62792630|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
33414516|NCT00403546|62792628|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
33414517|NCT00403546|62792629|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
33414518|NCT00403546|62792630|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
33414519|NCT00403546|62792628|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
33414520|NCT00403546|62792629|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
33414521|NCT00403546|62792630|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
33414522|NCT00403546|62792628|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
33414523|NCT00403546|62792629|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
33414524|NCT00403546|62792630|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
33414525|NCT00403546|62792628|FG000|Screening Phase|Screening Failure|22|||
33414526|NCT00403546|62792629|FG001|Screening Phase|Screening Failure|0|||
33414527|NCT00403546|62792630|FG002|Screening Phase|Screening Failure|0|||
33414528|NCT00403546|62792628|FG000|Screening Phase|Adverse Event|1|||
33414529|NCT00403546|62792629|FG001|Screening Phase|Adverse Event|0|||
33414530|NCT00403546|62792630|FG002|Screening Phase|Adverse Event|0|||
33414531|NCT00403546|62792628|FG000|Screening Phase|Terminated Prior to Randomization|5|||
33414532|NCT00403546|62792629|FG001|Screening Phase|Terminated Prior to Randomization|0|||
33414533|NCT00403546|62792630|FG002|Screening Phase|Terminated Prior to Randomization|0|||
33414534|NCT00403546|62792628|FG000|Randomized Trial|Early Terminations|0|||
33414535|NCT00403546|62792629|FG001|Randomized Trial|Early Terminations|17|||
33414536|NCT00403546|62792630|FG002|Randomized Trial|Early Terminations|16|||
33414537|NCT00403390|62792641|FG000|Overall Study|Withdrawal by Subject|1|||
33414538|NCT00403390|62792642|FG001|Overall Study|Withdrawal by Subject|0|||
33414539|NCT00403390|62792641|FG000|Overall Study|samples lost|1|||
33414540|NCT00403390|62792642|FG001|Overall Study|samples lost|0|||
33414541|NCT00403390|62792641|FG000|Overall Study|non-compliant|1|||
33494090|NCT03739138|62872777|FG002|Overall Study|Withdrawal by Subject|0|||
33414542|NCT00403390|62792642|FG001|Overall Study|non-compliant|0|||
33414543|NCT00403234|62792652|FG000|Overall Study|Withdrawal by Subject|0|||
33414544|NCT00403234|62792653|FG001|Overall Study|Withdrawal by Subject|1|||
33414545|NCT00403234|62792654|FG002|Overall Study|Withdrawal by Subject|0|||
33414546|NCT00403234|62792655|FG003|Overall Study|Withdrawal by Subject|0|||
33414547|NCT00403234|62792652|FG000|Overall Study|Adverse Event|1|||
33414548|NCT00403234|62792653|FG001|Overall Study|Adverse Event|0|||
33414549|NCT00403234|62792654|FG002|Overall Study|Adverse Event|1|||
33414550|NCT00403234|62792655|FG003|Overall Study|Adverse Event|0|||
33414551|NCT00402688|62792668|FG000|Overall Study|Adverse Event|12|||
33414552|NCT00402688|62792669|FG001|Overall Study|Adverse Event|9|||
33414553|NCT00402688|62792670|FG002|Overall Study|Adverse Event|3|||
33414554|NCT00402688|62792668|FG000|Overall Study|Withdrawal by Subject|3|||
33414555|NCT00402688|62792669|FG001|Overall Study|Withdrawal by Subject|1|||
33414556|NCT00402688|62792670|FG002|Overall Study|Withdrawal by Subject|1|||
33414557|NCT00402688|62792668|FG000|Overall Study|Physician Decision|0|||
33414558|NCT00402688|62792669|FG001|Overall Study|Physician Decision|0|||
33414559|NCT00402688|62792670|FG002|Overall Study|Physician Decision|1|||
33414560|NCT00402688|62792668|FG000|Overall Study|Lack of Efficacy|4|||
33414561|NCT00402688|62792669|FG001|Overall Study|Lack of Efficacy|4|||
33414562|NCT00402688|62792670|FG002|Overall Study|Lack of Efficacy|5|||
33414563|NCT00402688|62792668|FG000|Overall Study|Protocol Violation|1|||
33414564|NCT00402688|62792669|FG001|Overall Study|Protocol Violation|1|||
33414565|NCT00402688|62792670|FG002|Overall Study|Protocol Violation|1|||
33414566|NCT00402688|62792668|FG000|Overall Study|Lost to Follow-up|1|||
33414567|NCT00402688|62792669|FG001|Overall Study|Lost to Follow-up|0|||
33414568|NCT00402688|62792670|FG002|Overall Study|Lost to Follow-up|2|||
33414569|NCT00402688|62792668|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
33414570|NCT00402688|62792669|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
33414571|NCT00402688|62792670|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
33414572|NCT00402688|62792668|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
33414573|NCT00402688|62792669|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
33414574|NCT00402688|62792670|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
33414575|NCT00402688|62792668|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
33414576|NCT00402688|62792669|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
33414577|NCT00402688|62792670|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
33414578|NCT00671879|62792681|FG000|Overall Study|Withdrawal by Subject|0|||
33414579|NCT00671879|62792682|FG001|Overall Study|Withdrawal by Subject|4|||
33414580|NCT00671879|62792683|FG002|Overall Study|Withdrawal by Subject|6|||
33414581|NCT00402298|62792694|FG000|Overall Study|Withdrawal by Subject|1|||
33414582|NCT00402298|62792695|FG001|Overall Study|Withdrawal by Subject|0|||
33414583|NCT00401830|62792703|FG000|Overall Study|Adverse Event|10|||
33414584|NCT00401830|62792704|FG001|Overall Study|Adverse Event|18|||
33414585|NCT00401830|62792703|FG000|Overall Study|Lack of Efficacy|11|||
33494091|NCT03739138|62872778|FG003|Overall Study|Withdrawal by Subject|1|||
33414586|NCT00401830|62792704|FG001|Overall Study|Lack of Efficacy|5|||
33414587|NCT00401830|62792703|FG000|Overall Study|Withdrawal by Subject|4|||
33414588|NCT00401830|62792704|FG001|Overall Study|Withdrawal by Subject|3|||
33414589|NCT00401830|62792703|FG000|Overall Study|Protocol Violation|3|||
33414590|NCT00401830|62792704|FG001|Overall Study|Protocol Violation|3|||
33414591|NCT00401830|62792703|FG000|Overall Study|Non-compliance with drug study|1|||
33414592|NCT00401830|62792704|FG001|Overall Study|Non-compliance with drug study|0|||
33414593|NCT00401830|62792703|FG000|Overall Study|Lost to Follow-up|1|||
33414594|NCT00401830|62792704|FG001|Overall Study|Lost to Follow-up|3|||
33414595|NCT00401830|62792703|FG000|Overall Study|Other: Personal / Family problems|1|||
33414596|NCT00401830|62792704|FG001|Overall Study|Other: Personal / Family problems|0|||
33414597|NCT00401752|62792712|FG000|Overall Study|Adverse Event|2|||
33414598|NCT00401752|62792713|FG001|Overall Study|Adverse Event|5|||
33414599|NCT00401752|62792712|FG000|Overall Study|Withdrawal by Subject|2|||
33414600|NCT00401752|62792713|FG001|Overall Study|Withdrawal by Subject|6|||
33414601|NCT00401752|62792712|FG000|Overall Study|Lost to Follow-up|1|||
33414602|NCT00401752|62792713|FG001|Overall Study|Lost to Follow-up|4|||
33414603|NCT00401752|62792712|FG000|Overall Study|Development of any exclusion criteria|4|||
33414604|NCT00401752|62792713|FG001|Overall Study|Development of any exclusion criteria|2|||
33414605|NCT00401752|62792712|FG000|Overall Study|Physician Decision|1|||
33414606|NCT00401752|62792713|FG001|Overall Study|Physician Decision|1|||
33414607|NCT00539240|62792722|FG000|Overall Study|Withdrawal by Subject|0|||
33414608|NCT00539240|62792723|FG001|Overall Study|Withdrawal by Subject|2|||
33414609|NCT00539240|62792724|FG002|Overall Study|Withdrawal by Subject|0|||
33414610|NCT00539240|62792722|FG000|Overall Study|Protocol Violation|1|||
33414611|NCT00539240|62792723|FG001|Overall Study|Protocol Violation|1|||
33414612|NCT00539240|62792724|FG002|Overall Study|Protocol Violation|4|||
33414613|NCT00539240|62792722|FG000|Overall Study|Lost to Follow-up|2|||
33414614|NCT00539240|62792723|FG001|Overall Study|Lost to Follow-up|3|||
33414615|NCT00539240|62792724|FG002|Overall Study|Lost to Follow-up|1|||
33414616|NCT00539240|62792722|FG000|Overall Study|Adverse Event|3|||
33414617|NCT00539240|62792723|FG001|Overall Study|Adverse Event|1|||
33414618|NCT00539240|62792724|FG002|Overall Study|Adverse Event|10|||
33414619|NCT00417976|62792732|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
33414620|NCT00417976|62792732|FG000|Overall Study|Treatment -related toxicity|2|||
33414621|NCT00673673|62792737|FG000|Overall Study|Progressive disease|27|||
33414622|NCT00673673|62792737|FG000|Overall Study|Adverse Event|4|||
33414623|NCT00673673|62792737|FG000|Overall Study|Withdrawal by Subject|3|||
33414624|NCT00673673|62792737|FG000|Overall Study|Investigators' discretion|2|||
33414625|NCT00069121|62792743|FG000|Overall Study|Death|286|||
33414626|NCT00069121|62792744|FG001|Overall Study|Death|242|||
33414627|NCT00069121|62792743|FG000|Overall Study|Withdrawal by Subject|18|||
33414628|NCT00069121|62792744|FG001|Overall Study|Withdrawal by Subject|20|||
33414629|NCT00069121|62792743|FG000|Overall Study|Lost to Follow-up|63|||
33414630|NCT00069121|62792744|FG001|Overall Study|Lost to Follow-up|63|||
33414631|NCT00399802|62792756|FG000|Overall Study|Adverse Event|0|||
33414632|NCT00399802|62792757|FG001|Overall Study|Adverse Event|2|||
33414633|NCT00399802|62792756|FG000|Overall Study|Participant discontinued by mistake|0|||
33414634|NCT00399802|62792757|FG001|Overall Study|Participant discontinued by mistake|1|||
33414635|NCT00399568|62792765|FG000|Overall Study|Adverse Event|1|||
33414636|NCT00399568|62792766|FG001|Overall Study|Adverse Event|2|||
33414637|NCT00399568|62792765|FG000|Overall Study|Withdrawal by Subject|7|||
33414638|NCT00399568|62792766|FG001|Overall Study|Withdrawal by Subject|3|||
33414639|NCT00399568|62792765|FG000|Overall Study|Protocol non-compliance|2|||
33414640|NCT00399568|62792766|FG001|Overall Study|Protocol non-compliance|2|||
33414641|NCT00399568|62792765|FG000|Overall Study|Lost to Follow-up|2|||
33414642|NCT00399568|62792766|FG001|Overall Study|Lost to Follow-up|2|||
33414643|NCT03900728|62792777|FG000|Overall Study|No text responses|0|||
33414644|NCT03900728|62792778|FG001|Overall Study|No text responses|0|||
33414645|NCT03900728|62792779|FG002|Overall Study|No text responses|4|||
33414646|NCT00068419|62792787|FG000|Overall Study|Adverse Event|3|||
33414647|NCT00068419|62792787|FG000|Overall Study|Lack of Efficacy|24|||
33414648|NCT00068419|62792787|FG000|Overall Study|Lost to Follow-up|1|||
33414649|NCT00068419|62792787|FG000|Overall Study|Physician Decision|7|||
33414650|NCT00068419|62792787|FG000|Overall Study|Withdrawal by Subject|14|||
33414651|NCT00068419|62792787|FG000|Overall Study|Ineligible|11|||
33414652|NCT00068107|62792791|FG000|Overall Study|end-stage renal disease|6|||
33414653|NCT00068107|62792791|FG000|Overall Study|Death|2|||
33414654|NCT00068107|62792791|FG000|Overall Study|Withdrawal by Subject|1|||
33414655|NCT00394654|62792800|FG000|Overall Study|Lost to Follow-up|1|||
33414656|NCT00394654|62792801|FG001|Overall Study|Lost to Follow-up|0|||
33414657|NCT00394654|62792800|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
33414658|NCT00394654|62792801|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
33414659|NCT03900416|62792809|FG000|Six Week Follow-up|Lost to Follow-up|1|||
33414660|NCT03900416|62792810|FG001|Six Week Follow-up|Lost to Follow-up|0|||
33414661|NCT03900416|62792809|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
33414662|NCT03900416|62792810|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
33414663|NCT03900416|62792809|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
33414664|NCT03900416|62792810|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
33414665|NCT03900416|62792809|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
33414666|NCT03900416|62792810|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
33414667|NCT03900416|62792809|FG000|Twelve Week Follow-up|Adverse Event|1|||
33414668|NCT03900416|62792810|FG001|Twelve Week Follow-up|Adverse Event|1|||
33414669|NCT03900416|62792809|FG000|Six Month Follow-up|Lost to Follow-up|4|||
33414670|NCT03900416|62792810|FG001|Six Month Follow-up|Lost to Follow-up|3|||
33414671|NCT03900416|62792809|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
33414672|NCT03900416|62792810|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
33414673|NCT00399490|62792816|FG000|Overall Study|Adverse Event|19|||
33414674|NCT00399490|62792816|FG000|Overall Study|Lack of Efficacy|31|||
33414675|NCT00399490|62792816|FG000|Overall Study|Lost to Follow-up|5|||
33414676|NCT00399490|62792816|FG000|Overall Study|Withdrawal by Subject|18|||
33414677|NCT00399490|62792816|FG000|Overall Study|Other|25|||
33414678|NCT00398866|62792825|FG000|Overall Study|Adverse Event|1|||
33414679|NCT00398866|62792826|FG001|Overall Study|Adverse Event|0|||
33414680|NCT00398866|62792827|FG002|Overall Study|Adverse Event|0|||
33414681|NCT00398866|62792825|FG000|Overall Study|Lack of Efficacy|0|||
33414682|NCT00398866|62792826|FG001|Overall Study|Lack of Efficacy|0|||
33414683|NCT00398866|62792827|FG002|Overall Study|Lack of Efficacy|1|||
33414684|NCT00398866|62792825|FG000|Overall Study|Lost to Follow-up|7|||
33414685|NCT00398866|62792826|FG001|Overall Study|Lost to Follow-up|6|||
33414686|NCT00398866|62792827|FG002|Overall Study|Lost to Follow-up|4|||
33414687|NCT00398866|62792825|FG000|Overall Study|Withdrawal by Subject|5|||
33414688|NCT00398866|62792826|FG001|Overall Study|Withdrawal by Subject|1|||
33414689|NCT00398866|62792827|FG002|Overall Study|Withdrawal by Subject|2|||
33414690|NCT00398866|62792825|FG000|Overall Study|Unable to complete requirements of study|1|||
33414691|NCT00398866|62792826|FG001|Overall Study|Unable to complete requirements of study|1|||
33414692|NCT00398866|62792827|FG002|Overall Study|Unable to complete requirements of study|1|||
33414693|NCT00398632|62792836|FG000|Overall Study|Withdrawal by Subject|1|||
33414694|NCT00398632|62792836|FG000|Overall Study|Lack of Efficacy|1|||
33414695|NCT00673361|62792841|FG000|Overall Study|Screen Failure|2|||
33414696|NCT00393718|62792847|FG000|Overall Study|Adverse Event|20|||
33414697|NCT00393718|62792848|FG001|Overall Study|Adverse Event|8|||
33414698|NCT00393718|62792847|FG000|Overall Study|Protocol Violation|1|||
33414699|NCT00393718|62792848|FG001|Overall Study|Protocol Violation|2|||
33414700|NCT00393718|62792847|FG000|Overall Study|Lack of Efficacy|10|||
33414701|NCT00393718|62792848|FG001|Overall Study|Lack of Efficacy|9|||
33414702|NCT00393718|62792847|FG000|Overall Study|Hypoglycaemia|3|||
33414703|NCT00393718|62792848|FG001|Overall Study|Hypoglycaemia|2|||
33414704|NCT00393718|62792847|FG000|Overall Study|Subject decision|5|||
33414705|NCT00393718|62792848|FG001|Overall Study|Subject decision|0|||
33414706|NCT00393718|62792847|FG000|Overall Study|Withdrawal of consent|2|||
33414707|NCT00393718|62792848|FG001|Overall Study|Withdrawal of consent|1|||
33414708|NCT00393718|62792847|FG000|Overall Study|Missed measurement|1|||
33414709|NCT00393718|62792848|FG001|Overall Study|Missed measurement|0|||
33414710|NCT00393718|62792847|FG000|Overall Study|Move|1|||
33414711|NCT00393718|62792848|FG001|Overall Study|Move|0|||
33414712|NCT00669071|62792854|FG000|Overall Study|Lost to Follow-up|3|||
33414713|NCT00669071|62792854|FG000|Overall Study|Final visit 40 days out of window|1|||
33414714|NCT00398320|62792860|FG000|Overall Study|Death|1|||
33414715|NCT00398320|62792860|FG000|Overall Study|Adverse Event|4|||
33414716|NCT00398320|62792860|FG000|Overall Study|Physician Decision|1|||
33414717|NCT00670007|62792864|FG000|Overall Study|Drug abuse|1|||
33414718|NCT00670007|62792864|FG000|Overall Study|Lung transplant|1|||
33414719|NCT00670007|62792864|FG000|Overall Study|Travel/Vacation|1|||
33414720|NCT00670007|62792864|FG000|Overall Study|Adverse event, serious fatal|1|||
33414721|NCT00670007|62792864|FG000|Overall Study|Adverse Event|1|||
33414722|NCT00670007|62792864|FG000|Overall Study|Withdrawal by Subject|4|||
33414723|NCT00535496|62792871|FG000|Overall Study|Lost to Follow-up|0|||
33414724|NCT00535496|62792872|FG001|Overall Study|Lost to Follow-up|1|||
33414725|NCT00535496|62792873|FG002|Overall Study|Lost to Follow-up|0|||
33414726|NCT00535496|62792874|FG003|Overall Study|Lost to Follow-up|0|||
33414727|NCT00535496|62792871|FG000|Overall Study|Not treated with sugammadex|0|||
33414728|NCT00535496|62792872|FG001|Overall Study|Not treated with sugammadex|1|||
33414729|NCT00535496|62792873|FG002|Overall Study|Not treated with sugammadex|0|||
33414730|NCT00535496|62792874|FG003|Overall Study|Not treated with sugammadex|0|||
33414731|NCT00539006|62792885|FG000|Pre-treatment|Other|0|||
33414732|NCT00539006|62792886|FG001|Pre-treatment|Other|1|||
33414733|NCT00539006|62792887|FG002|Pre-treatment|Other|0|||
33414734|NCT00539006|62792888|FG003|Pre-treatment|Other|0|||
33414735|NCT00539006|62792885|FG000|Treatment Period 1|Lost to Follow-up|0|||
33414736|NCT00539006|62792886|FG001|Treatment Period 1|Lost to Follow-up|0|||
33414737|NCT00539006|62792887|FG002|Treatment Period 1|Lost to Follow-up|1|||
33414738|NCT00539006|62792888|FG003|Treatment Period 1|Lost to Follow-up|0|||
33414739|NCT00539006|62792885|FG000|Treatment Period 1|Protocol Violation|0|||
33414740|NCT00539006|62792886|FG001|Treatment Period 1|Protocol Violation|0|||
33414741|NCT00539006|62792887|FG002|Treatment Period 1|Protocol Violation|1|||
33414742|NCT00539006|62792888|FG003|Treatment Period 1|Protocol Violation|0|||
33414743|NCT00539006|62792885|FG000|Treatment Period 1|Lack of Efficacy|0|||
33414744|NCT00539006|62792886|FG001|Treatment Period 1|Lack of Efficacy|0|||
33414745|NCT00539006|62792887|FG002|Treatment Period 1|Lack of Efficacy|0|||
33414746|NCT00539006|62792888|FG003|Treatment Period 1|Lack of Efficacy|1|||
33414747|NCT00539006|62792885|FG000|Washout|Adverse Event|2|||
33414748|NCT00539006|62792886|FG001|Washout|Adverse Event|1|||
33414749|NCT00539006|62792887|FG002|Washout|Adverse Event|0|||
33414750|NCT00539006|62792888|FG003|Washout|Adverse Event|0|||
33414751|NCT00539006|62792885|FG000|Washout|Protocol Violation|1|||
33414752|NCT00539006|62792886|FG001|Washout|Protocol Violation|1|||
33414753|NCT00539006|62792887|FG002|Washout|Protocol Violation|0|||
33414754|NCT00539006|62792888|FG003|Washout|Protocol Violation|0|||
33414755|NCT00539006|62792885|FG000|Washout|Withdrawal by Subject|0|||
33414756|NCT00539006|62792886|FG001|Washout|Withdrawal by Subject|2|||
33414757|NCT00539006|62792887|FG002|Washout|Withdrawal by Subject|0|||
33414758|NCT00539006|62792888|FG003|Washout|Withdrawal by Subject|0|||
33414759|NCT00539006|62792885|FG000|Washout|Failed to meet continuation criteria|16|||
33414760|NCT00539006|62792886|FG001|Washout|Failed to meet continuation criteria|5|||
33414761|NCT00539006|62792887|FG002|Washout|Failed to meet continuation criteria|14|||
33414762|NCT00539006|62792888|FG003|Washout|Failed to meet continuation criteria|6|||
33414763|NCT00539006|62792885|FG000|Washout|Other|1|||
33414764|NCT00539006|62792886|FG001|Washout|Other|1|||
33414765|NCT00539006|62792887|FG002|Washout|Other|2|||
33414766|NCT00539006|62792888|FG003|Washout|Other|3|||
33414767|NCT00539006|62792885|FG000|Treatment Period 2|Protocol Violation|1|||
33414768|NCT00539006|62792886|FG001|Treatment Period 2|Protocol Violation|0|||
33414769|NCT00539006|62792887|FG002|Treatment Period 2|Protocol Violation|0|||
33414770|NCT00539006|62792888|FG003|Treatment Period 2|Protocol Violation|0|||
33414771|NCT00539006|62792885|FG000|Treatment Period 2|Other|0|||
33414772|NCT00539006|62792886|FG001|Treatment Period 2|Other|1|||
33414773|NCT00539006|62792887|FG002|Treatment Period 2|Other|0|||
33414774|NCT00539006|62792888|FG003|Treatment Period 2|Other|0|||
33414775|NCT00537056|62792904|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
33414776|NCT00535262|62792910|FG000|Overall Study|No funding|3|||
33414777|NCT00074581|62792916|FG000|Overall Study|Death|15|||
33414778|NCT00074581|62792917|FG001|Overall Study|Death|16|||
33414779|NCT00074581|62792916|FG000|Overall Study|Withdrawal by Subject|50|||
33414780|NCT00074581|62792917|FG001|Overall Study|Withdrawal by Subject|49|||
33414781|NCT00074581|62792916|FG000|Overall Study|Unable to adhere to visit schedule|13|||
33414782|NCT00074581|62792917|FG001|Overall Study|Unable to adhere to visit schedule|14|||
33414783|NCT00074581|62792916|FG000|Overall Study|Relocated|14|||
33414784|NCT00074581|62792917|FG001|Overall Study|Relocated|9|||
33414785|NCT00074581|62792916|FG000|Overall Study|Were withdrawn by investigator|5|||
33414786|NCT00074581|62792917|FG001|Overall Study|Were withdrawn by investigator|2|||
33414787|NCT00074581|62792916|FG000|Overall Study|Lost to Follow-up|16|||
33414788|NCT00074581|62792917|FG001|Overall Study|Lost to Follow-up|11|||
33414789|NCT00074581|62792916|FG000|Overall Study|Ended relationship w. index participant|117|||
33414790|NCT00074581|62792917|FG001|Overall Study|Ended relationship w. index participant|106|||
33414791|NCT00074581|62792916|FG000|Overall Study|Other|14|||
33414792|NCT00074581|62792917|FG001|Overall Study|Other|19|||
33414793|NCT03895034|62792923|FG000|Overall Study|Lost to Follow-up|2|||
33414794|NCT00536978|62792927|FG000|Overall Study|Not eligible for Adback Infusion|22|||
33414795|NCT03809611|62792933|FG000|Overall Study|Withdrawal by Subject|1|||
33414796|NCT03809611|62792934|FG001|Overall Study|Withdrawal by Subject|1|||
33414797|NCT03807739|62792945|FG000|Overall Study|Adverse Event|1|||
33414798|NCT03807739|62792946|FG001|Overall Study|Adverse Event|0|||
33414799|NCT03807739|62792947|FG002|Overall Study|Adverse Event|0|||
33414800|NCT03807739|62792948|FG003|Overall Study|Adverse Event|0|||
33414801|NCT03807739|62792945|FG000|Overall Study|Withdrawal by Subject|1|||
33414802|NCT03807739|62792946|FG001|Overall Study|Withdrawal by Subject|0|||
33414803|NCT03807739|62792947|FG002|Overall Study|Withdrawal by Subject|0|||
33414804|NCT03807739|62792948|FG003|Overall Study|Withdrawal by Subject|0|||
33414805|NCT00536744|62792960|FG000|Overall Study|Adverse Event|13|||
33414806|NCT00536744|62792961|FG001|Overall Study|Adverse Event|10|||
33414807|NCT00536744|62792960|FG000|Overall Study|Death|2|||
33414808|NCT00536744|62792961|FG001|Overall Study|Death|1|||
33414809|NCT00536744|62792960|FG000|Overall Study|Physician Decision|3|||
33414810|NCT00536744|62792961|FG001|Overall Study|Physician Decision|1|||
33414811|NCT00536744|62792960|FG000|Overall Study|Lost to Follow-up|3|||
33414812|NCT00536744|62792961|FG001|Overall Study|Lost to Follow-up|5|||
33414813|NCT00536744|62792960|FG000|Overall Study|Withdrawal by Subject|7|||
33414814|NCT00536744|62792961|FG001|Overall Study|Withdrawal by Subject|8|||
33414815|NCT00536744|62792960|FG000|Overall Study|PI tried alternative treatment|1|||
33414816|NCT00536744|62792961|FG001|Overall Study|PI tried alternative treatment|3|||
33414817|NCT00536510|62792978|FG000|Overall Study|Adverse Event|27|||
33414818|NCT00536510|62792979|FG001|Overall Study|Adverse Event|4|||
33414819|NCT00536510|62792978|FG000|Overall Study|Lost to Follow-up|11|||
33414820|NCT00536510|62792979|FG001|Overall Study|Lost to Follow-up|8|||
33414821|NCT00536510|62792978|FG000|Overall Study|Protocol Violation|4|||
33414822|NCT00536510|62792979|FG001|Overall Study|Protocol Violation|5|||
33414823|NCT00536510|62792978|FG000|Overall Study|Withdrawal by Subject|16|||
33414824|NCT00536510|62792979|FG001|Overall Study|Withdrawal by Subject|9|||
33414825|NCT00536510|62792978|FG000|Overall Study|Flushing with Product|20|||
33414826|NCT00536510|62792979|FG001|Overall Study|Flushing with Product|0|||
33414827|NCT00536510|62792978|FG000|Overall Study|Laboratory Adverse Event|2|||
33414828|NCT00536510|62792979|FG001|Overall Study|Laboratory Adverse Event|1|||
33414829|NCT00536510|62792978|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
33414830|NCT00536510|62792979|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
33414831|NCT00398086|62792988|FG000|Overall Study|Unacceptable Toxicity|2|||
33414832|NCT00398086|62792989|FG001|Overall Study|Unacceptable Toxicity|8|||
33414833|NCT00398086|62792990|FG002|Overall Study|Unacceptable Toxicity|2|||
33414834|NCT00398086|62792988|FG000|Overall Study|Adverse Event|1|||
33414835|NCT00398086|62792989|FG001|Overall Study|Adverse Event|4|||
33414836|NCT00398086|62792990|FG002|Overall Study|Adverse Event|0|||
33414837|NCT00398086|62792988|FG000|Overall Study|Physician Decision|1|||
33414838|NCT00398086|62792989|FG001|Overall Study|Physician Decision|4|||
33414839|NCT00398086|62792990|FG002|Overall Study|Physician Decision|0|||
33414840|NCT00398086|62792988|FG000|Overall Study|Withdrawal by Subject|5|||
33414841|NCT00398086|62792989|FG001|Overall Study|Withdrawal by Subject|7|||
33414842|NCT00398086|62792990|FG002|Overall Study|Withdrawal by Subject|0|||
33414843|NCT00536198|62793000|FG000|Overall Study|Lost to Follow-up|15|||
33414844|NCT00536198|62793001|FG001|Overall Study|Lost to Follow-up|14|||
33414845|NCT00536198|62793000|FG000|Overall Study|Withdrawal by Subject|16|||
33414846|NCT00536198|62793001|FG001|Overall Study|Withdrawal by Subject|12|||
33414847|NCT00536198|62793000|FG000|Overall Study|Adverse Event|2|||
33414848|NCT00536198|62793001|FG001|Overall Study|Adverse Event|2|||
33414849|NCT00536198|62793000|FG000|Overall Study|Rescue|3|||
33414850|NCT00536198|62793001|FG001|Overall Study|Rescue|9|||
33414851|NCT00536198|62793000|FG000|Overall Study|Pregnancy|1|||
33414852|NCT00536198|62793001|FG001|Overall Study|Pregnancy|1|||
33414853|NCT00536198|62793000|FG000|Overall Study|Protocol Violation|0|||
33414854|NCT00536198|62793001|FG001|Overall Study|Protocol Violation|1|||
33414855|NCT00393484|62793011|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
33414856|NCT00393484|62793012|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
33414857|NCT00393484|62793011|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
33414858|NCT00393484|62793012|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
33414859|NCT00393484|62793011|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
33414860|NCT00393484|62793012|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
33414861|NCT00393484|62793011|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
33414862|NCT00393484|62793012|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
33414863|NCT00393484|62793011|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
33414864|NCT00393484|62793012|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
33414865|NCT00393484|62793011|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
33414866|NCT00393484|62793012|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
33414867|NCT00393484|62793011|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
33414868|NCT00393484|62793012|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
33414869|NCT00393484|62793011|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
33414870|NCT00393484|62793012|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
33414871|NCT00393484|62793011|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
33414872|NCT00393484|62793012|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
33414873|NCT00393484|62793011|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
33322710|NCT01146912|62698772|FG002|Overall Study|< 14 weeks gestational age|3|||
33322711|NCT01146912|62698773|FG003|Overall Study|< 14 weeks gestational age|2|||
33322712|NCT01146912|62698774|FG004|Overall Study|< 14 weeks gestational age|0|||
33322713|NCT01146912|62698775|FG005|Overall Study|< 14 weeks gestational age|0|||
33322714|NCT01146912|62698776|FG006|Overall Study|< 14 weeks gestational age|0|||
33322715|NCT01146912|62698777|FG007|Overall Study|< 14 weeks gestational age|0|||
33322716|NCT01146912|62698770|FG000|Overall Study|Duplicate patient|0|||
33322717|NCT01146912|62698771|FG001|Overall Study|Duplicate patient|0|||
33322718|NCT01146912|62698772|FG002|Overall Study|Duplicate patient|1|||
33322719|NCT01146912|62698773|FG003|Overall Study|Duplicate patient|0|||
33322720|NCT01146912|62698774|FG004|Overall Study|Duplicate patient|0|||
33322721|NCT01146912|62698775|FG005|Overall Study|Duplicate patient|0|||
33322722|NCT01146912|62698776|FG006|Overall Study|Duplicate patient|0|||
33322723|NCT01146912|62698777|FG007|Overall Study|Duplicate patient|0|||
33322724|NCT01134042|62698799|FG000|Overall Study|Adverse Event|3|||
33322725|NCT01134042|62698800|FG001|Overall Study|Adverse Event|7|||
33322726|NCT01134042|62698801|FG002|Overall Study|Adverse Event|2|||
33322727|NCT01134042|62698799|FG000|Overall Study|Lack of Efficacy|21|||
33322728|NCT01134042|62698800|FG001|Overall Study|Lack of Efficacy|6|||
33322729|NCT01134042|62698801|FG002|Overall Study|Lack of Efficacy|18|||
33322730|NCT01134042|62698799|FG000|Overall Study|Protocol Violation|5|||
33322731|NCT01134042|62698800|FG001|Overall Study|Protocol Violation|3|||
33322732|NCT01134042|62698801|FG002|Overall Study|Protocol Violation|5|||
33414874|NCT00393484|62793012|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
33414875|NCT00667823|62793020|FG000|Overall Study|Lost to Follow-up|5|||
33414876|NCT00667823|62793020|FG000|Overall Study|Adverse Event|7|||
33414877|NCT00667823|62793020|FG000|Overall Study|Death|182|||
33414878|NCT00667823|62793020|FG000|Overall Study|Withdrawal by Subject|12|||
33414879|NCT00667823|62793020|FG000|Overall Study|Other|8|||
33414880|NCT00667823|62793020|FG000|Overall Study|Missing (completion page missing)|2|||
33414881|NCT00397930|62793026|FG000|Overall Study|Personal reasons|14|||
33414882|NCT00397930|62793027|FG001|Overall Study|Personal reasons|8|||
33414883|NCT00397930|62793026|FG000|Overall Study|Other medical|9|||
33414884|NCT00397930|62793027|FG001|Overall Study|Other medical|4|||
33414885|NCT00397930|62793026|FG000|Overall Study|Unknown reasons|9|||
33414886|NCT00397930|62793027|FG001|Overall Study|Unknown reasons|14|||
33414887|NCT00397930|62793026|FG000|Overall Study|Noncompliant|3|||
33414888|NCT00397930|62793027|FG001|Overall Study|Noncompliant|2|||
33414889|NCT00397930|62793026|FG000|Overall Study|Too time-consuming|2|||
33414890|NCT00397930|62793027|FG001|Overall Study|Too time-consuming|9|||
33414891|NCT00397930|62793026|FG000|Overall Study|Started own yoga program|1|||
33414892|NCT00397930|62793027|FG001|Overall Study|Started own yoga program|1|||
33414893|NCT00397930|62793026|FG000|Overall Study|Did not want to be in control group|0|||
33414894|NCT00397930|62793027|FG001|Overall Study|Did not want to be in control group|1|||
33414895|NCT00397930|62793026|FG000|Overall Study|Withdrawal by Subject|0|||
33414896|NCT00397930|62793027|FG001|Overall Study|Withdrawal by Subject|8|||
33414897|NCT00397930|62793026|FG000|Overall Study|Missing data|0|||
33414898|NCT00397930|62793027|FG001|Overall Study|Missing data|4|||
33414899|NCT00397540|62793035|FG000|Overall Study|short follow-up duration < 12 months|1|||
33414900|NCT00397540|62793036|FG001|Overall Study|short follow-up duration < 12 months|0|||
33414901|NCT00536120|62793045|FG000|Overall Study|Lost to Follow-up|1|||
33414902|NCT00536120|62793046|FG001|Overall Study|Lost to Follow-up|0|||
33414903|NCT00536120|62793045|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
33414904|NCT00536120|62793046|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
33414905|NCT00536120|62793045|FG000|Overall Study|Non-compliance|1|||
33414906|NCT00536120|62793046|FG001|Overall Study|Non-compliance|0|||
33414907|NCT00536120|62793045|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
33414908|NCT00536120|62793046|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
33414909|NCT00536120|62793045|FG000|Overall Study|Steroid Use|0|||
33414910|NCT00536120|62793046|FG001|Overall Study|Steroid Use|2|||
33414911|NCT00536120|62793045|FG000|Overall Study|Missed Study Visit|0|||
33414912|NCT00536120|62793046|FG001|Overall Study|Missed Study Visit|1|||
33414913|NCT00057811|62793054|FG000|Overall Study|Lack of Efficacy|1|||
33414914|NCT00057811|62793055|FG001|Overall Study|Lack of Efficacy|4|||
33414915|NCT00057811|62793054|FG000|Overall Study|Physician Decision|1|||
33414916|NCT00057811|62793055|FG001|Overall Study|Physician Decision|0|||
33414917|NCT00057811|62793054|FG000|Overall Study|Withdrawal by Subject|3|||
33414918|NCT00057811|62793055|FG001|Overall Study|Withdrawal by Subject|4|||
33414919|NCT00057811|62793054|FG000|Overall Study|Ineligible|4|||
33414920|NCT00057811|62793055|FG001|Overall Study|Ineligible|2|||
33414921|NCT00057811|62793054|FG000|Overall Study|Inevaluable|1|||
33414922|NCT00057811|62793055|FG001|Overall Study|Inevaluable|2|||
33414923|NCT02866682|62793068|FG000|Overall Study|Death|0|||
33414924|NCT02866682|62793069|FG001|Overall Study|Death|1|||
33414925|NCT02866682|62793068|FG000|Overall Study|Lost to Follow-up|0|||
33414926|NCT02866682|62793069|FG001|Overall Study|Lost to Follow-up|4|||
33414927|NCT02866682|62793068|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
33322733|NCT01134042|62698799|FG000|Overall Study|Lost to Follow-up|2|||
33414928|NCT02866682|62793069|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
33414929|NCT02866682|62793068|FG000|Overall Study|Other|0|||
33414930|NCT02866682|62793069|FG001|Overall Study|Other|1|||
33414931|NCT00570713|62793086|FG000|Overall Study|Adverse Event|16|||
33414932|NCT00570713|62793087|FG001|Overall Study|Adverse Event|9|||
33414933|NCT00570713|62793086|FG000|Overall Study|Death|7|||
33414934|NCT00570713|62793087|FG001|Overall Study|Death|7|||
33414935|NCT00570713|62793086|FG000|Overall Study|Lack of Efficacy|40|||
33414936|NCT00570713|62793087|FG001|Overall Study|Lack of Efficacy|49|||
33414937|NCT00570713|62793086|FG000|Overall Study|Physician Decision|2|||
33414938|NCT00570713|62793087|FG001|Overall Study|Physician Decision|2|||
33414939|NCT00570713|62793086|FG000|Overall Study|Withdrawal by Subject|3|||
33414940|NCT00570713|62793087|FG001|Overall Study|Withdrawal by Subject|3|||
33414941|NCT00570713|62793086|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
33414942|NCT00570713|62793087|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
33414943|NCT00669617|62793097|FG000|Period 1|Withdrawal by Subject|0|||
33414944|NCT00669617|62793098|FG001|Period 1|Withdrawal by Subject|0|||
33414945|NCT00669617|62793099|FG002|Period 1|Withdrawal by Subject|1|||
33414946|NCT00669617|62793100|FG003|Period 1|Withdrawal by Subject|0|||
33414947|NCT00669617|62793101|FG004|Period 1|Withdrawal by Subject|0|||
33414948|NCT00669617|62793097|FG000|Period 1|Protocol Deviation|0|||
33414949|NCT00669617|62793098|FG001|Period 1|Protocol Deviation|0|||
33414950|NCT00669617|62793099|FG002|Period 1|Protocol Deviation|0|||
33414951|NCT00669617|62793100|FG003|Period 1|Protocol Deviation|0|||
33414952|NCT00669617|62793101|FG004|Period 1|Protocol Deviation|1|||
33414953|NCT00669617|62793097|FG000|Period 3|Lost to Follow-up|1|||
33414954|NCT00669617|62793098|FG001|Period 3|Lost to Follow-up|0|||
33414955|NCT00669617|62793099|FG002|Period 3|Lost to Follow-up|0|||
33414956|NCT00669617|62793100|FG003|Period 3|Lost to Follow-up|0|||
33414957|NCT00669617|62793101|FG004|Period 3|Lost to Follow-up|0|||
33414958|NCT00535730|62793115|FG000|Overall Study|Adverse Event|1|||
33414959|NCT00535730|62793116|FG001|Overall Study|Adverse Event|1|||
33414960|NCT00535730|62793115|FG000|Overall Study|Lost to Follow-up|0|||
33414961|NCT00535730|62793116|FG001|Overall Study|Lost to Follow-up|1|||
33414962|NCT00535730|62793115|FG000|Overall Study|Physician Decision|0|||
33414963|NCT00535730|62793116|FG001|Overall Study|Physician Decision|1|||
33414964|NCT00535730|62793115|FG000|Overall Study|Protocol Violation|1|||
33414965|NCT00535730|62793116|FG001|Overall Study|Protocol Violation|0|||
33414966|NCT00535730|62793115|FG000|Overall Study|Withdrawal by Subject|0|||
33414967|NCT00535730|62793116|FG001|Overall Study|Withdrawal by Subject|4|||
33414968|NCT00666965|62793127|FG000|Overall Study|Adverse Event|0|||
33414969|NCT00666965|62793128|FG001|Overall Study|Adverse Event|2|||
33414970|NCT00666965|62793129|FG002|Overall Study|Adverse Event|1|||
33414971|NCT00666965|62793130|FG003|Overall Study|Adverse Event|9|||
33414972|NCT00666965|62793127|FG000|Overall Study|Lack of Efficacy|1|||
33414973|NCT00666965|62793128|FG001|Overall Study|Lack of Efficacy|1|||
33414974|NCT00666965|62793129|FG002|Overall Study|Lack of Efficacy|0|||
33414975|NCT00666965|62793130|FG003|Overall Study|Lack of Efficacy|0|||
33414976|NCT00666965|62793127|FG000|Overall Study|Protocol Violation|0|||
33414977|NCT00666965|62793128|FG001|Overall Study|Protocol Violation|0|||
33414978|NCT00666965|62793129|FG002|Overall Study|Protocol Violation|0|||
33414979|NCT00666965|62793130|FG003|Overall Study|Protocol Violation|2|||
33414980|NCT00666965|62793127|FG000|Overall Study|Discontinuation criteria|2|||
33414981|NCT00666965|62793128|FG001|Overall Study|Discontinuation criteria|1|||
33414982|NCT00666965|62793129|FG002|Overall Study|Discontinuation criteria|1|||
33414983|NCT00666965|62793130|FG003|Overall Study|Discontinuation criteria|2|||
33414984|NCT00666965|62793127|FG000|Overall Study|Withdrawal by Subject|0|||
33414985|NCT00666965|62793128|FG001|Overall Study|Withdrawal by Subject|0|||
33414986|NCT00666965|62793129|FG002|Overall Study|Withdrawal by Subject|0|||
33414987|NCT00666965|62793130|FG003|Overall Study|Withdrawal by Subject|2|||
33414988|NCT03889886|62793144|FG000|Overall Study|Other|0|||
33414989|NCT03889886|62793145|FG001|Overall Study|Other|1|||
33414990|NCT03889886|62793146|FG002|Overall Study|Other|0|||
33414991|NCT03889886|62793147|FG003|Overall Study|Other|1|||
33414992|NCT03889886|62793144|FG000|Overall Study|Withdrawal by Subject|0|||
33414993|NCT03889886|62793145|FG001|Overall Study|Withdrawal by Subject|0|||
33414994|NCT03889886|62793146|FG002|Overall Study|Withdrawal by Subject|1|||
33414995|NCT03889886|62793147|FG003|Overall Study|Withdrawal by Subject|0|||
33414996|NCT03889886|62793144|FG000|Overall Study|Adverse Event|0|||
33414997|NCT03889886|62793145|FG001|Overall Study|Adverse Event|0|||
33414998|NCT03889886|62793146|FG002|Overall Study|Adverse Event|0|||
33414999|NCT03889886|62793147|FG003|Overall Study|Adverse Event|6|||
33322734|NCT01134042|62698800|FG001|Overall Study|Lost to Follow-up|0|||
33415000|NCT03888482|62793159|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
33415001|NCT03888482|62793160|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
33415002|NCT03888482|62793159|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
33415003|NCT03888482|62793160|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
33415004|NCT00667355|62793168|FG000|Overall Study|Adverse Event|5|||
33415005|NCT00667355|62793168|FG000|Overall Study|Lost to Follow-up|1|||
33415006|NCT00667355|62793168|FG000|Overall Study|Other reason was not specified|5|||
33415007|NCT00532844|62793174|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
33415008|NCT00532844|62793175|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
33415009|NCT00532844|62793174|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
33415010|NCT00532844|62793175|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
33415011|NCT00532844|62793174|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
33415012|NCT00532844|62793175|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
33415013|NCT00532844|62793174|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
33415014|NCT00532844|62793175|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
33415015|NCT00532844|62793174|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
33415016|NCT00532844|62793175|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
33415017|NCT00666263|62793203|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
33415018|NCT00666263|62793204|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
33415019|NCT00666263|62793203|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
33415020|NCT00666263|62793204|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
33415021|NCT00666263|62793203|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
33415022|NCT00666263|62793204|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
33415023|NCT00667277|62793249|FG000|Overall Study|Withdrawal by Subject|2|||
33415024|NCT00534638|62793255|FG000|Overall Study|Withdrawal by Subject|3|||
33415025|NCT00534638|62793256|FG001|Overall Study|Withdrawal by Subject|4|||
33415026|NCT00534638|62793255|FG000|Overall Study|Migrated/moved from study area|13|||
33415027|NCT00534638|62793256|FG001|Overall Study|Migrated/moved from study area|11|||
33415028|NCT00534638|62793255|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
33415029|NCT00534638|62793256|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
33415030|NCT00534638|62793255|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
33415031|NCT00534638|62793256|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
33415032|NCT00534638|62793255|FG000|Overall Study|Other|1685|||
33415033|NCT00534638|62793256|FG001|Overall Study|Other|902|||
33415034|NCT00662129|62793267|FG000|Overall Study|Protocol Violation|1|||
33415035|NCT00662129|62793267|FG000|Overall Study|Cancel prior to beginning treatment|1|||
33415036|NCT00662129|62793267|FG000|Overall Study|Ineligible|1|||
33415037|NCT00664859|62793274|FG000|Overall Study|Adverse Event|2|||
33415038|NCT00664859|62793275|FG001|Overall Study|Adverse Event|1|||
33415039|NCT00664859|62793276|FG002|Overall Study|Adverse Event|3|||
33415040|NCT00664859|62793274|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
33415041|NCT00664859|62793275|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
33415042|NCT00664859|62793276|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
33415043|NCT00664859|62793274|FG000|Overall Study|Noncompliance with protocol|1|||
33415044|NCT00664859|62793275|FG001|Overall Study|Noncompliance with protocol|0|||
33415045|NCT00664859|62793276|FG002|Overall Study|Noncompliance with protocol|4|||
33415046|NCT00664859|62793274|FG000|Overall Study|Laboratory abnormality|2|||
33415047|NCT00664859|62793275|FG001|Overall Study|Laboratory abnormality|1|||
33415048|NCT00664859|62793276|FG002|Overall Study|Laboratory abnormality|4|||
33415049|NCT00664859|62793274|FG000|Overall Study|Withdrawal by Subject|4|||
33415050|NCT00664859|62793275|FG001|Overall Study|Withdrawal by Subject|1|||
33415051|NCT00664859|62793276|FG002|Overall Study|Withdrawal by Subject|3|||
33415052|NCT00664859|62793274|FG000|Overall Study|Lost to Follow-up|2|||
33415053|NCT00664859|62793275|FG001|Overall Study|Lost to Follow-up|2|||
33415054|NCT00664859|62793276|FG002|Overall Study|Lost to Follow-up|1|||
33415055|NCT00664859|62793274|FG000|Overall Study|Other|0|||
33415056|NCT00664859|62793275|FG001|Overall Study|Other|1|||
33415057|NCT00664859|62793276|FG002|Overall Study|Other|2|||
33415058|NCT00570401|62793284|FG000|Overall Study|Adverse Event|2|||
33415059|NCT00532298|62793294|FG000|Overall Study|Adverse Event|1|||
33415060|NCT00532298|62793295|FG001|Overall Study|Adverse Event|0|||
33415061|NCT00532298|62793296|FG002|Overall Study|Adverse Event|0|||
33415062|NCT00532298|62793297|FG003|Overall Study|Adverse Event|0|||
33415063|NCT00532298|62793298|FG004|Overall Study|Adverse Event|1|||
33415064|NCT00532298|62793299|FG005|Overall Study|Adverse Event|1|||
33415065|NCT00532298|62793294|FG000|Overall Study|Lost to Follow-up|1|||
33415066|NCT00532298|62793295|FG001|Overall Study|Lost to Follow-up|1|||
33415067|NCT00532298|62793296|FG002|Overall Study|Lost to Follow-up|1|||
33415068|NCT00532298|62793297|FG003|Overall Study|Lost to Follow-up|0|||
33415069|NCT00532298|62793298|FG004|Overall Study|Lost to Follow-up|0|||
33415070|NCT00532298|62793299|FG005|Overall Study|Lost to Follow-up|1|||
33415071|NCT00410410|62793319|FG000|Induction Period (IP)|Death|1|||
33415072|NCT00410410|62793320|FG001|Induction Period (IP)|Death|0|||
33415073|NCT00410410|62793321|FG002|Induction Period (IP)|Death|0|||
33415074|NCT00410410|62793322|FG003|Induction Period (IP)|Death|0|||
33415075|NCT00410410|62793323|FG004|Induction Period (IP)|Death|0|||
33415076|NCT00410410|62793324|FG005|Induction Period (IP)|Death|0|||
33604863|NCT01806064|63004435|FG000|Overall Study|Randomized Not Enrolled|0|||
33604864|NCT01806064|63004436|FG001|Overall Study|Randomized Not Enrolled|0|||
33604865|NCT01806064|63004437|FG002|Overall Study|Randomized Not Enrolled|0|||
33415077|NCT00410410|62793325|FG006|Induction Period (IP)|Death|0|||
33415078|NCT00410410|62793326|FG007|Induction Period (IP)|Death|0|||
33415079|NCT00410410|62793327|FG008|Induction Period (IP)|Death|0|||
33415080|NCT00410410|62793319|FG000|Induction Period (IP)|Adverse Event|3|||
33415081|NCT00410410|62793320|FG001|Induction Period (IP)|Adverse Event|4|||
33415082|NCT00410410|62793321|FG002|Induction Period (IP)|Adverse Event|2|||
33415083|NCT00410410|62793322|FG003|Induction Period (IP)|Adverse Event|4|||
33415084|NCT00410410|62793323|FG004|Induction Period (IP)|Adverse Event|1|||
33415085|NCT00410410|62793324|FG005|Induction Period (IP)|Adverse Event|0|||
33415086|NCT00410410|62793325|FG006|Induction Period (IP)|Adverse Event|0|||
33415087|NCT00410410|62793326|FG007|Induction Period (IP)|Adverse Event|0|||
33415088|NCT00410410|62793327|FG008|Induction Period (IP)|Adverse Event|0|||
33415089|NCT00410410|62793319|FG000|Induction Period (IP)|Lack of Efficacy|26|||
33415090|NCT00410410|62793320|FG001|Induction Period (IP)|Lack of Efficacy|24|||
33415091|NCT00410410|62793321|FG002|Induction Period (IP)|Lack of Efficacy|8|||
33415092|NCT00410410|62793322|FG003|Induction Period (IP)|Lack of Efficacy|8|||
33415093|NCT00410410|62793323|FG004|Induction Period (IP)|Lack of Efficacy|7|||
33415094|NCT00410410|62793324|FG005|Induction Period (IP)|Lack of Efficacy|7|||
33415095|NCT00410410|62793325|FG006|Induction Period (IP)|Lack of Efficacy|0|||
33415096|NCT00410410|62793326|FG007|Induction Period (IP)|Lack of Efficacy|0|||
33415097|NCT00410410|62793327|FG008|Induction Period (IP)|Lack of Efficacy|0|||
33415098|NCT00410410|62793319|FG000|Induction Period (IP)|Lost to Follow-up|2|||
33415099|NCT00410410|62793320|FG001|Induction Period (IP)|Lost to Follow-up|2|||
33415100|NCT00410410|62793321|FG002|Induction Period (IP)|Lost to Follow-up|2|||
33415101|NCT00410410|62793322|FG003|Induction Period (IP)|Lost to Follow-up|3|||
33415102|NCT00410410|62793323|FG004|Induction Period (IP)|Lost to Follow-up|0|||
33415103|NCT00410410|62793324|FG005|Induction Period (IP)|Lost to Follow-up|1|||
33415104|NCT00410410|62793325|FG006|Induction Period (IP)|Lost to Follow-up|0|||
33415105|NCT00410410|62793326|FG007|Induction Period (IP)|Lost to Follow-up|0|||
33415106|NCT00410410|62793327|FG008|Induction Period (IP)|Lost to Follow-up|0|||
33415107|NCT00410410|62793319|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
33415108|NCT00410410|62793320|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
33415109|NCT00410410|62793321|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
33415110|NCT00410410|62793322|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
33415111|NCT00410410|62793323|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
33415112|NCT00410410|62793324|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
33415113|NCT00410410|62793325|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
33415114|NCT00410410|62793326|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
33415115|NCT00410410|62793327|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
33415116|NCT00410410|62793319|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33415117|NCT00410410|62793320|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33415118|NCT00410410|62793321|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
33415119|NCT00410410|62793322|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33415120|NCT00410410|62793323|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33415121|NCT00410410|62793324|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33415122|NCT00410410|62793325|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33415123|NCT00410410|62793326|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33415124|NCT00410410|62793327|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33415125|NCT00410410|62793319|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
33415126|NCT00410410|62793320|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
33415127|NCT00410410|62793321|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
33415128|NCT00410410|62793322|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
33415129|NCT00410410|62793323|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
33415130|NCT00410410|62793324|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
33415131|NCT00410410|62793325|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
33415132|NCT00410410|62793326|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
33415133|NCT00410410|62793327|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
33415134|NCT00410410|62793319|FG000|Induction Period (IP)|Other|0|||
33415135|NCT00410410|62793320|FG001|Induction Period (IP)|Other|0|||
33415136|NCT00410410|62793321|FG002|Induction Period (IP)|Other|1|||
33415137|NCT00410410|62793322|FG003|Induction Period (IP)|Other|0|||
33415138|NCT00410410|62793323|FG004|Induction Period (IP)|Other|0|||
33415139|NCT00410410|62793324|FG005|Induction Period (IP)|Other|0|||
33415140|NCT00410410|62793325|FG006|Induction Period (IP)|Other|0|||
33415141|NCT00410410|62793326|FG007|Induction Period (IP)|Other|0|||
33415142|NCT00410410|62793327|FG008|Induction Period (IP)|Other|0|||
33415143|NCT00410410|62793319|FG000|Maintenance Period (MP)|Death|0|||
33415144|NCT00410410|62793320|FG001|Maintenance Period (MP)|Death|0|||
33415145|NCT00410410|62793321|FG002|Maintenance Period (MP)|Death|0|||
33415146|NCT00410410|62793322|FG003|Maintenance Period (MP)|Death|0|||
33415147|NCT00410410|62793323|FG004|Maintenance Period (MP)|Death|0|||
33415148|NCT00410410|62793324|FG005|Maintenance Period (MP)|Death|0|||
33415149|NCT00410410|62793325|FG006|Maintenance Period (MP)|Death|1|||
33415150|NCT00410410|62793326|FG007|Maintenance Period (MP)|Death|0|||
33415151|NCT00410410|62793327|FG008|Maintenance Period (MP)|Death|0|||
33415152|NCT00410410|62793319|FG000|Maintenance Period (MP)|Adverse Event|0|||
33415153|NCT00410410|62793320|FG001|Maintenance Period (MP)|Adverse Event|0|||
33415154|NCT00410410|62793321|FG002|Maintenance Period (MP)|Adverse Event|0|||
33415155|NCT00410410|62793322|FG003|Maintenance Period (MP)|Adverse Event|0|||
33415156|NCT00410410|62793323|FG004|Maintenance Period (MP)|Adverse Event|0|||
33415157|NCT00410410|62793324|FG005|Maintenance Period (MP)|Adverse Event|0|||
33415158|NCT00410410|62793325|FG006|Maintenance Period (MP)|Adverse Event|1|||
33415159|NCT00410410|62793326|FG007|Maintenance Period (MP)|Adverse Event|3|||
33415160|NCT00410410|62793327|FG008|Maintenance Period (MP)|Adverse Event|0|||
33415161|NCT00410410|62793319|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
33415162|NCT00410410|62793320|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
33415163|NCT00410410|62793321|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
33415164|NCT00410410|62793322|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
33415165|NCT00410410|62793323|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
33415166|NCT00410410|62793324|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
33415167|NCT00410410|62793325|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
33415168|NCT00410410|62793326|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
33415169|NCT00410410|62793327|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
33415170|NCT00410410|62793319|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
33415171|NCT00410410|62793320|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
33415172|NCT00410410|62793321|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
33415173|NCT00410410|62793322|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
33415174|NCT00410410|62793323|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
33415175|NCT00410410|62793324|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
33415176|NCT00410410|62793325|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
33415177|NCT00410410|62793326|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
33415178|NCT00410410|62793327|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
33415179|NCT00410410|62793319|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
33415180|NCT00410410|62793320|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
33415181|NCT00410410|62793321|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
33415182|NCT00410410|62793322|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
33415183|NCT00410410|62793323|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
33415184|NCT00410410|62793324|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
33415185|NCT00410410|62793325|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
33415186|NCT00410410|62793326|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
33415187|NCT00410410|62793327|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
33415188|NCT00410410|62793319|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
33415189|NCT00410410|62793320|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
33415190|NCT00410410|62793321|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
33415191|NCT00410410|62793322|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
33415192|NCT00410410|62793323|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
33415193|NCT00410410|62793324|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
33415194|NCT00410410|62793325|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
33415195|NCT00410410|62793326|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
33415196|NCT00410410|62793327|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
33415197|NCT00410410|62793319|FG000|Open-Label Period (OL)|Death|0|||
33415198|NCT00410410|62793320|FG001|Open-Label Period (OL)|Death|0|||
33415199|NCT00410410|62793321|FG002|Open-Label Period (OL)|Death|0|||
33415200|NCT00410410|62793322|FG003|Open-Label Period (OL)|Death|0|||
33415201|NCT00410410|62793323|FG004|Open-Label Period (OL)|Death|0|||
33415202|NCT00410410|62793324|FG005|Open-Label Period (OL)|Death|0|||
33415203|NCT00410410|62793325|FG006|Open-Label Period (OL)|Death|0|||
33415204|NCT00410410|62793326|FG007|Open-Label Period (OL)|Death|0|||
33415205|NCT00410410|62793327|FG008|Open-Label Period (OL)|Death|1|||
33415206|NCT00410410|62793319|FG000|Open-Label Period (OL)|Adverse Event|0|||
33415207|NCT00410410|62793320|FG001|Open-Label Period (OL)|Adverse Event|0|||
33604866|NCT01806064|63004438|FG003|Overall Study|Randomized Not Enrolled|1|||
33415208|NCT00410410|62793321|FG002|Open-Label Period (OL)|Adverse Event|0|||
33415209|NCT00410410|62793322|FG003|Open-Label Period (OL)|Adverse Event|0|||
33415210|NCT00410410|62793323|FG004|Open-Label Period (OL)|Adverse Event|0|||
33415211|NCT00410410|62793324|FG005|Open-Label Period (OL)|Adverse Event|0|||
33415212|NCT00410410|62793325|FG006|Open-Label Period (OL)|Adverse Event|0|||
33415213|NCT00410410|62793326|FG007|Open-Label Period (OL)|Adverse Event|0|||
33415214|NCT00410410|62793327|FG008|Open-Label Period (OL)|Adverse Event|10|||
33415215|NCT00410410|62793319|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
33415216|NCT00410410|62793320|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
33415217|NCT00410410|62793321|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
33415218|NCT00410410|62793322|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
33415219|NCT00410410|62793323|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
33415220|NCT00410410|62793324|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
33415221|NCT00410410|62793325|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
33415222|NCT00410410|62793326|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
33415223|NCT00410410|62793327|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
33415224|NCT00410410|62793319|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
33415225|NCT00410410|62793320|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
33415226|NCT00410410|62793321|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
33415227|NCT00410410|62793322|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
33415228|NCT00410410|62793323|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
33415229|NCT00410410|62793324|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
33415230|NCT00410410|62793325|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
33415231|NCT00410410|62793326|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
33415232|NCT00410410|62793327|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
33415233|NCT00410410|62793319|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
33415234|NCT00410410|62793320|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
33415235|NCT00410410|62793321|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
33415236|NCT00410410|62793322|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
33415237|NCT00410410|62793323|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
33415238|NCT00410410|62793324|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
33415239|NCT00410410|62793325|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
33415240|NCT00410410|62793326|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
33415241|NCT00410410|62793327|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
33415242|NCT00410410|62793319|FG000|Open-Label Period (OL)|Pregnancy|0|||
33415243|NCT00410410|62793320|FG001|Open-Label Period (OL)|Pregnancy|0|||
33415244|NCT00410410|62793321|FG002|Open-Label Period (OL)|Pregnancy|0|||
33415245|NCT00410410|62793322|FG003|Open-Label Period (OL)|Pregnancy|0|||
33415246|NCT00410410|62793323|FG004|Open-Label Period (OL)|Pregnancy|0|||
33415247|NCT00410410|62793324|FG005|Open-Label Period (OL)|Pregnancy|0|||
33415248|NCT00410410|62793325|FG006|Open-Label Period (OL)|Pregnancy|0|||
33415249|NCT00410410|62793326|FG007|Open-Label Period (OL)|Pregnancy|0|||
33415250|NCT00410410|62793327|FG008|Open-Label Period (OL)|Pregnancy|1|||
33415251|NCT00410410|62793319|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33415252|NCT00410410|62793320|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33415253|NCT00410410|62793321|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33415254|NCT00410410|62793322|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33415255|NCT00410410|62793323|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33415256|NCT00410410|62793324|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33415257|NCT00410410|62793325|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33415258|NCT00410410|62793326|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33415259|NCT00410410|62793327|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
33415260|NCT00410410|62793319|FG000|Open-Label Period (OL)|Other|0|||
33415261|NCT00410410|62793320|FG001|Open-Label Period (OL)|Other|0|||
33415262|NCT00410410|62793321|FG002|Open-Label Period (OL)|Other|0|||
33415263|NCT00410410|62793322|FG003|Open-Label Period (OL)|Other|0|||
33322735|NCT01134042|62698801|FG002|Overall Study|Lost to Follow-up|1|||
33322736|NCT01134042|62698799|FG000|Overall Study|Physician Decision|4|||
33415264|NCT00410410|62793323|FG004|Open-Label Period (OL)|Other|0|||
33415265|NCT00410410|62793324|FG005|Open-Label Period (OL)|Other|0|||
33415266|NCT00410410|62793325|FG006|Open-Label Period (OL)|Other|0|||
33415267|NCT00410410|62793326|FG007|Open-Label Period (OL)|Other|0|||
33415268|NCT00410410|62793327|FG008|Open-Label Period (OL)|Other|7|||
33415269|NCT00534404|62793365|FG000|Overall Study|Death|0|||
33415270|NCT00534404|62793366|FG001|Overall Study|Death|0|||
33415271|NCT00534404|62793367|FG002|Overall Study|Death|2|||
33415272|NCT00534404|62793365|FG000|Overall Study|Withdrawal by Subject|8|||
33415273|NCT00534404|62793366|FG001|Overall Study|Withdrawal by Subject|2|||
33415274|NCT00534404|62793367|FG002|Overall Study|Withdrawal by Subject|38|||
33415275|NCT00534404|62793365|FG000|Overall Study|Removed by study staff|2|||
33415276|NCT00534404|62793366|FG001|Overall Study|Removed by study staff|3|||
33415277|NCT00534404|62793367|FG002|Overall Study|Removed by study staff|1|||
33415278|NCT00534404|62793365|FG000|Overall Study|Lost to Follow-up|170|||
33415279|NCT00534404|62793366|FG001|Overall Study|Lost to Follow-up|138|||
33415280|NCT00534404|62793367|FG002|Overall Study|Lost to Follow-up|201|||
33415281|NCT00393094|62793375|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
33415282|NCT00393094|62793375|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
33415283|NCT00409786|62793381|FG000|Overall Study|Withdrawal by Subject|3|||
33415284|NCT00409708|62793387|FG000|Treatment|Abnormal test procedure result(s)|1|||
33415285|NCT00409708|62793388|FG001|Treatment|Abnormal test procedure result(s)|0|||
33415286|NCT00409708|62793387|FG000|Treatment|Lack of Efficacy|0|||
33415287|NCT00409708|62793388|FG001|Treatment|Lack of Efficacy|1|||
33415288|NCT00409708|62793387|FG000|Treatment|Protocol Violation|6|||
33415289|NCT00409708|62793388|FG001|Treatment|Protocol Violation|2|||
33415290|NCT00409708|62793387|FG000|Treatment|Withdrawal by Subject|3|||
33415291|NCT00409708|62793388|FG001|Treatment|Withdrawal by Subject|8|||
33415292|NCT00409708|62793387|FG000|Treatment|Lost to Follow-up|0|||
33415293|NCT00409708|62793388|FG001|Treatment|Lost to Follow-up|6|||
33415294|NCT00409708|62793387|FG000|Treatment|Administrative problems|5|||
33415295|NCT00409708|62793388|FG001|Treatment|Administrative problems|0|||
33415296|NCT00409708|62793387|FG000|Washout|Lack of Efficacy|9|||
33415297|NCT00409708|62793388|FG001|Washout|Lack of Efficacy|1|||
33415298|NCT00409708|62793387|FG000|Washout|Protocol Violation|0|||
33415299|NCT00409708|62793388|FG001|Washout|Protocol Violation|1|||
33415300|NCT00409708|62793387|FG000|Washout|Withdrawal by Subject|11|||
33415301|NCT00409708|62793388|FG001|Washout|Withdrawal by Subject|5|||
33415302|NCT00409708|62793387|FG000|Washout|Lost to Follow-up|1|||
33415303|NCT00409708|62793388|FG001|Washout|Lost to Follow-up|3|||
33415304|NCT00391846|62793405|FG000|Overall Study|Adverse Event|4|||
33415305|NCT00391846|62793406|FG001|Overall Study|Adverse Event|1|||
33415306|NCT00391846|62793405|FG000|Overall Study|Did not meet the required elig. crit|2|||
33415307|NCT00391846|62793406|FG001|Overall Study|Did not meet the required elig. crit|2|||
33322737|NCT01134042|62698800|FG001|Overall Study|Physician Decision|8|||
33322738|NCT01134042|62698801|FG002|Overall Study|Physician Decision|1|||
33322739|NCT01134042|62698799|FG000|Overall Study|Withdrawal by Subject|13|||
33322740|NCT01134042|62698800|FG001|Overall Study|Withdrawal by Subject|4|||
33415308|NCT00391846|62793405|FG000|Overall Study|Withdrawal by Subject|2|||
33415309|NCT00391846|62793406|FG001|Overall Study|Withdrawal by Subject|3|||
33322741|NCT01134042|62698801|FG002|Overall Study|Withdrawal by Subject|7|||
33322742|NCT01179347|62698812|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
33322743|NCT01179347|62698813|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
33322744|NCT01179347|62698812|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
33322745|NCT01179347|62698813|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
33415310|NCT00391846|62793405|FG000|Overall Study|Developed study specific DC criteria|0|||
33415311|NCT00391846|62793406|FG001|Overall Study|Developed study specific DC criteria|1|||
33415312|NCT00534248|62793431|FG000|Overall Study|Adverse Event|19|||
33415313|NCT00534248|62793432|FG001|Overall Study|Adverse Event|29|||
33415314|NCT00534248|62793431|FG000|Overall Study|Lost to Follow-up|353|||
33415315|NCT00534248|62793432|FG001|Overall Study|Lost to Follow-up|375|||
33415316|NCT00534248|62793431|FG000|Overall Study|Other protocol specified criteria|13|||
33415317|NCT00534248|62793432|FG001|Overall Study|Other protocol specified criteria|3|||
33415318|NCT00534248|62793431|FG000|Overall Study|Physician Decision|10|||
33415319|NCT00534248|62793432|FG001|Overall Study|Physician Decision|7|||
33415320|NCT00534248|62793431|FG000|Overall Study|Protocol Violation|3|||
33415321|NCT00534248|62793432|FG001|Overall Study|Protocol Violation|4|||
33415322|NCT00534248|62793431|FG000|Overall Study|Withdrawal by Subject|263|||
33415323|NCT00534248|62793432|FG001|Overall Study|Withdrawal by Subject|255|||
33415324|NCT00391768|62793445|FG000|Overall Study|Withdrawal by Subject|0|||
33415325|NCT00391768|62793446|FG001|Overall Study|Withdrawal by Subject|0|||
33415326|NCT00391768|62793447|FG002|Overall Study|Withdrawal by Subject|1|||
33415327|NCT00391768|62793448|FG003|Overall Study|Withdrawal by Subject|0|||
33415328|NCT00391768|62793449|FG004|Overall Study|Withdrawal by Subject|0|||
33415329|NCT00391768|62793450|FG005|Overall Study|Withdrawal by Subject|1|||
33322746|NCT01179347|62698812|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
33415330|NCT00391768|62793451|FG006|Overall Study|Withdrawal by Subject|1|||
33415331|NCT00391768|62793445|FG000|Overall Study|Lost to Follow-up|0|||
33415332|NCT00391768|62793446|FG001|Overall Study|Lost to Follow-up|0|||
33415333|NCT00391768|62793447|FG002|Overall Study|Lost to Follow-up|0|||
33415334|NCT00391768|62793448|FG003|Overall Study|Lost to Follow-up|1|||
33415335|NCT00391768|62793449|FG004|Overall Study|Lost to Follow-up|2|||
33415336|NCT00391768|62793450|FG005|Overall Study|Lost to Follow-up|2|||
33415337|NCT00391768|62793451|FG006|Overall Study|Lost to Follow-up|3|||
33415338|NCT00391222|62793488|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
33415339|NCT00391222|62793489|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
33415340|NCT00391222|62793490|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
33415341|NCT00391222|62793491|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
33415342|NCT00391222|62793488|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
33415343|NCT00391222|62793489|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
33415344|NCT00391222|62793490|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
33415345|NCT00391222|62793491|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
33415346|NCT00391222|62793488|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
33415347|NCT00391222|62793489|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
33415348|NCT00391222|62793490|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
33415349|NCT00391222|62793491|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
33415350|NCT00391222|62793488|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
33415351|NCT00391222|62793489|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
33415352|NCT00391222|62793490|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
33415353|NCT00391222|62793491|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
33415354|NCT00391222|62793488|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
33415355|NCT00391222|62793489|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
33415356|NCT00391222|62793490|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
33415357|NCT00391222|62793491|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
33415358|NCT00391222|62793488|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
33415359|NCT00391222|62793489|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
33415360|NCT00391222|62793490|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
33415361|NCT00391222|62793491|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
33415362|NCT00391222|62793488|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
33415363|NCT00391222|62793489|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
33415364|NCT00391222|62793490|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
33415365|NCT00391222|62793491|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
33415366|NCT00391222|62793488|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
33415367|NCT00391222|62793489|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
33415368|NCT00391222|62793490|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
33415369|NCT00391222|62793491|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
33415370|NCT00391222|62793488|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
33415371|NCT00391222|62793489|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
33415372|NCT00391222|62793490|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
33415373|NCT00391222|62793491|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
33322747|NCT01179347|62698813|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
33322748|NCT01179347|62698812|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
33322749|NCT01179347|62698813|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
33415374|NCT00391222|62793488|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
33415375|NCT00391222|62793489|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
33415376|NCT00391222|62793490|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
33415377|NCT00391222|62793491|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
33415378|NCT00391222|62793488|FG000|Period III (Double-Blind Treatment)|Other|6|||
33415379|NCT00391222|62793489|FG001|Period III (Double-Blind Treatment)|Other|1|||
33415380|NCT00391222|62793490|FG002|Period III (Double-Blind Treatment)|Other|6|||
33415381|NCT00391222|62793491|FG003|Period III (Double-Blind Treatment)|Other|0|||
33415382|NCT00409006|62793503|FG000|Overall Study|Death|15|||
33415383|NCT00409006|62793504|FG001|Overall Study|Death|6|||
33415384|NCT00409006|62793503|FG000|Overall Study|Lost to Follow-up|1|||
33415385|NCT00409006|62793504|FG001|Overall Study|Lost to Follow-up|2|||
33415386|NCT00409006|62793503|FG000|Overall Study|Withdrawal by Subject|3|||
33415387|NCT00409006|62793504|FG001|Overall Study|Withdrawal by Subject|2|||
33415388|NCT00409006|62793503|FG000|Overall Study|Physician Decision|1|||
33415389|NCT00409006|62793504|FG001|Overall Study|Physician Decision|2|||
33415390|NCT00534092|62793512|FG000|Overall Study|Lost to Follow-up|1|||
33415391|NCT00534092|62793513|FG001|Overall Study|Lost to Follow-up|0|||
33415392|NCT00534092|62793512|FG000|Overall Study|personal reasons/family concerns|1|||
33415393|NCT00534092|62793513|FG001|Overall Study|personal reasons/family concerns|0|||
33415394|NCT00408928|62793521|FG000|Overall Study|Withdrawal by Subject|1|||
33415395|NCT00408928|62793521|FG000|Overall Study|Death|1|||
33415396|NCT00408928|62793521|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
33415397|NCT00390910|62793528|FG000|Overall Study|Adverse Event|1|||
33415398|NCT00390910|62793529|FG001|Overall Study|Adverse Event|0|||
33415399|NCT00390910|62793530|FG002|Overall Study|Adverse Event|0|||
33415400|NCT00390910|62793528|FG000|Overall Study|Lost to Follow-up|0|||
33415401|NCT00390910|62793529|FG001|Overall Study|Lost to Follow-up|1|||
33415402|NCT00390910|62793530|FG002|Overall Study|Lost to Follow-up|5|||
33415403|NCT00390910|62793528|FG000|Overall Study|Withdrawal by Subject|1|||
33415404|NCT00390910|62793529|FG001|Overall Study|Withdrawal by Subject|3|||
33415405|NCT00390910|62793530|FG002|Overall Study|Withdrawal by Subject|2|||
33415406|NCT00390910|62793528|FG000|Overall Study|Migrated/moved from study area|0|||
33415407|NCT00390910|62793529|FG001|Overall Study|Migrated/moved from study area|0|||
33415408|NCT00390910|62793530|FG002|Overall Study|Migrated/moved from study area|3|||
33415409|NCT00533702|62793542|FG000|Overall Study|Withdrawal by Subject|3|||
33415410|NCT00533702|62793543|FG001|Overall Study|Withdrawal by Subject|1|||
33415411|NCT00533702|62793542|FG000|Overall Study|Found ineligible after randomization|2|||
33415412|NCT00533702|62793543|FG001|Overall Study|Found ineligible after randomization|1|||
33415413|NCT00408694|62793549|FG000|Overall Study|Ineligible|1|||
33415414|NCT00408694|62793549|FG000|Overall Study|No protocol treatment|1|||
33415415|NCT00396136|62793553|FG000|Overall Study|Death|43|||
33415416|NCT00396136|62793553|FG000|Overall Study|Withdrawal by Subject|59|||
33415417|NCT00396136|62793553|FG000|Overall Study|Lost to Follow-up|15|||
33415418|NCT00396136|62793553|FG000|Overall Study|Study device explanted|8|||
33415419|NCT00530894|62793561|FG000|Overall Study|Death|84|||
33415420|NCT00530894|62793562|FG001|Overall Study|Death|89|||
33415421|NCT00530894|62793563|FG002|Overall Study|Death|55|||
33415422|NCT00530894|62793564|FG003|Overall Study|Death|89|||
33415423|NCT00530894|62793561|FG000|Overall Study|Lost to Follow-up|1|||
33415424|NCT00530894|62793562|FG001|Overall Study|Lost to Follow-up|3|||
33415425|NCT00530894|62793563|FG002|Overall Study|Lost to Follow-up|0|||
33415426|NCT00530894|62793564|FG003|Overall Study|Lost to Follow-up|0|||
33415427|NCT00530894|62793561|FG000|Overall Study|Withdrawal by Subject|1|||
33415428|NCT00530894|62793562|FG001|Overall Study|Withdrawal by Subject|23|||
33415429|NCT00530894|62793563|FG002|Overall Study|Withdrawal by Subject|0|||
33415430|NCT00530894|62793564|FG003|Overall Study|Withdrawal by Subject|5|||
33415431|NCT00530894|62793561|FG000|Overall Study|Alive and censored prior to 1 year|2|||
33415432|NCT00530894|62793562|FG001|Overall Study|Alive and censored prior to 1 year|0|||
33415433|NCT00530894|62793563|FG002|Overall Study|Alive and censored prior to 1 year|0|||
33415434|NCT00530894|62793564|FG003|Overall Study|Alive and censored prior to 1 year|0|||
33415435|NCT00056407|62793578|FG000|Overall Study|Adverse Event|282|||
33415436|NCT00056407|62793579|FG001|Overall Study|Adverse Event|364|||
33415437|NCT00056407|62793578|FG000|Overall Study|Withdrawal by Subject|377|||
33415438|NCT00056407|62793579|FG001|Overall Study|Withdrawal by Subject|361|||
33415439|NCT00056407|62793578|FG000|Overall Study|Lost to Follow-up|123|||
33415440|NCT00056407|62793579|FG001|Overall Study|Lost to Follow-up|113|||
33415441|NCT00056407|62793578|FG000|Overall Study|Protocol Violation|104|||
33415442|NCT00056407|62793579|FG001|Overall Study|Protocol Violation|95|||
33415443|NCT00056407|62793578|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
33415444|NCT00056407|62793579|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
33415445|NCT00056407|62793578|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
33415446|NCT00056407|62793579|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
33415447|NCT00056407|62793578|FG000|Overall Study|Missing|25|||
33415448|NCT00056407|62793579|FG001|Overall Study|Missing|34|||
33415449|NCT00388726|62793587|FG000|Overall Study|Adverse Event|50|||
33415450|NCT00388726|62793588|FG001|Overall Study|Adverse Event|24|||
33415451|NCT00388726|62793587|FG000|Overall Study|Progressive Disease|336|||
33415452|NCT00388726|62793588|FG001|Overall Study|Progressive Disease|153|||
33415453|NCT00388726|62793587|FG000|Overall Study|Clinical Progression|61|||
33415454|NCT00388726|62793588|FG001|Overall Study|Clinical Progression|36|||
33415455|NCT00388726|62793587|FG000|Overall Study|Withdrawal by Subject|10|||
33415456|NCT00388726|62793588|FG001|Overall Study|Withdrawal by Subject|7|||
33415457|NCT00388726|62793587|FG000|Overall Study|Administrative|6|||
33415458|NCT00388726|62793588|FG001|Overall Study|Administrative|9|||
33415459|NCT00388726|62793587|FG000|Overall Study|Physician Decision|18|||
33415460|NCT00388726|62793588|FG001|Overall Study|Physician Decision|13|||
33415461|NCT00388726|62793587|FG000|Overall Study|Death|3|||
33604867|NCT01806064|63004439|FG004|Overall Study|Randomized Not Enrolled|2|||
33415462|NCT00388726|62793588|FG001|Overall Study|Death|2|||
33415463|NCT00387790|62793594|FG000|Overall Study|Adverse Event|5|||
33415464|NCT00387790|62793594|FG000|Overall Study|Lack of Efficacy|2|||
33604868|NCT01804582|63004457|FG000|Overall Study|Lost to Follow-up|47|||
33415465|NCT00387790|62793594|FG000|Overall Study|Physician Decision|2|||
33415466|NCT00387790|62793594|FG000|Overall Study|Withdrawal by Subject|3|||
33415467|NCT00387790|62793594|FG000|Overall Study|Ineligible for study|2|||
33415468|NCT00073021|62793600|FG000|Overall Study|Protocol Violation|2|||
33415469|NCT00073021|62793601|FG001|Overall Study|Protocol Violation|1|||
33415470|NCT00073021|62793600|FG000|Overall Study|Adverse Event|4|||
33415471|NCT00073021|62793601|FG001|Overall Study|Adverse Event|4|||
33415472|NCT00073021|62793600|FG000|Overall Study|Withdrawal by Subject|6|||
33415473|NCT00073021|62793601|FG001|Overall Study|Withdrawal by Subject|5|||
33415474|NCT00073021|62793600|FG000|Overall Study|Physician Decision|3|||
33415475|NCT00073021|62793601|FG001|Overall Study|Physician Decision|1|||
33415476|NCT00073021|62793600|FG000|Overall Study|Lack of Efficacy|11|||
33415477|NCT00073021|62793601|FG001|Overall Study|Lack of Efficacy|5|||
33415478|NCT00407758|62793607|FG000|Overall Study|ineligible -improper prior treatment|1|||
33415479|NCT00531752|62793615|FG000|First Double-blind Intervention Period|Adverse Event|2|||
33415480|NCT00531752|62793616|FG001|First Double-blind Intervention Period|Adverse Event|0|||
33415481|NCT00531752|62793617|FG002|First Double-blind Intervention Period|Adverse Event|1|||
33415482|NCT00531752|62793618|FG003|First Double-blind Intervention Period|Adverse Event|1|||
33415483|NCT00531752|62793615|FG000|First Double-blind Intervention Period|Other|1|||
33415484|NCT00531752|62793616|FG001|First Double-blind Intervention Period|Other|4|||
33415485|NCT00531752|62793617|FG002|First Double-blind Intervention Period|Other|4|||
33415486|NCT00531752|62793618|FG003|First Double-blind Intervention Period|Other|0|||
33415487|NCT00531752|62793615|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
33415488|NCT00531752|62793616|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
33415489|NCT00531752|62793617|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
33415490|NCT00531752|62793618|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
33415491|NCT00531752|62793615|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
33415492|NCT00531752|62793616|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
33415493|NCT00531752|62793617|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
33415494|NCT00531752|62793618|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
33415495|NCT00531752|62793615|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
33415496|NCT00531752|62793616|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
33415497|NCT00531752|62793617|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
33415498|NCT00531752|62793618|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
33415499|NCT00531752|62793615|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
33415500|NCT00531752|62793616|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
33415501|NCT00531752|62793617|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
33415502|NCT00531752|62793618|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
33415503|NCT00531752|62793615|FG000|Second Double-blind Intervention Period|Other|1|||
33415504|NCT00531752|62793616|FG001|Second Double-blind Intervention Period|Other|1|||
33415505|NCT00531752|62793617|FG002|Second Double-blind Intervention Period|Other|0|||
33415506|NCT00531752|62793618|FG003|Second Double-blind Intervention Period|Other|0|||
33415507|NCT00531752|62793615|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
33415508|NCT00531752|62793616|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
33415509|NCT00531752|62793617|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
33415510|NCT00531752|62793618|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
33415511|NCT00531752|62793615|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
33415512|NCT00531752|62793616|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
33415513|NCT00531752|62793617|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
33415514|NCT00531752|62793618|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
33415515|NCT00395746|62793629|FG000|Overall Study|Adverse Event|5|||
33415516|NCT00395746|62793630|FG001|Overall Study|Adverse Event|2|||
33415517|NCT00395746|62793631|FG002|Overall Study|Adverse Event|2|||
33415518|NCT00395746|62793629|FG000|Overall Study|Protocol Violation|0|||
33415519|NCT00395746|62793630|FG001|Overall Study|Protocol Violation|1|||
33415520|NCT00395746|62793631|FG002|Overall Study|Protocol Violation|0|||
33415521|NCT00395746|62793629|FG000|Overall Study|Lack of Efficacy|2|||
33415522|NCT00395746|62793630|FG001|Overall Study|Lack of Efficacy|0|||
33415523|NCT00395746|62793631|FG002|Overall Study|Lack of Efficacy|17|||
33415524|NCT00395746|62793629|FG000|Overall Study|Hypoglycaemia|2|||
33415525|NCT00395746|62793630|FG001|Overall Study|Hypoglycaemia|1|||
33415526|NCT00395746|62793631|FG002|Overall Study|Hypoglycaemia|0|||
33415527|NCT00395746|62793629|FG000|Overall Study|Subject decision|0|||
33415528|NCT00395746|62793630|FG001|Overall Study|Subject decision|0|||
33415529|NCT00395746|62793631|FG002|Overall Study|Subject decision|1|||
33415530|NCT00395746|62793629|FG000|Overall Study|Withdrawal of consent|0|||
33415531|NCT00395746|62793630|FG001|Overall Study|Withdrawal of consent|0|||
33415532|NCT00395746|62793631|FG002|Overall Study|Withdrawal of consent|1|||
33415533|NCT00395746|62793629|FG000|Overall Study|Difficultulty in use of device|0|||
33415534|NCT00395746|62793630|FG001|Overall Study|Difficultulty in use of device|0|||
33415535|NCT00395746|62793631|FG002|Overall Study|Difficultulty in use of device|1|||
33415536|NCT00395746|62793629|FG000|Overall Study|Unable to visit site on schedule|1|||
33415537|NCT00395746|62793630|FG001|Overall Study|Unable to visit site on schedule|0|||
33415538|NCT00395746|62793631|FG002|Overall Study|Unable to visit site on schedule|0|||
33415539|NCT00055471|62793642|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
33415540|NCT00055471|62793643|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
33415541|NCT00055471|62793644|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
33415542|NCT00055471|62793642|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
33415543|NCT00055471|62793643|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
33415544|NCT00055471|62793644|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
33415545|NCT00055471|62793642|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
33415546|NCT00055471|62793643|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
33415547|NCT00055471|62793644|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
33415548|NCT00395512|62793656|FG000|Overall Study|Adverse Event|3|||
33415549|NCT00395512|62793657|FG001|Overall Study|Adverse Event|8|||
33415550|NCT00395512|62793658|FG002|Overall Study|Adverse Event|6|||
33415551|NCT00395512|62793659|FG003|Overall Study|Adverse Event|6|||
33415552|NCT00395512|62793656|FG000|Overall Study|Protocol Violation|2|||
33415553|NCT00395512|62793657|FG001|Overall Study|Protocol Violation|3|||
33415554|NCT00395512|62793658|FG002|Overall Study|Protocol Violation|6|||
33415555|NCT00395512|62793659|FG003|Overall Study|Protocol Violation|7|||
33415556|NCT00395512|62793656|FG000|Overall Study|Lost to Follow-up|2|||
33415557|NCT00395512|62793657|FG001|Overall Study|Lost to Follow-up|6|||
33415558|NCT00395512|62793658|FG002|Overall Study|Lost to Follow-up|5|||
33415559|NCT00395512|62793659|FG003|Overall Study|Lost to Follow-up|5|||
33415560|NCT00395512|62793656|FG000|Overall Study|Withdrawal by Subject|6|||
33415561|NCT00395512|62793657|FG001|Overall Study|Withdrawal by Subject|5|||
33415562|NCT00395512|62793658|FG002|Overall Study|Withdrawal by Subject|5|||
33415563|NCT00395512|62793659|FG003|Overall Study|Withdrawal by Subject|12|||
33415564|NCT00395512|62793656|FG000|Overall Study|Physician Decision|6|||
33415565|NCT00395512|62793657|FG001|Overall Study|Physician Decision|4|||
33415566|NCT00395512|62793658|FG002|Overall Study|Physician Decision|2|||
33415567|NCT00395512|62793659|FG003|Overall Study|Physician Decision|2|||
33415568|NCT00395512|62793656|FG000|Overall Study|Other|1|||
33415569|NCT00395512|62793657|FG001|Overall Study|Other|1|||
33415570|NCT00395512|62793658|FG002|Overall Study|Other|0|||
33604869|NCT01804582|63004458|FG001|Overall Study|Lost to Follow-up|56|||
33604870|NCT01804582|63004457|FG000|Overall Study|Physician Decision|2|||
33604871|NCT01804582|63004458|FG001|Overall Study|Physician Decision|0|||
33604872|NCT01787188|63004468|FG000|Overall Study|Adverse Event|2|||
33604873|NCT01787188|63004469|FG001|Overall Study|Adverse Event|4|||
33604874|NCT01787188|63004470|FG002|Overall Study|Adverse Event|6|||
33604875|NCT01787188|63004468|FG000|Overall Study|Lack of Efficacy|7|||
33415571|NCT00395512|62793659|FG003|Overall Study|Other|0|||
33415572|NCT00395512|62793656|FG000|Overall Study|Hyperglycemic Rescue|18|||
33415573|NCT00395512|62793657|FG001|Overall Study|Hyperglycemic Rescue|10|||
33415574|NCT00395512|62793658|FG002|Overall Study|Hyperglycemic Rescue|4|||
33604876|NCT01787188|63004469|FG001|Overall Study|Lack of Efficacy|3|||
33604877|NCT01787188|63004470|FG002|Overall Study|Lack of Efficacy|5|||
33415575|NCT00395512|62793659|FG003|Overall Study|Hyperglycemic Rescue|6|||
33415576|NCT00054691|62793669|FG000|Overall Study|Unmeasurable Disease|2|||
33415577|NCT00054691|62793669|FG000|Overall Study|Noncompliant|1|||
33415578|NCT00387712|62793675|FG000|Overall Study|Physician Decision|6|||
33415579|NCT00387712|62793676|FG001|Overall Study|Physician Decision|4|||
33415580|NCT00387712|62793675|FG000|Overall Study|Lost to Follow-up|17|||
33415581|NCT00387712|62793676|FG001|Overall Study|Lost to Follow-up|20|||
33415582|NCT00387712|62793675|FG000|Overall Study|Withdrawal by Subject|6|||
33415583|NCT00387712|62793676|FG001|Overall Study|Withdrawal by Subject|12|||
33415584|NCT00066703|62793684|FG000|Overall Study|Adverse Event|80|||
33415585|NCT00066703|62793685|FG001|Overall Study|Adverse Event|111|||
33415586|NCT00066703|62793684|FG000|Overall Study|Death|3|||
33415587|NCT00066703|62793685|FG001|Overall Study|Death|0|||
33415588|NCT00066703|62793684|FG000|Overall Study|Lack of Efficacy|114|||
33415589|NCT00066703|62793685|FG001|Overall Study|Lack of Efficacy|69|||
33415590|NCT00066703|62793684|FG000|Overall Study|Lost to Follow-up|31|||
33415591|NCT00066703|62793685|FG001|Overall Study|Lost to Follow-up|28|||
33415592|NCT00066703|62793684|FG000|Overall Study|Withdrawal by Subject|38|||
33415593|NCT00066703|62793685|FG001|Overall Study|Withdrawal by Subject|63|||
33415594|NCT00066703|62793684|FG000|Overall Study|Treatment ongoing|346|||
33415595|NCT00066703|62793685|FG001|Overall Study|Treatment ongoing|311|||
33415596|NCT00072475|62793691|FG000|Overall Study|Adverse Event|44|||
33415597|NCT00072475|62793691|FG000|Overall Study|Death|3|||
33415598|NCT00072475|62793691|FG000|Overall Study|Withdrawal by Subject|46|||
33415599|NCT00072475|62793691|FG000|Overall Study|Patient/Investigator Decision|4|||
33415600|NCT00066469|62793695|FG000|Overall Study|Death|3|||
33415601|NCT00066469|62793695|FG000|Overall Study|Lack of Efficacy|9|||
33415602|NCT00066469|62793695|FG000|Overall Study|Lost to Follow-up|1|||
33415603|NCT00066469|62793695|FG000|Overall Study|Physician Decision|1|||
33415604|NCT00066469|62793695|FG000|Overall Study|Withdrawal by Subject|1|||
33415605|NCT00066469|62793695|FG000|Overall Study|ineligible|1|||
33415606|NCT00387088|62793701|FG000|Overall Study|Adverse Event|143|||
33415607|NCT00387088|62793702|FG001|Overall Study|Adverse Event|156|||
33415608|NCT00387088|62793701|FG000|Overall Study|Protocol Violation|47|||
33415609|NCT00387088|62793702|FG001|Overall Study|Protocol Violation|35|||
33415610|NCT00387088|62793701|FG000|Overall Study|Withdrawal by Subject|20|||
33415611|NCT00387088|62793702|FG001|Overall Study|Withdrawal by Subject|35|||
33415612|NCT00387088|62793701|FG000|Overall Study|Lack of Efficacy|28|||
33415613|NCT00387088|62793702|FG001|Overall Study|Lack of Efficacy|67|||
33415614|NCT00387088|62793701|FG000|Overall Study|Lost to Follow-up|22|||
33415615|NCT00387088|62793702|FG001|Overall Study|Lost to Follow-up|28|||
33415616|NCT00387088|62793701|FG000|Overall Study|Other|58|||
33415617|NCT00387088|62793702|FG001|Overall Study|Other|52|||
33415618|NCT00053365|62793708|FG000|Overall Study|Incorrect cell type|1|||
33415619|NCT00053365|62793708|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
33415620|NCT00053365|62793708|FG000|Overall Study|Never treated|4|||
33415621|NCT00387010|62793714|FG000|Dose Titration Period|Adverse Event|12|||
33415622|NCT00387010|62793714|FG000|Dose Titration Period|Lack of Efficacy|5|||
33415623|NCT00387010|62793714|FG000|Dose Titration Period|Withdrawal by Subject|3|||
33415624|NCT00387010|62793714|FG000|Dose Titration Period|Protocol Violation|1|||
33415625|NCT00387010|62793714|FG000|Dose Titration Period|Lost to Follow-up|2|||
33415626|NCT00387010|62793714|FG000|Dose Titration Period|Noncompliance with study medication|8|||
33415627|NCT00387010|62793714|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
33604878|NCT01787188|63004468|FG000|Overall Study|Non-compliance with Study Drug|0|||
33604879|NCT01787188|63004469|FG001|Overall Study|Non-compliance with Study Drug|1|||
33604880|NCT01787188|63004470|FG002|Overall Study|Non-compliance with Study Drug|0|||
33604881|NCT01787188|63004468|FG000|Overall Study|Withdrawal by Subject|4|||
33604882|NCT01787188|63004469|FG001|Overall Study|Withdrawal by Subject|3|||
33415628|NCT00387010|62793714|FG000|Treatment Period|Adverse Event|4|||
33415629|NCT00387010|62793714|FG000|Treatment Period|Withdrawal by Subject|1|||
33604883|NCT01787188|63004470|FG002|Overall Study|Withdrawal by Subject|2|||
33604884|NCT01787188|63004468|FG000|Overall Study|Protocol Violation|3|||
33415630|NCT00387010|62793714|FG000|Treatment Period|Noncompliance with study medication|2|||
33415631|NCT00387010|62793714|FG000|Treatment Period|Noncompliance with study procedures|3|||
33415632|NCT00387010|62793714|FG000|Treatment Period|Participant reported study drug stolen|1|||
33415633|NCT00386776|62793718|FG000|Overall Study|Withdrawal by Subject|8|||
33415634|NCT00065065|62793726|FG000|Overall Study|Adverse Event|3|||
33415635|NCT00065065|62793727|FG001|Overall Study|Adverse Event|2|||
33415636|NCT00065065|62793726|FG000|Overall Study|Withdrawal by Subject|1|||
33415637|NCT00065065|62793727|FG001|Overall Study|Withdrawal by Subject|5|||
33415638|NCT00065065|62793726|FG000|Overall Study|Lack of Efficacy|4|||
33415639|NCT00065065|62793727|FG001|Overall Study|Lack of Efficacy|11|||
33415640|NCT00065065|62793726|FG000|Overall Study|Other|2|||
33415641|NCT00065065|62793727|FG001|Overall Study|Other|2|||
33415642|NCT00386308|62793737|FG000|Overall Study|Adverse Event|3|||
33415643|NCT00386308|62793738|FG001|Overall Study|Adverse Event|3|||
33415644|NCT00386308|62793737|FG000|Overall Study|Protocol Violation|2|||
33415645|NCT00386308|62793738|FG001|Overall Study|Protocol Violation|5|||
33415646|NCT00386308|62793737|FG000|Overall Study|Lack of Efficacy|0|||
33415647|NCT00386308|62793738|FG001|Overall Study|Lack of Efficacy|2|||
33415648|NCT00386308|62793737|FG000|Overall Study|Lost to Follow-up|10|||
33415649|NCT00386308|62793738|FG001|Overall Study|Lost to Follow-up|6|||
33415650|NCT00386308|62793737|FG000|Overall Study|Withdrawal by Subject|6|||
33415651|NCT00386308|62793738|FG001|Overall Study|Withdrawal by Subject|2|||
33415652|NCT00386308|62793737|FG000|Overall Study|Other Event|8|||
33415653|NCT00386308|62793738|FG001|Overall Study|Other Event|1|||
33415654|NCT00064987|62793746|FG000|Overall Study|Physician Decision|3|||
33415655|NCT00064987|62793747|FG001|Overall Study|Physician Decision|0|||
33415656|NCT00374452|62793755|FG000|Overall Study|Left clinic before intervention started|4|||
33415657|NCT00374452|62793756|FG001|Overall Study|Left clinic before intervention started|1|||
33415658|NCT00374452|62793755|FG000|Overall Study|Change in job role before intervention|0|||
33415659|NCT00374452|62793756|FG001|Overall Study|Change in job role before intervention|1|||
33415660|NCT00374452|62793755|FG000|Overall Study|Left clinic after intervention started|1|||
33415661|NCT00374452|62793756|FG001|Overall Study|Left clinic after intervention started|1|||
33415662|NCT00374452|62793755|FG000|Overall Study|Withdrawal by Subject|0|||
33415663|NCT00374452|62793756|FG001|Overall Study|Withdrawal by Subject|2|||
33415664|NCT00064753|62793764|FG000|Overall Study|Death|251|||
33415665|NCT00064753|62793765|FG001|Overall Study|Death|242|||
33415666|NCT00064753|62793764|FG000|Overall Study|Withdrawal by Subject|198|||
33415667|NCT00064753|62793765|FG001|Overall Study|Withdrawal by Subject|171|||
33415668|NCT00064753|62793764|FG000|Overall Study|Lost to Follow-up|225|||
33415669|NCT00064753|62793765|FG001|Overall Study|Lost to Follow-up|235|||
33415670|NCT00374140|62793771|FG000|Overall Study|Lost to Follow-up|1|||
33415671|NCT00374140|62793771|FG000|Overall Study|Protocol Violation|1|||
33415672|NCT00665561|62793777|FG000|Overall Study|Death recorded on subject summary pages|75|||
33415673|NCT00665561|62793778|FG001|Overall Study|Death recorded on subject summary pages|75|||
33415674|NCT00665561|62793777|FG000|Overall Study|Does not meet entrance criteria|19|||
33415675|NCT00665561|62793778|FG001|Overall Study|Does not meet entrance criteria|21|||
33415676|NCT00665561|62793777|FG000|Overall Study|Lost to Follow-up|203|||
33415677|NCT00665561|62793778|FG001|Overall Study|Lost to Follow-up|264|||
33415678|NCT00665561|62793777|FG000|Overall Study|Withdrawal by Subject|74|||
33415679|NCT00665561|62793778|FG001|Overall Study|Withdrawal by Subject|65|||
33415680|NCT00665561|62793777|FG000|Overall Study|Other|123|||
33415681|NCT00665561|62793778|FG001|Overall Study|Other|108|||
33415682|NCT00665561|62793777|FG000|Overall Study|Site closed|8|||
33415683|NCT00665561|62793778|FG001|Overall Study|Site closed|0|||
33415684|NCT00665561|62793777|FG000|Overall Study|Withdrawn due to pregnancy|0|||
33415685|NCT00665561|62793778|FG001|Overall Study|Withdrawn due to pregnancy|1|||
33604885|NCT01787188|63004469|FG001|Overall Study|Protocol Violation|2|||
33415686|NCT00663923|62793784|FG000|Overall Study|Lost to Follow-up|2|||
33415687|NCT00386152|62793793|FG000|Overall Study|Adverse Event|6|||
33415688|NCT00386152|62793794|FG001|Overall Study|Adverse Event|5|||
33415689|NCT00386152|62793795|FG002|Overall Study|Adverse Event|4|||
33415690|NCT00386152|62793793|FG000|Overall Study|Chang from original chemo stratification|4|||
33604886|NCT01787188|63004470|FG002|Overall Study|Protocol Violation|3|||
33415691|NCT00386152|62793794|FG001|Overall Study|Chang from original chemo stratification|5|||
33415692|NCT00386152|62793795|FG002|Overall Study|Chang from original chemo stratification|6|||
33415693|NCT00386152|62793793|FG000|Overall Study|Death|3|||
33415694|NCT00386152|62793794|FG001|Overall Study|Death|0|||
33415695|NCT00386152|62793795|FG002|Overall Study|Death|1|||
33415696|NCT00386152|62793793|FG000|Overall Study|Disease progression|7|||
33415697|NCT00386152|62793794|FG001|Overall Study|Disease progression|4|||
33415698|NCT00386152|62793795|FG002|Overall Study|Disease progression|5|||
33415699|NCT00386152|62793793|FG000|Overall Study|Physician Decision|13|||
33415700|NCT00386152|62793794|FG001|Overall Study|Physician Decision|10|||
33415701|NCT00386152|62793795|FG002|Overall Study|Physician Decision|4|||
33415702|NCT00386152|62793793|FG000|Overall Study|Lost to Follow-up|1|||
33415703|NCT00386152|62793794|FG001|Overall Study|Lost to Follow-up|0|||
33415704|NCT00386152|62793795|FG002|Overall Study|Lost to Follow-up|0|||
33415705|NCT00386152|62793793|FG000|Overall Study|Completed chemotherapy|4|||
33415706|NCT00386152|62793794|FG001|Overall Study|Completed chemotherapy|5|||
33415707|NCT00386152|62793795|FG002|Overall Study|Completed chemotherapy|1|||
33415708|NCT00386152|62793793|FG000|Overall Study|Protocol Violation|3|||
33415709|NCT00386152|62793794|FG001|Overall Study|Protocol Violation|5|||
33415710|NCT00386152|62793795|FG002|Overall Study|Protocol Violation|2|||
33415711|NCT00386152|62793793|FG000|Overall Study|Withdrawal by Subject|3|||
33415712|NCT00386152|62793794|FG001|Overall Study|Withdrawal by Subject|6|||
33415713|NCT00386152|62793795|FG002|Overall Study|Withdrawal by Subject|10|||
33415714|NCT00385918|62793805|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
33415715|NCT00385918|62793806|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
33415716|NCT00385918|62793807|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
33415717|NCT00385918|62793805|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
33415718|NCT00385918|62793806|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
33415719|NCT00385918|62793807|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
33415720|NCT00385918|62793805|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
33415721|NCT00385918|62793806|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
33415722|NCT00385918|62793807|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
33415723|NCT00385918|62793805|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
33415724|NCT00385918|62793806|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
33415725|NCT00385918|62793807|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
33415726|NCT00385918|62793805|FG000|Intervention Phase After Randomization|Physician Decision|1|||
33415727|NCT00385918|62793806|FG001|Intervention Phase After Randomization|Physician Decision|0|||
33415728|NCT00385918|62793807|FG002|Intervention Phase After Randomization|Physician Decision|0|||
33415729|NCT00385918|62793805|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
33415730|NCT00385918|62793806|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
33415731|NCT00385918|62793807|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
33415732|NCT00385840|62793816|FG000|Overall Study|Adverse Event|1|||
33415733|NCT00385840|62793817|FG001|Overall Study|Adverse Event|1|||
33415734|NCT00385840|62793816|FG000|Overall Study|Lost to Follow-up|3|||
33415735|NCT00385840|62793817|FG001|Overall Study|Lost to Follow-up|13|||
33415736|NCT00385762|62793823|FG000|Overall Study|Adverse Event|1|||
33415737|NCT00385762|62793823|FG000|Overall Study|Lost to Follow-up|1|||
33415738|NCT00385684|62793827|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
33415739|NCT00385684|62793828|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
33415740|NCT00385684|62793827|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
33415741|NCT00385684|62793828|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
33415742|NCT00385684|62793827|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
33415743|NCT00385684|62793828|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
33415744|NCT00661661|62793836|FG000|Overall Study|Adverse Event|99|||
33415745|NCT00661661|62793837|FG001|Overall Study|Adverse Event|24|||
33415746|NCT00661661|62793836|FG000|Overall Study|Lack of Efficacy|3|||
33415747|NCT00661661|62793837|FG001|Overall Study|Lack of Efficacy|2|||
33415748|NCT00661661|62793836|FG000|Overall Study|Lost to Follow-up|0|||
33415749|NCT00661661|62793837|FG001|Overall Study|Lost to Follow-up|1|||
33415750|NCT00661661|62793836|FG000|Overall Study|Withdrawal by Subject|15|||
33415751|NCT00661661|62793837|FG001|Overall Study|Withdrawal by Subject|5|||
33415752|NCT00661661|62793836|FG000|Overall Study|Other|22|||
33415753|NCT00661661|62793837|FG001|Overall Study|Other|7|||
33415754|NCT00661661|62793836|FG000|Overall Study|Not assigned treatment|1|||
33322750|NCT01179347|62698812|FG000|Double-blind Period (12 Weeks)|Other|2|||
33322751|NCT01179347|62698813|FG001|Double-blind Period (12 Weeks)|Other|4|||
33322752|NCT01179347|62698812|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
33415755|NCT00661661|62793837|FG001|Overall Study|Not assigned treatment|0|||
33415756|NCT00038467|62793847|FG000|Overall Study|Adverse Event|170|||
33415757|NCT00038467|62793848|FG001|Overall Study|Adverse Event|145|||
33415758|NCT00038467|62793847|FG000|Overall Study|Withdrawal by Subject|150|||
33415759|NCT00038467|62793848|FG001|Overall Study|Withdrawal by Subject|107|||
33415760|NCT00038467|62793847|FG000|Overall Study|Protocol Violation|19|||
33415761|NCT00038467|62793848|FG001|Overall Study|Protocol Violation|22|||
33415762|NCT00038467|62793847|FG000|Overall Study|Death|22|||
33415763|NCT00038467|62793848|FG001|Overall Study|Death|16|||
33415764|NCT00038467|62793847|FG000|Overall Study|Lost to Follow-up|15|||
33415765|NCT00038467|62793848|FG001|Overall Study|Lost to Follow-up|10|||
33415766|NCT00038467|62793847|FG000|Overall Study|Recurrence|109|||
33415767|NCT00038467|62793848|FG001|Overall Study|Recurrence|179|||
33415768|NCT00038467|62793847|FG000|Overall Study|Randomized, but not treated|31|||
33415769|NCT00038467|62793848|FG001|Overall Study|Randomized, but not treated|35|||
33415770|NCT00038467|62793847|FG000|Overall Study|Other|26|||
33415771|NCT00038467|62793848|FG001|Overall Study|Other|28|||
33415772|NCT00051025|62793856|FG000|Overall Study|Progressive Disease|1|||
33415773|NCT00051025|62793857|FG001|Overall Study|Progressive Disease|1|||
33415774|NCT00051025|62793856|FG000|Overall Study|Adverse Event|1|||
33415775|NCT00051025|62793857|FG001|Overall Study|Adverse Event|1|||
33415776|NCT00051025|62793856|FG000|Overall Study|Withdrawal by Subject|0|||
33415777|NCT00051025|62793857|FG001|Overall Study|Withdrawal by Subject|1|||
33415778|NCT00051025|62793856|FG000|Overall Study|Death|0|||
33415779|NCT00051025|62793857|FG001|Overall Study|Death|1|||
33415780|NCT00660179|62793866|FG000|Overall Study|Death|44|||
33415781|NCT00660179|62793867|FG001|Overall Study|Death|47|||
33415782|NCT00660179|62793868|FG002|Overall Study|Death|34|||
33415783|NCT00660179|62793866|FG000|Overall Study|Withdrawal of consent|4|||
33415784|NCT00660179|62793867|FG001|Overall Study|Withdrawal of consent|6|||
33415785|NCT00660179|62793868|FG002|Overall Study|Withdrawal of consent|4|||
33604887|NCT01787188|63004468|FG000|Overall Study|Lost to Follow-up|1|||
33604888|NCT01787188|63004469|FG001|Overall Study|Lost to Follow-up|2|||
33604889|NCT01787188|63004470|FG002|Overall Study|Lost to Follow-up|2|||
33604890|NCT01787188|63004468|FG000|Overall Study|Other, including patient moved|0|||
33322753|NCT01179347|62698813|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
33415786|NCT00660179|62793866|FG000|Overall Study|Lost to Follow-up|7|||
33415787|NCT00660179|62793867|FG001|Overall Study|Lost to Follow-up|5|||
33415788|NCT00660179|62793868|FG002|Overall Study|Lost to Follow-up|2|||
33415789|NCT00660179|62793866|FG000|Overall Study|Administrative reason|0|||
33415790|NCT00660179|62793867|FG001|Overall Study|Administrative reason|0|||
33415791|NCT00660179|62793868|FG002|Overall Study|Administrative reason|1|||
33415792|NCT00660179|62793866|FG000|Overall Study|Incorrect randomization|1|||
33415793|NCT00660179|62793867|FG001|Overall Study|Incorrect randomization|0|||
33604891|NCT01787188|63004469|FG001|Overall Study|Other, including patient moved|3|||
33415794|NCT00660179|62793868|FG002|Overall Study|Incorrect randomization|0|||
33415795|NCT00050167|62793878|FG000|Overall Study|not eligible not invasive|1|||
33604892|NCT01787188|63004470|FG002|Overall Study|Other, including patient moved|0|||
33415796|NCT00050167|62793879|FG001|Overall Study|not eligible not invasive|1|||
33415797|NCT00660023|62793885|FG000|Overall Study|Adverse Event|2|||
33415798|NCT00660023|62793885|FG000|Overall Study|Death|8|||
33415799|NCT00660023|62793885|FG000|Overall Study|Blood Transfusion|5|||
33415800|NCT00660023|62793885|FG000|Overall Study|Renal Transplantation|3|||
33415801|NCT00660023|62793885|FG000|Overall Study|Withdrawal by Subject|1|||
33415802|NCT00660023|62793885|FG000|Overall Study|Missed Pregnancy Test|1|||
33415803|NCT00660023|62793885|FG000|Overall Study|Other Screening Failure|9|||
33415804|NCT00062647|62793891|FG000|Overall Study|Death|2|||
33415805|NCT00062647|62793892|FG001|Overall Study|Death|2|||
33415806|NCT00062647|62793891|FG000|Overall Study|Adverse Event|1|||
33415807|NCT00062647|62793892|FG001|Overall Study|Adverse Event|1|||
33415808|NCT00062647|62793891|FG000|Overall Study|Withdrawal by Subject|2|||
33415809|NCT00062647|62793892|FG001|Overall Study|Withdrawal by Subject|1|||
33415810|NCT00062647|62793891|FG000|Overall Study|Protocol Violation|1|||
33415811|NCT00062647|62793892|FG001|Overall Study|Protocol Violation|0|||
33415812|NCT00062647|62793891|FG000|Overall Study|Lost to Follow-up|1|||
33415813|NCT00062647|62793892|FG001|Overall Study|Lost to Follow-up|2|||
33415814|NCT00062647|62793891|FG000|Overall Study|Failed continuation criteria|4|||
33415815|NCT00062647|62793892|FG001|Overall Study|Failed continuation criteria|2|||
33415816|NCT00062647|62793891|FG000|Overall Study|Other|4|||
33415817|NCT00062647|62793892|FG001|Overall Study|Other|4|||
33415818|NCT00062647|62793891|FG000|Overall Study|Never received study treatment|1|||
33415819|NCT00062647|62793892|FG001|Overall Study|Never received study treatment|1|||
33415820|NCT00570323|62793900|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
33415821|NCT00570323|62793901|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
33415822|NCT00570323|62793900|FG000|Started Treatment After Randomization|Protocol Violation|1|||
33415823|NCT00570323|62793901|FG001|Started Treatment After Randomization|Protocol Violation|0|||
33415824|NCT00570323|62793900|FG000|Started Treatment After Randomization|Physician Decision|1|||
33415825|NCT00570323|62793901|FG001|Started Treatment After Randomization|Physician Decision|0|||
33415826|NCT00570323|62793900|FG000|Complete Study After Start|Lost to Follow-up|0|||
33415827|NCT00570323|62793901|FG001|Complete Study After Start|Lost to Follow-up|1|||
33415828|NCT00570323|62793900|FG000|Complete Study After Start|Withdrawal by Subject|2|||
33415829|NCT00570323|62793901|FG001|Complete Study After Start|Withdrawal by Subject|0|||
33415830|NCT00570323|62793900|FG000|Complete Study After Start|Physician Decision|1|||
33415831|NCT00570323|62793901|FG001|Complete Study After Start|Physician Decision|0|||
33415832|NCT00661505|62793909|FG000|Overall Study|Adverse Event|3|||
33415833|NCT00661505|62793909|FG000|Overall Study|Protocol Violation|14|||
33415834|NCT00661505|62793909|FG000|Overall Study|Withdrawal by Subject|8|||
33415835|NCT00661505|62793909|FG000|Overall Study|Lost to Follow-up|3|||
33415836|NCT00661505|62793909|FG000|Overall Study|Other|2|||
33415837|NCT00662909|62793917|FG000|Overall Study|Adverse Event|17|||
33415838|NCT00662909|62793918|FG001|Overall Study|Adverse Event|18|||
33415839|NCT00662909|62793919|FG002|Overall Study|Adverse Event|19|||
33415840|NCT00662909|62793917|FG000|Overall Study|Lack of Efficacy|9|||
33415841|NCT00662909|62793918|FG001|Overall Study|Lack of Efficacy|1|||
33415842|NCT00662909|62793919|FG002|Overall Study|Lack of Efficacy|5|||
33415843|NCT00662909|62793917|FG000|Overall Study|Withdrawal by Subject|29|||
33415844|NCT00662909|62793918|FG001|Overall Study|Withdrawal by Subject|22|||
33415845|NCT00662909|62793919|FG002|Overall Study|Withdrawal by Subject|16|||
33415846|NCT00662909|62793917|FG000|Overall Study|Lost to Follow-up|2|||
33415847|NCT00662909|62793918|FG001|Overall Study|Lost to Follow-up|9|||
33415848|NCT00662909|62793919|FG002|Overall Study|Lost to Follow-up|3|||
33415849|NCT00662909|62793917|FG000|Overall Study|Protocol Violation|7|||
33415850|NCT00662909|62793918|FG001|Overall Study|Protocol Violation|4|||
33415851|NCT00662909|62793919|FG002|Overall Study|Protocol Violation|5|||
33415852|NCT00662909|62793917|FG000|Overall Study|Randomized- never received study drug|1|||
33415853|NCT00662909|62793918|FG001|Overall Study|Randomized- never received study drug|0|||
33415854|NCT00662909|62793919|FG002|Overall Study|Randomized- never received study drug|0|||
33415855|NCT00662909|62793917|FG000|Overall Study|Non-compliance with study procedures|3|||
33415856|NCT00662909|62793918|FG001|Overall Study|Non-compliance with study procedures|3|||
33415857|NCT00662909|62793919|FG002|Overall Study|Non-compliance with study procedures|2|||
33415858|NCT00662909|62793917|FG000|Overall Study|Physician Decision|1|||
33415859|NCT00662909|62793918|FG001|Overall Study|Physician Decision|1|||
33415860|NCT00662909|62793919|FG002|Overall Study|Physician Decision|2|||
33415861|NCT00662909|62793917|FG000|Overall Study|Eligibility criterion not met|0|||
33415862|NCT00662909|62793918|FG001|Overall Study|Eligibility criterion not met|1|||
33415863|NCT00662909|62793919|FG002|Overall Study|Eligibility criterion not met|1|||
33415864|NCT00050011|62793929|FG000|Overall Study|Adverse Event|41|||
33415865|NCT00050011|62793930|FG001|Overall Study|Adverse Event|46|||
33415866|NCT00050011|62793929|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33415867|NCT00050011|62793930|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33415868|NCT00050011|62793929|FG000|Overall Study|Abnormal test procedure results|0|||
33415869|NCT00050011|62793930|FG001|Overall Study|Abnormal test procedure results|1|||
33415870|NCT00050011|62793929|FG000|Overall Study|Lack of Efficacy|16|||
33415871|NCT00050011|62793930|FG001|Overall Study|Lack of Efficacy|21|||
33415872|NCT00050011|62793929|FG000|Overall Study|Participant condition no longer required|1|||
33415873|NCT00050011|62793930|FG001|Overall Study|Participant condition no longer required|0|||
33415874|NCT00050011|62793929|FG000|Overall Study|Protocol Violation|4|||
33415875|NCT00050011|62793930|FG001|Overall Study|Protocol Violation|10|||
33415876|NCT00050011|62793929|FG000|Overall Study|Withdrawal by Subject|34|||
33415877|NCT00050011|62793930|FG001|Overall Study|Withdrawal by Subject|26|||
33415878|NCT00050011|62793929|FG000|Overall Study|Lost to Follow-up|7|||
33415879|NCT00050011|62793930|FG001|Overall Study|Lost to Follow-up|9|||
33415880|NCT00050011|62793929|FG000|Overall Study|Administrative problems|10|||
33415881|NCT00050011|62793930|FG001|Overall Study|Administrative problems|6|||
33415882|NCT00050011|62793929|FG000|Overall Study|Death|7|||
33415883|NCT00050011|62793930|FG001|Overall Study|Death|4|||
33415884|NCT00050011|62793929|FG000|Overall Study|Unknown - Reason is missing|0|||
33415885|NCT00050011|62793930|FG001|Overall Study|Unknown - Reason is missing|2|||
33415886|NCT00661427|62793939|FG000|Overall Study|Adverse Event|5|||
33415887|NCT00661427|62793940|FG001|Overall Study|Adverse Event|5|||
33415888|NCT00661427|62793939|FG000|Overall Study|Patient not treated|0|||
33415889|NCT00661427|62793940|FG001|Overall Study|Patient not treated|2|||
33415890|NCT00049543|62793948|FG000|Overall Study|still on treatment|2|||
33415891|NCT00049543|62793949|FG001|Overall Study|still on treatment|9|||
33415892|NCT00048997|62793957|FG000|Overall Study|Protocol Violation|7|||
33415893|NCT00048997|62793958|FG001|Overall Study|Protocol Violation|2|||
33415894|NCT00048997|62793957|FG000|Overall Study|Withdrawal by Subject|6|||
33415895|NCT00048997|62793958|FG001|Overall Study|Withdrawal by Subject|1|||
33415896|NCT00035815|62793965|FG000|Overall Study|Withdrawal by Subject|17|||
33415897|NCT00035815|62793966|FG001|Overall Study|Withdrawal by Subject|11|||
33415898|NCT00662831|62793974|FG000|Overall Study|Death|4|||
33415899|NCT00662831|62793975|FG001|Overall Study|Death|1|||
33415900|NCT00662831|62793974|FG000|Overall Study|Lack of Efficacy|6|||
33415901|NCT00662831|62793975|FG001|Overall Study|Lack of Efficacy|6|||
33415902|NCT00662831|62793974|FG000|Overall Study|Lost to Follow-up|1|||
33415903|NCT00662831|62793975|FG001|Overall Study|Lost to Follow-up|0|||
33415904|NCT00662831|62793974|FG000|Overall Study|Withdrawal by Subject|2|||
33415905|NCT00662831|62793975|FG001|Overall Study|Withdrawal by Subject|1|||
33415906|NCT00662831|62793974|FG000|Overall Study|Other|62|||
33415907|NCT00662831|62793975|FG001|Overall Study|Other|31|||
33415908|NCT00662831|62793974|FG000|Overall Study|Protocol Violation|8|||
33415909|NCT00662831|62793975|FG001|Overall Study|Protocol Violation|4|||
33415910|NCT00662831|62793974|FG000|Overall Study|Adverse Event|23|||
33415911|NCT00662831|62793975|FG001|Overall Study|Adverse Event|16|||
33415912|NCT00662363|62793983|FG000|Overall Study|Withdrawal by Subject|6|||
33415913|NCT00662363|62793984|FG001|Overall Study|Withdrawal by Subject|5|||
33415914|NCT00662363|62793983|FG000|Overall Study|Adverse Event|0|||
33415915|NCT00662363|62793984|FG001|Overall Study|Adverse Event|3|||
33415916|NCT00662363|62793983|FG000|Overall Study|Discharged early from rehab|4|||
33415917|NCT00662363|62793984|FG001|Overall Study|Discharged early from rehab|1|||
33415918|NCT00662363|62793983|FG000|Overall Study|Protocol Violation|1|||
33415919|NCT00662363|62793984|FG001|Overall Study|Protocol Violation|1|||
33464751|NCT00356915|62838242|FG000|Overall Study|Administrative Decision|0|||
33464752|NCT00356915|62838243|FG001|Overall Study|Administrative Decision|0|||
33464753|NCT00356915|62838244|FG002|Overall Study|Administrative Decision|1|||
33464754|NCT00356915|62838242|FG000|Overall Study|Physician Decision|0|||
33464755|NCT00356915|62838243|FG001|Overall Study|Physician Decision|2|||
33464756|NCT00356915|62838244|FG002|Overall Study|Physician Decision|0|||
33464757|NCT00356915|62838242|FG000|Overall Study|Adverse Event|21|||
33464758|NCT00356915|62838243|FG001|Overall Study|Adverse Event|31|||
33464759|NCT00356915|62838244|FG002|Overall Study|Adverse Event|8|||
33464760|NCT00356915|62838242|FG000|Overall Study|Miscellaneous reasons|11|||
33464761|NCT00356915|62838243|FG001|Overall Study|Miscellaneous reasons|8|||
33464762|NCT00356915|62838244|FG002|Overall Study|Miscellaneous reasons|3|||
33464763|NCT00356759|62838260|FG000|Overall Study|Death|5|||
33464764|NCT00356759|62838261|FG001|Overall Study|Death|2|||
33464765|NCT00356759|62838260|FG000|Overall Study|Withdrawal by Subject|2|||
33464766|NCT00356759|62838261|FG001|Overall Study|Withdrawal by Subject|2|||
33464767|NCT00356759|62838260|FG000|Overall Study|Adverse Event|1|||
33464768|NCT00356759|62838261|FG001|Overall Study|Adverse Event|3|||
33464769|NCT00356759|62838260|FG000|Overall Study|Lost to Follow-up|1|||
33464770|NCT00356759|62838261|FG001|Overall Study|Lost to Follow-up|1|||
33464771|NCT00356759|62838260|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
33464772|NCT00356759|62838261|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
33464773|NCT03804710|62838269|FG000|Overall Study|Adverse Event|0|||
33464774|NCT03804710|62838270|FG001|Overall Study|Adverse Event|3|||
33464775|NCT03804710|62838269|FG000|Overall Study|Withdrawal by Subject|2|||
33464776|NCT03804710|62838270|FG001|Overall Study|Withdrawal by Subject|1|||
33464777|NCT03804710|62838269|FG000|Overall Study|Other|0|||
33464778|NCT03804710|62838270|FG001|Overall Study|Other|1|||
33464779|NCT00356603|62838282|FG000|Overall Study|Other|6|||
33464780|NCT00356603|62838283|FG001|Overall Study|Other|3|||
33464781|NCT00002558|62838293|FG000|Overall Study|Withdrawal by Subject|0|||
33494092|NCT03739138|62872779|FG004|Overall Study|Withdrawal by Subject|0|||
33494093|NCT03472326|62872789|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
33464782|NCT00002558|62838294|FG001|Overall Study|Withdrawal by Subject|1|||
33464783|NCT00002540|62838302|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
33464784|NCT00002540|62838303|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
33464785|NCT00002540|62838302|FG000|Overall Study|Died Before Randomization|2|||
33464786|NCT00002540|62838303|FG001|Overall Study|Died Before Randomization|6|||
33464787|NCT00002540|62838302|FG000|Overall Study|Died Before ASU (Control)|202|||
33464788|NCT00002540|62838303|FG001|Overall Study|Died Before ASU (Control)|0|||
33464789|NCT00002540|62838302|FG000|Overall Study|Refused ASU (Control)|597|||
33415920|NCT00661271|62793994|FG000|Overall Study|Lost to Follow-up|28|||
33415921|NCT00661271|62793995|FG001|Overall Study|Lost to Follow-up|25|||
33415922|NCT00661193|62794003|FG000|Overall Study|Adverse Event|2|||
33415923|NCT00661193|62794004|FG001|Overall Study|Adverse Event|1|||
33415924|NCT00661193|62794003|FG000|Overall Study|Withdrawal by Subject|3|||
33415925|NCT00661193|62794004|FG001|Overall Study|Withdrawal by Subject|1|||
33415926|NCT00661193|62794003|FG000|Overall Study|Progression|27|||
33415927|NCT00661193|62794004|FG001|Overall Study|Progression|24|||
33415928|NCT00661193|62794003|FG000|Overall Study|Not protocol specified|1|||
33415929|NCT00661193|62794004|FG001|Overall Study|Not protocol specified|0|||
33415930|NCT00658541|62794010|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
33415931|NCT00658541|62794011|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33415932|NCT00658541|62794010|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
33415933|NCT00658541|62794011|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33415934|NCT00048061|62794021|FG000|Overall Study|Adverse Event|41|||
33415935|NCT00048061|62794022|FG001|Overall Study|Adverse Event|32|||
33415936|NCT00048061|62794023|FG002|Overall Study|Adverse Event|44|||
33415937|NCT00048061|62794024|FG003|Overall Study|Adverse Event|37|||
33415938|NCT00048061|62794021|FG000|Overall Study|Lost to Follow-up|3|||
33415939|NCT00048061|62794022|FG001|Overall Study|Lost to Follow-up|2|||
33415940|NCT00048061|62794023|FG002|Overall Study|Lost to Follow-up|4|||
33415941|NCT00048061|62794024|FG003|Overall Study|Lost to Follow-up|5|||
33415942|NCT00048061|62794021|FG000|Overall Study|Withdrawal by Subject|20|||
33415943|NCT00048061|62794022|FG001|Overall Study|Withdrawal by Subject|29|||
33415944|NCT00048061|62794023|FG002|Overall Study|Withdrawal by Subject|29|||
33415945|NCT00048061|62794024|FG003|Overall Study|Withdrawal by Subject|32|||
33415946|NCT00048061|62794021|FG000|Overall Study|Did not follow-up|5|||
33415947|NCT00048061|62794022|FG001|Overall Study|Did not follow-up|5|||
33415948|NCT00048061|62794023|FG002|Overall Study|Did not follow-up|4|||
33415949|NCT00048061|62794024|FG003|Overall Study|Did not follow-up|5|||
33415950|NCT00048061|62794021|FG000|Overall Study|Early improvement|6|||
33415951|NCT00048061|62794022|FG001|Overall Study|Early improvement|5|||
33415952|NCT00048061|62794023|FG002|Overall Study|Early improvement|3|||
33415953|NCT00048061|62794024|FG003|Overall Study|Early improvement|0|||
33415954|NCT00656513|62794037|FG000|Overall Study|Protocol Violation|1|||
33415955|NCT00656513|62794038|FG001|Overall Study|Protocol Violation|0|||
33415956|NCT00656513|62794039|FG002|Overall Study|Protocol Violation|2|||
33415957|NCT00656513|62794037|FG000|Overall Study|Withdrawal by Subject|0|||
33415958|NCT00656513|62794038|FG001|Overall Study|Withdrawal by Subject|11|||
33415959|NCT00656513|62794039|FG002|Overall Study|Withdrawal by Subject|4|||
33415960|NCT00656513|62794037|FG000|Overall Study|Death|0|||
33415961|NCT00656513|62794038|FG001|Overall Study|Death|0|||
33415962|NCT00656513|62794039|FG002|Overall Study|Death|1|||
33415963|NCT00656513|62794037|FG000|Overall Study|Missing data|0|||
33415964|NCT00656513|62794038|FG001|Overall Study|Missing data|11|||
33415965|NCT00656513|62794039|FG002|Overall Study|Missing data|9|||
33415966|NCT00656513|62794037|FG000|Overall Study|Incomplete treatment|3|||
33415967|NCT00656513|62794038|FG001|Overall Study|Incomplete treatment|0|||
33415968|NCT00656513|62794039|FG002|Overall Study|Incomplete treatment|0|||
33415969|NCT00656513|62794037|FG000|Overall Study|Treatment completed outside of timeframe|0|||
33415970|NCT00656513|62794038|FG001|Overall Study|Treatment completed outside of timeframe|3|||
33415971|NCT00656513|62794039|FG002|Overall Study|Treatment completed outside of timeframe|1|||
33604893|NCT01787032|63004484|FG000|Overall Study|Protocol Violation|0|||
33604894|NCT01787032|63004485|FG001|Overall Study|Protocol Violation|0|||
33322754|NCT01179347|62698812|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
33415972|NCT00656513|62794037|FG000|Overall Study|Missing baseline form|0|||
33415973|NCT00656513|62794038|FG001|Overall Study|Missing baseline form|5|||
33415974|NCT00656513|62794039|FG002|Overall Study|Missing baseline form|5|||
33415975|NCT00655889|62794047|FG000|Overall Study|Inadequate cell growth|1|||
33415976|NCT00655889|62794047|FG000|Overall Study|Protocol Violation|1|||
33322755|NCT01179347|62698813|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
33415977|NCT00655733|62794053|FG000|Overall Study|Lost to Follow-up|2|||
33415978|NCT00655733|62794054|FG001|Overall Study|Lost to Follow-up|2|||
33415979|NCT00655733|62794053|FG000|Overall Study|Adverse Event|2|||
33415980|NCT00655733|62794054|FG001|Overall Study|Adverse Event|2|||
33415981|NCT00655733|62794053|FG000|Overall Study|Withdrawal by Subject|3|||
33604895|NCT01787032|63004486|FG002|Overall Study|Protocol Violation|0|||
33415982|NCT00655733|62794054|FG001|Overall Study|Withdrawal by Subject|3|||
33415983|NCT00655733|62794053|FG000|Overall Study|Physician Decision|0|||
33415984|NCT00655733|62794054|FG001|Overall Study|Physician Decision|1|||
33415985|NCT00657371|62794062|FG000|Overall Study|Poor bowel preparation|15|||
33415986|NCT00657371|62794062|FG000|Overall Study|Unable to intubate the cecum|5|||
33415987|NCT00657371|62794062|FG000|Overall Study|Protocol Violation|2|||
33415988|NCT00657371|62794062|FG000|Overall Study|Device- related reasons|13|||
33415989|NCT00657371|62794062|FG000|Overall Study|Pre-existing medical condition|4|||
33415990|NCT00658775|62794068|FG000|Overall Study|Adverse Event|4|||
33415991|NCT00658775|62794069|FG001|Overall Study|Adverse Event|6|||
33415992|NCT00658775|62794068|FG000|Overall Study|Lost to Follow-up|17|||
33415993|NCT00658775|62794069|FG001|Overall Study|Lost to Follow-up|18|||
33415994|NCT00658775|62794068|FG000|Overall Study|Withdrawal by Subject|6|||
33415995|NCT00658775|62794069|FG001|Overall Study|Withdrawal by Subject|4|||
33415996|NCT00658775|62794068|FG000|Overall Study|Withdrawal of consent|8|||
33415997|NCT00658775|62794069|FG001|Overall Study|Withdrawal of consent|7|||
33415998|NCT00658775|62794068|FG000|Overall Study|Other|7|||
33415999|NCT00658775|62794069|FG001|Overall Study|Other|8|||
33416000|NCT00488631|62794081|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
33416001|NCT00488631|62794082|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
33416002|NCT00488631|62794083|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
33416003|NCT00488631|62794084|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
33416004|NCT00488631|62794085|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
33416005|NCT00488631|62794086|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
33416006|NCT00488631|62794087|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
33416007|NCT00488631|62794088|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
33416008|NCT00488631|62794089|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
33416009|NCT00488631|62794090|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
33416010|NCT00488631|62794081|FG000|Double Blind Period (Week 0-54)|Death|0|||
33416011|NCT00488631|62794082|FG001|Double Blind Period (Week 0-54)|Death|0|||
33416012|NCT00488631|62794083|FG002|Double Blind Period (Week 0-54)|Death|0|||
33416013|NCT00488631|62794084|FG003|Double Blind Period (Week 0-54)|Death|0|||
33416014|NCT00488631|62794085|FG004|Double Blind Period (Week 0-54)|Death|0|||
33416015|NCT00488631|62794086|FG005|Double Blind Period (Week 0-54)|Death|1|||
33416016|NCT00488631|62794087|FG006|Double Blind Period (Week 0-54)|Death|0|||
33416017|NCT00488631|62794088|FG007|Double Blind Period (Week 0-54)|Death|0|||
33416018|NCT00488631|62794089|FG008|Double Blind Period (Week 0-54)|Death|0|||
33416019|NCT00488631|62794090|FG009|Double Blind Period (Week 0-54)|Death|0|||
33416020|NCT00488631|62794081|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
33416021|NCT00488631|62794082|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
33416022|NCT00488631|62794083|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
33416023|NCT00488631|62794084|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
33416024|NCT00488631|62794085|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
33416025|NCT00488631|62794086|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
33416026|NCT00488631|62794087|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
33416027|NCT00488631|62794088|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
33416028|NCT00488631|62794089|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
33416029|NCT00488631|62794090|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
33604896|NCT01787032|63004487|FG003|Overall Study|Protocol Violation|0|||
33416030|NCT00488631|62794081|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
33416031|NCT00488631|62794082|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
33416032|NCT00488631|62794083|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
33416033|NCT00488631|62794084|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
33416034|NCT00488631|62794085|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
33416035|NCT00488631|62794086|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
33416036|NCT00488631|62794087|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
33416037|NCT00488631|62794088|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
33416038|NCT00488631|62794089|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
33416039|NCT00488631|62794090|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
33416040|NCT00488631|62794081|FG000|Double Blind Period (Week 0-54)|Other|6|||
33416041|NCT00488631|62794082|FG001|Double Blind Period (Week 0-54)|Other|12|||
33416042|NCT00488631|62794083|FG002|Double Blind Period (Week 0-54)|Other|10|||
33416043|NCT00488631|62794084|FG003|Double Blind Period (Week 0-54)|Other|11|||
33416044|NCT00488631|62794085|FG004|Double Blind Period (Week 0-54)|Other|14|||
33416045|NCT00488631|62794086|FG005|Double Blind Period (Week 0-54)|Other|34|||
33416046|NCT00488631|62794087|FG006|Double Blind Period (Week 0-54)|Other|0|||
33416047|NCT00488631|62794088|FG007|Double Blind Period (Week 0-54)|Other|0|||
33416048|NCT00488631|62794089|FG008|Double Blind Period (Week 0-54)|Other|0|||
33416049|NCT00488631|62794090|FG009|Double Blind Period (Week 0-54)|Other|0|||
33416050|NCT00488631|62794081|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
33416051|NCT00488631|62794082|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
33416052|NCT00488631|62794083|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
33416053|NCT00488631|62794084|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
33416054|NCT00488631|62794085|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
33416055|NCT00488631|62794086|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
33416056|NCT00488631|62794087|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
33416057|NCT00488631|62794088|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
33416058|NCT00488631|62794089|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
33416059|NCT00488631|62794090|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
33416060|NCT00488631|62794081|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
33416061|NCT00488631|62794082|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
33416062|NCT00488631|62794083|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
33416063|NCT00488631|62794084|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
33416064|NCT00488631|62794085|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
33416065|NCT00488631|62794086|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
33416066|NCT00488631|62794087|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
33416067|NCT00488631|62794088|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
33416068|NCT00488631|62794089|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
33416069|NCT00488631|62794090|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
33416070|NCT00488631|62794081|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
33416071|NCT00488631|62794082|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
33416072|NCT00488631|62794083|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
33416073|NCT00488631|62794084|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
33416074|NCT00488631|62794085|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
33416075|NCT00488631|62794086|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
33416076|NCT00488631|62794087|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
33416077|NCT00488631|62794088|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
33416078|NCT00488631|62794089|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
33416079|NCT00488631|62794090|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
33416080|NCT00488631|62794081|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33416081|NCT00488631|62794082|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33416082|NCT00488631|62794083|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33416083|NCT00488631|62794084|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33416084|NCT00488631|62794085|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33416085|NCT00488631|62794086|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33416086|NCT00488631|62794087|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
33416087|NCT00488631|62794088|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33604897|NCT01787032|63004488|FG004|Overall Study|Protocol Violation|1|||
33322756|NCT01179347|62698812|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
33322757|NCT01179347|62698813|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
33322758|NCT01179347|62698812|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
33416088|NCT00488631|62794089|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
33416089|NCT00488631|62794090|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33416090|NCT00488631|62794081|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
33416091|NCT00488631|62794082|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
33416092|NCT00488631|62794083|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
33416093|NCT00488631|62794084|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
33416094|NCT00488631|62794085|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
33416095|NCT00488631|62794086|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
33416096|NCT00488631|62794087|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
33416097|NCT00488631|62794088|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
33416098|NCT00488631|62794089|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
33416099|NCT00488631|62794090|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
33416100|NCT00655499|62794113|FG000|Overall Study|not eligible|4|||
33416101|NCT00654875|62794120|FG000|Overall Study|Adverse Event|5|||
33416102|NCT00654875|62794121|FG001|Overall Study|Adverse Event|5|||
33416103|NCT00654875|62794120|FG000|Overall Study|Withdrawal by Subject|4|||
33416104|NCT00654875|62794121|FG001|Overall Study|Withdrawal by Subject|4|||
33416105|NCT00654875|62794120|FG000|Overall Study|Protocol Violation|3|||
33416106|NCT00654875|62794121|FG001|Overall Study|Protocol Violation|3|||
33416107|NCT00654875|62794120|FG000|Overall Study|Lack of Efficacy|2|||
33416108|NCT00654875|62794121|FG001|Overall Study|Lack of Efficacy|2|||
33416109|NCT00654875|62794120|FG000|Overall Study|Lost to Follow-up|1|||
33416110|NCT00654875|62794121|FG001|Overall Study|Lost to Follow-up|3|||
33416111|NCT00654875|62794120|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
33416112|NCT00654875|62794121|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
33416113|NCT00654875|62794120|FG000|Overall Study|Administrative Problems|1|||
33604898|NCT01787032|63004489|FG005|Overall Study|Protocol Violation|1|||
33322759|NCT01179347|62698813|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
33322760|NCT01179347|62698812|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
33322761|NCT01179347|62698813|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
33322762|NCT01179347|62698812|FG000|Open-label Period (12 Weeks)|Other|7|||
33322763|NCT01179347|62698813|FG001|Open-label Period (12 Weeks)|Other|4|||
33322764|NCT01146288|62698823|FG000|First Intervention(1 Day)|Adverse Event|0|||
33322765|NCT01146288|62698824|FG001|First Intervention(1 Day)|Adverse Event|1|||
33322766|NCT01146054|62698831|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
33322767|NCT01146054|62698831|FG000|Overall Study|Rapid tumor progression|2|||
33322768|NCT01146054|62698831|FG000|Overall Study|Other illness precluded treatment|2|||
33322769|NCT01146054|62698831|FG000|Overall Study|Lost to Follow-up|1|||
33322770|NCT01145898|62698837|FG000|3-year Treatment|medication change by treating physician|3|||
33322771|NCT01145898|62698838|FG001|3-year Treatment|medication change by treating physician|16|||
33322772|NCT01133418|62698845|FG000|Overall Study|Lost to Follow-up|5|||
33322773|NCT01133418|62698846|FG001|Overall Study|Lost to Follow-up|6|||
33322774|NCT00931918|62698854|FG000|Overall Study|Adverse Event|4|||
33322775|NCT00931918|62698855|FG001|Overall Study|Adverse Event|6|||
33322776|NCT00931918|62698854|FG000|Overall Study|Progressive Disease|2|||
33322777|NCT00931918|62698855|FG001|Overall Study|Progressive Disease|1|||
33322778|NCT00931918|62698854|FG000|Overall Study|Symptomatic Deterioration|1|||
33322779|NCT00931918|62698855|FG001|Overall Study|Symptomatic Deterioration|0|||
33322780|NCT00931918|62698854|FG000|Overall Study|Withdrawal by Patient|3|||
33416114|NCT00654875|62794121|FG001|Overall Study|Administrative Problems|0|||
33416115|NCT00651755|62794127|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
33416116|NCT00651755|62794128|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
33416117|NCT00651755|62794127|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
33416118|NCT00651755|62794128|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
33416119|NCT00654641|62794137|FG000|Overall Study|Lost to Follow-up|2|||
33416120|NCT00654641|62794138|FG001|Overall Study|Lost to Follow-up|3|||
33416121|NCT00569777|62794146|FG000|Overall Study|Withdrawal by Subject|4|||
33416122|NCT00569777|62794147|FG001|Overall Study|Withdrawal by Subject|0|||
33416123|NCT00569777|62794146|FG000|Overall Study|Adverse Event|3|||
33416124|NCT00569777|62794147|FG001|Overall Study|Adverse Event|0|||
33416125|NCT00569777|62794146|FG000|Overall Study|Lost to Follow-up|1|||
33416126|NCT00569777|62794147|FG001|Overall Study|Lost to Follow-up|0|||
33416127|NCT00569777|62794146|FG000|Overall Study|scheduled eye surgery|0|||
33416128|NCT00569777|62794147|FG001|Overall Study|scheduled eye surgery|1|||
33416129|NCT00569777|62794146|FG000|Overall Study|did not meet exclusion criteria|1|||
33416130|NCT00569777|62794147|FG001|Overall Study|did not meet exclusion criteria|2|||
33416131|NCT00569777|62794146|FG000|Overall Study|pregnant|1|||
33416132|NCT00569777|62794147|FG001|Overall Study|pregnant|0|||
33416133|NCT00569231|62794153|FG000|Overall Study|Study unrelated surgery|1|||
33416134|NCT00569231|62794153|FG000|Overall Study|Airfare expense|2|||
33416135|NCT00569231|62794153|FG000|Overall Study|Withdrawal by Subject|1|||
33416136|NCT00569231|62794153|FG000|Overall Study|Car accident injury|1|||
33416137|NCT00569231|62794153|FG000|Overall Study|Non-compliance|2|||
33416138|NCT00654095|62794157|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
33416139|NCT00654095|62794157|FG000|Overall Study|Elevated triglyceride level (2)|1|||
33416140|NCT00654095|62794157|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
33416141|NCT00654095|62794157|FG000|Overall Study|Adverse Event|11|||
33416142|NCT00654095|62794157|FG000|Overall Study|Withdrawal by Subject|5|||
33416143|NCT00654095|62794157|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
33416144|NCT00654095|62794157|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
33416145|NCT00654095|62794157|FG000|Overall Study|Did not meet inclusion criteria|1|||
33416146|NCT00650585|62794163|FG000|Overall Study|Lost to Follow-up|505|||
33416147|NCT00650585|62794164|FG001|Overall Study|Lost to Follow-up|482|||
33416148|NCT00650585|62794163|FG000|Overall Study|No parental consent|935|||
33416149|NCT00650585|62794164|FG001|Overall Study|No parental consent|866|||
33416150|NCT00650585|62794163|FG000|Overall Study|Excluded/ruled ineligible|357|||
33416151|NCT00650585|62794164|FG001|Overall Study|Excluded/ruled ineligible|129|||
33416152|NCT00653939|62794172|FG000|Overall Study|Adverse Event|1|||
33416153|NCT00653939|62794173|FG001|Overall Study|Adverse Event|3|||
33416154|NCT00653939|62794172|FG000|Overall Study|Withdrawal by Subject|3|||
33416155|NCT00653939|62794173|FG001|Overall Study|Withdrawal by Subject|3|||
33416156|NCT00653939|62794172|FG000|Overall Study|Physician Decision|4|||
33416157|NCT00653939|62794173|FG001|Overall Study|Physician Decision|0|||
33416158|NCT00653939|62794172|FG000|Overall Study|Disease Progression|2|||
33416159|NCT00653939|62794173|FG001|Overall Study|Disease Progression|3|||
33416160|NCT00653939|62794172|FG000|Overall Study|Other|2|||
33416161|NCT00653939|62794173|FG001|Overall Study|Other|6|||
33416162|NCT00646451|62794181|FG000|Overall Study|Adverse Event|3|||
33416163|NCT00646451|62794182|FG001|Overall Study|Adverse Event|0|||
33416164|NCT00646451|62794181|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
33416165|NCT00646451|62794182|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
33416166|NCT00642707|62794194|FG000|Overall Study|Adverse Event|0|||
33416167|NCT00642707|62794195|FG001|Overall Study|Adverse Event|0|||
33416168|NCT00642707|62794196|FG002|Overall Study|Adverse Event|0|||
33416169|NCT00642707|62794197|FG003|Overall Study|Adverse Event|2|||
33416170|NCT00642707|62794194|FG000|Overall Study|Withdrawal by Subject|1|||
33416171|NCT00642707|62794195|FG001|Overall Study|Withdrawal by Subject|0|||
33416172|NCT00642707|62794196|FG002|Overall Study|Withdrawal by Subject|0|||
33416173|NCT00642707|62794197|FG003|Overall Study|Withdrawal by Subject|0|||
33416174|NCT00568685|62794210|FG000|Overall Study|Adverse Event|2|||
33416175|NCT00568685|62794211|FG001|Overall Study|Adverse Event|3|||
33416176|NCT00568685|62794212|FG002|Overall Study|Adverse Event|3|||
33416177|NCT00568685|62794210|FG000|Overall Study|Withdrawal by Subject|7|||
33416178|NCT00568685|62794211|FG001|Overall Study|Withdrawal by Subject|2|||
33416179|NCT00568685|62794212|FG002|Overall Study|Withdrawal by Subject|2|||
33416180|NCT00568685|62794210|FG000|Overall Study|Protocol Violation|1|||
33416181|NCT00568685|62794211|FG001|Overall Study|Protocol Violation|0|||
33416182|NCT00568685|62794212|FG002|Overall Study|Protocol Violation|0|||
33416183|NCT00061945|62794226|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
33416184|NCT00061945|62794227|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
33416185|NCT00061945|62794226|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
33416186|NCT00061945|62794227|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
33416187|NCT00061945|62794226|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
33416188|NCT00061945|62794227|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
33416189|NCT00061945|62794226|FG000|Course IV: Alemtuzumab|Early exits|6|||
33416190|NCT00061945|62794227|FG001|Course IV: Alemtuzumab|Early exits|15|||
33416191|NCT00642473|62794238|FG000|Overall Study|Withdrawal by Subject|0|||
33416192|NCT00642473|62794239|FG001|Overall Study|Withdrawal by Subject|5|||
33416193|NCT00642473|62794238|FG000|Overall Study|Progression or death|2|||
33416194|NCT00642473|62794239|FG001|Overall Study|Progression or death|4|||
33416195|NCT00642473|62794238|FG000|Overall Study|Other|2|||
33416196|NCT00642473|62794239|FG001|Overall Study|Other|2|||
33416197|NCT00645671|62794250|FG000|Overall Study|Protocol Violation|1|||
33416198|NCT00645671|62794251|FG001|Overall Study|Protocol Violation|0|||
33416199|NCT00645671|62794250|FG000|Overall Study|Withdrawal by Subject|0|||
33416200|NCT00645671|62794251|FG001|Overall Study|Withdrawal by Subject|4|||
33416201|NCT00645671|62794250|FG000|Overall Study|Adverse Event|0|||
33416202|NCT00645671|62794251|FG001|Overall Study|Adverse Event|1|||
33416203|NCT00645671|62794250|FG000|Overall Study|Physician Decision|0|||
33416204|NCT00645671|62794251|FG001|Overall Study|Physician Decision|1|||
33416205|NCT00366340|62794259|FG000|Infant Series|Protocol Violation|3|||
33416206|NCT00366340|62794260|FG001|Infant Series|Protocol Violation|4|||
33416207|NCT00366340|62794259|FG000|Infant Series|Withdrawal by Subject|3|||
33416208|NCT00366340|62794260|FG001|Infant Series|Withdrawal by Subject|3|||
33416209|NCT00366340|62794259|FG000|Infant Series|Adverse Event|0|||
33416210|NCT00366340|62794260|FG001|Infant Series|Adverse Event|2|||
33416211|NCT00366340|62794259|FG000|Infant Series|Lost to Follow-up|1|||
33416212|NCT00366340|62794260|FG001|Infant Series|Lost to Follow-up|1|||
33416213|NCT00366340|62794259|FG000|Infant Series|Failure to return|1|||
33416214|NCT00366340|62794260|FG001|Infant Series|Failure to return|0|||
33416215|NCT00366340|62794259|FG000|After the Infant Series|Parent/legal guardian request|1|||
33416216|NCT00366340|62794260|FG001|After the Infant Series|Parent/legal guardian request|1|||
33416217|NCT00366340|62794259|FG000|After the Infant Series|Failed to return|0|||
33416218|NCT00366340|62794260|FG001|After the Infant Series|Failed to return|1|||
33416219|NCT00366340|62794259|FG000|After the Infant Series|Protocol Violation|2|||
33416220|NCT00366340|62794260|FG001|After the Infant Series|Protocol Violation|2|||
33416221|NCT00366340|62794259|FG000|After the Infant Series|Adverse Event|0|||
33416222|NCT00366340|62794260|FG001|After the Infant Series|Adverse Event|1|||
33416223|NCT00366340|62794259|FG000|After the Infant Series|Lost to Follow-up|0|||
33416224|NCT00366340|62794260|FG001|After the Infant Series|Lost to Follow-up|1|||
33416225|NCT00366340|62794259|FG000|Toddler Dose|Failed to return|1|||
33416226|NCT00366340|62794260|FG001|Toddler Dose|Failed to return|0|||
33416227|NCT00366340|62794259|FG000|Toddler Dose|Parent/legal guardian request|0|||
33416228|NCT00366340|62794260|FG001|Toddler Dose|Parent/legal guardian request|1|||
33416229|NCT00061633|62794292|FG000|Overall Study|Adverse Event|1|||
33322781|NCT00931918|62698855|FG001|Overall Study|Withdrawal by Patient|4|||
33322782|NCT00931918|62698854|FG000|Overall Study|Other Reason not Specified|4|||
33322783|NCT00931918|62698855|FG001|Overall Study|Other Reason not Specified|4|||
33322784|NCT00931918|62698854|FG000|Overall Study|Did not receive study drug|3|||
33416230|NCT00061633|62794293|FG001|Overall Study|Adverse Event|2|||
33416231|NCT00061633|62794292|FG000|Overall Study|Withdrawal by Subject|2|||
33416232|NCT00061633|62794293|FG001|Overall Study|Withdrawal by Subject|2|||
33416233|NCT00061633|62794292|FG000|Overall Study|Lost to Follow-up|1|||
33416234|NCT00061633|62794293|FG001|Overall Study|Lost to Follow-up|4|||
33416235|NCT00061633|62794292|FG000|Overall Study|Other|1|||
33416236|NCT00061633|62794293|FG001|Overall Study|Other|1|||
33416237|NCT00061633|62794292|FG000|Overall Study|Never received study treatment|0|||
33416238|NCT00061633|62794293|FG001|Overall Study|Never received study treatment|2|||
33416239|NCT00645593|62794301|FG000|Overall Study|Later found to be ineligible|1|||
33416240|NCT00645593|62794302|FG001|Overall Study|Later found to be ineligible|0|||
33416241|NCT03832738|62794311|FG000|Overall Study|Withdrawal by Subject|6|||
33416242|NCT03832738|62794312|FG001|Overall Study|Withdrawal by Subject|7|||
33416243|NCT03832738|62794313|FG002|Overall Study|Withdrawal by Subject|16|||
33416244|NCT03832738|62794311|FG000|Overall Study|Physician Decision|0|||
33416245|NCT03832738|62794312|FG001|Overall Study|Physician Decision|1|||
33416246|NCT03832738|62794313|FG002|Overall Study|Physician Decision|2|||
33416247|NCT03832738|62794311|FG000|Overall Study|Adverse Event|2|||
33416248|NCT03832738|62794312|FG001|Overall Study|Adverse Event|3|||
33416249|NCT03832738|62794313|FG002|Overall Study|Adverse Event|1|||
33416250|NCT03832738|62794311|FG000|Overall Study|Pregnancy|0|||
33416251|NCT03832738|62794312|FG001|Overall Study|Pregnancy|1|||
33416252|NCT03832738|62794313|FG002|Overall Study|Pregnancy|0|||
33416253|NCT00046891|62794323|FG000|Overall Study|Cancels|5|||
33416254|NCT00046891|62794324|FG001|Overall Study|Cancels|9|||
33416255|NCT00046891|62794323|FG000|Overall Study|Ineligible|1|||
33416256|NCT00046891|62794324|FG001|Overall Study|Ineligible|1|||
33416257|NCT00046891|62794323|FG000|Overall Study|Withdrawal by Subject|18|||
33416258|NCT00046891|62794324|FG001|Overall Study|Withdrawal by Subject|15|||
33416259|NCT00046891|62794323|FG000|Overall Study|Adverse Event|5|||
33416260|NCT00046891|62794324|FG001|Overall Study|Adverse Event|5|||
33416261|NCT00365794|62794338|FG000|Overall Study|Withdrawal by Subject|2|||
33416262|NCT00383500|62794346|FG000|Overall Study|Withdrawal by Subject|8|||
33416263|NCT00383500|62794347|FG001|Overall Study|Withdrawal by Subject|3|||
33416264|NCT00383500|62794348|FG002|Overall Study|Withdrawal by Subject|0|||
33416265|NCT00383500|62794346|FG000|Overall Study|Lost to Follow-up|0|||
33416266|NCT00383500|62794347|FG001|Overall Study|Lost to Follow-up|0|||
33416267|NCT00383500|62794348|FG002|Overall Study|Lost to Follow-up|2|||
33416268|NCT00365716|62794362|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
33416269|NCT00365716|62794363|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
33416270|NCT00365716|62794364|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
33416271|NCT00365716|62794365|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
33416272|NCT00365716|62794366|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
33416273|NCT00365716|62794367|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
33416274|NCT00365716|62794368|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
33416275|NCT00365716|62794362|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
33416276|NCT00365716|62794363|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
33416277|NCT00365716|62794364|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
33416278|NCT00365716|62794365|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
33416279|NCT00365716|62794366|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
33416280|NCT00365716|62794367|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
33416281|NCT00365716|62794368|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
33416282|NCT00365716|62794362|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
33416283|NCT00365716|62794363|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
33416284|NCT00365716|62794364|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
33416285|NCT00365716|62794365|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
33416286|NCT00365716|62794366|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
33416287|NCT00365716|62794367|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
33416288|NCT00365716|62794368|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
33416289|NCT00365716|62794362|FG000|Base Study (Day 1 to Month 7)|Other|0|||
33416290|NCT00365716|62794363|FG001|Base Study (Day 1 to Month 7)|Other|1|||
33416291|NCT00365716|62794364|FG002|Base Study (Day 1 to Month 7)|Other|0|||
33416292|NCT00365716|62794365|FG003|Base Study (Day 1 to Month 7)|Other|0|||
33416293|NCT00365716|62794366|FG004|Base Study (Day 1 to Month 7)|Other|0|||
33416294|NCT00365716|62794367|FG005|Base Study (Day 1 to Month 7)|Other|0|||
33416295|NCT00365716|62794368|FG006|Base Study (Day 1 to Month 7)|Other|0|||
33322785|NCT00931918|62698855|FG001|Overall Study|Did not receive study drug|2|||
33322786|NCT01179191|62698861|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
33416296|NCT00365716|62794362|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
33416297|NCT00365716|62794363|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
33416298|NCT00365716|62794364|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
33416299|NCT00365716|62794365|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
33416300|NCT00365716|62794366|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
33416301|NCT00365716|62794367|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
33416302|NCT00365716|62794368|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
33416303|NCT00365716|62794362|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
33416304|NCT00365716|62794363|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
33416305|NCT00365716|62794364|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
33416306|NCT00365716|62794365|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
33416307|NCT00365716|62794366|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
33416308|NCT00365716|62794367|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
33416309|NCT00365716|62794368|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
33416310|NCT00365716|62794362|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
33416311|NCT00365716|62794363|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
33416312|NCT00365716|62794364|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
33322787|NCT01179191|62698861|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
33416313|NCT00365716|62794365|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
33416314|NCT00365716|62794366|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
33416315|NCT00365716|62794367|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
33416316|NCT00365716|62794368|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
33416317|NCT00365716|62794362|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
33416318|NCT00365716|62794363|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
33416319|NCT00365716|62794364|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
33416320|NCT00365716|62794365|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
33416321|NCT00365716|62794366|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
33416322|NCT00365716|62794367|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
33416323|NCT00365716|62794368|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
33416324|NCT00365716|62794362|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
33416325|NCT00365716|62794363|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
33416326|NCT00365716|62794364|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
33416327|NCT00365716|62794365|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
33416328|NCT00365716|62794366|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
33416329|NCT00365716|62794367|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
33416330|NCT00365716|62794368|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
33416331|NCT00365716|62794362|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
33416332|NCT00365716|62794363|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
33416333|NCT00365716|62794364|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
33416334|NCT00365716|62794365|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
33416335|NCT00365716|62794366|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
33416336|NCT00365716|62794367|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
33416337|NCT00365716|62794368|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
33416338|NCT00365716|62794362|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
33416339|NCT00365716|62794363|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
33416340|NCT00365716|62794364|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
33416341|NCT00365716|62794365|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
33416342|NCT00365716|62794366|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
33416343|NCT00365716|62794367|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
33416344|NCT00365716|62794368|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
33416345|NCT00365716|62794362|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
33416346|NCT00365716|62794363|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
33416347|NCT00365716|62794364|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
33416348|NCT00365716|62794365|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
33416349|NCT00365716|62794366|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
33416350|NCT00365716|62794367|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
33416351|NCT00365716|62794368|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
33416352|NCT00365716|62794362|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
33416353|NCT00365716|62794363|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
33416354|NCT00365716|62794364|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
33416355|NCT00365716|62794365|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
33416356|NCT00365716|62794366|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
33416357|NCT00365716|62794367|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
33416358|NCT00365716|62794368|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
33416359|NCT00365716|62794362|FG000|Extension 1|Lost to Follow-up|0|||
33416360|NCT00365716|62794363|FG001|Extension 1|Lost to Follow-up|0|||
33416361|NCT00365716|62794364|FG002|Extension 1|Lost to Follow-up|0|||
33416362|NCT00365716|62794365|FG003|Extension 1|Lost to Follow-up|0|||
33416363|NCT00365716|62794366|FG004|Extension 1|Lost to Follow-up|0|||
33416364|NCT00365716|62794367|FG005|Extension 1|Lost to Follow-up|1|||
33416365|NCT00365716|62794368|FG006|Extension 1|Lost to Follow-up|0|||
33416366|NCT00365716|62794362|FG000|Extension 1|Other|0|||
33416367|NCT00365716|62794363|FG001|Extension 1|Other|0|||
33416368|NCT00365716|62794364|FG002|Extension 1|Other|0|||
33416369|NCT00365716|62794365|FG003|Extension 1|Other|0|||
33416370|NCT00365716|62794366|FG004|Extension 1|Other|0|||
33416371|NCT00365716|62794367|FG005|Extension 1|Other|9|||
33416372|NCT00365716|62794368|FG006|Extension 1|Other|0|||
33416373|NCT00365716|62794362|FG000|Extension 1|Moved|0|||
33416374|NCT00365716|62794363|FG001|Extension 1|Moved|0|||
33604899|NCT01737268|63004499|FG000|Overall Study|Adverse Event|6|||
33416375|NCT00365716|62794364|FG002|Extension 1|Moved|0|||
33604900|NCT01737268|63004499|FG000|Overall Study|Worsening of Target Disease|2|||
33604901|NCT01737268|63004499|FG000|Overall Study|In consideration of the patient's safety|1|||
33416376|NCT00365716|62794365|FG003|Extension 1|Moved|0|||
33416377|NCT00365716|62794366|FG004|Extension 1|Moved|0|||
33416378|NCT00365716|62794367|FG005|Extension 1|Moved|4|||
33416379|NCT00365716|62794368|FG006|Extension 1|Moved|0|||
33416380|NCT00365716|62794362|FG000|Extension 1|Withdrawal by Subject|0|||
33604902|NCT01769404|63004504|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
33416381|NCT00365716|62794363|FG001|Extension 1|Withdrawal by Subject|0|||
33416382|NCT00365716|62794364|FG002|Extension 1|Withdrawal by Subject|0|||
33416383|NCT00365716|62794365|FG003|Extension 1|Withdrawal by Subject|0|||
33416384|NCT00365716|62794366|FG004|Extension 1|Withdrawal by Subject|0|||
33416385|NCT00365716|62794367|FG005|Extension 1|Withdrawal by Subject|3|||
33416386|NCT00365716|62794368|FG006|Extension 1|Withdrawal by Subject|0|||
33416387|NCT00365716|62794362|FG000|Extension 1|Pregnancy|0|||
33416388|NCT00365716|62794363|FG001|Extension 1|Pregnancy|0|||
33416389|NCT00365716|62794364|FG002|Extension 1|Pregnancy|0|||
33416390|NCT00365716|62794365|FG003|Extension 1|Pregnancy|0|||
33416391|NCT00365716|62794366|FG004|Extension 1|Pregnancy|0|||
33416392|NCT00365716|62794367|FG005|Extension 1|Pregnancy|4|||
33416393|NCT00365716|62794368|FG006|Extension 1|Pregnancy|0|||
33416394|NCT00365716|62794362|FG000|Extension 1|Protocol Violation|0|||
33416395|NCT00365716|62794363|FG001|Extension 1|Protocol Violation|0|||
33416396|NCT00365716|62794364|FG002|Extension 1|Protocol Violation|0|||
33416397|NCT00365716|62794365|FG003|Extension 1|Protocol Violation|0|||
33416398|NCT00365716|62794366|FG004|Extension 1|Protocol Violation|0|||
33416399|NCT00365716|62794367|FG005|Extension 1|Protocol Violation|1|||
33416400|NCT00365716|62794368|FG006|Extension 1|Protocol Violation|0|||
33416401|NCT00365716|62794362|FG000|Extension 2|Lost to Follow-up|0|||
33416402|NCT00365716|62794363|FG001|Extension 2|Lost to Follow-up|0|||
33416403|NCT00365716|62794364|FG002|Extension 2|Lost to Follow-up|0|||
33416404|NCT00365716|62794365|FG003|Extension 2|Lost to Follow-up|0|||
33416405|NCT00365716|62794366|FG004|Extension 2|Lost to Follow-up|0|||
33416406|NCT00365716|62794367|FG005|Extension 2|Lost to Follow-up|0|||
33416407|NCT00365716|62794368|FG006|Extension 2|Lost to Follow-up|2|||
33416408|NCT00365716|62794362|FG000|Extension 2|Other|0|||
33416409|NCT00365716|62794363|FG001|Extension 2|Other|0|||
33416410|NCT00365716|62794364|FG002|Extension 2|Other|0|||
33416411|NCT00365716|62794365|FG003|Extension 2|Other|0|||
33416412|NCT00365716|62794366|FG004|Extension 2|Other|0|||
33416413|NCT00365716|62794367|FG005|Extension 2|Other|0|||
33416414|NCT00365716|62794368|FG006|Extension 2|Other|3|||
33416415|NCT00365716|62794362|FG000|Extension 2|Withdrawal by Subject|0|||
33416416|NCT00365716|62794363|FG001|Extension 2|Withdrawal by Subject|0|||
33416417|NCT00365716|62794364|FG002|Extension 2|Withdrawal by Subject|0|||
33416418|NCT00365716|62794365|FG003|Extension 2|Withdrawal by Subject|0|||
33416419|NCT00365716|62794366|FG004|Extension 2|Withdrawal by Subject|0|||
33416420|NCT00365716|62794367|FG005|Extension 2|Withdrawal by Subject|0|||
33416421|NCT00365716|62794368|FG006|Extension 2|Withdrawal by Subject|5|||
33416422|NCT00059839|62794384|FG000|Overall Study|Death|1|||
33416423|NCT00059839|62794385|FG001|Overall Study|Death|1|||
33416424|NCT00059839|62794384|FG000|Overall Study|Lack of Efficacy|6|||
33416425|NCT00059839|62794385|FG001|Overall Study|Lack of Efficacy|5|||
33416426|NCT00059839|62794384|FG000|Overall Study|Lost to Follow-up|2|||
33416427|NCT00059839|62794385|FG001|Overall Study|Lost to Follow-up|0|||
33416428|NCT00059839|62794384|FG000|Overall Study|Physician Decision|1|||
33416429|NCT00059839|62794385|FG001|Overall Study|Physician Decision|2|||
33416430|NCT00059839|62794384|FG000|Overall Study|Withdrawal by Subject|1|||
33416431|NCT00059839|62794385|FG001|Overall Study|Withdrawal by Subject|6|||
33416432|NCT00059839|62794384|FG000|Overall Study|Ineligible|1|||
33416433|NCT00059839|62794385|FG001|Overall Study|Ineligible|3|||
33416434|NCT00059215|62794395|FG000|Overall Study|Adverse Event|5|||
33416435|NCT00059215|62794396|FG001|Overall Study|Adverse Event|5|||
33416436|NCT00059215|62794397|FG002|Overall Study|Adverse Event|9|||
33416437|NCT00059215|62794398|FG003|Overall Study|Adverse Event|9|||
33416438|NCT00059215|62794395|FG000|Overall Study|Death|0|||
33416439|NCT00059215|62794396|FG001|Overall Study|Death|0|||
33416440|NCT00059215|62794397|FG002|Overall Study|Death|3|||
33416441|NCT00059215|62794398|FG003|Overall Study|Death|0|||
33416442|NCT00059215|62794395|FG000|Overall Study|Lost to Follow-up|1|||
33416443|NCT00059215|62794396|FG001|Overall Study|Lost to Follow-up|2|||
33416444|NCT00059215|62794397|FG002|Overall Study|Lost to Follow-up|0|||
33416445|NCT00059215|62794398|FG003|Overall Study|Lost to Follow-up|0|||
33416446|NCT00059215|62794395|FG000|Overall Study|Withdrawal by Subject|4|||
33416447|NCT00059215|62794396|FG001|Overall Study|Withdrawal by Subject|4|||
33604903|NCT01769404|63004505|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
33416448|NCT00059215|62794397|FG002|Overall Study|Withdrawal by Subject|1|||
33416449|NCT00059215|62794398|FG003|Overall Study|Withdrawal by Subject|3|||
33416450|NCT00059215|62794395|FG000|Overall Study|Protocol Violation|1|||
33604904|NCT01769404|63004504|FG000|Treatment Period 1|Withdrawal by Subject|3|||
33416451|NCT00059215|62794396|FG001|Overall Study|Protocol Violation|0|||
33416452|NCT00059215|62794397|FG002|Overall Study|Protocol Violation|1|||
33416453|NCT00059215|62794398|FG003|Overall Study|Protocol Violation|0|||
33416454|NCT00059215|62794395|FG000|Overall Study|Protocol entry criteria not met|1|||
33416455|NCT00059215|62794396|FG001|Overall Study|Protocol entry criteria not met|1|||
33416456|NCT00059215|62794397|FG002|Overall Study|Protocol entry criteria not met|0|||
33416457|NCT00059215|62794398|FG003|Overall Study|Protocol entry criteria not met|2|||
33416458|NCT00059215|62794395|FG000|Overall Study|Physician Decision|1|||
33416459|NCT00059215|62794396|FG001|Overall Study|Physician Decision|2|||
33416460|NCT00059215|62794397|FG002|Overall Study|Physician Decision|1|||
33416461|NCT00059215|62794398|FG003|Overall Study|Physician Decision|1|||
33416462|NCT00058825|62794409|FG000|Overall Study|Relapse|9|||
33416463|NCT00058825|62794409|FG000|Overall Study|Progressive Disease|5|||
33416464|NCT00058825|62794409|FG000|Overall Study|Graft Failure|5|||
33416465|NCT00058825|62794409|FG000|Overall Study|Death|3|||
33416466|NCT00364858|62794417|FG000|Overall Study|Adverse Event|1|||
33416467|NCT00364858|62794418|FG001|Overall Study|Adverse Event|5|||
33416468|NCT00364858|62794417|FG000|Overall Study|Withdrawal by Subject|1|||
33416469|NCT00364858|62794418|FG001|Overall Study|Withdrawal by Subject|1|||
33416470|NCT00364858|62794417|FG000|Overall Study|Pregnancy|1|||
33416471|NCT00364858|62794418|FG001|Overall Study|Pregnancy|1|||
33416472|NCT00364858|62794417|FG000|Overall Study|Clinical failure|2|||
33416473|NCT00364858|62794418|FG001|Overall Study|Clinical failure|13|||
33416474|NCT00364858|62794417|FG000|Overall Study|Discontinuation at baseline|1|||
33416475|NCT00364858|62794418|FG001|Overall Study|Discontinuation at baseline|0|||
33416476|NCT00364858|62794417|FG000|Overall Study|Non-compliant|1|||
33416477|NCT00364858|62794418|FG001|Overall Study|Non-compliant|0|||
33416478|NCT00364858|62794417|FG000|Overall Study|Return to Q2 regimen|0|||
33416479|NCT00364858|62794418|FG001|Overall Study|Return to Q2 regimen|1|||
33416480|NCT00364858|62794417|FG000|Overall Study|Clinical baseline issue|0|||
33416481|NCT00364858|62794418|FG001|Overall Study|Clinical baseline issue|1|||
33416482|NCT03803059|62794425|FG000|Overall Study|Protocol Violation|2|||
33416483|NCT03803059|62794425|FG000|Overall Study|Lost to Follow-up|1|||
33416484|NCT00372424|62794430|FG000|Overall Study|Adverse Event|2|||
33416485|NCT00372424|62794430|FG000|Overall Study|Withdrawal by Subject|1|||
33416486|NCT00372424|62794430|FG000|Overall Study|Death|1|||
33416487|NCT00372424|62794430|FG000|Overall Study|Objective Progression or Relapse|14|||
33416488|NCT00372424|62794430|FG000|Overall Study|Other|7|||
33416489|NCT00372424|62794430|FG000|Overall Study|Enrolled, Not Treated|1|||
33416490|NCT00372190|62794436|FG000|Overall Study|Lost to Follow-up|3|||
33416491|NCT00372190|62794437|FG001|Overall Study|Lost to Follow-up|1|||
33416492|NCT00044083|62794447|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
33416493|NCT00044083|62794448|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
33416494|NCT00044083|62794447|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
33416495|NCT00044083|62794448|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
33416496|NCT00044083|62794447|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
33416497|NCT00044083|62794448|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
33416498|NCT00044083|62794447|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
33416499|NCT00044083|62794448|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
33416500|NCT00044083|62794447|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
33416501|NCT00044083|62794448|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
33416502|NCT00044083|62794447|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
33416503|NCT00044083|62794448|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
33416504|NCT00044083|62794447|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
33416505|NCT00044083|62794448|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
33416506|NCT00044083|62794447|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
33416507|NCT00044083|62794448|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
33416508|NCT00044083|62794447|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
33416509|NCT00044083|62794448|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
33416510|NCT00044083|62794447|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
33416511|NCT00044083|62794448|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
33416512|NCT00058123|62794481|FG000|Overall Study|Wrong histology|9|||
33416513|NCT00058123|62794481|FG000|Overall Study|Received >3 prior treatments|1|||
33416514|NCT00022633|62794488|FG000|Overall Study|Adverse Event|11|||
33416515|NCT00022633|62794489|FG001|Overall Study|Adverse Event|1|||
33604905|NCT01769404|63004505|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33416516|NCT00022633|62794488|FG000|Overall Study|Refusal unrelated to adverse event|1|||
33416517|NCT00022633|62794489|FG001|Overall Study|Refusal unrelated to adverse event|0|||
33416518|NCT00022633|62794488|FG000|Overall Study|Progression/relapse|9|||
33416519|NCT00022633|62794489|FG001|Overall Study|Progression/relapse|2|||
33416520|NCT00022633|62794488|FG000|Overall Study|Death|4|||
33416521|NCT00022633|62794489|FG001|Overall Study|Death|0|||
33416522|NCT00022633|62794488|FG000|Overall Study|Other - not protocol specified|3|||
33416523|NCT00022633|62794489|FG001|Overall Study|Other - not protocol specified|2|||
33416524|NCT00022633|62794488|FG000|Overall Study|Ineligible|4|||
33416525|NCT00022633|62794489|FG001|Overall Study|Ineligible|0|||
33416526|NCT00021541|62794496|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
33416527|NCT00021541|62794497|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
33416528|NCT00021541|62794496|FG000|Period 1-First Treatment|Adverse Event|2|||
33416529|NCT00021541|62794497|FG001|Period 1-First Treatment|Adverse Event|1|||
33416530|NCT00021541|62794496|FG000|Period 1-First Treatment|non-adherence|3|||
33416531|NCT00021541|62794497|FG001|Period 1-First Treatment|non-adherence|0|||
33416532|NCT00021541|62794496|FG000|Period 1-First Treatment|Death|1|||
33416533|NCT00021541|62794497|FG001|Period 1-First Treatment|Death|0|||
33416534|NCT00021541|62794496|FG000|Period 1-First Treatment|Pts that did not progress|2|||
33416535|NCT00021541|62794497|FG001|Period 1-First Treatment|Pts that did not progress|2|||
33416536|NCT00021541|62794496|FG000|Period 1-First Treatment|Ineligible|0|||
33416537|NCT00021541|62794497|FG001|Period 1-First Treatment|Ineligible|2|||
33416538|NCT00021541|62794496|FG000|Period 2-crossover|refused phase B|2|||
33416539|NCT00021541|62794497|FG001|Period 2-crossover|refused phase B|2|||
33416540|NCT00021541|62794496|FG000|Period 2-crossover|Withdrawal by Subject|3|||
33416541|NCT00021541|62794497|FG001|Period 2-crossover|Withdrawal by Subject|4|||
33416542|NCT00021541|62794496|FG000|Period 2-crossover|Adverse Event|2|||
33416543|NCT00021541|62794497|FG001|Period 2-crossover|Adverse Event|2|||
33416544|NCT00021541|62794496|FG000|Period 2-crossover|non-adherence|1|||
33416545|NCT00021541|62794497|FG001|Period 2-crossover|non-adherence|0|||
33416546|NCT00021541|62794496|FG000|Period 2-crossover|Pts that did not progress|2|||
33416547|NCT00021541|62794497|FG001|Period 2-crossover|Pts that did not progress|3|||
33416548|NCT00021229|62794508|FG000|Overall Study|Adverse Event|10|||
33416549|NCT00021229|62794509|FG001|Overall Study|Adverse Event|5|||
33416550|NCT00021229|62794510|FG002|Overall Study|Adverse Event|2|||
33416551|NCT00021229|62794508|FG000|Overall Study|Death|0|||
33416552|NCT00021229|62794509|FG001|Overall Study|Death|1|||
33416553|NCT00021229|62794510|FG002|Overall Study|Death|0|||
33416554|NCT00021229|62794508|FG000|Overall Study|Withdrawal by Subject|7|||
33416555|NCT00021229|62794509|FG001|Overall Study|Withdrawal by Subject|7|||
33416556|NCT00021229|62794510|FG002|Overall Study|Withdrawal by Subject|1|||
33416557|NCT00021229|62794508|FG000|Overall Study|Progressive Disease|15|||
33416558|NCT00021229|62794509|FG001|Overall Study|Progressive Disease|19|||
33416559|NCT00021229|62794510|FG002|Overall Study|Progressive Disease|12|||
33416560|NCT00021229|62794508|FG000|Overall Study|Protocol Violation|1|||
33416561|NCT00021229|62794509|FG001|Overall Study|Protocol Violation|1|||
33416562|NCT00021229|62794510|FG002|Overall Study|Protocol Violation|0|||
33416563|NCT00021229|62794508|FG000|Overall Study|Physician Decision|0|||
33416564|NCT00021229|62794509|FG001|Overall Study|Physician Decision|0|||
33416565|NCT00021229|62794510|FG002|Overall Study|Physician Decision|1|||
33416566|NCT00021229|62794508|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
33416567|NCT00021229|62794509|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
33416568|NCT00021229|62794510|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
33416569|NCT00372112|62794524|FG000|Overall Study|Adverse Event|0|||
33416570|NCT00372112|62794525|FG001|Overall Study|Adverse Event|1|||
33416571|NCT00372112|62794526|FG002|Overall Study|Adverse Event|1|||
33416572|NCT00372112|62794527|FG003|Overall Study|Adverse Event|1|||
33416573|NCT00372112|62794524|FG000|Overall Study|Withdrawal by Subject|0|||
33416574|NCT00372112|62794525|FG001|Overall Study|Withdrawal by Subject|0|||
33416575|NCT00372112|62794526|FG002|Overall Study|Withdrawal by Subject|2|||
33416576|NCT00372112|62794527|FG003|Overall Study|Withdrawal by Subject|1|||
33416577|NCT00372112|62794524|FG000|Overall Study|Exacerbation|0|||
33416578|NCT00372112|62794525|FG001|Overall Study|Exacerbation|0|||
33416579|NCT00372112|62794526|FG002|Overall Study|Exacerbation|0|||
33416580|NCT00372112|62794527|FG003|Overall Study|Exacerbation|1|||
33416581|NCT00372112|62794524|FG000|Overall Study|PR >240 at Visit 3|0|||
33416582|NCT00372112|62794525|FG001|Overall Study|PR >240 at Visit 3|0|||
33416583|NCT00372112|62794526|FG002|Overall Study|PR >240 at Visit 3|0|||
33416584|NCT00372112|62794527|FG003|Overall Study|PR >240 at Visit 3|1|||
33416585|NCT00372112|62794524|FG000|Overall Study|Hepatitis B|1|||
33416586|NCT00372112|62794525|FG001|Overall Study|Hepatitis B|0|||
33416587|NCT00372112|62794526|FG002|Overall Study|Hepatitis B|0|||
33416588|NCT00372112|62794527|FG003|Overall Study|Hepatitis B|0|||
33416589|NCT00372112|62794524|FG000|Overall Study|Other-protocol violation|0|||
33416590|NCT00372112|62794525|FG001|Overall Study|Other-protocol violation|0|||
33416591|NCT00372112|62794526|FG002|Overall Study|Other-protocol violation|1|||
33416592|NCT00372112|62794527|FG003|Overall Study|Other-protocol violation|0|||
33416593|NCT00488475|62794540|FG000|Overall Study|Other|1754|||
33416594|NCT00042991|62794551|FG000|Overall Study|Adverse Event|1|||
33416595|NCT00042991|62794552|FG001|Overall Study|Adverse Event|4|||
33416596|NCT00042991|62794553|FG002|Overall Study|Adverse Event|2|||
33416597|NCT00042991|62794554|FG003|Overall Study|Adverse Event|0|||
33416598|NCT00042991|62794555|FG004|Overall Study|Adverse Event|0|||
33416599|NCT00042991|62794556|FG005|Overall Study|Adverse Event|1|||
33416600|NCT00042991|62794557|FG006|Overall Study|Adverse Event|0|||
33416601|NCT00042991|62794551|FG000|Overall Study|Withdrawal by Subject|0|||
33416602|NCT00042991|62794552|FG001|Overall Study|Withdrawal by Subject|7|||
33416603|NCT00042991|62794553|FG002|Overall Study|Withdrawal by Subject|2|||
33416604|NCT00042991|62794554|FG003|Overall Study|Withdrawal by Subject|0|||
33416605|NCT00042991|62794555|FG004|Overall Study|Withdrawal by Subject|1|||
33416606|NCT00042991|62794556|FG005|Overall Study|Withdrawal by Subject|0|||
33416607|NCT00042991|62794557|FG006|Overall Study|Withdrawal by Subject|0|||
33416608|NCT00042991|62794551|FG000|Overall Study|Disease Progression|5|||
33416609|NCT00042991|62794552|FG001|Overall Study|Disease Progression|29|||
33416610|NCT00042991|62794553|FG002|Overall Study|Disease Progression|2|||
33416611|NCT00042991|62794554|FG003|Overall Study|Disease Progression|2|||
33416612|NCT00042991|62794555|FG004|Overall Study|Disease Progression|1|||
33416613|NCT00042991|62794556|FG005|Overall Study|Disease Progression|4|||
33416614|NCT00042991|62794557|FG006|Overall Study|Disease Progression|2|||
33416615|NCT00042991|62794551|FG000|Overall Study|Alternative Therapy|0|||
33416616|NCT00042991|62794552|FG001|Overall Study|Alternative Therapy|0|||
33416617|NCT00042991|62794553|FG002|Overall Study|Alternative Therapy|0|||
33416618|NCT00042991|62794554|FG003|Overall Study|Alternative Therapy|0|||
33416619|NCT00042991|62794555|FG004|Overall Study|Alternative Therapy|1|||
33416620|NCT00042991|62794556|FG005|Overall Study|Alternative Therapy|0|||
33416621|NCT00042991|62794557|FG006|Overall Study|Alternative Therapy|0|||
33416622|NCT00466167|62794578|FG000|Overall Study|Adverse Event|8|||
33416623|NCT00466167|62794579|FG001|Overall Study|Adverse Event|8|||
33416624|NCT00466167|62794580|FG002|Overall Study|Adverse Event|7|||
33416625|NCT00466167|62794578|FG000|Overall Study|Lack of Efficacy|2|||
33416626|NCT00466167|62794579|FG001|Overall Study|Lack of Efficacy|0|||
33416627|NCT00466167|62794580|FG002|Overall Study|Lack of Efficacy|3|||
33416628|NCT00466167|62794578|FG000|Overall Study|Protocol Violation|1|||
33416629|NCT00466167|62794579|FG001|Overall Study|Protocol Violation|1|||
33416630|NCT00466167|62794580|FG002|Overall Study|Protocol Violation|2|||
33416631|NCT00466167|62794578|FG000|Overall Study|Lost to Follow-up|3|||
33416632|NCT00466167|62794579|FG001|Overall Study|Lost to Follow-up|2|||
33416633|NCT00466167|62794580|FG002|Overall Study|Lost to Follow-up|2|||
33416634|NCT00466167|62794578|FG000|Overall Study|Withdrawal by Subject|4|||
33416635|NCT00466167|62794579|FG001|Overall Study|Withdrawal by Subject|1|||
33416636|NCT00466167|62794580|FG002|Overall Study|Withdrawal by Subject|6|||
33416637|NCT00466167|62794578|FG000|Overall Study|patient did not meet inclusion criteria|1|||
33416638|NCT00466167|62794579|FG001|Overall Study|patient did not meet inclusion criteria|0|||
33416639|NCT00466167|62794580|FG002|Overall Study|patient did not meet inclusion criteria|1|||
33416640|NCT00466167|62794578|FG000|Overall Study|Not treated|1|||
33416641|NCT00466167|62794579|FG001|Overall Study|Not treated|0|||
33416642|NCT00466167|62794580|FG002|Overall Study|Not treated|0|||
33416643|NCT00480441|62794590|FG000|Screening|Not Eligible|37|||
33416644|NCT00480441|62794591|FG001|Screening|Not Eligible|0|||
33416645|NCT00480441|62794592|FG002|Screening|Not Eligible|0|||
33416646|NCT00480441|62794590|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
33416647|NCT00480441|62794591|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
33416648|NCT00480441|62794592|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
33416649|NCT00480441|62794590|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
33416650|NCT00480441|62794591|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
33416651|NCT00480441|62794592|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
33416652|NCT00480441|62794590|FG000|Baseline Functional MRI|physical contraindication|4|||
33416653|NCT00480441|62794591|FG001|Baseline Functional MRI|physical contraindication|0|||
33416654|NCT00480441|62794592|FG002|Baseline Functional MRI|physical contraindication|0|||
33416655|NCT00480441|62794590|FG000|Randomization|Lost to Follow-up|0|||
33416656|NCT00480441|62794591|FG001|Randomization|Lost to Follow-up|7|||
33416657|NCT00480441|62794592|FG002|Randomization|Lost to Follow-up|2|||
33416658|NCT00488319|62794602|FG000|Overall Study|Adverse Event|1|||
33416659|NCT00488319|62794603|FG001|Overall Study|Adverse Event|2|||
33416660|NCT00488319|62794604|FG002|Overall Study|Adverse Event|23|||
33416661|NCT00488319|62794602|FG000|Overall Study|Lack of Efficacy|6|||
33416662|NCT00488319|62794603|FG001|Overall Study|Lack of Efficacy|12|||
33416663|NCT00488319|62794604|FG002|Overall Study|Lack of Efficacy|27|||
33416664|NCT00488319|62794602|FG000|Overall Study|Lost to Follow-up|3|||
33416665|NCT00488319|62794603|FG001|Overall Study|Lost to Follow-up|5|||
33416666|NCT00488319|62794604|FG002|Overall Study|Lost to Follow-up|16|||
33416667|NCT00488319|62794602|FG000|Overall Study|Withdrawal by Subject|5|||
33416668|NCT00488319|62794603|FG001|Overall Study|Withdrawal by Subject|20|||
33416669|NCT00488319|62794604|FG002|Overall Study|Withdrawal by Subject|44|||
33416670|NCT00488319|62794602|FG000|Overall Study|Other reasons for withdrawal|0|||
33416671|NCT00488319|62794603|FG001|Overall Study|Other reasons for withdrawal|4|||
33416672|NCT00488319|62794604|FG002|Overall Study|Other reasons for withdrawal|12|||
33416673|NCT00463047|62794613|FG000|Titration Period 1|Adverse Event|10|||
33416674|NCT00463047|62794614|FG001|Titration Period 1|Adverse Event|8|||
33416675|NCT00463047|62794613|FG000|Titration Period 1|Lack of Efficacy|10|||
33416676|NCT00463047|62794614|FG001|Titration Period 1|Lack of Efficacy|4|||
33416677|NCT00463047|62794613|FG000|Titration Period 1|Lost to Follow-up|2|||
33322788|NCT01179191|62698861|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
33322789|NCT01179191|62698861|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
33322790|NCT01179191|62698861|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
33322791|NCT01179191|62698861|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
33322792|NCT01179191|62698861|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
33322793|NCT01179191|62698861|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
33322794|NCT01179191|62698861|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
33416678|NCT00463047|62794614|FG001|Titration Period 1|Lost to Follow-up|0|||
33416679|NCT00463047|62794613|FG000|Titration Period 1|Non-compliance with study medication|3|||
33416680|NCT00463047|62794614|FG001|Titration Period 1|Non-compliance with study medication|5|||
33416681|NCT00463047|62794613|FG000|Titration Period 1|Protocol Violation|5|||
33416682|NCT00463047|62794614|FG001|Titration Period 1|Protocol Violation|5|||
33416683|NCT00463047|62794613|FG000|Titration Period 1|Withdrawal by Subject|3|||
33416684|NCT00463047|62794614|FG001|Titration Period 1|Withdrawal by Subject|5|||
33416685|NCT00463047|62794613|FG000|Titration Period 1|Non-compliance procedures|4|||
33416686|NCT00463047|62794614|FG001|Titration Period 1|Non-compliance procedures|10|||
33416687|NCT00463047|62794613|FG000|Titration Period 1|Other|0|||
33416688|NCT00463047|62794614|FG001|Titration Period 1|Other|2|||
33416689|NCT00463047|62794613|FG000|Titration Period 2|Adverse Event|9|||
33416690|NCT00463047|62794614|FG001|Titration Period 2|Adverse Event|9|||
33416691|NCT00463047|62794613|FG000|Titration Period 2|Lack of Efficacy|6|||
33416692|NCT00463047|62794614|FG001|Titration Period 2|Lack of Efficacy|4|||
33416693|NCT00463047|62794613|FG000|Titration Period 2|Withdrawal by Subject|1|||
33416694|NCT00463047|62794614|FG001|Titration Period 2|Withdrawal by Subject|0|||
33416695|NCT00463047|62794613|FG000|Titration Period 2|Protocol Violation|2|||
33416696|NCT00463047|62794614|FG001|Titration Period 2|Protocol Violation|3|||
33416697|NCT00463047|62794613|FG000|Titration Period 2|Lost to Follow-up|1|||
33416698|NCT00463047|62794614|FG001|Titration Period 2|Lost to Follow-up|2|||
33416699|NCT00463047|62794613|FG000|Titration Period 2|Non-compliance study medication|4|||
33416700|NCT00463047|62794614|FG001|Titration Period 2|Non-compliance study medication|2|||
33416701|NCT00463047|62794613|FG000|Titration Period 2|Non-compliance procedures|4|||
33416702|NCT00463047|62794614|FG001|Titration Period 2|Non-compliance procedures|1|||
33416703|NCT00463047|62794613|FG000|Titration Period 2|Other|3|||
33416704|NCT00463047|62794614|FG001|Titration Period 2|Other|2|||
33416705|NCT00463047|62794613|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
33416706|NCT00463047|62794614|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
33416707|NCT00463047|62794613|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
33416708|NCT00463047|62794614|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
33416709|NCT00463047|62794613|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
33416710|NCT00463047|62794614|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
33416711|NCT00463047|62794613|FG000|Double-Blind Treatment Period 1|Other|1|||
33416712|NCT00463047|62794614|FG001|Double-Blind Treatment Period 1|Other|0|||
33416713|NCT00463047|62794613|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
33416714|NCT00463047|62794614|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
33416715|NCT00463047|62794613|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
33416716|NCT00463047|62794614|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
33416717|NCT00463047|62794613|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
33416718|NCT00463047|62794614|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
33416719|NCT00487695|62794621|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
33416720|NCT00487695|62794622|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
33416721|NCT00487695|62794621|FG000|First Procedure|active wheezing (did not have procedure)|1|||
33416722|NCT00487695|62794622|FG001|First Procedure|active wheezing (did not have procedure)|0|||
33416723|NCT00487695|62794621|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
33416724|NCT00487695|62794622|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
33494094|NCT03472326|62872790|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
33416725|NCT00487695|62794621|FG000|Second Procedure|active wheezing|0|||
33416726|NCT00487695|62794622|FG001|Second Procedure|active wheezing|1|||
33416727|NCT00487695|62794621|FG000|Second Procedure|Withdrawal by Subject|1|||
33416728|NCT00487695|62794622|FG001|Second Procedure|Withdrawal by Subject|2|||
33416729|NCT00487539|62794632|FG000|Overall Study|Adverse Event|3|||
33416730|NCT00487539|62794633|FG001|Overall Study|Adverse Event|2|||
33416731|NCT00487539|62794634|FG002|Overall Study|Adverse Event|1|||
33416732|NCT00487539|62794635|FG003|Overall Study|Adverse Event|1|||
33416733|NCT00487539|62794632|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33416734|NCT00487539|62794633|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33416735|NCT00487539|62794634|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33416736|NCT00487539|62794635|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
33416737|NCT00487539|62794632|FG000|Overall Study|Other|3|||
33416738|NCT00487539|62794633|FG001|Overall Study|Other|1|||
33416739|NCT00487539|62794634|FG002|Overall Study|Other|2|||
33416740|NCT00487539|62794635|FG003|Overall Study|Other|2|||
33416741|NCT00486837|62794646|FG000|Overall Study|Withdrawal by Subject|1|||
33416742|NCT00486837|62794647|FG001|Overall Study|Withdrawal by Subject|0|||
33416743|NCT00486837|62794646|FG000|Overall Study|Adverse Event|1|||
33416744|NCT00486837|62794647|FG001|Overall Study|Adverse Event|1|||
33416745|NCT00486837|62794646|FG000|Overall Study|Protocol Violation|4|||
33416746|NCT00486837|62794647|FG001|Overall Study|Protocol Violation|2|||
33416747|NCT00486837|62794646|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
33416748|NCT00486837|62794647|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
33416749|NCT00486759|62794657|FG000|Treatment|Adverse event/intercurrent illness|86|||
33416750|NCT00486759|62794658|FG001|Treatment|Adverse event/intercurrent illness|39|||
33416751|NCT00486759|62794657|FG000|Treatment|Insufficient therapeutic response|37|||
33416752|NCT00486759|62794658|FG001|Treatment|Insufficient therapeutic response|39|||
33416753|NCT00486759|62794657|FG000|Treatment|Death|17|||
33416754|NCT00486759|62794658|FG001|Treatment|Death|10|||
33416755|NCT00486759|62794657|FG000|Treatment|Withdrew consent|15|||
33416756|NCT00486759|62794658|FG001|Treatment|Withdrew consent|12|||
33416757|NCT00486759|62794657|FG000|Treatment|Administrative/reason not specified|17|||
33416758|NCT00486759|62794658|FG001|Treatment|Administrative/reason not specified|21|||
33416759|NCT00486759|62794657|FG000|Treatment|Refused treatment|10|||
33416760|NCT00486759|62794658|FG001|Treatment|Refused treatment|7|||
33416761|NCT00486759|62794657|FG000|Treatment|Violation of selection criteria at entry|3|||
33416762|NCT00486759|62794658|FG001|Treatment|Violation of selection criteria at entry|3|||
33416763|NCT00486759|62794657|FG000|Treatment|Other protocol violation|1|||
33416764|NCT00486759|62794658|FG001|Treatment|Other protocol violation|5|||
33416765|NCT00486759|62794657|FG000|Treatment|Failure to return|1|||
33416766|NCT00486759|62794658|FG001|Treatment|Failure to return|1|||
33416767|NCT00486759|62794657|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
33416768|NCT00486759|62794658|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
33416769|NCT00486759|62794657|FG000|Safety Follow-up|Death|40|||
33416770|NCT00486759|62794658|FG001|Safety Follow-up|Death|29|||
33416771|NCT00486759|62794657|FG000|Safety Follow-up|Withdrew consent|32|||
33416772|NCT00486759|62794658|FG001|Safety Follow-up|Withdrew consent|23|||
33416773|NCT00486759|62794657|FG000|Safety Follow-up|Failure to return|9|||
33416774|NCT00486759|62794658|FG001|Safety Follow-up|Failure to return|6|||
33416775|NCT00486759|62794657|FG000|Safety Follow-up|Administrative/not specified|8|||
33416776|NCT00486759|62794658|FG001|Safety Follow-up|Administrative/not specified|6|||
33416777|NCT00486759|62794657|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
33416778|NCT00486759|62794658|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
33416779|NCT00486759|62794657|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
33416780|NCT00486759|62794658|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
33416781|NCT00486603|62794666|FG000|Overall Study|Withdrawal by Subject|1|||
33416782|NCT00486603|62794667|FG001|Overall Study|Withdrawal by Subject|0|||
33416783|NCT00486603|62794668|FG002|Overall Study|Withdrawal by Subject|0|||
33416784|NCT00486603|62794669|FG003|Overall Study|Withdrawal by Subject|0|||
33416785|NCT00486603|62794670|FG004|Overall Study|Withdrawal by Subject|0|||
33416786|NCT00486603|62794666|FG000|Overall Study|Physician Decision|0|||
33416787|NCT00486603|62794667|FG001|Overall Study|Physician Decision|1|||
33416788|NCT00486603|62794668|FG002|Overall Study|Physician Decision|0|||
33416789|NCT00486603|62794669|FG003|Overall Study|Physician Decision|0|||
33416790|NCT00486603|62794670|FG004|Overall Study|Physician Decision|0|||
33416791|NCT00486291|62794687|FG000|Overall Study|Adverse Event|3|||
33322795|NCT01179191|62698861|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
33416792|NCT00486291|62794688|FG001|Overall Study|Adverse Event|4|||
33416793|NCT00486291|62794687|FG000|Overall Study|Lost to Follow-up|3|||
33416794|NCT00486291|62794688|FG001|Overall Study|Lost to Follow-up|7|||
33416795|NCT00486291|62794687|FG000|Overall Study|protocol non-compliance|10|||
33416796|NCT00486291|62794688|FG001|Overall Study|protocol non-compliance|15|||
33416797|NCT00486291|62794687|FG000|Overall Study|requirement for restricted medication|0|||
33416798|NCT00486291|62794688|FG001|Overall Study|requirement for restricted medication|3|||
33416799|NCT00474045|62794696|FG000|Overall Study|Adverse Event|18|||
33416800|NCT00474045|62794697|FG001|Overall Study|Adverse Event|8|||
33416801|NCT00474045|62794696|FG000|Overall Study|Unclassified|1|||
33416802|NCT00474045|62794697|FG001|Overall Study|Unclassified|3|||
33416803|NCT00474045|62794696|FG000|Overall Study|Lack of Efficacy|0|||
33416804|NCT00474045|62794697|FG001|Overall Study|Lack of Efficacy|9|||
33416805|NCT00474045|62794696|FG000|Overall Study|Lost to Follow-up|1|||
33416806|NCT00474045|62794697|FG001|Overall Study|Lost to Follow-up|1|||
33416807|NCT00474045|62794696|FG000|Overall Study|Protocol Violation|10|||
33416808|NCT00474045|62794697|FG001|Overall Study|Protocol Violation|12|||
33416809|NCT00474045|62794696|FG000|Overall Study|Withdrawal by Subject|16|||
33416810|NCT00474045|62794697|FG001|Overall Study|Withdrawal by Subject|18|||
33416811|NCT00474045|62794696|FG000|Overall Study|Withdrawal criteria|60|||
33416812|NCT00474045|62794697|FG001|Overall Study|Withdrawal criteria|50|||
33416813|NCT00462501|62794703|FG000|Overall Study|Not treated|3|||
33416814|NCT00462501|62794703|FG000|Overall Study|Adverse Event|2|||
33416815|NCT00383188|62794712|FG000|Overall Study|Adverse Event|4|||
33416816|NCT00383188|62794713|FG001|Overall Study|Adverse Event|7|||
33416817|NCT00383188|62794714|FG002|Overall Study|Adverse Event|9|||
33416818|NCT00383188|62794715|FG003|Overall Study|Adverse Event|8|||
33416819|NCT00383188|62794716|FG004|Overall Study|Adverse Event|8|||
33416820|NCT00383188|62794712|FG000|Overall Study|Lack of Efficacy|9|||
33416821|NCT00383188|62794713|FG001|Overall Study|Lack of Efficacy|3|||
33416822|NCT00383188|62794714|FG002|Overall Study|Lack of Efficacy|3|||
33416823|NCT00383188|62794715|FG003|Overall Study|Lack of Efficacy|2|||
33416824|NCT00383188|62794716|FG004|Overall Study|Lack of Efficacy|6|||
33416825|NCT00383188|62794712|FG000|Overall Study|Other|3|||
33416826|NCT00383188|62794713|FG001|Overall Study|Other|1|||
33416827|NCT00383188|62794714|FG002|Overall Study|Other|0|||
33416828|NCT00383188|62794715|FG003|Overall Study|Other|2|||
33416829|NCT00383188|62794716|FG004|Overall Study|Other|6|||
33416830|NCT00383188|62794712|FG000|Overall Study|No longer willing to participate|1|||
33416831|NCT00383188|62794713|FG001|Overall Study|No longer willing to participate|0|||
33416832|NCT00383188|62794714|FG002|Overall Study|No longer willing to participate|1|||
33416833|NCT00383188|62794715|FG003|Overall Study|No longer willing to participate|0|||
33416834|NCT00383188|62794716|FG004|Overall Study|No longer willing to participate|2|||
33416835|NCT00383188|62794712|FG000|Overall Study|Lost to Follow-up|0|||
33416836|NCT00383188|62794713|FG001|Overall Study|Lost to Follow-up|0|||
33416837|NCT00383188|62794714|FG002|Overall Study|Lost to Follow-up|0|||
33416838|NCT00383188|62794715|FG003|Overall Study|Lost to Follow-up|0|||
33416839|NCT00383188|62794716|FG004|Overall Study|Lost to Follow-up|1|||
33416840|NCT00462345|62794730|FG000|Overall Study|Withdrawal by Subject|2|||
33416841|NCT00462345|62794730|FG000|Overall Study|Did not complete second course|1|||
33416842|NCT00453999|62794737|FG000|Overall Study|Adverse Event|1|||
33416843|NCT00453999|62794738|FG001|Overall Study|Adverse Event|2|||
33416844|NCT00453999|62794739|FG002|Overall Study|Adverse Event|1|||
33416845|NCT00453999|62794737|FG000|Overall Study|Lost to Follow-up|0|||
33416846|NCT00453999|62794738|FG001|Overall Study|Lost to Follow-up|1|||
33416847|NCT00453999|62794739|FG002|Overall Study|Lost to Follow-up|1|||
33416848|NCT00453999|62794737|FG000|Overall Study|Withdrawal by Subject|2|||
33416849|NCT00453999|62794738|FG001|Overall Study|Withdrawal by Subject|1|||
33416850|NCT00453999|62794739|FG002|Overall Study|Withdrawal by Subject|1|||
33416851|NCT00453999|62794737|FG000|Overall Study|Subject Request|2|||
33416852|NCT00453999|62794738|FG001|Overall Study|Subject Request|1|||
33322796|NCT01179191|62698861|FG000|Maintenance Phase (8 Weeks)|Other|66|||
33416853|NCT00453999|62794739|FG002|Overall Study|Subject Request|0|||
33416854|NCT00453921|62794752|FG000|Overall Study|Withdrawal by Subject|1|||
33416855|NCT00453921|62794753|FG001|Overall Study|Withdrawal by Subject|1|||
33416856|NCT00453921|62794754|FG002|Overall Study|Withdrawal by Subject|1|||
33416857|NCT00453921|62794755|FG003|Overall Study|Withdrawal by Subject|1|||
33416858|NCT00453921|62794752|FG000|Overall Study|Lost to Follow-up|0|||
33416859|NCT00453921|62794753|FG001|Overall Study|Lost to Follow-up|0|||
33416860|NCT00453921|62794754|FG002|Overall Study|Lost to Follow-up|1|||
33416861|NCT00453921|62794755|FG003|Overall Study|Lost to Follow-up|0|||
33416862|NCT00382720|62794772|FG000|Overall Study|Adverse Event|21|||
33416863|NCT00382720|62794773|FG001|Overall Study|Adverse Event|23|||
33416864|NCT00382720|62794774|FG002|Overall Study|Adverse Event|15|||
33416865|NCT00382720|62794772|FG000|Overall Study|Protocol Violation|2|||
33416866|NCT00382720|62794773|FG001|Overall Study|Protocol Violation|5|||
33322797|NCT01169844|62698867|FG000|Overall Study|Adverse Event|0|||
33416867|NCT00382720|62794774|FG002|Overall Study|Protocol Violation|1|||
33416868|NCT00382720|62794772|FG000|Overall Study|Death|0|||
33416869|NCT00382720|62794773|FG001|Overall Study|Death|1|||
33416870|NCT00382720|62794774|FG002|Overall Study|Death|2|||
33416871|NCT00382720|62794772|FG000|Overall Study|Progressive disease|37|||
33416872|NCT00382720|62794773|FG001|Overall Study|Progressive disease|28|||
33416873|NCT00382720|62794774|FG002|Overall Study|Progressive disease|38|||
33416874|NCT00382720|62794772|FG000|Overall Study|Withdrew consent|1|||
33416875|NCT00382720|62794773|FG001|Overall Study|Withdrew consent|1|||
33416876|NCT00382720|62794774|FG002|Overall Study|Withdrew consent|2|||
33416877|NCT00382720|62794772|FG000|Overall Study|Withdrawal by Subject|11|||
33416878|NCT00382720|62794773|FG001|Overall Study|Withdrawal by Subject|20|||
33416879|NCT00382720|62794774|FG002|Overall Study|Withdrawal by Subject|12|||
33416880|NCT00382720|62794772|FG000|Overall Study|Surgery|1|||
33416881|NCT00382720|62794773|FG001|Overall Study|Surgery|1|||
33416882|NCT00382720|62794774|FG002|Overall Study|Surgery|4|||
33416883|NCT00382720|62794772|FG000|Overall Study|Patient did not receive study medication|1|||
33416884|NCT00382720|62794773|FG001|Overall Study|Patient did not receive study medication|1|||
33416885|NCT00382720|62794774|FG002|Overall Study|Patient did not receive study medication|4|||
33416886|NCT00382720|62794772|FG000|Overall Study|Clinically progressive disease|0|||
33416887|NCT00382720|62794773|FG001|Overall Study|Clinically progressive disease|1|||
33416888|NCT00382720|62794774|FG002|Overall Study|Clinically progressive disease|0|||
33416889|NCT00382720|62794772|FG000|Overall Study|Good prognosis|0|||
33416890|NCT00382720|62794773|FG001|Overall Study|Good prognosis|1|||
33416891|NCT00382720|62794774|FG002|Overall Study|Good prognosis|0|||
33416892|NCT00382720|62794772|FG000|Overall Study|Investigator/Clinical decision|5|||
33416893|NCT00382720|62794773|FG001|Overall Study|Investigator/Clinical decision|6|||
33416894|NCT00382720|62794774|FG002|Overall Study|Investigator/Clinical decision|6|||
33416895|NCT00382720|62794772|FG000|Overall Study|Discontinued at end of study|0|||
33416896|NCT00382720|62794773|FG001|Overall Study|Discontinued at end of study|1|||
33416897|NCT00382720|62794774|FG002|Overall Study|Discontinued at end of study|2|||
33416898|NCT00453063|62794784|FG000|Overall Study|Adverse Event|1|||
33416899|NCT00453063|62794785|FG001|Overall Study|Adverse Event|2|||
33416900|NCT00453063|62794784|FG000|Overall Study|Withdrawal by Subject|1|||
33416901|NCT00453063|62794785|FG001|Overall Study|Withdrawal by Subject|1|||
33416902|NCT00453063|62794784|FG000|Overall Study|Protocol Violation|1|||
33416903|NCT00453063|62794785|FG001|Overall Study|Protocol Violation|0|||
33416904|NCT00371566|62794793|FG000|Treatment Phase|Withdrawal by Subject|0|||
33416905|NCT00371566|62794794|FG001|Treatment Phase|Withdrawal by Subject|1|||
33416906|NCT00371566|62794793|FG000|Treatment Phase|Adverse Event|0|||
33416907|NCT00371566|62794794|FG001|Treatment Phase|Adverse Event|1|||
33416908|NCT00371566|62794793|FG000|Treatment Phase|Protocol Violation|0|||
33416909|NCT00371566|62794794|FG001|Treatment Phase|Protocol Violation|1|||
33416910|NCT00371566|62794793|FG000|Chemoradiation Phase|Physician Decision|2|||
33416911|NCT00371566|62794794|FG001|Chemoradiation Phase|Physician Decision|0|||
33416912|NCT00371566|62794793|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
33416913|NCT00371566|62794794|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
33416914|NCT00371566|62794793|FG000|Chemoradiation Phase|Non compliant|0|||
33416915|NCT00371566|62794794|FG001|Chemoradiation Phase|Non compliant|1|||
33416916|NCT00371566|62794793|FG000|Chemoradiation Phase|Progressive Disease|1|||
33416917|NCT00371566|62794794|FG001|Chemoradiation Phase|Progressive Disease|1|||
33416918|NCT00371566|62794793|FG000|Chemoradiation Phase|Death|2|||
33416919|NCT00371566|62794794|FG001|Chemoradiation Phase|Death|0|||
33416920|NCT00371566|62794793|FG000|Follow Up Phase|Death|0|||
33416921|NCT00371566|62794794|FG001|Follow Up Phase|Death|5|||
33416922|NCT00371566|62794793|FG000|Follow Up Phase|Disease progression|1|||
33416923|NCT00371566|62794794|FG001|Follow Up Phase|Disease progression|0|||
33416924|NCT00371566|62794793|FG000|Follow Up Phase|Withdrawal by Subject|0|||
33416925|NCT00371566|62794794|FG001|Follow Up Phase|Withdrawal by Subject|1|||
33416926|NCT00371566|62794793|FG000|Follow Up Phase|Physician Decision|1|||
33416927|NCT00371566|62794794|FG001|Follow Up Phase|Physician Decision|1|||
33416928|NCT00371566|62794793|FG000|Follow Up Phase|Lost to Follow-up|1|||
33416929|NCT00371566|62794794|FG001|Follow Up Phase|Lost to Follow-up|0|||
33416930|NCT00382408|62794802|FG000|Overall Study|Did not meet protocol requirement|3|||
33416931|NCT00382408|62794803|FG001|Overall Study|Did not meet protocol requirement|3|||
33416932|NCT00382408|62794802|FG000|Overall Study|Protocol Violation|2|||
33416933|NCT00382408|62794803|FG001|Overall Study|Protocol Violation|2|||
33604906|NCT01769404|63004504|FG000|Treatment Period 1|Sponsor decision|1|||
33322798|NCT01169844|62698868|FG001|Overall Study|Adverse Event|1|||
33322799|NCT01169844|62698867|FG000|Overall Study|Patient withdrew consent|4|||
33416934|NCT00382408|62794802|FG000|Overall Study|Physician Decision|1|||
33416935|NCT00382408|62794803|FG001|Overall Study|Physician Decision|0|||
33416936|NCT00382408|62794802|FG000|Overall Study|Withdrawal by Subject|17|||
33416937|NCT00382408|62794803|FG001|Overall Study|Withdrawal by Subject|6|||
33416938|NCT00382408|62794802|FG000|Overall Study|Pregnancy|2|||
33416939|NCT00382408|62794803|FG001|Overall Study|Pregnancy|0|||
33416940|NCT00382408|62794802|FG000|Overall Study|Lost to Follow-up|19|||
33416941|NCT00382408|62794803|FG001|Overall Study|Lost to Follow-up|8|||
33416942|NCT00382408|62794802|FG000|Overall Study|Other|100|||
33416943|NCT00382408|62794803|FG001|Overall Study|Other|35|||
33416944|NCT00371254|62794811|FG000|Overall Study|Disease progression|13|||
33416945|NCT00371254|62794812|FG001|Overall Study|Disease progression|13|||
33322800|NCT01169844|62698868|FG001|Overall Study|Patient withdrew consent|0|||
33322801|NCT01169844|62698867|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33416946|NCT00371254|62794811|FG000|Overall Study|Study drug toxicity|3|||
33416947|NCT00371254|62794812|FG001|Overall Study|Study drug toxicity|5|||
33416948|NCT00371254|62794811|FG000|Overall Study|Subject request|5|||
33416949|NCT00371254|62794812|FG001|Overall Study|Subject request|0|||
33416950|NCT00371254|62794811|FG000|Overall Study|Investigator Decision|2|||
33416951|NCT00371254|62794812|FG001|Overall Study|Investigator Decision|0|||
33416952|NCT00371254|62794811|FG000|Overall Study|Adverse event unrelated to study drug|0|||
33416953|NCT00371254|62794812|FG001|Overall Study|Adverse event unrelated to study drug|1|||
33416954|NCT00371254|62794811|FG000|Overall Study|Lost to Follow-up|0|||
33416955|NCT00371254|62794812|FG001|Overall Study|Lost to Follow-up|1|||
33416956|NCT00371254|62794811|FG000|Overall Study|Withdrawal by Subject|0|||
33416957|NCT00371254|62794812|FG001|Overall Study|Withdrawal by Subject|1|||
33416958|NCT00452673|62794822|FG000|Dose Escalation Period|Disease Progression|6|||
33416959|NCT00452673|62794823|FG001|Dose Escalation Period|Disease Progression|6|||
33416960|NCT00452673|62794824|FG002|Dose Escalation Period|Disease Progression|2|||
33416961|NCT00452673|62794825|FG003|Dose Escalation Period|Disease Progression|6|||
33416962|NCT00452673|62794826|FG004|Dose Escalation Period|Disease Progression|0|||
33416963|NCT00452673|62794822|FG000|Dose Escalation Period|study drug toxicity|1|||
33416964|NCT00452673|62794823|FG001|Dose Escalation Period|study drug toxicity|3|||
33416965|NCT00452673|62794824|FG002|Dose Escalation Period|study drug toxicity|3|||
33416966|NCT00452673|62794825|FG003|Dose Escalation Period|study drug toxicity|1|||
33416967|NCT00452673|62794826|FG004|Dose Escalation Period|study drug toxicity|0|||
33416968|NCT00452673|62794822|FG000|Dose Escalation Period|Other|0|||
33416969|NCT00452673|62794823|FG001|Dose Escalation Period|Other|0|||
33416970|NCT00452673|62794824|FG002|Dose Escalation Period|Other|1|||
33416971|NCT00452673|62794825|FG003|Dose Escalation Period|Other|0|||
33416972|NCT00452673|62794826|FG004|Dose Escalation Period|Other|0|||
33416973|NCT00452673|62794822|FG000|Dose Escalation Period|Adverse Event|0|||
33416974|NCT00452673|62794823|FG001|Dose Escalation Period|Adverse Event|0|||
33416975|NCT00452673|62794824|FG002|Dose Escalation Period|Adverse Event|0|||
33416976|NCT00452673|62794825|FG003|Dose Escalation Period|Adverse Event|1|||
33416977|NCT00452673|62794826|FG004|Dose Escalation Period|Adverse Event|0|||
33416978|NCT00452673|62794822|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
33416979|NCT00452673|62794823|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
33416980|NCT00452673|62794824|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
33416981|NCT00452673|62794825|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
33416982|NCT00452673|62794826|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
33416983|NCT00452673|62794822|FG000|Dose Expansion Period|Disease Progression|0|||
33416984|NCT00452673|62794823|FG001|Dose Expansion Period|Disease Progression|0|||
33416985|NCT00452673|62794824|FG002|Dose Expansion Period|Disease Progression|0|||
33416986|NCT00452673|62794825|FG003|Dose Expansion Period|Disease Progression|0|||
33416987|NCT00452673|62794826|FG004|Dose Expansion Period|Disease Progression|19|||
33416988|NCT00452673|62794822|FG000|Dose Expansion Period|Other|0|||
33416989|NCT00452673|62794823|FG001|Dose Expansion Period|Other|0|||
33416990|NCT00452673|62794824|FG002|Dose Expansion Period|Other|0|||
33416991|NCT00452673|62794825|FG003|Dose Expansion Period|Other|0|||
33322802|NCT01169844|62698868|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33322803|NCT01132482|62698876|FG000|Overall Study|Adverse Event|1|||
33322804|NCT01132482|62698877|FG001|Overall Study|Adverse Event|0|||
33322805|NCT00931762|62698883|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
33322806|NCT00931762|62698883|FG000|Overall Study|Administrative Problems|5|||
33322807|NCT00931762|62698883|FG000|Overall Study|Death|1|||
33322808|NCT00931762|62698883|FG000|Overall Study|Disease Progression|3|||
33322809|NCT00931762|62698883|FG000|Overall Study|Adverse Event (s)|11|||
33322810|NCT00931762|62698883|FG000|Overall Study|Subject withdrew consent|13|||
33322811|NCT01132326|62698887|FG000|Overall Study|Lack of Efficacy|25|||
33322812|NCT01132326|62698887|FG000|Overall Study|Adverse Event|37|||
33322813|NCT01132326|62698887|FG000|Overall Study|Protocol Violation|1|||
33416992|NCT00452673|62794826|FG004|Dose Expansion Period|Other|2|||
33416993|NCT00461253|62794839|FG000|Overall Study|Death|985|||
33416994|NCT00461253|62794840|FG001|Overall Study|Death|0|||
33416995|NCT00461253|62794839|FG000|Overall Study|Protocol Violation|613|||
33416996|NCT00461253|62794840|FG001|Overall Study|Protocol Violation|236|||
33416997|NCT00461253|62794839|FG000|Overall Study|no response|2609|||
33416998|NCT00461253|62794840|FG001|Overall Study|no response|11789|||
33416999|NCT00461253|62794839|FG000|Overall Study|administrative|773|||
33417000|NCT00461253|62794840|FG001|Overall Study|administrative|7773|||
33417001|NCT00469833|62794846|FG000|Overall Study|No IV access|2|||
33417002|NCT00382174|62794858|FG000|Overall Study|Lost to Follow-up|1|||
33417003|NCT00382174|62794859|FG001|Overall Study|Lost to Follow-up|4|||
33417004|NCT00382174|62794860|FG002|Overall Study|Lost to Follow-up|5|||
33417005|NCT00382174|62794858|FG000|Overall Study|Adverse Event|1|||
33417006|NCT00382174|62794859|FG001|Overall Study|Adverse Event|4|||
33417007|NCT00382174|62794860|FG002|Overall Study|Adverse Event|5|||
33417008|NCT00382174|62794858|FG000|Overall Study|Withdrawal by Subject|1|||
33417009|NCT00382174|62794859|FG001|Overall Study|Withdrawal by Subject|4|||
33417010|NCT00382174|62794860|FG002|Overall Study|Withdrawal by Subject|5|||
33417011|NCT00382174|62794858|FG000|Overall Study|Non compliance|1|||
33417012|NCT00382174|62794859|FG001|Overall Study|Non compliance|0|||
33417013|NCT00382174|62794860|FG002|Overall Study|Non compliance|1|||
33417014|NCT00382174|62794858|FG000|Overall Study|Physician Decision|0|||
33417015|NCT00382174|62794859|FG001|Overall Study|Physician Decision|2|||
33417016|NCT00382174|62794860|FG002|Overall Study|Physician Decision|2|||
33417017|NCT00382174|62794858|FG000|Overall Study|Failed to meet criteria|0|||
33417018|NCT00382174|62794859|FG001|Overall Study|Failed to meet criteria|1|||
33417019|NCT00382174|62794860|FG002|Overall Study|Failed to meet criteria|1|||
33417020|NCT00382174|62794858|FG000|Overall Study|Wounds merged|0|||
33417021|NCT00382174|62794859|FG001|Overall Study|Wounds merged|2|||
33417022|NCT00382174|62794860|FG002|Overall Study|Wounds merged|2|||
33417023|NCT00641537|62794873|FG000|96-week Period|Adverse Event|0|||
33417024|NCT00641537|62794874|FG001|96-week Period|Adverse Event|1|||
33417025|NCT00641537|62794875|FG002|96-week Period|Adverse Event|3|||
33417026|NCT00641537|62794876|FG003|96-week Period|Adverse Event|0|||
33417027|NCT00641537|62794877|FG004|96-week Period|Adverse Event|2|||
33417028|NCT00641537|62794878|FG005|96-week Period|Adverse Event|0|||
33417029|NCT00641537|62794879|FG006|96-week Period|Adverse Event|0|||
33417030|NCT00641537|62794880|FG007|96-week Period|Adverse Event|0|||
33417031|NCT00641537|62794873|FG000|96-week Period|Lost to Follow-up|3|||
33417032|NCT00641537|62794874|FG001|96-week Period|Lost to Follow-up|1|||
33417033|NCT00641537|62794875|FG002|96-week Period|Lost to Follow-up|2|||
33417034|NCT00641537|62794876|FG003|96-week Period|Lost to Follow-up|2|||
33417035|NCT00641537|62794877|FG004|96-week Period|Lost to Follow-up|4|||
33417036|NCT00641537|62794878|FG005|96-week Period|Lost to Follow-up|0|||
33417037|NCT00641537|62794879|FG006|96-week Period|Lost to Follow-up|1|||
33417038|NCT00641537|62794880|FG007|96-week Period|Lost to Follow-up|0|||
33417039|NCT00641537|62794873|FG000|96-week Period|Protocol Violation|0|||
33417040|NCT00641537|62794874|FG001|96-week Period|Protocol Violation|1|||
33417041|NCT00641537|62794875|FG002|96-week Period|Protocol Violation|0|||
33417042|NCT00641537|62794876|FG003|96-week Period|Protocol Violation|1|||
33417043|NCT00641537|62794877|FG004|96-week Period|Protocol Violation|0|||
33417044|NCT00641537|62794878|FG005|96-week Period|Protocol Violation|1|||
33417045|NCT00641537|62794879|FG006|96-week Period|Protocol Violation|0|||
33417046|NCT00641537|62794880|FG007|96-week Period|Protocol Violation|0|||
33417047|NCT00641537|62794873|FG000|96-week Period|Death|2|||
33417048|NCT00641537|62794874|FG001|96-week Period|Death|0|||
33417049|NCT00641537|62794875|FG002|96-week Period|Death|1|||
33417050|NCT00641537|62794876|FG003|96-week Period|Death|0|||
33417051|NCT00641537|62794877|FG004|96-week Period|Death|0|||
33417052|NCT00641537|62794878|FG005|96-week Period|Death|0|||
33417053|NCT00641537|62794879|FG006|96-week Period|Death|0|||
33417054|NCT00641537|62794880|FG007|96-week Period|Death|0|||
33417055|NCT00641537|62794873|FG000|96-week Period|Other|4|||
33417056|NCT00641537|62794874|FG001|96-week Period|Other|7|||
33417057|NCT00641537|62794875|FG002|96-week Period|Other|14|||
33417058|NCT00641537|62794876|FG003|96-week Period|Other|9|||
33417059|NCT00641537|62794877|FG004|96-week Period|Other|11|||
33417060|NCT00641537|62794878|FG005|96-week Period|Other|6|||
33417061|NCT00641537|62794879|FG006|96-week Period|Other|4|||
33417062|NCT00641537|62794880|FG007|96-week Period|Other|6|||
33417063|NCT00641537|62794873|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
33417064|NCT00641537|62794874|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
33417065|NCT00641537|62794875|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
33417066|NCT00641537|62794876|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
33417067|NCT00641537|62794877|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
33417068|NCT00641537|62794878|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
33417069|NCT00641537|62794879|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
33417070|NCT00641537|62794880|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
33417071|NCT00641537|62794873|FG000|24-Week Supplemental Follow-up Period|Other|0|||
33417072|NCT00641537|62794874|FG001|24-Week Supplemental Follow-up Period|Other|2|||
33417073|NCT00641537|62794875|FG002|24-Week Supplemental Follow-up Period|Other|2|||
33417074|NCT00641537|62794876|FG003|24-Week Supplemental Follow-up Period|Other|1|||
33417075|NCT00641537|62794877|FG004|24-Week Supplemental Follow-up Period|Other|3|||
33417076|NCT00641537|62794878|FG005|24-Week Supplemental Follow-up Period|Other|0|||
33417077|NCT00641537|62794879|FG006|24-Week Supplemental Follow-up Period|Other|1|||
33417078|NCT00641537|62794880|FG007|24-Week Supplemental Follow-up Period|Other|1|||
33417079|NCT03840135|62794900|FG000|Overall Study|Protocol Violation|6|||
33417080|NCT03840135|62794901|FG001|Overall Study|Protocol Violation|1|||
33417081|NCT03840135|62794900|FG000|Overall Study|Withdrawal by Subject|1|||
33417082|NCT03840135|62794901|FG001|Overall Study|Withdrawal by Subject|0|||
33417083|NCT00461175|62794913|FG000|Overall Study|Protocol Violation|522|||
33417084|NCT00461175|62794914|FG001|Overall Study|Protocol Violation|365|||
33417085|NCT00641147|62794922|FG000|Completed 4 Months.|Physician Decision|1|||
33417086|NCT00641147|62794923|FG001|Completed 4 Months.|Physician Decision|0|||
33417087|NCT00641147|62794922|FG000|Completed 4 Months.|Adverse Event|1|||
33417088|NCT00641147|62794923|FG001|Completed 4 Months.|Adverse Event|0|||
33417089|NCT00641147|62794922|FG000|Completed 8 Months.|Physician Decision|2|||
33417090|NCT00641147|62794923|FG001|Completed 8 Months.|Physician Decision|1|||
33417091|NCT00641147|62794922|FG000|Completed 8 Months.|non compliance|1|||
33417092|NCT00641147|62794923|FG001|Completed 8 Months.|non compliance|0|||
33417093|NCT00641147|62794922|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
33417094|NCT00641147|62794923|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
33417095|NCT00641147|62794922|FG000|Completed 12 Months.|Physician Decision|1|||
33417096|NCT00641147|62794923|FG001|Completed 12 Months.|Physician Decision|1|||
33417097|NCT00641147|62794922|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
33417098|NCT00641147|62794923|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
33322814|NCT01132326|62698887|FG000|Overall Study|Lost to Follow-up|16|||
33322815|NCT01132326|62698887|FG000|Overall Study|Withdrawal by Subject|40|||
33322816|NCT01132326|62698887|FG000|Overall Study|Physician Decision|10|||
33322817|NCT01132326|62698887|FG000|Overall Study|Study Termination|80|||
33322818|NCT01132326|62698887|FG000|Overall Study|Declining Health|1|||
33322819|NCT01132326|62698887|FG000|Overall Study|Pregnancy|1|||
33322820|NCT01132326|62698887|FG000|Overall Study|Caregiver Withdrew Consent|1|||
33417099|NCT00641147|62794922|FG000|Completed 16 Months.|Physician Decision|1|||
33322821|NCT01132326|62698887|FG000|Overall Study|Death|5|||
33417100|NCT00641147|62794923|FG001|Completed 16 Months.|Physician Decision|0|||
33417101|NCT00641147|62794922|FG000|Completed 16 Months.|Lost to Follow-up|1|||
33417102|NCT00641147|62794923|FG001|Completed 16 Months.|Lost to Follow-up|0|||
33417103|NCT00460239|62794933|FG000|Overall Study|Physician Decision|0|||
33417104|NCT00460239|62794934|FG001|Overall Study|Physician Decision|1|||
33417105|NCT00460239|62794935|FG002|Overall Study|Physician Decision|0|||
33417106|NCT00460239|62794936|FG003|Overall Study|Physician Decision|0|||
33417107|NCT00460239|62794937|FG004|Overall Study|Physician Decision|0|||
33417108|NCT00460239|62794938|FG005|Overall Study|Physician Decision|2|||
33417109|NCT00460239|62794939|FG006|Overall Study|Physician Decision|0|||
33417110|NCT00460239|62794940|FG007|Overall Study|Physician Decision|0|||
33417111|NCT00460239|62794941|FG008|Overall Study|Physician Decision|0|||
33417112|NCT00460239|62794933|FG000|Overall Study|Withdrawal by Subject|0|||
33417113|NCT00460239|62794934|FG001|Overall Study|Withdrawal by Subject|0|||
33417114|NCT00460239|62794935|FG002|Overall Study|Withdrawal by Subject|0|||
33417115|NCT00460239|62794936|FG003|Overall Study|Withdrawal by Subject|0|||
33417116|NCT00460239|62794937|FG004|Overall Study|Withdrawal by Subject|0|||
33417117|NCT00460239|62794938|FG005|Overall Study|Withdrawal by Subject|1|||
33417118|NCT00460239|62794939|FG006|Overall Study|Withdrawal by Subject|0|||
33417119|NCT00460239|62794940|FG007|Overall Study|Withdrawal by Subject|0|||
33417120|NCT00460239|62794941|FG008|Overall Study|Withdrawal by Subject|0|||
33417121|NCT00640835|62794956|FG000|Overall Study|Adverse Event|5|||
33417122|NCT00640835|62794957|FG001|Overall Study|Adverse Event|3|||
33417123|NCT00640835|62794956|FG000|Overall Study|Withdrawal by Subject|12|||
33417124|NCT00640835|62794957|FG001|Overall Study|Withdrawal by Subject|14|||
33417125|NCT00640835|62794956|FG000|Overall Study|Physician Decision|10|||
33417126|NCT00640835|62794957|FG001|Overall Study|Physician Decision|14|||
33417127|NCT00640835|62794956|FG000|Overall Study|Sponsor's Decision|11|||
33417128|NCT00640835|62794957|FG001|Overall Study|Sponsor's Decision|7|||
33417129|NCT00640835|62794956|FG000|Overall Study|Protocol Violation|2|||
33417130|NCT00640835|62794957|FG001|Overall Study|Protocol Violation|2|||
33417131|NCT00640835|62794956|FG000|Overall Study|Lost to Follow-up|17|||
33417132|NCT00640835|62794957|FG001|Overall Study|Lost to Follow-up|13|||
33417133|NCT00640835|62794956|FG000|Overall Study|Other Reason|19|||
33417134|NCT00640835|62794957|FG001|Overall Study|Other Reason|4|||
33417135|NCT03839355|62794965|FG000|Overall Study|Withdrawal by Subject|1|||
33417136|NCT03839355|62794966|FG001|Overall Study|Withdrawal by Subject|0|||
33417137|NCT00382018|62794976|FG000|Overall Study|Progression|0|||
33417138|NCT00382018|62794977|FG001|Overall Study|Progression|136|||
33417139|NCT00382018|62794978|FG002|Overall Study|Progression|51|||
33417140|NCT00382018|62794979|FG003|Overall Study|Progression|43|||
33417141|NCT00382018|62794976|FG000|Overall Study|Death|0|||
33417142|NCT00382018|62794977|FG001|Overall Study|Death|9|||
33417143|NCT00382018|62794978|FG002|Overall Study|Death|7|||
33417144|NCT00382018|62794979|FG003|Overall Study|Death|11|||
33417145|NCT00382018|62794976|FG000|Overall Study|Withdrawal by Subject|0|||
33417146|NCT00382018|62794977|FG001|Overall Study|Withdrawal by Subject|4|||
33417147|NCT00382018|62794978|FG002|Overall Study|Withdrawal by Subject|3|||
33417148|NCT00382018|62794979|FG003|Overall Study|Withdrawal by Subject|4|||
33417149|NCT00382018|62794976|FG000|Overall Study|Other, not protocol specified|0|||
33417150|NCT00382018|62794977|FG001|Overall Study|Other, not protocol specified|16|||
33417151|NCT00382018|62794978|FG002|Overall Study|Other, not protocol specified|3|||
33417152|NCT00382018|62794979|FG003|Overall Study|Other, not protocol specified|1|||
33417153|NCT00640601|62794992|FG000|Overall Study|Adverse Event|43|||
33417154|NCT00640601|62794992|FG000|Overall Study|Withdrawal by Subject|20|||
33417155|NCT00640601|62794992|FG000|Overall Study|Protocol Violation|6|||
33417156|NCT00640601|62794992|FG000|Overall Study|Lack of Efficacy|16|||
33417157|NCT00640601|62794992|FG000|Overall Study|Lost to Follow-up|9|||
33417158|NCT00640601|62794992|FG000|Overall Study|Physician Decision|8|||
33417159|NCT00640601|62794992|FG000|Overall Study|treatment naive, combination therapy|10|||
33417160|NCT03838731|62794998|FG000|Overall Study|Pregnancy|0|||
33417161|NCT03838731|62794999|FG001|Overall Study|Pregnancy|1|||
33417162|NCT03838731|62794998|FG000|Overall Study|Withdrawal of consent|1|||
33417163|NCT03838731|62794999|FG001|Overall Study|Withdrawal of consent|0|||
33417164|NCT00452439|62795007|FG000|Overall Study|Lost to Follow-up|1|||
33417165|NCT00452439|62795008|FG001|Overall Study|Lost to Follow-up|1|||
33417166|NCT00452439|62795007|FG000|Overall Study|Refused Treatment|4|||
33417167|NCT00452439|62795008|FG001|Overall Study|Refused Treatment|3|||
33417168|NCT00452439|62795007|FG000|Overall Study|Death|3|||
33417169|NCT00452439|62795008|FG001|Overall Study|Death|1|||
33417170|NCT00452439|62795007|FG000|Overall Study|Bone Marrow Transplant|0|||
33417171|NCT00452439|62795008|FG001|Overall Study|Bone Marrow Transplant|1|||
33417172|NCT00452439|62795007|FG000|Overall Study|Too Ill to Continue|0|||
33417173|NCT00452439|62795008|FG001|Overall Study|Too Ill to Continue|1|||
33417174|NCT00452439|62795007|FG000|Overall Study|Failed to achieve complete response|2|||
33417175|NCT00452439|62795008|FG001|Overall Study|Failed to achieve complete response|0|||
33417176|NCT00452439|62795007|FG000|Overall Study|Relapse|3|||
33417177|NCT00452439|62795008|FG001|Overall Study|Relapse|0|||
33417178|NCT00452439|62795007|FG000|Overall Study|Fracture|1|||
33417179|NCT00452439|62795008|FG001|Overall Study|Fracture|0|||
33417180|NCT00381940|62795014|FG000|Overall Study|Lack of Efficacy|3|||
33417181|NCT00381940|62795014|FG000|Overall Study|Protocol Violation|1|||
33417182|NCT00381940|62795014|FG000|Overall Study|Ineligible|1|||
33417183|NCT00364156|62795020|FG000|Overall Study|Withdrawal by Subject|73|||
33417184|NCT00364156|62795021|FG001|Overall Study|Withdrawal by Subject|80|||
33417185|NCT00364156|62795020|FG000|Overall Study|Protocol Violation|6|||
33322822|NCT01132326|62698887|FG000|Overall Study|Subject Unable to Come To Visits|1|||
33322823|NCT01178411|62698891|FG000|Overall Study|Adverse Event|5|||
33322824|NCT01178411|62698891|FG000|Overall Study|Withdrawal by Subject|4|||
33322825|NCT01178411|62698891|FG000|Overall Study|Protocol Violation|1|||
33322826|NCT01178411|62698891|FG000|Overall Study|Progressive disease per RECIST|32|||
33322827|NCT01178411|62698891|FG000|Overall Study|Progressive disease per clinician|9|||
33322828|NCT01178411|62698891|FG000|Overall Study|Physician Decision|6|||
33322829|NCT01178411|62698891|FG000|Overall Study|Death|1|||
33322830|NCT01178411|62698891|FG000|Overall Study|No reason provided|1|||
33322831|NCT01178411|62698891|FG000|Overall Study|Drug manufacturing ended|1|||
33322832|NCT01145508|62698897|FG000|Overall Study|Adverse Event|1|||
33322833|NCT01145508|62698898|FG001|Overall Study|Adverse Event|0|||
33322834|NCT01145508|62698897|FG000|Overall Study|Death|1|||
33322835|NCT01145508|62698898|FG001|Overall Study|Death|0|||
33322836|NCT01145508|62698897|FG000|Overall Study|Physician Decision|2|||
33322837|NCT01145508|62698898|FG001|Overall Study|Physician Decision|1|||
33322838|NCT01145508|62698897|FG000|Overall Study|Never started treatment|1|||
33322839|NCT01145508|62698898|FG001|Overall Study|Never started treatment|1|||
33322840|NCT00931528|62698906|FG000|Overall Study|Protocol Violation|9|||
33322841|NCT00931528|62698907|FG001|Overall Study|Protocol Violation|12|||
33322842|NCT00931528|62698906|FG000|Overall Study|Withdrawal by Subject|4|||
33322843|NCT00931528|62698907|FG001|Overall Study|Withdrawal by Subject|12|||
33322844|NCT00931528|62698906|FG000|Overall Study|Lost to Follow-up|6|||
33322845|NCT00931528|62698907|FG001|Overall Study|Lost to Follow-up|13|||
33322846|NCT00931528|62698906|FG000|Overall Study|Assessment outside of Time Frame|22|||
33322847|NCT00931528|62698907|FG001|Overall Study|Assessment outside of Time Frame|23|||
33322848|NCT00975195|62698916|FG000|Overall Study|Adverse Event|108|||
33322849|NCT00975195|62698917|FG001|Overall Study|Adverse Event|101|||
33322850|NCT00975195|62698916|FG000|Overall Study|Lack of Efficacy|6|||
33322851|NCT00975195|62698917|FG001|Overall Study|Lack of Efficacy|6|||
33322852|NCT00975195|62698916|FG000|Overall Study|Protocol Violation|27|||
33322853|NCT00975195|62698917|FG001|Overall Study|Protocol Violation|23|||
33322854|NCT00975195|62698916|FG000|Overall Study|Lost to Follow-up|9|||
33322855|NCT00975195|62698917|FG001|Overall Study|Lost to Follow-up|7|||
33322856|NCT00975195|62698916|FG000|Overall Study|Withdrawal by Subject|48|||
33322857|NCT00975195|62698917|FG001|Overall Study|Withdrawal by Subject|61|||
33322858|NCT00975195|62698916|FG000|Overall Study|Other reason not defined above|29|||
33322859|NCT00975195|62698917|FG001|Overall Study|Other reason not defined above|33|||
33322860|NCT00975195|62698916|FG000|Overall Study|Not treated|1|||
33417186|NCT00364156|62795021|FG001|Overall Study|Protocol Violation|1|||
33417187|NCT00452361|62795029|FG000|Overall Study|Adverse Event|8|||
33417188|NCT00452361|62795030|FG001|Overall Study|Adverse Event|0|||
33417189|NCT00452361|62795029|FG000|Overall Study|Withdrawal by Subject|0|||
33417190|NCT00452361|62795030|FG001|Overall Study|Withdrawal by Subject|1|||
33417191|NCT00452361|62795029|FG000|Overall Study|Premature termination|13|||
33417192|NCT00452361|62795030|FG001|Overall Study|Premature termination|9|||
33417193|NCT00640289|62795036|FG000|Overall Study|Death|3|||
33417194|NCT00640289|62795036|FG000|Overall Study|Withdrawal by Subject|1|||
33417195|NCT00640289|62795036|FG000|Overall Study|Lost to Follow-up|1|||
33417196|NCT00640289|62795036|FG000|Overall Study|Data collected under different amendment|2|||
33417197|NCT00640289|62795036|FG000|Overall Study|Transferred to another center|1|||
33417198|NCT00640289|62795036|FG000|Overall Study|Missing status|5|||
33417199|NCT00568451|62795044|FG000|Overall Study|Disease Progression|0|||
33417200|NCT00568451|62795045|FG001|Overall Study|Disease Progression|0|||
33417201|NCT00568451|62795046|FG002|Overall Study|Disease Progression|2|||
33417202|NCT00568451|62795047|FG003|Overall Study|Disease Progression|7|||
33417203|NCT00459537|62795060|FG000|Overall Study|Adverse Event|1|||
33417204|NCT00459537|62795061|FG001|Overall Study|Adverse Event|6|||
33417205|NCT00459537|62795060|FG000|Overall Study|Lack of Efficacy|10|||
33417206|NCT00459537|62795061|FG001|Overall Study|Lack of Efficacy|11|||
33417207|NCT00459537|62795060|FG000|Overall Study|Withdrawal by Subject|20|||
33417208|NCT00459537|62795061|FG001|Overall Study|Withdrawal by Subject|26|||
33417209|NCT00459537|62795060|FG000|Overall Study|Lost to Follow-up|27|||
33417210|NCT00459537|62795061|FG001|Overall Study|Lost to Follow-up|30|||
33417211|NCT00459537|62795060|FG000|Overall Study|Administrative problems|3|||
33417212|NCT00459537|62795061|FG001|Overall Study|Administrative problems|0|||
33417213|NCT00459537|62795060|FG000|Overall Study|Protocol Violation|4|||
33417214|NCT00459537|62795061|FG001|Overall Study|Protocol Violation|3|||
33417215|NCT00459537|62795060|FG000|Overall Study|Missing|1|||
33417216|NCT00459537|62795061|FG001|Overall Study|Missing|0|||
33417217|NCT03850509|62795069|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
33417218|NCT03850509|62795070|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
33417219|NCT00635999|62795079|FG000|Overall Study|Withdrawal by Subject|4|||
33417220|NCT00635999|62795080|FG001|Overall Study|Withdrawal by Subject|2|||
33417221|NCT00635999|62795081|FG002|Overall Study|Withdrawal by Subject|1|||
33417222|NCT00469209|62795092|FG000|Overall Study|Adverse Event|1|||
33417223|NCT00469209|62795093|FG001|Overall Study|Adverse Event|0|||
33417224|NCT00469209|62795094|FG002|Overall Study|Adverse Event|1|||
33417225|NCT00635219|62795107|FG000|Overall Study|Adverse Event|12|||
33417226|NCT00635219|62795108|FG001|Overall Study|Adverse Event|10|||
33417227|NCT00635219|62795109|FG002|Overall Study|Adverse Event|18|||
33417228|NCT00635219|62795110|FG003|Overall Study|Adverse Event|15|||
33417229|NCT00635219|62795111|FG004|Overall Study|Adverse Event|19|||
33417230|NCT00635219|62795107|FG000|Overall Study|Lack of Efficacy|5|||
33417231|NCT00635219|62795108|FG001|Overall Study|Lack of Efficacy|6|||
33417232|NCT00635219|62795109|FG002|Overall Study|Lack of Efficacy|3|||
33417233|NCT00635219|62795110|FG003|Overall Study|Lack of Efficacy|4|||
33417234|NCT00635219|62795111|FG004|Overall Study|Lack of Efficacy|6|||
33417235|NCT00635219|62795107|FG000|Overall Study|Non-compliance With Study Product|0|||
33417236|NCT00635219|62795108|FG001|Overall Study|Non-compliance With Study Product|0|||
33417237|NCT00635219|62795109|FG002|Overall Study|Non-compliance With Study Product|0|||
33417238|NCT00635219|62795110|FG003|Overall Study|Non-compliance With Study Product|2|||
33417239|NCT00635219|62795111|FG004|Overall Study|Non-compliance With Study Product|1|||
33417240|NCT00635219|62795107|FG000|Overall Study|Protocol Violation|0|||
33417241|NCT00635219|62795108|FG001|Overall Study|Protocol Violation|2|||
33417242|NCT00635219|62795109|FG002|Overall Study|Protocol Violation|3|||
33417243|NCT00635219|62795110|FG003|Overall Study|Protocol Violation|2|||
33417244|NCT00635219|62795111|FG004|Overall Study|Protocol Violation|4|||
33417245|NCT00635219|62795107|FG000|Overall Study|Withdrawal of Consent|8|||
33417246|NCT00635219|62795108|FG001|Overall Study|Withdrawal of Consent|6|||
33417247|NCT00635219|62795109|FG002|Overall Study|Withdrawal of Consent|8|||
33417248|NCT00635219|62795110|FG003|Overall Study|Withdrawal of Consent|11|||
33417249|NCT00635219|62795111|FG004|Overall Study|Withdrawal of Consent|8|||
33417250|NCT00635219|62795107|FG000|Overall Study|Lost to Follow-up|0|||
33417251|NCT00635219|62795108|FG001|Overall Study|Lost to Follow-up|0|||
33417252|NCT00635219|62795109|FG002|Overall Study|Lost to Follow-up|2|||
33417253|NCT00635219|62795110|FG003|Overall Study|Lost to Follow-up|0|||
33417254|NCT00635219|62795111|FG004|Overall Study|Lost to Follow-up|3|||
33417255|NCT00635219|62795107|FG000|Overall Study|Administrative or Other Reasons|0|||
33417256|NCT00635219|62795108|FG001|Overall Study|Administrative or Other Reasons|1|||
33417257|NCT00635219|62795109|FG002|Overall Study|Administrative or Other Reasons|1|||
33417258|NCT00635219|62795110|FG003|Overall Study|Administrative or Other Reasons|0|||
33417259|NCT00635219|62795111|FG004|Overall Study|Administrative or Other Reasons|1|||
33417260|NCT00363766|62795125|FG000|Overall Study|Progressive Disease|15|||
33417261|NCT00363766|62795126|FG001|Overall Study|Progressive Disease|9|||
33417262|NCT00363766|62795125|FG000|Overall Study|Adverse Event|10|||
33417263|NCT00363766|62795126|FG001|Overall Study|Adverse Event|2|||
33417264|NCT00363766|62795125|FG000|Overall Study|Disease Related Death|1|||
33417265|NCT00363766|62795126|FG001|Overall Study|Disease Related Death|3|||
33417266|NCT00363766|62795125|FG000|Overall Study|Not Disease Related Death|3|||
33417267|NCT00363766|62795126|FG001|Overall Study|Not Disease Related Death|4|||
33417268|NCT00363766|62795125|FG000|Overall Study|Withdrawal by Subject|2|||
33417269|NCT00363766|62795126|FG001|Overall Study|Withdrawal by Subject|0|||
33417270|NCT00363766|62795125|FG000|Overall Study|Physician Decision|1|||
33417271|NCT00363766|62795126|FG001|Overall Study|Physician Decision|2|||
33417272|NCT00468819|62795136|FG000|Overall Study|Withdrawal by Subject|4|||
33417273|NCT00468819|62795137|FG001|Overall Study|Withdrawal by Subject|0|||
33417274|NCT00468819|62795138|FG002|Overall Study|Withdrawal by Subject|1|||
33417275|NCT00468819|62795136|FG000|Overall Study|Lost to Follow-up|0|||
33417276|NCT00468819|62795137|FG001|Overall Study|Lost to Follow-up|0|||
33417277|NCT00468819|62795138|FG002|Overall Study|Lost to Follow-up|1|||
33417278|NCT00468819|62795136|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
33417279|NCT00468819|62795137|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
33417280|NCT00468819|62795138|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
33417281|NCT00451191|62795150|FG000|Overall Study|withdrawal or received alternate tx|15|||
33417282|NCT00451191|62795151|FG001|Overall Study|withdrawal or received alternate tx|11|||
33417283|NCT00451035|62795157|FG000|Overall Study|Disease progression|11|||
33417284|NCT00451035|62795157|FG000|Overall Study|Death|3|||
33417285|NCT00451035|62795157|FG000|Overall Study|New anti-neoplastic therapy|3|||
33417286|NCT00468585|62795166|FG000|Overall Study|Patient not treated|1|||
33417287|NCT00468585|62795167|FG001|Overall Study|Patient not treated|0|||
33417288|NCT00468585|62795168|FG002|Overall Study|Patient not treated|1|||
33417289|NCT00468585|62795169|FG003|Overall Study|Patient not treated|0|||
33417290|NCT00468585|62795166|FG000|Overall Study|Patient found to be ineligible|0|||
33417291|NCT00468585|62795167|FG001|Overall Study|Patient found to be ineligible|0|||
33417292|NCT00468585|62795168|FG002|Overall Study|Patient found to be ineligible|1|||
33417293|NCT00468585|62795169|FG003|Overall Study|Patient found to be ineligible|0|||
33417294|NCT00468585|62795166|FG000|Overall Study|Adverse Event|0|||
33417295|NCT00468585|62795167|FG001|Overall Study|Adverse Event|0|||
33417296|NCT00468585|62795168|FG002|Overall Study|Adverse Event|1|||
33417297|NCT00468585|62795169|FG003|Overall Study|Adverse Event|0|||
33417298|NCT00468585|62795166|FG000|Overall Study|Withdrawal by Subject|0|||
33417299|NCT00468585|62795167|FG001|Overall Study|Withdrawal by Subject|0|||
33417300|NCT00468585|62795168|FG002|Overall Study|Withdrawal by Subject|2|||
33417301|NCT00468585|62795169|FG003|Overall Study|Withdrawal by Subject|1|||
33417302|NCT00450801|62795179|FG000|Overall Study|Death|1|||
33417303|NCT00458211|62795188|FG000|Overall Study|Lack of Efficacy|12|||
33417304|NCT00458211|62795188|FG000|Overall Study|Withdrawal by Subject|2|||
33417305|NCT00458211|62795188|FG000|Overall Study|Protocol Violation|2|||
33417306|NCT00450723|62795196|FG000|Overall Study|Physician Decision|5|||
33417307|NCT00467961|62795201|FG000|Overall Study|Technical Failures|5|||
33417308|NCT00467961|62795201|FG000|Overall Study|Disease Progression|2|||
33417309|NCT00457821|62795213|FG000|Part 2|Withdrawal by Subject|0|||
33417310|NCT00457821|62795214|FG001|Part 2|Withdrawal by Subject|0|||
33417311|NCT00457821|62795215|FG002|Part 2|Withdrawal by Subject|0|||
33417312|NCT00457821|62795216|FG003|Part 2|Withdrawal by Subject|0|||
33417313|NCT00457821|62795217|FG004|Part 2|Withdrawal by Subject|0|||
33417314|NCT00457821|62795218|FG005|Part 2|Withdrawal by Subject|0|||
33417315|NCT00457821|62795219|FG006|Part 2|Withdrawal by Subject|0|||
33417316|NCT00457821|62795220|FG007|Part 2|Withdrawal by Subject|1|||
33417317|NCT00633893|62795240|FG000|Overall Study|Death|1|||
33417318|NCT00633893|62795241|FG001|Overall Study|Death|3|||
33417319|NCT00633893|62795242|FG002|Overall Study|Death|9|||
33417320|NCT00633893|62795240|FG000|Overall Study|Adverse Event|65|||
33494095|NCT03472326|62872791|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
33417321|NCT00633893|62795241|FG001|Overall Study|Adverse Event|58|||
33417322|NCT00633893|62795242|FG002|Overall Study|Adverse Event|126|||
33417323|NCT00633893|62795240|FG000|Overall Study|Withdrawal by Subject|7|||
33417324|NCT00633893|62795241|FG001|Overall Study|Withdrawal by Subject|12|||
33417325|NCT00633893|62795242|FG002|Overall Study|Withdrawal by Subject|6|||
33417326|NCT00633893|62795240|FG000|Overall Study|Lost to Follow-up|2|||
33417327|NCT00633893|62795241|FG001|Overall Study|Lost to Follow-up|4|||
33417328|NCT00633893|62795242|FG002|Overall Study|Lost to Follow-up|8|||
33417329|NCT00633893|62795240|FG000|Overall Study|Poor/non-compliance|5|||
33417330|NCT00633893|62795241|FG001|Overall Study|Poor/non-compliance|12|||
33417331|NCT00633893|62795242|FG002|Overall Study|Poor/non-compliance|3|||
33417332|NCT00633893|62795240|FG000|Overall Study|Pregnancy|2|||
33417333|NCT00633893|62795241|FG001|Overall Study|Pregnancy|1|||
33417334|NCT00633893|62795242|FG002|Overall Study|Pregnancy|1|||
33417335|NCT00633893|62795240|FG000|Overall Study|Not meet/no longer meets criteria|4|||
33417336|NCT00633893|62795241|FG001|Overall Study|Not meet/no longer meets criteria|6|||
33417337|NCT00633893|62795242|FG002|Overall Study|Not meet/no longer meets criteria|4|||
33417338|NCT00633893|62795240|FG000|Overall Study|Other|28|||
33417339|NCT00633893|62795241|FG001|Overall Study|Other|33|||
33417340|NCT00633893|62795242|FG002|Overall Study|Other|31|||
33417341|NCT00457743|62795253|FG000|Overall Study|Adverse Event|0|||
33417342|NCT00457743|62795254|FG001|Overall Study|Adverse Event|4|||
33417343|NCT00457743|62795255|FG002|Overall Study|Adverse Event|0|||
33417344|NCT00457743|62795253|FG000|Overall Study|Lack of Efficacy|3|||
33417345|NCT00457743|62795254|FG001|Overall Study|Lack of Efficacy|23|||
33417346|NCT00457743|62795255|FG002|Overall Study|Lack of Efficacy|3|||
33417347|NCT00450411|62795264|FG000|Overall Study|Protocol Violation|6|||
33417348|NCT00450411|62795264|FG000|Overall Study|No protocol treatment|2|||
33417349|NCT00644969|62795270|FG000|Treatment Phase|Randomized, not treated|1|||
33417350|NCT00644969|62795271|FG001|Treatment Phase|Randomized, not treated|0|||
33417351|NCT00644969|62795270|FG000|Treatment Phase|Adverse Event|3|||
33417352|NCT00644969|62795271|FG001|Treatment Phase|Adverse Event|0|||
33417353|NCT00644969|62795270|FG000|Treatment Phase|Withdrawal by Subject|4|||
33417354|NCT00644969|62795271|FG001|Treatment Phase|Withdrawal by Subject|0|||
33417355|NCT00644969|62795270|FG000|Treatment Phase|Lost to Follow-up|2|||
33417356|NCT00644969|62795271|FG001|Treatment Phase|Lost to Follow-up|2|||
33417357|NCT00644969|62795270|FG000|Treatment Phase|Other|4|||
33417358|NCT00644969|62795271|FG001|Treatment Phase|Other|1|||
33417359|NCT00644969|62795270|FG000|Post Treatment Phase|Death|1|||
33417360|NCT00644969|62795271|FG001|Post Treatment Phase|Death|0|||
33417361|NCT00644969|62795270|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
33417362|NCT00644969|62795271|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
33417363|NCT00644969|62795270|FG000|Post Treatment Phase|Lost to Follow-up|4|||
33417364|NCT00644969|62795271|FG001|Post Treatment Phase|Lost to Follow-up|1|||
33417365|NCT00644969|62795270|FG000|Post Treatment Phase|Other|1|||
33417366|NCT00644969|62795271|FG001|Post Treatment Phase|Other|0|||
33417367|NCT00644423|62795279|FG000|Overall Study|Lost to Follow-up|1|||
33417368|NCT00644423|62795280|FG001|Overall Study|Lost to Follow-up|1|||
33417369|NCT00628355|62795288|FG000|Overall Study|Withdrawal by Subject|1|||
33417370|NCT00628355|62795289|FG001|Overall Study|Withdrawal by Subject|1|||
33417371|NCT00627497|62795300|FG000|Overall Study|Lost to Follow-up|1|||
33417372|NCT00627497|62795301|FG001|Overall Study|Lost to Follow-up|1|||
33417373|NCT00627497|62795302|FG002|Overall Study|Lost to Follow-up|0|||
33417374|NCT00627497|62795303|FG003|Overall Study|Lost to Follow-up|0|||
33417375|NCT00648167|62795313|FG000|Overall Study|Adverse Event|6|||
33417376|NCT00648167|62795313|FG000|Overall Study|unable to swallow tablets|1|||
33417377|NCT00647699|62795347|FG000|Overall Study|Lost to Follow-up|5|||
33417378|NCT00647699|62795348|FG001|Overall Study|Lost to Follow-up|4|||
33417379|NCT00647699|62795347|FG000|Overall Study|Withdrawal by Subject|3|||
33417380|NCT00647699|62795348|FG001|Overall Study|Withdrawal by Subject|8|||
33417381|NCT00467649|62795356|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
33417382|NCT00467649|62795357|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
33417383|NCT00467649|62795358|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
33417384|NCT00467649|62795359|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
33417385|NCT00467649|62795360|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
33417386|NCT00467649|62795361|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
33417387|NCT00467649|62795356|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
33417388|NCT00467649|62795357|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
33417389|NCT00467649|62795358|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
33417390|NCT00467649|62795359|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
33417391|NCT00467649|62795360|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
33417392|NCT00467649|62795361|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
33417393|NCT00467649|62795356|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
33417394|NCT00467649|62795357|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
33417395|NCT00467649|62795358|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
33417396|NCT00467649|62795359|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
33417397|NCT00467649|62795360|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
33417398|NCT00467649|62795361|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
33417399|NCT00467649|62795356|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
33417400|NCT00467649|62795357|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
33417401|NCT00467649|62795358|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
33417402|NCT00467649|62795359|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
33417403|NCT00467649|62795360|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
33417404|NCT00467649|62795361|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
33417405|NCT00467649|62795356|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
33417406|NCT00467649|62795357|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
33417407|NCT00467649|62795358|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
33417408|NCT00467649|62795359|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
33417409|NCT00467649|62795360|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
33417410|NCT00467649|62795361|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
33417411|NCT00467649|62795356|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
33417412|NCT00467649|62795357|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
33417413|NCT00467649|62795358|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
33417414|NCT00467649|62795359|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
33417415|NCT00467649|62795360|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
33417416|NCT00467649|62795361|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
33417417|NCT00467649|62795356|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
33417418|NCT00467649|62795357|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
33417419|NCT00467649|62795358|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
33417420|NCT00467649|62795359|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
33417421|NCT00467649|62795360|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
33417422|NCT00467649|62795361|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
33417423|NCT00450333|62795383|FG000|Overall Study|Study terminated|47|||
33417424|NCT00450333|62795384|FG001|Overall Study|Study terminated|54|||
33417425|NCT00450333|62795385|FG002|Overall Study|Study terminated|16|||
33417426|NCT00450333|62795386|FG003|Overall Study|Study terminated|21|||
33417427|NCT00450333|62795383|FG000|Overall Study|Adverse Event|1|||
33417428|NCT00450333|62795384|FG001|Overall Study|Adverse Event|7|||
33417429|NCT00450333|62795385|FG002|Overall Study|Adverse Event|2|||
33417430|NCT00450333|62795386|FG003|Overall Study|Adverse Event|2|||
33417431|NCT00450333|62795383|FG000|Overall Study|Protocol Violation|1|||
33417432|NCT00450333|62795384|FG001|Overall Study|Protocol Violation|0|||
33417433|NCT00450333|62795385|FG002|Overall Study|Protocol Violation|1|||
33417434|NCT00450333|62795386|FG003|Overall Study|Protocol Violation|0|||
33417435|NCT00450333|62795383|FG000|Overall Study|Withdrawal by Subject|1|||
33417436|NCT00450333|62795384|FG001|Overall Study|Withdrawal by Subject|0|||
33417437|NCT00450333|62795385|FG002|Overall Study|Withdrawal by Subject|3|||
33417438|NCT00450333|62795386|FG003|Overall Study|Withdrawal by Subject|0|||
33417439|NCT00450333|62795383|FG000|Overall Study|Kidney transplant|1|||
33417440|NCT00450333|62795384|FG001|Overall Study|Kidney transplant|0|||
33417441|NCT00450333|62795385|FG002|Overall Study|Kidney transplant|1|||
33417442|NCT00450333|62795386|FG003|Overall Study|Kidney transplant|3|||
33417443|NCT00450333|62795383|FG000|Overall Study|Death|3|||
33417444|NCT00450333|62795384|FG001|Overall Study|Death|2|||
33417445|NCT00450333|62795385|FG002|Overall Study|Death|2|||
33417446|NCT00450333|62795386|FG003|Overall Study|Death|2|||
33417447|NCT00643565|62795398|FG000|Overall Study|Death|12|||
33417448|NCT00643565|62795399|FG001|Overall Study|Death|11|||
33417449|NCT00643565|62795398|FG000|Overall Study|Withdrawal by Subject|4|||
33417450|NCT00643565|62795399|FG001|Overall Study|Withdrawal by Subject|1|||
33417451|NCT00643565|62795398|FG000|Overall Study|Lost to Follow-up|0|||
33604907|NCT01769404|63004505|FG001|Treatment Period 1|Sponsor decision|0|||
33604908|NCT01769404|63004504|FG000|Treatment Period 2|Sponsor decision|7|||
33604909|NCT01769404|63004505|FG001|Treatment Period 2|Sponsor decision|0|||
33604910|NCT01769326|63004517|FG000|Overall Study|Lost to Follow-up|1|||
33417452|NCT00643565|62795399|FG001|Overall Study|Lost to Follow-up|6|||
33604911|NCT01769326|63004518|FG001|Overall Study|Lost to Follow-up|2|||
33417453|NCT00643565|62795398|FG000|Overall Study|Other|7|||
33417454|NCT00643565|62795399|FG001|Overall Study|Other|8|||
33417455|NCT00643565|62795398|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
33417456|NCT00643565|62795399|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
33417457|NCT00643565|62795398|FG000|Overall Study|Recurrence of Disease|2|||
33417458|NCT00643565|62795399|FG001|Overall Study|Recurrence of Disease|1|||
33417459|NCT00643565|62795398|FG000|Overall Study|Progression of Disease|18|||
33417460|NCT00643565|62795399|FG001|Overall Study|Progression of Disease|14|||
33417461|NCT00643565|62795398|FG000|Overall Study|Protocol Violation|3|||
33417462|NCT00643565|62795399|FG001|Overall Study|Protocol Violation|0|||
33417463|NCT00643565|62795398|FG000|Overall Study|Did Not Cooperate|0|||
33417464|NCT00643565|62795399|FG001|Overall Study|Did Not Cooperate|1|||
33417465|NCT00643565|62795398|FG000|Overall Study|Administrative|22|||
33417466|NCT00643565|62795399|FG001|Overall Study|Administrative|16|||
33417467|NCT00643565|62795398|FG000|Overall Study|Adverse Event|5|||
33417468|NCT00643565|62795399|FG001|Overall Study|Adverse Event|8|||
33417469|NCT00643487|62795406|FG000|Overall Study|Technical difficulty|3|||
33417470|NCT00450255|62795410|FG000|Overall Study|Prior RFA ablation of liver|1|||
33417471|NCT00450177|62795417|FG000|Overall Study|Adverse Event|7|||
33417472|NCT00450177|62795418|FG001|Overall Study|Adverse Event|4|||
33417473|NCT00450177|62795417|FG000|Overall Study|Withdrawal by Subject|1|||
33417474|NCT00450177|62795418|FG001|Overall Study|Withdrawal by Subject|6|||
33417475|NCT00450177|62795417|FG000|Overall Study|Withdrawal by Primary Team|1|||
33417476|NCT00450177|62795418|FG001|Overall Study|Withdrawal by Primary Team|1|||
33417477|NCT03848949|62795426|FG000|Overall Study|Lost to Follow-up|5|||
33417478|NCT03848949|62795427|FG001|Overall Study|Lost to Follow-up|7|||
33417479|NCT00467259|62795435|FG000|Overall Study|Adverse Event|24|||
33417480|NCT00467259|62795436|FG001|Overall Study|Adverse Event|90|||
33604912|NCT01769326|63004519|FG002|Overall Study|Lost to Follow-up|0|||
33604913|NCT01769326|63004520|FG003|Overall Study|Lost to Follow-up|0|||
33417481|NCT00467259|62795435|FG000|Overall Study|Protocol Violation|1|||
33417482|NCT00467259|62795436|FG001|Overall Study|Protocol Violation|7|||
33417483|NCT00467259|62795435|FG000|Overall Study|Withdrawal by Subject|34|||
33417484|NCT00467259|62795436|FG001|Overall Study|Withdrawal by Subject|108|||
33417485|NCT00467259|62795435|FG000|Overall Study|Physician Decision|0|||
33417486|NCT00467259|62795436|FG001|Overall Study|Physician Decision|2|||
33417487|NCT00467259|62795435|FG000|Overall Study|Lost to Follow-up|14|||
33417488|NCT00467259|62795436|FG001|Overall Study|Lost to Follow-up|34|||
33417489|NCT00467259|62795435|FG000|Overall Study|Site Closed|2|||
33417490|NCT00467259|62795436|FG001|Overall Study|Site Closed|1|||
33417491|NCT00449865|62795444|FG000|Overall Study|Withdrawal by Subject|110|||
33417492|NCT00449865|62795445|FG001|Overall Study|Withdrawal by Subject|110|||
33417493|NCT00449865|62795444|FG000|Overall Study|Lost to Follow-up|36|||
33417494|NCT00449865|62795445|FG001|Overall Study|Lost to Follow-up|37|||
33417495|NCT00449865|62795444|FG000|Overall Study|Physician Decision|13|||
33417496|NCT00449865|62795445|FG001|Overall Study|Physician Decision|12|||
33604914|NCT01769326|63004517|FG000|Overall Study|unrelated injry|1|||
33604915|NCT01769326|63004518|FG001|Overall Study|unrelated injry|1|||
33604916|NCT01769326|63004519|FG002|Overall Study|unrelated injry|0|||
33417497|NCT00449865|62795444|FG000|Overall Study|Death|31|||
33417498|NCT00449865|62795445|FG001|Overall Study|Death|40|||
33417499|NCT00449865|62795444|FG000|Overall Study|Protocol Violation|8|||
33417500|NCT00449865|62795445|FG001|Overall Study|Protocol Violation|7|||
33417501|NCT00449865|62795444|FG000|Overall Study|Study was stopped|324|||
33417502|NCT00449865|62795445|FG001|Overall Study|Study was stopped|328|||
33417503|NCT00449787|62795453|FG000|Overall Study|Lost to Follow-up|10|||
33417504|NCT00449787|62795454|FG001|Overall Study|Lost to Follow-up|8|||
33417505|NCT00449787|62795453|FG000|Overall Study|Did not require medication|95|||
33604917|NCT01769326|63004520|FG003|Overall Study|unrelated injry|0|||
33417506|NCT00449787|62795454|FG001|Overall Study|Did not require medication|92|||
33417507|NCT00449163|62795462|FG000|Overall Study|Physician Decision|3|||
33417508|NCT00448539|62795468|FG000|Overall Study|Medication non-compliance|4|||
33417509|NCT00448539|62795469|FG001|Overall Study|Medication non-compliance|1|||
33417510|NCT00448539|62795468|FG000|Overall Study|Protocol Violation|1|||
33417511|NCT00448539|62795469|FG001|Overall Study|Protocol Violation|0|||
33417512|NCT00448539|62795468|FG000|Overall Study|Request of the investigator or sponsor|67|||
33417513|NCT00448539|62795469|FG001|Overall Study|Request of the investigator or sponsor|54|||
33417514|NCT00448539|62795468|FG000|Overall Study|Withdrawal by Subject|20|||
33417515|NCT00448539|62795469|FG001|Overall Study|Withdrawal by Subject|24|||
33417516|NCT00448539|62795468|FG000|Overall Study|Diary non-compliance|1|||
33417517|NCT00448539|62795469|FG001|Overall Study|Diary non-compliance|0|||
33417518|NCT00448539|62795468|FG000|Overall Study|Adverse Event|9|||
33417519|NCT00448539|62795469|FG001|Overall Study|Adverse Event|26|||
33417520|NCT00448539|62795468|FG000|Overall Study|Lack of Efficacy|27|||
33417521|NCT00448539|62795469|FG001|Overall Study|Lack of Efficacy|40|||
33417522|NCT00448539|62795468|FG000|Overall Study|Miscellaneous|2|||
33417523|NCT00448539|62795469|FG001|Overall Study|Miscellaneous|1|||
33417524|NCT00448539|62795468|FG000|Overall Study|Change of meds|2|||
33417525|NCT00448539|62795469|FG001|Overall Study|Change of meds|3|||
33417526|NCT00448539|62795468|FG000|Overall Study|Lost to Follow-up|1|||
33417527|NCT00448539|62795469|FG001|Overall Study|Lost to Follow-up|3|||
33417528|NCT00457665|62795477|FG000|12 Months|Drug allergy|1|||
33417529|NCT00457665|62795478|FG001|12 Months|Drug allergy|1|||
33417530|NCT00457665|62795477|FG000|12 Months|High HIV viral load|5|||
33417531|NCT00457665|62795478|FG001|12 Months|High HIV viral load|1|||
33417532|NCT00457665|62795477|FG000|12 Months|Lipodystrophy|2|||
33417533|NCT00457665|62795478|FG001|12 Months|Lipodystrophy|0|||
33417534|NCT00457665|62795477|FG000|12 Months|Withdrawal by Subject|0|||
33417535|NCT00457665|62795478|FG001|12 Months|Withdrawal by Subject|2|||
33417536|NCT00457665|62795477|FG000|12 Months|Abnormal Liver function tests|0|||
33417537|NCT00457665|62795478|FG001|12 Months|Abnormal Liver function tests|5|||
33417538|NCT00457665|62795477|FG000|24 Months|Withdrawal by Subject|3|||
33417539|NCT00457665|62795478|FG001|24 Months|Withdrawal by Subject|2|||
33417540|NCT00457665|62795477|FG000|24 Months|Lipodystrophy|1|||
33417541|NCT00457665|62795478|FG001|24 Months|Lipodystrophy|1|||
33417542|NCT00457665|62795477|FG000|24 Months|Abnormal liver function tests|1|||
33417543|NCT00457665|62795478|FG001|24 Months|Abnormal liver function tests|5|||
33417544|NCT00447603|62795484|FG000|Screening|Withdrawal by Subject|1|||
33417545|NCT00447603|62795485|FG001|Screening|Withdrawal by Subject|0|||
33417546|NCT00447603|62795486|FG002|Screening|Withdrawal by Subject|0|||
33417547|NCT00447603|62795484|FG000|Screening|Protocol Violation|1|||
33417548|NCT00447603|62795485|FG001|Screening|Protocol Violation|0|||
33417549|NCT00447603|62795486|FG002|Screening|Protocol Violation|0|||
33417550|NCT00447603|62795484|FG000|Screening|Screen Failure|4|||
33417551|NCT00447603|62795485|FG001|Screening|Screen Failure|0|||
33417552|NCT00447603|62795486|FG002|Screening|Screen Failure|0|||
33417553|NCT00447603|62795484|FG000|Screening|Study Terminated by Sponsor|15|||
33417554|NCT00447603|62795485|FG001|Screening|Study Terminated by Sponsor|0|||
33417555|NCT00447603|62795486|FG002|Screening|Study Terminated by Sponsor|0|||
33417556|NCT00447603|62795484|FG000|Filter Period|Adverse Event|0|||
33417557|NCT00447603|62795485|FG001|Filter Period|Adverse Event|0|||
33417558|NCT00447603|62795486|FG002|Filter Period|Adverse Event|1|||
33417559|NCT00447603|62795484|FG000|Filter Period|Screen Failure|0|||
33417560|NCT00447603|62795485|FG001|Filter Period|Screen Failure|3|||
33604918|NCT01769326|63004517|FG000|Overall Study|got a job|0|||
33604919|NCT01769326|63004518|FG001|Overall Study|got a job|1|||
33604920|NCT01769326|63004519|FG002|Overall Study|got a job|0|||
33604921|NCT01769326|63004520|FG003|Overall Study|got a job|0|||
33604922|NCT01769326|63004517|FG000|Overall Study|Got sick and could not complete study|0|||
33604923|NCT01769326|63004518|FG001|Overall Study|Got sick and could not complete study|0|||
33604924|NCT01769326|63004519|FG002|Overall Study|Got sick and could not complete study|1|||
33604925|NCT01769326|63004520|FG003|Overall Study|Got sick and could not complete study|0|||
33417561|NCT00447603|62795486|FG002|Filter Period|Screen Failure|4|||
33417562|NCT00447603|62795484|FG000|Filter Period|Study terminated by Sponsor|0|||
33604926|NCT01786564|63004530|FG000|Overall Study|Lost to Follow-up|47|||
33604927|NCT01786564|63004530|FG000|Overall Study|Ineligible|17|||
33417563|NCT00447603|62795485|FG001|Filter Period|Study terminated by Sponsor|1|||
33417564|NCT00447603|62795486|FG002|Filter Period|Study terminated by Sponsor|10|||
33417565|NCT00447057|62795498|FG000|Overall Study|Adverse Event|4|||
33417566|NCT00447057|62795499|FG001|Overall Study|Adverse Event|10|||
33417567|NCT00447057|62795500|FG002|Overall Study|Adverse Event|0|||
33417568|NCT00447057|62795501|FG003|Overall Study|Adverse Event|3|||
33604928|NCT01786330|63004536|FG000|Overall Study|Withdrawal by Subject|0|||
33417569|NCT00447057|62795498|FG000|Overall Study|Death due to study disease|6|||
33417570|NCT00447057|62795499|FG001|Overall Study|Death due to study disease|4|||
33417571|NCT00447057|62795500|FG002|Overall Study|Death due to study disease|1|||
33417572|NCT00447057|62795501|FG003|Overall Study|Death due to study disease|1|||
33417573|NCT00447057|62795498|FG000|Overall Study|Lost to Follow-up|0|||
33417574|NCT00447057|62795499|FG001|Overall Study|Lost to Follow-up|1|||
33417575|NCT00447057|62795500|FG002|Overall Study|Lost to Follow-up|0|||
33417576|NCT00447057|62795501|FG003|Overall Study|Lost to Follow-up|0|||
33417577|NCT00447057|62795498|FG000|Overall Study|Entry criteria not met|1|||
33417578|NCT00447057|62795499|FG001|Overall Study|Entry criteria not met|1|||
33417579|NCT00447057|62795500|FG002|Overall Study|Entry criteria not met|0|||
33417580|NCT00447057|62795501|FG003|Overall Study|Entry criteria not met|0|||
33417581|NCT00447057|62795498|FG000|Overall Study|Protocol Violation|0|||
33417582|NCT00447057|62795499|FG001|Overall Study|Protocol Violation|1|||
33417583|NCT00447057|62795500|FG002|Overall Study|Protocol Violation|0|||
33417584|NCT00447057|62795501|FG003|Overall Study|Protocol Violation|0|||
33417585|NCT00447057|62795498|FG000|Overall Study|Withdrawal by Subject|4|||
33417586|NCT00447057|62795499|FG001|Overall Study|Withdrawal by Subject|5|||
33417587|NCT00447057|62795500|FG002|Overall Study|Withdrawal by Subject|1|||
33417588|NCT00447057|62795501|FG003|Overall Study|Withdrawal by Subject|1|||
33417589|NCT00447057|62795498|FG000|Overall Study|Physician Decision|9|||
33417590|NCT00447057|62795499|FG001|Overall Study|Physician Decision|6|||
33417591|NCT00447057|62795500|FG002|Overall Study|Physician Decision|3|||
33417592|NCT00447057|62795501|FG003|Overall Study|Physician Decision|1|||
33417593|NCT00447057|62795498|FG000|Overall Study|Sponsor decision|1|||
33417594|NCT00447057|62795499|FG001|Overall Study|Sponsor decision|1|||
33322861|NCT00975195|62698917|FG001|Overall Study|Not treated|2|||
33417595|NCT00447057|62795500|FG002|Overall Study|Sponsor decision|0|||
33417596|NCT00447057|62795501|FG003|Overall Study|Sponsor decision|0|||
33417597|NCT00447057|62795498|FG000|Overall Study|Progressive disease|58|||
33417598|NCT00447057|62795499|FG001|Overall Study|Progressive disease|43|||
33417599|NCT00447057|62795500|FG002|Overall Study|Progressive disease|13|||
33417600|NCT00447057|62795501|FG003|Overall Study|Progressive disease|18|||
33417601|NCT00447057|62795498|FG000|Overall Study|Death due to adverse event|0|||
33417602|NCT00447057|62795499|FG001|Overall Study|Death due to adverse event|0|||
33417603|NCT00447057|62795500|FG002|Overall Study|Death due to adverse event|1|||
33417604|NCT00447057|62795501|FG003|Overall Study|Death due to adverse event|2|||
33417605|NCT00447057|62795498|FG000|Overall Study|Death, study drug related|0|||
33417606|NCT00447057|62795499|FG001|Overall Study|Death, study drug related|1|||
33417607|NCT00447057|62795500|FG002|Overall Study|Death, study drug related|0|||
33417608|NCT00447057|62795501|FG003|Overall Study|Death, study drug related|0|||
33417609|NCT00446511|62795513|FG000|Overall Study|Adverse Event|7|||
33417610|NCT00446511|62795514|FG001|Overall Study|Adverse Event|2|||
33417611|NCT00446511|62795515|FG002|Overall Study|Adverse Event|3|||
33417612|NCT00446511|62795516|FG003|Overall Study|Adverse Event|1|||
33417613|NCT00446511|62795513|FG000|Overall Study|Protocol Violation|0|||
33417614|NCT00446511|62795514|FG001|Overall Study|Protocol Violation|0|||
33417615|NCT00446511|62795515|FG002|Overall Study|Protocol Violation|0|||
33417616|NCT00446511|62795516|FG003|Overall Study|Protocol Violation|1|||
33417617|NCT00446511|62795513|FG000|Overall Study|Withdrawal by Subject|0|||
33417618|NCT00446511|62795514|FG001|Overall Study|Withdrawal by Subject|0|||
33417619|NCT00446511|62795515|FG002|Overall Study|Withdrawal by Subject|0|||
33417620|NCT00446511|62795516|FG003|Overall Study|Withdrawal by Subject|3|||
33417621|NCT00446511|62795513|FG000|Overall Study|Administrative Problems|3|||
33417622|NCT00446511|62795514|FG001|Overall Study|Administrative Problems|0|||
33417623|NCT00446511|62795515|FG002|Overall Study|Administrative Problems|4|||
33417624|NCT00446511|62795516|FG003|Overall Study|Administrative Problems|1|||
33417625|NCT00446199|62795532|FG000|Overall Study|Adverse Event|7|||
33417626|NCT00446199|62795533|FG001|Overall Study|Adverse Event|4|||
33417627|NCT00446199|62795534|FG002|Overall Study|Adverse Event|6|||
33417628|NCT00446199|62795535|FG003|Overall Study|Adverse Event|4|||
33417629|NCT00446199|62795532|FG000|Overall Study|Lost to Follow-up|4|||
33417630|NCT00446199|62795533|FG001|Overall Study|Lost to Follow-up|5|||
33417631|NCT00446199|62795534|FG002|Overall Study|Lost to Follow-up|2|||
33417632|NCT00446199|62795535|FG003|Overall Study|Lost to Follow-up|6|||
33417633|NCT00446199|62795532|FG000|Overall Study|Protocol Violation|1|||
33417634|NCT00446199|62795533|FG001|Overall Study|Protocol Violation|2|||
33417635|NCT00446199|62795534|FG002|Overall Study|Protocol Violation|1|||
33417636|NCT00446199|62795535|FG003|Overall Study|Protocol Violation|3|||
33417637|NCT00446199|62795532|FG000|Overall Study|Withdrawal by Subject|2|||
33417638|NCT00446199|62795533|FG001|Overall Study|Withdrawal by Subject|5|||
33417639|NCT00446199|62795534|FG002|Overall Study|Withdrawal by Subject|9|||
33417640|NCT00446199|62795535|FG003|Overall Study|Withdrawal by Subject|10|||
33417641|NCT00446199|62795532|FG000|Overall Study|Site termination|2|||
33417642|NCT00446199|62795533|FG001|Overall Study|Site termination|0|||
33417643|NCT00446199|62795534|FG002|Overall Study|Site termination|0|||
33417644|NCT00446199|62795535|FG003|Overall Study|Site termination|1|||
33417645|NCT00446199|62795532|FG000|Overall Study|Randomization in Error|2|||
33417646|NCT00446199|62795533|FG001|Overall Study|Randomization in Error|0|||
33417647|NCT00446199|62795534|FG002|Overall Study|Randomization in Error|1|||
33417648|NCT00446199|62795535|FG003|Overall Study|Randomization in Error|1|||
33417649|NCT00446199|62795532|FG000|Overall Study|Lack of Efficacy|1|||
33417650|NCT00446199|62795533|FG001|Overall Study|Lack of Efficacy|0|||
33417651|NCT00446199|62795534|FG002|Overall Study|Lack of Efficacy|0|||
33417652|NCT00446199|62795535|FG003|Overall Study|Lack of Efficacy|1|||
33417653|NCT00446199|62795532|FG000|Overall Study|Non-compliant with study drug|1|||
33417654|NCT00446199|62795533|FG001|Overall Study|Non-compliant with study drug|0|||
33417655|NCT00446199|62795534|FG002|Overall Study|Non-compliant with study drug|5|||
33417656|NCT00446199|62795535|FG003|Overall Study|Non-compliant with study drug|0|||
33417657|NCT00446199|62795532|FG000|Overall Study|Non-compliant with visit schedule|1|||
33417658|NCT00446199|62795533|FG001|Overall Study|Non-compliant with visit schedule|1|||
33604929|NCT01786330|63004537|FG001|Overall Study|Withdrawal by Subject|1|||
33604930|NCT01786330|63004536|FG000|Overall Study|Lost to Follow-up|0|||
33604931|NCT01786330|63004537|FG001|Overall Study|Lost to Follow-up|1|||
33604932|NCT01786330|63004536|FG000|Overall Study|Excluded intraoperatively|0|||
33604933|NCT01786330|63004537|FG001|Overall Study|Excluded intraoperatively|1|||
33417659|NCT00446199|62795534|FG002|Overall Study|Non-compliant with visit schedule|1|||
33604934|NCT01786330|63004536|FG000|Overall Study|Protocol Violation|1|||
33604935|NCT01786330|63004537|FG001|Overall Study|Protocol Violation|0|||
33417660|NCT00446199|62795535|FG003|Overall Study|Non-compliant with visit schedule|2|||
33417661|NCT00446199|62795532|FG000|Overall Study|Hormone fear|0|||
33604936|NCT01786174|63004545|FG000|Overall Study|Discontinued Study Drug|2|||
33604937|NCT01786174|63004546|FG001|Overall Study|Discontinued Study Drug|0|||
33417662|NCT00446199|62795533|FG001|Overall Study|Hormone fear|0|||
33417663|NCT00446199|62795534|FG002|Overall Study|Hormone fear|0|||
33417664|NCT00446199|62795535|FG003|Overall Study|Hormone fear|1|||
33417665|NCT00446199|62795532|FG000|Overall Study|Lost interest in study participation|0|||
33417666|NCT00446199|62795533|FG001|Overall Study|Lost interest in study participation|1|||
33417667|NCT00446199|62795534|FG002|Overall Study|Lost interest in study participation|0|||
33417668|NCT00446199|62795535|FG003|Overall Study|Lost interest in study participation|0|||
33417669|NCT00446199|62795532|FG000|Overall Study|In-/Exclusion criterion violated|2|||
33417670|NCT00446199|62795533|FG001|Overall Study|In-/Exclusion criterion violated|1|||
33417671|NCT00446199|62795534|FG002|Overall Study|In-/Exclusion criterion violated|2|||
33417672|NCT00446199|62795535|FG003|Overall Study|In-/Exclusion criterion violated|1|||
33417673|NCT00446199|62795532|FG000|Overall Study|Move|0|||
33417674|NCT00446199|62795533|FG001|Overall Study|Move|1|||
33417675|NCT00446199|62795534|FG002|Overall Study|Move|0|||
33417676|NCT00446199|62795535|FG003|Overall Study|Move|0|||
33417677|NCT00456495|62795545|FG000|Overall Study|Physician Decision|2|||
33417678|NCT00445341|62795550|FG000|Overall Study|refused further treatment|1|||
33417679|NCT00445341|62795550|FG000|Overall Study|taken off treatment too early|1|||
33417680|NCT03846453|62795556|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
33417681|NCT03846453|62795557|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
33417682|NCT03846453|62795558|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
33417683|NCT03846453|62795556|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
33417684|NCT03846453|62795557|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
33417685|NCT03846453|62795558|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
33417686|NCT03846453|62795556|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
33417687|NCT03846453|62795557|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
33417688|NCT03846453|62795558|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
33417689|NCT03846453|62795556|FG000|Placebo Run-in (14 Days)|Other|2|||
33417690|NCT03846453|62795557|FG001|Placebo Run-in (14 Days)|Other|0|||
33417691|NCT03846453|62795558|FG002|Placebo Run-in (14 Days)|Other|0|||
33417692|NCT03846453|62795556|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
33417693|NCT03846453|62795557|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
33417694|NCT03846453|62795558|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
33417695|NCT03846453|62795556|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
33417696|NCT03846453|62795557|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
33417697|NCT03846453|62795558|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
33417698|NCT03846453|62795556|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
33417699|NCT03846453|62795557|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
33417700|NCT03846453|62795558|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
33417701|NCT03846453|62795556|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
33417702|NCT03846453|62795557|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
33417703|NCT03846453|62795558|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
33417704|NCT03846453|62795556|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
33417705|NCT03846453|62795557|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
33417706|NCT03846453|62795558|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
33417707|NCT00444951|62795569|FG000|Overall Study|Lost to Follow-up|1|||
33417708|NCT00444951|62795570|FG001|Overall Study|Lost to Follow-up|1|||
33417709|NCT00444951|62795571|FG002|Overall Study|Lost to Follow-up|0|||
33417710|NCT00444951|62795569|FG000|Overall Study|Withdrawal by Subject|4|||
33604938|NCT01736566|63004557|FG000|Long Term Follow-up|Still collecting data|42|||
33604939|NCT01736566|63004558|FG001|Long Term Follow-up|Still collecting data|0|||
33604940|NCT01736566|63004559|FG002|Long Term Follow-up|Still collecting data|49|||
33604941|NCT01736566|63004560|FG003|Long Term Follow-up|Still collecting data|0|||
33604942|NCT01736566|63004561|FG004|Long Term Follow-up|Still collecting data|1|||
33417711|NCT00444951|62795570|FG001|Overall Study|Withdrawal by Subject|5|||
33417712|NCT00444951|62795571|FG002|Overall Study|Withdrawal by Subject|3|||
33417713|NCT00444795|62795579|FG000|Overall Study|Not Treated|1|||
33417714|NCT00444795|62795579|FG000|Overall Study|Treated Prior to the Contract Date|2|||
33604943|NCT01768858|63004586|FG000|Overall Study|Lost to Follow-up|9|||
33604944|NCT01768858|63004586|FG000|Overall Study|Lack of Efficacy|8|||
33604945|NCT01768858|63004586|FG000|Overall Study|Serious Adverse Event|1|||
33604946|NCT01768858|63004586|FG000|Overall Study|Participant moved to Germany|1|||
33604947|NCT01768858|63004586|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
33604948|NCT01768858|63004586|FG000|Overall Study|Exanthema|1|||
33604949|NCT01768858|63004586|FG000|Overall Study|Withdrawal by Subject|1|||
33604950|NCT01736254|63004590|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
33604951|NCT01736254|63004590|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
33604952|NCT01767376|63004601|FG000|Overall Study|Lost to Follow-up|3|||
33604953|NCT01767376|63004602|FG001|Overall Study|Lost to Follow-up|2|||
33604954|NCT01767376|63004603|FG002|Overall Study|Lost to Follow-up|0|||
33604955|NCT01767376|63004601|FG000|Overall Study|Withdrawal by Subject|1|||
33604956|NCT01767376|63004602|FG001|Overall Study|Withdrawal by Subject|1|||
33322862|NCT01145352|62698923|FG000|Overall Study|Found to have been registered twice|6|||
33417715|NCT03846219|62795586|FG000|Overall Study|Withdrawal by Subject|3|||
33417716|NCT03846219|62795587|FG001|Overall Study|Withdrawal by Subject|2|||
33417717|NCT03846219|62795588|FG002|Overall Study|Withdrawal by Subject|2|||
33604957|NCT01767376|63004603|FG002|Overall Study|Withdrawal by Subject|0|||
33604958|NCT01767142|63004613|FG000|Overall Study|Lost to Follow-up|3|||
33604959|NCT01785628|63004619|FG000|Overall Study|Lost to Follow-up|2|||
33604960|NCT01785628|63004620|FG001|Overall Study|Lost to Follow-up|3|||
33604961|NCT01785472|63004629|FG000|Overall Study|Adverse Event|5|||
33604962|NCT01785472|63004630|FG001|Overall Study|Adverse Event|4|||
33417718|NCT03846219|62795586|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
33417719|NCT03846219|62795587|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
33417720|NCT03846219|62795588|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
33417721|NCT03846219|62795586|FG000|Overall Study|Physician Decision|0|||
33417722|NCT03846219|62795587|FG001|Overall Study|Physician Decision|0|||
33417723|NCT03846219|62795588|FG002|Overall Study|Physician Decision|2|||
33417724|NCT00455325|62795604|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
33417725|NCT00455325|62795605|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
33417726|NCT00455325|62795606|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
33417727|NCT00455325|62795607|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
33417728|NCT00455325|62795604|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
33417729|NCT00455325|62795605|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
33417730|NCT00455325|62795606|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
33417731|NCT00455325|62795607|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
33417732|NCT00455325|62795604|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
33417733|NCT00455325|62795605|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
33417734|NCT00455325|62795606|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
33417735|NCT00455325|62795607|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
33417736|NCT00455325|62795604|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
33417737|NCT00455325|62795605|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
33604963|NCT01785472|63004631|FG002|Overall Study|Adverse Event|6|||
33604964|NCT01785472|63004629|FG000|Overall Study|Lack of Efficacy|2|||
33604965|NCT01785472|63004630|FG001|Overall Study|Lack of Efficacy|0|||
33604966|NCT01785472|63004631|FG002|Overall Study|Lack of Efficacy|1|||
33604967|NCT01785472|63004629|FG000|Overall Study|Lost to Follow-up|1|||
33604968|NCT01785472|63004630|FG001|Overall Study|Lost to Follow-up|2|||
33604969|NCT01785472|63004631|FG002|Overall Study|Lost to Follow-up|0|||
33604970|NCT01785472|63004629|FG000|Overall Study|Physician Decision|1|||
33604971|NCT01785472|63004630|FG001|Overall Study|Physician Decision|1|||
33604972|NCT01785472|63004631|FG002|Overall Study|Physician Decision|1|||
33604973|NCT01785472|63004629|FG000|Overall Study|Protocol deviation|0|||
33604974|NCT01785472|63004630|FG001|Overall Study|Protocol deviation|2|||
33604975|NCT01785472|63004631|FG002|Overall Study|Protocol deviation|2|||
33604976|NCT01785472|63004629|FG000|Overall Study|Subject/guardian decision|15|||
33417738|NCT00455325|62795606|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
33417739|NCT00455325|62795607|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
33417740|NCT00455325|62795604|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
33417741|NCT00455325|62795605|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
33604977|NCT01785472|63004630|FG001|Overall Study|Subject/guardian decision|10|||
33604978|NCT01785472|63004631|FG002|Overall Study|Subject/guardian decision|11|||
33604979|NCT01785472|63004629|FG000|Overall Study|Technical problems|0|||
33322863|NCT01145352|62698923|FG000|Overall Study|Treated before marketing approval|4|||
33417742|NCT00455325|62795606|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
33417743|NCT00455325|62795607|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
33417744|NCT00455325|62795604|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
33417745|NCT00455325|62795605|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
33417746|NCT00455325|62795606|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
33417747|NCT00455325|62795607|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
33417748|NCT00455325|62795604|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
33417749|NCT00455325|62795605|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
33417750|NCT00455325|62795606|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
33417751|NCT00455325|62795607|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
33417752|NCT00443781|62795618|FG000|Overall Study|Lost to Follow-up|10|||
33417753|NCT00443781|62795618|FG000|Overall Study|Physician Decision|2|||
33417754|NCT00443781|62795618|FG000|Overall Study|Protocol Violation|1|||
33417755|NCT00443781|62795618|FG000|Overall Study|Withdrawal by Subject|6|||
33417756|NCT00443781|62795618|FG000|Overall Study|Unable to comply with study follow up|2|||
33417757|NCT00443781|62795618|FG000|Overall Study|Investigator terminated participation|1|||
33417758|NCT00443781|62795618|FG000|Overall Study|Insurance not covered|2|||
33417759|NCT00443781|62795618|FG000|Overall Study|PD/FAD not done|1|||
33417760|NCT00443703|62795624|FG000|Overall Study|Never Treated|3|||
33417761|NCT00443703|62795625|FG001|Overall Study|Never Treated|1|||
33417762|NCT00443703|62795624|FG000|Overall Study|Adverse Event|7|||
33417763|NCT00443703|62795625|FG001|Overall Study|Adverse Event|3|||
33417764|NCT00443703|62795624|FG000|Overall Study|Lack of Efficacy|3|||
33417765|NCT00443703|62795625|FG001|Overall Study|Lack of Efficacy|1|||
33417766|NCT00443703|62795624|FG000|Overall Study|Lost to Follow-up|0|||
33417767|NCT00443703|62795625|FG001|Overall Study|Lost to Follow-up|4|||
33417768|NCT00443703|62795624|FG000|Overall Study|Physician Decision|4|||
33417769|NCT00443703|62795625|FG001|Overall Study|Physician Decision|2|||
33417770|NCT00443703|62795624|FG000|Overall Study|Protocol Violation|1|||
33417771|NCT00443703|62795625|FG001|Overall Study|Protocol Violation|1|||
33417772|NCT00443703|62795624|FG000|Overall Study|Withdrawal by Subject|9|||
33417773|NCT00443703|62795625|FG001|Overall Study|Withdrawal by Subject|6|||
33417774|NCT00443703|62795624|FG000|Overall Study|Progressive Disease|1|||
33417775|NCT00443703|62795625|FG001|Overall Study|Progressive Disease|0|||
33417776|NCT00381706|62795637|FG000|Overall Study|Never treated|7|||
33417777|NCT00381706|62795638|FG001|Overall Study|Never treated|2|||
33417778|NCT00381706|62795639|FG002|Overall Study|Never treated|1|||
33417779|NCT00535236|62795663|FG000|Overall Study|Adverse Event|1|||
33417780|NCT00535236|62795664|FG001|Overall Study|Adverse Event|0|||
33417781|NCT00535236|62795665|FG002|Overall Study|Adverse Event|9|||
33417782|NCT00535236|62795666|FG003|Overall Study|Adverse Event|3|||
33417783|NCT00535236|62795667|FG004|Overall Study|Adverse Event|3|||
33417784|NCT00535236|62795668|FG005|Overall Study|Adverse Event|0|||
33417785|NCT00535236|62795669|FG006|Overall Study|Adverse Event|5|||
33417786|NCT00535236|62795670|FG007|Overall Study|Adverse Event|1|||
33417787|NCT00535236|62795671|FG008|Overall Study|Adverse Event|2|||
33417788|NCT00535236|62795672|FG009|Overall Study|Adverse Event|1|||
33417789|NCT00535236|62795663|FG000|Overall Study|Lost to Follow-up|1|||
33417790|NCT00535236|62795664|FG001|Overall Study|Lost to Follow-up|2|||
33417791|NCT00535236|62795665|FG002|Overall Study|Lost to Follow-up|0|||
33417792|NCT00535236|62795666|FG003|Overall Study|Lost to Follow-up|0|||
33417793|NCT00535236|62795667|FG004|Overall Study|Lost to Follow-up|2|||
33417794|NCT00535236|62795668|FG005|Overall Study|Lost to Follow-up|0|||
33417795|NCT00535236|62795669|FG006|Overall Study|Lost to Follow-up|0|||
33417796|NCT00535236|62795670|FG007|Overall Study|Lost to Follow-up|0|||
33417797|NCT00535236|62795671|FG008|Overall Study|Lost to Follow-up|6|||
33417798|NCT00535236|62795672|FG009|Overall Study|Lost to Follow-up|1|||
33417799|NCT00535236|62795663|FG000|Overall Study|Physician Decision|0|||
33417800|NCT00535236|62795664|FG001|Overall Study|Physician Decision|0|||
33417801|NCT00535236|62795665|FG002|Overall Study|Physician Decision|0|||
33417802|NCT00535236|62795666|FG003|Overall Study|Physician Decision|0|||
33417803|NCT00535236|62795667|FG004|Overall Study|Physician Decision|1|||
33417804|NCT00535236|62795668|FG005|Overall Study|Physician Decision|0|||
33417805|NCT00535236|62795669|FG006|Overall Study|Physician Decision|1|||
33417806|NCT00535236|62795670|FG007|Overall Study|Physician Decision|0|||
33417807|NCT00535236|62795671|FG008|Overall Study|Physician Decision|0|||
33417808|NCT00535236|62795672|FG009|Overall Study|Physician Decision|0|||
33494096|NCT03472326|62872792|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
33417809|NCT00535236|62795663|FG000|Overall Study|Protocol Violation|2|||
33417810|NCT00535236|62795664|FG001|Overall Study|Protocol Violation|0|||
33417811|NCT00535236|62795665|FG002|Overall Study|Protocol Violation|1|||
33417812|NCT00535236|62795666|FG003|Overall Study|Protocol Violation|0|||
33417813|NCT00535236|62795667|FG004|Overall Study|Protocol Violation|0|||
33417814|NCT00535236|62795668|FG005|Overall Study|Protocol Violation|0|||
33417815|NCT00535236|62795669|FG006|Overall Study|Protocol Violation|0|||
33417816|NCT00535236|62795670|FG007|Overall Study|Protocol Violation|0|||
33417817|NCT00535236|62795671|FG008|Overall Study|Protocol Violation|1|||
33417818|NCT00535236|62795672|FG009|Overall Study|Protocol Violation|0|||
33417819|NCT00535236|62795663|FG000|Overall Study|Withdrawal by Subject|3|||
33417820|NCT00535236|62795664|FG001|Overall Study|Withdrawal by Subject|0|||
33417821|NCT00535236|62795665|FG002|Overall Study|Withdrawal by Subject|2|||
33417822|NCT00535236|62795666|FG003|Overall Study|Withdrawal by Subject|1|||
33417823|NCT00535236|62795667|FG004|Overall Study|Withdrawal by Subject|6|||
33417824|NCT00535236|62795668|FG005|Overall Study|Withdrawal by Subject|1|||
33417825|NCT00535236|62795669|FG006|Overall Study|Withdrawal by Subject|5|||
33417826|NCT00535236|62795670|FG007|Overall Study|Withdrawal by Subject|0|||
33417827|NCT00535236|62795671|FG008|Overall Study|Withdrawal by Subject|4|||
33417828|NCT00535236|62795672|FG009|Overall Study|Withdrawal by Subject|2|||
33417829|NCT00370552|62795700|FG000|Overall Study|Adverse Event|2|||
33417830|NCT00370552|62795701|FG001|Overall Study|Adverse Event|2|||
33417831|NCT00370552|62795702|FG002|Overall Study|Adverse Event|2|||
33417832|NCT00370552|62795700|FG000|Overall Study|Disease progression|23|||
33417833|NCT00370552|62795701|FG001|Overall Study|Disease progression|23|||
33417834|NCT00370552|62795702|FG002|Overall Study|Disease progression|15|||
33417835|NCT00370552|62795700|FG000|Overall Study|Maximum clinical benefit|3|||
33417836|NCT00370552|62795701|FG001|Overall Study|Maximum clinical benefit|5|||
33417837|NCT00370552|62795702|FG002|Overall Study|Maximum clinical benefit|5|||
33417838|NCT00370552|62795700|FG000|Overall Study|Poor or noncompliance|0|||
33417839|NCT00370552|62795701|FG001|Overall Study|Poor or noncompliance|0|||
33417840|NCT00370552|62795702|FG002|Overall Study|Poor or noncompliance|1|||
33417841|NCT00370552|62795700|FG000|Overall Study|Study drug toxicity|11|||
33417842|NCT00370552|62795701|FG001|Overall Study|Study drug toxicity|8|||
33322864|NCT01145352|62698923|FG000|Overall Study|Syringe formulation was used|1|||
33322865|NCT01178099|62698931|FG000|Overall Study|Physician Decision|0|||
33417843|NCT00370552|62795702|FG002|Overall Study|Study drug toxicity|6|||
33417844|NCT00370552|62795700|FG000|Overall Study|Withdrawal by Subject|2|||
33417845|NCT00370552|62795701|FG001|Overall Study|Withdrawal by Subject|0|||
33417846|NCT00370552|62795702|FG002|Overall Study|Withdrawal by Subject|1|||
33417847|NCT00370552|62795700|FG000|Overall Study|Still on treatment|1|||
33417848|NCT00370552|62795701|FG001|Overall Study|Still on treatment|3|||
33417849|NCT00370552|62795702|FG002|Overall Study|Still on treatment|2|||
33417850|NCT00370552|62795700|FG000|Overall Study|Never treated|1|||
33417851|NCT00370552|62795701|FG001|Overall Study|Never treated|0|||
33417852|NCT00370552|62795702|FG002|Overall Study|Never treated|0|||
33417853|NCT00370552|62795700|FG000|Overall Study|Physician Decision|1|||
33494097|NCT03472326|62872789|FG000|Part 2: Combination Therapy|Pregnancy|0|||
33494098|NCT03472326|62872790|FG001|Part 2: Combination Therapy|Pregnancy|0|||
33494099|NCT03472326|62872791|FG002|Part 2: Combination Therapy|Pregnancy|0|||
33494100|NCT03472326|62872792|FG003|Part 2: Combination Therapy|Pregnancy|1|||
33494101|NCT02737618|62872801|FG000|Overall Study|Withdrawal by Subject|9|||
33494102|NCT03472014|62872805|FG000|Overall Study|Lost to Follow-up|4|||
33494103|NCT03526458|62872811|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
33494104|NCT03526458|62872812|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
33494105|NCT03526458|62872811|FG000|Overall Study|Stone passed, surgery cancelled|2|||
33494106|NCT03526458|62872812|FG001|Overall Study|Stone passed, surgery cancelled|1|||
33494107|NCT03526458|62872811|FG000|Overall Study|Withdrawal by Subject|1|||
33494108|NCT03526458|62872812|FG001|Overall Study|Withdrawal by Subject|0|||
33494109|NCT03526458|62872811|FG000|Overall Study|Physician Decision|2|||
33494110|NCT03526458|62872812|FG001|Overall Study|Physician Decision|1|||
33494111|NCT03526458|62872811|FG000|Overall Study|Lack of equipment|1|||
33417854|NCT00370552|62795701|FG001|Overall Study|Physician Decision|1|||
33417855|NCT00370552|62795702|FG002|Overall Study|Physician Decision|0|||
33417856|NCT00370552|62795700|FG000|Overall Study|Investigator decision|2|||
33417857|NCT00370552|62795701|FG001|Overall Study|Investigator decision|1|||
33417858|NCT00370552|62795702|FG002|Overall Study|Investigator decision|0|||
33417859|NCT00370552|62795700|FG000|Overall Study|High risk of allergic reaction|0|||
33417860|NCT00370552|62795701|FG001|Overall Study|High risk of allergic reaction|1|||
33417861|NCT00370552|62795702|FG002|Overall Study|High risk of allergic reaction|0|||
33417862|NCT00370552|62795700|FG000|Overall Study|Planned radiation for palliation|0|||
33417863|NCT00370552|62795701|FG001|Overall Study|Planned radiation for palliation|1|||
33417864|NCT00370552|62795702|FG002|Overall Study|Planned radiation for palliation|0|||
33417865|NCT00537030|62795710|FG000|Overall Study|Physician Decision|2|||
33417866|NCT00537030|62795710|FG000|Overall Study|Withdrawal by Subject|2|||
33417867|NCT00537030|62795710|FG000|Overall Study|≥ Grade 2 allergy|7|||
33417868|NCT00537030|62795710|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
33417869|NCT00537030|62795710|FG000|Overall Study|Ineligible|2|||
33417870|NCT00537030|62795710|FG000|Overall Study|Inevaluable|2|||
33417871|NCT00381238|62795714|FG000|Overall Study|Adverse Event|3|||
33417872|NCT00381238|62795714|FG000|Overall Study|Protocol Violation|1|||
33417873|NCT00381238|62795714|FG000|Overall Study|Withdrawal by Subject|4|||
33417874|NCT00381238|62795714|FG000|Overall Study|Lack of Efficacy|2|||
33417875|NCT00381238|62795714|FG000|Overall Study|Withdrew by physician|1|||
33417876|NCT00381238|62795714|FG000|Overall Study|Disease progression|1|||
33417877|NCT03896022|62795721|FG000|Overall Study|Withdrawal by Subject|1|||
33417878|NCT03896022|62795722|FG001|Overall Study|Withdrawal by Subject|0|||
33417879|NCT03896022|62795723|FG002|Overall Study|Withdrawal by Subject|0|||
33417880|NCT03896022|62795721|FG000|Overall Study|Did not have procedure|3|||
33417881|NCT03896022|62795722|FG001|Overall Study|Did not have procedure|0|||
33417882|NCT03896022|62795723|FG002|Overall Study|Did not have procedure|0|||
33417883|NCT03831880|62795735|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
33417884|NCT03831880|62795736|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
33417885|NCT03831880|62795735|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
33417886|NCT03831880|62795736|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
33417887|NCT00380692|62795759|FG000|Study Period II - Double Blind|Adverse Event|1|||
33417888|NCT00380692|62795760|FG001|Study Period II - Double Blind|Adverse Event|0|||
33417889|NCT00380692|62795759|FG000|Study Period II - Double Blind|Protocol Violation|2|||
33417890|NCT00380692|62795760|FG001|Study Period II - Double Blind|Protocol Violation|2|||
33417891|NCT00380692|62795759|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
33417892|NCT00380692|62795760|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
33417893|NCT00380692|62795759|FG000|Study Period II - Double Blind|Physician Decision|0|||
33417894|NCT00380692|62795760|FG001|Study Period II - Double Blind|Physician Decision|1|||
33417895|NCT00380692|62795759|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
33417896|NCT00380692|62795760|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
33417897|NCT00380692|62795759|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
33417898|NCT00380692|62795760|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
33417899|NCT00380692|62795759|FG000|Study Period III - Open Label|Adverse Event|5|||
33417900|NCT00380692|62795760|FG001|Study Period III - Open Label|Adverse Event|3|||
33417901|NCT00380692|62795759|FG000|Study Period III - Open Label|Protocol Violation|0|||
33417902|NCT00380692|62795760|FG001|Study Period III - Open Label|Protocol Violation|0|||
33417903|NCT00380692|62795759|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
33417904|NCT00380692|62795760|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
33417905|NCT00380692|62795759|FG000|Study Period III - Open Label|Physician Decision|0|||
33417906|NCT00380692|62795760|FG001|Study Period III - Open Label|Physician Decision|3|||
33604980|NCT01785472|63004630|FG001|Overall Study|Technical problems|0|||
33604981|NCT01785472|63004631|FG002|Overall Study|Technical problems|1|||
33604982|NCT01785160|63004641|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
33604983|NCT01785160|63004641|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
33322866|NCT01178099|62698932|FG001|Overall Study|Physician Decision|1|||
33322867|NCT01169532|62698942|FG000|Overall Study|Withdrawal by Subject|1|||
33417907|NCT00380692|62795759|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
33417908|NCT00380692|62795760|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
33604984|NCT01736176|63004647|FG000|Overall Study|Adverse Event|3|||
33604985|NCT01736176|63004647|FG000|Overall Study|Withdrawal by Subject|4|||
33322868|NCT00928564|62698948|FG000|Overall Study|Lost to Follow-up|6|||
33322869|NCT00928564|62698949|FG001|Overall Study|Lost to Follow-up|0|||
33417909|NCT00380692|62795759|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
33417910|NCT00380692|62795760|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
33417911|NCT00536874|62795766|FG000|Overall Study|Adverse Event|1|||
33417912|NCT00536874|62795766|FG000|Overall Study|Death|2|||
33417913|NCT00536874|62795766|FG000|Overall Study|Withdrawal by Subject|1|||
33417914|NCT00380068|62795770|FG000|Overall Study|Adverse Event|40|||
33417915|NCT00380068|62795770|FG000|Overall Study|Withdrawal by Subject|10|||
33322870|NCT01177943|62698957|FG000|First Intervention|Withdrawal by Subject|2|||
33417916|NCT00380068|62795770|FG000|Overall Study|Not compliant|6|||
33417917|NCT00380068|62795770|FG000|Overall Study|Lost to Follow-up|1|||
33417918|NCT00380068|62795770|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
33417919|NCT00380068|62795770|FG000|Overall Study|Lung transplant|3|||
33417920|NCT00380068|62795770|FG000|Overall Study|Physician Decision|2|||
33417921|NCT00380068|62795770|FG000|Overall Study|Partipant moved away|1|||
33417922|NCT00380068|62795770|FG000|Overall Study|Lack of Efficacy|5|||
33417923|NCT00536484|62795776|FG000|Overall Study|Adverse Event|21|||
33417924|NCT00536484|62795777|FG001|Overall Study|Adverse Event|34|||
33417925|NCT00536484|62795776|FG000|Overall Study|Withdrawal by Subject|11|||
33417926|NCT00536484|62795777|FG001|Overall Study|Withdrawal by Subject|11|||
33417927|NCT00536484|62795776|FG000|Overall Study|Lost to Follow-up|8|||
33417928|NCT00536484|62795777|FG001|Overall Study|Lost to Follow-up|6|||
33417929|NCT00536484|62795776|FG000|Overall Study|Lack of Efficacy|16|||
33417930|NCT00536484|62795777|FG001|Overall Study|Lack of Efficacy|5|||
33417931|NCT00536484|62795776|FG000|Overall Study|Other|4|||
33417932|NCT00536484|62795777|FG001|Overall Study|Other|0|||
33417933|NCT00370396|62795786|FG000|Overall Study|Withdrawal by Subject|0|||
33417934|NCT00370396|62795787|FG001|Overall Study|Withdrawal by Subject|0|||
33417935|NCT00370396|62795788|FG002|Overall Study|Withdrawal by Subject|1|||
33417936|NCT00370396|62795786|FG000|Overall Study|Lost to Follow-up|11|||
33417937|NCT00370396|62795787|FG001|Overall Study|Lost to Follow-up|1|||
33417938|NCT00370396|62795788|FG002|Overall Study|Lost to Follow-up|0|||
33417939|NCT00455013|62795799|FG000|Short Term Period|Adverse Event|2|||
33417940|NCT00455013|62795800|FG001|Short Term Period|Adverse Event|5|||
33417941|NCT00455013|62795801|FG002|Short Term Period|Adverse Event|0|||
33417942|NCT00455013|62795799|FG000|Short Term Period|Withdrawal by Subject|0|||
33417943|NCT00455013|62795800|FG001|Short Term Period|Withdrawal by Subject|0|||
33417944|NCT00455013|62795801|FG002|Short Term Period|Withdrawal by Subject|1|||
33417945|NCT00455013|62795799|FG000|Short Term Period|Lack of Efficacy|4|||
33417946|NCT00455013|62795800|FG001|Short Term Period|Lack of Efficacy|0|||
33417947|NCT00455013|62795801|FG002|Short Term Period|Lack of Efficacy|0|||
33417948|NCT00455013|62795799|FG000|Short Term Period|Other|0|||
33417949|NCT00455013|62795800|FG001|Short Term Period|Other|0|||
33417950|NCT00455013|62795801|FG002|Short Term Period|Other|1|||
33417951|NCT00455013|62795799|FG000|Long Term Extension (LTE)|Adverse Event|0|||
33417952|NCT00455013|62795800|FG001|Long Term Extension (LTE)|Adverse Event|1|||
33417953|NCT00455013|62795801|FG002|Long Term Extension (LTE)|Adverse Event|1|||
33417954|NCT00455013|62795799|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
33417955|NCT00455013|62795800|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
33417956|NCT00455013|62795801|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
33417957|NCT00455013|62795799|FG000|Long Term Extension (LTE)|Death|1|||
33417958|NCT00455013|62795800|FG001|Long Term Extension (LTE)|Death|1|||
33417959|NCT00455013|62795801|FG002|Long Term Extension (LTE)|Death|0|||
33417960|NCT00455013|62795799|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
33417961|NCT00455013|62795800|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
33417962|NCT00455013|62795801|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
33417963|NCT00455013|62795799|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
33417964|NCT00455013|62795800|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
33417965|NCT00455013|62795801|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
33417966|NCT00455013|62795799|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
33417967|NCT00455013|62795800|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
33417968|NCT00455013|62795801|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
33417969|NCT00455013|62795799|FG000|Long Term Extension (LTE)|non-specified|0|||
33417970|NCT00455013|62795800|FG001|Long Term Extension (LTE)|non-specified|0|||
33417971|NCT00455013|62795801|FG002|Long Term Extension (LTE)|non-specified|1|||
33417972|NCT00363298|62795811|FG000|First Study Week|Lack of Efficacy|6|||
33417973|NCT00363298|62795812|FG001|First Study Week|Lack of Efficacy|5|||
33417974|NCT00363298|62795811|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
33417975|NCT00363298|62795812|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
33417976|NCT00363142|62795821|FG000|Overall Study|Adverse Event|2|||
33417977|NCT00363142|62795822|FG001|Overall Study|Adverse Event|0|||
33417978|NCT00363142|62795821|FG000|Overall Study|Lack of Efficacy|0|||
33417979|NCT00363142|62795822|FG001|Overall Study|Lack of Efficacy|1|||
33417980|NCT00363142|62795821|FG000|Overall Study|Lost to Follow-up|1|||
33417981|NCT00363142|62795822|FG001|Overall Study|Lost to Follow-up|0|||
33417982|NCT00363142|62795821|FG000|Overall Study|Non-compliance|1|||
33417983|NCT00363142|62795822|FG001|Overall Study|Non-compliance|1|||
33417984|NCT00363142|62795821|FG000|Overall Study|Withdrawal by Subject|3|||
33417985|NCT00363142|62795822|FG001|Overall Study|Withdrawal by Subject|1|||
33417986|NCT00454857|62795831|FG000|Overall Study|Withdrawal by Subject|15|||
33417987|NCT00454857|62795831|FG000|Overall Study|Lost to Follow-up|16|||
33417988|NCT00454857|62795831|FG000|Overall Study|Noncompliance|6|||
33417989|NCT00454857|62795831|FG000|Overall Study|Death|5|||
33417990|NCT00454857|62795831|FG000|Overall Study|Other|11|||
33417991|NCT00454857|62795831|FG000|Overall Study|Reason unknown|1|||
33417992|NCT00379912|62795837|FG000|Overall Study|Lack of Efficacy|1|||
33417993|NCT00379912|62795838|FG001|Overall Study|Lack of Efficacy|0|||
33417994|NCT00379834|62795850|FG000|Overall Study|Time constraints|2|||
33417995|NCT00379210|62795856|FG000|Overall Study|Withdrawal by Subject|10|||
33417996|NCT00379210|62795857|FG001|Overall Study|Withdrawal by Subject|7|||
33417997|NCT00378898|62795865|FG000|Overall Study|Withdrawal by Subject|10|||
33417998|NCT00378898|62795866|FG001|Overall Study|Withdrawal by Subject|5|||
33417999|NCT00378898|62795865|FG000|Overall Study|Protocol Violation|1|||
33418000|NCT00378898|62795866|FG001|Overall Study|Protocol Violation|1|||
33418001|NCT00378508|62795876|FG000|Overall Study|Withdrawal by Subject|1|||
33418002|NCT00378508|62795877|FG001|Overall Study|Withdrawal by Subject|3|||
33418003|NCT00378508|62795876|FG000|Overall Study|Lost to Follow-up|1|||
33418004|NCT00378508|62795877|FG001|Overall Study|Lost to Follow-up|0|||
33418005|NCT00454779|62795886|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
33418006|NCT00454779|62795887|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
33418007|NCT00454779|62795886|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
33418008|NCT00454779|62795887|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
33418009|NCT00454779|62795886|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
33418010|NCT00454779|62795887|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
33418011|NCT00454779|62795886|FG000|First-line Treatment Phase|Protocol Violation|0|||
33418012|NCT00454779|62795887|FG001|First-line Treatment Phase|Protocol Violation|1|||
33418013|NCT00454779|62795886|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
33418014|NCT00454779|62795887|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
33418015|NCT00454779|62795886|FG000|First-line Treatment Phase|Ongoing|1|||
33418016|NCT00454779|62795887|FG001|First-line Treatment Phase|Ongoing|0|||
33418017|NCT00454779|62795886|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
33418018|NCT00454779|62795887|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
33418019|NCT00454779|62795886|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
33418020|NCT00454779|62795887|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
33418021|NCT00454779|62795886|FG000|Second-line Treatment Phase|Ongoing|0|||
33418022|NCT00454779|62795887|FG001|Second-line Treatment Phase|Ongoing|1|||
33418023|NCT00439569|62795897|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
33418024|NCT00439569|62795897|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
33418025|NCT00439569|62795897|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
33418026|NCT00443079|62795903|FG000|Overall Study|Lost to Follow-up|0|||
33418027|NCT00443079|62795904|FG001|Overall Study|Lost to Follow-up|1|||
33418028|NCT00427635|62795940|FG000|Treatment Phase|Withdrawal by Subject|1|||
33418029|NCT00427635|62795941|FG001|Treatment Phase|Withdrawal by Subject|0|||
33418030|NCT00427635|62795940|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
33418031|NCT00427635|62795941|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
33418032|NCT00427011|62795947|FG000|Overall Study|Adverse Event|10|||
33418033|NCT00427011|62795947|FG000|Overall Study|Withdrawal by Subject|1|||
33418034|NCT00427011|62795947|FG000|Overall Study|Lack of Efficacy|2|||
33418035|NCT00427011|62795947|FG000|Overall Study|Other|12|||
33418036|NCT03891264|62795952|FG000|Overall Study|Adverse Event|1|||
33418037|NCT03891264|62795952|FG000|Overall Study|Withdrawal by Subject|2|||
33418038|NCT03891264|62795952|FG000|Overall Study|Physician Decision|2|||
33418039|NCT00439179|62795960|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
33418040|NCT00439179|62795961|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
33418041|NCT00439179|62795962|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
33418042|NCT00439179|62795963|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
33604986|NCT01736176|63004647|FG000|Overall Study|Lack of Efficacy|3|||
33604987|NCT01736176|63004647|FG000|Overall Study|Unable to Complete PEG Placement|1|||
33604988|NCT01735630|63004657|FG000|Overall Study|Adverse Event|8|||
33604989|NCT01735630|63004658|FG001|Overall Study|Adverse Event|7|||
33418043|NCT00438633|62795978|FG000|Overall Study|Withdrawal by Subject|1|||
33418044|NCT00438633|62795979|FG001|Overall Study|Withdrawal by Subject|0|||
33418045|NCT00438633|62795978|FG000|Overall Study|Lost to Follow-up|15|||
33418046|NCT00438633|62795979|FG001|Overall Study|Lost to Follow-up|17|||
33418047|NCT00438399|62795988|FG000|Overall Study|Lost to Follow-up|2|||
33604990|NCT01735630|63004657|FG000|Overall Study|Lost to Follow-up|1|||
33604991|NCT01735630|63004658|FG001|Overall Study|Lost to Follow-up|0|||
33604992|NCT01735630|63004657|FG000|Overall Study|Physician Decision|0|||
33604993|NCT01735630|63004658|FG001|Overall Study|Physician Decision|1|||
33604994|NCT01735630|63004657|FG000|Overall Study|Sponsor Decision|2|||
33604995|NCT01735630|63004658|FG001|Overall Study|Sponsor Decision|1|||
33604996|NCT01735630|63004657|FG000|Overall Study|Withdrawal by Subject|7|||
33604997|NCT01735630|63004658|FG001|Overall Study|Withdrawal by Subject|9|||
33604998|NCT01735396|63004664|FG000|Overall Study|not evaluable|1|||
33604999|NCT01766206|63004668|FG000|Overall Study|Withdrawal by Subject|22|||
33418048|NCT00438399|62795989|FG001|Overall Study|Lost to Follow-up|2|||
33418049|NCT00438399|62795990|FG002|Overall Study|Lost to Follow-up|1|||
33418050|NCT00438399|62795991|FG003|Overall Study|Lost to Follow-up|1|||
33418051|NCT00438399|62795992|FG004|Overall Study|Lost to Follow-up|1|||
33605000|NCT01766206|63004668|FG000|Overall Study|Lost to Follow-up|10|||
33605001|NCT01766206|63004668|FG000|Overall Study|Inappropriate enrollment|18|||
33605002|NCT01766206|63004668|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
33605003|NCT01734850|63004675|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
33605004|NCT01734850|63004676|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
33605005|NCT01734850|63004677|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
33605006|NCT01734850|63004675|FG000|Overall Study|Not infused due to manufacturing failure|0|||
33605007|NCT01734850|63004676|FG001|Overall Study|Not infused due to manufacturing failure|0|||
33605008|NCT01734850|63004677|FG002|Overall Study|Not infused due to manufacturing failure|1|||
33605009|NCT01766050|63004688|FG000|Overall Study|Adverse Event|1|||
33605010|NCT01766050|63004688|FG000|Overall Study|Lost to Follow-up|1|||
33418052|NCT00438399|62795993|FG005|Overall Study|Lost to Follow-up|1|||
33418053|NCT00438399|62795988|FG000|Overall Study|Adverse Event|0|||
33418054|NCT00438399|62795989|FG001|Overall Study|Adverse Event|0|||
33418055|NCT00438399|62795990|FG002|Overall Study|Adverse Event|1|||
33418056|NCT00438399|62795991|FG003|Overall Study|Adverse Event|1|||
33418057|NCT00438399|62795992|FG004|Overall Study|Adverse Event|0|||
33418058|NCT00438399|62795993|FG005|Overall Study|Adverse Event|1|||
33418059|NCT00438399|62795988|FG000|Overall Study|Withdrawal by Subject|5|||
33418060|NCT00438399|62795989|FG001|Overall Study|Withdrawal by Subject|6|||
33418061|NCT00438399|62795990|FG002|Overall Study|Withdrawal by Subject|3|||
33418062|NCT00438399|62795991|FG003|Overall Study|Withdrawal by Subject|2|||
33418063|NCT00438399|62795992|FG004|Overall Study|Withdrawal by Subject|2|||
33418064|NCT00438399|62795993|FG005|Overall Study|Withdrawal by Subject|2|||
33418065|NCT00438399|62795988|FG000|Overall Study|Protocol Violation|0|||
33418066|NCT00438399|62795989|FG001|Overall Study|Protocol Violation|0|||
33418067|NCT00438399|62795990|FG002|Overall Study|Protocol Violation|1|||
33418068|NCT00438399|62795991|FG003|Overall Study|Protocol Violation|0|||
33418069|NCT00438399|62795992|FG004|Overall Study|Protocol Violation|0|||
33418070|NCT00438399|62795993|FG005|Overall Study|Protocol Violation|1|||
33418071|NCT00438399|62795988|FG000|Overall Study|Subje stopped study|0|||
33418072|NCT00438399|62795989|FG001|Overall Study|Subje stopped study|0|||
33418073|NCT00438399|62795990|FG002|Overall Study|Subje stopped study|1|||
33418074|NCT00438399|62795991|FG003|Overall Study|Subje stopped study|0|||
33418075|NCT00438399|62795992|FG004|Overall Study|Subje stopped study|0|||
33418076|NCT00438399|62795993|FG005|Overall Study|Subje stopped study|0|||
33418077|NCT00438399|62795988|FG000|Overall Study|Pregnancy|0|||
33418078|NCT00438399|62795989|FG001|Overall Study|Pregnancy|0|||
33418079|NCT00438399|62795990|FG002|Overall Study|Pregnancy|0|||
33418080|NCT00438399|62795991|FG003|Overall Study|Pregnancy|0|||
33418081|NCT00438399|62795992|FG004|Overall Study|Pregnancy|0|||
33418082|NCT00438399|62795993|FG005|Overall Study|Pregnancy|1|||
33418083|NCT00438399|62795988|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
33418084|NCT00438399|62795989|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
33418085|NCT00438399|62795990|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
33418086|NCT00438399|62795991|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
33418087|NCT00438399|62795992|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
33418088|NCT00438399|62795993|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
33418089|NCT00426231|62796004|FG000|Overall Study|Withdrawal by Subject|9|||
33418090|NCT00426231|62796005|FG001|Overall Study|Withdrawal by Subject|12|||
33418091|NCT00425607|62796011|FG000|Overall Study|Death|1|||
33605011|NCT01766050|63004688|FG000|Overall Study|Withdrawal by Subject|2|||
33605012|NCT02341625|63004716|FG000|Overall Study|Disease Progression|2|||
33605013|NCT02341625|63004717|FG001|Overall Study|Disease Progression|2|||
33418092|NCT00425607|62796011|FG000|Overall Study|Withdrawal by Subject|1|||
33418093|NCT00437073|62796017|FG000|Overall Study|Sponsor Terminated Study|1|||
33418094|NCT00437073|62796018|FG001|Overall Study|Sponsor Terminated Study|0|||
33418095|NCT00437073|62796017|FG000|Overall Study|Physician Decision|0|||
33418096|NCT00437073|62796018|FG001|Overall Study|Physician Decision|1|||
33418097|NCT00425373|62796033|FG000|Overall Study|Adverse Event|2|||
33418098|NCT00425373|62796034|FG001|Overall Study|Adverse Event|2|||
33418099|NCT00425373|62796035|FG002|Overall Study|Adverse Event|0|||
33418100|NCT00425373|62796036|FG003|Overall Study|Adverse Event|1|||
33418101|NCT00425373|62796037|FG004|Overall Study|Adverse Event|4|||
33418102|NCT00425373|62796038|FG005|Overall Study|Adverse Event|6|||
33418103|NCT00425373|62796039|FG006|Overall Study|Adverse Event|2|||
33418104|NCT00425373|62796040|FG007|Overall Study|Adverse Event|3|||
33418105|NCT00425373|62796041|FG008|Overall Study|Adverse Event|8|||
33418106|NCT00425373|62796033|FG000|Overall Study|Lost to Follow-up|0|||
33418107|NCT00425373|62796034|FG001|Overall Study|Lost to Follow-up|1|||
33418108|NCT00425373|62796035|FG002|Overall Study|Lost to Follow-up|0|||
33418109|NCT00425373|62796036|FG003|Overall Study|Lost to Follow-up|0|||
33418110|NCT00425373|62796037|FG004|Overall Study|Lost to Follow-up|1|||
33418111|NCT00425373|62796038|FG005|Overall Study|Lost to Follow-up|0|||
33418112|NCT00425373|62796039|FG006|Overall Study|Lost to Follow-up|0|||
33418113|NCT00425373|62796040|FG007|Overall Study|Lost to Follow-up|0|||
33418114|NCT00425373|62796041|FG008|Overall Study|Lost to Follow-up|0|||
33418115|NCT00425373|62796033|FG000|Overall Study|Protocol Violation|1|||
33418116|NCT00425373|62796034|FG001|Overall Study|Protocol Violation|0|||
33418117|NCT00425373|62796035|FG002|Overall Study|Protocol Violation|1|||
33418118|NCT00425373|62796036|FG003|Overall Study|Protocol Violation|0|||
33418119|NCT00425373|62796037|FG004|Overall Study|Protocol Violation|0|||
33418120|NCT00425373|62796038|FG005|Overall Study|Protocol Violation|0|||
33418121|NCT00425373|62796039|FG006|Overall Study|Protocol Violation|0|||
33418122|NCT00425373|62796040|FG007|Overall Study|Protocol Violation|5|||
33418123|NCT00425373|62796041|FG008|Overall Study|Protocol Violation|3|||
33418124|NCT00425373|62796033|FG000|Overall Study|Withdrawal by Subject|2|||
33418125|NCT00425373|62796034|FG001|Overall Study|Withdrawal by Subject|0|||
33418126|NCT00425373|62796035|FG002|Overall Study|Withdrawal by Subject|2|||
33418127|NCT00425373|62796036|FG003|Overall Study|Withdrawal by Subject|1|||
33418128|NCT00425373|62796037|FG004|Overall Study|Withdrawal by Subject|4|||
33418129|NCT00425373|62796038|FG005|Overall Study|Withdrawal by Subject|0|||
33418130|NCT00425373|62796039|FG006|Overall Study|Withdrawal by Subject|2|||
33418131|NCT00425373|62796040|FG007|Overall Study|Withdrawal by Subject|2|||
33418132|NCT00425373|62796041|FG008|Overall Study|Withdrawal by Subject|2|||
33418133|NCT00425373|62796033|FG000|Overall Study|Lack of Efficacy|0|||
33418134|NCT00425373|62796034|FG001|Overall Study|Lack of Efficacy|0|||
33418135|NCT00425373|62796035|FG002|Overall Study|Lack of Efficacy|0|||
33418136|NCT00425373|62796036|FG003|Overall Study|Lack of Efficacy|0|||
33418137|NCT00425373|62796037|FG004|Overall Study|Lack of Efficacy|1|||
33418138|NCT00425373|62796038|FG005|Overall Study|Lack of Efficacy|3|||
33418139|NCT00425373|62796039|FG006|Overall Study|Lack of Efficacy|3|||
33418140|NCT00425373|62796040|FG007|Overall Study|Lack of Efficacy|0|||
33418141|NCT00425373|62796041|FG008|Overall Study|Lack of Efficacy|5|||
33418142|NCT03894540|62796067|FG000|Overall Study|Adverse Event|0|||
33418143|NCT03894540|62796068|FG001|Overall Study|Adverse Event|0|||
33418144|NCT03894540|62796069|FG002|Overall Study|Adverse Event|0|||
33322871|NCT01177943|62698958|FG001|First Intervention|Withdrawal by Subject|0|||
33322872|NCT01131312|62698967|FG000|Overall Study|Lost to Follow-up|425|||
33418145|NCT03894540|62796070|FG003|Overall Study|Adverse Event|0|||
33418146|NCT03894540|62796071|FG004|Overall Study|Adverse Event|1|||
33418147|NCT03894540|62796072|FG005|Overall Study|Adverse Event|0|||
33418148|NCT03894540|62796067|FG000|Overall Study|Withdrawal by Subject|0|||
33418149|NCT03894540|62796068|FG001|Overall Study|Withdrawal by Subject|0|||
33418150|NCT03894540|62796069|FG002|Overall Study|Withdrawal by Subject|0|||
33418151|NCT03894540|62796070|FG003|Overall Study|Withdrawal by Subject|0|||
33418152|NCT03894540|62796071|FG004|Overall Study|Withdrawal by Subject|1|||
33418153|NCT03894540|62796072|FG005|Overall Study|Withdrawal by Subject|0|||
33418154|NCT03894540|62796067|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
33418155|NCT03894540|62796068|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
33418156|NCT03894540|62796069|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
33418157|NCT03894540|62796070|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
33418158|NCT03894540|62796071|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
33418159|NCT03894540|62796072|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
33418160|NCT03894540|62796067|FG000|Overall Study|Progressive Disease Clinical|1|||
33418161|NCT03894540|62796068|FG001|Overall Study|Progressive Disease Clinical|1|||
33418162|NCT03894540|62796069|FG002|Overall Study|Progressive Disease Clinical|0|||
33418163|NCT03894540|62796070|FG003|Overall Study|Progressive Disease Clinical|1|||
33418164|NCT03894540|62796071|FG004|Overall Study|Progressive Disease Clinical|5|||
33418165|NCT03894540|62796072|FG005|Overall Study|Progressive Disease Clinical|1|||
33418166|NCT03894540|62796067|FG000|Overall Study|Study termination by sponsor|0|||
33418167|NCT03894540|62796068|FG001|Overall Study|Study termination by sponsor|0|||
33418168|NCT03894540|62796069|FG002|Overall Study|Study termination by sponsor|0|||
33418169|NCT03894540|62796070|FG003|Overall Study|Study termination by sponsor|0|||
33418170|NCT03894540|62796071|FG004|Overall Study|Study termination by sponsor|2|||
33418171|NCT03894540|62796072|FG005|Overall Study|Study termination by sponsor|0|||
33418172|NCT00535626|62796090|FG000|Overall Study|Death|15|||
33418173|NCT00535626|62796090|FG000|Overall Study|Lost to Follow-up|29|||
33418174|NCT00535626|62796090|FG000|Overall Study|Withdrawal by Subject|20|||
33418175|NCT00535626|62796090|FG000|Overall Study|Removal/revision of study component|8|||
33322873|NCT01131312|62698968|FG001|Overall Study|Lost to Follow-up|229|||
33418176|NCT00535626|62796090|FG000|Overall Study|Subject terminated|31|||
33418177|NCT00535626|62796090|FG000|Overall Study|Unable to return|2|||
33418178|NCT03889704|62796113|FG000|Overall Study|Study terminated due to pandemic|1|||
33418179|NCT03887442|62796119|FG000|Overall Study|Adverse Event|1|||
33418180|NCT03887442|62796120|FG001|Overall Study|Adverse Event|0|||
33418181|NCT00425061|62796135|FG000|Overall Study|Adverse Event|1|||
33418182|NCT00425061|62796136|FG001|Overall Study|Adverse Event|0|||
33418183|NCT00425061|62796137|FG002|Overall Study|Adverse Event|0|||
33605014|NCT02341625|63004718|FG002|Overall Study|Disease Progression|3|||
33605015|NCT02341625|63004719|FG003|Overall Study|Disease Progression|6|||
33605016|NCT02341625|63004720|FG004|Overall Study|Disease Progression|7|||
33418184|NCT00425061|62796138|FG003|Overall Study|Adverse Event|2|||
33418185|NCT00425061|62796139|FG004|Overall Study|Adverse Event|2|||
33418186|NCT00425061|62796140|FG005|Overall Study|Adverse Event|0|||
33418187|NCT00425061|62796141|FG006|Overall Study|Adverse Event|0|||
33418188|NCT00425061|62796135|FG000|Overall Study|Lost to Follow-up|0|||
33418189|NCT00425061|62796136|FG001|Overall Study|Lost to Follow-up|1|||
33418190|NCT00425061|62796137|FG002|Overall Study|Lost to Follow-up|0|||
33418191|NCT00425061|62796138|FG003|Overall Study|Lost to Follow-up|0|||
33418192|NCT00425061|62796139|FG004|Overall Study|Lost to Follow-up|0|||
33418193|NCT00425061|62796140|FG005|Overall Study|Lost to Follow-up|0|||
33418194|NCT00425061|62796141|FG006|Overall Study|Lost to Follow-up|0|||
33418195|NCT00425061|62796135|FG000|Overall Study|Protocol Violation|1|||
33418196|NCT00425061|62796136|FG001|Overall Study|Protocol Violation|0|||
33418197|NCT00425061|62796137|FG002|Overall Study|Protocol Violation|0|||
33418198|NCT00425061|62796138|FG003|Overall Study|Protocol Violation|0|||
33418199|NCT00425061|62796139|FG004|Overall Study|Protocol Violation|0|||
33418200|NCT00425061|62796140|FG005|Overall Study|Protocol Violation|0|||
33418201|NCT00425061|62796141|FG006|Overall Study|Protocol Violation|0|||
33418202|NCT00425061|62796135|FG000|Overall Study|Withdrawal by Subject|0|||
33418203|NCT00425061|62796136|FG001|Overall Study|Withdrawal by Subject|1|||
33418204|NCT00425061|62796137|FG002|Overall Study|Withdrawal by Subject|0|||
33418205|NCT00425061|62796138|FG003|Overall Study|Withdrawal by Subject|0|||
33418206|NCT00425061|62796139|FG004|Overall Study|Withdrawal by Subject|1|||
33418207|NCT00425061|62796140|FG005|Overall Study|Withdrawal by Subject|0|||
33418208|NCT00425061|62796141|FG006|Overall Study|Withdrawal by Subject|3|||
33418209|NCT00425061|62796135|FG000|Overall Study|Sponsor's request|0|||
33418210|NCT00425061|62796136|FG001|Overall Study|Sponsor's request|0|||
33418211|NCT00425061|62796137|FG002|Overall Study|Sponsor's request|0|||
33418212|NCT00425061|62796138|FG003|Overall Study|Sponsor's request|0|||
33418213|NCT00425061|62796139|FG004|Overall Study|Sponsor's request|19|||
33418214|NCT00425061|62796140|FG005|Overall Study|Sponsor's request|4|||
33418215|NCT00425061|62796141|FG006|Overall Study|Sponsor's request|15|||
33418216|NCT00425061|62796135|FG000|Overall Study|Physician Decision|0|||
33418217|NCT00425061|62796136|FG001|Overall Study|Physician Decision|0|||
33418218|NCT00425061|62796137|FG002|Overall Study|Physician Decision|0|||
33418219|NCT00425061|62796138|FG003|Overall Study|Physician Decision|0|||
33418220|NCT00425061|62796139|FG004|Overall Study|Physician Decision|1|||
33418221|NCT00425061|62796140|FG005|Overall Study|Physician Decision|0|||
33418222|NCT00425061|62796141|FG006|Overall Study|Physician Decision|0|||
33418223|NCT00425061|62796135|FG000|Overall Study|Other|0|||
33418224|NCT00425061|62796136|FG001|Overall Study|Other|0|||
33418225|NCT00425061|62796137|FG002|Overall Study|Other|0|||
33418226|NCT00425061|62796138|FG003|Overall Study|Other|0|||
33418227|NCT00425061|62796139|FG004|Overall Study|Other|3|||
33418228|NCT00425061|62796140|FG005|Overall Study|Other|0|||
33418229|NCT00425061|62796141|FG006|Overall Study|Other|1|||
33418230|NCT00424827|62796159|FG000|Overall Study|Adverse Event|1|||
33418231|NCT03885726|62796164|FG000|Overall Study|Staffing issues/lost interest|1|||
33418232|NCT03885726|62796164|FG000|Overall Study|Early discharge from hospital|3|||
33418233|NCT00377962|62796174|FG000|Core Study: 0-12 Months|Adverse Event|18|||
33418234|NCT00377962|62796175|FG001|Core Study: 0-12 Months|Adverse Event|2|||
33418235|NCT00377962|62796174|FG000|Core Study: 0-12 Months|Death|3|||
33418236|NCT00377962|62796175|FG001|Core Study: 0-12 Months|Death|0|||
33418237|NCT00377962|62796174|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
33418238|NCT00377962|62796175|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
33418239|NCT00377962|62796174|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
33418240|NCT00377962|62796175|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
33418241|NCT00377962|62796174|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
33418242|NCT00377962|62796175|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
33418243|NCT00377962|62796174|FG000|Extension Study: 12-24 Months|Death|1|||
33418244|NCT00377962|62796175|FG001|Extension Study: 12-24 Months|Death|1|||
33418245|NCT00377962|62796174|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
33418246|NCT00377962|62796175|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
33418247|NCT00377962|62796174|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
33418248|NCT00377962|62796175|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
33418249|NCT00377962|62796174|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
33605017|NCT02341625|63004721|FG005|Overall Study|Disease Progression|7|||
33605018|NCT02341625|63004722|FG006|Overall Study|Disease Progression|28|||
33605019|NCT02341625|63004723|FG007|Overall Study|Disease Progression|5|||
33605020|NCT02341625|63004724|FG008|Overall Study|Disease Progression|4|||
33605021|NCT02341625|63004725|FG009|Overall Study|Disease Progression|19|||
33605022|NCT02341625|63004716|FG000|Overall Study|Study Drug Toxicity|0|||
33605023|NCT02341625|63004717|FG001|Overall Study|Study Drug Toxicity|0|||
33605024|NCT02341625|63004718|FG002|Overall Study|Study Drug Toxicity|0|||
33605025|NCT02341625|63004719|FG003|Overall Study|Study Drug Toxicity|1|||
33605026|NCT02341625|63004720|FG004|Overall Study|Study Drug Toxicity|0|||
33605027|NCT02341625|63004721|FG005|Overall Study|Study Drug Toxicity|3|||
33605028|NCT02341625|63004722|FG006|Overall Study|Study Drug Toxicity|10|||
33418250|NCT00377962|62796175|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
33418251|NCT00424749|62796187|FG000|Overall Study|Withdrawal by Subject|1|||
33418252|NCT00424593|62796193|FG000|Acute Double-Blind Period|Adverse Event|16|||
33418253|NCT00424593|62796194|FG001|Acute Double-Blind Period|Adverse Event|7|||
33418254|NCT00424593|62796193|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
33418255|NCT00424593|62796194|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
33418256|NCT00424593|62796193|FG000|Acute Double-Blind Period|Protocol Violation|2|||
33418257|NCT00424593|62796194|FG001|Acute Double-Blind Period|Protocol Violation|2|||
33418258|NCT00424593|62796193|FG000|Acute Double-Blind Period|Physician Decision|1|||
33418259|NCT00424593|62796194|FG001|Acute Double-Blind Period|Physician Decision|2|||
33418260|NCT00424593|62796193|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
33418261|NCT00424593|62796194|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
33418262|NCT00424593|62796193|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
33418263|NCT00424593|62796194|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
33418264|NCT00424593|62796193|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
33418265|NCT00424593|62796194|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
33418266|NCT00424593|62796193|FG000|Dose-Blind Extension Period|Adverse Event|18|||
33418267|NCT00424593|62796194|FG001|Dose-Blind Extension Period|Adverse Event|0|||
33418268|NCT00424593|62796193|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
33418269|NCT00424593|62796194|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
33418270|NCT00424593|62796193|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
33418271|NCT00424593|62796194|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
33418272|NCT00424593|62796193|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
33418273|NCT00424593|62796194|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
33418274|NCT00424593|62796193|FG000|Dose-Blind Extension Period|Physician Decision|3|||
33418275|NCT00424593|62796194|FG001|Dose-Blind Extension Period|Physician Decision|0|||
33418276|NCT00369382|62796202|FG000|Overall Study|Death|0|||
33418277|NCT00369382|62796203|FG001|Overall Study|Death|2|||
33418278|NCT00369382|62796202|FG000|Overall Study|Physician Decision|2|||
33418279|NCT00369382|62796203|FG001|Overall Study|Physician Decision|1|||
33418280|NCT00369382|62796202|FG000|Overall Study|Withdrawal by Subject|5|||
33418281|NCT00369382|62796203|FG001|Overall Study|Withdrawal by Subject|0|||
33418282|NCT00369382|62796202|FG000|Overall Study|Randomized, not treated|2|||
33418283|NCT00369382|62796203|FG001|Overall Study|Randomized, not treated|0|||
33418284|NCT00369382|62796202|FG000|Overall Study|Other|1|||
33418285|NCT00369382|62796203|FG001|Overall Study|Other|0|||
33418286|NCT00424515|62796212|FG000|Overall Study|Progressive Disease|10|||
33418287|NCT00424515|62796213|FG001|Overall Study|Progressive Disease|11|||
33418288|NCT00424515|62796212|FG000|Overall Study|Adverse Event|0|||
33418289|NCT00424515|62796213|FG001|Overall Study|Adverse Event|1|||
33418290|NCT00424515|62796212|FG000|Overall Study|Intercurrent Illness|0|||
33418291|NCT00424515|62796213|FG001|Overall Study|Intercurrent Illness|1|||
33418292|NCT00424515|62796212|FG000|Overall Study|Withdrawal by Subject|1|||
33418293|NCT00424515|62796213|FG001|Overall Study|Withdrawal by Subject|0|||
33418294|NCT00377260|62796221|FG000|Overall Study|Lost to Follow-up|0|||
33605029|NCT02341625|63004723|FG007|Overall Study|Study Drug Toxicity|0|||
33605030|NCT02341625|63004724|FG008|Overall Study|Study Drug Toxicity|0|||
33605031|NCT02341625|63004725|FG009|Overall Study|Study Drug Toxicity|3|||
33605032|NCT02341625|63004716|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33605033|NCT02341625|63004717|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33418295|NCT00377260|62796222|FG001|Overall Study|Lost to Follow-up|1|||
33418296|NCT00377260|62796221|FG000|Overall Study|Withdrawal by Subject|2|||
33605034|NCT02341625|63004718|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33418297|NCT00377260|62796222|FG001|Overall Study|Withdrawal by Subject|4|||
33418298|NCT00441441|62796230|FG000|Overall Study|Adverse Event|2|||
33418299|NCT00441441|62796231|FG001|Overall Study|Adverse Event|1|||
33418300|NCT00441441|62796230|FG000|Overall Study|Protocol Violation|4|||
33605035|NCT02341625|63004719|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33605036|NCT02341625|63004720|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33418301|NCT00441441|62796231|FG001|Overall Study|Protocol Violation|6|||
33418302|NCT00441441|62796230|FG000|Overall Study|Exacerbation of asthma|1|||
33418303|NCT00441441|62796231|FG001|Overall Study|Exacerbation of asthma|2|||
33418304|NCT00441441|62796230|FG000|Overall Study|Withdrawal by Subject|1|||
33418305|NCT00441441|62796231|FG001|Overall Study|Withdrawal by Subject|2|||
33418306|NCT00441441|62796230|FG000|Overall Study|Other|3|||
33418307|NCT00441441|62796231|FG001|Overall Study|Other|3|||
33418308|NCT00436917|62796251|FG000|Overall Study|Withdrawal by Subject|13|||
33418309|NCT00436917|62796251|FG000|Overall Study|Adverse Event|2|||
33418310|NCT00436917|62796251|FG000|Overall Study|Physician Decision|1|||
33418311|NCT00436917|62796251|FG000|Overall Study|Death|1|||
33418312|NCT00436917|62796251|FG000|Overall Study|Lost to Follow-up|1|||
33418313|NCT00436917|62796251|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
33418314|NCT00436917|62796251|FG000|Overall Study|Increased creatinine|1|||
33418315|NCT00436917|62796251|FG000|Overall Study|Personal conflicts of patient|1|||
33418316|NCT00436605|62796255|FG000|Overall Study|Protocol Violation|3|||
33418317|NCT00368992|62796259|FG000|Overall Study|Ineligible|5|||
33418318|NCT00368992|62796259|FG000|Overall Study|Refused treatment|3|||
33418319|NCT00368992|62796259|FG000|Overall Study|Lack of Efficacy|63|||
33418320|NCT00368992|62796259|FG000|Overall Study|Adverse Event|26|||
33418321|NCT00368992|62796259|FG000|Overall Study|Death|4|||
33418322|NCT00368992|62796259|FG000|Overall Study|Other|9|||
33418323|NCT00376246|62796264|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
33418324|NCT00376246|62796265|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
33418325|NCT00376246|62796264|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
33418326|NCT00376246|62796265|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
33418327|NCT00376246|62796264|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
33418328|NCT00376246|62796265|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
33418329|NCT00368836|62796275|FG000|Phase II|Screen Failure|1|||
33418330|NCT00368836|62796275|FG000|Phase II|Withdrawal by Subject|1|||
33418331|NCT00368836|62796275|FG000|Phase II|unable to collect blood and/or breath|17|||
33418332|NCT00368836|62796275|FG000|Phase II|Protocol Violation|2|||
33418333|NCT00376168|62796284|FG000|Overall Study|Adverse Event|1|||
33418334|NCT00376168|62796285|FG001|Overall Study|Adverse Event|1|||
33418335|NCT00376168|62796284|FG000|Overall Study|Pregnancy|1|||
33418336|NCT00376168|62796285|FG001|Overall Study|Pregnancy|0|||
33418337|NCT00375934|62796293|FG000|Overall Study|Adverse Event|1|||
33418338|NCT00375934|62796294|FG001|Overall Study|Adverse Event|1|||
33418339|NCT00375934|62796293|FG000|Overall Study|Withdrawal by Subject|2|||
33418340|NCT00375934|62796294|FG001|Overall Study|Withdrawal by Subject|2|||
33418341|NCT00375934|62796293|FG000|Overall Study|Lack of Efficacy|0|||
33418342|NCT00375934|62796294|FG001|Overall Study|Lack of Efficacy|2|||
33418343|NCT00375934|62796293|FG000|Overall Study|Physician Decision|0|||
33418344|NCT00375934|62796294|FG001|Overall Study|Physician Decision|1|||
33418345|NCT00642941|62796312|FG000|Overall Study|Physician Decision|3|||
33418346|NCT00642941|62796313|FG001|Overall Study|Physician Decision|1|||
33418347|NCT00642941|62796314|FG002|Overall Study|Physician Decision|0|||
33418348|NCT00642941|62796315|FG003|Overall Study|Physician Decision|0|||
33418349|NCT00642941|62796316|FG004|Overall Study|Physician Decision|0|||
33418350|NCT00642941|62796317|FG005|Overall Study|Physician Decision|0|||
33418351|NCT00642941|62796318|FG006|Overall Study|Physician Decision|1|||
33418352|NCT00642941|62796319|FG007|Overall Study|Physician Decision|0|||
33418353|NCT00642941|62796320|FG008|Overall Study|Physician Decision|0|||
33418354|NCT00642941|62796321|FG009|Overall Study|Physician Decision|1|||
33418355|NCT00642941|62796322|FG010|Overall Study|Physician Decision|0|||
33418356|NCT00642941|62796323|FG011|Overall Study|Physician Decision|1|||
33418357|NCT00642941|62796312|FG000|Overall Study|Death|4|||
33418358|NCT00642941|62796313|FG001|Overall Study|Death|0|||
33418359|NCT00642941|62796314|FG002|Overall Study|Death|1|||
33418360|NCT00642941|62796315|FG003|Overall Study|Death|1|||
33418361|NCT00642941|62796316|FG004|Overall Study|Death|2|||
33418362|NCT00642941|62796317|FG005|Overall Study|Death|1|||
33418363|NCT00642941|62796318|FG006|Overall Study|Death|0|||
33418364|NCT00642941|62796319|FG007|Overall Study|Death|0|||
33418365|NCT00642941|62796320|FG008|Overall Study|Death|0|||
33418366|NCT00642941|62796321|FG009|Overall Study|Death|0|||
33494112|NCT03526458|62872812|FG001|Overall Study|Lack of equipment|1|||
33322874|NCT01131312|62698969|FG002|Overall Study|Lost to Follow-up|351|||
33418367|NCT00642941|62796322|FG010|Overall Study|Death|0|||
33418368|NCT00642941|62796323|FG011|Overall Study|Death|1|||
33418369|NCT00642941|62796312|FG000|Overall Study|Study closed by Sponsor|0|||
33418370|NCT00642941|62796313|FG001|Overall Study|Study closed by Sponsor|1|||
33418371|NCT00642941|62796314|FG002|Overall Study|Study closed by Sponsor|0|||
33418372|NCT00642941|62796315|FG003|Overall Study|Study closed by Sponsor|0|||
33418373|NCT00642941|62796316|FG004|Overall Study|Study closed by Sponsor|0|||
33418374|NCT00642941|62796317|FG005|Overall Study|Study closed by Sponsor|0|||
33418375|NCT00642941|62796318|FG006|Overall Study|Study closed by Sponsor|0|||
33418376|NCT00642941|62796319|FG007|Overall Study|Study closed by Sponsor|0|||
33418377|NCT00642941|62796320|FG008|Overall Study|Study closed by Sponsor|0|||
33418378|NCT00642941|62796321|FG009|Overall Study|Study closed by Sponsor|0|||
33418379|NCT00642941|62796322|FG010|Overall Study|Study closed by Sponsor|0|||
33418380|NCT00642941|62796323|FG011|Overall Study|Study closed by Sponsor|0|||
33418381|NCT00642941|62796312|FG000|Overall Study|Withdrawal by Subject|1|||
33418382|NCT00642941|62796313|FG001|Overall Study|Withdrawal by Subject|0|||
33418383|NCT00642941|62796314|FG002|Overall Study|Withdrawal by Subject|0|||
33418384|NCT00642941|62796315|FG003|Overall Study|Withdrawal by Subject|2|||
33418385|NCT00642941|62796316|FG004|Overall Study|Withdrawal by Subject|0|||
33418386|NCT00642941|62796317|FG005|Overall Study|Withdrawal by Subject|0|||
33418387|NCT00642941|62796318|FG006|Overall Study|Withdrawal by Subject|2|||
33418388|NCT00642941|62796319|FG007|Overall Study|Withdrawal by Subject|0|||
33418389|NCT00642941|62796320|FG008|Overall Study|Withdrawal by Subject|1|||
33418390|NCT00642941|62796321|FG009|Overall Study|Withdrawal by Subject|0|||
33418391|NCT00642941|62796322|FG010|Overall Study|Withdrawal by Subject|0|||
33418392|NCT00642941|62796323|FG011|Overall Study|Withdrawal by Subject|1|||
33418393|NCT00642941|62796312|FG000|Overall Study|Protocol Violation|0|||
33418394|NCT00642941|62796313|FG001|Overall Study|Protocol Violation|0|||
33418395|NCT00642941|62796314|FG002|Overall Study|Protocol Violation|0|||
33418396|NCT00642941|62796315|FG003|Overall Study|Protocol Violation|0|||
33418397|NCT00642941|62796316|FG004|Overall Study|Protocol Violation|0|||
33418398|NCT00642941|62796317|FG005|Overall Study|Protocol Violation|0|||
33418399|NCT00642941|62796318|FG006|Overall Study|Protocol Violation|1|||
33418400|NCT00642941|62796319|FG007|Overall Study|Protocol Violation|0|||
33418401|NCT00642941|62796320|FG008|Overall Study|Protocol Violation|0|||
33418402|NCT00642941|62796321|FG009|Overall Study|Protocol Violation|0|||
33418403|NCT00642941|62796322|FG010|Overall Study|Protocol Violation|0|||
33418404|NCT00642941|62796323|FG011|Overall Study|Protocol Violation|0|||
33418405|NCT00642941|62796312|FG000|Overall Study|Adverse Event|1|||
33418406|NCT00642941|62796313|FG001|Overall Study|Adverse Event|1|||
33418407|NCT00642941|62796314|FG002|Overall Study|Adverse Event|0|||
33418408|NCT00642941|62796315|FG003|Overall Study|Adverse Event|0|||
33418409|NCT00642941|62796316|FG004|Overall Study|Adverse Event|0|||
33418410|NCT00642941|62796317|FG005|Overall Study|Adverse Event|0|||
33418411|NCT00642941|62796318|FG006|Overall Study|Adverse Event|1|||
33418412|NCT00642941|62796319|FG007|Overall Study|Adverse Event|1|||
33418413|NCT00642941|62796320|FG008|Overall Study|Adverse Event|0|||
33418414|NCT00642941|62796321|FG009|Overall Study|Adverse Event|1|||
33418415|NCT00642941|62796322|FG010|Overall Study|Adverse Event|0|||
33418416|NCT00642941|62796323|FG011|Overall Study|Adverse Event|0|||
33418417|NCT00642941|62796312|FG000|Overall Study|Other|1|||
33418418|NCT00642941|62796313|FG001|Overall Study|Other|1|||
33418419|NCT00642941|62796314|FG002|Overall Study|Other|1|||
33418420|NCT00642941|62796315|FG003|Overall Study|Other|1|||
33418421|NCT00642941|62796316|FG004|Overall Study|Other|0|||
33418422|NCT00642941|62796317|FG005|Overall Study|Other|1|||
33418423|NCT00642941|62796318|FG006|Overall Study|Other|0|||
33418424|NCT00642941|62796319|FG007|Overall Study|Other|1|||
33418425|NCT00642941|62796320|FG008|Overall Study|Other|0|||
33418426|NCT00642941|62796321|FG009|Overall Study|Other|0|||
33418427|NCT00642941|62796322|FG010|Overall Study|Other|0|||
33418428|NCT00642941|62796323|FG011|Overall Study|Other|1|||
33418429|NCT00642941|62796312|FG000|Overall Study|Disease progression|60|||
33418430|NCT00642941|62796313|FG001|Overall Study|Disease progression|50|||
33418431|NCT00642941|62796314|FG002|Overall Study|Disease progression|5|||
33418432|NCT00642941|62796315|FG003|Overall Study|Disease progression|36|||
33418433|NCT00642941|62796316|FG004|Overall Study|Disease progression|23|||
33418434|NCT00642941|62796317|FG005|Overall Study|Disease progression|39|||
33418435|NCT00642941|62796318|FG006|Overall Study|Disease progression|18|||
33418436|NCT00642941|62796319|FG007|Overall Study|Disease progression|12|||
33418437|NCT00642941|62796320|FG008|Overall Study|Disease progression|10|||
33418438|NCT00642941|62796321|FG009|Overall Study|Disease progression|7|||
33322875|NCT01177787|62698977|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
33322876|NCT01177787|62698977|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
33418439|NCT00642941|62796322|FG010|Overall Study|Disease progression|12|||
33418440|NCT00642941|62796323|FG011|Overall Study|Disease progression|7|||
33418441|NCT00531960|62796372|FG000|Overall Study|Adverse Event|5|||
33418442|NCT00531960|62796373|FG001|Overall Study|Adverse Event|4|||
33418443|NCT00531960|62796372|FG000|Overall Study|Death|3|||
33418444|NCT00531960|62796373|FG001|Overall Study|Death|2|||
33418445|NCT00531960|62796372|FG000|Overall Study|Lack of Efficacy|42|||
33418446|NCT00531960|62796373|FG001|Overall Study|Lack of Efficacy|41|||
33418447|NCT00531960|62796372|FG000|Overall Study|Violation of Selection Criteria|2|||
33418448|NCT00531960|62796373|FG001|Overall Study|Violation of Selection Criteria|0|||
33418449|NCT00531960|62796372|FG000|Overall Study|Refused Treatment|5|||
33418450|NCT00531960|62796373|FG001|Overall Study|Refused Treatment|6|||
33418451|NCT00531960|62796372|FG000|Overall Study|Other|4|||
33418452|NCT00531960|62796373|FG001|Overall Study|Other|10|||
33418453|NCT00361504|62796381|FG000|Overall Study|Withdrawal by Subject|94|||
33418454|NCT00361504|62796382|FG001|Overall Study|Withdrawal by Subject|31|||
33418455|NCT00361504|62796381|FG000|Overall Study|Lost to Follow-up|40|||
33418456|NCT00361504|62796382|FG001|Overall Study|Lost to Follow-up|7|||
33418457|NCT00361504|62796381|FG000|Overall Study|Adverse Event|203|||
33418458|NCT00361504|62796382|FG001|Overall Study|Adverse Event|82|||
33418459|NCT00361504|62796381|FG000|Overall Study|Lack of Efficacy|72|||
33418460|NCT00361504|62796382|FG001|Overall Study|Lack of Efficacy|7|||
33418461|NCT00361504|62796381|FG000|Overall Study|Resolution of Pain|2|||
33418462|NCT00361504|62796382|FG001|Overall Study|Resolution of Pain|0|||
33418463|NCT00361504|62796381|FG000|Overall Study|Study medication non compliant|42|||
33418464|NCT00361504|62796382|FG001|Overall Study|Study medication non compliant|15|||
33418465|NCT00361504|62796381|FG000|Overall Study|All other|28|||
33418466|NCT00361504|62796382|FG001|Overall Study|All other|3|||
33418467|NCT00361270|62796392|FG000|Overall Study|Death|0|||
33418468|NCT00361270|62796393|FG001|Overall Study|Death|0|||
33418469|NCT00361270|62796394|FG002|Overall Study|Death|0|||
33418470|NCT00361270|62796395|FG003|Overall Study|Death|2|||
33418471|NCT00361270|62796392|FG000|Overall Study|Lost to Follow-up|4|||
33418472|NCT00361270|62796393|FG001|Overall Study|Lost to Follow-up|1|||
33418473|NCT00361270|62796394|FG002|Overall Study|Lost to Follow-up|0|||
33418474|NCT00361270|62796395|FG003|Overall Study|Lost to Follow-up|0|||
33418475|NCT00361270|62796392|FG000|Overall Study|Physician Decision|0|||
33418476|NCT00361270|62796393|FG001|Overall Study|Physician Decision|0|||
33418477|NCT00361270|62796394|FG002|Overall Study|Physician Decision|1|||
33418478|NCT00361270|62796395|FG003|Overall Study|Physician Decision|0|||
33418479|NCT00361270|62796392|FG000|Overall Study|Protocol Violation|9|||
33418480|NCT00361270|62796393|FG001|Overall Study|Protocol Violation|4|||
33418481|NCT00361270|62796394|FG002|Overall Study|Protocol Violation|5|||
33418482|NCT00361270|62796395|FG003|Overall Study|Protocol Violation|4|||
33418483|NCT00361270|62796392|FG000|Overall Study|Withdrawal by Subject|6|||
33418484|NCT00361270|62796393|FG001|Overall Study|Withdrawal by Subject|6|||
33418485|NCT00361270|62796394|FG002|Overall Study|Withdrawal by Subject|3|||
33418486|NCT00361270|62796395|FG003|Overall Study|Withdrawal by Subject|7|||
33418487|NCT00361270|62796392|FG000|Overall Study|Afraid of Hypnosis|1|||
33418488|NCT00361270|62796393|FG001|Overall Study|Afraid of Hypnosis|2|||
33418489|NCT00361270|62796394|FG002|Overall Study|Afraid of Hypnosis|0|||
33418490|NCT00361270|62796395|FG003|Overall Study|Afraid of Hypnosis|0|||
33418491|NCT00361270|62796392|FG000|Overall Study|Problems with Transportation|4|||
33418492|NCT00361270|62796393|FG001|Overall Study|Problems with Transportation|0|||
33418493|NCT00361270|62796394|FG002|Overall Study|Problems with Transportation|0|||
33418494|NCT00361270|62796395|FG003|Overall Study|Problems with Transportation|0|||
33418495|NCT00361270|62796392|FG000|Overall Study|Adverse Event|0|||
33418496|NCT00361270|62796393|FG001|Overall Study|Adverse Event|1|||
33418497|NCT00361270|62796394|FG002|Overall Study|Adverse Event|1|||
33418498|NCT00361270|62796395|FG003|Overall Study|Adverse Event|0|||
33418499|NCT00367744|62796414|FG000|Overall Study|Lost to Follow-up|4|||
33418500|NCT00367744|62796415|FG001|Overall Study|Lost to Follow-up|5|||
33418501|NCT03883386|62796424|FG000|First Assignment|Lost to Follow-up|1|||
33418502|NCT03883386|62796425|FG001|First Assignment|Lost to Follow-up|0|||
33418503|NCT03883386|62796424|FG000|First Assignment|Withdrawal by Subject|1|||
33418504|NCT03883386|62796425|FG001|First Assignment|Withdrawal by Subject|1|||
33418505|NCT00530946|62796435|FG000|Overall Study|Adverse Event|1|||
33418506|NCT00530946|62796436|FG001|Overall Study|Adverse Event|2|||
33418507|NCT00530946|62796437|FG002|Overall Study|Adverse Event|1|||
33418508|NCT00530946|62796438|FG003|Overall Study|Adverse Event|1|||
33494113|NCT03488238|62872818|FG000|Overall Study|Equipment malfunction|1|||
33494114|NCT03488238|62872818|FG000|Overall Study|Adverse Event|1|||
33494115|NCT03525834|62872822|FG000|Overall Study|Progressive disease|1|||
33494116|NCT03525444|62872864|FG000|Overall Study|Adverse Event|0|||
33494117|NCT03525444|62872865|FG001|Overall Study|Adverse Event|1|||
33494118|NCT03525444|62872864|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
33418509|NCT00530946|62796435|FG000|Overall Study|Protocol Violation|0|||
33418510|NCT00530946|62796436|FG001|Overall Study|Protocol Violation|0|||
33418511|NCT00530946|62796437|FG002|Overall Study|Protocol Violation|0|||
33494119|NCT03525444|62872865|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
33494120|NCT03525444|62872864|FG000|Overall Study|Other|0|||
33494121|NCT03525444|62872865|FG001|Overall Study|Other|1|||
33418512|NCT00530946|62796438|FG003|Overall Study|Protocol Violation|1|||
33418513|NCT00530946|62796435|FG000|Overall Study|Noncompliance|1|||
33418514|NCT00530946|62796436|FG001|Overall Study|Noncompliance|0|||
33418515|NCT00530946|62796437|FG002|Overall Study|Noncompliance|0|||
33418516|NCT00530946|62796438|FG003|Overall Study|Noncompliance|0|||
33418517|NCT00424047|62796450|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
33418518|NCT00424047|62796451|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
33418519|NCT00424047|62796450|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
33418520|NCT00424047|62796451|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
33418521|NCT00424047|62796450|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
33418522|NCT00424047|62796451|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
33418523|NCT00424047|62796450|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
33418524|NCT00424047|62796451|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
33418525|NCT00424047|62796450|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
33418526|NCT00424047|62796451|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
33418527|NCT00424047|62796450|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
33418528|NCT00424047|62796451|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
33418529|NCT00424047|62796450|FG000|On Study at Time of Unblinding|Adverse Event|22|||
33418530|NCT00424047|62796451|FG001|On Study at Time of Unblinding|Adverse Event|12|||
33418531|NCT00424047|62796450|FG000|On Study at Time of Unblinding|Progression of disease|92|||
33418532|NCT00424047|62796451|FG001|On Study at Time of Unblinding|Progression of disease|128|||
33418533|NCT00424047|62796450|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
33418534|NCT00424047|62796451|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
33418535|NCT00424047|62796450|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
33418536|NCT00424047|62796451|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
33418537|NCT00424047|62796450|FG000|On Study at Time of Unblinding|Death|11|||
33418538|NCT00424047|62796451|FG001|On Study at Time of Unblinding|Death|11|||
33418539|NCT00424047|62796450|FG000|On Study at Time of Unblinding|Other|5|||
33418540|NCT00424047|62796451|FG001|On Study at Time of Unblinding|Other|4|||
33418541|NCT00424047|62796450|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
33418542|NCT00424047|62796451|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
33418543|NCT00424047|62796450|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
33418544|NCT00424047|62796451|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
33418545|NCT00424047|62796450|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
33418546|NCT00424047|62796451|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
33418547|NCT00424047|62796450|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
33418548|NCT00424047|62796451|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
33418549|NCT00424047|62796450|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
33418550|NCT00424047|62796451|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
33418551|NCT00530790|62796462|FG000|Overall Study|Adverse Event|2|||
33418552|NCT00530790|62796462|FG000|Overall Study|Withdrawal by Subject|2|||
33418553|NCT00530790|62796462|FG000|Overall Study|Physician Decision|1|||
33418554|NCT00530088|62796466|FG000|Overall Study|Disease Progression|4|||
33418555|NCT00530088|62796466|FG000|Overall Study|Physician Decision|4|||
33418556|NCT00530088|62796466|FG000|Overall Study|Other Not Specified|2|||
33418557|NCT00360568|62796472|FG000|Overall Study|Adverse Event|1|||
33418558|NCT00360568|62796473|FG001|Overall Study|Adverse Event|2|||
33418559|NCT00360568|62796472|FG000|Overall Study|Lack of Efficacy|1|||
33418560|NCT00360568|62796473|FG001|Overall Study|Lack of Efficacy|0|||
33418561|NCT00360568|62796472|FG000|Overall Study|Withdrawal by Subject|0|||
33418562|NCT00360568|62796473|FG001|Overall Study|Withdrawal by Subject|3|||
33418563|NCT00436215|62796481|FG000|Overall Study|Refused further treatment|3|||
33418564|NCT00436215|62796481|FG000|Overall Study|Small bowel obstruction|1|||
33418565|NCT00441363|62796487|FG000|Overall Study|Adverse Event|4|||
33418566|NCT00441363|62796488|FG001|Overall Study|Adverse Event|2|||
33418567|NCT00441363|62796487|FG000|Overall Study|Withdrawal by Subject|3|||
33418568|NCT00441363|62796488|FG001|Overall Study|Withdrawal by Subject|4|||
33418569|NCT00441363|62796487|FG000|Overall Study|Physician Decision|6|||
33418570|NCT00441363|62796488|FG001|Overall Study|Physician Decision|7|||
33418571|NCT00441363|62796487|FG000|Overall Study|Lost to Follow-up|2|||
33418572|NCT00441363|62796488|FG001|Overall Study|Lost to Follow-up|2|||
33418573|NCT00441363|62796487|FG000|Overall Study|Other|2|||
33418574|NCT00441363|62796488|FG001|Overall Study|Other|0|||
33418575|NCT00530712|62796494|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
33418576|NCT00530712|62796494|FG000|30 Day Follow-up Visit|Missed Visit|5|||
33418577|NCT00530712|62796494|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
33418578|NCT00530712|62796494|FG000|6 Month Follow-up Visit|Missed Visit|3|||
33418579|NCT00530712|62796494|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
33418580|NCT00530712|62796494|FG000|6 Month Follow-up Visit|Death|2|||
33418581|NCT00530712|62796494|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
33418582|NCT00530712|62796494|FG000|12 Month Follow-up Visit|Missed Visit|3|||
33418583|NCT00530712|62796494|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
33418584|NCT00530712|62796494|FG000|12 Month Follow-up Visit|Death|9|||
33418585|NCT00626795|62796502|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
33418586|NCT00626795|62796503|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
33418587|NCT00626795|62796504|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
33418588|NCT00626795|62796502|FG000|Blinded Treatment|Lack of Efficacy|2|||
33418589|NCT00626795|62796503|FG001|Blinded Treatment|Lack of Efficacy|0|||
33418590|NCT00626795|62796504|FG002|Blinded Treatment|Lack of Efficacy|0|||
33418591|NCT00626795|62796502|FG000|Blinded Treatment|Unacceptable adverse event|0|||
33418592|NCT00626795|62796503|FG001|Blinded Treatment|Unacceptable adverse event|0|||
33418593|NCT00626795|62796504|FG002|Blinded Treatment|Unacceptable adverse event|1|||
33418594|NCT00626795|62796502|FG000|Blinded Treatment|Protocol Violation|0|||
33418595|NCT00626795|62796503|FG001|Blinded Treatment|Protocol Violation|1|||
33418596|NCT00626795|62796504|FG002|Blinded Treatment|Protocol Violation|1|||
33418597|NCT00626795|62796502|FG000|Blinded Treatment|Withdrawal by Subject|1|||
33418598|NCT00626795|62796503|FG001|Blinded Treatment|Withdrawal by Subject|1|||
33418599|NCT00626795|62796504|FG002|Blinded Treatment|Withdrawal by Subject|0|||
33418600|NCT00626795|62796502|FG000|Blinded Treatment|Other reasons|2|||
33418601|NCT00626795|62796503|FG001|Blinded Treatment|Other reasons|0|||
33418602|NCT00626795|62796504|FG002|Blinded Treatment|Other reasons|2|||
33418603|NCT00626795|62796502|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
33418604|NCT00626795|62796503|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
33418605|NCT00626795|62796504|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
33418606|NCT00626639|62796518|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
33418607|NCT00626639|62796519|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
33418608|NCT00626561|62796527|FG000|Overall Study|Withdrawal by Subject|2|||
33418609|NCT00626561|62796527|FG000|Overall Study|Disease Progression|2|||
33418610|NCT03880266|62796539|FG000|Overall Study|Withdrawal by Subject|0|||
33418611|NCT03880266|62796540|FG001|Overall Study|Withdrawal by Subject|1|||
33418612|NCT03880266|62796541|FG002|Overall Study|Withdrawal by Subject|1|||
33418613|NCT03880266|62796542|FG003|Overall Study|Withdrawal by Subject|0|||
33418614|NCT03880266|62796543|FG004|Overall Study|Withdrawal by Subject|0|||
33418615|NCT03880266|62796544|FG005|Overall Study|Withdrawal by Subject|0|||
33418616|NCT03880266|62796545|FG006|Overall Study|Withdrawal by Subject|0|||
33418617|NCT03880266|62796546|FG007|Overall Study|Withdrawal by Subject|0|||
33418618|NCT00423891|62796567|FG000|Enrolled|Withdrawal by Subject|0|||
33418619|NCT00423891|62796568|FG001|Enrolled|Withdrawal by Subject|0|||
33418620|NCT00423891|62796569|FG002|Enrolled|Withdrawal by Subject|1|||
33418621|NCT00423891|62796567|FG000|Enrolled|Lost to Follow-up|0|||
33418622|NCT00423891|62796568|FG001|Enrolled|Lost to Follow-up|0|||
33418623|NCT00423891|62796569|FG002|Enrolled|Lost to Follow-up|1|||
33418624|NCT00423891|62796567|FG000|Enrolled|No longer met criteria|11|||
33418625|NCT00423891|62796568|FG001|Enrolled|No longer met criteria|2|||
33418626|NCT00423891|62796569|FG002|Enrolled|No longer met criteria|1|||
33418627|NCT00423891|62796567|FG000|Treatment|Withdrawal by Subject|1|||
33418628|NCT00423891|62796568|FG001|Treatment|Withdrawal by Subject|0|||
33418629|NCT00423891|62796569|FG002|Treatment|Withdrawal by Subject|0|||
33418630|NCT00423891|62796567|FG000|Treatment|Lost to Follow-up|1|||
33418631|NCT00423891|62796568|FG001|Treatment|Lost to Follow-up|0|||
33418632|NCT00423891|62796569|FG002|Treatment|Lost to Follow-up|0|||
33418633|NCT00423891|62796567|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
33418634|NCT00423891|62796568|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
33418635|NCT00423891|62796569|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
33418636|NCT00423891|62796567|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
33418637|NCT00423891|62796568|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
33418638|NCT00423891|62796569|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
33418639|NCT00423813|62796582|FG000|Overall Study|Adverse Event|11|||
33418640|NCT00423813|62796583|FG001|Overall Study|Adverse Event|30|||
33418641|NCT00423813|62796584|FG002|Overall Study|Adverse Event|40|||
33418642|NCT00423813|62796582|FG000|Overall Study|Withdrawal by Subject|6|||
33418643|NCT00423813|62796583|FG001|Overall Study|Withdrawal by Subject|8|||
33418644|NCT00423813|62796584|FG002|Overall Study|Withdrawal by Subject|5|||
33418645|NCT00423813|62796582|FG000|Overall Study|Lost to Follow-up|5|||
33418646|NCT00423813|62796583|FG001|Overall Study|Lost to Follow-up|4|||
33418647|NCT00423813|62796584|FG002|Overall Study|Lost to Follow-up|4|||
33418648|NCT00423813|62796582|FG000|Overall Study|Lack of Efficacy|23|||
33418649|NCT00423813|62796583|FG001|Overall Study|Lack of Efficacy|18|||
33418650|NCT00423813|62796584|FG002|Overall Study|Lack of Efficacy|19|||
33418651|NCT00423813|62796582|FG000|Overall Study|Physician Decision|2|||
33418652|NCT00423813|62796583|FG001|Overall Study|Physician Decision|0|||
33418653|NCT00423813|62796584|FG002|Overall Study|Physician Decision|0|||
33418654|NCT00423813|62796582|FG000|Overall Study|Sponsor Decision|0|||
33418655|NCT00423813|62796583|FG001|Overall Study|Sponsor Decision|1|||
33418656|NCT00423813|62796584|FG002|Overall Study|Sponsor Decision|0|||
33418657|NCT00423813|62796582|FG000|Overall Study|Protocol Violation|9|||
33418658|NCT00423813|62796583|FG001|Overall Study|Protocol Violation|4|||
33418659|NCT00423813|62796584|FG002|Overall Study|Protocol Violation|4|||
33418660|NCT00423813|62796582|FG000|Overall Study|Pregnancy|0|||
33418661|NCT00423813|62796583|FG001|Overall Study|Pregnancy|0|||
33418662|NCT00423813|62796584|FG002|Overall Study|Pregnancy|1|||
33418663|NCT00423813|62796582|FG000|Overall Study|Subject started night shift work|1|||
33418664|NCT00423813|62796583|FG001|Overall Study|Subject started night shift work|0|||
33418665|NCT00423813|62796584|FG002|Overall Study|Subject started night shift work|0|||
33418666|NCT00423813|62796582|FG000|Overall Study|Will start exclusionary medications|0|||
33418667|NCT00423813|62796583|FG001|Overall Study|Will start exclusionary medications|1|||
33418668|NCT00423813|62796584|FG002|Overall Study|Will start exclusionary medications|0|||
33418669|NCT00423813|62796582|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
33418670|NCT00423813|62796583|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
33418671|NCT00423813|62796584|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
33418672|NCT03687372|62796594|FG000|Overall Study|Lost to Follow-up|12|||
33418673|NCT03687372|62796595|FG001|Overall Study|Lost to Follow-up|21|||
33418674|NCT03687372|62796594|FG000|Overall Study|Withdrawal by Subject|4|||
33418675|NCT03687372|62796595|FG001|Overall Study|Withdrawal by Subject|17|||
33418676|NCT03687372|62796594|FG000|Overall Study|Investigator Decision|1|||
33418677|NCT03687372|62796595|FG001|Overall Study|Investigator Decision|1|||
33418678|NCT00626405|62796605|FG000|Overall Study|Deemed Ineligible|1|||
33418679|NCT00626405|62796606|FG001|Overall Study|Deemed Ineligible|0|||
33418680|NCT00626405|62796605|FG000|Overall Study|Withdrawal by Subject|0|||
33418681|NCT00626405|62796606|FG001|Overall Study|Withdrawal by Subject|1|||
33418682|NCT00358150|62796612|FG000|Overall Study|Adverse Event|3|||
33418683|NCT00358150|62796612|FG000|Overall Study|Withdrawal by Subject|1|||
33418684|NCT00358150|62796612|FG000|Overall Study|Undefined|3|||
33418685|NCT05061966|62796639|FG000|Overall Study|Lost to Follow-up|13|||
33418686|NCT05061966|62796640|FG001|Overall Study|Lost to Follow-up|13|||
33418687|NCT05027815|62796648|FG000|Overall Study|Death|2|||
33418688|NCT05027815|62796649|FG001|Overall Study|Death|1|||
33418689|NCT04827134|62796659|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
33418690|NCT04827134|62796660|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
33418691|NCT04827134|62796661|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
33322877|NCT01177787|62698977|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
33322878|NCT00928486|62698989|FG000|Overall Study|Adverse Event|2|||
33322879|NCT00928486|62698989|FG000|Overall Study|Disease Progression|7|||
33418692|NCT04827134|62796662|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
33418693|NCT04818593|62796676|FG000|Overall Study|Low Oocyte Yield|8|||
33418694|NCT04818593|62796677|FG001|Overall Study|Low Oocyte Yield|8|||
33418695|NCT04818593|62796676|FG000|Overall Study|Not ICSI Insemination|7|||
33418696|NCT04818593|62796677|FG001|Overall Study|Not ICSI Insemination|7|||
33418697|NCT04818593|62796676|FG000|Overall Study|Poor Sperm Quality|2|||
33418698|NCT04818593|62796677|FG001|Overall Study|Poor Sperm Quality|2|||
33418699|NCT04818593|62796676|FG000|Overall Study|Withdrawal by Subject|2|||
33418700|NCT04818593|62796677|FG001|Overall Study|Withdrawal by Subject|2|||
33418701|NCT04818593|62796676|FG000|Overall Study|Conversion to IUI due to low response|1|||
33418702|NCT04818593|62796677|FG001|Overall Study|Conversion to IUI due to low response|1|||
33418703|NCT04680975|62796683|FG000|Overall Study|Adverse Event|3|||
33418704|NCT04680975|62796683|FG000|Overall Study|Death|1|||
33418705|NCT04680975|62796683|FG000|Overall Study|Progressive Disease|1|||
33418706|NCT04680975|62796683|FG000|Overall Study|Withdrawal by Subject|1|||
33418707|NCT04673786|62796689|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
33418708|NCT04673786|62796690|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
33418709|NCT04673786|62796691|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
33418710|NCT04673786|62796689|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
33418711|NCT04673786|62796690|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
33418712|NCT04673786|62796691|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
33418713|NCT04673786|62796689|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
33418714|NCT04673786|62796690|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
33418715|NCT04673786|62796691|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
33418716|NCT04673786|62796689|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
33418717|NCT04673786|62796690|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
33418718|NCT04673786|62796691|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
33418719|NCT04673786|62796689|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
33418720|NCT04673786|62796690|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
33418721|NCT04673786|62796691|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
33418722|NCT04673786|62796689|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
33418723|NCT04673786|62796690|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
33418724|NCT04673786|62796691|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
33418725|NCT04583969|62796715|FG000|Overall Study|Death|31|||
33418726|NCT04583969|62796716|FG001|Overall Study|Death|38|||
33418727|NCT04583969|62796715|FG000|Overall Study|Lost to Follow-up|16|||
33605037|NCT02341625|63004721|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33322880|NCT00928486|62698989|FG000|Overall Study|Withdrawal by Subject|1|||
33418728|NCT04583969|62796716|FG001|Overall Study|Lost to Follow-up|13|||
33418729|NCT04583969|62796715|FG000|Overall Study|Protocol Violation|1|||
33418730|NCT04583969|62796716|FG001|Overall Study|Protocol Violation|0|||
33418731|NCT04583969|62796715|FG000|Overall Study|Withdrawal by Subject|3|||
33418732|NCT04583969|62796716|FG001|Overall Study|Withdrawal by Subject|3|||
33418733|NCT04583969|62796715|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
33418734|NCT04583969|62796716|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
33418735|NCT04583969|62796715|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
33418736|NCT04583969|62796716|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
33605038|NCT02341625|63004722|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
33605039|NCT02341625|63004723|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
33605040|NCT02341625|63004724|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33605041|NCT02341625|63004725|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
33605042|NCT02341625|63004716|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33322881|NCT01168596|62698995|FG000|Overall Study|Withdrawal by Subject|3|||
33322882|NCT01168596|62698996|FG001|Overall Study|Withdrawal by Subject|1|||
33418737|NCT04583969|62796715|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
33418738|NCT04583969|62796716|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
33418739|NCT04583969|62796715|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
33418740|NCT04583969|62796716|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
33418741|NCT04583969|62796715|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
33418742|NCT04583969|62796716|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
33418743|NCT04561115|62796722|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
33418744|NCT04561115|62796723|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
33418745|NCT04561115|62796722|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
33418746|NCT04561115|62796723|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
33418747|NCT04561115|62796722|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
33418748|NCT04561115|62796723|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
33418749|NCT04546425|62796731|FG000|Overall Study|Protocol Violation|2|||
33418750|NCT04546425|62796732|FG001|Overall Study|Protocol Violation|1|||
33418751|NCT04546425|62796731|FG000|Overall Study|Adverse Event|3|||
33418752|NCT04546425|62796732|FG001|Overall Study|Adverse Event|0|||
33418753|NCT04546425|62796731|FG000|Overall Study|No Longer met eligibility criteria|3|||
33418754|NCT04546425|62796732|FG001|Overall Study|No Longer met eligibility criteria|3|||
33418755|NCT04546425|62796731|FG000|Overall Study|Withdrawal by parent/guardian|7|||
33418756|NCT04546425|62796732|FG001|Overall Study|Withdrawal by parent/guardian|5|||
33418757|NCT04546425|62796731|FG000|Overall Study|Lost to Follow-up|5|||
33418758|NCT04546425|62796732|FG001|Overall Study|Lost to Follow-up|4|||
33418759|NCT04546425|62796731|FG000|Overall Study|Other|0|||
33418760|NCT04546425|62796732|FG001|Overall Study|Other|1|||
33418761|NCT04366258|62796738|FG000|Baseline Assessments|Screen Failure|21|||
33418762|NCT04366258|62796738|FG000|Baseline Assessments|Early Termination|3|||
33418763|NCT04101331|62796786|FG000|Overall Study|Adverse Event|7|||
33418764|NCT04101331|62796786|FG000|Overall Study|Disease progression|79|||
33418765|NCT04101331|62796786|FG000|Overall Study|Withdrawal by Subject|1|||
33418766|NCT04101331|62796786|FG000|Overall Study|Investigator decision|6|||
33418767|NCT04101331|62796786|FG000|Overall Study|Death|6|||
33418768|NCT04101331|62796786|FG000|Overall Study|Allogenic transplant|1|||
33418769|NCT04082884|62796790|FG000|Overall Study|Withdrawal by Subject|1|||
33418770|NCT03891667|62796796|FG000|Overall Study|Physician Decision|1|||
33418771|NCT03891667|62796797|FG001|Overall Study|Physician Decision|0|||
33418772|NCT03891667|62796796|FG000|Overall Study|COVID related pause|1|||
33418773|NCT03891667|62796797|FG001|Overall Study|COVID related pause|1|||
33418774|NCT03891667|62796796|FG000|Overall Study|Withdrawal by Subject|0|||
33418775|NCT03891667|62796797|FG001|Overall Study|Withdrawal by Subject|1|||
33418776|NCT03891667|62796796|FG000|Overall Study|Adverse Event|0|||
33418777|NCT03891667|62796797|FG001|Overall Study|Adverse Event|1|||
33418778|NCT03715153|62796821|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
33418779|NCT03715153|62796822|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
33418780|NCT03715153|62796821|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
33418781|NCT03715153|62796822|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
33418782|NCT03715153|62796821|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
33418783|NCT03715153|62796822|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
33418784|NCT03715153|62796821|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
33418785|NCT03715153|62796822|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
33418786|NCT03715153|62796821|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
33418787|NCT03715153|62796822|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
33418788|NCT03715153|62796821|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
33418789|NCT03715153|62796822|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
33418790|NCT03569293|62796851|FG000|Overall Study|Adverse Event|4|||
33418791|NCT03569293|62796852|FG001|Overall Study|Adverse Event|1|||
33418792|NCT03569293|62796853|FG002|Overall Study|Adverse Event|5|||
33418793|NCT03569293|62796854|FG003|Overall Study|Adverse Event|1|||
33418794|NCT03569293|62796855|FG004|Overall Study|Adverse Event|0|||
33418795|NCT03569293|62796856|FG005|Overall Study|Adverse Event|0|||
33418796|NCT03569293|62796851|FG000|Overall Study|Withdrawal by Subject|16|||
33418797|NCT03569293|62796852|FG001|Overall Study|Withdrawal by Subject|2|||
33418798|NCT03569293|62796853|FG002|Overall Study|Withdrawal by Subject|4|||
33418799|NCT03569293|62796854|FG003|Overall Study|Withdrawal by Subject|1|||
33418800|NCT03569293|62796855|FG004|Overall Study|Withdrawal by Subject|0|||
33418801|NCT03569293|62796856|FG005|Overall Study|Withdrawal by Subject|0|||
33418802|NCT03569293|62796851|FG000|Overall Study|Lost to Follow-up|1|||
33418803|NCT03569293|62796852|FG001|Overall Study|Lost to Follow-up|3|||
33418804|NCT03569293|62796853|FG002|Overall Study|Lost to Follow-up|1|||
33418805|NCT03569293|62796854|FG003|Overall Study|Lost to Follow-up|1|||
33418806|NCT03569293|62796855|FG004|Overall Study|Lost to Follow-up|0|||
33418807|NCT03569293|62796856|FG005|Overall Study|Lost to Follow-up|0|||
33418808|NCT03569293|62796851|FG000|Overall Study|Other|8|||
33418809|NCT03569293|62796852|FG001|Overall Study|Other|2|||
33418810|NCT03569293|62796853|FG002|Overall Study|Other|1|||
33418811|NCT03569293|62796854|FG003|Overall Study|Other|1|||
33418812|NCT03569293|62796855|FG004|Overall Study|Other|0|||
33418813|NCT03569293|62796856|FG005|Overall Study|Other|0|||
33418814|NCT03569293|62796851|FG000|Overall Study|Ongoing at Time of Analysis|8|||
33418815|NCT03569293|62796852|FG001|Overall Study|Ongoing at Time of Analysis|1|||
33418816|NCT03569293|62796853|FG002|Overall Study|Ongoing at Time of Analysis|3|||
33418817|NCT03569293|62796854|FG003|Overall Study|Ongoing at Time of Analysis|0|||
33418818|NCT03569293|62796855|FG004|Overall Study|Ongoing at Time of Analysis|0|||
33418819|NCT03569293|62796856|FG005|Overall Study|Ongoing at Time of Analysis|0|||
33418820|NCT03464136|62796872|FG000|Overall Study|Lost to Follow-up|5|||
33418821|NCT03464136|62796873|FG001|Overall Study|Lost to Follow-up|8|||
33418822|NCT03464136|62796872|FG000|Overall Study|Withdrawal by Subject|16|||
33418823|NCT03464136|62796873|FG001|Overall Study|Withdrawal by Subject|13|||
33418824|NCT03464136|62796872|FG000|Overall Study|Death|1|||
33418825|NCT03464136|62796873|FG001|Overall Study|Death|0|||
33418826|NCT03464136|62796872|FG000|Overall Study|Other|8|||
33418827|NCT03464136|62796873|FG001|Overall Study|Other|4|||
33418828|NCT03020823|62796897|FG000|Overall Study|Physician Decision|4|||
33418829|NCT03020823|62796897|FG000|Overall Study|Lack of Efficacy|4|||
33418830|NCT03020823|62796897|FG000|Overall Study|Adverse Event|2|||
33418831|NCT02969369|62796905|FG000|Study|Adverse Event|1|||
33418832|NCT02969369|62796906|FG001|Study|Adverse Event|6|||
33418833|NCT02969369|62796905|FG000|Study|Lack of Efficacy|0|||
33418834|NCT02969369|62796906|FG001|Study|Lack of Efficacy|1|||
33418835|NCT02969369|62796905|FG000|Study|Lost to Follow-up|0|||
33418836|NCT02969369|62796906|FG001|Study|Lost to Follow-up|1|||
33418837|NCT02969369|62796905|FG000|Study|Withdrawal by Subject|3|||
33418838|NCT02969369|62796906|FG001|Study|Withdrawal by Subject|5|||
33418839|NCT02969369|62796905|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
33418840|NCT02969369|62796906|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
33418841|NCT02969369|62796905|FG000|Double-blind Period|Adverse Event|1|||
33418842|NCT02969369|62796906|FG001|Double-blind Period|Adverse Event|5|||
33418843|NCT02969369|62796905|FG000|Double-blind Period|Lost to Follow-up|0|||
33418844|NCT02969369|62796906|FG001|Double-blind Period|Lost to Follow-up|1|||
33418845|NCT02969369|62796905|FG000|Double-blind Period|Withdrawal by Subject|2|||
33418846|NCT02969369|62796906|FG001|Double-blind Period|Withdrawal by Subject|3|||
33418847|NCT02969369|62796905|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
33418848|NCT02969369|62796906|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
33418849|NCT02969369|62796905|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
33418850|NCT02969369|62796906|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
33418851|NCT02969369|62796905|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
33418852|NCT02969369|62796906|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
33418853|NCT02969369|62796905|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
33418854|NCT02969369|62796906|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
33418855|NCT02583269|62796935|FG000|Overall Study|Patient hospitalized prior to start|1|||
33418856|NCT02583269|62796936|FG001|Overall Study|Patient hospitalized prior to start|0|||
33418857|NCT02583269|62796937|FG002|Overall Study|Patient hospitalized prior to start|0|||
33418858|NCT02583269|62796938|FG003|Overall Study|Patient hospitalized prior to start|0|||
33418859|NCT02583269|62796939|FG004|Overall Study|Patient hospitalized prior to start|0|||
33418860|NCT02546921|62796959|FG000|Overall Study|Adverse Event|0|||
33418861|NCT02546921|62796960|FG001|Overall Study|Adverse Event|5|||
33418862|NCT02546921|62796961|FG002|Overall Study|Adverse Event|2|||
33418863|NCT02546921|62796962|FG003|Overall Study|Adverse Event|0|||
33418864|NCT02546921|62796963|FG004|Overall Study|Adverse Event|0|||
33418865|NCT02546921|62796964|FG005|Overall Study|Adverse Event|0|||
33418866|NCT02546921|62796965|FG006|Overall Study|Adverse Event|0|||
33418867|NCT02546921|62796959|FG000|Overall Study|Evidence of Disease Progression|1|||
33418868|NCT02546921|62796960|FG001|Overall Study|Evidence of Disease Progression|0|||
33418869|NCT02546921|62796961|FG002|Overall Study|Evidence of Disease Progression|0|||
33418870|NCT02546921|62796962|FG003|Overall Study|Evidence of Disease Progression|0|||
33418871|NCT02546921|62796963|FG004|Overall Study|Evidence of Disease Progression|1|||
33418872|NCT02546921|62796964|FG005|Overall Study|Evidence of Disease Progression|0|||
33418873|NCT02546921|62796965|FG006|Overall Study|Evidence of Disease Progression|0|||
33418874|NCT02546921|62796959|FG000|Overall Study|Patient Choice|0|||
33418875|NCT02546921|62796960|FG001|Overall Study|Patient Choice|1|||
33418876|NCT02546921|62796961|FG002|Overall Study|Patient Choice|0|||
33418877|NCT02546921|62796962|FG003|Overall Study|Patient Choice|0|||
33418878|NCT02546921|62796963|FG004|Overall Study|Patient Choice|0|||
33418879|NCT02546921|62796964|FG005|Overall Study|Patient Choice|1|||
33418880|NCT02546921|62796965|FG006|Overall Study|Patient Choice|0|||
33418881|NCT02513329|62796999|FG000|Overall Study|Lost to Follow-up|5|||
33418882|NCT02513329|62797000|FG001|Overall Study|Lost to Follow-up|2|||
33418883|NCT02425826|62797010|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
33418884|NCT02425826|62797011|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
33418885|NCT02425826|62797012|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
33418886|NCT02425826|62797010|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
33418887|NCT02425826|62797011|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
33322883|NCT01177553|62699004|FG000|Overall Study|babies not yet 6 months of age|1|||
33322884|NCT01177553|62699005|FG001|Overall Study|babies not yet 6 months of age|0|||
33322885|NCT00928408|62699011|FG000|Overall Study|Other|2|||
33418888|NCT02425826|62797012|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
33418889|NCT02425826|62797010|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
33418890|NCT02425826|62797011|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
33418891|NCT02425826|62797012|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
33418892|NCT02425826|62797010|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
33418893|NCT02425826|62797011|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
33605043|NCT02341625|63004717|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33605044|NCT02341625|63004718|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33322886|NCT00928408|62699011|FG000|Overall Study|Withdrawal by Subject|4|||
33322887|NCT00928408|62699011|FG000|Overall Study|Death|5|||
33418894|NCT02425826|62797012|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
33418895|NCT02425826|62797010|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
33418896|NCT02425826|62797011|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
33418897|NCT02425826|62797012|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
33418898|NCT02425826|62797010|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
33418899|NCT02425826|62797011|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
33418900|NCT02425826|62797012|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
33418901|NCT02425826|62797010|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
33418902|NCT02425826|62797011|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
33418903|NCT02425826|62797012|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
33418904|NCT02425826|62797010|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
33418905|NCT02425826|62797011|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
33418906|NCT02425826|62797012|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
33418907|NCT02425826|62797010|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
33418908|NCT02425826|62797011|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
33418909|NCT02425826|62797012|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
33418910|NCT02425826|62797010|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
33418911|NCT02425826|62797011|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
33418912|NCT02425826|62797012|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
33418913|NCT02406027|62797025|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
33418914|NCT02406027|62797026|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
33418915|NCT02406027|62797027|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
33418916|NCT02406027|62797028|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
33418917|NCT02406027|62797029|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
33418918|NCT02406027|62797030|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
33418919|NCT02406027|62797031|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
33418920|NCT02406027|62797025|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
33418921|NCT02406027|62797026|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
33418922|NCT02406027|62797027|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
33418923|NCT02406027|62797028|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
33418924|NCT02406027|62797029|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
33418925|NCT02406027|62797030|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
33322888|NCT00928408|62699011|FG000|Overall Study|Lost to Follow-up|12|||
33418926|NCT02406027|62797031|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
33418927|NCT02406027|62797025|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
33418928|NCT02406027|62797026|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
33418929|NCT02406027|62797027|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
33322889|NCT00928252|62699015|FG000|Overall Study|Physician Decision|3|||
33418930|NCT02406027|62797028|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
33418931|NCT02406027|62797029|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
33418932|NCT02406027|62797030|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
33418933|NCT02406027|62797031|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
33418934|NCT02406027|62797025|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
33418935|NCT02406027|62797026|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
33418936|NCT02406027|62797027|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
33418937|NCT02406027|62797028|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
33418938|NCT02406027|62797029|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
33418939|NCT02406027|62797030|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
33418940|NCT02406027|62797031|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
33322890|NCT01177007|62699021|FG000|Overall Study|Lost to Follow-up|2|||
33418941|NCT02406027|62797025|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
33418942|NCT02406027|62797026|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
33418943|NCT02406027|62797027|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
33418944|NCT02406027|62797028|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
33418945|NCT02406027|62797029|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
33418946|NCT02406027|62797030|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
33418947|NCT02406027|62797031|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
33322891|NCT01177007|62699021|FG000|Overall Study|Death|4|||
33322892|NCT01177007|62699021|FG000|Overall Study|Entered hospice care|5|||
33418948|NCT02406027|62797025|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
33418949|NCT02406027|62797026|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
33418950|NCT02406027|62797027|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
33418951|NCT02406027|62797028|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
33418952|NCT02406027|62797029|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
33418953|NCT02406027|62797030|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
33418954|NCT02406027|62797031|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
33418955|NCT02406027|62797025|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
33418956|NCT02406027|62797026|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
33418957|NCT02406027|62797027|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
33418958|NCT02406027|62797028|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
33418959|NCT02406027|62797029|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
33418960|NCT02406027|62797030|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
33418961|NCT02406027|62797031|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
33418962|NCT02406027|62797025|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
33418963|NCT02406027|62797026|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
33418964|NCT02406027|62797027|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
33418965|NCT02406027|62797028|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
33418966|NCT02406027|62797029|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
33418967|NCT02406027|62797030|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
33418968|NCT02406027|62797031|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
33418969|NCT02406027|62797025|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
33418970|NCT02406027|62797026|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
33418971|NCT02406027|62797027|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
33418972|NCT02406027|62797028|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
33418973|NCT02406027|62797029|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
33418974|NCT02406027|62797030|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
33418975|NCT02406027|62797031|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
33418976|NCT02406027|62797025|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
33418977|NCT02406027|62797026|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
33418978|NCT02406027|62797027|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
33418979|NCT02406027|62797028|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
33418980|NCT02406027|62797029|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
33418981|NCT02406027|62797030|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
33418982|NCT02406027|62797031|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
33418983|NCT02278120|62797049|FG000|Overall Study|Progressive disease|122|||
33418984|NCT02278120|62797050|FG001|Overall Study|Progressive disease|174|||
33605045|NCT02341625|63004719|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33605046|NCT02341625|63004720|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33322893|NCT01177007|62699021|FG000|Overall Study|Required additional Y90 treatment|6|||
33605047|NCT02341625|63004721|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33322894|NCT01177007|62699021|FG000|Overall Study|Change in treatment modality|21|||
33605048|NCT02341625|63004722|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
33605049|NCT02341625|63004723|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
33605050|NCT02341625|63004724|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33605051|NCT02341625|63004725|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33605052|NCT02341625|63004716|FG000|Overall Study|Participant Withdrew Consent|0|||
33605053|NCT02341625|63004717|FG001|Overall Study|Participant Withdrew Consent|0|||
33605054|NCT02341625|63004718|FG002|Overall Study|Participant Withdrew Consent|0|||
33605055|NCT02341625|63004719|FG003|Overall Study|Participant Withdrew Consent|1|||
33605056|NCT02341625|63004720|FG004|Overall Study|Participant Withdrew Consent|0|||
33605057|NCT02341625|63004721|FG005|Overall Study|Participant Withdrew Consent|0|||
33605058|NCT02341625|63004722|FG006|Overall Study|Participant Withdrew Consent|0|||
33605059|NCT02341625|63004723|FG007|Overall Study|Participant Withdrew Consent|0|||
33605060|NCT02341625|63004724|FG008|Overall Study|Participant Withdrew Consent|0|||
33605061|NCT02341625|63004725|FG009|Overall Study|Participant Withdrew Consent|0|||
33605062|NCT02341625|63004716|FG000|Overall Study|Completed Treatment as per Protocol|0|||
33605063|NCT02341625|63004717|FG001|Overall Study|Completed Treatment as per Protocol|0|||
33605064|NCT02341625|63004718|FG002|Overall Study|Completed Treatment as per Protocol|0|||
33605065|NCT02341625|63004719|FG003|Overall Study|Completed Treatment as per Protocol|0|||
33605066|NCT02341625|63004720|FG004|Overall Study|Completed Treatment as per Protocol|0|||
33605067|NCT02341625|63004721|FG005|Overall Study|Completed Treatment as per Protocol|0|||
33605068|NCT02341625|63004722|FG006|Overall Study|Completed Treatment as per Protocol|0|||
33605069|NCT02341625|63004723|FG007|Overall Study|Completed Treatment as per Protocol|0|||
33605070|NCT02341625|63004724|FG008|Overall Study|Completed Treatment as per Protocol|0|||
33605071|NCT02341625|63004725|FG009|Overall Study|Completed Treatment as per Protocol|1|||
33418985|NCT02278120|62797049|FG000|Overall Study|Patient/guardian decision|14|||
33418986|NCT02278120|62797050|FG001|Overall Study|Patient/guardian decision|8|||
33418987|NCT02278120|62797049|FG000|Overall Study|Adverse Event|12|||
33322895|NCT00930982|62699029|FG000|Overall Study|Adverse Event|19|||
33322896|NCT00930982|62699030|FG001|Overall Study|Adverse Event|23|||
33418988|NCT02278120|62797050|FG001|Overall Study|Adverse Event|10|||
33605072|NCT02341625|63004716|FG000|Overall Study|Other Reasons|0|||
33605073|NCT02341625|63004717|FG001|Overall Study|Other Reasons|0|||
33605074|NCT02341625|63004718|FG002|Overall Study|Other Reasons|0|||
33605075|NCT02341625|63004719|FG003|Overall Study|Other Reasons|0|||
33605076|NCT02341625|63004720|FG004|Overall Study|Other Reasons|1|||
33322897|NCT00930982|62699029|FG000|Overall Study|Protocol Violation|1|||
33605077|NCT02341625|63004721|FG005|Overall Study|Other Reasons|0|||
33418989|NCT02278120|62797049|FG000|Overall Study|Physician Decision|8|||
33418990|NCT02278120|62797050|FG001|Overall Study|Physician Decision|19|||
33418991|NCT02278120|62797049|FG000|Overall Study|Death|3|||
33322898|NCT00930982|62699030|FG001|Overall Study|Protocol Violation|5|||
33494122|NCT03487848|62872872|FG000|Overall Study|Lost to Follow-up|1|||
33418992|NCT02278120|62797050|FG001|Overall Study|Death|3|||
33418993|NCT02278120|62797049|FG000|Overall Study|Lost to Follow-up|2|||
33418994|NCT02278120|62797050|FG001|Overall Study|Lost to Follow-up|0|||
33418995|NCT02278120|62797049|FG000|Overall Study|Protocol Violation|0|||
33418996|NCT02278120|62797050|FG001|Overall Study|Protocol Violation|2|||
33418997|NCT02255357|62797058|FG000|Overall Study|Physician Decision|10|||
33322899|NCT00930982|62699029|FG000|Overall Study|Withdrawal by Subject|1|||
33322900|NCT00930982|62699030|FG001|Overall Study|Withdrawal by Subject|1|||
33322901|NCT01176773|62699036|FG000|Overall Study|Screen Failure|2|||
33322902|NCT01176773|62699036|FG000|Overall Study|Withdrew consent|1|||
33418998|NCT02255357|62797059|FG001|Overall Study|Physician Decision|24|||
33605078|NCT02341625|63004722|FG006|Overall Study|Other Reasons|5|||
33418999|NCT02211131|62797067|FG000|Overall Study|Death|26|||
33419000|NCT02211131|62797068|FG001|Overall Study|Death|16|||
33419001|NCT02211131|62797067|FG000|Overall Study|Lost to Follow-up|4|||
33419002|NCT02211131|62797068|FG001|Overall Study|Lost to Follow-up|3|||
33419003|NCT02211131|62797067|FG000|Overall Study|Decision by Sponsor|1|||
33419004|NCT02211131|62797068|FG001|Overall Study|Decision by Sponsor|1|||
33419005|NCT02211131|62797067|FG000|Overall Study|Withdrawal by Subject|3|||
33419006|NCT02211131|62797068|FG001|Overall Study|Withdrawal by Subject|8|||
33419007|NCT02155647|62797083|FG000|Overall Study|Still on Treatment|26|||
33419008|NCT02155647|62797084|FG001|Overall Study|Still on Treatment|26|||
33419009|NCT02155647|62797083|FG000|Overall Study|Off-Treatment, but follow up ongoing|15|||
33419010|NCT02155647|62797084|FG001|Overall Study|Off-Treatment, but follow up ongoing|26|||
33419011|NCT02134587|62797094|FG000|Overall Study|Did not completed all meetings|30|||
33419012|NCT01752920|62797111|FG000|Overall Study|Adverse Event|1|||
33419013|NCT01752920|62797112|FG001|Overall Study|Adverse Event|0|||
33419014|NCT01752920|62797113|FG002|Overall Study|Adverse Event|5|||
33419015|NCT01752920|62797114|FG003|Overall Study|Adverse Event|10|||
33419016|NCT01752920|62797111|FG000|Overall Study|Clinical Disease Progression|6|||
33419017|NCT01752920|62797112|FG001|Overall Study|Clinical Disease Progression|4|||
33419018|NCT01752920|62797113|FG002|Overall Study|Clinical Disease Progression|1|||
33419019|NCT01752920|62797114|FG003|Overall Study|Clinical Disease Progression|13|||
33419020|NCT01752920|62797111|FG000|Overall Study|Physician Decision|1|||
33419021|NCT01752920|62797112|FG001|Overall Study|Physician Decision|0|||
33419022|NCT01752920|62797113|FG002|Overall Study|Physician Decision|0|||
33419023|NCT01752920|62797114|FG003|Overall Study|Physician Decision|3|||
33419024|NCT01752920|62797111|FG000|Overall Study|Radiographic Disease Progression|20|||
33419025|NCT01752920|62797112|FG001|Overall Study|Radiographic Disease Progression|7|||
33419026|NCT01752920|62797113|FG002|Overall Study|Radiographic Disease Progression|12|||
33419027|NCT01752920|62797114|FG003|Overall Study|Radiographic Disease Progression|29|||
33419028|NCT01752920|62797111|FG000|Overall Study|Study Terminated by Sponsor|0|||
33419029|NCT01752920|62797112|FG001|Overall Study|Study Terminated by Sponsor|0|||
33419030|NCT01752920|62797113|FG002|Overall Study|Study Terminated by Sponsor|0|||
33419031|NCT01752920|62797114|FG003|Overall Study|Study Terminated by Sponsor|1|||
33419032|NCT01752920|62797111|FG000|Overall Study|Withdrawal by Subject|0|||
33419033|NCT01752920|62797112|FG001|Overall Study|Withdrawal by Subject|1|||
33419034|NCT01752920|62797113|FG002|Overall Study|Withdrawal by Subject|0|||
33419035|NCT01752920|62797114|FG003|Overall Study|Withdrawal by Subject|1|||
33419036|NCT01752920|62797111|FG000|Overall Study|Lack of clinical benefit|1|||
33419037|NCT01752920|62797112|FG001|Overall Study|Lack of clinical benefit|1|||
33419038|NCT01752920|62797113|FG002|Overall Study|Lack of clinical benefit|1|||
33419039|NCT01752920|62797114|FG003|Overall Study|Lack of clinical benefit|1|||
33419040|NCT00976963|62797128|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
33419041|NCT00976963|62797129|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
33419042|NCT00976963|62797128|FG000|Overall Study|administrative error|1|||
33419043|NCT00976963|62797129|FG001|Overall Study|administrative error|0|||
33419044|NCT00976963|62797128|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
33419045|NCT00976963|62797129|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
33419046|NCT00423735|62797146|FG000|Overall Study|Ineligible / No protocol treatment|8|||
33419047|NCT00423735|62797147|FG001|Overall Study|Ineligible / No protocol treatment|6|||
33419048|NCT00423735|62797148|FG002|Overall Study|Ineligible / No protocol treatment|0|||
33419049|NCT00626327|62797161|FG000|Overall Study|Withdrawal by Subject|21|||
33419050|NCT00626327|62797162|FG001|Overall Study|Withdrawal by Subject|29|||
33419051|NCT00626327|62797163|FG002|Overall Study|Withdrawal by Subject|30|||
33419052|NCT00626327|62797161|FG000|Overall Study|Adverse Event|1|||
33419053|NCT00626327|62797162|FG001|Overall Study|Adverse Event|0|||
33419054|NCT00626327|62797163|FG002|Overall Study|Adverse Event|0|||
33419055|NCT00626327|62797161|FG000|Overall Study|Lost to Follow-up|24|||
33419056|NCT00626327|62797162|FG001|Overall Study|Lost to Follow-up|21|||
33419057|NCT00626327|62797163|FG002|Overall Study|Lost to Follow-up|23|||
33605079|NCT02341625|63004723|FG007|Overall Study|Other Reasons|0|||
33605080|NCT02341625|63004724|FG008|Overall Study|Other Reasons|0|||
33605081|NCT02341625|63004725|FG009|Overall Study|Other Reasons|2|||
33605082|NCT02341625|63004716|FG000|Overall Study|Not Reported|0|||
33605083|NCT02341625|63004717|FG001|Overall Study|Not Reported|0|||
33605084|NCT02341625|63004718|FG002|Overall Study|Not Reported|0|||
33605085|NCT02341625|63004719|FG003|Overall Study|Not Reported|0|||
33605086|NCT02341625|63004720|FG004|Overall Study|Not Reported|0|||
33605087|NCT02341625|63004721|FG005|Overall Study|Not Reported|0|||
33605088|NCT02341625|63004722|FG006|Overall Study|Not Reported|0|||
33605089|NCT02341625|63004723|FG007|Overall Study|Not Reported|0|||
33605090|NCT02341625|63004724|FG008|Overall Study|Not Reported|0|||
33605091|NCT02341625|63004725|FG009|Overall Study|Not Reported|3|||
33605092|NCT02370095|63004772|FG000|Overall Study|Withdrawal by Subject|0|||
33605093|NCT02370095|63004773|FG001|Overall Study|Withdrawal by Subject|1|||
33605094|NCT01783678|63004785|FG000|Overall Study|Randomized but Not Treated|0|||
33605095|NCT01783678|63004786|FG001|Overall Study|Randomized but Not Treated|0|||
33605096|NCT01783678|63004787|FG002|Overall Study|Randomized but Not Treated|0|||
33605097|NCT01783678|63004788|FG003|Overall Study|Randomized but Not Treated|1|||
33605098|NCT01783678|63004789|FG004|Overall Study|Randomized but Not Treated|0|||
33605099|NCT01783678|63004790|FG005|Overall Study|Randomized but Not Treated|0|||
33605100|NCT01783678|63004785|FG000|Overall Study|Lack of Efficacy|1|||
33605101|NCT01783678|63004786|FG001|Overall Study|Lack of Efficacy|13|||
33605102|NCT01783678|63004787|FG002|Overall Study|Lack of Efficacy|1|||
33605103|NCT01783678|63004788|FG003|Overall Study|Lack of Efficacy|3|||
33605104|NCT01783678|63004789|FG004|Overall Study|Lack of Efficacy|6|||
33605105|NCT01783678|63004790|FG005|Overall Study|Lack of Efficacy|5|||
33605106|NCT01783678|63004785|FG000|Overall Study|Lost to Follow-up|0|||
33419058|NCT00626327|62797161|FG000|Overall Study|Inappropriate enrollment|4|||
33605107|NCT01783678|63004786|FG001|Overall Study|Lost to Follow-up|4|||
33322903|NCT00928018|62699043|FG000|Overall Study|Withdrawal by Subject|1|||
33322904|NCT00928018|62699044|FG001|Overall Study|Withdrawal by Subject|0|||
33322905|NCT00927940|62699054|FG000|Overall Study|Death|1|||
33322906|NCT00927862|62699061|FG000|Overall Study|Missing data needed for endpt analyses|27|||
33419059|NCT00626327|62797162|FG001|Overall Study|Inappropriate enrollment|5|||
33605108|NCT01783678|63004787|FG002|Overall Study|Lost to Follow-up|0|||
33605109|NCT01783678|63004788|FG003|Overall Study|Lost to Follow-up|2|||
33605110|NCT01783678|63004789|FG004|Overall Study|Lost to Follow-up|1|||
33605111|NCT01783678|63004790|FG005|Overall Study|Lost to Follow-up|0|||
33605112|NCT01783678|63004785|FG000|Overall Study|Withdrew Consent|1|||
33605113|NCT01783678|63004786|FG001|Overall Study|Withdrew Consent|1|||
33605114|NCT01783678|63004787|FG002|Overall Study|Withdrew Consent|0|||
33605115|NCT01783678|63004788|FG003|Overall Study|Withdrew Consent|2|||
33605116|NCT01783678|63004789|FG004|Overall Study|Withdrew Consent|0|||
33605117|NCT01783678|63004790|FG005|Overall Study|Withdrew Consent|0|||
33605118|NCT01734772|63004807|FG000|Overall Study|Adverse Event|1|||
33605119|NCT01734772|63004808|FG001|Overall Study|Adverse Event|2|||
33605120|NCT01734772|63004807|FG000|Overall Study|Withdrawal by Subject|0|||
33605121|NCT01734772|63004808|FG001|Overall Study|Withdrawal by Subject|1|||
33605122|NCT02340221|63004822|FG000|Overall Study|Death|100|||
33605123|NCT02340221|63004823|FG001|Overall Study|Death|197|||
33605124|NCT02340221|63004822|FG000|Overall Study|Withdrawal by Participant|24|||
33605125|NCT02340221|63004823|FG001|Overall Study|Withdrawal by Participant|37|||
33605126|NCT02340221|63004822|FG000|Overall Study|Lost to Follow-up|4|||
33605127|NCT02340221|63004823|FG001|Overall Study|Lost to Follow-up|15|||
33605128|NCT02340221|63004822|FG000|Overall Study|Reason Not Specified|85|||
33605129|NCT02340221|63004823|FG001|Overall Study|Reason Not Specified|165|||
33605130|NCT02340221|63004822|FG000|Overall Study|Study Terminated by Sponsor|1|||
33605131|NCT02340221|63004823|FG001|Overall Study|Study Terminated by Sponsor|3|||
33605132|NCT02339909|63004833|FG000|Overall Study|Became ineligible after randomisation|89|||
33605133|NCT02339909|63004834|FG001|Overall Study|Became ineligible after randomisation|63|||
33605134|NCT02339909|63004835|FG002|Overall Study|Became ineligible after randomisation|71|||
33605135|NCT02395133|63004847|FG000|Overall Study|Adverse Event|4|||
33605136|NCT02395133|63004848|FG001|Overall Study|Adverse Event|1|||
33419060|NCT00626327|62797163|FG002|Overall Study|Inappropriate enrollment|3|||
33419061|NCT00626327|62797161|FG000|Overall Study|Administrative Reason|2|||
33419062|NCT00626327|62797162|FG001|Overall Study|Administrative Reason|0|||
33494123|NCT03524664|62872878|FG000|Overall Study|Withdrawal by Subject|1|||
33419063|NCT00626327|62797163|FG002|Overall Study|Administrative Reason|6|||
33419064|NCT00626327|62797161|FG000|Overall Study|Protocol Violation|26|||
33419065|NCT00626327|62797162|FG001|Overall Study|Protocol Violation|4|||
33605137|NCT02395133|63004849|FG002|Overall Study|Adverse Event|3|||
33419066|NCT00626327|62797163|FG002|Overall Study|Protocol Violation|26|||
33419067|NCT00357994|62797181|FG000|Overall Study|Adverse Event|1|||
33419068|NCT00357994|62797182|FG001|Overall Study|Adverse Event|2|||
33605138|NCT02395133|63004850|FG003|Overall Study|Adverse Event|0|||
33419069|NCT00357994|62797181|FG000|Overall Study|Lack of Efficacy|0|||
33419070|NCT00357994|62797182|FG001|Overall Study|Lack of Efficacy|1|||
33419071|NCT00357994|62797181|FG000|Overall Study|Protocol Violation|1|||
33322907|NCT00927862|62699062|FG001|Overall Study|Missing data needed for endpt analyses|45|||
33419072|NCT00357994|62797182|FG001|Overall Study|Protocol Violation|0|||
33419073|NCT00423657|62797190|FG000|Overall Study|Withdrew consent|10|||
33419074|NCT00423657|62797191|FG001|Overall Study|Withdrew consent|8|||
33419075|NCT00423657|62797190|FG000|Overall Study|Non-compliance|0|||
33419076|NCT00423657|62797191|FG001|Overall Study|Non-compliance|1|||
33419077|NCT00423657|62797190|FG000|Overall Study|Other|15|||
33419078|NCT00423657|62797191|FG001|Overall Study|Other|16|||
33419079|NCT00423657|62797190|FG000|Overall Study|Request of sponsor/investigator|1|||
33419080|NCT00423657|62797191|FG001|Overall Study|Request of sponsor/investigator|0|||
33419081|NCT00367432|62797197|FG000|First Period (16 Weeks)|Adverse Event|6|||
33419082|NCT00367432|62797198|FG001|First Period (16 Weeks)|Adverse Event|0|||
33419083|NCT00367432|62797197|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
33419084|NCT00367432|62797198|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
33419085|NCT00367432|62797197|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
33419086|NCT00367432|62797198|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
33419087|NCT00367432|62797197|FG000|First Period (16 Weeks)|Other Reason|2|||
33419088|NCT00367432|62797198|FG001|First Period (16 Weeks)|Other Reason|0|||
33419089|NCT00367432|62797197|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
33419090|NCT00367432|62797198|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
33419091|NCT00367432|62797197|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
33419092|NCT00367432|62797198|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
33419093|NCT00367432|62797197|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
33419094|NCT00367432|62797198|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
33419095|NCT00367432|62797197|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
33419096|NCT00367432|62797198|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
33419097|NCT00367432|62797197|FG000|Second Period (up to 54 Months)|Other Reason|6|||
33419098|NCT00367432|62797198|FG001|Second Period (up to 54 Months)|Other Reason|2|||
33419099|NCT00623363|62797204|FG000|Overall Study|Adverse Event|2|||
33419100|NCT00623363|62797205|FG001|Overall Study|Adverse Event|2|||
33419101|NCT00423267|62797214|FG000|Period A|Withdrawal by Subject|0|||
33419102|NCT00423267|62797215|FG001|Period A|Withdrawal by Subject|1|||
33419103|NCT00423267|62797214|FG000|Period A|Non-compliance with protocol|1|||
33419104|NCT00423267|62797215|FG001|Period A|Non-compliance with protocol|0|||
33419105|NCT00423267|62797214|FG000|Period A|Administrative|1|||
33419106|NCT00423267|62797215|FG001|Period A|Administrative|0|||
33419107|NCT00626093|62797223|FG000|Overall Study|Lost to Follow-up|5|||
33419108|NCT00626093|62797223|FG000|Overall Study|Death|1|||
33419109|NCT00626093|62797223|FG000|Overall Study|Physician Decision|4|||
33419110|NCT00626093|62797223|FG000|Overall Study|Withdrawal by Subject|6|||
33419111|NCT00626093|62797223|FG000|Overall Study|Protocol Violation|1|||
33419112|NCT00626093|62797223|FG000|Overall Study|One of the required devices not implante|6|||
33419113|NCT00357760|62797229|FG000|Overall Study|Disease progression|44|||
33419114|NCT00357760|62797230|FG001|Overall Study|Disease progression|17|||
33419115|NCT00357760|62797229|FG000|Overall Study|Adverse Event|10|||
33419116|NCT00357760|62797230|FG001|Overall Study|Adverse Event|7|||
33419117|NCT00357760|62797229|FG000|Overall Study|Death|0|||
33419118|NCT00357760|62797230|FG001|Overall Study|Death|3|||
33419119|NCT00357760|62797229|FG000|Overall Study|Alternative therapy|1|||
33419120|NCT00357760|62797230|FG001|Overall Study|Alternative therapy|0|||
33419121|NCT00357760|62797229|FG000|Overall Study|Withdrawal by Subject|0|||
33419122|NCT00357760|62797230|FG001|Overall Study|Withdrawal by Subject|2|||
33419123|NCT00357760|62797229|FG000|Overall Study|Never started treatment|2|||
33419124|NCT00357760|62797230|FG001|Overall Study|Never started treatment|1|||
33419125|NCT00357760|62797229|FG000|Overall Study|Ineligible|0|||
33419126|NCT00357760|62797230|FG001|Overall Study|Ineligible|2|||
33419127|NCT00357760|62797229|FG000|Overall Study|Physician Decision|2|||
33419128|NCT00357760|62797230|FG001|Overall Study|Physician Decision|1|||
33419129|NCT00357760|62797229|FG000|Overall Study|Protocol Violation|0|||
33419130|NCT00357760|62797230|FG001|Overall Study|Protocol Violation|1|||
33419131|NCT00357760|62797229|FG000|Overall Study|To receive hospice care|0|||
33419132|NCT00357760|62797230|FG001|Overall Study|To receive hospice care|1|||
33419133|NCT00622739|62797238|FG000|Overall Study|Physician Decision|1|||
33419134|NCT00622739|62797239|FG001|Overall Study|Physician Decision|0|||
33419135|NCT00622739|62797238|FG000|Overall Study|Adverse Event|1|||
33419136|NCT00622739|62797239|FG001|Overall Study|Adverse Event|2|||
33419137|NCT00622739|62797238|FG000|Overall Study|Lack of Efficacy|0|||
33419138|NCT00622739|62797239|FG001|Overall Study|Lack of Efficacy|2|||
33419139|NCT00622739|62797238|FG000|Overall Study|Withdrawal by Subject|0|||
33419140|NCT00622739|62797239|FG001|Overall Study|Withdrawal by Subject|1|||
33419141|NCT00622739|62797238|FG000|Overall Study|Lost to Follow-up|0|||
33419142|NCT00622739|62797239|FG001|Overall Study|Lost to Follow-up|1|||
33419143|NCT00435825|62797251|FG000|Overall Study|Abnormality of Laboratory Test|0|||
33419144|NCT00435825|62797252|FG001|Overall Study|Abnormality of Laboratory Test|1|||
33419145|NCT00435825|62797253|FG002|Overall Study|Abnormality of Laboratory Test|0|||
33419146|NCT00435825|62797254|FG003|Overall Study|Abnormality of Laboratory Test|0|||
33419147|NCT00435825|62797251|FG000|Overall Study|Insufficient Therapeutic Response|3|||
33419148|NCT00435825|62797252|FG001|Overall Study|Insufficient Therapeutic Response|1|||
33419149|NCT00435825|62797253|FG002|Overall Study|Insufficient Therapeutic Response|0|||
33419150|NCT00435825|62797254|FG003|Overall Study|Insufficient Therapeutic Response|3|||
33419151|NCT00435825|62797251|FG000|Overall Study|Other Protocol Violation|1|||
33419152|NCT00435825|62797252|FG001|Overall Study|Other Protocol Violation|0|||
33419153|NCT00435825|62797253|FG002|Overall Study|Other Protocol Violation|0|||
33419154|NCT00435825|62797254|FG003|Overall Study|Other Protocol Violation|0|||
33419155|NCT00435825|62797251|FG000|Overall Study|Refused treatment|2|||
33419156|NCT00435825|62797252|FG001|Overall Study|Refused treatment|0|||
33419157|NCT00435825|62797253|FG002|Overall Study|Refused treatment|0|||
33419158|NCT00435825|62797254|FG003|Overall Study|Refused treatment|5|||
33419159|NCT00435825|62797251|FG000|Overall Study|Failure to return|5|||
33419160|NCT00435825|62797252|FG001|Overall Study|Failure to return|0|||
33419161|NCT00435825|62797253|FG002|Overall Study|Failure to return|4|||
33419162|NCT00435825|62797254|FG003|Overall Study|Failure to return|0|||
33419163|NCT00435825|62797251|FG000|Overall Study|Did not receive study drug|1|||
33419164|NCT00435825|62797252|FG001|Overall Study|Did not receive study drug|0|||
33605139|NCT02395133|63004847|FG000|Overall Study|Lack of Efficacy|1|||
33419165|NCT00435825|62797253|FG002|Overall Study|Did not receive study drug|2|||
33419166|NCT00435825|62797254|FG003|Overall Study|Did not receive study drug|0|||
33419167|NCT00435825|62797251|FG000|Overall Study|Did not enter follow-up|0|||
33419168|NCT00435825|62797252|FG001|Overall Study|Did not enter follow-up|4|||
33605140|NCT02395133|63004848|FG001|Overall Study|Lack of Efficacy|0|||
33419169|NCT00435825|62797253|FG002|Overall Study|Did not enter follow-up|1|||
33419170|NCT00435825|62797254|FG003|Overall Study|Did not enter follow-up|3|||
33419171|NCT00435825|62797251|FG000|Overall Study|Did not complete full follow-up period|6|||
33419172|NCT00435825|62797252|FG001|Overall Study|Did not complete full follow-up period|6|||
33419173|NCT00435825|62797253|FG002|Overall Study|Did not complete full follow-up period|4|||
33419174|NCT00435825|62797254|FG003|Overall Study|Did not complete full follow-up period|5|||
33419175|NCT00574145|62797266|FG000|Overall Study|Withdrawal by Subject|2|||
33419176|NCT00574145|62797267|FG001|Overall Study|Withdrawal by Subject|1|||
33419177|NCT00423189|62797276|FG000|Overall Study|Death|0|||
33419178|NCT00423189|62797277|FG001|Overall Study|Death|1|||
33419179|NCT00423189|62797278|FG002|Overall Study|Death|0|||
33419180|NCT00422799|62797291|FG000|Overall Study|Withdrawal by Subject|6|||
33419181|NCT00422799|62797291|FG000|Overall Study|Adverse Event|7|||
33419182|NCT00435045|62797297|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
33419183|NCT00435045|62797298|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
33419184|NCT00435045|62797297|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
33419185|NCT00435045|62797298|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
33419186|NCT00435045|62797297|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
33419187|NCT00435045|62797298|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
33419188|NCT00435045|62797297|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
33419189|NCT00435045|62797298|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
33419190|NCT00435045|62797297|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
33419191|NCT00435045|62797298|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
33419192|NCT00435045|62797297|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
33419193|NCT00435045|62797298|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
33419194|NCT00435045|62797297|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
33419195|NCT00435045|62797298|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
33419196|NCT00435045|62797297|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
33419197|NCT00435045|62797298|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
33419198|NCT00435045|62797297|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
33419199|NCT00435045|62797298|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
33419200|NCT00435045|62797297|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
33419201|NCT00435045|62797298|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
33419202|NCT00435045|62797297|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
33419203|NCT00435045|62797298|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
33419204|NCT00441129|62797306|FG000|Overall Study|Withdrawal by Subject|6|||
33419205|NCT00441129|62797307|FG001|Overall Study|Withdrawal by Subject|14|||
33419206|NCT00622505|62797315|FG000|Overall Study|Adverse Event|9|||
33419207|NCT00622505|62797316|FG001|Overall Study|Adverse Event|7|||
33419208|NCT00622505|62797315|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
33419209|NCT00622505|62797316|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
33419210|NCT00622505|62797315|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
33419211|NCT00622505|62797316|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
33419212|NCT00622505|62797315|FG000|Overall Study|Withdrawal by Subject|12|||
33419213|NCT00622505|62797316|FG001|Overall Study|Withdrawal by Subject|5|||
33419214|NCT00622505|62797315|FG000|Overall Study|Administrative Problems|2|||
33419215|NCT00622505|62797316|FG001|Overall Study|Administrative Problems|4|||
33419216|NCT00622505|62797315|FG000|Overall Study|Death|2|||
33419217|NCT00622505|62797316|FG001|Overall Study|Death|2|||
33419218|NCT00357370|62797325|FG000|Cohort 2|Lack of Efficacy|0|||
33419219|NCT00357370|62797326|FG001|Cohort 2|Lack of Efficacy|2|||
33419220|NCT00357370|62797327|FG002|Cohort 2|Lack of Efficacy|1|||
33419221|NCT00357370|62797325|FG000|Cohort 2|Adverse Event|1|||
33419222|NCT00357370|62797326|FG001|Cohort 2|Adverse Event|1|||
33419223|NCT00357370|62797327|FG002|Cohort 2|Adverse Event|1|||
33419224|NCT00357370|62797325|FG000|Cohort 2|Lost to Follow-up|0|||
33419225|NCT00357370|62797326|FG001|Cohort 2|Lost to Follow-up|1|||
33419226|NCT00357370|62797327|FG002|Cohort 2|Lost to Follow-up|0|||
33419227|NCT00357370|62797325|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
33419228|NCT00357370|62797326|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
33419229|NCT00357370|62797327|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
33419230|NCT00357370|62797325|FG000|Cohort 2|Withdrawal by Subject|0|||
33419231|NCT00357370|62797326|FG001|Cohort 2|Withdrawal by Subject|2|||
33419232|NCT00357370|62797327|FG002|Cohort 2|Withdrawal by Subject|0|||
33419233|NCT00574847|62797337|FG000|Overall Study|Adverse Event|2|||
33419234|NCT00574847|62797338|FG001|Overall Study|Adverse Event|0|||
33419235|NCT00574847|62797337|FG000|Overall Study|Death|1|||
33419236|NCT00574847|62797338|FG001|Overall Study|Death|0|||
33419237|NCT00574847|62797337|FG000|Overall Study|Withdrawal by Subject|2|||
33605141|NCT02395133|63004849|FG002|Overall Study|Lack of Efficacy|1|||
33605142|NCT02395133|63004850|FG003|Overall Study|Lack of Efficacy|1|||
33419238|NCT00574847|62797338|FG001|Overall Study|Withdrawal by Subject|2|||
33419239|NCT00574847|62797337|FG000|Overall Study|Physician Decision|1|||
33419240|NCT00574847|62797338|FG001|Overall Study|Physician Decision|0|||
33419241|NCT00574847|62797337|FG000|Overall Study|Did not receive medication (declined)|2|||
33419242|NCT00574847|62797338|FG001|Overall Study|Did not receive medication (declined)|5|||
33419243|NCT00348790|62797344|FG000|Completed Treatment|Withdrawal by Subject|4|||
33419244|NCT00348790|62797344|FG000|Completed Treatment|Disease progression|14|||
33419245|NCT00348790|62797344|FG000|Completed Treatment|Adverse Event|4|||
33419246|NCT00348790|62797344|FG000|Completed Treatment|Required surgery|2|||
33419247|NCT00348790|62797344|FG000|Completed Treatment|Unable to travel to study site|1|||
33419248|NCT00360490|62797351|FG000|Overall Study|Adverse Event|4|||
33605143|NCT02395133|63004847|FG000|Overall Study|Protocol Violation|1|||
33419249|NCT00360490|62797352|FG001|Overall Study|Adverse Event|2|||
33419250|NCT00360490|62797351|FG000|Overall Study|Lost to Follow-up|2|||
33419251|NCT00360490|62797352|FG001|Overall Study|Lost to Follow-up|1|||
33419252|NCT00360490|62797351|FG000|Overall Study|Physician Decision|2|||
33419253|NCT00360490|62797352|FG001|Overall Study|Physician Decision|1|||
33419254|NCT00360490|62797351|FG000|Overall Study|Protocol Violation|0|||
33419255|NCT00360490|62797352|FG001|Overall Study|Protocol Violation|4|||
33419256|NCT00360490|62797351|FG000|Overall Study|Withdrawal by Subject|1|||
33419257|NCT00360490|62797352|FG001|Overall Study|Withdrawal by Subject|3|||
33419258|NCT00624377|62797358|FG000|Overall Study|Lost to Follow-up|355|||
33419259|NCT00624377|62797358|FG000|Overall Study|Withdrawal by Subject|100|||
33419260|NCT00624377|62797358|FG000|Overall Study|Adverse Event|14|||
33419261|NCT00624377|62797358|FG000|Overall Study|Other|91|||
33419262|NCT00624377|62797358|FG000|Overall Study|Non-evaluable population|84|||
33419263|NCT00624065|62797364|FG000|Overall Study|Adverse Event|5|||
33419264|NCT00624065|62797365|FG001|Overall Study|Adverse Event|6|||
33419265|NCT00624065|62797364|FG000|Overall Study|Lost to Follow-up|4|||
33419266|NCT00624065|62797365|FG001|Overall Study|Lost to Follow-up|1|||
33419267|NCT00624065|62797364|FG000|Overall Study|Consent withdrawn|6|||
33419268|NCT00624065|62797365|FG001|Overall Study|Consent withdrawn|5|||
33419269|NCT00624065|62797364|FG000|Overall Study|Lack of Efficacy|0|||
33419270|NCT00624065|62797365|FG001|Overall Study|Lack of Efficacy|3|||
33419271|NCT00624065|62797364|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
33419272|NCT00624065|62797365|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
33419273|NCT00360412|62797373|FG000|Overall Study|Adverse Event|37|||
33419274|NCT00360412|62797374|FG001|Overall Study|Adverse Event|65|||
33419275|NCT00360412|62797373|FG000|Overall Study|Protocol Violation|2|||
33419276|NCT00360412|62797374|FG001|Overall Study|Protocol Violation|5|||
33419277|NCT00360412|62797373|FG000|Overall Study|Patient withdrew consent|27|||
33419278|NCT00360412|62797374|FG001|Overall Study|Patient withdrew consent|52|||
33419279|NCT00360412|62797373|FG000|Overall Study|Lack of therapeutic efficacy|46|||
33419280|NCT00360412|62797374|FG001|Overall Study|Lack of therapeutic efficacy|61|||
33419281|NCT00360412|62797373|FG000|Overall Study|Physician Decision|2|||
33419282|NCT00360412|62797374|FG001|Overall Study|Physician Decision|4|||
33419283|NCT00360412|62797373|FG000|Overall Study|Other|5|||
33419284|NCT00360412|62797374|FG001|Overall Study|Other|6|||
33419285|NCT00360412|62797373|FG000|Overall Study|Study termination by Sponsor|214|||
33419286|NCT00360412|62797374|FG001|Overall Study|Study termination by Sponsor|469|||
33419287|NCT00623831|62797382|FG000|Overall Study|Withdrawal by Subject|1|||
33419288|NCT00623831|62797383|FG001|Overall Study|Withdrawal by Subject|0|||
33419289|NCT00623831|62797382|FG000|Overall Study|Progressive Disease|0|||
33419290|NCT00623831|62797383|FG001|Overall Study|Progressive Disease|1|||
33605144|NCT02395133|63004848|FG001|Overall Study|Protocol Violation|1|||
33605145|NCT02395133|63004849|FG002|Overall Study|Protocol Violation|0|||
33605146|NCT02395133|63004850|FG003|Overall Study|Protocol Violation|3|||
33605147|NCT02395133|63004847|FG000|Overall Study|Lost to Follow-up|0|||
33605148|NCT02395133|63004848|FG001|Overall Study|Lost to Follow-up|1|||
33605149|NCT02395133|63004849|FG002|Overall Study|Lost to Follow-up|1|||
33605150|NCT02395133|63004850|FG003|Overall Study|Lost to Follow-up|0|||
33605151|NCT02395133|63004847|FG000|Overall Study|Pregnancy|0|||
33605152|NCT02395133|63004848|FG001|Overall Study|Pregnancy|0|||
33605153|NCT02395133|63004849|FG002|Overall Study|Pregnancy|3|||
33419291|NCT00360334|62797394|FG000|Overall Study|Adverse Event|7|||
33419292|NCT00360334|62797395|FG001|Overall Study|Adverse Event|4|||
33419293|NCT00360334|62797394|FG000|Overall Study|Protocol Violation|1|||
33419294|NCT00360334|62797395|FG001|Overall Study|Protocol Violation|1|||
33419295|NCT00360334|62797394|FG000|Overall Study|Physician Decision|2|||
33419296|NCT00360334|62797395|FG001|Overall Study|Physician Decision|3|||
33419297|NCT00360334|62797394|FG000|Overall Study|Lack of Efficacy|0|||
33419298|NCT00360334|62797395|FG001|Overall Study|Lack of Efficacy|1|||
33419299|NCT00360334|62797394|FG000|Overall Study|Entry criterion not met|1|||
33419300|NCT00360334|62797395|FG001|Overall Study|Entry criterion not met|2|||
33419301|NCT00360334|62797394|FG000|Overall Study|Subject decision|8|||
33419302|NCT00360334|62797395|FG001|Overall Study|Subject decision|2|||
33419303|NCT00422097|62797407|FG000|Dose Level 2|Still on treatment|0|||
33419304|NCT00422097|62797408|FG001|Dose Level 2|Still on treatment|1|||
33419305|NCT00422097|62797409|FG002|Dose Level 2|Still on treatment|0|||
33419306|NCT00422097|62797410|FG003|Dose Level 2|Still on treatment|0|||
33419307|NCT00422097|62797411|FG004|Dose Level 2|Still on treatment|0|||
33419308|NCT00422097|62797412|FG005|Dose Level 2|Still on treatment|0|||
33419309|NCT00422097|62797413|FG006|Dose Level 2|Still on treatment|0|||
33419310|NCT00422097|62797414|FG007|Dose Level 2|Still on treatment|0|||
33419311|NCT00348556|62797438|FG000|Overall Study|Adverse Event|1|||
33419312|NCT00434967|62797446|FG000|Overall Study|Adverse Event|2|||
33419313|NCT00434967|62797447|FG001|Overall Study|Adverse Event|4|||
33419314|NCT00434967|62797448|FG002|Overall Study|Adverse Event|3|||
33419315|NCT00434967|62797449|FG003|Overall Study|Adverse Event|3|||
33419316|NCT00434967|62797446|FG000|Overall Study|Lost to Follow-up|0|||
33419317|NCT00434967|62797447|FG001|Overall Study|Lost to Follow-up|0|||
33419318|NCT00434967|62797448|FG002|Overall Study|Lost to Follow-up|1|||
33419319|NCT00434967|62797449|FG003|Overall Study|Lost to Follow-up|0|||
33419320|NCT00434967|62797446|FG000|Overall Study|Withdrawal by Subject|2|||
33419321|NCT00434967|62797447|FG001|Overall Study|Withdrawal by Subject|2|||
33419322|NCT00434967|62797448|FG002|Overall Study|Withdrawal by Subject|4|||
33419323|NCT00434967|62797449|FG003|Overall Study|Withdrawal by Subject|6|||
33419324|NCT00434967|62797446|FG000|Overall Study|Randomized in error|0|||
33419325|NCT00434967|62797447|FG001|Overall Study|Randomized in error|0|||
33322908|NCT00976989|62699073|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
33419326|NCT00434967|62797448|FG002|Overall Study|Randomized in error|0|||
33419327|NCT00434967|62797449|FG003|Overall Study|Randomized in error|1|||
33419328|NCT00434967|62797446|FG000|Overall Study|Protocol Violation|0|||
33419329|NCT00434967|62797447|FG001|Overall Study|Protocol Violation|1|||
33419330|NCT00434967|62797448|FG002|Overall Study|Protocol Violation|0|||
33419331|NCT00434967|62797449|FG003|Overall Study|Protocol Violation|1|||
33419332|NCT00434967|62797446|FG000|Overall Study|Physician Decision|1|||
33419333|NCT00434967|62797447|FG001|Overall Study|Physician Decision|1|||
33419334|NCT00434967|62797448|FG002|Overall Study|Physician Decision|1|||
33419335|NCT00434967|62797449|FG003|Overall Study|Physician Decision|0|||
33419336|NCT00434967|62797446|FG000|Overall Study|Patient Disposition Challenges|2|||
33419337|NCT00434967|62797447|FG001|Overall Study|Patient Disposition Challenges|0|||
33419338|NCT00434967|62797448|FG002|Overall Study|Patient Disposition Challenges|0|||
33419339|NCT00434967|62797449|FG003|Overall Study|Patient Disposition Challenges|3|||
33419340|NCT00356590|62797459|FG000|Overall Study|Adverse Event|54|||
33419341|NCT00356590|62797459|FG000|Overall Study|Death|10|||
33419342|NCT00356590|62797459|FG000|Overall Study|Lost to Follow-up|35|||
33419343|NCT00356590|62797459|FG000|Overall Study|Physician Decision|46|||
33419344|NCT00356590|62797459|FG000|Overall Study|Withdrawal by Subject|41|||
33419345|NCT00356590|62797459|FG000|Overall Study|Completed month 12 only|2|||
33419346|NCT00356590|62797459|FG000|Overall Study|Protocol issues|6|||
33419347|NCT00356590|62797459|FG000|Overall Study|Response status|28|||
33419348|NCT00356590|62797459|FG000|Overall Study|Other|52|||
33419349|NCT00356278|62797466|FG000|Overall Study|Withdrawal by Subject|25|||
33419350|NCT00356278|62797467|FG001|Overall Study|Withdrawal by Subject|15|||
33419351|NCT00356278|62797468|FG002|Overall Study|Withdrawal by Subject|19|||
33419352|NCT00356200|62797478|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
33419353|NCT00356200|62797479|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
33419354|NCT00356200|62797478|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
33419355|NCT00356200|62797479|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
33419356|NCT00356122|62797491|FG000|TREATMENT|Lack of Efficacy|26|||
33419357|NCT00356122|62797491|FG000|TREATMENT|Adverse Event|10|||
33419358|NCT00356122|62797491|FG000|TREATMENT|Subject's request|4|||
33419359|NCT00356122|62797491|FG000|TREATMENT|Other|4|||
33419360|NCT00356122|62797491|FG000|TREATMENT|Did not receive study medication|1|||
33419361|NCT00356122|62797491|FG000|FOLLOW-UP|Death|37|||
33419362|NCT00356122|62797491|FG000|FOLLOW-UP|Lost to Follow-up|2|||
33419363|NCT00356122|62797491|FG000|FOLLOW-UP|Other|2|||
33419364|NCT00347932|62797497|FG000|Overall Study|Adverse Event|4|||
33419365|NCT00347932|62797498|FG001|Overall Study|Adverse Event|5|||
33419366|NCT00347932|62797497|FG000|Overall Study|Lack of Efficacy|3|||
33419367|NCT00347932|62797498|FG001|Overall Study|Lack of Efficacy|14|||
33419368|NCT00347932|62797497|FG000|Overall Study|Lost to Follow-up|10|||
33419369|NCT00347932|62797498|FG001|Overall Study|Lost to Follow-up|9|||
33419370|NCT00347932|62797497|FG000|Overall Study|Withdrawal by Subject|10|||
33419371|NCT00347932|62797498|FG001|Overall Study|Withdrawal by Subject|16|||
33419372|NCT00347932|62797497|FG000|Overall Study|Did not meet inclusion criteria|4|||
33419373|NCT00347932|62797498|FG001|Overall Study|Did not meet inclusion criteria|8|||
33419374|NCT00528996|62797509|FG000|Overall Study|Other reasons than listing|6|||
33419375|NCT00528996|62797510|FG001|Overall Study|Other reasons than listing|7|||
33419376|NCT00528996|62797511|FG002|Overall Study|Other reasons than listing|14|||
33419377|NCT00528996|62797512|FG003|Overall Study|Other reasons than listing|11|||
33419378|NCT00528996|62797513|FG004|Overall Study|Other reasons than listing|5|||
33419379|NCT00528996|62797509|FG000|Overall Study|Refused continue medication|16|||
33419380|NCT00528996|62797510|FG001|Overall Study|Refused continue medication|0|||
33419381|NCT00528996|62797511|FG002|Overall Study|Refused continue medication|3|||
33419382|NCT00528996|62797512|FG003|Overall Study|Refused continue medication|3|||
33419383|NCT00528996|62797513|FG004|Overall Study|Refused continue medication|6|||
33419384|NCT00528996|62797509|FG000|Overall Study|Lost to Follow-up|2|||
33419385|NCT00528996|62797510|FG001|Overall Study|Lost to Follow-up|0|||
33419386|NCT00528996|62797511|FG002|Overall Study|Lost to Follow-up|4|||
33419387|NCT00528996|62797512|FG003|Overall Study|Lost to Follow-up|1|||
33419388|NCT00528996|62797513|FG004|Overall Study|Lost to Follow-up|3|||
33419389|NCT00528996|62797509|FG000|Overall Study|Protocol Violation|1|||
33419390|NCT00528996|62797510|FG001|Overall Study|Protocol Violation|2|||
33419391|NCT00528996|62797511|FG002|Overall Study|Protocol Violation|3|||
33419392|NCT00528996|62797512|FG003|Overall Study|Protocol Violation|3|||
33419393|NCT00528996|62797513|FG004|Overall Study|Protocol Violation|2|||
33605154|NCT02395133|63004850|FG003|Overall Study|Pregnancy|0|||
33419394|NCT00528996|62797509|FG000|Overall Study|Lack of Efficacy|7|||
33419395|NCT00528996|62797510|FG001|Overall Study|Lack of Efficacy|2|||
33419396|NCT00528996|62797511|FG002|Overall Study|Lack of Efficacy|1|||
33419397|NCT00528996|62797512|FG003|Overall Study|Lack of Efficacy|3|||
33419398|NCT00528996|62797513|FG004|Overall Study|Lack of Efficacy|3|||
33419399|NCT00528996|62797509|FG000|Overall Study|Adverse Event|32|||
33419400|NCT00528996|62797510|FG001|Overall Study|Adverse Event|13|||
33419401|NCT00528996|62797511|FG002|Overall Study|Adverse Event|18|||
33419402|NCT00528996|62797512|FG003|Overall Study|Adverse Event|29|||
33419403|NCT00528996|62797513|FG004|Overall Study|Adverse Event|18|||
33419404|NCT00359788|62797530|FG000|Overall Study|Adverse Event|11|||
33419405|NCT00359788|62797531|FG001|Overall Study|Adverse Event|10|||
33419406|NCT00359788|62797530|FG000|Overall Study|Lack of Efficacy|1|||
33419407|NCT00359788|62797531|FG001|Overall Study|Lack of Efficacy|2|||
33419408|NCT00359788|62797530|FG000|Overall Study|Lost to Follow-up|3|||
33419409|NCT00359788|62797531|FG001|Overall Study|Lost to Follow-up|2|||
33419410|NCT00359788|62797530|FG000|Overall Study|Withdrawal by Subject|4|||
33419411|NCT00359788|62797531|FG001|Overall Study|Withdrawal by Subject|1|||
33419412|NCT00359788|62797530|FG000|Overall Study|Protocol Violation|4|||
33419413|NCT00359788|62797531|FG001|Overall Study|Protocol Violation|2|||
33419414|NCT03878160|62797540|FG000|Overall Study|Lost to Follow-up|1|||
33419415|NCT03878160|62797541|FG001|Overall Study|Lost to Follow-up|1|||
33419416|NCT03878160|62797542|FG002|Overall Study|Lost to Follow-up|1|||
33419417|NCT03878160|62797540|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
33419418|NCT03878160|62797541|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
33419419|NCT03878160|62797542|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
33419420|NCT00623597|62797552|FG000|Overall Study|Failed to return|1|||
33419421|NCT00623597|62797553|FG001|Overall Study|Failed to return|0|||
33419422|NCT00347776|62797564|FG000|1.5 Month Follow-up|Death|2|||
33419423|NCT00347776|62797565|FG001|1.5 Month Follow-up|Death|0|||
33419424|NCT00347776|62797566|FG002|1.5 Month Follow-up|Death|0|||
33419425|NCT00347776|62797564|FG000|1.5 Month Follow-up|reached the endpoint|12|||
33419426|NCT00347776|62797565|FG001|1.5 Month Follow-up|reached the endpoint|8|||
33419427|NCT00347776|62797566|FG002|1.5 Month Follow-up|reached the endpoint|12|||
33419428|NCT00347776|62797564|FG000|6 Month Follow-up|Death|2|||
33419429|NCT00347776|62797565|FG001|6 Month Follow-up|Death|1|||
33419430|NCT00347776|62797566|FG002|6 Month Follow-up|Death|3|||
33419431|NCT00347776|62797564|FG000|6 Month Follow-up|reached endpont|20|||
33419432|NCT00347776|62797565|FG001|6 Month Follow-up|reached endpont|12|||
33419433|NCT00347776|62797566|FG002|6 Month Follow-up|reached endpont|15|||
33419434|NCT00347776|62797564|FG000|12 Month Follow-up|Lost to Follow-up|7|||
33419435|NCT00347776|62797565|FG001|12 Month Follow-up|Lost to Follow-up|6|||
33419436|NCT00347776|62797566|FG002|12 Month Follow-up|Lost to Follow-up|6|||
33419437|NCT00347776|62797564|FG000|12 Month Follow-up|Death|3|||
33419438|NCT00347776|62797565|FG001|12 Month Follow-up|Death|4|||
33419439|NCT00347776|62797566|FG002|12 Month Follow-up|Death|4|||
33419440|NCT00347776|62797564|FG000|12 Month Follow-up|Reached endpoint|13|||
33419441|NCT00347776|62797565|FG001|12 Month Follow-up|Reached endpoint|6|||
33419442|NCT00347776|62797566|FG002|12 Month Follow-up|Reached endpoint|9|||
33419443|NCT03829228|62797574|FG000|Overall Study|Protocol Violation|1|||
33419444|NCT00529542|62797580|FG000|Overall Study|Withdrawal by Subject|1|||
33419445|NCT00529542|62797581|FG001|Overall Study|Withdrawal by Subject|0|||
33419446|NCT00529542|62797580|FG000|Overall Study|Lost to Follow-up|0|||
33419447|NCT00529542|62797581|FG001|Overall Study|Lost to Follow-up|1|||
33419448|NCT00621959|62797589|FG000|Overall Study|Adverse Event|4|||
33419449|NCT00621959|62797590|FG001|Overall Study|Adverse Event|2|||
33419450|NCT00621959|62797589|FG000|Overall Study|Lack of Efficacy|1|||
33419451|NCT00621959|62797590|FG001|Overall Study|Lack of Efficacy|1|||
33419452|NCT00621959|62797589|FG000|Overall Study|Lost to Follow-up|0|||
33419453|NCT00621959|62797590|FG001|Overall Study|Lost to Follow-up|2|||
33419454|NCT00621959|62797589|FG000|Overall Study|Withdrawal by Subject|1|||
33419455|NCT00621959|62797590|FG001|Overall Study|Withdrawal by Subject|1|||
33419456|NCT00621959|62797589|FG000|Overall Study|Other|1|||
33419457|NCT00621959|62797590|FG001|Overall Study|Other|3|||
33419458|NCT03877224|62797598|FG000|Overall Study|Death|3|||
33419459|NCT03877224|62797599|FG001|Overall Study|Death|2|||
33419460|NCT03877224|62797598|FG000|Overall Study|Withdrawal by Subject|1|||
33419461|NCT03877224|62797599|FG001|Overall Study|Withdrawal by Subject|6|||
33419462|NCT03877224|62797598|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
33419463|NCT03877224|62797599|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
33419464|NCT00528606|62797607|FG000|Overall Study|Withdrew consent|4|||
33419465|NCT00528606|62797608|FG001|Overall Study|Withdrew consent|3|||
33419466|NCT00528606|62797607|FG000|Overall Study|Lost to Follow-up|4|||
33419467|NCT00528606|62797608|FG001|Overall Study|Lost to Follow-up|1|||
33419468|NCT00528606|62797607|FG000|Overall Study|Adverse Event|3|||
33419469|NCT00528606|62797608|FG001|Overall Study|Adverse Event|0|||
33419470|NCT00528606|62797607|FG000|Overall Study|Other|2|||
33419471|NCT00528606|62797608|FG001|Overall Study|Other|0|||
33419472|NCT00621257|62797619|FG000|Overall Study|Lost to Follow-up|4|||
33419473|NCT00621257|62797620|FG001|Overall Study|Lost to Follow-up|0|||
33419474|NCT00621257|62797621|FG002|Overall Study|Lost to Follow-up|2|||
33419475|NCT00621257|62797622|FG003|Overall Study|Lost to Follow-up|4|||
33419476|NCT00621257|62797623|FG004|Overall Study|Lost to Follow-up|7|||
33419477|NCT00621257|62797619|FG000|Overall Study|Adverse Event|0|||
33419478|NCT00621257|62797620|FG001|Overall Study|Adverse Event|1|||
33419479|NCT00621257|62797621|FG002|Overall Study|Adverse Event|1|||
33419480|NCT00621257|62797622|FG003|Overall Study|Adverse Event|0|||
33419481|NCT00621257|62797623|FG004|Overall Study|Adverse Event|0|||
33419482|NCT00621257|62797619|FG000|Overall Study|Physician Decision|0|||
33419483|NCT00621257|62797620|FG001|Overall Study|Physician Decision|2|||
33419484|NCT00621257|62797621|FG002|Overall Study|Physician Decision|0|||
33419485|NCT00621257|62797622|FG003|Overall Study|Physician Decision|1|||
33419486|NCT00621257|62797623|FG004|Overall Study|Physician Decision|1|||
33419487|NCT00621257|62797619|FG000|Overall Study|Withdrawal by Subject|0|||
33419488|NCT00621257|62797620|FG001|Overall Study|Withdrawal by Subject|0|||
33419489|NCT00621257|62797621|FG002|Overall Study|Withdrawal by Subject|0|||
33419490|NCT00621257|62797622|FG003|Overall Study|Withdrawal by Subject|1|||
33419491|NCT00621257|62797623|FG004|Overall Study|Withdrawal by Subject|1|||
33419492|NCT00528840|62797635|FG000|Overall Study|Lost to Follow-up|10|||
33419493|NCT00528840|62797635|FG000|Overall Study|Adverse Event|1|||
33419494|NCT00528840|62797635|FG000|Overall Study|Withdrawal by Subject|17|||
33419495|NCT00528840|62797635|FG000|Overall Study|Death|2|||
33419496|NCT00528840|62797635|FG000|Overall Study|Administrative Reasons|1|||
33419497|NCT00528840|62797635|FG000|Overall Study|Other|2|||
33419498|NCT00528528|62797643|FG000|Overall Study|Lost to Follow-up|0|||
33419499|NCT00528528|62797644|FG001|Overall Study|Lost to Follow-up|0|||
33419500|NCT00528528|62797645|FG002|Overall Study|Lost to Follow-up|1|||
33419501|NCT00528528|62797646|FG003|Overall Study|Lost to Follow-up|1|||
33419502|NCT00528528|62797643|FG000|Overall Study|Ineligible to continue the trial|0|||
33419503|NCT00528528|62797644|FG001|Overall Study|Ineligible to continue the trial|0|||
33419504|NCT00528528|62797645|FG002|Overall Study|Ineligible to continue the trial|0|||
33419505|NCT00528528|62797646|FG003|Overall Study|Ineligible to continue the trial|1|||
33419506|NCT00528528|62797643|FG000|Overall Study|Other|0|||
33419507|NCT00528528|62797644|FG001|Overall Study|Other|1|||
33419508|NCT00528528|62797645|FG002|Overall Study|Other|0|||
33419509|NCT00528528|62797646|FG003|Overall Study|Other|0|||
33419510|NCT00528528|62797643|FG000|Overall Study|Withdrawal by Subject|3|||
33419511|NCT00528528|62797644|FG001|Overall Study|Withdrawal by Subject|2|||
33419512|NCT00528528|62797645|FG002|Overall Study|Withdrawal by Subject|1|||
33419513|NCT00528528|62797646|FG003|Overall Study|Withdrawal by Subject|1|||
33419514|NCT00528528|62797643|FG000|Overall Study|Ongoing participant|0|||
33419515|NCT00528528|62797644|FG001|Overall Study|Ongoing participant|0|||
33419516|NCT00528528|62797645|FG002|Overall Study|Ongoing participant|1|||
33419517|NCT00528528|62797646|FG003|Overall Study|Ongoing participant|0|||
33419518|NCT00620555|62797658|FG000|Overall Study|Adverse Event|4|||
33322909|NCT00976989|62699074|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
33322910|NCT00976989|62699075|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
33322911|NCT00976989|62699073|FG000|Overall Study|Death|5|||
33322912|NCT00976989|62699074|FG001|Overall Study|Death|7|||
33322913|NCT00976989|62699075|FG002|Overall Study|Death|10|||
33322914|NCT00976989|62699073|FG000|Overall Study|Refused Treatment|4|||
33419519|NCT00620555|62797658|FG000|Overall Study|Protocol Violation|2|||
33419520|NCT00620555|62797658|FG000|Overall Study|Lack of Efficacy|12|||
33419521|NCT00620555|62797658|FG000|Overall Study|Withdrawal by Subject|1|||
33419522|NCT00620555|62797658|FG000|Overall Study|Choice of other treatment|1|||
33419523|NCT00620555|62797658|FG000|Overall Study|Visit failure against planned|1|||
33419524|NCT00529386|62797662|FG000|Overall Study|Lost to Follow-up|1|||
33419525|NCT03875118|62797668|FG000|Overall Study|Withdrawal by Subject|4|||
33419526|NCT03875118|62797669|FG001|Overall Study|Withdrawal by Subject|4|||
33419527|NCT00529308|62797677|FG000|Overall Study|Withdrawal by Subject|1|||
33419528|NCT00529308|62797678|FG001|Overall Study|Withdrawal by Subject|1|||
33419529|NCT03875508|62797684|FG000|Overall Study|Adverse Event|1|||
33322915|NCT00976989|62699074|FG001|Overall Study|Refused Treatment|3|||
33322916|NCT00976989|62699075|FG002|Overall Study|Refused Treatment|5|||
33419530|NCT03875508|62797684|FG000|Overall Study|Lost to Follow-up|8|||
33419531|NCT03875508|62797684|FG000|Overall Study|Lack of Efficacy|1|||
33419532|NCT03875508|62797684|FG000|Overall Study|Other, not specified|2|||
33419533|NCT00620321|62797690|FG000|Overall Study|Adverse Event|1|||
33419534|NCT00620321|62797691|FG001|Overall Study|Adverse Event|1|||
33419535|NCT00620321|62797690|FG000|Overall Study|Death|1|||
33419536|NCT00620321|62797691|FG001|Overall Study|Death|1|||
33419537|NCT00620321|62797690|FG000|Overall Study|Physician Decision|0|||
33419538|NCT00620321|62797691|FG001|Overall Study|Physician Decision|7|||
33419539|NCT00620321|62797690|FG000|Overall Study|Progressive Disease|5|||
33419540|NCT00620321|62797691|FG001|Overall Study|Progressive Disease|5|||
33419541|NCT00620321|62797690|FG000|Overall Study|Sponsor Decision|0|||
33419542|NCT00620321|62797691|FG001|Overall Study|Sponsor Decision|1|||
33419543|NCT00620321|62797690|FG000|Overall Study|Withdrawal by Subject|1|||
33419544|NCT00620321|62797691|FG001|Overall Study|Withdrawal by Subject|1|||
33419545|NCT00621023|62797697|FG000|Overall Study|Death|5|||
33419546|NCT00621023|62797697|FG000|Overall Study|Follow up discontinued|1|||
33419547|NCT00528372|62797710|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
33419548|NCT00528372|62797711|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33419549|NCT00528372|62797712|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33419550|NCT00528372|62797713|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33419551|NCT00528372|62797714|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33419552|NCT00528372|62797715|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33419553|NCT00528372|62797716|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33419554|NCT00528372|62797717|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33419555|NCT00528372|62797718|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33419556|NCT00528372|62797710|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
33419557|NCT00528372|62797711|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
33419558|NCT00528372|62797712|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
33419559|NCT00528372|62797713|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
33419560|NCT00528372|62797714|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
33419561|NCT00528372|62797715|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
33419562|NCT00528372|62797716|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
33419563|NCT00528372|62797717|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
33419564|NCT00528372|62797718|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
33419565|NCT00528372|62797710|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
33419566|NCT00528372|62797711|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
33419567|NCT00528372|62797712|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
33419568|NCT00528372|62797713|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
33419569|NCT00528372|62797714|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
33419570|NCT00528372|62797715|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
33419571|NCT00528372|62797716|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
33419572|NCT00528372|62797717|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
33419573|NCT00528372|62797718|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
33419574|NCT00528372|62797710|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
33419575|NCT00528372|62797711|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
33419576|NCT00528372|62797712|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
33419577|NCT00528372|62797713|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
33419578|NCT00528372|62797714|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
33419579|NCT00528372|62797715|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
33419580|NCT00528372|62797716|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
33419581|NCT00528372|62797717|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
33419582|NCT00528372|62797718|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
33419583|NCT00528372|62797710|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
33419584|NCT00528372|62797711|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
33419585|NCT00528372|62797712|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
33419586|NCT00528372|62797713|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
33419587|NCT00528372|62797714|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
33419588|NCT00528372|62797715|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
33419589|NCT00528372|62797716|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
33605155|NCT02395133|63004847|FG000|Overall Study|Consent withdrawn with no reason given|1|||
33322917|NCT00976989|62699073|FG000|Overall Study|Failure to Return|2|||
33419590|NCT00528372|62797717|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
33419591|NCT00528372|62797718|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
33419592|NCT00528372|62797710|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
33419593|NCT00528372|62797711|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
33419594|NCT00528372|62797712|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
33419595|NCT00528372|62797713|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
33419596|NCT00528372|62797714|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
33419597|NCT00528372|62797715|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
33419598|NCT00528372|62797716|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
33419599|NCT00528372|62797717|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
33419600|NCT00528372|62797718|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
33419601|NCT00528372|62797710|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
33419602|NCT00528372|62797711|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
33419603|NCT00528372|62797712|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
33419604|NCT00528372|62797713|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
33419605|NCT00528372|62797714|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
33419606|NCT00528372|62797715|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
33419607|NCT00528372|62797716|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
33419608|NCT00528372|62797717|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
33419609|NCT00528372|62797718|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
33419610|NCT00528372|62797710|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
33419611|NCT00528372|62797711|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
33419612|NCT00528372|62797712|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
33419613|NCT00528372|62797713|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
33419614|NCT00528372|62797714|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
33419615|NCT00528372|62797715|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
33419616|NCT00528372|62797716|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
33419617|NCT00528372|62797717|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
33419618|NCT00528372|62797718|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
33419619|NCT00528372|62797710|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
33419620|NCT00528372|62797711|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
33419621|NCT00528372|62797712|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
33419622|NCT00528372|62797713|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
33419623|NCT00528372|62797714|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
33419624|NCT00528372|62797715|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
33419625|NCT00528372|62797716|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
33419626|NCT00528372|62797717|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
33419627|NCT00528372|62797718|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
33419628|NCT00528372|62797710|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
33419629|NCT00528372|62797711|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
33419630|NCT00528372|62797712|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
33419631|NCT00528372|62797713|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
33419632|NCT00528372|62797714|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
33419633|NCT00528372|62797715|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
33605156|NCT02395133|63004848|FG001|Overall Study|Consent withdrawn with no reason given|3|||
33605157|NCT02395133|63004849|FG002|Overall Study|Consent withdrawn with no reason given|0|||
33605158|NCT02395133|63004850|FG003|Overall Study|Consent withdrawn with no reason given|2|||
33419634|NCT00528372|62797716|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
33419635|NCT00528372|62797717|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
33419636|NCT00528372|62797718|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
33419637|NCT00528372|62797710|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
33419638|NCT00528372|62797711|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
33419639|NCT00528372|62797712|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
33419640|NCT00528372|62797713|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
33419641|NCT00528372|62797714|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
33419642|NCT00528372|62797715|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
33419643|NCT00528372|62797716|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
33419644|NCT00528372|62797717|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
33419645|NCT00528372|62797718|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
33419646|NCT00528372|62797710|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
33419647|NCT00528372|62797711|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
33419648|NCT00528372|62797712|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
33419649|NCT00528372|62797713|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
33419650|NCT00528372|62797714|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
33419651|NCT00528372|62797715|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
33419652|NCT00528372|62797716|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
33419653|NCT00528372|62797717|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
33419654|NCT00528372|62797718|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
33419655|NCT00528372|62797710|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
33419656|NCT00528372|62797711|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
33419657|NCT00528372|62797712|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
33419658|NCT00528372|62797713|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
33419659|NCT00528372|62797714|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
33419660|NCT00528372|62797715|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
33419661|NCT00528372|62797716|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
33419662|NCT00528372|62797717|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
33419663|NCT00528372|62797718|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
33419664|NCT00528372|62797710|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
33419665|NCT00528372|62797711|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
33419666|NCT00528372|62797712|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
33419667|NCT00528372|62797713|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
33419668|NCT00528372|62797714|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
33419669|NCT00528372|62797715|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
33419670|NCT00528372|62797716|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
33419671|NCT00528372|62797717|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
33419672|NCT00528372|62797718|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
33419673|NCT00528372|62797710|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
33419674|NCT00528372|62797711|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
33419675|NCT00528372|62797712|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
33419676|NCT00528372|62797713|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
33419677|NCT00528372|62797714|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
33419678|NCT00528372|62797715|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
33419679|NCT00528372|62797716|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
33419680|NCT00528372|62797717|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
33419681|NCT00528372|62797718|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
33419682|NCT00527982|62797766|FG000|Overall Study|Physician Decision|1|||
33419683|NCT00527982|62797767|FG001|Overall Study|Physician Decision|0|||
33419684|NCT00527904|62797773|FG000|Overall Study|Adverse Event|45|||
33419685|NCT00527904|62797773|FG000|Overall Study|Withdrawal by Subject|21|||
33419686|NCT00527904|62797773|FG000|Overall Study|Lost to Follow-up|8|||
33419687|NCT00527904|62797773|FG000|Overall Study|misc|22|||
33419688|NCT00619619|62797785|FG000|Overall Study|Physician Decision|0|||
33419689|NCT00619619|62797786|FG001|Overall Study|Physician Decision|0|||
33419690|NCT00619619|62797787|FG002|Overall Study|Physician Decision|1|||
33419691|NCT00619619|62797788|FG003|Overall Study|Physician Decision|0|||
33419692|NCT00619619|62797789|FG004|Overall Study|Physician Decision|0|||
33419693|NCT00619619|62797790|FG005|Overall Study|Physician Decision|0|||
33419694|NCT00619619|62797791|FG006|Overall Study|Physician Decision|0|||
33419695|NCT00619619|62797792|FG007|Overall Study|Physician Decision|0|||
33419696|NCT00619619|62797785|FG000|Overall Study|Protocol Violation|0|||
33419697|NCT00619619|62797786|FG001|Overall Study|Protocol Violation|0|||
33419698|NCT00619619|62797787|FG002|Overall Study|Protocol Violation|0|||
33419699|NCT00619619|62797788|FG003|Overall Study|Protocol Violation|1|||
33419700|NCT00619619|62797789|FG004|Overall Study|Protocol Violation|0|||
33419701|NCT00619619|62797790|FG005|Overall Study|Protocol Violation|0|||
33419702|NCT00619619|62797791|FG006|Overall Study|Protocol Violation|1|||
33419703|NCT00619619|62797792|FG007|Overall Study|Protocol Violation|1|||
33419704|NCT00619619|62797785|FG000|Overall Study|Adverse Event|0|||
33419705|NCT00619619|62797786|FG001|Overall Study|Adverse Event|0|||
33419706|NCT00619619|62797787|FG002|Overall Study|Adverse Event|0|||
33419707|NCT00619619|62797788|FG003|Overall Study|Adverse Event|0|||
33419708|NCT00619619|62797789|FG004|Overall Study|Adverse Event|2|||
33419709|NCT00619619|62797790|FG005|Overall Study|Adverse Event|0|||
33419710|NCT00619619|62797791|FG006|Overall Study|Adverse Event|0|||
33419711|NCT00619619|62797792|FG007|Overall Study|Adverse Event|2|||
33419712|NCT00527826|62797815|FG000|Overall Study|Adverse Event|10|||
33419713|NCT00527826|62797816|FG001|Overall Study|Adverse Event|10|||
33419714|NCT00527826|62797815|FG000|Overall Study|Lost to Follow-up|3|||
33419715|NCT00527826|62797816|FG001|Overall Study|Lost to Follow-up|2|||
33419716|NCT00527826|62797815|FG000|Overall Study|Withdrawal by Subject|5|||
33419717|NCT00527826|62797816|FG001|Overall Study|Withdrawal by Subject|8|||
33419718|NCT00527826|62797815|FG000|Overall Study|Inclusion Criteria Not Met|3|||
33419719|NCT00527826|62797816|FG001|Overall Study|Inclusion Criteria Not Met|3|||
33419720|NCT00527826|62797815|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
33419721|NCT00527826|62797816|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
33419722|NCT00527826|62797815|FG000|Overall Study|Additional Intake of Viani forte|0|||
33419723|NCT00527826|62797816|FG001|Overall Study|Additional Intake of Viani forte|1|||
33419724|NCT00527826|62797815|FG000|Overall Study|Participant moved away|0|||
33419725|NCT00527826|62797816|FG001|Overall Study|Participant moved away|1|||
33419726|NCT00527748|62797834|FG000|Overall Study|Other|3|||
33419727|NCT00619385|62797841|FG000|Overall Study|Adverse Event|0|||
33419728|NCT00619385|62797842|FG001|Overall Study|Adverse Event|0|||
33419729|NCT00619385|62797843|FG002|Overall Study|Adverse Event|3|||
33605159|NCT02395133|63004847|FG000|Overall Study|Consent withdrawn with personal reason|0|||
33419730|NCT00619385|62797841|FG000|Overall Study|Other|1|||
33419731|NCT00619385|62797842|FG001|Overall Study|Other|2|||
33419732|NCT00619385|62797843|FG002|Overall Study|Other|1|||
33419733|NCT00619307|62797856|FG000|Overall Study|Adverse Event|0|||
33419734|NCT00619307|62797857|FG001|Overall Study|Adverse Event|1|||
33419735|NCT00619307|62797856|FG000|Overall Study|Lost to Follow-up|0|||
33419736|NCT00619307|62797857|FG001|Overall Study|Lost to Follow-up|1|||
33419737|NCT00619307|62797856|FG000|Overall Study|Protocol Violation|3|||
33419738|NCT00619307|62797857|FG001|Overall Study|Protocol Violation|0|||
33419739|NCT00619307|62797856|FG000|Overall Study|Withdrew consent|1|||
33419740|NCT00619307|62797857|FG001|Overall Study|Withdrew consent|0|||
33419741|NCT00619307|62797856|FG000|Overall Study|Severe migraine|0|||
33419742|NCT00619307|62797857|FG001|Overall Study|Severe migraine|1|||
33419743|NCT00619307|62797856|FG000|Overall Study|MS attack plus steroids|0|||
33419744|NCT00619307|62797857|FG001|Overall Study|MS attack plus steroids|1|||
33419745|NCT00619229|62797865|FG000|Overall Study|Withdrawal by Subject|1|||
33419746|NCT00619229|62797866|FG001|Overall Study|Withdrawal by Subject|1|||
33419747|NCT00619229|62797865|FG000|Overall Study|Lost to Follow-up|1|||
33419748|NCT00619229|62797866|FG001|Overall Study|Lost to Follow-up|0|||
33419749|NCT00619229|62797865|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
33419750|NCT00619229|62797866|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
33419751|NCT00619229|62797865|FG000|Overall Study|Investigator planned Cataract Operation|1|||
33419752|NCT00619229|62797866|FG001|Overall Study|Investigator planned Cataract Operation|0|||
33419753|NCT00619151|62797874|FG000|Overall Study|Study terminated prior to followup|1|||
33419754|NCT00619151|62797875|FG001|Overall Study|Study terminated prior to followup|0|||
33419755|NCT00618995|62797881|FG000|Period 1|Adverse Event|0|||
33419756|NCT00618995|62797882|FG001|Period 1|Adverse Event|0|||
33419757|NCT00618995|62797883|FG002|Period 1|Adverse Event|1|||
33419758|NCT00618995|62797884|FG003|Period 1|Adverse Event|0|||
33419759|NCT00618995|62797881|FG000|Period 1|Protocol Violation|0|||
33419760|NCT00618995|62797882|FG001|Period 1|Protocol Violation|1|||
33419761|NCT00618995|62797883|FG002|Period 1|Protocol Violation|1|||
33419762|NCT00618995|62797884|FG003|Period 1|Protocol Violation|0|||
33419763|NCT00618995|62797881|FG000|Period 2|Protocol Violation|0|||
33419764|NCT00618995|62797882|FG001|Period 2|Protocol Violation|0|||
33419765|NCT00618995|62797883|FG002|Period 2|Protocol Violation|1|||
33419766|NCT00618995|62797884|FG003|Period 2|Protocol Violation|0|||
33419767|NCT00618995|62797881|FG000|Period 4|Adverse Event|1|||
33419768|NCT00618995|62797882|FG001|Period 4|Adverse Event|0|||
33419769|NCT00618995|62797883|FG002|Period 4|Adverse Event|0|||
33419770|NCT00618995|62797884|FG003|Period 4|Adverse Event|0|||
33419771|NCT03685344|62797898|FG000|Overall Study|Withdrawal by Subject|1|||
33419772|NCT03685344|62797899|FG001|Overall Study|Withdrawal by Subject|1|||
33419773|NCT03685344|62797900|FG002|Overall Study|Withdrawal by Subject|2|||
33419774|NCT03685344|62797901|FG003|Overall Study|Withdrawal by Subject|0|||
33419775|NCT03685344|62797898|FG000|Overall Study|Physician Decision|1|||
33419776|NCT03685344|62797899|FG001|Overall Study|Physician Decision|1|||
33419777|NCT03685344|62797900|FG002|Overall Study|Physician Decision|5|||
33419778|NCT03685344|62797901|FG003|Overall Study|Physician Decision|0|||
33419779|NCT03685344|62797898|FG000|Overall Study|Death|1|||
33419780|NCT03685344|62797899|FG001|Overall Study|Death|1|||
33419781|NCT03685344|62797900|FG002|Overall Study|Death|0|||
33419782|NCT03685344|62797901|FG003|Overall Study|Death|0|||
33419783|NCT00520572|62797917|FG000|Overall Study|Adverse Event|9|||
33419784|NCT00520572|62797918|FG001|Overall Study|Adverse Event|3|||
33419785|NCT00520572|62797919|FG002|Overall Study|Adverse Event|6|||
33419786|NCT00520572|62797920|FG003|Overall Study|Adverse Event|9|||
33419787|NCT00520572|62797921|FG004|Overall Study|Adverse Event|7|||
33419788|NCT00520572|62797922|FG005|Overall Study|Adverse Event|2|||
33419789|NCT00520572|62797917|FG000|Overall Study|Withdrawal by Subject|0|||
33419790|NCT00520572|62797918|FG001|Overall Study|Withdrawal by Subject|9|||
33419791|NCT00520572|62797919|FG002|Overall Study|Withdrawal by Subject|5|||
33419792|NCT00520572|62797920|FG003|Overall Study|Withdrawal by Subject|2|||
33419793|NCT00520572|62797921|FG004|Overall Study|Withdrawal by Subject|2|||
33605160|NCT02395133|63004848|FG001|Overall Study|Consent withdrawn with personal reason|1|||
33605161|NCT02395133|63004849|FG002|Overall Study|Consent withdrawn with personal reason|0|||
33605162|NCT02395133|63004850|FG003|Overall Study|Consent withdrawn with personal reason|3|||
33605163|NCT02395133|63004847|FG000|Overall Study|Sponsor decision|2|||
33605164|NCT02395133|63004848|FG001|Overall Study|Sponsor decision|0|||
33605165|NCT02395133|63004849|FG002|Overall Study|Sponsor decision|0|||
33605166|NCT02395133|63004850|FG003|Overall Study|Sponsor decision|1|||
33605167|NCT02395133|63004847|FG000|Overall Study|Other than specified above|5|||
33605168|NCT02395133|63004848|FG001|Overall Study|Other than specified above|2|||
33605169|NCT02395133|63004849|FG002|Overall Study|Other than specified above|2|||
33605170|NCT02395133|63004850|FG003|Overall Study|Other than specified above|4|||
33605171|NCT02395055|63004862|FG000|Overall Study|Withdrawal by Subject|7|||
33605172|NCT02395055|63004863|FG001|Overall Study|Withdrawal by Subject|3|||
33605173|NCT02369159|63004871|FG000|Overall Study|Adverse Event|0|||
33419794|NCT00520572|62797922|FG005|Overall Study|Withdrawal by Subject|0|||
33605174|NCT02369159|63004872|FG001|Overall Study|Adverse Event|1|||
33419795|NCT00520572|62797917|FG000|Overall Study|Protocol Violation|0|||
33419796|NCT00520572|62797918|FG001|Overall Study|Protocol Violation|0|||
33419797|NCT00520572|62797919|FG002|Overall Study|Protocol Violation|1|||
33419798|NCT00520572|62797920|FG003|Overall Study|Protocol Violation|0|||
33419799|NCT00520572|62797921|FG004|Overall Study|Protocol Violation|0|||
33419800|NCT00520572|62797922|FG005|Overall Study|Protocol Violation|0|||
33419801|NCT00520572|62797917|FG000|Overall Study|Lack of Efficacy|1|||
33419802|NCT00520572|62797918|FG001|Overall Study|Lack of Efficacy|1|||
33419803|NCT00520572|62797919|FG002|Overall Study|Lack of Efficacy|1|||
33419804|NCT00520572|62797920|FG003|Overall Study|Lack of Efficacy|2|||
33605175|NCT02369159|63004871|FG000|Overall Study|Lost to Follow-up|1|||
33605176|NCT02369159|63004872|FG001|Overall Study|Lost to Follow-up|1|||
33605177|NCT02369159|63004871|FG000|Overall Study|Withdrawal by Subject|7|||
33605178|NCT02369159|63004872|FG001|Overall Study|Withdrawal by Subject|0|||
33419805|NCT00520572|62797921|FG004|Overall Study|Lack of Efficacy|1|||
33419806|NCT00520572|62797922|FG005|Overall Study|Lack of Efficacy|0|||
33419807|NCT00520572|62797917|FG000|Overall Study|Lost to Follow-up|0|||
33419808|NCT00520572|62797918|FG001|Overall Study|Lost to Follow-up|0|||
33419809|NCT00520572|62797919|FG002|Overall Study|Lost to Follow-up|0|||
33419810|NCT00520572|62797920|FG003|Overall Study|Lost to Follow-up|0|||
33419811|NCT00520572|62797921|FG004|Overall Study|Lost to Follow-up|1|||
33419812|NCT00520572|62797922|FG005|Overall Study|Lost to Follow-up|0|||
33419813|NCT00520572|62797917|FG000|Overall Study|Incorrect enrollment|1|||
33419814|NCT00520572|62797918|FG001|Overall Study|Incorrect enrollment|0|||
33419815|NCT00520572|62797919|FG002|Overall Study|Incorrect enrollment|1|||
33419816|NCT00520572|62797920|FG003|Overall Study|Incorrect enrollment|0|||
33419817|NCT00520572|62797921|FG004|Overall Study|Incorrect enrollment|1|||
33419818|NCT00520572|62797922|FG005|Overall Study|Incorrect enrollment|0|||
33419819|NCT00520572|62797917|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
33419820|NCT00520572|62797918|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
33419821|NCT00520572|62797919|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
33419822|NCT00520572|62797920|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
33419823|NCT00520572|62797921|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
33419824|NCT00520572|62797922|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
33419825|NCT00520572|62797917|FG000|Overall Study|Long break in taking Medication|0|||
33419826|NCT00520572|62797918|FG001|Overall Study|Long break in taking Medication|0|||
33419827|NCT00520572|62797919|FG002|Overall Study|Long break in taking Medication|0|||
33419828|NCT00520572|62797920|FG003|Overall Study|Long break in taking Medication|1|||
33419829|NCT00520572|62797921|FG004|Overall Study|Long break in taking Medication|0|||
33419830|NCT00520572|62797922|FG005|Overall Study|Long break in taking Medication|0|||
33419831|NCT00520572|62797917|FG000|Overall Study|Did not receive Treatment|1|||
33419832|NCT00520572|62797918|FG001|Overall Study|Did not receive Treatment|0|||
33419833|NCT00520572|62797919|FG002|Overall Study|Did not receive Treatment|1|||
33419834|NCT00520572|62797920|FG003|Overall Study|Did not receive Treatment|0|||
33419835|NCT00520572|62797921|FG004|Overall Study|Did not receive Treatment|0|||
33419836|NCT00520572|62797922|FG005|Overall Study|Did not receive Treatment|0|||
33419837|NCT00573833|62797936|FG000|Overall Study|Not Treated|2|||
33419838|NCT00520494|62797940|FG000|Overall Study|Withdrawal by Subject|1|||
33419839|NCT00527514|62797944|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
33419840|NCT00527514|62797944|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
33419841|NCT00527514|62797944|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
33419842|NCT00527514|62797944|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
33419843|NCT00527514|62797944|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
33419844|NCT00527514|62797944|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
33419845|NCT00527514|62797944|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
33419846|NCT00618449|62797957|FG000|Overall Study|Lost to Follow-up|98|||
33419847|NCT00618449|62797958|FG001|Overall Study|Lost to Follow-up|110|||
33419848|NCT03684642|62797967|FG000|Overall Study|Adverse Event|6|||
33419849|NCT03684642|62797968|FG001|Overall Study|Adverse Event|15|||
33419850|NCT03684642|62797969|FG002|Overall Study|Adverse Event|11|||
33419851|NCT03684642|62797967|FG000|Overall Study|Withdrawal by Subject|35|||
33419852|NCT03684642|62797968|FG001|Overall Study|Withdrawal by Subject|53|||
33419853|NCT03684642|62797969|FG002|Overall Study|Withdrawal by Subject|23|||
33419854|NCT03684642|62797967|FG000|Overall Study|Lack of Efficacy|0|||
33419855|NCT03684642|62797968|FG001|Overall Study|Lack of Efficacy|0|||
33419856|NCT03684642|62797969|FG002|Overall Study|Lack of Efficacy|1|||
33419857|NCT03684642|62797967|FG000|Overall Study|Poor compliance to protocol|0|||
33419858|NCT03684642|62797968|FG001|Overall Study|Poor compliance to protocol|4|||
33419859|NCT03684642|62797969|FG002|Overall Study|Poor compliance to protocol|1|||
33419860|NCT03684642|62797967|FG000|Overall Study|Other than specified|62|||
33419861|NCT03684642|62797968|FG001|Overall Study|Other than specified|60|||
33419862|NCT03684642|62797969|FG002|Overall Study|Other than specified|67|||
33419863|NCT03684642|62797967|FG000|Overall Study|Randomized and not treated|0|||
33419864|NCT03684642|62797968|FG001|Overall Study|Randomized and not treated|0|||
33419865|NCT03684642|62797969|FG002|Overall Study|Randomized and not treated|1|||
33419866|NCT03684642|62797967|FG000|Overall Study|Missing completion status but alive at last contact|0|||
33419867|NCT03684642|62797968|FG001|Overall Study|Missing completion status but alive at last contact|1|||
33605179|NCT02368691|63004889|FG000|Overall Study|Death|13|||
33605180|NCT02368691|63004889|FG000|Overall Study|Lack of Efficacy|15|||
33605181|NCT02368691|63004889|FG000|Overall Study|Physician Decision|4|||
33605182|NCT02394665|63004896|FG000|Overall Study|Physician Decision|1|||
33605183|NCT02394665|63004897|FG001|Overall Study|Physician Decision|0|||
33605184|NCT02394665|63004898|FG002|Overall Study|Physician Decision|0|||
33605185|NCT02367911|63004908|FG000|Overall Study|Withdrawal by Subject|3|||
33605186|NCT02367911|63004909|FG001|Overall Study|Withdrawal by Subject|2|||
33605187|NCT02367911|63004908|FG000|Overall Study|Lost to Follow-up|2|||
33605188|NCT02367911|63004909|FG001|Overall Study|Lost to Follow-up|2|||
33605189|NCT02339285|63004918|FG000|Overall Study|Withdrawal by Subject|0|||
33605190|NCT02339285|63004919|FG001|Overall Study|Withdrawal by Subject|1|||
33605191|NCT02339285|63004920|FG002|Overall Study|Withdrawal by Subject|1|||
33419868|NCT03684642|62797969|FG002|Overall Study|Missing completion status but alive at last contact|2|||
33605192|NCT02339285|63004918|FG000|Overall Study|Lost to Follow-up|1|||
33605193|NCT02339285|63004919|FG001|Overall Study|Lost to Follow-up|1|||
33419869|NCT00519636|62797981|FG000|Treatment Period 1|Adverse Event|1|||
33419870|NCT00519636|62797982|FG001|Treatment Period 1|Adverse Event|0|||
33419871|NCT00519636|62797983|FG002|Treatment Period 1|Adverse Event|1|||
33419872|NCT00519636|62797984|FG003|Treatment Period 1|Adverse Event|0|||
33605194|NCT02339285|63004920|FG002|Overall Study|Lost to Follow-up|1|||
33419873|NCT00519636|62797981|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
33419874|NCT00519636|62797982|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
33419875|NCT00519636|62797983|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
33419876|NCT00519636|62797984|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
33419877|NCT00519636|62797981|FG000|Washout Period|Adverse Event|2|||
33419878|NCT00519636|62797982|FG001|Washout Period|Adverse Event|1|||
33419879|NCT00519636|62797983|FG002|Washout Period|Adverse Event|1|||
33419880|NCT00519636|62797984|FG003|Washout Period|Adverse Event|0|||
33419881|NCT00519636|62797981|FG000|Washout Period|Lost to Follow-up|1|||
33419882|NCT00519636|62797982|FG001|Washout Period|Lost to Follow-up|0|||
33419883|NCT00519636|62797983|FG002|Washout Period|Lost to Follow-up|0|||
33419884|NCT00519636|62797984|FG003|Washout Period|Lost to Follow-up|0|||
33419885|NCT00519636|62797981|FG000|Washout Period|Protocol Violation|0|||
33419886|NCT00519636|62797982|FG001|Washout Period|Protocol Violation|0|||
33419887|NCT00519636|62797983|FG002|Washout Period|Protocol Violation|1|||
33419888|NCT00519636|62797984|FG003|Washout Period|Protocol Violation|2|||
33419889|NCT00519636|62797981|FG000|Washout Period|Withdrawal by Subject|1|||
33419890|NCT00519636|62797982|FG001|Washout Period|Withdrawal by Subject|0|||
33419891|NCT00519636|62797983|FG002|Washout Period|Withdrawal by Subject|1|||
33419892|NCT00519636|62797984|FG003|Washout Period|Withdrawal by Subject|0|||
33419893|NCT00519636|62797981|FG000|Washout Period|Failed to meet continuation criteria|14|||
33419894|NCT00519636|62797982|FG001|Washout Period|Failed to meet continuation criteria|11|||
33419895|NCT00519636|62797983|FG002|Washout Period|Failed to meet continuation criteria|9|||
33419896|NCT00519636|62797984|FG003|Washout Period|Failed to meet continuation criteria|3|||
33419897|NCT00519636|62797981|FG000|Washout Period|Out of pollen area > 48 hours|1|||
33419898|NCT00519636|62797982|FG001|Washout Period|Out of pollen area > 48 hours|0|||
33419899|NCT00519636|62797983|FG002|Washout Period|Out of pollen area > 48 hours|0|||
33419900|NCT00519636|62797984|FG003|Washout Period|Out of pollen area > 48 hours|0|||
33419901|NCT00519636|62797981|FG000|Washout Period|Participating in study at another site|1|||
33419902|NCT00519636|62797982|FG001|Washout Period|Participating in study at another site|0|||
33419903|NCT00519636|62797983|FG002|Washout Period|Participating in study at another site|0|||
33419904|NCT00519636|62797984|FG003|Washout Period|Participating in study at another site|0|||
33419905|NCT00519636|62797981|FG000|Washout Period|Non-compliant|0|||
33419906|NCT00519636|62797982|FG001|Washout Period|Non-compliant|1|||
33419907|NCT00519636|62797983|FG002|Washout Period|Non-compliant|0|||
33419908|NCT00519636|62797984|FG003|Washout Period|Non-compliant|0|||
33419909|NCT00519636|62797981|FG000|Washout Period|Per doctors request|0|||
33419910|NCT00519636|62797982|FG001|Washout Period|Per doctors request|1|||
33419911|NCT00519636|62797983|FG002|Washout Period|Per doctors request|0|||
33419912|NCT00519636|62797984|FG003|Washout Period|Per doctors request|0|||
33419913|NCT00519636|62797981|FG000|Washout Period|Subject randomized in error|0|||
33419914|NCT00519636|62797982|FG001|Washout Period|Subject randomized in error|0|||
33419915|NCT00519636|62797983|FG002|Washout Period|Subject randomized in error|1|||
33419916|NCT00519636|62797984|FG003|Washout Period|Subject randomized in error|0|||
33419917|NCT00519636|62797981|FG000|Washout Period|Prohibited medications|0|||
33419918|NCT00519636|62797982|FG001|Washout Period|Prohibited medications|0|||
33419919|NCT00519636|62797983|FG002|Washout Period|Prohibited medications|1|||
33419920|NCT00519636|62797984|FG003|Washout Period|Prohibited medications|0|||
33419921|NCT00519636|62797981|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
33419922|NCT00519636|62797982|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
33419923|NCT00519636|62797983|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
33419924|NCT00519636|62797984|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
33419925|NCT00519636|62797981|FG000|Treatment Period 2|Subject randomized in error|0|||
33419926|NCT00519636|62797982|FG001|Treatment Period 2|Subject randomized in error|1|||
33419927|NCT00519636|62797983|FG002|Treatment Period 2|Subject randomized in error|0|||
33419928|NCT00519636|62797984|FG003|Treatment Period 2|Subject randomized in error|0|||
33419929|NCT00519636|62797981|FG000|Treatment Period 2|Per doctors request|0|||
33419930|NCT00519636|62797982|FG001|Treatment Period 2|Per doctors request|0|||
33419931|NCT00519636|62797983|FG002|Treatment Period 2|Per doctors request|1|||
33419932|NCT00519636|62797984|FG003|Treatment Period 2|Per doctors request|0|||
33419933|NCT00519636|62797981|FG000|Treatment Period 2|Subject misrandomized|0|||
33419934|NCT00519636|62797982|FG001|Treatment Period 2|Subject misrandomized|0|||
33419935|NCT00519636|62797983|FG002|Treatment Period 2|Subject misrandomized|0|||
33419936|NCT00519636|62797984|FG003|Treatment Period 2|Subject misrandomized|1|||
33419937|NCT00519636|62797981|FG000|Post Study Period|Subject randomized in error|0|||
33419938|NCT00519636|62797982|FG001|Post Study Period|Subject randomized in error|0|||
33419939|NCT00519636|62797983|FG002|Post Study Period|Subject randomized in error|0|||
33419940|NCT00519636|62797984|FG003|Post Study Period|Subject randomized in error|1|||
33419941|NCT00618371|62797998|FG000|Overall Study|Withdrawal by Subject|2|||
33419942|NCT00526890|62798003|FG000|Overall Study|Adverse Event|2|||
33419943|NCT03864900|62798009|FG000|Overall Study|Withdrawal by Subject|1|||
33419944|NCT03864900|62798010|FG001|Overall Study|Withdrawal by Subject|1|||
33419945|NCT03864900|62798009|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
33419946|NCT03864900|62798010|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
33419947|NCT00526656|62798016|FG000|Overall Study|Death|1|||
33419948|NCT00526656|62798016|FG000|Overall Study|Refused surgery|1|||
33419949|NCT00617903|62798023|FG000|Overall Study|Withdrawal by Subject|2|||
33419950|NCT00617903|62798024|FG001|Overall Study|Withdrawal by Subject|3|||
33419951|NCT00617903|62798023|FG000|Overall Study|Lost to Follow-up|1|||
33419952|NCT00617903|62798024|FG001|Overall Study|Lost to Follow-up|1|||
33419953|NCT00617903|62798023|FG000|Overall Study|Lack of Efficacy|0|||
33419954|NCT00617903|62798024|FG001|Overall Study|Lack of Efficacy|1|||
33419955|NCT00617903|62798023|FG000|Overall Study|Adverse Event|0|||
33419956|NCT00617903|62798024|FG001|Overall Study|Adverse Event|1|||
33419957|NCT00617903|62798023|FG000|Overall Study|noncompliance|0|||
33419958|NCT00617903|62798024|FG001|Overall Study|noncompliance|1|||
33419959|NCT00526110|62798032|FG000|Overall Study|Adverse Event|2|||
33419960|NCT00526110|62798033|FG001|Overall Study|Adverse Event|9|||
33419961|NCT00526110|62798032|FG000|Overall Study|Disease Progression|0|||
33419962|NCT00526110|62798033|FG001|Overall Study|Disease Progression|19|||
33419963|NCT00526110|62798032|FG000|Overall Study|Maximal Response|0|||
33419964|NCT00526110|62798033|FG001|Overall Study|Maximal Response|6|||
33419965|NCT00526110|62798032|FG000|Overall Study|Withdrawal by Subject|0|||
33419966|NCT00526110|62798033|FG001|Overall Study|Withdrawal by Subject|2|||
33419967|NCT00526110|62798032|FG000|Overall Study|Poor Tolerance|0|||
33419968|NCT00526110|62798033|FG001|Overall Study|Poor Tolerance|5|||
33419969|NCT00512148|62798039|FG000|Primay Study Period|Withdrawal by Subject|1|||
33419970|NCT00511836|62798047|FG000|Double-blind Period|Lost to Follow-up|1|||
33419971|NCT00511836|62798048|FG001|Double-blind Period|Lost to Follow-up|0|||
33419972|NCT00573755|62798070|FG000|Overall Study|Still receiving treatment|1|||
33419973|NCT00573755|62798071|FG001|Overall Study|Still receiving treatment|0|||
33419974|NCT00524316|62798077|FG000|Overall Study|Withdrawal by Subject|2|||
33419975|NCT00524316|62798077|FG000|Overall Study|Adverse Event|7|||
33419976|NCT00524316|62798077|FG000|Overall Study|Disease Progression|7|||
33419977|NCT03861936|62798094|FG000|Overall Study|Withdrawal by Subject|4|||
33419978|NCT03861936|62798095|FG001|Overall Study|Withdrawal by Subject|1|||
33419979|NCT03861936|62798096|FG002|Overall Study|Withdrawal by Subject|3|||
33419980|NCT03861936|62798094|FG000|Overall Study|Lost to Follow-up|5|||
33419981|NCT03861936|62798095|FG001|Overall Study|Lost to Follow-up|3|||
33419982|NCT03861936|62798096|FG002|Overall Study|Lost to Follow-up|3|||
33419983|NCT03861936|62798094|FG000|Overall Study|Physician Decision|0|||
33419984|NCT03861936|62798095|FG001|Overall Study|Physician Decision|1|||
33419985|NCT03861936|62798096|FG002|Overall Study|Physician Decision|0|||
33419986|NCT03861936|62798094|FG000|Overall Study|Protocol Deviation|0|||
33419987|NCT03861936|62798095|FG001|Overall Study|Protocol Deviation|0|||
33419988|NCT03861936|62798096|FG002|Overall Study|Protocol Deviation|1|||
33419989|NCT03861936|62798094|FG000|Overall Study|Reason not Specified|5|||
33419990|NCT03861936|62798095|FG001|Overall Study|Reason not Specified|5|||
33419991|NCT03861936|62798096|FG002|Overall Study|Reason not Specified|3|||
33419992|NCT00434577|62798109|FG000|Months 0-3|Serious Adverse Event|0|||
33419993|NCT00434577|62798110|FG001|Months 0-3|Serious Adverse Event|0|||
33419994|NCT00434577|62798111|FG002|Months 0-3|Serious Adverse Event|1|||
33419995|NCT00434577|62798112|FG003|Months 0-3|Serious Adverse Event|0|||
33419996|NCT00434577|62798113|FG004|Months 0-3|Serious Adverse Event|0|||
33419997|NCT00434577|62798109|FG000|Months 0-3|Adverse Event|0|||
33419998|NCT00434577|62798110|FG001|Months 0-3|Adverse Event|1|||
33419999|NCT00434577|62798111|FG002|Months 0-3|Adverse Event|1|||
33420000|NCT00434577|62798112|FG003|Months 0-3|Adverse Event|0|||
33420001|NCT00434577|62798113|FG004|Months 0-3|Adverse Event|0|||
33420002|NCT00434577|62798109|FG000|Months 0-3|Lost to Follow-up|0|||
33420003|NCT00434577|62798110|FG001|Months 0-3|Lost to Follow-up|0|||
33420004|NCT00434577|62798111|FG002|Months 0-3|Lost to Follow-up|0|||
33420005|NCT00434577|62798112|FG003|Months 0-3|Lost to Follow-up|0|||
33420006|NCT00434577|62798113|FG004|Months 0-3|Lost to Follow-up|2|||
33420007|NCT00434577|62798109|FG000|Months 0-3|Protocol Violation|1|||
33420008|NCT00434577|62798110|FG001|Months 0-3|Protocol Violation|0|||
33420009|NCT00434577|62798111|FG002|Months 0-3|Protocol Violation|1|||
33420010|NCT00434577|62798112|FG003|Months 0-3|Protocol Violation|0|||
33420011|NCT00434577|62798113|FG004|Months 0-3|Protocol Violation|0|||
33420012|NCT00434577|62798109|FG000|Months 0-3|Withdrawal by Subject|2|||
33420013|NCT00434577|62798110|FG001|Months 0-3|Withdrawal by Subject|1|||
33420014|NCT00434577|62798111|FG002|Months 0-3|Withdrawal by Subject|1|||
33420015|NCT00434577|62798112|FG003|Months 0-3|Withdrawal by Subject|1|||
33420016|NCT00434577|62798113|FG004|Months 0-3|Withdrawal by Subject|1|||
33420017|NCT00434421|62798125|FG000|Overall Study|Withdrawal by Subject|1|||
33420018|NCT00434421|62798125|FG000|Overall Study|Non-compliance with study treatment|1|||
33420019|NCT00421707|62798131|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
33420020|NCT00421707|62798132|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
33420021|NCT00421707|62798131|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
33420022|NCT00421707|62798132|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
33420023|NCT00421707|62798131|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
33420024|NCT00421707|62798132|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
33420025|NCT00421707|62798131|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
33420026|NCT00421707|62798132|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
33420027|NCT00421707|62798131|FG000|Period 2: Washout|Adverse Event|1|||
33420028|NCT00421707|62798132|FG001|Period 2: Washout|Adverse Event|1|||
33420029|NCT00421707|62798131|FG000|Period 2: Washout|Withdrawal by Subject|0|||
33420030|NCT00421707|62798132|FG001|Period 2: Washout|Withdrawal by Subject|1|||
33420031|NCT00421707|62798131|FG000|Period 2: Washout|Lost to Follow-up|0|||
33420032|NCT00421707|62798132|FG001|Period 2: Washout|Lost to Follow-up|1|||
33420033|NCT00421707|62798131|FG000|Period 2: Washout|Other: Pregnancy|0|||
33420034|NCT00421707|62798132|FG001|Period 2: Washout|Other: Pregnancy|1|||
33420035|NCT00421707|62798131|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
33420036|NCT00421707|62798132|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
33420037|NCT00421707|62798131|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
33420038|NCT00421707|62798132|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
33420039|NCT00421707|62798131|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
33420040|NCT00421707|62798132|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
33420041|NCT00518622|62798158|FG000|Overall Study|Lost to Follow-up|0|||
33420042|NCT00518622|62798159|FG001|Overall Study|Lost to Follow-up|0|||
33420043|NCT00518622|62798160|FG002|Overall Study|Lost to Follow-up|1|||
33420044|NCT00518622|62798161|FG003|Overall Study|Lost to Follow-up|0|||
33420045|NCT00518622|62798162|FG004|Overall Study|Lost to Follow-up|0|||
33420046|NCT00518622|62798163|FG005|Overall Study|Lost to Follow-up|0|||
33420047|NCT00518622|62798164|FG006|Overall Study|Lost to Follow-up|0|||
33420048|NCT00518622|62798165|FG007|Overall Study|Lost to Follow-up|0|||
33420049|NCT00518622|62798158|FG000|Overall Study|Study medication taken incorrectly|0|||
33420050|NCT00518622|62798159|FG001|Overall Study|Study medication taken incorrectly|1|||
33420051|NCT00518622|62798160|FG002|Overall Study|Study medication taken incorrectly|0|||
33420052|NCT00518622|62798161|FG003|Overall Study|Study medication taken incorrectly|0|||
33420053|NCT00518622|62798162|FG004|Overall Study|Study medication taken incorrectly|0|||
33420054|NCT00518622|62798163|FG005|Overall Study|Study medication taken incorrectly|0|||
33420055|NCT00518622|62798164|FG006|Overall Study|Study medication taken incorrectly|0|||
33420056|NCT00518622|62798165|FG007|Overall Study|Study medication taken incorrectly|0|||
33420057|NCT03783078|62798183|FG000|Overall Study|Participants Ongoing|29|||
33420058|NCT03783078|62798183|FG000|Overall Study|Death|26|||
33420059|NCT00517296|62798189|FG000|Overall Study|Withdrawal by Subject|1|||
33420060|NCT00517296|62798190|FG001|Overall Study|Withdrawal by Subject|0|||
33420061|NCT00516906|62798198|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
33420062|NCT00516906|62798199|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
33420063|NCT00523848|62798205|FG000|Overall Study|Adverse Event|11|||
33420064|NCT00523848|62798205|FG000|Overall Study|Withdrawal by Subject|2|||
33605195|NCT02339285|63004918|FG000|Overall Study|Protocol Deviation|0|||
33420065|NCT00523848|62798205|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
33420066|NCT00523848|62798205|FG000|Overall Study|Disease Progression|5|||
33420067|NCT00523848|62798205|FG000|Overall Study|Other, unspecified|4|||
33420068|NCT00617669|62798211|FG000|Overall Study|Withdrawal by Subject|71|||
33420069|NCT00617669|62798212|FG001|Overall Study|Withdrawal by Subject|77|||
33420070|NCT00617669|62798211|FG000|Overall Study|Lost to Follow-up|3|||
33420071|NCT00617669|62798212|FG001|Overall Study|Lost to Follow-up|2|||
33420072|NCT00617669|62798211|FG000|Overall Study|Adverse Event|87|||
33420073|NCT00617669|62798212|FG001|Overall Study|Adverse Event|76|||
33420074|NCT00617669|62798211|FG000|Overall Study|Protocol Violation|2|||
33420075|NCT00617669|62798212|FG001|Overall Study|Protocol Violation|3|||
33420076|NCT00617669|62798211|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
33420077|NCT00617669|62798212|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
33420078|NCT00617669|62798211|FG000|Overall Study|Patients randomized but not treated|2|||
33420079|NCT00617669|62798212|FG001|Overall Study|Patients randomized but not treated|3|||
33420080|NCT03682848|62798218|FG000|Overall Study|Withdrawal by Subject|2|||
33420081|NCT03682848|62798218|FG000|Overall Study|Site closed|5|||
33420082|NCT03682848|62798218|FG000|Overall Study|Protocol Deviation|1|||
33420083|NCT03682848|62798218|FG000|Overall Study|Adverse Event|1|||
33420084|NCT00510510|62798225|FG000|Overall Study|Adverse Event|4|||
33420085|NCT00510510|62798226|FG001|Overall Study|Adverse Event|3|||
33420086|NCT00510510|62798227|FG002|Overall Study|Adverse Event|6|||
33420087|NCT00510510|62798225|FG000|Overall Study|Lack of Efficacy|0|||
33420088|NCT00510510|62798226|FG001|Overall Study|Lack of Efficacy|1|||
33420089|NCT00510510|62798227|FG002|Overall Study|Lack of Efficacy|1|||
33420090|NCT00510510|62798225|FG000|Overall Study|Subjects no longer requires study drug|0|||
33420091|NCT00510510|62798226|FG001|Overall Study|Subjects no longer requires study drug|0|||
33420092|NCT00510510|62798227|FG002|Overall Study|Subjects no longer requires study drug|2|||
33420093|NCT00510510|62798225|FG000|Overall Study|Withdrawal by Subject|1|||
33420094|NCT00510510|62798226|FG001|Overall Study|Withdrawal by Subject|2|||
33420095|NCT00510510|62798227|FG002|Overall Study|Withdrawal by Subject|3|||
33420096|NCT00510510|62798225|FG000|Overall Study|Lost to Follow-up|0|||
33420097|NCT00510510|62798226|FG001|Overall Study|Lost to Follow-up|0|||
33420098|NCT00510510|62798227|FG002|Overall Study|Lost to Follow-up|1|||
33420099|NCT00510510|62798225|FG000|Overall Study|Protocol Violation|0|||
33420100|NCT00510510|62798226|FG001|Overall Study|Protocol Violation|3|||
33420101|NCT00510510|62798227|FG002|Overall Study|Protocol Violation|4|||
33420102|NCT00617591|62798235|FG000|Overall Study|Withdrew consent during Induction|4|||
33420103|NCT00617591|62798235|FG000|Overall Study|Withdrew consent during Maintenance|6|||
33420104|NCT00510276|62798242|FG000|Acute Double-Blind Phase|Adverse Event|21|||
33420105|NCT00510276|62798243|FG001|Acute Double-Blind Phase|Adverse Event|6|||
33420106|NCT00510276|62798242|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
33420107|NCT00510276|62798243|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
33420108|NCT00510276|62798242|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
33420109|NCT00510276|62798243|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
33420110|NCT00510276|62798242|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
33420111|NCT00510276|62798243|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
33420112|NCT00510276|62798242|FG000|Acute Double-Blind Phase|Physician Decision|0|||
33420113|NCT00510276|62798243|FG001|Acute Double-Blind Phase|Physician Decision|3|||
33420114|NCT00510276|62798242|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
33420115|NCT00510276|62798243|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
33420116|NCT00510276|62798242|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
33420117|NCT00510276|62798243|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
33420118|NCT00510276|62798242|FG000|Acute Double-Blind Phase|Subject Decision|26|||
33420119|NCT00510276|62798243|FG001|Acute Double-Blind Phase|Subject Decision|28|||
33605196|NCT02339285|63004919|FG001|Overall Study|Protocol Deviation|1|||
33322918|NCT00976989|62699074|FG001|Overall Study|Failure to Return|1|||
33420120|NCT00510276|62798242|FG000|Extension Open-Label Phase|Adverse Event|9|||
33420121|NCT00510276|62798243|FG001|Extension Open-Label Phase|Adverse Event|18|||
33420122|NCT00510276|62798242|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
33420123|NCT00510276|62798243|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
33420124|NCT00510276|62798242|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
33420125|NCT00510276|62798243|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
33420126|NCT00510276|62798242|FG000|Extension Open-Label Phase|Physician Decision|2|||
33420127|NCT00510276|62798243|FG001|Extension Open-Label Phase|Physician Decision|3|||
33420128|NCT00510276|62798242|FG000|Extension Open-Label Phase|Protocol Violation|0|||
33420129|NCT00510276|62798243|FG001|Extension Open-Label Phase|Protocol Violation|1|||
33420130|NCT00510276|62798242|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
33420131|NCT00510276|62798243|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
33420132|NCT00510276|62798242|FG000|Extension Open-Label Phase|Subject Decision|7|||
33420133|NCT00510276|62798243|FG001|Extension Open-Label Phase|Subject Decision|9|||
33420134|NCT00616655|62798259|FG000|Overall Study|Adverse Event|10|||
33420135|NCT00616655|62798260|FG001|Overall Study|Adverse Event|7|||
33420136|NCT00616655|62798261|FG002|Overall Study|Adverse Event|12|||
33420137|NCT00616655|62798259|FG000|Overall Study|Lack of Efficacy|5|||
33420138|NCT00616655|62798260|FG001|Overall Study|Lack of Efficacy|5|||
33420139|NCT00616655|62798261|FG002|Overall Study|Lack of Efficacy|5|||
33420140|NCT00616655|62798259|FG000|Overall Study|Lost to Follow-up|3|||
33420141|NCT00616655|62798260|FG001|Overall Study|Lost to Follow-up|12|||
33420142|NCT00616655|62798261|FG002|Overall Study|Lost to Follow-up|10|||
33420143|NCT00616655|62798259|FG000|Overall Study|Protocol Violation|2|||
33420144|NCT00616655|62798260|FG001|Overall Study|Protocol Violation|4|||
33420145|NCT00616655|62798261|FG002|Overall Study|Protocol Violation|3|||
33420146|NCT00616655|62798259|FG000|Overall Study|Withdrawal by Subject|9|||
33420147|NCT00616655|62798260|FG001|Overall Study|Withdrawal by Subject|7|||
33420148|NCT00616655|62798261|FG002|Overall Study|Withdrawal by Subject|11|||
33420149|NCT00616655|62798259|FG000|Overall Study|Does not meet in/ex criteria|0|||
33420150|NCT00616655|62798260|FG001|Overall Study|Does not meet in/ex criteria|0|||
33420151|NCT00616655|62798261|FG002|Overall Study|Does not meet in/ex criteria|2|||
33420152|NCT00616655|62798259|FG000|Overall Study|Other|6|||
33420153|NCT00616655|62798260|FG001|Overall Study|Other|6|||
33420154|NCT00616655|62798261|FG002|Overall Study|Other|5|||
33420155|NCT00510198|62798271|FG000|Overall Study|Withdrawal by Subject|5|||
33420156|NCT00510198|62798272|FG001|Overall Study|Withdrawal by Subject|4|||
33420157|NCT00516048|62798282|FG000|Overall Study|Death|0|||
33420158|NCT00516048|62798283|FG001|Overall Study|Death|0|||
33420159|NCT00516048|62798284|FG002|Overall Study|Death|1|||
33420160|NCT00516048|62798282|FG000|Overall Study|Subject Decision|0|||
33420161|NCT00516048|62798283|FG001|Overall Study|Subject Decision|2|||
33420162|NCT00516048|62798284|FG002|Overall Study|Subject Decision|0|||
33420163|NCT00617357|62798292|FG000|Overall Study|Lost to Follow-up|7|||
33420164|NCT00617357|62798292|FG000|Overall Study|Death|5|||
33420165|NCT00617357|62798292|FG000|Overall Study|insurance concerns|2|||
33420166|NCT00617357|62798292|FG000|Overall Study|Withdrawal by Subject|1|||
33420167|NCT00617357|62798292|FG000|Overall Study|Physician Decision|1|||
33420168|NCT00420927|62798304|FG000|Period 1|Adverse Event|19|||
33420169|NCT00420927|62798305|FG001|Period 1|Adverse Event|15|||
33420170|NCT00420927|62798306|FG002|Period 1|Adverse Event|0|||
33420171|NCT00420927|62798307|FG003|Period 1|Adverse Event|0|||
33420172|NCT00420927|62798308|FG004|Period 1|Adverse Event|0|||
33420173|NCT00420927|62798309|FG005|Period 1|Adverse Event|0|||
33420174|NCT00420927|62798310|FG006|Period 1|Adverse Event|0|||
33420175|NCT00420927|62798304|FG000|Period 1|Withdrawal by Subject|7|||
33420176|NCT00420927|62798305|FG001|Period 1|Withdrawal by Subject|12|||
33420177|NCT00420927|62798306|FG002|Period 1|Withdrawal by Subject|0|||
33420178|NCT00420927|62798307|FG003|Period 1|Withdrawal by Subject|0|||
33322919|NCT00976989|62699075|FG002|Overall Study|Failure to Return|0|||
33420179|NCT00420927|62798308|FG004|Period 1|Withdrawal by Subject|0|||
33420180|NCT00420927|62798309|FG005|Period 1|Withdrawal by Subject|0|||
33420181|NCT00420927|62798310|FG006|Period 1|Withdrawal by Subject|0|||
33420182|NCT00420927|62798304|FG000|Period 1|Lost to Follow-up|8|||
33420183|NCT00420927|62798305|FG001|Period 1|Lost to Follow-up|6|||
33420184|NCT00420927|62798306|FG002|Period 1|Lost to Follow-up|0|||
33420185|NCT00420927|62798307|FG003|Period 1|Lost to Follow-up|0|||
33420186|NCT00420927|62798308|FG004|Period 1|Lost to Follow-up|0|||
33420187|NCT00420927|62798309|FG005|Period 1|Lost to Follow-up|0|||
33420188|NCT00420927|62798310|FG006|Period 1|Lost to Follow-up|0|||
33420189|NCT00420927|62798304|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
33605197|NCT02339285|63004920|FG002|Overall Study|Protocol Deviation|0|||
33420190|NCT00420927|62798305|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
33420191|NCT00420927|62798306|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
33420192|NCT00420927|62798307|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
33420193|NCT00420927|62798308|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
33420194|NCT00420927|62798309|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
33420195|NCT00420927|62798310|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
33420196|NCT00420927|62798304|FG000|Period 1|Death|2|||
33420197|NCT00420927|62798305|FG001|Period 1|Death|0|||
33420198|NCT00420927|62798306|FG002|Period 1|Death|0|||
33420199|NCT00420927|62798307|FG003|Period 1|Death|0|||
33420200|NCT00420927|62798308|FG004|Period 1|Death|0|||
33420201|NCT00420927|62798309|FG005|Period 1|Death|0|||
33420202|NCT00420927|62798310|FG006|Period 1|Death|0|||
33420203|NCT00420927|62798304|FG000|Period 1|Subject moved/relocated|0|||
33420204|NCT00420927|62798305|FG001|Period 1|Subject moved/relocated|2|||
33420205|NCT00420927|62798306|FG002|Period 1|Subject moved/relocated|0|||
33420206|NCT00420927|62798307|FG003|Period 1|Subject moved/relocated|0|||
33420207|NCT00420927|62798308|FG004|Period 1|Subject moved/relocated|0|||
33420208|NCT00420927|62798309|FG005|Period 1|Subject moved/relocated|0|||
33420209|NCT00420927|62798310|FG006|Period 1|Subject moved/relocated|0|||
33420210|NCT00420927|62798304|FG000|Period 1|Noncompliant with study drug|1|||
33420211|NCT00420927|62798305|FG001|Period 1|Noncompliant with study drug|1|||
33420212|NCT00420927|62798306|FG002|Period 1|Noncompliant with study drug|0|||
33420213|NCT00420927|62798307|FG003|Period 1|Noncompliant with study drug|0|||
33420214|NCT00420927|62798308|FG004|Period 1|Noncompliant with study drug|0|||
33420215|NCT00420927|62798309|FG005|Period 1|Noncompliant with study drug|0|||
33420216|NCT00420927|62798310|FG006|Period 1|Noncompliant with study drug|0|||
33420217|NCT00420927|62798304|FG000|Period 1|Randomization error|1|||
33420218|NCT00420927|62798305|FG001|Period 1|Randomization error|0|||
33420219|NCT00420927|62798306|FG002|Period 1|Randomization error|0|||
33420220|NCT00420927|62798307|FG003|Period 1|Randomization error|0|||
33420221|NCT00420927|62798308|FG004|Period 1|Randomization error|0|||
33420222|NCT00420927|62798309|FG005|Period 1|Randomization error|0|||
33420223|NCT00420927|62798310|FG006|Period 1|Randomization error|0|||
33420224|NCT00420927|62798304|FG000|Period 1|Suspected tuberculosis/positive test|1|||
33420225|NCT00420927|62798305|FG001|Period 1|Suspected tuberculosis/positive test|1|||
33420226|NCT00420927|62798306|FG002|Period 1|Suspected tuberculosis/positive test|0|||
33420227|NCT00420927|62798307|FG003|Period 1|Suspected tuberculosis/positive test|0|||
33420228|NCT00420927|62798308|FG004|Period 1|Suspected tuberculosis/positive test|0|||
33420229|NCT00420927|62798309|FG005|Period 1|Suspected tuberculosis/positive test|0|||
33420230|NCT00420927|62798310|FG006|Period 1|Suspected tuberculosis/positive test|0|||
33420231|NCT00420927|62798304|FG000|Period 1|Study site closure|0|||
33420232|NCT00420927|62798305|FG001|Period 1|Study site closure|1|||
33420233|NCT00420927|62798306|FG002|Period 1|Study site closure|0|||
33420234|NCT00420927|62798307|FG003|Period 1|Study site closure|0|||
33420235|NCT00420927|62798308|FG004|Period 1|Study site closure|0|||
33420236|NCT00420927|62798309|FG005|Period 1|Study site closure|0|||
33420237|NCT00420927|62798310|FG006|Period 1|Study site closure|0|||
33420238|NCT00420927|62798304|FG000|Period 1|Subject received new diagnosis|0|||
33420239|NCT00420927|62798305|FG001|Period 1|Subject received new diagnosis|2|||
33420240|NCT00420927|62798306|FG002|Period 1|Subject received new diagnosis|0|||
33420241|NCT00420927|62798307|FG003|Period 1|Subject received new diagnosis|0|||
33420242|NCT00420927|62798308|FG004|Period 1|Subject received new diagnosis|0|||
33420243|NCT00420927|62798309|FG005|Period 1|Subject received new diagnosis|0|||
33420244|NCT00420927|62798310|FG006|Period 1|Subject received new diagnosis|0|||
33420245|NCT00420927|62798304|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
33420246|NCT00420927|62798305|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
33420247|NCT00420927|62798306|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
33420248|NCT00420927|62798307|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
33420249|NCT00420927|62798308|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
33420250|NCT00420927|62798309|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
33420251|NCT00420927|62798310|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
33420252|NCT00420927|62798304|FG000|Period 1|Failed to meet entry criteria|8|||
33420253|NCT00420927|62798305|FG001|Period 1|Failed to meet entry criteria|7|||
33420254|NCT00420927|62798306|FG002|Period 1|Failed to meet entry criteria|0|||
33420255|NCT00420927|62798307|FG003|Period 1|Failed to meet entry criteria|0|||
33420256|NCT00420927|62798308|FG004|Period 1|Failed to meet entry criteria|0|||
33420257|NCT00420927|62798309|FG005|Period 1|Failed to meet entry criteria|0|||
33420258|NCT00420927|62798310|FG006|Period 1|Failed to meet entry criteria|0|||
33420259|NCT00420927|62798304|FG000|Period 1|Took prohibited medication|1|||
33420260|NCT00420927|62798305|FG001|Period 1|Took prohibited medication|3|||
33420261|NCT00420927|62798306|FG002|Period 1|Took prohibited medication|0|||
33420262|NCT00420927|62798307|FG003|Period 1|Took prohibited medication|0|||
33420263|NCT00420927|62798308|FG004|Period 1|Took prohibited medication|0|||
33420264|NCT00420927|62798309|FG005|Period 1|Took prohibited medication|0|||
33420265|NCT00420927|62798310|FG006|Period 1|Took prohibited medication|0|||
33420266|NCT00420927|62798304|FG000|Period 2|Adverse Event|0|||
33420267|NCT00420927|62798305|FG001|Period 2|Adverse Event|0|||
33420268|NCT00420927|62798306|FG002|Period 2|Adverse Event|7|||
33420269|NCT00420927|62798307|FG003|Period 2|Adverse Event|3|||
33420270|NCT00420927|62798308|FG004|Period 2|Adverse Event|17|||
33420271|NCT00420927|62798309|FG005|Period 2|Adverse Event|6|||
33420272|NCT00420927|62798310|FG006|Period 2|Adverse Event|20|||
33420273|NCT00420927|62798304|FG000|Period 2|Withdrawal by Subject|0|||
33420274|NCT00420927|62798305|FG001|Period 2|Withdrawal by Subject|0|||
33420275|NCT00420927|62798306|FG002|Period 2|Withdrawal by Subject|1|||
33420276|NCT00420927|62798307|FG003|Period 2|Withdrawal by Subject|3|||
33420277|NCT00420927|62798308|FG004|Period 2|Withdrawal by Subject|11|||
33420278|NCT00420927|62798309|FG005|Period 2|Withdrawal by Subject|2|||
33420279|NCT00420927|62798310|FG006|Period 2|Withdrawal by Subject|12|||
33420280|NCT00420927|62798304|FG000|Period 2|Lost to Follow-up|0|||
33420281|NCT00420927|62798305|FG001|Period 2|Lost to Follow-up|0|||
33420282|NCT00420927|62798306|FG002|Period 2|Lost to Follow-up|2|||
33420283|NCT00420927|62798307|FG003|Period 2|Lost to Follow-up|2|||
33420284|NCT00420927|62798308|FG004|Period 2|Lost to Follow-up|6|||
33420285|NCT00420927|62798309|FG005|Period 2|Lost to Follow-up|3|||
33420286|NCT00420927|62798310|FG006|Period 2|Lost to Follow-up|9|||
33420287|NCT00420927|62798304|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
33420288|NCT00420927|62798305|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
33420289|NCT00420927|62798306|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
33420290|NCT00420927|62798307|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
33420291|NCT00420927|62798308|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
33420292|NCT00420927|62798309|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
33420293|NCT00420927|62798310|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
33420294|NCT00420927|62798304|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
33420295|NCT00420927|62798305|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
33420296|NCT00420927|62798306|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
33420297|NCT00420927|62798307|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
33420298|NCT00420927|62798308|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
33420299|NCT00420927|62798309|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
33420300|NCT00420927|62798310|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
33420301|NCT00420927|62798304|FG000|Period 2|Subject unable to find transportation|0|||
33420302|NCT00420927|62798305|FG001|Period 2|Subject unable to find transportation|0|||
33420303|NCT00420927|62798306|FG002|Period 2|Subject unable to find transportation|0|||
33420304|NCT00420927|62798307|FG003|Period 2|Subject unable to find transportation|0|||
33420305|NCT00420927|62798308|FG004|Period 2|Subject unable to find transportation|0|||
33420306|NCT00420927|62798309|FG005|Period 2|Subject unable to find transportation|0|||
33420307|NCT00420927|62798310|FG006|Period 2|Subject unable to find transportation|1|||
33420308|NCT00420927|62798304|FG000|Period 2|Physician Decision|0|||
33420309|NCT00420927|62798305|FG001|Period 2|Physician Decision|0|||
33420310|NCT00420927|62798306|FG002|Period 2|Physician Decision|0|||
33420311|NCT00420927|62798307|FG003|Period 2|Physician Decision|0|||
33420312|NCT00420927|62798308|FG004|Period 2|Physician Decision|1|||
33420313|NCT00420927|62798309|FG005|Period 2|Physician Decision|1|||
33420314|NCT00420927|62798310|FG006|Period 2|Physician Decision|0|||
33420315|NCT00420927|62798304|FG000|Period 2|Sponsor decision|0|||
33420316|NCT00420927|62798305|FG001|Period 2|Sponsor decision|0|||
33420317|NCT00420927|62798306|FG002|Period 2|Sponsor decision|1|||
33420318|NCT00420927|62798307|FG003|Period 2|Sponsor decision|0|||
33420319|NCT00420927|62798308|FG004|Period 2|Sponsor decision|0|||
33420320|NCT00420927|62798309|FG005|Period 2|Sponsor decision|0|||
33420321|NCT00420927|62798310|FG006|Period 2|Sponsor decision|1|||
33420322|NCT00420927|62798304|FG000|Period 2|Randomization error|0|||
33420323|NCT00420927|62798305|FG001|Period 2|Randomization error|0|||
33420324|NCT00420927|62798306|FG002|Period 2|Randomization error|0|||
33420325|NCT00420927|62798307|FG003|Period 2|Randomization error|0|||
33420326|NCT00420927|62798308|FG004|Period 2|Randomization error|1|||
33420327|NCT00420927|62798309|FG005|Period 2|Randomization error|1|||
33420328|NCT00420927|62798310|FG006|Period 2|Randomization error|0|||
33420329|NCT00420927|62798304|FG000|Period 2|Noncompliant with study drug|0|||
33420330|NCT00420927|62798305|FG001|Period 2|Noncompliant with study drug|0|||
33420331|NCT00420927|62798306|FG002|Period 2|Noncompliant with study drug|0|||
33420332|NCT00420927|62798307|FG003|Period 2|Noncompliant with study drug|1|||
33420333|NCT00420927|62798308|FG004|Period 2|Noncompliant with study drug|0|||
33420334|NCT00420927|62798309|FG005|Period 2|Noncompliant with study drug|0|||
33420335|NCT00420927|62798310|FG006|Period 2|Noncompliant with study drug|2|||
33420336|NCT00420927|62798304|FG000|Period 2|Methotrexate intolerance|0|||
33420337|NCT00420927|62798305|FG001|Period 2|Methotrexate intolerance|0|||
33420338|NCT00420927|62798306|FG002|Period 2|Methotrexate intolerance|0|||
33420339|NCT00420927|62798307|FG003|Period 2|Methotrexate intolerance|0|||
33420340|NCT00420927|62798308|FG004|Period 2|Methotrexate intolerance|0|||
33420341|NCT00420927|62798309|FG005|Period 2|Methotrexate intolerance|0|||
33420342|NCT00420927|62798310|FG006|Period 2|Methotrexate intolerance|1|||
33420343|NCT00420927|62798304|FG000|Period 2|Took prohibited medication|0|||
33420344|NCT00420927|62798305|FG001|Period 2|Took prohibited medication|0|||
33420345|NCT00420927|62798306|FG002|Period 2|Took prohibited medication|0|||
33420346|NCT00420927|62798307|FG003|Period 2|Took prohibited medication|0|||
33420347|NCT00420927|62798308|FG004|Period 2|Took prohibited medication|1|||
33420348|NCT00420927|62798309|FG005|Period 2|Took prohibited medication|0|||
33420349|NCT00420927|62798310|FG006|Period 2|Took prohibited medication|0|||
33420350|NCT00573443|62798327|FG000|Double-Blind Phase|Lost to Follow-up|1|||
33420351|NCT00573443|62798328|FG001|Double-Blind Phase|Lost to Follow-up|3|||
33420352|NCT00573443|62798329|FG002|Double-Blind Phase|Lost to Follow-up|2|||
33420353|NCT00573443|62798327|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
33420354|NCT00573443|62798328|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
33420355|NCT00573443|62798329|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
33420356|NCT00573443|62798327|FG000|Double-Blind Phase|Adverse Event|1|||
33420357|NCT00573443|62798328|FG001|Double-Blind Phase|Adverse Event|5|||
33420358|NCT00573443|62798329|FG002|Double-Blind Phase|Adverse Event|0|||
33420359|NCT00573443|62798327|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
33420360|NCT00573443|62798328|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
33420361|NCT00573443|62798329|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
33420362|NCT00573443|62798327|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
33420363|NCT00573443|62798328|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
33420364|NCT00573443|62798329|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
33420365|NCT00573443|62798327|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
33420366|NCT00573443|62798328|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
33420367|NCT00573443|62798329|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
33420368|NCT00573443|62798327|FG000|Double-Blind Phase|Protocol Violation|0|||
33420369|NCT00573443|62798328|FG001|Double-Blind Phase|Protocol Violation|2|||
33420370|NCT00573443|62798329|FG002|Double-Blind Phase|Protocol Violation|1|||
33420371|NCT00573443|62798327|FG000|Double-Blind Phase|Other|0|||
33420372|NCT00573443|62798328|FG001|Double-Blind Phase|Other|2|||
33420373|NCT00573443|62798329|FG002|Double-Blind Phase|Other|3|||
33420374|NCT00573443|62798327|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
33420375|NCT00573443|62798328|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
33420376|NCT00573443|62798329|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
33420377|NCT00573443|62798327|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
33420378|NCT00573443|62798328|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
33420379|NCT00573443|62798329|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
33420380|NCT00573443|62798327|FG000|Open-Label Extension Phase|Adverse Event|3|||
33420381|NCT00573443|62798328|FG001|Open-Label Extension Phase|Adverse Event|0|||
33420382|NCT00573443|62798329|FG002|Open-Label Extension Phase|Adverse Event|0|||
33420383|NCT00573443|62798327|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
33420384|NCT00573443|62798328|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
33420385|NCT00573443|62798329|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
33420386|NCT00573443|62798327|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
33420387|NCT00573443|62798328|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
33420388|NCT00573443|62798329|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
33420389|NCT00573443|62798327|FG000|Open-Label Extension Phase|Protocol Violation|2|||
33420390|NCT00573443|62798328|FG001|Open-Label Extension Phase|Protocol Violation|0|||
33420391|NCT00573443|62798329|FG002|Open-Label Extension Phase|Protocol Violation|0|||
33420392|NCT00573443|62798327|FG000|Open-Label Extension Phase|Other|2|||
33420393|NCT00573443|62798328|FG001|Open-Label Extension Phase|Other|0|||
33420394|NCT00573443|62798329|FG002|Open-Label Extension Phase|Other|0|||
33420395|NCT00420849|62798351|FG000|Overall Study|Lack of Efficacy|154|||
33420396|NCT00420849|62798351|FG000|Overall Study|Adverse Event|107|||
33420397|NCT00420849|62798351|FG000|Overall Study|Withdrawal by Subject|28|||
33420398|NCT00420849|62798351|FG000|Overall Study|Death|18|||
33420399|NCT00420849|62798351|FG000|Overall Study|Other|14|||
33420400|NCT00420849|62798351|FG000|Overall Study|Transplant|8|||
33420401|NCT00420849|62798351|FG000|Overall Study|Protocol Violation|1|||
33420402|NCT00420849|62798351|FG000|Overall Study|Lost to Follow-up|1|||
33420403|NCT00617279|62798360|FG000|Overall Study|Study terminated by Sponsor|10|||
33420404|NCT00617279|62798361|FG001|Overall Study|Study terminated by Sponsor|15|||
33420405|NCT00617279|62798360|FG000|Overall Study|Graft abandonment|2|||
33420406|NCT00617279|62798361|FG001|Overall Study|Graft abandonment|0|||
33420407|NCT00617279|62798360|FG000|Overall Study|Lost to Follow-up|1|||
33420408|NCT00617279|62798361|FG001|Overall Study|Lost to Follow-up|0|||
33420409|NCT00617279|62798360|FG000|Overall Study|Death|1|||
33420410|NCT00617279|62798361|FG001|Overall Study|Death|2|||
33420411|NCT00420381|62798367|FG000|Overall Study|Protocol Violation|1|||
33420412|NCT00617201|62798373|FG000|Overall Study|Lost to Follow-up|9|||
33420413|NCT00617201|62798374|FG001|Overall Study|Lost to Follow-up|13|||
33420414|NCT00420303|62798384|FG000|Overall Study|Serious Adverse Event|1|||
33420415|NCT00420303|62798385|FG001|Overall Study|Serious Adverse Event|0|||
33420416|NCT00420303|62798384|FG000|Overall Study|Lack of Efficacy|0|||
33420417|NCT00420303|62798385|FG001|Overall Study|Lack of Efficacy|3|||
33420418|NCT00420303|62798384|FG000|Overall Study|Physician Decision|0|||
33322920|NCT00976989|62699073|FG000|Overall Study|Recurrence of Disease|0|||
33420419|NCT00420303|62798385|FG001|Overall Study|Physician Decision|1|||
33420420|NCT00617123|62798393|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
33420421|NCT00617123|62798394|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
33420422|NCT00617123|62798393|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
33420423|NCT00617123|62798394|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
33420424|NCT00617123|62798393|FG000|Referral Screening Period|Adverse Event|0|||
33420425|NCT00617123|62798394|FG001|Referral Screening Period|Adverse Event|1|||
33420426|NCT00617123|62798393|FG000|Study Treatment Period|Withdrawal by Subject|8|||
33420427|NCT00617123|62798394|FG001|Study Treatment Period|Withdrawal by Subject|12|||
33420428|NCT00617123|62798393|FG000|Study Treatment Period|Adverse Event|7|||
33420429|NCT00617123|62798394|FG001|Study Treatment Period|Adverse Event|3|||
33420430|NCT00617123|62798393|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
33420431|NCT00617123|62798394|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
33420432|NCT00617123|62798393|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
33420433|NCT00617123|62798394|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
33420434|NCT00419757|62798402|FG000|Overall Study|Adverse Event|1|||
33420435|NCT00419757|62798403|FG001|Overall Study|Adverse Event|4|||
33420436|NCT00419757|62798402|FG000|Overall Study|Lost to Follow-up|1|||
33420437|NCT00419757|62798403|FG001|Overall Study|Lost to Follow-up|4|||
33420438|NCT00419757|62798402|FG000|Overall Study|Withdrawal by Subject|7|||
33420439|NCT00419757|62798403|FG001|Overall Study|Withdrawal by Subject|1|||
33420440|NCT00419757|62798402|FG000|Overall Study|Protocol Violation|2|||
33420441|NCT00419757|62798403|FG001|Overall Study|Protocol Violation|3|||
33420442|NCT00419757|62798402|FG000|Overall Study|Study specific discontinuation criteria|4|||
33420443|NCT00419757|62798403|FG001|Overall Study|Study specific discontinuation criteria|8|||
33420444|NCT00419757|62798402|FG000|Overall Study|Multiple reasons|3|||
33420445|NCT00419757|62798403|FG001|Overall Study|Multiple reasons|1|||
33420446|NCT00434109|62798411|FG000|Overall Study|Physician Decision|9|||
33420447|NCT00434109|62798411|FG000|Overall Study|Adverse Event|5|||
33420448|NCT00434109|62798411|FG000|Overall Study|Protocol Violation|1|||
33420449|NCT00434109|62798411|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
33420450|NCT00433329|62798415|FG000|Overall Study|Adverse Event|9|||
33420451|NCT00433329|62798415|FG000|Overall Study|Death|4|||
33420452|NCT00433329|62798415|FG000|Overall Study|Withdrew consent|3|||
33420453|NCT00433329|62798415|FG000|Overall Study|Discontinued sildenafil|2|||
33420454|NCT00433329|62798415|FG000|Overall Study|Moved out of state|1|||
33420455|NCT00433329|62798415|FG000|Overall Study|Lost to Follow-up|1|||
33420456|NCT00433329|62798415|FG000|Overall Study|Physician Decision|1|||
33420457|NCT00616421|62798422|FG000|Overall Study|Withdrawal by Subject|9|||
33420458|NCT00616421|62798423|FG001|Overall Study|Withdrawal by Subject|11|||
33420459|NCT00616421|62798424|FG002|Overall Study|Withdrawal by Subject|8|||
33420460|NCT00616421|62798422|FG000|Overall Study|Lost to Follow-up|12|||
33420461|NCT00616421|62798423|FG001|Overall Study|Lost to Follow-up|26|||
33420462|NCT00616421|62798424|FG002|Overall Study|Lost to Follow-up|30|||
33420463|NCT00616421|62798422|FG000|Overall Study|Inappropriate enrollment|3|||
33420464|NCT00616421|62798423|FG001|Overall Study|Inappropriate enrollment|0|||
33420465|NCT00616421|62798424|FG002|Overall Study|Inappropriate enrollment|1|||
33420466|NCT00616421|62798422|FG000|Overall Study|Administrative reason|1|||
33420467|NCT00616421|62798423|FG001|Overall Study|Administrative reason|0|||
33420468|NCT00616421|62798424|FG002|Overall Study|Administrative reason|0|||
33420469|NCT00616421|62798422|FG000|Overall Study|Protocol Violation|0|||
33420470|NCT00616421|62798423|FG001|Overall Study|Protocol Violation|1|||
33420471|NCT00616421|62798424|FG002|Overall Study|Protocol Violation|2|||
33420472|NCT00616421|62798422|FG000|Overall Study|Unable to classify|1|||
33420473|NCT00616421|62798423|FG001|Overall Study|Unable to classify|0|||
33420474|NCT00616421|62798424|FG002|Overall Study|Unable to classify|0|||
33420475|NCT00433017|62798448|FG000|Overall Study|Adverse Event|5|||
33420476|NCT00433017|62798449|FG001|Overall Study|Adverse Event|3|||
33420477|NCT00433017|62798448|FG000|Overall Study|Withdrawal by Subject|4|||
33420478|NCT00433017|62798449|FG001|Overall Study|Withdrawal by Subject|5|||
33420479|NCT00433017|62798448|FG000|Overall Study|Lost to Follow-up|3|||
33420480|NCT00433017|62798449|FG001|Overall Study|Lost to Follow-up|4|||
33420481|NCT00433017|62798448|FG000|Overall Study|Administrative problems|80|||
33420482|NCT00433017|62798449|FG001|Overall Study|Administrative problems|86|||
33420483|NCT00433017|62798448|FG000|Overall Study|Protocol Violation|1|||
33420484|NCT00433017|62798449|FG001|Overall Study|Protocol Violation|0|||
33420485|NCT00433017|62798448|FG000|Overall Study|Death|2|||
33420486|NCT00433017|62798449|FG001|Overall Study|Death|2|||
33420487|NCT00433017|62798448|FG000|Overall Study|Subject no longer requires study drug|1|||
33420488|NCT00433017|62798449|FG001|Overall Study|Subject no longer requires study drug|1|||
33420489|NCT00615719|62798481|FG000|Overall Study|Physician Decision|5|||
33420490|NCT00418665|62798488|FG000|Treatment Period|Ineligibility determined|1|||
33420491|NCT00418665|62798489|FG001|Treatment Period|Ineligibility determined|1|||
33420492|NCT00418665|62798490|FG002|Treatment Period|Ineligibility determined|0|||
33420493|NCT00418665|62798488|FG000|Treatment Period|Adverse Event|2|||
33420494|NCT00418665|62798489|FG001|Treatment Period|Adverse Event|2|||
33420495|NCT00418665|62798490|FG002|Treatment Period|Adverse Event|0|||
33420496|NCT00418665|62798488|FG000|Treatment Period|Withdrawal by Subject|0|||
33420497|NCT00418665|62798489|FG001|Treatment Period|Withdrawal by Subject|3|||
33420498|NCT00418665|62798490|FG002|Treatment Period|Withdrawal by Subject|1|||
33420499|NCT00418665|62798488|FG000|Treatment Period|Requirement for alternative therapy|1|||
33420500|NCT00418665|62798489|FG001|Treatment Period|Requirement for alternative therapy|0|||
33420501|NCT00418665|62798490|FG002|Treatment Period|Requirement for alternative therapy|0|||
33420502|NCT00418665|62798488|FG000|Treatment Period|Physician Decision|1|||
33420503|NCT00418665|62798489|FG001|Treatment Period|Physician Decision|0|||
33420504|NCT00418665|62798490|FG002|Treatment Period|Physician Decision|3|||
33420505|NCT00418665|62798488|FG000|Treatment Extension|Adverse Event|1|||
33420506|NCT00418665|62798489|FG001|Treatment Extension|Adverse Event|0|||
33420507|NCT00418665|62798490|FG002|Treatment Extension|Adverse Event|0|||
33420508|NCT00418665|62798488|FG000|Treatment Extension|Withdrawal by Subject|1|||
33420509|NCT00418665|62798489|FG001|Treatment Extension|Withdrawal by Subject|0|||
33420510|NCT00418665|62798490|FG002|Treatment Extension|Withdrawal by Subject|0|||
33420511|NCT00418665|62798488|FG000|Treatment Extension|Requirement for alternative therapy|2|||
33420512|NCT00418665|62798489|FG001|Treatment Extension|Requirement for alternative therapy|2|||
33420513|NCT00418665|62798490|FG002|Treatment Extension|Requirement for alternative therapy|0|||
33420514|NCT00418665|62798488|FG000|Treatment Extension|Physician Decision|2|||
33420515|NCT00418665|62798489|FG001|Treatment Extension|Physician Decision|2|||
33420516|NCT00418665|62798490|FG002|Treatment Extension|Physician Decision|1|||
33420517|NCT00418665|62798488|FG000|Treatment Extension|Death|0|||
33420518|NCT00418665|62798489|FG001|Treatment Extension|Death|0|||
33420519|NCT00418665|62798490|FG002|Treatment Extension|Death|1|||
33420520|NCT00432237|62798502|FG000|Overall Study|Adverse Event|0|||
33420521|NCT00432237|62798503|FG001|Overall Study|Adverse Event|0|||
33420522|NCT00432237|62798504|FG002|Overall Study|Adverse Event|0|||
33420523|NCT00432237|62798505|FG003|Overall Study|Adverse Event|1|||
33420524|NCT00432237|62798502|FG000|Overall Study|Lack of Efficacy|0|||
33420525|NCT00432237|62798503|FG001|Overall Study|Lack of Efficacy|0|||
33420526|NCT00432237|62798504|FG002|Overall Study|Lack of Efficacy|0|||
33420527|NCT00432237|62798505|FG003|Overall Study|Lack of Efficacy|1|||
33420528|NCT00432237|62798502|FG000|Overall Study|Lost to Follow-up|10|||
33420529|NCT00432237|62798503|FG001|Overall Study|Lost to Follow-up|10|||
33420530|NCT00432237|62798504|FG002|Overall Study|Lost to Follow-up|18|||
33420531|NCT00432237|62798505|FG003|Overall Study|Lost to Follow-up|18|||
33420532|NCT00432237|62798502|FG000|Overall Study|Physician Decision|1|||
33420533|NCT00432237|62798503|FG001|Overall Study|Physician Decision|3|||
33420534|NCT00432237|62798504|FG002|Overall Study|Physician Decision|2|||
33420535|NCT00432237|62798505|FG003|Overall Study|Physician Decision|1|||
33420536|NCT00432237|62798502|FG000|Overall Study|Pregnancy|0|||
33420537|NCT00432237|62798503|FG001|Overall Study|Pregnancy|1|||
33420538|NCT00432237|62798504|FG002|Overall Study|Pregnancy|0|||
33420539|NCT00432237|62798505|FG003|Overall Study|Pregnancy|0|||
33420540|NCT00432237|62798502|FG000|Overall Study|Protocol Violation|13|||
33420541|NCT00432237|62798503|FG001|Overall Study|Protocol Violation|10|||
33420542|NCT00432237|62798504|FG002|Overall Study|Protocol Violation|11|||
33420543|NCT00432237|62798505|FG003|Overall Study|Protocol Violation|8|||
33420544|NCT00432237|62798502|FG000|Overall Study|Withdrawal by Subject|5|||
33420545|NCT00432237|62798503|FG001|Overall Study|Withdrawal by Subject|6|||
33420546|NCT00432237|62798504|FG002|Overall Study|Withdrawal by Subject|9|||
33420547|NCT00432237|62798505|FG003|Overall Study|Withdrawal by Subject|11|||
33420548|NCT00432237|62798502|FG000|Overall Study|Lack of Qualifying Event|38|||
33420549|NCT00432237|62798503|FG001|Overall Study|Lack of Qualifying Event|71|||
33420550|NCT00432237|62798504|FG002|Overall Study|Lack of Qualifying Event|69|||
33420551|NCT00432237|62798505|FG003|Overall Study|Lack of Qualifying Event|84|||
33420552|NCT00531284|62798532|FG000|Overall Study|Progressive Disease|1|||
33420553|NCT00531284|62798533|FG001|Overall Study|Progressive Disease|3|||
33420554|NCT00531284|62798534|FG002|Overall Study|Progressive Disease|5|||
33420555|NCT00531284|62798535|FG003|Overall Study|Progressive Disease|42|||
33420556|NCT00531284|62798536|FG004|Overall Study|Progressive Disease|4|||
33420557|NCT00531284|62798537|FG005|Overall Study|Progressive Disease|4|||
33420558|NCT00531284|62798538|FG006|Overall Study|Progressive Disease|3|||
33420559|NCT00531284|62798539|FG007|Overall Study|Progressive Disease|8|||
33420560|NCT00531284|62798540|FG008|Overall Study|Progressive Disease|6|||
33420561|NCT00531284|62798541|FG009|Overall Study|Progressive Disease|3|||
33420562|NCT00531284|62798542|FG010|Overall Study|Progressive Disease|3|||
33420563|NCT00531284|62798543|FG011|Overall Study|Progressive Disease|14|||
33420564|NCT00531284|62798544|FG012|Overall Study|Progressive Disease|2|||
33420565|NCT00531284|62798545|FG013|Overall Study|Progressive Disease|1|||
33420566|NCT00531284|62798546|FG014|Overall Study|Progressive Disease|2|||
33420567|NCT00531284|62798547|FG015|Overall Study|Progressive Disease|11|||
33420568|NCT00531284|62798548|FG016|Overall Study|Progressive Disease|5|||
33420569|NCT00531284|62798532|FG000|Overall Study|Adverse Event|0|||
33420570|NCT00531284|62798533|FG001|Overall Study|Adverse Event|1|||
33420571|NCT00531284|62798534|FG002|Overall Study|Adverse Event|1|||
33420572|NCT00531284|62798535|FG003|Overall Study|Adverse Event|7|||
33420573|NCT00531284|62798536|FG004|Overall Study|Adverse Event|0|||
33420574|NCT00531284|62798537|FG005|Overall Study|Adverse Event|2|||
33420575|NCT00531284|62798538|FG006|Overall Study|Adverse Event|3|||
33420576|NCT00531284|62798539|FG007|Overall Study|Adverse Event|2|||
33420577|NCT00531284|62798540|FG008|Overall Study|Adverse Event|3|||
33420578|NCT00531284|62798541|FG009|Overall Study|Adverse Event|0|||
33420579|NCT00531284|62798542|FG010|Overall Study|Adverse Event|0|||
33420580|NCT00531284|62798543|FG011|Overall Study|Adverse Event|5|||
33420581|NCT00531284|62798544|FG012|Overall Study|Adverse Event|0|||
33420582|NCT00531284|62798545|FG013|Overall Study|Adverse Event|1|||
33420583|NCT00531284|62798546|FG014|Overall Study|Adverse Event|1|||
33420584|NCT00531284|62798547|FG015|Overall Study|Adverse Event|0|||
33420585|NCT00531284|62798548|FG016|Overall Study|Adverse Event|2|||
33420586|NCT00531284|62798532|FG000|Overall Study|Withdrawal by Subject|1|||
33420587|NCT00531284|62798533|FG001|Overall Study|Withdrawal by Subject|0|||
33420588|NCT00531284|62798534|FG002|Overall Study|Withdrawal by Subject|0|||
33420589|NCT00531284|62798535|FG003|Overall Study|Withdrawal by Subject|4|||
33420590|NCT00531284|62798536|FG004|Overall Study|Withdrawal by Subject|0|||
33420591|NCT00531284|62798537|FG005|Overall Study|Withdrawal by Subject|0|||
33420592|NCT00531284|62798538|FG006|Overall Study|Withdrawal by Subject|0|||
33420593|NCT00531284|62798539|FG007|Overall Study|Withdrawal by Subject|0|||
33420594|NCT00531284|62798540|FG008|Overall Study|Withdrawal by Subject|0|||
33420595|NCT00531284|62798541|FG009|Overall Study|Withdrawal by Subject|0|||
33420596|NCT00531284|62798542|FG010|Overall Study|Withdrawal by Subject|0|||
33420597|NCT00531284|62798543|FG011|Overall Study|Withdrawal by Subject|3|||
33420598|NCT00531284|62798544|FG012|Overall Study|Withdrawal by Subject|0|||
33420599|NCT00531284|62798545|FG013|Overall Study|Withdrawal by Subject|1|||
33420600|NCT00531284|62798546|FG014|Overall Study|Withdrawal by Subject|0|||
33420601|NCT00531284|62798547|FG015|Overall Study|Withdrawal by Subject|1|||
33420602|NCT00531284|62798548|FG016|Overall Study|Withdrawal by Subject|1|||
33420603|NCT00531284|62798532|FG000|Overall Study|Other|1|||
33420604|NCT00531284|62798533|FG001|Overall Study|Other|0|||
33420605|NCT00531284|62798534|FG002|Overall Study|Other|0|||
33420606|NCT00531284|62798535|FG003|Overall Study|Other|10|||
33420607|NCT00531284|62798536|FG004|Overall Study|Other|2|||
33420608|NCT00531284|62798537|FG005|Overall Study|Other|1|||
33420609|NCT00531284|62798538|FG006|Overall Study|Other|0|||
33420610|NCT00531284|62798539|FG007|Overall Study|Other|0|||
33420611|NCT00531284|62798540|FG008|Overall Study|Other|2|||
33420612|NCT00531284|62798541|FG009|Overall Study|Other|1|||
33420613|NCT00531284|62798542|FG010|Overall Study|Other|0|||
33420614|NCT00531284|62798543|FG011|Overall Study|Other|2|||
33420615|NCT00531284|62798544|FG012|Overall Study|Other|0|||
33420616|NCT00531284|62798545|FG013|Overall Study|Other|0|||
33420617|NCT00531284|62798546|FG014|Overall Study|Other|1|||
33420618|NCT00531284|62798547|FG015|Overall Study|Other|0|||
33420619|NCT00531284|62798548|FG016|Overall Study|Other|0|||
33420620|NCT00531206|62798604|FG000|Overall Study|Adverse Event related|5|||
33420621|NCT00531206|62798604|FG000|Overall Study|Lack of Efficacy|2|||
33420622|NCT00531206|62798604|FG000|Overall Study|Lost to Follow-up|5|||
33420623|NCT00531206|62798604|FG000|Overall Study|including non-related adverse events|8|||
33420624|NCT00530816|62798611|FG000|Overall Study|Progressive Disease|16|||
33420625|NCT00530816|62798612|FG001|Overall Study|Progressive Disease|24|||
33420626|NCT00530816|62798613|FG002|Overall Study|Progressive Disease|24|||
33420627|NCT00530816|62798611|FG000|Overall Study|Adverse Event|6|||
33420628|NCT00530816|62798612|FG001|Overall Study|Adverse Event|13|||
33420629|NCT00530816|62798613|FG002|Overall Study|Adverse Event|7|||
33420630|NCT00530816|62798611|FG000|Overall Study|Other|3|||
33420631|NCT00530816|62798612|FG001|Overall Study|Other|3|||
33420632|NCT00530816|62798613|FG002|Overall Study|Other|4|||
33420633|NCT00530816|62798611|FG000|Overall Study|Withdrawal by Subject|1|||
33605198|NCT02367833|63004931|FG000|Overall Study|Withdrawal by Subject|1|||
33420634|NCT00530816|62798612|FG001|Overall Study|Withdrawal by Subject|2|||
33420635|NCT00530816|62798613|FG002|Overall Study|Withdrawal by Subject|6|||
33420636|NCT00615017|62798627|FG000|Overall Study|Adverse Event|0|||
33605199|NCT02367833|63004932|FG001|Overall Study|Withdrawal by Subject|1|||
33420637|NCT00615017|62798628|FG001|Overall Study|Adverse Event|1|||
33420638|NCT00615017|62798629|FG002|Overall Study|Adverse Event|2|||
33420639|NCT00615017|62798630|FG003|Overall Study|Adverse Event|0|||
33420640|NCT00615017|62798631|FG004|Overall Study|Adverse Event|0|||
33420641|NCT00615017|62798632|FG005|Overall Study|Adverse Event|1|||
33420642|NCT00615017|62798627|FG000|Overall Study|Death|0|||
33420643|NCT00615017|62798628|FG001|Overall Study|Death|0|||
33420644|NCT00615017|62798629|FG002|Overall Study|Death|2|||
33420645|NCT00615017|62798630|FG003|Overall Study|Death|0|||
33420646|NCT00615017|62798631|FG004|Overall Study|Death|1|||
33420647|NCT00615017|62798632|FG005|Overall Study|Death|1|||
33420648|NCT00615017|62798627|FG000|Overall Study|Sepsis resolved|0|||
33420649|NCT00615017|62798628|FG001|Overall Study|Sepsis resolved|0|||
33420650|NCT00615017|62798629|FG002|Overall Study|Sepsis resolved|1|||
33420651|NCT00615017|62798630|FG003|Overall Study|Sepsis resolved|0|||
33420652|NCT00615017|62798631|FG004|Overall Study|Sepsis resolved|0|||
33420653|NCT00615017|62798632|FG005|Overall Study|Sepsis resolved|0|||
33420654|NCT00615017|62798627|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
33420655|NCT00615017|62798628|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
33420656|NCT00615017|62798629|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
33420657|NCT00615017|62798630|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
33420658|NCT00615017|62798631|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
33420659|NCT00615017|62798632|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
33420660|NCT00615017|62798627|FG000|Overall Study|Physician discontinued drug|0|||
33420661|NCT00615017|62798628|FG001|Overall Study|Physician discontinued drug|0|||
33420662|NCT00615017|62798629|FG002|Overall Study|Physician discontinued drug|0|||
33420663|NCT00615017|62798630|FG003|Overall Study|Physician discontinued drug|0|||
33420664|NCT00615017|62798631|FG004|Overall Study|Physician discontinued drug|0|||
33420665|NCT00615017|62798632|FG005|Overall Study|Physician discontinued drug|1|||
33420666|NCT00614939|62798648|FG000|Overall Study|Withdrawal by Subject|10|||
33420667|NCT00614939|62798649|FG001|Overall Study|Withdrawal by Subject|17|||
33420668|NCT00614939|62798648|FG000|Overall Study|Study specific discontinuation criteris|13|||
33420669|NCT00614939|62798649|FG001|Overall Study|Study specific discontinuation criteris|16|||
33420670|NCT00614939|62798648|FG000|Overall Study|Adverse Event|2|||
33420671|NCT00614939|62798649|FG001|Overall Study|Adverse Event|5|||
33420672|NCT00614939|62798648|FG000|Overall Study|Incorrect enrollment|1|||
33420673|NCT00614939|62798649|FG001|Overall Study|Incorrect enrollment|2|||
33420674|NCT00614939|62798648|FG000|Overall Study|Death|4|||
33420675|NCT00614939|62798649|FG001|Overall Study|Death|3|||
33420676|NCT00614939|62798648|FG000|Overall Study|Poor/non-compliance|4|||
33420677|NCT00614939|62798649|FG001|Overall Study|Poor/non-compliance|0|||
33420678|NCT00614939|62798648|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
33420679|NCT00614939|62798649|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
33420680|NCT00530504|62798655|FG000|Overall Study|Death|54|||
33420681|NCT00530504|62798655|FG000|Overall Study|Lost to Follow-up|26|||
33420682|NCT00530504|62798655|FG000|Overall Study|Withdrawal by Subject|39|||
33420683|NCT00530504|62798655|FG000|Overall Study|Exited study due to other reasons|33|||
33420684|NCT04720664|62798685|FG000|Overall Study|Adverse Event|2|||
33420685|NCT04720664|62798685|FG000|Overall Study|Lack of Efficacy|9|||
33420686|NCT04626297|62798691|FG000|Overall Study|Adverse Event|5|||
33494124|NCT03524664|62872879|FG001|Overall Study|Withdrawal by Subject|2|||
33420687|NCT04626297|62798692|FG001|Overall Study|Adverse Event|3|||
33420688|NCT04626297|62798691|FG000|Overall Study|Lost to Follow-up|7|||
33494125|NCT03524664|62872878|FG000|Overall Study|Lost to Follow-up|4|||
33494126|NCT03524664|62872879|FG001|Overall Study|Lost to Follow-up|13|||
33420689|NCT04626297|62798692|FG001|Overall Study|Lost to Follow-up|3|||
33420690|NCT04626297|62798691|FG000|Overall Study|Protocol Violation|5|||
33420691|NCT04626297|62798692|FG001|Overall Study|Protocol Violation|1|||
33420692|NCT04626297|62798691|FG000|Overall Study|Withdrawal by Subject|20|||
33420693|NCT04626297|62798692|FG001|Overall Study|Withdrawal by Subject|6|||
33494127|NCT04377620|62872888|FG000|Overall Study|Death|42|||
33420694|NCT04626297|62798691|FG000|Overall Study|Sponsor decision|2|||
33420695|NCT04626297|62798692|FG001|Overall Study|Sponsor decision|1|||
33420696|NCT04371198|62798707|FG000|Overall Study|inadequate sample|4|||
33420697|NCT04288154|62798713|FG000|Overall Study|Withdrawal by Subject|9|||
33420698|NCT04288154|62798714|FG001|Overall Study|Withdrawal by Subject|9|||
33420699|NCT04258579|62798720|FG000|Overall Study|Withdrawal by Subject|7|||
33420700|NCT04258579|62798720|FG000|Overall Study|Lost to Follow-up|3|||
33420701|NCT04258579|62798720|FG000|Overall Study|Protocol Violation|2|||
33420702|NCT04258579|62798720|FG000|Overall Study|Adverse Event|1|||
33420703|NCT03945214|62798728|FG000|Overall Study|Lost to Follow-up|3|||
33420704|NCT03945214|62798729|FG001|Overall Study|Lost to Follow-up|4|||
33420705|NCT03945214|62798730|FG002|Overall Study|Lost to Follow-up|7|||
33420706|NCT03945214|62798731|FG003|Overall Study|Lost to Follow-up|4|||
33420707|NCT03829683|62798743|FG000|Overall Study|Lost to Follow-up|1|||
33420708|NCT03829683|62798744|FG001|Overall Study|Lost to Follow-up|0|||
33420709|NCT03829683|62798743|FG000|Overall Study|Physician Decision|3|||
33420710|NCT03829683|62798744|FG001|Overall Study|Physician Decision|1|||
33420711|NCT03829683|62798743|FG000|Overall Study|Withdrawal by Subject|0|||
33420712|NCT03829683|62798744|FG001|Overall Study|Withdrawal by Subject|1|||
33420713|NCT03829683|62798743|FG000|Overall Study|Discharge from hospital|1|||
33420714|NCT03829683|62798744|FG001|Overall Study|Discharge from hospital|0|||
33420715|NCT03810456|62798753|FG000|Treatment|Urgent Family Matters|3|||
33420716|NCT03810456|62798754|FG001|Treatment|Urgent Family Matters|0|||
33420717|NCT03810456|62798755|FG002|Treatment|Urgent Family Matters|0|||
33420718|NCT03810456|62798753|FG000|Treatment|Scheduling Conflicts|0|||
33420719|NCT03810456|62798754|FG001|Treatment|Scheduling Conflicts|11|||
33420720|NCT03810456|62798755|FG002|Treatment|Scheduling Conflicts|0|||
33420721|NCT03810456|62798753|FG000|Treatment|No Longer Interested|0|||
33420722|NCT03810456|62798754|FG001|Treatment|No Longer Interested|12|||
33420723|NCT03810456|62798755|FG002|Treatment|No Longer Interested|0|||
33420724|NCT03810456|62798753|FG000|Treatment|Transportation Issues|0|||
33420725|NCT03810456|62798754|FG001|Treatment|Transportation Issues|1|||
33420726|NCT03810456|62798755|FG002|Treatment|Transportation Issues|0|||
33420727|NCT03810456|62798753|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
33420728|NCT03810456|62798754|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
33420729|NCT03810456|62798755|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
33420730|NCT03810456|62798753|FG000|1 Month Follow-Up|Relocated to Different State|1|||
33420731|NCT03810456|62798754|FG001|1 Month Follow-Up|Relocated to Different State|0|||
33420732|NCT03810456|62798755|FG002|1 Month Follow-Up|Relocated to Different State|1|||
33420733|NCT03810456|62798753|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
33420734|NCT03810456|62798754|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
33420735|NCT03810456|62798755|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
33420736|NCT03810456|62798753|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
33420737|NCT03810456|62798754|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
33420738|NCT03810456|62798755|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
33420739|NCT03810456|62798753|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
33420740|NCT03810456|62798754|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
33420741|NCT03810456|62798755|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
33420742|NCT03810456|62798753|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
33420743|NCT03810456|62798754|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
33420744|NCT03810456|62798755|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
33420745|NCT03810456|62798753|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
33420746|NCT03810456|62798754|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
33420747|NCT03810456|62798755|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
33420748|NCT03450057|62798767|FG000|Overall Study|Death|17|||
33420749|NCT03450057|62798767|FG000|Overall Study|ICF withdrawal|4|||
33420750|NCT03450057|62798767|FG000|Overall Study|Lost to Follow-up|2|||
33420751|NCT03353415|62798780|FG000|Masked CGM Wear|Lost to Follow-up|2|||
33420752|NCT03353415|62798780|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
33420753|NCT02658890|62798822|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420754|NCT02658890|62798823|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420755|NCT02658890|62798824|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420756|NCT02658890|62798825|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420757|NCT02658890|62798826|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420758|NCT02658890|62798827|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420759|NCT02658890|62798828|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420760|NCT02658890|62798829|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420761|NCT02658890|62798830|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
33420762|NCT02658890|62798831|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420763|NCT02658890|62798832|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420764|NCT02658890|62798833|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420765|NCT02658890|62798834|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420766|NCT02658890|62798835|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420767|NCT02658890|62798836|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420768|NCT02658890|62798837|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420769|NCT02658890|62798838|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420770|NCT02658890|62798839|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420771|NCT02658890|62798840|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420772|NCT02658890|62798841|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420773|NCT02658890|62798842|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420774|NCT02658890|62798843|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420775|NCT02658890|62798844|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420776|NCT02658890|62798845|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420777|NCT02658890|62798846|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420778|NCT02658890|62798847|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420779|NCT02658890|62798848|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420780|NCT02658890|62798822|FG000|Treatment Phase|Adverse Event|0|||
33420781|NCT02658890|62798823|FG001|Treatment Phase|Adverse Event|1|||
33420782|NCT02658890|62798824|FG002|Treatment Phase|Adverse Event|2|||
33420783|NCT02658890|62798825|FG003|Treatment Phase|Adverse Event|2|||
33420784|NCT02658890|62798826|FG004|Treatment Phase|Adverse Event|1|||
33420785|NCT02658890|62798827|FG005|Treatment Phase|Adverse Event|0|||
33420786|NCT02658890|62798828|FG006|Treatment Phase|Adverse Event|0|||
33420787|NCT02658890|62798829|FG007|Treatment Phase|Adverse Event|2|||
33420788|NCT02658890|62798830|FG008|Treatment Phase|Adverse Event|1|||
33420789|NCT02658890|62798831|FG009|Treatment Phase|Adverse Event|2|||
33420790|NCT02658890|62798832|FG010|Treatment Phase|Adverse Event|3|||
33420791|NCT02658890|62798833|FG011|Treatment Phase|Adverse Event|0|||
33420792|NCT02658890|62798834|FG012|Treatment Phase|Adverse Event|1|||
33420793|NCT02658890|62798835|FG013|Treatment Phase|Adverse Event|4|||
33420794|NCT02658890|62798836|FG014|Treatment Phase|Adverse Event|0|||
33420795|NCT02658890|62798837|FG015|Treatment Phase|Adverse Event|0|||
33420796|NCT02658890|62798838|FG016|Treatment Phase|Adverse Event|0|||
33420797|NCT02658890|62798839|FG017|Treatment Phase|Adverse Event|0|||
33420798|NCT02658890|62798840|FG018|Treatment Phase|Adverse Event|5|||
33420799|NCT02658890|62798841|FG019|Treatment Phase|Adverse Event|1|||
33420800|NCT02658890|62798842|FG020|Treatment Phase|Adverse Event|3|||
33420801|NCT02658890|62798843|FG021|Treatment Phase|Adverse Event|0|||
33420802|NCT02658890|62798844|FG022|Treatment Phase|Adverse Event|5|||
33420803|NCT02658890|62798845|FG023|Treatment Phase|Adverse Event|0|||
33420804|NCT02658890|62798846|FG024|Treatment Phase|Adverse Event|0|||
33420805|NCT02658890|62798847|FG025|Treatment Phase|Adverse Event|2|||
33420806|NCT02658890|62798848|FG026|Treatment Phase|Adverse Event|1|||
33420807|NCT02658890|62798822|FG000|Treatment Phase|Death|0|||
33420808|NCT02658890|62798823|FG001|Treatment Phase|Death|0|||
33420809|NCT02658890|62798824|FG002|Treatment Phase|Death|0|||
33420810|NCT02658890|62798825|FG003|Treatment Phase|Death|0|||
33420811|NCT02658890|62798826|FG004|Treatment Phase|Death|0|||
33420812|NCT02658890|62798827|FG005|Treatment Phase|Death|0|||
33420813|NCT02658890|62798828|FG006|Treatment Phase|Death|0|||
33420814|NCT02658890|62798829|FG007|Treatment Phase|Death|0|||
33420815|NCT02658890|62798830|FG008|Treatment Phase|Death|0|||
33420816|NCT02658890|62798831|FG009|Treatment Phase|Death|0|||
33420817|NCT02658890|62798832|FG010|Treatment Phase|Death|0|||
33420818|NCT02658890|62798833|FG011|Treatment Phase|Death|0|||
33420819|NCT02658890|62798834|FG012|Treatment Phase|Death|0|||
33420820|NCT02658890|62798835|FG013|Treatment Phase|Death|0|||
33420821|NCT02658890|62798836|FG014|Treatment Phase|Death|0|||
33420822|NCT02658890|62798837|FG015|Treatment Phase|Death|0|||
33420823|NCT02658890|62798838|FG016|Treatment Phase|Death|0|||
33420824|NCT02658890|62798839|FG017|Treatment Phase|Death|0|||
33420825|NCT02658890|62798840|FG018|Treatment Phase|Death|1|||
33420826|NCT02658890|62798841|FG019|Treatment Phase|Death|0|||
33420827|NCT02658890|62798842|FG020|Treatment Phase|Death|0|||
33420828|NCT02658890|62798843|FG021|Treatment Phase|Death|0|||
33420829|NCT02658890|62798844|FG022|Treatment Phase|Death|0|||
33420830|NCT02658890|62798845|FG023|Treatment Phase|Death|0|||
33420831|NCT02658890|62798846|FG024|Treatment Phase|Death|0|||
33420832|NCT02658890|62798847|FG025|Treatment Phase|Death|0|||
33420833|NCT02658890|62798848|FG026|Treatment Phase|Death|0|||
33420834|NCT02658890|62798822|FG000|Treatment Phase|Lost to Follow-up|0|||
33420835|NCT02658890|62798823|FG001|Treatment Phase|Lost to Follow-up|0|||
33420836|NCT02658890|62798824|FG002|Treatment Phase|Lost to Follow-up|0|||
33420837|NCT02658890|62798825|FG003|Treatment Phase|Lost to Follow-up|0|||
33420838|NCT02658890|62798826|FG004|Treatment Phase|Lost to Follow-up|0|||
33420839|NCT02658890|62798827|FG005|Treatment Phase|Lost to Follow-up|0|||
33420840|NCT02658890|62798828|FG006|Treatment Phase|Lost to Follow-up|1|||
33420841|NCT02658890|62798829|FG007|Treatment Phase|Lost to Follow-up|0|||
33420842|NCT02658890|62798830|FG008|Treatment Phase|Lost to Follow-up|0|||
33420843|NCT02658890|62798831|FG009|Treatment Phase|Lost to Follow-up|0|||
33420844|NCT02658890|62798832|FG010|Treatment Phase|Lost to Follow-up|0|||
33420845|NCT02658890|62798833|FG011|Treatment Phase|Lost to Follow-up|0|||
33420846|NCT02658890|62798834|FG012|Treatment Phase|Lost to Follow-up|0|||
33420847|NCT02658890|62798835|FG013|Treatment Phase|Lost to Follow-up|0|||
33420848|NCT02658890|62798836|FG014|Treatment Phase|Lost to Follow-up|0|||
33420849|NCT02658890|62798837|FG015|Treatment Phase|Lost to Follow-up|0|||
33420850|NCT02658890|62798838|FG016|Treatment Phase|Lost to Follow-up|0|||
33420851|NCT02658890|62798839|FG017|Treatment Phase|Lost to Follow-up|0|||
33420852|NCT02658890|62798840|FG018|Treatment Phase|Lost to Follow-up|0|||
33420853|NCT02658890|62798841|FG019|Treatment Phase|Lost to Follow-up|0|||
33420854|NCT02658890|62798842|FG020|Treatment Phase|Lost to Follow-up|0|||
33420855|NCT02658890|62798843|FG021|Treatment Phase|Lost to Follow-up|0|||
33420856|NCT02658890|62798844|FG022|Treatment Phase|Lost to Follow-up|0|||
33420857|NCT02658890|62798845|FG023|Treatment Phase|Lost to Follow-up|0|||
33420858|NCT02658890|62798846|FG024|Treatment Phase|Lost to Follow-up|0|||
33420859|NCT02658890|62798847|FG025|Treatment Phase|Lost to Follow-up|0|||
33420860|NCT02658890|62798848|FG026|Treatment Phase|Lost to Follow-up|0|||
33420861|NCT02658890|62798822|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
33420862|NCT02658890|62798823|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
33420863|NCT02658890|62798824|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
33420864|NCT02658890|62798825|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
33420865|NCT02658890|62798826|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
33420866|NCT02658890|62798827|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
33420867|NCT02658890|62798828|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
33420868|NCT02658890|62798829|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
33420869|NCT02658890|62798830|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
33420870|NCT02658890|62798831|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
33420871|NCT02658890|62798832|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
33420872|NCT02658890|62798833|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
33420873|NCT02658890|62798834|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
33420874|NCT02658890|62798835|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
33420875|NCT02658890|62798836|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
33420876|NCT02658890|62798837|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
33420877|NCT02658890|62798838|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
33420878|NCT02658890|62798839|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
33420879|NCT02658890|62798840|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
33420880|NCT02658890|62798841|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
33420881|NCT02658890|62798842|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
33420882|NCT02658890|62798843|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
33420883|NCT02658890|62798844|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
33420884|NCT02658890|62798845|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
33420885|NCT02658890|62798846|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
33420886|NCT02658890|62798847|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
33420887|NCT02658890|62798848|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
33420888|NCT02658890|62798822|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
33420889|NCT02658890|62798823|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
33420890|NCT02658890|62798824|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
33420891|NCT02658890|62798825|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
33420892|NCT02658890|62798826|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
33322921|NCT00976989|62699074|FG001|Overall Study|Recurrence of Disease|1|||
33420893|NCT02658890|62798827|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
33420894|NCT02658890|62798828|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
33420895|NCT02658890|62798829|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
33420896|NCT02658890|62798830|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
33420897|NCT02658890|62798831|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
33420898|NCT02658890|62798832|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
33420899|NCT02658890|62798833|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
33420900|NCT02658890|62798834|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
33420901|NCT02658890|62798835|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
33420902|NCT02658890|62798836|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
33420903|NCT02658890|62798837|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
33420904|NCT02658890|62798838|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
33420905|NCT02658890|62798839|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
33420906|NCT02658890|62798840|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
33420907|NCT02658890|62798841|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
33420908|NCT02658890|62798842|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
33420909|NCT02658890|62798843|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
33420910|NCT02658890|62798844|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
33420911|NCT02658890|62798845|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
33420912|NCT02658890|62798846|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
33420913|NCT02658890|62798847|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
33420914|NCT02658890|62798848|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
33420915|NCT02658890|62798822|FG000|Treatment Phase|Other Reasons|0|||
33420916|NCT02658890|62798823|FG001|Treatment Phase|Other Reasons|0|||
33420917|NCT02658890|62798824|FG002|Treatment Phase|Other Reasons|0|||
33420918|NCT02658890|62798825|FG003|Treatment Phase|Other Reasons|0|||
33420919|NCT02658890|62798826|FG004|Treatment Phase|Other Reasons|0|||
33420920|NCT02658890|62798827|FG005|Treatment Phase|Other Reasons|0|||
33420921|NCT02658890|62798828|FG006|Treatment Phase|Other Reasons|1|||
33420922|NCT02658890|62798829|FG007|Treatment Phase|Other Reasons|0|||
33420923|NCT02658890|62798830|FG008|Treatment Phase|Other Reasons|1|||
33420924|NCT02658890|62798831|FG009|Treatment Phase|Other Reasons|0|||
33420925|NCT02658890|62798832|FG010|Treatment Phase|Other Reasons|0|||
33420926|NCT02658890|62798833|FG011|Treatment Phase|Other Reasons|0|||
33420927|NCT02658890|62798834|FG012|Treatment Phase|Other Reasons|0|||
33420928|NCT02658890|62798835|FG013|Treatment Phase|Other Reasons|2|||
33420929|NCT02658890|62798836|FG014|Treatment Phase|Other Reasons|0|||
33420930|NCT02658890|62798837|FG015|Treatment Phase|Other Reasons|0|||
33420931|NCT02658890|62798838|FG016|Treatment Phase|Other Reasons|0|||
33420932|NCT02658890|62798839|FG017|Treatment Phase|Other Reasons|0|||
33420933|NCT02658890|62798840|FG018|Treatment Phase|Other Reasons|1|||
33420934|NCT02658890|62798841|FG019|Treatment Phase|Other Reasons|0|||
33420935|NCT02658890|62798842|FG020|Treatment Phase|Other Reasons|0|||
33420936|NCT02658890|62798843|FG021|Treatment Phase|Other Reasons|0|||
33420937|NCT02658890|62798844|FG022|Treatment Phase|Other Reasons|0|||
33420938|NCT02658890|62798845|FG023|Treatment Phase|Other Reasons|0|||
33420939|NCT02658890|62798846|FG024|Treatment Phase|Other Reasons|1|||
33420940|NCT02658890|62798847|FG025|Treatment Phase|Other Reasons|0|||
33420941|NCT02658890|62798848|FG026|Treatment Phase|Other Reasons|1|||
33420942|NCT02658890|62798822|FG000|Treatment Phase|Progressive Disease|6|||
33420943|NCT02658890|62798823|FG001|Treatment Phase|Progressive Disease|7|||
33420944|NCT02658890|62798824|FG002|Treatment Phase|Progressive Disease|6|||
33420945|NCT02658890|62798825|FG003|Treatment Phase|Progressive Disease|12|||
33420946|NCT02658890|62798826|FG004|Treatment Phase|Progressive Disease|6|||
33420947|NCT02658890|62798827|FG005|Treatment Phase|Progressive Disease|18|||
33420948|NCT02658890|62798828|FG006|Treatment Phase|Progressive Disease|12|||
33420949|NCT02658890|62798829|FG007|Treatment Phase|Progressive Disease|19|||
33420950|NCT02658890|62798830|FG008|Treatment Phase|Progressive Disease|26|||
33420951|NCT02658890|62798831|FG009|Treatment Phase|Progressive Disease|8|||
33420952|NCT02658890|62798832|FG010|Treatment Phase|Progressive Disease|7|||
33420953|NCT02658890|62798833|FG011|Treatment Phase|Progressive Disease|9|||
33420954|NCT02658890|62798834|FG012|Treatment Phase|Progressive Disease|8|||
33420955|NCT02658890|62798835|FG013|Treatment Phase|Progressive Disease|29|||
33420956|NCT02658890|62798836|FG014|Treatment Phase|Progressive Disease|6|||
33420957|NCT02658890|62798837|FG015|Treatment Phase|Progressive Disease|2|||
33420958|NCT02658890|62798838|FG016|Treatment Phase|Progressive Disease|32|||
33420959|NCT02658890|62798839|FG017|Treatment Phase|Progressive Disease|14|||
33420960|NCT02658890|62798840|FG018|Treatment Phase|Progressive Disease|40|||
33420961|NCT02658890|62798841|FG019|Treatment Phase|Progressive Disease|32|||
33420962|NCT02658890|62798842|FG020|Treatment Phase|Progressive Disease|19|||
33420963|NCT02658890|62798843|FG021|Treatment Phase|Progressive Disease|30|||
33420964|NCT02658890|62798844|FG022|Treatment Phase|Progressive Disease|15|||
33420965|NCT02658890|62798845|FG023|Treatment Phase|Progressive Disease|0|||
33420966|NCT02658890|62798846|FG024|Treatment Phase|Progressive Disease|0|||
33420967|NCT02658890|62798847|FG025|Treatment Phase|Progressive Disease|14|||
33420968|NCT02658890|62798848|FG026|Treatment Phase|Progressive Disease|11|||
33420969|NCT02658890|62798822|FG000|Treatment Phase|Study Drug Toxicity|0|||
33420970|NCT02658890|62798823|FG001|Treatment Phase|Study Drug Toxicity|0|||
33420971|NCT02658890|62798824|FG002|Treatment Phase|Study Drug Toxicity|2|||
33420972|NCT02658890|62798825|FG003|Treatment Phase|Study Drug Toxicity|0|||
33420973|NCT02658890|62798826|FG004|Treatment Phase|Study Drug Toxicity|0|||
33420974|NCT02658890|62798827|FG005|Treatment Phase|Study Drug Toxicity|0|||
33420975|NCT02658890|62798828|FG006|Treatment Phase|Study Drug Toxicity|0|||
33420976|NCT02658890|62798829|FG007|Treatment Phase|Study Drug Toxicity|0|||
33420977|NCT02658890|62798830|FG008|Treatment Phase|Study Drug Toxicity|3|||
33420978|NCT02658890|62798831|FG009|Treatment Phase|Study Drug Toxicity|0|||
33420979|NCT02658890|62798832|FG010|Treatment Phase|Study Drug Toxicity|1|||
33420980|NCT02658890|62798833|FG011|Treatment Phase|Study Drug Toxicity|1|||
33420981|NCT02658890|62798834|FG012|Treatment Phase|Study Drug Toxicity|2|||
33420982|NCT02658890|62798835|FG013|Treatment Phase|Study Drug Toxicity|9|||
33420983|NCT02658890|62798836|FG014|Treatment Phase|Study Drug Toxicity|0|||
33420984|NCT02658890|62798837|FG015|Treatment Phase|Study Drug Toxicity|1|||
33420985|NCT02658890|62798838|FG016|Treatment Phase|Study Drug Toxicity|1|||
33420986|NCT02658890|62798839|FG017|Treatment Phase|Study Drug Toxicity|0|||
33420987|NCT02658890|62798840|FG018|Treatment Phase|Study Drug Toxicity|8|||
33420988|NCT02658890|62798841|FG019|Treatment Phase|Study Drug Toxicity|3|||
33420989|NCT02658890|62798842|FG020|Treatment Phase|Study Drug Toxicity|2|||
33420990|NCT02658890|62798843|FG021|Treatment Phase|Study Drug Toxicity|0|||
33420991|NCT02658890|62798844|FG022|Treatment Phase|Study Drug Toxicity|8|||
33420992|NCT02658890|62798845|FG023|Treatment Phase|Study Drug Toxicity|0|||
33420993|NCT02658890|62798846|FG024|Treatment Phase|Study Drug Toxicity|0|||
33420994|NCT02658890|62798847|FG025|Treatment Phase|Study Drug Toxicity|2|||
33420995|NCT02658890|62798848|FG026|Treatment Phase|Study Drug Toxicity|0|||
33420996|NCT02658890|62798822|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420997|NCT02658890|62798823|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420998|NCT02658890|62798824|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33420999|NCT02658890|62798825|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
33421000|NCT02658890|62798826|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421001|NCT02658890|62798827|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421002|NCT02658890|62798828|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33322922|NCT00976989|62699075|FG002|Overall Study|Recurrence of Disease|0|||
33322923|NCT00976989|62699073|FG000|Overall Study|Other|1|||
33322924|NCT00976989|62699074|FG001|Overall Study|Other|0|||
33322925|NCT00976989|62699075|FG002|Overall Study|Other|1|||
33421003|NCT02658890|62798829|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421004|NCT02658890|62798830|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421005|NCT02658890|62798831|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
33494128|NCT04377620|62872889|FG001|Overall Study|Death|48|||
33494129|NCT04377620|62872890|FG002|Overall Study|Death|36|||
33494130|NCT04377620|62872888|FG000|Overall Study|Withdrawal by Subject|0|||
33421006|NCT02658890|62798832|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33494131|NCT04377620|62872889|FG001|Overall Study|Withdrawal by Subject|2|||
33421007|NCT02658890|62798833|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421008|NCT02658890|62798834|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421009|NCT02658890|62798835|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421010|NCT02658890|62798836|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421011|NCT02658890|62798837|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421012|NCT02658890|62798838|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421013|NCT02658890|62798839|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421014|NCT02658890|62798840|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
33421015|NCT02658890|62798841|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421016|NCT02658890|62798842|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421017|NCT02658890|62798843|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421018|NCT02658890|62798844|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
33421019|NCT02658890|62798845|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421020|NCT02658890|62798846|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421021|NCT02658890|62798847|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421022|NCT02658890|62798848|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33421023|NCT02658890|62798822|FG000|Treatment Phase|Withdrawal by Subject|0|||
33421024|NCT02658890|62798823|FG001|Treatment Phase|Withdrawal by Subject|1|||
33421025|NCT02658890|62798824|FG002|Treatment Phase|Withdrawal by Subject|0|||
33421026|NCT02658890|62798825|FG003|Treatment Phase|Withdrawal by Subject|0|||
33421027|NCT02658890|62798826|FG004|Treatment Phase|Withdrawal by Subject|0|||
33421028|NCT02658890|62798827|FG005|Treatment Phase|Withdrawal by Subject|0|||
33421029|NCT02658890|62798828|FG006|Treatment Phase|Withdrawal by Subject|1|||
33421030|NCT02658890|62798829|FG007|Treatment Phase|Withdrawal by Subject|0|||
33421031|NCT02658890|62798830|FG008|Treatment Phase|Withdrawal by Subject|0|||
33421032|NCT02658890|62798831|FG009|Treatment Phase|Withdrawal by Subject|1|||
33421033|NCT02658890|62798832|FG010|Treatment Phase|Withdrawal by Subject|0|||
33421034|NCT02658890|62798833|FG011|Treatment Phase|Withdrawal by Subject|0|||
33421035|NCT02658890|62798834|FG012|Treatment Phase|Withdrawal by Subject|1|||
33421036|NCT02658890|62798835|FG013|Treatment Phase|Withdrawal by Subject|3|||
33421037|NCT02658890|62798836|FG014|Treatment Phase|Withdrawal by Subject|0|||
33421038|NCT02658890|62798837|FG015|Treatment Phase|Withdrawal by Subject|0|||
33421039|NCT02658890|62798838|FG016|Treatment Phase|Withdrawal by Subject|1|||
33421040|NCT02658890|62798839|FG017|Treatment Phase|Withdrawal by Subject|0|||
33421041|NCT02658890|62798840|FG018|Treatment Phase|Withdrawal by Subject|4|||
33421042|NCT02658890|62798841|FG019|Treatment Phase|Withdrawal by Subject|3|||
33421043|NCT02658890|62798842|FG020|Treatment Phase|Withdrawal by Subject|0|||
33421044|NCT02658890|62798843|FG021|Treatment Phase|Withdrawal by Subject|4|||
33421045|NCT02658890|62798844|FG022|Treatment Phase|Withdrawal by Subject|1|||
33421046|NCT02658890|62798845|FG023|Treatment Phase|Withdrawal by Subject|1|||
33421047|NCT02658890|62798846|FG024|Treatment Phase|Withdrawal by Subject|0|||
33421048|NCT02658890|62798847|FG025|Treatment Phase|Withdrawal by Subject|0|||
33421049|NCT02658890|62798848|FG026|Treatment Phase|Withdrawal by Subject|0|||
33421050|NCT02597062|62798940|FG000|Overall Study|Ineligible|1|||
33421051|NCT05159362|62798981|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
33421052|NCT05159362|62798982|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
33421053|NCT05159362|62798983|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
33421054|NCT04975191|62798998|FG000|Overall Study|Protocol Violation|1|||
33421055|NCT04975191|62798999|FG001|Overall Study|Protocol Violation|2|||
33421056|NCT04975191|62799000|FG002|Overall Study|Protocol Violation|2|||
33421057|NCT04975191|62799001|FG003|Overall Study|Protocol Violation|2|||
33421058|NCT04975191|62798998|FG000|Overall Study|Lost to Follow-up|13|||
33421059|NCT04975191|62798999|FG001|Overall Study|Lost to Follow-up|3|||
33421060|NCT04975191|62799000|FG002|Overall Study|Lost to Follow-up|8|||
33421061|NCT04975191|62799001|FG003|Overall Study|Lost to Follow-up|8|||
33421062|NCT04492020|62799027|FG000|Overall Study|Adverse Event|1|||
33421063|NCT04492020|62799028|FG001|Overall Study|Adverse Event|3|||
33421064|NCT04492020|62799027|FG000|Overall Study|Withdrawal by Subject|4|||
33421065|NCT04492020|62799028|FG001|Overall Study|Withdrawal by Subject|3|||
33421066|NCT04492020|62799027|FG000|Overall Study|Lost to Follow-up|4|||
33421067|NCT04492020|62799028|FG001|Overall Study|Lost to Follow-up|3|||
33421068|NCT04492020|62799027|FG000|Overall Study|Protocol Violation|5|||
33421069|NCT04492020|62799028|FG001|Overall Study|Protocol Violation|2|||
33421070|NCT04492020|62799027|FG000|Overall Study|Lack of Qualifying Event|25|||
33421071|NCT04492020|62799028|FG001|Overall Study|Lack of Qualifying Event|27|||
33421072|NCT04492020|62799027|FG000|Overall Study|Non-compliance with Study Drug|2|||
33421073|NCT04492020|62799028|FG001|Overall Study|Non-compliance with Study Drug|1|||
33421074|NCT04382911|62799034|FG000|Overall Study|unable to be imaged prior to surgery|2|||
33421075|NCT04072575|62799042|FG000|Overall Study|Physician Decision|1|||
33421076|NCT04072575|62799042|FG000|Overall Study|Adverse Event|7|||
33421077|NCT04072575|62799042|FG000|Overall Study|Withdrawal by Subject|14|||
33421078|NCT04072575|62799042|FG000|Overall Study|Other|2|||
33421079|NCT03911869|62799048|FG000|Safety Lead-in Phase|Death|7|||
33421080|NCT03911869|62799049|FG001|Safety Lead-in Phase|Death|0|||
33421081|NCT03911869|62799050|FG002|Safety Lead-in Phase|Death|0|||
33421082|NCT03911869|62799048|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
33421083|NCT03911869|62799049|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
33421084|NCT03911869|62799050|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
33421085|NCT03911869|62799048|FG000|Safety Lead-in Phase|Other|1|||
33421086|NCT03911869|62799049|FG001|Safety Lead-in Phase|Other|0|||
33421087|NCT03911869|62799050|FG002|Safety Lead-in Phase|Other|0|||
33421088|NCT03911869|62799048|FG000|Phase 2|Death|0|||
33421089|NCT03911869|62799049|FG001|Phase 2|Death|3|||
33421090|NCT03911869|62799050|FG002|Phase 2|Death|0|||
33421091|NCT03897088|62799059|FG000|Overall Study|Withdrawal by Subject|12|||
33421092|NCT03897088|62799060|FG001|Overall Study|Withdrawal by Subject|12|||
33421093|NCT03897088|62799059|FG000|Overall Study|Lost to Follow-up|7|||
33421094|NCT03897088|62799060|FG001|Overall Study|Lost to Follow-up|15|||
33421095|NCT03897088|62799059|FG000|Overall Study|Sponsor Decision|1|||
33421096|NCT03897088|62799060|FG001|Overall Study|Sponsor Decision|2|||
33421097|NCT03897088|62799059|FG000|Overall Study|COVID-19|2|||
33421098|NCT03897088|62799060|FG001|Overall Study|COVID-19|0|||
33421099|NCT03897088|62799059|FG000|Overall Study|Other|3|||
33421100|NCT03897088|62799060|FG001|Overall Study|Other|0|||
33421101|NCT03897088|62799059|FG000|Overall Study|Non-compliance with Study Drug|1|||
33421102|NCT03897088|62799060|FG001|Overall Study|Non-compliance with Study Drug|1|||
33421103|NCT03897088|62799059|FG000|Overall Study|Pregnancy|0|||
33421104|NCT03897088|62799060|FG001|Overall Study|Pregnancy|1|||
33421105|NCT03700684|62799088|FG000|Overall Study|COVID-19|0|||
33421106|NCT03700684|62799089|FG001|Overall Study|COVID-19|0|||
33421107|NCT03700684|62799090|FG002|Overall Study|COVID-19|2|||
33421108|NCT03659136|62799100|FG000|Overall Study|Not treated|2|||
33421109|NCT03659136|62799101|FG001|Overall Study|Not treated|0|||
33421110|NCT03659136|62799100|FG000|Overall Study|Covid-19 related|1|||
33421111|NCT03659136|62799101|FG001|Overall Study|Covid-19 related|1|||
33421112|NCT03659136|62799100|FG000|Overall Study|Withdrawal by Subject|1|||
33421113|NCT03659136|62799101|FG001|Overall Study|Withdrawal by Subject|6|||
33421114|NCT03659136|62799100|FG000|Overall Study|Adverse Event|4|||
33421115|NCT03659136|62799101|FG001|Overall Study|Adverse Event|6|||
33421116|NCT03659136|62799100|FG000|Overall Study|Progressive disease|37|||
33421117|NCT03659136|62799101|FG001|Overall Study|Progressive disease|31|||
33421118|NCT03659136|62799100|FG000|Overall Study|Study closure|2|||
33421119|NCT03659136|62799101|FG001|Overall Study|Study closure|2|||
33421120|NCT03659136|62799100|FG000|Overall Study|Sponsor decision/recommendation|3|||
33421121|NCT03659136|62799101|FG001|Overall Study|Sponsor decision/recommendation|2|||
33421122|NCT03659136|62799100|FG000|Overall Study|Switched to other drug/therapy|2|||
33421123|NCT03659136|62799101|FG001|Overall Study|Switched to other drug/therapy|2|||
33421124|NCT03659136|62799100|FG000|Overall Study|Lack of clinical benefit|0|||
33421125|NCT03659136|62799101|FG001|Overall Study|Lack of clinical benefit|1|||
33421126|NCT03390036|62799136|FG000|Overall Study|Lost to Follow-up|1|||
33421127|NCT03390036|62799137|FG001|Overall Study|Lost to Follow-up|0|||
33421128|NCT03390036|62799138|FG002|Overall Study|Lost to Follow-up|0|||
33421129|NCT03390036|62799136|FG000|Overall Study|Lack of Efficacy|1|||
33421130|NCT03390036|62799137|FG001|Overall Study|Lack of Efficacy|0|||
33421131|NCT03390036|62799138|FG002|Overall Study|Lack of Efficacy|0|||
33421132|NCT03366844|62799163|FG000|Overall Study|Physician Decision|1|||
33421133|NCT03366844|62799163|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
33421134|NCT03341936|62799169|FG000|Overall Study|Ineligible|1|||
33421135|NCT03341936|62799169|FG000|Overall Study|Disease Progression|2|||
33421136|NCT03341936|62799169|FG000|Overall Study|Withdrew Consent|4|||
33421137|NCT03341936|62799169|FG000|Overall Study|Non-Compliance|1|||
33421138|NCT03341936|62799169|FG000|Overall Study|Physician Decision|1|||
33421139|NCT03341936|62799169|FG000|Overall Study|Withdrawal by Subject|1|||
33421140|NCT03341936|62799169|FG000|Overall Study|Other|1|||
33421141|NCT03284203|62799173|FG000|Overall Study|Lost to Follow-up|3|||
33421142|NCT03233724|62799192|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
33421143|NCT03233724|62799193|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
33421144|NCT03233724|62799194|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
33421145|NCT03233724|62799195|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
33421146|NCT03233724|62799196|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
33421147|NCT03233724|62799192|FG000|Phase I Dose Escalation|Best interest of participant|1|||
33421148|NCT03233724|62799193|FG001|Phase I Dose Escalation|Best interest of participant|1|||
33421149|NCT03233724|62799194|FG002|Phase I Dose Escalation|Best interest of participant|1|||
33421150|NCT03233724|62799195|FG003|Phase I Dose Escalation|Best interest of participant|0|||
33421151|NCT03233724|62799196|FG004|Phase I Dose Escalation|Best interest of participant|0|||
33421152|NCT03233724|62799192|FG000|Phase I Dose Escalation|Physician Decision|0|||
33421153|NCT03233724|62799193|FG001|Phase I Dose Escalation|Physician Decision|0|||
33421154|NCT03233724|62799194|FG002|Phase I Dose Escalation|Physician Decision|1|||
33421155|NCT03233724|62799195|FG003|Phase I Dose Escalation|Physician Decision|0|||
33421156|NCT03233724|62799196|FG004|Phase I Dose Escalation|Physician Decision|0|||
33421157|NCT03233724|62799192|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
33322926|NCT00927784|62699085|FG000|Overall Study|Death|1|||
33322927|NCT00927784|62699086|FG001|Overall Study|Death|0|||
33494132|NCT04377620|62872890|FG002|Overall Study|Withdrawal by Subject|0|||
33322928|NCT00927784|62699085|FG000|Overall Study|Withdrawal by Subject|1|||
33322929|NCT00927784|62699086|FG001|Overall Study|Withdrawal by Subject|0|||
33421158|NCT03233724|62799193|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
33421159|NCT03233724|62799194|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
33421160|NCT03233724|62799195|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
33494133|NCT03486834|62872902|FG000|Overall Study|Withdrawal by Subject|46|||
33494134|NCT03486834|62872903|FG001|Overall Study|Withdrawal by Subject|46|||
33421161|NCT03233724|62799196|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
33421162|NCT03026283|62799210|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
33421163|NCT03026283|62799211|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
33421164|NCT03026283|62799212|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
33421165|NCT03026283|62799213|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
33421166|NCT03026283|62799214|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
33421167|NCT03026283|62799215|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
33421168|NCT03026283|62799216|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
33421169|NCT03026283|62799217|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
33421170|NCT03026283|62799210|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
33421171|NCT03026283|62799211|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
33421172|NCT03026283|62799212|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
33421173|NCT03026283|62799213|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
33421174|NCT03026283|62799214|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
33421175|NCT03026283|62799215|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
33421176|NCT03026283|62799216|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
33421177|NCT03026283|62799217|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
33421178|NCT03026283|62799210|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
33421179|NCT03026283|62799211|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
33421180|NCT03026283|62799212|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
33421181|NCT03026283|62799213|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
33421182|NCT03026283|62799214|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
33421183|NCT03026283|62799215|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
33421184|NCT03026283|62799216|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
33421185|NCT03026283|62799217|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
33421186|NCT03026283|62799210|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
33421187|NCT03026283|62799211|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
33421188|NCT03026283|62799212|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
33421189|NCT03026283|62799213|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
33421190|NCT03026283|62799214|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
33421191|NCT03026283|62799215|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
33421192|NCT03026283|62799216|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
33421193|NCT03026283|62799217|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
33421194|NCT03026283|62799210|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
33421195|NCT03026283|62799211|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
33421196|NCT03026283|62799212|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
33421197|NCT03026283|62799213|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
33421198|NCT03026283|62799214|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
33421199|NCT03026283|62799215|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
33421200|NCT03026283|62799216|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
33421201|NCT03026283|62799217|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
33421202|NCT03026283|62799210|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
33421203|NCT03026283|62799211|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
33421204|NCT03026283|62799212|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
33421205|NCT03026283|62799213|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
33421206|NCT03026283|62799214|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
33421207|NCT03026283|62799215|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
33421208|NCT03026283|62799216|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
33421209|NCT03026283|62799217|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
33421210|NCT03026283|62799210|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
33421211|NCT03026283|62799211|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
33421212|NCT03026283|62799212|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
33421213|NCT03026283|62799213|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
33421214|NCT03026283|62799214|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
33421215|NCT03026283|62799215|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
33421216|NCT03026283|62799216|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
33421217|NCT03026283|62799217|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
33421218|NCT03026283|62799210|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
33421219|NCT03026283|62799211|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
33421220|NCT03026283|62799212|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
33421221|NCT03026283|62799213|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
33421222|NCT03026283|62799214|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
33421223|NCT03026283|62799215|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
33421224|NCT03026283|62799216|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
33421225|NCT03026283|62799217|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
33421226|NCT03026283|62799210|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
33421227|NCT03026283|62799211|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
33421228|NCT03026283|62799212|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
33421229|NCT03026283|62799213|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
33421230|NCT03026283|62799214|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
33421231|NCT03026283|62799215|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
33421232|NCT03026283|62799216|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
33421233|NCT03026283|62799217|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
33421234|NCT02701283|62799251|FG000|Overall Study|Death|25|||
33421235|NCT02701283|62799252|FG001|Overall Study|Death|29|||
33421236|NCT02701283|62799253|FG002|Overall Study|Death|19|||
33421237|NCT02701283|62799251|FG000|Overall Study|Lost to Follow-up|3|||
33421238|NCT02701283|62799252|FG001|Overall Study|Lost to Follow-up|8|||
33421239|NCT02701283|62799253|FG002|Overall Study|Lost to Follow-up|1|||
33421240|NCT02701283|62799251|FG000|Overall Study|Withdrawal by Subject|12|||
33421241|NCT02701283|62799252|FG001|Overall Study|Withdrawal by Subject|41|||
33421242|NCT02701283|62799253|FG002|Overall Study|Withdrawal by Subject|1|||
33421243|NCT02701283|62799251|FG000|Overall Study|Missed 2-year visit|22|||
33421244|NCT02701283|62799252|FG001|Overall Study|Missed 2-year visit|27|||
33421245|NCT02701283|62799253|FG002|Overall Study|Missed 2-year visit|0|||
33421246|NCT02701283|62799251|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
33421247|NCT02701283|62799252|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
33421248|NCT02701283|62799253|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
33421249|NCT02166463|62799300|FG000|Overall Study|Lost to Follow-up|0|||
33421250|NCT02166463|62799301|FG001|Overall Study|Lost to Follow-up|1|||
33421251|NCT02166463|62799300|FG000|Overall Study|Physician Decision|10|||
33421252|NCT02166463|62799301|FG001|Overall Study|Physician Decision|10|||
33421253|NCT02166463|62799300|FG000|Overall Study|Ineligible|11|||
33421254|NCT02166463|62799301|FG001|Overall Study|Ineligible|2|||
33421255|NCT02166463|62799300|FG000|Overall Study|Progressive Disease|9|||
33421256|NCT02166463|62799301|FG001|Overall Study|Progressive Disease|6|||
33421257|NCT02166463|62799300|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
33421258|NCT02166463|62799301|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
33421259|NCT02166463|62799300|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
33421260|NCT02166463|62799301|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
33421261|NCT02166463|62799300|FG000|Overall Study|Refusal of further protocol therapy|5|||
33421262|NCT02166463|62799301|FG001|Overall Study|Refusal of further protocol therapy|6|||
33421263|NCT01994954|62799318|FG000|Overall Study|Death|1|||
33421264|NCT01994954|62799319|FG001|Overall Study|Death|0|||
33421265|NCT01994954|62799318|FG000|Overall Study|Withdrawal by Subject|9|||
33421266|NCT01994954|62799319|FG001|Overall Study|Withdrawal by Subject|14|||
33421267|NCT01994954|62799318|FG000|Overall Study|Physician Decision|2|||
33421268|NCT01994954|62799319|FG001|Overall Study|Physician Decision|2|||
33421269|NCT01994954|62799318|FG000|Overall Study|Lost to Follow-up|8|||
33421270|NCT01994954|62799319|FG001|Overall Study|Lost to Follow-up|10|||
33421271|NCT01994954|62799318|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
33421272|NCT01994954|62799319|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
33421273|NCT00861705|62799393|FG000|Overall Study|Never Began Treatment|7|||
33421274|NCT00861705|62799394|FG001|Overall Study|Never Began Treatment|3|||
33421275|NCT00861705|62799395|FG002|Overall Study|Never Began Treatment|0|||
33421276|NCT00861705|62799396|FG003|Overall Study|Never Began Treatment|1|||
33421277|NCT00380367|62799421|FG000|Overall Study|Lost to Follow-up|1|||
33421278|NCT00380367|62799421|FG000|Overall Study|Withdrawal by Subject|1|||
33421279|NCT00531050|62799431|FG000|Part 1: Period 1|Adverse Event|0|||
33421280|NCT00531050|62799432|FG001|Part 1: Period 1|Adverse Event|1|||
33421281|NCT00531050|62799433|FG002|Part 1: Period 1|Adverse Event|0|||
33421282|NCT00531050|62799434|FG003|Part 1: Period 1|Adverse Event|0|||
33421283|NCT00531050|62799435|FG004|Part 1: Period 1|Adverse Event|0|||
33322930|NCT05056987|62699103|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
33322931|NCT05056987|62699104|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
33322932|NCT05056987|62699103|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
33322933|NCT05056987|62699104|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
33322934|NCT03439852|62699137|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
33322935|NCT03439852|62699138|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
33322936|NCT03439852|62699137|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
33322937|NCT03439852|62699138|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
33322938|NCT03439852|62699137|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
33322939|NCT03439852|62699138|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
33322940|NCT03355300|62699149|FG000|Overall Study|Physician Decision|0|||
33421284|NCT00531050|62799436|FG005|Part 1: Period 1|Adverse Event|0|||
33421285|NCT00531050|62799431|FG000|Part 1: Period 1|Protocol Deviation|0|||
33421286|NCT00531050|62799432|FG001|Part 1: Period 1|Protocol Deviation|0|||
33421287|NCT00531050|62799433|FG002|Part 1: Period 1|Protocol Deviation|0|||
33421288|NCT00531050|62799434|FG003|Part 1: Period 1|Protocol Deviation|1|||
33421289|NCT00531050|62799435|FG004|Part 1: Period 1|Protocol Deviation|0|||
33421290|NCT00531050|62799436|FG005|Part 1: Period 1|Protocol Deviation|0|||
33421291|NCT00531050|62799431|FG000|Part 1: Period 3|Adverse Event|1|||
33421292|NCT00531050|62799432|FG001|Part 1: Period 3|Adverse Event|0|||
33421293|NCT00531050|62799433|FG002|Part 1: Period 3|Adverse Event|0|||
33421294|NCT00531050|62799434|FG003|Part 1: Period 3|Adverse Event|0|||
33421295|NCT00531050|62799435|FG004|Part 1: Period 3|Adverse Event|0|||
33421296|NCT00531050|62799436|FG005|Part 1: Period 3|Adverse Event|0|||
33322941|NCT03355300|62699150|FG001|Overall Study|Physician Decision|1|||
33322942|NCT03355300|62699149|FG000|Overall Study|Lack of Efficacy|2|||
33421297|NCT00531050|62799431|FG000|Part 2: Period 1|Adverse Event|0|||
33421298|NCT00531050|62799432|FG001|Part 2: Period 1|Adverse Event|0|||
33421299|NCT00531050|62799433|FG002|Part 2: Period 1|Adverse Event|0|||
33421300|NCT00531050|62799434|FG003|Part 2: Period 1|Adverse Event|0|||
33421301|NCT00531050|62799435|FG004|Part 2: Period 1|Adverse Event|0|||
33421302|NCT00531050|62799436|FG005|Part 2: Period 1|Adverse Event|1|||
33421303|NCT00531050|62799431|FG000|Part 2: Period 3|Abnormal test procedure|1|||
33421304|NCT00531050|62799432|FG001|Part 2: Period 3|Abnormal test procedure|0|||
33421305|NCT00531050|62799433|FG002|Part 2: Period 3|Abnormal test procedure|0|||
33421306|NCT00531050|62799434|FG003|Part 2: Period 3|Abnormal test procedure|0|||
33421307|NCT00531050|62799435|FG004|Part 2: Period 3|Abnormal test procedure|0|||
33421308|NCT00531050|62799436|FG005|Part 2: Period 3|Abnormal test procedure|1|||
33421309|NCT00530348|62799455|FG000|Overall Study|Adverse Event|5|||
33421310|NCT00530348|62799456|FG001|Overall Study|Adverse Event|1|||
33421311|NCT00530348|62799455|FG000|Overall Study|Death|0|||
33421312|NCT00530348|62799456|FG001|Overall Study|Death|1|||
33421313|NCT00530348|62799455|FG000|Overall Study|Lack of Efficacy|2|||
33421314|NCT00530348|62799456|FG001|Overall Study|Lack of Efficacy|0|||
33421315|NCT00530348|62799455|FG000|Overall Study|Lost to Follow-up|0|||
33421316|NCT00530348|62799456|FG001|Overall Study|Lost to Follow-up|2|||
33421317|NCT00530348|62799455|FG000|Overall Study|Physician Decision|1|||
33421318|NCT00530348|62799456|FG001|Overall Study|Physician Decision|2|||
33421319|NCT00530348|62799455|FG000|Overall Study|Pregnancy|1|||
33421320|NCT00530348|62799456|FG001|Overall Study|Pregnancy|0|||
33421321|NCT00530348|62799455|FG000|Overall Study|Withdrawal by Subject|12|||
33421322|NCT00530348|62799456|FG001|Overall Study|Withdrawal by Subject|12|||
33421323|NCT00530348|62799455|FG000|Overall Study|Randomised in error|1|||
33421324|NCT00530348|62799456|FG001|Overall Study|Randomised in error|0|||
33421325|NCT00530348|62799455|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
33421326|NCT00530348|62799456|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
33421327|NCT03886220|62799464|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
33421328|NCT03886220|62799465|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
33421329|NCT03886220|62799464|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
33421330|NCT03886220|62799465|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33421331|NCT03886220|62799464|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
33421332|NCT03886220|62799465|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
33421333|NCT00530270|62799473|FG000|Overall Study|Protocol Violation|1|||
33421334|NCT00530270|62799474|FG001|Overall Study|Protocol Violation|0|||
33421335|NCT03885596|62799484|FG000|Overall Study|Withdrawal by Subject|2|||
33421336|NCT03885596|62799485|FG001|Overall Study|Withdrawal by Subject|1|||
33421337|NCT03885596|62799486|FG002|Overall Study|Withdrawal by Subject|0|||
33421338|NCT03885596|62799487|FG003|Overall Study|Withdrawal by Subject|0|||
33421339|NCT00529100|62799503|FG000|Overall Study|Adverse Event|0|||
33421340|NCT00529100|62799504|FG001|Overall Study|Adverse Event|5|||
33421341|NCT00529100|62799503|FG000|Overall Study|Protocol Violation|0|||
33421342|NCT00529100|62799504|FG001|Overall Study|Protocol Violation|1|||
33421343|NCT00529100|62799503|FG000|Overall Study|Progressive Disease|0|||
33421344|NCT00529100|62799504|FG001|Overall Study|Progressive Disease|1|||
33421345|NCT00529100|62799503|FG000|Overall Study|Withdrawal by Subject|0|||
33421346|NCT00529100|62799504|FG001|Overall Study|Withdrawal by Subject|1|||
33421347|NCT00529100|62799503|FG000|Overall Study|Participant Ineligibility|0|||
33421348|NCT00529100|62799504|FG001|Overall Study|Participant Ineligibility|1|||
33421349|NCT03878108|62799516|FG000|Overall Study|Adverse Event|1|||
33421350|NCT03878108|62799517|FG001|Overall Study|Adverse Event|0|||
33421351|NCT00529958|62799526|FG000|2-Year Follow-up|Lost to Follow-up|1|||
33421352|NCT00529958|62799527|FG001|2-Year Follow-up|Lost to Follow-up|2|||
33421353|NCT00529958|62799528|FG002|2-Year Follow-up|Lost to Follow-up|2|||
33421354|NCT00529958|62799526|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
33421355|NCT00529958|62799527|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
33421356|NCT00529958|62799528|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
33421357|NCT00529958|62799526|FG000|5-Year Follow-up|Lost to Follow-up|2|||
33421358|NCT00529958|62799527|FG001|5-Year Follow-up|Lost to Follow-up|3|||
33421359|NCT00529958|62799528|FG002|5-Year Follow-up|Lost to Follow-up|1|||
33421360|NCT00529958|62799526|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
33421361|NCT00529958|62799527|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
33421362|NCT00529958|62799528|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
33421363|NCT00529802|62799536|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
33421364|NCT00529802|62799536|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
33421365|NCT00529802|62799536|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
33421366|NCT00529802|62799536|FG000|Evaluable for Primary Endpoint|Death|1|||
33421367|NCT00529802|62799536|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
33421368|NCT00529802|62799536|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
33421369|NCT00529802|62799536|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
33421370|NCT00528866|62799542|FG000|Overall Study|Protocol Violation|6|||
33421371|NCT00614393|62799552|FG000|Overall Study|Adverse Event|20|||
33421372|NCT00614393|62799553|FG001|Overall Study|Adverse Event|2|||
33421373|NCT00614393|62799554|FG002|Overall Study|Adverse Event|3|||
33421374|NCT00614393|62799555|FG003|Overall Study|Adverse Event|13|||
33421375|NCT00614393|62799556|FG004|Overall Study|Adverse Event|21|||
33421376|NCT00614393|62799552|FG000|Overall Study|Lost to Follow-up|0|||
33421377|NCT00614393|62799553|FG001|Overall Study|Lost to Follow-up|0|||
33421378|NCT00614393|62799554|FG002|Overall Study|Lost to Follow-up|0|||
33421379|NCT00614393|62799555|FG003|Overall Study|Lost to Follow-up|1|||
33421380|NCT00614393|62799556|FG004|Overall Study|Lost to Follow-up|2|||
33421381|NCT00614393|62799552|FG000|Overall Study|Physician Decision|17|||
33421382|NCT00614393|62799553|FG001|Overall Study|Physician Decision|0|||
33421383|NCT00614393|62799554|FG002|Overall Study|Physician Decision|1|||
33421384|NCT00614393|62799555|FG003|Overall Study|Physician Decision|8|||
33421385|NCT00614393|62799556|FG004|Overall Study|Physician Decision|9|||
33421386|NCT00614393|62799552|FG000|Overall Study|Progressive Disease|118|||
33421387|NCT00614393|62799553|FG001|Overall Study|Progressive Disease|5|||
33421388|NCT00614393|62799554|FG002|Overall Study|Progressive Disease|5|||
33421389|NCT00614393|62799555|FG003|Overall Study|Progressive Disease|138|||
33421390|NCT00614393|62799556|FG004|Overall Study|Progressive Disease|130|||
33421391|NCT00614393|62799552|FG000|Overall Study|Protocol Violation|1|||
33421392|NCT00614393|62799553|FG001|Overall Study|Protocol Violation|0|||
33421393|NCT00614393|62799554|FG002|Overall Study|Protocol Violation|0|||
33421394|NCT00614393|62799555|FG003|Overall Study|Protocol Violation|0|||
33421395|NCT00614393|62799556|FG004|Overall Study|Protocol Violation|0|||
33421396|NCT00614393|62799552|FG000|Overall Study|Terminated by Sponsor|0|||
33421397|NCT00614393|62799553|FG001|Overall Study|Terminated by Sponsor|0|||
33421398|NCT00614393|62799554|FG002|Overall Study|Terminated by Sponsor|0|||
33421399|NCT00614393|62799555|FG003|Overall Study|Terminated by Sponsor|0|||
33421400|NCT00614393|62799556|FG004|Overall Study|Terminated by Sponsor|1|||
33421401|NCT00614393|62799552|FG000|Overall Study|Withdrawal by Subject|20|||
33421402|NCT00614393|62799553|FG001|Overall Study|Withdrawal by Subject|1|||
33421403|NCT00614393|62799554|FG002|Overall Study|Withdrawal by Subject|1|||
33421404|NCT00614393|62799555|FG003|Overall Study|Withdrawal by Subject|16|||
33421405|NCT00614393|62799556|FG004|Overall Study|Withdrawal by Subject|13|||
33421406|NCT00614393|62799552|FG000|Overall Study|Other|4|||
33421407|NCT00614393|62799553|FG001|Overall Study|Other|0|||
33421408|NCT00614393|62799554|FG002|Overall Study|Other|0|||
33421409|NCT00614393|62799555|FG003|Overall Study|Other|4|||
33421410|NCT00614393|62799556|FG004|Overall Study|Other|2|||
33421411|NCT00614393|62799552|FG000|Overall Study|Not Treated|0|||
33421412|NCT00614393|62799553|FG001|Overall Study|Not Treated|0|||
33421413|NCT00614393|62799554|FG002|Overall Study|Not Treated|0|||
33421414|NCT00614393|62799555|FG003|Overall Study|Not Treated|0|||
33421415|NCT00614393|62799556|FG004|Overall Study|Not Treated|2|||
33421416|NCT00612677|62799568|FG000|Overall Study|study closed before treatment started|1|||
33421417|NCT00613925|62799574|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
33421418|NCT00613925|62799575|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
33421419|NCT00613301|62799581|FG000|Overall Study|Adverse Event|49|||
33421420|NCT00613301|62799581|FG000|Overall Study|Lost to Follow-up|88|||
33421421|NCT00613301|62799581|FG000|Overall Study|Withdrawal by Subject|5|||
33421422|NCT00613301|62799581|FG000|Overall Study|Death|6|||
33421423|NCT00613301|62799581|FG000|Overall Study|Lack of Efficacy|13|||
33421424|NCT00613301|62799581|FG000|Overall Study|Physician Decision|2|||
33421425|NCT00613301|62799581|FG000|Overall Study|No data was collected|53|||
33421426|NCT00613301|62799581|FG000|Overall Study|Irregularly enrolled patients|12|||
33421427|NCT00609947|62799586|FG000|Overall Study|Death|1|||
33421428|NCT00609869|62799591|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
33421429|NCT00609869|62799591|FG000|Overall Study|Severe hematologic toxicity|1|||
33421430|NCT00609869|62799591|FG000|Overall Study|Withdrawal by Subject|1|||
33421431|NCT00609869|62799591|FG000|Overall Study|Seizures|1|||
33421432|NCT00609869|62799591|FG000|Overall Study|Severe tumor flare reaction|1|||
33421433|NCT00609869|62799591|FG000|Overall Study|Hepatitis B infection|1|||
33421434|NCT00609869|62799591|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
33421435|NCT00609869|62799591|FG000|Overall Study|Mantle cell: not evaluable|4|||
33421436|NCT00529568|62799597|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
33421437|NCT00529568|62799598|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
33421438|NCT00529568|62799599|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
33421439|NCT00529568|62799597|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
33421440|NCT00529568|62799598|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
33421441|NCT00529568|62799599|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
33421442|NCT00529568|62799597|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
33421443|NCT00529568|62799598|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
33421444|NCT00529568|62799599|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
33421445|NCT00529568|62799597|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
33421446|NCT00529568|62799598|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
33421447|NCT00529568|62799599|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
33421448|NCT00529568|62799597|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
33421449|NCT00529568|62799598|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
33322943|NCT03355300|62699150|FG001|Overall Study|Lack of Efficacy|1|||
33322944|NCT03355300|62699149|FG000|Overall Study|Other reason|1|||
33421450|NCT00529568|62799599|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
33421451|NCT00529568|62799597|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
33421452|NCT00529568|62799598|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
33421453|NCT00529568|62799599|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
33421454|NCT00529568|62799597|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
33421455|NCT00529568|62799598|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
33421456|NCT00529568|62799599|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
33421457|NCT00529568|62799597|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
33421458|NCT00529568|62799598|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
33421459|NCT00529568|62799599|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
33421460|NCT00529568|62799597|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
33421461|NCT00529568|62799598|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
33421462|NCT00529568|62799599|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
33421463|NCT00529568|62799597|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
33421464|NCT00529568|62799598|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
33421465|NCT00529568|62799599|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
33421466|NCT00529568|62799597|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
33421467|NCT00529568|62799598|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
33421468|NCT00529568|62799599|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
33421469|NCT00611975|62799610|FG000|Overall Study|Withdrawal by Subject|3|||
33421470|NCT00611975|62799611|FG001|Overall Study|Withdrawal by Subject|7|||
33421471|NCT00611975|62799610|FG000|Overall Study|Pregnancy|2|||
33421472|NCT00611975|62799611|FG001|Overall Study|Pregnancy|1|||
33421473|NCT00573131|62799619|FG000|Overall Study|Withdrawal by Subject|10|||
33421474|NCT00573131|62799620|FG001|Overall Study|Withdrawal by Subject|8|||
33421475|NCT00521144|62799631|FG000|Overall Study|Not Treated|0|||
33421476|NCT00521144|62799632|FG001|Overall Study|Not Treated|0|||
33421477|NCT00521144|62799633|FG002|Overall Study|Not Treated|0|||
33421478|NCT00521144|62799634|FG003|Overall Study|Not Treated|1|||
33421479|NCT00521144|62799635|FG004|Overall Study|Not Treated|0|||
33421480|NCT00521144|62799631|FG000|Overall Study|Adverse Event|0|||
33421481|NCT00521144|62799632|FG001|Overall Study|Adverse Event|1|||
33421482|NCT00521144|62799633|FG002|Overall Study|Adverse Event|0|||
33421483|NCT00521144|62799634|FG003|Overall Study|Adverse Event|0|||
33421484|NCT00521144|62799635|FG004|Overall Study|Adverse Event|1|||
33421485|NCT00521144|62799631|FG000|Overall Study|Progressive Disease|4|||
33421486|NCT00521144|62799632|FG001|Overall Study|Progressive Disease|2|||
33421487|NCT00521144|62799633|FG002|Overall Study|Progressive Disease|2|||
33421488|NCT00521144|62799634|FG003|Overall Study|Progressive Disease|0|||
33421489|NCT00521144|62799635|FG004|Overall Study|Progressive Disease|6|||
33421490|NCT00520676|62799649|FG000|Overall Study|Death|84|||
33421491|NCT00520676|62799650|FG001|Overall Study|Death|81|||
33421492|NCT00520676|62799649|FG000|Overall Study|Lost to Follow-up|6|||
33421493|NCT00520676|62799650|FG001|Overall Study|Lost to Follow-up|10|||
33421494|NCT00520676|62799649|FG000|Overall Study|Physician Decision|4|||
33421495|NCT00520676|62799650|FG001|Overall Study|Physician Decision|1|||
33421496|NCT00520676|62799649|FG000|Overall Study|Withdrawal by Subject|7|||
33421497|NCT00520676|62799650|FG001|Overall Study|Withdrawal by Subject|11|||
33421498|NCT00610649|62799667|FG000|Overall Study|Adverse Event|1|||
33421499|NCT00610649|62799668|FG001|Overall Study|Adverse Event|0|||
33322945|NCT03355300|62699150|FG001|Overall Study|Other reason|0|||
33421500|NCT00610649|62799669|FG002|Overall Study|Adverse Event|0|||
33421501|NCT00610649|62799670|FG003|Overall Study|Adverse Event|0|||
33421502|NCT00610649|62799671|FG004|Overall Study|Adverse Event|0|||
33421503|NCT00610649|62799672|FG005|Overall Study|Adverse Event|0|||
33421504|NCT00610649|62799673|FG006|Overall Study|Adverse Event|0|||
33421505|NCT00610649|62799674|FG007|Overall Study|Adverse Event|0|||
33421506|NCT00610649|62799675|FG008|Overall Study|Adverse Event|0|||
33421507|NCT00610649|62799676|FG009|Overall Study|Adverse Event|0|||
33421508|NCT00610649|62799677|FG010|Overall Study|Adverse Event|1|||
33421509|NCT00610649|62799667|FG000|Overall Study|Family Emergency|0|||
33421510|NCT00610649|62799668|FG001|Overall Study|Family Emergency|1|||
33605200|NCT02367833|63004933|FG002|Overall Study|Withdrawal by Subject|0|||
33605201|NCT02367521|63004943|FG000|Overall Study|severe headache after intervention|2|||
33605202|NCT02367521|63004944|FG001|Overall Study|severe headache after intervention|0|||
33605203|NCT02367521|63004943|FG000|Overall Study|unable to find transportation|2|||
33605204|NCT02367521|63004944|FG001|Overall Study|unable to find transportation|0|||
33605205|NCT02338193|63004953|FG000|Overall Study|Withdrawal by Subject|0|||
33605206|NCT02338193|63004954|FG001|Overall Study|Withdrawal by Subject|0|||
33605207|NCT02338193|63004955|FG002|Overall Study|Withdrawal by Subject|2|||
33605208|NCT02338193|63004953|FG000|Overall Study|Pregnancy|0|||
33605209|NCT02338193|63004954|FG001|Overall Study|Pregnancy|1|||
33605210|NCT02338193|63004955|FG002|Overall Study|Pregnancy|1|||
33605211|NCT02338193|63004953|FG000|Overall Study|Noncompliant with visits|2|||
33605212|NCT02338193|63004954|FG001|Overall Study|Noncompliant with visits|2|||
33605213|NCT02338193|63004955|FG002|Overall Study|Noncompliant with visits|7|||
33605214|NCT02338193|63004953|FG000|Overall Study|moved out of state|0|||
33605215|NCT02338193|63004954|FG001|Overall Study|moved out of state|1|||
33605216|NCT02338193|63004955|FG002|Overall Study|moved out of state|0|||
33605217|NCT02338193|63004953|FG000|Overall Study|intolerant of side effects|1|||
33605218|NCT02338193|63004954|FG001|Overall Study|intolerant of side effects|0|||
33605219|NCT02338193|63004955|FG002|Overall Study|intolerant of side effects|0|||
33605220|NCT01783444|63004966|FG000|Treatment Phase|Adverse Event|9|||
33421511|NCT00610649|62799669|FG002|Overall Study|Family Emergency|0|||
33421512|NCT00610649|62799670|FG003|Overall Study|Family Emergency|0|||
33421513|NCT00610649|62799671|FG004|Overall Study|Family Emergency|0|||
33421514|NCT00610649|62799672|FG005|Overall Study|Family Emergency|0|||
33421515|NCT00610649|62799673|FG006|Overall Study|Family Emergency|0|||
33421516|NCT00610649|62799674|FG007|Overall Study|Family Emergency|0|||
33421517|NCT00610649|62799675|FG008|Overall Study|Family Emergency|0|||
33421518|NCT00610649|62799676|FG009|Overall Study|Family Emergency|0|||
33421519|NCT00610649|62799677|FG010|Overall Study|Family Emergency|0|||
33421520|NCT00610649|62799667|FG000|Overall Study|Withdrawal by Subject|0|||
33421521|NCT00610649|62799668|FG001|Overall Study|Withdrawal by Subject|0|||
33421522|NCT00610649|62799669|FG002|Overall Study|Withdrawal by Subject|0|||
33605221|NCT01783444|63004967|FG001|Treatment Phase|Adverse Event|20|||
33605222|NCT01783444|63004968|FG002|Treatment Phase|Adverse Event|19|||
33421523|NCT00610649|62799670|FG003|Overall Study|Withdrawal by Subject|0|||
33421524|NCT00610649|62799671|FG004|Overall Study|Withdrawal by Subject|0|||
33421525|NCT00610649|62799672|FG005|Overall Study|Withdrawal by Subject|0|||
33421526|NCT00610649|62799673|FG006|Overall Study|Withdrawal by Subject|0|||
33421527|NCT00610649|62799674|FG007|Overall Study|Withdrawal by Subject|0|||
33421528|NCT00610649|62799675|FG008|Overall Study|Withdrawal by Subject|0|||
33421529|NCT00610649|62799676|FG009|Overall Study|Withdrawal by Subject|1|||
33421530|NCT00610649|62799677|FG010|Overall Study|Withdrawal by Subject|0|||
33421531|NCT00608543|62799701|FG000|Overall Study|Adverse Event|4|||
33421532|NCT00520130|62799708|FG000|Overall Study|Disease progression on study|4|||
33421533|NCT00520130|62799709|FG001|Overall Study|Disease progression on study|0|||
33421534|NCT00520130|62799708|FG000|Overall Study|Physician Decision|1|||
33421535|NCT00520130|62799709|FG001|Overall Study|Physician Decision|1|||
33421536|NCT00519896|62799719|FG000|Overall Study|Protocol Violation|1|||
33421537|NCT00519896|62799719|FG000|Overall Study|Adverse Event|1|||
33421538|NCT00527618|62799732|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
33421539|NCT00527618|62799733|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
33421540|NCT00527618|62799732|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
33421541|NCT00527618|62799733|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
33421542|NCT00527618|62799732|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
33421543|NCT00527618|62799733|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
33421544|NCT00527618|62799732|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
33421545|NCT00527618|62799733|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
33421546|NCT00527618|62799732|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
33421547|NCT00527618|62799733|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
33421548|NCT00527618|62799732|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
33421549|NCT00527618|62799733|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
33421550|NCT00527072|62799740|FG000|Overall Study|Adverse Event|13|||
33421551|NCT00527072|62799740|FG000|Overall Study|Lack of Efficacy|11|||
33421552|NCT00527072|62799740|FG000|Overall Study|Lost to Follow-up|3|||
33421553|NCT00527072|62799740|FG000|Overall Study|Protocol Violation|2|||
33421554|NCT00527072|62799740|FG000|Overall Study|Withdrawal by Subject|7|||
33421555|NCT00526994|62799748|FG000|Overall Study|Lost to Follow-up|98|||
33421556|NCT00526994|62799749|FG001|Overall Study|Lost to Follow-up|108|||
33421557|NCT00526994|62799750|FG002|Overall Study|Lost to Follow-up|96|||
33421558|NCT00526994|62799748|FG000|Overall Study|Death|4|||
33421559|NCT00526994|62799749|FG001|Overall Study|Death|3|||
33421560|NCT00526994|62799750|FG002|Overall Study|Death|3|||
33421561|NCT00526994|62799748|FG000|Overall Study|Withdrawal by Subject|2|||
33421562|NCT00526994|62799749|FG001|Overall Study|Withdrawal by Subject|7|||
33421563|NCT00526994|62799750|FG002|Overall Study|Withdrawal by Subject|5|||
33421564|NCT00526994|62799748|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
33421565|NCT00526994|62799749|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
33421566|NCT00526994|62799750|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
33421567|NCT00519428|62799761|FG000|Overall Study|Adverse Event|5|||
33421568|NCT00519428|62799762|FG001|Overall Study|Adverse Event|2|||
33421569|NCT00519428|62799763|FG002|Overall Study|Adverse Event|10|||
33421570|NCT00519428|62799761|FG000|Overall Study|Lost to Follow-up|7|||
33421571|NCT00519428|62799762|FG001|Overall Study|Lost to Follow-up|7|||
33421572|NCT00519428|62799763|FG002|Overall Study|Lost to Follow-up|6|||
33421573|NCT00519428|62799761|FG000|Overall Study|Withdrawal by Subject|8|||
33421574|NCT00519428|62799762|FG001|Overall Study|Withdrawal by Subject|3|||
33421575|NCT00519428|62799763|FG002|Overall Study|Withdrawal by Subject|7|||
33421576|NCT00519428|62799761|FG000|Overall Study|unstated|1|||
33421577|NCT00519428|62799762|FG001|Overall Study|unstated|3|||
33421578|NCT00519428|62799763|FG002|Overall Study|unstated|2|||
33421579|NCT00432159|62799779|FG000|Overall Study|Death|0|||
33421580|NCT00432159|62799780|FG001|Overall Study|Death|1|||
33421581|NCT00432159|62799781|FG002|Overall Study|Death|0|||
33605223|NCT01783444|63004966|FG000|Treatment Phase|Disease Progression|76|||
33421582|NCT00432159|62799782|FG003|Overall Study|Death|0|||
33421583|NCT00432159|62799783|FG004|Overall Study|Death|0|||
33421584|NCT00432159|62799779|FG000|Overall Study|Failure|9|||
33421585|NCT00432159|62799780|FG001|Overall Study|Failure|5|||
33421586|NCT00432159|62799781|FG002|Overall Study|Failure|3|||
33421587|NCT00432159|62799782|FG003|Overall Study|Failure|2|||
33421588|NCT00432159|62799783|FG004|Overall Study|Failure|3|||
33421589|NCT00432159|62799779|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
33421590|NCT00432159|62799780|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
33421591|NCT00432159|62799781|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
33421592|NCT00432159|62799782|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
33421593|NCT00432159|62799783|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
33421594|NCT00519194|62799795|FG000|Overall Study|Withdrawal by Subject|9|||
33421595|NCT00519194|62799795|FG000|Overall Study|Death|9|||
33421596|NCT00519194|62799795|FG000|Overall Study|Lost to Follow-up|3|||
33421597|NCT00431847|62799803|FG000|Overall Study|completion of less than two study visits|6|||
33421598|NCT00431847|62799804|FG001|Overall Study|completion of less than two study visits|3|||
33421599|NCT00431847|62799805|FG002|Overall Study|completion of less than two study visits|4|||
33421600|NCT00431847|62799806|FG003|Overall Study|completion of less than two study visits|14|||
33421601|NCT00431847|62799807|FG004|Overall Study|completion of less than two study visits|0|||
33421602|NCT00431847|62799803|FG000|Overall Study|Protocol Violation|0|||
33421603|NCT00431847|62799804|FG001|Overall Study|Protocol Violation|0|||
33421604|NCT00431847|62799805|FG002|Overall Study|Protocol Violation|0|||
33421605|NCT00431847|62799806|FG003|Overall Study|Protocol Violation|0|||
33421606|NCT00431847|62799807|FG004|Overall Study|Protocol Violation|1|||
33421607|NCT00431067|62799817|FG000|Overall Study|Other Adverse Event|9|||
33421608|NCT00431067|62799817|FG000|Overall Study|Progressive disease|30|||
33421609|NCT00431067|62799817|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
33421610|NCT00430989|62799823|FG000|Overall Study|Lost to Follow-up|2|||
33421611|NCT00430989|62799824|FG001|Overall Study|Lost to Follow-up|3|||
33421612|NCT00430989|62799823|FG000|Overall Study|Withdrawal by Subject|15|||
33421613|NCT00430989|62799824|FG001|Overall Study|Withdrawal by Subject|14|||
33421614|NCT00430989|62799823|FG000|Overall Study|Protocol Violation|30|||
33421615|NCT00430989|62799824|FG001|Overall Study|Protocol Violation|37|||
33421616|NCT00430989|62799823|FG000|Overall Study|Not eligible|13|||
33421617|NCT00430989|62799824|FG001|Overall Study|Not eligible|6|||
33421618|NCT00430755|62799832|FG000|Overall Study|Withdrawal by Subject|53|||
33421619|NCT00518882|62799838|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
33421620|NCT00518882|62799839|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
33421621|NCT00518882|62799838|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
33421622|NCT00518882|62799839|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
33421623|NCT00518882|62799838|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
33421624|NCT00518882|62799839|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
33421625|NCT00518882|62799838|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
33605224|NCT01783444|63004967|FG001|Treatment Phase|Disease Progression|66|||
33421626|NCT00518882|62799839|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
33421627|NCT00518882|62799838|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
33421628|NCT00518882|62799839|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
33421629|NCT00518882|62799838|FG000|Double-Blind, Week 0-26|Subject decision|1|||
33421630|NCT00518882|62799839|FG001|Double-Blind, Week 0-26|Subject decision|1|||
33421631|NCT00518882|62799838|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
33421632|NCT00518882|62799839|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
33605225|NCT01783444|63004968|FG002|Treatment Phase|Disease Progression|64|||
33421633|NCT00518882|62799838|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
33421634|NCT00518882|62799839|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
33421635|NCT00518882|62799838|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
33421636|NCT00518882|62799839|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
33421637|NCT00518882|62799838|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
33421638|NCT00518882|62799839|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
33421639|NCT00518882|62799838|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
33421640|NCT00518882|62799839|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
33421641|NCT00518882|62799838|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
33421642|NCT00518882|62799839|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
33421643|NCT00518882|62799838|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
33421644|NCT00518882|62799839|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
33421645|NCT00518882|62799838|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
33421646|NCT00518882|62799839|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
33421647|NCT00518882|62799838|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
33421648|NCT00518882|62799839|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
33421649|NCT00518882|62799838|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
33605226|NCT01783444|63004966|FG000|Treatment Phase|Death|2|||
33605227|NCT01783444|63004967|FG001|Treatment Phase|Death|2|||
33421650|NCT00518882|62799839|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
33421651|NCT00518882|62799838|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
33421652|NCT00518882|62799839|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
33421653|NCT00518882|62799838|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
33421654|NCT00518882|62799839|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
33421655|NCT00518882|62799838|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
33421656|NCT00518882|62799839|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
33421657|NCT00518882|62799838|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
33421658|NCT00518882|62799839|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
33421659|NCT00518882|62799838|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
33421660|NCT00518882|62799839|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
33421661|NCT00518882|62799838|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
33421662|NCT00518882|62799839|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
33421663|NCT00518882|62799838|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
33421664|NCT00518882|62799839|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
33421665|NCT00518882|62799838|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
33421666|NCT00518882|62799839|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
33421667|NCT00518336|62799847|FG000|Year 7|Lost to Follow-up|2|||
33421668|NCT00518336|62799848|FG001|Year 7|Lost to Follow-up|0|||
33421669|NCT00518336|62799847|FG000|Year 7|Could not attend in time|0|||
33421670|NCT00518336|62799848|FG001|Year 7|Could not attend in time|3|||
33421671|NCT00518336|62799847|FG000|Year 8|Lost to Follow-up|1|||
33421672|NCT00518336|62799848|FG001|Year 8|Lost to Follow-up|1|||
33421673|NCT00518336|62799847|FG000|Year 8|Could not attend in time|0|||
33605228|NCT01783444|63004968|FG002|Treatment Phase|Death|2|||
33605229|NCT01783444|63004966|FG000|Treatment Phase|Protocol Violation|1|||
33421674|NCT00518336|62799848|FG001|Year 8|Could not attend in time|1|||
33421675|NCT00518336|62799847|FG000|Year 9|Migrated/moved from study area|1|||
33421676|NCT00518336|62799848|FG001|Year 9|Migrated/moved from study area|1|||
33421677|NCT00518336|62799847|FG000|Year 9|Lost to Follow-up|3|||
33421678|NCT00518336|62799848|FG001|Year 9|Lost to Follow-up|0|||
33421679|NCT00518336|62799847|FG000|Year 9|Personal reasons|1|||
33421680|NCT00518336|62799848|FG001|Year 9|Personal reasons|0|||
33421681|NCT00518180|62799857|FG000|Overall Study|Withdrawal by Subject|29|||
33421682|NCT00518180|62799858|FG001|Overall Study|Withdrawal by Subject|30|||
33421683|NCT00518180|62799859|FG002|Overall Study|Withdrawal by Subject|42|||
33421684|NCT00518180|62799857|FG000|Overall Study|Lost to Follow-up|30|||
33421685|NCT00518180|62799858|FG001|Overall Study|Lost to Follow-up|28|||
33421686|NCT00518180|62799859|FG002|Overall Study|Lost to Follow-up|34|||
33421687|NCT00518180|62799857|FG000|Overall Study|Administrative reason|0|||
33421688|NCT00518180|62799858|FG001|Overall Study|Administrative reason|2|||
33421689|NCT00518180|62799859|FG002|Overall Study|Administrative reason|2|||
33421690|NCT00518180|62799857|FG000|Overall Study|Protocol Violation|5|||
33421691|NCT00518180|62799858|FG001|Overall Study|Protocol Violation|7|||
33421692|NCT00518180|62799859|FG002|Overall Study|Protocol Violation|4|||
33421693|NCT00518180|62799857|FG000|Overall Study|Unable to classify|0|||
33421694|NCT00518180|62799858|FG001|Overall Study|Unable to classify|2|||
33421695|NCT00518180|62799859|FG002|Overall Study|Unable to classify|0|||
33421696|NCT00518180|62799857|FG000|Overall Study|Adverse Event|1|||
33421697|NCT00518180|62799858|FG001|Overall Study|Adverse Event|0|||
33421698|NCT00518180|62799859|FG002|Overall Study|Adverse Event|0|||
33421699|NCT00525902|62799876|FG000|Overall Study|Lack of Efficacy|1|||
33421700|NCT00525824|62799884|FG000|Overall Study|Adverse Event|7|||
33421701|NCT00525824|62799885|FG001|Overall Study|Adverse Event|11|||
33421702|NCT00525824|62799886|FG002|Overall Study|Adverse Event|6|||
33421703|NCT00525824|62799887|FG003|Overall Study|Adverse Event|7|||
33421704|NCT00525824|62799884|FG000|Overall Study|Withdrawal by Subject|5|||
33421705|NCT00525824|62799885|FG001|Overall Study|Withdrawal by Subject|9|||
33421706|NCT00525824|62799886|FG002|Overall Study|Withdrawal by Subject|3|||
33421707|NCT00525824|62799887|FG003|Overall Study|Withdrawal by Subject|4|||
33421708|NCT00525824|62799884|FG000|Overall Study|Lost to Follow-up|4|||
33421709|NCT00525824|62799885|FG001|Overall Study|Lost to Follow-up|2|||
33421710|NCT00525824|62799886|FG002|Overall Study|Lost to Follow-up|4|||
33421711|NCT00525824|62799887|FG003|Overall Study|Lost to Follow-up|0|||
33421712|NCT00525824|62799884|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
33421713|NCT00525824|62799885|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
33421714|NCT00525824|62799886|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
33421715|NCT00525824|62799887|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
33421716|NCT00525824|62799884|FG000|Overall Study|Severe non-compliance|0|||
33421717|NCT00525824|62799885|FG001|Overall Study|Severe non-compliance|1|||
33421718|NCT00525824|62799886|FG002|Overall Study|Severe non-compliance|1|||
33421719|NCT00525824|62799887|FG003|Overall Study|Severe non-compliance|1|||
33421720|NCT00525824|62799884|FG000|Overall Study|Safety reasons|1|||
33421721|NCT00525824|62799885|FG001|Overall Study|Safety reasons|0|||
33421722|NCT00525824|62799886|FG002|Overall Study|Safety reasons|1|||
33421723|NCT00525824|62799887|FG003|Overall Study|Safety reasons|0|||
33421724|NCT00525824|62799884|FG000|Overall Study|Other|1|||
33421725|NCT00525824|62799885|FG001|Overall Study|Other|3|||
33421726|NCT00525824|62799886|FG002|Overall Study|Other|3|||
33421727|NCT00525824|62799887|FG003|Overall Study|Other|1|||
33421728|NCT00525590|62799901|FG000|Overall Study|Adverse Event|3|||
33421729|NCT00525590|62799901|FG000|Overall Study|Physician Decision|3|||
33421730|NCT00525590|62799901|FG000|Overall Study|Withdrawal by Subject|16|||
33421731|NCT00525590|62799901|FG000|Overall Study|Lost to Follow-up|1|||
33421732|NCT00525590|62799901|FG000|Overall Study|Death|9|||
33421733|NCT00525590|62799901|FG000|Overall Study|Other|13|||
33421734|NCT00430677|62799908|FG000|Short-term Period|Death|1|||
33421735|NCT00430677|62799909|FG001|Short-term Period|Death|1|||
33421736|NCT00430677|62799910|FG002|Short-term Period|Death|5|||
33421737|NCT00430677|62799908|FG000|Short-term Period|Adverse Event|15|||
33421738|NCT00430677|62799909|FG001|Short-term Period|Adverse Event|13|||
33421739|NCT00430677|62799910|FG002|Short-term Period|Adverse Event|9|||
33421740|NCT00430677|62799908|FG000|Short-term Period|Lack of Efficacy|5|||
33421741|NCT00430677|62799909|FG001|Short-term Period|Lack of Efficacy|6|||
33421742|NCT00430677|62799910|FG002|Short-term Period|Lack of Efficacy|4|||
33421743|NCT00430677|62799908|FG000|Short-term Period|Withdrawal by Subject|1|||
33421744|NCT00430677|62799909|FG001|Short-term Period|Withdrawal by Subject|1|||
33421745|NCT00430677|62799910|FG002|Short-term Period|Withdrawal by Subject|2|||
33421746|NCT00430677|62799908|FG000|Short-term Period|Participant no longer met study criteria|1|||
33421747|NCT00430677|62799909|FG001|Short-term Period|Participant no longer met study criteria|1|||
33421748|NCT00430677|62799910|FG002|Short-term Period|Participant no longer met study criteria|2|||
33421749|NCT00430677|62799908|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
33421750|NCT00430677|62799909|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
33421751|NCT00430677|62799910|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
33421752|NCT00430677|62799908|FG000|Short-term Period|Pregnancy|0|||
33421753|NCT00430677|62799909|FG001|Short-term Period|Pregnancy|2|||
33421754|NCT00430677|62799910|FG002|Short-term Period|Pregnancy|0|||
33421755|NCT00430677|62799908|FG000|Long-term Extension Period|Death|1|||
33421756|NCT00430677|62799909|FG001|Long-term Extension Period|Death|0|||
33421757|NCT00430677|62799910|FG002|Long-term Extension Period|Death|0|||
33421758|NCT00430677|62799908|FG000|Long-term Extension Period|Adverse Event|3|||
33421759|NCT00430677|62799909|FG001|Long-term Extension Period|Adverse Event|2|||
33421760|NCT00430677|62799910|FG002|Long-term Extension Period|Adverse Event|5|||
33421761|NCT00430677|62799908|FG000|Long-term Extension Period|Lack of Efficacy|5|||
33421762|NCT00430677|62799909|FG001|Long-term Extension Period|Lack of Efficacy|3|||
33421763|NCT00430677|62799910|FG002|Long-term Extension Period|Lack of Efficacy|8|||
33421764|NCT00430677|62799908|FG000|Long-term Extension Period|Lost to Follow-up|1|||
33421765|NCT00430677|62799909|FG001|Long-term Extension Period|Lost to Follow-up|1|||
33421766|NCT00430677|62799910|FG002|Long-term Extension Period|Lost to Follow-up|1|||
33421767|NCT00430677|62799908|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
33421768|NCT00430677|62799909|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
33421769|NCT00430677|62799910|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
33421770|NCT00430677|62799908|FG000|Long-term Extension Period|Pregnancy|1|||
33421771|NCT00430677|62799909|FG001|Long-term Extension Period|Pregnancy|1|||
33421772|NCT00430677|62799910|FG002|Long-term Extension Period|Pregnancy|0|||
33421773|NCT00430677|62799908|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
33421774|NCT00430677|62799909|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
33421775|NCT00430677|62799910|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
33421776|NCT00430677|62799908|FG000|Long-term Extension Period|Other|2|||
33421777|NCT00430677|62799909|FG001|Long-term Extension Period|Other|1|||
33421778|NCT00430677|62799910|FG002|Long-term Extension Period|Other|1|||
33421779|NCT00430677|62799908|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
33421780|NCT00430677|62799909|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
33421781|NCT00430677|62799910|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
33421782|NCT00525512|62799938|FG000|Double-Blind Phase|Adverse Event|48|||
33421783|NCT00525512|62799939|FG001|Double-Blind Phase|Adverse Event|28|||
33421784|NCT00525512|62799940|FG002|Double-Blind Phase|Adverse Event|0|||
33421785|NCT00525512|62799941|FG003|Double-Blind Phase|Adverse Event|0|||
33421786|NCT00525512|62799938|FG000|Double-Blind Phase|Protocol Violation|3|||
33421787|NCT00525512|62799939|FG001|Double-Blind Phase|Protocol Violation|1|||
33421788|NCT00525512|62799940|FG002|Double-Blind Phase|Protocol Violation|0|||
33421789|NCT00525512|62799941|FG003|Double-Blind Phase|Protocol Violation|0|||
33421790|NCT00525512|62799938|FG000|Double-Blind Phase|Lost to Follow-up|3|||
33421791|NCT00525512|62799939|FG001|Double-Blind Phase|Lost to Follow-up|7|||
33421792|NCT00525512|62799940|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33421793|NCT00525512|62799941|FG003|Double-Blind Phase|Lost to Follow-up|0|||
33421794|NCT00525512|62799938|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
33421795|NCT00525512|62799939|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
33421796|NCT00525512|62799940|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
33421797|NCT00525512|62799941|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
33421798|NCT00525512|62799938|FG000|Double-Blind Phase|Lack of Efficacy|13|||
33421799|NCT00525512|62799939|FG001|Double-Blind Phase|Lack of Efficacy|5|||
33421800|NCT00525512|62799940|FG002|Double-Blind Phase|Lack of Efficacy|0|||
33421801|NCT00525512|62799941|FG003|Double-Blind Phase|Lack of Efficacy|0|||
33421802|NCT00525512|62799938|FG000|Double-Blind Phase|Other reason (not specified)|12|||
33421803|NCT00525512|62799939|FG001|Double-Blind Phase|Other reason (not specified)|13|||
33421804|NCT00525512|62799940|FG002|Double-Blind Phase|Other reason (not specified)|0|||
33421805|NCT00525512|62799941|FG003|Double-Blind Phase|Other reason (not specified)|0|||
33421806|NCT00525512|62799938|FG000|Open-Label Phase|Adverse Event|0|||
33421807|NCT00525512|62799939|FG001|Open-Label Phase|Adverse Event|0|||
33421808|NCT00525512|62799940|FG002|Open-Label Phase|Adverse Event|1|||
33421809|NCT00525512|62799941|FG003|Open-Label Phase|Adverse Event|0|||
33421810|NCT00525512|62799938|FG000|Open-Label Phase|Lost to Follow-up|0|||
33421811|NCT00525512|62799939|FG001|Open-Label Phase|Lost to Follow-up|0|||
33421812|NCT00525512|62799940|FG002|Open-Label Phase|Lost to Follow-up|1|||
33421813|NCT00525512|62799941|FG003|Open-Label Phase|Lost to Follow-up|0|||
33421814|NCT00525512|62799938|FG000|Open-Label Phase|Other reason (not specified)|0|||
33421815|NCT00525512|62799939|FG001|Open-Label Phase|Other reason (not specified)|0|||
33421816|NCT00525512|62799940|FG002|Open-Label Phase|Other reason (not specified)|4|||
33421817|NCT00525512|62799941|FG003|Open-Label Phase|Other reason (not specified)|5|||
33421818|NCT00517634|62799953|FG000|Second Treatment Period|Withdrawal by Subject|0|||
33421819|NCT00517634|62799954|FG001|Second Treatment Period|Withdrawal by Subject|0|||
33421820|NCT00517634|62799955|FG002|Second Treatment Period|Withdrawal by Subject|0|||
33421821|NCT00517634|62799956|FG003|Second Treatment Period|Withdrawal by Subject|0|||
33421822|NCT00517634|62799957|FG004|Second Treatment Period|Withdrawal by Subject|1|||
33421823|NCT00517634|62799958|FG005|Second Treatment Period|Withdrawal by Subject|0|||
33421824|NCT03683576|62799970|FG000|Overall Study|Withdrawal by Subject|2|||
33421825|NCT03683576|62799971|FG001|Overall Study|Withdrawal by Subject|0|||
33421826|NCT03683576|62799972|FG002|Overall Study|Withdrawal by Subject|8|||
33421827|NCT03683576|62799973|FG003|Overall Study|Withdrawal by Subject|3|||
33421828|NCT03683576|62799970|FG000|Overall Study|Adverse Event|3|||
33421829|NCT03683576|62799971|FG001|Overall Study|Adverse Event|0|||
33421830|NCT03683576|62799972|FG002|Overall Study|Adverse Event|0|||
33421831|NCT03683576|62799973|FG003|Overall Study|Adverse Event|4|||
33421832|NCT03683576|62799970|FG000|Overall Study|Lack of Efficacy|1|||
33421833|NCT03683576|62799971|FG001|Overall Study|Lack of Efficacy|0|||
33421834|NCT03683576|62799972|FG002|Overall Study|Lack of Efficacy|1|||
33421835|NCT03683576|62799973|FG003|Overall Study|Lack of Efficacy|1|||
33421836|NCT03683576|62799970|FG000|Overall Study|Lost to Follow-up|0|||
33421837|NCT03683576|62799971|FG001|Overall Study|Lost to Follow-up|1|||
33421838|NCT03683576|62799972|FG002|Overall Study|Lost to Follow-up|2|||
33421839|NCT03683576|62799973|FG003|Overall Study|Lost to Follow-up|0|||
33421840|NCT03683576|62799970|FG000|Overall Study|Other, Not Specified|0|||
33421841|NCT03683576|62799971|FG001|Overall Study|Other, Not Specified|2|||
33421842|NCT03683576|62799972|FG002|Overall Study|Other, Not Specified|0|||
33421843|NCT03683576|62799973|FG003|Overall Study|Other, Not Specified|0|||
33421844|NCT03683576|62799970|FG000|Overall Study|Protocol Violation|0|||
33421845|NCT03683576|62799971|FG001|Overall Study|Protocol Violation|1|||
33421846|NCT03683576|62799972|FG002|Overall Study|Protocol Violation|1|||
33421847|NCT03683576|62799973|FG003|Overall Study|Protocol Violation|0|||
33421848|NCT03863834|62799983|FG000|Overall Study|Lost to Follow-up|3|||
33421849|NCT00430521|62799995|FG000|Overall Study|Adverse Event|0|||
33421850|NCT00430521|62799996|FG001|Overall Study|Adverse Event|0|||
33421851|NCT00430521|62799997|FG002|Overall Study|Adverse Event|0|||
33421852|NCT00430521|62799998|FG003|Overall Study|Adverse Event|0|||
33421853|NCT00430521|62799999|FG004|Overall Study|Adverse Event|0|||
33421854|NCT00430521|62800000|FG005|Overall Study|Adverse Event|2|||
33421855|NCT00430521|62800001|FG006|Overall Study|Adverse Event|1|||
33421856|NCT00430521|62800002|FG007|Overall Study|Adverse Event|0|||
33421857|NCT00430521|62799995|FG000|Overall Study|Lost to Follow-up|7|||
33421858|NCT00430521|62799996|FG001|Overall Study|Lost to Follow-up|8|||
33421859|NCT00430521|62799997|FG002|Overall Study|Lost to Follow-up|3|||
33421860|NCT00430521|62799998|FG003|Overall Study|Lost to Follow-up|5|||
33421861|NCT00430521|62799999|FG004|Overall Study|Lost to Follow-up|5|||
33421862|NCT00430521|62800000|FG005|Overall Study|Lost to Follow-up|2|||
33421863|NCT00430521|62800001|FG006|Overall Study|Lost to Follow-up|8|||
33421864|NCT00430521|62800002|FG007|Overall Study|Lost to Follow-up|10|||
33421865|NCT00430521|62799995|FG000|Overall Study|Pregnancy|0|||
33421866|NCT00430521|62799996|FG001|Overall Study|Pregnancy|0|||
33421867|NCT00430521|62799997|FG002|Overall Study|Pregnancy|0|||
33421868|NCT00430521|62799998|FG003|Overall Study|Pregnancy|0|||
33421869|NCT00430521|62799999|FG004|Overall Study|Pregnancy|0|||
33421870|NCT00430521|62800000|FG005|Overall Study|Pregnancy|0|||
33421871|NCT00430521|62800001|FG006|Overall Study|Pregnancy|1|||
33421872|NCT00430521|62800002|FG007|Overall Study|Pregnancy|0|||
33421873|NCT00430521|62799995|FG000|Overall Study|Vaccine Expired|0|||
33421874|NCT00430521|62799996|FG001|Overall Study|Vaccine Expired|0|||
33421875|NCT00430521|62799997|FG002|Overall Study|Vaccine Expired|0|||
33421876|NCT00430521|62799998|FG003|Overall Study|Vaccine Expired|0|||
33421877|NCT00430521|62799999|FG004|Overall Study|Vaccine Expired|0|||
33421878|NCT00430521|62800000|FG005|Overall Study|Vaccine Expired|1|||
33421879|NCT00430521|62800001|FG006|Overall Study|Vaccine Expired|0|||
33421880|NCT00430521|62800002|FG007|Overall Study|Vaccine Expired|0|||
33421881|NCT00430521|62799995|FG000|Overall Study|Protocol Violation|1|||
33421882|NCT00430521|62799996|FG001|Overall Study|Protocol Violation|0|||
33421883|NCT00430521|62799997|FG002|Overall Study|Protocol Violation|0|||
33421884|NCT00430521|62799998|FG003|Overall Study|Protocol Violation|0|||
33421885|NCT00430521|62799999|FG004|Overall Study|Protocol Violation|0|||
33421886|NCT00430521|62800000|FG005|Overall Study|Protocol Violation|0|||
33421887|NCT00430521|62800001|FG006|Overall Study|Protocol Violation|0|||
33421888|NCT00430521|62800002|FG007|Overall Study|Protocol Violation|0|||
33421889|NCT00430521|62799995|FG000|Overall Study|Withdrawal by Subject|3|||
33421890|NCT00430521|62799996|FG001|Overall Study|Withdrawal by Subject|1|||
33421891|NCT00430521|62799997|FG002|Overall Study|Withdrawal by Subject|0|||
33421892|NCT00430521|62799998|FG003|Overall Study|Withdrawal by Subject|3|||
33421893|NCT00430521|62799999|FG004|Overall Study|Withdrawal by Subject|0|||
33421894|NCT00430521|62800000|FG005|Overall Study|Withdrawal by Subject|0|||
33421895|NCT00430521|62800001|FG006|Overall Study|Withdrawal by Subject|0|||
33421896|NCT00430521|62800002|FG007|Overall Study|Withdrawal by Subject|2|||
33421897|NCT00429663|62800035|FG000|Overall Study|Lost to Follow-up|24|||
33421898|NCT00429663|62800036|FG001|Overall Study|Lost to Follow-up|31|||
33421899|NCT00429663|62800035|FG000|Overall Study|Physician Decision|6|||
33421900|NCT00429663|62800036|FG001|Overall Study|Physician Decision|3|||
33421901|NCT00429663|62800035|FG000|Overall Study|Withdrawal by Subject|2|||
33421902|NCT00429663|62800036|FG001|Overall Study|Withdrawal by Subject|5|||
33421903|NCT00429663|62800035|FG000|Overall Study|Death|4|||
33421904|NCT00429663|62800036|FG001|Overall Study|Death|0|||
33421905|NCT00429585|62800044|FG000|Overall Study|Death|1|||
33421906|NCT00429585|62800045|FG001|Overall Study|Death|0|||
33421907|NCT00429585|62800044|FG000|Overall Study|Lost to Follow-up|27|||
33421908|NCT00429585|62800045|FG001|Overall Study|Lost to Follow-up|20|||
33421909|NCT00429585|62800044|FG000|Overall Study|Physician Decision|2|||
33421910|NCT00429585|62800045|FG001|Overall Study|Physician Decision|0|||
33421911|NCT05607043|62800051|FG000|Overall Study|Lost to Follow-up|2|||
33421912|NCT04550221|62800082|FG000|Overall Study|Lost to Follow-up|0|||
33421913|NCT04550221|62800083|FG001|Overall Study|Lost to Follow-up|4|||
33421914|NCT04550221|62800082|FG000|Overall Study|Withdrawn|3|||
33421915|NCT04550221|62800083|FG001|Overall Study|Withdrawn|0|||
33421916|NCT04550221|62800082|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
33421917|NCT04550221|62800083|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
33421918|NCT04193176|62800104|FG000|Overall Study|Withdrawal by Subject|6|||
33421919|NCT04193176|62800105|FG001|Overall Study|Withdrawal by Subject|10|||
33421920|NCT04050982|62800113|FG000|Overall Study|Did not meet eligibility criteria|0|||
33421921|NCT04050982|62800114|FG001|Overall Study|Did not meet eligibility criteria|1|||
33421922|NCT04050982|62800115|FG002|Overall Study|Did not meet eligibility criteria|0|||
33421923|NCT04050982|62800113|FG000|Overall Study|Withdrawal by Subject|1|||
33421924|NCT04050982|62800114|FG001|Overall Study|Withdrawal by Subject|0|||
33421925|NCT04050982|62800115|FG002|Overall Study|Withdrawal by Subject|0|||
33421926|NCT04050982|62800113|FG000|Overall Study|Unable to enroll on platform|1|||
33421927|NCT04050982|62800114|FG001|Overall Study|Unable to enroll on platform|0|||
33421928|NCT04050982|62800115|FG002|Overall Study|Unable to enroll on platform|0|||
33421929|NCT03905265|62800125|FG000|Overall Study|Withdrawal by Subject|1|||
33421930|NCT03905265|62800126|FG001|Overall Study|Withdrawal by Subject|1|||
33421931|NCT03905265|62800127|FG002|Overall Study|Withdrawal by Subject|0|||
33421932|NCT03905265|62800128|FG003|Overall Study|Withdrawal by Subject|0|||
33421933|NCT03848845|62800141|FG000|Overall Study|Lost to Follow-up|0|||
33421934|NCT03848845|62800142|FG001|Overall Study|Lost to Follow-up|1|||
33421935|NCT03848845|62800143|FG002|Overall Study|Lost to Follow-up|0|||
33421936|NCT03848845|62800141|FG000|Overall Study|Withdrawal by Subject|3|||
33421937|NCT03848845|62800142|FG001|Overall Study|Withdrawal by Subject|2|||
33421938|NCT03848845|62800143|FG002|Overall Study|Withdrawal by Subject|6|||
33421939|NCT03848845|62800141|FG000|Overall Study|In Follow-up|0|||
33421940|NCT03848845|62800142|FG001|Overall Study|In Follow-up|1|||
33421941|NCT03848845|62800143|FG002|Overall Study|In Follow-up|12|||
33421942|NCT03848845|62800141|FG000|Overall Study|On Study Treatment|0|||
33421943|NCT03848845|62800142|FG001|Overall Study|On Study Treatment|0|||
33421944|NCT03848845|62800143|FG002|Overall Study|On Study Treatment|4|||
33421945|NCT03848845|62800141|FG000|Overall Study|Physician Decision|0|||
33421946|NCT03848845|62800142|FG001|Overall Study|Physician Decision|0|||
33421947|NCT03848845|62800143|FG002|Overall Study|Physician Decision|1|||
33421948|NCT03759379|62800163|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
33421949|NCT03759379|62800164|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
33421950|NCT03759379|62800163|FG000|Treatment Period|Death|2|||
33421951|NCT03759379|62800164|FG001|Treatment Period|Death|3|||
33421952|NCT03759379|62800163|FG000|Treatment Period|Lost to Follow-up|1|||
33421953|NCT03759379|62800164|FG001|Treatment Period|Lost to Follow-up|0|||
33421954|NCT03759379|62800163|FG000|Treatment Period|Physician Decision|0|||
33421955|NCT03759379|62800164|FG001|Treatment Period|Physician Decision|1|||
33421956|NCT03742037|62800175|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
33421957|NCT03742037|62800176|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
33421958|NCT03742037|62800177|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
33421959|NCT03742037|62800178|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
33421960|NCT03742037|62800179|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
33421961|NCT03742037|62800180|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
33421962|NCT03742037|62800181|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
33421963|NCT03742037|62800175|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
33421964|NCT03742037|62800176|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
33421965|NCT03742037|62800177|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
33421966|NCT03742037|62800178|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
33421967|NCT03742037|62800179|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
33421968|NCT03742037|62800180|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
33421969|NCT03742037|62800181|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
33421970|NCT03742037|62800175|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
33421971|NCT03742037|62800176|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
33421972|NCT03742037|62800177|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
33421973|NCT03742037|62800178|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
33421974|NCT03742037|62800179|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
33421975|NCT03742037|62800180|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
33421976|NCT03742037|62800181|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
33421977|NCT03742037|62800175|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
33421978|NCT03742037|62800176|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
33421979|NCT03742037|62800177|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
33421980|NCT03742037|62800178|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
33421981|NCT03742037|62800179|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
33421982|NCT03742037|62800180|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
33421983|NCT03742037|62800181|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
33421984|NCT03742037|62800175|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
33421985|NCT03742037|62800176|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
33421986|NCT03742037|62800177|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
33421987|NCT03742037|62800178|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
33421988|NCT03742037|62800179|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
33421989|NCT03742037|62800180|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
33421990|NCT03742037|62800181|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
33421991|NCT03742037|62800175|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
33421992|NCT03742037|62800176|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
33421993|NCT03742037|62800177|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
33421994|NCT03742037|62800178|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
33421995|NCT03742037|62800179|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
33421996|NCT03742037|62800180|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
33421997|NCT03742037|62800181|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
33421998|NCT03742037|62800175|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
33421999|NCT03742037|62800176|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
33422000|NCT03742037|62800177|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
33422001|NCT03742037|62800178|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
33422002|NCT03742037|62800179|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
33422003|NCT03742037|62800180|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
33422004|NCT03742037|62800181|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
33422005|NCT03742037|62800175|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
33422006|NCT03742037|62800176|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
33422007|NCT03742037|62800177|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
33422008|NCT03742037|62800178|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
33422009|NCT03742037|62800179|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
33422010|NCT03742037|62800180|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
33422011|NCT03742037|62800181|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
33422012|NCT03742037|62800175|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
33422013|NCT03742037|62800176|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
33422014|NCT03742037|62800177|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
33422015|NCT03742037|62800178|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
33422016|NCT03742037|62800179|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
33422017|NCT03742037|62800180|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
33422018|NCT03742037|62800181|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
33422019|NCT03742037|62800175|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
33422020|NCT03742037|62800176|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
33422021|NCT03742037|62800177|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
33422022|NCT03742037|62800178|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
33422023|NCT03742037|62800179|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
33422024|NCT03742037|62800180|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
33422025|NCT03742037|62800181|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
33422026|NCT03742037|62800175|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
33422027|NCT03742037|62800176|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
33422028|NCT03742037|62800177|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
33422029|NCT03742037|62800178|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
33422030|NCT03742037|62800179|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
33422031|NCT03742037|62800180|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
33422032|NCT03742037|62800181|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
33422033|NCT03742037|62800175|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
33422034|NCT03742037|62800176|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
33422035|NCT03742037|62800177|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
33422036|NCT03742037|62800178|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
33422037|NCT03742037|62800179|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
33422038|NCT03742037|62800180|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
33422039|NCT03742037|62800181|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
33422040|NCT03742037|62800175|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
33422041|NCT03742037|62800176|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
33422042|NCT03742037|62800177|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
33422043|NCT03742037|62800178|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
33422044|NCT03742037|62800179|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
33422045|NCT03742037|62800180|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
33422046|NCT03742037|62800181|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
33422047|NCT03742037|62800175|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
33422048|NCT03742037|62800176|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
33422049|NCT03742037|62800177|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
33422050|NCT03742037|62800178|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
33422051|NCT03742037|62800179|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
33422052|NCT03742037|62800180|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
33422053|NCT03742037|62800181|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
33422054|NCT03742037|62800175|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
33422055|NCT03742037|62800176|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
33422056|NCT03742037|62800177|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
33422057|NCT03742037|62800178|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
33422058|NCT03742037|62800179|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
33422059|NCT03742037|62800180|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
33422060|NCT03742037|62800181|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
33422061|NCT03714815|62800198|FG000|Overall Study|Physician Decision|2|||
33422062|NCT03714815|62800198|FG000|Overall Study|Withdrawal by Subject|2|||
33422063|NCT03714815|62800198|FG000|Overall Study|Death|11|||
33422064|NCT03640312|62800208|FG000|Overall Study|Lost to Follow-up|3|||
33422065|NCT03640312|62800209|FG001|Overall Study|Lost to Follow-up|6|||
33422066|NCT03635983|62800217|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
33422067|NCT03635983|62800218|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
33422068|NCT03635983|62800217|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
33422069|NCT03635983|62800218|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
33422070|NCT03635983|62800217|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
33422071|NCT03635983|62800218|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33422072|NCT03635983|62800217|FG000|Pre-Treatment Period|Other reasons|1|||
33422073|NCT03635983|62800218|FG001|Pre-Treatment Period|Other reasons|2|||
33422074|NCT03635983|62800217|FG000|Pre-Treatment Period|Disease Progression|0|||
33422075|NCT03635983|62800218|FG001|Pre-Treatment Period|Disease Progression|1|||
33422076|NCT03635983|62800217|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
33422077|NCT03635983|62800218|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
33422078|NCT03635983|62800217|FG000|Treatment Period|Completed treatment period|13|||
33422079|NCT03635983|62800218|FG001|Treatment Period|Completed treatment period|20|||
33422080|NCT03635983|62800217|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
33422081|NCT03635983|62800218|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
33422082|NCT03635983|62800217|FG000|Treatment Period|Withdrawal by Subject|2|||
33422083|NCT03635983|62800218|FG001|Treatment Period|Withdrawal by Subject|4|||
33422084|NCT03635983|62800217|FG000|Treatment Period|Death|3|||
33422085|NCT03635983|62800218|FG001|Treatment Period|Death|4|||
33422086|NCT03635983|62800217|FG000|Treatment Period|Poor/Non-compliance|1|||
33422087|NCT03635983|62800218|FG001|Treatment Period|Poor/Non-compliance|0|||
33422088|NCT03635983|62800217|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
33422089|NCT03635983|62800218|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
33422090|NCT03635983|62800217|FG000|Treatment Period|Other reasons|5|||
33422091|NCT03635983|62800218|FG001|Treatment Period|Other reasons|2|||
33422092|NCT03635983|62800217|FG000|Treatment Period|Disease progression|184|||
33422093|NCT03635983|62800218|FG001|Treatment Period|Disease progression|168|||
33422094|NCT03635983|62800217|FG000|Treatment Period|Study drug toxicity|26|||
33422095|NCT03635983|62800218|FG001|Treatment Period|Study drug toxicity|29|||
33422096|NCT03635983|62800217|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
33422097|NCT03635983|62800218|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
33422098|NCT03635983|62800217|FG000|Treatment Period|Maximum clinical benefit|3|||
33422099|NCT03635983|62800218|FG001|Treatment Period|Maximum clinical benefit|2|||
33422100|NCT03551496|62800226|FG000|Overall Study|Death|11|||
33422101|NCT03551496|62800227|FG001|Overall Study|Death|7|||
33422102|NCT03551496|62800226|FG000|Overall Study|Withdrawal by Subject|4|||
33422103|NCT03551496|62800227|FG001|Overall Study|Withdrawal by Subject|3|||
33422104|NCT03551496|62800226|FG000|Overall Study|Other Reasons|1|||
33422105|NCT03551496|62800227|FG001|Overall Study|Other Reasons|0|||
33422106|NCT02927262|62800248|FG000|Overall Study|Adverse Event|7|||
33422107|NCT02927262|62800249|FG001|Overall Study|Adverse Event|1|||
33422108|NCT02927262|62800248|FG000|Overall Study|Death|1|||
33422109|NCT02927262|62800249|FG001|Overall Study|Death|0|||
33422110|NCT02927262|62800248|FG000|Overall Study|Withdrawal by Subject|3|||
33422111|NCT02927262|62800249|FG001|Overall Study|Withdrawal by Subject|0|||
33422112|NCT02927262|62800248|FG000|Overall Study|Disease Relapse|23|||
33422113|NCT02927262|62800249|FG001|Overall Study|Disease Relapse|18|||
33422114|NCT02927262|62800248|FG000|Overall Study|Miscellaneous|5|||
33422115|NCT02927262|62800249|FG001|Overall Study|Miscellaneous|4|||
33422116|NCT02927262|62800248|FG000|Overall Study|Ongoing|4|||
33605230|NCT01783444|63004967|FG001|Treatment Phase|Protocol Violation|1|||
33605231|NCT01783444|63004968|FG002|Treatment Phase|Protocol Violation|2|||
33422117|NCT02927262|62800249|FG001|Overall Study|Ongoing|0|||
33605232|NCT01783444|63004966|FG000|Treatment Phase|Withdrawal by Subject|6|||
33605233|NCT01783444|63004967|FG001|Treatment Phase|Withdrawal by Subject|8|||
33605234|NCT01783444|63004968|FG002|Treatment Phase|Withdrawal by Subject|9|||
33605235|NCT01783444|63004966|FG000|Treatment Phase|Administrative problems|2|||
33605236|NCT01783444|63004967|FG001|Treatment Phase|Administrative problems|0|||
33605237|NCT01783444|63004968|FG002|Treatment Phase|Administrative problems|1|||
33605238|NCT01783444|63004966|FG000|Treatment Phase|Physician Decision|8|||
33605239|NCT01783444|63004967|FG001|Treatment Phase|Physician Decision|6|||
33605240|NCT01783444|63004968|FG002|Treatment Phase|Physician Decision|5|||
33605241|NCT01783444|63004966|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
33605242|NCT01783444|63004967|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
33605243|NCT01783444|63004968|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
33605244|NCT01783444|63004966|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
33605245|NCT01783444|63004967|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
33605246|NCT01783444|63004968|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
33605247|NCT01783444|63004966|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
33605248|NCT01783444|63004967|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
33605249|NCT01783444|63004968|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
33605250|NCT01783444|63004966|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
33605251|NCT01783444|63004967|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
33605252|NCT01783444|63004968|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
33605253|NCT01783444|63004966|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
33605254|NCT01783444|63004967|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
33605255|NCT01783444|63004968|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
33605256|NCT01783444|63004966|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
33605257|NCT01783444|63004967|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
33605258|NCT01783444|63004968|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
33605259|NCT02367131|63004977|FG000|Overall Study|Adverse Event|64|||
33605260|NCT02367131|63004977|FG000|Overall Study|No visit since the first visit|4|||
33422150|NCT02257736|62800270|FG000|Overall Study|Progressive disease|365|||
33422151|NCT02257736|62800271|FG001|Overall Study|Progressive disease|327|||
33422152|NCT02257736|62800270|FG000|Overall Study|Adverse Event|45|||
33422153|NCT02257736|62800271|FG001|Overall Study|Adverse Event|56|||
33422154|NCT02257736|62800270|FG000|Overall Study|Withdrawal by Subject|21|||
33422155|NCT02257736|62800271|FG001|Overall Study|Withdrawal by Subject|38|||
33422156|NCT02257736|62800270|FG000|Overall Study|Death|11|||
33422157|NCT02257736|62800271|FG001|Overall Study|Death|6|||
33422158|NCT02257736|62800270|FG000|Overall Study|Physician Decision|5|||
33422159|NCT02257736|62800271|FG001|Overall Study|Physician Decision|9|||
33422160|NCT02257736|62800270|FG000|Overall Study|Non-Compliance with study drug|1|||
33422161|NCT02257736|62800271|FG001|Overall Study|Non-Compliance with study drug|2|||
33422162|NCT02257736|62800270|FG000|Overall Study|Protocol Violation|1|||
33422163|NCT02257736|62800271|FG001|Overall Study|Protocol Violation|0|||
33422164|NCT02257736|62800270|FG000|Overall Study|Other|1|||
33422165|NCT02257736|62800271|FG001|Overall Study|Other|7|||
33422166|NCT02257736|62800270|FG000|Overall Study|Randomized, not treated|1|||
33422167|NCT02257736|62800271|FG001|Overall Study|Randomized, not treated|2|||
33422168|NCT02254278|62800279|FG000|Overall Study|Protocol Violation|1|||
33422169|NCT02254278|62800280|FG001|Overall Study|Protocol Violation|1|||
33422170|NCT02252172|62800291|FG000|Overall Study|Lost to Follow-up|3|||
33422171|NCT02252172|62800292|FG001|Overall Study|Lost to Follow-up|1|||
33422172|NCT02252172|62800291|FG000|Overall Study|Ongoing|276|||
33422173|NCT02252172|62800292|FG001|Overall Study|Ongoing|298|||
33494135|NCT03486834|62872904|FG002|Overall Study|Withdrawal by Subject|52|||
33422174|NCT01998841|62800301|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
33422175|NCT01998841|62800302|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
33422176|NCT01998841|62800303|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
33422177|NCT01998841|62800304|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
33422178|NCT01998841|62800305|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
33422179|NCT01998841|62800301|FG000|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|0|||
33422180|NCT01998841|62800302|FG001|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|0|||
33422181|NCT01998841|62800303|FG002|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|0|||
33422182|NCT01998841|62800304|FG003|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|147|||
33422183|NCT01998841|62800305|FG004|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|72|||
33422184|NCT01701674|62800313|FG000|Overall Study|Unable to safely complete treatment|1|||
33422185|NCT01607879|62800319|FG000|Overall Study|Death|1|||
33422186|NCT01607879|62800320|FG001|Overall Study|Death|0|||
33422187|NCT01375114|62800329|FG000|Overall Study|Lost to Follow-up|1|||
33422188|NCT01375114|62800330|FG001|Overall Study|Lost to Follow-up|0|||
33422189|NCT01375114|62800331|FG002|Overall Study|Lost to Follow-up|1|||
33422190|NCT01375114|62800329|FG000|Overall Study|Disease Progression|3|||
33422191|NCT01375114|62800330|FG001|Overall Study|Disease Progression|2|||
33422192|NCT01375114|62800331|FG002|Overall Study|Disease Progression|2|||
33422193|NCT01375114|62800329|FG000|Overall Study|Patient Changed Mind|0|||
33422194|NCT01375114|62800330|FG001|Overall Study|Patient Changed Mind|0|||
33422195|NCT01375114|62800331|FG002|Overall Study|Patient Changed Mind|2|||
33422196|NCT01375114|62800329|FG000|Overall Study|Pruritus|0|||
33422197|NCT01375114|62800330|FG001|Overall Study|Pruritus|0|||
33422198|NCT01375114|62800331|FG002|Overall Study|Pruritus|1|||
33422199|NCT01375114|62800329|FG000|Overall Study|Restlessness|0|||
33422200|NCT01375114|62800330|FG001|Overall Study|Restlessness|0|||
33422201|NCT01375114|62800331|FG002|Overall Study|Restlessness|1|||
33422202|NCT01375114|62800329|FG000|Overall Study|Diarrhea|0|||
33422203|NCT01375114|62800330|FG001|Overall Study|Diarrhea|0|||
33422204|NCT01375114|62800331|FG002|Overall Study|Diarrhea|1|||
33422205|NCT01375114|62800329|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
33422206|NCT01375114|62800330|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
33422207|NCT01375114|62800331|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
33422208|NCT01375114|62800329|FG000|Overall Study|Nausea|0|||
33422209|NCT01375114|62800330|FG001|Overall Study|Nausea|1|||
33422210|NCT01375114|62800331|FG002|Overall Study|Nausea|0|||
33422211|NCT01375114|62800329|FG000|Overall Study|Increased AST/ALT|0|||
33422212|NCT01375114|62800330|FG001|Overall Study|Increased AST/ALT|1|||
33422213|NCT01375114|62800331|FG002|Overall Study|Increased AST/ALT|0|||
33422214|NCT01375114|62800329|FG000|Overall Study|Vaginal Hemorrhage|0|||
33422215|NCT01375114|62800330|FG001|Overall Study|Vaginal Hemorrhage|1|||
33422216|NCT01375114|62800331|FG002|Overall Study|Vaginal Hemorrhage|0|||
33422217|NCT01375114|62800329|FG000|Overall Study|Family problem|0|||
33422218|NCT01375114|62800330|FG001|Overall Study|Family problem|1|||
33422219|NCT01375114|62800331|FG002|Overall Study|Family problem|0|||
33422220|NCT01375114|62800329|FG000|Overall Study|Protocol Violation|2|||
33422221|NCT01375114|62800330|FG001|Overall Study|Protocol Violation|0|||
33422222|NCT01375114|62800331|FG002|Overall Study|Protocol Violation|0|||
33422223|NCT01065454|62800350|FG000|Treatment|Adverse Event|7|||
33422224|NCT01065454|62800351|FG001|Treatment|Adverse Event|4|||
33422225|NCT01065454|62800352|FG002|Treatment|Adverse Event|3|||
33422226|NCT01065454|62800353|FG003|Treatment|Adverse Event|6|||
33422227|NCT01065454|62800350|FG000|Treatment|Death|1|||
33422228|NCT01065454|62800351|FG001|Treatment|Death|0|||
33422229|NCT01065454|62800352|FG002|Treatment|Death|0|||
33422230|NCT01065454|62800353|FG003|Treatment|Death|0|||
33422231|NCT01065454|62800350|FG000|Treatment|Non-compliance|1|||
33422232|NCT01065454|62800351|FG001|Treatment|Non-compliance|0|||
33422233|NCT01065454|62800352|FG002|Treatment|Non-compliance|0|||
33422234|NCT01065454|62800353|FG003|Treatment|Non-compliance|1|||
33422235|NCT01065454|62800350|FG000|Treatment|Protocol Decision|0|||
33422236|NCT01065454|62800351|FG001|Treatment|Protocol Decision|0|||
33422237|NCT01065454|62800352|FG002|Treatment|Protocol Decision|3|||
33422238|NCT01065454|62800353|FG003|Treatment|Protocol Decision|2|||
33422239|NCT01065454|62800350|FG000|Treatment|Protocol Violation|1|||
33422240|NCT01065454|62800351|FG001|Treatment|Protocol Violation|0|||
33422241|NCT01065454|62800352|FG002|Treatment|Protocol Violation|1|||
33422242|NCT01065454|62800353|FG003|Treatment|Protocol Violation|0|||
33422243|NCT01065454|62800350|FG000|Treatment|Withdrawal by Subject|3|||
33422244|NCT01065454|62800351|FG001|Treatment|Withdrawal by Subject|1|||
33422245|NCT01065454|62800352|FG002|Treatment|Withdrawal by Subject|2|||
33422246|NCT01065454|62800353|FG003|Treatment|Withdrawal by Subject|3|||
33422247|NCT01065454|62800350|FG000|Follow up|Adverse Event|1|||
33422248|NCT01065454|62800351|FG001|Follow up|Adverse Event|0|||
33422249|NCT01065454|62800352|FG002|Follow up|Adverse Event|0|||
33422250|NCT01065454|62800353|FG003|Follow up|Adverse Event|1|||
33422251|NCT01065454|62800350|FG000|Follow up|Death|0|||
33422252|NCT01065454|62800351|FG001|Follow up|Death|1|||
33422253|NCT01065454|62800352|FG002|Follow up|Death|1|||
33422254|NCT01065454|62800353|FG003|Follow up|Death|0|||
33422255|NCT01065454|62800350|FG000|Follow up|Lost to Follow-up|0|||
33422256|NCT01065454|62800351|FG001|Follow up|Lost to Follow-up|0|||
33422257|NCT01065454|62800352|FG002|Follow up|Lost to Follow-up|0|||
33422258|NCT01065454|62800353|FG003|Follow up|Lost to Follow-up|1|||
33422259|NCT01065454|62800350|FG000|Follow up|Progressive disease|0|||
33422260|NCT01065454|62800351|FG001|Follow up|Progressive disease|0|||
33422261|NCT01065454|62800352|FG002|Follow up|Progressive disease|0|||
33422262|NCT01065454|62800353|FG003|Follow up|Progressive disease|1|||
33422263|NCT01065454|62800350|FG000|Follow up|Withdrawal by Subject|1|||
33422264|NCT01065454|62800351|FG001|Follow up|Withdrawal by Subject|1|||
33422265|NCT01065454|62800352|FG002|Follow up|Withdrawal by Subject|1|||
33422266|NCT01065454|62800353|FG003|Follow up|Withdrawal by Subject|0|||
33422267|NCT01065454|62800350|FG000|Follow up|study ongoing|37|||
33422268|NCT01065454|62800351|FG001|Follow up|study ongoing|22|||
33422269|NCT01065454|62800352|FG002|Follow up|study ongoing|15|||
33422270|NCT01065454|62800353|FG003|Follow up|study ongoing|41|||
33422271|NCT00352027|62800363|FG000|Overall Study|Progressive disease|3|||
33422272|NCT00440271|62800411|FG000|Overall Study|Protocol Violation|1|||
33422273|NCT00440271|62800412|FG001|Overall Study|Protocol Violation|1|||
33422274|NCT00440271|62800411|FG000|Overall Study|Adverse Event|0|||
33422275|NCT00440271|62800412|FG001|Overall Study|Adverse Event|1|||
33422276|NCT00440271|62800411|FG000|Overall Study|Lost to Follow-up|1|||
33422277|NCT00440271|62800412|FG001|Overall Study|Lost to Follow-up|0|||
33422278|NCT00440271|62800411|FG000|Overall Study|Withdrawal by Subject|0|||
33422279|NCT00440271|62800412|FG001|Overall Study|Withdrawal by Subject|2|||
33422280|NCT00440271|62800411|FG000|Overall Study|Lack of Efficacy|0|||
33422281|NCT00440271|62800412|FG001|Overall Study|Lack of Efficacy|1|||
33422282|NCT00440271|62800411|FG000|Overall Study|Due to closure of trial|8|||
33422283|NCT00440271|62800412|FG001|Overall Study|Due to closure of trial|10|||
33422284|NCT00440271|62800411|FG000|Overall Study|Other|2|||
33422285|NCT00440271|62800412|FG001|Overall Study|Other|0|||
33422286|NCT00346216|62800421|FG000|Overall Study|Other|181|||
33422287|NCT00346216|62800422|FG001|Overall Study|Other|231|||
33422288|NCT00346216|62800423|FG002|Overall Study|Other|205|||
33422289|NCT00346216|62800421|FG000|Overall Study|No longer willing to participate|600|||
33422290|NCT00346216|62800422|FG001|Overall Study|No longer willing to participate|606|||
33422291|NCT00346216|62800423|FG002|Overall Study|No longer willing to participate|585|||
33422292|NCT00346216|62800421|FG000|Overall Study|Withdrawal by Subject|661|||
33422293|NCT00346216|62800422|FG001|Overall Study|Withdrawal by Subject|692|||
33422294|NCT00346216|62800423|FG002|Overall Study|Withdrawal by Subject|651|||
33422295|NCT00346216|62800421|FG000|Overall Study|Lost to Follow-up|611|||
33422296|NCT00346216|62800422|FG001|Overall Study|Lost to Follow-up|588|||
33422297|NCT00346216|62800423|FG002|Overall Study|Lost to Follow-up|542|||
33422298|NCT00346216|62800421|FG000|Overall Study|Physician Decision|80|||
33422299|NCT00346216|62800422|FG001|Overall Study|Physician Decision|76|||
33422300|NCT00346216|62800423|FG002|Overall Study|Physician Decision|59|||
33422301|NCT00346216|62800421|FG000|Overall Study|Does not meet entrance criteria|13|||
33422302|NCT00346216|62800422|FG001|Overall Study|Does not meet entrance criteria|10|||
33422303|NCT00346216|62800423|FG002|Overall Study|Does not meet entrance criteria|8|||
33422304|NCT00346216|62800421|FG000|Overall Study|Death|189|||
33422305|NCT00346216|62800422|FG001|Overall Study|Death|192|||
33422306|NCT00346216|62800423|FG002|Overall Study|Death|228|||
33422307|NCT00346216|62800421|FG000|Overall Study|Study terminated by sponsor|11|||
33422308|NCT00346216|62800422|FG001|Overall Study|Study terminated by sponsor|4|||
33422309|NCT00346216|62800423|FG002|Overall Study|Study terminated by sponsor|8|||
33422310|NCT00346216|62800421|FG000|Overall Study|Missing Subject Summary Status|62|||
33422311|NCT00346216|62800422|FG001|Overall Study|Missing Subject Summary Status|61|||
33422312|NCT00346216|62800423|FG002|Overall Study|Missing Subject Summary Status|62|||
33422313|NCT00417963|62800431|FG000|Overall Study|Lost to Follow-up|3|||
33422314|NCT00417963|62800431|FG000|Overall Study|Withdrawal by Subject|18|||
33422315|NCT00417963|62800431|FG000|Overall Study|Death|17|||
33422316|NCT00417963|62800431|FG000|Overall Study|Study device could not be deployed|3|||
33422317|NCT00429273|62800443|FG000|Overall Study|Lost to Follow-up|1|||
33422318|NCT00429273|62800444|FG001|Overall Study|Lost to Follow-up|2|||
33422319|NCT00429273|62800445|FG002|Overall Study|Lost to Follow-up|2|||
33422320|NCT00429273|62800443|FG000|Overall Study|Physician Decision|6|||
33422321|NCT00429273|62800444|FG001|Overall Study|Physician Decision|5|||
33422322|NCT00429273|62800445|FG002|Overall Study|Physician Decision|5|||
33422323|NCT00429273|62800443|FG000|Overall Study|Adverse Event|1|||
33422324|NCT00429273|62800444|FG001|Overall Study|Adverse Event|1|||
33422325|NCT00429273|62800445|FG002|Overall Study|Adverse Event|2|||
33422326|NCT00359632|62800455|FG000|Overall Study|Death|2|||
33422327|NCT00359632|62800456|FG001|Overall Study|Death|0|||
33422328|NCT00359632|62800455|FG000|Overall Study|Adverse Event|1|||
33422329|NCT00359632|62800456|FG001|Overall Study|Adverse Event|0|||
33422330|NCT00359632|62800455|FG000|Overall Study|Non-compliance with visit schedule|1|||
33422331|NCT00359632|62800456|FG001|Overall Study|Non-compliance with visit schedule|0|||
33422332|NCT00417885|62800462|FG000|Overall Study|Adverse Event|1|||
33422333|NCT00417885|62800462|FG000|Overall Study|Objective Progression or Relapse|3|||
33422334|NCT00417885|62800462|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
33422335|NCT04488770|62800479|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33422336|NCT04488770|62800480|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33422337|NCT04488770|62800481|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33422338|NCT04488770|62800482|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
33422339|NCT04488770|62800483|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33422340|NCT04488770|62800484|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33422341|NCT04488770|62800485|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33422342|NCT04488770|62800486|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33422343|NCT04488770|62800487|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33422344|NCT04488770|62800488|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33422345|NCT04488770|62800489|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33422346|NCT04488770|62800490|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33422347|NCT04488770|62800491|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33422348|NCT04488770|62800479|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
33422349|NCT04488770|62800480|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33422350|NCT04488770|62800481|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33422351|NCT04488770|62800482|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33422352|NCT04488770|62800483|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33422353|NCT04488770|62800484|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33422354|NCT04488770|62800485|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33422355|NCT04488770|62800486|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33422356|NCT04488770|62800487|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33422357|NCT04488770|62800488|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33422358|NCT04488770|62800489|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33422359|NCT04488770|62800490|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33422360|NCT04488770|62800491|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33422361|NCT04488770|62800479|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33422362|NCT04488770|62800480|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33422363|NCT04488770|62800481|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33422364|NCT04488770|62800482|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33422365|NCT04488770|62800483|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33422366|NCT04488770|62800484|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
33422367|NCT04488770|62800485|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
33422368|NCT04488770|62800486|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33422369|NCT04488770|62800487|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33422370|NCT04488770|62800488|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33422371|NCT04488770|62800489|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33422372|NCT04488770|62800490|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33422373|NCT04488770|62800491|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33422374|NCT04488770|62800479|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33422375|NCT04488770|62800480|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33422376|NCT04488770|62800481|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33422377|NCT04488770|62800482|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33422378|NCT04488770|62800483|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
33422379|NCT04488770|62800484|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33422380|NCT04488770|62800485|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33422381|NCT04488770|62800486|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33422382|NCT04488770|62800487|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33422383|NCT04488770|62800488|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33422384|NCT04488770|62800489|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33422385|NCT04488770|62800490|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33422386|NCT04488770|62800491|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33422387|NCT00525044|62800537|FG000|Overall Study|Lost to Follow-up|0|||
33422388|NCT00525044|62800538|FG001|Overall Study|Lost to Follow-up|1|||
33422389|NCT00355342|62800546|FG000|Overall Study|Adverse Event|13|||
33422390|NCT00355342|62800547|FG001|Overall Study|Adverse Event|15|||
33422391|NCT00355342|62800546|FG000|Overall Study|Lost to Follow-up|4|||
33422392|NCT00355342|62800547|FG001|Overall Study|Lost to Follow-up|2|||
33422393|NCT00355342|62800546|FG000|Overall Study|Withdrawal by Subject|14|||
33422394|NCT00355342|62800547|FG001|Overall Study|Withdrawal by Subject|11|||
33422395|NCT00355342|62800546|FG000|Overall Study|Sponsor terminated study|2|||
33422396|NCT00355342|62800547|FG001|Overall Study|Sponsor terminated study|2|||
33422397|NCT00355342|62800546|FG000|Overall Study|Overcompliant-PI discretion|1|||
33422398|NCT00355342|62800547|FG001|Overall Study|Overcompliant-PI discretion|0|||
33422399|NCT00355342|62800546|FG000|Overall Study|Use of prohibited medication|1|||
33422400|NCT00355342|62800547|FG001|Overall Study|Use of prohibited medication|0|||
33422401|NCT00355342|62800546|FG000|Overall Study|COPD exacerbation|1|||
33422402|NCT00355342|62800547|FG001|Overall Study|COPD exacerbation|1|||
33422403|NCT00355342|62800546|FG000|Overall Study|Dispensed wrong study drug kit|1|||
33422404|NCT00355342|62800547|FG001|Overall Study|Dispensed wrong study drug kit|0|||
33422405|NCT00355342|62800546|FG000|Overall Study|Non-compliance with Dexa scans|1|||
33422406|NCT00355342|62800547|FG001|Overall Study|Non-compliance with Dexa scans|0|||
33422407|NCT00355342|62800546|FG000|Overall Study|Withdrawal by participant and physician|1|||
33422408|NCT00355342|62800547|FG001|Overall Study|Withdrawal by participant and physician|0|||
33422409|NCT00355342|62800546|FG000|Overall Study|Participant relocated|0|||
33422410|NCT00355342|62800547|FG001|Overall Study|Participant relocated|1|||
33422411|NCT00355342|62800546|FG000|Overall Study|Participant discontinued study drug|0|||
33422412|NCT00355342|62800547|FG001|Overall Study|Participant discontinued study drug|1|||
33422413|NCT00355342|62800546|FG000|Overall Study|Study management|0|||
33422414|NCT00355342|62800547|FG001|Overall Study|Study management|1|||
33422415|NCT00355342|62800546|FG000|Overall Study|Protocol Violation|0|||
33422416|NCT00355342|62800547|FG001|Overall Study|Protocol Violation|1|||
33422417|NCT00355342|62800546|FG000|Overall Study|Use of protocol excluded medication|0|||
33422418|NCT00355342|62800547|FG001|Overall Study|Use of protocol excluded medication|1|||
33422419|NCT01573754|62800555|FG000|Overall Study|Noncompliance or remission not achieved|3|||
33422420|NCT01573754|62800556|FG001|Overall Study|Noncompliance or remission not achieved|15|||
33422421|NCT00355264|62800562|FG000|Extension (Variable Duration)|Adverse Event|1|||
33422422|NCT00355264|62800562|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
33422423|NCT00355030|62800573|FG000|Study Period 1 Treatment|Adverse Event|1|||
33422424|NCT00355030|62800574|FG001|Study Period 1 Treatment|Adverse Event|1|||
33422425|NCT00355030|62800573|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
33422426|NCT00355030|62800574|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
33422427|NCT00355030|62800573|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
33422428|NCT00355030|62800574|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
33422429|NCT00355030|62800573|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
33422430|NCT00355030|62800574|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
33422431|NCT00355030|62800573|FG000|Study Period 1 Treatment|Physician Decision|0|||
33422432|NCT00355030|62800574|FG001|Study Period 1 Treatment|Physician Decision|1|||
33422433|NCT00355030|62800573|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
33422434|NCT00355030|62800574|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
33422435|NCT00355030|62800573|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
33422436|NCT00355030|62800574|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
33422437|NCT00355030|62800573|FG000|Study Period 1 Treatment|Other|2|||
33422438|NCT00355030|62800574|FG001|Study Period 1 Treatment|Other|6|||
33422439|NCT00355030|62800573|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
33422440|NCT00355030|62800574|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
33422441|NCT00355030|62800573|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
33422442|NCT00355030|62800574|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
33422443|NCT00354172|62800580|FG000|Overall Study|Did not receive transplant|1|||
33422444|NCT00345592|62800586|FG000|Overall Study|Death|14|||
33422445|NCT00345592|62800587|FG001|Overall Study|Death|16|||
33422446|NCT00345592|62800586|FG000|Overall Study|Withdrawal by Subject|11|||
33422447|NCT00345592|62800587|FG001|Overall Study|Withdrawal by Subject|8|||
33422448|NCT00353704|62800595|FG000|Overall Study|Protocol Violation|3|||
33422449|NCT00353704|62800596|FG001|Overall Study|Protocol Violation|1|||
33422450|NCT00512252|62800605|FG000|Overall Study|Lost to Follow-up|0|||
33322946|NCT03332056|62699158|FG000|Overall Study|Incomplete questionnaires|8|||
33322947|NCT03332056|62699159|FG001|Overall Study|Incomplete questionnaires|9|||
33322948|NCT03332056|62699158|FG000|Overall Study|Passed stone prior to surgery date|1|||
33422451|NCT00512252|62800606|FG001|Overall Study|Lost to Follow-up|0|||
33422452|NCT00512252|62800607|FG002|Overall Study|Lost to Follow-up|1|||
33422453|NCT00512252|62800605|FG000|Overall Study|Protocol Violation|0|||
33422454|NCT00512252|62800606|FG001|Overall Study|Protocol Violation|0|||
33422455|NCT00512252|62800607|FG002|Overall Study|Protocol Violation|1|||
33422456|NCT00512252|62800605|FG000|Overall Study|Death|0|||
33422457|NCT00512252|62800606|FG001|Overall Study|Death|0|||
33422458|NCT00512252|62800607|FG002|Overall Study|Death|1|||
33422459|NCT00516386|62800622|FG000|Overall Study|not interested in the study|4|||
33422460|NCT00516386|62800622|FG000|Overall Study|Lost to Follow-up|2|||
33422461|NCT00524420|62800628|FG000|Overall Study|Lack of Efficacy|1|||
33422462|NCT00524420|62800629|FG001|Overall Study|Lack of Efficacy|0|||
33422463|NCT00512096|62800637|FG000|Overall Study|Adverse Event|2|||
33422464|NCT00512096|62800637|FG000|Overall Study|Withdrawal by Subject|2|||
33422465|NCT00512096|62800637|FG000|Overall Study|Lack of Efficacy|3|||
33422466|NCT00524030|62800643|FG000|Overall Study|Lack of Efficacy|10|||
33422467|NCT00524030|62800644|FG001|Overall Study|Lack of Efficacy|24|||
33422468|NCT00524030|62800643|FG000|Overall Study|Lost to Follow-up|0|||
33422469|NCT00524030|62800644|FG001|Overall Study|Lost to Follow-up|2|||
33422470|NCT00524030|62800643|FG000|Overall Study|Withdrawal by Subject|3|||
33422471|NCT00524030|62800644|FG001|Overall Study|Withdrawal by Subject|8|||
33422472|NCT00524030|62800643|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
33422473|NCT00524030|62800644|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
33422474|NCT00524030|62800643|FG000|Overall Study|Protocol Violation|0|||
33422475|NCT00524030|62800644|FG001|Overall Study|Protocol Violation|1|||
33422476|NCT00524030|62800643|FG000|Overall Study|Pregnancy|1|||
33422477|NCT00524030|62800644|FG001|Overall Study|Pregnancy|0|||
33422478|NCT00524030|62800643|FG000|Overall Study|Adverse Event|3|||
33422479|NCT00524030|62800644|FG001|Overall Study|Adverse Event|21|||
33422480|NCT00524030|62800643|FG000|Overall Study|Death|0|||
33422481|NCT00524030|62800644|FG001|Overall Study|Death|1|||
33422482|NCT00523718|62800653|FG000|Overall Study|Withdrawal by Subject|1|||
33422483|NCT00523718|62800654|FG001|Overall Study|Withdrawal by Subject|0|||
33422484|NCT00523718|62800653|FG000|Overall Study|Protocol Violation|2|||
33422485|NCT00523718|62800654|FG001|Overall Study|Protocol Violation|0|||
33422486|NCT00523640|62800660|FG000|Overall Study|Death|1|||
33422487|NCT00345358|62800668|FG000|Primary Vaccination Phase|Other|0|||
33422488|NCT00345358|62800669|FG001|Primary Vaccination Phase|Other|1|||
33422489|NCT00345358|62800670|FG002|Primary Vaccination Phase|Other|1|||
33422490|NCT00345358|62800671|FG003|Primary Vaccination Phase|Other|0|||
33422491|NCT00345358|62800668|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
33422492|NCT00345358|62800669|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
33422493|NCT00345358|62800670|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
33422494|NCT00345358|62800671|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
33422495|NCT00345358|62800668|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
33422496|NCT00345358|62800669|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
33422497|NCT00345358|62800670|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
33422498|NCT00345358|62800671|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
33422499|NCT00345358|62800668|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
33422500|NCT00345358|62800669|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
33422501|NCT00345358|62800670|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
33422502|NCT00345358|62800671|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
33422503|NCT00345358|62800668|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
33422504|NCT00345358|62800669|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
33422505|NCT00345358|62800670|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
33422506|NCT00345358|62800671|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
33422507|NCT00345358|62800668|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
33422508|NCT00345358|62800669|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
33422509|NCT00345358|62800670|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
33422510|NCT00345358|62800671|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
33422511|NCT03869684|62800684|FG000|Overall Study|Adverse Event|0|||
33422512|NCT03869684|62800685|FG001|Overall Study|Adverse Event|3|||
33422513|NCT03869684|62800686|FG002|Overall Study|Adverse Event|1|||
33422514|NCT03869684|62800684|FG000|Overall Study|Withdrawal by Subject|1|||
33422515|NCT03869684|62800685|FG001|Overall Study|Withdrawal by Subject|0|||
33422516|NCT03869684|62800686|FG002|Overall Study|Withdrawal by Subject|0|||
33422517|NCT03869684|62800684|FG000|Overall Study|Lost to Follow-up|1|||
33422518|NCT03869684|62800685|FG001|Overall Study|Lost to Follow-up|0|||
33422519|NCT03869684|62800686|FG002|Overall Study|Lost to Follow-up|0|||
33422520|NCT03869684|62800684|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
33422521|NCT03869684|62800685|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
33422522|NCT03869684|62800686|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
33422523|NCT00516074|62800696|FG000|Overall Study|Adverse Event|0|||
33422524|NCT00516074|62800697|FG001|Overall Study|Adverse Event|1|||
33422525|NCT00516074|62800696|FG000|Overall Study|Subject Decision|4|||
33605261|NCT02367131|63004977|FG000|Overall Study|Request by patient|54|||
33605262|NCT02367131|63004977|FG000|Overall Study|Improvement/remission|2|||
33605263|NCT02367131|63004977|FG000|Overall Study|No change/progressive disease|78|||
33605264|NCT02367131|63004977|FG000|Overall Study|Other than stated above|20|||
33605265|NCT02394275|63004981|FG000|Overall Study|Adverse Event|22|||
33605266|NCT02394275|63004981|FG000|Overall Study|Lost to Follow-up|7|||
33605267|NCT01608724|63004986|FG000|Overall Study|Withdrawal by Subject|131|||
33605268|NCT01608724|63004986|FG000|Overall Study|Lost to Follow-up|41|||
33605269|NCT01608724|63004986|FG000|Overall Study|Study-specific discontinuation criteria|32|||
33605270|NCT01608724|63004986|FG000|Overall Study|Adverse Event|29|||
33605271|NCT01608724|63004986|FG000|Overall Study|Protocol Violation|6|||
33605272|NCT01608724|63004986|FG000|Overall Study|bood sugar too high, etc.|3|||
33605273|NCT01608724|63004986|FG000|Overall Study|Safety reasons|1|||
33605274|NCT02366195|63004990|FG000|Overall Study|Protocol-specified criteria|3|||
33605275|NCT02366195|63004990|FG000|Overall Study|Withdrawal by Subject|9|||
33605276|NCT02366195|63004990|FG000|Overall Study|Lost to Follow-up|1|||
33605277|NCT02366195|63004990|FG000|Overall Study|Death|41|||
33605278|NCT02364947|63004997|FG000|Overall Study|Withdrawal by Subject|10|||
33605279|NCT02364947|63004998|FG001|Overall Study|Withdrawal by Subject|8|||
33605280|NCT02364947|63004999|FG002|Overall Study|Withdrawal by Subject|9|||
33605281|NCT02364947|63004997|FG000|Overall Study|Adverse Event|45|||
33605282|NCT02364947|63004998|FG001|Overall Study|Adverse Event|33|||
33605283|NCT02364947|63004999|FG002|Overall Study|Adverse Event|11|||
33605284|NCT02364947|63004997|FG000|Overall Study|Protocol Violation|1|||
33605285|NCT02364947|63004998|FG001|Overall Study|Protocol Violation|1|||
33605286|NCT02364947|63004999|FG002|Overall Study|Protocol Violation|1|||
33422526|NCT00516074|62800697|FG001|Overall Study|Subject Decision|2|||
33422527|NCT00516074|62800696|FG000|Overall Study|Loss of Glucose Control|2|||
33422528|NCT00516074|62800697|FG001|Overall Study|Loss of Glucose Control|0|||
33605287|NCT02364947|63004997|FG000|Overall Study|Physician Decision|3|||
33605288|NCT02364947|63004998|FG001|Overall Study|Physician Decision|2|||
33422529|NCT00515294|62800707|FG000|Overall Study|Lost to Follow-up|3|||
33605289|NCT02364947|63004999|FG002|Overall Study|Physician Decision|5|||
33605290|NCT02364947|63004997|FG000|Overall Study|Death|0|||
33605291|NCT02364947|63004998|FG001|Overall Study|Death|1|||
33605292|NCT02364947|63004999|FG002|Overall Study|Death|0|||
33605293|NCT02392481|63005011|FG000|Overall Study|Adverse Event|0|||
33605294|NCT02392481|63005012|FG001|Overall Study|Adverse Event|0|||
33422530|NCT00515294|62800708|FG001|Overall Study|Lost to Follow-up|2|||
33322949|NCT03332056|62699159|FG001|Overall Study|Passed stone prior to surgery date|0|||
33422531|NCT00515294|62800709|FG002|Overall Study|Lost to Follow-up|3|||
33422532|NCT00515294|62800710|FG003|Overall Study|Lost to Follow-up|1|||
33422533|NCT00515294|62800707|FG000|Overall Study|Driver simulator problems|1|||
33422534|NCT00515294|62800708|FG001|Overall Study|Driver simulator problems|1|||
33422535|NCT00515294|62800709|FG002|Overall Study|Driver simulator problems|1|||
33422536|NCT00515294|62800710|FG003|Overall Study|Driver simulator problems|3|||
33422537|NCT00515294|62800707|FG000|Overall Study|Caffeine amount inaccurate|5|||
33422538|NCT00515294|62800708|FG001|Overall Study|Caffeine amount inaccurate|0|||
33422539|NCT00515294|62800709|FG002|Overall Study|Caffeine amount inaccurate|7|||
33422540|NCT00515294|62800710|FG003|Overall Study|Caffeine amount inaccurate|0|||
33422541|NCT00345046|62800723|FG000|Overall Study|Protocol Violation|1|||
33422542|NCT00345046|62800724|FG001|Overall Study|Protocol Violation|1|||
33422543|NCT00345046|62800725|FG002|Overall Study|Protocol Violation|2|||
33422544|NCT00515216|62800733|FG000|Overall Study|Withdrawal by Subject|1|||
33422545|NCT01004978|62800740|FG000|Overall Study|Disease progression|31|||
33422546|NCT01004978|62800741|FG001|Overall Study|Disease progression|48|||
33422547|NCT01004978|62800740|FG000|Overall Study|Adverse Event|42|||
33422548|NCT01004978|62800741|FG001|Overall Study|Adverse Event|22|||
33422549|NCT01004978|62800740|FG000|Overall Study|Death|3|||
33422550|NCT01004978|62800741|FG001|Overall Study|Death|2|||
33422551|NCT01004978|62800740|FG000|Overall Study|Withdrawal by Subject|16|||
33422552|NCT01004978|62800741|FG001|Overall Study|Withdrawal by Subject|16|||
33422553|NCT01004978|62800740|FG000|Overall Study|Alternative therapy|4|||
33422554|NCT01004978|62800741|FG001|Overall Study|Alternative therapy|8|||
33422555|NCT01004978|62800740|FG000|Overall Study|Physician Decision|6|||
33422556|NCT01004978|62800741|FG001|Overall Study|Physician Decision|3|||
33322950|NCT03332056|62699158|FG000|Overall Study|Did not require a ureteral stent|0|||
33322951|NCT03332056|62699159|FG001|Overall Study|Did not require a ureteral stent|1|||
33422557|NCT01004978|62800740|FG000|Overall Study|Other complicating disease|2|||
33422558|NCT01004978|62800741|FG001|Overall Study|Other complicating disease|2|||
33422559|NCT01004978|62800740|FG000|Overall Study|Protocol Violation|2|||
33422560|NCT01004978|62800741|FG001|Overall Study|Protocol Violation|3|||
33422561|NCT01004978|62800740|FG000|Overall Study|Non-compliance|3|||
33422562|NCT01004978|62800741|FG001|Overall Study|Non-compliance|2|||
33422563|NCT01004978|62800740|FG000|Overall Study|Ineligible|1|||
33422564|NCT01004978|62800741|FG001|Overall Study|Ineligible|0|||
33422565|NCT01004978|62800740|FG000|Overall Study|Unblinded|0|||
33422566|NCT01004978|62800741|FG001|Overall Study|Unblinded|1|||
33422567|NCT01004978|62800740|FG000|Overall Study|Performance status worsening|0|||
33422568|NCT01004978|62800741|FG001|Overall Study|Performance status worsening|1|||
33422569|NCT01004978|62800740|FG000|Overall Study|Never started treatment|8|||
33422570|NCT01004978|62800741|FG001|Overall Study|Never started treatment|9|||
33422571|NCT00522626|62800747|FG000|Overall Study|Lost to Follow-up|7|||
33422572|NCT00440193|62800753|FG000|Treatment Period|Adverse Event|74|||
33422573|NCT00440193|62800754|FG001|Treatment Period|Adverse Event|67|||
33422574|NCT00440193|62800753|FG000|Treatment Period|Death|19|||
33422575|NCT00440193|62800754|FG001|Treatment Period|Death|22|||
33422576|NCT00440193|62800753|FG000|Treatment Period|Lack of Efficacy|0|||
33422577|NCT00440193|62800754|FG001|Treatment Period|Lack of Efficacy|1|||
33422578|NCT00440193|62800753|FG000|Treatment Period|Lost to Follow-up|12|||
33422579|NCT00440193|62800754|FG001|Treatment Period|Lost to Follow-up|18|||
33422580|NCT00440193|62800753|FG000|Treatment Period|Physician Decision|3|||
33422581|NCT00440193|62800754|FG001|Treatment Period|Physician Decision|6|||
33422582|NCT00440193|62800753|FG000|Treatment Period|Protocol Violation|16|||
33422583|NCT00440193|62800754|FG001|Treatment Period|Protocol Violation|19|||
33422584|NCT00440193|62800753|FG000|Treatment Period|Withdrawal by Subject|36|||
33422585|NCT00440193|62800754|FG001|Treatment Period|Withdrawal by Subject|77|||
33422586|NCT00440193|62800753|FG000|Treatment Period|Clinical endpoint reached|28|||
33422587|NCT00440193|62800754|FG001|Treatment Period|Clinical endpoint reached|25|||
33422588|NCT00440193|62800753|FG000|Treatment Period|Study terminated by sponsor|102|||
33422589|NCT00440193|62800754|FG001|Treatment Period|Study terminated by sponsor|94|||
33422590|NCT00440193|62800753|FG000|Treatment Period|Protocol driven decision point|2|||
33422591|NCT00440193|62800754|FG001|Treatment Period|Protocol driven decision point|2|||
33422592|NCT00440193|62800753|FG000|Treatment Period|Switch to commercial drug|0|||
33422593|NCT00440193|62800754|FG001|Treatment Period|Switch to commercial drug|2|||
33422594|NCT00440193|62800753|FG000|Treatment Period|Technical problems|1|||
33422595|NCT00440193|62800754|FG001|Treatment Period|Technical problems|1|||
33422596|NCT00440193|62800753|FG000|Treatment Period|Participant convenience|5|||
33422597|NCT00440193|62800754|FG001|Treatment Period|Participant convenience|2|||
33422598|NCT00440193|62800753|FG000|Treatment Period|Participant did not receive treatment|7|||
33422599|NCT00440193|62800754|FG001|Treatment Period|Participant did not receive treatment|13|||
33422600|NCT00440193|62800753|FG000|Treatment Period|Site closed by investigator|0|||
33422601|NCT00440193|62800754|FG001|Treatment Period|Site closed by investigator|2|||
33422602|NCT00440193|62800753|FG000|Observational Period|Adverse Event|2|||
33422603|NCT00440193|62800754|FG001|Observational Period|Adverse Event|2|||
33422604|NCT00440193|62800753|FG000|Observational Period|Death|15|||
33422605|NCT00440193|62800754|FG001|Observational Period|Death|20|||
33422606|NCT00440193|62800753|FG000|Observational Period|Lost to Follow-up|12|||
33422607|NCT00440193|62800754|FG001|Observational Period|Lost to Follow-up|8|||
33422608|NCT00440193|62800753|FG000|Observational Period|Protocol Violation|1|||
33422609|NCT00440193|62800754|FG001|Observational Period|Protocol Violation|0|||
33422610|NCT00440193|62800753|FG000|Observational Period|Withdrawal by Subject|11|||
33422611|NCT00440193|62800754|FG001|Observational Period|Withdrawal by Subject|8|||
33422612|NCT00440193|62800753|FG000|Observational Period|Physician Decision|1|||
33422613|NCT00440193|62800754|FG001|Observational Period|Physician Decision|0|||
33422614|NCT00440193|62800753|FG000|Observational Period|Clinical endpoint reached|1|||
33422615|NCT00440193|62800754|FG001|Observational Period|Clinical endpoint reached|0|||
33422616|NCT00440193|62800753|FG000|Observational Period|Participant convenience|2|||
33422617|NCT00440193|62800754|FG001|Observational Period|Participant convenience|0|||
33422618|NCT00511472|62800762|FG000|Overall Study|Clinical Adverse Event|1|||
33422619|NCT00511472|62800763|FG001|Overall Study|Clinical Adverse Event|2|||
33422620|NCT00511472|62800762|FG000|Overall Study|Laboratory Adverse Event|0|||
33422621|NCT00511472|62800763|FG001|Overall Study|Laboratory Adverse Event|2|||
33422622|NCT00511472|62800762|FG000|Overall Study|Not reported|2|||
33422623|NCT00511472|62800763|FG001|Overall Study|Not reported|2|||
33422624|NCT00514904|62800780|FG000|Overall Study|Withdrawal by Subject|3|||
33422625|NCT00514904|62800781|FG001|Overall Study|Withdrawal by Subject|2|||
33422626|NCT00514904|62800780|FG000|Overall Study|Lost to Follow-up|21|||
33422627|NCT00514904|62800781|FG001|Overall Study|Lost to Follow-up|3|||
33422628|NCT00440115|62800790|FG000|Overall Study|Death|7|||
33422629|NCT00440115|62800791|FG001|Overall Study|Death|9|||
33422630|NCT00440115|62800792|FG002|Overall Study|Death|5|||
33422631|NCT00440115|62800790|FG000|Overall Study|Incarceration|0|||
33422632|NCT00440115|62800791|FG001|Overall Study|Incarceration|2|||
33422633|NCT00440115|62800792|FG002|Overall Study|Incarceration|1|||
33422634|NCT00440037|62800800|FG000|Overall Study|Withdrawal by Subject|6|||
33422635|NCT00440037|62800800|FG000|Overall Study|Administrative decision|3|||
33422636|NCT00417027|62800807|FG000|Overall Study|Protocol Violation|0|||
33422637|NCT00417027|62800808|FG001|Overall Study|Protocol Violation|5|||
33422638|NCT00417027|62800809|FG002|Overall Study|Protocol Violation|5|||
33422639|NCT00416949|62800817|FG000|Overall Study|Patients refused to participate|5|||
33422640|NCT00416715|62800821|FG000|Overall Study|Not evaluable for joint aches|7|||
33422641|NCT00416715|62800821|FG000|Overall Study|Vitamin D levels not evaluable|8|||
33422642|NCT00406029|62800833|FG000|Overall Study|Adverse Event|12|||
33422643|NCT00406029|62800834|FG001|Overall Study|Adverse Event|2|||
33422644|NCT00406029|62800835|FG002|Overall Study|Adverse Event|5|||
33422645|NCT00406029|62800836|FG003|Overall Study|Adverse Event|10|||
33422646|NCT00406029|62800837|FG004|Overall Study|Adverse Event|7|||
33422647|NCT00406029|62800833|FG000|Overall Study|Withdrawal by Subject|3|||
33422648|NCT00406029|62800834|FG001|Overall Study|Withdrawal by Subject|4|||
33422649|NCT00406029|62800835|FG002|Overall Study|Withdrawal by Subject|2|||
33422650|NCT00406029|62800836|FG003|Overall Study|Withdrawal by Subject|2|||
33422651|NCT00406029|62800837|FG004|Overall Study|Withdrawal by Subject|0|||
33422652|NCT00406029|62800833|FG000|Overall Study|Protocol Violation|1|||
33422653|NCT00406029|62800834|FG001|Overall Study|Protocol Violation|2|||
33422654|NCT00406029|62800835|FG002|Overall Study|Protocol Violation|0|||
33422655|NCT00406029|62800836|FG003|Overall Study|Protocol Violation|2|||
33422656|NCT00406029|62800837|FG004|Overall Study|Protocol Violation|0|||
33422657|NCT00406029|62800833|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
33422658|NCT00406029|62800834|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
33422659|NCT00406029|62800835|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
33422660|NCT00406029|62800836|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
33422661|NCT00406029|62800837|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
33422662|NCT00406029|62800833|FG000|Overall Study|Randomized in Error|0|||
33422663|NCT00406029|62800834|FG001|Overall Study|Randomized in Error|0|||
33422664|NCT00406029|62800835|FG002|Overall Study|Randomized in Error|2|||
33422665|NCT00406029|62800836|FG003|Overall Study|Randomized in Error|3|||
33422666|NCT00406029|62800837|FG004|Overall Study|Randomized in Error|1|||
33422667|NCT00514514|62800852|FG000|Pre-phase|Death|10|||
33422668|NCT00514514|62800853|FG001|Pre-phase|Death|0|||
33422669|NCT00514514|62800854|FG002|Pre-phase|Death|0|||
33422670|NCT00514514|62800852|FG000|Pre-phase|administrative problems|2|||
33422671|NCT00514514|62800853|FG001|Pre-phase|administrative problems|0|||
33422672|NCT00514514|62800854|FG002|Pre-phase|administrative problems|0|||
33422673|NCT00514514|62800852|FG000|Pre-phase|Protocol Violation|6|||
33422674|NCT00514514|62800853|FG001|Pre-phase|Protocol Violation|0|||
33422675|NCT00514514|62800854|FG002|Pre-phase|Protocol Violation|0|||
33422676|NCT00514514|62800852|FG000|Pre-phase|condition no longer requires study drug|7|||
33422677|NCT00514514|62800853|FG001|Pre-phase|condition no longer requires study drug|0|||
33422678|NCT00514514|62800854|FG002|Pre-phase|condition no longer requires study drug|0|||
33422679|NCT00514514|62800852|FG000|Pre-phase|abnormal test procedure results|15|||
33422680|NCT00514514|62800853|FG001|Pre-phase|abnormal test procedure results|0|||
33422681|NCT00514514|62800854|FG002|Pre-phase|abnormal test procedure results|0|||
33422682|NCT00514514|62800852|FG000|Pre-phase|Lost to Follow-up|2|||
33422683|NCT00514514|62800853|FG001|Pre-phase|Lost to Follow-up|0|||
33422684|NCT00514514|62800854|FG002|Pre-phase|Lost to Follow-up|0|||
33422685|NCT00514514|62800852|FG000|Pre-phase|abnormal lab values|23|||
33422686|NCT00514514|62800853|FG001|Pre-phase|abnormal lab values|0|||
33422687|NCT00514514|62800854|FG002|Pre-phase|abnormal lab values|0|||
33422688|NCT00514514|62800852|FG000|Pre-phase|Lack of Efficacy|35|||
33422689|NCT00514514|62800853|FG001|Pre-phase|Lack of Efficacy|0|||
33422690|NCT00514514|62800854|FG002|Pre-phase|Lack of Efficacy|0|||
33422691|NCT00514514|62800852|FG000|Pre-phase|Adverse Event|137|||
33422692|NCT00514514|62800853|FG001|Pre-phase|Adverse Event|0|||
33422693|NCT00514514|62800854|FG002|Pre-phase|Adverse Event|0|||
33422694|NCT00514514|62800852|FG000|Pre-phase|Withdrawal by Subject|66|||
33422695|NCT00514514|62800853|FG001|Pre-phase|Withdrawal by Subject|0|||
33422696|NCT00514514|62800854|FG002|Pre-phase|Withdrawal by Subject|0|||
33422697|NCT00514514|62800852|FG000|Randomized - 9 Month|Death|3|||
33422698|NCT00514514|62800853|FG001|Randomized - 9 Month|Death|2|||
33422699|NCT00514514|62800854|FG002|Randomized - 9 Month|Death|2|||
33422700|NCT00514514|62800852|FG000|Randomized - 9 Month|Administrative problems|1|||
33422701|NCT00514514|62800853|FG001|Randomized - 9 Month|Administrative problems|1|||
33422702|NCT00514514|62800854|FG002|Randomized - 9 Month|Administrative problems|2|||
33422703|NCT00514514|62800852|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
33422704|NCT00514514|62800853|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
33422705|NCT00514514|62800854|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
33422706|NCT00514514|62800852|FG000|Randomized - 9 Month|Protocol Violation|1|||
33422707|NCT00514514|62800853|FG001|Randomized - 9 Month|Protocol Violation|1|||
33422708|NCT00514514|62800854|FG002|Randomized - 9 Month|Protocol Violation|0|||
33422709|NCT00514514|62800852|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
33422710|NCT00514514|62800853|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
33422711|NCT00514514|62800854|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
33422712|NCT00514514|62800852|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
33422713|NCT00514514|62800853|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
33422714|NCT00514514|62800854|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
33422715|NCT00514514|62800852|FG000|Randomized - 9 Month|Adverse Event|25|||
33422716|NCT00514514|62800853|FG001|Randomized - 9 Month|Adverse Event|44|||
33422717|NCT00514514|62800854|FG002|Randomized - 9 Month|Adverse Event|27|||
33422718|NCT00514514|62800852|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
33422719|NCT00514514|62800853|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
33422720|NCT00514514|62800854|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
33422721|NCT00514514|62800852|FG000|Extension - 4 Years|Lost to Follow-up|12|||
33422722|NCT00514514|62800853|FG001|Extension - 4 Years|Lost to Follow-up|10|||
33422723|NCT00514514|62800854|FG002|Extension - 4 Years|Lost to Follow-up|9|||
33422724|NCT00514514|62800852|FG000|Extension - 4 Years|Administrative problems|3|||
33422725|NCT00514514|62800853|FG001|Extension - 4 Years|Administrative problems|1|||
33422726|NCT00514514|62800854|FG002|Extension - 4 Years|Administrative problems|1|||
33422727|NCT00514514|62800852|FG000|Extension - 4 Years|Death|8|||
33422728|NCT00514514|62800853|FG001|Extension - 4 Years|Death|3|||
33422729|NCT00514514|62800854|FG002|Extension - 4 Years|Death|6|||
33422730|NCT00514514|62800852|FG000|Extension - 4 Years|Adverse Event|9|||
33422731|NCT00514514|62800853|FG001|Extension - 4 Years|Adverse Event|6|||
33422732|NCT00514514|62800854|FG002|Extension - 4 Years|Adverse Event|3|||
33422733|NCT00405639|62800864|FG000|Overall Study|Withdrawal by Subject|1|||
33422734|NCT00405639|62800865|FG001|Overall Study|Withdrawal by Subject|0|||
33422735|NCT00405639|62800864|FG000|Overall Study|Adverse Event|1|||
33422736|NCT00405639|62800865|FG001|Overall Study|Adverse Event|0|||
33422737|NCT00405639|62800864|FG000|Overall Study|Seizure prior to receiving BNP|1|||
33422738|NCT00405639|62800865|FG001|Overall Study|Seizure prior to receiving BNP|0|||
33422739|NCT00439725|62800873|FG000|Treatment Period|Withdrawal by Subject|22|||
33422740|NCT00439725|62800874|FG001|Treatment Period|Withdrawal by Subject|19|||
33422741|NCT00439725|62800873|FG000|Treatment Period|Study terminated by sponsor|156|||
33422742|NCT00439725|62800874|FG001|Treatment Period|Study terminated by sponsor|148|||
33422743|NCT00439725|62800873|FG000|Treatment Period|Site closed by investigator|1|||
33422744|NCT00439725|62800874|FG001|Treatment Period|Site closed by investigator|2|||
33422745|NCT00439725|62800873|FG000|Treatment Period|Adverse Event|39|||
33422746|NCT00439725|62800874|FG001|Treatment Period|Adverse Event|18|||
33422747|NCT00439725|62800873|FG000|Treatment Period|Physician Decision|1|||
33422748|NCT00439725|62800874|FG001|Treatment Period|Physician Decision|1|||
33422749|NCT00439725|62800873|FG000|Treatment Period|Protocol Violation|2|||
33422750|NCT00439725|62800874|FG001|Treatment Period|Protocol Violation|1|||
33422751|NCT00439725|62800873|FG000|Treatment Period|Clinical endpoint reached|6|||
33422752|NCT00439725|62800874|FG001|Treatment Period|Clinical endpoint reached|50|||
33422753|NCT00439725|62800873|FG000|Treatment Period|Technical problems|1|||
33422754|NCT00439725|62800874|FG001|Treatment Period|Technical problems|0|||
33422755|NCT00439725|62800873|FG000|Treatment Period|Lost to Follow-up|1|||
33422756|NCT00439725|62800874|FG001|Treatment Period|Lost to Follow-up|1|||
33422757|NCT00439725|62800873|FG000|Treatment Period|Participant convenience|1|||
33422758|NCT00439725|62800874|FG001|Treatment Period|Participant convenience|0|||
33422759|NCT00439725|62800873|FG000|Treatment Period|Protocol driven decision point|1|||
33422760|NCT00439725|62800874|FG001|Treatment Period|Protocol driven decision point|1|||
33422761|NCT00439725|62800873|FG000|Treatment Period|Death|1|||
33422762|NCT00439725|62800874|FG001|Treatment Period|Death|1|||
33422763|NCT00439725|62800873|FG000|Treatment Period|Participant did not receive treatment|4|||
33422764|NCT00439725|62800874|FG001|Treatment Period|Participant did not receive treatment|4|||
33422765|NCT00439725|62800873|FG000|Observational Period|Withdrawal by Subject|2|||
33422766|NCT00439725|62800874|FG001|Observational Period|Withdrawal by Subject|2|||
33422767|NCT00439725|62800873|FG000|Observational Period|Lost to Follow-up|0|||
33422768|NCT00439725|62800874|FG001|Observational Period|Lost to Follow-up|1|||
33422769|NCT00439725|62800873|FG000|Observational Period|Death|0|||
33422770|NCT00439725|62800874|FG001|Observational Period|Death|2|||
33422771|NCT00439725|62800873|FG000|Observational Period|Study termination by sponsor|1|||
33422772|NCT00439725|62800874|FG001|Observational Period|Study termination by sponsor|1|||
33422773|NCT00439725|62800873|FG000|Observational Period|Clinical endpoint reached|3|||
33422774|NCT00439725|62800874|FG001|Observational Period|Clinical endpoint reached|1|||
33422775|NCT00439725|62800873|FG000|Observational Period|Technical problems|1|||
33422776|NCT00439725|62800874|FG001|Observational Period|Technical problems|0|||
33422777|NCT00439725|62800873|FG000|Observational Period|Participant convenience|1|||
33422778|NCT00439725|62800874|FG001|Observational Period|Participant convenience|0|||
33422779|NCT00521586|62800882|FG000|Initial Vaccination (Year 0)|Subject request|8|||
33422780|NCT00521586|62800883|FG001|Initial Vaccination (Year 0)|Subject request|11|||
33422781|NCT00521586|62800882|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
33422782|NCT00521586|62800883|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
33422783|NCT00521586|62800882|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
33422784|NCT00521586|62800883|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
33422785|NCT00521586|62800882|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
33494136|NCT03486834|62872902|FG000|Overall Study|Adverse Event|8|||
33422786|NCT00521586|62800883|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
33422787|NCT00521586|62800882|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
33422788|NCT00521586|62800883|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
33422789|NCT00521586|62800882|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
33422790|NCT00521586|62800883|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
33422791|NCT00521586|62800882|FG000|Initial Vaccination (Year 0)|Death|1|||
33422792|NCT00521586|62800883|FG001|Initial Vaccination (Year 0)|Death|0|||
33422793|NCT00521586|62800882|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
33422794|NCT00521586|62800883|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
33422795|NCT00521586|62800882|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
33494137|NCT03486834|62872903|FG001|Overall Study|Adverse Event|7|||
33322952|NCT03093350|62699165|FG000|Overall Study|Death|1|||
33422796|NCT00521586|62800883|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
33422797|NCT00521586|62800882|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
33422798|NCT00521586|62800883|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
33422799|NCT00521586|62800882|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
33422800|NCT00521586|62800883|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
33422801|NCT00521586|62800882|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
33422802|NCT00521586|62800883|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
33422803|NCT00521586|62800882|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
33422804|NCT00521586|62800883|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
33422805|NCT00521586|62800882|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
33422806|NCT00521586|62800883|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
33422807|NCT00521586|62800882|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
33422808|NCT00521586|62800883|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
33422809|NCT00521586|62800882|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
33422810|NCT00521586|62800883|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
33422811|NCT00521586|62800882|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
33422812|NCT00521586|62800883|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
33422813|NCT00521586|62800882|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
33422814|NCT00521586|62800883|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
33422815|NCT00521586|62800882|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
33422816|NCT00521586|62800883|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
33422817|NCT00515502|62800901|FG000|Treatment Period 1|Adverse Event|0|||
33422818|NCT00515502|62800902|FG001|Treatment Period 1|Adverse Event|0|||
33422819|NCT00515502|62800903|FG002|Treatment Period 1|Adverse Event|0|||
33422820|NCT00515502|62800904|FG003|Treatment Period 1|Adverse Event|0|||
33422821|NCT00515502|62800905|FG004|Treatment Period 1|Adverse Event|0|||
33422822|NCT00515502|62800906|FG005|Treatment Period 1|Adverse Event|0|||
33422823|NCT00515502|62800907|FG006|Treatment Period 1|Adverse Event|1|||
33422824|NCT00515502|62800908|FG007|Treatment Period 1|Adverse Event|0|||
33422825|NCT00515502|62800909|FG008|Treatment Period 1|Adverse Event|1|||
33422826|NCT00515502|62800910|FG009|Treatment Period 1|Adverse Event|0|||
33422827|NCT00515502|62800911|FG010|Treatment Period 1|Adverse Event|0|||
33422828|NCT00515502|62800912|FG011|Treatment Period 1|Adverse Event|1|||
33422829|NCT00515502|62800901|FG000|Treatment Period 2|Adverse Event|0|||
33422830|NCT00515502|62800902|FG001|Treatment Period 2|Adverse Event|1|||
33422831|NCT00515502|62800903|FG002|Treatment Period 2|Adverse Event|0|||
33422832|NCT00515502|62800904|FG003|Treatment Period 2|Adverse Event|0|||
33322953|NCT03093350|62699165|FG000|Overall Study|Signed consent, never began treartment|1|||
33322954|NCT02901041|62699171|FG000|Overall Study|Withdrawal by PI|4|||
33422833|NCT00515502|62800905|FG004|Treatment Period 2|Adverse Event|0|||
33422834|NCT00515502|62800906|FG005|Treatment Period 2|Adverse Event|0|||
33422835|NCT00515502|62800907|FG006|Treatment Period 2|Adverse Event|0|||
33422836|NCT00515502|62800908|FG007|Treatment Period 2|Adverse Event|0|||
33422837|NCT00515502|62800909|FG008|Treatment Period 2|Adverse Event|0|||
33422838|NCT00515502|62800910|FG009|Treatment Period 2|Adverse Event|0|||
33422839|NCT00515502|62800911|FG010|Treatment Period 2|Adverse Event|0|||
33422840|NCT00515502|62800912|FG011|Treatment Period 2|Adverse Event|0|||
33422841|NCT00439647|62800931|FG000|Overall Study|Withdrawal by Subject|25|||
33422842|NCT00439647|62800932|FG001|Overall Study|Withdrawal by Subject|22|||
33422843|NCT00439647|62800931|FG000|Overall Study|Death|15|||
33422844|NCT00439647|62800932|FG001|Overall Study|Death|18|||
33422845|NCT00439647|62800931|FG000|Overall Study|Adverse Event|11|||
33422846|NCT00439647|62800932|FG001|Overall Study|Adverse Event|11|||
33422847|NCT00439647|62800931|FG000|Overall Study|Lost to Follow-up|4|||
33422848|NCT00439647|62800932|FG001|Overall Study|Lost to Follow-up|12|||
33422849|NCT00439647|62800931|FG000|Overall Study|Protocol Violation|3|||
33422850|NCT00439647|62800932|FG001|Overall Study|Protocol Violation|4|||
33422851|NCT00439647|62800931|FG000|Overall Study|Lack of Efficacy|0|||
33422852|NCT00439647|62800932|FG001|Overall Study|Lack of Efficacy|4|||
33422853|NCT00515112|62800940|FG000|Overall Study|Death|0|||
33422854|NCT00515112|62800941|FG001|Overall Study|Death|1|||
33422855|NCT00515112|62800940|FG000|Overall Study|The study was terminated|3|||
33422856|NCT00515112|62800941|FG001|Overall Study|The study was terminated|2|||
33422857|NCT00404547|62800949|FG000|Overall Study|Adverse Event|39|||
33422858|NCT00404547|62800950|FG001|Overall Study|Adverse Event|6|||
33422859|NCT00404547|62800949|FG000|Overall Study|Withdrawal by Subject|19|||
33422860|NCT00404547|62800950|FG001|Overall Study|Withdrawal by Subject|2|||
33422861|NCT00404547|62800949|FG000|Overall Study|Protocol Violation|0|||
33422862|NCT00404547|62800950|FG001|Overall Study|Protocol Violation|1|||
33422863|NCT00404547|62800949|FG000|Overall Study|Lost to Follow-up|20|||
33422864|NCT00404547|62800950|FG001|Overall Study|Lost to Follow-up|9|||
33422865|NCT00404547|62800949|FG000|Overall Study|Lack of compliance|5|||
33422866|NCT00404547|62800950|FG001|Overall Study|Lack of compliance|1|||
33422867|NCT00404547|62800949|FG000|Overall Study|Other|4|||
33422868|NCT00404547|62800950|FG001|Overall Study|Other|0|||
33422869|NCT00404547|62800949|FG000|Overall Study|Reason not stated|3|||
33422870|NCT00404547|62800950|FG001|Overall Study|Reason not stated|6|||
33422871|NCT00515034|62800960|FG000|Overall Study|Adverse Event|2|||
33422872|NCT00515034|62800961|FG001|Overall Study|Adverse Event|0|||
33422873|NCT00515034|62800962|FG002|Overall Study|Adverse Event|1|||
33422874|NCT00515034|62800963|FG003|Overall Study|Adverse Event|0|||
33422875|NCT00515034|62800960|FG000|Overall Study|Death|4|||
33422876|NCT00515034|62800961|FG001|Overall Study|Death|2|||
33422877|NCT00515034|62800962|FG002|Overall Study|Death|1|||
33422878|NCT00515034|62800963|FG003|Overall Study|Death|3|||
33422879|NCT00515034|62800960|FG000|Overall Study|Withdrawal by Subject|1|||
33422880|NCT00515034|62800961|FG001|Overall Study|Withdrawal by Subject|0|||
33422881|NCT00515034|62800962|FG002|Overall Study|Withdrawal by Subject|3|||
33422882|NCT00515034|62800963|FG003|Overall Study|Withdrawal by Subject|0|||
33422883|NCT00515034|62800960|FG000|Overall Study|Physician Decision|0|||
33422884|NCT00515034|62800961|FG001|Overall Study|Physician Decision|0|||
33422885|NCT00515034|62800962|FG002|Overall Study|Physician Decision|1|||
33422886|NCT00515034|62800963|FG003|Overall Study|Physician Decision|1|||
33422887|NCT00515034|62800960|FG000|Overall Study|Other|1|||
33422888|NCT00515034|62800961|FG001|Overall Study|Other|0|||
33422889|NCT00515034|62800962|FG002|Overall Study|Other|2|||
33422890|NCT00515034|62800963|FG003|Overall Study|Other|1|||
33422891|NCT00404235|62800975|FG000|Overall Study|Withdrawal by Subject|1|||
33422892|NCT00404235|62800976|FG001|Overall Study|Withdrawal by Subject|2|||
33422893|NCT00404079|62800984|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
33422894|NCT00404079|62800985|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
33422895|NCT00403845|62800991|FG000|Treatment Period 1|Subject withdrew consent|1|||
33422896|NCT00403845|62800992|FG001|Treatment Period 1|Subject withdrew consent|0|||
33422897|NCT00403845|62800993|FG002|Treatment Period 1|Subject withdrew consent|0|||
33422898|NCT00403845|62800994|FG003|Treatment Period 1|Subject withdrew consent|0|||
33422899|NCT00403845|62800991|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
33422900|NCT00403845|62800992|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
33422901|NCT00403845|62800993|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
33422902|NCT00403845|62800994|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
33422903|NCT00403845|62800991|FG000|Treatment Period 2|Subject withdrew consent|1|||
33422904|NCT00403845|62800992|FG001|Treatment Period 2|Subject withdrew consent|0|||
33422905|NCT00403845|62800993|FG002|Treatment Period 2|Subject withdrew consent|0|||
33422906|NCT00403845|62800994|FG003|Treatment Period 2|Subject withdrew consent|0|||
33422907|NCT00403845|62800991|FG000|Treatment Period 3|Subject withdrew consent|0|||
33422908|NCT00403845|62800992|FG001|Treatment Period 3|Subject withdrew consent|0|||
33422909|NCT00403845|62800993|FG002|Treatment Period 3|Subject withdrew consent|0|||
33422910|NCT00403845|62800994|FG003|Treatment Period 3|Subject withdrew consent|1|||
33422911|NCT00403845|62800991|FG000|Treatment Period 3|Adverse Event|0|||
33422912|NCT00403845|62800992|FG001|Treatment Period 3|Adverse Event|0|||
33422913|NCT00403845|62800993|FG002|Treatment Period 3|Adverse Event|0|||
33422914|NCT00403845|62800994|FG003|Treatment Period 3|Adverse Event|1|||
33422915|NCT00509262|62801006|FG000|Overall Study|Adverse Event|16|||
33422916|NCT00509262|62801007|FG001|Overall Study|Adverse Event|18|||
33422917|NCT00509262|62801006|FG000|Overall Study|Other|2|||
33422918|NCT00509262|62801007|FG001|Overall Study|Other|2|||
33422919|NCT00509262|62801006|FG000|Overall Study|Lack of Efficacy|1|||
33422920|NCT00509262|62801007|FG001|Overall Study|Lack of Efficacy|0|||
33422921|NCT00509262|62801006|FG000|Overall Study|Lost to Follow-up|1|||
33422922|NCT00509262|62801007|FG001|Overall Study|Lost to Follow-up|6|||
33422923|NCT00509262|62801006|FG000|Overall Study|Physician Decision|1|||
33422924|NCT00509262|62801007|FG001|Overall Study|Physician Decision|3|||
33422925|NCT00509262|62801006|FG000|Overall Study|Protocol Violation|2|||
33422926|NCT00509262|62801007|FG001|Overall Study|Protocol Violation|2|||
33422927|NCT00509262|62801006|FG000|Overall Study|Withdrawal by Subject|24|||
33422928|NCT00509262|62801007|FG001|Overall Study|Withdrawal by Subject|11|||
33422929|NCT00607997|62801017|FG000|Overall Study|Lack of Efficacy|6|||
33422930|NCT00607997|62801018|FG001|Overall Study|Lack of Efficacy|20|||
33422931|NCT00607997|62801019|FG002|Overall Study|Lack of Efficacy|14|||
33422932|NCT00607997|62801020|FG003|Overall Study|Lack of Efficacy|10|||
33422933|NCT00607997|62801017|FG000|Overall Study|Death|8|||
33422934|NCT00607997|62801018|FG001|Overall Study|Death|5|||
33422935|NCT00607997|62801019|FG002|Overall Study|Death|2|||
33422936|NCT00607997|62801020|FG003|Overall Study|Death|5|||
33422937|NCT00607997|62801017|FG000|Overall Study|Adverse Event|3|||
33422938|NCT00607997|62801018|FG001|Overall Study|Adverse Event|1|||
33422939|NCT00607997|62801019|FG002|Overall Study|Adverse Event|2|||
33422940|NCT00607997|62801020|FG003|Overall Study|Adverse Event|0|||
33422941|NCT00607997|62801017|FG000|Overall Study|Physician Decision|4|||
33422942|NCT00607997|62801018|FG001|Overall Study|Physician Decision|1|||
33422943|NCT00607997|62801019|FG002|Overall Study|Physician Decision|0|||
33422944|NCT00607997|62801020|FG003|Overall Study|Physician Decision|0|||
33422945|NCT00607997|62801017|FG000|Overall Study|Relapse, recurrent illness|4|||
33422946|NCT00607997|62801018|FG001|Overall Study|Relapse, recurrent illness|0|||
33422947|NCT00607997|62801019|FG002|Overall Study|Relapse, recurrent illness|2|||
33422948|NCT00607997|62801020|FG003|Overall Study|Relapse, recurrent illness|0|||
33422949|NCT00607997|62801017|FG000|Overall Study|Other without explanation|2|||
33422950|NCT00607997|62801018|FG001|Overall Study|Other without explanation|0|||
33422951|NCT00607997|62801019|FG002|Overall Study|Other without explanation|4|||
33422952|NCT00607997|62801020|FG003|Overall Study|Other without explanation|1|||
33422953|NCT00509106|62801037|FG000|Overall Study|Adverse Event|3|||
33422954|NCT00509106|62801038|FG001|Overall Study|Adverse Event|2|||
33422955|NCT00509106|62801037|FG000|Overall Study|Noncompliance|0|||
33422956|NCT00509106|62801038|FG001|Overall Study|Noncompliance|1|||
33422957|NCT00509106|62801037|FG000|Overall Study|At the request of sponsor/investigator|1|||
33422958|NCT00509106|62801038|FG001|Overall Study|At the request of sponsor/investigator|2|||
33422959|NCT00509106|62801037|FG000|Overall Study|Withdrew consent|4|||
33422960|NCT00509106|62801038|FG001|Overall Study|Withdrew consent|8|||
33322955|NCT02901041|62699172|FG001|Overall Study|Withdrawal by PI|8|||
33422961|NCT00509106|62801037|FG000|Overall Study|Lost to Follow-up|16|||
33422962|NCT00509106|62801038|FG001|Overall Study|Lost to Follow-up|10|||
33422963|NCT00509106|62801037|FG000|Overall Study|Other|1|||
33422964|NCT00509106|62801038|FG001|Overall Study|Other|0|||
33422965|NCT00509106|62801037|FG000|Overall Study|Death|6|||
33422966|NCT00509106|62801038|FG001|Overall Study|Death|6|||
33422967|NCT00607919|62801046|FG000|Acute Phase|Adverse Event|9|||
33422968|NCT00607919|62801047|FG001|Acute Phase|Adverse Event|2|||
33422969|NCT00607919|62801046|FG000|Acute Phase|Entry Criteria Not Met|1|||
33422970|NCT00607919|62801047|FG001|Acute Phase|Entry Criteria Not Met|1|||
33422971|NCT00607919|62801046|FG000|Acute Phase|Lack of Efficacy|1|||
33422972|NCT00607919|62801047|FG001|Acute Phase|Lack of Efficacy|2|||
33422973|NCT00607919|62801046|FG000|Acute Phase|Lost to Follow-up|9|||
33422974|NCT00607919|62801047|FG001|Acute Phase|Lost to Follow-up|3|||
33422975|NCT00607919|62801046|FG000|Acute Phase|Parent/Caregiver Decision|6|||
33422976|NCT00607919|62801047|FG001|Acute Phase|Parent/Caregiver Decision|4|||
33422977|NCT00607919|62801046|FG000|Acute Phase|Protocol Violation|5|||
33422978|NCT00607919|62801047|FG001|Acute Phase|Protocol Violation|1|||
33422979|NCT00607919|62801046|FG000|Acute Phase|Withdrawal by Subject|3|||
33422980|NCT00607919|62801047|FG001|Acute Phase|Withdrawal by Subject|3|||
33422981|NCT00607919|62801046|FG000|Open-Label Phase|Adverse Event|1|||
33422982|NCT00607919|62801047|FG001|Open-Label Phase|Adverse Event|5|||
33422983|NCT00607919|62801046|FG000|Open-Label Phase|Lost to Follow-up|4|||
33422984|NCT00607919|62801047|FG001|Open-Label Phase|Lost to Follow-up|1|||
33322956|NCT02901041|62699171|FG000|Overall Study|Withdrawal by Subject|7|||
33422985|NCT00607919|62801046|FG000|Open-Label Phase|Protocol Violation|2|||
33422986|NCT00607919|62801047|FG001|Open-Label Phase|Protocol Violation|2|||
33422987|NCT00607919|62801046|FG000|Open-Label Phase|Withdrawal by Subject|2|||
33422988|NCT00607919|62801047|FG001|Open-Label Phase|Withdrawal by Subject|2|||
33422989|NCT00607919|62801046|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
33422990|NCT00607919|62801047|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
33422991|NCT00344968|62801058|FG000|Overall Study|Adverse Event|5|||
33422992|NCT00344968|62801059|FG001|Overall Study|Adverse Event|4|||
33422993|NCT00344968|62801060|FG002|Overall Study|Adverse Event|15|||
33422994|NCT00344968|62801058|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
33422995|NCT00344968|62801059|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33422996|NCT00344968|62801060|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
33422997|NCT00344968|62801058|FG000|Overall Study|Protocol Violation|2|||
33422998|NCT00344968|62801059|FG001|Overall Study|Protocol Violation|2|||
33422999|NCT00344968|62801060|FG002|Overall Study|Protocol Violation|5|||
33423000|NCT00344968|62801058|FG000|Overall Study|Withdrawal by Subject|14|||
33423001|NCT00344968|62801059|FG001|Overall Study|Withdrawal by Subject|31|||
33423002|NCT00344968|62801060|FG002|Overall Study|Withdrawal by Subject|27|||
33423003|NCT00344968|62801058|FG000|Overall Study|Lost to Follow-up|24|||
33423004|NCT00344968|62801059|FG001|Overall Study|Lost to Follow-up|37|||
33423005|NCT00344968|62801060|FG002|Overall Study|Lost to Follow-up|37|||
33423006|NCT00344968|62801058|FG000|Overall Study|Death|11|||
33423007|NCT00344968|62801059|FG001|Overall Study|Death|27|||
33423008|NCT00344968|62801060|FG002|Overall Study|Death|31|||
33423009|NCT00344968|62801058|FG000|Overall Study|Other|0|||
33423010|NCT00344968|62801059|FG001|Overall Study|Other|1|||
33423011|NCT00344968|62801060|FG002|Overall Study|Other|0|||
33423012|NCT00509028|62801071|FG000|Overall Study|Adverse Event|2|||
33423013|NCT00509028|62801072|FG001|Overall Study|Adverse Event|0|||
33423014|NCT00509028|62801071|FG000|Overall Study|Withdrawal by Subject|4|||
33423015|NCT00509028|62801072|FG001|Overall Study|Withdrawal by Subject|3|||
33423016|NCT00509028|62801071|FG000|Overall Study|Lost to Follow-up|0|||
33423017|NCT00509028|62801072|FG001|Overall Study|Lost to Follow-up|1|||
33423018|NCT00509028|62801071|FG000|Overall Study|Protocol Violation|4|||
33423019|NCT00509028|62801072|FG001|Overall Study|Protocol Violation|2|||
33423020|NCT00509028|62801071|FG000|Overall Study|Non-compliance|2|||
33423021|NCT00509028|62801072|FG001|Overall Study|Non-compliance|1|||
33423022|NCT00352846|62801080|FG000|Overall Study|Disease progression|0|||
33423023|NCT00352846|62801081|FG001|Overall Study|Disease progression|2|||
33423024|NCT00352846|62801080|FG000|Overall Study|Withdrawal by Subject|3|||
33423025|NCT00352846|62801081|FG001|Overall Study|Withdrawal by Subject|8|||
33423026|NCT00352846|62801080|FG000|Overall Study|Ineligible|3|||
33423027|NCT00352846|62801081|FG001|Overall Study|Ineligible|2|||
33423028|NCT00352846|62801080|FG000|Overall Study|Non-compliance|2|||
33423029|NCT00352846|62801081|FG001|Overall Study|Non-compliance|0|||
33423030|NCT00352846|62801080|FG000|Overall Study|Death|0|||
33423031|NCT00352846|62801081|FG001|Overall Study|Death|1|||
33423032|NCT00508872|62801087|FG000|Overall Study|Lost to Follow-up|1|||
33423033|NCT00508872|62801087|FG000|Overall Study|Physician Decision|1|||
33423034|NCT00508482|62801094|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
33423035|NCT00508482|62801095|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
33423036|NCT00508482|62801096|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
33423037|NCT00508482|62801094|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
33423038|NCT00508482|62801095|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
33423039|NCT00508482|62801096|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
33423040|NCT00508482|62801094|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
33423041|NCT00508482|62801095|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
33423042|NCT00508482|62801096|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
33423043|NCT00344500|62801107|FG000|Overall Study|Adverse Event|6|||
33423044|NCT00344500|62801108|FG001|Overall Study|Adverse Event|2|||
33423045|NCT00344500|62801109|FG002|Overall Study|Adverse Event|0|||
33423046|NCT00344500|62801107|FG000|Overall Study|Lost to Follow-up|5|||
33423047|NCT00344500|62801108|FG001|Overall Study|Lost to Follow-up|13|||
33423048|NCT00344500|62801109|FG002|Overall Study|Lost to Follow-up|1|||
33423049|NCT00344500|62801107|FG000|Overall Study|Withdrawal by Subject|7|||
33423050|NCT00344500|62801108|FG001|Overall Study|Withdrawal by Subject|10|||
33423051|NCT00344500|62801109|FG002|Overall Study|Withdrawal by Subject|0|||
33423052|NCT00344500|62801107|FG000|Overall Study|Protocol Violation|4|||
33423053|NCT00344500|62801108|FG001|Overall Study|Protocol Violation|7|||
33423054|NCT00344500|62801109|FG002|Overall Study|Protocol Violation|1|||
33423055|NCT00344500|62801107|FG000|Overall Study|Not Noted|1|||
33423056|NCT00344500|62801108|FG001|Overall Study|Not Noted|3|||
33423057|NCT00344500|62801109|FG002|Overall Study|Not Noted|0|||
33423058|NCT00344032|62801118|FG000|Overall Study|Adverse Event|0|||
33423059|NCT00344032|62801119|FG001|Overall Study|Adverse Event|1|||
33423060|NCT00344032|62801118|FG000|Overall Study|Withdrawal by Subject|6|||
33423061|NCT00344032|62801119|FG001|Overall Study|Withdrawal by Subject|2|||
33423062|NCT00344032|62801118|FG000|Overall Study|Lost to Follow-up|4|||
33423063|NCT00344032|62801119|FG001|Overall Study|Lost to Follow-up|6|||
33423064|NCT00344032|62801118|FG000|Overall Study|Physician Decision|4|||
33423065|NCT00344032|62801119|FG001|Overall Study|Physician Decision|1|||
33423066|NCT00607373|62801127|FG000|Treatment Period|Adverse Event|0|||
33423067|NCT00607373|62801128|FG001|Treatment Period|Adverse Event|4|||
33423068|NCT00607373|62801127|FG000|Treatment Period|Physician Decision|0|||
33423069|NCT00607373|62801128|FG001|Treatment Period|Physician Decision|1|||
33423070|NCT00607373|62801127|FG000|Treatment Period|Withdrawal by Subject|0|||
33423071|NCT00607373|62801128|FG001|Treatment Period|Withdrawal by Subject|1|||
33423072|NCT00607373|62801127|FG000|Follow-up Period|Other|0|||
33423073|NCT00607373|62801128|FG001|Follow-up Period|Other|1|||
33423074|NCT00607373|62801127|FG000|Follow-up Period|Protocol Violation|0|||
33423075|NCT00607373|62801128|FG001|Follow-up Period|Protocol Violation|1|||
33423076|NCT00607373|62801127|FG000|Follow-up Period|Withdrawal by Subject|1|||
33423077|NCT00607373|62801128|FG001|Follow-up Period|Withdrawal by Subject|3|||
33423078|NCT00508404|62801134|FG000|Overall Study|Ongoing at Data Cut-off|12|||
33423079|NCT00508404|62801134|FG000|Overall Study|Adverse Event|2|||
33423080|NCT00508404|62801134|FG000|Overall Study|Death|16|||
33423081|NCT00508404|62801134|FG000|Overall Study|Physician Decision|2|||
33423082|NCT00508404|62801134|FG000|Overall Study|Withdrawal by Subject|3|||
33423083|NCT00508404|62801134|FG000|Overall Study|Protocol-specified Criteria|2|||
33423084|NCT00508404|62801134|FG000|Overall Study|Lost to Follow-up|2|||
33423085|NCT00508404|62801134|FG000|Overall Study|Other - Not Specified|3|||
33423086|NCT00352690|62801141|FG000|Overall Study|Determined to be ineligible|2|||
33423087|NCT00352690|62801142|FG001|Overall Study|Determined to be ineligible|0|||
33423088|NCT00609245|62801148|FG000|Overall Study|Adverse Event|1|||
33423089|NCT00343642|62801157|FG000|Overall Study|Lost to Follow-up|0|||
33423090|NCT00343642|62801158|FG001|Overall Study|Lost to Follow-up|1|||
33423091|NCT00343642|62801159|FG002|Overall Study|Lost to Follow-up|0|||
33423092|NCT00343642|62801157|FG000|Overall Study|Pregnancy|1|||
33423093|NCT00343642|62801158|FG001|Overall Study|Pregnancy|0|||
33423094|NCT00343642|62801159|FG002|Overall Study|Pregnancy|2|||
33423095|NCT00343642|62801157|FG000|Overall Study|Withdrawal by Subject|2|||
33423096|NCT00343642|62801158|FG001|Overall Study|Withdrawal by Subject|3|||
33423097|NCT00343642|62801159|FG002|Overall Study|Withdrawal by Subject|4|||
33423098|NCT00343642|62801157|FG000|Overall Study|Adverse Event|0|||
33423099|NCT00343642|62801158|FG001|Overall Study|Adverse Event|0|||
33423100|NCT00343642|62801159|FG002|Overall Study|Adverse Event|1|||
33423101|NCT00343642|62801157|FG000|Overall Study|Flare up|6|||
33423102|NCT00343642|62801158|FG001|Overall Study|Flare up|4|||
33423103|NCT00343642|62801159|FG002|Overall Study|Flare up|0|||
33423104|NCT00609167|62801172|FG000|Overall Study|Withdrawal by Subject|1|||
33423105|NCT00609167|62801173|FG001|Overall Study|Withdrawal by Subject|0|||
33423106|NCT00609167|62801172|FG000|Overall Study|Lack of Efficacy|1|||
33423107|NCT00609167|62801173|FG001|Overall Study|Lack of Efficacy|0|||
33423108|NCT00609167|62801172|FG000|Overall Study|Adverse Event|5|||
33423109|NCT00609167|62801173|FG001|Overall Study|Adverse Event|1|||
33423110|NCT00609167|62801172|FG000|Overall Study|Disease Progression|1|||
33423111|NCT00609167|62801173|FG001|Overall Study|Disease Progression|0|||
33423112|NCT00609167|62801172|FG000|Overall Study|Stem Cell Transplant|0|||
33423113|NCT00609167|62801173|FG001|Overall Study|Stem Cell Transplant|6|||
33423114|NCT00606281|62801181|FG000|Overall Study|Adverse Event|11|||
33423115|NCT00606281|62801182|FG001|Overall Study|Adverse Event|12|||
33423116|NCT00606281|62801181|FG000|Overall Study|Death|1|||
33423117|NCT00606281|62801182|FG001|Overall Study|Death|0|||
33423118|NCT00606281|62801181|FG000|Overall Study|Lack of Efficacy|28|||
33423119|NCT00606281|62801182|FG001|Overall Study|Lack of Efficacy|35|||
33423120|NCT00606281|62801181|FG000|Overall Study|Physician Decision|0|||
33423121|NCT00606281|62801182|FG001|Overall Study|Physician Decision|1|||
33423122|NCT00606281|62801181|FG000|Overall Study|Protocol Violation|3|||
33423123|NCT00606281|62801182|FG001|Overall Study|Protocol Violation|3|||
33423124|NCT00606281|62801181|FG000|Overall Study|Withdrawal by Subject|11|||
33423125|NCT00606281|62801182|FG001|Overall Study|Withdrawal by Subject|13|||
33423126|NCT00606281|62801181|FG000|Overall Study|Progression to depressive phase|1|||
33423127|NCT00606281|62801182|FG001|Overall Study|Progression to depressive phase|1|||
33423128|NCT00606281|62801181|FG000|Overall Study|Change of residence or other commitments|1|||
33423129|NCT00606281|62801182|FG001|Overall Study|Change of residence or other commitments|1|||
33423130|NCT00506142|62801190|FG000|Overall Study|Adverse Event|8|||
33423131|NCT00506142|62801191|FG001|Overall Study|Adverse Event|7|||
33423132|NCT00506142|62801190|FG000|Overall Study|Lack of Efficacy|21|||
33423133|NCT00506142|62801191|FG001|Overall Study|Lack of Efficacy|7|||
33423134|NCT00506142|62801190|FG000|Overall Study|Withdrawal by Subject|4|||
33423135|NCT00506142|62801191|FG001|Overall Study|Withdrawal by Subject|5|||
33423136|NCT00506142|62801190|FG000|Overall Study|Physician Decision|1|||
33423137|NCT00506142|62801191|FG001|Overall Study|Physician Decision|0|||
33423138|NCT00506142|62801190|FG000|Overall Study|New health condition|1|||
33423139|NCT00506142|62801191|FG001|Overall Study|New health condition|0|||
33423140|NCT00514020|62801197|FG000|Overall Study|Adverse Event|6|||
33423141|NCT00514020|62801197|FG000|Overall Study|Withdrawal by Subject|3|||
33423142|NCT00514020|62801197|FG000|Overall Study|Physician Decision|1|||
33423143|NCT00514020|62801197|FG000|Overall Study|disease progression|9|||
33423144|NCT00514020|62801197|FG000|Overall Study|other complicating disease|2|||
33423145|NCT00514020|62801197|FG000|Overall Study|patient went to radiation treatment|1|||
33423146|NCT00514020|62801197|FG000|Overall Study|"patients moved to the no tx group"|6|||
33423147|NCT00513708|62801204|FG000|Overall Study|Lost to Follow-up|4|||
33423148|NCT00513708|62801205|FG001|Overall Study|Lost to Follow-up|4|||
33423149|NCT00513708|62801206|FG002|Overall Study|Lost to Follow-up|4|||
33423150|NCT00513474|62801216|FG000|Overall Study|Death|6|||
33423151|NCT00513474|62801217|FG001|Overall Study|Death|9|||
33423152|NCT00513474|62801216|FG000|Overall Study|Participant Withdrew Consent|1|||
33494138|NCT03486834|62872904|FG002|Overall Study|Adverse Event|0|||
33494139|NCT03486834|62872902|FG000|Overall Study|Lost to Follow-up|41|||
33423153|NCT00513474|62801217|FG001|Overall Study|Participant Withdrew Consent|0|||
33423154|NCT00505752|62801227|FG000|Overall Study|Adverse Event|1|||
33423155|NCT00505752|62801228|FG001|Overall Study|Adverse Event|0|||
33423156|NCT00505752|62801229|FG002|Overall Study|Adverse Event|1|||
33423157|NCT00505752|62801230|FG003|Overall Study|Adverse Event|0|||
33423158|NCT00505752|62801227|FG000|Overall Study|Lost to Follow-up|1|||
33423159|NCT00505752|62801228|FG001|Overall Study|Lost to Follow-up|0|||
33423160|NCT00505752|62801229|FG002|Overall Study|Lost to Follow-up|0|||
33423161|NCT00505752|62801230|FG003|Overall Study|Lost to Follow-up|0|||
33423162|NCT00505752|62801227|FG000|Overall Study|Lack of ovarian response|1|||
33423163|NCT00505752|62801228|FG001|Overall Study|Lack of ovarian response|3|||
33423164|NCT00505752|62801229|FG002|Overall Study|Lack of ovarian response|0|||
33423165|NCT00505752|62801230|FG003|Overall Study|Lack of ovarian response|0|||
33423166|NCT00505752|62801227|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
33423167|NCT00505752|62801228|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
33423168|NCT00505752|62801229|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
33322957|NCT02901041|62699172|FG001|Overall Study|Withdrawal by Subject|3|||
33322958|NCT02547987|62699206|FG000|Overall Study|Withdrawal by Subject|1|||
33423169|NCT00505752|62801230|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
33423170|NCT00505752|62801227|FG000|Overall Study|No oocytes retrieved|0|||
33423171|NCT00505752|62801228|FG001|Overall Study|No oocytes retrieved|2|||
33423172|NCT00505752|62801229|FG002|Overall Study|No oocytes retrieved|0|||
33423173|NCT00505752|62801230|FG003|Overall Study|No oocytes retrieved|1|||
33423174|NCT00505752|62801227|FG000|Overall Study|No Fertilization|1|||
33423175|NCT00505752|62801228|FG001|Overall Study|No Fertilization|1|||
33423176|NCT00505752|62801229|FG002|Overall Study|No Fertilization|2|||
33423177|NCT00505752|62801230|FG003|Overall Study|No Fertilization|1|||
33423178|NCT00505752|62801227|FG000|Overall Study|All embryos/blastocysts discarded|0|||
33423179|NCT00505752|62801228|FG001|Overall Study|All embryos/blastocysts discarded|0|||
33423180|NCT00505752|62801229|FG002|Overall Study|All embryos/blastocysts discarded|1|||
33423181|NCT00505752|62801230|FG003|Overall Study|All embryos/blastocysts discarded|1|||
33423182|NCT00505752|62801227|FG000|Overall Study|Other|1|||
33423183|NCT00505752|62801228|FG001|Overall Study|Other|2|||
33423184|NCT00505752|62801229|FG002|Overall Study|Other|1|||
33423185|NCT00505752|62801230|FG003|Overall Study|Other|2|||
33423186|NCT03601637|62801242|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
33423187|NCT03601637|62801243|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
33423188|NCT03601637|62801242|FG000|Overall Study|Adverse Event|1|||
33423189|NCT03601637|62801243|FG001|Overall Study|Adverse Event|1|||
33423190|NCT03601637|62801242|FG000|Overall Study|Other|0|||
33423191|NCT03601637|62801243|FG001|Overall Study|Other|1|||
33423192|NCT00343252|62801258|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
33423193|NCT00343252|62801259|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
33423194|NCT00343252|62801258|FG000|6 Months (All Treated Participants)|Death|0|||
33423195|NCT00343252|62801259|FG001|6 Months (All Treated Participants)|Death|2|||
33423196|NCT00343252|62801258|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
33423197|NCT00343252|62801259|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
33423198|NCT00343252|62801258|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
33423199|NCT00343252|62801259|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
33423200|NCT00343252|62801258|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
33423201|NCT00343252|62801259|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
33423202|NCT00343252|62801258|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
33423203|NCT00343252|62801259|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
33423204|NCT00343252|62801258|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
33423205|NCT00343252|62801259|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
33423206|NCT00343252|62801258|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
33423207|NCT00343252|62801259|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
33423208|NCT00343252|62801258|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
33423209|NCT00343252|62801259|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
33423210|NCT00343252|62801258|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
33423211|NCT00343252|62801259|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
33423212|NCT00343252|62801258|FG000|12 Months (All Treated Participants)|Death|3|||
33423213|NCT00343252|62801259|FG001|12 Months (All Treated Participants)|Death|3|||
33423214|NCT00343252|62801258|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
33423215|NCT00343252|62801259|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
33423216|NCT00343252|62801258|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
33423217|NCT00343252|62801259|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
33423218|NCT00343252|62801258|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
33322959|NCT02547987|62699206|FG000|Overall Study|Adverse Event|2|||
33423219|NCT00343252|62801259|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
33423220|NCT00343252|62801258|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
33423221|NCT00343252|62801259|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
33423222|NCT00343252|62801258|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
33494140|NCT03486834|62872903|FG001|Overall Study|Lost to Follow-up|24|||
33494141|NCT03486834|62872904|FG002|Overall Study|Lost to Follow-up|39|||
33423223|NCT00343252|62801259|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
33423224|NCT00343252|62801258|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
33423225|NCT00343252|62801259|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
33423226|NCT00343252|62801258|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
33423227|NCT00343252|62801259|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
33423228|NCT00343252|62801258|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
33423229|NCT00343252|62801259|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
33423230|NCT00343252|62801258|FG000|18 Months (All Treated Participants)|Death|4|||
33423231|NCT00343252|62801259|FG001|18 Months (All Treated Participants)|Death|5|||
33423232|NCT00343252|62801258|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
33423233|NCT00343252|62801259|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
33423234|NCT00343252|62801258|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
33423235|NCT00343252|62801259|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
33423236|NCT00343252|62801258|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
33423237|NCT00343252|62801259|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
33423238|NCT00343252|62801258|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
33423239|NCT00343252|62801259|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
33423240|NCT00343252|62801258|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
33423241|NCT00343252|62801259|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
33423242|NCT00343252|62801258|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
33423243|NCT00343252|62801259|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
33423244|NCT00343252|62801258|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
33423245|NCT00343252|62801259|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
33423246|NCT00342628|62801268|FG000|Overall Study|Withdrawal by Subject|19|||
33423247|NCT00342628|62801269|FG001|Overall Study|Withdrawal by Subject|19|||
33423248|NCT00342628|62801270|FG002|Overall Study|Withdrawal by Subject|18|||
33423249|NCT00342628|62801268|FG000|Overall Study|Death|1|||
33423250|NCT00342628|62801269|FG001|Overall Study|Death|1|||
33423251|NCT00342628|62801270|FG002|Overall Study|Death|0|||
33423252|NCT00342628|62801268|FG000|Overall Study|moved residence|0|||
33423253|NCT00342628|62801269|FG001|Overall Study|moved residence|1|||
33423254|NCT00342628|62801270|FG002|Overall Study|moved residence|1|||
33423255|NCT00505284|62801283|FG000|Overall Study|Adverse Event|3|||
33423256|NCT00505284|62801284|FG001|Overall Study|Adverse Event|7|||
33423257|NCT00505284|62801285|FG002|Overall Study|Adverse Event|9|||
33423258|NCT00505284|62801286|FG003|Overall Study|Adverse Event|14|||
33423259|NCT00505284|62801287|FG004|Overall Study|Adverse Event|22|||
33423260|NCT00505284|62801283|FG000|Overall Study|Protocol Violation|0|||
33423261|NCT00505284|62801284|FG001|Overall Study|Protocol Violation|1|||
33423262|NCT00505284|62801285|FG002|Overall Study|Protocol Violation|1|||
33423263|NCT00505284|62801286|FG003|Overall Study|Protocol Violation|0|||
33423264|NCT00505284|62801287|FG004|Overall Study|Protocol Violation|0|||
33423265|NCT00505284|62801283|FG000|Overall Study|Withdrawal by Subject|2|||
33423266|NCT00505284|62801284|FG001|Overall Study|Withdrawal by Subject|6|||
33423267|NCT00505284|62801285|FG002|Overall Study|Withdrawal by Subject|1|||
33423268|NCT00505284|62801286|FG003|Overall Study|Withdrawal by Subject|0|||
33423269|NCT00505284|62801287|FG004|Overall Study|Withdrawal by Subject|6|||
33423270|NCT00505284|62801283|FG000|Overall Study|Lack of Efficacy|0|||
33423271|NCT00505284|62801284|FG001|Overall Study|Lack of Efficacy|1|||
33423272|NCT00505284|62801285|FG002|Overall Study|Lack of Efficacy|1|||
33423273|NCT00505284|62801286|FG003|Overall Study|Lack of Efficacy|1|||
33423274|NCT00505284|62801287|FG004|Overall Study|Lack of Efficacy|1|||
33423275|NCT00505284|62801283|FG000|Overall Study|Physician Decision|0|||
33423276|NCT00505284|62801284|FG001|Overall Study|Physician Decision|1|||
33423277|NCT00505284|62801285|FG002|Overall Study|Physician Decision|0|||
33423278|NCT00505284|62801286|FG003|Overall Study|Physician Decision|0|||
33423279|NCT00505284|62801287|FG004|Overall Study|Physician Decision|0|||
33423280|NCT00505284|62801283|FG000|Overall Study|Other|5|||
33423281|NCT00505284|62801284|FG001|Overall Study|Other|0|||
33423282|NCT00505284|62801285|FG002|Overall Study|Other|0|||
33423283|NCT00505284|62801286|FG003|Overall Study|Other|4|||
33423284|NCT00505284|62801287|FG004|Overall Study|Other|4|||
33423285|NCT00337168|62801299|FG000|Overall Study|Death|5|||
33423286|NCT00337168|62801299|FG000|Overall Study|Not protocol specified|2|||
33423287|NCT00337168|62801299|FG000|Overall Study|Did not start therapy|1|||
33423288|NCT00606905|62801306|FG000|Overall Study|No Pregnancy|9|||
33423289|NCT00606905|62801307|FG001|Overall Study|No Pregnancy|6|||
33423290|NCT00606905|62801306|FG000|Overall Study|Non-Index Pregnancy|1|||
33423291|NCT00606905|62801307|FG001|Overall Study|Non-Index Pregnancy|4|||
33423292|NCT00606905|62801306|FG000|Overall Study|Withdrew|5|||
33423293|NCT00606905|62801307|FG001|Overall Study|Withdrew|5|||
33423294|NCT00606593|62801313|FG000|Overall Study|Adverse Event|0|||
33423295|NCT00606593|62801314|FG001|Overall Study|Adverse Event|0|||
33423296|NCT00606593|62801315|FG002|Overall Study|Adverse Event|0|||
33423297|NCT00606593|62801316|FG003|Overall Study|Adverse Event|1|||
33423298|NCT00606593|62801317|FG004|Overall Study|Adverse Event|1|||
33423299|NCT00606593|62801318|FG005|Overall Study|Adverse Event|0|||
33423300|NCT00606593|62801319|FG006|Overall Study|Adverse Event|1|||
33423301|NCT00606593|62801320|FG007|Overall Study|Adverse Event|2|||
33423302|NCT00606593|62801321|FG008|Overall Study|Adverse Event|1|||
33423303|NCT00606593|62801322|FG009|Overall Study|Adverse Event|0|||
33423304|NCT00606593|62801313|FG000|Overall Study|Withdrawal of consent|1|||
33423305|NCT00606593|62801314|FG001|Overall Study|Withdrawal of consent|0|||
33423306|NCT00606593|62801315|FG002|Overall Study|Withdrawal of consent|1|||
33423307|NCT00606593|62801316|FG003|Overall Study|Withdrawal of consent|0|||
33423308|NCT00606593|62801317|FG004|Overall Study|Withdrawal of consent|0|||
33423309|NCT00606593|62801318|FG005|Overall Study|Withdrawal of consent|0|||
33423310|NCT00606593|62801319|FG006|Overall Study|Withdrawal of consent|0|||
33423311|NCT00606593|62801320|FG007|Overall Study|Withdrawal of consent|0|||
33423312|NCT00606593|62801321|FG008|Overall Study|Withdrawal of consent|0|||
33423313|NCT00606593|62801322|FG009|Overall Study|Withdrawal of consent|0|||
33423314|NCT00606593|62801313|FG000|Overall Study|Administrative/Other|0|||
33423315|NCT00606593|62801314|FG001|Overall Study|Administrative/Other|0|||
33423316|NCT00606593|62801315|FG002|Overall Study|Administrative/Other|1|||
33423317|NCT00606593|62801316|FG003|Overall Study|Administrative/Other|0|||
33423318|NCT00606593|62801317|FG004|Overall Study|Administrative/Other|0|||
33423319|NCT00606593|62801318|FG005|Overall Study|Administrative/Other|0|||
33423320|NCT00606593|62801319|FG006|Overall Study|Administrative/Other|0|||
33423321|NCT00606593|62801320|FG007|Overall Study|Administrative/Other|0|||
33423322|NCT00606593|62801321|FG008|Overall Study|Administrative/Other|0|||
33423323|NCT00606593|62801322|FG009|Overall Study|Administrative/Other|0|||
33423324|NCT00605267|62801337|FG000|Overall Study|Adverse Event|0|||
33423325|NCT00605267|62801338|FG001|Overall Study|Adverse Event|1|||
33423326|NCT00605267|62801337|FG000|Overall Study|Lack of Efficacy|1|||
33423327|NCT00605267|62801338|FG001|Overall Study|Lack of Efficacy|5|||
33423328|NCT00605267|62801337|FG000|Overall Study|Withdrawal by Subject|2|||
33423329|NCT00605267|62801338|FG001|Overall Study|Withdrawal by Subject|3|||
33423330|NCT00605813|62801344|FG000|Overall Study|Protocol Violation|25|||
33423331|NCT00604721|62801357|FG000|Overall Study|Physician Decision|1|||
33423332|NCT00604721|62801357|FG000|Overall Study|Withdrawal by Subject|1|||
33423333|NCT00605657|62801362|FG000|Overall Study|Adverse Event|1|||
33423334|NCT00605657|62801362|FG000|Overall Study|Protocol Violation|1|||
33423335|NCT00604565|62801368|FG000|Overall Study|Study terminated|0|||
33423336|NCT00604565|62801369|FG001|Overall Study|Study terminated|3|||
33423337|NCT00605345|62801377|FG000|Overall Study|Withdrawal by Subject|1|||
33423338|NCT00605345|62801378|FG001|Overall Study|Withdrawal by Subject|0|||
33423339|NCT00605345|62801377|FG000|Overall Study|Adverse Event|0|||
33423340|NCT00605345|62801378|FG001|Overall Study|Adverse Event|1|||
33423341|NCT00605345|62801377|FG000|Overall Study|Protocol Violation|0|||
33423342|NCT00605345|62801378|FG001|Overall Study|Protocol Violation|2|||
33423343|NCT00604175|62801387|FG000|Entry Through Week 28|Death|2|||
33423344|NCT00604175|62801388|FG001|Entry Through Week 28|Death|0|||
33423345|NCT00604175|62801389|FG002|Entry Through Week 28|Death|0|||
33423346|NCT00604175|62801387|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
33423347|NCT00604175|62801388|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
33423348|NCT00604175|62801389|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
33423349|NCT00604175|62801387|FG000|Entry Through Week 28|Lost to Follow-up|4|||
33423350|NCT00604175|62801388|FG001|Entry Through Week 28|Lost to Follow-up|3|||
33423351|NCT00604175|62801389|FG002|Entry Through Week 28|Lost to Follow-up|0|||
33423352|NCT00604175|62801387|FG000|Entry Through Week 28|Ineligible|1|||
33423353|NCT00604175|62801388|FG001|Entry Through Week 28|Ineligible|0|||
33423354|NCT00604175|62801389|FG002|Entry Through Week 28|Ineligible|0|||
33423355|NCT00604175|62801387|FG000|Entry Through Week 28|Did not start intervention|2|||
33423356|NCT00604175|62801388|FG001|Entry Through Week 28|Did not start intervention|0|||
33423357|NCT00604175|62801389|FG002|Entry Through Week 28|Did not start intervention|1|||
33423358|NCT00604175|62801387|FG000|Week 29 Through Week 72|Death|0|||
33423359|NCT00604175|62801388|FG001|Week 29 Through Week 72|Death|0|||
33423360|NCT00604175|62801389|FG002|Week 29 Through Week 72|Death|1|||
33423361|NCT00604175|62801387|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
33423362|NCT00604175|62801388|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
33423363|NCT00604175|62801389|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
33423364|NCT00604175|62801387|FG000|Week 29 Through Week 72|Site closure|0|||
33423365|NCT00604175|62801388|FG001|Week 29 Through Week 72|Site closure|1|||
33423366|NCT00604175|62801389|FG002|Week 29 Through Week 72|Site closure|0|||
33423367|NCT00604175|62801387|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
33423368|NCT00604175|62801388|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
33423369|NCT00604175|62801389|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
33423370|NCT00605189|62801424|FG000|Overall Study|Adverse Event|1|||
33423371|NCT00605189|62801425|FG001|Overall Study|Adverse Event|0|||
33423372|NCT00605189|62801426|FG002|Overall Study|Adverse Event|0|||
33423373|NCT00605189|62801424|FG000|Overall Study|Other|2|||
33423374|NCT00605189|62801425|FG001|Overall Study|Other|2|||
33423375|NCT00605189|62801426|FG002|Overall Study|Other|0|||
33423376|NCT00340834|62801439|FG000|Core Phase of Study|Adverse Event|26|||
33423377|NCT00340834|62801440|FG001|Core Phase of Study|Adverse Event|9|||
33423378|NCT00340834|62801441|FG002|Core Phase of Study|Adverse Event|9|||
33423379|NCT00340834|62801442|FG003|Core Phase of Study|Adverse Event|0|||
33423380|NCT00340834|62801443|FG004|Core Phase of Study|Adverse Event|0|||
33423381|NCT00340834|62801439|FG000|Core Phase of Study|Withdrawal by Subject|11|||
33423382|NCT00340834|62801440|FG001|Core Phase of Study|Withdrawal by Subject|9|||
33423383|NCT00340834|62801441|FG002|Core Phase of Study|Withdrawal by Subject|16|||
33423384|NCT00340834|62801442|FG003|Core Phase of Study|Withdrawal by Subject|0|||
33423385|NCT00340834|62801443|FG004|Core Phase of Study|Withdrawal by Subject|0|||
33423386|NCT00340834|62801439|FG000|Core Phase of Study|Administrative Problems|6|||
33423387|NCT00340834|62801440|FG001|Core Phase of Study|Administrative Problems|2|||
33423388|NCT00340834|62801441|FG002|Core Phase of Study|Administrative Problems|7|||
33423389|NCT00340834|62801442|FG003|Core Phase of Study|Administrative Problems|0|||
33423390|NCT00340834|62801443|FG004|Core Phase of Study|Administrative Problems|0|||
33423391|NCT00340834|62801439|FG000|Core Phase of Study|Lack of Efficacy|3|||
33423392|NCT00340834|62801440|FG001|Core Phase of Study|Lack of Efficacy|3|||
33423393|NCT00340834|62801441|FG002|Core Phase of Study|Lack of Efficacy|7|||
33423394|NCT00340834|62801442|FG003|Core Phase of Study|Lack of Efficacy|0|||
33423395|NCT00340834|62801443|FG004|Core Phase of Study|Lack of Efficacy|0|||
33423396|NCT00340834|62801439|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
33423397|NCT00340834|62801440|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
33423398|NCT00340834|62801441|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
33423399|NCT00340834|62801442|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
33423400|NCT00340834|62801443|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
33423401|NCT00340834|62801439|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
33423402|NCT00340834|62801440|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
33423403|NCT00340834|62801441|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
33423404|NCT00340834|62801442|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
33423405|NCT00340834|62801443|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
33423406|NCT00340834|62801439|FG000|Core Phase of Study|Lost to Follow-up|1|||
33423407|NCT00340834|62801440|FG001|Core Phase of Study|Lost to Follow-up|1|||
33423408|NCT00340834|62801441|FG002|Core Phase of Study|Lost to Follow-up|4|||
33423409|NCT00340834|62801442|FG003|Core Phase of Study|Lost to Follow-up|0|||
33423410|NCT00340834|62801443|FG004|Core Phase of Study|Lost to Follow-up|0|||
33423411|NCT00340834|62801439|FG000|Core Phase of Study|Death|2|||
33423412|NCT00340834|62801440|FG001|Core Phase of Study|Death|0|||
33423413|NCT00340834|62801441|FG002|Core Phase of Study|Death|0|||
33423414|NCT00340834|62801442|FG003|Core Phase of Study|Death|0|||
33423415|NCT00340834|62801443|FG004|Core Phase of Study|Death|0|||
33423416|NCT00340834|62801439|FG000|Core Phase of Study|Protocol Violation|0|||
33423417|NCT00340834|62801440|FG001|Core Phase of Study|Protocol Violation|0|||
33423418|NCT00340834|62801441|FG002|Core Phase of Study|Protocol Violation|2|||
33423419|NCT00340834|62801442|FG003|Core Phase of Study|Protocol Violation|0|||
33423420|NCT00340834|62801443|FG004|Core Phase of Study|Protocol Violation|0|||
33423421|NCT00340834|62801439|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
33423422|NCT00340834|62801440|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
33423423|NCT00340834|62801441|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
33423424|NCT00340834|62801442|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
33423425|NCT00340834|62801443|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
33423426|NCT00340834|62801439|FG000|Extension Phase of Study|Subject withdrew consent|26|||
33423427|NCT00340834|62801440|FG001|Extension Phase of Study|Subject withdrew consent|31|||
33494142|NCT03486834|62872902|FG000|Overall Study|Non-compliance with Study Drug|2|||
33605295|NCT02392481|63005013|FG002|Overall Study|Adverse Event|1|||
33322960|NCT02513199|62699210|FG000|Treatment|Death|1|||
33423428|NCT00340834|62801441|FG002|Extension Phase of Study|Subject withdrew consent|0|||
33423429|NCT00340834|62801442|FG003|Extension Phase of Study|Subject withdrew consent|12|||
33423430|NCT00340834|62801443|FG004|Extension Phase of Study|Subject withdrew consent|15|||
33423431|NCT00340834|62801439|FG000|Extension Phase of Study|Adverse Event|21|||
33423432|NCT00340834|62801440|FG001|Extension Phase of Study|Adverse Event|22|||
33423433|NCT00340834|62801441|FG002|Extension Phase of Study|Adverse Event|0|||
33423434|NCT00340834|62801442|FG003|Extension Phase of Study|Adverse Event|19|||
33423435|NCT00340834|62801443|FG004|Extension Phase of Study|Adverse Event|7|||
33423436|NCT00340834|62801439|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
33423437|NCT00340834|62801440|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
33423438|NCT00340834|62801441|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
33423439|NCT00340834|62801442|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
33423440|NCT00340834|62801443|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
33423441|NCT00340834|62801439|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
33423442|NCT00340834|62801440|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
33423443|NCT00340834|62801441|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
33423444|NCT00340834|62801442|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
33423445|NCT00340834|62801443|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
33423446|NCT00340834|62801439|FG000|Extension Phase of Study|Lost to Follow-up|1|||
33423447|NCT00340834|62801440|FG001|Extension Phase of Study|Lost to Follow-up|1|||
33423448|NCT00340834|62801441|FG002|Extension Phase of Study|Lost to Follow-up|0|||
33423449|NCT00340834|62801442|FG003|Extension Phase of Study|Lost to Follow-up|2|||
33423450|NCT00340834|62801443|FG004|Extension Phase of Study|Lost to Follow-up|3|||
33423451|NCT00340834|62801439|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
33423452|NCT00340834|62801440|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
33423453|NCT00340834|62801441|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
33423454|NCT00340834|62801442|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
33423455|NCT00340834|62801443|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
33423456|NCT00340834|62801439|FG000|Extension Phase of Study|Administrative problems|3|||
33423457|NCT00340834|62801440|FG001|Extension Phase of Study|Administrative problems|0|||
33423458|NCT00340834|62801441|FG002|Extension Phase of Study|Administrative problems|0|||
33423459|NCT00340834|62801442|FG003|Extension Phase of Study|Administrative problems|1|||
33423460|NCT00340834|62801443|FG004|Extension Phase of Study|Administrative problems|1|||
33423461|NCT00340834|62801439|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
33423462|NCT00340834|62801440|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
33423463|NCT00340834|62801441|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
33423464|NCT00340834|62801442|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
33423465|NCT00340834|62801443|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
33423466|NCT00340834|62801439|FG000|Extension Phase of Study|Protocol Violation|3|||
33423467|NCT00340834|62801440|FG001|Extension Phase of Study|Protocol Violation|0|||
33423468|NCT00340834|62801441|FG002|Extension Phase of Study|Protocol Violation|0|||
33423469|NCT00340834|62801442|FG003|Extension Phase of Study|Protocol Violation|0|||
33423470|NCT00340834|62801443|FG004|Extension Phase of Study|Protocol Violation|0|||
33423471|NCT00340834|62801439|FG000|Extension Phase of Study|Death|0|||
33423472|NCT00340834|62801440|FG001|Extension Phase of Study|Death|0|||
33423473|NCT00340834|62801441|FG002|Extension Phase of Study|Death|0|||
33423474|NCT00340834|62801442|FG003|Extension Phase of Study|Death|0|||
33423475|NCT00340834|62801443|FG004|Extension Phase of Study|Death|1|||
33423476|NCT00603941|62801456|FG000|Overall Study|Disease progression|6|||
33423477|NCT00603941|62801457|FG001|Overall Study|Disease progression|7|||
33423478|NCT00603941|62801458|FG002|Overall Study|Disease progression|1|||
33423479|NCT00603941|62801456|FG000|Overall Study|Adverse Event|1|||
33423480|NCT00603941|62801457|FG001|Overall Study|Adverse Event|0|||
33423481|NCT00603941|62801458|FG002|Overall Study|Adverse Event|1|||
33423482|NCT00603941|62801456|FG000|Overall Study|Physician Decision|0|||
33423483|NCT00603941|62801457|FG001|Overall Study|Physician Decision|1|||
33423484|NCT00603941|62801458|FG002|Overall Study|Physician Decision|0|||
33423485|NCT00603941|62801456|FG000|Overall Study|Withdrawal by Subject|0|||
33423486|NCT00603941|62801457|FG001|Overall Study|Withdrawal by Subject|2|||
33423487|NCT00603941|62801458|FG002|Overall Study|Withdrawal by Subject|0|||
33423488|NCT00340678|62801471|FG000|Overall Study|Lost to Follow-up|1|||
33423489|NCT00340678|62801472|FG001|Overall Study|Lost to Follow-up|0|||
33423490|NCT00340678|62801473|FG002|Overall Study|Lost to Follow-up|0|||
33423491|NCT00340678|62801474|FG003|Overall Study|Lost to Follow-up|0|||
33423492|NCT00336544|62801484|FG000|Overall Study|Lack of Efficacy|8|||
33423493|NCT00336544|62801485|FG001|Overall Study|Lack of Efficacy|5|||
33423494|NCT00336544|62801484|FG000|Overall Study|Adverse Event|4|||
33423495|NCT00336544|62801485|FG001|Overall Study|Adverse Event|9|||
33423496|NCT00336544|62801484|FG000|Overall Study|Withdrawal by Subject|4|||
33423497|NCT00336544|62801485|FG001|Overall Study|Withdrawal by Subject|3|||
33423498|NCT00336544|62801484|FG000|Overall Study|Other|3|||
33423499|NCT00336544|62801485|FG001|Overall Study|Other|5|||
33423500|NCT00605033|62801493|FG000|Overall Study|Adverse Event|2|||
33423501|NCT00605033|62801494|FG001|Overall Study|Adverse Event|2|||
33423502|NCT00605033|62801493|FG000|Overall Study|Lost to Follow-up|1|||
33423503|NCT00605033|62801494|FG001|Overall Study|Lost to Follow-up|1|||
33423504|NCT00605033|62801493|FG000|Overall Study|Withdrawal by Subject|3|||
33423505|NCT00605033|62801494|FG001|Overall Study|Withdrawal by Subject|4|||
33423506|NCT00605033|62801493|FG000|Overall Study|Protocol Violation|1|||
33423507|NCT00605033|62801494|FG001|Overall Study|Protocol Violation|1|||
33423508|NCT00339040|62801502|FG000|Stage I|Not able to attend clinic|1|||
33423509|NCT00339040|62801503|FG001|Stage I|Not able to attend clinic|0|||
33423510|NCT00339040|62801502|FG000|Stage I|Protocol Violation|1|||
33423511|NCT00339040|62801503|FG001|Stage I|Protocol Violation|1|||
33423512|NCT00339040|62801502|FG000|Stage II|Lost to Follow-up|3|||
33423513|NCT00339040|62801503|FG001|Stage II|Lost to Follow-up|0|||
33423514|NCT00339040|62801502|FG000|Stage II|Withdrawal by Subject|1|||
33423515|NCT00339040|62801503|FG001|Stage II|Withdrawal by Subject|2|||
33423516|NCT00339040|62801502|FG000|Stage II|Protocol Violation|3|||
33423517|NCT00339040|62801503|FG001|Stage II|Protocol Violation|0|||
33423518|NCT00339040|62801502|FG000|Stage II|Not able to attend clinic|1|||
33423519|NCT00339040|62801503|FG001|Stage II|Not able to attend clinic|0|||
33423520|NCT00339040|62801502|FG000|Stage II|Site closing|2|||
33423521|NCT00339040|62801503|FG001|Stage II|Site closing|0|||
33423522|NCT00338962|62801513|FG000|Overall Study|Lost to Follow-up|3|||
33423523|NCT00338962|62801514|FG001|Overall Study|Lost to Follow-up|3|||
33423524|NCT00338962|62801515|FG002|Overall Study|Lost to Follow-up|2|||
33423525|NCT00338962|62801516|FG003|Overall Study|Lost to Follow-up|3|||
33423526|NCT00338962|62801513|FG000|Overall Study|Withdrawal by Subject|1|||
33423527|NCT00338962|62801514|FG001|Overall Study|Withdrawal by Subject|0|||
33423528|NCT00338962|62801515|FG002|Overall Study|Withdrawal by Subject|0|||
33423529|NCT00338962|62801516|FG003|Overall Study|Withdrawal by Subject|0|||
33423530|NCT00338962|62801513|FG000|Overall Study|No Transportation|2|||
33423531|NCT00338962|62801514|FG001|Overall Study|No Transportation|0|||
33423532|NCT00338962|62801515|FG002|Overall Study|No Transportation|0|||
33423533|NCT00338962|62801516|FG003|Overall Study|No Transportation|0|||
33423534|NCT00338962|62801513|FG000|Overall Study|Time Constraint|2|||
33423535|NCT00338962|62801514|FG001|Overall Study|Time Constraint|0|||
33423536|NCT00338962|62801515|FG002|Overall Study|Time Constraint|0|||
33423537|NCT00338962|62801516|FG003|Overall Study|Time Constraint|0|||
33423538|NCT00338962|62801513|FG000|Overall Study|Moved|0|||
33423539|NCT00338962|62801514|FG001|Overall Study|Moved|1|||
33423540|NCT00338962|62801515|FG002|Overall Study|Moved|0|||
33423541|NCT00338962|62801516|FG003|Overall Study|Moved|0|||
33423542|NCT00338962|62801513|FG000|Overall Study|Adverse Event|0|||
33423543|NCT00338962|62801514|FG001|Overall Study|Adverse Event|0|||
33423544|NCT00338962|62801515|FG002|Overall Study|Adverse Event|2|||
33423545|NCT00338962|62801516|FG003|Overall Study|Adverse Event|0|||
33423546|NCT00338962|62801513|FG000|Overall Study|Poor Compliance|0|||
33423547|NCT00338962|62801514|FG001|Overall Study|Poor Compliance|0|||
33423548|NCT00338962|62801515|FG002|Overall Study|Poor Compliance|2|||
33423549|NCT00338962|62801516|FG003|Overall Study|Poor Compliance|0|||
33423550|NCT00568061|62801528|FG000|Overall Study|Inclusion / exclusion criteria|5|||
33423551|NCT00568061|62801529|FG001|Overall Study|Inclusion / exclusion criteria|1|||
33423552|NCT00568061|62801528|FG000|Overall Study|Adverse Event|0|||
33423553|NCT00568061|62801529|FG001|Overall Study|Adverse Event|1|||
33423554|NCT00338884|62801536|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
33423555|NCT00338884|62801536|FG000|Overall Study|Adverse Event|14|||
33423556|NCT00338884|62801536|FG000|Overall Study|Death|8|||
33423557|NCT00338884|62801536|FG000|Overall Study|Other|4|||
33423558|NCT00338884|62801536|FG000|Overall Study|Global Deterioration of Health Status|3|||
33423559|NCT00338884|62801536|FG000|Overall Study|Withdrawal by Subject|3|||
33423560|NCT00338884|62801536|FG000|Overall Study|Lost to Follow-up|1|||
33423561|NCT00338884|62801536|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
33423562|NCT00338806|62801542|FG000|Acute Phase|Withdrawal by Subject|0|||
33423563|NCT00338806|62801543|FG001|Acute Phase|Withdrawal by Subject|1|||
33423564|NCT00338806|62801542|FG000|Follow-up|Lost to Follow-up|1|||
33423565|NCT00338806|62801543|FG001|Follow-up|Lost to Follow-up|3|||
33423566|NCT03038100|62801553|FG000|Overall Study|Death|289|||
33423567|NCT03038100|62801554|FG001|Overall Study|Death|272|||
33423568|NCT03038100|62801553|FG000|Overall Study|Lost to Follow-up|9|||
33423569|NCT03038100|62801554|FG001|Overall Study|Lost to Follow-up|10|||
33322961|NCT02513199|62699210|FG000|Treatment|Lost to Follow-up|1|||
33423570|NCT03038100|62801553|FG000|Overall Study|Protocol Deviation|1|||
33423571|NCT03038100|62801554|FG001|Overall Study|Protocol Deviation|4|||
33423572|NCT03038100|62801553|FG000|Overall Study|Withdrawal by Subject|45|||
33423573|NCT03038100|62801554|FG001|Overall Study|Withdrawal by Subject|51|||
33423574|NCT03038100|62801553|FG000|Overall Study|Study Terminated By Sponsor|305|||
33423575|NCT03038100|62801554|FG001|Overall Study|Study Terminated By Sponsor|311|||
33423576|NCT03038100|62801553|FG000|Overall Study|Physician Decision|1|||
33423577|NCT03038100|62801554|FG001|Overall Study|Physician Decision|3|||
33322962|NCT02513199|62699210|FG000|Follow-Up|Death|11|||
33322963|NCT02097134|62699215|FG000|Overall Study|Physician Decision|4|||
33423578|NCT00338728|62801561|FG000|Overall Study|Screen Failure|14|||
33423579|NCT00336856|62801565|FG000|Overall Study|Withdrawal by Subject|3|||
33423580|NCT00336856|62801565|FG000|Overall Study|Found ineligible at time of analysis|1|||
33423581|NCT00566501|62801571|FG000|Overall Study|Adverse Event|68|||
33423582|NCT00566501|62801572|FG001|Overall Study|Adverse Event|59|||
33423583|NCT00566501|62801571|FG000|Overall Study|Medication Non-compliance|5|||
33423584|NCT00566501|62801572|FG001|Overall Study|Medication Non-compliance|0|||
33423585|NCT00566501|62801571|FG000|Overall Study|Protocol Violation|2|||
33423586|NCT00566501|62801572|FG001|Overall Study|Protocol Violation|2|||
33423587|NCT00566501|62801571|FG000|Overall Study|Request of Investigator or Sponsor|6|||
33423588|NCT00566501|62801572|FG001|Overall Study|Request of Investigator or Sponsor|7|||
33423589|NCT00566501|62801571|FG000|Overall Study|Withdrawal by Subject|33|||
33423590|NCT00566501|62801572|FG001|Overall Study|Withdrawal by Subject|30|||
33423591|NCT00566501|62801571|FG000|Overall Study|Lack of Efficacy|8|||
33423592|NCT00566501|62801572|FG001|Overall Study|Lack of Efficacy|3|||
33423593|NCT00566501|62801571|FG000|Overall Study|Other|25|||
33423594|NCT00566501|62801572|FG001|Overall Study|Other|21|||
33423595|NCT00504894|62801581|FG000|Overall Study|fMRI technical problems|1|||
33423596|NCT00504894|62801582|FG001|Overall Study|fMRI technical problems|1|||
33423597|NCT00504894|62801583|FG002|Overall Study|fMRI technical problems|0|||
33423598|NCT00504894|62801581|FG000|Overall Study|Withdrawal by Subject|0|||
33423599|NCT00504894|62801582|FG001|Overall Study|Withdrawal by Subject|1|||
33423600|NCT00504894|62801583|FG002|Overall Study|Withdrawal by Subject|0|||
33423601|NCT00504894|62801581|FG000|Overall Study|Infusion technical problems|0|||
33423602|NCT00504894|62801582|FG001|Overall Study|Infusion technical problems|1|||
33423603|NCT00504894|62801583|FG002|Overall Study|Infusion technical problems|0|||
33423604|NCT00504894|62801581|FG000|Overall Study|poor subject data|2|||
33423605|NCT00504894|62801582|FG001|Overall Study|poor subject data|0|||
33423606|NCT00504894|62801583|FG002|Overall Study|poor subject data|0|||
33423607|NCT00513240|62801593|FG000|Overall Study|Did not have intended surgery|3|||
33423608|NCT00513240|62801594|FG001|Overall Study|Did not have intended surgery|0|||
33423609|NCT00513240|62801593|FG000|Overall Study|Death|3|||
33423610|NCT00513240|62801594|FG001|Overall Study|Death|3|||
33423611|NCT00513240|62801593|FG000|Overall Study|Withdrawal by Subject|7|||
33423612|NCT00513240|62801594|FG001|Overall Study|Withdrawal by Subject|4|||
33423613|NCT00504426|62801607|FG000|Overall Study|Adverse Event|0|||
33423614|NCT00504426|62801608|FG001|Overall Study|Adverse Event|0|||
33423615|NCT00504426|62801609|FG002|Overall Study|Adverse Event|2|||
33423616|NCT00504426|62801610|FG003|Overall Study|Adverse Event|0|||
33423617|NCT00504426|62801607|FG000|Overall Study|Protocol Violation|1|||
33423618|NCT00504426|62801608|FG001|Overall Study|Protocol Violation|1|||
33423619|NCT00504426|62801609|FG002|Overall Study|Protocol Violation|2|||
33423620|NCT00504426|62801610|FG003|Overall Study|Protocol Violation|0|||
33423621|NCT00504426|62801607|FG000|Overall Study|Withdrawal by Subject|2|||
33423622|NCT00504426|62801608|FG001|Overall Study|Withdrawal by Subject|0|||
33423623|NCT00504426|62801609|FG002|Overall Study|Withdrawal by Subject|0|||
33423624|NCT00504426|62801610|FG003|Overall Study|Withdrawal by Subject|0|||
33423625|NCT00504348|62801623|FG000|Overall Study|Adverse Event|3|||
33423626|NCT00504348|62801623|FG000|Overall Study|Lack of Efficacy|4|||
33423627|NCT00504348|62801623|FG000|Overall Study|Physician Decision|1|||
33423628|NCT00507546|62801629|FG000|Overall Study|Withdrawal by Subject|1|||
33423629|NCT00507546|62801630|FG001|Overall Study|Withdrawal by Subject|0|||
33423630|NCT00507546|62801629|FG000|Overall Study|Protocol Violation|1|||
33423631|NCT00507546|62801630|FG001|Overall Study|Protocol Violation|0|||
33423632|NCT00507546|62801629|FG000|Overall Study|Physician Decision|0|||
33423633|NCT00507546|62801630|FG001|Overall Study|Physician Decision|1|||
33423634|NCT00567593|62801638|FG000|Overall Study|Adverse Event|1|||
33423635|NCT00567593|62801638|FG000|Overall Study|Physician Decision|1|||
33423636|NCT00335764|62801647|FG000|Overall Study|wrong histology|1|||
33423637|NCT00335764|62801648|FG001|Overall Study|wrong histology|0|||
33423638|NCT00335764|62801649|FG002|Overall Study|wrong histology|0|||
33423639|NCT00335764|62801650|FG003|Overall Study|wrong histology|0|||
33423640|NCT00335764|62801651|FG004|Overall Study|wrong histology|1|||
33423641|NCT00567359|62801687|FG000|Overall Study|Withdrawal by Subject|1|||
33423642|NCT00492726|62801693|FG000|Overall Study|Adverse Event|10|||
33423643|NCT00492726|62801694|FG001|Overall Study|Adverse Event|6|||
33423644|NCT00492726|62801693|FG000|Overall Study|Death|7|||
33423645|NCT00492726|62801694|FG001|Overall Study|Death|2|||
33423646|NCT00492726|62801693|FG000|Overall Study|Lack of Efficacy|0|||
33423647|NCT00492726|62801694|FG001|Overall Study|Lack of Efficacy|2|||
33423648|NCT00492726|62801693|FG000|Overall Study|Lost to Follow-up|27|||
33423649|NCT00492726|62801694|FG001|Overall Study|Lost to Follow-up|19|||
33423650|NCT00492726|62801693|FG000|Overall Study|Physician Decision|0|||
33423651|NCT00492726|62801694|FG001|Overall Study|Physician Decision|1|||
33423652|NCT00492726|62801693|FG000|Overall Study|Withdrawal by Subject|6|||
33423653|NCT00492726|62801694|FG001|Overall Study|Withdrawal by Subject|3|||
33423654|NCT00492726|62801693|FG000|Overall Study|Non compliant with study medication|0|||
33423655|NCT00492726|62801694|FG001|Overall Study|Non compliant with study medication|3|||
33423656|NCT00309946|62801700|FG000|Overall Study|Withdrawal by Subject|1|||
33423657|NCT00492648|62801706|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
33423658|NCT00492648|62801707|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
33423659|NCT00506922|62801718|FG000|Overall Study|Physician Decision|0|||
33423660|NCT00506922|62801719|FG001|Overall Study|Physician Decision|0|||
33423661|NCT00506922|62801720|FG002|Overall Study|Physician Decision|0|||
33423662|NCT00506922|62801721|FG003|Overall Study|Physician Decision|2|||
33423663|NCT00506922|62801722|FG004|Overall Study|Physician Decision|0|||
33423664|NCT00506922|62801718|FG000|Overall Study|Withdrawal by Subject|0|||
33423665|NCT00506922|62801719|FG001|Overall Study|Withdrawal by Subject|0|||
33423666|NCT00506922|62801720|FG002|Overall Study|Withdrawal by Subject|0|||
33423667|NCT00506922|62801721|FG003|Overall Study|Withdrawal by Subject|0|||
33423668|NCT00506922|62801722|FG004|Overall Study|Withdrawal by Subject|1|||
33423669|NCT00492024|62801732|FG000|Treatment|Adverse Event|3|||
33423670|NCT00492024|62801733|FG001|Treatment|Adverse Event|1|||
33423671|NCT00492024|62801732|FG000|Treatment|Lack of Efficacy|21|||
33423672|NCT00492024|62801733|FG001|Treatment|Lack of Efficacy|20|||
33423673|NCT00492024|62801732|FG000|Treatment|Lost to Follow-up|3|||
33423674|NCT00492024|62801733|FG001|Treatment|Lost to Follow-up|1|||
33423675|NCT00492024|62801732|FG000|Treatment|Withdrawal by Subject|2|||
33423676|NCT00492024|62801733|FG001|Treatment|Withdrawal by Subject|0|||
33423677|NCT00492024|62801732|FG000|Follow up|Lack of Efficacy|0|||
33423678|NCT00492024|62801733|FG001|Follow up|Lack of Efficacy|1|||
33423679|NCT00492024|62801732|FG000|Follow up|Lost to Follow-up|1|||
33423680|NCT00492024|62801733|FG001|Follow up|Lost to Follow-up|1|||
33423681|NCT00491556|62801741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
33423682|NCT00491556|62801742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
33423683|NCT00491556|62801741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
33423684|NCT00491556|62801742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
33423685|NCT00491556|62801741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
33423686|NCT00491556|62801742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
33423687|NCT00491556|62801741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
33423688|NCT00491556|62801742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
33423689|NCT00491556|62801741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
33423690|NCT00491556|62801742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
33423691|NCT00491556|62801741|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
33423692|NCT00491556|62801742|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
33423693|NCT00491556|62801741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
33423694|NCT00491556|62801742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
33423695|NCT00491556|62801741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
33605296|NCT02392481|63005014|FG003|Overall Study|Adverse Event|2|||
33423696|NCT00491556|62801742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
33423697|NCT00491556|62801741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
33423698|NCT00491556|62801742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
33423699|NCT00491556|62801741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
33423700|NCT00491556|62801742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
33423701|NCT00491556|62801741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
33423702|NCT00491556|62801742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
33423703|NCT00491556|62801741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
33423704|NCT00491556|62801742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
33423705|NCT00491556|62801741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
33423706|NCT00491556|62801742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
33423707|NCT00491556|62801741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
33423708|NCT00491556|62801742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
33423709|NCT00491556|62801741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
33423710|NCT00491556|62801742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
33423711|NCT00491556|62801741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
33423712|NCT00491556|62801742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
33423713|NCT00491556|62801741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
33423714|NCT00491556|62801742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
33423715|NCT00491556|62801741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
33423716|NCT00491556|62801742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
33423717|NCT00491556|62801741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
33423718|NCT00491556|62801742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
33423719|NCT00491556|62801741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
33423720|NCT00491556|62801742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
33423721|NCT00506454|62801750|FG000|Overall Study|Withdrawal by Subject|1|||
33423722|NCT00506454|62801751|FG001|Overall Study|Withdrawal by Subject|1|||
33423723|NCT00485472|62801759|FG000|Overall Study|Adverse Event|8|||
33423724|NCT00485472|62801760|FG001|Overall Study|Adverse Event|5|||
33423725|NCT00485472|62801759|FG000|Overall Study|Lack of Efficacy|5|||
33423726|NCT00485472|62801760|FG001|Overall Study|Lack of Efficacy|4|||
33423727|NCT00485472|62801759|FG000|Overall Study|Withdrawal by Subject|1|||
33423728|NCT00485472|62801760|FG001|Overall Study|Withdrawal by Subject|0|||
33423729|NCT00485472|62801759|FG000|Overall Study|Protocol Violation|0|||
33423730|NCT00485472|62801760|FG001|Overall Study|Protocol Violation|1|||
33423731|NCT00485472|62801759|FG000|Overall Study|Other|2|||
33423732|NCT00485472|62801760|FG001|Overall Study|Other|1|||
33423733|NCT00485472|62801759|FG000|Overall Study|Lost to Follow-up|0|||
33423734|NCT00485472|62801760|FG001|Overall Study|Lost to Follow-up|1|||
33423735|NCT00491400|62801768|FG000|Overall Study|Withdrawal by Subject|5|||
33423736|NCT00491400|62801769|FG001|Overall Study|Withdrawal by Subject|4|||
33423737|NCT00491322|62801779|FG000|Overall Study|Protocol Violation|1|||
33423738|NCT00491322|62801780|FG001|Overall Study|Protocol Violation|0|||
33423739|NCT00491322|62801779|FG000|Overall Study|Pregnancy|0|||
33423740|NCT00491322|62801780|FG001|Overall Study|Pregnancy|1|||
33423741|NCT00502320|62801788|FG000|Overall Study|Lost to Follow-up|1|||
33423742|NCT00502320|62801789|FG001|Overall Study|Lost to Follow-up|1|||
33423743|NCT00502320|62801788|FG000|Overall Study|Withdrew Consent|1|||
33423744|NCT00502320|62801789|FG001|Overall Study|Withdrew Consent|0|||
33423745|NCT00502320|62801788|FG000|Overall Study|No longer met criteria|1|||
33423746|NCT00502320|62801789|FG001|Overall Study|No longer met criteria|0|||
33423747|NCT00502320|62801788|FG000|Overall Study|Screen Failure|0|||
33423748|NCT00502320|62801789|FG001|Overall Study|Screen Failure|1|||
33423749|NCT00502320|62801788|FG000|Overall Study|Adverse Event|3|||
33423750|NCT00502320|62801789|FG001|Overall Study|Adverse Event|5|||
33423751|NCT02567825|62801797|FG000|Overall Study|No follow-up post-randomization|5|||
33423752|NCT02567825|62801798|FG001|Overall Study|No follow-up post-randomization|1|||
33423753|NCT02567825|62801797|FG000|Overall Study|Follow-up less than 23 months|16|||
33423754|NCT02567825|62801798|FG001|Overall Study|Follow-up less than 23 months|20|||
33423755|NCT00490776|62801804|FG000|Overall Study|Withdrawal by Subject|1|||
33423756|NCT00490776|62801804|FG000|Overall Study|Administrative Problems|1|||
33423757|NCT00490776|62801804|FG000|Overall Study|Death|1|||
33423758|NCT00490776|62801804|FG000|Overall Study|New Cancer Therapy|1|||
33322964|NCT02097134|62699215|FG000|Overall Study|Non-Protocol Therapy|1|||
33322965|NCT02097134|62699215|FG000|Overall Study|Progressive Disease|3|||
33423759|NCT00490776|62801804|FG000|Overall Study|Disease Progression|5|||
33322966|NCT02097134|62699215|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
33423760|NCT00566735|62801810|FG000|Overall Study|Withdrawal by Subject|0|||
33494143|NCT03486834|62872903|FG001|Overall Study|Non-compliance with Study Drug|2|||
33423761|NCT00566735|62801811|FG001|Overall Study|Withdrawal by Subject|1|||
33423762|NCT00566735|62801810|FG000|Overall Study|Refused neuropsychological testing|2|||
33423763|NCT00566735|62801811|FG001|Overall Study|Refused neuropsychological testing|5|||
33423764|NCT00566735|62801810|FG000|Overall Study|Switched into a manic episode|0|||
33423765|NCT00566735|62801811|FG001|Overall Study|Switched into a manic episode|1|||
33423766|NCT00566111|62801819|FG000|Overall Study|Adverse Event|0|||
33423767|NCT00566111|62801820|FG001|Overall Study|Adverse Event|2|||
33423768|NCT00514046|62801835|FG000|Overall Study|transferred to another protocol|2|||
33423769|NCT00514046|62801836|FG001|Overall Study|transferred to another protocol|1|||
33423770|NCT00514046|62801837|FG002|Overall Study|transferred to another protocol|3|||
33423771|NCT00514046|62801838|FG003|Overall Study|transferred to another protocol|0|||
33423772|NCT00514046|62801839|FG004|Overall Study|transferred to another protocol|1|||
33423773|NCT00514046|62801840|FG005|Overall Study|transferred to another protocol|0|||
33423774|NCT00514046|62801841|FG006|Overall Study|transferred to another protocol|0|||
33423775|NCT00514046|62801842|FG007|Overall Study|transferred to another protocol|0|||
33423776|NCT00514046|62801843|FG008|Overall Study|transferred to another protocol|0|||
33423777|NCT00514046|62801835|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
33423778|NCT00514046|62801836|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
33423779|NCT00514046|62801837|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
33423780|NCT00514046|62801838|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
33423781|NCT00514046|62801839|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
33423782|NCT00514046|62801840|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
33423783|NCT00514046|62801841|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
33423784|NCT00514046|62801842|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
33423785|NCT00514046|62801843|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
33423786|NCT00514046|62801835|FG000|Overall Study|Disease progression on study|0|||
33423787|NCT00514046|62801836|FG001|Overall Study|Disease progression on study|0|||
33423788|NCT00514046|62801837|FG002|Overall Study|Disease progression on study|2|||
33423789|NCT00514046|62801838|FG003|Overall Study|Disease progression on study|0|||
33423790|NCT00514046|62801839|FG004|Overall Study|Disease progression on study|0|||
33423791|NCT00514046|62801840|FG005|Overall Study|Disease progression on study|1|||
33423792|NCT00514046|62801841|FG006|Overall Study|Disease progression on study|0|||
33423793|NCT00514046|62801842|FG007|Overall Study|Disease progression on study|0|||
33423794|NCT00514046|62801843|FG008|Overall Study|Disease progression on study|0|||
33423795|NCT00564629|62801867|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
33423796|NCT00564629|62801868|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
33423797|NCT00564395|62801874|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
33423798|NCT00564395|62801875|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
33423799|NCT00564395|62801874|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
33423800|NCT00564395|62801875|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
33423801|NCT00502242|62801883|FG000|Overall Study|Lack of Efficacy|1|||
33423802|NCT00502242|62801884|FG001|Overall Study|Lack of Efficacy|11|||
33423803|NCT00502242|62801883|FG000|Overall Study|Adverse Event|31|||
33423804|NCT00502242|62801884|FG001|Overall Study|Adverse Event|20|||
33423805|NCT00502242|62801883|FG000|Overall Study|Physician Decision|2|||
33423806|NCT00502242|62801884|FG001|Overall Study|Physician Decision|3|||
33423807|NCT00502242|62801883|FG000|Overall Study|Other - Unspecified|8|||
33423808|NCT00502242|62801884|FG001|Overall Study|Other - Unspecified|14|||
33423809|NCT00502242|62801883|FG000|Overall Study|Protocol Violation|3|||
33423810|NCT00502242|62801884|FG001|Overall Study|Protocol Violation|1|||
33423811|NCT00502242|62801883|FG000|Overall Study|Withdrawal by Subject|6|||
33423812|NCT00502242|62801884|FG001|Overall Study|Withdrawal by Subject|7|||
33423813|NCT03972137|62801894|FG000|Overall Study|Lost to Follow-up|2|||
33423814|NCT03972137|62801894|FG000|Overall Study|Withdrawal by Subject|4|||
33423815|NCT00490698|62801910|FG000|Overall Study|Withdrawal by Subject|1|||
33423816|NCT00490698|62801910|FG000|Overall Study|Disease Progression|7|||
33423817|NCT00490698|62801910|FG000|Overall Study|Physician Decision|2|||
33423818|NCT03855228|62801918|FG000|Overall Study|Adverse Event|2|||
33423819|NCT03855228|62801919|FG001|Overall Study|Adverse Event|4|||
33423820|NCT03855228|62801920|FG002|Overall Study|Adverse Event|4|||
33423821|NCT03855228|62801921|FG003|Overall Study|Adverse Event|8|||
33423822|NCT03855228|62801918|FG000|Overall Study|Treatment Failure|1|||
33423823|NCT03855228|62801919|FG001|Overall Study|Treatment Failure|2|||
33322967|NCT00999804|62699237|FG000|Overall Study|Lack of Efficacy|9|||
33423824|NCT03855228|62801920|FG002|Overall Study|Treatment Failure|1|||
33423825|NCT03855228|62801921|FG003|Overall Study|Treatment Failure|8|||
33423826|NCT03855228|62801918|FG000|Overall Study|Lost to Follow-up|0|||
33423827|NCT03855228|62801919|FG001|Overall Study|Lost to Follow-up|0|||
33423828|NCT03855228|62801920|FG002|Overall Study|Lost to Follow-up|0|||
33423829|NCT03855228|62801921|FG003|Overall Study|Lost to Follow-up|1|||
33423830|NCT03855228|62801918|FG000|Overall Study|Protocol Violation|0|||
33423831|NCT03855228|62801919|FG001|Overall Study|Protocol Violation|1|||
33423832|NCT03855228|62801920|FG002|Overall Study|Protocol Violation|2|||
33423833|NCT03855228|62801921|FG003|Overall Study|Protocol Violation|1|||
33423834|NCT03855228|62801918|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
33423835|NCT03855228|62801919|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
33423836|NCT03855228|62801920|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
33423837|NCT03855228|62801921|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
33423838|NCT00511238|62801933|FG000|Overall Study|Adverse Event|13|||
33423839|NCT00511238|62801934|FG001|Overall Study|Adverse Event|33|||
33423840|NCT00511238|62801933|FG000|Overall Study|Withdrawal by Subject|2|||
33423841|NCT00511238|62801934|FG001|Overall Study|Withdrawal by Subject|22|||
33423842|NCT00511238|62801933|FG000|Overall Study|Progressive Disease|23|||
33423843|NCT00511238|62801934|FG001|Overall Study|Progressive Disease|157|||
33423844|NCT00511238|62801933|FG000|Overall Study|various reasons|4|||
33423845|NCT00511238|62801934|FG001|Overall Study|various reasons|14|||
33423846|NCT00513500|62801952|FG000|Overall Study|Lost to Follow-up|35|||
33423847|NCT00513500|62801953|FG001|Overall Study|Lost to Follow-up|39|||
33423848|NCT00513500|62801952|FG000|Overall Study|Death|2|||
33423849|NCT00513500|62801953|FG001|Overall Study|Death|1|||
33423850|NCT00513500|62801952|FG000|Overall Study|Hospitalized|4|||
33423851|NCT00513500|62801953|FG001|Overall Study|Hospitalized|14|||
33423852|NCT03969719|62801962|FG000|Overall Study|Other reasons not specified|1|||
33423853|NCT03969719|62801963|FG001|Overall Study|Other reasons not specified|1|||
33423854|NCT03969719|62801964|FG002|Overall Study|Other reasons not specified|3|||
33423855|NCT03969719|62801962|FG000|Overall Study|Withdrawal by Subject|2|||
33423856|NCT03969719|62801963|FG001|Overall Study|Withdrawal by Subject|3|||
33423857|NCT03969719|62801964|FG002|Overall Study|Withdrawal by Subject|2|||
33423858|NCT03969719|62801962|FG000|Overall Study|Protocol Violation|1|||
33423859|NCT03969719|62801963|FG001|Overall Study|Protocol Violation|2|||
33423860|NCT03969719|62801964|FG002|Overall Study|Protocol Violation|0|||
33423861|NCT03969719|62801962|FG000|Overall Study|Adverse Event|0|||
33423862|NCT03969719|62801963|FG001|Overall Study|Adverse Event|2|||
33423863|NCT03969719|62801964|FG002|Overall Study|Adverse Event|0|||
33423864|NCT03969719|62801962|FG000|Overall Study|Lost to Follow-up|0|||
33423865|NCT03969719|62801963|FG001|Overall Study|Lost to Follow-up|1|||
33423866|NCT03969719|62801964|FG002|Overall Study|Lost to Follow-up|0|||
33423867|NCT00511004|62801975|FG000|Overall Study|Lost to Follow-up|0|||
33423868|NCT00511004|62801976|FG001|Overall Study|Lost to Follow-up|0|||
33423869|NCT00511004|62801977|FG002|Overall Study|Lost to Follow-up|4|||
33423870|NCT02877134|62802004|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
33423871|NCT02877134|62802005|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
33423872|NCT02877134|62802006|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
33423873|NCT02877134|62802007|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
33423874|NCT02877134|62802008|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
33423875|NCT02877134|62802009|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
33322968|NCT00999804|62699238|FG001|Overall Study|Lack of Efficacy|2|||
33322969|NCT00999804|62699237|FG000|Overall Study|Adverse Event|4|||
33423876|NCT02877134|62802010|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
33423877|NCT02877134|62802011|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
33423878|NCT02877134|62802012|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
33423879|NCT02877134|62802013|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
33423880|NCT02877134|62802014|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
33423881|NCT02877134|62802015|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
33423882|NCT02877134|62802004|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33423883|NCT02877134|62802005|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
33423884|NCT02877134|62802006|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33423885|NCT02877134|62802007|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
33423886|NCT02877134|62802008|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33423887|NCT02877134|62802009|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33423888|NCT02877134|62802010|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
33423889|NCT02877134|62802011|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33423890|NCT02877134|62802012|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33423891|NCT02877134|62802013|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33423892|NCT02877134|62802014|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33423893|NCT02877134|62802015|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33423894|NCT02877134|62802004|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
33423895|NCT02877134|62802005|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
33423896|NCT02877134|62802006|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
33423897|NCT02877134|62802007|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
33423898|NCT02877134|62802008|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
33423899|NCT02877134|62802009|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
33423900|NCT02877134|62802010|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
33423901|NCT02877134|62802011|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
33423902|NCT02877134|62802012|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
33423903|NCT02877134|62802013|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
33423904|NCT02877134|62802014|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
33423905|NCT02877134|62802015|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
33423906|NCT02877134|62802004|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
33423907|NCT02877134|62802005|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
33423908|NCT02877134|62802006|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
33423909|NCT02877134|62802007|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
33423910|NCT02877134|62802008|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
33423911|NCT02877134|62802009|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
33423912|NCT02877134|62802010|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
33423913|NCT02877134|62802011|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
33423914|NCT02877134|62802012|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
33423915|NCT02877134|62802013|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
33423916|NCT02877134|62802014|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
33423917|NCT02877134|62802015|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
33423918|NCT02877134|62802004|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33423919|NCT02877134|62802005|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33423920|NCT02877134|62802006|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33423921|NCT02877134|62802007|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33423922|NCT02877134|62802008|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33423923|NCT02877134|62802009|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33423924|NCT02877134|62802010|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33423925|NCT02877134|62802011|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33423926|NCT02877134|62802012|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
33423927|NCT02877134|62802013|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33423928|NCT02877134|62802014|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33423929|NCT02877134|62802015|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33423930|NCT02877134|62802004|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
33322970|NCT00999804|62699238|FG001|Overall Study|Adverse Event|3|||
33322971|NCT00999804|62699237|FG000|Overall Study|Withdrawal by Subject|4|||
33322972|NCT00999804|62699238|FG001|Overall Study|Withdrawal by Subject|0|||
33322973|NCT00999804|62699237|FG000|Overall Study|Death|1|||
33322974|NCT00999804|62699238|FG001|Overall Study|Death|0|||
33423931|NCT02877134|62802005|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
33423932|NCT02877134|62802006|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
33322975|NCT00999804|62699237|FG000|Overall Study|Ineligible|3|||
33423933|NCT02877134|62802007|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
33423934|NCT02877134|62802008|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
33423935|NCT02877134|62802009|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
33423936|NCT02877134|62802010|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
33423937|NCT02877134|62802011|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
33423938|NCT02877134|62802012|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
33423939|NCT02877134|62802013|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
33423940|NCT02877134|62802014|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
33423941|NCT02877134|62802015|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
33423942|NCT02877134|62802004|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33423943|NCT02877134|62802005|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33423944|NCT02877134|62802006|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33423945|NCT02877134|62802007|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33423946|NCT02877134|62802008|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33423947|NCT02877134|62802009|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33423948|NCT02877134|62802010|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33423949|NCT02877134|62802011|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
33423950|NCT02877134|62802012|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
33423951|NCT02877134|62802013|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
33423952|NCT02877134|62802014|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33423953|NCT02877134|62802015|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33423954|NCT02877134|62802004|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
33423955|NCT02877134|62802005|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
33423956|NCT02877134|62802006|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
33423957|NCT02877134|62802007|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
33423958|NCT02877134|62802008|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
33423959|NCT02877134|62802009|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
33423960|NCT02877134|62802010|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
33423961|NCT02877134|62802011|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
33423962|NCT02877134|62802012|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
33423963|NCT02877134|62802013|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
33423964|NCT02877134|62802014|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
33423965|NCT02877134|62802015|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
33423966|NCT00563381|62802041|FG000|Overall Study|Adverse Event|264|||
33423967|NCT00563381|62802042|FG001|Overall Study|Adverse Event|292|||
33423968|NCT00563381|62802041|FG000|Overall Study|Protocol Violation|66|||
33423969|NCT00563381|62802042|FG001|Overall Study|Protocol Violation|74|||
33423970|NCT00563381|62802041|FG000|Overall Study|Lost to Follow-up|7|||
33423971|NCT00563381|62802042|FG001|Overall Study|Lost to Follow-up|15|||
33423972|NCT00563381|62802041|FG000|Overall Study|Withdrawal by Subject|192|||
33423973|NCT00563381|62802042|FG001|Overall Study|Withdrawal by Subject|209|||
33423974|NCT00563381|62802041|FG000|Overall Study|Lack of Efficacy|32|||
33423975|NCT00563381|62802042|FG001|Overall Study|Lack of Efficacy|24|||
33423976|NCT00563381|62802041|FG000|Overall Study|Individual different reasons|24|||
33423977|NCT00563381|62802042|FG001|Overall Study|Individual different reasons|34|||
33423978|NCT00512798|62802050|FG000|Overall Study|Death|0|||
33423979|NCT00512798|62802051|FG001|Overall Study|Death|3|||
33423980|NCT00512798|62802050|FG000|Overall Study|Adverse Event|2|||
33423981|NCT00512798|62802051|FG001|Overall Study|Adverse Event|4|||
33423982|NCT00512798|62802050|FG000|Overall Study|Progression of disease|14|||
33423983|NCT00512798|62802051|FG001|Overall Study|Progression of disease|20|||
33423984|NCT00512798|62802050|FG000|Overall Study|Withdrawal by Subject|3|||
33423985|NCT00512798|62802051|FG001|Overall Study|Withdrawal by Subject|0|||
33423986|NCT00565721|62802058|FG000|Overall Study|Screen Failure|2|||
33423987|NCT00565721|62802058|FG000|Overall Study|Lost to Follow-up|6|||
33423988|NCT00565721|62802058|FG000|Overall Study|Technical Problems|1|||
33423989|NCT00565721|62802058|FG000|Overall Study|Physician Decision|2|||
33423990|NCT00565721|62802058|FG000|Overall Study|Other reasons|6|||
33423991|NCT00561977|62802088|FG000|Overall Study|Withdrawal by Subject|0|||
33423992|NCT00561977|62802089|FG001|Overall Study|Withdrawal by Subject|2|||
33423993|NCT00561977|62802090|FG002|Overall Study|Withdrawal by Subject|1|||
33423994|NCT00561977|62802088|FG000|Overall Study|Pregnancy|0|||
33423995|NCT00561977|62802089|FG001|Overall Study|Pregnancy|1|||
33423996|NCT00561977|62802090|FG002|Overall Study|Pregnancy|1|||
33423997|NCT00561821|62802102|FG000|Overall Study|Not treated|0|||
33423998|NCT00561821|62802103|FG001|Overall Study|Not treated|0|||
33423999|NCT00561821|62802104|FG002|Overall Study|Not treated|1|||
33424000|NCT00561821|62802105|FG003|Overall Study|Not treated|0|||
33424001|NCT00561821|62802102|FG000|Overall Study|Withdrawal by Subject|0|||
33424002|NCT00561821|62802103|FG001|Overall Study|Withdrawal by Subject|1|||
33424003|NCT00561821|62802104|FG002|Overall Study|Withdrawal by Subject|0|||
33424004|NCT00561821|62802105|FG003|Overall Study|Withdrawal by Subject|2|||
33424005|NCT00561821|62802102|FG000|Overall Study|Reasons not related to trial|2|||
33424006|NCT00561821|62802103|FG001|Overall Study|Reasons not related to trial|1|||
33424007|NCT00561821|62802104|FG002|Overall Study|Reasons not related to trial|0|||
33424008|NCT00561821|62802105|FG003|Overall Study|Reasons not related to trial|0|||
33424009|NCT00561821|62802102|FG000|Overall Study|Other (reason not specified)|1|||
33424010|NCT00561821|62802103|FG001|Overall Study|Other (reason not specified)|1|||
33424011|NCT00561821|62802104|FG002|Overall Study|Other (reason not specified)|0|||
33424012|NCT00561821|62802105|FG003|Overall Study|Other (reason not specified)|0|||
33424013|NCT00561821|62802102|FG000|Overall Study|Adverse Event|2|||
33424014|NCT00561821|62802103|FG001|Overall Study|Adverse Event|3|||
33424015|NCT00561821|62802104|FG002|Overall Study|Adverse Event|1|||
33424016|NCT00561821|62802105|FG003|Overall Study|Adverse Event|1|||
33424017|NCT00558701|62802117|FG000|Overall Study|Protocol Deviations|1|||
33424018|NCT00558701|62802118|FG001|Overall Study|Protocol Deviations|4|||
33424019|NCT03684044|62802126|FG000|Overall Study|Adverse Event|3|||
33424020|NCT03684044|62802127|FG001|Overall Study|Adverse Event|0|||
33424021|NCT03684044|62802126|FG000|Overall Study|Death|4|||
33424022|NCT03684044|62802127|FG001|Overall Study|Death|7|||
33424023|NCT03684044|62802126|FG000|Overall Study|Lost to Follow-up|3|||
33424024|NCT03684044|62802127|FG001|Overall Study|Lost to Follow-up|2|||
33424025|NCT03684044|62802126|FG000|Overall Study|Patient Not Available|0|||
33424026|NCT03684044|62802127|FG001|Overall Study|Patient Not Available|2|||
33424027|NCT03684044|62802126|FG000|Overall Study|Physician Decision|1|||
33424028|NCT03684044|62802127|FG001|Overall Study|Physician Decision|0|||
33424029|NCT03684044|62802126|FG000|Overall Study|Withdrawal by Subject|11|||
33424030|NCT03684044|62802127|FG001|Overall Study|Withdrawal by Subject|9|||
33424031|NCT00510692|62802135|FG000|Overall Study|Adverse Event|1|||
33424032|NCT00510692|62802136|FG001|Overall Study|Adverse Event|3|||
33424033|NCT00510692|62802135|FG000|Overall Study|Withdrawal by Subject|1|||
33424034|NCT00510692|62802136|FG001|Overall Study|Withdrawal by Subject|0|||
33424035|NCT00335452|62802148|FG000|Overall Study|Death|156|||
33424036|NCT00335452|62802149|FG001|Overall Study|Death|144|||
33424037|NCT00335452|62802150|FG002|Overall Study|Death|158|||
33424038|NCT00335452|62802151|FG003|Overall Study|Death|129|||
33424039|NCT00335452|62802148|FG000|Overall Study|Lost to Follow-up|2|||
33424040|NCT00335452|62802149|FG001|Overall Study|Lost to Follow-up|3|||
33424041|NCT00335452|62802150|FG002|Overall Study|Lost to Follow-up|1|||
33424042|NCT00335452|62802151|FG003|Overall Study|Lost to Follow-up|2|||
33424043|NCT00522548|62802168|FG000|Overall Study|Adverse Event|2|||
33424044|NCT00522548|62802169|FG001|Overall Study|Adverse Event|2|||
33424045|NCT00522548|62802168|FG000|Overall Study|Withdrawal by Subject|0|||
33424046|NCT00522548|62802169|FG001|Overall Study|Withdrawal by Subject|2|||
33424047|NCT00522392|62802177|FG000|Overall Study|Disease progression|0|||
33424048|NCT00522392|62802178|FG001|Overall Study|Disease progression|3|||
33424049|NCT00522392|62802177|FG000|Overall Study|Adverse Event|7|||
33424050|NCT00522392|62802178|FG001|Overall Study|Adverse Event|7|||
33424051|NCT00522392|62802177|FG000|Overall Study|Withdrawal by Subject|1|||
33424052|NCT00522392|62802178|FG001|Overall Study|Withdrawal by Subject|1|||
33424053|NCT00522392|62802177|FG000|Overall Study|Physician Decision|0|||
33424054|NCT00522392|62802178|FG001|Overall Study|Physician Decision|1|||
33424055|NCT00522392|62802177|FG000|Overall Study|Non-compliance|0|||
33424056|NCT00522392|62802178|FG001|Overall Study|Non-compliance|1|||
33424057|NCT00309244|62802186|FG000|Overall Study|Adverse Event|29|||
33424058|NCT00309244|62802187|FG001|Overall Study|Adverse Event|12|||
33424059|NCT00309244|62802186|FG000|Overall Study|Lost to Follow-up|6|||
33494144|NCT03486834|62872904|FG002|Overall Study|Non-compliance with Study Drug|0|||
33424060|NCT00309244|62802187|FG001|Overall Study|Lost to Follow-up|22|||
33424061|NCT00309244|62802186|FG000|Overall Study|Physician Decision|5|||
33424062|NCT00309244|62802187|FG001|Overall Study|Physician Decision|8|||
33424063|NCT00309244|62802186|FG000|Overall Study|Protocol Violation|6|||
33424064|NCT00309244|62802187|FG001|Overall Study|Protocol Violation|3|||
33424065|NCT00309244|62802186|FG000|Overall Study|Withdrawal by Subject|50|||
33424066|NCT00309244|62802187|FG001|Overall Study|Withdrawal by Subject|32|||
33424067|NCT00309244|62802186|FG000|Overall Study|Various|7|||
33424068|NCT00309244|62802187|FG001|Overall Study|Various|7|||
33424069|NCT00309244|62802186|FG000|Overall Study|Randomized but not dosed|11|||
33424070|NCT00309244|62802187|FG001|Overall Study|Randomized but not dosed|12|||
33424071|NCT00309244|62802186|FG000|Overall Study|Death|4|||
33424072|NCT00309244|62802187|FG001|Overall Study|Death|1|||
33424073|NCT00483756|62802196|FG000|Overall Study|Death|2|||
33424074|NCT00483756|62802197|FG001|Overall Study|Death|0|||
33424075|NCT00483756|62802198|FG002|Overall Study|Death|1|||
33424076|NCT00483756|62802196|FG000|Overall Study|Adverse Event|19|||
33424077|NCT00483756|62802197|FG001|Overall Study|Adverse Event|38|||
33424078|NCT00483756|62802198|FG002|Overall Study|Adverse Event|40|||
33424079|NCT00483756|62802196|FG000|Overall Study|Lack of Efficacy|1|||
33424080|NCT00483756|62802197|FG001|Overall Study|Lack of Efficacy|0|||
33424081|NCT00483756|62802198|FG002|Overall Study|Lack of Efficacy|0|||
33424082|NCT00483756|62802196|FG000|Overall Study|Lost to Follow-up|3|||
33322976|NCT00999804|62699238|FG001|Overall Study|Ineligible|0|||
33424083|NCT00483756|62802197|FG001|Overall Study|Lost to Follow-up|1|||
33424084|NCT00483756|62802198|FG002|Overall Study|Lost to Follow-up|0|||
33424085|NCT00483756|62802196|FG000|Overall Study|Withdrawal by Subject|5|||
33424086|NCT00483756|62802197|FG001|Overall Study|Withdrawal by Subject|3|||
33424087|NCT00483756|62802198|FG002|Overall Study|Withdrawal by Subject|4|||
33424088|NCT00483756|62802196|FG000|Overall Study|Other|2|||
33424089|NCT00483756|62802197|FG001|Overall Study|Other|4|||
33424090|NCT00483756|62802198|FG002|Overall Study|Other|3|||
33424091|NCT00483756|62802196|FG000|Overall Study|Randomized, Not Treated|1|||
33424092|NCT00483756|62802197|FG001|Overall Study|Randomized, Not Treated|4|||
33424093|NCT00483756|62802198|FG002|Overall Study|Randomized, Not Treated|4|||
33424094|NCT00309166|62802208|FG000|Overall Study|Adverse event, non-fatal|1|||
33424095|NCT00309166|62802209|FG001|Overall Study|Adverse event, non-fatal|0|||
33424096|NCT00309166|62802208|FG000|Overall Study|Withdrawal by Subject|4|||
33424097|NCT00309166|62802209|FG001|Overall Study|Withdrawal by Subject|3|||
33424098|NCT00501852|62802215|FG000|Overall Study|Adverse Event|3|||
33424099|NCT00501852|62802215|FG000|Overall Study|Withdrawal by Subject|2|||
33424100|NCT00482274|62802229|FG000|Overall Study|Adverse Event|1|||
33424101|NCT00490542|62802235|FG000|Overall Study|Lost to Follow-up|3|||
33424102|NCT00490542|62802236|FG001|Overall Study|Lost to Follow-up|0|||
33424103|NCT00490542|62802235|FG000|Overall Study|Adverse Event|3|||
33424104|NCT00490542|62802236|FG001|Overall Study|Adverse Event|3|||
33424105|NCT00490542|62802235|FG000|Overall Study|Lack of Efficacy|1|||
33424106|NCT00490542|62802236|FG001|Overall Study|Lack of Efficacy|1|||
33424107|NCT00501540|62802242|FG000|Overall Study|Death|5|||
33424108|NCT00322348|62802248|FG000|Overall Study|Adverse Event|0|||
33424109|NCT00322348|62802249|FG001|Overall Study|Adverse Event|1|||
33424110|NCT00322348|62802248|FG000|Overall Study|Withdrawal by Subject|1|||
33424111|NCT00322348|62802249|FG001|Overall Study|Withdrawal by Subject|4|||
33424112|NCT00322348|62802248|FG000|Overall Study|Lost to Follow-up|1|||
33424113|NCT00322348|62802249|FG001|Overall Study|Lost to Follow-up|0|||
33424114|NCT00322348|62802248|FG000|Overall Study|Death|0|||
33424115|NCT00322348|62802249|FG001|Overall Study|Death|2|||
33424116|NCT00322348|62802248|FG000|Overall Study|Disease Progression|30|||
33424117|NCT00322348|62802249|FG001|Overall Study|Disease Progression|25|||
33424118|NCT00322348|62802248|FG000|Overall Study|Reasons not specified|5|||
33424119|NCT00322348|62802249|FG001|Overall Study|Reasons not specified|1|||
33424120|NCT00501228|62802255|FG000|Overall Study|Withdrawal by Subject|1|||
33424121|NCT00308620|62802262|FG000|Overall Study|Death|1|||
33424122|NCT00308620|62802263|FG001|Overall Study|Death|1|||
33424123|NCT00308620|62802264|FG002|Overall Study|Death|0|||
33424124|NCT00308620|62802262|FG000|Overall Study|Lost to Follow-up|0|||
33424125|NCT00308620|62802263|FG001|Overall Study|Lost to Follow-up|0|||
33424126|NCT00308620|62802264|FG002|Overall Study|Lost to Follow-up|1|||
33424127|NCT00492752|62802274|FG000|Double Blind Treatment|Death|13|||
33424128|NCT00492752|62802275|FG001|Double Blind Treatment|Death|0|||
33424129|NCT00492752|62802276|FG002|Double Blind Treatment|Death|2|||
33424130|NCT00492752|62802277|FG003|Double Blind Treatment|Death|0|||
33424131|NCT00492752|62802274|FG000|Double Blind Treatment|Adverse Event|1|||
33494145|NCT03486834|62872902|FG000|Overall Study|Physician Decision|5|||
33424132|NCT00492752|62802275|FG001|Double Blind Treatment|Adverse Event|0|||
33424133|NCT00492752|62802276|FG002|Double Blind Treatment|Adverse Event|0|||
33424134|NCT00492752|62802277|FG003|Double Blind Treatment|Adverse Event|0|||
33424135|NCT00492752|62802274|FG000|Double Blind Treatment|Protocol Violation|0|||
33424136|NCT00492752|62802275|FG001|Double Blind Treatment|Protocol Violation|0|||
33424137|NCT00492752|62802276|FG002|Double Blind Treatment|Protocol Violation|1|||
33424138|NCT00492752|62802277|FG003|Double Blind Treatment|Protocol Violation|0|||
33424139|NCT00492752|62802274|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
33424140|NCT00492752|62802275|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
33424141|NCT00492752|62802276|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
33424142|NCT00492752|62802277|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
33424143|NCT00492752|62802274|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
33424144|NCT00492752|62802275|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
33424145|NCT00492752|62802276|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
33424146|NCT00492752|62802277|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
33424147|NCT00492752|62802274|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
33424148|NCT00492752|62802275|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
33424149|NCT00492752|62802276|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
33424150|NCT00492752|62802277|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
33424151|NCT00492752|62802274|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
33424152|NCT00492752|62802275|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
33424153|NCT00492752|62802276|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
33424154|NCT00492752|62802277|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
33424155|NCT00492752|62802274|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
33424156|NCT00492752|62802275|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
33424157|NCT00492752|62802276|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
33424158|NCT00492752|62802277|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
33424159|NCT00492752|62802274|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
33424160|NCT00492752|62802275|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
33424161|NCT00492752|62802276|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
33424162|NCT00492752|62802277|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
33424163|NCT00492752|62802274|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
33424164|NCT00492752|62802275|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
33424165|NCT00492752|62802276|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
33424166|NCT00492752|62802277|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
33424167|NCT00492752|62802274|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
33424168|NCT00492752|62802275|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
33424169|NCT00492752|62802276|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
33424170|NCT00492752|62802277|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
33424171|NCT00308308|62802286|FG000|Overall Study|Adverse Event|17|||
33424172|NCT00308308|62802287|FG001|Overall Study|Adverse Event|2|||
33424173|NCT00308308|62802286|FG000|Overall Study|Lost to Follow-up|5|||
33424174|NCT00308308|62802287|FG001|Overall Study|Lost to Follow-up|5|||
33424175|NCT00308308|62802286|FG000|Overall Study|Physician Decision|15|||
33424176|NCT00308308|62802287|FG001|Overall Study|Physician Decision|7|||
33424177|NCT00308308|62802286|FG000|Overall Study|Protocol Violation|3|||
33424178|NCT00308308|62802287|FG001|Overall Study|Protocol Violation|14|||
33424179|NCT00308308|62802286|FG000|Overall Study|Withdrawal by Subject|47|||
33424180|NCT00308308|62802287|FG001|Overall Study|Withdrawal by Subject|19|||
33424181|NCT00308308|62802286|FG000|Overall Study|Various|7|||
33424182|NCT00308308|62802287|FG001|Overall Study|Various|5|||
33424183|NCT00308308|62802286|FG000|Overall Study|Randomized but not dosed|8|||
33424184|NCT00308308|62802287|FG001|Overall Study|Randomized but not dosed|16|||
33424185|NCT00308308|62802286|FG000|Overall Study|Other|1|||
33424186|NCT00308308|62802287|FG001|Overall Study|Other|0|||
33424187|NCT00505934|62802293|FG000|Overall Study|Adverse Event|1|||
33424188|NCT00505934|62802293|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
33424189|NCT00505934|62802293|FG000|Overall Study|Other: IV dose needed to be changed|1|||
33424190|NCT00505778|62802299|FG000|Overall Study|Adverse Event|2|||
33424191|NCT00505778|62802300|FG001|Overall Study|Adverse Event|7|||
33424192|NCT00505778|62802299|FG000|Overall Study|Physician Decision|8|||
33424193|NCT00505778|62802300|FG001|Overall Study|Physician Decision|14|||
33424194|NCT00505778|62802299|FG000|Overall Study|Lost to Follow-up|17|||
33424195|NCT00505778|62802300|FG001|Overall Study|Lost to Follow-up|23|||
33424196|NCT00505778|62802299|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
33424197|NCT00505778|62802300|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
33424198|NCT00505778|62802299|FG000|Overall Study|Protocol Violation|7|||
33424199|NCT00505778|62802300|FG001|Overall Study|Protocol Violation|9|||
33424200|NCT00505778|62802299|FG000|Overall Study|Withdrawal by Subject|29|||
33424201|NCT00505778|62802300|FG001|Overall Study|Withdrawal by Subject|14|||
33424202|NCT00505778|62802299|FG000|Overall Study|Relapse|65|||
33424203|NCT00505778|62802300|FG001|Overall Study|Relapse|65|||
33424204|NCT00505778|62802299|FG000|Overall Study|Took No Study Drug|2|||
33424205|NCT00505778|62802300|FG001|Overall Study|Took No Study Drug|2|||
33424206|NCT00308074|62802306|FG000|Overall Study|Withdrawal by Subject|1|||
33424207|NCT00500760|62802312|FG000|Overall Study|Death|32|||
33424208|NCT00500760|62802313|FG001|Overall Study|Death|15|||
33424209|NCT00500760|62802312|FG000|Overall Study|Withdrawal by Subject|5|||
33424210|NCT00500760|62802313|FG001|Overall Study|Withdrawal by Subject|7|||
33424211|NCT00500760|62802312|FG000|Overall Study|Administrative decision|2|||
33424212|NCT00500760|62802313|FG001|Overall Study|Administrative decision|0|||
33424213|NCT00500760|62802312|FG000|Overall Study|Lost to Follow-up|3|||
33424214|NCT00500760|62802313|FG001|Overall Study|Lost to Follow-up|0|||
33424215|NCT00500760|62802312|FG000|Overall Study|Other|1|||
33424216|NCT00500760|62802313|FG001|Overall Study|Other|2|||
33424217|NCT00505622|62802322|FG000|Overall Study|Adverse Event|5|||
33424218|NCT00505622|62802323|FG001|Overall Study|Adverse Event|6|||
33424219|NCT00505622|62802324|FG002|Overall Study|Adverse Event|4|||
33424220|NCT00505622|62802322|FG000|Overall Study|Protocol Violation|1|||
33424221|NCT00505622|62802323|FG001|Overall Study|Protocol Violation|1|||
33424222|NCT00505622|62802324|FG002|Overall Study|Protocol Violation|0|||
33424223|NCT00505622|62802322|FG000|Overall Study|Withdrawal by Subject|0|||
33424224|NCT00505622|62802323|FG001|Overall Study|Withdrawal by Subject|3|||
33424225|NCT00505622|62802324|FG002|Overall Study|Withdrawal by Subject|2|||
33424226|NCT00505622|62802322|FG000|Overall Study|Study termination by sponsor|115|||
33424227|NCT00505622|62802323|FG001|Overall Study|Study termination by sponsor|98|||
33424228|NCT00505622|62802324|FG002|Overall Study|Study termination by sponsor|90|||
33424229|NCT03851094|62802334|FG000|Overall Study|Withdrawal by Subject|0|||
33424230|NCT03851094|62802335|FG001|Overall Study|Withdrawal by Subject|1|||
33424231|NCT03851094|62802334|FG000|Overall Study|Participant lost device|0|||
33424232|NCT03851094|62802335|FG001|Overall Study|Participant lost device|1|||
33424233|NCT03851094|62802334|FG000|Overall Study|Participant returned device|0|||
33424234|NCT03851094|62802335|FG001|Overall Study|Participant returned device|2|||
33424235|NCT00505076|62802346|FG000|Overall Study|Adverse Event|1|||
33424236|NCT00505076|62802347|FG001|Overall Study|Adverse Event|0|||
33424237|NCT00505076|62802348|FG002|Overall Study|Adverse Event|1|||
33424238|NCT00505076|62802346|FG000|Overall Study|Protocol Violation|2|||
33322977|NCT00927472|62699250|FG000|Overall Study|Withdrawal by Subject|10|||
33424239|NCT00505076|62802347|FG001|Overall Study|Protocol Violation|1|||
33424240|NCT00505076|62802348|FG002|Overall Study|Protocol Violation|2|||
33424241|NCT00505076|62802346|FG000|Overall Study|Withdrawal by Subject|0|||
33424242|NCT00505076|62802347|FG001|Overall Study|Withdrawal by Subject|1|||
33424243|NCT00505076|62802348|FG002|Overall Study|Withdrawal by Subject|2|||
33424244|NCT00307684|62802356|FG000|Open Label Phase|Lack of Efficacy|0|||
33424245|NCT00307684|62802357|FG001|Open Label Phase|Lack of Efficacy|0|||
33424246|NCT00307684|62802358|FG002|Open Label Phase|Lack of Efficacy|3|||
33424247|NCT00307684|62802356|FG000|Open Label Phase|Adverse Event|0|||
33424248|NCT00307684|62802357|FG001|Open Label Phase|Adverse Event|0|||
33424249|NCT00307684|62802358|FG002|Open Label Phase|Adverse Event|16|||
33424250|NCT00307684|62802356|FG000|Open Label Phase|Withdrawal by Subject|0|||
33424251|NCT00307684|62802357|FG001|Open Label Phase|Withdrawal by Subject|0|||
33424252|NCT00307684|62802358|FG002|Open Label Phase|Withdrawal by Subject|15|||
33424253|NCT00307684|62802356|FG000|Open Label Phase|Lost to Follow-up|0|||
33424254|NCT00307684|62802357|FG001|Open Label Phase|Lost to Follow-up|0|||
33424255|NCT00307684|62802358|FG002|Open Label Phase|Lost to Follow-up|11|||
33424256|NCT00307684|62802356|FG000|Open Label Phase|non compliance|0|||
33424257|NCT00307684|62802357|FG001|Open Label Phase|non compliance|0|||
33424258|NCT00307684|62802358|FG002|Open Label Phase|non compliance|5|||
33424259|NCT00307684|62802356|FG000|Open Label Phase|other|0|||
33424260|NCT00307684|62802357|FG001|Open Label Phase|other|0|||
33424261|NCT00307684|62802358|FG002|Open Label Phase|other|6|||
33424262|NCT00307684|62802356|FG000|Double Blind Phase|Lack of Efficacy|2|||
33424263|NCT00307684|62802357|FG001|Double Blind Phase|Lack of Efficacy|5|||
33424264|NCT00307684|62802358|FG002|Double Blind Phase|Lack of Efficacy|0|||
33424265|NCT00489918|62802371|FG000|Overall Study|Withdrawal by Subject|2|||
33424266|NCT00489918|62802372|FG001|Overall Study|Withdrawal by Subject|1|||
33424267|NCT00489918|62802373|FG002|Overall Study|Withdrawal by Subject|1|||
33424268|NCT00489918|62802374|FG003|Overall Study|Withdrawal by Subject|0|||
33424269|NCT00489918|62802375|FG004|Overall Study|Withdrawal by Subject|1|||
33424270|NCT00489918|62802371|FG000|Overall Study|Adverse Event|0|||
33424271|NCT00489918|62802372|FG001|Overall Study|Adverse Event|1|||
33424272|NCT00489918|62802373|FG002|Overall Study|Adverse Event|1|||
33424273|NCT00489918|62802374|FG003|Overall Study|Adverse Event|0|||
33424274|NCT00489918|62802375|FG004|Overall Study|Adverse Event|0|||
33424275|NCT00489918|62802371|FG000|Overall Study|Lost to Follow-up|0|||
33424276|NCT00489918|62802372|FG001|Overall Study|Lost to Follow-up|0|||
33424277|NCT00489918|62802373|FG002|Overall Study|Lost to Follow-up|1|||
33424278|NCT00489918|62802374|FG003|Overall Study|Lost to Follow-up|1|||
33424279|NCT00489918|62802375|FG004|Overall Study|Lost to Follow-up|0|||
33424280|NCT00489918|62802371|FG000|Overall Study|Physician Decision|0|||
33424281|NCT00489918|62802372|FG001|Overall Study|Physician Decision|0|||
33424282|NCT00489918|62802373|FG002|Overall Study|Physician Decision|1|||
33424283|NCT00489918|62802374|FG003|Overall Study|Physician Decision|0|||
33424284|NCT00489918|62802375|FG004|Overall Study|Physician Decision|0|||
33424285|NCT00307294|62802387|FG000|Overall Study|Withdrawal by Subject|1|||
33424286|NCT03963401|62802398|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
33424287|NCT03963401|62802399|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
33424288|NCT03963401|62802400|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
33424289|NCT03963401|62802401|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
33424290|NCT03963401|62802402|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
33424291|NCT03963401|62802403|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
33424292|NCT03963401|62802398|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
33424293|NCT03963401|62802399|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
33424294|NCT03963401|62802400|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
33424295|NCT03963401|62802401|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
33424296|NCT03963401|62802402|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
33424297|NCT03963401|62802403|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
33424298|NCT03963401|62802398|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
33424299|NCT03963401|62802399|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
33424300|NCT03963401|62802400|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
33424301|NCT03963401|62802401|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
33424302|NCT03963401|62802402|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
33424303|NCT03963401|62802403|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
33424304|NCT03963401|62802398|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
33424305|NCT03963401|62802399|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
33424306|NCT03963401|62802400|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
33424307|NCT03963401|62802401|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
33424308|NCT03963401|62802402|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
33424309|NCT03963401|62802403|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
33605297|NCT02392481|63005011|FG000|Overall Study|Withdrawal by Subject|0|||
33605298|NCT02392481|63005012|FG001|Overall Study|Withdrawal by Subject|0|||
33605299|NCT02392481|63005013|FG002|Overall Study|Withdrawal by Subject|1|||
33605300|NCT02392481|63005014|FG003|Overall Study|Withdrawal by Subject|0|||
33424310|NCT03963401|62802398|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
33424311|NCT03963401|62802399|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
33605301|NCT02392403|63005024|FG000|Overall Study|Adverse Event|1|||
33424312|NCT03963401|62802400|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
33424313|NCT03963401|62802401|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
33424314|NCT03963401|62802402|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
33424315|NCT03963401|62802403|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
33424316|NCT03963401|62802398|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
33424317|NCT03963401|62802399|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
33424318|NCT03963401|62802400|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
33424319|NCT03963401|62802401|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
33424320|NCT03963401|62802402|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
33424321|NCT03963401|62802403|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
33424322|NCT03963401|62802398|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
33424323|NCT03963401|62802399|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
33424324|NCT03963401|62802400|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
33424325|NCT03963401|62802401|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
33424326|NCT03963401|62802402|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
33424327|NCT03963401|62802403|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
33424328|NCT03963401|62802398|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
33424329|NCT03963401|62802399|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
33424330|NCT03963401|62802400|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
33424331|NCT03963401|62802401|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
33424332|NCT03963401|62802402|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
33424333|NCT03963401|62802403|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
33424334|NCT03963401|62802398|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
33424335|NCT03963401|62802399|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
33424336|NCT03963401|62802400|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
33424337|NCT03963401|62802401|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
33424338|NCT03963401|62802402|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
33424339|NCT03963401|62802403|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
33424340|NCT03963401|62802398|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
33424341|NCT03963401|62802399|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
33424342|NCT03963401|62802400|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
33424343|NCT03963401|62802401|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
33424344|NCT03963401|62802402|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
33424345|NCT03963401|62802403|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
33424346|NCT03963401|62802398|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
33424347|NCT03963401|62802399|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
33424348|NCT03963401|62802400|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
33424349|NCT03963401|62802401|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
33424350|NCT03963401|62802402|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
33424351|NCT03963401|62802403|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
33424352|NCT00334282|62802423|FG000|Overall Study|Lost to Follow-up|11|||
33424353|NCT00334282|62802424|FG001|Overall Study|Lost to Follow-up|5|||
33424354|NCT00334282|62802423|FG000|Overall Study|Withdrawal by Subject|17|||
33424355|NCT00334282|62802424|FG001|Overall Study|Withdrawal by Subject|3|||
33424356|NCT00334282|62802423|FG000|Overall Study|Death|194|||
33424357|NCT00334282|62802424|FG001|Overall Study|Death|100|||
33424358|NCT00306670|62802436|FG000|Overall Study|patients recruited; Genentech, the st|0|||
33424359|NCT00306670|62802437|FG001|Overall Study|patients recruited; Genentech, the st|2|||
33424360|NCT00306592|62802443|FG000|Overall Study|Adverse Event|8|||
33424361|NCT00306592|62802444|FG001|Overall Study|Adverse Event|15|||
33424362|NCT00306592|62802443|FG000|Overall Study|Lost to Follow-up|1|||
33424363|NCT00306592|62802444|FG001|Overall Study|Lost to Follow-up|0|||
33424364|NCT00306592|62802443|FG000|Overall Study|Noncompliance|0|||
33424365|NCT00306592|62802444|FG001|Overall Study|Noncompliance|2|||
33424366|NCT00306592|62802443|FG000|Overall Study|Persistent Antibodies|6|||
33424367|NCT00306592|62802444|FG001|Overall Study|Persistent Antibodies|3|||
33424368|NCT00306592|62802443|FG000|Overall Study|Voluntary|10|||
33424369|NCT00306592|62802444|FG001|Overall Study|Voluntary|6|||
33424370|NCT00306592|62802443|FG000|Overall Study|Other|5|||
33424371|NCT00306592|62802444|FG001|Overall Study|Other|10|||
33424372|NCT00306592|62802443|FG000|Overall Study|Other|1|||
33424373|NCT00306592|62802444|FG001|Overall Study|Other|2|||
33424374|NCT00306592|62802443|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
33424375|NCT00306592|62802444|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
33424376|NCT00321646|62802448|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
33424377|NCT00321646|62802448|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
33424378|NCT00321646|62802448|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
33424379|NCT00403767|62802454|FG000|Overall Study|Adverse Event|993|||
33424380|NCT00403767|62802455|FG001|Overall Study|Adverse Event|919|||
33424381|NCT00403767|62802454|FG000|Overall Study|Non-compliant with study medication|134|||
33424382|NCT00403767|62802455|FG001|Overall Study|Non-compliant with study medication|164|||
33424383|NCT00403767|62802454|FG000|Overall Study|Consent withdrawn|671|||
33424384|NCT00403767|62802455|FG001|Overall Study|Consent withdrawn|673|||
33424385|NCT00403767|62802454|FG000|Overall Study|Investigator dec./not protocol-related|191|||
33424386|NCT00403767|62802455|FG001|Overall Study|Investigator dec./not protocol-related|178|||
33424387|NCT00403767|62802454|FG000|Overall Study|Lost to Follow-up|6|||
33424388|NCT00403767|62802455|FG001|Overall Study|Lost to Follow-up|8|||
33424389|NCT00403767|62802454|FG000|Overall Study|Protocol Violation|142|||
33424390|NCT00403767|62802455|FG001|Overall Study|Protocol Violation|124|||
33424391|NCT00403767|62802454|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
33424392|NCT00403767|62802455|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
33424393|NCT00403767|62802454|FG000|Overall Study|Study terminated by sponsor|82|||
33424394|NCT00403767|62802455|FG001|Overall Study|Study terminated by sponsor|69|||
33424395|NCT00403767|62802454|FG000|Overall Study|Missing/incomplete data|1|||
33424396|NCT00403767|62802455|FG001|Overall Study|Missing/incomplete data|1|||
33424397|NCT00492284|62802465|FG000|Overall Study|Adverse Event|0|||
33424398|NCT00492284|62802466|FG001|Overall Study|Adverse Event|1|||
33424399|NCT00492284|62802467|FG002|Overall Study|Adverse Event|1|||
33424400|NCT00492284|62802468|FG003|Overall Study|Adverse Event|2|||
33424401|NCT00492284|62802465|FG000|Overall Study|Lost to Follow-up|0|||
33424402|NCT00492284|62802466|FG001|Overall Study|Lost to Follow-up|0|||
33424403|NCT00492284|62802467|FG002|Overall Study|Lost to Follow-up|3|||
33424404|NCT00492284|62802468|FG003|Overall Study|Lost to Follow-up|1|||
33424405|NCT00492284|62802465|FG000|Overall Study|Death|0|||
33424406|NCT00492284|62802466|FG001|Overall Study|Death|3|||
33424407|NCT00492284|62802467|FG002|Overall Study|Death|2|||
33424408|NCT00492284|62802468|FG003|Overall Study|Death|5|||
33424409|NCT00492284|62802465|FG000|Overall Study|Withdrawal by Subject|1|||
33424410|NCT00492284|62802466|FG001|Overall Study|Withdrawal by Subject|0|||
33424411|NCT00492284|62802467|FG002|Overall Study|Withdrawal by Subject|0|||
33424412|NCT00492284|62802468|FG003|Overall Study|Withdrawal by Subject|2|||
33424413|NCT00510458|62802478|FG000|Overall Study|5 year not evaluable/missed|21|||
33424414|NCT00510458|62802478|FG000|Overall Study|Death|1|||
33424415|NCT00510458|62802478|FG000|Overall Study|Terminated|14|||
33424416|NCT00510458|62802478|FG000|Overall Study|Lost to Follow-up|6|||
33424417|NCT00510458|62802478|FG000|Overall Study|Withdrawal by Subject|3|||
33424418|NCT00510458|62802478|FG000|Overall Study|Revision|2|||
33424419|NCT00414765|62802485|FG000|Overall Study|Adverse Event|5|||
33424420|NCT00414765|62802486|FG001|Overall Study|Adverse Event|9|||
33424421|NCT00414765|62802485|FG000|Overall Study|Withdrawal by Subject|1|||
33424422|NCT00414765|62802486|FG001|Overall Study|Withdrawal by Subject|1|||
33424423|NCT00414765|62802485|FG000|Overall Study|Disease Progression|0|||
33424424|NCT00414765|62802486|FG001|Overall Study|Disease Progression|1|||
33424425|NCT00500682|62802494|FG000|Overall Study|Adverse Event|37|||
33424426|NCT00500682|62802495|FG001|Overall Study|Adverse Event|29|||
33424427|NCT00500682|62802494|FG000|Overall Study|Death|25|||
33424428|NCT00500682|62802495|FG001|Overall Study|Death|16|||
33424429|NCT00500682|62802494|FG000|Overall Study|Lost to Follow-up|11|||
33424430|NCT00500682|62802495|FG001|Overall Study|Lost to Follow-up|11|||
33424431|NCT00500682|62802494|FG000|Overall Study|Physician Decision|6|||
33424432|NCT00500682|62802495|FG001|Overall Study|Physician Decision|10|||
33424433|NCT00500682|62802494|FG000|Overall Study|Pregnancy|2|||
33424434|NCT00500682|62802495|FG001|Overall Study|Pregnancy|0|||
33424435|NCT00500682|62802494|FG000|Overall Study|Protocol Violation|1|||
33424436|NCT00500682|62802495|FG001|Overall Study|Protocol Violation|3|||
33424437|NCT00500682|62802494|FG000|Overall Study|Withdrawal by Subject|80|||
33424438|NCT00500682|62802495|FG001|Overall Study|Withdrawal by Subject|74|||
33424439|NCT00500682|62802494|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
33424440|NCT00500682|62802495|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
33424441|NCT00500370|62802503|FG000|Overall Study|Adverse Event|9|||
33424442|NCT00500370|62802504|FG001|Overall Study|Adverse Event|3|||
33424443|NCT00500370|62802503|FG000|Overall Study|Lost to Follow-up|10|||
33424444|NCT00500370|62802504|FG001|Overall Study|Lost to Follow-up|10|||
33424445|NCT00500370|62802503|FG000|Overall Study|Protocol Violation|2|||
33424446|NCT00500370|62802504|FG001|Overall Study|Protocol Violation|4|||
33424447|NCT00500370|62802503|FG000|Overall Study|Sponsor Decision|2|||
33424448|NCT00500370|62802504|FG001|Overall Study|Sponsor Decision|0|||
33424449|NCT00500370|62802503|FG000|Overall Study|Subject Decision|10|||
33424450|NCT00500370|62802504|FG001|Overall Study|Subject Decision|17|||
33424451|NCT00320788|62802515|FG000|Overall Study|Adverse Event|0|||
33424452|NCT00320788|62802516|FG001|Overall Study|Adverse Event|0|||
33424453|NCT00320788|62802517|FG002|Overall Study|Adverse Event|0|||
33424454|NCT00320788|62802518|FG003|Overall Study|Adverse Event|1|||
33424455|NCT00320788|62802519|FG004|Overall Study|Adverse Event|0|||
33424456|NCT00320788|62802515|FG000|Overall Study|Death|0|||
33424457|NCT00320788|62802516|FG001|Overall Study|Death|0|||
33424458|NCT00320788|62802517|FG002|Overall Study|Death|1|||
33424459|NCT00320788|62802518|FG003|Overall Study|Death|0|||
33424460|NCT00320788|62802519|FG004|Overall Study|Death|1|||
33424461|NCT00320788|62802515|FG000|Overall Study|Lost to Follow-up|0|||
33424462|NCT00320788|62802516|FG001|Overall Study|Lost to Follow-up|2|||
33424463|NCT00320788|62802517|FG002|Overall Study|Lost to Follow-up|1|||
33424464|NCT00320788|62802518|FG003|Overall Study|Lost to Follow-up|0|||
33424465|NCT00320788|62802519|FG004|Overall Study|Lost to Follow-up|0|||
33424466|NCT00320788|62802515|FG000|Overall Study|Decision by the Sponsor|1|||
33424467|NCT00320788|62802516|FG001|Overall Study|Decision by the Sponsor|1|||
33424468|NCT00320788|62802517|FG002|Overall Study|Decision by the Sponsor|0|||
33424469|NCT00320788|62802518|FG003|Overall Study|Decision by the Sponsor|0|||
33424470|NCT00320788|62802519|FG004|Overall Study|Decision by the Sponsor|1|||
33424471|NCT00320788|62802515|FG000|Overall Study|Other|1|||
33424472|NCT00320788|62802516|FG001|Overall Study|Other|2|||
33424473|NCT00320788|62802517|FG002|Overall Study|Other|1|||
33424474|NCT00320788|62802518|FG003|Overall Study|Other|1|||
33424475|NCT00320788|62802519|FG004|Overall Study|Other|1|||
33424476|NCT00320788|62802515|FG000|Overall Study|Physician Decision|1|||
33424477|NCT00320788|62802516|FG001|Overall Study|Physician Decision|1|||
33424478|NCT00320788|62802517|FG002|Overall Study|Physician Decision|0|||
33424479|NCT00320788|62802518|FG003|Overall Study|Physician Decision|0|||
33424480|NCT00320788|62802519|FG004|Overall Study|Physician Decision|0|||
33424481|NCT00320788|62802515|FG000|Overall Study|Protocol Violation|0|||
33424482|NCT00320788|62802516|FG001|Overall Study|Protocol Violation|0|||
33424483|NCT00320788|62802517|FG002|Overall Study|Protocol Violation|0|||
33424484|NCT00320788|62802518|FG003|Overall Study|Protocol Violation|0|||
33424485|NCT00320788|62802519|FG004|Overall Study|Protocol Violation|1|||
33424486|NCT00320788|62802515|FG000|Overall Study|Withdrawal by Subject|3|||
33424487|NCT00320788|62802516|FG001|Overall Study|Withdrawal by Subject|0|||
33424488|NCT00320788|62802517|FG002|Overall Study|Withdrawal by Subject|0|||
33424489|NCT00320788|62802518|FG003|Overall Study|Withdrawal by Subject|3|||
33424490|NCT00320788|62802519|FG004|Overall Study|Withdrawal by Subject|1|||
33424491|NCT00503984|62802539|FG000|Overall Study|Protocol Violation|0|||
33424492|NCT00503984|62802540|FG001|Overall Study|Protocol Violation|1|||
33424493|NCT00503984|62802541|FG002|Overall Study|Protocol Violation|0|||
33424494|NCT00503984|62802542|FG003|Overall Study|Protocol Violation|0|||
33424495|NCT00503984|62802543|FG004|Overall Study|Protocol Violation|0|||
33424496|NCT00503984|62802544|FG005|Overall Study|Protocol Violation|0|||
33424497|NCT00503984|62802539|FG000|Overall Study|Adverse Event|0|||
33424498|NCT00503984|62802540|FG001|Overall Study|Adverse Event|1|||
33424499|NCT00503984|62802541|FG002|Overall Study|Adverse Event|0|||
33424500|NCT00503984|62802542|FG003|Overall Study|Adverse Event|0|||
33424501|NCT00503984|62802543|FG004|Overall Study|Adverse Event|0|||
33322978|NCT00927472|62699251|FG001|Overall Study|Withdrawal by Subject|11|||
33322979|NCT00927472|62699250|FG000|Overall Study|Lost to Follow-up|1|||
33322980|NCT00927472|62699251|FG001|Overall Study|Lost to Follow-up|6|||
33424502|NCT00503984|62802544|FG005|Overall Study|Adverse Event|0|||
33424503|NCT00503984|62802539|FG000|Overall Study|Death|0|||
33424504|NCT00503984|62802540|FG001|Overall Study|Death|0|||
33424505|NCT00503984|62802541|FG002|Overall Study|Death|0|||
33424506|NCT00503984|62802542|FG003|Overall Study|Death|0|||
33424507|NCT00503984|62802543|FG004|Overall Study|Death|1|||
33424508|NCT00503984|62802544|FG005|Overall Study|Death|0|||
33424509|NCT00565409|62802568|FG000|Period 1 Open Label|Adverse Event|17|||
33424510|NCT00565409|62802569|FG001|Period 1 Open Label|Adverse Event|0|||
33424511|NCT00565409|62802570|FG002|Period 1 Open Label|Adverse Event|0|||
33424512|NCT00565409|62802571|FG003|Period 1 Open Label|Adverse Event|0|||
33424513|NCT00565409|62802568|FG000|Period 1 Open Label|Death|2|||
33424514|NCT00565409|62802569|FG001|Period 1 Open Label|Death|0|||
33424515|NCT00565409|62802570|FG002|Period 1 Open Label|Death|0|||
33424516|NCT00565409|62802571|FG003|Period 1 Open Label|Death|0|||
33424517|NCT00565409|62802568|FG000|Period 1 Open Label|Lost to Follow-up|1|||
33424518|NCT00565409|62802569|FG001|Period 1 Open Label|Lost to Follow-up|0|||
33424519|NCT00565409|62802570|FG002|Period 1 Open Label|Lost to Follow-up|0|||
33424520|NCT00565409|62802571|FG003|Period 1 Open Label|Lost to Follow-up|0|||
33424521|NCT00565409|62802568|FG000|Period 1 Open Label|Other|21|||
33424522|NCT00565409|62802569|FG001|Period 1 Open Label|Other|0|||
33424523|NCT00565409|62802570|FG002|Period 1 Open Label|Other|0|||
33424524|NCT00565409|62802571|FG003|Period 1 Open Label|Other|0|||
33424525|NCT00565409|62802568|FG000|Period 1 Open Label|Protocol Violation|14|||
33424526|NCT00565409|62802569|FG001|Period 1 Open Label|Protocol Violation|0|||
33424527|NCT00565409|62802570|FG002|Period 1 Open Label|Protocol Violation|0|||
33424528|NCT00565409|62802571|FG003|Period 1 Open Label|Protocol Violation|0|||
33424529|NCT00565409|62802568|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
33424530|NCT00565409|62802569|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
33424531|NCT00565409|62802570|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
33424532|NCT00565409|62802571|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
33424533|NCT00565409|62802568|FG000|Period 1 Open Label|no conclusion of participation record|1|||
33424534|NCT00565409|62802569|FG001|Period 1 Open Label|no conclusion of participation record|0|||
33424535|NCT00565409|62802570|FG002|Period 1 Open Label|no conclusion of participation record|0|||
33424536|NCT00565409|62802571|FG003|Period 1 Open Label|no conclusion of participation record|0|||
33424537|NCT00565409|62802568|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
33424538|NCT00565409|62802569|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
33424539|NCT00565409|62802570|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
33424540|NCT00565409|62802571|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
33424541|NCT00565409|62802568|FG000|Period 2 Double-Blind|Adverse Event|0|||
33424542|NCT00565409|62802569|FG001|Period 2 Double-Blind|Adverse Event|7|||
33424543|NCT00565409|62802570|FG002|Period 2 Double-Blind|Adverse Event|4|||
33424544|NCT00565409|62802571|FG003|Period 2 Double-Blind|Adverse Event|5|||
33424545|NCT00565409|62802568|FG000|Period 2 Double-Blind|Death|0|||
33424546|NCT00565409|62802569|FG001|Period 2 Double-Blind|Death|2|||
33424547|NCT00565409|62802570|FG002|Period 2 Double-Blind|Death|0|||
33424548|NCT00565409|62802571|FG003|Period 2 Double-Blind|Death|0|||
33424549|NCT00565409|62802568|FG000|Period 2 Double-Blind|Protocol Violation|0|||
33424550|NCT00565409|62802569|FG001|Period 2 Double-Blind|Protocol Violation|4|||
33424551|NCT00565409|62802570|FG002|Period 2 Double-Blind|Protocol Violation|6|||
33424552|NCT00565409|62802571|FG003|Period 2 Double-Blind|Protocol Violation|2|||
33424553|NCT00565409|62802568|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
33424554|NCT00565409|62802569|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
33424555|NCT00565409|62802570|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
33424556|NCT00565409|62802571|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
33424557|NCT00565409|62802568|FG000|Period 2 Double-Blind|Other|0|||
33424558|NCT00565409|62802569|FG001|Period 2 Double-Blind|Other|4|||
33424559|NCT00565409|62802570|FG002|Period 2 Double-Blind|Other|5|||
33424560|NCT00565409|62802571|FG003|Period 2 Double-Blind|Other|9|||
33424561|NCT00565409|62802568|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
33424562|NCT00565409|62802569|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
33424563|NCT00565409|62802570|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
33424564|NCT00565409|62802571|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
33424565|NCT00394251|62802583|FG000|Overall Study|Adverse Event|7|||
33424566|NCT00394251|62802584|FG001|Overall Study|Adverse Event|5|||
33424567|NCT00394251|62802583|FG000|Overall Study|Unacceptable Toxicity|20|||
33424568|NCT00394251|62802584|FG001|Overall Study|Unacceptable Toxicity|18|||
33424569|NCT00394251|62802583|FG000|Overall Study|Physician Decision|1|||
33424570|NCT00394251|62802584|FG001|Overall Study|Physician Decision|1|||
33424571|NCT00394251|62802583|FG000|Overall Study|Protocol Violation|0|||
33424572|NCT00394251|62802584|FG001|Overall Study|Protocol Violation|1|||
33424573|NCT00394251|62802583|FG000|Overall Study|Withdrawal by Subject|7|||
33424574|NCT00394251|62802584|FG001|Overall Study|Withdrawal by Subject|11|||
33424575|NCT00394251|62802583|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
33424576|NCT00394251|62802584|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
33424577|NCT00394095|62802596|FG000|Overall Study|Adverse Event|1|||
33424578|NCT00394095|62802597|FG001|Overall Study|Adverse Event|0|||
33424579|NCT00503906|62802604|FG000|Overall Study|Withdrawal by Subject|1|||
33424580|NCT00305110|62802609|FG000|Overall Study|Missing data|29|||
33424581|NCT00491894|62802613|FG000|Overall Study|Adverse Event|14|||
33424582|NCT00491894|62802613|FG000|Overall Study|Withdrawal by Subject|5|||
33424583|NCT00491894|62802613|FG000|Overall Study|Death|3|||
33424584|NCT00491894|62802613|FG000|Overall Study|Lost to Follow-up|3|||
33424585|NCT00491894|62802613|FG000|Overall Study|Lack of Efficacy|2|||
33424586|NCT00491894|62802613|FG000|Overall Study|Other-Failed to meet any criteria|2|||
33424587|NCT00491894|62802613|FG000|Overall Study|Physician Decision|2|||
33424588|NCT00491894|62802613|FG000|Overall Study|Protocol Violation|2|||
33424589|NCT00491894|62802613|FG000|Overall Study|Other-Intake of prohibited medication|1|||
33424590|NCT00491504|62802621|FG000|Overall Study|Adverse Event|0|||
33424591|NCT00491504|62802622|FG001|Overall Study|Adverse Event|1|||
33424592|NCT00491504|62802623|FG002|Overall Study|Adverse Event|0|||
33424593|NCT00491504|62802624|FG003|Overall Study|Adverse Event|0|||
33424594|NCT00491504|62802621|FG000|Overall Study|Withdrawal by Subject|0|||
33424595|NCT00491504|62802622|FG001|Overall Study|Withdrawal by Subject|0|||
33424596|NCT00491504|62802623|FG002|Overall Study|Withdrawal by Subject|1|||
33424597|NCT00491504|62802624|FG003|Overall Study|Withdrawal by Subject|2|||
33424598|NCT00491504|62802621|FG000|Overall Study|Protocol Violation|0|||
33424599|NCT00491504|62802622|FG001|Overall Study|Protocol Violation|0|||
33424600|NCT00491504|62802623|FG002|Overall Study|Protocol Violation|3|||
33424601|NCT00491504|62802624|FG003|Overall Study|Protocol Violation|2|||
33424602|NCT00500292|62802635|FG000|Overall Study|Adverse Event|3|||
33424603|NCT00500292|62802636|FG001|Overall Study|Adverse Event|6|||
33424604|NCT00500292|62802637|FG002|Overall Study|Adverse Event|4|||
33424605|NCT00500292|62802635|FG000|Overall Study|Condition under investigation worsened|21|||
33424606|NCT00500292|62802636|FG001|Overall Study|Condition under investigation worsened|23|||
33424607|NCT00500292|62802637|FG002|Overall Study|Condition under investigation worsened|19|||
33424608|NCT00500292|62802635|FG000|Overall Study|Withdrawal by Subject|0|||
33424609|NCT00500292|62802636|FG001|Overall Study|Withdrawal by Subject|1|||
33424610|NCT00500292|62802637|FG002|Overall Study|Withdrawal by Subject|0|||
33424611|NCT00500292|62802635|FG000|Overall Study|Other|1|||
33424612|NCT00500292|62802636|FG001|Overall Study|Other|1|||
33424613|NCT00500292|62802637|FG002|Overall Study|Other|4|||
33424614|NCT00499746|62802645|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
33424615|NCT00499746|62802645|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
33424616|NCT00499746|62802645|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
33424617|NCT00499746|62802645|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
33424618|NCT00489216|62802659|FG000|Overall Study|Adverse Event|1|||
33424619|NCT00499590|62802666|FG000|Overall Study|Study Terminated|112|||
33424620|NCT00499590|62802667|FG001|Overall Study|Study Terminated|112|||
33424621|NCT00499590|62802668|FG002|Overall Study|Study Terminated|112|||
33424622|NCT00499590|62802666|FG000|Overall Study|Not treated|1|||
33424623|NCT00499590|62802667|FG001|Overall Study|Not treated|0|||
33424624|NCT00499590|62802668|FG002|Overall Study|Not treated|1|||
33424625|NCT00510146|62802679|FG000|Double-Blind Treatment|Adverse Event|30|||
33424626|NCT00510146|62802680|FG001|Double-Blind Treatment|Adverse Event|13|||
33424627|NCT00510146|62802679|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
33424628|NCT00510146|62802680|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
33424629|NCT00510146|62802679|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
33424630|NCT00510146|62802680|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
33424631|NCT00510146|62802679|FG000|Double-Blind Treatment|Physician Decision|6|||
33424632|NCT00510146|62802680|FG001|Double-Blind Treatment|Physician Decision|0|||
33424633|NCT00510146|62802679|FG000|Double-Blind Treatment|Protocol Violation|1|||
33424634|NCT00510146|62802680|FG001|Double-Blind Treatment|Protocol Violation|2|||
33424635|NCT00510146|62802679|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
33424636|NCT00510146|62802680|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
33424637|NCT00510146|62802679|FG000|Double-Blind Treatment|Clinical Relapse|0|||
33424638|NCT00510146|62802680|FG001|Double-Blind Treatment|Clinical Relapse|1|||
33424639|NCT00510146|62802679|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
33424640|NCT00510146|62802680|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
33424641|NCT00510146|62802679|FG000|Open-Label Treatment|Adverse Event|22|||
33424642|NCT00510146|62802680|FG001|Open-Label Treatment|Adverse Event|8|||
33424643|NCT00510146|62802679|FG000|Open-Label Treatment|Death|1|||
33424644|NCT00510146|62802680|FG001|Open-Label Treatment|Death|1|||
33424645|NCT00510146|62802679|FG000|Open-Label Treatment|Lack of Efficacy|4|||
33424646|NCT00510146|62802680|FG001|Open-Label Treatment|Lack of Efficacy|0|||
33424647|NCT00510146|62802679|FG000|Open-Label Treatment|Lost to Follow-up|10|||
33424648|NCT00510146|62802680|FG001|Open-Label Treatment|Lost to Follow-up|1|||
33424649|NCT00510146|62802679|FG000|Open-Label Treatment|Physician Decision|3|||
33424650|NCT00510146|62802680|FG001|Open-Label Treatment|Physician Decision|1|||
33424651|NCT00510146|62802679|FG000|Open-Label Treatment|Protocol Violation|4|||
33424652|NCT00510146|62802680|FG001|Open-Label Treatment|Protocol Violation|2|||
33424653|NCT00510146|62802679|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
33424654|NCT00510146|62802680|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
33424655|NCT00510146|62802679|FG000|Open-Label Treatment|Clinical Relapse|1|||
33424656|NCT00510146|62802680|FG001|Open-Label Treatment|Clinical Relapse|1|||
33424657|NCT00510146|62802679|FG000|Open-Label Treatment|Sponsor Decision|2|||
33424658|NCT00510146|62802680|FG001|Open-Label Treatment|Sponsor Decision|0|||
33424659|NCT00480636|62802688|FG000|Overall Study|Death|12|||
33424660|NCT00480636|62802688|FG000|Overall Study|Lost to Follow-up|4|||
33424661|NCT00480636|62802688|FG000|Overall Study|Other|2|||
33424662|NCT00480636|62802688|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
33424663|NCT00499122|62802692|FG000|Overall Study|Withdrawal by Subject|2|||
33424664|NCT00393939|62802699|FG000|Overall Study|Protocol Violation|1|||
33605302|NCT02392403|63005024|FG000|Overall Study|Death|1|||
33605303|NCT02392403|63005024|FG000|Overall Study|Withdrawal by Subject|1|||
33605304|NCT02392247|63005028|FG000|Overall Study|Withdrawal by Subject|1|||
33605305|NCT02392247|63005028|FG000|Overall Study|Surgery cancelled; no data|1|||
33605306|NCT02337725|63005034|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
33605307|NCT02337725|63005035|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
33605308|NCT02337725|63005034|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
33605309|NCT02337725|63005035|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
33605310|NCT02337725|63005034|FG000|Overall Study|Major Protocol Deviation|0|||
33605311|NCT02337725|63005035|FG001|Overall Study|Major Protocol Deviation|1|||
33605312|NCT02337725|63005034|FG000|Overall Study|Voluntary Withdrawal|14|||
33605313|NCT02337725|63005035|FG001|Overall Study|Voluntary Withdrawal|3|||
33605314|NCT02337725|63005034|FG000|Overall Study|Lack of Efficacy|4|||
33605315|NCT02337725|63005035|FG001|Overall Study|Lack of Efficacy|0|||
33424665|NCT00393939|62802700|FG001|Overall Study|Protocol Violation|1|||
33424666|NCT00393939|62802699|FG000|Overall Study|Lost to Follow-up|2|||
33424667|NCT00393939|62802700|FG001|Overall Study|Lost to Follow-up|4|||
33424668|NCT00393939|62802699|FG000|Overall Study|Death|10|||
33424669|NCT00393939|62802700|FG001|Overall Study|Death|4|||
33424670|NCT00393939|62802699|FG000|Overall Study|Sponsor|5|||
33424671|NCT00393939|62802700|FG001|Overall Study|Sponsor|13|||
33424672|NCT00393939|62802699|FG000|Overall Study|Objective progression or relapse|239|||
33424673|NCT00393939|62802700|FG001|Overall Study|Objective progression or relapse|223|||
33424674|NCT00393939|62802699|FG000|Overall Study|Withdrawal by Subject|2|||
33424675|NCT00393939|62802700|FG001|Overall Study|Withdrawal by Subject|7|||
33424676|NCT00393939|62802699|FG000|Overall Study|Other|37|||
33424677|NCT00393939|62802700|FG001|Overall Study|Other|45|||
33424678|NCT00488982|62802706|FG000|Course 1|Physician Decision|0|||
33424679|NCT00488982|62802707|FG001|Course 1|Physician Decision|2|||
33424680|NCT00488982|62802708|FG002|Course 1|Physician Decision|4|||
33424681|NCT00488982|62802706|FG000|Course 1|Withdrawal by Subject|0|||
33424682|NCT00488982|62802707|FG001|Course 1|Withdrawal by Subject|8|||
33424683|NCT00488982|62802708|FG002|Course 1|Withdrawal by Subject|2|||
33424684|NCT00488982|62802706|FG000|Course 1|nonprotocol therapy|0|||
33424685|NCT00488982|62802707|FG001|Course 1|nonprotocol therapy|2|||
33424686|NCT00488982|62802708|FG002|Course 1|nonprotocol therapy|2|||
33424687|NCT00488982|62802706|FG000|Course 1|Adverse Event|0|||
33424688|NCT00488982|62802707|FG001|Course 1|Adverse Event|0|||
33424689|NCT00488982|62802708|FG002|Course 1|Adverse Event|6|||
33424690|NCT00488826|62802725|FG000|Overall Study|Withdrawal by Subject|40|||
33424691|NCT00488826|62802726|FG001|Overall Study|Withdrawal by Subject|35|||
33424692|NCT00488826|62802727|FG002|Overall Study|Withdrawal by Subject|19|||
33424693|NCT00488826|62802725|FG000|Overall Study|Protocol Violation|0|||
33424694|NCT00488826|62802726|FG001|Overall Study|Protocol Violation|0|||
33424695|NCT00488826|62802727|FG002|Overall Study|Protocol Violation|2|||
33424696|NCT00488826|62802725|FG000|Overall Study|Adverse Event|9|||
33424697|NCT00488826|62802726|FG001|Overall Study|Adverse Event|15|||
33424698|NCT00488826|62802727|FG002|Overall Study|Adverse Event|4|||
33424699|NCT00488826|62802725|FG000|Overall Study|Lost to Follow-up|5|||
33424700|NCT00488826|62802726|FG001|Overall Study|Lost to Follow-up|1|||
33424701|NCT00488826|62802727|FG002|Overall Study|Lost to Follow-up|0|||
33424702|NCT00488826|62802725|FG000|Overall Study|Protocol Deviations|2|||
33424703|NCT00488826|62802726|FG001|Overall Study|Protocol Deviations|1|||
33424704|NCT00488826|62802727|FG002|Overall Study|Protocol Deviations|1|||
33424705|NCT00393861|62802735|FG000|Overall Study|Adverse Event|2|||
33424706|NCT00393861|62802735|FG000|Overall Study|Disease Progression|24|||
33605316|NCT02337491|63005043|FG000|Overall Study|Death|1|||
33605317|NCT02337491|63005044|FG001|Overall Study|Death|1|||
33424707|NCT00480324|62802741|FG000|Overall Study|Adverse Event|1|||
33424708|NCT00480324|62802742|FG001|Overall Study|Adverse Event|1|||
33424709|NCT00480324|62802741|FG000|Overall Study|Protocol Violation|0|||
33424710|NCT00480324|62802742|FG001|Overall Study|Protocol Violation|1|||
33424711|NCT00480324|62802741|FG000|Overall Study|Withdrawal by Subject|14|||
33424712|NCT00480324|62802742|FG001|Overall Study|Withdrawal by Subject|5|||
33424713|NCT00480324|62802741|FG000|Overall Study|Lost to Follow-up|17|||
33424714|NCT00480324|62802742|FG001|Overall Study|Lost to Follow-up|8|||
33424715|NCT00480324|62802741|FG000|Overall Study|Subject's mother pregnant|0|||
33424716|NCT00480324|62802742|FG001|Overall Study|Subject's mother pregnant|1|||
33424717|NCT00488592|62802748|FG000|Overall Study|Withdrawal by Subject|1|||
33424718|NCT00488592|62802748|FG000|Overall Study|Disease progression|1|||
33424719|NCT00488592|62802748|FG000|Overall Study|Enrolled but not treated|1|||
33605318|NCT02337491|63005043|FG000|Overall Study|Adverse Event|0|||
33605319|NCT02337491|63005044|FG001|Overall Study|Adverse Event|1|||
33605320|NCT02337491|63005043|FG000|Overall Study|Withdrawal by Subject|3|||
33424720|NCT00488514|62802752|FG000|Overall Study|Adverse Event|41|||
33424721|NCT00488514|62802752|FG000|Overall Study|Lost to Follow-up|44|||
33424722|NCT00488514|62802752|FG000|Overall Study|Protocol Violation|32|||
33424723|NCT00488514|62802752|FG000|Overall Study|Withdrawal by Subject|106|||
33424724|NCT00488514|62802752|FG000|Overall Study|Lack of Efficacy|28|||
33424725|NCT00488514|62802752|FG000|Overall Study|Did not meet criteria for treatment|30|||
33424726|NCT00488514|62802752|FG000|Overall Study|Postive drug screen|1|||
33424727|NCT00488514|62802752|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
33424728|NCT00488514|62802752|FG000|Overall Study|Investigator decision|1|||
33424729|NCT00488514|62802752|FG000|Overall Study|Participant had too few migraines|5|||
33424730|NCT00488514|62802752|FG000|Overall Study|Increase in number of migraines|2|||
33424731|NCT00488514|62802752|FG000|Overall Study|Increased use of concomitant medication|1|||
33424732|NCT00320710|62802776|FG000|Overall Study|Disease progression|24|||
33424733|NCT00320710|62802777|FG001|Overall Study|Disease progression|19|||
33424734|NCT00320710|62802778|FG002|Overall Study|Disease progression|2|||
33424735|NCT00320710|62802776|FG000|Overall Study|Death|10|||
33424736|NCT00320710|62802777|FG001|Overall Study|Death|7|||
33424737|NCT00320710|62802778|FG002|Overall Study|Death|1|||
33424738|NCT00320710|62802776|FG000|Overall Study|Administrative problems|1|||
33424739|NCT00320710|62802777|FG001|Overall Study|Administrative problems|2|||
33424740|NCT00320710|62802778|FG002|Overall Study|Administrative problems|0|||
33424741|NCT00320710|62802776|FG000|Overall Study|Withdrawal by Subject|20|||
33424742|NCT00320710|62802777|FG001|Overall Study|Withdrawal by Subject|26|||
33424743|NCT00320710|62802778|FG002|Overall Study|Withdrawal by Subject|1|||
33424744|NCT00320710|62802776|FG000|Overall Study|Protocol Violation|6|||
33424745|NCT00320710|62802777|FG001|Overall Study|Protocol Violation|5|||
33424746|NCT00320710|62802778|FG002|Overall Study|Protocol Violation|0|||
33424747|NCT00320710|62802776|FG000|Overall Study|Abnormal test procedure result(s)|2|||
33424748|NCT00320710|62802777|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33424749|NCT00320710|62802778|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33424750|NCT00320710|62802776|FG000|Overall Study|Abnormal laboratory value(s)|12|||
33424751|NCT00320710|62802777|FG001|Overall Study|Abnormal laboratory value(s)|3|||
33424752|NCT00320710|62802778|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33424753|NCT00320710|62802776|FG000|Overall Study|Adverse Event|18|||
33424754|NCT00320710|62802777|FG001|Overall Study|Adverse Event|14|||
33424755|NCT00320710|62802778|FG002|Overall Study|Adverse Event|1|||
33424756|NCT00320710|62802776|FG000|Overall Study|Lost to Follow-up|1|||
33424757|NCT00320710|62802777|FG001|Overall Study|Lost to Follow-up|0|||
33424758|NCT00320710|62802778|FG002|Overall Study|Lost to Follow-up|0|||
33424759|NCT00320398|62802787|FG000|Overall Study|Adverse Event|1|||
33424760|NCT00320398|62802788|FG001|Overall Study|Adverse Event|4|||
33424761|NCT00320398|62802787|FG000|Overall Study|Other|1|||
33424762|NCT00320398|62802788|FG001|Overall Study|Other|0|||
33424763|NCT00498186|62802795|FG000|Overall Study|Protocol Violation|10|||
33424764|NCT00498186|62802795|FG000|Overall Study|Lack of Efficacy|31|||
33424765|NCT00498186|62802795|FG000|Overall Study|Adverse Event|89|||
33424766|NCT00498186|62802795|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
33424767|NCT00498186|62802795|FG000|Overall Study|Withdrawal by Subject|18|||
33424768|NCT00498186|62802795|FG000|Overall Study|Lost to Follow-up|3|||
33424769|NCT00498186|62802795|FG000|Overall Study|Other|10|||
33424770|NCT00333970|62802801|FG000|Overall Study|Withdrawal by Subject|13|||
33424771|NCT00333970|62802802|FG001|Overall Study|Withdrawal by Subject|7|||
33424772|NCT00477594|62802810|FG000|Year 1 and Year 2|Adverse Event|4|||
33424773|NCT00477594|62802811|FG001|Year 1 and Year 2|Adverse Event|2|||
33424774|NCT00477594|62802810|FG000|Year 1 and Year 2|Physician Decision|2|||
33424775|NCT00477594|62802811|FG001|Year 1 and Year 2|Physician Decision|1|||
33424776|NCT00477594|62802810|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
33424777|NCT00477594|62802811|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
33605321|NCT02337491|63005044|FG001|Overall Study|Withdrawal by Subject|0|||
33605322|NCT02337491|63005043|FG000|Overall Study|Progressive Disease|44|||
33605323|NCT02337491|63005044|FG001|Overall Study|Progressive Disease|28|||
33605324|NCT02337491|63005043|FG000|Overall Study|On Treatment|2|||
33424778|NCT00477594|62802810|FG000|Year 1 and Year 2|Other|1|||
33424779|NCT00477594|62802811|FG001|Year 1 and Year 2|Other|0|||
33424780|NCT00477594|62802810|FG000|Year 3|Adverse Event|1|||
33605325|NCT02337491|63005044|FG001|Overall Study|On Treatment|0|||
33424781|NCT00477594|62802811|FG001|Year 3|Adverse Event|0|||
33424782|NCT00477594|62802810|FG000|Year 3|Withdrawal by Subject|1|||
33424783|NCT00477594|62802811|FG001|Year 3|Withdrawal by Subject|0|||
33424784|NCT00477594|62802810|FG000|Follow-up Period|Withdrawal by Subject|2|||
33424785|NCT00477594|62802811|FG001|Follow-up Period|Withdrawal by Subject|1|||
33424786|NCT00477594|62802810|FG000|Follow-up Period|Other|1|||
33424787|NCT00477594|62802811|FG001|Follow-up Period|Other|0|||
33424788|NCT00475722|62802819|FG000|Overall Study|Withdrawal by Subject|12|||
33605326|NCT01765582|63005054|FG000|Overall Study|Other|3|||
33424789|NCT00475722|62802820|FG001|Overall Study|Withdrawal by Subject|12|||
33424790|NCT00475722|62802819|FG000|Overall Study|Protocol Violation|3|||
33424791|NCT00475722|62802820|FG001|Overall Study|Protocol Violation|0|||
33424792|NCT00304954|62802830|FG000|Overall Study|Withdrawal by Subject|0|||
33424793|NCT00304954|62802831|FG001|Overall Study|Withdrawal by Subject|0|||
33424794|NCT00304954|62802832|FG002|Overall Study|Withdrawal by Subject|1|||
33424795|NCT00304954|62802833|FG003|Overall Study|Withdrawal by Subject|0|||
33424796|NCT00304954|62802830|FG000|Overall Study|Adverse Event|1|||
33424797|NCT00304954|62802831|FG001|Overall Study|Adverse Event|0|||
33424798|NCT00304954|62802832|FG002|Overall Study|Adverse Event|0|||
33424799|NCT00304954|62802833|FG003|Overall Study|Adverse Event|0|||
33424800|NCT00475176|62802851|FG000|Overall Study|Adverse Event|2|||
33424801|NCT00475176|62802851|FG000|Overall Study|Withdrawal by Subject|1|||
33424802|NCT00475176|62802851|FG000|Overall Study|Protocol Violation|1|||
33322981|NCT00927472|62699250|FG000|Overall Study|Protocol Violation|0|||
33322982|NCT00927472|62699251|FG001|Overall Study|Protocol Violation|1|||
33424803|NCT00414609|62802857|FG000|Core Study|Adverse Event|9|||
33424804|NCT00414609|62802858|FG001|Core Study|Adverse Event|11|||
33424805|NCT00414609|62802859|FG002|Core Study|Adverse Event|0|||
33424806|NCT00414609|62802857|FG000|Core Study|Abnormal laboratory values|0|||
33424807|NCT00414609|62802858|FG001|Core Study|Abnormal laboratory values|1|||
33424808|NCT00414609|62802859|FG002|Core Study|Abnormal laboratory values|0|||
33424809|NCT00414609|62802857|FG000|Core Study|Abnormal test procedure results|1|||
33424810|NCT00414609|62802858|FG001|Core Study|Abnormal test procedure results|1|||
33424811|NCT00414609|62802859|FG002|Core Study|Abnormal test procedure results|0|||
33424812|NCT00414609|62802857|FG000|Core Study|Protocol deviation|0|||
33424813|NCT00414609|62802858|FG001|Core Study|Protocol deviation|1|||
33424814|NCT00414609|62802859|FG002|Core Study|Protocol deviation|0|||
33424815|NCT00414609|62802857|FG000|Core Study|Patient withdrew consent|10|||
33424816|NCT00414609|62802858|FG001|Core Study|Patient withdrew consent|11|||
33424817|NCT00414609|62802859|FG002|Core Study|Patient withdrew consent|0|||
33424818|NCT00414609|62802857|FG000|Core Study|Lost to Follow-up|7|||
33424819|NCT00414609|62802858|FG001|Core Study|Lost to Follow-up|4|||
33424820|NCT00414609|62802859|FG002|Core Study|Lost to Follow-up|0|||
33424821|NCT00414609|62802857|FG000|Core Study|Administrative problems|0|||
33424822|NCT00414609|62802858|FG001|Core Study|Administrative problems|2|||
33424823|NCT00414609|62802859|FG002|Core Study|Administrative problems|0|||
33424824|NCT00414609|62802857|FG000|Core Study|Death|7|||
33424825|NCT00414609|62802858|FG001|Core Study|Death|14|||
33424826|NCT00414609|62802859|FG002|Core Study|Death|0|||
33424827|NCT00414609|62802857|FG000|Extension Study|Adverse Event|0|||
33424828|NCT00414609|62802858|FG001|Extension Study|Adverse Event|0|||
33424829|NCT00414609|62802859|FG002|Extension Study|Adverse Event|14|||
33424830|NCT00414609|62802857|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
33424831|NCT00414609|62802858|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
33424832|NCT00414609|62802859|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
33424833|NCT00414609|62802857|FG000|Extension Study|Withdrawal by Subject|0|||
33424834|NCT00414609|62802858|FG001|Extension Study|Withdrawal by Subject|0|||
33424835|NCT00414609|62802859|FG002|Extension Study|Withdrawal by Subject|13|||
33424836|NCT00414609|62802857|FG000|Extension Study|Lost to Follow-up|0|||
33424837|NCT00414609|62802858|FG001|Extension Study|Lost to Follow-up|0|||
33424838|NCT00414609|62802859|FG002|Extension Study|Lost to Follow-up|10|||
33424839|NCT00414609|62802857|FG000|Extension Study|Administrative problems|0|||
33424840|NCT00414609|62802858|FG001|Extension Study|Administrative problems|0|||
33424841|NCT00414609|62802859|FG002|Extension Study|Administrative problems|1|||
33424842|NCT00414609|62802857|FG000|Extension Study|Death|0|||
33424843|NCT00414609|62802858|FG001|Extension Study|Death|0|||
33322983|NCT00927472|62699250|FG000|Overall Study|Post treatment Assessment out of window|0|||
33424844|NCT00414609|62802859|FG002|Extension Study|Death|17|||
33424845|NCT00393705|62802870|FG000|Overall Study|Adverse Event|0|||
33424846|NCT00393705|62802871|FG001|Overall Study|Adverse Event|2|||
33424847|NCT00393705|62802870|FG000|Overall Study|Death|0|||
33424848|NCT00393705|62802871|FG001|Overall Study|Death|1|||
33424849|NCT00393705|62802870|FG000|Overall Study|Lost to Follow-up|2|||
33424850|NCT00393705|62802871|FG001|Overall Study|Lost to Follow-up|2|||
33424851|NCT00393705|62802870|FG000|Overall Study|Entry Criteria Not Met|10|||
33424852|NCT00393705|62802871|FG001|Overall Study|Entry Criteria Not Met|10|||
33424853|NCT00393705|62802870|FG000|Overall Study|Protocol Violation|4|||
33424854|NCT00393705|62802871|FG001|Overall Study|Protocol Violation|3|||
33424855|NCT00393705|62802870|FG000|Overall Study|Withdrawal by Subject|5|||
33424856|NCT00393705|62802871|FG001|Overall Study|Withdrawal by Subject|3|||
33424857|NCT00393705|62802870|FG000|Overall Study|Physician Decision|2|||
33424858|NCT00393705|62802871|FG001|Overall Study|Physician Decision|2|||
33424859|NCT00303628|62802879|FG000|Overall Study|Disease progression|0|||
33424860|NCT00303628|62802880|FG001|Overall Study|Disease progression|1|||
33424861|NCT00303628|62802879|FG000|Overall Study|Adverse Event|26|||
33424862|NCT00303628|62802880|FG001|Overall Study|Adverse Event|36|||
33424863|NCT00303628|62802879|FG000|Overall Study|Death|0|||
33424864|NCT00303628|62802880|FG001|Overall Study|Death|1|||
33424865|NCT00303628|62802879|FG000|Overall Study|Withdrawal by Subject|11|||
33424866|NCT00303628|62802880|FG001|Overall Study|Withdrawal by Subject|20|||
33424867|NCT00303628|62802879|FG000|Overall Study|Alternative therapy|2|||
33424868|NCT00303628|62802880|FG001|Overall Study|Alternative therapy|0|||
33424869|NCT00303628|62802879|FG000|Overall Study|Other complicating disease|0|||
33424870|NCT00303628|62802880|FG001|Overall Study|Other complicating disease|1|||
33424871|NCT00303628|62802879|FG000|Overall Study|Not start protocol therapy|3|||
33424872|NCT00303628|62802880|FG001|Overall Study|Not start protocol therapy|5|||
33424873|NCT00303628|62802879|FG000|Overall Study|Other|8|||
33424874|NCT00303628|62802880|FG001|Overall Study|Other|9|||
33424875|NCT00414453|62802886|FG000|Overall Study|Abnormal lab work|16|||
33424876|NCT00332488|62802899|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
33424877|NCT00332488|62802900|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
33424878|NCT00332488|62802901|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
33424879|NCT00332488|62802899|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
33424880|NCT00332488|62802900|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
33424881|NCT00332488|62802901|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
33424882|NCT00332488|62802899|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
33424883|NCT00332488|62802900|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
33424884|NCT00332488|62802901|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
33424885|NCT00332488|62802899|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
33424886|NCT00332488|62802900|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
33424887|NCT00332488|62802901|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
33424888|NCT00332488|62802899|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
33424889|NCT00332488|62802900|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
33424890|NCT00332488|62802901|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
33424891|NCT00332488|62802899|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
33424892|NCT00332488|62802900|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
33424893|NCT00332488|62802901|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
33424894|NCT00332488|62802899|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
33424895|NCT00332488|62802900|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
33424896|NCT00332488|62802901|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
33424897|NCT00332488|62802899|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
33424898|NCT00332488|62802900|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
33424899|NCT00332488|62802901|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
33424900|NCT00332488|62802899|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
33424901|NCT00332488|62802900|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
33424902|NCT00332488|62802901|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
33424903|NCT00332488|62802899|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
33424904|NCT00332488|62802900|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
33424905|NCT00332488|62802901|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
33424906|NCT00332488|62802899|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
33424907|NCT00332488|62802900|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
33424908|NCT00332488|62802901|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
33322984|NCT00927472|62699251|FG001|Overall Study|Post treatment Assessment out of window|4|||
33322985|NCT00927394|62699259|FG000|Overall Study|Adverse Event|14|||
33322986|NCT00927394|62699260|FG001|Overall Study|Adverse Event|9|||
33424909|NCT00332488|62802899|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
33424910|NCT00332488|62802900|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
33424911|NCT00332488|62802901|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
33322987|NCT00927394|62699259|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
33424912|NCT00332332|62802911|FG000|Overall Study|Adverse Event|13|||
33424913|NCT00332332|62802911|FG000|Overall Study|Death|1|||
33424914|NCT00332332|62802911|FG000|Overall Study|Withdrawal by Subject|8|||
33424915|NCT00332332|62802911|FG000|Overall Study|Physician Decision|1|||
33424916|NCT00332332|62802911|FG000|Overall Study|Lost to Follow-up|3|||
33424917|NCT00332332|62802911|FG000|Overall Study|Protocol deviation|4|||
33424918|NCT00332332|62802911|FG000|Overall Study|Noncompliance|2|||
33424919|NCT00332332|62802911|FG000|Overall Study|Disease progression|2|||
33424920|NCT00332332|62802911|FG000|Overall Study|Other|18|||
33424921|NCT00332332|62802911|FG000|Overall Study|Did not receive study treatment|16|||
33424922|NCT00392925|62802919|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
33424923|NCT00392925|62802920|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
33424924|NCT00392925|62802921|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
33424925|NCT00392925|62802922|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
33424926|NCT00392925|62802919|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
33424927|NCT00392925|62802920|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
33424928|NCT00392925|62802921|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
33424929|NCT00392925|62802922|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
33424930|NCT00392925|62802919|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
33424931|NCT00392925|62802920|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
33424932|NCT00392925|62802921|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
33424933|NCT00392925|62802922|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
33424934|NCT00392925|62802919|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
33424935|NCT00392925|62802920|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
33424936|NCT00392925|62802921|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
33424937|NCT00392925|62802922|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
33424938|NCT00392925|62802919|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
33424939|NCT00392925|62802920|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
33424940|NCT00392925|62802921|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
33424941|NCT00392925|62802922|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
33424942|NCT00392925|62802919|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
33424943|NCT00392925|62802920|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
33424944|NCT00392925|62802921|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
33424945|NCT00392925|62802922|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
33424946|NCT00392925|62802919|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
33605327|NCT01765582|63005055|FG001|Overall Study|Other|6|||
33605328|NCT01765582|63005056|FG002|Overall Study|Other|9|||
33322988|NCT00927394|62699260|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
33424947|NCT00392925|62802920|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
33424948|NCT00392925|62802921|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
33424949|NCT00392925|62802922|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
33424950|NCT00392925|62802919|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
33424951|NCT00392925|62802920|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
33424952|NCT00392925|62802921|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
33424953|NCT00392925|62802922|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
33424954|NCT00392925|62802919|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
33424955|NCT00392925|62802920|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
33424956|NCT00392925|62802921|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
33424957|NCT00392925|62802922|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
33424958|NCT00474786|62802940|FG000|Overall Study|Not Meeting Study Criteria|0|||
33424959|NCT00474786|62802941|FG001|Overall Study|Not Meeting Study Criteria|1|||
33424960|NCT00474786|62802940|FG000|Overall Study|Investigator Request|2|||
33424961|NCT00474786|62802941|FG001|Overall Study|Investigator Request|1|||
33424962|NCT00474786|62802940|FG000|Overall Study|Death|189|||
33424963|NCT00474786|62802941|FG001|Overall Study|Death|170|||
33424964|NCT00474786|62802940|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
33424965|NCT00474786|62802941|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
33424966|NCT00474786|62802940|FG000|Overall Study|Lost to Follow-up|4|||
33424967|NCT00474786|62802941|FG001|Overall Study|Lost to Follow-up|7|||
33424968|NCT00474786|62802940|FG000|Overall Study|Protocol Violation|2|||
33424969|NCT00474786|62802941|FG001|Overall Study|Protocol Violation|0|||
33424970|NCT00474786|62802940|FG000|Overall Study|Withdrawal by Subject|15|||
33424971|NCT00474786|62802941|FG001|Overall Study|Withdrawal by Subject|15|||
33424972|NCT00474786|62802940|FG000|Overall Study|Other|5|||
33424973|NCT00474786|62802941|FG001|Overall Study|Other|0|||
33424974|NCT00392769|62802947|FG000|Overall Study|Clinical Deterioration|9|||
33424975|NCT00392769|62802947|FG000|Overall Study|Adverse Event|1|||
33424976|NCT00319696|62802951|FG000|Overall Study|Adverse Event|36|||
33424977|NCT00319696|62802951|FG000|Overall Study|withdrawal of consent|14|||
33424978|NCT00319696|62802951|FG000|Overall Study|administrative|7|||
33424979|NCT00319696|62802951|FG000|Overall Study|Lost to Follow-up|3|||
33424980|NCT00474630|62802963|FG000|Overall Study|Adverse Event|98|||
33424981|NCT00474630|62802964|FG001|Overall Study|Adverse Event|26|||
33424982|NCT00474630|62802963|FG000|Overall Study|Lost to Follow-up|22|||
33424983|NCT00474630|62802964|FG001|Overall Study|Lost to Follow-up|15|||
33424984|NCT00474630|62802963|FG000|Overall Study|Withdrawal by Subject|21|||
33424985|NCT00474630|62802964|FG001|Overall Study|Withdrawal by Subject|15|||
33424986|NCT00474630|62802963|FG000|Overall Study|Protocol Violation|3|||
33424987|NCT00474630|62802964|FG001|Overall Study|Protocol Violation|4|||
33424988|NCT00474630|62802963|FG000|Overall Study|Lack of Efficacy|5|||
33424989|NCT00474630|62802964|FG001|Overall Study|Lack of Efficacy|6|||
33424990|NCT00474630|62802963|FG000|Overall Study|Drug noncompliance, other|11|||
33424991|NCT00474630|62802964|FG001|Overall Study|Drug noncompliance, other|4|||
33424992|NCT00392379|62802973|FG000|Overall Study|Withdrawal by Subject|17|||
33424993|NCT00392379|62802974|FG001|Overall Study|Withdrawal by Subject|28|||
33424994|NCT00392379|62802973|FG000|Overall Study|Lost to Follow-up|4|||
33424995|NCT00392379|62802974|FG001|Overall Study|Lost to Follow-up|9|||
33424996|NCT00392379|62802973|FG000|Overall Study|Adverse Event|1|||
33424997|NCT00392379|62802974|FG001|Overall Study|Adverse Event|1|||
33424998|NCT00497874|62802982|FG000|Overall Study|Withdrawal by Subject|48|||
33424999|NCT00497874|62802983|FG001|Overall Study|Withdrawal by Subject|17|||
33425000|NCT00497874|62802982|FG000|Overall Study|Illness|8|||
33425001|NCT00497874|62802983|FG001|Overall Study|Illness|4|||
33425002|NCT00497874|62802982|FG000|Overall Study|Death|2|||
33425003|NCT00497874|62802983|FG001|Overall Study|Death|4|||
33425004|NCT00497874|62802982|FG000|Overall Study|Unable to contact|52|||
33425005|NCT00497874|62802983|FG001|Overall Study|Unable to contact|67|||
33425006|NCT00497874|62802982|FG000|Overall Study|Unable to schedule|37|||
33425007|NCT00497874|62802983|FG001|Overall Study|Unable to schedule|24|||
33425008|NCT00403455|62802991|FG000|Overall Study|Withdrawal by Subject|1|||
33605329|NCT01765582|63005054|FG000|Overall Study|Lost to Follow-up|2|||
33425009|NCT00318370|62802995|FG000|Period 1|Lack of Efficacy|5|||
33425010|NCT00318370|62802996|FG001|Period 1|Lack of Efficacy|0|||
33425011|NCT00318370|62802997|FG002|Period 1|Lack of Efficacy|0|||
33425012|NCT00318370|62802995|FG000|Period 1|Physician Decision|1|||
33425013|NCT00318370|62802996|FG001|Period 1|Physician Decision|0|||
33425014|NCT00318370|62802997|FG002|Period 1|Physician Decision|0|||
33425015|NCT00318370|62802995|FG000|Period 1|Withdrawal by Subject|1|||
33425016|NCT00318370|62802996|FG001|Period 1|Withdrawal by Subject|0|||
33425017|NCT00318370|62802997|FG002|Period 1|Withdrawal by Subject|0|||
33425018|NCT00318370|62802995|FG000|Period 2|Adverse Event|0|||
33425019|NCT00318370|62802996|FG001|Period 2|Adverse Event|3|||
33425020|NCT00318370|62802997|FG002|Period 2|Adverse Event|0|||
33425021|NCT00318370|62802995|FG000|Period 2|Lack of Efficacy|0|||
33425022|NCT00318370|62802996|FG001|Period 2|Lack of Efficacy|5|||
33425023|NCT00318370|62802997|FG002|Period 2|Lack of Efficacy|0|||
33425024|NCT00318370|62802995|FG000|Period 2|Physician Decision|0|||
33425025|NCT00318370|62802996|FG001|Period 2|Physician Decision|1|||
33425026|NCT00318370|62802997|FG002|Period 2|Physician Decision|0|||
33425027|NCT00318370|62802995|FG000|Period 2|Withdrawal by Subject|0|||
33425028|NCT00318370|62802996|FG001|Period 2|Withdrawal by Subject|1|||
33425029|NCT00318370|62802997|FG002|Period 2|Withdrawal by Subject|0|||
33425030|NCT00318370|62802995|FG000|Period 2|Other|0|||
33425031|NCT00318370|62802996|FG001|Period 2|Other|1|||
33425032|NCT00318370|62802997|FG002|Period 2|Other|0|||
33425033|NCT00318370|62802995|FG000|Period 3|Adverse Event|0|||
33425034|NCT00318370|62802996|FG001|Period 3|Adverse Event|0|||
33425035|NCT00318370|62802997|FG002|Period 3|Adverse Event|1|||
33425036|NCT00318370|62802995|FG000|Period 3|Lack of Efficacy|0|||
33425037|NCT00318370|62802996|FG001|Period 3|Lack of Efficacy|0|||
33425038|NCT00318370|62802997|FG002|Period 3|Lack of Efficacy|24|||
33425039|NCT00318370|62802995|FG000|Period 3|Death|0|||
33425040|NCT00318370|62802996|FG001|Period 3|Death|0|||
33425041|NCT00318370|62802997|FG002|Period 3|Death|1|||
33425042|NCT00318370|62802995|FG000|Period 3|Physician Decision|0|||
33425043|NCT00318370|62802996|FG001|Period 3|Physician Decision|0|||
33425044|NCT00318370|62802997|FG002|Period 3|Physician Decision|1|||
33425045|NCT00318370|62802995|FG000|Period 3|Withdrawal by Subject|0|||
33425046|NCT00318370|62802996|FG001|Period 3|Withdrawal by Subject|0|||
33425047|NCT00318370|62802997|FG002|Period 3|Withdrawal by Subject|3|||
33425048|NCT00318370|62802995|FG000|Period 3|Other|0|||
33425049|NCT00318370|62802996|FG001|Period 3|Other|0|||
33425050|NCT00318370|62802997|FG002|Period 3|Other|3|||
33425051|NCT00510068|62803005|FG000|Double-blind Period|Disease progression|98|||
33425052|NCT00510068|62803006|FG001|Double-blind Period|Disease progression|169|||
33425053|NCT00510068|62803005|FG000|Double-blind Period|Final primary analysis|52|||
33425054|NCT00510068|62803006|FG001|Double-blind Period|Final primary analysis|18|||
33425055|NCT00510068|62803005|FG000|Double-blind Period|Adverse Event|37|||
33425056|NCT00510068|62803006|FG001|Double-blind Period|Adverse Event|7|||
33425057|NCT00510068|62803005|FG000|Double-blind Period|Withdrawal by Subject|8|||
33425058|NCT00510068|62803006|FG001|Double-blind Period|Withdrawal by Subject|6|||
33425059|NCT00510068|62803005|FG000|Double-blind Period|Death|4|||
33425060|NCT00510068|62803006|FG001|Double-blind Period|Death|3|||
33425061|NCT00510068|62803005|FG000|Double-blind Period|Abnormal test result (s)|1|||
33425062|NCT00510068|62803006|FG001|Double-blind Period|Abnormal test result (s)|0|||
33425063|NCT00510068|62803005|FG000|Double-blind Period|Lost to Follow-up|1|||
33425064|NCT00510068|62803006|FG001|Double-blind Period|Lost to Follow-up|0|||
33425065|NCT00510068|62803005|FG000|Double-blind Period|Protocol Violation|6|||
33425066|NCT00510068|62803006|FG001|Double-blind Period|Protocol Violation|0|||
33425067|NCT00510068|62803005|FG000|Open-label Period|Disease Progression|124|||
33425068|NCT00510068|62803006|FG001|Open-label Period|Disease Progression|0|||
33425069|NCT00510068|62803005|FG000|Open-label Period|Adverse Event|46|||
33425070|NCT00510068|62803006|FG001|Open-label Period|Adverse Event|0|||
33425071|NCT00510068|62803005|FG000|Open-label Period|Withdrawal by Subject|21|||
33425072|NCT00510068|62803006|FG001|Open-label Period|Withdrawal by Subject|0|||
33425073|NCT00510068|62803005|FG000|Open-label Period|Administrative problems|17|||
33425074|NCT00510068|62803006|FG001|Open-label Period|Administrative problems|0|||
33425075|NCT00510068|62803005|FG000|Open-label Period|Death|7|||
33425076|NCT00510068|62803006|FG001|Open-label Period|Death|0|||
33425077|NCT00510068|62803005|FG000|Open-label Period|New cancer therapy|7|||
33425078|NCT00510068|62803006|FG001|Open-label Period|New cancer therapy|0|||
33425079|NCT00510068|62803005|FG000|Open-label Period|Protocol Violation|2|||
33425080|NCT00510068|62803006|FG001|Open-label Period|Protocol Violation|0|||
33425081|NCT00510068|62803005|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
33425082|NCT00510068|62803006|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
33425083|NCT00509600|62803014|FG000|Overall Study|Adverse Event|1|||
33425084|NCT00402987|62803022|FG000|Overall Study|Lack of Efficacy|0|||
33425085|NCT00402987|62803023|FG001|Overall Study|Lack of Efficacy|0|||
33425086|NCT00402987|62803024|FG002|Overall Study|Lack of Efficacy|1|||
33425087|NCT00402987|62803025|FG003|Overall Study|Lack of Efficacy|0|||
33425088|NCT00501644|62803049|FG000|Overall Study|Adverse Event|4|||
33425089|NCT00501644|62803049|FG000|Overall Study|Withdrawal by Subject|1|||
33425090|NCT00497796|62803055|FG000|Overall Study|Adverse event (not related)|9|||
33425091|NCT00497796|62803056|FG001|Overall Study|Adverse event (not related)|9|||
33425092|NCT00497796|62803055|FG000|Overall Study|Adverse event (related)|5|||
33425093|NCT00497796|62803056|FG001|Overall Study|Adverse event (related)|4|||
33425094|NCT00497796|62803055|FG000|Overall Study|CMV infection or disease treatment|30|||
33425095|NCT00497796|62803056|FG001|Overall Study|CMV infection or disease treatment|4|||
33425096|NCT00497796|62803055|FG000|Overall Study|Consent withdrawn|10|||
33425097|NCT00497796|62803056|FG001|Overall Study|Consent withdrawn|3|||
33425098|NCT00497796|62803055|FG000|Overall Study|Investigator/sponsor discretion|31|||
33425099|NCT00497796|62803056|FG001|Overall Study|Investigator/sponsor discretion|34|||
33425100|NCT00497796|62803055|FG000|Overall Study|Lost to Follow-up|0|||
33425101|NCT00497796|62803056|FG001|Overall Study|Lost to Follow-up|1|||
33425102|NCT00497796|62803055|FG000|Overall Study|Not applicable (randomized not treated)|0|||
33425103|NCT00497796|62803056|FG001|Overall Study|Not applicable (randomized not treated)|4|||
33425104|NCT00496782|62803064|FG000|Overall Study|Protocol Violation|1|||
33425105|NCT00496782|62803065|FG001|Overall Study|Protocol Violation|2|||
33425106|NCT00402831|62803073|FG000|Overall Study|Lost to Follow-up|1|||
33425107|NCT00402831|62803074|FG001|Overall Study|Lost to Follow-up|2|||
33425108|NCT00402831|62803073|FG000|Overall Study|Non-compliance with protocol|0|||
33425109|NCT00402831|62803074|FG001|Overall Study|Non-compliance with protocol|1|||
33425110|NCT00496626|62803084|FG000|Overall Study|Lost to Follow-up|0|||
33425111|NCT00496626|62803085|FG001|Overall Study|Lost to Follow-up|1|||
33425112|NCT00496626|62803084|FG000|Overall Study|Protocol Violation|1|||
33425113|NCT00496626|62803085|FG001|Overall Study|Protocol Violation|0|||
33425114|NCT00496626|62803084|FG000|Overall Study|Withdrawal by Subject|5|||
33425115|NCT00496626|62803085|FG001|Overall Study|Withdrawal by Subject|4|||
33425116|NCT00496626|62803084|FG000|Overall Study|Relocated|0|||
33425117|NCT00496626|62803085|FG001|Overall Study|Relocated|1|||
33425118|NCT00471822|62803095|FG000|Overall Study|Protocol Violation|2|||
33425119|NCT00471276|62803099|FG000|Overall Study|Death|2|||
33425120|NCT00471276|62803099|FG000|Overall Study|Adverse Event|16|||
33425121|NCT00471276|62803099|FG000|Overall Study|Protocol Violation|1|||
33425122|NCT00471276|62803099|FG000|Overall Study|Objective progression or relapse|54|||
33425123|NCT00471276|62803099|FG000|Overall Study|Global deterioration of health status|1|||
33425124|NCT00471276|62803099|FG000|Overall Study|Other|3|||
33425125|NCT00471276|62803099|FG000|Overall Study|Refused treatment|6|||
33425126|NCT00470262|62803105|FG000|Overall Study|Withdrawal by Subject|2|||
33425127|NCT00470262|62803106|FG001|Overall Study|Withdrawal by Subject|0|||
33425128|NCT00496470|62803115|FG000|Overall Study|Adverse Event|8|||
33425129|NCT00496470|62803116|FG001|Overall Study|Adverse Event|10|||
33425130|NCT00496470|62803115|FG000|Overall Study|Withdrawal by Subject|5|||
33425131|NCT00496470|62803116|FG001|Overall Study|Withdrawal by Subject|12|||
33425132|NCT00496470|62803115|FG000|Overall Study|Incorrectly enrolled|13|||
33425133|NCT00496470|62803116|FG001|Overall Study|Incorrectly enrolled|5|||
33425134|NCT00496470|62803115|FG000|Overall Study|Other reason|0|||
33425135|NCT00496470|62803116|FG001|Overall Study|Other reason|2|||
33425136|NCT00496080|62803122|FG000|Overall Study|Lost to Follow-up|9|||
33425137|NCT00496080|62803122|FG000|Overall Study|Surgical re-intervention|7|||
33425138|NCT00496080|62803122|FG000|Overall Study|Withdrawal by Subject|5|||
33425139|NCT00496080|62803122|FG000|Overall Study|Physician Decision|6|||
33425140|NCT00487578|62803129|FG000|Overall Study|Adverse Event|1|||
33494146|NCT03486834|62872903|FG001|Overall Study|Physician Decision|2|||
33425141|NCT00487578|62803130|FG001|Overall Study|Adverse Event|2|||
33425142|NCT00487578|62803129|FG000|Overall Study|Lack of Efficacy|0|||
33425143|NCT00487578|62803130|FG001|Overall Study|Lack of Efficacy|1|||
33425144|NCT00487578|62803129|FG000|Overall Study|Lost to Follow-up|0|||
33425145|NCT00487578|62803130|FG001|Overall Study|Lost to Follow-up|1|||
33425146|NCT00495612|62803138|FG000|Overall Study|Lost to Follow-up|1|||
33425147|NCT00495612|62803139|FG001|Overall Study|Lost to Follow-up|0|||
33425148|NCT00495612|62803138|FG000|Overall Study|Subject's Decision to Withdraw|3|||
33425149|NCT00495612|62803139|FG001|Overall Study|Subject's Decision to Withdraw|0|||
33425150|NCT00487188|62803147|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
33425151|NCT00487188|62803148|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
33425152|NCT00487188|62803149|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
33425153|NCT00487188|62803147|FG000|Induction Phase|Adverse Event|5|||
33425154|NCT00487188|62803148|FG001|Induction Phase|Adverse Event|0|||
33425155|NCT00487188|62803149|FG002|Induction Phase|Adverse Event|0|||
33425156|NCT00487188|62803147|FG000|Induction Phase|Lack of Efficacy|0|||
33425157|NCT00487188|62803148|FG001|Induction Phase|Lack of Efficacy|1|||
33425158|NCT00487188|62803149|FG002|Induction Phase|Lack of Efficacy|0|||
33425159|NCT00487188|62803147|FG000|Induction Phase|Protocol Violation|1|||
33425160|NCT00487188|62803148|FG001|Induction Phase|Protocol Violation|0|||
33425161|NCT00487188|62803149|FG002|Induction Phase|Protocol Violation|0|||
33425162|NCT00487188|62803147|FG000|Induction Phase|Refused Treatment|1|||
33425163|NCT00487188|62803148|FG001|Induction Phase|Refused Treatment|2|||
33425164|NCT00487188|62803149|FG002|Induction Phase|Refused Treatment|0|||
33425165|NCT00487188|62803147|FG000|Induction Phase|Lost to Follow-up|2|||
33425166|NCT00487188|62803148|FG001|Induction Phase|Lost to Follow-up|2|||
33425167|NCT00487188|62803149|FG002|Induction Phase|Lost to Follow-up|0|||
33425168|NCT00487188|62803147|FG000|Induction Phase|Administrative|0|||
33425169|NCT00487188|62803148|FG001|Induction Phase|Administrative|1|||
33425170|NCT00487188|62803149|FG002|Induction Phase|Administrative|0|||
33425171|NCT00487188|62803147|FG000|Maintenance Phase|Adverse Event|1|||
33425172|NCT00487188|62803148|FG001|Maintenance Phase|Adverse Event|0|||
33425173|NCT00487188|62803149|FG002|Maintenance Phase|Adverse Event|0|||
33425174|NCT00487188|62803147|FG000|Maintenance Phase|Death|1|||
33425175|NCT00487188|62803148|FG001|Maintenance Phase|Death|0|||
33425176|NCT00487188|62803149|FG002|Maintenance Phase|Death|0|||
33425177|NCT00487188|62803147|FG000|Maintenance Phase|Lost to Follow-up|1|||
33425178|NCT00487188|62803148|FG001|Maintenance Phase|Lost to Follow-up|0|||
33425179|NCT00487188|62803149|FG002|Maintenance Phase|Lost to Follow-up|0|||
33425180|NCT00487188|62803147|FG000|Maintenance Phase|Administrative|0|||
33425181|NCT00487188|62803148|FG001|Maintenance Phase|Administrative|0|||
33425182|NCT00487188|62803149|FG002|Maintenance Phase|Administrative|1|||
33425183|NCT00509366|62803170|FG000|Overall Study|Not Treated (Screen Failure)|1|||
33425184|NCT00509366|62803171|FG001|Overall Study|Not Treated (Screen Failure)|1|||
33425185|NCT00509366|62803172|FG002|Overall Study|Not Treated (Screen Failure)|1|||
33425186|NCT00509366|62803173|FG003|Overall Study|Not Treated (Screen Failure)|0|||
33425187|NCT00509366|62803174|FG004|Overall Study|Not Treated (Screen Failure)|0|||
33425188|NCT00500318|62803186|FG000|Overall Study|Adverse Event|3|||
33425189|NCT00500318|62803187|FG001|Overall Study|Adverse Event|8|||
33425190|NCT00500318|62803186|FG000|Overall Study|Protocol Violation|1|||
33425191|NCT00500318|62803187|FG001|Overall Study|Protocol Violation|3|||
33425192|NCT00500318|62803186|FG000|Overall Study|Withdrawal by Subject|1|||
33425193|NCT00500318|62803187|FG001|Overall Study|Withdrawal by Subject|2|||
33425194|NCT00500318|62803186|FG000|Overall Study|Lack of Efficacy|0|||
33425195|NCT00500318|62803187|FG001|Overall Study|Lack of Efficacy|3|||
33425196|NCT00500318|62803186|FG000|Overall Study|Other Reason|0|||
33425197|NCT00500318|62803187|FG001|Overall Study|Other Reason|1|||
33425198|NCT00508820|62803195|FG000|Overall Study|Adverse Event|6|||
33425199|NCT00508820|62803196|FG001|Overall Study|Adverse Event|10|||
33425200|NCT00508820|62803195|FG000|Overall Study|Death|6|||
33425201|NCT00508820|62803196|FG001|Overall Study|Death|8|||
33425202|NCT00508820|62803195|FG000|Overall Study|Lost to Follow-up|1|||
33425203|NCT00508820|62803196|FG001|Overall Study|Lost to Follow-up|1|||
33425204|NCT00508820|62803195|FG000|Overall Study|Physician Decision|8|||
33425205|NCT00508820|62803196|FG001|Overall Study|Physician Decision|2|||
33425206|NCT00508820|62803195|FG000|Overall Study|Pregnancy|0|||
33425207|NCT00508820|62803196|FG001|Overall Study|Pregnancy|2|||
33425208|NCT00508820|62803195|FG000|Overall Study|Protocol Violation|2|||
33425209|NCT00508820|62803196|FG001|Overall Study|Protocol Violation|0|||
33494147|NCT03486834|62872904|FG002|Overall Study|Physician Decision|3|||
33425210|NCT00508820|62803195|FG000|Overall Study|Withdrawal by Subject|10|||
33425211|NCT00508820|62803196|FG001|Overall Study|Withdrawal by Subject|12|||
33425212|NCT00508820|62803195|FG000|Overall Study|Other|11|||
33425213|NCT00508820|62803196|FG001|Overall Study|Other|2|||
33425214|NCT00508820|62803195|FG000|Overall Study|Noncompliance|1|||
33425215|NCT00508820|62803196|FG001|Overall Study|Noncompliance|0|||
33425216|NCT00508820|62803195|FG000|Overall Study|Requirement for alternative therapy|7|||
33425217|NCT00508820|62803196|FG001|Overall Study|Requirement for alternative therapy|15|||
33425218|NCT00508820|62803195|FG000|Overall Study|Protocol-specified Criteria|3|||
33425219|NCT00508820|62803196|FG001|Overall Study|Protocol-specified Criteria|12|||
33425220|NCT00499694|62803202|FG000|Overall Study|Patient never received treatment.|1|||
33425221|NCT00486954|62803211|FG000|Pilot Part|Adverse Event|4|||
33425222|NCT00486954|62803212|FG001|Pilot Part|Adverse Event|0|||
33425223|NCT00486954|62803213|FG002|Pilot Part|Adverse Event|5|||
33425224|NCT00486954|62803214|FG003|Pilot Part|Adverse Event|0|||
33425225|NCT00486954|62803215|FG004|Pilot Part|Adverse Event|0|||
33425226|NCT00486954|62803211|FG000|Pilot Part|Disease Progression|2|||
33425227|NCT00486954|62803212|FG001|Pilot Part|Disease Progression|0|||
33425228|NCT00486954|62803213|FG002|Pilot Part|Disease Progression|1|||
33425229|NCT00486954|62803214|FG003|Pilot Part|Disease Progression|0|||
33425230|NCT00486954|62803215|FG004|Pilot Part|Disease Progression|0|||
33425231|NCT00486954|62803211|FG000|Randomized Part|Lost to Follow-up|0|||
33425232|NCT00486954|62803212|FG001|Randomized Part|Lost to Follow-up|0|||
33425233|NCT00486954|62803213|FG002|Randomized Part|Lost to Follow-up|0|||
33425234|NCT00486954|62803214|FG003|Randomized Part|Lost to Follow-up|0|||
33425235|NCT00486954|62803215|FG004|Randomized Part|Lost to Follow-up|1|||
33425236|NCT00486954|62803211|FG000|Randomized Part|Withdrawal by Subject|0|||
33425237|NCT00486954|62803212|FG001|Randomized Part|Withdrawal by Subject|0|||
33425238|NCT00486954|62803213|FG002|Randomized Part|Withdrawal by Subject|0|||
33425239|NCT00486954|62803214|FG003|Randomized Part|Withdrawal by Subject|1|||
33425240|NCT00486954|62803215|FG004|Randomized Part|Withdrawal by Subject|0|||
33425241|NCT00486954|62803211|FG000|Randomized Part|Sponsor Terminated Study|0|||
33425242|NCT00486954|62803212|FG001|Randomized Part|Sponsor Terminated Study|0|||
33425243|NCT00486954|62803213|FG002|Randomized Part|Sponsor Terminated Study|0|||
33425244|NCT00486954|62803214|FG003|Randomized Part|Sponsor Terminated Study|19|||
33425245|NCT00486954|62803215|FG004|Randomized Part|Sponsor Terminated Study|13|||
33425246|NCT00494676|62803225|FG000|Allocation|Withdrawal by Subject|2|||
33425247|NCT00494676|62803226|FG001|Allocation|Withdrawal by Subject|4|||
33425248|NCT00494676|62803225|FG000|First Intervention|Withdrawal by Subject|1|||
33425249|NCT00494676|62803226|FG001|First Intervention|Withdrawal by Subject|3|||
33425250|NCT00494676|62803225|FG000|Second Intervention|Withdrawal by Subject|1|||
33425251|NCT00494676|62803226|FG001|Second Intervention|Withdrawal by Subject|1|||
33605330|NCT01765582|63005055|FG001|Overall Study|Lost to Follow-up|2|||
33605331|NCT01765582|63005056|FG002|Overall Study|Lost to Follow-up|1|||
33425252|NCT00486720|62803234|FG000|Overall Study|Adverse Event|1|||
33425253|NCT00486720|62803235|FG001|Overall Study|Adverse Event|2|||
33425254|NCT00486720|62803234|FG000|Overall Study|Lack of Efficacy|4|||
33425255|NCT00486720|62803235|FG001|Overall Study|Lack of Efficacy|6|||
33425256|NCT00486720|62803234|FG000|Overall Study|Physician Decision|1|||
33425257|NCT00486720|62803235|FG001|Overall Study|Physician Decision|2|||
33425258|NCT00486720|62803234|FG000|Overall Study|Protocol Violation|1|||
33425259|NCT00486720|62803235|FG001|Overall Study|Protocol Violation|0|||
33425260|NCT00486720|62803234|FG000|Overall Study|Withdrawal by Subject|3|||
33425261|NCT00486720|62803235|FG001|Overall Study|Withdrawal by Subject|1|||
33605332|NCT01765582|63005054|FG000|Overall Study|Death|31|||
33425262|NCT00486720|62803234|FG000|Overall Study|Progressive Disease|0|||
33425263|NCT00486720|62803235|FG001|Overall Study|Progressive Disease|1|||
33425264|NCT00486330|62803241|FG000|Overall Study|Adverse Event|2|||
33425265|NCT00486252|62803245|FG000|Overall Study|Adverse Event|7|||
33425266|NCT00486252|62803245|FG000|Overall Study|Lack of Efficacy|9|||
33425267|NCT00486252|62803245|FG000|Overall Study|Lost to Follow-up|24|||
33425268|NCT00486252|62803245|FG000|Overall Study|Other|18|||
33425269|NCT00494442|62803253|FG000|Overall Study|Death|1|||
33425270|NCT00494442|62803254|FG001|Overall Study|Death|1|||
33425271|NCT00494442|62803253|FG000|Overall Study|Lack of Efficacy|16|||
33425272|NCT00494442|62803254|FG001|Overall Study|Lack of Efficacy|10|||
33425273|NCT00494442|62803253|FG000|Overall Study|Adverse Event|0|||
33425274|NCT00494442|62803254|FG001|Overall Study|Adverse Event|2|||
33425275|NCT00494442|62803253|FG000|Overall Study|Physician Decision|0|||
33425276|NCT00494442|62803254|FG001|Overall Study|Physician Decision|1|||
33425277|NCT00494442|62803253|FG000|Overall Study|Non-compliance|0|||
33425278|NCT00494442|62803254|FG001|Overall Study|Non-compliance|1|||
33425279|NCT00494442|62803253|FG000|Overall Study|Intercurrent illness|0|||
33425280|NCT00494442|62803254|FG001|Overall Study|Intercurrent illness|1|||
33425281|NCT03851016|62803262|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33425282|NCT03851016|62803263|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
33425283|NCT00493974|62803271|FG000|Overall Study|Death|1|||
33425284|NCT00493974|62803272|FG001|Overall Study|Death|2|||
33425285|NCT00493974|62803271|FG000|Overall Study|Withdrawal by Subject|8|||
33425286|NCT00493974|62803272|FG001|Overall Study|Withdrawal by Subject|6|||
33425287|NCT00493974|62803271|FG000|Overall Study|Lost to Follow-up|4|||
33425288|NCT00493974|62803272|FG001|Overall Study|Lost to Follow-up|6|||
33425289|NCT00469092|62803280|FG000|Overall Study|Adverse Event|5|||
33425290|NCT00469092|62803281|FG001|Overall Study|Adverse Event|4|||
33425291|NCT00469092|62803280|FG000|Overall Study|Lack of Efficacy|1|||
33425292|NCT00469092|62803281|FG001|Overall Study|Lack of Efficacy|0|||
33425293|NCT00469092|62803280|FG000|Overall Study|Lost to Follow-up|1|||
33425294|NCT00469092|62803281|FG001|Overall Study|Lost to Follow-up|2|||
33425295|NCT00469092|62803280|FG000|Overall Study|Protocol Violation|3|||
33425296|NCT00469092|62803281|FG001|Overall Study|Protocol Violation|3|||
33425297|NCT00469092|62803280|FG000|Overall Study|Withdrawal by Subject|4|||
33425298|NCT00469092|62803281|FG001|Overall Study|Withdrawal by Subject|4|||
33425299|NCT00469092|62803280|FG000|Overall Study|Withdrawal Criteria|3|||
33425300|NCT00469092|62803281|FG001|Overall Study|Withdrawal Criteria|4|||
33425301|NCT00469092|62803280|FG000|Overall Study|Incorrectly Randomised|4|||
33425302|NCT00469092|62803281|FG001|Overall Study|Incorrectly Randomised|3|||
33425303|NCT00469092|62803280|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
33425304|NCT00469092|62803281|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
33425305|NCT00469092|62803280|FG000|Overall Study|Use of lipid lowering drug|1|||
33425306|NCT00469092|62803281|FG001|Overall Study|Use of lipid lowering drug|0|||
33425307|NCT00469092|62803280|FG000|Overall Study|Hypoglycaemic Episodes|1|||
33425308|NCT00469092|62803281|FG001|Overall Study|Hypoglycaemic Episodes|1|||
33425309|NCT00469092|62803280|FG000|Overall Study|Abnormal lab value|1|||
33425310|NCT00469092|62803281|FG001|Overall Study|Abnormal lab value|0|||
33425311|NCT00469092|62803280|FG000|Overall Study|Use of Corticosteroid|1|||
33425312|NCT00469092|62803281|FG001|Overall Study|Use of Corticosteroid|0|||
33425313|NCT00499616|62803291|FG000|Overall Study|Death|1|||
33425314|NCT00499616|62803292|FG001|Overall Study|Death|5|||
33425315|NCT00499616|62803293|FG002|Overall Study|Death|3|||
33425316|NCT00499616|62803294|FG003|Overall Study|Death|1|||
33425317|NCT00499616|62803291|FG000|Overall Study|Lack of Efficacy|5|||
33425318|NCT00499616|62803292|FG001|Overall Study|Lack of Efficacy|0|||
33425319|NCT00499616|62803293|FG002|Overall Study|Lack of Efficacy|19|||
33425320|NCT00499616|62803294|FG003|Overall Study|Lack of Efficacy|0|||
33425321|NCT00499616|62803291|FG000|Overall Study|Lost to Follow-up|0|||
33425322|NCT00499616|62803292|FG001|Overall Study|Lost to Follow-up|0|||
33425323|NCT00499616|62803293|FG002|Overall Study|Lost to Follow-up|1|||
33425324|NCT00499616|62803294|FG003|Overall Study|Lost to Follow-up|0|||
33425325|NCT00499616|62803291|FG000|Overall Study|Physician Decision|6|||
33425326|NCT00499616|62803292|FG001|Overall Study|Physician Decision|16|||
33425327|NCT00499616|62803293|FG002|Overall Study|Physician Decision|9|||
33425328|NCT00499616|62803294|FG003|Overall Study|Physician Decision|0|||
33425329|NCT00499616|62803291|FG000|Overall Study|Withdrawal by Subject|1|||
33425330|NCT00499616|62803292|FG001|Overall Study|Withdrawal by Subject|0|||
33425331|NCT00499616|62803293|FG002|Overall Study|Withdrawal by Subject|1|||
33425332|NCT00499616|62803294|FG003|Overall Study|Withdrawal by Subject|0|||
33425333|NCT00499616|62803291|FG000|Overall Study|Ineligible|1|||
33425334|NCT00499616|62803292|FG001|Overall Study|Ineligible|2|||
33425335|NCT00499616|62803293|FG002|Overall Study|Ineligible|0|||
33425336|NCT00499616|62803294|FG003|Overall Study|Ineligible|15|||
33425337|NCT00499616|62803291|FG000|Overall Study|Not evaluable|0|||
33425338|NCT00499616|62803292|FG001|Overall Study|Not evaluable|0|||
33425339|NCT00499616|62803293|FG002|Overall Study|Not evaluable|0|||
33425340|NCT00499616|62803294|FG003|Overall Study|Not evaluable|41|||
33425341|NCT00499616|62803291|FG000|Overall Study|Patient/Parent Refusal|1|||
33425342|NCT00499616|62803292|FG001|Overall Study|Patient/Parent Refusal|5|||
33425343|NCT00499616|62803293|FG002|Overall Study|Patient/Parent Refusal|3|||
33425344|NCT00499616|62803294|FG003|Overall Study|Patient/Parent Refusal|0|||
33425345|NCT00402597|62803312|FG000|Overall Study|Death|15|||
33425346|NCT00402597|62803313|FG001|Overall Study|Death|7|||
33425347|NCT00402597|62803314|FG002|Overall Study|Death|6|||
33425348|NCT00402597|62803315|FG003|Overall Study|Death|4|||
33425349|NCT00402597|62803316|FG004|Overall Study|Death|6|||
33425350|NCT00402597|62803312|FG000|Overall Study|Adverse Event|81|||
33425351|NCT00402597|62803313|FG001|Overall Study|Adverse Event|18|||
33425352|NCT00402597|62803314|FG002|Overall Study|Adverse Event|106|||
33425353|NCT00402597|62803315|FG003|Overall Study|Adverse Event|39|||
33425354|NCT00402597|62803316|FG004|Overall Study|Adverse Event|71|||
33425355|NCT00402597|62803312|FG000|Overall Study|Lost to Follow-up|8|||
33425356|NCT00402597|62803313|FG001|Overall Study|Lost to Follow-up|1|||
33425357|NCT00402597|62803314|FG002|Overall Study|Lost to Follow-up|8|||
33425358|NCT00402597|62803315|FG003|Overall Study|Lost to Follow-up|2|||
33425359|NCT00402597|62803316|FG004|Overall Study|Lost to Follow-up|3|||
33425360|NCT00402597|62803312|FG000|Overall Study|Withdrawal by Subject|57|||
33425361|NCT00402597|62803313|FG001|Overall Study|Withdrawal by Subject|16|||
33425362|NCT00402597|62803314|FG002|Overall Study|Withdrawal by Subject|65|||
33425363|NCT00402597|62803315|FG003|Overall Study|Withdrawal by Subject|15|||
33425364|NCT00402597|62803316|FG004|Overall Study|Withdrawal by Subject|24|||
33425365|NCT00402597|62803312|FG000|Overall Study|reason not specified|30|||
33425366|NCT00402597|62803313|FG001|Overall Study|reason not specified|4|||
33425367|NCT00402597|62803314|FG002|Overall Study|reason not specified|27|||
33425368|NCT00402597|62803315|FG003|Overall Study|reason not specified|14|||
33425369|NCT00402597|62803316|FG004|Overall Study|reason not specified|20|||
33425370|NCT00402363|62803332|FG000|Overall Study|Adverse Event|9|||
33425371|NCT00402363|62803333|FG001|Overall Study|Adverse Event|14|||
33425372|NCT00402363|62803334|FG002|Overall Study|Adverse Event|2|||
33425373|NCT00402363|62803335|FG003|Overall Study|Adverse Event|2|||
33425374|NCT00402363|62803332|FG000|Overall Study|Withdrew Consent|10|||
33425375|NCT00402363|62803333|FG001|Overall Study|Withdrew Consent|5|||
33425376|NCT00402363|62803334|FG002|Overall Study|Withdrew Consent|2|||
33425377|NCT00402363|62803335|FG003|Overall Study|Withdrew Consent|1|||
33425378|NCT00402363|62803332|FG000|Overall Study|Protocol Violation|3|||
33425379|NCT00402363|62803333|FG001|Overall Study|Protocol Violation|5|||
33425380|NCT00402363|62803334|FG002|Overall Study|Protocol Violation|0|||
33425381|NCT00402363|62803335|FG003|Overall Study|Protocol Violation|3|||
33425382|NCT00402363|62803332|FG000|Overall Study|Lost to Follow-up|5|||
33425383|NCT00402363|62803333|FG001|Overall Study|Lost to Follow-up|4|||
33425384|NCT00402363|62803334|FG002|Overall Study|Lost to Follow-up|0|||
33425385|NCT00402363|62803335|FG003|Overall Study|Lost to Follow-up|2|||
33425386|NCT00402363|62803332|FG000|Overall Study|"Captured as Other"|6|||
33425387|NCT00402363|62803333|FG001|Overall Study|"Captured as Other"|2|||
33425388|NCT00402363|62803334|FG002|Overall Study|"Captured as Other"|2|||
33425389|NCT00402363|62803335|FG003|Overall Study|"Captured as Other"|2|||
33425390|NCT00469014|62803355|FG000|Initial Phase Randomization|Disease Progression|0|||
33425391|NCT00469014|62803356|FG001|Initial Phase Randomization|Disease Progression|1|||
33425392|NCT00469014|62803357|FG002|Initial Phase Randomization|Disease Progression|1|||
33425393|NCT00469014|62803358|FG003|Initial Phase Randomization|Disease Progression|0|||
33425394|NCT00469014|62803355|FG000|Initial Phase Randomization|No Response|1|||
33425395|NCT00469014|62803356|FG001|Initial Phase Randomization|No Response|0|||
33425396|NCT00469014|62803357|FG002|Initial Phase Randomization|No Response|0|||
33494148|NCT03486834|62872902|FG000|Overall Study|Pregnancy|10|||
33494149|NCT03486834|62872903|FG001|Overall Study|Pregnancy|12|||
33425397|NCT00469014|62803358|FG003|Initial Phase Randomization|No Response|1|||
33425398|NCT00469014|62803355|FG000|Adaptive Randomization|Not Evaluable|1|||
33425399|NCT00469014|62803356|FG001|Adaptive Randomization|Not Evaluable|0|||
33425400|NCT00469014|62803357|FG002|Adaptive Randomization|Not Evaluable|0|||
33425401|NCT00469014|62803358|FG003|Adaptive Randomization|Not Evaluable|1|||
33425402|NCT00469014|62803355|FG000|Adaptive Randomization|No Response|0|||
33425403|NCT00469014|62803356|FG001|Adaptive Randomization|No Response|1|||
33425404|NCT00469014|62803357|FG002|Adaptive Randomization|No Response|0|||
33425405|NCT00469014|62803358|FG003|Adaptive Randomization|No Response|0|||
33425406|NCT00469014|62803355|FG000|Adaptive Randomization|Death|0|||
33425407|NCT00469014|62803356|FG001|Adaptive Randomization|Death|0|||
33425408|NCT00469014|62803357|FG002|Adaptive Randomization|Death|1|||
33425409|NCT00469014|62803358|FG003|Adaptive Randomization|Death|0|||
33425410|NCT00493038|62803370|FG000|Treatment|Adverse Event|8|||
33425411|NCT00493038|62803371|FG001|Treatment|Adverse Event|4|||
33425412|NCT00493038|62803370|FG000|Treatment|Lost to Follow-up|5|||
33425413|NCT00493038|62803371|FG001|Treatment|Lost to Follow-up|3|||
33425414|NCT00493038|62803370|FG000|Treatment|Withdrawal by Subject|11|||
33425415|NCT00493038|62803371|FG001|Treatment|Withdrawal by Subject|12|||
33425416|NCT00493038|62803370|FG000|Treatment|Other|0|||
33425417|NCT00493038|62803371|FG001|Treatment|Other|1|||
33425418|NCT00493038|62803370|FG000|Follow-up|Lost to Follow-up|1|||
33425419|NCT00493038|62803371|FG001|Follow-up|Lost to Follow-up|0|||
33425420|NCT00392223|62803379|FG000|Overall Study|Adverse Event|5|||
33425421|NCT00392223|62803380|FG001|Overall Study|Adverse Event|4|||
33425422|NCT00392223|62803379|FG000|Overall Study|Lost to Follow-up|1|||
33425423|NCT00392223|62803380|FG001|Overall Study|Lost to Follow-up|4|||
33425424|NCT00392223|62803379|FG000|Overall Study|Protocol Violation|0|||
33425425|NCT00392223|62803380|FG001|Overall Study|Protocol Violation|3|||
33425426|NCT00392223|62803379|FG000|Overall Study|Withdrawal by Subject|3|||
33425427|NCT00392223|62803380|FG001|Overall Study|Withdrawal by Subject|2|||
33425428|NCT00402285|62803389|FG000|Overall Study|insufficient RNA quality|7|||
33425429|NCT00402285|62803390|FG001|Overall Study|insufficient RNA quality|6|||
33425430|NCT00402285|62803391|FG002|Overall Study|insufficient RNA quality|2|||
33425431|NCT00413283|62803401|FG000|Overall Study|Withdrawal by Subject|1|||
33425432|NCT00413283|62803402|FG001|Overall Study|Withdrawal by Subject|0|||
33425433|NCT00413283|62803403|FG002|Overall Study|Withdrawal by Subject|0|||
33425434|NCT00413283|62803404|FG003|Overall Study|Withdrawal by Subject|1|||
33425435|NCT00413283|62803401|FG000|Overall Study|Death|0|||
33425436|NCT00413283|62803402|FG001|Overall Study|Death|0|||
33425437|NCT00413283|62803403|FG002|Overall Study|Death|1|||
33425438|NCT00413283|62803404|FG003|Overall Study|Death|1|||
33425439|NCT00413283|62803401|FG000|Overall Study|Adverse Event|0|||
33425440|NCT00413283|62803402|FG001|Overall Study|Adverse Event|0|||
33425441|NCT00413283|62803403|FG002|Overall Study|Adverse Event|0|||
33425442|NCT00413283|62803404|FG003|Overall Study|Adverse Event|1|||
33425443|NCT00413283|62803401|FG000|Overall Study|Ineligibility determined|0|||
33425444|NCT00413283|62803402|FG001|Overall Study|Ineligibility determined|0|||
33425445|NCT00413283|62803403|FG002|Overall Study|Ineligibility determined|0|||
33425446|NCT00413283|62803404|FG003|Overall Study|Ineligibility determined|1|||
33425447|NCT00413283|62803401|FG000|Overall Study|Protocol deviation|0|||
33425448|NCT00413283|62803402|FG001|Overall Study|Protocol deviation|1|||
33425449|NCT00413283|62803403|FG002|Overall Study|Protocol deviation|0|||
33425450|NCT00413283|62803404|FG003|Overall Study|Protocol deviation|0|||
33322989|NCT00927394|62699259|FG000|Overall Study|Withdrawal by Subject|20|||
33425451|NCT00413283|62803401|FG000|Overall Study|Requirement for alternative therapy|0|||
33425452|NCT00413283|62803402|FG001|Overall Study|Requirement for alternative therapy|2|||
33425453|NCT00413283|62803403|FG002|Overall Study|Requirement for alternative therapy|0|||
33425454|NCT00413283|62803404|FG003|Overall Study|Requirement for alternative therapy|0|||
33425455|NCT00413283|62803401|FG000|Overall Study|Other|0|||
33425456|NCT00413283|62803402|FG001|Overall Study|Other|0|||
33425457|NCT00413283|62803403|FG002|Overall Study|Other|1|||
33425458|NCT00413283|62803404|FG003|Overall Study|Other|0|||
33425459|NCT00402051|62803416|FG000|Overall Study|Progressive Disease|13|||
33425460|NCT00402051|62803417|FG001|Overall Study|Progressive Disease|20|||
33425461|NCT00402051|62803416|FG000|Overall Study|Adverse Event|11|||
33425462|NCT00402051|62803417|FG001|Overall Study|Adverse Event|4|||
33425463|NCT00402051|62803416|FG000|Overall Study|Physician Decision|7|||
33425464|NCT00402051|62803417|FG001|Overall Study|Physician Decision|3|||
33425465|NCT00402051|62803416|FG000|Overall Study|Withdrawal by Subject|3|||
33425466|NCT00402051|62803417|FG001|Overall Study|Withdrawal by Subject|3|||
33425467|NCT00402051|62803416|FG000|Overall Study|Death - Related to Study Drug|1|||
33425468|NCT00402051|62803417|FG001|Overall Study|Death - Related to Study Drug|2|||
33425469|NCT00402051|62803416|FG000|Overall Study|Death Due to Study Disease|2|||
33425470|NCT00402051|62803417|FG001|Overall Study|Death Due to Study Disease|1|||
33425471|NCT00402051|62803416|FG000|Overall Study|Death Due to Adverse Event|0|||
33425472|NCT00402051|62803417|FG001|Overall Study|Death Due to Adverse Event|2|||
33425473|NCT00402051|62803416|FG000|Overall Study|Lost to Follow-up|1|||
33425474|NCT00402051|62803417|FG001|Overall Study|Lost to Follow-up|0|||
33425475|NCT00468858|62803426|FG000|Overall Study|Adverse Event|0|||
33425476|NCT00468858|62803427|FG001|Overall Study|Adverse Event|1|||
33425477|NCT00468858|62803428|FG002|Overall Study|Adverse Event|0|||
33425478|NCT00468858|62803426|FG000|Overall Study|Withdrawal by Subject|7|||
33425479|NCT00468858|62803427|FG001|Overall Study|Withdrawal by Subject|4|||
33425480|NCT00468858|62803428|FG002|Overall Study|Withdrawal by Subject|5|||
33425481|NCT00468858|62803426|FG000|Overall Study|Relocation|1|||
33425482|NCT00468858|62803427|FG001|Overall Study|Relocation|3|||
33425483|NCT00468858|62803428|FG002|Overall Study|Relocation|3|||
33425484|NCT00468858|62803426|FG000|Overall Study|Lost to Follow-up|1|||
33425485|NCT00468858|62803427|FG001|Overall Study|Lost to Follow-up|2|||
33425486|NCT00468858|62803428|FG002|Overall Study|Lost to Follow-up|5|||
33425487|NCT00468858|62803426|FG000|Overall Study|Other|0|||
33425488|NCT00468858|62803427|FG001|Overall Study|Other|0|||
33425489|NCT00468858|62803428|FG002|Overall Study|Other|1|||
33425490|NCT00401973|62803493|FG000|Overall Study|Adverse Event|2|||
33425491|NCT00401973|62803494|FG001|Overall Study|Adverse Event|8|||
33425492|NCT00401973|62803495|FG002|Overall Study|Adverse Event|4|||
33425493|NCT00401973|62803493|FG000|Overall Study|Clinical Relapse|0|||
33425494|NCT00401973|62803494|FG001|Overall Study|Clinical Relapse|1|||
33425495|NCT00401973|62803495|FG002|Overall Study|Clinical Relapse|1|||
33425496|NCT00401973|62803493|FG000|Overall Study|Lack of Efficacy|0|||
33425497|NCT00401973|62803494|FG001|Overall Study|Lack of Efficacy|0|||
33425498|NCT00401973|62803495|FG002|Overall Study|Lack of Efficacy|3|||
33425499|NCT00401973|62803493|FG000|Overall Study|Lost to Follow-up|2|||
33425500|NCT00401973|62803494|FG001|Overall Study|Lost to Follow-up|2|||
33425501|NCT00401973|62803495|FG002|Overall Study|Lost to Follow-up|2|||
33425502|NCT00401973|62803493|FG000|Overall Study|Physician Decision|2|||
33425503|NCT00401973|62803494|FG001|Overall Study|Physician Decision|0|||
33425504|NCT00401973|62803495|FG002|Overall Study|Physician Decision|1|||
33425505|NCT00401973|62803493|FG000|Overall Study|Protocol Violation|1|||
33425506|NCT00401973|62803494|FG001|Overall Study|Protocol Violation|2|||
33425507|NCT00401973|62803495|FG002|Overall Study|Protocol Violation|3|||
33425508|NCT00401973|62803493|FG000|Overall Study|Sponsor Decision|0|||
33425509|NCT00401973|62803494|FG001|Overall Study|Sponsor Decision|1|||
33425510|NCT00401973|62803495|FG002|Overall Study|Sponsor Decision|0|||
33425511|NCT00401973|62803493|FG000|Overall Study|Withdrawal by Subject|4|||
33425512|NCT00401973|62803494|FG001|Overall Study|Withdrawal by Subject|12|||
33425513|NCT00401973|62803495|FG002|Overall Study|Withdrawal by Subject|9|||
33425514|NCT00401193|62803508|FG000|Overall Study|Adverse Event|1|||
33425515|NCT00401193|62803509|FG001|Overall Study|Adverse Event|3|||
33425516|NCT00401193|62803510|FG002|Overall Study|Adverse Event|1|||
33425517|NCT00401193|62803508|FG000|Overall Study|Protocol Violation|3|||
33425518|NCT00401193|62803509|FG001|Overall Study|Protocol Violation|1|||
33425519|NCT00401193|62803510|FG002|Overall Study|Protocol Violation|1|||
33425520|NCT00401193|62803508|FG000|Overall Study|Lost to Follow-up|6|||
33425521|NCT00401193|62803509|FG001|Overall Study|Lost to Follow-up|5|||
33425522|NCT00401193|62803510|FG002|Overall Study|Lost to Follow-up|1|||
33425523|NCT00401193|62803508|FG000|Overall Study|Withdrawal by Subject|2|||
33425524|NCT00401193|62803509|FG001|Overall Study|Withdrawal by Subject|0|||
33425525|NCT00401193|62803510|FG002|Overall Study|Withdrawal by Subject|1|||
33425526|NCT00401193|62803508|FG000|Overall Study|Other Event|3|||
33425527|NCT00401193|62803509|FG001|Overall Study|Other Event|2|||
33425528|NCT00401193|62803510|FG002|Overall Study|Other Event|2|||
33425529|NCT00400569|62803519|FG000|Overall Study|Death|1|||
33425530|NCT00413049|62803528|FG000|Overall Study|Adverse Event|10|||
33425531|NCT00413049|62803529|FG001|Overall Study|Adverse Event|8|||
33425532|NCT00413049|62803528|FG000|Overall Study|Withdrawal by Subject|7|||
33425533|NCT00413049|62803529|FG001|Overall Study|Withdrawal by Subject|5|||
33425534|NCT00413049|62803528|FG000|Overall Study|Lost to Follow-up|2|||
33425535|NCT00413049|62803529|FG001|Overall Study|Lost to Follow-up|3|||
33425536|NCT00413049|62803528|FG000|Overall Study|Protocol Violation|3|||
33425537|NCT00413049|62803529|FG001|Overall Study|Protocol Violation|1|||
33425538|NCT00413049|62803528|FG000|Overall Study|Subject no longer requires study drug|0|||
33425539|NCT00413049|62803529|FG001|Overall Study|Subject no longer requires study drug|1|||
33425540|NCT00413049|62803528|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33425541|NCT00413049|62803529|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33425542|NCT00413049|62803528|FG000|Overall Study|Lack of Efficacy|1|||
33425543|NCT00413049|62803529|FG001|Overall Study|Lack of Efficacy|0|||
33425544|NCT00454194|62803537|FG000|Overall Study|Adverse Event|7|||
33425545|NCT00454194|62803538|FG001|Overall Study|Adverse Event|2|||
33425546|NCT00454194|62803537|FG000|Overall Study|Withdrawal by Subject|12|||
33425547|NCT00454194|62803538|FG001|Overall Study|Withdrawal by Subject|8|||
33425548|NCT00454194|62803537|FG000|Overall Study|Other Medical Problems|1|||
33425549|NCT00454194|62803538|FG001|Overall Study|Other Medical Problems|2|||
33425550|NCT00454194|62803537|FG000|Overall Study|Other Unspecified Reason|2|||
33425551|NCT00454194|62803538|FG001|Overall Study|Other Unspecified Reason|2|||
33425552|NCT00412971|62803546|FG000|Overall Study|Lost to Follow-up|17|||
33425553|NCT00412971|62803547|FG001|Overall Study|Lost to Follow-up|9|||
33425554|NCT00412971|62803546|FG000|Overall Study|Protocol Violation|13|||
33425555|NCT00412971|62803547|FG001|Overall Study|Protocol Violation|1|||
33425556|NCT00303472|62803560|FG000|Treatment Period|Adverse Event|0|||
33425557|NCT00303472|62803561|FG001|Treatment Period|Adverse Event|0|||
33425558|NCT00303472|62803562|FG002|Treatment Period|Adverse Event|0|||
33425559|NCT00303472|62803563|FG003|Treatment Period|Adverse Event|0|||
33425560|NCT00303472|62803564|FG004|Treatment Period|Adverse Event|1|||
33425561|NCT00303472|62803565|FG005|Treatment Period|Adverse Event|0|||
33425562|NCT00303472|62803566|FG006|Treatment Period|Adverse Event|0|||
33425563|NCT00303472|62803560|FG000|Treatment Period|Death|0|||
33425564|NCT00303472|62803561|FG001|Treatment Period|Death|0|||
33425565|NCT00303472|62803562|FG002|Treatment Period|Death|0|||
33425566|NCT00303472|62803563|FG003|Treatment Period|Death|1|||
33425567|NCT00303472|62803564|FG004|Treatment Period|Death|0|||
33425568|NCT00303472|62803565|FG005|Treatment Period|Death|0|||
33425569|NCT00303472|62803566|FG006|Treatment Period|Death|1|||
33425570|NCT00303472|62803560|FG000|Treatment Period|Withdrawal by Subject|0|||
33425571|NCT00303472|62803561|FG001|Treatment Period|Withdrawal by Subject|0|||
33425572|NCT00303472|62803562|FG002|Treatment Period|Withdrawal by Subject|0|||
33425573|NCT00303472|62803563|FG003|Treatment Period|Withdrawal by Subject|1|||
33425574|NCT00303472|62803564|FG004|Treatment Period|Withdrawal by Subject|0|||
33425575|NCT00303472|62803565|FG005|Treatment Period|Withdrawal by Subject|1|||
33425576|NCT00303472|62803566|FG006|Treatment Period|Withdrawal by Subject|0|||
33425577|NCT00303472|62803560|FG000|Treatment Period|Other|0|||
33425578|NCT00303472|62803561|FG001|Treatment Period|Other|0|||
33494150|NCT03486834|62872904|FG002|Overall Study|Pregnancy|12|||
33425579|NCT00303472|62803562|FG002|Treatment Period|Other|0|||
33425580|NCT00303472|62803563|FG003|Treatment Period|Other|0|||
33425581|NCT00303472|62803564|FG004|Treatment Period|Other|1|||
33425582|NCT00303472|62803565|FG005|Treatment Period|Other|0|||
33425583|NCT00303472|62803566|FG006|Treatment Period|Other|1|||
33425584|NCT00303472|62803560|FG000|Treatment Period|Disease Progression (to AML)|0|||
33425585|NCT00303472|62803561|FG001|Treatment Period|Disease Progression (to AML)|0|||
33425586|NCT00303472|62803562|FG002|Treatment Period|Disease Progression (to AML)|0|||
33425587|NCT00303472|62803563|FG003|Treatment Period|Disease Progression (to AML)|0|||
33425588|NCT00303472|62803564|FG004|Treatment Period|Disease Progression (to AML)|1|||
33425589|NCT00303472|62803565|FG005|Treatment Period|Disease Progression (to AML)|0|||
33425590|NCT00303472|62803566|FG006|Treatment Period|Disease Progression (to AML)|0|||
33425591|NCT00303472|62803560|FG000|Treatment Extension (Optional)|Adverse Event|1|||
33425592|NCT00303472|62803561|FG001|Treatment Extension (Optional)|Adverse Event|0|||
33425593|NCT00303472|62803562|FG002|Treatment Extension (Optional)|Adverse Event|1|||
33425594|NCT00303472|62803563|FG003|Treatment Extension (Optional)|Adverse Event|0|||
33425595|NCT00303472|62803564|FG004|Treatment Extension (Optional)|Adverse Event|0|||
33425596|NCT00303472|62803565|FG005|Treatment Extension (Optional)|Adverse Event|0|||
33425597|NCT00303472|62803566|FG006|Treatment Extension (Optional)|Adverse Event|0|||
33425598|NCT00303472|62803560|FG000|Treatment Extension (Optional)|Death|2|||
33425599|NCT00303472|62803561|FG001|Treatment Extension (Optional)|Death|0|||
33425600|NCT00303472|62803562|FG002|Treatment Extension (Optional)|Death|1|||
33425601|NCT00303472|62803563|FG003|Treatment Extension (Optional)|Death|0|||
33425602|NCT00303472|62803564|FG004|Treatment Extension (Optional)|Death|0|||
33425603|NCT00303472|62803565|FG005|Treatment Extension (Optional)|Death|0|||
33425604|NCT00303472|62803566|FG006|Treatment Extension (Optional)|Death|0|||
33425605|NCT00303472|62803560|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
33425606|NCT00303472|62803561|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
33425607|NCT00303472|62803562|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
33425608|NCT00303472|62803563|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
33425609|NCT00303472|62803564|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
33425610|NCT00303472|62803565|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
33425611|NCT00303472|62803566|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
33425612|NCT00303472|62803560|FG000|Treatment Extension (Optional)|Physician Decision|0|||
33425613|NCT00303472|62803561|FG001|Treatment Extension (Optional)|Physician Decision|4|||
33425614|NCT00303472|62803562|FG002|Treatment Extension (Optional)|Physician Decision|2|||
33425615|NCT00303472|62803563|FG003|Treatment Extension (Optional)|Physician Decision|3|||
33425616|NCT00303472|62803564|FG004|Treatment Extension (Optional)|Physician Decision|2|||
33425617|NCT00303472|62803565|FG005|Treatment Extension (Optional)|Physician Decision|0|||
33425618|NCT00303472|62803566|FG006|Treatment Extension (Optional)|Physician Decision|0|||
33425619|NCT00303472|62803560|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
33425620|NCT00303472|62803561|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
33425621|NCT00303472|62803562|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
33425622|NCT00303472|62803563|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
33425623|NCT00303472|62803564|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
33425624|NCT00303472|62803565|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
33425625|NCT00303472|62803566|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
33425626|NCT00303472|62803560|FG000|Treatment Extension (Optional)|Other|0|||
33425627|NCT00303472|62803561|FG001|Treatment Extension (Optional)|Other|2|||
33425628|NCT00303472|62803562|FG002|Treatment Extension (Optional)|Other|4|||
33425629|NCT00303472|62803563|FG003|Treatment Extension (Optional)|Other|2|||
33425630|NCT00303472|62803564|FG004|Treatment Extension (Optional)|Other|1|||
33425631|NCT00303472|62803565|FG005|Treatment Extension (Optional)|Other|0|||
33425632|NCT00303472|62803566|FG006|Treatment Extension (Optional)|Other|0|||
33425633|NCT00303472|62803560|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
33425634|NCT00303472|62803561|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
33425635|NCT00303472|62803562|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
33425636|NCT00303472|62803563|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
33425637|NCT00303472|62803564|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
33425638|NCT00303472|62803565|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
33425639|NCT00303472|62803566|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
33425640|NCT00468546|62803584|FG000|Week 24 Analysis|Lack of Efficacy|83|||
33425641|NCT00468546|62803585|FG001|Week 24 Analysis|Lack of Efficacy|37|||
33425642|NCT00468546|62803584|FG000|Week 24 Analysis|Refused treatment|5|||
33425643|NCT00468546|62803585|FG001|Week 24 Analysis|Refused treatment|5|||
33425644|NCT00468546|62803584|FG000|Week 24 Analysis|Adverse Event|1|||
33425645|NCT00468546|62803585|FG001|Week 24 Analysis|Adverse Event|8|||
33494151|NCT03486834|62872902|FG000|Overall Study|Protocol Deviation|2|||
33425646|NCT00468546|62803584|FG000|Week 24 Analysis|Failure to return|3|||
33494152|NCT03486834|62872903|FG001|Overall Study|Protocol Deviation|3|||
33425647|NCT00468546|62803585|FG001|Week 24 Analysis|Failure to return|4|||
33425648|NCT00468546|62803584|FG000|Week 24 Analysis|Rescue therapy|2|||
33425649|NCT00468546|62803585|FG001|Week 24 Analysis|Rescue therapy|0|||
33425650|NCT00468546|62803584|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
33425651|NCT00468546|62803585|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
33425652|NCT00468546|62803584|FG000|Week 24 Analysis|Due to clinical hold|1|||
33425653|NCT00468546|62803585|FG001|Week 24 Analysis|Due to clinical hold|0|||
33425654|NCT00468546|62803584|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
33425655|NCT00468546|62803585|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
33425656|NCT00468546|62803584|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
33425657|NCT00468546|62803585|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
33425658|NCT00468546|62803584|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
33425659|NCT00468546|62803585|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
33425660|NCT00468546|62803584|FG000|Week 24 to Week 104 Analysis|Death|1|||
33425661|NCT00468546|62803585|FG001|Week 24 to Week 104 Analysis|Death|0|||
33425662|NCT00468546|62803584|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
33425663|NCT00468546|62803585|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
33425664|NCT00468546|62803584|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
33425665|NCT00468546|62803585|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
33425666|NCT00468546|62803584|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
33425667|NCT00468546|62803585|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
33425668|NCT00468546|62803584|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
33425669|NCT00468546|62803585|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
33425670|NCT00468546|62803584|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
33425671|NCT00468546|62803585|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
33425672|NCT00468546|62803584|FG000|Week 24 to Week 104 Analysis|Other|17|||
33425673|NCT00468546|62803585|FG001|Week 24 to Week 104 Analysis|Other|14|||
33425674|NCT00303316|62803593|FG000|Overall Study|Protocol Violation|1|||
33425675|NCT00303316|62803594|FG001|Overall Study|Protocol Violation|0|||
33425676|NCT00303316|62803593|FG000|Overall Study|Lost to Follow-up|0|||
33425677|NCT00303316|62803594|FG001|Overall Study|Lost to Follow-up|1|||
33425678|NCT00303316|62803593|FG000|Overall Study|Withdrawal by Subject|1|||
33425679|NCT00303316|62803594|FG001|Overall Study|Withdrawal by Subject|2|||
33425680|NCT00468312|62803602|FG000|Overall Study|Adverse Event|2|||
33425681|NCT00468312|62803603|FG001|Overall Study|Adverse Event|1|||
33425682|NCT00468312|62803602|FG000|Overall Study|Lack of Efficacy|0|||
33425683|NCT00468312|62803603|FG001|Overall Study|Lack of Efficacy|1|||
33425684|NCT00468312|62803602|FG000|Overall Study|Withdrawal by Subject|0|||
33425685|NCT00468312|62803603|FG001|Overall Study|Withdrawal by Subject|1|||
33425686|NCT00468312|62803602|FG000|Overall Study|Protocol Violation|2|||
33425687|NCT00468312|62803603|FG001|Overall Study|Protocol Violation|1|||
33425688|NCT00468312|62803602|FG000|Overall Study|Did not meet protocol eligibility|0|||
33425689|NCT00468312|62803603|FG001|Overall Study|Did not meet protocol eligibility|1|||
33425690|NCT00331864|62803611|FG000|Overall Study|Adverse Event|30|||
33425691|NCT00331864|62803612|FG001|Overall Study|Adverse Event|1|||
33425692|NCT00331864|62803611|FG000|Overall Study|Lack of Efficacy|4|||
33425693|NCT00331864|62803612|FG001|Overall Study|Lack of Efficacy|0|||
33425694|NCT00331864|62803611|FG000|Overall Study|Protocol Violation|3|||
33425695|NCT00331864|62803612|FG001|Overall Study|Protocol Violation|0|||
33425696|NCT00331864|62803611|FG000|Overall Study|Withdrawal by Subject|10|||
33425697|NCT00331864|62803612|FG001|Overall Study|Withdrawal by Subject|0|||
33425698|NCT00331864|62803611|FG000|Overall Study|Lost to Follow-up|4|||
33425699|NCT00331864|62803612|FG001|Overall Study|Lost to Follow-up|3|||
33425700|NCT00331864|62803611|FG000|Overall Study|Administrative Problems|1|||
33425701|NCT00331864|62803612|FG001|Overall Study|Administrative Problems|0|||
33425702|NCT00331864|62803611|FG000|Overall Study|Death|6|||
33425703|NCT00331864|62803612|FG001|Overall Study|Death|0|||
33425704|NCT00331630|62803618|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
33425705|NCT00331630|62803618|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
33425706|NCT00331630|62803618|FG000|Follow up for 5 Years|Death|5|||
33425707|NCT00331630|62803618|FG000|Follow up for 5 Years|Data collection was stopped|24|||
33425708|NCT00331552|62803624|FG000|Period 3: Phase II|Neurological Symptoms|1|||
33425709|NCT00331552|62803625|FG001|Period 3: Phase II|Neurological Symptoms|0|||
33425710|NCT00331552|62803624|FG000|Period 3: Phase II|Severe Nausea|1|||
33425711|NCT00331552|62803625|FG001|Period 3: Phase II|Severe Nausea|0|||
33425712|NCT00317356|62803640|FG000|Overall Study|Adverse Event|0|||
33425713|NCT00317356|62803641|FG001|Overall Study|Adverse Event|0|||
33425714|NCT00317356|62803642|FG002|Overall Study|Adverse Event|1|||
33425715|NCT00317356|62803643|FG003|Overall Study|Adverse Event|0|||
33425716|NCT00317356|62803640|FG000|Overall Study|Lack of Efficacy|1|||
33425717|NCT00317356|62803641|FG001|Overall Study|Lack of Efficacy|1|||
33425718|NCT00317356|62803642|FG002|Overall Study|Lack of Efficacy|0|||
33425719|NCT00317356|62803643|FG003|Overall Study|Lack of Efficacy|3|||
33425720|NCT00317356|62803640|FG000|Overall Study|Physician Decision|0|||
33425721|NCT00317356|62803641|FG001|Overall Study|Physician Decision|1|||
33425722|NCT00317356|62803642|FG002|Overall Study|Physician Decision|0|||
33425723|NCT00317356|62803643|FG003|Overall Study|Physician Decision|0|||
33425724|NCT00331006|62803653|FG000|Screening Phase|Withdrawal by Subject|1|||
33425725|NCT00331006|62803653|FG000|Screening Phase|enrollment halted|1|||
33425726|NCT00331006|62803653|FG000|Screening Phase|Lost to Follow-up|1|||
33425727|NCT00331006|62803653|FG000|Screening Phase|Ineligible for treatment phase|4|||
33425728|NCT00331006|62803653|FG000|Treatment Phase|Withdrawal by Subject|1|||
33425729|NCT00331006|62803653|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
33425730|NCT00331006|62803653|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
33425731|NCT00302458|62803657|FG000|Overall Study|Lost to Follow-up|1|||
33425732|NCT00302458|62803657|FG000|Overall Study|Ineligible after screening|1|||
33425733|NCT00302458|62803657|FG000|Overall Study|Withdrawal by Subject|1|||
33425734|NCT00391053|62803669|FG000|Overall Study|Serious Adverse Events|1|||
33425735|NCT00391053|62803670|FG001|Overall Study|Serious Adverse Events|0|||
33425736|NCT00391053|62803671|FG002|Overall Study|Serious Adverse Events|1|||
33425737|NCT00391053|62803672|FG003|Overall Study|Serious Adverse Events|4|||
33425738|NCT00391053|62803669|FG000|Overall Study|Protocol Violation|2|||
33425739|NCT00391053|62803670|FG001|Overall Study|Protocol Violation|0|||
33425740|NCT00391053|62803671|FG002|Overall Study|Protocol Violation|0|||
33425741|NCT00391053|62803672|FG003|Overall Study|Protocol Violation|0|||
33425742|NCT00391053|62803669|FG000|Overall Study|Lost to Follow-up|1|||
33425743|NCT00391053|62803670|FG001|Overall Study|Lost to Follow-up|0|||
33425744|NCT00391053|62803671|FG002|Overall Study|Lost to Follow-up|0|||
33425745|NCT00391053|62803672|FG003|Overall Study|Lost to Follow-up|5|||
33425746|NCT00391053|62803669|FG000|Overall Study|Withdrawal by Subject|5|||
33425747|NCT00391053|62803670|FG001|Overall Study|Withdrawal by Subject|1|||
33425748|NCT00391053|62803671|FG002|Overall Study|Withdrawal by Subject|1|||
33425749|NCT00391053|62803672|FG003|Overall Study|Withdrawal by Subject|1|||
33425750|NCT00317044|62803685|FG000|Overall Study|Protocol Violation|28|||
33425751|NCT00317044|62803686|FG001|Overall Study|Protocol Violation|22|||
33425752|NCT00317044|62803687|FG002|Overall Study|Protocol Violation|20|||
33425753|NCT00317044|62803685|FG000|Overall Study|Adverse Event|4|||
33425754|NCT00317044|62803686|FG001|Overall Study|Adverse Event|7|||
33425755|NCT00317044|62803687|FG002|Overall Study|Adverse Event|4|||
33425756|NCT00317044|62803685|FG000|Overall Study|Withdrawal by Subject|10|||
33425757|NCT00317044|62803686|FG001|Overall Study|Withdrawal by Subject|7|||
33425758|NCT00317044|62803687|FG002|Overall Study|Withdrawal by Subject|12|||
33425759|NCT00317044|62803685|FG000|Overall Study|Lost to Follow-up|0|||
33425760|NCT00317044|62803686|FG001|Overall Study|Lost to Follow-up|2|||
33425761|NCT00317044|62803687|FG002|Overall Study|Lost to Follow-up|3|||
33425762|NCT00317044|62803685|FG000|Overall Study|Multiple Reasons|6|||
33425763|NCT00317044|62803686|FG001|Overall Study|Multiple Reasons|2|||
33425764|NCT00317044|62803687|FG002|Overall Study|Multiple Reasons|6|||
33425765|NCT00301834|62803695|FG000|Overall Study|Death|1|||
33425766|NCT00301366|62803702|FG000|Overall Study|Adverse Event|1|||
33425767|NCT00330928|62803706|FG000|Overall Study|Lost to Follow-up|6|||
33425768|NCT00330928|62803706|FG000|Overall Study|Physician Decision|9|||
33425769|NCT00330928|62803706|FG000|Overall Study|Death|1|||
33425770|NCT00330928|62803706|FG000|Overall Study|IVUS could not be performed.|1|||
33425771|NCT00330616|62803710|FG000|Overall Study|Adverse Event|13|||
33425772|NCT00330616|62803710|FG000|Overall Study|Lack of Efficacy|1|||
33425773|NCT00330616|62803710|FG000|Overall Study|Lost to Follow-up|2|||
33425774|NCT00330616|62803710|FG000|Overall Study|Withdrawal by Subject|4|||
33425775|NCT00330616|62803710|FG000|Overall Study|Other|1|||
33425776|NCT00466440|62803717|FG000|Overall Study|Adverse Event|0|||
33425777|NCT00466440|62803718|FG001|Overall Study|Adverse Event|3|||
33425778|NCT00466440|62803719|FG002|Overall Study|Adverse Event|1|||
33425779|NCT00466440|62803717|FG000|Overall Study|Death|1|||
33425780|NCT00466440|62803718|FG001|Overall Study|Death|1|||
33425781|NCT00466440|62803719|FG002|Overall Study|Death|0|||
33425782|NCT00466440|62803717|FG000|Overall Study|Progressive disease|13|||
33425783|NCT00466440|62803718|FG001|Overall Study|Progressive disease|5|||
33425784|NCT00466440|62803719|FG002|Overall Study|Progressive disease|4|||
33425785|NCT00466440|62803717|FG000|Overall Study|Lost to Follow-up|0|||
33425786|NCT00466440|62803718|FG001|Overall Study|Lost to Follow-up|1|||
33425787|NCT00466440|62803719|FG002|Overall Study|Lost to Follow-up|0|||
33425788|NCT00466440|62803717|FG000|Overall Study|Physician Decision|0|||
33425789|NCT00466440|62803718|FG001|Overall Study|Physician Decision|1|||
33425790|NCT00466440|62803719|FG002|Overall Study|Physician Decision|2|||
33425791|NCT00466440|62803717|FG000|Overall Study|Protocol entry criteria not met|0|||
33425792|NCT00466440|62803718|FG001|Overall Study|Protocol entry criteria not met|0|||
33425793|NCT00466440|62803719|FG002|Overall Study|Protocol entry criteria not met|4|||
33425794|NCT00466440|62803717|FG000|Overall Study|Withdrawal by Subject|0|||
33425795|NCT00466440|62803718|FG001|Overall Study|Withdrawal by Subject|1|||
33425796|NCT00466440|62803719|FG002|Overall Study|Withdrawal by Subject|0|||
33605333|NCT01765582|63005055|FG001|Overall Study|Death|36|||
33425797|NCT00466440|62803717|FG000|Overall Study|Sponsor decision|0|||
33425798|NCT00466440|62803718|FG001|Overall Study|Sponsor decision|0|||
33425799|NCT00466440|62803719|FG002|Overall Study|Sponsor decision|1|||
33425800|NCT00465972|62803738|FG000|Overall Study|Withdrawal by Subject|2|||
33425801|NCT00465972|62803739|FG001|Overall Study|Withdrawal by Subject|1|||
33425802|NCT00465894|62803749|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
33425803|NCT00465894|62803750|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
33425804|NCT00465894|62803749|FG000|Treatment For 12 Weeks|Family Issues|1|||
33425805|NCT00465894|62803750|FG001|Treatment For 12 Weeks|Family Issues|1|||
33425806|NCT00465894|62803749|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
33425807|NCT00465894|62803750|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
33425808|NCT00330460|62803774|FG000|Overall Study|Physician Decision|1|||
33425809|NCT00330460|62803775|FG001|Overall Study|Physician Decision|0|||
33425810|NCT00330460|62803774|FG000|Overall Study|Adverse Event|10|||
33425811|NCT00330460|62803775|FG001|Overall Study|Adverse Event|8|||
33425812|NCT00330460|62803774|FG000|Overall Study|Withdrawal by Subject|18|||
33425813|NCT00330460|62803775|FG001|Overall Study|Withdrawal by Subject|17|||
33425814|NCT00330460|62803774|FG000|Overall Study|Death|1|||
33425815|NCT00330460|62803775|FG001|Overall Study|Death|1|||
33425816|NCT00330460|62803774|FG000|Overall Study|Ineligibility determined|1|||
33425817|NCT00330460|62803775|FG001|Overall Study|Ineligibility determined|3|||
33425818|NCT00330460|62803774|FG000|Overall Study|Lost to Follow-up|8|||
33425819|NCT00330460|62803775|FG001|Overall Study|Lost to Follow-up|3|||
33425820|NCT00330460|62803774|FG000|Overall Study|Noncompliance|2|||
33425821|NCT00330460|62803775|FG001|Overall Study|Noncompliance|1|||
33425822|NCT00330460|62803774|FG000|Overall Study|Other|1|||
33425823|NCT00330460|62803775|FG001|Overall Study|Other|0|||
33425824|NCT00454116|62803784|FG000|Overall Study|Adverse Event|5|||
33425825|NCT00454116|62803785|FG001|Overall Study|Adverse Event|11|||
33425826|NCT00454116|62803786|FG002|Overall Study|Adverse Event|9|||
33425827|NCT00454116|62803784|FG000|Overall Study|Condition under investigation worsened|17|||
33425828|NCT00454116|62803785|FG001|Overall Study|Condition under investigation worsened|13|||
33425829|NCT00454116|62803786|FG002|Overall Study|Condition under investigation worsened|18|||
33425830|NCT00454116|62803784|FG000|Overall Study|Withdrawal by Subject|3|||
33425831|NCT00454116|62803785|FG001|Overall Study|Withdrawal by Subject|3|||
33425832|NCT00454116|62803786|FG002|Overall Study|Withdrawal by Subject|1|||
33425833|NCT00454116|62803784|FG000|Overall Study|Other|2|||
33425834|NCT00454116|62803785|FG001|Overall Study|Other|2|||
33425835|NCT00454116|62803786|FG002|Overall Study|Other|0|||
33425836|NCT00465816|62803797|FG000|Overall Study|Lost to Follow-up|0|||
33425837|NCT00465816|62803798|FG001|Overall Study|Lost to Follow-up|0|||
33425838|NCT00465816|62803799|FG002|Overall Study|Lost to Follow-up|2|||
33425839|NCT00465738|62803810|FG000|Overall Study|Lost to Follow-up|2|||
33425840|NCT00465738|62803811|FG001|Overall Study|Lost to Follow-up|0|||
33425841|NCT00465738|62803810|FG000|Overall Study|Adverse Event|0|||
33425842|NCT00465738|62803811|FG001|Overall Study|Adverse Event|1|||
33494153|NCT03486834|62872904|FG002|Overall Study|Protocol Deviation|3|||
33494154|NCT03486834|62872902|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
33494155|NCT03486834|62872903|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
33494156|NCT03486834|62872904|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
33494157|NCT03486834|62872902|FG000|Overall Study|Randomized but not treated|4|||
33494158|NCT03486834|62872903|FG001|Overall Study|Randomized but not treated|4|||
33494159|NCT03486834|62872904|FG002|Overall Study|Randomized but not treated|1|||
33494160|NCT03522948|62872914|FG000|Overall Study|Lost to Follow-up|1|||
33494161|NCT03406078|62872920|FG000|Overall Study|Death|1|||
33494162|NCT03406078|62872921|FG001|Overall Study|Death|0|||
33425843|NCT00465738|62803810|FG000|Overall Study|Withdrawal by Subject|2|||
33425844|NCT00465738|62803811|FG001|Overall Study|Withdrawal by Subject|0|||
33425845|NCT00465738|62803810|FG000|Overall Study|Other|2|||
33425846|NCT00465738|62803811|FG001|Overall Study|Other|5|||
33425847|NCT00400179|62803819|FG000|Overall Study|Adverse Event|2|||
33425848|NCT00400179|62803820|FG001|Overall Study|Adverse Event|2|||
33425849|NCT00400179|62803819|FG000|Overall Study|Death|1|||
33494163|NCT03406078|62872920|FG000|Overall Study|Lost to Follow-up|0|||
33494164|NCT03406078|62872921|FG001|Overall Study|Lost to Follow-up|1|||
33425850|NCT00400179|62803820|FG001|Overall Study|Death|2|||
33425851|NCT00400179|62803819|FG000|Overall Study|Withdrew Consent|1|||
33425852|NCT00400179|62803820|FG001|Overall Study|Withdrew Consent|5|||
33494165|NCT03406078|62872920|FG000|Overall Study|Withdrawal by Subject|5|||
33425853|NCT00400179|62803819|FG000|Overall Study|Disease progression|1|||
33605334|NCT01765582|63005056|FG002|Overall Study|Death|33|||
33425854|NCT00400179|62803820|FG001|Overall Study|Disease progression|1|||
33425855|NCT00400179|62803819|FG000|Overall Study|Intercurrent illness|0|||
33425856|NCT00400179|62803820|FG001|Overall Study|Intercurrent illness|1|||
33425857|NCT00400179|62803819|FG000|Overall Study|Investigator judgment|0|||
33425858|NCT00400179|62803820|FG001|Overall Study|Investigator judgment|1|||
33425859|NCT00400179|62803819|FG000|Overall Study|Randomization error/patient ineligible|1|||
33425860|NCT00400179|62803820|FG001|Overall Study|Randomization error/patient ineligible|6|||
33425861|NCT00465270|62803828|FG000|Overall Study|Death|7|||
33605335|NCT01765582|63005054|FG000|Overall Study|Sponsor Decision|46|||
33425862|NCT00465270|62803829|FG001|Overall Study|Death|11|||
33425863|NCT00465270|62803828|FG000|Overall Study|Withdrawal by Subject|34|||
33425864|NCT00465270|62803829|FG001|Overall Study|Withdrawal by Subject|78|||
33425865|NCT00465270|62803828|FG000|Overall Study|Lost to Follow-up|60|||
33425866|NCT00465270|62803829|FG001|Overall Study|Lost to Follow-up|67|||
33425867|NCT00465270|62803828|FG000|Overall Study|Investigator request|3|||
33425868|NCT00465270|62803829|FG001|Overall Study|Investigator request|4|||
33425869|NCT00464568|62803835|FG000|Overall Study|Adverse Event|2|||
33425870|NCT00464490|62803854|FG000|Overall Study|Physician Decision|11|||
33425871|NCT00464490|62803855|FG001|Overall Study|Physician Decision|11|||
33425872|NCT03849300|62803865|FG000|Overall Study|move out to different area|1|||
33425873|NCT03849300|62803866|FG001|Overall Study|move out to different area|3|||
33425874|NCT03849300|62803867|FG002|Overall Study|move out to different area|1|||
33425875|NCT03849300|62803868|FG003|Overall Study|move out to different area|4|||
33425876|NCT03849300|62803865|FG000|Overall Study|scheduling/transportation conflict|4|||
33425877|NCT03849300|62803866|FG001|Overall Study|scheduling/transportation conflict|4|||
33425878|NCT03849300|62803867|FG002|Overall Study|scheduling/transportation conflict|3|||
33425879|NCT03849300|62803868|FG003|Overall Study|scheduling/transportation conflict|2|||
33425880|NCT00412893|62803882|FG000|Overall Study|Adverse Event|31|||
33425881|NCT00412893|62803883|FG001|Overall Study|Adverse Event|53|||
33425882|NCT00412893|62803882|FG000|Overall Study|Death|17|||
33425883|NCT00412893|62803883|FG001|Overall Study|Death|21|||
33425884|NCT00412893|62803882|FG000|Overall Study|Insufficient Therapeutic Response|39|||
33425885|NCT00412893|62803883|FG001|Overall Study|Insufficient Therapeutic Response|23|||
33425886|NCT00412893|62803882|FG000|Overall Study|Lost to Follow-up|2|||
33425887|NCT00412893|62803883|FG001|Overall Study|Lost to Follow-up|1|||
33425888|NCT00412893|62803882|FG000|Overall Study|Violation of Selection at Entry|17|||
33425889|NCT00412893|62803883|FG001|Overall Study|Violation of Selection at Entry|10|||
33425890|NCT00412893|62803882|FG000|Overall Study|Other Protocol Violation|10|||
33425891|NCT00412893|62803883|FG001|Overall Study|Other Protocol Violation|6|||
33425892|NCT00412893|62803882|FG000|Overall Study|Did Not Cooperate|12|||
33425893|NCT00412893|62803883|FG001|Overall Study|Did Not Cooperate|9|||
33425894|NCT00412893|62803882|FG000|Overall Study|Administrative Reason|12|||
33425895|NCT00412893|62803883|FG001|Overall Study|Administrative Reason|15|||
33425896|NCT00412893|62803882|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
33425897|NCT00412893|62803883|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
33425898|NCT00412737|62803891|FG000|Overall Study|Death|1|||
33425899|NCT00412737|62803892|FG001|Overall Study|Death|0|||
33425900|NCT00412737|62803891|FG000|Overall Study|Adverse Event|3|||
33425901|NCT00412737|62803892|FG001|Overall Study|Adverse Event|2|||
33605336|NCT01765582|63005055|FG001|Overall Study|Sponsor Decision|42|||
33605337|NCT01765582|63005056|FG002|Overall Study|Sponsor Decision|42|||
33605338|NCT01765582|63005054|FG000|Overall Study|Withdrawal of Consent|11|||
33494166|NCT03406078|62872921|FG001|Overall Study|Withdrawal by Subject|2|||
33494167|NCT03634033|62872934|FG000|Overall Study|Did not have a post-assessment|384|||
33605339|NCT01765582|63005055|FG001|Overall Study|Withdrawal of Consent|6|||
33425902|NCT00412737|62803891|FG000|Overall Study|Refused Treatment|6|||
33425903|NCT00412737|62803892|FG001|Overall Study|Refused Treatment|2|||
33425904|NCT00412737|62803891|FG000|Overall Study|Failure to Return|6|||
33425905|NCT00412737|62803892|FG001|Overall Study|Failure to Return|2|||
33425906|NCT00508742|62803900|FG000|Period 1: Infant Series|Adverse Event|5|||
33425907|NCT00508742|62803901|FG001|Period 1: Infant Series|Adverse Event|4|||
33425908|NCT00508742|62803900|FG000|Period 1: Infant Series|Protocol Violation|1|||
33425909|NCT00508742|62803901|FG001|Period 1: Infant Series|Protocol Violation|0|||
33425910|NCT00508742|62803900|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
33425911|NCT00508742|62803901|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
33425912|NCT00508742|62803900|FG000|Period 1: Infant Series|Physician Decision|1|||
33425913|NCT00508742|62803901|FG001|Period 1: Infant Series|Physician Decision|0|||
33425914|NCT00508742|62803900|FG000|Period 1: Infant Series|Other|4|||
33425915|NCT00508742|62803901|FG001|Period 1: Infant Series|Other|1|||
33425916|NCT00508742|62803900|FG000|Period 2: After Infant Series|Adverse Event|2|||
33425917|NCT00508742|62803901|FG001|Period 2: After Infant Series|Adverse Event|6|||
33425918|NCT00508742|62803900|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
33425919|NCT00508742|62803901|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
33605340|NCT01765582|63005056|FG002|Overall Study|Withdrawal of Consent|10|||
33605341|NCT01649375|63005068|FG000|Up to Week 16|Adverse Event|2|||
33425920|NCT00508742|62803900|FG000|Period 2: After Infant Series|Protocol Violation|1|||
33425921|NCT00508742|62803901|FG001|Period 2: After Infant Series|Protocol Violation|0|||
33425922|NCT00508742|62803900|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
33425923|NCT00508742|62803901|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
33425924|NCT00508742|62803900|FG000|Period 2: After Infant Series|Failed to Return|1|||
33425925|NCT00508742|62803901|FG001|Period 2: After Infant Series|Failed to Return|0|||
33425926|NCT00508742|62803900|FG000|Period 2: After Infant Series|Other|2|||
33425927|NCT00508742|62803901|FG001|Period 2: After Infant Series|Other|1|||
33425928|NCT00508742|62803900|FG000|Period 3: Toddler Dose|Adverse Event|1|||
33425929|NCT00508742|62803901|FG001|Period 3: Toddler Dose|Adverse Event|0|||
33425930|NCT00508742|62803900|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
33425931|NCT00508742|62803901|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
33425932|NCT00508742|62803900|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
33425933|NCT00508742|62803901|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
33425934|NCT00508742|62803900|FG000|Period 3: Toddler Dose|Other|5|||
33425935|NCT00508742|62803901|FG001|Period 3: Toddler Dose|Other|4|||
33425936|NCT00508274|62803922|FG000|Overall Study|Adverse Event|5|||
33425937|NCT00508274|62803922|FG000|Overall Study|Death|7|||
33425938|NCT00508274|62803922|FG000|Overall Study|Disease progression|32|||
33425939|NCT00508274|62803922|FG000|Overall Study|Withdrawal by Subject|1|||
33425940|NCT00508274|62803922|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
33425941|NCT00508274|62803922|FG000|Overall Study|Missing|3|||
33425942|NCT00499460|62803928|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
33425943|NCT00499460|62803929|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
33425944|NCT00499460|62803928|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
33425945|NCT00499460|62803929|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
33425946|NCT00499460|62803928|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
33425947|NCT00499460|62803929|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
33425948|NCT00412113|62803947|FG000|Overall Study|Adverse Event|11|||
33425949|NCT00412113|62803948|FG001|Overall Study|Adverse Event|15|||
33425950|NCT00412113|62803947|FG000|Overall Study|did not receive treatment|1|||
33425951|NCT00412113|62803948|FG001|Overall Study|did not receive treatment|0|||
33425952|NCT00411645|62803956|FG000|Overall Study|Consent Withdrawn|13|||
33425953|NCT00411645|62803957|FG001|Overall Study|Consent Withdrawn|22|||
33425954|NCT00411645|62803956|FG000|Overall Study|Death|56|||
33425955|NCT00411645|62803957|FG001|Overall Study|Death|135|||
33425956|NCT00411645|62803956|FG000|Overall Study|Investigator/Sponsor Decision|10|||
33425957|NCT00411645|62803957|FG001|Overall Study|Investigator/Sponsor Decision|7|||
33425958|NCT00411645|62803956|FG000|Overall Study|Lost to Follow-up|2|||
33425959|NCT00411645|62803957|FG001|Overall Study|Lost to Follow-up|0|||
33425960|NCT00490724|62803967|FG000|Period I|Physician Decision|0|||
33425961|NCT00490724|62803968|FG001|Period I|Physician Decision|0|||
33425962|NCT00490724|62803969|FG002|Period I|Physician Decision|1|||
33425963|NCT00490724|62803967|FG000|Period II|Treatment Discontinuation|3|||
33425964|NCT00490724|62803968|FG001|Period II|Treatment Discontinuation|1|||
33425965|NCT00490724|62803969|FG002|Period II|Treatment Discontinuation|3|||
33425966|NCT03835221|62803977|FG000|Methafilcon A|Withdrawal by Subject|1|||
33425967|NCT00398073|62803985|FG000|Overall Study|Withdrawal by Subject|1|||
33425968|NCT00398073|62803986|FG001|Overall Study|Withdrawal by Subject|0|||
33425969|NCT00490646|62803994|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
33425970|NCT00490646|62803995|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
33425971|NCT00490646|62803994|FG000|Overall Study|Never Treated (had an adverse event)|1|||
33425972|NCT00490646|62803995|FG001|Overall Study|Never Treated (had an adverse event)|0|||
33425973|NCT00490646|62803994|FG000|Overall Study|Never Treated (withdrew consent)|0|||
33425974|NCT00490646|62803995|FG001|Overall Study|Never Treated (withdrew consent)|1|||
33425975|NCT00388947|62804001|FG000|Overall Study|Protocol Violation|47|||
33425976|NCT00490568|62804005|FG000|Overall Study|Adverse Event|116|||
33425977|NCT00490568|62804005|FG000|Overall Study|Lost to Follow-up|13|||
33425978|NCT00490568|62804005|FG000|Overall Study|Protocol Violation|45|||
33425979|NCT00490568|62804005|FG000|Overall Study|Withdrawal by Subject|135|||
33425980|NCT00490568|62804005|FG000|Overall Study|Still in the study at termination|974|||
33425981|NCT00490568|62804005|FG000|Overall Study|Other|1|||
33425982|NCT00490568|62804005|FG000|Overall Study|Exclusion criteria met|1|||
33425983|NCT00490568|62804005|FG000|Overall Study|Caregiver related|20|||
33425984|NCT00490568|62804005|FG000|Overall Study|Abnormal ECG|25|||
33425985|NCT00490568|62804005|FG000|Overall Study|Participant refused follow-up|9|||
33425986|NCT00490568|62804005|FG000|Overall Study|Legal representative withdrew consent|1|||
33425987|NCT00490568|62804005|FG000|Overall Study|Disease progression|4|||
33425988|NCT00490568|62804005|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
33425989|NCT00490568|62804005|FG000|Overall Study|Investigator decision|3|||
33425990|NCT00490568|62804005|FG000|Overall Study|Non-Compliance|7|||
33425991|NCT00490568|62804005|FG000|Overall Study|Efficacy related|3|||
33425992|NCT00490568|62804005|FG000|Overall Study|Participant died|1|||
33425993|NCT00490568|62804005|FG000|Overall Study|Participant withdrawal due to surgery|1|||
33425994|NCT00561353|62804020|FG000|Overall Study|Subject reached a virologic endpoint|2|||
33425995|NCT00561353|62804021|FG001|Overall Study|Subject reached a virologic endpoint|1|||
33425996|NCT00561353|62804022|FG002|Overall Study|Subject reached a virologic endpoint|1|||
33425997|NCT00561353|62804023|FG003|Overall Study|Subject reached a virologic endpoint|4|||
33425998|NCT00561353|62804024|FG004|Overall Study|Subject reached a virologic endpoint|1|||
33425999|NCT00561353|62804025|FG005|Overall Study|Subject reached a virologic endpoint|3|||
33426000|NCT00561353|62804026|FG006|Overall Study|Subject reached a virologic endpoint|4|||
33426001|NCT00561353|62804027|FG007|Overall Study|Subject reached a virologic endpoint|4|||
33426002|NCT00561353|62804028|FG008|Overall Study|Subject reached a virologic endpoint|5|||
33426003|NCT00561353|62804029|FG009|Overall Study|Subject reached a virologic endpoint|0|||
33426004|NCT00561353|62804020|FG000|Overall Study|Subject ineligible to continue the trial|0|||
33426005|NCT00561353|62804021|FG001|Overall Study|Subject ineligible to continue the trial|0|||
33426006|NCT00561353|62804022|FG002|Overall Study|Subject ineligible to continue the trial|0|||
33426007|NCT00561353|62804023|FG003|Overall Study|Subject ineligible to continue the trial|0|||
33426008|NCT00561353|62804024|FG004|Overall Study|Subject ineligible to continue the trial|0|||
33426009|NCT00561353|62804025|FG005|Overall Study|Subject ineligible to continue the trial|1|||
33426010|NCT00561353|62804026|FG006|Overall Study|Subject ineligible to continue the trial|1|||
33426011|NCT00561353|62804027|FG007|Overall Study|Subject ineligible to continue the trial|0|||
33426012|NCT00561353|62804028|FG008|Overall Study|Subject ineligible to continue the trial|2|||
33426013|NCT00561353|62804029|FG009|Overall Study|Subject ineligible to continue the trial|1|||
33426014|NCT00561353|62804020|FG000|Overall Study|Other|1|||
33426015|NCT00561353|62804021|FG001|Overall Study|Other|0|||
33426016|NCT00561353|62804022|FG002|Overall Study|Other|1|||
33426017|NCT00561353|62804023|FG003|Overall Study|Other|0|||
33426018|NCT00561353|62804024|FG004|Overall Study|Other|0|||
33426019|NCT00561353|62804025|FG005|Overall Study|Other|2|||
33426020|NCT00561353|62804026|FG006|Overall Study|Other|0|||
33426021|NCT00561353|62804027|FG007|Overall Study|Other|0|||
33426022|NCT00561353|62804028|FG008|Overall Study|Other|0|||
33426023|NCT00561353|62804029|FG009|Overall Study|Other|0|||
33426024|NCT00561353|62804020|FG000|Overall Study|Adverse Event|0|||
33426025|NCT00561353|62804021|FG001|Overall Study|Adverse Event|0|||
33426026|NCT00561353|62804022|FG002|Overall Study|Adverse Event|0|||
33426027|NCT00561353|62804023|FG003|Overall Study|Adverse Event|2|||
33426028|NCT00561353|62804024|FG004|Overall Study|Adverse Event|0|||
33426029|NCT00561353|62804025|FG005|Overall Study|Adverse Event|0|||
33426030|NCT00561353|62804026|FG006|Overall Study|Adverse Event|1|||
33426031|NCT00561353|62804027|FG007|Overall Study|Adverse Event|0|||
33426032|NCT00561353|62804028|FG008|Overall Study|Adverse Event|0|||
33426033|NCT00561353|62804029|FG009|Overall Study|Adverse Event|1|||
33426034|NCT00561353|62804020|FG000|Overall Study|Lost to Follow-up|2|||
33426035|NCT00561353|62804021|FG001|Overall Study|Lost to Follow-up|0|||
33426036|NCT00561353|62804022|FG002|Overall Study|Lost to Follow-up|1|||
33426037|NCT00561353|62804023|FG003|Overall Study|Lost to Follow-up|0|||
33426038|NCT00561353|62804024|FG004|Overall Study|Lost to Follow-up|0|||
33426039|NCT00561353|62804025|FG005|Overall Study|Lost to Follow-up|0|||
33426040|NCT00561353|62804026|FG006|Overall Study|Lost to Follow-up|0|||
33426041|NCT00561353|62804027|FG007|Overall Study|Lost to Follow-up|0|||
33426042|NCT00561353|62804028|FG008|Overall Study|Lost to Follow-up|0|||
33426043|NCT00561353|62804029|FG009|Overall Study|Lost to Follow-up|0|||
33426044|NCT00561353|62804020|FG000|Overall Study|Withdrawal by Subject|0|||
33426045|NCT00561353|62804021|FG001|Overall Study|Withdrawal by Subject|2|||
33426046|NCT00561353|62804022|FG002|Overall Study|Withdrawal by Subject|0|||
33426047|NCT00561353|62804023|FG003|Overall Study|Withdrawal by Subject|0|||
33426048|NCT00561353|62804024|FG004|Overall Study|Withdrawal by Subject|0|||
33426049|NCT00561353|62804025|FG005|Overall Study|Withdrawal by Subject|0|||
33426050|NCT00561353|62804026|FG006|Overall Study|Withdrawal by Subject|0|||
33426051|NCT00561353|62804027|FG007|Overall Study|Withdrawal by Subject|0|||
33426052|NCT00561353|62804028|FG008|Overall Study|Withdrawal by Subject|0|||
33426053|NCT00561353|62804029|FG009|Overall Study|Withdrawal by Subject|0|||
33426054|NCT00560885|62804096|FG000|Overall Study|Death|7|||
33426055|NCT00560885|62804096|FG000|Overall Study|Withdrawal by Subject|1|||
33426056|NCT00397215|62804104|FG000|Month 0 (Day 0)|Adverse Event|0|||
33426057|NCT00397215|62804105|FG001|Month 0 (Day 0)|Adverse Event|1|||
33426058|NCT00397215|62804106|FG002|Month 0 (Day 0)|Adverse Event|0|||
33426059|NCT00397215|62804107|FG003|Month 0 (Day 0)|Adverse Event|0|||
33426060|NCT00397215|62804104|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
33426061|NCT00397215|62804105|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
33426062|NCT00397215|62804106|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
33605342|NCT01649375|63005069|FG001|Up to Week 16|Adverse Event|5|||
33426063|NCT00397215|62804107|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
33426064|NCT00397215|62804104|FG000|Month 0 (Day 0)|Other|4|||
33426065|NCT00397215|62804105|FG001|Month 0 (Day 0)|Other|1|||
33426066|NCT00397215|62804106|FG002|Month 0 (Day 0)|Other|3|||
33426067|NCT00397215|62804107|FG003|Month 0 (Day 0)|Other|3|||
33426068|NCT00397215|62804104|FG000|Month 6 (Day 180)|Adverse Event|0|||
33426069|NCT00397215|62804105|FG001|Month 6 (Day 180)|Adverse Event|3|||
33426070|NCT00397215|62804106|FG002|Month 6 (Day 180)|Adverse Event|2|||
33426071|NCT00397215|62804107|FG003|Month 6 (Day 180)|Adverse Event|0|||
33426072|NCT00397215|62804104|FG000|Month 6 (Day 180)|Other|2|||
33426073|NCT00397215|62804105|FG001|Month 6 (Day 180)|Other|0|||
33426074|NCT00397215|62804106|FG002|Month 6 (Day 180)|Other|3|||
33426075|NCT00397215|62804107|FG003|Month 6 (Day 180)|Other|0|||
33426076|NCT00556439|62804124|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
33426077|NCT00556439|62804125|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
33426078|NCT00556439|62804126|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
33426079|NCT00556439|62804127|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
33426080|NCT00556439|62804124|FG000|Study Entry to Week 12|Physician Decision|1|||
33426081|NCT00556439|62804125|FG001|Study Entry to Week 12|Physician Decision|0|||
33426082|NCT00556439|62804126|FG002|Study Entry to Week 12|Physician Decision|0|||
33426083|NCT00556439|62804127|FG003|Study Entry to Week 12|Physician Decision|0|||
33426084|NCT00556439|62804124|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
33426085|NCT00556439|62804125|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
33426086|NCT00556439|62804126|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
33426087|NCT00556439|62804127|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
33426088|NCT00556439|62804124|FG000|Study Entry to Week 12|Recurrent infection|1|||
33426089|NCT00556439|62804125|FG001|Study Entry to Week 12|Recurrent infection|0|||
33426090|NCT00556439|62804126|FG002|Study Entry to Week 12|Recurrent infection|0|||
33426091|NCT00556439|62804127|FG003|Study Entry to Week 12|Recurrent infection|0|||
33426092|NCT00556439|62804124|FG000|Study Entry to Week 12|Malignancy|0|||
33426093|NCT00556439|62804125|FG001|Study Entry to Week 12|Malignancy|0|||
33426094|NCT00556439|62804126|FG002|Study Entry to Week 12|Malignancy|1|||
33426095|NCT00556439|62804127|FG003|Study Entry to Week 12|Malignancy|0|||
33426096|NCT00556439|62804124|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
33426097|NCT00556439|62804125|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
33426098|NCT00556439|62804126|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
33426099|NCT00556439|62804127|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
33426100|NCT00556439|62804124|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
33426101|NCT00556439|62804125|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
33426102|NCT00556439|62804126|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
33426103|NCT00556439|62804127|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
33426104|NCT00556439|62804124|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
33426105|NCT00556439|62804125|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
33426106|NCT00556439|62804126|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
33426107|NCT00556439|62804127|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
33426108|NCT00556439|62804124|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
33426109|NCT00556439|62804125|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
33426110|NCT00556439|62804126|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
33426111|NCT00556439|62804127|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
33426112|NCT00387465|62804140|FG000|Overall Study|Withdrawal by Subject|0|||
33426113|NCT00387465|62804141|FG001|Overall Study|Withdrawal by Subject|1|||
33426114|NCT00387465|62804142|FG002|Overall Study|Withdrawal by Subject|0|||
33426115|NCT00387153|62804159|FG000|Overall Study|Adverse Event|1|||
33426116|NCT00387153|62804159|FG000|Overall Study|Disease Progression|3|||
33426117|NCT00387153|62804159|FG000|Overall Study|Lack of Response|4|||
33426118|NCT00386607|62804163|FG000|Core|Adverse Event|40|||
33426119|NCT00386607|62804164|FG001|Core|Adverse Event|0|||
33426120|NCT00386607|62804163|FG000|Core|Abnormal laboratory value(s)|3|||
33426121|NCT00386607|62804164|FG001|Core|Abnormal laboratory value(s)|0|||
33426122|NCT00386607|62804163|FG000|Core|Unsatisfactory therapeutic effect|23|||
33426123|NCT00386607|62804164|FG001|Core|Unsatisfactory therapeutic effect|0|||
33426124|NCT00386607|62804163|FG000|Core|Condition no longer requires study drug|4|||
33426125|NCT00386607|62804164|FG001|Core|Condition no longer requires study drug|0|||
33426126|NCT00386607|62804163|FG000|Core|Patient withdrew consent|15|||
33426127|NCT00386607|62804164|FG001|Core|Patient withdrew consent|0|||
33426128|NCT00386607|62804163|FG000|Core|Lost to Follow-up|23|||
33426129|NCT00386607|62804164|FG001|Core|Lost to Follow-up|0|||
33426130|NCT00386607|62804163|FG000|Core|Administrative problems|1|||
33426131|NCT00386607|62804164|FG001|Core|Administrative problems|0|||
33426132|NCT00386607|62804163|FG000|Core|Protocol Deviation|6|||
33426133|NCT00386607|62804164|FG001|Core|Protocol Deviation|0|||
33426134|NCT00386607|62804163|FG000|Extension|Adverse Event|0|||
33426135|NCT00386607|62804164|FG001|Extension|Adverse Event|6|||
33426136|NCT00386607|62804163|FG000|Extension|Abnormal laboratory value(s)|0|||
33426137|NCT00386607|62804164|FG001|Extension|Abnormal laboratory value(s)|1|||
33426138|NCT00386607|62804163|FG000|Extension|Administrative problems|0|||
33426139|NCT00386607|62804164|FG001|Extension|Administrative problems|1|||
33426140|NCT00386607|62804163|FG000|Extension|Lost to Follow-up|0|||
33426141|NCT00386607|62804164|FG001|Extension|Lost to Follow-up|3|||
33426142|NCT00386607|62804163|FG000|Extension|Patient withdrew consent|0|||
33426143|NCT00386607|62804164|FG001|Extension|Patient withdrew consent|5|||
33426144|NCT00386607|62804163|FG000|Extension|Unsatisfactory therapeutic effect|0|||
33426145|NCT00386607|62804164|FG001|Extension|Unsatisfactory therapeutic effect|1|||
33426146|NCT00410163|62804178|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
33426147|NCT00410163|62804179|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
33426148|NCT00410163|62804178|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
33426149|NCT00410163|62804179|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
33426150|NCT00410163|62804178|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
33426151|NCT00410163|62804179|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
33426152|NCT00410163|62804178|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
33426153|NCT00410163|62804179|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
33426154|NCT00410163|62804178|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
33426155|NCT00410163|62804179|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
33426156|NCT00410163|62804178|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
33426157|NCT00410163|62804179|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
33426158|NCT00410163|62804178|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
33426159|NCT00410163|62804179|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
33426160|NCT00410163|62804178|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
33426161|NCT00410163|62804179|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
33426162|NCT00410163|62804178|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
33426163|NCT00410163|62804179|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
33426164|NCT00410163|62804178|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
33426165|NCT00410163|62804179|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
33426166|NCT00410163|62804178|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
33426167|NCT00410163|62804179|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
33426168|NCT00410163|62804178|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
33426169|NCT00410163|62804179|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
33426170|NCT00410163|62804178|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
33426171|NCT00410163|62804179|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
33426172|NCT00410163|62804178|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
33426173|NCT00410163|62804179|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
33426174|NCT00409617|62804215|FG000|Overall Study|Adverse Event|57|||
33426175|NCT00409617|62804215|FG000|Overall Study|Lack of Efficacy|54|||
33426176|NCT00409617|62804215|FG000|Overall Study|Lost to Follow-up|2|||
33426177|NCT00409617|62804215|FG000|Overall Study|Protocol Violation|24|||
33426178|NCT00409617|62804215|FG000|Overall Study|Withdrawal by Subject|8|||
33426179|NCT00409617|62804215|FG000|Overall Study|Administrative reasons|1|||
33426180|NCT00409617|62804215|FG000|Overall Study|Not described|14|||
33426181|NCT00300274|62804222|FG000|Overall Study|Withdrawal by Subject|12|||
33426182|NCT00300274|62804223|FG001|Overall Study|Withdrawal by Subject|3|||
33426183|NCT00300274|62804224|FG002|Overall Study|Withdrawal by Subject|14|||
33426184|NCT00300274|62804222|FG000|Overall Study|Lost to Follow-up|3|||
33494168|NCT03634033|62872935|FG001|Overall Study|Did not have a post-assessment|291|||
33494169|NCT03634033|62872936|FG002|Overall Study|Did not have a post-assessment|114|||
33494170|NCT03634033|62872937|FG003|Overall Study|Did not have a post-assessment|161|||
33605343|NCT01649375|63005070|FG002|Up to Week 16|Adverse Event|4|||
33605344|NCT01649375|63005071|FG003|Up to Week 16|Adverse Event|0|||
33605345|NCT01649375|63005072|FG004|Up to Week 16|Adverse Event|0|||
33426185|NCT00300274|62804223|FG001|Overall Study|Lost to Follow-up|4|||
33426186|NCT00300274|62804224|FG002|Overall Study|Lost to Follow-up|5|||
33426187|NCT00300274|62804222|FG000|Overall Study|Death|31|||
33426188|NCT00300274|62804223|FG001|Overall Study|Death|20|||
33426189|NCT00300274|62804224|FG002|Overall Study|Death|25|||
33426190|NCT00300274|62804222|FG000|Overall Study|Re-transplant|0|||
33426191|NCT00300274|62804223|FG001|Overall Study|Re-transplant|0|||
33426192|NCT00300274|62804224|FG002|Overall Study|Re-transplant|1|||
33426193|NCT00299728|62804234|FG000|Overall Study|Lost to Follow-up|0|||
33426194|NCT00299728|62804235|FG001|Overall Study|Lost to Follow-up|1|||
33426195|NCT00299728|62804234|FG000|Overall Study|Withdrawal by Subject|0|||
33426196|NCT00299728|62804235|FG001|Overall Study|Withdrawal by Subject|1|||
33426197|NCT00299728|62804234|FG000|Overall Study|Progressive disease|0|||
33426198|NCT00299728|62804235|FG001|Overall Study|Progressive disease|1|||
33426199|NCT00396591|62804241|FG000|Overall Study|Disease Progression|13|||
33426200|NCT00396591|62804241|FG000|Overall Study|Adverse Event|2|||
33426201|NCT00396591|62804241|FG000|Overall Study|Participant request|1|||
33426202|NCT00316264|62804248|FG000|Overall Study|Lost to Follow-up|0|||
33426203|NCT00316264|62804249|FG001|Overall Study|Lost to Follow-up|1|||
33426204|NCT00316264|62804250|FG002|Overall Study|Lost to Follow-up|0|||
33426205|NCT00316264|62804248|FG000|Overall Study|Withdrawal of Consent|3|||
33426206|NCT00316264|62804249|FG001|Overall Study|Withdrawal of Consent|5|||
33426207|NCT00316264|62804250|FG002|Overall Study|Withdrawal of Consent|6|||
33426208|NCT00316264|62804248|FG000|Overall Study|Death|2|||
33426209|NCT00316264|62804249|FG001|Overall Study|Death|0|||
33426210|NCT00316264|62804250|FG002|Overall Study|Death|0|||
33426211|NCT00316264|62804248|FG000|Overall Study|Other|1|||
33426212|NCT00316264|62804249|FG001|Overall Study|Other|1|||
33426213|NCT00316264|62804250|FG002|Overall Study|Other|0|||
33426214|NCT00385827|62804261|FG000|Part 1|Adverse Event|1|||
33426215|NCT00385827|62804262|FG001|Part 1|Adverse Event|0|||
33426216|NCT00385827|62804263|FG002|Part 1|Adverse Event|0|||
33426217|NCT00385827|62804261|FG000|Part 1|Death|2|||
33426218|NCT00385827|62804262|FG001|Part 1|Death|0|||
33426219|NCT00385827|62804263|FG002|Part 1|Death|0|||
33426220|NCT00385827|62804261|FG000|Part 1|Lack of Efficacy|5|||
33426221|NCT00385827|62804262|FG001|Part 1|Lack of Efficacy|0|||
33426222|NCT00385827|62804263|FG002|Part 1|Lack of Efficacy|0|||
33426223|NCT00385827|62804261|FG000|Part 1|Other|1|||
33426224|NCT00385827|62804262|FG001|Part 1|Other|0|||
33426225|NCT00385827|62804263|FG002|Part 1|Other|0|||
33426226|NCT00385827|62804261|FG000|Part 2|Adverse Event|0|||
33426227|NCT00385827|62804262|FG001|Part 2|Adverse Event|6|||
33426228|NCT00385827|62804263|FG002|Part 2|Adverse Event|10|||
33426229|NCT00385827|62804261|FG000|Part 2|Death|0|||
33426230|NCT00385827|62804262|FG001|Part 2|Death|0|||
33426231|NCT00385827|62804263|FG002|Part 2|Death|2|||
33426232|NCT00385827|62804261|FG000|Part 2|Lack of Efficacy|0|||
33426233|NCT00385827|62804262|FG001|Part 2|Lack of Efficacy|14|||
33426234|NCT00385827|62804263|FG002|Part 2|Lack of Efficacy|13|||
33426235|NCT00385827|62804261|FG000|Part 2|Randomized but not treated|0|||
33426236|NCT00385827|62804262|FG001|Part 2|Randomized but not treated|2|||
33426237|NCT00385827|62804263|FG002|Part 2|Randomized but not treated|2|||
33426238|NCT00385827|62804261|FG000|Part 2|Other|0|||
33426239|NCT00385827|62804262|FG001|Part 2|Other|11|||
33426240|NCT00385827|62804263|FG002|Part 2|Other|21|||
33426241|NCT00498602|62804280|FG000|Overall Study|Death|0|||
33426242|NCT00498602|62804281|FG001|Overall Study|Death|0|||
33426243|NCT00498602|62804282|FG002|Overall Study|Death|0|||
33426244|NCT00498602|62804283|FG003|Overall Study|Death|0|||
33426245|NCT00498602|62804284|FG004|Overall Study|Death|0|||
33426246|NCT00498602|62804285|FG005|Overall Study|Death|1|||
33426247|NCT00498602|62804286|FG006|Overall Study|Death|0|||
33426248|NCT00498602|62804280|FG000|Overall Study|Lack of Efficacy|1|||
33426249|NCT00498602|62804281|FG001|Overall Study|Lack of Efficacy|0|||
33426250|NCT00498602|62804282|FG002|Overall Study|Lack of Efficacy|0|||
33426251|NCT00498602|62804283|FG003|Overall Study|Lack of Efficacy|0|||
33426252|NCT00498602|62804284|FG004|Overall Study|Lack of Efficacy|0|||
33426253|NCT00498602|62804285|FG005|Overall Study|Lack of Efficacy|0|||
33426254|NCT00498602|62804286|FG006|Overall Study|Lack of Efficacy|0|||
33426255|NCT00498602|62804280|FG000|Overall Study|Lost to Follow-up|0|||
33426256|NCT00498602|62804281|FG001|Overall Study|Lost to Follow-up|2|||
33426257|NCT00498602|62804282|FG002|Overall Study|Lost to Follow-up|0|||
33426258|NCT00498602|62804283|FG003|Overall Study|Lost to Follow-up|2|||
33426259|NCT00498602|62804284|FG004|Overall Study|Lost to Follow-up|0|||
33426260|NCT00498602|62804285|FG005|Overall Study|Lost to Follow-up|0|||
33426261|NCT00498602|62804286|FG006|Overall Study|Lost to Follow-up|0|||
33426262|NCT00498602|62804280|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
33426263|NCT00498602|62804281|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
33426264|NCT00498602|62804282|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
33426265|NCT00498602|62804283|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
33426266|NCT00498602|62804284|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
33426267|NCT00498602|62804285|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
33426268|NCT00498602|62804286|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
33426269|NCT00498602|62804280|FG000|Overall Study|AE not related to Study Drug|1|||
33426270|NCT00498602|62804281|FG001|Overall Study|AE not related to Study Drug|3|||
33426271|NCT00498602|62804282|FG002|Overall Study|AE not related to Study Drug|0|||
33426272|NCT00498602|62804283|FG003|Overall Study|AE not related to Study Drug|0|||
33426273|NCT00498602|62804284|FG004|Overall Study|AE not related to Study Drug|2|||
33426274|NCT00498602|62804285|FG005|Overall Study|AE not related to Study Drug|2|||
33426275|NCT00498602|62804286|FG006|Overall Study|AE not related to Study Drug|1|||
33426276|NCT00498602|62804280|FG000|Overall Study|Caregiver Request|2|||
33426277|NCT00498602|62804281|FG001|Overall Study|Caregiver Request|2|||
33426278|NCT00498602|62804282|FG002|Overall Study|Caregiver Request|2|||
33426279|NCT00498602|62804283|FG003|Overall Study|Caregiver Request|0|||
33426280|NCT00498602|62804284|FG004|Overall Study|Caregiver Request|1|||
33426281|NCT00498602|62804285|FG005|Overall Study|Caregiver Request|2|||
33426282|NCT00498602|62804286|FG006|Overall Study|Caregiver Request|0|||
33426283|NCT00498602|62804280|FG000|Overall Study|Investigator Request|0|||
33426284|NCT00498602|62804281|FG001|Overall Study|Investigator Request|0|||
33426285|NCT00498602|62804282|FG002|Overall Study|Investigator Request|1|||
33426286|NCT00498602|62804283|FG003|Overall Study|Investigator Request|0|||
33426287|NCT00498602|62804284|FG004|Overall Study|Investigator Request|0|||
33426288|NCT00498602|62804285|FG005|Overall Study|Investigator Request|0|||
33426289|NCT00498602|62804286|FG006|Overall Study|Investigator Request|0|||
33426290|NCT00498602|62804280|FG000|Overall Study|Subject Request|3|||
33426291|NCT00498602|62804281|FG001|Overall Study|Subject Request|0|||
33426292|NCT00498602|62804282|FG002|Overall Study|Subject Request|1|||
33426293|NCT00498602|62804283|FG003|Overall Study|Subject Request|1|||
33426294|NCT00498602|62804284|FG004|Overall Study|Subject Request|1|||
33426295|NCT00498602|62804285|FG005|Overall Study|Subject Request|4|||
33426296|NCT00498602|62804286|FG006|Overall Study|Subject Request|1|||
33426297|NCT00498602|62804280|FG000|Overall Study|Other|2|||
33426298|NCT00498602|62804281|FG001|Overall Study|Other|3|||
33426299|NCT00498602|62804282|FG002|Overall Study|Other|1|||
33426300|NCT00498602|62804283|FG003|Overall Study|Other|0|||
33426301|NCT00498602|62804284|FG004|Overall Study|Other|0|||
33426302|NCT00498602|62804285|FG005|Overall Study|Other|3|||
33426303|NCT00498602|62804286|FG006|Overall Study|Other|0|||
33426304|NCT00507728|62804305|FG000|Randomization to Month 3|Lost to Follow-up|15|||
33426305|NCT00507728|62804306|FG001|Randomization to Month 3|Lost to Follow-up|14|||
33426306|NCT00507728|62804307|FG002|Randomization to Month 3|Lost to Follow-up|20|||
33426307|NCT00507728|62804305|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
33426308|NCT00507728|62804306|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
33426309|NCT00507728|62804307|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
33426310|NCT00498368|62804323|FG000|Overall Study|Withdrawal by Subject|3|||
33426311|NCT00498368|62804324|FG001|Overall Study|Withdrawal by Subject|2|||
33426312|NCT00385671|62804333|FG000|Overall Study|Adverse Event|14|||
33426313|NCT00385671|62804334|FG001|Overall Study|Adverse Event|27|||
33426314|NCT00385671|62804335|FG002|Overall Study|Adverse Event|18|||
33426315|NCT00385671|62804333|FG000|Overall Study|Lack of Efficacy|5|||
33426316|NCT00385671|62804334|FG001|Overall Study|Lack of Efficacy|9|||
33426317|NCT00385671|62804335|FG002|Overall Study|Lack of Efficacy|5|||
33426318|NCT00385671|62804333|FG000|Overall Study|Lost to Follow-up|6|||
33426319|NCT00385671|62804334|FG001|Overall Study|Lost to Follow-up|6|||
33426320|NCT00385671|62804335|FG002|Overall Study|Lost to Follow-up|5|||
33426321|NCT00385671|62804333|FG000|Overall Study|Physician Decision|2|||
33426322|NCT00385671|62804334|FG001|Overall Study|Physician Decision|1|||
33426323|NCT00385671|62804335|FG002|Overall Study|Physician Decision|2|||
33426324|NCT00385671|62804333|FG000|Overall Study|Protocol Violation|5|||
33426325|NCT00385671|62804334|FG001|Overall Study|Protocol Violation|2|||
33426326|NCT00385671|62804335|FG002|Overall Study|Protocol Violation|1|||
33426327|NCT00385671|62804333|FG000|Overall Study|Sponsor Decision|2|||
33426328|NCT00385671|62804334|FG001|Overall Study|Sponsor Decision|2|||
33426329|NCT00385671|62804335|FG002|Overall Study|Sponsor Decision|1|||
33426330|NCT00385671|62804333|FG000|Overall Study|Withdrawal by Subject|4|||
33426331|NCT00385671|62804334|FG001|Overall Study|Withdrawal by Subject|4|||
33426332|NCT00385671|62804335|FG002|Overall Study|Withdrawal by Subject|4|||
33426333|NCT00497198|62804347|FG000|Overall Study|Adverse Event|4|||
33426334|NCT00497198|62804348|FG001|Overall Study|Adverse Event|2|||
33426335|NCT00497198|62804347|FG000|Overall Study|Physician Decision|1|||
33426336|NCT00497198|62804348|FG001|Overall Study|Physician Decision|2|||
33426337|NCT00497198|62804347|FG000|Overall Study|Withdrawal by Subject|0|||
33426338|NCT00497198|62804348|FG001|Overall Study|Withdrawal by Subject|1|||
33426339|NCT00496964|62804356|FG000|Overall Study|Withdrawal by Subject|0|||
33426340|NCT00496964|62804357|FG001|Overall Study|Withdrawal by Subject|1|||
33426341|NCT00490490|62804365|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
33426342|NCT00490490|62804365|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
33426343|NCT00385593|62804371|FG000|Overall Study|Adverse Event|3|||
33426344|NCT00385593|62804372|FG001|Overall Study|Adverse Event|2|||
33426345|NCT00385593|62804371|FG000|Overall Study|Withdrawal by Subject|17|||
33426346|NCT00385593|62804372|FG001|Overall Study|Withdrawal by Subject|7|||
33426347|NCT00385593|62804371|FG000|Overall Study|Lost to Follow-up|12|||
33426348|NCT00385593|62804372|FG001|Overall Study|Lost to Follow-up|8|||
33426349|NCT00385593|62804371|FG000|Overall Study|Protocol Violation|7|||
33426350|NCT00385593|62804372|FG001|Overall Study|Protocol Violation|4|||
33426351|NCT00385593|62804371|FG000|Overall Study|Several reasons|17|||
33426352|NCT00385593|62804372|FG001|Overall Study|Several reasons|15|||
33426353|NCT00385593|62804371|FG000|Overall Study|Incorrect inclusion|2|||
33426354|NCT00385593|62804372|FG001|Overall Study|Incorrect inclusion|0|||
33426355|NCT00385593|62804371|FG000|Overall Study|Incorrect randomization|0|||
33426356|NCT00385593|62804372|FG001|Overall Study|Incorrect randomization|1|||
33426357|NCT00495794|62804380|FG000|Overall Study|Pharmacist did not activate patient|522|||
33426358|NCT00495794|62804381|FG001|Overall Study|Pharmacist did not activate patient|0|||
33426359|NCT00495170|62804387|FG000|Overall Study|Lost to Follow-up|9|||
33426360|NCT00495170|62804387|FG000|Overall Study|Withdrawal by Subject|3|||
33426361|NCT00495170|62804387|FG000|Overall Study|Inappropriate staging|8|||
33426362|NCT03853148|62804395|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
33426363|NCT03853148|62804396|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
33426364|NCT03853148|62804397|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
33426365|NCT03853148|62804398|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
33426366|NCT00385203|62804410|FG000|Overall Study|Adverse Event|5|||
33426367|NCT00385203|62804411|FG001|Overall Study|Adverse Event|4|||
33426368|NCT00385203|62804410|FG000|Overall Study|Death|1|||
33426369|NCT00385203|62804411|FG001|Overall Study|Death|0|||
33426370|NCT00385203|62804410|FG000|Overall Study|Condition under investigation worsened|18|||
33426371|NCT00385203|62804411|FG001|Overall Study|Condition under investigation worsened|3|||
33426372|NCT00385203|62804410|FG000|Overall Study|Incorrect enrollment|2|||
33426373|NCT00385203|62804411|FG001|Overall Study|Incorrect enrollment|0|||
33426374|NCT00408993|62804420|FG000|Overall Study|Adverse Event|15|||
33426375|NCT00408993|62804421|FG001|Overall Study|Adverse Event|4|||
33426376|NCT00408993|62804420|FG000|Overall Study|Protocol Violation|1|||
33426377|NCT00408993|62804421|FG001|Overall Study|Protocol Violation|6|||
33426378|NCT00408993|62804420|FG000|Overall Study|Lack of Efficacy|1|||
33426379|NCT00408993|62804421|FG001|Overall Study|Lack of Efficacy|4|||
33426380|NCT00408993|62804420|FG000|Overall Study|Withdrawal by Subject|2|||
33426381|NCT00408993|62804421|FG001|Overall Study|Withdrawal by Subject|3|||
33426382|NCT00395967|62804431|FG000|Treatment Period|Failed Mobilization|1|||
33426383|NCT00395967|62804431|FG000|Follow-up Period|Death|1|||
33322990|NCT00927394|62699260|FG001|Overall Study|Withdrawal by Subject|24|||
33426384|NCT00395967|62804431|FG000|Follow-up Period|Lost to Follow-up|1|||
33426385|NCT00395733|62804437|FG000|Period 2|Withdrawal by Subject|1|||
33426386|NCT00395733|62804438|FG001|Period 2|Withdrawal by Subject|2|||
33426387|NCT00395733|62804437|FG000|Period 2|Protocol Violation|0|||
33426388|NCT00395733|62804438|FG001|Period 2|Protocol Violation|1|||
33426389|NCT00395733|62804437|FG000|Period 2|Adverse Event|0|||
33426390|NCT00395733|62804438|FG001|Period 2|Adverse Event|2|||
33426391|NCT00395733|62804437|FG000|Period 2|Technical problems|1|||
33426392|NCT00395733|62804438|FG001|Period 2|Technical problems|0|||
33426393|NCT00395343|62804446|FG000|Overall Study|Adverse Event|13|||
33426394|NCT00395343|62804447|FG001|Overall Study|Adverse Event|5|||
33426395|NCT00395343|62804446|FG000|Overall Study|Lack of Efficacy|0|||
33426396|NCT00395343|62804447|FG001|Overall Study|Lack of Efficacy|1|||
33426397|NCT00395343|62804446|FG000|Overall Study|Lost to Follow-up|4|||
33426398|NCT00395343|62804447|FG001|Overall Study|Lost to Follow-up|4|||
33426399|NCT00395343|62804446|FG000|Overall Study|Physician Decision|2|||
33426400|NCT00395343|62804447|FG001|Overall Study|Physician Decision|4|||
33426401|NCT00395343|62804446|FG000|Overall Study|Protocol Violation|6|||
33426402|NCT00395343|62804447|FG001|Overall Study|Protocol Violation|8|||
33426403|NCT00395343|62804446|FG000|Overall Study|Withdrawal by Subject|11|||
33426404|NCT00395343|62804447|FG001|Overall Study|Withdrawal by Subject|12|||
33426405|NCT00395343|62804446|FG000|Overall Study|Other|5|||
33426406|NCT00395343|62804447|FG001|Overall Study|Other|2|||
33426407|NCT00560573|62804453|FG000|Overall Study|Death|4|||
33426408|NCT00560573|62804454|FG001|Overall Study|Death|1|||
33426409|NCT00560573|62804455|FG002|Overall Study|Death|4|||
33426410|NCT00560573|62804456|FG003|Overall Study|Death|5|||
33426411|NCT00560573|62804457|FG004|Overall Study|Death|1|||
33426412|NCT00560573|62804458|FG005|Overall Study|Death|10|||
33426413|NCT00560573|62804453|FG000|Overall Study|Lost to Follow-up|0|||
33426414|NCT00560573|62804454|FG001|Overall Study|Lost to Follow-up|0|||
33426415|NCT00560573|62804455|FG002|Overall Study|Lost to Follow-up|0|||
33426416|NCT00560573|62804456|FG003|Overall Study|Lost to Follow-up|1|||
33426417|NCT00560573|62804457|FG004|Overall Study|Lost to Follow-up|1|||
33426418|NCT00560573|62804458|FG005|Overall Study|Lost to Follow-up|0|||
33426419|NCT00560573|62804453|FG000|Overall Study|Withdrawal by Subject|0|||
33426420|NCT00560573|62804454|FG001|Overall Study|Withdrawal by Subject|0|||
33426421|NCT00560573|62804455|FG002|Overall Study|Withdrawal by Subject|0|||
33426422|NCT00560573|62804456|FG003|Overall Study|Withdrawal by Subject|1|||
33426423|NCT00560573|62804457|FG004|Overall Study|Withdrawal by Subject|1|||
33426424|NCT00560573|62804458|FG005|Overall Study|Withdrawal by Subject|0|||
33426425|NCT00560573|62804453|FG000|Overall Study|Other|2|||
33426426|NCT00560573|62804454|FG001|Overall Study|Other|2|||
33426427|NCT00560573|62804455|FG002|Overall Study|Other|2|||
33426428|NCT00560573|62804456|FG003|Overall Study|Other|3|||
33426429|NCT00560573|62804457|FG004|Overall Study|Other|3|||
33426430|NCT00560573|62804458|FG005|Overall Study|Other|3|||
33426431|NCT00560573|62804453|FG000|Overall Study|Enrolled, not treated|0|||
33426432|NCT00560573|62804454|FG001|Overall Study|Enrolled, not treated|0|||
33426433|NCT00560573|62804455|FG002|Overall Study|Enrolled, not treated|0|||
33426434|NCT00560573|62804456|FG003|Overall Study|Enrolled, not treated|0|||
33426435|NCT00560573|62804457|FG004|Overall Study|Enrolled, not treated|1|||
33426436|NCT00560573|62804458|FG005|Overall Study|Enrolled, not treated|0|||
33426437|NCT03961529|62804491|FG000|Overall Study|Adverse Event|13|||
33426438|NCT03961529|62804492|FG001|Overall Study|Adverse Event|5|||
33426439|NCT03961529|62804493|FG002|Overall Study|Adverse Event|2|||
33426440|NCT03961529|62804491|FG000|Overall Study|Withdrawal by Subject|17|||
33426441|NCT03961529|62804492|FG001|Overall Study|Withdrawal by Subject|2|||
33426442|NCT03961529|62804493|FG002|Overall Study|Withdrawal by Subject|1|||
33426443|NCT03961529|62804491|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33426444|NCT03961529|62804492|FG001|Overall Study|Withdrawal by parent/guardian|7|||
33426445|NCT03961529|62804493|FG002|Overall Study|Withdrawal by parent/guardian|0|||
33426446|NCT03961529|62804491|FG000|Overall Study|Physician Decision|2|||
33426447|NCT03961529|62804492|FG001|Overall Study|Physician Decision|1|||
33426448|NCT03961529|62804493|FG002|Overall Study|Physician Decision|1|||
33426449|NCT03961529|62804491|FG000|Overall Study|Lost to Follow-up|2|||
33426450|NCT03961529|62804492|FG001|Overall Study|Lost to Follow-up|1|||
33426451|NCT03961529|62804493|FG002|Overall Study|Lost to Follow-up|0|||
33426452|NCT03961529|62804491|FG000|Overall Study|Lack of Efficacy|2|||
33426453|NCT03961529|62804492|FG001|Overall Study|Lack of Efficacy|0|||
33426454|NCT03961529|62804493|FG002|Overall Study|Lack of Efficacy|1|||
33426455|NCT03961529|62804491|FG000|Overall Study|Other|6|||
33426456|NCT03961529|62804492|FG001|Overall Study|Other|1|||
33426457|NCT03961529|62804493|FG002|Overall Study|Other|0|||
33426458|NCT00494780|62804503|FG000|Overall Study|Adverse Event|1|||
33426459|NCT00494780|62804504|FG001|Overall Study|Adverse Event|0|||
33426460|NCT00494780|62804503|FG000|Overall Study|Withdrew before Dosed|0|||
33426461|NCT00494780|62804504|FG001|Overall Study|Withdrew before Dosed|1|||
33426462|NCT00494780|62804503|FG000|Overall Study|Progression of Study Disease|7|||
33426463|NCT00494780|62804504|FG001|Overall Study|Progression of Study Disease|8|||
33426464|NCT00494780|62804503|FG000|Overall Study|New Treatment|2|||
33426465|NCT00494780|62804504|FG001|Overall Study|New Treatment|2|||
33426466|NCT00494780|62804503|FG000|Overall Study|Non-compliance|1|||
33426467|NCT00494780|62804504|FG001|Overall Study|Non-compliance|0|||
33426468|NCT00494780|62804503|FG000|Overall Study|Residual Tumour Mass|0|||
33426469|NCT00494780|62804504|FG001|Overall Study|Residual Tumour Mass|1|||
33426470|NCT00494780|62804503|FG000|Overall Study|Insurance Issues|0|||
33426471|NCT00494780|62804504|FG001|Overall Study|Insurance Issues|1|||
33426472|NCT00490022|62804514|FG000|Overall Study|Adverse Event|0|||
33426473|NCT00490022|62804515|FG001|Overall Study|Adverse Event|2|||
33426474|NCT00490022|62804514|FG000|Overall Study|Withdrawal by Subject|1|||
33426475|NCT00490022|62804515|FG001|Overall Study|Withdrawal by Subject|0|||
33426476|NCT00490022|62804514|FG000|Overall Study|Subject failed to disclose concommitant|0|||
33426477|NCT00490022|62804515|FG001|Overall Study|Subject failed to disclose concommitant|1|||
33426478|NCT00493454|62804521|FG000|Overall Study|Withdrawal by Subject|1|||
33426479|NCT00493220|62804531|FG000|Third Intervention|Withdrawal by Subject|1|||
33426480|NCT00493220|62804532|FG001|Third Intervention|Withdrawal by Subject|0|||
33426481|NCT00493220|62804533|FG002|Third Intervention|Withdrawal by Subject|0|||
33426482|NCT00493220|62804534|FG003|Third Intervention|Withdrawal by Subject|0|||
33426483|NCT00493220|62804535|FG004|Third Intervention|Withdrawal by Subject|0|||
33426484|NCT00493220|62804536|FG005|Third Intervention|Withdrawal by Subject|0|||
33426485|NCT00394953|62804548|FG000|First Treatment Period|Adverse Event|1|||
33426486|NCT00394953|62804549|FG001|First Treatment Period|Adverse Event|2|||
33426487|NCT00394953|62804548|FG000|First Treatment Period|Death|6|||
33426488|NCT00394953|62804549|FG001|First Treatment Period|Death|7|||
33426489|NCT00394953|62804548|FG000|First Treatment Period|Lack of Efficacy|1|||
33426490|NCT00394953|62804549|FG001|First Treatment Period|Lack of Efficacy|1|||
33426491|NCT00394953|62804548|FG000|First Treatment Period|Withdrawal by Subject|6|||
33426492|NCT00394953|62804549|FG001|First Treatment Period|Withdrawal by Subject|3|||
33426493|NCT00394953|62804548|FG000|First Treatment Period|Lost to Follow-up|0|||
33426494|NCT00394953|62804549|FG001|First Treatment Period|Lost to Follow-up|1|||
33426495|NCT00394953|62804548|FG000|First Treatment Period|Renal transplant|11|||
33426496|NCT00394953|62804549|FG001|First Treatment Period|Renal transplant|7|||
33426497|NCT00394953|62804548|FG000|First Treatment Period|Not defined|4|||
33426498|NCT00394953|62804549|FG001|First Treatment Period|Not defined|1|||
33426499|NCT00394953|62804548|FG000|Second Treatment Period|Adverse Event|2|||
33426500|NCT00394953|62804549|FG001|Second Treatment Period|Adverse Event|5|||
33426501|NCT00394953|62804548|FG000|Second Treatment Period|Death|8|||
33426502|NCT00394953|62804549|FG001|Second Treatment Period|Death|4|||
33426503|NCT00394953|62804548|FG000|Second Treatment Period|Lack of Efficacy|9|||
33426504|NCT00394953|62804549|FG001|Second Treatment Period|Lack of Efficacy|47|||
33426505|NCT00394953|62804548|FG000|Second Treatment Period|Withdrawal by Subject|3|||
33426506|NCT00394953|62804549|FG001|Second Treatment Period|Withdrawal by Subject|3|||
33426507|NCT00394953|62804548|FG000|Second Treatment Period|Lost to Follow-up|0|||
33426508|NCT00394953|62804549|FG001|Second Treatment Period|Lost to Follow-up|1|||
33426509|NCT00394953|62804548|FG000|Second Treatment Period|Renal transplant|4|||
33426510|NCT00394953|62804549|FG001|Second Treatment Period|Renal transplant|6|||
33426511|NCT00394953|62804548|FG000|Second Treatment Period|Not defined|3|||
33426512|NCT00394953|62804549|FG001|Second Treatment Period|Not defined|8|||
33426513|NCT00485732|62804557|FG000|Overall Study|Protocol Violation|1|||
33426514|NCT00485732|62804558|FG001|Overall Study|Protocol Violation|3|||
33426515|NCT00485732|62804557|FG000|Overall Study|Withdrawal by Subject|5|||
33426516|NCT00485732|62804558|FG001|Overall Study|Withdrawal by Subject|4|||
33426517|NCT00485732|62804557|FG000|Overall Study|Lost to Follow-up|2|||
33426518|NCT00485732|62804558|FG001|Overall Study|Lost to Follow-up|2|||
33426519|NCT00489554|62804564|FG000|Overall Study|Adverse Event|2|||
33426520|NCT00489554|62804564|FG000|Overall Study|Withdrawal by Subject|1|||
33426521|NCT00489554|62804564|FG000|Overall Study|Lost to Follow-up|1|||
33426522|NCT00408681|62804568|FG000|Overall Study|Lack of Efficacy|2|||
33426523|NCT00408681|62804568|FG000|Overall Study|Adverse Event|7|||
33426524|NCT00560417|62804575|FG000|Overall Study|Adverse Event|3|||
33426525|NCT00560417|62804576|FG001|Overall Study|Adverse Event|2|||
33426526|NCT00560417|62804575|FG000|Overall Study|Entry Criteria Not Met|1|||
33426527|NCT00560417|62804576|FG001|Overall Study|Entry Criteria Not Met|0|||
33426528|NCT00560417|62804575|FG000|Overall Study|Lost to Follow-up|0|||
33426529|NCT00560417|62804576|FG001|Overall Study|Lost to Follow-up|1|||
33426530|NCT00560417|62804575|FG000|Overall Study|Physician Decision|2|||
33426531|NCT00560417|62804576|FG001|Overall Study|Physician Decision|6|||
33426532|NCT00560417|62804575|FG000|Overall Study|Protocol Violation|6|||
33426533|NCT00560417|62804576|FG001|Overall Study|Protocol Violation|5|||
33426534|NCT00560417|62804575|FG000|Overall Study|Sponsor Decision|2|||
33426535|NCT00560417|62804576|FG001|Overall Study|Sponsor Decision|0|||
33426536|NCT00560417|62804575|FG000|Overall Study|Withdrawal by Subject|3|||
33426537|NCT00560417|62804576|FG001|Overall Study|Withdrawal by Subject|3|||
33426538|NCT03968159|62804589|FG000|Overall Study|Adverse Event|4|||
33426539|NCT03968159|62804590|FG001|Overall Study|Adverse Event|4|||
33426540|NCT03968159|62804589|FG000|Overall Study|Lost to Follow-up|1|||
33426541|NCT03968159|62804590|FG001|Overall Study|Lost to Follow-up|1|||
33426542|NCT03968159|62804589|FG000|Overall Study|Use of prohibited medication|0|||
33426543|NCT03968159|62804590|FG001|Overall Study|Use of prohibited medication|1|||
33426544|NCT03968159|62804589|FG000|Overall Study|Protocol Violation|2|||
33426545|NCT03968159|62804590|FG001|Overall Study|Protocol Violation|2|||
33426546|NCT03968159|62804589|FG000|Overall Study|Withdrawal by Subject|4|||
33426547|NCT03968159|62804590|FG001|Overall Study|Withdrawal by Subject|6|||
33426548|NCT03968159|62804589|FG000|Overall Study|Lack of Efficacy|0|||
33426549|NCT03968159|62804590|FG001|Overall Study|Lack of Efficacy|1|||
33426550|NCT03968159|62804589|FG000|Overall Study|Not further specified|2|||
33426551|NCT03968159|62804590|FG001|Overall Study|Not further specified|0|||
33426552|NCT03966911|62804598|FG000|Overall Study|Adverse Event|1|||
33426553|NCT03966911|62804599|FG001|Overall Study|Adverse Event|1|||
33426554|NCT03966911|62804598|FG000|Overall Study|Withdrawal by Subject|8|||
33426555|NCT03966911|62804599|FG001|Overall Study|Withdrawal by Subject|2|||
33426556|NCT03966911|62804598|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
33426557|NCT03966911|62804599|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
33426558|NCT03966365|62804609|FG000|Overall Study|Protocol Violation|1|||
33426559|NCT03966365|62804610|FG001|Overall Study|Protocol Violation|0|||
33426560|NCT00375219|62804619|FG000|Overall Study|Failure to achieve a response|16|||
33426561|NCT00375219|62804620|FG001|Overall Study|Failure to achieve a response|2|||
33426562|NCT00375219|62804621|FG002|Overall Study|Failure to achieve a response|0|||
33426563|NCT00375219|62804619|FG000|Overall Study|Adverse Event|8|||
33426564|NCT00375219|62804620|FG001|Overall Study|Adverse Event|2|||
33494171|NCT03634033|62872938|FG004|Overall Study|Did not have a post-assessment|5|||
33494172|NCT03634033|62872939|FG005|Overall Study|Did not have a post-assessment|0|||
33426565|NCT00375219|62804621|FG002|Overall Study|Adverse Event|1|||
33426566|NCT00375219|62804619|FG000|Overall Study|Protocol Violation|1|||
33426567|NCT00375219|62804620|FG001|Overall Study|Protocol Violation|0|||
33426568|NCT00375219|62804621|FG002|Overall Study|Protocol Violation|1|||
33426569|NCT00375219|62804619|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
33426570|NCT00375219|62804620|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
33426571|NCT00375219|62804621|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
33426572|NCT00375219|62804619|FG000|Overall Study|Lost to Follow-up|1|||
33426573|NCT00375219|62804620|FG001|Overall Study|Lost to Follow-up|1|||
33426574|NCT00375219|62804621|FG002|Overall Study|Lost to Follow-up|0|||
33426575|NCT00375219|62804619|FG000|Overall Study|Disease progression|18|||
33426576|NCT00375219|62804620|FG001|Overall Study|Disease progression|9|||
33426577|NCT00375219|62804621|FG002|Overall Study|Disease progression|12|||
33426578|NCT00375219|62804619|FG000|Overall Study|Death|4|||
33426579|NCT00375219|62804620|FG001|Overall Study|Death|3|||
33426580|NCT00375219|62804621|FG002|Overall Study|Death|7|||
33426581|NCT00375219|62804619|FG000|Overall Study|Hematologic resistance|1|||
33426582|NCT00375219|62804620|FG001|Overall Study|Hematologic resistance|0|||
33426583|NCT00375219|62804621|FG002|Overall Study|Hematologic resistance|0|||
33426584|NCT00375219|62804619|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
33426585|NCT00375219|62804620|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
33426586|NCT00375219|62804621|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
33426587|NCT00375219|62804619|FG000|Overall Study|Allograft|2|||
33426588|NCT00375219|62804620|FG001|Overall Study|Allograft|0|||
33426589|NCT00375219|62804621|FG002|Overall Study|Allograft|0|||
33426590|NCT00375219|62804619|FG000|Overall Study|Cord blood transplantation|1|||
33426591|NCT00375219|62804620|FG001|Overall Study|Cord blood transplantation|0|||
33426592|NCT00375219|62804621|FG002|Overall Study|Cord blood transplantation|0|||
33426593|NCT00375219|62804619|FG000|Overall Study|Withdrawal by Subject|1|||
33426594|NCT00375219|62804620|FG001|Overall Study|Withdrawal by Subject|0|||
33426595|NCT00375219|62804621|FG002|Overall Study|Withdrawal by Subject|0|||
33426596|NCT03965351|62804630|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
33426597|NCT03965351|62804631|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
33426598|NCT03965351|62804630|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
33426599|NCT03965351|62804631|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
33426600|NCT00554801|62804639|FG000|Overall Study|left area before completion|5|||
33426601|NCT00554801|62804640|FG001|Overall Study|left area before completion|0|||
33426602|NCT00554801|62804639|FG000|Overall Study|Withdrawal by Subject|14|||
33426603|NCT00554801|62804640|FG001|Overall Study|Withdrawal by Subject|0|||
33426604|NCT00374907|62804650|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
33426605|NCT00374907|62804651|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
33426606|NCT00374907|62804650|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
33426607|NCT00374907|62804651|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
33426608|NCT00374907|62804650|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
33426609|NCT00374907|62804651|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
33426610|NCT00374907|62804650|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
33426611|NCT00374907|62804651|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
33426612|NCT00374907|62804650|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
33426613|NCT00374907|62804651|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
33426614|NCT00374127|62804659|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
33426615|NCT00374127|62804659|FG000|Overall Study|Blood could not be drawn.|2|||
33426616|NCT00374127|62804659|FG000|Overall Study|Protocol Violation|5|||
33426617|NCT00374127|62804659|FG000|Overall Study|Pregnancy|1|||
33426618|NCT00553787|62804672|FG000|Overall Study|Adverse Event|34|||
33426619|NCT00553787|62804673|FG001|Overall Study|Adverse Event|21|||
33426620|NCT00553787|62804674|FG002|Overall Study|Adverse Event|67|||
33426621|NCT00553787|62804672|FG000|Overall Study|Lost to Follow-up|132|||
33426622|NCT00553787|62804673|FG001|Overall Study|Lost to Follow-up|44|||
33426623|NCT00553787|62804674|FG002|Overall Study|Lost to Follow-up|78|||
33426624|NCT00553787|62804672|FG000|Overall Study|Withdrawal by Subject|151|||
33426625|NCT00553787|62804673|FG001|Overall Study|Withdrawal by Subject|40|||
33426626|NCT00553787|62804674|FG002|Overall Study|Withdrawal by Subject|83|||
33426627|NCT00553787|62804672|FG000|Overall Study|Lack of Efficacy|31|||
33426628|NCT00553787|62804673|FG001|Overall Study|Lack of Efficacy|1|||
33426629|NCT00553787|62804674|FG002|Overall Study|Lack of Efficacy|3|||
33426630|NCT00553787|62804672|FG000|Overall Study|Pregnancy|0|||
33426631|NCT00553787|62804673|FG001|Overall Study|Pregnancy|1|||
33426632|NCT00553787|62804674|FG002|Overall Study|Pregnancy|2|||
33426633|NCT00553787|62804672|FG000|Overall Study|non compliance|4|||
33426634|NCT00553787|62804673|FG001|Overall Study|non compliance|0|||
33426635|NCT00553787|62804674|FG002|Overall Study|non compliance|11|||
33426636|NCT00553787|62804672|FG000|Overall Study|Requirement for restricted medication|8|||
33426637|NCT00553787|62804673|FG001|Overall Study|Requirement for restricted medication|7|||
33426638|NCT00553787|62804674|FG002|Overall Study|Requirement for restricted medication|5|||
33426639|NCT00553787|62804672|FG000|Overall Study|Other|18|||
33322991|NCT00927394|62699259|FG000|Overall Study|Lost to Follow-up|8|||
33426640|NCT00553787|62804673|FG001|Overall Study|Other|10|||
33426641|NCT00553787|62804674|FG002|Overall Study|Other|13|||
33426642|NCT00407745|62804684|FG000|Overall Study|Lack of Efficacy|1|||
33426643|NCT00407745|62804685|FG001|Overall Study|Lack of Efficacy|2|||
33426644|NCT00407745|62804684|FG000|Overall Study|Withdrawal by Subject|3|||
33426645|NCT00407745|62804685|FG001|Overall Study|Withdrawal by Subject|3|||
33426646|NCT00407745|62804684|FG000|Overall Study|Protocol Violation|5|||
33426647|NCT00407745|62804685|FG001|Overall Study|Protocol Violation|3|||
33426648|NCT00407745|62804684|FG000|Overall Study|Adverse Event|8|||
33426649|NCT00407745|62804685|FG001|Overall Study|Adverse Event|8|||
33426650|NCT00407745|62804684|FG000|Overall Study|Other|2|||
33426651|NCT00407745|62804685|FG001|Overall Study|Other|0|||
33426652|NCT00407745|62804684|FG000|Overall Study|Randomized, unknown if treated|0|||
33426653|NCT00407745|62804685|FG001|Overall Study|Randomized, unknown if treated|1|||
33426654|NCT03958955|62804691|FG000|Overall Study|Adverse Event|1|||
33426655|NCT00464334|62804708|FG000|Overall Study|Adverse Event|0|||
33426656|NCT00464334|62804709|FG001|Overall Study|Adverse Event|0|||
33426657|NCT00464334|62804710|FG002|Overall Study|Adverse Event|0|||
33426658|NCT00464334|62804711|FG003|Overall Study|Adverse Event|1|||
33426659|NCT00464334|62804712|FG004|Overall Study|Adverse Event|1|||
33426660|NCT00464334|62804713|FG005|Overall Study|Adverse Event|1|||
33426661|NCT00464334|62804714|FG006|Overall Study|Adverse Event|0|||
33426662|NCT00464334|62804715|FG007|Overall Study|Adverse Event|0|||
33426663|NCT00464334|62804716|FG008|Overall Study|Adverse Event|2|||
33426664|NCT00464334|62804717|FG009|Overall Study|Adverse Event|1|||
33426665|NCT00464334|62804718|FG010|Overall Study|Adverse Event|2|||
33426666|NCT00464334|62804708|FG000|Overall Study|Lack of Efficacy|0|||
33426667|NCT00464334|62804709|FG001|Overall Study|Lack of Efficacy|1|||
33426668|NCT00464334|62804710|FG002|Overall Study|Lack of Efficacy|0|||
33426669|NCT00464334|62804711|FG003|Overall Study|Lack of Efficacy|0|||
33426670|NCT00464334|62804712|FG004|Overall Study|Lack of Efficacy|0|||
33426671|NCT00464334|62804713|FG005|Overall Study|Lack of Efficacy|0|||
33426672|NCT00464334|62804714|FG006|Overall Study|Lack of Efficacy|0|||
33426673|NCT00464334|62804715|FG007|Overall Study|Lack of Efficacy|0|||
33426674|NCT00464334|62804716|FG008|Overall Study|Lack of Efficacy|0|||
33426675|NCT00464334|62804717|FG009|Overall Study|Lack of Efficacy|0|||
33426676|NCT00464334|62804718|FG010|Overall Study|Lack of Efficacy|0|||
33426677|NCT00464334|62804708|FG000|Overall Study|Lost to Follow-up|0|||
33426678|NCT00464334|62804709|FG001|Overall Study|Lost to Follow-up|0|||
33426679|NCT00464334|62804710|FG002|Overall Study|Lost to Follow-up|1|||
33426680|NCT00464334|62804711|FG003|Overall Study|Lost to Follow-up|0|||
33426681|NCT00464334|62804712|FG004|Overall Study|Lost to Follow-up|1|||
33426682|NCT00464334|62804713|FG005|Overall Study|Lost to Follow-up|0|||
33426683|NCT00464334|62804714|FG006|Overall Study|Lost to Follow-up|1|||
33426684|NCT00464334|62804715|FG007|Overall Study|Lost to Follow-up|0|||
33426685|NCT00464334|62804716|FG008|Overall Study|Lost to Follow-up|0|||
33426686|NCT00464334|62804717|FG009|Overall Study|Lost to Follow-up|0|||
33426687|NCT00464334|62804718|FG010|Overall Study|Lost to Follow-up|2|||
33426688|NCT00464334|62804708|FG000|Overall Study|Progressive Disease|0|||
33426689|NCT00464334|62804709|FG001|Overall Study|Progressive Disease|0|||
33426690|NCT00464334|62804710|FG002|Overall Study|Progressive Disease|0|||
33426691|NCT00464334|62804711|FG003|Overall Study|Progressive Disease|0|||
33426692|NCT00464334|62804712|FG004|Overall Study|Progressive Disease|0|||
33426693|NCT00464334|62804713|FG005|Overall Study|Progressive Disease|1|||
33426694|NCT00464334|62804714|FG006|Overall Study|Progressive Disease|0|||
33426695|NCT00464334|62804715|FG007|Overall Study|Progressive Disease|0|||
33605346|NCT01649375|63005068|FG000|Up to Week 16|Lack of Efficacy|0|||
33605347|NCT01649375|63005069|FG001|Up to Week 16|Lack of Efficacy|0|||
33605348|NCT01649375|63005070|FG002|Up to Week 16|Lack of Efficacy|1|||
33605349|NCT01649375|63005071|FG003|Up to Week 16|Lack of Efficacy|0|||
33605350|NCT01649375|63005072|FG004|Up to Week 16|Lack of Efficacy|0|||
33426696|NCT00464334|62804716|FG008|Overall Study|Progressive Disease|1|||
33426697|NCT00464334|62804717|FG009|Overall Study|Progressive Disease|0|||
33426698|NCT00464334|62804718|FG010|Overall Study|Progressive Disease|0|||
33426699|NCT00464334|62804708|FG000|Overall Study|Study Terminated by Sponsor|0|||
33426700|NCT00464334|62804709|FG001|Overall Study|Study Terminated by Sponsor|0|||
33426701|NCT00464334|62804710|FG002|Overall Study|Study Terminated by Sponsor|0|||
33426702|NCT00464334|62804711|FG003|Overall Study|Study Terminated by Sponsor|1|||
33426703|NCT00464334|62804712|FG004|Overall Study|Study Terminated by Sponsor|0|||
33426704|NCT00464334|62804713|FG005|Overall Study|Study Terminated by Sponsor|0|||
33426705|NCT00464334|62804714|FG006|Overall Study|Study Terminated by Sponsor|0|||
33426706|NCT00464334|62804715|FG007|Overall Study|Study Terminated by Sponsor|0|||
33426707|NCT00464334|62804716|FG008|Overall Study|Study Terminated by Sponsor|0|||
33426708|NCT00464334|62804717|FG009|Overall Study|Study Terminated by Sponsor|0|||
33426709|NCT00464334|62804718|FG010|Overall Study|Study Terminated by Sponsor|0|||
33426710|NCT00464334|62804708|FG000|Overall Study|Withdrawal by Subject|1|||
33605351|NCT01649375|63005068|FG000|Up to Week 16|Physician Decision|0|||
33426711|NCT00464334|62804709|FG001|Overall Study|Withdrawal by Subject|7|||
33426712|NCT00464334|62804710|FG002|Overall Study|Withdrawal by Subject|4|||
33426713|NCT00464334|62804711|FG003|Overall Study|Withdrawal by Subject|2|||
33605352|NCT01649375|63005069|FG001|Up to Week 16|Physician Decision|0|||
33426714|NCT00464334|62804712|FG004|Overall Study|Withdrawal by Subject|2|||
33426715|NCT00464334|62804713|FG005|Overall Study|Withdrawal by Subject|2|||
33426716|NCT00464334|62804714|FG006|Overall Study|Withdrawal by Subject|2|||
33426717|NCT00464334|62804715|FG007|Overall Study|Withdrawal by Subject|1|||
33426718|NCT00464334|62804716|FG008|Overall Study|Withdrawal by Subject|3|||
33426719|NCT00464334|62804717|FG009|Overall Study|Withdrawal by Subject|0|||
33426720|NCT00464334|62804718|FG010|Overall Study|Withdrawal by Subject|0|||
33426721|NCT00299494|62804759|FG000|Overall Study|Withdrawal by Subject|0|||
33426722|NCT00299494|62804760|FG001|Overall Study|Withdrawal by Subject|0|||
33426723|NCT00299494|62804761|FG002|Overall Study|Withdrawal by Subject|0|||
33426724|NCT00299494|62804762|FG003|Overall Study|Withdrawal by Subject|3|||
33426725|NCT00299494|62804763|FG004|Overall Study|Withdrawal by Subject|1|||
33426726|NCT00299494|62804764|FG005|Overall Study|Withdrawal by Subject|4|||
33426727|NCT00299494|62804759|FG000|Overall Study|Physician Decision|0|||
33426728|NCT00299494|62804760|FG001|Overall Study|Physician Decision|0|||
33426729|NCT00299494|62804761|FG002|Overall Study|Physician Decision|0|||
33426730|NCT00299494|62804762|FG003|Overall Study|Physician Decision|0|||
33426731|NCT00299494|62804763|FG004|Overall Study|Physician Decision|1|||
33426732|NCT00299494|62804764|FG005|Overall Study|Physician Decision|0|||
33426733|NCT00299494|62804759|FG000|Overall Study|Death|3|||
33426734|NCT00299494|62804760|FG001|Overall Study|Death|1|||
33426735|NCT00299494|62804761|FG002|Overall Study|Death|4|||
33426736|NCT00299494|62804762|FG003|Overall Study|Death|6|||
33426737|NCT00299494|62804763|FG004|Overall Study|Death|18|||
33426738|NCT00299494|62804764|FG005|Overall Study|Death|19|||
33426739|NCT00299494|62804759|FG000|Overall Study|Lost to Follow-up|0|||
33426740|NCT00299494|62804760|FG001|Overall Study|Lost to Follow-up|0|||
33426741|NCT00299494|62804761|FG002|Overall Study|Lost to Follow-up|0|||
33426742|NCT00299494|62804762|FG003|Overall Study|Lost to Follow-up|0|||
33426743|NCT00299494|62804763|FG004|Overall Study|Lost to Follow-up|3|||
33426744|NCT00299494|62804764|FG005|Overall Study|Lost to Follow-up|1|||
33426745|NCT00299494|62804759|FG000|Overall Study|Other - Unspecified|0|||
33426746|NCT00299494|62804760|FG001|Overall Study|Other - Unspecified|0|||
33426747|NCT00299494|62804761|FG002|Overall Study|Other - Unspecified|0|||
33426748|NCT00299494|62804762|FG003|Overall Study|Other - Unspecified|0|||
33426749|NCT00299494|62804763|FG004|Overall Study|Other - Unspecified|3|||
33426750|NCT00299494|62804764|FG005|Overall Study|Other - Unspecified|1|||
33426751|NCT00299494|62804759|FG000|Overall Study|Other - site closure|0|||
33426752|NCT00299494|62804760|FG001|Overall Study|Other - site closure|0|||
33426753|NCT00299494|62804761|FG002|Overall Study|Other - site closure|0|||
33426754|NCT00299494|62804762|FG003|Overall Study|Other - site closure|1|||
33426755|NCT00299494|62804763|FG004|Overall Study|Other - site closure|1|||
33426756|NCT00299494|62804764|FG005|Overall Study|Other - site closure|1|||
33464790|NCT00002540|62838303|FG001|Overall Study|Refused ASU (Control)|0|||
33464791|NCT00002540|62838302|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
33464792|NCT00002540|62838303|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
33464793|NCT00001880|62838309|FG000|Overall Study|Death|14|||
33464794|NCT00043550|62838316|FG000|Overall Study|Withdrawal by Subject|22|||
33464795|NCT00043550|62838317|FG001|Overall Study|Withdrawal by Subject|12|||
33464796|NCT00043550|62838318|FG002|Overall Study|Withdrawal by Subject|20|||
33464797|NCT00041756|62838331|FG000|Overall Study|Adverse Event|4|||
33464798|NCT00041756|62838332|FG001|Overall Study|Adverse Event|10|||
33464799|NCT00041756|62838333|FG002|Overall Study|Adverse Event|6|||
33464800|NCT00041756|62838334|FG003|Overall Study|Adverse Event|11|||
33464801|NCT00041756|62838335|FG004|Overall Study|Adverse Event|34|||
33464802|NCT00041756|62838331|FG000|Overall Study|Protocol Violation|1|||
33464803|NCT00041756|62838332|FG001|Overall Study|Protocol Violation|1|||
33464804|NCT00041756|62838333|FG002|Overall Study|Protocol Violation|2|||
33464805|NCT00041756|62838334|FG003|Overall Study|Protocol Violation|2|||
33605353|NCT01649375|63005070|FG002|Up to Week 16|Physician Decision|1|||
33605354|NCT01649375|63005071|FG003|Up to Week 16|Physician Decision|0|||
33464806|NCT00041756|62838335|FG004|Overall Study|Protocol Violation|1|||
33464807|NCT00041756|62838331|FG000|Overall Study|Withdrawal by Subject|3|||
33464808|NCT00041756|62838332|FG001|Overall Study|Withdrawal by Subject|3|||
33464809|NCT00041756|62838333|FG002|Overall Study|Withdrawal by Subject|4|||
33464810|NCT00041756|62838334|FG003|Overall Study|Withdrawal by Subject|2|||
33464811|NCT00041756|62838335|FG004|Overall Study|Withdrawal by Subject|3|||
33464812|NCT00041756|62838331|FG000|Overall Study|Lost to Follow-up|0|||
33464813|NCT00041756|62838332|FG001|Overall Study|Lost to Follow-up|1|||
33464814|NCT00041756|62838333|FG002|Overall Study|Lost to Follow-up|0|||
33464815|NCT00041756|62838334|FG003|Overall Study|Lost to Follow-up|1|||
33464816|NCT00041756|62838335|FG004|Overall Study|Lost to Follow-up|0|||
33464817|NCT00041756|62838331|FG000|Overall Study|Unable to meet protocol criteria|0|||
33426757|NCT00453180|62804791|FG000|Overall Study|Lost to Follow-up|2|||
33426758|NCT00453180|62804792|FG001|Overall Study|Lost to Follow-up|1|||
33426759|NCT00453180|62804791|FG000|Overall Study|Adverse Event|1|||
33426760|NCT00453180|62804792|FG001|Overall Study|Adverse Event|2|||
33426761|NCT00464178|62804798|FG000|Overall Study|Protocol Violation|1|||
33426762|NCT00464178|62804798|FG000|Overall Study|Withdrawal by Subject|1|||
33426763|NCT00560105|62804805|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
33426764|NCT00560105|62804806|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
33426765|NCT00467610|62804812|FG000|Overall Study|Withdrawal by Subject|1|||
33426766|NCT00316186|62804816|FG000|Overall Study|Adverse Event|6|||
33426767|NCT00316186|62804816|FG000|Overall Study|Disease Progression|4|||
33426768|NCT00316186|62804816|FG000|Overall Study|Lost to Follow-up|1|||
33426769|NCT00316186|62804816|FG000|Overall Study|Other|1|||
33426770|NCT00453102|62804820|FG000|Overall Study|Withdrawal by Subject|2|||
33426771|NCT00299182|62804831|FG000|Overall Study|Withdrawal by Subject|0|||
33426772|NCT00299182|62804832|FG001|Overall Study|Withdrawal by Subject|0|||
33426773|NCT00299182|62804833|FG002|Overall Study|Withdrawal by Subject|1|||
33426774|NCT00299182|62804834|FG003|Overall Study|Withdrawal by Subject|0|||
33426775|NCT00299182|62804835|FG004|Overall Study|Withdrawal by Subject|1|||
33426776|NCT00299182|62804836|FG005|Overall Study|Withdrawal by Subject|2|||
33426777|NCT00299182|62804837|FG006|Overall Study|Withdrawal by Subject|0|||
33426778|NCT00299182|62804831|FG000|Overall Study|Chemotherapy Changed|0|||
33426779|NCT00299182|62804832|FG001|Overall Study|Chemotherapy Changed|0|||
33426780|NCT00299182|62804833|FG002|Overall Study|Chemotherapy Changed|1|||
33426781|NCT00299182|62804834|FG003|Overall Study|Chemotherapy Changed|0|||
33426782|NCT00299182|62804835|FG004|Overall Study|Chemotherapy Changed|1|||
33426783|NCT00299182|62804836|FG005|Overall Study|Chemotherapy Changed|0|||
33426784|NCT00299182|62804837|FG006|Overall Study|Chemotherapy Changed|1|||
33426785|NCT00299182|62804831|FG000|Overall Study|Adverse Event|0|||
33426786|NCT00299182|62804832|FG001|Overall Study|Adverse Event|0|||
33426787|NCT00299182|62804833|FG002|Overall Study|Adverse Event|0|||
33426788|NCT00299182|62804834|FG003|Overall Study|Adverse Event|0|||
33426789|NCT00299182|62804835|FG004|Overall Study|Adverse Event|0|||
33426790|NCT00299182|62804836|FG005|Overall Study|Adverse Event|1|||
33426791|NCT00299182|62804837|FG006|Overall Study|Adverse Event|0|||
33426792|NCT00299182|62804831|FG000|Overall Study|Not Eligible|0|||
33426793|NCT00299182|62804832|FG001|Overall Study|Not Eligible|0|||
33426794|NCT00299182|62804833|FG002|Overall Study|Not Eligible|0|||
33426795|NCT00299182|62804834|FG003|Overall Study|Not Eligible|0|||
33426796|NCT00299182|62804835|FG004|Overall Study|Not Eligible|1|||
33426797|NCT00299182|62804836|FG005|Overall Study|Not Eligible|0|||
33426798|NCT00299182|62804837|FG006|Overall Study|Not Eligible|0|||
33426799|NCT00467142|62804855|FG000|Overall Study|Withdrawal by Subject|1|||
33426800|NCT00467142|62804855|FG000|Overall Study|Adverse Event|1|||
33426801|NCT00467142|62804855|FG000|Overall Study|Protocol Violation|1|||
33426802|NCT00553475|62804862|FG000|Overall Study|Adverse Event|7|||
33426803|NCT00553475|62804863|FG001|Overall Study|Adverse Event|17|||
33426804|NCT00553475|62804864|FG002|Overall Study|Adverse Event|13|||
33426805|NCT00553475|62804862|FG000|Overall Study|Lack of Efficacy|7|||
33426806|NCT00553475|62804863|FG001|Overall Study|Lack of Efficacy|1|||
33426807|NCT00553475|62804864|FG002|Overall Study|Lack of Efficacy|0|||
33426808|NCT00553475|62804862|FG000|Overall Study|Withdrawal by Subject|1|||
33426809|NCT00553475|62804863|FG001|Overall Study|Withdrawal by Subject|1|||
33426810|NCT00553475|62804864|FG002|Overall Study|Withdrawal by Subject|0|||
33426811|NCT00553475|62804862|FG000|Overall Study|Physician Decision|1|||
33426812|NCT00553475|62804863|FG001|Overall Study|Physician Decision|0|||
33426813|NCT00553475|62804864|FG002|Overall Study|Physician Decision|0|||
33426814|NCT00553475|62804862|FG000|Overall Study|Due to moving|0|||
33426815|NCT00553475|62804863|FG001|Overall Study|Due to moving|1|||
33426816|NCT00553475|62804864|FG002|Overall Study|Due to moving|0|||
33426817|NCT00329602|62804876|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
33426818|NCT00329602|62804877|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
33426819|NCT00329602|62804878|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
33426820|NCT00329602|62804876|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
33426821|NCT00329602|62804877|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
33426822|NCT00329602|62804878|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
33426823|NCT00329602|62804876|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
33426824|NCT00329602|62804877|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
33426825|NCT00329602|62804878|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
33426826|NCT00329602|62804876|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
33426827|NCT00329602|62804877|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
33426828|NCT00329602|62804878|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
33426829|NCT00329602|62804876|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
33426830|NCT00329602|62804877|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
33426831|NCT00329602|62804878|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
33426832|NCT00329602|62804876|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
33426833|NCT00329602|62804877|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
33426834|NCT00329602|62804878|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
33426835|NCT00463866|62804896|FG000|Overall Study|Adverse Event|70|||
33426836|NCT00463866|62804897|FG001|Overall Study|Adverse Event|93|||
33426837|NCT00463866|62804896|FG000|Overall Study|Withdrawal by Subject|81|||
33426838|NCT00463866|62804897|FG001|Overall Study|Withdrawal by Subject|79|||
33426839|NCT00463866|62804896|FG000|Overall Study|Lost to Follow-up|46|||
33426840|NCT00463866|62804897|FG001|Overall Study|Lost to Follow-up|55|||
33426841|NCT00463866|62804896|FG000|Overall Study|Incorrect Enrolment|64|||
33426842|NCT00463866|62804897|FG001|Overall Study|Incorrect Enrolment|66|||
33426843|NCT00463866|62804896|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
33426844|NCT00463866|62804897|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
33426845|NCT00463866|62804896|FG000|Overall Study|Safety Reason|1|||
33426846|NCT00463866|62804897|FG001|Overall Study|Safety Reason|3|||
33426847|NCT00463866|62804896|FG000|Overall Study|Mis-Randomization of subject|0|||
33426848|NCT00463866|62804897|FG001|Overall Study|Mis-Randomization of subject|1|||
33426849|NCT00463866|62804896|FG000|Overall Study|Other|22|||
33426850|NCT00463866|62804897|FG001|Overall Study|Other|22|||
33426851|NCT00313846|62804905|FG000|Overall Study|Withdrawal by Subject|2|||
33426852|NCT00313846|62804906|FG001|Overall Study|Withdrawal by Subject|0|||
33426853|NCT00313846|62804905|FG000|Overall Study|Adverse Event|1|||
33426854|NCT00313846|62804906|FG001|Overall Study|Adverse Event|8|||
33426855|NCT00313846|62804905|FG000|Overall Study|Administrative|2|||
33426856|NCT00313846|62804906|FG001|Overall Study|Administrative|3|||
33426857|NCT00551135|62804917|FG000|Overall Study|Adverse Event|1|||
33426858|NCT00551135|62804918|FG001|Overall Study|Adverse Event|0|||
33426859|NCT00551135|62804919|FG002|Overall Study|Adverse Event|1|||
33426860|NCT00551135|62804920|FG003|Overall Study|Adverse Event|1|||
33426861|NCT00551135|62804917|FG000|Overall Study|Lost to Follow-up|0|||
33426862|NCT00551135|62804918|FG001|Overall Study|Lost to Follow-up|0|||
33426863|NCT00551135|62804919|FG002|Overall Study|Lost to Follow-up|0|||
33426864|NCT00551135|62804920|FG003|Overall Study|Lost to Follow-up|1|||
33426865|NCT00551135|62804917|FG000|Overall Study|Other|3|||
33426866|NCT00551135|62804918|FG001|Overall Study|Other|2|||
33426867|NCT00551135|62804919|FG002|Overall Study|Other|1|||
33426868|NCT00551135|62804920|FG003|Overall Study|Other|2|||
33426869|NCT00551135|62804917|FG000|Overall Study|Withdrawal by Subject|1|||
33426870|NCT00551135|62804918|FG001|Overall Study|Withdrawal by Subject|0|||
33426871|NCT00551135|62804919|FG002|Overall Study|Withdrawal by Subject|3|||
33426872|NCT00551135|62804920|FG003|Overall Study|Withdrawal by Subject|1|||
33426873|NCT00299104|62804933|FG000|Treatment Period|Adverse Event|14|||
33426874|NCT00299104|62804934|FG001|Treatment Period|Adverse Event|9|||
33426875|NCT00299104|62804935|FG002|Treatment Period|Adverse Event|7|||
33426876|NCT00299104|62804933|FG000|Treatment Period|Death|1|||
33426877|NCT00299104|62804934|FG001|Treatment Period|Death|1|||
33426878|NCT00299104|62804935|FG002|Treatment Period|Death|1|||
33426879|NCT00299104|62804933|FG000|Treatment Period|Insufficient therapeutic response|34|||
33426880|NCT00299104|62804934|FG001|Treatment Period|Insufficient therapeutic response|13|||
33426881|NCT00299104|62804935|FG002|Treatment Period|Insufficient therapeutic response|8|||
33426882|NCT00299104|62804933|FG000|Treatment Period|Failure to return|9|||
33426883|NCT00299104|62804934|FG001|Treatment Period|Failure to return|8|||
33426884|NCT00299104|62804935|FG002|Treatment Period|Failure to return|8|||
33426885|NCT00299104|62804933|FG000|Treatment Period|Violation of selection criteria|1|||
33426886|NCT00299104|62804934|FG001|Treatment Period|Violation of selection criteria|2|||
33426887|NCT00299104|62804935|FG002|Treatment Period|Violation of selection criteria|0|||
33426888|NCT00299104|62804933|FG000|Treatment Period|Protocol Violation|1|||
33426889|NCT00299104|62804934|FG001|Treatment Period|Protocol Violation|1|||
33426890|NCT00299104|62804935|FG002|Treatment Period|Protocol Violation|0|||
33426891|NCT00299104|62804933|FG000|Treatment Period|Refused treatment|9|||
33426892|NCT00299104|62804934|FG001|Treatment Period|Refused treatment|2|||
33426893|NCT00299104|62804935|FG002|Treatment Period|Refused treatment|2|||
33426894|NCT00299104|62804933|FG000|Treatment Period|Withdrew consent|14|||
33426895|NCT00299104|62804934|FG001|Treatment Period|Withdrew consent|19|||
33426896|NCT00299104|62804935|FG002|Treatment Period|Withdrew consent|9|||
33426897|NCT00299104|62804933|FG000|Treatment Period|Administrative reasons|106|||
33426898|NCT00299104|62804934|FG001|Treatment Period|Administrative reasons|120|||
33426899|NCT00299104|62804935|FG002|Treatment Period|Administrative reasons|137|||
33426900|NCT00299104|62804933|FG000|Safety Follow-Up (SFU) Period|Death|3|||
33426901|NCT00299104|62804934|FG001|Safety Follow-Up (SFU) Period|Death|2|||
33426902|NCT00299104|62804935|FG002|Safety Follow-Up (SFU) Period|Death|1|||
33426903|NCT00299104|62804933|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
33426904|NCT00299104|62804934|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
33426905|NCT00299104|62804935|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
33426906|NCT00299104|62804933|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
33426907|NCT00299104|62804934|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
33322992|NCT00927394|62699260|FG001|Overall Study|Lost to Follow-up|14|||
33426908|NCT00299104|62804935|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
33426909|NCT00299104|62804933|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
33426910|NCT00299104|62804934|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
33426911|NCT00299104|62804935|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
33426912|NCT00299104|62804933|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
33426913|NCT00299104|62804934|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
33426914|NCT00299104|62804935|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
33426915|NCT00299104|62804933|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
33426916|NCT00299104|62804934|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
33426917|NCT00299104|62804935|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
33426918|NCT00299104|62804933|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
33426919|NCT00299104|62804934|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
33426920|NCT00299104|62804935|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
33426921|NCT00299104|62804933|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
33426922|NCT00299104|62804934|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
33426923|NCT00299104|62804935|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
33426924|NCT00313612|62804945|FG000|Overall Study|Patient never received treatment|0|||
33426925|NCT00313612|62804946|FG001|Overall Study|Patient never received treatment|1|||
33426926|NCT00507416|62804955|FG000|Overall Study|Adverse Event|58|||
33426927|NCT00507416|62804956|FG001|Overall Study|Adverse Event|67|||
33426928|NCT00507416|62804957|FG002|Overall Study|Adverse Event|65|||
33426929|NCT00507416|62804955|FG000|Overall Study|Protocol Violation|1|||
33426930|NCT00507416|62804956|FG001|Overall Study|Protocol Violation|2|||
33426931|NCT00507416|62804957|FG002|Overall Study|Protocol Violation|0|||
33426932|NCT00507416|62804955|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
33426933|NCT00507416|62804956|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
33426934|NCT00507416|62804957|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
33426935|NCT00507416|62804955|FG000|Overall Study|Progressive Disease|20|||
33426936|NCT00507416|62804956|FG001|Overall Study|Progressive Disease|10|||
33426937|NCT00507416|62804957|FG002|Overall Study|Progressive Disease|13|||
33426938|NCT00507416|62804955|FG000|Overall Study|Patient declined further treatment|18|||
33426939|NCT00507416|62804956|FG001|Overall Study|Patient declined further treatment|14|||
33426940|NCT00507416|62804957|FG002|Overall Study|Patient declined further treatment|11|||
33426941|NCT00507416|62804955|FG000|Overall Study|Other|11|||
33426942|NCT00507416|62804956|FG001|Overall Study|Other|16|||
33426943|NCT00507416|62804957|FG002|Overall Study|Other|13|||
33426944|NCT00507416|62804955|FG000|Overall Study|Did not Receive Study Treatment|3|||
33426945|NCT00507416|62804956|FG001|Overall Study|Did not Receive Study Treatment|9|||
33426946|NCT00507416|62804957|FG002|Overall Study|Did not Receive Study Treatment|4|||
33426947|NCT00489476|62804969|FG000|Overall Study|Lost to Follow-up|0|||
33426948|NCT00489476|62804970|FG001|Overall Study|Lost to Follow-up|1|||
33426949|NCT00489476|62804971|FG002|Overall Study|Lost to Follow-up|0|||
33426950|NCT00489476|62804972|FG003|Overall Study|Lost to Follow-up|0|||
33426951|NCT00550745|62804984|FG000|Overall Study|Death|20|||
33426952|NCT00550745|62804985|FG001|Overall Study|Death|16|||
33426953|NCT00550745|62804984|FG000|Overall Study|Lost to Follow-up|45|||
33426954|NCT00550745|62804985|FG001|Overall Study|Lost to Follow-up|30|||
33426955|NCT00550745|62804984|FG000|Overall Study|Physician Decision|0|||
33605355|NCT01649375|63005072|FG004|Up to Week 16|Physician Decision|0|||
33605356|NCT01649375|63005068|FG000|Up to Week 16|Withdrawal by Subject|2|||
33605357|NCT01649375|63005069|FG001|Up to Week 16|Withdrawal by Subject|1|||
33605358|NCT01649375|63005070|FG002|Up to Week 16|Withdrawal by Subject|2|||
33605359|NCT01649375|63005071|FG003|Up to Week 16|Withdrawal by Subject|0|||
33426956|NCT00550745|62804985|FG001|Overall Study|Physician Decision|2|||
33426957|NCT00550745|62804984|FG000|Overall Study|Protocol Violation|4|||
33426958|NCT00550745|62804985|FG001|Overall Study|Protocol Violation|2|||
33426959|NCT00550745|62804984|FG000|Overall Study|Withdrawal by Subject|17|||
33426960|NCT00550745|62804985|FG001|Overall Study|Withdrawal by Subject|10|||
33426961|NCT00550745|62804984|FG000|Overall Study|Screen failure|1|||
33426962|NCT00550745|62804985|FG001|Overall Study|Screen failure|0|||
33426963|NCT00452790|62804993|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
33426964|NCT00452790|62804994|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
33426965|NCT00452790|62804993|FG000|Infant Series|Parent/legal guardian request|8|||
33426966|NCT00452790|62804994|FG001|Infant Series|Parent/legal guardian request|6|||
33426967|NCT00452790|62804993|FG000|Infant Series|Failed to return|4|||
33426968|NCT00452790|62804994|FG001|Infant Series|Failed to return|1|||
33426969|NCT00452790|62804993|FG000|Infant Series|Protocol Violation|1|||
33426970|NCT00452790|62804994|FG001|Infant Series|Protocol Violation|3|||
33426971|NCT00452790|62804993|FG000|Infant Series|Lost to Follow-up|2|||
33426972|NCT00452790|62804994|FG001|Infant Series|Lost to Follow-up|2|||
33426973|NCT00452790|62804993|FG000|Infant Series|Adverse Event|1|||
33426974|NCT00452790|62804994|FG001|Infant Series|Adverse Event|2|||
33426975|NCT00452790|62804993|FG000|Infant Series|Other reasons|1|||
33426976|NCT00452790|62804994|FG001|Infant Series|Other reasons|2|||
33426977|NCT00452790|62804993|FG000|Infant Series|Investigator request|0|||
33426978|NCT00452790|62804994|FG001|Infant Series|Investigator request|1|||
33426979|NCT00452790|62804993|FG000|Infant Series|Death|0|||
33426980|NCT00452790|62804994|FG001|Infant Series|Death|1|||
33426981|NCT00452790|62804993|FG000|After Infant Series|Investigator request|10|||
33605360|NCT01649375|63005072|FG004|Up to Week 16|Withdrawal by Subject|0|||
33605361|NCT01649375|63005068|FG000|Up to Week 16|Death|1|||
33426982|NCT00452790|62804994|FG001|After Infant Series|Investigator request|10|||
33426983|NCT00452790|62804993|FG000|After Infant Series|Adverse Event|4|||
33426984|NCT00452790|62804994|FG001|After Infant Series|Adverse Event|1|||
33426985|NCT00452790|62804993|FG000|After Infant Series|Parent/legal guardian request|1|||
33426986|NCT00452790|62804994|FG001|After Infant Series|Parent/legal guardian request|3|||
33426987|NCT00452790|62804993|FG000|After Infant Series|Lost to Follow-up|4|||
33426988|NCT00452790|62804994|FG001|After Infant Series|Lost to Follow-up|0|||
33426989|NCT00452790|62804993|FG000|After Infant Series|Failed to return|1|||
33426990|NCT00452790|62804994|FG001|After Infant Series|Failed to return|0|||
33426991|NCT00452790|62804993|FG000|After Infant Series|Other reasons|1|||
33426992|NCT00452790|62804994|FG001|After Infant Series|Other reasons|0|||
33426993|NCT00452790|62804993|FG000|Toddler Dose|Failed to return|0|||
33426994|NCT00452790|62804994|FG001|Toddler Dose|Failed to return|1|||
33426995|NCT00452790|62804993|FG000|Toddler Dose|Parent/legal guardian request|0|||
33426996|NCT00452790|62804994|FG001|Toddler Dose|Parent/legal guardian request|1|||
33426997|NCT00463788|62805006|FG000|Overall Study|Progressive Disease|86|||
33426998|NCT00463788|62805007|FG001|Overall Study|Progressive Disease|42|||
33426999|NCT00463788|62805006|FG000|Overall Study|Adverse Event|6|||
33427000|NCT00463788|62805007|FG001|Overall Study|Adverse Event|2|||
33427001|NCT00463788|62805006|FG000|Overall Study|Withdrawal by Subject|6|||
33427002|NCT00463788|62805007|FG001|Overall Study|Withdrawal by Subject|2|||
33427003|NCT00463788|62805006|FG000|Overall Study|Death|4|||
33427004|NCT00463788|62805007|FG001|Overall Study|Death|3|||
33427005|NCT00463788|62805006|FG000|Overall Study|Symptomatic Deterioration|2|||
33427006|NCT00463788|62805007|FG001|Overall Study|Symptomatic Deterioration|3|||
33427007|NCT00463788|62805006|FG000|Overall Study|Lost to Follow-up|1|||
33427008|NCT00463788|62805007|FG001|Overall Study|Lost to Follow-up|0|||
33427009|NCT00463788|62805006|FG000|Overall Study|Protocol Violation|0|||
33427010|NCT00463788|62805007|FG001|Overall Study|Protocol Violation|1|||
33427011|NCT00463788|62805006|FG000|Overall Study|Other|3|||
33427012|NCT00463788|62805007|FG001|Overall Study|Other|0|||
33427013|NCT00463788|62805006|FG000|Overall Study|Randomized but not treated|1|||
33427014|NCT00463788|62805007|FG001|Overall Study|Randomized but not treated|1|||
33427015|NCT00548249|62805019|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
33427016|NCT00548249|62805020|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
33427017|NCT00548249|62805021|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
33427018|NCT00548249|62805022|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
33427019|NCT00548249|62805023|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
33427020|NCT00548249|62805019|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
33427021|NCT00548249|62805020|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
33427022|NCT00548249|62805021|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
33427023|NCT00548249|62805022|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
33427024|NCT00548249|62805023|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
33427025|NCT00548249|62805019|FG000|Overall Study|Protocol Violation|1|||
33427026|NCT00548249|62805020|FG001|Overall Study|Protocol Violation|1|||
33427027|NCT00548249|62805021|FG002|Overall Study|Protocol Violation|4|||
33427028|NCT00548249|62805022|FG003|Overall Study|Protocol Violation|0|||
33427029|NCT00548249|62805023|FG004|Overall Study|Protocol Violation|3|||
33427030|NCT00548249|62805019|FG000|Overall Study|Miscellaneous|2|||
33427031|NCT00548249|62805020|FG001|Overall Study|Miscellaneous|3|||
33427032|NCT00548249|62805021|FG002|Overall Study|Miscellaneous|2|||
33427033|NCT00548249|62805022|FG003|Overall Study|Miscellaneous|0|||
33427034|NCT00548249|62805023|FG004|Overall Study|Miscellaneous|2|||
33427035|NCT00548249|62805019|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
33427036|NCT00548249|62805020|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
33427037|NCT00548249|62805021|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
33427038|NCT00548249|62805022|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
33427039|NCT00548249|62805023|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
33427040|NCT00548249|62805019|FG000|Overall Study|Adverse Event|2|||
33427041|NCT00548249|62805020|FG001|Overall Study|Adverse Event|2|||
33427042|NCT00548249|62805021|FG002|Overall Study|Adverse Event|0|||
33427043|NCT00548249|62805022|FG003|Overall Study|Adverse Event|1|||
33427044|NCT00548249|62805023|FG004|Overall Study|Adverse Event|1|||
33427045|NCT00548249|62805019|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
33427046|NCT00548249|62805020|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
33427047|NCT00548249|62805021|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
33427048|NCT00548249|62805022|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
33427049|NCT00548249|62805023|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
33427050|NCT00548249|62805019|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
33427051|NCT00548249|62805020|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
33427052|NCT00548249|62805021|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
33427053|NCT00548249|62805022|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
33427054|NCT00548249|62805023|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
33427055|NCT00548249|62805019|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
33427056|NCT00548249|62805020|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
33427057|NCT00548249|62805021|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
33427058|NCT00548249|62805022|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
33427059|NCT00548249|62805023|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
33427060|NCT00548249|62805019|FG000|Overall Study|Prolonged hospitalization|0|||
33427061|NCT00548249|62805020|FG001|Overall Study|Prolonged hospitalization|0|||
33427062|NCT00548249|62805021|FG002|Overall Study|Prolonged hospitalization|2|||
33427063|NCT00548249|62805022|FG003|Overall Study|Prolonged hospitalization|1|||
33427064|NCT00548249|62805023|FG004|Overall Study|Prolonged hospitalization|0|||
33427065|NCT00548249|62805019|FG000|Overall Study|Withdrawal by Subject|2|||
33427066|NCT00548249|62805020|FG001|Overall Study|Withdrawal by Subject|0|||
33427067|NCT00548249|62805021|FG002|Overall Study|Withdrawal by Subject|0|||
33427068|NCT00548249|62805022|FG003|Overall Study|Withdrawal by Subject|0|||
33427069|NCT00548249|62805023|FG004|Overall Study|Withdrawal by Subject|0|||
33427070|NCT00548249|62805019|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
33427071|NCT00548249|62805020|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
33427072|NCT00548249|62805021|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
33427073|NCT00548249|62805022|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
33427074|NCT00548249|62805023|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
33427075|NCT00548249|62805019|FG000|Overall Study|Sponsor's request|0|||
33427076|NCT00548249|62805020|FG001|Overall Study|Sponsor's request|0|||
33427077|NCT00548249|62805021|FG002|Overall Study|Sponsor's request|0|||
33427078|NCT00548249|62805022|FG003|Overall Study|Sponsor's request|1|||
33427079|NCT00548249|62805023|FG004|Overall Study|Sponsor's request|0|||
33427080|NCT00463476|62805037|FG000|Overall Study|Withdrawal by Subject|1|||
33427081|NCT00463476|62805038|FG001|Overall Study|Withdrawal by Subject|2|||
33427082|NCT00463476|62805037|FG000|Overall Study|Lost to Follow-up|1|||
33427083|NCT00463476|62805038|FG001|Overall Study|Lost to Follow-up|1|||
33427084|NCT03839940|62805046|FG000|Overall Study|Withdrawal by Subject|3|||
33427085|NCT03839940|62805047|FG001|Overall Study|Withdrawal by Subject|0|||
33427086|NCT03839940|62805046|FG000|Overall Study|Protocol Violation|0|||
33427087|NCT03839940|62805047|FG001|Overall Study|Protocol Violation|1|||
33427088|NCT03839940|62805046|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
33427089|NCT03839940|62805047|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
33427090|NCT03839628|62805055|FG000|Overall Study|Withdrawal by Subject|1|||
33427091|NCT00462462|62805061|FG000|Overall Study|Physician Decision|0|||
33427092|NCT00462462|62805062|FG001|Overall Study|Physician Decision|1|||
33427093|NCT00462384|62805070|FG000|Overall Study|Adverse Event|2|||
33427094|NCT00462384|62805070|FG000|Overall Study|Death|2|||
33427095|NCT00462384|62805070|FG000|Overall Study|Withdrawal by Subject|1|||
33427096|NCT00462384|62805070|FG000|Overall Study|Other|4|||
33427097|NCT00452400|62805079|FG000|Overall Study|Adverse Event|1|||
33427098|NCT00452400|62805080|FG001|Overall Study|Adverse Event|1|||
33427099|NCT00452400|62805081|FG002|Overall Study|Adverse Event|5|||
33427100|NCT00452400|62805082|FG003|Overall Study|Adverse Event|0|||
33427101|NCT00452400|62805083|FG004|Overall Study|Adverse Event|2|||
33427102|NCT00452400|62805079|FG000|Overall Study|Protocol Violation|0|||
33427103|NCT00452400|62805080|FG001|Overall Study|Protocol Violation|0|||
33427104|NCT00452400|62805081|FG002|Overall Study|Protocol Violation|1|||
33427105|NCT00452400|62805082|FG003|Overall Study|Protocol Violation|0|||
33427106|NCT00452400|62805083|FG004|Overall Study|Protocol Violation|0|||
33427107|NCT00452400|62805079|FG000|Overall Study|Lost to Follow-up|1|||
33427108|NCT00452400|62805080|FG001|Overall Study|Lost to Follow-up|0|||
33427109|NCT00452400|62805081|FG002|Overall Study|Lost to Follow-up|0|||
33427110|NCT00452400|62805082|FG003|Overall Study|Lost to Follow-up|0|||
33494173|NCT03634033|62872940|FG006|Overall Study|Did not have a post-assessment|0|||
33322993|NCT00927394|62699259|FG000|Overall Study|Administrative Problem|1|||
33427111|NCT00452400|62805083|FG004|Overall Study|Lost to Follow-up|0|||
33427112|NCT00452400|62805079|FG000|Overall Study|Withdrawal by Subject|1|||
33427113|NCT00452400|62805080|FG001|Overall Study|Withdrawal by Subject|0|||
33427114|NCT00452400|62805081|FG002|Overall Study|Withdrawal by Subject|1|||
33427115|NCT00452400|62805082|FG003|Overall Study|Withdrawal by Subject|0|||
33427116|NCT00452400|62805083|FG004|Overall Study|Withdrawal by Subject|0|||
33427117|NCT00452400|62805079|FG000|Overall Study|Lack of Efficacy|2|||
33427118|NCT00452400|62805080|FG001|Overall Study|Lack of Efficacy|0|||
33427119|NCT00452400|62805081|FG002|Overall Study|Lack of Efficacy|0|||
33427120|NCT00452400|62805082|FG003|Overall Study|Lack of Efficacy|0|||
33427121|NCT00452400|62805083|FG004|Overall Study|Lack of Efficacy|0|||
33427122|NCT00452400|62805079|FG000|Overall Study|Other reasons not listed above|0|||
33427123|NCT00452400|62805080|FG001|Overall Study|Other reasons not listed above|0|||
33427124|NCT00452400|62805081|FG002|Overall Study|Other reasons not listed above|0|||
33427125|NCT00452400|62805082|FG003|Overall Study|Other reasons not listed above|1|||
33427126|NCT00452400|62805083|FG004|Overall Study|Other reasons not listed above|1|||
33427127|NCT00462306|62805097|FG000|Overall Study|insufficient data|0|||
33427128|NCT00462306|62805098|FG001|Overall Study|insufficient data|13|||
33427129|NCT00461682|62805106|FG000|Overall Study|Protocol Violation|1|||
33427130|NCT00443430|62805114|FG000|Overall Study|Lack of Efficacy|3|||
33427131|NCT00443430|62805115|FG001|Overall Study|Lack of Efficacy|3|||
33427132|NCT00443430|62805114|FG000|Overall Study|Adverse Event|1|||
33427133|NCT00443430|62805115|FG001|Overall Study|Adverse Event|1|||
33427134|NCT00460746|62805121|FG000|Overall Study|Adverse Event|1|||
33427135|NCT00460746|62805121|FG000|Overall Study|Lost to Follow-up|1|||
33427136|NCT00443118|62805128|FG000|Overall Study|unknown primary outcome|3|||
33427137|NCT00443118|62805129|FG001|Overall Study|unknown primary outcome|1|||
33427138|NCT00443118|62805130|FG002|Overall Study|unknown primary outcome|0|||
33427139|NCT00443118|62805128|FG000|Overall Study|Withdrawal by Subject|1|||
33427140|NCT00443118|62805129|FG001|Overall Study|Withdrawal by Subject|0|||
33427141|NCT00443118|62805130|FG002|Overall Study|Withdrawal by Subject|0|||
33427142|NCT00460434|62805158|FG000|Overall Study|Lost to Follow-up|3|||
33427143|NCT00460434|62805159|FG001|Overall Study|Lost to Follow-up|7|||
33427144|NCT00373425|62805170|FG000|Overall Study|Relapse of NSCLC|116|||
33427145|NCT00373425|62805171|FG001|Overall Study|Relapse of NSCLC|104|||
33427146|NCT00373425|62805172|FG002|Overall Study|Relapse of NSCLC|19|||
33427147|NCT00373425|62805173|FG003|Overall Study|Relapse of NSCLC|2|||
33427148|NCT00373425|62805174|FG004|Overall Study|Relapse of NSCLC|26|||
33427149|NCT00373425|62805170|FG000|Overall Study|Adverse Event|191|||
33427150|NCT00373425|62805171|FG001|Overall Study|Adverse Event|22|||
33427151|NCT00373425|62805172|FG002|Overall Study|Adverse Event|59|||
33427152|NCT00373425|62805173|FG003|Overall Study|Adverse Event|0|||
33427153|NCT00373425|62805174|FG004|Overall Study|Adverse Event|34|||
33427154|NCT00373425|62805170|FG000|Overall Study|Patient request|35|||
33427155|NCT00373425|62805171|FG001|Overall Study|Patient request|18|||
33427156|NCT00373425|62805172|FG002|Overall Study|Patient request|43|||
33427157|NCT00373425|62805173|FG003|Overall Study|Patient request|6|||
33427158|NCT00373425|62805174|FG004|Overall Study|Patient request|7|||
33427159|NCT00373425|62805170|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
33427160|NCT00373425|62805171|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
33427161|NCT00373425|62805172|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
33427162|NCT00373425|62805173|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
33427163|NCT00373425|62805174|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
33427164|NCT00373425|62805170|FG000|Overall Study|Death|7|||
33322994|NCT00927394|62699260|FG001|Overall Study|Administrative Problem|0|||
33322995|NCT00927394|62699259|FG000|Overall Study|Death|1|||
33322996|NCT00927394|62699260|FG001|Overall Study|Death|1|||
33322997|NCT00927394|62699259|FG000|Overall Study|Protocol deviation|16|||
33322998|NCT00927394|62699260|FG001|Overall Study|Protocol deviation|13|||
33322999|NCT00927394|62699259|FG000|Overall Study|Randomized in error|0|||
33323000|NCT00927394|62699260|FG001|Overall Study|Randomized in error|1|||
33323001|NCT00976911|62699269|FG000|Overall Study|Withdrawal by Subject|4|||
33323002|NCT00976911|62699270|FG001|Overall Study|Withdrawal by Subject|6|||
33323003|NCT00976911|62699269|FG000|Overall Study|Death|138|||
33323004|NCT00976911|62699270|FG001|Overall Study|Death|126|||
33323005|NCT00976911|62699269|FG000|Overall Study|Adverse Event|0|||
33323006|NCT00976911|62699270|FG001|Overall Study|Adverse Event|1|||
33323007|NCT00976911|62699269|FG000|Overall Study|Protocol Violation|2|||
33323008|NCT00976911|62699270|FG001|Overall Study|Protocol Violation|0|||
33323009|NCT00976911|62699269|FG000|Overall Study|Other|8|||
33323010|NCT00976911|62699270|FG001|Overall Study|Other|9|||
33323011|NCT00976911|62699269|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
33323012|NCT00976911|62699270|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
33323013|NCT00934648|62699276|FG000|Overall Study|Failure to return|8|||
33323014|NCT00934648|62699276|FG000|Overall Study|Withdrawal by Subject|1|||
33323015|NCT01175213|62699284|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
33323016|NCT01175213|62699285|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
33323017|NCT01175213|62699284|FG000|IGSC, 10%/rHuPH20|Death|1|||
33427165|NCT00373425|62805171|FG001|Overall Study|Death|0|||
33427166|NCT00373425|62805172|FG002|Overall Study|Death|3|||
33323018|NCT01175213|62699285|FG001|IGSC, 10%/rHuPH20|Death|0|||
33323019|NCT01175213|62699284|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
33323020|NCT01175213|62699285|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
33323021|NCT01175213|62699284|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
33427167|NCT00373425|62805173|FG003|Overall Study|Death|1|||
33427168|NCT00373425|62805174|FG004|Overall Study|Death|0|||
33427169|NCT00459342|62805183|FG000|Overall Study|Not eligible|1|||
33427170|NCT00443040|62805190|FG000|Overall Study|Withdrawal by Subject|1|||
33427171|NCT00443040|62805191|FG001|Overall Study|Withdrawal by Subject|0|||
33427172|NCT00443040|62805192|FG002|Overall Study|Withdrawal by Subject|0|||
33427173|NCT00443040|62805190|FG000|Overall Study|Converted to an open laparotomy|3|||
33427174|NCT00443040|62805191|FG001|Overall Study|Converted to an open laparotomy|0|||
33427175|NCT00443040|62805192|FG002|Overall Study|Converted to an open laparotomy|1|||
33427176|NCT00442962|62805200|FG000|Overall Study|Pregnancy|1|||
33427177|NCT00442962|62805200|FG000|Overall Study|Lost to Follow-up|7|||
33427178|NCT00313300|62805209|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
33427179|NCT00313300|62805210|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
33427180|NCT00313300|62805211|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
33427181|NCT00313300|62805212|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
33427182|NCT00313300|62805213|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
33427183|NCT00313300|62805209|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
33427184|NCT00313300|62805210|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
33427185|NCT00313300|62805211|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
33427186|NCT00313300|62805212|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
33427187|NCT00313300|62805213|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
33427188|NCT00313300|62805209|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
33427189|NCT00313300|62805210|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
33427190|NCT00313300|62805211|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
33427191|NCT00313300|62805212|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
33427192|NCT00313300|62805213|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
33427193|NCT00313300|62805209|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
33427194|NCT00313300|62805210|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
33427195|NCT00313300|62805211|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
33427196|NCT00313300|62805212|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
33427197|NCT00313300|62805213|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
33427198|NCT00313300|62805209|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
33427199|NCT00313300|62805210|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
33427200|NCT00313300|62805211|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
33427201|NCT00313300|62805212|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
33427202|NCT00313300|62805213|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
33427203|NCT00313300|62805209|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
33427204|NCT00313300|62805210|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
33427205|NCT00313300|62805211|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
33427206|NCT00313300|62805212|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
33427207|NCT00313300|62805213|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
33427208|NCT00313300|62805209|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
33427209|NCT00313300|62805210|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
33427210|NCT00313300|62805211|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
33427211|NCT00313300|62805212|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
33427212|NCT00313300|62805213|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
33427213|NCT00313300|62805209|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
33427214|NCT00313300|62805210|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
33427215|NCT00313300|62805211|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
33427216|NCT00313300|62805212|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
33427217|NCT00313300|62805213|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
33427218|NCT00313300|62805209|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
33427219|NCT00313300|62805210|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
33427220|NCT00313300|62805211|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
33427221|NCT00313300|62805212|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
33427222|NCT00313300|62805213|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
33427223|NCT00313300|62805209|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
33427224|NCT00313300|62805210|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
33427225|NCT00313300|62805211|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
33427226|NCT00313300|62805212|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
33427227|NCT00313300|62805213|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
33427228|NCT00313300|62805209|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
33605362|NCT01649375|63005069|FG001|Up to Week 16|Death|0|||
33605363|NCT01649375|63005070|FG002|Up to Week 16|Death|0|||
33605364|NCT01649375|63005071|FG003|Up to Week 16|Death|0|||
33605365|NCT01649375|63005072|FG004|Up to Week 16|Death|0|||
33605366|NCT01649375|63005068|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
33427229|NCT00313300|62805210|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
33427230|NCT00313300|62805211|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
33427231|NCT00313300|62805212|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
33427232|NCT00313300|62805213|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
33494174|NCT03634033|62872934|FG000|Overall Study|Death|0|||
33427233|NCT00313300|62805209|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
33427234|NCT00313300|62805210|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
33427235|NCT00313300|62805211|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
33427236|NCT00313300|62805212|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
33427237|NCT00313300|62805213|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
33427238|NCT00313300|62805209|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
33427239|NCT00313300|62805210|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
33427240|NCT00313300|62805211|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
33427241|NCT00313300|62805212|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
33427242|NCT00313300|62805213|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
33427243|NCT00313300|62805209|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
33427244|NCT00313300|62805210|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
33427245|NCT00313300|62805211|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
33427246|NCT00313300|62805212|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
33427247|NCT00313300|62805213|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
33427248|NCT00313300|62805209|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
33427249|NCT00313300|62805210|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
33427250|NCT00313300|62805211|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
33427251|NCT00313300|62805212|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
33427252|NCT00313300|62805213|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
33427253|NCT00313300|62805209|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
33427254|NCT00313300|62805210|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
33427255|NCT00313300|62805211|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
33427256|NCT00313300|62805212|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
33427257|NCT00313300|62805213|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
33427258|NCT00313300|62805209|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
33427259|NCT00313300|62805210|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
33427260|NCT00313300|62805211|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
33427261|NCT00313300|62805212|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
33427262|NCT00313300|62805213|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
33427263|NCT00313300|62805209|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
33427264|NCT00313300|62805210|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
33427265|NCT00313300|62805211|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
33427266|NCT00313300|62805212|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
33427267|NCT00313300|62805213|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
33427268|NCT00313300|62805209|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
33427269|NCT00313300|62805210|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
33427270|NCT00313300|62805211|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
33427271|NCT00313300|62805212|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
33427272|NCT00313300|62805213|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
33427273|NCT00313300|62805209|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
33427274|NCT00313300|62805210|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
33427275|NCT00313300|62805211|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
33427276|NCT00313300|62805212|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
33427277|NCT00313300|62805213|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
33427278|NCT00313300|62805209|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
33427279|NCT00313300|62805210|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
33427280|NCT00313300|62805211|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
33427281|NCT00313300|62805212|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
33427282|NCT00313300|62805213|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
33427283|NCT00459186|62805231|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
33427284|NCT00459186|62805231|FG000|PET Imaging and Assessment|Adverse Event|3|||
33427285|NCT00328510|62805237|FG000|Overall Study|Gag disorder, could not use frame|4|||
33427286|NCT00328510|62805238|FG001|Overall Study|Gag disorder, could not use frame|0|||
33427287|NCT00328510|62805237|FG000|Overall Study|Dentition problems, could not use frame|1|||
33427288|NCT00328510|62805238|FG001|Overall Study|Dentition problems, could not use frame|0|||
33427289|NCT00328510|62805237|FG000|Overall Study|Withdrawal by Subject|4|||
33427290|NCT00328510|62805238|FG001|Overall Study|Withdrawal by Subject|2|||
33427291|NCT00328510|62805237|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
33427292|NCT00328510|62805238|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
33427293|NCT00328510|62805237|FG000|Overall Study|Treatment changed to a single fraction|1|||
33427294|NCT00328510|62805238|FG001|Overall Study|Treatment changed to a single fraction|1|||
33427295|NCT00313144|62805244|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
33427296|NCT00313144|62805244|FG000|Overall Study|Death|7|||
33427297|NCT00313144|62805244|FG000|Overall Study|Lost to Follow-up|5|||
33427298|NCT00313144|62805244|FG000|Overall Study|Withdrawal by Subject|4|||
33494175|NCT03634033|62872935|FG001|Overall Study|Death|0|||
33427299|NCT00313144|62805244|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
33427300|NCT00313144|62805244|FG000|Overall Study|Physician Decision|4|||
33427301|NCT00313144|62805244|FG000|Overall Study|Adverse event - transient|5|||
33427302|NCT00313144|62805244|FG000|Overall Study|Liver transplant|1|||
33427303|NCT00313144|62805244|FG000|Overall Study|Insurance (homecare provider) change|1|||
33427304|NCT00313144|62805244|FG000|Overall Study|Change to different product|1|||
33427305|NCT00313144|62805244|FG000|Overall Study|Due to termination of the study|66|||
33427306|NCT00459108|62805257|FG000|Overall Study|Withdrawal by Subject|5|||
33427307|NCT00459108|62805257|FG000|Overall Study|Adverse Event|3|||
33427308|NCT00459108|62805257|FG000|Overall Study|Death|2|||
33427309|NCT00459108|62805257|FG000|Overall Study|Progression|1|||
33427310|NCT00458484|62805269|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
33427311|NCT00458484|62805270|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
33427312|NCT00458484|62805271|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
33427313|NCT00458484|62805272|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
33427314|NCT00458484|62805273|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
33427315|NCT00458484|62805274|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
33427316|NCT00458484|62805275|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
33427317|NCT00328198|62805300|FG000|Treatment|Adverse Event|21|||
33427318|NCT00328198|62805300|FG000|Treatment|Death|1|||
33427319|NCT00328198|62805300|FG000|Treatment|Physician Decision|5|||
33427320|NCT00328198|62805300|FG000|Treatment|Withdrawal by Subject|5|||
33427321|NCT00328198|62805300|FG000|Treatment|Evidence of disease progression|2|||
33427322|NCT00328198|62805300|FG000|Treatment|Non-compliance|1|||
33427323|NCT00328198|62805300|FG000|Treatment|Confirmed complete response, MRD -|3|||
33427324|NCT00328198|62805300|FG000|Follow-up|Lost to Follow-up|4|||
33427325|NCT00328198|62805300|FG000|Follow-up|Death|31|||
33427326|NCT00450450|62805306|FG000|Overall Study|Death|1|||
33427327|NCT00450450|62805307|FG001|Overall Study|Death|3|||
33427328|NCT00450450|62805306|FG000|Overall Study|Relapse|2|||
33427329|NCT00450450|62805307|FG001|Overall Study|Relapse|0|||
33427330|NCT00450450|62805306|FG000|Overall Study|Missing Data|2|||
33427331|NCT00450450|62805307|FG001|Overall Study|Missing Data|0|||
33427332|NCT00442572|62805315|FG000|Overall Study|Relapse|8|||
33427333|NCT00442572|62805316|FG001|Overall Study|Relapse|1|||
33427334|NCT00442572|62805315|FG000|Overall Study|Lost to Follow-up|0|||
33427335|NCT00442572|62805316|FG001|Overall Study|Lost to Follow-up|1|||
33427336|NCT00442572|62805315|FG000|Overall Study|Withdrawal by Subject|0|||
33427337|NCT00442572|62805316|FG001|Overall Study|Withdrawal by Subject|1|||
33427338|NCT00442416|62805325|FG000|Overall Study|Adverse Event|4|||
33427339|NCT00442416|62805326|FG001|Overall Study|Adverse Event|1|||
33427340|NCT00442416|62805325|FG000|Overall Study|Death|1|||
33427341|NCT00442416|62805326|FG001|Overall Study|Death|0|||
33427342|NCT00442416|62805325|FG000|Overall Study|Lack of Efficacy|2|||
33427343|NCT00442416|62805326|FG001|Overall Study|Lack of Efficacy|0|||
33427344|NCT00442416|62805325|FG000|Overall Study|Protocol Violation|2|||
33427345|NCT00442416|62805326|FG001|Overall Study|Protocol Violation|3|||
33427346|NCT00442416|62805325|FG000|Overall Study|Withdrew consent|1|||
33427347|NCT00442416|62805326|FG001|Overall Study|Withdrew consent|2|||
33427348|NCT00442416|62805325|FG000|Overall Study|Administrative/Other|27|||
33427349|NCT00442416|62805326|FG001|Overall Study|Administrative/Other|33|||
33427350|NCT00441792|62805334|FG000|Overall Study|Lost to Follow-up|0|||
33427351|NCT00441792|62805335|FG001|Overall Study|Lost to Follow-up|2|||
33427352|NCT00312208|62805343|FG000|Overall Study|Adverse Event|97|||
33427353|NCT00312208|62805344|FG001|Overall Study|Adverse Event|61|||
33427354|NCT00312208|62805343|FG000|Overall Study|Protocol Violation|5|||
33427355|NCT00312208|62805344|FG001|Overall Study|Protocol Violation|3|||
33427356|NCT00312208|62805343|FG000|Overall Study|Death|2|||
33427357|NCT00312208|62805344|FG001|Overall Study|Death|1|||
33427358|NCT00312208|62805343|FG000|Overall Study|Lack of Efficacy|7|||
33427359|NCT00312208|62805344|FG001|Overall Study|Lack of Efficacy|4|||
33427360|NCT00312208|62805343|FG000|Overall Study|Lost to Follow-up|3|||
33427361|NCT00312208|62805344|FG001|Overall Study|Lost to Follow-up|5|||
33427362|NCT00312208|62805343|FG000|Overall Study|Withdrawal by Subject|53|||
33427363|NCT00312208|62805344|FG001|Overall Study|Withdrawal by Subject|42|||
33427364|NCT00312208|62805343|FG000|Overall Study|Other|5|||
33427365|NCT00312208|62805344|FG001|Overall Study|Other|7|||
33427366|NCT00297778|62805352|FG000|Overall Study|Adverse Event|16|||
33427367|NCT00297778|62805353|FG001|Overall Study|Adverse Event|10|||
33427368|NCT00297778|62805352|FG000|Overall Study|Withdrawal by Subject|1|||
33427369|NCT00297778|62805353|FG001|Overall Study|Withdrawal by Subject|5|||
33427370|NCT00297778|62805352|FG000|Overall Study|Lack of Efficacy|2|||
33427371|NCT00297778|62805353|FG001|Overall Study|Lack of Efficacy|1|||
33427372|NCT00297778|62805352|FG000|Overall Study|Non-compliant with trial protocol|0|||
33427373|NCT00297778|62805353|FG001|Overall Study|Non-compliant with trial protocol|3|||
33427374|NCT00297778|62805352|FG000|Overall Study|Other|0|||
33427375|NCT00297778|62805353|FG001|Overall Study|Other|1|||
33427376|NCT03848832|62805362|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
33427377|NCT03848832|62805363|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
33427378|NCT03848832|62805364|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
33427379|NCT03848832|62805362|FG000|Overall Study|Withdrawal by Subject|0|||
33427380|NCT03848832|62805363|FG001|Overall Study|Withdrawal by Subject|0|||
33427381|NCT03848832|62805364|FG002|Overall Study|Withdrawal by Subject|1|||
33427382|NCT03848832|62805362|FG000|Overall Study|Withdrawal (Covid-19)|0|||
33427383|NCT03848832|62805363|FG001|Overall Study|Withdrawal (Covid-19)|2|||
33427384|NCT03848832|62805364|FG002|Overall Study|Withdrawal (Covid-19)|0|||
33427385|NCT03848832|62805362|FG000|Overall Study|Physician Decision|2|||
33427386|NCT03848832|62805363|FG001|Overall Study|Physician Decision|1|||
33427387|NCT03848832|62805364|FG002|Overall Study|Physician Decision|3|||
33427388|NCT03848832|62805362|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
33427389|NCT03848832|62805363|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
33427390|NCT03848832|62805364|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
33427391|NCT03848832|62805362|FG000|Overall Study|Adverse Event|1|||
33427392|NCT03848832|62805363|FG001|Overall Study|Adverse Event|0|||
33427393|NCT03848832|62805364|FG002|Overall Study|Adverse Event|0|||
33427394|NCT00450372|62805374|FG000|Overall Study|Physician Decision|1|||
33427395|NCT00327340|62805383|FG000|Overall Study|Withdrawal by Subject|1|||
33427396|NCT00327340|62805384|FG001|Overall Study|Withdrawal by Subject|5|||
33427397|NCT00327340|62805383|FG000|Overall Study|Physician Decision|1|||
33427398|NCT00327340|62805384|FG001|Overall Study|Physician Decision|1|||
33427399|NCT00327340|62805383|FG000|Overall Study|Disease Progression|10|||
33427400|NCT00327340|62805384|FG001|Overall Study|Disease Progression|19|||
33427401|NCT00327340|62805383|FG000|Overall Study|Symptomatic Disease|0|||
33427402|NCT00327340|62805384|FG001|Overall Study|Symptomatic Disease|2|||
33427403|NCT00327340|62805383|FG000|Overall Study|Adverse Event|3|||
33427404|NCT00327340|62805384|FG001|Overall Study|Adverse Event|3|||
33427405|NCT00548093|62805394|FG000|Overall Study|Death|33|||
33427406|NCT00548093|62805395|FG001|Overall Study|Death|13|||
33427407|NCT00548093|62805394|FG000|Overall Study|Lost to Follow-up|3|||
33427408|NCT00548093|62805395|FG001|Overall Study|Lost to Follow-up|1|||
33427409|NCT00548093|62805394|FG000|Overall Study|Objective progression or relapse|1|||
33427410|NCT00548093|62805395|FG001|Overall Study|Objective progression or relapse|1|||
33427411|NCT00548093|62805394|FG000|Overall Study|Other|11|||
33427412|NCT00548093|62805395|FG001|Overall Study|Other|1|||
33427413|NCT00548093|62805394|FG000|Overall Study|Withdrawal by Subject|1|||
33427414|NCT00548093|62805395|FG001|Overall Study|Withdrawal by Subject|0|||
33427415|NCT00548093|62805394|FG000|Overall Study|Completed post-treatment follow-up|1|||
33427416|NCT00548093|62805395|FG001|Overall Study|Completed post-treatment follow-up|0|||
33427417|NCT00450216|62805406|FG000|Overall Study|Adverse Event|38|||
33605367|NCT01649375|63005069|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
33605368|NCT01649375|63005070|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
33427418|NCT00450216|62805407|FG001|Overall Study|Adverse Event|23|||
33427419|NCT00450216|62805406|FG000|Overall Study|Withdrawal by Subject|48|||
33427420|NCT00450216|62805407|FG001|Overall Study|Withdrawal by Subject|26|||
33427421|NCT00450216|62805406|FG000|Overall Study|Lost to Follow-up|16|||
33427422|NCT00450216|62805407|FG001|Overall Study|Lost to Follow-up|9|||
33427423|NCT00450216|62805406|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
33427424|NCT00450216|62805407|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
33427425|NCT00450216|62805406|FG000|Overall Study|misc|21|||
33427426|NCT00450216|62805407|FG001|Overall Study|misc|20|||
33427427|NCT00441480|62805415|FG000|Overall Study|Protocol Violation|1|||
33427428|NCT00441480|62805416|FG001|Overall Study|Protocol Violation|1|||
33427429|NCT00441480|62805415|FG000|Overall Study|Withdrawal by Subject|2|||
33427430|NCT00441480|62805416|FG001|Overall Study|Withdrawal by Subject|3|||
33427431|NCT00547703|62805424|FG000|Overall Study|Lost to Follow-up|1|||
33427432|NCT00547703|62805425|FG001|Overall Study|Lost to Follow-up|0|||
33427433|NCT00297232|62805431|FG000|Overall Study|Lack of Efficacy|7|||
33427434|NCT00297232|62805431|FG000|Overall Study|Lost to Follow-up|10|||
33427435|NCT00297232|62805431|FG000|Overall Study|Adverse Event|63|||
33427436|NCT00297232|62805431|FG000|Overall Study|Voluntary Withdrawal|120|||
33427437|NCT00297232|62805431|FG000|Overall Study|Subject was Noncompliant|9|||
33427438|NCT00297232|62805431|FG000|Overall Study|Death|9|||
33427439|NCT00297232|62805431|FG000|Overall Study|Anti-natalizumab Positive|8|||
33427440|NCT00297232|62805431|FG000|Overall Study|Switched to Commercial Tysabri|22|||
33427441|NCT00297232|62805431|FG000|Overall Study|Disease Progression|8|||
33427442|NCT00297232|62805431|FG000|Overall Study|Fear of PML|10|||
33427443|NCT00297232|62805431|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
33427444|NCT00297232|62805431|FG000|Overall Study|Miscellaneous|5|||
33427445|NCT00297232|62805431|FG000|Overall Study|Sponsor Decision|34|||
33427446|NCT00297232|62805431|FG000|Overall Study|Subject Relocated|7|||
33427447|NCT00297232|62805431|FG000|Overall Study|Subject Withdrew Consent|37|||
33427448|NCT00297232|62805431|FG000|Overall Study|Persistently Positive Antibodies|11|||
33427449|NCT00297232|62805431|FG000|Overall Study|Investigator Withdrew From Program|19|||
33427450|NCT00297232|62805431|FG000|Overall Study|Did Not Enroll to Week 264|34|||
33427451|NCT00297232|62805431|FG000|Overall Study|Did Not Enroll to Week 480|17|||
33427452|NCT00297232|62805431|FG000|Overall Study|No data available after Week 264|161|||
33427453|NCT00297232|62805431|FG000|Overall Study|Other|1|||
33427454|NCT00449670|62805447|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
33427455|NCT00449670|62805448|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
33427456|NCT00449670|62805447|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
33427457|NCT00449670|62805448|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
33427458|NCT00449670|62805447|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
33427459|NCT00449670|62805448|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
33427460|NCT00449670|62805447|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
33427461|NCT00449670|62805448|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
33427462|NCT00449670|62805447|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
33427463|NCT00449670|62805448|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
33427464|NCT00449670|62805447|FG000|Booster Phase (Study no.109873)|Other|0|||
33427465|NCT00449670|62805448|FG001|Booster Phase (Study no.109873)|Other|2|||
33427466|NCT00296374|62805464|FG000|Overall Study|Adverse Event|14|||
33427467|NCT00296374|62805465|FG001|Overall Study|Adverse Event|10|||
33427468|NCT00296374|62805466|FG002|Overall Study|Adverse Event|7|||
33427469|NCT00296374|62805464|FG000|Overall Study|Withdrawal by Subject|3|||
33427470|NCT00296374|62805465|FG001|Overall Study|Withdrawal by Subject|5|||
33427471|NCT00296374|62805466|FG002|Overall Study|Withdrawal by Subject|11|||
33427472|NCT00296374|62805464|FG000|Overall Study|Incorrect enrollment|3|||
33427473|NCT00296374|62805465|FG001|Overall Study|Incorrect enrollment|3|||
33427474|NCT00296374|62805466|FG002|Overall Study|Incorrect enrollment|4|||
33427475|NCT00296374|62805464|FG000|Overall Study|Protocol Violation|1|||
33427476|NCT00296374|62805465|FG001|Overall Study|Protocol Violation|2|||
33427477|NCT00296374|62805466|FG002|Overall Study|Protocol Violation|3|||
33427478|NCT00296374|62805464|FG000|Overall Study|Lost to Follow-up|3|||
33427479|NCT00296374|62805465|FG001|Overall Study|Lost to Follow-up|1|||
33427480|NCT00296374|62805466|FG002|Overall Study|Lost to Follow-up|1|||
33427481|NCT00296374|62805464|FG000|Overall Study|Relocated to another state|1|||
33427482|NCT00296374|62805465|FG001|Overall Study|Relocated to another state|0|||
33427483|NCT00296374|62805466|FG002|Overall Study|Relocated to another state|0|||
33427484|NCT00296374|62805464|FG000|Overall Study|Stopped drug before end of study visit|0|||
33427485|NCT00296374|62805465|FG001|Overall Study|Stopped drug before end of study visit|1|||
33427486|NCT00296374|62805466|FG002|Overall Study|Stopped drug before end of study visit|0|||
33427487|NCT00296374|62805464|FG000|Overall Study|Nephrologist introduced ACE|0|||
33427488|NCT00296374|62805465|FG001|Overall Study|Nephrologist introduced ACE|1|||
33427489|NCT00296374|62805466|FG002|Overall Study|Nephrologist introduced ACE|0|||
33427490|NCT00296374|62805464|FG000|Overall Study|Pregnancy|0|||
33427491|NCT00296374|62805465|FG001|Overall Study|Pregnancy|0|||
33427492|NCT00296374|62805466|FG002|Overall Study|Pregnancy|2|||
33427493|NCT00296374|62805464|FG000|Overall Study|Other|0|||
33427494|NCT00296374|62805465|FG001|Overall Study|Other|0|||
33427495|NCT00296374|62805466|FG002|Overall Study|Other|1|||
33427496|NCT00326950|62805489|FG000|Overall Study|Progressive Disease|1|||
33427497|NCT00548717|62805495|FG000|Overall Study|Death|5|||
33427498|NCT00548717|62805496|FG001|Overall Study|Death|2|||
33427499|NCT00548717|62805495|FG000|Overall Study|Relapse|3|||
33427500|NCT00548717|62805496|FG001|Overall Study|Relapse|0|||
33427501|NCT00548717|62805495|FG000|Overall Study|Alternative treatment for GVHD|1|||
33427502|NCT00548717|62805496|FG001|Overall Study|Alternative treatment for GVHD|0|||
33427503|NCT00441168|62805507|FG000|Treatment Period|Death|3|||
33427504|NCT00441168|62805508|FG001|Treatment Period|Death|0|||
33427505|NCT00441168|62805507|FG000|Treatment Period|Adverse Event|1|||
33427506|NCT00441168|62805508|FG001|Treatment Period|Adverse Event|2|||
33427507|NCT00441168|62805507|FG000|Treatment Period|Progressive Disease|0|||
33427508|NCT00441168|62805508|FG001|Treatment Period|Progressive Disease|2|||
33427509|NCT00441168|62805507|FG000|Treatment Period|Protocol Violation|0|||
33427510|NCT00441168|62805508|FG001|Treatment Period|Protocol Violation|1|||
33427511|NCT00441168|62805507|FG000|Treatment Period|Lost to Follow-up|0|||
33427512|NCT00441168|62805508|FG001|Treatment Period|Lost to Follow-up|1|||
33427513|NCT00441168|62805507|FG000|Treatment Period|Withdrawal by Subject|3|||
33427514|NCT00441168|62805508|FG001|Treatment Period|Withdrawal by Subject|0|||
33427515|NCT00441168|62805507|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
33427516|NCT00441168|62805508|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
33427517|NCT00441168|62805507|FG000|Treatment Period|refractory disease|1|||
33427518|NCT00441168|62805508|FG001|Treatment Period|refractory disease|0|||
33427519|NCT00441168|62805507|FG000|Follow-up Period|Death|3|||
33427520|NCT00441168|62805508|FG001|Follow-up Period|Death|0|||
33427521|NCT00441168|62805507|FG000|Follow-up Period|Lost to Follow-up|5|||
33427522|NCT00441168|62805508|FG001|Follow-up Period|Lost to Follow-up|6|||
33427523|NCT00441168|62805507|FG000|Follow-up Period|Withdrawal by Subject|3|||
33427524|NCT00441168|62805508|FG001|Follow-up Period|Withdrawal by Subject|0|||
33427525|NCT00441168|62805507|FG000|Follow-up Period|Other|1|||
33427526|NCT00441168|62805508|FG001|Follow-up Period|Other|3|||
33427527|NCT00296140|62805516|FG000|Overall Study|Lost to Follow-up|1|||
33427528|NCT00296140|62805517|FG001|Overall Study|Lost to Follow-up|0|||
33427529|NCT00296140|62805516|FG000|Overall Study|Withdrawal by Subject|1|||
33427530|NCT00296140|62805517|FG001|Overall Study|Withdrawal by Subject|0|||
33427531|NCT00296140|62805516|FG000|Overall Study|Discharge to Nursing Home|1|||
33427532|NCT00296140|62805517|FG001|Overall Study|Discharge to Nursing Home|0|||
33427533|NCT03958331|62805526|FG000|Overall Study|Withdrawal by Subject|3|||
33427534|NCT03958331|62805527|FG001|Overall Study|Withdrawal by Subject|1|||
33427535|NCT03958331|62805528|FG002|Overall Study|Withdrawal by Subject|5|||
33427536|NCT03958331|62805526|FG000|Overall Study|Weaned from medicine|2|||
33427537|NCT03958331|62805527|FG001|Overall Study|Weaned from medicine|0|||
33427538|NCT03958331|62805528|FG002|Overall Study|Weaned from medicine|0|||
33427539|NCT03958331|62805526|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
33427540|NCT03958331|62805527|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
33427541|NCT03958331|62805528|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
33427542|NCT03956615|62805534|FG000|Overall Study|No multiple myeloma confirmed|2|||
33427543|NCT03956615|62805534|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
33427544|NCT03956615|62805534|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
33427545|NCT03956615|62805534|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
33427546|NCT03956225|62805540|FG000|Overall Study|Lack of Efficacy|1|||
33427547|NCT03956225|62805541|FG001|Overall Study|Lack of Efficacy|1|||
33427548|NCT03956225|62805540|FG000|Overall Study|Lost to Follow-up|0|||
33427549|NCT03956225|62805541|FG001|Overall Study|Lost to Follow-up|1|||
33427550|NCT03956225|62805540|FG000|Overall Study|Withdrawal by Subject|2|||
33427551|NCT03956225|62805541|FG001|Overall Study|Withdrawal by Subject|1|||
33427552|NCT03956225|62805540|FG000|Overall Study|Other Reasons|2|||
33427553|NCT03956225|62805541|FG001|Overall Study|Other Reasons|1|||
33427554|NCT00457626|62805550|FG000|Overall Study|Adverse Event|3|||
33427555|NCT00457626|62805550|FG000|Overall Study|Administrative Problems|2|||
33427556|NCT00457626|62805550|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
33427557|NCT00373113|62805556|FG000|Overall Study|Death|1|||
33427558|NCT00373113|62805557|FG001|Overall Study|Death|7|||
33427559|NCT00373113|62805556|FG000|Overall Study|Adverse Event|38|||
33427560|NCT00373113|62805557|FG001|Overall Study|Adverse Event|24|||
33427561|NCT00373113|62805556|FG000|Overall Study|Study terminated by sponsor|9|||
33427562|NCT00373113|62805557|FG001|Overall Study|Study terminated by sponsor|1|||
33427563|NCT00373113|62805556|FG000|Overall Study|Global deterioration of health status|10|||
33427564|NCT00373113|62805557|FG001|Overall Study|Global deterioration of health status|7|||
33427565|NCT00373113|62805556|FG000|Overall Study|Lost to Follow-up|1|||
33605369|NCT01649375|63005071|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
33427566|NCT00373113|62805557|FG001|Overall Study|Lost to Follow-up|3|||
33427567|NCT00373113|62805556|FG000|Overall Study|Objective progression or relapse|150|||
33427568|NCT00373113|62805557|FG001|Overall Study|Objective progression or relapse|169|||
33427569|NCT00373113|62805556|FG000|Overall Study|Other|14|||
33427570|NCT00373113|62805557|FG001|Overall Study|Other|17|||
33427571|NCT00373113|62805556|FG000|Overall Study|Protocol Violation|5|||
33427572|NCT00373113|62805557|FG001|Overall Study|Protocol Violation|1|||
33427573|NCT00373113|62805556|FG000|Overall Study|Withdrawal by Subject|10|||
33605370|NCT01649375|63005072|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
33605371|NCT01649375|63005068|FG000|Week 16 up to Week 260|Non-compliance|0|||
33427574|NCT00373113|62805557|FG001|Overall Study|Withdrawal by Subject|15|||
33427575|NCT00407511|62805563|FG000|Overall Study|Adverse Event|9|||
33427576|NCT00407511|62805563|FG000|Overall Study|Lost to Follow-up|4|||
33605372|NCT01649375|63005069|FG001|Week 16 up to Week 260|Non-compliance|1|||
33427577|NCT00407511|62805563|FG000|Overall Study|Other|5|||
33427578|NCT00407511|62805563|FG000|Overall Study|Withdrawal by Subject|4|||
33427579|NCT00384189|62805571|FG000|Overall Study|Reason Not Specified|50|||
33427580|NCT00384189|62805572|FG001|Overall Study|Reason Not Specified|57|||
33427581|NCT00384189|62805573|FG002|Overall Study|Reason Not Specified|58|||
33427582|NCT00384189|62805574|FG003|Overall Study|Reason Not Specified|40|||
33427583|NCT00326716|62805586|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
33427584|NCT00326716|62805587|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
33427585|NCT00326716|62805588|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
33427586|NCT00326716|62805589|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
33427587|NCT00548405|62805622|FG000|Overall Study|Adverse Event|6|||
33427588|NCT00548405|62805623|FG001|Overall Study|Adverse Event|2|||
33427589|NCT00548405|62805624|FG002|Overall Study|Adverse Event|0|||
33427590|NCT00548405|62805622|FG000|Overall Study|Lack of Efficacy|6|||
33427591|NCT00548405|62805623|FG001|Overall Study|Lack of Efficacy|0|||
33427592|NCT00548405|62805624|FG002|Overall Study|Lack of Efficacy|0|||
33427593|NCT00548405|62805622|FG000|Overall Study|Physician Decision|3|||
33427594|NCT00548405|62805623|FG001|Overall Study|Physician Decision|4|||
33427595|NCT00548405|62805624|FG002|Overall Study|Physician Decision|1|||
33427596|NCT00548405|62805622|FG000|Overall Study|Pregnancy|1|||
33427597|NCT00548405|62805623|FG001|Overall Study|Pregnancy|0|||
33427598|NCT00548405|62805624|FG002|Overall Study|Pregnancy|0|||
33427599|NCT00548405|62805622|FG000|Overall Study|Protocol Violation|1|||
33427600|NCT00548405|62805623|FG001|Overall Study|Protocol Violation|0|||
33427601|NCT00548405|62805624|FG002|Overall Study|Protocol Violation|0|||
33427602|NCT00548405|62805622|FG000|Overall Study|Withdrawal by Subject|36|||
33427603|NCT00548405|62805623|FG001|Overall Study|Withdrawal by Subject|12|||
33427604|NCT00548405|62805624|FG002|Overall Study|Withdrawal by Subject|5|||
33427605|NCT00548405|62805622|FG000|Overall Study|Lost to Follow-up|1|||
33427606|NCT00548405|62805623|FG001|Overall Study|Lost to Follow-up|1|||
33427607|NCT00548405|62805624|FG002|Overall Study|Lost to Follow-up|2|||
33427608|NCT00548405|62805622|FG000|Overall Study|Death|0|||
33427609|NCT00548405|62805623|FG001|Overall Study|Death|1|||
33427610|NCT00548405|62805624|FG002|Overall Study|Death|1|||
33427611|NCT00548405|62805622|FG000|Overall Study|Sponsor decision|1|||
33427612|NCT00548405|62805623|FG001|Overall Study|Sponsor decision|0|||
33427613|NCT00548405|62805624|FG002|Overall Study|Sponsor decision|0|||
33427614|NCT00548405|62805622|FG000|Overall Study|Randomized but not treated|1|||
33427615|NCT00548405|62805623|FG001|Overall Study|Randomized but not treated|0|||
33427616|NCT00548405|62805624|FG002|Overall Study|Randomized but not treated|0|||
33427617|NCT00295750|62805636|FG000|Overall Study|Adverse Event|19|||
33427618|NCT00295750|62805637|FG001|Overall Study|Adverse Event|15|||
33427619|NCT00295750|62805638|FG002|Overall Study|Adverse Event|12|||
33427620|NCT00295750|62805636|FG000|Overall Study|Lack of Efficacy|1|||
33427621|NCT00295750|62805637|FG001|Overall Study|Lack of Efficacy|1|||
33427622|NCT00295750|62805638|FG002|Overall Study|Lack of Efficacy|0|||
33427623|NCT00295750|62805636|FG000|Overall Study|Lost to Follow-up|1|||
33427624|NCT00295750|62805637|FG001|Overall Study|Lost to Follow-up|4|||
33427625|NCT00295750|62805638|FG002|Overall Study|Lost to Follow-up|1|||
33427626|NCT00295750|62805636|FG000|Overall Study|Taking prohibited therapy|2|||
33427627|NCT00295750|62805637|FG001|Overall Study|Taking prohibited therapy|3|||
33427628|NCT00295750|62805638|FG002|Overall Study|Taking prohibited therapy|2|||
33427629|NCT00295750|62805636|FG000|Overall Study|Administrative errors|2|||
33427630|NCT00295750|62805637|FG001|Overall Study|Administrative errors|4|||
33427631|NCT00295750|62805638|FG002|Overall Study|Administrative errors|5|||
33427632|NCT00295750|62805636|FG000|Overall Study|Trial drug errors|1|||
33427633|NCT00295750|62805637|FG001|Overall Study|Trial drug errors|1|||
33427634|NCT00295750|62805638|FG002|Overall Study|Trial drug errors|0|||
33427635|NCT00295750|62805636|FG000|Overall Study|Disease progression|2|||
33427636|NCT00295750|62805637|FG001|Overall Study|Disease progression|1|||
33427637|NCT00295750|62805638|FG002|Overall Study|Disease progression|0|||
33427638|NCT00295750|62805636|FG000|Overall Study|Personal reasons|0|||
33427639|NCT00295750|62805637|FG001|Overall Study|Personal reasons|1|||
33427640|NCT00295750|62805638|FG002|Overall Study|Personal reasons|0|||
33427641|NCT00295750|62805636|FG000|Overall Study|Randomized but never received trial drug|4|||
33427642|NCT00295750|62805637|FG001|Overall Study|Randomized but never received trial drug|3|||
33427643|NCT00295750|62805638|FG002|Overall Study|Randomized but never received trial drug|3|||
33427644|NCT00295750|62805636|FG000|Overall Study|Withdrawal by Subject|9|||
33427645|NCT00295750|62805637|FG001|Overall Study|Withdrawal by Subject|4|||
33427646|NCT00295750|62805638|FG002|Overall Study|Withdrawal by Subject|7|||
33427647|NCT00295750|62805636|FG000|Overall Study|Protocol Violation|2|||
33427648|NCT00295750|62805637|FG001|Overall Study|Protocol Violation|4|||
33427649|NCT00295750|62805638|FG002|Overall Study|Protocol Violation|2|||
33427650|NCT03948581|62805648|FG000|Overall Study|Lost to Follow-up|0|||
33427651|NCT03948581|62805649|FG001|Overall Study|Lost to Follow-up|1|||
33427652|NCT00548327|62805657|FG000|Overall Study|Adverse Event|0|||
33427653|NCT00548327|62805658|FG001|Overall Study|Adverse Event|1|||
33427654|NCT03953183|62805680|FG000|Overall Study|Physician Decision|0|||
33427655|NCT03953183|62805681|FG001|Overall Study|Physician Decision|1|||
33427656|NCT03953183|62805680|FG000|Overall Study|Withdrawal by Subject|0|||
33427657|NCT03953183|62805681|FG001|Overall Study|Withdrawal by Subject|1|||
33427658|NCT00406653|62805691|FG000|Induction Period|Adverse Event|1|||
33427659|NCT00406653|62805692|FG001|Induction Period|Adverse Event|10|||
33427660|NCT00406653|62805693|FG002|Induction Period|Adverse Event|4|||
33427661|NCT00406653|62805694|FG003|Induction Period|Adverse Event|11|||
33427662|NCT00406653|62805695|FG004|Induction Period|Adverse Event|0|||
33427663|NCT00406653|62805696|FG005|Induction Period|Adverse Event|0|||
33427664|NCT00406653|62805697|FG006|Induction Period|Adverse Event|0|||
33427665|NCT00406653|62805691|FG000|Induction Period|Lack of Efficacy|11|||
33427666|NCT00406653|62805692|FG001|Induction Period|Lack of Efficacy|14|||
33427667|NCT00406653|62805693|FG002|Induction Period|Lack of Efficacy|8|||
33427668|NCT00406653|62805694|FG003|Induction Period|Lack of Efficacy|10|||
33427669|NCT00406653|62805695|FG004|Induction Period|Lack of Efficacy|0|||
33427670|NCT00406653|62805696|FG005|Induction Period|Lack of Efficacy|0|||
33427671|NCT00406653|62805697|FG006|Induction Period|Lack of Efficacy|0|||
33427672|NCT00406653|62805691|FG000|Induction Period|Lost to Follow-up|0|||
33427673|NCT00406653|62805692|FG001|Induction Period|Lost to Follow-up|2|||
33427674|NCT00406653|62805693|FG002|Induction Period|Lost to Follow-up|0|||
33427675|NCT00406653|62805694|FG003|Induction Period|Lost to Follow-up|0|||
33427676|NCT00406653|62805695|FG004|Induction Period|Lost to Follow-up|0|||
33427677|NCT00406653|62805696|FG005|Induction Period|Lost to Follow-up|0|||
33427678|NCT00406653|62805697|FG006|Induction Period|Lost to Follow-up|0|||
33427679|NCT00406653|62805691|FG000|Induction Period|Withdrawal of Consent|2|||
33427680|NCT00406653|62805692|FG001|Induction Period|Withdrawal of Consent|5|||
33427681|NCT00406653|62805693|FG002|Induction Period|Withdrawal of Consent|1|||
33427682|NCT00406653|62805694|FG003|Induction Period|Withdrawal of Consent|2|||
33427683|NCT00406653|62805695|FG004|Induction Period|Withdrawal of Consent|0|||
33427684|NCT00406653|62805696|FG005|Induction Period|Withdrawal of Consent|0|||
33427685|NCT00406653|62805697|FG006|Induction Period|Withdrawal of Consent|0|||
33427686|NCT00406653|62805691|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
33427687|NCT00406653|62805692|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
33427688|NCT00406653|62805693|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
33427689|NCT00406653|62805694|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
33427690|NCT00406653|62805695|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
33427691|NCT00406653|62805696|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
33427692|NCT00406653|62805697|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
33427693|NCT00406653|62805691|FG000|Induction Period|Pregnancy|1|||
33427694|NCT00406653|62805692|FG001|Induction Period|Pregnancy|0|||
33427695|NCT00406653|62805693|FG002|Induction Period|Pregnancy|0|||
33427696|NCT00406653|62805694|FG003|Induction Period|Pregnancy|0|||
33427697|NCT00406653|62805695|FG004|Induction Period|Pregnancy|0|||
33427698|NCT00406653|62805696|FG005|Induction Period|Pregnancy|0|||
33427699|NCT00406653|62805697|FG006|Induction Period|Pregnancy|0|||
33427700|NCT00406653|62805691|FG000|Induction Period|Declined participation but followup done|0|||
33427701|NCT00406653|62805692|FG001|Induction Period|Declined participation but followup done|2|||
33427702|NCT00406653|62805693|FG002|Induction Period|Declined participation but followup done|1|||
33427703|NCT00406653|62805694|FG003|Induction Period|Declined participation but followup done|1|||
33427704|NCT00406653|62805695|FG004|Induction Period|Declined participation but followup done|0|||
33427705|NCT00406653|62805696|FG005|Induction Period|Declined participation but followup done|0|||
33427706|NCT00406653|62805697|FG006|Induction Period|Declined participation but followup done|0|||
33427707|NCT00406653|62805691|FG000|Induction Period|Given prohibited drug|0|||
33427708|NCT00406653|62805692|FG001|Induction Period|Given prohibited drug|1|||
33427709|NCT00406653|62805693|FG002|Induction Period|Given prohibited drug|2|||
33427710|NCT00406653|62805694|FG003|Induction Period|Given prohibited drug|0|||
33427711|NCT00406653|62805695|FG004|Induction Period|Given prohibited drug|0|||
33427712|NCT00406653|62805696|FG005|Induction Period|Given prohibited drug|0|||
33427713|NCT00406653|62805697|FG006|Induction Period|Given prohibited drug|0|||
33427714|NCT00406653|62805691|FG000|Induction Period|Incarcerated|0|||
33427715|NCT00406653|62805692|FG001|Induction Period|Incarcerated|0|||
33427716|NCT00406653|62805693|FG002|Induction Period|Incarcerated|1|||
33427717|NCT00406653|62805694|FG003|Induction Period|Incarcerated|0|||
33427718|NCT00406653|62805695|FG004|Induction Period|Incarcerated|0|||
33427719|NCT00406653|62805696|FG005|Induction Period|Incarcerated|0|||
33427720|NCT00406653|62805697|FG006|Induction Period|Incarcerated|0|||
33427721|NCT00406653|62805691|FG000|Induction Period|Patient relocated|0|||
33427722|NCT00406653|62805692|FG001|Induction Period|Patient relocated|0|||
33427723|NCT00406653|62805693|FG002|Induction Period|Patient relocated|1|||
33427724|NCT00406653|62805694|FG003|Induction Period|Patient relocated|0|||
33427725|NCT00406653|62805695|FG004|Induction Period|Patient relocated|0|||
33427726|NCT00406653|62805696|FG005|Induction Period|Patient relocated|0|||
33427727|NCT00406653|62805697|FG006|Induction Period|Patient relocated|0|||
33427728|NCT00406653|62805691|FG000|Maintenance Period|Adverse Event|0|||
33427729|NCT00406653|62805692|FG001|Maintenance Period|Adverse Event|0|||
33427730|NCT00406653|62805693|FG002|Maintenance Period|Adverse Event|0|||
33427731|NCT00406653|62805694|FG003|Maintenance Period|Adverse Event|0|||
33427732|NCT00406653|62805695|FG004|Maintenance Period|Adverse Event|1|||
33427733|NCT00406653|62805696|FG005|Maintenance Period|Adverse Event|1|||
33427734|NCT00406653|62805697|FG006|Maintenance Period|Adverse Event|0|||
33427735|NCT00406653|62805691|FG000|Maintenance Period|Lack of Efficacy|0|||
33427736|NCT00406653|62805692|FG001|Maintenance Period|Lack of Efficacy|0|||
33427737|NCT00406653|62805693|FG002|Maintenance Period|Lack of Efficacy|0|||
33427738|NCT00406653|62805694|FG003|Maintenance Period|Lack of Efficacy|0|||
33427739|NCT00406653|62805695|FG004|Maintenance Period|Lack of Efficacy|20|||
33427740|NCT00406653|62805696|FG005|Maintenance Period|Lack of Efficacy|26|||
33427741|NCT00406653|62805697|FG006|Maintenance Period|Lack of Efficacy|0|||
33427742|NCT00406653|62805691|FG000|Maintenance Period|Lost to Follow-up|0|||
33427743|NCT00406653|62805692|FG001|Maintenance Period|Lost to Follow-up|0|||
33427744|NCT00406653|62805693|FG002|Maintenance Period|Lost to Follow-up|0|||
33427745|NCT00406653|62805694|FG003|Maintenance Period|Lost to Follow-up|0|||
33427746|NCT00406653|62805695|FG004|Maintenance Period|Lost to Follow-up|2|||
33427747|NCT00406653|62805696|FG005|Maintenance Period|Lost to Follow-up|1|||
33427748|NCT00406653|62805697|FG006|Maintenance Period|Lost to Follow-up|0|||
33427749|NCT00406653|62805691|FG000|Maintenance Period|Withdrawal of Consent|0|||
33427750|NCT00406653|62805692|FG001|Maintenance Period|Withdrawal of Consent|0|||
33427751|NCT00406653|62805693|FG002|Maintenance Period|Withdrawal of Consent|0|||
33427752|NCT00406653|62805694|FG003|Maintenance Period|Withdrawal of Consent|0|||
33427753|NCT00406653|62805695|FG004|Maintenance Period|Withdrawal of Consent|2|||
33427754|NCT00406653|62805696|FG005|Maintenance Period|Withdrawal of Consent|0|||
33427755|NCT00406653|62805697|FG006|Maintenance Period|Withdrawal of Consent|0|||
33427756|NCT00406653|62805691|FG000|Maintenance Period|Pregnancy|0|||
33427757|NCT00406653|62805692|FG001|Maintenance Period|Pregnancy|0|||
33427758|NCT00406653|62805693|FG002|Maintenance Period|Pregnancy|0|||
33427759|NCT00406653|62805694|FG003|Maintenance Period|Pregnancy|0|||
33427760|NCT00406653|62805695|FG004|Maintenance Period|Pregnancy|0|||
33427761|NCT00406653|62805696|FG005|Maintenance Period|Pregnancy|1|||
33427762|NCT00406653|62805697|FG006|Maintenance Period|Pregnancy|0|||
33427763|NCT00406653|62805691|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
33427764|NCT00406653|62805692|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
33427765|NCT00406653|62805693|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
33427766|NCT00406653|62805694|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
33427767|NCT00406653|62805695|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
33427768|NCT00406653|62805696|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
33427769|NCT00406653|62805697|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
33427770|NCT00406653|62805691|FG000|Maintenance Period|Error in disease score evaluation|0|||
33427771|NCT00406653|62805692|FG001|Maintenance Period|Error in disease score evaluation|0|||
33427772|NCT00406653|62805693|FG002|Maintenance Period|Error in disease score evaluation|0|||
33427773|NCT00406653|62805694|FG003|Maintenance Period|Error in disease score evaluation|0|||
33427774|NCT00406653|62805695|FG004|Maintenance Period|Error in disease score evaluation|1|||
33427775|NCT00406653|62805696|FG005|Maintenance Period|Error in disease score evaluation|0|||
33427776|NCT00406653|62805697|FG006|Maintenance Period|Error in disease score evaluation|0|||
33427777|NCT00406653|62805691|FG000|Open-Label Period|Death|0|||
33427778|NCT00406653|62805692|FG001|Open-Label Period|Death|0|||
33427779|NCT00406653|62805693|FG002|Open-Label Period|Death|0|||
33427780|NCT00406653|62805694|FG003|Open-Label Period|Death|0|||
33427781|NCT00406653|62805695|FG004|Open-Label Period|Death|0|||
33427782|NCT00406653|62805696|FG005|Open-Label Period|Death|0|||
33427783|NCT00406653|62805697|FG006|Open-Label Period|Death|1|||
33427784|NCT00406653|62805691|FG000|Open-Label Period|Adverse Event|0|||
33427785|NCT00406653|62805692|FG001|Open-Label Period|Adverse Event|0|||
33427786|NCT00406653|62805693|FG002|Open-Label Period|Adverse Event|0|||
33427787|NCT00406653|62805694|FG003|Open-Label Period|Adverse Event|0|||
33427788|NCT00406653|62805695|FG004|Open-Label Period|Adverse Event|0|||
33427789|NCT00406653|62805696|FG005|Open-Label Period|Adverse Event|0|||
33427790|NCT00406653|62805697|FG006|Open-Label Period|Adverse Event|18|||
33427791|NCT00406653|62805691|FG000|Open-Label Period|Lack of Efficacy|0|||
33427792|NCT00406653|62805692|FG001|Open-Label Period|Lack of Efficacy|0|||
33427793|NCT00406653|62805693|FG002|Open-Label Period|Lack of Efficacy|0|||
33427794|NCT00406653|62805694|FG003|Open-Label Period|Lack of Efficacy|0|||
33427795|NCT00406653|62805695|FG004|Open-Label Period|Lack of Efficacy|0|||
33427796|NCT00406653|62805696|FG005|Open-Label Period|Lack of Efficacy|0|||
33427797|NCT00406653|62805697|FG006|Open-Label Period|Lack of Efficacy|160|||
33427798|NCT00406653|62805691|FG000|Open-Label Period|Lost to Follow-up|0|||
33427799|NCT00406653|62805692|FG001|Open-Label Period|Lost to Follow-up|0|||
33427800|NCT00406653|62805693|FG002|Open-Label Period|Lost to Follow-up|0|||
33427801|NCT00406653|62805694|FG003|Open-Label Period|Lost to Follow-up|0|||
33427802|NCT00406653|62805695|FG004|Open-Label Period|Lost to Follow-up|0|||
33427803|NCT00406653|62805696|FG005|Open-Label Period|Lost to Follow-up|0|||
33427804|NCT00406653|62805697|FG006|Open-Label Period|Lost to Follow-up|6|||
33427805|NCT00406653|62805691|FG000|Open-Label Period|Withdrawal of Consent|0|||
33427806|NCT00406653|62805692|FG001|Open-Label Period|Withdrawal of Consent|0|||
33427807|NCT00406653|62805693|FG002|Open-Label Period|Withdrawal of Consent|0|||
33605373|NCT01649375|63005070|FG002|Week 16 up to Week 260|Non-compliance|0|||
33605374|NCT01649375|63005071|FG003|Week 16 up to Week 260|Non-compliance|1|||
33605375|NCT01649375|63005072|FG004|Week 16 up to Week 260|Non-compliance|0|||
33427808|NCT00406653|62805694|FG003|Open-Label Period|Withdrawal of Consent|0|||
33427809|NCT00406653|62805695|FG004|Open-Label Period|Withdrawal of Consent|0|||
33427810|NCT00406653|62805696|FG005|Open-Label Period|Withdrawal of Consent|0|||
33427811|NCT00406653|62805697|FG006|Open-Label Period|Withdrawal of Consent|11|||
33427812|NCT00406653|62805691|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
33427813|NCT00406653|62805692|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
33427814|NCT00406653|62805693|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
33427815|NCT00406653|62805694|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
33427816|NCT00406653|62805695|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
33427817|NCT00406653|62805696|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
33427818|NCT00406653|62805697|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
33427819|NCT00406653|62805691|FG000|Open-Label Period|Pregnancy|0|||
33427820|NCT00406653|62805692|FG001|Open-Label Period|Pregnancy|0|||
33427821|NCT00406653|62805693|FG002|Open-Label Period|Pregnancy|0|||
33427822|NCT00406653|62805694|FG003|Open-Label Period|Pregnancy|0|||
33427823|NCT00406653|62805695|FG004|Open-Label Period|Pregnancy|0|||
33427824|NCT00406653|62805696|FG005|Open-Label Period|Pregnancy|0|||
33427825|NCT00406653|62805697|FG006|Open-Label Period|Pregnancy|2|||
33427826|NCT00406653|62805691|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
33427827|NCT00406653|62805692|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
33427828|NCT00406653|62805693|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
33427829|NCT00406653|62805694|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
33427830|NCT00406653|62805695|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
33427831|NCT00406653|62805696|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
33427832|NCT00406653|62805697|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
33427833|NCT00406653|62805691|FG000|Open-Label Period|Declined participation but followup done|0|||
33427834|NCT00406653|62805692|FG001|Open-Label Period|Declined participation but followup done|0|||
33427835|NCT00406653|62805693|FG002|Open-Label Period|Declined participation but followup done|0|||
33427836|NCT00406653|62805694|FG003|Open-Label Period|Declined participation but followup done|0|||
33427837|NCT00406653|62805695|FG004|Open-Label Period|Declined participation but followup done|0|||
33427838|NCT00406653|62805696|FG005|Open-Label Period|Declined participation but followup done|0|||
33427839|NCT00406653|62805697|FG006|Open-Label Period|Declined participation but followup done|8|||
33427840|NCT00406653|62805691|FG000|Open-Label Period|Discontinued by Sponsor|0|||
33427841|NCT00406653|62805692|FG001|Open-Label Period|Discontinued by Sponsor|0|||
33427842|NCT00406653|62805693|FG002|Open-Label Period|Discontinued by Sponsor|0|||
33427843|NCT00406653|62805694|FG003|Open-Label Period|Discontinued by Sponsor|0|||
33427844|NCT00406653|62805695|FG004|Open-Label Period|Discontinued by Sponsor|0|||
33427845|NCT00406653|62805696|FG005|Open-Label Period|Discontinued by Sponsor|0|||
33427846|NCT00406653|62805697|FG006|Open-Label Period|Discontinued by Sponsor|1|||
33427847|NCT00406653|62805691|FG000|Open-Label Period|Refused followup|0|||
33427848|NCT00406653|62805692|FG001|Open-Label Period|Refused followup|0|||
33427849|NCT00406653|62805693|FG002|Open-Label Period|Refused followup|0|||
33427850|NCT00406653|62805694|FG003|Open-Label Period|Refused followup|0|||
33427851|NCT00406653|62805695|FG004|Open-Label Period|Refused followup|0|||
33427852|NCT00406653|62805696|FG005|Open-Label Period|Refused followup|0|||
33427853|NCT00406653|62805697|FG006|Open-Label Period|Refused followup|1|||
33427854|NCT00547157|62805719|FG000|Overall Study|Other|1|||
33427855|NCT00547157|62805720|FG001|Overall Study|Other|0|||
33427856|NCT00547157|62805719|FG000|Overall Study|Death|38|||
33427857|NCT00547157|62805720|FG001|Overall Study|Death|18|||
33427858|NCT00547157|62805719|FG000|Overall Study|Withdrawal by Subject|3|||
33427859|NCT00547157|62805720|FG001|Overall Study|Withdrawal by Subject|1|||
33427860|NCT00547157|62805719|FG000|Overall Study|Administrative decision|3|||
33427861|NCT00547157|62805720|FG001|Overall Study|Administrative decision|2|||
33427862|NCT00547157|62805719|FG000|Overall Study|Lost to Follow-up|4|||
33427863|NCT00547157|62805720|FG001|Overall Study|Lost to Follow-up|2|||
33427864|NCT00384033|62805730|FG000|Overall Study|Adverse Event|10|||
33427865|NCT00384033|62805731|FG001|Overall Study|Adverse Event|8|||
33427866|NCT00384033|62805732|FG002|Overall Study|Adverse Event|11|||
33427867|NCT00384033|62805733|FG003|Overall Study|Adverse Event|20|||
33427868|NCT00384033|62805730|FG000|Overall Study|Failed to return|1|||
33427869|NCT00384033|62805731|FG001|Overall Study|Failed to return|3|||
33427870|NCT00384033|62805732|FG002|Overall Study|Failed to return|2|||
33427871|NCT00384033|62805733|FG003|Overall Study|Failed to return|2|||
33427872|NCT00384033|62805730|FG000|Overall Study|Physician Decision|1|||
33427873|NCT00384033|62805731|FG001|Overall Study|Physician Decision|0|||
33427874|NCT00384033|62805732|FG002|Overall Study|Physician Decision|0|||
33427875|NCT00384033|62805733|FG003|Overall Study|Physician Decision|0|||
33427876|NCT00384033|62805730|FG000|Overall Study|Lost to Follow-up|6|||
33427877|NCT00384033|62805731|FG001|Overall Study|Lost to Follow-up|12|||
33427878|NCT00384033|62805732|FG002|Overall Study|Lost to Follow-up|7|||
33427879|NCT00384033|62805733|FG003|Overall Study|Lost to Follow-up|7|||
33427880|NCT00384033|62805730|FG000|Overall Study|Other|2|||
33427881|NCT00384033|62805731|FG001|Overall Study|Other|0|||
33427882|NCT00384033|62805732|FG002|Overall Study|Other|0|||
33427883|NCT00384033|62805733|FG003|Overall Study|Other|0|||
33427884|NCT00384033|62805730|FG000|Overall Study|Protocol Violation|5|||
33427885|NCT00384033|62805731|FG001|Overall Study|Protocol Violation|0|||
33427886|NCT00384033|62805732|FG002|Overall Study|Protocol Violation|5|||
33427887|NCT00384033|62805733|FG003|Overall Study|Protocol Violation|6|||
33427888|NCT00384033|62805730|FG000|Overall Study|Withdrawal by Subject|6|||
33427889|NCT00384033|62805731|FG001|Overall Study|Withdrawal by Subject|2|||
33427890|NCT00384033|62805732|FG002|Overall Study|Withdrawal by Subject|5|||
33427891|NCT00384033|62805733|FG003|Overall Study|Withdrawal by Subject|2|||
33427892|NCT00384033|62805730|FG000|Overall Study|Lack of Efficacy|7|||
33427893|NCT00384033|62805731|FG001|Overall Study|Lack of Efficacy|3|||
33427894|NCT00384033|62805732|FG002|Overall Study|Lack of Efficacy|3|||
33427895|NCT00384033|62805733|FG003|Overall Study|Lack of Efficacy|1|||
33427896|NCT00384033|62805730|FG000|Overall Study|Randomized but not treated|3|||
33427897|NCT00384033|62805731|FG001|Overall Study|Randomized but not treated|7|||
33427898|NCT00384033|62805732|FG002|Overall Study|Randomized but not treated|10|||
33427899|NCT00384033|62805733|FG003|Overall Study|Randomized but not treated|2|||
33427900|NCT00546377|62805743|FG000|Overall Study|Deemed ineligible|1|||
33427901|NCT00546377|62805743|FG000|Overall Study|Adverse Event|6|||
33427902|NCT00545753|62805750|FG000|Overall Study|Withdrawal by Subject|0|||
33427903|NCT00545753|62805751|FG001|Overall Study|Withdrawal by Subject|1|||
33427904|NCT00545753|62805752|FG002|Overall Study|Withdrawal by Subject|10|||
33427905|NCT00545753|62805750|FG000|Overall Study|Lost to Follow-up|13|||
33427906|NCT00545753|62805751|FG001|Overall Study|Lost to Follow-up|3|||
33427907|NCT00545753|62805752|FG002|Overall Study|Lost to Follow-up|12|||
33427908|NCT00545753|62805750|FG000|Overall Study|Protocol Violation|3|||
33427909|NCT00545753|62805751|FG001|Overall Study|Protocol Violation|1|||
33427910|NCT00545753|62805752|FG002|Overall Study|Protocol Violation|4|||
33427911|NCT00406419|62805764|FG000|Overall Study|Death|3|||
33427912|NCT00406419|62805765|FG001|Overall Study|Death|1|||
33427913|NCT00406419|62805766|FG002|Overall Study|Death|4|||
33427914|NCT00406419|62805764|FG000|Overall Study|Protocol Violation|6|||
33427915|NCT00406419|62805765|FG001|Overall Study|Protocol Violation|2|||
33427916|NCT00406419|62805766|FG002|Overall Study|Protocol Violation|5|||
33427917|NCT00406419|62805764|FG000|Overall Study|Study Terminated by Sponsor|260|||
33427918|NCT00406419|62805765|FG001|Overall Study|Study Terminated by Sponsor|288|||
33427919|NCT00406419|62805766|FG002|Overall Study|Study Terminated by Sponsor|282|||
33427920|NCT00406419|62805764|FG000|Overall Study|Withdrawal by Subject|17|||
33427921|NCT00406419|62805765|FG001|Overall Study|Withdrawal by Subject|24|||
33427922|NCT00406419|62805766|FG002|Overall Study|Withdrawal by Subject|26|||
33427923|NCT00406419|62805764|FG000|Overall Study|Lack of Efficacy|12|||
33427924|NCT00406419|62805765|FG001|Overall Study|Lack of Efficacy|1|||
33427925|NCT00406419|62805766|FG002|Overall Study|Lack of Efficacy|6|||
33427926|NCT00406419|62805764|FG000|Overall Study|Non-Compliance with Study Drug|5|||
33427927|NCT00406419|62805765|FG001|Overall Study|Non-Compliance with Study Drug|6|||
33427928|NCT00406419|62805766|FG002|Overall Study|Non-Compliance with Study Drug|3|||
33427929|NCT00406419|62805764|FG000|Overall Study|Adverse Event|10|||
33427930|NCT00406419|62805765|FG001|Overall Study|Adverse Event|12|||
33427931|NCT00406419|62805766|FG002|Overall Study|Adverse Event|16|||
33427932|NCT00406419|62805764|FG000|Overall Study|Lost to Follow-up|11|||
33427933|NCT00406419|62805765|FG001|Overall Study|Lost to Follow-up|10|||
33427934|NCT00406419|62805766|FG002|Overall Study|Lost to Follow-up|5|||
33427935|NCT00325468|62805779|FG000|Overall Study|Adverse Event|1|||
33427936|NCT00325468|62805780|FG001|Overall Study|Adverse Event|1|||
33427937|NCT00325468|62805781|FG002|Overall Study|Adverse Event|0|||
33427938|NCT00325468|62805782|FG003|Overall Study|Adverse Event|5|||
33427939|NCT00325468|62805783|FG004|Overall Study|Adverse Event|1|||
33427940|NCT00325468|62805779|FG000|Overall Study|Death|2|||
33427941|NCT00325468|62805780|FG001|Overall Study|Death|0|||
33427942|NCT00325468|62805781|FG002|Overall Study|Death|2|||
33427943|NCT00325468|62805782|FG003|Overall Study|Death|4|||
33427944|NCT00325468|62805783|FG004|Overall Study|Death|0|||
33427945|NCT00325468|62805779|FG000|Overall Study|Lost to Follow-up|0|||
33427946|NCT00325468|62805780|FG001|Overall Study|Lost to Follow-up|0|||
33427947|NCT00325468|62805781|FG002|Overall Study|Lost to Follow-up|1|||
33427948|NCT00325468|62805782|FG003|Overall Study|Lost to Follow-up|2|||
33427949|NCT00325468|62805783|FG004|Overall Study|Lost to Follow-up|2|||
33427950|NCT00325468|62805779|FG000|Overall Study|Physician Decision|1|||
33427951|NCT00325468|62805780|FG001|Overall Study|Physician Decision|1|||
33427952|NCT00325468|62805781|FG002|Overall Study|Physician Decision|0|||
33427953|NCT00325468|62805782|FG003|Overall Study|Physician Decision|1|||
33427954|NCT00325468|62805783|FG004|Overall Study|Physician Decision|0|||
33427955|NCT00325468|62805779|FG000|Overall Study|Withdrawal by Subject|3|||
33427956|NCT00325468|62805780|FG001|Overall Study|Withdrawal by Subject|1|||
33427957|NCT00325468|62805781|FG002|Overall Study|Withdrawal by Subject|0|||
33427958|NCT00325468|62805782|FG003|Overall Study|Withdrawal by Subject|14|||
33427959|NCT00325468|62805783|FG004|Overall Study|Withdrawal by Subject|4|||
33427960|NCT00325468|62805779|FG000|Overall Study|site closure etc|4|||
33427961|NCT00325468|62805780|FG001|Overall Study|site closure etc|2|||
33427962|NCT00325468|62805781|FG002|Overall Study|site closure etc|1|||
33427963|NCT00325468|62805782|FG003|Overall Study|site closure etc|8|||
33427964|NCT00325468|62805783|FG004|Overall Study|site closure etc|1|||
33427965|NCT03833661|62805796|FG000|Overall Study|Treatment ongoing|9|||
33427966|NCT00311584|62805802|FG000|Overall Study|Death|1|||
33427967|NCT00311584|62805803|FG001|Overall Study|Death|0|||
33427968|NCT00311584|62805802|FG000|Overall Study|Lack of Efficacy|12|||
33427969|NCT00311584|62805803|FG001|Overall Study|Lack of Efficacy|15|||
33427970|NCT00311584|62805802|FG000|Overall Study|Physician Decision|4|||
33427971|NCT00311584|62805803|FG001|Overall Study|Physician Decision|5|||
33427972|NCT00311584|62805802|FG000|Overall Study|Withdrawal by Subject|1|||
33427973|NCT00311584|62805803|FG001|Overall Study|Withdrawal by Subject|1|||
33427974|NCT00311584|62805802|FG000|Overall Study|ineligible|2|||
33427975|NCT00311584|62805803|FG001|Overall Study|ineligible|2|||
33427976|NCT00383331|62805811|FG000|Overall Study|Protocol Violation|0|||
33427977|NCT00383331|62805812|FG001|Overall Study|Protocol Violation|1|||
33427978|NCT03934541|62805822|FG000|Overall Study|Study Terminated by Sponsor|0|||
33427979|NCT03934541|62805823|FG001|Overall Study|Study Terminated by Sponsor|1|||
33427980|NCT03934541|62805824|FG002|Overall Study|Study Terminated by Sponsor|0|||
33427981|NCT03934541|62805825|FG003|Overall Study|Study Terminated by Sponsor|0|||
33427982|NCT00325234|62805837|FG000|Overall Study|Adverse Event|10|||
33427983|NCT00325234|62805838|FG001|Overall Study|Adverse Event|7|||
33427984|NCT00325234|62805837|FG000|Overall Study|Death due to Study Disease|1|||
33427985|NCT00325234|62805838|FG001|Overall Study|Death due to Study Disease|0|||
33427986|NCT00325234|62805837|FG000|Overall Study|Entry Criteria Not Met|1|||
33427987|NCT00325234|62805838|FG001|Overall Study|Entry Criteria Not Met|2|||
33427988|NCT00325234|62805837|FG000|Overall Study|Subject Decision|6|||
33427989|NCT00325234|62805838|FG001|Overall Study|Subject Decision|8|||
33427990|NCT00325234|62805837|FG000|Overall Study|Physician Decision|17|||
33427991|NCT00325234|62805838|FG001|Overall Study|Physician Decision|12|||
33427992|NCT00325234|62805837|FG000|Overall Study|Progressive Disease|34|||
33427993|NCT00325234|62805838|FG001|Overall Study|Progressive Disease|37|||
33427994|NCT00366249|62805848|FG000|Overall Study|Adverse Event|53|||
33427995|NCT00366249|62805849|FG001|Overall Study|Adverse Event|28|||
33427996|NCT00366249|62805848|FG000|Overall Study|Death|0|||
33427997|NCT00366249|62805849|FG001|Overall Study|Death|1|||
33427998|NCT00366249|62805848|FG000|Overall Study|Physician Decision|5|||
33427999|NCT00366249|62805849|FG001|Overall Study|Physician Decision|2|||
33428000|NCT00366249|62805848|FG000|Overall Study|Lost to Follow-up|2|||
33428001|NCT00366249|62805849|FG001|Overall Study|Lost to Follow-up|0|||
33428002|NCT00366249|62805848|FG000|Overall Study|Protocol Violation|1|||
33428003|NCT00366249|62805849|FG001|Overall Study|Protocol Violation|2|||
33428004|NCT00366249|62805848|FG000|Overall Study|Withdrawal by Subject|18|||
33428005|NCT00366249|62805849|FG001|Overall Study|Withdrawal by Subject|4|||
33428006|NCT00366249|62805848|FG000|Overall Study|Lack of Efficacy|21|||
33428007|NCT00366249|62805849|FG001|Overall Study|Lack of Efficacy|21|||
33428008|NCT00366249|62805848|FG000|Overall Study|Most due to osteomylitis status|31|||
33428009|NCT00366249|62805849|FG001|Overall Study|Most due to osteomylitis status|20|||
33428010|NCT00325156|62805855|FG000|Overall Study|Protocol Violation|8|||
33428011|NCT00325156|62805855|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
33428012|NCT00325156|62805855|FG000|Overall Study|Migrated/moved from study area|12|||
33428013|NCT00325156|62805855|FG000|Overall Study|Adverse event, non-fatal|3|||
33428014|NCT00325156|62805855|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
33428015|NCT00325156|62805855|FG000|Overall Study|Other|1|||
33428016|NCT00325156|62805855|FG000|Overall Study|Withdrawal by Subject|31|||
33428017|NCT03927911|62805865|FG000|Overall Study|problems with eDiary|0|||
33428018|NCT03927911|62805866|FG001|Overall Study|problems with eDiary|1|||
33428019|NCT03927911|62805867|FG002|Overall Study|problems with eDiary|0|||
33428020|NCT03927911|62805868|FG003|Overall Study|problems with eDiary|1|||
33428021|NCT03927911|62805869|FG004|Overall Study|problems with eDiary|0|||
33428022|NCT03927911|62805870|FG005|Overall Study|problems with eDiary|4|||
33428023|NCT03927911|62805865|FG000|Overall Study|Adverse Event|0|||
33428024|NCT03927911|62805866|FG001|Overall Study|Adverse Event|0|||
33428025|NCT03927911|62805867|FG002|Overall Study|Adverse Event|0|||
33428026|NCT03927911|62805868|FG003|Overall Study|Adverse Event|0|||
33428027|NCT03927911|62805869|FG004|Overall Study|Adverse Event|0|||
33428028|NCT03927911|62805870|FG005|Overall Study|Adverse Event|1|||
33428029|NCT03927911|62805865|FG000|Overall Study|not treated -study terminated by sponsor|0|||
33428030|NCT03927911|62805866|FG001|Overall Study|not treated -study terminated by sponsor|1|||
33428031|NCT03927911|62805867|FG002|Overall Study|not treated -study terminated by sponsor|0|||
33428032|NCT03927911|62805868|FG003|Overall Study|not treated -study terminated by sponsor|0|||
33428033|NCT03927911|62805869|FG004|Overall Study|not treated -study terminated by sponsor|0|||
33428034|NCT03927911|62805870|FG005|Overall Study|not treated -study terminated by sponsor|0|||
33428035|NCT03927911|62805865|FG000|Overall Study|Surgery cancelled|0|||
33428036|NCT03927911|62805866|FG001|Overall Study|Surgery cancelled|0|||
33428037|NCT03927911|62805867|FG002|Overall Study|Surgery cancelled|0|||
33428038|NCT03927911|62805868|FG003|Overall Study|Surgery cancelled|1|||
33428039|NCT03927911|62805869|FG004|Overall Study|Surgery cancelled|0|||
33428040|NCT03927911|62805870|FG005|Overall Study|Surgery cancelled|1|||
33428041|NCT03927911|62805865|FG000|Overall Study|Protocol Violation|0|||
33428042|NCT03927911|62805866|FG001|Overall Study|Protocol Violation|0|||
33428043|NCT03927911|62805867|FG002|Overall Study|Protocol Violation|0|||
33428044|NCT03927911|62805868|FG003|Overall Study|Protocol Violation|0|||
33428045|NCT03927911|62805869|FG004|Overall Study|Protocol Violation|0|||
33428046|NCT03927911|62805870|FG005|Overall Study|Protocol Violation|1|||
33428047|NCT00383019|62805886|FG000|Overall Study|Adverse Event|5|||
33428048|NCT00383019|62805887|FG001|Overall Study|Adverse Event|1|||
33428049|NCT00383019|62805886|FG000|Overall Study|Withdrawal by Subject|0|||
33428050|NCT00383019|62805887|FG001|Overall Study|Withdrawal by Subject|1|||
33428051|NCT00310804|62805895|FG000|Overall Study|Lost to Follow-up|2|||
33428052|NCT00310804|62805896|FG001|Overall Study|Lost to Follow-up|0|||
33428053|NCT00310804|62805895|FG000|Overall Study|Withdrawal by Subject|3|||
33428054|NCT00310804|62805896|FG001|Overall Study|Withdrawal by Subject|0|||
33428055|NCT03826186|62805918|FG000|Overall Study|Protocol Violation|2|||
33428056|NCT03826186|62805919|FG001|Overall Study|Protocol Violation|0|||
33428057|NCT03826186|62805918|FG000|Overall Study|Withdrawal by Subject|1|||
33428058|NCT03826186|62805919|FG001|Overall Study|Withdrawal by Subject|0|||
33428059|NCT00382863|62805927|FG000|Overall Study|Death|9|||
33428060|NCT00382863|62805928|FG001|Overall Study|Death|9|||
33428061|NCT00382863|62805927|FG000|Overall Study|Lost to Follow-up|1|||
33428062|NCT00382863|62805928|FG001|Overall Study|Lost to Follow-up|2|||
33428063|NCT00382863|62805927|FG000|Overall Study|Withdrawal by Subject|5|||
33428064|NCT00382863|62805928|FG001|Overall Study|Withdrawal by Subject|25|||
33428065|NCT03933449|62805936|FG000|Overall Study|Adverse Event|6|||
33428066|NCT03933449|62805937|FG001|Overall Study|Adverse Event|4|||
33428067|NCT03933449|62805936|FG000|Overall Study|Death|55|||
33428068|NCT03933449|62805937|FG001|Overall Study|Death|57|||
33428069|NCT03933449|62805936|FG000|Overall Study|Sponsor Decision|1|||
33428070|NCT03933449|62805937|FG001|Overall Study|Sponsor Decision|0|||
33428071|NCT00290758|62805960|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
33428072|NCT00290758|62805961|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
33428073|NCT00290758|62805960|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
33428074|NCT00290758|62805961|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
33428075|NCT00290758|62805960|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
33428076|NCT00290758|62805961|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
33428077|NCT00290758|62805960|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
33428078|NCT00290758|62805961|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
33428079|NCT00290758|62805960|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
33428080|NCT00290758|62805961|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
33428081|NCT00290758|62805960|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
33428082|NCT00290758|62805961|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
33428083|NCT00290758|62805960|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
33428084|NCT00290758|62805961|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
33428085|NCT00290758|62805960|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
33428086|NCT00290758|62805961|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
33428087|NCT00372567|62805974|FG000|Phase 3 Study|Adverse Event|5|||
33428088|NCT00372567|62805975|FG001|Phase 3 Study|Adverse Event|1|||
33428089|NCT00372567|62805976|FG002|Phase 3 Study|Adverse Event|1|||
33428090|NCT00372567|62805974|FG000|Phase 3 Study|Death|1|||
33428091|NCT00372567|62805975|FG001|Phase 3 Study|Death|1|||
33428092|NCT00372567|62805976|FG002|Phase 3 Study|Death|0|||
33428093|NCT00372567|62805974|FG000|Phase 3 Study|Protocol Violation|0|||
33428094|NCT00372567|62805975|FG001|Phase 3 Study|Protocol Violation|0|||
33428095|NCT00372567|62805976|FG002|Phase 3 Study|Protocol Violation|1|||
33428096|NCT00372567|62805974|FG000|Phase 3 Study|Objective progression or relapse|10|||
33428097|NCT00372567|62805975|FG001|Phase 3 Study|Objective progression or relapse|13|||
33428098|NCT00372567|62805976|FG002|Phase 3 Study|Objective progression or relapse|4|||
33428099|NCT00372567|62805974|FG000|Phase 3 Study|Global deterioration of health status|0|||
33428100|NCT00372567|62805975|FG001|Phase 3 Study|Global deterioration of health status|1|||
33428101|NCT00372567|62805976|FG002|Phase 3 Study|Global deterioration of health status|0|||
33428102|NCT00372567|62805974|FG000|Phase 3 Study|Other|2|||
33428103|NCT00372567|62805975|FG001|Phase 3 Study|Other|2|||
33428104|NCT00372567|62805976|FG002|Phase 3 Study|Other|1|||
33428105|NCT00372567|62805974|FG000|Phase 3 Study|study terminated by sponsor|13|||
33428106|NCT00372567|62805975|FG001|Phase 3 Study|study terminated by sponsor|8|||
33428107|NCT00372567|62805976|FG002|Phase 3 Study|study terminated by sponsor|5|||
33428108|NCT00365547|62805984|FG000|Overall Study|Insurance did not cover Avastin|1|||
33428109|NCT00365547|62805984|FG000|Overall Study|Screen failure|1|||
33428110|NCT00365547|62805984|FG000|Overall Study|Withdrawal by Subject|1|||
33428111|NCT00545441|62805993|FG000|Overall Study|Fistula draining at 6 months|2|||
33428112|NCT00545441|62805994|FG001|Overall Study|Fistula draining at 6 months|4|||
33428113|NCT00545441|62805993|FG000|Overall Study|Lost to Follow-up|9|||
33428114|NCT00545441|62805994|FG001|Overall Study|Lost to Follow-up|5|||
33428115|NCT00545441|62805993|FG000|Overall Study|Technical failure|0|||
33428116|NCT00545441|62805994|FG001|Overall Study|Technical failure|1|||
33428117|NCT00545441|62805993|FG000|Overall Study|Withdrawal by Subject|1|||
33428118|NCT00545441|62805994|FG001|Overall Study|Withdrawal by Subject|1|||
33428119|NCT00545441|62805993|FG000|Overall Study|Persistence or recurrence of fistula|5|||
33428120|NCT00545441|62805994|FG001|Overall Study|Persistence or recurrence of fistula|2|||
33428121|NCT00545441|62805993|FG000|Overall Study|Patients were not treated|1|||
33428122|NCT00545441|62805994|FG001|Overall Study|Patients were not treated|3|||
33428123|NCT00294658|62806002|FG000|Overall Study|Death|0|||
33428124|NCT00294658|62806003|FG001|Overall Study|Death|1|||
33428125|NCT00294658|62806002|FG000|Overall Study|Lost to Follow-up|4|||
33428126|NCT00294658|62806003|FG001|Overall Study|Lost to Follow-up|0|||
33428127|NCT00294658|62806002|FG000|Overall Study|Physician Decision|1|||
33428128|NCT00294658|62806003|FG001|Overall Study|Physician Decision|2|||
33428129|NCT00294658|62806002|FG000|Overall Study|Pregnancy|0|||
33428130|NCT00294658|62806003|FG001|Overall Study|Pregnancy|1|||
33428131|NCT00294658|62806002|FG000|Overall Study|Withdrawal by Subject|0|||
33428132|NCT00294658|62806003|FG001|Overall Study|Withdrawal by Subject|4|||
33428133|NCT00294658|62806002|FG000|Overall Study|Found to have invasive thymoma|1|||
33428134|NCT00294658|62806003|FG001|Overall Study|Found to have invasive thymoma|0|||
33428135|NCT00294658|62806002|FG000|Overall Study|Patient and family were not satisfied|0|||
33428136|NCT00294658|62806003|FG001|Overall Study|Patient and family were not satisfied|1|||
33428137|NCT03923933|62806011|FG000|Overall Study|Lost to Follow-up|1|||
33428138|NCT03923933|62806012|FG001|Overall Study|Lost to Follow-up|0|||
33428139|NCT03923933|62806011|FG000|Overall Study|Withdrawal by Subject|0|||
33428140|NCT03923933|62806012|FG001|Overall Study|Withdrawal by Subject|1|||
33428141|NCT00372489|62806018|FG000|Overall Study|Adverse Event|18|||
33428142|NCT00372489|62806018|FG000|Overall Study|Lack of Efficacy|1|||
33428143|NCT00372489|62806018|FG000|Overall Study|Lost to Follow-up|3|||
33428144|NCT00372489|62806018|FG000|Overall Study|Physician Decision|3|||
33428145|NCT00372489|62806018|FG000|Overall Study|Withdrawal by Subject|5|||
33428146|NCT00372489|62806018|FG000|Overall Study|Patient Relocation|2|||
33428147|NCT00372489|62806018|FG000|Overall Study|Renal transplant|6|||
33428148|NCT00372489|62806018|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
33428149|NCT00372411|62806025|FG000|Overall Study|Withdrawal by Subject|3|||
33428150|NCT00372411|62806026|FG001|Overall Study|Withdrawal by Subject|4|||
33428151|NCT00372411|62806027|FG002|Overall Study|Withdrawal by Subject|1|||
33428152|NCT00372411|62806025|FG000|Overall Study|Death|0|||
33428153|NCT00372411|62806026|FG001|Overall Study|Death|2|||
33428154|NCT00372411|62806027|FG002|Overall Study|Death|1|||
33428155|NCT00372411|62806025|FG000|Overall Study|Lost to Follow-up|1|||
33428156|NCT00372411|62806026|FG001|Overall Study|Lost to Follow-up|1|||
33428157|NCT00372411|62806027|FG002|Overall Study|Lost to Follow-up|1|||
33428158|NCT00372411|62806025|FG000|Overall Study|Adverse Event|1|||
33428159|NCT00372411|62806026|FG001|Overall Study|Adverse Event|1|||
33428160|NCT00372411|62806027|FG002|Overall Study|Adverse Event|0|||
33428161|NCT00372255|62806037|FG000|Overall Study|Withdrawn for other reasons|2|||
33428162|NCT00372255|62806038|FG001|Overall Study|Withdrawn for other reasons|1|||
33428163|NCT00274456|62806049|FG000|Overall Study|Still on treatment|2|||
33428164|NCT00274456|62806050|FG001|Overall Study|Still on treatment|3|||
33428165|NCT00274456|62806051|FG002|Overall Study|Still on treatment|5|||
33428166|NCT00274456|62806052|FG003|Overall Study|Still on treatment|1|||
33428167|NCT00274456|62806049|FG000|Overall Study|Unacceptable toxicity|10|||
33428168|NCT00274456|62806050|FG001|Overall Study|Unacceptable toxicity|5|||
33428169|NCT00274456|62806051|FG002|Overall Study|Unacceptable toxicity|12|||
33428170|NCT00274456|62806052|FG003|Overall Study|Unacceptable toxicity|16|||
33428171|NCT00274456|62806049|FG000|Overall Study|Adverse Event|0|||
33428172|NCT00274456|62806050|FG001|Overall Study|Adverse Event|1|||
33428173|NCT00274456|62806051|FG002|Overall Study|Adverse Event|2|||
33428174|NCT00274456|62806052|FG003|Overall Study|Adverse Event|2|||
33428175|NCT00274456|62806049|FG000|Overall Study|Physician Decision|7|||
33428176|NCT00274456|62806050|FG001|Overall Study|Physician Decision|5|||
33428177|NCT00274456|62806051|FG002|Overall Study|Physician Decision|6|||
33428178|NCT00274456|62806052|FG003|Overall Study|Physician Decision|13|||
33428179|NCT00274456|62806049|FG000|Overall Study|Lost to Follow-up|0|||
33428180|NCT00274456|62806050|FG001|Overall Study|Lost to Follow-up|0|||
33428181|NCT00274456|62806051|FG002|Overall Study|Lost to Follow-up|1|||
33428182|NCT00274456|62806052|FG003|Overall Study|Lost to Follow-up|0|||
33428183|NCT00274456|62806049|FG000|Overall Study|Withdrawal by Subject|18|||
33428184|NCT00274456|62806050|FG001|Overall Study|Withdrawal by Subject|13|||
33428185|NCT00274456|62806051|FG002|Overall Study|Withdrawal by Subject|9|||
33428186|NCT00274456|62806052|FG003|Overall Study|Withdrawal by Subject|13|||
33428187|NCT00364923|62806062|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
33428188|NCT00364923|62806062|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
33428189|NCT00381849|62806068|FG000|Wash Out|Withdrawal by Subject|0|||
33428190|NCT00381849|62806069|FG001|Wash Out|Withdrawal by Subject|1|||
33428191|NCT00273052|62806077|FG000|Overall Study|Withdrawal by Subject|16|||
33428192|NCT00273052|62806078|FG001|Overall Study|Withdrawal by Subject|19|||
33428193|NCT00273052|62806077|FG000|Overall Study|Adverse Event|21|||
33428194|NCT00273052|62806078|FG001|Overall Study|Adverse Event|19|||
33428195|NCT00273052|62806077|FG000|Overall Study|Protocol Violation|14|||
33428196|NCT00273052|62806078|FG001|Overall Study|Protocol Violation|18|||
33428197|NCT00273052|62806077|FG000|Overall Study|Lost to Follow-up|7|||
33428198|NCT00273052|62806078|FG001|Overall Study|Lost to Follow-up|25|||
33428199|NCT00273052|62806077|FG000|Overall Study|Lack of Efficacy|6|||
33428200|NCT00273052|62806078|FG001|Overall Study|Lack of Efficacy|4|||
33428201|NCT00273052|62806077|FG000|Overall Study|Non-Compliance|3|||
33428202|NCT00273052|62806078|FG001|Overall Study|Non-Compliance|1|||
33428203|NCT00273052|62806077|FG000|Overall Study|Other|2|||
33428204|NCT00273052|62806078|FG001|Overall Study|Other|0|||
33428205|NCT00273052|62806077|FG000|Overall Study|Worsening serum lipid levels|0|||
33428206|NCT00273052|62806078|FG001|Overall Study|Worsening serum lipid levels|2|||
33428207|NCT00290290|62806086|FG000|Overall Study|Death|3|||
33428208|NCT00290290|62806087|FG001|Overall Study|Death|4|||
33428209|NCT00290290|62806086|FG000|Overall Study|Withdrawal by Subject|2|||
33428210|NCT00290290|62806087|FG001|Overall Study|Withdrawal by Subject|2|||
33428211|NCT00290290|62806086|FG000|Overall Study|Underwent clean surgical procedure|13|||
33428212|NCT00290290|62806087|FG001|Overall Study|Underwent clean surgical procedure|12|||
33428213|NCT00272038|62806093|FG000|Overall Study|withdrew before they received 2 cycles|7|||
33428214|NCT00271024|62806102|FG000|Overall Study|Lost Interest|3|||
33428215|NCT00271024|62806103|FG001|Overall Study|Lost Interest|4|||
33428216|NCT00271024|62806104|FG002|Overall Study|Lost Interest|2|||
33428217|NCT00271024|62806105|FG003|Overall Study|Lost Interest|3|||
33428218|NCT00271024|62806102|FG000|Overall Study|Unknown/Unspecified|11|||
33428219|NCT00271024|62806103|FG001|Overall Study|Unknown/Unspecified|11|||
33428220|NCT00271024|62806104|FG002|Overall Study|Unknown/Unspecified|8|||
33428221|NCT00271024|62806105|FG003|Overall Study|Unknown/Unspecified|4|||
33428222|NCT00271024|62806102|FG000|Overall Study|Protocol Violation|1|||
33428223|NCT00271024|62806103|FG001|Overall Study|Protocol Violation|6|||
33428224|NCT00271024|62806104|FG002|Overall Study|Protocol Violation|5|||
33428225|NCT00271024|62806105|FG003|Overall Study|Protocol Violation|11|||
33428226|NCT00271024|62806102|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
33428227|NCT00271024|62806103|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
33428228|NCT00271024|62806104|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
33428229|NCT00271024|62806105|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
33428230|NCT00271024|62806102|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
33428231|NCT00271024|62806103|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
33428232|NCT00271024|62806104|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
33428233|NCT00271024|62806105|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
33428234|NCT00381693|62806115|FG000|Overall Study|Death|1|||
33428235|NCT00381693|62806115|FG000|Overall Study|Adverse Event|4|||
33428236|NCT00381693|62806115|FG000|Overall Study|Patient Choice|1|||
33428237|NCT00381693|62806115|FG000|Overall Study|Progression|2|||
33428238|NCT00545363|62806121|FG000|Overall Study|Adverse Event|6|||
33428239|NCT00545363|62806122|FG001|Overall Study|Adverse Event|7|||
33428240|NCT00545363|62806121|FG000|Overall Study|Withdrawal by Subject|6|||
33428241|NCT00545363|62806122|FG001|Overall Study|Withdrawal by Subject|5|||
33428242|NCT00545363|62806121|FG000|Overall Study|Non-compliance|3|||
33428243|NCT00545363|62806122|FG001|Overall Study|Non-compliance|1|||
33428244|NCT00545363|62806121|FG000|Overall Study|Did not meet entry criteria|1|||
33428245|NCT00545363|62806122|FG001|Overall Study|Did not meet entry criteria|1|||
33428246|NCT00545363|62806121|FG000|Overall Study|Lost to Follow-up|2|||
33428247|NCT00545363|62806122|FG001|Overall Study|Lost to Follow-up|0|||
33428248|NCT00545363|62806121|FG000|Overall Study|Other|1|||
33428249|NCT00545363|62806122|FG001|Overall Study|Other|1|||
33428250|NCT00457392|62806130|FG000|Overall Study|Objective Progression or Relapse|229|||
33428251|NCT00457392|62806131|FG001|Overall Study|Objective Progression or Relapse|296|||
33428252|NCT00457392|62806130|FG000|Overall Study|Death|106|||
33428253|NCT00457392|62806131|FG001|Overall Study|Death|106|||
33428254|NCT00457392|62806130|FG000|Overall Study|Adverse Event|84|||
33428255|NCT00457392|62806131|FG001|Overall Study|Adverse Event|41|||
33428256|NCT00457392|62806130|FG000|Overall Study|Global Deterioration of Health Status|22|||
33428257|NCT00457392|62806131|FG001|Overall Study|Global Deterioration of Health Status|8|||
33428258|NCT00457392|62806130|FG000|Overall Study|Withdrawal by Subject|14|||
33428259|NCT00457392|62806131|FG001|Overall Study|Withdrawal by Subject|8|||
33428260|NCT00457392|62806130|FG000|Overall Study|Lost to Follow-up|6|||
33428261|NCT00457392|62806131|FG001|Overall Study|Lost to Follow-up|7|||
33428262|NCT00457392|62806130|FG000|Overall Study|Protocol Violation|4|||
33428263|NCT00457392|62806131|FG001|Overall Study|Protocol Violation|3|||
33605376|NCT01649375|63005068|FG000|Week 16 up to Week 260|Physician Decision|0|||
33428264|NCT00457392|62806130|FG000|Overall Study|Other|7|||
33428265|NCT00457392|62806131|FG001|Overall Study|Other|4|||
33428266|NCT00457392|62806130|FG000|Overall Study|Study Terminated by Sponsor|1|||
33428267|NCT00457392|62806131|FG001|Overall Study|Study Terminated by Sponsor|4|||
33428268|NCT00457392|62806130|FG000|Overall Study|Randomized, Not Treated|7|||
33428269|NCT00457392|62806131|FG001|Overall Study|Randomized, Not Treated|3|||
33428270|NCT00545051|62806139|FG000|Overall Study|Adverse Event|7|||
33428271|NCT00545051|62806140|FG001|Overall Study|Adverse Event|3|||
33605377|NCT01649375|63005069|FG001|Week 16 up to Week 260|Physician Decision|2|||
33428272|NCT00545051|62806139|FG000|Overall Study|Death|1|||
33428273|NCT00545051|62806140|FG001|Overall Study|Death|0|||
33428274|NCT00545051|62806139|FG000|Overall Study|Violation of inclusion/exclusion|0|||
33428275|NCT00545051|62806140|FG001|Overall Study|Violation of inclusion/exclusion|2|||
33428276|NCT00545051|62806139|FG000|Overall Study|Protocol Violation|1|||
33428277|NCT00545051|62806140|FG001|Overall Study|Protocol Violation|0|||
33428278|NCT00545051|62806139|FG000|Overall Study|Withdrawal by Subject|0|||
33428279|NCT00545051|62806140|FG001|Overall Study|Withdrawal by Subject|1|||
33428280|NCT00545051|62806139|FG000|Overall Study|Administrative reasons|0|||
33428281|NCT00545051|62806140|FG001|Overall Study|Administrative reasons|1|||
33428282|NCT00381615|62806150|FG000|Overall Study|Withdrawal by Subject|1|||
33428283|NCT00381615|62806151|FG001|Overall Study|Withdrawal by Subject|3|||
33428284|NCT00381615|62806152|FG002|Overall Study|Withdrawal by Subject|0|||
33428285|NCT00381615|62806153|FG003|Overall Study|Withdrawal by Subject|1|||
33428286|NCT00381615|62806150|FG000|Overall Study|Lost to Follow-up|3|||
33428287|NCT00381615|62806151|FG001|Overall Study|Lost to Follow-up|2|||
33428288|NCT00381615|62806152|FG002|Overall Study|Lost to Follow-up|0|||
33428289|NCT00381615|62806153|FG003|Overall Study|Lost to Follow-up|1|||
33428290|NCT00381615|62806150|FG000|Overall Study|Protocol Violation|0|||
33428291|NCT00381615|62806151|FG001|Overall Study|Protocol Violation|0|||
33428292|NCT00381615|62806152|FG002|Overall Study|Protocol Violation|1|||
33428293|NCT00381615|62806153|FG003|Overall Study|Protocol Violation|0|||
33428294|NCT00371865|62806167|FG000|Overall Study|Lack of Efficacy|0|||
33428295|NCT00371865|62806168|FG001|Overall Study|Lack of Efficacy|2|||
33428296|NCT00371865|62806167|FG000|Overall Study|Protocol Violation|3|||
33428297|NCT00371865|62806168|FG001|Overall Study|Protocol Violation|2|||
33428298|NCT00371865|62806167|FG000|Overall Study|Withdrawal by Subject|12|||
33428299|NCT00371865|62806168|FG001|Overall Study|Withdrawal by Subject|10|||
33428300|NCT00364845|62806176|FG000|Overall Study|Adverse Event|1|||
33428301|NCT00364845|62806177|FG001|Overall Study|Adverse Event|0|||
33428302|NCT00364845|62806176|FG000|Overall Study|Withdrawal by Subject|2|||
33428303|NCT00364845|62806177|FG001|Overall Study|Withdrawal by Subject|1|||
33428304|NCT00364845|62806176|FG000|Overall Study|Physician Decision|8|||
33428305|NCT00364845|62806177|FG001|Overall Study|Physician Decision|8|||
33323022|NCT01175213|62699285|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
33428306|NCT00364845|62806176|FG000|Overall Study|Lost to Follow-up|0|||
33428307|NCT00364845|62806177|FG001|Overall Study|Lost to Follow-up|1|||
33323023|NCT01175213|62699284|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
33428308|NCT00364845|62806176|FG000|Overall Study|Death|0|||
33428309|NCT00364845|62806177|FG001|Overall Study|Death|1|||
33428310|NCT00293722|62806183|FG000|Overall Study|Other|427|||
33428311|NCT00381303|62806189|FG000|Overall Study|Lost to Follow-up|25|||
33428312|NCT00381303|62806190|FG001|Overall Study|Lost to Follow-up|9|||
33428313|NCT00381303|62806189|FG000|Overall Study|AE/HIV-related event|22|||
33428314|NCT00381303|62806190|FG001|Overall Study|AE/HIV-related event|6|||
33428315|NCT00381303|62806189|FG000|Overall Study|Non-Adherence|13|||
33428316|NCT00381303|62806190|FG001|Overall Study|Non-Adherence|6|||
33428317|NCT00381303|62806189|FG000|Overall Study|Withdrawal by Subject|13|||
33428318|NCT00381303|62806190|FG001|Overall Study|Withdrawal by Subject|6|||
33428319|NCT00381303|62806189|FG000|Overall Study|Virologic failure|6|||
33428320|NCT00381303|62806190|FG001|Overall Study|Virologic failure|4|||
33428321|NCT00381303|62806189|FG000|Overall Study|Ineligible to continue the trial|2|||
33428322|NCT00381303|62806190|FG001|Overall Study|Ineligible to continue the trial|1|||
33428323|NCT00381303|62806189|FG000|Overall Study|Pregnancy|2|||
33428324|NCT00381303|62806190|FG001|Overall Study|Pregnancy|0|||
33428325|NCT00381303|62806189|FG000|Overall Study|Physician Decision|1|||
33428326|NCT00381303|62806190|FG001|Overall Study|Physician Decision|0|||
33428327|NCT00381303|62806189|FG000|Overall Study|Physician's decision to close the site|3|||
33428328|NCT00381303|62806190|FG001|Overall Study|Physician's decision to close the site|1|||
33428329|NCT00381303|62806189|FG000|Overall Study|Subject moved out of state|2|||
33428330|NCT00381303|62806190|FG001|Overall Study|Subject moved out of state|0|||
33428331|NCT00381303|62806189|FG000|Overall Study|Subject taking too many different meds|1|||
33428332|NCT00381303|62806190|FG001|Overall Study|Subject taking too many different meds|0|||
33428333|NCT00381303|62806189|FG000|Overall Study|No virologic response by week 12|1|||
33428334|NCT00381303|62806190|FG001|Overall Study|No virologic response by week 12|0|||
33428335|NCT00381303|62806189|FG000|Overall Study|Subject was too busy for appointments|1|||
33428336|NCT00381303|62806190|FG001|Overall Study|Subject was too busy for appointments|0|||
33428337|NCT00381303|62806189|FG000|Overall Study|Subject did not continue visits|1|||
33428338|NCT00381303|62806190|FG001|Overall Study|Subject did not continue visits|0|||
33428339|NCT00381303|62806189|FG000|Overall Study|Subject primary physician's decision|1|||
33428340|NCT00381303|62806190|FG001|Overall Study|Subject primary physician's decision|0|||
33428341|NCT00448812|62806210|FG000|Year 2|Missed visit but remained in study|4|||
33428342|NCT00448812|62806211|FG001|Year 2|Missed visit but remained in study|1|||
33428343|NCT00448812|62806210|FG000|Year 3|Withdrawal by Subject|1|||
33428344|NCT00448812|62806211|FG001|Year 3|Withdrawal by Subject|3|||
33428345|NCT00448812|62806210|FG000|Year 3|Lost to Follow-up|1|||
33428346|NCT00448812|62806211|FG001|Year 3|Lost to Follow-up|0|||
33428347|NCT00448812|62806210|FG000|Year 3|Missed visit but remained in study|2|||
33428348|NCT00448812|62806211|FG001|Year 3|Missed visit but remained in study|0|||
33428349|NCT00448812|62806210|FG000|Year 5|Missed visit but remained in study|1|||
33428350|NCT00448812|62806211|FG001|Year 5|Missed visit but remained in study|0|||
33428351|NCT00364689|62806232|FG000|Overall Study|Lost to Follow-up|1|||
33428352|NCT00545129|62806240|FG000|Overall Study|Lack of Efficacy|2|||
33428353|NCT00545129|62806241|FG001|Overall Study|Lack of Efficacy|5|||
33428354|NCT00545129|62806240|FG000|Overall Study|Death|2|||
33428355|NCT00545129|62806241|FG001|Overall Study|Death|1|||
33428356|NCT00545129|62806240|FG000|Overall Study|Adverse Event|1|||
33428357|NCT00545129|62806241|FG001|Overall Study|Adverse Event|1|||
33428358|NCT00545129|62806240|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
33428359|NCT00545129|62806241|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
33428360|NCT00545129|62806240|FG000|Overall Study|Other|3|||
33428361|NCT00545129|62806241|FG001|Overall Study|Other|3|||
33428362|NCT00364611|62806249|FG000|Overall Study|Did not receive study medication|0|||
33428363|NCT00364611|62806250|FG001|Overall Study|Did not receive study medication|1|||
33428364|NCT00364611|62806249|FG000|Overall Study|Adverse Event|7|||
33428365|NCT00364611|62806250|FG001|Overall Study|Adverse Event|4|||
33428366|NCT00364611|62806249|FG000|Overall Study|Participant's Request|3|||
33428367|NCT00364611|62806250|FG001|Overall Study|Participant's Request|4|||
33428368|NCT00364611|62806249|FG000|Overall Study|Disease Progression|38|||
33428369|NCT00364611|62806250|FG001|Overall Study|Disease Progression|8|||
33428370|NCT00364611|62806249|FG000|Overall Study|Investigator decision|2|||
33428371|NCT00364611|62806250|FG001|Overall Study|Investigator decision|2|||
33428372|NCT00364611|62806249|FG000|Overall Study|Found Ineligible|1|||
33428373|NCT00364611|62806250|FG001|Overall Study|Found Ineligible|0|||
33428374|NCT00364611|62806249|FG000|Overall Study|Presumed CR on Study|0|||
33428375|NCT00364611|62806250|FG001|Overall Study|Presumed CR on Study|1|||
33428376|NCT00364611|62806249|FG000|Overall Study|Receiving Liver Ablation|0|||
33428377|NCT00364611|62806250|FG001|Overall Study|Receiving Liver Ablation|1|||
33428378|NCT00364533|62806261|FG000|Overall Study|Adverse Event|8|||
33428379|NCT00364533|62806262|FG001|Overall Study|Adverse Event|7|||
33428380|NCT00364533|62806263|FG002|Overall Study|Adverse Event|15|||
33428381|NCT00364533|62806264|FG003|Overall Study|Adverse Event|5|||
33428382|NCT00364533|62806265|FG004|Overall Study|Adverse Event|2|||
33428383|NCT00364533|62806261|FG000|Overall Study|Withdrawal by Subject|4|||
33428384|NCT00364533|62806262|FG001|Overall Study|Withdrawal by Subject|8|||
33428385|NCT00364533|62806263|FG002|Overall Study|Withdrawal by Subject|6|||
33428386|NCT00364533|62806264|FG003|Overall Study|Withdrawal by Subject|6|||
33428387|NCT00364533|62806265|FG004|Overall Study|Withdrawal by Subject|6|||
33428388|NCT00364533|62806261|FG000|Overall Study|Lack of Efficacy|22|||
33428389|NCT00364533|62806262|FG001|Overall Study|Lack of Efficacy|22|||
33428390|NCT00364533|62806263|FG002|Overall Study|Lack of Efficacy|21|||
33428391|NCT00364533|62806264|FG003|Overall Study|Lack of Efficacy|17|||
33428392|NCT00364533|62806265|FG004|Overall Study|Lack of Efficacy|42|||
33428393|NCT00364533|62806261|FG000|Overall Study|Subject discharged from hospital|4|||
33428394|NCT00364533|62806262|FG001|Overall Study|Subject discharged from hospital|1|||
33428395|NCT00364533|62806263|FG002|Overall Study|Subject discharged from hospital|2|||
33428396|NCT00364533|62806264|FG003|Overall Study|Subject discharged from hospital|3|||
33428397|NCT00364533|62806265|FG004|Overall Study|Subject discharged from hospital|1|||
33428398|NCT00364533|62806261|FG000|Overall Study|Variations in drug compliance|2|||
33428399|NCT00364533|62806262|FG001|Overall Study|Variations in drug compliance|1|||
33428400|NCT00364533|62806263|FG002|Overall Study|Variations in drug compliance|1|||
33428401|NCT00364533|62806264|FG003|Overall Study|Variations in drug compliance|0|||
33428402|NCT00364533|62806265|FG004|Overall Study|Variations in drug compliance|0|||
33428403|NCT00364533|62806261|FG000|Overall Study|Non-compliance|1|||
33428404|NCT00364533|62806262|FG001|Overall Study|Non-compliance|0|||
33428405|NCT00364533|62806263|FG002|Overall Study|Non-compliance|0|||
33428406|NCT00364533|62806264|FG003|Overall Study|Non-compliance|0|||
33428407|NCT00364533|62806265|FG004|Overall Study|Non-compliance|0|||
33428408|NCT00364533|62806261|FG000|Overall Study|Protocol Violation|1|||
33428409|NCT00364533|62806262|FG001|Overall Study|Protocol Violation|1|||
33428410|NCT00364533|62806263|FG002|Overall Study|Protocol Violation|0|||
33428411|NCT00364533|62806264|FG003|Overall Study|Protocol Violation|0|||
33428412|NCT00364533|62806265|FG004|Overall Study|Protocol Violation|0|||
33428413|NCT04006847|62806277|FG000|Overall Study|Product issue|1|||
33428414|NCT00544817|62806281|FG000|Combined Modality|Lack of Efficacy|2|||
33428415|NCT00544817|62806281|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
33428416|NCT00544817|62806281|FG000|Combined Modality|Adverse Event|2|||
33428417|NCT00544817|62806281|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
33428418|NCT00544817|62806281|FG000|No Treatment Interval|Lack of Efficacy|8|||
33428419|NCT00544817|62806281|FG000|No Treatment Interval|Physician Decision|3|||
33428420|NCT00544817|62806281|FG000|No Treatment Interval|Adverse Event|1|||
33428421|NCT00544817|62806281|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
33428422|NCT00544817|62806281|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
33428423|NCT00544817|62806281|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
33428424|NCT00289978|62806288|FG000|Overall Study|Withdrawal by Subject|31|||
33428425|NCT00289978|62806289|FG001|Overall Study|Withdrawal by Subject|17|||
33428426|NCT00289978|62806290|FG002|Overall Study|Withdrawal by Subject|28|||
33428427|NCT00289978|62806288|FG000|Overall Study|Adverse Event|22|||
33428428|NCT00289978|62806289|FG001|Overall Study|Adverse Event|13|||
33428429|NCT00289978|62806290|FG002|Overall Study|Adverse Event|18|||
33428430|NCT00289978|62806288|FG000|Overall Study|Lack of Efficacy|13|||
33428431|NCT00289978|62806289|FG001|Overall Study|Lack of Efficacy|6|||
33428432|NCT00289978|62806290|FG002|Overall Study|Lack of Efficacy|25|||
33428433|NCT00289978|62806288|FG000|Overall Study|Abnormal laboratory value(s)|20|||
33428434|NCT00289978|62806289|FG001|Overall Study|Abnormal laboratory value(s)|9|||
33428435|NCT00289978|62806290|FG002|Overall Study|Abnormal laboratory value(s)|1|||
33428436|NCT00289978|62806288|FG000|Overall Study|Lost to Follow-up|3|||
33428437|NCT00289978|62806289|FG001|Overall Study|Lost to Follow-up|5|||
33428438|NCT00289978|62806290|FG002|Overall Study|Lost to Follow-up|7|||
33428439|NCT00289978|62806288|FG000|Overall Study|Protocol Violation|5|||
33428440|NCT00289978|62806289|FG001|Overall Study|Protocol Violation|5|||
33428441|NCT00289978|62806290|FG002|Overall Study|Protocol Violation|4|||
33428442|NCT00289978|62806288|FG000|Overall Study|Abnormal test procedure result(s)|2|||
33428443|NCT00289978|62806289|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33428444|NCT00289978|62806290|FG002|Overall Study|Abnormal test procedure result(s)|1|||
33428445|NCT00289978|62806288|FG000|Overall Study|Death|1|||
33428446|NCT00289978|62806289|FG001|Overall Study|Death|0|||
33428447|NCT00289978|62806290|FG002|Overall Study|Death|2|||
33605378|NCT01649375|63005070|FG002|Week 16 up to Week 260|Physician Decision|0|||
33428448|NCT00543803|62806298|FG000|Overall Study|Adverse Event|14|||
33428449|NCT00543803|62806298|FG000|Overall Study|Lack of Efficacy|22|||
33428450|NCT00543803|62806298|FG000|Overall Study|Lost to Follow-up|20|||
33428451|NCT00543803|62806298|FG000|Overall Study|Other|86|||
33428452|NCT00542321|62806306|FG000|Overall Study|Death|0|||
33428453|NCT00542321|62806307|FG001|Overall Study|Death|1|||
33428454|NCT00289900|62806319|FG000|Overall Study|Adverse Event|28|||
33428455|NCT00289900|62806320|FG001|Overall Study|Adverse Event|40|||
33428456|NCT00289900|62806321|FG002|Overall Study|Adverse Event|13|||
33428457|NCT00289900|62806322|FG003|Overall Study|Adverse Event|19|||
33428458|NCT00289900|62806323|FG004|Overall Study|Adverse Event|20|||
33428459|NCT00289900|62806324|FG005|Overall Study|Adverse Event|33|||
33428460|NCT00289900|62806319|FG000|Overall Study|Lost to Follow-up|7|||
33428461|NCT00289900|62806320|FG001|Overall Study|Lost to Follow-up|7|||
33428462|NCT00289900|62806321|FG002|Overall Study|Lost to Follow-up|8|||
33428463|NCT00289900|62806322|FG003|Overall Study|Lost to Follow-up|8|||
33428464|NCT00289900|62806323|FG004|Overall Study|Lost to Follow-up|4|||
33428465|NCT00289900|62806324|FG005|Overall Study|Lost to Follow-up|8|||
33428466|NCT00289900|62806319|FG000|Overall Study|Participant had flushing|18|||
33428467|NCT00289900|62806320|FG001|Overall Study|Participant had flushing|42|||
33428468|NCT00289900|62806321|FG002|Overall Study|Participant had flushing|1|||
33428469|NCT00289900|62806322|FG003|Overall Study|Participant had flushing|2|||
33428470|NCT00289900|62806323|FG004|Overall Study|Participant had flushing|0|||
33428471|NCT00289900|62806324|FG005|Overall Study|Participant had flushing|4|||
33428472|NCT00289900|62806319|FG000|Overall Study|Other|0|||
33428473|NCT00289900|62806320|FG001|Overall Study|Other|0|||
33428474|NCT00289900|62806321|FG002|Overall Study|Other|0|||
33428475|NCT00289900|62806322|FG003|Overall Study|Other|5|||
33428476|NCT00289900|62806323|FG004|Overall Study|Other|1|||
33428477|NCT00289900|62806324|FG005|Overall Study|Other|0|||
33428478|NCT00289900|62806319|FG000|Overall Study|Participant moved|1|||
33428479|NCT00289900|62806320|FG001|Overall Study|Participant moved|0|||
33428480|NCT00289900|62806321|FG002|Overall Study|Participant moved|0|||
33428481|NCT00289900|62806322|FG003|Overall Study|Participant moved|1|||
33428482|NCT00289900|62806323|FG004|Overall Study|Participant moved|1|||
33428483|NCT00289900|62806324|FG005|Overall Study|Participant moved|1|||
33428484|NCT00289900|62806319|FG000|Overall Study|Withdrawal by Subject|10|||
33428485|NCT00289900|62806320|FG001|Overall Study|Withdrawal by Subject|21|||
33428486|NCT00289900|62806321|FG002|Overall Study|Withdrawal by Subject|8|||
33428487|NCT00289900|62806322|FG003|Overall Study|Withdrawal by Subject|18|||
33428488|NCT00289900|62806323|FG004|Overall Study|Withdrawal by Subject|12|||
33428489|NCT00289900|62806324|FG005|Overall Study|Withdrawal by Subject|11|||
33428490|NCT00289900|62806319|FG000|Overall Study|Protocol Violation|3|||
33428491|NCT00289900|62806320|FG001|Overall Study|Protocol Violation|9|||
33428492|NCT00289900|62806321|FG002|Overall Study|Protocol Violation|2|||
33428493|NCT00289900|62806322|FG003|Overall Study|Protocol Violation|6|||
33428494|NCT00289900|62806323|FG004|Overall Study|Protocol Violation|7|||
33428495|NCT00289900|62806324|FG005|Overall Study|Protocol Violation|4|||
33428496|NCT00289900|62806319|FG000|Overall Study|site terminated|1|||
33428497|NCT00289900|62806320|FG001|Overall Study|site terminated|0|||
33428498|NCT00289900|62806321|FG002|Overall Study|site terminated|1|||
33428499|NCT00289900|62806322|FG003|Overall Study|site terminated|0|||
33428500|NCT00289900|62806323|FG004|Overall Study|site terminated|0|||
33428501|NCT00289900|62806324|FG005|Overall Study|site terminated|0|||
33428502|NCT00289900|62806319|FG000|Overall Study|Not treated|0|||
33428503|NCT00289900|62806320|FG001|Overall Study|Not treated|1|||
33428504|NCT00289900|62806321|FG002|Overall Study|Not treated|0|||
33323024|NCT01175213|62699285|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
33323025|NCT01175213|62699284|FG000|Safety Follow-up|Adverse Event|1|||
33323026|NCT01175213|62699285|FG001|Safety Follow-up|Adverse Event|0|||
33323027|NCT00974259|62699296|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
33323028|NCT00974259|62699297|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
33323029|NCT00927082|62699307|FG000|Overall Study|Lost to Follow-up|9|||
33323030|NCT00927082|62699308|FG001|Overall Study|Lost to Follow-up|8|||
33323031|NCT00927082|62699309|FG002|Overall Study|Lost to Follow-up|12|||
33323032|NCT00927082|62699310|FG003|Overall Study|Lost to Follow-up|16|||
33323033|NCT00927082|62699307|FG000|Overall Study|Withdrawal by Subject|3|||
33323034|NCT00927082|62699308|FG001|Overall Study|Withdrawal by Subject|2|||
33323035|NCT00927082|62699309|FG002|Overall Study|Withdrawal by Subject|7|||
33323036|NCT00927082|62699310|FG003|Overall Study|Withdrawal by Subject|2|||
33323037|NCT00927082|62699307|FG000|Overall Study|Death|0|||
33323038|NCT00927082|62699308|FG001|Overall Study|Death|0|||
33323039|NCT00927082|62699309|FG002|Overall Study|Death|1|||
33323040|NCT00927082|62699310|FG003|Overall Study|Death|0|||
33323041|NCT00927082|62699307|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
33323042|NCT00927082|62699308|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
33323043|NCT00927082|62699309|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
33323044|NCT00927082|62699310|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
33323045|NCT00976677|62699326|FG000|Overall Study|Adverse Event|1|||
33323046|NCT00976677|62699327|FG001|Overall Study|Adverse Event|0|||
33323047|NCT00976677|62699326|FG000|Overall Study|Withdrawal by Subject|0|||
33323048|NCT00976677|62699327|FG001|Overall Study|Withdrawal by Subject|2|||
33323049|NCT00976677|62699326|FG000|Overall Study|Disease progression|1|||
33323050|NCT00976677|62699327|FG001|Overall Study|Disease progression|1|||
33323051|NCT00976677|62699326|FG000|Overall Study|Trial unblinded|2|||
33323052|NCT00976677|62699327|FG001|Overall Study|Trial unblinded|2|||
33428505|NCT00289900|62806322|FG003|Overall Study|Not treated|0|||
33428506|NCT00289900|62806323|FG004|Overall Study|Not treated|0|||
33323053|NCT00976677|62699326|FG000|Overall Study|Unknown/Missing|1|||
33428507|NCT00289900|62806324|FG005|Overall Study|Not treated|0|||
33428508|NCT00543725|62806343|FG000|Overall Study|Adverse Event|18|||
33428509|NCT00543725|62806344|FG001|Overall Study|Adverse Event|27|||
33428510|NCT00543725|62806343|FG000|Overall Study|Sponsor's Decision|0|||
33428511|NCT00543725|62806344|FG001|Overall Study|Sponsor's Decision|1|||
33428512|NCT00543725|62806343|FG000|Overall Study|Subject Non-Compliant|4|||
33428513|NCT00543725|62806344|FG001|Overall Study|Subject Non-Compliant|4|||
33428514|NCT00543725|62806343|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
33428515|NCT00543725|62806344|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
33428516|NCT00543725|62806343|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
33428517|NCT00543725|62806344|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
33428518|NCT00543725|62806343|FG000|Overall Study|Protocol Violation|0|||
33428519|NCT00543725|62806344|FG001|Overall Study|Protocol Violation|1|||
33428520|NCT00543725|62806343|FG000|Overall Study|Withdrawal by Subject|4|||
33428521|NCT00543725|62806344|FG001|Overall Study|Withdrawal by Subject|13|||
33428522|NCT00543725|62806343|FG000|Overall Study|Lost to Follow-up|15|||
33428523|NCT00543725|62806344|FG001|Overall Study|Lost to Follow-up|11|||
33428524|NCT00543725|62806343|FG000|Overall Study|Other|3|||
33428525|NCT00543725|62806344|FG001|Overall Study|Other|3|||
33428526|NCT00269152|62806352|FG000|Overall Study|Adverse Event|9|||
33428527|NCT00269152|62806353|FG001|Overall Study|Adverse Event|3|||
33428528|NCT00269152|62806352|FG000|Overall Study|Withdrawal by Subject|7|||
33428529|NCT00269152|62806353|FG001|Overall Study|Withdrawal by Subject|3|||
33428530|NCT00269152|62806352|FG000|Overall Study|Physician Decision|2|||
33428531|NCT00269152|62806353|FG001|Overall Study|Physician Decision|3|||
33428532|NCT00269152|62806352|FG000|Overall Study|Protocol Violation|0|||
33428533|NCT00269152|62806353|FG001|Overall Study|Protocol Violation|1|||
33428534|NCT00379899|62806361|FG000|Overall Study|Adverse Event|7|||
33428535|NCT00379899|62806362|FG001|Overall Study|Adverse Event|3|||
33428536|NCT00379899|62806361|FG000|Overall Study|Death|10|||
33428537|NCT00379899|62806362|FG001|Overall Study|Death|10|||
33428538|NCT00379899|62806361|FG000|Overall Study|Lost to Follow-up|2|||
33428539|NCT00379899|62806362|FG001|Overall Study|Lost to Follow-up|4|||
33428540|NCT00379899|62806361|FG000|Overall Study|Physician Decision|3|||
33428541|NCT00379899|62806362|FG001|Overall Study|Physician Decision|4|||
33428542|NCT00379899|62806361|FG000|Overall Study|Withdrawal by Subject|5|||
33428543|NCT00379899|62806362|FG001|Overall Study|Withdrawal by Subject|5|||
33428544|NCT00379899|62806361|FG000|Overall Study|Ineligibility determined|0|||
33428545|NCT00379899|62806362|FG001|Overall Study|Ineligibility determined|1|||
33428546|NCT00379899|62806361|FG000|Overall Study|Noncompliance|1|||
33428547|NCT00379899|62806362|FG001|Overall Study|Noncompliance|1|||
33428548|NCT00379899|62806361|FG000|Overall Study|Parathyroidectomy|0|||
33428549|NCT00379899|62806362|FG001|Overall Study|Parathyroidectomy|2|||
33428550|NCT00379899|62806361|FG000|Overall Study|Renal transplantation|5|||
33428551|NCT00379899|62806362|FG001|Overall Study|Renal transplantation|4|||
33428552|NCT00379899|62806361|FG000|Overall Study|Coronary artery bypass graft|1|||
33428553|NCT00379899|62806362|FG001|Overall Study|Coronary artery bypass graft|1|||
33428554|NCT00379899|62806361|FG000|Overall Study|Other protocol-specified criteria|3|||
33428555|NCT00379899|62806362|FG001|Overall Study|Other protocol-specified criteria|4|||
33428556|NCT00379899|62806361|FG000|Overall Study|Other|3|||
33428557|NCT00379899|62806362|FG001|Overall Study|Other|1|||
33428558|NCT00371787|62806370|FG000|Overall Study|Withdrawal by Subject|3|||
33428559|NCT00371787|62806371|FG001|Overall Study|Withdrawal by Subject|1|||
33428560|NCT00363129|62806379|FG000|Overall Study|Withdrawal by Subject|11|||
33428561|NCT00363129|62806380|FG001|Overall Study|Withdrawal by Subject|18|||
33428562|NCT00363129|62806379|FG000|Overall Study|Adverse Event|8|||
33428563|NCT00363129|62806380|FG001|Overall Study|Adverse Event|3|||
33428564|NCT00363129|62806379|FG000|Overall Study|Alternate Treatment|2|||
33428565|NCT00363129|62806380|FG001|Overall Study|Alternate Treatment|4|||
33428566|NCT00363129|62806379|FG000|Overall Study|Other Medical Problems|2|||
33428567|NCT00363129|62806380|FG001|Overall Study|Other Medical Problems|4|||
33428568|NCT00363129|62806379|FG000|Overall Study|Death|0|||
33428569|NCT00363129|62806380|FG001|Overall Study|Death|1|||
33428570|NCT00363129|62806379|FG000|Overall Study|Other Reasons|6|||
33428571|NCT00363129|62806380|FG001|Overall Study|Other Reasons|3|||
33428572|NCT00268996|62806388|FG000|Overall Study|Adverse Event|11|||
33428573|NCT00268996|62806389|FG001|Overall Study|Adverse Event|7|||
33428574|NCT00268996|62806388|FG000|Overall Study|Lost to Follow-up|3|||
33428575|NCT00268996|62806389|FG001|Overall Study|Lost to Follow-up|1|||
33428576|NCT00268996|62806388|FG000|Overall Study|Withdrawal by Subject|5|||
33428577|NCT00268996|62806389|FG001|Overall Study|Withdrawal by Subject|11|||
33428578|NCT00268996|62806388|FG000|Overall Study|Non-compliance|1|||
33428579|NCT00268996|62806389|FG001|Overall Study|Non-compliance|0|||
33428580|NCT00268996|62806388|FG000|Overall Study|Other|1|||
33428581|NCT00268996|62806389|FG001|Overall Study|Other|1|||
33428582|NCT00371397|62806397|FG000|Session 1|Withdrawal by Subject|1|||
33428583|NCT00371397|62806398|FG001|Session 1|Withdrawal by Subject|0|||
33428584|NCT00371397|62806399|FG002|Session 1|Withdrawal by Subject|0|||
33428585|NCT00371397|62806400|FG003|Session 1|Withdrawal by Subject|0|||
33428586|NCT00371397|62806401|FG004|Session 1|Withdrawal by Subject|0|||
33428587|NCT00371397|62806402|FG005|Session 1|Withdrawal by Subject|0|||
33428588|NCT00371397|62806403|FG006|Session 1|Withdrawal by Subject|0|||
33428589|NCT00371397|62806404|FG007|Session 1|Withdrawal by Subject|1|||
33428590|NCT00371397|62806405|FG008|Session 1|Withdrawal by Subject|0|||
33428591|NCT00371397|62806406|FG009|Session 1|Withdrawal by Subject|0|||
33428592|NCT00371397|62806407|FG010|Session 1|Withdrawal by Subject|0|||
33428593|NCT00371397|62806408|FG011|Session 1|Withdrawal by Subject|0|||
33428594|NCT00379587|62806414|FG000|Overall Study|Lost to Follow-up|2|||
33428595|NCT00289276|62806420|FG000|Second Part of FAST Study (Expansion)|Death|0|||
33428596|NCT00289276|62806421|FG001|Second Part of FAST Study (Expansion)|Death|2|||
33428597|NCT00289276|62806420|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
33428598|NCT00289276|62806421|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
33428599|NCT00289198|62806429|FG000|Overall Study|Adverse Event|0|||
33428600|NCT00289198|62806430|FG001|Overall Study|Adverse Event|2|||
33428601|NCT00289198|62806429|FG000|Overall Study|Protocol Violation|2|||
33428602|NCT00289198|62806430|FG001|Overall Study|Protocol Violation|1|||
33428603|NCT00289198|62806429|FG000|Overall Study|Withdrawal by Subject|4|||
33428604|NCT00289198|62806430|FG001|Overall Study|Withdrawal by Subject|1|||
33428605|NCT00289198|62806429|FG000|Overall Study|Lack of Efficacy|2|||
33428606|NCT00289198|62806430|FG001|Overall Study|Lack of Efficacy|0|||
33428607|NCT00289198|62806429|FG000|Overall Study|Other: Low compliance|0|||
33428608|NCT00289198|62806430|FG001|Overall Study|Other: Low compliance|1|||
33428609|NCT00289198|62806429|FG000|Overall Study|Other: Physician's decision|0|||
33428610|NCT00289198|62806430|FG001|Overall Study|Other: Physician's decision|1|||
33428611|NCT00289198|62806429|FG000|Overall Study|Other: Unable to attend on schedule|2|||
33428612|NCT00289198|62806430|FG001|Overall Study|Other: Unable to attend on schedule|1|||
33428613|NCT00289198|62806429|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
33428614|NCT00289198|62806430|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
33428615|NCT00289198|62806429|FG000|Overall Study|Other: Impossible to come on visit|0|||
33428616|NCT00289198|62806430|FG001|Overall Study|Other: Impossible to come on visit|1|||
33428617|NCT00363051|62806439|FG000|Overall Study|Adminstrative problems|1|||
33428618|NCT00363051|62806440|FG001|Overall Study|Adminstrative problems|1|||
33428619|NCT00363051|62806439|FG000|Overall Study|Adverse Event|21|||
33428620|NCT00363051|62806440|FG001|Overall Study|Adverse Event|12|||
33428621|NCT00363051|62806439|FG000|Overall Study|New Cancer Therapy|2|||
33428622|NCT00363051|62806440|FG001|Overall Study|New Cancer Therapy|1|||
33428623|NCT00363051|62806439|FG000|Overall Study|Withdrawal by Subject|11|||
33428624|NCT00363051|62806440|FG001|Overall Study|Withdrawal by Subject|3|||
33428625|NCT00363051|62806439|FG000|Overall Study|Lost to Follow-up|0|||
33428626|NCT00363051|62806440|FG001|Overall Study|Lost to Follow-up|1|||
33428627|NCT00363051|62806439|FG000|Overall Study|Protocol Violation|0|||
33428628|NCT00363051|62806440|FG001|Overall Study|Protocol Violation|2|||
33428629|NCT00363051|62806439|FG000|Overall Study|Death|3|||
33428630|NCT00363051|62806440|FG001|Overall Study|Death|2|||
33428631|NCT00379353|62806450|FG000|Overall Study|Hospitalization|3|||
33428632|NCT00379353|62806451|FG001|Overall Study|Hospitalization|3|||
33428633|NCT00379353|62806450|FG000|Overall Study|Withdrawal by Subject|5|||
33428634|NCT00379353|62806451|FG001|Overall Study|Withdrawal by Subject|2|||
33428635|NCT00379353|62806450|FG000|Overall Study|Death|1|||
33428636|NCT00379353|62806451|FG001|Overall Study|Death|0|||
33428637|NCT00379353|62806450|FG000|Overall Study|Cardiac Tamponade|1|||
33428638|NCT00379353|62806451|FG001|Overall Study|Cardiac Tamponade|0|||
33428639|NCT00379353|62806450|FG000|Overall Study|Non-compliance|1|||
33428640|NCT00379353|62806451|FG001|Overall Study|Non-compliance|0|||
33428641|NCT00379353|62806450|FG000|Overall Study|Conflicting drug treatment|0|||
33428642|NCT00379353|62806451|FG001|Overall Study|Conflicting drug treatment|1|||
33428643|NCT00378573|62806467|FG000|Treatment Period|Adverse Event|9|||
33428644|NCT00378573|62806467|FG000|Treatment Period|Physician Decision|1|||
33323054|NCT00976677|62699327|FG001|Overall Study|Unknown/Missing|0|||
33323055|NCT00926536|62699335|FG000|Overall Study|Physician Decision|1|||
33323056|NCT00926536|62699336|FG001|Overall Study|Physician Decision|2|||
33323057|NCT00923260|62699344|FG000|Overall Study|Lost to Follow-up|1|||
33323058|NCT00923260|62699345|FG001|Overall Study|Lost to Follow-up|1|||
33323059|NCT00934102|62699351|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
33323060|NCT00934102|62699352|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
33323061|NCT00934102|62699353|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
33323062|NCT00970281|62699372|FG000|Overall Study|Lack of Efficacy|1|||
33323063|NCT00970281|62699373|FG001|Overall Study|Lack of Efficacy|14|||
33323064|NCT00970281|62699372|FG000|Overall Study|Withdrawal by Subject|0|||
33323065|NCT00970281|62699373|FG001|Overall Study|Withdrawal by Subject|1|||
33323066|NCT00970281|62699372|FG000|Overall Study|Physician Decision|1|||
33323067|NCT00970281|62699373|FG001|Overall Study|Physician Decision|1|||
33323068|NCT00976209|62699381|FG000|Treatment Period 1|Protocol Violation|1|||
33323069|NCT00976209|62699382|FG001|Treatment Period 1|Protocol Violation|0|||
33323070|NCT00976209|62699381|FG000|Treatment Period 1|Lost to Follow-up|2|||
33428645|NCT00378573|62806467|FG000|Treatment Period|Withdrawal by Subject|2|||
33428646|NCT00378573|62806467|FG000|Treatment Period|Disease Progression|4|||
33428647|NCT00378573|62806467|FG000|Treatment Period|Sponsor decision to close study|1|||
33428648|NCT00378573|62806467|FG000|Follow-up|Death|12|||
33428649|NCT00378573|62806467|FG000|Follow-up|Lost to Follow-up|1|||
33428650|NCT00378573|62806467|FG000|Follow-up|Withdrawal by Subject|1|||
33428651|NCT03831945|62806473|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
33494176|NCT03634033|62872936|FG002|Overall Study|Death|0|||
33428652|NCT03831945|62806474|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
33428653|NCT03831945|62806473|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
33428654|NCT03831945|62806474|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
33428655|NCT03831945|62806473|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
33428656|NCT03831945|62806474|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
33428657|NCT00457002|62806482|FG000|Overall Study|Death|40|||
33428658|NCT00457002|62806483|FG001|Overall Study|Death|47|||
33428659|NCT00457002|62806482|FG000|Overall Study|Adverse Event|284|||
33428660|NCT00457002|62806483|FG001|Overall Study|Adverse Event|260|||
33428661|NCT00457002|62806482|FG000|Overall Study|Withdrawal by Subject|299|||
33428662|NCT00457002|62806483|FG001|Overall Study|Withdrawal by Subject|271|||
33428663|NCT00457002|62806482|FG000|Overall Study|Lost to Follow-up|72|||
33428664|NCT00457002|62806483|FG001|Overall Study|Lost to Follow-up|71|||
33428665|NCT00457002|62806482|FG000|Overall Study|Poor/Non-compliance|46|||
33428666|NCT00457002|62806483|FG001|Overall Study|Poor/Non-compliance|33|||
33428667|NCT00457002|62806482|FG000|Overall Study|No longer met criteria|41|||
33428668|NCT00457002|62806483|FG001|Overall Study|No longer met criteria|37|||
33428669|NCT00457002|62806482|FG000|Overall Study|Administrative reason by Sponsor|1|||
33428670|NCT00457002|62806483|FG001|Overall Study|Administrative reason by Sponsor|0|||
33428671|NCT00457002|62806482|FG000|Overall Study|non-specified|29|||
33428672|NCT00457002|62806483|FG001|Overall Study|non-specified|38|||
33428673|NCT00457002|62806482|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
33428674|NCT00457002|62806483|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
33428675|NCT00362115|62806496|FG000|Overall Study|Adverse Event|0|||
33428676|NCT00362115|62806497|FG001|Overall Study|Adverse Event|1|||
33428677|NCT00362115|62806498|FG002|Overall Study|Adverse Event|1|||
33428678|NCT00362115|62806499|FG003|Overall Study|Adverse Event|1|||
33428679|NCT00362115|62806500|FG004|Overall Study|Adverse Event|2|||
33428680|NCT00362115|62806501|FG005|Overall Study|Adverse Event|2|||
33428681|NCT00362115|62806502|FG006|Overall Study|Adverse Event|1|||
33428682|NCT00362115|62806496|FG000|Overall Study|Protocol Violation|0|||
33428683|NCT00362115|62806497|FG001|Overall Study|Protocol Violation|0|||
33428684|NCT00362115|62806498|FG002|Overall Study|Protocol Violation|0|||
33428685|NCT00362115|62806499|FG003|Overall Study|Protocol Violation|0|||
33428686|NCT00362115|62806500|FG004|Overall Study|Protocol Violation|0|||
33428687|NCT00362115|62806501|FG005|Overall Study|Protocol Violation|1|||
33428688|NCT00362115|62806502|FG006|Overall Study|Protocol Violation|0|||
33428689|NCT00362115|62806496|FG000|Overall Study|Lost to Follow-up|0|||
33428690|NCT00362115|62806497|FG001|Overall Study|Lost to Follow-up|1|||
33428691|NCT00362115|62806498|FG002|Overall Study|Lost to Follow-up|0|||
33428692|NCT00362115|62806499|FG003|Overall Study|Lost to Follow-up|0|||
33428693|NCT00362115|62806500|FG004|Overall Study|Lost to Follow-up|2|||
33428694|NCT00362115|62806501|FG005|Overall Study|Lost to Follow-up|0|||
33428695|NCT00362115|62806502|FG006|Overall Study|Lost to Follow-up|1|||
33428696|NCT00362115|62806496|FG000|Overall Study|Withdrawal by Subject|1|||
33428697|NCT00362115|62806497|FG001|Overall Study|Withdrawal by Subject|3|||
33428698|NCT00362115|62806498|FG002|Overall Study|Withdrawal by Subject|1|||
33428699|NCT00362115|62806499|FG003|Overall Study|Withdrawal by Subject|0|||
33428700|NCT00362115|62806500|FG004|Overall Study|Withdrawal by Subject|1|||
33428701|NCT00362115|62806501|FG005|Overall Study|Withdrawal by Subject|3|||
33428702|NCT00362115|62806502|FG006|Overall Study|Withdrawal by Subject|4|||
33428703|NCT00362115|62806496|FG000|Overall Study|Lack of Efficacy|1|||
33428704|NCT00362115|62806497|FG001|Overall Study|Lack of Efficacy|0|||
33428705|NCT00362115|62806498|FG002|Overall Study|Lack of Efficacy|5|||
33428706|NCT00362115|62806499|FG003|Overall Study|Lack of Efficacy|2|||
33428707|NCT00362115|62806500|FG004|Overall Study|Lack of Efficacy|2|||
33428708|NCT00362115|62806501|FG005|Overall Study|Lack of Efficacy|0|||
33428709|NCT00362115|62806502|FG006|Overall Study|Lack of Efficacy|3|||
33428710|NCT00362115|62806496|FG000|Overall Study|Physician Decision|0|||
33428711|NCT00362115|62806497|FG001|Overall Study|Physician Decision|0|||
33428712|NCT00362115|62806498|FG002|Overall Study|Physician Decision|0|||
33428713|NCT00362115|62806499|FG003|Overall Study|Physician Decision|0|||
33428714|NCT00362115|62806500|FG004|Overall Study|Physician Decision|0|||
33428715|NCT00362115|62806501|FG005|Overall Study|Physician Decision|0|||
33428716|NCT00362115|62806502|FG006|Overall Study|Physician Decision|3|||
33428717|NCT00362115|62806496|FG000|Overall Study|Other|0|||
33428718|NCT00362115|62806497|FG001|Overall Study|Other|1|||
33428719|NCT00362115|62806498|FG002|Overall Study|Other|0|||
33428720|NCT00362115|62806499|FG003|Overall Study|Other|1|||
33428721|NCT00362115|62806500|FG004|Overall Study|Other|0|||
33428722|NCT00362115|62806501|FG005|Overall Study|Other|1|||
33428723|NCT00362115|62806502|FG006|Overall Study|Other|0|||
33428724|NCT00485264|62806524|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
33428725|NCT00485264|62806525|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
33605379|NCT01649375|63005071|FG003|Week 16 up to Week 260|Physician Decision|0|||
33605380|NCT01649375|63005072|FG004|Week 16 up to Week 260|Physician Decision|0|||
33428726|NCT00485264|62806526|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
33428727|NCT00485264|62806527|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
33428728|NCT00485264|62806528|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
33428729|NCT00485264|62806529|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
33428730|NCT00485264|62806524|FG000|Overall Study|Death|1|||
33428731|NCT00485264|62806525|FG001|Overall Study|Death|0|||
33428732|NCT00485264|62806526|FG002|Overall Study|Death|0|||
33428733|NCT00485264|62806527|FG003|Overall Study|Death|0|||
33428734|NCT00485264|62806528|FG004|Overall Study|Death|1|||
33428735|NCT00485264|62806529|FG005|Overall Study|Death|0|||
33428736|NCT00485264|62806524|FG000|Overall Study|Adverse Event|1|||
33428737|NCT00485264|62806525|FG001|Overall Study|Adverse Event|0|||
33428738|NCT00485264|62806526|FG002|Overall Study|Adverse Event|2|||
33428739|NCT00485264|62806527|FG003|Overall Study|Adverse Event|3|||
33428740|NCT00485264|62806528|FG004|Overall Study|Adverse Event|1|||
33428741|NCT00485264|62806529|FG005|Overall Study|Adverse Event|3|||
33428742|NCT00485264|62806524|FG000|Overall Study|Pregnancy|4|||
33428743|NCT00485264|62806525|FG001|Overall Study|Pregnancy|0|||
33428744|NCT00485264|62806526|FG002|Overall Study|Pregnancy|0|||
33428745|NCT00485264|62806527|FG003|Overall Study|Pregnancy|0|||
33428746|NCT00485264|62806528|FG004|Overall Study|Pregnancy|0|||
33428747|NCT00485264|62806529|FG005|Overall Study|Pregnancy|0|||
33428748|NCT00485264|62806524|FG000|Overall Study|Disallowed Medication|0|||
33428749|NCT00485264|62806525|FG001|Overall Study|Disallowed Medication|0|||
33428750|NCT00485264|62806526|FG002|Overall Study|Disallowed Medication|0|||
33428751|NCT00485264|62806527|FG003|Overall Study|Disallowed Medication|0|||
33428752|NCT00485264|62806528|FG004|Overall Study|Disallowed Medication|0|||
33428753|NCT00485264|62806529|FG005|Overall Study|Disallowed Medication|1|||
33428754|NCT00485264|62806524|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
33428755|NCT00485264|62806525|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
33428756|NCT00485264|62806526|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
33428757|NCT00485264|62806527|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
33428758|NCT00485264|62806528|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
33428759|NCT00485264|62806529|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
33428760|NCT00485264|62806524|FG000|Overall Study|Lack of Efficacy|0|||
33428761|NCT00485264|62806525|FG001|Overall Study|Lack of Efficacy|1|||
33428762|NCT00485264|62806526|FG002|Overall Study|Lack of Efficacy|0|||
33428763|NCT00485264|62806527|FG003|Overall Study|Lack of Efficacy|0|||
33428764|NCT00485264|62806528|FG004|Overall Study|Lack of Efficacy|0|||
33428765|NCT00485264|62806529|FG005|Overall Study|Lack of Efficacy|0|||
33428766|NCT00485264|62806524|FG000|Overall Study|Guardian Consent Withdrawn|1|||
33428767|NCT00485264|62806525|FG001|Overall Study|Guardian Consent Withdrawn|0|||
33428768|NCT00485264|62806526|FG002|Overall Study|Guardian Consent Withdrawn|0|||
33428769|NCT00485264|62806527|FG003|Overall Study|Guardian Consent Withdrawn|0|||
33428770|NCT00485264|62806528|FG004|Overall Study|Guardian Consent Withdrawn|1|||
33428771|NCT00485264|62806529|FG005|Overall Study|Guardian Consent Withdrawn|0|||
33428772|NCT00485264|62806524|FG000|Overall Study|Physician Decision|0|||
33428773|NCT00485264|62806525|FG001|Overall Study|Physician Decision|2|||
33428774|NCT00485264|62806526|FG002|Overall Study|Physician Decision|0|||
33428775|NCT00485264|62806527|FG003|Overall Study|Physician Decision|0|||
33428776|NCT00485264|62806528|FG004|Overall Study|Physician Decision|0|||
33428777|NCT00485264|62806529|FG005|Overall Study|Physician Decision|0|||
33428778|NCT00485264|62806524|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
33428779|NCT00485264|62806525|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
33428780|NCT00485264|62806526|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
33428781|NCT00485264|62806527|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
33428782|NCT00485264|62806528|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
33428783|NCT00485264|62806529|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
33428784|NCT00485264|62806524|FG000|Overall Study|Not Able to Attend Clinic|5|||
33428785|NCT00485264|62806525|FG001|Overall Study|Not Able to Attend Clinic|0|||
33428786|NCT00485264|62806526|FG002|Overall Study|Not Able to Attend Clinic|0|||
33428787|NCT00485264|62806527|FG003|Overall Study|Not Able to Attend Clinic|1|||
33428788|NCT00485264|62806528|FG004|Overall Study|Not Able to Attend Clinic|1|||
33428789|NCT00485264|62806529|FG005|Overall Study|Not Able to Attend Clinic|2|||
33428790|NCT00485264|62806524|FG000|Overall Study|Non-Compliant|17|||
33428791|NCT00485264|62806525|FG001|Overall Study|Non-Compliant|2|||
33428792|NCT00485264|62806526|FG002|Overall Study|Non-Compliant|1|||
33428793|NCT00485264|62806527|FG003|Overall Study|Non-Compliant|0|||
33428794|NCT00485264|62806528|FG004|Overall Study|Non-Compliant|1|||
33428795|NCT00485264|62806529|FG005|Overall Study|Non-Compliant|0|||
33428796|NCT00485264|62806524|FG000|Overall Study|Lost to Follow-up|2|||
33428797|NCT00485264|62806525|FG001|Overall Study|Lost to Follow-up|1|||
33428798|NCT00485264|62806526|FG002|Overall Study|Lost to Follow-up|1|||
33428799|NCT00485264|62806527|FG003|Overall Study|Lost to Follow-up|0|||
33428800|NCT00485264|62806528|FG004|Overall Study|Lost to Follow-up|0|||
33428801|NCT00485264|62806529|FG005|Overall Study|Lost to Follow-up|1|||
33428802|NCT00485264|62806524|FG000|Overall Study|Other Reason|3|||
33428803|NCT00485264|62806525|FG001|Overall Study|Other Reason|0|||
33428804|NCT00485264|62806526|FG002|Overall Study|Other Reason|0|||
33428805|NCT00485264|62806527|FG003|Overall Study|Other Reason|0|||
33428806|NCT00485264|62806528|FG004|Overall Study|Other Reason|0|||
33428807|NCT00485264|62806529|FG005|Overall Study|Other Reason|0|||
33428808|NCT00293254|62806550|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
33428809|NCT00293254|62806551|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
33428810|NCT00293254|62806550|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
33428811|NCT00293254|62806551|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
33428812|NCT00293254|62806550|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
33428813|NCT00293254|62806551|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
33428814|NCT00293254|62806550|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
33428815|NCT00293254|62806551|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
33428816|NCT00293254|62806550|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
33428817|NCT00293254|62806551|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
33428818|NCT00293254|62806550|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
33428819|NCT00293254|62806551|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
33428820|NCT00293254|62806550|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
33428821|NCT00293254|62806551|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
33428822|NCT00293254|62806550|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
33428823|NCT00293254|62806551|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
33428824|NCT00293254|62806550|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
33428825|NCT00293254|62806551|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
33428826|NCT00293254|62806550|FG000|Extension - Double-Blind Week 49-156|Death|4|||
33428827|NCT00293254|62806551|FG001|Extension - Double-Blind Week 49-156|Death|1|||
33428828|NCT00293254|62806550|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
33428829|NCT00293254|62806551|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
33428830|NCT00293254|62806550|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
33428831|NCT00293254|62806551|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
33428832|NCT00293254|62806550|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
33428833|NCT00293254|62806551|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
33428834|NCT00293254|62806550|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
33428835|NCT00293254|62806551|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
33428836|NCT00293254|62806550|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
33428837|NCT00293254|62806551|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
33428838|NCT00293254|62806550|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
33428839|NCT00293254|62806551|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
33428840|NCT00293254|62806550|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
33428841|NCT00293254|62806551|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
33428842|NCT00293254|62806550|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
33428843|NCT00293254|62806551|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
33428844|NCT00293254|62806550|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
33428845|NCT00293254|62806551|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
33428846|NCT00293254|62806550|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
33428847|NCT00293254|62806551|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
33428848|NCT00293254|62806550|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
33428849|NCT00293254|62806551|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
33428850|NCT00293254|62806550|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
33428851|NCT00293254|62806551|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
33428852|NCT00293254|62806550|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
33428853|NCT00293254|62806551|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
33428854|NCT00293254|62806550|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
33428855|NCT00293254|62806551|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
33428856|NCT00293254|62806550|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
33428857|NCT00293254|62806551|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
33428858|NCT00293254|62806550|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
33428859|NCT00293254|62806551|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
33428860|NCT00293254|62806550|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
33428861|NCT00293254|62806551|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
33428862|NCT00456846|62806565|FG000|Overall Study|Adverse Event|2|||
33428863|NCT00456846|62806566|FG001|Overall Study|Adverse Event|15|||
33428864|NCT00456846|62806565|FG000|Overall Study|Physician Decision|11|||
33428865|NCT00456846|62806566|FG001|Overall Study|Physician Decision|6|||
33428866|NCT00456846|62806565|FG000|Overall Study|Protocol Deviation|2|||
33428867|NCT00456846|62806566|FG001|Overall Study|Protocol Deviation|0|||
33428868|NCT00456846|62806565|FG000|Overall Study|Participant Discretion|1|||
33428869|NCT00456846|62806566|FG001|Overall Study|Participant Discretion|5|||
33428870|NCT00456846|62806565|FG000|Overall Study|Other|0|||
33428871|NCT00456846|62806566|FG001|Overall Study|Other|2|||
33428872|NCT00448344|62806574|FG000|Overall Study|Lost to Follow-up|20|||
33428873|NCT00448344|62806575|FG001|Overall Study|Lost to Follow-up|22|||
33428874|NCT00448344|62806574|FG000|Overall Study|Withdrawal by Subject|6|||
33428875|NCT00448344|62806575|FG001|Overall Study|Withdrawal by Subject|8|||
33428876|NCT00448344|62806574|FG000|Overall Study|Death|3|||
33428877|NCT00448344|62806575|FG001|Overall Study|Death|4|||
33428878|NCT00448344|62806574|FG000|Overall Study|Physician Decision|1|||
33428879|NCT00448344|62806575|FG001|Overall Study|Physician Decision|2|||
33428880|NCT00484094|62806581|FG000|Overall Study|Discontinued|39|||
33428881|NCT00484094|62806581|FG000|Overall Study|Other|3|||
33428882|NCT00447876|62806587|FG000|Overall Study|Withdrawal by Subject|1|||
33428883|NCT00447876|62806588|FG001|Overall Study|Withdrawal by Subject|4|||
33428884|NCT00447876|62806587|FG000|Overall Study|Lost to Follow-up|1|||
33428885|NCT00447876|62806588|FG001|Overall Study|Lost to Follow-up|0|||
33428886|NCT00447876|62806587|FG000|Overall Study|Deterioration of symptomology|1|||
33428887|NCT00447876|62806588|FG001|Overall Study|Deterioration of symptomology|0|||
33428888|NCT00456612|62806594|FG000|Overall Study|Withdrawal by Subject|3|||
33428889|NCT00456300|62806599|FG000|Overall Study|Adverse Event|1|||
33428890|NCT00456300|62806600|FG001|Overall Study|Adverse Event|0|||
33428891|NCT00267748|62806611|FG000|Non-randomized Period|Progressive disease|10|||
33428892|NCT00267748|62806612|FG001|Non-randomized Period|Progressive disease|0|||
33428893|NCT00267748|62806613|FG002|Non-randomized Period|Progressive disease|0|||
33428894|NCT00267748|62806611|FG000|Non-randomized Period|Adverse Event|8|||
33428895|NCT00267748|62806612|FG001|Non-randomized Period|Adverse Event|0|||
33428896|NCT00267748|62806613|FG002|Non-randomized Period|Adverse Event|0|||
33428897|NCT00267748|62806611|FG000|Non-randomized Period|Death|1|||
33428898|NCT00267748|62806612|FG001|Non-randomized Period|Death|0|||
33428899|NCT00267748|62806613|FG002|Non-randomized Period|Death|0|||
33428900|NCT00267748|62806611|FG000|Non-randomized Period|Participant not willing to participate|1|||
33428901|NCT00267748|62806612|FG001|Non-randomized Period|Participant not willing to participate|0|||
33428902|NCT00267748|62806613|FG002|Non-randomized Period|Participant not willing to participate|0|||
33428903|NCT00267748|62806611|FG000|Non-randomized Period|Other|3|||
33428904|NCT00267748|62806612|FG001|Non-randomized Period|Other|0|||
33428905|NCT00267748|62806613|FG002|Non-randomized Period|Other|0|||
33428906|NCT00267748|62806611|FG000|Randomized Period|Death|0|||
33428907|NCT00267748|62806612|FG001|Randomized Period|Death|2|||
33428908|NCT00267748|62806613|FG002|Randomized Period|Death|3|||
33428909|NCT00267748|62806611|FG000|Randomized Period|Adverse Event|0|||
33428910|NCT00267748|62806612|FG001|Randomized Period|Adverse Event|23|||
33428911|NCT00267748|62806613|FG002|Randomized Period|Adverse Event|25|||
33428912|NCT00267748|62806611|FG000|Randomized Period|Global deterioration of health status|0|||
33428913|NCT00267748|62806612|FG001|Randomized Period|Global deterioration of health status|6|||
33428914|NCT00267748|62806613|FG002|Randomized Period|Global deterioration of health status|7|||
33428915|NCT00267748|62806611|FG000|Randomized Period|Lost to Follow-up|0|||
33428916|NCT00267748|62806612|FG001|Randomized Period|Lost to Follow-up|1|||
33428917|NCT00267748|62806613|FG002|Randomized Period|Lost to Follow-up|0|||
33428918|NCT00267748|62806611|FG000|Randomized Period|Objective progression or relapse|0|||
33428919|NCT00267748|62806612|FG001|Randomized Period|Objective progression or relapse|77|||
33428920|NCT00267748|62806613|FG002|Randomized Period|Objective progression or relapse|86|||
33428921|NCT00267748|62806611|FG000|Randomized Period|Withdrawal by Subject|0|||
33428922|NCT00267748|62806612|FG001|Randomized Period|Withdrawal by Subject|9|||
33428923|NCT00267748|62806613|FG002|Randomized Period|Withdrawal by Subject|2|||
33428924|NCT00267748|62806611|FG000|Randomized Period|Other|0|||
33428925|NCT00267748|62806612|FG001|Randomized Period|Other|9|||
33428926|NCT00267748|62806613|FG002|Randomized Period|Other|6|||
33428927|NCT00267748|62806611|FG000|Randomized Period|randomized but not treated|0|||
33428928|NCT00267748|62806612|FG001|Randomized Period|randomized but not treated|0|||
33428929|NCT00267748|62806613|FG002|Randomized Period|randomized but not treated|3|||
33428930|NCT00267202|62806622|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
33428931|NCT00267202|62806623|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
33428932|NCT00267202|62806622|FG000|Overall Study|Withdrawal by Subject|12|||
33428933|NCT00267202|62806623|FG001|Overall Study|Withdrawal by Subject|15|||
33428934|NCT00267202|62806622|FG000|Overall Study|Adverse Event|13|||
33428935|NCT00267202|62806623|FG001|Overall Study|Adverse Event|7|||
33428936|NCT00267202|62806622|FG000|Overall Study|Protocol Violation|2|||
33428937|NCT00267202|62806623|FG001|Overall Study|Protocol Violation|3|||
33428938|NCT00267202|62806622|FG000|Overall Study|Administrative problems|2|||
33428939|NCT00267202|62806623|FG001|Overall Study|Administrative problems|1|||
33428940|NCT00267202|62806622|FG000|Overall Study|Lost to Follow-up|3|||
33428941|NCT00267202|62806623|FG001|Overall Study|Lost to Follow-up|0|||
33428942|NCT00267046|62806632|FG000|Overall Study|Disease progression|4|||
33428943|NCT00267046|62806633|FG001|Overall Study|Disease progression|2|||
33428944|NCT00267046|62806632|FG000|Overall Study|Chemotoxicity|2|||
33428945|NCT00267046|62806633|FG001|Overall Study|Chemotoxicity|0|||
33428946|NCT00267046|62806632|FG000|Overall Study|Open-label palifermin|2|||
33428947|NCT00267046|62806633|FG001|Overall Study|Open-label palifermin|7|||
33428948|NCT00267046|62806632|FG000|Overall Study|Surgery|3|||
33428949|NCT00267046|62806633|FG001|Overall Study|Surgery|1|||
33428950|NCT00267046|62806632|FG000|Overall Study|Withdrawal by Subject|1|||
33428951|NCT00267046|62806633|FG001|Overall Study|Withdrawal by Subject|0|||
33428952|NCT00267046|62806632|FG000|Overall Study|Radiation|0|||
33428953|NCT00267046|62806633|FG001|Overall Study|Radiation|1|||
33428954|NCT00441090|62806644|FG000|Overall Study|Adverse Event|0|||
33428955|NCT00441090|62806645|FG001|Overall Study|Adverse Event|1|||
33428956|NCT00441090|62806646|FG002|Overall Study|Adverse Event|1|||
33428957|NCT00441090|62806647|FG003|Overall Study|Adverse Event|0|||
33428958|NCT00441090|62806648|FG004|Overall Study|Adverse Event|0|||
33428959|NCT00441090|62806644|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
33428960|NCT00441090|62806645|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
33428961|NCT00441090|62806646|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
33428962|NCT00441090|62806647|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
33428963|NCT00441090|62806648|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
33428964|NCT00441090|62806644|FG000|Overall Study|Withdrawal by Subject|1|||
33428965|NCT00441090|62806645|FG001|Overall Study|Withdrawal by Subject|0|||
33428966|NCT00441090|62806646|FG002|Overall Study|Withdrawal by Subject|1|||
33428967|NCT00441090|62806647|FG003|Overall Study|Withdrawal by Subject|0|||
33428968|NCT00441090|62806648|FG004|Overall Study|Withdrawal by Subject|0|||
33428969|NCT00441090|62806644|FG000|Overall Study|Lack of Efficacy|1|||
33428970|NCT00441090|62806645|FG001|Overall Study|Lack of Efficacy|0|||
33428971|NCT00441090|62806646|FG002|Overall Study|Lack of Efficacy|0|||
33428972|NCT00441090|62806647|FG003|Overall Study|Lack of Efficacy|0|||
33428973|NCT00441090|62806648|FG004|Overall Study|Lack of Efficacy|0|||
33428974|NCT00441012|62806662|FG000|Overall Study|Adverse Event|0|||
33428975|NCT00441012|62806663|FG001|Overall Study|Adverse Event|1|||
33428976|NCT00441012|62806662|FG000|Overall Study|Lost to Follow-up|3|||
33428977|NCT00441012|62806663|FG001|Overall Study|Lost to Follow-up|3|||
33428978|NCT00441012|62806662|FG000|Overall Study|Protocol Violation|10|||
33428979|NCT00441012|62806663|FG001|Overall Study|Protocol Violation|9|||
33428980|NCT00441012|62806662|FG000|Overall Study|Withdrawal by Subject|4|||
33428981|NCT00441012|62806663|FG001|Overall Study|Withdrawal by Subject|0|||
33428982|NCT00441012|62806662|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
33428983|NCT00441012|62806663|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
33428984|NCT00286468|62806672|FG000|Overall Study|Hyperglycemic Rescue|28|||
33428985|NCT00286468|62806673|FG001|Overall Study|Hyperglycemic Rescue|30|||
33428986|NCT00286468|62806674|FG002|Overall Study|Hyperglycemic Rescue|31|||
33428987|NCT00286468|62806672|FG000|Overall Study|Adverse Event|2|||
33428988|NCT00286468|62806673|FG001|Overall Study|Adverse Event|6|||
33428989|NCT00286468|62806674|FG002|Overall Study|Adverse Event|4|||
33428990|NCT00286468|62806672|FG000|Overall Study|Protocol Violation|0|||
33428991|NCT00286468|62806673|FG001|Overall Study|Protocol Violation|3|||
33428992|NCT00286468|62806674|FG002|Overall Study|Protocol Violation|1|||
33428993|NCT00286468|62806672|FG000|Overall Study|Lost to Follow-up|1|||
33428994|NCT00286468|62806673|FG001|Overall Study|Lost to Follow-up|1|||
33428995|NCT00286468|62806674|FG002|Overall Study|Lost to Follow-up|2|||
33428996|NCT00286468|62806672|FG000|Overall Study|Withdrawal by Subject|3|||
33428997|NCT00286468|62806673|FG001|Overall Study|Withdrawal by Subject|8|||
33428998|NCT00286468|62806674|FG002|Overall Study|Withdrawal by Subject|11|||
33428999|NCT00286468|62806672|FG000|Overall Study|Physician Decision|3|||
33429000|NCT00286468|62806673|FG001|Overall Study|Physician Decision|2|||
33429001|NCT00286468|62806674|FG002|Overall Study|Physician Decision|1|||
33429002|NCT00507026|62806685|FG000|Overall Study|Lack of Efficacy|6|||
33429003|NCT00507026|62806686|FG001|Overall Study|Lack of Efficacy|4|||
33429004|NCT00507026|62806687|FG002|Overall Study|Lack of Efficacy|21|||
33429005|NCT00507026|62806685|FG000|Overall Study|Withdrawal by Subject|2|||
33429006|NCT00507026|62806686|FG001|Overall Study|Withdrawal by Subject|0|||
33429007|NCT00507026|62806687|FG002|Overall Study|Withdrawal by Subject|0|||
33429008|NCT00507026|62806685|FG000|Overall Study|Investigator Decision|1|||
33429009|NCT00507026|62806686|FG001|Overall Study|Investigator Decision|0|||
33429010|NCT00507026|62806687|FG002|Overall Study|Investigator Decision|0|||
33429011|NCT00507026|62806685|FG000|Overall Study|Adverse Event|2|||
33429012|NCT00507026|62806686|FG001|Overall Study|Adverse Event|0|||
33429013|NCT00507026|62806687|FG002|Overall Study|Adverse Event|0|||
33429014|NCT00507026|62806685|FG000|Overall Study|Protocol Violation|1|||
33429015|NCT00507026|62806686|FG001|Overall Study|Protocol Violation|0|||
33429016|NCT00507026|62806687|FG002|Overall Study|Protocol Violation|0|||
33429017|NCT00507026|62806685|FG000|Overall Study|Other|1|||
33429018|NCT00507026|62806686|FG001|Overall Study|Other|0|||
33429019|NCT00507026|62806687|FG002|Overall Study|Other|0|||
33429020|NCT00446550|62806697|FG000|Overall Study|Adverse Event|1|||
33429021|NCT00446550|62806698|FG001|Overall Study|Adverse Event|0|||
33429022|NCT03847974|62806705|FG000|Overall Study|relocated out of region|3|||
33429023|NCT03847974|62806705|FG000|Overall Study|Withdrawal by Subject|2|||
33429024|NCT03847974|62806705|FG000|Overall Study|Adverse Event|1|||
33429025|NCT00506948|62806709|FG000|Overall Study|Death|4|||
33429026|NCT00506948|62806709|FG000|Overall Study|Adverse Event|5|||
33429027|NCT00506948|62806709|FG000|Overall Study|Physician Decision|1|||
33429028|NCT00286234|62806717|FG000|Overall Study|Protocol Violation|1|||
33429029|NCT00286234|62806718|FG001|Overall Study|Protocol Violation|2|||
33429030|NCT00286234|62806719|FG002|Overall Study|Protocol Violation|0|||
33429031|NCT00286234|62806720|FG003|Overall Study|Protocol Violation|1|||
33429032|NCT00286234|62806717|FG000|Overall Study|Physician Decision|1|||
33429033|NCT00286234|62806718|FG001|Overall Study|Physician Decision|0|||
33429034|NCT00286234|62806719|FG002|Overall Study|Physician Decision|0|||
33429035|NCT00286234|62806720|FG003|Overall Study|Physician Decision|1|||
33429036|NCT00286234|62806717|FG000|Overall Study|Adverse Event|0|||
33429037|NCT00286234|62806718|FG001|Overall Study|Adverse Event|0|||
33429038|NCT00286234|62806719|FG002|Overall Study|Adverse Event|0|||
33429039|NCT00286234|62806720|FG003|Overall Study|Adverse Event|1|||
33429040|NCT00286234|62806717|FG000|Overall Study|Adverse Event|0|||
33429041|NCT00286234|62806718|FG001|Overall Study|Adverse Event|0|||
33429042|NCT00286234|62806719|FG002|Overall Study|Adverse Event|0|||
33429043|NCT00286234|62806720|FG003|Overall Study|Adverse Event|1|||
33429044|NCT00445848|62806730|FG000|Overall Study|Adverse Event|14|||
33429045|NCT00445848|62806730|FG000|Overall Study|Withdrawal by Subject|4|||
33605381|NCT01649375|63005068|FG000|Week 16 up to Week 260|Technical issues|0|||
33429046|NCT00445848|62806730|FG000|Overall Study|Progression|62|||
33429047|NCT00445848|62806730|FG000|Overall Study|Other-Not protocol specified|5|||
33429048|NCT00286156|62806737|FG000|Overall Study|Missed 12 month visit|0|||
33429049|NCT00286156|62806738|FG001|Overall Study|Missed 12 month visit|0|||
33429050|NCT00286156|62806739|FG002|Overall Study|Missed 12 month visit|1|||
33429051|NCT00286156|62806737|FG000|Overall Study|AE: pulmonary embolus|0|||
33429052|NCT00286156|62806738|FG001|Overall Study|AE: pulmonary embolus|1|||
33429053|NCT00286156|62806739|FG002|Overall Study|AE: pulmonary embolus|0|||
33429054|NCT00286156|62806737|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
33429055|NCT00286156|62806738|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
33605382|NCT01649375|63005069|FG001|Week 16 up to Week 260|Technical issues|1|||
33429056|NCT00286156|62806739|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
33429057|NCT00286156|62806737|FG000|Overall Study|AE: pneumonia|1|||
33429058|NCT00286156|62806738|FG001|Overall Study|AE: pneumonia|0|||
33429059|NCT00286156|62806739|FG002|Overall Study|AE: pneumonia|0|||
33429060|NCT00455520|62806749|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
33429061|NCT00455520|62806750|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
33429062|NCT00455520|62806749|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
33429063|NCT00455520|62806750|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
33429064|NCT00455520|62806749|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
33429065|NCT00455520|62806750|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
33429066|NCT00455520|62806749|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
33429067|NCT00455520|62806750|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
33429068|NCT00455520|62806749|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
33429069|NCT00455520|62806750|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
33429070|NCT00455520|62806749|FG000|Open Label Tapentadol Extended Release|All other|33|||
33429071|NCT00455520|62806750|FG001|Open Label Tapentadol Extended Release|All other|0|||
33429072|NCT00455520|62806749|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
33429073|NCT00455520|62806750|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
33429074|NCT00455520|62806749|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
33429075|NCT00455520|62806750|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
33429076|NCT00455520|62806749|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
33429077|NCT00455520|62806750|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
33429078|NCT00455520|62806749|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
33429079|NCT00455520|62806750|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
33429080|NCT00455520|62806749|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
33429081|NCT00455520|62806750|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
33429082|NCT00455520|62806749|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
33429083|NCT00455520|62806750|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
33429084|NCT00440700|62806759|FG000|Overall Study|Withdrawal by Subject|8|||
33429085|NCT00440700|62806760|FG001|Overall Study|Withdrawal by Subject|8|||
33429086|NCT00440700|62806761|FG002|Overall Study|Withdrawal by Subject|4|||
33429087|NCT00284050|62806772|FG000|Overall Study|Adverse Event|1|||
33429088|NCT00284050|62806773|FG001|Overall Study|Adverse Event|1|||
33429089|NCT00284050|62806774|FG002|Overall Study|Adverse Event|1|||
33429090|NCT00284050|62806772|FG000|Overall Study|Lack of Efficacy|0|||
33429091|NCT00284050|62806773|FG001|Overall Study|Lack of Efficacy|1|||
33429092|NCT00284050|62806774|FG002|Overall Study|Lack of Efficacy|3|||
33429093|NCT00284050|62806772|FG000|Overall Study|Protocol Violation|0|||
33429094|NCT00284050|62806773|FG001|Overall Study|Protocol Violation|1|||
33429095|NCT00284050|62806774|FG002|Overall Study|Protocol Violation|2|||
33429096|NCT00284050|62806772|FG000|Overall Study|Withdrawal by Subject|2|||
33429097|NCT00284050|62806773|FG001|Overall Study|Withdrawal by Subject|2|||
33429098|NCT00284050|62806774|FG002|Overall Study|Withdrawal by Subject|2|||
33429099|NCT00284050|62806772|FG000|Overall Study|Lost to Follow-up|1|||
33429100|NCT00284050|62806773|FG001|Overall Study|Lost to Follow-up|0|||
33429101|NCT00284050|62806774|FG002|Overall Study|Lost to Follow-up|1|||
33429102|NCT00284050|62806772|FG000|Overall Study|Death|1|||
33429103|NCT00284050|62806773|FG001|Overall Study|Death|0|||
33429104|NCT00284050|62806774|FG002|Overall Study|Death|0|||
33429105|NCT00293020|62806782|FG000|Overall Study|Withdrawal by Subject|34|||
33429106|NCT00293020|62806782|FG000|Overall Study|Adverse Event|30|||
33429107|NCT00293020|62806782|FG000|Overall Study|Death|32|||
33429108|NCT00293020|62806782|FG000|Overall Study|Lack of Efficacy|12|||
33429109|NCT00293020|62806782|FG000|Overall Study|Lost to Follow-up|4|||
33429110|NCT00293020|62806782|FG000|Overall Study|Protocol Violation|6|||
33429111|NCT00293020|62806782|FG000|Overall Study|Physician Decision|21|||
33429112|NCT00293020|62806782|FG000|Overall Study|Other Reason|22|||
33429113|NCT00293020|62806782|FG000|Overall Study|No dose taken|1|||
33429114|NCT00377637|62806790|FG000|Induction Phase|Adverse Event|12|||
33429115|NCT00377637|62806791|FG001|Induction Phase|Adverse Event|21|||
33429116|NCT00377637|62806792|FG002|Induction Phase|Adverse Event|0|||
33429117|NCT00377637|62806793|FG003|Induction Phase|Adverse Event|0|||
33429118|NCT00377637|62806790|FG000|Induction Phase|Deterioration/serum creatinine|2|||
33429119|NCT00377637|62806791|FG001|Induction Phase|Deterioration/serum creatinine|0|||
33429120|NCT00377637|62806792|FG002|Induction Phase|Deterioration/serum creatinine|0|||
33429121|NCT00377637|62806793|FG003|Induction Phase|Deterioration/serum creatinine|0|||
33429122|NCT00377637|62806790|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
33429123|NCT00377637|62806791|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
33429124|NCT00377637|62806792|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
33429125|NCT00377637|62806793|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
33429126|NCT00377637|62806790|FG000|Induction Phase|Lost to Follow-up|2|||
33429127|NCT00377637|62806791|FG001|Induction Phase|Lost to Follow-up|1|||
33429128|NCT00377637|62806792|FG002|Induction Phase|Lost to Follow-up|0|||
33429129|NCT00377637|62806793|FG003|Induction Phase|Lost to Follow-up|0|||
33429130|NCT00377637|62806790|FG000|Induction Phase|Death|1|||
33429131|NCT00377637|62806791|FG001|Induction Phase|Death|3|||
33429132|NCT00377637|62806792|FG002|Induction Phase|Death|0|||
33429133|NCT00377637|62806793|FG003|Induction Phase|Death|0|||
33429134|NCT00377637|62806790|FG000|Induction Phase|Withdrawal by Subject|5|||
33429135|NCT00377637|62806791|FG001|Induction Phase|Withdrawal by Subject|6|||
33429136|NCT00377637|62806792|FG002|Induction Phase|Withdrawal by Subject|0|||
33429137|NCT00377637|62806793|FG003|Induction Phase|Withdrawal by Subject|0|||
33429138|NCT00377637|62806790|FG000|Induction Phase|Physician Decision|3|||
33429139|NCT00377637|62806791|FG001|Induction Phase|Physician Decision|1|||
33429140|NCT00377637|62806792|FG002|Induction Phase|Physician Decision|0|||
33429141|NCT00377637|62806793|FG003|Induction Phase|Physician Decision|0|||
33429142|NCT00377637|62806790|FG000|Induction Phase|Sponsor decision|1|||
33429143|NCT00377637|62806791|FG001|Induction Phase|Sponsor decision|2|||
33429144|NCT00377637|62806792|FG002|Induction Phase|Sponsor decision|0|||
33429145|NCT00377637|62806793|FG003|Induction Phase|Sponsor decision|0|||
33429146|NCT00377637|62806790|FG000|Induction Phase|Non-Compliance|1|||
33429147|NCT00377637|62806791|FG001|Induction Phase|Non-Compliance|0|||
33429148|NCT00377637|62806792|FG002|Induction Phase|Non-Compliance|0|||
33429149|NCT00377637|62806793|FG003|Induction Phase|Non-Compliance|0|||
33429150|NCT00377637|62806790|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
33429151|NCT00377637|62806791|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
33429152|NCT00377637|62806792|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
33429153|NCT00377637|62806793|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
33429154|NCT00377637|62806790|FG000|Maintenance Phase|Adverse Event|0|||
33429155|NCT00377637|62806791|FG001|Maintenance Phase|Adverse Event|0|||
33429156|NCT00377637|62806792|FG002|Maintenance Phase|Adverse Event|29|||
33429157|NCT00377637|62806793|FG003|Maintenance Phase|Adverse Event|43|||
33429158|NCT00377637|62806790|FG000|Maintenance Phase|Physician Decision|0|||
33429159|NCT00377637|62806791|FG001|Maintenance Phase|Physician Decision|0|||
33429160|NCT00377637|62806792|FG002|Maintenance Phase|Physician Decision|5|||
33429161|NCT00377637|62806793|FG003|Maintenance Phase|Physician Decision|4|||
33429162|NCT00377637|62806790|FG000|Maintenance Phase|Lost to Follow-up|0|||
33429163|NCT00377637|62806791|FG001|Maintenance Phase|Lost to Follow-up|0|||
33429164|NCT00377637|62806792|FG002|Maintenance Phase|Lost to Follow-up|3|||
33429165|NCT00377637|62806793|FG003|Maintenance Phase|Lost to Follow-up|1|||
33429166|NCT00377637|62806790|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33429167|NCT00377637|62806791|FG001|Maintenance Phase|Withdrawal by Subject|0|||
33429168|NCT00377637|62806792|FG002|Maintenance Phase|Withdrawal by Subject|3|||
33429169|NCT00377637|62806793|FG003|Maintenance Phase|Withdrawal by Subject|3|||
33429170|NCT00377637|62806790|FG000|Maintenance Phase|Sponsor decision|0|||
33429171|NCT00377637|62806791|FG001|Maintenance Phase|Sponsor decision|0|||
33429172|NCT00377637|62806792|FG002|Maintenance Phase|Sponsor decision|2|||
33429173|NCT00377637|62806793|FG003|Maintenance Phase|Sponsor decision|3|||
33429174|NCT00377637|62806790|FG000|Maintenance Phase|Non-compliance|0|||
33429175|NCT00377637|62806791|FG001|Maintenance Phase|Non-compliance|0|||
33429176|NCT00377637|62806792|FG002|Maintenance Phase|Non-compliance|1|||
33429177|NCT00377637|62806793|FG003|Maintenance Phase|Non-compliance|1|||
33429178|NCT00377637|62806790|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
33429179|NCT00377637|62806791|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
33429180|NCT00377637|62806792|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
33429181|NCT00377637|62806793|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
33429182|NCT00377637|62806790|FG000|Maintenance Phase|Death|0|||
33429183|NCT00377637|62806791|FG001|Maintenance Phase|Death|0|||
33429184|NCT00377637|62806792|FG002|Maintenance Phase|Death|0|||
33429185|NCT00377637|62806793|FG003|Maintenance Phase|Death|1|||
33429186|NCT00377403|62806809|FG000|Overall Study|Unable to contact for telephone intervie|4|||
33429187|NCT00377403|62806810|FG001|Overall Study|Unable to contact for telephone intervie|7|||
33429188|NCT00370149|62806818|FG000|Overall Study|Physician Decision|16|||
33429189|NCT00370149|62806819|FG001|Overall Study|Physician Decision|16|||
33429190|NCT00370149|62806818|FG000|Overall Study|Protocol Violation|1|||
33429191|NCT00370149|62806819|FG001|Overall Study|Protocol Violation|0|||
33429192|NCT00370149|62806818|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
33429193|NCT00370149|62806819|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
33429194|NCT00370149|62806818|FG000|Overall Study|Pre-existing infection|0|||
33429195|NCT00370149|62806819|FG001|Overall Study|Pre-existing infection|1|||
33429196|NCT00370149|62806818|FG000|Overall Study|Antibiotic coated dressing placed|0|||
33429197|NCT00370149|62806819|FG001|Overall Study|Antibiotic coated dressing placed|1|||
33429198|NCT00292942|62806832|FG000|Overall Study|Withdrawal by Subject|0|||
33429199|NCT00292942|62806833|FG001|Overall Study|Withdrawal by Subject|0|||
33429200|NCT00292942|62806834|FG002|Overall Study|Withdrawal by Subject|1|||
33429201|NCT00292942|62806835|FG003|Overall Study|Withdrawal by Subject|0|||
33429202|NCT00292942|62806832|FG000|Overall Study|Adverse Event|0|||
33429203|NCT00292942|62806833|FG001|Overall Study|Adverse Event|0|||
33429204|NCT00292942|62806834|FG002|Overall Study|Adverse Event|0|||
33429205|NCT00292942|62806835|FG003|Overall Study|Adverse Event|1|||
33429206|NCT00483938|62806855|FG000|Overall Study|Protocol Violation|0|||
33429207|NCT00483938|62806856|FG001|Overall Study|Protocol Violation|0|||
33429208|NCT00483938|62806857|FG002|Overall Study|Protocol Violation|0|||
33429209|NCT00483938|62806858|FG003|Overall Study|Protocol Violation|0|||
33429210|NCT00483938|62806859|FG004|Overall Study|Protocol Violation|0|||
33429211|NCT00483938|62806860|FG005|Overall Study|Protocol Violation|0|||
33429212|NCT00483938|62806861|FG006|Overall Study|Protocol Violation|3|||
33429213|NCT00483938|62806855|FG000|Overall Study|Withdrawal by Subject|1|||
33429214|NCT00483938|62806856|FG001|Overall Study|Withdrawal by Subject|6|||
33429215|NCT00483938|62806857|FG002|Overall Study|Withdrawal by Subject|0|||
33429216|NCT00483938|62806858|FG003|Overall Study|Withdrawal by Subject|0|||
33429217|NCT00483938|62806859|FG004|Overall Study|Withdrawal by Subject|1|||
33429218|NCT00483938|62806860|FG005|Overall Study|Withdrawal by Subject|3|||
33429219|NCT00483938|62806861|FG006|Overall Study|Withdrawal by Subject|2|||
33429220|NCT00483938|62806855|FG000|Overall Study|Lost to Follow-up|1|||
33429221|NCT00483938|62806856|FG001|Overall Study|Lost to Follow-up|2|||
33429222|NCT00483938|62806857|FG002|Overall Study|Lost to Follow-up|0|||
33429223|NCT00483938|62806858|FG003|Overall Study|Lost to Follow-up|2|||
33429224|NCT00483938|62806859|FG004|Overall Study|Lost to Follow-up|1|||
33429225|NCT00483938|62806860|FG005|Overall Study|Lost to Follow-up|1|||
33429226|NCT00483938|62806861|FG006|Overall Study|Lost to Follow-up|3|||
33429227|NCT00483938|62806855|FG000|Overall Study|Death|0|||
33429228|NCT00483938|62806856|FG001|Overall Study|Death|2|||
33429229|NCT00483938|62806857|FG002|Overall Study|Death|0|||
33429230|NCT00483938|62806858|FG003|Overall Study|Death|0|||
33429231|NCT00483938|62806859|FG004|Overall Study|Death|0|||
33429232|NCT00483938|62806860|FG005|Overall Study|Death|0|||
33429233|NCT00483938|62806861|FG006|Overall Study|Death|0|||
33429234|NCT00483938|62806855|FG000|Overall Study|Other|3|||
33429235|NCT00483938|62806856|FG001|Overall Study|Other|9|||
33429236|NCT00483938|62806857|FG002|Overall Study|Other|0|||
33429237|NCT00483938|62806858|FG003|Overall Study|Other|4|||
33429238|NCT00483938|62806859|FG004|Overall Study|Other|0|||
33429239|NCT00483938|62806860|FG005|Overall Study|Other|4|||
33429240|NCT00483938|62806861|FG006|Overall Study|Other|32|||
33429241|NCT00370071|62806880|FG000|Overall Study|Withdrawal by Subject|2|||
33429242|NCT00369915|62806886|FG000|Overall Study|expected side effects|2|||
33429243|NCT00369915|62806887|FG001|Overall Study|expected side effects|1|||
33429244|NCT00369915|62806886|FG000|Overall Study|Withdrawal by Subject|4|||
33429245|NCT00369915|62806887|FG001|Overall Study|Withdrawal by Subject|1|||
33429246|NCT00369915|62806886|FG000|Overall Study|W/drawl by investigators|0|||
33429247|NCT00369915|62806887|FG001|Overall Study|W/drawl by investigators|1|||
33429248|NCT00369681|62806893|FG000|Overall Study|Death|1|||
33429249|NCT00266812|62806899|FG000|Overall Study|Disease Progression|9|||
33429250|NCT00266812|62806900|FG001|Overall Study|Disease Progression|3|||
33429251|NCT00266812|62806899|FG000|Overall Study|Death|5|||
33429252|NCT00266812|62806900|FG001|Overall Study|Death|4|||
33429253|NCT00266812|62806899|FG000|Overall Study|Adverse Event|3|||
33429254|NCT00266812|62806900|FG001|Overall Study|Adverse Event|1|||
33429255|NCT00266812|62806899|FG000|Overall Study|Protocol Violation|0|||
33429256|NCT00266812|62806900|FG001|Overall Study|Protocol Violation|1|||
33429257|NCT00266812|62806899|FG000|Overall Study|Withdrawal by Subject|0|||
33429258|NCT00266812|62806900|FG001|Overall Study|Withdrawal by Subject|2|||
33429259|NCT00266812|62806899|FG000|Overall Study|Discontinued before starting study drug|4|||
33429260|NCT00266812|62806900|FG001|Overall Study|Discontinued before starting study drug|0|||
33429261|NCT00488774|62806910|FG000|Overall Study|Withdrawal of consent|2|||
33429262|NCT00488774|62806911|FG001|Overall Study|Withdrawal of consent|2|||
33429263|NCT00488774|62806912|FG002|Overall Study|Withdrawal of consent|2|||
33429264|NCT00488774|62806913|FG003|Overall Study|Withdrawal of consent|0|||
33323071|NCT00976209|62699382|FG001|Treatment Period 1|Lost to Follow-up|0|||
33429265|NCT00488774|62806910|FG000|Overall Study|Other|6|||
33429266|NCT00488774|62806911|FG001|Overall Study|Other|3|||
33429267|NCT00488774|62806912|FG002|Overall Study|Other|2|||
33429268|NCT00488774|62806913|FG003|Overall Study|Other|2|||
33429269|NCT00488774|62806910|FG000|Overall Study|Lost to Follow-up|0|||
33429270|NCT00488774|62806911|FG001|Overall Study|Lost to Follow-up|0|||
33429271|NCT00488774|62806912|FG002|Overall Study|Lost to Follow-up|1|||
33429272|NCT00488774|62806913|FG003|Overall Study|Lost to Follow-up|1|||
33429273|NCT00361569|62806928|FG000|Overall Study|Protocol Violation|3|||
33429274|NCT00361569|62806929|FG001|Overall Study|Protocol Violation|2|||
33429275|NCT00361569|62806930|FG002|Overall Study|Protocol Violation|4|||
33429276|NCT00361569|62806931|FG003|Overall Study|Protocol Violation|2|||
33429277|NCT00361569|62806928|FG000|Overall Study|Withdrawal by Subject|2|||
33429278|NCT00361569|62806929|FG001|Overall Study|Withdrawal by Subject|1|||
33429279|NCT00361569|62806930|FG002|Overall Study|Withdrawal by Subject|9|||
33429280|NCT00361569|62806931|FG003|Overall Study|Withdrawal by Subject|14|||
33429281|NCT00361569|62806928|FG000|Overall Study|Adverse Event|3|||
33429282|NCT00361569|62806929|FG001|Overall Study|Adverse Event|5|||
33429283|NCT00361569|62806930|FG002|Overall Study|Adverse Event|2|||
33429284|NCT00361569|62806931|FG003|Overall Study|Adverse Event|2|||
33429285|NCT00361569|62806928|FG000|Overall Study|Lost to Follow-up|2|||
33429286|NCT00361569|62806929|FG001|Overall Study|Lost to Follow-up|3|||
33429287|NCT00361569|62806930|FG002|Overall Study|Lost to Follow-up|3|||
33429288|NCT00361569|62806931|FG003|Overall Study|Lost to Follow-up|2|||
33429289|NCT00361569|62806928|FG000|Overall Study|Not specified by investigator|2|||
33429290|NCT00361569|62806929|FG001|Overall Study|Not specified by investigator|0|||
33429291|NCT00361569|62806930|FG002|Overall Study|Not specified by investigator|0|||
33429292|NCT00361569|62806931|FG003|Overall Study|Not specified by investigator|1|||
33429293|NCT00488618|62806943|FG000|Overall Study|Adverse Event|13|||
33429294|NCT00488618|62806944|FG001|Overall Study|Adverse Event|17|||
33429295|NCT00488618|62806943|FG000|Overall Study|Insufficient Therapeutic Response|18|||
33429296|NCT00488618|62806944|FG001|Overall Study|Insufficient Therapeutic Response|11|||
33429297|NCT00488618|62806943|FG000|Overall Study|Protocol Violation|0|||
33429298|NCT00488618|62806944|FG001|Overall Study|Protocol Violation|2|||
33429299|NCT00488618|62806943|FG000|Overall Study|Withdrawal of Consent|15|||
33429300|NCT00488618|62806944|FG001|Overall Study|Withdrawal of Consent|13|||
33429301|NCT00488618|62806943|FG000|Overall Study|Lost to Follow-up|1|||
33429302|NCT00488618|62806944|FG001|Overall Study|Lost to Follow-up|0|||
33429303|NCT00266656|62806952|FG000|Overall Study|Death|1|||
33429304|NCT00266656|62806953|FG001|Overall Study|Death|0|||
33429305|NCT00266656|62806952|FG000|Overall Study|Lost to Follow-up|4|||
33429306|NCT00266656|62806953|FG001|Overall Study|Lost to Follow-up|1|||
33429307|NCT00266656|62806952|FG000|Overall Study|Withdrawal by Subject|4|||
33429308|NCT00266656|62806953|FG001|Overall Study|Withdrawal by Subject|2|||
33429309|NCT00266656|62806952|FG000|Overall Study|Did Not Reach Final Height|4|||
33429310|NCT00266656|62806953|FG001|Overall Study|Did Not Reach Final Height|8|||
33429311|NCT00266656|62806952|FG000|Overall Study|Parent/Caregiver Decision|1|||
33429312|NCT00266656|62806953|FG001|Overall Study|Parent/Caregiver Decision|2|||
33429313|NCT00483704|62806962|FG000|Randomization|Withdrawal by Subject|19|||
33429314|NCT00483704|62806963|FG001|Randomization|Withdrawal by Subject|28|||
33429315|NCT00483704|62806964|FG002|Randomization|Withdrawal by Subject|18|||
33429316|NCT00483704|62806962|FG000|Randomization|Protocol Violation|14|||
33429317|NCT00483704|62806963|FG001|Randomization|Protocol Violation|25|||
33429318|NCT00483704|62806964|FG002|Randomization|Protocol Violation|22|||
33429319|NCT00483704|62806962|FG000|Randomization|Lost to Follow-up|14|||
33429320|NCT00483704|62806963|FG001|Randomization|Lost to Follow-up|14|||
33429321|NCT00483704|62806964|FG002|Randomization|Lost to Follow-up|19|||
33429322|NCT00483704|62806962|FG000|Randomization|Pregnancy|1|||
33429323|NCT00483704|62806963|FG001|Randomization|Pregnancy|0|||
33429324|NCT00483704|62806964|FG002|Randomization|Pregnancy|0|||
33429325|NCT00483704|62806962|FG000|Randomization|Physician Decision|2|||
33429326|NCT00483704|62806963|FG001|Randomization|Physician Decision|4|||
33429327|NCT00483704|62806964|FG002|Randomization|Physician Decision|0|||
33429328|NCT00483704|62806962|FG000|Randomization|Progressive disease|0|||
33429329|NCT00483704|62806963|FG001|Randomization|Progressive disease|0|||
33429330|NCT00483704|62806964|FG002|Randomization|Progressive disease|1|||
33429331|NCT00483704|62806962|FG000|Randomization|Lack of qualifying migraines|21|||
33429332|NCT00483704|62806963|FG001|Randomization|Lack of qualifying migraines|25|||
33429333|NCT00483704|62806964|FG002|Randomization|Lack of qualifying migraines|31|||
33429334|NCT00483704|62806962|FG000|Treatment|Lack of qualifying migraines|101|||
33429335|NCT00483704|62806963|FG001|Treatment|Lack of qualifying migraines|99|||
33429336|NCT00483704|62806964|FG002|Treatment|Lack of qualifying migraines|116|||
33429337|NCT00483704|62806962|FG000|Treatment|Adverse Event|3|||
33429338|NCT00483704|62806963|FG001|Treatment|Adverse Event|5|||
33429339|NCT00483704|62806964|FG002|Treatment|Adverse Event|4|||
33605383|NCT01649375|63005070|FG002|Week 16 up to Week 260|Technical issues|0|||
33605384|NCT01649375|63005071|FG003|Week 16 up to Week 260|Technical issues|1|||
33605385|NCT01649375|63005072|FG004|Week 16 up to Week 260|Technical issues|0|||
33323072|NCT00976209|62699381|FG000|Treatment Period 1|Other|0|||
33429340|NCT00483704|62806962|FG000|Treatment|Withdrawal by Subject|16|||
33429341|NCT00483704|62806963|FG001|Treatment|Withdrawal by Subject|12|||
33429342|NCT00483704|62806964|FG002|Treatment|Withdrawal by Subject|21|||
33429343|NCT00483704|62806962|FG000|Treatment|Protocol Violation|6|||
33429344|NCT00483704|62806963|FG001|Treatment|Protocol Violation|3|||
33429345|NCT00483704|62806964|FG002|Treatment|Protocol Violation|5|||
33429346|NCT00483704|62806962|FG000|Treatment|Lost to Follow-up|2|||
33429347|NCT00483704|62806963|FG001|Treatment|Lost to Follow-up|7|||
33429348|NCT00483704|62806964|FG002|Treatment|Lost to Follow-up|5|||
33429349|NCT00483704|62806962|FG000|Treatment|Lack of Efficacy|1|||
33429350|NCT00483704|62806963|FG001|Treatment|Lack of Efficacy|1|||
33429351|NCT00483704|62806964|FG002|Treatment|Lack of Efficacy|1|||
33429352|NCT00483704|62806962|FG000|Treatment|Pregnancy|0|||
33429353|NCT00483704|62806963|FG001|Treatment|Pregnancy|1|||
33429354|NCT00483704|62806964|FG002|Treatment|Pregnancy|0|||
33429355|NCT00483704|62806962|FG000|Treatment|Physician Decision|0|||
33429356|NCT00483704|62806963|FG001|Treatment|Physician Decision|1|||
33429357|NCT00483704|62806964|FG002|Treatment|Physician Decision|4|||
33429358|NCT00483548|62806977|FG000|Overall Study|Randomized; not treated with study drug|1|||
33429359|NCT00483548|62806978|FG001|Overall Study|Randomized; not treated with study drug|3|||
33429360|NCT00483548|62806977|FG000|Overall Study|Adverse Event|25|||
33429361|NCT00483548|62806978|FG001|Overall Study|Adverse Event|14|||
33429362|NCT00483548|62806977|FG000|Overall Study|Laboratory abnormality|1|||
33429363|NCT00483548|62806978|FG001|Overall Study|Laboratory abnormality|2|||
33429364|NCT00483548|62806977|FG000|Overall Study|Lack of Efficacy|4|||
33429365|NCT00483548|62806978|FG001|Overall Study|Lack of Efficacy|8|||
33429366|NCT00483548|62806977|FG000|Overall Study|Protocol Violation|11|||
33429367|NCT00483548|62806978|FG001|Overall Study|Protocol Violation|7|||
33429368|NCT00483548|62806977|FG000|Overall Study|Pregnancy|1|||
33429369|NCT00483548|62806978|FG001|Overall Study|Pregnancy|0|||
33429370|NCT00483548|62806977|FG000|Overall Study|Protocol required discontinuation|6|||
33429371|NCT00483548|62806978|FG001|Overall Study|Protocol required discontinuation|6|||
33429372|NCT00483548|62806977|FG000|Overall Study|Unable to comply with protocol schedule|1|||
33429373|NCT00483548|62806978|FG001|Overall Study|Unable to comply with protocol schedule|0|||
33429374|NCT00483548|62806977|FG000|Overall Study|Non-compliance with medication|2|||
33429375|NCT00483548|62806978|FG001|Overall Study|Non-compliance with medication|0|||
33429376|NCT00483548|62806977|FG000|Overall Study|Lost to Follow-up|3|||
33429377|NCT00483548|62806978|FG001|Overall Study|Lost to Follow-up|4|||
33429378|NCT00483548|62806977|FG000|Overall Study|Withdrawal by Subject|5|||
33429379|NCT00483548|62806978|FG001|Overall Study|Withdrawal by Subject|2|||
33429380|NCT00445770|62806987|FG000|Overall Study|Adverse Event|9|||
33429381|NCT00445770|62806988|FG001|Overall Study|Adverse Event|15|||
33429382|NCT00445770|62806989|FG002|Overall Study|Adverse Event|19|||
33429383|NCT00445770|62806987|FG000|Overall Study|Lack of Efficacy|38|||
33429384|NCT00445770|62806988|FG001|Overall Study|Lack of Efficacy|13|||
33429385|NCT00445770|62806989|FG002|Overall Study|Lack of Efficacy|6|||
33429386|NCT00445770|62806987|FG000|Overall Study|Lost to Follow-up|0|||
33429387|NCT00445770|62806988|FG001|Overall Study|Lost to Follow-up|2|||
33429388|NCT00445770|62806989|FG002|Overall Study|Lost to Follow-up|0|||
33429389|NCT00445770|62806987|FG000|Overall Study|Other|6|||
33429390|NCT00445770|62806988|FG001|Overall Study|Other|5|||
33429391|NCT00445770|62806989|FG002|Overall Study|Other|6|||
33429392|NCT00266032|62807002|FG000|Treatment|Adverse Event|42|||
33429393|NCT00266032|62807003|FG001|Treatment|Adverse Event|26|||
33429394|NCT00266032|62807004|FG002|Treatment|Adverse Event|10|||
33429395|NCT00266032|62807002|FG000|Treatment|Lost to Follow-up|19|||
33429396|NCT00266032|62807003|FG001|Treatment|Lost to Follow-up|4|||
33429397|NCT00266032|62807004|FG002|Treatment|Lost to Follow-up|2|||
33429398|NCT00266032|62807002|FG000|Treatment|Pregnancy|3|||
33429399|NCT00266032|62807003|FG001|Treatment|Pregnancy|2|||
33429400|NCT00266032|62807004|FG002|Treatment|Pregnancy|2|||
33429401|NCT00266032|62807002|FG000|Treatment|Protocol Violation|6|||
33429402|NCT00266032|62807003|FG001|Treatment|Protocol Violation|14|||
33429403|NCT00266032|62807004|FG002|Treatment|Protocol Violation|13|||
33429404|NCT00266032|62807002|FG000|Treatment|Withdrawal by Subject|28|||
33429405|NCT00266032|62807003|FG001|Treatment|Withdrawal by Subject|13|||
33429406|NCT00266032|62807004|FG002|Treatment|Withdrawal by Subject|12|||
33429407|NCT00266032|62807002|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
33429408|NCT00266032|62807003|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
33429409|NCT00266032|62807004|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
33429410|NCT00266032|62807002|FG000|Open-label Safety Extension|Adverse Event|5|||
33429411|NCT00266032|62807003|FG001|Open-label Safety Extension|Adverse Event|0|||
33429412|NCT00266032|62807004|FG002|Open-label Safety Extension|Adverse Event|4|||
33429413|NCT00266032|62807002|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
33429414|NCT00266032|62807003|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
33429415|NCT00266032|62807004|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
33429416|NCT00266032|62807002|FG000|Open-label Safety Extension|Pregnancy|4|||
33429417|NCT00266032|62807003|FG001|Open-label Safety Extension|Pregnancy|1|||
33323073|NCT00976209|62699382|FG001|Treatment Period 1|Other|1|||
33429418|NCT00266032|62807004|FG002|Open-label Safety Extension|Pregnancy|2|||
33429419|NCT00266032|62807002|FG000|Open-label Safety Extension|Protocol Violation|1|||
33429420|NCT00266032|62807003|FG001|Open-label Safety Extension|Protocol Violation|3|||
33429421|NCT00266032|62807004|FG002|Open-label Safety Extension|Protocol Violation|2|||
33429422|NCT00266032|62807002|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
33429423|NCT00266032|62807003|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
33429424|NCT00266032|62807004|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
33429425|NCT00266032|62807002|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
33429426|NCT00266032|62807003|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
33429427|NCT00266032|62807004|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
33429428|NCT00483002|62807012|FG000|Overall Study|Adverse Event|68|||
33429429|NCT00483002|62807012|FG000|Overall Study|Lack of Efficacy|555|||
33429430|NCT00483002|62807012|FG000|Overall Study|Lost to Follow-up|962|||
33429431|NCT00483002|62807012|FG000|Overall Study|Other|2|||
33429432|NCT00483002|62807012|FG000|Overall Study|Other|967|||
33429433|NCT00482612|62807020|FG000|In-treatment Period|No study medication administered|0|||
33429434|NCT00482612|62807021|FG001|In-treatment Period|No study medication administered|0|||
33429435|NCT00482612|62807022|FG002|In-treatment Period|No study medication administered|1|||
33429436|NCT00482612|62807023|FG003|In-treatment Period|No study medication administered|0|||
33429437|NCT00482612|62807020|FG000|Follow-up Period|Other|4|||
33429438|NCT00482612|62807021|FG001|Follow-up Period|Other|2|||
33429439|NCT00482612|62807022|FG002|Follow-up Period|Other|1|||
33429440|NCT00482612|62807023|FG003|Follow-up Period|Other|2|||
33429441|NCT00482612|62807020|FG000|Follow-up Period|Lack of compliance|0|||
33429442|NCT00482612|62807021|FG001|Follow-up Period|Lack of compliance|0|||
33429443|NCT00482612|62807022|FG002|Follow-up Period|Lack of compliance|1|||
33429444|NCT00482612|62807023|FG003|Follow-up Period|Lack of compliance|0|||
33429445|NCT00482612|62807020|FG000|Follow-up Period|Lost to Follow-up|0|||
33429446|NCT00482612|62807021|FG001|Follow-up Period|Lost to Follow-up|4|||
33429447|NCT00482612|62807022|FG002|Follow-up Period|Lost to Follow-up|2|||
33429448|NCT00482612|62807023|FG003|Follow-up Period|Lost to Follow-up|1|||
33429449|NCT00482612|62807020|FG000|Follow-up Period|Adverse Event|4|||
33429450|NCT00482612|62807021|FG001|Follow-up Period|Adverse Event|7|||
33429451|NCT00482612|62807022|FG002|Follow-up Period|Adverse Event|9|||
33429452|NCT00482612|62807023|FG003|Follow-up Period|Adverse Event|0|||
33429453|NCT00482612|62807020|FG000|Follow-up Period|Lack of Efficacy|2|||
33429454|NCT00482612|62807021|FG001|Follow-up Period|Lack of Efficacy|0|||
33429455|NCT00482612|62807022|FG002|Follow-up Period|Lack of Efficacy|1|||
33429456|NCT00482612|62807023|FG003|Follow-up Period|Lack of Efficacy|0|||
33429457|NCT00482612|62807020|FG000|Follow-up Period|Withdrawal by Subject|3|||
33429458|NCT00482612|62807021|FG001|Follow-up Period|Withdrawal by Subject|5|||
33429459|NCT00482612|62807022|FG002|Follow-up Period|Withdrawal by Subject|7|||
33429460|NCT00482612|62807023|FG003|Follow-up Period|Withdrawal by Subject|2|||
33429461|NCT00482612|62807020|FG000|Follow-up Period|Reasons not related to trial|1|||
33429462|NCT00482612|62807021|FG001|Follow-up Period|Reasons not related to trial|0|||
33429463|NCT00482612|62807022|FG002|Follow-up Period|Reasons not related to trial|1|||
33429464|NCT00482612|62807023|FG003|Follow-up Period|Reasons not related to trial|3|||
33429465|NCT00282568|62807037|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
33429466|NCT00282568|62807037|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
33429467|NCT00282568|62807037|FG000|Extended Treatment Period|Adverse Event|17|||
33429468|NCT00282568|62807037|FG000|Extended Treatment Period|Non-compliance|4|||
33429469|NCT00282568|62807037|FG000|Extended Treatment Period|Physician Decision|1|||
33429470|NCT00282568|62807037|FG000|Extended Treatment Period|Lost to Follow-up|2|||
33429471|NCT00265564|62807043|FG000|Overall Study|Lost to Follow-up|5|||
33429472|NCT00265564|62807044|FG001|Overall Study|Lost to Follow-up|7|||
33429473|NCT00265564|62807043|FG000|Overall Study|met exclusion criteria|5|||
33429474|NCT00265564|62807044|FG001|Overall Study|met exclusion criteria|2|||
33429475|NCT00376623|62807053|FG000|Overall Study|Progressive disease|35|||
33429476|NCT00376623|62807054|FG001|Overall Study|Progressive disease|22|||
33429477|NCT00376623|62807055|FG002|Overall Study|Progressive disease|17|||
33429478|NCT00376623|62807053|FG000|Overall Study|Lost to Follow-up|0|||
33429479|NCT00376623|62807054|FG001|Overall Study|Lost to Follow-up|1|||
33429480|NCT00376623|62807055|FG002|Overall Study|Lost to Follow-up|0|||
33429481|NCT00376623|62807053|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
33429482|NCT00376623|62807054|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
33429483|NCT00376623|62807055|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
33429484|NCT00376623|62807053|FG000|Overall Study|Not treated with BI 2536|1|||
33429485|NCT00376623|62807054|FG001|Overall Study|Not treated with BI 2536|0|||
33429486|NCT00376623|62807055|FG002|Overall Study|Not treated with BI 2536|0|||
33429487|NCT00376623|62807053|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
33429488|NCT00376623|62807054|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
33429489|NCT00376623|62807055|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
33429490|NCT00376623|62807053|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
33429491|NCT00376623|62807054|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
33429492|NCT00376623|62807055|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
33429493|NCT00376623|62807053|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
33605386|NCT01649375|63005068|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
33323074|NCT00976209|62699381|FG000|Wash-out Period|Adverse Event|1|||
33323075|NCT00976209|62699382|FG001|Wash-out Period|Adverse Event|2|||
33429494|NCT00376623|62807054|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
33429495|NCT00376623|62807055|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
33429496|NCT00376623|62807053|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
33429497|NCT00376623|62807054|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
33429498|NCT00376623|62807055|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
33429499|NCT00376623|62807053|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
33429500|NCT00376623|62807054|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
33429501|NCT00376623|62807055|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
33429502|NCT00376623|62807053|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
33429503|NCT00376623|62807054|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
33429504|NCT00376623|62807055|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
33429505|NCT00376623|62807053|FG000|Overall Study|Increase of tumour markers|0|||
33429506|NCT00376623|62807054|FG001|Overall Study|Increase of tumour markers|1|||
33429507|NCT00376623|62807055|FG002|Overall Study|Increase of tumour markers|0|||
33429508|NCT00376623|62807053|FG000|Overall Study|Bone metastasis|1|||
33429509|NCT00376623|62807054|FG001|Overall Study|Bone metastasis|0|||
33429510|NCT00376623|62807055|FG002|Overall Study|Bone metastasis|0|||
33429511|NCT00445692|62807069|FG000|Overall Study|Adverse Event|11|||
33429512|NCT00445692|62807069|FG000|Overall Study|Lack of Efficacy|5|||
33429513|NCT03824236|62807078|FG000|Overall Study|Lost to Follow-up|0|||
33429514|NCT03824236|62807079|FG001|Overall Study|Lost to Follow-up|0|||
33429515|NCT03824236|62807080|FG002|Overall Study|Lost to Follow-up|1|||
33429516|NCT00282412|62807088|FG000|Overall Study|Death|2|||
33429517|NCT00282334|62807094|FG000|Overall Study|Withdrawal by Subject|8|||
33429518|NCT00282334|62807095|FG001|Overall Study|Withdrawal by Subject|5|||
33429519|NCT00282256|62807101|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
33429520|NCT00282256|62807101|FG000|Extension Treatment Period|Adverse Event|2|||
33429521|NCT00265330|62807105|FG000|Overall Study|Adverse Event|41|||
33429522|NCT00265330|62807105|FG000|Overall Study|Lost to Follow-up|8|||
33429523|NCT00265330|62807105|FG000|Overall Study|Withdrawal by Subject|34|||
33429524|NCT00265330|62807105|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
33429525|NCT00265330|62807105|FG000|Overall Study|Lack of Efficacy|4|||
33429526|NCT00265330|62807105|FG000|Overall Study|Family Scheduling Conflicts|1|||
33429527|NCT00265330|62807105|FG000|Overall Study|Began Taking Formulary Geodon|1|||
33429528|NCT00265330|62807105|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
33429529|NCT00265330|62807105|FG000|Overall Study|Site Closed by Sponsor|1|||
33429530|NCT00265330|62807105|FG000|Overall Study|Principal Investigators Request|1|||
33429531|NCT00265330|62807105|FG000|Overall Study|Withdrew Consent|1|||
33429532|NCT00265330|62807105|FG000|Overall Study|Protocol Violation|1|||
33429533|NCT00292318|62807111|FG000|Overall Study|Study terminated by officials|2|||
33429534|NCT00292318|62807112|FG001|Overall Study|Study terminated by officials|1|||
33429535|NCT00281632|62807118|FG000|Overall Study|Adverse Event|7|||
33429536|NCT00281632|62807118|FG000|Overall Study|Withdrawal by Subject|2|||
33429537|NCT00281632|62807118|FG000|Overall Study|Disease Progression|22|||
33429538|NCT00281632|62807118|FG000|Overall Study|Death|1|||
33429539|NCT00281632|62807118|FG000|Overall Study|Physician Decision|1|||
33429540|NCT00281632|62807118|FG000|Overall Study|Ongoing|3|||
33429541|NCT00543569|62807134|FG000|Overall Study|Death|2|||
33429542|NCT00543569|62807135|FG001|Overall Study|Death|2|||
33429543|NCT00543569|62807136|FG002|Overall Study|Death|3|||
33429544|NCT00543569|62807137|FG003|Overall Study|Death|1|||
33429545|NCT00543569|62807134|FG000|Overall Study|Lost to Follow-up|0|||
33429546|NCT00543569|62807135|FG001|Overall Study|Lost to Follow-up|0|||
33429547|NCT00543569|62807136|FG002|Overall Study|Lost to Follow-up|1|||
33429548|NCT00543569|62807137|FG003|Overall Study|Lost to Follow-up|1|||
33429549|NCT00543569|62807134|FG000|Overall Study|Miscellaneous Reasons|7|||
33429550|NCT00543569|62807135|FG001|Overall Study|Miscellaneous Reasons|3|||
33605387|NCT01649375|63005069|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
33429551|NCT00543569|62807136|FG002|Overall Study|Miscellaneous Reasons|11|||
33429552|NCT00543569|62807137|FG003|Overall Study|Miscellaneous Reasons|4|||
33429553|NCT00543569|62807134|FG000|Overall Study|Randomized but never received study drug|3|||
33429554|NCT00543569|62807135|FG001|Overall Study|Randomized but never received study drug|3|||
33429555|NCT00543569|62807136|FG002|Overall Study|Randomized but never received study drug|5|||
33605388|NCT01649375|63005070|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
33429556|NCT00543569|62807137|FG003|Overall Study|Randomized but never received study drug|3|||
33429557|NCT00445458|62807151|FG000|Overall Study|Disease Progression|3|||
33429558|NCT00445458|62807152|FG001|Overall Study|Disease Progression|4|||
33429559|NCT00445458|62807153|FG002|Overall Study|Disease Progression|54|||
33429560|NCT00445458|62807154|FG003|Overall Study|Disease Progression|27|||
33429561|NCT00445458|62807151|FG000|Overall Study|Withdrawal by Subject|0|||
33429562|NCT00445458|62807152|FG001|Overall Study|Withdrawal by Subject|0|||
33429563|NCT00445458|62807153|FG002|Overall Study|Withdrawal by Subject|7|||
33429564|NCT00445458|62807154|FG003|Overall Study|Withdrawal by Subject|0|||
33429565|NCT00445458|62807151|FG000|Overall Study|Adverse Event|0|||
33429566|NCT00445458|62807152|FG001|Overall Study|Adverse Event|0|||
33429567|NCT00445458|62807153|FG002|Overall Study|Adverse Event|3|||
33429568|NCT00445458|62807154|FG003|Overall Study|Adverse Event|0|||
33429569|NCT00445458|62807151|FG000|Overall Study|Death|0|||
33429570|NCT00445458|62807152|FG001|Overall Study|Death|1|||
33429571|NCT00445458|62807153|FG002|Overall Study|Death|2|||
33429572|NCT00445458|62807154|FG003|Overall Study|Death|0|||
33429573|NCT00445458|62807151|FG000|Overall Study|Physician Decision|0|||
33429574|NCT00445458|62807152|FG001|Overall Study|Physician Decision|0|||
33429575|NCT00445458|62807153|FG002|Overall Study|Physician Decision|1|||
33429576|NCT00445458|62807154|FG003|Overall Study|Physician Decision|1|||
33429577|NCT00445458|62807151|FG000|Overall Study|Surgery|0|||
33429578|NCT00445458|62807152|FG001|Overall Study|Surgery|0|||
33429579|NCT00445458|62807153|FG002|Overall Study|Surgery|1|||
33429580|NCT00445458|62807154|FG003|Overall Study|Surgery|0|||
33429581|NCT03914417|62807167|FG000|Overall Study|Withdrawal by Subject|2|||
33429582|NCT00541385|62807173|FG000|Overall Study|Adverse Event|6|||
33429583|NCT00541385|62807174|FG001|Overall Study|Adverse Event|3|||
33429584|NCT00541385|62807173|FG000|Overall Study|Withdrawal by Subject|2|||
33429585|NCT00541385|62807174|FG001|Overall Study|Withdrawal by Subject|2|||
33429586|NCT00541385|62807173|FG000|Overall Study|Lost to Follow-up|6|||
33429587|NCT00541385|62807174|FG001|Overall Study|Lost to Follow-up|1|||
33429588|NCT00541385|62807173|FG000|Overall Study|Parasite reappearance/malaria|67|||
33429589|NCT00541385|62807174|FG001|Overall Study|Parasite reappearance/malaria|32|||
33429590|NCT00265096|62807183|FG000|Overall Study|Adverse Event|14|||
33429591|NCT00265096|62807184|FG001|Overall Study|Adverse Event|18|||
33429592|NCT00265096|62807185|FG002|Overall Study|Adverse Event|18|||
33429593|NCT00265096|62807183|FG000|Overall Study|Lost to Follow-up|2|||
33429594|NCT00265096|62807184|FG001|Overall Study|Lost to Follow-up|5|||
33429595|NCT00265096|62807185|FG002|Overall Study|Lost to Follow-up|3|||
33429596|NCT00265096|62807183|FG000|Overall Study|Death|0|||
33429597|NCT00265096|62807184|FG001|Overall Study|Death|1|||
33429598|NCT00265096|62807185|FG002|Overall Study|Death|2|||
33429599|NCT00265096|62807183|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
33429600|NCT00265096|62807184|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
33429601|NCT00265096|62807185|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
33429602|NCT00265096|62807183|FG000|Overall Study|Other|11|||
33429603|NCT00265096|62807184|FG001|Overall Study|Other|19|||
33429604|NCT00265096|62807185|FG002|Overall Study|Other|10|||
33429605|NCT00281320|62807197|FG000|Overall Study|Adverse Event|12|||
33429606|NCT00281320|62807198|FG001|Overall Study|Adverse Event|9|||
33429607|NCT00281320|62807197|FG000|Overall Study|Lack of Efficacy|4|||
33429608|NCT00281320|62807198|FG001|Overall Study|Lack of Efficacy|3|||
33429609|NCT00281320|62807197|FG000|Overall Study|Withdrawal by Subject|5|||
33429610|NCT00281320|62807198|FG001|Overall Study|Withdrawal by Subject|6|||
33429611|NCT00281320|62807197|FG000|Overall Study|Lost to Follow-up|1|||
33429612|NCT00281320|62807198|FG001|Overall Study|Lost to Follow-up|2|||
33429613|NCT00281320|62807197|FG000|Overall Study|Other|3|||
33429614|NCT00281320|62807198|FG001|Overall Study|Other|1|||
33429615|NCT00541307|62807210|FG000|Overall Study|Death|5|||
33429616|NCT00541307|62807210|FG000|Overall Study|Physician Decision|3|||
33429617|NCT00541307|62807210|FG000|Overall Study|Withdrawal by Subject|6|||
33429618|NCT00541307|62807210|FG000|Overall Study|Lost to Follow-up|4|||
33429619|NCT00541307|62807210|FG000|Overall Study|Subject returned early (outside window)|1|||
33429620|NCT00541307|62807210|FG000|Overall Study|Surgical Bypass|5|||
33429621|NCT00541229|62807220|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
33323076|NCT00976209|62699381|FG000|Wash-out Period|Lost to Follow-up|1|||
33429622|NCT00541229|62807221|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
33429623|NCT00541229|62807222|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
33323077|NCT00976209|62699382|FG001|Wash-out Period|Lost to Follow-up|0|||
33429624|NCT00541229|62807223|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
33429625|NCT00541229|62807224|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
33429626|NCT00541229|62807225|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
33429627|NCT00541229|62807220|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
33429628|NCT00541229|62807221|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
33429629|NCT00541229|62807222|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
33429630|NCT00541229|62807223|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
33429631|NCT00541229|62807224|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
33429632|NCT00541229|62807225|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
33429633|NCT00541229|62807220|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
33494177|NCT03634033|62872937|FG003|Overall Study|Death|0|||
33429634|NCT00541229|62807221|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
33429635|NCT00541229|62807222|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
33429636|NCT00541229|62807223|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
33429637|NCT00541229|62807224|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
33429638|NCT00541229|62807225|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
33429639|NCT00541229|62807220|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
33429640|NCT00541229|62807221|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
33429641|NCT00541229|62807222|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
33429642|NCT00541229|62807223|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
33429643|NCT00541229|62807224|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
33429644|NCT00541229|62807225|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
33429645|NCT00541229|62807220|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
33429646|NCT00541229|62807221|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
33429647|NCT00541229|62807222|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
33429648|NCT00541229|62807223|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
33429649|NCT00541229|62807224|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
33429650|NCT00541229|62807225|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
33429651|NCT00541229|62807220|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
33429652|NCT00541229|62807221|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
33429653|NCT00541229|62807222|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
33429654|NCT00541229|62807223|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
33429655|NCT00541229|62807224|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
33429656|NCT00541229|62807225|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
33429657|NCT00541229|62807220|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
33429658|NCT00541229|62807221|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
33429659|NCT00541229|62807222|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
33429660|NCT00541229|62807223|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
33429661|NCT00541229|62807224|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
33429662|NCT00541229|62807225|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
33429663|NCT00541229|62807220|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
33429664|NCT00541229|62807221|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
33429665|NCT00541229|62807222|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
33429666|NCT00541229|62807223|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
33429667|NCT00541229|62807224|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
33429668|NCT00541229|62807225|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
33429669|NCT00541229|62807220|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
33429670|NCT00541229|62807221|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
33429671|NCT00541229|62807222|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
33429672|NCT00541229|62807223|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
33429673|NCT00541229|62807224|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
33429674|NCT00541229|62807225|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
33429675|NCT00541229|62807220|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
33429676|NCT00541229|62807221|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
33429677|NCT00541229|62807222|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
33429678|NCT00541229|62807223|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
33429679|NCT00541229|62807224|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
33429680|NCT00541229|62807225|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
33429681|NCT00541229|62807220|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
33429682|NCT00541229|62807221|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
33429683|NCT00541229|62807222|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
33429684|NCT00541229|62807223|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
33429685|NCT00541229|62807224|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
33429686|NCT00541229|62807225|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
33429687|NCT00541229|62807220|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
33429688|NCT00541229|62807221|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
33429689|NCT00541229|62807222|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
33429690|NCT00541229|62807223|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
33429691|NCT00541229|62807224|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
33429692|NCT00541229|62807225|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
33429693|NCT00541229|62807220|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
33429694|NCT00541229|62807221|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
33429695|NCT00541229|62807222|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
33429696|NCT00541229|62807223|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
33429697|NCT00541229|62807224|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
33429698|NCT00541229|62807225|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
33429699|NCT00541229|62807220|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
33429700|NCT00541229|62807221|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
33429701|NCT00541229|62807222|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
33429702|NCT00541229|62807223|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
33429703|NCT00541229|62807224|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
33429704|NCT00541229|62807225|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
33429705|NCT00541229|62807220|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
33429706|NCT00541229|62807221|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
33429707|NCT00541229|62807222|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
33429708|NCT00541229|62807223|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
33429709|NCT00541229|62807224|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
33429710|NCT00541229|62807225|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
33429711|NCT00541229|62807220|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
33429712|NCT00541229|62807221|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
33429713|NCT00541229|62807222|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
33429714|NCT00541229|62807223|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
33429715|NCT00541229|62807224|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
33429716|NCT00541229|62807225|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
33429717|NCT00481988|62807235|FG000|Overall Study|Withdrawal by Subject|1|||
33429718|NCT00481988|62807236|FG001|Overall Study|Withdrawal by Subject|1|||
33429719|NCT00481832|62807253|FG000|Enrollment|Physician Decision|8|||
33429720|NCT00481832|62807253|FG000|Enrollment|Unable to collect enough stem cells|2|||
33429721|NCT00481832|62807253|FG000|Inter-transplant Period|Adverse Event|4|||
33429722|NCT00481832|62807253|FG000|Inter-transplant Period|Death|3|||
33429723|NCT00481832|62807253|FG000|Inter-transplant Period|Physician Decision|4|||
33429724|NCT00481832|62807253|FG000|Inter-transplant Period|Disease relapse|11|||
33429725|NCT00481832|62807253|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
33429726|NCT00481676|62807259|FG000|Overall Study|Adverse Event|0|||
33429727|NCT00481676|62807260|FG001|Overall Study|Adverse Event|1|||
33429728|NCT00481676|62807259|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33429729|NCT00481676|62807260|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
33429730|NCT00481676|62807259|FG000|Overall Study|Administrative problem|1|||
33429731|NCT00481676|62807260|FG001|Overall Study|Administrative problem|0|||
33429732|NCT00542789|62807268|FG000|Overall Study|Adverse Event|18|||
33429733|NCT00542789|62807269|FG001|Overall Study|Adverse Event|17|||
33429734|NCT00542789|62807268|FG000|Overall Study|Withdrawal by Subject|7|||
33429735|NCT00542789|62807269|FG001|Overall Study|Withdrawal by Subject|3|||
33429736|NCT00542789|62807268|FG000|Overall Study|Protocol Violation|8|||
33429737|NCT00542789|62807269|FG001|Overall Study|Protocol Violation|1|||
33429738|NCT00542789|62807268|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
33429739|NCT00542789|62807269|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
33429740|NCT00464672|62807277|FG000|Overall Study|withdrawal of consent|0|||
33429741|NCT00464672|62807278|FG001|Overall Study|withdrawal of consent|0|||
33429742|NCT00464672|62807279|FG002|Overall Study|withdrawal of consent|0|||
33429743|NCT00464672|62807280|FG003|Overall Study|withdrawal of consent|1|||
33429744|NCT00464672|62807281|FG004|Overall Study|withdrawal of consent|9|||
33429745|NCT00464672|62807282|FG005|Overall Study|withdrawal of consent|4|||
33429746|NCT00464672|62807277|FG000|Overall Study|Lost to Follow-up|25|||
33429747|NCT00464672|62807278|FG001|Overall Study|Lost to Follow-up|10|||
33429748|NCT00464672|62807279|FG002|Overall Study|Lost to Follow-up|0|||
33429749|NCT00464672|62807280|FG003|Overall Study|Lost to Follow-up|0|||
33429750|NCT00464672|62807281|FG004|Overall Study|Lost to Follow-up|1|||
33429751|NCT00464672|62807282|FG005|Overall Study|Lost to Follow-up|0|||
33429752|NCT00473876|62807312|FG000|Overall Study|Lost to Follow-up|3|||
33429753|NCT00473876|62807313|FG001|Overall Study|Lost to Follow-up|1|||
33429754|NCT00463580|62807323|FG000|Overall Study|Lost to Follow-up|1|||
33429755|NCT00463580|62807324|FG001|Overall Study|Lost to Follow-up|0|||
33429756|NCT00463580|62807323|FG000|Overall Study|Schedule conflict|2|||
33429757|NCT00463580|62807324|FG001|Overall Study|Schedule conflict|0|||
33429758|NCT00463580|62807323|FG000|Overall Study|Medical/psychiatric complications|0|||
33429759|NCT00463580|62807324|FG001|Overall Study|Medical/psychiatric complications|2|||
33429760|NCT00540449|62807338|FG000|Overall Study|Adverse Event|12|||
33429761|NCT00540449|62807339|FG001|Overall Study|Adverse Event|32|||
33429762|NCT00540449|62807338|FG000|Overall Study|Sponsor's Decision|1|||
33429763|NCT00540449|62807339|FG001|Overall Study|Sponsor's Decision|1|||
33429764|NCT00540449|62807338|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
33429765|NCT00540449|62807339|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
33429766|NCT00540449|62807338|FG000|Overall Study|Lost to Follow-up|19|||
33429767|NCT00540449|62807339|FG001|Overall Study|Lost to Follow-up|17|||
33429768|NCT00540449|62807338|FG000|Overall Study|Subject Non-Compliant|7|||
33429769|NCT00540449|62807339|FG001|Overall Study|Subject Non-Compliant|5|||
33429770|NCT00540449|62807338|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
33429771|NCT00540449|62807339|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
33429772|NCT00540449|62807338|FG000|Overall Study|Withdrawal by Subject|10|||
33429773|NCT00540449|62807339|FG001|Overall Study|Withdrawal by Subject|10|||
33429774|NCT00540449|62807338|FG000|Overall Study|Other|1|||
33429775|NCT00540449|62807339|FG001|Overall Study|Other|4|||
33429776|NCT03911843|62807347|FG000|Overall Study|Adverse Event|2|||
33429777|NCT03911843|62807348|FG001|Overall Study|Adverse Event|0|||
33429778|NCT03911843|62807347|FG000|Overall Study|Protocol Violation|2|||
33429779|NCT03911843|62807348|FG001|Overall Study|Protocol Violation|0|||
33429780|NCT03911843|62807347|FG000|Overall Study|Lost to Follow-up|0|||
33429781|NCT03911843|62807348|FG001|Overall Study|Lost to Follow-up|1|||
33429782|NCT00361335|62807359|FG000|IV Period: Baseline to E0|Adverse Event|9|||
33429783|NCT00361335|62807360|FG001|IV Period: Baseline to E0|Adverse Event|4|||
33429784|NCT00361335|62807361|FG002|IV Period: Baseline to E0|Adverse Event|5|||
33429785|NCT00361335|62807362|FG003|IV Period: Baseline to E0|Adverse Event|9|||
33429786|NCT00361335|62807363|FG004|IV Period: Baseline to E0|Adverse Event|8|||
33429787|NCT00361335|62807364|FG005|IV Period: Baseline to E0|Adverse Event|0|||
33429788|NCT00361335|62807365|FG006|IV Period: Baseline to E0|Adverse Event|0|||
33429789|NCT00361335|62807359|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
33429790|NCT00361335|62807360|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
33429791|NCT00361335|62807361|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
33429792|NCT00361335|62807362|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
33429793|NCT00361335|62807363|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
33429794|NCT00361335|62807364|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
33429795|NCT00361335|62807365|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
33429796|NCT00361335|62807359|FG000|IV Period: Baseline to E0|Death|1|||
33429797|NCT00361335|62807360|FG001|IV Period: Baseline to E0|Death|1|||
33429798|NCT00361335|62807361|FG002|IV Period: Baseline to E0|Death|1|||
33429799|NCT00361335|62807362|FG003|IV Period: Baseline to E0|Death|1|||
33429800|NCT00361335|62807363|FG004|IV Period: Baseline to E0|Death|0|||
33429801|NCT00361335|62807364|FG005|IV Period: Baseline to E0|Death|0|||
33429802|NCT00361335|62807365|FG006|IV Period: Baseline to E0|Death|0|||
33429803|NCT00361335|62807359|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
33429804|NCT00361335|62807360|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
33429805|NCT00361335|62807361|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
33429806|NCT00361335|62807362|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
33429807|NCT00361335|62807363|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
33429808|NCT00361335|62807364|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
33429809|NCT00361335|62807365|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
33429810|NCT00361335|62807359|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
33429811|NCT00361335|62807360|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
33429812|NCT00361335|62807361|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
33429813|NCT00361335|62807362|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
33429814|NCT00361335|62807363|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
33429815|NCT00361335|62807364|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
33429816|NCT00361335|62807365|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
33429817|NCT00361335|62807359|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
33429818|NCT00361335|62807360|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
33429819|NCT00361335|62807361|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
33429820|NCT00361335|62807362|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
33429821|NCT00361335|62807363|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
33429822|NCT00361335|62807364|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
33429823|NCT00361335|62807365|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
33429824|NCT00361335|62807359|FG000|IV Period: Baseline to E0|Other|2|||
33429825|NCT00361335|62807360|FG001|IV Period: Baseline to E0|Other|9|||
33429826|NCT00361335|62807361|FG002|IV Period: Baseline to E0|Other|9|||
33429827|NCT00361335|62807362|FG003|IV Period: Baseline to E0|Other|3|||
33429828|NCT00361335|62807363|FG004|IV Period: Baseline to E0|Other|2|||
33429829|NCT00361335|62807364|FG005|IV Period: Baseline to E0|Other|0|||
33429830|NCT00361335|62807365|FG006|IV Period: Baseline to E0|Other|0|||
33429831|NCT00361335|62807359|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
33429832|NCT00361335|62807360|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
33429833|NCT00361335|62807361|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
33429834|NCT00361335|62807362|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
33429835|NCT00361335|62807363|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
33429836|NCT00361335|62807364|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
33429837|NCT00361335|62807365|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
33605389|NCT01649375|63005071|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
33429838|NCT00361335|62807359|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
33429839|NCT00361335|62807360|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
33429840|NCT00361335|62807361|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
33429841|NCT00361335|62807362|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
33429842|NCT00361335|62807363|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
33429843|NCT00361335|62807364|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
33429844|NCT00361335|62807365|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
33429845|NCT00361335|62807359|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
33429846|NCT00361335|62807360|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
33429847|NCT00361335|62807361|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
33429848|NCT00361335|62807362|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
33429849|NCT00361335|62807363|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
33429850|NCT00361335|62807364|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
33429851|NCT00361335|62807365|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
33429852|NCT00361335|62807359|FG000|SC Period: Week E0 to Week E24|Death|0|||
33429853|NCT00361335|62807360|FG001|SC Period: Week E0 to Week E24|Death|0|||
33429854|NCT00361335|62807361|FG002|SC Period: Week E0 to Week E24|Death|0|||
33429855|NCT00361335|62807362|FG003|SC Period: Week E0 to Week E24|Death|0|||
33429856|NCT00361335|62807363|FG004|SC Period: Week E0 to Week E24|Death|0|||
33429857|NCT00361335|62807364|FG005|SC Period: Week E0 to Week E24|Death|0|||
33429858|NCT00361335|62807365|FG006|SC Period: Week E0 to Week E24|Death|1|||
33429859|NCT00361335|62807359|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
33429860|NCT00361335|62807360|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
33429861|NCT00361335|62807361|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
33429862|NCT00361335|62807362|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
33429863|NCT00361335|62807363|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
33429864|NCT00361335|62807364|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
33429865|NCT00361335|62807365|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
33429866|NCT00361335|62807359|FG000|SC Period: Week E0 to Week E24|Other|1|||
33429867|NCT00361335|62807360|FG001|SC Period: Week E0 to Week E24|Other|0|||
33429868|NCT00361335|62807361|FG002|SC Period: Week E0 to Week E24|Other|0|||
33429869|NCT00361335|62807362|FG003|SC Period: Week E0 to Week E24|Other|1|||
33429870|NCT00361335|62807363|FG004|SC Period: Week E0 to Week E24|Other|0|||
33429871|NCT00361335|62807364|FG005|SC Period: Week E0 to Week E24|Other|1|||
33429872|NCT00361335|62807365|FG006|SC Period: Week E0 to Week E24|Other|2|||
33429873|NCT00361335|62807359|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
33429874|NCT00361335|62807360|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
33429875|NCT00361335|62807361|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
33429876|NCT00361335|62807362|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
33429877|NCT00361335|62807363|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
33429878|NCT00361335|62807364|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
33429879|NCT00361335|62807365|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
33429880|NCT00264550|62807385|FG000|Overall Study|Death|0|||
33429881|NCT00264550|62807386|FG001|Overall Study|Death|3|||
33429882|NCT00264550|62807387|FG002|Overall Study|Death|0|||
33429883|NCT00264550|62807388|FG003|Overall Study|Death|0|||
33429884|NCT00264550|62807385|FG000|Overall Study|Lost to Follow-up|3|||
33429885|NCT00264550|62807386|FG001|Overall Study|Lost to Follow-up|1|||
33429886|NCT00264550|62807387|FG002|Overall Study|Lost to Follow-up|1|||
33429887|NCT00264550|62807388|FG003|Overall Study|Lost to Follow-up|1|||
33429888|NCT00264550|62807385|FG000|Overall Study|Adverse Event|23|||
33429889|NCT00264550|62807386|FG001|Overall Study|Adverse Event|18|||
33429890|NCT00264550|62807387|FG002|Overall Study|Adverse Event|9|||
33429891|NCT00264550|62807388|FG003|Overall Study|Adverse Event|14|||
33429892|NCT00264550|62807385|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33429893|NCT00264550|62807386|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
33429894|NCT00264550|62807387|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
33429895|NCT00264550|62807388|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
33429896|NCT00264550|62807385|FG000|Overall Study|Discontinued oral study agent|0|||
33429897|NCT00264550|62807386|FG001|Overall Study|Discontinued oral study agent|1|||
33429898|NCT00264550|62807387|FG002|Overall Study|Discontinued oral study agent|0|||
33429899|NCT00264550|62807388|FG003|Overall Study|Discontinued oral study agent|0|||
33605390|NCT01649375|63005072|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
33429900|NCT00264550|62807385|FG000|Overall Study|Other|13|||
33429901|NCT00264550|62807386|FG001|Overall Study|Other|7|||
33429902|NCT00264550|62807387|FG002|Overall Study|Other|3|||
33429903|NCT00264550|62807388|FG003|Overall Study|Other|9|||
33429904|NCT00541931|62807400|FG000|Overall Study|Adverse Event|1|||
33429905|NCT00541931|62807401|FG001|Overall Study|Adverse Event|0|||
33429906|NCT00541931|62807400|FG000|Overall Study|Lost to Follow-up|3|||
33429907|NCT00541931|62807401|FG001|Overall Study|Lost to Follow-up|3|||
33429908|NCT00541931|62807400|FG000|Overall Study|Withdrawal by Subject|1|||
33429909|NCT00541931|62807401|FG001|Overall Study|Withdrawal by Subject|0|||
33429910|NCT00541931|62807400|FG000|Overall Study|Transportation Issue|0|||
33429911|NCT00541931|62807401|FG001|Overall Study|Transportation Issue|1|||
33429912|NCT00368979|62807411|FG000|Overall Study|Adverse Event|9|||
33429913|NCT00368979|62807412|FG001|Overall Study|Adverse Event|16|||
33429914|NCT00368979|62807411|FG000|Overall Study|Lack of Efficacy|5|||
33429915|NCT00368979|62807412|FG001|Overall Study|Lack of Efficacy|3|||
33429916|NCT00368979|62807411|FG000|Overall Study|Other|3|||
33429917|NCT00368979|62807412|FG001|Overall Study|Other|1|||
33429918|NCT00368979|62807411|FG000|Overall Study|Lost to Follow-up|1|||
33429919|NCT00368979|62807412|FG001|Overall Study|Lost to Follow-up|0|||
33429920|NCT00368979|62807411|FG000|Overall Study|Protocol Violation|2|||
33429921|NCT00368979|62807412|FG001|Overall Study|Protocol Violation|1|||
33429922|NCT00368979|62807411|FG000|Overall Study|Withdrawal by Subject|5|||
33429923|NCT00368979|62807412|FG001|Overall Study|Withdrawal by Subject|9|||
33429924|NCT00264238|62807418|FG000|Overall Study|Protocol Violation|1|||
33429925|NCT00540293|62807424|FG000|Overall Study|Adverse event related to study drug|10|||
33429926|NCT00540293|62807424|FG000|Overall Study|Adverse event not related to study drug|7|||
33429927|NCT00540293|62807424|FG000|Overall Study|Withdrawal by Subject|6|||
33429928|NCT00540293|62807424|FG000|Overall Study|Protocol violation, & subject schedule|12|||
33429929|NCT00359073|62807465|FG000|Overall Study|Withdrawal by Subject|1|||
33429930|NCT00359073|62807466|FG001|Overall Study|Withdrawal by Subject|1|||
33429931|NCT00359073|62807465|FG000|Overall Study|Eligibility criteria no longer met|3|||
33429932|NCT00359073|62807466|FG001|Overall Study|Eligibility criteria no longer met|0|||
33429933|NCT00359073|62807465|FG000|Overall Study|developed RV16 antibody|0|||
33429934|NCT00359073|62807466|FG001|Overall Study|developed RV16 antibody|1|||
33429935|NCT03918239|62807476|FG000|Overall Study|Lost to Follow-up|3|||
33429936|NCT03918239|62807477|FG001|Overall Study|Lost to Follow-up|1|||
33429937|NCT03918239|62807476|FG000|Overall Study|Pregnancy|0|||
33429938|NCT03918239|62807477|FG001|Overall Study|Pregnancy|2|||
33429939|NCT03918239|62807476|FG000|Overall Study|Withdrawal by Subject|3|||
33429940|NCT03918239|62807477|FG001|Overall Study|Withdrawal by Subject|3|||
33429941|NCT03918239|62807476|FG000|Overall Study|positive urine drug screening results|4|||
33429942|NCT03918239|62807477|FG001|Overall Study|positive urine drug screening results|1|||
33429943|NCT00368745|62807485|FG000|Double-blind Treatment Period|Adverse Event|6|||
33429944|NCT00368745|62807486|FG001|Double-blind Treatment Period|Adverse Event|6|||
33429945|NCT00368745|62807485|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
33429946|NCT00368745|62807486|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
33429947|NCT00368745|62807485|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
33429948|NCT00368745|62807486|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
33429949|NCT00368745|62807485|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
33429950|NCT00368745|62807486|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
33429951|NCT00368745|62807485|FG000|Double-blind Treatment Period|Other|7|||
33429952|NCT00368745|62807486|FG001|Double-blind Treatment Period|Other|6|||
33429953|NCT00454818|62807500|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
33429954|NCT00454818|62807501|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
33429955|NCT00454818|62807502|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
33429956|NCT00454818|62807503|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
33429957|NCT00454818|62807504|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
33429958|NCT00454818|62807500|FG000|Phase I: Open-label Dose-escalation|Death|0|||
33429959|NCT00454818|62807501|FG001|Phase I: Open-label Dose-escalation|Death|1|||
33429960|NCT00454818|62807502|FG002|Phase I: Open-label Dose-escalation|Death|0|||
33429961|NCT00454818|62807503|FG003|Phase I: Open-label Dose-escalation|Death|0|||
33429962|NCT00454818|62807504|FG004|Phase I: Open-label Dose-escalation|Death|0|||
33429963|NCT00454818|62807500|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
33429964|NCT00454818|62807501|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
33429965|NCT00454818|62807502|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
33429966|NCT00454818|62807503|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
33429967|NCT00454818|62807504|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
33429968|NCT00454818|62807500|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
33429969|NCT00454818|62807501|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
33429970|NCT00454818|62807502|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
33429971|NCT00454818|62807503|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
33429972|NCT00454818|62807504|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
33429973|NCT00454818|62807500|FG000|Phase 2: Randomized Double-blind|Death|0|||
33429974|NCT00454818|62807501|FG001|Phase 2: Randomized Double-blind|Death|1|||
33429975|NCT00454818|62807502|FG002|Phase 2: Randomized Double-blind|Death|0|||
33429976|NCT00454818|62807503|FG003|Phase 2: Randomized Double-blind|Death|0|||
33429977|NCT00454818|62807504|FG004|Phase 2: Randomized Double-blind|Death|1|||
33429978|NCT00454818|62807500|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
33429979|NCT00454818|62807501|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
33429980|NCT00454818|62807502|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
33429981|NCT00454818|62807503|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
33429982|NCT00454818|62807504|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
33429983|NCT00454818|62807500|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
33429984|NCT00454818|62807501|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
33429985|NCT00454818|62807502|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
33429986|NCT00454818|62807503|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
33429987|NCT00454818|62807504|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
33429988|NCT00445224|62807523|FG000|Specific Exercises|Withdrawal by Subject|3|||
33429989|NCT00445224|62807524|FG001|Specific Exercises|Withdrawal by Subject|3|||
33429990|NCT00445224|62807523|FG000|Specific Exercises|Withdrawal by Subject|1|||
33429991|NCT00445224|62807524|FG001|Specific Exercises|Withdrawal by Subject|0|||
33429992|NCT00358917|62807541|FG000|Overall Study|Adverse Event|14|||
33429993|NCT00358917|62807542|FG001|Overall Study|Adverse Event|21|||
33429994|NCT00358917|62807541|FG000|Overall Study|Withdrawal by Subject|5|||
33429995|NCT00358917|62807542|FG001|Overall Study|Withdrawal by Subject|7|||
33429996|NCT00358917|62807541|FG000|Overall Study|Lost to Follow-up|20|||
33429997|NCT00358917|62807542|FG001|Overall Study|Lost to Follow-up|17|||
33429998|NCT00358917|62807541|FG000|Overall Study|Noncompliance|12|||
33429999|NCT00358917|62807542|FG001|Overall Study|Noncompliance|11|||
33430000|NCT00358917|62807541|FG000|Overall Study|Death|2|||
33430001|NCT00358917|62807542|FG001|Overall Study|Death|3|||
33430002|NCT00358917|62807541|FG000|Overall Study|Virologic failure|11|||
33430003|NCT00358917|62807542|FG001|Overall Study|Virologic failure|8|||
33430004|NCT00358917|62807541|FG000|Overall Study|Unable to Continue Participation|2|||
33430005|NCT00358917|62807542|FG001|Overall Study|Unable to Continue Participation|2|||
33430006|NCT00264004|62807554|FG000|Overall Study|Adverse Event|2|||
33430007|NCT00264004|62807555|FG001|Overall Study|Adverse Event|3|||
33430008|NCT00264004|62807556|FG002|Overall Study|Adverse Event|6|||
33430009|NCT00264004|62807557|FG003|Overall Study|Adverse Event|4|||
33430010|NCT00264004|62807554|FG000|Overall Study|Withdrawal by Subject|0|||
33430011|NCT00264004|62807555|FG001|Overall Study|Withdrawal by Subject|1|||
33430012|NCT00264004|62807556|FG002|Overall Study|Withdrawal by Subject|2|||
33430013|NCT00264004|62807557|FG003|Overall Study|Withdrawal by Subject|2|||
33430014|NCT00264004|62807554|FG000|Overall Study|Other|2|||
33430015|NCT00264004|62807555|FG001|Overall Study|Other|2|||
33430016|NCT00264004|62807556|FG002|Overall Study|Other|0|||
33605391|NCT01649375|63005068|FG000|Week 16 up to Week 260|Death|1|||
33430017|NCT00264004|62807557|FG003|Overall Study|Other|3|||
33430018|NCT00264004|62807554|FG000|Overall Study|Development study specific disc. crit.|1|||
33430019|NCT00264004|62807555|FG001|Overall Study|Development study specific disc. crit.|0|||
33430020|NCT00264004|62807556|FG002|Overall Study|Development study specific disc. crit.|1|||
33430021|NCT00264004|62807557|FG003|Overall Study|Development study specific disc. crit.|0|||
33605392|NCT01649375|63005069|FG001|Week 16 up to Week 260|Death|1|||
33605393|NCT01649375|63005070|FG002|Week 16 up to Week 260|Death|0|||
33605394|NCT01649375|63005071|FG003|Week 16 up to Week 260|Death|0|||
33430022|NCT00264004|62807554|FG000|Overall Study|Cond. under inv. worsened|9|||
33430023|NCT00264004|62807555|FG001|Overall Study|Cond. under inv. worsened|5|||
33430024|NCT00264004|62807556|FG002|Overall Study|Cond. under inv. worsened|3|||
33605395|NCT01649375|63005072|FG004|Week 16 up to Week 260|Death|0|||
33605396|NCT01649375|63005068|FG000|Week 16 up to Week 260|Adverse Event|5|||
33605397|NCT01649375|63005069|FG001|Week 16 up to Week 260|Adverse Event|2|||
33430025|NCT00264004|62807557|FG003|Overall Study|Cond. under inv. worsened|4|||
33430026|NCT00264004|62807554|FG000|Overall Study|Not treated|3|||
33430027|NCT00264004|62807555|FG001|Overall Study|Not treated|0|||
33430028|NCT00264004|62807556|FG002|Overall Study|Not treated|2|||
33430029|NCT00264004|62807557|FG003|Overall Study|Not treated|2|||
33430030|NCT00368355|62807569|FG000|Overall Study|Adverse Event|1|||
33430031|NCT00368355|62807570|FG001|Overall Study|Adverse Event|0|||
33430032|NCT00368355|62807569|FG000|Overall Study|Death|2|||
33430033|NCT00368355|62807570|FG001|Overall Study|Death|4|||
33430034|NCT00368355|62807569|FG000|Overall Study|Relapse|6|||
33430035|NCT00368355|62807570|FG001|Overall Study|Relapse|10|||
33430036|NCT00368355|62807569|FG000|Overall Study|Subsequent transplant|0|||
33430037|NCT00368355|62807570|FG001|Overall Study|Subsequent transplant|3|||
33430038|NCT00368355|62807569|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
33430039|NCT00368355|62807570|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
33430040|NCT00445146|62807576|FG000|Overall Study|Withdrew Consent|29|||
33430041|NCT00445146|62807576|FG000|Overall Study|Lack of Efficacy|28|||
33430042|NCT00445146|62807576|FG000|Overall Study|Investigator's Discretion|22|||
33430043|NCT00445146|62807576|FG000|Overall Study|Adverse Event|13|||
33430044|NCT00445146|62807576|FG000|Overall Study|Lost to Follow-up|13|||
33430045|NCT00445146|62807576|FG000|Overall Study|Death|9|||
33430046|NCT00445146|62807576|FG000|Overall Study|Protocol Violation|4|||
33430047|NCT00445146|62807576|FG000|Overall Study|Pregnancy|1|||
33430048|NCT00368277|62807582|FG000|Overall Study|Adverse Event|33|||
33430049|NCT00368277|62807583|FG001|Overall Study|Adverse Event|49|||
33430050|NCT00368277|62807582|FG000|Overall Study|Death|2|||
33430051|NCT00368277|62807583|FG001|Overall Study|Death|1|||
33430052|NCT00368277|62807582|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
33430053|NCT00368277|62807583|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
33430054|NCT00368277|62807582|FG000|Overall Study|Protocol deviation|7|||
33430055|NCT00368277|62807583|FG001|Overall Study|Protocol deviation|0|||
33430056|NCT00368277|62807582|FG000|Overall Study|Patient withdrew consent|32|||
33430057|NCT00368277|62807583|FG001|Overall Study|Patient withdrew consent|28|||
33430058|NCT00368277|62807582|FG000|Overall Study|Lost to Follow-up|8|||
33430059|NCT00368277|62807583|FG001|Overall Study|Lost to Follow-up|6|||
33430060|NCT00280150|62807593|FG000|Overall Study|Adverse Event|0|||
33430061|NCT00280150|62807594|FG001|Overall Study|Adverse Event|1|||
33430062|NCT00280150|62807595|FG002|Overall Study|Adverse Event|2|||
33430063|NCT00280150|62807596|FG003|Overall Study|Adverse Event|3|||
33430064|NCT00280150|62807593|FG000|Overall Study|Lack of Efficacy|0|||
33430065|NCT00280150|62807594|FG001|Overall Study|Lack of Efficacy|0|||
33430066|NCT00280150|62807595|FG002|Overall Study|Lack of Efficacy|0|||
33430067|NCT00280150|62807596|FG003|Overall Study|Lack of Efficacy|3|||
33430068|NCT00280150|62807593|FG000|Overall Study|Physician Decision|0|||
33430069|NCT00280150|62807594|FG001|Overall Study|Physician Decision|0|||
33430070|NCT00280150|62807595|FG002|Overall Study|Physician Decision|0|||
33430071|NCT00280150|62807596|FG003|Overall Study|Physician Decision|1|||
33430072|NCT00280150|62807593|FG000|Overall Study|Protocol Violation|0|||
33430073|NCT00280150|62807594|FG001|Overall Study|Protocol Violation|0|||
33430074|NCT00280150|62807595|FG002|Overall Study|Protocol Violation|0|||
33430075|NCT00280150|62807596|FG003|Overall Study|Protocol Violation|1|||
33430076|NCT00280150|62807593|FG000|Overall Study|Withdrawal by Subject|0|||
33430077|NCT00280150|62807594|FG001|Overall Study|Withdrawal by Subject|0|||
33430078|NCT00280150|62807595|FG002|Overall Study|Withdrawal by Subject|0|||
33430079|NCT00280150|62807596|FG003|Overall Study|Withdrawal by Subject|1|||
33430080|NCT00280150|62807593|FG000|Overall Study|Did not get consolidation therapy|3|||
33430081|NCT00280150|62807594|FG001|Overall Study|Did not get consolidation therapy|0|||
33430082|NCT00280150|62807595|FG002|Overall Study|Did not get consolidation therapy|3|||
33430083|NCT00280150|62807596|FG003|Overall Study|Did not get consolidation therapy|0|||
33430084|NCT00280150|62807593|FG000|Overall Study|Declining Performance Status|0|||
33430085|NCT00280150|62807594|FG001|Overall Study|Declining Performance Status|0|||
33605398|NCT01649375|63005070|FG002|Week 16 up to Week 260|Adverse Event|0|||
33605399|NCT01649375|63005071|FG003|Week 16 up to Week 260|Adverse Event|3|||
33605400|NCT01649375|63005072|FG004|Week 16 up to Week 260|Adverse Event|2|||
33605401|NCT02336555|63005082|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33430086|NCT00280150|62807595|FG002|Overall Study|Declining Performance Status|0|||
33430087|NCT00280150|62807596|FG003|Overall Study|Declining Performance Status|1|||
33430088|NCT00279916|62807609|FG000|Overall Study|Withdrawal by Subject|4|||
33605402|NCT02336555|63005083|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
33430089|NCT00279916|62807610|FG001|Overall Study|Withdrawal by Subject|3|||
33430090|NCT00279916|62807609|FG000|Overall Study|Lost to Follow-up|3|||
33430091|NCT00279916|62807610|FG001|Overall Study|Lost to Follow-up|2|||
33430092|NCT00358527|62807618|FG000|Overall Study|Adverse Event|4|||
33430093|NCT00358527|62807619|FG001|Overall Study|Adverse Event|0|||
33430094|NCT00358527|62807618|FG000|Overall Study|Withdrawal by Subject|1|||
33430095|NCT00358527|62807619|FG001|Overall Study|Withdrawal by Subject|1|||
33430096|NCT00358527|62807618|FG000|Overall Study|Non-compliance with protocol|6|||
33430097|NCT00358527|62807619|FG001|Overall Study|Non-compliance with protocol|1|||
33430098|NCT00358527|62807618|FG000|Overall Study|Administrative|2|||
33430099|NCT00358527|62807619|FG001|Overall Study|Administrative|1|||
33430100|NCT00251758|62807628|FG000|Overall Study|Adverse Event|7|||
33430101|NCT00251758|62807629|FG001|Overall Study|Adverse Event|9|||
33430102|NCT00251758|62807630|FG002|Overall Study|Adverse Event|11|||
33430103|NCT00251758|62807628|FG000|Overall Study|Lost to Follow-up|4|||
33430104|NCT00251758|62807629|FG001|Overall Study|Lost to Follow-up|2|||
33430105|NCT00251758|62807630|FG002|Overall Study|Lost to Follow-up|5|||
33430106|NCT00251758|62807628|FG000|Overall Study|Withdrawal by Subject|13|||
33430107|NCT00251758|62807629|FG001|Overall Study|Withdrawal by Subject|7|||
33430108|NCT00251758|62807630|FG002|Overall Study|Withdrawal by Subject|3|||
33430109|NCT00251758|62807628|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
33430110|NCT00251758|62807629|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
33430111|NCT00251758|62807630|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
33430112|NCT00251758|62807628|FG000|Overall Study|Lack of Efficacy|3|||
33430113|NCT00251758|62807629|FG001|Overall Study|Lack of Efficacy|0|||
33430114|NCT00251758|62807630|FG002|Overall Study|Lack of Efficacy|0|||
33430115|NCT00251758|62807628|FG000|Overall Study|Noncompliant|0|||
33430116|NCT00251758|62807629|FG001|Overall Study|Noncompliant|2|||
33430117|NCT00251758|62807630|FG002|Overall Study|Noncompliant|2|||
33430118|NCT00251758|62807628|FG000|Overall Study|Pregnancy|0|||
33430119|NCT00251758|62807629|FG001|Overall Study|Pregnancy|1|||
33430120|NCT00251758|62807630|FG002|Overall Study|Pregnancy|0|||
33430121|NCT00251758|62807628|FG000|Overall Study|Per Subject Request|0|||
33430122|NCT00251758|62807629|FG001|Overall Study|Per Subject Request|0|||
33430123|NCT00251758|62807630|FG002|Overall Study|Per Subject Request|1|||
33430124|NCT00251758|62807628|FG000|Overall Study|Per Investigator Request|1|||
33430125|NCT00251758|62807629|FG001|Overall Study|Per Investigator Request|0|||
33430126|NCT00251758|62807630|FG002|Overall Study|Per Investigator Request|0|||
33430127|NCT00279214|62807640|FG000|Overall Study|Physician Decision|3|||
33430128|NCT00279214|62807641|FG001|Overall Study|Physician Decision|2|||
33430129|NCT00262834|62807649|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
33430130|NCT00262834|62807650|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
33430131|NCT00541775|62807663|FG000|Overall Study|Adverse Event|3|||
33430132|NCT00541775|62807664|FG001|Overall Study|Adverse Event|2|||
33430133|NCT00541775|62807665|FG002|Overall Study|Adverse Event|1|||
33430134|NCT00541775|62807663|FG000|Overall Study|Lack of Efficacy|0|||
33430135|NCT00541775|62807664|FG001|Overall Study|Lack of Efficacy|0|||
33430136|NCT00541775|62807665|FG002|Overall Study|Lack of Efficacy|3|||
33430137|NCT00541775|62807663|FG000|Overall Study|Lost to Follow-up|0|||
33430138|NCT00541775|62807664|FG001|Overall Study|Lost to Follow-up|0|||
33430139|NCT00541775|62807665|FG002|Overall Study|Lost to Follow-up|2|||
33430140|NCT00541775|62807663|FG000|Overall Study|Protocol Violation|1|||
33430141|NCT00541775|62807664|FG001|Overall Study|Protocol Violation|0|||
33430142|NCT00541775|62807665|FG002|Overall Study|Protocol Violation|0|||
33430143|NCT00541775|62807663|FG000|Overall Study|Withdrawal by Subject and Other|5|||
33430144|NCT00541775|62807664|FG001|Overall Study|Withdrawal by Subject and Other|0|||
33430145|NCT00541775|62807665|FG002|Overall Study|Withdrawal by Subject and Other|2|||
33430146|NCT00539513|62807675|FG000|Overall Study|Withdrawal by Subject|2|||
33430147|NCT00539513|62807676|FG001|Overall Study|Withdrawal by Subject|1|||
33430148|NCT00539513|62807675|FG000|Overall Study|Lost to Follow-up|0|||
33430149|NCT00539513|62807676|FG001|Overall Study|Lost to Follow-up|1|||
33430150|NCT00454584|62807685|FG000|Controlled Period|Adverse Event|5|||
33430151|NCT00454584|62807686|FG001|Controlled Period|Adverse Event|2|||
33430152|NCT00454584|62807687|FG002|Controlled Period|Adverse Event|1|||
33430153|NCT00454584|62807688|FG003|Controlled Period|Adverse Event|0|||
33430154|NCT00454584|62807689|FG004|Controlled Period|Adverse Event|0|||
33430155|NCT00454584|62807690|FG005|Controlled Period|Adverse Event|0|||
33430156|NCT00454584|62807685|FG000|Controlled Period|Lost to Follow-up|1|||
33430157|NCT00454584|62807686|FG001|Controlled Period|Lost to Follow-up|2|||
33430158|NCT00454584|62807687|FG002|Controlled Period|Lost to Follow-up|2|||
33430159|NCT00454584|62807688|FG003|Controlled Period|Lost to Follow-up|0|||
33430160|NCT00454584|62807689|FG004|Controlled Period|Lost to Follow-up|0|||
33430161|NCT00454584|62807690|FG005|Controlled Period|Lost to Follow-up|0|||
33430162|NCT00454584|62807685|FG000|Controlled Period|Other|5|||
33430163|NCT00454584|62807686|FG001|Controlled Period|Other|4|||
33430164|NCT00454584|62807687|FG002|Controlled Period|Other|2|||
33430165|NCT00454584|62807688|FG003|Controlled Period|Other|0|||
33430166|NCT00454584|62807689|FG004|Controlled Period|Other|0|||
33430167|NCT00454584|62807690|FG005|Controlled Period|Other|0|||
33430168|NCT00454584|62807685|FG000|After Controlled Period|Adverse Event|0|||
33430169|NCT00454584|62807686|FG001|After Controlled Period|Adverse Event|0|||
33430170|NCT00454584|62807687|FG002|After Controlled Period|Adverse Event|0|||
33430171|NCT00454584|62807688|FG003|After Controlled Period|Adverse Event|9|||
33430172|NCT00454584|62807689|FG004|After Controlled Period|Adverse Event|3|||
33430173|NCT00454584|62807690|FG005|After Controlled Period|Adverse Event|9|||
33430174|NCT00454584|62807685|FG000|After Controlled Period|Lack of Efficacy|0|||
33430175|NCT00454584|62807686|FG001|After Controlled Period|Lack of Efficacy|0|||
33430176|NCT00454584|62807687|FG002|After Controlled Period|Lack of Efficacy|0|||
33430177|NCT00454584|62807688|FG003|After Controlled Period|Lack of Efficacy|1|||
33430178|NCT00454584|62807689|FG004|After Controlled Period|Lack of Efficacy|0|||
33430179|NCT00454584|62807690|FG005|After Controlled Period|Lack of Efficacy|0|||
33430180|NCT00454584|62807685|FG000|After Controlled Period|Lost to Follow-up|0|||
33430181|NCT00454584|62807686|FG001|After Controlled Period|Lost to Follow-up|0|||
33430182|NCT00454584|62807687|FG002|After Controlled Period|Lost to Follow-up|0|||
33430183|NCT00454584|62807688|FG003|After Controlled Period|Lost to Follow-up|2|||
33430184|NCT00454584|62807689|FG004|After Controlled Period|Lost to Follow-up|4|||
33430185|NCT00454584|62807690|FG005|After Controlled Period|Lost to Follow-up|6|||
33430186|NCT00454584|62807685|FG000|After Controlled Period|Other|0|||
33430187|NCT00454584|62807686|FG001|After Controlled Period|Other|0|||
33430188|NCT00454584|62807687|FG002|After Controlled Period|Other|0|||
33430189|NCT00454584|62807688|FG003|After Controlled Period|Other|1|||
33430190|NCT00454584|62807689|FG004|After Controlled Period|Other|0|||
33430191|NCT00454584|62807690|FG005|After Controlled Period|Other|0|||
33430192|NCT00454584|62807685|FG000|After Controlled Period|Other|0|||
33430193|NCT00454584|62807686|FG001|After Controlled Period|Other|0|||
33430194|NCT00454584|62807687|FG002|After Controlled Period|Other|0|||
33430195|NCT00454584|62807688|FG003|After Controlled Period|Other|13|||
33430196|NCT00454584|62807689|FG004|After Controlled Period|Other|5|||
33430197|NCT00454584|62807690|FG005|After Controlled Period|Other|17|||
33430198|NCT00445068|62807704|FG000|Overall Study|Disease progression|26|||
33430199|NCT00445068|62807704|FG000|Overall Study|Adverse Event|5|||
33430200|NCT00445068|62807704|FG000|Overall Study|Abnormal laboratory value|2|||
33430201|NCT00445068|62807704|FG000|Overall Study|Withdrawal by Subject|2|||
33430202|NCT00445068|62807704|FG000|Overall Study|Death|1|||
33430203|NCT00539279|62807710|FG000|Treatment|Withdrawal by Subject|10|||
33430204|NCT00539279|62807711|FG001|Treatment|Withdrawal by Subject|8|||
33430205|NCT00539279|62807710|FG000|Treatment|Death|1|||
33430206|NCT00539279|62807711|FG001|Treatment|Death|0|||
33430207|NCT00539279|62807710|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
33430208|NCT00539279|62807711|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
33430209|NCT00539279|62807710|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
33430210|NCT00539279|62807711|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
33430211|NCT00444912|62807719|FG000|Overall Study|Death|1|||
33430212|NCT00444912|62807720|FG001|Overall Study|Death|2|||
33430213|NCT00444912|62807719|FG000|Overall Study|Lost to Follow-up|1|||
33430214|NCT00444912|62807720|FG001|Overall Study|Lost to Follow-up|0|||
33430215|NCT00444912|62807719|FG000|Overall Study|Participant Failed Mobilization|1|||
33430216|NCT00444912|62807720|FG001|Overall Study|Participant Failed Mobilization|0|||
33430217|NCT00538733|62807726|FG000|Overall Study|Adverse Event|8|||
33430218|NCT00538733|62807726|FG000|Overall Study|Death|1|||
33430219|NCT00538733|62807726|FG000|Overall Study|declined to participate|2|||
33430220|NCT00538733|62807726|FG000|Overall Study|still on therapy|1|||
33430221|NCT00444678|62807733|FG000|Overall Study|Toxicity|11|||
33430222|NCT00444678|62807733|FG000|Overall Study|Disease Progression|12|||
33430223|NCT00444678|62807733|FG000|Overall Study|Death|3|||
33430224|NCT00444678|62807733|FG000|Overall Study|Physician Decision|3|||
33430225|NCT00444678|62807733|FG000|Overall Study|Withdrawal by Subject|2|||
33430226|NCT00358449|62807740|FG000|Overall Study|Adverse Event|1|||
33430227|NCT00358449|62807741|FG001|Overall Study|Adverse Event|0|||
33430228|NCT00358449|62807742|FG002|Overall Study|Adverse Event|1|||
33430229|NCT00358449|62807740|FG000|Overall Study|Lost to Follow-up|1|||
33430230|NCT00358449|62807741|FG001|Overall Study|Lost to Follow-up|0|||
33430231|NCT00358449|62807742|FG002|Overall Study|Lost to Follow-up|0|||
33430232|NCT00358449|62807740|FG000|Overall Study|Withdrawal by Subject|2|||
33430233|NCT00358449|62807741|FG001|Overall Study|Withdrawal by Subject|0|||
33430234|NCT00358449|62807742|FG002|Overall Study|Withdrawal by Subject|0|||
33430235|NCT00358449|62807740|FG000|Overall Study|Lack of Efficacy|0|||
33430236|NCT00358449|62807741|FG001|Overall Study|Lack of Efficacy|1|||
33430237|NCT00358449|62807742|FG002|Overall Study|Lack of Efficacy|0|||
33430238|NCT00358449|62807740|FG000|Overall Study|Steriod Inhaler was Increased|0|||
33430239|NCT00358449|62807741|FG001|Overall Study|Steriod Inhaler was Increased|0|||
33430240|NCT00358449|62807742|FG002|Overall Study|Steriod Inhaler was Increased|1|||
33430241|NCT00539981|62807754|FG000|Overall Study|Adverse events (AE)|3|||
33430242|NCT00539981|62807755|FG001|Overall Study|Adverse events (AE)|3|||
33430243|NCT00539981|62807754|FG000|Overall Study|Lost to Follow-up|260|||
33605403|NCT02336555|63005082|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
33430244|NCT00539981|62807755|FG001|Overall Study|Lost to Follow-up|251|||
33430245|NCT00539981|62807754|FG000|Overall Study|Withdrew consent|22|||
33430246|NCT00539981|62807755|FG001|Overall Study|Withdrew consent|14|||
33430247|NCT00539981|62807754|FG000|Overall Study|Death|1|||
33430248|NCT00539981|62807755|FG001|Overall Study|Death|1|||
33605404|NCT02336555|63005083|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
33605405|NCT02336555|63005082|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
33605406|NCT02336555|63005083|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
33605407|NCT01648283|63005089|FG000|Overall Study|Withdrawal by Subject|14|||
33605408|NCT01649297|63005100|FG000|Overall Study|Adverse Event|5|||
33605409|NCT01649297|63005101|FG001|Overall Study|Adverse Event|5|||
33605410|NCT01649297|63005102|FG002|Overall Study|Adverse Event|4|||
33605411|NCT01649297|63005103|FG003|Overall Study|Adverse Event|13|||
33605412|NCT01649297|63005104|FG004|Overall Study|Adverse Event|1|||
33605413|NCT01649297|63005100|FG000|Overall Study|Lack of Efficacy|0|||
33430249|NCT00539981|62807754|FG000|Overall Study|Other reason-unspecified|9|||
33605414|NCT01649297|63005101|FG001|Overall Study|Lack of Efficacy|0|||
33605415|NCT01649297|63005102|FG002|Overall Study|Lack of Efficacy|0|||
33605416|NCT01649297|63005103|FG003|Overall Study|Lack of Efficacy|0|||
33430250|NCT00539981|62807755|FG001|Overall Study|Other reason-unspecified|13|||
33430251|NCT00367341|62807766|FG000|Overall Study|Physician Decision|1|||
33430252|NCT00367341|62807767|FG001|Overall Study|Physician Decision|0|||
33430253|NCT00367341|62807766|FG000|Overall Study|Protocol Violation|1|||
33430254|NCT00367341|62807767|FG001|Overall Study|Protocol Violation|0|||
33430255|NCT00440466|62807776|FG000|Overall Study|Death|3|||
33430256|NCT00440466|62807777|FG001|Overall Study|Death|2|||
33430257|NCT00440466|62807778|FG002|Overall Study|Death|9|||
33430258|NCT00440466|62807776|FG000|Overall Study|Adverse Event|3|||
33430259|NCT00440466|62807777|FG001|Overall Study|Adverse Event|4|||
33430260|NCT00440466|62807778|FG002|Overall Study|Adverse Event|11|||
33430261|NCT00440466|62807776|FG000|Overall Study|Lost to Follow-up|1|||
33430262|NCT00440466|62807777|FG001|Overall Study|Lost to Follow-up|0|||
33430263|NCT00440466|62807778|FG002|Overall Study|Lost to Follow-up|2|||
33430264|NCT00440466|62807776|FG000|Overall Study|Physician Decision|2|||
33430265|NCT00440466|62807777|FG001|Overall Study|Physician Decision|0|||
33430266|NCT00440466|62807778|FG002|Overall Study|Physician Decision|1|||
33430267|NCT00440466|62807776|FG000|Overall Study|Protocol Violation|2|||
33430268|NCT00440466|62807777|FG001|Overall Study|Protocol Violation|0|||
33430269|NCT00440466|62807778|FG002|Overall Study|Protocol Violation|4|||
33430270|NCT00440466|62807776|FG000|Overall Study|Withdrawal by Subject|2|||
33430271|NCT00440466|62807777|FG001|Overall Study|Withdrawal by Subject|5|||
33430272|NCT00440466|62807778|FG002|Overall Study|Withdrawal by Subject|9|||
33430273|NCT00440466|62807776|FG000|Overall Study|Began Dialysis|0|||
33430274|NCT00440466|62807777|FG001|Overall Study|Began Dialysis|0|||
33430275|NCT00440466|62807778|FG002|Overall Study|Began Dialysis|1|||
33430276|NCT00440466|62807776|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
33430277|NCT00440466|62807777|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
33430278|NCT00440466|62807778|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
33430279|NCT00537485|62807810|FG000|Overall Study|Adverse Event|10|||
33430280|NCT00537485|62807811|FG001|Overall Study|Adverse Event|5|||
33430281|NCT00537485|62807810|FG000|Overall Study|Withdrawal by Subject|3|||
33430282|NCT00537485|62807811|FG001|Overall Study|Withdrawal by Subject|2|||
33430283|NCT00537485|62807810|FG000|Overall Study|Withdrawal by Subject|1|||
33430284|NCT00537485|62807811|FG001|Overall Study|Withdrawal by Subject|3|||
33430285|NCT00537485|62807810|FG000|Overall Study|Physician Decision|1|||
33430286|NCT00537485|62807811|FG001|Overall Study|Physician Decision|0|||
33430287|NCT00616967|62807819|FG000|Overall Study|Withdrawal by Subject|0|||
33430288|NCT00616967|62807820|FG001|Overall Study|Withdrawal by Subject|0|||
33430289|NCT00616967|62807821|FG002|Overall Study|Withdrawal by Subject|1|||
33430290|NCT00537329|62807839|FG000|Overall Study|Death|10|||
33430291|NCT00537329|62807839|FG000|Overall Study|Adverse Event|3|||
33430292|NCT00537329|62807839|FG000|Overall Study|Lack of Efficacy|2|||
33430293|NCT00537329|62807839|FG000|Overall Study|Lost to Follow-up|6|||
33430294|NCT00537329|62807839|FG000|Overall Study|Withdrawal by Subject|4|||
33430295|NCT00537329|62807839|FG000|Overall Study|Other|1|||
33430296|NCT03897179|62807843|FG000|Overall Study|Withdrawal by Subject|1|||
33430297|NCT03905135|62807849|FG000|Dose Escalation|Adverse Event|1|||
33430298|NCT03905135|62807850|FG001|Dose Escalation|Adverse Event|1|||
33430299|NCT03905135|62807849|FG000|Dose Escalation|Progressive disease|3|||
33430300|NCT03905135|62807850|FG001|Dose Escalation|Progressive disease|1|||
33430301|NCT03905135|62807849|FG000|Dose Escalation|Intercurrent illness|1|||
33430302|NCT03905135|62807850|FG001|Dose Escalation|Intercurrent illness|0|||
33430303|NCT00357903|62807860|FG000|Overall Study|Adverse Event|87|||
33430304|NCT00357903|62807861|FG001|Overall Study|Adverse Event|4|||
33430305|NCT00357903|62807860|FG000|Overall Study|Death|33|||
33430306|NCT00357903|62807861|FG001|Overall Study|Death|0|||
33430307|NCT00357903|62807860|FG000|Overall Study|Lost to Follow-up|23|||
33430308|NCT00357903|62807861|FG001|Overall Study|Lost to Follow-up|4|||
33430309|NCT00357903|62807860|FG000|Overall Study|Physician Decision|39|||
33430310|NCT00357903|62807861|FG001|Overall Study|Physician Decision|5|||
33430311|NCT00357903|62807860|FG000|Overall Study|Withdrawal by Subject|57|||
33430312|NCT00357903|62807861|FG001|Overall Study|Withdrawal by Subject|7|||
33430313|NCT00357903|62807860|FG000|Overall Study|Completed month 12 only|0|||
33430314|NCT00357903|62807861|FG001|Overall Study|Completed month 12 only|1|||
33605417|NCT01649297|63005104|FG004|Overall Study|Lack of Efficacy|1|||
33430315|NCT00357903|62807860|FG000|Overall Study|Protocol issues|14|||
33430316|NCT00357903|62807861|FG001|Overall Study|Protocol issues|3|||
33430317|NCT00357903|62807860|FG000|Overall Study|Response status|61|||
33430318|NCT00357903|62807861|FG001|Overall Study|Response status|9|||
33430319|NCT00357903|62807860|FG000|Overall Study|Other|49|||
33430320|NCT00357903|62807861|FG001|Overall Study|Other|10|||
33430321|NCT00348933|62807868|FG000|Overall Study|Withdrawal by Subject|10|||
33430322|NCT00348933|62807868|FG000|Overall Study|Lost to Follow-up|6|||
33430323|NCT00348933|62807868|FG000|Overall Study|Protocol Violation|2|||
33430324|NCT00348933|62807868|FG000|Overall Study|Adverse Event|7|||
33430325|NCT03896477|62807876|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
33430326|NCT03896477|62807877|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
33430327|NCT03896477|62807878|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
33430328|NCT03896477|62807876|FG000|Overall Study|Parent Requested Withdrawal|8|||
33430329|NCT03896477|62807877|FG001|Overall Study|Parent Requested Withdrawal|12|||
33430330|NCT03896477|62807878|FG002|Overall Study|Parent Requested Withdrawal|9|||
33430331|NCT03896477|62807876|FG000|Overall Study|Adverse Event|0|||
33430332|NCT03896477|62807877|FG001|Overall Study|Adverse Event|0|||
33430333|NCT03896477|62807878|FG002|Overall Study|Adverse Event|1|||
33430334|NCT03896477|62807876|FG000|Overall Study|Death|1|||
33430335|NCT03896477|62807877|FG001|Overall Study|Death|0|||
33430336|NCT03896477|62807878|FG002|Overall Study|Death|0|||
33430337|NCT03896477|62807876|FG000|Overall Study|Other|5|||
33430338|NCT03896477|62807877|FG001|Overall Study|Other|6|||
33430339|NCT03896477|62807878|FG002|Overall Study|Other|7|||
33430340|NCT03896477|62807876|FG000|Overall Study|Lost to Follow-up|2|||
33430341|NCT03896477|62807877|FG001|Overall Study|Lost to Follow-up|1|||
33430342|NCT03896477|62807878|FG002|Overall Study|Lost to Follow-up|1|||
33430343|NCT00444600|62807893|FG000|Overall Study|Death|7|||
33430344|NCT00444600|62807894|FG001|Overall Study|Death|5|||
33430345|NCT00444600|62807895|FG002|Overall Study|Death|3|||
33430346|NCT00444600|62807896|FG003|Overall Study|Death|2|||
33430347|NCT00444600|62807893|FG000|Overall Study|Dropped|11|||
33430348|NCT00444600|62807894|FG001|Overall Study|Dropped|11|||
33430349|NCT00444600|62807895|FG002|Overall Study|Dropped|7|||
33430350|NCT00444600|62807896|FG003|Overall Study|Dropped|7|||
33430351|NCT00444600|62807893|FG000|Overall Study|Missed visit|1|||
33430352|NCT00444600|62807894|FG001|Overall Study|Missed visit|0|||
33430353|NCT00444600|62807895|FG002|Overall Study|Missed visit|0|||
33430354|NCT00444600|62807896|FG003|Overall Study|Missed visit|1|||
33430355|NCT00537095|62807914|FG000|Overall Study|surgery|1|||
33430356|NCT00537095|62807915|FG001|Overall Study|surgery|0|||
33430357|NCT00537095|62807914|FG000|Overall Study|Adverse Event|24|||
33430358|NCT00537095|62807915|FG001|Overall Study|Adverse Event|4|||
33430359|NCT00537095|62807914|FG000|Overall Study|disease progression|21|||
33430360|NCT00537095|62807915|FG001|Overall Study|disease progression|48|||
33430361|NCT00537095|62807914|FG000|Overall Study|Death|3|||
33430362|NCT00537095|62807915|FG001|Overall Study|Death|1|||
33430363|NCT00537095|62807914|FG000|Overall Study|Withdrawal by Subject|2|||
33430364|NCT00537095|62807915|FG001|Overall Study|Withdrawal by Subject|2|||
33430365|NCT00537095|62807914|FG000|Overall Study|subjective disease progression|0|||
33430366|NCT00537095|62807915|FG001|Overall Study|subjective disease progression|1|||
33430367|NCT00537095|62807914|FG000|Overall Study|Incorrect enrolment|0|||
33430368|NCT00537095|62807915|FG001|Overall Study|Incorrect enrolment|1|||
33430369|NCT00443898|62807925|FG000|Overall Study|Adverse Event|0|||
33430370|NCT00443898|62807926|FG001|Overall Study|Adverse Event|0|||
33430371|NCT00443898|62807927|FG002|Overall Study|Adverse Event|1|||
33430372|NCT00443898|62807928|FG003|Overall Study|Adverse Event|1|||
33430373|NCT00443898|62807925|FG000|Overall Study|Lack of Efficacy|2|||
33430374|NCT00443898|62807926|FG001|Overall Study|Lack of Efficacy|3|||
33430375|NCT00443898|62807927|FG002|Overall Study|Lack of Efficacy|3|||
33430376|NCT00443898|62807928|FG003|Overall Study|Lack of Efficacy|1|||
33430377|NCT00443898|62807925|FG000|Overall Study|Protocol Violation|1|||
33430378|NCT00443898|62807926|FG001|Overall Study|Protocol Violation|1|||
33430379|NCT00443898|62807927|FG002|Overall Study|Protocol Violation|1|||
33430380|NCT00443898|62807928|FG003|Overall Study|Protocol Violation|0|||
33430381|NCT00443898|62807925|FG000|Overall Study|Withdrawal by Subject|11|||
33323078|NCT00976209|62699381|FG000|Wash-out Period|Protocol Violation|1|||
33430382|NCT00443898|62807926|FG001|Overall Study|Withdrawal by Subject|10|||
33430383|NCT00443898|62807927|FG002|Overall Study|Withdrawal by Subject|10|||
33605418|NCT01649297|63005100|FG000|Overall Study|Non compliant with Protocol|1|||
33323079|NCT00976209|62699382|FG001|Wash-out Period|Protocol Violation|0|||
33430384|NCT00443898|62807928|FG003|Overall Study|Withdrawal by Subject|6|||
33430385|NCT00443898|62807925|FG000|Overall Study|Lost to Follow-up|10|||
33430386|NCT00443898|62807926|FG001|Overall Study|Lost to Follow-up|10|||
33430387|NCT00443898|62807927|FG002|Overall Study|Lost to Follow-up|14|||
33430388|NCT00443898|62807928|FG003|Overall Study|Lost to Follow-up|10|||
33430389|NCT00443898|62807925|FG000|Overall Study|Death|0|||
33430390|NCT00443898|62807926|FG001|Overall Study|Death|1|||
33430391|NCT00443898|62807927|FG002|Overall Study|Death|0|||
33430392|NCT00443898|62807928|FG003|Overall Study|Death|0|||
33430393|NCT00537017|62807938|FG000|Treatment Phase|Adverse Event|19|||
33430394|NCT00537017|62807938|FG000|Treatment Phase|Withdrawal by Subject|13|||
33430395|NCT00537017|62807938|FG000|Treatment Phase|Protocol Violation|2|||
33430396|NCT00537017|62807938|FG000|Follow-up Phase|Withdrawal by Subject|9|||
33430397|NCT00348309|62807945|FG000|Overall Study|Adverse Event|56|||
33430398|NCT00348309|62807946|FG001|Overall Study|Adverse Event|28|||
33430399|NCT00348309|62807947|FG002|Overall Study|Adverse Event|63|||
33430400|NCT00348309|62807945|FG000|Overall Study|Lost to Follow-up|6|||
33430401|NCT00348309|62807946|FG001|Overall Study|Lost to Follow-up|7|||
33430402|NCT00348309|62807947|FG002|Overall Study|Lost to Follow-up|4|||
33430403|NCT00348309|62807945|FG000|Overall Study|Protocol Violation|7|||
33430404|NCT00348309|62807946|FG001|Overall Study|Protocol Violation|12|||
33430405|NCT00348309|62807947|FG002|Overall Study|Protocol Violation|7|||
33430406|NCT00348309|62807945|FG000|Overall Study|Withdrawal by Subject|33|||
33430407|NCT00348309|62807946|FG001|Overall Study|Withdrawal by Subject|37|||
33430408|NCT00348309|62807947|FG002|Overall Study|Withdrawal by Subject|40|||
33430409|NCT00348309|62807945|FG000|Overall Study|Non-compliance|8|||
33430410|NCT00348309|62807946|FG001|Overall Study|Non-compliance|6|||
33430411|NCT00348309|62807947|FG002|Overall Study|Non-compliance|8|||
33430412|NCT00348309|62807945|FG000|Overall Study|Death of caregiver|1|||
33430413|NCT00348309|62807946|FG001|Overall Study|Death of caregiver|0|||
33430414|NCT00348309|62807947|FG002|Overall Study|Death of caregiver|1|||
33430415|NCT00348309|62807945|FG000|Overall Study|Lack of insight, dementia|1|||
33430416|NCT00348309|62807946|FG001|Overall Study|Lack of insight, dementia|0|||
33430417|NCT00348309|62807947|FG002|Overall Study|Lack of insight, dementia|0|||
33430418|NCT00348309|62807945|FG000|Overall Study|Wrong bottle allocated|1|||
33430419|NCT00348309|62807946|FG001|Overall Study|Wrong bottle allocated|0|||
33430420|NCT00348309|62807947|FG002|Overall Study|Wrong bottle allocated|0|||
33430421|NCT00348309|62807945|FG000|Overall Study|Caregiver sick|1|||
33430422|NCT00348309|62807946|FG001|Overall Study|Caregiver sick|0|||
33430423|NCT00348309|62807947|FG002|Overall Study|Caregiver sick|0|||
33430424|NCT00348309|62807945|FG000|Overall Study|Use of prohibited medication|5|||
33430425|NCT00348309|62807946|FG001|Overall Study|Use of prohibited medication|2|||
33430426|NCT00348309|62807947|FG002|Overall Study|Use of prohibited medication|2|||
33430427|NCT00348309|62807945|FG000|Overall Study|Caregiver withdrawal|3|||
33430428|NCT00348309|62807946|FG001|Overall Study|Caregiver withdrawal|0|||
33430429|NCT00348309|62807947|FG002|Overall Study|Caregiver withdrawal|7|||
33430430|NCT00348309|62807945|FG000|Overall Study|Unable to complete ET visit|1|||
33430431|NCT00348309|62807946|FG001|Overall Study|Unable to complete ET visit|0|||
33430432|NCT00348309|62807947|FG002|Overall Study|Unable to complete ET visit|0|||
33430433|NCT00348309|62807945|FG000|Overall Study|PI closing medical practice|1|||
33430434|NCT00348309|62807946|FG001|Overall Study|PI closing medical practice|0|||
33430435|NCT00348309|62807947|FG002|Overall Study|PI closing medical practice|0|||
33430436|NCT00348309|62807945|FG000|Overall Study|Principal investigator's decision|1|||
33430437|NCT00348309|62807946|FG001|Overall Study|Principal investigator's decision|0|||
33430438|NCT00348309|62807947|FG002|Overall Study|Principal investigator's decision|0|||
33430439|NCT00348309|62807945|FG000|Overall Study|No disponibility of medication|1|||
33430440|NCT00348309|62807946|FG001|Overall Study|No disponibility of medication|0|||
33430441|NCT00348309|62807947|FG002|Overall Study|No disponibility of medication|0|||
33430442|NCT00348309|62807945|FG000|Overall Study|Worsened neurodegenerative disease|1|||
33430443|NCT00348309|62807946|FG001|Overall Study|Worsened neurodegenerative disease|0|||
33430444|NCT00348309|62807947|FG002|Overall Study|Worsened neurodegenerative disease|0|||
33430445|NCT00348309|62807945|FG000|Overall Study|Cognitive and behaviour worsening|2|||
33430446|NCT00348309|62807946|FG001|Overall Study|Cognitive and behaviour worsening|0|||
33430447|NCT00348309|62807947|FG002|Overall Study|Cognitive and behaviour worsening|0|||
33430448|NCT00348309|62807945|FG000|Overall Study|Worsening of alzheimer|1|||
33430449|NCT00348309|62807946|FG001|Overall Study|Worsening of alzheimer|0|||
33430450|NCT00348309|62807947|FG002|Overall Study|Worsening of alzheimer|1|||
33430451|NCT00348309|62807945|FG000|Overall Study|Did not appear in time for Visit 3|1|||
33430452|NCT00348309|62807946|FG001|Overall Study|Did not appear in time for Visit 3|0|||
33430453|NCT00348309|62807947|FG002|Overall Study|Did not appear in time for Visit 3|0|||
33430454|NCT00348309|62807945|FG000|Overall Study|Participant died|2|||
33430455|NCT00348309|62807946|FG001|Overall Study|Participant died|1|||
33430456|NCT00348309|62807947|FG002|Overall Study|Participant died|1|||
33430457|NCT00348309|62807945|FG000|Overall Study|Decision of sponsor|1|||
33430458|NCT00348309|62807946|FG001|Overall Study|Decision of sponsor|0|||
33430459|NCT00348309|62807947|FG002|Overall Study|Decision of sponsor|0|||
33430460|NCT00348309|62807945|FG000|Overall Study|Ineffectiveness of treatment|0|||
33430461|NCT00348309|62807946|FG001|Overall Study|Ineffectiveness of treatment|1|||
33430462|NCT00348309|62807947|FG002|Overall Study|Ineffectiveness of treatment|0|||
33430463|NCT00348309|62807945|FG000|Overall Study|A foul of exclusion criteria|0|||
33430464|NCT00348309|62807946|FG001|Overall Study|A foul of exclusion criteria|1|||
33430465|NCT00348309|62807947|FG002|Overall Study|A foul of exclusion criteria|0|||
33430466|NCT00348309|62807945|FG000|Overall Study|Participant was hospitalized|0|||
33430467|NCT00348309|62807946|FG001|Overall Study|Participant was hospitalized|1|||
33430468|NCT00348309|62807947|FG002|Overall Study|Participant was hospitalized|0|||
33430469|NCT00348309|62807945|FG000|Overall Study|Sponsor refuseal|0|||
33430470|NCT00348309|62807946|FG001|Overall Study|Sponsor refuseal|1|||
33430471|NCT00348309|62807947|FG002|Overall Study|Sponsor refuseal|1|||
33430472|NCT00348309|62807945|FG000|Overall Study|Forgot often medication|0|||
33430473|NCT00348309|62807946|FG001|Overall Study|Forgot often medication|1|||
33430474|NCT00348309|62807947|FG002|Overall Study|Forgot often medication|0|||
33430475|NCT00348309|62807945|FG000|Overall Study|Medical Monitor decision|0|||
33430476|NCT00348309|62807946|FG001|Overall Study|Medical Monitor decision|0|||
33430477|NCT00348309|62807947|FG002|Overall Study|Medical Monitor decision|1|||
33430478|NCT00348309|62807945|FG000|Overall Study|Increased dose of Aricept|0|||
33430479|NCT00348309|62807946|FG001|Overall Study|Increased dose of Aricept|0|||
33430480|NCT00348309|62807947|FG002|Overall Study|Increased dose of Aricept|1|||
33430481|NCT00348309|62807945|FG000|Overall Study|Site closure|0|||
33430482|NCT00348309|62807946|FG001|Overall Study|Site closure|0|||
33430483|NCT00348309|62807947|FG002|Overall Study|Site closure|1|||
33430484|NCT00348309|62807945|FG000|Overall Study|Adverse event not attended|0|||
33430485|NCT00348309|62807946|FG001|Overall Study|Adverse event not attended|0|||
33430486|NCT00348309|62807947|FG002|Overall Study|Adverse event not attended|1|||
33430487|NCT00348309|62807945|FG000|Overall Study|ECG abnormal|0|||
33430488|NCT00348309|62807946|FG001|Overall Study|ECG abnormal|0|||
33430489|NCT00348309|62807947|FG002|Overall Study|ECG abnormal|2|||
33430490|NCT00348309|62807945|FG000|Overall Study|Cardiologist recommendations|0|||
33430491|NCT00348309|62807946|FG001|Overall Study|Cardiologist recommendations|0|||
33430492|NCT00348309|62807947|FG002|Overall Study|Cardiologist recommendations|1|||
33430493|NCT00348309|62807945|FG000|Overall Study|HCV career|0|||
33430494|NCT00348309|62807946|FG001|Overall Study|HCV career|0|||
33430495|NCT00348309|62807947|FG002|Overall Study|HCV career|1|||
33430496|NCT00440310|62807958|FG000|Overall Study|Lost to Follow-up|4|||
33430497|NCT00440310|62807959|FG001|Overall Study|Lost to Follow-up|5|||
33430498|NCT00440310|62807958|FG000|Overall Study|Protocol Violation|0|||
33430499|NCT00440310|62807959|FG001|Overall Study|Protocol Violation|1|||
33430500|NCT00440310|62807958|FG000|Overall Study|Withdrawal by Subject|15|||
33430501|NCT00440310|62807959|FG001|Overall Study|Withdrawal by Subject|14|||
33430502|NCT00440310|62807958|FG000|Overall Study|No Reply at EOS|7|||
33430503|NCT00440310|62807959|FG001|Overall Study|No Reply at EOS|7|||
33430504|NCT00440310|62807958|FG000|Overall Study|Other|1|||
33430505|NCT00440310|62807959|FG001|Overall Study|Other|0|||
33430506|NCT00440310|62807958|FG000|Overall Study|Status Unknown|1|||
33430507|NCT00440310|62807959|FG001|Overall Study|Status Unknown|3|||
33430508|NCT00440232|62807967|FG000|Overall Study|Lost to Follow-up|1|||
33430509|NCT00440232|62807968|FG001|Overall Study|Lost to Follow-up|1|||
33430510|NCT00440232|62807967|FG000|Overall Study|Unable to treat within allowed time|0|||
33430511|NCT00440232|62807968|FG001|Overall Study|Unable to treat within allowed time|1|||
33430512|NCT00440232|62807967|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
33430513|NCT00440232|62807968|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
33430514|NCT00356889|62807974|FG000|Overall Study|Protocol Violation|2|||
33430515|NCT00356889|62807974|FG000|Overall Study|Adverse Event|1|||
33430516|NCT00356811|62807979|FG000|Overall Study|Death|35|||
33430517|NCT00356811|62807979|FG000|Overall Study|Lost to Follow-up|2|||
33430518|NCT00356811|62807979|FG000|Overall Study|Withdrawal by Subject|6|||
33430519|NCT00356811|62807979|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
33430520|NCT00356811|62807979|FG000|Overall Study|Study Is Terminating|3|||
33430521|NCT00356811|62807979|FG000|Overall Study|Site Closed during Follow-up|2|||
33430522|NCT00439218|62807984|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
33430523|NCT00535223|62808003|FG000|Overall Study|Withdrawal by Subject|4|||
33430524|NCT00535223|62808004|FG001|Overall Study|Withdrawal by Subject|1|||
33430525|NCT00536939|62808010|FG000|Overall Study|Withdrawal by Subject|1|||
33430526|NCT00536939|62808011|FG001|Overall Study|Withdrawal by Subject|0|||
33430527|NCT00536939|62808010|FG000|Overall Study|Other Complicating Disease|1|||
33430528|NCT00536939|62808011|FG001|Overall Study|Other Complicating Disease|0|||
33430529|NCT00347919|62808019|FG000|Overall Study|Lost to Follow-up|11|||
33430530|NCT00347919|62808020|FG001|Overall Study|Lost to Follow-up|13|||
33430531|NCT00347919|62808021|FG002|Overall Study|Lost to Follow-up|0|||
33430532|NCT00347919|62808019|FG000|Overall Study|Withdrawal by Subject|6|||
33430533|NCT00347919|62808020|FG001|Overall Study|Withdrawal by Subject|8|||
33430534|NCT00347919|62808021|FG002|Overall Study|Withdrawal by Subject|0|||
33430535|NCT00347919|62808019|FG000|Overall Study|Physician Decision|1|||
33430536|NCT00347919|62808020|FG001|Overall Study|Physician Decision|1|||
33430537|NCT00347919|62808021|FG002|Overall Study|Physician Decision|0|||
33430538|NCT00347919|62808019|FG000|Overall Study|Sponsor terminated study|15|||
33430539|NCT00347919|62808020|FG001|Overall Study|Sponsor terminated study|10|||
33430540|NCT00347919|62808021|FG002|Overall Study|Sponsor terminated study|16|||
33430541|NCT00347919|62808019|FG000|Overall Study|Death|35|||
33430542|NCT00347919|62808020|FG001|Overall Study|Death|42|||
33430543|NCT00347919|62808021|FG002|Overall Study|Death|19|||
33430544|NCT00347919|62808019|FG000|Overall Study|Par. Started Other Treatment|1|||
33430545|NCT00347919|62808020|FG001|Overall Study|Par. Started Other Treatment|1|||
33430546|NCT00347919|62808021|FG002|Overall Study|Par. Started Other Treatment|1|||
33430547|NCT00347919|62808019|FG000|Overall Study|Missing|2|||
33430548|NCT00347919|62808020|FG001|Overall Study|Missing|1|||
33430549|NCT00347919|62808021|FG002|Overall Study|Missing|2|||
33430550|NCT00439140|62808034|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
33430551|NCT00439140|62808035|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
33430552|NCT00439140|62808036|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
33430553|NCT00439140|62808034|FG000|Treatment Cycle 1|Personal reasons|0|||
33430554|NCT00439140|62808035|FG001|Treatment Cycle 1|Personal reasons|2|||
33430555|NCT00439140|62808036|FG002|Treatment Cycle 1|Personal reasons|0|||
33430556|NCT00439140|62808034|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
33430557|NCT00439140|62808035|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
33430558|NCT00439140|62808036|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
33430559|NCT00439140|62808034|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
33430560|NCT00439140|62808035|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
33430561|NCT00439140|62808036|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
33430562|NCT00439140|62808034|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
33430563|NCT00439140|62808035|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
33430564|NCT00439140|62808036|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
33430565|NCT00356421|62808046|FG000|Overall Study|Lack of Efficacy|3|||
33430566|NCT00356421|62808047|FG001|Overall Study|Lack of Efficacy|0|||
33430567|NCT00356421|62808046|FG000|Overall Study|Withdrawal by Subject|9|||
33430568|NCT00356421|62808047|FG001|Overall Study|Withdrawal by Subject|2|||
33430569|NCT00356421|62808046|FG000|Overall Study|Related to study drug|15|||
33430570|NCT00356421|62808047|FG001|Overall Study|Related to study drug|12|||
33430571|NCT00356421|62808046|FG000|Overall Study|Not related to study drug|5|||
33430572|NCT00356421|62808047|FG001|Overall Study|Not related to study drug|3|||
33430573|NCT00443820|62808057|FG000|Overall Study|Adverse Event|1|||
33430574|NCT00443820|62808058|FG001|Overall Study|Adverse Event|1|||
33323080|NCT00976209|62699381|FG000|Wash-out Period|Other|1|||
33430575|NCT00443820|62808059|FG002|Overall Study|Adverse Event|0|||
33430576|NCT00443820|62808060|FG003|Overall Study|Adverse Event|0|||
33430577|NCT00443820|62808057|FG000|Overall Study|Lack of Efficacy|3|||
33430578|NCT00443820|62808058|FG001|Overall Study|Lack of Efficacy|2|||
33430579|NCT00443820|62808059|FG002|Overall Study|Lack of Efficacy|1|||
33430580|NCT00443820|62808060|FG003|Overall Study|Lack of Efficacy|1|||
33430581|NCT00443820|62808057|FG000|Overall Study|Protocol Violation|2|||
33605419|NCT01649297|63005101|FG001|Overall Study|Non compliant with Protocol|0|||
33430582|NCT00443820|62808058|FG001|Overall Study|Protocol Violation|1|||
33605420|NCT01649297|63005102|FG002|Overall Study|Non compliant with Protocol|3|||
33605421|NCT01649297|63005103|FG003|Overall Study|Non compliant with Protocol|2|||
33430583|NCT00443820|62808059|FG002|Overall Study|Protocol Violation|2|||
33430584|NCT00443820|62808060|FG003|Overall Study|Protocol Violation|1|||
33430585|NCT00443820|62808057|FG000|Overall Study|Withdrawal by Subject|6|||
33430586|NCT00443820|62808058|FG001|Overall Study|Withdrawal by Subject|7|||
33430587|NCT00443820|62808059|FG002|Overall Study|Withdrawal by Subject|8|||
33430588|NCT00443820|62808060|FG003|Overall Study|Withdrawal by Subject|9|||
33430589|NCT00443820|62808057|FG000|Overall Study|Lost to Follow-up|9|||
33430590|NCT00443820|62808058|FG001|Overall Study|Lost to Follow-up|8|||
33430591|NCT00443820|62808059|FG002|Overall Study|Lost to Follow-up|6|||
33430592|NCT00443820|62808060|FG003|Overall Study|Lost to Follow-up|5|||
33430593|NCT00443820|62808057|FG000|Overall Study|Administrative problems|0|||
33430594|NCT00443820|62808058|FG001|Overall Study|Administrative problems|0|||
33430595|NCT00443820|62808059|FG002|Overall Study|Administrative problems|0|||
33430596|NCT00443820|62808060|FG003|Overall Study|Administrative problems|1|||
33430597|NCT00443820|62808057|FG000|Overall Study|Death|0|||
33430598|NCT00443820|62808058|FG001|Overall Study|Death|0|||
33430599|NCT00443820|62808059|FG002|Overall Study|Death|1|||
33430600|NCT00443820|62808060|FG003|Overall Study|Death|0|||
33430601|NCT00438672|62808072|FG000|Overall Study|Lost to Follow-up|7|||
33430602|NCT00438672|62808073|FG001|Overall Study|Lost to Follow-up|9|||
33430603|NCT00438360|62808081|FG000|Overall Study|Adverse Event|6|||
33430604|NCT00438360|62808082|FG001|Overall Study|Adverse Event|1|||
33430605|NCT00438360|62808081|FG000|Overall Study|Lack of Efficacy|42|||
33430606|NCT00438360|62808082|FG001|Overall Study|Lack of Efficacy|27|||
33430607|NCT00438360|62808081|FG000|Overall Study|Other|24|||
33430608|NCT00438360|62808082|FG001|Overall Study|Other|15|||
33430609|NCT00536471|62808092|FG000|Overall Study|Lost to Follow-up|48|||
33430610|NCT00536471|62808093|FG001|Overall Study|Lost to Follow-up|23|||
33430611|NCT00536471|62808094|FG002|Overall Study|Lost to Follow-up|48|||
33430612|NCT00536471|62808095|FG003|Overall Study|Lost to Follow-up|22|||
33430613|NCT00536471|62808092|FG000|Overall Study|Adverse Event|32|||
33430614|NCT00536471|62808093|FG001|Overall Study|Adverse Event|16|||
33430615|NCT00536471|62808094|FG002|Overall Study|Adverse Event|28|||
33430616|NCT00536471|62808095|FG003|Overall Study|Adverse Event|13|||
33430617|NCT00536471|62808092|FG000|Overall Study|Withdrawal by Subject|40|||
33430618|NCT00536471|62808093|FG001|Overall Study|Withdrawal by Subject|24|||
33430619|NCT00536471|62808094|FG002|Overall Study|Withdrawal by Subject|43|||
33430620|NCT00536471|62808095|FG003|Overall Study|Withdrawal by Subject|21|||
33430621|NCT00536471|62808092|FG000|Overall Study|Lack of Efficacy|17|||
33430622|NCT00536471|62808093|FG001|Overall Study|Lack of Efficacy|18|||
33430623|NCT00536471|62808094|FG002|Overall Study|Lack of Efficacy|11|||
33430624|NCT00536471|62808095|FG003|Overall Study|Lack of Efficacy|9|||
33430625|NCT00536471|62808092|FG000|Overall Study|Protocol Violation|8|||
33430626|NCT00536471|62808093|FG001|Overall Study|Protocol Violation|1|||
33430627|NCT00536471|62808094|FG002|Overall Study|Protocol Violation|2|||
33430628|NCT00536471|62808095|FG003|Overall Study|Protocol Violation|3|||
33430629|NCT00536471|62808092|FG000|Overall Study|Physician Decision|11|||
33430630|NCT00536471|62808093|FG001|Overall Study|Physician Decision|1|||
33430631|NCT00536471|62808094|FG002|Overall Study|Physician Decision|3|||
33430632|NCT00536471|62808095|FG003|Overall Study|Physician Decision|2|||
33430633|NCT00536471|62808092|FG000|Overall Study|Death|0|||
33430634|NCT00536471|62808093|FG001|Overall Study|Death|0|||
33430635|NCT00536471|62808094|FG002|Overall Study|Death|1|||
33430636|NCT00536471|62808095|FG003|Overall Study|Death|2|||
33430637|NCT00536471|62808092|FG000|Overall Study|Sponsor Decision|0|||
33430638|NCT00536471|62808093|FG001|Overall Study|Sponsor Decision|1|||
33430639|NCT00536471|62808094|FG002|Overall Study|Sponsor Decision|3|||
33430640|NCT00536471|62808095|FG003|Overall Study|Sponsor Decision|2|||
33430641|NCT00359619|62808119|FG000|Overall Study|Adverse Event|0|||
33430642|NCT00359619|62808120|FG001|Overall Study|Adverse Event|0|||
33430643|NCT00359619|62808121|FG002|Overall Study|Adverse Event|1|||
33430644|NCT00359619|62808122|FG003|Overall Study|Adverse Event|0|||
33430645|NCT00359619|62808123|FG004|Overall Study|Adverse Event|0|||
33430646|NCT00359619|62808124|FG005|Overall Study|Adverse Event|0|||
33430647|NCT00359619|62808125|FG006|Overall Study|Adverse Event|1|||
33430648|NCT00359619|62808119|FG000|Overall Study|Withdrawal by Subject|3|||
33430649|NCT00359619|62808120|FG001|Overall Study|Withdrawal by Subject|1|||
33430650|NCT00359619|62808121|FG002|Overall Study|Withdrawal by Subject|4|||
33430651|NCT00359619|62808122|FG003|Overall Study|Withdrawal by Subject|2|||
33430652|NCT00359619|62808123|FG004|Overall Study|Withdrawal by Subject|2|||
33430653|NCT00359619|62808124|FG005|Overall Study|Withdrawal by Subject|0|||
33430654|NCT00359619|62808125|FG006|Overall Study|Withdrawal by Subject|3|||
33430655|NCT00359619|62808119|FG000|Overall Study|Other|1|||
33430656|NCT00359619|62808120|FG001|Overall Study|Other|0|||
33430657|NCT00359619|62808121|FG002|Overall Study|Other|0|||
33430658|NCT00359619|62808122|FG003|Overall Study|Other|0|||
33430659|NCT00359619|62808123|FG004|Overall Study|Other|0|||
33430660|NCT00359619|62808124|FG005|Overall Study|Other|0|||
33430661|NCT00359619|62808125|FG006|Overall Study|Other|0|||
33430662|NCT00359619|62808119|FG000|Overall Study|Lost to Follow-up|4|||
33430663|NCT00359619|62808120|FG001|Overall Study|Lost to Follow-up|4|||
33430664|NCT00359619|62808121|FG002|Overall Study|Lost to Follow-up|2|||
33430665|NCT00359619|62808122|FG003|Overall Study|Lost to Follow-up|1|||
33430666|NCT00359619|62808123|FG004|Overall Study|Lost to Follow-up|1|||
33430667|NCT00359619|62808124|FG005|Overall Study|Lost to Follow-up|5|||
33430668|NCT00359619|62808125|FG006|Overall Study|Lost to Follow-up|0|||
33430669|NCT00437658|62808144|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
33430670|NCT00437658|62808145|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
33430671|NCT00437658|62808146|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
33430672|NCT00437658|62808144|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
33430673|NCT00437658|62808145|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
33430674|NCT00437658|62808146|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
33430675|NCT00437658|62808144|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
33430676|NCT00437658|62808145|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
33430677|NCT00437658|62808146|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
33430678|NCT00437658|62808144|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
33430679|NCT00437658|62808145|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
33430680|NCT00437658|62808146|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
33430681|NCT00437658|62808144|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
33430682|NCT00437658|62808145|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
33430683|NCT00437658|62808146|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
33430684|NCT00437658|62808144|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
33430685|NCT00437658|62808145|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
33430686|NCT00437658|62808146|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
33430687|NCT00437658|62808144|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
33430688|NCT00437658|62808145|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
33430689|NCT00437658|62808146|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
33430690|NCT00437658|62808144|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
33430691|NCT00437658|62808145|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
33430692|NCT00437658|62808146|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
33430693|NCT00437658|62808144|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
33605422|NCT01649297|63005104|FG004|Overall Study|Non compliant with Protocol|1|||
33430694|NCT00437658|62808145|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
33430695|NCT00437658|62808146|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
33430696|NCT00437658|62808144|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
33430697|NCT00437658|62808145|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
33605423|NCT01649297|63005100|FG000|Overall Study|Lost to Follow-up|1|||
33430698|NCT00437658|62808146|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
33430699|NCT00437658|62808144|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
33430700|NCT00437658|62808145|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
33430701|NCT00437658|62808146|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
33430702|NCT00437658|62808144|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
33430703|NCT00437658|62808145|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
33430704|NCT00437658|62808146|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
33430705|NCT00356265|62808157|FG000|Overall Study|Withdrawal by Subject|0|||
33430706|NCT00356265|62808158|FG001|Overall Study|Withdrawal by Subject|0|||
33430707|NCT00356265|62808159|FG002|Overall Study|Withdrawal by Subject|1|||
33430708|NCT00535145|62808168|FG000|Phase I|Adverse Event|3|||
33430709|NCT00535145|62808168|FG000|Phase I|Lost to Follow-up|7|||
33430710|NCT00535145|62808168|FG000|Phase I|Withdrawal by Subject|6|||
33430711|NCT00535145|62808168|FG000|Phase I|(eligibility)|8|||
33430712|NCT00535145|62808168|FG000|Phase I|(protocol violation)|1|||
33430713|NCT00535145|62808168|FG000|Phase I|(PI decision)|1|||
33430714|NCT00535145|62808168|FG000|Phase I|(diagnosis)|3|||
33430715|NCT00535145|62808168|FG000|Phase II|Adverse Event|2|||
33430716|NCT00535145|62808168|FG000|Phase II|Lack of Efficacy|1|||
33430717|NCT00535145|62808168|FG000|Phase II|Lost to Follow-up|5|||
33430718|NCT00535145|62808168|FG000|Phase II|Withdrawal by Subject|5|||
33430719|NCT00535145|62808168|FG000|Phase II|Subject non-compliance|2|||
33430720|NCT00437268|62808178|FG000|Overall Study|Adverse Event|1|||
33430721|NCT00437268|62808179|FG001|Overall Study|Adverse Event|1|||
33430722|NCT00437268|62808178|FG000|Overall Study|Withdrawal by Subject|2|||
33430723|NCT00437268|62808179|FG001|Overall Study|Withdrawal by Subject|2|||
33430724|NCT00437268|62808178|FG000|Overall Study|Progressive disease|9|||
33430725|NCT00437268|62808179|FG001|Overall Study|Progressive disease|9|||
33430726|NCT00437268|62808178|FG000|Overall Study|Physician Decision|1|||
33430727|NCT00437268|62808179|FG001|Overall Study|Physician Decision|0|||
33430728|NCT00437268|62808178|FG000|Overall Study|Death|0|||
33430729|NCT00437268|62808179|FG001|Overall Study|Death|1|||
33430730|NCT00437034|62808187|FG000|Overall Study|Adverse Event|1|||
33430731|NCT00437034|62808187|FG000|Overall Study|Disease progression during treatment|5|||
33430732|NCT00337467|62808191|FG000|Overall Study|Adverse Event|3|||
33430733|NCT00337467|62808191|FG000|Overall Study|Subject Withdrew Consent|2|||
33430734|NCT00337467|62808191|FG000|Overall Study|Pregnancy|1|||
33430735|NCT00337467|62808191|FG000|Overall Study|Lost to Follow-up|2|||
33605424|NCT01649297|63005101|FG001|Overall Study|Lost to Follow-up|1|||
33605425|NCT01649297|63005102|FG002|Overall Study|Lost to Follow-up|4|||
33605426|NCT01649297|63005103|FG003|Overall Study|Lost to Follow-up|3|||
33605427|NCT01649297|63005104|FG004|Overall Study|Lost to Follow-up|0|||
33605428|NCT01649297|63005100|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
33605429|NCT01649297|63005101|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
33605430|NCT01649297|63005102|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
33430736|NCT00337467|62808191|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
33430737|NCT00337077|62808201|FG000|Overall Study|Progressive disease|25|||
33430738|NCT00337077|62808202|FG001|Overall Study|Progressive disease|37|||
33430739|NCT00337077|62808203|FG002|Overall Study|Progressive disease|19|||
33430740|NCT00337077|62808201|FG000|Overall Study|Adverse Event|7|||
33430741|NCT00337077|62808202|FG001|Overall Study|Adverse Event|7|||
33430742|NCT00337077|62808203|FG002|Overall Study|Adverse Event|1|||
33430743|NCT00337077|62808201|FG000|Overall Study|Death|0|||
33605431|NCT01649297|63005103|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
33605432|NCT01649297|63005104|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
33605433|NCT01649297|63005100|FG000|Overall Study|For other reason|4|||
33430744|NCT00337077|62808202|FG001|Overall Study|Death|1|||
33430745|NCT00337077|62808203|FG002|Overall Study|Death|0|||
33430746|NCT00337077|62808201|FG000|Overall Study|Withdrawal by Subject|7|||
33430747|NCT00337077|62808202|FG001|Overall Study|Withdrawal by Subject|2|||
33430748|NCT00337077|62808203|FG002|Overall Study|Withdrawal by Subject|2|||
33430749|NCT00337077|62808201|FG000|Overall Study|Alternative therapy|1|||
33430750|NCT00337077|62808202|FG001|Overall Study|Alternative therapy|0|||
33430751|NCT00337077|62808203|FG002|Overall Study|Alternative therapy|0|||
33430752|NCT00337077|62808201|FG000|Overall Study|Physician Decision|1|||
33430753|NCT00337077|62808202|FG001|Overall Study|Physician Decision|4|||
33430754|NCT00337077|62808203|FG002|Overall Study|Physician Decision|2|||
33430755|NCT00337077|62808201|FG000|Overall Study|Never started treatment|1|||
33430756|NCT00337077|62808202|FG001|Overall Study|Never started treatment|1|||
33430757|NCT00337077|62808203|FG002|Overall Study|Never started treatment|0|||
33430758|NCT00337077|62808201|FG000|Overall Study|Ineligible|1|||
33430759|NCT00337077|62808202|FG001|Overall Study|Ineligible|1|||
33430760|NCT00337077|62808203|FG002|Overall Study|Ineligible|1|||
33430761|NCT00428220|62808209|FG000|Overall Study|Participant died|8|||
33430762|NCT00428220|62808209|FG000|Overall Study|Global deterioration of health status|7|||
33430763|NCT00428220|62808209|FG000|Overall Study|Lost to Follow-up|4|||
33430764|NCT00428220|62808209|FG000|Overall Study|Objective progression or relapse|123|||
33430765|NCT00428220|62808209|FG000|Overall Study|Participant refused continued treatment|7|||
33430766|NCT00428220|62808209|FG000|Overall Study|Adverse Event|51|||
33430767|NCT00428220|62808209|FG000|Overall Study|Other|23|||
33430768|NCT00345579|62808239|FG000|Overall Study|Adverse Event|9|||
33430769|NCT00345579|62808240|FG001|Overall Study|Adverse Event|6|||
33430770|NCT00345579|62808239|FG000|Overall Study|Protocol Violation|14|||
33430771|NCT00345579|62808240|FG001|Overall Study|Protocol Violation|5|||
33430772|NCT00345579|62808239|FG000|Overall Study|Withdrawal by Subject|50|||
33430773|NCT00345579|62808240|FG001|Overall Study|Withdrawal by Subject|17|||
33430774|NCT00345579|62808239|FG000|Overall Study|Lost to Follow-up|82|||
33430775|NCT00345579|62808240|FG001|Overall Study|Lost to Follow-up|36|||
33430776|NCT00345579|62808239|FG000|Overall Study|Other|9|||
33430777|NCT00345579|62808240|FG001|Overall Study|Other|1|||
33430778|NCT00335829|62808247|FG000|Overall Study|Withdrawal by Subject|1|||
33430779|NCT00335829|62808247|FG000|Overall Study|Lost to Follow-up|1|||
33430780|NCT00335829|62808247|FG000|Overall Study|Adverse Event|1|||
33430781|NCT00344019|62808254|FG000|Overall Study|did not meet final inclusion criteria|0|||
33430782|NCT00344019|62808255|FG001|Overall Study|did not meet final inclusion criteria|0|||
33430783|NCT00344019|62808256|FG002|Overall Study|did not meet final inclusion criteria|74|||
33430784|NCT00535847|62808270|FG000|Overall Study|Adverse Event|5|||
33430785|NCT00535847|62808271|FG001|Overall Study|Adverse Event|3|||
33430786|NCT00535847|62808272|FG002|Overall Study|Adverse Event|2|||
33430787|NCT00535847|62808270|FG000|Overall Study|Non compliance|1|||
33430788|NCT00535847|62808271|FG001|Overall Study|Non compliance|1|||
33430789|NCT00535847|62808272|FG002|Overall Study|Non compliance|0|||
33430790|NCT00535847|62808270|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
33430791|NCT00535847|62808271|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
33430792|NCT00535847|62808272|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
33430793|NCT00334893|62808286|FG000|Overall Study|Not Treated|1|||
33430794|NCT00334893|62808287|FG001|Overall Study|Not Treated|0|||
33430795|NCT00334737|62808298|FG000|Hospital Phase|Death|1|||
33605434|NCT01649297|63005101|FG001|Overall Study|For other reason|1|||
33430796|NCT00334737|62808299|FG001|Hospital Phase|Death|2|||
33430797|NCT00334737|62808300|FG002|Hospital Phase|Death|3|||
33430798|NCT00334737|62808298|FG000|Hospital Phase|Withdrawal by Subject|0|||
33430799|NCT00334737|62808299|FG001|Hospital Phase|Withdrawal by Subject|0|||
33430800|NCT00334737|62808300|FG002|Hospital Phase|Withdrawal by Subject|1|||
33430801|NCT00334737|62808298|FG000|Hospital Phase|Did not receive study drug|1|||
33430802|NCT00334737|62808299|FG001|Hospital Phase|Did not receive study drug|0|||
33430803|NCT00334737|62808300|FG002|Hospital Phase|Did not receive study drug|0|||
33430804|NCT00334737|62808298|FG000|Follow up Phase|Lost to Follow-up|5|||
33430805|NCT00334737|62808299|FG001|Follow up Phase|Lost to Follow-up|3|||
33430806|NCT00334737|62808300|FG002|Follow up Phase|Lost to Follow-up|6|||
33430807|NCT00427908|62808312|FG000|Primary Phase|Lost to Follow-up|4|||
33430808|NCT00427908|62808313|FG001|Primary Phase|Lost to Follow-up|0|||
33430809|NCT00427908|62808314|FG002|Primary Phase|Lost to Follow-up|2|||
33430810|NCT00427908|62808315|FG003|Primary Phase|Lost to Follow-up|0|||
33430811|NCT00427908|62808312|FG000|Primary Phase|Withdrawal by Subject|1|||
33430812|NCT00427908|62808313|FG001|Primary Phase|Withdrawal by Subject|2|||
33430813|NCT00427908|62808314|FG002|Primary Phase|Withdrawal by Subject|1|||
33430814|NCT00427908|62808315|FG003|Primary Phase|Withdrawal by Subject|0|||
33430815|NCT00427908|62808312|FG000|Primary Phase|Adverse Event|0|||
33430816|NCT00427908|62808313|FG001|Primary Phase|Adverse Event|1|||
33430817|NCT00427908|62808314|FG002|Primary Phase|Adverse Event|0|||
33430818|NCT00427908|62808315|FG003|Primary Phase|Adverse Event|0|||
33430819|NCT00334113|62808352|FG000|Overall Study|Lost to Follow-up|2|||
33430820|NCT00334113|62808353|FG001|Overall Study|Lost to Follow-up|2|||
33430821|NCT00334113|62808352|FG000|Overall Study|Withdrawal by Subject|0|||
33430822|NCT00334113|62808353|FG001|Overall Study|Withdrawal by Subject|1|||
33430823|NCT00416598|62808359|FG000|Induction & Intensification|Adverse Event|38|||
33430824|NCT00416598|62808359|FG000|Induction & Intensification|Death|32|||
33430825|NCT00416598|62808359|FG000|Induction & Intensification|Withdrawal by Subject|46|||
33430826|NCT00416598|62808359|FG000|Induction & Intensification|Alternative Treatment|135|||
33430827|NCT00416598|62808359|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
33430828|NCT00416598|62808359|FG000|Induction & Intensification|Relapse/progression|29|||
33430829|NCT00416598|62808359|FG000|Induction & Intensification|Failed induction|87|||
33430830|NCT00416598|62808359|FG000|Decitabine Maintenance|Adverse Event|5|||
33430831|NCT00416598|62808359|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
33430832|NCT00416598|62808359|FG000|Decitabine Maintenance|Progression/relapse|38|||
33430833|NCT00416598|62808359|FG000|Decitabine Maintenance|Alternative treatment|2|||
33430834|NCT00416598|62808359|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
33430835|NCT00534599|62808365|FG000|Overall Study|Adverse Event|25|||
33430836|NCT00534599|62808366|FG001|Overall Study|Adverse Event|4|||
33430837|NCT00534599|62808365|FG000|Overall Study|Incorrect enrollment|2|||
33430838|NCT00534599|62808366|FG001|Overall Study|Incorrect enrollment|1|||
33430839|NCT00534599|62808365|FG000|Overall Study|Mis-randomization|2|||
33430840|NCT00534599|62808366|FG001|Overall Study|Mis-randomization|2|||
33430841|NCT00534599|62808365|FG000|Overall Study|Developed study-specific d/c criteria|5|||
33430842|NCT00534599|62808366|FG001|Overall Study|Developed study-specific d/c criteria|0|||
33430843|NCT00534599|62808365|FG000|Overall Study|Lack of Efficacy|0|||
33430844|NCT00534599|62808366|FG001|Overall Study|Lack of Efficacy|1|||
33430845|NCT00534599|62808365|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
33430846|NCT00534599|62808366|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
33430847|NCT00534599|62808365|FG000|Overall Study|Protocol Violation|1|||
33430848|NCT00534599|62808366|FG001|Overall Study|Protocol Violation|3|||
33430849|NCT00534599|62808365|FG000|Overall Study|Lost to Follow-up|11|||
33430850|NCT00534599|62808366|FG001|Overall Study|Lost to Follow-up|14|||
33430851|NCT00534599|62808365|FG000|Overall Study|Withdrawal by Subject|4|||
33430852|NCT00534599|62808366|FG001|Overall Study|Withdrawal by Subject|6|||
33430853|NCT00534599|62808365|FG000|Overall Study|Other|7|||
33430854|NCT00534599|62808366|FG001|Overall Study|Other|0|||
33430855|NCT03892889|62808389|FG000|Overall Study|Adverse Event|17|||
33430856|NCT03892889|62808389|FG000|Overall Study|Lack of Efficacy|1|||
33430857|NCT03892889|62808389|FG000|Overall Study|Lost to Follow-up|46|||
33430858|NCT03892889|62808389|FG000|Overall Study|Non-compliance with study drug|22|||
33430859|NCT03892889|62808389|FG000|Overall Study|Pregnancy|1|||
33430860|NCT03892889|62808389|FG000|Overall Study|Protocol Deviation|3|||
33430861|NCT03892889|62808389|FG000|Overall Study|Withdrawal by Subject|50|||
33430862|NCT03892889|62808389|FG000|Overall Study|Withdrawal by Caregiver|1|||
33430863|NCT03892889|62808389|FG000|Overall Study|Study Terminated by Sponsor|50|||
33430864|NCT03892889|62808389|FG000|Overall Study|Physician Decision|8|||
33430865|NCT03892889|62808389|FG000|Overall Study|Reason not Specified|5|||
33430866|NCT00473330|62808396|FG000|Core Study|Adverse Event|4|||
33430867|NCT00473330|62808397|FG001|Core Study|Adverse Event|4|||
33430868|NCT00473330|62808398|FG002|Core Study|Adverse Event|1|||
33430869|NCT00473330|62808396|FG000|Core Study|Death|6|||
33430870|NCT00473330|62808397|FG001|Core Study|Death|4|||
33430871|NCT00473330|62808398|FG002|Core Study|Death|4|||
33430872|NCT00473330|62808396|FG000|Core Study|Lost to Follow-up|5|||
33430873|NCT00473330|62808397|FG001|Core Study|Lost to Follow-up|5|||
33430874|NCT00473330|62808398|FG002|Core Study|Lost to Follow-up|10|||
33430875|NCT00473330|62808396|FG000|Core Study|Physician Decision|2|||
33430876|NCT00473330|62808397|FG001|Core Study|Physician Decision|1|||
33430877|NCT00473330|62808398|FG002|Core Study|Physician Decision|3|||
33430878|NCT00473330|62808396|FG000|Core Study|Subject Non-compliance|1|||
33430879|NCT00473330|62808397|FG001|Core Study|Subject Non-compliance|2|||
33430880|NCT00473330|62808398|FG002|Core Study|Subject Non-compliance|1|||
33430881|NCT00473330|62808396|FG000|Core Study|Subject Required Other Therapy|0|||
33430882|NCT00473330|62808397|FG001|Core Study|Subject Required Other Therapy|1|||
33430883|NCT00473330|62808398|FG002|Core Study|Subject Required Other Therapy|3|||
33430884|NCT00473330|62808396|FG000|Core Study|Subject's Decision|9|||
33430885|NCT00473330|62808397|FG001|Core Study|Subject's Decision|8|||
33605435|NCT01649297|63005102|FG002|Overall Study|For other reason|2|||
33430886|NCT00473330|62808398|FG002|Core Study|Subject's Decision|19|||
33430887|NCT00473330|62808396|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
33430888|NCT00473330|62808397|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
33430889|NCT00473330|62808398|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
33430890|NCT00473330|62808396|FG000|Open-label Extension Through Month 48|Death|2|||
33430891|NCT00473330|62808397|FG001|Open-label Extension Through Month 48|Death|0|||
33430892|NCT00473330|62808398|FG002|Open-label Extension Through Month 48|Death|0|||
33430893|NCT00473330|62808396|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
33430894|NCT00473330|62808397|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
33430895|NCT00473330|62808398|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
33430896|NCT00473330|62808396|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
33430897|NCT00473330|62808397|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
33430898|NCT00473330|62808398|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
33430899|NCT00473330|62808396|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
33430900|NCT00473330|62808397|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
33430901|NCT00473330|62808398|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
33430902|NCT00473330|62808396|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
33430903|NCT00473330|62808397|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
33430904|NCT00473330|62808398|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
33430905|NCT00473330|62808396|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
33430906|NCT00473330|62808397|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
33430907|NCT00473330|62808398|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
33430908|NCT00473330|62808396|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
33430909|NCT00473330|62808397|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
33430910|NCT00473330|62808398|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
33430911|NCT00473330|62808396|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
33430912|NCT00473330|62808397|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
33430913|NCT00473330|62808398|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
33430914|NCT00473330|62808396|FG000|Open-label Extension Through Month 60|Death|2|||
33430915|NCT00473330|62808397|FG001|Open-label Extension Through Month 60|Death|2|||
33430916|NCT00473330|62808398|FG002|Open-label Extension Through Month 60|Death|1|||
33430917|NCT00473330|62808396|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
33430918|NCT00473330|62808397|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
33430919|NCT00473330|62808398|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
33430920|NCT00473330|62808396|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
33430921|NCT00473330|62808397|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
33430922|NCT00473330|62808398|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
33430923|NCT00473330|62808396|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
33430924|NCT00473330|62808397|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
33430925|NCT00473330|62808398|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
33430926|NCT00473330|62808396|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
33430927|NCT00473330|62808397|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
33430928|NCT00473330|62808398|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
33430929|NCT00473330|62808396|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
33430930|NCT00473330|62808397|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
33430931|NCT00473330|62808398|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
33430932|NCT00473330|62808396|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
33430933|NCT00473330|62808397|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
33430934|NCT00473330|62808398|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
33430935|NCT00416520|62808428|FG000|Open-label Period|Adverse Event|28|||
33430936|NCT00416520|62808429|FG001|Open-label Period|Adverse Event|10|||
33430937|NCT00416520|62808430|FG002|Open-label Period|Adverse Event|0|||
33430938|NCT00416520|62808431|FG003|Open-label Period|Adverse Event|0|||
33430939|NCT00416520|62808428|FG000|Open-label Period|Death|2|||
33430940|NCT00416520|62808429|FG001|Open-label Period|Death|1|||
33430941|NCT00416520|62808430|FG002|Open-label Period|Death|0|||
33430942|NCT00416520|62808431|FG003|Open-label Period|Death|0|||
33430943|NCT00416520|62808428|FG000|Open-label Period|Lack of Efficacy|8|||
33430944|NCT00416520|62808429|FG001|Open-label Period|Lack of Efficacy|1|||
33430945|NCT00416520|62808430|FG002|Open-label Period|Lack of Efficacy|0|||
33430946|NCT00416520|62808431|FG003|Open-label Period|Lack of Efficacy|0|||
33430947|NCT00416520|62808428|FG000|Open-label Period|Protocol Violation|3|||
33430948|NCT00416520|62808429|FG001|Open-label Period|Protocol Violation|3|||
33430949|NCT00416520|62808430|FG002|Open-label Period|Protocol Violation|0|||
33430950|NCT00416520|62808431|FG003|Open-label Period|Protocol Violation|0|||
33430951|NCT00416520|62808428|FG000|Open-label Period|Withdrawal by Subject|16|||
33430952|NCT00416520|62808429|FG001|Open-label Period|Withdrawal by Subject|5|||
33430953|NCT00416520|62808430|FG002|Open-label Period|Withdrawal by Subject|0|||
33430954|NCT00416520|62808431|FG003|Open-label Period|Withdrawal by Subject|0|||
33430955|NCT00416520|62808428|FG000|Open-label Period|Other Reasons|3|||
33430956|NCT00416520|62808429|FG001|Open-label Period|Other Reasons|12|||
33430957|NCT00416520|62808430|FG002|Open-label Period|Other Reasons|0|||
33430958|NCT00416520|62808431|FG003|Open-label Period|Other Reasons|0|||
33430959|NCT00416520|62808428|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
33430960|NCT00416520|62808429|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
33430961|NCT00416520|62808430|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
33430962|NCT00416520|62808431|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
33430963|NCT00416520|62808428|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
33430964|NCT00416520|62808429|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
33430965|NCT00416520|62808430|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
33430966|NCT00416520|62808431|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
33430967|NCT00416520|62808428|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
33430968|NCT00416520|62808429|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
33430969|NCT00416520|62808430|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
33430970|NCT00416520|62808431|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
33430971|NCT00533429|62808443|FG000|Overall Study|Adverse Event|3|||
33430972|NCT00533429|62808444|FG001|Overall Study|Adverse Event|1|||
33430973|NCT00533429|62808443|FG000|Overall Study|Death|1|||
33430974|NCT00533429|62808444|FG001|Overall Study|Death|0|||
33430975|NCT00533429|62808443|FG000|Overall Study|Withdrawal by Subject|2|||
33430976|NCT00533429|62808444|FG001|Overall Study|Withdrawal by Subject|0|||
33430977|NCT00533429|62808443|FG000|Overall Study|Progressive Disease|12|||
33430978|NCT00533429|62808444|FG001|Overall Study|Progressive Disease|13|||
33430979|NCT00533429|62808443|FG000|Overall Study|Symptomatic deterioration|1|||
33430980|NCT00533429|62808444|FG001|Overall Study|Symptomatic deterioration|2|||
33430981|NCT00533273|62808454|FG000|Double-blind|Withdrew consent|0|||
33430982|NCT00533273|62808455|FG001|Double-blind|Withdrew consent|2|||
33430983|NCT00533273|62808454|FG000|Open-label|Withdrawal by Subject|6|||
33430984|NCT00533273|62808455|FG001|Open-label|Withdrawal by Subject|0|||
33430985|NCT03891641|62808463|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
33430986|NCT03891641|62808464|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
33430987|NCT00339183|62808472|FG000|Overall Study|Adverse Event|5|||
33430988|NCT00339183|62808473|FG001|Overall Study|Adverse Event|3|||
33430989|NCT00339183|62808472|FG000|Overall Study|Withdrawal by Subject|16|||
33430990|NCT00339183|62808473|FG001|Overall Study|Withdrawal by Subject|19|||
33430991|NCT00339183|62808472|FG000|Overall Study|Physician Decision|2|||
33430992|NCT00339183|62808473|FG001|Overall Study|Physician Decision|4|||
33430993|NCT00339183|62808472|FG000|Overall Study|Lost to Follow-up|17|||
33430994|NCT00339183|62808473|FG001|Overall Study|Lost to Follow-up|17|||
33430995|NCT00339183|62808472|FG000|Overall Study|Protocol-specified criteria|12|||
33430996|NCT00339183|62808473|FG001|Overall Study|Protocol-specified criteria|8|||
33430997|NCT00339183|62808472|FG000|Overall Study|Missing reason|3|||
33430998|NCT00339183|62808473|FG001|Overall Study|Missing reason|1|||
33430999|NCT00339183|62808472|FG000|Overall Study|Other|46|||
33431000|NCT00339183|62808473|FG001|Overall Study|Other|40|||
33431001|NCT00339183|62808472|FG000|Overall Study|Ongoing|20|||
33431002|NCT00339183|62808473|FG001|Overall Study|Ongoing|13|||
33431003|NCT00333801|62808485|FG000|Overall Study|Moved to another state|5|||
33431004|NCT00333801|62808486|FG001|Overall Study|Moved to another state|3|||
33431005|NCT00333801|62808485|FG000|Overall Study|Lost to Follow-up|2|||
33431006|NCT00333801|62808486|FG001|Overall Study|Lost to Follow-up|0|||
33431007|NCT00333801|62808485|FG000|Overall Study|Incarcerated|1|||
33431008|NCT00333801|62808486|FG001|Overall Study|Incarcerated|2|||
33431009|NCT00333801|62808485|FG000|Overall Study|Withdrawal by Subject|0|||
33431010|NCT00333801|62808486|FG001|Overall Study|Withdrawal by Subject|1|||
33431011|NCT00532883|62808496|FG000|Overall Study|Adverse Event|1|||
33431012|NCT00532883|62808497|FG001|Overall Study|Adverse Event|0|||
33431013|NCT00532883|62808498|FG002|Overall Study|Adverse Event|0|||
33431014|NCT00532883|62808499|FG003|Overall Study|Adverse Event|1|||
33431015|NCT00532883|62808496|FG000|Overall Study|Lost to Follow-up|1|||
33431016|NCT00532883|62808497|FG001|Overall Study|Lost to Follow-up|1|||
33431017|NCT00532883|62808498|FG002|Overall Study|Lost to Follow-up|1|||
33431018|NCT00532883|62808499|FG003|Overall Study|Lost to Follow-up|0|||
33431019|NCT00532883|62808496|FG000|Overall Study|Withdrawal by Subject|0|||
33431020|NCT00532883|62808497|FG001|Overall Study|Withdrawal by Subject|1|||
33605436|NCT01649297|63005103|FG003|Overall Study|For other reason|0|||
33605437|NCT01649297|63005104|FG004|Overall Study|For other reason|0|||
33431021|NCT00532883|62808498|FG002|Overall Study|Withdrawal by Subject|1|||
33431022|NCT00532883|62808499|FG003|Overall Study|Withdrawal by Subject|0|||
33431023|NCT00532883|62808496|FG000|Overall Study|Subject was Nonadherent|0|||
33431024|NCT00532883|62808497|FG001|Overall Study|Subject was Nonadherent|1|||
33431025|NCT00532883|62808498|FG002|Overall Study|Subject was Nonadherent|1|||
33431026|NCT00532883|62808499|FG003|Overall Study|Subject was Nonadherent|0|||
33431027|NCT00532883|62808496|FG000|Overall Study|Early Study Termination|4|||
33494178|NCT03634033|62872938|FG004|Overall Study|Death|0|||
33431028|NCT00532883|62808497|FG001|Overall Study|Early Study Termination|4|||
33431029|NCT00532883|62808498|FG002|Overall Study|Early Study Termination|1|||
33431030|NCT00532883|62808499|FG003|Overall Study|Early Study Termination|4|||
33431031|NCT00354159|62808511|FG000|Randomized Study Period|Withdrawal by Subject|5|||
33431032|NCT00354159|62808512|FG001|Randomized Study Period|Withdrawal by Subject|3|||
33431033|NCT00354159|62808511|FG000|Randomized Study Period|Physician Decision|6|||
33431034|NCT00354159|62808512|FG001|Randomized Study Period|Physician Decision|10|||
33431035|NCT00354159|62808511|FG000|Randomized Study Period|Lost to Follow-up|4|||
33431036|NCT00354159|62808512|FG001|Randomized Study Period|Lost to Follow-up|0|||
33431037|NCT00354159|62808511|FG000|Randomized Study Period|Death|7|||
33431038|NCT00354159|62808512|FG001|Randomized Study Period|Death|9|||
33431039|NCT00354159|62808511|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
33431040|NCT00354159|62808512|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
33431041|NCT00354159|62808511|FG000|Long-term Follow-up|Physician Decision|127|||
33431042|NCT00354159|62808512|FG001|Long-term Follow-up|Physician Decision|122|||
33431043|NCT00354159|62808511|FG000|Long-term Follow-up|Lost to Follow-up|1|||
33431044|NCT00354159|62808512|FG001|Long-term Follow-up|Lost to Follow-up|0|||
33431045|NCT00354159|62808511|FG000|Long-term Follow-up|Death|14|||
33431046|NCT00354159|62808512|FG001|Long-term Follow-up|Death|11|||
33431047|NCT00354159|62808511|FG000|Long-term Follow-up|Study Closed|29|||
33431048|NCT00354159|62808512|FG001|Long-term Follow-up|Study Closed|34|||
33431049|NCT00338949|62808527|FG000|Subject Screening|Screen failures|11|||
33431050|NCT00338949|62808528|FG001|Subject Screening|Screen failures|11|||
33431051|NCT00338949|62808527|FG000|Randomization|Withdrawal by Subject|1|||
33431052|NCT00338949|62808528|FG001|Randomization|Withdrawal by Subject|0|||
33431053|NCT00338949|62808527|FG000|Randomization|Adverse Event|0|||
33431054|NCT00338949|62808528|FG001|Randomization|Adverse Event|5|||
33431055|NCT00332709|62808536|FG000|Overall Study|Adverse Event|11|||
33431056|NCT00332709|62808537|FG001|Overall Study|Adverse Event|14|||
33431057|NCT00332709|62808536|FG000|Overall Study|Withdrawal by Subject|2|||
33431058|NCT00332709|62808537|FG001|Overall Study|Withdrawal by Subject|3|||
33431059|NCT00332709|62808536|FG000|Overall Study|Lost to Follow-up|2|||
33431060|NCT00332709|62808537|FG001|Overall Study|Lost to Follow-up|0|||
33431061|NCT00332709|62808536|FG000|Overall Study|Administrative Problems|0|||
33431062|NCT00332709|62808537|FG001|Overall Study|Administrative Problems|3|||
33431063|NCT00332709|62808536|FG000|Overall Study|Abnormal test procedure result|1|||
33431064|NCT00332709|62808537|FG001|Overall Study|Abnormal test procedure result|0|||
33431065|NCT00332241|62808545|FG000|Overall Study|Lack of Efficacy|6|||
33431066|NCT00332241|62808546|FG001|Overall Study|Lack of Efficacy|1|||
33431067|NCT00332241|62808545|FG000|Overall Study|Adverse Event|3|||
33431068|NCT00332241|62808546|FG001|Overall Study|Adverse Event|5|||
33431069|NCT00332241|62808545|FG000|Overall Study|Withdrawal by Subject|2|||
33431070|NCT00332241|62808546|FG001|Overall Study|Withdrawal by Subject|1|||
33431071|NCT00332241|62808545|FG000|Overall Study|Lost to Follow-up|4|||
33431072|NCT00332241|62808546|FG001|Overall Study|Lost to Follow-up|1|||
33431073|NCT00337935|62808554|FG000|Overall Study|Adverse Event|2|||
33431074|NCT00337935|62808555|FG001|Overall Study|Adverse Event|5|||
33431075|NCT00337935|62808554|FG000|Overall Study|Death|2|||
33431076|NCT00337935|62808555|FG001|Overall Study|Death|8|||
33431077|NCT00337935|62808554|FG000|Overall Study|Physician Decision|1|||
33431078|NCT00337935|62808555|FG001|Overall Study|Physician Decision|1|||
33431079|NCT00337935|62808554|FG000|Overall Study|Lost to Follow-up|0|||
33431080|NCT00337935|62808555|FG001|Overall Study|Lost to Follow-up|1|||
33431081|NCT00337935|62808554|FG000|Overall Study|Protocol Violation|4|||
33431082|NCT00337935|62808555|FG001|Overall Study|Protocol Violation|3|||
33431083|NCT00337935|62808554|FG000|Overall Study|Withdrawal by Subject|1|||
33431084|NCT00337935|62808555|FG001|Overall Study|Withdrawal by Subject|7|||
33431085|NCT00337935|62808554|FG000|Overall Study|Other|0|||
33431086|NCT00337935|62808555|FG001|Overall Study|Other|1|||
33431087|NCT00337935|62808554|FG000|Overall Study|Lack of Efficacy|0|||
33431088|NCT00337935|62808555|FG001|Overall Study|Lack of Efficacy|1|||
33431089|NCT00337779|62808564|FG000|Overall Study|Withdrawal by Subject|10|||
33431090|NCT00337779|62808565|FG001|Overall Study|Withdrawal by Subject|12|||
33431091|NCT00337779|62808564|FG000|Overall Study|Sponsor decision|1|||
33431092|NCT00337779|62808565|FG001|Overall Study|Sponsor decision|1|||
33431093|NCT00337779|62808564|FG000|Overall Study|Physician Decision|3|||
33431094|NCT00337779|62808565|FG001|Overall Study|Physician Decision|6|||
33431095|NCT00337779|62808564|FG000|Overall Study|Protocol Violation|1|||
33431096|NCT00337779|62808565|FG001|Overall Study|Protocol Violation|1|||
33431097|NCT00337779|62808564|FG000|Overall Study|Lost to Follow-up|6|||
33431098|NCT00337779|62808565|FG001|Overall Study|Lost to Follow-up|5|||
33431099|NCT00337779|62808564|FG000|Overall Study|Adverse Event|28|||
33431100|NCT00337779|62808565|FG001|Overall Study|Adverse Event|51|||
33431101|NCT00337779|62808564|FG000|Overall Study|Pregnancy|3|||
33431102|NCT00337779|62808565|FG001|Overall Study|Pregnancy|2|||
33431103|NCT00337779|62808564|FG000|Overall Study|Death|0|||
33431104|NCT00337779|62808565|FG001|Overall Study|Death|1|||
33431105|NCT00352755|62808571|FG000|Overall Study|Physician Decision|1|||
33431106|NCT00352755|62808571|FG000|Overall Study|Adverse Event|1|||
33431107|NCT00533897|62808578|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
33431108|NCT00533897|62808579|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
33431109|NCT00533897|62808580|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
33431110|NCT00533897|62808581|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
33431111|NCT00533897|62808582|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
33431112|NCT00533897|62808583|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
33431113|NCT00533897|62808584|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
33431114|NCT00533897|62808585|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
33431115|NCT00533897|62808578|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
33431116|NCT00533897|62808579|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
33431117|NCT00533897|62808580|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
33431118|NCT00533897|62808581|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
33431119|NCT00533897|62808582|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
33431120|NCT00533897|62808583|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
33431121|NCT00533897|62808584|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
33431122|NCT00533897|62808585|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
33431123|NCT00533897|62808578|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
33431124|NCT00533897|62808579|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
33431125|NCT00533897|62808580|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
33431126|NCT00533897|62808581|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
33431127|NCT00533897|62808582|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
33431128|NCT00533897|62808583|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
33431129|NCT00533897|62808584|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
33431130|NCT00533897|62808585|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
33431131|NCT00533897|62808578|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
33431132|NCT00533897|62808579|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
33431133|NCT00533897|62808580|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
33431134|NCT00533897|62808581|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
33431135|NCT00533897|62808582|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
33431136|NCT00533897|62808583|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
33431137|NCT00533897|62808584|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
33431138|NCT00533897|62808585|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
33431139|NCT00533897|62808578|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
33431140|NCT00533897|62808579|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
33431141|NCT00533897|62808580|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
33431142|NCT00533897|62808581|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
33431143|NCT00533897|62808582|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
33431144|NCT00533897|62808583|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
33431145|NCT00533897|62808584|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
33431146|NCT00533897|62808585|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
33431147|NCT00533897|62808578|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
33431148|NCT00533897|62808579|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
33431149|NCT00533897|62808580|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
33431150|NCT00533897|62808581|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
33431151|NCT00533897|62808582|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
33431152|NCT00533897|62808583|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
33431153|NCT00533897|62808584|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
33431154|NCT00533897|62808585|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
33431155|NCT00533897|62808578|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
33431156|NCT00533897|62808579|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
33431157|NCT00533897|62808580|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
33431158|NCT00533897|62808581|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
33431159|NCT00533897|62808582|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
33431160|NCT00533897|62808583|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
33431161|NCT00533897|62808584|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
33431162|NCT00533897|62808585|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
33431163|NCT00533897|62808578|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
33431164|NCT00533897|62808579|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
33431165|NCT00533897|62808580|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
33431166|NCT00533897|62808581|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
33431167|NCT00533897|62808582|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
33431168|NCT00533897|62808583|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
33431169|NCT00533897|62808584|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
33431170|NCT00533897|62808585|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
33431171|NCT00533897|62808578|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
33431172|NCT00533897|62808579|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
33431173|NCT00533897|62808580|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
33431174|NCT00533897|62808581|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
33431175|NCT00533897|62808582|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
33431176|NCT00533897|62808583|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
33431177|NCT00533897|62808584|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
33431178|NCT00533897|62808585|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
33431179|NCT00533897|62808578|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
33431180|NCT00533897|62808579|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
33431181|NCT00533897|62808580|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
33431182|NCT00533897|62808581|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
33431183|NCT00533897|62808582|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
33431184|NCT00533897|62808583|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
33431185|NCT00533897|62808584|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
33431186|NCT00533897|62808585|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
33431187|NCT00533897|62808578|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
33431188|NCT00533897|62808579|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
33431189|NCT00533897|62808580|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
33431190|NCT00533897|62808581|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
33431191|NCT00533897|62808582|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
33431192|NCT00533897|62808583|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
33431193|NCT00533897|62808584|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
33431194|NCT00533897|62808585|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
33431195|NCT00533897|62808578|FG000|Long Term Extension (LTE)|Death|0|||
33431196|NCT00533897|62808579|FG001|Long Term Extension (LTE)|Death|0|||
33431197|NCT00533897|62808580|FG002|Long Term Extension (LTE)|Death|0|||
33431198|NCT00533897|62808581|FG003|Long Term Extension (LTE)|Death|0|||
33431199|NCT00533897|62808582|FG004|Long Term Extension (LTE)|Death|0|||
33431200|NCT00533897|62808583|FG005|Long Term Extension (LTE)|Death|0|||
33431201|NCT00533897|62808584|FG006|Long Term Extension (LTE)|Death|1|||
33431202|NCT00533897|62808585|FG007|Long Term Extension (LTE)|Death|3|||
33431203|NCT00533897|62808578|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
33431204|NCT00533897|62808579|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
33431205|NCT00533897|62808580|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
33431206|NCT00533897|62808581|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
33431207|NCT00533897|62808582|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
33431208|NCT00533897|62808583|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
33431209|NCT00533897|62808584|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
33431210|NCT00533897|62808585|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
33431211|NCT00533897|62808578|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
33431212|NCT00533897|62808579|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
33431213|NCT00533897|62808580|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
33431214|NCT00533897|62808581|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
33431215|NCT00533897|62808582|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
33431216|NCT00533897|62808583|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
33431217|NCT00533897|62808584|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
33431218|NCT00533897|62808585|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
33431219|NCT00533897|62808578|FG000|Long Term Extension (LTE)|Adverse Event|0|||
33431220|NCT00533897|62808579|FG001|Long Term Extension (LTE)|Adverse Event|0|||
33605438|NCT01648205|63005116|FG000|Placebo|Pregnancy|1|||
33431221|NCT00533897|62808580|FG002|Long Term Extension (LTE)|Adverse Event|0|||
33605439|NCT01648205|63005116|FG000|Placebo|Withdrawal by Subject|1|||
33431222|NCT00533897|62808581|FG003|Long Term Extension (LTE)|Adverse Event|0|||
33431223|NCT00533897|62808582|FG004|Long Term Extension (LTE)|Adverse Event|0|||
33431224|NCT00533897|62808583|FG005|Long Term Extension (LTE)|Adverse Event|0|||
33431225|NCT00533897|62808584|FG006|Long Term Extension (LTE)|Adverse Event|2|||
33431226|NCT00533897|62808585|FG007|Long Term Extension (LTE)|Adverse Event|5|||
33431227|NCT00533897|62808578|FG000|Long Term Extension (LTE)|Pregnancy|0|||
33431228|NCT00533897|62808579|FG001|Long Term Extension (LTE)|Pregnancy|0|||
33431229|NCT00533897|62808580|FG002|Long Term Extension (LTE)|Pregnancy|0|||
33431230|NCT00533897|62808581|FG003|Long Term Extension (LTE)|Pregnancy|0|||
33431231|NCT00533897|62808582|FG004|Long Term Extension (LTE)|Pregnancy|0|||
33431232|NCT00533897|62808583|FG005|Long Term Extension (LTE)|Pregnancy|0|||
33431233|NCT00533897|62808584|FG006|Long Term Extension (LTE)|Pregnancy|0|||
33431234|NCT00533897|62808585|FG007|Long Term Extension (LTE)|Pregnancy|2|||
33431235|NCT00533897|62808578|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
33431236|NCT00533897|62808579|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
33431237|NCT00533897|62808580|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
33431238|NCT00533897|62808581|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
33431239|NCT00533897|62808582|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
33431240|NCT00533897|62808583|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
33431241|NCT00533897|62808584|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
33431242|NCT00533897|62808585|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
33431243|NCT00533897|62808578|FG000|Long Term Extension (LTE)|Other|0|||
33431244|NCT00533897|62808579|FG001|Long Term Extension (LTE)|Other|0|||
33431245|NCT00533897|62808580|FG002|Long Term Extension (LTE)|Other|0|||
33431246|NCT00533897|62808581|FG003|Long Term Extension (LTE)|Other|0|||
33431247|NCT00533897|62808582|FG004|Long Term Extension (LTE)|Other|0|||
33431248|NCT00533897|62808583|FG005|Long Term Extension (LTE)|Other|0|||
33431249|NCT00533897|62808584|FG006|Long Term Extension (LTE)|Other|1|||
33431250|NCT00533897|62808585|FG007|Long Term Extension (LTE)|Other|6|||
33431251|NCT00426660|62808616|FG000|Overall Study|Death|14|||
33431252|NCT00426660|62808616|FG000|Overall Study|Adverse Event|23|||
33431253|NCT00426660|62808616|FG000|Overall Study|Insufficient Clinical Response|22|||
33431254|NCT00426660|62808616|FG000|Overall Study|Lost to Follow-up|15|||
33431255|NCT00426660|62808616|FG000|Overall Study|Other|23|||
33431256|NCT00426660|62808616|FG000|Overall Study|Withdrawal by Subject|18|||
33431257|NCT00426660|62808616|FG000|Overall Study|Protocol Violation|1|||
33431258|NCT00426660|62808616|FG000|Overall Study|Enrolled Not Treated|15|||
33431259|NCT00426270|62808620|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
33431260|NCT00426270|62808620|FG000|Overall Study|Adverse Event|5|||
33431261|NCT00330681|62808626|FG000|Overall Study|Adverse Event|3|||
33431262|NCT00330681|62808627|FG001|Overall Study|Adverse Event|6|||
33431263|NCT00330681|62808626|FG000|Overall Study|Protocol Violation|0|||
33431264|NCT00330681|62808627|FG001|Overall Study|Protocol Violation|1|||
33431265|NCT00330681|62808626|FG000|Overall Study|Withdrawal by Subject|5|||
33431266|NCT00330681|62808627|FG001|Overall Study|Withdrawal by Subject|5|||
33431267|NCT00330681|62808626|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
33431268|NCT00330681|62808627|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
33431269|NCT00329901|62808636|FG000|Overall Study|Withdrawal by Subject|4|||
33431270|NCT00329901|62808637|FG001|Overall Study|Withdrawal by Subject|3|||
33431271|NCT00329901|62808638|FG002|Overall Study|Withdrawal by Subject|2|||
33431272|NCT00329901|62808636|FG000|Overall Study|Lost to Follow-up|2|||
33431273|NCT00329901|62808637|FG001|Overall Study|Lost to Follow-up|0|||
33431274|NCT00329901|62808638|FG002|Overall Study|Lost to Follow-up|1|||
33431275|NCT00329901|62808636|FG000|Overall Study|Protocol Violation|1|||
33431276|NCT00329901|62808637|FG001|Overall Study|Protocol Violation|0|||
33431277|NCT00329901|62808638|FG002|Overall Study|Protocol Violation|1|||
33431278|NCT00329901|62808636|FG000|Overall Study|Unable to classify|2|||
33431279|NCT00329901|62808637|FG001|Overall Study|Unable to classify|2|||
33431280|NCT00329901|62808638|FG002|Overall Study|Unable to classify|0|||
33431281|NCT00436956|62808650|FG000|Overall Study|Not evaluable|1|||
33431282|NCT00436956|62808651|FG001|Overall Study|Not evaluable|0|||
33431283|NCT00329745|62808660|FG000|Overall Study|Protocol Violation|1|||
33431284|NCT00329745|62808661|FG001|Overall Study|Protocol Violation|0|||
33431285|NCT00329745|62808660|FG000|Overall Study|Withdrawal by Subject|0|||
33431286|NCT00329745|62808661|FG001|Overall Study|Withdrawal by Subject|1|||
33431287|NCT00329745|62808660|FG000|Overall Study|Lost to Follow-up|86|||
33431288|NCT00329745|62808661|FG001|Overall Study|Lost to Follow-up|101|||
33431289|NCT00436644|62808667|FG000|Overall Study|Adverse Event|2|||
33431290|NCT00436644|62808667|FG000|Overall Study|Death|1|||
33431291|NCT00324987|62808673|FG000|Overall Study|Adverse Event|2|||
33431292|NCT00324987|62808674|FG001|Overall Study|Adverse Event|1|||
33431293|NCT00324987|62808673|FG000|Overall Study|Withdrawal by Subject|1|||
33431294|NCT00324987|62808674|FG001|Overall Study|Withdrawal by Subject|1|||
33431295|NCT00324987|62808673|FG000|Overall Study|Progression|1|||
33431296|NCT00324987|62808674|FG001|Overall Study|Progression|1|||
33431297|NCT00324987|62808673|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
33494179|NCT03634033|62872939|FG005|Overall Study|Death|7|||
33431298|NCT00324987|62808674|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
33431299|NCT00324675|62808682|FG000|Overall Study|Adverse Event|1|||
33431300|NCT00324675|62808683|FG001|Overall Study|Adverse Event|0|||
33431301|NCT00436566|62808689|FG000|Overall Study|Withdrawal by Subject|2|||
33431302|NCT00436566|62808689|FG000|Overall Study|Protocol Violation|1|||
33431303|NCT00352365|62808693|FG000|Induction Therapy|Adverse Event|7|||
33431304|NCT00352365|62808693|FG000|Induction Therapy|Progression/Relapse|8|||
33431305|NCT00352365|62808693|FG000|Induction Therapy|Death|7|||
33431306|NCT00352365|62808693|FG000|Induction Therapy|Not protocol specified|1|||
33431307|NCT00352365|62808693|FG000|Induction Therapy|Not eligible|3|||
33431308|NCT00352365|62808693|FG000|Induction Therapy|Death before starting protocol therapy|1|||
33431309|NCT00352365|62808693|FG000|Maintenance Therapy|Progression/Relapse|3|||
33431310|NCT00352365|62808693|FG000|Maintenance Therapy|Death|2|||
33431311|NCT00352365|62808693|FG000|Maintenance Therapy|Not protocol specified|3|||
33431312|NCT00352365|62808693|FG000|Maintenance Therapy|Not eligible|4|||
33431313|NCT00532493|62808703|FG000|Overall Study|Death|1|||
33431314|NCT00532493|62808704|FG001|Overall Study|Death|1|||
33431315|NCT00532493|62808703|FG000|Overall Study|Lost to Follow-up|10|||
33431316|NCT00532493|62808704|FG001|Overall Study|Lost to Follow-up|7|||
33431317|NCT00532493|62808703|FG000|Overall Study|Withdrawal by Subject|7|||
33431318|NCT00532493|62808704|FG001|Overall Study|Withdrawal by Subject|9|||
33431319|NCT00532493|62808703|FG000|Overall Study|Physician Decision|1|||
33431320|NCT00532493|62808704|FG001|Overall Study|Physician Decision|6|||
33431321|NCT00532493|62808703|FG000|Overall Study|Adverse Event|6|||
33431322|NCT00532493|62808704|FG001|Overall Study|Adverse Event|5|||
33323081|NCT00976209|62699382|FG001|Wash-out Period|Other|0|||
33323082|NCT00976209|62699381|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33323083|NCT00976209|62699382|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33323084|NCT00976209|62699381|FG000|Treatment Period 2|Lost to Follow-up|0|||
33431323|NCT00532493|62808703|FG000|Overall Study|Protocol Deviation|1|||
33431324|NCT00532493|62808704|FG001|Overall Study|Protocol Deviation|0|||
33431325|NCT00532493|62808703|FG000|Overall Study|Subject Moved Away|3|||
33431326|NCT00532493|62808704|FG001|Overall Study|Subject Moved Away|1|||
33431327|NCT00532493|62808703|FG000|Overall Study|Contraindicative Medication|1|||
33431328|NCT00532493|62808704|FG001|Overall Study|Contraindicative Medication|0|||
33431329|NCT00533507|62808712|FG000|Overall Study|Withdrawal by Subject|1|||
33431330|NCT03886493|62808716|FG000|Overall Study|Adverse Event|1|||
33431331|NCT00352053|62808722|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
33431332|NCT00352053|62808723|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
33431333|NCT00352053|62808722|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
33431334|NCT00352053|62808723|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
33431335|NCT00352053|62808722|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
33431336|NCT00352053|62808723|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
33431337|NCT00352053|62808722|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
33431338|NCT00352053|62808723|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
33431339|NCT00352053|62808722|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
33431340|NCT00352053|62808723|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
33431341|NCT00352053|62808722|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
33431342|NCT00352053|62808723|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
33431343|NCT00352053|62808722|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
33431344|NCT00352053|62808723|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
33431345|NCT00352053|62808722|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
33431346|NCT00352053|62808723|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
33431347|NCT00352053|62808722|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
33431348|NCT00352053|62808723|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
33431349|NCT00352053|62808722|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
33431350|NCT00352053|62808723|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
33431351|NCT00352053|62808722|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
33431352|NCT00352053|62808723|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
33431353|NCT00352053|62808722|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
33431354|NCT00352053|62808723|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
33431355|NCT00352053|62808722|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
33431356|NCT00352053|62808723|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
33431357|NCT00351819|62808739|FG000|Overall Study|Lost to Follow-up|4|||
33431358|NCT00351819|62808740|FG001|Overall Study|Lost to Follow-up|4|||
33431359|NCT00351819|62808739|FG000|Overall Study|Withdrawal by Subject|0|||
33431360|NCT00351819|62808740|FG001|Overall Study|Withdrawal by Subject|4|||
33323085|NCT00976209|62699382|FG001|Treatment Period 2|Lost to Follow-up|1|||
33323086|NCT00925990|62699389|FG000|Overall Study|Adverse Event|1|||
33323087|NCT00925990|62699390|FG001|Overall Study|Adverse Event|3|||
33431361|NCT00351819|62808739|FG000|Overall Study|Elevated PSA|1|||
33431362|NCT00351819|62808740|FG001|Overall Study|Elevated PSA|1|||
33431363|NCT00351819|62808739|FG000|Overall Study|Traumatic ankle fracture|1|||
33431364|NCT00351819|62808740|FG001|Overall Study|Traumatic ankle fracture|0|||
33431365|NCT00351819|62808739|FG000|Overall Study|Unprofessional behavior|1|||
33431366|NCT00351819|62808740|FG001|Overall Study|Unprofessional behavior|0|||
33431367|NCT00351819|62808739|FG000|Overall Study|Non-compliance|0|||
33431368|NCT00351819|62808740|FG001|Overall Study|Non-compliance|1|||
33431369|NCT00351819|62808739|FG000|Overall Study|Incarcerated|0|||
33431370|NCT00351819|62808740|FG001|Overall Study|Incarcerated|1|||
33431371|NCT00351819|62808739|FG000|Overall Study|Enrolled in another trial|0|||
33431372|NCT00351819|62808740|FG001|Overall Study|Enrolled in another trial|1|||
33431373|NCT00351351|62808748|FG000|Overall Study|surgical access pbs; device issues|9|||
33431374|NCT00351351|62808749|FG001|Overall Study|surgical access pbs; device issues|4|||
33431375|NCT00323115|62808755|FG000|Vaccine Administration|Adverse Event|1|||
33431376|NCT00323115|62808755|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
33431377|NCT00322881|62808764|FG000|Overall Study|Death|2|||
33431378|NCT00322881|62808764|FG000|Overall Study|Adverse Event|1|||
33431379|NCT00322881|62808764|FG000|Overall Study|Disease Progression|2|||
33431380|NCT00415194|62808770|FG000|Overall Study|Adverse Event|37|||
33431381|NCT00415194|62808771|FG001|Overall Study|Adverse Event|32|||
33431382|NCT00415194|62808770|FG000|Overall Study|Entry Criteria Not Met|4|||
33431383|NCT00415194|62808771|FG001|Overall Study|Entry Criteria Not Met|8|||
33431384|NCT00415194|62808770|FG000|Overall Study|Lost to Follow-up|1|||
33431385|NCT00415194|62808771|FG001|Overall Study|Lost to Follow-up|0|||
33431386|NCT00415194|62808770|FG000|Overall Study|Physician Decision|10|||
33431387|NCT00415194|62808771|FG001|Overall Study|Physician Decision|16|||
33431388|NCT00415194|62808770|FG000|Overall Study|Progressive Disease|180|||
33431389|NCT00415194|62808771|FG001|Overall Study|Progressive Disease|217|||
33431390|NCT00415194|62808770|FG000|Overall Study|Protocol Violation|4|||
33431391|NCT00415194|62808771|FG001|Overall Study|Protocol Violation|2|||
33431392|NCT00415194|62808770|FG000|Overall Study|Withdrawal by Subject|28|||
33431393|NCT00415194|62808771|FG001|Overall Study|Withdrawal by Subject|21|||
33431394|NCT00415194|62808770|FG000|Overall Study|Death Due to Study Disease|26|||
33431395|NCT00415194|62808771|FG001|Overall Study|Death Due to Study Disease|29|||
33431396|NCT00415194|62808770|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
33431397|NCT00415194|62808771|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
33431398|NCT00415194|62808770|FG000|Overall Study|Death Due to Procedural Related AE|0|||
33431399|NCT00415194|62808771|FG001|Overall Study|Death Due to Procedural Related AE|1|||
33431400|NCT00415194|62808770|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
33431401|NCT00415194|62808771|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
33431402|NCT00436332|62808777|FG000|Overall Study|Adverse Event|9|||
33431403|NCT00436332|62808777|FG000|Overall Study|Withdrawal by Subject|2|||
33431404|NCT00436332|62808777|FG000|Overall Study|Progression|59|||
33431405|NCT00436332|62808777|FG000|Overall Study|Death|2|||
33431406|NCT00436332|62808777|FG000|Overall Study|Not Protocol Specified|6|||
33431407|NCT00436332|62808777|FG000|Overall Study|Ineligible|2|||
33431408|NCT00436332|62808777|FG000|Overall Study|Never Received Treatment|3|||
33431409|NCT00532259|62808781|FG000|Overall Study|Withdrawal by Subject|2|||
33431410|NCT00532259|62808781|FG000|Overall Study|Adverse Event|1|||
33431411|NCT00532259|62808781|FG000|Overall Study|Death|1|||
33431412|NCT00532259|62808781|FG000|Overall Study|Lack of Efficacy|21|||
33431413|NCT00532259|62808781|FG000|Overall Study|Lost to Follow-up|3|||
33431414|NCT00532259|62808781|FG000|Overall Study|Physician Decision|3|||
33431415|NCT00532259|62808781|FG000|Overall Study|Protocol Violation|1|||
33431416|NCT00322491|62808788|FG000|Overall Study|Adverse Event|1|||
33431417|NCT00322491|62808789|FG001|Overall Study|Adverse Event|0|||
33431418|NCT00322491|62808788|FG000|Overall Study|Death|1|||
33431419|NCT00322491|62808789|FG001|Overall Study|Death|2|||
33431420|NCT00322023|62808799|FG000|Overall Study|various|0|||
33431421|NCT00322023|62808800|FG001|Overall Study|various|2|||
33431422|NCT00322023|62808801|FG002|Overall Study|various|6|||
33431423|NCT00414960|62808811|FG000|Overall Study|Adverse Event|4|||
33431424|NCT00414960|62808812|FG001|Overall Study|Adverse Event|0|||
33431425|NCT00414960|62808811|FG000|Overall Study|Withdrawal by Subject|3|||
33431426|NCT00414960|62808812|FG001|Overall Study|Withdrawal by Subject|0|||
33431427|NCT00414960|62808811|FG000|Overall Study|Physician Decision|0|||
33431428|NCT00414960|62808812|FG001|Overall Study|Physician Decision|1|||
33431429|NCT00321789|62808820|FG000|Overall Study|Lost to Follow-up|4|||
33431430|NCT00321789|62808821|FG001|Overall Study|Lost to Follow-up|7|||
33431431|NCT00321789|62808820|FG000|Overall Study|Withdrawal by Subject|6|||
33431432|NCT00321789|62808821|FG001|Overall Study|Withdrawal by Subject|6|||
33431433|NCT00321789|62808820|FG000|Overall Study|Protocol Violation|5|||
33431434|NCT00321789|62808821|FG001|Overall Study|Protocol Violation|3|||
33431435|NCT00414726|62808829|FG000|Overall Study|Withdrawal by Subject|0|||
33431436|NCT00414726|62808830|FG001|Overall Study|Withdrawal by Subject|1|||
33431437|NCT00531947|62808838|FG000|Overall Study|Adverse Event|5|||
33431438|NCT00531947|62808839|FG001|Overall Study|Adverse Event|10|||
33431439|NCT00531947|62808838|FG000|Overall Study|Lost to Follow-up|12|||
33431440|NCT00531947|62808839|FG001|Overall Study|Lost to Follow-up|9|||
33431441|NCT00531947|62808838|FG000|Overall Study|Withdrawal by Subject|14|||
33431442|NCT00531947|62808839|FG001|Overall Study|Withdrawal by Subject|19|||
33431443|NCT00531947|62808838|FG000|Overall Study|Protocol Violation|2|||
33431444|NCT00531947|62808839|FG001|Overall Study|Protocol Violation|1|||
33431445|NCT00531947|62808838|FG000|Overall Study|Non-Compliance|4|||
33431446|NCT00531947|62808839|FG001|Overall Study|Non-Compliance|7|||
33431447|NCT00531947|62808838|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
33431448|NCT00531947|62808839|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
33431449|NCT00530855|62808845|FG000|Overall Study|Lack of Efficacy|20|||
33431450|NCT00530855|62808845|FG000|Overall Study|Withdrawal by Subject|30|||
33431451|NCT00530855|62808845|FG000|Overall Study|Fatal Serious AE|3|||
33431452|NCT00530855|62808845|FG000|Overall Study|Non Fatal Serious AE|7|||
33431453|NCT00530855|62808845|FG000|Overall Study|Non Fatal Non Serious AE|12|||
33431454|NCT00530855|62808845|FG000|Overall Study|Protocol Violation|3|||
33431455|NCT00530855|62808845|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
33431456|NCT00530855|62808845|FG000|Overall Study|Lost to Follow-up|9|||
33431457|NCT00530855|62808845|FG000|Overall Study|Other reason for premature termination|17|||
33431458|NCT00530777|62808851|FG000|Overall Study|Lost to Follow-up|0|||
33431459|NCT00530777|62808852|FG001|Overall Study|Lost to Follow-up|1|||
33431460|NCT00530777|62808851|FG000|Overall Study|Death|1|||
33431461|NCT00530777|62808852|FG001|Overall Study|Death|2|||
33431462|NCT00530777|62808851|FG000|Overall Study|Physician Decision|1|||
33431463|NCT00530777|62808852|FG001|Overall Study|Physician Decision|0|||
33431464|NCT00530777|62808851|FG000|Overall Study|Withdrawal by Subject|0|||
33431465|NCT00530777|62808852|FG001|Overall Study|Withdrawal by Subject|1|||
33431466|NCT00530777|62808851|FG000|Overall Study|Unable to adhere to visit schedule|5|||
33431467|NCT00530777|62808852|FG001|Overall Study|Unable to adhere to visit schedule|1|||
33431468|NCT03882047|62808861|FG000|Overall Study|Adverse Event|0|||
33431469|NCT03882047|62808862|FG001|Overall Study|Adverse Event|2|||
33431470|NCT03882047|62808863|FG002|Overall Study|Adverse Event|2|||
33431471|NCT03882047|62808861|FG000|Overall Study|Treatment Failure|3|||
33431472|NCT03882047|62808862|FG001|Overall Study|Treatment Failure|3|||
33431473|NCT03882047|62808863|FG002|Overall Study|Treatment Failure|12|||
33431474|NCT03882047|62808861|FG000|Overall Study|Lost to Follow-up|0|||
33431475|NCT03882047|62808862|FG001|Overall Study|Lost to Follow-up|1|||
33431476|NCT03882047|62808863|FG002|Overall Study|Lost to Follow-up|0|||
33431477|NCT03882047|62808861|FG000|Overall Study|Did Not Wish to Continue|1|||
33431478|NCT03882047|62808862|FG001|Overall Study|Did Not Wish to Continue|4|||
33431479|NCT03882047|62808863|FG002|Overall Study|Did Not Wish to Continue|1|||
33431480|NCT03882047|62808861|FG000|Overall Study|Noncompliance With Protocol|2|||
33431481|NCT03882047|62808862|FG001|Overall Study|Noncompliance With Protocol|0|||
33323088|NCT00925990|62699389|FG000|Overall Study|Withdrawal by Subject|2|||
33323089|NCT00925990|62699390|FG001|Overall Study|Withdrawal by Subject|2|||
33323090|NCT00925990|62699389|FG000|Overall Study|Lost to Follow-up|1|||
33323091|NCT00925990|62699390|FG001|Overall Study|Lost to Follow-up|3|||
33431482|NCT03882047|62808863|FG002|Overall Study|Noncompliance With Protocol|0|||
33431483|NCT03882047|62808861|FG000|Overall Study|Did Not Meet Eligibility|0|||
33431484|NCT03882047|62808862|FG001|Overall Study|Did Not Meet Eligibility|0|||
33431485|NCT03882047|62808863|FG002|Overall Study|Did Not Meet Eligibility|1|||
33431486|NCT00530621|62808873|FG000|Overall Study|Adverse Event|11|||
33431487|NCT00530621|62808874|FG001|Overall Study|Adverse Event|8|||
33431488|NCT00530621|62808873|FG000|Overall Study|Physician Decision|2|||
33431489|NCT00530621|62808874|FG001|Overall Study|Physician Decision|4|||
33431490|NCT00530621|62808873|FG000|Overall Study|Progressive Disease (PD)|47|||
33431491|NCT00530621|62808874|FG001|Overall Study|Progressive Disease (PD)|40|||
33431492|NCT00530621|62808873|FG000|Overall Study|Sponsor Decision|12|||
33431493|NCT00530621|62808874|FG001|Overall Study|Sponsor Decision|15|||
33431494|NCT00530621|62808873|FG000|Overall Study|Subject Decision|4|||
33431495|NCT00530621|62808874|FG001|Overall Study|Subject Decision|7|||
33431496|NCT00530621|62808873|FG000|Overall Study|Death|3|||
33431497|NCT00530621|62808874|FG001|Overall Study|Death|6|||
33431498|NCT00530621|62808873|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
33431499|NCT00530621|62808874|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
33431500|NCT00531479|62808886|FG000|Overall Study|Death|68|||
33431501|NCT00531479|62808887|FG001|Overall Study|Death|71|||
33431502|NCT00531479|62808886|FG000|Overall Study|Lost to Follow-up|0|||
33431503|NCT00531479|62808887|FG001|Overall Study|Lost to Follow-up|2|||
33431504|NCT00531479|62808886|FG000|Overall Study|Other|0|||
33431505|NCT00531479|62808887|FG001|Overall Study|Other|1|||
33431506|NCT00531479|62808886|FG000|Overall Study|Withdrawal by Subject|6|||
33431507|NCT00531479|62808887|FG001|Overall Study|Withdrawal by Subject|6|||
33431508|NCT00531479|62808886|FG000|Overall Study|Did not receive treatment|2|||
33431509|NCT00531479|62808887|FG001|Overall Study|Did not receive treatment|3|||
33431510|NCT00530075|62808893|FG000|Overall Study|Adverse Event|1|||
33431511|NCT00530075|62808893|FG000|Overall Study|Death|1|||
33431512|NCT00530075|62808893|FG000|Overall Study|Lack of Efficacy|3|||
33431513|NCT00530075|62808893|FG000|Overall Study|Protocol Violation|1|||
33431514|NCT00530075|62808893|FG000|Overall Study|Withdrawal by Subject|1|||
33431515|NCT00531011|62808899|FG000|Overall Study|Withdrawal by Subject|2|||
33431516|NCT00531011|62808900|FG001|Overall Study|Withdrawal by Subject|4|||
33431517|NCT00531011|62808899|FG000|Overall Study|Death|1|||
33431518|NCT00531011|62808900|FG001|Overall Study|Death|0|||
33431519|NCT00531011|62808899|FG000|Overall Study|Lost to Follow-up|1|||
33431520|NCT00531011|62808900|FG001|Overall Study|Lost to Follow-up|0|||
33431521|NCT00531011|62808899|FG000|Overall Study|Physician Decision|0|||
33431522|NCT00531011|62808900|FG001|Overall Study|Physician Decision|3|||
33431523|NCT00529217|62808906|FG000|Overall Study|Lack of Efficacy|2|||
33431524|NCT00529217|62808906|FG000|Overall Study|Unable to adhere to study schedule|2|||
33431525|NCT00471146|62808913|FG000|Overall Study|Adverse Event|32|||
33431526|NCT00471146|62808914|FG001|Overall Study|Adverse Event|33|||
33431527|NCT00471146|62808913|FG000|Overall Study|Withdrawal by Subject|14|||
33431528|NCT00471146|62808914|FG001|Overall Study|Withdrawal by Subject|11|||
33431529|NCT00471146|62808913|FG000|Overall Study|Death|11|||
33431530|NCT00471146|62808914|FG001|Overall Study|Death|12|||
33431531|NCT00471146|62808913|FG000|Overall Study|Lost to Follow-up|4|||
33323092|NCT00925990|62699389|FG000|Overall Study|Physician Decision|1|||
33431532|NCT00471146|62808914|FG001|Overall Study|Lost to Follow-up|2|||
33431533|NCT00471146|62808913|FG000|Overall Study|Protocol Violation|2|||
33431534|NCT00471146|62808914|FG001|Overall Study|Protocol Violation|2|||
33431535|NCT00471146|62808913|FG000|Overall Study|Objective progression or relapse|84|||
33431536|NCT00471146|62808914|FG001|Overall Study|Objective progression or relapse|87|||
33431537|NCT00471146|62808913|FG000|Overall Study|Global deterioration of health status|12|||
33431538|NCT00471146|62808914|FG001|Overall Study|Global deterioration of health status|14|||
33431539|NCT00471146|62808913|FG000|Overall Study|Randomized but not treated|9|||
33431540|NCT00471146|62808914|FG001|Overall Study|Randomized but not treated|8|||
33431541|NCT00471146|62808913|FG000|Overall Study|Other|4|||
33431542|NCT00471146|62808914|FG001|Overall Study|Other|5|||
33431543|NCT00469898|62808920|FG000|Overall Study|Adverse Event|7|||
33431544|NCT00469898|62808920|FG000|Overall Study|Withdrawal by Subject|4|||
33431545|NCT00469898|62808920|FG000|Overall Study|Death|4|||
33431546|NCT00469898|62808920|FG000|Overall Study|Disease progression|9|||
33431547|NCT00469898|62808920|FG000|Overall Study|Decreased performance status|1|||
33431548|NCT00529763|62808927|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
33431549|NCT00529763|62808928|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
33431550|NCT00529763|62808929|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
33431551|NCT00529763|62808927|FG000|Overall Study|Death|1|||
33431552|NCT00529763|62808928|FG001|Overall Study|Death|1|||
33431553|NCT00529763|62808929|FG002|Overall Study|Death|1|||
33431554|NCT00529763|62808927|FG000|Overall Study|Disease Progression|10|||
33431555|NCT00529763|62808928|FG001|Overall Study|Disease Progression|16|||
33431556|NCT00529763|62808929|FG002|Overall Study|Disease Progression|11|||
33431557|NCT00529763|62808927|FG000|Overall Study|Lost to Follow-up|1|||
33431558|NCT00529763|62808928|FG001|Overall Study|Lost to Follow-up|2|||
33431559|NCT00529763|62808929|FG002|Overall Study|Lost to Follow-up|3|||
33431560|NCT00529763|62808927|FG000|Overall Study|Stem Cell Transplant|0|||
33431561|NCT00529763|62808928|FG001|Overall Study|Stem Cell Transplant|3|||
33431562|NCT00529763|62808929|FG002|Overall Study|Stem Cell Transplant|1|||
33431563|NCT00529763|62808927|FG000|Overall Study|Study Drug Toxicity|3|||
33431564|NCT00529763|62808928|FG001|Overall Study|Study Drug Toxicity|6|||
33431565|NCT00529763|62808929|FG002|Overall Study|Study Drug Toxicity|4|||
33431566|NCT00529763|62808927|FG000|Overall Study|Participant Withdrew Consent|2|||
33431567|NCT00529763|62808928|FG001|Overall Study|Participant Withdrew Consent|3|||
33431568|NCT00529763|62808929|FG002|Overall Study|Participant Withdrew Consent|4|||
33431569|NCT00529763|62808927|FG000|Overall Study|Other reasons|2|||
33431570|NCT00529763|62808928|FG001|Overall Study|Other reasons|0|||
33431571|NCT00529763|62808929|FG002|Overall Study|Other reasons|2|||
33431572|NCT00529763|62808927|FG000|Overall Study|Participant request to discontinue treatment|1|||
33431573|NCT00529763|62808928|FG001|Overall Study|Participant request to discontinue treatment|1|||
33431574|NCT00529763|62808929|FG002|Overall Study|Participant request to discontinue treatment|3|||
33431575|NCT00486902|62808944|FG000|Overall Study|Withdrawal by Subject|1|||
33431576|NCT00486902|62808945|FG001|Overall Study|Withdrawal by Subject|2|||
33431577|NCT00486902|62808944|FG000|Overall Study|decision for postpartum tubal ligation|3|||
33431578|NCT00486902|62808945|FG001|Overall Study|decision for postpartum tubal ligation|1|||
33431579|NCT00486902|62808944|FG000|Overall Study|spinal anesthetic protocal violation|1|||
33431580|NCT00486902|62808945|FG001|Overall Study|spinal anesthetic protocal violation|1|||
33431581|NCT00486902|62808944|FG000|Overall Study|Did not meet inclusion criteria|1|||
33431582|NCT00486902|62808945|FG001|Overall Study|Did not meet inclusion criteria|0|||
33431583|NCT00486902|62808944|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
33431584|NCT00486902|62808945|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
33431585|NCT03687827|62808951|FG000|Treatment Period 1|Death|0|||
33431586|NCT03687827|62808952|FG001|Treatment Period 1|Death|1|||
33431587|NCT03687827|62808951|FG000|Treatment Period 1|Lost to Follow-up|2|||
33431588|NCT03687827|62808952|FG001|Treatment Period 1|Lost to Follow-up|2|||
33431589|NCT03687827|62808951|FG000|Treatment Period 1|Physician Decision|5|||
33431590|NCT03687827|62808952|FG001|Treatment Period 1|Physician Decision|2|||
33431591|NCT03687827|62808951|FG000|Treatment Period 1|Withdrawal by Subject|7|||
33431592|NCT03687827|62808952|FG001|Treatment Period 1|Withdrawal by Subject|3|||
33431593|NCT03687827|62808951|FG000|Treatment Period 2|Physician Decision|4|||
33431594|NCT03687827|62808952|FG001|Treatment Period 2|Physician Decision|1|||
33431595|NCT03687827|62808951|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33431596|NCT03687827|62808952|FG001|Treatment Period 2|Withdrawal by Subject|2|||
33431597|NCT00529529|62808961|FG000|Overall Study|Adverse Event|12|||
33431598|NCT00529529|62808962|FG001|Overall Study|Adverse Event|17|||
33431599|NCT00529529|62808963|FG002|Overall Study|Adverse Event|8|||
33431600|NCT00529529|62808961|FG000|Overall Study|Subject withdrew consent|12|||
33431601|NCT00529529|62808962|FG001|Overall Study|Subject withdrew consent|9|||
33431602|NCT00529529|62808963|FG002|Overall Study|Subject withdrew consent|12|||
33431603|NCT00529529|62808961|FG000|Overall Study|Protocol deviation|8|||
33431604|NCT00529529|62808962|FG001|Overall Study|Protocol deviation|12|||
33431605|NCT00529529|62808963|FG002|Overall Study|Protocol deviation|5|||
33431606|NCT00529529|62808961|FG000|Overall Study|Lost to Follow-up|5|||
33431607|NCT00529529|62808962|FG001|Overall Study|Lost to Follow-up|3|||
33431608|NCT00529529|62808963|FG002|Overall Study|Lost to Follow-up|1|||
33431609|NCT00529529|62808961|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33431610|NCT00529529|62808962|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33431611|NCT00529529|62808963|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
33431612|NCT00529529|62808961|FG000|Overall Study|Death|2|||
33431613|NCT00529529|62808962|FG001|Overall Study|Death|0|||
33431614|NCT00529529|62808963|FG002|Overall Study|Death|0|||
33431615|NCT00529529|62808961|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33431616|NCT00529529|62808962|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33431617|NCT00529529|62808963|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33431618|NCT00529529|62808961|FG000|Overall Study|Administrative problems|1|||
33431619|NCT00529529|62808962|FG001|Overall Study|Administrative problems|0|||
33431620|NCT00529529|62808963|FG002|Overall Study|Administrative problems|3|||
33431621|NCT05655377|62808971|FG000|Overall Study|Withdrawal by Subject|2|||
33431622|NCT00486434|62808977|FG000|Overall Study|Withdrawal by Subject|34|||
33431623|NCT00486434|62808978|FG001|Overall Study|Withdrawal by Subject|39|||
33431624|NCT00486434|62808977|FG000|Overall Study|Adverse Event|118|||
33431625|NCT00486434|62808978|FG001|Overall Study|Adverse Event|44|||
33431626|NCT00486434|62808977|FG000|Overall Study|Protocol Violation|22|||
33431627|NCT00486434|62808978|FG001|Overall Study|Protocol Violation|21|||
33431628|NCT00486434|62808977|FG000|Overall Study|Lack of Efficacy|12|||
33431629|NCT00486434|62808978|FG001|Overall Study|Lack of Efficacy|19|||
33431630|NCT00486434|62808977|FG000|Overall Study|Lost to Follow-up|2|||
33431631|NCT00486434|62808978|FG001|Overall Study|Lost to Follow-up|3|||
33431632|NCT00486434|62808977|FG000|Overall Study|Death|1|||
33431633|NCT00486434|62808978|FG001|Overall Study|Death|2|||
33431634|NCT00486434|62808977|FG000|Overall Study|Personal reasons|5|||
33431635|NCT00486434|62808978|FG001|Overall Study|Personal reasons|6|||
33431636|NCT00424632|62808987|FG000|Overall Study|Death|0|||
33431637|NCT00424632|62808988|FG001|Overall Study|Death|0|||
33431638|NCT00424632|62808989|FG002|Overall Study|Death|0|||
33431639|NCT00424632|62808990|FG003|Overall Study|Death|0|||
33431640|NCT00424632|62808991|FG004|Overall Study|Death|0|||
33431641|NCT00424632|62808992|FG005|Overall Study|Death|2|||
33431642|NCT00424632|62808993|FG006|Overall Study|Death|0|||
33431643|NCT00424632|62808994|FG007|Overall Study|Death|0|||
33431644|NCT00424632|62808995|FG008|Overall Study|Death|0|||
33431645|NCT00424632|62808996|FG009|Overall Study|Death|0|||
33431646|NCT00424632|62808987|FG000|Overall Study|Adverse Event|0|||
33431647|NCT00424632|62808988|FG001|Overall Study|Adverse Event|0|||
33431648|NCT00424632|62808989|FG002|Overall Study|Adverse Event|0|||
33431649|NCT00424632|62808990|FG003|Overall Study|Adverse Event|0|||
33431650|NCT00424632|62808991|FG004|Overall Study|Adverse Event|0|||
33431651|NCT00424632|62808992|FG005|Overall Study|Adverse Event|0|||
33431652|NCT00424632|62808993|FG006|Overall Study|Adverse Event|0|||
33431653|NCT00424632|62808994|FG007|Overall Study|Adverse Event|0|||
33431654|NCT00424632|62808995|FG008|Overall Study|Adverse Event|3|||
33431655|NCT00424632|62808996|FG009|Overall Study|Adverse Event|2|||
33431656|NCT00424632|62808987|FG000|Overall Study|Global deterioration of health status|0|||
33431657|NCT00424632|62808988|FG001|Overall Study|Global deterioration of health status|0|||
33431658|NCT00424632|62808989|FG002|Overall Study|Global deterioration of health status|0|||
33431659|NCT00424632|62808990|FG003|Overall Study|Global deterioration of health status|1|||
33431660|NCT00424632|62808991|FG004|Overall Study|Global deterioration of health status|1|||
33431661|NCT00424632|62808992|FG005|Overall Study|Global deterioration of health status|0|||
33431662|NCT00424632|62808993|FG006|Overall Study|Global deterioration of health status|0|||
33431663|NCT00424632|62808994|FG007|Overall Study|Global deterioration of health status|0|||
33431664|NCT00424632|62808995|FG008|Overall Study|Global deterioration of health status|0|||
33431665|NCT00424632|62808996|FG009|Overall Study|Global deterioration of health status|0|||
33431666|NCT00424632|62808987|FG000|Overall Study|Objective progression or relapse|1|||
33431667|NCT00424632|62808988|FG001|Overall Study|Objective progression or relapse|1|||
33431668|NCT00424632|62808989|FG002|Overall Study|Objective progression or relapse|1|||
33431669|NCT00424632|62808990|FG003|Overall Study|Objective progression or relapse|2|||
33431670|NCT00424632|62808991|FG004|Overall Study|Objective progression or relapse|2|||
33431671|NCT00424632|62808992|FG005|Overall Study|Objective progression or relapse|13|||
33323093|NCT00925990|62699390|FG001|Overall Study|Physician Decision|1|||
33431672|NCT00424632|62808993|FG006|Overall Study|Objective progression or relapse|7|||
33431673|NCT00424632|62808994|FG007|Overall Study|Objective progression or relapse|3|||
33431674|NCT00424632|62808995|FG008|Overall Study|Objective progression or relapse|12|||
33431675|NCT00424632|62808996|FG009|Overall Study|Objective progression or relapse|4|||
33431676|NCT00424632|62808987|FG000|Overall Study|Other|0|||
33431677|NCT00424632|62808988|FG001|Overall Study|Other|0|||
33431678|NCT00424632|62808989|FG002|Overall Study|Other|0|||
33431679|NCT00424632|62808990|FG003|Overall Study|Other|1|||
33431680|NCT00424632|62808991|FG004|Overall Study|Other|0|||
33431681|NCT00424632|62808992|FG005|Overall Study|Other|0|||
33431682|NCT00424632|62808993|FG006|Overall Study|Other|0|||
33431683|NCT00424632|62808994|FG007|Overall Study|Other|0|||
33431684|NCT00424632|62808995|FG008|Overall Study|Other|1|||
33431685|NCT00424632|62808996|FG009|Overall Study|Other|0|||
33431686|NCT00529451|62809031|FG000|Overall Study|Subject withdrew consent|16|||
33431687|NCT00529451|62809032|FG001|Overall Study|Subject withdrew consent|21|||
33431688|NCT00529451|62809033|FG002|Overall Study|Subject withdrew consent|13|||
33431689|NCT00529451|62809034|FG003|Overall Study|Subject withdrew consent|12|||
33431690|NCT00529451|62809031|FG000|Overall Study|Adverse Event|9|||
33431691|NCT00529451|62809032|FG001|Overall Study|Adverse Event|16|||
33431692|NCT00529451|62809033|FG002|Overall Study|Adverse Event|14|||
33431693|NCT00529451|62809034|FG003|Overall Study|Adverse Event|8|||
33431694|NCT00529451|62809031|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
33431695|NCT00529451|62809032|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
33431696|NCT00529451|62809033|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
33431697|NCT00529451|62809034|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
33431698|NCT00529451|62809031|FG000|Overall Study|Lost to Follow-up|4|||
33431699|NCT00529451|62809032|FG001|Overall Study|Lost to Follow-up|7|||
33431700|NCT00529451|62809033|FG002|Overall Study|Lost to Follow-up|4|||
33431701|NCT00529451|62809034|FG003|Overall Study|Lost to Follow-up|4|||
33431702|NCT00529451|62809031|FG000|Overall Study|Protocol deviation|1|||
33431703|NCT00529451|62809032|FG001|Overall Study|Protocol deviation|1|||
33431704|NCT00529451|62809033|FG002|Overall Study|Protocol deviation|4|||
33431705|NCT00529451|62809034|FG003|Overall Study|Protocol deviation|1|||
33431706|NCT00529451|62809031|FG000|Overall Study|Administrative problems|1|||
33431707|NCT00529451|62809032|FG001|Overall Study|Administrative problems|1|||
33431708|NCT00529451|62809033|FG002|Overall Study|Administrative problems|0|||
33431709|NCT00529451|62809034|FG003|Overall Study|Administrative problems|2|||
33431710|NCT03876743|62809051|FG000|Overall Study|Lost to Follow-up|6|||
33431711|NCT03876743|62809052|FG001|Overall Study|Lost to Follow-up|4|||
33431712|NCT03876743|62809053|FG002|Overall Study|Lost to Follow-up|4|||
33431713|NCT03876743|62809054|FG003|Overall Study|Lost to Follow-up|7|||
33431714|NCT00486278|62809068|FG000|Overall Study|Adverse Event|5|||
33431715|NCT00486278|62809068|FG000|Overall Study|Withdrawal by Subject|2|||
33431716|NCT00486278|62809068|FG000|Overall Study|Physician Decision|2|||
33431717|NCT00321711|62809087|FG000|Part A|Adverse Event|3|||
33431718|NCT00321711|62809088|FG001|Part A|Adverse Event|3|||
33431719|NCT00321711|62809089|FG002|Part A|Adverse Event|2|||
33431720|NCT00321711|62809090|FG003|Part A|Adverse Event|0|||
33431721|NCT00321711|62809091|FG004|Part A|Adverse Event|0|||
33431722|NCT00321711|62809087|FG000|Part A|Withdrawal by Subject|1|||
33431723|NCT00321711|62809088|FG001|Part A|Withdrawal by Subject|1|||
33431724|NCT00321711|62809089|FG002|Part A|Withdrawal by Subject|1|||
33431725|NCT00321711|62809090|FG003|Part A|Withdrawal by Subject|0|||
33431726|NCT00321711|62809091|FG004|Part A|Withdrawal by Subject|0|||
33431727|NCT00321711|62809087|FG000|Part A|Disease progression|0|||
33431728|NCT00321711|62809088|FG001|Part A|Disease progression|1|||
33431729|NCT00321711|62809089|FG002|Part A|Disease progression|0|||
33431730|NCT00321711|62809090|FG003|Part A|Disease progression|0|||
33431731|NCT00321711|62809091|FG004|Part A|Disease progression|0|||
33431732|NCT00321711|62809087|FG000|Part A|Requirement for alternative therapy|0|||
33431733|NCT00321711|62809088|FG001|Part A|Requirement for alternative therapy|2|||
33431734|NCT00321711|62809089|FG002|Part A|Requirement for alternative therapy|1|||
33431735|NCT00321711|62809090|FG003|Part A|Requirement for alternative therapy|0|||
33431736|NCT00321711|62809091|FG004|Part A|Requirement for alternative therapy|0|||
33431737|NCT00321711|62809087|FG000|Part A|Physician Decision|0|||
33431738|NCT00321711|62809088|FG001|Part A|Physician Decision|1|||
33431739|NCT00321711|62809089|FG002|Part A|Physician Decision|3|||
33431740|NCT00321711|62809090|FG003|Part A|Physician Decision|0|||
33431741|NCT00321711|62809091|FG004|Part A|Physician Decision|0|||
33431742|NCT00321711|62809087|FG000|Part A|Other|1|||
33431743|NCT00321711|62809088|FG001|Part A|Other|2|||
33431744|NCT00321711|62809089|FG002|Part A|Other|3|||
33431745|NCT00321711|62809090|FG003|Part A|Other|0|||
33431746|NCT00321711|62809091|FG004|Part A|Other|0|||
33431747|NCT00321711|62809087|FG000|Part A|Protocol deviation|0|||
33431748|NCT00321711|62809088|FG001|Part A|Protocol deviation|0|||
33431749|NCT00321711|62809089|FG002|Part A|Protocol deviation|1|||
33431750|NCT00321711|62809090|FG003|Part A|Protocol deviation|0|||
33431751|NCT00321711|62809091|FG004|Part A|Protocol deviation|0|||
33431752|NCT00321711|62809087|FG000|Part B|Noncompliance|0|||
33431753|NCT00321711|62809088|FG001|Part B|Noncompliance|0|||
33431754|NCT00321711|62809089|FG002|Part B|Noncompliance|0|||
33431755|NCT00321711|62809090|FG003|Part B|Noncompliance|0|||
33431756|NCT00321711|62809091|FG004|Part B|Noncompliance|1|||
33431757|NCT00321711|62809087|FG000|Part B|Adverse Event|0|||
33431758|NCT00321711|62809088|FG001|Part B|Adverse Event|0|||
33431759|NCT00321711|62809089|FG002|Part B|Adverse Event|0|||
33431760|NCT00321711|62809090|FG003|Part B|Adverse Event|2|||
33431761|NCT00321711|62809091|FG004|Part B|Adverse Event|1|||
33431762|NCT00321711|62809087|FG000|Part B|Disease progression|0|||
33431763|NCT00321711|62809088|FG001|Part B|Disease progression|0|||
33431764|NCT00321711|62809089|FG002|Part B|Disease progression|0|||
33431765|NCT00321711|62809090|FG003|Part B|Disease progression|1|||
33431766|NCT00321711|62809091|FG004|Part B|Disease progression|0|||
33431767|NCT00321711|62809087|FG000|Part B|Physician Decision|0|||
33431768|NCT00321711|62809088|FG001|Part B|Physician Decision|0|||
33431769|NCT00321711|62809089|FG002|Part B|Physician Decision|0|||
33431770|NCT00321711|62809090|FG003|Part B|Physician Decision|1|||
33431771|NCT00321711|62809091|FG004|Part B|Physician Decision|2|||
33431772|NCT00321711|62809087|FG000|Part B|Death|0|||
33431773|NCT00321711|62809088|FG001|Part B|Death|0|||
33431774|NCT00321711|62809089|FG002|Part B|Death|0|||
33431775|NCT00321711|62809090|FG003|Part B|Death|2|||
33431776|NCT00321711|62809091|FG004|Part B|Death|1|||
33431777|NCT00486044|62809105|FG000|Overall Study|Withdrawal by Subject|2|||
33431778|NCT00486044|62809106|FG001|Overall Study|Withdrawal by Subject|1|||
33431779|NCT00486044|62809105|FG000|Overall Study|Adverse Event|0|||
33431780|NCT00486044|62809106|FG001|Overall Study|Adverse Event|1|||
33431781|NCT00486044|62809105|FG000|Overall Study|Lost to Follow-up|0|||
33431782|NCT00486044|62809106|FG001|Overall Study|Lost to Follow-up|1|||
33431783|NCT00351273|62809115|FG000|Overall Study|Lost to Follow-up|1|||
33431784|NCT00351273|62809116|FG001|Overall Study|Lost to Follow-up|2|||
33431785|NCT00351273|62809117|FG002|Overall Study|Lost to Follow-up|5|||
33431786|NCT00327717|62809132|FG000|Overall Study|Adverse Event|6|||
33431787|NCT00327717|62809133|FG001|Overall Study|Adverse Event|6|||
33431788|NCT00327717|62809132|FG000|Overall Study|Lack of Efficacy|0|||
33431789|NCT00327717|62809133|FG001|Overall Study|Lack of Efficacy|1|||
33431790|NCT00327717|62809132|FG000|Overall Study|Withdrawal by Subject|3|||
33431791|NCT00327717|62809133|FG001|Overall Study|Withdrawal by Subject|7|||
33431792|NCT00463346|62809141|FG000|Overall Study|Withdrawal by Subject|3|||
33431793|NCT00463346|62809142|FG001|Overall Study|Withdrawal by Subject|3|||
33431794|NCT00462488|62809152|FG000|Overall Study|Protocol Violation|1|||
33431795|NCT00462488|62809153|FG001|Overall Study|Protocol Violation|0|||
33431796|NCT00462488|62809152|FG000|Overall Study|Lack of Efficacy|19|||
33431797|NCT00462488|62809153|FG001|Overall Study|Lack of Efficacy|17|||
33431798|NCT00454142|62809159|FG000|Overall Study|Withdrawal by Subject|1|||
33431799|NCT00424476|62809168|FG000|Overall Study|Withdrawal by Subject|7|||
33431800|NCT00424476|62809169|FG001|Overall Study|Withdrawal by Subject|6|||
33431801|NCT00424476|62809170|FG002|Overall Study|Withdrawal by Subject|3|||
33431802|NCT00424476|62809168|FG000|Overall Study|Adverse Event|19|||
33431803|NCT00424476|62809169|FG001|Overall Study|Adverse Event|16|||
33431804|NCT00424476|62809170|FG002|Overall Study|Adverse Event|15|||
33431805|NCT00424476|62809168|FG000|Overall Study|Lack of Efficacy|16|||
33431806|NCT00424476|62809169|FG001|Overall Study|Lack of Efficacy|12|||
33431807|NCT00424476|62809170|FG002|Overall Study|Lack of Efficacy|12|||
33431808|NCT00424476|62809168|FG000|Overall Study|Lack of Compliance|1|||
33431809|NCT00424476|62809169|FG001|Overall Study|Lack of Compliance|1|||
33431810|NCT00424476|62809170|FG002|Overall Study|Lack of Compliance|1|||
33431811|NCT00424476|62809168|FG000|Overall Study|Lost to Follow-up|4|||
33431812|NCT00424476|62809169|FG001|Overall Study|Lost to Follow-up|6|||
33431813|NCT00424476|62809170|FG002|Overall Study|Lost to Follow-up|3|||
33431814|NCT00424476|62809168|FG000|Overall Study|Protocol Violation|7|||
33431815|NCT00424476|62809169|FG001|Overall Study|Protocol Violation|2|||
33431816|NCT00424476|62809170|FG002|Overall Study|Protocol Violation|3|||
33431817|NCT00424476|62809168|FG000|Overall Study|Physician Decision|3|||
33431818|NCT00424476|62809169|FG001|Overall Study|Physician Decision|2|||
33431819|NCT00424476|62809170|FG002|Overall Study|Physician Decision|3|||
33431820|NCT00424476|62809168|FG000|Overall Study|Other|4|||
33431821|NCT00424476|62809169|FG001|Overall Study|Other|3|||
33431822|NCT00424476|62809170|FG002|Overall Study|Other|9|||
33431823|NCT00453986|62809183|FG000|Overall Study|Lost to Follow-up|6|||
33431824|NCT00453986|62809184|FG001|Overall Study|Lost to Follow-up|5|||
33431825|NCT00453986|62809185|FG002|Overall Study|Lost to Follow-up|6|||
33431826|NCT00453986|62809186|FG003|Overall Study|Lost to Follow-up|2|||
33431827|NCT00453986|62809187|FG004|Overall Study|Lost to Follow-up|0|||
33431828|NCT00435942|62809205|FG000|Overall Study|Death|17|||
33431829|NCT00435942|62809206|FG001|Overall Study|Death|10|||
33431830|NCT00435942|62809205|FG000|Overall Study|Withdrawal by Subject|2|||
33431831|NCT00435942|62809206|FG001|Overall Study|Withdrawal by Subject|0|||
33431832|NCT00435942|62809205|FG000|Overall Study|Lost to Follow-up|0|||
33431833|NCT00435942|62809206|FG001|Overall Study|Lost to Follow-up|16|||
33431834|NCT00435942|62809205|FG000|Overall Study|Conversion to Open Repair|1|||
33431835|NCT00435942|62809206|FG001|Overall Study|Conversion to Open Repair|0|||
33431836|NCT00435942|62809205|FG000|Overall Study|Technical Failure|3|||
33431837|NCT00435942|62809206|FG001|Overall Study|Technical Failure|0|||
33431838|NCT00435942|62809205|FG000|Overall Study|Other|0|||
33431839|NCT00435942|62809206|FG001|Overall Study|Other|1|||
33431840|NCT00453362|62809212|FG000|Overall Study|Adverse Event|5|||
33431841|NCT00453362|62809212|FG000|Overall Study|Death|7|||
33431842|NCT00453362|62809212|FG000|Overall Study|Physician Decision|2|||
33431843|NCT00453362|62809212|FG000|Overall Study|Withdrawal by Subject|3|||
33431844|NCT00453362|62809212|FG000|Overall Study|Progression of disease|56|||
33431845|NCT00453362|62809212|FG000|Overall Study|Screening Failure|14|||
33431846|NCT00424398|62809231|FG000|Overall Study|Withdrawal by Subject|2|||
33431847|NCT00424398|62809232|FG001|Overall Study|Withdrawal by Subject|1|||
33431848|NCT00424398|62809233|FG002|Overall Study|Withdrawal by Subject|0|||
33431849|NCT00424398|62809231|FG000|Overall Study|Subject met exclusion criteria|1|||
33431850|NCT00424398|62809232|FG001|Overall Study|Subject met exclusion criteria|0|||
33431851|NCT00424398|62809233|FG002|Overall Study|Subject met exclusion criteria|0|||
33431852|NCT00461786|62809241|FG000|Overall Study|Entry Criteria Not Met|2|||
33431853|NCT00461786|62809241|FG000|Overall Study|Inevaluable (Never Treated)|1|||
33431854|NCT00435162|62809248|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
33431855|NCT00435162|62809249|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
33431856|NCT00435162|62809250|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
33431857|NCT00435162|62809251|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
33431858|NCT00435162|62809252|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
33431859|NCT00435162|62809253|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
33431860|NCT03836664|62809268|FG000|Overall Study|Didn't complete forms and lost drug|3|||
33431861|NCT03836664|62809269|FG001|Overall Study|Didn't complete forms and lost drug|3|||
33431862|NCT00350727|62809282|FG000|Phase I: Dose Escalation|Adverse Event|4|||
33431863|NCT00350727|62809283|FG001|Phase I: Dose Escalation|Adverse Event|0|||
33431864|NCT00350727|62809284|FG002|Phase I: Dose Escalation|Adverse Event|0|||
33431865|NCT00350727|62809282|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
33431866|NCT00350727|62809283|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
33431867|NCT00350727|62809284|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
33431868|NCT00350727|62809282|FG000|Phase I: Dose Escalation|Death|1|||
33431869|NCT00350727|62809283|FG001|Phase I: Dose Escalation|Death|0|||
33431870|NCT00350727|62809284|FG002|Phase I: Dose Escalation|Death|0|||
33431871|NCT00350727|62809282|FG000|Phase I: Dose Escalation|Physician Decision|1|||
33431872|NCT00350727|62809283|FG001|Phase I: Dose Escalation|Physician Decision|0|||
33431873|NCT00350727|62809284|FG002|Phase I: Dose Escalation|Physician Decision|0|||
33431874|NCT00350727|62809282|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
33431875|NCT00350727|62809283|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
33431876|NCT00350727|62809284|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
33431877|NCT00350727|62809282|FG000|Phase II|Disease Progression|0|||
33431878|NCT00350727|62809283|FG001|Phase II|Disease Progression|15|||
33431879|NCT00350727|62809284|FG002|Phase II|Disease Progression|16|||
33431880|NCT00350727|62809282|FG000|Phase II|Clinical Deterioration|0|||
33431881|NCT00350727|62809283|FG001|Phase II|Clinical Deterioration|1|||
33431882|NCT00350727|62809284|FG002|Phase II|Clinical Deterioration|0|||
33431883|NCT00350727|62809282|FG000|Phase II|Withdrawal by Subject|0|||
33431884|NCT00350727|62809283|FG001|Phase II|Withdrawal by Subject|2|||
33431885|NCT00350727|62809284|FG002|Phase II|Withdrawal by Subject|1|||
33431886|NCT00350727|62809282|FG000|Phase II|Adverse Event|0|||
33431887|NCT00350727|62809283|FG001|Phase II|Adverse Event|1|||
33431888|NCT00350727|62809284|FG002|Phase II|Adverse Event|1|||
33431889|NCT00350727|62809282|FG000|Phase II|Death|0|||
33431890|NCT00350727|62809283|FG001|Phase II|Death|0|||
33431891|NCT00350727|62809284|FG002|Phase II|Death|2|||
33431892|NCT00350727|62809282|FG000|Phase II|Sponsor Terminated Study|0|||
33431893|NCT00350727|62809283|FG001|Phase II|Sponsor Terminated Study|0|||
33431894|NCT00350727|62809284|FG002|Phase II|Sponsor Terminated Study|1|||
33431895|NCT00350727|62809282|FG000|Phase II|Enrolled in Rollover Study|0|||
33431896|NCT00350727|62809283|FG001|Phase II|Enrolled in Rollover Study|0|||
33431897|NCT00350727|62809284|FG002|Phase II|Enrolled in Rollover Study|1|||
33431898|NCT00434304|62809303|FG000|Overall Study|Adverse Event|14|||
33431899|NCT00434304|62809303|FG000|Overall Study|Lack of Efficacy|2|||
33431900|NCT00434304|62809303|FG000|Overall Study|Withdrawal by Subject|4|||
33431901|NCT00424008|62809310|FG000|Overall Study|Adverse Event|8|||
33431902|NCT00424008|62809311|FG001|Overall Study|Adverse Event|6|||
33431903|NCT00424008|62809310|FG000|Overall Study|Lack of Efficacy|40|||
33431904|NCT00424008|62809311|FG001|Overall Study|Lack of Efficacy|34|||
33431905|NCT00424008|62809310|FG000|Overall Study|Lost to Follow-up|1|||
33431906|NCT00424008|62809311|FG001|Overall Study|Lost to Follow-up|2|||
33431907|NCT00424008|62809310|FG000|Overall Study|Withdrawal by Subject|5|||
33431908|NCT00424008|62809311|FG001|Overall Study|Withdrawal by Subject|8|||
33431909|NCT00424008|62809310|FG000|Overall Study|Noncompliance with protocol|13|||
33431910|NCT00424008|62809311|FG001|Overall Study|Noncompliance with protocol|7|||
33431911|NCT00424008|62809310|FG000|Overall Study|Did not meet protocol eligibility|16|||
33431912|NCT00424008|62809311|FG001|Overall Study|Did not meet protocol eligibility|21|||
33431913|NCT00424008|62809310|FG000|Overall Study|Administrative|266|||
33431914|NCT00424008|62809311|FG001|Overall Study|Administrative|257|||
33431915|NCT00423930|62809318|FG000|Overall Study|Withdrawal by Subject|2|||
33431916|NCT00423852|62809322|FG000|Overall Study|Removed pior to the high-dose portion|3|||
33431917|NCT00461708|62809328|FG000|Overall Study|Adverse Event|17|||
33431918|NCT00461708|62809329|FG001|Overall Study|Adverse Event|7|||
33431919|NCT00461708|62809328|FG000|Overall Study|Lack of Efficacy|68|||
33431920|NCT00461708|62809329|FG001|Overall Study|Lack of Efficacy|20|||
33431921|NCT00461708|62809328|FG000|Overall Study|Physician Decision|10|||
33431922|NCT00461708|62809329|FG001|Overall Study|Physician Decision|4|||
33431923|NCT00461708|62809328|FG000|Overall Study|Withdrawal by Subject|8|||
33431924|NCT00461708|62809329|FG001|Overall Study|Withdrawal by Subject|2|||
33431925|NCT00461708|62809328|FG000|Overall Study|Other|4|||
33431926|NCT00461708|62809329|FG001|Overall Study|Other|4|||
33431927|NCT00461708|62809328|FG000|Overall Study|Death|8|||
33431928|NCT00461708|62809329|FG001|Overall Study|Death|1|||
33431929|NCT00327171|62809340|FG000|Overall Study|Did not receive study medication|3|||
33431930|NCT00327171|62809341|FG001|Overall Study|Did not receive study medication|0|||
33431931|NCT00327171|62809340|FG000|Overall Study|Adverse Event|23|||
33431932|NCT00327171|62809341|FG001|Overall Study|Adverse Event|23|||
33431933|NCT00327171|62809340|FG000|Overall Study|Disease progression/lack of efficacy|68|||
33431934|NCT00327171|62809341|FG001|Overall Study|Disease progression/lack of efficacy|69|||
33431935|NCT00327171|62809340|FG000|Overall Study|Investigator/participant request|1|||
33431936|NCT00327171|62809341|FG001|Overall Study|Investigator/participant request|8|||
33431937|NCT00327171|62809340|FG000|Overall Study|Clinical progression|12|||
33431938|NCT00327171|62809341|FG001|Overall Study|Clinical progression|8|||
33431939|NCT00327171|62809340|FG000|Overall Study|Undisclosed history of ischemia|0|||
33431940|NCT00327171|62809341|FG001|Overall Study|Undisclosed history of ischemia|1|||
33431941|NCT00327171|62809340|FG000|Overall Study|Other|1|||
33431942|NCT00327171|62809341|FG001|Overall Study|Other|0|||
33431943|NCT00461630|62809349|FG000|Overall Study|Death|798|||
33431944|NCT00461630|62809350|FG001|Overall Study|Death|732|||
33431945|NCT00461630|62809349|FG000|Overall Study|Lost to Follow-up|108|||
33431946|NCT00461630|62809350|FG001|Overall Study|Lost to Follow-up|95|||
33431947|NCT00461552|62809358|FG000|Overall Study|Drug Dispensing error|0|||
33431948|NCT00461552|62809359|FG001|Overall Study|Drug Dispensing error|2|||
33431949|NCT00453206|62809365|FG000|Overall Study|Death|1|||
33431950|NCT03850496|62809372|FG000|Overall Study|Withdrawal by Subject|1|||
33431951|NCT03850496|62809373|FG001|Overall Study|Withdrawal by Subject|0|||
33431952|NCT03850496|62809374|FG002|Overall Study|Withdrawal by Subject|0|||
33431953|NCT03850496|62809372|FG000|Overall Study|Lost to Follow-up|0|||
33431954|NCT03850496|62809373|FG001|Overall Study|Lost to Follow-up|1|||
33431955|NCT03850496|62809374|FG002|Overall Study|Lost to Follow-up|4|||
33431956|NCT00327015|62809386|FG000|Overall Study|Lack of Efficacy|18|||
33431957|NCT00327015|62809387|FG001|Overall Study|Lack of Efficacy|18|||
33431958|NCT00327015|62809388|FG002|Overall Study|Lack of Efficacy|35|||
33431959|NCT00327015|62809389|FG003|Overall Study|Lack of Efficacy|29|||
33431960|NCT00327015|62809386|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
33431961|NCT00327015|62809387|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
33431962|NCT00327015|62809388|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
33431963|NCT00327015|62809389|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
33431964|NCT00327015|62809386|FG000|Overall Study|Lost to Follow-up|22|||
33431965|NCT00327015|62809387|FG001|Overall Study|Lost to Follow-up|23|||
33431966|NCT00327015|62809388|FG002|Overall Study|Lost to Follow-up|29|||
33431967|NCT00327015|62809389|FG003|Overall Study|Lost to Follow-up|22|||
33431968|NCT00327015|62809386|FG000|Overall Study|Adverse Event|14|||
33431969|NCT00327015|62809387|FG001|Overall Study|Adverse Event|10|||
33431970|NCT00327015|62809388|FG002|Overall Study|Adverse Event|14|||
33431971|NCT00327015|62809389|FG003|Overall Study|Adverse Event|14|||
33431972|NCT00327015|62809386|FG000|Overall Study|Subject no longer meets study criteria|4|||
33431973|NCT00327015|62809387|FG001|Overall Study|Subject no longer meets study criteria|2|||
33431974|NCT00327015|62809388|FG002|Overall Study|Subject no longer meets study criteria|8|||
33431975|NCT00327015|62809389|FG003|Overall Study|Subject no longer meets study criteria|7|||
33431976|NCT00327015|62809386|FG000|Overall Study|Poor/Noncompliance|11|||
33431977|NCT00327015|62809387|FG001|Overall Study|Poor/Noncompliance|8|||
33431978|NCT00327015|62809388|FG002|Overall Study|Poor/Noncompliance|4|||
33431979|NCT00327015|62809389|FG003|Overall Study|Poor/Noncompliance|5|||
33431980|NCT00327015|62809386|FG000|Overall Study|Physician Decision|0|||
33431981|NCT00327015|62809387|FG001|Overall Study|Physician Decision|1|||
33431982|NCT00327015|62809388|FG002|Overall Study|Physician Decision|3|||
33431983|NCT00327015|62809389|FG003|Overall Study|Physician Decision|2|||
33431984|NCT00327015|62809386|FG000|Overall Study|Death|1|||
33431985|NCT00327015|62809387|FG001|Overall Study|Death|2|||
33431986|NCT00327015|62809388|FG002|Overall Study|Death|2|||
33431987|NCT00327015|62809389|FG003|Overall Study|Death|3|||
33431988|NCT00327015|62809386|FG000|Overall Study|Pregnancy|0|||
33431989|NCT00327015|62809387|FG001|Overall Study|Pregnancy|2|||
33431990|NCT00327015|62809388|FG002|Overall Study|Pregnancy|1|||
33431991|NCT00327015|62809389|FG003|Overall Study|Pregnancy|1|||
33431992|NCT00327015|62809386|FG000|Overall Study|Administrative Reason by Sponsor|1|||
33431993|NCT00327015|62809387|FG001|Overall Study|Administrative Reason by Sponsor|2|||
33431994|NCT00327015|62809388|FG002|Overall Study|Administrative Reason by Sponsor|2|||
33431995|NCT00327015|62809389|FG003|Overall Study|Administrative Reason by Sponsor|1|||
33431996|NCT00434148|62809401|FG000|Overall Study|Adverse Event|18|||
33431997|NCT00434148|62809402|FG001|Overall Study|Adverse Event|18|||
33431998|NCT00434148|62809401|FG000|Overall Study|Lack of Efficacy|25|||
33431999|NCT00434148|62809402|FG001|Overall Study|Lack of Efficacy|28|||
33432000|NCT00434148|62809401|FG000|Overall Study|Withdrawal by Subject|15|||
33432001|NCT00434148|62809402|FG001|Overall Study|Withdrawal by Subject|15|||
33432002|NCT00434148|62809401|FG000|Overall Study|Protocol Violation|4|||
33432003|NCT00434148|62809402|FG001|Overall Study|Protocol Violation|0|||
33432004|NCT00434148|62809401|FG000|Overall Study|Administrative problems|6|||
33432005|NCT00434148|62809402|FG001|Overall Study|Administrative problems|10|||
33432006|NCT00434148|62809401|FG000|Overall Study|Lost to Follow-up|0|||
33432007|NCT00434148|62809402|FG001|Overall Study|Lost to Follow-up|1|||
33432008|NCT00434148|62809401|FG000|Overall Study|Condition no longer requires study drug|1|||
33432009|NCT00434148|62809402|FG001|Overall Study|Condition no longer requires study drug|0|||
33432010|NCT00434148|62809401|FG000|Overall Study|Abnormal test procedure result|0|||
33432011|NCT00434148|62809402|FG001|Overall Study|Abnormal test procedure result|1|||
33432012|NCT00468728|62809410|FG000|Treatment|criteria for mITT population|4|||
33432013|NCT00468728|62809411|FG001|Treatment|criteria for mITT population|11|||
33432014|NCT00468728|62809410|FG000|Follow-up|mITT failure|34|||
33432015|NCT00468728|62809411|FG001|Follow-up|mITT failure|31|||
33432016|NCT00433914|62809421|FG000|Overall Study|Withdrawal by Subject|0|||
33432017|NCT00433914|62809422|FG001|Overall Study|Withdrawal by Subject|2|||
33432018|NCT00433914|62809421|FG000|Overall Study|Lost to Follow-up|0|||
33432019|NCT00433914|62809422|FG001|Overall Study|Lost to Follow-up|1|||
33432020|NCT00468650|62809428|FG000|Overall Study|Lost to Follow-up|4|||
33432021|NCT00468650|62809428|FG000|Overall Study|Withdrawal by Subject|2|||
33432022|NCT00468650|62809428|FG000|Overall Study|Protocol Violation|1|||
33432023|NCT00423150|62809433|FG000|Overall Study|Adverse Event|11|||
33432024|NCT00423150|62809433|FG000|Overall Study|Progression of disease being studied|69|||
33432025|NCT00423150|62809433|FG000|Overall Study|Withdrawal by Subject|1|||
33432026|NCT00423150|62809433|FG000|Overall Study|Non-compliance with protocol|1|||
33432027|NCT00423150|62809433|FG000|Overall Study|Administrative|4|||
33432028|NCT00433836|62809439|FG000|Overall Study|Adverse Event|7|||
33432029|NCT00433836|62809440|FG001|Overall Study|Adverse Event|0|||
33432030|NCT00433836|62809439|FG000|Overall Study|Lost to Follow-up|3|||
33432031|NCT00433836|62809440|FG001|Overall Study|Lost to Follow-up|0|||
33432032|NCT00433836|62809439|FG000|Overall Study|Withdrawal by Subject|2|||
33432033|NCT00433836|62809440|FG001|Overall Study|Withdrawal by Subject|1|||
33432034|NCT00433836|62809439|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33432035|NCT00433836|62809440|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33432036|NCT00433836|62809439|FG000|Overall Study|Protocol Violation|0|||
33432037|NCT00433836|62809440|FG001|Overall Study|Protocol Violation|2|||
33432038|NCT00433836|62809439|FG000|Overall Study|Condition no longer requires study drug|0|||
33432039|NCT00433836|62809440|FG001|Overall Study|Condition no longer requires study drug|1|||
33432040|NCT00433836|62809439|FG000|Overall Study|Abnormal laboratory values|0|||
33432041|NCT00433836|62809440|FG001|Overall Study|Abnormal laboratory values|1|||
33432042|NCT00433446|62809446|FG000|Overall Study|Adverse Event|4|||
33432043|NCT00433446|62809446|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
33432044|NCT00433446|62809446|FG000|Overall Study|Progression|44|||
33432045|NCT00433446|62809446|FG000|Overall Study|Other - Not Protocol specified|3|||
33432046|NCT00433446|62809446|FG000|Overall Study|Ineligible|9|||
33432047|NCT00468104|62809450|FG000|First Intervention|Protocol Violation|2|||
33432048|NCT00468104|62809451|FG001|First Intervention|Protocol Violation|1|||
33432049|NCT00468104|62809450|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
33432050|NCT00468104|62809451|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
33432051|NCT00468104|62809450|FG000|First Intervention|died within 3 weeks|1|||
33432052|NCT00468104|62809451|FG001|First Intervention|died within 3 weeks|0|||
33432053|NCT00468104|62809450|FG000|First Intervention|malposition/blocked chest tube tube|2|||
33432054|NCT00468104|62809451|FG001|First Intervention|malposition/blocked chest tube tube|0|||
33432055|NCT00468104|62809450|FG000|First Intervention|large lung mass with minimal effusion|1|||
33432056|NCT00468104|62809451|FG001|First Intervention|large lung mass with minimal effusion|0|||
33432057|NCT00468104|62809450|FG000|First Intervention|associated prolonged pneumothorax|1|||
33432058|NCT00468104|62809451|FG001|First Intervention|associated prolonged pneumothorax|0|||
33432059|NCT00468104|62809450|FG000|First Intervention|trapped lung|1|||
33432060|NCT00468104|62809451|FG001|First Intervention|trapped lung|0|||
33432061|NCT00468104|62809450|FG000|Second Intervention|Withdrawal by Subject|5|||
33432062|NCT00468104|62809451|FG001|Second Intervention|Withdrawal by Subject|2|||
33432063|NCT00468104|62809450|FG000|Second Intervention|discarded for malposition of chest tube|0|||
33432064|NCT00468104|62809451|FG001|Second Intervention|discarded for malposition of chest tube|2|||
33432065|NCT00326625|62809462|FG000|Overall Study|Adverse Event|20|||
33432066|NCT00326625|62809463|FG001|Overall Study|Adverse Event|9|||
33432067|NCT00326625|62809462|FG000|Overall Study|Withdrawal by Subject|15|||
33432068|NCT00326625|62809463|FG001|Overall Study|Withdrawal by Subject|12|||
33432069|NCT00326625|62809462|FG000|Overall Study|Death|18|||
33432070|NCT00326625|62809463|FG001|Overall Study|Death|16|||
33432071|NCT00326625|62809462|FG000|Overall Study|Lost to Follow-up|1|||
33432072|NCT00326625|62809463|FG001|Overall Study|Lost to Follow-up|0|||
33432073|NCT00326625|62809462|FG000|Overall Study|prescheduled medical intervention|0|||
33432074|NCT00326625|62809463|FG001|Overall Study|prescheduled medical intervention|1|||
33432075|NCT00433290|62809471|FG000|Overall Study|Adverse Event|24|||
33432076|NCT00433290|62809472|FG001|Overall Study|Adverse Event|7|||
33432077|NCT00433290|62809471|FG000|Overall Study|Lack of Efficacy|1|||
33432078|NCT00433290|62809472|FG001|Overall Study|Lack of Efficacy|5|||
33432079|NCT00433290|62809471|FG000|Overall Study|Withdrawal by Subject|4|||
33432080|NCT00433290|62809472|FG001|Overall Study|Withdrawal by Subject|2|||
33432081|NCT00433290|62809471|FG000|Overall Study|Protocol Violation|3|||
33432082|NCT00433290|62809472|FG001|Overall Study|Protocol Violation|2|||
33432083|NCT00433290|62809471|FG000|Overall Study|Physician Decision|2|||
33432084|NCT00433290|62809472|FG001|Overall Study|Physician Decision|0|||
33432085|NCT00433290|62809471|FG000|Overall Study|Entry Criteria Not Met|0|||
33432086|NCT00433290|62809472|FG001|Overall Study|Entry Criteria Not Met|1|||
33432087|NCT00433290|62809471|FG000|Overall Study|Lost to Follow-up|1|||
33432088|NCT00433290|62809472|FG001|Overall Study|Lost to Follow-up|0|||
33432089|NCT00467870|62809484|FG000|Overall Study|Adverse Event|13|||
33432090|NCT00467870|62809485|FG001|Overall Study|Adverse Event|9|||
33432091|NCT00467870|62809486|FG002|Overall Study|Adverse Event|1|||
33432092|NCT00467870|62809487|FG003|Overall Study|Adverse Event|15|||
33432093|NCT00467870|62809488|FG004|Overall Study|Adverse Event|15|||
33432094|NCT00467870|62809489|FG005|Overall Study|Adverse Event|1|||
33432095|NCT00467870|62809484|FG000|Overall Study|Protocol Violation|2|||
33432096|NCT00467870|62809485|FG001|Overall Study|Protocol Violation|1|||
33432097|NCT00467870|62809486|FG002|Overall Study|Protocol Violation|1|||
33432098|NCT00467870|62809487|FG003|Overall Study|Protocol Violation|2|||
33432099|NCT00467870|62809488|FG004|Overall Study|Protocol Violation|0|||
33432100|NCT00467870|62809489|FG005|Overall Study|Protocol Violation|0|||
33432101|NCT00467870|62809484|FG000|Overall Study|Withdrawal by Subject|14|||
33432102|NCT00467870|62809485|FG001|Overall Study|Withdrawal by Subject|21|||
33432103|NCT00467870|62809486|FG002|Overall Study|Withdrawal by Subject|0|||
33432104|NCT00467870|62809487|FG003|Overall Study|Withdrawal by Subject|9|||
33432105|NCT00467870|62809488|FG004|Overall Study|Withdrawal by Subject|10|||
33432106|NCT00467870|62809489|FG005|Overall Study|Withdrawal by Subject|1|||
33432107|NCT00467870|62809484|FG000|Overall Study|Lost to Follow-up|5|||
33432108|NCT00467870|62809485|FG001|Overall Study|Lost to Follow-up|3|||
33432109|NCT00467870|62809486|FG002|Overall Study|Lost to Follow-up|1|||
33432110|NCT00467870|62809487|FG003|Overall Study|Lost to Follow-up|1|||
33432111|NCT00467870|62809488|FG004|Overall Study|Lost to Follow-up|3|||
33432112|NCT00467870|62809489|FG005|Overall Study|Lost to Follow-up|0|||
33432113|NCT00467870|62809484|FG000|Overall Study|Subject Non-compliance|3|||
33432114|NCT00467870|62809485|FG001|Overall Study|Subject Non-compliance|4|||
33432115|NCT00467870|62809486|FG002|Overall Study|Subject Non-compliance|0|||
33432116|NCT00467870|62809487|FG003|Overall Study|Subject Non-compliance|1|||
33432117|NCT00467870|62809488|FG004|Overall Study|Subject Non-compliance|5|||
33432118|NCT00467870|62809489|FG005|Overall Study|Subject Non-compliance|0|||
33432119|NCT00467870|62809484|FG000|Overall Study|Other/Unknown|8|||
33432120|NCT00467870|62809485|FG001|Overall Study|Other/Unknown|5|||
33432121|NCT00467870|62809486|FG002|Overall Study|Other/Unknown|1|||
33432122|NCT00467870|62809487|FG003|Overall Study|Other/Unknown|5|||
33432123|NCT00467870|62809488|FG004|Overall Study|Other/Unknown|4|||
33432124|NCT00467870|62809489|FG005|Overall Study|Other/Unknown|0|||
33432125|NCT00467558|62809501|FG000|Overall Study|Lost to Follow-up|2|||
33432126|NCT00467558|62809502|FG001|Overall Study|Lost to Follow-up|0|||
33432127|NCT00422292|62809512|FG000|Overall Study|Serious adverse events|1|||
33432128|NCT00422292|62809513|FG001|Overall Study|Serious adverse events|4|||
33432129|NCT00422292|62809514|FG002|Overall Study|Serious adverse events|0|||
33432130|NCT00422292|62809515|FG003|Overall Study|Serious adverse events|0|||
33432131|NCT00422292|62809512|FG000|Overall Study|Adverse Event|1|||
33432132|NCT00422292|62809513|FG001|Overall Study|Adverse Event|0|||
33432133|NCT00422292|62809514|FG002|Overall Study|Adverse Event|1|||
33432134|NCT00422292|62809515|FG003|Overall Study|Adverse Event|0|||
33432135|NCT00422292|62809512|FG000|Overall Study|Protocol Violation|4|||
33432136|NCT00422292|62809513|FG001|Overall Study|Protocol Violation|25|||
33432137|NCT00422292|62809514|FG002|Overall Study|Protocol Violation|8|||
33432138|NCT00422292|62809515|FG003|Overall Study|Protocol Violation|5|||
33432139|NCT00422292|62809512|FG000|Overall Study|Lost to Follow-up|6|||
33432140|NCT00422292|62809513|FG001|Overall Study|Lost to Follow-up|12|||
33432141|NCT00422292|62809514|FG002|Overall Study|Lost to Follow-up|6|||
33432142|NCT00422292|62809515|FG003|Overall Study|Lost to Follow-up|6|||
33432143|NCT00422292|62809512|FG000|Overall Study|Withdrawal by Subject|6|||
33432144|NCT00422292|62809513|FG001|Overall Study|Withdrawal by Subject|25|||
33432145|NCT00422292|62809514|FG002|Overall Study|Withdrawal by Subject|7|||
33432146|NCT00422292|62809515|FG003|Overall Study|Withdrawal by Subject|13|||
33432147|NCT00452348|62809527|FG000|Overall Study|Adverse Event|6|||
33432148|NCT00452348|62809528|FG001|Overall Study|Adverse Event|9|||
33432149|NCT00452348|62809527|FG000|Overall Study|Lack of Efficacy|10|||
33432150|NCT00452348|62809528|FG001|Overall Study|Lack of Efficacy|9|||
33432151|NCT00452348|62809527|FG000|Overall Study|Lost to Follow-up|14|||
33432152|NCT00452348|62809528|FG001|Overall Study|Lost to Follow-up|8|||
33432153|NCT00452348|62809527|FG000|Overall Study|Protocol Violation|22|||
33432154|NCT00452348|62809528|FG001|Overall Study|Protocol Violation|28|||
33432155|NCT00452348|62809527|FG000|Overall Study|Withdrawal by Subject|18|||
33432156|NCT00452348|62809528|FG001|Overall Study|Withdrawal by Subject|21|||
33432157|NCT00452348|62809527|FG000|Overall Study|Other|9|||
33432158|NCT00452348|62809528|FG001|Overall Study|Other|9|||
33432159|NCT00452114|62809536|FG000|Overall Study|Physician Decision|3|||
33432160|NCT00452114|62809537|FG001|Overall Study|Physician Decision|3|||
33432161|NCT00320541|62809545|FG000|Overall Study|Adverse Event|21|||
33432162|NCT00320541|62809546|FG001|Overall Study|Adverse Event|19|||
33432163|NCT00320541|62809545|FG000|Overall Study|Protocol Violation|0|||
33432164|NCT00320541|62809546|FG001|Overall Study|Protocol Violation|1|||
33432165|NCT00320541|62809545|FG000|Overall Study|Withdrawal by Subject|12|||
33432166|NCT00320541|62809546|FG001|Overall Study|Withdrawal by Subject|16|||
33432167|NCT00320541|62809545|FG000|Overall Study|Physician Decision|9|||
33432168|NCT00320541|62809546|FG001|Overall Study|Physician Decision|13|||
33432169|NCT00320541|62809545|FG000|Overall Study|Other|3|||
33432170|NCT00320541|62809546|FG001|Overall Study|Other|4|||
33432171|NCT00320541|62809545|FG000|Overall Study|Sponsor Decision|2|||
33432172|NCT00320541|62809546|FG001|Overall Study|Sponsor Decision|1|||
33432173|NCT00320541|62809545|FG000|Overall Study|Death due to Study Disease|1|||
33432174|NCT00320541|62809546|FG001|Overall Study|Death due to Study Disease|3|||
33432175|NCT00320541|62809545|FG000|Overall Study|Death due to Adverse Event(s)|1|||
33432176|NCT00320541|62809546|FG001|Overall Study|Death due to Adverse Event(s)|0|||
33432177|NCT00320541|62809545|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
33432178|NCT00320541|62809546|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
33432179|NCT00320385|62809554|FG000|Overall Study|Lost to Follow-up|7|||
33432180|NCT00320385|62809555|FG001|Overall Study|Lost to Follow-up|10|||
33432181|NCT00320385|62809554|FG000|Overall Study|Withdrawal by Subject|6|||
33432182|NCT00320385|62809555|FG001|Overall Study|Withdrawal by Subject|7|||
33432183|NCT00320385|62809554|FG000|Overall Study|Sponsor Terminated Study|2|||
33432184|NCT00320385|62809555|FG001|Overall Study|Sponsor Terminated Study|1|||
33432185|NCT00320385|62809554|FG000|Overall Study|Investigator Decision|0|||
33432186|NCT00320385|62809555|FG001|Overall Study|Investigator Decision|1|||
33432187|NCT00320385|62809554|FG000|Overall Study|Death|1|||
33432188|NCT00320385|62809555|FG001|Overall Study|Death|2|||
33432189|NCT00320385|62809554|FG000|Overall Study|Serious Adverse Event|1|||
33432190|NCT00320385|62809555|FG001|Overall Study|Serious Adverse Event|0|||
33432191|NCT00320385|62809554|FG000|Overall Study|Withdrew Consent|1|||
33432192|NCT00320385|62809555|FG001|Overall Study|Withdrew Consent|0|||
33432193|NCT00320385|62809554|FG000|Overall Study|Adverse Event|0|||
33432194|NCT00320385|62809555|FG001|Overall Study|Adverse Event|1|||
33432195|NCT00326001|62809563|FG000|Overall Study|Adverse Event|4|||
33432196|NCT00326001|62809564|FG001|Overall Study|Adverse Event|5|||
33432197|NCT00326001|62809563|FG000|Overall Study|Physician Decision|3|||
33432198|NCT00326001|62809564|FG001|Overall Study|Physician Decision|3|||
33432199|NCT00309777|62809574|FG000|Overall Study|Adverse Event|13|||
33432200|NCT00309777|62809575|FG001|Overall Study|Adverse Event|2|||
33432201|NCT00309777|62809576|FG002|Overall Study|Adverse Event|8|||
33432202|NCT00309777|62809577|FG003|Overall Study|Adverse Event|1|||
33432203|NCT00309777|62809574|FG000|Overall Study|Protocol Violation|4|||
33432204|NCT00309777|62809575|FG001|Overall Study|Protocol Violation|1|||
33432205|NCT00309777|62809576|FG002|Overall Study|Protocol Violation|3|||
33432206|NCT00309777|62809577|FG003|Overall Study|Protocol Violation|1|||
33432207|NCT00309777|62809574|FG000|Overall Study|Withdrawal by Subject|6|||
33432208|NCT00309777|62809575|FG001|Overall Study|Withdrawal by Subject|5|||
33432209|NCT00309777|62809576|FG002|Overall Study|Withdrawal by Subject|7|||
33432210|NCT00309777|62809577|FG003|Overall Study|Withdrawal by Subject|2|||
33432211|NCT00309777|62809574|FG000|Overall Study|Lost to Follow-up|0|||
33432212|NCT00309777|62809575|FG001|Overall Study|Lost to Follow-up|0|||
33432213|NCT00309777|62809576|FG002|Overall Study|Lost to Follow-up|1|||
33432214|NCT00309777|62809577|FG003|Overall Study|Lost to Follow-up|0|||
33432215|NCT00309777|62809574|FG000|Overall Study|Death|0|||
33432216|NCT00309777|62809575|FG001|Overall Study|Death|1|||
33432217|NCT00309777|62809576|FG002|Overall Study|Death|0|||
33432218|NCT00309777|62809577|FG003|Overall Study|Death|0|||
33432219|NCT00309387|62809589|FG000|Overall Study|Death|72|||
33432220|NCT00309387|62809590|FG001|Overall Study|Death|73|||
33432221|NCT00309387|62809589|FG000|Overall Study|Lost to Follow-up|70|||
33432222|NCT00309387|62809590|FG001|Overall Study|Lost to Follow-up|86|||
33432223|NCT00325143|62809597|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
33432224|NCT00325143|62809597|FG000|Overall Study|Migrated/moved from study area|1|||
33432225|NCT00325143|62809597|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
33432226|NCT00325143|62809597|FG000|Overall Study|Withdrawal by Subject|8|||
33432227|NCT00319839|62809601|FG000|Overall Study|Adverse Event|5|||
33432228|NCT00319839|62809601|FG000|Overall Study|Withdrawal by Subject|1|||
33432229|NCT00319449|62809607|FG000|Overall Study|Subject did not wish to continue|1|||
33432230|NCT00319449|62809608|FG001|Overall Study|Subject did not wish to continue|0|||
33432231|NCT00319449|62809607|FG000|Overall Study|Noncompliance with the protocol|1|||
33432232|NCT00319449|62809608|FG001|Overall Study|Noncompliance with the protocol|0|||
33432233|NCT00308997|62809616|FG000|Overall Study|Subject feigned clinical data|0|||
33432234|NCT00308997|62809617|FG001|Overall Study|Subject feigned clinical data|1|||
33432235|NCT00308997|62809616|FG000|Overall Study|Unable to tolerate intervention|1|||
33432236|NCT00308997|62809617|FG001|Overall Study|Unable to tolerate intervention|0|||
33432237|NCT00308685|62809625|FG000|Overall Study|Lost to Follow-up|1|||
33432238|NCT00308685|62809626|FG001|Overall Study|Lost to Follow-up|0|||
33432239|NCT00308685|62809625|FG000|Overall Study|Need to administer prohibited medication|1|||
33432240|NCT00308685|62809626|FG001|Overall Study|Need to administer prohibited medication|2|||
33432241|NCT00308685|62809625|FG000|Overall Study|Other than specified|1|||
33432242|NCT00308685|62809626|FG001|Overall Study|Other than specified|3|||
33432243|NCT00317109|62809634|FG000|Overall Study|Withdrawal by Subject|2|||
33432244|NCT00317109|62809635|FG001|Overall Study|Withdrawal by Subject|0|||
33432245|NCT00317109|62809634|FG000|Overall Study|Migated/moved from study area|1|||
33432246|NCT00317109|62809635|FG001|Overall Study|Migated/moved from study area|0|||
33432247|NCT00316719|62809643|FG000|Overall Study|Adverse Event|0|||
33432248|NCT00316719|62809644|FG001|Overall Study|Adverse Event|6|||
33605440|NCT01648205|63005116|FG000|Placebo|Protocol Violation|2|||
33323094|NCT00925990|62699389|FG000|Overall Study|moved out of state, missed medication|0|||
33323095|NCT00925990|62699390|FG001|Overall Study|moved out of state, missed medication|2|||
33323096|NCT01131078|62699399|FG000|Overall Study|Adverse Event|22|||
33323097|NCT01131078|62699400|FG001|Overall Study|Adverse Event|12|||
33323098|NCT01131078|62699401|FG002|Overall Study|Adverse Event|17|||
33323099|NCT01131078|62699399|FG000|Overall Study|Progressive Disease|58|||
33605441|NCT01648205|63005116|FG000|Ranolazine|Death|1|||
33605442|NCT01648205|63005116|FG000|Ranolazine|Withdrawal by Subject|1|||
33605443|NCT01648205|63005116|FG000|Ranolazine|Protocol Violation|3|||
33605444|NCT02362451|63005126|FG000|Overall Study|Withdrawal by Subject|0|||
33605445|NCT02362451|63005127|FG001|Overall Study|Withdrawal by Subject|1|||
33605446|NCT02362451|63005126|FG000|Overall Study|Lack of Efficacy|2|||
33605447|NCT02362451|63005127|FG001|Overall Study|Lack of Efficacy|0|||
33605448|NCT02362451|63005126|FG000|Overall Study|Progression|1|||
33323100|NCT01131078|62699400|FG001|Overall Study|Progressive Disease|77|||
33323101|NCT01131078|62699401|FG002|Overall Study|Progressive Disease|71|||
33323102|NCT01131078|62699399|FG000|Overall Study|Protocol Violation|1|||
33323103|NCT01131078|62699400|FG001|Overall Study|Protocol Violation|0|||
33323104|NCT01131078|62699401|FG002|Overall Study|Protocol Violation|0|||
33323105|NCT01131078|62699399|FG000|Overall Study|Lost to Follow-up|1|||
33323106|NCT01131078|62699400|FG001|Overall Study|Lost to Follow-up|1|||
33323107|NCT01131078|62699401|FG002|Overall Study|Lost to Follow-up|1|||
33323108|NCT01131078|62699399|FG000|Overall Study|Withdrawal by Subject|2|||
33323109|NCT01131078|62699400|FG001|Overall Study|Withdrawal by Subject|4|||
33323110|NCT01131078|62699401|FG002|Overall Study|Withdrawal by Subject|3|||
33323111|NCT01131078|62699399|FG000|Overall Study|Non-compliance|3|||
33323112|NCT01131078|62699400|FG001|Overall Study|Non-compliance|0|||
33323113|NCT01131078|62699401|FG002|Overall Study|Non-compliance|0|||
33323114|NCT01131078|62699399|FG000|Overall Study|Physician Decision|10|||
33323115|NCT01131078|62699400|FG001|Overall Study|Physician Decision|6|||
33323116|NCT01131078|62699401|FG002|Overall Study|Physician Decision|8|||
33323117|NCT01131078|62699399|FG000|Overall Study|Death|4|||
33323118|NCT01131078|62699400|FG001|Overall Study|Death|0|||
33323119|NCT01131078|62699401|FG002|Overall Study|Death|2|||
33323120|NCT01131078|62699399|FG000|Overall Study|Other|0|||
33323121|NCT01131078|62699400|FG001|Overall Study|Other|1|||
33323122|NCT01131078|62699401|FG002|Overall Study|Other|0|||
33323123|NCT01167582|62699413|FG000|Overall Study|Lost to Follow-up|0|||
33323124|NCT01167582|62699414|FG001|Overall Study|Lost to Follow-up|1|||
33323125|NCT01167426|62699420|FG000|Overall Study|Lost to Follow-up|6|||
33323126|NCT01167426|62699420|FG000|Overall Study|Protocol Violation|1|||
33323127|NCT01167426|62699420|FG000|Overall Study|Withdrawal by Subject|2|||
33323128|NCT01167426|62699420|FG000|Overall Study|Sponsor Decision|1|||
33323129|NCT00922636|62699430|FG000|Overall Study|Adverse Event|3|||
33323130|NCT00922636|62699431|FG001|Overall Study|Adverse Event|3|||
33323131|NCT00922636|62699432|FG002|Overall Study|Adverse Event|2|||
33323132|NCT00922636|62699433|FG003|Overall Study|Adverse Event|3|||
33323133|NCT00922636|62699434|FG004|Overall Study|Adverse Event|2|||
33323134|NCT00922636|62699430|FG000|Overall Study|Lack of Efficacy|1|||
33323135|NCT00922636|62699431|FG001|Overall Study|Lack of Efficacy|7|||
33323136|NCT00922636|62699432|FG002|Overall Study|Lack of Efficacy|3|||
33323137|NCT00922636|62699433|FG003|Overall Study|Lack of Efficacy|2|||
33605449|NCT02362451|63005127|FG001|Overall Study|Progression|0|||
33432249|NCT00316719|62809643|FG000|Overall Study|Consent withdrawn|2|||
33432250|NCT00316719|62809644|FG001|Overall Study|Consent withdrawn|0|||
33432251|NCT00422058|62809656|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
33432252|NCT00422058|62809657|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
33432253|NCT00422058|62809658|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
33432254|NCT00422058|62809659|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
33432255|NCT00422058|62809660|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
33432256|NCT00422058|62809661|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
33432257|NCT00422058|62809656|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
33432258|NCT00422058|62809657|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
33432259|NCT00422058|62809658|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
33432260|NCT00422058|62809659|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
33432261|NCT00422058|62809660|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
33432262|NCT00422058|62809661|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
33432263|NCT00422058|62809656|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
33432264|NCT00422058|62809657|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
33432265|NCT00422058|62809658|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
33432266|NCT00422058|62809659|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
33432267|NCT00422058|62809660|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
33432268|NCT00422058|62809661|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
33432269|NCT00422058|62809656|FG000|Double-Blind, Week 0-20|Other|11|||
33432270|NCT00422058|62809657|FG001|Double-Blind, Week 0-20|Other|3|||
33432271|NCT00422058|62809658|FG002|Double-Blind, Week 0-20|Other|8|||
33432272|NCT00422058|62809659|FG003|Double-Blind, Week 0-20|Other|8|||
33432273|NCT00422058|62809660|FG004|Double-Blind, Week 0-20|Other|4|||
33432274|NCT00422058|62809661|FG005|Double-Blind, Week 0-20|Other|10|||
33432275|NCT00422058|62809656|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
33323138|NCT00922636|62699434|FG004|Overall Study|Lack of Efficacy|4|||
33323139|NCT00922636|62699430|FG000|Overall Study|Sponsor Decision|0|||
33323140|NCT00922636|62699431|FG001|Overall Study|Sponsor Decision|0|||
33323141|NCT00922636|62699432|FG002|Overall Study|Sponsor Decision|2|||
33323142|NCT00922636|62699433|FG003|Overall Study|Sponsor Decision|0|||
33323143|NCT00922636|62699434|FG004|Overall Study|Sponsor Decision|0|||
33323144|NCT00922636|62699430|FG000|Overall Study|Withdrawal by Subject|0|||
33323145|NCT00922636|62699431|FG001|Overall Study|Withdrawal by Subject|0|||
33323146|NCT00922636|62699432|FG002|Overall Study|Withdrawal by Subject|5|||
33323147|NCT00922636|62699433|FG003|Overall Study|Withdrawal by Subject|2|||
33323148|NCT00922636|62699434|FG004|Overall Study|Withdrawal by Subject|4|||
33323149|NCT00922636|62699430|FG000|Overall Study|Protocol Violation|0|||
33432276|NCT00422058|62809657|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
33432277|NCT00422058|62809658|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
33432278|NCT00422058|62809659|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
33432279|NCT00422058|62809660|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
33432280|NCT00422058|62809661|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
33432281|NCT00422058|62809656|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
33432282|NCT00422058|62809657|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
33432283|NCT00422058|62809658|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
33432284|NCT00422058|62809659|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
33432285|NCT00422058|62809660|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
33432286|NCT00422058|62809661|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
33432287|NCT00422058|62809656|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
33432288|NCT00422058|62809657|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
33432289|NCT00422058|62809658|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
33432290|NCT00422058|62809659|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
33432291|NCT00422058|62809660|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
33432292|NCT00422058|62809661|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
33432293|NCT00422058|62809656|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
33432294|NCT00422058|62809657|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
33432295|NCT00422058|62809658|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
33432296|NCT00422058|62809659|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
33432297|NCT00422058|62809660|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
33432298|NCT00422058|62809661|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
33432299|NCT00422058|62809656|FG000|Open-Label Extension, Week 20-104|Other|13|||
33432300|NCT00422058|62809657|FG001|Open-Label Extension, Week 20-104|Other|14|||
33432301|NCT00422058|62809658|FG002|Open-Label Extension, Week 20-104|Other|6|||
33432302|NCT00422058|62809659|FG003|Open-Label Extension, Week 20-104|Other|13|||
33432303|NCT00422058|62809660|FG004|Open-Label Extension, Week 20-104|Other|16|||
33432304|NCT00422058|62809661|FG005|Open-Label Extension, Week 20-104|Other|18|||
33432305|NCT00413244|62809685|FG000|Overall Study|Withdrawal by Subject|10|||
33432306|NCT00413244|62809686|FG001|Overall Study|Withdrawal by Subject|1|||
33432307|NCT00420420|62809714|FG000|Overall Study|Adverse Event|5|||
33432308|NCT00420420|62809715|FG001|Overall Study|Adverse Event|3|||
33432309|NCT00420420|62809714|FG000|Overall Study|Protocol Violation|1|||
33432310|NCT00420420|62809715|FG001|Overall Study|Protocol Violation|1|||
33432311|NCT00420420|62809714|FG000|Overall Study|Withdrawal by Subject|1|||
33432312|NCT00420420|62809715|FG001|Overall Study|Withdrawal by Subject|0|||
33432313|NCT00420420|62809714|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
33432314|NCT00420420|62809715|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
33432315|NCT00420342|62809724|FG000|Overall Study|Lost to Follow-up|1|||
33432316|NCT00420342|62809725|FG001|Overall Study|Lost to Follow-up|0|||
33432317|NCT00420342|62809726|FG002|Overall Study|Lost to Follow-up|1|||
33432318|NCT00420342|62809724|FG000|Overall Study|Withdrawal by Subject|0|||
33432319|NCT00420342|62809725|FG001|Overall Study|Withdrawal by Subject|2|||
33432320|NCT00420342|62809726|FG002|Overall Study|Withdrawal by Subject|0|||
33432321|NCT00432744|62809736|FG000|Months 0-6|Withdrawal by Subject|4|||
33432322|NCT00432744|62809737|FG001|Months 0-6|Withdrawal by Subject|4|||
33432323|NCT00432744|62809736|FG000|Months 0-6|Too disabled to score|1|||
33432324|NCT00432744|62809737|FG001|Months 0-6|Too disabled to score|0|||
33432325|NCT00432744|62809736|FG000|Months 7 - 12|Withdrawal by Subject|1|||
33432326|NCT00432744|62809737|FG001|Months 7 - 12|Withdrawal by Subject|0|||
33432327|NCT00432744|62809736|FG000|Months 7 - 12|Too disabled to score|0|||
33432328|NCT00432744|62809737|FG001|Months 7 - 12|Too disabled to score|1|||
33432329|NCT00432666|62809745|FG000|Main Period|Adverse Event|1|||
33432330|NCT00432666|62809746|FG001|Main Period|Adverse Event|1|||
33432331|NCT00432666|62809745|FG000|Main Period|Consent Withdrawn|1|||
33432332|NCT00432666|62809746|FG001|Main Period|Consent Withdrawn|0|||
33432333|NCT00432666|62809745|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
33432334|NCT00432666|62809746|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
33432335|NCT00432666|62809745|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
33432336|NCT00432666|62809746|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
33432337|NCT00432666|62809745|FG000|Open-Label Extension Period|Adverse Event|5|||
33432338|NCT00432666|62809746|FG001|Open-Label Extension Period|Adverse Event|0|||
33432339|NCT00432666|62809745|FG000|Open-Label Extension Period|Consent withdrawn|10|||
33432340|NCT00432666|62809746|FG001|Open-Label Extension Period|Consent withdrawn|0|||
33432341|NCT00432666|62809745|FG000|Open-Label Extension Period|Physician Decision|3|||
33432342|NCT00432666|62809746|FG001|Open-Label Extension Period|Physician Decision|0|||
33432343|NCT00451958|62809756|FG000|CS21A (NCT00451958)|Adverse Event|21|||
33605450|NCT02362451|63005126|FG000|Overall Study|Participant chose other therapy.|1|||
33432344|NCT00451958|62809757|FG001|CS21A (NCT00451958)|Adverse Event|34|||
33432345|NCT00451958|62809758|FG002|CS21A (NCT00451958)|Adverse Event|14|||
33432346|NCT00451958|62809759|FG003|CS21A (NCT00451958)|Adverse Event|17|||
33432347|NCT00451958|62809760|FG004|CS21A (NCT00451958)|Adverse Event|0|||
33432348|NCT00451958|62809756|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
33432349|NCT00451958|62809757|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
33432350|NCT00451958|62809758|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
33432351|NCT00451958|62809759|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
33432352|NCT00451958|62809760|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
33432353|NCT00451958|62809756|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
33432354|NCT00451958|62809757|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
33432355|NCT00451958|62809758|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
33432356|NCT00451958|62809759|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
33432357|NCT00451958|62809760|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
33432358|NCT00451958|62809756|FG000|CS21A (NCT00451958)|Physician Decision|2|||
33432359|NCT00451958|62809757|FG001|CS21A (NCT00451958)|Physician Decision|4|||
33432360|NCT00451958|62809758|FG002|CS21A (NCT00451958)|Physician Decision|4|||
33432361|NCT00451958|62809759|FG003|CS21A (NCT00451958)|Physician Decision|4|||
33432362|NCT00451958|62809760|FG004|CS21A (NCT00451958)|Physician Decision|0|||
33323150|NCT00922636|62699431|FG001|Overall Study|Protocol Violation|0|||
33432363|NCT00451958|62809756|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
33432364|NCT00451958|62809757|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
33432365|NCT00451958|62809758|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
33432366|NCT00451958|62809759|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
33432367|NCT00451958|62809760|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
33605451|NCT02362451|63005127|FG001|Overall Study|Participant chose other therapy.|0|||
33432368|NCT00451958|62809756|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
33432369|NCT00451958|62809757|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
33432370|NCT00451958|62809758|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
33432371|NCT00451958|62809759|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
33432372|NCT00451958|62809760|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
33432373|NCT00432276|62809776|FG000|Overall Study|Hyperglycemic Rescue|44|||
33432374|NCT00432276|62809777|FG001|Overall Study|Hyperglycemic Rescue|87|||
33432375|NCT00432276|62809776|FG000|Overall Study|Adverse Event|13|||
33432376|NCT00432276|62809777|FG001|Overall Study|Adverse Event|16|||
33432377|NCT00432276|62809776|FG000|Overall Study|Protocol Violation|25|||
33432378|NCT00432276|62809777|FG001|Overall Study|Protocol Violation|20|||
33432379|NCT00432276|62809776|FG000|Overall Study|Lost to Follow-up|6|||
33432380|NCT00432276|62809777|FG001|Overall Study|Lost to Follow-up|2|||
33432381|NCT00432276|62809776|FG000|Overall Study|Withdrawal by Subject|25|||
33432382|NCT00432276|62809777|FG001|Overall Study|Withdrawal by Subject|20|||
33432383|NCT00432276|62809776|FG000|Overall Study|Physician Decision|6|||
33432384|NCT00432276|62809777|FG001|Overall Study|Physician Decision|8|||
33432385|NCT00432276|62809776|FG000|Overall Study|Other|2|||
33432386|NCT00432276|62809777|FG001|Overall Study|Other|3|||
33432387|NCT00413010|62809785|FG000|Overall Study|Adverse Event|8|||
33432388|NCT00413010|62809786|FG001|Overall Study|Adverse Event|4|||
33432389|NCT00413010|62809785|FG000|Overall Study|Laboratory abnormality|0|||
33432390|NCT00413010|62809786|FG001|Overall Study|Laboratory abnormality|2|||
33432391|NCT00413010|62809785|FG000|Overall Study|Lack of Efficacy|0|||
33432392|NCT00413010|62809786|FG001|Overall Study|Lack of Efficacy|3|||
33432393|NCT00413010|62809785|FG000|Overall Study|Lost to Follow-up|3|||
33432394|NCT00413010|62809786|FG001|Overall Study|Lost to Follow-up|0|||
33432395|NCT00413010|62809785|FG000|Overall Study|Withdrawal by Subject|7|||
33432396|NCT00413010|62809786|FG001|Overall Study|Withdrawal by Subject|2|||
33432397|NCT00413010|62809785|FG000|Overall Study|Due to termination of the study|54|||
33432398|NCT00413010|62809786|FG001|Overall Study|Due to termination of the study|52|||
33432399|NCT00459290|62809792|FG000|Overall Study|Adverse Event|3|||
33432400|NCT00459290|62809792|FG000|Overall Study|Ineligible|2|||
33432401|NCT00443534|62809803|FG000|Overall Study|Lack of Efficacy|67|||
33432402|NCT00443534|62809803|FG000|Overall Study|Adverse Event|16|||
33432403|NCT00443534|62809803|FG000|Overall Study|Death|9|||
33432404|NCT00443534|62809803|FG000|Overall Study|Withdrawal by Subject|8|||
33432405|NCT00443534|62809803|FG000|Overall Study|Study Terminated by Sponsor|12|||
33432406|NCT00443534|62809803|FG000|Overall Study|Other|10|||
33432407|NCT00443534|62809803|FG000|Overall Study|Enrolled, Not Treated|1|||
33432408|NCT00419952|62809809|FG000|Overall Study|Adverse Event|8|||
33432409|NCT00419952|62809810|FG001|Overall Study|Adverse Event|10|||
33432410|NCT00419952|62809809|FG000|Overall Study|Withdrawal by Subject|44|||
33432411|NCT00419952|62809810|FG001|Overall Study|Withdrawal by Subject|43|||
33432412|NCT00419952|62809809|FG000|Overall Study|Lost to Follow-up|43|||
33432413|NCT00419952|62809810|FG001|Overall Study|Lost to Follow-up|34|||
33432414|NCT00419952|62809809|FG000|Overall Study|Protocol Violation|32|||
33432415|NCT00419952|62809810|FG001|Overall Study|Protocol Violation|24|||
33432416|NCT00419952|62809809|FG000|Overall Study|Pregnancy|4|||
33432417|NCT00419952|62809810|FG001|Overall Study|Pregnancy|2|||
33432418|NCT00419952|62809809|FG000|Overall Study|Physician Decision|1|||
33432419|NCT00419952|62809810|FG001|Overall Study|Physician Decision|3|||
33432420|NCT00419952|62809809|FG000|Overall Study|Incorrectly enrolled|10|||
33432421|NCT00419952|62809810|FG001|Overall Study|Incorrectly enrolled|3|||
33432422|NCT00419952|62809809|FG000|Overall Study|Intake of prohibited medication|2|||
33432423|NCT00419952|62809810|FG001|Overall Study|Intake of prohibited medication|2|||
33432424|NCT00419952|62809809|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
33432425|NCT00419952|62809810|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
33432426|NCT00419952|62809809|FG000|Overall Study|Diary or medication non-compliance|2|||
33432427|NCT00419952|62809810|FG001|Overall Study|Diary or medication non-compliance|4|||
33432428|NCT00419952|62809809|FG000|Overall Study|Abnormal ECG|1|||
33432429|NCT00419952|62809810|FG001|Overall Study|Abnormal ECG|0|||
33432430|NCT00443456|62809816|FG000|Overall Study|Adverse Event|16|||
33432431|NCT00443456|62809816|FG000|Overall Study|Move|1|||
33432432|NCT00443456|62809816|FG000|Overall Study|Withdrawal by Subject|1|||
33432433|NCT00419562|62809826|FG000|Overall Study|Lost to Follow-up|12|||
33432434|NCT00419562|62809827|FG001|Overall Study|Lost to Follow-up|13|||
33432435|NCT00419562|62809826|FG000|Overall Study|Withdrawal by Subject|20|||
33432436|NCT00419562|62809827|FG001|Overall Study|Withdrawal by Subject|18|||
33432437|NCT00419562|62809826|FG000|Overall Study|Participant Institutionalized|1|||
33432438|NCT00419562|62809827|FG001|Overall Study|Participant Institutionalized|0|||
33432439|NCT00432042|62809836|FG000|Overall Study|Protocol Violation|2|||
33432440|NCT00432042|62809837|FG001|Overall Study|Protocol Violation|0|||
33432441|NCT00432042|62809838|FG002|Overall Study|Protocol Violation|0|||
33432442|NCT00432042|62809836|FG000|Overall Study|Withdrawal by Subject|0|||
33432443|NCT00432042|62809837|FG001|Overall Study|Withdrawal by Subject|0|||
33432444|NCT00432042|62809838|FG002|Overall Study|Withdrawal by Subject|2|||
33432445|NCT00432042|62809836|FG000|Overall Study|Lost to Follow-up|5|||
33432446|NCT00432042|62809837|FG001|Overall Study|Lost to Follow-up|1|||
33432447|NCT00432042|62809838|FG002|Overall Study|Lost to Follow-up|0|||
33432448|NCT00308139|62809848|FG000|Overall Study|Adverse Event|20|||
33432449|NCT00308139|62809849|FG001|Overall Study|Adverse Event|14|||
33432450|NCT00308139|62809848|FG000|Overall Study|Lost to Follow-up|13|||
33432451|NCT00308139|62809849|FG001|Overall Study|Lost to Follow-up|8|||
33432452|NCT00308139|62809848|FG000|Overall Study|Protocol Violation|3|||
33432453|NCT00308139|62809849|FG001|Overall Study|Protocol Violation|2|||
33432454|NCT00308139|62809848|FG000|Overall Study|Withdrawal of Consent|40|||
33432455|NCT00308139|62809849|FG001|Overall Study|Withdrawal of Consent|42|||
33432456|NCT00308139|62809848|FG000|Overall Study|Investigator Decision|11|||
33432457|NCT00308139|62809849|FG001|Overall Study|Investigator Decision|10|||
33432458|NCT00308139|62809848|FG000|Overall Study|Loss of Glucose Control|5|||
33432459|NCT00308139|62809849|FG001|Overall Study|Loss of Glucose Control|7|||
33432460|NCT00308139|62809848|FG000|Overall Study|Administrative|1|||
33432461|NCT00308139|62809849|FG001|Overall Study|Administrative|4|||
33432462|NCT00308139|62809848|FG000|Overall Study|Other|1|||
33432463|NCT00308139|62809849|FG001|Overall Study|Other|0|||
33432464|NCT00459134|62809877|FG000|Overall Study|Physician Decision|1|||
33432465|NCT00459134|62809878|FG001|Overall Study|Physician Decision|1|||
33432466|NCT00459134|62809877|FG000|Overall Study|Withdrawal by Subject|8|||
33432467|NCT00459134|62809878|FG001|Overall Study|Withdrawal by Subject|7|||
33432468|NCT00459134|62809877|FG000|Overall Study|Lost to Follow-up|6|||
33432469|NCT00459134|62809878|FG001|Overall Study|Lost to Follow-up|7|||
33432470|NCT00459134|62809877|FG000|Overall Study|Surgery|1|||
33432471|NCT00459134|62809878|FG001|Overall Study|Surgery|2|||
33432472|NCT00459134|62809877|FG000|Overall Study|Toxicity|4|||
33432473|NCT00459134|62809878|FG001|Overall Study|Toxicity|5|||
33432474|NCT00459134|62809877|FG000|Overall Study|Progression|1|||
33432475|NCT00459134|62809878|FG001|Overall Study|Progression|0|||
33432476|NCT00459134|62809877|FG000|Overall Study|Multiple Reasons|2|||
33432477|NCT00459134|62809878|FG001|Overall Study|Multiple Reasons|3|||
33432478|NCT00459056|62809886|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
33432479|NCT00459056|62809887|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
33432480|NCT00431964|62809895|FG000|Overall Study|Adverse Event|1|||
33432481|NCT00431964|62809896|FG001|Overall Study|Adverse Event|0|||
33432482|NCT00431964|62809895|FG000|Overall Study|Lost to Follow-up|1|||
33432483|NCT00431964|62809896|FG001|Overall Study|Lost to Follow-up|2|||
33432484|NCT00431964|62809895|FG000|Overall Study|Physician Decision|2|||
33432485|NCT00431964|62809896|FG001|Overall Study|Physician Decision|2|||
33432486|NCT00431964|62809895|FG000|Overall Study|Withdrawal by Subject|2|||
33432487|NCT00431964|62809896|FG001|Overall Study|Withdrawal by Subject|1|||
33432488|NCT00431964|62809895|FG000|Overall Study|Parental Consent Withdrawn|0|||
33432489|NCT00431964|62809896|FG001|Overall Study|Parental Consent Withdrawn|2|||
33432490|NCT00431964|62809895|FG000|Overall Study|Due to Unstable Health|0|||
33432491|NCT00431964|62809896|FG001|Overall Study|Due to Unstable Health|1|||
33432492|NCT00412854|62809904|FG000|Overall Study|Withdrawn due to adverse events|1|||
33432493|NCT00412854|62809905|FG001|Overall Study|Withdrawn due to adverse events|5|||
33605452|NCT01734382|63005136|FG000|Part 1|Adverse Event|2|||
33605453|NCT01734382|63005137|FG001|Part 1|Adverse Event|0|||
33432494|NCT00412854|62809904|FG000|Overall Study|Withdrawn for other reasons|13|||
33432495|NCT00412854|62809905|FG001|Overall Study|Withdrawn for other reasons|11|||
33432496|NCT00431496|62809911|FG000|Overall Study|Adverse Event|3|||
33432497|NCT00431496|62809911|FG000|Overall Study|Lost to Follow-up|1|||
33432498|NCT00431496|62809911|FG000|Overall Study|Withdrawal by Subject|2|||
33432499|NCT00431496|62809911|FG000|Overall Study|Protocol-specified criteria|5|||
33605454|NCT01734382|63005138|FG002|Part 1|Adverse Event|0|||
33605455|NCT01734382|63005136|FG000|Part 2|Adverse Event|0|||
33432500|NCT00316173|62809917|FG000|Run-in Phase|Adverse Event|1|||
33432501|NCT00316173|62809918|FG001|Run-in Phase|Adverse Event|0|||
33432502|NCT00316173|62809917|FG000|Run-in Phase|Protocol Violation|1|||
33605456|NCT01734382|63005137|FG001|Part 2|Adverse Event|0|||
33432503|NCT00316173|62809918|FG001|Run-in Phase|Protocol Violation|0|||
33432504|NCT00316173|62809917|FG000|Run-in Phase|Study Follow-up Stopped|5|||
33432505|NCT00316173|62809918|FG001|Run-in Phase|Study Follow-up Stopped|0|||
33432506|NCT00316173|62809917|FG000|Treatment Phase|Adverse Event|0|||
33605457|NCT01734382|63005138|FG002|Part 2|Adverse Event|1|||
33605458|NCT01734382|63005136|FG000|Part 2|Lack of Efficacy|0|||
33432507|NCT00316173|62809918|FG001|Treatment Phase|Adverse Event|1|||
33432508|NCT00316173|62809917|FG000|Treatment Phase|Lack of Efficacy|0|||
33432509|NCT00316173|62809918|FG001|Treatment Phase|Lack of Efficacy|3|||
33432510|NCT00316173|62809917|FG000|Treatment Phase|Lost to Follow-up|0|||
33432511|NCT00316173|62809918|FG001|Treatment Phase|Lost to Follow-up|3|||
33432512|NCT00316173|62809917|FG000|Treatment Phase|Withdrawal by Subject|0|||
33432513|NCT00316173|62809918|FG001|Treatment Phase|Withdrawal by Subject|1|||
33432514|NCT00316173|62809917|FG000|Treatment Phase|Study Follow-up Stopped|0|||
33432515|NCT00316173|62809918|FG001|Treatment Phase|Study Follow-up Stopped|34|||
33432516|NCT00412542|62809925|FG000|Overall Study|Withdrawal by Subject|0|||
33432517|NCT00412542|62809926|FG001|Overall Study|Withdrawal by Subject|2|||
33432518|NCT00412542|62809925|FG000|Overall Study|Not Eligible|0|||
33432519|NCT00412542|62809926|FG001|Overall Study|Not Eligible|1|||
33432520|NCT00316017|62809933|FG000|Overall Study|Protocol Violation|11|||
33432521|NCT00316017|62809934|FG001|Overall Study|Protocol Violation|13|||
33432522|NCT00316017|62809935|FG002|Overall Study|Protocol Violation|19|||
33432523|NCT00451178|62809945|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
33432524|NCT00451178|62809946|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
33432525|NCT00451178|62809945|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
33432526|NCT00451178|62809946|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
33432527|NCT00451178|62809945|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
33432528|NCT00451178|62809946|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
33432529|NCT00451178|62809945|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
33432530|NCT00451178|62809946|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
33432531|NCT00451178|62809945|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
33432532|NCT00451178|62809946|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
33432533|NCT00451178|62809945|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
33432534|NCT00451178|62809946|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
33432535|NCT00451178|62809945|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
33432536|NCT00451178|62809946|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
33432537|NCT00451178|62809945|FG000|Prior to Maintenance Therapy|PD|2|||
33432538|NCT00451178|62809946|FG001|Prior to Maintenance Therapy|PD|0|||
33432539|NCT00451178|62809945|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
33432540|NCT00451178|62809946|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
33432541|NCT00451178|62809945|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
33432542|NCT00451178|62809946|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
33432543|NCT00451178|62809945|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
33432544|NCT00451178|62809946|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
33432545|NCT00451178|62809945|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
33432546|NCT00451178|62809946|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
33432547|NCT00451178|62809945|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
33432548|NCT00451178|62809946|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
33432549|NCT00451178|62809945|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
33432550|NCT00451178|62809946|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
33432551|NCT00451178|62809945|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
33432552|NCT00451178|62809946|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
33432553|NCT00450866|62809956|FG000|Overall Study|Adverse Event|0|||
33432554|NCT00450866|62809957|FG001|Overall Study|Adverse Event|1|||
33432555|NCT00450866|62809956|FG000|Overall Study|Withdrawal by Subject|5|||
33432556|NCT00450866|62809957|FG001|Overall Study|Withdrawal by Subject|2|||
33432557|NCT00450866|62809956|FG000|Overall Study|Death|1|||
33605459|NCT01734382|63005137|FG001|Part 2|Lack of Efficacy|1|||
33432558|NCT00450866|62809957|FG001|Overall Study|Death|0|||
33432559|NCT00450866|62809956|FG000|Overall Study|Physician Decision|1|||
33432560|NCT00450866|62809957|FG001|Overall Study|Physician Decision|0|||
33432561|NCT00442598|62809966|FG000|Overall Study|Adverse Event|1|||
33432562|NCT00442598|62809967|FG001|Overall Study|Adverse Event|0|||
33432563|NCT00442598|62809968|FG002|Overall Study|Adverse Event|0|||
33432564|NCT00442598|62809966|FG000|Overall Study|Tumor progression|3|||
33432565|NCT00442598|62809967|FG001|Overall Study|Tumor progression|4|||
33432566|NCT00442598|62809968|FG002|Overall Study|Tumor progression|0|||
33432567|NCT00442598|62809966|FG000|Overall Study|Clinical deterioration|1|||
33432568|NCT00442598|62809967|FG001|Overall Study|Clinical deterioration|2|||
33432569|NCT00442598|62809968|FG002|Overall Study|Clinical deterioration|0|||
33432570|NCT00442598|62809966|FG000|Overall Study|CA125 progression|0|||
33432571|NCT00442598|62809967|FG001|Overall Study|CA125 progression|1|||
33432572|NCT00442598|62809968|FG002|Overall Study|CA125 progression|0|||
33432573|NCT00442598|62809966|FG000|Overall Study|Reduced creatinine clearance|1|||
33432574|NCT00442598|62809967|FG001|Overall Study|Reduced creatinine clearance|0|||
33432575|NCT00442598|62809968|FG002|Overall Study|Reduced creatinine clearance|0|||
33432576|NCT00442598|62809966|FG000|Overall Study|Death|0|||
33432577|NCT00442598|62809967|FG001|Overall Study|Death|1|||
33432578|NCT00442598|62809968|FG002|Overall Study|Death|0|||
33432579|NCT00442286|62809978|FG000|Overall Study|Death|2|||
33432580|NCT00442286|62809979|FG001|Overall Study|Death|2|||
33432581|NCT00442286|62809978|FG000|Overall Study|Lost to Follow-up|1|||
33432582|NCT00442286|62809979|FG001|Overall Study|Lost to Follow-up|0|||
33432583|NCT00442286|62809978|FG000|Overall Study|Withdrawal by Subject|2|||
33432584|NCT00442286|62809979|FG001|Overall Study|Withdrawal by Subject|0|||
33432585|NCT00442286|62809978|FG000|Overall Study|System explanted|1|||
33432586|NCT00442286|62809979|FG001|Overall Study|System explanted|0|||
33432587|NCT00442286|62809978|FG000|Overall Study|Patient Injury|1|||
33432588|NCT00442286|62809979|FG001|Overall Study|Patient Injury|0|||
33432589|NCT00441974|62809987|FG000|Overall Study|Adverse Event|6|||
33432590|NCT00441974|62809987|FG000|Overall Study|Consent Withdrawn|35|||
33432591|NCT00441974|62809987|FG000|Overall Study|Lost to Follow-up|80|||
33432592|NCT00441974|62809987|FG000|Overall Study|Protocol Violation|7|||
33432593|NCT00441584|62809994|FG000|Overall Study|Lack of Efficacy|79|||
33432594|NCT00441584|62809994|FG000|Overall Study|Withdrawal by Subject|8|||
33432595|NCT00441584|62809994|FG000|Overall Study|Adverse Event|6|||
33432596|NCT00441584|62809994|FG000|Overall Study|Protocol Violation|5|||
33432597|NCT00441584|62809994|FG000|Overall Study|Lost to Follow-up|4|||
33432598|NCT00441584|62809994|FG000|Overall Study|Failure to meet eligibility criteria|3|||
33432599|NCT00430716|62810001|FG000|Double Blind Phase|Death|1|||
33432600|NCT00430716|62810002|FG001|Double Blind Phase|Death|0|||
33432601|NCT00430716|62810003|FG002|Double Blind Phase|Death|0|||
33432602|NCT00430716|62810001|FG000|Double Blind Phase|No longer willing to participate|2|||
33432603|NCT00430716|62810002|FG001|Double Blind Phase|No longer willing to participate|1|||
33432604|NCT00430716|62810003|FG002|Double Blind Phase|No longer willing to participate|1|||
33432605|NCT00430716|62810001|FG000|Double Blind Phase|Other|0|||
33432606|NCT00430716|62810002|FG001|Double Blind Phase|Other|2|||
33432607|NCT00430716|62810003|FG002|Double Blind Phase|Other|0|||
33432608|NCT00430716|62810001|FG000|Double Blind Phase|Study terminated by sponsor|1|||
33432609|NCT00430716|62810002|FG001|Double Blind Phase|Study terminated by sponsor|1|||
33432610|NCT00430716|62810003|FG002|Double Blind Phase|Study terminated by sponsor|2|||
33432611|NCT00430716|62810001|FG000|Double Blind Phase|Adverse Event|1|||
33432612|NCT00430716|62810002|FG001|Double Blind Phase|Adverse Event|1|||
33432613|NCT00430716|62810003|FG002|Double Blind Phase|Adverse Event|3|||
33432614|NCT00430716|62810001|FG000|Double Blind Phase|Not treated|1|||
33432615|NCT00430716|62810002|FG001|Double Blind Phase|Not treated|0|||
33432616|NCT00430716|62810003|FG002|Double Blind Phase|Not treated|0|||
33432617|NCT00430716|62810001|FG000|Open Label Phase|Lost to Follow-up|1|||
33432618|NCT00430716|62810002|FG001|Open Label Phase|Lost to Follow-up|0|||
33432619|NCT00430716|62810003|FG002|Open Label Phase|Lost to Follow-up|1|||
33432620|NCT00430716|62810001|FG000|Open Label Phase|No longer willing to participate|0|||
33432621|NCT00430716|62810002|FG001|Open Label Phase|No longer willing to participate|1|||
33432622|NCT00430716|62810003|FG002|Open Label Phase|No longer willing to participate|1|||
33432623|NCT00430716|62810001|FG000|Open Label Phase|Other|3|||
33432624|NCT00430716|62810002|FG001|Open Label Phase|Other|1|||
33432625|NCT00430716|62810003|FG002|Open Label Phase|Other|1|||
33432626|NCT00430716|62810001|FG000|Open Label Phase|Protocol Violation|1|||
33432627|NCT00430716|62810002|FG001|Open Label Phase|Protocol Violation|0|||
33432628|NCT00430716|62810003|FG002|Open Label Phase|Protocol Violation|0|||
33432629|NCT00430716|62810001|FG000|Open Label Phase|Study terminated by sponsor|4|||
33432630|NCT00430716|62810002|FG001|Open Label Phase|Study terminated by sponsor|5|||
33432631|NCT00430716|62810003|FG002|Open Label Phase|Study terminated by sponsor|4|||
33432632|NCT00441272|62810013|FG000|Overall Study|Study terminated prior to enrollment|25|||
33432633|NCT00441272|62810014|FG001|Overall Study|Study terminated prior to enrollment|25|||
33432634|NCT00430638|62810022|FG000|Overall Study|Adverse Event|15|||
33432635|NCT00430638|62810023|FG001|Overall Study|Adverse Event|15|||
33432636|NCT00430638|62810022|FG000|Overall Study|Uncontrolled blood pressure|48|||
33432637|NCT00430638|62810023|FG001|Overall Study|Uncontrolled blood pressure|13|||
33432638|NCT00430638|62810022|FG000|Overall Study|Lost to Follow-up|1|||
33432639|NCT00430638|62810023|FG001|Overall Study|Lost to Follow-up|7|||
33432640|NCT00430638|62810022|FG000|Overall Study|Protocol Violation|6|||
33432641|NCT00430638|62810023|FG001|Overall Study|Protocol Violation|4|||
33432642|NCT00430638|62810022|FG000|Overall Study|Withdrawal by Subject|4|||
33432643|NCT00430638|62810023|FG001|Overall Study|Withdrawal by Subject|6|||
33432644|NCT00430638|62810022|FG000|Overall Study|Non-compliant|2|||
33432645|NCT00430638|62810023|FG001|Overall Study|Non-compliant|1|||
33432646|NCT00430638|62810022|FG000|Overall Study|Other|2|||
33432647|NCT00430638|62810023|FG001|Overall Study|Other|2|||
33432648|NCT00430482|62810035|FG000|Completed Treatment|Insufficient Treatment|7|||
33432649|NCT00430482|62810036|FG001|Completed Treatment|Insufficient Treatment|11|||
33432650|NCT00449930|62810044|FG000|Overall Study|Adverse Event|9|||
33432651|NCT00449930|62810045|FG001|Overall Study|Adverse Event|19|||
33432652|NCT00449930|62810044|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
33432653|NCT00449930|62810045|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
33432654|NCT00449930|62810044|FG000|Overall Study|Lack of Efficacy|10|||
33432655|NCT00449930|62810045|FG001|Overall Study|Lack of Efficacy|1|||
33432656|NCT00449930|62810044|FG000|Overall Study|Lost to Follow-up|9|||
33432657|NCT00449930|62810045|FG001|Overall Study|Lost to Follow-up|14|||
33432658|NCT00449930|62810044|FG000|Overall Study|Physician Decision|1|||
33432659|NCT00449930|62810045|FG001|Overall Study|Physician Decision|2|||
33432660|NCT00449930|62810044|FG000|Overall Study|Protocol Violation|14|||
33432661|NCT00449930|62810045|FG001|Overall Study|Protocol Violation|15|||
33432662|NCT00449930|62810044|FG000|Overall Study|Withdrawal by Subject|16|||
33432663|NCT00449930|62810045|FG001|Overall Study|Withdrawal by Subject|23|||
33432664|NCT00449930|62810044|FG000|Overall Study|Glycemic discontinuation criteria|1|||
33432665|NCT00449930|62810045|FG001|Overall Study|Glycemic discontinuation criteria|1|||
33432666|NCT00449696|62810053|FG000|Overall Study|Other Treatment Required|6|||
33432667|NCT00449696|62810054|FG001|Overall Study|Other Treatment Required|1|||
33432668|NCT00449696|62810053|FG000|Overall Study|Withdrawal by Subject|5|||
33432669|NCT00449696|62810054|FG001|Overall Study|Withdrawal by Subject|5|||
33432670|NCT00449696|62810053|FG000|Overall Study|Lost to Follow-up|2|||
33432671|NCT00449696|62810054|FG001|Overall Study|Lost to Follow-up|3|||
33432672|NCT00449696|62810053|FG000|Overall Study|Others|7|||
33432673|NCT00449696|62810054|FG001|Overall Study|Others|0|||
33432674|NCT00441116|62810062|FG000|Overall Study|Adverse Event|1|||
33432675|NCT00441116|62810063|FG001|Overall Study|Adverse Event|1|||
33432676|NCT00441116|62810062|FG000|Overall Study|Withdrawal by Subject|1|||
33432677|NCT00441116|62810063|FG001|Overall Study|Withdrawal by Subject|0|||
33432678|NCT00441116|62810062|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
33432679|NCT00441116|62810063|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
33432680|NCT00430248|62810072|FG000|Overall Study|Adverse Event|49|||
33432681|NCT00430248|62810073|FG001|Overall Study|Adverse Event|61|||
33432682|NCT00430248|62810074|FG002|Overall Study|Adverse Event|64|||
33432683|NCT00430248|62810072|FG000|Overall Study|Protocol Violation|10|||
33432684|NCT00430248|62810073|FG001|Overall Study|Protocol Violation|2|||
33432685|NCT00430248|62810074|FG002|Overall Study|Protocol Violation|4|||
33432686|NCT00430248|62810072|FG000|Overall Study|Personal Reasons|12|||
33432687|NCT00430248|62810073|FG001|Overall Study|Personal Reasons|24|||
33432688|NCT00430248|62810074|FG002|Overall Study|Personal Reasons|9|||
33432689|NCT00430248|62810072|FG000|Overall Study|Lost to Follow-up|28|||
33432690|NCT00430248|62810073|FG001|Overall Study|Lost to Follow-up|33|||
33432691|NCT00430248|62810074|FG002|Overall Study|Lost to Follow-up|28|||
33432692|NCT00430248|62810072|FG000|Overall Study|Therapeutic Failure|1|||
33432693|NCT00430248|62810073|FG001|Overall Study|Therapeutic Failure|1|||
33432694|NCT00430248|62810074|FG002|Overall Study|Therapeutic Failure|1|||
33432695|NCT00430248|62810072|FG000|Overall Study|Withdrawal by Subject|14|||
33432696|NCT00430248|62810073|FG001|Overall Study|Withdrawal by Subject|20|||
33432697|NCT00430248|62810074|FG002|Overall Study|Withdrawal by Subject|16|||
33432698|NCT00430248|62810072|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33432699|NCT00430248|62810073|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
33432700|NCT00430248|62810074|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33432701|NCT00430248|62810072|FG000|Overall Study|Gout Flare|3|||
33605460|NCT01734382|63005138|FG002|Part 2|Lack of Efficacy|1|||
33605461|NCT01734382|63005136|FG000|Part 2|Other|0|||
33605462|NCT01734382|63005137|FG001|Part 2|Other|0|||
33432702|NCT00430248|62810073|FG001|Overall Study|Gout Flare|7|||
33432703|NCT00430248|62810074|FG002|Overall Study|Gout Flare|2|||
33432704|NCT00430248|62810072|FG000|Overall Study|Reason Not Specified|8|||
33432705|NCT00430248|62810073|FG001|Overall Study|Reason Not Specified|8|||
33432706|NCT00430248|62810074|FG002|Overall Study|Reason Not Specified|11|||
33432707|NCT00449540|62810084|FG000|Pretreatment Phase|No migraine experienced|66|||
33432708|NCT00449540|62810085|FG001|Pretreatment Phase|No migraine experienced|0|||
33432709|NCT00449540|62810086|FG002|Pretreatment Phase|No migraine experienced|0|||
33432710|NCT00449540|62810084|FG000|Treatment Phase|did not experience or treat migraine|0|||
33432711|NCT00449540|62810085|FG001|Treatment Phase|did not experience or treat migraine|20|||
33432712|NCT00449540|62810086|FG002|Treatment Phase|did not experience or treat migraine|17|||
33432713|NCT00411762|62810094|FG000|Overall Study|Withdrawal by Subject|5|||
33494180|NCT03634033|62872940|FG006|Overall Study|Death|7|||
33605463|NCT01734382|63005138|FG002|Part 2|Other|1|||
33432714|NCT00429858|62810098|FG000|Overall Study|Withdrawal by Subject|1|||
33432715|NCT00429858|62810098|FG000|Overall Study|Study Termination|1|||
33432716|NCT00449150|62810106|FG000|Overall Study|Adverse Event|11|||
33432717|NCT00449150|62810107|FG001|Overall Study|Adverse Event|18|||
33432718|NCT00449150|62810108|FG002|Overall Study|Adverse Event|9|||
33432719|NCT00449150|62810106|FG000|Overall Study|Lack of Efficacy|1|||
33432720|NCT00449150|62810107|FG001|Overall Study|Lack of Efficacy|2|||
33432721|NCT00449150|62810108|FG002|Overall Study|Lack of Efficacy|2|||
33432722|NCT00449150|62810106|FG000|Overall Study|Other|16|||
33432723|NCT00449150|62810107|FG001|Overall Study|Other|13|||
33432724|NCT00449150|62810108|FG002|Overall Study|Other|14|||
33432725|NCT00449150|62810106|FG000|Overall Study|Withdrawal by Subject|17|||
33432726|NCT00449150|62810107|FG001|Overall Study|Withdrawal by Subject|18|||
33432727|NCT00449150|62810108|FG002|Overall Study|Withdrawal by Subject|21|||
33432728|NCT00449150|62810106|FG000|Overall Study|Protocol Violation|1|||
33432729|NCT00449150|62810107|FG001|Overall Study|Protocol Violation|2|||
33432730|NCT00449150|62810108|FG002|Overall Study|Protocol Violation|1|||
33432731|NCT00428844|62810122|FG000|Completed Study Drug Treatment|Adverse Event|2|||
33432732|NCT00428844|62810123|FG001|Completed Study Drug Treatment|Adverse Event|4|||
33432733|NCT00428844|62810124|FG002|Completed Study Drug Treatment|Adverse Event|4|||
33432734|NCT00428844|62810122|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
33432735|NCT00428844|62810123|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
33432736|NCT00428844|62810124|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
33432737|NCT00428844|62810122|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
33432738|NCT00428844|62810123|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
33432739|NCT00428844|62810124|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
33432740|NCT00428844|62810122|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
33432741|NCT00428844|62810123|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
33432742|NCT00428844|62810124|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
33432743|NCT00428844|62810122|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
33432744|NCT00428844|62810123|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
33432745|NCT00428844|62810124|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
33432746|NCT00428844|62810122|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
33432747|NCT00428844|62810123|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
33432748|NCT00428844|62810124|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
33432749|NCT00428844|62810122|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
33432750|NCT00428844|62810123|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
33432751|NCT00428844|62810124|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
33432752|NCT00428844|62810122|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
33432753|NCT00428844|62810123|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
33432754|NCT00428844|62810124|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
33432755|NCT00428844|62810122|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
33432756|NCT00428844|62810123|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
33432757|NCT00428844|62810124|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
33432758|NCT00457418|62810132|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
33432759|NCT00457418|62810132|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
33432760|NCT00457418|62810132|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
33432761|NCT00457418|62810132|FG000|Post PK Maintenance|Adverse Event|10|||
33432762|NCT00457418|62810132|FG000|Post PK Maintenance|Progression of Disease|6|||
33432763|NCT00457418|62810132|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
33432764|NCT00457418|62810132|FG000|Post PK Maintenance|Lost to Follow-up|1|||
33432765|NCT00449072|62810138|FG000|Overall Study|Adverse Event|3|||
33432766|NCT00449072|62810139|FG001|Overall Study|Adverse Event|1|||
33432767|NCT00449072|62810138|FG000|Overall Study|Protocol Violation|14|||
33432768|NCT00449072|62810139|FG001|Overall Study|Protocol Violation|12|||
33432769|NCT00449072|62810138|FG000|Overall Study|Lost to Follow-up|5|||
33432770|NCT00449072|62810139|FG001|Overall Study|Lost to Follow-up|7|||
33432771|NCT00449072|62810138|FG000|Overall Study|Withdrawal by Subject|11|||
33432772|NCT00449072|62810139|FG001|Overall Study|Withdrawal by Subject|8|||
33432773|NCT00449072|62810138|FG000|Overall Study|Lack of Efficacy|1|||
33432774|NCT00449072|62810139|FG001|Overall Study|Lack of Efficacy|1|||
33432775|NCT00449072|62810138|FG000|Overall Study|Physician Decision|1|||
33432776|NCT00449072|62810139|FG001|Overall Study|Physician Decision|0|||
33432777|NCT00449072|62810138|FG000|Overall Study|Not treated|0|||
33432778|NCT00449072|62810139|FG001|Overall Study|Not treated|1|||
33432779|NCT00449072|62810138|FG000|Overall Study|Excluded medication|0|||
33432780|NCT00449072|62810139|FG001|Overall Study|Excluded medication|2|||
33432781|NCT00449072|62810138|FG000|Overall Study|Non-compliance|2|||
33432782|NCT00449072|62810139|FG001|Overall Study|Non-compliance|5|||
33432783|NCT00449072|62810138|FG000|Overall Study|Sponsor decision|1|||
33432784|NCT00449072|62810139|FG001|Overall Study|Sponsor decision|3|||
33432785|NCT00449072|62810138|FG000|Overall Study|Relocation|3|||
33432786|NCT00449072|62810139|FG001|Overall Study|Relocation|2|||
33432787|NCT00428610|62810148|FG000|Overall Study|Death Due to Adverse Event|3|||
33432788|NCT00428610|62810149|FG001|Overall Study|Death Due to Adverse Event|0|||
33432789|NCT00428610|62810150|FG002|Overall Study|Death Due to Adverse Event|5|||
33432790|NCT00428610|62810148|FG000|Overall Study|Death Due to Progressive Disease|0|||
33432791|NCT00428610|62810149|FG001|Overall Study|Death Due to Progressive Disease|0|||
33432792|NCT00428610|62810150|FG002|Overall Study|Death Due to Progressive Disease|2|||
33432793|NCT00428610|62810148|FG000|Overall Study|Adverse Event|2|||
33432794|NCT00428610|62810149|FG001|Overall Study|Adverse Event|3|||
33432795|NCT00428610|62810150|FG002|Overall Study|Adverse Event|2|||
33432796|NCT00428610|62810148|FG000|Overall Study|Investigator Decision|2|||
33432797|NCT00428610|62810149|FG001|Overall Study|Investigator Decision|1|||
33432798|NCT00428610|62810150|FG002|Overall Study|Investigator Decision|1|||
33432799|NCT00428610|62810148|FG000|Overall Study|Progressive Disease|42|||
33432800|NCT00428610|62810149|FG001|Overall Study|Progressive Disease|14|||
33432801|NCT00428610|62810150|FG002|Overall Study|Progressive Disease|22|||
33432802|NCT00428610|62810148|FG000|Overall Study|Withdrawal by Subject|4|||
33432803|NCT00428610|62810149|FG001|Overall Study|Withdrawal by Subject|0|||
33432804|NCT00428610|62810150|FG002|Overall Study|Withdrawal by Subject|0|||
33432805|NCT00419094|62810160|FG000|Overall Study|Adverse Event|3|||
33432806|NCT00419094|62810161|FG001|Overall Study|Adverse Event|7|||
33432807|NCT00419094|62810160|FG000|Overall Study|Lack of Efficacy|1|||
33432808|NCT00419094|62810161|FG001|Overall Study|Lack of Efficacy|0|||
33432809|NCT00419094|62810160|FG000|Overall Study|Lost to Follow-up|0|||
33432810|NCT00419094|62810161|FG001|Overall Study|Lost to Follow-up|2|||
33432811|NCT00419094|62810160|FG000|Overall Study|Protocol Violation|1|||
33432812|NCT00419094|62810161|FG001|Overall Study|Protocol Violation|14|||
33432813|NCT00419094|62810160|FG000|Overall Study|Withdrawal of consent|1|||
33432814|NCT00419094|62810161|FG001|Overall Study|Withdrawal of consent|5|||
33432815|NCT00419094|62810160|FG000|Overall Study|Other: Error determining exit criteria|1|||
33432816|NCT00419094|62810161|FG001|Overall Study|Other: Error determining exit criteria|0|||
33432817|NCT00419094|62810160|FG000|Overall Study|Other: Patient non-compliant|0|||
33432818|NCT00419094|62810161|FG001|Overall Study|Other: Patient non-compliant|1|||
33432819|NCT00419094|62810160|FG000|Overall Study|Other: No contact for extended period|0|||
33432820|NCT00419094|62810161|FG001|Overall Study|Other: No contact for extended period|1|||
33432821|NCT00448916|62810171|FG000|Overall Study|Adverse Event|2|||
33432822|NCT00448916|62810172|FG001|Overall Study|Adverse Event|2|||
33432823|NCT00448916|62810173|FG002|Overall Study|Adverse Event|3|||
33432824|NCT00448916|62810174|FG003|Overall Study|Adverse Event|2|||
33432825|NCT00448916|62810171|FG000|Overall Study|Lack of Efficacy|1|||
33432826|NCT00448916|62810172|FG001|Overall Study|Lack of Efficacy|0|||
33432827|NCT00448916|62810173|FG002|Overall Study|Lack of Efficacy|2|||
33432828|NCT00448916|62810174|FG003|Overall Study|Lack of Efficacy|1|||
33432829|NCT00448916|62810171|FG000|Overall Study|Withdrawal by Subject|3|||
33432830|NCT00448916|62810172|FG001|Overall Study|Withdrawal by Subject|3|||
33432831|NCT00448916|62810173|FG002|Overall Study|Withdrawal by Subject|1|||
33432832|NCT00448916|62810174|FG003|Overall Study|Withdrawal by Subject|1|||
33432833|NCT00448916|62810171|FG000|Overall Study|Other|1|||
33432834|NCT00448916|62810172|FG001|Overall Study|Other|0|||
33432835|NCT00448916|62810173|FG002|Overall Study|Other|0|||
33432836|NCT00448916|62810174|FG003|Overall Study|Other|0|||
33432837|NCT00448916|62810171|FG000|Overall Study|Lost to Follow-up|0|||
33432838|NCT00448916|62810172|FG001|Overall Study|Lost to Follow-up|1|||
33432839|NCT00448916|62810173|FG002|Overall Study|Lost to Follow-up|0|||
33432840|NCT00448916|62810174|FG003|Overall Study|Lost to Follow-up|1|||
33432841|NCT00448916|62810171|FG000|Overall Study|Protocol Violation|0|||
33432842|NCT00448916|62810172|FG001|Overall Study|Protocol Violation|0|||
33605464|NCT01734382|63005136|FG000|Part 2|Physician Decision|0|||
33432843|NCT00448916|62810173|FG002|Overall Study|Protocol Violation|0|||
33432844|NCT00448916|62810174|FG003|Overall Study|Protocol Violation|1|||
33432845|NCT00418938|62810188|FG000|Overall Study|Reimbursement|1|||
33432846|NCT00418938|62810189|FG001|Overall Study|Reimbursement|0|||
33432847|NCT00418938|62810188|FG000|Overall Study|Administrative decision|3|||
33432848|NCT00418938|62810189|FG001|Overall Study|Administrative decision|3|||
33432849|NCT00418938|62810188|FG000|Overall Study|Withdrawal by Subject|16|||
33432850|NCT00418938|62810189|FG001|Overall Study|Withdrawal by Subject|15|||
33605465|NCT01734382|63005137|FG001|Part 2|Physician Decision|0|||
33432851|NCT00418938|62810188|FG000|Overall Study|Lost to Follow-up|1|||
33432852|NCT00418938|62810189|FG001|Overall Study|Lost to Follow-up|3|||
33432853|NCT00418938|62810188|FG000|Overall Study|Adverse Event|1|||
33432854|NCT00418938|62810189|FG001|Overall Study|Adverse Event|1|||
33432855|NCT00418938|62810188|FG000|Overall Study|On-going|1|||
33432856|NCT00418938|62810189|FG001|Overall Study|On-going|1|||
33432857|NCT00418938|62810188|FG000|Overall Study|Ineligibility Determined|1|||
33432858|NCT00418938|62810189|FG001|Overall Study|Ineligibility Determined|0|||
33432859|NCT00448760|62810195|FG000|Overall Study|Death|3|||
33432860|NCT00418314|62810201|FG000|Overall Study|Withdrawal by Subject|1|||
33432861|NCT00418314|62810202|FG001|Overall Study|Withdrawal by Subject|2|||
33432862|NCT00448448|62810210|FG000|Overall Study|Withdrawal by Subject|13|||
33432863|NCT00448448|62810211|FG001|Overall Study|Withdrawal by Subject|2|||
33432864|NCT00448448|62810210|FG000|Overall Study|On protocol when study ended|83|||
33432865|NCT00448448|62810211|FG001|Overall Study|On protocol when study ended|36|||
33432866|NCT00448448|62810210|FG000|Overall Study|Lost to Follow-up|2|||
33432867|NCT00448448|62810211|FG001|Overall Study|Lost to Follow-up|1|||
33432868|NCT00448448|62810210|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
33432869|NCT00448448|62810211|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
33432870|NCT00448448|62810210|FG000|Overall Study|Signed consent lost|0|||
33432871|NCT00448448|62810211|FG001|Overall Study|Signed consent lost|1|||
33432872|NCT00405912|62810220|FG000|Overall Study|Withdrawal by Subject|12|||
33432873|NCT00405912|62810221|FG001|Overall Study|Withdrawal by Subject|11|||
33432874|NCT00405912|62810222|FG002|Overall Study|Withdrawal by Subject|12|||
33432875|NCT00405912|62810220|FG000|Overall Study|Lost to Follow-up|4|||
33432876|NCT00405912|62810221|FG001|Overall Study|Lost to Follow-up|8|||
33432877|NCT00405912|62810222|FG002|Overall Study|Lost to Follow-up|4|||
33432878|NCT00448136|62810232|FG000|Overall Study|Death|3|||
33432879|NCT00448136|62810233|FG001|Overall Study|Death|8|||
33432880|NCT00448136|62810232|FG000|Overall Study|Investigator's decision (progression)|1|||
33432881|NCT00448136|62810233|FG001|Overall Study|Investigator's decision (progression)|0|||
33432882|NCT00447902|62810241|FG000|Overall Study|Adverse Event|0|||
33432883|NCT00447902|62810242|FG001|Overall Study|Adverse Event|3|||
33432884|NCT00447902|62810241|FG000|Overall Study|Protocol Violation|1|||
33432885|NCT00447902|62810242|FG001|Overall Study|Protocol Violation|0|||
33432886|NCT00447902|62810241|FG000|Overall Study|Withdrawal by Subject|0|||
33432887|NCT00447902|62810242|FG001|Overall Study|Withdrawal by Subject|1|||
33432888|NCT00447902|62810241|FG000|Overall Study|included patients who discontinued|1|||
33432889|NCT00447902|62810242|FG001|Overall Study|included patients who discontinued|1|||
33432890|NCT00447902|62810241|FG000|Overall Study|Lack of Efficacy|2|||
33432891|NCT00447902|62810242|FG001|Overall Study|Lack of Efficacy|1|||
33432892|NCT00307437|62810251|FG000|Controlled Period|Adverse Event|7|||
33432893|NCT00307437|62810252|FG001|Controlled Period|Adverse Event|2|||
33432894|NCT00307437|62810253|FG002|Controlled Period|Adverse Event|5|||
33432895|NCT00307437|62810254|FG003|Controlled Period|Adverse Event|0|||
33432896|NCT00307437|62810255|FG004|Controlled Period|Adverse Event|0|||
33432897|NCT00307437|62810256|FG005|Controlled Period|Adverse Event|0|||
33432898|NCT00307437|62810257|FG006|Controlled Period|Adverse Event|0|||
33432899|NCT00307437|62810251|FG000|Controlled Period|Death|0|||
33432900|NCT00307437|62810252|FG001|Controlled Period|Death|0|||
33432901|NCT00307437|62810253|FG002|Controlled Period|Death|1|||
33432902|NCT00307437|62810254|FG003|Controlled Period|Death|0|||
33432903|NCT00307437|62810255|FG004|Controlled Period|Death|0|||
33432904|NCT00307437|62810256|FG005|Controlled Period|Death|0|||
33432905|NCT00307437|62810257|FG006|Controlled Period|Death|0|||
33432906|NCT00307437|62810251|FG000|Controlled Period|Lack of Efficacy|2|||
33432907|NCT00307437|62810252|FG001|Controlled Period|Lack of Efficacy|0|||
33432908|NCT00307437|62810253|FG002|Controlled Period|Lack of Efficacy|0|||
33432909|NCT00307437|62810254|FG003|Controlled Period|Lack of Efficacy|0|||
33432910|NCT00307437|62810255|FG004|Controlled Period|Lack of Efficacy|0|||
33432911|NCT00307437|62810256|FG005|Controlled Period|Lack of Efficacy|0|||
33432912|NCT00307437|62810257|FG006|Controlled Period|Lack of Efficacy|0|||
33432913|NCT00307437|62810251|FG000|Controlled Period|Lost to Follow-up|2|||
33432914|NCT00307437|62810252|FG001|Controlled Period|Lost to Follow-up|3|||
33432915|NCT00307437|62810253|FG002|Controlled Period|Lost to Follow-up|0|||
33432916|NCT00307437|62810254|FG003|Controlled Period|Lost to Follow-up|0|||
33432917|NCT00307437|62810255|FG004|Controlled Period|Lost to Follow-up|0|||
33432918|NCT00307437|62810256|FG005|Controlled Period|Lost to Follow-up|0|||
33432919|NCT00307437|62810257|FG006|Controlled Period|Lost to Follow-up|0|||
33432920|NCT00307437|62810251|FG000|Controlled Period|Other|5|||
33432921|NCT00307437|62810252|FG001|Controlled Period|Other|1|||
33432922|NCT00307437|62810253|FG002|Controlled Period|Other|3|||
33432923|NCT00307437|62810254|FG003|Controlled Period|Other|0|||
33432924|NCT00307437|62810255|FG004|Controlled Period|Other|0|||
33432925|NCT00307437|62810256|FG005|Controlled Period|Other|0|||
33432926|NCT00307437|62810257|FG006|Controlled Period|Other|0|||
33432927|NCT00307437|62810251|FG000|After Controlled Period|Adverse Event|0|||
33432928|NCT00307437|62810252|FG001|After Controlled Period|Adverse Event|0|||
33432929|NCT00307437|62810253|FG002|After Controlled Period|Adverse Event|0|||
33432930|NCT00307437|62810254|FG003|After Controlled Period|Adverse Event|18|||
33432931|NCT00307437|62810255|FG004|After Controlled Period|Adverse Event|16|||
33432932|NCT00307437|62810256|FG005|After Controlled Period|Adverse Event|31|||
33432933|NCT00307437|62810257|FG006|After Controlled Period|Adverse Event|40|||
33432934|NCT00307437|62810251|FG000|After Controlled Period|Death|0|||
33432935|NCT00307437|62810252|FG001|After Controlled Period|Death|0|||
33432936|NCT00307437|62810253|FG002|After Controlled Period|Death|0|||
33432937|NCT00307437|62810254|FG003|After Controlled Period|Death|3|||
33432938|NCT00307437|62810255|FG004|After Controlled Period|Death|1|||
33432939|NCT00307437|62810256|FG005|After Controlled Period|Death|1|||
33432940|NCT00307437|62810257|FG006|After Controlled Period|Death|3|||
33432941|NCT00307437|62810251|FG000|After Controlled Period|Lack of Efficacy|0|||
33432942|NCT00307437|62810252|FG001|After Controlled Period|Lack of Efficacy|0|||
33432943|NCT00307437|62810253|FG002|After Controlled Period|Lack of Efficacy|0|||
33432944|NCT00307437|62810254|FG003|After Controlled Period|Lack of Efficacy|15|||
33432945|NCT00307437|62810255|FG004|After Controlled Period|Lack of Efficacy|17|||
33432946|NCT00307437|62810256|FG005|After Controlled Period|Lack of Efficacy|37|||
33432947|NCT00307437|62810257|FG006|After Controlled Period|Lack of Efficacy|24|||
33432948|NCT00307437|62810251|FG000|After Controlled Period|Lost to Follow-up|0|||
33432949|NCT00307437|62810252|FG001|After Controlled Period|Lost to Follow-up|0|||
33432950|NCT00307437|62810253|FG002|After Controlled Period|Lost to Follow-up|0|||
33432951|NCT00307437|62810254|FG003|After Controlled Period|Lost to Follow-up|7|||
33432952|NCT00307437|62810255|FG004|After Controlled Period|Lost to Follow-up|12|||
33432953|NCT00307437|62810256|FG005|After Controlled Period|Lost to Follow-up|13|||
33432954|NCT00307437|62810257|FG006|After Controlled Period|Lost to Follow-up|18|||
33432955|NCT00307437|62810251|FG000|After Controlled Period|Other|0|||
33432956|NCT00307437|62810252|FG001|After Controlled Period|Other|0|||
33432957|NCT00307437|62810253|FG002|After Controlled Period|Other|0|||
33432958|NCT00307437|62810254|FG003|After Controlled Period|Other|15|||
33432959|NCT00307437|62810255|FG004|After Controlled Period|Other|9|||
33432960|NCT00307437|62810256|FG005|After Controlled Period|Other|40|||
33432961|NCT00307437|62810257|FG006|After Controlled Period|Other|28|||
33432962|NCT00440726|62810282|FG000|Phase 1|Dose-Limiting Toxicity|0|||
33432963|NCT00440726|62810283|FG001|Phase 1|Dose-Limiting Toxicity|1|||
33432964|NCT00440726|62810284|FG002|Phase 1|Dose-Limiting Toxicity|0|||
33432965|NCT00440726|62810282|FG000|Phase 1|Physician Decision|1|||
33432966|NCT00440726|62810283|FG001|Phase 1|Physician Decision|0|||
33432967|NCT00440726|62810284|FG002|Phase 1|Physician Decision|0|||
33432968|NCT00440726|62810282|FG000|Phase 2|Death|0|||
33432969|NCT00440726|62810283|FG001|Phase 2|Death|0|||
33432970|NCT00440726|62810284|FG002|Phase 2|Death|1|||
33432971|NCT00440726|62810282|FG000|Phase 2|Adverse Event|0|||
33432972|NCT00440726|62810283|FG001|Phase 2|Adverse Event|0|||
33432973|NCT00440726|62810284|FG002|Phase 2|Adverse Event|1|||
33432974|NCT00447590|62810295|FG000|Overall Study|Withdrawal by Subject|26|||
33432975|NCT00447590|62810295|FG000|Overall Study|Lost to Follow-up|24|||
33432976|NCT00447590|62810295|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
33432977|NCT00447278|62810301|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
33432978|NCT00447278|62810302|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
33432979|NCT00447278|62810301|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
33432980|NCT00447278|62810302|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
33432981|NCT00447278|62810301|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
33432982|NCT00447278|62810302|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
33432983|NCT00447278|62810301|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
33432984|NCT00447278|62810302|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
33432985|NCT00447278|62810301|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
33432986|NCT00447278|62810302|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
33432987|NCT00447278|62810301|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
33432988|NCT00447278|62810302|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
33432989|NCT00447278|62810301|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
33432990|NCT00447278|62810302|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
33432991|NCT00447278|62810301|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
33432992|NCT00447278|62810302|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
33432993|NCT00447278|62810301|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
33432994|NCT00447278|62810302|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
33432995|NCT00447278|62810301|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
33432996|NCT00447278|62810302|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
33432997|NCT00447278|62810301|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
33432998|NCT00447278|62810302|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
33432999|NCT00447278|62810301|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
33433000|NCT00447278|62810302|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
33433001|NCT00447278|62810301|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
33605466|NCT01734382|63005138|FG002|Part 2|Physician Decision|3|||
33605467|NCT01734382|63005136|FG000|Part 2|Protocol Violation|0|||
33433002|NCT00447278|62810302|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
33433003|NCT00447278|62810301|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
33433004|NCT00447278|62810302|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
33433005|NCT00446966|62810311|FG000|Overall Study|Lost to Follow-up|10|||
33433006|NCT00446966|62810312|FG001|Overall Study|Lost to Follow-up|7|||
33433007|NCT00446654|62810320|FG000|Overall Study|Withdrawal by Subject|1|||
33433008|NCT00446654|62810321|FG001|Overall Study|Withdrawal by Subject|0|||
33433009|NCT00446654|62810320|FG000|Overall Study|Adverse Event|1|||
33433010|NCT00446654|62810321|FG001|Overall Study|Adverse Event|0|||
33433011|NCT00405756|62810330|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
33433012|NCT00405756|62810331|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
33433013|NCT00405756|62810332|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
33433014|NCT00405756|62810330|FG000|Double-blind Treatment|Adverse Event|31|||
33433015|NCT00405756|62810331|FG001|Double-blind Treatment|Adverse Event|27|||
33433016|NCT00405756|62810332|FG002|Double-blind Treatment|Adverse Event|12|||
33433017|NCT00405756|62810330|FG000|Double-blind Treatment|Disease Progression|47|||
33433018|NCT00405756|62810331|FG001|Double-blind Treatment|Disease Progression|81|||
33433019|NCT00405756|62810332|FG002|Double-blind Treatment|Disease Progression|102|||
33433020|NCT00405756|62810330|FG000|Double-blind Treatment|Lack of Efficacy|1|||
33433021|NCT00405756|62810331|FG001|Double-blind Treatment|Lack of Efficacy|4|||
33433022|NCT00405756|62810332|FG002|Double-blind Treatment|Lack of Efficacy|2|||
33433023|NCT00405756|62810330|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
33433024|NCT00405756|62810331|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
33433025|NCT00405756|62810332|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
33433026|NCT00405756|62810330|FG000|Double-blind Treatment|Lost to Follow-up|1|||
33433027|NCT00405756|62810331|FG001|Double-blind Treatment|Lost to Follow-up|0|||
33433028|NCT00405756|62810332|FG002|Double-blind Treatment|Lost to Follow-up|0|||
33433029|NCT00405756|62810330|FG000|Double-blind Treatment|Death|4|||
33433030|NCT00405756|62810331|FG001|Double-blind Treatment|Death|4|||
33433031|NCT00405756|62810332|FG002|Double-blind Treatment|Death|4|||
33433032|NCT00405756|62810330|FG000|Double-blind Treatment|Protocol Violation|1|||
33433033|NCT00405756|62810331|FG001|Double-blind Treatment|Protocol Violation|0|||
33433034|NCT00405756|62810332|FG002|Double-blind Treatment|Protocol Violation|2|||
33433035|NCT00405756|62810330|FG000|Double-blind Treatment|Other|7|||
33433036|NCT00405756|62810331|FG001|Double-blind Treatment|Other|4|||
33433037|NCT00405756|62810332|FG002|Double-blind Treatment|Other|4|||
33433038|NCT00405756|62810330|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
33433039|NCT00405756|62810331|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
33433040|NCT00405756|62810332|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
33433041|NCT00405756|62810330|FG000|Open-label Extension|Adverse Event|1|||
33433042|NCT00405756|62810331|FG001|Open-label Extension|Adverse Event|3|||
33433043|NCT00405756|62810332|FG002|Open-label Extension|Adverse Event|7|||
33433044|NCT00405756|62810330|FG000|Open-label Extension|Disease Progression|8|||
33433045|NCT00405756|62810331|FG001|Open-label Extension|Disease Progression|23|||
33433046|NCT00405756|62810332|FG002|Open-label Extension|Disease Progression|26|||
33433047|NCT00405756|62810330|FG000|Open-label Extension|Withdrawal by Subject|2|||
33433048|NCT00405756|62810331|FG001|Open-label Extension|Withdrawal by Subject|3|||
33433049|NCT00405756|62810332|FG002|Open-label Extension|Withdrawal by Subject|3|||
33433050|NCT00405756|62810330|FG000|Open-label Extension|Death|1|||
33433051|NCT00405756|62810331|FG001|Open-label Extension|Death|2|||
33433052|NCT00405756|62810332|FG002|Open-label Extension|Death|4|||
33433053|NCT00405756|62810330|FG000|Open-label Extension|Other|0|||
33433054|NCT00405756|62810331|FG001|Open-label Extension|Other|1|||
33433055|NCT00405756|62810332|FG002|Open-label Extension|Other|7|||
33433056|NCT00405756|62810330|FG000|Follow-up|Ongoing in Follow-up Period|52|||
33433057|NCT00405756|62810331|FG001|Follow-up|Ongoing in Follow-up Period|51|||
33433058|NCT00405756|62810332|FG002|Follow-up|Ongoing in Follow-up Period|60|||
33433059|NCT00405756|62810330|FG000|Follow-up|Death|21|||
33433060|NCT00405756|62810331|FG001|Follow-up|Death|31|||
33433061|NCT00405756|62810332|FG002|Follow-up|Death|24|||
33433062|NCT00405756|62810330|FG000|Follow-up|Lost to Follow-up|2|||
33433063|NCT00405756|62810331|FG001|Follow-up|Lost to Follow-up|8|||
33433064|NCT00405756|62810332|FG002|Follow-up|Lost to Follow-up|4|||
33433065|NCT00456092|62810343|FG000|Extension Phase|Grade 2 or Greater AE|2|||
33433066|NCT00456092|62810344|FG001|Extension Phase|Grade 2 or Greater AE|2|||
33433067|NCT00456092|62810345|FG002|Extension Phase|Grade 2 or Greater AE|0|||
33433068|NCT00456092|62810346|FG003|Extension Phase|Grade 2 or Greater AE|0|||
33433069|NCT00456092|62810347|FG004|Extension Phase|Grade 2 or Greater AE|2|||
33433070|NCT00456092|62810343|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
33433071|NCT00456092|62810344|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
33433072|NCT00456092|62810345|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
33433073|NCT00456092|62810346|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
33323151|NCT00922636|62699432|FG002|Overall Study|Protocol Violation|2|||
33323152|NCT00922636|62699433|FG003|Overall Study|Protocol Violation|2|||
33433074|NCT00456092|62810347|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
33433075|NCT00456092|62810343|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
33433076|NCT00456092|62810344|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
33433077|NCT00456092|62810345|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
33433078|NCT00456092|62810346|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
33433079|NCT00456092|62810347|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
33433080|NCT00456092|62810343|FG000|Extension Phase|Withdrew Consent|2|||
33433081|NCT00456092|62810344|FG001|Extension Phase|Withdrew Consent|0|||
33433082|NCT00456092|62810345|FG002|Extension Phase|Withdrew Consent|0|||
33433083|NCT00456092|62810346|FG003|Extension Phase|Withdrew Consent|0|||
33433084|NCT00456092|62810347|FG004|Extension Phase|Withdrew Consent|0|||
33433085|NCT00456092|62810343|FG000|Extension Phase|Lost to Follow-up|1|||
33433086|NCT00456092|62810344|FG001|Extension Phase|Lost to Follow-up|1|||
33433087|NCT00456092|62810345|FG002|Extension Phase|Lost to Follow-up|0|||
33433088|NCT00456092|62810346|FG003|Extension Phase|Lost to Follow-up|0|||
33433089|NCT00456092|62810347|FG004|Extension Phase|Lost to Follow-up|1|||
33433090|NCT00456092|62810343|FG000|Extension Phase|Other|2|||
33433091|NCT00456092|62810344|FG001|Extension Phase|Other|0|||
33433092|NCT00456092|62810345|FG002|Extension Phase|Other|0|||
33433093|NCT00456092|62810346|FG003|Extension Phase|Other|1|||
33433094|NCT00456092|62810347|FG004|Extension Phase|Other|1|||
33433095|NCT00456092|62810343|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
33433096|NCT00456092|62810344|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
33433097|NCT00456092|62810345|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
33433098|NCT00456092|62810346|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
33433099|NCT00456092|62810347|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
33433100|NCT00456092|62810343|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
33433101|NCT00456092|62810344|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
33433102|NCT00456092|62810345|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
33433103|NCT00456092|62810346|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
33433104|NCT00456092|62810347|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
33433105|NCT00456092|62810343|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
33433106|NCT00456092|62810344|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
33433107|NCT00456092|62810345|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
33433108|NCT00456092|62810346|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
33433109|NCT00456092|62810347|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
33433110|NCT00456092|62810343|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
33433111|NCT00456092|62810344|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
33433112|NCT00456092|62810345|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
33433113|NCT00456092|62810346|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
33433114|NCT00456092|62810347|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
33433115|NCT00456092|62810343|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
33433116|NCT00456092|62810344|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
33433117|NCT00456092|62810345|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
33433118|NCT00456092|62810346|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
33433119|NCT00456092|62810347|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
33433120|NCT00456092|62810343|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
33433121|NCT00456092|62810344|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
33433122|NCT00456092|62810345|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
33433123|NCT00456092|62810346|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
33433124|NCT00456092|62810347|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
33433125|NCT00456092|62810343|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
33433126|NCT00456092|62810344|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
33433127|NCT00456092|62810345|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
33433128|NCT00456092|62810346|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
33433129|NCT00456092|62810347|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
33433130|NCT00456092|62810343|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
33433131|NCT00456092|62810344|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
33433132|NCT00456092|62810345|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
33433133|NCT00456092|62810346|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
33433134|NCT00456092|62810347|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
33433135|NCT00456092|62810343|FG000|Treatment Phase (12 Weeks)|Other|1|||
33433136|NCT00456092|62810344|FG001|Treatment Phase (12 Weeks)|Other|0|||
33433137|NCT00456092|62810345|FG002|Treatment Phase (12 Weeks)|Other|1|||
33433138|NCT00456092|62810346|FG003|Treatment Phase (12 Weeks)|Other|0|||
33433139|NCT00456092|62810347|FG004|Treatment Phase (12 Weeks)|Other|0|||
33433140|NCT00411450|62810361|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
33433141|NCT00404820|62810369|FG000|Overall Study|Adverse Event|4|||
33433142|NCT00404820|62810370|FG001|Overall Study|Adverse Event|16|||
33433143|NCT00404820|62810369|FG000|Overall Study|Withdrawal by Subject|5|||
33433144|NCT00404820|62810370|FG001|Overall Study|Withdrawal by Subject|3|||
33433145|NCT00404820|62810369|FG000|Overall Study|Lost to Follow-up|7|||
33433146|NCT00404820|62810370|FG001|Overall Study|Lost to Follow-up|3|||
33433147|NCT00404820|62810369|FG000|Overall Study|Administrative problems|2|||
33433148|NCT00404820|62810370|FG001|Overall Study|Administrative problems|0|||
33433149|NCT00404820|62810369|FG000|Overall Study|Death|1|||
33433150|NCT00404820|62810370|FG001|Overall Study|Death|0|||
33433151|NCT00404820|62810369|FG000|Overall Study|Other|0|||
33433152|NCT00404820|62810370|FG001|Overall Study|Other|2|||
33433153|NCT00417612|62810378|FG000|Overall Study|Errant diagnosis|0|||
33433154|NCT00417612|62810379|FG001|Overall Study|Errant diagnosis|1|||
33433155|NCT00417612|62810378|FG000|Overall Study|Adverse Event|2|||
33433156|NCT00417612|62810379|FG001|Overall Study|Adverse Event|0|||
33433157|NCT00417612|62810378|FG000|Overall Study|Protocol Violation|0|||
33433158|NCT00417612|62810379|FG001|Overall Study|Protocol Violation|2|||
33433159|NCT00417612|62810378|FG000|Overall Study|Lost to Follow-up|1|||
33433160|NCT00417612|62810379|FG001|Overall Study|Lost to Follow-up|0|||
33433161|NCT00446030|62810389|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
33433162|NCT00446030|62810390|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
33433163|NCT00446030|62810389|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
33433164|NCT00446030|62810390|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
33433165|NCT00446030|62810389|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
33433166|NCT00446030|62810390|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
33433167|NCT00446030|62810389|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
33433168|NCT00446030|62810390|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
33433169|NCT00446030|62810389|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
33433170|NCT00446030|62810390|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
33433171|NCT00446030|62810389|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
33433172|NCT00446030|62810390|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
33433173|NCT00446030|62810389|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
33433174|NCT00446030|62810390|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
33433175|NCT00446030|62810389|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
33433176|NCT00446030|62810390|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
33433177|NCT00446030|62810389|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
33433178|NCT00446030|62810390|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
33433179|NCT00446030|62810389|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
33433180|NCT00446030|62810390|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
33433181|NCT00446030|62810389|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
33433182|NCT00446030|62810390|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
33433183|NCT00446030|62810389|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
33433184|NCT00446030|62810390|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
33433185|NCT00446030|62810389|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
33433186|NCT00446030|62810390|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
33433187|NCT00446030|62810389|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
33433188|NCT00446030|62810390|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
33433189|NCT00446030|62810389|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
33433190|NCT00446030|62810390|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
33433191|NCT00446030|62810389|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
33433192|NCT00446030|62810390|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
33433193|NCT00446030|62810389|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
33433194|NCT00446030|62810390|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
33433195|NCT00446030|62810389|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
33433196|NCT00446030|62810390|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
33433197|NCT00446030|62810389|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
33433198|NCT00446030|62810390|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
33433199|NCT00411216|62810398|FG000|Overall Study|Ten participants were entered into the c|0|||
33433200|NCT00411216|62810399|FG001|Overall Study|Ten participants were entered into the c|2|||
33323153|NCT00922636|62699434|FG004|Overall Study|Protocol Violation|0|||
33323154|NCT00922636|62699430|FG000|Overall Study|Entry Criteria Not Met|0|||
33433201|NCT00410514|62810408|FG000|Overall Study|Adverse Event|2|||
33433202|NCT00410514|62810409|FG001|Overall Study|Adverse Event|2|||
33433203|NCT00410514|62810410|FG002|Overall Study|Adverse Event|2|||
33433204|NCT00410514|62810408|FG000|Overall Study|Protocol Violation|0|||
33433205|NCT00410514|62810409|FG001|Overall Study|Protocol Violation|1|||
33433206|NCT00410514|62810410|FG002|Overall Study|Protocol Violation|1|||
33433207|NCT00410514|62810408|FG000|Overall Study|Lost to Follow-up|0|||
33433208|NCT00410514|62810409|FG001|Overall Study|Lost to Follow-up|0|||
33433209|NCT00410514|62810410|FG002|Overall Study|Lost to Follow-up|2|||
33433210|NCT00410514|62810408|FG000|Overall Study|Non-compliant with study procedures|0|||
33433211|NCT00410514|62810409|FG001|Overall Study|Non-compliant with study procedures|0|||
33433212|NCT00410514|62810410|FG002|Overall Study|Non-compliant with study procedures|2|||
33433213|NCT03847610|62810418|FG000|Overall Study|Withdrawal by Subject|1|||
33433214|NCT03843632|62810426|FG000|Overall Study|Withdrawal by Subject|1|||
33433215|NCT03843632|62810427|FG001|Overall Study|Withdrawal by Subject|0|||
33433216|NCT03843632|62810428|FG002|Overall Study|Withdrawal by Subject|0|||
33433217|NCT03843632|62810429|FG003|Overall Study|Withdrawal by Subject|0|||
33433218|NCT00455858|62810439|FG000|Overall Study|Lost to Follow-up|2|||
33433219|NCT00455858|62810439|FG000|Overall Study|Protocol Violation|1|||
33433220|NCT00455858|62810439|FG000|Overall Study|Lack of Efficacy|1|||
33433221|NCT00455858|62810439|FG000|Overall Study|Well controlled FPG without insulin|1|||
33433222|NCT00455858|62810439|FG000|Overall Study|Withdrawal|1|||
33433223|NCT00439556|62810446|FG000|Overall Study|Patient was taken off study for non-comp|0|||
33433224|NCT00439556|62810447|FG001|Overall Study|Patient was taken off study for non-comp|1|||
33433225|NCT00439556|62810448|FG002|Overall Study|Patient was taken off study for non-comp|0|||
33433226|NCT00410202|62810460|FG000|On-Treatment|Continuing treatment|69|||
33433227|NCT00410202|62810461|FG001|On-Treatment|Continuing treatment|71|||
33433228|NCT00410202|62810462|FG002|On-Treatment|Continuing treatment|66|||
33433229|NCT00410202|62810460|FG000|On-Treatment|Adverse Event|1|||
33433230|NCT00410202|62810461|FG001|On-Treatment|Adverse Event|3|||
33433231|NCT00410202|62810462|FG002|On-Treatment|Adverse Event|2|||
33433232|NCT00410202|62810460|FG000|On-Treatment|Death|1|||
33433233|NCT00410202|62810461|FG001|On-Treatment|Death|0|||
33433234|NCT00410202|62810462|FG002|On-Treatment|Death|0|||
33433235|NCT00410202|62810460|FG000|On-Treatment|Lost to Follow-up|1|||
33433236|NCT00410202|62810461|FG001|On-Treatment|Lost to Follow-up|0|||
33433237|NCT00410202|62810462|FG002|On-Treatment|Lost to Follow-up|1|||
33433238|NCT00410202|62810460|FG000|On-Treatment|Lack of Efficacy|1|||
33433239|NCT00410202|62810461|FG001|On-Treatment|Lack of Efficacy|4|||
33433240|NCT00410202|62810462|FG002|On-Treatment|Lack of Efficacy|0|||
33433241|NCT00410202|62810460|FG000|On-Treatment|Withdrawal by Subject|2|||
33433242|NCT00410202|62810461|FG001|On-Treatment|Withdrawal by Subject|1|||
33433243|NCT00410202|62810462|FG002|On-Treatment|Withdrawal by Subject|1|||
33605468|NCT01734382|63005137|FG001|Part 2|Protocol Violation|1|||
33605469|NCT01734382|63005138|FG002|Part 2|Protocol Violation|0|||
33433244|NCT00410202|62810460|FG000|On-Treatment|Other Reason|0|||
33433245|NCT00410202|62810461|FG001|On-Treatment|Other Reason|0|||
33433246|NCT00410202|62810462|FG002|On-Treatment|Other Reason|1|||
33433247|NCT00410202|62810460|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
33433248|NCT00410202|62810461|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
33433249|NCT00410202|62810462|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
33433250|NCT00410202|62810460|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
33433251|NCT00410202|62810461|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
33433252|NCT00410202|62810462|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
33433253|NCT00410202|62810460|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
33433254|NCT00410202|62810461|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
33433255|NCT00410202|62810462|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
33433256|NCT00445328|62810473|FG000|Overall Study|Death|0|||
33433257|NCT00445328|62810474|FG001|Overall Study|Death|1|||
33433258|NCT00445328|62810473|FG000|Overall Study|Adverse Event|0|||
33433259|NCT00445328|62810474|FG001|Overall Study|Adverse Event|3|||
33433260|NCT00445328|62810473|FG000|Overall Study|Other|0|||
33433261|NCT00445328|62810474|FG001|Overall Study|Other|2|||
33433262|NCT00445328|62810473|FG000|Overall Study|Withdrawal by Subject|2|||
33433263|NCT00445328|62810474|FG001|Overall Study|Withdrawal by Subject|0|||
33433264|NCT00445328|62810473|FG000|Overall Study|Protocol Violation|1|||
33433265|NCT00445328|62810474|FG001|Overall Study|Protocol Violation|0|||
33433266|NCT00455312|62810482|FG000|Overall Study|Death|0|||
33433267|NCT00455312|62810483|FG001|Overall Study|Death|1|||
33433268|NCT00444626|62810489|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
33433269|NCT00444626|62810489|FG000|Initial Treatment Period|Adverse Event|1|||
33433270|NCT00444626|62810489|FG000|Initial Treatment Period|Lost to Follow-up|9|||
33433271|NCT00404352|62810516|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
33433272|NCT00404352|62810517|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
33433273|NCT00404352|62810518|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
33433274|NCT00404352|62810519|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
33433275|NCT00404352|62810520|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
33433276|NCT00404352|62810521|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
33433277|NCT00404352|62810522|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
33433278|NCT00404352|62810523|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
33433279|NCT00404352|62810524|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
33433280|NCT00404352|62810516|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
33433281|NCT00404352|62810517|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
33433282|NCT00404352|62810518|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
33433283|NCT00404352|62810519|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
33433284|NCT00404352|62810520|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
33433285|NCT00404352|62810521|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
33433286|NCT00404352|62810522|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
33433287|NCT00404352|62810523|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
33433288|NCT00404352|62810524|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
33433289|NCT00404352|62810516|FG000|Double Blind (up to 24 Month)|Death|0|||
33433290|NCT00404352|62810517|FG001|Double Blind (up to 24 Month)|Death|0|||
33433291|NCT00404352|62810518|FG002|Double Blind (up to 24 Month)|Death|1|||
33433292|NCT00404352|62810519|FG003|Double Blind (up to 24 Month)|Death|0|||
33433293|NCT00404352|62810520|FG004|Double Blind (up to 24 Month)|Death|0|||
33433294|NCT00404352|62810521|FG005|Double Blind (up to 24 Month)|Death|0|||
33433295|NCT00404352|62810522|FG006|Double Blind (up to 24 Month)|Death|0|||
33433296|NCT00404352|62810523|FG007|Double Blind (up to 24 Month)|Death|0|||
33433297|NCT00404352|62810524|FG008|Double Blind (up to 24 Month)|Death|0|||
33433298|NCT00404352|62810516|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
33433299|NCT00404352|62810517|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
33605470|NCT01734382|63005136|FG000|Part 2|Withdrawal by Subject|0|||
33433300|NCT00404352|62810518|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
33433301|NCT00404352|62810519|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
33433302|NCT00404352|62810520|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
33433303|NCT00404352|62810521|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
33433304|NCT00404352|62810522|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
33433305|NCT00404352|62810523|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
33605471|NCT01734382|63005137|FG001|Part 2|Withdrawal by Subject|0|||
33433306|NCT00404352|62810524|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
33433307|NCT00404352|62810516|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
33433308|NCT00404352|62810517|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
33433309|NCT00404352|62810518|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
33433310|NCT00404352|62810519|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
33433311|NCT00404352|62810520|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
33433312|NCT00404352|62810521|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
33433313|NCT00404352|62810522|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
33433314|NCT00404352|62810523|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
33433315|NCT00404352|62810524|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
33433316|NCT00404352|62810516|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
33433317|NCT00404352|62810517|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
33433318|NCT00404352|62810518|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
33433319|NCT00404352|62810519|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
33433320|NCT00404352|62810520|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
33433321|NCT00404352|62810521|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
33433322|NCT00404352|62810522|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
33433323|NCT00404352|62810523|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
33433324|NCT00404352|62810524|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
33433325|NCT00404352|62810516|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
33433326|NCT00404352|62810517|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
33433327|NCT00404352|62810518|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
33433328|NCT00404352|62810519|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
33433329|NCT00404352|62810520|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
33433330|NCT00404352|62810521|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
33433331|NCT00404352|62810522|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
33433332|NCT00404352|62810523|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
33433333|NCT00404352|62810524|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
33433334|NCT00404352|62810516|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
33433335|NCT00404352|62810517|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
33433336|NCT00404352|62810518|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
33433337|NCT00404352|62810519|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
33433338|NCT00404352|62810520|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
33433339|NCT00404352|62810521|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
33433340|NCT00404352|62810522|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
33433341|NCT00404352|62810523|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
33433342|NCT00404352|62810524|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
33433343|NCT00404352|62810516|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33433344|NCT00404352|62810517|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
33433345|NCT00404352|62810518|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33433346|NCT00404352|62810519|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33433347|NCT00404352|62810520|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33433348|NCT00404352|62810521|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33433349|NCT00404352|62810522|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33433350|NCT00404352|62810523|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33433351|NCT00404352|62810524|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33433352|NCT00404352|62810516|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
33433353|NCT00404352|62810517|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
33433354|NCT00404352|62810518|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
33433355|NCT00404352|62810519|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
33433356|NCT00404352|62810520|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
33433357|NCT00404352|62810521|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
33323155|NCT00922636|62699431|FG001|Overall Study|Entry Criteria Not Met|0|||
33323156|NCT00922636|62699432|FG002|Overall Study|Entry Criteria Not Met|1|||
33433358|NCT00404352|62810522|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
33433359|NCT00404352|62810523|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
33433360|NCT00404352|62810524|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
33433361|NCT00404352|62810516|FG000|Double Blind (up to 24 Month)|Other|0|||
33433362|NCT00404352|62810517|FG001|Double Blind (up to 24 Month)|Other|1|||
33433363|NCT00404352|62810518|FG002|Double Blind (up to 24 Month)|Other|0|||
33433364|NCT00404352|62810519|FG003|Double Blind (up to 24 Month)|Other|0|||
33433365|NCT00404352|62810520|FG004|Double Blind (up to 24 Month)|Other|0|||
33433366|NCT00404352|62810521|FG005|Double Blind (up to 24 Month)|Other|0|||
33433367|NCT00404352|62810522|FG006|Double Blind (up to 24 Month)|Other|0|||
33433368|NCT00404352|62810523|FG007|Double Blind (up to 24 Month)|Other|0|||
33433369|NCT00404352|62810524|FG008|Double Blind (up to 24 Month)|Other|0|||
33433370|NCT00404352|62810516|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
33433371|NCT00404352|62810517|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
33433372|NCT00404352|62810518|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
33433373|NCT00404352|62810519|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
33433374|NCT00404352|62810520|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
33433375|NCT00404352|62810521|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
33433376|NCT00404352|62810522|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
33433377|NCT00404352|62810523|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
33433378|NCT00404352|62810524|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
33433379|NCT00404352|62810516|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
33433380|NCT00404352|62810517|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
33433381|NCT00404352|62810518|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
33433382|NCT00404352|62810519|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
33433383|NCT00404352|62810520|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
33323157|NCT00922636|62699433|FG003|Overall Study|Entry Criteria Not Met|1|||
33433384|NCT00404352|62810521|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
33433385|NCT00404352|62810522|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
33433386|NCT00404352|62810523|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
33433387|NCT00404352|62810524|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
33323158|NCT00922636|62699434|FG004|Overall Study|Entry Criteria Not Met|0|||
33323159|NCT00922636|62699430|FG000|Overall Study|Parent/Caregiver Decision|2|||
33323160|NCT00922636|62699431|FG001|Overall Study|Parent/Caregiver Decision|4|||
33323161|NCT00922636|62699432|FG002|Overall Study|Parent/Caregiver Decision|3|||
33323162|NCT00922636|62699433|FG003|Overall Study|Parent/Caregiver Decision|5|||
33323163|NCT00922636|62699434|FG004|Overall Study|Parent/Caregiver Decision|2|||
33323164|NCT00922636|62699430|FG000|Overall Study|Lost to Follow-up|1|||
33323165|NCT00922636|62699431|FG001|Overall Study|Lost to Follow-up|2|||
33323166|NCT00922636|62699432|FG002|Overall Study|Lost to Follow-up|2|||
33323167|NCT00922636|62699433|FG003|Overall Study|Lost to Follow-up|2|||
33323168|NCT00922636|62699434|FG004|Overall Study|Lost to Follow-up|4|||
33433388|NCT00404352|62810516|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33433389|NCT00404352|62810517|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33433390|NCT00404352|62810518|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33433391|NCT00404352|62810519|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33433392|NCT00404352|62810520|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
33433393|NCT00404352|62810521|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33433394|NCT00404352|62810522|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33433395|NCT00404352|62810523|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33433396|NCT00404352|62810524|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33433397|NCT00404352|62810516|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33433398|NCT00404352|62810517|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33433399|NCT00404352|62810518|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33433400|NCT00404352|62810519|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33433401|NCT00404352|62810520|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33433402|NCT00404352|62810521|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
33433403|NCT00404352|62810522|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33433404|NCT00404352|62810523|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33433405|NCT00404352|62810524|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33433406|NCT00404352|62810516|FG000|Open Label (up to 24 Month)|Disease progression|0|||
33433407|NCT00404352|62810517|FG001|Open Label (up to 24 Month)|Disease progression|0|||
33433408|NCT00404352|62810518|FG002|Open Label (up to 24 Month)|Disease progression|0|||
33433409|NCT00404352|62810519|FG003|Open Label (up to 24 Month)|Disease progression|1|||
33433410|NCT00404352|62810520|FG004|Open Label (up to 24 Month)|Disease progression|0|||
33433411|NCT00404352|62810521|FG005|Open Label (up to 24 Month)|Disease progression|0|||
33433412|NCT00404352|62810522|FG006|Open Label (up to 24 Month)|Disease progression|0|||
33433413|NCT00404352|62810523|FG007|Open Label (up to 24 Month)|Disease progression|0|||
33433414|NCT00404352|62810524|FG008|Open Label (up to 24 Month)|Disease progression|0|||
33433415|NCT00404352|62810516|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
33433416|NCT00404352|62810517|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
33433417|NCT00404352|62810518|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
33433418|NCT00404352|62810519|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
33433419|NCT00404352|62810520|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
33433420|NCT00404352|62810521|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
33433421|NCT00404352|62810522|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
33433422|NCT00404352|62810523|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
33433423|NCT00404352|62810524|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
33433424|NCT00404352|62810516|FG000|Open Label Extension (up to 36 Months)|Other|0|||
33433425|NCT00404352|62810517|FG001|Open Label Extension (up to 36 Months)|Other|0|||
33433426|NCT00404352|62810518|FG002|Open Label Extension (up to 36 Months)|Other|0|||
33433427|NCT00404352|62810519|FG003|Open Label Extension (up to 36 Months)|Other|0|||
33433428|NCT00404352|62810520|FG004|Open Label Extension (up to 36 Months)|Other|0|||
33433429|NCT00404352|62810521|FG005|Open Label Extension (up to 36 Months)|Other|0|||
33433430|NCT00404352|62810522|FG006|Open Label Extension (up to 36 Months)|Other|0|||
33433431|NCT00404352|62810523|FG007|Open Label Extension (up to 36 Months)|Other|0|||
33433432|NCT00404352|62810524|FG008|Open Label Extension (up to 36 Months)|Other|2|||
33433433|NCT00439244|62810544|FG000|Overall Study|Adverse Event|5|||
33433434|NCT00439244|62810545|FG001|Overall Study|Adverse Event|2|||
33433435|NCT00439244|62810546|FG002|Overall Study|Adverse Event|3|||
33433436|NCT00439244|62810544|FG000|Overall Study|Withdrawal by Subject|3|||
33433437|NCT00439244|62810545|FG001|Overall Study|Withdrawal by Subject|1|||
33433438|NCT00439244|62810546|FG002|Overall Study|Withdrawal by Subject|2|||
33433439|NCT00439244|62810544|FG000|Overall Study|Lost to Follow-up|2|||
33433440|NCT00439244|62810545|FG001|Overall Study|Lost to Follow-up|1|||
33433441|NCT00439244|62810546|FG002|Overall Study|Lost to Follow-up|2|||
33323169|NCT01175135|62699455|FG000|Overall Study|Adverse Event|2|||
33323170|NCT01175135|62699456|FG001|Overall Study|Adverse Event|5|||
33323171|NCT01175135|62699457|FG002|Overall Study|Adverse Event|3|||
33433442|NCT00439244|62810544|FG000|Overall Study|Death|0|||
33323172|NCT01175135|62699458|FG003|Overall Study|Adverse Event|4|||
33433443|NCT00439244|62810545|FG001|Overall Study|Death|1|||
33433444|NCT00439244|62810546|FG002|Overall Study|Death|0|||
33433445|NCT00439244|62810544|FG000|Overall Study|Protocol Violation|0|||
33433446|NCT00439244|62810545|FG001|Overall Study|Protocol Violation|1|||
33433447|NCT00439244|62810546|FG002|Overall Study|Protocol Violation|0|||
33433448|NCT00439244|62810544|FG000|Overall Study|Administrative problems|1|||
33433449|NCT00439244|62810545|FG001|Overall Study|Administrative problems|0|||
33433450|NCT00439244|62810546|FG002|Overall Study|Administrative problems|0|||
33433451|NCT00438464|62810565|FG000|Overall Study|Terminated Early|14|||
33433452|NCT00438464|62810566|FG001|Overall Study|Terminated Early|5|||
33433453|NCT00438464|62810565|FG000|Overall Study|Incomplete data submission|0|||
33433454|NCT00438464|62810566|FG001|Overall Study|Incomplete data submission|2|||
33433455|NCT00437294|62810586|FG000|Overall Study|Adverse Event|5|||
33433456|NCT00437294|62810587|FG001|Overall Study|Adverse Event|4|||
33433457|NCT00437294|62810586|FG000|Overall Study|Death|5|||
33433458|NCT00437294|62810587|FG001|Overall Study|Death|2|||
33433459|NCT00437294|62810586|FG000|Overall Study|Physician Decision|0|||
33433460|NCT00437294|62810587|FG001|Overall Study|Physician Decision|3|||
33433461|NCT00437294|62810586|FG000|Overall Study|Withdrawal by Subject|5|||
33433462|NCT00437294|62810587|FG001|Overall Study|Withdrawal by Subject|0|||
33433463|NCT00437294|62810586|FG000|Overall Study|Progressive Disease|19|||
33433464|NCT00437294|62810587|FG001|Overall Study|Progressive Disease|23|||
33433465|NCT00437294|62810586|FG000|Overall Study|Sponsor Decision|8|||
33433466|NCT00437294|62810587|FG001|Overall Study|Sponsor Decision|9|||
33433467|NCT00437294|62810586|FG000|Overall Study|Protocol Violation|0|||
33433468|NCT00437294|62810587|FG001|Overall Study|Protocol Violation|1|||
33433469|NCT00437294|62810586|FG000|Overall Study|Entry criteria not met|1|||
33433470|NCT00437294|62810587|FG001|Overall Study|Entry criteria not met|1|||
33433471|NCT00436982|62810601|FG000|Overall Study|Withdrawal by Subject|3|||
33433472|NCT00436982|62810602|FG001|Overall Study|Withdrawal by Subject|1|||
33433473|NCT00436982|62810601|FG000|Overall Study|Did not receive allocated intervention|0|||
33433474|NCT00436982|62810602|FG001|Overall Study|Did not receive allocated intervention|1|||
33433475|NCT00436982|62810601|FG000|Overall Study|no RSA data|1|||
33433476|NCT00436982|62810602|FG001|Overall Study|no RSA data|2|||
33433477|NCT00443846|62810614|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
33433478|NCT00443846|62810615|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
33433479|NCT00443846|62810614|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
33433480|NCT00443846|62810615|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
33433481|NCT00443846|62810614|FG000|Overall Study|Adverse Event|0|||
33433482|NCT00443846|62810615|FG001|Overall Study|Adverse Event|1|||
33433483|NCT00443846|62810614|FG000|Overall Study|Personal reason|8|||
33433484|NCT00443846|62810615|FG001|Overall Study|Personal reason|3|||
33433485|NCT00443846|62810614|FG000|Overall Study|Lost to Follow-up|1|||
33433486|NCT00443846|62810615|FG001|Overall Study|Lost to Follow-up|2|||
33433487|NCT00436826|62810623|FG000|Double Blind Period (DBP)|Adverse Event|2|||
33433488|NCT00436826|62810624|FG001|Double Blind Period (DBP)|Adverse Event|0|||
33433489|NCT00436826|62810625|FG002|Double Blind Period (DBP)|Adverse Event|0|||
33433490|NCT00436826|62810626|FG003|Double Blind Period (DBP)|Adverse Event|0|||
33433491|NCT00436826|62810627|FG004|Double Blind Period (DBP)|Adverse Event|0|||
33433492|NCT00436826|62810628|FG005|Double Blind Period (DBP)|Adverse Event|0|||
33433493|NCT00436826|62810623|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
33433494|NCT00436826|62810624|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
33433495|NCT00436826|62810625|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
33433496|NCT00436826|62810626|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
33433497|NCT00436826|62810627|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
33433498|NCT00436826|62810628|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
33433499|NCT00436826|62810623|FG000|Double Blind Period (DBP)|Other|10|||
33433500|NCT00436826|62810624|FG001|Double Blind Period (DBP)|Other|11|||
33433501|NCT00436826|62810625|FG002|Double Blind Period (DBP)|Other|0|||
33433502|NCT00436826|62810626|FG003|Double Blind Period (DBP)|Other|0|||
33433503|NCT00436826|62810627|FG004|Double Blind Period (DBP)|Other|0|||
33433504|NCT00436826|62810628|FG005|Double Blind Period (DBP)|Other|0|||
33433505|NCT00436826|62810623|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
33433506|NCT00436826|62810624|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
33433507|NCT00436826|62810625|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
33433508|NCT00436826|62810626|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
33433509|NCT00436826|62810627|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
33433510|NCT00436826|62810628|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
33433511|NCT00436826|62810623|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
33605472|NCT01734382|63005138|FG002|Part 2|Withdrawal by Subject|1|||
33605473|NCT02391311|63005152|FG000|Overall Study|Lost to Follow-up|2|||
33433512|NCT00436826|62810624|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
33433513|NCT00436826|62810625|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
33433514|NCT00436826|62810626|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
33433515|NCT00436826|62810627|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
33433516|NCT00436826|62810628|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
33433517|NCT00436826|62810623|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
33433518|NCT00436826|62810624|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
33433519|NCT00436826|62810625|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
33433520|NCT00436826|62810626|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
33433521|NCT00436826|62810627|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
33433522|NCT00436826|62810628|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
33433523|NCT00410124|62810646|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
33433524|NCT00410124|62810647|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
33433525|NCT00410124|62810646|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
33433526|NCT00410124|62810647|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
33433527|NCT00410124|62810646|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
33433528|NCT00410124|62810647|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
33433529|NCT00410124|62810646|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
33433530|NCT00410124|62810647|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
33433531|NCT00410124|62810646|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
33433532|NCT00410124|62810647|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
33433533|NCT00410124|62810646|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
33433534|NCT00410124|62810647|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
33433535|NCT00410124|62810646|FG000|Core Phase Double Blind (15 Months)|Death|7|||
33433536|NCT00410124|62810647|FG001|Core Phase Double Blind (15 Months)|Death|4|||
33433537|NCT00410124|62810646|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
33433538|NCT00410124|62810647|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
33433539|NCT00410124|62810646|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
33433540|NCT00410124|62810647|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
33433541|NCT00410124|62810646|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
33433542|NCT00410124|62810647|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
33433543|NCT00410124|62810646|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
33433544|NCT00410124|62810647|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
33433545|NCT00410124|62810646|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
33433546|NCT00410124|62810647|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
33433547|NCT00410124|62810646|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
33433548|NCT00410124|62810647|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
33433549|NCT00410124|62810646|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
33433550|NCT00410124|62810647|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
33433551|NCT00410124|62810646|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
33433552|NCT00410124|62810647|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
33433553|NCT00410124|62810646|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
33433554|NCT00410124|62810647|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
33433555|NCT00410046|62810657|FG000|Overall Study|Adverse Event|3|||
33433556|NCT00410046|62810657|FG000|Overall Study|Withdrawal by Subject|1|||
33433557|NCT00410046|62810657|FG000|Overall Study|Lost to Follow-up|1|||
33433558|NCT00416624|62810666|FG000|Overall Study|Withdrawal by Subject|1|||
33433559|NCT00416624|62810667|FG001|Overall Study|Withdrawal by Subject|6|||
33433560|NCT00416624|62810668|FG002|Overall Study|Withdrawal by Subject|4|||
33433561|NCT00416624|62810669|FG003|Overall Study|Withdrawal by Subject|9|||
33433562|NCT00416624|62810666|FG000|Overall Study|Death|4|||
33433563|NCT00416624|62810667|FG001|Overall Study|Death|7|||
33433564|NCT00416624|62810668|FG002|Overall Study|Death|7|||
33605474|NCT02391311|63005153|FG001|Overall Study|Lost to Follow-up|1|||
33605475|NCT02391311|63005152|FG000|Overall Study|deemed ineligible after baseline|1|||
33605476|NCT02391311|63005153|FG001|Overall Study|deemed ineligible after baseline|1|||
33433565|NCT00416624|62810669|FG003|Overall Study|Death|1|||
33433566|NCT00416624|62810666|FG000|Overall Study|Adverse Event|8|||
33433567|NCT00416624|62810667|FG001|Overall Study|Adverse Event|3|||
33433568|NCT00416624|62810668|FG002|Overall Study|Adverse Event|2|||
33433569|NCT00416624|62810669|FG003|Overall Study|Adverse Event|2|||
33605477|NCT01765426|63005163|FG000|Overall Study|Lost to Follow-up|0|||
33433570|NCT00416624|62810666|FG000|Overall Study|Other|8|||
33433571|NCT00416624|62810667|FG001|Overall Study|Other|11|||
33433572|NCT00416624|62810668|FG002|Overall Study|Other|5|||
33433573|NCT00416624|62810669|FG003|Overall Study|Other|5|||
33605478|NCT01765426|63005164|FG001|Overall Study|Lost to Follow-up|1|||
33433574|NCT00416624|62810666|FG000|Overall Study|Cancel|1|||
33433575|NCT00416624|62810667|FG001|Overall Study|Cancel|0|||
33433576|NCT00416624|62810668|FG002|Overall Study|Cancel|0|||
33433577|NCT00416624|62810669|FG003|Overall Study|Cancel|0|||
33433578|NCT00262600|62810682|FG000|Overall Study|Lost to Follow-up|17|||
33433579|NCT00262600|62810683|FG001|Overall Study|Lost to Follow-up|31|||
33433580|NCT00262600|62810684|FG002|Overall Study|Lost to Follow-up|41|||
33433581|NCT00262600|62810682|FG000|Overall Study|Withdrawal by Subject|128|||
33433582|NCT00262600|62810683|FG001|Overall Study|Withdrawal by Subject|145|||
33433583|NCT00262600|62810684|FG002|Overall Study|Withdrawal by Subject|139|||
33433584|NCT00262600|62810682|FG000|Overall Study|Not Treated|32|||
33433585|NCT00262600|62810683|FG001|Overall Study|Not Treated|17|||
33433586|NCT00262600|62810684|FG002|Overall Study|Not Treated|24|||
33433587|NCT00262600|62810682|FG000|Overall Study|Other|58|||
33433588|NCT00262600|62810683|FG001|Overall Study|Other|59|||
33433589|NCT00262600|62810684|FG002|Overall Study|Other|62|||
33433590|NCT00409578|62810696|FG000|Overall Study|Adverse Event|27|||
33433591|NCT00409578|62810697|FG001|Overall Study|Adverse Event|37|||
33433592|NCT00409578|62810698|FG002|Overall Study|Adverse Event|25|||
33433593|NCT00409578|62810699|FG003|Overall Study|Adverse Event|33|||
33433594|NCT00409578|62810696|FG000|Overall Study|Abnormal laboratory value(s)|2|||
33433595|NCT00409578|62810697|FG001|Overall Study|Abnormal laboratory value(s)|2|||
33433596|NCT00409578|62810698|FG002|Overall Study|Abnormal laboratory value(s)|2|||
33433597|NCT00409578|62810699|FG003|Overall Study|Abnormal laboratory value(s)|4|||
33433598|NCT00409578|62810696|FG000|Overall Study|Lack of Efficacy|0|||
33433599|NCT00409578|62810697|FG001|Overall Study|Lack of Efficacy|0|||
33433600|NCT00409578|62810698|FG002|Overall Study|Lack of Efficacy|0|||
33433601|NCT00409578|62810699|FG003|Overall Study|Lack of Efficacy|2|||
33433602|NCT00409578|62810696|FG000|Overall Study|Subject no longer requires study drug|0|||
33433603|NCT00409578|62810697|FG001|Overall Study|Subject no longer requires study drug|0|||
33433604|NCT00409578|62810698|FG002|Overall Study|Subject no longer requires study drug|0|||
33433605|NCT00409578|62810699|FG003|Overall Study|Subject no longer requires study drug|1|||
33433606|NCT00409578|62810696|FG000|Overall Study|Withdrawal by Subject|8|||
33433607|NCT00409578|62810697|FG001|Overall Study|Withdrawal by Subject|15|||
33433608|NCT00409578|62810698|FG002|Overall Study|Withdrawal by Subject|16|||
33433609|NCT00409578|62810699|FG003|Overall Study|Withdrawal by Subject|17|||
33433610|NCT00409578|62810696|FG000|Overall Study|Lost to Follow-up|2|||
33433611|NCT00409578|62810697|FG001|Overall Study|Lost to Follow-up|0|||
33433612|NCT00409578|62810698|FG002|Overall Study|Lost to Follow-up|2|||
33433613|NCT00409578|62810699|FG003|Overall Study|Lost to Follow-up|2|||
33433614|NCT00409578|62810696|FG000|Overall Study|Administrative problems|8|||
33433615|NCT00409578|62810697|FG001|Overall Study|Administrative problems|9|||
33433616|NCT00409578|62810698|FG002|Overall Study|Administrative problems|2|||
33433617|NCT00409578|62810699|FG003|Overall Study|Administrative problems|4|||
33433618|NCT00409578|62810696|FG000|Overall Study|Death|2|||
33433619|NCT00409578|62810697|FG001|Overall Study|Death|4|||
33433620|NCT00409578|62810698|FG002|Overall Study|Death|4|||
33433621|NCT00409578|62810699|FG003|Overall Study|Death|2|||
33433622|NCT00409578|62810696|FG000|Overall Study|Protocol Violation|3|||
33433623|NCT00409578|62810697|FG001|Overall Study|Protocol Violation|2|||
33433624|NCT00409578|62810698|FG002|Overall Study|Protocol Violation|3|||
33433625|NCT00409578|62810699|FG003|Overall Study|Protocol Violation|1|||
33433626|NCT00409578|62810696|FG000|Overall Study|Missing|0|||
33433627|NCT00409578|62810697|FG001|Overall Study|Missing|1|||
33433628|NCT00409578|62810698|FG002|Overall Study|Missing|0|||
33433629|NCT00409578|62810699|FG003|Overall Study|Missing|1|||
33433630|NCT00428090|62810713|FG000|Overall Study|Adverse Event|10|||
33433631|NCT00428090|62810714|FG001|Overall Study|Adverse Event|8|||
33433632|NCT00428090|62810715|FG002|Overall Study|Adverse Event|10|||
33433633|NCT00428090|62810716|FG003|Overall Study|Adverse Event|11|||
33433634|NCT00428090|62810713|FG000|Overall Study|Lost to Follow-up|3|||
33433635|NCT00428090|62810714|FG001|Overall Study|Lost to Follow-up|6|||
33433636|NCT00428090|62810715|FG002|Overall Study|Lost to Follow-up|1|||
33433637|NCT00428090|62810716|FG003|Overall Study|Lost to Follow-up|4|||
33433638|NCT00428090|62810713|FG000|Overall Study|Protocol Violation|3|||
33433639|NCT00428090|62810714|FG001|Overall Study|Protocol Violation|1|||
33433640|NCT00428090|62810715|FG002|Overall Study|Protocol Violation|3|||
33433641|NCT00428090|62810716|FG003|Overall Study|Protocol Violation|3|||
33433642|NCT00428090|62810713|FG000|Overall Study|Withdrawal by Subject|10|||
33433643|NCT00428090|62810714|FG001|Overall Study|Withdrawal by Subject|12|||
33433644|NCT00428090|62810715|FG002|Overall Study|Withdrawal by Subject|15|||
33433645|NCT00428090|62810716|FG003|Overall Study|Withdrawal by Subject|5|||
33433646|NCT00428090|62810713|FG000|Overall Study|Sponsor terminated study|0|||
33433647|NCT00428090|62810714|FG001|Overall Study|Sponsor terminated study|1|||
33433648|NCT00428090|62810715|FG002|Overall Study|Sponsor terminated study|0|||
33433649|NCT00428090|62810716|FG003|Overall Study|Sponsor terminated study|0|||
33433650|NCT00428090|62810713|FG000|Overall Study|Non-compliance|4|||
33433651|NCT00428090|62810714|FG001|Overall Study|Non-compliance|0|||
33433652|NCT00428090|62810715|FG002|Overall Study|Non-compliance|1|||
33433653|NCT00428090|62810716|FG003|Overall Study|Non-compliance|3|||
33433654|NCT00428090|62810713|FG000|Overall Study|Par. did not returned to visit|1|||
33433655|NCT00428090|62810714|FG001|Overall Study|Par. did not returned to visit|0|||
33433656|NCT00428090|62810715|FG002|Overall Study|Par. did not returned to visit|0|||
33433657|NCT00428090|62810716|FG003|Overall Study|Par. did not returned to visit|1|||
33433658|NCT00428090|62810713|FG000|Overall Study|Follow-Up visit not possible|1|||
33433659|NCT00428090|62810714|FG001|Overall Study|Follow-Up visit not possible|0|||
33433660|NCT00428090|62810715|FG002|Overall Study|Follow-Up visit not possible|0|||
33433661|NCT00428090|62810716|FG003|Overall Study|Follow-Up visit not possible|0|||
33433662|NCT00428090|62810713|FG000|Overall Study|Prohibited medication used for SAE|1|||
33433663|NCT00428090|62810714|FG001|Overall Study|Prohibited medication used for SAE|0|||
33433664|NCT00428090|62810715|FG002|Overall Study|Prohibited medication used for SAE|0|||
33433665|NCT00428090|62810716|FG003|Overall Study|Prohibited medication used for SAE|0|||
33433666|NCT00428090|62810713|FG000|Overall Study|Death of par.|1|||
33433667|NCT00428090|62810714|FG001|Overall Study|Death of par.|0|||
33433668|NCT00428090|62810715|FG002|Overall Study|Death of par.|1|||
33433669|NCT00428090|62810716|FG003|Overall Study|Death of par.|0|||
33433670|NCT00428090|62810713|FG000|Overall Study|Visit 7 exceed the visit window|0|||
33433671|NCT00428090|62810714|FG001|Overall Study|Visit 7 exceed the visit window|1|||
33433672|NCT00428090|62810715|FG002|Overall Study|Visit 7 exceed the visit window|0|||
33433673|NCT00428090|62810716|FG003|Overall Study|Visit 7 exceed the visit window|0|||
33433674|NCT00428090|62810713|FG000|Overall Study|Medical monitor terminated par.|0|||
33433675|NCT00428090|62810714|FG001|Overall Study|Medical monitor terminated par.|1|||
33433676|NCT00428090|62810715|FG002|Overall Study|Medical monitor terminated par.|0|||
33605479|NCT01765426|63005165|FG002|Overall Study|Lost to Follow-up|0|||
33433677|NCT00428090|62810716|FG003|Overall Study|Medical monitor terminated par.|0|||
33433678|NCT00428090|62810713|FG000|Overall Study|Mental status of par. was|0|||
33433679|NCT00428090|62810714|FG001|Overall Study|Mental status of par. was|1|||
33433680|NCT00428090|62810715|FG002|Overall Study|Mental status of par. was|0|||
33433681|NCT00428090|62810716|FG003|Overall Study|Mental status of par. was|0|||
33433682|NCT00428090|62810713|FG000|Overall Study|Worsening of AD|0|||
33433683|NCT00428090|62810714|FG001|Overall Study|Worsening of AD|0|||
33433684|NCT00428090|62810715|FG002|Overall Study|Worsening of AD|1|||
33433685|NCT00428090|62810716|FG003|Overall Study|Worsening of AD|0|||
33433686|NCT00428090|62810713|FG000|Overall Study|Excluded for concerning QTc value|0|||
33433687|NCT00428090|62810714|FG001|Overall Study|Excluded for concerning QTc value|0|||
33433688|NCT00428090|62810715|FG002|Overall Study|Excluded for concerning QTc value|1|||
33433689|NCT00428090|62810716|FG003|Overall Study|Excluded for concerning QTc value|0|||
33433690|NCT00428090|62810713|FG000|Overall Study|Insufficient AD documentation|0|||
33433691|NCT00428090|62810714|FG001|Overall Study|Insufficient AD documentation|0|||
33433692|NCT00428090|62810715|FG002|Overall Study|Insufficient AD documentation|1|||
33433693|NCT00428090|62810716|FG003|Overall Study|Insufficient AD documentation|0|||
33433694|NCT00428090|62810713|FG000|Overall Study|High MMSE scores|0|||
33433695|NCT00428090|62810714|FG001|Overall Study|High MMSE scores|0|||
33433696|NCT00428090|62810715|FG002|Overall Study|High MMSE scores|1|||
33433697|NCT00428090|62810716|FG003|Overall Study|High MMSE scores|0|||
33433698|NCT00428090|62810713|FG000|Overall Study|Deterioration of cognitive status|0|||
33433699|NCT00428090|62810714|FG001|Overall Study|Deterioration of cognitive status|0|||
33433700|NCT00428090|62810715|FG002|Overall Study|Deterioration of cognitive status|1|||
33433701|NCT00428090|62810716|FG003|Overall Study|Deterioration of cognitive status|0|||
33433702|NCT00428090|62810713|FG000|Overall Study|Serious adverse event|0|||
33433703|NCT00428090|62810714|FG001|Overall Study|Serious adverse event|0|||
33433704|NCT00428090|62810715|FG002|Overall Study|Serious adverse event|1|||
33433705|NCT00428090|62810716|FG003|Overall Study|Serious adverse event|0|||
33433706|NCT00428090|62810713|FG000|Overall Study|Excluded for heart insufficiency|0|||
33433707|NCT00428090|62810714|FG001|Overall Study|Excluded for heart insufficiency|0|||
33433708|NCT00428090|62810715|FG002|Overall Study|Excluded for heart insufficiency|1|||
33433709|NCT00428090|62810716|FG003|Overall Study|Excluded for heart insufficiency|0|||
33433710|NCT00428090|62810713|FG000|Overall Study|Raised Creatinine Value|0|||
33433711|NCT00428090|62810714|FG001|Overall Study|Raised Creatinine Value|0|||
33433712|NCT00428090|62810715|FG002|Overall Study|Raised Creatinine Value|0|||
33433713|NCT00428090|62810716|FG003|Overall Study|Raised Creatinine Value|1|||
33433714|NCT00416312|62810734|FG000|Overall Study|tumors not visible on imaging|2|||
33433715|NCT00436436|62810738|FG000|Overall Study|Progression|4|||
33433716|NCT00436436|62810738|FG000|Overall Study|Adverse Event|2|||
33433717|NCT00436436|62810738|FG000|Overall Study|Death|6|||
33433718|NCT00262522|62810746|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
33433719|NCT00262522|62810747|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
33433720|NCT00262522|62810748|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
33433721|NCT00262522|62810749|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
33433722|NCT00262522|62810746|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
33433723|NCT00262522|62810747|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
33433724|NCT00262522|62810748|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
33433725|NCT00262522|62810749|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
33433726|NCT00262522|62810746|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
33433727|NCT00262522|62810747|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
33433728|NCT00262522|62810748|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
33433729|NCT00262522|62810749|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
33433730|NCT00262522|62810746|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
33433731|NCT00262522|62810747|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
33433732|NCT00262522|62810748|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
33433733|NCT00262522|62810749|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
33433734|NCT00262522|62810746|FG000|Study Start Through 8 Weeks|Death|1|||
33433735|NCT00262522|62810747|FG001|Study Start Through 8 Weeks|Death|0|||
33433736|NCT00262522|62810748|FG002|Study Start Through 8 Weeks|Death|0|||
33433737|NCT00262522|62810749|FG003|Study Start Through 8 Weeks|Death|0|||
33433738|NCT00262522|62810746|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
33433739|NCT00262522|62810747|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
33433740|NCT00262522|62810748|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
33433741|NCT00262522|62810749|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
33433742|NCT00262522|62810746|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
33433743|NCT00262522|62810747|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
33433744|NCT00262522|62810748|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
33433745|NCT00262522|62810749|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
33433746|NCT00262522|62810746|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
33433747|NCT00262522|62810747|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
33433748|NCT00262522|62810748|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
33433749|NCT00262522|62810749|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
33433750|NCT00262522|62810746|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
33433751|NCT00262522|62810747|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
33433752|NCT00262522|62810748|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
33433753|NCT00262522|62810749|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
33433754|NCT00262522|62810746|FG000|Study Start Through 48 Weeks|Death|2|||
33433755|NCT00262522|62810747|FG001|Study Start Through 48 Weeks|Death|0|||
33433756|NCT00262522|62810748|FG002|Study Start Through 48 Weeks|Death|1|||
33433757|NCT00262522|62810749|FG003|Study Start Through 48 Weeks|Death|0|||
33433758|NCT00262522|62810746|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
33433759|NCT00262522|62810747|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
33433760|NCT00262522|62810748|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
33433761|NCT00262522|62810749|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
33433762|NCT00262522|62810746|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
33433763|NCT00262522|62810747|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
33433764|NCT00262522|62810748|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
33433765|NCT00262522|62810749|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
33433766|NCT00262522|62810746|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
33433767|NCT00262522|62810747|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
33433768|NCT00262522|62810748|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
33433769|NCT00262522|62810749|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
33433770|NCT00262522|62810746|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
33433771|NCT00262522|62810747|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
33433772|NCT00262522|62810748|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
33433773|NCT00262522|62810749|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
33433774|NCT00262522|62810746|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
33433775|NCT00262522|62810747|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
33433776|NCT00262522|62810748|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
33433777|NCT00262522|62810749|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
33433778|NCT00262522|62810746|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
33433779|NCT00262522|62810747|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
33433780|NCT00262522|62810748|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
33433781|NCT00262522|62810749|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
33433782|NCT00262522|62810746|FG000|Study Start Through 96 Weeks|Death|2|||
33433783|NCT00262522|62810747|FG001|Study Start Through 96 Weeks|Death|0|||
33433784|NCT00262522|62810748|FG002|Study Start Through 96 Weeks|Death|2|||
33433785|NCT00262522|62810749|FG003|Study Start Through 96 Weeks|Death|0|||
33433786|NCT00262522|62810746|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
33433787|NCT00262522|62810747|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
33433788|NCT00262522|62810748|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
33433789|NCT00262522|62810749|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
33433790|NCT00262522|62810746|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
33433791|NCT00262522|62810747|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
33433792|NCT00262522|62810748|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
33433793|NCT00262522|62810749|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
33433794|NCT00436280|62810757|FG000|Period 1: Induction|Adverse Event|8|||
33433795|NCT00436280|62810757|FG000|Period 1: Induction|Progressive Disease|12|||
33433796|NCT00436280|62810757|FG000|Period 1: Induction|Stable Disease|6|||
33433797|NCT00436280|62810757|FG000|Period 1: Induction|Withdrawal by Subject|1|||
33433798|NCT00436280|62810757|FG000|Period 1: Induction|Death|1|||
33433799|NCT00436280|62810757|FG000|Period 2: Consolidation|Adverse Event|1|||
33433800|NCT00436280|62810757|FG000|Period 2: Consolidation|Progressive Disease|10|||
33433801|NCT00436280|62810757|FG000|Period 2: Consolidation|Stable Disease|1|||
33433802|NCT00436280|62810757|FG000|Period 2: Consolidation|Physician Decision|2|||
33433803|NCT00436280|62810757|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
33433804|NCT00436280|62810757|FG000|Period 2: Consolidation|Death|1|||
33433805|NCT00436280|62810757|FG000|Period 3: Maintenance|Adverse Event|6|||
33433806|NCT00436280|62810757|FG000|Period 3: Maintenance|Progressive Disease|12|||
33433807|NCT00394836|62810763|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
33433808|NCT00394836|62810764|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
33433809|NCT00394836|62810763|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
33433810|NCT00394836|62810764|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
33433811|NCT00394836|62810763|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
33433812|NCT00394836|62810764|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
33433813|NCT00394836|62810763|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
33605480|NCT01765426|63005166|FG003|Overall Study|Lost to Follow-up|0|||
33433814|NCT00394836|62810764|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
33605481|NCT01765270|63005178|FG000|Overall Study|Physician Decision|1|||
33605482|NCT01765270|63005179|FG001|Overall Study|Physician Decision|0|||
33605483|NCT01765270|63005178|FG000|Overall Study|Withdrawal by Subject|0|||
33605484|NCT01765270|63005179|FG001|Overall Study|Withdrawal by Subject|1|||
33433815|NCT00394836|62810763|FG000|Teatment or Follow-up Phase|Death|0|||
33433816|NCT00394836|62810764|FG001|Teatment or Follow-up Phase|Death|1|||
33433817|NCT00394836|62810763|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
33433818|NCT00394836|62810764|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
33433819|NCT00394836|62810763|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
33433820|NCT00394836|62810764|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
33433821|NCT00394836|62810763|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
33433822|NCT00394836|62810764|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
33433823|NCT00394836|62810763|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
33433824|NCT00394836|62810764|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
33433825|NCT00394836|62810763|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
33433826|NCT00394836|62810764|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
33433827|NCT00394836|62810763|FG000|Teatment or Follow-up Phase|Non compliance|0|||
33433828|NCT00394836|62810764|FG001|Teatment or Follow-up Phase|Non compliance|1|||
33433829|NCT00394836|62810763|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
33433830|NCT00394836|62810764|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
33433831|NCT00394836|62810763|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
33433832|NCT00394836|62810764|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
33433833|NCT00394836|62810763|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
33433834|NCT00394836|62810764|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
33433835|NCT00394836|62810763|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
33433836|NCT00394836|62810764|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
33433837|NCT00250588|62810775|FG000|Overall Study|Withdrawal by Subject|3|||
33433838|NCT00250588|62810776|FG001|Overall Study|Withdrawal by Subject|6|||
33433839|NCT00250588|62810777|FG002|Overall Study|Withdrawal by Subject|0|||
33433840|NCT00250588|62810775|FG000|Overall Study|Lost to Follow-up|6|||
33433841|NCT00250588|62810776|FG001|Overall Study|Lost to Follow-up|13|||
33433842|NCT00250588|62810777|FG002|Overall Study|Lost to Follow-up|13|||
33433843|NCT00416078|62810787|FG000|Overall Study|Death|3|||
33433844|NCT00416078|62810788|FG001|Overall Study|Death|4|||
33433845|NCT00416078|62810787|FG000|Overall Study|Withdrawal by Subject|3|||
33433846|NCT00416078|62810788|FG001|Overall Study|Withdrawal by Subject|2|||
33433847|NCT00416078|62810787|FG000|Overall Study|Physician Decision|1|||
33433848|NCT00416078|62810788|FG001|Overall Study|Physician Decision|0|||
33433849|NCT00416078|62810787|FG000|Overall Study|Lost to Follow-up|4|||
33433850|NCT00416078|62810788|FG001|Overall Study|Lost to Follow-up|2|||
33433851|NCT00394524|62810796|FG000|Overall Study|Protocol Violation|2|||
33433852|NCT00394524|62810797|FG001|Overall Study|Protocol Violation|3|||
33433853|NCT00394524|62810796|FG000|Overall Study|Death|1|||
33433854|NCT00394524|62810797|FG001|Overall Study|Death|0|||
33433855|NCT00394524|62810796|FG000|Overall Study|Withdrawal by Subject|0|||
33433856|NCT00394524|62810797|FG001|Overall Study|Withdrawal by Subject|1|||
33433857|NCT00409344|62810807|FG000|Overall Study|no enrollment|0|||
33433858|NCT00409344|62810808|FG001|Overall Study|no enrollment|0|||
33433859|NCT00415610|62810817|FG000|Overall Study|Death|3|||
33433860|NCT00415610|62810818|FG001|Overall Study|Death|2|||
33433861|NCT00415610|62810819|FG002|Overall Study|Death|5|||
33433862|NCT00394212|62810829|FG000|Overall Study|Lost to Follow-up|3|||
33433863|NCT00394212|62810830|FG001|Overall Study|Lost to Follow-up|0|||
33433864|NCT00394212|62810829|FG000|Overall Study|Withdrawal by Subject|4|||
33433865|NCT00394212|62810830|FG001|Overall Study|Withdrawal by Subject|1|||
33433866|NCT00250432|62810838|FG000|Overall Study|Adverse Event|25|||
33433867|NCT00250432|62810839|FG001|Overall Study|Adverse Event|29|||
33433868|NCT00250432|62810838|FG000|Overall Study|Lack of Efficacy|2|||
33433869|NCT00250432|62810839|FG001|Overall Study|Lack of Efficacy|1|||
33433870|NCT00250432|62810838|FG000|Overall Study|Lost to Follow-up|6|||
33433871|NCT00250432|62810839|FG001|Overall Study|Lost to Follow-up|5|||
33433872|NCT00250432|62810838|FG000|Overall Study|Patient Moved|0|||
33433873|NCT00250432|62810839|FG001|Overall Study|Patient Moved|1|||
33433874|NCT00250432|62810838|FG000|Overall Study|Protocol Violation|0|||
33433875|NCT00250432|62810839|FG001|Overall Study|Protocol Violation|3|||
33433876|NCT00250432|62810838|FG000|Overall Study|Withdrawal by Subject|6|||
33433877|NCT00250432|62810839|FG001|Overall Study|Withdrawal by Subject|2|||
33433878|NCT00250432|62810838|FG000|Overall Study|Pt died out of posttherapy report period|6|||
33433879|NCT00250432|62810839|FG001|Overall Study|Pt died out of posttherapy report period|5|||
33433880|NCT00250432|62810838|FG000|Overall Study|Pt was considered untreatable|0|||
33433881|NCT00250432|62810839|FG001|Overall Study|Pt was considered untreatable|1|||
33433882|NCT00250276|62810849|FG000|Overall Study|Serious Adverse Event|0|||
33433883|NCT00250276|62810850|FG001|Overall Study|Serious Adverse Event|0|||
33433884|NCT00250276|62810851|FG002|Overall Study|Serious Adverse Event|1|||
33433885|NCT00250276|62810852|FG003|Overall Study|Serious Adverse Event|0|||
33433886|NCT00250276|62810849|FG000|Overall Study|Non-serious Adverse Event|2|||
33433887|NCT00250276|62810850|FG001|Overall Study|Non-serious Adverse Event|0|||
33433888|NCT00250276|62810851|FG002|Overall Study|Non-serious Adverse Event|0|||
33433889|NCT00250276|62810852|FG003|Overall Study|Non-serious Adverse Event|2|||
33433890|NCT00250276|62810849|FG000|Overall Study|Protocol Violation|0|||
33433891|NCT00250276|62810850|FG001|Overall Study|Protocol Violation|1|||
33433892|NCT00250276|62810851|FG002|Overall Study|Protocol Violation|0|||
33433893|NCT00250276|62810852|FG003|Overall Study|Protocol Violation|0|||
33433894|NCT00250276|62810849|FG000|Overall Study|Withdrawal by Subject|1|||
33433895|NCT00250276|62810850|FG001|Overall Study|Withdrawal by Subject|2|||
33433896|NCT00250276|62810851|FG002|Overall Study|Withdrawal by Subject|3|||
33433897|NCT00250276|62810852|FG003|Overall Study|Withdrawal by Subject|2|||
33433898|NCT00250276|62810849|FG000|Overall Study|Migrated/moved from study area|3|||
33433899|NCT00250276|62810850|FG001|Overall Study|Migrated/moved from study area|0|||
33433900|NCT00250276|62810851|FG002|Overall Study|Migrated/moved from study area|2|||
33433901|NCT00250276|62810852|FG003|Overall Study|Migrated/moved from study area|7|||
33433902|NCT00250276|62810849|FG000|Overall Study|Lost to Follow-up|11|||
33433903|NCT00250276|62810850|FG001|Overall Study|Lost to Follow-up|18|||
33433904|NCT00250276|62810851|FG002|Overall Study|Lost to Follow-up|13|||
33433905|NCT00250276|62810852|FG003|Overall Study|Lost to Follow-up|8|||
33433906|NCT00249808|62810867|FG000|Overall Study|Other|27|||
33433907|NCT00249808|62810867|FG000|Overall Study|Protocol Violation|3|||
33433908|NCT00249808|62810867|FG000|Overall Study|Lost to Follow-up|8|||
33433909|NCT00249808|62810867|FG000|Overall Study|Adverse Event|81|||
33433910|NCT00249808|62810867|FG000|Overall Study|Lack of Efficacy|52|||
33433911|NCT00249808|62810867|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
33433912|NCT00278512|62810873|FG000|Overall Study|Death|1|||
33433913|NCT00278512|62810874|FG001|Overall Study|Death|0|||
33433914|NCT00427934|62810884|FG000|Overall Study|Adverse Event|1|||
33433915|NCT00427934|62810885|FG001|Overall Study|Adverse Event|0|||
33433916|NCT00427934|62810886|FG002|Overall Study|Adverse Event|5|||
33433917|NCT00427934|62810887|FG003|Overall Study|Adverse Event|4|||
33433918|NCT00427934|62810884|FG000|Overall Study|Lack of Efficacy|0|||
33433919|NCT00427934|62810885|FG001|Overall Study|Lack of Efficacy|0|||
33433920|NCT00427934|62810886|FG002|Overall Study|Lack of Efficacy|5|||
33433921|NCT00427934|62810887|FG003|Overall Study|Lack of Efficacy|2|||
33433922|NCT00427934|62810884|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
33433923|NCT00427934|62810885|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
33433924|NCT00427934|62810886|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
33433925|NCT00427934|62810887|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
33433926|NCT00427934|62810884|FG000|Overall Study|Other|0|||
33433927|NCT00427934|62810885|FG001|Overall Study|Other|0|||
33433928|NCT00427934|62810886|FG002|Overall Study|Other|11|||
33433929|NCT00427934|62810887|FG003|Overall Study|Other|5|||
33433930|NCT00427934|62810884|FG000|Overall Study|Withdrawal by Subject|0|||
33433931|NCT00427934|62810885|FG001|Overall Study|Withdrawal by Subject|0|||
33433932|NCT00427934|62810886|FG002|Overall Study|Withdrawal by Subject|1|||
33433933|NCT00427934|62810887|FG003|Overall Study|Withdrawal by Subject|3|||
33433934|NCT00435188|62810901|FG000|Overall Study|Death|1|||
33433935|NCT00435188|62810902|FG001|Overall Study|Death|6|||
33433936|NCT00435188|62810901|FG000|Overall Study|Withdrawal by Subject|16|||
33433937|NCT00435188|62810902|FG001|Overall Study|Withdrawal by Subject|11|||
33433938|NCT00435188|62810901|FG000|Overall Study|Lost to Follow-up|5|||
33433939|NCT00435188|62810902|FG001|Overall Study|Lost to Follow-up|6|||
33433940|NCT00427778|62810910|FG000|First Intervention (4 Weeks)|no longer interested|1|||
33433941|NCT00427778|62810911|FG001|First Intervention (4 Weeks)|no longer interested|0|||
33433942|NCT00427778|62810910|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
33433943|NCT00427778|62810911|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
33433944|NCT00427778|62810910|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
33433945|NCT00427778|62810911|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
33433946|NCT00427778|62810910|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
33433947|NCT00427778|62810911|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
33433948|NCT00427700|62810932|FG000|Overall Study|Lost to Follow-up|2|||
33433949|NCT00427700|62810933|FG001|Overall Study|Lost to Follow-up|5|||
33433950|NCT00427700|62810932|FG000|Overall Study|no induction of menses|1|||
33433951|NCT00427700|62810933|FG001|Overall Study|no induction of menses|4|||
33433952|NCT00427700|62810932|FG000|Overall Study|Pregnancy|0|||
33433953|NCT00427700|62810933|FG001|Overall Study|Pregnancy|2|||
33433954|NCT00409188|62810942|FG000|Overall Study|Ongoing at data cut-off|383|||
33323173|NCT01175135|62699455|FG000|Overall Study|Death|1|||
33433955|NCT00409188|62810943|FG001|Overall Study|Ongoing at data cut-off|175|||
33433956|NCT00434954|62810951|FG000|Overall Study|Adverse Event|17|||
33433957|NCT00434954|62810952|FG001|Overall Study|Adverse Event|2|||
33433958|NCT00434954|62810951|FG000|Overall Study|Entry criteria not met|14|||
33433959|NCT00434954|62810952|FG001|Overall Study|Entry criteria not met|16|||
33433960|NCT00434954|62810951|FG000|Overall Study|Lost to Follow-up|0|||
33433961|NCT00434954|62810952|FG001|Overall Study|Lost to Follow-up|1|||
33433962|NCT00434954|62810951|FG000|Overall Study|Physician Decision|6|||
33433963|NCT00434954|62810952|FG001|Overall Study|Physician Decision|3|||
33433964|NCT00434954|62810951|FG000|Overall Study|Protocol Violation|36|||
33605485|NCT01733758|63005190|FG000|Overall Study|Adverse Event|5|||
33605486|NCT01733758|63005191|FG001|Overall Study|Adverse Event|7|||
33605487|NCT01733758|63005192|FG002|Overall Study|Adverse Event|8|||
33605488|NCT01733758|63005193|FG003|Overall Study|Adverse Event|1|||
33433965|NCT00434954|62810952|FG001|Overall Study|Protocol Violation|27|||
33433966|NCT00434954|62810951|FG000|Overall Study|Sponsor decision|1|||
33433967|NCT00434954|62810952|FG001|Overall Study|Sponsor decision|0|||
33433968|NCT00434954|62810951|FG000|Overall Study|Subject decision|8|||
33433969|NCT00434954|62810952|FG001|Overall Study|Subject decision|22|||
33433970|NCT00276484|62810960|FG000|Overall Study|Adverse Event|4|||
33433971|NCT00276484|62810961|FG001|Overall Study|Adverse Event|7|||
33433972|NCT00276484|62810960|FG000|Overall Study|Lost to Follow-up|1|||
33433973|NCT00276484|62810961|FG001|Overall Study|Lost to Follow-up|1|||
33433974|NCT00276484|62810960|FG000|Overall Study|Protocol Violation|0|||
33433975|NCT00276484|62810961|FG001|Overall Study|Protocol Violation|1|||
33433976|NCT00276484|62810960|FG000|Overall Study|Withdrawal by Subject|4|||
33433977|NCT00276484|62810961|FG001|Overall Study|Withdrawal by Subject|3|||
33433978|NCT00276484|62810960|FG000|Overall Study|Could not take time off work|0|||
33433979|NCT00276484|62810961|FG001|Overall Study|Could not take time off work|1|||
33433980|NCT00426842|62810967|FG000|Overall Study|Lost to Follow-up|1|||
33433981|NCT00434876|62810975|FG000|Overall Study|Lost to Follow-up|1|||
33433982|NCT00434876|62810976|FG001|Overall Study|Lost to Follow-up|1|||
33433983|NCT00276094|62810985|FG000|Overall Study|Adverse Event|15|||
33433984|NCT00276094|62810986|FG001|Overall Study|Adverse Event|13|||
33433985|NCT00276094|62810987|FG002|Overall Study|Adverse Event|11|||
33433986|NCT00276094|62810985|FG000|Overall Study|Withdrawal by Subject|14|||
33433987|NCT00276094|62810986|FG001|Overall Study|Withdrawal by Subject|14|||
33433988|NCT00276094|62810987|FG002|Overall Study|Withdrawal by Subject|12|||
33433989|NCT00276094|62810985|FG000|Overall Study|Protocol Violation|16|||
33433990|NCT00276094|62810986|FG001|Overall Study|Protocol Violation|7|||
33433991|NCT00276094|62810987|FG002|Overall Study|Protocol Violation|10|||
33433992|NCT00276094|62810985|FG000|Overall Study|Lost to Follow-up|8|||
33433993|NCT00276094|62810986|FG001|Overall Study|Lost to Follow-up|6|||
33433994|NCT00276094|62810987|FG002|Overall Study|Lost to Follow-up|4|||
33433995|NCT00276094|62810985|FG000|Overall Study|Other-Subject moved out of country|1|||
33433996|NCT00276094|62810986|FG001|Overall Study|Other-Subject moved out of country|0|||
33433997|NCT00276094|62810987|FG002|Overall Study|Other-Subject moved out of country|0|||
33433998|NCT00276094|62810985|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
33433999|NCT00276094|62810986|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
33434000|NCT00276094|62810987|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
33434001|NCT00276094|62810985|FG000|Overall Study|Other-Lack of efficacy|1|||
33434002|NCT00276094|62810986|FG001|Overall Study|Other-Lack of efficacy|0|||
33434003|NCT00276094|62810987|FG002|Overall Study|Other-Lack of efficacy|0|||
33434004|NCT00276094|62810985|FG000|Overall Study|Other-Refused follow-up visit|1|||
33434005|NCT00276094|62810986|FG001|Overall Study|Other-Refused follow-up visit|0|||
33434006|NCT00276094|62810987|FG002|Overall Study|Other-Refused follow-up visit|0|||
33434007|NCT00276094|62810985|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
33434008|NCT00276094|62810986|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
33434009|NCT00276094|62810987|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
33434010|NCT00276094|62810985|FG000|Overall Study|Other-Relocation|0|||
33434011|NCT00276094|62810986|FG001|Overall Study|Other-Relocation|1|||
33434012|NCT00276094|62810987|FG002|Overall Study|Other-Relocation|0|||
33434013|NCT00276094|62810985|FG000|Overall Study|Other-Study medication lost|0|||
33434014|NCT00276094|62810986|FG001|Overall Study|Other-Study medication lost|0|||
33434015|NCT00276094|62810987|FG002|Overall Study|Other-Study medication lost|1|||
33434016|NCT00276016|62811001|FG000|Intervention 1|Withdrawal by Subject|0|||
33434017|NCT00276016|62811002|FG001|Intervention 1|Withdrawal by Subject|1|||
33434018|NCT00276016|62811003|FG002|Intervention 1|Withdrawal by Subject|0|||
33434019|NCT00276016|62811004|FG003|Intervention 1|Withdrawal by Subject|0|||
33605489|NCT01733758|63005190|FG000|Overall Study|Withdrawal by Subject|1|||
33434020|NCT00276016|62811005|FG004|Intervention 1|Withdrawal by Subject|0|||
33434021|NCT00276016|62811006|FG005|Intervention 1|Withdrawal by Subject|0|||
33434022|NCT00434642|62811017|FG000|Blinded Treatment Phase|Adverse Event|12|||
33434023|NCT00434642|62811018|FG001|Blinded Treatment Phase|Adverse Event|58|||
33434024|NCT00434642|62811017|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
33434025|NCT00434642|62811018|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
33434026|NCT00434642|62811017|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
33434027|NCT00434642|62811018|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
33434028|NCT00434642|62811017|FG000|Blinded Treatment Phase|Physician Decision|19|||
33434029|NCT00434642|62811018|FG001|Blinded Treatment Phase|Physician Decision|27|||
33434030|NCT00434642|62811017|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
33605490|NCT01733758|63005191|FG001|Overall Study|Withdrawal by Subject|1|||
33323174|NCT01175135|62699456|FG001|Overall Study|Death|0|||
33323175|NCT01175135|62699457|FG002|Overall Study|Death|0|||
33434031|NCT00434642|62811018|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
33434032|NCT00434642|62811017|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
33434033|NCT00434642|62811018|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
33434034|NCT00434642|62811017|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
33434035|NCT00434642|62811018|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
33434036|NCT00434642|62811017|FG000|Open-label Treatment Phase|Adverse Event|0|||
33434037|NCT00434642|62811018|FG001|Open-label Treatment Phase|Adverse Event|5|||
33434038|NCT00434642|62811017|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
33434039|NCT00434642|62811018|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
33434040|NCT00434330|62811030|FG000|Overall Study|Adverse Event|0|||
33434041|NCT00434330|62811031|FG001|Overall Study|Adverse Event|0|||
33434042|NCT00434330|62811032|FG002|Overall Study|Adverse Event|1|||
33434043|NCT00434330|62811033|FG003|Overall Study|Adverse Event|0|||
33434044|NCT00434330|62811034|FG004|Overall Study|Adverse Event|0|||
33434045|NCT00434330|62811035|FG005|Overall Study|Adverse Event|0|||
33434046|NCT00434330|62811030|FG000|Overall Study|Death|1|||
33434047|NCT00434330|62811031|FG001|Overall Study|Death|0|||
33434048|NCT00434330|62811032|FG002|Overall Study|Death|0|||
33434049|NCT00434330|62811033|FG003|Overall Study|Death|0|||
33434050|NCT00434330|62811034|FG004|Overall Study|Death|1|||
33434051|NCT00434330|62811035|FG005|Overall Study|Death|1|||
33434052|NCT00434330|62811030|FG000|Overall Study|Withdrawal by Subject|0|||
33434053|NCT00434330|62811031|FG001|Overall Study|Withdrawal by Subject|0|||
33434054|NCT00434330|62811032|FG002|Overall Study|Withdrawal by Subject|1|||
33434055|NCT00434330|62811033|FG003|Overall Study|Withdrawal by Subject|1|||
33434056|NCT00434330|62811034|FG004|Overall Study|Withdrawal by Subject|0|||
33434057|NCT00434330|62811035|FG005|Overall Study|Withdrawal by Subject|0|||
33434058|NCT00434330|62811030|FG000|Overall Study|Renal transplant|0|||
33434059|NCT00434330|62811031|FG001|Overall Study|Renal transplant|0|||
33434060|NCT00434330|62811032|FG002|Overall Study|Renal transplant|0|||
33434061|NCT00434330|62811033|FG003|Overall Study|Renal transplant|1|||
33434062|NCT00434330|62811034|FG004|Overall Study|Renal transplant|0|||
33434063|NCT00434330|62811035|FG005|Overall Study|Renal transplant|0|||
33434064|NCT00434330|62811030|FG000|Overall Study|Subject Not Compliant With Study|0|||
33434065|NCT00434330|62811031|FG001|Overall Study|Subject Not Compliant With Study|0|||
33434066|NCT00434330|62811032|FG002|Overall Study|Subject Not Compliant With Study|1|||
33434067|NCT00434330|62811033|FG003|Overall Study|Subject Not Compliant With Study|0|||
33434068|NCT00434330|62811034|FG004|Overall Study|Subject Not Compliant With Study|0|||
33434069|NCT00434330|62811035|FG005|Overall Study|Subject Not Compliant With Study|0|||
33434070|NCT00426764|62811049|FG000|Overall Study|Protocol Violation|1|||
33434071|NCT00426764|62811049|FG000|Overall Study|Withdrawal by Subject|4|||
33434072|NCT00426764|62811049|FG000|Overall Study|Physician Decision|6|||
33434073|NCT00426764|62811049|FG000|Overall Study|Compassionate Use|1|||
33434074|NCT00426764|62811049|FG000|Overall Study|Progressive Disease|83|||
33434075|NCT00426764|62811049|FG000|Overall Study|Adverse Event|24|||
33434076|NCT00426764|62811049|FG000|Overall Study|Other|1|||
33434077|NCT00426764|62811049|FG000|Overall Study|Death|1|||
33434078|NCT00426764|62811049|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
33434079|NCT00434252|62811061|FG000|Overall Study|Lack of Efficacy|50|||
33434080|NCT00434252|62811062|FG001|Overall Study|Lack of Efficacy|100|||
33434081|NCT00434252|62811061|FG000|Overall Study|Adverse Event|6|||
33434082|NCT00434252|62811062|FG001|Overall Study|Adverse Event|13|||
33434083|NCT00434252|62811061|FG000|Overall Study|Death|1|||
33434084|NCT00434252|62811062|FG001|Overall Study|Death|2|||
33434085|NCT00434252|62811061|FG000|Overall Study|Lost to Follow-up|0|||
33434086|NCT00434252|62811062|FG001|Overall Study|Lost to Follow-up|1|||
33434087|NCT00434252|62811061|FG000|Overall Study|Physician Decision|4|||
33434088|NCT00434252|62811062|FG001|Overall Study|Physician Decision|8|||
33434089|NCT00434252|62811061|FG000|Overall Study|Withdrawal by Subject|3|||
33434090|NCT00434252|62811062|FG001|Overall Study|Withdrawal by Subject|7|||
33434091|NCT00425750|62811068|FG000|Overall Study|Death|1|||
33434092|NCT00425750|62811068|FG000|Overall Study|Withdrawal by Subject|3|||
33434093|NCT00425750|62811068|FG000|Overall Study|Adverse Event|3|||
33434094|NCT00425750|62811068|FG000|Overall Study|Progression of disease|18|||
33434095|NCT00414908|62811074|FG000|Overall Study|Protocol Violation|1|||
33605491|NCT01733758|63005192|FG002|Overall Study|Withdrawal by Subject|5|||
33434096|NCT00414908|62811075|FG001|Overall Study|Protocol Violation|1|||
33434097|NCT00242710|62811087|FG000|Core Study (up to Year 1)|Adverse Event|30|||
33605492|NCT01733758|63005193|FG003|Overall Study|Withdrawal by Subject|3|||
33434098|NCT00242710|62811088|FG001|Core Study (up to Year 1)|Adverse Event|25|||
33434099|NCT00242710|62811089|FG002|Core Study (up to Year 1)|Adverse Event|23|||
33434100|NCT00242710|62811090|FG003|Core Study (up to Year 1)|Adverse Event|14|||
33434101|NCT00242710|62811087|FG000|Core Study (up to Year 1)|Death|0|||
33323176|NCT01175135|62699458|FG003|Overall Study|Death|0|||
33434102|NCT00242710|62811088|FG001|Core Study (up to Year 1)|Death|0|||
33434103|NCT00242710|62811089|FG002|Core Study (up to Year 1)|Death|1|||
33434104|NCT00242710|62811090|FG003|Core Study (up to Year 1)|Death|0|||
33434105|NCT00242710|62811087|FG000|Core Study (up to Year 1)|Physician Decision|0|||
33434106|NCT00242710|62811088|FG001|Core Study (up to Year 1)|Physician Decision|1|||
33434107|NCT00242710|62811089|FG002|Core Study (up to Year 1)|Physician Decision|0|||
33434108|NCT00242710|62811090|FG003|Core Study (up to Year 1)|Physician Decision|1|||
33434109|NCT00242710|62811087|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
33434110|NCT00242710|62811088|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
33434111|NCT00242710|62811089|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
33434112|NCT00242710|62811090|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
33434113|NCT00242710|62811087|FG000|Core Study (up to Year 1)|Other|6|||
33434114|NCT00242710|62811088|FG001|Core Study (up to Year 1)|Other|1|||
33434115|NCT00242710|62811089|FG002|Core Study (up to Year 1)|Other|0|||
33434116|NCT00242710|62811090|FG003|Core Study (up to Year 1)|Other|2|||
33434117|NCT00242710|62811087|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
33434118|NCT00242710|62811088|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
33434119|NCT00242710|62811089|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
33434120|NCT00242710|62811090|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
33434121|NCT00242710|62811087|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
33434122|NCT00242710|62811088|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
33434123|NCT00242710|62811089|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
33434124|NCT00242710|62811090|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
33434125|NCT00242710|62811087|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
33434126|NCT00242710|62811088|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
33434127|NCT00242710|62811089|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
33434128|NCT00242710|62811090|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
33434129|NCT00242710|62811087|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
33434130|NCT00242710|62811088|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
33434131|NCT00242710|62811089|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
33434132|NCT00242710|62811090|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
33434133|NCT00242710|62811087|FG000|Period Between Core Study and Extension|Adverse Event|2|||
33434134|NCT00242710|62811088|FG001|Period Between Core Study and Extension|Adverse Event|3|||
33434135|NCT00242710|62811089|FG002|Period Between Core Study and Extension|Adverse Event|5|||
33323177|NCT01175135|62699455|FG000|Overall Study|Lack of Efficacy|4|||
33323178|NCT01175135|62699456|FG001|Overall Study|Lack of Efficacy|5|||
33434136|NCT00242710|62811090|FG003|Period Between Core Study and Extension|Adverse Event|2|||
33323179|NCT01175135|62699457|FG002|Overall Study|Lack of Efficacy|0|||
33434137|NCT00242710|62811087|FG000|Period Between Core Study and Extension|Physician Decision|1|||
33434138|NCT00242710|62811088|FG001|Period Between Core Study and Extension|Physician Decision|1|||
33434139|NCT00242710|62811089|FG002|Period Between Core Study and Extension|Physician Decision|0|||
33434140|NCT00242710|62811090|FG003|Period Between Core Study and Extension|Physician Decision|0|||
33434141|NCT00242710|62811087|FG000|Period Between Core Study and Extension|Other|24|||
33434142|NCT00242710|62811088|FG001|Period Between Core Study and Extension|Other|24|||
33434143|NCT00242710|62811089|FG002|Period Between Core Study and Extension|Other|9|||
33434144|NCT00242710|62811090|FG003|Period Between Core Study and Extension|Other|11|||
33434145|NCT00242710|62811087|FG000|Period Between Core Study and Extension|Extension not Available|17|||
33434146|NCT00242710|62811088|FG001|Period Between Core Study and Extension|Extension not Available|21|||
33434147|NCT00242710|62811089|FG002|Period Between Core Study and Extension|Extension not Available|8|||
33434148|NCT00242710|62811090|FG003|Period Between Core Study and Extension|Extension not Available|7|||
33434149|NCT00242710|62811087|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
33434150|NCT00242710|62811088|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
33434151|NCT00242710|62811089|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
33434152|NCT00242710|62811090|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
33434153|NCT00242710|62811087|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
33434154|NCT00242710|62811088|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
33434155|NCT00242710|62811089|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
33434156|NCT00242710|62811090|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
33434157|NCT00242710|62811087|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
33434158|NCT00242710|62811088|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
33434159|NCT00242710|62811089|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
33434160|NCT00242710|62811090|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
33434161|NCT00242710|62811087|FG000|Study Extension (up to Year 2)|Death|0|||
33434162|NCT00242710|62811088|FG001|Study Extension (up to Year 2)|Death|0|||
33434163|NCT00242710|62811089|FG002|Study Extension (up to Year 2)|Death|0|||
33434164|NCT00242710|62811090|FG003|Study Extension (up to Year 2)|Death|1|||
33434165|NCT00242710|62811087|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
33434166|NCT00242710|62811088|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
33434167|NCT00242710|62811089|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
33434168|NCT00242710|62811090|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
33434169|NCT00242710|62811087|FG000|Study Extension (up to Year 2)|Other|3|||
33434170|NCT00242710|62811088|FG001|Study Extension (up to Year 2)|Other|5|||
33434171|NCT00242710|62811089|FG002|Study Extension (up to Year 2)|Other|4|||
33434172|NCT00242710|62811090|FG003|Study Extension (up to Year 2)|Other|3|||
33434173|NCT00242710|62811087|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
33434174|NCT00242710|62811088|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
33434175|NCT00242710|62811089|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
33434176|NCT00242710|62811090|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
33434177|NCT00242710|62811087|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
33434178|NCT00242710|62811088|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
33434179|NCT00242710|62811089|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
33434180|NCT00242710|62811090|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
33434181|NCT00408876|62811104|FG000|Overall Study|Adverse Event|9|||
33434182|NCT00408876|62811105|FG001|Overall Study|Adverse Event|17|||
33434183|NCT00408876|62811106|FG002|Overall Study|Adverse Event|27|||
33434184|NCT00408876|62811107|FG003|Overall Study|Adverse Event|10|||
33434185|NCT00408876|62811104|FG000|Overall Study|Withdrawal by Subject|3|||
33434186|NCT00408876|62811105|FG001|Overall Study|Withdrawal by Subject|6|||
33434187|NCT00408876|62811106|FG002|Overall Study|Withdrawal by Subject|6|||
33434188|NCT00408876|62811107|FG003|Overall Study|Withdrawal by Subject|14|||
33434189|NCT00408876|62811104|FG000|Overall Study|Lack of Efficacy|2|||
33434190|NCT00408876|62811105|FG001|Overall Study|Lack of Efficacy|4|||
33434191|NCT00408876|62811106|FG002|Overall Study|Lack of Efficacy|5|||
33434192|NCT00408876|62811107|FG003|Overall Study|Lack of Efficacy|6|||
33434193|NCT00408876|62811104|FG000|Overall Study|Lost to Follow-up|1|||
33434194|NCT00408876|62811105|FG001|Overall Study|Lost to Follow-up|6|||
33434195|NCT00408876|62811106|FG002|Overall Study|Lost to Follow-up|5|||
33434196|NCT00408876|62811107|FG003|Overall Study|Lost to Follow-up|2|||
33434197|NCT00408876|62811104|FG000|Overall Study|Protocol Violation|0|||
33605493|NCT01733758|63005190|FG000|Overall Study|Persistent Hyperglycemia|3|||
33605494|NCT01733758|63005191|FG001|Overall Study|Persistent Hyperglycemia|2|||
33434198|NCT00408876|62811105|FG001|Overall Study|Protocol Violation|3|||
33434199|NCT00408876|62811106|FG002|Overall Study|Protocol Violation|4|||
33434200|NCT00408876|62811107|FG003|Overall Study|Protocol Violation|3|||
33434201|NCT00408876|62811104|FG000|Overall Study|Physician Decision|1|||
33434202|NCT00408876|62811105|FG001|Overall Study|Physician Decision|0|||
33434203|NCT00408876|62811106|FG002|Overall Study|Physician Decision|3|||
33605495|NCT01733758|63005192|FG002|Overall Study|Persistent Hyperglycemia|0|||
33605496|NCT01733758|63005193|FG003|Overall Study|Persistent Hyperglycemia|0|||
33434204|NCT00408876|62811107|FG003|Overall Study|Physician Decision|0|||
33605497|NCT01733758|63005190|FG000|Overall Study|Protocol Violation|0|||
33434205|NCT00240994|62811117|FG000|Overall Study|Lost to Follow-up|1|||
33434206|NCT00240994|62811117|FG000|Overall Study|Protocol Violation|1|||
33434207|NCT00240994|62811117|FG000|Overall Study|Graft failure|1|||
33434208|NCT00239590|62811121|FG000|Randomized|Lost to Follow-up|0|||
33434209|NCT00239590|62811122|FG001|Randomized|Lost to Follow-up|1|||
33434210|NCT00239590|62811121|FG000|Randomized|Withdrawal by Subject|0|||
33434211|NCT00239590|62811122|FG001|Randomized|Withdrawal by Subject|1|||
33434212|NCT00239590|62811121|FG000|Completed Study Protocol|Adverse Event|1|||
33434213|NCT00239590|62811122|FG001|Completed Study Protocol|Adverse Event|1|||
33434214|NCT00239590|62811121|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
33434215|NCT00239590|62811122|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
33434216|NCT00433160|62811132|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
33434217|NCT00433160|62811133|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
33434218|NCT00433160|62811132|FG000|52-Week Double-Blind (DB) Period|Death|0|||
33434219|NCT00433160|62811133|FG001|52-Week Double-Blind (DB) Period|Death|0|||
33434220|NCT00433160|62811132|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
33434221|NCT00433160|62811133|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
33434222|NCT00433160|62811132|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
33434223|NCT00433160|62811133|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
33434224|NCT00433160|62811132|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
33434225|NCT00433160|62811133|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
33434226|NCT00433160|62811132|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
33434227|NCT00433160|62811133|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
33434228|NCT00433160|62811132|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
33434229|NCT00433160|62811133|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
33434230|NCT00433160|62811132|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
33434231|NCT00433160|62811133|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
33434232|NCT00433160|62811132|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
33434233|NCT00433160|62811133|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
33434234|NCT00433160|62811132|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
33434235|NCT00433160|62811133|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
33434236|NCT00433160|62811132|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
33434237|NCT00433160|62811133|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
33434238|NCT00433160|62811132|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
33434239|NCT00433160|62811133|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
33434240|NCT00433160|62811132|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
33434241|NCT00433160|62811133|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
33434242|NCT00433160|62811132|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
33434243|NCT00433160|62811133|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
33434244|NCT00433160|62811132|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
33434245|NCT00433160|62811133|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
33434246|NCT00433160|62811132|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
33434247|NCT00433160|62811133|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
33434248|NCT00239356|62811145|FG000|Overall Study|Lack of Efficacy|1|||
33434249|NCT00239356|62811146|FG001|Overall Study|Lack of Efficacy|0|||
33434250|NCT00239356|62811145|FG000|Overall Study|Adverse Event|6|||
33434251|NCT00239356|62811146|FG001|Overall Study|Adverse Event|0|||
33434252|NCT00239356|62811145|FG000|Overall Study|Withdrawal by Subject|15|||
33434253|NCT00239356|62811146|FG001|Overall Study|Withdrawal by Subject|6|||
33434254|NCT00239356|62811145|FG000|Overall Study|Lost to Follow-up|3|||
33434255|NCT00239356|62811146|FG001|Overall Study|Lost to Follow-up|0|||
33434256|NCT00239356|62811145|FG000|Overall Study|poor/non-compliance|2|||
33434257|NCT00239356|62811146|FG001|Overall Study|poor/non-compliance|0|||
33434258|NCT00239356|62811145|FG000|Overall Study|Pregnancy|1|||
33434259|NCT00239356|62811146|FG001|Overall Study|Pregnancy|0|||
33434260|NCT00239356|62811145|FG000|Overall Study|Administrative reason|0|||
33434261|NCT00239356|62811146|FG001|Overall Study|Administrative reason|1|||
33434262|NCT00239356|62811145|FG000|Overall Study|Drug available on market|11|||
33434263|NCT00239356|62811146|FG001|Overall Study|Drug available on market|2|||
33434264|NCT00393510|62811154|FG000|Overall Study|Physician Decision|3|||
33434265|NCT00393510|62811155|FG001|Overall Study|Physician Decision|9|||
33434266|NCT00425438|62811163|FG000|Overall Study|Termination by Sponsor|25|||
33434267|NCT00425438|62811164|FG001|Overall Study|Termination by Sponsor|27|||
33434268|NCT00275002|62811172|FG000|Overall Study|Death|1|||
33434269|NCT00275002|62811173|FG001|Overall Study|Death|0|||
33434270|NCT00275002|62811172|FG000|Overall Study|Disease progression|21|||
33434271|NCT00275002|62811173|FG001|Overall Study|Disease progression|15|||
33434272|NCT00275002|62811172|FG000|Overall Study|Adverse Event|0|||
33434273|NCT00275002|62811173|FG001|Overall Study|Adverse Event|1|||
33434274|NCT00433004|62811181|FG000|Overall Study|Lost to Follow-up|5|||
33434275|NCT00433004|62811182|FG001|Overall Study|Lost to Follow-up|7|||
33434276|NCT00238264|62811188|FG000|Overall Study|Death|7|||
33434277|NCT00238264|62811188|FG000|Overall Study|Lost to Follow-up|18|||
33434278|NCT00238264|62811188|FG000|Overall Study|Withdrawal by Subject|4|||
33434279|NCT00238264|62811188|FG000|Overall Study|Ineligible|7|||
33434280|NCT00414596|62811192|FG000|Overall Study|Protocol Violation|2|||
33434281|NCT00393042|62811196|FG000|First Intervention|Withdrawal by Subject|1|||
33434282|NCT00393042|62811197|FG001|First Intervention|Withdrawal by Subject|2|||
33434283|NCT00393042|62811196|FG000|First Intervention|Lost to Follow-up|3|||
33434284|NCT00393042|62811197|FG001|First Intervention|Lost to Follow-up|3|||
33434285|NCT00393042|62811196|FG000|First Intervention|Protocol Violation|1|||
33434286|NCT00393042|62811197|FG001|First Intervention|Protocol Violation|0|||
33434287|NCT00393042|62811196|FG000|First Intervention|Adverse Event|0|||
33434288|NCT00393042|62811197|FG001|First Intervention|Adverse Event|1|||
33434289|NCT00393042|62811196|FG000|Second Intervetion|Adverse Event|0|||
33434290|NCT00393042|62811197|FG001|Second Intervetion|Adverse Event|3|||
33434291|NCT00393042|62811196|FG000|Second Intervetion|Withdrawal by Subject|0|||
33434292|NCT00393042|62811197|FG001|Second Intervetion|Withdrawal by Subject|2|||
33434293|NCT00393042|62811196|FG000|Second Intervetion|Lack of Efficacy|1|||
33434294|NCT00393042|62811197|FG001|Second Intervetion|Lack of Efficacy|0|||
33434295|NCT00393042|62811196|FG000|Second Intervetion|Lost to Follow-up|0|||
33434296|NCT00393042|62811197|FG001|Second Intervetion|Lost to Follow-up|2|||
33434297|NCT00393042|62811196|FG000|Second Intervetion|Protocol Violation|1|||
33434298|NCT00393042|62811197|FG001|Second Intervetion|Protocol Violation|1|||
33434299|NCT00392808|62811255|FG000|Overall Study|Lost to Follow-up|3|||
33434300|NCT00392808|62811256|FG001|Overall Study|Lost to Follow-up|2|||
33434301|NCT00392808|62811257|FG002|Overall Study|Lost to Follow-up|1|||
33434302|NCT00392808|62811258|FG003|Overall Study|Lost to Follow-up|2|||
33434303|NCT00392808|62811255|FG000|Overall Study|Unable to withdraw blood|3|||
33434304|NCT00392808|62811256|FG001|Overall Study|Unable to withdraw blood|1|||
33434305|NCT00392808|62811257|FG002|Overall Study|Unable to withdraw blood|1|||
33434306|NCT00392808|62811258|FG003|Overall Study|Unable to withdraw blood|2|||
33434307|NCT00274846|62811277|FG000|Overall Study|Did not receive adequate NK cells|1|||
33434308|NCT00237796|62811284|FG000|Overall Study|Baseline and one other ILSS required|10|||
33434309|NCT00237796|62811285|FG001|Overall Study|Baseline and one other ILSS required|5|||
33434310|NCT00414440|62811294|FG000|Core Period|Withdrawal by Subject|70|||
33434311|NCT00414440|62811295|FG001|Core Period|Withdrawal by Subject|32|||
33434312|NCT00414440|62811294|FG000|Extension Period|Lost to Follow-up|44|||
33434313|NCT00414440|62811295|FG001|Extension Period|Lost to Follow-up|52|||
33434314|NCT00414440|62811294|FG000|Extension Period|Did not consent to continue follow up|61|||
33434315|NCT00414440|62811295|FG001|Extension Period|Did not consent to continue follow up|54|||
33434316|NCT00414440|62811294|FG000|Extension Period|Other|1|||
33434317|NCT00414440|62811295|FG001|Extension Period|Other|1|||
33434318|NCT00414440|62811294|FG000|Extension Period|Administrative|16|||
33434319|NCT00414440|62811295|FG001|Extension Period|Administrative|16|||
33434320|NCT00414440|62811294|FG000|Extension Period|Death|1|||
33434321|NCT00414440|62811295|FG001|Extension Period|Death|2|||
33434322|NCT00414440|62811294|FG000|Extension Period|Withdrawal by Subject|9|||
33434323|NCT00414440|62811295|FG001|Extension Period|Withdrawal by Subject|7|||
33434324|NCT00414440|62811294|FG000|Extension Period|Not included in follow up period|18|||
33434325|NCT00414440|62811295|FG001|Extension Period|Not included in follow up period|8|||
33434326|NCT00209560|62811303|FG000|Overall Study|Lack of Efficacy|1|||
33434327|NCT00209560|62811304|FG001|Overall Study|Lack of Efficacy|0|||
33434328|NCT00236080|62811315|FG000|Overall Study|Adverse Event|0|||
33434329|NCT00236080|62811316|FG001|Overall Study|Adverse Event|0|||
33434330|NCT00236080|62811317|FG002|Overall Study|Adverse Event|3|||
33434331|NCT00236080|62811318|FG003|Overall Study|Adverse Event|1|||
33434332|NCT00236080|62811319|FG004|Overall Study|Adverse Event|0|||
33434333|NCT00236080|62811315|FG000|Overall Study|Lost to Follow-up|0|||
33434334|NCT00236080|62811316|FG001|Overall Study|Lost to Follow-up|1|||
33434335|NCT00236080|62811317|FG002|Overall Study|Lost to Follow-up|0|||
33434336|NCT00236080|62811318|FG003|Overall Study|Lost to Follow-up|0|||
33434337|NCT00236080|62811319|FG004|Overall Study|Lost to Follow-up|0|||
33434338|NCT00236080|62811315|FG000|Overall Study|Physician Decision|1|||
33434339|NCT00236080|62811316|FG001|Overall Study|Physician Decision|0|||
33434340|NCT00236080|62811317|FG002|Overall Study|Physician Decision|1|||
33434341|NCT00236080|62811318|FG003|Overall Study|Physician Decision|1|||
33434342|NCT00236080|62811319|FG004|Overall Study|Physician Decision|1|||
33434343|NCT00236080|62811315|FG000|Overall Study|Withdrawal by Subject|1|||
33434344|NCT00236080|62811316|FG001|Overall Study|Withdrawal by Subject|0|||
33434345|NCT00236080|62811317|FG002|Overall Study|Withdrawal by Subject|0|||
33434346|NCT00236080|62811318|FG003|Overall Study|Withdrawal by Subject|0|||
33434347|NCT00236080|62811319|FG004|Overall Study|Withdrawal by Subject|0|||
33434348|NCT00236080|62811315|FG000|Overall Study|Miscellaneous|0|||
33434349|NCT00236080|62811316|FG001|Overall Study|Miscellaneous|0|||
33434350|NCT00236080|62811317|FG002|Overall Study|Miscellaneous|1|||
33434351|NCT00236080|62811318|FG003|Overall Study|Miscellaneous|0|||
33434352|NCT00236080|62811319|FG004|Overall Study|Miscellaneous|0|||
33434353|NCT00432380|62811334|FG000|Overall Study|Migrated/moved from study area|3|||
33434354|NCT00432380|62811335|FG001|Overall Study|Migrated/moved from study area|4|||
33434355|NCT00432380|62811336|FG002|Overall Study|Migrated/moved from study area|1|||
33434356|NCT00432380|62811334|FG000|Overall Study|Adverse Event|1|||
33434357|NCT00432380|62811335|FG001|Overall Study|Adverse Event|0|||
33434358|NCT00432380|62811336|FG002|Overall Study|Adverse Event|0|||
33434359|NCT00234052|62811345|FG000|Treatment|Withdrawal by Subject|3|||
33434360|NCT00234052|62811345|FG000|Treatment|Adverse Event|5|||
33434361|NCT00234052|62811345|FG000|Treatment|Death|2|||
33434362|NCT00234052|62811345|FG000|Treatment|Progressive Disease|11|||
33434363|NCT00234052|62811345|FG000|Follow-up for 5 Years|Death|41|||
33434364|NCT00234052|62811345|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
33434365|NCT00234052|62811345|FG000|Follow-up for 5 Years|Other|7|||
33434366|NCT00408408|62811355|FG000|Overall Study|No follow up data|2|||
33434367|NCT00408408|62811356|FG001|Overall Study|No follow up data|3|||
33434368|NCT00408408|62811357|FG002|Overall Study|No follow up data|0|||
33434369|NCT00408408|62811358|FG003|Overall Study|No follow up data|7|||
33434370|NCT00408408|62811359|FG004|Overall Study|No follow up data|5|||
33434371|NCT00408408|62811360|FG005|Overall Study|No follow up data|3|||
33434372|NCT00414050|62811378|FG000|Overall Study|Adverse Event|1|||
33434373|NCT00414050|62811379|FG001|Overall Study|Adverse Event|1|||
33434374|NCT00414050|62811380|FG002|Overall Study|Adverse Event|1|||
33434375|NCT00414050|62811381|FG003|Overall Study|Adverse Event|1|||
33434376|NCT00414050|62811378|FG000|Overall Study|Lost to Follow-up|2|||
33434377|NCT00414050|62811379|FG001|Overall Study|Lost to Follow-up|2|||
33434378|NCT00414050|62811380|FG002|Overall Study|Lost to Follow-up|1|||
33434379|NCT00414050|62811381|FG003|Overall Study|Lost to Follow-up|1|||
33434380|NCT00414050|62811378|FG000|Overall Study|Withdrawal by Subject|5|||
33434381|NCT00414050|62811379|FG001|Overall Study|Withdrawal by Subject|3|||
33434382|NCT00414050|62811380|FG002|Overall Study|Withdrawal by Subject|2|||
33434383|NCT00414050|62811381|FG003|Overall Study|Withdrawal by Subject|4|||
33434384|NCT00414050|62811378|FG000|Overall Study|Subject discontinued for other reason|1|||
33434385|NCT00414050|62811379|FG001|Overall Study|Subject discontinued for other reason|2|||
33434386|NCT00414050|62811380|FG002|Overall Study|Subject discontinued for other reason|2|||
33434387|NCT00414050|62811381|FG003|Overall Study|Subject discontinued for other reason|1|||
33434388|NCT00414050|62811378|FG000|Overall Study|Subject Moved|0|||
33434389|NCT00414050|62811379|FG001|Overall Study|Subject Moved|0|||
33434390|NCT00414050|62811380|FG002|Overall Study|Subject Moved|0|||
33434391|NCT00414050|62811381|FG003|Overall Study|Subject Moved|1|||
33434392|NCT00413972|62811395|FG000|Overall Study|Adverse Event|2|||
33434393|NCT00413972|62811396|FG001|Overall Study|Adverse Event|1|||
33434394|NCT00413972|62811397|FG002|Overall Study|Adverse Event|0|||
33434395|NCT00413972|62811398|FG003|Overall Study|Adverse Event|0|||
33434396|NCT00413972|62811395|FG000|Overall Study|Lost to Follow-up|1|||
33434397|NCT00413972|62811396|FG001|Overall Study|Lost to Follow-up|2|||
33434398|NCT00413972|62811397|FG002|Overall Study|Lost to Follow-up|1|||
33434399|NCT00413972|62811398|FG003|Overall Study|Lost to Follow-up|0|||
33434400|NCT00413972|62811395|FG000|Overall Study|Withdrawal by Subject|4|||
33434401|NCT00413972|62811396|FG001|Overall Study|Withdrawal by Subject|5|||
33434402|NCT00413972|62811397|FG002|Overall Study|Withdrawal by Subject|7|||
33434403|NCT00413972|62811398|FG003|Overall Study|Withdrawal by Subject|2|||
33434404|NCT00413972|62811395|FG000|Overall Study|Protocol Violation|0|||
33434405|NCT00413972|62811396|FG001|Overall Study|Protocol Violation|0|||
33434406|NCT00413972|62811397|FG002|Overall Study|Protocol Violation|2|||
33434407|NCT00413972|62811398|FG003|Overall Study|Protocol Violation|0|||
33434408|NCT00413972|62811395|FG000|Overall Study|Other|0|||
33434409|NCT00413972|62811396|FG001|Overall Study|Other|0|||
33434410|NCT00413972|62811397|FG002|Overall Study|Other|0|||
33434411|NCT00413972|62811398|FG003|Overall Study|Other|1|||
33434412|NCT00259012|62811410|FG000|Overall Study|Adverse Event|0|||
33434413|NCT00259012|62811411|FG001|Overall Study|Adverse Event|1|||
33434414|NCT00259012|62811410|FG000|Overall Study|Withdrawal by Subject|1|||
33434415|NCT00259012|62811411|FG001|Overall Study|Withdrawal by Subject|0|||
33434416|NCT00259012|62811410|FG000|Overall Study|Physician Decision|0|||
33434417|NCT00259012|62811411|FG001|Overall Study|Physician Decision|1|||
33434418|NCT00259012|62811410|FG000|Overall Study|Lost to Follow-up|0|||
33434419|NCT00259012|62811411|FG001|Overall Study|Lost to Follow-up|1|||
33434420|NCT00259012|62811410|FG000|Overall Study|Protocol Violation|1|||
33434421|NCT00259012|62811411|FG001|Overall Study|Protocol Violation|1|||
33434422|NCT00209170|62811419|FG000|Overall Study|Adverse Event|0|||
33434423|NCT00209170|62811420|FG001|Overall Study|Adverse Event|1|||
33434424|NCT00209170|62811419|FG000|Overall Study|Withdrawal by Subject|2|||
33434425|NCT00209170|62811420|FG001|Overall Study|Withdrawal by Subject|1|||
33434426|NCT00209170|62811419|FG000|Overall Study|Lack of Efficacy|0|||
33434427|NCT00209170|62811420|FG001|Overall Study|Lack of Efficacy|1|||
33434428|NCT00413894|62811426|FG000|Overall Study|Withdrawal by Subject|10|||
33434429|NCT00413894|62811426|FG000|Overall Study|Administrative Reasons|1|||
33434430|NCT00413894|62811426|FG000|Overall Study|Hb <10 grams/deciliter|12|||
33434431|NCT00413894|62811426|FG000|Overall Study|Adverse Event|28|||
33434432|NCT00413894|62811426|FG000|Overall Study|Protocol Violation|11|||
33434433|NCT00413894|62811426|FG000|Overall Study|Other|18|||
33434434|NCT00407550|62811435|FG000|Overall Study|Adverse Event|0|||
33434435|NCT00407550|62811436|FG001|Overall Study|Adverse Event|1|||
33434436|NCT00407550|62811435|FG000|Overall Study|Withdrawal by Subject|0|||
33434437|NCT00407550|62811436|FG001|Overall Study|Withdrawal by Subject|2|||
33434438|NCT00407550|62811435|FG000|Overall Study|Death|1|||
33434439|NCT00407550|62811436|FG001|Overall Study|Death|0|||
33434440|NCT00407550|62811435|FG000|Overall Study|Insurance or Other medical condition|2|||
33434441|NCT00407550|62811436|FG001|Overall Study|Insurance or Other medical condition|1|||
33434442|NCT00209092|62811444|FG000|Overall Study|Progression of disease|7|||
33434443|NCT00209092|62811445|FG001|Overall Study|Progression of disease|1|||
33434444|NCT00209092|62811444|FG000|Overall Study|Adverse Event|0|||
33434445|NCT00209092|62811445|FG001|Overall Study|Adverse Event|1|||
33434446|NCT00209092|62811444|FG000|Overall Study|Withdrawal by Subject|1|||
33434447|NCT00209092|62811445|FG001|Overall Study|Withdrawal by Subject|0|||
33434448|NCT00403494|62811453|FG000|Overall Study|Adverse Event|10|||
33434449|NCT00403494|62811454|FG001|Overall Study|Adverse Event|8|||
33434450|NCT00403494|62811453|FG000|Overall Study|Withdrew Consent|3|||
33434451|NCT00403494|62811454|FG001|Overall Study|Withdrew Consent|2|||
33434452|NCT00403494|62811453|FG000|Overall Study|Inappropriately enrolled|0|||
33434453|NCT00403494|62811454|FG001|Overall Study|Inappropriately enrolled|1|||
33434454|NCT00403494|62811453|FG000|Overall Study|Lost to Follow-up|0|||
33434455|NCT00403494|62811454|FG001|Overall Study|Lost to Follow-up|2|||
33434456|NCT00403494|62811453|FG000|Overall Study|Protocol noncompliance|0|||
33434457|NCT00403494|62811454|FG001|Overall Study|Protocol noncompliance|1|||
33434458|NCT00403494|62811453|FG000|Overall Study|Death|1|||
33434459|NCT00403494|62811454|FG001|Overall Study|Death|0|||
33434460|NCT00403494|62811453|FG000|Overall Study|Sponsor Request|1|||
33434461|NCT00403494|62811454|FG001|Overall Study|Sponsor Request|0|||
33434462|NCT00403260|62811464|FG000|Overall Study|Adverse Event|5|||
33434463|NCT00403260|62811465|FG001|Overall Study|Adverse Event|4|||
33434464|NCT00403260|62811464|FG000|Overall Study|Withdrawal by Subject|5|||
33434465|NCT00403260|62811465|FG001|Overall Study|Withdrawal by Subject|6|||
33434466|NCT00403260|62811464|FG000|Overall Study|Lost to Follow-up|49|||
33434467|NCT00403260|62811465|FG001|Overall Study|Lost to Follow-up|25|||
33434468|NCT00403260|62811464|FG000|Overall Study|Re-appearance of P. falciparum|34|||
33434469|NCT00403260|62811465|FG001|Overall Study|Re-appearance of P. falciparum|25|||
33434470|NCT00403260|62811464|FG000|Overall Study|P. vivax infection|26|||
33434471|NCT00403260|62811465|FG001|Overall Study|P. vivax infection|4|||
33434472|NCT00403260|62811464|FG000|Overall Study|Mixed infection with P. vivax|2|||
33605498|NCT01733758|63005191|FG001|Overall Study|Protocol Violation|1|||
33605499|NCT01733758|63005192|FG002|Overall Study|Protocol Violation|2|||
33434473|NCT00403260|62811465|FG001|Overall Study|Mixed infection with P. vivax|0|||
33434474|NCT00403260|62811464|FG000|Overall Study|Mixed infection with P. falciparum|1|||
33434475|NCT00403260|62811465|FG001|Overall Study|Mixed infection with P. falciparum|0|||
33434476|NCT00403260|62811464|FG000|Overall Study|P. vivax infection at screening|1|||
33434477|NCT00403260|62811465|FG001|Overall Study|P. vivax infection at screening|0|||
33605500|NCT01733758|63005193|FG003|Overall Study|Protocol Violation|2|||
33434478|NCT00403260|62811464|FG000|Overall Study|P. ovale infection|1|||
33434479|NCT00403260|62811465|FG001|Overall Study|P. ovale infection|0|||
33434480|NCT00403260|62811464|FG000|Overall Study|Gametocyte re-appearance|1|||
33434481|NCT00403260|62811465|FG001|Overall Study|Gametocyte re-appearance|1|||
33434482|NCT00403260|62811464|FG000|Overall Study|Withdrawn from study accidentally|0|||
33434483|NCT00403260|62811465|FG001|Overall Study|Withdrawn from study accidentally|1|||
33434484|NCT00406848|62811473|FG000|Overall Study|Withdrawal by Subject|27|||
33434485|NCT00406848|62811474|FG001|Overall Study|Withdrawal by Subject|22|||
33434486|NCT00406848|62811473|FG000|Overall Study|Adverse Event|38|||
33434487|NCT00406848|62811474|FG001|Overall Study|Adverse Event|7|||
33434488|NCT00406848|62811473|FG000|Overall Study|Lack of Efficacy|9|||
33434489|NCT00406848|62811474|FG001|Overall Study|Lack of Efficacy|14|||
33434490|NCT00406848|62811473|FG000|Overall Study|Protocol Violation|10|||
33434491|NCT00406848|62811474|FG001|Overall Study|Protocol Violation|6|||
33434492|NCT00406848|62811473|FG000|Overall Study|Lost to Follow-up|6|||
33434493|NCT00406848|62811474|FG001|Overall Study|Lost to Follow-up|2|||
33434494|NCT00406848|62811473|FG000|Overall Study|Physician Decision|2|||
33434495|NCT00406848|62811474|FG001|Overall Study|Physician Decision|2|||
33434496|NCT00406848|62811473|FG000|Overall Study|Sponsor Decision|1|||
33434497|NCT00406848|62811474|FG001|Overall Study|Sponsor Decision|1|||
33434498|NCT00406692|62811483|FG000|Overall Study|Withdrawal by Subject|4|||
33434499|NCT00406692|62811483|FG000|Overall Study|Physician Decision|1|||
33434500|NCT00406692|62811483|FG000|Overall Study|Adverse Event|1|||
33434501|NCT00406692|62811483|FG000|Overall Study|Lack of Efficacy|1|||
33434502|NCT00315705|62811489|FG000|Phase 1|Refused further treatment|1|||
33434503|NCT00315705|62811489|FG000|Phase 1|Failure to achieve response|8|||
33434504|NCT00315705|62811489|FG000|Phase 1|Disease relapse|4|||
33434505|NCT00315705|62811489|FG000|Phase 1|Scheduled for transplant|9|||
33434506|NCT00315705|62811489|FG000|Phase 1|Death|3|||
33434507|NCT00315705|62811489|FG000|Phase 2|Physician Decision|4|||
33434508|NCT00315705|62811489|FG000|Phase 2|Adverse Event|1|||
33434509|NCT00315705|62811489|FG000|Phase 2|Failure to achieve response|3|||
33434510|NCT00315705|62811489|FG000|Phase 2|Disease relapse|1|||
33434511|NCT00315705|62811489|FG000|Phase 2|Scheduled for transplant|8|||
33434512|NCT00315705|62811489|FG000|Phase 2|Other|1|||
33434513|NCT00315705|62811489|FG000|Phase 2|Death|7|||
33434514|NCT00307125|62811508|FG000|Screening Phase|Adverse Event|1|||
33434515|NCT00307125|62811509|FG001|Screening Phase|Adverse Event|0|||
33434516|NCT00307125|62811510|FG002|Screening Phase|Adverse Event|0|||
33434517|NCT00307125|62811508|FG000|Screening Phase|Protocol Violation|27|||
33434518|NCT00307125|62811509|FG001|Screening Phase|Protocol Violation|0|||
33434519|NCT00307125|62811510|FG002|Screening Phase|Protocol Violation|0|||
33434520|NCT00307125|62811508|FG000|Screening Phase|Lost to Follow-up|87|||
33434521|NCT00307125|62811509|FG001|Screening Phase|Lost to Follow-up|0|||
33434522|NCT00307125|62811510|FG002|Screening Phase|Lost to Follow-up|0|||
33434523|NCT00307125|62811508|FG000|Screening Phase|Death|10|||
33434524|NCT00307125|62811509|FG001|Screening Phase|Death|0|||
33434525|NCT00307125|62811510|FG002|Screening Phase|Death|0|||
33434526|NCT00307125|62811508|FG000|Screening Phase|Withdrawal by Subject|77|||
33434527|NCT00307125|62811509|FG001|Screening Phase|Withdrawal by Subject|0|||
33434528|NCT00307125|62811510|FG002|Screening Phase|Withdrawal by Subject|0|||
33434529|NCT00307125|62811508|FG000|Screening Phase|Physician Decision|26|||
33434530|NCT00307125|62811509|FG001|Screening Phase|Physician Decision|0|||
33434531|NCT00307125|62811510|FG002|Screening Phase|Physician Decision|0|||
33434532|NCT00307125|62811508|FG000|Screening Phase|Sponsor Decision|4|||
33434533|NCT00307125|62811509|FG001|Screening Phase|Sponsor Decision|0|||
33434534|NCT00307125|62811510|FG002|Screening Phase|Sponsor Decision|0|||
33434535|NCT00307125|62811508|FG000|Screening Phase|Study Terminated|17|||
33434536|NCT00307125|62811509|FG001|Screening Phase|Study Terminated|0|||
33434537|NCT00307125|62811510|FG002|Screening Phase|Study Terminated|0|||
33434538|NCT00307125|62811508|FG000|Screening Phase|Graft Loss|3|||
33434539|NCT00307125|62811509|FG001|Screening Phase|Graft Loss|0|||
33434540|NCT00307125|62811510|FG002|Screening Phase|Graft Loss|0|||
33434541|NCT00307125|62811508|FG000|Screening Phase|Graft Failure|8|||
33434542|NCT00307125|62811509|FG001|Screening Phase|Graft Failure|0|||
33434543|NCT00307125|62811510|FG002|Screening Phase|Graft Failure|0|||
33434544|NCT00307125|62811508|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
33434545|NCT00307125|62811509|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
33434546|NCT00307125|62811510|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
33434547|NCT00307125|62811508|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
33434548|NCT00307125|62811509|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
33434549|NCT00307125|62811510|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
33434550|NCT00307125|62811508|FG000|Screening Phase|Moved or transferred facilities|34|||
33434551|NCT00307125|62811509|FG001|Screening Phase|Moved or transferred facilities|0|||
33434552|NCT00307125|62811510|FG002|Screening Phase|Moved or transferred facilities|0|||
33434553|NCT00307125|62811508|FG000|Screening Phase|Received Pancreas Transplant|8|||
33434554|NCT00307125|62811509|FG001|Screening Phase|Received Pancreas Transplant|0|||
33434555|NCT00307125|62811510|FG002|Screening Phase|Received Pancreas Transplant|0|||
33434556|NCT00307125|62811508|FG000|Screening Phase|Ineligible for pilot|4|||
33434557|NCT00307125|62811509|FG001|Screening Phase|Ineligible for pilot|0|||
33434558|NCT00307125|62811510|FG002|Screening Phase|Ineligible for pilot|0|||
33434559|NCT00307125|62811508|FG000|Screening Phase|Try to get pregnant|1|||
33434560|NCT00307125|62811509|FG001|Screening Phase|Try to get pregnant|0|||
33434561|NCT00307125|62811510|FG002|Screening Phase|Try to get pregnant|0|||
33434562|NCT00307125|62811508|FG000|Screening Phase|Developed acute leukemia|1|||
33434563|NCT00307125|62811509|FG001|Screening Phase|Developed acute leukemia|0|||
33434564|NCT00307125|62811510|FG002|Screening Phase|Developed acute leukemia|0|||
33434565|NCT00307125|62811508|FG000|Screening Phase|Metastatic colon cancer|1|||
33434566|NCT00307125|62811509|FG001|Screening Phase|Metastatic colon cancer|0|||
33434567|NCT00307125|62811510|FG002|Screening Phase|Metastatic colon cancer|0|||
33434568|NCT00307125|62811508|FG000|Screening Phase|Malignancy|1|||
33434569|NCT00307125|62811509|FG001|Screening Phase|Malignancy|0|||
33434570|NCT00307125|62811510|FG002|Screening Phase|Malignancy|0|||
33434571|NCT00307125|62811508|FG000|Screening Phase|PAK|1|||
33434572|NCT00307125|62811509|FG001|Screening Phase|PAK|0|||
33434573|NCT00307125|62811510|FG002|Screening Phase|PAK|0|||
33434574|NCT00307125|62811508|FG000|Screening Phase|Ineligible|1|||
33434575|NCT00307125|62811509|FG001|Screening Phase|Ineligible|0|||
33434576|NCT00307125|62811510|FG002|Screening Phase|Ineligible|0|||
33434577|NCT00307125|62811508|FG000|Screening Phase|Screen Error|1|||
33434578|NCT00307125|62811509|FG001|Screening Phase|Screen Error|0|||
33434579|NCT00307125|62811510|FG002|Screening Phase|Screen Error|0|||
33434580|NCT00307125|62811508|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
33434581|NCT00307125|62811509|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
33434582|NCT00307125|62811510|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
33434583|NCT00307125|62811508|FG000|Screening Phase|AMR and treated with rituximab|1|||
33434584|NCT00307125|62811509|FG001|Screening Phase|AMR and treated with rituximab|0|||
33434585|NCT00307125|62811510|FG002|Screening Phase|AMR and treated with rituximab|0|||
33434586|NCT00307125|62811508|FG000|Screening Phase|Coronary artery bypass|1|||
33434587|NCT00307125|62811509|FG001|Screening Phase|Coronary artery bypass|0|||
33434588|NCT00307125|62811510|FG002|Screening Phase|Coronary artery bypass|0|||
33434589|NCT00307125|62811508|FG000|Pilot Phase|Lost to Follow-up|0|||
33434590|NCT00307125|62811509|FG001|Pilot Phase|Lost to Follow-up|1|||
33434591|NCT00307125|62811510|FG002|Pilot Phase|Lost to Follow-up|0|||
33434592|NCT00307125|62811508|FG000|Pilot Phase|Withdrawal by Subject|0|||
33434593|NCT00307125|62811509|FG001|Pilot Phase|Withdrawal by Subject|1|||
33434594|NCT00307125|62811510|FG002|Pilot Phase|Withdrawal by Subject|1|||
33434595|NCT00307047|62811522|FG000|Overall Study|Lost to Follow-up|35|||
33434596|NCT00307047|62811523|FG001|Overall Study|Lost to Follow-up|24|||
33434597|NCT00307047|62811522|FG000|Overall Study|Withdrawal by Subject|6|||
33434598|NCT00307047|62811523|FG001|Overall Study|Withdrawal by Subject|6|||
33434599|NCT00307047|62811522|FG000|Overall Study|Physician Decision|1|||
33434600|NCT00307047|62811523|FG001|Overall Study|Physician Decision|2|||
33434601|NCT00307047|62811522|FG000|Overall Study|Lost to follow-up for other reasons|0|||
33434602|NCT00307047|62811523|FG001|Overall Study|Lost to follow-up for other reasons|1|||
33434603|NCT00307047|62811522|FG000|Overall Study|All death, all MI, all Revascularization|27|||
33434604|NCT00307047|62811523|FG001|Overall Study|All death, all MI, all Revascularization|16|||
33434605|NCT00306891|62811533|FG000|Part A|Withdrawal by Subject|1|||
33434606|NCT00306891|62811534|FG001|Part A|Withdrawal by Subject|1|||
33434607|NCT00306891|62811535|FG002|Part A|Withdrawal by Subject|0|||
33434608|NCT00306891|62811536|FG003|Part A|Withdrawal by Subject|0|||
33434609|NCT00306891|62811533|FG000|Part A|Condition under investigation worsened|2|||
33434610|NCT00306891|62811534|FG001|Part A|Condition under investigation worsened|2|||
33434611|NCT00306891|62811535|FG002|Part A|Condition under investigation worsened|0|||
33434612|NCT00306891|62811536|FG003|Part A|Condition under investigation worsened|0|||
33434613|NCT00306891|62811533|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
33434614|NCT00306891|62811534|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
33434615|NCT00306891|62811535|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
33434616|NCT00306891|62811536|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
33434617|NCT00306891|62811533|FG000|Part A|Partial bowel obstruction|1|||
33434618|NCT00306891|62811534|FG001|Part A|Partial bowel obstruction|0|||
33434619|NCT00306891|62811535|FG002|Part A|Partial bowel obstruction|0|||
33434620|NCT00306891|62811536|FG003|Part A|Partial bowel obstruction|0|||
33434621|NCT00306891|62811533|FG000|Part A|Reaccumul. of ascites following drainage|0|||
33434622|NCT00306891|62811534|FG001|Part A|Reaccumul. of ascites following drainage|1|||
33434623|NCT00306891|62811535|FG002|Part A|Reaccumul. of ascites following drainage|0|||
33434624|NCT00306891|62811536|FG003|Part A|Reaccumul. of ascites following drainage|0|||
33434625|NCT00306891|62811533|FG000|Part A|Suspicion of second malignancy|0|||
33434626|NCT00306891|62811534|FG001|Part A|Suspicion of second malignancy|1|||
33434627|NCT00306891|62811535|FG002|Part A|Suspicion of second malignancy|0|||
33434628|NCT00306891|62811536|FG003|Part A|Suspicion of second malignancy|0|||
33434629|NCT00306891|62811533|FG000|Part A|QTC interval outwith elig. criteria|1|||
33434630|NCT00306891|62811534|FG001|Part A|QTC interval outwith elig. criteria|0|||
33605501|NCT01733758|63005190|FG000|Overall Study|Non-compliance|1|||
33434631|NCT00306891|62811535|FG002|Part A|QTC interval outwith elig. criteria|0|||
33434632|NCT00306891|62811536|FG003|Part A|QTC interval outwith elig. criteria|0|||
33434633|NCT00306891|62811533|FG000|Part B|Death|0|||
33434634|NCT00306891|62811534|FG001|Part B|Death|0|||
33434635|NCT00306891|62811535|FG002|Part B|Death|1|||
33434636|NCT00306891|62811536|FG003|Part B|Death|2|||
33434637|NCT00306891|62811533|FG000|Part B|Adverse Event|0|||
33434638|NCT00306891|62811534|FG001|Part B|Adverse Event|0|||
33434639|NCT00306891|62811535|FG002|Part B|Adverse Event|5|||
33434640|NCT00306891|62811536|FG003|Part B|Adverse Event|5|||
33434641|NCT00306891|62811533|FG000|Part B|Withdrawal by Subject|0|||
33434642|NCT00306891|62811534|FG001|Part B|Withdrawal by Subject|0|||
33434643|NCT00306891|62811535|FG002|Part B|Withdrawal by Subject|3|||
33434644|NCT00306891|62811536|FG003|Part B|Withdrawal by Subject|1|||
33434645|NCT00306891|62811533|FG000|Part B|Condition under investigation worsened|0|||
33434646|NCT00306891|62811534|FG001|Part B|Condition under investigation worsened|0|||
33434647|NCT00306891|62811535|FG002|Part B|Condition under investigation worsened|2|||
33434648|NCT00306891|62811536|FG003|Part B|Condition under investigation worsened|8|||
33434649|NCT00306891|62811533|FG000|Part B|Development of study specific disc crit.|0|||
33434650|NCT00306891|62811534|FG001|Part B|Development of study specific disc crit.|0|||
33434651|NCT00306891|62811535|FG002|Part B|Development of study specific disc crit.|0|||
33434652|NCT00306891|62811536|FG003|Part B|Development of study specific disc crit.|1|||
33434653|NCT00314145|62811549|FG000|Overall Study|Withdrawal by Subject|8|||
33434654|NCT00314145|62811550|FG001|Overall Study|Withdrawal by Subject|10|||
33434655|NCT00314145|62811549|FG000|Overall Study|Lost to Follow-up|5|||
33434656|NCT00314145|62811550|FG001|Overall Study|Lost to Follow-up|12|||
33434657|NCT00314145|62811549|FG000|Overall Study|Physician Decision|3|||
33434658|NCT00314145|62811550|FG001|Overall Study|Physician Decision|4|||
33434659|NCT00314145|62811549|FG000|Overall Study|Adverse Event|0|||
33434660|NCT00314145|62811550|FG001|Overall Study|Adverse Event|3|||
33434661|NCT00314145|62811549|FG000|Overall Study|Protocol Violation|3|||
33434662|NCT00314145|62811550|FG001|Overall Study|Protocol Violation|0|||
33434663|NCT00314145|62811549|FG000|Overall Study|Sponsor Decision|2|||
33434664|NCT00314145|62811550|FG001|Overall Study|Sponsor Decision|0|||
33434665|NCT00313911|62811559|FG000|Overall Study|Serious adverse event|6|||
33434666|NCT00313911|62811560|FG001|Overall Study|Serious adverse event|1|||
33434667|NCT00313911|62811559|FG000|Overall Study|Adverse Event|2|||
33434668|NCT00313911|62811560|FG001|Overall Study|Adverse Event|3|||
33434669|NCT00313911|62811559|FG000|Overall Study|Protocol Violation|19|||
33434670|NCT00313911|62811560|FG001|Overall Study|Protocol Violation|10|||
33434671|NCT00313911|62811559|FG000|Overall Study|Lost to Follow-up|27|||
33434672|NCT00313911|62811560|FG001|Overall Study|Lost to Follow-up|14|||
33434673|NCT00313911|62811559|FG000|Overall Study|Withdrawal by Subject|39|||
33434674|NCT00313911|62811560|FG001|Overall Study|Withdrawal by Subject|12|||
33434675|NCT00313911|62811559|FG000|Overall Study|Did not meet age criteria|1|||
33434676|NCT00313911|62811560|FG001|Overall Study|Did not meet age criteria|1|||
33434677|NCT00391872|62811568|FG000|Overall Study|Protocol Violation|7|||
33434678|NCT00391872|62811569|FG001|Overall Study|Protocol Violation|2|||
33434679|NCT00391872|62811568|FG000|Overall Study|Withdrawal by Subject|296|||
33434680|NCT00391872|62811569|FG001|Overall Study|Withdrawal by Subject|249|||
33434681|NCT00391872|62811568|FG000|Overall Study|Reason unknown|2|||
33434682|NCT00391872|62811569|FG001|Overall Study|Reason unknown|4|||
33434683|NCT00391872|62811568|FG000|Overall Study|Lost to Follow-up|2|||
33434684|NCT00391872|62811569|FG001|Overall Study|Lost to Follow-up|0|||
33434685|NCT00391170|62811577|FG000|Overall Study|Withdrawal by Subject|1|||
33434686|NCT00391170|62811578|FG001|Overall Study|Withdrawal by Subject|0|||
33434687|NCT00391170|62811577|FG000|Overall Study|Adverse Event|3|||
33434688|NCT00391170|62811578|FG001|Overall Study|Adverse Event|2|||
33434689|NCT00391170|62811577|FG000|Overall Study|Physician Decision|2|||
33434690|NCT00391170|62811578|FG001|Overall Study|Physician Decision|2|||
33434691|NCT00402324|62811586|FG000|Overall Study|Lost to Follow-up|11|||
33434692|NCT00402324|62811587|FG001|Overall Study|Lost to Follow-up|11|||
33434693|NCT00402324|62811586|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
33434694|NCT00402324|62811587|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
33434695|NCT00402324|62811586|FG000|Overall Study|Protocol Violation|8|||
33434696|NCT00402324|62811587|FG001|Overall Study|Protocol Violation|7|||
33434697|NCT00402324|62811586|FG000|Overall Study|Withdrawal by Subject|5|||
33434698|NCT00402324|62811587|FG001|Overall Study|Withdrawal by Subject|2|||
33434699|NCT00402324|62811586|FG000|Overall Study|Physician Decision|2|||
33434700|NCT00402324|62811587|FG001|Overall Study|Physician Decision|4|||
33434701|NCT00402324|62811586|FG000|Overall Study|Sponsor Decision|4|||
33434702|NCT00402324|62811587|FG001|Overall Study|Sponsor Decision|5|||
33434703|NCT00402324|62811586|FG000|Overall Study|Lack of Efficacy|1|||
33434704|NCT00402324|62811587|FG001|Overall Study|Lack of Efficacy|4|||
33434705|NCT00402324|62811586|FG000|Overall Study|Adverse Event|6|||
33434706|NCT00402324|62811587|FG001|Overall Study|Adverse Event|4|||
33434707|NCT00402324|62811586|FG000|Overall Study|Death|1|||
33434708|NCT00402324|62811587|FG001|Overall Study|Death|0|||
33434709|NCT00294723|62811596|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
33434710|NCT00294723|62811597|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
33434711|NCT00294723|62811598|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
33434712|NCT00294723|62811596|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
33434713|NCT00294723|62811597|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
33434714|NCT00294723|62811598|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
33434715|NCT00294723|62811596|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
33434716|NCT00294723|62811597|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
33434717|NCT00294723|62811598|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
33434718|NCT00294723|62811596|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
33434719|NCT00294723|62811597|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
33434720|NCT00294723|62811598|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
33434721|NCT00294723|62811596|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
33434722|NCT00294723|62811597|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
33434723|NCT00294723|62811598|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
33434724|NCT00294723|62811596|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
33434725|NCT00294723|62811597|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
33434726|NCT00294723|62811598|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
33434727|NCT00294723|62811596|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
33434728|NCT00294723|62811597|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
33434729|NCT00294723|62811598|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
33434730|NCT00294723|62811596|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
33434731|NCT00294723|62811597|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
33434732|NCT00294723|62811598|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
33434733|NCT00294723|62811596|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
33434734|NCT00294723|62811597|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
33434735|NCT00294723|62811598|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
33434736|NCT00294723|62811596|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
33434737|NCT00294723|62811597|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
33434738|NCT00294723|62811598|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
33434739|NCT00294723|62811596|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
33434740|NCT00294723|62811597|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
33434741|NCT00294723|62811598|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
33434742|NCT00294723|62811596|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
33434743|NCT00294723|62811597|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
33434744|NCT00294723|62811598|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
33434745|NCT00402246|62811611|FG000|Overall Study|Death|62|||
33434746|NCT00402246|62811612|FG001|Overall Study|Death|58|||
33434747|NCT00402246|62811611|FG000|Overall Study|Lost to Follow-up|20|||
33434748|NCT00402246|62811612|FG001|Overall Study|Lost to Follow-up|28|||
33434749|NCT00402246|62811611|FG000|Overall Study|Withdrawal by Subject|72|||
33434750|NCT00402246|62811612|FG001|Overall Study|Withdrawal by Subject|87|||
33434751|NCT00402246|62811611|FG000|Overall Study|Physician Decision|24|||
33434752|NCT00402246|62811612|FG001|Overall Study|Physician Decision|26|||
33434753|NCT00402246|62811611|FG000|Overall Study|Protocol Violation|25|||
33434754|NCT00402246|62811612|FG001|Overall Study|Protocol Violation|24|||
33434755|NCT00402246|62811611|FG000|Overall Study|Missed Final Visit|1|||
33434756|NCT00402246|62811612|FG001|Overall Study|Missed Final Visit|2|||
33434757|NCT00402246|62811611|FG000|Overall Study|Insurance Issues|2|||
33434758|NCT00402246|62811612|FG001|Overall Study|Insurance Issues|1|||
33434759|NCT00402246|62811611|FG000|Overall Study|Heart Transplant|0|||
33434760|NCT00402246|62811612|FG001|Overall Study|Heart Transplant|1|||
33434761|NCT00402246|62811611|FG000|Overall Study|Patient's device explanted|6|||
33434762|NCT00402246|62811612|FG001|Overall Study|Patient's device explanted|2|||
33434763|NCT00402246|62811611|FG000|Overall Study|Center Closure|5|||
33434764|NCT00402246|62811612|FG001|Overall Study|Center Closure|3|||
33434765|NCT00402246|62811611|FG000|Overall Study|Deterioriating Condition|3|||
33434766|NCT00402246|62811612|FG001|Overall Study|Deterioriating Condition|2|||
33434767|NCT00375492|62811622|FG000|Overall Study|Adverse Event|4|||
33434768|NCT00375492|62811623|FG001|Overall Study|Adverse Event|5|||
33434769|NCT00375492|62811622|FG000|Overall Study|Entry Criteria Not Met|0|||
33434770|NCT00375492|62811623|FG001|Overall Study|Entry Criteria Not Met|1|||
33434771|NCT00375492|62811622|FG000|Overall Study|Loss of Glucose Control|0|||
33434772|NCT00375492|62811623|FG001|Overall Study|Loss of Glucose Control|1|||
33434773|NCT00375492|62811622|FG000|Overall Study|Lost to Follow-up|10|||
33434774|NCT00375492|62811623|FG001|Overall Study|Lost to Follow-up|5|||
33434775|NCT00375492|62811622|FG000|Overall Study|Physician Decision|0|||
33434776|NCT00375492|62811623|FG001|Overall Study|Physician Decision|4|||
33434777|NCT00375492|62811622|FG000|Overall Study|Protocol Violation|6|||
33434778|NCT00375492|62811623|FG001|Overall Study|Protocol Violation|3|||
33434779|NCT00375492|62811622|FG000|Overall Study|Sponsor Decision|0|||
33434780|NCT00375492|62811623|FG001|Overall Study|Sponsor Decision|1|||
33434781|NCT00375492|62811622|FG000|Overall Study|Withdrawal by Subject|6|||
33434782|NCT00375492|62811623|FG001|Overall Study|Withdrawal by Subject|6|||
33434783|NCT00306189|62811633|FG000|Overall Study|Physician Decision|0|||
33434784|NCT00306189|62811634|FG001|Overall Study|Physician Decision|0|||
33434785|NCT00306189|62811635|FG002|Overall Study|Physician Decision|0|||
33434786|NCT00306189|62811636|FG003|Overall Study|Physician Decision|1|||
33434787|NCT00306189|62811633|FG000|Overall Study|Adverse Event|3|||
33434788|NCT00306189|62811634|FG001|Overall Study|Adverse Event|3|||
33434789|NCT00306189|62811635|FG002|Overall Study|Adverse Event|2|||
33434790|NCT00306189|62811636|FG003|Overall Study|Adverse Event|2|||
33434791|NCT00306189|62811633|FG000|Overall Study|Withdrawal by Subject|4|||
33434792|NCT00306189|62811634|FG001|Overall Study|Withdrawal by Subject|2|||
33434793|NCT00306189|62811635|FG002|Overall Study|Withdrawal by Subject|8|||
33434794|NCT00306189|62811636|FG003|Overall Study|Withdrawal by Subject|1|||
33434795|NCT00306189|62811633|FG000|Overall Study|Ineligibility determined|1|||
33434796|NCT00306189|62811634|FG001|Overall Study|Ineligibility determined|1|||
33434797|NCT00306189|62811635|FG002|Overall Study|Ineligibility determined|1|||
33434798|NCT00306189|62811636|FG003|Overall Study|Ineligibility determined|1|||
33434799|NCT00306189|62811633|FG000|Overall Study|Other|1|||
33434800|NCT00306189|62811634|FG001|Overall Study|Other|0|||
33434801|NCT00306189|62811635|FG002|Overall Study|Other|0|||
33434802|NCT00306189|62811636|FG003|Overall Study|Other|0|||
33434803|NCT00312897|62811648|FG000|Overall Study|Adverse Event|1|||
33434804|NCT00312897|62811649|FG001|Overall Study|Adverse Event|0|||
33434805|NCT00312897|62811648|FG000|Overall Study|Lost to Follow-up|2|||
33434806|NCT00312897|62811649|FG001|Overall Study|Lost to Follow-up|0|||
33434807|NCT00312897|62811648|FG000|Overall Study|Physician Decision|1|||
33434808|NCT00312897|62811649|FG001|Overall Study|Physician Decision|0|||
33434809|NCT00312897|62811648|FG000|Overall Study|Withdrawal by Subject|1|||
33434810|NCT00312897|62811649|FG001|Overall Study|Withdrawal by Subject|3|||
33434811|NCT00312897|62811648|FG000|Overall Study|Pregnancy|1|||
33434812|NCT00312897|62811649|FG001|Overall Study|Pregnancy|0|||
33434813|NCT00312897|62811648|FG000|Overall Study|discontinued prior to getting treatment|0|||
33434814|NCT00312897|62811649|FG001|Overall Study|discontinued prior to getting treatment|3|||
33434815|NCT00312663|62811658|FG000|Immunization Phase|Adverse Event|0|||
33434816|NCT00312663|62811659|FG001|Immunization Phase|Adverse Event|1|||
33434817|NCT00312663|62811660|FG002|Immunization Phase|Adverse Event|0|||
33434818|NCT00294645|62811671|FG000|Overall Study|Death|10|||
33434819|NCT00294645|62811672|FG001|Overall Study|Death|18|||
33434820|NCT00294645|62811671|FG000|Overall Study|Lost to Follow-up|1|||
33434821|NCT00294645|62811672|FG001|Overall Study|Lost to Follow-up|10|||
33434822|NCT00294645|62811671|FG000|Overall Study|Withdrawal by Subject|18|||
33434823|NCT00294645|62811672|FG001|Overall Study|Withdrawal by Subject|34|||
33434824|NCT00294645|62811671|FG000|Overall Study|Physician Decision|15|||
33434825|NCT00294645|62811672|FG001|Overall Study|Physician Decision|20|||
33434826|NCT00294645|62811671|FG000|Overall Study|Other|4|||
33434827|NCT00294645|62811672|FG001|Overall Study|Other|10|||
33434828|NCT00305877|62811680|FG000|Overall Study|Lack of Efficacy|6|||
33434829|NCT00305877|62811681|FG001|Overall Study|Lack of Efficacy|9|||
33434830|NCT00305877|62811680|FG000|Overall Study|Adverse Event|9|||
33434831|NCT00305877|62811681|FG001|Overall Study|Adverse Event|14|||
33605502|NCT01733758|63005191|FG001|Overall Study|Non-compliance|0|||
33605503|NCT01733758|63005192|FG002|Overall Study|Non-compliance|0|||
33605504|NCT01733758|63005193|FG003|Overall Study|Non-compliance|0|||
33605505|NCT01733758|63005190|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
33434832|NCT00305877|62811680|FG000|Overall Study|Death|0|||
33434833|NCT00305877|62811681|FG001|Overall Study|Death|1|||
33434834|NCT00305877|62811680|FG000|Overall Study|Withdrawal by Subject|4|||
33434835|NCT00305877|62811681|FG001|Overall Study|Withdrawal by Subject|2|||
33434836|NCT00305877|62811680|FG000|Overall Study|Physician Decision|1|||
33434837|NCT00305877|62811681|FG001|Overall Study|Physician Decision|1|||
33434838|NCT00305877|62811680|FG000|Overall Study|Never start treatment|2|||
33434839|NCT00305877|62811681|FG001|Overall Study|Never start treatment|5|||
33434840|NCT00305877|62811680|FG000|Overall Study|Ineligible|2|||
33434841|NCT00305877|62811681|FG001|Overall Study|Ineligible|1|||
33434842|NCT00305877|62811680|FG000|Overall Study|Transportation issue with daily RT|0|||
33434843|NCT00305877|62811681|FG001|Overall Study|Transportation issue with daily RT|1|||
33434844|NCT00312195|62811689|FG000|Overall Study|Adverse Event|4|||
33434845|NCT00312195|62811690|FG001|Overall Study|Adverse Event|6|||
33434846|NCT00312195|62811689|FG000|Overall Study|Lost to Follow-up|1|||
33434847|NCT00312195|62811690|FG001|Overall Study|Lost to Follow-up|0|||
33434848|NCT00312195|62811689|FG000|Overall Study|Protocol Violation|1|||
33434849|NCT00312195|62811690|FG001|Overall Study|Protocol Violation|0|||
33434850|NCT00305253|62811700|FG000|Overall Study|Withdrawal by Subject|0|||
33434851|NCT00305253|62811701|FG001|Overall Study|Withdrawal by Subject|1|||
33434852|NCT00293709|62811707|FG000|Overall Study|Other|47|||
33434853|NCT00311181|62811711|FG000|Overall Study|Final DFTs were not obtained|96|||
33434854|NCT00293397|62811715|FG000|Overall Study|Death|2|||
33434855|NCT00290745|62811720|FG000|Overall Study|Withdrawal by Subject|4|||
33434856|NCT00290745|62811720|FG000|Overall Study|Physician Decision|2|||
33434857|NCT00290745|62811720|FG000|Overall Study|Surgery after 3 months for progression|3|||
33434858|NCT00290745|62811720|FG000|Overall Study|Baseline MRI not available|3|||
33434859|NCT00402168|62811726|FG000|Randomized|Lost to Follow-up|1|||
33434860|NCT00402168|62811727|FG001|Randomized|Lost to Follow-up|0|||
33434861|NCT00402168|62811726|FG000|Randomized|Withdrawal by Subject|0|||
33434862|NCT00402168|62811727|FG001|Randomized|Withdrawal by Subject|1|||
33434863|NCT00402168|62811726|FG000|Treatment (up to 12 Months)|Death|0|||
33434864|NCT00402168|62811727|FG001|Treatment (up to 12 Months)|Death|1|||
33434865|NCT00402168|62811726|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
33434866|NCT00402168|62811727|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
33434867|NCT00402168|62811726|FG000|Treatment (up to 12 Months)|non-specified|0|||
33434868|NCT00402168|62811727|FG001|Treatment (up to 12 Months)|non-specified|1|||
33434869|NCT00402168|62811726|FG000|Long Term (LT)|Adverse Event|1|||
33434870|NCT00402168|62811727|FG001|Long Term (LT)|Adverse Event|5|||
33434871|NCT00402168|62811726|FG000|Long Term (LT)|Withdrawal by Subject|4|||
33434872|NCT00402168|62811727|FG001|Long Term (LT)|Withdrawal by Subject|7|||
33434873|NCT00402168|62811726|FG000|Long Term (LT)|Pregnancy|0|||
33434874|NCT00402168|62811727|FG001|Long Term (LT)|Pregnancy|1|||
33434875|NCT00402168|62811726|FG000|Long Term (LT)|Lost to Follow-up|1|||
33434876|NCT00402168|62811727|FG001|Long Term (LT)|Lost to Follow-up|0|||
33434877|NCT00402168|62811726|FG000|Long Term (LT)|Death|4|||
33434878|NCT00402168|62811727|FG001|Long Term (LT)|Death|0|||
33434879|NCT00402168|62811726|FG000|Long Term (LT)|Lack of Efficacy|0|||
33434880|NCT00402168|62811727|FG001|Long Term (LT)|Lack of Efficacy|2|||
33434881|NCT00402168|62811726|FG000|Long Term (LT)|non-specified|1|||
33434882|NCT00402168|62811727|FG001|Long Term (LT)|non-specified|2|||
33434883|NCT00402168|62811726|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
33434884|NCT00402168|62811727|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
33434885|NCT00402168|62811726|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
33434886|NCT00402168|62811727|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
33434887|NCT00290589|62811743|FG000|Overall Study|Lost to Follow-up|2|||
33434888|NCT00290589|62811744|FG001|Overall Study|Lost to Follow-up|2|||
33434889|NCT00290511|62811750|FG000|Overall Study|Adverse Event|1|||
33434890|NCT00290511|62811750|FG000|Overall Study|Death|1|||
33434891|NCT00290511|62811750|FG000|Overall Study|Physician Decision|1|||
33434892|NCT00290511|62811750|FG000|Overall Study|Withdrawal by Subject|1|||
33434893|NCT00290433|62811754|FG000|Overall Study|Disease Progression|13|||
33434894|NCT00290433|62811754|FG000|Overall Study|Adverse Event|14|||
33434895|NCT00290433|62811754|FG000|Overall Study|Withdrawal by Subject|1|||
33434896|NCT00290433|62811754|FG000|Overall Study|Non-Compliance|1|||
33434897|NCT00290433|62811754|FG000|Overall Study|Congestive Heart Failure|1|||
33434898|NCT00290433|62811754|FG000|Overall Study|Transplant in CR|5|||
33434899|NCT00290433|62811754|FG000|Overall Study|Unrelated Infection/Death|1|||
33434900|NCT00304083|62811760|FG000|Overall Study|Withdrawal by Subject|4|||
33434901|NCT00304083|62811761|FG001|Overall Study|Withdrawal by Subject|2|||
33434902|NCT00304083|62811760|FG000|Overall Study|Physician Decision|8|||
33434903|NCT00304083|62811761|FG001|Overall Study|Physician Decision|3|||
33434904|NCT00304083|62811760|FG000|Overall Study|Disease Progression|5|||
33434905|NCT00304083|62811761|FG001|Overall Study|Disease Progression|1|||
33434906|NCT00304083|62811760|FG000|Overall Study|Other|5|||
33434907|NCT00304083|62811761|FG001|Overall Study|Other|2|||
33434908|NCT00293241|62811769|FG000|Overall Study|Lost to Follow-up|9|||
33434909|NCT00293241|62811770|FG001|Overall Study|Lost to Follow-up|16|||
33434910|NCT00293241|62811769|FG000|Overall Study|Physician Decision|23|||
33434911|NCT00293241|62811770|FG001|Overall Study|Physician Decision|17|||
33434912|NCT00293241|62811769|FG000|Overall Study|Withdrawal by Subject|4|||
33434913|NCT00293241|62811770|FG001|Overall Study|Withdrawal by Subject|8|||
33434914|NCT00391092|62811781|FG000|Overall Study|Death|78|||
33434915|NCT00391092|62811782|FG001|Overall Study|Death|81|||
33434916|NCT00391092|62811781|FG000|Overall Study|Lost to Follow-up|13|||
33434917|NCT00391092|62811782|FG001|Overall Study|Lost to Follow-up|18|||
33434918|NCT00391092|62811781|FG000|Overall Study|Alive on treatment|29|||
33434919|NCT00391092|62811782|FG001|Overall Study|Alive on treatment|33|||
33434920|NCT00391092|62811781|FG000|Overall Study|Alive in follow-up|88|||
33434921|NCT00391092|62811782|FG001|Overall Study|Alive in follow-up|84|||
33434922|NCT00374868|62811788|FG000|Overall Study|Adverse Event|12|||
33434923|NCT00374868|62811788|FG000|Overall Study|Progressive Disease|7|||
33434924|NCT00374868|62811788|FG000|Overall Study|Physician Decision|13|||
33434925|NCT00374868|62811788|FG000|Overall Study|Lost to Follow-up|1|||
33434926|NCT00374868|62811788|FG000|Overall Study|Death|2|||
33434927|NCT00374868|62811788|FG000|Overall Study|Other - Not Specified|1|||
33434928|NCT00374556|62811794|FG000|Overall Study|Lost to Follow-up|1|||
33434929|NCT00374556|62811795|FG001|Overall Study|Lost to Follow-up|0|||
33434930|NCT00374556|62811794|FG000|Overall Study|Removed at baseline due to medical cond|0|||
33434931|NCT00374556|62811795|FG001|Overall Study|Removed at baseline due to medical cond|1|||
33434932|NCT00290355|62811803|FG000|Overall Study|Serious adverse event|7|||
33434933|NCT00290355|62811804|FG001|Overall Study|Serious adverse event|4|||
33434934|NCT00290355|62811803|FG000|Overall Study|Study product reactogenicity|1|||
33434935|NCT00290355|62811804|FG001|Overall Study|Study product reactogenicity|0|||
33434936|NCT00290355|62811803|FG000|Overall Study|Protocol Violation|1|||
33434937|NCT00290355|62811804|FG001|Overall Study|Protocol Violation|0|||
33434938|NCT00290355|62811803|FG000|Overall Study|Withdrawal by Subject|2|||
33434939|NCT00290355|62811804|FG001|Overall Study|Withdrawal by Subject|0|||
33434940|NCT00290355|62811803|FG000|Overall Study|Migrated / moved from the study area|1|||
33434941|NCT00290355|62811804|FG001|Overall Study|Migrated / moved from the study area|0|||
33434942|NCT00290355|62811803|FG000|Overall Study|Lost to Follow-up|3|||
33434943|NCT00290355|62811804|FG001|Overall Study|Lost to Follow-up|1|||
33434944|NCT00290355|62811803|FG000|Overall Study|Other|2|||
33434945|NCT00290355|62811804|FG001|Overall Study|Other|0|||
33434946|NCT00374322|62811812|FG000|Overall Study|Lost to Follow-up|92|||
33434947|NCT00374322|62811813|FG001|Overall Study|Lost to Follow-up|90|||
33434948|NCT00374322|62811812|FG000|Overall Study|Protocol Violation|8|||
33434949|NCT00374322|62811813|FG001|Overall Study|Protocol Violation|3|||
33434950|NCT00374322|62811812|FG000|Overall Study|Withdrawal by Subject|235|||
33434951|NCT00374322|62811813|FG001|Overall Study|Withdrawal by Subject|167|||
33434952|NCT00374322|62811812|FG000|Overall Study|Sponsor Terminated Study|866|||
33434953|NCT00374322|62811813|FG001|Overall Study|Sponsor Terminated Study|990|||
33434954|NCT00374322|62811812|FG000|Overall Study|Physician Decision|36|||
33434955|NCT00374322|62811813|FG001|Overall Study|Physician Decision|32|||
33434956|NCT00374322|62811812|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
33434957|NCT00374322|62811813|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
33434958|NCT00374322|62811812|FG000|Overall Study|Sponsor Decision|2|||
33434959|NCT00374322|62811813|FG001|Overall Study|Sponsor Decision|3|||
33434960|NCT00374322|62811812|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
33434961|NCT00374322|62811813|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
33434962|NCT00374322|62811812|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
33434963|NCT00374322|62811813|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
33434964|NCT00374322|62811812|FG000|Overall Study|Severe Toxicity|1|||
33434965|NCT00374322|62811813|FG001|Overall Study|Severe Toxicity|0|||
33434966|NCT00374322|62811812|FG000|Overall Study|Site Closed|2|||
33434967|NCT00374322|62811813|FG001|Overall Study|Site Closed|2|||
33434968|NCT00374322|62811812|FG000|Overall Study|Participant Changed Physician|1|||
33434969|NCT00374322|62811813|FG001|Overall Study|Participant Changed Physician|0|||
33434970|NCT00374322|62811812|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
33434971|NCT00374322|62811813|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
33434972|NCT00374322|62811812|FG000|Overall Study|Noncompliance with Study Requirements|0|||
33434973|NCT00374322|62811813|FG001|Overall Study|Noncompliance with Study Requirements|1|||
33434974|NCT00374322|62811812|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
33434975|NCT00374322|62811813|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
33434976|NCT00374322|62811812|FG000|Overall Study|Did Not Receive Study Medication|8|||
33434977|NCT00374322|62811813|FG001|Overall Study|Did Not Receive Study Medication|6|||
33434978|NCT00303459|62811822|FG000|Overall Study|Death|33|||
33434979|NCT00303459|62811823|FG001|Overall Study|Death|44|||
33434980|NCT00303459|62811822|FG000|Overall Study|Withdrawal of consent|32|||
33434981|NCT00303459|62811823|FG001|Overall Study|Withdrawal of consent|26|||
33434982|NCT00303459|62811822|FG000|Overall Study|Lost to Follow-up|5|||
33434983|NCT00303459|62811823|FG001|Overall Study|Lost to Follow-up|4|||
33434984|NCT00303459|62811822|FG000|Overall Study|Administrative reason|7|||
33434985|NCT00303459|62811823|FG001|Overall Study|Administrative reason|7|||
33434986|NCT00303459|62811822|FG000|Overall Study|Decision by the investigator|5|||
33434987|NCT00303459|62811823|FG001|Overall Study|Decision by the investigator|7|||
33434988|NCT00303459|62811822|FG000|Overall Study|Lung transplantation|1|||
33434989|NCT00303459|62811823|FG001|Overall Study|Lung transplantation|1|||
33434990|NCT00289887|62811832|FG000|Overall Study|Adverse Event|3|||
33434991|NCT00289887|62811833|FG001|Overall Study|Adverse Event|3|||
33434992|NCT00289887|62811832|FG000|Overall Study|Lack of Efficacy|3|||
33434993|NCT00289887|62811833|FG001|Overall Study|Lack of Efficacy|11|||
33434994|NCT00289887|62811832|FG000|Overall Study|Lost to Follow-up|3|||
33434995|NCT00289887|62811833|FG001|Overall Study|Lost to Follow-up|3|||
33434996|NCT00289887|62811832|FG000|Overall Study|Protocol Violation|3|||
33434997|NCT00289887|62811833|FG001|Overall Study|Protocol Violation|1|||
33434998|NCT00289887|62811832|FG000|Overall Study|Withdrawal by Subject|3|||
33434999|NCT00289887|62811833|FG001|Overall Study|Withdrawal by Subject|8|||
33435000|NCT00289887|62811832|FG000|Overall Study|Other|7|||
33435001|NCT00289887|62811833|FG001|Overall Study|Other|3|||
33435002|NCT00303069|62811843|FG000|Overall Study|Lost to Follow-up|1|||
33435003|NCT00303069|62811844|FG001|Overall Study|Lost to Follow-up|0|||
33435004|NCT00303069|62811845|FG002|Overall Study|Lost to Follow-up|0|||
33435005|NCT00303069|62811846|FG003|Overall Study|Lost to Follow-up|2|||
33435006|NCT00303069|62811843|FG000|Overall Study|subject moved|1|||
33435007|NCT00303069|62811844|FG001|Overall Study|subject moved|0|||
33435008|NCT00303069|62811845|FG002|Overall Study|subject moved|0|||
33435009|NCT00303069|62811846|FG003|Overall Study|subject moved|0|||
33435010|NCT00303069|62811843|FG000|Overall Study|Recruitment into Army Reserves|0|||
33435011|NCT00303069|62811844|FG001|Overall Study|Recruitment into Army Reserves|0|||
33435012|NCT00303069|62811845|FG002|Overall Study|Recruitment into Army Reserves|1|||
33435013|NCT00303069|62811846|FG003|Overall Study|Recruitment into Army Reserves|0|||
33435014|NCT00401544|62811860|FG000|Overall Study|Adverse Event|5|||
33435015|NCT00401544|62811861|FG001|Overall Study|Adverse Event|1|||
33435016|NCT00401544|62811862|FG002|Overall Study|Adverse Event|1|||
33435017|NCT00401544|62811863|FG003|Overall Study|Adverse Event|1|||
33435018|NCT00401544|62811860|FG000|Overall Study|Death|3|||
33435019|NCT00401544|62811861|FG001|Overall Study|Death|6|||
33435020|NCT00401544|62811862|FG002|Overall Study|Death|2|||
33323180|NCT01175135|62699458|FG003|Overall Study|Lack of Efficacy|5|||
33323181|NCT01175135|62699455|FG000|Overall Study|Lost to Follow-up|1|||
33323182|NCT01175135|62699456|FG001|Overall Study|Lost to Follow-up|2|||
33323183|NCT01175135|62699457|FG002|Overall Study|Lost to Follow-up|0|||
33323184|NCT01175135|62699458|FG003|Overall Study|Lost to Follow-up|0|||
33323185|NCT01175135|62699455|FG000|Overall Study|Protocol Violation|1|||
33323186|NCT01175135|62699456|FG001|Overall Study|Protocol Violation|1|||
33435021|NCT00401544|62811863|FG003|Overall Study|Death|5|||
33435022|NCT00401544|62811860|FG000|Overall Study|Lost to Follow-up|2|||
33435023|NCT00401544|62811861|FG001|Overall Study|Lost to Follow-up|0|||
33435024|NCT00401544|62811862|FG002|Overall Study|Lost to Follow-up|1|||
33435025|NCT00401544|62811863|FG003|Overall Study|Lost to Follow-up|1|||
33435026|NCT00401544|62811860|FG000|Overall Study|Withdrawal by Subject|7|||
33435027|NCT00401544|62811861|FG001|Overall Study|Withdrawal by Subject|6|||
33435028|NCT00401544|62811862|FG002|Overall Study|Withdrawal by Subject|6|||
33435029|NCT00401544|62811863|FG003|Overall Study|Withdrawal by Subject|5|||
33435030|NCT00401544|62811860|FG000|Overall Study|Physician Decision|1|||
33435031|NCT00401544|62811861|FG001|Overall Study|Physician Decision|3|||
33435032|NCT00401544|62811862|FG002|Overall Study|Physician Decision|0|||
33435033|NCT00401544|62811863|FG003|Overall Study|Physician Decision|0|||
33435034|NCT00401544|62811860|FG000|Overall Study|Ineligibility determined|0|||
33435035|NCT00401544|62811861|FG001|Overall Study|Ineligibility determined|1|||
33435036|NCT00401544|62811862|FG002|Overall Study|Ineligibility determined|0|||
33435037|NCT00401544|62811863|FG003|Overall Study|Ineligibility determined|2|||
33435038|NCT00401544|62811860|FG000|Overall Study|Disease progression|0|||
33435039|NCT00401544|62811861|FG001|Overall Study|Disease progression|1|||
33435040|NCT00401544|62811862|FG002|Overall Study|Disease progression|0|||
33435041|NCT00401544|62811863|FG003|Overall Study|Disease progression|0|||
33435042|NCT00401544|62811860|FG000|Overall Study|Other|0|||
33435043|NCT00401544|62811861|FG001|Overall Study|Other|0|||
33435044|NCT00401544|62811862|FG002|Overall Study|Other|2|||
33435045|NCT00401544|62811863|FG003|Overall Study|Other|2|||
33435046|NCT00289731|62811881|FG000|Overall Study|Adverse Event|1|||
33435047|NCT00289731|62811882|FG001|Overall Study|Adverse Event|2|||
33435048|NCT00289731|62811883|FG002|Overall Study|Adverse Event|2|||
33605506|NCT01733758|63005191|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
33435049|NCT00289731|62811881|FG000|Overall Study|Other|1|||
33435050|NCT00289731|62811882|FG001|Overall Study|Other|0|||
33435051|NCT00289731|62811883|FG002|Overall Study|Other|0|||
33435052|NCT00289185|62811895|FG000|Overall Study|Withdrawal by Subject|4|||
33435053|NCT00289185|62811896|FG001|Overall Study|Withdrawal by Subject|8|||
33435054|NCT00289185|62811895|FG000|Overall Study|Lost to Follow-up|23|||
33435055|NCT00289185|62811896|FG001|Overall Study|Lost to Follow-up|17|||
33435056|NCT00289185|62811895|FG000|Overall Study|Death|1|||
33435057|NCT00289185|62811896|FG001|Overall Study|Death|1|||
33435058|NCT00292461|62811905|FG000|Overall Study|Adverse Event|4|||
33323187|NCT01175135|62699457|FG002|Overall Study|Protocol Violation|0|||
33323188|NCT01175135|62699458|FG003|Overall Study|Protocol Violation|0|||
33435059|NCT00292461|62811906|FG001|Overall Study|Adverse Event|2|||
33435060|NCT00292461|62811905|FG000|Overall Study|Lack of Efficacy|1|||
33435061|NCT00292461|62811906|FG001|Overall Study|Lack of Efficacy|0|||
33435062|NCT00292461|62811905|FG000|Overall Study|Withdrawal by Subject|0|||
33435063|NCT00292461|62811906|FG001|Overall Study|Withdrawal by Subject|1|||
33435064|NCT00292461|62811905|FG000|Overall Study|Protocol Violation|4|||
33435065|NCT00292461|62811906|FG001|Overall Study|Protocol Violation|3|||
33435066|NCT00292461|62811905|FG000|Overall Study|Lost to Follow-up|1|||
33435067|NCT00292461|62811906|FG001|Overall Study|Lost to Follow-up|0|||
33435068|NCT00288639|62811912|FG000|Overall Study|Adverse Event|5|||
33435069|NCT00288639|62811912|FG000|Overall Study|Lack of Efficacy|4|||
33435070|NCT00288639|62811912|FG000|Overall Study|Withdrawal by Subject|2|||
33435071|NCT00288639|62811912|FG000|Overall Study|Other|1|||
33435072|NCT00390858|62811918|FG000|Overall Study|Adverse Event|6|||
33435073|NCT00390858|62811919|FG001|Overall Study|Adverse Event|2|||
33435074|NCT00390858|62811918|FG000|Overall Study|Lack of Efficacy|0|||
33435075|NCT00390858|62811919|FG001|Overall Study|Lack of Efficacy|1|||
33435076|NCT00390858|62811918|FG000|Overall Study|Withdrawal by Subject|3|||
33435077|NCT00390858|62811919|FG001|Overall Study|Withdrawal by Subject|4|||
33435078|NCT00390780|62811927|FG000|Overall Study|Not completed|10|||
33435079|NCT00390780|62811928|FG001|Overall Study|Not completed|4|||
33435080|NCT00390780|62811927|FG000|Overall Study|Protocol Violation|6|||
33435081|NCT00390780|62811928|FG001|Overall Study|Protocol Violation|4|||
33435082|NCT00390780|62811927|FG000|Overall Study|Lost to Follow-up|3|||
33435083|NCT00390780|62811928|FG001|Overall Study|Lost to Follow-up|6|||
33435084|NCT00390780|62811927|FG000|Overall Study|Adverse Event|2|||
33435085|NCT00390780|62811928|FG001|Overall Study|Adverse Event|3|||
33435086|NCT00390780|62811927|FG000|Overall Study|Death|1|||
33435087|NCT00390780|62811928|FG001|Overall Study|Death|3|||
33435088|NCT00390780|62811927|FG000|Overall Study|Withdrawal by Subject|1|||
33435089|NCT00390780|62811928|FG001|Overall Study|Withdrawal by Subject|2|||
33435090|NCT00390780|62811927|FG000|Overall Study|Inclusion criteria not satisfied|0|||
33435091|NCT00390780|62811928|FG001|Overall Study|Inclusion criteria not satisfied|2|||
33435092|NCT00390780|62811927|FG000|Overall Study|Lost to follow up and other reasons|0|||
33435093|NCT00390780|62811928|FG001|Overall Study|Lost to follow up and other reasons|1|||
33435094|NCT00390780|62811927|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
33435095|NCT00390780|62811928|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
33435096|NCT00390780|62811927|FG000|Overall Study|SAE, death|0|||
33435097|NCT00390780|62811928|FG001|Overall Study|SAE, death|1|||
33435098|NCT00390546|62811936|FG000|Overall Study|Renal impairment|1|||
33435099|NCT00390546|62811937|FG001|Overall Study|Renal impairment|0|||
33435100|NCT00390546|62811936|FG000|Overall Study|Physician Decision|5|||
33435101|NCT00390546|62811937|FG001|Overall Study|Physician Decision|5|||
33435102|NCT00390468|62811944|FG000|Overall Study|Protocol Violation|2|||
33435103|NCT00390468|62811944|FG000|Overall Study|Lack of Efficacy|1|||
33435104|NCT00400764|62811953|FG000|Phase Ib|Adverse Event|1|||
33435105|NCT00400764|62811954|FG001|Phase Ib|Adverse Event|0|||
33435106|NCT00400764|62811955|FG002|Phase Ib|Adverse Event|0|||
33435107|NCT00400764|62811956|FG003|Phase Ib|Adverse Event|0|||
33435108|NCT00400764|62811957|FG004|Phase Ib|Adverse Event|0|||
33435109|NCT00400764|62811953|FG000|Phase Ib|Death|1|||
33435110|NCT00400764|62811954|FG001|Phase Ib|Death|0|||
33435111|NCT00400764|62811955|FG002|Phase Ib|Death|0|||
33435112|NCT00400764|62811956|FG003|Phase Ib|Death|0|||
33435113|NCT00400764|62811957|FG004|Phase Ib|Death|0|||
33435114|NCT00400764|62811953|FG000|Phase Ib|Disease Progression|4|||
33435115|NCT00400764|62811954|FG001|Phase Ib|Disease Progression|4|||
33435116|NCT00400764|62811955|FG002|Phase Ib|Disease Progression|0|||
33435117|NCT00400764|62811956|FG003|Phase Ib|Disease Progression|0|||
33435118|NCT00400764|62811957|FG004|Phase Ib|Disease Progression|0|||
33435119|NCT00400764|62811953|FG000|Phase II|Death|0|||
33435120|NCT00400764|62811954|FG001|Phase II|Death|0|||
33435121|NCT00400764|62811955|FG002|Phase II|Death|1|||
33435122|NCT00400764|62811956|FG003|Phase II|Death|2|||
33435123|NCT00400764|62811957|FG004|Phase II|Death|0|||
33605507|NCT01733758|63005192|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
33435124|NCT00400764|62811953|FG000|Phase II|Lost to Follow-up|0|||
33435125|NCT00400764|62811954|FG001|Phase II|Lost to Follow-up|0|||
33435126|NCT00400764|62811955|FG002|Phase II|Lost to Follow-up|1|||
33435127|NCT00400764|62811956|FG003|Phase II|Lost to Follow-up|0|||
33435128|NCT00400764|62811957|FG004|Phase II|Lost to Follow-up|0|||
33435129|NCT00400764|62811953|FG000|Phase II|Physician Decision|0|||
33435130|NCT00400764|62811954|FG001|Phase II|Physician Decision|0|||
33435131|NCT00400764|62811955|FG002|Phase II|Physician Decision|1|||
33435132|NCT00400764|62811956|FG003|Phase II|Physician Decision|1|||
33435133|NCT00400764|62811957|FG004|Phase II|Physician Decision|0|||
33435134|NCT00400764|62811953|FG000|Phase II|Sponsor's decision to terminate|0|||
33435135|NCT00400764|62811954|FG001|Phase II|Sponsor's decision to terminate|0|||
33435136|NCT00400764|62811955|FG002|Phase II|Sponsor's decision to terminate|18|||
33435137|NCT00400764|62811956|FG003|Phase II|Sponsor's decision to terminate|22|||
33435138|NCT00400764|62811957|FG004|Phase II|Sponsor's decision to terminate|11|||
33435139|NCT00400764|62811953|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
33435140|NCT00400764|62811954|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
33435141|NCT00400764|62811955|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
33435142|NCT00400764|62811956|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
33435143|NCT00400764|62811957|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
33435144|NCT00400764|62811953|FG000|Phase II|Withdrawal by Subject|0|||
33435145|NCT00400764|62811954|FG001|Phase II|Withdrawal by Subject|0|||
33435146|NCT00400764|62811955|FG002|Phase II|Withdrawal by Subject|1|||
33435147|NCT00400764|62811956|FG003|Phase II|Withdrawal by Subject|1|||
33435148|NCT00400764|62811957|FG004|Phase II|Withdrawal by Subject|0|||
33435149|NCT00302211|62811977|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
33435150|NCT00302211|62811978|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
33435151|NCT00302211|62811979|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
33435152|NCT00302211|62811980|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
33435153|NCT00302211|62811981|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
33435154|NCT00302211|62811977|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
33435155|NCT00302211|62811978|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
33435156|NCT00302211|62811979|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
33435157|NCT00302211|62811980|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
33435158|NCT00302211|62811981|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
33435159|NCT00302211|62811977|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
33435160|NCT00302211|62811978|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
33435161|NCT00302211|62811979|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
33435162|NCT00302211|62811980|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
33435163|NCT00302211|62811981|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
33435164|NCT00302211|62811977|FG000|Double Blind Period (New Patients)|Disease progression|0|||
33435165|NCT00302211|62811978|FG001|Double Blind Period (New Patients)|Disease progression|1|||
33435166|NCT00302211|62811979|FG002|Double Blind Period (New Patients)|Disease progression|1|||
33435167|NCT00302211|62811980|FG003|Double Blind Period (New Patients)|Disease progression|0|||
33435168|NCT00302211|62811981|FG004|Double Blind Period (New Patients)|Disease progression|0|||
33435169|NCT00302211|62811977|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
33435170|NCT00302211|62811978|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
33435171|NCT00302211|62811979|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
33435172|NCT00302211|62811980|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
33435173|NCT00302211|62811981|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
33435174|NCT00302211|62811977|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
33435175|NCT00302211|62811978|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
33435176|NCT00302211|62811979|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
33435177|NCT00302211|62811980|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
33435178|NCT00302211|62811981|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
33435179|NCT00302211|62811977|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
33435180|NCT00302211|62811978|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
33435181|NCT00302211|62811979|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
33435182|NCT00302211|62811980|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
33435183|NCT00302211|62811981|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
33435184|NCT00302211|62811977|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
33435185|NCT00302211|62811978|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
33435186|NCT00302211|62811979|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
33435187|NCT00302211|62811980|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
33605508|NCT01733758|63005193|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
33605509|NCT01733758|63005190|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
33435188|NCT00302211|62811981|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
33435189|NCT00302211|62811977|FG000|Open Label-Patients From Double-Blind|Death|0|||
33435190|NCT00302211|62811978|FG001|Open Label-Patients From Double-Blind|Death|0|||
33435191|NCT00302211|62811979|FG002|Open Label-Patients From Double-Blind|Death|0|||
33435192|NCT00302211|62811980|FG003|Open Label-Patients From Double-Blind|Death|1|||
33435193|NCT00302211|62811981|FG004|Open Label-Patients From Double-Blind|Death|1|||
33435194|NCT00302211|62811977|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
33435195|NCT00302211|62811978|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
33435196|NCT00302211|62811979|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
33435197|NCT00302211|62811980|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
33435198|NCT00302211|62811981|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
33435199|NCT00302211|62811977|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
33435200|NCT00302211|62811978|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
33435201|NCT00302211|62811979|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
33435202|NCT00302211|62811980|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
33435203|NCT00302211|62811981|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
33435204|NCT00302211|62811977|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
33435205|NCT00302211|62811978|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
33435206|NCT00302211|62811979|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
33435207|NCT00302211|62811980|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
33435208|NCT00302211|62811981|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
33435209|NCT00288015|62811993|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
33435210|NCT00288015|62811993|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
33435211|NCT00288015|62811993|FG000|First Response Assessment|Withdrawal by Subject|1|||
33435212|NCT00288015|62811993|FG000|First Response Assessment|Death|1|||
33435213|NCT00288015|62811993|FG000|First Response Assessment|Physician Decision|2|||
33435214|NCT00288015|62811993|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
33435215|NCT00288015|62811993|FG000|Follow up for Survival x 2 Years|Death|13|||
33435216|NCT00288015|62811993|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
33435217|NCT00288015|62811993|FG000|Follow up for Survival x 2 Years|Other|9|||
33435218|NCT00389064|62811999|FG000|Overall Study|Adverse Event|11|||
33435219|NCT00389064|62812000|FG001|Overall Study|Adverse Event|3|||
33435220|NCT00389064|62811999|FG000|Overall Study|Lack of Efficacy|3|||
33435221|NCT00389064|62812000|FG001|Overall Study|Lack of Efficacy|14|||
33435222|NCT00389064|62811999|FG000|Overall Study|Withdrawal by Subject|17|||
33435223|NCT00389064|62812000|FG001|Overall Study|Withdrawal by Subject|27|||
33435224|NCT00389064|62811999|FG000|Overall Study|Physician Decision|2|||
33435225|NCT00389064|62812000|FG001|Overall Study|Physician Decision|2|||
33435226|NCT00389064|62811999|FG000|Overall Study|Lost to Follow-up|1|||
33435227|NCT00389064|62812000|FG001|Overall Study|Lost to Follow-up|2|||
33435228|NCT00389064|62811999|FG000|Overall Study|Protocol Violation|2|||
33435229|NCT00389064|62812000|FG001|Overall Study|Protocol Violation|0|||
33435230|NCT00389064|62811999|FG000|Overall Study|Multiple Reasons|9|||
33435231|NCT00389064|62812000|FG001|Overall Study|Multiple Reasons|11|||
33435232|NCT00388674|62812008|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
33435233|NCT00388674|62812009|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
33435234|NCT00388674|62812008|FG000|Initial Treatment|Adverse Event|22|||
33435235|NCT00388674|62812009|FG001|Initial Treatment|Adverse Event|87|||
33435236|NCT00388674|62812008|FG000|Initial Treatment|Death|215|||
33435237|NCT00388674|62812009|FG001|Initial Treatment|Death|216|||
33435238|NCT00388674|62812008|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
33435239|NCT00388674|62812009|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
33435240|NCT00388674|62812008|FG000|Initial Treatment|HCC|12|||
33435241|NCT00388674|62812009|FG001|Initial Treatment|HCC|20|||
33435242|NCT00388674|62812008|FG000|Initial Treatment|Lost to Follow-up|526|||
33435243|NCT00388674|62812009|FG001|Initial Treatment|Lost to Follow-up|624|||
33435244|NCT00388674|62812008|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
33435245|NCT00388674|62812009|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
33435246|NCT00388674|62812008|FG000|Initial Treatment|Never Treated with Study Medication|1|||
33435247|NCT00388674|62812009|FG001|Initial Treatment|Never Treated with Study Medication|7|||
33435248|NCT00388674|62812008|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
33435249|NCT00388674|62812009|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
33435250|NCT00388674|62812008|FG000|Initial Treatment|Not Defined|125|||
33435251|NCT00388674|62812009|FG001|Initial Treatment|Not Defined|172|||
33435252|NCT00388674|62812008|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
33435253|NCT00388674|62812009|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
33435254|NCT00388674|62812008|FG000|Initial Treatment|Pregnancy|26|||
33435255|NCT00388674|62812009|FG001|Initial Treatment|Pregnancy|16|||
33435256|NCT00388674|62812008|FG000|Initial Treatment|Study Drug Toxicity|5|||
33435257|NCT00388674|62812009|FG001|Initial Treatment|Study Drug Toxicity|92|||
33435258|NCT00388674|62812008|FG000|Initial Treatment|Participant Request|501|||
33435259|NCT00388674|62812009|FG001|Initial Treatment|Participant Request|673|||
33435260|NCT00388674|62812008|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
33435261|NCT00388674|62812009|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
33435262|NCT00388674|62812008|FG000|Initial Treatment|Not Reported|10|||
33435263|NCT00388674|62812009|FG001|Initial Treatment|Not Reported|12|||
33435264|NCT00388674|62812008|FG000|End of Study|Administrative Reason By Sponsor|299|||
33435265|NCT00388674|62812009|FG001|End of Study|Administrative Reason By Sponsor|253|||
33435266|NCT00388674|62812008|FG000|End of Study|Death|239|||
33435267|NCT00388674|62812009|FG001|End of Study|Death|262|||
33435268|NCT00388674|62812008|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
33435269|NCT00388674|62812009|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
33435270|NCT00388674|62812008|FG000|End of Study|HCC|8|||
33435271|NCT00388674|62812009|FG001|End of Study|HCC|7|||
33435272|NCT00388674|62812008|FG000|End of Study|Lost to Follow-up|587|||
33435273|NCT00388674|62812009|FG001|End of Study|Lost to Follow-up|715|||
33435274|NCT00388674|62812008|FG000|End of Study|Malignancy (Non-HCC)|1|||
33435275|NCT00388674|62812009|FG001|End of Study|Malignancy (Non-HCC)|1|||
33435276|NCT00388674|62812008|FG000|End of Study|Non-Study Related Comorbidities|3|||
33435277|NCT00388674|62812009|FG001|End of Study|Non-Study Related Comorbidities|4|||
33435278|NCT00388674|62812008|FG000|End of Study|Not Defined|135|||
33435279|NCT00388674|62812009|FG001|End of Study|Not Defined|214|||
33435280|NCT00388674|62812008|FG000|End of Study|Participant Withdrew Consent|437|||
33435281|NCT00388674|62812009|FG001|End of Study|Participant Withdrew Consent|673|||
33435282|NCT00388674|62812008|FG000|End of Study|No Off-Treatment Status Data|22|||
33435283|NCT00388674|62812009|FG001|End of Study|No Off-Treatment Status Data|30|||
33435284|NCT00388674|62812008|FG000|End of Study|Not Reported|0|||
33435285|NCT00388674|62812009|FG001|End of Study|Not Reported|1|||
33435286|NCT00388362|62812015|FG000|Enrolled|Ineligible|1|||
33435287|NCT00388362|62812015|FG000|Enrolled|Adverse Event|9|||
33435288|NCT00388362|62812015|FG000|Enrolled|Death|1|||
33435289|NCT00388362|62812015|FG000|Enrolled|Loss insurance|1|||
33435290|NCT00388362|62812015|FG000|Enrolled|Withdrawal by Subject|1|||
33435291|NCT00388362|62812015|FG000|Remained on Study Median of 514 Days|Death|2|||
33435292|NCT00387894|62812019|FG000|Overall Study|Withdrawal by Subject|1|||
33435293|NCT00387426|62812023|FG000|Overall Study|Lack of Response|7|||
33435294|NCT00387426|62812023|FG000|Overall Study|Toxicities|4|||
33435295|NCT00387426|62812023|FG000|Overall Study|Disease Progression|3|||
33435296|NCT00387348|62812030|FG000|Overall Study|Death|1|||
33435297|NCT00387348|62812031|FG001|Overall Study|Death|1|||
33435298|NCT00387348|62812032|FG002|Overall Study|Death|0|||
33435299|NCT00387348|62812030|FG000|Overall Study|Physician Decision|1|||
33435300|NCT00387348|62812031|FG001|Overall Study|Physician Decision|0|||
33435301|NCT00387348|62812032|FG002|Overall Study|Physician Decision|1|||
33435302|NCT00387348|62812030|FG000|Overall Study|Withdrawal by Subject|0|||
33435303|NCT00387348|62812031|FG001|Overall Study|Withdrawal by Subject|2|||
33435304|NCT00387348|62812032|FG002|Overall Study|Withdrawal by Subject|2|||
33435305|NCT00387348|62812030|FG000|Overall Study|Adverse Event|1|||
33435306|NCT00387348|62812031|FG001|Overall Study|Adverse Event|0|||
33435307|NCT00387348|62812032|FG002|Overall Study|Adverse Event|1|||
33435308|NCT00413660|62812052|FG000|Up To Week 12|Adverse Event|1|||
33435309|NCT00413660|62812053|FG001|Up To Week 12|Adverse Event|3|||
33435310|NCT00413660|62812054|FG002|Up To Week 12|Adverse Event|1|||
33435311|NCT00413660|62812055|FG003|Up To Week 12|Adverse Event|4|||
33435312|NCT00413660|62812056|FG004|Up To Week 12|Adverse Event|6|||
33435313|NCT00413660|62812057|FG005|Up To Week 12|Adverse Event|4|||
33435314|NCT00413660|62812058|FG006|Up To Week 12|Adverse Event|1|||
33435315|NCT00413660|62812059|FG007|Up To Week 12|Adverse Event|0|||
33435316|NCT00413660|62812060|FG008|Up To Week 12|Adverse Event|0|||
33435317|NCT00413660|62812061|FG009|Up To Week 12|Adverse Event|0|||
33435318|NCT00413660|62812062|FG010|Up To Week 12|Adverse Event|0|||
33435319|NCT00413660|62812052|FG000|Up To Week 12|Lack of Efficacy|2|||
33435320|NCT00413660|62812053|FG001|Up To Week 12|Lack of Efficacy|0|||
33435321|NCT00413660|62812054|FG002|Up To Week 12|Lack of Efficacy|0|||
33435322|NCT00413660|62812055|FG003|Up To Week 12|Lack of Efficacy|0|||
33435323|NCT00413660|62812056|FG004|Up To Week 12|Lack of Efficacy|0|||
33435324|NCT00413660|62812057|FG005|Up To Week 12|Lack of Efficacy|0|||
33435325|NCT00413660|62812058|FG006|Up To Week 12|Lack of Efficacy|5|||
33435326|NCT00413660|62812059|FG007|Up To Week 12|Lack of Efficacy|0|||
33435327|NCT00413660|62812060|FG008|Up To Week 12|Lack of Efficacy|0|||
33435328|NCT00413660|62812061|FG009|Up To Week 12|Lack of Efficacy|0|||
33435329|NCT00413660|62812062|FG010|Up To Week 12|Lack of Efficacy|0|||
33435330|NCT00413660|62812052|FG000|Up To Week 12|Lost to Follow-up|0|||
33435331|NCT00413660|62812053|FG001|Up To Week 12|Lost to Follow-up|1|||
33435332|NCT00413660|62812054|FG002|Up To Week 12|Lost to Follow-up|0|||
33435333|NCT00413660|62812055|FG003|Up To Week 12|Lost to Follow-up|0|||
33435334|NCT00413660|62812056|FG004|Up To Week 12|Lost to Follow-up|1|||
33435335|NCT00413660|62812057|FG005|Up To Week 12|Lost to Follow-up|0|||
33435336|NCT00413660|62812058|FG006|Up To Week 12|Lost to Follow-up|0|||
33435337|NCT00413660|62812059|FG007|Up To Week 12|Lost to Follow-up|0|||
33435338|NCT00413660|62812060|FG008|Up To Week 12|Lost to Follow-up|0|||
33435339|NCT00413660|62812061|FG009|Up To Week 12|Lost to Follow-up|0|||
33435340|NCT00413660|62812062|FG010|Up To Week 12|Lost to Follow-up|0|||
33435341|NCT00413660|62812052|FG000|Up To Week 12|Withdrawal by Subject|0|||
33435342|NCT00413660|62812053|FG001|Up To Week 12|Withdrawal by Subject|2|||
33435343|NCT00413660|62812054|FG002|Up To Week 12|Withdrawal by Subject|0|||
33435344|NCT00413660|62812055|FG003|Up To Week 12|Withdrawal by Subject|2|||
33435345|NCT00413660|62812056|FG004|Up To Week 12|Withdrawal by Subject|0|||
33435346|NCT00413660|62812057|FG005|Up To Week 12|Withdrawal by Subject|2|||
33435347|NCT00413660|62812058|FG006|Up To Week 12|Withdrawal by Subject|2|||
33435348|NCT00413660|62812059|FG007|Up To Week 12|Withdrawal by Subject|0|||
33435349|NCT00413660|62812060|FG008|Up To Week 12|Withdrawal by Subject|0|||
33435350|NCT00413660|62812061|FG009|Up To Week 12|Withdrawal by Subject|0|||
33435351|NCT00413660|62812062|FG010|Up To Week 12|Withdrawal by Subject|0|||
33435352|NCT00413660|62812052|FG000|Up To Week 12|Randomized, Not Treated|1|||
33435353|NCT00413660|62812053|FG001|Up To Week 12|Randomized, Not Treated|0|||
33435354|NCT00413660|62812054|FG002|Up To Week 12|Randomized, Not Treated|0|||
33435355|NCT00413660|62812055|FG003|Up To Week 12|Randomized, Not Treated|1|||
33435356|NCT00413660|62812056|FG004|Up To Week 12|Randomized, Not Treated|0|||
33435357|NCT00413660|62812057|FG005|Up To Week 12|Randomized, Not Treated|0|||
33435358|NCT00413660|62812058|FG006|Up To Week 12|Randomized, Not Treated|0|||
33435359|NCT00413660|62812059|FG007|Up To Week 12|Randomized, Not Treated|0|||
33435360|NCT00413660|62812060|FG008|Up To Week 12|Randomized, Not Treated|0|||
33435361|NCT00413660|62812061|FG009|Up To Week 12|Randomized, Not Treated|0|||
33435362|NCT00413660|62812062|FG010|Up To Week 12|Randomized, Not Treated|0|||
33435363|NCT00413660|62812052|FG000|Up To Week 12|Other|3|||
33435364|NCT00413660|62812053|FG001|Up To Week 12|Other|1|||
33435365|NCT00413660|62812054|FG002|Up To Week 12|Other|6|||
33435366|NCT00413660|62812055|FG003|Up To Week 12|Other|1|||
33435367|NCT00413660|62812056|FG004|Up To Week 12|Other|2|||
33435368|NCT00413660|62812057|FG005|Up To Week 12|Other|4|||
33435369|NCT00413660|62812058|FG006|Up To Week 12|Other|3|||
33435370|NCT00413660|62812059|FG007|Up To Week 12|Other|0|||
33435371|NCT00413660|62812060|FG008|Up To Week 12|Other|0|||
33435372|NCT00413660|62812061|FG009|Up To Week 12|Other|0|||
33435373|NCT00413660|62812062|FG010|Up To Week 12|Other|0|||
33435374|NCT00413660|62812052|FG000|Post Week 12|Adverse Event|2|||
33435375|NCT00413660|62812053|FG001|Post Week 12|Adverse Event|0|||
33435376|NCT00413660|62812054|FG002|Post Week 12|Adverse Event|2|||
33435377|NCT00413660|62812055|FG003|Post Week 12|Adverse Event|1|||
33435378|NCT00413660|62812056|FG004|Post Week 12|Adverse Event|4|||
33435379|NCT00413660|62812057|FG005|Post Week 12|Adverse Event|2|||
33435380|NCT00413660|62812058|FG006|Post Week 12|Adverse Event|2|||
33435381|NCT00413660|62812059|FG007|Post Week 12|Adverse Event|0|||
33435382|NCT00413660|62812060|FG008|Post Week 12|Adverse Event|0|||
33435383|NCT00413660|62812061|FG009|Post Week 12|Adverse Event|0|||
33435384|NCT00413660|62812062|FG010|Post Week 12|Adverse Event|0|||
33435385|NCT00413660|62812052|FG000|Post Week 12|Lack of Efficacy|0|||
33435386|NCT00413660|62812053|FG001|Post Week 12|Lack of Efficacy|0|||
33435387|NCT00413660|62812054|FG002|Post Week 12|Lack of Efficacy|1|||
33435388|NCT00413660|62812055|FG003|Post Week 12|Lack of Efficacy|0|||
33435389|NCT00413660|62812056|FG004|Post Week 12|Lack of Efficacy|0|||
33435390|NCT00413660|62812057|FG005|Post Week 12|Lack of Efficacy|0|||
33435391|NCT00413660|62812058|FG006|Post Week 12|Lack of Efficacy|0|||
33435392|NCT00413660|62812059|FG007|Post Week 12|Lack of Efficacy|0|||
33435393|NCT00413660|62812060|FG008|Post Week 12|Lack of Efficacy|0|||
33435394|NCT00413660|62812061|FG009|Post Week 12|Lack of Efficacy|1|||
33435395|NCT00413660|62812062|FG010|Post Week 12|Lack of Efficacy|0|||
33435396|NCT00413660|62812052|FG000|Post Week 12|Lost to Follow-up|0|||
33435397|NCT00413660|62812053|FG001|Post Week 12|Lost to Follow-up|1|||
33435398|NCT00413660|62812054|FG002|Post Week 12|Lost to Follow-up|1|||
33435399|NCT00413660|62812055|FG003|Post Week 12|Lost to Follow-up|0|||
33435400|NCT00413660|62812056|FG004|Post Week 12|Lost to Follow-up|0|||
33435401|NCT00413660|62812057|FG005|Post Week 12|Lost to Follow-up|0|||
33435402|NCT00413660|62812058|FG006|Post Week 12|Lost to Follow-up|0|||
33435403|NCT00413660|62812059|FG007|Post Week 12|Lost to Follow-up|0|||
33435404|NCT00413660|62812060|FG008|Post Week 12|Lost to Follow-up|0|||
33435405|NCT00413660|62812061|FG009|Post Week 12|Lost to Follow-up|0|||
33435406|NCT00413660|62812062|FG010|Post Week 12|Lost to Follow-up|0|||
33323189|NCT01175135|62699455|FG000|Overall Study|Withdrawal by Subject|4|||
33435407|NCT00413660|62812052|FG000|Post Week 12|Withdrawal by Subject|0|||
33435408|NCT00413660|62812053|FG001|Post Week 12|Withdrawal by Subject|1|||
33323190|NCT01175135|62699456|FG001|Overall Study|Withdrawal by Subject|8|||
33435409|NCT00413660|62812054|FG002|Post Week 12|Withdrawal by Subject|1|||
33323191|NCT01175135|62699457|FG002|Overall Study|Withdrawal by Subject|5|||
33323192|NCT01175135|62699458|FG003|Overall Study|Withdrawal by Subject|5|||
33435410|NCT00413660|62812055|FG003|Post Week 12|Withdrawal by Subject|0|||
33435411|NCT00413660|62812056|FG004|Post Week 12|Withdrawal by Subject|1|||
33435412|NCT00413660|62812057|FG005|Post Week 12|Withdrawal by Subject|0|||
33435413|NCT00413660|62812058|FG006|Post Week 12|Withdrawal by Subject|0|||
33435414|NCT00413660|62812059|FG007|Post Week 12|Withdrawal by Subject|0|||
33435415|NCT00413660|62812060|FG008|Post Week 12|Withdrawal by Subject|0|||
33435416|NCT00413660|62812061|FG009|Post Week 12|Withdrawal by Subject|0|||
33435417|NCT00413660|62812062|FG010|Post Week 12|Withdrawal by Subject|1|||
33435418|NCT00413660|62812052|FG000|Post Week 12|Other|1|||
33435419|NCT00413660|62812053|FG001|Post Week 12|Other|2|||
33435420|NCT00413660|62812054|FG002|Post Week 12|Other|3|||
33435421|NCT00413660|62812055|FG003|Post Week 12|Other|0|||
33435422|NCT00413660|62812056|FG004|Post Week 12|Other|1|||
33435423|NCT00413660|62812057|FG005|Post Week 12|Other|1|||
33435424|NCT00413660|62812058|FG006|Post Week 12|Other|1|||
33435425|NCT00413660|62812059|FG007|Post Week 12|Other|0|||
33435426|NCT00413660|62812060|FG008|Post Week 12|Other|0|||
33435427|NCT00413660|62812061|FG009|Post Week 12|Other|0|||
33435428|NCT00413660|62812062|FG010|Post Week 12|Other|0|||
33435429|NCT00431834|62812096|FG000|Overall Study|Withdrawal by Subject|7|||
33435430|NCT00431834|62812096|FG000|Overall Study|Death|3|||
33435431|NCT00431834|62812096|FG000|Overall Study|Missed Endpoint Visit|2|||
33435432|NCT00431834|62812096|FG000|Overall Study|Lost to Follow-up|1|||
33435433|NCT00431444|62812105|FG000|Overall Study|Protocol Violation|1|||
33435434|NCT00431444|62812106|FG001|Overall Study|Protocol Violation|4|||
33435435|NCT00431444|62812105|FG000|Overall Study|Adverse Event|2|||
33435436|NCT00431444|62812106|FG001|Overall Study|Adverse Event|1|||
33435437|NCT00431444|62812105|FG000|Overall Study|Withdrawal by Subject|1|||
33435438|NCT00431444|62812106|FG001|Overall Study|Withdrawal by Subject|1|||
33435439|NCT00431444|62812105|FG000|Overall Study|Lost to Follow-up|1|||
33435440|NCT00431444|62812106|FG001|Overall Study|Lost to Follow-up|0|||
33435441|NCT00431444|62812105|FG000|Overall Study|Administrative Problems|0|||
33435442|NCT00431444|62812106|FG001|Overall Study|Administrative Problems|1|||
33435443|NCT00430352|62812112|FG000|Overall Study|Disease progression|58|||
33435444|NCT00430352|62812112|FG000|Overall Study|Withdrawal by Subject|11|||
33435445|NCT00430352|62812112|FG000|Overall Study|Adverse Event|16|||
33435446|NCT00430352|62812112|FG000|Overall Study|Death|5|||
33435447|NCT00430352|62812112|FG000|Overall Study|Other|48|||
33435448|NCT00287469|62812118|FG000|Overall Study|serious adverse event|1|||
33435449|NCT00287469|62812119|FG001|Overall Study|serious adverse event|6|||
33435450|NCT00287469|62812118|FG000|Overall Study|Adverse Event|1|||
33435451|NCT00287469|62812119|FG001|Overall Study|Adverse Event|1|||
33435452|NCT00287469|62812118|FG000|Overall Study|moved from area|144|||
33435453|NCT00287469|62812119|FG001|Overall Study|moved from area|138|||
33435454|NCT00287469|62812118|FG000|Overall Study|Lost to Follow-up|74|||
33435455|NCT00287469|62812119|FG001|Overall Study|Lost to Follow-up|69|||
33435456|NCT00429572|62812127|FG000|Overall Study|Disease progression|1|||
33435457|NCT00287079|62812133|FG000|Overall Study|Qualifying relapse|12|||
33435458|NCT00287079|62812134|FG001|Overall Study|Qualifying relapse|1|||
33435459|NCT00287079|62812133|FG000|Overall Study|Non-qualifying relapse|1|||
33435460|NCT00287079|62812134|FG001|Overall Study|Non-qualifying relapse|0|||
33435461|NCT00287079|62812133|FG000|Overall Study|Adverse Event|5|||
33435462|NCT00287079|62812134|FG001|Overall Study|Adverse Event|0|||
33435463|NCT00287079|62812133|FG000|Overall Study|Protocol Violation|1|||
33435464|NCT00287079|62812134|FG001|Overall Study|Protocol Violation|0|||
33435465|NCT00287079|62812133|FG000|Overall Study|Other|3|||
33435466|NCT00287079|62812134|FG001|Overall Study|Other|0|||
33435467|NCT00429494|62812140|FG000|Overall Study|Withdrawal by Subject|9|||
33435468|NCT00429494|62812140|FG000|Overall Study|Death|6|||
33435469|NCT00429416|62812144|FG000|Overall Study|Death|1|||
33435470|NCT00429182|62812148|FG000|Overall Study|Not evaluable, Disease Progression|2|||
33435471|NCT00429182|62812148|FG000|Overall Study|Not eligible|5|||
33323193|NCT01175135|62699455|FG000|Overall Study|Other|3|||
33435472|NCT00429104|62812152|FG000|Overall Study|Protocol Violation|1|||
33435473|NCT00429026|62812156|FG000|Overall Study|Inevaluable for response.|40|||
33435474|NCT00301821|62812160|FG000|Overall Study|Ineligible|25|||
33435475|NCT00301821|62812160|FG000|Overall Study|Cancel|1|||
33435476|NCT00372996|62812166|FG000|Overall Study|Death|11|||
33435477|NCT00372996|62812167|FG001|Overall Study|Death|4|||
33435478|NCT00372996|62812168|FG002|Overall Study|Death|8|||
33435479|NCT00372996|62812169|FG003|Overall Study|Death|7|||
33435480|NCT00372996|62812166|FG000|Overall Study|Lost to Follow-up|0|||
33435481|NCT00372996|62812167|FG001|Overall Study|Lost to Follow-up|2|||
33435482|NCT00372996|62812168|FG002|Overall Study|Lost to Follow-up|0|||
33435483|NCT00372996|62812169|FG003|Overall Study|Lost to Follow-up|1|||
33435484|NCT00372996|62812166|FG000|Overall Study|Withdrawal by Subject|12|||
33435485|NCT00372996|62812167|FG001|Overall Study|Withdrawal by Subject|6|||
33435486|NCT00372996|62812168|FG002|Overall Study|Withdrawal by Subject|9|||
33435487|NCT00372996|62812169|FG003|Overall Study|Withdrawal by Subject|5|||
33435488|NCT00372996|62812166|FG000|Overall Study|Study Terminated by Sponsor|4|||
33435489|NCT00372996|62812167|FG001|Overall Study|Study Terminated by Sponsor|0|||
33435490|NCT00372996|62812168|FG002|Overall Study|Study Terminated by Sponsor|4|||
33435491|NCT00372996|62812169|FG003|Overall Study|Study Terminated by Sponsor|0|||
33435492|NCT00372996|62812166|FG000|Overall Study|Other|10|||
33435493|NCT00372996|62812167|FG001|Overall Study|Other|2|||
33435494|NCT00372996|62812168|FG002|Overall Study|Other|7|||
33435495|NCT00372996|62812169|FG003|Overall Study|Other|7|||
33435496|NCT00399516|62812179|FG000|Overall Study|Lost to Follow-up|2|||
33435497|NCT00399360|62812187|FG000|Overall Study|Lost to Follow-up|2|||
33435498|NCT00399360|62812188|FG001|Overall Study|Lost to Follow-up|1|||
33435499|NCT00399360|62812189|FG002|Overall Study|Lost to Follow-up|2|||
33435500|NCT00399360|62812190|FG003|Overall Study|Lost to Follow-up|4|||
33435501|NCT00399360|62812187|FG000|Overall Study|Adverse Event|0|||
33435502|NCT00399360|62812188|FG001|Overall Study|Adverse Event|0|||
33435503|NCT00399360|62812189|FG002|Overall Study|Adverse Event|1|||
33435504|NCT00399360|62812190|FG003|Overall Study|Adverse Event|0|||
33435505|NCT00399360|62812187|FG000|Overall Study|Withdrawal by Subject|0|||
33435506|NCT00399360|62812188|FG001|Overall Study|Withdrawal by Subject|2|||
33435507|NCT00399360|62812189|FG002|Overall Study|Withdrawal by Subject|0|||
33435508|NCT00399360|62812190|FG003|Overall Study|Withdrawal by Subject|2|||
33435509|NCT00428948|62812207|FG000|Overall Study|Lost to Follow-up|15|||
33435510|NCT00428948|62812208|FG001|Overall Study|Lost to Follow-up|8|||
33435511|NCT00428948|62812207|FG000|Overall Study|Adverse Event|148|||
33435512|NCT00428948|62812208|FG001|Overall Study|Adverse Event|24|||
33435513|NCT00428948|62812207|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
33435514|NCT00428948|62812208|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
33435515|NCT00428948|62812207|FG000|Overall Study|Investigator Withdrew Subject|3|||
33435516|NCT00428948|62812208|FG001|Overall Study|Investigator Withdrew Subject|4|||
33435517|NCT00428948|62812207|FG000|Overall Study|Subject Withdrew Consent|50|||
33435518|NCT00428948|62812208|FG001|Overall Study|Subject Withdrew Consent|30|||
33435519|NCT00428948|62812207|FG000|Overall Study|Protocol Deviation|1|||
33435520|NCT00428948|62812208|FG001|Overall Study|Protocol Deviation|1|||
33435521|NCT00428792|62812216|FG000|Overall Study|Lack of Efficacy|1|||
33435522|NCT00428792|62812217|FG001|Overall Study|Lack of Efficacy|3|||
33435523|NCT00428792|62812216|FG000|Overall Study|Lost to Follow-up|0|||
33435524|NCT00428792|62812217|FG001|Overall Study|Lost to Follow-up|1|||
33435525|NCT00300885|62812225|FG000|Treatment|Adverse Event|134|||
33435526|NCT00300885|62812226|FG001|Treatment|Adverse Event|82|||
33435527|NCT00300885|62812225|FG000|Treatment|Death|20|||
33435528|NCT00300885|62812226|FG001|Treatment|Death|7|||
33435529|NCT00300885|62812225|FG000|Treatment|Lack of Efficacy|1|||
33435530|NCT00300885|62812226|FG001|Treatment|Lack of Efficacy|1|||
33435531|NCT00300885|62812225|FG000|Treatment|Lost to Follow-up|3|||
33435532|NCT00300885|62812226|FG001|Treatment|Lost to Follow-up|2|||
33435533|NCT00300885|62812225|FG000|Treatment|Physician Decision|4|||
33435534|NCT00300885|62812226|FG001|Treatment|Physician Decision|5|||
33435535|NCT00300885|62812225|FG000|Treatment|Protocol Violation|11|||
33435536|NCT00300885|62812226|FG001|Treatment|Protocol Violation|11|||
33435537|NCT00300885|62812225|FG000|Treatment|Withdrawal by Subject|26|||
33435538|NCT00300885|62812226|FG001|Treatment|Withdrawal by Subject|23|||
33435539|NCT00300885|62812225|FG000|Treatment|Disease progression|171|||
33435540|NCT00300885|62812226|FG001|Treatment|Disease progression|238|||
33435541|NCT00300885|62812225|FG000|Treatment|Random code broken (subject died)|0|||
33435542|NCT00300885|62812226|FG001|Treatment|Random code broken (subject died)|1|||
33435543|NCT00300885|62812225|FG000|Treatment|Non-compliant with study medication|3|||
33435544|NCT00300885|62812226|FG001|Treatment|Non-compliant with study medication|4|||
33435545|NCT00300885|62812225|FG000|Follow-up|Death|141|||
33435546|NCT00300885|62812226|FG001|Follow-up|Death|163|||
33435547|NCT00300885|62812225|FG000|Follow-up|Lost to Follow-up|11|||
33435548|NCT00300885|62812226|FG001|Follow-up|Lost to Follow-up|7|||
33435549|NCT00300885|62812225|FG000|Follow-up|Withdrawal by Subject|26|||
33435550|NCT00300885|62812226|FG001|Follow-up|Withdrawal by Subject|25|||
33435551|NCT00386334|62812234|FG000|Double Blind Period|Adverse Event|9|||
33435552|NCT00386334|62812235|FG001|Double Blind Period|Adverse Event|14|||
33435553|NCT00386334|62812234|FG000|Double Blind Period|Protocol Violation|1|||
33605510|NCT01733758|63005191|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
33323194|NCT01175135|62699456|FG001|Overall Study|Other|1|||
33435554|NCT00386334|62812235|FG001|Double Blind Period|Protocol Violation|1|||
33435555|NCT00386334|62812234|FG000|Double Blind Period|Withdrawal by Subject|9|||
33435556|NCT00386334|62812235|FG001|Double Blind Period|Withdrawal by Subject|13|||
33435557|NCT00386334|62812234|FG000|Double Blind Period|Lack of Efficacy|20|||
33605511|NCT01733758|63005192|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
33605512|NCT01733758|63005193|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
33435558|NCT00386334|62812235|FG001|Double Blind Period|Lack of Efficacy|11|||
33435559|NCT00386334|62812234|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
33435560|NCT00386334|62812235|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
33435561|NCT00386334|62812234|FG000|Double Blind Period|Other|3|||
33435562|NCT00386334|62812235|FG001|Double Blind Period|Other|3|||
33605513|NCT01607554|63005205|FG000|Overall Study|Disease progression|2|||
33435563|NCT00386334|62812234|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
33435564|NCT00386334|62812235|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
33435565|NCT00428714|62812252|FG000|Overall Study|Progressive Disease|28|||
33435566|NCT00428714|62812253|FG001|Overall Study|Progressive Disease|36|||
33435567|NCT00428714|62812252|FG000|Overall Study|Withdrawal by Subject|0|||
33435568|NCT00428714|62812253|FG001|Overall Study|Withdrawal by Subject|3|||
33435569|NCT00428714|62812252|FG000|Overall Study|Adverse Event|0|||
33435570|NCT00428714|62812253|FG001|Overall Study|Adverse Event|2|||
33435571|NCT00428714|62812252|FG000|Overall Study|Physician Decision|1|||
33435572|NCT00428714|62812253|FG001|Overall Study|Physician Decision|1|||
33435573|NCT00428714|62812252|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
33435574|NCT00428714|62812253|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
33435575|NCT00428714|62812252|FG000|Overall Study|Death due to other then PD|1|||
33435576|NCT00428714|62812253|FG001|Overall Study|Death due to other then PD|0|||
33435577|NCT00292227|62812262|FG000|Patch Period|Adverse Event|1|||
33435578|NCT00292227|62812263|FG001|Patch Period|Adverse Event|0|||
33435579|NCT00292227|62812264|FG002|Patch Period|Adverse Event|2|||
33435580|NCT00292227|62812262|FG000|Patch Period|Withdrawal by Subject|0|||
33435581|NCT00292227|62812263|FG001|Patch Period|Withdrawal by Subject|0|||
33435582|NCT00292227|62812264|FG002|Patch Period|Withdrawal by Subject|1|||
33435583|NCT00386100|62812274|FG000|Overall Study|Did not receive study medication|6|||
33435584|NCT00386100|62812275|FG001|Overall Study|Did not receive study medication|4|||
33435585|NCT00386100|62812274|FG000|Overall Study|Adverse Event|15|||
33435586|NCT00386100|62812275|FG001|Overall Study|Adverse Event|25|||
33435587|NCT00386100|62812274|FG000|Overall Study|Death|0|||
33435588|NCT00386100|62812275|FG001|Overall Study|Death|1|||
33435589|NCT00386100|62812274|FG000|Overall Study|Insufficient therapeutic effect|30|||
33435590|NCT00386100|62812275|FG001|Overall Study|Insufficient therapeutic effect|6|||
33435591|NCT00386100|62812274|FG000|Overall Study|Lost to Follow-up|29|||
33435592|NCT00386100|62812275|FG001|Overall Study|Lost to Follow-up|29|||
33435593|NCT00386100|62812274|FG000|Overall Study|Non-compliance|18|||
33435594|NCT00386100|62812275|FG001|Overall Study|Non-compliance|19|||
33435595|NCT00386100|62812274|FG000|Overall Study|Protocol Violation|5|||
33435596|NCT00386100|62812275|FG001|Overall Study|Protocol Violation|3|||
33435597|NCT00386100|62812274|FG000|Overall Study|Withdrawal by Subject|32|||
33435598|NCT00386100|62812275|FG001|Overall Study|Withdrawal by Subject|31|||
33435599|NCT00386100|62812274|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
33435600|NCT00386100|62812275|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
33435601|NCT00386100|62812274|FG000|Overall Study|BMD <2.5|1|||
33435602|NCT00386100|62812275|FG001|Overall Study|BMD <2.5|0|||
33435603|NCT00386100|62812274|FG000|Overall Study|Consecutive elevated Hba1C|1|||
33435604|NCT00386100|62812275|FG001|Overall Study|Consecutive elevated Hba1C|0|||
33435605|NCT00386100|62812274|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
33435606|NCT00386100|62812275|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
33435607|NCT00386100|62812274|FG000|Overall Study|Laboratory findings|1|||
33435608|NCT00386100|62812275|FG001|Overall Study|Laboratory findings|0|||
33435609|NCT00386100|62812274|FG000|Overall Study|Participant's concern due to CPK levels|1|||
33435610|NCT00386100|62812275|FG001|Overall Study|Participant's concern due to CPK levels|0|||
33435611|NCT00386100|62812274|FG000|Overall Study|Participant moving out of state|2|||
33435612|NCT00386100|62812275|FG001|Overall Study|Participant moving out of state|0|||
33435613|NCT00386100|62812274|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
33435614|NCT00386100|62812275|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
33435615|NCT00386100|62812274|FG000|Overall Study|Didn't meet entry criteria|1|||
33435616|NCT00386100|62812275|FG001|Overall Study|Didn't meet entry criteria|1|||
33435617|NCT00386100|62812274|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
33435618|NCT00386100|62812275|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
33435619|NCT00386100|62812274|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
33435620|NCT00386100|62812275|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
33435621|NCT00386100|62812274|FG000|Overall Study|Bad metabolic control & patient security|1|||
33435622|NCT00386100|62812275|FG001|Overall Study|Bad metabolic control & patient security|0|||
33435623|NCT00386100|62812274|FG000|Overall Study|Bone loss by DXA bone scan|1|||
33435624|NCT00386100|62812275|FG001|Overall Study|Bone loss by DXA bone scan|0|||
33435625|NCT00386100|62812274|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
33435626|NCT00386100|62812275|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
33435627|NCT00386100|62812274|FG000|Overall Study|7.6% bone loss|1|||
33435628|NCT00386100|62812275|FG001|Overall Study|7.6% bone loss|0|||
33435629|NCT00386100|62812274|FG000|Overall Study|Osteoporosis|0|||
33435630|NCT00386100|62812275|FG001|Overall Study|Osteoporosis|1|||
33435631|NCT00386100|62812274|FG000|Overall Study|Positive pregnancy test|1|||
33435632|NCT00386100|62812275|FG001|Overall Study|Positive pregnancy test|3|||
33435633|NCT00386100|62812274|FG000|Overall Study|Out of country for 5 months|1|||
33435634|NCT00386100|62812275|FG001|Overall Study|Out of country for 5 months|0|||
33435635|NCT00386100|62812274|FG000|Overall Study|Hb1Ac >8%|0|||
33435636|NCT00386100|62812275|FG001|Overall Study|Hb1Ac >8%|1|||
33435637|NCT00386100|62812274|FG000|Overall Study|Participant randomized in error|1|||
33435638|NCT00386100|62812275|FG001|Overall Study|Participant randomized in error|0|||
33435639|NCT00300495|62812283|FG000|Overall Study|Protocol Violation|4|||
33435640|NCT00300495|62812284|FG001|Overall Study|Protocol Violation|1|||
33435641|NCT00386022|62812292|FG000|Plus Estrogen|Lost to Follow-up|2|||
33435642|NCT00386022|62812293|FG001|Plus Estrogen|Lost to Follow-up|0|||
33435643|NCT00386022|62812292|FG000|Plus Estrogen|Adverse Event|0|||
33435644|NCT00386022|62812293|FG001|Plus Estrogen|Adverse Event|1|||
33435645|NCT00286455|62812304|FG000|Overall Study|Hyperglycemia rescue|19|||
33435646|NCT00286455|62812305|FG001|Overall Study|Hyperglycemia rescue|13|||
33435647|NCT00286455|62812306|FG002|Overall Study|Hyperglycemia rescue|10|||
33435648|NCT00286455|62812304|FG000|Overall Study|Adverse Event|1|||
33435649|NCT00286455|62812305|FG001|Overall Study|Adverse Event|3|||
33435650|NCT00286455|62812306|FG002|Overall Study|Adverse Event|2|||
33435651|NCT00286455|62812304|FG000|Overall Study|Lost to Follow-up|0|||
33435652|NCT00286455|62812305|FG001|Overall Study|Lost to Follow-up|3|||
33435653|NCT00286455|62812306|FG002|Overall Study|Lost to Follow-up|3|||
33435654|NCT00286455|62812304|FG000|Overall Study|Physician Decision|3|||
33435655|NCT00286455|62812305|FG001|Overall Study|Physician Decision|0|||
33435656|NCT00286455|62812306|FG002|Overall Study|Physician Decision|2|||
33435657|NCT00286455|62812304|FG000|Overall Study|Protocol Violation|1|||
33435658|NCT00286455|62812305|FG001|Overall Study|Protocol Violation|1|||
33435659|NCT00286455|62812306|FG002|Overall Study|Protocol Violation|0|||
33435660|NCT00286455|62812304|FG000|Overall Study|Participant Non-compliance|1|||
33435661|NCT00286455|62812305|FG001|Overall Study|Participant Non-compliance|0|||
33435662|NCT00286455|62812306|FG002|Overall Study|Participant Non-compliance|0|||
33435663|NCT00286455|62812304|FG000|Overall Study|Withdrawal by Subject|0|||
33435664|NCT00286455|62812305|FG001|Overall Study|Withdrawal by Subject|8|||
33435665|NCT00286455|62812306|FG002|Overall Study|Withdrawal by Subject|7|||
33435666|NCT00385944|62812316|FG000|1st Maintenance Dose Period|Physician Decision|1|||
33435667|NCT00385944|62812317|FG001|1st Maintenance Dose Period|Physician Decision|0|||
33435668|NCT00385944|62812318|FG002|1st Maintenance Dose Period|Physician Decision|0|||
33435669|NCT00385944|62812316|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
33435670|NCT00385944|62812317|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
33435671|NCT00385944|62812318|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
33435672|NCT00385944|62812316|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
33435673|NCT00385944|62812317|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
33435674|NCT00385944|62812318|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
33435675|NCT00385944|62812316|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
33435676|NCT00385944|62812317|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
33435677|NCT00385944|62812318|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
33435678|NCT00286221|62812337|FG000|Overall Study|Protocol Violation|2|||
33435679|NCT00286221|62812338|FG001|Overall Study|Protocol Violation|1|||
33435680|NCT00286221|62812339|FG002|Overall Study|Protocol Violation|6|||
33435681|NCT00286221|62812340|FG003|Overall Study|Protocol Violation|4|||
33435682|NCT00286221|62812337|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
33435683|NCT00286221|62812338|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
33435684|NCT00286221|62812339|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
33435685|NCT00286221|62812340|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
33435686|NCT00286221|62812337|FG000|Overall Study|Inability to trigger PCA|2|||
33435687|NCT00286221|62812338|FG001|Overall Study|Inability to trigger PCA|0|||
33435688|NCT00286221|62812339|FG002|Overall Study|Inability to trigger PCA|0|||
33435689|NCT00286221|62812340|FG003|Overall Study|Inability to trigger PCA|0|||
33435690|NCT00286221|62812337|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
33435691|NCT00286221|62812338|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
33435692|NCT00286221|62812339|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
33435693|NCT00286221|62812340|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
33435694|NCT00285207|62812352|FG000|Overall Study|Lost to Follow-up|3|||
33435695|NCT00285207|62812353|FG001|Overall Study|Lost to Follow-up|2|||
33435696|NCT00285207|62812352|FG000|Overall Study|Withdrawal by Subject|5|||
33435697|NCT00285207|62812353|FG001|Overall Study|Withdrawal by Subject|2|||
33435698|NCT00285207|62812352|FG000|Overall Study|Pregnancy|1|||
33435699|NCT00285207|62812353|FG001|Overall Study|Pregnancy|1|||
33435700|NCT00285207|62812352|FG000|Overall Study|non-compliance|0|||
33435701|NCT00285207|62812353|FG001|Overall Study|non-compliance|1|||
33435702|NCT00398112|62812359|FG000|Overall Study|Adverse Event|4|||
33435703|NCT00398112|62812359|FG000|Overall Study|Disease progression|9|||
33435704|NCT00398112|62812359|FG000|Overall Study|Alternative treatment|1|||
33435705|NCT00398112|62812359|FG000|Overall Study|Withdrawal by Subject|3|||
33435706|NCT00398112|62812359|FG000|Overall Study|Death|1|||
33435707|NCT00424346|62812367|FG000|Core Study|Adverse Event|5|||
33435708|NCT00424346|62812368|FG001|Core Study|Adverse Event|3|||
33435709|NCT00424346|62812369|FG002|Core Study|Adverse Event|1|||
33435710|NCT00424346|62812370|FG003|Core Study|Adverse Event|1|||
33435711|NCT00424346|62812367|FG000|Core Study|Abnormal Laboratory Values|0|||
33435712|NCT00424346|62812368|FG001|Core Study|Abnormal Laboratory Values|1|||
33435713|NCT00424346|62812369|FG002|Core Study|Abnormal Laboratory Values|0|||
33435714|NCT00424346|62812370|FG003|Core Study|Abnormal Laboratory Values|0|||
33435715|NCT00424346|62812367|FG000|Core Study|Lack of Efficacy|1|||
33435716|NCT00424346|62812368|FG001|Core Study|Lack of Efficacy|3|||
33435717|NCT00424346|62812369|FG002|Core Study|Lack of Efficacy|0|||
33435718|NCT00424346|62812370|FG003|Core Study|Lack of Efficacy|4|||
33435719|NCT00424346|62812367|FG000|Core Study|Withdrawal by Subject|1|||
33435720|NCT00424346|62812368|FG001|Core Study|Withdrawal by Subject|0|||
33435721|NCT00424346|62812369|FG002|Core Study|Withdrawal by Subject|0|||
33435722|NCT00424346|62812370|FG003|Core Study|Withdrawal by Subject|2|||
33435723|NCT00424346|62812367|FG000|Core Study|Lost to Follow-up|1|||
33435724|NCT00424346|62812368|FG001|Core Study|Lost to Follow-up|1|||
33435725|NCT00424346|62812369|FG002|Core Study|Lost to Follow-up|0|||
33435726|NCT00424346|62812370|FG003|Core Study|Lost to Follow-up|0|||
33435727|NCT00424346|62812367|FG000|Core Study|Administrative Problems|1|||
33435728|NCT00424346|62812368|FG001|Core Study|Administrative Problems|0|||
33435729|NCT00424346|62812369|FG002|Core Study|Administrative Problems|1|||
33435730|NCT00424346|62812370|FG003|Core Study|Administrative Problems|0|||
33435731|NCT00424346|62812367|FG000|Core Study|Protocol Violation|0|||
33435732|NCT00424346|62812368|FG001|Core Study|Protocol Violation|0|||
33435733|NCT00424346|62812369|FG002|Core Study|Protocol Violation|2|||
33435734|NCT00424346|62812370|FG003|Core Study|Protocol Violation|0|||
33435735|NCT00424346|62812367|FG000|Extension Phase|Adverse Event|0|||
33435736|NCT00424346|62812368|FG001|Extension Phase|Adverse Event|9|||
33435737|NCT00424346|62812369|FG002|Extension Phase|Adverse Event|5|||
33435738|NCT00424346|62812370|FG003|Extension Phase|Adverse Event|4|||
33435739|NCT00424346|62812367|FG000|Extension Phase|Lack of Efficacy|0|||
33435740|NCT00424346|62812368|FG001|Extension Phase|Lack of Efficacy|16|||
33435741|NCT00424346|62812369|FG002|Extension Phase|Lack of Efficacy|14|||
33435742|NCT00424346|62812370|FG003|Extension Phase|Lack of Efficacy|11|||
33435743|NCT00424346|62812367|FG000|Extension Phase|Withdrawal by Subject|0|||
33435744|NCT00424346|62812368|FG001|Extension Phase|Withdrawal by Subject|5|||
33435745|NCT00424346|62812369|FG002|Extension Phase|Withdrawal by Subject|3|||
33435746|NCT00424346|62812370|FG003|Extension Phase|Withdrawal by Subject|4|||
33435747|NCT00424346|62812367|FG000|Extension Phase|Lost to Follow-up|0|||
33435748|NCT00424346|62812368|FG001|Extension Phase|Lost to Follow-up|2|||
33435749|NCT00424346|62812369|FG002|Extension Phase|Lost to Follow-up|0|||
33435750|NCT00424346|62812370|FG003|Extension Phase|Lost to Follow-up|0|||
33435751|NCT00424346|62812367|FG000|Extension Phase|Administrative Problems|0|||
33435752|NCT00424346|62812368|FG001|Extension Phase|Administrative Problems|69|||
33435753|NCT00424346|62812369|FG002|Extension Phase|Administrative Problems|32|||
33435754|NCT00424346|62812370|FG003|Extension Phase|Administrative Problems|35|||
33435755|NCT00424346|62812367|FG000|Extension Phase|Death|0|||
33435756|NCT00424346|62812368|FG001|Extension Phase|Death|0|||
33435757|NCT00424346|62812369|FG002|Extension Phase|Death|0|||
33435758|NCT00424346|62812370|FG003|Extension Phase|Death|1|||
33435759|NCT00424346|62812367|FG000|Extension Phase|Protocol Violation|0|||
33435760|NCT00424346|62812368|FG001|Extension Phase|Protocol Violation|1|||
33435761|NCT00424346|62812369|FG002|Extension Phase|Protocol Violation|1|||
33435762|NCT00424346|62812370|FG003|Extension Phase|Protocol Violation|0|||
33435763|NCT00283959|62812383|FG000|Extension Period|Low Compliance|1|||
33435764|NCT00372528|62812387|FG000|Overall Study|Lack of Efficacy|1|||
33435765|NCT00372528|62812387|FG000|Overall Study|Adverse Event|1|||
33435766|NCT00372528|62812387|FG000|Overall Study|Study Terminated by Sponsor|18|||
33435767|NCT00372528|62812387|FG000|Overall Study|Other|1|||
33435768|NCT00283803|62812391|FG000|Overall Study|Physician Decision|9|||
33435769|NCT00283803|62812391|FG000|Overall Study|Withdrawal by Subject|4|||
33435770|NCT00397488|62812395|FG000|Overall Study|Withdrawal by Subject|3|||
33435771|NCT00397488|62812395|FG000|Overall Study|Adverse Event|3|||
33435772|NCT00397488|62812395|FG000|Overall Study|Death|1|||
33435773|NCT00424190|62812401|FG000|Overall Study|Withdrew consent|3|||
33435774|NCT00424190|62812402|FG001|Overall Study|Withdrew consent|4|||
33435775|NCT00424190|62812401|FG000|Overall Study|Death|3|||
33435776|NCT00424190|62812402|FG001|Overall Study|Death|0|||
33435777|NCT00424190|62812401|FG000|Overall Study|Noncompliance|1|||
33435778|NCT00424190|62812402|FG001|Overall Study|Noncompliance|2|||
33435779|NCT00424190|62812401|FG000|Overall Study|Request of sponsor or investigator|0|||
33435780|NCT00424190|62812402|FG001|Overall Study|Request of sponsor or investigator|2|||
33435781|NCT00424190|62812401|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
33435782|NCT00424190|62812402|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
33435783|NCT00424190|62812401|FG000|Overall Study|Other|15|||
33435784|NCT00424190|62812402|FG001|Overall Study|Other|21|||
33435785|NCT00428246|62812411|FG000|Overall Study|Withdrawal by Subject|0|||
33435786|NCT00428246|62812412|FG001|Overall Study|Withdrawal by Subject|0|||
33435787|NCT00428246|62812413|FG002|Overall Study|Withdrawal by Subject|1|||
33435788|NCT00428246|62812411|FG000|Overall Study|Adverse Event|1|||
33435789|NCT00428246|62812412|FG001|Overall Study|Adverse Event|0|||
33435790|NCT00428246|62812413|FG002|Overall Study|Adverse Event|0|||
33435791|NCT00274287|62812421|FG000|Overall Study|Withdrawal by Subject|1|||
33435792|NCT00274287|62812421|FG000|Overall Study|subject non-compliance|1|||
33435793|NCT00423800|62812428|FG000|Overall Study|Protocol Violation|0|||
33435794|NCT00423800|62812429|FG001|Overall Study|Protocol Violation|1|||
33435795|NCT00405548|62812438|FG000|Overall Study|Cognitive Memory problems on study day|1|||
33435796|NCT00405548|62812439|FG001|Overall Study|Cognitive Memory problems on study day|0|||
33435797|NCT00405548|62812438|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
33435798|NCT00405548|62812439|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
33435799|NCT00405548|62812438|FG000|Overall Study|Unable to self-administer shots|1|||
33435800|NCT00405548|62812439|FG001|Overall Study|Unable to self-administer shots|0|||
33435801|NCT00405548|62812438|FG000|Overall Study|Venous access failed during study day|1|||
33435802|NCT00405548|62812439|FG001|Overall Study|Venous access failed during study day|0|||
33435803|NCT00405548|62812438|FG000|Overall Study|Withdrawal by Subject|1|||
33435804|NCT00405548|62812439|FG001|Overall Study|Withdrawal by Subject|0|||
33435805|NCT00405392|62812447|FG000|Overall Study|Adverse Event|15|||
33435806|NCT00405392|62812448|FG001|Overall Study|Adverse Event|14|||
33435807|NCT00405392|62812447|FG000|Overall Study|Did not meet Eligibility criteria|7|||
33435808|NCT00405392|62812448|FG001|Overall Study|Did not meet Eligibility criteria|2|||
33435809|NCT00405392|62812447|FG000|Overall Study|Withdrawal by Subject|4|||
33435810|NCT00405392|62812448|FG001|Overall Study|Withdrawal by Subject|3|||
33435811|NCT00405392|62812447|FG000|Overall Study|Lost to Follow-up|1|||
33435812|NCT00405392|62812448|FG001|Overall Study|Lost to Follow-up|2|||
33435813|NCT00405392|62812447|FG000|Overall Study|Data missing|2|||
33435814|NCT00405392|62812448|FG001|Overall Study|Data missing|0|||
33435815|NCT00405392|62812447|FG000|Overall Study|Non-compliance|0|||
33435816|NCT00405392|62812448|FG001|Overall Study|Non-compliance|1|||
33435817|NCT00405392|62812447|FG000|Overall Study|Other|1|||
33435818|NCT00405392|62812448|FG001|Overall Study|Other|5|||
33435819|NCT00282243|62812454|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
33435820|NCT00282243|62812454|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
33435821|NCT00282243|62812454|FG000|Extension Treatment Period|Adverse Event|15|||
33435822|NCT00282243|62812454|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
33435823|NCT00282243|62812454|FG000|Extension Treatment Period|Non-compliance|2|||
33435824|NCT00282243|62812454|FG000|Extension Treatment Period|Physician Decision|1|||
33435825|NCT00272961|62812463|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
33435826|NCT00272961|62812464|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
33435827|NCT00272961|62812465|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
33435828|NCT00272961|62812466|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
33435829|NCT00272961|62812467|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
33435830|NCT00272961|62812463|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
33435831|NCT00272961|62812464|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
33435832|NCT00272961|62812465|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
33435833|NCT00272961|62812466|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
33435834|NCT00272961|62812467|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
33435835|NCT00272961|62812463|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
33435836|NCT00272961|62812464|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
33435837|NCT00272961|62812465|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
33435838|NCT00272961|62812466|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
33435839|NCT00272961|62812467|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
33435840|NCT00272961|62812463|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
33435841|NCT00272961|62812464|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
33435842|NCT00272961|62812465|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
33435843|NCT00272961|62812466|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
33435844|NCT00272961|62812467|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
33435845|NCT00272961|62812463|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
33435846|NCT00272961|62812464|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
33435847|NCT00272961|62812465|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
33435848|NCT00272961|62812466|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
33435849|NCT00272961|62812467|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
33435850|NCT00272961|62812463|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
33435851|NCT00272961|62812464|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
33435852|NCT00272961|62812465|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
33435853|NCT00272961|62812466|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
33435854|NCT00272961|62812467|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
33435855|NCT00272961|62812463|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
33435856|NCT00272961|62812464|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
33435857|NCT00272961|62812465|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
33323195|NCT01175135|62699457|FG002|Overall Study|Other|3|||
33323196|NCT01175135|62699458|FG003|Overall Study|Other|0|||
33323197|NCT01175135|62699455|FG000|Overall Study|Randomized But Not Treated|0|||
33435858|NCT00272961|62812466|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
33435859|NCT00272961|62812467|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
33435860|NCT00272961|62812463|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
33435861|NCT00272961|62812464|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
33435862|NCT00272961|62812465|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
33435863|NCT00272961|62812466|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
33435864|NCT00272961|62812467|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
33435865|NCT00282087|62812479|FG000|Overall Study|Death|1|||
33435866|NCT00404924|62812486|FG000|Overall Study|Adverse Event|75|||
33435867|NCT00404924|62812487|FG001|Overall Study|Adverse Event|16|||
33435868|NCT00404924|62812486|FG000|Overall Study|Condition under investigation worsened|475|||
33435869|NCT00404924|62812487|FG001|Overall Study|Condition under investigation worsened|264|||
33435870|NCT00404924|62812486|FG000|Overall Study|Lost to Follow-up|1|||
33435871|NCT00404924|62812487|FG001|Overall Study|Lost to Follow-up|1|||
33435872|NCT00404924|62812486|FG000|Overall Study|Withdrawal by Subject|26|||
33435873|NCT00404924|62812487|FG001|Overall Study|Withdrawal by Subject|13|||
33435874|NCT00404924|62812486|FG000|Overall Study|Other|25|||
33435875|NCT00404924|62812487|FG001|Overall Study|Other|11|||
33435876|NCT00404924|62812486|FG000|Overall Study|Randomised but not received treatment|1|||
33435877|NCT00404924|62812487|FG001|Overall Study|Randomised but not received treatment|1|||
33435878|NCT00281697|62812495|FG000|Overall Study|> 60 days since last dose of study drug|4|||
33435879|NCT00281697|62812496|FG001|Overall Study|> 60 days since last dose of study drug|4|||
33435880|NCT00281697|62812495|FG000|Overall Study|Adverse Event|54|||
33435881|NCT00281697|62812496|FG001|Overall Study|Adverse Event|15|||
33435882|NCT00281697|62812495|FG000|Overall Study|Death|8|||
33435883|NCT00281697|62812496|FG001|Overall Study|Death|3|||
33435884|NCT00281697|62812495|FG000|Overall Study|Disease progression|279|||
33435885|NCT00281697|62812496|FG001|Overall Study|Disease progression|149|||
33435886|NCT00281697|62812495|FG000|Overall Study|Other|5|||
33435887|NCT00281697|62812496|FG001|Overall Study|Other|6|||
33435888|NCT00281697|62812495|FG000|Overall Study|Physician's decision to withdraw|15|||
33435889|NCT00281697|62812496|FG001|Overall Study|Physician's decision to withdraw|12|||
33435890|NCT00281697|62812495|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
33435891|NCT00281697|62812496|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
33323198|NCT01175135|62699456|FG001|Overall Study|Randomized But Not Treated|0|||
33435892|NCT00281697|62812495|FG000|Overall Study|Did not receive study drug|3|||
33435893|NCT00281697|62812496|FG001|Overall Study|Did not receive study drug|2|||
33435894|NCT00271947|62812502|FG000|Overall Study|Lost to Follow-up|1|||
33435895|NCT00232180|62812508|FG000|Double-blind (DB) Phase|Death|186|||
33435896|NCT00232180|62812509|FG001|Double-blind (DB) Phase|Death|222|||
33435897|NCT00232180|62812510|FG002|Double-blind (DB) Phase|Death|0|||
33435898|NCT00232180|62812508|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
33435899|NCT00232180|62812509|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
33435900|NCT00232180|62812510|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
33435901|NCT00232180|62812508|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
33435902|NCT00232180|62812509|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
33323199|NCT01175135|62699457|FG002|Overall Study|Randomized But Not Treated|1|||
33435903|NCT00232180|62812510|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
33435904|NCT00232180|62812508|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
33435905|NCT00232180|62812509|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
33435906|NCT00232180|62812510|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
33435907|NCT00232180|62812508|FG000|Double-blind (DB) Phase|Adverse Event|83|||
33435908|NCT00232180|62812509|FG001|Double-blind (DB) Phase|Adverse Event|100|||
33435909|NCT00232180|62812510|FG002|Double-blind (DB) Phase|Adverse Event|0|||
33435910|NCT00232180|62812508|FG000|Double-blind (DB) Phase|Other|70|||
33435911|NCT00232180|62812509|FG001|Double-blind (DB) Phase|Other|75|||
33435912|NCT00232180|62812510|FG002|Double-blind (DB) Phase|Other|0|||
33435913|NCT00232180|62812508|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
33435914|NCT00232180|62812509|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
33435915|NCT00232180|62812510|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
33435916|NCT00232180|62812508|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
33435917|NCT00232180|62812509|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
33435918|NCT00232180|62812510|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
33435919|NCT00232180|62812508|FG000|Open Label Phase|Death|0|||
33435920|NCT00232180|62812509|FG001|Open Label Phase|Death|0|||
33435921|NCT00232180|62812510|FG002|Open Label Phase|Death|48|||
33435922|NCT00232180|62812508|FG000|Open Label Phase|Lost to Follow-up|0|||
33435923|NCT00232180|62812509|FG001|Open Label Phase|Lost to Follow-up|0|||
33435924|NCT00232180|62812510|FG002|Open Label Phase|Lost to Follow-up|5|||
33435925|NCT00232180|62812508|FG000|Open Label Phase|Protocol Violation|0|||
33435926|NCT00232180|62812509|FG001|Open Label Phase|Protocol Violation|0|||
33435927|NCT00232180|62812510|FG002|Open Label Phase|Protocol Violation|3|||
33435928|NCT00232180|62812508|FG000|Open Label Phase|Study terminated by sponsor|0|||
33435929|NCT00232180|62812509|FG001|Open Label Phase|Study terminated by sponsor|0|||
33435930|NCT00232180|62812510|FG002|Open Label Phase|Study terminated by sponsor|3|||
33435931|NCT00232180|62812508|FG000|Open Label Phase|Withdrawal by Subject|0|||
33435932|NCT00232180|62812509|FG001|Open Label Phase|Withdrawal by Subject|0|||
33435933|NCT00232180|62812510|FG002|Open Label Phase|Withdrawal by Subject|37|||
33435934|NCT00232180|62812508|FG000|Open Label Phase|Other|0|||
33435935|NCT00232180|62812509|FG001|Open Label Phase|Other|0|||
33435936|NCT00232180|62812510|FG002|Open Label Phase|Other|16|||
33435937|NCT00232180|62812508|FG000|Open Label Phase|Adverse Event|0|||
33435938|NCT00232180|62812509|FG001|Open Label Phase|Adverse Event|0|||
33435939|NCT00232180|62812510|FG002|Open Label Phase|Adverse Event|25|||
33435940|NCT00232180|62812508|FG000|Open Label Phase|Laboratory abnormality|0|||
33435941|NCT00232180|62812509|FG001|Open Label Phase|Laboratory abnormality|0|||
33435942|NCT00232180|62812510|FG002|Open Label Phase|Laboratory abnormality|10|||
33435943|NCT00232180|62812508|FG000|Open Label Phase|Randomized but not treated|0|||
33435944|NCT00232180|62812509|FG001|Open Label Phase|Randomized but not treated|0|||
33435945|NCT00232180|62812510|FG002|Open Label Phase|Randomized but not treated|1|||
33435946|NCT00280683|62812521|FG000|Overall Study|Withdrawal by Subject|1|||
33435947|NCT00280683|62812522|FG001|Overall Study|Withdrawal by Subject|2|||
33435948|NCT00280683|62812521|FG000|Overall Study|Adverse Event|1|||
33435949|NCT00280683|62812522|FG001|Overall Study|Adverse Event|1|||
33435950|NCT00270855|62812532|FG000|Overall Study|Withdrawal by Subject|8|||
33435951|NCT00270855|62812533|FG001|Overall Study|Withdrawal by Subject|8|||
33435952|NCT00404768|62812545|FG000|Part A and B|Withdrawn due to labor progression|1|||
33435953|NCT00404768|62812546|FG001|Part A and B|Withdrawn due to labor progression|0|||
33435954|NCT00404768|62812547|FG002|Part A and B|Withdrawn due to labor progression|0|||
33435955|NCT00404768|62812548|FG003|Part A and B|Withdrawn due to labor progression|0|||
33435956|NCT00404768|62812545|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
33435957|NCT00404768|62812546|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
33435958|NCT00404768|62812547|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
33435959|NCT00404768|62812548|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
33435960|NCT00404768|62812545|FG000|Part C|Adverse Event|0|||
33435961|NCT00404768|62812546|FG001|Part C|Adverse Event|0|||
33435962|NCT00404768|62812547|FG002|Part C|Adverse Event|0|||
33435963|NCT00404768|62812548|FG003|Part C|Adverse Event|3|||
33435964|NCT00404768|62812545|FG000|Part C|Lost to Follow-up|0|||
33435965|NCT00404768|62812546|FG001|Part C|Lost to Follow-up|0|||
33435966|NCT00404768|62812547|FG002|Part C|Lost to Follow-up|3|||
33435967|NCT00404768|62812548|FG003|Part C|Lost to Follow-up|1|||
33435968|NCT00404768|62812545|FG000|Part C|Withdrawal by Subject|0|||
33435969|NCT00404768|62812546|FG001|Part C|Withdrawal by Subject|0|||
33435970|NCT00404768|62812547|FG002|Part C|Withdrawal by Subject|2|||
33435971|NCT00404768|62812548|FG003|Part C|Withdrawal by Subject|1|||
33435972|NCT00404768|62812545|FG000|Part C|Early withdrawal from study medication|0|||
33435973|NCT00404768|62812546|FG001|Part C|Early withdrawal from study medication|0|||
33435974|NCT00404768|62812547|FG002|Part C|Early withdrawal from study medication|1|||
33435975|NCT00404768|62812548|FG003|Part C|Early withdrawal from study medication|0|||
33435976|NCT00404768|62812545|FG000|Part C|Participant did not respond to therapy|0|||
33435977|NCT00404768|62812546|FG001|Part C|Participant did not respond to therapy|0|||
33435978|NCT00404768|62812547|FG002|Part C|Participant did not respond to therapy|1|||
33435979|NCT00404768|62812548|FG003|Part C|Participant did not respond to therapy|1|||
33435980|NCT00404768|62812545|FG000|Part C|Physician withdrew the study medication|0|||
33435981|NCT00404768|62812546|FG001|Part C|Physician withdrew the study medication|0|||
33435982|NCT00404768|62812547|FG002|Part C|Physician withdrew the study medication|1|||
33435983|NCT00404768|62812548|FG003|Part C|Physician withdrew the study medication|0|||
33435984|NCT00404768|62812545|FG000|Part C|Participant delivered baby|0|||
33435985|NCT00404768|62812546|FG001|Part C|Participant delivered baby|0|||
33435986|NCT00404768|62812547|FG002|Part C|Participant delivered baby|0|||
33435987|NCT00404768|62812548|FG003|Part C|Participant delivered baby|1|||
33435988|NCT00404768|62812545|FG000|Part C|Unsatisfactory uterine response to IP|0|||
33435989|NCT00404768|62812546|FG001|Part C|Unsatisfactory uterine response to IP|0|||
33435990|NCT00404768|62812547|FG002|Part C|Unsatisfactory uterine response to IP|0|||
33435991|NCT00404768|62812548|FG003|Part C|Unsatisfactory uterine response to IP|1|||
33435992|NCT00404768|62812545|FG000|Part C|Active labor|0|||
33435993|NCT00404768|62812546|FG001|Part C|Active labor|0|||
33435994|NCT00404768|62812547|FG002|Part C|Active labor|0|||
33435995|NCT00404768|62812548|FG003|Part C|Active labor|1|||
33435996|NCT00404768|62812545|FG000|Part C|Lack of Efficacy|0|||
33435997|NCT00404768|62812546|FG001|Part C|Lack of Efficacy|0|||
33435998|NCT00404768|62812547|FG002|Part C|Lack of Efficacy|0|||
33435999|NCT00404768|62812548|FG003|Part C|Lack of Efficacy|2|||
33436000|NCT00404768|62812545|FG000|Part C|Treatment failure|0|||
33436001|NCT00404768|62812546|FG001|Part C|Treatment failure|0|||
33436002|NCT00404768|62812547|FG002|Part C|Treatment failure|0|||
33436003|NCT00404768|62812548|FG003|Part C|Treatment failure|1|||
33436004|NCT00404768|62812545|FG000|Part C|Investigator discretion|0|||
33436005|NCT00404768|62812546|FG001|Part C|Investigator discretion|0|||
33436006|NCT00404768|62812547|FG002|Part C|Investigator discretion|0|||
33436007|NCT00404768|62812548|FG003|Part C|Investigator discretion|1|||
33436008|NCT00404768|62812545|FG000|Part C|Researcher suspended study medication|0|||
33436009|NCT00404768|62812546|FG001|Part C|Researcher suspended study medication|0|||
33436010|NCT00404768|62812547|FG002|Part C|Researcher suspended study medication|0|||
33436011|NCT00404768|62812548|FG003|Part C|Researcher suspended study medication|1|||
33436012|NCT00270231|62812563|FG000|First Intervention|Lost to Follow-up|1|||
33436013|NCT00270231|62812564|FG001|First Intervention|Lost to Follow-up|1|||
33436014|NCT00270231|62812563|FG000|Washout Period|Lost to Follow-up|1|||
33436015|NCT00270231|62812564|FG001|Washout Period|Lost to Follow-up|0|||
33436016|NCT00270231|62812563|FG000|Second Intervention|Lost to Follow-up|0|||
33436017|NCT00270231|62812564|FG001|Second Intervention|Lost to Follow-up|1|||
33436018|NCT00258856|62812574|FG000|Overall Study|Lost to Follow-up|1|||
33436019|NCT00258856|62812575|FG001|Overall Study|Lost to Follow-up|0|||
33436020|NCT00258856|62812576|FG002|Overall Study|Lost to Follow-up|2|||
33436021|NCT00258856|62812577|FG003|Overall Study|Lost to Follow-up|0|||
33436022|NCT00258856|62812574|FG000|Overall Study|Non-compliance|2|||
33436023|NCT00258856|62812575|FG001|Overall Study|Non-compliance|0|||
33436024|NCT00258856|62812576|FG002|Overall Study|Non-compliance|0|||
33436025|NCT00258856|62812577|FG003|Overall Study|Non-compliance|1|||
33436026|NCT00269919|62812587|FG000|Overall Study|Other|26|||
33436027|NCT00269919|62812587|FG000|Overall Study|Started but not treated|1|||
33436028|NCT00258154|62812594|FG000|Overall Study|Adverse Event|1|||
33436029|NCT00258154|62812595|FG001|Overall Study|Adverse Event|0|||
33436030|NCT00258154|62812594|FG000|Overall Study|Lost to Follow-up|0|||
33436031|NCT00258154|62812595|FG001|Overall Study|Lost to Follow-up|1|||
33436032|NCT00258154|62812594|FG000|Overall Study|Protocol Violation|2|||
33436033|NCT00258154|62812595|FG001|Overall Study|Protocol Violation|1|||
33436034|NCT00258154|62812594|FG000|Overall Study|Withdrawal by Subject|3|||
33436035|NCT00258154|62812595|FG001|Overall Study|Withdrawal by Subject|4|||
33436036|NCT00258154|62812594|FG000|Overall Study|Patient Moved|3|||
33436037|NCT00258154|62812595|FG001|Overall Study|Patient Moved|1|||
33436038|NCT00257920|62812603|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
33436039|NCT00257920|62812604|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
33436040|NCT00257920|62812603|FG000|Period: Second Intervention|Other|2|||
33436041|NCT00257920|62812604|FG001|Period: Second Intervention|Other|1|||
33436042|NCT00268983|62812613|FG000|Overall Study|Death|3|||
33436043|NCT00268983|62812614|FG001|Overall Study|Death|0|||
33436044|NCT00257608|62812622|FG000|Chemotherapy Phase|Adverse Event|138|||
33436045|NCT00257608|62812623|FG001|Chemotherapy Phase|Adverse Event|0|||
33436046|NCT00257608|62812624|FG002|Chemotherapy Phase|Adverse Event|0|||
33436047|NCT00257608|62812622|FG000|Chemotherapy Phase|Disease progression|139|||
33436048|NCT00257608|62812623|FG001|Chemotherapy Phase|Disease progression|0|||
33436049|NCT00257608|62812624|FG002|Chemotherapy Phase|Disease progression|0|||
33436050|NCT00257608|62812622|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
33436051|NCT00257608|62812623|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
33436052|NCT00257608|62812624|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
33436053|NCT00257608|62812622|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
33436054|NCT00257608|62812623|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
33436055|NCT00257608|62812624|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
33436056|NCT00257608|62812622|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
33436057|NCT00257608|62812623|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
33436058|NCT00257608|62812624|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
33436059|NCT00257608|62812622|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
33436060|NCT00257608|62812623|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
33436061|NCT00257608|62812624|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
33436062|NCT00257608|62812622|FG000|Chemotherapy Phase|Physician Decision|28|||
33436063|NCT00257608|62812623|FG001|Chemotherapy Phase|Physician Decision|0|||
33436064|NCT00257608|62812624|FG002|Chemotherapy Phase|Physician Decision|0|||
33436065|NCT00257608|62812622|FG000|Post Chemotherapy Phase|Adverse Event|0|||
33436066|NCT00257608|62812623|FG001|Post Chemotherapy Phase|Adverse Event|34|||
33436067|NCT00257608|62812624|FG002|Post Chemotherapy Phase|Adverse Event|38|||
33436068|NCT00257608|62812622|FG000|Post Chemotherapy Phase|Disease progression|0|||
33436069|NCT00257608|62812623|FG001|Post Chemotherapy Phase|Disease progression|204|||
33436070|NCT00257608|62812624|FG002|Post Chemotherapy Phase|Disease progression|168|||
33436071|NCT00257608|62812622|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
33436072|NCT00257608|62812623|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
33436073|NCT00257608|62812624|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
33436074|NCT00257608|62812622|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
33436075|NCT00257608|62812623|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
33436076|NCT00257608|62812624|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
33436077|NCT00257608|62812622|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
33436078|NCT00257608|62812623|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
33436079|NCT00257608|62812624|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
33436080|NCT00257608|62812622|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
33436081|NCT00257608|62812623|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
33436082|NCT00257608|62812624|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
33436083|NCT00257608|62812622|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
33436084|NCT00257608|62812623|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
33436085|NCT00257608|62812624|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
33436086|NCT00257608|62812622|FG000|Post Chemotherapy Phase|Physician Decision|0|||
33436087|NCT00257608|62812623|FG001|Post Chemotherapy Phase|Physician Decision|8|||
33436088|NCT00257608|62812624|FG002|Post Chemotherapy Phase|Physician Decision|11|||
33436089|NCT00257608|62812622|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
33436090|NCT00257608|62812623|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
33436091|NCT00257608|62812624|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
33436092|NCT00257608|62812622|FG000|Post Chemotherapy Phase|Not treated|0|||
33436093|NCT00257608|62812623|FG001|Post Chemotherapy Phase|Not treated|4|||
33436094|NCT00257608|62812624|FG002|Post Chemotherapy Phase|Not treated|7|||
33436095|NCT00231478|62812639|FG000|Overall Study|Protocol Violation|3|||
33436096|NCT00231478|62812640|FG001|Overall Study|Protocol Violation|2|||
33436097|NCT00231478|62812639|FG000|Overall Study|Refused Treatment|1|||
33436098|NCT00231478|62812640|FG001|Overall Study|Refused Treatment|1|||
33436099|NCT00231478|62812639|FG000|Overall Study|Withdrawal by Subject|1|||
33436100|NCT00231478|62812640|FG001|Overall Study|Withdrawal by Subject|0|||
33436101|NCT00231478|62812639|FG000|Overall Study|Adverse Event|0|||
33436102|NCT00231478|62812640|FG001|Overall Study|Adverse Event|1|||
33436103|NCT00231478|62812639|FG000|Overall Study|Administrative|3|||
33436104|NCT00231478|62812640|FG001|Overall Study|Administrative|2|||
33436105|NCT00413192|62812650|FG000|Overall Study|Disease progression|26|||
33436106|NCT00413192|62812651|FG001|Overall Study|Disease progression|31|||
33436107|NCT00413192|62812652|FG002|Overall Study|Disease progression|16|||
33436108|NCT00413192|62812653|FG003|Overall Study|Disease progression|25|||
33436109|NCT00413192|62812650|FG000|Overall Study|Toxicity|3|||
33436110|NCT00413192|62812651|FG001|Overall Study|Toxicity|2|||
33436111|NCT00413192|62812652|FG002|Overall Study|Toxicity|2|||
33436112|NCT00413192|62812653|FG003|Overall Study|Toxicity|2|||
33436113|NCT00413192|62812650|FG000|Overall Study|Withdrawal by Subject|3|||
33436114|NCT00413192|62812651|FG001|Overall Study|Withdrawal by Subject|5|||
33436115|NCT00413192|62812652|FG002|Overall Study|Withdrawal by Subject|0|||
33436116|NCT00413192|62812653|FG003|Overall Study|Withdrawal by Subject|1|||
33436117|NCT00413192|62812650|FG000|Overall Study|Intercurrent illness|0|||
33436118|NCT00413192|62812651|FG001|Overall Study|Intercurrent illness|0|||
33436119|NCT00413192|62812652|FG002|Overall Study|Intercurrent illness|0|||
33436120|NCT00413192|62812653|FG003|Overall Study|Intercurrent illness|1|||
33436121|NCT00413192|62812650|FG000|Overall Study|Intercurrent death|0|||
33436122|NCT00413192|62812651|FG001|Overall Study|Intercurrent death|1|||
33436123|NCT00413192|62812652|FG002|Overall Study|Intercurrent death|0|||
33436124|NCT00413192|62812653|FG003|Overall Study|Intercurrent death|0|||
33436125|NCT00413192|62812650|FG000|Overall Study|Other|5|||
33436126|NCT00413192|62812651|FG001|Overall Study|Other|1|||
33436127|NCT00413192|62812652|FG002|Overall Study|Other|1|||
33436128|NCT00413192|62812653|FG003|Overall Study|Other|2|||
33436129|NCT00413192|62812650|FG000|Overall Study|Not treated|0|||
33436130|NCT00413192|62812651|FG001|Overall Study|Not treated|0|||
33436131|NCT00413192|62812652|FG002|Overall Study|Not treated|0|||
33436132|NCT00413192|62812653|FG003|Overall Study|Not treated|1|||
33436133|NCT00207142|62812666|FG000|Induction Phase|Adverse Event|9|||
33436134|NCT00207142|62812667|FG001|Induction Phase|Adverse Event|0|||
33436135|NCT00207142|62812668|FG002|Induction Phase|Adverse Event|0|||
33436136|NCT00207142|62812669|FG003|Induction Phase|Adverse Event|0|||
33436137|NCT00207142|62812666|FG000|Induction Phase|Death|1|||
33436138|NCT00207142|62812667|FG001|Induction Phase|Death|0|||
33436139|NCT00207142|62812668|FG002|Induction Phase|Death|0|||
33436140|NCT00207142|62812669|FG003|Induction Phase|Death|0|||
33436141|NCT00207142|62812666|FG000|Induction Phase|Lack of Efficacy|1|||
33436142|NCT00207142|62812667|FG001|Induction Phase|Lack of Efficacy|0|||
33436143|NCT00207142|62812668|FG002|Induction Phase|Lack of Efficacy|0|||
33436144|NCT00207142|62812669|FG003|Induction Phase|Lack of Efficacy|0|||
33436145|NCT00207142|62812666|FG000|Induction Phase|Lost to Follow-up|5|||
33436146|NCT00207142|62812667|FG001|Induction Phase|Lost to Follow-up|0|||
33436147|NCT00207142|62812668|FG002|Induction Phase|Lost to Follow-up|0|||
33436148|NCT00207142|62812669|FG003|Induction Phase|Lost to Follow-up|0|||
33436149|NCT00207142|62812666|FG000|Induction Phase|Physician Decision|2|||
33436150|NCT00207142|62812667|FG001|Induction Phase|Physician Decision|0|||
33436151|NCT00207142|62812668|FG002|Induction Phase|Physician Decision|0|||
33436152|NCT00207142|62812669|FG003|Induction Phase|Physician Decision|0|||
33436153|NCT00207142|62812666|FG000|Induction Phase|Poor/noncompliance|2|||
33436154|NCT00207142|62812667|FG001|Induction Phase|Poor/noncompliance|0|||
33436155|NCT00207142|62812668|FG002|Induction Phase|Poor/noncompliance|0|||
33436156|NCT00207142|62812669|FG003|Induction Phase|Poor/noncompliance|0|||
33436157|NCT00207142|62812666|FG000|Induction Phase|Pregnancy|1|||
33436158|NCT00207142|62812667|FG001|Induction Phase|Pregnancy|0|||
33436159|NCT00207142|62812668|FG002|Induction Phase|Pregnancy|0|||
33436160|NCT00207142|62812669|FG003|Induction Phase|Pregnancy|0|||
33436161|NCT00207142|62812666|FG000|Induction Phase|Subject no longer meets study criteria|3|||
33436162|NCT00207142|62812667|FG001|Induction Phase|Subject no longer meets study criteria|0|||
33436163|NCT00207142|62812668|FG002|Induction Phase|Subject no longer meets study criteria|0|||
33436164|NCT00207142|62812669|FG003|Induction Phase|Subject no longer meets study criteria|0|||
33436165|NCT00207142|62812666|FG000|Induction Phase|Withdrawal by Subject|4|||
33436166|NCT00207142|62812667|FG001|Induction Phase|Withdrawal by Subject|0|||
33436167|NCT00207142|62812668|FG002|Induction Phase|Withdrawal by Subject|0|||
33494181|NCT03634033|62872934|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
33494182|NCT03634033|62872935|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
33494183|NCT03634033|62872936|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
33494184|NCT03634033|62872937|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
33494185|NCT03634033|62872938|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
33436168|NCT00207142|62812669|FG003|Induction Phase|Withdrawal by Subject|0|||
33436169|NCT00207142|62812666|FG000|Induction Phase|Incarceration|1|||
33436170|NCT00207142|62812667|FG001|Induction Phase|Incarceration|0|||
33436171|NCT00207142|62812668|FG002|Induction Phase|Incarceration|0|||
33436172|NCT00207142|62812669|FG003|Induction Phase|Incarceration|0|||
33436173|NCT00207142|62812666|FG000|Induction Phase|Missing lab data|1|||
33436174|NCT00207142|62812667|FG001|Induction Phase|Missing lab data|0|||
33436175|NCT00207142|62812668|FG002|Induction Phase|Missing lab data|0|||
33436176|NCT00207142|62812669|FG003|Induction Phase|Missing lab data|0|||
33436177|NCT00207142|62812666|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
33436178|NCT00207142|62812667|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
33436179|NCT00207142|62812668|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
33436180|NCT00207142|62812669|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
33436181|NCT00207142|62812666|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
33436182|NCT00207142|62812667|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
33436183|NCT00207142|62812668|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
33436184|NCT00207142|62812669|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
33436185|NCT00207142|62812666|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
33436186|NCT00207142|62812667|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
33436187|NCT00207142|62812668|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
33436188|NCT00207142|62812669|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
33436189|NCT00207142|62812666|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
33436190|NCT00207142|62812667|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
33436191|NCT00207142|62812668|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
33436192|NCT00207142|62812669|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
33436193|NCT00207142|62812666|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
33436194|NCT00207142|62812667|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
33436195|NCT00207142|62812668|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
33436196|NCT00207142|62812669|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
33436197|NCT00207142|62812666|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
33436198|NCT00207142|62812667|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
33436199|NCT00207142|62812668|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
33436200|NCT00207142|62812669|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
33436201|NCT00207142|62812666|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
33436202|NCT00207142|62812667|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
33436203|NCT00207142|62812668|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
33436204|NCT00207142|62812669|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
33436205|NCT00207142|62812666|FG000|Maintenance Phase/Rescue Phase|Death|0|||
33436206|NCT00207142|62812667|FG001|Maintenance Phase/Rescue Phase|Death|0|||
33436207|NCT00207142|62812668|FG002|Maintenance Phase/Rescue Phase|Death|0|||
33436208|NCT00207142|62812669|FG003|Maintenance Phase/Rescue Phase|Death|1|||
33436209|NCT00207142|62812666|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
33436210|NCT00207142|62812667|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
33436211|NCT00207142|62812668|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
33436212|NCT00207142|62812669|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
33436213|NCT00268905|62812687|FG000|Overall Study|Adverse Event|3|||
33436214|NCT00268905|62812688|FG001|Overall Study|Adverse Event|0|||
33436215|NCT00268905|62812689|FG002|Overall Study|Adverse Event|4|||
33436216|NCT00268905|62812687|FG000|Overall Study|Lost to Follow-up|0|||
33436217|NCT00268905|62812688|FG001|Overall Study|Lost to Follow-up|1|||
33436218|NCT00268905|62812689|FG002|Overall Study|Lost to Follow-up|0|||
33436219|NCT00268905|62812687|FG000|Overall Study|Withdrawal by Subject|0|||
33436220|NCT00268905|62812688|FG001|Overall Study|Withdrawal by Subject|0|||
33436221|NCT00268905|62812689|FG002|Overall Study|Withdrawal by Subject|3|||
33436222|NCT00268905|62812687|FG000|Overall Study|Progressive Disease|28|||
33436223|NCT00268905|62812688|FG001|Overall Study|Progressive Disease|4|||
33436224|NCT00268905|62812689|FG002|Overall Study|Progressive Disease|3|||
33436225|NCT00268905|62812687|FG000|Overall Study|Physician Decision|3|||
33436226|NCT00268905|62812688|FG001|Overall Study|Physician Decision|0|||
33436227|NCT00268905|62812689|FG002|Overall Study|Physician Decision|1|||
33436228|NCT00268905|62812687|FG000|Overall Study|Clinical Progression|9|||
33436229|NCT00268905|62812688|FG001|Overall Study|Clinical Progression|4|||
33436230|NCT00268905|62812689|FG002|Overall Study|Clinical Progression|1|||
33436231|NCT00206518|62812699|FG000|Overall Study|Lack of Efficacy|6|||
33436232|NCT00206518|62812700|FG001|Overall Study|Lack of Efficacy|4|||
33436233|NCT00206518|62812699|FG000|Overall Study|Adverse Event|2|||
33436234|NCT00206518|62812700|FG001|Overall Study|Adverse Event|1|||
33436235|NCT00206518|62812699|FG000|Overall Study|Physician Decision|1|||
33436236|NCT00206518|62812700|FG001|Overall Study|Physician Decision|0|||
33436237|NCT00206518|62812699|FG000|Overall Study|Protocol Violation|1|||
33436238|NCT00206518|62812700|FG001|Overall Study|Protocol Violation|1|||
33436239|NCT00423722|62812708|FG000|Overall Study|Death|4|||
33436240|NCT00423722|62812709|FG001|Overall Study|Death|4|||
33436241|NCT00423722|62812708|FG000|Overall Study|Declined to participate|2|||
33436242|NCT00423722|62812709|FG001|Overall Study|Declined to participate|3|||
33436243|NCT00423722|62812708|FG000|Overall Study|Unable to complete questionnaires|4|||
33436244|NCT00423722|62812709|FG001|Overall Study|Unable to complete questionnaires|4|||
33436245|NCT00423722|62812708|FG000|Overall Study|Withdrawal by Subject|4|||
33436246|NCT00423722|62812709|FG001|Overall Study|Withdrawal by Subject|2|||
33436247|NCT00206440|62812723|FG000|Overall Study|Protocol Violation|1|||
33436248|NCT00206440|62812724|FG001|Overall Study|Protocol Violation|2|||
33436249|NCT00206440|62812723|FG000|Overall Study|Adverse Event|4|||
33436250|NCT00206440|62812724|FG001|Overall Study|Adverse Event|2|||
33436251|NCT00268437|62812730|FG000|Overall Study|Ineligible|1|||
33436252|NCT00423488|62812737|FG000|Overall Study|No evidence of study drug intake|2|||
33436253|NCT00423488|62812738|FG001|Overall Study|No evidence of study drug intake|1|||
33436254|NCT00423488|62812737|FG000|Overall Study|No post baseline data|3|||
33436255|NCT00423488|62812738|FG001|Overall Study|No post baseline data|0|||
33436256|NCT00404066|62812744|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
33436257|NCT00404066|62812744|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
33436258|NCT00423332|62812750|FG000|Overall Study|Adverse Event|6|||
33436259|NCT00423332|62812751|FG001|Overall Study|Adverse Event|2|||
33436260|NCT00423332|62812750|FG000|Overall Study|Withdrawal by Subject|1|||
33436261|NCT00423332|62812751|FG001|Overall Study|Withdrawal by Subject|0|||
33436262|NCT00423332|62812750|FG000|Overall Study|Condition under investigation worsened|1|||
33436263|NCT00423332|62812751|FG001|Overall Study|Condition under investigation worsened|1|||
33436264|NCT00423332|62812750|FG000|Overall Study|Progressive at Week 6|0|||
33436265|NCT00423332|62812751|FG001|Overall Study|Progressive at Week 6|1|||
33436266|NCT00423332|62812750|FG000|Overall Study|Unblinded before 12 weeks|1|||
33436267|NCT00423332|62812751|FG001|Overall Study|Unblinded before 12 weeks|3|||
33436268|NCT00413036|62812758|FG000|Overall Study|Adverse Event|44|||
33436269|NCT00413036|62812758|FG000|Overall Study|Lack of Efficacy|129|||
33436270|NCT00413036|62812758|FG000|Overall Study|Withdrawal by Subject|7|||
33436271|NCT00413036|62812758|FG000|Overall Study|Death|9|||
33436272|NCT00413036|62812758|FG000|Overall Study|Other|26|||
33436273|NCT00413036|62812758|FG000|Overall Study|Missing|2|||
33436274|NCT00412958|62812766|FG000|Overall Study|Withdrawal by Subject|3|||
33436275|NCT00412958|62812767|FG001|Overall Study|Withdrawal by Subject|0|||
33436276|NCT00412958|62812768|FG002|Overall Study|Withdrawal by Subject|0|||
33436277|NCT00412958|62812769|FG003|Overall Study|Withdrawal by Subject|1|||
33436278|NCT00412958|62812766|FG000|Overall Study|Adverse Event|0|||
33436279|NCT00412958|62812767|FG001|Overall Study|Adverse Event|1|||
33436280|NCT00412958|62812768|FG002|Overall Study|Adverse Event|0|||
33436281|NCT00412958|62812769|FG003|Overall Study|Adverse Event|0|||
33436282|NCT00412958|62812766|FG000|Overall Study|Lost to Follow-up|0|||
33436283|NCT00412958|62812767|FG001|Overall Study|Lost to Follow-up|1|||
33436284|NCT00412958|62812768|FG002|Overall Study|Lost to Follow-up|0|||
33436285|NCT00412958|62812769|FG003|Overall Study|Lost to Follow-up|0|||
33436286|NCT00412958|62812766|FG000|Overall Study|Death|0|||
33436287|NCT00412958|62812767|FG001|Overall Study|Death|1|||
33436288|NCT00412958|62812768|FG002|Overall Study|Death|0|||
33436289|NCT00412958|62812769|FG003|Overall Study|Death|0|||
33436290|NCT00412958|62812766|FG000|Overall Study|Transport issue|0|||
33436291|NCT00412958|62812767|FG001|Overall Study|Transport issue|1|||
33436292|NCT00412958|62812768|FG002|Overall Study|Transport issue|0|||
33436293|NCT00412958|62812769|FG003|Overall Study|Transport issue|0|||
33436294|NCT00423176|62812781|FG000|Overall Study|Adverse Event|4|||
33436295|NCT00423176|62812782|FG001|Overall Study|Adverse Event|6|||
33436296|NCT00423176|62812781|FG000|Overall Study|Treatment Failure|1|||
33436297|NCT00423176|62812782|FG001|Overall Study|Treatment Failure|6|||
33436298|NCT00423176|62812781|FG000|Overall Study|Lost to Follow-up|4|||
33436299|NCT00423176|62812782|FG001|Overall Study|Lost to Follow-up|7|||
33436300|NCT00423176|62812781|FG000|Overall Study|Withdrawal by Subject|4|||
33436301|NCT00423176|62812782|FG001|Overall Study|Withdrawal by Subject|3|||
33436302|NCT00423176|62812781|FG000|Overall Study|Protocol Violation|1|||
33436303|NCT00423176|62812782|FG001|Overall Study|Protocol Violation|3|||
33436304|NCT00423176|62812781|FG000|Overall Study|Did not meet protocol eligibility|2|||
33436305|NCT00423176|62812782|FG001|Overall Study|Did not meet protocol eligibility|4|||
33436306|NCT00412880|62812788|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
33436307|NCT00412880|62812788|FG000|Overall Study|Consent withdrawn|1|||
33436308|NCT00412880|62812788|FG000|Overall Study|Adverse Event|1|||
33436309|NCT00412880|62812788|FG000|Overall Study|Progressive disease|20|||
33436310|NCT00268203|62812792|FG000|Overall Study|Lost to Follow-up|92|||
33436311|NCT00268203|62812792|FG000|Overall Study|Withdrawal by Subject|9|||
33436312|NCT00268203|62812792|FG000|Overall Study|Received Other NHL Therapy|7|||
33436313|NCT00268203|62812792|FG000|Overall Study|Progressive Disease|359|||
33436314|NCT00268203|62812792|FG000|Overall Study|Death|84|||
33436315|NCT00268203|62812792|FG000|Overall Study|Reason Not Specified|34|||
33436316|NCT00268203|62812792|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
33436317|NCT00384930|62812801|FG000|Overall Study|Adverse Event|5|||
33436318|NCT00384930|62812802|FG001|Overall Study|Adverse Event|4|||
33436319|NCT00384930|62812803|FG002|Overall Study|Adverse Event|12|||
33436320|NCT00384930|62812804|FG003|Overall Study|Adverse Event|11|||
33436321|NCT00384930|62812805|FG004|Overall Study|Adverse Event|14|||
33436322|NCT00384930|62812801|FG000|Overall Study|Entry Criteria Not Met|2|||
33436323|NCT00384930|62812802|FG001|Overall Study|Entry Criteria Not Met|6|||
33436324|NCT00384930|62812803|FG002|Overall Study|Entry Criteria Not Met|7|||
33436325|NCT00384930|62812804|FG003|Overall Study|Entry Criteria Not Met|8|||
33436326|NCT00384930|62812805|FG004|Overall Study|Entry Criteria Not Met|4|||
33436327|NCT00384930|62812801|FG000|Overall Study|Lack of Efficacy|1|||
33436328|NCT00384930|62812802|FG001|Overall Study|Lack of Efficacy|1|||
33436329|NCT00384930|62812803|FG002|Overall Study|Lack of Efficacy|2|||
33436330|NCT00384930|62812804|FG003|Overall Study|Lack of Efficacy|1|||
33436331|NCT00384930|62812805|FG004|Overall Study|Lack of Efficacy|2|||
33436332|NCT00384930|62812801|FG000|Overall Study|Lost to Follow-up|5|||
33436333|NCT00384930|62812802|FG001|Overall Study|Lost to Follow-up|3|||
33436334|NCT00384930|62812803|FG002|Overall Study|Lost to Follow-up|0|||
33436335|NCT00384930|62812804|FG003|Overall Study|Lost to Follow-up|4|||
33436336|NCT00384930|62812805|FG004|Overall Study|Lost to Follow-up|6|||
33436337|NCT00384930|62812801|FG000|Overall Study|Physician Decision|0|||
33436338|NCT00384930|62812802|FG001|Overall Study|Physician Decision|1|||
33436339|NCT00384930|62812803|FG002|Overall Study|Physician Decision|1|||
33436340|NCT00384930|62812804|FG003|Overall Study|Physician Decision|0|||
33436341|NCT00384930|62812805|FG004|Overall Study|Physician Decision|1|||
33436342|NCT00384930|62812801|FG000|Overall Study|Protocol Violation|1|||
33436343|NCT00384930|62812802|FG001|Overall Study|Protocol Violation|0|||
33436344|NCT00384930|62812803|FG002|Overall Study|Protocol Violation|1|||
33436345|NCT00384930|62812804|FG003|Overall Study|Protocol Violation|6|||
33436346|NCT00384930|62812805|FG004|Overall Study|Protocol Violation|4|||
33436347|NCT00384930|62812801|FG000|Overall Study|Sponsor Decision|3|||
33436348|NCT00384930|62812802|FG001|Overall Study|Sponsor Decision|4|||
33436349|NCT00384930|62812803|FG002|Overall Study|Sponsor Decision|0|||
33436350|NCT00384930|62812804|FG003|Overall Study|Sponsor Decision|5|||
33436351|NCT00384930|62812805|FG004|Overall Study|Sponsor Decision|0|||
33436352|NCT00384930|62812801|FG000|Overall Study|Withdrawal by Subject|9|||
33436353|NCT00384930|62812802|FG001|Overall Study|Withdrawal by Subject|7|||
33436354|NCT00384930|62812803|FG002|Overall Study|Withdrawal by Subject|7|||
33436355|NCT00384930|62812804|FG003|Overall Study|Withdrawal by Subject|6|||
33436356|NCT00384930|62812805|FG004|Overall Study|Withdrawal by Subject|16|||
33436357|NCT00384930|62812801|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
33436358|NCT00384930|62812802|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
33436359|NCT00384930|62812803|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
33436360|NCT00384930|62812804|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
33436361|NCT00384930|62812805|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
33436362|NCT00423098|62812822|FG000|Overall Study|Adverse Event|1|||
33436363|NCT00423098|62812823|FG001|Overall Study|Adverse Event|2|||
33436364|NCT00423098|62812822|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33436365|NCT00423098|62812823|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33436366|NCT00423098|62812822|FG000|Overall Study|Administrative problems|0|||
33436367|NCT00423098|62812823|FG001|Overall Study|Administrative problems|1|||
33436368|NCT00423098|62812822|FG000|Overall Study|Death|2|||
33436369|NCT00423098|62812823|FG001|Overall Study|Death|0|||
33436370|NCT00750698|62812840|FG000|Overall Study|Withdrawal by Subject|1|||
33436371|NCT00750698|62812841|FG001|Overall Study|Withdrawal by Subject|0|||
33436372|NCT00750698|62812840|FG000|Overall Study|Progressive disease|5|||
33436373|NCT00750698|62812841|FG001|Overall Study|Progressive disease|2|||
33436374|NCT00411788|62812847|FG000|Overall Study|Protocol Violation|1|||
33436375|NCT00411788|62812847|FG000|Overall Study|Adverse Event|1|||
33436376|NCT00422942|62812851|FG000|Overall Study|Study terminated by Sponsor|3|||
33436377|NCT00422162|62812857|FG000|Overall Study|Adverse Event|11|||
33436378|NCT00422162|62812858|FG001|Overall Study|Adverse Event|9|||
33436379|NCT00422162|62812857|FG000|Overall Study|Lack of Efficacy|4|||
33436380|NCT00422162|62812858|FG001|Overall Study|Lack of Efficacy|10|||
33436381|NCT00422162|62812857|FG000|Overall Study|Withdrawal by Subject|7|||
33436382|NCT00422162|62812858|FG001|Overall Study|Withdrawal by Subject|6|||
33436383|NCT00422162|62812857|FG000|Overall Study|Lost to Follow-up|1|||
33436384|NCT00422162|62812858|FG001|Overall Study|Lost to Follow-up|2|||
33436385|NCT00422162|62812857|FG000|Overall Study|Non-Compliant with Protocol|1|||
33436386|NCT00422162|62812858|FG001|Overall Study|Non-Compliant with Protocol|1|||
33436387|NCT00422162|62812857|FG000|Overall Study|Other|0|||
33436388|NCT00422162|62812858|FG001|Overall Study|Other|1|||
33436389|NCT00422162|62812857|FG000|Overall Study|Didn't Receive Treatment|0|||
33436390|NCT00422162|62812858|FG001|Overall Study|Didn't Receive Treatment|1|||
33436391|NCT00411632|62812874|FG000|Overall Study|Death|1|||
33436392|NCT00422084|62812880|FG000|Overall Study|Adverse Event|21|||
33436393|NCT00422084|62812881|FG001|Overall Study|Adverse Event|7|||
33436394|NCT00422084|62812880|FG000|Overall Study|Withdrawal by Subject|12|||
33436395|NCT00422084|62812881|FG001|Overall Study|Withdrawal by Subject|9|||
33436396|NCT00422084|62812880|FG000|Overall Study|Lost to Follow-up|14|||
33436397|NCT00422084|62812881|FG001|Overall Study|Lost to Follow-up|9|||
33436398|NCT00422084|62812880|FG000|Overall Study|Protocol Violation|4|||
33436399|NCT00422084|62812881|FG001|Overall Study|Protocol Violation|1|||
33436400|NCT00422084|62812880|FG000|Overall Study|Lack of Efficacy|40|||
33436401|NCT00422084|62812881|FG001|Overall Study|Lack of Efficacy|42|||
33436402|NCT00422084|62812880|FG000|Overall Study|P. vivax infection|3|||
33436403|NCT00422084|62812881|FG001|Overall Study|P. vivax infection|6|||
33436404|NCT00422084|62812880|FG000|Overall Study|Cyesis|1|||
33436405|NCT00422084|62812881|FG001|Overall Study|Cyesis|0|||
33436406|NCT00422084|62812880|FG000|Overall Study|Withdrawn from study accidentally|1|||
33436407|NCT00422084|62812881|FG001|Overall Study|Withdrawn from study accidentally|0|||
33436408|NCT00422084|62812880|FG000|Overall Study|Non-compliance|1|||
33436409|NCT00422084|62812881|FG001|Overall Study|Non-compliance|0|||
33436410|NCT00422084|62812880|FG000|Overall Study|Re-location|0|||
33436411|NCT00422084|62812881|FG001|Overall Study|Re-location|1|||
33436412|NCT00422084|62812880|FG000|Overall Study|Not defined|1|||
33436413|NCT00422084|62812881|FG001|Overall Study|Not defined|1|||
33436414|NCT00421928|62812890|FG000|Overall Study|Adverse Event|61|||
33436415|NCT00421928|62812891|FG001|Overall Study|Adverse Event|140|||
33436416|NCT00421928|62812892|FG002|Overall Study|Adverse Event|22|||
33436417|NCT00421928|62812890|FG000|Overall Study|Lost to Follow-up|5|||
33436418|NCT00421928|62812891|FG001|Overall Study|Lost to Follow-up|0|||
33436419|NCT00421928|62812892|FG002|Overall Study|Lost to Follow-up|3|||
33436420|NCT00421928|62812890|FG000|Overall Study|Withdrawal by Subject|50|||
33436421|NCT00421928|62812891|FG001|Overall Study|Withdrawal by Subject|48|||
33436422|NCT00421928|62812892|FG002|Overall Study|Withdrawal by Subject|43|||
33436423|NCT00421928|62812890|FG000|Overall Study|Lack of Efficacy|15|||
33436424|NCT00421928|62812891|FG001|Overall Study|Lack of Efficacy|7|||
33436425|NCT00421928|62812892|FG002|Overall Study|Lack of Efficacy|35|||
33436426|NCT00421928|62812890|FG000|Overall Study|Study drug non-compliant|6|||
33436427|NCT00421928|62812891|FG001|Overall Study|Study drug non-compliant|7|||
33436428|NCT00421928|62812892|FG002|Overall Study|Study drug non-compliant|4|||
33436429|NCT00421928|62812890|FG000|Overall Study|All other|26|||
33436430|NCT00421928|62812891|FG001|Overall Study|All other|21|||
33436431|NCT00421928|62812892|FG002|Overall Study|All other|27|||
33436432|NCT00421928|62812890|FG000|Overall Study|Death|0|||
33436433|NCT00421928|62812891|FG001|Overall Study|Death|1|||
33436434|NCT00421928|62812892|FG002|Overall Study|Death|0|||
33436435|NCT00383292|62812903|FG000|Overall Study|Adverse Event|4|||
33436436|NCT00383292|62812904|FG001|Overall Study|Adverse Event|1|||
33436437|NCT00383292|62812905|FG002|Overall Study|Adverse Event|2|||
33436438|NCT00383292|62812903|FG000|Overall Study|Death|3|||
33436439|NCT00383292|62812904|FG001|Overall Study|Death|3|||
33436440|NCT00383292|62812905|FG002|Overall Study|Death|3|||
33436441|NCT00383292|62812903|FG000|Overall Study|Physician Decision|4|||
33436442|NCT00383292|62812904|FG001|Overall Study|Physician Decision|0|||
33436443|NCT00383292|62812905|FG002|Overall Study|Physician Decision|1|||
33436444|NCT00383292|62812903|FG000|Overall Study|Withdrawal by Subject|3|||
33436445|NCT00383292|62812904|FG001|Overall Study|Withdrawal by Subject|2|||
33323200|NCT01175135|62699458|FG003|Overall Study|Randomized But Not Treated|0|||
33323201|NCT00922480|62699470|FG000|Main Study|Protocol Violation|3|||
33436446|NCT00383292|62812905|FG002|Overall Study|Withdrawal by Subject|2|||
33436447|NCT00383292|62812903|FG000|Overall Study|Other|1|||
33436448|NCT00383292|62812904|FG001|Overall Study|Other|0|||
33436449|NCT00383292|62812905|FG002|Overall Study|Other|0|||
33436450|NCT00372060|62812916|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
33436451|NCT00372060|62812917|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
33436452|NCT00372060|62812916|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
33436453|NCT00372060|62812917|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
33436454|NCT00372060|62812916|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
33436455|NCT00372060|62812917|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
33323202|NCT00922480|62699471|FG001|Main Study|Protocol Violation|6|||
33436456|NCT00372060|62812916|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
33436457|NCT00372060|62812917|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
33436458|NCT00372060|62812916|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
33436459|NCT00372060|62812917|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
33436460|NCT00372060|62812916|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
33436461|NCT00372060|62812917|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
33436462|NCT00421304|62812929|FG000|Overall Study|Lost to Follow-up|5|||
33436463|NCT00421304|62812930|FG001|Overall Study|Lost to Follow-up|2|||
33436464|NCT00421304|62812931|FG002|Overall Study|Lost to Follow-up|5|||
33436465|NCT00421304|62812929|FG000|Overall Study|Withdrawal by Subject|2|||
33436466|NCT00421304|62812930|FG001|Overall Study|Withdrawal by Subject|2|||
33436467|NCT00421304|62812931|FG002|Overall Study|Withdrawal by Subject|2|||
33436468|NCT00421304|62812929|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
33436469|NCT00421304|62812930|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
33436470|NCT00421304|62812931|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
33436471|NCT00421304|62812929|FG000|Overall Study|Did not attend Day 360 visit|0|||
33436472|NCT00421304|62812930|FG001|Overall Study|Did not attend Day 360 visit|0|||
33436473|NCT00421304|62812931|FG002|Overall Study|Did not attend Day 360 visit|1|||
33436474|NCT00396630|62812943|FG000|Overall Study|Lost to Follow-up|1|||
33436475|NCT00396630|62812944|FG001|Overall Study|Lost to Follow-up|1|||
33436476|NCT00396630|62812943|FG000|Overall Study|Withdrawal by Subject|1|||
33436477|NCT00396630|62812944|FG001|Overall Study|Withdrawal by Subject|1|||
33436478|NCT00396630|62812943|FG000|Overall Study|Not vaccinated at Visit 3|3|||
33436479|NCT00396630|62812944|FG001|Overall Study|Not vaccinated at Visit 3|3|||
33436480|NCT00396318|62812951|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
33436481|NCT00396162|62812957|FG000|Overall Study|Withdrawal by Subject|2|||
33436482|NCT00396162|62812958|FG001|Overall Study|Withdrawal by Subject|3|||
33436483|NCT00381888|62812968|FG000|Overall Study|Death|1|||
33436484|NCT00381888|62812968|FG000|Overall Study|Withdrawal by Subject|1|||
33436485|NCT00381888|62812968|FG000|Overall Study|Physician Decision|1|||
33436486|NCT00381888|62812968|FG000|Overall Study|Protocol Violation|9|||
33436487|NCT00381888|62812968|FG000|Overall Study|Had laparoscopic surgery|2|||
33436488|NCT00381888|62812968|FG000|Overall Study|Surgery was cancelled|2|||
33436489|NCT00381888|62812968|FG000|Overall Study|Adverse Event|1|||
33436490|NCT00267969|62812975|FG000|Controlled Period|Adverse Event|6|||
33436491|NCT00267969|62812976|FG001|Controlled Period|Adverse Event|0|||
33323203|NCT00922480|62699470|FG000|Main Study|Adverse Event|6|||
33436492|NCT00267969|62812977|FG002|Controlled Period|Adverse Event|2|||
33436493|NCT00267969|62812978|FG003|Controlled Period|Adverse Event|0|||
33436494|NCT00267969|62812979|FG004|Controlled Period|Adverse Event|0|||
33436495|NCT00267969|62812980|FG005|Controlled Period|Adverse Event|0|||
33436496|NCT00267969|62812981|FG006|Controlled Period|Adverse Event|0|||
33436497|NCT00267969|62812975|FG000|Controlled Period|Lack of Efficacy|3|||
33436498|NCT00267969|62812976|FG001|Controlled Period|Lack of Efficacy|0|||
33436499|NCT00267969|62812977|FG002|Controlled Period|Lack of Efficacy|1|||
33436500|NCT00267969|62812978|FG003|Controlled Period|Lack of Efficacy|0|||
33436501|NCT00267969|62812979|FG004|Controlled Period|Lack of Efficacy|0|||
33436502|NCT00267969|62812980|FG005|Controlled Period|Lack of Efficacy|0|||
33436503|NCT00267969|62812981|FG006|Controlled Period|Lack of Efficacy|0|||
33436504|NCT00267969|62812975|FG000|Controlled Period|Lost to Follow-up|1|||
33436505|NCT00267969|62812976|FG001|Controlled Period|Lost to Follow-up|0|||
33436506|NCT00267969|62812977|FG002|Controlled Period|Lost to Follow-up|1|||
33436507|NCT00267969|62812978|FG003|Controlled Period|Lost to Follow-up|0|||
33436508|NCT00267969|62812979|FG004|Controlled Period|Lost to Follow-up|0|||
33436509|NCT00267969|62812980|FG005|Controlled Period|Lost to Follow-up|0|||
33436510|NCT00267969|62812981|FG006|Controlled Period|Lost to Follow-up|0|||
33436511|NCT00267969|62812975|FG000|Controlled Period|Randomized but not treated|0|||
33436512|NCT00267969|62812976|FG001|Controlled Period|Randomized but not treated|0|||
33436513|NCT00267969|62812977|FG002|Controlled Period|Randomized but not treated|1|||
33436514|NCT00267969|62812978|FG003|Controlled Period|Randomized but not treated|0|||
33436515|NCT00267969|62812979|FG004|Controlled Period|Randomized but not treated|0|||
33436516|NCT00267969|62812980|FG005|Controlled Period|Randomized but not treated|0|||
33323204|NCT00922480|62699471|FG001|Main Study|Adverse Event|7|||
33436517|NCT00267969|62812981|FG006|Controlled Period|Randomized but not treated|0|||
33436518|NCT00267969|62812975|FG000|Controlled Period|Other|2|||
33436519|NCT00267969|62812976|FG001|Controlled Period|Other|1|||
33436520|NCT00267969|62812977|FG002|Controlled Period|Other|6|||
33436521|NCT00267969|62812978|FG003|Controlled Period|Other|0|||
33436522|NCT00267969|62812979|FG004|Controlled Period|Other|0|||
33436523|NCT00267969|62812980|FG005|Controlled Period|Other|0|||
33436524|NCT00267969|62812981|FG006|Controlled Period|Other|0|||
33436525|NCT00267969|62812975|FG000|After Controlled Period|Adverse Event|0|||
33436526|NCT00267969|62812976|FG001|After Controlled Period|Adverse Event|0|||
33436527|NCT00267969|62812977|FG002|After Controlled Period|Adverse Event|0|||
33436528|NCT00267969|62812978|FG003|After Controlled Period|Adverse Event|7|||
33436529|NCT00267969|62812979|FG004|After Controlled Period|Adverse Event|8|||
33436530|NCT00267969|62812980|FG005|After Controlled Period|Adverse Event|23|||
33436531|NCT00267969|62812981|FG006|After Controlled Period|Adverse Event|21|||
33436532|NCT00267969|62812975|FG000|After Controlled Period|Death|0|||
33436533|NCT00267969|62812976|FG001|After Controlled Period|Death|0|||
33436534|NCT00267969|62812977|FG002|After Controlled Period|Death|0|||
33436535|NCT00267969|62812978|FG003|After Controlled Period|Death|1|||
33436536|NCT00267969|62812979|FG004|After Controlled Period|Death|2|||
33436537|NCT00267969|62812980|FG005|After Controlled Period|Death|0|||
33436538|NCT00267969|62812981|FG006|After Controlled Period|Death|1|||
33436539|NCT00267969|62812975|FG000|After Controlled Period|Lack of Efficacy|0|||
33436540|NCT00267969|62812976|FG001|After Controlled Period|Lack of Efficacy|0|||
33436541|NCT00267969|62812977|FG002|After Controlled Period|Lack of Efficacy|0|||
33436542|NCT00267969|62812978|FG003|After Controlled Period|Lack of Efficacy|10|||
33436543|NCT00267969|62812979|FG004|After Controlled Period|Lack of Efficacy|6|||
33436544|NCT00267969|62812980|FG005|After Controlled Period|Lack of Efficacy|28|||
33436545|NCT00267969|62812981|FG006|After Controlled Period|Lack of Efficacy|15|||
33436546|NCT00267969|62812975|FG000|After Controlled Period|Lost to Follow-up|0|||
33436547|NCT00267969|62812976|FG001|After Controlled Period|Lost to Follow-up|0|||
33436548|NCT00267969|62812977|FG002|After Controlled Period|Lost to Follow-up|0|||
33436549|NCT00267969|62812978|FG003|After Controlled Period|Lost to Follow-up|5|||
33436550|NCT00267969|62812979|FG004|After Controlled Period|Lost to Follow-up|8|||
33436551|NCT00267969|62812980|FG005|After Controlled Period|Lost to Follow-up|9|||
33436552|NCT00267969|62812981|FG006|After Controlled Period|Lost to Follow-up|10|||
33436553|NCT00267969|62812975|FG000|After Controlled Period|Other|0|||
33436554|NCT00267969|62812976|FG001|After Controlled Period|Other|0|||
33436555|NCT00267969|62812977|FG002|After Controlled Period|Other|0|||
33436556|NCT00267969|62812978|FG003|After Controlled Period|Other|13|||
33436557|NCT00267969|62812979|FG004|After Controlled Period|Other|11|||
33436558|NCT00267969|62812980|FG005|After Controlled Period|Other|22|||
33436559|NCT00267969|62812981|FG006|After Controlled Period|Other|25|||
33436560|NCT00280293|62813001|FG000|Overall Study|Protocol Violation|3|||
33494186|NCT03634033|62872939|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
33436561|NCT00280293|62813002|FG001|Overall Study|Protocol Violation|0|||
33436562|NCT00280293|62813001|FG000|Overall Study|Physician Decision|5|||
33436563|NCT00280293|62813002|FG001|Overall Study|Physician Decision|4|||
33436564|NCT00280293|62813001|FG000|Overall Study|Lost to Follow-up|14|||
33436565|NCT00280293|62813002|FG001|Overall Study|Lost to Follow-up|12|||
33436566|NCT00280293|62813001|FG000|Overall Study|Withdrawal by Subject|3|||
33436567|NCT00280293|62813002|FG001|Overall Study|Withdrawal by Subject|5|||
33436568|NCT00280293|62813001|FG000|Overall Study|Incarceration/Legal Reasons|1|||
33436569|NCT00280293|62813002|FG001|Overall Study|Incarceration/Legal Reasons|1|||
33436570|NCT00280293|62813001|FG000|Overall Study|Adverse Event|0|||
33436571|NCT00280293|62813002|FG001|Overall Study|Adverse Event|1|||
33436572|NCT00421148|62813028|FG000|Overall Study|Lost to Follow-up|0|||
33436573|NCT00421148|62813029|FG001|Overall Study|Lost to Follow-up|0|||
33436574|NCT00421148|62813030|FG002|Overall Study|Lost to Follow-up|0|||
33436575|NCT00421148|62813031|FG003|Overall Study|Lost to Follow-up|0|||
33436576|NCT00421148|62813032|FG004|Overall Study|Lost to Follow-up|0|||
33436577|NCT00421148|62813033|FG005|Overall Study|Lost to Follow-up|0|||
33436578|NCT00421148|62813034|FG006|Overall Study|Lost to Follow-up|0|||
33436579|NCT00421148|62813035|FG007|Overall Study|Lost to Follow-up|0|||
33436580|NCT00421148|62813036|FG008|Overall Study|Lost to Follow-up|0|||
33436581|NCT00421148|62813037|FG009|Overall Study|Lost to Follow-up|0|||
33436582|NCT00421148|62813038|FG010|Overall Study|Lost to Follow-up|0|||
33436583|NCT00421148|62813039|FG011|Overall Study|Lost to Follow-up|0|||
33436584|NCT00421148|62813040|FG012|Overall Study|Lost to Follow-up|0|||
33436585|NCT00421148|62813041|FG013|Overall Study|Lost to Follow-up|0|||
33436586|NCT00421148|62813042|FG014|Overall Study|Lost to Follow-up|0|||
33436587|NCT00421148|62813043|FG015|Overall Study|Lost to Follow-up|0|||
33436588|NCT00421148|62813044|FG016|Overall Study|Lost to Follow-up|0|||
33436589|NCT00421148|62813045|FG017|Overall Study|Lost to Follow-up|1|||
33436590|NCT00421148|62813046|FG018|Overall Study|Lost to Follow-up|0|||
33436591|NCT00421148|62813047|FG019|Overall Study|Lost to Follow-up|0|||
33436592|NCT00421148|62813028|FG000|Overall Study|Withdrawal by Subject|0|||
33436593|NCT00421148|62813029|FG001|Overall Study|Withdrawal by Subject|0|||
33436594|NCT00421148|62813030|FG002|Overall Study|Withdrawal by Subject|0|||
33436595|NCT00421148|62813031|FG003|Overall Study|Withdrawal by Subject|0|||
33436596|NCT00421148|62813032|FG004|Overall Study|Withdrawal by Subject|0|||
33436597|NCT00421148|62813033|FG005|Overall Study|Withdrawal by Subject|0|||
33436598|NCT00421148|62813034|FG006|Overall Study|Withdrawal by Subject|0|||
33436599|NCT00421148|62813035|FG007|Overall Study|Withdrawal by Subject|0|||
33436600|NCT00421148|62813036|FG008|Overall Study|Withdrawal by Subject|0|||
33436601|NCT00421148|62813037|FG009|Overall Study|Withdrawal by Subject|0|||
33436602|NCT00421148|62813038|FG010|Overall Study|Withdrawal by Subject|0|||
33436603|NCT00421148|62813039|FG011|Overall Study|Withdrawal by Subject|0|||
33436604|NCT00421148|62813040|FG012|Overall Study|Withdrawal by Subject|0|||
33436605|NCT00421148|62813041|FG013|Overall Study|Withdrawal by Subject|0|||
33436606|NCT00421148|62813042|FG014|Overall Study|Withdrawal by Subject|0|||
33436607|NCT00421148|62813043|FG015|Overall Study|Withdrawal by Subject|0|||
33436608|NCT00421148|62813044|FG016|Overall Study|Withdrawal by Subject|0|||
33436609|NCT00421148|62813045|FG017|Overall Study|Withdrawal by Subject|1|||
33436610|NCT00421148|62813046|FG018|Overall Study|Withdrawal by Subject|0|||
33436611|NCT00421148|62813047|FG019|Overall Study|Withdrawal by Subject|0|||
33436612|NCT00421148|62813028|FG000|Overall Study|Protocol Violation|0|||
33436613|NCT00421148|62813029|FG001|Overall Study|Protocol Violation|0|||
33436614|NCT00421148|62813030|FG002|Overall Study|Protocol Violation|0|||
33436615|NCT00421148|62813031|FG003|Overall Study|Protocol Violation|0|||
33436616|NCT00421148|62813032|FG004|Overall Study|Protocol Violation|0|||
33436617|NCT00421148|62813033|FG005|Overall Study|Protocol Violation|1|||
33436618|NCT00421148|62813034|FG006|Overall Study|Protocol Violation|0|||
33436619|NCT00421148|62813035|FG007|Overall Study|Protocol Violation|0|||
33436620|NCT00421148|62813036|FG008|Overall Study|Protocol Violation|0|||
33436621|NCT00421148|62813037|FG009|Overall Study|Protocol Violation|0|||
33436622|NCT00421148|62813038|FG010|Overall Study|Protocol Violation|0|||
33436623|NCT00421148|62813039|FG011|Overall Study|Protocol Violation|0|||
33436624|NCT00421148|62813040|FG012|Overall Study|Protocol Violation|0|||
33436625|NCT00421148|62813041|FG013|Overall Study|Protocol Violation|0|||
33436626|NCT00421148|62813042|FG014|Overall Study|Protocol Violation|0|||
33436627|NCT00421148|62813043|FG015|Overall Study|Protocol Violation|0|||
33436628|NCT00421148|62813044|FG016|Overall Study|Protocol Violation|0|||
33436629|NCT00421148|62813045|FG017|Overall Study|Protocol Violation|0|||
33436630|NCT00421148|62813046|FG018|Overall Study|Protocol Violation|1|||
33436631|NCT00421148|62813047|FG019|Overall Study|Protocol Violation|0|||
33436632|NCT00403754|62813089|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
33436633|NCT00403754|62813090|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
33436634|NCT00403754|62813091|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
33436635|NCT00403754|62813092|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
33436636|NCT00403754|62813089|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
33436637|NCT00403754|62813090|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
33436638|NCT00403754|62813091|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
33436639|NCT00403754|62813092|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
33436640|NCT00280059|62813106|FG000|Efficacy Assessment Phase|Death|2|||
33436641|NCT00280059|62813107|FG001|Efficacy Assessment Phase|Death|0|||
33436642|NCT00280059|62813106|FG000|Efficacy Assessment Phase|Adverse Event|33|||
33436643|NCT00280059|62813107|FG001|Efficacy Assessment Phase|Adverse Event|31|||
33436644|NCT00280059|62813106|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
33436645|NCT00280059|62813107|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
33436646|NCT00280059|62813106|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
33436647|NCT00280059|62813107|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
33436648|NCT00280059|62813106|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
33436649|NCT00280059|62813107|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
33436650|NCT00280059|62813106|FG000|Efficacy Assessment Phase|Other|7|||
33436651|NCT00280059|62813107|FG001|Efficacy Assessment Phase|Other|8|||
33436652|NCT00280059|62813106|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
33436653|NCT00280059|62813107|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
33436654|NCT00403130|62813121|FG000|2 Years From Start of Treatment|Not Eligible|3|||
33436655|NCT00403130|62813121|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
33436656|NCT00403130|62813121|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
33436657|NCT00403130|62813121|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
33436658|NCT00402740|62813125|FG000|Overall Study|Withdrawal by Subject|18|||
33436659|NCT00402740|62813125|FG000|Overall Study|Death|50|||
33494187|NCT03634033|62872940|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
33436660|NCT00402740|62813125|FG000|Overall Study|Lost to Follow-up|6|||
33436661|NCT00402740|62813125|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
33436662|NCT00402740|62813125|FG000|Overall Study|Subject disposition unknown.|1|||
33436663|NCT00420290|62813135|FG000|Overall Study|Adverse Event|3|||
33436664|NCT00420290|62813136|FG001|Overall Study|Adverse Event|1|||
33436665|NCT00420290|62813135|FG000|Overall Study|Withdrawal by Subject|0|||
33436666|NCT00420290|62813136|FG001|Overall Study|Withdrawal by Subject|2|||
33436667|NCT00420290|62813135|FG000|Overall Study|did not meet inclusion/exclusion|1|||
33436668|NCT00420290|62813136|FG001|Overall Study|did not meet inclusion/exclusion|1|||
33436669|NCT00267189|62813144|FG000|Overall Study|Patient withdrew consent|1|||
33436670|NCT00267189|62813145|FG001|Overall Study|Patient withdrew consent|1|||
33436671|NCT00267189|62813144|FG000|Overall Study|Death|1|||
33436672|NCT00267189|62813145|FG001|Overall Study|Death|0|||
33436673|NCT00267189|62813144|FG000|Overall Study|Missing|3|||
33436674|NCT00267189|62813145|FG001|Overall Study|Missing|0|||
33436675|NCT03834350|62813151|FG000|Overall Study|Withdrawal by Subject|1|||
33436676|NCT00402116|62813159|FG000|Overall Study|Jaw infection after surgery-other|1|||
33436677|NCT00402116|62813160|FG001|Overall Study|Jaw infection after surgery-other|0|||
33436678|NCT00402116|62813161|FG002|Overall Study|Jaw infection after surgery-other|0|||
33436679|NCT00402116|62813159|FG000|Overall Study|Withdrawal by Subject|1|||
33436680|NCT00402116|62813160|FG001|Overall Study|Withdrawal by Subject|0|||
33436681|NCT00402116|62813161|FG002|Overall Study|Withdrawal by Subject|5|||
33436682|NCT00402116|62813159|FG000|Overall Study|Treatment completed per protocol|1|||
33436683|NCT00402116|62813160|FG001|Overall Study|Treatment completed per protocol|1|||
33436684|NCT00402116|62813161|FG002|Overall Study|Treatment completed per protocol|2|||
33436685|NCT00402116|62813159|FG000|Overall Study|other complicating disease|0|||
33436686|NCT00402116|62813160|FG001|Overall Study|other complicating disease|0|||
33436687|NCT00402116|62813161|FG002|Overall Study|other complicating disease|2|||
33436688|NCT00402116|62813159|FG000|Overall Study|Disease Progression|0|||
33436689|NCT00402116|62813160|FG001|Overall Study|Disease Progression|4|||
33436690|NCT00402116|62813161|FG002|Overall Study|Disease Progression|38|||
33436691|NCT00402116|62813159|FG000|Overall Study|mistaken thrombocytopenia|0|||
33436692|NCT00402116|62813160|FG001|Overall Study|mistaken thrombocytopenia|0|||
33436693|NCT00402116|62813161|FG002|Overall Study|mistaken thrombocytopenia|1|||
33436694|NCT00402116|62813159|FG000|Overall Study|decline related hyponatremia/tumor|0|||
33436695|NCT00402116|62813160|FG001|Overall Study|decline related hyponatremia/tumor|0|||
33436696|NCT00402116|62813161|FG002|Overall Study|decline related hyponatremia/tumor|1|||
33436697|NCT00402116|62813159|FG000|Overall Study|Adverse Event|0|||
33436698|NCT00402116|62813160|FG001|Overall Study|Adverse Event|1|||
33436699|NCT00402116|62813161|FG002|Overall Study|Adverse Event|6|||
33436700|NCT00401960|62813191|FG000|Overall Study|Lost to Follow-up|3|||
33436701|NCT00401960|62813192|FG001|Overall Study|Lost to Follow-up|0|||
33436702|NCT00401960|62813191|FG000|Overall Study|Death|2|||
33436703|NCT00401960|62813192|FG001|Overall Study|Death|0|||
33436704|NCT00401726|62813202|FG000|Overall Study|Adverse Event|34|||
33436705|NCT00401726|62813203|FG001|Overall Study|Adverse Event|45|||
33436706|NCT00401726|62813202|FG000|Overall Study|Death|0|||
33436707|NCT00401726|62813203|FG001|Overall Study|Death|3|||
33436708|NCT00401726|62813202|FG000|Overall Study|Sponsor Request|0|||
33436709|NCT00401726|62813203|FG001|Overall Study|Sponsor Request|1|||
33436710|NCT00401726|62813202|FG000|Overall Study|Physician Decision|3|||
33436711|NCT00401726|62813203|FG001|Overall Study|Physician Decision|6|||
33436712|NCT00401726|62813202|FG000|Overall Study|Lost to Follow-up|23|||
33436713|NCT00401726|62813203|FG001|Overall Study|Lost to Follow-up|20|||
33436714|NCT00401726|62813202|FG000|Overall Study|Protocol Violation|6|||
33436715|NCT00401726|62813203|FG001|Overall Study|Protocol Violation|3|||
33436716|NCT00401726|62813202|FG000|Overall Study|Withdrawal by Subject|18|||
33436717|NCT00401726|62813203|FG001|Overall Study|Withdrawal by Subject|24|||
33436718|NCT00401726|62813202|FG000|Overall Study|Lack of Efficacy|4|||
33436719|NCT00401726|62813203|FG001|Overall Study|Lack of Efficacy|6|||
33436720|NCT00401726|62813202|FG000|Overall Study|Protocol Deviation|9|||
33436721|NCT00401726|62813203|FG001|Overall Study|Protocol Deviation|4|||
33436722|NCT00371826|62813212|FG000|Core Phase (12 Months)|Adverse Event|15|||
33436723|NCT00371826|62813213|FG001|Core Phase (12 Months)|Adverse Event|4|||
33436724|NCT00371826|62813214|FG002|Core Phase (12 Months)|Adverse Event|9|||
33436725|NCT00371826|62813212|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
33436726|NCT00371826|62813213|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
33436727|NCT00371826|62813214|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
33436728|NCT00371826|62813212|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
33436729|NCT00371826|62813213|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
33436730|NCT00371826|62813214|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
33436731|NCT00371826|62813212|FG000|Core Phase (12 Months)|Protocol Violation|1|||
33436732|NCT00371826|62813213|FG001|Core Phase (12 Months)|Protocol Violation|0|||
33436733|NCT00371826|62813214|FG002|Core Phase (12 Months)|Protocol Violation|1|||
33436734|NCT00371826|62813212|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
33436735|NCT00371826|62813213|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
33436736|NCT00371826|62813214|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
33436737|NCT00371826|62813212|FG000|Core Phase (12 Months)|Administrative problems|1|||
33436738|NCT00371826|62813213|FG001|Core Phase (12 Months)|Administrative problems|0|||
33436739|NCT00371826|62813214|FG002|Core Phase (12 Months)|Administrative problems|8|||
33436740|NCT00371826|62813212|FG000|Core Phase (12 Months)|Graft Loss|0|||
33436741|NCT00371826|62813213|FG001|Core Phase (12 Months)|Graft Loss|1|||
33436742|NCT00371826|62813214|FG002|Core Phase (12 Months)|Graft Loss|0|||
33436743|NCT00371826|62813212|FG000|Extension Phase (24 Months)|Adverse Event|4|||
33436744|NCT00371826|62813213|FG001|Extension Phase (24 Months)|Adverse Event|5|||
33436745|NCT00371826|62813214|FG002|Extension Phase (24 Months)|Adverse Event|0|||
33436746|NCT00371826|62813212|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
33436747|NCT00371826|62813213|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
33436748|NCT00371826|62813214|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
33436749|NCT00371826|62813212|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
33436750|NCT00371826|62813213|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
33436751|NCT00371826|62813214|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
33436752|NCT00371826|62813212|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
33436753|NCT00371826|62813213|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
33436754|NCT00371826|62813214|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
33436755|NCT00371826|62813212|FG000|Extension Phase (24 Months)|Administrative problems|0|||
33436756|NCT00371826|62813213|FG001|Extension Phase (24 Months)|Administrative problems|0|||
33436757|NCT00371826|62813214|FG002|Extension Phase (24 Months)|Administrative problems|2|||
33436758|NCT00396084|62813228|FG000|Overall Study|Adverse Event|0|||
33436759|NCT00396084|62813229|FG001|Overall Study|Adverse Event|0|||
33436760|NCT00396084|62813230|FG002|Overall Study|Adverse Event|0|||
33436761|NCT00396084|62813231|FG003|Overall Study|Adverse Event|0|||
33436762|NCT00396084|62813232|FG004|Overall Study|Adverse Event|1|||
33436763|NCT00396084|62813233|FG005|Overall Study|Adverse Event|2|||
33436764|NCT00396084|62813228|FG000|Overall Study|Withdrawal by Subject|0|||
33436765|NCT00396084|62813229|FG001|Overall Study|Withdrawal by Subject|0|||
33436766|NCT00396084|62813230|FG002|Overall Study|Withdrawal by Subject|0|||
33436767|NCT00396084|62813231|FG003|Overall Study|Withdrawal by Subject|1|||
33436768|NCT00396084|62813232|FG004|Overall Study|Withdrawal by Subject|0|||
33436769|NCT00396084|62813233|FG005|Overall Study|Withdrawal by Subject|0|||
33436770|NCT00395850|62813255|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
33436771|NCT00395850|62813256|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
33436772|NCT00395850|62813257|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
33436773|NCT00395850|62813258|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
33436774|NCT00395850|62813255|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
33436775|NCT00395850|62813256|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
33436776|NCT00395850|62813257|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
33436777|NCT00395850|62813258|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
33436778|NCT00395850|62813255|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
33436779|NCT00395850|62813256|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
33436780|NCT00395850|62813257|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
33436781|NCT00395850|62813258|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
33436782|NCT00395850|62813255|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
33436783|NCT00395850|62813256|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
33436784|NCT00395850|62813257|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
33436785|NCT00395850|62813258|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
33436786|NCT00395850|62813255|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
33436787|NCT00395850|62813256|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
33436788|NCT00395850|62813257|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
33436789|NCT00395850|62813258|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
33436790|NCT00395850|62813255|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
33436791|NCT00395850|62813256|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
33436792|NCT00395850|62813257|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
33436793|NCT00395850|62813258|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
33436794|NCT00395850|62813255|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
33436795|NCT00395850|62813256|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
33436796|NCT00395850|62813257|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
33436797|NCT00395850|62813258|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
33436798|NCT00420212|62813271|FG000|Overall Study|Adverse Event|22|||
33436799|NCT00420212|62813272|FG001|Overall Study|Adverse Event|40|||
33436800|NCT00420212|62813273|FG002|Overall Study|Adverse Event|36|||
33436801|NCT00420212|62813271|FG000|Overall Study|Lost to Follow-up|9|||
33436802|NCT00420212|62813272|FG001|Overall Study|Lost to Follow-up|11|||
33436803|NCT00420212|62813273|FG002|Overall Study|Lost to Follow-up|11|||
33436804|NCT00420212|62813271|FG000|Overall Study|Withdrawal by Subject|31|||
33436805|NCT00420212|62813272|FG001|Overall Study|Withdrawal by Subject|22|||
33436806|NCT00420212|62813273|FG002|Overall Study|Withdrawal by Subject|19|||
33436807|NCT00420212|62813271|FG000|Overall Study|Physician Decision|4|||
33436808|NCT00420212|62813272|FG001|Overall Study|Physician Decision|4|||
33436809|NCT00420212|62813273|FG002|Overall Study|Physician Decision|3|||
33436810|NCT00420212|62813271|FG000|Overall Study|Protocol Violation|4|||
33436811|NCT00420212|62813272|FG001|Overall Study|Protocol Violation|4|||
33436812|NCT00420212|62813273|FG002|Overall Study|Protocol Violation|8|||
33436813|NCT00420212|62813271|FG000|Overall Study|Death|0|||
33436814|NCT00420212|62813272|FG001|Overall Study|Death|0|||
33436815|NCT00420212|62813273|FG002|Overall Study|Death|1|||
33436816|NCT00420212|62813271|FG000|Overall Study|Other-Unspecified|21|||
33436817|NCT00420212|62813272|FG001|Overall Study|Other-Unspecified|14|||
33436818|NCT00420212|62813273|FG002|Overall Study|Other-Unspecified|18|||
33436819|NCT00401258|62813284|FG000|Overall Study|Adverse Event|7|||
33436820|NCT00380874|62813290|FG000|Overall Study|Adverse Event|7|||
33436821|NCT00380874|62813291|FG001|Overall Study|Adverse Event|7|||
33436822|NCT00380874|62813290|FG000|Overall Study|Death|1|||
33436823|NCT00380874|62813291|FG001|Overall Study|Death|0|||
33436824|NCT00380874|62813290|FG000|Overall Study|Withdrawal by Subject|2|||
33436825|NCT00380874|62813291|FG001|Overall Study|Withdrawal by Subject|1|||
33436826|NCT00380874|62813290|FG000|Overall Study|Not related to study drug|3|||
33436827|NCT00380874|62813291|FG001|Overall Study|Not related to study drug|2|||
33436828|NCT00420056|62813297|FG000|Overall Study|Objective progression or relapse|17|||
33436829|NCT00411554|62813303|FG000|Overall Study|Adverse Event|2|||
33436830|NCT00411554|62813304|FG001|Overall Study|Adverse Event|4|||
33436831|NCT00411554|62813303|FG000|Overall Study|Lack of Efficacy|2|||
33436832|NCT00411554|62813304|FG001|Overall Study|Lack of Efficacy|5|||
33436833|NCT00411554|62813303|FG000|Overall Study|Withdrawal by Subject|3|||
33436834|NCT00411554|62813304|FG001|Overall Study|Withdrawal by Subject|0|||
33436835|NCT00411554|62813303|FG000|Overall Study|Patient Moved|1|||
33436836|NCT00411554|62813304|FG001|Overall Study|Patient Moved|0|||
33436837|NCT00400712|62813312|FG000|Overall Study|Death|1|||
33436838|NCT00400712|62813313|FG001|Overall Study|Death|0|||
33436839|NCT00400712|62813312|FG000|Overall Study|Withdrawal by Subject|11|||
33436840|NCT00400712|62813313|FG001|Overall Study|Withdrawal by Subject|12|||
33436841|NCT00400712|62813312|FG000|Overall Study|Physician Decision|5|||
33436842|NCT00400712|62813313|FG001|Overall Study|Physician Decision|4|||
33436843|NCT00380718|62813321|FG000|Overall Study|Adverse Event|1|||
33436844|NCT00380718|62813321|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
33436845|NCT00380250|62813327|FG000|Overall Study|Withdrawal by Subject|39|||
33436846|NCT00380250|62813328|FG001|Overall Study|Withdrawal by Subject|28|||
33436847|NCT00380250|62813327|FG000|Overall Study|Adverse Event|20|||
33436848|NCT00380250|62813328|FG001|Overall Study|Adverse Event|9|||
33436849|NCT00380250|62813327|FG000|Overall Study|Lack of Efficacy|10|||
33436850|NCT00380250|62813328|FG001|Overall Study|Lack of Efficacy|8|||
33436851|NCT00380250|62813327|FG000|Overall Study|Protocol Violation|15|||
33436852|NCT00380250|62813328|FG001|Overall Study|Protocol Violation|5|||
33436853|NCT00380250|62813327|FG000|Overall Study|Lost to Follow-up|14|||
33436854|NCT00380250|62813328|FG001|Overall Study|Lost to Follow-up|5|||
33436855|NCT00380250|62813327|FG000|Overall Study|Physician Decision|1|||
33436856|NCT00380250|62813328|FG001|Overall Study|Physician Decision|0|||
33436857|NCT00400400|62813336|FG000|Overall Study|Adverse Event|9|||
33436858|NCT00400400|62813337|FG001|Overall Study|Adverse Event|8|||
33436859|NCT00400400|62813336|FG000|Overall Study|Protocol Violation|2|||
33436860|NCT00400400|62813337|FG001|Overall Study|Protocol Violation|0|||
33436861|NCT00400400|62813336|FG000|Overall Study|Withdrawal by Subject|1|||
33436862|NCT00400400|62813337|FG001|Overall Study|Withdrawal by Subject|3|||
33436863|NCT00400400|62813336|FG000|Overall Study|Administrative Problem|1|||
33436864|NCT00400400|62813337|FG001|Overall Study|Administrative Problem|0|||
33436865|NCT00400400|62813336|FG000|Overall Study|Lost to Follow-up|0|||
33436866|NCT00400400|62813337|FG001|Overall Study|Lost to Follow-up|1|||
33436867|NCT00400400|62813336|FG000|Overall Study|Did not receive study drug|1|||
33436868|NCT00400400|62813337|FG001|Overall Study|Did not receive study drug|3|||
33436869|NCT00395694|62813345|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
33436870|NCT00395694|62813346|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
33436871|NCT00395694|62813345|FG000|Continuation Phase|Adverse Event|1|||
33436872|NCT00395694|62813346|FG001|Continuation Phase|Adverse Event|0|||
33436873|NCT00395694|62813345|FG000|Continuation Phase|Lack of Efficacy|12|||
33436874|NCT00395694|62813346|FG001|Continuation Phase|Lack of Efficacy|11|||
33436875|NCT00395694|62813345|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
33436876|NCT00395694|62813346|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
33436877|NCT00395694|62813345|FG000|Continuation Phase|Poor Compliance|1|||
33436878|NCT00395694|62813346|FG001|Continuation Phase|Poor Compliance|0|||
33436879|NCT00395694|62813345|FG000|Continuation Phase|Withdrawal by Subject|0|||
33436880|NCT00395694|62813346|FG001|Continuation Phase|Withdrawal by Subject|2|||
33436881|NCT00419744|62813358|FG000|Overall Study|Adverse Event|39|||
33436882|NCT00419744|62813359|FG001|Overall Study|Adverse Event|40|||
33436883|NCT00419744|62813360|FG002|Overall Study|Adverse Event|50|||
33436884|NCT00419744|62813358|FG000|Overall Study|Withdrawal by Subject|45|||
33436885|NCT00419744|62813359|FG001|Overall Study|Withdrawal by Subject|49|||
33436886|NCT00419744|62813360|FG002|Overall Study|Withdrawal by Subject|52|||
33436887|NCT00419744|62813358|FG000|Overall Study|Lost to Follow-up|8|||
33436888|NCT00419744|62813359|FG001|Overall Study|Lost to Follow-up|10|||
33436889|NCT00419744|62813360|FG002|Overall Study|Lost to Follow-up|6|||
33436890|NCT00419744|62813358|FG000|Overall Study|Protocol Violation|4|||
33436891|NCT00419744|62813359|FG001|Overall Study|Protocol Violation|7|||
33436892|NCT00419744|62813360|FG002|Overall Study|Protocol Violation|8|||
33436893|NCT00419744|62813358|FG000|Overall Study|Randomized in error|9|||
33436894|NCT00419744|62813359|FG001|Overall Study|Randomized in error|6|||
33436895|NCT00419744|62813360|FG002|Overall Study|Randomized in error|7|||
33436896|NCT00419744|62813358|FG000|Overall Study|Moving out of state|2|||
33436897|NCT00419744|62813359|FG001|Overall Study|Moving out of state|0|||
33436898|NCT00419744|62813360|FG002|Overall Study|Moving out of state|1|||
33436899|NCT00419744|62813358|FG000|Overall Study|Physician Decision|10|||
33436900|NCT00419744|62813359|FG001|Overall Study|Physician Decision|5|||
33436901|NCT00419744|62813360|FG002|Overall Study|Physician Decision|6|||
33436902|NCT00419744|62813358|FG000|Overall Study|Spirometry mouthpiece issues|0|||
33436903|NCT00419744|62813359|FG001|Overall Study|Spirometry mouthpiece issues|1|||
33436904|NCT00419744|62813360|FG002|Overall Study|Spirometry mouthpiece issues|2|||
33436905|NCT00419744|62813358|FG000|Overall Study|Incorrect medication kit dispensed|0|||
33436906|NCT00419744|62813359|FG001|Overall Study|Incorrect medication kit dispensed|0|||
33436907|NCT00419744|62813360|FG002|Overall Study|Incorrect medication kit dispensed|1|||
33436908|NCT00395538|62813371|FG000|Overall Study|Did not re-consent to revised protocol|1|||
33436909|NCT00395538|62813372|FG001|Overall Study|Did not re-consent to revised protocol|10|||
33436910|NCT00395538|62813373|FG002|Overall Study|Did not re-consent to revised protocol|0|||
33436911|NCT00395538|62813371|FG000|Overall Study|FDA partial hold on PTH|0|||
33436912|NCT00395538|62813372|FG001|Overall Study|FDA partial hold on PTH|0|||
33436913|NCT00395538|62813373|FG002|Overall Study|FDA partial hold on PTH|11|||
33436914|NCT00395538|62813371|FG000|Overall Study|Failed screening|0|||
33436915|NCT00395538|62813372|FG001|Overall Study|Failed screening|0|||
33436916|NCT00395538|62813373|FG002|Overall Study|Failed screening|4|||
33436917|NCT00395538|62813371|FG000|Overall Study|Switch to Natpara|0|||
33436918|NCT00395538|62813372|FG001|Overall Study|Switch to Natpara|0|||
33436919|NCT00395538|62813373|FG002|Overall Study|Switch to Natpara|3|||
33436920|NCT00395538|62813371|FG000|Overall Study|Adverse Event|1|||
33436921|NCT00395538|62813372|FG001|Overall Study|Adverse Event|0|||
33436922|NCT00395538|62813373|FG002|Overall Study|Adverse Event|2|||
33436923|NCT00395538|62813371|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
33436924|NCT00395538|62813372|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
33436925|NCT00395538|62813373|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
33436926|NCT00395538|62813371|FG000|Overall Study|Non-compliance with study protocol|0|||
33436927|NCT00395538|62813372|FG001|Overall Study|Non-compliance with study protocol|1|||
33436928|NCT00395538|62813373|FG002|Overall Study|Non-compliance with study protocol|0|||
33436929|NCT00395538|62813371|FG000|Overall Study|PTH resistance|0|||
33436930|NCT00395538|62813372|FG001|Overall Study|PTH resistance|0|||
33436931|NCT00395538|62813373|FG002|Overall Study|PTH resistance|1|||
33436932|NCT00395538|62813371|FG000|Overall Study|Pregnancy|1|||
33436933|NCT00395538|62813372|FG001|Overall Study|Pregnancy|0|||
33436934|NCT00395538|62813373|FG002|Overall Study|Pregnancy|0|||
33436935|NCT00395538|62813371|FG000|Overall Study|Partial recovery of parathyroid function|0|||
33436936|NCT00395538|62813372|FG001|Overall Study|Partial recovery of parathyroid function|0|||
33436937|NCT00395538|62813373|FG002|Overall Study|Partial recovery of parathyroid function|1|||
33436938|NCT00395538|62813371|FG000|Overall Study|Participant elected to discontinue|0|||
33436939|NCT00395538|62813372|FG001|Overall Study|Participant elected to discontinue|0|||
33436940|NCT00395538|62813373|FG002|Overall Study|Participant elected to discontinue|1|||
33436941|NCT00395460|62813383|FG000|Overall Study|Withdrawal by Subject|1|||
33436942|NCT00395460|62813384|FG001|Overall Study|Withdrawal by Subject|0|||
33436943|NCT00395304|62813390|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33436944|NCT00395304|62813391|FG001|Treatment Period 1|Withdrawal by Subject|3|||
33436945|NCT00395304|62813392|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33436946|NCT00395304|62813393|FG003|Treatment Period 1|Withdrawal by Subject|2|||
33436947|NCT00395304|62813394|FG004|Treatment Period 1|Withdrawal by Subject|1|||
33436948|NCT00395304|62813395|FG005|Treatment Period 1|Withdrawal by Subject|1|||
33436949|NCT00395304|62813390|FG000|Treatment Period 1|Lost to Follow-up|1|||
33436950|NCT00395304|62813391|FG001|Treatment Period 1|Lost to Follow-up|0|||
33436951|NCT00395304|62813392|FG002|Treatment Period 1|Lost to Follow-up|0|||
33436952|NCT00395304|62813393|FG003|Treatment Period 1|Lost to Follow-up|1|||
33436953|NCT00395304|62813394|FG004|Treatment Period 1|Lost to Follow-up|0|||
33436954|NCT00395304|62813395|FG005|Treatment Period 1|Lost to Follow-up|1|||
33436955|NCT00395304|62813390|FG000|Treatment Period 1|Physician Decision|0|||
33436956|NCT00395304|62813391|FG001|Treatment Period 1|Physician Decision|1|||
33436957|NCT00395304|62813392|FG002|Treatment Period 1|Physician Decision|0|||
33436958|NCT00395304|62813393|FG003|Treatment Period 1|Physician Decision|0|||
33436959|NCT00395304|62813394|FG004|Treatment Period 1|Physician Decision|0|||
33436960|NCT00395304|62813395|FG005|Treatment Period 1|Physician Decision|0|||
33436961|NCT00395304|62813390|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33436962|NCT00395304|62813391|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33436963|NCT00395304|62813392|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33436964|NCT00395304|62813393|FG003|Treatment Period 2|Withdrawal by Subject|1|||
33436965|NCT00395304|62813394|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33436966|NCT00395304|62813395|FG005|Treatment Period 2|Withdrawal by Subject|2|||
33436967|NCT00395304|62813390|FG000|Treatment Period 2|Lost to Follow-up|0|||
33436968|NCT00395304|62813391|FG001|Treatment Period 2|Lost to Follow-up|3|||
33436969|NCT00395304|62813392|FG002|Treatment Period 2|Lost to Follow-up|0|||
33494188|NCT03634033|62872934|FG000|Overall Study|Lost to Follow-up|0|||
33494189|NCT03634033|62872935|FG001|Overall Study|Lost to Follow-up|0|||
33436970|NCT00395304|62813393|FG003|Treatment Period 2|Lost to Follow-up|0|||
33436971|NCT00395304|62813394|FG004|Treatment Period 2|Lost to Follow-up|0|||
33436972|NCT00395304|62813395|FG005|Treatment Period 2|Lost to Follow-up|0|||
33436973|NCT00395304|62813390|FG000|Treatment Period 2|Physician Decision|0|||
33436974|NCT00395304|62813391|FG001|Treatment Period 2|Physician Decision|0|||
33436975|NCT00395304|62813392|FG002|Treatment Period 2|Physician Decision|1|||
33436976|NCT00395304|62813393|FG003|Treatment Period 2|Physician Decision|0|||
33436977|NCT00395304|62813394|FG004|Treatment Period 2|Physician Decision|0|||
33436978|NCT00395304|62813395|FG005|Treatment Period 2|Physician Decision|0|||
33436979|NCT00395304|62813390|FG000|Treatment Period 2|Other|0|||
33436980|NCT00395304|62813391|FG001|Treatment Period 2|Other|1|||
33436981|NCT00395304|62813392|FG002|Treatment Period 2|Other|0|||
33436982|NCT00395304|62813393|FG003|Treatment Period 2|Other|0|||
33436983|NCT00395304|62813394|FG004|Treatment Period 2|Other|0|||
33436984|NCT00395304|62813395|FG005|Treatment Period 2|Other|0|||
33436985|NCT00395304|62813390|FG000|Treatment Period 3|Withdrawal by Subject|0|||
33436986|NCT00395304|62813391|FG001|Treatment Period 3|Withdrawal by Subject|0|||
33436987|NCT00395304|62813392|FG002|Treatment Period 3|Withdrawal by Subject|0|||
33436988|NCT00395304|62813393|FG003|Treatment Period 3|Withdrawal by Subject|1|||
33436989|NCT00395304|62813394|FG004|Treatment Period 3|Withdrawal by Subject|0|||
33436990|NCT00395304|62813395|FG005|Treatment Period 3|Withdrawal by Subject|1|||
33436991|NCT00395304|62813390|FG000|Treatment Period 3|Lost to Follow-up|1|||
33436992|NCT00395304|62813391|FG001|Treatment Period 3|Lost to Follow-up|1|||
33436993|NCT00395304|62813392|FG002|Treatment Period 3|Lost to Follow-up|0|||
33436994|NCT00395304|62813393|FG003|Treatment Period 3|Lost to Follow-up|0|||
33436995|NCT00395304|62813394|FG004|Treatment Period 3|Lost to Follow-up|0|||
33436996|NCT00395304|62813395|FG005|Treatment Period 3|Lost to Follow-up|0|||
33436997|NCT00395304|62813390|FG000|Treatment Period 3|Physician Decision|0|||
33436998|NCT00395304|62813391|FG001|Treatment Period 3|Physician Decision|1|||
33436999|NCT00395304|62813392|FG002|Treatment Period 3|Physician Decision|0|||
33437000|NCT00395304|62813393|FG003|Treatment Period 3|Physician Decision|0|||
33437001|NCT00395304|62813394|FG004|Treatment Period 3|Physician Decision|0|||
33437002|NCT00395304|62813395|FG005|Treatment Period 3|Physician Decision|0|||
33437003|NCT00395304|62813390|FG000|Treatment Period 3|Other|0|||
33323205|NCT00922480|62699470|FG000|Main Study|Lack of Efficacy|3|||
33437004|NCT00395304|62813391|FG001|Treatment Period 3|Other|0|||
33437005|NCT00395304|62813392|FG002|Treatment Period 3|Other|0|||
33323206|NCT00922480|62699471|FG001|Main Study|Lack of Efficacy|0|||
33323207|NCT00922480|62699470|FG000|Main Study|Withdrawal by Subject|20|||
33323208|NCT00922480|62699471|FG001|Main Study|Withdrawal by Subject|15|||
33437006|NCT00395304|62813393|FG003|Treatment Period 3|Other|1|||
33437007|NCT00395304|62813394|FG004|Treatment Period 3|Other|0|||
33437008|NCT00395304|62813395|FG005|Treatment Period 3|Other|0|||
33437009|NCT00395226|62813404|FG000|Overall Study|Adverse Event|4|||
33437010|NCT00395226|62813405|FG001|Overall Study|Adverse Event|3|||
33437011|NCT00395226|62813404|FG000|Overall Study|Withdrawal by Subject|0|||
33437012|NCT00395226|62813405|FG001|Overall Study|Withdrawal by Subject|1|||
33437013|NCT00395226|62813404|FG000|Overall Study|Lost to Follow-up|0|||
33437014|NCT00395226|62813405|FG001|Overall Study|Lost to Follow-up|1|||
33437015|NCT00394914|62813413|FG000|Treatment Period|Adverse Event|0|||
33437016|NCT00394914|62813414|FG001|Treatment Period|Adverse Event|3|||
33437017|NCT00394914|62813415|FG002|Treatment Period|Adverse Event|1|||
33437018|NCT00394914|62813413|FG000|Treatment Period|Lost to Follow-up|0|||
33437019|NCT00394914|62813414|FG001|Treatment Period|Lost to Follow-up|1|||
33437020|NCT00394914|62813415|FG002|Treatment Period|Lost to Follow-up|0|||
33437021|NCT00394914|62813413|FG000|Treatment Period|Withdrawal by Subject|0|||
33437022|NCT00394914|62813414|FG001|Treatment Period|Withdrawal by Subject|2|||
33437023|NCT00394914|62813415|FG002|Treatment Period|Withdrawal by Subject|2|||
33437024|NCT00394914|62813413|FG000|Treatment Period|Noncompliance with protocol|0|||
33437025|NCT00394914|62813414|FG001|Treatment Period|Noncompliance with protocol|3|||
33437026|NCT00394914|62813415|FG002|Treatment Period|Noncompliance with protocol|2|||
33437027|NCT00394914|62813413|FG000|Treatment Period|Did not meet protocol eligibility|0|||
33437028|NCT00394914|62813414|FG001|Treatment Period|Did not meet protocol eligibility|1|||
33437029|NCT00394914|62813415|FG002|Treatment Period|Did not meet protocol eligibility|1|||
33437030|NCT00366444|62813423|FG000|Overall Study|Withdrawal by Subject|1|||
33437031|NCT00366444|62813424|FG001|Overall Study|Withdrawal by Subject|1|||
33437032|NCT00366444|62813423|FG000|Overall Study|Lack of Efficacy|0|||
33437033|NCT00366444|62813424|FG001|Overall Study|Lack of Efficacy|1|||
33437034|NCT00365976|62813432|FG000|Overall Study|Withdrawal by Subject|1|||
33437035|NCT00365976|62813433|FG001|Overall Study|Withdrawal by Subject|5|||
33437036|NCT00379236|62813441|FG000|Double-blind|Adverse Event|11|||
33437037|NCT00379236|62813442|FG001|Double-blind|Adverse Event|6|||
33437038|NCT00379236|62813443|FG002|Double-blind|Adverse Event|0|||
33437039|NCT00379236|62813441|FG000|Double-blind|Protocol Violation|3|||
33437040|NCT00379236|62813442|FG001|Double-blind|Protocol Violation|3|||
33437041|NCT00379236|62813443|FG002|Double-blind|Protocol Violation|0|||
33323209|NCT00922480|62699470|FG000|Main Study|Lost to Follow-up|5|||
33323210|NCT00922480|62699471|FG001|Main Study|Lost to Follow-up|0|||
33437042|NCT00379236|62813441|FG000|Double-blind|Withdrawal by Subject|12|||
33437043|NCT00379236|62813442|FG001|Double-blind|Withdrawal by Subject|13|||
33437044|NCT00379236|62813443|FG002|Double-blind|Withdrawal by Subject|0|||
33437045|NCT00379236|62813441|FG000|Double-blind|Lost to Follow-up|4|||
33437046|NCT00379236|62813442|FG001|Double-blind|Lost to Follow-up|3|||
33437047|NCT00379236|62813443|FG002|Double-blind|Lost to Follow-up|0|||
33437048|NCT00379236|62813441|FG000|Double-blind|Use of exclusionary medication|1|||
33437049|NCT00379236|62813442|FG001|Double-blind|Use of exclusionary medication|2|||
33323211|NCT00922480|62699470|FG000|Main Study|Physician Decision|0|||
33323212|NCT00922480|62699471|FG001|Main Study|Physician Decision|1|||
33437050|NCT00379236|62813443|FG002|Double-blind|Use of exclusionary medication|0|||
33437051|NCT00379236|62813441|FG000|Double-blind|Other|3|||
33437052|NCT00379236|62813442|FG001|Double-blind|Other|7|||
33437053|NCT00379236|62813443|FG002|Double-blind|Other|0|||
33437054|NCT00379236|62813441|FG000|Double-blind|Data could not be retrieved|2|||
33437055|NCT00379236|62813442|FG001|Double-blind|Data could not be retrieved|2|||
33437056|NCT00379236|62813443|FG002|Double-blind|Data could not be retrieved|0|||
33437057|NCT00379236|62813441|FG000|Open-label Extension|Adverse Event|0|||
33437058|NCT00379236|62813442|FG001|Open-label Extension|Adverse Event|0|||
33437059|NCT00379236|62813443|FG002|Open-label Extension|Adverse Event|13|||
33437060|NCT00379236|62813441|FG000|Open-label Extension|Protocol Violation|0|||
33437061|NCT00379236|62813442|FG001|Open-label Extension|Protocol Violation|0|||
33437062|NCT00379236|62813443|FG002|Open-label Extension|Protocol Violation|7|||
33437063|NCT00379236|62813441|FG000|Open-label Extension|Withdrawal by Subject|0|||
33437064|NCT00379236|62813442|FG001|Open-label Extension|Withdrawal by Subject|0|||
33437065|NCT00379236|62813443|FG002|Open-label Extension|Withdrawal by Subject|13|||
33437066|NCT00379236|62813441|FG000|Open-label Extension|Lost to Follow-up|0|||
33437067|NCT00379236|62813442|FG001|Open-label Extension|Lost to Follow-up|0|||
33437068|NCT00379236|62813443|FG002|Open-label Extension|Lost to Follow-up|12|||
33437069|NCT00379236|62813441|FG000|Open-label Extension|Use of exclusionary medication|0|||
33437070|NCT00379236|62813442|FG001|Open-label Extension|Use of exclusionary medication|0|||
33437071|NCT00379236|62813443|FG002|Open-label Extension|Use of exclusionary medication|3|||
33437072|NCT00379236|62813441|FG000|Open-label Extension|Other|0|||
33437073|NCT00379236|62813442|FG001|Open-label Extension|Other|0|||
33437074|NCT00379236|62813443|FG002|Open-label Extension|Other|7|||
33437075|NCT00379080|62813458|FG000|Overall Study|Withdrawal by Subject|0|||
33437076|NCT00379080|62813459|FG001|Overall Study|Withdrawal by Subject|4|||
33437077|NCT00379080|62813460|FG002|Overall Study|Withdrawal by Subject|0|||
33437078|NCT00378534|62813485|FG000|Overall Study|Participants did not receive transplant|3|||
33437079|NCT00378534|62813486|FG001|Overall Study|Participants did not receive transplant|0|||
33437080|NCT00377676|62813493|FG000|Overall Study|Adverse Event|498|||
33437081|NCT00377676|62813494|FG001|Overall Study|Adverse Event|107|||
33437082|NCT00377676|62813493|FG000|Overall Study|Protocol Violation|33|||
33437083|NCT00377676|62813494|FG001|Overall Study|Protocol Violation|27|||
33437084|NCT00377676|62813493|FG000|Overall Study|Death|5|||
33437085|NCT00377676|62813494|FG001|Overall Study|Death|2|||
33437086|NCT00377676|62813493|FG000|Overall Study|Withdrawal by Subject|187|||
33437087|NCT00377676|62813494|FG001|Overall Study|Withdrawal by Subject|72|||
33437088|NCT00377676|62813493|FG000|Overall Study|Lost to Follow-up|120|||
33437089|NCT00377676|62813494|FG001|Overall Study|Lost to Follow-up|56|||
33437090|NCT00377676|62813493|FG000|Overall Study|Other|118|||
33437091|NCT00377676|62813494|FG001|Overall Study|Other|58|||
33437092|NCT00377520|62813500|FG000|Overall Study|Ineligible (Prior radiation)|1|||
33437093|NCT00377364|62813506|FG000|Overall Study|Lost to Follow-up|1|||
33437094|NCT00377364|62813507|FG001|Overall Study|Lost to Follow-up|0|||
33437095|NCT00377364|62813506|FG000|Overall Study|Withdrawal by Subject|1|||
33437096|NCT00377364|62813507|FG001|Overall Study|Withdrawal by Subject|0|||
33437097|NCT03831282|62813515|FG000|Overall Study|Could not place sensor|1|||
33437098|NCT00365508|62813521|FG000|Overall Study|Lost to Follow-up|139|||
33437099|NCT00365508|62813522|FG001|Overall Study|Lost to Follow-up|154|||
33437100|NCT00365352|62813531|FG000|Overall Study|Adverse Event|6|||
33437101|NCT00365352|62813532|FG001|Overall Study|Adverse Event|7|||
33437102|NCT00365352|62813533|FG002|Overall Study|Adverse Event|8|||
33437103|NCT00365352|62813531|FG000|Overall Study|Participant Withdrew Consent|8|||
33437104|NCT00365352|62813532|FG001|Overall Study|Participant Withdrew Consent|3|||
33437105|NCT00365352|62813533|FG002|Overall Study|Participant Withdrew Consent|4|||
33437106|NCT00365352|62813531|FG000|Overall Study|Lack of Efficacy|3|||
33437107|NCT00365352|62813532|FG001|Overall Study|Lack of Efficacy|0|||
33437108|NCT00365352|62813533|FG002|Overall Study|Lack of Efficacy|0|||
33437109|NCT00365352|62813531|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
33437110|NCT00365352|62813532|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
33437111|NCT00365352|62813533|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
33437112|NCT00365352|62813531|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
33437113|NCT00365352|62813532|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
33437114|NCT00365352|62813533|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
33437115|NCT00365352|62813531|FG000|Overall Study|Lost to Follow-up|1|||
33437116|NCT00365352|62813532|FG001|Overall Study|Lost to Follow-up|1|||
33437117|NCT00365352|62813533|FG002|Overall Study|Lost to Follow-up|0|||
33437118|NCT00365352|62813531|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
33437119|NCT00365352|62813532|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
33437120|NCT00365352|62813533|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
33437121|NCT00376506|62813546|FG000|Overall Study|Death|0|||
33437122|NCT00376506|62813547|FG001|Overall Study|Death|2|||
33437123|NCT00410384|62813559|FG000|Overall Study|Withdrawal by Subject|28|||
33437124|NCT00410384|62813560|FG001|Overall Study|Withdrawal by Subject|17|||
33437125|NCT00410384|62813561|FG002|Overall Study|Withdrawal by Subject|20|||
33437126|NCT00410384|62813559|FG000|Overall Study|Adverse Event|23|||
33437127|NCT00410384|62813560|FG001|Overall Study|Adverse Event|18|||
33437128|NCT00410384|62813561|FG002|Overall Study|Adverse Event|23|||
33437129|NCT00410384|62813559|FG000|Overall Study|Lack of Efficacy|20|||
33437130|NCT00410384|62813560|FG001|Overall Study|Lack of Efficacy|12|||
33437131|NCT00410384|62813561|FG002|Overall Study|Lack of Efficacy|17|||
33437132|NCT00410384|62813559|FG000|Overall Study|Lack of Compliance|2|||
33437133|NCT00410384|62813560|FG001|Overall Study|Lack of Compliance|2|||
33437134|NCT00410384|62813561|FG002|Overall Study|Lack of Compliance|2|||
33437135|NCT00410384|62813559|FG000|Overall Study|Lost to Follow-up|4|||
33437136|NCT00410384|62813560|FG001|Overall Study|Lost to Follow-up|6|||
33437137|NCT00410384|62813561|FG002|Overall Study|Lost to Follow-up|6|||
33437138|NCT00410384|62813559|FG000|Overall Study|Protocol Violation|6|||
33437139|NCT00410384|62813560|FG001|Overall Study|Protocol Violation|6|||
33437140|NCT00410384|62813561|FG002|Overall Study|Protocol Violation|6|||
33437141|NCT00410384|62813559|FG000|Overall Study|Physician Decision|3|||
33437142|NCT00410384|62813560|FG001|Overall Study|Physician Decision|3|||
33437143|NCT00410384|62813561|FG002|Overall Study|Physician Decision|4|||
33437144|NCT00410384|62813559|FG000|Overall Study|Other|3|||
33437145|NCT00410384|62813560|FG001|Overall Study|Other|8|||
33323213|NCT00922480|62699470|FG000|Extension Study|Protocol Violation|3|||
33437146|NCT00410384|62813561|FG002|Overall Study|Other|4|||
33437147|NCT00370032|62813571|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
33437148|NCT00370032|62813572|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
33437149|NCT00370032|62813571|FG000|Washout Period|Withdrawal by Subject|0|||
33437150|NCT00370032|62813572|FG001|Washout Period|Withdrawal by Subject|1|||
33437151|NCT00370032|62813571|FG000|Washout Period|Lost to Follow-up|0|||
33437152|NCT00370032|62813572|FG001|Washout Period|Lost to Follow-up|1|||
33437153|NCT00370032|62813571|FG000|Washout Period|Adverse Event|1|||
33437154|NCT00370032|62813572|FG001|Washout Period|Adverse Event|0|||
33437155|NCT00370032|62813571|FG000|Follow-up Period|Withdrawal by Subject|1|||
33437156|NCT00370032|62813572|FG001|Follow-up Period|Withdrawal by Subject|0|||
33437157|NCT00410072|62813589|FG000|Day 1 to Week 48|Adverse Event|1|||
33437158|NCT00410072|62813590|FG001|Day 1 to Week 48|Adverse Event|2|||
33437159|NCT00410072|62813589|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
33437160|NCT00410072|62813590|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
33437161|NCT00410072|62813589|FG000|Day 1 to Week 48|Other|0|||
33437162|NCT00410072|62813590|FG001|Day 1 to Week 48|Other|1|||
33437163|NCT00410072|62813589|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
33437164|NCT00410072|62813590|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
33437165|NCT00410072|62813589|FG000|Day 1 to Week 48|Pregnancy|0|||
33437166|NCT00410072|62813590|FG001|Day 1 to Week 48|Pregnancy|2|||
33437167|NCT00410072|62813589|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
33437168|NCT00410072|62813590|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
33437169|NCT00410072|62813589|FG000|After Week 48 to Week 96|Adverse Event|1|||
33437170|NCT00410072|62813590|FG001|After Week 48 to Week 96|Adverse Event|2|||
33323214|NCT00922480|62699471|FG001|Extension Study|Protocol Violation|0|||
33437171|NCT00410072|62813589|FG000|After Week 48 to Week 96|Death|0|||
33437172|NCT00410072|62813590|FG001|After Week 48 to Week 96|Death|1|||
33437173|NCT00410072|62813589|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
33437174|NCT00410072|62813590|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
33437175|NCT00410072|62813589|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
33437176|NCT00410072|62813590|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
33437177|NCT00410072|62813589|FG000|After Week 48 to Week 96|Other|2|||
33437178|NCT00410072|62813590|FG001|After Week 48 to Week 96|Other|0|||
33437179|NCT00410072|62813589|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
33437180|NCT00410072|62813590|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
33437181|NCT00410072|62813589|FG000|After Week 48 to Week 96|Pregnancy|0|||
33437182|NCT00410072|62813590|FG001|After Week 48 to Week 96|Pregnancy|2|||
33437183|NCT00410072|62813589|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
33437184|NCT00410072|62813590|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
33437185|NCT00409838|62813598|FG000|Short-term Period|Adverse Event|0|||
33437186|NCT00409838|62813599|FG001|Short-term Period|Adverse Event|1|||
33437187|NCT00409838|62813598|FG000|Short-term Period|Lost to Follow-up|0|||
33437188|NCT00409838|62813599|FG001|Short-term Period|Lost to Follow-up|1|||
33437189|NCT00409838|62813598|FG000|Short-term Period|Withdrawal by Subject|2|||
33437190|NCT00409838|62813599|FG001|Short-term Period|Withdrawal by Subject|3|||
33437191|NCT00409838|62813598|FG000|Short-term Period|Never Treated|1|||
33437192|NCT00409838|62813599|FG001|Short-term Period|Never Treated|0|||
33437193|NCT00409838|62813598|FG000|Long-term Extension Period|Adverse Event|10|||
33437194|NCT00409838|62813599|FG001|Long-term Extension Period|Adverse Event|0|||
33437195|NCT00409838|62813598|FG000|Long-term Extension Period|Death|1|||
33437196|NCT00409838|62813599|FG001|Long-term Extension Period|Death|0|||
33437197|NCT00409838|62813598|FG000|Long-term Extension Period|Lack of Efficacy|2|||
33437198|NCT00409838|62813599|FG001|Long-term Extension Period|Lack of Efficacy|0|||
33437199|NCT00409838|62813598|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
33437200|NCT00409838|62813599|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
33437201|NCT00409838|62813598|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
33437202|NCT00409838|62813599|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
33437203|NCT00409838|62813598|FG000|Long-term Extension Period|Pregnancy|1|||
33437204|NCT00409838|62813599|FG001|Long-term Extension Period|Pregnancy|0|||
33437205|NCT00399542|62813624|FG000|Overall Study|Adverse Event|18|||
33437206|NCT00399542|62813625|FG001|Overall Study|Adverse Event|15|||
33437207|NCT00399542|62813624|FG000|Overall Study|Protocol Violation|13|||
33437208|NCT00399542|62813625|FG001|Overall Study|Protocol Violation|3|||
33437209|NCT00399542|62813624|FG000|Overall Study|Withdrawal by Subject|28|||
33437210|NCT00399542|62813625|FG001|Overall Study|Withdrawal by Subject|10|||
33437211|NCT00399542|62813624|FG000|Overall Study|Lack of Efficacy|18|||
33437212|NCT00399542|62813625|FG001|Overall Study|Lack of Efficacy|8|||
33437213|NCT00399542|62813624|FG000|Overall Study|Lost to Follow-up|6|||
33437214|NCT00399542|62813625|FG001|Overall Study|Lost to Follow-up|6|||
33437215|NCT00399542|62813624|FG000|Overall Study|Other|1|||
33437216|NCT00399542|62813625|FG001|Overall Study|Other|0|||
33437217|NCT00399542|62813624|FG000|Overall Study|Physician Decision|0|||
33437218|NCT00399542|62813625|FG001|Overall Study|Physician Decision|1|||
33437219|NCT00409682|62813634|FG000|Open-label Induction Period|Adverse Event|1|||
33437220|NCT00409682|62813635|FG001|Open-label Induction Period|Adverse Event|0|||
33437221|NCT00409682|62813636|FG002|Open-label Induction Period|Adverse Event|0|||
33437222|NCT00409682|62813634|FG000|Open-label Induction Period|Lack of Efficacy|1|||
33437223|NCT00409682|62813635|FG001|Open-label Induction Period|Lack of Efficacy|0|||
33437224|NCT00409682|62813636|FG002|Open-label Induction Period|Lack of Efficacy|0|||
33437225|NCT00409682|62813634|FG000|Open-label Induction Period|Protocol Violation|1|||
33437226|NCT00409682|62813635|FG001|Open-label Induction Period|Protocol Violation|0|||
33437227|NCT00409682|62813636|FG002|Open-label Induction Period|Protocol Violation|0|||
33437228|NCT00409682|62813634|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
33437229|NCT00409682|62813635|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
33437230|NCT00409682|62813636|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
33437231|NCT00409682|62813634|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
33437232|NCT00409682|62813635|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
33437233|NCT00409682|62813636|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
33437234|NCT00409682|62813634|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
33437235|NCT00409682|62813635|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
33437236|NCT00409682|62813636|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
33437237|NCT00409682|62813634|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
33437238|NCT00409682|62813635|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
33437239|NCT00409682|62813636|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
33437240|NCT00409682|62813634|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
33437241|NCT00409682|62813635|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
33437242|NCT00409682|62813636|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
33437243|NCT00409682|62813634|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
33437244|NCT00409682|62813635|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
33437245|NCT00409682|62813636|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
33437246|NCT00409682|62813634|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
33437247|NCT00409682|62813635|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
33437248|NCT00409682|62813636|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
33437249|NCT00398216|62813648|FG000|Overall Study|Adverse Event|4|||
33437250|NCT00398216|62813649|FG001|Overall Study|Adverse Event|2|||
33437251|NCT00398216|62813650|FG002|Overall Study|Adverse Event|5|||
33437252|NCT00398216|62813651|FG003|Overall Study|Adverse Event|7|||
33437253|NCT00398216|62813652|FG004|Overall Study|Adverse Event|2|||
33437254|NCT00398216|62813648|FG000|Overall Study|Protocol Violation|2|||
33437255|NCT00398216|62813649|FG001|Overall Study|Protocol Violation|4|||
33437256|NCT00398216|62813650|FG002|Overall Study|Protocol Violation|5|||
33437257|NCT00398216|62813651|FG003|Overall Study|Protocol Violation|7|||
33437258|NCT00398216|62813652|FG004|Overall Study|Protocol Violation|5|||
33437259|NCT00398216|62813648|FG000|Overall Study|Lost to Follow-up|1|||
33437260|NCT00398216|62813649|FG001|Overall Study|Lost to Follow-up|6|||
33437261|NCT00398216|62813650|FG002|Overall Study|Lost to Follow-up|4|||
33437262|NCT00398216|62813651|FG003|Overall Study|Lost to Follow-up|4|||
33437263|NCT00398216|62813652|FG004|Overall Study|Lost to Follow-up|1|||
33437264|NCT00398216|62813648|FG000|Overall Study|Death|0|||
33437265|NCT00398216|62813649|FG001|Overall Study|Death|3|||
33437266|NCT00398216|62813650|FG002|Overall Study|Death|0|||
33437267|NCT00398216|62813651|FG003|Overall Study|Death|0|||
33437268|NCT00398216|62813652|FG004|Overall Study|Death|0|||
33437269|NCT00398216|62813648|FG000|Overall Study|Withdrawal by Subject|1|||
33437270|NCT00398216|62813649|FG001|Overall Study|Withdrawal by Subject|0|||
33437271|NCT00398216|62813650|FG002|Overall Study|Withdrawal by Subject|3|||
33437272|NCT00398216|62813651|FG003|Overall Study|Withdrawal by Subject|1|||
33437273|NCT00398216|62813652|FG004|Overall Study|Withdrawal by Subject|2|||
33437274|NCT00398216|62813648|FG000|Overall Study|administrative reasons|3|||
33437275|NCT00398216|62813649|FG001|Overall Study|administrative reasons|4|||
33437276|NCT00398216|62813650|FG002|Overall Study|administrative reasons|4|||
33437277|NCT00398216|62813651|FG003|Overall Study|administrative reasons|3|||
33437278|NCT00398216|62813652|FG004|Overall Study|administrative reasons|3|||
33437279|NCT00398216|62813648|FG000|Overall Study|entrance criteria|0|||
33437280|NCT00398216|62813649|FG001|Overall Study|entrance criteria|0|||
33437281|NCT00398216|62813650|FG002|Overall Study|entrance criteria|0|||
33437282|NCT00398216|62813651|FG003|Overall Study|entrance criteria|0|||
33437283|NCT00398216|62813652|FG004|Overall Study|entrance criteria|2|||
33437284|NCT00398138|62813664|FG000|Overall Study|Adverse Event|2|||
33437285|NCT00397982|62813668|FG000|Overall Study|Withdrawal by Subject|1|||
33437286|NCT00397982|62813668|FG000|Overall Study|Adverse Event|1|||
33437287|NCT00397982|62813668|FG000|Overall Study|noncompliance|1|||
33437288|NCT00397982|62813668|FG000|Overall Study|Unrelated health issues|1|||
33437289|NCT00408902|62813673|FG000|Overall Study|Lack of Efficacy|7|||
33437290|NCT00408902|62813673|FG000|Overall Study|Adverse Event|3|||
33437291|NCT00397514|62813678|FG000|Overall Study|Withdrawal by Subject|1|||
33437292|NCT00397514|62813678|FG000|Overall Study|Pacing wire malfunction|1|||
33437293|NCT00397514|62813678|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
33437294|NCT00397514|62813678|FG000|Overall Study|early extubation|2|||
33437295|NCT00397514|62813678|FG000|Overall Study|poor echocardiographic windows|1|||
33437296|NCT00397046|62813692|FG000|Overall Study|Disease Progression|3|||
33437297|NCT00397046|62813693|FG001|Overall Study|Disease Progression|3|||
33437298|NCT00397046|62813694|FG002|Overall Study|Disease Progression|10|||
33437299|NCT00397046|62813695|FG003|Overall Study|Disease Progression|5|||
33437300|NCT00396812|62813706|FG000|Overall Study|Physician Decision|1|||
33437301|NCT00396656|62813710|FG000|First Treatment Period|Withdrawal by Subject|0|||
33437302|NCT00396656|62813711|FG001|First Treatment Period|Withdrawal by Subject|2|||
33437303|NCT00396656|62813710|FG000|Second Treatment Period|Adverse Event|0|||
33437304|NCT00396656|62813711|FG001|Second Treatment Period|Adverse Event|1|||
33437305|NCT00408434|62813724|FG000|Overall Study|Adverse Event|0|||
33437306|NCT00408434|62813725|FG001|Overall Study|Adverse Event|0|||
33437307|NCT00408434|62813726|FG002|Overall Study|Adverse Event|1|||
33437308|NCT00408434|62813727|FG003|Overall Study|Adverse Event|0|||
33437309|NCT00408434|62813728|FG004|Overall Study|Adverse Event|0|||
33437310|NCT00408434|62813729|FG005|Overall Study|Adverse Event|0|||
33437311|NCT00408434|62813730|FG006|Overall Study|Adverse Event|0|||
33437312|NCT00408434|62813724|FG000|Overall Study|Progressive disease|6|||
33437313|NCT00408434|62813725|FG001|Overall Study|Progressive disease|3|||
33437314|NCT00408434|62813726|FG002|Overall Study|Progressive disease|4|||
33437315|NCT00408434|62813727|FG003|Overall Study|Progressive disease|3|||
33437316|NCT00408434|62813728|FG004|Overall Study|Progressive disease|3|||
33437317|NCT00408434|62813729|FG005|Overall Study|Progressive disease|1|||
33437318|NCT00408434|62813730|FG006|Overall Study|Progressive disease|4|||
33437319|NCT00408434|62813724|FG000|Overall Study|Other|0|||
33437320|NCT00408434|62813725|FG001|Overall Study|Other|0|||
33437321|NCT00408434|62813726|FG002|Overall Study|Other|1|||
33437322|NCT00408434|62813727|FG003|Overall Study|Other|0|||
33437323|NCT00408434|62813728|FG004|Overall Study|Other|2|||
33437324|NCT00408434|62813729|FG005|Overall Study|Other|1|||
33437325|NCT00408434|62813730|FG006|Overall Study|Other|0|||
33437326|NCT00408434|62813724|FG000|Overall Study|Terminated by Investigator|0|||
33437327|NCT00408434|62813725|FG001|Overall Study|Terminated by Investigator|0|||
33437328|NCT00408434|62813726|FG002|Overall Study|Terminated by Investigator|0|||
33437329|NCT00408434|62813727|FG003|Overall Study|Terminated by Investigator|0|||
33437330|NCT00408434|62813728|FG004|Overall Study|Terminated by Investigator|1|||
33437331|NCT00408434|62813729|FG005|Overall Study|Terminated by Investigator|1|||
33437332|NCT00408434|62813730|FG006|Overall Study|Terminated by Investigator|0|||
33605514|NCT01607476|63005212|FG000|Overall Study|Withdrawal by Subject|1|||
33605515|NCT01607476|63005213|FG001|Overall Study|Withdrawal by Subject|0|||
33605516|NCT01607476|63005214|FG002|Overall Study|Withdrawal by Subject|1|||
33605517|NCT01607476|63005212|FG000|Overall Study|Lost to Follow-up|0|||
33605518|NCT01607476|63005213|FG001|Overall Study|Lost to Follow-up|0|||
33605519|NCT01607476|63005214|FG002|Overall Study|Lost to Follow-up|2|||
33605520|NCT01765192|63005224|FG000|Treatment Period 1|Adverse Event|0|||
33605521|NCT01765192|63005225|FG001|Treatment Period 1|Adverse Event|1|||
33605522|NCT01765192|63005224|FG000|Washout Period|Voluntary Withdrawal|1|||
33605523|NCT01765192|63005225|FG001|Washout Period|Voluntary Withdrawal|1|||
33605524|NCT01765192|63005224|FG000|Washout Period|Reason not specified|1|||
33605525|NCT01765192|63005225|FG001|Washout Period|Reason not specified|0|||
33437345|NCT00418184|62813758|FG000|Double-blind Phase|Withdrawal by Subject|22|||
33437346|NCT00418184|62813759|FG001|Double-blind Phase|Withdrawal by Subject|9|||
33437347|NCT00418184|62813758|FG000|Double-blind Phase|Adverse Event|2|||
33437348|NCT00418184|62813759|FG001|Double-blind Phase|Adverse Event|1|||
33437349|NCT00418184|62813758|FG000|Double-blind Phase|Poor compliance|3|||
33437350|NCT00418184|62813759|FG001|Double-blind Phase|Poor compliance|1|||
33437351|NCT00407030|62813768|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
33437352|NCT00407030|62813769|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
33437353|NCT00407030|62813770|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
33437354|NCT00407030|62813768|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
33437355|NCT00407030|62813769|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
33437356|NCT00407030|62813770|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
33437357|NCT00407030|62813768|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
33437358|NCT00407030|62813769|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
33437359|NCT00407030|62813770|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
33437360|NCT00407030|62813768|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
33437361|NCT00407030|62813769|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
33437362|NCT00407030|62813770|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
33437363|NCT00407030|62813768|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
33437364|NCT00407030|62813769|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
33437365|NCT00407030|62813770|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
33437366|NCT00407030|62813768|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
33437367|NCT00407030|62813769|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
33437368|NCT00407030|62813770|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
33437369|NCT00407030|62813768|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
33494190|NCT03634033|62872936|FG002|Overall Study|Lost to Follow-up|0|||
33437370|NCT00407030|62813769|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
33437371|NCT00407030|62813770|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
33437372|NCT00407030|62813768|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
33437373|NCT00407030|62813769|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
33437374|NCT00407030|62813770|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
33437375|NCT00407030|62813768|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
33437376|NCT00407030|62813769|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
33437377|NCT00407030|62813770|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
33437378|NCT00407030|62813768|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
33605526|NCT01765192|63005224|FG000|Treatment Period 2|Reason not specified|0|||
33437379|NCT00407030|62813769|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
33437380|NCT00407030|62813770|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
33437381|NCT00407030|62813768|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
33437382|NCT00407030|62813769|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
33437383|NCT00407030|62813770|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
33437384|NCT00407030|62813768|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
33437385|NCT00407030|62813769|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
33437386|NCT00407030|62813770|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
33437387|NCT00407030|62813768|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
33437388|NCT00407030|62813769|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
33437389|NCT00407030|62813770|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
33437390|NCT00406718|62813783|FG000|Overall Study|Withdrawal by Subject|2|||
33437391|NCT00406718|62813784|FG001|Overall Study|Withdrawal by Subject|9|||
33437392|NCT00406718|62813785|FG002|Overall Study|Withdrawal by Subject|4|||
33437393|NCT00406718|62813783|FG000|Overall Study|Lost to Follow-up|2|||
33437394|NCT00406718|62813784|FG001|Overall Study|Lost to Follow-up|5|||
33437395|NCT00406718|62813785|FG002|Overall Study|Lost to Follow-up|4|||
33437396|NCT00406640|62813797|FG000|Acute Phase|Adverse Event|18|||
33437397|NCT00406640|62813798|FG001|Acute Phase|Adverse Event|13|||
33437398|NCT00406640|62813797|FG000|Acute Phase|Failed to Return|5|||
33437399|NCT00406640|62813798|FG001|Acute Phase|Failed to Return|1|||
33437400|NCT00406640|62813797|FG000|Acute Phase|Physician Decision|0|||
33437401|NCT00406640|62813798|FG001|Acute Phase|Physician Decision|1|||
33437402|NCT00406640|62813797|FG000|Acute Phase|Lost to Follow-up|7|||
33437403|NCT00406640|62813798|FG001|Acute Phase|Lost to Follow-up|4|||
33437404|NCT00406640|62813797|FG000|Acute Phase|Protocol deviation|4|||
33437405|NCT00406640|62813798|FG001|Acute Phase|Protocol deviation|10|||
33437406|NCT00406640|62813797|FG000|Acute Phase|Protocol Violation|3|||
33437407|NCT00406640|62813798|FG001|Acute Phase|Protocol Violation|2|||
33437408|NCT00406640|62813797|FG000|Acute Phase|Withdrawal by Subject|11|||
33437409|NCT00406640|62813798|FG001|Acute Phase|Withdrawal by Subject|9|||
33437410|NCT00406640|62813797|FG000|Acute Phase|Lack of Efficacy|3|||
33437411|NCT00406640|62813798|FG001|Acute Phase|Lack of Efficacy|3|||
33437412|NCT00406640|62813797|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
33437413|NCT00406640|62813798|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
33437414|NCT00406640|62813797|FG000|DB Continuation Phase for Responders|Death|1|||
33437415|NCT00406640|62813798|FG001|DB Continuation Phase for Responders|Death|0|||
33437416|NCT00406640|62813797|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
33437417|NCT00406640|62813798|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
33437418|NCT00406640|62813797|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
33437419|NCT00406640|62813798|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
33437420|NCT00406640|62813797|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
33437421|NCT00406640|62813798|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
33437422|NCT00406640|62813797|FG000|DB Continuation Phase for Responders|non-compliance|7|||
33437423|NCT00406640|62813798|FG001|DB Continuation Phase for Responders|non-compliance|5|||
33437424|NCT00406640|62813797|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
33437425|NCT00406640|62813798|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
33437426|NCT00406640|62813797|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
33323215|NCT00922480|62699470|FG000|Extension Study|Adverse Event|1|||
33437427|NCT00406640|62813798|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
33437428|NCT00406640|62813797|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
33437429|NCT00406640|62813798|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
33437430|NCT00406640|62813797|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
33437431|NCT00406640|62813798|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
33437432|NCT00406640|62813797|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
33437433|NCT00406640|62813798|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
33437434|NCT00406640|62813797|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
33437435|NCT00406640|62813798|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
33437436|NCT00406640|62813797|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
33323216|NCT00922480|62699471|FG001|Extension Study|Adverse Event|1|||
33437437|NCT00406640|62813798|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
33437438|NCT00406640|62813797|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
33437439|NCT00406640|62813798|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
33437440|NCT00406640|62813797|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
33437441|NCT00406640|62813798|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
33437442|NCT00406640|62813797|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
33437443|NCT00406640|62813798|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
33437444|NCT00394706|62813818|FG000|Overall Study|Withdrawal by Subject|2|||
33437445|NCT00394706|62813819|FG001|Overall Study|Withdrawal by Subject|0|||
33437446|NCT00394706|62813820|FG002|Overall Study|Withdrawal by Subject|1|||
33437447|NCT00394706|62813821|FG003|Overall Study|Withdrawal by Subject|0|||
33437448|NCT00394706|62813822|FG004|Overall Study|Withdrawal by Subject|0|||
33437449|NCT00394706|62813823|FG005|Overall Study|Withdrawal by Subject|2|||
33437450|NCT00394706|62813824|FG006|Overall Study|Withdrawal by Subject|1|||
33437451|NCT00394706|62813825|FG007|Overall Study|Withdrawal by Subject|0|||
33437452|NCT00394706|62813818|FG000|Overall Study|Lost to Follow-up|2|||
33437453|NCT00394706|62813819|FG001|Overall Study|Lost to Follow-up|2|||
33437454|NCT00394706|62813820|FG002|Overall Study|Lost to Follow-up|8|||
33437455|NCT00394706|62813821|FG003|Overall Study|Lost to Follow-up|1|||
33437456|NCT00394706|62813822|FG004|Overall Study|Lost to Follow-up|2|||
33437457|NCT00394706|62813823|FG005|Overall Study|Lost to Follow-up|5|||
33437458|NCT00394706|62813824|FG006|Overall Study|Lost to Follow-up|2|||
33437459|NCT00394706|62813825|FG007|Overall Study|Lost to Follow-up|0|||
33437460|NCT00394472|62813841|FG000|Overall Study|Protocol Violation|1|||
33437461|NCT00394472|62813842|FG001|Overall Study|Protocol Violation|3|||
33437462|NCT00394472|62813841|FG000|Overall Study|incorrect enrolment|4|||
33437463|NCT00394472|62813842|FG001|Overall Study|incorrect enrolment|2|||
33437464|NCT00394472|62813841|FG000|Overall Study|Adverse Event|4|||
33437465|NCT00394472|62813842|FG001|Overall Study|Adverse Event|2|||
33437466|NCT00394472|62813841|FG000|Overall Study|Withdrawal by Subject|0|||
33437467|NCT00394472|62813842|FG001|Overall Study|Withdrawal by Subject|2|||
33437468|NCT00394472|62813841|FG000|Overall Study|Physician Decision|0|||
33437469|NCT00394472|62813842|FG001|Overall Study|Physician Decision|1|||
33437470|NCT00394472|62813841|FG000|Overall Study|Lost to Follow-up|0|||
33437471|NCT00394472|62813842|FG001|Overall Study|Lost to Follow-up|1|||
33437472|NCT00419120|62813848|FG000|Long Term Follow up Period|study ongoing|10|||
33437473|NCT00395642|62813852|FG000|Overall Study|Death|4|||
33437474|NCT00395642|62813852|FG000|Overall Study|Lost to Follow-up|1|||
33437475|NCT00395642|62813852|FG000|Overall Study|Physician Decision|7|||
33437476|NCT00395642|62813852|FG000|Overall Study|Withdrawal by Subject|1|||
33437477|NCT00395486|62813858|FG000|Overall Study|Adverse Event|1|||
33437478|NCT00395486|62813859|FG001|Overall Study|Adverse Event|2|||
33437479|NCT00395486|62813858|FG000|Overall Study|Withdrawal by Subject|5|||
33437480|NCT00395486|62813859|FG001|Overall Study|Withdrawal by Subject|2|||
33437481|NCT00395486|62813858|FG000|Overall Study|Lost to Follow-up|0|||
33437482|NCT00395486|62813859|FG001|Overall Study|Lost to Follow-up|1|||
33437483|NCT00395018|62813865|FG000|On-Treatment|Death|4|||
33437484|NCT00395018|62813865|FG000|On-Treatment|Other Reason|2|||
33437485|NCT00395018|62813865|FG000|On-Treatment|Poor/non-compliance|2|||
33437486|NCT00395018|62813865|FG000|On-Treatment|Subject no longer meets study criteria|2|||
33437487|NCT00395018|62813865|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
33437488|NCT00395018|62813865|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
33437489|NCT00395018|62813865|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
33437490|NCT00375518|62813871|FG000|Overall Study|Withdrawal by Subject|2|||
33437491|NCT00375518|62813872|FG001|Overall Study|Withdrawal by Subject|10|||
33437492|NCT00375518|62813871|FG000|Overall Study|Patient Not Treated|6|||
33437493|NCT00375518|62813872|FG001|Overall Study|Patient Not Treated|6|||
33437494|NCT00375518|62813871|FG000|Overall Study|Death|0|||
33437495|NCT00375518|62813872|FG001|Overall Study|Death|1|||
33437496|NCT00256750|62813881|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
33437497|NCT00256750|62813882|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
33437498|NCT00256750|62813883|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
33437499|NCT00256750|62813881|FG000|Transplanted Pre-Treatment|Other|2|||
33437500|NCT00256750|62813882|FG001|Transplanted Pre-Treatment|Other|0|||
33437501|NCT00256750|62813883|FG002|Transplanted Pre-Treatment|Other|0|||
33437502|NCT00256750|62813881|FG000|Transplanted Pre-Treatment|Death|1|||
33437503|NCT00256750|62813882|FG001|Transplanted Pre-Treatment|Death|0|||
33437504|NCT00256750|62813883|FG002|Transplanted Pre-Treatment|Death|0|||
33437505|NCT00256750|62813881|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
33437506|NCT00256750|62813882|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
33437507|NCT00256750|62813883|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
33437508|NCT00256750|62813881|FG000|Post-Transplant Treated (12 Months)|Death|3|||
33437509|NCT00256750|62813882|FG001|Post-Transplant Treated (12 Months)|Death|2|||
33437510|NCT00256750|62813883|FG002|Post-Transplant Treated (12 Months)|Death|4|||
33437511|NCT00256750|62813881|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
33437512|NCT00256750|62813882|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
33437513|NCT00256750|62813883|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
33437514|NCT00256750|62813881|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
33437515|NCT00256750|62813882|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
33437516|NCT00256750|62813883|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
33437517|NCT00256750|62813881|FG000|Post-Transplant Treated (12 Months)|Other|5|||
33437518|NCT00256750|62813882|FG001|Post-Transplant Treated (12 Months)|Other|4|||
33437519|NCT00256750|62813883|FG002|Post-Transplant Treated (12 Months)|Other|2|||
33437520|NCT00256750|62813881|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
33437521|NCT00256750|62813882|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
33437522|NCT00256750|62813883|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
33437523|NCT00256750|62813881|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
33437524|NCT00256750|62813882|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
33437525|NCT00256750|62813883|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
33437526|NCT00256750|62813881|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
33437527|NCT00256750|62813882|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
33437528|NCT00256750|62813883|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
33437529|NCT00256750|62813881|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
33437530|NCT00256750|62813882|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
33437531|NCT00256750|62813883|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
33437532|NCT00256750|62813881|FG000|Post-Transplant Treated (24 Months)|Death|3|||
33437533|NCT00256750|62813882|FG001|Post-Transplant Treated (24 Months)|Death|0|||
33437534|NCT00256750|62813883|FG002|Post-Transplant Treated (24 Months)|Death|0|||
33437535|NCT00256750|62813881|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
33437536|NCT00256750|62813882|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
33437537|NCT00256750|62813883|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
33437538|NCT00256750|62813881|FG000|Post-Transplant Treated (24 Months)|Other|2|||
33437539|NCT00256750|62813882|FG001|Post-Transplant Treated (24 Months)|Other|0|||
33437540|NCT00256750|62813883|FG002|Post-Transplant Treated (24 Months)|Other|1|||
33437541|NCT00256750|62813881|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
33437542|NCT00256750|62813882|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
33437543|NCT00256750|62813883|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
33437544|NCT00256750|62813881|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
33437545|NCT00256750|62813882|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
33437546|NCT00256750|62813883|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
33437547|NCT00256750|62813881|FG000|Post-Transplant Treated (36 Months)|Death|0|||
33437548|NCT00256750|62813882|FG001|Post-Transplant Treated (36 Months)|Death|2|||
33437549|NCT00256750|62813883|FG002|Post-Transplant Treated (36 Months)|Death|1|||
33437550|NCT00256750|62813881|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
33437551|NCT00256750|62813882|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
33437552|NCT00256750|62813883|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
33437553|NCT00256750|62813881|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
33437554|NCT00256750|62813882|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
33437555|NCT00256750|62813883|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
33437556|NCT00256750|62813881|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
33437557|NCT00256750|62813882|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
33437558|NCT00256750|62813883|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
33437559|NCT00256750|62813881|FG000|Post-Transplant Treated (36 Months)|Other|0|||
33437560|NCT00256750|62813882|FG001|Post-Transplant Treated (36 Months)|Other|1|||
33437561|NCT00256750|62813883|FG002|Post-Transplant Treated (36 Months)|Other|1|||
33437562|NCT00256750|62813881|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
33437563|NCT00256750|62813882|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
33437564|NCT00256750|62813883|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
33437565|NCT00256750|62813881|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
33437566|NCT00256750|62813882|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
33437567|NCT00256750|62813883|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
33437568|NCT00256750|62813881|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
33437569|NCT00256750|62813882|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
33437570|NCT00256750|62813883|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
33437571|NCT00256750|62813881|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
33437572|NCT00256750|62813882|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
33437573|NCT00256750|62813883|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
33437574|NCT00256750|62813881|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
33437575|NCT00256750|62813882|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
33437576|NCT00256750|62813883|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
33437577|NCT00256750|62813881|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
33437578|NCT00256750|62813882|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
33437579|NCT00256750|62813883|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
33437580|NCT00256750|62813881|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
33437581|NCT00256750|62813882|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
33437582|NCT00256750|62813883|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
33437583|NCT00256750|62813881|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
33437584|NCT00256750|62813882|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
33437585|NCT00256750|62813883|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
33437586|NCT00256750|62813881|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
33437587|NCT00256750|62813882|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
33437588|NCT00256750|62813883|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
33437589|NCT00279201|62813894|FG000|Initiation|Death|1|||
33437590|NCT00279201|62813895|FG001|Initiation|Death|5|||
33437591|NCT00279201|62813896|FG002|Initiation|Death|0|||
33437592|NCT00279201|62813897|FG003|Initiation|Death|0|||
33437593|NCT00279201|62813898|FG004|Initiation|Death|0|||
33437594|NCT00279201|62813899|FG005|Initiation|Death|0|||
33437595|NCT00279201|62813894|FG000|Initiation|Adverse Event|6|||
33437596|NCT00279201|62813895|FG001|Initiation|Adverse Event|15|||
33437597|NCT00279201|62813896|FG002|Initiation|Adverse Event|0|||
33437598|NCT00279201|62813897|FG003|Initiation|Adverse Event|0|||
33437599|NCT00279201|62813898|FG004|Initiation|Adverse Event|0|||
33437600|NCT00279201|62813899|FG005|Initiation|Adverse Event|0|||
33437601|NCT00279201|62813894|FG000|Initiation|Lost to Follow-up|42|||
33437602|NCT00279201|62813895|FG001|Initiation|Lost to Follow-up|41|||
33437603|NCT00279201|62813896|FG002|Initiation|Lost to Follow-up|0|||
33437604|NCT00279201|62813897|FG003|Initiation|Lost to Follow-up|0|||
33437605|NCT00279201|62813898|FG004|Initiation|Lost to Follow-up|0|||
33437606|NCT00279201|62813899|FG005|Initiation|Lost to Follow-up|0|||
33437607|NCT00279201|62813894|FG000|Initiation|Entry Criteria Exclusion|7|||
33437608|NCT00279201|62813895|FG001|Initiation|Entry Criteria Exclusion|9|||
33437609|NCT00279201|62813896|FG002|Initiation|Entry Criteria Exclusion|0|||
33437610|NCT00279201|62813897|FG003|Initiation|Entry Criteria Exclusion|0|||
33437611|NCT00279201|62813898|FG004|Initiation|Entry Criteria Exclusion|0|||
33437612|NCT00279201|62813899|FG005|Initiation|Entry Criteria Exclusion|0|||
33437613|NCT00279201|62813894|FG000|Initiation|Protocol Violation|9|||
33437614|NCT00279201|62813895|FG001|Initiation|Protocol Violation|10|||
33437615|NCT00279201|62813896|FG002|Initiation|Protocol Violation|0|||
33437616|NCT00279201|62813897|FG003|Initiation|Protocol Violation|0|||
33437617|NCT00279201|62813898|FG004|Initiation|Protocol Violation|0|||
33437618|NCT00279201|62813899|FG005|Initiation|Protocol Violation|0|||
33437619|NCT00279201|62813894|FG000|Initiation|Withdrawal by Subject|35|||
33437620|NCT00279201|62813895|FG001|Initiation|Withdrawal by Subject|41|||
33437621|NCT00279201|62813896|FG002|Initiation|Withdrawal by Subject|0|||
33437622|NCT00279201|62813897|FG003|Initiation|Withdrawal by Subject|0|||
33437623|NCT00279201|62813898|FG004|Initiation|Withdrawal by Subject|0|||
33437624|NCT00279201|62813899|FG005|Initiation|Withdrawal by Subject|0|||
33437625|NCT00279201|62813894|FG000|Initiation|Physician Decision|15|||
33437626|NCT00279201|62813895|FG001|Initiation|Physician Decision|18|||
33437627|NCT00279201|62813896|FG002|Initiation|Physician Decision|0|||
33437628|NCT00279201|62813897|FG003|Initiation|Physician Decision|0|||
33437629|NCT00279201|62813898|FG004|Initiation|Physician Decision|0|||
33437630|NCT00279201|62813899|FG005|Initiation|Physician Decision|0|||
33437631|NCT00279201|62813894|FG000|Initiation|Sponsor Decision|13|||
33437632|NCT00279201|62813895|FG001|Initiation|Sponsor Decision|5|||
33437633|NCT00279201|62813896|FG002|Initiation|Sponsor Decision|0|||
33437634|NCT00279201|62813897|FG003|Initiation|Sponsor Decision|0|||
33437635|NCT00279201|62813898|FG004|Initiation|Sponsor Decision|0|||
33437636|NCT00279201|62813899|FG005|Initiation|Sponsor Decision|0|||
33437637|NCT00279201|62813894|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
33437638|NCT00279201|62813895|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
33437639|NCT00279201|62813896|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
33437640|NCT00279201|62813897|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
33437641|NCT00279201|62813898|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
33437642|NCT00279201|62813899|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
33437643|NCT00279201|62813894|FG000|Maintenance|Lack of Efficacy|32|||
33437644|NCT00279201|62813895|FG001|Maintenance|Lack of Efficacy|30|||
33437645|NCT00279201|62813896|FG002|Maintenance|Lack of Efficacy|0|||
33437646|NCT00279201|62813897|FG003|Maintenance|Lack of Efficacy|0|||
33437647|NCT00279201|62813898|FG004|Maintenance|Lack of Efficacy|0|||
33437648|NCT00279201|62813899|FG005|Maintenance|Lack of Efficacy|0|||
33437649|NCT00279201|62813894|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
33437650|NCT00279201|62813895|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
33437651|NCT00279201|62813896|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
33437652|NCT00279201|62813897|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
33437653|NCT00279201|62813898|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
33437654|NCT00279201|62813899|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
33437655|NCT00279201|62813894|FG000|Maintenance|Adverse Event|4|||
33437656|NCT00279201|62813895|FG001|Maintenance|Adverse Event|4|||
33437657|NCT00279201|62813896|FG002|Maintenance|Adverse Event|0|||
33437658|NCT00279201|62813897|FG003|Maintenance|Adverse Event|0|||
33437659|NCT00279201|62813898|FG004|Maintenance|Adverse Event|0|||
33437660|NCT00279201|62813899|FG005|Maintenance|Adverse Event|0|||
33437661|NCT00279201|62813894|FG000|Maintenance|Death|4|||
33437662|NCT00279201|62813895|FG001|Maintenance|Death|4|||
33437663|NCT00279201|62813896|FG002|Maintenance|Death|0|||
33437664|NCT00279201|62813897|FG003|Maintenance|Death|0|||
33605527|NCT01765192|63005225|FG001|Treatment Period 2|Reason not specified|2|||
33605528|NCT01765192|63005224|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
33605529|NCT01765192|63005225|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
33605530|NCT01733680|63005233|FG000|Overall Study|Withdrawal by Subject|0|||
33605531|NCT01733680|63005234|FG001|Overall Study|Withdrawal by Subject|1|||
33605532|NCT02336165|63005249|FG000|Overall Study|Death|3|||
33605533|NCT02336165|63005250|FG001|Overall Study|Death|0|||
33605534|NCT02336165|63005251|FG002|Overall Study|Death|0|||
33605535|NCT02336165|63005252|FG003|Overall Study|Death|0|||
33605536|NCT02336165|63005253|FG004|Overall Study|Death|1|||
33605537|NCT02336165|63005249|FG000|Overall Study|Physician Decision|2|||
33605538|NCT02336165|63005250|FG001|Overall Study|Physician Decision|2|||
33605539|NCT02336165|63005251|FG002|Overall Study|Physician Decision|1|||
33605540|NCT02336165|63005252|FG003|Overall Study|Physician Decision|1|||
33605541|NCT02336165|63005253|FG004|Overall Study|Physician Decision|0|||
33605542|NCT02336165|63005249|FG000|Overall Study|Withdrawal by Subject|0|||
33605543|NCT02336165|63005250|FG001|Overall Study|Withdrawal by Subject|0|||
33437665|NCT00279201|62813898|FG004|Maintenance|Death|0|||
33437666|NCT00279201|62813899|FG005|Maintenance|Death|0|||
33437667|NCT00279201|62813894|FG000|Maintenance|Lost to Follow-up|17|||
33437668|NCT00279201|62813895|FG001|Maintenance|Lost to Follow-up|13|||
33437669|NCT00279201|62813896|FG002|Maintenance|Lost to Follow-up|0|||
33437670|NCT00279201|62813897|FG003|Maintenance|Lost to Follow-up|0|||
33437671|NCT00279201|62813898|FG004|Maintenance|Lost to Follow-up|0|||
33437672|NCT00279201|62813899|FG005|Maintenance|Lost to Follow-up|0|||
33437673|NCT00279201|62813894|FG000|Maintenance|Entry Criteria Exclusion|1|||
33437674|NCT00279201|62813895|FG001|Maintenance|Entry Criteria Exclusion|4|||
33437675|NCT00279201|62813896|FG002|Maintenance|Entry Criteria Exclusion|0|||
33437676|NCT00279201|62813897|FG003|Maintenance|Entry Criteria Exclusion|0|||
33437677|NCT00279201|62813898|FG004|Maintenance|Entry Criteria Exclusion|0|||
33437678|NCT00279201|62813899|FG005|Maintenance|Entry Criteria Exclusion|0|||
33437679|NCT00279201|62813894|FG000|Maintenance|Protocol Violation|16|||
33437680|NCT00279201|62813895|FG001|Maintenance|Protocol Violation|24|||
33437681|NCT00279201|62813896|FG002|Maintenance|Protocol Violation|0|||
33437682|NCT00279201|62813897|FG003|Maintenance|Protocol Violation|0|||
33437683|NCT00279201|62813898|FG004|Maintenance|Protocol Violation|0|||
33437684|NCT00279201|62813899|FG005|Maintenance|Protocol Violation|0|||
33437685|NCT00279201|62813894|FG000|Maintenance|Withdrawal by Subject|18|||
33437686|NCT00279201|62813895|FG001|Maintenance|Withdrawal by Subject|18|||
33437687|NCT00279201|62813896|FG002|Maintenance|Withdrawal by Subject|0|||
33437688|NCT00279201|62813897|FG003|Maintenance|Withdrawal by Subject|0|||
33437689|NCT00279201|62813898|FG004|Maintenance|Withdrawal by Subject|0|||
33437690|NCT00279201|62813899|FG005|Maintenance|Withdrawal by Subject|0|||
33437691|NCT00279201|62813894|FG000|Maintenance|Physician Decision|9|||
33437692|NCT00279201|62813895|FG001|Maintenance|Physician Decision|9|||
33437693|NCT00279201|62813896|FG002|Maintenance|Physician Decision|0|||
33437694|NCT00279201|62813897|FG003|Maintenance|Physician Decision|0|||
33437695|NCT00279201|62813898|FG004|Maintenance|Physician Decision|0|||
33437696|NCT00279201|62813899|FG005|Maintenance|Physician Decision|0|||
33437697|NCT00279201|62813894|FG000|Maintenance|Sponsor Decision|4|||
33437698|NCT00279201|62813895|FG001|Maintenance|Sponsor Decision|0|||
33437699|NCT00279201|62813896|FG002|Maintenance|Sponsor Decision|0|||
33437700|NCT00279201|62813897|FG003|Maintenance|Sponsor Decision|0|||
33437701|NCT00279201|62813898|FG004|Maintenance|Sponsor Decision|0|||
33437702|NCT00279201|62813899|FG005|Maintenance|Sponsor Decision|0|||
33437703|NCT00279201|62813894|FG000|Maintenance|HbA1c>7.5%|123|||
33437704|NCT00279201|62813895|FG001|Maintenance|HbA1c>7.5%|126|||
33437705|NCT00279201|62813896|FG002|Maintenance|HbA1c>7.5%|0|||
33437706|NCT00279201|62813897|FG003|Maintenance|HbA1c>7.5%|0|||
33437707|NCT00279201|62813898|FG004|Maintenance|HbA1c>7.5%|0|||
33437708|NCT00279201|62813899|FG005|Maintenance|HbA1c>7.5%|0|||
33437709|NCT00279201|62813894|FG000|Intensification Addendum|Withdrawal by Subject|0|||
33437710|NCT00279201|62813895|FG001|Intensification Addendum|Withdrawal by Subject|0|||
33437711|NCT00279201|62813896|FG002|Intensification Addendum|Withdrawal by Subject|12|||
33437712|NCT00279201|62813897|FG003|Intensification Addendum|Withdrawal by Subject|14|||
33437713|NCT00279201|62813898|FG004|Intensification Addendum|Withdrawal by Subject|9|||
33437714|NCT00279201|62813899|FG005|Intensification Addendum|Withdrawal by Subject|18|||
33437715|NCT00279201|62813894|FG000|Intensification Addendum|Lost to Follow-up|0|||
33437716|NCT00279201|62813895|FG001|Intensification Addendum|Lost to Follow-up|0|||
33437717|NCT00279201|62813896|FG002|Intensification Addendum|Lost to Follow-up|4|||
33437718|NCT00279201|62813897|FG003|Intensification Addendum|Lost to Follow-up|6|||
33437719|NCT00279201|62813898|FG004|Intensification Addendum|Lost to Follow-up|7|||
33437720|NCT00279201|62813899|FG005|Intensification Addendum|Lost to Follow-up|7|||
33437721|NCT00279201|62813894|FG000|Intensification Addendum|Protocol Violation|0|||
33437722|NCT00279201|62813895|FG001|Intensification Addendum|Protocol Violation|0|||
33437723|NCT00279201|62813896|FG002|Intensification Addendum|Protocol Violation|2|||
33437724|NCT00279201|62813897|FG003|Intensification Addendum|Protocol Violation|2|||
33437725|NCT00279201|62813898|FG004|Intensification Addendum|Protocol Violation|6|||
33437726|NCT00279201|62813899|FG005|Intensification Addendum|Protocol Violation|6|||
33437727|NCT00279201|62813894|FG000|Intensification Addendum|Adverse Event|0|||
33437728|NCT00279201|62813895|FG001|Intensification Addendum|Adverse Event|0|||
33437729|NCT00279201|62813896|FG002|Intensification Addendum|Adverse Event|0|||
33437730|NCT00279201|62813897|FG003|Intensification Addendum|Adverse Event|4|||
33437731|NCT00279201|62813898|FG004|Intensification Addendum|Adverse Event|1|||
33437732|NCT00279201|62813899|FG005|Intensification Addendum|Adverse Event|3|||
33437733|NCT00279201|62813894|FG000|Intensification Addendum|Physician Decision|0|||
33437734|NCT00279201|62813895|FG001|Intensification Addendum|Physician Decision|0|||
33437735|NCT00279201|62813896|FG002|Intensification Addendum|Physician Decision|4|||
33437736|NCT00279201|62813897|FG003|Intensification Addendum|Physician Decision|1|||
33437737|NCT00279201|62813898|FG004|Intensification Addendum|Physician Decision|3|||
33437738|NCT00279201|62813899|FG005|Intensification Addendum|Physician Decision|2|||
33437739|NCT00279201|62813894|FG000|Intensification Addendum|Sponsor Decision|0|||
33437740|NCT00279201|62813895|FG001|Intensification Addendum|Sponsor Decision|0|||
33437741|NCT00279201|62813896|FG002|Intensification Addendum|Sponsor Decision|0|||
33437742|NCT00279201|62813897|FG003|Intensification Addendum|Sponsor Decision|0|||
33437743|NCT00279201|62813898|FG004|Intensification Addendum|Sponsor Decision|1|||
33437744|NCT00279201|62813899|FG005|Intensification Addendum|Sponsor Decision|1|||
33437745|NCT00279201|62813894|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
33437746|NCT00279201|62813895|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
33437747|NCT00279201|62813896|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
33437748|NCT00279201|62813897|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
33437749|NCT00279201|62813898|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
33437750|NCT00279201|62813899|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
33437751|NCT00279201|62813894|FG000|Intensification Addendum|Lack of Efficacy|0|||
33437752|NCT00279201|62813895|FG001|Intensification Addendum|Lack of Efficacy|0|||
33437753|NCT00279201|62813896|FG002|Intensification Addendum|Lack of Efficacy|0|||
33437754|NCT00279201|62813897|FG003|Intensification Addendum|Lack of Efficacy|1|||
33437755|NCT00279201|62813898|FG004|Intensification Addendum|Lack of Efficacy|1|||
33437756|NCT00279201|62813899|FG005|Intensification Addendum|Lack of Efficacy|0|||
33437757|NCT00279201|62813894|FG000|Intensification Addendum|Death|0|||
33437758|NCT00279201|62813895|FG001|Intensification Addendum|Death|0|||
33437759|NCT00279201|62813896|FG002|Intensification Addendum|Death|0|||
33437760|NCT00279201|62813897|FG003|Intensification Addendum|Death|0|||
33437761|NCT00279201|62813898|FG004|Intensification Addendum|Death|1|||
33437762|NCT00279201|62813899|FG005|Intensification Addendum|Death|0|||
33437763|NCT00203476|62813935|FG000|Overall Study|Lost to Follow-up|1|||
33437764|NCT00203476|62813936|FG001|Overall Study|Lost to Follow-up|0|||
33437765|NCT00203476|62813937|FG002|Overall Study|Lost to Follow-up|0|||
33437766|NCT00203476|62813935|FG000|Overall Study|Withdrawal by Subject|0|||
33437767|NCT00203476|62813936|FG001|Overall Study|Withdrawal by Subject|1|||
33437768|NCT00203476|62813937|FG002|Overall Study|Withdrawal by Subject|0|||
33437769|NCT00203242|62813945|FG000|Overall Study|Lost to Follow-up|1|||
33437770|NCT00200356|62813951|FG000|Overall Study|Lack of Efficacy|3|||
33437771|NCT00200356|62813952|FG001|Overall Study|Lack of Efficacy|3|||
33437772|NCT00200356|62813951|FG000|Overall Study|Protocol Violation|4|||
33437773|NCT00200356|62813952|FG001|Overall Study|Protocol Violation|4|||
33437774|NCT00200356|62813951|FG000|Overall Study|Nontreatment|1|||
33437775|NCT00200356|62813952|FG001|Overall Study|Nontreatment|0|||
33437776|NCT00227344|62813960|FG000|Overall Study|study terminated early|12|||
33437777|NCT00227344|62813961|FG001|Overall Study|study terminated early|5|||
33437778|NCT00227266|62813970|FG000|Overall Study|Withdrawal by Subject|0|||
33437779|NCT00227266|62813971|FG001|Overall Study|Withdrawal by Subject|0|||
33437780|NCT00227266|62813972|FG002|Overall Study|Withdrawal by Subject|1|||
33437781|NCT00227266|62813970|FG000|Overall Study|Protocol Violation|1|||
33437782|NCT00227266|62813971|FG001|Overall Study|Protocol Violation|0|||
33437783|NCT00227266|62813972|FG002|Overall Study|Protocol Violation|1|||
33437784|NCT00227266|62813970|FG000|Overall Study|Excessive weight gain|0|||
33437785|NCT00227266|62813971|FG001|Overall Study|Excessive weight gain|0|||
33437786|NCT00227266|62813972|FG002|Overall Study|Excessive weight gain|2|||
33437787|NCT00256282|62813983|FG000|Overall Study|Disease progression, relapse during acti|12|||
33437788|NCT00256282|62813983|FG000|Overall Study|Adverse Event|3|||
33437789|NCT00256282|62813983|FG000|Overall Study|Physician Decision|1|||
33437790|NCT00266877|62813990|FG000|Overall Study|Death|1|||
33437791|NCT00266877|62813991|FG001|Overall Study|Death|1|||
33437792|NCT00266877|62813992|FG002|Overall Study|Death|1|||
33437793|NCT00266877|62813990|FG000|Overall Study|Adverse Event|6|||
33437794|NCT00266877|62813991|FG001|Overall Study|Adverse Event|4|||
33437795|NCT00266877|62813992|FG002|Overall Study|Adverse Event|1|||
33437796|NCT00266877|62813990|FG000|Overall Study|Physician Decision|2|||
33437797|NCT00266877|62813991|FG001|Overall Study|Physician Decision|1|||
33437798|NCT00266877|62813992|FG002|Overall Study|Physician Decision|1|||
33437799|NCT00266877|62813990|FG000|Overall Study|Withdrawal by Subject|3|||
33437800|NCT00266877|62813991|FG001|Overall Study|Withdrawal by Subject|1|||
33494191|NCT03634033|62872937|FG003|Overall Study|Lost to Follow-up|0|||
33494192|NCT03634033|62872938|FG004|Overall Study|Lost to Follow-up|0|||
33494193|NCT03634033|62872939|FG005|Overall Study|Lost to Follow-up|1|||
33494194|NCT03634033|62872940|FG006|Overall Study|Lost to Follow-up|2|||
33437801|NCT00266877|62813992|FG002|Overall Study|Withdrawal by Subject|1|||
33437802|NCT00266877|62813990|FG000|Overall Study|Disease Progression|72|||
33437803|NCT00266877|62813991|FG001|Overall Study|Disease Progression|37|||
33437804|NCT00266877|62813992|FG002|Overall Study|Disease Progression|23|||
33437805|NCT00266877|62813990|FG000|Overall Study|Symptomatic Deterioration|6|||
33437806|NCT00266877|62813991|FG001|Overall Study|Symptomatic Deterioration|3|||
33437807|NCT00266877|62813992|FG002|Overall Study|Symptomatic Deterioration|1|||
33437808|NCT00266877|62813990|FG000|Overall Study|Hospitalization|1|||
33437809|NCT00266877|62813991|FG001|Overall Study|Hospitalization|0|||
33437810|NCT00266877|62813992|FG002|Overall Study|Hospitalization|0|||
33437811|NCT00266877|62813990|FG000|Overall Study|Concomitant Radiotherapy|0|||
33437812|NCT00266877|62813991|FG001|Overall Study|Concomitant Radiotherapy|1|||
33437813|NCT00266877|62813992|FG002|Overall Study|Concomitant Radiotherapy|0|||
33437814|NCT00256204|62814004|FG000|Overall Study|Adverse Event|10|||
33437815|NCT00256204|62814005|FG001|Overall Study|Adverse Event|14|||
33437816|NCT00256204|62814006|FG002|Overall Study|Adverse Event|16|||
33437817|NCT00256204|62814007|FG003|Overall Study|Adverse Event|14|||
33437818|NCT00256204|62814004|FG000|Overall Study|Death|0|||
33437819|NCT00256204|62814005|FG001|Overall Study|Death|1|||
33437820|NCT00256204|62814006|FG002|Overall Study|Death|0|||
33437821|NCT00256204|62814007|FG003|Overall Study|Death|0|||
33437822|NCT00256204|62814004|FG000|Overall Study|Lost to Follow-up|1|||
33437823|NCT00256204|62814005|FG001|Overall Study|Lost to Follow-up|1|||
33437824|NCT00256204|62814006|FG002|Overall Study|Lost to Follow-up|1|||
33437825|NCT00256204|62814007|FG003|Overall Study|Lost to Follow-up|2|||
33437826|NCT00256204|62814004|FG000|Overall Study|Protocol Violation|1|||
33437827|NCT00256204|62814005|FG001|Overall Study|Protocol Violation|0|||
33437828|NCT00256204|62814006|FG002|Overall Study|Protocol Violation|2|||
33437829|NCT00256204|62814007|FG003|Overall Study|Protocol Violation|1|||
33437830|NCT00256204|62814004|FG000|Overall Study|Physician Decision|0|||
33437831|NCT00256204|62814005|FG001|Overall Study|Physician Decision|0|||
33437832|NCT00256204|62814006|FG002|Overall Study|Physician Decision|1|||
33437833|NCT00256204|62814007|FG003|Overall Study|Physician Decision|2|||
33437834|NCT00256204|62814004|FG000|Overall Study|Withdrawal by Subject|17|||
33437835|NCT00256204|62814005|FG001|Overall Study|Withdrawal by Subject|6|||
33437836|NCT00256204|62814006|FG002|Overall Study|Withdrawal by Subject|7|||
33437837|NCT00256204|62814007|FG003|Overall Study|Withdrawal by Subject|5|||
33437838|NCT00256204|62814004|FG000|Overall Study|Need for additional prohibited treatment|38|||
33437839|NCT00256204|62814005|FG001|Overall Study|Need for additional prohibited treatment|28|||
33437840|NCT00256204|62814006|FG002|Overall Study|Need for additional prohibited treatment|27|||
33437841|NCT00256204|62814007|FG003|Overall Study|Need for additional prohibited treatment|25|||
33437842|NCT00256126|62814022|FG000|Overall Study|Adverse Event|1|||
33437843|NCT00256126|62814023|FG001|Overall Study|Adverse Event|0|||
33437844|NCT00256126|62814022|FG000|Overall Study|Other|1|||
33437845|NCT00256126|62814023|FG001|Overall Study|Other|2|||
33437846|NCT00278889|62814032|FG000|Overall Study|Withdrawal by Subject|0|||
33437847|NCT00278889|62814033|FG001|Overall Study|Withdrawal by Subject|5|||
33437848|NCT00278889|62814034|FG002|Overall Study|Withdrawal by Subject|3|||
33437849|NCT00278889|62814032|FG000|Overall Study|Lost to Follow-up|1|||
33437850|NCT00278889|62814033|FG001|Overall Study|Lost to Follow-up|1|||
33437851|NCT00278889|62814034|FG002|Overall Study|Lost to Follow-up|0|||
33437852|NCT00278889|62814032|FG000|Overall Study|Death|24|||
33437853|NCT00278889|62814033|FG001|Overall Study|Death|21|||
33437854|NCT00278889|62814034|FG002|Overall Study|Death|17|||
33437855|NCT00278109|62814042|FG000|Overall Study|Adverse Event|3|||
33437856|NCT00278109|62814042|FG000|Overall Study|social circumstances|1|||
33437857|NCT00296517|62814048|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
33437858|NCT00296517|62814049|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
33437859|NCT00296517|62814048|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
33437860|NCT00296517|62814049|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
33437861|NCT00296517|62814048|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
33437862|NCT00296517|62814049|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
33437863|NCT00296517|62814048|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
33437864|NCT00296517|62814049|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
33437865|NCT00296517|62814048|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
33437866|NCT00296517|62814049|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
33437867|NCT00296517|62814048|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
33437868|NCT00296517|62814049|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
33437869|NCT00296517|62814048|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
33437870|NCT00296517|62814049|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
33437871|NCT00296517|62814048|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
33437872|NCT00296517|62814049|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
33437873|NCT00296517|62814048|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
33437874|NCT00296517|62814049|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
33437875|NCT00224770|62814058|FG000|Overall Study|Lost to Follow-up|4|||
33437876|NCT00224770|62814059|FG001|Overall Study|Lost to Follow-up|2|||
33437877|NCT00224770|62814060|FG002|Overall Study|Lost to Follow-up|0|||
33437878|NCT00266409|62814073|FG000|Overall Study|Lack of Efficacy|2|||
33437879|NCT00266409|62814074|FG001|Overall Study|Lack of Efficacy|6|||
33437880|NCT00266409|62814075|FG002|Overall Study|Lack of Efficacy|1|||
33437881|NCT00266409|62814076|FG003|Overall Study|Lack of Efficacy|2|||
33437882|NCT00266409|62814073|FG000|Overall Study|Adverse Event|7|||
33437883|NCT00266409|62814074|FG001|Overall Study|Adverse Event|2|||
33437884|NCT00266409|62814075|FG002|Overall Study|Adverse Event|1|||
33437885|NCT00266409|62814076|FG003|Overall Study|Adverse Event|1|||
33437886|NCT00266409|62814073|FG000|Overall Study|Lost to Follow-up|18|||
33437887|NCT00266409|62814074|FG001|Overall Study|Lost to Follow-up|21|||
33437888|NCT00266409|62814075|FG002|Overall Study|Lost to Follow-up|6|||
33437889|NCT00266409|62814076|FG003|Overall Study|Lost to Follow-up|8|||
33437890|NCT00266409|62814073|FG000|Overall Study|Withdrawal by Subject|6|||
33437891|NCT00266409|62814074|FG001|Overall Study|Withdrawal by Subject|10|||
33437892|NCT00266409|62814075|FG002|Overall Study|Withdrawal by Subject|3|||
33437893|NCT00266409|62814076|FG003|Overall Study|Withdrawal by Subject|9|||
33437894|NCT00266409|62814073|FG000|Overall Study|Protocol Violation|5|||
33437895|NCT00266409|62814074|FG001|Overall Study|Protocol Violation|3|||
33437896|NCT00266409|62814075|FG002|Overall Study|Protocol Violation|4|||
33437897|NCT00266409|62814076|FG003|Overall Study|Protocol Violation|2|||
33437898|NCT00266409|62814073|FG000|Overall Study|Other|7|||
33437899|NCT00266409|62814074|FG001|Overall Study|Other|4|||
33437900|NCT00266409|62814075|FG002|Overall Study|Other|2|||
33437901|NCT00266409|62814076|FG003|Overall Study|Other|0|||
33437902|NCT00277095|62814086|FG000|Overall Study|Death|2|||
33437903|NCT00277095|62814086|FG000|Overall Study|Explanted|7|||
33437904|NCT00277095|62814086|FG000|Overall Study|Lost to Follow-up|2|||
33437905|NCT00277095|62814086|FG000|Overall Study|Missed Follow-up|9|||
33437906|NCT00277095|62814086|FG000|Overall Study|Physician Decision|1|||
33437907|NCT00265785|62814090|FG000|Overall Study|Adverse Event|4|||
33437908|NCT00265785|62814090|FG000|Overall Study|Withdrawal by Subject|3|||
33437909|NCT00265785|62814090|FG000|Overall Study|Progression/Relapse|15|||
33437910|NCT00265785|62814090|FG000|Overall Study|Not protocol specified|2|||
33437911|NCT00265785|62814090|FG000|Overall Study|Ineligible|1|||
33437912|NCT00265785|62814090|FG000|Overall Study|Did not receive protocol treatment|2|||
33437913|NCT00276159|62814094|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
33437914|NCT00265395|62814100|FG000|Overall Study|Adverse Event|3|||
33437915|NCT00265395|62814101|FG001|Overall Study|Adverse Event|6|||
33437916|NCT00265395|62814100|FG000|Overall Study|Lost to Follow-up|2|||
33437917|NCT00265395|62814101|FG001|Overall Study|Lost to Follow-up|1|||
33437918|NCT00265395|62814100|FG000|Overall Study|Withdrawal by Subject|1|||
33437919|NCT00265395|62814101|FG001|Overall Study|Withdrawal by Subject|6|||
33437920|NCT00265395|62814100|FG000|Overall Study|Protocol Violation|2|||
33437921|NCT00265395|62814101|FG001|Overall Study|Protocol Violation|2|||
33437922|NCT00265395|62814100|FG000|Overall Study|Lack of Efficacy|0|||
33437923|NCT00265395|62814101|FG001|Overall Study|Lack of Efficacy|1|||
33437924|NCT00265395|62814100|FG000|Overall Study|Administrative|0|||
33437925|NCT00265395|62814101|FG001|Overall Study|Administrative|1|||
33437926|NCT00195442|62814106|FG000|Overall Study|Less than expected therapeutic effect|38|||
33437927|NCT00195442|62814106|FG000|Overall Study|Lost to Follow-up|27|||
33437928|NCT00195442|62814106|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
33437929|NCT00195442|62814106|FG000|Overall Study|Intermittent product shortage|21|||
33437930|NCT00195442|62814106|FG000|Overall Study|Death|7|||
33437931|NCT00195442|62814106|FG000|Overall Study|No reason specified|4|||
33437932|NCT00195442|62814106|FG000|Overall Study|Poor cooperation|2|||
33437933|NCT00195442|62814106|FG000|Overall Study|Other|14|||
33437934|NCT00275301|62814110|FG000|Overall Study|Adverse Event|5|||
33437935|NCT00251745|62814117|FG000|Overall Study|Adverse Event|7|||
33437936|NCT00251745|62814118|FG001|Overall Study|Adverse Event|9|||
33437937|NCT00251745|62814119|FG002|Overall Study|Adverse Event|11|||
33437938|NCT00251745|62814117|FG000|Overall Study|Lost to Follow-up|4|||
33437939|NCT00251745|62814118|FG001|Overall Study|Lost to Follow-up|2|||
33437940|NCT00251745|62814119|FG002|Overall Study|Lost to Follow-up|5|||
33437941|NCT00251745|62814117|FG000|Overall Study|Withdrawal by Subject|13|||
33437942|NCT00251745|62814118|FG001|Overall Study|Withdrawal by Subject|7|||
33437943|NCT00251745|62814119|FG002|Overall Study|Withdrawal by Subject|3|||
33437944|NCT00251745|62814117|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
33437945|NCT00251745|62814118|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
33437946|NCT00251745|62814119|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
33437947|NCT00251745|62814117|FG000|Overall Study|Lack of Efficacy|3|||
33437948|NCT00251745|62814118|FG001|Overall Study|Lack of Efficacy|0|||
33437949|NCT00251745|62814119|FG002|Overall Study|Lack of Efficacy|0|||
33437950|NCT00251745|62814117|FG000|Overall Study|Noncompliant|0|||
33437951|NCT00251745|62814118|FG001|Overall Study|Noncompliant|2|||
33437952|NCT00251745|62814119|FG002|Overall Study|Noncompliant|2|||
33437953|NCT00251745|62814117|FG000|Overall Study|Pregnancy|0|||
33437954|NCT00251745|62814118|FG001|Overall Study|Pregnancy|1|||
33437955|NCT00251745|62814119|FG002|Overall Study|Pregnancy|0|||
33437956|NCT00251745|62814117|FG000|Overall Study|Per Subject Request|0|||
33437957|NCT00251745|62814118|FG001|Overall Study|Per Subject Request|0|||
33437958|NCT00251745|62814119|FG002|Overall Study|Per Subject Request|1|||
33437959|NCT00251745|62814117|FG000|Overall Study|Per Investigator Request|1|||
33437960|NCT00251745|62814118|FG001|Overall Study|Per Investigator Request|0|||
33437961|NCT00251745|62814119|FG002|Overall Study|Per Investigator Request|0|||
33437962|NCT00255190|62814129|FG000|Overall Study|Adverse Event|17|||
33437963|NCT00255190|62814130|FG001|Overall Study|Adverse Event|36|||
33437964|NCT00255190|62814129|FG000|Overall Study|Protocol Violation|2|||
33437965|NCT00255190|62814130|FG001|Overall Study|Protocol Violation|2|||
33437966|NCT00255190|62814129|FG000|Overall Study|Lost to Follow-up|10|||
33437967|NCT00255190|62814130|FG001|Overall Study|Lost to Follow-up|27|||
33437968|NCT00255190|62814129|FG000|Overall Study|Withdrew Consent|17|||
33437969|NCT00255190|62814130|FG001|Overall Study|Withdrew Consent|48|||
33437970|NCT00255190|62814129|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
33437971|NCT00255190|62814130|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
33437972|NCT00255190|62814129|FG000|Overall Study|Erosive esophagitis not healed|0|||
33437973|NCT00255190|62814130|FG001|Overall Study|Erosive esophagitis not healed|20|||
33437974|NCT00255190|62814129|FG000|Overall Study|Various|4|||
33437975|NCT00255190|62814130|FG001|Overall Study|Various|23|||
33437976|NCT00359424|62814138|FG000|Overall Study|Death|99|||
33437977|NCT00359424|62814139|FG001|Overall Study|Death|58|||
33437978|NCT00359424|62814138|FG000|Overall Study|Lost to Follow-up|19|||
33437979|NCT00359424|62814139|FG001|Overall Study|Lost to Follow-up|7|||
33437980|NCT00359424|62814138|FG000|Overall Study|Withdrawal by Subject|10|||
33437981|NCT00359424|62814139|FG001|Overall Study|Withdrawal by Subject|2|||
33437982|NCT00359424|62814138|FG000|Overall Study|follow up not conducted|2|||
33437983|NCT00359424|62814139|FG001|Overall Study|follow up not conducted|0|||
33437984|NCT00255034|62814147|FG000|Overall Study|Withdrawal by Subject|15|||
33437985|NCT00255034|62814148|FG001|Overall Study|Withdrawal by Subject|38|||
33437986|NCT00254566|62814156|FG000|Overall Study|Death|1|||
33437987|NCT00254566|62814157|FG001|Overall Study|Death|0|||
33437988|NCT00254566|62814156|FG000|Overall Study|Adverse Event|5|||
33437989|NCT00254566|62814157|FG001|Overall Study|Adverse Event|4|||
33437990|NCT00254566|62814156|FG000|Overall Study|Lack of Efficacy|12|||
33437991|NCT00254566|62814157|FG001|Overall Study|Lack of Efficacy|9|||
33437992|NCT00254566|62814156|FG000|Overall Study|Other|1|||
33437993|NCT00254566|62814157|FG001|Overall Study|Other|5|||
33437994|NCT00254566|62814156|FG000|Overall Study|Withdrawal by Subject|5|||
33437995|NCT00254566|62814157|FG001|Overall Study|Withdrawal by Subject|6|||
33437996|NCT00254566|62814156|FG000|Overall Study|Lost to Follow-up|7|||
33437997|NCT00254566|62814157|FG001|Overall Study|Lost to Follow-up|2|||
33437998|NCT00358956|62814163|FG000|Overall Study|Adverse Event|3|||
33437999|NCT00358956|62814163|FG000|Overall Study|condition under investigation worsened|4|||
33438000|NCT00358956|62814163|FG000|Overall Study|Withdrawal by Subject|1|||
33438001|NCT03830892|62814169|FG000|Overall Study|Physician Decision|2|||
33438002|NCT03830892|62814170|FG001|Overall Study|Physician Decision|3|||
33438003|NCT03830892|62814169|FG000|Overall Study|Study terminated due to COVID|4|||
33438004|NCT03830892|62814170|FG001|Overall Study|Study terminated due to COVID|0|||
33438005|NCT03830892|62814169|FG000|Overall Study|Protocol Violation|0|||
33438006|NCT03830892|62814170|FG001|Overall Study|Protocol Violation|1|||
33438007|NCT03830892|62814169|FG000|Overall Study|Withdrawal by Subject|0|||
33438008|NCT03830892|62814170|FG001|Overall Study|Withdrawal by Subject|2|||
33438009|NCT00253630|62814176|FG000|Overall Study|ineligible|2|||
33438010|NCT00358644|62814180|FG000|Overall Study|Progressive Disease|21|||
33438011|NCT00358644|62814180|FG000|Overall Study|Adverse Event|7|||
33438012|NCT00358644|62814180|FG000|Overall Study|Death|11|||
33438013|NCT00358644|62814180|FG000|Overall Study|Withdrawal by Subject|4|||
33438014|NCT00358644|62814180|FG000|Overall Study|Physician Decision|6|||
33438015|NCT00358644|62814180|FG000|Overall Study|Patient not eligible for study|1|||
33438016|NCT00364182|62814187|FG000|First Intervention|Secondary prophylaxis|1|||
33438017|NCT00364182|62814188|FG001|First Intervention|Secondary prophylaxis|0|||
33438018|NCT00364182|62814189|FG002|First Intervention|Secondary prophylaxis|0|||
33438019|NCT00364182|62814187|FG000|First Intervention|Withdrawal by Subject|2|||
33438020|NCT00364182|62814188|FG001|First Intervention|Withdrawal by Subject|0|||
33494195|NCT03634033|62872934|FG000|Overall Study|Withdrawal by Subject|0|||
33494196|NCT03634033|62872935|FG001|Overall Study|Withdrawal by Subject|0|||
33605544|NCT02336165|63005251|FG002|Overall Study|Withdrawal by Subject|1|||
33605545|NCT02336165|63005252|FG003|Overall Study|Withdrawal by Subject|0|||
33438021|NCT00364182|62814189|FG002|First Intervention|Withdrawal by Subject|0|||
33438022|NCT00364182|62814187|FG000|Second Intervention|non-compliance|0|||
33438023|NCT00364182|62814188|FG001|Second Intervention|non-compliance|1|||
33605546|NCT02336165|63005253|FG004|Overall Study|Withdrawal by Subject|1|||
33605547|NCT02336165|63005249|FG000|Overall Study|Adverse Event|4|||
33605548|NCT02336165|63005250|FG001|Overall Study|Adverse Event|1|||
33438024|NCT00364182|62814189|FG002|Second Intervention|non-compliance|1|||
33438025|NCT00364182|62814187|FG000|Second Intervention|Protocol Violation|0|||
33605549|NCT02336165|63005251|FG002|Overall Study|Adverse Event|2|||
33438026|NCT00364182|62814188|FG001|Second Intervention|Protocol Violation|1|||
33605550|NCT02336165|63005252|FG003|Overall Study|Adverse Event|4|||
33438027|NCT00364182|62814189|FG002|Second Intervention|Protocol Violation|0|||
33438028|NCT00364182|62814187|FG000|Second Intervention|Adverse Event|0|||
33438029|NCT00364182|62814188|FG001|Second Intervention|Adverse Event|0|||
33438030|NCT00364182|62814189|FG002|Second Intervention|Adverse Event|1|||
33605551|NCT02336165|63005253|FG004|Overall Study|Adverse Event|1|||
33605552|NCT02336165|63005249|FG000|Overall Study|Progressive disease|23|||
33605553|NCT02336165|63005250|FG001|Overall Study|Progressive disease|22|||
33605554|NCT02336165|63005251|FG002|Overall Study|Progressive disease|27|||
33438031|NCT00364182|62814187|FG000|Third Intervention|non-compliance|0|||
33438032|NCT00364182|62814188|FG001|Third Intervention|non-compliance|1|||
33438033|NCT00364182|62814189|FG002|Third Intervention|non-compliance|0|||
33438034|NCT00364182|62814187|FG000|Third Intervention|Lost to Follow-up|0|||
33438035|NCT00364182|62814188|FG001|Third Intervention|Lost to Follow-up|0|||
33438036|NCT00364182|62814189|FG002|Third Intervention|Lost to Follow-up|1|||
33438037|NCT00369486|62814204|FG000|4-Week Visit|Missed visit|2|||
33438038|NCT00369486|62814205|FG001|4-Week Visit|Missed visit|2|||
33438039|NCT00369486|62814206|FG002|4-Week Visit|Missed visit|0|||
33438040|NCT00369486|62814207|FG003|4-Week Visit|Missed visit|2|||
33438041|NCT00369486|62814208|FG004|4-Week Visit|Missed visit|1|||
33438042|NCT00369486|62814204|FG000|4-Week Visit|Dropped|0|||
33438043|NCT00369486|62814205|FG001|4-Week Visit|Dropped|0|||
33438044|NCT00369486|62814206|FG002|4-Week Visit|Dropped|1|||
33438045|NCT00369486|62814207|FG003|4-Week Visit|Dropped|0|||
33438046|NCT00369486|62814208|FG004|4-Week Visit|Dropped|0|||
33438047|NCT00369486|62814204|FG000|8-Week Visit|Missed visit|0|||
33438048|NCT00369486|62814205|FG001|8-Week Visit|Missed visit|1|||
33438049|NCT00369486|62814206|FG002|8-Week Visit|Missed visit|0|||
33438050|NCT00369486|62814207|FG003|8-Week Visit|Missed visit|0|||
33438051|NCT00369486|62814208|FG004|8-Week Visit|Missed visit|1|||
33438052|NCT00369486|62814204|FG000|8-Week Visit|Dropped|0|||
33438053|NCT00369486|62814205|FG001|8-Week Visit|Dropped|0|||
33438054|NCT00369486|62814206|FG002|8-Week Visit|Dropped|0|||
33438055|NCT00369486|62814207|FG003|8-Week Visit|Dropped|1|||
33438056|NCT00369486|62814208|FG004|8-Week Visit|Dropped|0|||
33438057|NCT00369486|62814204|FG000|17-Week Visit|Missed visit|0|||
33438058|NCT00369486|62814205|FG001|17-Week Visit|Missed visit|0|||
33438059|NCT00369486|62814206|FG002|17-Week Visit|Missed visit|1|||
33438060|NCT00369486|62814207|FG003|17-Week Visit|Missed visit|1|||
33438061|NCT00369486|62814208|FG004|17-Week Visit|Missed visit|1|||
33438062|NCT00369486|62814204|FG000|34-Week Visit|Dropped|0|||
33438063|NCT00369486|62814205|FG001|34-Week Visit|Dropped|1|||
33438064|NCT00369486|62814206|FG002|34-Week Visit|Dropped|1|||
33438065|NCT00369486|62814207|FG003|34-Week Visit|Dropped|3|||
33438066|NCT00369486|62814208|FG004|34-Week Visit|Dropped|3|||
33438067|NCT00363480|62814220|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
33438068|NCT00363480|62814220|FG000|Overall Study|Adverse Event|4|||
33438069|NCT00363480|62814220|FG000|Overall Study|Lost to Follow-up|5|||
33438070|NCT00363480|62814220|FG000|Overall Study|Withdrawal by Subject|5|||
33438071|NCT00363480|62814220|FG000|Overall Study|Non-compliance of subject|1|||
33438072|NCT00363480|62814220|FG000|Overall Study|Participant discontinued on its own|1|||
33438073|NCT00363246|62814224|FG000|Overall Study|Death|40|||
33438074|NCT00363246|62814224|FG000|Overall Study|Withdrawal by Subject|19|||
33438075|NCT00363246|62814224|FG000|Overall Study|Lost to Follow-up|14|||
33438076|NCT00363246|62814224|FG000|Overall Study|Bad health|6|||
33438077|NCT00363246|62814224|FG000|Overall Study|Stopped using wheelchair|11|||
33438078|NCT00363246|62814224|FG000|Overall Study|Subject expressed security concerns|2|||
33438079|NCT00363246|62814224|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
33438080|NCT00223990|62814231|FG000|Overall Study|Moved from area|2|||
33438081|NCT00223990|62814232|FG001|Overall Study|Moved from area|1|||
33438082|NCT00223990|62814231|FG000|Overall Study|Withdrawal by Subject|4|||
33438083|NCT00223990|62814232|FG001|Overall Study|Withdrawal by Subject|8|||
33438084|NCT00223990|62814231|FG000|Overall Study|Lost to Follow-up|1|||
33438085|NCT00223990|62814232|FG001|Overall Study|Lost to Follow-up|0|||
33438086|NCT00221104|62814240|FG000|Overall Study|Adverse Event|1|||
33438087|NCT00221104|62814241|FG001|Overall Study|Adverse Event|0|||
33438088|NCT00221104|62814240|FG000|Overall Study|Physician Decision|1|||
33438089|NCT00221104|62814241|FG001|Overall Study|Physician Decision|0|||
33438090|NCT00221104|62814240|FG000|Overall Study|Protocol Violation|2|||
33438091|NCT00221104|62814241|FG001|Overall Study|Protocol Violation|0|||
33438092|NCT00221104|62814240|FG000|Overall Study|Withdrawal by Subject|42|||
33438093|NCT00221104|62814241|FG001|Overall Study|Withdrawal by Subject|29|||
33438094|NCT00221104|62814240|FG000|Overall Study|Others|37|||
33438095|NCT00221104|62814241|FG001|Overall Study|Others|47|||
33438096|NCT00189202|62814249|FG000|Overall Study|Physician Decision|5|||
33438097|NCT00187486|62814253|FG000|Overall Study|Protocol Violation|1|||
33438098|NCT00220636|62814257|FG000|Overall Study|Withdrawal by Subject|4|||
33438099|NCT00362232|62814264|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
33438100|NCT00362232|62814265|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
33438101|NCT00362232|62814264|FG000|Treatment (12 +/- 2 Days)|Death|1|||
33438102|NCT00362232|62814265|FG001|Treatment (12 +/- 2 Days)|Death|3|||
33438103|NCT00362232|62814264|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
33438104|NCT00362232|62814265|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
33438105|NCT00362232|62814264|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
33438106|NCT00362232|62814265|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
33438107|NCT00362232|62814264|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
33438108|NCT00362232|62814265|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
33605555|NCT02336165|63005252|FG003|Overall Study|Progressive disease|24|||
33438109|NCT00362232|62814264|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
33438110|NCT00362232|62814265|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
33438111|NCT00362232|62814264|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
33438112|NCT00362232|62814265|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
33605556|NCT02336165|63005253|FG004|Overall Study|Progressive disease|19|||
33605557|NCT02336165|63005249|FG000|Overall Study|Non-compliance|1|||
33605558|NCT02336165|63005250|FG001|Overall Study|Non-compliance|0|||
33605559|NCT02336165|63005251|FG002|Overall Study|Non-compliance|0|||
33605560|NCT02336165|63005252|FG003|Overall Study|Non-compliance|1|||
33605561|NCT02336165|63005253|FG004|Overall Study|Non-compliance|0|||
33605562|NCT02336165|63005249|FG000|Overall Study|Other|1|||
33605563|NCT02336165|63005250|FG001|Overall Study|Other|0|||
33605564|NCT02336165|63005251|FG002|Overall Study|Other|0|||
33605565|NCT02336165|63005252|FG003|Overall Study|Other|1|||
33605566|NCT02336165|63005253|FG004|Overall Study|Other|0|||
33605567|NCT02360111|63005269|FG000|Overall Study|Death|2|||
33605568|NCT02334683|63005275|FG000|First 12 Week Period|Lost to Follow-up|1|||
33605569|NCT02334683|63005276|FG001|First 12 Week Period|Lost to Follow-up|0|||
33605570|NCT02334683|63005275|FG000|Second 12 Week Period|Adverse Event|0|||
33605571|NCT02334683|63005276|FG001|Second 12 Week Period|Adverse Event|1|||
33605572|NCT02319044|63005285|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
33605573|NCT02319044|63005286|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
33605574|NCT02319044|63005287|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
33605575|NCT02319044|63005285|FG000|Overall Study|Withdrawal by Subject|3|||
33438113|NCT00362232|62814264|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
33605576|NCT02319044|63005286|FG001|Overall Study|Withdrawal by Subject|3|||
33605577|NCT02319044|63005287|FG002|Overall Study|Withdrawal by Subject|6|||
33605578|NCT02319044|63005285|FG000|Overall Study|Condition under investigation worsened|100|||
33605579|NCT02319044|63005286|FG001|Overall Study|Condition under investigation worsened|50|||
33438114|NCT00362232|62814265|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
33438115|NCT00362232|62814264|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
33438116|NCT00362232|62814265|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
33438117|NCT00362232|62814264|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
33438118|NCT00362232|62814265|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
33438119|NCT00362232|62814264|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
33438120|NCT00362232|62814265|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
33438121|NCT00362232|62814264|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
33438122|NCT00362232|62814265|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
33438123|NCT00362232|62814264|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
33438124|NCT00362232|62814265|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
33438125|NCT00219544|62814271|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
33438126|NCT00219544|62814272|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
33438127|NCT00219544|62814271|FG000|Single Blind Treatment Period|Adverse Event|9|||
33438128|NCT00219544|62814272|FG001|Single Blind Treatment Period|Adverse Event|0|||
33438129|NCT00219544|62814271|FG000|Single Blind Treatment Period|Protocol Violation|4|||
33438130|NCT00219544|62814272|FG001|Single Blind Treatment Period|Protocol Violation|0|||
33438131|NCT00219544|62814271|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
33438132|NCT00219544|62814272|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
33438133|NCT00219544|62814271|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
33438134|NCT00219544|62814272|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
33438135|NCT00219544|62814271|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
33438136|NCT00219544|62814272|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
33438137|NCT00357552|62814280|FG000|Screening|Did not meet eligibility criteria|84|||
33438138|NCT00357552|62814280|FG000|Weeks 0 to 24|Death|1|||
33438139|NCT00357552|62814280|FG000|Weeks 24 to 104|Death|3|||
33438140|NCT00357552|62814280|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
33438141|NCT00187096|62814291|FG000|Overall Study|unacceptable toxicity|0|||
33438142|NCT00187096|62814292|FG001|Overall Study|unacceptable toxicity|0|||
33438143|NCT00187096|62814293|FG002|Overall Study|unacceptable toxicity|1|||
33438144|NCT00357396|62814303|FG000|Overall Study|Adverse Event|1|||
33438145|NCT00357396|62814304|FG001|Overall Study|Adverse Event|0|||
33438146|NCT00186628|62814309|FG000|Overall Study|Death|2|||
33438147|NCT00186628|62814309|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
33438148|NCT00368550|62814317|FG000|Overall Study|Adverse Event|7|||
33438149|NCT00368550|62814318|FG001|Overall Study|Adverse Event|4|||
33494197|NCT03634033|62872936|FG002|Overall Study|Withdrawal by Subject|0|||
33605580|NCT02319044|63005287|FG002|Overall Study|Condition under investigation worsened|46|||
33605581|NCT02319044|63005285|FG000|Overall Study|Adverse Event|17|||
33605582|NCT02319044|63005286|FG001|Overall Study|Adverse Event|2|||
33605583|NCT02319044|63005287|FG002|Overall Study|Adverse Event|8|||
33605584|NCT02319044|63005285|FG000|Overall Study|Study specific discontinuation criteria|2|||
33438150|NCT00368550|62814317|FG000|Overall Study|Lack of Efficacy|4|||
33438151|NCT00368550|62814318|FG001|Overall Study|Lack of Efficacy|9|||
33438152|NCT00368550|62814317|FG000|Overall Study|Withdrawal by Subject|17|||
33438153|NCT00368550|62814318|FG001|Overall Study|Withdrawal by Subject|10|||
33438154|NCT00368472|62814324|FG000|Overall Study|Adverse Event|22|||
33438155|NCT00368472|62814324|FG000|Overall Study|Medication non-compliance|4|||
33438156|NCT00368472|62814324|FG000|Overall Study|Protocol Violation|2|||
33438157|NCT00368472|62814324|FG000|Overall Study|Request of Investigator or Sponsor|3|||
33438158|NCT00368472|62814324|FG000|Overall Study|Withdrawal by Subject|40|||
33438159|NCT00368472|62814324|FG000|Overall Study|Diary non-compliance|1|||
33438160|NCT00368472|62814324|FG000|Overall Study|Other|32|||
33438161|NCT00368472|62814324|FG000|Overall Study|Missing Final Disposition Date|1|||
33438162|NCT00357006|62814331|FG000|Overall Study|Lost to Follow-up|1|||
33438163|NCT00357006|62814332|FG001|Overall Study|Lost to Follow-up|2|||
33438164|NCT00357006|62814333|FG002|Overall Study|Lost to Follow-up|1|||
33438165|NCT00357006|62814331|FG000|Overall Study|Withdrawal by Subject|1|||
33438166|NCT00357006|62814332|FG001|Overall Study|Withdrawal by Subject|3|||
33438167|NCT00357006|62814333|FG002|Overall Study|Withdrawal by Subject|2|||
33438168|NCT00165646|62814344|FG000|Overall Study|Adverse Event|1|||
33438169|NCT00165646|62814345|FG001|Overall Study|Adverse Event|1|||
33438170|NCT00165646|62814346|FG002|Overall Study|Adverse Event|1|||
33438171|NCT00165646|62814344|FG000|Overall Study|Lack of Efficacy|1|||
33438172|NCT00165646|62814345|FG001|Overall Study|Lack of Efficacy|2|||
33438173|NCT00165646|62814346|FG002|Overall Study|Lack of Efficacy|0|||
33438174|NCT00165646|62814344|FG000|Overall Study|Withdrawal by Subject|0|||
33438175|NCT00165646|62814345|FG001|Overall Study|Withdrawal by Subject|2|||
33438176|NCT00165646|62814346|FG002|Overall Study|Withdrawal by Subject|1|||
33438177|NCT00165646|62814344|FG000|Overall Study|Physician Decision|2|||
33438178|NCT00165646|62814345|FG001|Overall Study|Physician Decision|0|||
33438179|NCT00165646|62814346|FG002|Overall Study|Physician Decision|2|||
33438180|NCT00165646|62814344|FG000|Overall Study|Protocol Violation|1|||
33438181|NCT00165646|62814345|FG001|Overall Study|Protocol Violation|0|||
33438182|NCT00165646|62814346|FG002|Overall Study|Protocol Violation|0|||
33438183|NCT00367770|62814354|FG000|Overall Study|Adverse Event|1|||
33438184|NCT00367770|62814354|FG000|Overall Study|Withdrawal by Subject|1|||
33438185|NCT00185614|62814358|FG000|Inter-treatment Period|Physician Decision|1|||
33438186|NCT00185614|62814358|FG000|Inter-treatment Period|Relapse|2|||
33438187|NCT00185614|62814358|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
33605585|NCT02319044|63005286|FG001|Overall Study|Study specific discontinuation criteria|2|||
33605586|NCT02319044|63005287|FG002|Overall Study|Study specific discontinuation criteria|1|||
33605587|NCT02319044|63005285|FG000|Overall Study|Not treated|0|||
33438188|NCT00162370|62814362|FG000|Efficacy Population|Lost to Follow-up|51|||
33438189|NCT00361842|62814371|FG000|Overall Study|Withdrawal by Subject|2|||
33438190|NCT00361842|62814372|FG001|Overall Study|Withdrawal by Subject|3|||
33438191|NCT00361842|62814371|FG000|Overall Study|Death|2|||
33438192|NCT00361842|62814372|FG001|Overall Study|Death|1|||
33438193|NCT00361842|62814371|FG000|Overall Study|Disease progression|19|||
33438194|NCT00361842|62814372|FG001|Overall Study|Disease progression|20|||
33438195|NCT00361842|62814371|FG000|Overall Study|Adverse Event|2|||
33438196|NCT00361842|62814372|FG001|Overall Study|Adverse Event|3|||
33438197|NCT00361842|62814371|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
33438198|NCT00361842|62814372|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
33438199|NCT00361842|62814371|FG000|Overall Study|Other|1|||
33438200|NCT00361842|62814372|FG001|Overall Study|Other|0|||
33438201|NCT00361842|62814371|FG000|Overall Study|Other|0|||
33438202|NCT00361842|62814372|FG001|Overall Study|Other|2|||
33438203|NCT00361296|62814380|FG000|Overall Study|Physician Decision|1|||
33438204|NCT00361296|62814380|FG000|Overall Study|Lack of Efficacy|2|||
33605588|NCT02319044|63005286|FG001|Overall Study|Not treated|2|||
33605589|NCT02319044|63005287|FG002|Overall Study|Not treated|2|||
33605590|NCT01649765|63005298|FG000|Overall Study|Adverse Event|5|||
33605591|NCT01649765|63005299|FG001|Overall Study|Adverse Event|3|||
33605592|NCT01649765|63005298|FG000|Overall Study|Lack of Efficacy|1|||
33605593|NCT01649765|63005299|FG001|Overall Study|Lack of Efficacy|1|||
33438205|NCT00356148|62814386|FG000|Overall Study|Reoperation within 30 days|2|||
33438206|NCT00356148|62814387|FG001|Overall Study|Reoperation within 30 days|1|||
33438207|NCT00361218|62814394|FG000|Overall Study|Lost to Follow-up|11|||
33438208|NCT00361218|62814394|FG000|Overall Study|Personal Reasons|7|||
33438209|NCT00361218|62814394|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
33438210|NCT00367458|62814400|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
33438211|NCT00367458|62814401|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
33438212|NCT00162136|62814413|FG000|Overall Study|Adverse Event|1|||
33438213|NCT00162136|62814413|FG000|Overall Study|Death|1|||
33438214|NCT00162136|62814413|FG000|Overall Study|Disease Progression/Relapse|23|||
33438215|NCT00162136|62814413|FG000|Overall Study|Investigator Request|5|||
33605594|NCT01649765|63005298|FG000|Overall Study|Physician Decision|0|||
33605595|NCT01649765|63005299|FG001|Overall Study|Physician Decision|3|||
33605596|NCT01649765|63005298|FG000|Overall Study|Protocol Violation|1|||
33605597|NCT01649765|63005299|FG001|Overall Study|Protocol Violation|0|||
33605598|NCT01649765|63005298|FG000|Overall Study|Withdrawal by Subject|2|||
33438216|NCT00162136|62814413|FG000|Overall Study|Study Drug Toxicity|4|||
33438217|NCT00162136|62814413|FG000|Overall Study|Withdrawal by Subject|1|||
33438218|NCT00252694|62814439|FG000|Overall Study|Withdrawal by Subject|83|||
33438219|NCT00252694|62814440|FG001|Overall Study|Withdrawal by Subject|91|||
33605599|NCT01649765|63005299|FG001|Overall Study|Withdrawal by Subject|1|||
33438220|NCT00252694|62814439|FG000|Overall Study|Death|36|||
33438221|NCT00252694|62814440|FG001|Overall Study|Death|34|||
33605600|NCT02317562|63005306|FG000|Overall Study|Physician Decision|1|||
33605601|NCT02317562|63005306|FG000|Overall Study|early termination of the study|8|||
33605602|NCT02317562|63005306|FG000|Overall Study|Lack of Efficacy|4|||
33605603|NCT02317562|63005306|FG000|Overall Study|Withdrawal by Subject|1|||
33438222|NCT00252694|62814439|FG000|Overall Study|Mostly Lost to Follow Up|8|||
33438223|NCT00252694|62814440|FG001|Overall Study|Mostly Lost to Follow Up|13|||
33438224|NCT00252694|62814439|FG000|Overall Study|Patient Moving|17|||
33438225|NCT00252694|62814440|FG001|Overall Study|Patient Moving|16|||
33605604|NCT02317016|63005310|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
33605605|NCT02317016|63005310|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
33605606|NCT02317016|63005310|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
33605607|NCT02317016|63005310|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
33438226|NCT00185458|62814446|FG000|Contraception Phase|Adverse Event|37|||
33438227|NCT00185458|62814446|FG000|Contraception Phase|Lost to Follow-up|10|||
33438228|NCT00185458|62814446|FG000|Contraception Phase|Protocol Violation|2|||
33438229|NCT00185458|62814446|FG000|Contraception Phase|Physician Decision|2|||
33438230|NCT00185458|62814446|FG000|Contraception Phase|Withdrawal by Subject|7|||
33438231|NCT00185458|62814446|FG000|HRT Phase|Adverse Event|18|||
33438232|NCT00185458|62814446|FG000|HRT Phase|Lost to Follow-up|4|||
33438233|NCT00185458|62814446|FG000|HRT Phase|Protocol Violation|2|||
33438234|NCT00185458|62814446|FG000|HRT Phase|Withdrawal by Subject|3|||
33438235|NCT00185380|62814461|FG000|Overall Study|Adverse Event|41|||
33438236|NCT00185380|62814462|FG001|Overall Study|Adverse Event|43|||
33438237|NCT00185380|62814463|FG002|Overall Study|Adverse Event|48|||
33438238|NCT00185380|62814461|FG000|Overall Study|Lost to Follow-up|0|||
33438239|NCT00185380|62814462|FG001|Overall Study|Lost to Follow-up|4|||
33438240|NCT00185380|62814463|FG002|Overall Study|Lost to Follow-up|3|||
33438241|NCT00185380|62814461|FG000|Overall Study|Pregnancy|1|||
33438242|NCT00185380|62814462|FG001|Overall Study|Pregnancy|4|||
33438243|NCT00185380|62814463|FG002|Overall Study|Pregnancy|0|||
33438244|NCT00185380|62814461|FG000|Overall Study|Protocol Violation|2|||
33438245|NCT00185380|62814462|FG001|Overall Study|Protocol Violation|2|||
33438246|NCT00185380|62814463|FG002|Overall Study|Protocol Violation|1|||
33438247|NCT00185380|62814461|FG000|Overall Study|Withdrawal by Subject|1|||
33438248|NCT00185380|62814462|FG001|Overall Study|Withdrawal by Subject|2|||
33438249|NCT00185380|62814463|FG002|Overall Study|Withdrawal by Subject|0|||
33438250|NCT00185380|62814461|FG000|Overall Study|Failed insertion|1|||
33438251|NCT00185380|62814462|FG001|Overall Study|Failed insertion|1|||
33438252|NCT00185380|62814463|FG002|Overall Study|Failed insertion|2|||
33438253|NCT00185380|62814461|FG000|Overall Study|Planned pregnancy|9|||
33438254|NCT00185380|62814462|FG001|Overall Study|Planned pregnancy|12|||
33438255|NCT00185380|62814463|FG002|Overall Study|Planned pregnancy|12|||
33438256|NCT00185380|62814461|FG000|Overall Study|No need for contraception|3|||
33438257|NCT00185380|62814462|FG001|Overall Study|No need for contraception|3|||
33438258|NCT00185380|62814463|FG002|Overall Study|No need for contraception|3|||
33438259|NCT00185380|62814461|FG000|Overall Study|Could not attend visits|2|||
33438260|NCT00185380|62814462|FG001|Overall Study|Could not attend visits|0|||
33438261|NCT00185380|62814463|FG002|Overall Study|Could not attend visits|4|||
33438262|NCT00185380|62814461|FG000|Overall Study|personal reason|6|||
33438263|NCT00185380|62814462|FG001|Overall Study|personal reason|1|||
33438264|NCT00185380|62814463|FG002|Overall Study|personal reason|1|||
33438265|NCT00160654|62814471|FG000|Overall Study|Adverse Event|14|||
33438266|NCT00160654|62814471|FG000|Overall Study|Lack of Efficacy|4|||
33438267|NCT00160654|62814471|FG000|Overall Study|Lost to Follow-up|2|||
33438268|NCT00160654|62814471|FG000|Overall Study|Intake of expired drug|7|||
33605608|NCT02317016|63005310|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
33438269|NCT00160654|62814471|FG000|Overall Study|Psychological trauma|1|||
33438270|NCT00160654|62814471|FG000|Overall Study|Sponsor decision|1|||
33438271|NCT00160654|62814471|FG000|Overall Study|Patient met exclusion criteria|1|||
33438272|NCT00160654|62814471|FG000|Overall Study|Patient decision|1|||
33438273|NCT00160654|62814471|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
33438274|NCT00160654|62814471|FG000|Overall Study|Met exclusion criteria|1|||
33438275|NCT00366678|62814477|FG000|Infant Series|Withdrawal by Subject|8|||
33438276|NCT00366678|62814478|FG001|Infant Series|Withdrawal by Subject|6|||
33605609|NCT02317016|63005310|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
33605610|NCT02317016|63005310|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
33605611|NCT02311478|63005318|FG000|Overall Study|Withdrawal by Subject|1|||
33438277|NCT00366678|62814479|FG002|Infant Series|Withdrawal by Subject|0|||
33438278|NCT00366678|62814477|FG000|Infant Series|Protocol Violation|4|||
33438279|NCT00366678|62814478|FG001|Infant Series|Protocol Violation|3|||
33438280|NCT00366678|62814479|FG002|Infant Series|Protocol Violation|0|||
33438281|NCT00366678|62814477|FG000|Infant Series|Failed to return|1|||
33438282|NCT00366678|62814478|FG001|Infant Series|Failed to return|1|||
33438283|NCT00366678|62814479|FG002|Infant Series|Failed to return|0|||
33438284|NCT00366678|62814477|FG000|Infant Series|Adverse Event|1|||
33438285|NCT00366678|62814478|FG001|Infant Series|Adverse Event|0|||
33438286|NCT00366678|62814479|FG002|Infant Series|Adverse Event|0|||
33438287|NCT00366678|62814477|FG000|After Infant|Withdrawal by Subject|8|||
33438288|NCT00366678|62814478|FG001|After Infant|Withdrawal by Subject|4|||
33438289|NCT00366678|62814479|FG002|After Infant|Withdrawal by Subject|0|||
33438290|NCT00366678|62814477|FG000|After Infant|Lost to Follow-up|2|||
33438291|NCT00366678|62814478|FG001|After Infant|Lost to Follow-up|1|||
33438292|NCT00366678|62814479|FG002|After Infant|Lost to Follow-up|0|||
33438293|NCT00366678|62814477|FG000|After Infant|Failed to return|5|||
33438294|NCT00366678|62814478|FG001|After Infant|Failed to return|5|||
33438295|NCT00366678|62814479|FG002|After Infant|Failed to return|0|||
33438296|NCT00366678|62814477|FG000|After Infant|Adverse Event|1|||
33438297|NCT00366678|62814478|FG001|After Infant|Adverse Event|0|||
33438298|NCT00366678|62814479|FG002|After Infant|Adverse Event|0|||
33438299|NCT00366678|62814477|FG000|After Infant|Protocol Violation|1|||
33438300|NCT00366678|62814478|FG001|After Infant|Protocol Violation|0|||
33438301|NCT00366678|62814479|FG002|After Infant|Protocol Violation|0|||
33605612|NCT02311478|63005318|FG000|Overall Study|Lost to Follow-up|5|||
33438302|NCT00366678|62814477|FG000|Toddler Dose|Protocol Violation|2|||
33438303|NCT00366678|62814478|FG001|Toddler Dose|Protocol Violation|1|||
33605613|NCT02311478|63005318|FG000|Overall Study|Failed IUD Insertion|1|||
33605614|NCT02388932|63005323|FG000|Overall Study|Death|1|||
33438304|NCT00366678|62814479|FG002|Toddler Dose|Protocol Violation|0|||
33438305|NCT00366678|62814477|FG000|Toddler Dose|Failed to return|1|||
33438306|NCT00366678|62814478|FG001|Toddler Dose|Failed to return|0|||
33438307|NCT00366678|62814479|FG002|Toddler Dose|Failed to return|0|||
33438308|NCT00366678|62814477|FG000|Toddler Dose|Withdrawal by Subject|1|||
33438309|NCT00366678|62814478|FG001|Toddler Dose|Withdrawal by Subject|0|||
33438310|NCT00366678|62814479|FG002|Toddler Dose|Withdrawal by Subject|0|||
33438311|NCT00366678|62814477|FG000|Toddler Dose|protocol deviation|1|||
33438312|NCT00366678|62814478|FG001|Toddler Dose|protocol deviation|0|||
33438313|NCT00366678|62814479|FG002|Toddler Dose|protocol deviation|0|||
33438314|NCT00355368|62814526|FG000|Overall Study|Protocol Violation|8|||
33438315|NCT00355368|62814527|FG001|Overall Study|Protocol Violation|7|||
33438316|NCT00355368|62814526|FG000|Overall Study|cardiac arrest prior to intubation|2|||
33438317|NCT00355368|62814527|FG001|Overall Study|cardiac arrest prior to intubation|2|||
33438318|NCT00360282|62814533|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
33438319|NCT00360282|62814534|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
33438320|NCT00360282|62814535|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
33438321|NCT00360282|62814536|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
33438322|NCT00360282|62814533|FG000|Second Intervention|Adverse Event|0|||
33438323|NCT00360282|62814534|FG001|Second Intervention|Adverse Event|1|||
33438324|NCT00360282|62814535|FG002|Second Intervention|Adverse Event|0|||
33438325|NCT00360282|62814536|FG003|Second Intervention|Adverse Event|0|||
33438326|NCT00373958|62814546|FG000|Infant Series|Withdrawal by Subject|13|||
33438327|NCT00373958|62814547|FG001|Infant Series|Withdrawal by Subject|15|||
33438328|NCT00373958|62814546|FG000|Infant Series|Failed to return|8|||
33438329|NCT00373958|62814547|FG001|Infant Series|Failed to return|13|||
33438330|NCT00373958|62814546|FG000|Infant Series|Lost to Follow-up|6|||
33438331|NCT00373958|62814547|FG001|Infant Series|Lost to Follow-up|5|||
33438332|NCT00373958|62814546|FG000|Infant Series|Protocol Violation|3|||
33438333|NCT00373958|62814547|FG001|Infant Series|Protocol Violation|7|||
33438334|NCT00373958|62814546|FG000|Infant Series|Lost Kaiser coverage|4|||
33438335|NCT00373958|62814547|FG001|Infant Series|Lost Kaiser coverage|0|||
33438336|NCT00373958|62814546|FG000|Infant Series|Child relocated|1|||
33438337|NCT00373958|62814547|FG001|Infant Series|Child relocated|0|||
33438338|NCT00373958|62814546|FG000|Infant Series|Consent was not received|1|||
33438339|NCT00373958|62814547|FG001|Infant Series|Consent was not received|0|||
33438340|NCT00373958|62814546|FG000|Infant Series|Adverse Event|3|||
33438341|NCT00373958|62814547|FG001|Infant Series|Adverse Event|1|||
33438342|NCT00373958|62814546|FG000|Infant Series|Physician Decision|1|||
33438343|NCT00373958|62814547|FG001|Infant Series|Physician Decision|1|||
33438344|NCT00373958|62814546|FG000|Toddler Dose|Lost to Follow-up|5|||
33438345|NCT00373958|62814547|FG001|Toddler Dose|Lost to Follow-up|8|||
33438346|NCT00373958|62814546|FG000|Toddler Dose|Withdrawal by Subject|2|||
33438347|NCT00373958|62814547|FG001|Toddler Dose|Withdrawal by Subject|2|||
33438348|NCT00373958|62814546|FG000|Toddler Dose|Failed to return|1|||
33438349|NCT00373958|62814547|FG001|Toddler Dose|Failed to return|2|||
33438350|NCT00373958|62814546|FG000|Toddler Dose|Protocol Violation|0|||
33438351|NCT00373958|62814547|FG001|Toddler Dose|Protocol Violation|1|||
33438352|NCT00373958|62814546|FG000|Toddler Dose|Withdrawn after infant series|22|||
33438353|NCT00373958|62814547|FG001|Toddler Dose|Withdrawn after infant series|25|||
33438354|NCT00373880|62814576|FG000|Overall Study|Physician Decision|3|||
33438355|NCT00373880|62814576|FG000|Overall Study|Arrested|1|||
33438356|NCT00373880|62814576|FG000|Overall Study|Protocol Violation|14|||
33438357|NCT00184600|62814591|FG000|Overall Study|Adverse Event|9|||
33438358|NCT00184600|62814592|FG001|Overall Study|Adverse Event|0|||
33605615|NCT02388776|63005328|FG000|Overall Study|Death|1|||
33438359|NCT00184600|62814593|FG002|Overall Study|Adverse Event|5|||
33438360|NCT00184600|62814591|FG000|Overall Study|Death|3|||
33438361|NCT00184600|62814592|FG001|Overall Study|Death|9|||
33438362|NCT00184600|62814593|FG002|Overall Study|Death|7|||
33438363|NCT00184600|62814591|FG000|Overall Study|Lack of Efficacy|3|||
33438364|NCT00184600|62814592|FG001|Overall Study|Lack of Efficacy|1|||
33438365|NCT00184600|62814593|FG002|Overall Study|Lack of Efficacy|3|||
33438366|NCT00184600|62814591|FG000|Overall Study|Lost to Follow-up|4|||
33438367|NCT00184600|62814592|FG001|Overall Study|Lost to Follow-up|6|||
33438368|NCT00184600|62814593|FG002|Overall Study|Lost to Follow-up|1|||
33438369|NCT00184600|62814591|FG000|Overall Study|Protocol Violation|2|||
33605616|NCT02388776|63005328|FG000|Overall Study|Lost to Follow-up|1|||
33605617|NCT02316548|63005335|FG000|Overall Study|Protocol Violation|0|||
33605618|NCT02316548|63005336|FG001|Overall Study|Protocol Violation|1|||
33605619|NCT02281760|63005342|FG000|Overall Study|Withdrawal by Subject|1|||
33605620|NCT02390531|63005354|FG000|Overall Study|Death|0|||
33605621|NCT02390531|63005355|FG001|Overall Study|Death|2|||
33605622|NCT02390531|63005356|FG002|Overall Study|Death|0|||
33605623|NCT02390531|63005357|FG003|Overall Study|Death|1|||
33605624|NCT02390531|63005358|FG004|Overall Study|Death|0|||
33605625|NCT02390531|63005359|FG005|Overall Study|Death|0|||
33605626|NCT02390531|63005360|FG006|Overall Study|Death|0|||
33605627|NCT02390531|63005361|FG007|Overall Study|Death|1|||
33605628|NCT02390531|63005354|FG000|Overall Study|Protocol Violation|0|||
33605629|NCT02390531|63005355|FG001|Overall Study|Protocol Violation|0|||
33605630|NCT02390531|63005356|FG002|Overall Study|Protocol Violation|0|||
33605631|NCT02390531|63005357|FG003|Overall Study|Protocol Violation|0|||
33438370|NCT00184600|62814592|FG001|Overall Study|Protocol Violation|2|||
33438371|NCT00184600|62814593|FG002|Overall Study|Protocol Violation|3|||
33438372|NCT00184600|62814591|FG000|Overall Study|Withdrawal by Subject|20|||
33605632|NCT02390531|63005358|FG004|Overall Study|Protocol Violation|1|||
33605633|NCT02390531|63005359|FG005|Overall Study|Protocol Violation|0|||
33605634|NCT02390531|63005360|FG006|Overall Study|Protocol Violation|2|||
33605635|NCT02390531|63005361|FG007|Overall Study|Protocol Violation|0|||
33605636|NCT02390219|63005397|FG000|Overall Study|Death|1|||
33605637|NCT02390219|63005397|FG000|Overall Study|Physician Decision|1|||
33605638|NCT02390219|63005397|FG000|Overall Study|Adverse Event|6|||
33605639|NCT02390219|63005397|FG000|Overall Study|Withdrawal by Subject|1|||
33605640|NCT02390219|63005397|FG000|Overall Study|Lost to Follow-up|2|||
33605641|NCT02390219|63005397|FG000|Overall Study|Other|2|||
33605642|NCT02334215|63005404|FG000|Overall Study|Death|1|||
33605643|NCT02334215|63005405|FG001|Overall Study|Death|1|||
33605644|NCT02334215|63005406|FG002|Overall Study|Death|0|||
33438373|NCT00184600|62814592|FG001|Overall Study|Withdrawal by Subject|28|||
33438374|NCT00184600|62814593|FG002|Overall Study|Withdrawal by Subject|12|||
33438375|NCT00184600|62814591|FG000|Overall Study|Unclassified|4|||
33438376|NCT00184600|62814592|FG001|Overall Study|Unclassified|5|||
33438377|NCT00184600|62814593|FG002|Overall Study|Unclassified|3|||
33438378|NCT00265317|62814605|FG000|Lead-In|Objective progression or relapse|6|||
33438379|NCT00265317|62814606|FG001|Lead-In|Objective progression or relapse|11|||
33438380|NCT00265317|62814607|FG002|Lead-In|Objective progression or relapse|0|||
33494198|NCT03634033|62872937|FG003|Overall Study|Withdrawal by Subject|0|||
33438381|NCT00265317|62814608|FG003|Lead-In|Objective progression or relapse|0|||
33438382|NCT00265317|62814605|FG000|Lead-In|Adverse Event|2|||
33438383|NCT00265317|62814606|FG001|Lead-In|Adverse Event|1|||
33605645|NCT02334215|63005404|FG000|Overall Study|Lost to Follow-up|1|||
33605646|NCT02334215|63005405|FG001|Overall Study|Lost to Follow-up|0|||
33605647|NCT02334215|63005406|FG002|Overall Study|Lost to Follow-up|4|||
33605648|NCT02334215|63005404|FG000|Overall Study|Withdrawal by Subject|2|||
33438384|NCT00265317|62814607|FG002|Lead-In|Adverse Event|0|||
33438385|NCT00265317|62814608|FG003|Lead-In|Adverse Event|0|||
33605649|NCT02334215|63005405|FG001|Overall Study|Withdrawal by Subject|2|||
33605650|NCT02334215|63005406|FG002|Overall Study|Withdrawal by Subject|1|||
33605651|NCT02334215|63005404|FG000|Overall Study|Not released from incarceration on time|3|||
33605652|NCT02334215|63005405|FG001|Overall Study|Not released from incarceration on time|3|||
33323217|NCT00922480|62699470|FG000|Extension Study|Withdrawal by Subject|1|||
33438386|NCT00265317|62814605|FG000|Lead-In|Death|3|||
33438387|NCT00265317|62814606|FG001|Lead-In|Death|5|||
33438388|NCT00265317|62814607|FG002|Lead-In|Death|0|||
33438389|NCT00265317|62814608|FG003|Lead-In|Death|0|||
33438390|NCT00265317|62814605|FG000|Lead-In|Withdrawal/other than adverse event|1|||
33438391|NCT00265317|62814606|FG001|Lead-In|Withdrawal/other than adverse event|0|||
33438392|NCT00265317|62814607|FG002|Lead-In|Withdrawal/other than adverse event|0|||
33438393|NCT00265317|62814608|FG003|Lead-In|Withdrawal/other than adverse event|0|||
33438394|NCT00265317|62814605|FG000|Phase 2|Objective progression or relapse|0|||
33438395|NCT00265317|62814606|FG001|Phase 2|Objective progression or relapse|0|||
33438396|NCT00265317|62814607|FG002|Phase 2|Objective progression or relapse|37|||
33438397|NCT00265317|62814608|FG003|Phase 2|Objective progression or relapse|38|||
33438398|NCT00265317|62814605|FG000|Phase 2|Global deterioration of health status|0|||
33438399|NCT00265317|62814606|FG001|Phase 2|Global deterioration of health status|0|||
33438400|NCT00265317|62814607|FG002|Phase 2|Global deterioration of health status|3|||
33438401|NCT00265317|62814608|FG003|Phase 2|Global deterioration of health status|0|||
33438402|NCT00265317|62814605|FG000|Phase 2|Adverse Event|0|||
33438403|NCT00265317|62814606|FG001|Phase 2|Adverse Event|0|||
33438404|NCT00265317|62814607|FG002|Phase 2|Adverse Event|7|||
33438405|NCT00265317|62814608|FG003|Phase 2|Adverse Event|5|||
33438406|NCT00265317|62814605|FG000|Phase 2|Death|0|||
33438407|NCT00265317|62814606|FG001|Phase 2|Death|0|||
33605653|NCT02334215|63005406|FG002|Overall Study|Not released from incarceration on time|3|||
33605654|NCT02334215|63005404|FG000|Overall Study|Incarcerated|0|||
33605655|NCT02334215|63005405|FG001|Overall Study|Incarcerated|0|||
33605656|NCT02334215|63005406|FG002|Overall Study|Incarcerated|7|||
33605657|NCT02359877|63005418|FG000|Overall Study|Withdrawal by Subject|1|||
33605658|NCT02359877|63005419|FG001|Overall Study|Withdrawal by Subject|0|||
33605659|NCT02359877|63005420|FG002|Overall Study|Withdrawal by Subject|0|||
33605660|NCT02359877|63005421|FG003|Overall Study|Withdrawal by Subject|2|||
33605661|NCT02359877|63005418|FG000|Overall Study|Adverse Event|0|||
33605662|NCT02359877|63005419|FG001|Overall Study|Adverse Event|0|||
33605663|NCT02359877|63005420|FG002|Overall Study|Adverse Event|0|||
33605664|NCT02359877|63005421|FG003|Overall Study|Adverse Event|1|||
33605665|NCT02389829|63005451|FG000|Overall Study|Lost to Follow-up|0|||
33605666|NCT02389829|63005452|FG001|Overall Study|Lost to Follow-up|1|||
33605667|NCT02358863|63005458|FG000|Overall Study|Physician Decision|3|||
33605668|NCT02358473|63005462|FG000|Overall Study|Disease Progession|6|||
33605669|NCT02358473|63005462|FG000|Overall Study|Adverse Event|3|||
33605670|NCT02358473|63005462|FG000|Overall Study|Withdrawal by Subject|2|||
33605671|NCT02358473|63005462|FG000|Overall Study|Physician Decision|2|||
33605672|NCT02357459|63005469|FG000|Overall Study|Adverse Event|0|||
33605673|NCT02357459|63005470|FG001|Overall Study|Adverse Event|1|||
33605674|NCT02357459|63005471|FG002|Overall Study|Adverse Event|1|||
33438408|NCT00265317|62814607|FG002|Phase 2|Death|12|||
33438409|NCT00265317|62814608|FG003|Phase 2|Death|15|||
33438410|NCT00265317|62814605|FG000|Phase 2|Protocol Violation|0|||
33438411|NCT00265317|62814606|FG001|Phase 2|Protocol Violation|0|||
33438412|NCT00265317|62814607|FG002|Phase 2|Protocol Violation|1|||
33605675|NCT02357459|63005469|FG000|Overall Study|Withdrawal by Subject|5|||
33605676|NCT02357459|63005470|FG001|Overall Study|Withdrawal by Subject|3|||
33605677|NCT02357459|63005471|FG002|Overall Study|Withdrawal by Subject|3|||
33605678|NCT02357459|63005469|FG000|Overall Study|Physician Decision|0|||
33438413|NCT00265317|62814608|FG003|Phase 2|Protocol Violation|4|||
33438414|NCT00265317|62814605|FG000|Phase 2|Lost to Follow-up|0|||
33438415|NCT00265317|62814606|FG001|Phase 2|Lost to Follow-up|0|||
33438416|NCT00265317|62814607|FG002|Phase 2|Lost to Follow-up|0|||
33438417|NCT00265317|62814608|FG003|Phase 2|Lost to Follow-up|1|||
33438418|NCT00265317|62814605|FG000|Phase 2|Withdrawal/other than adverse event|0|||
33438419|NCT00265317|62814606|FG001|Phase 2|Withdrawal/other than adverse event|0|||
33438420|NCT00265317|62814607|FG002|Phase 2|Withdrawal/other than adverse event|2|||
33438421|NCT00265317|62814608|FG003|Phase 2|Withdrawal/other than adverse event|1|||
33438422|NCT00265317|62814605|FG000|Phase 2|Study terminated by sponsor|0|||
33438423|NCT00265317|62814606|FG001|Phase 2|Study terminated by sponsor|0|||
33438424|NCT00265317|62814607|FG002|Phase 2|Study terminated by sponsor|1|||
33438425|NCT00265317|62814608|FG003|Phase 2|Study terminated by sponsor|0|||
33438426|NCT00265317|62814605|FG000|Phase 2|Other|0|||
33438427|NCT00265317|62814606|FG001|Phase 2|Other|0|||
33438428|NCT00265317|62814607|FG002|Phase 2|Other|1|||
33438429|NCT00265317|62814608|FG003|Phase 2|Other|1|||
33438430|NCT00373490|62814629|FG000|Overall Study|Adverse Event|0|||
33438431|NCT00373490|62814630|FG001|Overall Study|Adverse Event|1|||
33438432|NCT00373490|62814629|FG000|Overall Study|Lack of Efficacy|9|||
33438433|NCT00373490|62814630|FG001|Overall Study|Lack of Efficacy|4|||
33438434|NCT00373490|62814629|FG000|Overall Study|Withdrawal by Subject|0|||
33438435|NCT00373490|62814630|FG001|Overall Study|Withdrawal by Subject|1|||
33438436|NCT00251589|62814640|FG000|Overall Study|Adverse Event|5|||
33438437|NCT00251589|62814641|FG001|Overall Study|Adverse Event|1|||
33438438|NCT00251589|62814642|FG002|Overall Study|Adverse Event|2|||
33438439|NCT00251589|62814643|FG003|Overall Study|Adverse Event|1|||
33438440|NCT00251589|62814640|FG000|Overall Study|Withdrawal by Subject|1|||
33438441|NCT00251589|62814641|FG001|Overall Study|Withdrawal by Subject|1|||
33438442|NCT00251589|62814642|FG002|Overall Study|Withdrawal by Subject|0|||
33438443|NCT00251589|62814643|FG003|Overall Study|Withdrawal by Subject|0|||
33438444|NCT00251589|62814640|FG000|Overall Study|Discontinued due to progressive disease|9|||
33438445|NCT00251589|62814641|FG001|Overall Study|Discontinued due to progressive disease|1|||
33438446|NCT00251589|62814642|FG002|Overall Study|Discontinued due to progressive disease|0|||
33438447|NCT00251589|62814643|FG003|Overall Study|Discontinued due to progressive disease|1|||
33438448|NCT00265239|62814655|FG000|Overall Study|Adverse Event|2|||
33438449|NCT00265239|62814656|FG001|Overall Study|Adverse Event|1|||
33438450|NCT00350298|62814664|FG000|Overall Study|Death|7|||
33438451|NCT00350298|62814665|FG001|Overall Study|Death|8|||
33438452|NCT00350298|62814664|FG000|Overall Study|Lost to Follow-up|1|||
33438453|NCT00350298|62814665|FG001|Overall Study|Lost to Follow-up|2|||
33438454|NCT00350298|62814664|FG000|Overall Study|Withdrawal by Subject|1|||
33438455|NCT00350298|62814665|FG001|Overall Study|Withdrawal by Subject|3|||
33438456|NCT00159874|62814678|FG000|Overall Study|Adverse Event|2|||
33438457|NCT00159874|62814679|FG001|Overall Study|Adverse Event|2|||
33438458|NCT00159874|62814680|FG002|Overall Study|Adverse Event|5|||
33438459|NCT00159874|62814681|FG003|Overall Study|Adverse Event|1|||
33438460|NCT00159874|62814682|FG004|Overall Study|Adverse Event|1|||
33438461|NCT00159874|62814683|FG005|Overall Study|Adverse Event|2|||
33438462|NCT00159874|62814684|FG006|Overall Study|Adverse Event|0|||
33438463|NCT00159874|62814678|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
33438464|NCT00159874|62814679|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
33438465|NCT00159874|62814680|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
33438466|NCT00159874|62814681|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
33438467|NCT00159874|62814682|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
33438468|NCT00159874|62814683|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
33438469|NCT00159874|62814684|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
33438470|NCT00159874|62814678|FG000|Overall Study|Lack of Efficacy|2|||
33438471|NCT00159874|62814679|FG001|Overall Study|Lack of Efficacy|0|||
33438472|NCT00159874|62814680|FG002|Overall Study|Lack of Efficacy|1|||
33438473|NCT00159874|62814681|FG003|Overall Study|Lack of Efficacy|1|||
33438474|NCT00159874|62814682|FG004|Overall Study|Lack of Efficacy|0|||
33438475|NCT00159874|62814683|FG005|Overall Study|Lack of Efficacy|3|||
33438476|NCT00159874|62814684|FG006|Overall Study|Lack of Efficacy|0|||
33438477|NCT00159874|62814678|FG000|Overall Study|Lost to Follow-up|1|||
33438478|NCT00159874|62814679|FG001|Overall Study|Lost to Follow-up|0|||
33438479|NCT00159874|62814680|FG002|Overall Study|Lost to Follow-up|3|||
33438480|NCT00159874|62814681|FG003|Overall Study|Lost to Follow-up|0|||
33438481|NCT00159874|62814682|FG004|Overall Study|Lost to Follow-up|1|||
33438482|NCT00159874|62814683|FG005|Overall Study|Lost to Follow-up|2|||
33438483|NCT00159874|62814684|FG006|Overall Study|Lost to Follow-up|1|||
33438484|NCT00159874|62814678|FG000|Overall Study|Other|8|||
33438485|NCT00159874|62814679|FG001|Overall Study|Other|8|||
33438486|NCT00159874|62814680|FG002|Overall Study|Other|8|||
33438487|NCT00159874|62814681|FG003|Overall Study|Other|0|||
33438488|NCT00159874|62814682|FG004|Overall Study|Other|2|||
33438489|NCT00159874|62814683|FG005|Overall Study|Other|1|||
33438490|NCT00159874|62814684|FG006|Overall Study|Other|3|||
33438491|NCT00159874|62814678|FG000|Overall Study|Protocol Violation|0|||
33438492|NCT00159874|62814679|FG001|Overall Study|Protocol Violation|5|||
33438493|NCT00159874|62814680|FG002|Overall Study|Protocol Violation|2|||
33438494|NCT00159874|62814681|FG003|Overall Study|Protocol Violation|0|||
33438495|NCT00159874|62814682|FG004|Overall Study|Protocol Violation|0|||
33438496|NCT00159874|62814683|FG005|Overall Study|Protocol Violation|0|||
33438497|NCT00159874|62814684|FG006|Overall Study|Protocol Violation|0|||
33438498|NCT00159874|62814678|FG000|Overall Study|Death|3|||
33438499|NCT00159874|62814679|FG001|Overall Study|Death|8|||
33438500|NCT00159874|62814680|FG002|Overall Study|Death|15|||
33438501|NCT00159874|62814681|FG003|Overall Study|Death|0|||
33438502|NCT00159874|62814682|FG004|Overall Study|Death|1|||
33438503|NCT00159874|62814683|FG005|Overall Study|Death|2|||
33438504|NCT00159874|62814684|FG006|Overall Study|Death|0|||
33438505|NCT00159874|62814678|FG000|Overall Study|Withdrawal by Subject|2|||
33438506|NCT00159874|62814679|FG001|Overall Study|Withdrawal by Subject|6|||
33438507|NCT00159874|62814680|FG002|Overall Study|Withdrawal by Subject|8|||
33438508|NCT00159874|62814681|FG003|Overall Study|Withdrawal by Subject|4|||
33438509|NCT00159874|62814682|FG004|Overall Study|Withdrawal by Subject|3|||
33438510|NCT00159874|62814683|FG005|Overall Study|Withdrawal by Subject|2|||
33438511|NCT00159874|62814684|FG006|Overall Study|Withdrawal by Subject|1|||
33438512|NCT00159874|62814678|FG000|Overall Study|Pregnancy|1|||
33438513|NCT00159874|62814679|FG001|Overall Study|Pregnancy|1|||
33438514|NCT00159874|62814680|FG002|Overall Study|Pregnancy|0|||
33438515|NCT00159874|62814681|FG003|Overall Study|Pregnancy|0|||
33438516|NCT00159874|62814682|FG004|Overall Study|Pregnancy|0|||
33438517|NCT00159874|62814683|FG005|Overall Study|Pregnancy|0|||
33438518|NCT00159874|62814684|FG006|Overall Study|Pregnancy|0|||
33438519|NCT00349908|62814702|FG000|Overall Study|Withdrawal by Subject|0|||
33438520|NCT00349908|62814703|FG001|Overall Study|Withdrawal by Subject|4|||
33438521|NCT00184054|62814710|FG000|Overall Study|Adverse Event|1|||
33438522|NCT00183430|62814716|FG000|Overall Study|Adverse Event|1|||
33438523|NCT00183430|62814717|FG001|Overall Study|Adverse Event|0|||
33438524|NCT00183430|62814716|FG000|Overall Study|Lost to Follow-up|3|||
33438525|NCT00183430|62814717|FG001|Overall Study|Lost to Follow-up|0|||
33438526|NCT00183430|62814716|FG000|Overall Study|did not meet inclusion criteria|1|||
33438527|NCT00183430|62814717|FG001|Overall Study|did not meet inclusion criteria|0|||
33438528|NCT00183430|62814716|FG000|Overall Study|Withdrawal by Subject|1|||
33438529|NCT00183430|62814717|FG001|Overall Study|Withdrawal by Subject|0|||
33438530|NCT00183274|62814723|FG000|Phase 1: Open-Label|Adverse Event|31|||
33438531|NCT00183274|62814724|FG001|Phase 1: Open-Label|Adverse Event|0|||
33438532|NCT00183274|62814725|FG002|Phase 1: Open-Label|Adverse Event|0|||
33438533|NCT00183274|62814726|FG003|Phase 1: Open-Label|Adverse Event|0|||
33438534|NCT00183274|62814727|FG004|Phase 1: Open-Label|Adverse Event|0|||
33438535|NCT00183274|62814728|FG005|Phase 1: Open-Label|Adverse Event|0|||
33438536|NCT00183274|62814723|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
33438537|NCT00183274|62814724|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
33438538|NCT00183274|62814725|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
33438539|NCT00183274|62814726|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
33438540|NCT00183274|62814727|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
33438541|NCT00183274|62814728|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
33438542|NCT00183274|62814723|FG000|Phase 1: Open-Label|Protocol Violation|11|||
33438543|NCT00183274|62814724|FG001|Phase 1: Open-Label|Protocol Violation|0|||
33438544|NCT00183274|62814725|FG002|Phase 1: Open-Label|Protocol Violation|0|||
33438545|NCT00183274|62814726|FG003|Phase 1: Open-Label|Protocol Violation|0|||
33438546|NCT00183274|62814727|FG004|Phase 1: Open-Label|Protocol Violation|0|||
33438547|NCT00183274|62814728|FG005|Phase 1: Open-Label|Protocol Violation|0|||
33438548|NCT00183274|62814723|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
33438549|NCT00183274|62814724|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
33438550|NCT00183274|62814725|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
33438551|NCT00183274|62814726|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
33438552|NCT00183274|62814727|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
33438553|NCT00183274|62814728|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
33438554|NCT00183274|62814723|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
33438555|NCT00183274|62814724|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
33438556|NCT00183274|62814725|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
33438557|NCT00183274|62814726|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
33438558|NCT00183274|62814727|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
33438559|NCT00183274|62814728|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
33438560|NCT00183274|62814723|FG000|Phase 1: Open-Label|Other|9|||
33438561|NCT00183274|62814724|FG001|Phase 1: Open-Label|Other|0|||
33438562|NCT00183274|62814725|FG002|Phase 1: Open-Label|Other|0|||
33438563|NCT00183274|62814726|FG003|Phase 1: Open-Label|Other|0|||
33438564|NCT00183274|62814727|FG004|Phase 1: Open-Label|Other|0|||
33438565|NCT00183274|62814728|FG005|Phase 1: Open-Label|Other|0|||
33438566|NCT00183274|62814723|FG000|Phase 2: Double-Blind|Relapsed|0|||
33438567|NCT00183274|62814724|FG001|Phase 2: Double-Blind|Relapsed|8|||
33438568|NCT00183274|62814725|FG002|Phase 2: Double-Blind|Relapsed|29|||
33438569|NCT00183274|62814726|FG003|Phase 2: Double-Blind|Relapsed|0|||
33438570|NCT00183274|62814727|FG004|Phase 2: Double-Blind|Relapsed|0|||
33438571|NCT00183274|62814728|FG005|Phase 2: Double-Blind|Relapsed|0|||
33438572|NCT00183274|62814723|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
33438573|NCT00183274|62814724|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
33438574|NCT00183274|62814725|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
33438575|NCT00183274|62814726|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
33438576|NCT00183274|62814727|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
33438577|NCT00183274|62814728|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
33438578|NCT00183274|62814723|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
33438579|NCT00183274|62814724|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
33438580|NCT00183274|62814725|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
33438581|NCT00183274|62814726|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
33438582|NCT00183274|62814727|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
33438583|NCT00183274|62814728|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
33438584|NCT00183274|62814723|FG000|Phase 3: Double-Blind|Relapsed|0|||
33438585|NCT00183274|62814724|FG001|Phase 3: Double-Blind|Relapsed|0|||
33438586|NCT00183274|62814725|FG002|Phase 3: Double-Blind|Relapsed|0|||
33438587|NCT00183274|62814726|FG003|Phase 3: Double-Blind|Relapsed|1|||
33438588|NCT00183274|62814727|FG004|Phase 3: Double-Blind|Relapsed|11|||
33438589|NCT00183274|62814728|FG005|Phase 3: Double-Blind|Relapsed|2|||
33438590|NCT00183196|62814746|FG000|Overall Study|Withdrawal by Subject|18|||
33438591|NCT00183196|62814747|FG001|Overall Study|Withdrawal by Subject|11|||
33438592|NCT00183196|62814748|FG002|Overall Study|Withdrawal by Subject|13|||
33438593|NCT00183196|62814746|FG000|Overall Study|Adverse Event|1|||
33438594|NCT00183196|62814747|FG001|Overall Study|Adverse Event|2|||
33438595|NCT00183196|62814748|FG002|Overall Study|Adverse Event|2|||
33438596|NCT00183196|62814746|FG000|Overall Study|Legal event|1|||
33438597|NCT00183196|62814747|FG001|Overall Study|Legal event|1|||
33438598|NCT00183196|62814748|FG002|Overall Study|Legal event|1|||
33438599|NCT00183196|62814746|FG000|Overall Study|Required more intensive care|0|||
33438600|NCT00183196|62814747|FG001|Overall Study|Required more intensive care|1|||
33438601|NCT00183196|62814748|FG002|Overall Study|Required more intensive care|2|||
33438602|NCT00349752|62814758|FG000|Overall Study|Adverse Event|8|||
33438603|NCT00349752|62814759|FG001|Overall Study|Adverse Event|12|||
33438604|NCT00349752|62814758|FG000|Overall Study|Lack of Efficacy|37|||
33438605|NCT00349752|62814759|FG001|Overall Study|Lack of Efficacy|42|||
33438606|NCT00349752|62814758|FG000|Overall Study|Lost to Follow-up|4|||
33438607|NCT00349752|62814759|FG001|Overall Study|Lost to Follow-up|2|||
33438608|NCT00349752|62814758|FG000|Overall Study|Personal reasons|6|||
33438609|NCT00349752|62814759|FG001|Overall Study|Personal reasons|5|||
33438610|NCT00349752|62814758|FG000|Overall Study|Other: Required exclusionary medication|0|||
33438611|NCT00349752|62814759|FG001|Overall Study|Other: Required exclusionary medication|1|||
33438612|NCT00349752|62814758|FG000|Overall Study|Other: Non compliance|0|||
33438613|NCT00349752|62814759|FG001|Overall Study|Other: Non compliance|1|||
33323218|NCT00922480|62699471|FG001|Extension Study|Withdrawal by Subject|1|||
33438614|NCT00349752|62814758|FG000|Overall Study|Other: Patient stopped steroids|0|||
33438615|NCT00349752|62814759|FG001|Overall Study|Other: Patient stopped steroids|1|||
33438616|NCT00349752|62814758|FG000|Overall Study|Other: Patient's steroid use|1|||
33438617|NCT00349752|62814759|FG001|Overall Study|Other: Patient's steroid use|0|||
33438618|NCT00349752|62814758|FG000|Overall Study|Other: Ineligible|1|||
33438619|NCT00349752|62814759|FG001|Overall Study|Other: Ineligible|0|||
33438620|NCT00349752|62814758|FG000|Overall Study|Other: Inadvertently unblinded|1|||
33438621|NCT00349752|62814759|FG001|Overall Study|Other: Inadvertently unblinded|0|||
33438622|NCT00349752|62814758|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
33438623|NCT00349752|62814759|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
33438624|NCT00174460|62814767|FG000|Overall Study|Withdrawal by Subject|0|||
33438625|NCT00174460|62814768|FG001|Overall Study|Withdrawal by Subject|1|||
33438626|NCT00348816|62814775|FG000|Overall Study|Noncompliance with radiation treatment|1|||
33438627|NCT00265083|62814784|FG000|Overall Study|Adverse Event|5|||
33438628|NCT00265083|62814785|FG001|Overall Study|Adverse Event|13|||
33438629|NCT00265083|62814786|FG002|Overall Study|Adverse Event|15|||
33438630|NCT00265083|62814784|FG000|Overall Study|Lost to Follow-up|3|||
33438631|NCT00265083|62814785|FG001|Overall Study|Lost to Follow-up|4|||
33438632|NCT00265083|62814786|FG002|Overall Study|Lost to Follow-up|4|||
33438633|NCT00265083|62814784|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
33438634|NCT00265083|62814785|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
33438635|NCT00265083|62814786|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
33438636|NCT00265083|62814784|FG000|Overall Study|Other|1|||
33438637|NCT00265083|62814785|FG001|Overall Study|Other|12|||
33438638|NCT00265083|62814786|FG002|Overall Study|Other|9|||
33438639|NCT00264849|62814797|FG000|Overall Study|Adverse Event|7|||
33438640|NCT00264849|62814798|FG001|Overall Study|Adverse Event|2|||
33438641|NCT00264849|62814797|FG000|Overall Study|Withdrawal by Subject|7|||
33438642|NCT00264849|62814798|FG001|Overall Study|Withdrawal by Subject|11|||
33438643|NCT00264849|62814797|FG000|Overall Study|Protocol Violation|5|||
33438644|NCT00264849|62814798|FG001|Overall Study|Protocol Violation|3|||
33438645|NCT00264849|62814797|FG000|Overall Study|Lack of Efficacy|1|||
33438646|NCT00264849|62814798|FG001|Overall Study|Lack of Efficacy|6|||
33438647|NCT00264849|62814797|FG000|Overall Study|Lost to Follow-up|0|||
33438648|NCT00264849|62814798|FG001|Overall Study|Lost to Follow-up|2|||
33438649|NCT00264849|62814797|FG000|Overall Study|Death|0|||
33438650|NCT00264849|62814798|FG001|Overall Study|Death|1|||
33438651|NCT00264849|62814797|FG000|Overall Study|Administrative Problems|2|||
33438652|NCT00264849|62814798|FG001|Overall Study|Administrative Problems|0|||
33438653|NCT00211809|62814804|FG000|Overall Study|Lack of Efficacy|1|||
33438654|NCT00211809|62814804|FG000|Overall Study|Lost to Follow-up|2|||
33438655|NCT00211809|62814804|FG000|Overall Study|Pregnancy|1|||
33438656|NCT00211809|62814804|FG000|Overall Study|side effects|2|||
33438657|NCT00129766|62814812|FG000|Overall Study|Death|3|||
33438658|NCT00129766|62814813|FG001|Overall Study|Death|8|||
33438659|NCT00129766|62814812|FG000|Overall Study|Withdrawal of consent|31|||
33438660|NCT00129766|62814813|FG001|Overall Study|Withdrawal of consent|30|||
33438661|NCT00129766|62814812|FG000|Overall Study|Lost to Follow-up|26|||
33438662|NCT00129766|62814813|FG001|Overall Study|Lost to Follow-up|21|||
33438663|NCT00150592|62814822|FG000|Overall Study|Adverse Event|4|||
33438664|NCT00150592|62814823|FG001|Overall Study|Adverse Event|1|||
33438665|NCT00150592|62814822|FG000|Overall Study|Protocol Violation|1|||
33438666|NCT00150592|62814823|FG001|Overall Study|Protocol Violation|0|||
33438667|NCT00150592|62814822|FG000|Overall Study|Withdrawal by Subject|1|||
33438668|NCT00150592|62814823|FG001|Overall Study|Withdrawal by Subject|2|||
33438669|NCT00150592|62814822|FG000|Overall Study|Non-compliance|1|||
33438670|NCT00150592|62814823|FG001|Overall Study|Non-compliance|0|||
33438671|NCT00149890|62814831|FG000|Overall Study|Adverse Event|1|||
33605679|NCT02357459|63005470|FG001|Overall Study|Physician Decision|2|||
33605680|NCT02357459|63005471|FG002|Overall Study|Physician Decision|0|||
33605681|NCT02357459|63005469|FG000|Overall Study|Protocol Violation|1|||
33605682|NCT02357459|63005470|FG001|Overall Study|Protocol Violation|1|||
33605683|NCT02357459|63005471|FG002|Overall Study|Protocol Violation|0|||
33605684|NCT02357459|63005469|FG000|Overall Study|Lost to Follow-up|1|||
33438672|NCT00149890|62814832|FG001|Overall Study|Adverse Event|8|||
33438673|NCT00149890|62814831|FG000|Overall Study|Lack of Efficacy|8|||
33438674|NCT00149890|62814832|FG001|Overall Study|Lack of Efficacy|9|||
33438675|NCT00149890|62814831|FG000|Overall Study|Protocol Violation|1|||
33438676|NCT00149890|62814832|FG001|Overall Study|Protocol Violation|0|||
33438677|NCT00149890|62814831|FG000|Overall Study|Lost to Follow-up|1|||
33438678|NCT00149890|62814832|FG001|Overall Study|Lost to Follow-up|0|||
33438679|NCT00149890|62814831|FG000|Overall Study|Graft Loss|2|||
33438680|NCT00149890|62814832|FG001|Overall Study|Graft Loss|1|||
33438681|NCT00174382|62814838|FG000|Overall Study|Death|2|||
33438682|NCT00174382|62814838|FG000|Overall Study|Adverse Event|19|||
33438683|NCT00174382|62814838|FG000|Overall Study|Withdrawal by Subject|6|||
33438684|NCT00174382|62814838|FG000|Overall Study|Protocol Violation|3|||
33438685|NCT00174382|62814838|FG000|Overall Study|Arrived early for last visit in error|1|||
33605685|NCT02357459|63005470|FG001|Overall Study|Lost to Follow-up|3|||
33605686|NCT02357459|63005471|FG002|Overall Study|Lost to Follow-up|0|||
33605687|NCT02357459|63005469|FG000|Overall Study|Lack of Efficacy|7|||
33605688|NCT02357459|63005470|FG001|Overall Study|Lack of Efficacy|4|||
33605689|NCT02357459|63005471|FG002|Overall Study|Lack of Efficacy|4|||
33605690|NCT02357459|63005469|FG000|Overall Study|Patient Relocated|2|||
33438686|NCT00174382|62814838|FG000|Overall Study|Subject felt pill not effective enough|1|||
33438687|NCT00174382|62814838|FG000|Overall Study|Lost to Follow-up|1|||
33438688|NCT00355134|62814847|FG000|Core Phase|Withdrawal by Subject|35|||
33438689|NCT00355134|62814848|FG001|Core Phase|Withdrawal by Subject|24|||
33605691|NCT02357459|63005470|FG001|Overall Study|Patient Relocated|0|||
33605692|NCT02357459|63005471|FG002|Overall Study|Patient Relocated|0|||
33605693|NCT02357459|63005469|FG000|Overall Study|Instruction from PCP|1|||
33438690|NCT00355134|62814849|FG002|Core Phase|Withdrawal by Subject|35|||
33438691|NCT00355134|62814850|FG003|Core Phase|Withdrawal by Subject|0|||
33438692|NCT00355134|62814851|FG004|Core Phase|Withdrawal by Subject|0|||
33438693|NCT00355134|62814847|FG000|Core Phase|Adverse Event|28|||
33438694|NCT00355134|62814848|FG001|Core Phase|Adverse Event|22|||
33438695|NCT00355134|62814849|FG002|Core Phase|Adverse Event|16|||
33438696|NCT00355134|62814850|FG003|Core Phase|Adverse Event|0|||
33438697|NCT00355134|62814851|FG004|Core Phase|Adverse Event|0|||
33438698|NCT00355134|62814847|FG000|Core Phase|Lost to Follow-up|17|||
33438699|NCT00355134|62814848|FG001|Core Phase|Lost to Follow-up|13|||
33438700|NCT00355134|62814849|FG002|Core Phase|Lost to Follow-up|21|||
33438701|NCT00355134|62814850|FG003|Core Phase|Lost to Follow-up|0|||
33438702|NCT00355134|62814851|FG004|Core Phase|Lost to Follow-up|0|||
33438703|NCT00355134|62814847|FG000|Core Phase|Abnormal laboratory value(s)|19|||
33438704|NCT00355134|62814848|FG001|Core Phase|Abnormal laboratory value(s)|14|||
33438705|NCT00355134|62814849|FG002|Core Phase|Abnormal laboratory value(s)|2|||
33438706|NCT00355134|62814850|FG003|Core Phase|Abnormal laboratory value(s)|0|||
33438707|NCT00355134|62814851|FG004|Core Phase|Abnormal laboratory value(s)|0|||
33438708|NCT00355134|62814847|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
33438709|NCT00355134|62814848|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
33438710|NCT00355134|62814849|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
33438711|NCT00355134|62814850|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
33438712|NCT00355134|62814851|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
33438713|NCT00355134|62814847|FG000|Core Phase|Administrative problems|5|||
33438714|NCT00355134|62814848|FG001|Core Phase|Administrative problems|3|||
33438715|NCT00355134|62814849|FG002|Core Phase|Administrative problems|5|||
33438716|NCT00355134|62814850|FG003|Core Phase|Administrative problems|0|||
33438717|NCT00355134|62814851|FG004|Core Phase|Administrative problems|0|||
33438718|NCT00355134|62814847|FG000|Core Phase|Protocol Violation|3|||
33438719|NCT00355134|62814848|FG001|Core Phase|Protocol Violation|2|||
33438720|NCT00355134|62814849|FG002|Core Phase|Protocol Violation|2|||
33438721|NCT00355134|62814850|FG003|Core Phase|Protocol Violation|0|||
33438722|NCT00355134|62814851|FG004|Core Phase|Protocol Violation|0|||
33438723|NCT00355134|62814847|FG000|Core Phase|Abnormal test procedure result(s)|1|||
33438724|NCT00355134|62814848|FG001|Core Phase|Abnormal test procedure result(s)|2|||
33438725|NCT00355134|62814849|FG002|Core Phase|Abnormal test procedure result(s)|1|||
33438726|NCT00355134|62814850|FG003|Core Phase|Abnormal test procedure result(s)|0|||
33438727|NCT00355134|62814851|FG004|Core Phase|Abnormal test procedure result(s)|0|||
33438728|NCT00355134|62814847|FG000|Core Phase|Condition no longer requires study drug|1|||
33438729|NCT00355134|62814848|FG001|Core Phase|Condition no longer requires study drug|0|||
33438730|NCT00355134|62814849|FG002|Core Phase|Condition no longer requires study drug|1|||
33438731|NCT00355134|62814850|FG003|Core Phase|Condition no longer requires study drug|0|||
33438732|NCT00355134|62814851|FG004|Core Phase|Condition no longer requires study drug|0|||
33438733|NCT00355134|62814847|FG000|Extension Phase|Withdrawal by Subject|7|||
33438734|NCT00355134|62814848|FG001|Extension Phase|Withdrawal by Subject|11|||
33438735|NCT00355134|62814849|FG002|Extension Phase|Withdrawal by Subject|0|||
33438736|NCT00355134|62814850|FG003|Extension Phase|Withdrawal by Subject|7|||
33438737|NCT00355134|62814851|FG004|Extension Phase|Withdrawal by Subject|5|||
33438738|NCT00355134|62814847|FG000|Extension Phase|Adverse Event|13|||
33438739|NCT00355134|62814848|FG001|Extension Phase|Adverse Event|9|||
33438740|NCT00355134|62814849|FG002|Extension Phase|Adverse Event|0|||
33438741|NCT00355134|62814850|FG003|Extension Phase|Adverse Event|3|||
33438742|NCT00355134|62814851|FG004|Extension Phase|Adverse Event|5|||
33438743|NCT00355134|62814847|FG000|Extension Phase|Lost to Follow-up|2|||
33438744|NCT00355134|62814848|FG001|Extension Phase|Lost to Follow-up|6|||
33438745|NCT00355134|62814849|FG002|Extension Phase|Lost to Follow-up|0|||
33438746|NCT00355134|62814850|FG003|Extension Phase|Lost to Follow-up|2|||
33438747|NCT00355134|62814851|FG004|Extension Phase|Lost to Follow-up|4|||
33438748|NCT00355134|62814847|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
33438749|NCT00355134|62814848|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
33438750|NCT00355134|62814849|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
33438751|NCT00355134|62814850|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
33438752|NCT00355134|62814851|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
33438753|NCT00355134|62814847|FG000|Extension Phase|Administrative problems|2|||
33438754|NCT00355134|62814848|FG001|Extension Phase|Administrative problems|4|||
33438755|NCT00355134|62814849|FG002|Extension Phase|Administrative problems|0|||
33438756|NCT00355134|62814850|FG003|Extension Phase|Administrative problems|1|||
33438757|NCT00355134|62814851|FG004|Extension Phase|Administrative problems|1|||
33438758|NCT00355134|62814847|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
33438759|NCT00355134|62814848|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
33438760|NCT00355134|62814849|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
33438761|NCT00355134|62814850|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
33438762|NCT00355134|62814851|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
33438763|NCT00355134|62814847|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
33438764|NCT00355134|62814848|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
33438765|NCT00355134|62814849|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
33438766|NCT00355134|62814850|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
33438767|NCT00355134|62814851|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
33438768|NCT00355134|62814847|FG000|Extension Phase|Protocol Violation|0|||
33438769|NCT00355134|62814848|FG001|Extension Phase|Protocol Violation|0|||
33438770|NCT00355134|62814849|FG002|Extension Phase|Protocol Violation|0|||
33438771|NCT00355134|62814850|FG003|Extension Phase|Protocol Violation|1|||
33605694|NCT02357459|63005470|FG001|Overall Study|Instruction from PCP|0|||
33605695|NCT02357459|63005471|FG002|Overall Study|Instruction from PCP|0|||
33605696|NCT02357459|63005469|FG000|Overall Study|Incarceration|0|||
33605697|NCT02357459|63005470|FG001|Overall Study|Incarceration|0|||
33438772|NCT00355134|62814851|FG004|Extension Phase|Protocol Violation|0|||
33438773|NCT00171730|62814861|FG000|Overall Study|Adverse Event|3|||
33438774|NCT00171730|62814861|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
33438775|NCT00171730|62814861|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
33438776|NCT00171730|62814861|FG000|Overall Study|Withdrawal by Subject|3|||
33464818|NCT00041756|62838332|FG001|Overall Study|Unable to meet protocol criteria|0|||
33464819|NCT00041756|62838333|FG002|Overall Study|Unable to meet protocol criteria|1|||
33464820|NCT00041756|62838334|FG003|Overall Study|Unable to meet protocol criteria|0|||
33464821|NCT00041756|62838335|FG004|Overall Study|Unable to meet protocol criteria|1|||
33464822|NCT00041756|62838331|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
33464823|NCT00041756|62838332|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
33464824|NCT00041756|62838333|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
33464825|NCT00041756|62838334|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
33464826|NCT00041756|62838335|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
33464827|NCT00041132|62838347|FG000|Overall Study|Adverse Event|19|||
33464828|NCT00041132|62838347|FG000|Overall Study|Death|1|||
33464829|NCT00041132|62838347|FG000|Overall Study|Not Eligible|7|||
33464830|NCT00041132|62838347|FG000|Overall Study|Withdrawal by Subject|1|||
33464831|NCT00041132|62838347|FG000|Overall Study|Physician Decision|2|||
33464832|NCT00040742|62838355|FG000|Overall Study|Death|0|||
33464833|NCT00040742|62838356|FG001|Overall Study|Death|0|||
33464834|NCT00040742|62838357|FG002|Overall Study|Death|1|||
33464835|NCT00040742|62838358|FG003|Overall Study|Death|0|||
33464836|NCT00040742|62838355|FG000|Overall Study|Adverse Event|15|||
33464837|NCT00040742|62838356|FG001|Overall Study|Adverse Event|16|||
33464838|NCT00040742|62838357|FG002|Overall Study|Adverse Event|21|||
33464839|NCT00040742|62838358|FG003|Overall Study|Adverse Event|9|||
33464840|NCT00040742|62838355|FG000|Overall Study|Withdrawal by Subject|7|||
33464841|NCT00040742|62838356|FG001|Overall Study|Withdrawal by Subject|15|||
33464842|NCT00040742|62838357|FG002|Overall Study|Withdrawal by Subject|10|||
33464843|NCT00040742|62838358|FG003|Overall Study|Withdrawal by Subject|13|||
33464844|NCT00040742|62838355|FG000|Overall Study|Chemotoxicity|4|||
33464845|NCT00040742|62838356|FG001|Overall Study|Chemotoxicity|3|||
33464846|NCT00040742|62838357|FG002|Overall Study|Chemotoxicity|5|||
33464847|NCT00040742|62838358|FG003|Overall Study|Chemotoxicity|2|||
33464848|NCT00040742|62838355|FG000|Overall Study|Incomplete Forms|6|||
33464849|NCT00040742|62838356|FG001|Overall Study|Incomplete Forms|10|||
33464850|NCT00040742|62838357|FG002|Overall Study|Incomplete Forms|4|||
33464851|NCT00040742|62838358|FG003|Overall Study|Incomplete Forms|5|||
33464852|NCT00040742|62838355|FG000|Overall Study|Other medical|7|||
33464853|NCT00040742|62838356|FG001|Overall Study|Other medical|5|||
33464854|NCT00040742|62838357|FG002|Overall Study|Other medical|5|||
33464855|NCT00040742|62838358|FG003|Overall Study|Other medical|5|||
33464856|NCT00040664|62838368|FG000|Overall Study|Adverse Event|12|||
33464857|NCT00040664|62838369|FG001|Overall Study|Adverse Event|3|||
33464858|NCT00040664|62838370|FG002|Overall Study|Adverse Event|2|||
33464859|NCT00040664|62838371|FG003|Overall Study|Adverse Event|7|||
33464860|NCT00040664|62838368|FG000|Overall Study|Lack of Efficacy|9|||
33494199|NCT03634033|62872938|FG004|Overall Study|Withdrawal by Subject|0|||
33605698|NCT02357459|63005471|FG002|Overall Study|Incarceration|1|||
33605699|NCT02357459|63005469|FG000|Overall Study|Pre-planned Knee surgery|0|||
33323219|NCT00922480|62699470|FG000|Extension Study|Others|0|||
33323220|NCT00922480|62699471|FG001|Extension Study|Others|1|||
33323221|NCT00973479|62699481|FG000|Overall Study|Lost to Follow-up|0|||
33464861|NCT00040664|62838369|FG001|Overall Study|Lack of Efficacy|2|||
33464862|NCT00040664|62838370|FG002|Overall Study|Lack of Efficacy|3|||
33464863|NCT00040664|62838371|FG003|Overall Study|Lack of Efficacy|4|||
33464864|NCT00040664|62838368|FG000|Overall Study|Insufficient CD4 response|1|||
33464865|NCT00040664|62838369|FG001|Overall Study|Insufficient CD4 response|0|||
33464866|NCT00040664|62838370|FG002|Overall Study|Insufficient CD4 response|1|||
33464867|NCT00040664|62838371|FG003|Overall Study|Insufficient CD4 response|0|||
33464868|NCT00040664|62838368|FG000|Overall Study|Lost to Follow-up|4|||
33464869|NCT00040664|62838369|FG001|Overall Study|Lost to Follow-up|2|||
33323222|NCT00973479|62699482|FG001|Overall Study|Lost to Follow-up|3|||
33464870|NCT00040664|62838370|FG002|Overall Study|Lost to Follow-up|0|||
33605700|NCT02357459|63005470|FG001|Overall Study|Pre-planned Knee surgery|0|||
33438777|NCT00355056|62814873|FG000|Randomization Period|Early Termination|4|||
33438778|NCT00355056|62814874|FG001|Randomization Period|Early Termination|6|||
33438779|NCT00348348|62814890|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
33438780|NCT00348348|62814891|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
33438781|NCT00348348|62814890|FG000|Overall Study|Lack of Efficacy|1|||
33438782|NCT00348348|62814891|FG001|Overall Study|Lack of Efficacy|1|||
33438783|NCT00348348|62814890|FG000|Overall Study|Lost to Follow-up|8|||
33438784|NCT00348348|62814891|FG001|Overall Study|Lost to Follow-up|10|||
33438785|NCT00348348|62814890|FG000|Overall Study|Withdrawal by Subject|4|||
33438786|NCT00348348|62814891|FG001|Overall Study|Withdrawal by Subject|1|||
33438787|NCT00348348|62814890|FG000|Overall Study|Other|7|||
33438788|NCT00348348|62814891|FG001|Overall Study|Other|4|||
33438789|NCT00348348|62814890|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
33438790|NCT00348348|62814891|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
33438791|NCT00348348|62814890|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
33438792|NCT00348348|62814891|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
33438793|NCT00348348|62814890|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
33438794|NCT00348348|62814891|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
33438795|NCT00348348|62814890|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
33438796|NCT00348348|62814891|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
33438797|NCT00348348|62814890|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
33438798|NCT00348348|62814891|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
33438799|NCT00348348|62814890|FG000|Overall Study|Adverse event probably related to study|1|||
33438800|NCT00348348|62814891|FG001|Overall Study|Adverse event probably related to study|0|||
33438801|NCT00347958|62814897|FG000|Overall Study|Adverse Event|1|||
33438802|NCT00347958|62814897|FG000|Overall Study|Protocol Violation|2|||
33438803|NCT00347958|62814897|FG000|Overall Study|Withdrawal by Subject|1|||
33438804|NCT00354744|62814901|FG000|Overall Study|Adverse Event|2|||
33438805|NCT00354744|62814901|FG000|Overall Study|Death|2|||
33438806|NCT00354744|62814901|FG000|Overall Study|Lack of Efficacy|11|||
33438807|NCT00354744|62814901|FG000|Overall Study|Lost to Follow-up|2|||
33438808|NCT00354744|62814901|FG000|Overall Study|Physician Decision|11|||
33438809|NCT00354744|62814901|FG000|Overall Study|Withdrawal by Subject|14|||
33438810|NCT00373256|62814909|FG000|Overall Study|Adverse Event (AE)|1|||
33438811|NCT00373256|62814910|FG001|Overall Study|Adverse Event (AE)|5|||
33438812|NCT00373256|62814909|FG000|Overall Study|Lost to Follow-up|2|||
33438813|NCT00373256|62814910|FG001|Overall Study|Lost to Follow-up|1|||
33438814|NCT00373256|62814909|FG000|Overall Study|Death|9|||
33438815|NCT00373256|62814910|FG001|Overall Study|Death|8|||
33438816|NCT00373256|62814909|FG000|Overall Study|Objective Progression or Relapse|111|||
33438817|NCT00373256|62814910|FG001|Overall Study|Objective Progression or Relapse|104|||
33438818|NCT00373256|62814909|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
33438819|NCT00373256|62814910|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
33438820|NCT00373256|62814909|FG000|Overall Study|Other|73|||
33438821|NCT00373256|62814910|FG001|Overall Study|Other|107|||
33438822|NCT00373256|62814909|FG000|Overall Study|Protocol Violation|0|||
33438823|NCT00373256|62814910|FG001|Overall Study|Protocol Violation|2|||
33438824|NCT00373256|62814909|FG000|Overall Study|Study Terminated by Sponsor|41|||
33438825|NCT00373256|62814910|FG001|Overall Study|Study Terminated by Sponsor|13|||
33438826|NCT00394082|62814916|FG000|Overall Study|Unacceptable toxicity|15|||
33438827|NCT00394082|62814916|FG000|Overall Study|Adverse Event|4|||
33438828|NCT00394082|62814916|FG000|Overall Study|Physician Decision|4|||
33438829|NCT00394082|62814916|FG000|Overall Study|Withdrawal by Subject|2|||
33438830|NCT00394082|62814916|FG000|Overall Study|Other|1|||
33438831|NCT00393848|62814924|FG000|Overall Study|Surgical schedule|0|||
33438832|NCT00393848|62814925|FG001|Overall Study|Surgical schedule|0|||
33438833|NCT00393848|62814926|FG002|Overall Study|Surgical schedule|0|||
33438834|NCT00393848|62814927|FG003|Overall Study|Surgical schedule|1|||
33438835|NCT00393848|62814924|FG000|Overall Study|Personal reasons|0|||
33438836|NCT00393848|62814925|FG001|Overall Study|Personal reasons|0|||
33438837|NCT00393848|62814926|FG002|Overall Study|Personal reasons|2|||
33438838|NCT00393848|62814927|FG003|Overall Study|Personal reasons|0|||
33438839|NCT00393458|62814942|FG000|Overall Study|Adverse Event|35|||
33438840|NCT00393458|62814943|FG001|Overall Study|Adverse Event|24|||
33438841|NCT00393458|62814944|FG002|Overall Study|Adverse Event|40|||
33438842|NCT00393458|62814945|FG003|Overall Study|Adverse Event|35|||
33438843|NCT00393458|62814942|FG000|Overall Study|Subject withdrew consent|27|||
33438844|NCT00393458|62814943|FG001|Overall Study|Subject withdrew consent|40|||
33438845|NCT00393458|62814944|FG002|Overall Study|Subject withdrew consent|33|||
33438846|NCT00393458|62814945|FG003|Overall Study|Subject withdrew consent|50|||
33438847|NCT00393458|62814942|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
33438848|NCT00393458|62814943|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
33438849|NCT00393458|62814944|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
33438850|NCT00393458|62814945|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
33438851|NCT00393458|62814942|FG000|Overall Study|Protocol deviation|11|||
33438852|NCT00393458|62814943|FG001|Overall Study|Protocol deviation|11|||
33438853|NCT00393458|62814944|FG002|Overall Study|Protocol deviation|11|||
33438854|NCT00393458|62814945|FG003|Overall Study|Protocol deviation|10|||
33438855|NCT00393458|62814942|FG000|Overall Study|Administrative problems|7|||
33438856|NCT00393458|62814943|FG001|Overall Study|Administrative problems|8|||
33438857|NCT00393458|62814944|FG002|Overall Study|Administrative problems|5|||
33438858|NCT00393458|62814945|FG003|Overall Study|Administrative problems|2|||
33438859|NCT00393458|62814942|FG000|Overall Study|Lost to Follow-up|5|||
33438860|NCT00393458|62814943|FG001|Overall Study|Lost to Follow-up|6|||
33438861|NCT00393458|62814944|FG002|Overall Study|Lost to Follow-up|5|||
33438862|NCT00393458|62814945|FG003|Overall Study|Lost to Follow-up|3|||
33438863|NCT00393458|62814942|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33438864|NCT00393458|62814943|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33438865|NCT00393458|62814944|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33438866|NCT00393458|62814945|FG003|Overall Study|Abnormal laboratory value(s)|0|||
33438867|NCT00393458|62814942|FG000|Overall Study|Death|1|||
33438868|NCT00393458|62814943|FG001|Overall Study|Death|1|||
33438869|NCT00393458|62814944|FG002|Overall Study|Death|5|||
33438870|NCT00393458|62814945|FG003|Overall Study|Death|5|||
33438871|NCT00393458|62814942|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33438872|NCT00393458|62814943|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33438873|NCT00393458|62814944|FG002|Overall Study|Abnormal test procedure result(s)|1|||
33438874|NCT00393458|62814945|FG003|Overall Study|Abnormal test procedure result(s)|2|||
33438875|NCT00393458|62814942|FG000|Overall Study|Subject no longer requires study drug|0|||
33438876|NCT00393458|62814943|FG001|Overall Study|Subject no longer requires study drug|1|||
33438877|NCT00393458|62814944|FG002|Overall Study|Subject no longer requires study drug|0|||
33438878|NCT00393458|62814945|FG003|Overall Study|Subject no longer requires study drug|0|||
33438879|NCT00417482|62814958|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
33438880|NCT00417482|62814959|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
33438881|NCT00417482|62814960|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
33438882|NCT00417482|62814958|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
33438883|NCT00417482|62814959|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
33438884|NCT00417482|62814960|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
33438885|NCT00417482|62814958|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
33438886|NCT00417482|62814959|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
33438887|NCT00417482|62814960|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
33438888|NCT00417482|62814958|FG000|Phase B 1st 16 Weeks|Death|1|||
33438889|NCT00417482|62814959|FG001|Phase B 1st 16 Weeks|Death|0|||
33438890|NCT00417482|62814960|FG002|Phase B 1st 16 Weeks|Death|0|||
33438891|NCT00417482|62814958|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
33438892|NCT00417482|62814959|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
33438893|NCT00417482|62814960|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
33438894|NCT00417482|62814958|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
33438895|NCT00417482|62814959|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
33438896|NCT00417482|62814960|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
33438897|NCT00417482|62814958|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
33438898|NCT00417482|62814959|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
33438899|NCT00417482|62814960|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
33438900|NCT00417482|62814958|FG000|Phase B 2nd 16 Weeks|Death|1|||
33438901|NCT00417482|62814959|FG001|Phase B 2nd 16 Weeks|Death|1|||
33438902|NCT00417482|62814960|FG002|Phase B 2nd 16 Weeks|Death|0|||
33438903|NCT00417248|62814974|FG000|Overall Study|Study Terminated|6|||
33438904|NCT00417248|62814974|FG000|Overall Study|Death|1|||
33438905|NCT00417248|62814974|FG000|Overall Study|Lack of Efficacy|1|||
33438906|NCT00392288|62814982|FG000|Overall Study|Adverse Event|17|||
33438907|NCT00392288|62814983|FG001|Overall Study|Adverse Event|7|||
33438908|NCT00392288|62814984|FG002|Overall Study|Adverse Event|8|||
33438909|NCT00392288|62814982|FG000|Overall Study|Lack of Efficacy|8|||
33438910|NCT00392288|62814983|FG001|Overall Study|Lack of Efficacy|5|||
33438911|NCT00392288|62814984|FG002|Overall Study|Lack of Efficacy|3|||
33438912|NCT00392288|62814982|FG000|Overall Study|Protocol Violation|1|||
33438913|NCT00392288|62814983|FG001|Overall Study|Protocol Violation|3|||
33438914|NCT00392288|62814984|FG002|Overall Study|Protocol Violation|1|||
33438915|NCT00392288|62814982|FG000|Overall Study|Lost to Follow-up|1|||
33438916|NCT00392288|62814983|FG001|Overall Study|Lost to Follow-up|1|||
33438917|NCT00392288|62814984|FG002|Overall Study|Lost to Follow-up|1|||
33438918|NCT00392288|62814982|FG000|Overall Study|Withdrawal by Subject|1|||
33438919|NCT00392288|62814983|FG001|Overall Study|Withdrawal by Subject|0|||
33438920|NCT00392288|62814984|FG002|Overall Study|Withdrawal by Subject|2|||
33438921|NCT00392288|62814982|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
33438922|NCT00392288|62814983|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
33438923|NCT00392288|62814984|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
33438924|NCT00392288|62814982|FG000|Overall Study|Other|3|||
33438925|NCT00392288|62814983|FG001|Overall Study|Other|4|||
33438926|NCT00392288|62814984|FG002|Overall Study|Other|1|||
33438927|NCT00417170|62814994|FG000|Overall Study|Adverse Event|1|||
33438928|NCT00417170|62814995|FG001|Overall Study|Adverse Event|1|||
33438929|NCT00417170|62814994|FG000|Overall Study|Withdrawal by Subject|1|||
33605701|NCT02357459|63005471|FG002|Overall Study|Pre-planned Knee surgery|2|||
33605702|NCT02357459|63005469|FG000|Overall Study|Job Commitments|0|||
33605703|NCT02357459|63005470|FG001|Overall Study|Job Commitments|0|||
33438930|NCT00417170|62814995|FG001|Overall Study|Withdrawal by Subject|1|||
33438931|NCT00417170|62814994|FG000|Overall Study|Lost to Follow-up|0|||
33438932|NCT00417170|62814995|FG001|Overall Study|Lost to Follow-up|1|||
33438933|NCT00392990|62815003|FG000|Treatment on Study|Adverse Event|3|||
33438934|NCT00392990|62815004|FG001|Treatment on Study|Adverse Event|1|||
33438935|NCT00392990|62815003|FG000|Follow up for 2 Years|Death|4|||
33438936|NCT00392990|62815004|FG001|Follow up for 2 Years|Death|0|||
33438937|NCT00249873|62815012|FG000|Overall Study|Not treated|7|||
33438938|NCT00249873|62815013|FG001|Overall Study|Not treated|8|||
33438939|NCT00249873|62815012|FG000|Overall Study|Significant thrombocytopenia|9|||
33438940|NCT00249873|62815013|FG001|Overall Study|Significant thrombocytopenia|8|||
33438941|NCT00249873|62815012|FG000|Overall Study|Severe allergic reaction|8|||
33438942|NCT00249873|62815013|FG001|Overall Study|Severe allergic reaction|1|||
33438943|NCT00249873|62815012|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
33438944|NCT00249873|62815013|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
33438945|NCT00249873|62815012|FG000|Overall Study|Other Serious Adverse Event|86|||
33438946|NCT00249873|62815013|FG001|Overall Study|Other Serious Adverse Event|97|||
33438947|NCT00249873|62815012|FG000|Overall Study|Qualifying condition not present|20|||
33438948|NCT00249873|62815013|FG001|Overall Study|Qualifying condition not present|23|||
33438949|NCT00249873|62815012|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
33438950|NCT00249873|62815013|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
33605704|NCT02357459|63005471|FG002|Overall Study|Job Commitments|1|||
33605705|NCT02332889|63005482|FG000|Overall Study|Physician Decision|1|||
33605706|NCT02357147|63005488|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
33605707|NCT02357147|63005489|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
33438951|NCT00249873|62815012|FG000|Overall Study|Withdrawal by Subject|504|||
33438952|NCT00249873|62815013|FG001|Overall Study|Withdrawal by Subject|466|||
33438953|NCT00249873|62815012|FG000|Overall Study|Lost to Follow-up|4|||
33438954|NCT00249873|62815013|FG001|Overall Study|Lost to Follow-up|7|||
33438955|NCT00249873|62815012|FG000|Overall Study|Minor bleeding|99|||
33438956|NCT00249873|62815013|FG001|Overall Study|Minor bleeding|37|||
33438957|NCT00249873|62815012|FG000|Overall Study|Non-compliance|41|||
33438958|NCT00249873|62815013|FG001|Overall Study|Non-compliance|46|||
33438959|NCT00249873|62815012|FG000|Overall Study|Other non serious Adverse Event|112|||
33438960|NCT00249873|62815013|FG001|Overall Study|Other non serious Adverse Event|108|||
33438961|NCT00249873|62815012|FG000|Overall Study|Other contraindicated medication|1|||
33438962|NCT00249873|62815013|FG001|Overall Study|Other contraindicated medication|0|||
33438963|NCT00249873|62815012|FG000|Overall Study|Patient not wish to continue after May08|3|||
33438964|NCT00249873|62815013|FG001|Overall Study|Patient not wish to continue after May08|4|||
33438965|NCT00249873|62815012|FG000|Overall Study|Physician withdrew consent|59|||
33438966|NCT00249873|62815013|FG001|Overall Study|Physician withdrew consent|60|||
33438967|NCT00249873|62815012|FG000|Overall Study|Open label clopidogrel required|31|||
33438968|NCT00249873|62815013|FG001|Overall Study|Open label clopidogrel required|42|||
33438969|NCT00249873|62815012|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
33605708|NCT02357147|63005488|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
33438970|NCT00249873|62815013|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
33438971|NCT00249873|62815012|FG000|Overall Study|Oral anticoagulant required|159|||
33438972|NCT00249873|62815013|FG001|Overall Study|Oral anticoagulant required|157|||
33438973|NCT00249873|62815012|FG000|Overall Study|Study drug intolerance|5|||
33438974|NCT00249873|62815013|FG001|Overall Study|Study drug intolerance|0|||
33438975|NCT00249873|62815012|FG000|Overall Study|Surgery/ procedure|9|||
33438976|NCT00249873|62815013|FG001|Overall Study|Surgery/ procedure|9|||
33438977|NCT00249873|62815012|FG000|Overall Study|Event related to cardiac condition|12|||
33438978|NCT00249873|62815013|FG001|Overall Study|Event related to cardiac condition|21|||
33438979|NCT00249873|62815012|FG000|Overall Study|Thromboembolic/outcome event|82|||
33438980|NCT00249873|62815013|FG001|Overall Study|Thromboembolic/outcome event|122|||
33438981|NCT00392210|62815021|FG000|First Voiding Trial|Physician Decision|2|||
33438982|NCT00392210|62815022|FG001|First Voiding Trial|Physician Decision|2|||
33605709|NCT02357147|63005489|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
33605710|NCT02357147|63005488|FG000|Combination Treatment Phase|Investigator Discretion|1|||
33605711|NCT02357147|63005489|FG001|Combination Treatment Phase|Investigator Discretion|1|||
33605712|NCT02357147|63005488|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
33605713|NCT02357147|63005489|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
33605714|NCT02357147|63005488|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
33605715|NCT02357147|63005489|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
33605716|NCT02357147|63005488|FG000|Combination Treatment Phase|Adverse Event|12|||
33605717|NCT02357147|63005489|FG001|Combination Treatment Phase|Adverse Event|4|||
33605718|NCT02357147|63005488|FG000|Combination Treatment Phase|Death|1|||
33605719|NCT02357147|63005489|FG001|Combination Treatment Phase|Death|1|||
33605720|NCT02357147|63005488|FG000|Combination Treatment Phase|Sponsor Decision|0|||
33605721|NCT02357147|63005489|FG001|Combination Treatment Phase|Sponsor Decision|12|||
33605722|NCT02357147|63005488|FG000|Combination Treatment Phase|Other|1|||
33605723|NCT02357147|63005489|FG001|Combination Treatment Phase|Other|0|||
33605724|NCT02357147|63005488|FG000|Combination Treatment Phase|Not treated|0|||
33438983|NCT00391976|62815031|FG000|Overall Study|Adverse Event|0|||
33438984|NCT00391976|62815032|FG001|Overall Study|Adverse Event|0|||
33438985|NCT00391976|62815033|FG002|Overall Study|Adverse Event|1|||
33438986|NCT00391976|62815031|FG000|Overall Study|Withdrawal of consent|0|||
33438987|NCT00391976|62815032|FG001|Overall Study|Withdrawal of consent|1|||
33438988|NCT00391976|62815033|FG002|Overall Study|Withdrawal of consent|1|||
33438989|NCT00391976|62815031|FG000|Overall Study|Lost to Follow-up|1|||
33438990|NCT00391976|62815032|FG001|Overall Study|Lost to Follow-up|2|||
33438991|NCT00391976|62815033|FG002|Overall Study|Lost to Follow-up|0|||
33438992|NCT00391976|62815031|FG000|Overall Study|Inappropriate enrollment|1|||
33438993|NCT00391976|62815032|FG001|Overall Study|Inappropriate enrollment|1|||
33438994|NCT00391976|62815033|FG002|Overall Study|Inappropriate enrollment|0|||
33438995|NCT00391976|62815031|FG000|Overall Study|Protocol deviation/violation|4|||
33438996|NCT00391976|62815032|FG001|Overall Study|Protocol deviation/violation|2|||
33438997|NCT00391976|62815033|FG002|Overall Study|Protocol deviation/violation|1|||
33438998|NCT00391976|62815031|FG000|Overall Study|Recurrence/no eradication of infection|21|||
33438999|NCT00391976|62815032|FG001|Overall Study|Recurrence/no eradication of infection|19|||
33439000|NCT00391976|62815033|FG002|Overall Study|Recurrence/no eradication of infection|0|||
33439001|NCT00391976|62815031|FG000|Overall Study|Unable to classify|0|||
33439002|NCT00391976|62815032|FG001|Overall Study|Unable to classify|0|||
33439003|NCT00391976|62815033|FG002|Overall Study|Unable to classify|1|||
33439004|NCT00391976|62815031|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
33439005|NCT00391976|62815032|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
33439006|NCT00391976|62815033|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
33439007|NCT00391898|62815045|FG000|Overall Study|Adverse Event|3|||
33439008|NCT00391898|62815046|FG001|Overall Study|Adverse Event|0|||
33439009|NCT00391898|62815045|FG000|Overall Study|Other|8|||
33439010|NCT00391898|62815046|FG001|Overall Study|Other|10|||
33439011|NCT00391586|62815052|FG000|Overall Study|Progressive disease|13|||
33439012|NCT00391586|62815052|FG000|Overall Study|Adverse Event|5|||
33439013|NCT00391586|62815052|FG000|Overall Study|Physician Decision|2|||
33439014|NCT00391586|62815052|FG000|Overall Study|Death|4|||
33439015|NCT00391430|62815059|FG000|Overall Study|Withdrawal by Subject|3|||
33439016|NCT00391430|62815060|FG001|Overall Study|Withdrawal by Subject|0|||
33439017|NCT00391430|62815061|FG002|Overall Study|Withdrawal by Subject|12|||
33439018|NCT00391274|62815071|FG000|Overall Study|Death Due to Study Disease|55|||
33439019|NCT00391274|62815072|FG001|Overall Study|Death Due to Study Disease|45|||
33494200|NCT03634033|62872939|FG005|Overall Study|Withdrawal by Subject|0|||
33439020|NCT00391274|62815071|FG000|Overall Study|Lost to Follow-up|0|||
33439021|NCT00391274|62815072|FG001|Overall Study|Lost to Follow-up|3|||
33605725|NCT02357147|63005489|FG001|Combination Treatment Phase|Not treated|2|||
33605726|NCT02357147|63005488|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
33439022|NCT00391274|62815071|FG000|Overall Study|Physician Decision|4|||
33439023|NCT00391274|62815072|FG001|Overall Study|Physician Decision|2|||
33439024|NCT00391274|62815071|FG000|Overall Study|Withdrawal by Subject|0|||
33439025|NCT00391274|62815072|FG001|Overall Study|Withdrawal by Subject|3|||
33439026|NCT00391274|62815071|FG000|Overall Study|Death Due to Adverse Event|1|||
33439027|NCT00391274|62815072|FG001|Overall Study|Death Due to Adverse Event|3|||
33439028|NCT00391274|62815071|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
33439029|NCT00391274|62815072|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
33439030|NCT00391274|62815071|FG000|Overall Study|Death Not Study Related|0|||
33439031|NCT00391274|62815072|FG001|Overall Study|Death Not Study Related|1|||
33439032|NCT00391118|62815081|FG000|Overall Study|Adverse Event|3|||
33439033|NCT00391118|62815082|FG001|Overall Study|Adverse Event|10|||
33439034|NCT00391118|62815083|FG002|Overall Study|Adverse Event|7|||
33439035|NCT00391118|62815081|FG000|Overall Study|Lost to Follow-up|0|||
33439036|NCT00391118|62815082|FG001|Overall Study|Lost to Follow-up|2|||
33439037|NCT00391118|62815083|FG002|Overall Study|Lost to Follow-up|3|||
33439038|NCT00391118|62815081|FG000|Overall Study|Withdrawal by Subject|0|||
33439039|NCT00391118|62815082|FG001|Overall Study|Withdrawal by Subject|9|||
33439040|NCT00391118|62815083|FG002|Overall Study|Withdrawal by Subject|1|||
33439041|NCT00391118|62815081|FG000|Overall Study|Death|0|||
33439042|NCT00391118|62815082|FG001|Overall Study|Death|1|||
33439043|NCT00391118|62815083|FG002|Overall Study|Death|0|||
33439044|NCT00391118|62815081|FG000|Overall Study|Physician Decision|0|||
33439045|NCT00391118|62815082|FG001|Overall Study|Physician Decision|3|||
33439046|NCT00391118|62815083|FG002|Overall Study|Physician Decision|0|||
33439047|NCT00391118|62815081|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
33439048|NCT00391118|62815082|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
33439049|NCT00391118|62815083|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
33439050|NCT00391118|62815081|FG000|Overall Study|Progressive Disease|7|||
33439051|NCT00391118|62815082|FG001|Overall Study|Progressive Disease|26|||
33439052|NCT00391118|62815083|FG002|Overall Study|Progressive Disease|43|||
33439053|NCT00391118|62815081|FG000|Overall Study|Sponsor Decision|0|||
33439054|NCT00391118|62815082|FG001|Overall Study|Sponsor Decision|1|||
33439055|NCT00391118|62815083|FG002|Overall Study|Sponsor Decision|3|||
33439056|NCT00391118|62815081|FG000|Overall Study|Protocol Violation|1|||
33439057|NCT00391118|62815082|FG001|Overall Study|Protocol Violation|0|||
33439058|NCT00391118|62815083|FG002|Overall Study|Protocol Violation|0|||
33439059|NCT00390884|62815096|FG000|Overall Study|Withdrawal by Subject|2|||
33439060|NCT00390884|62815097|FG001|Overall Study|Withdrawal by Subject|2|||
33439061|NCT00365846|62815103|FG000|Overall Study|Lost to Follow-up|1|||
33439062|NCT00264537|62815113|FG000|Overall Study|Death|0|||
33439063|NCT00264537|62815114|FG001|Overall Study|Death|3|||
33439064|NCT00264537|62815115|FG002|Overall Study|Death|3|||
33439065|NCT00264537|62815116|FG003|Overall Study|Death|2|||
33439066|NCT00264537|62815113|FG000|Overall Study|Lost to Follow-up|3|||
33439067|NCT00264537|62815114|FG001|Overall Study|Lost to Follow-up|4|||
33439068|NCT00264537|62815115|FG002|Overall Study|Lost to Follow-up|7|||
33439069|NCT00264537|62815116|FG003|Overall Study|Lost to Follow-up|6|||
33439070|NCT00264537|62815113|FG000|Overall Study|Adverse Event|21|||
33439071|NCT00264537|62815114|FG001|Overall Study|Adverse Event|32|||
33439072|NCT00264537|62815115|FG002|Overall Study|Adverse Event|24|||
33439073|NCT00264537|62815116|FG003|Overall Study|Adverse Event|34|||
33439074|NCT00264537|62815113|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
33439075|NCT00264537|62815114|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
33439076|NCT00264537|62815115|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
33439077|NCT00264537|62815116|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
33439078|NCT00264537|62815113|FG000|Overall Study|Other|21|||
33439079|NCT00264537|62815114|FG001|Overall Study|Other|11|||
33439080|NCT00264537|62815115|FG002|Overall Study|Other|10|||
33439081|NCT00264537|62815116|FG003|Overall Study|Other|11|||
33439082|NCT00264537|62815113|FG000|Overall Study|Not treated|0|||
33439083|NCT00264537|62815114|FG001|Overall Study|Not treated|2|||
33439084|NCT00264537|62815115|FG002|Overall Study|Not treated|1|||
33439085|NCT00264537|62815116|FG003|Overall Study|Not treated|0|||
33439086|NCT00371462|62815130|FG000|Overall Study|Withdrawal by Subject|1|||
33439087|NCT00371462|62815131|FG001|Overall Study|Withdrawal by Subject|0|||
33439088|NCT00371462|62815130|FG000|Overall Study|Other|7|||
33439089|NCT00371462|62815131|FG001|Overall Study|Other|8|||
33439090|NCT00371150|62815139|FG000|Overall Study|Lost to Follow-up|3|||
33439091|NCT00371150|62815140|FG001|Overall Study|Lost to Follow-up|2|||
33439092|NCT00264303|62815152|FG000|Overall Study|Adverse Event|4|||
33439093|NCT00264303|62815153|FG001|Overall Study|Adverse Event|3|||
33439094|NCT00264303|62815152|FG000|Overall Study|Lack of Efficacy|10|||
33439095|NCT00264303|62815153|FG001|Overall Study|Lack of Efficacy|13|||
33439096|NCT00264303|62815152|FG000|Overall Study|Lost to Follow-up|3|||
33439097|NCT00264303|62815153|FG001|Overall Study|Lost to Follow-up|3|||
33439098|NCT00264303|62815152|FG000|Overall Study|Withdrawal by Subject|2|||
33439099|NCT00264303|62815153|FG001|Overall Study|Withdrawal by Subject|3|||
33605727|NCT02357147|63005489|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
33605728|NCT02357147|63005488|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33605729|NCT02357147|63005489|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
33439100|NCT00264303|62815152|FG000|Overall Study|Various reasons listed in study report|6|||
33439101|NCT00264303|62815153|FG001|Overall Study|Various reasons listed in study report|7|||
33439102|NCT00370682|62815162|FG000|Overall Study|Moved from area|0|||
33439103|NCT00370682|62815163|FG001|Overall Study|Moved from area|2|||
33439104|NCT00370682|62815164|FG002|Overall Study|Moved from area|0|||
33439105|NCT00370682|62815162|FG000|Overall Study|Lost to Follow-up|0|||
33439106|NCT00370682|62815163|FG001|Overall Study|Lost to Follow-up|1|||
33439107|NCT00370682|62815164|FG002|Overall Study|Lost to Follow-up|1|||
33439108|NCT00264147|62815181|FG000|Treatment I Period|Adverse Event|3|||
33439109|NCT00264147|62815182|FG001|Treatment I Period|Adverse Event|6|||
33439110|NCT00264147|62815183|FG002|Treatment I Period|Adverse Event|3|||
33439111|NCT00264147|62815184|FG003|Treatment I Period|Adverse Event|5|||
33439112|NCT00264147|62815185|FG004|Treatment I Period|Adverse Event|7|||
33439113|NCT00264147|62815186|FG005|Treatment I Period|Adverse Event|0|||
33439114|NCT00264147|62815181|FG000|Treatment I Period|Laboratory Adverse Event|0|||
33439115|NCT00264147|62815182|FG001|Treatment I Period|Laboratory Adverse Event|0|||
33439116|NCT00264147|62815183|FG002|Treatment I Period|Laboratory Adverse Event|0|||
33439117|NCT00264147|62815184|FG003|Treatment I Period|Laboratory Adverse Event|1|||
33439118|NCT00264147|62815185|FG004|Treatment I Period|Laboratory Adverse Event|0|||
33439119|NCT00264147|62815186|FG005|Treatment I Period|Laboratory Adverse Event|0|||
33439120|NCT00264147|62815181|FG000|Treatment I Period|Lack of Efficacy|6|||
33439121|NCT00264147|62815182|FG001|Treatment I Period|Lack of Efficacy|2|||
33439122|NCT00264147|62815183|FG002|Treatment I Period|Lack of Efficacy|8|||
33439123|NCT00264147|62815184|FG003|Treatment I Period|Lack of Efficacy|0|||
33439124|NCT00264147|62815185|FG004|Treatment I Period|Lack of Efficacy|1|||
33439125|NCT00264147|62815186|FG005|Treatment I Period|Lack of Efficacy|0|||
33439126|NCT00264147|62815181|FG000|Treatment I Period|Lost to Follow-up|1|||
33439127|NCT00264147|62815182|FG001|Treatment I Period|Lost to Follow-up|0|||
33439128|NCT00264147|62815183|FG002|Treatment I Period|Lost to Follow-up|0|||
33439129|NCT00264147|62815184|FG003|Treatment I Period|Lost to Follow-up|1|||
33439130|NCT00264147|62815185|FG004|Treatment I Period|Lost to Follow-up|1|||
33439131|NCT00264147|62815186|FG005|Treatment I Period|Lost to Follow-up|0|||
33439132|NCT00264147|62815181|FG000|Treatment I Period|Protocol Violation|2|||
33439133|NCT00264147|62815182|FG001|Treatment I Period|Protocol Violation|2|||
33439134|NCT00264147|62815183|FG002|Treatment I Period|Protocol Violation|0|||
33439135|NCT00264147|62815184|FG003|Treatment I Period|Protocol Violation|0|||
33439136|NCT00264147|62815185|FG004|Treatment I Period|Protocol Violation|0|||
33439137|NCT00264147|62815186|FG005|Treatment I Period|Protocol Violation|0|||
33439138|NCT00264147|62815181|FG000|Treatment I Period|Withdrawal by Subject|2|||
33439139|NCT00264147|62815182|FG001|Treatment I Period|Withdrawal by Subject|0|||
33439140|NCT00264147|62815183|FG002|Treatment I Period|Withdrawal by Subject|0|||
33439141|NCT00264147|62815184|FG003|Treatment I Period|Withdrawal by Subject|2|||
33439142|NCT00264147|62815185|FG004|Treatment I Period|Withdrawal by Subject|2|||
33439143|NCT00264147|62815186|FG005|Treatment I Period|Withdrawal by Subject|0|||
33439144|NCT00264147|62815181|FG000|Treatment I Period|Patient out of town for an extended time|0|||
33605730|NCT02357147|63005488|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
33605731|NCT02357147|63005489|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
33439145|NCT00264147|62815182|FG001|Treatment I Period|Patient out of town for an extended time|1|||
33439146|NCT00264147|62815183|FG002|Treatment I Period|Patient out of town for an extended time|0|||
33439147|NCT00264147|62815184|FG003|Treatment I Period|Patient out of town for an extended time|0|||
33439148|NCT00264147|62815185|FG004|Treatment I Period|Patient out of town for an extended time|0|||
33439149|NCT00264147|62815186|FG005|Treatment I Period|Patient out of town for an extended time|0|||
33439150|NCT00264147|62815181|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
33439151|NCT00264147|62815182|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
33439152|NCT00264147|62815183|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
33439153|NCT00264147|62815184|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
33439154|NCT00264147|62815185|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
33439155|NCT00264147|62815186|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
33439156|NCT00264147|62815181|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
33439157|NCT00264147|62815182|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
33439158|NCT00264147|62815183|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
33439159|NCT00264147|62815184|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
33439160|NCT00264147|62815185|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
33439161|NCT00264147|62815186|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
33439162|NCT00264147|62815181|FG000|Treatment II Period|Adverse Event|0|||
33439163|NCT00264147|62815182|FG001|Treatment II Period|Adverse Event|0|||
33439164|NCT00264147|62815183|FG002|Treatment II Period|Adverse Event|0|||
33439165|NCT00264147|62815184|FG003|Treatment II Period|Adverse Event|0|||
33439166|NCT00264147|62815185|FG004|Treatment II Period|Adverse Event|9|||
33439167|NCT00264147|62815186|FG005|Treatment II Period|Adverse Event|9|||
33439168|NCT00264147|62815181|FG000|Treatment II Period|Laboratory Adverse Event|0|||
33439169|NCT00264147|62815182|FG001|Treatment II Period|Laboratory Adverse Event|0|||
33439170|NCT00264147|62815183|FG002|Treatment II Period|Laboratory Adverse Event|0|||
33439171|NCT00264147|62815184|FG003|Treatment II Period|Laboratory Adverse Event|0|||
33439172|NCT00264147|62815185|FG004|Treatment II Period|Laboratory Adverse Event|0|||
33439173|NCT00264147|62815186|FG005|Treatment II Period|Laboratory Adverse Event|1|||
33605732|NCT02357147|63005488|FG000|Maintenance Treatment Phase|Adverse Event|0|||
33605733|NCT02357147|63005489|FG001|Maintenance Treatment Phase|Adverse Event|3|||
33605734|NCT02357147|63005488|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
33605735|NCT02357147|63005489|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
33605736|NCT02357147|63005488|FG000|Maintenance Treatment Phase|Not Treated|1|||
33605737|NCT02357147|63005489|FG001|Maintenance Treatment Phase|Not Treated|0|||
33605738|NCT02356211|63005501|FG000|Overall Study|Withdrawal by Subject|2|||
33605739|NCT02356211|63005502|FG001|Overall Study|Withdrawal by Subject|2|||
33605740|NCT02356211|63005501|FG000|Overall Study|ineligible|1|||
33605741|NCT02356211|63005502|FG001|Overall Study|ineligible|8|||
33605742|NCT02332655|63005508|FG000|Overall Study|Lack of Efficacy|1|||
33605743|NCT02388737|63005515|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
33605744|NCT02388737|63005516|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
33439174|NCT00264147|62815181|FG000|Treatment II Period|Lack of Efficacy|0|||
33605745|NCT02388737|63005517|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
33605746|NCT02388737|63005515|FG000|Overall Study|Major Protocol Deviation|18|||
33605747|NCT02388737|63005516|FG001|Overall Study|Major Protocol Deviation|25|||
33605748|NCT02388737|63005517|FG002|Overall Study|Major Protocol Deviation|22|||
33605749|NCT02388737|63005515|FG000|Overall Study|Lost to Follow-up|5|||
33605750|NCT02388737|63005516|FG001|Overall Study|Lost to Follow-up|1|||
33605751|NCT02388737|63005517|FG002|Overall Study|Lost to Follow-up|4|||
33605752|NCT02388737|63005515|FG000|Overall Study|Voluntary Withdrawal|10|||
33605753|NCT02388737|63005516|FG001|Overall Study|Voluntary Withdrawal|18|||
33605754|NCT02388737|63005517|FG002|Overall Study|Voluntary Withdrawal|17|||
33605755|NCT02388737|63005515|FG000|Overall Study|Lack of Efficacy|3|||
33439175|NCT00264147|62815182|FG001|Treatment II Period|Lack of Efficacy|0|||
33439176|NCT00264147|62815183|FG002|Treatment II Period|Lack of Efficacy|0|||
33439177|NCT00264147|62815184|FG003|Treatment II Period|Lack of Efficacy|0|||
33439178|NCT00264147|62815185|FG004|Treatment II Period|Lack of Efficacy|20|||
33605756|NCT02388737|63005516|FG001|Overall Study|Lack of Efficacy|0|||
33605757|NCT02388737|63005517|FG002|Overall Study|Lack of Efficacy|3|||
33605758|NCT02388737|63005515|FG000|Overall Study|Reason Not Specified|5|||
33605759|NCT02388737|63005516|FG001|Overall Study|Reason Not Specified|5|||
33439179|NCT00264147|62815186|FG005|Treatment II Period|Lack of Efficacy|19|||
33439180|NCT00264147|62815181|FG000|Treatment II Period|Lost to Follow-up|0|||
33439181|NCT00264147|62815182|FG001|Treatment II Period|Lost to Follow-up|0|||
33439182|NCT00264147|62815183|FG002|Treatment II Period|Lost to Follow-up|0|||
33439183|NCT00264147|62815184|FG003|Treatment II Period|Lost to Follow-up|0|||
33439184|NCT00264147|62815185|FG004|Treatment II Period|Lost to Follow-up|1|||
33439185|NCT00264147|62815186|FG005|Treatment II Period|Lost to Follow-up|1|||
33439186|NCT00264147|62815181|FG000|Treatment II Period|Withdrawal by Subject|0|||
33439187|NCT00264147|62815182|FG001|Treatment II Period|Withdrawal by Subject|0|||
33439188|NCT00264147|62815183|FG002|Treatment II Period|Withdrawal by Subject|0|||
33439189|NCT00264147|62815184|FG003|Treatment II Period|Withdrawal by Subject|0|||
33605760|NCT02388737|63005517|FG002|Overall Study|Reason Not Specified|4|||
33439190|NCT00264147|62815185|FG004|Treatment II Period|Withdrawal by Subject|3|||
33439191|NCT00264147|62815186|FG005|Treatment II Period|Withdrawal by Subject|2|||
33605761|NCT02355743|63005525|FG000|Overall Study|Withdrawal by Subject|1|||
33605762|NCT02355743|63005525|FG000|Overall Study|Lost to Follow-up|1|||
33605763|NCT02388347|63005534|FG000|Overall Study|Withdrawal by Subject|0|||
33605764|NCT02388347|63005535|FG001|Overall Study|Withdrawal by Subject|0|||
33605765|NCT02388347|63005536|FG002|Overall Study|Withdrawal by Subject|1|||
33605766|NCT02388347|63005537|FG003|Overall Study|Withdrawal by Subject|0|||
33605767|NCT02388347|63005538|FG004|Overall Study|Withdrawal by Subject|0|||
33605768|NCT02355665|63005556|FG000|Overall Study|Adverse Event|16|||
33605769|NCT02355665|63005557|FG001|Overall Study|Adverse Event|24|||
33605770|NCT02355665|63005556|FG000|Overall Study|Protocol Violation|2|||
33605771|NCT02355665|63005557|FG001|Overall Study|Protocol Violation|0|||
33605772|NCT02355665|63005556|FG000|Overall Study|Withdrawal by Subject|90|||
33605773|NCT02355665|63005557|FG001|Overall Study|Withdrawal by Subject|100|||
33605774|NCT02355665|63005556|FG000|Overall Study|Lost to Follow-up|131|||
33605775|NCT02355665|63005557|FG001|Overall Study|Lost to Follow-up|103|||
33605776|NCT02355665|63005556|FG000|Overall Study|Death|4|||
33605777|NCT02355665|63005557|FG001|Overall Study|Death|2|||
33605778|NCT02355665|63005556|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
33605779|NCT02355665|63005557|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
33605780|NCT02010255|63005577|FG000|Overall Study|Death|0|||
33605781|NCT02010255|63005578|FG001|Overall Study|Death|1|||
33605782|NCT02010255|63005579|FG002|Overall Study|Death|4|||
33605783|NCT02010255|63005580|FG003|Overall Study|Death|4|||
33605784|NCT02010255|63005581|FG004|Overall Study|Death|2|||
33605785|NCT02010255|63005582|FG005|Overall Study|Death|0|||
33605786|NCT02010255|63005583|FG006|Overall Study|Death|1|||
33605787|NCT02010255|63005584|FG007|Overall Study|Death|1|||
33605788|NCT02010255|63005585|FG008|Overall Study|Death|1|||
33605789|NCT02010255|63005586|FG009|Overall Study|Death|0|||
33605790|NCT02010255|63005587|FG010|Overall Study|Death|1|||
33605791|NCT02010255|63005588|FG011|Overall Study|Death|1|||
33605792|NCT02010255|63005589|FG012|Overall Study|Death|0|||
33605793|NCT02010255|63005590|FG013|Overall Study|Death|0|||
33605794|NCT02010255|63005577|FG000|Overall Study|Lack of Efficacy|4|||
33605795|NCT02010255|63005578|FG001|Overall Study|Lack of Efficacy|1|||
33605796|NCT02010255|63005579|FG002|Overall Study|Lack of Efficacy|2|||
33439192|NCT00264147|62815181|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
33439193|NCT00264147|62815182|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
33439194|NCT00264147|62815183|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
33439195|NCT00264147|62815184|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
33439196|NCT00264147|62815185|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
33439197|NCT00264147|62815186|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
33439198|NCT00263757|62815202|FG000|Overall Study|Withdrawal by Subject|5|||
33439199|NCT00263757|62815203|FG001|Overall Study|Withdrawal by Subject|4|||
33439200|NCT00263757|62815202|FG000|Overall Study|Screen failure|0|||
33439201|NCT00263757|62815203|FG001|Overall Study|Screen failure|1|||
33439202|NCT00263757|62815202|FG000|Overall Study|Adverse Event|3|||
33439203|NCT00263757|62815203|FG001|Overall Study|Adverse Event|3|||
33439204|NCT00263211|62815211|FG000|Overall Study|Death|1|||
33439205|NCT00263211|62815212|FG001|Overall Study|Death|0|||
33439206|NCT00263211|62815211|FG000|Overall Study|Withdrawal by Subject|3|||
33439207|NCT00263211|62815212|FG001|Overall Study|Withdrawal by Subject|0|||
33439208|NCT00263211|62815211|FG000|Overall Study|Protocol Violation|1|||
33439209|NCT00263211|62815212|FG001|Overall Study|Protocol Violation|0|||
33439210|NCT00263211|62815211|FG000|Overall Study|Disease Progression|0|||
33439211|NCT00263211|62815212|FG001|Overall Study|Disease Progression|1|||
33439212|NCT00248625|62815223|FG000|Overall Study|Withdrawal by Subject|0|||
33439213|NCT00248625|62815224|FG001|Overall Study|Withdrawal by Subject|2|||
33439214|NCT00262821|62815232|FG000|Overall Study|Ineligible - wrong stage|0|||
33439215|NCT00262821|62815233|FG001|Overall Study|Ineligible - wrong stage|3|||
33439216|NCT00262821|62815232|FG000|Overall Study|Ineligible - wrong cell type|2|||
33439217|NCT00262821|62815233|FG001|Overall Study|Ineligible - wrong cell type|2|||
33439218|NCT00262821|62815232|FG000|Overall Study|Ineligible - wrong primary|0|||
33439219|NCT00262821|62815233|FG001|Overall Study|Ineligible - wrong primary|1|||
33439220|NCT00262821|62815232|FG000|Overall Study|Ineligible - inadequate pathology|1|||
33439221|NCT00262821|62815233|FG001|Overall Study|Ineligible - inadequate pathology|3|||
33439222|NCT00262821|62815232|FG000|Overall Study|Ineligible - elevated creatinine|0|||
33439223|NCT00262821|62815233|FG001|Overall Study|Ineligible - elevated creatinine|2|||
33439224|NCT00262821|62815232|FG000|Overall Study|Ineligible - required test not done|1|||
33439225|NCT00262821|62815233|FG001|Overall Study|Ineligible - required test not done|4|||
33439226|NCT00262821|62815232|FG000|Overall Study|Inevaluable - inadequate data|0|||
33605797|NCT02010255|63005580|FG003|Overall Study|Lack of Efficacy|1|||
33605798|NCT02010255|63005581|FG004|Overall Study|Lack of Efficacy|1|||
33605799|NCT02010255|63005582|FG005|Overall Study|Lack of Efficacy|0|||
33605800|NCT02010255|63005583|FG006|Overall Study|Lack of Efficacy|0|||
33605801|NCT02010255|63005584|FG007|Overall Study|Lack of Efficacy|0|||
33605802|NCT02010255|63005585|FG008|Overall Study|Lack of Efficacy|0|||
33605803|NCT02010255|63005586|FG009|Overall Study|Lack of Efficacy|0|||
33605804|NCT02010255|63005587|FG010|Overall Study|Lack of Efficacy|1|||
33605805|NCT02010255|63005588|FG011|Overall Study|Lack of Efficacy|0|||
33439227|NCT00262821|62815233|FG001|Overall Study|Inevaluable - inadequate data|4|||
33439228|NCT00262743|62815241|FG000|Overall Study|Adverse Event|0|||
33439229|NCT00262743|62815242|FG001|Overall Study|Adverse Event|9|||
33439230|NCT00262743|62815241|FG000|Overall Study|Disease progression|0|||
33439231|NCT00262743|62815242|FG001|Overall Study|Disease progression|3|||
33439232|NCT00262119|62815249|FG000|Overall Study|Lost to Follow-up|38|||
33439233|NCT00262119|62815250|FG001|Overall Study|Lost to Follow-up|51|||
33439234|NCT00262119|62815251|FG002|Overall Study|Lost to Follow-up|42|||
33439235|NCT00262119|62815249|FG000|Overall Study|Death|20|||
33439236|NCT00262119|62815250|FG001|Overall Study|Death|19|||
33439237|NCT00262119|62815251|FG002|Overall Study|Death|16|||
33439238|NCT00170950|62815261|FG000|Overall Study|Death|236|||
33439239|NCT00170950|62815262|FG001|Overall Study|Death|274|||
33439240|NCT00170950|62815261|FG000|Overall Study|Withdrawal by Subject|496|||
33439241|NCT00170950|62815262|FG001|Overall Study|Withdrawal by Subject|498|||
33439242|NCT00170950|62815261|FG000|Overall Study|Lost to Follow-up|134|||
33439243|NCT00170950|62815262|FG001|Overall Study|Lost to Follow-up|115|||
33439244|NCT00170950|62815261|FG000|Overall Study|Missing|2|||
33439245|NCT00170950|62815262|FG001|Overall Study|Missing|1|||
33439246|NCT00170950|62815261|FG000|Overall Study|Termination Data Not Recorded|17|||
33439247|NCT00170950|62815262|FG001|Overall Study|Termination Data Not Recorded|22|||
33439248|NCT00239577|62815272|FG000|Primary Phase|Adverse Event|0|||
33439249|NCT00239577|62815273|FG001|Primary Phase|Adverse Event|0|||
33439250|NCT00239577|62815274|FG002|Primary Phase|Adverse Event|1|||
33439251|NCT00239577|62815275|FG003|Primary Phase|Adverse Event|0|||
33439252|NCT00239577|62815272|FG000|Primary Phase|Other|5|||
33439253|NCT00239577|62815273|FG001|Primary Phase|Other|3|||
33439254|NCT00239577|62815274|FG002|Primary Phase|Other|2|||
33605806|NCT02010255|63005589|FG012|Overall Study|Lack of Efficacy|0|||
33605807|NCT02010255|63005590|FG013|Overall Study|Lack of Efficacy|0|||
33605808|NCT02010255|63005577|FG000|Overall Study|Withdrew Consent|1|||
33605809|NCT02010255|63005578|FG001|Overall Study|Withdrew Consent|0|||
33605810|NCT02010255|63005579|FG002|Overall Study|Withdrew Consent|0|||
33605811|NCT02010255|63005580|FG003|Overall Study|Withdrew Consent|1|||
33605812|NCT02010255|63005581|FG004|Overall Study|Withdrew Consent|0|||
33605813|NCT02010255|63005582|FG005|Overall Study|Withdrew Consent|0|||
33605814|NCT02010255|63005583|FG006|Overall Study|Withdrew Consent|0|||
33605815|NCT02010255|63005584|FG007|Overall Study|Withdrew Consent|0|||
33605816|NCT02010255|63005585|FG008|Overall Study|Withdrew Consent|0|||
33605817|NCT02010255|63005586|FG009|Overall Study|Withdrew Consent|0|||
33605818|NCT02010255|63005587|FG010|Overall Study|Withdrew Consent|0|||
33605819|NCT02010255|63005588|FG011|Overall Study|Withdrew Consent|0|||
33605820|NCT02010255|63005589|FG012|Overall Study|Withdrew Consent|0|||
33605821|NCT02010255|63005590|FG013|Overall Study|Withdrew Consent|0|||
33439255|NCT00239577|62815275|FG003|Primary Phase|Other|0|||
33439256|NCT00262041|62815291|FG000|Overall Study|Withdrawal by Subject|0|||
33439257|NCT00262041|62815292|FG001|Overall Study|Withdrawal by Subject|3|||
33439258|NCT00262041|62815293|FG002|Overall Study|Withdrawal by Subject|1|||
33605822|NCT02010255|63005577|FG000|Overall Study|Adverse Event|1|||
33605823|NCT02010255|63005578|FG001|Overall Study|Adverse Event|0|||
33439259|NCT00262041|62815291|FG000|Overall Study|Lost to Follow-up|1|||
33439260|NCT00262041|62815292|FG001|Overall Study|Lost to Follow-up|1|||
33439261|NCT00262041|62815293|FG002|Overall Study|Lost to Follow-up|5|||
33605824|NCT02010255|63005579|FG002|Overall Study|Adverse Event|0|||
33605825|NCT02010255|63005580|FG003|Overall Study|Adverse Event|0|||
33605826|NCT02010255|63005581|FG004|Overall Study|Adverse Event|0|||
33439262|NCT00262041|62815291|FG000|Overall Study|Unable to classify|1|||
33439263|NCT00262041|62815292|FG001|Overall Study|Unable to classify|0|||
33439264|NCT00262041|62815293|FG002|Overall Study|Unable to classify|0|||
33439265|NCT00208767|62815309|FG000|Overall Study|Adverse Event|9|||
33439266|NCT00208767|62815310|FG001|Overall Study|Adverse Event|1|||
33439267|NCT00208767|62815309|FG000|Overall Study|Withdrawal by Subject|14|||
33439268|NCT00208767|62815310|FG001|Overall Study|Withdrawal by Subject|3|||
33439269|NCT00208767|62815309|FG000|Overall Study|Death|1|||
33439270|NCT00208767|62815310|FG001|Overall Study|Death|0|||
33439271|NCT00208767|62815309|FG000|Overall Study|Lost to Follow-up|3|||
33439272|NCT00208767|62815310|FG001|Overall Study|Lost to Follow-up|3|||
33439273|NCT00390806|62815318|FG000|Overall Study|Lost to Follow-up|7|||
33439274|NCT00390806|62815319|FG001|Overall Study|Lost to Follow-up|6|||
33439275|NCT00390806|62815318|FG000|Overall Study|Protocol Violation|2|||
33439276|NCT00390806|62815319|FG001|Overall Study|Protocol Violation|2|||
33439277|NCT00390806|62815318|FG000|Overall Study|Withdrawal by Subject|12|||
33439278|NCT00390806|62815319|FG001|Overall Study|Withdrawal by Subject|15|||
33439279|NCT00390806|62815318|FG000|Overall Study|Investigator Decision|4|||
33439280|NCT00390806|62815319|FG001|Overall Study|Investigator Decision|6|||
33439281|NCT00390806|62815318|FG000|Overall Study|Death|1|||
33439282|NCT00390806|62815319|FG001|Overall Study|Death|0|||
33439283|NCT00390806|62815318|FG000|Overall Study|Physician Decision|0|||
33439284|NCT00390806|62815319|FG001|Overall Study|Physician Decision|1|||
33439285|NCT00390806|62815318|FG000|Overall Study|Ongoing|4|||
33439286|NCT00390806|62815319|FG001|Overall Study|Ongoing|2|||
33439287|NCT00390572|62815327|FG000|Overall Study|Lost to Follow-up|8|||
33439288|NCT00390572|62815328|FG001|Overall Study|Lost to Follow-up|4|||
33439289|NCT00390572|62815327|FG000|Overall Study|health condition|0|||
33439290|NCT00390572|62815328|FG001|Overall Study|health condition|1|||
33439291|NCT00390416|62815338|FG000|Overall Study|Withdrawal by Subject|1|||
33439292|NCT00390416|62815338|FG000|Overall Study|Not treated|3|||
33439293|NCT00261495|62815344|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
33439294|NCT00261495|62815345|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
33439295|NCT00261495|62815344|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
33439296|NCT00261495|62815345|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
33439297|NCT00261495|62815344|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
33439298|NCT00261495|62815345|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
33439299|NCT00261495|62815344|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
33439300|NCT00261495|62815345|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
33439301|NCT00261495|62815344|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
33439302|NCT00261495|62815345|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
33439303|NCT00261495|62815344|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
33439304|NCT00261495|62815345|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
33439305|NCT00261495|62815344|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
33439306|NCT00261495|62815345|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
33439307|NCT00261495|62815344|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
33439308|NCT00261495|62815345|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
33439309|NCT00261495|62815344|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
33439310|NCT00261495|62815345|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
33439311|NCT00261495|62815344|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
33439312|NCT00261495|62815345|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
33439313|NCT00261495|62815344|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
33439314|NCT00261495|62815345|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
33439315|NCT00261495|62815344|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
33439316|NCT00261495|62815345|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
33439317|NCT00261495|62815344|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
33439318|NCT00261495|62815345|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
33439319|NCT00261495|62815344|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
33439320|NCT00261495|62815345|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
33439321|NCT00261495|62815344|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
33439322|NCT00261495|62815345|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
33439323|NCT00261495|62815344|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
33439324|NCT00261495|62815345|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
33439325|NCT00261495|62815344|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
33439326|NCT00261495|62815345|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
33439327|NCT00261495|62815344|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
33439328|NCT00261495|62815345|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
33439329|NCT00261495|62815344|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
33439330|NCT00261495|62815345|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
33439331|NCT00261495|62815344|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
33323223|NCT00973479|62699481|FG000|Overall Study|Death|2|||
33439332|NCT00261495|62815345|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
33439333|NCT00261495|62815344|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
33605827|NCT02010255|63005582|FG005|Overall Study|Adverse Event|0|||
33605828|NCT02010255|63005583|FG006|Overall Study|Adverse Event|0|||
33605829|NCT02010255|63005584|FG007|Overall Study|Adverse Event|0|||
33605830|NCT02010255|63005585|FG008|Overall Study|Adverse Event|0|||
33605831|NCT02010255|63005586|FG009|Overall Study|Adverse Event|0|||
33605832|NCT02010255|63005587|FG010|Overall Study|Adverse Event|0|||
33605833|NCT02010255|63005588|FG011|Overall Study|Adverse Event|0|||
33605834|NCT02010255|63005589|FG012|Overall Study|Adverse Event|0|||
33605835|NCT02010255|63005590|FG013|Overall Study|Adverse Event|0|||
33605836|NCT02010255|63005577|FG000|Overall Study|Lost to Follow-up|0|||
33605837|NCT02010255|63005578|FG001|Overall Study|Lost to Follow-up|0|||
33605838|NCT02010255|63005579|FG002|Overall Study|Lost to Follow-up|1|||
33605839|NCT02010255|63005580|FG003|Overall Study|Lost to Follow-up|0|||
33605840|NCT02010255|63005581|FG004|Overall Study|Lost to Follow-up|1|||
33605841|NCT02010255|63005582|FG005|Overall Study|Lost to Follow-up|0|||
33605842|NCT02010255|63005583|FG006|Overall Study|Lost to Follow-up|0|||
33605843|NCT02010255|63005584|FG007|Overall Study|Lost to Follow-up|0|||
33605844|NCT02010255|63005585|FG008|Overall Study|Lost to Follow-up|0|||
33605845|NCT02010255|63005586|FG009|Overall Study|Lost to Follow-up|0|||
33605846|NCT02010255|63005587|FG010|Overall Study|Lost to Follow-up|0|||
33605847|NCT02010255|63005588|FG011|Overall Study|Lost to Follow-up|0|||
33605848|NCT02010255|63005589|FG012|Overall Study|Lost to Follow-up|0|||
33605849|NCT02010255|63005590|FG013|Overall Study|Lost to Follow-up|0|||
33605850|NCT02010255|63005577|FG000|Overall Study|Randomized but Not Treated|0|||
33605851|NCT02010255|63005578|FG001|Overall Study|Randomized but Not Treated|0|||
33605852|NCT02010255|63005579|FG002|Overall Study|Randomized but Not Treated|0|||
33605853|NCT02010255|63005580|FG003|Overall Study|Randomized but Not Treated|0|||
33605854|NCT02010255|63005581|FG004|Overall Study|Randomized but Not Treated|0|||
33605855|NCT02010255|63005582|FG005|Overall Study|Randomized but Not Treated|0|||
33605856|NCT02010255|63005583|FG006|Overall Study|Randomized but Not Treated|0|||
33605857|NCT02010255|63005584|FG007|Overall Study|Randomized but Not Treated|0|||
33605858|NCT02010255|63005585|FG008|Overall Study|Randomized but Not Treated|0|||
33605859|NCT02010255|63005586|FG009|Overall Study|Randomized but Not Treated|0|||
33439334|NCT00261495|62815345|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33439335|NCT00168844|62815354|FG000|Overall Study|Adverse Event|31|||
33439336|NCT00168844|62815355|FG001|Overall Study|Adverse Event|32|||
33439337|NCT00168844|62815356|FG002|Overall Study|Adverse Event|48|||
33439338|NCT00168844|62815354|FG000|Overall Study|Lost to Follow-up|4|||
33439339|NCT00168844|62815355|FG001|Overall Study|Lost to Follow-up|5|||
33439340|NCT00168844|62815356|FG002|Overall Study|Lost to Follow-up|11|||
33439341|NCT00168844|62815354|FG000|Overall Study|Withdrawal by Subject|12|||
33439342|NCT00168844|62815355|FG001|Overall Study|Withdrawal by Subject|9|||
33439343|NCT00168844|62815356|FG002|Overall Study|Withdrawal by Subject|19|||
33439344|NCT00168844|62815354|FG000|Overall Study|Protocol Violation|2|||
33439345|NCT00168844|62815355|FG001|Overall Study|Protocol Violation|2|||
33439346|NCT00168844|62815356|FG002|Overall Study|Protocol Violation|4|||
33439347|NCT00168844|62815354|FG000|Overall Study|Other|6|||
33439348|NCT00168844|62815355|FG001|Overall Study|Other|7|||
33439349|NCT00168844|62815356|FG002|Overall Study|Other|9|||
33439350|NCT00365456|62815364|FG000|Trial Period I (12 Months)|Adverse Event|84|||
33439351|NCT00365456|62815365|FG001|Trial Period I (12 Months)|Adverse Event|0|||
33439352|NCT00365456|62815364|FG000|Trial Period I (12 Months)|Non-compliance|3|||
33439353|NCT00365456|62815365|FG001|Trial Period I (12 Months)|Non-compliance|0|||
33439354|NCT00365456|62815364|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
33439355|NCT00365456|62815365|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
33439356|NCT00365456|62815364|FG000|Trial Period I (12 Months)|Other|11|||
33439357|NCT00365456|62815365|FG001|Trial Period I (12 Months)|Other|0|||
33439358|NCT00365456|62815364|FG000|Trial Period II (12 Months)|Adverse Event|0|||
33439359|NCT00365456|62815365|FG001|Trial Period II (12 Months)|Adverse Event|6|||
33439360|NCT00365456|62815364|FG000|Trial Period II (12 Months)|Non-compliance|0|||
33439361|NCT00365456|62815365|FG001|Trial Period II (12 Months)|Non-compliance|2|||
33439362|NCT00365456|62815364|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
33439363|NCT00365456|62815365|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
33439364|NCT00365456|62815364|FG000|Trial Period II (12 Months)|Other|0|||
33605860|NCT02010255|63005587|FG010|Overall Study|Randomized but Not Treated|0|||
33605861|NCT02010255|63005588|FG011|Overall Study|Randomized but Not Treated|0|||
33323224|NCT00973479|62699482|FG001|Overall Study|Death|2|||
33439365|NCT00365456|62815365|FG001|Trial Period II (12 Months)|Other|1|||
33439366|NCT00365456|62815364|FG000|Trial Period III (12 Months)|Adverse Event|13|||
33439367|NCT00365456|62815365|FG001|Trial Period III (12 Months)|Adverse Event|3|||
33605862|NCT02010255|63005589|FG012|Overall Study|Randomized but Not Treated|0|||
33605863|NCT02010255|63005590|FG013|Overall Study|Randomized but Not Treated|1|||
33605864|NCT02354417|63005645|FG000|Overall Study|Physician Decision|1|||
33605865|NCT02332187|63005651|FG000|Overall Study|Withdrawal by Subject|2|||
33439368|NCT00365456|62815364|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
33439369|NCT00365456|62815365|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
33439370|NCT00365456|62815364|FG000|Trial Period III (12 Months)|Other|1|||
33439371|NCT00365456|62815365|FG001|Trial Period III (12 Months)|Other|1|||
33605866|NCT02332187|63005652|FG001|Overall Study|Withdrawal by Subject|2|||
33605867|NCT02332187|63005651|FG000|Overall Study|Adverse Event|0|||
33605868|NCT02332187|63005652|FG001|Overall Study|Adverse Event|1|||
33605869|NCT02330549|63005660|FG000|Overall Study|Adverse Event|1|||
33605870|NCT02330549|63005661|FG001|Overall Study|Adverse Event|0|||
33605871|NCT02330549|63005660|FG000|Overall Study|Subject withdrew consent|2|||
33605872|NCT02330549|63005661|FG001|Overall Study|Subject withdrew consent|1|||
33605873|NCT02330549|63005660|FG000|Overall Study|Failure to meet randomization criteria|1|||
33605874|NCT02330549|63005661|FG001|Overall Study|Failure to meet randomization criteria|0|||
33605875|NCT02009865|63005669|FG000|Overall Study|Adverse Event|0|||
33605876|NCT02009865|63005670|FG001|Overall Study|Adverse Event|2|||
33605877|NCT02009865|63005669|FG000|Overall Study|Protocol Violation|0|||
33605878|NCT02009865|63005670|FG001|Overall Study|Protocol Violation|2|||
33605879|NCT02009865|63005669|FG000|Overall Study|Withdrawal by Subject|1|||
33605880|NCT02009865|63005670|FG001|Overall Study|Withdrawal by Subject|1|||
33605881|NCT01620177|63005676|FG000|Overall Study|Failure at Screening Visit|43|||
33605882|NCT01620177|63005676|FG000|Overall Study|Withdrawal by Subject|26|||
33605883|NCT01620177|63005676|FG000|Overall Study|Lost to Follow-up|7|||
33605884|NCT01620177|63005676|FG000|Overall Study|Physician Decision|2|||
33605885|NCT01620177|63005676|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
33605886|NCT02075541|63005695|FG000|Overall Study|Serious Adverse Event|1|||
33605887|NCT02075541|63005696|FG001|Overall Study|Serious Adverse Event|4|||
33605888|NCT02075541|63005695|FG000|Overall Study|Protocol Violation|1|||
33605889|NCT02075541|63005696|FG001|Overall Study|Protocol Violation|0|||
33605890|NCT02075541|63005695|FG000|Overall Study|Withdrawal by Subject|1|||
33605891|NCT02075541|63005696|FG001|Overall Study|Withdrawal by Subject|3|||
33605892|NCT02075541|63005695|FG000|Overall Study|Sponsor study termination|0|||
33605893|NCT02075541|63005696|FG001|Overall Study|Sponsor study termination|1|||
33605894|NCT02075541|63005695|FG000|Overall Study|Other- unable to perform study procedure|1|||
33605895|NCT02075541|63005696|FG001|Overall Study|Other- unable to perform study procedure|0|||
33605896|NCT02330081|63005702|FG000|Overall Study|Adverse Event|1|||
33605897|NCT02330081|63005702|FG000|Overall Study|Donation did not meet criteria|1|||
33605898|NCT02330081|63005702|FG000|Overall Study|Protocol Violation|6|||
33605899|NCT01986855|63005712|FG000|Overall Study|Adverse Event|1|||
33605900|NCT01986855|63005713|FG001|Overall Study|Adverse Event|0|||
33605901|NCT01986855|63005714|FG002|Overall Study|Adverse Event|0|||
33439372|NCT00147238|62815371|FG000|Overall Study|Inevaluable|8|||
33439373|NCT00206427|62815375|FG000|Overall Study|Adverse Event|2|||
33439374|NCT00146848|62815382|FG000|Pre-randomization|Death|19|||
33439375|NCT00146848|62815383|FG001|Pre-randomization|Death|0|||
33439376|NCT00146848|62815384|FG002|Pre-randomization|Death|0|||
33439377|NCT00146848|62815382|FG000|Pre-randomization|Lost to Follow-up|70|||
33439378|NCT00146848|62815383|FG001|Pre-randomization|Lost to Follow-up|0|||
33439379|NCT00146848|62815384|FG002|Pre-randomization|Lost to Follow-up|0|||
33439380|NCT00146848|62815382|FG000|Pre-randomization|Physician Decision|8|||
33439381|NCT00146848|62815383|FG001|Pre-randomization|Physician Decision|0|||
33439382|NCT00146848|62815384|FG002|Pre-randomization|Physician Decision|0|||
33439383|NCT00146848|62815382|FG000|Pre-randomization|Protocol Violation|172|||
33439384|NCT00146848|62815383|FG001|Pre-randomization|Protocol Violation|0|||
33439385|NCT00146848|62815384|FG002|Pre-randomization|Protocol Violation|0|||
33439386|NCT00146848|62815382|FG000|Pre-randomization|Withdrawal by Subject|40|||
33439387|NCT00146848|62815383|FG001|Pre-randomization|Withdrawal by Subject|0|||
33439388|NCT00146848|62815384|FG002|Pre-randomization|Withdrawal by Subject|0|||
33439389|NCT00146848|62815382|FG000|Post-randomization|Lost to Follow-up|12|||
33439390|NCT00146848|62815383|FG001|Post-randomization|Lost to Follow-up|15|||
33439391|NCT00146848|62815384|FG002|Post-randomization|Lost to Follow-up|12|||
33439392|NCT00146848|62815382|FG000|Post-randomization|Withdrawn|26|||
33439393|NCT00146848|62815383|FG001|Post-randomization|Withdrawn|32|||
33605902|NCT01986855|63005712|FG000|Overall Study|Death|3|||
33605903|NCT01986855|63005713|FG001|Overall Study|Death|4|||
33605904|NCT01986855|63005714|FG002|Overall Study|Death|4|||
33605905|NCT01986855|63005712|FG000|Overall Study|Lost to Follow-up|2|||
33323225|NCT00973479|62699481|FG000|Overall Study|Withdrawal by Subject|15|||
33323226|NCT00973479|62699482|FG001|Overall Study|Withdrawal by Subject|16|||
33439394|NCT00146848|62815384|FG002|Post-randomization|Withdrawn|27|||
33439395|NCT00205881|62815392|FG000|Overall Study|Withdrawal by Subject|16|||
33439396|NCT00365378|62815399|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
33439397|NCT00365378|62815400|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
33439398|NCT00365378|62815401|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
33605906|NCT01986855|63005713|FG001|Overall Study|Lost to Follow-up|1|||
33605907|NCT01986855|63005714|FG002|Overall Study|Lost to Follow-up|0|||
33605908|NCT01986855|63005712|FG000|Overall Study|Screen Failure|0|||
33605909|NCT01986855|63005713|FG001|Overall Study|Screen Failure|1|||
33439399|NCT00365378|62815399|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
33439400|NCT00365378|62815400|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
33439401|NCT00365378|62815401|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
33439402|NCT00365378|62815399|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
33439403|NCT00365378|62815400|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
33439404|NCT00365378|62815401|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
33439405|NCT00365378|62815399|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
33439406|NCT00365378|62815400|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
33439407|NCT00365378|62815401|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
33439408|NCT00365378|62815399|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
33439409|NCT00365378|62815400|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
33439410|NCT00365378|62815401|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
33439411|NCT00365378|62815399|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
33439412|NCT00365378|62815400|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
33439413|NCT00365378|62815401|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
33439414|NCT00365378|62815399|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
33439415|NCT00365378|62815400|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
33439416|NCT00365378|62815401|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
33439417|NCT00365378|62815399|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
33439418|NCT00365378|62815400|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
33439419|NCT00365378|62815401|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
33439420|NCT00365378|62815399|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
33439421|NCT00365378|62815400|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
33439422|NCT00365378|62815401|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
33439423|NCT00365378|62815399|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
33439424|NCT00365378|62815400|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
33439425|NCT00365378|62815401|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
33439426|NCT00365378|62815399|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
33439427|NCT00365378|62815400|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
33439428|NCT00365378|62815401|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
33439429|NCT00365378|62815399|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
33439430|NCT00365378|62815400|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
33439431|NCT00365378|62815401|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
33439432|NCT00365378|62815399|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
33439433|NCT00365378|62815400|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
33439434|NCT00365378|62815401|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
33439435|NCT00365378|62815399|FG000|Extension|Adverse Event|0|||
33439436|NCT00365378|62815400|FG001|Extension|Adverse Event|0|||
33439437|NCT00365378|62815401|FG002|Extension|Adverse Event|1|||
33439438|NCT00365378|62815399|FG000|Extension|Moved|0|||
33439439|NCT00365378|62815400|FG001|Extension|Moved|0|||
33439440|NCT00365378|62815401|FG002|Extension|Moved|8|||
33439441|NCT00365378|62815399|FG000|Extension|Lost to Follow-up|0|||
33439442|NCT00365378|62815400|FG001|Extension|Lost to Follow-up|0|||
33439443|NCT00365378|62815401|FG002|Extension|Lost to Follow-up|57|||
33439444|NCT00365378|62815399|FG000|Extension|Protocol Violation|0|||
33439445|NCT00365378|62815400|FG001|Extension|Protocol Violation|0|||
33439446|NCT00365378|62815401|FG002|Extension|Protocol Violation|2|||
33439447|NCT00365378|62815399|FG000|Extension|Withdrawal by Subject|0|||
33439448|NCT00365378|62815400|FG001|Extension|Withdrawal by Subject|0|||
33439449|NCT00365378|62815401|FG002|Extension|Withdrawal by Subject|98|||
33439450|NCT00365378|62815399|FG000|Extension|Other|0|||
33439451|NCT00365378|62815400|FG001|Extension|Other|0|||
33439452|NCT00365378|62815401|FG002|Extension|Other|31|||
33439453|NCT00389324|62815408|FG000|Run-In Phase|Adverse Event|1|||
33439454|NCT00389324|62815408|FG000|Run-In Phase|Lost to Follow-up|1|||
33439455|NCT00389324|62815408|FG000|Run-In Phase|Withdrawal by Subject|1|||
33439456|NCT00389324|62815408|FG000|Subcutaneous Phase|Adverse Event|2|||
33439457|NCT00389324|62815408|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
33439458|NCT00389324|62815408|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
33439459|NCT00389324|62815408|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
33439460|NCT00365300|62815417|FG000|Open-label Phase|Adverse Event|4|||
33439461|NCT00365300|62815418|FG001|Open-label Phase|Adverse Event|0|||
33439462|NCT00365300|62815417|FG000|Open-label Phase|Failed to Return|1|||
33439463|NCT00365300|62815418|FG001|Open-label Phase|Failed to Return|0|||
33439464|NCT00365300|62815417|FG000|Open-label Phase|Physician Decision|1|||
33439465|NCT00365300|62815418|FG001|Open-label Phase|Physician Decision|0|||
33439466|NCT00365300|62815417|FG000|Open-label Phase|Noncompliance|9|||
33439467|NCT00365300|62815418|FG001|Open-label Phase|Noncompliance|0|||
33439468|NCT00365300|62815417|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
33439469|NCT00365300|62815418|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
33439470|NCT00365300|62815417|FG000|Open-label Phase|Protocol Violation|1|||
33439471|NCT00365300|62815418|FG001|Open-label Phase|Protocol Violation|0|||
33439472|NCT00365300|62815417|FG000|Open-label Phase|Lack of Efficacy|1|||
33439473|NCT00365300|62815418|FG001|Open-label Phase|Lack of Efficacy|0|||
33439474|NCT00365300|62815417|FG000|Open-label Phase|Patient skipped open label phase|1|||
33439475|NCT00365300|62815418|FG001|Open-label Phase|Patient skipped open label phase|0|||
33439476|NCT00365300|62815417|FG000|Double-blind Phase|Failed to return|1|||
33439477|NCT00365300|62815418|FG001|Double-blind Phase|Failed to return|0|||
33439478|NCT00365300|62815417|FG000|Double-blind Phase|Noncompliance|1|||
33439479|NCT00365300|62815418|FG001|Double-blind Phase|Noncompliance|1|||
33439480|NCT00365300|62815417|FG000|Double-blind Phase|Withdrawal by Subject|0|||
33439481|NCT00365300|62815418|FG001|Double-blind Phase|Withdrawal by Subject|1|||
33439482|NCT00365300|62815417|FG000|Double-blind Phase|Protocol Violation|3|||
33439483|NCT00365300|62815418|FG001|Double-blind Phase|Protocol Violation|1|||
33439484|NCT00365300|62815417|FG000|Double-blind Phase|Lack of Efficacy|6|||
33439485|NCT00365300|62815418|FG001|Double-blind Phase|Lack of Efficacy|6|||
33439486|NCT00370292|62815429|FG000|Overall Study|Disease Progression|4|||
33439487|NCT00370292|62815429|FG000|Overall Study|Adverse Event|7|||
33439488|NCT00370292|62815429|FG000|Overall Study|Physician Decision|2|||
33439489|NCT00369824|62815446|FG000|Overall Study|Adverse Event|0|||
33439490|NCT00369824|62815447|FG001|Overall Study|Adverse Event|2|||
33439491|NCT00369824|62815448|FG002|Overall Study|Adverse Event|0|||
33439492|NCT00369824|62815449|FG003|Overall Study|Adverse Event|0|||
33439493|NCT00369824|62815450|FG004|Overall Study|Adverse Event|1|||
33439494|NCT00369824|62815451|FG005|Overall Study|Adverse Event|0|||
33439495|NCT00369824|62815446|FG000|Overall Study|Protocol Violation|0|||
33439496|NCT00369824|62815447|FG001|Overall Study|Protocol Violation|1|||
33439497|NCT00369824|62815448|FG002|Overall Study|Protocol Violation|0|||
33439498|NCT00369824|62815449|FG003|Overall Study|Protocol Violation|1|||
33439499|NCT00369824|62815450|FG004|Overall Study|Protocol Violation|1|||
33439500|NCT00369824|62815451|FG005|Overall Study|Protocol Violation|0|||
33439501|NCT00369824|62815446|FG000|Overall Study|Withdrawal by Subject|9|||
33605910|NCT01986855|63005714|FG002|Overall Study|Screen Failure|0|||
33605911|NCT01986855|63005712|FG000|Overall Study|Participant Moved|0|||
33605912|NCT01986855|63005713|FG001|Overall Study|Participant Moved|0|||
33605913|NCT01986855|63005714|FG002|Overall Study|Participant Moved|2|||
33605914|NCT01986855|63005712|FG000|Overall Study|Withdrawal by Subject|7|||
33605915|NCT01986855|63005713|FG001|Overall Study|Withdrawal by Subject|8|||
33605916|NCT01986855|63005714|FG002|Overall Study|Withdrawal by Subject|5|||
33605917|NCT02075463|63005722|FG000|Overall Study|Adverse Event|3|||
33605918|NCT02075463|63005722|FG000|Overall Study|Par. reached stopping criteria|4|||
33605919|NCT02075463|63005722|FG000|Overall Study|Withdrawal by Subject|1|||
33605920|NCT02353871|63005729|FG000|Overall Study|Protocol deviation|0|||
33605921|NCT02353871|63005730|FG001|Overall Study|Protocol deviation|1|||
33605922|NCT02353871|63005729|FG000|Overall Study|Consent withdrawn|1|||
33605923|NCT02353871|63005730|FG001|Overall Study|Consent withdrawn|8|||
33605924|NCT02353871|63005729|FG000|Overall Study|Lost to Follow-up|2|||
33605925|NCT02353871|63005730|FG001|Overall Study|Lost to Follow-up|0|||
33605926|NCT02009397|63005736|FG000|Overall Study|Protocol Violation|6|||
33605927|NCT02009397|63005736|FG000|Overall Study|Death|8|||
33605928|NCT02009397|63005736|FG000|Overall Study|Lost to Follow-up|6|||
33605929|NCT02312219|63005742|FG000|Overall Study|Withdrawal by Subject|1|||
33605930|NCT02312219|63005743|FG001|Overall Study|Withdrawal by Subject|2|||
33605931|NCT02312219|63005742|FG000|Overall Study|could not schedule imaging in time|0|||
33605932|NCT02312219|63005743|FG001|Overall Study|could not schedule imaging in time|2|||
33605933|NCT02312219|63005742|FG000|Overall Study|Other|0|||
33605934|NCT02312219|63005743|FG001|Overall Study|Other|1|||
33605935|NCT02312219|63005742|FG000|Overall Study|Not randomized. Ineligible|0|||
33439502|NCT00369824|62815447|FG001|Overall Study|Withdrawal by Subject|5|||
33439503|NCT00369824|62815448|FG002|Overall Study|Withdrawal by Subject|5|||
33439504|NCT00369824|62815449|FG003|Overall Study|Withdrawal by Subject|4|||
33439505|NCT00369824|62815450|FG004|Overall Study|Withdrawal by Subject|6|||
33439506|NCT00369824|62815451|FG005|Overall Study|Withdrawal by Subject|2|||
33439507|NCT00369824|62815446|FG000|Overall Study|Lost to Follow-up|6|||
33323227|NCT00973479|62699481|FG000|Overall Study|Lack of Efficacy|5|||
33439508|NCT00369824|62815447|FG001|Overall Study|Lost to Follow-up|11|||
33439509|NCT00369824|62815448|FG002|Overall Study|Lost to Follow-up|7|||
33439510|NCT00369824|62815449|FG003|Overall Study|Lost to Follow-up|8|||
33439511|NCT00369824|62815450|FG004|Overall Study|Lost to Follow-up|9|||
33439512|NCT00369824|62815451|FG005|Overall Study|Lost to Follow-up|6|||
33439513|NCT00369824|62815446|FG000|Overall Study|Other|0|||
33439514|NCT00369824|62815447|FG001|Overall Study|Other|0|||
33439515|NCT00369824|62815448|FG002|Overall Study|Other|0|||
33439516|NCT00369824|62815449|FG003|Overall Study|Other|2|||
33439517|NCT00369824|62815450|FG004|Overall Study|Other|1|||
33439518|NCT00369824|62815451|FG005|Overall Study|Other|3|||
33439519|NCT00369668|62815468|FG000|Overall Study|Lack of Efficacy|4|||
33439520|NCT00369668|62815469|FG001|Overall Study|Lack of Efficacy|5|||
33439521|NCT00369668|62815470|FG002|Overall Study|Lack of Efficacy|7|||
33439522|NCT00388154|62815481|FG000|Overall Study|Withdrawal by Subject|1|||
33439523|NCT00387764|62815485|FG000|Overall Study|Adverse Event|12|||
33439524|NCT00387764|62815485|FG000|Overall Study|Withdrawal by Subject|8|||
33439525|NCT00387764|62815485|FG000|Overall Study|Sponsor Terminated Study|1|||
33439526|NCT00387764|62815485|FG000|Overall Study|Physician Decision|1|||
33439527|NCT00387764|62815485|FG000|Overall Study|Other|2|||
33439528|NCT00387764|62815485|FG000|Overall Study|Death|7|||
33439529|NCT00386360|62815491|FG000|Overall Study|Adverse Event|4|||
33605936|NCT02312219|63005743|FG001|Overall Study|Not randomized. Ineligible|1|||
33605937|NCT01986231|63005749|FG000|Overall Study|Adverse Event|1|||
33605938|NCT02312063|63005755|FG000|Overall Study|Withdrawal by Subject|0|||
33605939|NCT02312063|63005756|FG001|Overall Study|Withdrawal by Subject|1|||
33605940|NCT02353169|63005767|FG000|Overall Study|QTc > 450 msec|1|||
33605941|NCT02353169|63005768|FG001|Overall Study|QTc > 450 msec|1|||
33605942|NCT02353169|63005769|FG002|Overall Study|QTc > 450 msec|1|||
33605943|NCT02353169|63005770|FG003|Overall Study|QTc > 450 msec|1|||
33605944|NCT02353169|63005767|FG000|Overall Study|OR team declined|2|||
33605945|NCT02353169|63005768|FG001|Overall Study|OR team declined|0|||
33605946|NCT02353169|63005769|FG002|Overall Study|OR team declined|0|||
33605947|NCT02353169|63005770|FG003|Overall Study|OR team declined|0|||
33605948|NCT02353169|63005767|FG000|Overall Study|Inhalational induction|0|||
33605949|NCT02353169|63005768|FG001|Overall Study|Inhalational induction|2|||
33605950|NCT02353169|63005769|FG002|Overall Study|Inhalational induction|0|||
33605951|NCT02353169|63005770|FG003|Overall Study|Inhalational induction|0|||
33605952|NCT02353169|63005767|FG000|Overall Study|ECG data error|0|||
33605953|NCT02353169|63005768|FG001|Overall Study|ECG data error|3|||
33605954|NCT02353169|63005769|FG002|Overall Study|ECG data error|2|||
33605955|NCT02353169|63005770|FG003|Overall Study|ECG data error|2|||
33605956|NCT02353169|63005767|FG000|Overall Study|Pre-op medication|0|||
33605957|NCT02353169|63005768|FG001|Overall Study|Pre-op medication|0|||
33605958|NCT02353169|63005769|FG002|Overall Study|Pre-op medication|1|||
33605959|NCT02353169|63005770|FG003|Overall Study|Pre-op medication|0|||
33439530|NCT00386360|62815492|FG001|Overall Study|Adverse Event|2|||
33439531|NCT00386360|62815491|FG000|Overall Study|Physician Decision|2|||
33439532|NCT00386360|62815492|FG001|Overall Study|Physician Decision|2|||
33439533|NCT00386360|62815491|FG000|Overall Study|Lost to Follow-up|0|||
33439534|NCT00386360|62815492|FG001|Overall Study|Lost to Follow-up|2|||
33439535|NCT00386360|62815491|FG000|Overall Study|Protocol Violation|0|||
33439536|NCT00386360|62815492|FG001|Overall Study|Protocol Violation|3|||
33439537|NCT00386360|62815491|FG000|Overall Study|Withdrawal by Subject|3|||
33439538|NCT00386360|62815492|FG001|Overall Study|Withdrawal by Subject|6|||
33439539|NCT00386360|62815491|FG000|Overall Study|Did not take any study medication|0|||
33439540|NCT00386360|62815492|FG001|Overall Study|Did not take any study medication|2|||
33439541|NCT00369278|62815500|FG000|Overall Study|Adverse Event|14|||
33439542|NCT00369278|62815501|FG001|Overall Study|Adverse Event|11|||
33439543|NCT00369278|62815500|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33439544|NCT00369278|62815501|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
33439545|NCT00369278|62815500|FG000|Overall Study|Protocol Violation|2|||
33439546|NCT00369278|62815501|FG001|Overall Study|Protocol Violation|1|||
33439547|NCT00369278|62815500|FG000|Overall Study|Withdrawal by Subject|2|||
33439548|NCT00369278|62815501|FG001|Overall Study|Withdrawal by Subject|2|||
33605960|NCT02009163|63005780|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
33439549|NCT00369278|62815500|FG000|Overall Study|Lost to Follow-up|1|||
33439550|NCT00369278|62815501|FG001|Overall Study|Lost to Follow-up|0|||
33439551|NCT00369278|62815500|FG000|Overall Study|Graft loss|1|||
33439552|NCT00369278|62815501|FG001|Overall Study|Graft loss|2|||
33439553|NCT00529373|62815509|FG000|Base Study|Adverse Event|525|||
33439554|NCT00529373|62815510|FG001|Base Study|Adverse Event|470|||
33439555|NCT00529373|62815509|FG000|Base Study|Lack of Efficacy|16|||
33439556|NCT00529373|62815510|FG001|Base Study|Lack of Efficacy|75|||
33439557|NCT00529373|62815509|FG000|Base Study|Lost to Follow-up|221|||
33605961|NCT02009163|63005781|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
33605962|NCT02009163|63005782|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
33605963|NCT02009163|63005780|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
33605964|NCT02009163|63005781|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
33605965|NCT02009163|63005782|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
33605966|NCT02009163|63005780|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
33605967|NCT02009163|63005781|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
33605968|NCT02009163|63005782|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
33605969|NCT02009163|63005780|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
33605970|NCT02009163|63005781|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
33605971|NCT02009163|63005782|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
33605972|NCT02009163|63005780|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
33439558|NCT00529373|62815510|FG001|Base Study|Lost to Follow-up|208|||
33439559|NCT00529373|62815509|FG000|Base Study|Other Protocol Specified Criteria|19|||
33439560|NCT00529373|62815510|FG001|Base Study|Other Protocol Specified Criteria|20|||
33439561|NCT00529373|62815509|FG000|Base Study|Physician Decision|60|||
33439562|NCT00529373|62815510|FG001|Base Study|Physician Decision|52|||
33439563|NCT00529373|62815509|FG000|Base Study|Protocol Violation|48|||
33439564|NCT00529373|62815510|FG001|Base Study|Protocol Violation|38|||
33439565|NCT00529373|62815509|FG000|Base Study|Withdrawal by Subject|1062|||
33439566|NCT00529373|62815510|FG001|Base Study|Withdrawal by Subject|967|||
33439567|NCT00529373|62815509|FG000|Base Study|Did not continue into Extension|1795|||
33439568|NCT00529373|62815510|FG001|Base Study|Did not continue into Extension|2238|||
33439569|NCT00529373|62815509|FG000|First Extension Study|Adverse Event|162|||
33439570|NCT00529373|62815510|FG001|First Extension Study|Adverse Event|142|||
33439571|NCT00529373|62815509|FG000|First Extension Study|Lack of Efficacy|65|||
33439572|NCT00529373|62815510|FG001|First Extension Study|Lack of Efficacy|427|||
33439573|NCT00529373|62815509|FG000|First Extension Study|Lost to Follow-up|41|||
33439574|NCT00529373|62815510|FG001|First Extension Study|Lost to Follow-up|37|||
33439575|NCT00529373|62815509|FG000|First Extension Study|Other|27|||
33439576|NCT00529373|62815510|FG001|First Extension Study|Other|47|||
33439577|NCT00529373|62815509|FG000|First Extension Study|Physician Decision|50|||
33439578|NCT00529373|62815510|FG001|First Extension Study|Physician Decision|45|||
33439579|NCT00529373|62815509|FG000|First Extension Study|Protocol Violation|16|||
33439580|NCT00529373|62815510|FG001|First Extension Study|Protocol Violation|13|||
33439581|NCT00529373|62815509|FG000|First Extension Study|Withdrawal by Subject|296|||
33439582|NCT00529373|62815510|FG001|First Extension Study|Withdrawal by Subject|287|||
33439583|NCT00529373|62815509|FG000|First Extension Study|Disposition record non-existing|0|||
33439584|NCT00529373|62815510|FG001|First Extension Study|Disposition record non-existing|1|||
33439585|NCT00529373|62815509|FG000|First Extension Study|Discontinued after 5 years completion|208|||
33439586|NCT00529373|62815510|FG001|First Extension Study|Discontinued after 5 years completion|346|||
33439587|NCT00529373|62815509|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
33439588|NCT00529373|62815510|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
33439589|NCT00529373|62815509|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
33439590|NCT00529373|62815510|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
33439591|NCT00529373|62815509|FG000|Second Extension Study|Adverse Event|101|||
33439592|NCT00529373|62815510|FG001|Second Extension Study|Adverse Event|51|||
33439593|NCT00529373|62815509|FG000|Second Extension Study|Lack of Efficacy|7|||
33439594|NCT00529373|62815510|FG001|Second Extension Study|Lack of Efficacy|15|||
33439595|NCT00529373|62815509|FG000|Second Extension Study|Lost to Follow-up|18|||
33439596|NCT00529373|62815510|FG001|Second Extension Study|Lost to Follow-up|12|||
33439597|NCT00529373|62815509|FG000|Second Extension Study|Other|7|||
33439598|NCT00529373|62815510|FG001|Second Extension Study|Other|12|||
33439599|NCT00529373|62815509|FG000|Second Extension Study|Physician Decision|63|||
33439600|NCT00529373|62815510|FG001|Second Extension Study|Physician Decision|26|||
33439601|NCT00529373|62815509|FG000|Second Extension Study|Protocol Violation|2|||
33439602|NCT00529373|62815510|FG001|Second Extension Study|Protocol Violation|1|||
33439603|NCT00529373|62815509|FG000|Second Extension Study|Withdrawal by Subject|97|||
33439604|NCT00529373|62815510|FG001|Second Extension Study|Withdrawal by Subject|75|||
33439605|NCT00529373|62815509|FG000|Second Extension Study|Status Missing|5|||
33439606|NCT00529373|62815510|FG001|Second Extension Study|Status Missing|5|||
33439607|NCT00369122|62815524|FG000|Overall Study|Ineligible|10|||
33439608|NCT00369122|62815524|FG000|Overall Study|No protocol treatment|1|||
33605973|NCT02009163|63005781|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
33605974|NCT02009163|63005782|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
33439609|NCT03687125|62815530|FG000|Overall Study|Progressive Disease|2|||
33439610|NCT03687125|62815531|FG001|Overall Study|Progressive Disease|1|||
33439611|NCT03687125|62815530|FG000|Overall Study|Protocol Violation|1|||
33439612|NCT03687125|62815531|FG001|Overall Study|Protocol Violation|0|||
33439613|NCT03872843|62815541|FG000|Overall Study|Lost to Follow-up|5|||
33439614|NCT03872843|62815542|FG001|Overall Study|Lost to Follow-up|7|||
33605975|NCT02009163|63005780|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
33605976|NCT02009163|63005781|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
33439615|NCT00146770|62815550|FG000|Overall Study|Adverse Event|2|||
33439616|NCT00146770|62815551|FG001|Overall Study|Adverse Event|0|||
33439617|NCT00146770|62815550|FG000|Overall Study|Pregnancy|1|||
33439618|NCT00146770|62815551|FG001|Overall Study|Pregnancy|0|||
33439619|NCT00146770|62815550|FG000|Overall Study|Withdrawal by Subject|2|||
33439620|NCT00146770|62815551|FG001|Overall Study|Withdrawal by Subject|0|||
33439621|NCT03874013|62815559|FG000|Overall Study|Adverse Event|0|||
33439622|NCT03874013|62815560|FG001|Overall Study|Adverse Event|1|||
33439623|NCT00168064|62815568|FG000|Overall Study|Adverse Event|26|||
33439624|NCT00168064|62815569|FG001|Overall Study|Adverse Event|22|||
33439625|NCT00168064|62815568|FG000|Overall Study|Withdrawal by Subject|3|||
33439626|NCT00168064|62815569|FG001|Overall Study|Withdrawal by Subject|4|||
33439627|NCT00168064|62815568|FG000|Overall Study|Lack of Efficacy|4|||
33439628|NCT00168064|62815569|FG001|Overall Study|Lack of Efficacy|4|||
33439629|NCT00168064|62815568|FG000|Overall Study|Lost to Follow-up|4|||
33439630|NCT00168064|62815569|FG001|Overall Study|Lost to Follow-up|3|||
33439631|NCT00168064|62815568|FG000|Overall Study|Non-compliance|2|||
33439632|NCT00168064|62815569|FG001|Overall Study|Non-compliance|3|||
33439633|NCT00168064|62815568|FG000|Overall Study|Concurrent Illness|4|||
33439634|NCT00168064|62815569|FG001|Overall Study|Concurrent Illness|3|||
33439635|NCT00168064|62815568|FG000|Overall Study|Subject's Best interest|2|||
33439636|NCT00168064|62815569|FG001|Overall Study|Subject's Best interest|2|||
33439637|NCT00168064|62815568|FG000|Overall Study|Various|4|||
33439638|NCT00168064|62815569|FG001|Overall Study|Various|3|||
33439639|NCT00166114|62815579|FG000|Overall Study|Protocol Violation|2|||
33439640|NCT00166114|62815580|FG001|Overall Study|Protocol Violation|1|||
33439641|NCT00166114|62815579|FG000|Overall Study|Withdrawal by Subject|10|||
33439642|NCT00166114|62815580|FG001|Overall Study|Withdrawal by Subject|4|||
33439643|NCT00166114|62815579|FG000|Overall Study|Adverse Event|2|||
33439644|NCT00166114|62815580|FG001|Overall Study|Adverse Event|1|||
33439645|NCT03686969|62815588|FG000|Overall Study|Study terminated|1|||
33439646|NCT03686969|62815589|FG001|Overall Study|Study terminated|0|||
33439647|NCT00145600|62815599|FG000|Overall Study|Death|1|||
33439648|NCT00145600|62815600|FG001|Overall Study|Death|2|||
33439649|NCT00145600|62815601|FG002|Overall Study|Death|2|||
33439650|NCT00145600|62815602|FG003|Overall Study|Death|6|||
33439651|NCT00145600|62815599|FG000|Overall Study|Ineligible|3|||
33439652|NCT00145600|62815600|FG001|Overall Study|Ineligible|0|||
33439653|NCT00145600|62815601|FG002|Overall Study|Ineligible|1|||
33439654|NCT00145600|62815602|FG003|Overall Study|Ineligible|5|||
33439655|NCT00145600|62815599|FG000|Overall Study|Lost to Follow-up|2|||
33439656|NCT00145600|62815600|FG001|Overall Study|Lost to Follow-up|6|||
33439657|NCT00145600|62815601|FG002|Overall Study|Lost to Follow-up|2|||
33439658|NCT00145600|62815602|FG003|Overall Study|Lost to Follow-up|4|||
33439659|NCT00145600|62815599|FG000|Overall Study|Noncompliance|1|||
33439660|NCT00145600|62815600|FG001|Overall Study|Noncompliance|0|||
33439661|NCT00145600|62815601|FG002|Overall Study|Noncompliance|0|||
33439662|NCT00145600|62815602|FG003|Overall Study|Noncompliance|0|||
33494201|NCT03634033|62872940|FG006|Overall Study|Withdrawal by Subject|1|||
33439663|NCT00145600|62815599|FG000|Overall Study|Withdrawal by Subject|1|||
33439664|NCT00145600|62815600|FG001|Overall Study|Withdrawal by Subject|2|||
33439665|NCT00145600|62815601|FG002|Overall Study|Withdrawal by Subject|0|||
33439666|NCT00145600|62815602|FG003|Overall Study|Withdrawal by Subject|1|||
33439667|NCT00129376|62815626|FG000|Overall Study|Adverse Event|1|||
33439668|NCT00129376|62815626|FG000|Overall Study|Lack of Efficacy|1|||
33439669|NCT00129220|62815633|FG000|Study Period II|Adverse Event|9|||
33439670|NCT00129220|62815634|FG001|Study Period II|Adverse Event|5|||
33439671|NCT00129220|62815635|FG002|Study Period II|Adverse Event|7|||
33439672|NCT00129220|62815633|FG000|Study Period II|Lack of Efficacy|15|||
33439673|NCT00129220|62815634|FG001|Study Period II|Lack of Efficacy|1|||
33439674|NCT00129220|62815635|FG002|Study Period II|Lack of Efficacy|28|||
33439675|NCT00129220|62815633|FG000|Study Period II|Entry Criteria Not Met|2|||
33439676|NCT00129220|62815634|FG001|Study Period II|Entry Criteria Not Met|0|||
33439677|NCT00129220|62815635|FG002|Study Period II|Entry Criteria Not Met|2|||
33439678|NCT00129220|62815633|FG000|Study Period II|Protocol Violation|4|||
33439679|NCT00129220|62815634|FG001|Study Period II|Protocol Violation|2|||
33439680|NCT00129220|62815635|FG002|Study Period II|Protocol Violation|1|||
33439681|NCT00129220|62815633|FG000|Study Period II|Physician Decision|0|||
33439682|NCT00129220|62815634|FG001|Study Period II|Physician Decision|1|||
33439683|NCT00129220|62815635|FG002|Study Period II|Physician Decision|0|||
33439684|NCT00129220|62815633|FG000|Study Period II|Withdrawal by Subject|1|||
33439685|NCT00129220|62815634|FG001|Study Period II|Withdrawal by Subject|3|||
33439686|NCT00129220|62815635|FG002|Study Period II|Withdrawal by Subject|4|||
33439687|NCT00129220|62815633|FG000|Study Period II|Reason Not Specified|2|||
33439688|NCT00129220|62815634|FG001|Study Period II|Reason Not Specified|0|||
33439689|NCT00129220|62815635|FG002|Study Period II|Reason Not Specified|5|||
33439690|NCT00129220|62815633|FG000|Study Period III|Adverse Event|1|||
33439691|NCT00129220|62815634|FG001|Study Period III|Adverse Event|0|||
33439692|NCT00129220|62815635|FG002|Study Period III|Adverse Event|3|||
33439693|NCT00129220|62815633|FG000|Study Period III|Protocol Violation|1|||
33439694|NCT00129220|62815634|FG001|Study Period III|Protocol Violation|1|||
33439695|NCT00129220|62815635|FG002|Study Period III|Protocol Violation|2|||
33439696|NCT00129220|62815633|FG000|Study Period III|Withdrawal by Subject|1|||
33439697|NCT00129220|62815634|FG001|Study Period III|Withdrawal by Subject|0|||
33439698|NCT00129220|62815635|FG002|Study Period III|Withdrawal by Subject|3|||
33439699|NCT00129220|62815633|FG000|Study Period III|Sponsor Decision|1|||
33439700|NCT00129220|62815634|FG001|Study Period III|Sponsor Decision|0|||
33439701|NCT00129220|62815635|FG002|Study Period III|Sponsor Decision|0|||
33439702|NCT00129220|62815633|FG000|Study Period III|Reason Not Specified|9|||
33439703|NCT00129220|62815634|FG001|Study Period III|Reason Not Specified|0|||
33439704|NCT00129220|62815635|FG002|Study Period III|Reason Not Specified|2|||
33439705|NCT00128830|62815655|FG000|Overall Study|Adverse Event|10|||
33439706|NCT00128830|62815655|FG000|Overall Study|Withdrawal by Subject|14|||
33439707|NCT00128830|62815655|FG000|Overall Study|Lost to Follow-up|4|||
33439708|NCT00128830|62815655|FG000|Overall Study|Reached a virologic endpoint|29|||
33439709|NCT00128830|62815655|FG000|Overall Study|Non-compliant|4|||
33439710|NCT00128830|62815655|FG000|Overall Study|Discontinued or ineligible for study|2|||
33439711|NCT00128830|62815655|FG000|Overall Study|Other|9|||
33439712|NCT03686033|62815661|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
33439713|NCT03686033|62815662|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
33439714|NCT03686033|62815663|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
33439715|NCT03686033|62815664|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
33439716|NCT03686033|62815665|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
33439717|NCT03686033|62815666|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
33439718|NCT00128206|62815682|FG000|Overall Study|Lost to Follow-up|137|||
33439719|NCT00128206|62815683|FG001|Overall Study|Lost to Follow-up|118|||
33439720|NCT00128206|62815682|FG000|Overall Study|Adverse Event|0|||
33439721|NCT00128206|62815683|FG001|Overall Study|Adverse Event|2|||
33439722|NCT03685643|62815691|FG000|Overall Study|Lost to Follow-up|14|||
33439723|NCT03685643|62815692|FG001|Overall Study|Lost to Follow-up|22|||
33439724|NCT03823378|62815704|FG000|Overall Study|Adverse Event|2|||
33439725|NCT03823378|62815705|FG001|Overall Study|Adverse Event|2|||
33439726|NCT03823378|62815706|FG002|Overall Study|Adverse Event|0|||
33439727|NCT03823378|62815707|FG003|Overall Study|Adverse Event|0|||
33439728|NCT03823378|62815708|FG004|Overall Study|Adverse Event|0|||
33439729|NCT03823378|62815709|FG005|Overall Study|Adverse Event|0|||
33439730|NCT03823378|62815704|FG000|Overall Study|Lost to Follow-up|0|||
33439731|NCT03823378|62815705|FG001|Overall Study|Lost to Follow-up|1|||
33439732|NCT03823378|62815706|FG002|Overall Study|Lost to Follow-up|0|||
33439733|NCT03823378|62815707|FG003|Overall Study|Lost to Follow-up|0|||
33439734|NCT03823378|62815708|FG004|Overall Study|Lost to Follow-up|1|||
33439735|NCT03823378|62815709|FG005|Overall Study|Lost to Follow-up|0|||
33439736|NCT03823378|62815704|FG000|Overall Study|Withdrawal by Subject|0|||
33439737|NCT03823378|62815705|FG001|Overall Study|Withdrawal by Subject|1|||
33439738|NCT03823378|62815706|FG002|Overall Study|Withdrawal by Subject|4|||
33439739|NCT03823378|62815707|FG003|Overall Study|Withdrawal by Subject|2|||
33439740|NCT03823378|62815708|FG004|Overall Study|Withdrawal by Subject|0|||
33439741|NCT03823378|62815709|FG005|Overall Study|Withdrawal by Subject|1|||
33439742|NCT03823378|62815704|FG000|Overall Study|Other, not specified|19|||
33439743|NCT03823378|62815705|FG001|Overall Study|Other, not specified|12|||
33439744|NCT03823378|62815706|FG002|Overall Study|Other, not specified|6|||
33439745|NCT03823378|62815707|FG003|Overall Study|Other, not specified|8|||
33439746|NCT03823378|62815708|FG004|Overall Study|Other, not specified|17|||
33439747|NCT03823378|62815709|FG005|Overall Study|Other, not specified|7|||
33439748|NCT00142792|62815726|FG000|Overall Study|Death|0|||
33439749|NCT00142792|62815727|FG001|Overall Study|Death|0|||
33439750|NCT00142792|62815728|FG002|Overall Study|Death|1|||
33439751|NCT00142792|62815726|FG000|Overall Study|Withdrawal by Subject|3|||
33439752|NCT00142792|62815727|FG001|Overall Study|Withdrawal by Subject|2|||
33439753|NCT00142792|62815728|FG002|Overall Study|Withdrawal by Subject|3|||
33439754|NCT00142792|62815726|FG000|Overall Study|Lost to Follow-up|8|||
33439755|NCT00142792|62815727|FG001|Overall Study|Lost to Follow-up|11|||
33439756|NCT00142792|62815728|FG002|Overall Study|Lost to Follow-up|7|||
33439757|NCT00142792|62815726|FG000|Overall Study|No category|1|||
33439758|NCT00142792|62815727|FG001|Overall Study|No category|2|||
33439759|NCT00142792|62815728|FG002|Overall Study|No category|1|||
33439760|NCT00141778|62815739|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
33439761|NCT00141778|62815740|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
33439762|NCT00141778|62815741|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
33439763|NCT00141778|62815739|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
33439764|NCT00141778|62815740|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
33439765|NCT00141778|62815741|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
33439766|NCT00141778|62815739|FG000|Started Study Medication|Withdrawal by Subject|0|||
33439767|NCT00141778|62815740|FG001|Started Study Medication|Withdrawal by Subject|2|||
33439768|NCT00141778|62815741|FG002|Started Study Medication|Withdrawal by Subject|0|||
33439769|NCT00141778|62815739|FG000|Started Study Medication|Difficulty Swallowing|0|||
33439770|NCT00141778|62815740|FG001|Started Study Medication|Difficulty Swallowing|1|||
33439771|NCT00141778|62815741|FG002|Started Study Medication|Difficulty Swallowing|0|||
33439772|NCT00141778|62815739|FG000|Started Study Medication|Chest Discomfort|0|||
33439773|NCT00141778|62815740|FG001|Started Study Medication|Chest Discomfort|0|||
33439774|NCT00141778|62815741|FG002|Started Study Medication|Chest Discomfort|1|||
33439775|NCT00127660|62815753|FG000|Overall Study|Protocol Violation|3|||
33439776|NCT00127660|62815754|FG001|Overall Study|Protocol Violation|3|||
33439777|NCT00127660|62815755|FG002|Overall Study|Protocol Violation|5|||
33439778|NCT00127660|62815756|FG003|Overall Study|Protocol Violation|0|||
33439779|NCT03817528|62815766|FG000|Overall Study|Withdrawal by Subject|1|||
33439780|NCT03817528|62815766|FG000|Overall Study|Adverse Event|2|||
33439781|NCT00115336|62815772|FG000|Overall Study|Hospital discharge before study drug|0|||
33439782|NCT00115336|62815773|FG001|Overall Study|Hospital discharge before study drug|1|||
33439783|NCT00205803|62815783|FG000|Infant Series|Lost to Follow-up|10|||
33439784|NCT00205803|62815784|FG001|Infant Series|Lost to Follow-up|4|||
33439785|NCT00205803|62815783|FG000|Infant Series|Withdrawal by Subject|2|||
33439786|NCT00205803|62815784|FG001|Infant Series|Withdrawal by Subject|5|||
33439787|NCT00205803|62815783|FG000|Infant Series|Physician Decision|3|||
33439788|NCT00205803|62815784|FG001|Infant Series|Physician Decision|1|||
33439789|NCT00205803|62815783|FG000|Infant Series|Protocol Violation|1|||
33439790|NCT00205803|62815784|FG001|Infant Series|Protocol Violation|0|||
33439791|NCT00205803|62815783|FG000|Infant Series|Lost Kaiser coverage|0|||
33439792|NCT00205803|62815784|FG001|Infant Series|Lost Kaiser coverage|1|||
33439793|NCT00205803|62815783|FG000|Infant Series|Non-compliant|1|||
33439794|NCT00205803|62815784|FG001|Infant Series|Non-compliant|0|||
33439795|NCT00205803|62815783|FG000|Infant Series|Sponsor request|1|||
33439796|NCT00205803|62815784|FG001|Infant Series|Sponsor request|0|||
33439797|NCT00205803|62815783|FG000|After Infant Series|Adverse Event|1|||
33439798|NCT00205803|62815784|FG001|After Infant Series|Adverse Event|1|||
33439799|NCT00205803|62815783|FG000|After Infant Series|Protocol Violation|1|||
33439800|NCT00205803|62815784|FG001|After Infant Series|Protocol Violation|1|||
33439801|NCT00205803|62815783|FG000|After Infant Series|Lost to Follow-up|2|||
33439802|NCT00205803|62815784|FG001|After Infant Series|Lost to Follow-up|1|||
33439803|NCT00205803|62815783|FG000|After Infant Series|Physician Decision|3|||
33439804|NCT00205803|62815784|FG001|After Infant Series|Physician Decision|2|||
33439805|NCT00205803|62815783|FG000|After Infant Series|Withdrawal by Subject|1|||
33439806|NCT00205803|62815784|FG001|After Infant Series|Withdrawal by Subject|4|||
33439807|NCT00205803|62815783|FG000|After Infant Series|Other|10|||
33439808|NCT00205803|62815784|FG001|After Infant Series|Other|4|||
33439809|NCT00205803|62815783|FG000|Toddler Dose|Lost to Follow-up|2|||
33439810|NCT00205803|62815784|FG001|Toddler Dose|Lost to Follow-up|3|||
33439811|NCT00127192|62815813|FG000|Overall Study|Adverse Event|0|||
33439812|NCT00127192|62815814|FG001|Overall Study|Adverse Event|1|||
33439813|NCT00127192|62815815|FG002|Overall Study|Adverse Event|1|||
33439814|NCT00127192|62815816|FG003|Overall Study|Adverse Event|1|||
33439815|NCT00127192|62815817|FG004|Overall Study|Adverse Event|0|||
33439816|NCT00127192|62815813|FG000|Overall Study|Lack of Efficacy|2|||
33439817|NCT00127192|62815814|FG001|Overall Study|Lack of Efficacy|0|||
33439818|NCT00127192|62815815|FG002|Overall Study|Lack of Efficacy|0|||
33439819|NCT00127192|62815816|FG003|Overall Study|Lack of Efficacy|0|||
33439820|NCT00127192|62815817|FG004|Overall Study|Lack of Efficacy|2|||
33439821|NCT00127192|62815813|FG000|Overall Study|Withdrawal by Subject|0|||
33439822|NCT00127192|62815814|FG001|Overall Study|Withdrawal by Subject|0|||
33439823|NCT00127192|62815815|FG002|Overall Study|Withdrawal by Subject|1|||
33439824|NCT00127192|62815816|FG003|Overall Study|Withdrawal by Subject|0|||
33439825|NCT00127192|62815817|FG004|Overall Study|Withdrawal by Subject|3|||
33439826|NCT00127192|62815813|FG000|Overall Study|Adverse event in pre-treatment period|1|||
33605977|NCT02009163|63005782|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
33605978|NCT02009163|63005780|FG000|Open-label Period (Non-randomized)|Other|13|||
33605979|NCT02009163|63005781|FG001|Open-label Period (Non-randomized)|Other|0|||
33605980|NCT02009163|63005782|FG002|Open-label Period (Non-randomized)|Other|0|||
33605981|NCT02009163|63005780|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
33605982|NCT02009163|63005781|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
33605983|NCT02009163|63005782|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
33605984|NCT02009163|63005780|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
33605985|NCT02009163|63005781|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
33439827|NCT00127192|62815814|FG001|Overall Study|Adverse event in pre-treatment period|0|||
33439828|NCT00127192|62815815|FG002|Overall Study|Adverse event in pre-treatment period|0|||
33439829|NCT00127192|62815816|FG003|Overall Study|Adverse event in pre-treatment period|0|||
33439830|NCT00127192|62815817|FG004|Overall Study|Adverse event in pre-treatment period|0|||
33439831|NCT00205179|62815831|FG000|Overall Study|Death|0|||
33439832|NCT00205179|62815832|FG001|Overall Study|Death|2|||
33439833|NCT00205179|62815831|FG000|Overall Study|Physician Decision|1|||
33439834|NCT00205179|62815832|FG001|Overall Study|Physician Decision|1|||
33439835|NCT00205179|62815831|FG000|Overall Study|Adverse Event|1|||
33439836|NCT00205179|62815832|FG001|Overall Study|Adverse Event|1|||
33439837|NCT00127036|62815841|FG000|Overall Study|Insufficient Data for Analysis|6|||
33439838|NCT00127036|62815842|FG001|Overall Study|Insufficient Data for Analysis|11|||
33439839|NCT00127036|62815841|FG000|Overall Study|Screen Failure|2|||
33439840|NCT00127036|62815842|FG001|Overall Study|Screen Failure|0|||
33439841|NCT00259857|62815850|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
33439842|NCT00259857|62815851|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
33439843|NCT00259857|62815850|FG000|24 Months Treatment|Lost to Follow-up|0|||
33439844|NCT00259857|62815851|FG001|24 Months Treatment|Lost to Follow-up|3|||
33439845|NCT00203307|62815859|FG000|First Intervention|Adverse Event|2|||
33439846|NCT00203307|62815860|FG001|First Intervention|Adverse Event|0|||
33439847|NCT00126568|62815866|FG000|Overall Study|Death|2|||
33439848|NCT00114634|62815871|FG000|Overall Study|failure to return forms|3|||
33439849|NCT00202839|62815879|FG000|Overall Study|Adverse Event|1|||
33439850|NCT00202839|62815880|FG001|Overall Study|Adverse Event|5|||
33439851|NCT00202839|62815879|FG000|Overall Study|Physician Decision|12|||
33439852|NCT00202839|62815880|FG001|Overall Study|Physician Decision|0|||
33439853|NCT00202839|62815879|FG000|Overall Study|Withdrawal by Subject|6|||
33439854|NCT00202839|62815880|FG001|Overall Study|Withdrawal by Subject|2|||
33439855|NCT00202839|62815879|FG000|Overall Study|Protocol Violation|2|||
33439856|NCT00202839|62815880|FG001|Overall Study|Protocol Violation|1|||
33439857|NCT00202839|62815879|FG000|Overall Study|Lost to Follow-up|3|||
33439858|NCT00202839|62815880|FG001|Overall Study|Lost to Follow-up|2|||
33439859|NCT00201201|62815888|FG000|Overall Study|Death|0|||
33439860|NCT00201201|62815889|FG001|Overall Study|Death|2|||
33439861|NCT00201201|62815888|FG000|Overall Study|Withdrawal by Subject|5|||
33439862|NCT00201201|62815889|FG001|Overall Study|Withdrawal by Subject|5|||
33439863|NCT00126490|62815895|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
33439864|NCT00346632|62815901|FG000|Overall Study|Progressive Disease|2|||
33439865|NCT00346632|62815902|FG001|Overall Study|Progressive Disease|2|||
33439866|NCT00346632|62815903|FG002|Overall Study|Progressive Disease|4|||
33439867|NCT00346632|62815904|FG003|Overall Study|Progressive Disease|3|||
33439868|NCT00346632|62815905|FG004|Overall Study|Progressive Disease|3|||
33439869|NCT00346632|62815906|FG005|Overall Study|Progressive Disease|1|||
33439870|NCT00346632|62815907|FG006|Overall Study|Progressive Disease|2|||
33439871|NCT00346632|62815908|FG007|Overall Study|Progressive Disease|2|||
33494202|NCT03103100|62872974|FG000|Overall Study|Adverse Event|1|||
33605986|NCT02009163|63005782|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
33439872|NCT00346632|62815909|FG008|Overall Study|Progressive Disease|2|||
33439873|NCT00346632|62815910|FG009|Overall Study|Progressive Disease|2|||
33439874|NCT00346632|62815901|FG000|Overall Study|Adverse Event|0|||
33439875|NCT00346632|62815902|FG001|Overall Study|Adverse Event|0|||
33439876|NCT00346632|62815903|FG002|Overall Study|Adverse Event|0|||
33439877|NCT00346632|62815904|FG003|Overall Study|Adverse Event|0|||
33439878|NCT00346632|62815905|FG004|Overall Study|Adverse Event|1|||
33439879|NCT00346632|62815906|FG005|Overall Study|Adverse Event|1|||
33439880|NCT00346632|62815907|FG006|Overall Study|Adverse Event|1|||
33439881|NCT00346632|62815908|FG007|Overall Study|Adverse Event|0|||
33439882|NCT00346632|62815909|FG008|Overall Study|Adverse Event|0|||
33439883|NCT00346632|62815910|FG009|Overall Study|Adverse Event|0|||
33439884|NCT00346632|62815901|FG000|Overall Study|Death|0|||
33439885|NCT00346632|62815902|FG001|Overall Study|Death|0|||
33439886|NCT00346632|62815903|FG002|Overall Study|Death|1|||
33439887|NCT00346632|62815904|FG003|Overall Study|Death|0|||
33439888|NCT00346632|62815905|FG004|Overall Study|Death|0|||
33439889|NCT00346632|62815906|FG005|Overall Study|Death|0|||
33439890|NCT00346632|62815907|FG006|Overall Study|Death|0|||
33439891|NCT00346632|62815908|FG007|Overall Study|Death|0|||
33439892|NCT00346632|62815909|FG008|Overall Study|Death|0|||
33439893|NCT00346632|62815910|FG009|Overall Study|Death|0|||
33439894|NCT00346632|62815901|FG000|Overall Study|Protocol Violation|0|||
33439895|NCT00346632|62815902|FG001|Overall Study|Protocol Violation|0|||
33605987|NCT02009163|63005780|FG000|Randomized-withdrawal Period|Adverse Event|0|||
33605988|NCT02009163|63005781|FG001|Randomized-withdrawal Period|Adverse Event|0|||
33605989|NCT02009163|63005782|FG002|Randomized-withdrawal Period|Adverse Event|6|||
33605990|NCT02009163|63005780|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
33605991|NCT02009163|63005781|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
33605992|NCT02009163|63005782|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
33605993|NCT02009163|63005780|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
33605994|NCT02009163|63005781|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
33605995|NCT02009163|63005782|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
33605996|NCT02009163|63005780|FG000|Randomized-withdrawal Period|Pregnancy|0|||
33439896|NCT00346632|62815903|FG002|Overall Study|Protocol Violation|0|||
33439897|NCT00346632|62815904|FG003|Overall Study|Protocol Violation|0|||
33439898|NCT00346632|62815905|FG004|Overall Study|Protocol Violation|0|||
33439899|NCT00346632|62815906|FG005|Overall Study|Protocol Violation|0|||
33439900|NCT00346632|62815907|FG006|Overall Study|Protocol Violation|1|||
33439901|NCT00346632|62815908|FG007|Overall Study|Protocol Violation|0|||
33439902|NCT00346632|62815909|FG008|Overall Study|Protocol Violation|0|||
33439903|NCT00346632|62815910|FG009|Overall Study|Protocol Violation|0|||
33439904|NCT00346632|62815901|FG000|Overall Study|Withdrawal by Subject|0|||
33439905|NCT00346632|62815902|FG001|Overall Study|Withdrawal by Subject|0|||
33439906|NCT00346632|62815903|FG002|Overall Study|Withdrawal by Subject|0|||
33439907|NCT00346632|62815904|FG003|Overall Study|Withdrawal by Subject|0|||
33439908|NCT00346632|62815905|FG004|Overall Study|Withdrawal by Subject|0|||
33439909|NCT00346632|62815906|FG005|Overall Study|Withdrawal by Subject|0|||
33439910|NCT00346632|62815907|FG006|Overall Study|Withdrawal by Subject|1|||
33439911|NCT00346632|62815908|FG007|Overall Study|Withdrawal by Subject|0|||
33439912|NCT00346632|62815909|FG008|Overall Study|Withdrawal by Subject|0|||
33439913|NCT00346632|62815910|FG009|Overall Study|Withdrawal by Subject|0|||
33439914|NCT00346632|62815901|FG000|Overall Study|Switched to alternative treatment|0|||
33605997|NCT02009163|63005781|FG001|Randomized-withdrawal Period|Pregnancy|0|||
33605998|NCT02009163|63005782|FG002|Randomized-withdrawal Period|Pregnancy|2|||
33605999|NCT02009163|63005780|FG000|Randomized-withdrawal Period|Other|0|||
33606000|NCT02009163|63005781|FG001|Randomized-withdrawal Period|Other|9|||
33606001|NCT02009163|63005782|FG002|Randomized-withdrawal Period|Other|5|||
33439915|NCT00346632|62815902|FG001|Overall Study|Switched to alternative treatment|0|||
33439916|NCT00346632|62815903|FG002|Overall Study|Switched to alternative treatment|1|||
33439917|NCT00346632|62815904|FG003|Overall Study|Switched to alternative treatment|0|||
33439918|NCT00346632|62815905|FG004|Overall Study|Switched to alternative treatment|0|||
33606002|NCT01983969|63005795|FG000|Overall Study|Disease Progression|0|||
33606003|NCT01983969|63005796|FG001|Overall Study|Disease Progression|1|||
33606004|NCT01983969|63005797|FG002|Overall Study|Disease Progression|0|||
33439919|NCT00346632|62815906|FG005|Overall Study|Switched to alternative treatment|0|||
33439920|NCT00346632|62815907|FG006|Overall Study|Switched to alternative treatment|0|||
33439921|NCT00346632|62815908|FG007|Overall Study|Switched to alternative treatment|0|||
33439922|NCT00346632|62815909|FG008|Overall Study|Switched to alternative treatment|0|||
33439923|NCT00346632|62815910|FG009|Overall Study|Switched to alternative treatment|0|||
33439924|NCT00346632|62815901|FG000|Overall Study|Not Stated|1|||
33439925|NCT00346632|62815902|FG001|Overall Study|Not Stated|1|||
33439926|NCT00346632|62815903|FG002|Overall Study|Not Stated|0|||
33606005|NCT02008773|63005813|FG000|Overall Study|Adverse Event|3|||
33606006|NCT02008773|63005814|FG001|Overall Study|Adverse Event|3|||
33439927|NCT00346632|62815904|FG003|Overall Study|Not Stated|0|||
33606007|NCT02008773|63005815|FG002|Overall Study|Adverse Event|1|||
33606008|NCT02008773|63005816|FG003|Overall Study|Adverse Event|2|||
33439928|NCT00346632|62815905|FG004|Overall Study|Not Stated|0|||
33439929|NCT00346632|62815906|FG005|Overall Study|Not Stated|0|||
33439930|NCT00346632|62815907|FG006|Overall Study|Not Stated|0|||
33439931|NCT00346632|62815908|FG007|Overall Study|Not Stated|2|||
33439932|NCT00346632|62815909|FG008|Overall Study|Not Stated|2|||
33439933|NCT00346632|62815910|FG009|Overall Study|Not Stated|1|||
33606009|NCT02008773|63005813|FG000|Overall Study|Medication Non-compliance|2|||
33439934|NCT00200967|62815974|FG000|First Treatment Period|Withdrawal by Subject|5|||
33439935|NCT00200967|62815975|FG001|First Treatment Period|Withdrawal by Subject|1|||
33439936|NCT00200967|62815974|FG000|First Treatment Period|Pregnancy|1|||
33439937|NCT00200967|62815975|FG001|First Treatment Period|Pregnancy|0|||
33606010|NCT02008773|63005814|FG001|Overall Study|Medication Non-compliance|1|||
33439938|NCT00200967|62815974|FG000|Wash-out Period|Lost to Follow-up|0|||
33439939|NCT00200967|62815975|FG001|Wash-out Period|Lost to Follow-up|1|||
33439940|NCT00200967|62815974|FG000|Second Treatment Period|Withdrawal by Subject|1|||
33439941|NCT00200967|62815975|FG001|Second Treatment Period|Withdrawal by Subject|2|||
33439942|NCT00200967|62815974|FG000|Run-out Period|Lost to Follow-up|1|||
33439943|NCT00200967|62815975|FG001|Run-out Period|Lost to Follow-up|0|||
33439944|NCT00354432|62815985|FG000|Overall Study|Adverse Event|3|||
33439945|NCT00354432|62815986|FG001|Overall Study|Adverse Event|1|||
33439946|NCT00354432|62815987|FG002|Overall Study|Adverse Event|5|||
33439947|NCT00354432|62815988|FG003|Overall Study|Adverse Event|5|||
33439948|NCT00354432|62815985|FG000|Overall Study|Off/Toxicity|3|||
33439949|NCT00354432|62815986|FG001|Overall Study|Off/Toxicity|7|||
33439950|NCT00354432|62815987|FG002|Overall Study|Off/Toxicity|5|||
33439951|NCT00354432|62815988|FG003|Overall Study|Off/Toxicity|5|||
33439952|NCT00140140|62816001|FG000|Overall Study|Unacceptable toxicity|1|||
33439953|NCT00140140|62816002|FG001|Overall Study|Unacceptable toxicity|1|||
33439954|NCT00140140|62816003|FG002|Overall Study|Unacceptable toxicity|2|||
33439955|NCT00140140|62816001|FG000|Overall Study|Physician Decision|1|||
33439956|NCT00140140|62816002|FG001|Overall Study|Physician Decision|1|||
33439957|NCT00140140|62816003|FG002|Overall Study|Physician Decision|0|||
33439958|NCT00346398|62816012|FG000|Overall Study|Lost to Follow-up|3|||
33439959|NCT00346398|62816013|FG001|Overall Study|Lost to Follow-up|0|||
33439960|NCT00346398|62816012|FG000|Overall Study|Withdrawal by Subject|0|||
33439961|NCT00346398|62816013|FG001|Overall Study|Withdrawal by Subject|2|||
33439962|NCT00346164|62816023|FG000|Overall Study|Adverse Event|0|||
33439963|NCT00346164|62816024|FG001|Overall Study|Adverse Event|0|||
33439964|NCT00346164|62816025|FG002|Overall Study|Adverse Event|0|||
33439965|NCT00346164|62816026|FG003|Overall Study|Adverse Event|1|||
33439966|NCT00346164|62816023|FG000|Overall Study|Lack of Efficacy|0|||
33439967|NCT00346164|62816024|FG001|Overall Study|Lack of Efficacy|1|||
33439968|NCT00346164|62816025|FG002|Overall Study|Lack of Efficacy|7|||
33439969|NCT00346164|62816026|FG003|Overall Study|Lack of Efficacy|25|||
33439970|NCT00346164|62816023|FG000|Overall Study|Physician Decision|0|||
33439971|NCT00346164|62816024|FG001|Overall Study|Physician Decision|1|||
33439972|NCT00346164|62816025|FG002|Overall Study|Physician Decision|2|||
33439973|NCT00346164|62816026|FG003|Overall Study|Physician Decision|27|||
33439974|NCT00346164|62816023|FG000|Overall Study|Protocol Violation|6|||
33439975|NCT00346164|62816024|FG001|Overall Study|Protocol Violation|2|||
33439976|NCT00346164|62816025|FG002|Overall Study|Protocol Violation|10|||
33439977|NCT00346164|62816026|FG003|Overall Study|Protocol Violation|4|||
33439978|NCT00346164|62816023|FG000|Overall Study|Withdrawal by Subject|0|||
33439979|NCT00346164|62816024|FG001|Overall Study|Withdrawal by Subject|0|||
33439980|NCT00346164|62816025|FG002|Overall Study|Withdrawal by Subject|2|||
33439981|NCT00346164|62816026|FG003|Overall Study|Withdrawal by Subject|0|||
33439982|NCT00346164|62816023|FG000|Overall Study|Ineligible|11|||
33439983|NCT00346164|62816024|FG001|Overall Study|Ineligible|2|||
33439984|NCT00346164|62816025|FG002|Overall Study|Ineligible|2|||
33439985|NCT00346164|62816026|FG003|Overall Study|Ineligible|23|||
33439986|NCT00346164|62816023|FG000|Overall Study|Refusal of further protocol therapy|0|||
33439987|NCT00346164|62816024|FG001|Overall Study|Refusal of further protocol therapy|1|||
33439988|NCT00346164|62816025|FG002|Overall Study|Refusal of further protocol therapy|3|||
33439989|NCT00346164|62816026|FG003|Overall Study|Refusal of further protocol therapy|15|||
33439990|NCT00346164|62816023|FG000|Overall Study|Inability to start week 16 tx on time|0|||
33439991|NCT00346164|62816024|FG001|Overall Study|Inability to start week 16 tx on time|0|||
33439992|NCT00346164|62816025|FG002|Overall Study|Inability to start week 16 tx on time|0|||
33439993|NCT00346164|62816026|FG003|Overall Study|Inability to start week 16 tx on time|11|||
33439994|NCT00114244|62816054|FG000|Overall Study|Adverse Event|2|||
33606011|NCT02008773|63005815|FG002|Overall Study|Medication Non-compliance|3|||
33439995|NCT00114244|62816055|FG001|Overall Study|Adverse Event|5|||
33439996|NCT00114244|62816054|FG000|Overall Study|Withdrawal by Subject|0|||
33439997|NCT00114244|62816055|FG001|Overall Study|Withdrawal by Subject|2|||
33439998|NCT00138658|62816061|FG000|Overall Study|Adverse Event|23|||
33439999|NCT00138658|62816061|FG000|Overall Study|Death|1|||
33440000|NCT00138658|62816061|FG000|Overall Study|Disease Progression|21|||
33440001|NCT00138658|62816061|FG000|Overall Study|Physician Decision|11|||
33440002|NCT00138658|62816061|FG000|Overall Study|Withdrawal by Subject|5|||
33440003|NCT00337662|62816070|FG000|Study Period II|Lost to Follow-up|0|||
33440004|NCT00337662|62816071|FG001|Study Period II|Lost to Follow-up|0|||
33440005|NCT00337662|62816072|FG002|Study Period II|Lost to Follow-up|0|||
33440006|NCT00337662|62816073|FG003|Study Period II|Lost to Follow-up|35|||
33440007|NCT00337662|62816070|FG000|Study Period II|Withdrawal by Subject|0|||
33440008|NCT00337662|62816071|FG001|Study Period II|Withdrawal by Subject|0|||
33440009|NCT00337662|62816072|FG002|Study Period II|Withdrawal by Subject|0|||
33440010|NCT00337662|62816073|FG003|Study Period II|Withdrawal by Subject|20|||
33440011|NCT00337662|62816070|FG000|Study Period II|Adverse Event|0|||
33440012|NCT00337662|62816071|FG001|Study Period II|Adverse Event|0|||
33606012|NCT02008773|63005816|FG003|Overall Study|Medication Non-compliance|2|||
33440013|NCT00337662|62816072|FG002|Study Period II|Adverse Event|0|||
33440014|NCT00337662|62816073|FG003|Study Period II|Adverse Event|16|||
33440015|NCT00337662|62816070|FG000|Study Period II|Physician Decision|0|||
33440016|NCT00337662|62816071|FG001|Study Period II|Physician Decision|0|||
33440017|NCT00337662|62816072|FG002|Study Period II|Physician Decision|0|||
33440018|NCT00337662|62816073|FG003|Study Period II|Physician Decision|13|||
33440019|NCT00337662|62816070|FG000|Study Period II|Entry Criteria Not Met|0|||
33440020|NCT00337662|62816071|FG001|Study Period II|Entry Criteria Not Met|0|||
33440021|NCT00337662|62816072|FG002|Study Period II|Entry Criteria Not Met|0|||
33440022|NCT00337662|62816073|FG003|Study Period II|Entry Criteria Not Met|6|||
33440023|NCT00337662|62816070|FG000|Study Period II|Protocol Violation|0|||
33440024|NCT00337662|62816071|FG001|Study Period II|Protocol Violation|0|||
33440025|NCT00337662|62816072|FG002|Study Period II|Protocol Violation|0|||
33440026|NCT00337662|62816073|FG003|Study Period II|Protocol Violation|6|||
33440027|NCT00337662|62816070|FG000|Study Period II|Lack of Efficacy|0|||
33440028|NCT00337662|62816071|FG001|Study Period II|Lack of Efficacy|0|||
33440029|NCT00337662|62816072|FG002|Study Period II|Lack of Efficacy|0|||
33440030|NCT00337662|62816073|FG003|Study Period II|Lack of Efficacy|7|||
33440031|NCT00337662|62816070|FG000|Study Period II|Sponsor Decision|0|||
33440032|NCT00337662|62816071|FG001|Study Period II|Sponsor Decision|0|||
33440033|NCT00337662|62816072|FG002|Study Period II|Sponsor Decision|0|||
33440034|NCT00337662|62816073|FG003|Study Period II|Sponsor Decision|2|||
33440035|NCT00337662|62816070|FG000|Study Period II|Parent/Caregiver Decision|0|||
33440036|NCT00337662|62816071|FG001|Study Period II|Parent/Caregiver Decision|0|||
33440037|NCT00337662|62816072|FG002|Study Period II|Parent/Caregiver Decision|0|||
33440038|NCT00337662|62816073|FG003|Study Period II|Parent/Caregiver Decision|1|||
33440039|NCT00337662|62816070|FG000|Study Period III|Lost to Follow-up|14|||
33440040|NCT00337662|62816071|FG001|Study Period III|Lost to Follow-up|16|||
33440041|NCT00337662|62816072|FG002|Study Period III|Lost to Follow-up|14|||
33440042|NCT00337662|62816073|FG003|Study Period III|Lost to Follow-up|0|||
33440043|NCT00337662|62816070|FG000|Study Period III|Withdrawal by Subject|18|||
33440044|NCT00337662|62816071|FG001|Study Period III|Withdrawal by Subject|14|||
33440045|NCT00337662|62816072|FG002|Study Period III|Withdrawal by Subject|12|||
33440046|NCT00337662|62816073|FG003|Study Period III|Withdrawal by Subject|0|||
33440047|NCT00337662|62816070|FG000|Study Period III|Adverse Event|9|||
33440048|NCT00337662|62816071|FG001|Study Period III|Adverse Event|10|||
33440049|NCT00337662|62816072|FG002|Study Period III|Adverse Event|8|||
33606013|NCT02008773|63005813|FG000|Overall Study|Withdrawal by Subject|8|||
33606014|NCT02008773|63005814|FG001|Overall Study|Withdrawal by Subject|4|||
33440050|NCT00337662|62816073|FG003|Study Period III|Adverse Event|0|||
33440051|NCT00337662|62816070|FG000|Study Period III|Protocol Violation|3|||
33606015|NCT02008773|63005815|FG002|Overall Study|Withdrawal by Subject|7|||
33606016|NCT02008773|63005816|FG003|Overall Study|Withdrawal by Subject|6|||
33440052|NCT00337662|62816071|FG001|Study Period III|Protocol Violation|8|||
33440053|NCT00337662|62816072|FG002|Study Period III|Protocol Violation|2|||
33440054|NCT00337662|62816073|FG003|Study Period III|Protocol Violation|0|||
33440055|NCT00337662|62816070|FG000|Study Period III|Physician Decision|6|||
33440056|NCT00337662|62816071|FG001|Study Period III|Physician Decision|5|||
33440057|NCT00337662|62816072|FG002|Study Period III|Physician Decision|0|||
33440058|NCT00337662|62816073|FG003|Study Period III|Physician Decision|0|||
33440059|NCT00337662|62816070|FG000|Study Period III|Entry Criteria Not Met|4|||
33440060|NCT00337662|62816071|FG001|Study Period III|Entry Criteria Not Met|1|||
33440061|NCT00337662|62816072|FG002|Study Period III|Entry Criteria Not Met|3|||
33440062|NCT00337662|62816073|FG003|Study Period III|Entry Criteria Not Met|0|||
33440063|NCT00337662|62816070|FG000|Study Period III|Lack of Efficacy|4|||
33440064|NCT00337662|62816071|FG001|Study Period III|Lack of Efficacy|4|||
33440065|NCT00337662|62816072|FG002|Study Period III|Lack of Efficacy|2|||
33440066|NCT00337662|62816073|FG003|Study Period III|Lack of Efficacy|0|||
33440067|NCT00337662|62816070|FG000|Study Period III|Parent/Caregiver Decision|0|||
33606017|NCT02008773|63005813|FG000|Overall Study|Lost to Follow-up|0|||
33440068|NCT00337662|62816071|FG001|Study Period III|Parent/Caregiver Decision|0|||
33440069|NCT00337662|62816072|FG002|Study Period III|Parent/Caregiver Decision|2|||
33440070|NCT00337662|62816073|FG003|Study Period III|Parent/Caregiver Decision|0|||
33440071|NCT00337662|62816070|FG000|Study Period III|Sponsor Decision|1|||
33440072|NCT00337662|62816071|FG001|Study Period III|Sponsor Decision|0|||
33440073|NCT00337662|62816072|FG002|Study Period III|Sponsor Decision|1|||
33440074|NCT00337662|62816073|FG003|Study Period III|Sponsor Decision|0|||
33440075|NCT00337662|62816070|FG000|Study Period III|Clinical Relapse|1|||
33440076|NCT00337662|62816071|FG001|Study Period III|Clinical Relapse|0|||
33440077|NCT00337662|62816072|FG002|Study Period III|Clinical Relapse|0|||
33440078|NCT00337662|62816073|FG003|Study Period III|Clinical Relapse|0|||
33440079|NCT00138424|62816088|FG000|Overall Study|Physician Decision|0|||
33440080|NCT00138424|62816089|FG001|Overall Study|Physician Decision|1|||
33440081|NCT00138424|62816090|FG002|Overall Study|Physician Decision|0|||
33440082|NCT00138424|62816091|FG003|Overall Study|Physician Decision|0|||
33440083|NCT00368966|62816105|FG000|Infant Series|Withdrawal by Subject|11|||
33440084|NCT00368966|62816106|FG001|Infant Series|Withdrawal by Subject|6|||
33440085|NCT00368966|62816105|FG000|Infant Series|Protocol Violation|2|||
33440086|NCT00368966|62816106|FG001|Infant Series|Protocol Violation|1|||
33440087|NCT00368966|62816105|FG000|Infant Series|Lost to Follow-up|2|||
33440088|NCT00368966|62816106|FG001|Infant Series|Lost to Follow-up|0|||
33440089|NCT00368966|62816105|FG000|Infant Series|Randomization error|0|||
33440090|NCT00368966|62816106|FG001|Infant Series|Randomization error|1|||
33440091|NCT00368966|62816105|FG000|Infant Series|Failed to meet eligibility criteria|0|||
33440092|NCT00368966|62816106|FG001|Infant Series|Failed to meet eligibility criteria|1|||
33440093|NCT00368966|62816105|FG000|Infant Series|Adverse Event|0|||
33440094|NCT00368966|62816106|FG001|Infant Series|Adverse Event|1|||
33440095|NCT00368966|62816105|FG000|Infant Series|Failed to return|1|||
33440096|NCT00368966|62816106|FG001|Infant Series|Failed to return|0|||
33440097|NCT00368966|62816105|FG000|After Infant|Failed to return|3|||
33440098|NCT00368966|62816106|FG001|After Infant|Failed to return|1|||
33440099|NCT00368966|62816105|FG000|After Infant|Adverse Event|1|||
33440100|NCT00368966|62816106|FG001|After Infant|Adverse Event|2|||
33440101|NCT00368966|62816105|FG000|After Infant|Withdrawal by Subject|1|||
33440102|NCT00368966|62816106|FG001|After Infant|Withdrawal by Subject|1|||
33440103|NCT00368966|62816105|FG000|After Infant|Death|1|||
33440104|NCT00368966|62816106|FG001|After Infant|Death|0|||
33440105|NCT00368966|62816105|FG000|After Infant|Lost to Follow-up|0|||
33440106|NCT00368966|62816106|FG001|After Infant|Lost to Follow-up|1|||
33440107|NCT00368966|62816105|FG000|Toddler Dose|Withdrawal by Subject|1|||
33440108|NCT00368966|62816106|FG001|Toddler Dose|Withdrawal by Subject|1|||
33440109|NCT00368966|62816105|FG000|Toddler Dose|Lost to Follow-up|0|||
33440110|NCT00368966|62816106|FG001|Toddler Dose|Lost to Follow-up|2|||
33440111|NCT00114166|62816139|FG000|Overall Study|Wrong primary|0|||
33440112|NCT00114166|62816140|FG001|Overall Study|Wrong primary|1|||
33440113|NCT00125242|62816150|FG000|Overall Study|did not qualify|7|||
33440114|NCT00125242|62816151|FG001|Overall Study|did not qualify|2|||
33440115|NCT00337428|62816158|FG000|Overall Study|Withdrawal by Subject|1|||
33440116|NCT00337428|62816159|FG001|Overall Study|Withdrawal by Subject|2|||
33440117|NCT00337428|62816158|FG000|Overall Study|Lack of Time|1|||
33440118|NCT00337428|62816159|FG001|Overall Study|Lack of Time|1|||
33440119|NCT00337428|62816158|FG000|Overall Study|Unwilling to Continue|1|||
33440120|NCT00337428|62816159|FG001|Overall Study|Unwilling to Continue|0|||
33440121|NCT00337428|62816158|FG000|Overall Study|Anorexia|1|||
33440122|NCT00337428|62816159|FG001|Overall Study|Anorexia|0|||
33440123|NCT00235989|62816169|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
33440124|NCT00235989|62816170|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
33440125|NCT00235989|62816171|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
33440126|NCT00235989|62816172|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
33440127|NCT00235989|62816173|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
33440128|NCT00235989|62816174|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
33440129|NCT00235989|62816169|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
33440130|NCT00235989|62816170|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
33440131|NCT00235989|62816171|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
33440132|NCT00235989|62816172|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
33440133|NCT00235989|62816173|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
33440134|NCT00235989|62816174|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
33440135|NCT00235989|62816169|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
33440136|NCT00235989|62816170|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
33440137|NCT00235989|62816171|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
33440138|NCT00235989|62816172|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
33440139|NCT00235989|62816173|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
33440140|NCT00235989|62816174|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
33440141|NCT00235989|62816169|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
33606018|NCT02008773|63005814|FG001|Overall Study|Lost to Follow-up|1|||
33606019|NCT02008773|63005815|FG002|Overall Study|Lost to Follow-up|3|||
33606020|NCT02008773|63005816|FG003|Overall Study|Lost to Follow-up|2|||
33606021|NCT02257567|63005835|FG000|Overall Study|Adverse Event|0|||
33606022|NCT02257567|63005836|FG001|Overall Study|Adverse Event|0|||
33606023|NCT02257567|63005837|FG002|Overall Study|Adverse Event|0|||
33606024|NCT02257567|63005838|FG003|Overall Study|Adverse Event|1|||
33606025|NCT02257567|63005839|FG004|Overall Study|Adverse Event|1|||
33606026|NCT02257567|63005840|FG005|Overall Study|Adverse Event|0|||
33606027|NCT02257567|63005841|FG006|Overall Study|Adverse Event|0|||
33606028|NCT02257567|63005842|FG007|Overall Study|Adverse Event|0|||
33606029|NCT02257567|63005843|FG008|Overall Study|Adverse Event|1|||
33440142|NCT00235989|62816170|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
33440143|NCT00235989|62816171|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
33440144|NCT00235989|62816172|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
33440145|NCT00235989|62816173|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
33440146|NCT00235989|62816174|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
33440147|NCT00235989|62816169|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
33440148|NCT00235989|62816170|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
33440149|NCT00235989|62816171|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
33440150|NCT00235989|62816172|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
33440151|NCT00235989|62816173|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
33440152|NCT00235989|62816174|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
33440153|NCT00113386|62816186|FG000|Overall Study|Withdrawal by Subject|1|||
33440154|NCT00113386|62816187|FG001|Overall Study|Withdrawal by Subject|0|||
33440155|NCT00113386|62816186|FG000|Overall Study|Physician Decision|0|||
33440156|NCT00113386|62816187|FG001|Overall Study|Physician Decision|1|||
33440157|NCT00113386|62816186|FG000|Overall Study|Toxicity|3|||
33440158|NCT00113386|62816187|FG001|Overall Study|Toxicity|0|||
33440159|NCT00113386|62816186|FG000|Overall Study|Ineligible|1|||
33440160|NCT00113386|62816187|FG001|Overall Study|Ineligible|2|||
33440161|NCT00113386|62816186|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
33440162|NCT00113386|62816187|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
33440163|NCT00353262|62816193|FG000|Overall Study|Adverse Event|8|||
33440164|NCT00353262|62816193|FG000|Overall Study|Withdrawal by Subject|2|||
33440165|NCT00353262|62816193|FG000|Overall Study|Insufficient Therapeutic Response|13|||
33440166|NCT00353262|62816193|FG000|Overall Study|Progression|1|||
33440167|NCT00353262|62816193|FG000|Overall Study|Surgery|4|||
33440168|NCT00353262|62816193|FG000|Overall Study|Break from Chemotherapy|1|||
33440169|NCT00337272|62816199|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
33440170|NCT00337272|62816200|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
33440171|NCT00337272|62816199|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
33440172|NCT00337272|62816200|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
33440173|NCT00337272|62816199|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
33440174|NCT00337272|62816200|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
33440175|NCT00337272|62816199|FG000|Treatment Period|Non-compliance|1|||
33440176|NCT00337272|62816200|FG001|Treatment Period|Non-compliance|1|||
33440177|NCT00337272|62816199|FG000|Treatment Period|Withdrawal by Subject|0|||
33440178|NCT00337272|62816200|FG001|Treatment Period|Withdrawal by Subject|1|||
33440179|NCT00337272|62816199|FG000|Withdrawal Period|Non-compliance|0|||
33440180|NCT00337272|62816200|FG001|Withdrawal Period|Non-compliance|1|||
33440181|NCT00125164|62816210|FG000|Overall Study|Adverse Event|0|||
33440182|NCT00125164|62816211|FG001|Overall Study|Adverse Event|0|||
33440183|NCT00125164|62816212|FG002|Overall Study|Adverse Event|2|||
33440184|NCT00125164|62816213|FG003|Overall Study|Adverse Event|4|||
33440185|NCT00125164|62816210|FG000|Overall Study|Lost to Follow-up|0|||
33440186|NCT00125164|62816211|FG001|Overall Study|Lost to Follow-up|0|||
33440187|NCT00125164|62816212|FG002|Overall Study|Lost to Follow-up|1|||
33440188|NCT00125164|62816213|FG003|Overall Study|Lost to Follow-up|1|||
33494203|NCT03103100|62872975|FG001|Overall Study|Adverse Event|0|||
33494204|NCT03103100|62872976|FG002|Overall Study|Adverse Event|0|||
33494205|NCT03103100|62872974|FG000|Overall Study|Physician Decision|1|||
33606030|NCT02257567|63005844|FG009|Overall Study|Adverse Event|0|||
33606031|NCT02257567|63005845|FG010|Overall Study|Adverse Event|0|||
33606032|NCT02257567|63005835|FG000|Overall Study|Death|2|||
33606033|NCT02257567|63005836|FG001|Overall Study|Death|2|||
33440189|NCT00125164|62816210|FG000|Overall Study|Withdrawal by Subject|2|||
33440190|NCT00125164|62816211|FG001|Overall Study|Withdrawal by Subject|0|||
33440191|NCT00125164|62816212|FG002|Overall Study|Withdrawal by Subject|1|||
33440192|NCT00125164|62816213|FG003|Overall Study|Withdrawal by Subject|1|||
33440193|NCT00136318|62816225|FG000|Overall Study|Adverse Event|5|||
33440194|NCT00136318|62816226|FG001|Overall Study|Adverse Event|5|||
33440195|NCT00136318|62816225|FG000|Overall Study|Withdrawal by Subject|2|||
33440196|NCT00136318|62816226|FG001|Overall Study|Withdrawal by Subject|2|||
33440197|NCT00136084|62816235|FG000|Overall Study|Death|12|||
33440198|NCT00136084|62816236|FG001|Overall Study|Death|5|||
33440199|NCT00136084|62816235|FG000|Overall Study|Unacceptable toxicity|8|||
33440200|NCT00136084|62816236|FG001|Overall Study|Unacceptable toxicity|11|||
33440201|NCT00136084|62816235|FG000|Overall Study|Relapse|20|||
33440202|NCT00136084|62816236|FG001|Overall Study|Relapse|23|||
33440203|NCT00136084|62816235|FG000|Overall Study|Lost to Follow-up|2|||
33440204|NCT00136084|62816236|FG001|Overall Study|Lost to Follow-up|0|||
33440205|NCT00136084|62816235|FG000|Overall Study|No Response|1|||
33440206|NCT00136084|62816236|FG001|Overall Study|No Response|2|||
33440207|NCT00136084|62816235|FG000|Overall Study|Withdrawal by Subject|5|||
33440208|NCT00136084|62816236|FG001|Overall Study|Withdrawal by Subject|1|||
33440209|NCT00364832|62816257|FG000|Core Period|Early Withdrawals|2|||
33440210|NCT00364832|62816258|FG001|Core Period|Early Withdrawals|2|||
33440211|NCT00364832|62816259|FG002|Core Period|Early Withdrawals|1|||
33440212|NCT00364832|62816260|FG003|Core Period|Early Withdrawals|1|||
33440213|NCT00364832|62816261|FG004|Core Period|Early Withdrawals|0|||
33440214|NCT00364832|62816262|FG005|Core Period|Early Withdrawals|0|||
33440215|NCT00364832|62816263|FG006|Core Period|Early Withdrawals|4|||
33440216|NCT00364832|62816264|FG007|Core Period|Early Withdrawals|1|||
33606034|NCT02257567|63005837|FG002|Overall Study|Death|2|||
33606035|NCT02257567|63005838|FG003|Overall Study|Death|4|||
33606036|NCT02257567|63005839|FG004|Overall Study|Death|15|||
33606037|NCT02257567|63005840|FG005|Overall Study|Death|11|||
33606038|NCT02257567|63005841|FG006|Overall Study|Death|26|||
33606039|NCT02257567|63005842|FG007|Overall Study|Death|30|||
33606040|NCT02257567|63005843|FG008|Overall Study|Death|2|||
33440217|NCT00364832|62816265|FG008|Core Period|Early Withdrawals|0|||
33440218|NCT00364832|62816266|FG009|Core Period|Early Withdrawals|0|||
33440219|NCT00364832|62816267|FG010|Core Period|Early Withdrawals|0|||
33440220|NCT00364832|62816268|FG011|Core Period|Early Withdrawals|0|||
33440221|NCT00364832|62816257|FG000|Extension Year 1|Early Withdrawals|0|||
33440222|NCT00364832|62816258|FG001|Extension Year 1|Early Withdrawals|0|||
33440223|NCT00364832|62816259|FG002|Extension Year 1|Early Withdrawals|0|||
33440224|NCT00364832|62816260|FG003|Extension Year 1|Early Withdrawals|0|||
33440225|NCT00364832|62816261|FG004|Extension Year 1|Early Withdrawals|0|||
33440226|NCT00364832|62816262|FG005|Extension Year 1|Early Withdrawals|0|||
33440227|NCT00364832|62816263|FG006|Extension Year 1|Early Withdrawals|0|||
33440228|NCT00364832|62816264|FG007|Extension Year 1|Early Withdrawals|0|||
33440229|NCT00364832|62816265|FG008|Extension Year 1|Early Withdrawals|0|||
33440230|NCT00364832|62816266|FG009|Extension Year 1|Early Withdrawals|4|||
33440231|NCT00364832|62816267|FG010|Extension Year 1|Early Withdrawals|2|||
33440232|NCT00364832|62816268|FG011|Extension Year 1|Early Withdrawals|10|||
33440233|NCT00364832|62816257|FG000|Extension Year 2|Early Withdrawals|0|||
33440234|NCT00364832|62816258|FG001|Extension Year 2|Early Withdrawals|0|||
33440235|NCT00364832|62816259|FG002|Extension Year 2|Early Withdrawals|0|||
33440236|NCT00364832|62816260|FG003|Extension Year 2|Early Withdrawals|0|||
33440237|NCT00364832|62816261|FG004|Extension Year 2|Early Withdrawals|0|||
33440238|NCT00364832|62816262|FG005|Extension Year 2|Early Withdrawals|0|||
33440239|NCT00364832|62816263|FG006|Extension Year 2|Early Withdrawals|0|||
33440240|NCT00364832|62816264|FG007|Extension Year 2|Early Withdrawals|0|||
33440241|NCT00364832|62816265|FG008|Extension Year 2|Early Withdrawals|0|||
33440242|NCT00364832|62816266|FG009|Extension Year 2|Early Withdrawals|5|||
33440243|NCT00364832|62816267|FG010|Extension Year 2|Early Withdrawals|5|||
33440244|NCT00364832|62816268|FG011|Extension Year 2|Early Withdrawals|3|||
33440245|NCT00235755|62816288|FG000|4-Week Titration Phase|Adverse Event|6|||
33440246|NCT00235755|62816289|FG001|4-Week Titration Phase|Adverse Event|14|||
33440247|NCT00235755|62816290|FG002|4-Week Titration Phase|Adverse Event|20|||
33440248|NCT00235755|62816288|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
33606041|NCT02257567|63005844|FG009|Overall Study|Death|18|||
33440249|NCT00235755|62816289|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
33440250|NCT00235755|62816290|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
33440251|NCT00235755|62816288|FG000|4-Week Titration Phase|Protocol Violation|2|||
33440252|NCT00235755|62816289|FG001|4-Week Titration Phase|Protocol Violation|2|||
33440253|NCT00235755|62816290|FG002|4-Week Titration Phase|Protocol Violation|1|||
33440254|NCT00235755|62816288|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
33440255|NCT00235755|62816289|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
33606042|NCT02257567|63005845|FG010|Overall Study|Death|65|||
33606043|NCT02257567|63005835|FG000|Overall Study|Lost to Follow-up|0|||
33440256|NCT00235755|62816290|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
33440257|NCT00235755|62816288|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
33440258|NCT00235755|62816289|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
33440259|NCT00235755|62816290|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
33440260|NCT00235755|62816288|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
33440261|NCT00235755|62816289|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
33440262|NCT00235755|62816290|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
33440263|NCT00235755|62816288|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
33440264|NCT00235755|62816289|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
33440265|NCT00235755|62816290|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
33440266|NCT00235755|62816288|FG000|12-Week Maintenance Phase|Adverse Event|8|||
33440267|NCT00235755|62816289|FG001|12-Week Maintenance Phase|Adverse Event|12|||
33440268|NCT00235755|62816290|FG002|12-Week Maintenance Phase|Adverse Event|26|||
33440269|NCT00235755|62816288|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
33440270|NCT00235755|62816289|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
33440271|NCT00235755|62816290|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
33440272|NCT00235755|62816288|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
33440273|NCT00235755|62816289|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
33440274|NCT00235755|62816290|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
33440275|NCT00235755|62816288|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
33440276|NCT00235755|62816289|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
33440277|NCT00235755|62816290|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
33440278|NCT00235755|62816288|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
33440279|NCT00235755|62816289|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
33440280|NCT00235755|62816290|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
33440281|NCT00235755|62816288|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
33440282|NCT00235755|62816289|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
33440283|NCT00235755|62816290|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
33440284|NCT00337194|62816315|FG000|Overall Study|Adverse Event|5|||
33440285|NCT00337194|62816316|FG001|Overall Study|Adverse Event|1|||
33440286|NCT00337194|62816315|FG000|Overall Study|Death|2|||
33440287|NCT00337194|62816316|FG001|Overall Study|Death|0|||
33440288|NCT00337194|62816315|FG000|Overall Study|Withdrawal by Subject|1|||
33440289|NCT00337194|62816316|FG001|Overall Study|Withdrawal by Subject|0|||
33440290|NCT00337194|62816315|FG000|Overall Study|Disease progression|1|||
33440291|NCT00337194|62816316|FG001|Overall Study|Disease progression|2|||
33440292|NCT00337194|62816315|FG000|Overall Study|Subsequent non-protocol therapy|3|||
33440293|NCT00337194|62816316|FG001|Overall Study|Subsequent non-protocol therapy|1|||
33440294|NCT03826914|62816326|FG000|Overall Study|Withdrawal by Subject|1|||
33440295|NCT03826914|62816327|FG001|Overall Study|Withdrawal by Subject|1|||
33440296|NCT00385736|62816338|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
33440297|NCT00385736|62816339|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
33440298|NCT00385736|62816340|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
33440299|NCT00385736|62816338|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
33440300|NCT00385736|62816339|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
33440301|NCT00385736|62816340|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
33440302|NCT00385736|62816338|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
33440303|NCT00385736|62816339|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
33440304|NCT00385736|62816340|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
33440305|NCT00385736|62816338|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
33440306|NCT00385736|62816339|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
33440307|NCT00385736|62816340|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
33440308|NCT00385736|62816338|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
33440309|NCT00385736|62816339|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
33440310|NCT00385736|62816340|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
33440311|NCT00385736|62816338|FG000|Efficacy Analysis Set - Induction|Other|0|||
33440312|NCT00385736|62816339|FG001|Efficacy Analysis Set - Induction|Other|0|||
33440313|NCT00385736|62816340|FG002|Efficacy Analysis Set - Induction|Other|1|||
33606044|NCT02257567|63005836|FG001|Overall Study|Lost to Follow-up|0|||
33606045|NCT02257567|63005837|FG002|Overall Study|Lost to Follow-up|0|||
33606046|NCT02257567|63005838|FG003|Overall Study|Lost to Follow-up|0|||
33606047|NCT02257567|63005839|FG004|Overall Study|Lost to Follow-up|2|||
33440314|NCT00385736|62816338|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
33440315|NCT00385736|62816339|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
33440316|NCT00385736|62816340|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
33440317|NCT00385736|62816338|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
33440318|NCT00385736|62816339|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
33606048|NCT02257567|63005840|FG005|Overall Study|Lost to Follow-up|2|||
33606049|NCT02257567|63005841|FG006|Overall Study|Lost to Follow-up|0|||
33606050|NCT02257567|63005842|FG007|Overall Study|Lost to Follow-up|0|||
33606051|NCT02257567|63005843|FG008|Overall Study|Lost to Follow-up|0|||
33606052|NCT02257567|63005844|FG009|Overall Study|Lost to Follow-up|1|||
33606053|NCT02257567|63005845|FG010|Overall Study|Lost to Follow-up|1|||
33606054|NCT02257567|63005835|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33606055|NCT02257567|63005836|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33606056|NCT02257567|63005837|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33606057|NCT02257567|63005838|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33606058|NCT02257567|63005839|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
33606059|NCT02257567|63005840|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33606060|NCT02257567|63005841|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
33606061|NCT02257567|63005842|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33606062|NCT02257567|63005843|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33606063|NCT02257567|63005844|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33606064|NCT02257567|63005845|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33606065|NCT02257567|63005835|FG000|Overall Study|Physician Decision|0|||
33606066|NCT02257567|63005836|FG001|Overall Study|Physician Decision|0|||
33606067|NCT02257567|63005837|FG002|Overall Study|Physician Decision|0|||
33606068|NCT02257567|63005838|FG003|Overall Study|Physician Decision|0|||
33606069|NCT02257567|63005839|FG004|Overall Study|Physician Decision|0|||
33606070|NCT02257567|63005840|FG005|Overall Study|Physician Decision|0|||
33606071|NCT02257567|63005841|FG006|Overall Study|Physician Decision|0|||
33606072|NCT02257567|63005842|FG007|Overall Study|Physician Decision|2|||
33606073|NCT02257567|63005843|FG008|Overall Study|Physician Decision|0|||
33606074|NCT02257567|63005844|FG009|Overall Study|Physician Decision|1|||
33606075|NCT02257567|63005845|FG010|Overall Study|Physician Decision|0|||
33606076|NCT02257567|63005835|FG000|Overall Study|Withdrawal by Subject|0|||
33606077|NCT02257567|63005836|FG001|Overall Study|Withdrawal by Subject|0|||
33606078|NCT02257567|63005837|FG002|Overall Study|Withdrawal by Subject|2|||
33606079|NCT02257567|63005838|FG003|Overall Study|Withdrawal by Subject|0|||
33606080|NCT02257567|63005839|FG004|Overall Study|Withdrawal by Subject|0|||
33606081|NCT02257567|63005840|FG005|Overall Study|Withdrawal by Subject|6|||
33606082|NCT02257567|63005841|FG006|Overall Study|Withdrawal by Subject|6|||
33606083|NCT02257567|63005842|FG007|Overall Study|Withdrawal by Subject|6|||
33606084|NCT02257567|63005843|FG008|Overall Study|Withdrawal by Subject|1|||
33606085|NCT02257567|63005844|FG009|Overall Study|Withdrawal by Subject|1|||
33606086|NCT02257567|63005845|FG010|Overall Study|Withdrawal by Subject|10|||
33606087|NCT01642615|63005902|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
33606088|NCT01642615|63005903|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
33606089|NCT01642615|63005904|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
33606090|NCT01642615|63005902|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
33606091|NCT01642615|63005903|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
33606092|NCT01642615|63005904|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
33606093|NCT01642615|63005902|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
33606094|NCT01642615|63005903|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
33606095|NCT01642615|63005904|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
33606096|NCT01642615|63005902|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
33606097|NCT01642615|63005903|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
33606098|NCT01642615|63005904|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
33606099|NCT01642615|63005902|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
33606100|NCT01642615|63005903|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
33606101|NCT01642615|63005904|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
33606102|NCT01642615|63005902|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
33440319|NCT00385736|62816340|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
33440320|NCT00385736|62816338|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
33440321|NCT00385736|62816339|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
33606103|NCT01642615|63005903|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
33606104|NCT01642615|63005904|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
33606105|NCT01642615|63005902|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
33606106|NCT01642615|63005903|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
33606107|NCT01642615|63005904|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
33440322|NCT00385736|62816340|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
33440323|NCT00385736|62816338|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
33440324|NCT00385736|62816339|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
33440325|NCT00385736|62816340|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
33440326|NCT00385736|62816338|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
33440327|NCT00385736|62816339|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
33440328|NCT00385736|62816340|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
33440329|NCT00385736|62816338|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
33440330|NCT00385736|62816339|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
33440331|NCT00385736|62816340|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
33440332|NCT00385736|62816338|FG000|Safety Analysis Set|Adverse Event|23|||
33440333|NCT00385736|62816339|FG001|Safety Analysis Set|Adverse Event|15|||
33440334|NCT00385736|62816340|FG002|Safety Analysis Set|Adverse Event|23|||
33440335|NCT00385736|62816338|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
33440336|NCT00385736|62816339|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
33440337|NCT00385736|62816340|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
33440338|NCT00385736|62816338|FG000|Safety Analysis Set|Lost to Follow-up|0|||
33440339|NCT00385736|62816339|FG001|Safety Analysis Set|Lost to Follow-up|2|||
33440340|NCT00385736|62816340|FG002|Safety Analysis Set|Lost to Follow-up|2|||
33440341|NCT00385736|62816338|FG000|Safety Analysis Set|Lack of Efficacy|38|||
33440342|NCT00385736|62816339|FG001|Safety Analysis Set|Lack of Efficacy|16|||
33440343|NCT00385736|62816340|FG002|Safety Analysis Set|Lack of Efficacy|31|||
33440344|NCT00385736|62816338|FG000|Safety Analysis Set|Protocol Violation|2|||
33440345|NCT00385736|62816339|FG001|Safety Analysis Set|Protocol Violation|1|||
33440346|NCT00385736|62816340|FG002|Safety Analysis Set|Protocol Violation|6|||
33440347|NCT00385736|62816338|FG000|Safety Analysis Set|Other|1|||
33440348|NCT00385736|62816339|FG001|Safety Analysis Set|Other|4|||
33440349|NCT00385736|62816340|FG002|Safety Analysis Set|Other|4|||
33440350|NCT00195819|62816351|FG000|Double-Blind|Withdrawal by Subject|1|||
33440351|NCT00195819|62816352|FG001|Double-Blind|Withdrawal by Subject|0|||
33440352|NCT00195819|62816351|FG000|Double-Blind|Moved|1|||
33440353|NCT00195819|62816352|FG001|Double-Blind|Moved|0|||
33440354|NCT00195819|62816351|FG000|Open-label|Adverse Event|0|||
33440355|NCT00195819|62816352|FG001|Open-label|Adverse Event|9|||
33440356|NCT00195819|62816351|FG000|Open-label|Lack of Efficacy|0|||
33440357|NCT00195819|62816352|FG001|Open-label|Lack of Efficacy|2|||
33440358|NCT00195819|62816351|FG000|Open-label|Pregnancy|0|||
33440359|NCT00195819|62816352|FG001|Open-label|Pregnancy|1|||
33440360|NCT00195819|62816351|FG000|Open-label|Protocol Violation|0|||
33440361|NCT00195819|62816352|FG001|Open-label|Protocol Violation|2|||
33440362|NCT00195819|62816351|FG000|Open-label|Moved|0|||
33440363|NCT00195819|62816352|FG001|Open-label|Moved|1|||
33440364|NCT00195819|62816351|FG000|Open-label|Withdrawal by Subject|0|||
33440365|NCT00195819|62816352|FG001|Open-label|Withdrawal by Subject|5|||
33440366|NCT00527735|62816367|FG000|Overall Study|Disease progression|47|||
33440367|NCT00527735|62816368|FG001|Overall Study|Disease progression|61|||
33440368|NCT00527735|62816369|FG002|Overall Study|Disease progression|53|||
33440369|NCT00527735|62816367|FG000|Overall Study|Death|23|||
33440370|NCT00527735|62816368|FG001|Overall Study|Death|13|||
33440371|NCT00527735|62816369|FG002|Overall Study|Death|15|||
33440372|NCT00527735|62816367|FG000|Overall Study|Completed treatment in treatment phase|14|||
33440373|NCT00527735|62816368|FG001|Overall Study|Completed treatment in treatment phase|13|||
33440374|NCT00527735|62816369|FG002|Overall Study|Completed treatment in treatment phase|18|||
33440375|NCT00527735|62816367|FG000|Overall Study|Adverse Event|10|||
33440376|NCT00527735|62816368|FG001|Overall Study|Adverse Event|6|||
33440377|NCT00527735|62816369|FG002|Overall Study|Adverse Event|7|||
33440378|NCT00527735|62816367|FG000|Overall Study|Not identified|5|||
33440379|NCT00527735|62816368|FG001|Overall Study|Not identified|5|||
33440380|NCT00527735|62816369|FG002|Overall Study|Not identified|5|||
33440381|NCT00527735|62816367|FG000|Overall Study|Withdrawal by Subject|5|||
33440382|NCT00527735|62816368|FG001|Overall Study|Withdrawal by Subject|4|||
33440383|NCT00527735|62816369|FG002|Overall Study|Withdrawal by Subject|3|||
33440384|NCT00527735|62816367|FG000|Overall Study|No longer met study criteria|2|||
33606108|NCT01642615|63005902|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
33440385|NCT00527735|62816368|FG001|Overall Study|No longer met study criteria|2|||
33440386|NCT00527735|62816369|FG002|Overall Study|No longer met study criteria|1|||
33440387|NCT00527735|62816367|FG000|Overall Study|Lost to Follow-up|0|||
33440388|NCT00527735|62816368|FG001|Overall Study|Lost to Follow-up|0|||
33440389|NCT00527735|62816369|FG002|Overall Study|Lost to Follow-up|3|||
33440390|NCT00527735|62816367|FG000|Overall Study|Poor compliance or noncompliance|0|||
33440391|NCT00527735|62816368|FG001|Overall Study|Poor compliance or noncompliance|1|||
33440392|NCT00527735|62816369|FG002|Overall Study|Poor compliance or noncompliance|1|||
33440393|NCT00527735|62816367|FG000|Overall Study|Completed treatment during maintenance|2|||
33440394|NCT00527735|62816368|FG001|Overall Study|Completed treatment during maintenance|2|||
33440395|NCT00527735|62816369|FG002|Overall Study|Completed treatment during maintenance|1|||
33440396|NCT00336492|62816392|FG000|Overall Study|Adverse Event|4|||
33440397|NCT00336492|62816393|FG001|Overall Study|Adverse Event|3|||
33440398|NCT00336492|62816394|FG002|Overall Study|Adverse Event|6|||
33440399|NCT00336492|62816392|FG000|Overall Study|Lack of Efficacy|6|||
33440400|NCT00336492|62816393|FG001|Overall Study|Lack of Efficacy|1|||
33440401|NCT00336492|62816394|FG002|Overall Study|Lack of Efficacy|4|||
33440402|NCT00336492|62816392|FG000|Overall Study|Other|5|||
33440403|NCT00336492|62816393|FG001|Overall Study|Other|0|||
33440404|NCT00336492|62816394|FG002|Overall Study|Other|1|||
33440405|NCT00194025|62816402|FG000|Overall Study|Adverse Event|1|||
33440406|NCT00194025|62816402|FG000|Overall Study|non-adherence with study medication|4|||
33440407|NCT00368108|62816409|FG000|Overall Study|Adverse Event|38|||
33440408|NCT00368108|62816410|FG001|Overall Study|Adverse Event|26|||
33440409|NCT00368108|62816411|FG002|Overall Study|Adverse Event|44|||
33440410|NCT00368108|62816409|FG000|Overall Study|Abnormal Laboratory Value|0|||
33440411|NCT00368108|62816410|FG001|Overall Study|Abnormal Laboratory Value|0|||
33440412|NCT00368108|62816411|FG002|Overall Study|Abnormal Laboratory Value|3|||
33440413|NCT00368108|62816409|FG000|Overall Study|Protocol Violation|5|||
33440414|NCT00368108|62816410|FG001|Overall Study|Protocol Violation|9|||
33440415|NCT00368108|62816411|FG002|Overall Study|Protocol Violation|9|||
33440416|NCT00368108|62816409|FG000|Overall Study|Withdrawal by Subject|9|||
33440417|NCT00368108|62816410|FG001|Overall Study|Withdrawal by Subject|3|||
33440418|NCT00368108|62816411|FG002|Overall Study|Withdrawal by Subject|5|||
33440419|NCT00368108|62816409|FG000|Overall Study|Lack of Efficacy|7|||
33440420|NCT00368108|62816410|FG001|Overall Study|Lack of Efficacy|8|||
33440421|NCT00368108|62816411|FG002|Overall Study|Lack of Efficacy|5|||
33440422|NCT00368108|62816409|FG000|Overall Study|Physician Decision|2|||
33440423|NCT00368108|62816410|FG001|Overall Study|Physician Decision|0|||
33440424|NCT00368108|62816411|FG002|Overall Study|Physician Decision|1|||
33440425|NCT00368108|62816409|FG000|Overall Study|Other|3|||
33440426|NCT00368108|62816410|FG001|Overall Study|Other|7|||
33440427|NCT00368108|62816411|FG002|Overall Study|Other|1|||
33440428|NCT00364130|62816421|FG000|Intervention Period|Lost to Follow-up|4|||
33440429|NCT00364130|62816422|FG001|Intervention Period|Lost to Follow-up|3|||
33440430|NCT00364130|62816421|FG000|Intervention Period|Pregnancy|1|||
33440431|NCT00364130|62816422|FG001|Intervention Period|Pregnancy|0|||
33440432|NCT00364130|62816421|FG000|Intervention Period|Withdrawal by Subject|4|||
33440433|NCT00364130|62816422|FG001|Intervention Period|Withdrawal by Subject|5|||
33440434|NCT00364130|62816421|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
33440435|NCT00364130|62816422|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
33440436|NCT00521339|62816430|FG000|Treatment Phase|Adverse Event|2|||
33440437|NCT00521339|62816431|FG001|Treatment Phase|Adverse Event|0|||
33440438|NCT00521339|62816432|FG002|Treatment Phase|Adverse Event|0|||
33440439|NCT00521339|62816430|FG000|Treatment Phase|Intolerability to study drug|2|||
33440440|NCT00521339|62816431|FG001|Treatment Phase|Intolerability to study drug|0|||
33440441|NCT00521339|62816432|FG002|Treatment Phase|Intolerability to study drug|0|||
33440442|NCT00521339|62816430|FG000|Treatment Phase|Lack of Efficacy|3|||
33440443|NCT00521339|62816431|FG001|Treatment Phase|Lack of Efficacy|0|||
33440444|NCT00521339|62816432|FG002|Treatment Phase|Lack of Efficacy|0|||
33440445|NCT00521339|62816430|FG000|Treatment Phase|Withdrawal by Subject|3|||
33440446|NCT00521339|62816431|FG001|Treatment Phase|Withdrawal by Subject|0|||
33440447|NCT00521339|62816432|FG002|Treatment Phase|Withdrawal by Subject|0|||
33440448|NCT00521339|62816430|FG000|Treatment Phase|Lost to Follow-up|1|||
33440449|NCT00521339|62816431|FG001|Treatment Phase|Lost to Follow-up|0|||
33440450|NCT00521339|62816432|FG002|Treatment Phase|Lost to Follow-up|0|||
33440451|NCT00521339|62816430|FG000|Treatment Phase|Protocol Violation|1|||
33440452|NCT00521339|62816431|FG001|Treatment Phase|Protocol Violation|0|||
33440453|NCT00521339|62816432|FG002|Treatment Phase|Protocol Violation|0|||
33440454|NCT00521339|62816430|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
33440455|NCT00521339|62816431|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
33440456|NCT00521339|62816432|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
33440457|NCT00521339|62816430|FG000|Treatment Extension Phase|Death|0|||
33440458|NCT00521339|62816431|FG001|Treatment Extension Phase|Death|0|||
33606109|NCT01642615|63005903|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
33606110|NCT01642615|63005904|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
33440459|NCT00521339|62816432|FG002|Treatment Extension Phase|Death|1|||
33440460|NCT00363896|62816455|FG000|Overall Study|Withdrawal by Subject|29|||
33440461|NCT00363896|62816456|FG001|Overall Study|Withdrawal by Subject|16|||
33440462|NCT00363896|62816455|FG000|Overall Study|Adverse Event|24|||
33494206|NCT03103100|62872975|FG001|Overall Study|Physician Decision|0|||
33494207|NCT03103100|62872976|FG002|Overall Study|Physician Decision|2|||
33494208|NCT03438006|62872984|FG000|Overall Study|Adverse Event|1|||
33440463|NCT00363896|62816456|FG001|Overall Study|Adverse Event|13|||
33440464|NCT00363896|62816455|FG000|Overall Study|COPD exacerbation|13|||
33440465|NCT00363896|62816456|FG001|Overall Study|COPD exacerbation|7|||
33440466|NCT00363896|62816455|FG000|Overall Study|Lack of Efficacy|12|||
33440467|NCT00363896|62816456|FG001|Overall Study|Lack of Efficacy|8|||
33440468|NCT00363896|62816455|FG000|Overall Study|Protocol Violation|6|||
33440469|NCT00363896|62816456|FG001|Overall Study|Protocol Violation|1|||
33440470|NCT00363896|62816455|FG000|Overall Study|Lost to Follow-up|3|||
33440471|NCT00363896|62816456|FG001|Overall Study|Lost to Follow-up|0|||
33440472|NCT00363896|62816455|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
33440473|NCT00363896|62816456|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
33440474|NCT00363896|62816455|FG000|Overall Study|Other|1|||
33440475|NCT00363896|62816456|FG001|Overall Study|Other|2|||
33440476|NCT00527423|62816465|FG000|Overall Study|Protocol Violation|1|||
33440477|NCT00527423|62816465|FG000|Overall Study|Adverse Event|5|||
33440478|NCT00527423|62816465|FG000|Overall Study|Physician Decision|4|||
33440479|NCT00527423|62816465|FG000|Overall Study|Withdrawal by Subject|10|||
33606111|NCT01642615|63005902|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
33440480|NCT00527423|62816465|FG000|Overall Study|Lost to Follow-up|4|||
33440481|NCT00527423|62816465|FG000|Overall Study|OTHER|4|||
33440482|NCT00527423|62816465|FG000|Overall Study|Death|9|||
33440483|NCT00527111|62816473|FG000|Overall Study|Adverse Event|14|||
33440484|NCT00527111|62816474|FG001|Overall Study|Adverse Event|13|||
33440485|NCT00527111|62816473|FG000|Overall Study|Death|0|||
33440486|NCT00527111|62816474|FG001|Overall Study|Death|1|||
33440487|NCT00527111|62816473|FG000|Overall Study|Investigator Request|2|||
33440488|NCT00527111|62816474|FG001|Overall Study|Investigator Request|1|||
33440489|NCT00527111|62816473|FG000|Overall Study|Patient Request|2|||
33440490|NCT00527111|62816474|FG001|Overall Study|Patient Request|5|||
33440491|NCT00527111|62816473|FG000|Overall Study|Other|2|||
33440492|NCT00527111|62816474|FG001|Overall Study|Other|2|||
33440493|NCT00384956|62816480|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
33440494|NCT00367640|62816488|FG000|Overall Study|Adverse Event|3|||
33440495|NCT00367640|62816489|FG001|Overall Study|Adverse Event|6|||
33440496|NCT00367640|62816490|FG002|Overall Study|Adverse Event|8|||
33440497|NCT00367640|62816491|FG003|Overall Study|Adverse Event|0|||
33440498|NCT00367640|62816488|FG000|Overall Study|Withdrawal by Subject|8|||
33440499|NCT00367640|62816489|FG001|Overall Study|Withdrawal by Subject|11|||
33440500|NCT00367640|62816490|FG002|Overall Study|Withdrawal by Subject|8|||
33440501|NCT00367640|62816491|FG003|Overall Study|Withdrawal by Subject|6|||
33440502|NCT00367640|62816488|FG000|Overall Study|Any other reason not above-mentioned|7|||
33606112|NCT01642615|63005903|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
33440503|NCT00367640|62816489|FG001|Overall Study|Any other reason not above-mentioned|5|||
33440504|NCT00367640|62816490|FG002|Overall Study|Any other reason not above-mentioned|3|||
33440505|NCT00367640|62816491|FG003|Overall Study|Any other reason not above-mentioned|4|||
33440506|NCT00367484|62816501|FG000|Overall Study|Adverse Event|7|||
33440507|NCT00367484|62816501|FG000|Overall Study|Withdrew informed consent|5|||
33440508|NCT00367484|62816501|FG000|Overall Study|Travel to USA|1|||
33440509|NCT00367484|62816501|FG000|Overall Study|Lost to Follow-up|1|||
33440510|NCT00367484|62816501|FG000|Overall Study|Protocol Violation|1|||
33440511|NCT00367484|62816501|FG000|Overall Study|The choice of the patient|1|||
33440512|NCT00367484|62816501|FG000|Overall Study|Lack of Efficacy|1|||
33440513|NCT00526799|62816507|FG000|Overall Study|Withdrawal by Subject|1|||
33440514|NCT00526799|62816508|FG001|Overall Study|Withdrawal by Subject|0|||
33440515|NCT00526799|62816507|FG000|Overall Study|Intercurrent Complicating Disease|0|||
33440516|NCT00526799|62816508|FG001|Overall Study|Intercurrent Complicating Disease|1|||
33440517|NCT00526331|62816514|FG000|Overall Study|Sponsor Termination|55|||
33440518|NCT00520481|62816520|FG000|Overall Study|Adverse Event|4|||
33440519|NCT00520481|62816521|FG001|Overall Study|Adverse Event|1|||
33440520|NCT00520481|62816520|FG000|Overall Study|Withdrawal by Subject|3|||
33440521|NCT00520481|62816521|FG001|Overall Study|Withdrawal by Subject|0|||
33440522|NCT00520403|62816529|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
33440523|NCT00520403|62816529|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
33440524|NCT00520403|62816529|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
33440525|NCT00520403|62816529|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
33440526|NCT00520403|62816529|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
33440527|NCT00520403|62816529|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
33440528|NCT00520403|62816529|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
33440529|NCT00520403|62816529|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
33440530|NCT00520013|62816536|FG000|Overall Study|Withdrawal by Subject|0|||
33440531|NCT00520013|62816537|FG001|Overall Study|Withdrawal by Subject|0|||
33606113|NCT01642615|63005904|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
33606114|NCT02311361|63005916|FG000|Overall Study|Did not receive treatment|0|||
33440532|NCT00520013|62816538|FG002|Overall Study|Withdrawal by Subject|1|||
33440533|NCT00520013|62816536|FG000|Overall Study|Adverse Event|2|||
33440534|NCT00520013|62816537|FG001|Overall Study|Adverse Event|10|||
33440535|NCT00520013|62816538|FG002|Overall Study|Adverse Event|7|||
33440536|NCT00520013|62816536|FG000|Overall Study|Progressive Disease|7|||
33440537|NCT00520013|62816537|FG001|Overall Study|Progressive Disease|3|||
33440538|NCT00520013|62816538|FG002|Overall Study|Progressive Disease|0|||
33440539|NCT00520013|62816536|FG000|Overall Study|Clinical Progression|3|||
33440540|NCT00520013|62816537|FG001|Overall Study|Clinical Progression|1|||
33606115|NCT02311361|63005917|FG001|Overall Study|Did not receive treatment|1|||
33606116|NCT02311361|63005918|FG002|Overall Study|Did not receive treatment|0|||
33440541|NCT00520013|62816538|FG002|Overall Study|Clinical Progression|0|||
33440542|NCT00520013|62816536|FG000|Overall Study|Death|0|||
33440543|NCT00520013|62816537|FG001|Overall Study|Death|1|||
33440544|NCT00520013|62816538|FG002|Overall Study|Death|0|||
33440545|NCT00520013|62816536|FG000|Overall Study|Physician Decision|0|||
33440546|NCT00520013|62816537|FG001|Overall Study|Physician Decision|0|||
33440547|NCT00520013|62816538|FG002|Overall Study|Physician Decision|3|||
33440548|NCT00519779|62816546|FG000|Overall Study|Withdrawal by Subject|0|||
33440549|NCT00519779|62816547|FG001|Overall Study|Withdrawal by Subject|1|||
33440550|NCT00526097|62816555|FG000|Overall Study|Adverse Event|6|||
33440551|NCT00526097|62816556|FG001|Overall Study|Adverse Event|44|||
33440552|NCT00526097|62816555|FG000|Overall Study|Protocol Violation|4|||
33440553|NCT00526097|62816556|FG001|Overall Study|Protocol Violation|10|||
33440554|NCT00526097|62816555|FG000|Overall Study|Withdrawal by Subject|3|||
33440555|NCT00526097|62816556|FG001|Overall Study|Withdrawal by Subject|1|||
33440556|NCT00526097|62816555|FG000|Overall Study|Other|2|||
33440557|NCT00526097|62816556|FG001|Overall Study|Other|1|||
33440558|NCT00525785|62816562|FG000|Overall Study|Withdrawal by Subject|1|||
33440559|NCT00525785|62816562|FG000|Overall Study|Lack of Efficacy|1|||
33440560|NCT00525785|62816562|FG000|Overall Study|Physician Decision|1|||
33440561|NCT00525161|62816566|FG000|Overall Study|Adverse Event|1|||
33440562|NCT00524771|62816572|FG000|Overall Study|Protocol Violation|220|||
33440563|NCT00524771|62816573|FG001|Overall Study|Protocol Violation|585|||
33440564|NCT00135694|62816583|FG000|Overall Study|Adverse Event|17|||
33440565|NCT00135694|62816584|FG001|Overall Study|Adverse Event|4|||
33440566|NCT00135694|62816585|FG002|Overall Study|Adverse Event|0|||
33440567|NCT00135694|62816583|FG000|Overall Study|Death|14|||
33440568|NCT00135694|62816584|FG001|Overall Study|Death|1|||
33440569|NCT00135694|62816585|FG002|Overall Study|Death|2|||
33440570|NCT00135694|62816583|FG000|Overall Study|Lost to Follow-up|8|||
33440571|NCT00135694|62816584|FG001|Overall Study|Lost to Follow-up|7|||
33606117|NCT02311361|63005919|FG003|Overall Study|Did not receive treatment|1|||
33606118|NCT02352779|63005936|FG000|Overall Study|Personal Issues|1|||
33440572|NCT00135694|62816585|FG002|Overall Study|Lost to Follow-up|1|||
33440573|NCT00135694|62816583|FG000|Overall Study|Withdrawal by Subject|41|||
33440574|NCT00135694|62816584|FG001|Overall Study|Withdrawal by Subject|7|||
33440575|NCT00135694|62816585|FG002|Overall Study|Withdrawal by Subject|4|||
33440576|NCT00135694|62816583|FG000|Overall Study|Protocol Violation|19|||
33440577|NCT00135694|62816584|FG001|Overall Study|Protocol Violation|1|||
33440578|NCT00135694|62816585|FG002|Overall Study|Protocol Violation|0|||
33440579|NCT00135694|62816583|FG000|Overall Study|Hepatitis C related reasons|39|||
33440580|NCT00135694|62816584|FG001|Overall Study|Hepatitis C related reasons|1|||
33440581|NCT00135694|62816585|FG002|Overall Study|Hepatitis C related reasons|0|||
33440582|NCT00135694|62816583|FG000|Overall Study|Ineligible for Random assignment|42|||
33440583|NCT00135694|62816584|FG001|Overall Study|Ineligible for Random assignment|0|||
33440584|NCT00135694|62816585|FG002|Overall Study|Ineligible for Random assignment|0|||
33440585|NCT00524459|62816593|FG000|Overall Study|Withdrawal by Subject|1|||
33440586|NCT00524459|62816593|FG000|Overall Study|Other|1|||
33440587|NCT00519623|62816597|FG000|Overall Study|Adverse Event|1|||
33440588|NCT00519077|62816601|FG000|Overall Study|Death|6|||
33440589|NCT00519077|62816601|FG000|Overall Study|Other|2|||
33440590|NCT00124618|62816605|FG000|Overall Study|Ineligible|1|||
33440591|NCT00124462|62816611|FG000|Overall Study|Lost to Follow-up|3|||
33440592|NCT00124462|62816612|FG001|Overall Study|Lost to Follow-up|3|||
33440593|NCT00124462|62816611|FG000|Overall Study|Physician Decision|3|||
33323228|NCT00973479|62699482|FG001|Overall Study|Lack of Efficacy|7|||
33323229|NCT00973479|62699481|FG000|Overall Study|Adverse Event|12|||
33323230|NCT00973479|62699482|FG001|Overall Study|Adverse Event|32|||
33440594|NCT00124462|62816612|FG001|Overall Study|Physician Decision|4|||
33440595|NCT00124462|62816611|FG000|Overall Study|Withdrawal by Subject|4|||
33440596|NCT00124462|62816612|FG001|Overall Study|Withdrawal by Subject|5|||
33440597|NCT00124462|62816611|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
33440598|NCT00124462|62816612|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
33440599|NCT00124072|62816622|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
33440600|NCT00124072|62816623|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
33494209|NCT03438006|62872984|FG000|Overall Study|Lost to Follow-up|67|||
33440601|NCT00124072|62816624|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
33440602|NCT00124072|62816625|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
33440603|NCT00124072|62816622|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
33440604|NCT00124072|62816623|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
33606119|NCT02352779|63005937|FG001|Overall Study|Personal Issues|1|||
33323231|NCT00973479|62699481|FG000|Overall Study|Protocol Violation|2|||
33440605|NCT00124072|62816624|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
33440606|NCT00124072|62816625|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
33440607|NCT00124072|62816622|FG000|Overall Study|Death|499|||
33440608|NCT00124072|62816623|FG001|Overall Study|Death|484|||
33440609|NCT00124072|62816624|FG002|Overall Study|Death|471|||
33440610|NCT00124072|62816625|FG003|Overall Study|Death|480|||
33440611|NCT00362648|62816639|FG000|Overall Study|Adverse Event|12|||
33440612|NCT00362648|62816640|FG001|Overall Study|Adverse Event|21|||
33440613|NCT00362648|62816641|FG002|Overall Study|Adverse Event|1|||
33440614|NCT00362648|62816642|FG003|Overall Study|Adverse Event|0|||
33440615|NCT00362648|62816639|FG000|Overall Study|Lost to Follow-up|62|||
33440616|NCT00362648|62816640|FG001|Overall Study|Lost to Follow-up|69|||
33440617|NCT00362648|62816641|FG002|Overall Study|Lost to Follow-up|4|||
33440618|NCT00362648|62816642|FG003|Overall Study|Lost to Follow-up|3|||
33440619|NCT00362648|62816639|FG000|Overall Study|Protocol Violation|4|||
33440620|NCT00362648|62816640|FG001|Overall Study|Protocol Violation|2|||
33440621|NCT00362648|62816641|FG002|Overall Study|Protocol Violation|2|||
33440622|NCT00362648|62816642|FG003|Overall Study|Protocol Violation|2|||
33440623|NCT00362648|62816639|FG000|Overall Study|Withdrawal by Subject|48|||
33440624|NCT00362648|62816640|FG001|Overall Study|Withdrawal by Subject|42|||
33440625|NCT00362648|62816641|FG002|Overall Study|Withdrawal by Subject|2|||
33440626|NCT00362648|62816642|FG003|Overall Study|Withdrawal by Subject|6|||
33440627|NCT00524303|62816659|FG000|Overall Study|Lost to Follow-up|6|||
33440628|NCT00524303|62816660|FG001|Overall Study|Lost to Follow-up|0|||
33440629|NCT00524303|62816661|FG002|Overall Study|Lost to Follow-up|3|||
33440630|NCT00524303|62816659|FG000|Overall Study|Protocol Violation|0|||
33440631|NCT00524303|62816660|FG001|Overall Study|Protocol Violation|1|||
33440632|NCT00524303|62816661|FG002|Overall Study|Protocol Violation|1|||
33440633|NCT00524303|62816659|FG000|Overall Study|Withdrawal by Subject|3|||
33440634|NCT00524303|62816660|FG001|Overall Study|Withdrawal by Subject|0|||
33440635|NCT00524303|62816661|FG002|Overall Study|Withdrawal by Subject|4|||
33440636|NCT00524303|62816659|FG000|Overall Study|Death|0|||
33440637|NCT00524303|62816660|FG001|Overall Study|Death|2|||
33440638|NCT00524303|62816661|FG002|Overall Study|Death|3|||
33440639|NCT00524303|62816659|FG000|Overall Study|Adverse Event|1|||
33440640|NCT00524303|62816660|FG001|Overall Study|Adverse Event|2|||
33440641|NCT00524303|62816661|FG002|Overall Study|Adverse Event|3|||
33440642|NCT00524303|62816659|FG000|Overall Study|Did not Complete Study Dosing|1|||
33440643|NCT00524303|62816660|FG001|Overall Study|Did not Complete Study Dosing|0|||
33440644|NCT00524303|62816661|FG002|Overall Study|Did not Complete Study Dosing|0|||
33440645|NCT00524303|62816659|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
33440646|NCT00524303|62816660|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
33440647|NCT00524303|62816661|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
33440648|NCT00524303|62816659|FG000|Overall Study|Disease Progression|0|||
33440649|NCT00524303|62816660|FG001|Overall Study|Disease Progression|4|||
33440650|NCT00524303|62816661|FG002|Overall Study|Disease Progression|1|||
33440651|NCT00524303|62816659|FG000|Overall Study|Disease Recurrence|0|||
33440652|NCT00524303|62816660|FG001|Overall Study|Disease Recurrence|1|||
33440653|NCT00524303|62816661|FG002|Overall Study|Disease Recurrence|0|||
33440654|NCT00524303|62816659|FG000|Overall Study|Sponsor Request|0|||
33440655|NCT00524303|62816660|FG001|Overall Study|Sponsor Request|0|||
33440656|NCT00524303|62816661|FG002|Overall Study|Sponsor Request|1|||
33440657|NCT00524303|62816659|FG000|Overall Study|Physician Decision|0|||
33440658|NCT00524303|62816660|FG001|Overall Study|Physician Decision|0|||
33440659|NCT00524303|62816661|FG002|Overall Study|Physician Decision|1|||
33440660|NCT00524303|62816659|FG000|Overall Study|Completed 5 years|0|||
33440661|NCT00524303|62816660|FG001|Overall Study|Completed 5 years|0|||
33440662|NCT00524303|62816661|FG002|Overall Study|Completed 5 years|1|||
33440663|NCT00335556|62816678|FG000|Overall Study|Death|0|||
33440664|NCT00335556|62816679|FG001|Overall Study|Death|5|||
33440665|NCT00335556|62816680|FG002|Overall Study|Death|0|||
33440666|NCT00335556|62816681|FG003|Overall Study|Death|0|||
33440667|NCT00335556|62816682|FG004|Overall Study|Death|1|||
33440668|NCT00335556|62816683|FG005|Overall Study|Death|0|||
33440669|NCT00335556|62816678|FG000|Overall Study|Lack of Efficacy|0|||
33440670|NCT00335556|62816679|FG001|Overall Study|Lack of Efficacy|19|||
33440671|NCT00335556|62816680|FG002|Overall Study|Lack of Efficacy|3|||
33440672|NCT00335556|62816681|FG003|Overall Study|Lack of Efficacy|3|||
33323232|NCT00973479|62699482|FG001|Overall Study|Protocol Violation|2|||
33323233|NCT00973479|62699481|FG000|Overall Study|Other|1|||
33323234|NCT00973479|62699482|FG001|Overall Study|Other|7|||
33440673|NCT00335556|62816682|FG004|Overall Study|Lack of Efficacy|0|||
33440674|NCT00335556|62816683|FG005|Overall Study|Lack of Efficacy|1|||
33440675|NCT00335556|62816678|FG000|Overall Study|Physician Decision|0|||
33440676|NCT00335556|62816679|FG001|Overall Study|Physician Decision|6|||
33440677|NCT00335556|62816680|FG002|Overall Study|Physician Decision|2|||
33440678|NCT00335556|62816681|FG003|Overall Study|Physician Decision|1|||
33440679|NCT00335556|62816682|FG004|Overall Study|Physician Decision|0|||
33440680|NCT00335556|62816683|FG005|Overall Study|Physician Decision|0|||
33440681|NCT00335556|62816678|FG000|Overall Study|Ineligible|2|||
33440682|NCT00335556|62816679|FG001|Overall Study|Ineligible|0|||
33440683|NCT00335556|62816680|FG002|Overall Study|Ineligible|0|||
33440684|NCT00335556|62816681|FG003|Overall Study|Ineligible|0|||
33440685|NCT00335556|62816682|FG004|Overall Study|Ineligible|0|||
33440686|NCT00335556|62816683|FG005|Overall Study|Ineligible|0|||
33440687|NCT00335556|62816678|FG000|Overall Study|Refusal of further protocol therapy|0|||
33440688|NCT00335556|62816679|FG001|Overall Study|Refusal of further protocol therapy|4|||
33440689|NCT00335556|62816680|FG002|Overall Study|Refusal of further protocol therapy|0|||
33440690|NCT00335556|62816681|FG003|Overall Study|Refusal of further protocol therapy|1|||
33440691|NCT00335556|62816682|FG004|Overall Study|Refusal of further protocol therapy|0|||
33440692|NCT00335556|62816683|FG005|Overall Study|Refusal of further protocol therapy|0|||
33440693|NCT00518687|62816704|FG000|Overall Study|Adverse Event|201|||
33440694|NCT00518687|62816705|FG001|Overall Study|Adverse Event|177|||
33440695|NCT00518687|62816704|FG000|Overall Study|Lost to Follow-up|144|||
33440696|NCT00518687|62816705|FG001|Overall Study|Lost to Follow-up|155|||
33440697|NCT00518687|62816704|FG000|Overall Study|Physician Decision|42|||
33440698|NCT00518687|62816705|FG001|Overall Study|Physician Decision|48|||
33440699|NCT00518687|62816704|FG000|Overall Study|Progressive disease|2|||
33440700|NCT00518687|62816705|FG001|Overall Study|Progressive disease|2|||
33440701|NCT00518687|62816704|FG000|Overall Study|Protocol Violation|8|||
33440702|NCT00518687|62816705|FG001|Overall Study|Protocol Violation|10|||
33440703|NCT00518687|62816704|FG000|Overall Study|Study terminated by sponsor|930|||
33440704|NCT00518687|62816705|FG001|Overall Study|Study terminated by sponsor|918|||
33440705|NCT00518687|62816704|FG000|Overall Study|Withdrawal by Subject|110|||
33440706|NCT00518687|62816705|FG001|Overall Study|Withdrawal by Subject|110|||
33440707|NCT00134056|62816713|FG000|Randomization|Not eligible for assigned treatment|22|||
33440708|NCT00134056|62816714|FG001|Randomization|Not eligible for assigned treatment|20|||
33440709|NCT00134056|62816713|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
33440710|NCT00134056|62816714|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
33440711|NCT00134056|62816713|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
33440712|NCT00134056|62816714|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
33440713|NCT00134056|62816713|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
33440714|NCT00134056|62816714|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
33440715|NCT00134056|62816713|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
33440716|NCT00134056|62816714|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
33440717|NCT00518531|62816725|FG000|Treatment Period 1|Adverse Event|5|||
33440718|NCT00518531|62816726|FG001|Treatment Period 1|Adverse Event|0|||
33440719|NCT00518531|62816725|FG000|Treatment Period 1|Lost to Follow-up|5|||
33440720|NCT00518531|62816726|FG001|Treatment Period 1|Lost to Follow-up|3|||
33440721|NCT00518531|62816725|FG000|Treatment Period 1|Physician Decision|1|||
33440722|NCT00518531|62816726|FG001|Treatment Period 1|Physician Decision|0|||
33440723|NCT00518531|62816725|FG000|Treatment Period 1|Protocol Violation|2|||
33440724|NCT00518531|62816726|FG001|Treatment Period 1|Protocol Violation|0|||
33440725|NCT00518531|62816725|FG000|Treatment Period 1|Withdrawal by Subject|4|||
33440726|NCT00518531|62816726|FG001|Treatment Period 1|Withdrawal by Subject|6|||
33440727|NCT00518531|62816725|FG000|Treatment Period 1|Early crossover|1|||
33440728|NCT00518531|62816726|FG001|Treatment Period 1|Early crossover|3|||
33440729|NCT00518531|62816725|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33440730|NCT00518531|62816726|FG001|Treatment Period 2|Withdrawal by Subject|8|||
33440731|NCT00518531|62816725|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
33440732|NCT00518531|62816726|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
33440733|NCT00518531|62816725|FG000|Treatment Period 2|Adverse Event|1|||
33440734|NCT00518531|62816726|FG001|Treatment Period 2|Adverse Event|7|||
33440735|NCT00518531|62816725|FG000|Treatment Period 2|Protocol-specified criteria|0|||
33440736|NCT00518531|62816726|FG001|Treatment Period 2|Protocol-specified criteria|1|||
33323235|NCT01174043|62699490|FG000|Overall Study|Disease progression|5|||
33323236|NCT01174043|62699490|FG000|Overall Study|Adverse Event|3|||
33323237|NCT01174043|62699490|FG000|Overall Study|Death|1|||
33323238|NCT01174043|62699490|FG000|Overall Study|Withdrawal by Subject|2|||
33323239|NCT01173653|62699496|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
33323240|NCT01173653|62699497|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
33323241|NCT01172873|62699505|FG000|Overall Study|Withdrawal by Subject|3|||
33323242|NCT01172873|62699506|FG001|Overall Study|Withdrawal by Subject|2|||
33323243|NCT00925600|62699518|FG000|Overall Study|Withdrawal by Subject|16|||
33323244|NCT00925600|62699519|FG001|Overall Study|Withdrawal by Subject|14|||
33323245|NCT00925600|62699518|FG000|Overall Study|Death|4|||
33323246|NCT00925600|62699519|FG001|Overall Study|Death|3|||
33323247|NCT00925600|62699518|FG000|Overall Study|Lost to Follow-up|2|||
33323248|NCT00925600|62699519|FG001|Overall Study|Lost to Follow-up|2|||
33323249|NCT00925600|62699518|FG000|Overall Study|Disease Progression|1|||
33440737|NCT00518531|62816725|FG000|Treatment Period 2|Non-compliance|1|||
33440738|NCT00518531|62816726|FG001|Treatment Period 2|Non-compliance|2|||
33323250|NCT00925600|62699519|FG001|Overall Study|Disease Progression|3|||
33323251|NCT00925600|62699518|FG000|Overall Study|Administrative Decision|1|||
33323252|NCT00925600|62699519|FG001|Overall Study|Administrative Decision|1|||
33323253|NCT00925600|62699518|FG000|Overall Study|Noncompliance|2|||
33323254|NCT00925600|62699519|FG001|Overall Study|Noncompliance|0|||
33323255|NCT00925600|62699518|FG000|Overall Study|Ineligibility Determined|2|||
33440739|NCT00351468|62816734|FG000|Overall Study|Adverse Event|42|||
33440740|NCT00351468|62816734|FG000|Overall Study|Withdrawal by Subject|39|||
33440741|NCT00351468|62816734|FG000|Overall Study|Various -follow up w clinical team|39|||
33323256|NCT00925600|62699519|FG001|Overall Study|Ineligibility Determined|0|||
33323257|NCT00925600|62699518|FG000|Overall Study|Protocol Deviation|0|||
33323258|NCT00925600|62699519|FG001|Overall Study|Protocol Deviation|1|||
33323259|NCT00925600|62699518|FG000|Overall Study|Requirement for Alternative Therapy|0|||
33323260|NCT00925600|62699519|FG001|Overall Study|Requirement for Alternative Therapy|1|||
33323261|NCT00925600|62699518|FG000|Overall Study|Other|3|||
33323262|NCT00925600|62699519|FG001|Overall Study|Other|1|||
33440742|NCT00351468|62816734|FG000|Overall Study|Lack of Efficacy|32|||
33440743|NCT00351468|62816734|FG000|Overall Study|Non-compliance|8|||
33440744|NCT00351468|62816734|FG000|Overall Study|Lost to Follow-up|4|||
33440745|NCT00351468|62816734|FG000|Overall Study|Protocol Violation|3|||
33440746|NCT00523991|62816741|FG000|Overall Study|Adverse Event|6|||
33323263|NCT00925600|62699518|FG000|Overall Study|Adverse Event|1|||
33323264|NCT00925600|62699519|FG001|Overall Study|Adverse Event|2|||
33323265|NCT00968253|62699532|FG000|Overall Study|Death|0|||
33440747|NCT00523991|62816742|FG001|Overall Study|Adverse Event|5|||
33440748|NCT00523991|62816741|FG000|Overall Study|Protocol Violation|1|||
33440749|NCT00523991|62816742|FG001|Overall Study|Protocol Violation|4|||
33440750|NCT00523991|62816741|FG000|Overall Study|Lost to Follow-up|4|||
33440751|NCT00523991|62816742|FG001|Overall Study|Lost to Follow-up|1|||
33440752|NCT00523991|62816741|FG000|Overall Study|Withdrawal by Subject|7|||
33440753|NCT00523991|62816742|FG001|Overall Study|Withdrawal by Subject|17|||
33440754|NCT00523991|62816741|FG000|Overall Study|Other reason (not specified)|3|||
33440755|NCT00523991|62816742|FG001|Overall Study|Other reason (not specified)|0|||
33323266|NCT00968253|62699533|FG001|Overall Study|Death|0|||
33323267|NCT00968253|62699534|FG002|Overall Study|Death|2|||
33323268|NCT00968253|62699532|FG000|Overall Study|Withdrawal by Subject|0|||
33323269|NCT00968253|62699533|FG001|Overall Study|Withdrawal by Subject|0|||
33323270|NCT00968253|62699534|FG002|Overall Study|Withdrawal by Subject|1|||
33323271|NCT00968253|62699532|FG000|Overall Study|Disease Progression|0|||
33323272|NCT00968253|62699533|FG001|Overall Study|Disease Progression|3|||
33323273|NCT00968253|62699534|FG002|Overall Study|Disease Progression|3|||
33323274|NCT00968253|62699532|FG000|Overall Study|Adverse Event|0|||
33323275|NCT00968253|62699533|FG001|Overall Study|Adverse Event|0|||
33323276|NCT00968253|62699534|FG002|Overall Study|Adverse Event|1|||
33323277|NCT00964743|62699543|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
33323278|NCT00925522|62699547|FG000|Overall Study|study closed -- business decision|20|||
33440756|NCT00350844|62816748|FG000|Overall Study|Lost to Follow-up|1|||
33440757|NCT00345540|62816752|FG000|Overall Study|Withdrawal by Subject|1|||
33440758|NCT00335322|62816759|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
33440759|NCT00335322|62816760|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
33440760|NCT00335322|62816761|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
33440761|NCT00523367|62816772|FG000|Overall Study|19 screen failures|19|||
33323279|NCT01130532|62699554|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
33323280|NCT01130532|62699555|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
33323281|NCT01130532|62699556|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
33323282|NCT01130532|62699557|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
33323283|NCT01130532|62699554|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
33323284|NCT01130532|62699555|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
33323285|NCT01130532|62699556|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
33323286|NCT01130532|62699557|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
33323287|NCT01130532|62699554|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
33323288|NCT01130532|62699555|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
33323289|NCT01130532|62699556|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
33606120|NCT02352779|63005938|FG002|Overall Study|Personal Issues|0|||
33606121|NCT02352779|63005936|FG000|Overall Study|Too Many Forms|2|||
33606122|NCT02352779|63005937|FG001|Overall Study|Too Many Forms|0|||
33440762|NCT00523367|62816772|FG000|Overall Study|4 Withdrawn by PI|4|||
33440763|NCT03755765|62816779|FG000|Overall Study|Withdrawal by Subject|2|||
33440764|NCT03755765|62816780|FG001|Overall Study|Withdrawal by Subject|4|||
33440765|NCT03755765|62816781|FG002|Overall Study|Withdrawal by Subject|4|||
33606123|NCT02352779|63005938|FG002|Overall Study|Too Many Forms|0|||
33606124|NCT02352779|63005936|FG000|Overall Study|Feeling Overwhelmed|1|||
33323290|NCT01130532|62699557|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
33606125|NCT02352779|63005937|FG001|Overall Study|Feeling Overwhelmed|0|||
33440766|NCT00344448|62816789|FG000|Screening|Withdrawal by Subject|0|||
33440767|NCT00344448|62816790|FG001|Screening|Withdrawal by Subject|1|||
33323291|NCT01130532|62699554|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
33323292|NCT01130532|62699555|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
33440768|NCT00344448|62816789|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
33440769|NCT00344448|62816790|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
33323293|NCT01130532|62699556|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
33464871|NCT00040664|62838371|FG003|Overall Study|Lost to Follow-up|2|||
33606126|NCT02352779|63005938|FG002|Overall Study|Feeling Overwhelmed|0|||
33440770|NCT00344448|62816789|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
33440771|NCT00344448|62816790|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
33440772|NCT00344448|62816789|FG000|Open Label|Withdrawal by Subject|1|||
33440773|NCT00344448|62816790|FG001|Open Label|Withdrawal by Subject|1|||
33440774|NCT00344448|62816789|FG000|Open Label|Study terminated|1|||
33440775|NCT00344448|62816790|FG001|Open Label|Study terminated|0|||
33440776|NCT00324168|62816798|FG000|Overall Study|Lost to Follow-up|19|||
33606127|NCT02352779|63005936|FG000|Overall Study|Disliked Intervention|1|||
33606128|NCT02352779|63005937|FG001|Overall Study|Disliked Intervention|0|||
33606129|NCT02352779|63005938|FG002|Overall Study|Disliked Intervention|0|||
33606130|NCT02352779|63005936|FG000|Overall Study|Changed Mind|1|||
33606131|NCT02352779|63005937|FG001|Overall Study|Changed Mind|0|||
33606132|NCT02352779|63005938|FG002|Overall Study|Changed Mind|0|||
33606133|NCT02352779|63005936|FG000|Overall Study|Study Related Symptoms|1|||
33606134|NCT02352779|63005937|FG001|Overall Study|Study Related Symptoms|0|||
33606135|NCT02352779|63005938|FG002|Overall Study|Study Related Symptoms|0|||
33606136|NCT02352779|63005936|FG000|Overall Study|Absence of Symptoms|1|||
33440777|NCT00324168|62816799|FG001|Overall Study|Lost to Follow-up|18|||
33440778|NCT00324168|62816798|FG000|Overall Study|Death|3|||
33440779|NCT00324168|62816799|FG001|Overall Study|Death|3|||
33440780|NCT00324168|62816798|FG000|Overall Study|Patient did not visit in f/u window|6|||
33440781|NCT00324168|62816799|FG001|Overall Study|Patient did not visit in f/u window|9|||
33440782|NCT00517829|62816807|FG000|Overall Study|Adverse Event|22|||
33440783|NCT00517829|62816808|FG001|Overall Study|Adverse Event|34|||
33440784|NCT00517829|62816807|FG000|Overall Study|Disease Progression|39|||
33440785|NCT00517829|62816808|FG001|Overall Study|Disease Progression|32|||
33440786|NCT00517829|62816807|FG000|Overall Study|Patient Request|6|||
33440787|NCT00517829|62816808|FG001|Overall Study|Patient Request|5|||
33440788|NCT00517829|62816807|FG000|Overall Study|Investigator Request|5|||
33440789|NCT00517829|62816808|FG001|Overall Study|Investigator Request|3|||
33440790|NCT00517829|62816807|FG000|Overall Study|Other|3|||
33440791|NCT00517829|62816808|FG001|Overall Study|Other|1|||
33440792|NCT00343512|62816814|FG000|Overall Study|Withdrawal by Subject|2|||
33440793|NCT00334542|62816819|FG000|Overall Study|Adverse Event|3|||
33440794|NCT00334542|62816819|FG000|Overall Study|Withdrawal by Subject|1|||
33440795|NCT00334542|62816819|FG000|Overall Study|New cancer diagnosis|1|||
33440796|NCT00112294|62816826|FG000|Overall Study|Still on study|5|||
33440797|NCT00112294|62816827|FG001|Overall Study|Still on study|0|||
33440798|NCT00235443|62816839|FG000|Overall Study|Adverse Event|4|||
33440799|NCT00235443|62816840|FG001|Overall Study|Adverse Event|12|||
33440800|NCT00235443|62816841|FG002|Overall Study|Adverse Event|17|||
33440801|NCT00235443|62816842|FG003|Overall Study|Adverse Event|44|||
33440802|NCT00235443|62816843|FG004|Overall Study|Adverse Event|10|||
33440803|NCT00235443|62816844|FG005|Overall Study|Adverse Event|15|||
33440804|NCT00235443|62816839|FG000|Overall Study|Lack of Efficacy|0|||
33440805|NCT00235443|62816840|FG001|Overall Study|Lack of Efficacy|1|||
33440806|NCT00235443|62816841|FG002|Overall Study|Lack of Efficacy|5|||
33440807|NCT00235443|62816842|FG003|Overall Study|Lack of Efficacy|12|||
33440808|NCT00235443|62816843|FG004|Overall Study|Lack of Efficacy|2|||
33440809|NCT00235443|62816844|FG005|Overall Study|Lack of Efficacy|9|||
33440810|NCT00235443|62816839|FG000|Overall Study|Withdrawal by Subject|3|||
33440811|NCT00235443|62816840|FG001|Overall Study|Withdrawal by Subject|9|||
33440812|NCT00235443|62816841|FG002|Overall Study|Withdrawal by Subject|25|||
33440813|NCT00235443|62816842|FG003|Overall Study|Withdrawal by Subject|24|||
33440814|NCT00235443|62816843|FG004|Overall Study|Withdrawal by Subject|10|||
33440815|NCT00235443|62816844|FG005|Overall Study|Withdrawal by Subject|12|||
33440816|NCT00235443|62816839|FG000|Overall Study|Lost to Follow-up|0|||
33440817|NCT00235443|62816840|FG001|Overall Study|Lost to Follow-up|8|||
33440818|NCT00235443|62816841|FG002|Overall Study|Lost to Follow-up|6|||
33440819|NCT00235443|62816842|FG003|Overall Study|Lost to Follow-up|6|||
33440820|NCT00235443|62816843|FG004|Overall Study|Lost to Follow-up|4|||
33440821|NCT00235443|62816844|FG005|Overall Study|Lost to Follow-up|3|||
33440822|NCT00235443|62816839|FG000|Overall Study|Unsatisfactory compliance|0|||
33440823|NCT00235443|62816840|FG001|Overall Study|Unsatisfactory compliance|2|||
33440824|NCT00235443|62816841|FG002|Overall Study|Unsatisfactory compliance|3|||
33440825|NCT00235443|62816842|FG003|Overall Study|Unsatisfactory compliance|4|||
33440826|NCT00235443|62816843|FG004|Overall Study|Unsatisfactory compliance|1|||
33440827|NCT00235443|62816844|FG005|Overall Study|Unsatisfactory compliance|0|||
33440828|NCT00235443|62816839|FG000|Overall Study|Other reasons for premature termination|1|||
33440829|NCT00235443|62816840|FG001|Overall Study|Other reasons for premature termination|6|||
33440830|NCT00235443|62816841|FG002|Overall Study|Other reasons for premature termination|6|||
33440831|NCT00235443|62816842|FG003|Overall Study|Other reasons for premature termination|7|||
33440832|NCT00235443|62816843|FG004|Overall Study|Other reasons for premature termination|3|||
33440833|NCT00235443|62816844|FG005|Overall Study|Other reasons for premature termination|6|||
33440834|NCT00234039|62816860|FG000|Overall Study|Adverse Event|2|||
33440835|NCT00234039|62816860|FG000|Overall Study|Progression/relapse|34|||
33606137|NCT02352779|63005937|FG001|Overall Study|Absence of Symptoms|0|||
33606138|NCT02352779|63005938|FG002|Overall Study|Absence of Symptoms|0|||
33440836|NCT00234039|62816860|FG000|Overall Study|Other - Not Protocol Specified|3|||
33440837|NCT00234039|62816860|FG000|Overall Study|Ineligible|9|||
33606139|NCT02352779|63005936|FG000|Overall Study|Other Medical Reason|0|||
33606140|NCT02352779|63005937|FG001|Overall Study|Other Medical Reason|0|||
33606141|NCT02352779|63005938|FG002|Overall Study|Other Medical Reason|1|||
33606142|NCT02352779|63005936|FG000|Overall Study|No Reason|0|||
33606143|NCT02352779|63005937|FG001|Overall Study|No Reason|0|||
33606144|NCT02352779|63005938|FG002|Overall Study|No Reason|1|||
33606145|NCT02257489|63005955|FG000|Overall Study|Withdrawal by Subject|0|||
33606146|NCT02257489|63005956|FG001|Overall Study|Withdrawal by Subject|0|||
33606147|NCT02257489|63005957|FG002|Overall Study|Withdrawal by Subject|0|||
33606148|NCT02257489|63005958|FG003|Overall Study|Withdrawal by Subject|1|||
33606149|NCT02257489|63005959|FG004|Overall Study|Withdrawal by Subject|0|||
33606150|NCT02257489|63005960|FG005|Overall Study|Withdrawal by Subject|0|||
33606151|NCT02257489|63005961|FG006|Overall Study|Withdrawal by Subject|0|||
33606152|NCT02257489|63005962|FG007|Overall Study|Withdrawal by Subject|0|||
33606153|NCT02257489|63005963|FG008|Overall Study|Withdrawal by Subject|0|||
33606154|NCT02329223|63005986|FG000|Overall Study|Withdrawal by Subject|1|||
33606155|NCT02329223|63005987|FG001|Overall Study|Withdrawal by Subject|2|||
33606156|NCT02329223|63005988|FG002|Overall Study|Withdrawal by Subject|5|||
33606157|NCT02329223|63005986|FG000|Overall Study|Physician Decision|0|||
33606158|NCT02329223|63005987|FG001|Overall Study|Physician Decision|0|||
33606159|NCT02329223|63005988|FG002|Overall Study|Physician Decision|1|||
33606160|NCT02329223|63005986|FG000|Overall Study|Adverse Event|0|||
33606161|NCT02329223|63005987|FG001|Overall Study|Adverse Event|1|||
33606162|NCT02329223|63005988|FG002|Overall Study|Adverse Event|0|||
33606163|NCT01641601|63005998|FG000|Overall Study|Study discontinued.|3|||
33606164|NCT01641601|63005999|FG001|Overall Study|Study discontinued.|5|||
33606165|NCT02350127|63006007|FG000|4-Month Assessment|Withdrawal by Subject|10|||
33606166|NCT02350127|63006008|FG001|4-Month Assessment|Withdrawal by Subject|9|||
33606167|NCT02350127|63006007|FG000|4-Month Assessment|Death|1|||
33606168|NCT02350127|63006008|FG001|4-Month Assessment|Death|0|||
33606169|NCT02350127|63006007|FG000|8-Month Assessment|Death|1|||
33606170|NCT02350127|63006008|FG001|8-Month Assessment|Death|1|||
33606171|NCT02350127|63006007|FG000|8-Month Assessment|Withdrawal by Subject|5|||
33606172|NCT02350127|63006008|FG001|8-Month Assessment|Withdrawal by Subject|8|||
33606173|NCT02256553|63006015|FG000|Period I|Adverse Event|5|||
33606174|NCT02256553|63006015|FG000|Period I|Protocol Violation|1|||
33606175|NCT02256553|63006015|FG000|Period II|Adverse Event|1|||
33606176|NCT02256553|63006015|FG000|Period II|Subject Moved|1|||
33440838|NCT00234039|62816860|FG000|Overall Study|No Protocol Treatment Received|2|||
33440839|NCT00323622|62816872|FG000|Overall Study|Other|30|||
33440840|NCT00323622|62816873|FG001|Overall Study|Other|91|||
33440841|NCT00323622|62816874|FG002|Overall Study|Other|4|||
33440842|NCT00323622|62816875|FG003|Overall Study|Other|12|||
33440843|NCT00323622|62816876|FG004|Overall Study|Other|32|||
33440844|NCT00323622|62816877|FG005|Overall Study|Other|74|||
33440845|NCT00323622|62816878|FG006|Overall Study|Other|5|||
33440846|NCT00323622|62816879|FG007|Overall Study|Other|13|||
33440847|NCT00323622|62816872|FG000|Overall Study|Death|1|||
33440848|NCT00323622|62816873|FG001|Overall Study|Death|1|||
33440849|NCT00323622|62816874|FG002|Overall Study|Death|0|||
33440850|NCT00323622|62816875|FG003|Overall Study|Death|0|||
33440851|NCT00323622|62816876|FG004|Overall Study|Death|7|||
33440852|NCT00323622|62816877|FG005|Overall Study|Death|0|||
33440853|NCT00323622|62816878|FG006|Overall Study|Death|0|||
33440854|NCT00323622|62816879|FG007|Overall Study|Death|2|||
33440855|NCT00189423|62816907|FG000|Overall Study|Death|746|||
33440856|NCT00189423|62816908|FG001|Overall Study|Death|747|||
33606177|NCT02256553|63006015|FG000|Period III|Adverse Event|3|||
33606178|NCT02349425|63006025|FG000|Period 1|Adverse Event|1|||
33606179|NCT02349425|63006026|FG001|Period 1|Adverse Event|1|||
33606180|NCT02349425|63006027|FG002|Period 1|Adverse Event|0|||
33606181|NCT02349425|63006028|FG003|Period 1|Adverse Event|0|||
33606182|NCT02349425|63006025|FG000|Period 2|Adverse Event|0|||
33440857|NCT00189423|62816907|FG000|Overall Study|Withdrawal by Subject|9|||
33440858|NCT00189423|62816908|FG001|Overall Study|Withdrawal by Subject|9|||
33440859|NCT00189423|62816907|FG000|Overall Study|Lost to Follow-up|10|||
33440860|NCT00189423|62816908|FG001|Overall Study|Lost to Follow-up|10|||
33440861|NCT00323310|62816914|FG000|Overall Study|Withdrawal by Subject|1|||
33440862|NCT00323310|62816914|FG000|Overall Study|a parent refused blood draw|1|||
33606183|NCT02349425|63006026|FG001|Period 2|Adverse Event|1|||
33606184|NCT02349425|63006027|FG002|Period 2|Adverse Event|1|||
33606185|NCT02349425|63006028|FG003|Period 2|Adverse Event|0|||
33606186|NCT02310581|63006070|FG000|Overall Study|Adverse Event|1|||
33606187|NCT02310581|63006071|FG001|Overall Study|Adverse Event|1|||
33606188|NCT02310581|63006072|FG002|Overall Study|Adverse Event|1|||
33606189|NCT02310581|63006073|FG003|Overall Study|Adverse Event|0|||
33606190|NCT02310581|63006070|FG000|Overall Study|Withdrawal by Subject|2|||
33606191|NCT02310581|63006071|FG001|Overall Study|Withdrawal by Subject|1|||
33606192|NCT02310581|63006072|FG002|Overall Study|Withdrawal by Subject|0|||
33440863|NCT00323310|62816914|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
33440864|NCT00186537|62816921|FG000|Overall Study|Withdrawal by Subject|4|||
33440865|NCT00186537|62816922|FG001|Overall Study|Withdrawal by Subject|0|||
33440866|NCT00186537|62816923|FG002|Overall Study|Withdrawal by Subject|3|||
33440867|NCT00186537|62816921|FG000|Overall Study|ALT > 1.5 x ULN|3|||
33440868|NCT00186537|62816922|FG001|Overall Study|ALT > 1.5 x ULN|0|||
33440869|NCT00186537|62816923|FG002|Overall Study|ALT > 1.5 x ULN|0|||
33440870|NCT00517751|62816931|FG000|Overall Study|Death|3|||
33440871|NCT00517751|62816931|FG000|Overall Study|Withdrawal by Subject|37|||
33440872|NCT00517751|62816931|FG000|Overall Study|Lost to Follow-up|4|||
33440873|NCT00517751|62816931|FG000|Overall Study|patient not over due|6|||
33440874|NCT00517751|62816931|FG000|Overall Study|Patient not due for visit|76|||
33440875|NCT00517751|62816931|FG000|Overall Study|Missing|3|||
33440876|NCT00322842|62816937|FG000|Overall Study|Withdrawal by Subject|0|||
33440877|NCT00322842|62816938|FG001|Overall Study|Withdrawal by Subject|1|||
33440878|NCT00322842|62816937|FG000|Overall Study|Lost to Follow-up|0|||
33440879|NCT00322842|62816938|FG001|Overall Study|Lost to Follow-up|1|||
33440880|NCT00322842|62816937|FG000|Overall Study|Refused transplant|1|||
33440881|NCT00322842|62816938|FG001|Overall Study|Refused transplant|0|||
33440882|NCT00322842|62816937|FG000|Overall Study|Death|1|||
33440883|NCT00322842|62816938|FG001|Overall Study|Death|0|||
33606193|NCT02310581|63006073|FG003|Overall Study|Withdrawal by Subject|1|||
33606194|NCT02309723|63006086|FG000|Overall Study|Withdrawal by Subject|24|||
33606195|NCT02309723|63006087|FG001|Overall Study|Withdrawal by Subject|23|||
33606196|NCT02309723|63006088|FG002|Overall Study|Withdrawal by Subject|24|||
33440884|NCT00255723|62816947|FG000|Overall Study|Adverse Event|1|||
33440885|NCT00255723|62816948|FG001|Overall Study|Adverse Event|1|||
33606197|NCT02309411|63006099|FG000|Overall Study|Physician Decision|1|||
33606198|NCT02309411|63006100|FG001|Overall Study|Physician Decision|0|||
33606199|NCT02309411|63006101|FG002|Overall Study|Physician Decision|0|||
33606200|NCT02309411|63006099|FG000|Overall Study|Withdrawal by Subject|1|||
33606201|NCT02309411|63006100|FG001|Overall Study|Withdrawal by Subject|1|||
33606202|NCT02309411|63006101|FG002|Overall Study|Withdrawal by Subject|0|||
33606203|NCT02008227|63006110|FG000|Overall Study|Lost to Follow-up|7|||
33606204|NCT02008227|63006111|FG001|Overall Study|Lost to Follow-up|9|||
33606205|NCT02008227|63006110|FG000|Overall Study|Death|494|||
33606206|NCT02008227|63006111|FG001|Overall Study|Death|485|||
33606207|NCT02008227|63006110|FG000|Overall Study|Withdrawal by Subject|67|||
33606208|NCT02008227|63006111|FG001|Overall Study|Withdrawal by Subject|36|||
33606209|NCT02008227|63006110|FG000|Overall Study|Study Terminated By Sponsor|44|||
33606210|NCT02008227|63006111|FG001|Overall Study|Study Terminated By Sponsor|83|||
33606211|NCT02006979|63006120|FG000|Overall Study|Withdrawal by Subject|1|||
33606212|NCT02006979|63006121|FG001|Overall Study|Withdrawal by Subject|1|||
33606213|NCT02006979|63006120|FG000|Overall Study|Protocol Violation|0|||
33606214|NCT02006979|63006121|FG001|Overall Study|Protocol Violation|1|||
33606215|NCT02348723|63006129|FG000|Overall Study|No ablation|21|||
33606216|NCT02348723|63006130|FG001|Overall Study|No ablation|20|||
33606217|NCT02348723|63006129|FG000|Overall Study|Non-compliant with Protocol|1|||
33606218|NCT02348723|63006130|FG001|Overall Study|Non-compliant with Protocol|0|||
33606219|NCT02348723|63006129|FG000|Overall Study|Lost to Follow-up|1|||
33606220|NCT02348723|63006130|FG001|Overall Study|Lost to Follow-up|1|||
33440886|NCT00255723|62816947|FG000|Overall Study|Death|0|||
33440887|NCT00255723|62816948|FG001|Overall Study|Death|1|||
33440888|NCT00255723|62816947|FG000|Overall Study|Response Data Not Available|1|||
33440889|NCT00255723|62816948|FG001|Overall Study|Response Data Not Available|0|||
33606221|NCT02348723|63006129|FG000|Overall Study|Consent withdrawn|1|||
33606222|NCT02348723|63006130|FG001|Overall Study|Consent withdrawn|3|||
33606223|NCT02348723|63006129|FG000|Overall Study|Reason other than specified|1|||
33606224|NCT02348723|63006130|FG001|Overall Study|Reason other than specified|1|||
33606225|NCT02348723|63006129|FG000|Overall Study|Adverse Event|3|||
33606226|NCT02348723|63006130|FG001|Overall Study|Adverse Event|1|||
33606227|NCT01967277|63006138|FG000|Overall Study|Lost to Follow-up|1|||
33606228|NCT01967277|63006139|FG001|Overall Study|Lost to Follow-up|2|||
33440890|NCT00132808|62816957|FG000|Stratum I|Adverse Event|2|||
33440891|NCT00132808|62816958|FG001|Stratum I|Adverse Event|1|||
33606229|NCT01967277|63006138|FG000|Overall Study|Unrelated illness|0|||
33606230|NCT01967277|63006139|FG001|Overall Study|Unrelated illness|1|||
33606231|NCT02326883|63006148|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
33606232|NCT02326883|63006149|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
33440892|NCT00132808|62816959|FG002|Stratum I|Adverse Event|0|||
33440893|NCT00132808|62816957|FG000|Stratum I|Lost to Follow-up|3|||
33440894|NCT00132808|62816958|FG001|Stratum I|Lost to Follow-up|4|||
33440895|NCT00132808|62816959|FG002|Stratum I|Lost to Follow-up|1|||
33440896|NCT00132808|62816957|FG000|Stratum I|Withdrawal by Subject|4|||
33440897|NCT00132808|62816958|FG001|Stratum I|Withdrawal by Subject|7|||
33440898|NCT00132808|62816959|FG002|Stratum I|Withdrawal by Subject|3|||
33440899|NCT00132808|62816957|FG000|Stratum I|Abnormal test procedure result (s)|0|||
33440900|NCT00132808|62816958|FG001|Stratum I|Abnormal test procedure result (s)|0|||
33440901|NCT00132808|62816959|FG002|Stratum I|Abnormal test procedure result (s)|1|||
33440902|NCT00132808|62816957|FG000|Stratum II|Adverse Event|1|||
33440903|NCT00132808|62816958|FG001|Stratum II|Adverse Event|2|||
33440904|NCT00132808|62816959|FG002|Stratum II|Adverse Event|1|||
33606233|NCT02326883|63006150|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
33606234|NCT02006667|63006158|FG000|Overall Study|Adverse Event|3|||
33606235|NCT02006667|63006158|FG000|Overall Study|Death|2|||
33606236|NCT02006667|63006158|FG000|Overall Study|Withdrawal by Subject|1|||
33606237|NCT01983111|63006164|FG000|Overall Study|Withdrawal by Subject|8|||
33606238|NCT01983111|63006165|FG001|Overall Study|Withdrawal by Subject|6|||
33606239|NCT01983111|63006164|FG000|Overall Study|Adverse Event|4|||
33606240|NCT01983111|63006165|FG001|Overall Study|Adverse Event|0|||
33606241|NCT01983111|63006164|FG000|Overall Study|Protocol Violation|0|||
33606242|NCT01983111|63006165|FG001|Overall Study|Protocol Violation|1|||
33606243|NCT02348489|63006173|FG000|Overall Study|Death|336|||
33606244|NCT02348489|63006174|FG001|Overall Study|Death|335|||
33606245|NCT02348489|63006173|FG000|Overall Study|Withdrawal by Subject|14|||
33606246|NCT02348489|63006174|FG001|Overall Study|Withdrawal by Subject|27|||
33606247|NCT02348489|63006173|FG000|Overall Study|Lost to Follow-up|3|||
33606248|NCT02348489|63006174|FG001|Overall Study|Lost to Follow-up|5|||
33606249|NCT02309099|63006184|FG000|Overall Study|Adverse Event|2|||
33606250|NCT02309099|63006185|FG001|Overall Study|Adverse Event|0|||
33606251|NCT01966107|63006193|FG000|Overall Study|excluded from FAS|21|||
33606252|NCT01966107|63006194|FG001|Overall Study|excluded from FAS|20|||
33606253|NCT01966107|63006193|FG000|Overall Study|discontinued treatment|345|||
33606254|NCT01966107|63006194|FG001|Overall Study|discontinued treatment|372|||
33606255|NCT01966107|63006193|FG000|Overall Study|due to study closure|164|||
33606256|NCT01966107|63006194|FG001|Overall Study|due to study closure|186|||
33606257|NCT01966107|63006193|FG000|Overall Study|withdrew from the study|272|||
33606258|NCT01966107|63006194|FG001|Overall Study|withdrew from the study|303|||
33606259|NCT02347943|63006203|FG000|Overall Study|Study was cancelled|140|||
33606260|NCT02347943|63006204|FG001|Overall Study|Study was cancelled|67|||
33606261|NCT02347943|63006205|FG002|Overall Study|Study was cancelled|45|||
33606262|NCT01982331|63006215|FG000|Received Vaccination 2|Adverse Event|1|||
33606263|NCT01982331|63006216|FG001|Received Vaccination 2|Adverse Event|2|||
33606264|NCT01982331|63006215|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
33606265|NCT01982331|63006216|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
33606266|NCT01982331|63006215|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
33606267|NCT01982331|63006216|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
33606268|NCT02326025|63006224|FG000|Overall Study|Adverse Event|3|||
33606269|NCT02326025|63006225|FG001|Overall Study|Adverse Event|0|||
33606270|NCT02326025|63006224|FG000|Overall Study|Physician Decision|1|||
33606271|NCT02326025|63006225|FG001|Overall Study|Physician Decision|2|||
33606272|NCT02326025|63006224|FG000|Overall Study|Physician and Participant Decision|1|||
33440905|NCT00132808|62816957|FG000|Stratum II|Death|1|||
33440906|NCT00132808|62816958|FG001|Stratum II|Death|0|||
33440907|NCT00132808|62816959|FG002|Stratum II|Death|0|||
33440908|NCT00132808|62816957|FG000|Stratum II|Lost to Follow-up|2|||
33440909|NCT00132808|62816958|FG001|Stratum II|Lost to Follow-up|2|||
33440910|NCT00132808|62816959|FG002|Stratum II|Lost to Follow-up|1|||
33440911|NCT00132808|62816957|FG000|Stratum II|Protocol Violation|0|||
33440912|NCT00132808|62816958|FG001|Stratum II|Protocol Violation|2|||
33440913|NCT00132808|62816959|FG002|Stratum II|Protocol Violation|1|||
33440914|NCT00132808|62816957|FG000|Stratum II|Withdrawal by Subject|4|||
33440915|NCT00132808|62816958|FG001|Stratum II|Withdrawal by Subject|9|||
33440916|NCT00132808|62816959|FG002|Stratum II|Withdrawal by Subject|6|||
33440917|NCT00517361|62816967|FG000|Overall Study|Death|6|||
33440918|NCT00517361|62816967|FG000|Overall Study|The study was terminated|5|||
33606273|NCT02326025|63006225|FG001|Overall Study|Physician and Participant Decision|0|||
33606274|NCT02326025|63006224|FG000|Overall Study|Withdrawal by Subject|0|||
33606275|NCT02326025|63006225|FG001|Overall Study|Withdrawal by Subject|2|||
33606276|NCT02326025|63006224|FG000|Overall Study|Protocol Violation|0|||
33606277|NCT02326025|63006225|FG001|Overall Study|Protocol Violation|1|||
33440919|NCT00516893|62816971|FG000|Overall Study|Lost to Follow-up|4|||
33606278|NCT01619865|63006244|FG000|Overall Study|Adverse Event|1|||
33606279|NCT01619865|63006244|FG000|Overall Study|Death|2|||
33606280|NCT01619865|63006244|FG000|Overall Study|subject not able to comply|1|||
33606281|NCT02006121|63006251|FG000|Double Blind Phase|Adverse Event|6|||
33606282|NCT02006121|63006252|FG001|Double Blind Phase|Adverse Event|0|||
33606283|NCT02006121|63006251|FG000|Double Blind Phase|Lack of Efficacy|1|||
33440920|NCT00516893|62816971|FG000|Overall Study|Adverse Event|3|||
33606284|NCT02006121|63006252|FG001|Double Blind Phase|Lack of Efficacy|16|||
33606285|NCT02006121|63006251|FG000|Double Blind Phase|Withdrawal by Subject|3|||
33440921|NCT00516893|62816971|FG000|Overall Study|Withdrawal by Subject|2|||
33440922|NCT00516893|62816971|FG000|Overall Study|Noncompliance|2|||
33440923|NCT00516893|62816971|FG000|Overall Study|Death|1|||
33440924|NCT00516893|62816971|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
33440925|NCT00516893|62816971|FG000|Overall Study|Relocated|1|||
33440926|NCT00516893|62816971|FG000|Overall Study|Pregnancy|1|||
33440927|NCT00516893|62816971|FG000|Overall Study|Received Medication From Another Study|1|||
33440928|NCT00522431|62816975|FG000|Overall Study|Adverse Event|5|||
33440929|NCT00522431|62816975|FG000|Overall Study|Protocol Violation|2|||
33440930|NCT00522431|62816975|FG000|Overall Study|Withdrawal by Subject|2|||
33440931|NCT00522431|62816975|FG000|Overall Study|Subject non-compliance|1|||
33440932|NCT00522431|62816975|FG000|Overall Study|Other/unknown|1|||
33440933|NCT00185211|62816981|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
33440934|NCT00185211|62816982|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
33440935|NCT00185211|62816981|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
33440936|NCT00185211|62816982|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
33440937|NCT00185211|62816981|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
33440938|NCT00185211|62816982|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
33440939|NCT00185211|62816981|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
33440940|NCT00185211|62816982|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
33440941|NCT00185211|62816981|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
33440942|NCT00185211|62816982|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
33440943|NCT00185211|62816981|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
33440944|NCT00185211|62816982|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
33440945|NCT00185211|62816981|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
33440946|NCT00185211|62816982|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
33440947|NCT00185211|62816981|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
33494210|NCT03438006|62872984|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
33494211|NCT03438006|62872984|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
33606286|NCT02006121|63006252|FG001|Double Blind Phase|Withdrawal by Subject|4|||
33606287|NCT02006121|63006251|FG000|Double Blind Phase|Non-compliance with study drug|1|||
33440948|NCT00185211|62816982|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
33440949|NCT00185211|62816981|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
33440950|NCT00185211|62816982|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
33606288|NCT02006121|63006252|FG001|Double Blind Phase|Non-compliance with study drug|3|||
33606289|NCT02006121|63006251|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
33606290|NCT02006121|63006252|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
33606291|NCT02006121|63006251|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
33606292|NCT02006121|63006252|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
33606293|NCT02006121|63006251|FG000|Open Label Phase|Adverse Event|15|||
33606294|NCT02006121|63006252|FG001|Open Label Phase|Adverse Event|0|||
33606295|NCT02006121|63006251|FG000|Open Label Phase|Lack of Efficacy|2|||
33606296|NCT02006121|63006252|FG001|Open Label Phase|Lack of Efficacy|0|||
33606297|NCT02006121|63006251|FG000|Open Label Phase|Protocol Violation|2|||
33606298|NCT02006121|63006252|FG001|Open Label Phase|Protocol Violation|0|||
33606299|NCT02006121|63006251|FG000|Open Label Phase|Withdrawal by Subject|3|||
33464872|NCT00040664|62838368|FG000|Overall Study|Protocol Violation|2|||
33323294|NCT01130532|62699557|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
33494212|NCT04206020|62872990|FG000|Overall Study|Adverse Event|1|||
33440951|NCT00185211|62816981|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
33440952|NCT00185211|62816982|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
33440953|NCT00185211|62816981|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
33440954|NCT00185211|62816982|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
33464873|NCT00040664|62838369|FG001|Overall Study|Protocol Violation|1|||
33440955|NCT00185211|62816981|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
33440956|NCT00185211|62816982|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
33440957|NCT00516737|62816991|FG000|Overall Study|Lost to Follow-up|2|||
33440958|NCT00516737|62816992|FG001|Overall Study|Lost to Follow-up|0|||
33440959|NCT00516737|62816991|FG000|Overall Study|Physician Decision|0|||
33440960|NCT00516737|62816992|FG001|Overall Study|Physician Decision|1|||
33440961|NCT00516737|62816991|FG000|Overall Study|Withdrawal by Subject|0|||
33440962|NCT00516737|62816992|FG001|Overall Study|Withdrawal by Subject|1|||
33440963|NCT00516737|62816991|FG000|Overall Study|Lack of Qualifying Event|9|||
33440964|NCT00516737|62816992|FG001|Overall Study|Lack of Qualifying Event|6|||
33440965|NCT00132730|62817002|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
33606300|NCT02006121|63006252|FG001|Open Label Phase|Withdrawal by Subject|0|||
33606301|NCT02006121|63006251|FG000|Open Label Phase|Non-compliance with study drug|3|||
33440966|NCT00132730|62817003|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
33440967|NCT00132730|62817004|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
33440968|NCT00132730|62817005|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
33440969|NCT00132730|62817006|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
33440970|NCT00132730|62817007|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
33440971|NCT00132730|62817002|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
33440972|NCT00132730|62817003|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
33440973|NCT00132730|62817004|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
33440974|NCT00132730|62817005|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
33440975|NCT00132730|62817006|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
33440976|NCT00132730|62817007|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
33440977|NCT00132730|62817002|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
33440978|NCT00132730|62817003|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
33440979|NCT00132730|62817004|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
33440980|NCT00132730|62817005|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
33440981|NCT00132730|62817006|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
33440982|NCT00132730|62817007|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
33606302|NCT02006121|63006252|FG001|Open Label Phase|Non-compliance with study drug|0|||
33606303|NCT02005887|63006264|FG000|Overall Study|Protocol Violation|0|||
33606304|NCT02005887|63006265|FG001|Overall Study|Protocol Violation|2|||
33606305|NCT01982253|63006274|FG000|Overall Study|Withdrawal by Subject|1|||
33440983|NCT00132730|62817002|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
33440984|NCT00132730|62817003|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
33440985|NCT00132730|62817004|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
33440986|NCT00132730|62817005|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
33440987|NCT00132730|62817006|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
33440988|NCT00132730|62817007|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
33440989|NCT00132730|62817002|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
33440990|NCT00132730|62817003|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
33494213|NCT04206020|62872991|FG001|Overall Study|Adverse Event|4|||
33606306|NCT01982253|63006275|FG001|Overall Study|Withdrawal by Subject|0|||
33606307|NCT01982253|63006276|FG002|Overall Study|Withdrawal by Subject|0|||
33606308|NCT01982253|63006274|FG000|Overall Study|Study terminated by sponsor|1|||
33606309|NCT01982253|63006275|FG001|Overall Study|Study terminated by sponsor|4|||
33440991|NCT00132730|62817004|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
33440992|NCT00132730|62817005|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
33440993|NCT00132730|62817006|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
33440994|NCT00132730|62817007|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
33440995|NCT00132730|62817002|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
33440996|NCT00132730|62817003|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
33440997|NCT00132730|62817004|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
33440998|NCT00132730|62817005|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
33440999|NCT00132730|62817006|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
33441000|NCT00132730|62817007|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
33494214|NCT04206020|62872990|FG000|Overall Study|Protocol Violation|2|||
33606310|NCT01982253|63006276|FG002|Overall Study|Study terminated by sponsor|4|||
33606311|NCT01619787|63006286|FG000|Overall Study|Lost to Follow-up|5|||
33441001|NCT00132730|62817002|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
33606312|NCT01981473|63006295|FG000|Overall Study|Incorrect diagnosis of RA|0|||
33441002|NCT00132730|62817003|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
33441003|NCT00132730|62817004|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
33441004|NCT00132730|62817005|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
33441005|NCT00132730|62817006|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
33441006|NCT00132730|62817007|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
33441007|NCT00132730|62817002|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
33441008|NCT00132730|62817003|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
33441009|NCT00132730|62817004|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
33441010|NCT00132730|62817005|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
33441011|NCT00132730|62817006|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
33441012|NCT00132730|62817007|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
33441013|NCT00132730|62817002|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
33441014|NCT00132730|62817003|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
33441015|NCT00132730|62817004|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
33441016|NCT00132730|62817005|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
33441017|NCT00132730|62817006|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
33441018|NCT00132730|62817007|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
33441019|NCT00132730|62817002|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
33441020|NCT00132730|62817003|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
33441021|NCT00132730|62817004|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
33441022|NCT00132730|62817005|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
33441023|NCT00132730|62817006|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
33441024|NCT00132730|62817007|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
33441025|NCT00132730|62817002|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
33441026|NCT00132730|62817003|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
33441027|NCT00132730|62817004|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
33441028|NCT00132730|62817005|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
33441029|NCT00132730|62817006|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
33494215|NCT04206020|62872991|FG001|Overall Study|Protocol Violation|0|||
33606313|NCT01981473|63006296|FG001|Overall Study|Incorrect diagnosis of RA|0|||
33606314|NCT01981473|63006297|FG002|Overall Study|Incorrect diagnosis of RA|1|||
33606315|NCT01981473|63006295|FG000|Overall Study|Received treatment for < 6 months|0|||
33441030|NCT00132730|62817007|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
33441031|NCT00132730|62817002|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
33441032|NCT00132730|62817003|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
33441033|NCT00132730|62817004|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
33441034|NCT00132730|62817005|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
33441035|NCT00132730|62817006|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
33441036|NCT00132730|62817007|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
33441037|NCT00232557|62817023|FG000|Overall Study|Lost to Follow-up|3|||
33441038|NCT00232557|62817024|FG001|Overall Study|Lost to Follow-up|5|||
33441039|NCT00522275|62817030|FG000|Overall Study|Adverse Event|35|||
33606316|NCT01981473|63006296|FG001|Overall Study|Received treatment for < 6 months|0|||
33606317|NCT01981473|63006297|FG002|Overall Study|Received treatment for < 6 months|1|||
33606318|NCT01981473|63006295|FG000|Overall Study|Received treatment for >24 months|2|||
33606319|NCT01981473|63006296|FG001|Overall Study|Received treatment for >24 months|0|||
33606320|NCT01981473|63006297|FG002|Overall Study|Received treatment for >24 months|6|||
33606321|NCT02005029|63006310|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
33606322|NCT02005029|63006311|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
33606323|NCT02325791|63006339|FG000|Overall Study|Adverse Event|0|||
33606324|NCT02325791|63006340|FG001|Overall Study|Adverse Event|1|||
33606325|NCT02325791|63006341|FG002|Overall Study|Adverse Event|1|||
33606326|NCT02325791|63006342|FG003|Overall Study|Adverse Event|0|||
33606327|NCT02325791|63006339|FG000|Overall Study|Death|0|||
33606328|NCT02325791|63006340|FG001|Overall Study|Death|3|||
33606329|NCT02325791|63006341|FG002|Overall Study|Death|0|||
33606330|NCT02325791|63006342|FG003|Overall Study|Death|1|||
33606331|NCT02325791|63006339|FG000|Overall Study|Lost to Follow-up|0|||
33441040|NCT00522275|62817030|FG000|Overall Study|Lack of Efficacy|80|||
33441041|NCT00522275|62817030|FG000|Overall Study|Subject withdrew consent|16|||
33441042|NCT00522275|62817030|FG000|Overall Study|Protocol deviation|1|||
33441043|NCT00522275|62817030|FG000|Overall Study|Unsatisfactory compliance|11|||
33441044|NCT00522275|62817030|FG000|Overall Study|Lost to Follow-up|8|||
33441045|NCT00522275|62817030|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
33441046|NCT00522275|62817030|FG000|Overall Study|Other: Subject is pregnant|2|||
33441047|NCT00522275|62817030|FG000|Overall Study|Other: Subject relocated|2|||
33441048|NCT00522275|62817030|FG000|Overall Study|Other: Subject arrested|1|||
33441049|NCT00522275|62817030|FG000|Overall Study|Other: Site / clinic closed|4|||
33441050|NCT00522275|62817030|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
33441051|NCT00522275|62817030|FG000|Overall Study|Other: Sponsor request|2|||
33441052|NCT00522275|62817030|FG000|Overall Study|Other: Subject ran out of medication|1|||
33441053|NCT00522275|62817030|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
33441054|NCT00522041|62817036|FG000|Overall Study|Adverse Event|9|||
33441055|NCT00522041|62817037|FG001|Overall Study|Adverse Event|3|||
33441056|NCT00522041|62817036|FG000|Overall Study|Protocol Violation|2|||
33441057|NCT00522041|62817037|FG001|Overall Study|Protocol Violation|0|||
33441058|NCT00522041|62817036|FG000|Overall Study|Lost to Follow-up|1|||
33441059|NCT00522041|62817037|FG001|Overall Study|Lost to Follow-up|4|||
33441060|NCT00522041|62817036|FG000|Overall Study|Voluntary withdrawal|5|||
33441061|NCT00522041|62817037|FG001|Overall Study|Voluntary withdrawal|4|||
33441062|NCT00522041|62817036|FG000|Overall Study|Did not receive treatment|0|||
33441063|NCT00522041|62817037|FG001|Overall Study|Did not receive treatment|1|||
33441064|NCT00122980|62817046|FG000|Overall Study|Death|0|||
33441065|NCT00122980|62817047|FG001|Overall Study|Death|1|||
33441066|NCT00122980|62817046|FG000|Overall Study|Physician Decision|2|||
33441067|NCT00122980|62817047|FG001|Overall Study|Physician Decision|0|||
33441068|NCT00122980|62817046|FG000|Overall Study|Protocol Violation|5|||
33441069|NCT00122980|62817047|FG001|Overall Study|Protocol Violation|1|||
33441070|NCT00122980|62817046|FG000|Overall Study|Withdrawal by Subject|2|||
33441071|NCT00122980|62817047|FG001|Overall Study|Withdrawal by Subject|3|||
33441072|NCT00122980|62817046|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
33441073|NCT00122980|62817047|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
33441074|NCT00122980|62817046|FG000|Overall Study|Study termination|27|||
33441075|NCT00122980|62817047|FG001|Overall Study|Study termination|35|||
33441076|NCT03868631|62817055|FG000|Baseline to Week 6|Adverse Event|0|||
33441077|NCT03868631|62817056|FG001|Baseline to Week 6|Adverse Event|3|||
33441078|NCT03868631|62817055|FG000|Baseline to Week 6|Protocol Violation|1|||
33441079|NCT03868631|62817056|FG001|Baseline to Week 6|Protocol Violation|1|||
33441080|NCT03868631|62817055|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
33441081|NCT03868631|62817056|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
33441082|NCT03868631|62817055|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
33606332|NCT02325791|63006340|FG001|Overall Study|Lost to Follow-up|15|||
33606333|NCT02325791|63006341|FG002|Overall Study|Lost to Follow-up|14|||
33441083|NCT03868631|62817056|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
33441084|NCT03868631|62817055|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
33441085|NCT03868631|62817056|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
33441086|NCT03868631|62817055|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
33441087|NCT03868631|62817056|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
33441088|NCT00340704|62817071|FG000|PK Study|Adverse Event|0|||
33441089|NCT00340704|62817072|FG001|PK Study|Adverse Event|1|||
33441090|NCT00340704|62817073|FG002|PK Study|Adverse Event|0|||
33441091|NCT00340704|62817074|FG003|PK Study|Adverse Event|0|||
33441092|NCT00340704|62817075|FG004|PK Study|Adverse Event|0|||
33441093|NCT00340704|62817076|FG005|PK Study|Adverse Event|0|||
33441094|NCT00340704|62817077|FG006|PK Study|Adverse Event|0|||
33441095|NCT00340704|62817078|FG007|PK Study|Adverse Event|0|||
33441096|NCT00340704|62817079|FG008|PK Study|Adverse Event|0|||
33441097|NCT00340704|62817071|FG000|PK Study|Not treated|0|||
33441098|NCT00340704|62817072|FG001|PK Study|Not treated|0|||
33441099|NCT00340704|62817073|FG002|PK Study|Not treated|1|||
33441100|NCT00340704|62817074|FG003|PK Study|Not treated|0|||
33441101|NCT00340704|62817075|FG004|PK Study|Not treated|0|||
33441102|NCT00340704|62817076|FG005|PK Study|Not treated|0|||
33441103|NCT00340704|62817077|FG006|PK Study|Not treated|0|||
33441104|NCT00340704|62817078|FG007|PK Study|Not treated|0|||
33441105|NCT00340704|62817079|FG008|PK Study|Not treated|0|||
33441106|NCT00340704|62817071|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
33441107|NCT00340704|62817072|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
33441108|NCT00340704|62817073|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
33441109|NCT00340704|62817074|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
33441110|NCT00340704|62817075|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
33441111|NCT00340704|62817076|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
33606334|NCT02325791|63006342|FG003|Overall Study|Lost to Follow-up|9|||
33606335|NCT02325791|63006339|FG000|Overall Study|Physician Decision|0|||
33606336|NCT02325791|63006340|FG001|Overall Study|Physician Decision|1|||
33606337|NCT02325791|63006341|FG002|Overall Study|Physician Decision|1|||
33606338|NCT02325791|63006342|FG003|Overall Study|Physician Decision|0|||
33606339|NCT02325791|63006339|FG000|Overall Study|Protocol Violation|0|||
33606340|NCT02325791|63006340|FG001|Overall Study|Protocol Violation|0|||
33606341|NCT02325791|63006341|FG002|Overall Study|Protocol Violation|1|||
33606342|NCT02325791|63006342|FG003|Overall Study|Protocol Violation|0|||
33606343|NCT02325791|63006339|FG000|Overall Study|Withdrawal by Subject|0|||
33606344|NCT02325791|63006340|FG001|Overall Study|Withdrawal by Subject|5|||
33606345|NCT02325791|63006341|FG002|Overall Study|Withdrawal by Subject|8|||
33606346|NCT02325791|63006342|FG003|Overall Study|Withdrawal by Subject|16|||
33606347|NCT02004873|63006355|FG000|Overall Study|Implant unsuccessful|6|||
33606348|NCT02004873|63006355|FG000|Overall Study|Awaiting 6-month visit|390|||
33606349|NCT02004873|63006355|FG000|Overall Study|Missed 6-month visit|4|||
33606350|NCT02004873|63006355|FG000|Overall Study|Death|23|||
33606351|NCT02004873|63006355|FG000|Overall Study|Withdrawal by Subject|1|||
33441112|NCT00340704|62817077|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
33441113|NCT00340704|62817078|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
33441114|NCT00340704|62817079|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
33441115|NCT00340704|62817071|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33441116|NCT00340704|62817072|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33441117|NCT00340704|62817073|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33441118|NCT00340704|62817074|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33441119|NCT00340704|62817075|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33464874|NCT00040664|62838370|FG002|Overall Study|Protocol Violation|0|||
33606352|NCT02347787|63006364|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
33606353|NCT02347787|63006365|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
33441120|NCT00340704|62817076|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
33441121|NCT00340704|62817077|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33441122|NCT00340704|62817078|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33441123|NCT00340704|62817079|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33441124|NCT00340704|62817071|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
33441125|NCT00340704|62817072|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
33441126|NCT00340704|62817073|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
33441127|NCT00340704|62817074|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
33441128|NCT00340704|62817075|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
33441129|NCT00340704|62817076|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
33441130|NCT00340704|62817077|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
33323295|NCT01130532|62699554|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
33441131|NCT00340704|62817078|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
33441132|NCT00340704|62817079|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
33441133|NCT00340704|62817071|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
33441134|NCT00340704|62817072|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
33441135|NCT00340704|62817073|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
33441136|NCT00340704|62817074|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
33441137|NCT00340704|62817075|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
33441138|NCT00340704|62817076|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
33441139|NCT00340704|62817077|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
33441140|NCT00340704|62817078|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
33441141|NCT00340704|62817079|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
33441142|NCT00132496|62817107|FG000|Overall Study|Withdrawal by Subject|1|||
33441143|NCT00132496|62817108|FG001|Overall Study|Withdrawal by Subject|2|||
33441144|NCT00132496|62817107|FG000|Overall Study|Physician Decision|1|||
33441145|NCT00132496|62817108|FG001|Overall Study|Physician Decision|0|||
33441146|NCT00231777|62817116|FG000|Overall Study|Lost to Follow-up|3|||
33441147|NCT00231777|62817117|FG001|Overall Study|Lost to Follow-up|0|||
33441148|NCT00231777|62817116|FG000|Overall Study|Other|3|||
33441149|NCT00231777|62817117|FG001|Overall Study|Other|2|||
33441150|NCT00231465|62817123|FG000|Overall Study|Completed only one cycle|1|||
33441151|NCT00231465|62817123|FG000|Overall Study|Did not have follow up CT scans|1|||
33441152|NCT00254397|62817131|FG000|Overall Study|Disease Progression|4|||
33441153|NCT00254397|62817132|FG001|Overall Study|Disease Progression|1|||
33441154|NCT00254397|62817133|FG002|Overall Study|Disease Progression|16|||
33441155|NCT00254397|62817134|FG003|Overall Study|Disease Progression|23|||
33441156|NCT00254397|62817131|FG000|Overall Study|Non-Compliant|0|||
33441157|NCT00254397|62817132|FG001|Overall Study|Non-Compliant|0|||
33441158|NCT00254397|62817133|FG002|Overall Study|Non-Compliant|0|||
33441159|NCT00254397|62817134|FG003|Overall Study|Non-Compliant|1|||
33441160|NCT00254397|62817131|FG000|Overall Study|Adverse Event|2|||
33441161|NCT00254397|62817132|FG001|Overall Study|Adverse Event|0|||
33441162|NCT00254397|62817133|FG002|Overall Study|Adverse Event|3|||
33441163|NCT00254397|62817134|FG003|Overall Study|Adverse Event|1|||
33441164|NCT00254163|62817145|FG000|Overall Study|Adverse Event|29|||
33441165|NCT00254163|62817146|FG001|Overall Study|Adverse Event|26|||
33441166|NCT00254163|62817145|FG000|Overall Study|Patient request/withdrew consent|6|||
33441167|NCT00254163|62817146|FG001|Overall Study|Patient request/withdrew consent|4|||
33441168|NCT00254163|62817145|FG000|Overall Study|Investigator request|1|||
33441169|NCT00254163|62817146|FG001|Overall Study|Investigator request|3|||
33441170|NCT00254163|62817145|FG000|Overall Study|Failed entry|1|||
33441171|NCT00254163|62817146|FG001|Overall Study|Failed entry|3|||
33441172|NCT00254163|62817145|FG000|Overall Study|Progressive disease|0|||
33441173|NCT00254163|62817146|FG001|Overall Study|Progressive disease|1|||
33441174|NCT00254163|62817145|FG000|Overall Study|Death|0|||
33441175|NCT00254163|62817146|FG001|Overall Study|Death|1|||
33441176|NCT00254163|62817145|FG000|Overall Study|Other|8|||
33441177|NCT00254163|62817146|FG001|Overall Study|Other|8|||
33441178|NCT03869333|62817156|FG000|Overall Study|Lost to Follow-up|1|||
33441179|NCT03869333|62817157|FG001|Overall Study|Lost to Follow-up|0|||
33441180|NCT03869333|62817158|FG002|Overall Study|Lost to Follow-up|0|||
33441181|NCT03869333|62817159|FG003|Overall Study|Lost to Follow-up|0|||
33441182|NCT03869333|62817156|FG000|Overall Study|Pregnancy|1|||
33323296|NCT01130532|62699555|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
33441183|NCT03869333|62817157|FG001|Overall Study|Pregnancy|0|||
33494216|NCT04206020|62872990|FG000|Overall Study|Withdrawal by Subject|2|||
33441184|NCT03869333|62817158|FG002|Overall Study|Pregnancy|0|||
33441185|NCT03869333|62817159|FG003|Overall Study|Pregnancy|0|||
33441186|NCT03869333|62817156|FG000|Overall Study|Physician Decision|0|||
33441187|NCT03869333|62817157|FG001|Overall Study|Physician Decision|1|||
33441188|NCT03869333|62817158|FG002|Overall Study|Physician Decision|0|||
33441189|NCT03869333|62817159|FG003|Overall Study|Physician Decision|0|||
33441190|NCT00110890|62817171|FG000|Overall Study|Adverse Event|30|||
33441191|NCT00110890|62817172|FG001|Overall Study|Adverse Event|7|||
33606354|NCT02347787|63006364|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
33441192|NCT00110890|62817171|FG000|Overall Study|Death|16|||
33441193|NCT00110890|62817172|FG001|Overall Study|Death|9|||
33441194|NCT00110890|62817171|FG000|Overall Study|Lost to Follow-up|3|||
33441195|NCT00110890|62817172|FG001|Overall Study|Lost to Follow-up|1|||
33606355|NCT02347787|63006365|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
33606356|NCT02347787|63006364|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
33606357|NCT02347787|63006365|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
33606358|NCT02347787|63006364|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
33606359|NCT02347787|63006365|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
33606360|NCT01979835|63006376|FG000|Primary Outcome SA Measurment|failed insertion|18|||
33606361|NCT01979835|63006376|FG000|Follow-up|Lost to Follow-up|32|||
33606362|NCT02282345|63006382|FG000|Overall Study|Progression|0|||
33606363|NCT02282345|63006383|FG001|Overall Study|Progression|1|||
33441196|NCT00110890|62817171|FG000|Overall Study|Physician Decision|4|||
33441197|NCT00110890|62817172|FG001|Overall Study|Physician Decision|5|||
33441198|NCT00110890|62817171|FG000|Overall Study|Withdrawal by Subject|17|||
33441199|NCT00110890|62817172|FG001|Overall Study|Withdrawal by Subject|5|||
33441200|NCT00110890|62817171|FG000|Overall Study|Protocol Deviation|1|||
33441201|NCT00110890|62817172|FG001|Overall Study|Protocol Deviation|0|||
33441202|NCT00110890|62817171|FG000|Overall Study|Noncompliance|10|||
33441203|NCT00110890|62817172|FG001|Overall Study|Noncompliance|0|||
33441204|NCT00110890|62817171|FG000|Overall Study|Kidney Transplant|16|||
33441205|NCT00110890|62817172|FG001|Overall Study|Kidney Transplant|12|||
33441206|NCT00110890|62817171|FG000|Overall Study|Invest. Product Commercially Available|217|||
33441207|NCT00110890|62817172|FG001|Overall Study|Invest. Product Commercially Available|110|||
33441208|NCT00110890|62817171|FG000|Overall Study|Other|34|||
33441209|NCT00110890|62817172|FG001|Overall Study|Other|23|||
33441210|NCT00110890|62817171|FG000|Overall Study|Ineligibility determined|3|||
33441211|NCT00110890|62817172|FG001|Overall Study|Ineligibility determined|0|||
33441212|NCT00110890|62817171|FG000|Overall Study|Requirement for alternative therapy|0|||
33441213|NCT00110890|62817172|FG001|Overall Study|Requirement for alternative therapy|1|||
33441214|NCT00110890|62817171|FG000|Overall Study|Disease progression|0|||
33441215|NCT00110890|62817172|FG001|Overall Study|Disease progression|1|||
33441216|NCT00110890|62817171|FG000|Overall Study|Parathyroidectomy|0|||
33441217|NCT00110890|62817172|FG001|Overall Study|Parathyroidectomy|1|||
33441218|NCT00110890|62817171|FG000|Overall Study|Did not enter follow-up phase|10|||
33441219|NCT00110890|62817172|FG001|Overall Study|Did not enter follow-up phase|4|||
33441220|NCT00182637|62817178|FG000|Overall Study|Adverse Event|2|||
33441221|NCT00182637|62817178|FG000|Overall Study|Disease Progression|1|||
33441222|NCT00182325|62817185|FG000|Overall Study|Lost to Follow-up|7|||
33441223|NCT00182325|62817186|FG001|Overall Study|Lost to Follow-up|7|||
33606364|NCT01732822|63006394|FG000|Overall Study|Withdrawal by Subject|123|||
33606365|NCT01732822|63006395|FG001|Overall Study|Withdrawal by Subject|113|||
33606366|NCT02004093|63006425|FG000|Overall Study|Death|2|||
33606367|NCT02004093|63006426|FG001|Overall Study|Death|1|||
33441224|NCT00182325|62817185|FG000|Overall Study|Miscarriage|5|||
33441225|NCT00182325|62817186|FG001|Overall Study|Miscarriage|3|||
33441226|NCT00182325|62817185|FG000|Overall Study|Did not complete survey|22|||
33441227|NCT00182325|62817186|FG001|Overall Study|Did not complete survey|43|||
33441228|NCT00122278|62817194|FG000|Overall Study|Lost to Follow-up|2|||
33441229|NCT00122278|62817195|FG001|Overall Study|Lost to Follow-up|0|||
33441230|NCT00182091|62817205|FG000|Overall Study|Withdrawal by Subject|1|||
33606368|NCT02004093|63006425|FG000|Overall Study|Lack of Efficacy|66|||
33441231|NCT00182091|62817206|FG001|Overall Study|Withdrawal by Subject|0|||
33441232|NCT00182091|62817207|FG002|Overall Study|Withdrawal by Subject|0|||
33441233|NCT00182091|62817208|FG003|Overall Study|Withdrawal by Subject|0|||
33441234|NCT00181155|62817216|FG000|Overall Study|Physician Decision|1|||
33441235|NCT00181155|62817217|FG001|Overall Study|Physician Decision|0|||
33441236|NCT00181155|62817216|FG000|Overall Study|Withdrawal by Subject|1|||
33441237|NCT00181155|62817217|FG001|Overall Study|Withdrawal by Subject|0|||
33441238|NCT00322452|62817226|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33441239|NCT00322452|62817227|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33441240|NCT00322452|62817226|FG000|Overall Study|Lost to Follow-up|5|||
33441241|NCT00322452|62817227|FG001|Overall Study|Lost to Follow-up|2|||
33441242|NCT00322452|62817226|FG000|Overall Study|Withdrawal by Subject|19|||
33441243|NCT00322452|62817227|FG001|Overall Study|Withdrawal by Subject|46|||
33441244|NCT00322452|62817226|FG000|Overall Study|Death|223|||
33441245|NCT00322452|62817227|FG001|Overall Study|Death|227|||
33441246|NCT00110812|62817236|FG000|Main Study|Death|0|||
33441247|NCT00110812|62817237|FG001|Main Study|Death|0|||
33441248|NCT00110812|62817238|FG002|Main Study|Death|2|||
33441249|NCT00110812|62817236|FG000|Main Study|Withdrawal by Subject|0|||
33441250|NCT00110812|62817237|FG001|Main Study|Withdrawal by Subject|0|||
33441251|NCT00110812|62817238|FG002|Main Study|Withdrawal by Subject|1|||
33441252|NCT00110812|62817236|FG000|Main Study|Lost to Follow-up|8|||
33441253|NCT00110812|62817237|FG001|Main Study|Lost to Follow-up|11|||
33441254|NCT00110812|62817238|FG002|Main Study|Lost to Follow-up|10|||
33441255|NCT00110812|62817236|FG000|Extended Follow-up|Death|1|||
33441256|NCT00110812|62817237|FG001|Extended Follow-up|Death|0|||
33441257|NCT00110812|62817238|FG002|Extended Follow-up|Death|3|||
33441258|NCT00110812|62817236|FG000|Extended Follow-up|Withdrawal by Subject|0|||
33441259|NCT00110812|62817237|FG001|Extended Follow-up|Withdrawal by Subject|1|||
33441260|NCT00110812|62817238|FG002|Extended Follow-up|Withdrawal by Subject|0|||
33441261|NCT00110812|62817236|FG000|Extended Follow-up|Lost to Follow-up|1|||
33441262|NCT00110812|62817237|FG001|Extended Follow-up|Lost to Follow-up|3|||
33441263|NCT00110812|62817238|FG002|Extended Follow-up|Lost to Follow-up|1|||
33441264|NCT00516269|62817253|FG000|Overall Study|Adverse Event|2|||
33441265|NCT00516269|62817254|FG001|Overall Study|Adverse Event|1|||
33441266|NCT00516269|62817253|FG000|Overall Study|Lost to Follow-up|0|||
33441267|NCT00516269|62817254|FG001|Overall Study|Lost to Follow-up|1|||
33441268|NCT00516269|62817253|FG000|Overall Study|Protocol Violation|0|||
33441269|NCT00516269|62817254|FG001|Overall Study|Protocol Violation|1|||
33441270|NCT00229203|62817262|FG000|Overall Study|Progressive disease|18|||
33441271|NCT00229203|62817263|FG001|Overall Study|Progressive disease|9|||
33441272|NCT00229203|62817262|FG000|Overall Study|Toxicity|6|||
33441273|NCT00229203|62817263|FG001|Overall Study|Toxicity|1|||
33441274|NCT00229203|62817262|FG000|Overall Study|Death|4|||
33441275|NCT00229203|62817263|FG001|Overall Study|Death|2|||
33441276|NCT00229203|62817262|FG000|Overall Study|Other|3|||
33441277|NCT00229203|62817263|FG001|Overall Study|Other|3|||
33441278|NCT00229203|62817262|FG000|Overall Study|Withdrawal by Subject|1|||
33441279|NCT00229203|62817263|FG001|Overall Study|Withdrawal by Subject|4|||
33441280|NCT00228813|62817269|FG000|Overall Study|Death|4|||
33441281|NCT00322374|62817276|FG000|Starting Dose|Physician Decision|2|||
33441282|NCT00322374|62817277|FG001|Starting Dose|Physician Decision|0|||
33441283|NCT00322374|62817278|FG002|Starting Dose|Physician Decision|0|||
33441284|NCT00322374|62817279|FG003|Starting Dose|Physician Decision|0|||
33441285|NCT00322374|62817276|FG000|Starting Dose|Study Drug Toxicity|4|||
33441286|NCT00322374|62817277|FG001|Starting Dose|Study Drug Toxicity|0|||
33441287|NCT00322374|62817278|FG002|Starting Dose|Study Drug Toxicity|0|||
33441288|NCT00322374|62817279|FG003|Starting Dose|Study Drug Toxicity|0|||
33441289|NCT00322374|62817276|FG000|First Escalation|Documented Disease Progression|0|||
33441290|NCT00322374|62817277|FG001|First Escalation|Documented Disease Progression|6|||
33441291|NCT00322374|62817278|FG002|First Escalation|Documented Disease Progression|0|||
33441292|NCT00322374|62817279|FG003|First Escalation|Documented Disease Progression|0|||
33441293|NCT00322374|62817276|FG000|First Escalation|Physician Decision|0|||
33441294|NCT00322374|62817277|FG001|First Escalation|Physician Decision|12|||
33441295|NCT00322374|62817278|FG002|First Escalation|Physician Decision|0|||
33441296|NCT00322374|62817279|FG003|First Escalation|Physician Decision|0|||
33441297|NCT00322374|62817276|FG000|First Escalation|Study Drug Toxicity|0|||
33441298|NCT00322374|62817277|FG001|First Escalation|Study Drug Toxicity|11|||
33441299|NCT00322374|62817278|FG002|First Escalation|Study Drug Toxicity|0|||
33441300|NCT00322374|62817279|FG003|First Escalation|Study Drug Toxicity|0|||
33441301|NCT00322374|62817276|FG000|First Escalation|Participant Request|0|||
33441302|NCT00322374|62817277|FG001|First Escalation|Participant Request|1|||
33441303|NCT00322374|62817278|FG002|First Escalation|Participant Request|0|||
33441304|NCT00322374|62817279|FG003|First Escalation|Participant Request|0|||
33441305|NCT00322374|62817276|FG000|Second Escalation|Physician Decision|0|||
33441306|NCT00322374|62817277|FG001|Second Escalation|Physician Decision|0|||
33441307|NCT00322374|62817278|FG002|Second Escalation|Physician Decision|5|||
33441308|NCT00322374|62817279|FG003|Second Escalation|Physician Decision|0|||
33441309|NCT00322374|62817276|FG000|Second Escalation|Study Drug Toxicity|0|||
33441310|NCT00322374|62817277|FG001|Second Escalation|Study Drug Toxicity|0|||
33441311|NCT00322374|62817278|FG002|Second Escalation|Study Drug Toxicity|1|||
33441312|NCT00322374|62817279|FG003|Second Escalation|Study Drug Toxicity|0|||
33441313|NCT00174447|62817292|FG000|Overall Study|Adverse Event|19|||
33441314|NCT00174447|62817292|FG000|Overall Study|Withdrawal by Subject|15|||
33441315|NCT00174447|62817292|FG000|Overall Study|Protocol Violation|1|||
33441316|NCT00174447|62817292|FG000|Overall Study|Lack of Efficacy|1|||
33441317|NCT00174447|62817292|FG000|Overall Study|Administrative reason/Other|2|||
33441318|NCT00321984|62817299|FG000|Overall Study|Adverse Event|9|||
33441319|NCT00321984|62817300|FG001|Overall Study|Adverse Event|6|||
33441320|NCT00321984|62817301|FG002|Overall Study|Adverse Event|8|||
33441321|NCT00321984|62817299|FG000|Overall Study|Protocol Violation|0|||
33441322|NCT00321984|62817300|FG001|Overall Study|Protocol Violation|1|||
33441323|NCT00321984|62817301|FG002|Overall Study|Protocol Violation|1|||
33441324|NCT00321984|62817299|FG000|Overall Study|Lost to Follow-up|2|||
33441325|NCT00321984|62817300|FG001|Overall Study|Lost to Follow-up|4|||
33441326|NCT00321984|62817301|FG002|Overall Study|Lost to Follow-up|2|||
33441327|NCT00321984|62817299|FG000|Overall Study|Withdrawal by Subject|8|||
33441328|NCT00321984|62817300|FG001|Overall Study|Withdrawal by Subject|6|||
33441329|NCT00321984|62817301|FG002|Overall Study|Withdrawal by Subject|5|||
33441330|NCT00321984|62817299|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
33441331|NCT00321984|62817300|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
33441332|NCT00321984|62817301|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
33441333|NCT00321984|62817299|FG000|Overall Study|Lack of Efficacy|3|||
33441334|NCT00321984|62817300|FG001|Overall Study|Lack of Efficacy|1|||
33441335|NCT00321984|62817301|FG002|Overall Study|Lack of Efficacy|3|||
33441336|NCT00321984|62817299|FG000|Overall Study|Noncompliant|0|||
33441337|NCT00321984|62817300|FG001|Overall Study|Noncompliant|0|||
33441338|NCT00321984|62817301|FG002|Overall Study|Noncompliant|2|||
33441339|NCT00321984|62817299|FG000|Overall Study|Pregnancy|0|||
33441340|NCT00321984|62817300|FG001|Overall Study|Pregnancy|1|||
33441341|NCT00321984|62817301|FG002|Overall Study|Pregnancy|0|||
33441342|NCT00321984|62817299|FG000|Overall Study|Per Subject Request|1|||
33441343|NCT00321984|62817300|FG001|Overall Study|Per Subject Request|0|||
33441344|NCT00321984|62817301|FG002|Overall Study|Per Subject Request|0|||
33441345|NCT00321984|62817299|FG000|Overall Study|Per Investigator Request|1|||
33441346|NCT00321984|62817300|FG001|Overall Study|Per Investigator Request|0|||
33441347|NCT00321984|62817301|FG002|Overall Study|Per Investigator Request|0|||
33441348|NCT00321984|62817299|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
33441349|NCT00321984|62817300|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
33441350|NCT00321984|62817301|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
33441351|NCT00515099|62817311|FG000|Overall Study|Lost to Follow-up|0|||
33441352|NCT00515099|62817312|FG001|Overall Study|Lost to Follow-up|4|||
33441353|NCT00515099|62817311|FG000|Overall Study|Withdrawal by Subject|2|||
33441354|NCT00515099|62817312|FG001|Overall Study|Withdrawal by Subject|0|||
33441355|NCT00515099|62817311|FG000|Overall Study|IRB Recommendation|1|||
33441356|NCT00515099|62817312|FG001|Overall Study|IRB Recommendation|0|||
33441357|NCT00110266|62817318|FG000|Overall Study|Adverse Event|27|||
33441358|NCT00110266|62817318|FG000|Overall Study|Abnormal laboratory value|15|||
33441359|NCT00110266|62817318|FG000|Overall Study|Withdrawal by Subject|16|||
33606369|NCT02004093|63006426|FG001|Overall Study|Lack of Efficacy|62|||
33441360|NCT00110266|62817318|FG000|Overall Study|Death|17|||
33441361|NCT00110266|62817318|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33441362|NCT00110266|62817318|FG000|Overall Study|Participant condition no longer requires study drug|1|||
33441363|NCT00174291|62817325|FG000|Overall Study|Lost to Follow-up|1|||
33441364|NCT00174291|62817326|FG001|Overall Study|Lost to Follow-up|1|||
33441365|NCT00174291|62817325|FG000|Overall Study|Protocol Violation|0|||
33441366|NCT00174291|62817326|FG001|Overall Study|Protocol Violation|2|||
33441367|NCT00174291|62817325|FG000|Overall Study|Study terminated by sponsor|1|||
33441368|NCT00174291|62817326|FG001|Overall Study|Study terminated by sponsor|0|||
33441369|NCT00174291|62817325|FG000|Overall Study|Withdrawal by Subject|3|||
33441370|NCT00174291|62817326|FG001|Overall Study|Withdrawal by Subject|3|||
33441371|NCT00366548|62817334|FG000|Infant Series|Adverse Event|1|||
33441372|NCT00366548|62817335|FG001|Infant Series|Adverse Event|3|||
33441373|NCT00366548|62817334|FG000|Infant Series|Protocol Violation|0|||
33441374|NCT00366548|62817335|FG001|Infant Series|Protocol Violation|1|||
33441375|NCT00366548|62817334|FG000|Infant Series|Withdrawal by Subject|3|||
33441376|NCT00366548|62817335|FG001|Infant Series|Withdrawal by Subject|1|||
33441377|NCT00366548|62817334|FG000|After Infant Series|Withdrawal by Subject|3|||
33441378|NCT00366548|62817335|FG001|After Infant Series|Withdrawal by Subject|1|||
33441379|NCT00366548|62817334|FG000|After Infant Series|Adverse Event|2|||
33441380|NCT00366548|62817335|FG001|After Infant Series|Adverse Event|0|||
33441381|NCT00366548|62817334|FG000|After Infant Series|Lost to Follow-up|1|||
33441382|NCT00366548|62817335|FG001|After Infant Series|Lost to Follow-up|0|||
33441383|NCT00252057|62817361|FG000|Overall Study|Withdrawal by Subject|2|||
33441384|NCT00252057|62817362|FG001|Overall Study|Withdrawal by Subject|5|||
33441385|NCT00252057|62817361|FG000|Overall Study|Death|1|||
33441386|NCT00252057|62817362|FG001|Overall Study|Death|2|||
33441387|NCT00252057|62817361|FG000|Overall Study|Participant previously enrolled|0|||
33441388|NCT00252057|62817362|FG001|Overall Study|Participant previously enrolled|1|||
33441389|NCT00132028|62817368|FG000|Overall Study|Adverse Event|7|||
33441390|NCT00132028|62817368|FG000|Overall Study|Death|2|||
33441391|NCT00132028|62817368|FG000|Overall Study|Lack of Efficacy|11|||
33441392|NCT00132028|62817368|FG000|Overall Study|Withdrawal by Subject|2|||
33441393|NCT00132028|62817368|FG000|Overall Study|not eligible|2|||
33441394|NCT00132028|62817368|FG000|Overall Study|Physician Decision|3|||
33441395|NCT00131248|62817372|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
33441396|NCT00131248|62817373|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
33441397|NCT00362414|62817379|FG000|Overall Study|Death|2|||
33441398|NCT00362414|62817379|FG000|Overall Study|Adverse Event|1|||
33441399|NCT00096382|62817388|FG000|Overall Study|Not treated|1|||
33441400|NCT00096382|62817389|FG001|Overall Study|Not treated|0|||
33441401|NCT00096382|62817388|FG000|Overall Study|Death during treatment|1|||
33441402|NCT00096382|62817389|FG001|Overall Study|Death during treatment|0|||
33441403|NCT00359294|62817400|FG000|Overall Study|Progressive disease|1|||
33606370|NCT02004093|63006425|FG000|Overall Study|Protocol Violation|0|||
33441404|NCT00359294|62817401|FG001|Overall Study|Progressive disease|1|||
33441405|NCT00359294|62817402|FG002|Overall Study|Progressive disease|2|||
33441406|NCT00359294|62817403|FG003|Overall Study|Progressive disease|3|||
33441407|NCT00359294|62817404|FG004|Overall Study|Progressive disease|2|||
33441408|NCT00359294|62817400|FG000|Overall Study|Withdrawal by Subject|0|||
33441409|NCT00359294|62817401|FG001|Overall Study|Withdrawal by Subject|0|||
33441410|NCT00359294|62817402|FG002|Overall Study|Withdrawal by Subject|0|||
33441411|NCT00359294|62817403|FG003|Overall Study|Withdrawal by Subject|0|||
33441412|NCT00359294|62817404|FG004|Overall Study|Withdrawal by Subject|1|||
33441413|NCT00359294|62817400|FG000|Overall Study|Not treated|0|||
33441414|NCT00359294|62817401|FG001|Overall Study|Not treated|0|||
33441415|NCT00359294|62817402|FG002|Overall Study|Not treated|0|||
33441416|NCT00359294|62817403|FG003|Overall Study|Not treated|1|||
33441417|NCT00359294|62817404|FG004|Overall Study|Not treated|0|||
33441418|NCT00359294|62817400|FG000|Overall Study|Physician Decision|0|||
33441419|NCT00359294|62817401|FG001|Overall Study|Physician Decision|0|||
33441420|NCT00359294|62817402|FG002|Overall Study|Physician Decision|1|||
33441421|NCT00359294|62817403|FG003|Overall Study|Physician Decision|0|||
33441422|NCT00359294|62817404|FG004|Overall Study|Physician Decision|0|||
33441423|NCT00384332|62817414|FG000|Overall Study|Lost to Follow-up|4|||
33441424|NCT00384332|62817415|FG001|Overall Study|Lost to Follow-up|0|||
33441425|NCT00096226|62817423|FG000|Overall Study|Ineligible|2|||
33441426|NCT00096226|62817423|FG000|Overall Study|Protocol treatment not started|1|||
33441427|NCT00105508|62817429|FG000|Overall Study|Prephase Dropout|1|||
33441428|NCT00105508|62817430|FG001|Overall Study|Prephase Dropout|0|||
33441429|NCT00105508|62817429|FG000|Overall Study|Adverse Event|16|||
33441430|NCT00105508|62817430|FG001|Overall Study|Adverse Event|19|||
33441431|NCT00105508|62817429|FG000|Overall Study|Insufficient Efficacy|1|||
33441432|NCT00105508|62817430|FG001|Overall Study|Insufficient Efficacy|0|||
33441433|NCT00105508|62817429|FG000|Overall Study|Withdrawal by Subject|10|||
33441434|NCT00105508|62817430|FG001|Overall Study|Withdrawal by Subject|6|||
33441435|NCT00105508|62817429|FG000|Overall Study|Lost to Follow-up|3|||
33441436|NCT00105508|62817430|FG001|Overall Study|Lost to Follow-up|0|||
33441437|NCT00105508|62817429|FG000|Overall Study|Protocol Violation|1|||
33441438|NCT00105508|62817430|FG001|Overall Study|Protocol Violation|2|||
33441439|NCT00105508|62817429|FG000|Overall Study|Other|8|||
33441440|NCT00105508|62817430|FG001|Overall Study|Other|9|||
33441441|NCT00105196|62817438|FG000|Overall Study|Lack of Efficacy|2|||
33441442|NCT00105196|62817439|FG001|Overall Study|Lack of Efficacy|3|||
33441443|NCT00105196|62817438|FG000|Overall Study|Adverse Event|11|||
33441444|NCT00105196|62817439|FG001|Overall Study|Adverse Event|3|||
33441445|NCT00105196|62817438|FG000|Overall Study|Withdrawal by Subject|6|||
33441446|NCT00105196|62817439|FG001|Overall Study|Withdrawal by Subject|6|||
33441447|NCT00105196|62817438|FG000|Overall Study|Lost to Follow-up|3|||
33441448|NCT00105196|62817439|FG001|Overall Study|Lost to Follow-up|2|||
33441449|NCT00105196|62817438|FG000|Overall Study|Poor/noncompliance|3|||
33441450|NCT00105196|62817439|FG001|Overall Study|Poor/noncompliance|4|||
33441451|NCT00105196|62817438|FG000|Overall Study|Protocol Violation|5|||
33441452|NCT00105196|62817439|FG001|Overall Study|Protocol Violation|2|||
33441453|NCT00105196|62817438|FG000|Overall Study|pending surgery|0|||
33441454|NCT00105196|62817439|FG001|Overall Study|pending surgery|1|||
33441455|NCT00105196|62817438|FG000|Overall Study|marijuana use|0|||
33441456|NCT00105196|62817439|FG001|Overall Study|marijuana use|1|||
33441457|NCT00105196|62817438|FG000|Overall Study|Subject became unblinded|0|||
33441458|NCT00105196|62817439|FG001|Overall Study|Subject became unblinded|1|||
33441459|NCT03820024|62817447|FG000|Overall Study|Physician Decision|1|||
33441460|NCT03820024|62817448|FG001|Overall Study|Physician Decision|2|||
33441461|NCT03819634|62817454|FG000|Overall Study|Physician Decision|2|||
33606371|NCT02004093|63006426|FG001|Overall Study|Protocol Violation|1|||
33606372|NCT02004093|63006425|FG000|Overall Study|Lost to Follow-up|0|||
33606373|NCT02004093|63006426|FG001|Overall Study|Lost to Follow-up|1|||
33606374|NCT02004093|63006425|FG000|Overall Study|Withdrawal by Subject|3|||
33606375|NCT02004093|63006426|FG001|Overall Study|Withdrawal by Subject|7|||
33606376|NCT02004093|63006425|FG000|Overall Study|Other|3|||
33606377|NCT02004093|63006426|FG001|Overall Study|Other|1|||
33606378|NCT01641367|63006441|FG000|Cohorts|Death|18|||
33606379|NCT01641367|63006442|FG001|Cohorts|Death|1|||
33606380|NCT01641367|63006443|FG002|Cohorts|Death|2|||
33606381|NCT01641367|63006444|FG003|Cohorts|Death|0|||
33606382|NCT01641367|63006445|FG004|Cohorts|Death|1|||
33606383|NCT01641367|63006446|FG005|Cohorts|Death|1|||
33606384|NCT01641367|63006447|FG006|Cohorts|Death|0|||
33606385|NCT01641367|63006448|FG007|Cohorts|Death|0|||
33606386|NCT01641367|63006441|FG000|Cohorts|Lost to Follow-up|16|||
33606387|NCT01641367|63006442|FG001|Cohorts|Lost to Follow-up|0|||
33606388|NCT01641367|63006443|FG002|Cohorts|Lost to Follow-up|2|||
33441462|NCT00104572|62817461|FG000|Overall Study|Withdrawal by Subject|3|||
33441463|NCT00104572|62817462|FG001|Overall Study|Withdrawal by Subject|3|||
33441464|NCT00104572|62817463|FG002|Overall Study|Withdrawal by Subject|0|||
33441465|NCT00514943|62817473|FG000|Stage 1|Progressive disease|4|||
33441466|NCT00514943|62817474|FG001|Stage 1|Progressive disease|8|||
33441467|NCT00514943|62817473|FG000|Stage 1|Other Adverse Event|16|||
33441468|NCT00514943|62817474|FG001|Stage 1|Other Adverse Event|6|||
33441469|NCT00514943|62817473|FG000|Stage 1|Not treated|1|||
33441470|NCT00514943|62817474|FG001|Stage 1|Not treated|2|||
33606389|NCT01641367|63006444|FG003|Cohorts|Lost to Follow-up|0|||
33606390|NCT01641367|63006445|FG004|Cohorts|Lost to Follow-up|2|||
33441471|NCT00514943|62817473|FG000|Stage 1|Patient refused to continue study meds|8|||
33441472|NCT00514943|62817474|FG001|Stage 1|Patient refused to continue study meds|3|||
33441473|NCT00514943|62817473|FG000|Stage 1|Other than stated above|1|||
33441474|NCT00514943|62817474|FG001|Stage 1|Other than stated above|7|||
33441475|NCT00514943|62817473|FG000|Stage 2|Progressive disease|27|||
33441476|NCT00514943|62817474|FG001|Stage 2|Progressive disease|24|||
33441477|NCT00514943|62817473|FG000|Stage 2|Other Adverse Event|3|||
33441478|NCT00514943|62817474|FG001|Stage 2|Other Adverse Event|10|||
33441479|NCT00514943|62817473|FG000|Stage 2|Patient refused to continue study meds|2|||
33441480|NCT00514943|62817474|FG001|Stage 2|Patient refused to continue study meds|0|||
33441481|NCT00514943|62817473|FG000|Stage 2|Other than stated above|0|||
33441482|NCT00514943|62817474|FG001|Stage 2|Other than stated above|2|||
33441483|NCT03864653|62817495|FG000|Overall Study|Withdrawal by Subject|1|||
33441484|NCT00103402|62817501|FG000|Overall Study|Adverse Event|3|||
33441485|NCT00103402|62817502|FG001|Overall Study|Adverse Event|4|||
33441486|NCT00103402|62817501|FG000|Overall Study|Lost to Follow-up|8|||
33441487|NCT00103402|62817502|FG001|Overall Study|Lost to Follow-up|7|||
33441488|NCT00103402|62817501|FG000|Overall Study|Dissatisfied/No longer interested|6|||
33441489|NCT00103402|62817502|FG001|Overall Study|Dissatisfied/No longer interested|6|||
33441490|NCT00103402|62817501|FG000|Overall Study|Personal constraints/Other|5|||
33441491|NCT00103402|62817502|FG001|Overall Study|Personal constraints/Other|0|||
33441492|NCT03864341|62817508|FG000|Overall Study|Withdrawal by Subject|1|||
33441493|NCT00095836|62817512|FG000|Overall Study|Lost to Follow-up|1|||
33441494|NCT00095836|62817512|FG000|Overall Study|Adverse Event|1|||
33441495|NCT00095836|62817512|FG000|Overall Study|Death|2|||
33441496|NCT00168831|62817519|FG000|Overall Study|Adverse Event|36|||
33441497|NCT00168831|62817520|FG001|Overall Study|Adverse Event|47|||
33441498|NCT00168831|62817521|FG002|Overall Study|Adverse Event|74|||
33441499|NCT00168831|62817519|FG000|Overall Study|Lost to Follow-up|5|||
33441500|NCT00168831|62817520|FG001|Overall Study|Lost to Follow-up|6|||
33441501|NCT00168831|62817521|FG002|Overall Study|Lost to Follow-up|4|||
33606391|NCT01641367|63006446|FG005|Cohorts|Lost to Follow-up|0|||
33606392|NCT01641367|63006447|FG006|Cohorts|Lost to Follow-up|0|||
33606393|NCT01641367|63006448|FG007|Cohorts|Lost to Follow-up|0|||
33606394|NCT01641367|63006441|FG000|Randomized Adherence Intervention|Death|0|||
33606395|NCT01641367|63006442|FG001|Randomized Adherence Intervention|Death|0|||
33606396|NCT01641367|63006443|FG002|Randomized Adherence Intervention|Death|0|||
33606397|NCT01641367|63006444|FG003|Randomized Adherence Intervention|Death|0|||
33441502|NCT00168831|62817519|FG000|Overall Study|Withdrawal by Subject|7|||
33441503|NCT00168831|62817520|FG001|Overall Study|Withdrawal by Subject|14|||
33441504|NCT00168831|62817521|FG002|Overall Study|Withdrawal by Subject|19|||
33441505|NCT00168831|62817519|FG000|Overall Study|Protocol Violation|6|||
33441506|NCT00168831|62817520|FG001|Overall Study|Protocol Violation|11|||
33441507|NCT00168831|62817521|FG002|Overall Study|Protocol Violation|11|||
33441508|NCT00168831|62817519|FG000|Overall Study|Other|6|||
33441509|NCT00168831|62817520|FG001|Overall Study|Other|3|||
33441510|NCT00168831|62817521|FG002|Overall Study|Other|6|||
33441511|NCT00103012|62817532|FG000|Overall Study|Withdrawal by Subject|2|||
33323297|NCT01130532|62699556|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
33441512|NCT00103012|62817533|FG001|Overall Study|Withdrawal by Subject|1|||
33441513|NCT00103012|62817534|FG002|Overall Study|Withdrawal by Subject|2|||
33606398|NCT01641367|63006445|FG004|Randomized Adherence Intervention|Death|0|||
33441514|NCT00103012|62817532|FG000|Overall Study|Pregnancy|1|||
33441515|NCT00103012|62817533|FG001|Overall Study|Pregnancy|0|||
33441516|NCT00103012|62817534|FG002|Overall Study|Pregnancy|0|||
33441517|NCT00103012|62817532|FG000|Overall Study|Adverse Event|0|||
33441518|NCT00103012|62817533|FG001|Overall Study|Adverse Event|0|||
33441519|NCT00103012|62817534|FG002|Overall Study|Adverse Event|1|||
33441520|NCT00103012|62817532|FG000|Overall Study|Subject non-compliant with medications|0|||
33441521|NCT00103012|62817533|FG001|Overall Study|Subject non-compliant with medications|0|||
33441522|NCT00103012|62817534|FG002|Overall Study|Subject non-compliant with medications|1|||
33441523|NCT00512135|62817542|FG000|Overall Study|Not Treated|5|||
33441524|NCT00512135|62817542|FG000|Overall Study|Lack of Efficacy|2|||
33441525|NCT00512135|62817542|FG000|Overall Study|Adverse Event|6|||
33441526|NCT00512135|62817542|FG000|Overall Study|Withdrawal by Subject|22|||
33441527|NCT00512135|62817542|FG000|Overall Study|Lost to Follow-up|27|||
33441528|NCT00512135|62817542|FG000|Overall Study|Other|22|||
33441529|NCT00251979|62817549|FG000|Overall Study|Protocol Violation|3|||
33606399|NCT01641367|63006446|FG005|Randomized Adherence Intervention|Death|0|||
33606400|NCT01641367|63006447|FG006|Randomized Adherence Intervention|Death|11|||
33606401|NCT01641367|63006448|FG007|Randomized Adherence Intervention|Death|12|||
33606402|NCT01641367|63006441|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
33606403|NCT01641367|63006442|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
33606404|NCT01641367|63006443|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
33606405|NCT01641367|63006444|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
33606406|NCT01641367|63006445|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
33606407|NCT01641367|63006446|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
33606408|NCT01641367|63006447|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
33606409|NCT01641367|63006448|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
33606410|NCT02325713|63006487|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33441530|NCT00251979|62817550|FG001|Overall Study|Protocol Violation|5|||
33441531|NCT00251979|62817549|FG000|Overall Study|Adverse Event|11|||
33441532|NCT00251979|62817550|FG001|Overall Study|Adverse Event|17|||
33441533|NCT00251979|62817549|FG000|Overall Study|Withdrawal by Subject|13|||
33606411|NCT02325713|63006488|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33441534|NCT00251979|62817550|FG001|Overall Study|Withdrawal by Subject|7|||
33606412|NCT02325713|63006489|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33441535|NCT00251979|62817549|FG000|Overall Study|Lost to Follow-up|8|||
33441536|NCT00251979|62817550|FG001|Overall Study|Lost to Follow-up|6|||
33441537|NCT00251979|62817549|FG000|Overall Study|Death|3|||
33441538|NCT00251979|62817550|FG001|Overall Study|Death|5|||
33441539|NCT00511901|62817558|FG000|Overall Study|Withdrawal by Subject|1|||
33441540|NCT00511901|62817559|FG001|Overall Study|Withdrawal by Subject|3|||
33441541|NCT03862625|62817567|FG000|Overall Study|Lost to Follow-up|0|||
33441542|NCT03862625|62817568|FG001|Overall Study|Lost to Follow-up|1|||
33441543|NCT00163215|62817574|FG000|Overall Study|Lack of Efficacy|3|||
33441544|NCT00163215|62817574|FG000|Overall Study|Withdrawal by Subject|5|||
33441545|NCT00163215|62817574|FG000|Overall Study|Other|7|||
33441546|NCT00228423|62817580|FG000|Overall Study|Adverse Event|2|||
33441547|NCT00228423|62817581|FG001|Overall Study|Adverse Event|5|||
33441548|NCT00228423|62817580|FG000|Overall Study|Withdrawal by Subject|7|||
33441549|NCT00228423|62817581|FG001|Overall Study|Withdrawal by Subject|3|||
33441550|NCT00228423|62817580|FG000|Overall Study|Protocol Violation|1|||
33441551|NCT00228423|62817581|FG001|Overall Study|Protocol Violation|3|||
33441552|NCT00228423|62817580|FG000|Overall Study|Physician Decision|0|||
33441553|NCT00228423|62817581|FG001|Overall Study|Physician Decision|1|||
33441554|NCT00511667|62817589|FG000|Overall Study|Adverse Event|1|||
33441555|NCT00511667|62817590|FG001|Overall Study|Adverse Event|0|||
33441556|NCT00511667|62817589|FG000|Overall Study|Protocol Violation|1|||
33441557|NCT00511667|62817590|FG001|Overall Study|Protocol Violation|1|||
33441558|NCT00511667|62817589|FG000|Overall Study|Withdrawal by Subject|2|||
33441559|NCT00511667|62817590|FG001|Overall Study|Withdrawal by Subject|0|||
33441560|NCT00511667|62817589|FG000|Overall Study|Site terminated|6|||
33441561|NCT00511667|62817590|FG001|Overall Study|Site terminated|1|||
33441562|NCT00511667|62817589|FG000|Overall Study|Other|2|||
33441563|NCT00511667|62817590|FG001|Overall Study|Other|1|||
33441564|NCT00227877|62817606|FG000|Pre-visit Assessment|Technical difficulties|7|||
33441565|NCT00227877|62817607|FG001|Pre-visit Assessment|Technical difficulties|3|||
33441566|NCT00227877|62817608|FG002|Pre-visit Assessment|Technical difficulties|0|||
33441567|NCT00227877|62817609|FG003|Pre-visit Assessment|Technical difficulties|0|||
33441568|NCT00227877|62817606|FG000|Post-visit Checklist|Lost to Follow-up|24|||
33441569|NCT00227877|62817607|FG001|Post-visit Checklist|Lost to Follow-up|13|||
33441570|NCT00227877|62817608|FG002|Post-visit Checklist|Lost to Follow-up|1|||
33441571|NCT00227877|62817609|FG003|Post-visit Checklist|Lost to Follow-up|0|||
33441572|NCT00227877|62817606|FG000|3-months Follow-up|Completed late|135|||
33441573|NCT00227877|62817607|FG001|3-months Follow-up|Completed late|128|||
33441574|NCT00227877|62817608|FG002|3-months Follow-up|Completed late|34|||
33441575|NCT00227877|62817609|FG003|3-months Follow-up|Completed late|8|||
33441576|NCT00227877|62817606|FG000|3-months Follow-up|Lost to Follow-up|178|||
33441577|NCT00227877|62817607|FG001|3-months Follow-up|Lost to Follow-up|139|||
33441578|NCT00227877|62817608|FG002|3-months Follow-up|Lost to Follow-up|18|||
33441579|NCT00227877|62817609|FG003|3-months Follow-up|Lost to Follow-up|13|||
33441580|NCT00227877|62817606|FG000|12-months Follow-up|Completed late|78|||
33441581|NCT00227877|62817607|FG001|12-months Follow-up|Completed late|74|||
33441582|NCT00227877|62817608|FG002|12-months Follow-up|Completed late|1|||
33441583|NCT00227877|62817609|FG003|12-months Follow-up|Completed late|0|||
33441584|NCT00227877|62817606|FG000|12-months Follow-up|Lost to Follow-up|232|||
33441585|NCT00227877|62817607|FG001|12-months Follow-up|Lost to Follow-up|189|||
33441586|NCT00227877|62817608|FG002|12-months Follow-up|Lost to Follow-up|30|||
33441587|NCT00227877|62817609|FG003|12-months Follow-up|Lost to Follow-up|26|||
33441588|NCT00513695|62817621|FG000|Overall Study|Discontinued therapy|2|||
33441589|NCT00513695|62817621|FG000|Overall Study|Progression prior to surgery|3|||
33441590|NCT00162981|62817627|FG000|Overall Study|Adverse Event|2|||
33441591|NCT00162981|62817628|FG001|Overall Study|Adverse Event|5|||
33441592|NCT00162981|62817627|FG000|Overall Study|Withdrawal by Subject|1|||
33441593|NCT00162981|62817628|FG001|Overall Study|Withdrawal by Subject|1|||
33441594|NCT00162981|62817627|FG000|Overall Study|Physician Decision|1|||
33441595|NCT00162981|62817628|FG001|Overall Study|Physician Decision|0|||
33441596|NCT00511433|62817636|FG000|Overall Study|Adverse Event|5|||
33441597|NCT00511433|62817637|FG001|Overall Study|Adverse Event|0|||
33441598|NCT00511433|62817636|FG000|Overall Study|Other Reason|1|||
33441599|NCT00511433|62817637|FG001|Overall Study|Other Reason|1|||
33441600|NCT00099268|62817647|FG000|Overall Study|Withdrawal by Subject|46|||
33323298|NCT01130532|62699557|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
33441601|NCT00099268|62817648|FG001|Overall Study|Withdrawal by Subject|28|||
33441602|NCT00099268|62817647|FG000|Overall Study|Adverse Event|19|||
33441603|NCT00099268|62817648|FG001|Overall Study|Adverse Event|19|||
33441604|NCT00099268|62817647|FG000|Overall Study|Protocol Violation|9|||
33441605|NCT00099268|62817648|FG001|Overall Study|Protocol Violation|8|||
33441606|NCT00099268|62817647|FG000|Overall Study|Lost to Follow-up|6|||
33441607|NCT00099268|62817648|FG001|Overall Study|Lost to Follow-up|4|||
33441608|NCT00099268|62817647|FG000|Overall Study|Lack of Efficacy|5|||
33441609|NCT00099268|62817648|FG001|Overall Study|Lack of Efficacy|18|||
33441610|NCT00099268|62817647|FG000|Overall Study|Administrative problems|4|||
33441611|NCT00099268|62817648|FG001|Overall Study|Administrative problems|4|||
33441612|NCT00099268|62817647|FG000|Overall Study|Death|3|||
33441613|NCT00099268|62817648|FG001|Overall Study|Death|1|||
33441614|NCT00511355|62817656|FG000|Overall Study|Adverse Event|4|||
33441615|NCT00511355|62817657|FG001|Overall Study|Adverse Event|4|||
33441616|NCT00511355|62817656|FG000|Overall Study|Pregnancy Wish|1|||
33441617|NCT00511355|62817657|FG001|Overall Study|Pregnancy Wish|0|||
33441618|NCT00511355|62817656|FG000|Overall Study|Lost to Follow-up|2|||
33441619|NCT00511355|62817657|FG001|Overall Study|Lost to Follow-up|1|||
33441620|NCT00511355|62817656|FG000|Overall Study|Other Reason|0|||
33441621|NCT00511355|62817657|FG001|Overall Study|Other Reason|1|||
33441622|NCT00511355|62817656|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
33441623|NCT00511355|62817657|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
33441624|NCT00511355|62817656|FG000|Overall Study|Withdrawal of informed consent|0|||
33441625|NCT00511355|62817657|FG001|Overall Study|Withdrawal of informed consent|1|||
33441626|NCT00511355|62817656|FG000|Overall Study|Other reason pre-treatment|0|||
33441627|NCT00511355|62817657|FG001|Overall Study|Other reason pre-treatment|1|||
33441628|NCT00095212|62817667|FG000|Overall Study|Withdrawal by Subject|1|||
33441629|NCT00095212|62817668|FG001|Overall Study|Withdrawal by Subject|3|||
33441630|NCT00120874|62817676|FG000|Overall Study|Death|0|||
33441631|NCT00120874|62817677|FG001|Overall Study|Death|1|||
33606413|NCT02325713|63006490|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33606414|NCT02325713|63006491|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33606415|NCT02325713|63006492|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33606416|NCT02325713|63006493|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33323299|NCT01130532|62699554|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
33441632|NCT00120406|62817685|FG000|Overall Study|Death|9|||
33441633|NCT00120406|62817686|FG001|Overall Study|Death|4|||
33441634|NCT00120406|62817685|FG000|Overall Study|Withdrawal by Subject|5|||
33441635|NCT00120406|62817686|FG001|Overall Study|Withdrawal by Subject|7|||
33441636|NCT00120406|62817685|FG000|Overall Study|Lost to Follow-up|5|||
33441637|NCT00120406|62817686|FG001|Overall Study|Lost to Follow-up|2|||
33441638|NCT00120406|62817685|FG000|Overall Study|received non-study stent|0|||
33441639|NCT00120406|62817686|FG001|Overall Study|received non-study stent|2|||
33441640|NCT00120406|62817685|FG000|Overall Study|patient moved but has not withdrawn|0|||
33441641|NCT00120406|62817686|FG001|Overall Study|patient moved but has not withdrawn|1|||
33441642|NCT00120250|62817692|FG000|Overall Study|Lost to Follow-up|1|||
33441643|NCT00120250|62817693|FG001|Overall Study|Lost to Follow-up|1|||
33441644|NCT00120250|62817692|FG000|Overall Study|Protocol Violation|0|||
33441645|NCT00120250|62817693|FG001|Overall Study|Protocol Violation|1|||
33441646|NCT00511199|62817702|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
33441647|NCT00511199|62817703|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
33441648|NCT00511199|62817702|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
33441649|NCT00511199|62817703|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
33441650|NCT00511199|62817702|FG000|Overall Study|Withdrawal of Informed Consent|19|||
33441651|NCT00511199|62817703|FG001|Overall Study|Withdrawal of Informed Consent|4|||
33441652|NCT00511199|62817702|FG000|Overall Study|Pregnancy|6|||
33441653|NCT00511199|62817703|FG001|Overall Study|Pregnancy|3|||
33441654|NCT00511199|62817702|FG000|Overall Study|Pregnancy Wish|16|||
33441655|NCT00511199|62817703|FG001|Overall Study|Pregnancy Wish|8|||
33441656|NCT00511199|62817702|FG000|Overall Study|Lost to Follow-up|40|||
33441657|NCT00511199|62817703|FG001|Overall Study|Lost to Follow-up|17|||
33441658|NCT00511199|62817702|FG000|Overall Study|Other Reason|78|||
33441659|NCT00511199|62817703|FG001|Overall Study|Other Reason|37|||
33441660|NCT00384176|62817714|FG000|Overall Study|Death|239|||
33494217|NCT04206020|62872991|FG001|Overall Study|Withdrawal by Subject|0|||
33494218|NCT04206020|62872990|FG000|Overall Study|Lost to Follow-up|2|||
33323300|NCT01130532|62699555|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
33441661|NCT00384176|62817715|FG001|Overall Study|Death|247|||
33441662|NCT00384176|62817716|FG002|Overall Study|Death|105|||
33441663|NCT00384176|62817714|FG000|Overall Study|Withdrawal by Subject|52|||
33441664|NCT00384176|62817715|FG001|Overall Study|Withdrawal by Subject|48|||
33441665|NCT00384176|62817716|FG002|Overall Study|Withdrawal by Subject|22|||
33441666|NCT00384176|62817714|FG000|Overall Study|Lost to Follow-up|16|||
33441667|NCT00384176|62817715|FG001|Overall Study|Lost to Follow-up|18|||
33441668|NCT00384176|62817716|FG002|Overall Study|Lost to Follow-up|4|||
33441669|NCT00384176|62817714|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
33441670|NCT00384176|62817715|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
33441671|NCT00384176|62817716|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
33441672|NCT00384176|62817714|FG000|Overall Study|Longer QTC as Visit 1|1|||
33441673|NCT00384176|62817715|FG001|Overall Study|Longer QTC as Visit 1|0|||
33441674|NCT00384176|62817716|FG002|Overall Study|Longer QTC as Visit 1|0|||
33441675|NCT00384176|62817714|FG000|Overall Study|Toxicity of treatment|1|||
33441676|NCT00384176|62817715|FG001|Overall Study|Toxicity of treatment|0|||
33441677|NCT00384176|62817716|FG002|Overall Study|Toxicity of treatment|0|||
33441678|NCT00384176|62817714|FG000|Overall Study|Did not receive study treatment|0|||
33441679|NCT00384176|62817715|FG001|Overall Study|Did not receive study treatment|1|||
33441680|NCT00384176|62817716|FG002|Overall Study|Did not receive study treatment|1|||
33441681|NCT00384176|62817714|FG000|Overall Study|Physician Decision|0|||
33441682|NCT00384176|62817715|FG001|Overall Study|Physician Decision|2|||
33441683|NCT00384176|62817716|FG002|Overall Study|Physician Decision|0|||
33441684|NCT00384176|62817714|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
33441685|NCT00384176|62817715|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
33441686|NCT00384176|62817716|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
33441687|NCT00513305|62817726|FG000|Overall Study|Adverse Event|6|||
33441688|NCT00513305|62817727|FG001|Overall Study|Adverse Event|2|||
33441689|NCT00513305|62817726|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
33441690|NCT00513305|62817727|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
33441691|NCT00513305|62817726|FG000|Overall Study|Lack of Efficacy|8|||
33441692|NCT00513305|62817727|FG001|Overall Study|Lack of Efficacy|13|||
33441693|NCT00513305|62817726|FG000|Overall Study|Withdrawal by Subject|1|||
33441694|NCT00513305|62817727|FG001|Overall Study|Withdrawal by Subject|2|||
33441695|NCT00513305|62817726|FG000|Overall Study|Disease progression|8|||
33441696|NCT00513305|62817727|FG001|Overall Study|Disease progression|5|||
33441697|NCT00513305|62817726|FG000|Overall Study|Eligible for stem cell transplant|1|||
33441698|NCT00513305|62817727|FG001|Overall Study|Eligible for stem cell transplant|0|||
33441699|NCT00513305|62817726|FG000|Overall Study|Hematologic counts did not recover|1|||
33441700|NCT00513305|62817727|FG001|Overall Study|Hematologic counts did not recover|0|||
33441701|NCT00513305|62817726|FG000|Overall Study|Physician Decision|1|||
33441702|NCT00513305|62817727|FG001|Overall Study|Physician Decision|0|||
33441703|NCT00513305|62817726|FG000|Overall Study|Persistent hypocellularity|0|||
33441704|NCT00513305|62817727|FG001|Overall Study|Persistent hypocellularity|1|||
33441705|NCT00513305|62817726|FG000|Overall Study|Sponsor Decision|0|||
33441706|NCT00513305|62817727|FG001|Overall Study|Sponsor Decision|2|||
33441707|NCT00513071|62817733|FG000|Overall Study|Adverse Event|1|||
33441708|NCT00513071|62817733|FG000|Overall Study|Withdrawal by Subject|1|||
33441709|NCT00513071|62817733|FG000|Overall Study|Physician Decision|3|||
33441710|NCT00510887|62817737|FG000|Overall Study|Lost to Follow-up|1|||
33441711|NCT00358826|62817745|FG000|Core Study|Adverse Event|1|||
33441712|NCT00358826|62817746|FG001|Core Study|Adverse Event|3|||
33441713|NCT00358826|62817747|FG002|Core Study|Adverse Event|1|||
33441714|NCT00358826|62817748|FG003|Core Study|Adverse Event|1|||
33441715|NCT00358826|62817749|FG004|Core Study|Adverse Event|0|||
33441716|NCT00358826|62817750|FG005|Core Study|Adverse Event|0|||
33441717|NCT00358826|62817751|FG006|Core Study|Adverse Event|0|||
33441718|NCT00358826|62817752|FG007|Core Study|Adverse Event|0|||
33441719|NCT00358826|62817745|FG000|Core Study|Withdrawal by Subject|2|||
33441720|NCT00358826|62817746|FG001|Core Study|Withdrawal by Subject|2|||
33441721|NCT00358826|62817747|FG002|Core Study|Withdrawal by Subject|0|||
33441722|NCT00358826|62817748|FG003|Core Study|Withdrawal by Subject|0|||
33441723|NCT00358826|62817749|FG004|Core Study|Withdrawal by Subject|0|||
33441724|NCT00358826|62817750|FG005|Core Study|Withdrawal by Subject|0|||
33441725|NCT00358826|62817751|FG006|Core Study|Withdrawal by Subject|0|||
33441726|NCT00358826|62817752|FG007|Core Study|Withdrawal by Subject|0|||
33441727|NCT00358826|62817745|FG000|Core Study|Lost to Follow-up|0|||
33441728|NCT00358826|62817746|FG001|Core Study|Lost to Follow-up|0|||
33441729|NCT00358826|62817747|FG002|Core Study|Lost to Follow-up|0|||
33441730|NCT00358826|62817748|FG003|Core Study|Lost to Follow-up|1|||
33441731|NCT00358826|62817749|FG004|Core Study|Lost to Follow-up|0|||
33441732|NCT00358826|62817750|FG005|Core Study|Lost to Follow-up|0|||
33441733|NCT00358826|62817751|FG006|Core Study|Lost to Follow-up|0|||
33441734|NCT00358826|62817752|FG007|Core Study|Lost to Follow-up|0|||
33441735|NCT00358826|62817745|FG000|Core Study|Physician Decision|0|||
33441736|NCT00358826|62817746|FG001|Core Study|Physician Decision|0|||
33441737|NCT00358826|62817747|FG002|Core Study|Physician Decision|1|||
33441738|NCT00358826|62817748|FG003|Core Study|Physician Decision|0|||
33441739|NCT00358826|62817749|FG004|Core Study|Physician Decision|0|||
33441740|NCT00358826|62817750|FG005|Core Study|Physician Decision|0|||
33441741|NCT00358826|62817751|FG006|Core Study|Physician Decision|0|||
33441742|NCT00358826|62817752|FG007|Core Study|Physician Decision|0|||
33441743|NCT00358826|62817745|FG000|MDCT Substudy|Adverse Event|0|||
33441744|NCT00358826|62817746|FG001|MDCT Substudy|Adverse Event|0|||
33441745|NCT00358826|62817747|FG002|MDCT Substudy|Adverse Event|0|||
33441746|NCT00358826|62817748|FG003|MDCT Substudy|Adverse Event|0|||
33441747|NCT00358826|62817749|FG004|MDCT Substudy|Adverse Event|1|||
33441748|NCT00358826|62817750|FG005|MDCT Substudy|Adverse Event|0|||
33441749|NCT00358826|62817751|FG006|MDCT Substudy|Adverse Event|0|||
33441750|NCT00358826|62817752|FG007|MDCT Substudy|Adverse Event|0|||
33441751|NCT00358826|62817745|FG000|MDCT Substudy|Lost to Follow-up|0|||
33441752|NCT00358826|62817746|FG001|MDCT Substudy|Lost to Follow-up|0|||
33441753|NCT00358826|62817747|FG002|MDCT Substudy|Lost to Follow-up|0|||
33441754|NCT00358826|62817748|FG003|MDCT Substudy|Lost to Follow-up|0|||
33441755|NCT00358826|62817749|FG004|MDCT Substudy|Lost to Follow-up|0|||
33441756|NCT00358826|62817750|FG005|MDCT Substudy|Lost to Follow-up|1|||
33441757|NCT00358826|62817751|FG006|MDCT Substudy|Lost to Follow-up|0|||
33441758|NCT00358826|62817752|FG007|MDCT Substudy|Lost to Follow-up|0|||
33441759|NCT00358826|62817745|FG000|MDCT Substudy|Withdrawal by Subject|0|||
33441760|NCT00358826|62817746|FG001|MDCT Substudy|Withdrawal by Subject|0|||
33441761|NCT00358826|62817747|FG002|MDCT Substudy|Withdrawal by Subject|0|||
33441762|NCT00358826|62817748|FG003|MDCT Substudy|Withdrawal by Subject|0|||
33323301|NCT01130532|62699556|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
33323302|NCT01130532|62699557|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
33323303|NCT01130532|62699554|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
33441763|NCT00358826|62817749|FG004|MDCT Substudy|Withdrawal by Subject|0|||
33441764|NCT00358826|62817750|FG005|MDCT Substudy|Withdrawal by Subject|1|||
33441765|NCT00358826|62817751|FG006|MDCT Substudy|Withdrawal by Subject|0|||
33441766|NCT00358826|62817752|FG007|MDCT Substudy|Withdrawal by Subject|0|||
33441767|NCT00510653|62817766|FG000|Overall Study|Withdrawal by Subject|8|||
33441768|NCT00510653|62817766|FG000|Overall Study|Monetary|3|||
33441769|NCT00362336|62817773|FG000|Overall Study|Serious Adverse Event|1|||
33441770|NCT00362336|62817774|FG001|Overall Study|Serious Adverse Event|0|||
33441771|NCT00362336|62817775|FG002|Overall Study|Serious Adverse Event|1|||
33441772|NCT00362336|62817773|FG000|Overall Study|Protocol Violation|0|||
33441773|NCT00362336|62817774|FG001|Overall Study|Protocol Violation|0|||
33441774|NCT00362336|62817775|FG002|Overall Study|Protocol Violation|1|||
33606417|NCT02325713|63006494|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33606418|NCT02325713|63006495|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33441775|NCT00362336|62817773|FG000|Overall Study|Lost to Follow-up|6|||
33441776|NCT00362336|62817774|FG001|Overall Study|Lost to Follow-up|4|||
33441777|NCT00362336|62817775|FG002|Overall Study|Lost to Follow-up|0|||
33441778|NCT00362336|62817773|FG000|Overall Study|Withdrawal by Subject|3|||
33441779|NCT00362336|62817774|FG001|Overall Study|Withdrawal by Subject|3|||
33441780|NCT00362336|62817775|FG002|Overall Study|Withdrawal by Subject|1|||
33441781|NCT00506285|62817792|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
33441782|NCT00506285|62817793|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
33441783|NCT00506285|62817792|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
33441784|NCT00506285|62817793|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
33441785|NCT00506285|62817792|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
33441786|NCT00506285|62817793|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
33441787|NCT00506285|62817792|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
33441788|NCT00506285|62817793|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
33441789|NCT00506285|62817792|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
33441790|NCT00506285|62817793|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
33441791|NCT00506129|62817801|FG000|Overall Study|Disease Progression/Relapse|15|||
33441792|NCT00506129|62817801|FG000|Overall Study|Death|7|||
33441793|NCT00358670|62817807|FG000|Overall Study|Adverse Event|26|||
33441794|NCT00358670|62817808|FG001|Overall Study|Adverse Event|29|||
33441795|NCT00358670|62817807|FG000|Overall Study|Lack of Efficacy|20|||
33441796|NCT00358670|62817808|FG001|Overall Study|Lack of Efficacy|23|||
33441797|NCT00358670|62817807|FG000|Overall Study|Protocol Violation|6|||
33441798|NCT00358670|62817808|FG001|Overall Study|Protocol Violation|9|||
33441799|NCT00358670|62817807|FG000|Overall Study|Lost to Follow-up|4|||
33441800|NCT00358670|62817808|FG001|Overall Study|Lost to Follow-up|5|||
33441801|NCT00358670|62817807|FG000|Overall Study|Withdrawal by Subject|13|||
33441802|NCT00358670|62817808|FG001|Overall Study|Withdrawal by Subject|24|||
33441803|NCT00358670|62817807|FG000|Overall Study|Protocol Defined Clinical Event|0|||
33441804|NCT00358670|62817808|FG001|Overall Study|Protocol Defined Clinical Event|1|||
33441805|NCT00358670|62817807|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
33441806|NCT00358670|62817808|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
33441807|NCT00358670|62817807|FG000|Overall Study|Administrative|153|||
33441808|NCT00358670|62817808|FG001|Overall Study|Administrative|125|||
33441809|NCT00505661|62817814|FG000|Overall Study|Not Eligible|4|||
33441810|NCT00383786|62817820|FG000|Overall Study|Protocol Violation|2|||
33441811|NCT00383786|62817821|FG001|Overall Study|Protocol Violation|6|||
33441812|NCT00383786|62817820|FG000|Overall Study|Withdrawal by Subject|2|||
33441813|NCT00383786|62817821|FG001|Overall Study|Withdrawal by Subject|5|||
33441814|NCT00383786|62817820|FG000|Overall Study|Physician Decision|0|||
33441815|NCT00383786|62817821|FG001|Overall Study|Physician Decision|1|||
33441816|NCT00383708|62817827|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
33441817|NCT00383708|62817827|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
33441818|NCT00383708|62817827|FG000|Run-in Period|Protocol Violation|4|||
33441819|NCT00383708|62817827|FG000|Run-in Period|Adverse Event|2|||
33441820|NCT00383708|62817827|FG000|Run-in Period|Claustrophobia|1|||
33441821|NCT00383708|62817827|FG000|Co-administration Period|Adverse Event|5|||
33441822|NCT00504881|62817834|FG000|Overall Study|Lack of Efficacy|1|||
33441823|NCT00504881|62817835|FG001|Overall Study|Lack of Efficacy|5|||
33441824|NCT00504881|62817834|FG000|Overall Study|Lost to Follow-up|0|||
33441825|NCT00504881|62817835|FG001|Overall Study|Lost to Follow-up|2|||
33441826|NCT00504881|62817834|FG000|Overall Study|Withdrawal by Subject|1|||
33441827|NCT00504881|62817835|FG001|Overall Study|Withdrawal by Subject|4|||
33441828|NCT00504881|62817834|FG000|Overall Study|Non-Compliance|1|||
33441829|NCT00504881|62817835|FG001|Overall Study|Non-Compliance|0|||
33441830|NCT00504881|62817834|FG000|Overall Study|No Birth Control|0|||
33441831|NCT00504881|62817835|FG001|Overall Study|No Birth Control|1|||
33441832|NCT00504881|62817834|FG000|Overall Study|Safety Visit not performed|0|||
33441833|NCT00504881|62817835|FG001|Overall Study|Safety Visit not performed|1|||
33606419|NCT02325713|63006496|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33606420|NCT02325713|63006497|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
33441834|NCT00504881|62817834|FG000|Overall Study|AE, serious fatal|0|||
33441835|NCT00504881|62817835|FG001|Overall Study|AE, serious fatal|1|||
33606421|NCT02325713|63006498|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33441836|NCT00504881|62817834|FG000|Overall Study|SAE, non-fatal|2|||
33441837|NCT00504881|62817835|FG001|Overall Study|SAE, non-fatal|6|||
33441838|NCT00504881|62817834|FG000|Overall Study|AE, non-serious non-fatal|4|||
33606422|NCT02325713|63006499|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33441839|NCT00504881|62817835|FG001|Overall Study|AE, non-serious non-fatal|14|||
33464875|NCT00040664|62838371|FG003|Overall Study|Protocol Violation|1|||
33606423|NCT02325713|63006500|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33441840|NCT00504881|62817834|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
33441841|NCT00504881|62817835|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
33441842|NCT00504881|62817834|FG000|Overall Study|AE of unknown type|1|||
33441843|NCT00504881|62817835|FG001|Overall Study|AE of unknown type|0|||
33441844|NCT00504725|62817845|FG000|Overall Study|Protocol Violation|1|||
33441845|NCT00504725|62817846|FG001|Overall Study|Protocol Violation|0|||
33441846|NCT00383240|62817856|FG000|Overall Study|Adverse Event|4|||
33441847|NCT00383240|62817857|FG001|Overall Study|Adverse Event|6|||
33441848|NCT00383240|62817858|FG002|Overall Study|Adverse Event|9|||
33441849|NCT00383240|62817859|FG003|Overall Study|Adverse Event|7|||
33441850|NCT00383240|62817856|FG000|Overall Study|Treatment Failure|8|||
33441851|NCT00383240|62817857|FG001|Overall Study|Treatment Failure|13|||
33441852|NCT00383240|62817858|FG002|Overall Study|Treatment Failure|47|||
33441853|NCT00383240|62817859|FG003|Overall Study|Treatment Failure|46|||
33441854|NCT00383240|62817856|FG000|Overall Study|Lost to Follow-up|3|||
33441855|NCT00383240|62817857|FG001|Overall Study|Lost to Follow-up|0|||
33441856|NCT00383240|62817858|FG002|Overall Study|Lost to Follow-up|0|||
33441857|NCT00383240|62817859|FG003|Overall Study|Lost to Follow-up|2|||
33441858|NCT00383240|62817856|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
33441859|NCT00383240|62817857|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
33441860|NCT00383240|62817858|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
33441861|NCT00383240|62817859|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
33441862|NCT00383240|62817856|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
33441863|NCT00383240|62817857|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
33441864|NCT00383240|62817858|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
33441865|NCT00383240|62817859|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
33441866|NCT00383240|62817856|FG000|Overall Study|Protocol Violation|4|||
33441867|NCT00383240|62817857|FG001|Overall Study|Protocol Violation|5|||
33441868|NCT00383240|62817858|FG002|Overall Study|Protocol Violation|9|||
33441869|NCT00383240|62817859|FG003|Overall Study|Protocol Violation|6|||
33606424|NCT02325713|63006501|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33606425|NCT02325713|63006502|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33606426|NCT02325713|63006487|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
33606427|NCT02325713|63006488|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33606428|NCT02325713|63006489|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33606429|NCT02325713|63006490|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33606430|NCT02325713|63006491|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33606431|NCT02325713|63006492|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33606432|NCT02325713|63006493|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33606433|NCT02325713|63006494|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33606434|NCT02325713|63006495|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33606435|NCT02325713|63006496|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33606436|NCT02325713|63006497|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33606437|NCT02325713|63006498|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33606438|NCT02325713|63006499|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33606439|NCT02325713|63006500|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33606440|NCT02325713|63006501|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33606441|NCT02325713|63006502|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33606442|NCT02325713|63006487|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33606443|NCT02325713|63006488|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33606444|NCT02325713|63006489|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33606445|NCT02325713|63006490|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33606446|NCT02325713|63006491|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33606447|NCT02325713|63006492|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33606448|NCT02325713|63006493|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33606449|NCT02325713|63006494|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33606450|NCT02325713|63006495|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33441870|NCT00383240|62817856|FG000|Overall Study|Did not meet protocol eligibility|9|||
33441871|NCT00383240|62817857|FG001|Overall Study|Did not meet protocol eligibility|4|||
33441872|NCT00383240|62817858|FG002|Overall Study|Did not meet protocol eligibility|9|||
33441873|NCT00383240|62817859|FG003|Overall Study|Did not meet protocol eligibility|3|||
33441874|NCT00383240|62817856|FG000|Overall Study|Administrative|1|||
33441875|NCT00383240|62817857|FG001|Overall Study|Administrative|1|||
33441876|NCT00383240|62817858|FG002|Overall Study|Administrative|0|||
33441877|NCT00383240|62817859|FG003|Overall Study|Administrative|0|||
33606451|NCT02325713|63006496|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
33606452|NCT02325713|63006497|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33606453|NCT02325713|63006498|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33606454|NCT02325713|63006499|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33606455|NCT02325713|63006500|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33441878|NCT00362180|62817879|FG000|Treated Period|Withdrawal by Subject|1|||
33441879|NCT00362180|62817880|FG001|Treated Period|Withdrawal by Subject|0|||
33323304|NCT01130532|62699555|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
33441880|NCT00362180|62817881|FG002|Treated Period|Withdrawal by Subject|0|||
33441881|NCT00362180|62817882|FG003|Treated Period|Withdrawal by Subject|0|||
33441882|NCT00362180|62817883|FG004|Treated Period|Withdrawal by Subject|0|||
33441883|NCT00362180|62817884|FG005|Treated Period|Withdrawal by Subject|0|||
33441884|NCT00362180|62817885|FG006|Treated Period|Withdrawal by Subject|0|||
33441885|NCT00362180|62817886|FG007|Treated Period|Withdrawal by Subject|0|||
33441886|NCT00362180|62817887|FG008|Treated Period|Withdrawal by Subject|0|||
33441887|NCT00362180|62817879|FG000|Treated Period|Adverse Event|0|||
33441888|NCT00362180|62817880|FG001|Treated Period|Adverse Event|0|||
33441889|NCT00362180|62817881|FG002|Treated Period|Adverse Event|0|||
33441890|NCT00362180|62817882|FG003|Treated Period|Adverse Event|0|||
33441891|NCT00362180|62817883|FG004|Treated Period|Adverse Event|0|||
33441892|NCT00362180|62817884|FG005|Treated Period|Adverse Event|1|||
33441893|NCT00362180|62817885|FG006|Treated Period|Adverse Event|0|||
33441894|NCT00362180|62817886|FG007|Treated Period|Adverse Event|1|||
33441895|NCT00362180|62817887|FG008|Treated Period|Adverse Event|0|||
33441896|NCT00383162|62817905|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
33441897|NCT00383162|62817906|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
33441898|NCT00383162|62817905|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
33441899|NCT00383162|62817906|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
33441900|NCT00383162|62817905|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
33441901|NCT00383162|62817906|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
33441902|NCT00383162|62817905|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
33441903|NCT00383162|62817906|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
33441904|NCT00383162|62817905|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
33441905|NCT00383162|62817906|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
33441906|NCT00383162|62817905|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
33441907|NCT00383162|62817906|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
33441908|NCT00383162|62817905|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
33441909|NCT00383162|62817906|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
33441910|NCT00383162|62817905|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
33441911|NCT00383162|62817906|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
33441912|NCT00383162|62817905|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
33441913|NCT00383162|62817906|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
33441914|NCT00358436|62817914|FG000|Overall Study|Adverse Event|29|||
33441915|NCT00358436|62817915|FG001|Overall Study|Adverse Event|13|||
33441916|NCT00358436|62817914|FG000|Overall Study|Lack of Efficacy|34|||
33441917|NCT00358436|62817915|FG001|Overall Study|Lack of Efficacy|36|||
33441918|NCT00358436|62817914|FG000|Overall Study|Lost to Follow-up|11|||
33441919|NCT00358436|62817915|FG001|Overall Study|Lost to Follow-up|6|||
33441920|NCT00358436|62817914|FG000|Overall Study|Protocol Violation|8|||
33441921|NCT00358436|62817915|FG001|Overall Study|Protocol Violation|3|||
33441922|NCT00358436|62817914|FG000|Overall Study|Withdrawal by Subject|40|||
33441923|NCT00358436|62817915|FG001|Overall Study|Withdrawal by Subject|17|||
33441924|NCT00358436|62817914|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
33441925|NCT00358436|62817915|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
33441926|NCT00358436|62817914|FG000|Overall Study|COPD exacerbation|22|||
33441927|NCT00358436|62817915|FG001|Overall Study|COPD exacerbation|10|||
33441928|NCT00358436|62817914|FG000|Overall Study|Other|6|||
33441929|NCT00358436|62817915|FG001|Overall Study|Other|1|||
33441930|NCT00383084|62817925|FG000|Overall Study|Withdrawal by Subject|12|||
33441931|NCT00383084|62817926|FG001|Overall Study|Withdrawal by Subject|10|||
33441932|NCT00361634|62817932|FG000|Overall Study|Lost to Follow-up|1|||
33441933|NCT00361634|62817932|FG000|Overall Study|Withdrawal by Subject|1|||
33441934|NCT00357968|62817938|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
33441935|NCT00357968|62817939|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
33441936|NCT00357968|62817938|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
33441937|NCT00357968|62817939|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
33441938|NCT00357656|62817962|FG000|Overall Study|Other, No surgery performed|0|||
33441939|NCT00357656|62817963|FG001|Overall Study|Other, No surgery performed|3|||
33441940|NCT00357500|62817981|FG000|Overall Study|Adverse Event|3|||
33441941|NCT00357500|62817981|FG000|Overall Study|Withdrawal by Subject|5|||
33441942|NCT00357500|62817981|FG000|Overall Study|Progressive Disease|65|||
33441943|NCT00357500|62817981|FG000|Overall Study|Not Started Protocol Therapy|4|||
33441944|NCT00357110|62817987|FG000|Overall Study|Early study termination|5|||
33441945|NCT00357110|62817988|FG001|Overall Study|Early study termination|5|||
33441946|NCT00098722|62817997|FG000|Double Blind Phase|Adverse Event|7|||
33441947|NCT00098722|62817998|FG001|Double Blind Phase|Adverse Event|7|||
33441948|NCT00098722|62817999|FG002|Double Blind Phase|Adverse Event|3|||
33441949|NCT00098722|62818000|FG003|Double Blind Phase|Adverse Event|0|||
33441950|NCT00098722|62818001|FG004|Double Blind Phase|Adverse Event|0|||
33441951|NCT00098722|62818002|FG005|Double Blind Phase|Adverse Event|0|||
33441952|NCT00098722|62818003|FG006|Double Blind Phase|Adverse Event|0|||
33441953|NCT00098722|62817997|FG000|Double Blind Phase|Death|2|||
33441954|NCT00098722|62817998|FG001|Double Blind Phase|Death|5|||
33441955|NCT00098722|62817999|FG002|Double Blind Phase|Death|0|||
33441956|NCT00098722|62818000|FG003|Double Blind Phase|Death|0|||
33441957|NCT00098722|62818001|FG004|Double Blind Phase|Death|0|||
33441958|NCT00098722|62818002|FG005|Double Blind Phase|Death|0|||
33441959|NCT00098722|62818003|FG006|Double Blind Phase|Death|0|||
33441960|NCT00098722|62817997|FG000|Double Blind Phase|Lack of Efficacy|21|||
33441961|NCT00098722|62817998|FG001|Double Blind Phase|Lack of Efficacy|23|||
33441962|NCT00098722|62817999|FG002|Double Blind Phase|Lack of Efficacy|15|||
33441963|NCT00098722|62818000|FG003|Double Blind Phase|Lack of Efficacy|0|||
33441964|NCT00098722|62818001|FG004|Double Blind Phase|Lack of Efficacy|0|||
33494219|NCT04206020|62872991|FG001|Overall Study|Lost to Follow-up|0|||
33441965|NCT00098722|62818002|FG005|Double Blind Phase|Lack of Efficacy|0|||
33441966|NCT00098722|62818003|FG006|Double Blind Phase|Lack of Efficacy|0|||
33441967|NCT00098722|62817997|FG000|Double Blind Phase|Participant defaulted|16|||
33441968|NCT00098722|62817998|FG001|Double Blind Phase|Participant defaulted|11|||
33441969|NCT00098722|62817999|FG002|Double Blind Phase|Participant defaulted|9|||
33441970|NCT00098722|62818000|FG003|Double Blind Phase|Participant defaulted|0|||
33441971|NCT00098722|62818001|FG004|Double Blind Phase|Participant defaulted|0|||
33441972|NCT00098722|62818002|FG005|Double Blind Phase|Participant defaulted|0|||
33441973|NCT00098722|62818003|FG006|Double Blind Phase|Participant defaulted|0|||
33441974|NCT00098722|62817997|FG000|Double Blind Phase|Pregnancy|1|||
33441975|NCT00098722|62817998|FG001|Double Blind Phase|Pregnancy|0|||
33441976|NCT00098722|62817999|FG002|Double Blind Phase|Pregnancy|0|||
33441977|NCT00098722|62818000|FG003|Double Blind Phase|Pregnancy|0|||
33441978|NCT00098722|62818001|FG004|Double Blind Phase|Pregnancy|0|||
33441979|NCT00098722|62818002|FG005|Double Blind Phase|Pregnancy|0|||
33441980|NCT00098722|62818003|FG006|Double Blind Phase|Pregnancy|0|||
33441981|NCT00098722|62817997|FG000|Double Blind Phase|Randomized, not treated|4|||
33441982|NCT00098722|62817998|FG001|Double Blind Phase|Randomized, not treated|3|||
33441983|NCT00098722|62817999|FG002|Double Blind Phase|Randomized, not treated|3|||
33441984|NCT00098722|62818000|FG003|Double Blind Phase|Randomized, not treated|0|||
33441985|NCT00098722|62818001|FG004|Double Blind Phase|Randomized, not treated|0|||
33441986|NCT00098722|62818002|FG005|Double Blind Phase|Randomized, not treated|0|||
33441987|NCT00098722|62818003|FG006|Double Blind Phase|Randomized, not treated|0|||
33606456|NCT02325713|63006501|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33606457|NCT02325713|63006502|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33606458|NCT02325401|63006517|FG000|Overall Study|Withdrawal by Subject|0|||
33606459|NCT02325401|63006518|FG001|Overall Study|Withdrawal by Subject|1|||
33606460|NCT02325401|63006519|FG002|Overall Study|Withdrawal by Subject|1|||
33606461|NCT02324699|63006533|FG000|Overall Study|study terminated|1|||
33606462|NCT01764256|63006541|FG000|Received All Vaccinations|Adverse Event|1|||
33441988|NCT00098722|62817997|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
33441989|NCT00098722|62817998|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
33441990|NCT00098722|62817999|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
33441991|NCT00098722|62818000|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
33441992|NCT00098722|62818001|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
33441993|NCT00098722|62818002|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
33441994|NCT00098722|62818003|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
33441995|NCT00098722|62817997|FG000|Double Blind Phase|Other|7|||
33441996|NCT00098722|62817998|FG001|Double Blind Phase|Other|8|||
33441997|NCT00098722|62817999|FG002|Double Blind Phase|Other|7|||
33441998|NCT00098722|62818000|FG003|Double Blind Phase|Other|0|||
33441999|NCT00098722|62818001|FG004|Double Blind Phase|Other|0|||
33442000|NCT00098722|62818002|FG005|Double Blind Phase|Other|0|||
33442001|NCT00098722|62818003|FG006|Double Blind Phase|Other|0|||
33442002|NCT00098722|62817997|FG000|Open Label Phase|Adverse Event|0|||
33442003|NCT00098722|62817998|FG001|Open Label Phase|Adverse Event|0|||
33442004|NCT00098722|62817999|FG002|Open Label Phase|Adverse Event|0|||
33442005|NCT00098722|62818000|FG003|Open Label Phase|Adverse Event|5|||
33442006|NCT00098722|62818001|FG004|Open Label Phase|Adverse Event|0|||
33442007|NCT00098722|62818002|FG005|Open Label Phase|Adverse Event|0|||
33442008|NCT00098722|62818003|FG006|Open Label Phase|Adverse Event|0|||
33442009|NCT00098722|62817997|FG000|Open Label Phase|Death|0|||
33442010|NCT00098722|62817998|FG001|Open Label Phase|Death|0|||
33442011|NCT00098722|62817999|FG002|Open Label Phase|Death|0|||
33442012|NCT00098722|62818000|FG003|Open Label Phase|Death|2|||
33442013|NCT00098722|62818001|FG004|Open Label Phase|Death|0|||
33442014|NCT00098722|62818002|FG005|Open Label Phase|Death|0|||
33442015|NCT00098722|62818003|FG006|Open Label Phase|Death|0|||
33442016|NCT00098722|62817997|FG000|Open Label Phase|Lack of Efficacy|0|||
33442017|NCT00098722|62817998|FG001|Open Label Phase|Lack of Efficacy|0|||
33442018|NCT00098722|62817999|FG002|Open Label Phase|Lack of Efficacy|0|||
33442019|NCT00098722|62818000|FG003|Open Label Phase|Lack of Efficacy|8|||
33442020|NCT00098722|62818001|FG004|Open Label Phase|Lack of Efficacy|0|||
33442021|NCT00098722|62818002|FG005|Open Label Phase|Lack of Efficacy|0|||
33442022|NCT00098722|62818003|FG006|Open Label Phase|Lack of Efficacy|0|||
33442023|NCT00098722|62817997|FG000|Open Label Phase|Pregnancy|0|||
33442024|NCT00098722|62817998|FG001|Open Label Phase|Pregnancy|0|||
33442025|NCT00098722|62817999|FG002|Open Label Phase|Pregnancy|0|||
33442026|NCT00098722|62818000|FG003|Open Label Phase|Pregnancy|1|||
33442027|NCT00098722|62818001|FG004|Open Label Phase|Pregnancy|0|||
33442028|NCT00098722|62818002|FG005|Open Label Phase|Pregnancy|0|||
33442029|NCT00098722|62818003|FG006|Open Label Phase|Pregnancy|0|||
33442030|NCT00098722|62817997|FG000|Open Label Phase|Participant defaulted|0|||
33442031|NCT00098722|62817998|FG001|Open Label Phase|Participant defaulted|0|||
33442032|NCT00098722|62817999|FG002|Open Label Phase|Participant defaulted|0|||
33442033|NCT00098722|62818000|FG003|Open Label Phase|Participant defaulted|18|||
33442034|NCT00098722|62818001|FG004|Open Label Phase|Participant defaulted|0|||
33442035|NCT00098722|62818002|FG005|Open Label Phase|Participant defaulted|0|||
33442036|NCT00098722|62818003|FG006|Open Label Phase|Participant defaulted|0|||
33442037|NCT00098722|62817997|FG000|Open Label Phase|Ongoing at cut-off date|0|||
33442038|NCT00098722|62817998|FG001|Open Label Phase|Ongoing at cut-off date|0|||
33442039|NCT00098722|62817999|FG002|Open Label Phase|Ongoing at cut-off date|0|||
33442040|NCT00098722|62818000|FG003|Open Label Phase|Ongoing at cut-off date|220|||
33442041|NCT00098722|62818001|FG004|Open Label Phase|Ongoing at cut-off date|50|||
33442042|NCT00098722|62818002|FG005|Open Label Phase|Ongoing at cut-off date|0|||
33442043|NCT00098722|62818003|FG006|Open Label Phase|Ongoing at cut-off date|0|||
33442044|NCT00098722|62817997|FG000|Open Label Phase|Other|0|||
33442045|NCT00098722|62817998|FG001|Open Label Phase|Other|0|||
33442046|NCT00098722|62817999|FG002|Open Label Phase|Other|0|||
33442047|NCT00098722|62818000|FG003|Open Label Phase|Other|18|||
33442048|NCT00098722|62818001|FG004|Open Label Phase|Other|0|||
33442049|NCT00098722|62818002|FG005|Open Label Phase|Other|0|||
33442050|NCT00098722|62818003|FG006|Open Label Phase|Other|0|||
33442051|NCT00098722|62817997|FG000|Observation Phase|Death|0|||
33442052|NCT00098722|62817998|FG001|Observation Phase|Death|0|||
33442053|NCT00098722|62817999|FG002|Observation Phase|Death|0|||
33442054|NCT00098722|62818000|FG003|Observation Phase|Death|0|||
33442055|NCT00098722|62818001|FG004|Observation Phase|Death|0|||
33442056|NCT00098722|62818002|FG005|Observation Phase|Death|5|||
33442057|NCT00098722|62818003|FG006|Observation Phase|Death|3|||
33442058|NCT00098722|62817997|FG000|Observation Phase|Lack of Efficacy|0|||
33442059|NCT00098722|62817998|FG001|Observation Phase|Lack of Efficacy|0|||
33442060|NCT00098722|62817999|FG002|Observation Phase|Lack of Efficacy|0|||
33442061|NCT00098722|62818000|FG003|Observation Phase|Lack of Efficacy|0|||
33442062|NCT00098722|62818001|FG004|Observation Phase|Lack of Efficacy|0|||
33442063|NCT00098722|62818002|FG005|Observation Phase|Lack of Efficacy|2|||
33442064|NCT00098722|62818003|FG006|Observation Phase|Lack of Efficacy|0|||
33442065|NCT00098722|62817997|FG000|Observation Phase|Participant defaulted|0|||
33442066|NCT00098722|62817998|FG001|Observation Phase|Participant defaulted|0|||
33442067|NCT00098722|62817999|FG002|Observation Phase|Participant defaulted|0|||
33442068|NCT00098722|62818000|FG003|Observation Phase|Participant defaulted|0|||
33442069|NCT00098722|62818001|FG004|Observation Phase|Participant defaulted|0|||
33442070|NCT00098722|62818002|FG005|Observation Phase|Participant defaulted|17|||
33442071|NCT00098722|62818003|FG006|Observation Phase|Participant defaulted|4|||
33442072|NCT00098722|62817997|FG000|Observation Phase|Other|0|||
33442073|NCT00098722|62817998|FG001|Observation Phase|Other|0|||
33442074|NCT00098722|62817999|FG002|Observation Phase|Other|0|||
33442075|NCT00098722|62818000|FG003|Observation Phase|Other|0|||
33442076|NCT00098722|62818001|FG004|Observation Phase|Other|0|||
33442077|NCT00098722|62818002|FG005|Observation Phase|Other|21|||
33442078|NCT00098722|62818003|FG006|Observation Phase|Other|10|||
33442079|NCT00098254|62818015|FG000|Overall Study|Adverse Event|2|||
33442080|NCT00098254|62818015|FG000|Overall Study|Death|1|||
33442081|NCT00095056|62818021|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
33442082|NCT00095056|62818022|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
33442083|NCT00095056|62818021|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
33442084|NCT00095056|62818022|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
33442085|NCT00095056|62818021|FG000|Phase A (Weeks 0-12)|Death|1|||
33442086|NCT00095056|62818022|FG001|Phase A (Weeks 0-12)|Death|0|||
33442087|NCT00095056|62818021|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
33442088|NCT00095056|62818022|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
33442089|NCT00095056|62818021|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
33442090|NCT00095056|62818022|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
33442091|NCT00095056|62818021|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
33442092|NCT00095056|62818022|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
33442093|NCT00095056|62818021|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
33442094|NCT00095056|62818022|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
33442095|NCT00095056|62818021|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
33442096|NCT00095056|62818022|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
33442097|NCT00095056|62818021|FG000|Phase B (Weeks 12-54)|Death|3|||
33442098|NCT00095056|62818022|FG001|Phase B (Weeks 12-54)|Death|1|||
33442099|NCT00095056|62818021|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
33442100|NCT00095056|62818022|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
33442101|NCT00095056|62818021|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
33442102|NCT00095056|62818022|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
33442103|NCT00098020|62818028|FG000|Overall Study|Adverse Event|2|||
33442104|NCT00098020|62818028|FG000|Overall Study|Lost to Follow-up|1|||
33442105|NCT00098020|62818028|FG000|Overall Study|elevated liver enzymes|1|||
33442106|NCT00098020|62818028|FG000|Overall Study|Low urine PCR|1|||
33442107|NCT00098020|62818028|FG000|Overall Study|Low epidermal growth factor receptor|1|||
33442108|NCT00381680|62818034|FG000|Overall Study|Adverse Event|9|||
33442109|NCT00381680|62818035|FG001|Overall Study|Adverse Event|3|||
33442110|NCT00381680|62818034|FG000|Overall Study|Death|10|||
33442111|NCT00381680|62818035|FG001|Overall Study|Death|7|||
33442112|NCT00381680|62818034|FG000|Overall Study|Lost to Follow-up|3|||
33442113|NCT00381680|62818035|FG001|Overall Study|Lost to Follow-up|2|||
33606463|NCT01764256|63006542|FG001|Received All Vaccinations|Adverse Event|1|||
33323305|NCT01130532|62699556|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
33323306|NCT01130532|62699557|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
33323307|NCT01130532|62699554|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
33442114|NCT00381680|62818034|FG000|Overall Study|Physician Decision|25|||
33442115|NCT00381680|62818035|FG001|Overall Study|Physician Decision|6|||
33442116|NCT00381680|62818034|FG000|Overall Study|Withdrawal by Subject|3|||
33442117|NCT00381680|62818035|FG001|Overall Study|Withdrawal by Subject|1|||
33442118|NCT00381680|62818034|FG000|Overall Study|Entry onto another COG Trial|1|||
33442119|NCT00381680|62818035|FG001|Overall Study|Entry onto another COG Trial|2|||
33442120|NCT00381680|62818034|FG000|Overall Study|Alternative Therapy|11|||
33442121|NCT00381680|62818035|FG001|Overall Study|Alternative Therapy|5|||
33442122|NCT00381680|62818034|FG000|Overall Study|Secondary Malignancy|3|||
33442123|NCT00381680|62818035|FG001|Overall Study|Secondary Malignancy|0|||
33442124|NCT00381680|62818034|FG000|Overall Study|Delay initiation|1|||
33442125|NCT00381680|62818035|FG001|Overall Study|Delay initiation|0|||
33442126|NCT00381680|62818034|FG000|Overall Study|Stem Cell Transplant|26|||
33442127|NCT00381680|62818035|FG001|Overall Study|Stem Cell Transplant|10|||
33442128|NCT00381680|62818034|FG000|Overall Study|Relapse|18|||
33606464|NCT01764256|63006543|FG002|Received All Vaccinations|Adverse Event|0|||
33606465|NCT01764256|63006544|FG003|Received All Vaccinations|Adverse Event|0|||
33606466|NCT01764256|63006541|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
33606467|NCT01764256|63006542|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
33606468|NCT01764256|63006543|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
33606469|NCT01764256|63006544|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
33442129|NCT00381680|62818035|FG001|Overall Study|Relapse|9|||
33442130|NCT00381680|62818034|FG000|Overall Study|Induction Failure|4|||
33442131|NCT00381680|62818035|FG001|Overall Study|Induction Failure|1|||
33442132|NCT00381680|62818034|FG000|Overall Study|Progression|1|||
33442133|NCT00381680|62818035|FG001|Overall Study|Progression|1|||
33442134|NCT00381680|62818034|FG000|Overall Study|Other not otherwise specified|7|||
33442135|NCT00381680|62818035|FG001|Overall Study|Other not otherwise specified|2|||
33442136|NCT00381680|62818034|FG000|Overall Study|Ineligible|3|||
33442137|NCT00381680|62818035|FG001|Overall Study|Ineligible|1|||
33442138|NCT00360698|62818047|FG000|Run-In|Physician Decision|0|||
33442139|NCT00360698|62818048|FG001|Run-In|Physician Decision|1|||
33442140|NCT00360698|62818047|FG000|Run-In|Withdrawal by Subject|0|||
33442141|NCT00360698|62818048|FG001|Run-In|Withdrawal by Subject|2|||
33442142|NCT00360698|62818047|FG000|Run-In|Non compliance with treatment procedure|0|||
33606470|NCT01764256|63006541|FG000|Received All Vaccinations|Lost to Follow-up|1|||
33606471|NCT01764256|63006542|FG001|Received All Vaccinations|Lost to Follow-up|0|||
33442143|NCT00360698|62818048|FG001|Run-In|Non compliance with treatment procedure|1|||
33442144|NCT00360698|62818047|FG000|Run-In|Sponsor request|0|||
33442145|NCT00360698|62818048|FG001|Run-In|Sponsor request|2|||
33442146|NCT00360698|62818047|FG000|Run-In|Patient did not meet inclusion criteria|0|||
33442147|NCT00360698|62818048|FG001|Run-In|Patient did not meet inclusion criteria|1|||
33442148|NCT00360698|62818047|FG000|Run-In|Patient personal reasons|0|||
33606472|NCT01764256|63006543|FG002|Received All Vaccinations|Lost to Follow-up|0|||
33606473|NCT01764256|63006544|FG003|Received All Vaccinations|Lost to Follow-up|0|||
33606474|NCT01764256|63006541|FG000|Completed Study|Lost to Follow-up|0|||
33606475|NCT01764256|63006542|FG001|Completed Study|Lost to Follow-up|0|||
33606476|NCT01764256|63006543|FG002|Completed Study|Lost to Follow-up|0|||
33606477|NCT01764256|63006544|FG003|Completed Study|Lost to Follow-up|1|||
33442149|NCT00360698|62818048|FG001|Run-In|Patient personal reasons|2|||
33442150|NCT00360698|62818047|FG000|Run-In|Need of insulin with meals|0|||
33606478|NCT01979523|63006560|FG000|Overall Study|Withdrawal by Subject|1|||
33606479|NCT01979523|63006561|FG001|Overall Study|Withdrawal by Subject|0|||
33606480|NCT02255461|63006573|FG000|Overall Study|Adverse Event|0|||
33606481|NCT02255461|63006574|FG001|Overall Study|Adverse Event|1|||
33606482|NCT02255461|63006575|FG002|Overall Study|Adverse Event|0|||
33606483|NCT02255461|63006576|FG003|Overall Study|Adverse Event|0|||
33442151|NCT00360698|62818048|FG001|Run-In|Need of insulin with meals|1|||
33442152|NCT00360698|62818047|FG000|Treatment Period|Non compliance with treatment procedure|1|||
33442153|NCT00360698|62818048|FG001|Treatment Period|Non compliance with treatment procedure|0|||
33442154|NCT00360698|62818047|FG000|Treatment Period|Early termination by error|0|||
33606484|NCT02255461|63006577|FG004|Overall Study|Adverse Event|1|||
33606485|NCT02255461|63006573|FG000|Overall Study|Withdrawal by Subject|0|||
33606486|NCT02255461|63006574|FG001|Overall Study|Withdrawal by Subject|0|||
33606487|NCT02255461|63006575|FG002|Overall Study|Withdrawal by Subject|1|||
33442155|NCT00360698|62818048|FG001|Treatment Period|Early termination by error|1|||
33442156|NCT00380978|62818056|FG000|Overall Study|Refused allocated intervention|0|||
33442157|NCT00380978|62818057|FG001|Overall Study|Refused allocated intervention|6|||
33442158|NCT00380978|62818056|FG000|Overall Study|Wrong study envelope|0|||
33442159|NCT00380978|62818057|FG001|Overall Study|Wrong study envelope|2|||
33442160|NCT00380978|62818056|FG000|Overall Study|Allocation prior to analgesia request|1|||
33442161|NCT00380978|62818057|FG001|Overall Study|Allocation prior to analgesia request|2|||
33323308|NCT01130532|62699555|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
33442162|NCT00380978|62818056|FG000|Overall Study|Parous patient|1|||
33442163|NCT00380978|62818057|FG001|Overall Study|Parous patient|0|||
33323309|NCT01130532|62699556|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
33323310|NCT01130532|62699557|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
33323311|NCT01130532|62699554|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
33323312|NCT01130532|62699555|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
33323313|NCT01130532|62699556|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
33323314|NCT01130532|62699557|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
33323315|NCT01130532|62699554|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
33323316|NCT01130532|62699555|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
33323317|NCT01130532|62699556|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
33323318|NCT01130532|62699557|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
33323319|NCT01130532|62699554|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
33323320|NCT01130532|62699555|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
33323321|NCT01130532|62699556|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
33323322|NCT01130532|62699557|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
33323323|NCT00972777|62699571|FG000|Overall Study|Adverse Event|3|||
33323324|NCT00972777|62699572|FG001|Overall Study|Adverse Event|2|||
33323325|NCT00972777|62699571|FG000|Overall Study|Lost to Follow-up|0|||
33323326|NCT00972777|62699572|FG001|Overall Study|Lost to Follow-up|4|||
33323327|NCT00972777|62699571|FG000|Overall Study|Withdrawal by Subject|4|||
33323328|NCT00972777|62699572|FG001|Overall Study|Withdrawal by Subject|5|||
33323329|NCT00972777|62699571|FG000|Overall Study|Physician Decision|4|||
33323330|NCT00972777|62699572|FG001|Overall Study|Physician Decision|0|||
33323331|NCT00972777|62699571|FG000|Overall Study|Protocol Violation|0|||
33323332|NCT00972777|62699572|FG001|Overall Study|Protocol Violation|2|||
33323333|NCT00972777|62699571|FG000|Overall Study|Screening Failure|2|||
33323334|NCT00972777|62699572|FG001|Overall Study|Screening Failure|1|||
33442164|NCT00162123|62818071|FG000|Overall Study|Disease progression|27|||
33442165|NCT00162123|62818072|FG001|Overall Study|Disease progression|19|||
33442166|NCT00162123|62818073|FG002|Overall Study|Disease progression|10|||
33442167|NCT00162123|62818074|FG003|Overall Study|Disease progression|4|||
33442168|NCT00162123|62818075|FG004|Overall Study|Disease progression|8|||
33442169|NCT00162123|62818076|FG005|Overall Study|Disease progression|3|||
33442170|NCT00162123|62818077|FG006|Overall Study|Disease progression|1|||
33442171|NCT00162123|62818078|FG007|Overall Study|Disease progression|0|||
33442172|NCT00162123|62818071|FG000|Overall Study|Study drug toxicity|6|||
33442173|NCT00162123|62818072|FG001|Overall Study|Study drug toxicity|1|||
33606488|NCT02255461|63006576|FG003|Overall Study|Withdrawal by Subject|0|||
33606489|NCT02255461|63006577|FG004|Overall Study|Withdrawal by Subject|1|||
33323335|NCT00972777|62699571|FG000|Overall Study|Missed visit|1|||
33323336|NCT00972777|62699572|FG001|Overall Study|Missed visit|0|||
33323337|NCT00918736|62699578|FG000|Overall Study|Withdrawal by Subject|4|||
33323338|NCT01172639|62699587|FG000|Overall Study|Death|1|||
33323339|NCT01172639|62699588|FG001|Overall Study|Death|1|||
33323340|NCT01172639|62699589|FG002|Overall Study|Death|0|||
33442174|NCT00162123|62818073|FG002|Overall Study|Study drug toxicity|5|||
33442175|NCT00162123|62818074|FG003|Overall Study|Study drug toxicity|0|||
33442176|NCT00162123|62818075|FG004|Overall Study|Study drug toxicity|4|||
33323341|NCT01172639|62699590|FG003|Overall Study|Death|0|||
33323342|NCT01172639|62699591|FG004|Overall Study|Death|0|||
33442177|NCT00162123|62818076|FG005|Overall Study|Study drug toxicity|1|||
33442178|NCT00162123|62818077|FG006|Overall Study|Study drug toxicity|1|||
33442179|NCT00162123|62818078|FG007|Overall Study|Study drug toxicity|0|||
33442180|NCT00162123|62818071|FG000|Overall Study|Death|3|||
33442181|NCT00162123|62818072|FG001|Overall Study|Death|3|||
33442182|NCT00162123|62818073|FG002|Overall Study|Death|1|||
33442183|NCT00162123|62818074|FG003|Overall Study|Death|1|||
33442184|NCT00162123|62818075|FG004|Overall Study|Death|1|||
33442185|NCT00162123|62818076|FG005|Overall Study|Death|1|||
33442186|NCT00162123|62818077|FG006|Overall Study|Death|0|||
33442187|NCT00162123|62818078|FG007|Overall Study|Death|0|||
33442188|NCT00162123|62818071|FG000|Overall Study|Withdrawal by Subject|2|||
33442189|NCT00162123|62818072|FG001|Overall Study|Withdrawal by Subject|0|||
33442190|NCT00162123|62818073|FG002|Overall Study|Withdrawal by Subject|2|||
33442191|NCT00162123|62818074|FG003|Overall Study|Withdrawal by Subject|1|||
33442192|NCT00162123|62818075|FG004|Overall Study|Withdrawal by Subject|1|||
33442193|NCT00162123|62818076|FG005|Overall Study|Withdrawal by Subject|2|||
33442194|NCT00162123|62818077|FG006|Overall Study|Withdrawal by Subject|1|||
33442195|NCT00162123|62818078|FG007|Overall Study|Withdrawal by Subject|0|||
33442196|NCT00162123|62818071|FG000|Overall Study|Deterioration without progression|2|||
33442197|NCT00162123|62818072|FG001|Overall Study|Deterioration without progression|2|||
33442198|NCT00162123|62818073|FG002|Overall Study|Deterioration without progression|3|||
33442199|NCT00162123|62818074|FG003|Overall Study|Deterioration without progression|0|||
33442200|NCT00162123|62818075|FG004|Overall Study|Deterioration without progression|1|||
33442201|NCT00162123|62818076|FG005|Overall Study|Deterioration without progression|0|||
33442202|NCT00162123|62818077|FG006|Overall Study|Deterioration without progression|0|||
33442203|NCT00162123|62818078|FG007|Overall Study|Deterioration without progression|0|||
33442204|NCT00162123|62818071|FG000|Overall Study|Adverse Event|1|||
33442205|NCT00162123|62818072|FG001|Overall Study|Adverse Event|2|||
33442206|NCT00162123|62818073|FG002|Overall Study|Adverse Event|0|||
33442207|NCT00162123|62818074|FG003|Overall Study|Adverse Event|2|||
33442208|NCT00162123|62818075|FG004|Overall Study|Adverse Event|1|||
33442209|NCT00162123|62818076|FG005|Overall Study|Adverse Event|0|||
33442210|NCT00162123|62818077|FG006|Overall Study|Adverse Event|0|||
33442211|NCT00162123|62818078|FG007|Overall Study|Adverse Event|0|||
33442212|NCT00162123|62818071|FG000|Overall Study|Not specified (before treatment)|2|||
33442213|NCT00162123|62818072|FG001|Overall Study|Not specified (before treatment)|0|||
33442214|NCT00162123|62818073|FG002|Overall Study|Not specified (before treatment)|0|||
33442215|NCT00162123|62818074|FG003|Overall Study|Not specified (before treatment)|0|||
33442216|NCT00162123|62818075|FG004|Overall Study|Not specified (before treatment)|12|||
33442217|NCT00162123|62818076|FG005|Overall Study|Not specified (before treatment)|1|||
33442218|NCT00162123|62818077|FG006|Overall Study|Not specified (before treatment)|0|||
33442219|NCT00162123|62818078|FG007|Overall Study|Not specified (before treatment)|0|||
33442220|NCT00162123|62818071|FG000|Overall Study|Not specified (after start of treatment)|0|||
33442221|NCT00162123|62818072|FG001|Overall Study|Not specified (after start of treatment)|0|||
33442222|NCT00162123|62818073|FG002|Overall Study|Not specified (after start of treatment)|0|||
33442223|NCT00162123|62818074|FG003|Overall Study|Not specified (after start of treatment)|0|||
33442224|NCT00162123|62818075|FG004|Overall Study|Not specified (after start of treatment)|3|||
33442225|NCT00162123|62818076|FG005|Overall Study|Not specified (after start of treatment)|0|||
33442226|NCT00162123|62818077|FG006|Overall Study|Not specified (after start of treatment)|0|||
33442227|NCT00162123|62818078|FG007|Overall Study|Not specified (after start of treatment)|0|||
33606490|NCT02255461|63006573|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
33606491|NCT02255461|63006574|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
33606492|NCT02255461|63006575|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
33606493|NCT02255461|63006576|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
33606494|NCT02255461|63006577|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
33606495|NCT02255149|63006594|FG000|Overall Study|Lost to Follow-up|2|||
33606496|NCT02255149|63006594|FG000|Overall Study|Withdrawal by Subject|1|||
33606497|NCT02255149|63006594|FG000|Overall Study|Withdrawal by PI|1|||
33606498|NCT02255149|63006594|FG000|Overall Study|Implant Failure|1|||
33606499|NCT01764022|63006600|FG000|Overall Study|Death|3|||
33606500|NCT01764022|63006601|FG001|Overall Study|Death|5|||
33442228|NCT00162123|62818071|FG000|Overall Study|Physician Decision|1|||
33606501|NCT01764022|63006600|FG000|Overall Study|Withdrawal by Subject|2|||
33606502|NCT01764022|63006601|FG001|Overall Study|Withdrawal by Subject|6|||
33606503|NCT01764022|63006600|FG000|Overall Study|Lack of Efficacy|0|||
33606504|NCT01764022|63006601|FG001|Overall Study|Lack of Efficacy|1|||
33442229|NCT00162123|62818072|FG001|Overall Study|Physician Decision|2|||
33442230|NCT00162123|62818073|FG002|Overall Study|Physician Decision|0|||
33442231|NCT00162123|62818074|FG003|Overall Study|Physician Decision|0|||
33442232|NCT00162123|62818075|FG004|Overall Study|Physician Decision|0|||
33442233|NCT00162123|62818076|FG005|Overall Study|Physician Decision|1|||
33442234|NCT00162123|62818077|FG006|Overall Study|Physician Decision|1|||
33442235|NCT00162123|62818078|FG007|Overall Study|Physician Decision|0|||
33442236|NCT00162123|62818071|FG000|Overall Study|Tumor assessment only (not treated)|0|||
33442237|NCT00162123|62818072|FG001|Overall Study|Tumor assessment only (not treated)|0|||
33442238|NCT00162123|62818073|FG002|Overall Study|Tumor assessment only (not treated)|0|||
33442239|NCT00162123|62818074|FG003|Overall Study|Tumor assessment only (not treated)|0|||
33442240|NCT00162123|62818075|FG004|Overall Study|Tumor assessment only (not treated)|0|||
33442241|NCT00162123|62818076|FG005|Overall Study|Tumor assessment only (not treated)|0|||
33442242|NCT00162123|62818077|FG006|Overall Study|Tumor assessment only (not treated)|0|||
33442243|NCT00162123|62818078|FG007|Overall Study|Tumor assessment only (not treated)|1|||
33442244|NCT00162123|62818071|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
33442245|NCT00162123|62818072|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
33442246|NCT00162123|62818073|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
33442247|NCT00162123|62818074|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
33442248|NCT00162123|62818075|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
33442249|NCT00162123|62818076|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
33442250|NCT00162123|62818077|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
33442251|NCT00162123|62818078|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
33442252|NCT00227721|62818097|FG000|Overall Study|On study, but never treated.|1|||
33442253|NCT00226941|62818105|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
33442254|NCT00226941|62818106|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
33442255|NCT00226941|62818107|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
33442256|NCT00226941|62818108|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
33442257|NCT00226941|62818105|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
33442258|NCT00226941|62818106|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
33442259|NCT00226941|62818107|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
33442260|NCT00226941|62818108|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
33442261|NCT00356408|62818128|FG000|Overall Study|Adverse Event|9|||
33442262|NCT00356408|62818128|FG000|Overall Study|Lack of Efficacy|36|||
33442263|NCT00356408|62818128|FG000|Overall Study|Lost to Follow-up|2|||
33442264|NCT00356408|62818128|FG000|Overall Study|Withdrawal by Subject|6|||
33442265|NCT00356408|62818128|FG000|Overall Study|Other: Principal investigator discretion|3|||
33442266|NCT00356408|62818128|FG000|Overall Study|Other: Sponsor request|1|||
33442267|NCT00356408|62818128|FG000|Overall Study|Other: Azathioprine stopped|1|||
33442268|NCT00356408|62818128|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
33442269|NCT00356408|62818128|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
33442270|NCT00509795|62818143|FG000|Overall Study|Adverse Event|4|||
33442271|NCT00509795|62818144|FG001|Overall Study|Adverse Event|3|||
33442272|NCT00509795|62818145|FG002|Overall Study|Adverse Event|5|||
33442273|NCT00509795|62818146|FG003|Overall Study|Adverse Event|4|||
33442274|NCT00509795|62818143|FG000|Overall Study|Death|3|||
33442275|NCT00509795|62818144|FG001|Overall Study|Death|1|||
33442276|NCT00509795|62818145|FG002|Overall Study|Death|2|||
33442277|NCT00509795|62818146|FG003|Overall Study|Death|7|||
33442278|NCT00509795|62818143|FG000|Overall Study|Lack of Efficacy|0|||
33442279|NCT00509795|62818144|FG001|Overall Study|Lack of Efficacy|0|||
33442280|NCT00509795|62818145|FG002|Overall Study|Lack of Efficacy|2|||
33442281|NCT00509795|62818146|FG003|Overall Study|Lack of Efficacy|2|||
33442282|NCT00509795|62818143|FG000|Overall Study|Lost to Follow-up|1|||
33442283|NCT00509795|62818144|FG001|Overall Study|Lost to Follow-up|2|||
33442284|NCT00509795|62818145|FG002|Overall Study|Lost to Follow-up|4|||
33442285|NCT00509795|62818146|FG003|Overall Study|Lost to Follow-up|4|||
33442286|NCT00509795|62818143|FG000|Overall Study|OTHER|1|||
33442287|NCT00509795|62818144|FG001|Overall Study|OTHER|0|||
33442288|NCT00509795|62818145|FG002|Overall Study|OTHER|4|||
33442289|NCT00509795|62818146|FG003|Overall Study|OTHER|1|||
33606505|NCT01764022|63006600|FG000|Overall Study|Physician Decision|0|||
33606506|NCT01764022|63006601|FG001|Overall Study|Physician Decision|2|||
33606507|NCT01764022|63006600|FG000|Overall Study|Lost to Follow-up|2|||
33606508|NCT01764022|63006601|FG001|Overall Study|Lost to Follow-up|0|||
33606509|NCT01764022|63006600|FG000|Overall Study|Protocol Violation|1|||
33606510|NCT01764022|63006601|FG001|Overall Study|Protocol Violation|0|||
33442290|NCT00509795|62818143|FG000|Overall Study|Protocol Violation|3|||
33606511|NCT02003391|63006611|FG000|Overall Study|Withdrawal by Subject|2|||
33606512|NCT02003391|63006612|FG001|Overall Study|Withdrawal by Subject|1|||
33606513|NCT02003391|63006611|FG000|Overall Study|Protocol Violation|0|||
33442291|NCT00509795|62818144|FG001|Overall Study|Protocol Violation|0|||
33606514|NCT02003391|63006612|FG001|Overall Study|Protocol Violation|1|||
33442292|NCT00509795|62818145|FG002|Overall Study|Protocol Violation|3|||
33442293|NCT00509795|62818146|FG003|Overall Study|Protocol Violation|1|||
33442294|NCT00509795|62818143|FG000|Overall Study|Withdrawal by Subject|10|||
33442295|NCT00509795|62818144|FG001|Overall Study|Withdrawal by Subject|5|||
33442296|NCT00509795|62818145|FG002|Overall Study|Withdrawal by Subject|7|||
33442297|NCT00509795|62818146|FG003|Overall Study|Withdrawal by Subject|8|||
33442298|NCT00165789|62818161|FG000|Overall Study|Adverse Event|0|||
33442299|NCT00165789|62818162|FG001|Overall Study|Adverse Event|3|||
33442300|NCT00165789|62818163|FG002|Overall Study|Adverse Event|0|||
33606515|NCT02003391|63006611|FG000|Overall Study|Adverse Event|1|||
33606516|NCT02003391|63006612|FG001|Overall Study|Adverse Event|0|||
33606517|NCT02254681|63006618|FG000|Overall Study|Lack of Efficacy|6|||
33606518|NCT01965327|63006623|FG000|Overall Study|Physician Decision|2|||
33606519|NCT02002689|63006627|FG000|Overall Study|Disease Progression|7|||
33323343|NCT01172639|62699587|FG000|Overall Study|Lost to Follow-up|9|||
33323344|NCT01172639|62699588|FG001|Overall Study|Lost to Follow-up|7|||
33323345|NCT01172639|62699589|FG002|Overall Study|Lost to Follow-up|11|||
33442301|NCT00165789|62818164|FG003|Overall Study|Adverse Event|12|||
33442302|NCT00165789|62818161|FG000|Overall Study|Withdrawal by Subject|0|||
33442303|NCT00165789|62818162|FG001|Overall Study|Withdrawal by Subject|1|||
33442304|NCT00165789|62818163|FG002|Overall Study|Withdrawal by Subject|1|||
33442305|NCT00165789|62818164|FG003|Overall Study|Withdrawal by Subject|2|||
33442306|NCT00504257|62818174|FG000|Overall Study|Withdrawal by Subject|2|||
33442307|NCT00504257|62818174|FG000|Overall Study|ineligible histology|2|||
33442308|NCT00509093|62818178|FG000|Overall Study|Adverse Event|10|||
33442309|NCT00509093|62818178|FG000|Overall Study|Disease Progression|9|||
33442310|NCT00509093|62818178|FG000|Overall Study|Transformed into MDS|1|||
33442311|NCT00509093|62818178|FG000|Overall Study|Withdrawal by Subject|3|||
33442312|NCT00509093|62818178|FG000|Overall Study|Physician Decision|1|||
33323346|NCT01172639|62699590|FG003|Overall Study|Lost to Follow-up|6|||
33323347|NCT01172639|62699591|FG004|Overall Study|Lost to Follow-up|6|||
33323348|NCT01172639|62699587|FG000|Overall Study|Withdrawal by Subject|3|||
33323349|NCT01172639|62699588|FG001|Overall Study|Withdrawal by Subject|3|||
33323350|NCT01172639|62699589|FG002|Overall Study|Withdrawal by Subject|5|||
33442313|NCT00160641|62818182|FG000|Overall Study|Adverse Event|102|||
33442314|NCT00160641|62818182|FG000|Overall Study|Withdrawal by Subject|87|||
33442315|NCT00160641|62818182|FG000|Overall Study|Lost to Follow-up|8|||
33442316|NCT00160641|62818182|FG000|Overall Study|Lack of Efficacy|12|||
33442317|NCT00160641|62818182|FG000|Overall Study|Protocol Violation|3|||
33442318|NCT00160641|62818182|FG000|Overall Study|Other|9|||
33442319|NCT00493025|62818186|FG000|Overall Study|Physician Decision|19|||
33442320|NCT00160563|62818194|FG000|Overall Study|Adverse Event|1|||
33442321|NCT00160563|62818195|FG001|Overall Study|Adverse Event|1|||
33442322|NCT00160563|62818196|FG002|Overall Study|Adverse Event|1|||
33442323|NCT00160563|62818194|FG000|Overall Study|Lost to Follow-up|1|||
33442324|NCT00160563|62818195|FG001|Overall Study|Lost to Follow-up|1|||
33442325|NCT00160563|62818196|FG002|Overall Study|Lost to Follow-up|2|||
33442326|NCT00160563|62818194|FG000|Overall Study|Protocol Violation|0|||
33442327|NCT00160563|62818195|FG001|Overall Study|Protocol Violation|0|||
33442328|NCT00160563|62818196|FG002|Overall Study|Protocol Violation|3|||
33442329|NCT00160563|62818194|FG000|Overall Study|Withdrawal by Subject|1|||
33442330|NCT00160563|62818195|FG001|Overall Study|Withdrawal by Subject|2|||
33442331|NCT00160563|62818196|FG002|Overall Study|Withdrawal by Subject|3|||
33442332|NCT00160563|62818194|FG000|Overall Study|Other (listed in the study report)|48|||
33442333|NCT00160563|62818195|FG001|Overall Study|Other (listed in the study report)|40|||
33442334|NCT00160563|62818196|FG002|Overall Study|Other (listed in the study report)|81|||
33442335|NCT00160563|62818194|FG000|Overall Study|Missing reason|0|||
33442336|NCT00160563|62818195|FG001|Overall Study|Missing reason|1|||
33442337|NCT00160563|62818196|FG002|Overall Study|Missing reason|0|||
33442338|NCT00380744|62818212|FG000|Overall Study|Death|0|||
33442339|NCT00380744|62818213|FG001|Overall Study|Death|0|||
33442340|NCT00380744|62818214|FG002|Overall Study|Death|0|||
33442341|NCT00380744|62818215|FG003|Overall Study|Death|0|||
33442342|NCT00380744|62818216|FG004|Overall Study|Death|0|||
33442343|NCT00380744|62818217|FG005|Overall Study|Death|0|||
33442344|NCT00380744|62818218|FG006|Overall Study|Death|1|||
33442345|NCT00380744|62818212|FG000|Overall Study|Withdrawal by Subject|1|||
33442346|NCT00380744|62818213|FG001|Overall Study|Withdrawal by Subject|0|||
33442347|NCT00380744|62818214|FG002|Overall Study|Withdrawal by Subject|0|||
33606520|NCT02002689|63006627|FG000|Overall Study|Adverse Event|3|||
33606521|NCT01639729|63006631|FG000|Overall Study|Withdrawal by Subject|1|||
33606522|NCT01639729|63006632|FG001|Overall Study|Withdrawal by Subject|0|||
33323351|NCT01172639|62699590|FG003|Overall Study|Withdrawal by Subject|5|||
33323352|NCT01172639|62699591|FG004|Overall Study|Withdrawal by Subject|0|||
33442348|NCT00380744|62818215|FG003|Overall Study|Withdrawal by Subject|0|||
33442349|NCT00380744|62818216|FG004|Overall Study|Withdrawal by Subject|0|||
33442350|NCT00380744|62818217|FG005|Overall Study|Withdrawal by Subject|0|||
33442351|NCT00380744|62818218|FG006|Overall Study|Withdrawal by Subject|0|||
33442352|NCT00380588|62818237|FG000|Overall Study|Unequivocal Disease Progression|25|||
33442353|NCT00380588|62818238|FG001|Overall Study|Unequivocal Disease Progression|34|||
33442354|NCT00380588|62818237|FG000|Overall Study|Next Cycle Not Started|4|||
33442355|NCT00380588|62818238|FG001|Overall Study|Next Cycle Not Started|0|||
33442356|NCT00380588|62818237|FG000|Overall Study|Adverse Event|7|||
33442357|NCT00380588|62818238|FG001|Overall Study|Adverse Event|3|||
33442358|NCT00380588|62818237|FG000|Overall Study|Withdrawal by Subject|1|||
33442359|NCT00380588|62818238|FG001|Overall Study|Withdrawal by Subject|3|||
33442360|NCT00380588|62818237|FG000|Overall Study|Physician Decision|2|||
33442361|NCT00380588|62818238|FG001|Overall Study|Physician Decision|0|||
33442362|NCT00379808|62818244|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
33442363|NCT00379808|62818245|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
33442364|NCT00355784|62818254|FG000|Overall Study|Withdrawal by Subject|0|||
33442365|NCT00355784|62818255|FG001|Overall Study|Withdrawal by Subject|0|||
33442366|NCT00355784|62818256|FG002|Overall Study|Withdrawal by Subject|2|||
33442367|NCT00355472|62818265|FG000|Overall Study|Physician Decision|1|||
33442368|NCT00492557|62818279|FG000|Overall Study|Subject request|12|||
33442369|NCT00492557|62818280|FG001|Overall Study|Subject request|11|||
33442370|NCT00492557|62818279|FG000|Overall Study|Protocol Violation|7|||
33442371|NCT00492557|62818280|FG001|Overall Study|Protocol Violation|8|||
33442372|NCT00492557|62818279|FG000|Overall Study|Other|2|||
33442373|NCT00492557|62818280|FG001|Overall Study|Other|2|||
33442374|NCT00492557|62818279|FG000|Overall Study|Death|1|||
33442375|NCT00492557|62818280|FG001|Overall Study|Death|1|||
33442376|NCT00492557|62818279|FG000|Overall Study|Adverse Event|1|||
33442377|NCT00492557|62818280|FG001|Overall Study|Adverse Event|0|||
33442378|NCT00492557|62818279|FG000|Overall Study|Failed to return|1|||
33442379|NCT00492557|62818280|FG001|Overall Study|Failed to return|0|||
33442380|NCT00492557|62818279|FG000|Overall Study|Lost to Follow-up|0|||
33442381|NCT00492557|62818280|FG001|Overall Study|Lost to Follow-up|1|||
33442382|NCT00508391|62818291|FG000|First Treatment|Withdrawal by Subject|6|||
33442383|NCT00508391|62818292|FG001|First Treatment|Withdrawal by Subject|3|||
33442384|NCT00508391|62818291|FG000|Second Treatment|Withdrawal by Subject|2|||
33442385|NCT00508391|62818292|FG001|Second Treatment|Withdrawal by Subject|0|||
33442386|NCT00508157|62818302|FG000|Overall Study|Adverse Event|0|||
33442387|NCT00508157|62818303|FG001|Overall Study|Adverse Event|1|||
33442388|NCT00508157|62818302|FG000|Overall Study|Subject Withdrew Consent|1|||
33442389|NCT00508157|62818303|FG001|Overall Study|Subject Withdrew Consent|0|||
33442390|NCT00508157|62818302|FG000|Overall Study|Lost to Follow-up|1|||
33442391|NCT00508157|62818303|FG001|Overall Study|Lost to Follow-up|0|||
33442392|NCT00508157|62818302|FG000|Overall Study|Subject no longer met study criteria|0|||
33442393|NCT00508157|62818303|FG001|Overall Study|Subject no longer met study criteria|1|||
33442394|NCT00508157|62818302|FG000|Overall Study|Other known cause|0|||
33442395|NCT00508157|62818303|FG001|Overall Study|Other known cause|1|||
33442396|NCT00378560|62818311|FG000|Overall Study|Adverse Event|1|||
33442397|NCT00378560|62818312|FG001|Overall Study|Adverse Event|0|||
33442398|NCT00378560|62818311|FG000|Overall Study|Lost to Follow-up|24|||
33442399|NCT00378560|62818312|FG001|Overall Study|Lost to Follow-up|29|||
33442400|NCT00378560|62818311|FG000|Overall Study|Protocol Violation|2|||
33442401|NCT00378560|62818312|FG001|Overall Study|Protocol Violation|0|||
33442402|NCT00378560|62818311|FG000|Overall Study|Withdrawal by Subject|17|||
33442403|NCT00378560|62818312|FG001|Overall Study|Withdrawal by Subject|21|||
33442404|NCT00378560|62818311|FG000|Overall Study|Moved|4|||
33442405|NCT00378560|62818312|FG001|Overall Study|Moved|3|||
33442406|NCT00378560|62818311|FG000|Overall Study|Pregnancy|7|||
33442407|NCT00378560|62818312|FG001|Overall Study|Pregnancy|5|||
33442408|NCT00378560|62818311|FG000|Overall Study|Laboratory test values abnormal|1|||
33442409|NCT00378560|62818312|FG001|Overall Study|Laboratory test values abnormal|0|||
33442410|NCT00508001|62818321|FG000|Overall Study|Adverse Event|2|||
33442411|NCT00508001|62818322|FG001|Overall Study|Adverse Event|0|||
33442412|NCT00508001|62818323|FG002|Overall Study|Adverse Event|4|||
33442413|NCT00508001|62818321|FG000|Overall Study|condition under investigation worsened|13|||
33442414|NCT00508001|62818322|FG001|Overall Study|condition under investigation worsened|7|||
33442415|NCT00508001|62818323|FG002|Overall Study|condition under investigation worsened|1|||
33442416|NCT00508001|62818321|FG000|Overall Study|Death|0|||
33442417|NCT00508001|62818322|FG001|Overall Study|Death|1|||
33442418|NCT00508001|62818323|FG002|Overall Study|Death|1|||
33442419|NCT00508001|62818321|FG000|Overall Study|Withdrawal by Subject|4|||
33442420|NCT00508001|62818322|FG001|Overall Study|Withdrawal by Subject|4|||
33442421|NCT00508001|62818323|FG002|Overall Study|Withdrawal by Subject|1|||
33494220|NCT04206020|62872990|FG000|Overall Study|Pregnancy|0|||
33442422|NCT00507689|62818334|FG000|Pre-Randomization Period|Adverse Event|1|||
33442423|NCT00507689|62818335|FG001|Pre-Randomization Period|Adverse Event|0|||
33442424|NCT00507689|62818334|FG000|Pre-Randomization Period|Physician Decision|1|||
33442425|NCT00507689|62818335|FG001|Pre-Randomization Period|Physician Decision|0|||
33442426|NCT00507689|62818334|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
33442427|NCT00507689|62818335|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
33442428|NCT00507689|62818334|FG000|Randomized Period|Adverse Event|1|||
33442429|NCT00507689|62818335|FG001|Randomized Period|Adverse Event|1|||
33442430|NCT00507689|62818334|FG000|Randomized Period|Withdrawal by Subject|0|||
33442431|NCT00507689|62818335|FG001|Randomized Period|Withdrawal by Subject|1|||
33442432|NCT00491387|62818342|FG000|Overall Study|study terminated|20|||
33442433|NCT00491075|62818346|FG000|Overall Study|Withdrawal by Subject|1|||
33442434|NCT00491075|62818346|FG000|Overall Study|Physician Decision|1|||
33442435|NCT00507455|62818353|FG000|Overall Study|Adverse Event|3|||
33442436|NCT00507455|62818354|FG001|Overall Study|Adverse Event|3|||
33442437|NCT00507455|62818355|FG002|Overall Study|Adverse Event|6|||
33442438|NCT00507455|62818353|FG000|Overall Study|Withdrawal by Subject|2|||
33442439|NCT00507455|62818354|FG001|Overall Study|Withdrawal by Subject|1|||
33442440|NCT00507455|62818355|FG002|Overall Study|Withdrawal by Subject|2|||
33442441|NCT00507455|62818353|FG000|Overall Study|Protocol Violation|4|||
33442442|NCT00507455|62818354|FG001|Overall Study|Protocol Violation|1|||
33442443|NCT00507455|62818355|FG002|Overall Study|Protocol Violation|1|||
33442444|NCT00507455|62818353|FG000|Overall Study|Lost to Follow-up|2|||
33442445|NCT00507455|62818354|FG001|Overall Study|Lost to Follow-up|0|||
33442446|NCT00507455|62818355|FG002|Overall Study|Lost to Follow-up|2|||
33442447|NCT00507455|62818353|FG000|Overall Study|Lack of Efficacy|0|||
33442448|NCT00507455|62818354|FG001|Overall Study|Lack of Efficacy|1|||
33442449|NCT00507455|62818355|FG002|Overall Study|Lack of Efficacy|0|||
33442450|NCT00507455|62818353|FG000|Overall Study|Other - miscellaneous reason|1|||
33442451|NCT00507455|62818354|FG001|Overall Study|Other - miscellaneous reason|0|||
33442452|NCT00507455|62818355|FG002|Overall Study|Other - miscellaneous reason|1|||
33442453|NCT00506831|62818363|FG000|Overall Study|Death|1|||
33442454|NCT00506831|62818363|FG000|Overall Study|Withdrawal by Subject|1|||
33442455|NCT00506753|62818369|FG000|Overall Study|Lost to Follow-up|21|||
33442456|NCT00506753|62818370|FG001|Overall Study|Lost to Follow-up|15|||
33442457|NCT00490919|62818378|FG000|Open-label Run-in Period|Adverse Event|239|||
33442458|NCT00490919|62818379|FG001|Open-label Run-in Period|Adverse Event|0|||
33442459|NCT00490919|62818380|FG002|Open-label Run-in Period|Adverse Event|0|||
33442460|NCT00490919|62818378|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
33442461|NCT00490919|62818379|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
33442462|NCT00490919|62818380|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
33442463|NCT00490919|62818378|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
33606523|NCT01639729|63006633|FG002|Overall Study|Withdrawal by Subject|1|||
33606524|NCT01639729|63006634|FG003|Overall Study|Withdrawal by Subject|1|||
33606525|NCT01639729|63006635|FG004|Overall Study|Withdrawal by Subject|0|||
33606526|NCT01639729|63006636|FG005|Overall Study|Withdrawal by Subject|0|||
33606527|NCT02002533|63006648|FG000|Overall Study|Withdrawal by Subject|6|||
33606528|NCT02002533|63006649|FG001|Overall Study|Withdrawal by Subject|13|||
33606529|NCT02002533|63006648|FG000|Overall Study|Protocol Violation|0|||
33606530|NCT02002533|63006649|FG001|Overall Study|Protocol Violation|1|||
33442464|NCT00490919|62818379|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
33442465|NCT00490919|62818380|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
33442466|NCT00490919|62818378|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
33442467|NCT00490919|62818379|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
33442468|NCT00490919|62818380|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
33442469|NCT00490919|62818378|FG000|Open-label Run-in Period|Administrative|40|||
33442470|NCT00490919|62818379|FG001|Open-label Run-in Period|Administrative|0|||
33442471|NCT00490919|62818380|FG002|Open-label Run-in Period|Administrative|0|||
33442472|NCT00490919|62818378|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
33442473|NCT00490919|62818379|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
33442474|NCT00490919|62818380|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
33442475|NCT00490919|62818378|FG000|Double-blind Phase|Adverse Event|0|||
33442476|NCT00490919|62818379|FG001|Double-blind Phase|Adverse Event|40|||
33442477|NCT00490919|62818380|FG002|Double-blind Phase|Adverse Event|20|||
33442478|NCT00490919|62818378|FG000|Double-blind Phase|Withdrawal by Subject|0|||
33442479|NCT00490919|62818379|FG001|Double-blind Phase|Withdrawal by Subject|10|||
33442480|NCT00490919|62818380|FG002|Double-blind Phase|Withdrawal by Subject|11|||
33442481|NCT00490919|62818378|FG000|Double-blind Phase|Lost to Follow-up|0|||
33442482|NCT00490919|62818379|FG001|Double-blind Phase|Lost to Follow-up|8|||
33442483|NCT00490919|62818380|FG002|Double-blind Phase|Lost to Follow-up|11|||
33442484|NCT00490919|62818378|FG000|Double-blind Phase|Lack of Efficacy|0|||
33442485|NCT00490919|62818379|FG001|Double-blind Phase|Lack of Efficacy|22|||
33442486|NCT00490919|62818380|FG002|Double-blind Phase|Lack of Efficacy|36|||
33442487|NCT00490919|62818378|FG000|Double-blind Phase|Administrative|0|||
33442488|NCT00490919|62818379|FG001|Double-blind Phase|Administrative|6|||
33442489|NCT00490919|62818380|FG002|Double-blind Phase|Administrative|6|||
33442490|NCT00503867|62818387|FG000|Overall Study|Lost to Follow-up|1|||
33442491|NCT00503867|62818387|FG000|Overall Study|Adverse Event|1|||
33442492|NCT00503399|62818393|FG000|Overall Study|Death|2|||
33442493|NCT00503399|62818394|FG001|Overall Study|Death|1|||
33442494|NCT00503399|62818393|FG000|Overall Study|Protocol Violation|1|||
33606531|NCT02002533|63006648|FG000|Overall Study|Adverse Event|0|||
33442495|NCT00503399|62818394|FG001|Overall Study|Protocol Violation|0|||
33323353|NCT01144182|62699605|FG000|Overall Study|Death|5|||
33606532|NCT02002533|63006649|FG001|Overall Study|Adverse Event|3|||
33442496|NCT00503399|62818393|FG000|Overall Study|Withdrawal by Subject|4|||
33442497|NCT00503399|62818394|FG001|Overall Study|Withdrawal by Subject|2|||
33442498|NCT00503399|62818393|FG000|Overall Study|Adverse Event|0|||
33442499|NCT00503399|62818394|FG001|Overall Study|Adverse Event|3|||
33442500|NCT00503399|62818393|FG000|Overall Study|Lost to Follow-up|0|||
33442501|NCT00503399|62818394|FG001|Overall Study|Lost to Follow-up|2|||
33442502|NCT00506519|62818403|FG000|Overall Study|Death|4|||
33442503|NCT00506519|62818404|FG001|Overall Study|Death|6|||
33442504|NCT00506519|62818405|FG002|Overall Study|Death|0|||
33442505|NCT00506519|62818403|FG000|Overall Study|Adverse Event|1|||
33442506|NCT00506519|62818404|FG001|Overall Study|Adverse Event|0|||
33442507|NCT00506519|62818405|FG002|Overall Study|Adverse Event|0|||
33442508|NCT00503009|62818419|FG000|Overall Study|Protocol Violation|1|||
33442509|NCT00503009|62818420|FG001|Overall Study|Protocol Violation|0|||
33442510|NCT00503009|62818421|FG002|Overall Study|Protocol Violation|1|||
33442511|NCT00503009|62818419|FG000|Overall Study|Withdrawal by Subject|0|||
33442512|NCT00503009|62818420|FG001|Overall Study|Withdrawal by Subject|1|||
33442513|NCT00503009|62818421|FG002|Overall Study|Withdrawal by Subject|1|||
33442514|NCT00503009|62818419|FG000|Overall Study|Physician Decision|0|||
33442515|NCT00503009|62818420|FG001|Overall Study|Physician Decision|1|||
33442516|NCT00503009|62818421|FG002|Overall Study|Physician Decision|1|||
33442517|NCT00160251|62818435|FG000|Prior to Amendment 2|Adverse Event|2|||
33442518|NCT00160251|62818436|FG001|Prior to Amendment 2|Adverse Event|1|||
33442519|NCT00160251|62818437|FG002|Prior to Amendment 2|Adverse Event|3|||
33442520|NCT00160251|62818438|FG003|Prior to Amendment 2|Adverse Event|1|||
33442521|NCT00160251|62818439|FG004|Prior to Amendment 2|Adverse Event|1|||
33442522|NCT00160251|62818440|FG005|Prior to Amendment 2|Adverse Event|1|||
33442523|NCT00160251|62818441|FG006|Prior to Amendment 2|Adverse Event|1|||
33442524|NCT00160251|62818442|FG007|Prior to Amendment 2|Adverse Event|0|||
33442525|NCT00160251|62818435|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
33442526|NCT00160251|62818436|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
33442527|NCT00160251|62818437|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
33442528|NCT00160251|62818438|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
33442529|NCT00160251|62818439|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
33442530|NCT00160251|62818440|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
33442531|NCT00160251|62818441|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
33442532|NCT00160251|62818442|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
33442533|NCT00160251|62818435|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
33442534|NCT00160251|62818436|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
33442535|NCT00160251|62818437|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
33442536|NCT00160251|62818438|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
33442537|NCT00160251|62818439|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
33442538|NCT00160251|62818440|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
33442539|NCT00160251|62818441|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
33442540|NCT00160251|62818442|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
33442541|NCT00160251|62818435|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
33442542|NCT00160251|62818436|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
33442543|NCT00160251|62818437|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
33442544|NCT00160251|62818438|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
33442545|NCT00160251|62818439|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
33442546|NCT00160251|62818440|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
33442547|NCT00160251|62818441|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
33442548|NCT00160251|62818442|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
33442549|NCT00160251|62818435|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
33442550|NCT00160251|62818436|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
33442551|NCT00160251|62818437|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
33442552|NCT00160251|62818438|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
33442553|NCT00160251|62818439|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
33442554|NCT00160251|62818440|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
33442555|NCT00160251|62818441|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
33442556|NCT00160251|62818442|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
33442557|NCT00160251|62818435|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
33442558|NCT00160251|62818436|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
33442559|NCT00160251|62818437|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
33442560|NCT00160251|62818438|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
33442561|NCT00160251|62818439|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
33442562|NCT00160251|62818440|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
33442563|NCT00160251|62818441|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
33442564|NCT00160251|62818442|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
33442565|NCT00160251|62818435|FG000|Post-amendment 2|Adverse Event|0|||
33442566|NCT00160251|62818436|FG001|Post-amendment 2|Adverse Event|0|||
33442567|NCT00160251|62818437|FG002|Post-amendment 2|Adverse Event|0|||
33442568|NCT00160251|62818438|FG003|Post-amendment 2|Adverse Event|0|||
33442569|NCT00160251|62818439|FG004|Post-amendment 2|Adverse Event|0|||
33606533|NCT02002533|63006648|FG000|Overall Study|Lost to Follow-up|0|||
33442570|NCT00160251|62818440|FG005|Post-amendment 2|Adverse Event|0|||
33442571|NCT00160251|62818441|FG006|Post-amendment 2|Adverse Event|0|||
33442572|NCT00160251|62818442|FG007|Post-amendment 2|Adverse Event|20|||
33442573|NCT00160251|62818435|FG000|Post-amendment 2|Lack of Efficacy|0|||
33442574|NCT00160251|62818436|FG001|Post-amendment 2|Lack of Efficacy|0|||
33442575|NCT00160251|62818437|FG002|Post-amendment 2|Lack of Efficacy|0|||
33442576|NCT00160251|62818438|FG003|Post-amendment 2|Lack of Efficacy|0|||
33442577|NCT00160251|62818439|FG004|Post-amendment 2|Lack of Efficacy|0|||
33442578|NCT00160251|62818440|FG005|Post-amendment 2|Lack of Efficacy|0|||
33442579|NCT00160251|62818441|FG006|Post-amendment 2|Lack of Efficacy|0|||
33442580|NCT00160251|62818442|FG007|Post-amendment 2|Lack of Efficacy|24|||
33442581|NCT00160251|62818435|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
33442582|NCT00160251|62818436|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
33442583|NCT00160251|62818437|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
33442584|NCT00160251|62818438|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
33442585|NCT00160251|62818439|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
33442586|NCT00160251|62818440|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
33442587|NCT00160251|62818441|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
33442588|NCT00160251|62818442|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
33442589|NCT00506441|62818499|FG000|Period 1; Open-label Period|Adverse Event|21|||
33442590|NCT00506441|62818500|FG001|Period 1; Open-label Period|Adverse Event|0|||
33442591|NCT00506441|62818499|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
33606534|NCT02002533|63006649|FG001|Overall Study|Lost to Follow-up|1|||
33606535|NCT02002221|63006658|FG000|Overall Study|Adverse Event|2|||
33606536|NCT02002221|63006659|FG001|Overall Study|Adverse Event|1|||
33442592|NCT00506441|62818500|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
33442593|NCT00506441|62818499|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
33442594|NCT00506441|62818500|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
33442595|NCT00506441|62818499|FG000|Period 1; Open-label Period|Physician Decision|5|||
33442596|NCT00506441|62818500|FG001|Period 1; Open-label Period|Physician Decision|0|||
33442597|NCT00506441|62818499|FG000|Period 1; Open-label Period|Protocol Violation|9|||
33442598|NCT00506441|62818500|FG001|Period 1; Open-label Period|Protocol Violation|0|||
33442599|NCT00506441|62818499|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
33442600|NCT00506441|62818500|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
33442601|NCT00506441|62818499|FG000|Period 1; Open-label Period|Other Reasons|13|||
33442602|NCT00506441|62818500|FG001|Period 1; Open-label Period|Other Reasons|0|||
33442603|NCT00506441|62818499|FG000|Period 2; Double-blind Period|Adverse Event|0|||
33442604|NCT00506441|62818500|FG001|Period 2; Double-blind Period|Adverse Event|1|||
33442605|NCT00506441|62818499|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
33442606|NCT00506441|62818500|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
33442607|NCT00506441|62818499|FG000|Period 2; Double-blind Period|Physician Decision|1|||
33442608|NCT00506441|62818500|FG001|Period 2; Double-blind Period|Physician Decision|1|||
33442609|NCT00506441|62818499|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
33442610|NCT00506441|62818500|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
33442611|NCT00506441|62818499|FG000|Period 2; Double-blind Period|Other Reason|1|||
33442612|NCT00506441|62818500|FG001|Period 2; Double-blind Period|Other Reason|1|||
33442613|NCT00378014|62818527|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
33442614|NCT00378014|62818528|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
33442615|NCT00378014|62818527|FG000|Core (Randomization to Month 11)|Graft loss|1|||
33442616|NCT00378014|62818528|FG001|Core (Randomization to Month 11)|Graft loss|2|||
33442617|NCT00378014|62818527|FG000|Core (Randomization to Month 11)|Death|5|||
33442618|NCT00378014|62818528|FG001|Core (Randomization to Month 11)|Death|3|||
33442619|NCT00378014|62818527|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
33442620|NCT00378014|62818528|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
33442621|NCT00378014|62818527|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
33442622|NCT00378014|62818528|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
33442623|NCT00378014|62818527|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
33606537|NCT02002221|63006658|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33606538|NCT02002221|63006659|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33606539|NCT02002221|63006658|FG000|Overall Study|Patient withdrew consent|0|||
33606540|NCT02002221|63006659|FG001|Overall Study|Patient withdrew consent|1|||
33442624|NCT00378014|62818528|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
33442625|NCT00378014|62818527|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
33323354|NCT01144182|62699606|FG001|Overall Study|Death|6|||
33442626|NCT00378014|62818528|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
33442627|NCT00378014|62818527|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
33442628|NCT00378014|62818528|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
33442629|NCT00378014|62818527|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
33442630|NCT00378014|62818528|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
33442631|NCT00378014|62818527|FG000|Extension (Month 12 to Month 59)|Death|1|||
33606541|NCT01639495|63006665|FG000|Overall Study|Lost to Follow-up|6|||
33442632|NCT00378014|62818528|FG001|Extension (Month 12 to Month 59)|Death|2|||
33442633|NCT00378014|62818527|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
33442634|NCT00378014|62818528|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
33442635|NCT00378014|62818527|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
33442636|NCT00378014|62818528|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
33442637|NCT00378014|62818527|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
33442638|NCT00378014|62818528|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
33442639|NCT00378014|62818527|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
33442640|NCT00378014|62818528|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
33442641|NCT00485303|62818536|FG000|Overall Study|Adverse Event|5|||
33442642|NCT00485303|62818536|FG000|Overall Study|Progressive Disease|44|||
33442643|NCT00485303|62818536|FG000|Overall Study|Other|3|||
33442644|NCT00485303|62818536|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
33442645|NCT00485303|62818536|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
33442646|NCT00490841|62818540|FG000|Overall Study|Death|5|||
33442647|NCT00490841|62818540|FG000|Overall Study|Withdrawal by Subject|4|||
33442648|NCT00490841|62818540|FG000|Overall Study|Lost to Follow-up|1|||
33442649|NCT00490841|62818540|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
33442650|NCT00377858|62818547|FG000|Overall Study|Withdrawal by Subject|12|||
33442651|NCT00377858|62818548|FG001|Overall Study|Withdrawal by Subject|11|||
33442652|NCT00377858|62818547|FG000|Overall Study|Lost to Follow-up|6|||
33442653|NCT00377858|62818548|FG001|Overall Study|Lost to Follow-up|1|||
33442654|NCT00377858|62818547|FG000|Overall Study|Physician Decision|5|||
33442655|NCT00377858|62818548|FG001|Overall Study|Physician Decision|5|||
33606542|NCT01639495|63006665|FG000|Overall Study|Consented but didn't have study catheter|4|||
33606543|NCT01639495|63006665|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
33442656|NCT00377858|62818547|FG000|Overall Study|Protocol Violation|3|||
33442657|NCT00377858|62818548|FG001|Overall Study|Protocol Violation|4|||
33442658|NCT00377858|62818547|FG000|Overall Study|Adverse Event|2|||
33442659|NCT00377858|62818548|FG001|Overall Study|Adverse Event|1|||
33442660|NCT00377858|62818547|FG000|Overall Study|Entry Criteria Not Met|2|||
33442661|NCT00377858|62818548|FG001|Overall Study|Entry Criteria Not Met|0|||
33442662|NCT00377858|62818547|FG000|Overall Study|Sponsor Decision|1|||
33606544|NCT01639495|63006665|FG000|Overall Study|No radiofrequency energy applied|2|||
33606545|NCT02001987|63006669|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
33606546|NCT02001987|63006669|FG000|Core Study Period (24 Weeks)|Death|1|||
33442663|NCT00377858|62818548|FG001|Overall Study|Sponsor Decision|2|||
33442664|NCT00377858|62818547|FG000|Overall Study|Death|0|||
33442665|NCT00377858|62818548|FG001|Overall Study|Death|3|||
33442666|NCT00502775|62818557|FG000|Overall Study|Adverse Event|1|||
33442667|NCT00502775|62818558|FG001|Overall Study|Adverse Event|2|||
33442668|NCT00502775|62818559|FG002|Overall Study|Adverse Event|1|||
33442669|NCT00502775|62818557|FG000|Overall Study|Protocol Violation|1|||
33442670|NCT00502775|62818558|FG001|Overall Study|Protocol Violation|5|||
33442671|NCT00502775|62818559|FG002|Overall Study|Protocol Violation|2|||
33442672|NCT00502775|62818557|FG000|Overall Study|Withdrawal by Subject|1|||
33606547|NCT02001987|63006669|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
33606548|NCT02001987|63006669|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
33606549|NCT02001987|63006669|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
33606550|NCT02001987|63006669|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
33606551|NCT02001987|63006669|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
33606552|NCT02001987|63006669|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
33606553|NCT02001987|63006669|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
33606554|NCT02001987|63006669|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
33606555|NCT02001987|63006669|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
33606556|NCT02001987|63006669|FG000|LTE Period (52 Weeks)|Other|3|||
33606557|NCT01363765|63006680|FG000|Overall Study|non-diagnostic|2621|||
33606558|NCT01363765|63006681|FG001|Overall Study|non-diagnostic|1124|||
33606559|NCT01363765|63006680|FG000|Overall Study|duplicate records|736|||
33606560|NCT01363765|63006681|FG001|Overall Study|duplicate records|3177|||
33606561|NCT01363765|63006680|FG000|Overall Study|non-resident|156|||
33606562|NCT01363765|63006681|FG001|Overall Study|non-resident|76|||
33442673|NCT00502775|62818558|FG001|Overall Study|Withdrawal by Subject|1|||
33442674|NCT00502775|62818559|FG002|Overall Study|Withdrawal by Subject|2|||
33442675|NCT00502775|62818557|FG000|Overall Study|Sponsor Terminated Study|1|||
33442676|NCT00502775|62818558|FG001|Overall Study|Sponsor Terminated Study|0|||
33442677|NCT00502775|62818559|FG002|Overall Study|Sponsor Terminated Study|1|||
33442678|NCT00502775|62818557|FG000|Overall Study|Non-compliance with eDiary|4|||
33442679|NCT00502775|62818558|FG001|Overall Study|Non-compliance with eDiary|1|||
33442680|NCT00502775|62818559|FG002|Overall Study|Non-compliance with eDiary|1|||
33606563|NCT01363765|63006680|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
33606564|NCT01363765|63006681|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
33606565|NCT01363765|63006680|FG000|Overall Study|smear during intervention|2170|||
33606566|NCT01363765|63006681|FG001|Overall Study|smear during intervention|0|||
33606567|NCT02001051|63006691|FG000|Overall Study|Deemed not eligible following enrollment|0|||
33442681|NCT00502775|62818557|FG000|Overall Study|Subject unable to swallow capsule|1|||
33442682|NCT00502775|62818558|FG001|Overall Study|Subject unable to swallow capsule|0|||
33442683|NCT00502775|62818559|FG002|Overall Study|Subject unable to swallow capsule|1|||
33442684|NCT00502775|62818557|FG000|Overall Study|Logpad compliance <80%|1|||
33442685|NCT00502775|62818558|FG001|Overall Study|Logpad compliance <80%|0|||
33442686|NCT00502775|62818559|FG002|Overall Study|Logpad compliance <80%|0|||
33442687|NCT00502775|62818557|FG000|Overall Study|Randomized in error|0|||
33442688|NCT00502775|62818558|FG001|Overall Study|Randomized in error|1|||
33442689|NCT00502775|62818559|FG002|Overall Study|Randomized in error|1|||
33442690|NCT00502775|62818557|FG000|Overall Study|Non-compliance|0|||
33442691|NCT00502775|62818558|FG001|Overall Study|Non-compliance|2|||
33442692|NCT00502775|62818559|FG002|Overall Study|Non-compliance|2|||
33442693|NCT00502775|62818557|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
33442694|NCT00502775|62818558|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
33442695|NCT00502775|62818559|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
33442696|NCT00502775|62818557|FG000|Overall Study|Declining pollen counts|0|||
33442697|NCT00502775|62818558|FG001|Overall Study|Declining pollen counts|1|||
33442698|NCT00502775|62818559|FG002|Overall Study|Declining pollen counts|1|||
33442699|NCT00502775|62818557|FG000|Overall Study|Subject in jail|0|||
33442700|NCT00502775|62818558|FG001|Overall Study|Subject in jail|1|||
33442701|NCT00502775|62818559|FG002|Overall Study|Subject in jail|0|||
33442702|NCT00502775|62818557|FG000|Overall Study|Subject took disallowed drug|0|||
33442703|NCT00502775|62818558|FG001|Overall Study|Subject took disallowed drug|0|||
33606568|NCT02001051|63006692|FG001|Overall Study|Deemed not eligible following enrollment|1|||
33606569|NCT01763164|63006700|FG000|Treatment Phase|Participant/Guardian decision|26|||
33606570|NCT01763164|63006701|FG001|Treatment Phase|Participant/Guardian decision|14|||
33606571|NCT01763164|63006700|FG000|Treatment Phase|Protocol Violation|1|||
33606572|NCT01763164|63006701|FG001|Treatment Phase|Protocol Violation|1|||
33606573|NCT01763164|63006700|FG000|Treatment Phase|Progressive Disease|142|||
33606574|NCT01763164|63006701|FG001|Treatment Phase|Progressive Disease|76|||
33442704|NCT00502775|62818559|FG002|Overall Study|Subject took disallowed drug|1|||
33442705|NCT00502697|62818569|FG000|Overall Study|Withdrawal by Subject|3|||
33442706|NCT00502697|62818570|FG001|Overall Study|Withdrawal by Subject|1|||
33442707|NCT00502697|62818569|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
33442708|NCT00502697|62818570|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
33442709|NCT00502697|62818569|FG000|Overall Study|found not to meet eligibility criteria|3|||
33606575|NCT01763164|63006700|FG000|Treatment Phase|Physician Decision|24|||
33606576|NCT01763164|63006701|FG001|Treatment Phase|Physician Decision|13|||
33606577|NCT01763164|63006700|FG000|Treatment Phase|Death|10|||
33606578|NCT01763164|63006701|FG001|Treatment Phase|Death|1|||
33606579|NCT01763164|63006700|FG000|Treatment Phase|Adverse Event|66|||
33606580|NCT01763164|63006701|FG001|Treatment Phase|Adverse Event|8|||
33606581|NCT01763164|63006700|FG000|Treatment Phase|Randomized but not Treated|0|||
33606582|NCT01763164|63006701|FG001|Treatment Phase|Randomized but not Treated|19|||
33442710|NCT00502697|62818570|FG001|Overall Study|found not to meet eligibility criteria|4|||
33442711|NCT00502697|62818569|FG000|Overall Study|did not meet assignment criteria|4|||
33442712|NCT00502697|62818570|FG001|Overall Study|did not meet assignment criteria|2|||
33442713|NCT00485069|62818578|FG000|Overall Study|Adverse Event|10|||
33442714|NCT00485069|62818579|FG001|Overall Study|Adverse Event|4|||
33442715|NCT00485069|62818578|FG000|Overall Study|Lack of Efficacy|2|||
33442716|NCT00485069|62818579|FG001|Overall Study|Lack of Efficacy|1|||
33442717|NCT00485069|62818578|FG000|Overall Study|Protocol Violation|0|||
33442718|NCT00485069|62818579|FG001|Overall Study|Protocol Violation|1|||
33442719|NCT00485069|62818578|FG000|Overall Study|Withdrawal by Subject|6|||
33442720|NCT00485069|62818579|FG001|Overall Study|Withdrawal by Subject|6|||
33442721|NCT00355082|62818594|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
33442722|NCT00355082|62818595|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
33442723|NCT00355082|62818596|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
33442724|NCT00355082|62818594|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
33442725|NCT00355082|62818595|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
33442726|NCT00355082|62818596|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
33442727|NCT00355082|62818594|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
33606583|NCT01763164|63006700|FG000|Treatment Phase|Other|0|||
33606584|NCT01763164|63006701|FG001|Treatment Phase|Other|1|||
33442728|NCT00355082|62818595|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
33442729|NCT00355082|62818596|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
33442730|NCT00355082|62818594|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
33442731|NCT00355082|62818595|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
33442732|NCT00355082|62818596|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
33606585|NCT01763164|63006700|FG000|Follow up Phase|New therapy for study indication|12|||
33442733|NCT00355082|62818594|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
33442734|NCT00355082|62818595|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
33442735|NCT00355082|62818596|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
33442736|NCT00355082|62818594|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
33442737|NCT00355082|62818595|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
33442738|NCT00355082|62818596|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
33442739|NCT00355082|62818594|FG000|Continuation Phase|Adverse Event|2|||
33442740|NCT00355082|62818595|FG001|Continuation Phase|Adverse Event|0|||
33442741|NCT00355082|62818596|FG002|Continuation Phase|Adverse Event|1|||
33442742|NCT00355082|62818594|FG000|Continuation Phase|Lost to Follow-up|2|||
33442743|NCT00355082|62818595|FG001|Continuation Phase|Lost to Follow-up|0|||
33442744|NCT00355082|62818596|FG002|Continuation Phase|Lost to Follow-up|1|||
33442745|NCT00355082|62818594|FG000|Continuation Phase|Protocol Violation|1|||
33442746|NCT00355082|62818595|FG001|Continuation Phase|Protocol Violation|0|||
33442747|NCT00355082|62818596|FG002|Continuation Phase|Protocol Violation|1|||
33442748|NCT00355082|62818594|FG000|Continuation Phase|Withdrawal by Subject|4|||
33442749|NCT00355082|62818595|FG001|Continuation Phase|Withdrawal by Subject|0|||
33442750|NCT00355082|62818596|FG002|Continuation Phase|Withdrawal by Subject|0|||
33442751|NCT00355082|62818594|FG000|Continuation Phase|Lack of Efficacy|5|||
33442752|NCT00355082|62818595|FG001|Continuation Phase|Lack of Efficacy|0|||
33442753|NCT00355082|62818596|FG002|Continuation Phase|Lack of Efficacy|0|||
33442754|NCT00355082|62818594|FG000|Continuation Phase|Site Closed by Sponsor|8|||
33442755|NCT00355082|62818595|FG001|Continuation Phase|Site Closed by Sponsor|0|||
33442756|NCT00355082|62818596|FG002|Continuation Phase|Site Closed by Sponsor|0|||
33442757|NCT00355082|62818594|FG000|Continuation Phase|Scheduling Error|1|||
33442758|NCT00355082|62818595|FG001|Continuation Phase|Scheduling Error|0|||
33442759|NCT00355082|62818596|FG002|Continuation Phase|Scheduling Error|0|||
33442760|NCT00355082|62818594|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
33442761|NCT00355082|62818595|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
33442762|NCT00355082|62818596|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
33442763|NCT00502307|62818607|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
33442764|NCT00502307|62818608|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
33442765|NCT00502307|62818609|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
33442766|NCT00502307|62818607|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
33442767|NCT00502307|62818608|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
33442768|NCT00502307|62818609|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
33442769|NCT00502307|62818607|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
33606586|NCT01763164|63006701|FG001|Follow up Phase|New therapy for study indication|3|||
33606587|NCT01763164|63006700|FG000|Follow up Phase|Death|21|||
33606588|NCT01763164|63006701|FG001|Follow up Phase|Death|4|||
33606589|NCT01763164|63006700|FG000|Follow up Phase|Subject/guardian decision|9|||
33606590|NCT01763164|63006701|FG001|Follow up Phase|Subject/guardian decision|2|||
33442770|NCT00502307|62818608|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
33442771|NCT00502307|62818609|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
33442772|NCT00502307|62818607|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
33442773|NCT00502307|62818608|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
33442774|NCT00502307|62818609|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
33442775|NCT00502307|62818607|FG000|Maintenance Period|Progressive disease|80|||
33442776|NCT00502307|62818608|FG001|Maintenance Period|Progressive disease|0|||
33442777|NCT00502307|62818609|FG002|Maintenance Period|Progressive disease|0|||
33442778|NCT00502307|62818607|FG000|Maintenance Period|Discontinued due to other reasons|68|||
33442779|NCT00502307|62818608|FG001|Maintenance Period|Discontinued due to other reasons|0|||
33442780|NCT00502307|62818609|FG002|Maintenance Period|Discontinued due to other reasons|0|||
33442781|NCT00484679|62818626|FG000|Overall Study|Withdrawal by Subject|3|||
33606591|NCT01763164|63006700|FG000|Follow up Phase|Progressive disease|127|||
33323355|NCT01144182|62699605|FG000|Overall Study|Withdrawal by Subject|3|||
33606592|NCT01763164|63006701|FG001|Follow up Phase|Progressive disease|62|||
33606593|NCT01763164|63006700|FG000|Follow up Phase|Physician Decision|10|||
33606594|NCT01763164|63006701|FG001|Follow up Phase|Physician Decision|3|||
33442782|NCT00377312|62818632|FG000|Overall Study|Adverse Event|1|||
33442783|NCT00377312|62818633|FG001|Overall Study|Adverse Event|1|||
33442784|NCT00377234|62818641|FG000|Overall Study|Adverse Event|14|||
33442785|NCT00377234|62818642|FG001|Overall Study|Adverse Event|17|||
33442786|NCT00377234|62818641|FG000|Overall Study|Withdrawal by Subject|11|||
33442787|NCT00377234|62818642|FG001|Overall Study|Withdrawal by Subject|9|||
33442788|NCT00377234|62818641|FG000|Overall Study|Lost to Follow-up|4|||
33442789|NCT00377234|62818642|FG001|Overall Study|Lost to Follow-up|2|||
33442790|NCT00377234|62818641|FG000|Overall Study|Administrative|2|||
33442791|NCT00377234|62818642|FG001|Overall Study|Administrative|1|||
33442792|NCT00377234|62818641|FG000|Overall Study|Not assigned|3|||
33442793|NCT00377234|62818642|FG001|Overall Study|Not assigned|2|||
33442794|NCT00377156|62818656|FG000|Overall Study|Death|23|||
33442795|NCT00377156|62818657|FG001|Overall Study|Death|19|||
33442796|NCT00377156|62818656|FG000|Overall Study|Withdrawal by Subject|16|||
33442797|NCT00377156|62818657|FG001|Overall Study|Withdrawal by Subject|24|||
33442798|NCT00377156|62818656|FG000|Overall Study|Had follow-up <90 d|3|||
33442799|NCT00377156|62818657|FG001|Overall Study|Had follow-up <90 d|6|||
33442800|NCT00377156|62818656|FG000|Overall Study|Cancellation|1|||
33442801|NCT00377156|62818657|FG001|Overall Study|Cancellation|0|||
33442802|NCT00377156|62818656|FG000|Overall Study|Refused testing|0|||
33442803|NCT00377156|62818657|FG001|Overall Study|Refused testing|1|||
33442804|NCT00377156|62818656|FG000|Overall Study|Ineligible|0|||
33442805|NCT00377156|62818657|FG001|Overall Study|Ineligible|1|||
33442806|NCT00377156|62818656|FG000|Overall Study|Disability or language problem|0|||
33442807|NCT00377156|62818657|FG001|Overall Study|Disability or language problem|1|||
33442808|NCT00377156|62818656|FG000|Overall Study|Other|5|||
33442809|NCT00377156|62818657|FG001|Overall Study|Other|2|||
33442810|NCT00376688|62818665|FG000|Overall Study|Adverse Event|3|||
33442811|NCT00376688|62818665|FG000|Overall Study|Death|1|||
33442812|NCT00376532|62818671|FG000|Overall Study|Lack sufficient blood sample|6|||
33442813|NCT00376532|62818672|FG001|Overall Study|Lack sufficient blood sample|6|||
33442814|NCT00376220|62818680|FG000|Overall Study|Lost to Follow-up|7|||
33442815|NCT00376220|62818681|FG001|Overall Study|Lost to Follow-up|10|||
33442816|NCT00376220|62818680|FG000|Overall Study|Withdrawal by Subject|3|||
33442817|NCT00376220|62818681|FG001|Overall Study|Withdrawal by Subject|2|||
33442818|NCT00375752|62818689|FG000|Overall Study|Lack of Efficacy|4|||
33442819|NCT00375752|62818690|FG001|Overall Study|Lack of Efficacy|4|||
33442820|NCT00375752|62818689|FG000|Overall Study|Adverse Event|1|||
33442821|NCT00375752|62818690|FG001|Overall Study|Adverse Event|6|||
33442822|NCT00375752|62818689|FG000|Overall Study|Withdrawal by Subject|6|||
33442823|NCT00375752|62818690|FG001|Overall Study|Withdrawal by Subject|1|||
33442824|NCT00375752|62818689|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
33442825|NCT00375752|62818690|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
33442826|NCT00375752|62818689|FG000|Overall Study|Protocol Violation|0|||
33442827|NCT00375752|62818690|FG001|Overall Study|Protocol Violation|2|||
33442828|NCT00375752|62818689|FG000|Overall Study|Administrative Problems|0|||
33442829|NCT00375752|62818690|FG001|Overall Study|Administrative Problems|1|||
33442830|NCT00484289|62818699|FG000|Long Term Phase|Adverse Event|1|||
33442831|NCT00484289|62818700|FG001|Long Term Phase|Adverse Event|17|||
33606595|NCT01763164|63006700|FG000|Follow up Phase|Lost to Follow-up|1|||
33606596|NCT01763164|63006701|FG001|Follow up Phase|Lost to Follow-up|0|||
33606597|NCT01763164|63006700|FG000|Follow up Phase|Adverse Event|17|||
33606598|NCT01763164|63006701|FG001|Follow up Phase|Adverse Event|1|||
33606599|NCT01782742|63006709|FG000|Double-blind Treatment Phase|Adverse Event|1|||
33606600|NCT01782742|63006710|FG001|Double-blind Treatment Phase|Adverse Event|0|||
33606601|NCT01782664|63006724|FG000|Overall Study|Adverse Event|2|||
33606602|NCT01782664|63006725|FG001|Overall Study|Adverse Event|2|||
33606603|NCT01782664|63006726|FG002|Overall Study|Adverse Event|2|||
33442832|NCT00484289|62818701|FG002|Long Term Phase|Adverse Event|5|||
33442833|NCT00484289|62818699|FG000|Long Term Phase|Withdrawal by Subject|0|||
33442834|NCT00484289|62818700|FG001|Long Term Phase|Withdrawal by Subject|7|||
33442835|NCT00484289|62818701|FG002|Long Term Phase|Withdrawal by Subject|6|||
33442836|NCT00484289|62818699|FG000|Long Term Phase|Inadequate response|2|||
33442837|NCT00484289|62818700|FG001|Long Term Phase|Inadequate response|7|||
33442838|NCT00484289|62818701|FG002|Long Term Phase|Inadequate response|4|||
33442839|NCT00484289|62818699|FG000|Long Term Phase|Other Reason|0|||
33442840|NCT00484289|62818700|FG001|Long Term Phase|Other Reason|5|||
33442841|NCT00484289|62818701|FG002|Long Term Phase|Other Reason|1|||
33442842|NCT00484289|62818699|FG000|Post Marketing Phase|Adverse Event|0|||
33606604|NCT01782664|63006727|FG003|Overall Study|Adverse Event|2|||
33442843|NCT00484289|62818700|FG001|Post Marketing Phase|Adverse Event|1|||
33442844|NCT00484289|62818701|FG002|Post Marketing Phase|Adverse Event|0|||
33442845|NCT00490529|62818710|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
33442846|NCT00490529|62818710|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
33442847|NCT00490529|62818710|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
33442848|NCT00490529|62818710|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
33442849|NCT00490529|62818710|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
33442850|NCT00490529|62818710|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
33442851|NCT00333840|62818716|FG000|First-line Treatment Period|Adverse Event|38|||
33442852|NCT00333840|62818717|FG001|First-line Treatment Period|Adverse Event|37|||
33442853|NCT00333840|62818718|FG002|First-line Treatment Period|Adverse Event|0|||
33442854|NCT00333840|62818719|FG003|First-line Treatment Period|Adverse Event|0|||
33442855|NCT00333840|62818716|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
33442856|NCT00333840|62818717|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
33442857|NCT00333840|62818718|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
33442858|NCT00333840|62818719|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
33442859|NCT00333840|62818716|FG000|First-line Treatment Period|Abnormal procedure|2|||
33442860|NCT00333840|62818717|FG001|First-line Treatment Period|Abnormal procedure|0|||
33442861|NCT00333840|62818718|FG002|First-line Treatment Period|Abnormal procedure|0|||
33442862|NCT00333840|62818719|FG003|First-line Treatment Period|Abnormal procedure|0|||
33442863|NCT00333840|62818716|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
33442864|NCT00333840|62818717|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
33442865|NCT00333840|62818718|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
33442866|NCT00333840|62818719|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
33442867|NCT00333840|62818716|FG000|First-line Treatment Period|No longer required study drug|21|||
33442868|NCT00333840|62818717|FG001|First-line Treatment Period|No longer required study drug|8|||
33442869|NCT00333840|62818718|FG002|First-line Treatment Period|No longer required study drug|0|||
33442870|NCT00333840|62818719|FG003|First-line Treatment Period|No longer required study drug|0|||
33442871|NCT00333840|62818716|FG000|First-line Treatment Period|Protocol Violation|17|||
33442872|NCT00333840|62818717|FG001|First-line Treatment Period|Protocol Violation|17|||
33442873|NCT00333840|62818718|FG002|First-line Treatment Period|Protocol Violation|0|||
33442874|NCT00333840|62818719|FG003|First-line Treatment Period|Protocol Violation|0|||
33442875|NCT00333840|62818716|FG000|First-line Treatment Period|Subject withdrew consent|57|||
33442876|NCT00333840|62818717|FG001|First-line Treatment Period|Subject withdrew consent|77|||
33442877|NCT00333840|62818718|FG002|First-line Treatment Period|Subject withdrew consent|0|||
33442878|NCT00333840|62818719|FG003|First-line Treatment Period|Subject withdrew consent|0|||
33442879|NCT00333840|62818716|FG000|First-line Treatment Period|Lost to Follow-up|15|||
33442880|NCT00333840|62818717|FG001|First-line Treatment Period|Lost to Follow-up|6|||
33442881|NCT00333840|62818718|FG002|First-line Treatment Period|Lost to Follow-up|0|||
33442882|NCT00333840|62818719|FG003|First-line Treatment Period|Lost to Follow-up|0|||
33442883|NCT00333840|62818716|FG000|First-line Treatment Period|Administrative problems|12|||
33442884|NCT00333840|62818717|FG001|First-line Treatment Period|Administrative problems|6|||
33442885|NCT00333840|62818718|FG002|First-line Treatment Period|Administrative problems|0|||
33442886|NCT00333840|62818719|FG003|First-line Treatment Period|Administrative problems|0|||
33442887|NCT00333840|62818716|FG000|First-line Treatment Period|Death|19|||
33442888|NCT00333840|62818717|FG001|First-line Treatment Period|Death|2|||
33442889|NCT00333840|62818718|FG002|First-line Treatment Period|Death|0|||
33442890|NCT00333840|62818719|FG003|First-line Treatment Period|Death|0|||
33442891|NCT00333840|62818716|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
33442892|NCT00333840|62818717|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
33442893|NCT00333840|62818718|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
33606605|NCT01782664|63006728|FG004|Overall Study|Adverse Event|0|||
33606606|NCT01782664|63006729|FG005|Overall Study|Adverse Event|0|||
33606607|NCT01782664|63006724|FG000|Overall Study|Lack of Efficacy|2|||
33606608|NCT01782664|63006725|FG001|Overall Study|Lack of Efficacy|0|||
33606609|NCT01782664|63006726|FG002|Overall Study|Lack of Efficacy|2|||
33606610|NCT01782664|63006727|FG003|Overall Study|Lack of Efficacy|2|||
33606611|NCT01782664|63006728|FG004|Overall Study|Lack of Efficacy|0|||
33606612|NCT01782664|63006729|FG005|Overall Study|Lack of Efficacy|0|||
33606613|NCT01782664|63006724|FG000|Overall Study|Protocol Violation|0|||
33442894|NCT00333840|62818719|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
33442895|NCT00333840|62818716|FG000|Second-line Treatment Period|Adverse Event|0|||
33494221|NCT04206020|62872991|FG001|Overall Study|Pregnancy|1|||
33606614|NCT01782664|63006725|FG001|Overall Study|Protocol Violation|1|||
33606615|NCT01782664|63006726|FG002|Overall Study|Protocol Violation|0|||
33606616|NCT01782664|63006727|FG003|Overall Study|Protocol Violation|1|||
33442896|NCT00333840|62818717|FG001|Second-line Treatment Period|Adverse Event|0|||
33606617|NCT01782664|63006728|FG004|Overall Study|Protocol Violation|0|||
33606618|NCT01782664|63006729|FG005|Overall Study|Protocol Violation|0|||
33442897|NCT00333840|62818718|FG002|Second-line Treatment Period|Adverse Event|3|||
33442898|NCT00333840|62818719|FG003|Second-line Treatment Period|Adverse Event|34|||
33442899|NCT00333840|62818716|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
33442900|NCT00333840|62818717|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
33442901|NCT00333840|62818718|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
33442902|NCT00333840|62818719|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
33442903|NCT00333840|62818716|FG000|Second-line Treatment Period|Abnormal procedure|0|||
33442904|NCT00333840|62818717|FG001|Second-line Treatment Period|Abnormal procedure|0|||
33442905|NCT00333840|62818718|FG002|Second-line Treatment Period|Abnormal procedure|0|||
33442906|NCT00333840|62818719|FG003|Second-line Treatment Period|Abnormal procedure|1|||
33442907|NCT00333840|62818716|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
33442908|NCT00333840|62818717|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
33442909|NCT00333840|62818718|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
33442910|NCT00333840|62818719|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
33442911|NCT00333840|62818716|FG000|Second-line Treatment Period|No longer required study drug|0|||
33442912|NCT00333840|62818717|FG001|Second-line Treatment Period|No longer required study drug|0|||
33442913|NCT00333840|62818718|FG002|Second-line Treatment Period|No longer required study drug|1|||
33442914|NCT00333840|62818719|FG003|Second-line Treatment Period|No longer required study drug|14|||
33442915|NCT00333840|62818716|FG000|Second-line Treatment Period|Protocol Violation|0|||
33442916|NCT00333840|62818717|FG001|Second-line Treatment Period|Protocol Violation|0|||
33442917|NCT00333840|62818718|FG002|Second-line Treatment Period|Protocol Violation|1|||
33442918|NCT00333840|62818719|FG003|Second-line Treatment Period|Protocol Violation|10|||
33442919|NCT00333840|62818716|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
33442920|NCT00333840|62818717|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
33442921|NCT00333840|62818718|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
33442922|NCT00333840|62818719|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
33442923|NCT00333840|62818716|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
33442924|NCT00333840|62818717|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
33442925|NCT00333840|62818718|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
33442926|NCT00333840|62818719|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
33442927|NCT00333840|62818716|FG000|Second-line Treatment Period|Administrative problems|0|||
33442928|NCT00333840|62818717|FG001|Second-line Treatment Period|Administrative problems|0|||
33442929|NCT00333840|62818718|FG002|Second-line Treatment Period|Administrative problems|0|||
33442930|NCT00333840|62818719|FG003|Second-line Treatment Period|Administrative problems|7|||
33442931|NCT00333840|62818716|FG000|Second-line Treatment Period|Death|0|||
33442932|NCT00333840|62818717|FG001|Second-line Treatment Period|Death|0|||
33442933|NCT00333840|62818718|FG002|Second-line Treatment Period|Death|0|||
33442934|NCT00333840|62818719|FG003|Second-line Treatment Period|Death|9|||
33442935|NCT00490451|62818735|FG000|Overall Study|Adverse Event|3|||
33442936|NCT00490451|62818736|FG001|Overall Study|Adverse Event|3|||
33442937|NCT00490451|62818735|FG000|Overall Study|Death|3|||
33442938|NCT00490451|62818736|FG001|Overall Study|Death|1|||
33442939|NCT00490451|62818735|FG000|Overall Study|Withdrawal by Subject|2|||
33442940|NCT00490451|62818736|FG001|Overall Study|Withdrawal by Subject|0|||
33442941|NCT00490451|62818735|FG000|Overall Study|Investigator Decision|1|||
33442942|NCT00490451|62818736|FG001|Overall Study|Investigator Decision|0|||
33442943|NCT00490451|62818735|FG000|Overall Study|Protocol Violation|1|||
33442944|NCT00490451|62818736|FG001|Overall Study|Protocol Violation|0|||
33442945|NCT00490451|62818735|FG000|Overall Study|Progressive Disease|53|||
33442946|NCT00490451|62818736|FG001|Overall Study|Progressive Disease|34|||
33442947|NCT00321906|62818744|FG000|Overall Study|Adverse Event|36|||
33442948|NCT00321906|62818745|FG001|Overall Study|Adverse Event|44|||
33442949|NCT00321906|62818744|FG000|Overall Study|Death|9|||
33442950|NCT00321906|62818745|FG001|Overall Study|Death|6|||
33442951|NCT00321906|62818744|FG000|Overall Study|Lost to Follow-up|1|||
33442952|NCT00321906|62818745|FG001|Overall Study|Lost to Follow-up|2|||
33442953|NCT00321906|62818744|FG000|Overall Study|Withdrawal by Subject|0|||
33442954|NCT00321906|62818745|FG001|Overall Study|Withdrawal by Subject|4|||
33442955|NCT00339144|62818754|FG000|Overall Study|Disease progression|5|||
33442956|NCT00339144|62818755|FG001|Overall Study|Disease progression|2|||
33442957|NCT00339144|62818756|FG002|Overall Study|Disease progression|2|||
33442958|NCT00339144|62818754|FG000|Overall Study|Study drug toxicity|3|||
33442959|NCT00339144|62818755|FG001|Overall Study|Study drug toxicity|1|||
33442960|NCT00339144|62818756|FG002|Overall Study|Study drug toxicity|1|||
33442961|NCT00339144|62818754|FG000|Overall Study|Participant's request to discontinuation|1|||
33442962|NCT00339144|62818755|FG001|Overall Study|Participant's request to discontinuation|0|||
33442963|NCT00339144|62818756|FG002|Overall Study|Participant's request to discontinuation|1|||
33442964|NCT00321828|62818765|FG000|Overall Study|Ineligible|3|||
33442965|NCT00321828|62818765|FG000|Overall Study|No follow up data|1|||
33442966|NCT00333138|62818772|FG000|Core Study (6 Months)|Adverse Event|4|||
33442967|NCT00333138|62818773|FG001|Core Study (6 Months)|Adverse Event|5|||
33442968|NCT00333138|62818774|FG002|Core Study (6 Months)|Adverse Event|8|||
33442969|NCT00333138|62818772|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
33442970|NCT00333138|62818773|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
33442971|NCT00333138|62818774|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
33442972|NCT00333138|62818772|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
33442973|NCT00333138|62818773|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
33442974|NCT00333138|62818774|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
33442975|NCT00333138|62818772|FG000|Core Study (6 Months)|Protocol Violation|1|||
33442976|NCT00333138|62818773|FG001|Core Study (6 Months)|Protocol Violation|0|||
33442977|NCT00333138|62818774|FG002|Core Study (6 Months)|Protocol Violation|1|||
33442978|NCT00333138|62818772|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
33442979|NCT00333138|62818773|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
33442980|NCT00333138|62818774|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
33442981|NCT00333138|62818772|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
33442982|NCT00333138|62818773|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
33442983|NCT00333138|62818774|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
33442984|NCT00333138|62818772|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
33442985|NCT00333138|62818773|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
33442986|NCT00333138|62818774|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
33442987|NCT00333138|62818772|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
33442988|NCT00333138|62818773|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
33442989|NCT00333138|62818774|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
33442990|NCT00333138|62818772|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
33442991|NCT00333138|62818773|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
33442992|NCT00333138|62818774|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
33442993|NCT00333138|62818772|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
33442994|NCT00333138|62818773|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
33442995|NCT00333138|62818774|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
33442996|NCT00333138|62818772|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
33442997|NCT00333138|62818773|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
33442998|NCT00333138|62818774|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
33442999|NCT00333138|62818772|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
33443000|NCT00333138|62818773|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
33443001|NCT00333138|62818774|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
33443002|NCT00333138|62818772|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
33443003|NCT00333138|62818773|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
33443004|NCT00333138|62818774|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
33443005|NCT00333138|62818772|FG000|Extension Study (Month6 to End of Study)|Death|0|||
33443006|NCT00333138|62818773|FG001|Extension Study (Month6 to End of Study)|Death|1|||
33443007|NCT00333138|62818774|FG002|Extension Study (Month6 to End of Study)|Death|0|||
33443008|NCT00332202|62818786|FG000|Overall Study|Adverse Event|72|||
33443009|NCT00332202|62818787|FG001|Overall Study|Adverse Event|28|||
33443010|NCT00332202|62818786|FG000|Overall Study|Lost to Follow-up|2|||
33443011|NCT00332202|62818787|FG001|Overall Study|Lost to Follow-up|1|||
33443012|NCT00332202|62818786|FG000|Overall Study|Physician Decision|6|||
33443013|NCT00332202|62818787|FG001|Overall Study|Physician Decision|8|||
33443014|NCT00332202|62818786|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
33443015|NCT00332202|62818787|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
33443016|NCT00332202|62818786|FG000|Overall Study|Protocol Violation|7|||
33443017|NCT00332202|62818787|FG001|Overall Study|Protocol Violation|2|||
33443018|NCT00332202|62818786|FG000|Overall Study|Sponsor Decision|1|||
33443019|NCT00332202|62818787|FG001|Overall Study|Sponsor Decision|2|||
33443020|NCT00332202|62818786|FG000|Overall Study|Withdrawal by Subject|36|||
33443021|NCT00332202|62818787|FG001|Overall Study|Withdrawal by Subject|17|||
33443022|NCT00332202|62818786|FG000|Overall Study|Progressive Disease|106|||
33443023|NCT00332202|62818787|FG001|Overall Study|Progressive Disease|60|||
33443024|NCT00332202|62818786|FG000|Overall Study|Death|5|||
33443025|NCT00332202|62818787|FG001|Overall Study|Death|2|||
33443026|NCT00331422|62818802|FG000|Overall Study|Did not receive entire study regimen|5|||
33443027|NCT00331344|62818807|FG000|Phase I|Adverse Event|0|||
33443028|NCT00331344|62818808|FG001|Phase I|Adverse Event|0|||
33443029|NCT00331344|62818809|FG002|Phase I|Adverse Event|0|||
33443030|NCT00331344|62818810|FG003|Phase I|Adverse Event|1|||
33443031|NCT00331344|62818811|FG004|Phase I|Adverse Event|2|||
33443032|NCT00331344|62818812|FG005|Phase I|Adverse Event|2|||
33443033|NCT00331344|62818813|FG006|Phase I|Adverse Event|0|||
33443034|NCT00331344|62818814|FG007|Phase I|Adverse Event|1|||
33494222|NCT04206020|62872990|FG000|Overall Study|Unable to attend visits|1|||
33494223|NCT04206020|62872991|FG001|Overall Study|Unable to attend visits|2|||
33443035|NCT00331344|62818815|FG008|Phase I|Adverse Event|0|||
33443036|NCT00331344|62818807|FG000|Phase II|Death|0|||
33443037|NCT00331344|62818808|FG001|Phase II|Death|0|||
33494224|NCT03466086|62872997|FG000|Period 1|Sponsor decision due to study timeline|1|||
33443038|NCT00331344|62818809|FG002|Phase II|Death|0|||
33443039|NCT00331344|62818810|FG003|Phase II|Death|0|||
33443040|NCT00331344|62818811|FG004|Phase II|Death|0|||
33443041|NCT00331344|62818812|FG005|Phase II|Death|0|||
33443042|NCT00331344|62818813|FG006|Phase II|Death|0|||
33443043|NCT00331344|62818814|FG007|Phase II|Death|0|||
33443044|NCT00331344|62818815|FG008|Phase II|Death|4|||
33443045|NCT00321672|62818832|FG000|Overall Study|Withdrawal by Subject|5|||
33443046|NCT00321672|62818833|FG001|Overall Study|Withdrawal by Subject|1|||
33443047|NCT00321672|62818834|FG002|Overall Study|Withdrawal by Subject|2|||
33443048|NCT00321672|62818835|FG003|Overall Study|Withdrawal by Subject|0|||
33443049|NCT00321672|62818832|FG000|Overall Study|Noncompliance|1|||
33443050|NCT00321672|62818833|FG001|Overall Study|Noncompliance|2|||
33443051|NCT00321672|62818834|FG002|Overall Study|Noncompliance|1|||
33443052|NCT00321672|62818835|FG003|Overall Study|Noncompliance|0|||
33443053|NCT00321672|62818832|FG000|Overall Study|Adverse Event|1|||
33443054|NCT00321672|62818833|FG001|Overall Study|Adverse Event|1|||
33443055|NCT00321672|62818834|FG002|Overall Study|Adverse Event|0|||
33443056|NCT00321672|62818835|FG003|Overall Study|Adverse Event|0|||
33443057|NCT00321672|62818832|FG000|Overall Study|Lack of Efficacy|1|||
33443058|NCT00321672|62818833|FG001|Overall Study|Lack of Efficacy|1|||
33323356|NCT01144182|62699606|FG001|Overall Study|Withdrawal by Subject|6|||
33323357|NCT01144182|62699605|FG000|Overall Study|Lost to Follow-up|9|||
33323358|NCT01144182|62699606|FG001|Overall Study|Lost to Follow-up|9|||
33323359|NCT01225562|62699616|FG000|Overall Study|Withdrawal by Subject|52|||
33323360|NCT01225562|62699617|FG001|Overall Study|Withdrawal by Subject|50|||
33443059|NCT00321672|62818834|FG002|Overall Study|Lack of Efficacy|0|||
33443060|NCT00321672|62818835|FG003|Overall Study|Lack of Efficacy|0|||
33443061|NCT00321672|62818832|FG000|Overall Study|Lost to Follow-up|2|||
33443062|NCT00321672|62818833|FG001|Overall Study|Lost to Follow-up|0|||
33443063|NCT00321672|62818834|FG002|Overall Study|Lost to Follow-up|4|||
33443064|NCT00321672|62818835|FG003|Overall Study|Lost to Follow-up|2|||
33443065|NCT00321672|62818832|FG000|Overall Study|Death|1|||
33443066|NCT00321672|62818833|FG001|Overall Study|Death|0|||
33443067|NCT00321672|62818834|FG002|Overall Study|Death|0|||
33443068|NCT00321672|62818835|FG003|Overall Study|Death|0|||
33443069|NCT00321672|62818832|FG000|Overall Study|Too far to travel for visits|1|||
33443070|NCT00321672|62818833|FG001|Overall Study|Too far to travel for visits|0|||
33443071|NCT00321672|62818834|FG002|Overall Study|Too far to travel for visits|0|||
33443072|NCT00321672|62818835|FG003|Overall Study|Too far to travel for visits|0|||
33443073|NCT00321672|62818832|FG000|Overall Study|Incarcerated|0|||
33443074|NCT00321672|62818833|FG001|Overall Study|Incarcerated|0|||
33443075|NCT00321672|62818834|FG002|Overall Study|Incarcerated|2|||
33443076|NCT00321672|62818835|FG003|Overall Study|Incarcerated|0|||
33443077|NCT00321672|62818832|FG000|Overall Study|Moved out of state|0|||
33443078|NCT00321672|62818833|FG001|Overall Study|Moved out of state|1|||
33443079|NCT00321672|62818834|FG002|Overall Study|Moved out of state|1|||
33443080|NCT00321672|62818835|FG003|Overall Study|Moved out of state|0|||
33443081|NCT00321672|62818832|FG000|Overall Study|Protocol Violation|0|||
33443082|NCT00321672|62818833|FG001|Overall Study|Protocol Violation|0|||
33443083|NCT00321672|62818834|FG002|Overall Study|Protocol Violation|1|||
33443084|NCT00321672|62818835|FG003|Overall Study|Protocol Violation|0|||
33443085|NCT00321672|62818832|FG000|Overall Study|Diagnosis of testicular cancer|0|||
33443086|NCT00321672|62818833|FG001|Overall Study|Diagnosis of testicular cancer|1|||
33443087|NCT00321672|62818834|FG002|Overall Study|Diagnosis of testicular cancer|0|||
33443088|NCT00321672|62818835|FG003|Overall Study|Diagnosis of testicular cancer|0|||
33443089|NCT00321672|62818832|FG000|Overall Study|Extensive travel required for new job|0|||
33443090|NCT00321672|62818833|FG001|Overall Study|Extensive travel required for new job|1|||
33443091|NCT00321672|62818834|FG002|Overall Study|Extensive travel required for new job|0|||
33443092|NCT00321672|62818835|FG003|Overall Study|Extensive travel required for new job|0|||
33443093|NCT00321048|62818851|FG000|Overall Study|Withdrawal by Subject|6|||
33443094|NCT00321048|62818852|FG001|Overall Study|Withdrawal by Subject|8|||
33443095|NCT00330174|62818860|FG000|Overall Study|Withdrawal by Subject|7|||
33443096|NCT00330174|62818861|FG001|Overall Study|Withdrawal by Subject|7|||
33443097|NCT00330174|62818860|FG000|Overall Study|Lost to Follow-up|4|||
33494225|NCT03466086|62872998|FG001|Period 1|Sponsor decision due to study timeline|0|||
33443098|NCT00330174|62818861|FG001|Overall Study|Lost to Follow-up|1|||
33443099|NCT00330174|62818860|FG000|Overall Study|Clinical deterioration|1|||
33443100|NCT00330174|62818861|FG001|Overall Study|Clinical deterioration|2|||
33443101|NCT00330174|62818860|FG000|Overall Study|Excessive missed visits|3|||
33443102|NCT00330174|62818861|FG001|Overall Study|Excessive missed visits|8|||
33443103|NCT00330174|62818860|FG000|Overall Study|Miscellaneous reasons|7|||
33494226|NCT03466086|62872997|FG000|Period 1|Withdrawal by Subject|1|||
33323361|NCT01225562|62699618|FG002|Overall Study|Withdrawal by Subject|52|||
33443104|NCT00330174|62818861|FG001|Overall Study|Miscellaneous reasons|1|||
33443105|NCT00320424|62818867|FG000|Overall Study|Adverse Event|3|||
33443106|NCT00320424|62818867|FG000|Overall Study|Other|3|||
33443107|NCT00338286|62818873|FG000|Overall Study|Withdrawal by Subject|50|||
33443108|NCT00338286|62818874|FG001|Overall Study|Withdrawal by Subject|54|||
33443109|NCT00338286|62818873|FG000|Overall Study|Lost to Follow-up|80|||
33443110|NCT00338286|62818874|FG001|Overall Study|Lost to Follow-up|66|||
33443111|NCT00338286|62818873|FG000|Overall Study|Other|103|||
33443112|NCT00338286|62818874|FG001|Overall Study|Other|93|||
33443113|NCT00329784|62818884|FG000|Overall Study|Lost to Follow-up|0|||
33443114|NCT00329784|62818885|FG001|Overall Study|Lost to Follow-up|1|||
33443115|NCT00329784|62818886|FG002|Overall Study|Lost to Follow-up|0|||
33443116|NCT00329784|62818887|FG003|Overall Study|Lost to Follow-up|0|||
33443117|NCT00329784|62818884|FG000|Overall Study|Withdrawal by Subject|4|||
33443118|NCT00329784|62818885|FG001|Overall Study|Withdrawal by Subject|2|||
33443119|NCT00329784|62818886|FG002|Overall Study|Withdrawal by Subject|0|||
33443120|NCT00329784|62818887|FG003|Overall Study|Withdrawal by Subject|0|||
33443121|NCT00329784|62818884|FG000|Overall Study|Other|1|||
33443122|NCT00329784|62818885|FG001|Overall Study|Other|2|||
33443123|NCT00329784|62818886|FG002|Overall Study|Other|0|||
33443124|NCT00329784|62818887|FG003|Overall Study|Other|0|||
33443125|NCT00337818|62818902|FG000|Overall Study|Lost to Follow-up|289|||
33443126|NCT00337818|62818903|FG001|Overall Study|Lost to Follow-up|91|||
33443127|NCT00337818|62818904|FG002|Overall Study|Lost to Follow-up|107|||
33443128|NCT00329550|62818915|FG000|Overall Study|Adverse Event|3|||
33443129|NCT00329550|62818916|FG001|Overall Study|Adverse Event|4|||
33443130|NCT00329550|62818917|FG002|Overall Study|Adverse Event|2|||
33443131|NCT00329550|62818915|FG000|Overall Study|Withdrawal of Consent|1|||
33443132|NCT00329550|62818916|FG001|Overall Study|Withdrawal of Consent|0|||
33443133|NCT00329550|62818917|FG002|Overall Study|Withdrawal of Consent|1|||
33443134|NCT00329550|62818915|FG000|Overall Study|Due to Relocation|0|||
33443135|NCT00329550|62818916|FG001|Overall Study|Due to Relocation|0|||
33443136|NCT00329550|62818917|FG002|Overall Study|Due to Relocation|1|||
33443137|NCT00375674|62818929|FG000|Overall Study|Other|26|||
33443138|NCT00375674|62818930|FG001|Overall Study|Other|18|||
33443139|NCT00375674|62818929|FG000|Overall Study|Death|67|||
33443140|NCT00375674|62818930|FG001|Overall Study|Death|76|||
33443141|NCT00375674|62818929|FG000|Overall Study|Participants refused further follow-up|31|||
33443142|NCT00375674|62818930|FG001|Overall Study|Participants refused further follow-up|30|||
33443143|NCT00375674|62818929|FG000|Overall Study|Lost to Follow-up|17|||
33443144|NCT00375674|62818930|FG001|Overall Study|Lost to Follow-up|15|||
33443145|NCT00375674|62818929|FG000|Overall Study|Enrolled but not treated|3|||
33443146|NCT00375674|62818930|FG001|Overall Study|Enrolled but not treated|2|||
33443147|NCT00350402|62818938|FG000|Overall Study|Lost to Follow-up|1|||
33443148|NCT00350402|62818939|FG001|Overall Study|Lost to Follow-up|1|||
33443149|NCT00320190|62818953|FG000|First 12 Months|Completed but did not enter extension|5|||
33443150|NCT00320190|62818954|FG001|First 12 Months|Completed but did not enter extension|3|||
33443151|NCT00320190|62818953|FG000|First 12 Months|Sponsor terminated study|2|||
33443152|NCT00320190|62818954|FG001|First 12 Months|Sponsor terminated study|2|||
33443153|NCT00320190|62818953|FG000|First 12 Months|Lost to Follow-up|0|||
33443154|NCT00320190|62818954|FG001|First 12 Months|Lost to Follow-up|1|||
33443155|NCT00320190|62818953|FG000|First 12 Months|Enrollment failure|0|||
33443156|NCT00320190|62818954|FG001|First 12 Months|Enrollment failure|1|||
33443157|NCT00320190|62818953|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
33443158|NCT00320190|62818954|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
33443159|NCT00320190|62818953|FG000|First 12 Months|Investigator request|0|||
33443160|NCT00320190|62818954|FG001|First 12 Months|Investigator request|1|||
33443161|NCT00320190|62818953|FG000|First 12 Months|Study drug toxicity|0|||
33443162|NCT00320190|62818954|FG001|First 12 Months|Study drug toxicity|1|||
33443163|NCT00320190|62818953|FG000|First 12 Months|Withdrawal by Subject|0|||
33443164|NCT00320190|62818954|FG001|First 12 Months|Withdrawal by Subject|1|||
33443165|NCT00320190|62818953|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
33443166|NCT00320190|62818954|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
33443167|NCT00320190|62818953|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
33443168|NCT00320190|62818954|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
33443169|NCT00320190|62818953|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
33443170|NCT00320190|62818954|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
33443171|NCT00320112|62818962|FG000|Overall Study|Lost to Follow-up|3|||
33323362|NCT01225562|62699616|FG000|Overall Study|Lost to Follow-up|3|||
33494227|NCT03466086|62872998|FG001|Period 1|Withdrawal by Subject|0|||
33494228|NCT03101462|62873006|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
33443172|NCT00320112|62818963|FG001|Overall Study|Lost to Follow-up|4|||
33443173|NCT00320112|62818962|FG000|Overall Study|Withdrawal by Subject|3|||
33443174|NCT00320112|62818963|FG001|Overall Study|Withdrawal by Subject|0|||
33443175|NCT00320112|62818962|FG000|Overall Study|Death|2|||
33443176|NCT00320112|62818963|FG001|Overall Study|Death|1|||
33443177|NCT00319956|62818977|FG000|Overall Study|Death|20|||
33443178|NCT00319956|62818978|FG001|Overall Study|Death|24|||
33443179|NCT00349622|62818986|FG000|Overall Study|Death|168|||
33443180|NCT00349622|62818987|FG001|Overall Study|Death|86|||
33443181|NCT00349622|62818986|FG000|Overall Study|Lost to Follow-up|5|||
33443182|NCT00349622|62818987|FG001|Overall Study|Lost to Follow-up|1|||
33443183|NCT00349622|62818986|FG000|Overall Study|Withdrawal by Subject|5|||
33443184|NCT00349622|62818987|FG001|Overall Study|Withdrawal by Subject|9|||
33443185|NCT00354614|62818993|FG000|Overall Study|Lack of Efficacy|28|||
33443186|NCT00360308|62819000|FG000|Overall Study|Adverse Event|15|||
33443187|NCT00360308|62819001|FG001|Overall Study|Adverse Event|14|||
33443188|NCT00360308|62819002|FG002|Overall Study|Adverse Event|25|||
33443189|NCT00360308|62819000|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
33443190|NCT00360308|62819001|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
33443191|NCT00360308|62819002|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
33443192|NCT00360308|62819000|FG000|Overall Study|Protocol Violation|2|||
33443193|NCT00360308|62819001|FG001|Overall Study|Protocol Violation|1|||
33443194|NCT00360308|62819002|FG002|Overall Study|Protocol Violation|2|||
33443195|NCT00360308|62819000|FG000|Overall Study|Withdrawal by Subject|11|||
33443196|NCT00360308|62819001|FG001|Overall Study|Withdrawal by Subject|7|||
33443197|NCT00360308|62819002|FG002|Overall Study|Withdrawal by Subject|14|||
33443198|NCT00360308|62819000|FG000|Overall Study|Lack of Efficacy|3|||
33443199|NCT00360308|62819001|FG001|Overall Study|Lack of Efficacy|0|||
33443200|NCT00360308|62819002|FG002|Overall Study|Lack of Efficacy|2|||
33443201|NCT00360308|62819000|FG000|Overall Study|Other|2|||
33443202|NCT00360308|62819001|FG001|Overall Study|Other|1|||
33443203|NCT00360308|62819002|FG002|Overall Study|Other|1|||
33443204|NCT00360308|62819000|FG000|Overall Study|Study termination by sponsor|43|||
33443205|NCT00360308|62819001|FG001|Overall Study|Study termination by sponsor|55|||
33443206|NCT00360308|62819002|FG002|Overall Study|Study termination by sponsor|44|||
33443207|NCT00348686|62819014|FG000|Overall Study|Withdrawal by Subject|45|||
33443208|NCT00348686|62819014|FG000|Overall Study|Adverse Event|5|||
33443209|NCT00348686|62819014|FG000|Overall Study|Protocol Violation|6|||
33443210|NCT00348686|62819014|FG000|Overall Study|Lost to Follow-up|2|||
33443211|NCT00348686|62819014|FG000|Overall Study|Multiple Reasons|8|||
33443212|NCT00360230|62819025|FG000|Overall Study|Withdrawal by Subject|1|||
33443213|NCT00360230|62819026|FG001|Overall Study|Withdrawal by Subject|1|||
33443214|NCT00360230|62819027|FG002|Overall Study|Withdrawal by Subject|0|||
33443215|NCT00360230|62819028|FG003|Overall Study|Withdrawal by Subject|1|||
33443216|NCT00360230|62819029|FG004|Overall Study|Withdrawal by Subject|1|||
33443217|NCT00360230|62819030|FG005|Overall Study|Withdrawal by Subject|1|||
33443218|NCT00360230|62819031|FG006|Overall Study|Withdrawal by Subject|0|||
33443219|NCT00360230|62819025|FG000|Overall Study|Migrated|4|||
33443220|NCT00360230|62819026|FG001|Overall Study|Migrated|1|||
33443221|NCT00360230|62819027|FG002|Overall Study|Migrated|3|||
33443222|NCT00360230|62819028|FG003|Overall Study|Migrated|1|||
33443223|NCT00360230|62819029|FG004|Overall Study|Migrated|4|||
33443224|NCT00360230|62819030|FG005|Overall Study|Migrated|1|||
33443225|NCT00360230|62819031|FG006|Overall Study|Migrated|1|||
33443226|NCT00360230|62819025|FG000|Overall Study|Other|1|||
33443227|NCT00360230|62819026|FG001|Overall Study|Other|0|||
33443228|NCT00360230|62819027|FG002|Overall Study|Other|0|||
33443229|NCT00360230|62819028|FG003|Overall Study|Other|0|||
33443230|NCT00360230|62819029|FG004|Overall Study|Other|0|||
33443231|NCT00360230|62819030|FG005|Overall Study|Other|0|||
33443232|NCT00360230|62819031|FG006|Overall Study|Other|0|||
33443233|NCT00360230|62819025|FG000|Overall Study|Protocol Violation|0|||
33443234|NCT00360230|62819026|FG001|Overall Study|Protocol Violation|0|||
33443235|NCT00360230|62819027|FG002|Overall Study|Protocol Violation|0|||
33443236|NCT00360230|62819028|FG003|Overall Study|Protocol Violation|0|||
33443237|NCT00360230|62819029|FG004|Overall Study|Protocol Violation|0|||
33443238|NCT00360230|62819030|FG005|Overall Study|Protocol Violation|1|||
33443239|NCT00360230|62819031|FG006|Overall Study|Protocol Violation|0|||
33443240|NCT00360230|62819025|FG000|Overall Study|Death|0|||
33443241|NCT00360230|62819026|FG001|Overall Study|Death|1|||
33443242|NCT00360230|62819027|FG002|Overall Study|Death|0|||
33443243|NCT00360230|62819028|FG003|Overall Study|Death|0|||
33443244|NCT00360230|62819029|FG004|Overall Study|Death|0|||
33443245|NCT00360230|62819030|FG005|Overall Study|Death|1|||
33443246|NCT00360230|62819031|FG006|Overall Study|Death|1|||
33443247|NCT00348374|62819051|FG000|Overall Study|Adverse Event|1|||
33443248|NCT00348374|62819052|FG001|Overall Study|Adverse Event|4|||
33443249|NCT00348374|62819051|FG000|Overall Study|Lost to Follow-up|1|||
33494229|NCT03101462|62873007|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
33606619|NCT01782664|63006724|FG000|Overall Study|Withdrawal by Subject|2|||
33606620|NCT01782664|63006725|FG001|Overall Study|Withdrawal by Subject|2|||
33606621|NCT01782664|63006726|FG002|Overall Study|Withdrawal by Subject|0|||
33606622|NCT01782664|63006727|FG003|Overall Study|Withdrawal by Subject|0|||
33606623|NCT01782664|63006728|FG004|Overall Study|Withdrawal by Subject|0|||
33606624|NCT01782664|63006729|FG005|Overall Study|Withdrawal by Subject|0|||
33606625|NCT01732588|63006746|FG000|First Intervention (7 Days)|Adverse Event|0|||
33606626|NCT01732588|63006747|FG001|First Intervention (7 Days)|Adverse Event|1|||
33606627|NCT01732588|63006748|FG002|First Intervention (7 Days)|Adverse Event|0|||
33606628|NCT01781962|63006756|FG000|Overall Study|Other Miscellaneous Reasons|5|||
33606629|NCT01639339|63006762|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
33606630|NCT01639339|63006763|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
33606631|NCT01639339|63006762|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
33606632|NCT01639339|63006763|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
33606633|NCT01639339|63006762|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
33606634|NCT01639339|63006763|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
33606635|NCT01639339|63006762|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
33606636|NCT01639339|63006763|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
33606637|NCT01639339|63006762|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
33606638|NCT01639339|63006763|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
33606639|NCT01639339|63006762|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
33606640|NCT01639339|63006763|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
33606641|NCT01639339|63006762|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
33606642|NCT01639339|63006763|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
33606643|NCT01639339|63006762|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
33443250|NCT00348374|62819052|FG001|Overall Study|Lost to Follow-up|3|||
33443251|NCT00348374|62819051|FG000|Overall Study|Withdrawal by Subject|5|||
33443252|NCT00348374|62819052|FG001|Overall Study|Withdrawal by Subject|5|||
33606644|NCT01639339|63006763|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
33606645|NCT01639339|63006762|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
33443253|NCT00348374|62819051|FG000|Overall Study|Other|11|||
33443254|NCT00348374|62819052|FG001|Overall Study|Other|12|||
33443255|NCT00348374|62819051|FG000|Overall Study|ongoing at date of cutoff|1|||
33443256|NCT00348374|62819052|FG001|Overall Study|ongoing at date of cutoff|1|||
33443257|NCT00348374|62819051|FG000|Overall Study|randomized but did not receive treatment|0|||
33443258|NCT00348374|62819052|FG001|Overall Study|randomized but did not receive treatment|7|||
33443259|NCT00353366|62819059|FG000|Overall Study|Adverse Event|8|||
33443260|NCT00353366|62819059|FG000|Overall Study|Protocol Violation|12|||
33443261|NCT00353366|62819059|FG000|Overall Study|Withdrawal by Subject|12|||
33443262|NCT00353366|62819059|FG000|Overall Study|Lost to Follow-up|92|||
33443263|NCT00353366|62819059|FG000|Overall Study|Other|19|||
33443264|NCT00352664|62819065|FG000|Overall Study|Withdrawal by Subject|7|||
33443265|NCT00352664|62819066|FG001|Overall Study|Withdrawal by Subject|0|||
33443266|NCT00490139|62819076|FG000|Overall Study|Death|106|||
33443267|NCT00490139|62819077|FG001|Overall Study|Death|119|||
33443268|NCT00490139|62819078|FG002|Overall Study|Death|168|||
33443269|NCT00490139|62819079|FG003|Overall Study|Death|135|||
33443270|NCT00490139|62819076|FG000|Overall Study|Lost to Follow-up|56|||
33443271|NCT00490139|62819077|FG001|Overall Study|Lost to Follow-up|46|||
33443272|NCT00490139|62819078|FG002|Overall Study|Lost to Follow-up|58|||
33443273|NCT00490139|62819079|FG003|Overall Study|Lost to Follow-up|56|||
33443274|NCT00490139|62819076|FG000|Overall Study|Participant Withdrew Consent|146|||
33443275|NCT00490139|62819077|FG001|Overall Study|Participant Withdrew Consent|110|||
33443276|NCT00490139|62819078|FG002|Overall Study|Participant Withdrew Consent|208|||
33443277|NCT00490139|62819079|FG003|Overall Study|Participant Withdrew Consent|116|||
33443278|NCT00348140|62819094|FG000|Overall Study|Adverse Event|46|||
33443279|NCT00348140|62819095|FG001|Overall Study|Adverse Event|49|||
33443280|NCT00348140|62819096|FG002|Overall Study|Adverse Event|78|||
33443281|NCT00348140|62819094|FG000|Overall Study|Lost to Follow-up|4|||
33443282|NCT00348140|62819095|FG001|Overall Study|Lost to Follow-up|4|||
33443283|NCT00348140|62819096|FG002|Overall Study|Lost to Follow-up|4|||
33443284|NCT00348140|62819094|FG000|Overall Study|Protocol Violation|12|||
33443285|NCT00348140|62819095|FG001|Overall Study|Protocol Violation|13|||
33443286|NCT00348140|62819096|FG002|Overall Study|Protocol Violation|14|||
33443287|NCT00348140|62819094|FG000|Overall Study|Withdrawal by Subject|32|||
33443288|NCT00348140|62819095|FG001|Overall Study|Withdrawal by Subject|40|||
33494230|NCT02873936|62873016|FG000|Overall Study|Withdrew Consent|4|||
33606646|NCT01639339|63006763|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
33606647|NCT01639339|63006762|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
33606648|NCT01639339|63006763|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
33606649|NCT02000817|63006777|FG000|Overall Study|Withdrawal by Subject|2|||
33606650|NCT02000817|63006778|FG001|Overall Study|Withdrawal by Subject|0|||
33606651|NCT02000817|63006779|FG002|Overall Study|Withdrawal by Subject|0|||
33606652|NCT02000817|63006780|FG003|Overall Study|Withdrawal by Subject|0|||
33606653|NCT02000817|63006777|FG000|Overall Study|Adverse Event|0|||
33606654|NCT02000817|63006778|FG001|Overall Study|Adverse Event|1|||
33606655|NCT02000817|63006779|FG002|Overall Study|Adverse Event|0|||
33606656|NCT02000817|63006780|FG003|Overall Study|Adverse Event|0|||
33606657|NCT02000817|63006777|FG000|Overall Study|Lost to Follow-up|0|||
33606658|NCT02000817|63006778|FG001|Overall Study|Lost to Follow-up|0|||
33606659|NCT02000817|63006779|FG002|Overall Study|Lost to Follow-up|1|||
33606660|NCT02000817|63006780|FG003|Overall Study|Lost to Follow-up|0|||
33606661|NCT01641133|63006796|FG000|Overall Study|Protocol Violation|0|||
33606662|NCT01641133|63006797|FG001|Overall Study|Protocol Violation|1|||
33606663|NCT01641133|63006798|FG002|Overall Study|Protocol Violation|1|||
33606664|NCT01641133|63006796|FG000|Overall Study|Migrated/moved from study area|5|||
33606665|NCT01641133|63006797|FG001|Overall Study|Migrated/moved from study area|3|||
33606666|NCT01641133|63006798|FG002|Overall Study|Migrated/moved from study area|1|||
33606667|NCT01641133|63006796|FG000|Overall Study|Adverse Event|0|||
33606668|NCT01641133|63006797|FG001|Overall Study|Adverse Event|0|||
33606669|NCT01641133|63006798|FG002|Overall Study|Adverse Event|1|||
33606670|NCT01641133|63006796|FG000|Overall Study|Withdrawal by Subject|5|||
33606671|NCT01641133|63006797|FG001|Overall Study|Withdrawal by Subject|3|||
33606672|NCT01641133|63006798|FG002|Overall Study|Withdrawal by Subject|3|||
33443289|NCT00348140|62819096|FG002|Overall Study|Withdrawal by Subject|40|||
33443290|NCT00348140|62819094|FG000|Overall Study|Non-compliance|8|||
33443291|NCT00348140|62819095|FG001|Overall Study|Non-compliance|13|||
33443292|NCT00348140|62819096|FG002|Overall Study|Non-compliance|5|||
33443293|NCT00348140|62819094|FG000|Overall Study|Participant at risk due to study drug|2|||
33443294|NCT00348140|62819095|FG001|Overall Study|Participant at risk due to study drug|0|||
33443295|NCT00348140|62819096|FG002|Overall Study|Participant at risk due to study drug|0|||
33443296|NCT00348140|62819094|FG000|Overall Study|Conditional medication increased dose|1|||
33494231|NCT02873936|62873017|FG001|Overall Study|Withdrew Consent|11|||
33606673|NCT01641133|63006796|FG000|Overall Study|Lost to Follow-up|0|||
33443297|NCT00348140|62819095|FG001|Overall Study|Conditional medication increased dose|0|||
33443298|NCT00348140|62819096|FG002|Overall Study|Conditional medication increased dose|0|||
33443299|NCT00348140|62819094|FG000|Overall Study|Caregiver related|4|||
33443300|NCT00348140|62819095|FG001|Overall Study|Caregiver related|7|||
33443301|NCT00348140|62819096|FG002|Overall Study|Caregiver related|3|||
33443302|NCT00348140|62819094|FG000|Overall Study|Participant hospitalised|3|||
33443303|NCT00348140|62819095|FG001|Overall Study|Participant hospitalised|0|||
33443304|NCT00348140|62819096|FG002|Overall Study|Participant hospitalised|0|||
33443305|NCT00348140|62819094|FG000|Overall Study|Efficacy related|1|||
33443306|NCT00348140|62819095|FG001|Overall Study|Efficacy related|1|||
33443307|NCT00348140|62819096|FG002|Overall Study|Efficacy related|0|||
33443308|NCT00348140|62819094|FG000|Overall Study|Administration related|3|||
33443309|NCT00348140|62819095|FG001|Overall Study|Administration related|1|||
33443310|NCT00348140|62819096|FG002|Overall Study|Administration related|1|||
33443311|NCT00348140|62819094|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
33443312|NCT00348140|62819095|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
33443313|NCT00348140|62819096|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
33443314|NCT00348140|62819094|FG000|Overall Study|Participant unwell|1|||
33606674|NCT01641133|63006797|FG001|Overall Study|Lost to Follow-up|2|||
33606675|NCT01641133|63006798|FG002|Overall Study|Lost to Follow-up|2|||
33606676|NCT02000427|63006806|FG000|Overall Study|Death|22|||
33606677|NCT01600885|63006810|FG000|First Period|Adverse Event|1|||
33443315|NCT00348140|62819095|FG001|Overall Study|Participant unwell|0|||
33443316|NCT00348140|62819096|FG002|Overall Study|Participant unwell|0|||
33443317|NCT00348140|62819094|FG000|Overall Study|Screen failure|1|||
33323363|NCT01225562|62699617|FG001|Overall Study|Lost to Follow-up|6|||
33323364|NCT01225562|62699618|FG002|Overall Study|Lost to Follow-up|1|||
33323365|NCT00925288|62699628|FG000|Overall Study|Lost to Follow-up|9|||
33323366|NCT00925288|62699629|FG001|Overall Study|Lost to Follow-up|7|||
33323367|NCT01143714|62699639|FG000|Overall Study|Adverse Event|4|||
33443318|NCT00348140|62819095|FG001|Overall Study|Screen failure|0|||
33443319|NCT00348140|62819096|FG002|Overall Study|Screen failure|0|||
33443320|NCT00348140|62819094|FG000|Overall Study|Investigator decided to discontinue|4|||
33443321|NCT00348140|62819095|FG001|Overall Study|Investigator decided to discontinue|1|||
33443322|NCT00348140|62819096|FG002|Overall Study|Investigator decided to discontinue|4|||
33443323|NCT00348140|62819094|FG000|Overall Study|Decided to discontinue on their own|1|||
33443324|NCT00348140|62819095|FG001|Overall Study|Decided to discontinue on their own|4|||
33443325|NCT00348140|62819096|FG002|Overall Study|Decided to discontinue on their own|1|||
33606678|NCT01600885|63006811|FG001|First Period|Adverse Event|1|||
33606679|NCT01600885|63006810|FG000|First Period|moved out of area|1|||
33606680|NCT01600885|63006811|FG001|First Period|moved out of area|0|||
33606681|NCT01732510|63006824|FG000|Overall Study|Adverse Event|0|||
33606682|NCT01732510|63006825|FG001|Overall Study|Adverse Event|1|||
33606683|NCT01732510|63006826|FG002|Overall Study|Adverse Event|1|||
33606684|NCT01732510|63006827|FG003|Overall Study|Adverse Event|0|||
33606685|NCT01732510|63006828|FG004|Overall Study|Adverse Event|0|||
33606686|NCT01732510|63006829|FG005|Overall Study|Adverse Event|0|||
33606687|NCT01732510|63006830|FG006|Overall Study|Adverse Event|1|||
33606688|NCT01732510|63006824|FG000|Overall Study|Protocol Violation|0|||
33606689|NCT01732510|63006825|FG001|Overall Study|Protocol Violation|0|||
33606690|NCT01732510|63006826|FG002|Overall Study|Protocol Violation|0|||
33606691|NCT01732510|63006827|FG003|Overall Study|Protocol Violation|1|||
33606692|NCT01732510|63006828|FG004|Overall Study|Protocol Violation|0|||
33606693|NCT01732510|63006829|FG005|Overall Study|Protocol Violation|0|||
33606694|NCT01732510|63006830|FG006|Overall Study|Protocol Violation|0|||
33606695|NCT01732510|63006824|FG000|Overall Study|Withdrawal by Subject|1|||
33606696|NCT01732510|63006825|FG001|Overall Study|Withdrawal by Subject|3|||
33606697|NCT01732510|63006826|FG002|Overall Study|Withdrawal by Subject|2|||
33606698|NCT01732510|63006827|FG003|Overall Study|Withdrawal by Subject|1|||
33323368|NCT01143714|62699640|FG001|Overall Study|Adverse Event|2|||
33323369|NCT01143714|62699639|FG000|Overall Study|Withdrawal by Subject|1|||
33323370|NCT01143714|62699640|FG001|Overall Study|Withdrawal by Subject|0|||
33323371|NCT01143714|62699639|FG000|Overall Study|Subject non-compliance|0|||
33323372|NCT01143714|62699640|FG001|Overall Study|Subject non-compliance|1|||
33323373|NCT01143714|62699639|FG000|Overall Study|wound closed = deemed healed|1|||
33323374|NCT01143714|62699640|FG001|Overall Study|wound closed = deemed healed|0|||
33606699|NCT01732510|63006828|FG004|Overall Study|Withdrawal by Subject|5|||
33606700|NCT01732510|63006829|FG005|Overall Study|Withdrawal by Subject|0|||
33606701|NCT01732510|63006830|FG006|Overall Study|Withdrawal by Subject|1|||
33606702|NCT01732510|63006824|FG000|Overall Study|Lost to Follow-up|0|||
33606703|NCT01732510|63006825|FG001|Overall Study|Lost to Follow-up|0|||
33606704|NCT01732510|63006826|FG002|Overall Study|Lost to Follow-up|1|||
33606705|NCT01732510|63006827|FG003|Overall Study|Lost to Follow-up|1|||
33606706|NCT01732510|63006828|FG004|Overall Study|Lost to Follow-up|0|||
33606707|NCT01732510|63006829|FG005|Overall Study|Lost to Follow-up|1|||
33606708|NCT01732510|63006830|FG006|Overall Study|Lost to Follow-up|0|||
33606709|NCT01732510|63006824|FG000|Overall Study|Physician Decision|0|||
33606710|NCT01732510|63006825|FG001|Overall Study|Physician Decision|1|||
33606711|NCT01732510|63006826|FG002|Overall Study|Physician Decision|0|||
33606712|NCT01732510|63006827|FG003|Overall Study|Physician Decision|0|||
33606713|NCT01732510|63006828|FG004|Overall Study|Physician Decision|0|||
33606714|NCT01732510|63006829|FG005|Overall Study|Physician Decision|0|||
33323375|NCT01143714|62699639|FG000|Overall Study|wound size increased|1|||
33443326|NCT00348140|62819094|FG000|Overall Study|Use of prohibited drug|1|||
33443327|NCT00348140|62819095|FG001|Overall Study|Use of prohibited drug|0|||
33443328|NCT00348140|62819096|FG002|Overall Study|Use of prohibited drug|2|||
33443329|NCT00348140|62819094|FG000|Overall Study|Disease progression|1|||
33443330|NCT00348140|62819095|FG001|Overall Study|Disease progression|2|||
33443331|NCT00348140|62819096|FG002|Overall Study|Disease progression|5|||
33443332|NCT00348140|62819094|FG000|Overall Study|Increased risk of cardiac infarction|0|||
33443333|NCT00348140|62819095|FG001|Overall Study|Increased risk of cardiac infarction|1|||
33443334|NCT00348140|62819096|FG002|Overall Study|Increased risk of cardiac infarction|0|||
33443335|NCT00348140|62819094|FG000|Overall Study|Serious adverse event|0|||
33443336|NCT00348140|62819095|FG001|Overall Study|Serious adverse event|1|||
33443337|NCT00348140|62819096|FG002|Overall Study|Serious adverse event|0|||
33323376|NCT01143714|62699640|FG001|Overall Study|wound size increased|0|||
33323377|NCT00972543|62699661|FG000|Overall Study|Adverse Event|1|||
33323378|NCT00972543|62699662|FG001|Overall Study|Adverse Event|0|||
33323379|NCT00972543|62699661|FG000|Overall Study|Early study termination by sponsor|4|||
33323380|NCT00972543|62699662|FG001|Overall Study|Early study termination by sponsor|1|||
33323381|NCT00925132|62699668|FG000|Overall Study|Withdrawal by Subject|2|||
33323382|NCT00925132|62699669|FG001|Overall Study|Withdrawal by Subject|0|||
33323383|NCT00925132|62699670|FG002|Overall Study|Withdrawal by Subject|0|||
33443338|NCT00348140|62819094|FG000|Overall Study|Abnormal ECG|0|||
33443339|NCT00348140|62819095|FG001|Overall Study|Abnormal ECG|1|||
33443340|NCT00348140|62819096|FG002|Overall Study|Abnormal ECG|3|||
33443341|NCT00348140|62819094|FG000|Overall Study|Participant died|0|||
33443342|NCT00348140|62819095|FG001|Overall Study|Participant died|1|||
33443343|NCT00348140|62819096|FG002|Overall Study|Participant died|0|||
33443344|NCT00348140|62819094|FG000|Overall Study|Exclusion criteria met|0|||
33443345|NCT00348140|62819095|FG001|Overall Study|Exclusion criteria met|0|||
33443346|NCT00348140|62819096|FG002|Overall Study|Exclusion criteria met|1|||
33443347|NCT00348140|62819094|FG000|Overall Study|Memory declined|0|||
33443348|NCT00348140|62819095|FG001|Overall Study|Memory declined|0|||
33443349|NCT00348140|62819096|FG002|Overall Study|Memory declined|1|||
33443350|NCT00490061|62819105|FG000|Overall Study|Physician Decision|1|||
33443351|NCT00483119|62819111|FG000|Overall Study|Adverse Event|0|||
33443352|NCT00483119|62819112|FG001|Overall Study|Adverse Event|1|||
33443353|NCT00483119|62819111|FG000|Overall Study|Physician Decision|1|||
33443354|NCT00483119|62819112|FG001|Overall Study|Physician Decision|0|||
33443355|NCT00483041|62819120|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
33443356|NCT00483041|62819121|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
33443357|NCT00501293|62819129|FG000|Optimization Period|Enrolled in error|1|||
33443358|NCT00501293|62819130|FG001|Optimization Period|Enrolled in error|0|||
33443359|NCT00501293|62819129|FG000|Maintenance Period|Withdrawal by Subject|14|||
33443360|NCT00501293|62819130|FG001|Maintenance Period|Withdrawal by Subject|13|||
33443361|NCT00501293|62819129|FG000|Maintenance Period|Lost to Follow-up|12|||
33443362|NCT00501293|62819130|FG001|Maintenance Period|Lost to Follow-up|7|||
33443363|NCT00501293|62819129|FG000|Maintenance Period|Adverse Event|6|||
33443364|NCT00501293|62819130|FG001|Maintenance Period|Adverse Event|6|||
33443365|NCT00501293|62819129|FG000|Maintenance Period|Protocol Violation|2|||
33443366|NCT00501293|62819130|FG001|Maintenance Period|Protocol Violation|1|||
33443367|NCT00501293|62819129|FG000|Maintenance Period|Lack of Efficacy|4|||
33443368|NCT00501293|62819130|FG001|Maintenance Period|Lack of Efficacy|1|||
33443369|NCT00501293|62819129|FG000|Maintenance Period|Noncompliant with study medication|5|||
33443370|NCT00501293|62819130|FG001|Maintenance Period|Noncompliant with study medication|0|||
33443371|NCT00501293|62819129|FG000|Maintenance Period|Went into rehabilitation|1|||
33443372|NCT00501293|62819130|FG001|Maintenance Period|Went into rehabilitation|0|||
33606715|NCT01732510|63006830|FG006|Overall Study|Physician Decision|0|||
33606716|NCT01732510|63006824|FG000|Overall Study|Pregnancy|0|||
33606717|NCT01732510|63006825|FG001|Overall Study|Pregnancy|0|||
33323384|NCT00925132|62699671|FG003|Overall Study|Withdrawal by Subject|0|||
33323385|NCT00925132|62699672|FG004|Overall Study|Withdrawal by Subject|1|||
33323386|NCT00925132|62699668|FG000|Overall Study|Removed due to disease progression|0|||
33443373|NCT00501293|62819129|FG000|Maintenance Period|Would not wear patch|1|||
33606718|NCT01732510|63006826|FG002|Overall Study|Pregnancy|0|||
33443374|NCT00501293|62819130|FG001|Maintenance Period|Would not wear patch|0|||
33443375|NCT00501293|62819129|FG000|Maintenance Period|Application site reaction|1|||
33443376|NCT00501293|62819130|FG001|Maintenance Period|Application site reaction|0|||
33443377|NCT00482729|62819139|FG000|Overall Study|Adverse Event|29|||
33443378|NCT00482729|62819140|FG001|Overall Study|Adverse Event|33|||
33443379|NCT00482729|62819139|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
33443380|NCT00482729|62819140|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
33443381|NCT00482729|62819139|FG000|Overall Study|Hyperglycemia Criteria|7|||
33443382|NCT00482729|62819140|FG001|Overall Study|Hyperglycemia Criteria|5|||
33443383|NCT00482729|62819139|FG000|Overall Study|Lack of Efficacy|4|||
33443384|NCT00482729|62819140|FG001|Overall Study|Lack of Efficacy|16|||
33443385|NCT00482729|62819139|FG000|Overall Study|Lost to Follow-up|86|||
33443386|NCT00482729|62819140|FG001|Overall Study|Lost to Follow-up|66|||
33443387|NCT00482729|62819139|FG000|Overall Study|Physician Decision|10|||
33443388|NCT00482729|62819140|FG001|Overall Study|Physician Decision|7|||
33443389|NCT00482729|62819139|FG000|Overall Study|Pregnancy|4|||
33443390|NCT00482729|62819140|FG001|Overall Study|Pregnancy|2|||
33443391|NCT00482729|62819139|FG000|Overall Study|Protocol Violation|10|||
33443392|NCT00482729|62819140|FG001|Overall Study|Protocol Violation|18|||
33443393|NCT00482729|62819139|FG000|Overall Study|Withdrawal by Subject|67|||
33443394|NCT00482729|62819140|FG001|Overall Study|Withdrawal by Subject|69|||
33443395|NCT00359762|62819148|FG000|Period II|Adverse Event|17|||
33443396|NCT00359762|62819149|FG001|Period II|Adverse Event|0|||
33443397|NCT00359762|62819150|FG002|Period II|Adverse Event|0|||
33443398|NCT00359762|62819151|FG003|Period II|Adverse Event|0|||
33443399|NCT00359762|62819152|FG004|Period II|Adverse Event|49|||
33443400|NCT00359762|62819148|FG000|Period II|Protocol Violation|18|||
33443401|NCT00359762|62819149|FG001|Period II|Protocol Violation|0|||
33443402|NCT00359762|62819150|FG002|Period II|Protocol Violation|0|||
33443403|NCT00359762|62819151|FG003|Period II|Protocol Violation|0|||
33443404|NCT00359762|62819152|FG004|Period II|Protocol Violation|11|||
33443405|NCT00359762|62819148|FG000|Period II|Physician Decision|17|||
33443406|NCT00359762|62819149|FG001|Period II|Physician Decision|0|||
33443407|NCT00359762|62819150|FG002|Period II|Physician Decision|0|||
33606719|NCT01732510|63006827|FG003|Overall Study|Pregnancy|1|||
33606720|NCT01732510|63006828|FG004|Overall Study|Pregnancy|0|||
33606721|NCT01732510|63006829|FG005|Overall Study|Pregnancy|0|||
33606722|NCT01732510|63006830|FG006|Overall Study|Pregnancy|0|||
33443408|NCT00359762|62819151|FG003|Period II|Physician Decision|0|||
33443409|NCT00359762|62819152|FG004|Period II|Physician Decision|23|||
33443410|NCT00359762|62819148|FG000|Period II|Death|2|||
33443411|NCT00359762|62819149|FG001|Period II|Death|0|||
33443412|NCT00359762|62819150|FG002|Period II|Death|0|||
33443413|NCT00359762|62819151|FG003|Period II|Death|0|||
33443414|NCT00359762|62819152|FG004|Period II|Death|4|||
33443415|NCT00359762|62819148|FG000|Period II|Lack of Efficacy|11|||
33443416|NCT00359762|62819149|FG001|Period II|Lack of Efficacy|0|||
33606723|NCT01732510|63006824|FG000|Overall Study|Study Terminated By Sponsor|0|||
33443417|NCT00359762|62819150|FG002|Period II|Lack of Efficacy|0|||
33443418|NCT00359762|62819151|FG003|Period II|Lack of Efficacy|0|||
33443419|NCT00359762|62819152|FG004|Period II|Lack of Efficacy|8|||
33443420|NCT00359762|62819148|FG000|Period II|Lost to follow up|5|||
33443421|NCT00359762|62819149|FG001|Period II|Lost to follow up|0|||
33443422|NCT00359762|62819150|FG002|Period II|Lost to follow up|0|||
33443423|NCT00359762|62819151|FG003|Period II|Lost to follow up|0|||
33443424|NCT00359762|62819152|FG004|Period II|Lost to follow up|5|||
33606724|NCT01732510|63006825|FG001|Overall Study|Study Terminated By Sponsor|0|||
33606725|NCT01732510|63006826|FG002|Overall Study|Study Terminated By Sponsor|0|||
33606726|NCT01732510|63006827|FG003|Overall Study|Study Terminated By Sponsor|1|||
33606727|NCT01732510|63006828|FG004|Overall Study|Study Terminated By Sponsor|0|||
33606728|NCT01732510|63006829|FG005|Overall Study|Study Terminated By Sponsor|12|||
33443425|NCT00359762|62819148|FG000|Period II|Entry Criteria Not Met|8|||
33443426|NCT00359762|62819149|FG001|Period II|Entry Criteria Not Met|0|||
33443427|NCT00359762|62819150|FG002|Period II|Entry Criteria Not Met|0|||
33606729|NCT01732510|63006830|FG006|Overall Study|Study Terminated By Sponsor|6|||
33443428|NCT00359762|62819151|FG003|Period II|Entry Criteria Not Met|0|||
33443429|NCT00359762|62819152|FG004|Period II|Entry Criteria Not Met|4|||
33443430|NCT00359762|62819148|FG000|Period II|Subject Decision|50|||
33443431|NCT00359762|62819149|FG001|Period II|Subject Decision|0|||
33606730|NCT01637077|63006851|FG000|Overall Study|Cancel|1|||
33606731|NCT01637077|63006852|FG001|Overall Study|Cancel|1|||
33443432|NCT00359762|62819150|FG002|Period II|Subject Decision|0|||
33443433|NCT00359762|62819151|FG003|Period II|Subject Decision|0|||
33443434|NCT00359762|62819152|FG004|Period II|Subject Decision|70|||
33606732|NCT01637077|63006851|FG000|Overall Study|Withdrawal by Subject|1|||
33606733|NCT01637077|63006852|FG001|Overall Study|Withdrawal by Subject|0|||
33606734|NCT01637077|63006851|FG000|Overall Study|No cycle 1 questionnaire data|2|||
33606735|NCT01637077|63006852|FG001|Overall Study|No cycle 1 questionnaire data|0|||
33606736|NCT02308163|63006862|FG000|Overall Study|Not fulfill eligible criteria|1|||
33443435|NCT00359762|62819148|FG000|Period III|Protocol Violation|0|||
33443436|NCT00359762|62819149|FG001|Period III|Protocol Violation|5|||
33443437|NCT00359762|62819150|FG002|Period III|Protocol Violation|3|||
33443438|NCT00359762|62819151|FG003|Period III|Protocol Violation|8|||
33443439|NCT00359762|62819152|FG004|Period III|Protocol Violation|0|||
33443440|NCT00359762|62819148|FG000|Period III|Adverse Event|0|||
33606737|NCT02308163|63006863|FG001|Overall Study|Not fulfill eligible criteria|2|||
33606738|NCT02308163|63006864|FG002|Overall Study|Not fulfill eligible criteria|0|||
33606739|NCT02308163|63006865|FG003|Overall Study|Not fulfill eligible criteria|1|||
33606740|NCT02308163|63006866|FG004|Overall Study|Not fulfill eligible criteria|1|||
33606741|NCT02308163|63006862|FG000|Overall Study|Adverse Event|9|||
33606742|NCT02308163|63006863|FG001|Overall Study|Adverse Event|5|||
33606743|NCT02308163|63006864|FG002|Overall Study|Adverse Event|2|||
33606744|NCT02308163|63006865|FG003|Overall Study|Adverse Event|2|||
33606745|NCT02308163|63006866|FG004|Overall Study|Adverse Event|11|||
33606746|NCT02308163|63006862|FG000|Overall Study|Lack of Efficacy|11|||
33606747|NCT02308163|63006863|FG001|Overall Study|Lack of Efficacy|3|||
33606748|NCT02308163|63006864|FG002|Overall Study|Lack of Efficacy|8|||
33606749|NCT02308163|63006865|FG003|Overall Study|Lack of Efficacy|4|||
33443441|NCT00359762|62819149|FG001|Period III|Adverse Event|3|||
33443442|NCT00359762|62819150|FG002|Period III|Adverse Event|4|||
33443443|NCT00359762|62819151|FG003|Period III|Adverse Event|10|||
33443444|NCT00359762|62819152|FG004|Period III|Adverse Event|0|||
33443445|NCT00359762|62819148|FG000|Period III|Physician Decision|0|||
33443446|NCT00359762|62819149|FG001|Period III|Physician Decision|5|||
33443447|NCT00359762|62819150|FG002|Period III|Physician Decision|9|||
33443448|NCT00359762|62819151|FG003|Period III|Physician Decision|15|||
33443449|NCT00359762|62819152|FG004|Period III|Physician Decision|0|||
33443450|NCT00359762|62819148|FG000|Period III|Lack of Efficacy|0|||
33443451|NCT00359762|62819149|FG001|Period III|Lack of Efficacy|7|||
33443452|NCT00359762|62819150|FG002|Period III|Lack of Efficacy|5|||
33443453|NCT00359762|62819151|FG003|Period III|Lack of Efficacy|9|||
33443454|NCT00359762|62819152|FG004|Period III|Lack of Efficacy|0|||
33443455|NCT00359762|62819148|FG000|Period III|Lost to follow up|0|||
33443456|NCT00359762|62819149|FG001|Period III|Lost to follow up|1|||
33443457|NCT00359762|62819150|FG002|Period III|Lost to follow up|1|||
33443458|NCT00359762|62819151|FG003|Period III|Lost to follow up|2|||
33443459|NCT00359762|62819152|FG004|Period III|Lost to follow up|0|||
33443460|NCT00359762|62819148|FG000|Period III|Entry Criteria Not Met|0|||
33443461|NCT00359762|62819149|FG001|Period III|Entry Criteria Not Met|1|||
33443462|NCT00359762|62819150|FG002|Period III|Entry Criteria Not Met|0|||
33443463|NCT00359762|62819151|FG003|Period III|Entry Criteria Not Met|1|||
33443464|NCT00359762|62819152|FG004|Period III|Entry Criteria Not Met|0|||
33443465|NCT00359762|62819148|FG000|Period III|Subject Decision|0|||
33443466|NCT00359762|62819149|FG001|Period III|Subject Decision|7|||
33443467|NCT00359762|62819150|FG002|Period III|Subject Decision|8|||
33443468|NCT00359762|62819151|FG003|Period III|Subject Decision|20|||
33443469|NCT00359762|62819152|FG004|Period III|Subject Decision|0|||
33443470|NCT00347438|62819166|FG000|Overall Study|Withdrawal by Subject|1|||
33443471|NCT00347438|62819166|FG000|Overall Study|Physician Decision|1|||
33443472|NCT00329238|62819172|FG000|Overall Study|Adverse Event|147|||
33443473|NCT00329238|62819173|FG001|Overall Study|Adverse Event|129|||
33443474|NCT00329238|62819172|FG000|Overall Study|Protocol Violation|23|||
33443475|NCT00329238|62819173|FG001|Overall Study|Protocol Violation|34|||
33443476|NCT00329238|62819172|FG000|Overall Study|Lost to Follow-up|2|||
33443477|NCT00329238|62819173|FG001|Overall Study|Lost to Follow-up|6|||
33443478|NCT00329238|62819172|FG000|Overall Study|Withdrawal by Subject|64|||
33443479|NCT00329238|62819173|FG001|Overall Study|Withdrawal by Subject|58|||
33443480|NCT00329238|62819172|FG000|Overall Study|Other reason (not specified)|40|||
33443481|NCT00329238|62819173|FG001|Overall Study|Other reason (not specified)|54|||
33443482|NCT00329160|62819181|FG000|Overall Study|Adverse Event|27|||
33443483|NCT00329160|62819181|FG000|Overall Study|Withdrawal by Subject|13|||
33443484|NCT00329160|62819181|FG000|Overall Study|Protocol Violation|2|||
33443485|NCT00329160|62819181|FG000|Overall Study|Did not Receive Study Drug|1|||
33606750|NCT02308163|63006866|FG004|Overall Study|Lack of Efficacy|6|||
33606751|NCT02308163|63006862|FG000|Overall Study|Withdrawal of consent|2|||
33606752|NCT02308163|63006863|FG001|Overall Study|Withdrawal of consent|3|||
33443486|NCT00329160|62819181|FG000|Overall Study|Incomplete IVUS|45|||
33606753|NCT02308163|63006864|FG002|Overall Study|Withdrawal of consent|0|||
33606754|NCT02308163|63006865|FG003|Overall Study|Withdrawal of consent|2|||
33443487|NCT00328926|62819188|FG000|Overall Study|Pregnancy|2|||
33443488|NCT00328926|62819189|FG001|Overall Study|Pregnancy|1|||
33443489|NCT00328926|62819190|FG002|Overall Study|Pregnancy|0|||
33443490|NCT00328926|62819188|FG000|Overall Study|Lost to Follow-up|0|||
33443491|NCT00328926|62819189|FG001|Overall Study|Lost to Follow-up|1|||
33443492|NCT00328926|62819190|FG002|Overall Study|Lost to Follow-up|0|||
33443493|NCT00328926|62819188|FG000|Overall Study|Death|0|||
33443494|NCT00328926|62819189|FG001|Overall Study|Death|0|||
33443495|NCT00328926|62819190|FG002|Overall Study|Death|1|||
33443496|NCT00328926|62819188|FG000|Overall Study|In vitro fertilization treatment|0|||
33443497|NCT00328926|62819189|FG001|Overall Study|In vitro fertilization treatment|0|||
33443498|NCT00328926|62819190|FG002|Overall Study|In vitro fertilization treatment|1|||
33443499|NCT00328926|62819188|FG000|Overall Study|Lack of ovarian response|0|||
33443500|NCT00328926|62819189|FG001|Overall Study|Lack of ovarian response|1|||
33606755|NCT02308163|63006866|FG004|Overall Study|Withdrawal of consent|6|||
33494232|NCT02873936|62873018|FG002|Overall Study|Withdrew Consent|20|||
33494233|NCT02873936|62873016|FG000|Overall Study|Investigator's Discretion|3|||
33494234|NCT02873936|62873017|FG001|Overall Study|Investigator's Discretion|5|||
33494235|NCT02873936|62873018|FG002|Overall Study|Investigator's Discretion|4|||
33494236|NCT02873936|62873016|FG000|Overall Study|Adverse Event|3|||
33494237|NCT02873936|62873017|FG001|Overall Study|Adverse Event|5|||
33494238|NCT02873936|62873018|FG002|Overall Study|Adverse Event|3|||
33494239|NCT02873936|62873016|FG000|Overall Study|Protocol Violation|0|||
33494240|NCT02873936|62873017|FG001|Overall Study|Protocol Violation|1|||
33606756|NCT02308163|63006862|FG000|Overall Study|Protocol Violation|3|||
33606757|NCT02308163|63006863|FG001|Overall Study|Protocol Violation|3|||
33606758|NCT02308163|63006864|FG002|Overall Study|Protocol Violation|3|||
33606759|NCT02308163|63006865|FG003|Overall Study|Protocol Violation|2|||
33606760|NCT02308163|63006866|FG004|Overall Study|Protocol Violation|5|||
33443501|NCT00328926|62819190|FG002|Overall Study|Lack of ovarian response|0|||
33443502|NCT00319254|62819198|FG000|Overall Study|Withdrawal by Subject|4|||
33443503|NCT00319254|62819198|FG000|Overall Study|Death|46|||
33443504|NCT00319254|62819198|FG000|Overall Study|Lost to Follow-up|2|||
33606761|NCT02308163|63006862|FG000|Overall Study|Lab data met discontinuation criteria|3|||
33606762|NCT02308163|63006863|FG001|Overall Study|Lab data met discontinuation criteria|0|||
33606763|NCT02308163|63006864|FG002|Overall Study|Lab data met discontinuation criteria|0|||
33606764|NCT02308163|63006865|FG003|Overall Study|Lab data met discontinuation criteria|2|||
33606765|NCT02308163|63006866|FG004|Overall Study|Lab data met discontinuation criteria|0|||
33606766|NCT02308163|63006862|FG000|Overall Study|Miscellaneous|2|||
33606767|NCT02308163|63006863|FG001|Overall Study|Miscellaneous|2|||
33606768|NCT02308163|63006864|FG002|Overall Study|Miscellaneous|1|||
33606769|NCT02308163|63006865|FG003|Overall Study|Miscellaneous|0|||
33606770|NCT02308163|63006866|FG004|Overall Study|Miscellaneous|5|||
33606771|NCT02000115|63006896|FG000|Overall Study|Death|56|||
33606772|NCT02000115|63006897|FG001|Overall Study|Death|45|||
33606773|NCT02000115|63006898|FG002|Overall Study|Death|0|||
33606774|NCT02000115|63006899|FG003|Overall Study|Death|0|||
33606775|NCT02000115|63006896|FG000|Overall Study|Missed Visit|6|||
33606776|NCT02000115|63006897|FG001|Overall Study|Missed Visit|8|||
33606777|NCT02000115|63006898|FG002|Overall Study|Missed Visit|1|||
33606778|NCT02000115|63006899|FG003|Overall Study|Missed Visit|0|||
33606779|NCT02000115|63006896|FG000|Overall Study|Protocol Violation|2|||
33606780|NCT02000115|63006897|FG001|Overall Study|Protocol Violation|1|||
33606781|NCT02000115|63006898|FG002|Overall Study|Protocol Violation|0|||
33443505|NCT00319254|62819198|FG000|Overall Study|Enrolled, Not Treated|2|||
33443506|NCT00319098|62819206|FG000|Overall Study|Serious adverse event|3|||
33443507|NCT00319098|62819207|FG001|Overall Study|Serious adverse event|0|||
33443508|NCT00319098|62819206|FG000|Overall Study|Adverse Event|20|||
33443509|NCT00319098|62819207|FG001|Overall Study|Adverse Event|1|||
33443510|NCT00319098|62819206|FG000|Overall Study|Withdrawal by Subject|37|||
33443511|NCT00319098|62819207|FG001|Overall Study|Withdrawal by Subject|8|||
33443512|NCT00319098|62819206|FG000|Overall Study|Migrated/moved from study area|2|||
33443513|NCT00319098|62819207|FG001|Overall Study|Migrated/moved from study area|1|||
33443514|NCT00319098|62819206|FG000|Overall Study|Lost to Follow-up|37|||
33443515|NCT00319098|62819207|FG001|Overall Study|Lost to Follow-up|13|||
33443516|NCT00319098|62819206|FG000|Overall Study|Others|33|||
33443517|NCT00319098|62819207|FG001|Overall Study|Others|8|||
33443518|NCT00319098|62819206|FG000|Overall Study|Protocol Violation|3|||
33606782|NCT02000115|63006899|FG003|Overall Study|Protocol Violation|0|||
33606783|NCT02000115|63006896|FG000|Overall Study|Physician Decision|2|||
33606784|NCT02000115|63006897|FG001|Overall Study|Physician Decision|0|||
33606785|NCT02000115|63006898|FG002|Overall Study|Physician Decision|0|||
33606786|NCT02000115|63006899|FG003|Overall Study|Physician Decision|0|||
33443519|NCT00319098|62819207|FG001|Overall Study|Protocol Violation|1|||
33494241|NCT02873936|62873018|FG002|Overall Study|Protocol Violation|3|||
33606787|NCT02000115|63006896|FG000|Overall Study|Withdrawal by Subject|11|||
33606788|NCT02000115|63006897|FG001|Overall Study|Withdrawal by Subject|11|||
33443520|NCT00347360|62819232|FG000|Overall Study|Adverse Event|1|||
33443521|NCT00347360|62819233|FG001|Overall Study|Adverse Event|2|||
33443522|NCT00347360|62819234|FG002|Overall Study|Adverse Event|0|||
33606789|NCT02000115|63006898|FG002|Overall Study|Withdrawal by Subject|0|||
33606790|NCT02000115|63006899|FG003|Overall Study|Withdrawal by Subject|0|||
33606791|NCT02000115|63006896|FG000|Overall Study|Lost to Follow-up|0|||
33606792|NCT02000115|63006897|FG001|Overall Study|Lost to Follow-up|1|||
33443523|NCT00347360|62819235|FG003|Overall Study|Adverse Event|4|||
33443524|NCT00347360|62819236|FG004|Overall Study|Adverse Event|1|||
33443525|NCT00347360|62819237|FG005|Overall Study|Adverse Event|2|||
33443526|NCT00347360|62819238|FG006|Overall Study|Adverse Event|2|||
33443527|NCT00347360|62819239|FG007|Overall Study|Adverse Event|0|||
33443528|NCT00347360|62819240|FG008|Overall Study|Adverse Event|2|||
33443529|NCT00347360|62819241|FG009|Overall Study|Adverse Event|3|||
33443530|NCT00347360|62819242|FG010|Overall Study|Adverse Event|3|||
33443531|NCT00347360|62819243|FG011|Overall Study|Adverse Event|1|||
33443532|NCT00347360|62819244|FG012|Overall Study|Adverse Event|3|||
33443533|NCT00347360|62819245|FG013|Overall Study|Adverse Event|2|||
33443534|NCT00347360|62819246|FG014|Overall Study|Adverse Event|2|||
33443535|NCT00347360|62819232|FG000|Overall Study|Lost to Follow-up|0|||
33443536|NCT00347360|62819233|FG001|Overall Study|Lost to Follow-up|0|||
33443537|NCT00347360|62819234|FG002|Overall Study|Lost to Follow-up|0|||
33443538|NCT00347360|62819235|FG003|Overall Study|Lost to Follow-up|2|||
33443539|NCT00347360|62819236|FG004|Overall Study|Lost to Follow-up|1|||
33443540|NCT00347360|62819237|FG005|Overall Study|Lost to Follow-up|1|||
33443541|NCT00347360|62819238|FG006|Overall Study|Lost to Follow-up|0|||
33443542|NCT00347360|62819239|FG007|Overall Study|Lost to Follow-up|1|||
33443543|NCT00347360|62819240|FG008|Overall Study|Lost to Follow-up|1|||
33443544|NCT00347360|62819241|FG009|Overall Study|Lost to Follow-up|2|||
33443545|NCT00347360|62819242|FG010|Overall Study|Lost to Follow-up|0|||
33443546|NCT00347360|62819243|FG011|Overall Study|Lost to Follow-up|0|||
33443547|NCT00347360|62819244|FG012|Overall Study|Lost to Follow-up|1|||
33443548|NCT00347360|62819245|FG013|Overall Study|Lost to Follow-up|0|||
33443549|NCT00347360|62819246|FG014|Overall Study|Lost to Follow-up|0|||
33443550|NCT00347360|62819232|FG000|Overall Study|Protocol Violation|2|||
33443551|NCT00347360|62819233|FG001|Overall Study|Protocol Violation|3|||
33443552|NCT00347360|62819234|FG002|Overall Study|Protocol Violation|1|||
33443553|NCT00347360|62819235|FG003|Overall Study|Protocol Violation|2|||
33443554|NCT00347360|62819236|FG004|Overall Study|Protocol Violation|1|||
33443555|NCT00347360|62819237|FG005|Overall Study|Protocol Violation|2|||
33443556|NCT00347360|62819238|FG006|Overall Study|Protocol Violation|0|||
33443557|NCT00347360|62819239|FG007|Overall Study|Protocol Violation|0|||
33443558|NCT00347360|62819240|FG008|Overall Study|Protocol Violation|1|||
33443559|NCT00347360|62819241|FG009|Overall Study|Protocol Violation|2|||
33443560|NCT00347360|62819242|FG010|Overall Study|Protocol Violation|0|||
33443561|NCT00347360|62819243|FG011|Overall Study|Protocol Violation|0|||
33443562|NCT00347360|62819244|FG012|Overall Study|Protocol Violation|0|||
33443563|NCT00347360|62819245|FG013|Overall Study|Protocol Violation|1|||
33443564|NCT00347360|62819246|FG014|Overall Study|Protocol Violation|0|||
33443565|NCT00347360|62819232|FG000|Overall Study|Withdrawal by Subject|0|||
33443566|NCT00347360|62819233|FG001|Overall Study|Withdrawal by Subject|1|||
33443567|NCT00347360|62819234|FG002|Overall Study|Withdrawal by Subject|2|||
33443568|NCT00347360|62819235|FG003|Overall Study|Withdrawal by Subject|4|||
33443569|NCT00347360|62819236|FG004|Overall Study|Withdrawal by Subject|1|||
33443570|NCT00347360|62819237|FG005|Overall Study|Withdrawal by Subject|2|||
33443571|NCT00347360|62819238|FG006|Overall Study|Withdrawal by Subject|1|||
33443572|NCT00347360|62819239|FG007|Overall Study|Withdrawal by Subject|1|||
33443573|NCT00347360|62819240|FG008|Overall Study|Withdrawal by Subject|1|||
33443574|NCT00347360|62819241|FG009|Overall Study|Withdrawal by Subject|1|||
33443575|NCT00347360|62819242|FG010|Overall Study|Withdrawal by Subject|0|||
33443576|NCT00347360|62819243|FG011|Overall Study|Withdrawal by Subject|3|||
33443577|NCT00347360|62819244|FG012|Overall Study|Withdrawal by Subject|4|||
33443578|NCT00347360|62819245|FG013|Overall Study|Withdrawal by Subject|2|||
33443579|NCT00347360|62819246|FG014|Overall Study|Withdrawal by Subject|1|||
33443580|NCT00347360|62819232|FG000|Overall Study|Lack of Efficacy|1|||
33443581|NCT00347360|62819233|FG001|Overall Study|Lack of Efficacy|1|||
33443582|NCT00347360|62819234|FG002|Overall Study|Lack of Efficacy|3|||
33443583|NCT00347360|62819235|FG003|Overall Study|Lack of Efficacy|1|||
33443584|NCT00347360|62819236|FG004|Overall Study|Lack of Efficacy|0|||
33443585|NCT00347360|62819237|FG005|Overall Study|Lack of Efficacy|1|||
33443586|NCT00347360|62819238|FG006|Overall Study|Lack of Efficacy|0|||
33443587|NCT00347360|62819239|FG007|Overall Study|Lack of Efficacy|1|||
33443588|NCT00347360|62819240|FG008|Overall Study|Lack of Efficacy|1|||
33443589|NCT00347360|62819241|FG009|Overall Study|Lack of Efficacy|0|||
33443590|NCT00347360|62819242|FG010|Overall Study|Lack of Efficacy|0|||
33443591|NCT00347360|62819243|FG011|Overall Study|Lack of Efficacy|0|||
33443592|NCT00347360|62819244|FG012|Overall Study|Lack of Efficacy|0|||
33443593|NCT00347360|62819245|FG013|Overall Study|Lack of Efficacy|0|||
33443594|NCT00347360|62819246|FG014|Overall Study|Lack of Efficacy|0|||
33443595|NCT00347360|62819232|FG000|Overall Study|Reason not listed/blank|1|||
33443596|NCT00347360|62819233|FG001|Overall Study|Reason not listed/blank|0|||
33443597|NCT00347360|62819234|FG002|Overall Study|Reason not listed/blank|0|||
33443598|NCT00347360|62819235|FG003|Overall Study|Reason not listed/blank|0|||
33443599|NCT00347360|62819236|FG004|Overall Study|Reason not listed/blank|0|||
33443600|NCT00347360|62819237|FG005|Overall Study|Reason not listed/blank|0|||
33443601|NCT00347360|62819238|FG006|Overall Study|Reason not listed/blank|1|||
33443602|NCT00347360|62819239|FG007|Overall Study|Reason not listed/blank|0|||
33443603|NCT00347360|62819240|FG008|Overall Study|Reason not listed/blank|0|||
33443604|NCT00347360|62819241|FG009|Overall Study|Reason not listed/blank|0|||
33443605|NCT00347360|62819242|FG010|Overall Study|Reason not listed/blank|0|||
33443606|NCT00347360|62819243|FG011|Overall Study|Reason not listed/blank|0|||
33443607|NCT00347360|62819244|FG012|Overall Study|Reason not listed/blank|0|||
33443608|NCT00347360|62819245|FG013|Overall Study|Reason not listed/blank|1|||
33443609|NCT00347360|62819246|FG014|Overall Study|Reason not listed/blank|0|||
33443610|NCT00347360|62819232|FG000|Overall Study|Per sponsors instruction|0|||
33443611|NCT00347360|62819233|FG001|Overall Study|Per sponsors instruction|1|||
33443612|NCT00347360|62819234|FG002|Overall Study|Per sponsors instruction|0|||
33443613|NCT00347360|62819235|FG003|Overall Study|Per sponsors instruction|0|||
33443614|NCT00347360|62819236|FG004|Overall Study|Per sponsors instruction|0|||
33443615|NCT00347360|62819237|FG005|Overall Study|Per sponsors instruction|0|||
33443616|NCT00347360|62819238|FG006|Overall Study|Per sponsors instruction|0|||
33443617|NCT00347360|62819239|FG007|Overall Study|Per sponsors instruction|0|||
33443618|NCT00347360|62819240|FG008|Overall Study|Per sponsors instruction|0|||
33443619|NCT00347360|62819241|FG009|Overall Study|Per sponsors instruction|0|||
33443620|NCT00347360|62819242|FG010|Overall Study|Per sponsors instruction|0|||
33443621|NCT00347360|62819243|FG011|Overall Study|Per sponsors instruction|0|||
33443622|NCT00347360|62819244|FG012|Overall Study|Per sponsors instruction|0|||
33443623|NCT00347360|62819245|FG013|Overall Study|Per sponsors instruction|0|||
33443624|NCT00347360|62819246|FG014|Overall Study|Per sponsors instruction|0|||
33443625|NCT00347360|62819232|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
33443626|NCT00347360|62819233|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
33443627|NCT00347360|62819234|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
33606793|NCT02000115|63006898|FG002|Overall Study|Lost to Follow-up|0|||
33606794|NCT02000115|63006899|FG003|Overall Study|Lost to Follow-up|0|||
33606795|NCT02000115|63006896|FG000|Overall Study|Non-compliance|2|||
33606796|NCT02000115|63006897|FG001|Overall Study|Non-compliance|1|||
33443628|NCT00347360|62819235|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
33443629|NCT00347360|62819236|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
33443630|NCT00347360|62819237|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
33443631|NCT00347360|62819238|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
33443632|NCT00347360|62819239|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
33443633|NCT00347360|62819240|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
33443634|NCT00347360|62819241|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
33443635|NCT00347360|62819242|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
33443636|NCT00347360|62819243|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
33443637|NCT00347360|62819244|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
33443638|NCT00347360|62819245|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
33443639|NCT00347360|62819246|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
33443640|NCT00347360|62819232|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
33443641|NCT00347360|62819233|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
33443642|NCT00347360|62819234|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
33443643|NCT00347360|62819235|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
33443644|NCT00347360|62819236|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
33443645|NCT00347360|62819237|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
33443646|NCT00347360|62819238|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
33606797|NCT02000115|63006898|FG002|Overall Study|Non-compliance|0|||
33606798|NCT02000115|63006899|FG003|Overall Study|Non-compliance|0|||
33606799|NCT02000115|63006896|FG000|Overall Study|Withdrawn on day of randomization|0|||
33606800|NCT02000115|63006897|FG001|Overall Study|Withdrawn on day of randomization|1|||
33606801|NCT02000115|63006898|FG002|Overall Study|Withdrawn on day of randomization|0|||
33606802|NCT02000115|63006899|FG003|Overall Study|Withdrawn on day of randomization|0|||
33606803|NCT02000115|63006896|FG000|Overall Study|Still on Study|0|||
33443647|NCT00347360|62819239|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
33443648|NCT00347360|62819240|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
33443649|NCT00347360|62819241|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
33443650|NCT00347360|62819242|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
33606804|NCT02000115|63006897|FG001|Overall Study|Still on Study|0|||
33606805|NCT02000115|63006898|FG002|Overall Study|Still on Study|0|||
33443651|NCT00347360|62819243|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
33443652|NCT00347360|62819244|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
33443653|NCT00347360|62819245|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
33443654|NCT00347360|62819246|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
33443655|NCT00347360|62819232|FG000|Overall Study|Abnormal lab values|0|||
33443656|NCT00347360|62819233|FG001|Overall Study|Abnormal lab values|0|||
33443657|NCT00347360|62819234|FG002|Overall Study|Abnormal lab values|0|||
33443658|NCT00347360|62819235|FG003|Overall Study|Abnormal lab values|0|||
33443659|NCT00347360|62819236|FG004|Overall Study|Abnormal lab values|0|||
33443660|NCT00347360|62819237|FG005|Overall Study|Abnormal lab values|0|||
33443661|NCT00347360|62819238|FG006|Overall Study|Abnormal lab values|1|||
33443662|NCT00347360|62819239|FG007|Overall Study|Abnormal lab values|0|||
33443663|NCT00347360|62819240|FG008|Overall Study|Abnormal lab values|0|||
33443664|NCT00347360|62819241|FG009|Overall Study|Abnormal lab values|0|||
33443665|NCT00347360|62819242|FG010|Overall Study|Abnormal lab values|0|||
33443666|NCT00347360|62819243|FG011|Overall Study|Abnormal lab values|0|||
33443667|NCT00347360|62819244|FG012|Overall Study|Abnormal lab values|0|||
33443668|NCT00347360|62819245|FG013|Overall Study|Abnormal lab values|0|||
33443669|NCT00347360|62819246|FG014|Overall Study|Abnormal lab values|0|||
33443670|NCT00347360|62819232|FG000|Overall Study|PI recommended early withdrawal|0|||
33443671|NCT00347360|62819233|FG001|Overall Study|PI recommended early withdrawal|0|||
33443672|NCT00347360|62819234|FG002|Overall Study|PI recommended early withdrawal|0|||
33443673|NCT00347360|62819235|FG003|Overall Study|PI recommended early withdrawal|0|||
33443674|NCT00347360|62819236|FG004|Overall Study|PI recommended early withdrawal|0|||
33443675|NCT00347360|62819237|FG005|Overall Study|PI recommended early withdrawal|0|||
33443676|NCT00347360|62819238|FG006|Overall Study|PI recommended early withdrawal|0|||
33443677|NCT00347360|62819239|FG007|Overall Study|PI recommended early withdrawal|0|||
33443678|NCT00347360|62819240|FG008|Overall Study|PI recommended early withdrawal|0|||
33443679|NCT00347360|62819241|FG009|Overall Study|PI recommended early withdrawal|1|||
33443680|NCT00347360|62819242|FG010|Overall Study|PI recommended early withdrawal|0|||
33443681|NCT00347360|62819243|FG011|Overall Study|PI recommended early withdrawal|0|||
33443682|NCT00347360|62819244|FG012|Overall Study|PI recommended early withdrawal|0|||
33443683|NCT00347360|62819245|FG013|Overall Study|PI recommended early withdrawal|0|||
33443684|NCT00347360|62819246|FG014|Overall Study|PI recommended early withdrawal|0|||
33443685|NCT00347360|62819232|FG000|Overall Study|Did not meet criteria before ABPM|0|||
33443686|NCT00347360|62819233|FG001|Overall Study|Did not meet criteria before ABPM|0|||
33443687|NCT00347360|62819234|FG002|Overall Study|Did not meet criteria before ABPM|0|||
33443688|NCT00347360|62819235|FG003|Overall Study|Did not meet criteria before ABPM|0|||
33443689|NCT00347360|62819236|FG004|Overall Study|Did not meet criteria before ABPM|0|||
33443690|NCT00347360|62819237|FG005|Overall Study|Did not meet criteria before ABPM|0|||
33443691|NCT00347360|62819238|FG006|Overall Study|Did not meet criteria before ABPM|0|||
33443692|NCT00347360|62819239|FG007|Overall Study|Did not meet criteria before ABPM|0|||
33443693|NCT00347360|62819240|FG008|Overall Study|Did not meet criteria before ABPM|0|||
33443694|NCT00347360|62819241|FG009|Overall Study|Did not meet criteria before ABPM|0|||
33443695|NCT00347360|62819242|FG010|Overall Study|Did not meet criteria before ABPM|1|||
33443696|NCT00347360|62819243|FG011|Overall Study|Did not meet criteria before ABPM|0|||
33443697|NCT00347360|62819244|FG012|Overall Study|Did not meet criteria before ABPM|0|||
33443698|NCT00347360|62819245|FG013|Overall Study|Did not meet criteria before ABPM|0|||
33443699|NCT00347360|62819246|FG014|Overall Study|Did not meet criteria before ABPM|0|||
33443700|NCT00347360|62819232|FG000|Overall Study|Randomized in error|0|||
33606806|NCT02000115|63006899|FG003|Overall Study|Still on Study|53|||
33606807|NCT01999335|63006913|FG000|Overall Study|Discontinued before receiving treatment|0|||
33443701|NCT00347360|62819233|FG001|Overall Study|Randomized in error|0|||
33443702|NCT00347360|62819234|FG002|Overall Study|Randomized in error|0|||
33443703|NCT00347360|62819235|FG003|Overall Study|Randomized in error|0|||
33443704|NCT00347360|62819236|FG004|Overall Study|Randomized in error|0|||
33443705|NCT00347360|62819237|FG005|Overall Study|Randomized in error|0|||
33443706|NCT00347360|62819238|FG006|Overall Study|Randomized in error|0|||
33443707|NCT00347360|62819239|FG007|Overall Study|Randomized in error|0|||
33443708|NCT00347360|62819240|FG008|Overall Study|Randomized in error|0|||
33443709|NCT00347360|62819241|FG009|Overall Study|Randomized in error|0|||
33443710|NCT00347360|62819242|FG010|Overall Study|Randomized in error|0|||
33443711|NCT00347360|62819243|FG011|Overall Study|Randomized in error|1|||
33443712|NCT00347360|62819244|FG012|Overall Study|Randomized in error|0|||
33443713|NCT00347360|62819245|FG013|Overall Study|Randomized in error|0|||
33443714|NCT00347360|62819246|FG014|Overall Study|Randomized in error|0|||
33443715|NCT00347360|62819232|FG000|Overall Study|Failed inclusion criteria #4|0|||
33443716|NCT00347360|62819233|FG001|Overall Study|Failed inclusion criteria #4|0|||
33443717|NCT00347360|62819234|FG002|Overall Study|Failed inclusion criteria #4|0|||
33443718|NCT00347360|62819235|FG003|Overall Study|Failed inclusion criteria #4|0|||
33606808|NCT01999335|63006914|FG001|Overall Study|Discontinued before receiving treatment|0|||
33606809|NCT01999335|63006915|FG002|Overall Study|Discontinued before receiving treatment|0|||
33606810|NCT01999335|63006916|FG003|Overall Study|Discontinued before receiving treatment|0|||
33606811|NCT01999335|63006917|FG004|Overall Study|Discontinued before receiving treatment|2|||
33606812|NCT01978119|63006932|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
33606813|NCT01978119|63006933|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
33443719|NCT00347360|62819236|FG004|Overall Study|Failed inclusion criteria #4|0|||
33443720|NCT00347360|62819237|FG005|Overall Study|Failed inclusion criteria #4|0|||
33443721|NCT00347360|62819238|FG006|Overall Study|Failed inclusion criteria #4|0|||
33443722|NCT00347360|62819239|FG007|Overall Study|Failed inclusion criteria #4|0|||
33443723|NCT00347360|62819240|FG008|Overall Study|Failed inclusion criteria #4|0|||
33443724|NCT00347360|62819241|FG009|Overall Study|Failed inclusion criteria #4|0|||
33443725|NCT00347360|62819242|FG010|Overall Study|Failed inclusion criteria #4|0|||
33443726|NCT00347360|62819243|FG011|Overall Study|Failed inclusion criteria #4|1|||
33443727|NCT00347360|62819244|FG012|Overall Study|Failed inclusion criteria #4|0|||
33443728|NCT00347360|62819245|FG013|Overall Study|Failed inclusion criteria #4|0|||
33443729|NCT00347360|62819246|FG014|Overall Study|Failed inclusion criteria #4|0|||
33443730|NCT00347360|62819232|FG000|Overall Study|Prolonged duration between visits|0|||
33443731|NCT00347360|62819233|FG001|Overall Study|Prolonged duration between visits|0|||
33443732|NCT00347360|62819234|FG002|Overall Study|Prolonged duration between visits|0|||
33443733|NCT00347360|62819235|FG003|Overall Study|Prolonged duration between visits|0|||
33443734|NCT00347360|62819236|FG004|Overall Study|Prolonged duration between visits|0|||
33443735|NCT00347360|62819237|FG005|Overall Study|Prolonged duration between visits|0|||
33443736|NCT00347360|62819238|FG006|Overall Study|Prolonged duration between visits|0|||
33443737|NCT00347360|62819239|FG007|Overall Study|Prolonged duration between visits|0|||
33443738|NCT00347360|62819240|FG008|Overall Study|Prolonged duration between visits|0|||
33443739|NCT00347360|62819241|FG009|Overall Study|Prolonged duration between visits|0|||
33443740|NCT00347360|62819242|FG010|Overall Study|Prolonged duration between visits|0|||
33443741|NCT00347360|62819243|FG011|Overall Study|Prolonged duration between visits|0|||
33443742|NCT00347360|62819244|FG012|Overall Study|Prolonged duration between visits|1|||
33443743|NCT00347360|62819245|FG013|Overall Study|Prolonged duration between visits|0|||
33443744|NCT00347360|62819246|FG014|Overall Study|Prolonged duration between visits|0|||
33443745|NCT00347360|62819232|FG000|Overall Study|Subject left town, ran out of study drug|0|||
33443746|NCT00347360|62819233|FG001|Overall Study|Subject left town, ran out of study drug|0|||
33443747|NCT00347360|62819234|FG002|Overall Study|Subject left town, ran out of study drug|0|||
33443748|NCT00347360|62819235|FG003|Overall Study|Subject left town, ran out of study drug|0|||
33443749|NCT00347360|62819236|FG004|Overall Study|Subject left town, ran out of study drug|0|||
33443750|NCT00347360|62819237|FG005|Overall Study|Subject left town, ran out of study drug|0|||
33443751|NCT00347360|62819238|FG006|Overall Study|Subject left town, ran out of study drug|0|||
33443752|NCT00347360|62819239|FG007|Overall Study|Subject left town, ran out of study drug|0|||
33443753|NCT00347360|62819240|FG008|Overall Study|Subject left town, ran out of study drug|0|||
33443754|NCT00347360|62819241|FG009|Overall Study|Subject left town, ran out of study drug|0|||
33443755|NCT00347360|62819242|FG010|Overall Study|Subject left town, ran out of study drug|0|||
33443756|NCT00347360|62819243|FG011|Overall Study|Subject left town, ran out of study drug|0|||
33443757|NCT00347360|62819244|FG012|Overall Study|Subject left town, ran out of study drug|0|||
33443758|NCT00347360|62819245|FG013|Overall Study|Subject left town, ran out of study drug|1|||
33443759|NCT00347360|62819246|FG014|Overall Study|Subject left town, ran out of study drug|0|||
33443760|NCT00347360|62819232|FG000|Overall Study|Subject refuse to sign updated consent|0|||
33443761|NCT00347360|62819233|FG001|Overall Study|Subject refuse to sign updated consent|0|||
33443762|NCT00347360|62819234|FG002|Overall Study|Subject refuse to sign updated consent|0|||
33443763|NCT00347360|62819235|FG003|Overall Study|Subject refuse to sign updated consent|0|||
33443764|NCT00347360|62819236|FG004|Overall Study|Subject refuse to sign updated consent|0|||
33443765|NCT00347360|62819237|FG005|Overall Study|Subject refuse to sign updated consent|0|||
33443766|NCT00347360|62819238|FG006|Overall Study|Subject refuse to sign updated consent|0|||
33443767|NCT00347360|62819239|FG007|Overall Study|Subject refuse to sign updated consent|0|||
33443768|NCT00347360|62819240|FG008|Overall Study|Subject refuse to sign updated consent|0|||
33443769|NCT00347360|62819241|FG009|Overall Study|Subject refuse to sign updated consent|0|||
33443770|NCT00347360|62819242|FG010|Overall Study|Subject refuse to sign updated consent|0|||
33443771|NCT00347360|62819243|FG011|Overall Study|Subject refuse to sign updated consent|0|||
33443772|NCT00347360|62819244|FG012|Overall Study|Subject refuse to sign updated consent|0|||
33443773|NCT00347360|62819245|FG013|Overall Study|Subject refuse to sign updated consent|0|||
33443774|NCT00347360|62819246|FG014|Overall Study|Subject refuse to sign updated consent|1|||
33443775|NCT00347360|62819232|FG000|Overall Study|Visits conflicted with new job|0|||
33443776|NCT00347360|62819233|FG001|Overall Study|Visits conflicted with new job|0|||
33443777|NCT00347360|62819234|FG002|Overall Study|Visits conflicted with new job|0|||
33443778|NCT00347360|62819235|FG003|Overall Study|Visits conflicted with new job|0|||
33443779|NCT00347360|62819236|FG004|Overall Study|Visits conflicted with new job|0|||
33443780|NCT00347360|62819237|FG005|Overall Study|Visits conflicted with new job|0|||
33443781|NCT00347360|62819238|FG006|Overall Study|Visits conflicted with new job|1|||
33443782|NCT00347360|62819239|FG007|Overall Study|Visits conflicted with new job|0|||
33443783|NCT00347360|62819240|FG008|Overall Study|Visits conflicted with new job|0|||
33443784|NCT00347360|62819241|FG009|Overall Study|Visits conflicted with new job|0|||
33443785|NCT00347360|62819242|FG010|Overall Study|Visits conflicted with new job|0|||
33443786|NCT00347360|62819243|FG011|Overall Study|Visits conflicted with new job|0|||
33443787|NCT00347360|62819244|FG012|Overall Study|Visits conflicted with new job|0|||
33443788|NCT00347360|62819245|FG013|Overall Study|Visits conflicted with new job|0|||
33443789|NCT00347360|62819246|FG014|Overall Study|Visits conflicted with new job|0|||
33443790|NCT00319020|62819280|FG000|Overall Study|Death|2|||
33443791|NCT00319020|62819281|FG001|Overall Study|Death|2|||
33443792|NCT00319020|62819280|FG000|Overall Study|Withdrawal by Subject|4|||
33443793|NCT00319020|62819281|FG001|Overall Study|Withdrawal by Subject|1|||
33443794|NCT00319020|62819280|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
33443795|NCT00319020|62819281|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
33443796|NCT00319020|62819280|FG000|Overall Study|Administrative reason|0|||
33443797|NCT00319020|62819281|FG001|Overall Study|Administrative reason|5|||
33443798|NCT00319020|62819280|FG000|Overall Study|Disease progression|0|||
33443799|NCT00319020|62819281|FG001|Overall Study|Disease progression|2|||
33443800|NCT00319020|62819280|FG000|Overall Study|Transplant|0|||
33443801|NCT00319020|62819281|FG001|Overall Study|Transplant|1|||
33443802|NCT00319020|62819280|FG000|Overall Study|Treatment failure|0|||
33443803|NCT00319020|62819281|FG001|Overall Study|Treatment failure|1|||
33443804|NCT00319020|62819280|FG000|Overall Study|Adverse Event|0|||
33443805|NCT00319020|62819281|FG001|Overall Study|Adverse Event|1|||
33443806|NCT00352118|62819289|FG000|Overall Study|Physician Decision|4|||
33443807|NCT00318474|62819295|FG000|Overall Study|Adverse Event|1|||
33443808|NCT00318474|62819296|FG001|Overall Study|Adverse Event|1|||
33443809|NCT00318474|62819295|FG000|Overall Study|Lost to Follow-up|0|||
33443810|NCT00318474|62819296|FG001|Overall Study|Lost to Follow-up|1|||
33606814|NCT01978119|63006932|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
33606815|NCT01978119|63006933|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33606816|NCT01978119|63006932|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33443811|NCT00318474|62819295|FG000|Overall Study|Pregnancy|0|||
33443812|NCT00318474|62819296|FG001|Overall Study|Pregnancy|2|||
33443813|NCT00318474|62819295|FG000|Overall Study|Protocol Violation|1|||
33443814|NCT00318474|62819296|FG001|Overall Study|Protocol Violation|0|||
33443815|NCT00318474|62819295|FG000|Overall Study|Withdrawal by Subject|3|||
33443816|NCT00318474|62819296|FG001|Overall Study|Withdrawal by Subject|2|||
33443817|NCT00318474|62819295|FG000|Overall Study|Fall in GFR|3|||
33443818|NCT00318474|62819296|FG001|Overall Study|Fall in GFR|3|||
33443819|NCT00318474|62819295|FG000|Overall Study|Post-therapy hyperflycemia|0|||
33443820|NCT00318474|62819296|FG001|Overall Study|Post-therapy hyperflycemia|1|||
33606817|NCT01978119|63006933|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
33606818|NCT01999179|63006939|FG000|Overall Study|Adverse Event|1|||
33606819|NCT01999179|63006939|FG000|Overall Study|Lost to Follow-up|1|||
33443821|NCT00318474|62819295|FG000|Overall Study|Trial terminated|10|||
33443822|NCT00318474|62819296|FG001|Overall Study|Trial terminated|7|||
33443823|NCT00350870|62819306|FG000|Overall Study|Withdrawal by Subject|21|||
33443824|NCT00350870|62819307|FG001|Overall Study|Withdrawal by Subject|17|||
33443825|NCT00350870|62819308|FG002|Overall Study|Withdrawal by Subject|15|||
33443826|NCT00350870|62819309|FG003|Overall Study|Withdrawal by Subject|14|||
33443827|NCT00350870|62819306|FG000|Overall Study|Physician Decision|1|||
33443828|NCT00350870|62819307|FG001|Overall Study|Physician Decision|0|||
33443829|NCT00350870|62819308|FG002|Overall Study|Physician Decision|1|||
33443830|NCT00350870|62819309|FG003|Overall Study|Physician Decision|1|||
33443831|NCT00350792|62819319|FG000|Overall Study|Adverse Event|11|||
33443832|NCT00350792|62819319|FG000|Overall Study|Death from Study Disease|1|||
33443833|NCT00350792|62819319|FG000|Overall Study|Death from Study Drug Toxicity|1|||
33443834|NCT00350792|62819319|FG000|Overall Study|Death Not Study Drug Related|2|||
33443835|NCT00350792|62819319|FG000|Overall Study|Protocol Violation|1|||
33443836|NCT00350792|62819319|FG000|Overall Study|Withdrawal by Subject|4|||
33443837|NCT00350792|62819319|FG000|Overall Study|Physician Decision|2|||
33443838|NCT00350792|62819319|FG000|Overall Study|Lack of Efficacy|11|||
33443839|NCT00317772|62819327|FG000|Overall Study|Adverse Event|0|||
33443840|NCT00317772|62819328|FG001|Overall Study|Adverse Event|0|||
33443841|NCT00317772|62819329|FG002|Overall Study|Adverse Event|0|||
33443842|NCT00317772|62819330|FG003|Overall Study|Adverse Event|2|||
33443843|NCT00317772|62819327|FG000|Overall Study|Disease Progression|2|||
33443844|NCT00317772|62819328|FG001|Overall Study|Disease Progression|2|||
33443845|NCT00317772|62819329|FG002|Overall Study|Disease Progression|1|||
33443846|NCT00317772|62819330|FG003|Overall Study|Disease Progression|7|||
33443847|NCT00350636|62819343|FG000|Overall Study|Adverse Event|19|||
33443848|NCT00350636|62819344|FG001|Overall Study|Adverse Event|13|||
33443849|NCT00350636|62819343|FG000|Overall Study|Protocol Violation|1|||
33443850|NCT00350636|62819344|FG001|Overall Study|Protocol Violation|3|||
33443851|NCT00350636|62819343|FG000|Overall Study|Withdrawal by Subject|13|||
33443852|NCT00350636|62819344|FG001|Overall Study|Withdrawal by Subject|17|||
33443853|NCT00350636|62819343|FG000|Overall Study|Lost to Follow-up|9|||
33443854|NCT00350636|62819344|FG001|Overall Study|Lost to Follow-up|8|||
33443855|NCT00350636|62819343|FG000|Overall Study|Physician Decision|0|||
33443856|NCT00350636|62819344|FG001|Overall Study|Physician Decision|2|||
33443857|NCT00350636|62819343|FG000|Overall Study|Other|1|||
33443858|NCT00350636|62819344|FG001|Overall Study|Other|2|||
33443859|NCT00346268|62819352|FG000|Overall Study|Adverse Event|1|||
33443860|NCT00346268|62819353|FG001|Overall Study|Adverse Event|0|||
33443861|NCT00346268|62819352|FG000|Overall Study|Protocol Violation|1|||
33443862|NCT00346268|62819353|FG001|Overall Study|Protocol Violation|0|||
33443863|NCT00346268|62819352|FG000|Overall Study|Participant refused|0|||
33443864|NCT00346268|62819353|FG001|Overall Study|Participant refused|3|||
33443865|NCT00327444|62819361|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
33443866|NCT00327444|62819362|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
33443867|NCT00327444|62819361|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
33443868|NCT00327444|62819362|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
33443869|NCT00327444|62819361|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
33443870|NCT00327444|62819362|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
33443871|NCT00327444|62819361|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
33443872|NCT00327444|62819362|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
33443873|NCT00327444|62819361|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
33443874|NCT00327444|62819362|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
33443875|NCT00327444|62819361|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
33443876|NCT00327444|62819362|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
33443877|NCT00327444|62819361|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
33443878|NCT00327444|62819362|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
33443879|NCT00327444|62819361|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
33443880|NCT00327444|62819362|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
33443881|NCT00337610|62819372|FG000|Overall Study|Adverse Event|2|||
33443882|NCT00337610|62819373|FG001|Overall Study|Adverse Event|2|||
33443883|NCT00337610|62819372|FG000|Overall Study|Death|0|||
33443884|NCT00337610|62819373|FG001|Overall Study|Death|1|||
33443885|NCT00337610|62819372|FG000|Overall Study|Lack of Efficacy|6|||
33443886|NCT00337610|62819373|FG001|Overall Study|Lack of Efficacy|3|||
33443887|NCT00337610|62819372|FG000|Overall Study|Lost to Follow-up|3|||
33443888|NCT00337610|62819373|FG001|Overall Study|Lost to Follow-up|3|||
33443889|NCT00337610|62819372|FG000|Overall Study|Withdrawal by Subject|6|||
33443890|NCT00337610|62819373|FG001|Overall Study|Withdrawal by Subject|5|||
33443891|NCT00316914|62819381|FG000|Overall Study|Withdrawal by Subject|5|||
33443892|NCT00316914|62819382|FG001|Overall Study|Withdrawal by Subject|3|||
33443893|NCT00316914|62819381|FG000|Overall Study|Adverse Event|8|||
33443894|NCT00316914|62819382|FG001|Overall Study|Adverse Event|7|||
33443895|NCT00316914|62819381|FG000|Overall Study|Other Problems|6|||
33443896|NCT00316914|62819382|FG001|Overall Study|Other Problems|11|||
33443897|NCT00316914|62819381|FG000|Overall Study|Missing end of treatment documentation|14|||
33443898|NCT00316914|62819382|FG001|Overall Study|Missing end of treatment documentation|15|||
33443899|NCT00336284|62819390|FG000|Overall Study|Death|52|||
33443900|NCT00336284|62819391|FG001|Overall Study|Death|26|||
33443901|NCT00336284|62819390|FG000|Overall Study|Lost to Follow-up|82|||
33443902|NCT00336284|62819391|FG001|Overall Study|Lost to Follow-up|61|||
33443903|NCT00336284|62819390|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
33443904|NCT00336284|62819391|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
33443905|NCT00316602|62819399|FG000|Overall Study|Withdrawal by Subject|3|||
33443906|NCT00316602|62819400|FG001|Overall Study|Withdrawal by Subject|2|||
33443907|NCT00316602|62819399|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
33443908|NCT00316602|62819400|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
33443909|NCT00316602|62819399|FG000|Overall Study|Adverse Event|1|||
33443910|NCT00316602|62819400|FG001|Overall Study|Adverse Event|0|||
33443911|NCT00316602|62819399|FG000|Overall Study|Other|3|||
33443912|NCT00316602|62819400|FG001|Overall Study|Other|6|||
33606820|NCT01999179|63006939|FG000|Overall Study|Change in Therapy|3|||
33606821|NCT01999179|63006939|FG000|Overall Study|New catheter|2|||
33606822|NCT01977729|63006943|FG000|Overall Study|Study terminated|1|||
33443913|NCT00335972|62819408|FG000|Overall Study|not given treatments|0|||
33443914|NCT00335972|62819409|FG001|Overall Study|not given treatments|3|||
33443915|NCT00346034|62819415|FG000|Overall Study|Adverse Event|34|||
33443916|NCT00346034|62819415|FG000|Overall Study|Lack of Efficacy|8|||
33443917|NCT00346034|62819415|FG000|Overall Study|Withdrawal by Subject|13|||
33443918|NCT00346034|62819415|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
33443919|NCT00346034|62819415|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
33443920|NCT00345878|62819421|FG000|Overall Study|Adverse Event|1|||
33443921|NCT00345878|62819422|FG001|Overall Study|Adverse Event|0|||
33443922|NCT00345878|62819421|FG000|Overall Study|Lost to Follow-up|2|||
33443923|NCT00345878|62819422|FG001|Overall Study|Lost to Follow-up|1|||
33443924|NCT00345878|62819421|FG000|Overall Study|Other|1|||
33443925|NCT00345878|62819422|FG001|Overall Study|Other|0|||
33443926|NCT00335738|62819430|FG000|Overall Study|Physician Decision|6|||
33443927|NCT00335738|62819431|FG001|Overall Study|Physician Decision|0|||
33443928|NCT00335738|62819430|FG000|Overall Study|Withdrawal by Subject|2|||
33443929|NCT00335738|62819431|FG001|Overall Study|Withdrawal by Subject|0|||
33443930|NCT00335738|62819430|FG000|Overall Study|Ineligible|3|||
33443931|NCT00335738|62819431|FG001|Overall Study|Ineligible|4|||
33443932|NCT00334958|62819449|FG000|Overall Study|Medication Noncompliance|0|||
33443933|NCT00334958|62819450|FG001|Overall Study|Medication Noncompliance|3|||
33443934|NCT00334958|62819449|FG000|Overall Study|Protocol Violation|2|||
33443935|NCT00334958|62819450|FG001|Overall Study|Protocol Violation|2|||
33443936|NCT00334958|62819449|FG000|Overall Study|Request of the investigator or sponsor|0|||
33443937|NCT00334958|62819450|FG001|Overall Study|Request of the investigator or sponsor|1|||
33443938|NCT00334958|62819449|FG000|Overall Study|Withdrawal by Subject|7|||
33443939|NCT00334958|62819450|FG001|Overall Study|Withdrawal by Subject|4|||
33443940|NCT00334958|62819449|FG000|Overall Study|Adverse Event|27|||
33443941|NCT00334958|62819450|FG001|Overall Study|Adverse Event|12|||
33443942|NCT00334958|62819449|FG000|Overall Study|Other|1|||
33443943|NCT00334958|62819450|FG001|Overall Study|Other|2|||
33443944|NCT00326898|62819459|FG000|Overall Study|Disease progression|52|||
33443945|NCT00326898|62819460|FG001|Overall Study|Disease progression|54|||
33443946|NCT00326898|62819461|FG002|Overall Study|Disease progression|102|||
33443947|NCT00326898|62819459|FG000|Overall Study|Adverse Event|124|||
33443948|NCT00326898|62819460|FG001|Overall Study|Adverse Event|128|||
33443949|NCT00326898|62819461|FG002|Overall Study|Adverse Event|33|||
33443950|NCT00326898|62819459|FG000|Overall Study|Death|2|||
33443951|NCT00326898|62819460|FG001|Overall Study|Death|0|||
33443952|NCT00326898|62819461|FG002|Overall Study|Death|0|||
33443953|NCT00326898|62819459|FG000|Overall Study|Withdrawal by Subject|134|||
33443954|NCT00326898|62819460|FG001|Overall Study|Withdrawal by Subject|128|||
33443955|NCT00326898|62819461|FG002|Overall Study|Withdrawal by Subject|32|||
33443956|NCT00326898|62819459|FG000|Overall Study|Alternative therapy|1|||
33443957|NCT00326898|62819460|FG001|Overall Study|Alternative therapy|0|||
33443958|NCT00326898|62819461|FG002|Overall Study|Alternative therapy|0|||
33443959|NCT00326898|62819459|FG000|Overall Study|Other complicating disease|5|||
33443960|NCT00326898|62819460|FG001|Overall Study|Other complicating disease|5|||
33443961|NCT00326898|62819461|FG002|Overall Study|Other complicating disease|4|||
33443962|NCT00326898|62819459|FG000|Overall Study|Other/Missing/Unknown|33|||
33443963|NCT00326898|62819460|FG001|Overall Study|Other/Missing/Unknown|28|||
33443964|NCT00326898|62819461|FG002|Overall Study|Other/Missing/Unknown|32|||
33443965|NCT00326118|62819471|FG000|Active Phase|Withdrawal by Subject|4|||
33443966|NCT00326118|62819472|FG001|Active Phase|Withdrawal by Subject|1|||
33443967|NCT00334802|62819481|FG000|Overall Study|Progressive Disease|2|||
33443968|NCT00334802|62819482|FG001|Overall Study|Progressive Disease|24|||
33443969|NCT00334802|62819481|FG000|Overall Study|Toxicity|1|||
33443970|NCT00334802|62819482|FG001|Overall Study|Toxicity|5|||
33443971|NCT00334802|62819481|FG000|Overall Study|Lack of Efficacy|1|||
33443972|NCT00334802|62819482|FG001|Overall Study|Lack of Efficacy|3|||
33443973|NCT00334802|62819481|FG000|Overall Study|Patient Condition Aggrevated|1|||
33443974|NCT00334802|62819482|FG001|Overall Study|Patient Condition Aggrevated|0|||
33443975|NCT00334802|62819481|FG000|Overall Study|Physician Decision|1|||
33443976|NCT00334802|62819482|FG001|Overall Study|Physician Decision|0|||
33443977|NCT00334802|62819481|FG000|Overall Study|Withdrawal by Subject|0|||
33443978|NCT00334802|62819482|FG001|Overall Study|Withdrawal by Subject|4|||
33443979|NCT00334802|62819481|FG000|Overall Study|Adverse Event|0|||
33443980|NCT00334802|62819482|FG001|Overall Study|Adverse Event|3|||
33443981|NCT00334802|62819481|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
33443982|NCT00334802|62819482|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
33443983|NCT00307164|62819493|FG000|Overall Study|Death|1|||
33443984|NCT00307164|62819494|FG001|Overall Study|Death|0|||
33443985|NCT00307164|62819493|FG000|Overall Study|Severe debilitation, unable to continue|1|||
33443986|NCT00307164|62819494|FG001|Overall Study|Severe debilitation, unable to continue|0|||
33443987|NCT00307164|62819493|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
33443988|NCT00307164|62819494|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
33443989|NCT00307164|62819493|FG000|Overall Study|Withdrawal by Subject|1|||
33443990|NCT00307164|62819494|FG001|Overall Study|Withdrawal by Subject|8|||
33443991|NCT00307164|62819493|FG000|Overall Study|Not compliant with requirements|4|||
33443992|NCT00307164|62819494|FG001|Overall Study|Not compliant with requirements|4|||
33443993|NCT00307164|62819493|FG000|Overall Study|Lost to Follow-up|6|||
33443994|NCT00307164|62819494|FG001|Overall Study|Lost to Follow-up|1|||
33443995|NCT03827564|62819502|FG000|Overall Study|Discontinued due to Study Termination|1|||
33443996|NCT03827564|62819503|FG001|Overall Study|Discontinued due to Study Termination|0|||
33443997|NCT00307086|62819509|FG000|Overall Study|ineligible|5|||
33443998|NCT00325416|62819515|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
33443999|NCT00325416|62819516|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
33444000|NCT00325416|62819515|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
33444001|NCT00325416|62819516|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
33444002|NCT00325416|62819515|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
33444003|NCT00325416|62819516|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
33444004|NCT00325416|62819515|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
33444005|NCT00325416|62819516|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
33444006|NCT00325416|62819515|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
33444007|NCT00325416|62819516|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
33444008|NCT00325416|62819515|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
33444009|NCT00325416|62819516|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
33444010|NCT00314808|62819522|FG000|Overall Study|Disease Progression without AE|4|||
33444011|NCT00314808|62819522|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
33444012|NCT00314574|62819528|FG000|Overall Study|Death|3|||
33444013|NCT00314574|62819529|FG001|Overall Study|Death|0|||
33444014|NCT00314574|62819528|FG000|Overall Study|Adverse Event|11|||
33444015|NCT00314574|62819529|FG001|Overall Study|Adverse Event|16|||
33444016|NCT00314574|62819528|FG000|Overall Study|Lost to Follow-up|19|||
33444017|NCT00314574|62819529|FG001|Overall Study|Lost to Follow-up|25|||
33444018|NCT00314574|62819528|FG000|Overall Study|Withdrawal by Subject|33|||
33444019|NCT00314574|62819529|FG001|Overall Study|Withdrawal by Subject|22|||
33444020|NCT00314574|62819528|FG000|Overall Study|Physician Decision|22|||
33444021|NCT00314574|62819529|FG001|Overall Study|Physician Decision|15|||
33444022|NCT00314574|62819528|FG000|Overall Study|Pregnancy|6|||
33444023|NCT00314574|62819529|FG001|Overall Study|Pregnancy|4|||
33444024|NCT00314574|62819528|FG000|Overall Study|Data unknown at database lock|0|||
33444025|NCT00314574|62819529|FG001|Overall Study|Data unknown at database lock|1|||
33444026|NCT00314340|62819535|FG000|Overall Study|lost interest|1|||
33444027|NCT00306852|62819543|FG000|Overall Study|Death|14|||
33444028|NCT00306852|62819544|FG001|Overall Study|Death|14|||
33444029|NCT00306852|62819543|FG000|Overall Study|Lost to Follow-up|15|||
33444030|NCT00306852|62819544|FG001|Overall Study|Lost to Follow-up|24|||
33444031|NCT00314262|62819550|FG000|Overall Study|Adverse Event|2|||
33444032|NCT00314262|62819550|FG000|Overall Study|Withdrawal by Subject|2|||
33444033|NCT00314262|62819550|FG000|Overall Study|Physician Decision|1|||
33444034|NCT00333866|62819558|FG000|Overall Study|Adverse Event|23|||
33444035|NCT00333866|62819559|FG001|Overall Study|Adverse Event|37|||
33444036|NCT00333866|62819560|FG002|Overall Study|Adverse Event|38|||
33444037|NCT00333866|62819561|FG003|Overall Study|Adverse Event|47|||
33444038|NCT00333866|62819558|FG000|Overall Study|Other|3|||
33444039|NCT00333866|62819559|FG001|Overall Study|Other|2|||
33444040|NCT00333866|62819560|FG002|Overall Study|Other|2|||
33444041|NCT00333866|62819561|FG003|Overall Study|Other|2|||
33444042|NCT00333866|62819558|FG000|Overall Study|Lack of Efficacy|8|||
33444043|NCT00333866|62819559|FG001|Overall Study|Lack of Efficacy|6|||
33444044|NCT00333866|62819560|FG002|Overall Study|Lack of Efficacy|3|||
33444045|NCT00333866|62819561|FG003|Overall Study|Lack of Efficacy|5|||
33444046|NCT00333866|62819558|FG000|Overall Study|Lost to Follow-up|1|||
33444047|NCT00333866|62819559|FG001|Overall Study|Lost to Follow-up|2|||
33444048|NCT00333866|62819560|FG002|Overall Study|Lost to Follow-up|2|||
33444049|NCT00333866|62819561|FG003|Overall Study|Lost to Follow-up|2|||
33444050|NCT00333866|62819558|FG000|Overall Study|Withdrawal by Subject|8|||
33444051|NCT00333866|62819559|FG001|Overall Study|Withdrawal by Subject|14|||
33444052|NCT00333866|62819560|FG002|Overall Study|Withdrawal by Subject|4|||
33444053|NCT00333866|62819561|FG003|Overall Study|Withdrawal by Subject|9|||
33444054|NCT00333866|62819558|FG000|Overall Study|Randomized but not Treated|5|||
33444055|NCT00333866|62819559|FG001|Overall Study|Randomized but not Treated|3|||
33444056|NCT00333866|62819560|FG002|Overall Study|Randomized but not Treated|2|||
33444057|NCT00333866|62819561|FG003|Overall Study|Randomized but not Treated|1|||
33444058|NCT00324740|62819571|FG000|Overall Study|Withdrawal by Subject|1|||
33444059|NCT00324740|62819572|FG001|Overall Study|Withdrawal by Subject|0|||
33444060|NCT00324740|62819573|FG002|Overall Study|Withdrawal by Subject|1|||
33606823|NCT01998477|63006951|FG000|Overall Study|Lost to Follow-up|4|||
33606824|NCT01998477|63006952|FG001|Overall Study|Lost to Follow-up|5|||
33606825|NCT01998477|63006951|FG000|Overall Study|Withdrawal by Subject|6|||
33444061|NCT00333788|62819580|FG000|Overall Study|Adverse Event|44|||
33444062|NCT00333788|62819580|FG000|Overall Study|Lack of Efficacy|80|||
33444063|NCT00333788|62819580|FG000|Overall Study|Lost to Follow-up|2|||
33444064|NCT00333788|62819580|FG000|Overall Study|Withdrawal by Subject|24|||
33444065|NCT00333788|62819580|FG000|Overall Study|Other: Non-compliance|2|||
33444066|NCT00333788|62819580|FG000|Overall Study|Other: Moved|2|||
33444067|NCT00333788|62819580|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
33444068|NCT00333788|62819580|FG000|Overall Study|Other: Investigator decision|1|||
33444069|NCT00333788|62819580|FG000|Overall Study|Other: Quality of life concern|1|||
33444070|NCT00333788|62819580|FG000|Overall Study|Other: Sponsor decision|1|||
33444071|NCT00333788|62819580|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
33444072|NCT00333788|62819580|FG000|Overall Study|Other: Medical monitor decision|1|||
33444073|NCT00333788|62819580|FG000|Overall Study|Other: Physician decision|1|||
33444074|NCT00333788|62819580|FG000|Overall Study|Other: Signed consent for another study|1|||
33444075|NCT00324116|62819584|FG000|Overall Study|Adverse Event|5|||
33444076|NCT00324116|62819584|FG000|Overall Study|Lack of Efficacy|17|||
33444077|NCT00324116|62819584|FG000|Overall Study|Withdrawal by Subject|5|||
33444078|NCT00324116|62819584|FG000|Overall Study|Other|5|||
33444079|NCT00332696|62819590|FG000|Overall Study|Death|24|||
33444080|NCT00332696|62819591|FG001|Overall Study|Death|14|||
33444081|NCT00332696|62819590|FG000|Overall Study|Insufficient therapeutic effect|4|||
33444082|NCT00332696|62819591|FG001|Overall Study|Insufficient therapeutic effect|11|||
33444083|NCT00332696|62819590|FG000|Overall Study|Adverse Event|1|||
33444084|NCT00332696|62819591|FG001|Overall Study|Adverse Event|2|||
33444085|NCT00332696|62819590|FG000|Overall Study|Condition does not justify treatment|0|||
33606826|NCT01998477|63006952|FG001|Overall Study|Withdrawal by Subject|0|||
33606827|NCT01998399|63006985|FG000|Overall Study|Lost to Follow-up|1|||
33606828|NCT01998399|63006986|FG001|Overall Study|Lost to Follow-up|3|||
33606829|NCT01998399|63006985|FG000|Overall Study|Death|4|||
33606830|NCT01998399|63006986|FG001|Overall Study|Death|2|||
33606831|NCT01998399|63006985|FG000|Overall Study|Study stopped before dosing completed|3|||
33606832|NCT01998399|63006986|FG001|Overall Study|Study stopped before dosing completed|3|||
33606833|NCT01998399|63006985|FG000|Overall Study|Withdrawal by Subject|0|||
33606834|NCT01998399|63006986|FG001|Overall Study|Withdrawal by Subject|1|||
33323387|NCT00925132|62699669|FG001|Overall Study|Removed due to disease progression|0|||
33323388|NCT00925132|62699670|FG002|Overall Study|Removed due to disease progression|0|||
33444086|NCT00332696|62819591|FG001|Overall Study|Condition does not justify treatment|2|||
33444087|NCT00332696|62819590|FG000|Overall Study|Lost to Follow-up|0|||
33444088|NCT00332696|62819591|FG001|Overall Study|Lost to Follow-up|1|||
33444089|NCT00332696|62819590|FG000|Overall Study|Withdrawal by Subject|1|||
33606835|NCT01781572|63007003|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
33606836|NCT01781572|63007004|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
33444090|NCT00332696|62819591|FG001|Overall Study|Withdrawal by Subject|0|||
33444091|NCT00313716|62819603|FG000|Overall Study|Death|3|||
33444092|NCT00313716|62819604|FG001|Overall Study|Death|2|||
33444093|NCT00313716|62819605|FG002|Overall Study|Death|9|||
33444094|NCT00313716|62819606|FG003|Overall Study|Death|3|||
33444095|NCT00313716|62819607|FG004|Overall Study|Death|5|||
33444096|NCT00313716|62819608|FG005|Overall Study|Death|9|||
33444097|NCT00313716|62819603|FG000|Overall Study|Lost to Follow-up|2|||
33444098|NCT00313716|62819604|FG001|Overall Study|Lost to Follow-up|5|||
33444099|NCT00313716|62819605|FG002|Overall Study|Lost to Follow-up|2|||
33444100|NCT00313716|62819606|FG003|Overall Study|Lost to Follow-up|1|||
33444101|NCT00313716|62819607|FG004|Overall Study|Lost to Follow-up|0|||
33444102|NCT00313716|62819608|FG005|Overall Study|Lost to Follow-up|4|||
33444103|NCT00313716|62819603|FG000|Overall Study|Withdrawal by Subject|0|||
33444104|NCT00313716|62819604|FG001|Overall Study|Withdrawal by Subject|1|||
33444105|NCT00313716|62819605|FG002|Overall Study|Withdrawal by Subject|1|||
33444106|NCT00313716|62819606|FG003|Overall Study|Withdrawal by Subject|0|||
33444107|NCT00313716|62819607|FG004|Overall Study|Withdrawal by Subject|1|||
33444108|NCT00313716|62819608|FG005|Overall Study|Withdrawal by Subject|0|||
33444109|NCT00313170|62819629|FG000|Overall Study|Death|2|||
33444110|NCT00313170|62819630|FG001|Overall Study|Death|4|||
33444111|NCT00313170|62819631|FG002|Overall Study|Death|2|||
33444112|NCT00313170|62819629|FG000|Overall Study|Adverse Event|1|||
33444113|NCT00313170|62819630|FG001|Overall Study|Adverse Event|2|||
33444114|NCT00313170|62819631|FG002|Overall Study|Adverse Event|0|||
33444115|NCT00313170|62819629|FG000|Overall Study|Disease progression|31|||
33444116|NCT00313170|62819630|FG001|Overall Study|Disease progression|26|||
33444117|NCT00313170|62819631|FG002|Overall Study|Disease progression|27|||
33444118|NCT00313170|62819629|FG000|Overall Study|Withdrawal by Subject|1|||
33444119|NCT00313170|62819630|FG001|Overall Study|Withdrawal by Subject|0|||
33444120|NCT00313170|62819631|FG002|Overall Study|Withdrawal by Subject|1|||
33444121|NCT00313170|62819629|FG000|Overall Study|Incorrect enrollment|0|||
33444122|NCT00313170|62819630|FG001|Overall Study|Incorrect enrollment|2|||
33444123|NCT00313170|62819631|FG002|Overall Study|Incorrect enrollment|1|||
33444124|NCT00313170|62819629|FG000|Overall Study|Lost to Follow-up|0|||
33444125|NCT00313170|62819630|FG001|Overall Study|Lost to Follow-up|0|||
33444126|NCT00313170|62819631|FG002|Overall Study|Lost to Follow-up|1|||
33444127|NCT00313170|62819629|FG000|Overall Study|Progression (investigators opinion)|1|||
33444128|NCT00313170|62819630|FG001|Overall Study|Progression (investigators opinion)|0|||
33444129|NCT00313170|62819631|FG002|Overall Study|Progression (investigators opinion)|0|||
33444130|NCT00332462|62819640|FG000|Overall Study|Adverse Event|5|||
33444131|NCT00332462|62819640|FG000|Overall Study|Abnormal Lab Value|1|||
33444132|NCT00332462|62819640|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33444133|NCT00332462|62819640|FG000|Overall Study|no longer requires study drug|1|||
33444134|NCT00332462|62819640|FG000|Overall Study|Death|3|||
33444135|NCT00332462|62819640|FG000|Overall Study|Graft Loss|2|||
33444136|NCT00324038|62819649|FG000|Overall Study|Adverse Event|38|||
33444137|NCT00324038|62819650|FG001|Overall Study|Adverse Event|23|||
33444138|NCT00324038|62819649|FG000|Overall Study|Lack of Efficacy|5|||
33444139|NCT00324038|62819650|FG001|Overall Study|Lack of Efficacy|13|||
33444140|NCT00324038|62819649|FG000|Overall Study|Lost to Follow-up|0|||
33444141|NCT00324038|62819650|FG001|Overall Study|Lost to Follow-up|2|||
33444142|NCT00324038|62819649|FG000|Overall Study|Other|6|||
33444143|NCT00324038|62819650|FG001|Overall Study|Other|13|||
33444144|NCT00159861|62819658|FG000|Core Study - 16 Weeks|Death|3|||
33444145|NCT00159861|62819659|FG001|Core Study - 16 Weeks|Death|0|||
33444146|NCT00159861|62819658|FG000|Core Study - 16 Weeks|Adverse Event|12|||
33444147|NCT00159861|62819659|FG001|Core Study - 16 Weeks|Adverse Event|6|||
33444148|NCT00159861|62819658|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
33444149|NCT00159861|62819659|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
33444150|NCT00159861|62819658|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
33444151|NCT00159861|62819659|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
33444152|NCT00159861|62819658|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
33444153|NCT00159861|62819659|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
33444154|NCT00159861|62819658|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
33444155|NCT00159861|62819659|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
33444156|NCT00159861|62819658|FG000|Extension Study - up to 3 Years|Death|24|||
33444157|NCT00159861|62819659|FG001|Extension Study - up to 3 Years|Death|28|||
33444158|NCT00159861|62819658|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
33444159|NCT00159861|62819659|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
33444160|NCT00159861|62819658|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
33444161|NCT00159861|62819659|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
33444162|NCT00159861|62819658|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
33444163|NCT00159861|62819659|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
33444164|NCT00159861|62819658|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
33444165|NCT00159861|62819659|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
33444166|NCT00331760|62819672|FG000|Overall Study|Ineligible / no protocol treatment|15|||
33444167|NCT00331760|62819673|FG001|Overall Study|Ineligible / no protocol treatment|8|||
33444168|NCT00225147|62819684|FG000|Open-label Phase|Lost to Follow-up|0|||
33444169|NCT00225147|62819685|FG001|Open-label Phase|Lost to Follow-up|0|||
33444170|NCT00225147|62819686|FG002|Open-label Phase|Lost to Follow-up|0|||
33444171|NCT00225147|62819687|FG003|Open-label Phase|Lost to Follow-up|4|||
33444172|NCT00225147|62819684|FG000|Open-label Phase|Withdrawal by Subject|0|||
33444173|NCT00225147|62819685|FG001|Open-label Phase|Withdrawal by Subject|0|||
33444174|NCT00225147|62819686|FG002|Open-label Phase|Withdrawal by Subject|0|||
33606837|NCT01781572|63007005|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
33444175|NCT00225147|62819687|FG003|Open-label Phase|Withdrawal by Subject|6|||
33444176|NCT00313014|62819702|FG000|Overall Study|Withdrawal by Subject|11|||
33444177|NCT00313014|62819703|FG001|Overall Study|Withdrawal by Subject|7|||
33606838|NCT01781572|63007003|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
33606839|NCT01781572|63007004|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
33606840|NCT01781572|63007005|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
33606841|NCT01781572|63007003|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
33606842|NCT01781572|63007004|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
33606843|NCT01781572|63007005|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
33606844|NCT01781572|63007003|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
33606845|NCT01781572|63007004|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
33606846|NCT01781572|63007005|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
33606847|NCT01781572|63007003|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
33606848|NCT01781572|63007004|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
33606849|NCT01781572|63007005|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
33606850|NCT01781572|63007003|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
33606851|NCT01781572|63007004|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
33606852|NCT01781572|63007005|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
33606853|NCT01781572|63007003|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
33606854|NCT01781572|63007004|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
33606855|NCT01781572|63007005|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
33606856|NCT01781572|63007003|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
33606857|NCT01781572|63007004|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
33606858|NCT01781572|63007005|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
33606859|NCT01781572|63007003|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
33606860|NCT01781572|63007004|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
33606861|NCT01781572|63007005|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
33606862|NCT01781572|63007003|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
33606863|NCT01781572|63007004|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
33606864|NCT01781572|63007005|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
33606865|NCT01781572|63007003|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
33606866|NCT01781572|63007004|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
33444178|NCT00313014|62819704|FG002|Overall Study|Withdrawal by Subject|5|||
33444179|NCT00313014|62819702|FG000|Overall Study|Adverse Event|14|||
33444180|NCT00313014|62819703|FG001|Overall Study|Adverse Event|29|||
33444181|NCT00313014|62819704|FG002|Overall Study|Adverse Event|16|||
33444182|NCT00313014|62819702|FG000|Overall Study|Lost to Follow-up|7|||
33444183|NCT00313014|62819703|FG001|Overall Study|Lost to Follow-up|6|||
33444184|NCT00313014|62819704|FG002|Overall Study|Lost to Follow-up|10|||
33444185|NCT00313014|62819702|FG000|Overall Study|Administrative|9|||
33444186|NCT00313014|62819703|FG001|Overall Study|Administrative|6|||
33444187|NCT00313014|62819704|FG002|Overall Study|Administrative|14|||
33444188|NCT00313014|62819702|FG000|Overall Study|Lack of Efficacy|52|||
33444189|NCT00313014|62819703|FG001|Overall Study|Lack of Efficacy|25|||
33444190|NCT00313014|62819704|FG002|Overall Study|Lack of Efficacy|16|||
33444191|NCT00157209|62819715|FG000|Overall Study|Ongoing at data cut-off|10|||
33444192|NCT00157209|62819716|FG001|Overall Study|Ongoing at data cut-off|0|||
33444193|NCT00312858|62819724|FG000|Overall Study|Adverse Event|0|||
33444194|NCT00312858|62819725|FG001|Overall Study|Adverse Event|1|||
33444195|NCT00312858|62819724|FG000|Overall Study|Lost to Follow-up|25|||
33606867|NCT01781572|63007005|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
33606868|NCT01781572|63007003|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
33606869|NCT01781572|63007004|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
33606870|NCT01781572|63007005|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
33606871|NCT01781572|63007003|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
33606872|NCT01781572|63007004|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
33444196|NCT00312858|62819725|FG001|Overall Study|Lost to Follow-up|42|||
33444197|NCT00312858|62819724|FG000|Overall Study|Protocol Violation|3|||
33444198|NCT00312858|62819725|FG001|Overall Study|Protocol Violation|8|||
33444199|NCT00312858|62819724|FG000|Overall Study|Withdraw by Participant|20|||
33444200|NCT00312858|62819725|FG001|Overall Study|Withdraw by Participant|20|||
33444201|NCT00312858|62819724|FG000|Overall Study|Participant Moved|11|||
33444202|NCT00312858|62819725|FG001|Overall Study|Participant Moved|10|||
33444203|NCT00312858|62819724|FG000|Overall Study|Other|9|||
33444204|NCT00312858|62819725|FG001|Overall Study|Other|12|||
33444205|NCT00312702|62819734|FG000|Immunization Phase|Lost to Follow-up|0|||
33444206|NCT00312702|62819735|FG001|Immunization Phase|Lost to Follow-up|1|||
33444207|NCT00312702|62819736|FG002|Immunization Phase|Lost to Follow-up|0|||
33444208|NCT00156819|62819747|FG000|Overall Study|Lost to Follow-up|1|||
33444209|NCT00156819|62819748|FG001|Overall Study|Lost to Follow-up|1|||
33444210|NCT00156819|62819749|FG002|Overall Study|Lost to Follow-up|3|||
33444211|NCT03825042|62819759|FG000|Overall Study|Adverse Event|1|||
33444212|NCT03825042|62819760|FG001|Overall Study|Adverse Event|0|||
33444213|NCT03825042|62819759|FG000|Overall Study|Withdrawal by Subject|1|||
33444214|NCT03825042|62819760|FG001|Overall Study|Withdrawal by Subject|0|||
33444215|NCT00129987|62819768|FG000|1st Educational Session|Withdrawal by Subject|141|||
33444216|NCT00129987|62819769|FG001|1st Educational Session|Withdrawal by Subject|109|||
33444217|NCT00129987|62819768|FG000|1 Year|Withdrawal by Subject|32|||
33444218|NCT00129987|62819769|FG001|1 Year|Withdrawal by Subject|21|||
33444219|NCT00224133|62819775|FG000|Overall Study|Adverse Event|93|||
33444220|NCT00224133|62819775|FG000|Overall Study|Protocol Violation|6|||
33444221|NCT00224133|62819775|FG000|Overall Study|Withdrawal by Subject|33|||
33444222|NCT00224133|62819775|FG000|Overall Study|Lack of Efficacy|58|||
33444223|NCT00224133|62819775|FG000|Overall Study|Lost to Follow-up|21|||
33444224|NCT00224133|62819775|FG000|Overall Study|Physician Decision|1|||
33444225|NCT00224133|62819775|FG000|Overall Study|Other|14|||
33444226|NCT00224055|62819781|FG000|Overall Study|Adverse Event|9|||
33444227|NCT00224055|62819782|FG001|Overall Study|Adverse Event|3|||
33444228|NCT00224055|62819781|FG000|Overall Study|Lost to Follow-up|1|||
33444229|NCT00224055|62819782|FG001|Overall Study|Lost to Follow-up|2|||
33444230|NCT00224055|62819781|FG000|Overall Study|Protocol Violation|1|||
33444231|NCT00224055|62819782|FG001|Overall Study|Protocol Violation|1|||
33444232|NCT00224055|62819781|FG000|Overall Study|Inclusion Violation|3|||
33444233|NCT00224055|62819782|FG001|Overall Study|Inclusion Violation|6|||
33444234|NCT00224055|62819781|FG000|Overall Study|Withdrawal by Subject|0|||
33444235|NCT00224055|62819782|FG001|Overall Study|Withdrawal by Subject|2|||
33444236|NCT00224055|62819781|FG000|Overall Study|Other|1|||
33444237|NCT00224055|62819782|FG001|Overall Study|Other|0|||
33444238|NCT00150969|62819790|FG000|24 Month Main Study|Adverse Event|3|||
33444239|NCT00150969|62819791|FG001|24 Month Main Study|Adverse Event|4|||
33444240|NCT00150969|62819790|FG000|24 Month Main Study|Death|1|||
33444241|NCT00150969|62819791|FG001|24 Month Main Study|Death|1|||
33444242|NCT00150969|62819790|FG000|24 Month Main Study|Lack of Efficacy|1|||
33444243|NCT00150969|62819791|FG001|24 Month Main Study|Lack of Efficacy|8|||
33444244|NCT00150969|62819790|FG000|24 Month Main Study|Lost to Follow-up|3|||
33444245|NCT00150969|62819791|FG001|24 Month Main Study|Lost to Follow-up|2|||
33444246|NCT00150969|62819790|FG000|24 Month Main Study|Protocol Violation|4|||
33444247|NCT00150969|62819791|FG001|24 Month Main Study|Protocol Violation|2|||
33444248|NCT00150969|62819790|FG000|24 Month Main Study|Withdrawal by Subject|7|||
33444249|NCT00150969|62819791|FG001|24 Month Main Study|Withdrawal by Subject|4|||
33444250|NCT00150969|62819790|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
33444251|NCT00150969|62819791|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
33444252|NCT00150969|62819790|FG000|24-48 Month Extension|Lack of Efficacy|0|||
33444253|NCT00150969|62819791|FG001|24-48 Month Extension|Lack of Efficacy|1|||
33444254|NCT00150969|62819790|FG000|24-48 Month Extension|Adverse Event|1|||
33444255|NCT00150969|62819791|FG001|24-48 Month Extension|Adverse Event|3|||
33444256|NCT00150969|62819790|FG000|24-48 Month Extension|Other Reason|81|||
33444257|NCT00150969|62819791|FG001|24-48 Month Extension|Other Reason|91|||
33444258|NCT00150345|62819800|FG000|Overall Study|Death|5|||
33444259|NCT00150345|62819801|FG001|Overall Study|Death|2|||
33444260|NCT00150345|62819800|FG000|Overall Study|Adverse Event|8|||
33444261|NCT00150345|62819801|FG001|Overall Study|Adverse Event|6|||
33494242|NCT02873936|62873016|FG000|Overall Study|Lost to Follow-up|1|||
33444262|NCT00150345|62819800|FG000|Overall Study|Lack of Efficacy|5|||
33444263|NCT00150345|62819801|FG001|Overall Study|Lack of Efficacy|4|||
33444264|NCT00150345|62819800|FG000|Overall Study|Withdrawal by Subject|3|||
33444265|NCT00150345|62819801|FG001|Overall Study|Withdrawal by Subject|4|||
33444266|NCT00150345|62819800|FG000|Overall Study|Laboratory abnormality|1|||
33444267|NCT00150345|62819801|FG001|Overall Study|Laboratory abnormality|2|||
33444268|NCT00150345|62819800|FG000|Overall Study|Other|12|||
33444269|NCT00150345|62819801|FG001|Overall Study|Other|14|||
33444270|NCT00223977|62819811|FG000|Overall Study|Adverse Event|7|||
33444271|NCT00223977|62819812|FG001|Overall Study|Adverse Event|10|||
33444272|NCT00223977|62819813|FG002|Overall Study|Adverse Event|0|||
33444273|NCT00223977|62819811|FG000|Overall Study|Protocol Violation|0|||
33444274|NCT00223977|62819812|FG001|Overall Study|Protocol Violation|0|||
33444275|NCT00223977|62819813|FG002|Overall Study|Protocol Violation|1|||
33444276|NCT00223977|62819811|FG000|Overall Study|Withdrawal by Subject|1|||
33444277|NCT00223977|62819812|FG001|Overall Study|Withdrawal by Subject|1|||
33444278|NCT00223977|62819813|FG002|Overall Study|Withdrawal by Subject|2|||
33444279|NCT00223977|62819811|FG000|Overall Study|Other|1|||
33444280|NCT00223977|62819812|FG001|Overall Study|Other|0|||
33444281|NCT00223977|62819813|FG002|Overall Study|Other|0|||
33444282|NCT00148941|62819825|FG000|Overall Study|Lost to Follow-up|17|||
33444283|NCT00148941|62819826|FG001|Overall Study|Lost to Follow-up|24|||
33444284|NCT00148941|62819827|FG002|Overall Study|Lost to Follow-up|18|||
33444285|NCT00148941|62819828|FG003|Overall Study|Lost to Follow-up|22|||
33444286|NCT00148941|62819825|FG000|Overall Study|Withdrawal by Subject|1|||
33444287|NCT00148941|62819826|FG001|Overall Study|Withdrawal by Subject|0|||
33444288|NCT00148941|62819827|FG002|Overall Study|Withdrawal by Subject|1|||
33444289|NCT00148941|62819828|FG003|Overall Study|Withdrawal by Subject|0|||
33444290|NCT00148941|62819825|FG000|Overall Study|Other|0|||
33444291|NCT00148941|62819826|FG001|Overall Study|Other|0|||
33444292|NCT00148941|62819827|FG002|Overall Study|Other|1|||
33444293|NCT00148941|62819828|FG003|Overall Study|Other|2|||
33444294|NCT00148317|62819838|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
33444295|NCT00148317|62819838|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
33444296|NCT00148317|62819838|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
33444297|NCT00323882|62819850|FG000|Overall Study|Adverse Event|2|||
33444298|NCT00323882|62819851|FG001|Overall Study|Adverse Event|1|||
33444299|NCT00323882|62819852|FG002|Overall Study|Adverse Event|1|||
33444300|NCT00323882|62819853|FG003|Overall Study|Adverse Event|1|||
33444301|NCT00323882|62819854|FG004|Overall Study|Adverse Event|3|||
33444302|NCT00323882|62819850|FG000|Overall Study|Disease Progression|6|||
33444303|NCT00323882|62819851|FG001|Overall Study|Disease Progression|4|||
33444304|NCT00323882|62819852|FG002|Overall Study|Disease Progression|10|||
33444305|NCT00323882|62819853|FG003|Overall Study|Disease Progression|5|||
33444306|NCT00323882|62819854|FG004|Overall Study|Disease Progression|22|||
33444307|NCT00323882|62819850|FG000|Overall Study|Death|0|||
33606873|NCT01781572|63007005|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
33606874|NCT01781572|63007003|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
33606875|NCT01781572|63007004|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
33606876|NCT01781572|63007005|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
33606877|NCT01781572|63007003|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
33606878|NCT01781572|63007004|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
33606879|NCT01781572|63007005|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
33606880|NCT01781572|63007003|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
33606881|NCT01781572|63007004|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
33606882|NCT01781572|63007005|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
33606883|NCT01781572|63007003|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
33606884|NCT01781572|63007004|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
33606885|NCT01781572|63007005|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
33606886|NCT01781572|63007003|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
33606887|NCT01781572|63007004|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
33606888|NCT01781572|63007005|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
33606889|NCT01977651|63007034|FG000|4 Month Treatment Period|Adverse Event|34|||
33606890|NCT01977651|63007034|FG000|4 Month Treatment Period|Death|3|||
33606891|NCT01977651|63007034|FG000|4 Month Treatment Period|Progressive Disease|43|||
33606892|NCT01977651|63007034|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
33606893|NCT01977651|63007034|FG000|4 Month Treatment Period|Physician Decision|4|||
33606894|NCT01977651|63007034|FG000|1 Year Extension Period|Adverse Event|14|||
33606895|NCT01977651|63007034|FG000|1 Year Extension Period|Death|10|||
33606896|NCT01977651|63007034|FG000|1 Year Extension Period|Lost to Follow-up|2|||
33606897|NCT01977651|63007034|FG000|1 Year Extension Period|Progressive Disease|86|||
33606898|NCT01977651|63007034|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
33606899|NCT01977651|63007034|FG000|1 Year Extension Period|Physician Decision|6|||
33606900|NCT01977651|63007034|FG000|1 Year Extension Period|Miscellaneous|1|||
33606901|NCT01977651|63007034|FG000|Post 1 Year Extension Period|Adverse Event|5|||
33606902|NCT01977651|63007034|FG000|Post 1 Year Extension Period|Death|13|||
33606903|NCT01977651|63007034|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
33606904|NCT01977651|63007034|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
33606905|NCT01977651|63007034|FG000|Post 1 Year Extension Period|Physician Decision|4|||
33444308|NCT00323882|62819851|FG001|Overall Study|Death|1|||
33606906|NCT01977651|63007034|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
33606907|NCT01998243|63007040|FG000|Overall Study|Pregnancy|0|||
33606908|NCT01998243|63007041|FG001|Overall Study|Pregnancy|1|||
33444309|NCT00323882|62819852|FG002|Overall Study|Death|1|||
33444310|NCT00323882|62819853|FG003|Overall Study|Death|0|||
33444311|NCT00323882|62819854|FG004|Overall Study|Death|5|||
33606909|NCT01998243|63007040|FG000|Overall Study|Protocol Violation|5|||
33444312|NCT00323882|62819850|FG000|Overall Study|Lost to Follow-up|0|||
33444313|NCT00323882|62819851|FG001|Overall Study|Lost to Follow-up|0|||
33444314|NCT00323882|62819852|FG002|Overall Study|Lost to Follow-up|1|||
33444315|NCT00323882|62819853|FG003|Overall Study|Lost to Follow-up|0|||
33606910|NCT01998243|63007041|FG001|Overall Study|Protocol Violation|2|||
33606911|NCT01998243|63007040|FG000|Overall Study|Withdrawal by Subject|3|||
33606912|NCT01998243|63007041|FG001|Overall Study|Withdrawal by Subject|4|||
33606913|NCT01977573|63007053|FG000|Overall Study|Adverse Event|7|||
33606914|NCT01977573|63007054|FG001|Overall Study|Adverse Event|0|||
33606915|NCT01977573|63007055|FG002|Overall Study|Adverse Event|2|||
33444316|NCT00323882|62819854|FG004|Overall Study|Lost to Follow-up|1|||
33444317|NCT00323882|62819850|FG000|Overall Study|Other|0|||
33444318|NCT00323882|62819851|FG001|Overall Study|Other|0|||
33444319|NCT00323882|62819852|FG002|Overall Study|Other|0|||
33444320|NCT00323882|62819853|FG003|Overall Study|Other|1|||
33444321|NCT00323882|62819854|FG004|Overall Study|Other|1|||
33444322|NCT00331682|62819875|FG000|Overall Study|Adverse Event|1|||
33444323|NCT00323492|62819881|FG000|Study Phase 1|Adverse Event|2|||
33444324|NCT00323492|62819882|FG001|Study Phase 1|Adverse Event|0|||
33444325|NCT00323492|62819883|FG002|Study Phase 1|Adverse Event|0|||
33444326|NCT00323492|62819881|FG000|Study Phase 2|Adverse Event|1|||
33444327|NCT00323492|62819882|FG001|Study Phase 2|Adverse Event|0|||
33444328|NCT00323492|62819883|FG002|Study Phase 2|Adverse Event|0|||
33444329|NCT00323492|62819881|FG000|Study Phase 2|Physician Decision|1|||
33444330|NCT00323492|62819882|FG001|Study Phase 2|Physician Decision|0|||
33606916|NCT01977573|63007056|FG003|Overall Study|Adverse Event|1|||
33606917|NCT01977573|63007053|FG000|Overall Study|Lost to Follow-up|1|||
33606918|NCT01977573|63007054|FG001|Overall Study|Lost to Follow-up|0|||
33606919|NCT01977573|63007055|FG002|Overall Study|Lost to Follow-up|0|||
33606920|NCT01977573|63007056|FG003|Overall Study|Lost to Follow-up|1|||
33606921|NCT01977573|63007053|FG000|Overall Study|Physician Decision|1|||
33606922|NCT01977573|63007054|FG001|Overall Study|Physician Decision|0|||
33606923|NCT01977573|63007055|FG002|Overall Study|Physician Decision|0|||
33606924|NCT01977573|63007056|FG003|Overall Study|Physician Decision|0|||
33606925|NCT01977573|63007053|FG000|Overall Study|Protocol Violation|3|||
33606926|NCT01977573|63007054|FG001|Overall Study|Protocol Violation|1|||
33606927|NCT01977573|63007055|FG002|Overall Study|Protocol Violation|0|||
33606928|NCT01977573|63007056|FG003|Overall Study|Protocol Violation|0|||
33606929|NCT01977573|63007053|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
33606930|NCT01977573|63007054|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
33606931|NCT01977573|63007055|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
33444331|NCT00323492|62819883|FG002|Study Phase 2|Physician Decision|0|||
33444332|NCT00323492|62819881|FG000|Study Phase 2|Lost to Follow-up|1|||
33444333|NCT00323492|62819882|FG001|Study Phase 2|Lost to Follow-up|0|||
33444334|NCT00323492|62819883|FG002|Study Phase 2|Lost to Follow-up|0|||
33444335|NCT00323492|62819881|FG000|Study Phase 2|Withdrawal by Subject|0|||
33444336|NCT00323492|62819882|FG001|Study Phase 2|Withdrawal by Subject|1|||
33444337|NCT00323492|62819883|FG002|Study Phase 2|Withdrawal by Subject|0|||
33444338|NCT00323492|62819881|FG000|Study Phase 2|Noncompliance with study schedule|0|||
33444339|NCT00323492|62819882|FG001|Study Phase 2|Noncompliance with study schedule|0|||
33444340|NCT00323492|62819883|FG002|Study Phase 2|Noncompliance with study schedule|1|||
33444341|NCT00323492|62819881|FG000|Study Phase 2|Protocol Violation|1|||
33444342|NCT00323492|62819882|FG001|Study Phase 2|Protocol Violation|0|||
33444343|NCT00323492|62819883|FG002|Study Phase 2|Protocol Violation|0|||
33444344|NCT00331136|62819894|FG000|Overall Study|Adverse Event|3|||
33444345|NCT00331136|62819895|FG001|Overall Study|Adverse Event|5|||
33444346|NCT00331136|62819896|FG002|Overall Study|Adverse Event|0|||
33444347|NCT00331136|62819897|FG003|Overall Study|Adverse Event|1|||
33444348|NCT00331136|62819894|FG000|Overall Study|Withdrawal by Subject|0|||
33444349|NCT00331136|62819895|FG001|Overall Study|Withdrawal by Subject|1|||
33444350|NCT00331136|62819896|FG002|Overall Study|Withdrawal by Subject|0|||
33444351|NCT00331136|62819897|FG003|Overall Study|Withdrawal by Subject|0|||
33444352|NCT00331136|62819894|FG000|Overall Study|Lost to Follow-up|0|||
33444353|NCT00331136|62819895|FG001|Overall Study|Lost to Follow-up|1|||
33444354|NCT00331136|62819896|FG002|Overall Study|Lost to Follow-up|0|||
33444355|NCT00331136|62819897|FG003|Overall Study|Lost to Follow-up|0|||
33444356|NCT00331136|62819894|FG000|Overall Study|Protocol Violation|1|||
33606932|NCT01977573|63007056|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
33606933|NCT01977573|63007053|FG000|Overall Study|Withdrawal by Subject|6|||
33606934|NCT01977573|63007054|FG001|Overall Study|Withdrawal by Subject|1|||
33444357|NCT00331136|62819895|FG001|Overall Study|Protocol Violation|0|||
33444358|NCT00331136|62819896|FG002|Overall Study|Protocol Violation|0|||
33444359|NCT00331136|62819897|FG003|Overall Study|Protocol Violation|0|||
33444360|NCT00331136|62819894|FG000|Overall Study|Not treated|1|||
33444361|NCT00331136|62819895|FG001|Overall Study|Not treated|0|||
33444362|NCT00331136|62819896|FG002|Overall Study|Not treated|0|||
33444363|NCT00331136|62819897|FG003|Overall Study|Not treated|0|||
33444364|NCT00323414|62819909|FG000|Overall Study|Withdrawal by Subject|0|||
33606935|NCT01977573|63007055|FG002|Overall Study|Withdrawal by Subject|1|||
33606936|NCT01977573|63007056|FG003|Overall Study|Withdrawal by Subject|1|||
33606937|NCT01963767|63007069|FG000|Overall Study|Withdrawal by Subject|4|||
33444365|NCT00323414|62819910|FG001|Overall Study|Withdrawal by Subject|1|||
33606938|NCT01963767|63007070|FG001|Overall Study|Withdrawal by Subject|2|||
33606939|NCT01963767|63007069|FG000|Overall Study|Adverse Event|2|||
33606940|NCT01963767|63007070|FG001|Overall Study|Adverse Event|0|||
33606941|NCT01761292|63007079|FG000|Part 1|Adverse Event|1|||
33606942|NCT01761292|63007079|FG000|Part 1|not receiving treatment in Part 1|1|||
33606943|NCT01761292|63007079|FG000|Extension 1|Withdrawal by Subject|1|||
33606944|NCT01731886|63007092|FG000|Overall Study|Death|1|||
33606945|NCT01731886|63007093|FG001|Overall Study|Death|0|||
33606946|NCT01731886|63007092|FG000|Overall Study|Never started treatment|0|||
33444366|NCT00330668|62819916|FG000|BID Dosing Period|Adverse Event|1|||
33444367|NCT00330668|62819916|FG000|BID Dosing Period|Lost to Follow-up|7|||
33444368|NCT00330668|62819916|FG000|BID Dosing Period|Non-Compliance|5|||
33444369|NCT00330668|62819916|FG000|BID Dosing Period|Withdrawal by Subject|19|||
33444370|NCT00330668|62819916|FG000|BID Dosing Period|Sponsor's decision|1|||
33444371|NCT00330668|62819916|FG000|BID Dosing Period|Other|3|||
33444372|NCT00330668|62819916|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
33444373|NCT00330668|62819916|FG000|QD Dosing Period|Other|1|||
33444374|NCT00330668|62819916|FG000|QD Dosing Period|Withdrawal by Subject|1|||
33444375|NCT00330668|62819916|FG000|QD Dosing Period|Lost to Follow-up|2|||
33444376|NCT00306384|62819923|FG000|Overall Study|Adverse Event|103|||
33444377|NCT00306384|62819924|FG001|Overall Study|Adverse Event|87|||
33606947|NCT01731886|63007093|FG001|Overall Study|Never started treatment|1|||
33606948|NCT01731886|63007092|FG000|Overall Study|Non-compliant|1|||
33323389|NCT00925132|62699671|FG003|Overall Study|Removed due to disease progression|0|||
33323390|NCT00925132|62699672|FG004|Overall Study|Removed due to disease progression|4|||
33323391|NCT01143402|62699681|FG000|Overall Study|Rapid clinical decline|1|||
33323392|NCT01143402|62699682|FG001|Overall Study|Rapid clinical decline|1|||
33323393|NCT01143402|62699683|FG002|Overall Study|Rapid clinical decline|0|||
33323394|NCT01143402|62699681|FG000|Overall Study|Not Treated|0|||
33323395|NCT01143402|62699682|FG001|Overall Study|Not Treated|0|||
33606949|NCT01731886|63007093|FG001|Overall Study|Non-compliant|0|||
33323396|NCT01143402|62699683|FG002|Overall Study|Not Treated|1|||
33606950|NCT01759420|63007100|FG000|Overall Study|Screen failure|5|||
33323397|NCT01171625|62699690|FG000|Overall Study|On-Protocol|67|||
33323398|NCT01171625|62699690|FG000|Overall Study|Death|38|||
33323399|NCT01171625|62699690|FG000|Overall Study|Withdrawal by Subject|31|||
33323400|NCT01171625|62699690|FG000|Overall Study|Explanted|10|||
33444378|NCT00306384|62819925|FG002|Overall Study|Adverse Event|40|||
33444379|NCT00306384|62819923|FG000|Overall Study|Major protocol deviation|43|||
33444380|NCT00306384|62819924|FG001|Overall Study|Major protocol deviation|51|||
33606951|NCT01759420|63007100|FG000|Overall Study|Inaccurate EKG machine readings|1|||
33444381|NCT00306384|62819925|FG002|Overall Study|Major protocol deviation|18|||
33444382|NCT00306384|62819923|FG000|Overall Study|Lost to Follow-up|57|||
33444383|NCT00306384|62819924|FG001|Overall Study|Lost to Follow-up|41|||
33444384|NCT00306384|62819925|FG002|Overall Study|Lost to Follow-up|35|||
33444385|NCT00306384|62819923|FG000|Overall Study|Voluntary withdrawal|199|||
33444386|NCT00306384|62819924|FG001|Overall Study|Voluntary withdrawal|187|||
33444387|NCT00306384|62819925|FG002|Overall Study|Voluntary withdrawal|91|||
33444388|NCT00306384|62819923|FG000|Overall Study|Study termination|1|||
33444389|NCT00306384|62819924|FG001|Overall Study|Study termination|0|||
33444390|NCT00306384|62819925|FG002|Overall Study|Study termination|1|||
33444391|NCT00306384|62819923|FG000|Overall Study|Pregnancy|3|||
33444392|NCT00306384|62819924|FG001|Overall Study|Pregnancy|1|||
33444393|NCT00306384|62819925|FG002|Overall Study|Pregnancy|1|||
33444394|NCT00306384|62819923|FG000|Overall Study|Lack of Efficacy|26|||
33444395|NCT00306384|62819924|FG001|Overall Study|Lack of Efficacy|40|||
33444396|NCT00306384|62819925|FG002|Overall Study|Lack of Efficacy|38|||
33444397|NCT00306384|62819923|FG000|Overall Study|Investigator discretion|28|||
33444398|NCT00306384|62819924|FG001|Overall Study|Investigator discretion|31|||
33444399|NCT00306384|62819925|FG002|Overall Study|Investigator discretion|21|||
33444400|NCT00306384|62819923|FG000|Overall Study|Other|80|||
33444401|NCT00306384|62819924|FG001|Overall Study|Other|70|||
33444402|NCT00306384|62819925|FG002|Overall Study|Other|32|||
33444403|NCT00306384|62819923|FG000|Overall Study|Site closure|2|||
33444404|NCT00306384|62819924|FG001|Overall Study|Site closure|0|||
33444405|NCT00306384|62819925|FG002|Overall Study|Site closure|0|||
33444406|NCT00305604|62819935|FG000|Overall Study|Adverse Event|6|||
33444407|NCT00305604|62819936|FG001|Overall Study|Adverse Event|3|||
33444408|NCT00305604|62819935|FG000|Overall Study|Lack of Efficacy|11|||
33444409|NCT00305604|62819936|FG001|Overall Study|Lack of Efficacy|18|||
33444410|NCT00305604|62819935|FG000|Overall Study|Lost to Follow-up|0|||
33444411|NCT00305604|62819936|FG001|Overall Study|Lost to Follow-up|4|||
33444412|NCT00305604|62819935|FG000|Overall Study|Protocol Violation|2|||
33444413|NCT00305604|62819936|FG001|Overall Study|Protocol Violation|1|||
33444414|NCT00305604|62819935|FG000|Overall Study|Withdrawal by Subject|12|||
33444415|NCT00305604|62819936|FG001|Overall Study|Withdrawal by Subject|21|||
33444416|NCT00305604|62819935|FG000|Overall Study|Patient moved|1|||
33444417|NCT00305604|62819936|FG001|Overall Study|Patient moved|0|||
33444418|NCT00501059|62819944|FG000|Overall Study|Protocol Violation|80|||
33444419|NCT00501059|62819945|FG001|Overall Study|Protocol Violation|69|||
33444420|NCT00501059|62819944|FG000|Overall Study|Death|140|||
33444421|NCT00501059|62819945|FG001|Overall Study|Death|137|||
33444422|NCT00501059|62819944|FG000|Overall Study|Other|236|||
33444423|NCT00501059|62819945|FG001|Overall Study|Other|239|||
33444424|NCT00501059|62819944|FG000|Overall Study|Missing end-of-study page|91|||
33444425|NCT00501059|62819945|FG001|Overall Study|Missing end-of-study page|92|||
33444426|NCT00501059|62819944|FG000|Overall Study|Clinical endpoint reached|110|||
33444427|NCT00501059|62819945|FG001|Overall Study|Clinical endpoint reached|123|||
33444428|NCT00501059|62819944|FG000|Overall Study|Insufficient therapeutic effect|4|||
33444429|NCT00501059|62819945|FG001|Overall Study|Insufficient therapeutic effect|5|||
33444430|NCT00501059|62819944|FG000|Overall Study|Consent withdrawn by subject|817|||
33444431|NCT00501059|62819945|FG001|Overall Study|Consent withdrawn by subject|873|||
33444432|NCT00501059|62819944|FG000|Overall Study|Non-compliant with study treatment|23|||
33444433|NCT00501059|62819945|FG001|Overall Study|Non-compliant with study treatment|16|||
33444434|NCT00501059|62819944|FG000|Overall Study|Reason not given|3|||
33444435|NCT00501059|62819945|FG001|Overall Study|Reason not given|1|||
33444436|NCT00501059|62819944|FG000|Overall Study|Adverse Event|129|||
33444437|NCT00501059|62819945|FG001|Overall Study|Adverse Event|122|||
33444438|NCT00501059|62819944|FG000|Overall Study|Lost to Follow-up|210|||
33444439|NCT00501059|62819945|FG001|Overall Study|Lost to Follow-up|198|||
33444440|NCT00501059|62819944|FG000|Overall Study|Not treated|25|||
33444441|NCT00501059|62819945|FG001|Overall Study|Not treated|17|||
33444442|NCT00344318|62819957|FG000|Overall Study|Adverse Event|0|||
33444443|NCT00344318|62819958|FG001|Overall Study|Adverse Event|3|||
33444444|NCT00344318|62819959|FG002|Overall Study|Adverse Event|0|||
33444445|NCT00344318|62819960|FG003|Overall Study|Adverse Event|1|||
33444446|NCT00344318|62819957|FG000|Overall Study|Withdrawal by Subject|2|||
33444447|NCT00344318|62819958|FG001|Overall Study|Withdrawal by Subject|2|||
33444448|NCT00344318|62819959|FG002|Overall Study|Withdrawal by Subject|0|||
33444449|NCT00344318|62819960|FG003|Overall Study|Withdrawal by Subject|2|||
33444450|NCT00344318|62819957|FG000|Overall Study|Lost to Follow-up|2|||
33444451|NCT00344318|62819958|FG001|Overall Study|Lost to Follow-up|0|||
33444452|NCT00344318|62819959|FG002|Overall Study|Lost to Follow-up|1|||
33444453|NCT00344318|62819960|FG003|Overall Study|Lost to Follow-up|0|||
33444454|NCT00323258|62819974|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
33444455|NCT00323258|62819975|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
33444456|NCT00323258|62819974|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
33444457|NCT00323258|62819975|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
33444458|NCT00323258|62819974|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
33444459|NCT00323258|62819975|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
33444460|NCT00323258|62819974|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
33444461|NCT00323258|62819975|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
33444462|NCT00323258|62819974|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
33444463|NCT00323258|62819975|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
33444464|NCT00323258|62819974|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
33444465|NCT00323258|62819975|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
33444466|NCT00323258|62819974|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
33444467|NCT00323258|62819975|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
33444468|NCT00322868|62819981|FG000|Overall Study|disease progression|1|||
33444469|NCT00322712|62819986|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
33444470|NCT00343382|62819993|FG000|Overall Study|Adverse Event|2|||
33444471|NCT00343382|62819994|FG001|Overall Study|Adverse Event|10|||
33444472|NCT00343382|62819995|FG002|Overall Study|Adverse Event|7|||
33444473|NCT00343382|62819993|FG000|Overall Study|Withdrawal by Subject|1|||
33444474|NCT00343382|62819994|FG001|Overall Study|Withdrawal by Subject|2|||
33444475|NCT00343382|62819995|FG002|Overall Study|Withdrawal by Subject|6|||
33444476|NCT00343382|62819993|FG000|Overall Study|Other Reason Not Specified|1|||
33444477|NCT00343382|62819994|FG001|Overall Study|Other Reason Not Specified|2|||
33444478|NCT00343382|62819995|FG002|Overall Study|Other Reason Not Specified|4|||
33444479|NCT00481871|62820008|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
33444480|NCT00481871|62820009|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
33444481|NCT00481871|62820010|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
33444482|NCT00481871|62820011|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
33444483|NCT00481871|62820012|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
33444484|NCT00329420|62820023|FG000|Re-induction Phase|Lack of Efficacy|0|||
33444485|NCT00329420|62820024|FG001|Re-induction Phase|Lack of Efficacy|1|||
33444486|NCT00329420|62820025|FG002|Re-induction Phase|Lack of Efficacy|0|||
33444487|NCT00329420|62820023|FG000|Re-induction Phase|Withdrawal of Consent|0|||
33444488|NCT00329420|62820024|FG001|Re-induction Phase|Withdrawal of Consent|0|||
33444489|NCT00329420|62820025|FG002|Re-induction Phase|Withdrawal of Consent|1|||
33444490|NCT00329420|62820023|FG000|Re-induction Phase|Did not respond to re-induction|6|||
33444491|NCT00329420|62820024|FG001|Re-induction Phase|Did not respond to re-induction|5|||
33444492|NCT00329420|62820025|FG002|Re-induction Phase|Did not respond to re-induction|7|||
33444493|NCT00329420|62820023|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
33444494|NCT00329420|62820024|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
33444495|NCT00329420|62820025|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
33444496|NCT00329420|62820023|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
33444497|NCT00329420|62820024|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
33444498|NCT00329420|62820025|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
33444499|NCT00329420|62820023|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
33444500|NCT00329420|62820024|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
33444501|NCT00329420|62820025|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
33444502|NCT00329108|62820037|FG000|Overall Study|Adverse Event|2|||
33444503|NCT00329108|62820038|FG001|Overall Study|Adverse Event|2|||
33444504|NCT00329108|62820037|FG000|Overall Study|Lack of Efficacy|3|||
33444505|NCT00329108|62820038|FG001|Overall Study|Lack of Efficacy|3|||
33444506|NCT00329108|62820037|FG000|Overall Study|Withdrawal by Subject|0|||
33444507|NCT00329108|62820038|FG001|Overall Study|Withdrawal by Subject|2|||
33444508|NCT00329108|62820037|FG000|Overall Study|symptomatic deterioration|1|||
33444509|NCT00329108|62820038|FG001|Overall Study|symptomatic deterioration|1|||
33444510|NCT00329108|62820037|FG000|Overall Study|Subject no longer willing to participate|2|||
33444511|NCT00329108|62820038|FG001|Overall Study|Subject no longer willing to participate|2|||
33444512|NCT00329108|62820037|FG000|Overall Study|study terminated by sponsor|1|||
33444513|NCT00329108|62820038|FG001|Overall Study|study terminated by sponsor|0|||
33444514|NCT00329108|62820037|FG000|Overall Study|withdrew patient after SAE resolved|1|||
33444515|NCT00329108|62820038|FG001|Overall Study|withdrew patient after SAE resolved|0|||
33444516|NCT00329108|62820037|FG000|Overall Study|Protocol Violation|0|||
33444517|NCT00329108|62820038|FG001|Overall Study|Protocol Violation|2|||
33444518|NCT00329030|62820046|FG000|Overall Study|Withdrawal by Subject|1|||
33444519|NCT00329030|62820047|FG001|Overall Study|Withdrawal by Subject|3|||
33444520|NCT00329030|62820046|FG000|Overall Study|Progressive Disease|6|||
33444521|NCT00329030|62820047|FG001|Overall Study|Progressive Disease|2|||
33444522|NCT00329030|62820046|FG000|Overall Study|Ineligible Pathology|1|||
33444523|NCT00329030|62820047|FG001|Overall Study|Ineligible Pathology|1|||
33444524|NCT00328562|62820053|FG000|Overall Study|Disease progression|1|||
33444525|NCT00328172|62820062|FG000|Overall Study|Adverse Event|3|||
33444526|NCT00328172|62820063|FG001|Overall Study|Adverse Event|2|||
33444527|NCT00328172|62820064|FG002|Overall Study|Adverse Event|1|||
33444528|NCT00328172|62820065|FG003|Overall Study|Adverse Event|2|||
33444529|NCT00328172|62820066|FG004|Overall Study|Adverse Event|1|||
33444530|NCT00328172|62820062|FG000|Overall Study|Protocol Violation|0|||
33444531|NCT00328172|62820063|FG001|Overall Study|Protocol Violation|1|||
33444532|NCT00328172|62820064|FG002|Overall Study|Protocol Violation|1|||
33444533|NCT00328172|62820065|FG003|Overall Study|Protocol Violation|0|||
33444534|NCT00328172|62820066|FG004|Overall Study|Protocol Violation|0|||
33444535|NCT00328172|62820062|FG000|Overall Study|Lost to Follow-up|1|||
33444536|NCT00328172|62820063|FG001|Overall Study|Lost to Follow-up|1|||
33444537|NCT00328172|62820064|FG002|Overall Study|Lost to Follow-up|2|||
33444538|NCT00328172|62820065|FG003|Overall Study|Lost to Follow-up|1|||
33444539|NCT00328172|62820066|FG004|Overall Study|Lost to Follow-up|1|||
33444540|NCT00328172|62820062|FG000|Overall Study|Withdrawal by Subject|1|||
33444541|NCT00328172|62820063|FG001|Overall Study|Withdrawal by Subject|1|||
33444542|NCT00328172|62820064|FG002|Overall Study|Withdrawal by Subject|1|||
33444543|NCT00328172|62820065|FG003|Overall Study|Withdrawal by Subject|6|||
33444544|NCT00328172|62820066|FG004|Overall Study|Withdrawal by Subject|0|||
33444545|NCT00328172|62820062|FG000|Overall Study|Lack of Efficacy|14|||
33444546|NCT00328172|62820063|FG001|Overall Study|Lack of Efficacy|9|||
33444547|NCT00328172|62820064|FG002|Overall Study|Lack of Efficacy|4|||
33444548|NCT00328172|62820065|FG003|Overall Study|Lack of Efficacy|4|||
33444549|NCT00328172|62820066|FG004|Overall Study|Lack of Efficacy|3|||
33444550|NCT00328172|62820062|FG000|Overall Study|Other reason (not specified)|3|||
33444551|NCT00328172|62820063|FG001|Overall Study|Other reason (not specified)|0|||
33444552|NCT00328172|62820064|FG002|Overall Study|Other reason (not specified)|1|||
33444553|NCT00328172|62820065|FG003|Overall Study|Other reason (not specified)|0|||
33444554|NCT00328172|62820066|FG004|Overall Study|Other reason (not specified)|0|||
33444555|NCT00328094|62820080|FG000|Overall Study|Physician Decision|3|||
33444556|NCT00328094|62820081|FG001|Overall Study|Physician Decision|3|||
33444557|NCT00500903|62820090|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
33444558|NCT00500903|62820091|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
33444559|NCT00500903|62820092|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
33444560|NCT00500903|62820090|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
33444561|NCT00500903|62820091|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
33444562|NCT00500903|62820092|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
33444563|NCT00500903|62820090|FG000|Overall Study|Progressive Disease|41|||
33444564|NCT00500903|62820091|FG001|Overall Study|Progressive Disease|2|||
33444565|NCT00500903|62820092|FG002|Overall Study|Progressive Disease|15|||
33444566|NCT00500903|62820090|FG000|Overall Study|Patient Declined Further Treatment|0|||
33444567|NCT00500903|62820091|FG001|Overall Study|Patient Declined Further Treatment|0|||
33444568|NCT00500903|62820092|FG002|Overall Study|Patient Declined Further Treatment|3|||
33444569|NCT00500903|62820090|FG000|Overall Study|Symptomatic Deterioration|2|||
33444570|NCT00500903|62820091|FG001|Overall Study|Symptomatic Deterioration|0|||
33444571|NCT00500903|62820092|FG002|Overall Study|Symptomatic Deterioration|0|||
33444572|NCT00500903|62820090|FG000|Overall Study|Reason Not Specified|10|||
33444573|NCT00500903|62820091|FG001|Overall Study|Reason Not Specified|0|||
33323401|NCT01171625|62699690|FG000|Overall Study|Lost to Follow-up|5|||
33444574|NCT00500903|62820092|FG002|Overall Study|Reason Not Specified|2|||
33444575|NCT00295932|62820141|FG000|Overall Study|Not Treated|0|||
33323402|NCT01171625|62699690|FG000|Overall Study|Patient received valve-in-valve|3|||
33323403|NCT01171625|62699690|FG000|Overall Study|Other|1|||
33323404|NCT01171625|62699690|FG000|Overall Study|Consented but did not receive device|25|||
33323405|NCT00924898|62699702|FG000|Overall Study|Withdrawal by Subject|2|||
33323406|NCT01167192|62699711|FG000|Overall Study|Adverse Event|1|||
33323407|NCT01167192|62699711|FG000|Overall Study|Death|1|||
33323408|NCT01167192|62699711|FG000|Overall Study|Withdrawal by Subject|1|||
33323409|NCT01167192|62699711|FG000|Overall Study|Insurance denial|1|||
33323410|NCT01166958|62699717|FG000|Overall Study|Withdrawal by Subject|1|||
33323411|NCT01166958|62699718|FG001|Overall Study|Withdrawal by Subject|0|||
33323412|NCT01170221|62699726|FG000|Overall Study|Lost to Follow-up|22|||
33323413|NCT01170221|62699727|FG001|Overall Study|Lost to Follow-up|21|||
33323414|NCT01170221|62699726|FG000|Overall Study|Withdrawal by Subject|9|||
33323415|NCT01170221|62699727|FG001|Overall Study|Withdrawal by Subject|7|||
33323416|NCT01170221|62699726|FG000|Overall Study|Subject completed only screening and LFU|1|||
33323417|NCT01170221|62699727|FG001|Overall Study|Subject completed only screening and LFU|0|||
33323418|NCT01170221|62699726|FG000|Overall Study|Randomized but not treated|1|||
33323419|NCT01170221|62699727|FG001|Overall Study|Randomized but not treated|0|||
33323420|NCT01166646|62699735|FG000|Overall Study|Protocol Violation|0|||
33323421|NCT01166646|62699736|FG001|Overall Study|Protocol Violation|1|||
33323422|NCT01166646|62699735|FG000|Overall Study|Adverse Event|1|||
33323423|NCT01166646|62699736|FG001|Overall Study|Adverse Event|0|||
33323424|NCT01129284|62699745|FG000|Overall Study|Adverse Event|2|||
33323425|NCT01129284|62699746|FG001|Overall Study|Adverse Event|0|||
33323426|NCT01129284|62699747|FG002|Overall Study|Adverse Event|1|||
33323427|NCT01166568|62699758|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
33323428|NCT01166568|62699759|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
33323429|NCT01166568|62699760|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
33323430|NCT01166568|62699758|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
33323431|NCT01166568|62699759|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
33323432|NCT01166568|62699760|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
33323433|NCT01166568|62699758|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
33323434|NCT01166568|62699759|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
33323435|NCT01166568|62699760|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
33323436|NCT01166178|62699768|FG000|Overall Study|Withdrawal by Subject|1|||
33323437|NCT01166178|62699769|FG001|Overall Study|Withdrawal by Subject|0|||
33323438|NCT01166178|62699768|FG000|Overall Study|Study was terminated|20|||
33323439|NCT01166178|62699769|FG001|Overall Study|Study was terminated|8|||
33323440|NCT00924820|62699775|FG000|Overall Study|Death|2|||
33323441|NCT00924820|62699775|FG000|Overall Study|Ineligible, Screen Failure|5|||
33323442|NCT01225172|62699781|FG000|Overall Study|Subject decision to stop|1|||
33323443|NCT01225172|62699782|FG001|Overall Study|Subject decision to stop|0|||
33323444|NCT01225172|62699781|FG000|Overall Study|Subject request to discontinue treatment|3|||
33323445|NCT01225172|62699782|FG001|Overall Study|Subject request to discontinue treatment|1|||
33323446|NCT01225172|62699781|FG000|Overall Study|Subject no longer meets study criteria|1|||
33323447|NCT01225172|62699782|FG001|Overall Study|Subject no longer meets study criteria|0|||
33323448|NCT01225172|62699781|FG000|Overall Study|Withdrawal by Subject|1|||
33323449|NCT01225172|62699782|FG001|Overall Study|Withdrawal by Subject|0|||
33323450|NCT01143324|62699788|FG000|Overall Study|Lost to Follow-up|11|||
33323451|NCT01143324|62699788|FG000|Overall Study|Withdrawal by Subject|4|||
33444576|NCT00295932|62820142|FG001|Overall Study|Not Treated|0|||
33444577|NCT00295932|62820143|FG002|Overall Study|Not Treated|0|||
33323452|NCT01143324|62699788|FG000|Overall Study|Explant of the device|4|||
33323453|NCT01224782|62699792|FG000|Overall Study|Lost to Follow-up|177|||
33444578|NCT00295932|62820144|FG003|Overall Study|Not Treated|0|||
33444579|NCT00295932|62820145|FG004|Overall Study|Not Treated|0|||
33444580|NCT00295932|62820146|FG005|Overall Study|Not Treated|0|||
33444581|NCT00295932|62820147|FG006|Overall Study|Not Treated|0|||
33444582|NCT00295932|62820148|FG007|Overall Study|Not Treated|0|||
33444583|NCT00295932|62820149|FG008|Overall Study|Not Treated|0|||
33444584|NCT00295932|62820150|FG009|Overall Study|Not Treated|0|||
33444585|NCT00295932|62820151|FG010|Overall Study|Not Treated|1|||
33323454|NCT01224782|62699792|FG000|Overall Study|Withdrawal by Subject|16|||
33323455|NCT01224782|62699792|FG000|Overall Study|Death|14|||
33323456|NCT01224782|62699792|FG000|Overall Study|Improvement|13|||
33323457|NCT01224782|62699792|FG000|Overall Study|Adverse Event|12|||
33323458|NCT01224782|62699792|FG000|Overall Study|Adverse Reaction|11|||
33323459|NCT01224782|62699792|FG000|Overall Study|Noncompliance|10|||
33323460|NCT01224782|62699792|FG000|Overall Study|Other|4|||
33323461|NCT01224782|62699792|FG000|Overall Study|Start of Dialysis|3|||
33323462|NCT01224782|62699792|FG000|Overall Study|Change of Treatment|1|||
33323463|NCT01224782|62699792|FG000|Overall Study|Financial Reasons|1|||
33323464|NCT01224782|62699792|FG000|Overall Study|Deterioration|1|||
33323465|NCT01224782|62699792|FG000|Overall Study|Transplantation|1|||
33323466|NCT01224158|62699798|FG000|Overall Study|Withdrawal by Subject|1|||
33323467|NCT01224158|62699799|FG001|Overall Study|Withdrawal by Subject|0|||
33323468|NCT01129128|62699808|FG000|Overall Study|Lost to Follow-up|2|||
33323469|NCT01129128|62699809|FG001|Overall Study|Lost to Follow-up|2|||
33323470|NCT01129128|62699810|FG002|Overall Study|Lost to Follow-up|1|||
33323471|NCT01129128|62699808|FG000|Overall Study|Protocol Violation|0|||
33323472|NCT01129128|62699809|FG001|Overall Study|Protocol Violation|1|||
33323473|NCT01129128|62699810|FG002|Overall Study|Protocol Violation|0|||
33323474|NCT01129128|62699808|FG000|Overall Study|Withdrawal by Subject|0|||
33323475|NCT01129128|62699809|FG001|Overall Study|Withdrawal by Subject|1|||
33323476|NCT01129128|62699810|FG002|Overall Study|Withdrawal by Subject|3|||
33323477|NCT01129128|62699808|FG000|Overall Study|Physician Decision|1|||
33444586|NCT00305448|62820180|FG000|Overall Study|Protocol Violation|0|||
33444587|NCT00305448|62820181|FG001|Overall Study|Protocol Violation|1|||
33444588|NCT00305448|62820182|FG002|Overall Study|Protocol Violation|0|||
33444589|NCT00305448|62820180|FG000|Overall Study|Withdrawal by Subject|2|||
33444590|NCT00305448|62820181|FG001|Overall Study|Withdrawal by Subject|0|||
33444591|NCT00305448|62820182|FG002|Overall Study|Withdrawal by Subject|1|||
33444592|NCT00305448|62820180|FG000|Overall Study|Adverse Event|1|||
33444593|NCT00305448|62820181|FG001|Overall Study|Adverse Event|0|||
33444594|NCT00305448|62820182|FG002|Overall Study|Adverse Event|1|||
33444595|NCT00305448|62820180|FG000|Overall Study|Disease Progression|27|||
33444596|NCT00305448|62820181|FG001|Overall Study|Disease Progression|31|||
33444597|NCT00305448|62820182|FG002|Overall Study|Disease Progression|28|||
33444598|NCT00305448|62820180|FG000|Overall Study|Subjective Disease Progression|1|||
33444599|NCT00305448|62820181|FG001|Overall Study|Subjective Disease Progression|2|||
33444600|NCT00305448|62820182|FG002|Overall Study|Subjective Disease Progression|2|||
33444601|NCT00305448|62820180|FG000|Overall Study|Tumor Marker Elevation|0|||
33444602|NCT00305448|62820181|FG001|Overall Study|Tumor Marker Elevation|0|||
33444603|NCT00305448|62820182|FG002|Overall Study|Tumor Marker Elevation|1|||
33444604|NCT00305058|62820193|FG000|Overall Study|Participant too young|1|||
33444605|NCT00305058|62820194|FG001|Overall Study|Participant too young|0|||
33444606|NCT00305058|62820193|FG000|Overall Study|Missing data collection instrument|3|||
33444607|NCT00305058|62820194|FG001|Overall Study|Missing data collection instrument|2|||
33444608|NCT00305058|62820193|FG000|Overall Study|Missing outcome data|3|||
33444609|NCT00305058|62820194|FG001|Overall Study|Missing outcome data|2|||
33444610|NCT00295854|62820203|FG000|Overall Study|Adverse Event|7|||
33444611|NCT00295854|62820204|FG001|Overall Study|Adverse Event|7|||
33323478|NCT01129128|62699809|FG001|Overall Study|Physician Decision|0|||
33444612|NCT00295854|62820205|FG002|Overall Study|Adverse Event|6|||
33444613|NCT00295854|62820203|FG000|Overall Study|Protocol Violation|1|||
33444614|NCT00295854|62820204|FG001|Overall Study|Protocol Violation|1|||
33444615|NCT00295854|62820205|FG002|Overall Study|Protocol Violation|1|||
33444616|NCT00295854|62820203|FG000|Overall Study|Lost to Follow-up|2|||
33444617|NCT00295854|62820204|FG001|Overall Study|Lost to Follow-up|0|||
33444618|NCT00295854|62820205|FG002|Overall Study|Lost to Follow-up|1|||
33444619|NCT00295854|62820203|FG000|Overall Study|Withdrawal by Subject|3|||
33444620|NCT00295854|62820204|FG001|Overall Study|Withdrawal by Subject|7|||
33444621|NCT00295854|62820205|FG002|Overall Study|Withdrawal by Subject|4|||
33444622|NCT00295854|62820203|FG000|Overall Study|did not continue to meet criteria|1|||
33323479|NCT01129128|62699810|FG002|Overall Study|Physician Decision|0|||
33444623|NCT00295854|62820204|FG001|Overall Study|did not continue to meet criteria|1|||
33323480|NCT01222520|62699820|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
33323481|NCT01222520|62699821|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
33323482|NCT01222520|62699820|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
33444624|NCT00295854|62820205|FG002|Overall Study|did not continue to meet criteria|2|||
33444625|NCT00295854|62820203|FG000|Overall Study|required a prohibited medication|1|||
33444626|NCT00295854|62820204|FG001|Overall Study|required a prohibited medication|0|||
33444627|NCT00295854|62820205|FG002|Overall Study|required a prohibited medication|0|||
33444628|NCT00295854|62820203|FG000|Overall Study|Other|3|||
33444629|NCT00295854|62820204|FG001|Overall Study|Other|5|||
33444630|NCT00295854|62820205|FG002|Overall Study|Other|1|||
33444631|NCT00327470|62820215|FG000|Overall Study|Randomized, but not treated|0|||
33444632|NCT00327470|62820216|FG001|Overall Study|Randomized, but not treated|2|||
33444633|NCT00327470|62820215|FG000|Overall Study|Adverse Event|9|||
33444634|NCT00327470|62820216|FG001|Overall Study|Adverse Event|14|||
33444635|NCT00327470|62820215|FG000|Overall Study|Lack of Efficacy|7|||
33444636|NCT00327470|62820216|FG001|Overall Study|Lack of Efficacy|19|||
33444637|NCT00327470|62820215|FG000|Overall Study|Other|5|||
33444638|NCT00327470|62820216|FG001|Overall Study|Other|9|||
33444639|NCT00327470|62820215|FG000|Overall Study|Lost to Follow-up|1|||
33444640|NCT00327470|62820216|FG001|Overall Study|Lost to Follow-up|3|||
33444641|NCT00327470|62820215|FG000|Overall Study|Withdrawal by Subject|6|||
33444642|NCT00327470|62820216|FG001|Overall Study|Withdrawal by Subject|12|||
33444643|NCT00327470|62820215|FG000|Overall Study|Death|1|||
33444644|NCT00327470|62820216|FG001|Overall Study|Death|4|||
33444645|NCT00322556|62820222|FG000|Overall Study|Adverse Event|1|||
33444646|NCT00322556|62820222|FG000|Overall Study|Withdrawal by Subject|1|||
33444647|NCT00322556|62820222|FG000|Overall Study|Lost to Follow-up|3|||
33444648|NCT00322556|62820222|FG000|Overall Study|Other Reason|7|||
33444649|NCT00321932|62820231|FG000|Overall Study|Death|3|||
33444650|NCT00321932|62820232|FG001|Overall Study|Death|6|||
33444651|NCT00321932|62820231|FG000|Overall Study|Withdrawal by Subject|3|||
33444652|NCT00321932|62820232|FG001|Overall Study|Withdrawal by Subject|6|||
33444653|NCT00321932|62820231|FG000|Overall Study|Early relapse|2|||
33444654|NCT00321932|62820232|FG001|Overall Study|Early relapse|8|||
33444655|NCT00321932|62820231|FG000|Overall Study|Missing data|2|||
33444656|NCT00321932|62820232|FG001|Overall Study|Missing data|1|||
33444657|NCT00326612|62820241|FG000|Overall Study|They did not have a seizure requiring tx|129|||
33444658|NCT00326612|62820242|FG001|Overall Study|They did not have a seizure requiring tx|137|||
33444659|NCT00325130|62820254|FG000|Overall Study|Lost to Follow-up|6|||
33444660|NCT00325130|62820255|FG001|Overall Study|Lost to Follow-up|14|||
33444661|NCT00325130|62820254|FG000|Overall Study|Withdrawal by Subject|12|||
33444662|NCT00325130|62820255|FG001|Overall Study|Withdrawal by Subject|14|||
33444663|NCT00325130|62820254|FG000|Overall Study|Protocol Deviation|0|||
33444664|NCT00325130|62820255|FG001|Overall Study|Protocol Deviation|1|||
33444665|NCT00325130|62820254|FG000|Overall Study|Moved|0|||
33444666|NCT00325130|62820255|FG001|Overall Study|Moved|1|||
33444667|NCT00325130|62820254|FG000|Overall Study|Patient Discontinued for Other|1|||
33444668|NCT00325130|62820255|FG001|Overall Study|Patient Discontinued for Other|0|||
33444669|NCT00321854|62820263|FG000|Overall Study|Adverse Event|41|||
33444670|NCT00321854|62820264|FG001|Overall Study|Adverse Event|43|||
33444671|NCT00321854|62820263|FG000|Overall Study|Lack of Efficacy|9|||
33444672|NCT00321854|62820264|FG001|Overall Study|Lack of Efficacy|14|||
33444673|NCT00321854|62820263|FG000|Overall Study|Protocol Violation|6|||
33444674|NCT00321854|62820264|FG001|Overall Study|Protocol Violation|5|||
33444675|NCT00321854|62820263|FG000|Overall Study|Lost to Follow-up|0|||
33444676|NCT00321854|62820264|FG001|Overall Study|Lost to Follow-up|2|||
33444677|NCT00321854|62820263|FG000|Overall Study|Withdrawal by Subject|6|||
33444678|NCT00321854|62820264|FG001|Overall Study|Withdrawal by Subject|17|||
33606952|NCT01781026|63007104|FG000|Overall Study|Lack of Efficacy|2|||
33606953|NCT01607398|63007110|FG000|Overall Study|Adverse Event|0|||
33606954|NCT01607398|63007111|FG001|Overall Study|Adverse Event|2|||
33606955|NCT01607398|63007110|FG000|Overall Study|Severe COPD|2|||
33606956|NCT01607398|63007111|FG001|Overall Study|Severe COPD|0|||
33606957|NCT01779856|63007117|FG000|Overall Study|Withdrawal by Subject|15|||
33606958|NCT01779856|63007117|FG000|Overall Study|Death|3|||
33606959|NCT01779856|63007117|FG000|Overall Study|Physician Decision|1|||
33606960|NCT01779856|63007117|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
33606961|NCT01779856|63007117|FG000|Overall Study|Delays in scheduling implant|1|||
33606962|NCT01779856|63007117|FG000|Overall Study|Subject ineligible for Implant|2|||
33606963|NCT01729156|63007131|FG000|Overall Study|Withdrawal by Subject|1|||
33606964|NCT01729156|63007132|FG001|Overall Study|Withdrawal by Subject|0|||
33444679|NCT00321854|62820263|FG000|Overall Study|Other|1|||
33444680|NCT00321854|62820264|FG001|Overall Study|Other|1|||
33444681|NCT00310388|62820272|FG000|Primary Reporting Phase|Adverse Event|101|||
33444682|NCT00310388|62820273|FG001|Primary Reporting Phase|Adverse Event|0|||
33444683|NCT00310388|62820272|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
33606965|NCT01729156|63007133|FG002|Overall Study|Withdrawal by Subject|0|||
33444684|NCT00310388|62820273|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
33444685|NCT00310388|62820272|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
33444686|NCT00310388|62820273|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
33444687|NCT00310388|62820272|FG000|Primary Reporting Phase|Protocol Violation|10|||
33606966|NCT01779700|63007144|FG000|Overall Study|Adverse Event|4|||
33444688|NCT00310388|62820273|FG001|Primary Reporting Phase|Protocol Violation|0|||
33444689|NCT00310388|62820272|FG000|Primary Reporting Phase|Pregnancy|3|||
33444690|NCT00310388|62820273|FG001|Primary Reporting Phase|Pregnancy|0|||
33444691|NCT00310388|62820272|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
33444692|NCT00310388|62820273|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
33444693|NCT00310388|62820272|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
33444694|NCT00310388|62820273|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
33444695|NCT00310388|62820272|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
33444696|NCT00310388|62820273|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
33444697|NCT00310388|62820272|FG000|Primary Reporting Phase|Physician Decision|2|||
33444698|NCT00310388|62820273|FG001|Primary Reporting Phase|Physician Decision|0|||
33444699|NCT00310388|62820272|FG000|Primary Reporting Phase|Request of the sponsor|19|||
33444700|NCT00310388|62820273|FG001|Primary Reporting Phase|Request of the sponsor|0|||
33444701|NCT00310388|62820272|FG000|Primary Reporting Phase|Failed to return|8|||
33444702|NCT00310388|62820273|FG001|Primary Reporting Phase|Failed to return|0|||
33444703|NCT00310388|62820272|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
33444704|NCT00310388|62820273|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
33444705|NCT00310388|62820272|FG000|Primary Reporting Phase|Participant request|2|||
33444706|NCT00310388|62820273|FG001|Primary Reporting Phase|Participant request|0|||
33606967|NCT01779700|63007145|FG001|Overall Study|Adverse Event|3|||
33444707|NCT00310388|62820272|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
33444708|NCT00310388|62820273|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
33444709|NCT00310388|62820272|FG000|Primary Reporting Phase|Discontinuation of study|1|||
33444710|NCT00310388|62820273|FG001|Primary Reporting Phase|Discontinuation of study|0|||
33444711|NCT00310388|62820272|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
33444712|NCT00310388|62820273|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
33444713|NCT00310388|62820272|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
33444714|NCT00310388|62820273|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
33444715|NCT00310388|62820272|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
33444716|NCT00310388|62820273|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
33444717|NCT00310388|62820272|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
33444718|NCT00310388|62820273|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
33444719|NCT00310388|62820272|FG000|Primary Reporting Phase|Participant passed away|1|||
33444720|NCT00310388|62820273|FG001|Primary Reporting Phase|Participant passed away|0|||
33444721|NCT00310388|62820272|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
33444722|NCT00310388|62820273|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
33444723|NCT00310388|62820272|FG000|Primary Reporting Phase|Missing|1|||
33444724|NCT00310388|62820273|FG001|Primary Reporting Phase|Missing|0|||
33444725|NCT00310388|62820272|FG000|Primary Reporting Phase|Other|1|||
33444726|NCT00310388|62820273|FG001|Primary Reporting Phase|Other|0|||
33444727|NCT00310388|62820272|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
33444728|NCT00310388|62820273|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
33444729|NCT00310388|62820272|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
33444730|NCT00310388|62820273|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
33444731|NCT00310388|62820272|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
33444732|NCT00310388|62820273|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
33444733|NCT00310388|62820272|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
33444734|NCT00310388|62820273|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
33444735|NCT00500357|62820278|FG000|Overall Study|Death|1|||
33444736|NCT00309842|62820293|FG000|Overall Study|Lost to Follow-up|1|||
33444737|NCT00325754|62820299|FG000|Overall Study|Adverse Event|4|||
33444738|NCT00325754|62820300|FG001|Overall Study|Adverse Event|1|||
33606968|NCT01779700|63007144|FG000|Overall Study|Withdrawal by Subject|0|||
33606969|NCT01779700|63007145|FG001|Overall Study|Withdrawal by Subject|2|||
33606970|NCT01778530|63007151|FG000|Overall Study|Progression on study|1|||
33606971|NCT01778530|63007151|FG000|Overall Study|Adverse event/side effect|1|||
33606972|NCT01778062|63007157|FG000|Overall Study|Adverse Event|1|||
33606973|NCT01778062|63007158|FG001|Overall Study|Adverse Event|3|||
33606974|NCT01778062|63007157|FG000|Overall Study|Consent Withdrawal|1|||
33606975|NCT01778062|63007158|FG001|Overall Study|Consent Withdrawal|5|||
33606976|NCT01778062|63007157|FG000|Overall Study|major protocol deviation|4|||
33606977|NCT01778062|63007158|FG001|Overall Study|major protocol deviation|3|||
33606978|NCT01759264|63007164|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
33606979|NCT01759264|63007164|FG000|Overall Study|Adverse Event|1|||
33606980|NCT01759264|63007164|FG000|Overall Study|Other|2|||
33606981|NCT01759264|63007164|FG000|Overall Study|Lost to Follow-up|2|||
33606982|NCT01759264|63007164|FG000|Overall Study|Withdrawal by Subject|3|||
33606983|NCT01759264|63007164|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
33444739|NCT00499889|62820306|FG000|Overall Study|Infection prior to treatment|1|||
33444740|NCT00309608|62820315|FG000|Overall Study|Adverse Event|1|||
33444741|NCT00309608|62820316|FG001|Overall Study|Adverse Event|5|||
33444742|NCT00309608|62820317|FG002|Overall Study|Adverse Event|3|||
33444743|NCT00309608|62820318|FG003|Overall Study|Adverse Event|2|||
33444744|NCT00309608|62820319|FG004|Overall Study|Adverse Event|3|||
33444745|NCT00309608|62820315|FG000|Overall Study|Protocol Violation|2|||
33444746|NCT00309608|62820316|FG001|Overall Study|Protocol Violation|0|||
33444747|NCT00309608|62820317|FG002|Overall Study|Protocol Violation|0|||
33444748|NCT00309608|62820318|FG003|Overall Study|Protocol Violation|0|||
33444749|NCT00309608|62820319|FG004|Overall Study|Protocol Violation|0|||
33444750|NCT00309608|62820315|FG000|Overall Study|Lost to Follow-up|0|||
33444751|NCT00309608|62820316|FG001|Overall Study|Lost to Follow-up|0|||
33444752|NCT00309608|62820317|FG002|Overall Study|Lost to Follow-up|2|||
33444753|NCT00309608|62820318|FG003|Overall Study|Lost to Follow-up|0|||
33444754|NCT00309608|62820319|FG004|Overall Study|Lost to Follow-up|1|||
33444755|NCT00309608|62820315|FG000|Overall Study|Withdrawal by Subject|1|||
33444756|NCT00309608|62820316|FG001|Overall Study|Withdrawal by Subject|4|||
33444757|NCT00309608|62820317|FG002|Overall Study|Withdrawal by Subject|2|||
33444758|NCT00309608|62820318|FG003|Overall Study|Withdrawal by Subject|0|||
33444759|NCT00309608|62820319|FG004|Overall Study|Withdrawal by Subject|0|||
33444760|NCT00309608|62820315|FG000|Overall Study|Other incl. Lack of efficacy|10|||
33444761|NCT00309608|62820316|FG001|Overall Study|Other incl. Lack of efficacy|4|||
33444762|NCT00309608|62820317|FG002|Overall Study|Other incl. Lack of efficacy|3|||
33444763|NCT00309608|62820318|FG003|Overall Study|Other incl. Lack of efficacy|4|||
33444764|NCT00309608|62820319|FG004|Overall Study|Other incl. Lack of efficacy|0|||
33444765|NCT00309452|62820333|FG000|Overall Study|Withdrawal by Subject|3|||
33444766|NCT00309452|62820334|FG001|Overall Study|Withdrawal by Subject|0|||
33444767|NCT00308750|62820343|FG000|Overall Study|Adverse Event|9|||
33444768|NCT00308750|62820344|FG001|Overall Study|Adverse Event|9|||
33444769|NCT00308750|62820345|FG002|Overall Study|Adverse Event|13|||
33444770|NCT00308750|62820343|FG000|Overall Study|Withdrawal by Subject|6|||
33444771|NCT00308750|62820344|FG001|Overall Study|Withdrawal by Subject|2|||
33444772|NCT00308750|62820345|FG002|Overall Study|Withdrawal by Subject|3|||
33444773|NCT00308750|62820343|FG000|Overall Study|Physician Decision|3|||
33444774|NCT00308750|62820344|FG001|Overall Study|Physician Decision|4|||
33444775|NCT00308750|62820345|FG002|Overall Study|Physician Decision|3|||
33444776|NCT00308750|62820343|FG000|Overall Study|Sponsor Decision|1|||
33444777|NCT00308750|62820344|FG001|Overall Study|Sponsor Decision|0|||
33444778|NCT00308750|62820345|FG002|Overall Study|Sponsor Decision|0|||
33444779|NCT00308750|62820343|FG000|Overall Study|Disease Progression|47|||
33444780|NCT00308750|62820344|FG001|Overall Study|Disease Progression|24|||
33444781|NCT00308750|62820345|FG002|Overall Study|Disease Progression|28|||
33444782|NCT00308750|62820343|FG000|Overall Study|Unrelated Complication|3|||
33444783|NCT00308750|62820344|FG001|Overall Study|Unrelated Complication|0|||
33444784|NCT00308750|62820345|FG002|Overall Study|Unrelated Complication|1|||
33444785|NCT00308750|62820343|FG000|Overall Study|Death|1|||
33444786|NCT00308750|62820344|FG001|Overall Study|Death|0|||
33444787|NCT00308750|62820345|FG002|Overall Study|Death|1|||
33444788|NCT00308750|62820343|FG000|Overall Study|Protocol Violation|1|||
33444789|NCT00308750|62820344|FG001|Overall Study|Protocol Violation|0|||
33444790|NCT00308750|62820345|FG002|Overall Study|Protocol Violation|0|||
33444791|NCT00308750|62820343|FG000|Overall Study|New Primary Disease Identified|1|||
33444792|NCT00308750|62820344|FG001|Overall Study|New Primary Disease Identified|1|||
33444793|NCT00308750|62820345|FG002|Overall Study|New Primary Disease Identified|0|||
33444794|NCT00489359|62820356|FG000|Overall Study|Death|0|||
33444795|NCT00489359|62820357|FG001|Overall Study|Death|2|||
33444796|NCT00489359|62820356|FG000|Overall Study|Progressive Disease|5|||
33444797|NCT00489359|62820357|FG001|Overall Study|Progressive Disease|6|||
33444798|NCT00489359|62820356|FG000|Overall Study|Lost to Follow-up|1|||
33444799|NCT00489359|62820357|FG001|Overall Study|Lost to Follow-up|0|||
33606984|NCT01757704|63007171|FG000|Overall Study|Protocol Violation|1|||
33444800|NCT00489359|62820356|FG000|Overall Study|Withdrawal by Subject|1|||
33444801|NCT00489359|62820357|FG001|Overall Study|Withdrawal by Subject|5|||
33444802|NCT00489359|62820356|FG000|Overall Study|Adverse Event|0|||
33444803|NCT00489359|62820357|FG001|Overall Study|Adverse Event|16|||
33444804|NCT00481247|62820370|FG000|Overall Study|Death|0|||
33444805|NCT00481247|62820371|FG001|Overall Study|Death|1|||
33444806|NCT00481247|62820370|FG000|Overall Study|Disease progression|18|||
33444807|NCT00481247|62820371|FG001|Overall Study|Disease progression|22|||
33444808|NCT00481247|62820370|FG000|Overall Study|Intolerance|42|||
33444809|NCT00481247|62820371|FG001|Overall Study|Intolerance|17|||
33444810|NCT00481247|62820370|FG000|Overall Study|Treatment failure|10|||
33444811|NCT00481247|62820371|FG001|Overall Study|Treatment failure|14|||
33444812|NCT00481247|62820370|FG000|Overall Study|AE unrelated to study drug|13|||
33444813|NCT00481247|62820371|FG001|Overall Study|AE unrelated to study drug|4|||
33444814|NCT00481247|62820370|FG000|Overall Study|Withdrawal by Subject|8|||
33444815|NCT00481247|62820371|FG001|Overall Study|Withdrawal by Subject|13|||
33444816|NCT00481247|62820370|FG000|Overall Study|Pregnancy|2|||
33444817|NCT00481247|62820371|FG001|Overall Study|Pregnancy|1|||
33444818|NCT00481247|62820370|FG000|Overall Study|Lost to Follow-up|1|||
33444819|NCT00481247|62820371|FG001|Overall Study|Lost to Follow-up|2|||
33444820|NCT00481247|62820370|FG000|Overall Study|Poor compliance/noncompliance|1|||
33444821|NCT00481247|62820371|FG001|Overall Study|Poor compliance/noncompliance|7|||
33444822|NCT00481247|62820370|FG000|Overall Study|Administrative reason by sponsor|157|||
33444823|NCT00481247|62820371|FG001|Overall Study|Administrative reason by sponsor|162|||
33444824|NCT00481247|62820370|FG000|Overall Study|Varied|6|||
33444825|NCT00481247|62820371|FG001|Overall Study|Varied|15|||
33444826|NCT00481247|62820370|FG000|Overall Study|Did not receive treatment|1|||
33444827|NCT00481247|62820371|FG001|Overall Study|Did not receive treatment|2|||
33444828|NCT00480857|62820377|FG000|Overall Study|Lack of Efficacy|2|||
33444829|NCT00480779|62820383|FG000|Overall Study|Other|2|||
33444830|NCT00480779|62820384|FG001|Overall Study|Other|0|||
33444831|NCT00480779|62820383|FG000|Overall Study|Job and Health-related|0|||
33444832|NCT00480779|62820384|FG001|Overall Study|Job and Health-related|3|||
33444833|NCT00499031|62820390|FG000|Overall Study|Improper pre-protocol treatment|1|||
33444834|NCT00499031|62820390|FG000|Overall Study|Required test not done|1|||
33444835|NCT00499031|62820390|FG000|Overall Study|Never treated|1|||
33444836|NCT00498797|62820396|FG000|Overall Study|Withdrawal by Subject|4|||
33444837|NCT00498797|62820397|FG001|Overall Study|Withdrawal by Subject|2|||
33444838|NCT00498797|62820396|FG000|Overall Study|Adverse Event|12|||
33444839|NCT00498797|62820397|FG001|Overall Study|Adverse Event|5|||
33444840|NCT00498797|62820396|FG000|Overall Study|Condition under investigation worsened|19|||
33444841|NCT00498797|62820397|FG001|Overall Study|Condition under investigation worsened|21|||
33444842|NCT00498797|62820396|FG000|Overall Study|Other|3|||
33444843|NCT00498797|62820397|FG001|Overall Study|Other|1|||
33444844|NCT00498485|62820405|FG000|Overall Study|Adverse Event|1|||
33444845|NCT00498485|62820406|FG001|Overall Study|Adverse Event|5|||
33444846|NCT00480077|62820416|FG000|Overall Study|Death|19|||
33444847|NCT00480077|62820417|FG001|Overall Study|Death|15|||
33444848|NCT00480077|62820416|FG000|Overall Study|early exit|12|||
33444849|NCT00480077|62820417|FG001|Overall Study|early exit|11|||
33444850|NCT00498173|62820425|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
33444851|NCT00498173|62820426|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
33444852|NCT00498173|62820427|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
33444853|NCT00295620|62820437|FG000|Overall Study|Lost to Follow-up|9|||
33444854|NCT00295620|62820438|FG001|Overall Study|Lost to Follow-up|5|||
33444855|NCT00295620|62820437|FG000|Overall Study|Withdrawal by Subject|37|||
33444856|NCT00295620|62820438|FG001|Overall Study|Withdrawal by Subject|50|||
33444857|NCT00295620|62820437|FG000|Overall Study|Death|206|||
33444858|NCT00295620|62820438|FG001|Overall Study|Death|207|||
33444859|NCT00295620|62820437|FG000|Overall Study|Other reasons|10|||
33606985|NCT01757704|63007172|FG001|Overall Study|Protocol Violation|3|||
33606986|NCT01757392|63007178|FG000|Overall Study|Withdrawal by Subject|1|||
33606987|NCT01757392|63007178|FG000|Overall Study|Screen Fail|3|||
33606988|NCT01756846|63007184|FG000|Overall Study|Lost to Follow-up|5|||
33606989|NCT01756846|63007185|FG001|Overall Study|Lost to Follow-up|10|||
33606990|NCT01756846|63007184|FG000|Overall Study|Withdrawal by Subject|1|||
33606991|NCT01756846|63007185|FG001|Overall Study|Withdrawal by Subject|2|||
33606992|NCT01963611|63007196|FG000|Overall Study|Adverse Event|1|||
33606993|NCT01963611|63007197|FG001|Overall Study|Adverse Event|1|||
33606994|NCT01963611|63007198|FG002|Overall Study|Adverse Event|3|||
33606995|NCT01963611|63007199|FG003|Overall Study|Adverse Event|4|||
33606996|NCT01963611|63007200|FG004|Overall Study|Adverse Event|3|||
33606997|NCT01963611|63007196|FG000|Overall Study|Protocol Violation|0|||
33606998|NCT01963611|63007197|FG001|Overall Study|Protocol Violation|0|||
33606999|NCT01963611|63007198|FG002|Overall Study|Protocol Violation|0|||
33607000|NCT01963611|63007199|FG003|Overall Study|Protocol Violation|1|||
33607001|NCT01963611|63007200|FG004|Overall Study|Protocol Violation|0|||
33607002|NCT01963611|63007196|FG000|Overall Study|Lack of Efficacy|0|||
33444860|NCT00295620|62820438|FG001|Overall Study|Other reasons|9|||
33444861|NCT00295620|62820437|FG000|Overall Study|Discontinuation by sponsor|580|||
33444862|NCT00295620|62820438|FG001|Overall Study|Discontinuation by sponsor|593|||
33444863|NCT00295620|62820437|FG000|Overall Study|Protocol Violation|30|||
33444864|NCT00295620|62820438|FG001|Overall Study|Protocol Violation|32|||
33444865|NCT00310440|62820446|FG000|Overall Study|Lost to Follow-up|17|||
33444866|NCT00310440|62820447|FG001|Overall Study|Lost to Follow-up|8|||
33444867|NCT00310440|62820446|FG000|Overall Study|Withdrawal by Subject|2|||
33444868|NCT00310440|62820447|FG001|Overall Study|Withdrawal by Subject|1|||
33444869|NCT00310440|62820446|FG000|Overall Study|Missed 12 Month Visit|7|||
33444870|NCT00310440|62820447|FG001|Overall Study|Missed 12 Month Visit|4|||
33444871|NCT00304356|62820453|FG000|Nitazoxanide|Physician Decision|5|||
33444872|NCT00304356|62820453|FG000|Nitazoxanide|Physician Decision|1|||
33444873|NCT00304356|62820453|FG000|Nitazoxanide|number is 0|1|||
33444874|NCT00304356|62820453|FG000|Nitazoxanide|Physician Decision|1|||
33444875|NCT00304356|62820453|FG000|Nitazoxanide|Physician Decision|1|||
33444876|NCT00304356|62820453|FG000|Nitazoxanide|Physician Decision|1|||
33444877|NCT00321620|62820459|FG000|Overall Study|Death|269|||
33444878|NCT00321620|62820460|FG001|Overall Study|Death|294|||
33444879|NCT00321620|62820459|FG000|Overall Study|Withdrawal by Subject|164|||
33444880|NCT00321620|62820460|FG001|Overall Study|Withdrawal by Subject|147|||
33444881|NCT00321620|62820459|FG000|Overall Study|Disease progression|113|||
33607003|NCT01963611|63007197|FG001|Overall Study|Lack of Efficacy|0|||
33607004|NCT01963611|63007198|FG002|Overall Study|Lack of Efficacy|0|||
33607005|NCT01963611|63007199|FG003|Overall Study|Lack of Efficacy|1|||
33607006|NCT01963611|63007200|FG004|Overall Study|Lack of Efficacy|0|||
33607007|NCT01963611|63007196|FG000|Overall Study|Withdrawal by Subject|3|||
33607008|NCT01963611|63007197|FG001|Overall Study|Withdrawal by Subject|2|||
33444882|NCT00321620|62820460|FG001|Overall Study|Disease progression|117|||
33444883|NCT00321620|62820459|FG000|Overall Study|Adverse Event|43|||
33444884|NCT00321620|62820460|FG001|Overall Study|Adverse Event|56|||
33444885|NCT00321620|62820459|FG000|Overall Study|Lost to Follow-up|13|||
33444886|NCT00321620|62820460|FG001|Overall Study|Lost to Follow-up|9|||
33444887|NCT00321620|62820459|FG000|Overall Study|Physician Decision|4|||
33607009|NCT01963611|63007198|FG002|Overall Study|Withdrawal by Subject|1|||
33607010|NCT01963611|63007199|FG003|Overall Study|Withdrawal by Subject|1|||
33607011|NCT01963611|63007200|FG004|Overall Study|Withdrawal by Subject|3|||
33607012|NCT01963611|63007196|FG000|Overall Study|Other|47|||
33607013|NCT01963611|63007197|FG001|Overall Study|Other|46|||
33607014|NCT01963611|63007198|FG002|Overall Study|Other|48|||
33607015|NCT01963611|63007199|FG003|Overall Study|Other|45|||
33607016|NCT01963611|63007200|FG004|Overall Study|Other|45|||
33607017|NCT01975701|63007213|FG000|Overall Study|Lost to Follow-up|1|||
33607018|NCT01975701|63007213|FG000|Overall Study|Death|23|||
33607019|NCT01975701|63007213|FG000|Overall Study|Physician Decision|1|||
33607020|NCT01962987|63007220|FG000|Overall Study|Adverse Event|4|||
33444888|NCT00321620|62820460|FG001|Overall Study|Physician Decision|1|||
33607021|NCT01962987|63007221|FG001|Overall Study|Adverse Event|4|||
33607022|NCT01962987|63007222|FG002|Overall Study|Adverse Event|0|||
33607023|NCT01962987|63007220|FG000|Overall Study|Lost to Follow-up|0|||
33607024|NCT01962987|63007221|FG001|Overall Study|Lost to Follow-up|0|||
33607025|NCT01962987|63007222|FG002|Overall Study|Lost to Follow-up|1|||
33607026|NCT01962987|63007220|FG000|Overall Study|Non compliance with dosing requirements|4|||
33444889|NCT00321620|62820459|FG000|Overall Study|Noncompliance|14|||
33444890|NCT00321620|62820460|FG001|Overall Study|Noncompliance|7|||
33444891|NCT00321620|62820459|FG000|Overall Study|Protocol deviation|4|||
33444892|NCT00321620|62820460|FG001|Overall Study|Protocol deviation|3|||
33444893|NCT00321620|62820459|FG000|Overall Study|Ineligibility determined|2|||
33444894|NCT00321620|62820460|FG001|Overall Study|Ineligibility determined|3|||
33444895|NCT00321620|62820459|FG000|Overall Study|Participant request|75|||
33444896|NCT00321620|62820460|FG001|Overall Study|Participant request|52|||
33444897|NCT00321620|62820459|FG000|Overall Study|Other|42|||
33444898|NCT00321620|62820460|FG001|Overall Study|Other|33|||
33444899|NCT00304278|62820466|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
33444900|NCT00304278|62820466|FG000|Overall Study|PT had medical condition preventing TX|1|||
33444901|NCT00291018|62820473|FG000|Overall Study|Not Consented or Declined PAS|12|||
33444902|NCT00291018|62820474|FG001|Overall Study|Not Consented or Declined PAS|15|||
33444903|NCT00291018|62820475|FG002|Overall Study|Not Consented or Declined PAS|15|||
33444904|NCT00291018|62820473|FG000|Overall Study|Death|3|||
33444905|NCT00291018|62820474|FG001|Overall Study|Death|3|||
33444906|NCT00291018|62820475|FG002|Overall Study|Death|4|||
33444907|NCT00291018|62820473|FG000|Overall Study|Withdrawal by Subject|2|||
33444908|NCT00291018|62820474|FG001|Overall Study|Withdrawal by Subject|8|||
33444909|NCT00291018|62820475|FG002|Overall Study|Withdrawal by Subject|1|||
33444910|NCT00291018|62820473|FG000|Overall Study|Failures|5|||
33444911|NCT00291018|62820474|FG001|Overall Study|Failures|12|||
33444912|NCT00291018|62820475|FG002|Overall Study|Failures|5|||
33444913|NCT00291018|62820473|FG000|Overall Study|Lost to Follow-up|3|||
33444914|NCT00291018|62820474|FG001|Overall Study|Lost to Follow-up|4|||
33444915|NCT00291018|62820475|FG002|Overall Study|Lost to Follow-up|18|||
33444916|NCT00320606|62820486|FG000|Overall Study|Adverse Event|1|||
33444917|NCT00320606|62820486|FG000|Overall Study|Protocol Violation|1|||
33444918|NCT00320606|62820486|FG000|Overall Study|Withdrawal by Subject|1|||
33444919|NCT00307736|62820491|FG000|Overall Study|Adverse Event|0|||
33444920|NCT00307736|62820492|FG001|Overall Study|Adverse Event|0|||
33444921|NCT00307736|62820493|FG002|Overall Study|Adverse Event|1|||
33444922|NCT00307736|62820494|FG003|Overall Study|Adverse Event|3|||
33444923|NCT00307736|62820491|FG000|Overall Study|Withdrawal by Subject|0|||
33444924|NCT00307736|62820492|FG001|Overall Study|Withdrawal by Subject|0|||
33444925|NCT00307736|62820493|FG002|Overall Study|Withdrawal by Subject|2|||
33444926|NCT00307736|62820494|FG003|Overall Study|Withdrawal by Subject|0|||
33444927|NCT00320528|62820508|FG000|Study Period II|Adverse Event|3|||
33444928|NCT00320528|62820509|FG001|Study Period II|Adverse Event|4|||
33444929|NCT00320528|62820510|FG002|Study Period II|Adverse Event|8|||
33444930|NCT00320528|62820508|FG000|Study Period II|Parent/Caregiver Decision|8|||
33607027|NCT01962987|63007221|FG001|Overall Study|Non compliance with dosing requirements|2|||
33607028|NCT01962987|63007222|FG002|Overall Study|Non compliance with dosing requirements|0|||
33607029|NCT01962987|63007220|FG000|Overall Study|Miscellaneous|1|||
33607030|NCT01962987|63007221|FG001|Overall Study|Miscellaneous|9|||
33607031|NCT01962987|63007222|FG002|Overall Study|Miscellaneous|2|||
33444931|NCT00320528|62820509|FG001|Study Period II|Parent/Caregiver Decision|3|||
33444932|NCT00320528|62820510|FG002|Study Period II|Parent/Caregiver Decision|11|||
33444933|NCT00320528|62820508|FG000|Study Period II|Withdrawal by Subject|0|||
33444934|NCT00320528|62820509|FG001|Study Period II|Withdrawal by Subject|1|||
33444935|NCT00320528|62820510|FG002|Study Period II|Withdrawal by Subject|1|||
33444936|NCT00320528|62820508|FG000|Study Period II|Entry Criteria Exclusion|0|||
33444937|NCT00320528|62820509|FG001|Study Period II|Entry Criteria Exclusion|2|||
33444938|NCT00320528|62820510|FG002|Study Period II|Entry Criteria Exclusion|2|||
33444939|NCT00320528|62820508|FG000|Study Period III|Adverse Event|1|||
33444940|NCT00320528|62820509|FG001|Study Period III|Adverse Event|0|||
33444941|NCT00320528|62820510|FG002|Study Period III|Adverse Event|0|||
33444942|NCT00320528|62820508|FG000|Study Period III|Lost to Follow-up|1|||
33444943|NCT00320528|62820509|FG001|Study Period III|Lost to Follow-up|0|||
33607032|NCT01962987|63007220|FG000|Overall Study|Restricted medication|5|||
33444944|NCT00320528|62820510|FG002|Study Period III|Lost to Follow-up|0|||
33444945|NCT00320528|62820508|FG000|Study Period III|Withdrawal by Subject|1|||
33444946|NCT00320528|62820509|FG001|Study Period III|Withdrawal by Subject|1|||
33444947|NCT00320528|62820510|FG002|Study Period III|Withdrawal by Subject|2|||
33444948|NCT00320528|62820508|FG000|Study Period III|Lack of Efficacy|2|||
33444949|NCT00320528|62820509|FG001|Study Period III|Lack of Efficacy|0|||
33444950|NCT00320528|62820510|FG002|Study Period III|Lack of Efficacy|0|||
33444951|NCT00320528|62820508|FG000|Study Period III|Parent/Caregiver Decision|14|||
33444952|NCT00320528|62820509|FG001|Study Period III|Parent/Caregiver Decision|3|||
33444953|NCT00320528|62820510|FG002|Study Period III|Parent/Caregiver Decision|11|||
33444954|NCT00320528|62820508|FG000|Study Period III|Protocol Violation|0|||
33444955|NCT00320528|62820509|FG001|Study Period III|Protocol Violation|1|||
33444956|NCT00320528|62820510|FG002|Study Period III|Protocol Violation|0|||
33444957|NCT00320528|62820508|FG000|Study Period III|Physician Decision|0|||
33444958|NCT00320528|62820509|FG001|Study Period III|Physician Decision|1|||
33444959|NCT00320528|62820510|FG002|Study Period III|Physician Decision|2|||
33444960|NCT00320528|62820508|FG000|Study Period III|Sponsor Decision|0|||
33444961|NCT00320528|62820509|FG001|Study Period III|Sponsor Decision|0|||
33444962|NCT00320528|62820510|FG002|Study Period III|Sponsor Decision|1|||
33444963|NCT00320528|62820508|FG000|Study Period III|Atomoxetine Commercially Available|68|||
33444964|NCT00320528|62820509|FG001|Study Period III|Atomoxetine Commercially Available|25|||
33444965|NCT00320528|62820510|FG002|Study Period III|Atomoxetine Commercially Available|90|||
33444966|NCT00320372|62820521|FG000|Overall Study|Physician Decision|4|||
33444967|NCT00320372|62820522|FG001|Overall Study|Physician Decision|7|||
33444968|NCT00320372|62820521|FG000|Overall Study|Death|7|||
33444969|NCT00320372|62820522|FG001|Overall Study|Death|8|||
33444970|NCT00320372|62820521|FG000|Overall Study|Withdrawal by Subject|55|||
33444971|NCT00320372|62820522|FG001|Overall Study|Withdrawal by Subject|37|||
33444972|NCT00320372|62820521|FG000|Overall Study|Non-Compliance|40|||
33444973|NCT00320372|62820522|FG001|Overall Study|Non-Compliance|39|||
33444974|NCT00320372|62820521|FG000|Overall Study|Did not Meet (I/E)|3|||
33444975|NCT00320372|62820522|FG001|Overall Study|Did not Meet (I/E)|1|||
33444976|NCT00320372|62820521|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
33444977|NCT00320372|62820522|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
33444978|NCT00294762|62820538|FG000|Overall Study|Did not receive study treatment|3|||
33444979|NCT00294762|62820539|FG001|Overall Study|Did not receive study treatment|3|||
33444980|NCT00294684|62820547|FG000|Overall Study|Lost to Follow-up|5|||
33444981|NCT00294684|62820548|FG001|Overall Study|Lost to Follow-up|8|||
33444982|NCT00307034|62820556|FG000|Overall Study|Adverse Event|1|||
33444983|NCT00307034|62820557|FG001|Overall Study|Adverse Event|2|||
33444984|NCT00307034|62820556|FG000|Overall Study|Withdrawal by Subject|1|||
33444985|NCT00307034|62820557|FG001|Overall Study|Withdrawal by Subject|2|||
33444986|NCT00307034|62820556|FG000|Overall Study|Lost to Follow-up|0|||
33444987|NCT00307034|62820557|FG001|Overall Study|Lost to Follow-up|3|||
33444988|NCT00320216|62820568|FG000|Overall Study|Adverse Event|0|||
33444989|NCT00320216|62820569|FG001|Overall Study|Adverse Event|6|||
33444990|NCT00320216|62820570|FG002|Overall Study|Adverse Event|0|||
33444991|NCT00320216|62820571|FG003|Overall Study|Adverse Event|2|||
33444992|NCT00320216|62820572|FG004|Overall Study|Adverse Event|2|||
33444993|NCT00320216|62820568|FG000|Overall Study|Lack of Efficacy|6|||
33444994|NCT00320216|62820569|FG001|Overall Study|Lack of Efficacy|2|||
33444995|NCT00320216|62820570|FG002|Overall Study|Lack of Efficacy|1|||
33444996|NCT00320216|62820571|FG003|Overall Study|Lack of Efficacy|0|||
33444997|NCT00320216|62820572|FG004|Overall Study|Lack of Efficacy|1|||
33444998|NCT00320216|62820568|FG000|Overall Study|Lost to Follow-up|3|||
33444999|NCT00320216|62820569|FG001|Overall Study|Lost to Follow-up|0|||
33445000|NCT00320216|62820570|FG002|Overall Study|Lost to Follow-up|0|||
33445001|NCT00320216|62820571|FG003|Overall Study|Lost to Follow-up|0|||
33445002|NCT00320216|62820572|FG004|Overall Study|Lost to Follow-up|0|||
33445003|NCT00320216|62820568|FG000|Overall Study|Other|7|||
33445004|NCT00320216|62820569|FG001|Overall Study|Other|2|||
33445005|NCT00320216|62820570|FG002|Overall Study|Other|5|||
33445006|NCT00320216|62820571|FG003|Overall Study|Other|1|||
33445007|NCT00320216|62820572|FG004|Overall Study|Other|3|||
33445008|NCT00290706|62820593|FG000|Overall Study|Withdrawal by Subject|2|||
33445009|NCT00290706|62820594|FG001|Overall Study|Withdrawal by Subject|0|||
33445010|NCT00290706|62820595|FG002|Overall Study|Withdrawal by Subject|0|||
33445011|NCT00290706|62820596|FG003|Overall Study|Withdrawal by Subject|0|||
33445012|NCT00290706|62820593|FG000|Overall Study|Progressive Disease|3|||
33445013|NCT00290706|62820594|FG001|Overall Study|Progressive Disease|5|||
33445014|NCT00290706|62820595|FG002|Overall Study|Progressive Disease|4|||
33445015|NCT00290706|62820596|FG003|Overall Study|Progressive Disease|10|||
33445016|NCT00290706|62820593|FG000|Overall Study|Adverse Event|0|||
33445017|NCT00290706|62820594|FG001|Overall Study|Adverse Event|1|||
33445018|NCT00290706|62820595|FG002|Overall Study|Adverse Event|2|||
33445019|NCT00290706|62820596|FG003|Overall Study|Adverse Event|0|||
33445020|NCT00290706|62820593|FG000|Overall Study|Receive auto transplant or radiation|0|||
33445021|NCT00290706|62820594|FG001|Overall Study|Receive auto transplant or radiation|0|||
33445022|NCT00290706|62820595|FG002|Overall Study|Receive auto transplant or radiation|0|||
33445023|NCT00290706|62820596|FG003|Overall Study|Receive auto transplant or radiation|1|||
33445024|NCT00290706|62820593|FG000|Overall Study|Physician Decision|0|||
33445025|NCT00290706|62820594|FG001|Overall Study|Physician Decision|0|||
33445026|NCT00290706|62820595|FG002|Overall Study|Physician Decision|0|||
33445027|NCT00290706|62820596|FG003|Overall Study|Physician Decision|1|||
33445028|NCT00303186|62820607|FG000|Overall Study|Other|52|||
33445029|NCT00294060|62820611|FG000|Overall Study|Death|225|||
33445030|NCT00294060|62820611|FG000|Overall Study|Other|59|||
33445031|NCT00294060|62820611|FG000|Overall Study|Lost to Follow-up|55|||
33445032|NCT00294060|62820611|FG000|Overall Study|Withdrawal by Subject|11|||
33445033|NCT00294060|62820611|FG000|Overall Study|Physician Decision|797|||
33445034|NCT00294060|62820611|FG000|Overall Study|Medical condition|3|||
33445035|NCT00294060|62820611|FG000|Overall Study|Device explanted/not replaced|23|||
33445036|NCT00303108|62820618|FG000|Overall Study|Adverse Event|5|||
33445037|NCT00303108|62820619|FG001|Overall Study|Adverse Event|6|||
33445038|NCT00303108|62820620|FG002|Overall Study|Adverse Event|7|||
33445039|NCT00303108|62820618|FG000|Overall Study|Patient Request|4|||
33445040|NCT00303108|62820619|FG001|Overall Study|Patient Request|2|||
33607033|NCT01962987|63007221|FG001|Overall Study|Restricted medication|1|||
33607034|NCT01962987|63007222|FG002|Overall Study|Restricted medication|1|||
33607035|NCT01962987|63007220|FG000|Overall Study|Serious Adverse Event|1|||
33607036|NCT01962987|63007221|FG001|Overall Study|Serious Adverse Event|0|||
33445041|NCT00303108|62820620|FG002|Overall Study|Patient Request|8|||
33445042|NCT00303108|62820618|FG000|Overall Study|Failed Entry|1|||
33445043|NCT00303108|62820619|FG001|Overall Study|Failed Entry|0|||
33445044|NCT00303108|62820620|FG002|Overall Study|Failed Entry|1|||
33445045|NCT00303108|62820618|FG000|Overall Study|ineligible|2|||
33445046|NCT00303108|62820619|FG001|Overall Study|ineligible|1|||
33445047|NCT00303108|62820620|FG002|Overall Study|ineligible|0|||
33445048|NCT00302952|62820629|FG000|Overall Study|Physician Decision|1|||
33445049|NCT00302952|62820630|FG001|Overall Study|Physician Decision|1|||
33445050|NCT00302952|62820629|FG000|Overall Study|Withdrawal by Subject|2|||
33445051|NCT00302952|62820630|FG001|Overall Study|Withdrawal by Subject|3|||
33445052|NCT00302952|62820629|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
33445053|NCT00302952|62820630|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
33445054|NCT00302718|62820640|FG000|Overall Study|Participant left the hospital|1|||
33445055|NCT00302718|62820641|FG001|Overall Study|Participant left the hospital|0|||
33445056|NCT00302718|62820642|FG002|Overall Study|Participant left the hospital|0|||
33445057|NCT00302718|62820643|FG003|Overall Study|Participant left the hospital|1|||
33445058|NCT00302718|62820640|FG000|Overall Study|Withdrawal by Subject|0|||
33445059|NCT00302718|62820641|FG001|Overall Study|Withdrawal by Subject|1|||
33445060|NCT00302718|62820642|FG002|Overall Study|Withdrawal by Subject|0|||
33445061|NCT00302718|62820643|FG003|Overall Study|Withdrawal by Subject|0|||
33445062|NCT00302718|62820640|FG000|Overall Study|Participant left primary care setting|0|||
33445063|NCT00302718|62820641|FG001|Overall Study|Participant left primary care setting|0|||
33445064|NCT00302718|62820642|FG002|Overall Study|Participant left primary care setting|2|||
33445065|NCT00302718|62820643|FG003|Overall Study|Participant left primary care setting|1|||
33445066|NCT00302328|62820661|FG000|Overall Study|Physician Decision|0|||
33445067|NCT00302328|62820662|FG001|Overall Study|Physician Decision|1|||
33445068|NCT00302328|62820663|FG002|Overall Study|Physician Decision|0|||
33445069|NCT00301080|62820674|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
33445070|NCT00301080|62820675|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
33445071|NCT00301080|62820676|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
33445072|NCT00301080|62820677|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
33445073|NCT00301080|62820678|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
33445074|NCT00290238|62820689|FG000|Overall Study|Study terminated|27|||
33445075|NCT00290238|62820690|FG001|Overall Study|Study terminated|27|||
33445076|NCT00290238|62820689|FG000|Overall Study|Lost to Follow-up|0|||
33607037|NCT01962987|63007222|FG002|Overall Study|Serious Adverse Event|0|||
33494243|NCT02873936|62873017|FG001|Overall Study|Lost to Follow-up|1|||
33607038|NCT01962987|63007220|FG000|Overall Study|Withdrawal by Subject|11|||
33607039|NCT01962987|63007221|FG001|Overall Study|Withdrawal by Subject|10|||
33607040|NCT01962987|63007222|FG002|Overall Study|Withdrawal by Subject|6|||
33445077|NCT00290238|62820690|FG001|Overall Study|Lost to Follow-up|1|||
33445078|NCT00290238|62820689|FG000|Overall Study|Withdrawal by Subject|15|||
33445079|NCT00290238|62820690|FG001|Overall Study|Withdrawal by Subject|13|||
33445080|NCT00289848|62820698|FG000|Overall Study|Adverse Event|6|||
33607041|NCT01962987|63007220|FG000|Overall Study|Randomized in Error|4|||
33607042|NCT01962987|63007221|FG001|Overall Study|Randomized in Error|2|||
33445081|NCT00289848|62820699|FG001|Overall Study|Adverse Event|4|||
33607043|NCT01962987|63007222|FG002|Overall Study|Randomized in Error|2|||
33445082|NCT00289848|62820698|FG000|Overall Study|Death|1|||
33445083|NCT00289848|62820699|FG001|Overall Study|Death|0|||
33445084|NCT00289848|62820698|FG000|Overall Study|Lack of Efficacy|20|||
33445085|NCT00289848|62820699|FG001|Overall Study|Lack of Efficacy|24|||
33445086|NCT00289848|62820698|FG000|Overall Study|Lost to Follow-up|3|||
33445087|NCT00289848|62820699|FG001|Overall Study|Lost to Follow-up|1|||
33445088|NCT00289848|62820698|FG000|Overall Study|Protocol Violation|5|||
33445089|NCT00289848|62820699|FG001|Overall Study|Protocol Violation|2|||
33445090|NCT00289848|62820698|FG000|Overall Study|Withdrawal by Subject|5|||
33607044|NCT01962441|63007233|FG000|Randomized Period|Randomized but Never Treated|4|||
33607045|NCT01962441|63007234|FG001|Randomized Period|Randomized but Never Treated|2|||
33607046|NCT01962441|63007235|FG002|Randomized Period|Randomized but Never Treated|3|||
33607047|NCT01962441|63007233|FG000|Randomized Period|Lost to Follow-up|2|||
33607048|NCT01962441|63007234|FG001|Randomized Period|Lost to Follow-up|4|||
33607049|NCT01962441|63007235|FG002|Randomized Period|Lost to Follow-up|4|||
33445091|NCT00289848|62820699|FG001|Overall Study|Withdrawal by Subject|11|||
33445092|NCT00289848|62820698|FG000|Overall Study|Patient Moved|6|||
33445093|NCT00289848|62820699|FG001|Overall Study|Patient Moved|2|||
33445094|NCT00289848|62820698|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
33445095|NCT00289848|62820699|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
33445096|NCT00289770|62820705|FG000|Year 15|Withdrawal by Subject|1|||
33445097|NCT00289536|62820709|FG000|Period 3|Lost to Follow-up|0|||
33445098|NCT00289536|62820710|FG001|Period 3|Lost to Follow-up|0|||
33445099|NCT00289536|62820711|FG002|Period 3|Lost to Follow-up|1|||
33445100|NCT00289458|62820720|FG000|Overall Study|Death|1|||
33607050|NCT01962441|63007233|FG000|Randomized Period|Withdrew Consent|3|||
33607051|NCT01962441|63007234|FG001|Randomized Period|Withdrew Consent|3|||
33607052|NCT01962441|63007235|FG002|Randomized Period|Withdrew Consent|2|||
33607053|NCT01962441|63007233|FG000|Randomized Period|Adverse Event|1|||
33607054|NCT01962441|63007234|FG001|Randomized Period|Adverse Event|1|||
33445101|NCT00289458|62820721|FG001|Overall Study|Death|0|||
33445102|NCT00289458|62820722|FG002|Overall Study|Death|0|||
33445103|NCT00289458|62820720|FG000|Overall Study|Physician Decision|3|||
33445104|NCT00289458|62820721|FG001|Overall Study|Physician Decision|4|||
33445105|NCT00289458|62820722|FG002|Overall Study|Physician Decision|2|||
33445106|NCT00289458|62820720|FG000|Overall Study|Withdrawal by Subject|2|||
33445107|NCT00289458|62820721|FG001|Overall Study|Withdrawal by Subject|2|||
33445108|NCT00289458|62820722|FG002|Overall Study|Withdrawal by Subject|4|||
33445109|NCT00288912|62820733|FG000|Overall Study|Developed exclusion criterion|4|||
33445110|NCT00288912|62820734|FG001|Overall Study|Developed exclusion criterion|6|||
33445111|NCT00288912|62820735|FG002|Overall Study|Developed exclusion criterion|7|||
33445112|NCT00288912|62820733|FG000|Overall Study|Lost to Follow-up|9|||
33445113|NCT00288912|62820734|FG001|Overall Study|Lost to Follow-up|6|||
33445114|NCT00288912|62820735|FG002|Overall Study|Lost to Follow-up|9|||
33445115|NCT00288912|62820733|FG000|Overall Study|Withdrawal by Subject|4|||
33445116|NCT00288912|62820734|FG001|Overall Study|Withdrawal by Subject|5|||
33445117|NCT00288912|62820735|FG002|Overall Study|Withdrawal by Subject|12|||
33445118|NCT00305864|62820747|FG000|Overall Study|Ineligible / No protocol treatment|0|||
33445119|NCT00305864|62820748|FG001|Overall Study|Ineligible / No protocol treatment|1|||
33445120|NCT00305864|62820749|FG002|Overall Study|Ineligible / No protocol treatment|1|||
33445121|NCT00305864|62820750|FG003|Overall Study|Ineligible / No protocol treatment|13|||
33445122|NCT00295880|62820760|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
33445123|NCT00295880|62820760|FG000|Overall Study|Unit randomization did not occur|1|||
33445124|NCT00319982|62820766|FG000|Overall Study|Withdrawal by Subject|1|||
33445125|NCT00319982|62820767|FG001|Overall Study|Withdrawal by Subject|0|||
33445126|NCT00319592|62820775|FG000|Overall Study|Protocol Violation|1|||
33607055|NCT01962441|63007235|FG002|Randomized Period|Adverse Event|0|||
33607056|NCT01962441|63007233|FG000|Randomized Period|Death|0|||
33607057|NCT01962441|63007234|FG001|Randomized Period|Death|0|||
33607058|NCT01962441|63007235|FG002|Randomized Period|Death|2|||
33607059|NCT01962441|63007233|FG000|Randomized Period|Protocol Violation|0|||
33607060|NCT01962441|63007234|FG001|Randomized Period|Protocol Violation|1|||
33445127|NCT00319592|62820776|FG001|Overall Study|Protocol Violation|0|||
33445128|NCT00319592|62820775|FG000|Overall Study|Physician Decision|0|||
33445129|NCT00319592|62820776|FG001|Overall Study|Physician Decision|1|||
33445130|NCT00295490|62820786|FG000|Overall Study|Protocol Violation|0|||
33445131|NCT00295490|62820787|FG001|Overall Study|Protocol Violation|0|||
33445132|NCT00295490|62820788|FG002|Overall Study|Protocol Violation|3|||
33445133|NCT00295490|62820789|FG003|Overall Study|Protocol Violation|3|||
33445134|NCT00295490|62820786|FG000|Overall Study|Withdrawal by Subject|0|||
33607061|NCT01962441|63007235|FG002|Randomized Period|Protocol Violation|0|||
33607062|NCT01962441|63007233|FG000|Retreatment Substudy|Lack of Efficacy|1|||
33607063|NCT01962441|63007234|FG001|Retreatment Substudy|Lack of Efficacy|0|||
33607064|NCT01962441|63007235|FG002|Retreatment Substudy|Lack of Efficacy|0|||
33607065|NCT01962441|63007233|FG000|Retreatment Substudy|Lost to Follow-up|1|||
33607066|NCT01962441|63007234|FG001|Retreatment Substudy|Lost to Follow-up|0|||
33607067|NCT01962441|63007235|FG002|Retreatment Substudy|Lost to Follow-up|0|||
33607068|NCT01638013|63007247|FG000|Overall Study|Adverse Event|36|||
33607069|NCT01638013|63007248|FG001|Overall Study|Adverse Event|29|||
33607070|NCT01638013|63007249|FG002|Overall Study|Adverse Event|48|||
33607071|NCT01638013|63007247|FG000|Overall Study|Lack of Efficacy|39|||
33607072|NCT01638013|63007248|FG001|Overall Study|Lack of Efficacy|11|||
33607073|NCT01638013|63007249|FG002|Overall Study|Lack of Efficacy|14|||
33607074|NCT01638013|63007247|FG000|Overall Study|Protocol Violation|10|||
33607075|NCT01638013|63007248|FG001|Overall Study|Protocol Violation|7|||
33607076|NCT01638013|63007249|FG002|Overall Study|Protocol Violation|11|||
33607077|NCT01638013|63007247|FG000|Overall Study|Met discontinuation criteria|4|||
33445135|NCT00295490|62820787|FG001|Overall Study|Withdrawal by Subject|2|||
33445136|NCT00295490|62820788|FG002|Overall Study|Withdrawal by Subject|0|||
33445137|NCT00295490|62820789|FG003|Overall Study|Withdrawal by Subject|1|||
33445138|NCT00295490|62820786|FG000|Overall Study|Lost to Follow-up|0|||
33445139|NCT00295490|62820787|FG001|Overall Study|Lost to Follow-up|0|||
33445140|NCT00295490|62820788|FG002|Overall Study|Lost to Follow-up|1|||
33445141|NCT00295490|62820789|FG003|Overall Study|Lost to Follow-up|0|||
33445142|NCT00295490|62820786|FG000|Overall Study|Adverse Event|1|||
33445143|NCT00295490|62820787|FG001|Overall Study|Adverse Event|0|||
33445144|NCT00295490|62820788|FG002|Overall Study|Adverse Event|0|||
33445145|NCT00295490|62820789|FG003|Overall Study|Adverse Event|0|||
33445146|NCT00295490|62820786|FG000|Overall Study|Other|0|||
33445147|NCT00295490|62820787|FG001|Overall Study|Other|2|||
33445148|NCT00295490|62820788|FG002|Overall Study|Other|0|||
33445149|NCT00295490|62820789|FG003|Overall Study|Other|1|||
33445150|NCT00305006|62820801|FG000|Overall Study|Withdrawal by Subject|1|||
33445151|NCT00305006|62820802|FG001|Overall Study|Withdrawal by Subject|0|||
33445152|NCT00305006|62820801|FG000|Overall Study|Failure to complete pretest|0|||
33445153|NCT00305006|62820802|FG001|Overall Study|Failure to complete pretest|1|||
33445154|NCT00319436|62820810|FG000|Overall Study|Withdrawal by Subject|6|||
33445155|NCT00319436|62820811|FG001|Overall Study|Withdrawal by Subject|7|||
33445156|NCT00319046|62820817|FG000|Overall Study|withdrawal of subject's consent|7|||
33445157|NCT00319046|62820817|FG000|Overall Study|administrative reason|1|||
33445158|NCT00303602|62820823|FG000|Overall Study|Adverse Event|2|||
33445159|NCT00303602|62820824|FG001|Overall Study|Adverse Event|2|||
33445160|NCT00303602|62820823|FG000|Overall Study|Withdrawal by Subject|5|||
33445161|NCT00303602|62820824|FG001|Overall Study|Withdrawal by Subject|6|||
33445162|NCT00303602|62820823|FG000|Overall Study|Lost to Follow-up|5|||
33445163|NCT00303602|62820824|FG001|Overall Study|Lost to Follow-up|2|||
33445164|NCT00303602|62820823|FG000|Overall Study|Protocol entry criteria not met|2|||
33445165|NCT00303602|62820824|FG001|Overall Study|Protocol entry criteria not met|2|||
33445166|NCT00303602|62820823|FG000|Overall Study|Physician Decision|2|||
33445167|NCT00303602|62820824|FG001|Overall Study|Physician Decision|1|||
33445168|NCT00303602|62820823|FG000|Overall Study|Noncompliance|2|||
33445169|NCT00303602|62820824|FG001|Overall Study|Noncompliance|2|||
33445170|NCT00303602|62820823|FG000|Overall Study|Protocol Violation|1|||
33445171|NCT00303602|62820824|FG001|Overall Study|Protocol Violation|0|||
33445172|NCT00299130|62820833|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
33445173|NCT00299130|62820834|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
33445174|NCT00299130|62820835|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
33445175|NCT00299130|62820833|FG000|Treatment Period (up to 5 Years)|Death|1|||
33445176|NCT00299130|62820834|FG001|Treatment Period (up to 5 Years)|Death|3|||
33445177|NCT00299130|62820835|FG002|Treatment Period (up to 5 Years)|Death|1|||
33445178|NCT00299130|62820833|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
33445179|NCT00299130|62820834|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
33445180|NCT00299130|62820835|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
33445181|NCT00299130|62820833|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
33445182|NCT00299130|62820834|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
33445183|NCT00299130|62820835|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
33607078|NCT01638013|63007248|FG001|Overall Study|Met discontinuation criteria|0|||
33607079|NCT01638013|63007249|FG002|Overall Study|Met discontinuation criteria|7|||
33607080|NCT01638013|63007247|FG000|Overall Study|Subject Lost to Follow up|1|||
33445184|NCT00299130|62820833|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
33445185|NCT00299130|62820834|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
33607081|NCT01638013|63007248|FG001|Overall Study|Subject Lost to Follow up|0|||
33445186|NCT00299130|62820835|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
33445187|NCT00299130|62820833|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
33445188|NCT00299130|62820834|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
33445189|NCT00299130|62820835|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
33445190|NCT00299130|62820833|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
33445191|NCT00299130|62820834|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
33445192|NCT00299130|62820835|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
33445193|NCT00299130|62820833|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
33445194|NCT00299130|62820834|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
33445195|NCT00299130|62820835|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
33445196|NCT00299130|62820833|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
33445197|NCT00299130|62820834|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
33445198|NCT00299130|62820835|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
33445199|NCT00299130|62820833|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
33445200|NCT00299130|62820834|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
33445201|NCT00299130|62820835|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
33445202|NCT00299130|62820833|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
33445203|NCT00299130|62820834|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
33445204|NCT00299130|62820835|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
33445205|NCT00299130|62820833|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
33445206|NCT00299130|62820834|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
33445207|NCT00299130|62820835|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
33445208|NCT00299130|62820833|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
33445209|NCT00299130|62820834|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
33445210|NCT00299130|62820835|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
33445211|NCT00299130|62820833|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
33445212|NCT00299130|62820834|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
33445213|NCT00299130|62820835|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
33445214|NCT00299130|62820833|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
33445215|NCT00299130|62820834|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
33445216|NCT00299130|62820835|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
33445217|NCT00299130|62820833|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
33445218|NCT00299130|62820834|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
33445219|NCT00299130|62820835|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
33445220|NCT00299130|62820833|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
33445221|NCT00299130|62820834|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
33445222|NCT00299130|62820835|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
33445223|NCT00288054|62820850|FG000|Overall Study|Protocol Violation|2|||
33445224|NCT00288054|62820850|FG000|Overall Study|Lack of Efficacy|16|||
33445225|NCT00288054|62820850|FG000|Overall Study|Adverse Event|3|||
33445226|NCT00288054|62820850|FG000|Overall Study|Withdrawal by Subject|1|||
33445227|NCT00288054|62820850|FG000|Overall Study|Not protocol specified|2|||
33607082|NCT01638013|63007249|FG002|Overall Study|Subject Lost to Follow up|1|||
33607083|NCT01638013|63007247|FG000|Overall Study|Miscellaneous|25|||
33445228|NCT00287586|62820858|FG000|Overall Study|Withdrew Consent|19|||
33445229|NCT00287586|62820859|FG001|Overall Study|Withdrew Consent|30|||
33445230|NCT00287586|62820858|FG000|Overall Study|Lost to Follow-up|5|||
33445231|NCT00287586|62820859|FG001|Overall Study|Lost to Follow-up|4|||
33445232|NCT00287586|62820858|FG000|Overall Study|Death|2|||
33445233|NCT00287586|62820859|FG001|Overall Study|Death|3|||
33445234|NCT00287586|62820858|FG000|Overall Study|Elevated Hematocrit|3|||
33445235|NCT00287586|62820859|FG001|Overall Study|Elevated Hematocrit|0|||
33445236|NCT00287586|62820858|FG000|Overall Study|Rash|3|||
33607084|NCT01638013|63007248|FG001|Overall Study|Miscellaneous|19|||
33607085|NCT01638013|63007249|FG002|Overall Study|Miscellaneous|23|||
33445237|NCT00287586|62820859|FG001|Overall Study|Rash|0|||
33445238|NCT00287586|62820858|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
33445239|NCT00287586|62820859|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
33323483|NCT01222520|62699821|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
33323484|NCT01222520|62699820|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
33323485|NCT01222520|62699821|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
33323486|NCT01222520|62699820|FG000|Double-blind Period|Adverse Event|0|||
33323487|NCT01222520|62699821|FG001|Double-blind Period|Adverse Event|1|||
33445240|NCT00287586|62820858|FG000|Overall Study|Stroke|2|||
33445241|NCT00287586|62820859|FG001|Overall Study|Stroke|0|||
33445242|NCT00287586|62820858|FG000|Overall Study|Myocardial Infarction|1|||
33445243|NCT00287586|62820859|FG001|Overall Study|Myocardial Infarction|0|||
33445244|NCT00287586|62820858|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
33607086|NCT01638013|63007247|FG000|Overall Study|Withdrawal of Consent|16|||
33607087|NCT01638013|63007248|FG001|Overall Study|Withdrawal of Consent|12|||
33323488|NCT01222520|62699820|FG000|Double-blind Period|Lack of Efficacy|0|||
33445245|NCT00287586|62820859|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
33445246|NCT00287586|62820858|FG000|Overall Study|Cognitive Impairment|1|||
33445247|NCT00287586|62820859|FG001|Overall Study|Cognitive Impairment|0|||
33445248|NCT00287586|62820858|FG000|Overall Study|Pancreatic Cancer|1|||
33445249|NCT00287586|62820859|FG001|Overall Study|Pancreatic Cancer|3|||
33445250|NCT00287586|62820858|FG000|Overall Study|Sleep Apnea|1|||
33445251|NCT00287586|62820859|FG001|Overall Study|Sleep Apnea|0|||
33445252|NCT00287586|62820858|FG000|Overall Study|Shoulder Pain|1|||
33445253|NCT00287586|62820859|FG001|Overall Study|Shoulder Pain|0|||
33445254|NCT00287586|62820858|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
33445255|NCT00287586|62820859|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
33445256|NCT00287586|62820858|FG000|Overall Study|Nonadherence|1|||
33445257|NCT00287586|62820859|FG001|Overall Study|Nonadherence|1|||
33445258|NCT00287586|62820858|FG000|Overall Study|Enrolled in Another Study|1|||
33445259|NCT00287586|62820859|FG001|Overall Study|Enrolled in Another Study|0|||
33445260|NCT00287586|62820858|FG000|Overall Study|Major Depression|0|||
33445261|NCT00287586|62820859|FG001|Overall Study|Major Depression|2|||
33445262|NCT00287586|62820858|FG000|Overall Study|Lung Cancer|0|||
33445263|NCT00287586|62820859|FG001|Overall Study|Lung Cancer|2|||
33445264|NCT00287586|62820858|FG000|Overall Study|Elevated IPSS Score|0|||
33445265|NCT00287586|62820859|FG001|Overall Study|Elevated IPSS Score|1|||
33445266|NCT00287586|62820858|FG000|Overall Study|Retroperitoneal Cancer|0|||
33445267|NCT00287586|62820859|FG001|Overall Study|Retroperitoneal Cancer|1|||
33445268|NCT00287586|62820858|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
33445269|NCT00287586|62820859|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
33445270|NCT00287586|62820858|FG000|Overall Study|Mood Swings and Irritability|0|||
33445271|NCT00287586|62820859|FG001|Overall Study|Mood Swings and Irritability|1|||
33445272|NCT00287586|62820858|FG000|Overall Study|Bradycardia|0|||
33445273|NCT00287586|62820859|FG001|Overall Study|Bradycardia|1|||
33445274|NCT00287586|62820858|FG000|Overall Study|Itchy Swollen Eyes|0|||
33445275|NCT00287586|62820859|FG001|Overall Study|Itchy Swollen Eyes|1|||
33607088|NCT01638013|63007249|FG002|Overall Study|Withdrawal of Consent|16|||
33607089|NCT01638013|63007247|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
33607090|NCT01638013|63007248|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
33607091|NCT01638013|63007249|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
33607092|NCT01637623|63007264|FG000|Overall Study|Lost to Follow-up|0|||
33607093|NCT01637623|63007265|FG001|Overall Study|Lost to Follow-up|0|||
33607094|NCT01637623|63007266|FG002|Overall Study|Lost to Follow-up|2|||
33607095|NCT01637623|63007264|FG000|Overall Study|Physician Decision|1|||
33607096|NCT01637623|63007265|FG001|Overall Study|Physician Decision|0|||
33607097|NCT01637623|63007266|FG002|Overall Study|Physician Decision|1|||
33607098|NCT01962207|63007278|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
33607099|NCT01962207|63007279|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
33607100|NCT01962207|63007280|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
33607101|NCT01962207|63007281|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
33607102|NCT01962207|63007278|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
33607103|NCT01962207|63007279|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
33607104|NCT01962207|63007280|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
33607105|NCT01962207|63007281|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
33607106|NCT01962207|63007278|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
33607107|NCT01962207|63007279|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
33607108|NCT01962207|63007280|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
33607109|NCT01962207|63007281|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
33607110|NCT01962207|63007278|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
33607111|NCT01962207|63007279|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
33607112|NCT01962207|63007280|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
33607113|NCT01962207|63007281|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
33323489|NCT01222520|62699821|FG001|Double-blind Period|Lack of Efficacy|1|||
33445276|NCT00287586|62820858|FG000|Overall Study|Recurrent Melanoma|0|||
33607114|NCT01962207|63007278|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
33445277|NCT00287586|62820859|FG001|Overall Study|Recurrent Melanoma|1|||
33445278|NCT00287118|62820865|FG000|Overall Study|Adverse Event|30|||
33445279|NCT00287118|62820865|FG000|Overall Study|Death|1|||
33445280|NCT00287118|62820865|FG000|Overall Study|Lack of Efficacy|11|||
33445281|NCT00287118|62820865|FG000|Overall Study|Lost to Follow-up|1|||
33445282|NCT00287118|62820865|FG000|Overall Study|Protocol Violation|2|||
33607115|NCT01962207|63007279|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
33607116|NCT01962207|63007280|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
33607117|NCT01962207|63007281|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
33445283|NCT00287118|62820865|FG000|Overall Study|Other|7|||
33445284|NCT00293202|62820871|FG000|Overall Study|Withdrawal by Subject|1|||
33607118|NCT01962207|63007278|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
33607119|NCT01962207|63007279|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
33607120|NCT01962207|63007280|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
33607121|NCT01962207|63007281|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
33445285|NCT00293202|62820872|FG001|Overall Study|Withdrawal by Subject|2|||
33445286|NCT00293202|62820871|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
33445287|NCT00293202|62820872|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
33445288|NCT00293202|62820871|FG000|Overall Study|on-hold due to fistula maturation time|1|||
33445289|NCT00293202|62820872|FG001|Overall Study|on-hold due to fistula maturation time|0|||
33445290|NCT00298896|62820882|FG000|Overall Study|Death|3|||
33445291|NCT00298896|62820882|FG000|Overall Study|Physician Decision|2|||
33445292|NCT00298896|62820882|FG000|Overall Study|Intercurrent Illness|1|||
33445293|NCT00298896|62820882|FG000|Overall Study|Disease Progression|41|||
33445294|NCT00298896|62820882|FG000|Overall Study|Withdrawal by Subject|2|||
33445295|NCT00298896|62820882|FG000|Overall Study|Assigned to treatment in error|1|||
33445296|NCT00286494|62820889|FG000|Overall Study|Hyperglycemic rescue|12|||
33445297|NCT00286494|62820890|FG001|Overall Study|Hyperglycemic rescue|19|||
33445298|NCT00286494|62820891|FG002|Overall Study|Hyperglycemic rescue|18|||
33445299|NCT00286494|62820889|FG000|Overall Study|Withdrawal by Subject|2|||
33445300|NCT00286494|62820890|FG001|Overall Study|Withdrawal by Subject|10|||
33445301|NCT00286494|62820891|FG002|Overall Study|Withdrawal by Subject|9|||
33445302|NCT00286494|62820889|FG000|Overall Study|Adverse Event|3|||
33445303|NCT00286494|62820890|FG001|Overall Study|Adverse Event|8|||
33445304|NCT00286494|62820891|FG002|Overall Study|Adverse Event|6|||
33607122|NCT01995825|63007297|FG000|Overall Study|Withdrawal by Subject|1|||
33607123|NCT01995825|63007298|FG001|Overall Study|Withdrawal by Subject|0|||
33445305|NCT00286494|62820889|FG000|Overall Study|Physician Decision|5|||
33445306|NCT00286494|62820890|FG001|Overall Study|Physician Decision|5|||
33445307|NCT00286494|62820891|FG002|Overall Study|Physician Decision|1|||
33445308|NCT00286494|62820889|FG000|Overall Study|Lost to Follow-up|3|||
33445309|NCT00286494|62820890|FG001|Overall Study|Lost to Follow-up|1|||
33445310|NCT00286494|62820891|FG002|Overall Study|Lost to Follow-up|3|||
33445311|NCT00286494|62820889|FG000|Overall Study|Protocol Violation|1|||
33445312|NCT00286494|62820890|FG001|Overall Study|Protocol Violation|1|||
33445313|NCT00286494|62820891|FG002|Overall Study|Protocol Violation|2|||
33445314|NCT00298740|62820899|FG000|Overall Study|Lack of Efficacy|6|||
33445315|NCT00298740|62820899|FG000|Overall Study|Withdrawal by Subject|3|||
33445316|NCT00285012|62820905|FG000|Assigned to Study Treatment (Tx)|Other|2|||
33445317|NCT00285012|62820906|FG001|Assigned to Study Treatment (Tx)|Other|3|||
33445318|NCT00285012|62820905|FG000|Received Study Tx|Death|2|||
33445319|NCT00285012|62820906|FG001|Received Study Tx|Death|1|||
33445320|NCT00285012|62820905|FG000|Received Study Tx|Adverse Event|5|||
33445321|NCT00285012|62820906|FG001|Received Study Tx|Adverse Event|11|||
33445322|NCT00285012|62820905|FG000|Received Study Tx|Lack of Efficacy|0|||
33445323|NCT00285012|62820906|FG001|Received Study Tx|Lack of Efficacy|3|||
33445324|NCT00285012|62820905|FG000|Received Study Tx|Lost to Follow-up|29|||
33445325|NCT00285012|62820906|FG001|Received Study Tx|Lost to Follow-up|31|||
33445326|NCT00285012|62820905|FG000|Received Study Tx|Withdrawal by Subject|31|||
33445327|NCT00285012|62820906|FG001|Received Study Tx|Withdrawal by Subject|43|||
33445328|NCT00285012|62820905|FG000|Received Study Tx|Other|5|||
33445329|NCT00285012|62820906|FG001|Received Study Tx|Other|5|||
33445330|NCT00284934|62820914|FG000|Overall Study|Adverse Event|1|||
33445331|NCT00284934|62820915|FG001|Overall Study|Adverse Event|2|||
33445332|NCT00284934|62820914|FG000|Overall Study|Other reasons|3|||
33445333|NCT00284934|62820915|FG001|Overall Study|Other reasons|1|||
33445334|NCT00284856|62820924|FG000|Overall Study|Adverse Event|3|||
33445335|NCT00284856|62820925|FG001|Overall Study|Adverse Event|3|||
33445336|NCT00284856|62820926|FG002|Overall Study|Adverse Event|3|||
33445337|NCT00284856|62820924|FG000|Overall Study|Lack of Efficacy|2|||
33445338|NCT00284856|62820925|FG001|Overall Study|Lack of Efficacy|1|||
33445339|NCT00284856|62820926|FG002|Overall Study|Lack of Efficacy|8|||
33445340|NCT00284856|62820924|FG000|Overall Study|Lost to Follow-up|25|||
33445341|NCT00284856|62820925|FG001|Overall Study|Lost to Follow-up|21|||
33445342|NCT00284856|62820926|FG002|Overall Study|Lost to Follow-up|22|||
33607124|NCT01995357|63007304|FG000|Period 5|Lack of Efficacy|1|||
33445343|NCT00284856|62820924|FG000|Overall Study|Protocol Violation|5|||
33445344|NCT00284856|62820925|FG001|Overall Study|Protocol Violation|4|||
33445345|NCT00284856|62820926|FG002|Overall Study|Protocol Violation|5|||
33445346|NCT00284856|62820924|FG000|Overall Study|Withdrawal by Subject|12|||
33445347|NCT00284856|62820925|FG001|Overall Study|Withdrawal by Subject|16|||
33445348|NCT00284856|62820926|FG002|Overall Study|Withdrawal by Subject|18|||
33445349|NCT00284856|62820924|FG000|Overall Study|Other|4|||
33445350|NCT00284856|62820925|FG001|Overall Study|Other|5|||
33445351|NCT00284856|62820926|FG002|Overall Study|Other|4|||
33445352|NCT00298272|62820936|FG000|Double-blind Phase|Adverse Event|2|||
33445353|NCT00298272|62820937|FG001|Double-blind Phase|Adverse Event|0|||
33445354|NCT00298272|62820936|FG000|Double-blind Phase|Failure to Return|2|||
33445355|NCT00298272|62820937|FG001|Double-blind Phase|Failure to Return|0|||
33445356|NCT00298272|62820936|FG000|Double-blind Phase|Protocol Violation|2|||
33445357|NCT00298272|62820937|FG001|Double-blind Phase|Protocol Violation|0|||
33445358|NCT00298272|62820936|FG000|Double-blind Phase|Withdrawal by Subject|2|||
33445359|NCT00298272|62820937|FG001|Double-blind Phase|Withdrawal by Subject|0|||
33445360|NCT00298272|62820936|FG000|Open Label Retreatment Phase|Adverse Event|1|||
33445361|NCT00298272|62820937|FG001|Open Label Retreatment Phase|Adverse Event|2|||
33445362|NCT00298272|62820936|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
33445363|NCT00298272|62820937|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
33445364|NCT00298272|62820936|FG000|Open Label Retreatment Phase|Failure to Return|1|||
33445365|NCT00298272|62820937|FG001|Open Label Retreatment Phase|Failure to Return|0|||
33445366|NCT00298272|62820936|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
33445367|NCT00298272|62820937|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
33445368|NCT00298272|62820936|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
33445369|NCT00298272|62820937|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
33445370|NCT00298272|62820936|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
33445371|NCT00298272|62820937|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
33445372|NCT00298272|62820936|FG000|Safety Follow-up Phase|Failure to Return|1|||
33445373|NCT00298272|62820937|FG001|Safety Follow-up Phase|Failure to Return|1|||
33445374|NCT00298272|62820936|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
33445375|NCT00298272|62820937|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
33445376|NCT00298272|62820936|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
33445377|NCT00298272|62820937|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
33445378|NCT00283842|62820951|FG000|Overall Study|Adverse Event|8|||
33445379|NCT00283842|62820952|FG001|Overall Study|Adverse Event|7|||
33445380|NCT00283842|62820953|FG002|Overall Study|Adverse Event|21|||
33445381|NCT00283842|62820954|FG003|Overall Study|Adverse Event|21|||
33445382|NCT00283842|62820955|FG004|Overall Study|Adverse Event|5|||
33445383|NCT00283842|62820951|FG000|Overall Study|Protocol Violation|1|||
33445384|NCT00283842|62820952|FG001|Overall Study|Protocol Violation|5|||
33445385|NCT00283842|62820953|FG002|Overall Study|Protocol Violation|4|||
33445386|NCT00283842|62820954|FG003|Overall Study|Protocol Violation|0|||
33445387|NCT00283842|62820955|FG004|Overall Study|Protocol Violation|0|||
33445388|NCT00283842|62820951|FG000|Overall Study|Protocol deviation|0|||
33445389|NCT00283842|62820952|FG001|Overall Study|Protocol deviation|0|||
33445390|NCT00283842|62820953|FG002|Overall Study|Protocol deviation|0|||
33445391|NCT00283842|62820954|FG003|Overall Study|Protocol deviation|0|||
33445392|NCT00283842|62820955|FG004|Overall Study|Protocol deviation|2|||
33445393|NCT00283842|62820951|FG000|Overall Study|Withdrawal by Subject|2|||
33445394|NCT00283842|62820952|FG001|Overall Study|Withdrawal by Subject|1|||
33445395|NCT00283842|62820953|FG002|Overall Study|Withdrawal by Subject|1|||
33445396|NCT00283842|62820954|FG003|Overall Study|Withdrawal by Subject|5|||
33445397|NCT00283842|62820955|FG004|Overall Study|Withdrawal by Subject|4|||
33445398|NCT00283842|62820951|FG000|Overall Study|Lack of Efficacy|1|||
33445399|NCT00283842|62820952|FG001|Overall Study|Lack of Efficacy|3|||
33445400|NCT00283842|62820953|FG002|Overall Study|Lack of Efficacy|1|||
33445401|NCT00283842|62820954|FG003|Overall Study|Lack of Efficacy|0|||
33445402|NCT00283842|62820955|FG004|Overall Study|Lack of Efficacy|3|||
33445403|NCT00283842|62820951|FG000|Overall Study|Lost to Follow-up|0|||
33445404|NCT00283842|62820952|FG001|Overall Study|Lost to Follow-up|2|||
33445405|NCT00283842|62820953|FG002|Overall Study|Lost to Follow-up|4|||
33445406|NCT00283842|62820954|FG003|Overall Study|Lost to Follow-up|1|||
33445407|NCT00283842|62820955|FG004|Overall Study|Lost to Follow-up|1|||
33445408|NCT00298038|62820969|FG000|Overall Study|Lost to Follow-up|0|||
33445409|NCT00298038|62820970|FG001|Overall Study|Lost to Follow-up|1|||
33445410|NCT00298038|62820969|FG000|Overall Study|Liver Transplant|0|||
33445411|NCT00298038|62820970|FG001|Overall Study|Liver Transplant|1|||
33445412|NCT00298038|62820969|FG000|Overall Study|Protocol Violation|1|||
33445413|NCT00298038|62820970|FG001|Overall Study|Protocol Violation|3|||
33607125|NCT01995357|63007305|FG001|Period 5|Lack of Efficacy|0|||
33323490|NCT01222520|62699820|FG000|Double-blind Period|Study medication stolen|1|||
33323491|NCT01222520|62699821|FG001|Double-blind Period|Study medication stolen|0|||
33445414|NCT00298038|62820969|FG000|Overall Study|Death|6|||
33445415|NCT00298038|62820970|FG001|Overall Study|Death|3|||
33445416|NCT00298038|62820969|FG000|Overall Study|Withdrawal by Subject|6|||
33445417|NCT00298038|62820970|FG001|Overall Study|Withdrawal by Subject|9|||
33445418|NCT00298038|62820969|FG000|Overall Study|Adverse Event|8|||
33445419|NCT00298038|62820970|FG001|Overall Study|Adverse Event|7|||
33445420|NCT00298038|62820969|FG000|Overall Study|Breakthrough overt HE episode|28|||
33445421|NCT00298038|62820970|FG001|Overall Study|Breakthrough overt HE episode|69|||
33445422|NCT00298038|62820969|FG000|Overall Study|Noncompliance|1|||
33445423|NCT00298038|62820970|FG001|Overall Study|Noncompliance|0|||
33445424|NCT00298038|62820969|FG000|Overall Study|Cocaine Abuse|1|||
33445425|NCT00298038|62820970|FG001|Overall Study|Cocaine Abuse|0|||
33445426|NCT00298038|62820969|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
33445427|NCT00298038|62820970|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
33445428|NCT00283686|62820980|FG000|Overall Study|Death|1|||
33445429|NCT00283686|62820981|FG001|Overall Study|Death|1|||
33445430|NCT00283686|62820982|FG002|Overall Study|Death|1|||
33445431|NCT00283686|62820983|FG003|Overall Study|Death|0|||
33445432|NCT00283686|62820980|FG000|Overall Study|Lost to Follow-up|21|||
33445433|NCT00283686|62820981|FG001|Overall Study|Lost to Follow-up|31|||
33445434|NCT00283686|62820982|FG002|Overall Study|Lost to Follow-up|26|||
33445435|NCT00283686|62820983|FG003|Overall Study|Lost to Follow-up|20|||
33445436|NCT00283686|62820980|FG000|Overall Study|Less than full participation|7|||
33445437|NCT00283686|62820981|FG001|Overall Study|Less than full participation|9|||
33445438|NCT00283686|62820982|FG002|Overall Study|Less than full participation|6|||
33445439|NCT00283686|62820983|FG003|Overall Study|Less than full participation|12|||
33445440|NCT00297882|62820995|FG000|Day 14|Lack of Efficacy|12|||
33445441|NCT00297882|62820996|FG001|Day 14|Lack of Efficacy|49|||
33445442|NCT00297882|62820995|FG000|Day 28|Lost to Follow-up|13|||
33445443|NCT00297882|62820996|FG001|Day 28|Lost to Follow-up|23|||
33445444|NCT00297882|62820995|FG000|Day 28|Lack of Efficacy|3|||
33445445|NCT00297882|62820996|FG001|Day 28|Lack of Efficacy|0|||
33445446|NCT00297648|62821004|FG000|Overall Study|Adverse Event|13|||
33445447|NCT00297648|62821004|FG000|Overall Study|Lack of Efficacy|18|||
33445448|NCT00297648|62821004|FG000|Overall Study|Lost to Follow-up|1|||
33445449|NCT00297648|62821004|FG000|Overall Study|Withdrawal by Subject|3|||
33445450|NCT00297648|62821004|FG000|Overall Study|Other: Incompliance|1|||
33445451|NCT00283296|62821008|FG000|Overall Study|in-home trial not completed|5|||
33445452|NCT00297492|62821016|FG000|Set Quit Date|Lost to Follow-up|7|||
33445453|NCT00297492|62821017|FG001|Set Quit Date|Lost to Follow-up|13|||
33445454|NCT00297492|62821018|FG002|Set Quit Date|Lost to Follow-up|5|||
33445455|NCT00297492|62821016|FG000|6 Month Follow-up|Lost to Follow-up|63|||
33445456|NCT00297492|62821017|FG001|6 Month Follow-up|Lost to Follow-up|49|||
33445457|NCT00297492|62821018|FG002|6 Month Follow-up|Lost to Follow-up|27|||
33445458|NCT00297258|62821026|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
33445459|NCT00297258|62821026|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
33445460|NCT00297258|62821026|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
33445461|NCT00297258|62821026|FG000|Overall Study|Intercurrent Illness|3|||
33445462|NCT00297258|62821026|FG000|Overall Study|Intercurrent Death|2|||
33445463|NCT00297258|62821026|FG000|Overall Study|Deteriorization of General Condition|1|||
33445464|NCT00297258|62821026|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
33445465|NCT00297258|62821026|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
33445466|NCT00297258|62821026|FG000|Overall Study|Switch to Commercial Treatment|1|||
33445467|NCT00297258|62821026|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
33445468|NCT00496769|62821035|FG000|Double Blind|>=1 reason assigned per patient|558|||
33445469|NCT00496769|62821036|FG001|Double Blind|>=1 reason assigned per patient|649|||
33445470|NCT00496769|62821037|FG002|Double Blind|>=1 reason assigned per patient|0|||
33445471|NCT00496769|62821035|FG000|Open Label|>=1 reason assigned per patient|0|||
33445472|NCT00496769|62821036|FG001|Open Label|>=1 reason assigned per patient|0|||
33445473|NCT00496769|62821037|FG002|Open Label|>=1 reason assigned per patient|1011|||
33445474|NCT00478673|62821046|FG000|30-Days Post-Procedure|Death|2|||
33445475|NCT00478673|62821046|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
33445476|NCT00478673|62821046|FG000|30-Days Post-Procedure|Missed Visit|7|||
33445477|NCT00478673|62821046|FG000|12-Months Post-Procedure|Death|23|||
33445478|NCT00478673|62821046|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
33445479|NCT00478673|62821046|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
33445480|NCT00478673|62821046|FG000|12-Months Post-Procedure|Missed Visit|25|||
33445481|NCT00478673|62821046|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
33445482|NCT00488345|62821053|FG000|Overall Study|Adverse Event|0|||
33445483|NCT00488345|62821054|FG001|Overall Study|Adverse Event|1|||
33445484|NCT00488345|62821055|FG002|Overall Study|Adverse Event|1|||
33445485|NCT00488345|62821053|FG000|Overall Study|Unable to administer antibiotics at home|0|||
33445486|NCT00488345|62821054|FG001|Overall Study|Unable to administer antibiotics at home|1|||
33445487|NCT00488345|62821055|FG002|Overall Study|Unable to administer antibiotics at home|0|||
33445488|NCT00488345|62821053|FG000|Overall Study|Institutional Review Board review|0|||
33445489|NCT00488345|62821054|FG001|Overall Study|Institutional Review Board review|0|||
33607126|NCT01995357|63007306|FG002|Period 5|Lack of Efficacy|0|||
33445490|NCT00488345|62821055|FG002|Overall Study|Institutional Review Board review|1|||
33445491|NCT00488345|62821053|FG000|Overall Study|Surgical team recommendation|0|||
33445492|NCT00488345|62821054|FG001|Overall Study|Surgical team recommendation|1|||
33445493|NCT00488345|62821055|FG002|Overall Study|Surgical team recommendation|0|||
33445494|NCT00488345|62821053|FG000|Overall Study|Parent/legal guardian request|0|||
33445495|NCT00488345|62821054|FG001|Overall Study|Parent/legal guardian request|1|||
33445496|NCT00488345|62821055|FG002|Overall Study|Parent/legal guardian request|1|||
33445497|NCT00283062|62821068|FG000|Overall Study|Did not receive any study medication|5|||
33445498|NCT00283062|62821069|FG001|Overall Study|Did not receive any study medication|4|||
33445499|NCT00283062|62821070|FG002|Overall Study|Did not receive any study medication|36|||
33445500|NCT00283062|62821071|FG003|Overall Study|Did not receive any study medication|45|||
33445501|NCT00283062|62821068|FG000|Overall Study|Adverse Event|2|||
33445502|NCT00283062|62821069|FG001|Overall Study|Adverse Event|0|||
33445503|NCT00283062|62821070|FG002|Overall Study|Adverse Event|1|||
33445504|NCT00283062|62821071|FG003|Overall Study|Adverse Event|0|||
33445505|NCT00283062|62821068|FG000|Overall Study|Lost to Follow-up|1|||
33445506|NCT00283062|62821069|FG001|Overall Study|Lost to Follow-up|0|||
33445507|NCT00283062|62821070|FG002|Overall Study|Lost to Follow-up|1|||
33445508|NCT00283062|62821071|FG003|Overall Study|Lost to Follow-up|0|||
33445509|NCT00283062|62821068|FG000|Overall Study|Progressive disease|0|||
33607127|NCT01995357|63007307|FG003|Period 5|Lack of Efficacy|0|||
33607128|NCT01995357|63007308|FG004|Period 5|Lack of Efficacy|0|||
33607129|NCT01995357|63007309|FG005|Period 5|Lack of Efficacy|0|||
33607130|NCT01995357|63007304|FG000|Period 5|Adverse Event|1|||
33607131|NCT01995357|63007305|FG001|Period 5|Adverse Event|0|||
33607132|NCT01995357|63007306|FG002|Period 5|Adverse Event|1|||
33607133|NCT01995357|63007307|FG003|Period 5|Adverse Event|0|||
33607134|NCT01995357|63007308|FG004|Period 5|Adverse Event|0|||
33607135|NCT01995357|63007309|FG005|Period 5|Adverse Event|0|||
33607136|NCT01638559|63007325|FG000|Overall Study|Lost to Follow-up|1|||
33607137|NCT01638559|63007325|FG000|Overall Study|Withdrawal by Subject|1|||
33607138|NCT01638559|63007325|FG000|Overall Study|Subject declined to travel for biopsy|1|||
33607139|NCT01756456|63007346|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
33607140|NCT01756456|63007347|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
33607141|NCT01756456|63007348|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
33607142|NCT01756456|63007349|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
33607143|NCT01756456|63007350|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
33607144|NCT01756456|63007351|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
33607145|NCT01756456|63007346|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
33607146|NCT01756456|63007347|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
33607147|NCT01756456|63007348|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
33323492|NCT01221350|62699829|FG000|Overall Study|Discontinued intervention (GERD)|1|||
33323493|NCT01221350|62699830|FG001|Overall Study|Discontinued intervention (GERD)|0|||
33323494|NCT01221350|62699829|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
33323495|NCT01221350|62699830|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
33323496|NCT01221350|62699829|FG000|Overall Study|Withdrawal by Subject|4|||
33323497|NCT01221350|62699830|FG001|Overall Study|Withdrawal by Subject|2|||
33323498|NCT01221272|62699838|FG000|Period 1|Adverse Event|2|||
33323499|NCT01221272|62699839|FG001|Period 1|Adverse Event|0|||
33323500|NCT01221272|62699838|FG000|Period 1|Consent Withdrawal|0|||
33323501|NCT01221272|62699839|FG001|Period 1|Consent Withdrawal|1|||
33323502|NCT01221272|62699838|FG000|Period 1|Significant Dosing Noncompliance|0|||
33323503|NCT01221272|62699839|FG001|Period 1|Significant Dosing Noncompliance|1|||
33323504|NCT01221272|62699838|FG000|Period 2|Adverse Event|0|||
33323505|NCT01221272|62699839|FG001|Period 2|Adverse Event|2|||
33323506|NCT01220414|62699850|FG000|Overall Study|Withdrawal by Subject|1|||
33323507|NCT01220414|62699851|FG001|Overall Study|Withdrawal by Subject|0|||
33323508|NCT01220414|62699852|FG002|Overall Study|Withdrawal by Subject|0|||
33323509|NCT01220414|62699853|FG003|Overall Study|Withdrawal by Subject|1|||
33323510|NCT01128894|62699862|FG000|Overall Study|Adverse Event|31|||
33323511|NCT01128894|62699863|FG001|Overall Study|Adverse Event|41|||
33323512|NCT01128894|62699862|FG000|Overall Study|Protocol Violation|2|||
33323513|NCT01128894|62699863|FG001|Overall Study|Protocol Violation|1|||
33323514|NCT01128894|62699862|FG000|Overall Study|Noncompliance|4|||
33323515|NCT01128894|62699863|FG001|Overall Study|Noncompliance|5|||
33445510|NCT00283062|62821069|FG001|Overall Study|Progressive disease|0|||
33445511|NCT00283062|62821070|FG002|Overall Study|Progressive disease|1|||
33323516|NCT01128894|62699862|FG000|Overall Study|Lost to Follow-up|8|||
33323517|NCT01128894|62699863|FG001|Overall Study|Lost to Follow-up|8|||
33323518|NCT01128894|62699862|FG000|Overall Study|Withdrawal by Subject|10|||
33323519|NCT01128894|62699863|FG001|Overall Study|Withdrawal by Subject|12|||
33323520|NCT01128894|62699862|FG000|Overall Study|Physician Decision|2|||
33323521|NCT01128894|62699863|FG001|Overall Study|Physician Decision|1|||
33323522|NCT01128894|62699862|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
33323523|NCT01128894|62699863|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
33445512|NCT00283062|62821071|FG003|Overall Study|Progressive disease|0|||
33445513|NCT00283062|62821068|FG000|Overall Study|Participant did not wish to continue|3|||
33445514|NCT00283062|62821069|FG001|Overall Study|Participant did not wish to continue|2|||
33323524|NCT01220180|62699872|FG000|Overall Study|Lost to Follow-up|76|||
33323525|NCT01220180|62699872|FG000|Overall Study|Other|72|||
33323526|NCT01220180|62699872|FG000|Overall Study|Adverse Event|35|||
33323527|NCT01220180|62699872|FG000|Overall Study|Lack of Efficacy|22|||
33323528|NCT01220180|62699872|FG000|Overall Study|Death|1|||
33323529|NCT01220180|62699872|FG000|Overall Study|Randomized but not treated|1|||
33323530|NCT01220024|62699878|FG000|Overall Study|Lost to Follow-up|1|||
33607148|NCT01756456|63007349|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
33445515|NCT00283062|62821070|FG002|Overall Study|Participant did not wish to continue|1|||
33607149|NCT01756456|63007350|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
33607150|NCT01756456|63007351|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
33607151|NCT01756456|63007346|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
33607152|NCT01756456|63007347|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
33607153|NCT01756456|63007348|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
33607154|NCT01756456|63007349|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
33607155|NCT01756456|63007350|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
33323531|NCT01220024|62699879|FG001|Overall Study|Lost to Follow-up|1|||
33445516|NCT00283062|62821071|FG003|Overall Study|Participant did not wish to continue|0|||
33445517|NCT00283062|62821068|FG000|Overall Study|Undefined|0|||
33445518|NCT00283062|62821069|FG001|Overall Study|Undefined|1|||
33445519|NCT00283062|62821070|FG002|Overall Study|Undefined|1|||
33445520|NCT00283062|62821071|FG003|Overall Study|Undefined|4|||
33445521|NCT00283062|62821068|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
33445522|NCT00283062|62821069|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
33445523|NCT00283062|62821070|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
33445524|NCT00283062|62821071|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
33445525|NCT00282984|62821083|FG000|Overall Study|Death|2|||
33445526|NCT00282984|62821084|FG001|Overall Study|Death|5|||
33445527|NCT00282984|62821083|FG000|Overall Study|Adverse Event|8|||
33445528|NCT00282984|62821084|FG001|Overall Study|Adverse Event|5|||
33445529|NCT00282984|62821083|FG000|Overall Study|Lack of Efficacy|0|||
33445530|NCT00282984|62821084|FG001|Overall Study|Lack of Efficacy|2|||
33445531|NCT00282984|62821083|FG000|Overall Study|Lost to Follow-up|14|||
33445532|NCT00282984|62821084|FG001|Overall Study|Lost to Follow-up|10|||
33445533|NCT00282984|62821083|FG000|Overall Study|Withdrawal by Participant|22|||
33445534|NCT00282984|62821084|FG001|Overall Study|Withdrawal by Participant|34|||
33445535|NCT00282984|62821083|FG000|Overall Study|Participant stopped study medication|2|||
33445536|NCT00282984|62821084|FG001|Overall Study|Participant stopped study medication|2|||
33445537|NCT00282984|62821083|FG000|Overall Study|Participant only allowed phone follow-up|0|||
33445538|NCT00282984|62821084|FG001|Overall Study|Participant only allowed phone follow-up|1|||
33445539|NCT00282984|62821083|FG000|Overall Study|Participant used antipsychosis meds|0|||
33445540|NCT00282984|62821084|FG001|Overall Study|Participant used antipsychosis meds|1|||
33445541|NCT00282984|62821083|FG000|Overall Study|lack of motivation|1|||
33445542|NCT00282984|62821084|FG001|Overall Study|lack of motivation|0|||
33445543|NCT00282984|62821083|FG000|Overall Study|in prison|0|||
33445544|NCT00282984|62821084|FG001|Overall Study|in prison|1|||
33445545|NCT00282984|62821083|FG000|Overall Study|Protocol Violation|2|||
33445546|NCT00282984|62821084|FG001|Overall Study|Protocol Violation|0|||
33445547|NCT00282438|62821092|FG000|Overall Study|Lack of Efficacy|1|||
33445548|NCT00282438|62821093|FG001|Overall Study|Lack of Efficacy|0|||
33445549|NCT00282438|62821092|FG000|Overall Study|Death|0|||
33445550|NCT00282438|62821093|FG001|Overall Study|Death|1|||
33445551|NCT00296400|62821102|FG000|Overall Study|Adverse Event|7|||
33445552|NCT00296400|62821103|FG001|Overall Study|Adverse Event|7|||
33445553|NCT00296400|62821104|FG002|Overall Study|Adverse Event|7|||
33445554|NCT00296400|62821102|FG000|Overall Study|Withdrawal by Subject|5|||
33445555|NCT00296400|62821103|FG001|Overall Study|Withdrawal by Subject|6|||
33445556|NCT00296400|62821104|FG002|Overall Study|Withdrawal by Subject|2|||
33445557|NCT00296400|62821102|FG000|Overall Study|Incorrect enrollment|2|||
33445558|NCT00296400|62821103|FG001|Overall Study|Incorrect enrollment|0|||
33445559|NCT00296400|62821104|FG002|Overall Study|Incorrect enrollment|0|||
33445560|NCT00296400|62821102|FG000|Overall Study|Protocol Violation|1|||
33445561|NCT00296400|62821103|FG001|Overall Study|Protocol Violation|1|||
33445562|NCT00296400|62821104|FG002|Overall Study|Protocol Violation|1|||
33607156|NCT01756456|63007351|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
33445563|NCT00296400|62821102|FG000|Overall Study|Lost to Follow-up|1|||
33445564|NCT00296400|62821103|FG001|Overall Study|Lost to Follow-up|1|||
33445565|NCT00296400|62821104|FG002|Overall Study|Lost to Follow-up|2|||
33445566|NCT00296400|62821102|FG000|Overall Study|Study specific discontinuation criteria|0|||
33445567|NCT00296400|62821103|FG001|Overall Study|Study specific discontinuation criteria|0|||
33445568|NCT00296400|62821104|FG002|Overall Study|Study specific discontinuation criteria|1|||
33607157|NCT01756456|63007346|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
33607158|NCT01756456|63007347|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
33323532|NCT01128738|62699887|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
33445569|NCT00296400|62821102|FG000|Overall Study|Visit 10 was performed earlier|0|||
33445570|NCT00296400|62821103|FG001|Overall Study|Visit 10 was performed earlier|1|||
33445571|NCT00296400|62821104|FG002|Overall Study|Visit 10 was performed earlier|0|||
33445572|NCT00296400|62821102|FG000|Overall Study|Pregnancy|1|||
33445573|NCT00296400|62821103|FG001|Overall Study|Pregnancy|2|||
33445574|NCT00296400|62821104|FG002|Overall Study|Pregnancy|0|||
33445575|NCT00296244|62821117|FG000|Overall Study|Underwent retransplant|0|||
33445576|NCT00296244|62821118|FG001|Overall Study|Underwent retransplant|1|||
33445577|NCT00274716|62821135|FG000|Phase A|Other non-reported reason|4|||
33445578|NCT00274716|62821136|FG001|Phase A|Other non-reported reason|2|||
33445579|NCT00274716|62821137|FG002|Phase A|Other non-reported reason|1|||
33445580|NCT00274716|62821138|FG003|Phase A|Other non-reported reason|2|||
33445581|NCT00274716|62821139|FG004|Phase A|Other non-reported reason|0|||
33445582|NCT00274716|62821140|FG005|Phase A|Other non-reported reason|1|||
33445583|NCT00274716|62821135|FG000|Phase A|Participant moved|0|||
33445584|NCT00274716|62821136|FG001|Phase A|Participant moved|0|||
33445585|NCT00274716|62821137|FG002|Phase A|Participant moved|1|||
33445586|NCT00274716|62821138|FG003|Phase A|Participant moved|0|||
33445587|NCT00274716|62821139|FG004|Phase A|Participant moved|0|||
33445588|NCT00274716|62821140|FG005|Phase A|Participant moved|1|||
33445589|NCT00274716|62821135|FG000|Phase A|Site Terminated|0|||
33445590|NCT00274716|62821136|FG001|Phase A|Site Terminated|0|||
33445591|NCT00274716|62821137|FG002|Phase A|Site Terminated|0|||
33445592|NCT00274716|62821138|FG003|Phase A|Site Terminated|1|||
33445593|NCT00274716|62821139|FG004|Phase A|Site Terminated|0|||
33445594|NCT00274716|62821140|FG005|Phase A|Site Terminated|0|||
33445595|NCT00274716|62821135|FG000|Phase A|Protocol Violation|1|||
33445596|NCT00274716|62821136|FG001|Phase A|Protocol Violation|0|||
33445597|NCT00274716|62821137|FG002|Phase A|Protocol Violation|0|||
33445598|NCT00274716|62821138|FG003|Phase A|Protocol Violation|1|||
33445599|NCT00274716|62821139|FG004|Phase A|Protocol Violation|0|||
33445600|NCT00274716|62821140|FG005|Phase A|Protocol Violation|0|||
33445601|NCT00274716|62821135|FG000|Phase A|Met criteria for discontinuation|1|||
33445602|NCT00274716|62821136|FG001|Phase A|Met criteria for discontinuation|1|||
33445603|NCT00274716|62821137|FG002|Phase A|Met criteria for discontinuation|0|||
33445604|NCT00274716|62821138|FG003|Phase A|Met criteria for discontinuation|0|||
33445605|NCT00274716|62821139|FG004|Phase A|Met criteria for discontinuation|0|||
33445606|NCT00274716|62821140|FG005|Phase A|Met criteria for discontinuation|0|||
33445607|NCT00274716|62821135|FG000|Phase A|Withdrawal by Subject|2|||
33445608|NCT00274716|62821136|FG001|Phase A|Withdrawal by Subject|2|||
33445609|NCT00274716|62821137|FG002|Phase A|Withdrawal by Subject|1|||
33445610|NCT00274716|62821138|FG003|Phase A|Withdrawal by Subject|3|||
33445611|NCT00274716|62821139|FG004|Phase A|Withdrawal by Subject|0|||
33445612|NCT00274716|62821140|FG005|Phase A|Withdrawal by Subject|1|||
33445613|NCT00274716|62821135|FG000|Phase A|Adverse Event|2|||
33445614|NCT00274716|62821136|FG001|Phase A|Adverse Event|3|||
33445615|NCT00274716|62821137|FG002|Phase A|Adverse Event|3|||
33445616|NCT00274716|62821138|FG003|Phase A|Adverse Event|0|||
33445617|NCT00274716|62821139|FG004|Phase A|Adverse Event|2|||
33445618|NCT00274716|62821140|FG005|Phase A|Adverse Event|0|||
33445619|NCT00274716|62821135|FG000|Phase A|Completed but did not enter Phase B|1|||
33445620|NCT00274716|62821136|FG001|Phase A|Completed but did not enter Phase B|2|||
33445621|NCT00274716|62821137|FG002|Phase A|Completed but did not enter Phase B|2|||
33445622|NCT00274716|62821138|FG003|Phase A|Completed but did not enter Phase B|2|||
33445623|NCT00274716|62821139|FG004|Phase A|Completed but did not enter Phase B|1|||
33445624|NCT00274716|62821140|FG005|Phase A|Completed but did not enter Phase B|1|||
33445625|NCT00274716|62821135|FG000|Phase B|Adverse Event|0|||
33445626|NCT00274716|62821136|FG001|Phase B|Adverse Event|0|||
33445627|NCT00274716|62821137|FG002|Phase B|Adverse Event|2|||
33445628|NCT00274716|62821138|FG003|Phase B|Adverse Event|0|||
33445629|NCT00274716|62821139|FG004|Phase B|Adverse Event|0|||
33445630|NCT00274716|62821140|FG005|Phase B|Adverse Event|1|||
33445631|NCT00274716|62821135|FG000|Phase B|Protocol Violation|0|||
33445632|NCT00274716|62821136|FG001|Phase B|Protocol Violation|2|||
33445633|NCT00274716|62821137|FG002|Phase B|Protocol Violation|0|||
33445634|NCT00274716|62821138|FG003|Phase B|Protocol Violation|0|||
33445635|NCT00274716|62821139|FG004|Phase B|Protocol Violation|0|||
33445636|NCT00274716|62821140|FG005|Phase B|Protocol Violation|0|||
33445637|NCT00274716|62821135|FG000|Phase B|Withdrawal by Subject|0|||
33445638|NCT00274716|62821136|FG001|Phase B|Withdrawal by Subject|1|||
33445639|NCT00274716|62821137|FG002|Phase B|Withdrawal by Subject|0|||
33445640|NCT00274716|62821138|FG003|Phase B|Withdrawal by Subject|0|||
33445641|NCT00274716|62821139|FG004|Phase B|Withdrawal by Subject|0|||
33445642|NCT00274716|62821140|FG005|Phase B|Withdrawal by Subject|0|||
33445643|NCT00274716|62821135|FG000|Phase B|Participant moved|1|||
33445644|NCT00274716|62821136|FG001|Phase B|Participant moved|0|||
33445645|NCT00274716|62821137|FG002|Phase B|Participant moved|0|||
33445646|NCT00274716|62821138|FG003|Phase B|Participant moved|0|||
33445647|NCT00274716|62821139|FG004|Phase B|Participant moved|0|||
33445648|NCT00274716|62821140|FG005|Phase B|Participant moved|0|||
33445649|NCT00274716|62821135|FG000|Phase B|Other non-reported reason|0|||
33445650|NCT00274716|62821136|FG001|Phase B|Other non-reported reason|0|||
33445651|NCT00274716|62821137|FG002|Phase B|Other non-reported reason|1|||
33445652|NCT00274716|62821138|FG003|Phase B|Other non-reported reason|1|||
33445653|NCT00274716|62821139|FG004|Phase B|Other non-reported reason|0|||
33445654|NCT00274716|62821140|FG005|Phase B|Other non-reported reason|0|||
33445655|NCT00274716|62821135|FG000|Phase B|Lost to Follow-up|0|||
33445656|NCT00274716|62821136|FG001|Phase B|Lost to Follow-up|1|||
33445657|NCT00274716|62821137|FG002|Phase B|Lost to Follow-up|0|||
33445658|NCT00274716|62821138|FG003|Phase B|Lost to Follow-up|0|||
33445659|NCT00274716|62821139|FG004|Phase B|Lost to Follow-up|0|||
33445660|NCT00274716|62821140|FG005|Phase B|Lost to Follow-up|0|||
33323533|NCT01128738|62699888|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
33445661|NCT00282048|62821158|FG000|Overall Study|Lack of Efficacy|30|||
33445662|NCT00282048|62821158|FG000|Overall Study|Adverse Event|22|||
33445663|NCT00282048|62821158|FG000|Overall Study|Withdrawal by Subject|1|||
33445664|NCT00282048|62821158|FG000|Overall Study|Other|8|||
33445665|NCT00282048|62821158|FG000|Overall Study|Ongoing|1|||
33445666|NCT00474539|62821164|FG000|Infant Series|Withdrawal by Subject|3|||
33445667|NCT00474539|62821165|FG001|Infant Series|Withdrawal by Subject|4|||
33445668|NCT00474539|62821164|FG000|Infant Series|Randomization error|5|||
33445669|NCT00474539|62821165|FG001|Infant Series|Randomization error|0|||
33445670|NCT00474539|62821164|FG000|Infant Series|Lost to Follow-up|2|||
33445671|NCT00474539|62821165|FG001|Infant Series|Lost to Follow-up|1|||
33445672|NCT00474539|62821164|FG000|Infant Series|Protocol Violation|0|||
33445673|NCT00474539|62821165|FG001|Infant Series|Protocol Violation|1|||
33445674|NCT00474539|62821164|FG000|After Infant Series|Lost to Follow-up|3|||
33445675|NCT00474539|62821165|FG001|After Infant Series|Lost to Follow-up|0|||
33445676|NCT00474539|62821164|FG000|After Infant Series|Withdrawal by Subject|1|||
33445677|NCT00474539|62821165|FG001|After Infant Series|Withdrawal by Subject|0|||
33445678|NCT00474539|62821164|FG000|Toddler Dose|Protocol Violation|1|||
33445679|NCT00474539|62821165|FG001|Toddler Dose|Protocol Violation|0|||
33445680|NCT00281580|62821212|FG000|Overall Study|Adverse Event|2|||
33445681|NCT00281580|62821213|FG001|Overall Study|Adverse Event|0|||
33445682|NCT00281580|62821214|FG002|Overall Study|Adverse Event|2|||
33445683|NCT00281580|62821215|FG003|Overall Study|Adverse Event|4|||
33445684|NCT00281580|62821216|FG004|Overall Study|Adverse Event|1|||
33445685|NCT00281580|62821217|FG005|Overall Study|Adverse Event|0|||
33445686|NCT00281580|62821218|FG006|Overall Study|Adverse Event|1|||
33445687|NCT00281580|62821219|FG007|Overall Study|Adverse Event|0|||
33445688|NCT00281580|62821220|FG008|Overall Study|Adverse Event|1|||
33445689|NCT00281580|62821221|FG009|Overall Study|Adverse Event|6|||
33445690|NCT00281580|62821222|FG010|Overall Study|Adverse Event|0|||
33445691|NCT00281580|62821223|FG011|Overall Study|Adverse Event|5|||
33445692|NCT00281580|62821224|FG012|Overall Study|Adverse Event|8|||
33445693|NCT00281580|62821225|FG013|Overall Study|Adverse Event|2|||
33445694|NCT00281580|62821226|FG014|Overall Study|Adverse Event|3|||
33445695|NCT00281580|62821227|FG015|Overall Study|Adverse Event|3|||
33445696|NCT00281580|62821212|FG000|Overall Study|Protocol Violation|0|||
33445697|NCT00281580|62821213|FG001|Overall Study|Protocol Violation|0|||
33445698|NCT00281580|62821214|FG002|Overall Study|Protocol Violation|1|||
33445699|NCT00281580|62821215|FG003|Overall Study|Protocol Violation|1|||
33445700|NCT00281580|62821216|FG004|Overall Study|Protocol Violation|0|||
33445701|NCT00281580|62821217|FG005|Overall Study|Protocol Violation|0|||
33445702|NCT00281580|62821218|FG006|Overall Study|Protocol Violation|1|||
33445703|NCT00281580|62821219|FG007|Overall Study|Protocol Violation|0|||
33445704|NCT00281580|62821220|FG008|Overall Study|Protocol Violation|2|||
33445705|NCT00281580|62821221|FG009|Overall Study|Protocol Violation|0|||
33445706|NCT00281580|62821222|FG010|Overall Study|Protocol Violation|1|||
33445707|NCT00281580|62821223|FG011|Overall Study|Protocol Violation|2|||
33445708|NCT00281580|62821224|FG012|Overall Study|Protocol Violation|0|||
33607159|NCT01756456|63007348|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
33607160|NCT01756456|63007349|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
33607161|NCT01756456|63007350|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
33607162|NCT01756456|63007351|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
33607163|NCT01756456|63007346|FG000|Treatment Period: Phase I/II|Other causes|0|||
33607164|NCT01756456|63007347|FG001|Treatment Period: Phase I/II|Other causes|0|||
33607165|NCT01756456|63007348|FG002|Treatment Period: Phase I/II|Other causes|0|||
33607166|NCT01756456|63007349|FG003|Treatment Period: Phase I/II|Other causes|1|||
33607167|NCT01756456|63007350|FG004|Treatment Period: Phase I/II|Other causes|2|||
33607168|NCT01756456|63007351|FG005|Treatment Period: Phase I/II|Other causes|2|||
33607169|NCT01756456|63007346|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
33607170|NCT01756456|63007347|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
33607171|NCT01756456|63007348|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
33607172|NCT01756456|63007349|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
33607173|NCT01756456|63007350|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
33445709|NCT00281580|62821225|FG013|Overall Study|Protocol Violation|1|||
33445710|NCT00281580|62821226|FG014|Overall Study|Protocol Violation|1|||
33445711|NCT00281580|62821227|FG015|Overall Study|Protocol Violation|3|||
33445712|NCT00281580|62821212|FG000|Overall Study|Withdrawal by Subject|3|||
33445713|NCT00281580|62821213|FG001|Overall Study|Withdrawal by Subject|0|||
33445714|NCT00281580|62821214|FG002|Overall Study|Withdrawal by Subject|1|||
33445715|NCT00281580|62821215|FG003|Overall Study|Withdrawal by Subject|1|||
33445716|NCT00281580|62821216|FG004|Overall Study|Withdrawal by Subject|1|||
33445717|NCT00281580|62821217|FG005|Overall Study|Withdrawal by Subject|2|||
33607174|NCT01756456|63007351|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
33607175|NCT01756456|63007346|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
33607176|NCT01756456|63007347|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
33607177|NCT01756456|63007348|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
33607178|NCT01756456|63007349|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
33607179|NCT01756456|63007350|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
33607180|NCT01756456|63007351|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
33607181|NCT01756456|63007346|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
33607182|NCT01756456|63007347|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
33607183|NCT01756456|63007348|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
33607184|NCT01756456|63007349|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
33607185|NCT01756456|63007350|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
33607186|NCT01756456|63007351|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
33607187|NCT01756456|63007346|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
33607188|NCT01756456|63007347|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
33607189|NCT01756456|63007348|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
33607190|NCT01756456|63007349|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
33607191|NCT01756456|63007350|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
33607192|NCT01756456|63007351|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
33607193|NCT01756456|63007346|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
33607194|NCT01756456|63007347|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
33607195|NCT01756456|63007348|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
33607196|NCT01756456|63007349|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
33607197|NCT01756456|63007350|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
33607198|NCT01756456|63007351|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
33607199|NCT01756456|63007346|FG000|Follow Up Period Phase I/II|Other causes|0|||
33607200|NCT01756456|63007347|FG001|Follow Up Period Phase I/II|Other causes|0|||
33607201|NCT01756456|63007348|FG002|Follow Up Period Phase I/II|Other causes|0|||
33607202|NCT01756456|63007349|FG003|Follow Up Period Phase I/II|Other causes|1|||
33607203|NCT01756456|63007350|FG004|Follow Up Period Phase I/II|Other causes|3|||
33607204|NCT01756456|63007351|FG005|Follow Up Period Phase I/II|Other causes|5|||
33607205|NCT01756300|63007374|FG000|Overall Study|Death|1|||
33607206|NCT01756300|63007374|FG000|Overall Study|Withdrawal by Subject|1|||
33607207|NCT01995201|63007397|FG000|From Baseline Until Week 24|Adverse Event|4|||
33607208|NCT01995201|63007398|FG001|From Baseline Until Week 24|Adverse Event|15|||
33607209|NCT01995201|63007399|FG002|From Baseline Until Week 24|Adverse Event|0|||
33607210|NCT01995201|63007400|FG003|From Baseline Until Week 24|Adverse Event|0|||
33607211|NCT01995201|63007401|FG004|From Baseline Until Week 24|Adverse Event|0|||
33607212|NCT01995201|63007402|FG005|From Baseline Until Week 24|Adverse Event|0|||
33607213|NCT01995201|63007403|FG006|From Baseline Until Week 24|Adverse Event|0|||
33607214|NCT01995201|63007397|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
33607215|NCT01995201|63007398|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
33607216|NCT01995201|63007399|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
33607217|NCT01995201|63007400|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
33607218|NCT01995201|63007401|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
33607219|NCT01995201|63007402|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
33607220|NCT01995201|63007403|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
33607221|NCT01995201|63007397|FG000|From Baseline Until Week 24|Death|0|||
33607222|NCT01995201|63007398|FG001|From Baseline Until Week 24|Death|1|||
33607223|NCT01995201|63007399|FG002|From Baseline Until Week 24|Death|0|||
33607224|NCT01995201|63007400|FG003|From Baseline Until Week 24|Death|0|||
33607225|NCT01995201|63007401|FG004|From Baseline Until Week 24|Death|0|||
33607226|NCT01995201|63007402|FG005|From Baseline Until Week 24|Death|0|||
33607227|NCT01995201|63007403|FG006|From Baseline Until Week 24|Death|0|||
33607228|NCT01995201|63007397|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
33607229|NCT01995201|63007398|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
33607230|NCT01995201|63007399|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
33607231|NCT01995201|63007400|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
33607232|NCT01995201|63007401|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
33607233|NCT01995201|63007402|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
33607234|NCT01995201|63007403|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
33607235|NCT01995201|63007397|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
33607236|NCT01995201|63007398|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
33607237|NCT01995201|63007399|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
33607238|NCT01995201|63007400|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
33607239|NCT01995201|63007401|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
33607240|NCT01995201|63007402|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
33607241|NCT01995201|63007403|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
33607242|NCT01995201|63007397|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
33607243|NCT01995201|63007398|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
33607244|NCT01995201|63007399|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
33607245|NCT01995201|63007400|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
33607246|NCT01995201|63007401|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
33607247|NCT01995201|63007402|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
33607248|NCT01995201|63007403|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
33607249|NCT01995201|63007397|FG000|From Baseline Until Week 24|Physician Decision|0|||
33607250|NCT01995201|63007398|FG001|From Baseline Until Week 24|Physician Decision|2|||
33607251|NCT01995201|63007399|FG002|From Baseline Until Week 24|Physician Decision|0|||
33607252|NCT01995201|63007400|FG003|From Baseline Until Week 24|Physician Decision|0|||
33607253|NCT01995201|63007401|FG004|From Baseline Until Week 24|Physician Decision|0|||
33607254|NCT01995201|63007402|FG005|From Baseline Until Week 24|Physician Decision|0|||
33607255|NCT01995201|63007403|FG006|From Baseline Until Week 24|Physician Decision|0|||
33607256|NCT01995201|63007397|FG000|From Baseline Until Week 24|Protocol Violation|0|||
33607257|NCT01995201|63007398|FG001|From Baseline Until Week 24|Protocol Violation|9|||
33607258|NCT01995201|63007399|FG002|From Baseline Until Week 24|Protocol Violation|0|||
33607259|NCT01995201|63007400|FG003|From Baseline Until Week 24|Protocol Violation|0|||
33607260|NCT01995201|63007401|FG004|From Baseline Until Week 24|Protocol Violation|0|||
33607261|NCT01995201|63007402|FG005|From Baseline Until Week 24|Protocol Violation|0|||
33607262|NCT01995201|63007403|FG006|From Baseline Until Week 24|Protocol Violation|0|||
33607263|NCT01995201|63007397|FG000|From Week 24 Until Week 48|Adverse Event|0|||
33607264|NCT01995201|63007398|FG001|From Week 24 Until Week 48|Adverse Event|0|||
33607265|NCT01995201|63007399|FG002|From Week 24 Until Week 48|Adverse Event|2|||
33607266|NCT01995201|63007400|FG003|From Week 24 Until Week 48|Adverse Event|1|||
33607267|NCT01995201|63007401|FG004|From Week 24 Until Week 48|Adverse Event|1|||
33607268|NCT01995201|63007402|FG005|From Week 24 Until Week 48|Adverse Event|3|||
33607269|NCT01995201|63007403|FG006|From Week 24 Until Week 48|Adverse Event|1|||
33607270|NCT01995201|63007397|FG000|From Week 24 Until Week 48|Death|0|||
33607271|NCT01995201|63007398|FG001|From Week 24 Until Week 48|Death|0|||
33607272|NCT01995201|63007399|FG002|From Week 24 Until Week 48|Death|0|||
33607273|NCT01995201|63007400|FG003|From Week 24 Until Week 48|Death|0|||
33607274|NCT01995201|63007401|FG004|From Week 24 Until Week 48|Death|0|||
33607275|NCT01995201|63007402|FG005|From Week 24 Until Week 48|Death|2|||
33607276|NCT01995201|63007403|FG006|From Week 24 Until Week 48|Death|0|||
33323534|NCT01128738|62699887|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
33323535|NCT01128738|62699888|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
33323536|NCT01128738|62699887|FG000|Second TP|Lost to Follow-up|0|||
33323537|NCT01128738|62699888|FG001|Second TP|Lost to Follow-up|1|||
33323538|NCT01128738|62699887|FG000|Second TP|Withdrawal by Subject|0|||
33323539|NCT01128738|62699888|FG001|Second TP|Withdrawal by Subject|2|||
33323540|NCT01143090|62699895|FG000|Overall Study|Lack of Efficacy|2|||
33323541|NCT01143090|62699895|FG000|Overall Study|Adverse Event|17|||
33323542|NCT01143090|62699895|FG000|Overall Study|Lost to Follow-up|9|||
33323543|NCT01143090|62699895|FG000|Overall Study|Protocol Violation|2|||
33323544|NCT01143090|62699895|FG000|Overall Study|Withdrawal by Subject|18|||
33323545|NCT01143090|62699895|FG000|Overall Study|Non-compliance with study drug|1|||
33323546|NCT01143090|62699895|FG000|Overall Study|Failure to meet eligibility criteria|1|||
33323547|NCT01143090|62699895|FG000|Overall Study|Administrative|1|||
33323548|NCT01165554|62699899|FG000|Overall Study|Withdrawal by Subject|23|||
33323549|NCT01218308|62699908|FG000|Overall Study|Adverse Event|1|||
33323550|NCT01218308|62699909|FG001|Overall Study|Adverse Event|2|||
33323551|NCT01218308|62699908|FG000|Overall Study|Protocol Violation|0|||
33323552|NCT01218308|62699909|FG001|Overall Study|Protocol Violation|2|||
33323553|NCT01218308|62699908|FG000|Overall Study|Withdrawal by Subject|61|||
33323554|NCT01218308|62699909|FG001|Overall Study|Withdrawal by Subject|64|||
33323555|NCT01218308|62699908|FG000|Overall Study|Lost to Follow-up|27|||
33323556|NCT01218308|62699909|FG001|Overall Study|Lost to Follow-up|31|||
33323557|NCT01218308|62699908|FG000|Overall Study|Other|14|||
33323558|NCT01218308|62699909|FG001|Overall Study|Other|21|||
33323559|NCT01165320|62699917|FG000|Overall Study|Clinical adverse experience|2|||
33323560|NCT01165320|62699918|FG001|Overall Study|Clinical adverse experience|1|||
33323561|NCT01165320|62699919|FG002|Overall Study|Clinical adverse experience|0|||
33323562|NCT01165320|62699917|FG000|Overall Study|Laboratory adverse experience|1|||
33323563|NCT01165320|62699918|FG001|Overall Study|Laboratory adverse experience|0|||
33323564|NCT01165320|62699919|FG002|Overall Study|Laboratory adverse experience|0|||
33323565|NCT01165320|62699917|FG000|Overall Study|Lack of Efficacy|0|||
33323566|NCT01165320|62699918|FG001|Overall Study|Lack of Efficacy|2|||
33323567|NCT01165320|62699919|FG002|Overall Study|Lack of Efficacy|0|||
33323568|NCT01165320|62699917|FG000|Overall Study|Reason unknown|0|||
33323569|NCT01165320|62699918|FG001|Overall Study|Reason unknown|1|||
33323570|NCT01165320|62699919|FG002|Overall Study|Reason unknown|0|||
33607277|NCT01995201|63007397|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
33607278|NCT01995201|63007398|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
33607279|NCT01995201|63007399|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
33323571|NCT01217606|62699927|FG000|Initial Treatment Phase|Other Reasons|0|||
33323572|NCT01217606|62699928|FG001|Initial Treatment Phase|Other Reasons|2|||
33323573|NCT01217606|62699927|FG000|Initial Treatment Phase|Protocol Violation|3|||
33323574|NCT01217606|62699928|FG001|Initial Treatment Phase|Protocol Violation|2|||
33323575|NCT01217606|62699927|FG000|Initial Treatment Phase|Personal Reasons|0|||
33323576|NCT01217606|62699928|FG001|Initial Treatment Phase|Personal Reasons|2|||
33323577|NCT01217606|62699927|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
33323578|NCT01217606|62699928|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
33323579|NCT01217606|62699927|FG000|Initial Treatment Phase|Adverse Event|10|||
33323580|NCT01217606|62699928|FG001|Initial Treatment Phase|Adverse Event|6|||
33323581|NCT01217606|62699927|FG000|9-Month Masked Extension|Adverse Event|3|||
33323582|NCT01217606|62699928|FG001|9-Month Masked Extension|Adverse Event|6|||
33323583|NCT01217606|62699927|FG000|9-Month Masked Extension|Other Reasons|4|||
33323584|NCT01217606|62699928|FG001|9-Month Masked Extension|Other Reasons|4|||
33323585|NCT01217606|62699927|FG000|9-Month Masked Extension|Personal Reasons|2|||
33323586|NCT01217606|62699928|FG001|9-Month Masked Extension|Personal Reasons|1|||
33323587|NCT01217606|62699927|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
33323588|NCT01217606|62699928|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
33323589|NCT01217606|62699927|FG000|9-Month Masked Extension|Pregnancy|1|||
33323590|NCT01217606|62699928|FG001|9-Month Masked Extension|Pregnancy|0|||
33323591|NCT01217606|62699927|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
33323592|NCT01217606|62699928|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
33323593|NCT01128114|62699934|FG000|Overall Study|Treatment Withdrawn|6|||
33323594|NCT01128114|62699934|FG000|Overall Study|Screening Failed|2|||
33323595|NCT01217060|62699938|FG000|Overall Study|Withdrawal by Subject|1|||
33445718|NCT00281580|62821218|FG006|Overall Study|Withdrawal by Subject|2|||
33445719|NCT00281580|62821219|FG007|Overall Study|Withdrawal by Subject|0|||
33445720|NCT00281580|62821220|FG008|Overall Study|Withdrawal by Subject|1|||
33445721|NCT00281580|62821221|FG009|Overall Study|Withdrawal by Subject|4|||
33445722|NCT00281580|62821222|FG010|Overall Study|Withdrawal by Subject|1|||
33445723|NCT00281580|62821223|FG011|Overall Study|Withdrawal by Subject|1|||
33445724|NCT00281580|62821224|FG012|Overall Study|Withdrawal by Subject|2|||
33445725|NCT00281580|62821225|FG013|Overall Study|Withdrawal by Subject|2|||
33445726|NCT00281580|62821226|FG014|Overall Study|Withdrawal by Subject|1|||
33445727|NCT00281580|62821227|FG015|Overall Study|Withdrawal by Subject|5|||
33445728|NCT00281580|62821212|FG000|Overall Study|Lack of Efficacy|2|||
33445729|NCT00281580|62821213|FG001|Overall Study|Lack of Efficacy|1|||
33445730|NCT00281580|62821214|FG002|Overall Study|Lack of Efficacy|1|||
33445731|NCT00281580|62821215|FG003|Overall Study|Lack of Efficacy|6|||
33445732|NCT00281580|62821216|FG004|Overall Study|Lack of Efficacy|2|||
33445733|NCT00281580|62821217|FG005|Overall Study|Lack of Efficacy|0|||
33445734|NCT00281580|62821218|FG006|Overall Study|Lack of Efficacy|0|||
33445735|NCT00281580|62821219|FG007|Overall Study|Lack of Efficacy|0|||
33445736|NCT00281580|62821220|FG008|Overall Study|Lack of Efficacy|0|||
33445737|NCT00281580|62821221|FG009|Overall Study|Lack of Efficacy|0|||
33445738|NCT00281580|62821222|FG010|Overall Study|Lack of Efficacy|0|||
33445739|NCT00281580|62821223|FG011|Overall Study|Lack of Efficacy|1|||
33445740|NCT00281580|62821224|FG012|Overall Study|Lack of Efficacy|0|||
33445741|NCT00281580|62821225|FG013|Overall Study|Lack of Efficacy|2|||
33445742|NCT00281580|62821226|FG014|Overall Study|Lack of Efficacy|1|||
33445743|NCT00281580|62821227|FG015|Overall Study|Lack of Efficacy|0|||
33445744|NCT00281580|62821212|FG000|Overall Study|Lost to Follow-up|0|||
33445745|NCT00281580|62821213|FG001|Overall Study|Lost to Follow-up|0|||
33445746|NCT00281580|62821214|FG002|Overall Study|Lost to Follow-up|0|||
33445747|NCT00281580|62821215|FG003|Overall Study|Lost to Follow-up|3|||
33445748|NCT00281580|62821216|FG004|Overall Study|Lost to Follow-up|0|||
33445749|NCT00281580|62821217|FG005|Overall Study|Lost to Follow-up|1|||
33445750|NCT00281580|62821218|FG006|Overall Study|Lost to Follow-up|0|||
33445751|NCT00281580|62821219|FG007|Overall Study|Lost to Follow-up|1|||
33445752|NCT00281580|62821220|FG008|Overall Study|Lost to Follow-up|2|||
33445753|NCT00281580|62821221|FG009|Overall Study|Lost to Follow-up|1|||
33445754|NCT00281580|62821222|FG010|Overall Study|Lost to Follow-up|1|||
33445755|NCT00281580|62821223|FG011|Overall Study|Lost to Follow-up|0|||
33445756|NCT00281580|62821224|FG012|Overall Study|Lost to Follow-up|1|||
33445757|NCT00281580|62821225|FG013|Overall Study|Lost to Follow-up|0|||
33445758|NCT00281580|62821226|FG014|Overall Study|Lost to Follow-up|0|||
33323596|NCT01216202|62699944|FG000|Overall Study|Withdrawal by Subject|8|||
33323597|NCT01216202|62699945|FG001|Overall Study|Withdrawal by Subject|0|||
33323598|NCT01216202|62699944|FG000|Overall Study|Death|0|||
33323599|NCT01216202|62699945|FG001|Overall Study|Death|2|||
33323600|NCT01216202|62699944|FG000|Overall Study|Lost to Follow-up|14|||
33323601|NCT01216202|62699945|FG001|Overall Study|Lost to Follow-up|0|||
33323602|NCT04816669|62699957|FG000|Part 1|Adverse Event|1|||
33323603|NCT04816669|62699958|FG001|Part 1|Adverse Event|1|||
33445759|NCT00281580|62821227|FG015|Overall Study|Lost to Follow-up|0|||
33323604|NCT04816669|62699959|FG002|Part 1|Adverse Event|0|||
33445760|NCT00281580|62821212|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
33445761|NCT00281580|62821213|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
33445762|NCT00281580|62821214|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
33445763|NCT00281580|62821215|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
33445764|NCT00281580|62821216|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
33445765|NCT00281580|62821217|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
33445766|NCT00281580|62821218|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
33445767|NCT00281580|62821219|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
33445768|NCT00281580|62821220|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
33445769|NCT00281580|62821221|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
33445770|NCT00281580|62821222|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
33445771|NCT00281580|62821223|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
33445772|NCT00281580|62821224|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
33445773|NCT00281580|62821225|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
33445774|NCT00281580|62821226|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
33445775|NCT00281580|62821227|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
33445776|NCT00495755|62821296|FG000|Overall Study|Adverse Event|3|||
33445777|NCT00495677|62821308|FG000|Stage 1 (25 Days)|Adverse Event|0|||
33445778|NCT00495677|62821309|FG001|Stage 1 (25 Days)|Adverse Event|0|||
33445779|NCT00495677|62821310|FG002|Stage 1 (25 Days)|Adverse Event|1|||
33445780|NCT00495677|62821311|FG003|Stage 1 (25 Days)|Adverse Event|0|||
33445781|NCT00495677|62821312|FG004|Stage 1 (25 Days)|Adverse Event|0|||
33445782|NCT00495677|62821313|FG005|Stage 1 (25 Days)|Adverse Event|0|||
33445783|NCT00495677|62821314|FG006|Stage 1 (25 Days)|Adverse Event|0|||
33445784|NCT00495521|62821332|FG000|Overall Study|Physician Decision|0|||
33445785|NCT00495521|62821333|FG001|Overall Study|Physician Decision|1|||
33445786|NCT00273858|62821339|FG000|Overall Study|Not completed 24 month observation time|334|||
33445787|NCT00273858|62821339|FG000|Overall Study|Lost to Follow-up|101|||
33445788|NCT00273858|62821339|FG000|Overall Study|Withdrawal by Subject|21|||
33445789|NCT00273858|62821339|FG000|Overall Study|Adverse Event|81|||
33445790|NCT00494507|62821347|FG000|Double-Blind Phase|Adverse Event|2|||
33445791|NCT00494507|62821348|FG001|Double-Blind Phase|Adverse Event|0|||
33445792|NCT00494507|62821349|FG002|Double-Blind Phase|Adverse Event|1|||
33445793|NCT00494507|62821350|FG003|Double-Blind Phase|Adverse Event|0|||
33445794|NCT00494507|62821347|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
33445795|NCT00494507|62821348|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
33445796|NCT00494507|62821349|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
33445797|NCT00494507|62821350|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
33445798|NCT00494507|62821347|FG000|Double-Blind Phase|Subject Non-compliance|0|||
33445799|NCT00494507|62821348|FG001|Double-Blind Phase|Subject Non-compliance|0|||
33445800|NCT00494507|62821349|FG002|Double-Blind Phase|Subject Non-compliance|1|||
33445801|NCT00494507|62821350|FG003|Double-Blind Phase|Subject Non-compliance|0|||
33445802|NCT00494507|62821347|FG000|Double-Blind Phase|Negative DNA test|0|||
33445803|NCT00494507|62821348|FG001|Double-Blind Phase|Negative DNA test|0|||
33445804|NCT00494507|62821349|FG002|Double-Blind Phase|Negative DNA test|0|||
33445805|NCT00494507|62821350|FG003|Double-Blind Phase|Negative DNA test|1|||
33445806|NCT00494507|62821347|FG000|Open-Label Phase|Adverse Event|0|||
33445807|NCT00494507|62821348|FG001|Open-Label Phase|Adverse Event|1|||
33445808|NCT00494507|62821349|FG002|Open-Label Phase|Adverse Event|5|||
33445809|NCT00494507|62821350|FG003|Open-Label Phase|Adverse Event|3|||
33445810|NCT00494507|62821347|FG000|Open-Label Phase|Worsening Disease|0|||
33445811|NCT00494507|62821348|FG001|Open-Label Phase|Worsening Disease|0|||
33445812|NCT00494507|62821349|FG002|Open-Label Phase|Worsening Disease|0|||
33445813|NCT00494507|62821350|FG003|Open-Label Phase|Worsening Disease|2|||
33445814|NCT00292188|62821372|FG000|Single-Blind|Adverse Event|14|||
33445815|NCT00292188|62821373|FG001|Single-Blind|Adverse Event|0|||
33445816|NCT00292188|62821374|FG002|Single-Blind|Adverse Event|0|||
33445817|NCT00292188|62821372|FG000|Single-Blind|Lack of Efficacy|2|||
33445818|NCT00292188|62821373|FG001|Single-Blind|Lack of Efficacy|0|||
33445819|NCT00292188|62821374|FG002|Single-Blind|Lack of Efficacy|0|||
33445820|NCT00292188|62821372|FG000|Single-Blind|Laboratory Abnormality|5|||
33445821|NCT00292188|62821373|FG001|Single-Blind|Laboratory Abnormality|0|||
33323605|NCT04816669|62699960|FG003|Part 1|Adverse Event|0|||
33323606|NCT04816669|62699957|FG000|Part 1|Lost to Follow-up|2|||
33445822|NCT00292188|62821374|FG002|Single-Blind|Laboratory Abnormality|0|||
33445823|NCT00292188|62821372|FG000|Single-Blind|Lost to Follow-up|3|||
33445824|NCT00292188|62821373|FG001|Single-Blind|Lost to Follow-up|0|||
33445825|NCT00292188|62821374|FG002|Single-Blind|Lost to Follow-up|0|||
33445826|NCT00292188|62821372|FG000|Single-Blind|Other|77|||
33445827|NCT00292188|62821373|FG001|Single-Blind|Other|0|||
33445828|NCT00292188|62821374|FG002|Single-Blind|Other|0|||
33445829|NCT00292188|62821372|FG000|Single-Blind|Withdrawal by Subject|12|||
33445830|NCT00292188|62821373|FG001|Single-Blind|Withdrawal by Subject|0|||
33445831|NCT00292188|62821374|FG002|Single-Blind|Withdrawal by Subject|0|||
33445832|NCT00292188|62821372|FG000|Single-Blind|Did not receive treatment|1|||
33445833|NCT00292188|62821373|FG001|Single-Blind|Did not receive treatment|0|||
33445834|NCT00292188|62821374|FG002|Single-Blind|Did not receive treatment|0|||
33445835|NCT00292188|62821372|FG000|Double-Blind|Adverse Event|0|||
33323607|NCT04816669|62699958|FG001|Part 1|Lost to Follow-up|2|||
33323608|NCT04816669|62699959|FG002|Part 1|Lost to Follow-up|0|||
33323609|NCT04816669|62699960|FG003|Part 1|Lost to Follow-up|0|||
33323610|NCT04816669|62699957|FG000|Part 1|Protocol Violation|0|||
33323611|NCT04816669|62699958|FG001|Part 1|Protocol Violation|1|||
33445836|NCT00292188|62821373|FG001|Double-Blind|Adverse Event|25|||
33445837|NCT00292188|62821374|FG002|Double-Blind|Adverse Event|9|||
33445838|NCT00292188|62821372|FG000|Double-Blind|Lack of Efficacy|0|||
33445839|NCT00292188|62821373|FG001|Double-Blind|Lack of Efficacy|2|||
33445840|NCT00292188|62821374|FG002|Double-Blind|Lack of Efficacy|12|||
33445841|NCT00292188|62821372|FG000|Double-Blind|Lost to Follow-up|0|||
33445842|NCT00292188|62821373|FG001|Double-Blind|Lost to Follow-up|1|||
33445843|NCT00292188|62821374|FG002|Double-Blind|Lost to Follow-up|0|||
33445844|NCT00292188|62821372|FG000|Double-Blind|Other|0|||
33445845|NCT00292188|62821373|FG001|Double-Blind|Other|3|||
33445846|NCT00292188|62821374|FG002|Double-Blind|Other|4|||
33445847|NCT00292188|62821372|FG000|Double-Blind|Withdrawal by Subject|0|||
33445848|NCT00292188|62821373|FG001|Double-Blind|Withdrawal by Subject|0|||
33445849|NCT00292188|62821374|FG002|Double-Blind|Withdrawal by Subject|3|||
33445850|NCT00292188|62821372|FG000|Double-Blind|Laboratory Abnormality|0|||
33445851|NCT00292188|62821373|FG001|Double-Blind|Laboratory Abnormality|0|||
33445852|NCT00292188|62821374|FG002|Double-Blind|Laboratory Abnormality|1|||
33445853|NCT00272844|62821381|FG000|Overall Study|Withdrawal by Subject|5|||
33445854|NCT00271596|62821387|FG000|Overall Study|Protocol Violation|1|||
33445855|NCT00271596|62821388|FG001|Overall Study|Protocol Violation|0|||
33445856|NCT00271596|62821387|FG000|Overall Study|Withdrawal by Subject|0|||
33445857|NCT00271596|62821388|FG001|Overall Study|Withdrawal by Subject|1|||
33445858|NCT00291642|62821399|FG000|Overall Study|Adverse Event|1|||
33445859|NCT00291642|62821400|FG001|Overall Study|Adverse Event|0|||
33445860|NCT00291642|62821401|FG002|Overall Study|Adverse Event|1|||
33445861|NCT00291642|62821402|FG003|Overall Study|Adverse Event|0|||
33445862|NCT00291642|62821403|FG004|Overall Study|Adverse Event|1|||
33445863|NCT00291642|62821399|FG000|Overall Study|Patient missed visit|0|||
33445864|NCT00291642|62821400|FG001|Overall Study|Patient missed visit|0|||
33445865|NCT00291642|62821401|FG002|Overall Study|Patient missed visit|1|||
33445866|NCT00291642|62821402|FG003|Overall Study|Patient missed visit|0|||
33445867|NCT00291642|62821403|FG004|Overall Study|Patient missed visit|0|||
33445868|NCT00291642|62821399|FG000|Overall Study|Intake of prohibited medication|1|||
33445869|NCT00291642|62821400|FG001|Overall Study|Intake of prohibited medication|0|||
33445870|NCT00291642|62821401|FG002|Overall Study|Intake of prohibited medication|0|||
33445871|NCT00291642|62821402|FG003|Overall Study|Intake of prohibited medication|0|||
33445872|NCT00291642|62821403|FG004|Overall Study|Intake of prohibited medication|0|||
33445873|NCT00280566|62821417|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
33445874|NCT00280566|62821418|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
33445875|NCT00280566|62821419|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
33445876|NCT00280566|62821417|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
33445877|NCT00280566|62821418|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
33445878|NCT00280566|62821419|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
33445879|NCT00280566|62821417|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
33445880|NCT00280566|62821418|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
33445881|NCT00280566|62821419|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
33445882|NCT00280566|62821417|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
33445883|NCT00280566|62821418|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
33445884|NCT00280566|62821419|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
33445885|NCT00280566|62821417|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
33445886|NCT00280566|62821418|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
33445887|NCT00280566|62821419|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
33445888|NCT00280566|62821417|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
33445889|NCT00280566|62821418|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
33445890|NCT00280566|62821419|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
33445891|NCT00280566|62821417|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
33445892|NCT00280566|62821418|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
33445893|NCT00280566|62821419|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
33445894|NCT00280566|62821417|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
33323612|NCT04816669|62699959|FG002|Part 1|Protocol Violation|0|||
33445895|NCT00280566|62821418|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
33445896|NCT00280566|62821419|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
33445897|NCT00280566|62821417|FG000|Period 2 Double Blind|Adverse Event|0|||
33445898|NCT00280566|62821418|FG001|Period 2 Double Blind|Adverse Event|11|||
33494244|NCT02873936|62873018|FG002|Overall Study|Lost to Follow-up|1|||
33323613|NCT04816669|62699960|FG003|Part 1|Protocol Violation|0|||
33445899|NCT00280566|62821419|FG002|Period 2 Double Blind|Adverse Event|15|||
33445900|NCT00280566|62821417|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
33445901|NCT00280566|62821418|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
33445902|NCT00280566|62821419|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
33445903|NCT00280566|62821417|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
33445904|NCT00280566|62821418|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
33445905|NCT00280566|62821419|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
33445906|NCT00280566|62821417|FG000|Period 2 Double Blind|miscellaneous|0|||
33445907|NCT00280566|62821418|FG001|Period 2 Double Blind|miscellaneous|10|||
33445908|NCT00280566|62821419|FG002|Period 2 Double Blind|miscellaneous|5|||
33445909|NCT00270894|62821426|FG000|Overall Study|Adverse Event|1|||
33445910|NCT00270894|62821426|FG000|Overall Study|Withdrawal by Subject|1|||
33445911|NCT00317642|62821432|FG000|Overall Study|Not Received Either Study Drug|1|||
33445912|NCT00317642|62821433|FG001|Overall Study|Not Received Either Study Drug|3|||
33445913|NCT00317642|62821432|FG000|Overall Study|Physician Decision|15|||
33445914|NCT00317642|62821433|FG001|Overall Study|Physician Decision|7|||
33445915|NCT00317642|62821432|FG000|Overall Study|Participant declined treatment|14|||
33445916|NCT00317642|62821433|FG001|Overall Study|Participant declined treatment|3|||
33445917|NCT00317642|62821432|FG000|Overall Study|Adverse Event|17|||
33445918|NCT00317642|62821433|FG001|Overall Study|Adverse Event|5|||
33445919|NCT00317642|62821432|FG000|Overall Study|Treatment Failure|56|||
33445920|NCT00317642|62821433|FG001|Overall Study|Treatment Failure|102|||
33445921|NCT00317642|62821432|FG000|Overall Study|Disease Recurrence|1|||
33445922|NCT00317642|62821433|FG001|Overall Study|Disease Recurrence|2|||
33445923|NCT00317642|62821432|FG000|Overall Study|Death|14|||
33445924|NCT00317642|62821433|FG001|Overall Study|Death|7|||
33445925|NCT00317642|62821432|FG000|Overall Study|Not Continue to Consolidation|2|||
33445926|NCT00317642|62821433|FG001|Overall Study|Not Continue to Consolidation|0|||
33445927|NCT00317642|62821432|FG000|Overall Study|Withdrawal by Subject|0|||
33445928|NCT00317642|62821433|FG001|Overall Study|Withdrawal by Subject|1|||
33445929|NCT00317642|62821432|FG000|Overall Study|Referred For Transplantation|1|||
33445930|NCT00317642|62821433|FG001|Overall Study|Referred For Transplantation|0|||
33445931|NCT00317642|62821432|FG000|Overall Study|AML Not Centrally Confirmed|1|||
33445932|NCT00317642|62821433|FG001|Overall Study|AML Not Centrally Confirmed|5|||
33445933|NCT00295022|62821449|FG000|Overall Study|Adverse Event|1|||
33445934|NCT00295022|62821450|FG001|Overall Study|Adverse Event|1|||
33445935|NCT00295022|62821451|FG002|Overall Study|Adverse Event|2|||
33445936|NCT00295022|62821449|FG000|Overall Study|Lost to Follow-up|0|||
33445937|NCT00295022|62821450|FG001|Overall Study|Lost to Follow-up|0|||
33445938|NCT00295022|62821451|FG002|Overall Study|Lost to Follow-up|1|||
33445939|NCT00295022|62821449|FG000|Overall Study|Withdrawal by Subject|0|||
33445940|NCT00295022|62821450|FG001|Overall Study|Withdrawal by Subject|0|||
33445941|NCT00295022|62821451|FG002|Overall Study|Withdrawal by Subject|2|||
33445942|NCT00303446|62821463|FG000|Overall Study|Withdrawal by Subject|2|||
33445943|NCT00303446|62821464|FG001|Overall Study|Withdrawal by Subject|2|||
33445944|NCT00303446|62821463|FG000|Overall Study|Death|0|||
33445945|NCT00303446|62821464|FG001|Overall Study|Death|1|||
33445946|NCT00303446|62821463|FG000|Overall Study|Physician Decision|0|||
33445947|NCT00303446|62821464|FG001|Overall Study|Physician Decision|1|||
33445948|NCT00316706|62821472|FG000|Overall Study|Lost to Follow-up|38|||
33445949|NCT00316706|62821473|FG001|Overall Study|Lost to Follow-up|48|||
33445950|NCT00291486|62821484|FG000|Overall Study|Adverse Event|0|||
33445951|NCT00291486|62821485|FG001|Overall Study|Adverse Event|3|||
33445952|NCT00291486|62821486|FG002|Overall Study|Adverse Event|0|||
33445953|NCT00291486|62821487|FG003|Overall Study|Adverse Event|1|||
33445954|NCT00291486|62821488|FG004|Overall Study|Adverse Event|0|||
33445955|NCT00291486|62821484|FG000|Overall Study|Withdrawal by Subject|0|||
33445956|NCT00291486|62821485|FG001|Overall Study|Withdrawal by Subject|0|||
33445957|NCT00291486|62821486|FG002|Overall Study|Withdrawal by Subject|0|||
33445958|NCT00291486|62821487|FG003|Overall Study|Withdrawal by Subject|0|||
33445959|NCT00291486|62821488|FG004|Overall Study|Withdrawal by Subject|1|||
33445960|NCT00291486|62821484|FG000|Overall Study|Disease progression|1|||
33445961|NCT00291486|62821485|FG001|Overall Study|Disease progression|0|||
33445962|NCT00291486|62821486|FG002|Overall Study|Disease progression|1|||
33445963|NCT00291486|62821487|FG003|Overall Study|Disease progression|0|||
33445964|NCT00291486|62821488|FG004|Overall Study|Disease progression|0|||
33445965|NCT00301964|62821509|FG000|Overall Study|Second primary|2|||
33445966|NCT00301964|62821509|FG000|Overall Study|Wrong primary|1|||
33445967|NCT00301964|62821509|FG000|Overall Study|Inadequate pathology|1|||
33445968|NCT00268242|62821519|FG000|Overall Study|Death|1|||
33445969|NCT00294554|62821525|FG000|Overall Study|Lack of Efficacy|0|||
33445970|NCT00294554|62821526|FG001|Overall Study|Lack of Efficacy|1|||
33445971|NCT00294554|62821525|FG000|Overall Study|Physician Decision|0|||
33445972|NCT00294554|62821526|FG001|Overall Study|Physician Decision|1|||
33445973|NCT00294398|62821534|FG000|Overall Study|Lost to Follow-up|21|||
33445974|NCT00294398|62821535|FG001|Overall Study|Lost to Follow-up|26|||
33445975|NCT00279708|62821543|FG000|Overall Study|Withdrawal by Subject|2|||
33445976|NCT00279708|62821544|FG001|Overall Study|Withdrawal by Subject|3|||
33445977|NCT00279708|62821543|FG000|Overall Study|Adverse Event|1|||
33445978|NCT00279708|62821544|FG001|Overall Study|Adverse Event|1|||
33445979|NCT00299702|62821552|FG000|Overall Study|Death|1|||
33445980|NCT00299702|62821553|FG001|Overall Study|Death|0|||
33445981|NCT00299702|62821552|FG000|Overall Study|Adverse Event|0|||
33445982|NCT00299702|62821553|FG001|Overall Study|Adverse Event|4|||
33445983|NCT00299702|62821552|FG000|Overall Study|Lost to Follow-up|18|||
33445984|NCT00299702|62821553|FG001|Overall Study|Lost to Follow-up|10|||
33445985|NCT00299702|62821552|FG000|Overall Study|Withdrawal by Subject|25|||
33445986|NCT00299702|62821553|FG001|Overall Study|Withdrawal by Subject|23|||
33445987|NCT00299702|62821552|FG000|Overall Study|Pregnancy|0|||
33445988|NCT00299702|62821553|FG001|Overall Study|Pregnancy|1|||
33445989|NCT00299702|62821552|FG000|Overall Study|Insufficient Response|4|||
33445990|NCT00299702|62821553|FG001|Overall Study|Insufficient Response|3|||
33445991|NCT00299702|62821552|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
33445992|NCT00299702|62821553|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
33445993|NCT00291330|62821561|FG000|Overall Study|Adverse Event|47|||
33445994|NCT00291330|62821562|FG001|Overall Study|Adverse Event|40|||
33445995|NCT00291330|62821561|FG000|Overall Study|Protocol Violation|13|||
33445996|NCT00291330|62821562|FG001|Overall Study|Protocol Violation|20|||
33445997|NCT00291330|62821561|FG000|Overall Study|Lost to Follow-up|16|||
33445998|NCT00291330|62821562|FG001|Overall Study|Lost to Follow-up|11|||
33445999|NCT00291330|62821561|FG000|Overall Study|Withdrawal by Subject|22|||
33446000|NCT00291330|62821562|FG001|Overall Study|Withdrawal by Subject|25|||
33446001|NCT00291330|62821561|FG000|Overall Study|Other|3|||
33446002|NCT00291330|62821562|FG001|Overall Study|Other|1|||
33446003|NCT00267150|62821568|FG000|Overall Study|Adverse Event|1|||
33494245|NCT02873936|62873016|FG000|Overall Study|Non-compliance With Study Drug|1|||
33446004|NCT00278148|62821572|FG000|Phase II - Expansion Phase|Disease progression|0|||
33446005|NCT00278148|62821573|FG001|Phase II - Expansion Phase|Disease progression|0|||
33446006|NCT00278148|62821574|FG002|Phase II - Expansion Phase|Disease progression|4|||
33446007|NCT00278148|62821572|FG000|Phase II - Expansion Phase|Adverse Event|0|||
33323614|NCT04816669|62699957|FG000|Part 1|Withdrawal by Subject|1|||
33323615|NCT04816669|62699958|FG001|Part 1|Withdrawal by Subject|2|||
33323616|NCT04816669|62699959|FG002|Part 1|Withdrawal by Subject|0|||
33323617|NCT04816669|62699960|FG003|Part 1|Withdrawal by Subject|0|||
33323618|NCT04816669|62699957|FG000|Part 2|Other|0|||
33323619|NCT04816669|62699958|FG001|Part 2|Other|0|||
33323620|NCT04816669|62699959|FG002|Part 2|Other|1|||
33323621|NCT04816669|62699960|FG003|Part 2|Other|0|||
33323622|NCT04816669|62699957|FG000|Part 2|Withdrawal by Subject|0|||
33323623|NCT04816669|62699958|FG001|Part 2|Withdrawal by Subject|0|||
33323624|NCT04816669|62699959|FG002|Part 2|Withdrawal by Subject|0|||
33323625|NCT04816669|62699960|FG003|Part 2|Withdrawal by Subject|1|||
33323626|NCT04816669|62699957|FG000|Part 2|Lost to Follow-up|0|||
33323627|NCT04816669|62699958|FG001|Part 2|Lost to Follow-up|0|||
33323628|NCT04816669|62699959|FG002|Part 2|Lost to Follow-up|1|||
33323629|NCT04816669|62699960|FG003|Part 2|Lost to Follow-up|0|||
33323630|NCT01165242|62699977|FG000|Overall Study|Unreachable Subjects|1|||
33323631|NCT01165242|62699978|FG001|Overall Study|Unreachable Subjects|0|||
33323632|NCT01165242|62699979|FG002|Overall Study|Unreachable Subjects|0|||
33323633|NCT01165242|62699977|FG000|Overall Study|Incarcerated Subjects|0|||
33323634|NCT01165242|62699978|FG001|Overall Study|Incarcerated Subjects|1|||
33323635|NCT01165242|62699979|FG002|Overall Study|Incarcerated Subjects|0|||
33323636|NCT01165242|62699977|FG000|Overall Study|Visit 2 Declined by Subject|0|||
33323637|NCT01165242|62699978|FG001|Overall Study|Visit 2 Declined by Subject|0|||
33323638|NCT01165242|62699979|FG002|Overall Study|Visit 2 Declined by Subject|1|||
33323639|NCT01165242|62699977|FG000|Overall Study|Withdrawal by Subject|0|||
33323640|NCT01165242|62699978|FG001|Overall Study|Withdrawal by Subject|2|||
33446008|NCT00278148|62821573|FG001|Phase II - Expansion Phase|Adverse Event|0|||
33446009|NCT00278148|62821574|FG002|Phase II - Expansion Phase|Adverse Event|2|||
33446010|NCT00299546|62821584|FG000|Overall Study|Death|3|||
33446011|NCT00299546|62821585|FG001|Overall Study|Death|2|||
33446012|NCT00299546|62821586|FG002|Overall Study|Death|0|||
33446013|NCT00299546|62821584|FG000|Overall Study|Lost to Follow-up|2|||
33446014|NCT00299546|62821585|FG001|Overall Study|Lost to Follow-up|2|||
33446015|NCT00299546|62821586|FG002|Overall Study|Lost to Follow-up|5|||
33446016|NCT00299546|62821584|FG000|Overall Study|Adverse Event|37|||
33323641|NCT01165242|62699979|FG002|Overall Study|Withdrawal by Subject|2|||
33323642|NCT01165242|62699977|FG000|Overall Study|Extended Holiday|0|||
33323643|NCT01165242|62699978|FG001|Overall Study|Extended Holiday|0|||
33323644|NCT01165242|62699979|FG002|Overall Study|Extended Holiday|1|||
33323645|NCT01165242|62699977|FG000|Overall Study|Lost to Follow-up|9|||
33323646|NCT01165242|62699978|FG001|Overall Study|Lost to Follow-up|7|||
33323647|NCT01165242|62699979|FG002|Overall Study|Lost to Follow-up|10|||
33446017|NCT00299546|62821585|FG001|Overall Study|Adverse Event|22|||
33446018|NCT00299546|62821586|FG002|Overall Study|Adverse Event|27|||
33323648|NCT01170065|62699992|FG000|Overall Study|Adverse Event|17|||
33323649|NCT01170065|62699993|FG001|Overall Study|Adverse Event|50|||
33323650|NCT01170065|62699994|FG002|Overall Study|Adverse Event|10|||
33323651|NCT01170065|62699992|FG000|Overall Study|Lost to Follow-up|1|||
33323652|NCT01170065|62699993|FG001|Overall Study|Lost to Follow-up|4|||
33323653|NCT01170065|62699994|FG002|Overall Study|Lost to Follow-up|1|||
33323654|NCT01170065|62699992|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
33323655|NCT01170065|62699993|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
33323656|NCT01170065|62699994|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
33323657|NCT01170065|62699992|FG000|Overall Study|Reason other than specified|3|||
33323658|NCT01170065|62699993|FG001|Overall Study|Reason other than specified|8|||
33323659|NCT01170065|62699994|FG002|Overall Study|Reason other than specified|3|||
33323660|NCT01170065|62699992|FG000|Overall Study|Ongoing after planned observation time|5|||
33323661|NCT01170065|62699993|FG001|Overall Study|Ongoing after planned observation time|26|||
33323662|NCT01170065|62699994|FG002|Overall Study|Ongoing after planned observation time|10|||
33323663|NCT00966693|62700006|FG000|Overall Study|Adverse Event|0|||
33323664|NCT00966693|62700007|FG001|Overall Study|Adverse Event|0|||
33446019|NCT00299546|62821584|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
33446020|NCT00299546|62821585|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
33323665|NCT00966693|62700008|FG002|Overall Study|Adverse Event|1|||
33323666|NCT00966693|62700009|FG003|Overall Study|Adverse Event|2|||
33323667|NCT00966693|62700006|FG000|Overall Study|Death|0|||
33323668|NCT00966693|62700007|FG001|Overall Study|Death|0|||
33323669|NCT00966693|62700008|FG002|Overall Study|Death|1|||
33323670|NCT00966693|62700009|FG003|Overall Study|Death|0|||
33323671|NCT00966693|62700006|FG000|Overall Study|Withdrawal by Subject|1|||
33323672|NCT00966693|62700007|FG001|Overall Study|Withdrawal by Subject|0|||
33323673|NCT00966693|62700008|FG002|Overall Study|Withdrawal by Subject|0|||
33323674|NCT00966693|62700009|FG003|Overall Study|Withdrawal by Subject|5|||
33323675|NCT00966693|62700006|FG000|Overall Study|Disease Progression|0|||
33323676|NCT00966693|62700007|FG001|Overall Study|Disease Progression|0|||
33323677|NCT00966693|62700008|FG002|Overall Study|Disease Progression|1|||
33323678|NCT00966693|62700009|FG003|Overall Study|Disease Progression|16|||
33323679|NCT01215968|62700021|FG000|Overall Study|Adverse Event|0|||
33323680|NCT01215968|62700022|FG001|Overall Study|Adverse Event|2|||
33446021|NCT00299546|62821586|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
33446022|NCT00299546|62821584|FG000|Overall Study|Other|24|||
33446023|NCT00299546|62821585|FG001|Overall Study|Other|26|||
33446024|NCT00299546|62821586|FG002|Overall Study|Other|19|||
33446025|NCT00299546|62821584|FG000|Overall Study|Not treated|0|||
33446026|NCT00299546|62821585|FG001|Overall Study|Not treated|1|||
33446027|NCT00299546|62821586|FG002|Overall Study|Not treated|1|||
33446028|NCT00299156|62821598|FG000|Period 2 (Randomized)|Screen Failure|0|||
33446029|NCT00299156|62821599|FG001|Period 2 (Randomized)|Screen Failure|1|||
33446030|NCT00299156|62821600|FG002|Period 2 (Randomized)|Screen Failure|0|||
33446031|NCT00277212|62821608|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
33446032|NCT00277212|62821609|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
33446033|NCT00277212|62821610|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
33446034|NCT00277212|62821608|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
33446035|NCT00277212|62821609|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
33446036|NCT00277212|62821610|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
33446037|NCT00277212|62821608|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
33446038|NCT00277212|62821609|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
33446039|NCT00277212|62821610|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
33446040|NCT00277212|62821608|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
33446041|NCT00277212|62821609|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
33446042|NCT00277212|62821610|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
33446043|NCT00277212|62821608|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
33446044|NCT00277212|62821609|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
33446045|NCT00277212|62821610|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
33446046|NCT00277212|62821608|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
33446047|NCT00277212|62821609|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
33446048|NCT00277212|62821610|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
33323681|NCT01215968|62700021|FG000|Overall Study|Protocol Violation|2|||
33323682|NCT01215968|62700022|FG001|Overall Study|Protocol Violation|4|||
33446049|NCT00277212|62821608|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
33446050|NCT00277212|62821609|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
33446051|NCT00277212|62821610|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
33323683|NCT01215968|62700021|FG000|Overall Study|Not received study drug|0|||
33323684|NCT01215968|62700022|FG001|Overall Study|Not received study drug|1|||
33323685|NCT00963807|62700031|FG000|Overall Study|Physician Decision|2|||
33446052|NCT00277212|62821608|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
33446053|NCT00277212|62821609|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
33323686|NCT00963807|62700031|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
33446054|NCT00277212|62821610|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
33446055|NCT00277212|62821608|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
33446056|NCT00277212|62821609|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
33446057|NCT00277212|62821610|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
33446058|NCT00277212|62821608|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
33446059|NCT00277212|62821609|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
33446060|NCT00277212|62821610|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
33446061|NCT00277212|62821608|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
33446062|NCT00277212|62821609|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
33446063|NCT00277212|62821610|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
33446064|NCT00277212|62821608|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
33446065|NCT00277212|62821609|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
33446066|NCT00277212|62821610|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
33446067|NCT00277212|62821608|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
33446068|NCT00277212|62821609|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
33446069|NCT00277212|62821610|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
33446070|NCT00277212|62821608|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
33446071|NCT00277212|62821609|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
33446072|NCT00277212|62821610|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
33446073|NCT00277212|62821608|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
33446074|NCT00277212|62821609|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
33446075|NCT00277212|62821610|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
33446076|NCT00277212|62821608|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
33446077|NCT00277212|62821609|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
33446078|NCT00277212|62821610|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
33446079|NCT00277212|62821608|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
33446080|NCT00277212|62821609|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
33446081|NCT00277212|62821610|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
33446082|NCT00277212|62821608|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
33446083|NCT00277212|62821609|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
33446084|NCT00277212|62821610|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
33446085|NCT00276744|62821618|FG000|PART A|Reason unknown|98|||
33446086|NCT00251316|62821624|FG000|Overall Study|Physician Decision|2|||
33446087|NCT00251316|62821625|FG001|Overall Study|Physician Decision|3|||
33446088|NCT00293462|62821634|FG000|Overall Study|Withdrawal by Subject|4|||
33446089|NCT00293462|62821635|FG001|Overall Study|Withdrawal by Subject|3|||
33446090|NCT00293462|62821636|FG002|Overall Study|Withdrawal by Subject|8|||
33446091|NCT00293462|62821634|FG000|Overall Study|Death|1|||
33446092|NCT00293462|62821635|FG001|Overall Study|Death|0|||
33446093|NCT00293462|62821636|FG002|Overall Study|Death|0|||
33446094|NCT00293462|62821634|FG000|Overall Study|Lost to Follow-up|0|||
33446095|NCT00293462|62821635|FG001|Overall Study|Lost to Follow-up|1|||
33446096|NCT00293462|62821636|FG002|Overall Study|Lost to Follow-up|0|||
33446097|NCT00293462|62821634|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
33446098|NCT00293462|62821635|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
33446099|NCT00293462|62821636|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
33446100|NCT00293462|62821634|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
33446101|NCT00293462|62821635|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
33446102|NCT00293462|62821636|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
33446103|NCT00293462|62821634|FG000|Overall Study|Refuse Radiation Treatment|1|||
33446104|NCT00293462|62821635|FG001|Overall Study|Refuse Radiation Treatment|0|||
33446105|NCT00293462|62821636|FG002|Overall Study|Refuse Radiation Treatment|0|||
33446106|NCT00293462|62821634|FG000|Overall Study|No Show|0|||
33446107|NCT00293462|62821635|FG001|Overall Study|No Show|0|||
33446108|NCT00293462|62821636|FG002|Overall Study|No Show|1|||
33446109|NCT00293462|62821634|FG000|Overall Study|Went back to his home country|0|||
33446110|NCT00293462|62821635|FG001|Overall Study|Went back to his home country|0|||
33446111|NCT00293462|62821636|FG002|Overall Study|Went back to his home country|1|||
33446112|NCT00293462|62821634|FG000|Overall Study|Blood clot after chemotherapy|0|||
33446113|NCT00293462|62821635|FG001|Overall Study|Blood clot after chemotherapy|0|||
33446114|NCT00293462|62821636|FG002|Overall Study|Blood clot after chemotherapy|1|||
33446115|NCT00293462|62821634|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
33446116|NCT00293462|62821635|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
33446117|NCT00293462|62821636|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
33446118|NCT00293462|62821634|FG000|Overall Study|Possible Tracheostomy leakage|0|||
33446119|NCT00293462|62821635|FG001|Overall Study|Possible Tracheostomy leakage|1|||
33446120|NCT00293462|62821636|FG002|Overall Study|Possible Tracheostomy leakage|0|||
33446121|NCT00293462|62821634|FG000|Overall Study|Low radiation dose in oral cavity|0|||
33446122|NCT00293462|62821635|FG001|Overall Study|Low radiation dose in oral cavity|1|||
33446123|NCT00293462|62821636|FG002|Overall Study|Low radiation dose in oral cavity|0|||
33446124|NCT00293462|62821634|FG000|Overall Study|Physician Decision|0|||
33446125|NCT00293462|62821635|FG001|Overall Study|Physician Decision|1|||
33446126|NCT00293462|62821636|FG002|Overall Study|Physician Decision|0|||
33446127|NCT00316082|62821649|FG000|Overall Study|Lack of Efficacy|2|||
33446128|NCT00316082|62821650|FG001|Overall Study|Lack of Efficacy|3|||
33446129|NCT00316082|62821651|FG002|Overall Study|Lack of Efficacy|3|||
33446130|NCT00316082|62821652|FG003|Overall Study|Lack of Efficacy|4|||
33446131|NCT00316082|62821653|FG004|Overall Study|Lack of Efficacy|6|||
33446132|NCT00316082|62821649|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
33446133|NCT00316082|62821650|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
33446134|NCT00316082|62821651|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
33446135|NCT00316082|62821652|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
33446136|NCT00316082|62821653|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
33446137|NCT00316082|62821649|FG000|Overall Study|Lost to Follow-up|7|||
33446138|NCT00316082|62821650|FG001|Overall Study|Lost to Follow-up|6|||
33446139|NCT00316082|62821651|FG002|Overall Study|Lost to Follow-up|7|||
33446140|NCT00316082|62821652|FG003|Overall Study|Lost to Follow-up|8|||
33446141|NCT00316082|62821653|FG004|Overall Study|Lost to Follow-up|6|||
33446142|NCT00316082|62821649|FG000|Overall Study|Poor/noncompliance|6|||
33446143|NCT00316082|62821650|FG001|Overall Study|Poor/noncompliance|1|||
33446144|NCT00316082|62821651|FG002|Overall Study|Poor/noncompliance|4|||
33446145|NCT00316082|62821652|FG003|Overall Study|Poor/noncompliance|1|||
33446146|NCT00316082|62821653|FG004|Overall Study|Poor/noncompliance|4|||
33446147|NCT00316082|62821649|FG000|Overall Study|Adverse Event|4|||
33446148|NCT00316082|62821650|FG001|Overall Study|Adverse Event|2|||
33446149|NCT00316082|62821651|FG002|Overall Study|Adverse Event|5|||
33446150|NCT00316082|62821652|FG003|Overall Study|Adverse Event|1|||
33446151|NCT00316082|62821653|FG004|Overall Study|Adverse Event|3|||
33446152|NCT00316082|62821649|FG000|Overall Study|Subject no longer meets study criteria|3|||
33446153|NCT00316082|62821650|FG001|Overall Study|Subject no longer meets study criteria|1|||
33446154|NCT00316082|62821651|FG002|Overall Study|Subject no longer meets study criteria|2|||
33446155|NCT00316082|62821652|FG003|Overall Study|Subject no longer meets study criteria|2|||
33446156|NCT00316082|62821653|FG004|Overall Study|Subject no longer meets study criteria|1|||
33446157|NCT00316082|62821649|FG000|Overall Study|Physician Decision|1|||
33446158|NCT00316082|62821650|FG001|Overall Study|Physician Decision|1|||
33446159|NCT00316082|62821651|FG002|Overall Study|Physician Decision|2|||
33446160|NCT00316082|62821652|FG003|Overall Study|Physician Decision|1|||
33446161|NCT00316082|62821653|FG004|Overall Study|Physician Decision|1|||
33446162|NCT00316082|62821649|FG000|Overall Study|Death|0|||
33446163|NCT00316082|62821650|FG001|Overall Study|Death|0|||
33446164|NCT00316082|62821651|FG002|Overall Study|Death|1|||
33446165|NCT00316082|62821652|FG003|Overall Study|Death|0|||
33446166|NCT00316082|62821653|FG004|Overall Study|Death|0|||
33446167|NCT00316082|62821649|FG000|Overall Study|Administrative reason by sponsor|0|||
33446168|NCT00316082|62821650|FG001|Overall Study|Administrative reason by sponsor|0|||
33446169|NCT00316082|62821651|FG002|Overall Study|Administrative reason by sponsor|1|||
33446170|NCT00316082|62821652|FG003|Overall Study|Administrative reason by sponsor|0|||
33446171|NCT00316082|62821653|FG004|Overall Study|Administrative reason by sponsor|0|||
33446172|NCT00316004|62821672|FG000|Overall Study|Subject was not given study fluid.|14|||
33446173|NCT00316004|62821673|FG001|Overall Study|Subject was not given study fluid.|14|||
33446174|NCT00316004|62821674|FG002|Overall Study|Subject was not given study fluid.|21|||
33446175|NCT00298766|62821682|FG000|Overall Study|Adverse Event|18|||
33446176|NCT00298766|62821682|FG000|Overall Study|Death|2|||
33446177|NCT00298766|62821682|FG000|Overall Study|Withdrawal by Subject|9|||
33446178|NCT00298766|62821682|FG000|Overall Study|Treatment ongoing|4|||
33446179|NCT00298766|62821682|FG000|Overall Study|Progression of amyloid markers|4|||
33446180|NCT00298766|62821682|FG000|Overall Study|Deterioration in KPS and organ function|1|||
33446181|NCT00298766|62821682|FG000|Overall Study|Subjects overall condition deterioration|4|||
33446182|NCT00298766|62821682|FG000|Overall Study|Other|4|||
33446183|NCT00315458|62821688|FG000|Overall Study|Administrative|0|||
33446184|NCT00315458|62821689|FG001|Overall Study|Administrative|3|||
33446185|NCT00315458|62821690|FG002|Overall Study|Administrative|8|||
33446186|NCT00315458|62821691|FG003|Overall Study|Administrative|21|||
33446187|NCT00315458|62821688|FG000|Overall Study|Adverse Event|2|||
33446188|NCT00315458|62821689|FG001|Overall Study|Adverse Event|4|||
33446189|NCT00315458|62821690|FG002|Overall Study|Adverse Event|23|||
33446190|NCT00315458|62821691|FG003|Overall Study|Adverse Event|3|||
33446191|NCT00315458|62821688|FG000|Overall Study|Lost to Follow-up|1|||
33446192|NCT00315458|62821689|FG001|Overall Study|Lost to Follow-up|2|||
33446193|NCT00315458|62821690|FG002|Overall Study|Lost to Follow-up|0|||
33446194|NCT00315458|62821691|FG003|Overall Study|Lost to Follow-up|2|||
33446195|NCT00315458|62821688|FG000|Overall Study|Withdrawal by Subject|0|||
33446196|NCT00315458|62821689|FG001|Overall Study|Withdrawal by Subject|3|||
33446197|NCT00315458|62821690|FG002|Overall Study|Withdrawal by Subject|0|||
33446198|NCT00315458|62821691|FG003|Overall Study|Withdrawal by Subject|2|||
33446199|NCT00315458|62821688|FG000|Overall Study|Lack of Efficacy|0|||
33446200|NCT00315458|62821689|FG001|Overall Study|Lack of Efficacy|0|||
33446201|NCT00315458|62821690|FG002|Overall Study|Lack of Efficacy|20|||
33446202|NCT00315458|62821691|FG003|Overall Study|Lack of Efficacy|1|||
33446203|NCT00315458|62821688|FG000|Overall Study|Did not qualify|0|||
33446204|NCT00315458|62821689|FG001|Overall Study|Did not qualify|0|||
33446205|NCT00315458|62821690|FG002|Overall Study|Did not qualify|1|||
33446206|NCT00315458|62821691|FG003|Overall Study|Did not qualify|0|||
33446207|NCT00293384|62821701|FG000|Overall Study|Non-compliance|2|||
33446208|NCT00293384|62821701|FG000|Overall Study|Missed dosage/study drug|1|||
33446209|NCT00293384|62821701|FG000|Overall Study|Ineligible|2|||
33446210|NCT00297830|62821708|FG000|6 Month Visit|Death|1|||
33446211|NCT00297830|62821709|FG001|6 Month Visit|Death|0|||
33446212|NCT00297830|62821710|FG002|6 Month Visit|Death|2|||
33446213|NCT00297830|62821708|FG000|6 Month Visit|Withdrawal by Subject|2|||
33446214|NCT00297830|62821709|FG001|6 Month Visit|Withdrawal by Subject|1|||
33446215|NCT00297830|62821710|FG002|6 Month Visit|Withdrawal by Subject|1|||
33446216|NCT00297830|62821708|FG000|6 Month Visit|Adverse Event|0|||
33446217|NCT00297830|62821709|FG001|6 Month Visit|Adverse Event|1|||
33446218|NCT00297830|62821710|FG002|6 Month Visit|Adverse Event|0|||
33446219|NCT00297830|62821708|FG000|12 Month Visit|Lost to Follow-up|1|||
33446220|NCT00297830|62821709|FG001|12 Month Visit|Lost to Follow-up|0|||
33446221|NCT00297830|62821710|FG002|12 Month Visit|Lost to Follow-up|0|||
33446222|NCT00297830|62821708|FG000|12 Month Visit|Adverse Event|0|||
33446223|NCT00297830|62821709|FG001|12 Month Visit|Adverse Event|3|||
33446224|NCT00297830|62821710|FG002|12 Month Visit|Adverse Event|0|||
33446225|NCT00297830|62821708|FG000|12 Month Visit|Withdrawal by Subject|0|||
33446226|NCT00297830|62821709|FG001|12 Month Visit|Withdrawal by Subject|3|||
33323687|NCT00963807|62700031|FG000|Overall Study|Disease progression|15|||
33446227|NCT00297830|62821710|FG002|12 Month Visit|Withdrawal by Subject|0|||
33446228|NCT00296816|62821720|FG000|Overall Study|Disease Progression|37|||
33446229|NCT00296816|62821720|FG000|Overall Study|Adverse Event|18|||
33446230|NCT00296816|62821720|FG000|Overall Study|Investigator/Participant request|5|||
33446231|NCT00296816|62821720|FG000|Overall Study|Non-compliance|1|||
33446232|NCT00296816|62821720|FG000|Overall Study|Missing for end of treatment|4|||
33446233|NCT00296816|62821720|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
33446234|NCT00296816|62821720|FG000|Overall Study|Poor performance status|1|||
33446235|NCT00296816|62821720|FG000|Overall Study|Relocation to Florida|1|||
33446236|NCT00296816|62821720|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
33446237|NCT00296816|62821720|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
33446238|NCT00296816|62821720|FG000|Overall Study|Neuropathy/patient preference|1|||
33446239|NCT00296816|62821720|FG000|Overall Study|Proteinuria|1|||
33446240|NCT00296816|62821720|FG000|Overall Study|ineligibility due to radiation treatment|1|||
33446241|NCT00314132|62821726|FG000|Overall Study|Lost to Follow-up|3|||
33446242|NCT00314132|62821727|FG001|Overall Study|Lost to Follow-up|13|||
33446243|NCT00314132|62821726|FG000|Overall Study|Withdrawal by Subject|3|||
33446244|NCT00314132|62821727|FG001|Overall Study|Withdrawal by Subject|5|||
33446245|NCT00314132|62821726|FG000|Overall Study|Adverse Event|1|||
33446246|NCT00314132|62821727|FG001|Overall Study|Adverse Event|0|||
33446247|NCT00314132|62821726|FG000|Overall Study|Physician Decision|1|||
33446248|NCT00314132|62821727|FG001|Overall Study|Physician Decision|0|||
33446249|NCT00097786|62821739|FG000|Overall Study|lost to follow-up for all-cause death|296|||
33446250|NCT00097786|62821740|FG001|Overall Study|lost to follow-up for all-cause death|292|||
33446251|NCT00097786|62821741|FG002|Overall Study|lost to follow-up for all-cause death|313|||
33323688|NCT01142466|62700039|FG000|Overall Study|Adverse Event|2|||
33446252|NCT00097786|62821742|FG003|Overall Study|lost to follow-up for all-cause death|310|||
33494246|NCT02873936|62873017|FG001|Overall Study|Non-compliance With Study Drug|0|||
33494247|NCT02873936|62873018|FG002|Overall Study|Non-compliance With Study Drug|1|||
33446253|NCT00117988|62821752|FG000|Overall Study|Death|3|||
33323689|NCT01142466|62700040|FG001|Overall Study|Adverse Event|1|||
33323690|NCT01142466|62700039|FG000|Overall Study|Withdrawal by Subject|1|||
33323691|NCT01142466|62700040|FG001|Overall Study|Withdrawal by Subject|1|||
33323692|NCT01215734|62700048|FG000|Overall Study|Death|0|||
33446254|NCT00117988|62821752|FG000|Overall Study|Adverse Event|1|||
33446255|NCT00117676|62821758|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
33446256|NCT00117676|62821759|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
33446257|NCT00117676|62821758|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
33446258|NCT00117676|62821759|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
33446259|NCT00117676|62821758|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
33446260|NCT00117676|62821759|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
33446261|NCT00117676|62821758|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
33446262|NCT00117676|62821759|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
33446263|NCT00117676|62821758|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
33323693|NCT01215734|62700049|FG001|Overall Study|Death|1|||
33446264|NCT00117676|62821759|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
33446265|NCT00117676|62821758|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
33446266|NCT00117676|62821759|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
33446267|NCT00117676|62821758|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
33446268|NCT00117676|62821759|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
33446269|NCT00117676|62821758|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
33446270|NCT00117676|62821759|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
33446271|NCT00117676|62821758|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
33323694|NCT01169987|62700055|FG000|Overall Study|Withdrawal by Subject|3|||
33323695|NCT01169987|62700055|FG000|Overall Study|Lost to Follow-up|24|||
33323696|NCT01169987|62700055|FG000|Overall Study|Other|4|||
33323697|NCT01215422|62700069|FG000|Overall Study|Relocation|1|||
33323698|NCT01215422|62700070|FG001|Overall Study|Relocation|0|||
33323699|NCT01215422|62700071|FG002|Overall Study|Relocation|0|||
33323700|NCT01215422|62700072|FG003|Overall Study|Relocation|0|||
33323701|NCT01215422|62700069|FG000|Overall Study|Failed intubations|0|||
33323702|NCT01215422|62700070|FG001|Overall Study|Failed intubations|0|||
33323703|NCT01215422|62700071|FG002|Overall Study|Failed intubations|3|||
33446272|NCT00117676|62821759|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
33446273|NCT00117676|62821758|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
33446274|NCT00117676|62821759|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
33446275|NCT00117676|62821758|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
33446276|NCT00117676|62821759|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
33446277|NCT00117676|62821758|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
33446278|NCT00117676|62821759|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
33446279|NCT00117676|62821758|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
33446280|NCT00117676|62821759|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
33446281|NCT00117676|62821758|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
33446282|NCT00117676|62821759|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
33446283|NCT00117676|62821758|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
33446284|NCT00117676|62821759|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
33446285|NCT00117676|62821758|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
33446286|NCT00117676|62821759|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
33446287|NCT00117676|62821758|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
33446288|NCT00117676|62821759|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
33446289|NCT00117676|62821758|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
33446290|NCT00117676|62821759|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
33446291|NCT00117676|62821758|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
33446292|NCT00117676|62821759|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
33323704|NCT01215422|62700072|FG003|Overall Study|Failed intubations|8|||
33323705|NCT01215422|62700069|FG000|Overall Study|Did not complete all intubations|7|||
33323706|NCT01215422|62700070|FG001|Overall Study|Did not complete all intubations|0|||
33323707|NCT01215422|62700071|FG002|Overall Study|Did not complete all intubations|0|||
33323708|NCT01215422|62700072|FG003|Overall Study|Did not complete all intubations|0|||
33323709|NCT00972153|62700097|FG000|Overall Study|Equipment malfunction during case|0|||
33323710|NCT00972153|62700098|FG001|Overall Study|Equipment malfunction during case|1|||
33323711|NCT00972153|62700099|FG002|Overall Study|Equipment malfunction during case|0|||
33323712|NCT00971997|62700107|FG000|Overall Study|Adverse Event|2|||
33323713|NCT00971997|62700107|FG000|Overall Study|Death|1|||
33323714|NCT00971997|62700107|FG000|Overall Study|Protocol Violation|4|||
33323715|NCT00971997|62700107|FG000|Overall Study|Withdrawal by Subject|5|||
33323716|NCT00971997|62700107|FG000|Overall Study|Physician Decision|7|||
33323717|NCT01127646|62700116|FG000|Overall Study|Entry Criteria Not Met|1|||
33323718|NCT01127646|62700117|FG001|Overall Study|Entry Criteria Not Met|0|||
33323719|NCT01127646|62700116|FG000|Overall Study|Protocol Violation|0|||
33323720|NCT01127646|62700117|FG001|Overall Study|Protocol Violation|1|||
33323721|NCT01215188|62700128|FG000|Overall Study|Lost to Follow-up|22|||
33323722|NCT01215188|62700129|FG001|Overall Study|Lost to Follow-up|22|||
33323723|NCT01215188|62700130|FG002|Overall Study|Lost to Follow-up|16|||
33323724|NCT01215188|62700128|FG000|Overall Study|Adverse Event|1|||
33446293|NCT00117676|62821758|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
33446294|NCT00117676|62821759|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
33446295|NCT00117676|62821758|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
33323725|NCT01215188|62700129|FG001|Overall Study|Adverse Event|1|||
33323726|NCT01215188|62700130|FG002|Overall Study|Adverse Event|3|||
33323727|NCT01215188|62700128|FG000|Overall Study|Physician Decision|2|||
33323728|NCT01215188|62700129|FG001|Overall Study|Physician Decision|1|||
33323729|NCT01215188|62700130|FG002|Overall Study|Physician Decision|0|||
33323730|NCT01215188|62700128|FG000|Overall Study|Lack of Efficacy|0|||
33323731|NCT01215188|62700129|FG001|Overall Study|Lack of Efficacy|0|||
33446296|NCT00117676|62821759|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
33446297|NCT00117676|62821758|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
33446298|NCT00117676|62821759|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
33446299|NCT00117676|62821758|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
33446300|NCT00117676|62821759|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
33446301|NCT00117676|62821758|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
33446302|NCT00117676|62821759|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
33446303|NCT00117676|62821758|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
33446304|NCT00117676|62821759|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
33446305|NCT00117676|62821758|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
33446306|NCT00117676|62821759|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
33446307|NCT00117676|62821758|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
33446308|NCT00117676|62821759|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
33446309|NCT00117676|62821758|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
33446310|NCT00117676|62821759|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
33446311|NCT00117676|62821758|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
33446312|NCT00117676|62821759|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
33446313|NCT00117676|62821758|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
33446314|NCT00117676|62821759|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
33446315|NCT00117676|62821758|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
33446316|NCT00117676|62821759|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
33446317|NCT00117676|62821758|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
33446318|NCT00117676|62821759|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
33446319|NCT00117676|62821758|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
33446320|NCT00117676|62821759|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
33446321|NCT00117676|62821758|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
33446322|NCT00117676|62821759|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
33446323|NCT00117676|62821758|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
33446324|NCT00117676|62821759|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
33446325|NCT00251004|62821773|FG000|Overall Study|Withdrawal by Subject|23|||
33446326|NCT00251004|62821774|FG001|Overall Study|Withdrawal by Subject|16|||
33446327|NCT00251004|62821775|FG002|Overall Study|Withdrawal by Subject|14|||
33446328|NCT00251004|62821773|FG000|Overall Study|Death|9|||
33446329|NCT00251004|62821774|FG001|Overall Study|Death|10|||
33446330|NCT00251004|62821775|FG002|Overall Study|Death|8|||
33446331|NCT00251004|62821773|FG000|Overall Study|Lost to Follow-up|1|||
33446332|NCT00251004|62821774|FG001|Overall Study|Lost to Follow-up|2|||
33446333|NCT00251004|62821775|FG002|Overall Study|Lost to Follow-up|1|||
33446334|NCT00251004|62821773|FG000|Overall Study|Graft Loss|12|||
33446335|NCT00251004|62821774|FG001|Overall Study|Graft Loss|13|||
33446336|NCT00251004|62821775|FG002|Overall Study|Graft Loss|8|||
33446337|NCT00275340|62821785|FG000|Overall Study|Lost to Follow-up|2|||
33446338|NCT00275340|62821786|FG001|Overall Study|Lost to Follow-up|4|||
33446339|NCT00275262|62821792|FG000|Overall Study|Adverse Event|2|||
33446340|NCT00275262|62821793|FG001|Overall Study|Adverse Event|0|||
33446341|NCT00275262|62821792|FG000|Overall Study|Disease progression|2|||
33446342|NCT00275262|62821793|FG001|Overall Study|Disease progression|5|||
33446343|NCT00275262|62821792|FG000|Overall Study|Lost to Follow-up|0|||
33446344|NCT00275262|62821793|FG001|Overall Study|Lost to Follow-up|2|||
33446345|NCT00275262|62821792|FG000|Overall Study|Protocol Violation|0|||
33446346|NCT00275262|62821793|FG001|Overall Study|Protocol Violation|2|||
33446347|NCT00275262|62821792|FG000|Overall Study|Death|1|||
33446348|NCT00275262|62821793|FG001|Overall Study|Death|0|||
33446349|NCT00275262|62821792|FG000|Overall Study|Started Chemotherapy|1|||
33446350|NCT00275262|62821793|FG001|Overall Study|Started Chemotherapy|0|||
33446351|NCT00275028|62821799|FG000|Overall Study|Withdrew consent before treatment began|1|||
33446352|NCT00275028|62821799|FG000|Overall Study|Withdrawal by Subject|5|||
33446353|NCT00275028|62821799|FG000|Overall Study|Adverse Event|9|||
33446354|NCT00275028|62821799|FG000|Overall Study|Progressive Disease|30|||
33446355|NCT00275028|62821799|FG000|Overall Study|Physician Decision|2|||
33446356|NCT00471497|62821806|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
33446357|NCT00471497|62821807|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
33446358|NCT00471497|62821808|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
33446359|NCT00471497|62821806|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
33446360|NCT00471497|62821807|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
33446361|NCT00471497|62821808|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
33446362|NCT00471497|62821806|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
33446363|NCT00471497|62821807|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
33446364|NCT00471497|62821808|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
33446365|NCT00471497|62821806|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
33446366|NCT00471497|62821807|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
33446367|NCT00471497|62821808|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
33446368|NCT00471497|62821806|FG000|Core Treatment Phase|Lost to Follow-up|6|||
33446369|NCT00471497|62821807|FG001|Core Treatment Phase|Lost to Follow-up|6|||
33446370|NCT00471497|62821808|FG002|Core Treatment Phase|Lost to Follow-up|3|||
33446371|NCT00471497|62821806|FG000|Core Treatment Phase|Death|3|||
33446372|NCT00471497|62821807|FG001|Core Treatment Phase|Death|9|||
33446373|NCT00471497|62821808|FG002|Core Treatment Phase|Death|3|||
33446374|NCT00471497|62821806|FG000|Core Treatment Phase|Disease Progression|10|||
33446375|NCT00471497|62821807|FG001|Core Treatment Phase|Disease Progression|2|||
33446376|NCT00471497|62821808|FG002|Core Treatment Phase|Disease Progression|4|||
33446377|NCT00471497|62821806|FG000|Core Treatment Phase|Protocol Violation|6|||
33446378|NCT00471497|62821807|FG001|Core Treatment Phase|Protocol Violation|15|||
33446379|NCT00471497|62821808|FG002|Core Treatment Phase|Protocol Violation|11|||
33446380|NCT00471497|62821806|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
33446381|NCT00471497|62821807|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
33446382|NCT00471497|62821808|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
33446383|NCT00471497|62821806|FG000|Core Treatment Phase|Administrative problems|14|||
33446384|NCT00471497|62821807|FG001|Core Treatment Phase|Administrative problems|14|||
33446385|NCT00471497|62821808|FG002|Core Treatment Phase|Administrative problems|12|||
33446386|NCT00471497|62821806|FG000|Core Treatment Phase|Adverse Event|43|||
33446387|NCT00471497|62821807|FG001|Core Treatment Phase|Adverse Event|53|||
33446388|NCT00471497|62821808|FG002|Core Treatment Phase|Adverse Event|89|||
33446389|NCT00471497|62821806|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
33323732|NCT01215188|62700130|FG002|Overall Study|Lack of Efficacy|1|||
33446390|NCT00471497|62821807|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
33446391|NCT00471497|62821808|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
33446392|NCT00471497|62821806|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
33446393|NCT00471497|62821807|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
33446394|NCT00471497|62821808|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
33446395|NCT00471497|62821806|FG000|Extension Phase|Adverse Event|9|||
33446396|NCT00471497|62821807|FG001|Extension Phase|Adverse Event|5|||
33446397|NCT00471497|62821808|FG002|Extension Phase|Adverse Event|1|||
33446398|NCT00471497|62821806|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
33446399|NCT00471497|62821807|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
33446400|NCT00471497|62821808|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
33446401|NCT00471497|62821806|FG000|Extension Phase|Withdrawal by Subject|3|||
33323733|NCT01215188|62700128|FG000|Overall Study|Protocol Violation|1|||
33323734|NCT01215188|62700129|FG001|Overall Study|Protocol Violation|1|||
33323735|NCT01215188|62700130|FG002|Overall Study|Protocol Violation|1|||
33323736|NCT01215188|62700128|FG000|Overall Study|Withdrawal by Subject|32|||
33323737|NCT01215188|62700129|FG001|Overall Study|Withdrawal by Subject|34|||
33323738|NCT01215188|62700130|FG002|Overall Study|Withdrawal by Subject|31|||
33323739|NCT01215032|62700138|FG000|Overall Study|Adverse Event|3|||
33323740|NCT01215032|62700138|FG000|Overall Study|Lack of Efficacy|17|||
33323741|NCT00962247|62700144|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
33323742|NCT00962247|62700144|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
33323743|NCT00918580|62700150|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
33323744|NCT00918580|62700150|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
33323745|NCT00918580|62700150|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
33323746|NCT00918580|62700150|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
33323747|NCT00918580|62700150|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
33323748|NCT00918580|62700150|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
33323749|NCT00918580|62700150|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
33323750|NCT00920686|62700160|FG000|Overall Study|Lost to Follow-up|2|||
33323751|NCT00920686|62700161|FG001|Overall Study|Lost to Follow-up|3|||
33323752|NCT00920686|62700162|FG002|Overall Study|Lost to Follow-up|1|||
33323753|NCT00920686|62700160|FG000|Overall Study|Study drug dosing criteria not met|17|||
33323754|NCT00920686|62700161|FG001|Overall Study|Study drug dosing criteria not met|19|||
33323755|NCT00920686|62700162|FG002|Overall Study|Study drug dosing criteria not met|12|||
33323756|NCT01214720|62700176|FG000|Overall Study|Alive and still on treatment|34|||
33323757|NCT01214720|62700177|FG001|Overall Study|Alive and still on treatment|18|||
33323758|NCT01214720|62700176|FG000|Overall Study|Alive and in follow-up|45|||
33323759|NCT01214720|62700177|FG001|Overall Study|Alive and in follow-up|48|||
33323760|NCT01214720|62700176|FG000|Overall Study|Lost to Follow-up|6|||
33323761|NCT01214720|62700177|FG001|Overall Study|Lost to Follow-up|2|||
33446402|NCT00471497|62821807|FG001|Extension Phase|Withdrawal by Subject|1|||
33446403|NCT00471497|62821808|FG002|Extension Phase|Withdrawal by Subject|0|||
33446404|NCT00471497|62821806|FG000|Extension Phase|Lost to Follow-up|2|||
33323762|NCT01142232|62700188|FG000|Overall Study|Adverse Event|1|||
33323763|NCT01142232|62700189|FG001|Overall Study|Adverse Event|2|||
33446405|NCT00471497|62821807|FG001|Extension Phase|Lost to Follow-up|0|||
33323764|NCT01142232|62700190|FG002|Overall Study|Adverse Event|1|||
33323765|NCT01142232|62700191|FG003|Overall Study|Adverse Event|0|||
33323766|NCT01142232|62700192|FG004|Overall Study|Adverse Event|4|||
33323767|NCT01142232|62700188|FG000|Overall Study|Death|0|||
33323768|NCT01142232|62700189|FG001|Overall Study|Death|0|||
33323769|NCT01142232|62700190|FG002|Overall Study|Death|0|||
33323770|NCT01142232|62700191|FG003|Overall Study|Death|0|||
33323771|NCT01142232|62700192|FG004|Overall Study|Death|1|||
33323772|NCT01142232|62700188|FG000|Overall Study|Disease Progression|2|||
33323773|NCT01142232|62700189|FG001|Overall Study|Disease Progression|0|||
33323774|NCT01142232|62700190|FG002|Overall Study|Disease Progression|1|||
33323775|NCT01142232|62700191|FG003|Overall Study|Disease Progression|2|||
33323776|NCT01142232|62700192|FG004|Overall Study|Disease Progression|12|||
33323777|NCT01142232|62700188|FG000|Overall Study|Withdrawal by Subject|0|||
33323778|NCT01142232|62700189|FG001|Overall Study|Withdrawal by Subject|0|||
33323779|NCT01142232|62700190|FG002|Overall Study|Withdrawal by Subject|0|||
33323780|NCT01142232|62700191|FG003|Overall Study|Withdrawal by Subject|1|||
33323781|NCT01142232|62700192|FG004|Overall Study|Withdrawal by Subject|3|||
33323782|NCT01142232|62700188|FG000|Overall Study|Physician Decision|0|||
33323783|NCT01142232|62700189|FG001|Overall Study|Physician Decision|1|||
33323784|NCT01142232|62700190|FG002|Overall Study|Physician Decision|0|||
33323785|NCT01142232|62700191|FG003|Overall Study|Physician Decision|2|||
33323786|NCT01142232|62700192|FG004|Overall Study|Physician Decision|10|||
33323787|NCT01142232|62700188|FG000|Overall Study|Alternative Therapy|0|||
33323788|NCT01142232|62700189|FG001|Overall Study|Alternative Therapy|1|||
33323789|NCT01142232|62700190|FG002|Overall Study|Alternative Therapy|1|||
33323790|NCT01142232|62700191|FG003|Overall Study|Alternative Therapy|0|||
33323791|NCT01142232|62700192|FG004|Overall Study|Alternative Therapy|1|||
33323792|NCT01142232|62700188|FG000|Overall Study|Off Trt for other complicating disease|0|||
33323793|NCT01142232|62700189|FG001|Overall Study|Off Trt for other complicating disease|0|||
33323794|NCT01142232|62700190|FG002|Overall Study|Off Trt for other complicating disease|0|||
33323795|NCT01142232|62700191|FG003|Overall Study|Off Trt for other complicating disease|0|||
33323796|NCT01142232|62700192|FG004|Overall Study|Off Trt for other complicating disease|1|||
33323797|NCT01142232|62700188|FG000|Overall Study|Noncompliance|0|||
33323798|NCT01142232|62700189|FG001|Overall Study|Noncompliance|0|||
33323799|NCT01142232|62700190|FG002|Overall Study|Noncompliance|0|||
33323800|NCT01142232|62700191|FG003|Overall Study|Noncompliance|0|||
33323801|NCT01142232|62700192|FG004|Overall Study|Noncompliance|2|||
33323802|NCT01140906|62700208|FG000|Overall Study|Adverse Event|7|||
33323803|NCT01140906|62700209|FG001|Overall Study|Adverse Event|10|||
33323804|NCT01140906|62700210|FG002|Overall Study|Adverse Event|17|||
33323805|NCT01140906|62700211|FG003|Overall Study|Adverse Event|7|||
33323806|NCT01140906|62700208|FG000|Overall Study|Lack of Efficacy|6|||
33323807|NCT01140906|62700209|FG001|Overall Study|Lack of Efficacy|8|||
33323808|NCT01140906|62700210|FG002|Overall Study|Lack of Efficacy|2|||
33323809|NCT01140906|62700211|FG003|Overall Study|Lack of Efficacy|1|||
33323810|NCT01140906|62700208|FG000|Overall Study|Non-compliance|0|||
33323811|NCT01140906|62700209|FG001|Overall Study|Non-compliance|1|||
33323812|NCT01140906|62700210|FG002|Overall Study|Non-compliance|0|||
33323813|NCT01140906|62700211|FG003|Overall Study|Non-compliance|1|||
33323814|NCT01140906|62700208|FG000|Overall Study|Protocol Violation|5|||
33323815|NCT01140906|62700209|FG001|Overall Study|Protocol Violation|3|||
33323816|NCT01140906|62700210|FG002|Overall Study|Protocol Violation|2|||
33323817|NCT01140906|62700211|FG003|Overall Study|Protocol Violation|1|||
33323818|NCT01140906|62700208|FG000|Overall Study|Withdrawal of consent|6|||
33323819|NCT01140906|62700209|FG001|Overall Study|Withdrawal of consent|6|||
33323820|NCT01140906|62700210|FG002|Overall Study|Withdrawal of consent|2|||
33323821|NCT01140906|62700211|FG003|Overall Study|Withdrawal of consent|2|||
33323822|NCT01140906|62700208|FG000|Overall Study|Lost to Follow-up|1|||
33323823|NCT01140906|62700209|FG001|Overall Study|Lost to Follow-up|1|||
33323824|NCT01140906|62700210|FG002|Overall Study|Lost to Follow-up|0|||
33446406|NCT00471497|62821808|FG002|Extension Phase|Lost to Follow-up|0|||
33446407|NCT00471497|62821806|FG000|Extension Phase|Death|1|||
33446408|NCT00471497|62821807|FG001|Extension Phase|Death|0|||
33323825|NCT01140906|62700211|FG003|Overall Study|Lost to Follow-up|2|||
33323826|NCT01140906|62700208|FG000|Overall Study|Administrative or other reason|0|||
33323827|NCT01140906|62700209|FG001|Overall Study|Administrative or other reason|5|||
33323828|NCT01140906|62700210|FG002|Overall Study|Administrative or other reason|3|||
33323829|NCT01140906|62700211|FG003|Overall Study|Administrative or other reason|2|||
33323830|NCT00962091|62700228|FG000|Overall Study|Withdrawal by Subject|1|||
33323831|NCT00962091|62700229|FG001|Overall Study|Withdrawal by Subject|2|||
33323832|NCT00962091|62700230|FG002|Overall Study|Withdrawal by Subject|1|||
33323833|NCT00962091|62700231|FG003|Overall Study|Withdrawal by Subject|1|||
33323834|NCT00962091|62700232|FG004|Overall Study|Withdrawal by Subject|0|||
33323835|NCT00962091|62700233|FG005|Overall Study|Withdrawal by Subject|1|||
33323836|NCT00962091|62700234|FG006|Overall Study|Withdrawal by Subject|0|||
33446409|NCT00471497|62821808|FG002|Extension Phase|Death|0|||
33446410|NCT00471497|62821806|FG000|Extension Phase|Disease progression|2|||
33446411|NCT00471497|62821807|FG001|Extension Phase|Disease progression|0|||
33323837|NCT00962091|62700228|FG000|Overall Study|Adverse Event|0|||
33323838|NCT00962091|62700229|FG001|Overall Study|Adverse Event|0|||
33323839|NCT00962091|62700230|FG002|Overall Study|Adverse Event|0|||
33323840|NCT00962091|62700231|FG003|Overall Study|Adverse Event|0|||
33446412|NCT00471497|62821808|FG002|Extension Phase|Disease progression|0|||
33446413|NCT00471497|62821806|FG000|Extension Phase|Protocol Violation|2|||
33446414|NCT00471497|62821807|FG001|Extension Phase|Protocol Violation|2|||
33446415|NCT00471497|62821808|FG002|Extension Phase|Protocol Violation|0|||
33446416|NCT00493649|62821819|FG000|Overall Study|Adverse Event|44|||
33446417|NCT00493649|62821819|FG000|Overall Study|Patient Request|21|||
33446418|NCT00493649|62821819|FG000|Overall Study|Investigator Request|2|||
33323841|NCT00962091|62700232|FG004|Overall Study|Adverse Event|0|||
33446419|NCT00493649|62821819|FG000|Overall Study|Disease Progression|1|||
33446420|NCT00493649|62821819|FG000|Overall Study|Lost to Follow-up|1|||
33446421|NCT00493649|62821819|FG000|Overall Study|Other|13|||
33446422|NCT00471107|62821829|FG000|Overall Study|Technical problems/data loss|3|||
33446423|NCT00471107|62821830|FG001|Overall Study|Technical problems/data loss|1|||
33446424|NCT00471107|62821831|FG002|Overall Study|Technical problems/data loss|3|||
33446425|NCT00488033|62821841|FG000|Overall Study|Withdrawal by Subject|1|||
33446426|NCT00488033|62821842|FG001|Overall Study|Withdrawal by Subject|0|||
33446427|NCT00117598|62821851|FG000|Prior to Treatment Cross Over|Death|40|||
33446428|NCT00117598|62821852|FG001|Prior to Treatment Cross Over|Death|41|||
33446429|NCT00117598|62821853|FG002|Prior to Treatment Cross Over|Death|37|||
33446430|NCT00117598|62821854|FG003|Prior to Treatment Cross Over|Death|0|||
33446431|NCT00117598|62821855|FG004|Prior to Treatment Cross Over|Death|0|||
33446432|NCT00117598|62821851|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
33446433|NCT00117598|62821852|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
33446434|NCT00117598|62821853|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
33446435|NCT00117598|62821854|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
33446436|NCT00117598|62821855|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
33446437|NCT00117598|62821851|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
33446438|NCT00117598|62821852|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
33446439|NCT00117598|62821853|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
33446440|NCT00117598|62821854|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
33446441|NCT00117598|62821855|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
33446442|NCT00117598|62821851|FG000|Prior to Treatment Cross Over|Other|15|||
33446443|NCT00117598|62821852|FG001|Prior to Treatment Cross Over|Other|9|||
33446444|NCT00117598|62821853|FG002|Prior to Treatment Cross Over|Other|9|||
33446445|NCT00117598|62821854|FG003|Prior to Treatment Cross Over|Other|0|||
33446446|NCT00117598|62821855|FG004|Prior to Treatment Cross Over|Other|0|||
33446447|NCT00117598|62821851|FG000|After Treament Cross Over|Death|0|||
33446448|NCT00117598|62821852|FG001|After Treament Cross Over|Death|0|||
33446449|NCT00117598|62821853|FG002|After Treament Cross Over|Death|0|||
33446450|NCT00117598|62821854|FG003|After Treament Cross Over|Death|1|||
33446451|NCT00117598|62821855|FG004|After Treament Cross Over|Death|2|||
33446452|NCT00117598|62821851|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
33446453|NCT00117598|62821852|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
33446454|NCT00117598|62821853|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
33446455|NCT00117598|62821854|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
33446456|NCT00117598|62821855|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
33446457|NCT00117598|62821851|FG000|After Treament Cross Over|Other|0|||
33446458|NCT00117598|62821852|FG001|After Treament Cross Over|Other|0|||
33446459|NCT00117598|62821853|FG002|After Treament Cross Over|Other|0|||
33446460|NCT00117598|62821854|FG003|After Treament Cross Over|Other|1|||
33446461|NCT00117598|62821855|FG004|After Treament Cross Over|Other|2|||
33446462|NCT00469859|62821867|FG000|Overall Study|Inevaluable|0|||
33446463|NCT00469859|62821868|FG001|Overall Study|Inevaluable|2|||
33446464|NCT00093808|62821874|FG000|Overall Study|Cancel participation before receiving tx|1|||
33446465|NCT00093808|62821874|FG000|Overall Study|Protocol Violation|1|||
33446466|NCT00469079|62821881|FG000|Overall Study|Lack of Efficacy|3|||
33446467|NCT00469079|62821882|FG001|Overall Study|Lack of Efficacy|8|||
33446468|NCT00469079|62821883|FG002|Overall Study|Lack of Efficacy|5|||
33446469|NCT00469079|62821881|FG000|Overall Study|Adverse Event|1|||
33446470|NCT00469079|62821882|FG001|Overall Study|Adverse Event|3|||
33446471|NCT00469079|62821883|FG002|Overall Study|Adverse Event|2|||
33446472|NCT00469079|62821881|FG000|Overall Study|Lost to Follow-up|4|||
33323842|NCT00962091|62700233|FG005|Overall Study|Adverse Event|0|||
33323843|NCT00962091|62700234|FG006|Overall Study|Adverse Event|1|||
33323844|NCT01163916|62700261|FG000|Overall Study|Withdrawal by Subject|2|||
33446473|NCT00469079|62821882|FG001|Overall Study|Lost to Follow-up|8|||
33446474|NCT00469079|62821883|FG002|Overall Study|Lost to Follow-up|10|||
33446475|NCT00469079|62821881|FG000|Overall Study|Withdrawal by Subject|1|||
33446476|NCT00469079|62821882|FG001|Overall Study|Withdrawal by Subject|2|||
33446477|NCT00469079|62821883|FG002|Overall Study|Withdrawal by Subject|2|||
33446478|NCT00469079|62821881|FG000|Overall Study|Ineligible|0|||
33323845|NCT01163916|62700262|FG001|Overall Study|Withdrawal by Subject|0|||
33446479|NCT00469079|62821882|FG001|Overall Study|Ineligible|1|||
33446480|NCT00469079|62821883|FG002|Overall Study|Ineligible|0|||
33446481|NCT00093496|62821899|FG000|Overall Study|Protocol Violation|1|||
33446482|NCT00093496|62821900|FG001|Overall Study|Protocol Violation|3|||
33446483|NCT00117286|62821907|FG000|Overall Study|Adverse Event|12|||
33446484|NCT00117286|62821908|FG001|Overall Study|Adverse Event|6|||
33446485|NCT00117286|62821907|FG000|Overall Study|Lost to Follow-up|2|||
33446486|NCT00117286|62821908|FG001|Overall Study|Lost to Follow-up|0|||
33446487|NCT00117286|62821907|FG000|Overall Study|Protocol Violation|3|||
33446488|NCT00117286|62821908|FG001|Overall Study|Protocol Violation|3|||
33446489|NCT00117286|62821907|FG000|Overall Study|Withdrawal by Subject|6|||
33446490|NCT00117286|62821908|FG001|Overall Study|Withdrawal by Subject|2|||
33446491|NCT00117286|62821907|FG000|Overall Study|Physician Decision|3|||
33446492|NCT00117286|62821908|FG001|Overall Study|Physician Decision|7|||
33446493|NCT00117286|62821907|FG000|Overall Study|Lack of Efficacy|2|||
33446494|NCT00117286|62821908|FG001|Overall Study|Lack of Efficacy|1|||
33446495|NCT00117286|62821907|FG000|Overall Study|Research site closing|0|||
33446496|NCT00117286|62821908|FG001|Overall Study|Research site closing|2|||
33446497|NCT00265122|62821920|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
33446498|NCT00265122|62821921|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
33446499|NCT00265122|62821922|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
33446500|NCT00265122|62821923|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
33446501|NCT00265122|62821924|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
33446502|NCT00265122|62821925|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
33446503|NCT00265122|62821920|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
33446504|NCT00265122|62821921|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
33446505|NCT00265122|62821922|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
33323846|NCT01163916|62700263|FG002|Overall Study|Withdrawal by Subject|2|||
33323847|NCT01163916|62700261|FG000|Overall Study|Adverse Event|2|||
33323848|NCT01163916|62700262|FG001|Overall Study|Adverse Event|0|||
33323849|NCT01163916|62700263|FG002|Overall Study|Adverse Event|1|||
33323850|NCT01163916|62700261|FG000|Overall Study|Lack of Efficacy|2|||
33446506|NCT00265122|62821923|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
33446507|NCT00265122|62821924|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
33446508|NCT00265122|62821925|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
33446509|NCT00265122|62821920|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
33446510|NCT00265122|62821921|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
33446511|NCT00265122|62821922|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
33446512|NCT00265122|62821923|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
33446513|NCT00265122|62821924|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
33446514|NCT00265122|62821925|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
33446515|NCT00265122|62821920|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
33446516|NCT00265122|62821921|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
33446517|NCT00265122|62821922|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
33446518|NCT00265122|62821923|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
33446519|NCT00265122|62821924|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
33446520|NCT00265122|62821925|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
33446521|NCT00265122|62821920|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
33446522|NCT00265122|62821921|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
33494248|NCT02873936|62873016|FG000|Overall Study|Randomized but not Dosed|1|||
33494249|NCT02873936|62873017|FG001|Overall Study|Randomized but not Dosed|0|||
33494250|NCT02873936|62873018|FG002|Overall Study|Randomized but not Dosed|0|||
33494251|NCT02874794|62873028|FG000|Overall Study|Physician Decision|3|||
33494252|NCT02874794|62873029|FG001|Overall Study|Physician Decision|2|||
33494253|NCT02874794|62873028|FG000|Overall Study|Withdrawal by Subject|2|||
33494254|NCT02874794|62873029|FG001|Overall Study|Withdrawal by Subject|8|||
33494255|NCT02874794|62873028|FG000|Overall Study|Death|2|||
33494256|NCT02874794|62873029|FG001|Overall Study|Death|1|||
33494257|NCT03102710|62873041|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
33323851|NCT01163916|62700262|FG001|Overall Study|Lack of Efficacy|0|||
33323852|NCT01163916|62700263|FG002|Overall Study|Lack of Efficacy|1|||
33323853|NCT01163916|62700261|FG000|Overall Study|Other|24|||
33446523|NCT00265122|62821922|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
33446524|NCT00265122|62821923|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
33446525|NCT00265122|62821924|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
33446526|NCT00265122|62821925|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
33446527|NCT00265122|62821920|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
33494258|NCT03102710|62873042|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
33494259|NCT03102710|62873043|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
33323854|NCT01163916|62700262|FG001|Overall Study|Other|4|||
33323855|NCT01163916|62700263|FG002|Overall Study|Other|16|||
33323856|NCT01122576|62700279|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
33494260|NCT03102710|62873041|FG000|Overall Study|Technical issues during final MRI scan|0|||
33494261|NCT03102710|62873042|FG001|Overall Study|Technical issues during final MRI scan|1|||
33494262|NCT03102710|62873043|FG002|Overall Study|Technical issues during final MRI scan|0|||
33494263|NCT03102710|62873041|FG000|Overall Study|Nausea during MRI scan|0|||
33494264|NCT03102710|62873042|FG001|Overall Study|Nausea during MRI scan|1|||
33494265|NCT03102710|62873043|FG002|Overall Study|Nausea during MRI scan|0|||
33494266|NCT03102710|62873041|FG000|Overall Study|Subject unable to attend final session|0|||
33494267|NCT03102710|62873042|FG001|Overall Study|Subject unable to attend final session|1|||
33494268|NCT03102710|62873043|FG002|Overall Study|Subject unable to attend final session|0|||
33494269|NCT03101150|62873053|FG000|Overall Study|Lost to Follow-up|2|||
33494270|NCT03101150|62873054|FG001|Overall Study|Lost to Follow-up|4|||
33494271|NCT03101150|62873053|FG000|Overall Study|Miscarriage|3|||
33494272|NCT03101150|62873054|FG001|Overall Study|Miscarriage|6|||
33494273|NCT03101930|62873063|FG000|Overall Study|Withdrawal by Subject|2|||
33494274|NCT03101930|62873064|FG001|Overall Study|Withdrawal by Subject|1|||
33494275|NCT03101930|62873065|FG002|Overall Study|Withdrawal by Subject|2|||
33494276|NCT02928848|62873075|FG000|Arm 2|Withdrawal by Subject|1|||
33494277|NCT02928848|62873076|FG001|Arm 2|Withdrawal by Subject|0|||
33494278|NCT02928770|62873084|FG000|Overall Study|Withdrawal by Subject|2|||
33494279|NCT03100838|62873088|FG000|Overall Study|Adverse Event|1|||
33494280|NCT03100838|62873089|FG001|Overall Study|Adverse Event|0|||
33494281|NCT03100838|62873090|FG002|Overall Study|Adverse Event|0|||
33494282|NCT03100838|62873091|FG003|Overall Study|Adverse Event|0|||
33494283|NCT03100838|62873088|FG000|Overall Study|Physician Decision|1|||
33494284|NCT03100838|62873089|FG001|Overall Study|Physician Decision|1|||
33494285|NCT03100838|62873090|FG002|Overall Study|Physician Decision|1|||
33494286|NCT03100838|62873091|FG003|Overall Study|Physician Decision|1|||
33494287|NCT03100838|62873088|FG000|Overall Study|Pregnancy|0|||
33494288|NCT03100838|62873089|FG001|Overall Study|Pregnancy|1|||
33494289|NCT03100838|62873090|FG002|Overall Study|Pregnancy|0|||
33494290|NCT03100838|62873091|FG003|Overall Study|Pregnancy|0|||
33494291|NCT03100838|62873088|FG000|Overall Study|Lost to Follow-up|0|||
33494292|NCT03100838|62873089|FG001|Overall Study|Lost to Follow-up|0|||
33494293|NCT03100838|62873090|FG002|Overall Study|Lost to Follow-up|1|||
33494294|NCT03100838|62873091|FG003|Overall Study|Lost to Follow-up|0|||
33494295|NCT03480750|62873107|FG000|Overall Study|Withdrawal by Subject|0|||
33494296|NCT03480750|62873108|FG001|Overall Study|Withdrawal by Subject|1|||
33494297|NCT03480750|62873109|FG002|Overall Study|Withdrawal by Subject|0|||
33494298|NCT03480750|62873110|FG003|Overall Study|Withdrawal by Subject|0|||
33494299|NCT03480750|62873111|FG004|Overall Study|Withdrawal by Subject|0|||
33494300|NCT03480750|62873112|FG005|Overall Study|Withdrawal by Subject|0|||
33494301|NCT03480750|62873107|FG000|Overall Study|The interruption in Trientine shippment|0|||
33494302|NCT03480750|62873108|FG001|Overall Study|The interruption in Trientine shippment|0|||
33494303|NCT03480750|62873109|FG002|Overall Study|The interruption in Trientine shippment|0|||
33494304|NCT03480750|62873110|FG003|Overall Study|The interruption in Trientine shippment|0|||
33494305|NCT03480750|62873111|FG004|Overall Study|The interruption in Trientine shippment|0|||
33323857|NCT01122576|62700280|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
33446528|NCT00265122|62821921|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
33446529|NCT00265122|62821922|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
33446530|NCT00265122|62821923|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
33446531|NCT00265122|62821924|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
33446532|NCT00265122|62821925|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
33446533|NCT00116584|62821946|FG000|Overall Study|Withdrawal by Subject|1|||
33446534|NCT00116584|62821947|FG001|Overall Study|Withdrawal by Subject|0|||
33446535|NCT00116584|62821946|FG000|Overall Study|Protocol Violation|1|||
33446536|NCT00116584|62821947|FG001|Overall Study|Protocol Violation|1|||
33446537|NCT00096538|62821953|FG000|Overall Study|Withdrawal by Subject|1|||
33446538|NCT00239928|62821957|FG000|Overall Study|Lack of Efficacy|1|||
33446539|NCT00239928|62821957|FG000|Overall Study|Adverse Event|4|||
33446540|NCT00239928|62821957|FG000|Overall Study|Not need to continue study|3|||
33446541|NCT00239928|62821957|FG000|Overall Study|Withdrawal by Subject|2|||
33446542|NCT00116428|62821963|FG000|Overall Study|Withdrawal by Subject|2|||
33446543|NCT00116428|62821964|FG001|Overall Study|Withdrawal by Subject|5|||
33446544|NCT00116428|62821963|FG000|Overall Study|Did not meet inclusion criteria|1|||
33446545|NCT00116428|62821964|FG001|Overall Study|Did not meet inclusion criteria|0|||
33446546|NCT00468845|62821976|FG000|Overall Study|Adverse Event|9|||
33494306|NCT03480750|62873112|FG005|Overall Study|The interruption in Trientine shippment|1|||
33494307|NCT03462030|62873137|FG000|Overall Study|Withdrawal by Subject|1|||
33494308|NCT03462030|62873138|FG001|Overall Study|Withdrawal by Subject|1|||
33494309|NCT03412734|62873146|FG000|Overall Study|Incorrect labeling of samples|2|||
33494310|NCT03412734|62873147|FG001|Overall Study|Incorrect labeling of samples|0|||
33446547|NCT00468845|62821977|FG001|Overall Study|Adverse Event|14|||
33494311|NCT03412734|62873146|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
33494312|NCT03412734|62873147|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
33494313|NCT02374814|62873159|FG000|Overall Study|Lost to Follow-up|1|||
33494314|NCT02374814|62873160|FG001|Overall Study|Lost to Follow-up|1|||
33494315|NCT02374814|62873161|FG002|Overall Study|Lost to Follow-up|0|||
33494316|NCT02374814|62873162|FG003|Overall Study|Lost to Follow-up|1|||
33494317|NCT02374814|62873163|FG004|Overall Study|Lost to Follow-up|0|||
33494318|NCT02374814|62873164|FG005|Overall Study|Lost to Follow-up|0|||
33494319|NCT02374814|62873159|FG000|Overall Study|Withdrawal by Subject|0|||
33494320|NCT02374814|62873160|FG001|Overall Study|Withdrawal by Subject|0|||
33494321|NCT02374814|62873161|FG002|Overall Study|Withdrawal by Subject|1|||
33494322|NCT02374814|62873162|FG003|Overall Study|Withdrawal by Subject|1|||
33494323|NCT02374814|62873163|FG004|Overall Study|Withdrawal by Subject|0|||
33494324|NCT02374814|62873164|FG005|Overall Study|Withdrawal by Subject|0|||
33494325|NCT04608344|62873188|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
33494326|NCT04608344|62873189|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
33494327|NCT04608344|62873188|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
33494328|NCT04608344|62873189|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
33494329|NCT03433482|62873207|FG000|Overall Study|Lost to Follow-up|1|||
33494330|NCT03433482|62873208|FG001|Overall Study|Lost to Follow-up|0|||
33494331|NCT03433482|62873209|FG002|Overall Study|Lost to Follow-up|1|||
33494332|NCT03433482|62873210|FG003|Overall Study|Lost to Follow-up|1|||
33494333|NCT03433482|62873207|FG000|Overall Study|Withdrawal by Subject|0|||
33494334|NCT03433482|62873208|FG001|Overall Study|Withdrawal by Subject|0|||
33494335|NCT03433482|62873209|FG002|Overall Study|Withdrawal by Subject|1|||
33494336|NCT03433482|62873210|FG003|Overall Study|Withdrawal by Subject|0|||
33494337|NCT03433482|62873207|FG000|Overall Study|Unknown reason|0|||
33494338|NCT03433482|62873208|FG001|Overall Study|Unknown reason|0|||
33494339|NCT03433482|62873209|FG002|Overall Study|Unknown reason|2|||
33494340|NCT03433482|62873210|FG003|Overall Study|Unknown reason|0|||
33494341|NCT03432858|62873223|FG000|Overall Study|Protocol Violation|2|||
33494342|NCT03432858|62873224|FG001|Overall Study|Protocol Violation|1|||
33494343|NCT03432858|62873225|FG002|Overall Study|Protocol Violation|9|||
33494344|NCT03432858|62873223|FG000|Overall Study|Withdrawal by Subject|0|||
33494345|NCT03432858|62873224|FG001|Overall Study|Withdrawal by Subject|1|||
33494346|NCT03432858|62873225|FG002|Overall Study|Withdrawal by Subject|1|||
33494347|NCT03432858|62873223|FG000|Overall Study|Procedure canceled/rescheduled|0|||
33494348|NCT03432858|62873224|FG001|Overall Study|Procedure canceled/rescheduled|9|||
33494349|NCT03432858|62873225|FG002|Overall Study|Procedure canceled/rescheduled|6|||
33494350|NCT03432858|62873223|FG000|Overall Study|Required postop mobilization with splinting|0|||
33446548|NCT00468845|62821978|FG002|Overall Study|Adverse Event|11|||
33494351|NCT03432858|62873224|FG001|Overall Study|Required postop mobilization with splinting|0|||
33446549|NCT00468845|62821976|FG000|Overall Study|Lost to Follow-up|2|||
33446550|NCT00468845|62821977|FG001|Overall Study|Lost to Follow-up|1|||
33446551|NCT00468845|62821978|FG002|Overall Study|Lost to Follow-up|2|||
33446552|NCT00468845|62821976|FG000|Overall Study|Other|4|||
33446553|NCT00468845|62821977|FG001|Overall Study|Other|9|||
33446554|NCT00468845|62821978|FG002|Overall Study|Other|5|||
33446555|NCT00468845|62821976|FG000|Overall Study|No longer willing to participate|5|||
33446556|NCT00468845|62821977|FG001|Overall Study|No longer willing to participate|6|||
33446557|NCT00468845|62821978|FG002|Overall Study|No longer willing to participate|10|||
33494352|NCT03432858|62873225|FG002|Overall Study|Required postop mobilization with splinting|1|||
33494353|NCT03432390|62873235|FG000|Apnea Period|Protocol Violation|2|||
33494354|NCT03432390|62873236|FG001|Apnea Period|Protocol Violation|2|||
33494355|NCT03456960|62873248|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
33494356|NCT03456960|62873249|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
33494357|NCT03456960|62873250|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
33494358|NCT03456960|62873251|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
33494359|NCT03456960|62873252|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
33494360|NCT03456960|62873253|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
33494361|NCT03456960|62873248|FG000|Period 2 (1 Day)|Adverse Event|1|||
33494362|NCT03456960|62873249|FG001|Period 2 (1 Day)|Adverse Event|0|||
33494363|NCT03456960|62873250|FG002|Period 2 (1 Day)|Adverse Event|0|||
33494364|NCT03456960|62873251|FG003|Period 2 (1 Day)|Adverse Event|1|||
33494365|NCT03456960|62873252|FG004|Period 2 (1 Day)|Adverse Event|0|||
33494366|NCT03456960|62873253|FG005|Period 2 (1 Day)|Adverse Event|0|||
33494367|NCT03430986|62873271|FG000|24-week Control Period|Adverse Event|1|||
33494368|NCT03430986|62873272|FG001|24-week Control Period|Adverse Event|0|||
33494369|NCT03430986|62873271|FG000|24-week Control Period|Lost to Follow-up|2|||
33494370|NCT03430986|62873272|FG001|24-week Control Period|Lost to Follow-up|2|||
33494371|NCT03430986|62873271|FG000|24-week Control Period|Withdrawal by Participant|5|||
33494372|NCT03430986|62873272|FG001|24-week Control Period|Withdrawal by Participant|0|||
33494373|NCT03430986|62873271|FG000|24-week Control Period|Protocol Deviation|0|||
33494374|NCT03430986|62873272|FG001|24-week Control Period|Protocol Deviation|2|||
33494375|NCT03430986|62873271|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
33494376|NCT03430986|62873272|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
33494377|NCT03430986|62873271|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
33494378|NCT03430986|62873272|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
33494379|NCT03448536|62873283|FG000|Overall Study|Protocol Violation|2|||
33494380|NCT03448536|62873284|FG001|Overall Study|Protocol Violation|0|||
33494381|NCT03448536|62873283|FG000|Overall Study|Pregnancy|1|||
33494382|NCT03448536|62873284|FG001|Overall Study|Pregnancy|0|||
33494383|NCT03448536|62873283|FG000|Overall Study|Withdrawal by Subject|1|||
33494384|NCT03448536|62873284|FG001|Overall Study|Withdrawal by Subject|2|||
33494385|NCT03448536|62873283|FG000|Overall Study|Lost to Follow-up|3|||
33494386|NCT03448536|62873284|FG001|Overall Study|Lost to Follow-up|2|||
33494387|NCT03448536|62873283|FG000|Overall Study|Inadequate pain reporter|1|||
33494388|NCT03448536|62873284|FG001|Overall Study|Inadequate pain reporter|0|||
33494389|NCT03448536|62873283|FG000|Overall Study|Other|3|||
33494390|NCT03448536|62873284|FG001|Overall Study|Other|0|||
33494391|NCT03448536|62873283|FG000|Overall Study|Physician Decision|1|||
33494392|NCT03448536|62873284|FG001|Overall Study|Physician Decision|0|||
33494393|NCT03448224|62873292|FG000|Overall Study|Provided same answer to every question|1|||
33494394|NCT03448224|62873293|FG001|Overall Study|Provided same answer to every question|0|||
33494395|NCT03424044|62873299|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33494396|NCT03424044|62873300|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33494397|NCT03424044|62873301|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
33494398|NCT03424044|62873302|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33494399|NCT03424044|62873303|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33494400|NCT03424044|62873304|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33494401|NCT03424044|62873305|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33494402|NCT03424044|62873306|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33494403|NCT03424044|62873307|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33494404|NCT03424044|62873299|FG000|First Intervention (76 Hours)|Adverse Event|0|||
33494405|NCT03424044|62873300|FG001|First Intervention (76 Hours)|Adverse Event|0|||
33494406|NCT03424044|62873301|FG002|First Intervention (76 Hours)|Adverse Event|0|||
33494407|NCT03424044|62873302|FG003|First Intervention (76 Hours)|Adverse Event|0|||
33494408|NCT03424044|62873303|FG004|First Intervention (76 Hours)|Adverse Event|1|||
33494409|NCT03424044|62873304|FG005|First Intervention (76 Hours)|Adverse Event|0|||
33494410|NCT03424044|62873305|FG006|First Intervention (76 Hours)|Adverse Event|0|||
33494411|NCT03424044|62873306|FG007|First Intervention (76 Hours)|Adverse Event|0|||
33494412|NCT03424044|62873307|FG008|First Intervention (76 Hours)|Adverse Event|0|||
33494413|NCT03424044|62873299|FG000|First Intervention (76 Hours)|device issues|0|||
33494414|NCT03424044|62873300|FG001|First Intervention (76 Hours)|device issues|0|||
33494415|NCT03424044|62873301|FG002|First Intervention (76 Hours)|device issues|0|||
33494416|NCT03424044|62873302|FG003|First Intervention (76 Hours)|device issues|0|||
33494417|NCT03424044|62873303|FG004|First Intervention (76 Hours)|device issues|0|||
33494418|NCT03424044|62873304|FG005|First Intervention (76 Hours)|device issues|0|||
33494419|NCT03424044|62873305|FG006|First Intervention (76 Hours)|device issues|1|||
33494420|NCT03424044|62873306|FG007|First Intervention (76 Hours)|device issues|1|||
33494421|NCT03424044|62873307|FG008|First Intervention (76 Hours)|device issues|1|||
33494422|NCT03424044|62873299|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
33494423|NCT03424044|62873300|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
33494424|NCT03424044|62873301|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
33494425|NCT03424044|62873302|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
33494426|NCT03424044|62873303|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
33494427|NCT03424044|62873304|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
33494428|NCT03424044|62873305|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
33494429|NCT03424044|62873306|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
33494430|NCT03424044|62873307|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
33494431|NCT03424044|62873299|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33494432|NCT03424044|62873300|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33494433|NCT03424044|62873301|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33494434|NCT03424044|62873302|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
33494435|NCT03424044|62873303|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33494436|NCT03424044|62873304|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33494437|NCT03424044|62873305|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33494438|NCT03424044|62873306|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33494439|NCT03424044|62873307|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33494440|NCT03422250|62873321|FG000|Intervention|Adverse Event|0|||
33494441|NCT03422250|62873322|FG001|Intervention|Adverse Event|1|||
33494442|NCT03422250|62873323|FG002|Intervention|Adverse Event|0|||
33494443|NCT03422250|62873324|FG003|Intervention|Adverse Event|1|||
33494444|NCT03422250|62873321|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
33494445|NCT03422250|62873322|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
33494446|NCT03422250|62873323|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
33494447|NCT03422250|62873324|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
33494448|NCT03422250|62873321|FG000|Follow-up|Withdrawal by Subject|0|||
33494449|NCT03422250|62873322|FG001|Follow-up|Withdrawal by Subject|0|||
33494450|NCT03422250|62873323|FG002|Follow-up|Withdrawal by Subject|0|||
33494451|NCT03422250|62873324|FG003|Follow-up|Withdrawal by Subject|1|||
33494452|NCT03422250|62873321|FG000|Follow-up|Adverse Event|0|||
33494453|NCT03422250|62873322|FG001|Follow-up|Adverse Event|0|||
33494454|NCT03422250|62873323|FG002|Follow-up|Adverse Event|0|||
33494455|NCT03422250|62873324|FG003|Follow-up|Adverse Event|1|||
33494456|NCT01266031|62873339|FG000|Overall Study|Not treated|0|||
33494457|NCT01266031|62873340|FG001|Overall Study|Not treated|3|||
33494458|NCT01266031|62873341|FG002|Overall Study|Not treated|2|||
33494459|NCT00075725|62873372|FG000|Overall Study|Adverse Event|6|||
33494460|NCT00075725|62873373|FG001|Overall Study|Adverse Event|6|||
33494461|NCT00075725|62873374|FG002|Overall Study|Adverse Event|20|||
33494462|NCT00075725|62873375|FG003|Overall Study|Adverse Event|8|||
33446558|NCT00468845|62821976|FG000|Overall Study|Randomized, not treated|1|||
33446559|NCT00468845|62821977|FG001|Overall Study|Randomized, not treated|4|||
33446560|NCT00468845|62821978|FG002|Overall Study|Randomized, not treated|2|||
33446561|NCT00468299|62821988|FG000|Overall Study|Withdrawal by Subject|0|||
33446562|NCT00468299|62821989|FG001|Overall Study|Withdrawal by Subject|1|||
33446563|NCT00468143|62821997|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
33446564|NCT00468143|62821998|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
33446565|NCT00468143|62821997|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
33446566|NCT00468143|62821998|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
33446567|NCT00467831|62822004|FG000|Overall Study|Death|2|||
33446568|NCT00467831|62822004|FG000|Overall Study|Withdrawal by Subject|1|||
33494463|NCT00075725|62873376|FG004|Overall Study|Adverse Event|4|||
33494464|NCT00075725|62873377|FG005|Overall Study|Adverse Event|38|||
33494465|NCT00075725|62873378|FG006|Overall Study|Adverse Event|3|||
33446569|NCT00467753|62822010|FG000|Overall Study|Lost to Follow-up|1|||
33446570|NCT00467753|62822011|FG001|Overall Study|Lost to Follow-up|2|||
33446571|NCT00467753|62822010|FG000|Overall Study|Adverse Event|2|||
33494466|NCT00075725|62873379|FG007|Overall Study|Adverse Event|51|||
33494467|NCT00075725|62873380|FG008|Overall Study|Adverse Event|15|||
33494468|NCT00075725|62873381|FG009|Overall Study|Adverse Event|4|||
33494469|NCT00075725|62873382|FG010|Overall Study|Adverse Event|2|||
33494470|NCT00075725|62873383|FG011|Overall Study|Adverse Event|2|||
33494471|NCT00075725|62873372|FG000|Overall Study|Death|3|||
33494472|NCT00075725|62873373|FG001|Overall Study|Death|5|||
33494473|NCT00075725|62873374|FG002|Overall Study|Death|10|||
33494474|NCT00075725|62873375|FG003|Overall Study|Death|2|||
33494475|NCT00075725|62873376|FG004|Overall Study|Death|3|||
33494476|NCT00075725|62873377|FG005|Overall Study|Death|25|||
33494477|NCT00075725|62873378|FG006|Overall Study|Death|4|||
33494478|NCT00075725|62873379|FG007|Overall Study|Death|22|||
33494479|NCT00075725|62873380|FG008|Overall Study|Death|14|||
33494480|NCT00075725|62873381|FG009|Overall Study|Death|4|||
33494481|NCT00075725|62873382|FG010|Overall Study|Death|3|||
33446572|NCT00467753|62822011|FG001|Overall Study|Adverse Event|0|||
33446573|NCT00116272|62822023|FG000|Overall Study|Lost to Follow-up|11|||
33446574|NCT00116272|62822024|FG001|Overall Study|Lost to Follow-up|6|||
33446575|NCT00467597|62822036|FG000|Overall Study|Withdrawal by Subject|2|||
33446576|NCT00467597|62822037|FG001|Overall Study|Withdrawal by Subject|0|||
33446577|NCT00115804|62822047|FG000|Overall Study|Adverse Event|2|||
33446578|NCT00467519|62822055|FG000|Overall Study|Protocol Violation|8|||
33494482|NCT00075725|62873383|FG011|Overall Study|Death|0|||
33494483|NCT00075725|62873372|FG000|Overall Study|Lost to Follow-up|1|||
33494484|NCT00075725|62873373|FG001|Overall Study|Lost to Follow-up|1|||
33494485|NCT00075725|62873374|FG002|Overall Study|Lost to Follow-up|4|||
33494486|NCT00075725|62873375|FG003|Overall Study|Lost to Follow-up|1|||
33494487|NCT00075725|62873376|FG004|Overall Study|Lost to Follow-up|0|||
33494488|NCT00075725|62873377|FG005|Overall Study|Lost to Follow-up|13|||
33494489|NCT00075725|62873378|FG006|Overall Study|Lost to Follow-up|2|||
33494490|NCT00075725|62873379|FG007|Overall Study|Lost to Follow-up|4|||
33494491|NCT00075725|62873380|FG008|Overall Study|Lost to Follow-up|1|||
33494492|NCT00075725|62873381|FG009|Overall Study|Lost to Follow-up|0|||
33494493|NCT00075725|62873382|FG010|Overall Study|Lost to Follow-up|0|||
33494494|NCT00075725|62873383|FG011|Overall Study|Lost to Follow-up|0|||
33494495|NCT00075725|62873372|FG000|Overall Study|Physician Decision|2|||
33494496|NCT00075725|62873373|FG001|Overall Study|Physician Decision|6|||
33494497|NCT00075725|62873374|FG002|Overall Study|Physician Decision|5|||
33494498|NCT00075725|62873375|FG003|Overall Study|Physician Decision|8|||
33494499|NCT00075725|62873376|FG004|Overall Study|Physician Decision|4|||
33494500|NCT00075725|62873377|FG005|Overall Study|Physician Decision|19|||
33494501|NCT00075725|62873378|FG006|Overall Study|Physician Decision|3|||
33494502|NCT00075725|62873379|FG007|Overall Study|Physician Decision|17|||
33494503|NCT00075725|62873380|FG008|Overall Study|Physician Decision|5|||
33494504|NCT00075725|62873381|FG009|Overall Study|Physician Decision|0|||
33494505|NCT00075725|62873382|FG010|Overall Study|Physician Decision|1|||
33494506|NCT00075725|62873383|FG011|Overall Study|Physician Decision|0|||
33494507|NCT00075725|62873372|FG000|Overall Study|Pregnancy|0|||
33494508|NCT00075725|62873373|FG001|Overall Study|Pregnancy|0|||
33494509|NCT00075725|62873374|FG002|Overall Study|Pregnancy|0|||
33494510|NCT00075725|62873375|FG003|Overall Study|Pregnancy|0|||
33494511|NCT00075725|62873376|FG004|Overall Study|Pregnancy|0|||
33494512|NCT00075725|62873377|FG005|Overall Study|Pregnancy|1|||
33494513|NCT00075725|62873378|FG006|Overall Study|Pregnancy|0|||
33494514|NCT00075725|62873379|FG007|Overall Study|Pregnancy|1|||
33494515|NCT00075725|62873380|FG008|Overall Study|Pregnancy|0|||
33494516|NCT00075725|62873381|FG009|Overall Study|Pregnancy|0|||
33494517|NCT00075725|62873382|FG010|Overall Study|Pregnancy|0|||
33494518|NCT00075725|62873383|FG011|Overall Study|Pregnancy|0|||
33494519|NCT00075725|62873372|FG000|Overall Study|Protocol Violation|1|||
33494520|NCT00075725|62873373|FG001|Overall Study|Protocol Violation|1|||
33494521|NCT00075725|62873374|FG002|Overall Study|Protocol Violation|0|||
33446579|NCT00467519|62822056|FG001|Overall Study|Protocol Violation|4|||
33494522|NCT00075725|62873375|FG003|Overall Study|Protocol Violation|3|||
33494523|NCT00075725|62873376|FG004|Overall Study|Protocol Violation|3|||
33494524|NCT00075725|62873377|FG005|Overall Study|Protocol Violation|2|||
33494525|NCT00075725|62873378|FG006|Overall Study|Protocol Violation|1|||
33446580|NCT00467519|62822055|FG000|Overall Study|Lost to Follow-up|2|||
33446581|NCT00467519|62822056|FG001|Overall Study|Lost to Follow-up|9|||
33494526|NCT00075725|62873379|FG007|Overall Study|Protocol Violation|2|||
33494527|NCT00075725|62873380|FG008|Overall Study|Protocol Violation|3|||
33494528|NCT00075725|62873381|FG009|Overall Study|Protocol Violation|0|||
33494529|NCT00075725|62873382|FG010|Overall Study|Protocol Violation|0|||
33494530|NCT00075725|62873383|FG011|Overall Study|Protocol Violation|1|||
33494531|NCT00075725|62873372|FG000|Overall Study|Withdrawal by Subject|12|||
33494532|NCT00075725|62873373|FG001|Overall Study|Withdrawal by Subject|3|||
33494533|NCT00075725|62873374|FG002|Overall Study|Withdrawal by Subject|6|||
33494534|NCT00075725|62873375|FG003|Overall Study|Withdrawal by Subject|10|||
33494535|NCT00075725|62873376|FG004|Overall Study|Withdrawal by Subject|6|||
33494536|NCT00075725|62873377|FG005|Overall Study|Withdrawal by Subject|27|||
33494537|NCT00075725|62873378|FG006|Overall Study|Withdrawal by Subject|7|||
33494538|NCT00075725|62873379|FG007|Overall Study|Withdrawal by Subject|31|||
33494539|NCT00075725|62873380|FG008|Overall Study|Withdrawal by Subject|10|||
33494540|NCT00075725|62873381|FG009|Overall Study|Withdrawal by Subject|2|||
33494541|NCT00075725|62873382|FG010|Overall Study|Withdrawal by Subject|0|||
33494542|NCT00075725|62873383|FG011|Overall Study|Withdrawal by Subject|0|||
33494543|NCT00075725|62873372|FG000|Overall Study|Disease Progression, all other reasons|17|||
33494544|NCT00075725|62873373|FG001|Overall Study|Disease Progression, all other reasons|5|||
33494545|NCT00075725|62873374|FG002|Overall Study|Disease Progression, all other reasons|33|||
33494546|NCT00075725|62873375|FG003|Overall Study|Disease Progression, all other reasons|6|||
33494547|NCT00075725|62873376|FG004|Overall Study|Disease Progression, all other reasons|21|||
33494548|NCT00075725|62873377|FG005|Overall Study|Disease Progression, all other reasons|59|||
33446582|NCT00467519|62822055|FG000|Overall Study|Withdrawal by Subject|4|||
33446583|NCT00467519|62822056|FG001|Overall Study|Withdrawal by Subject|10|||
33446584|NCT00264810|62822064|FG000|Baseline|Withdrawal by Subject|10|||
33446585|NCT00264810|62822065|FG001|Baseline|Withdrawal by Subject|10|||
33446586|NCT00264810|62822064|FG000|Baseline|Physician Decision|7|||
33446587|NCT00264810|62822065|FG001|Baseline|Physician Decision|8|||
33446588|NCT00264810|62822064|FG000|Baseline|Subject Compliance Failure|3|||
33446589|NCT00264810|62822065|FG001|Baseline|Subject Compliance Failure|3|||
33446590|NCT00264810|62822064|FG000|Baseline|Insufficient Seizure Frequency|2|||
33446591|NCT00264810|62822065|FG001|Baseline|Insufficient Seizure Frequency|2|||
33446592|NCT00264810|62822064|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
33446593|NCT00264810|62822065|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
33323858|NCT01122576|62700281|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
33323859|NCT01122576|62700279|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
33323860|NCT01122576|62700280|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
33323861|NCT01122576|62700281|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
33323862|NCT01122576|62700279|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
33323863|NCT01122576|62700280|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
33323864|NCT01122576|62700281|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
33323865|NCT00965523|62700292|FG000|Study 221|Progressive Disease|4|||
33323866|NCT00965523|62700292|FG000|Study 221|Physician Decision|3|||
33323867|NCT00965523|62700292|FG000|Study 224|Progressive Disease|5|||
33323868|NCT00965523|62700292|FG000|Study 224|Physician Decision|1|||
33323869|NCT01122264|62700299|FG000|Overall Study|Adverse Event|6|||
33323870|NCT01122264|62700300|FG001|Overall Study|Adverse Event|5|||
33323871|NCT01122264|62700301|FG002|Overall Study|Adverse Event|7|||
33323872|NCT01122264|62700299|FG000|Overall Study|Death|1|||
33323873|NCT01122264|62700300|FG001|Overall Study|Death|0|||
33323874|NCT01122264|62700301|FG002|Overall Study|Death|0|||
33323875|NCT01122264|62700299|FG000|Overall Study|Lost to Follow-up|5|||
33446594|NCT00264810|62822064|FG000|Baseline|Other|0|||
33446595|NCT00264810|62822065|FG001|Baseline|Other|1|||
33607280|NCT01995201|63007400|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
33607281|NCT01995201|63007401|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
33607282|NCT01995201|63007402|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
33607283|NCT01995201|63007403|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
33607284|NCT01995201|63007397|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
33494549|NCT00075725|62873378|FG006|Overall Study|Disease Progression, all other reasons|20|||
33494550|NCT00075725|62873379|FG007|Overall Study|Disease Progression, all other reasons|46|||
33607285|NCT01995201|63007398|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
33607286|NCT01995201|63007399|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
33607287|NCT01995201|63007400|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
33607288|NCT01995201|63007401|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
33446596|NCT00264810|62822064|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
33446597|NCT00264810|62822065|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
33446598|NCT00264810|62822064|FG000|Stimulation Optimization Period|Death|0|||
33494551|NCT00075725|62873380|FG008|Overall Study|Disease Progression, all other reasons|21|||
33494552|NCT00075725|62873381|FG009|Overall Study|Disease Progression, all other reasons|4|||
33607289|NCT01995201|63007402|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
33607290|NCT01995201|63007403|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
33494553|NCT00075725|62873382|FG010|Overall Study|Disease Progression, all other reasons|0|||
33494554|NCT00075725|62873383|FG011|Overall Study|Disease Progression, all other reasons|5|||
33494555|NCT00075725|62873372|FG000|Overall Study|Patient off treatment|0|||
33494556|NCT00075725|62873373|FG001|Overall Study|Patient off treatment|0|||
33494557|NCT00075725|62873374|FG002|Overall Study|Patient off treatment|1|||
33494558|NCT00075725|62873375|FG003|Overall Study|Patient off treatment|2|||
33494559|NCT00075725|62873376|FG004|Overall Study|Patient off treatment|1|||
33323876|NCT01122264|62700300|FG001|Overall Study|Lost to Follow-up|9|||
33446599|NCT00264810|62822065|FG001|Stimulation Optimization Period|Death|1|||
33494560|NCT00075725|62873377|FG005|Overall Study|Patient off treatment|0|||
33494561|NCT00075725|62873378|FG006|Overall Study|Patient off treatment|0|||
33494562|NCT00075725|62873379|FG007|Overall Study|Patient off treatment|2|||
33494563|NCT00075725|62873380|FG008|Overall Study|Patient off treatment|1|||
33494564|NCT00075725|62873381|FG009|Overall Study|Patient off treatment|0|||
33494565|NCT00075725|62873382|FG010|Overall Study|Patient off treatment|0|||
33494566|NCT00075725|62873383|FG011|Overall Study|Patient off treatment|0|||
33494567|NCT00075725|62873372|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
33494568|NCT00075725|62873373|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
33494569|NCT00075725|62873374|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
33494570|NCT00075725|62873375|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
33494571|NCT00075725|62873376|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
33494572|NCT00075725|62873377|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
33494573|NCT00075725|62873378|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
33494574|NCT00075725|62873379|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
33494575|NCT00075725|62873380|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
33494576|NCT00075725|62873381|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
33494577|NCT00075725|62873382|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
33494578|NCT00075725|62873383|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
33494579|NCT00075725|62873372|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
33494580|NCT00075725|62873373|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
33494581|NCT00075725|62873374|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
33494582|NCT00075725|62873375|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
33494583|NCT00075725|62873376|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
33494584|NCT00075725|62873377|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
33494585|NCT00075725|62873378|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
33494586|NCT00075725|62873379|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
33494587|NCT00075725|62873380|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
33494588|NCT00075725|62873381|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
33494589|NCT00075725|62873382|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
33494590|NCT00075725|62873383|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
33607291|NCT01995201|63007397|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
33607292|NCT01995201|63007398|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
33607293|NCT01995201|63007399|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
33607294|NCT01995201|63007400|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
33607295|NCT01995201|63007401|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
33607296|NCT01995201|63007402|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
33607297|NCT01995201|63007403|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
33607298|NCT01995201|63007397|FG000|From Week 24 Until Week 48|Physician Decision|0|||
33607299|NCT01995201|63007398|FG001|From Week 24 Until Week 48|Physician Decision|0|||
33607300|NCT01995201|63007399|FG002|From Week 24 Until Week 48|Physician Decision|0|||
33607301|NCT01995201|63007400|FG003|From Week 24 Until Week 48|Physician Decision|0|||
33607302|NCT01995201|63007401|FG004|From Week 24 Until Week 48|Physician Decision|1|||
33607303|NCT01995201|63007402|FG005|From Week 24 Until Week 48|Physician Decision|0|||
33607304|NCT01995201|63007403|FG006|From Week 24 Until Week 48|Physician Decision|0|||
33607305|NCT01995201|63007397|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
33607306|NCT01995201|63007398|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
33607307|NCT01995201|63007399|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
33607308|NCT01995201|63007400|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
33607309|NCT01995201|63007401|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
33607310|NCT01995201|63007402|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
33494591|NCT00075725|62873372|FG000|Overall Study|Pt non compliant with therapy|2|||
33494592|NCT00075725|62873373|FG001|Overall Study|Pt non compliant with therapy|1|||
33494593|NCT00075725|62873374|FG002|Overall Study|Pt non compliant with therapy|1|||
33494594|NCT00075725|62873375|FG003|Overall Study|Pt non compliant with therapy|0|||
33494595|NCT00075725|62873376|FG004|Overall Study|Pt non compliant with therapy|2|||
33494596|NCT00075725|62873377|FG005|Overall Study|Pt non compliant with therapy|14|||
33494597|NCT00075725|62873378|FG006|Overall Study|Pt non compliant with therapy|2|||
33494598|NCT00075725|62873379|FG007|Overall Study|Pt non compliant with therapy|5|||
33494599|NCT00075725|62873380|FG008|Overall Study|Pt non compliant with therapy|3|||
33494600|NCT00075725|62873381|FG009|Overall Study|Pt non compliant with therapy|0|||
33494601|NCT00075725|62873382|FG010|Overall Study|Pt non compliant with therapy|0|||
33607311|NCT01995201|63007403|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
33607312|NCT01728454|63007427|FG000|Stage 1 and 2|Pregnancy|1|||
33607313|NCT01728454|63007428|FG001|Stage 1 and 2|Pregnancy|0|||
33446600|NCT00264810|62822064|FG000|Blinded Evaluation Period|Explant due to infection|1|||
33446601|NCT00264810|62822065|FG001|Blinded Evaluation Period|Explant due to infection|1|||
33446602|NCT00264810|62822064|FG000|Open Label Evaluation Period|Explant due to infection|1|||
33446603|NCT00264810|62822065|FG001|Open Label Evaluation Period|Explant due to infection|1|||
33446604|NCT00264810|62822064|FG000|Open Label Evaluation Period|Death|3|||
33446605|NCT00264810|62822065|FG001|Open Label Evaluation Period|Death|2|||
33446606|NCT00264810|62822064|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
33446607|NCT00264810|62822065|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
33446608|NCT00467363|62822075|FG000|Overall Study|Lost to Follow-up|80|||
33446609|NCT00467363|62822076|FG001|Overall Study|Lost to Follow-up|70|||
33446610|NCT00091390|62822082|FG000|Overall Study|Protocol Violation|1|||
33446611|NCT00091390|62822082|FG000|Overall Study|No protocol treatment|3|||
33446612|NCT00239226|62822090|FG000|Overall Study|permAF during stabilization period|0|||
33446613|NCT00239226|62822091|FG001|Overall Study|permAF during stabilization period|0|||
33446614|NCT00239226|62822092|FG002|Overall Study|permAF during stabilization period|0|||
33446615|NCT00239226|62822093|FG003|Overall Study|permAF during stabilization period|3|||
33446616|NCT00239226|62822090|FG000|Overall Study|Lost to Follow-up|1|||
33446617|NCT00239226|62822091|FG001|Overall Study|Lost to Follow-up|0|||
33446618|NCT00239226|62822092|FG002|Overall Study|Lost to Follow-up|1|||
33446619|NCT00239226|62822093|FG003|Overall Study|Lost to Follow-up|0|||
33446620|NCT00467285|62822105|FG000|Overall Study|Lost to Follow-up|4|||
33446621|NCT00467285|62822106|FG001|Overall Study|Lost to Follow-up|4|||
33446622|NCT00264576|62822116|FG000|Overall Study|Lost to Follow-up|1|||
33446623|NCT00264576|62822117|FG001|Overall Study|Lost to Follow-up|1|||
33446624|NCT00466505|62822124|FG000|Overall Study|disease progression|13|||
33446625|NCT00466505|62822124|FG000|Overall Study|Adverse Event|4|||
33446626|NCT00467051|62822128|FG000|Overall Study|Adverse Event|2|||
33446627|NCT00264498|62822135|FG000|Randomized Treatment|Death|0|||
33446628|NCT00264498|62822136|FG001|Randomized Treatment|Death|3|||
33446629|NCT00264498|62822135|FG000|Randomized Treatment|Withdrawal by Subject|0|||
33446630|NCT00264498|62822136|FG001|Randomized Treatment|Withdrawal by Subject|1|||
33446631|NCT00264498|62822135|FG000|Randomized Treatment|Objective disease Progression|13|||
33446632|NCT00264498|62822136|FG001|Randomized Treatment|Objective disease Progression|14|||
33494602|NCT00075725|62873383|FG011|Overall Study|Pt non compliant with therapy|0|||
33494603|NCT00075725|62873372|FG000|Overall Study|Pt age out of range for treatment|0|||
33494604|NCT00075725|62873373|FG001|Overall Study|Pt age out of range for treatment|1|||
33494605|NCT00075725|62873374|FG002|Overall Study|Pt age out of range for treatment|0|||
33494606|NCT00075725|62873375|FG003|Overall Study|Pt age out of range for treatment|0|||
33494607|NCT00075725|62873376|FG004|Overall Study|Pt age out of range for treatment|0|||
33494608|NCT00075725|62873377|FG005|Overall Study|Pt age out of range for treatment|1|||
33494609|NCT00075725|62873378|FG006|Overall Study|Pt age out of range for treatment|0|||
33494610|NCT00075725|62873379|FG007|Overall Study|Pt age out of range for treatment|1|||
33494611|NCT00075725|62873380|FG008|Overall Study|Pt age out of range for treatment|0|||
33446633|NCT00264498|62822135|FG000|Randomized Treatment|Physician Decision|1|||
33446634|NCT00264498|62822136|FG001|Randomized Treatment|Physician Decision|0|||
33494612|NCT00075725|62873381|FG009|Overall Study|Pt age out of range for treatment|0|||
33494613|NCT00075725|62873382|FG010|Overall Study|Pt age out of range for treatment|0|||
33494614|NCT00075725|62873383|FG011|Overall Study|Pt age out of range for treatment|0|||
33494615|NCT00075725|62873372|FG000|Overall Study|Insurance issues|0|||
33446635|NCT00264498|62822135|FG000|Randomized Treatment|Incorrectly randomized|1|||
33446636|NCT00264498|62822136|FG001|Randomized Treatment|Incorrectly randomized|0|||
33446637|NCT00264498|62822135|FG000|Randomized Treatment|Study Closure|1|||
33446638|NCT00264498|62822136|FG001|Randomized Treatment|Study Closure|0|||
33446639|NCT00264498|62822135|FG000|Randomized Treatment|Protocol Violation|1|||
33446640|NCT00264498|62822136|FG001|Randomized Treatment|Protocol Violation|0|||
33446641|NCT00264498|62822135|FG000|Crossover Treatment|Death|1|||
33446642|NCT00264498|62822136|FG001|Crossover Treatment|Death|3|||
33494616|NCT00075725|62873373|FG001|Overall Study|Insurance issues|1|||
33494617|NCT00075725|62873374|FG002|Overall Study|Insurance issues|0|||
33494618|NCT00075725|62873375|FG003|Overall Study|Insurance issues|1|||
33494619|NCT00075725|62873376|FG004|Overall Study|Insurance issues|1|||
33494620|NCT00075725|62873377|FG005|Overall Study|Insurance issues|1|||
33494621|NCT00075725|62873378|FG006|Overall Study|Insurance issues|0|||
33494622|NCT00075725|62873379|FG007|Overall Study|Insurance issues|1|||
33446643|NCT00264498|62822135|FG000|Crossover Treatment|Objective disease progression|4|||
33446644|NCT00264498|62822136|FG001|Crossover Treatment|Objective disease progression|5|||
33446645|NCT00264498|62822135|FG000|Crossover Treatment|Study closure|0|||
33494623|NCT00075725|62873380|FG008|Overall Study|Insurance issues|0|||
33494624|NCT00075725|62873381|FG009|Overall Study|Insurance issues|0|||
33494625|NCT00075725|62873382|FG010|Overall Study|Insurance issues|0|||
33494626|NCT00075725|62873383|FG011|Overall Study|Insurance issues|0|||
33607314|NCT01728454|63007429|FG002|Stage 1 and 2|Pregnancy|0|||
33494627|NCT00075725|62873372|FG000|Overall Study|MRD positive after extended ind|0|||
33494628|NCT00075725|62873373|FG001|Overall Study|MRD positive after extended ind|1|||
33494629|NCT00075725|62873374|FG002|Overall Study|MRD positive after extended ind|1|||
33494630|NCT00075725|62873375|FG003|Overall Study|MRD positive after extended ind|0|||
33494631|NCT00075725|62873376|FG004|Overall Study|MRD positive after extended ind|1|||
33494632|NCT00075725|62873377|FG005|Overall Study|MRD positive after extended ind|2|||
33494633|NCT00075725|62873378|FG006|Overall Study|MRD positive after extended ind|0|||
33494634|NCT00075725|62873379|FG007|Overall Study|MRD positive after extended ind|1|||
33494635|NCT00075725|62873380|FG008|Overall Study|MRD positive after extended ind|0|||
33494636|NCT00075725|62873381|FG009|Overall Study|MRD positive after extended ind|0|||
33494637|NCT00075725|62873382|FG010|Overall Study|MRD positive after extended ind|0|||
33494638|NCT00075725|62873383|FG011|Overall Study|MRD positive after extended ind|0|||
33494639|NCT00075725|62873372|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
33494640|NCT00075725|62873373|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
33494641|NCT00075725|62873374|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
33494642|NCT00075725|62873375|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
33494643|NCT00075725|62873376|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
33494644|NCT00075725|62873377|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
33494645|NCT00075725|62873378|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
33494646|NCT00075725|62873379|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
33494647|NCT00075725|62873380|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
33494648|NCT00075725|62873381|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
33494649|NCT00075725|62873382|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
33494650|NCT00075725|62873383|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
33494651|NCT00075725|62873372|FG000|Overall Study|Inevaluable|1|||
33494652|NCT00075725|62873373|FG001|Overall Study|Inevaluable|1|||
33494653|NCT00075725|62873374|FG002|Overall Study|Inevaluable|4|||
33607315|NCT01728454|63007427|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
33607316|NCT01728454|63007428|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
33607317|NCT01728454|63007429|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
33607318|NCT01728454|63007427|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
33494654|NCT00075725|62873375|FG003|Overall Study|Inevaluable|2|||
33607319|NCT01728454|63007428|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
33446646|NCT00264498|62822136|FG001|Crossover Treatment|Study closure|1|||
33446647|NCT00264498|62822135|FG000|Crossover Treatment|Withdrawal by Subject|1|||
33446648|NCT00264498|62822136|FG001|Crossover Treatment|Withdrawal by Subject|0|||
33446649|NCT00466193|62822144|FG000|Overall Study|Adverse Event|0|||
33446650|NCT00466193|62822145|FG001|Overall Study|Adverse Event|1|||
33446651|NCT00466193|62822144|FG000|Overall Study|Lost to Follow-up|2|||
33446652|NCT00466193|62822145|FG001|Overall Study|Lost to Follow-up|4|||
33446653|NCT00466193|62822144|FG000|Overall Study|Physician Decision|1|||
33446654|NCT00466193|62822145|FG001|Overall Study|Physician Decision|0|||
33446655|NCT00466193|62822144|FG000|Overall Study|Protocol Violation|1|||
33446656|NCT00466193|62822145|FG001|Overall Study|Protocol Violation|1|||
33446657|NCT00466193|62822144|FG000|Overall Study|Withdrawal by Subject|7|||
33446658|NCT00466193|62822145|FG001|Overall Study|Withdrawal by Subject|2|||
33446659|NCT00466193|62822144|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
33446660|NCT00466193|62822145|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
33446661|NCT00263562|62822153|FG000|Overall Study|Protocol Violation|3|||
33446662|NCT00263562|62822154|FG001|Overall Study|Protocol Violation|0|||
33446663|NCT00454181|62822164|FG000|Overall Study|Adverse Event|1|||
33446664|NCT00454181|62822165|FG001|Overall Study|Adverse Event|1|||
33494655|NCT00075725|62873376|FG004|Overall Study|Inevaluable|2|||
33494656|NCT00075725|62873377|FG005|Overall Study|Inevaluable|9|||
33494657|NCT00075725|62873378|FG006|Overall Study|Inevaluable|1|||
33494658|NCT00075725|62873379|FG007|Overall Study|Inevaluable|11|||
33494659|NCT00075725|62873380|FG008|Overall Study|Inevaluable|2|||
33494660|NCT00075725|62873381|FG009|Overall Study|Inevaluable|0|||
33494661|NCT00075725|62873382|FG010|Overall Study|Inevaluable|1|||
33494662|NCT00075725|62873383|FG011|Overall Study|Inevaluable|0|||
33494663|NCT00075725|62873372|FG000|Overall Study|Other|4|||
33494664|NCT00075725|62873373|FG001|Overall Study|Other|2|||
33607320|NCT01728454|63007429|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
33446665|NCT00454181|62822164|FG000|Overall Study|Lost to Follow-up|11|||
33446666|NCT00454181|62822165|FG001|Overall Study|Lost to Follow-up|1|||
33446667|NCT00454181|62822164|FG000|Overall Study|Protocol Violation|1|||
33607321|NCT01728454|63007427|FG000|Stage 1 and 2|Lost to Follow-up|1|||
33607322|NCT01728454|63007428|FG001|Stage 1 and 2|Lost to Follow-up|1|||
33446668|NCT00454181|62822165|FG001|Overall Study|Protocol Violation|1|||
33446669|NCT00454181|62822164|FG000|Overall Study|Withdrawal by Subject|2|||
33446670|NCT00454181|62822165|FG001|Overall Study|Withdrawal by Subject|0|||
33494665|NCT00075725|62873374|FG002|Overall Study|Other|1|||
33494666|NCT00075725|62873375|FG003|Overall Study|Other|1|||
33494667|NCT00075725|62873376|FG004|Overall Study|Other|1|||
33494668|NCT00075725|62873377|FG005|Overall Study|Other|4|||
33494669|NCT00075725|62873378|FG006|Overall Study|Other|2|||
33494670|NCT00075725|62873379|FG007|Overall Study|Other|9|||
33494671|NCT00075725|62873380|FG008|Overall Study|Other|2|||
33494672|NCT00075725|62873381|FG009|Overall Study|Other|1|||
33494673|NCT00075725|62873382|FG010|Overall Study|Other|0|||
33494674|NCT00075725|62873383|FG011|Overall Study|Other|3|||
33494675|NCT00075725|62873372|FG000|Overall Study|Pt trying to find a BM donor|0|||
33494676|NCT00075725|62873373|FG001|Overall Study|Pt trying to find a BM donor|1|||
33494677|NCT00075725|62873374|FG002|Overall Study|Pt trying to find a BM donor|0|||
33494678|NCT00075725|62873375|FG003|Overall Study|Pt trying to find a BM donor|0|||
33494679|NCT00075725|62873376|FG004|Overall Study|Pt trying to find a BM donor|0|||
33494680|NCT00075725|62873377|FG005|Overall Study|Pt trying to find a BM donor|0|||
33494681|NCT00075725|62873378|FG006|Overall Study|Pt trying to find a BM donor|0|||
33494682|NCT00075725|62873379|FG007|Overall Study|Pt trying to find a BM donor|0|||
33494683|NCT00075725|62873380|FG008|Overall Study|Pt trying to find a BM donor|0|||
33494684|NCT00075725|62873381|FG009|Overall Study|Pt trying to find a BM donor|0|||
33494685|NCT00075725|62873382|FG010|Overall Study|Pt trying to find a BM donor|0|||
33494686|NCT00075725|62873383|FG011|Overall Study|Pt trying to find a BM donor|0|||
33494687|NCT00075725|62873372|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
33494688|NCT00075725|62873373|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
33494689|NCT00075725|62873374|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
33494690|NCT00075725|62873375|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
33494691|NCT00075725|62873376|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
33494692|NCT00075725|62873377|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
33494693|NCT00075725|62873378|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
33494694|NCT00075725|62873379|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
33494695|NCT00075725|62873380|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
33494696|NCT00075725|62873381|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
33494697|NCT00075725|62873382|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
33494698|NCT00075725|62873383|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
33494699|NCT00075725|62873372|FG000|Overall Study|Unsuccessful institutional transfer|0|||
33494700|NCT00075725|62873373|FG001|Overall Study|Unsuccessful institutional transfer|0|||
33494701|NCT00075725|62873374|FG002|Overall Study|Unsuccessful institutional transfer|2|||
33494702|NCT00075725|62873375|FG003|Overall Study|Unsuccessful institutional transfer|0|||
33494703|NCT00075725|62873376|FG004|Overall Study|Unsuccessful institutional transfer|0|||
33494704|NCT00075725|62873377|FG005|Overall Study|Unsuccessful institutional transfer|0|||
33494705|NCT00075725|62873378|FG006|Overall Study|Unsuccessful institutional transfer|0|||
33494706|NCT00075725|62873379|FG007|Overall Study|Unsuccessful institutional transfer|0|||
33494707|NCT00075725|62873380|FG008|Overall Study|Unsuccessful institutional transfer|0|||
33494708|NCT00075725|62873381|FG009|Overall Study|Unsuccessful institutional transfer|1|||
33494709|NCT00075725|62873382|FG010|Overall Study|Unsuccessful institutional transfer|0|||
33494710|NCT00075725|62873383|FG011|Overall Study|Unsuccessful institutional transfer|0|||
33494711|NCT00075725|62873372|FG000|Overall Study|specimen(s) not submitted|0|||
33494712|NCT00075725|62873373|FG001|Overall Study|specimen(s) not submitted|0|||
33494713|NCT00075725|62873374|FG002|Overall Study|specimen(s) not submitted|2|||
33446671|NCT00237744|62822174|FG000|Overall Study|Withdrawal by Subject|3|||
33446672|NCT00237744|62822175|FG001|Overall Study|Withdrawal by Subject|1|||
33446673|NCT00237744|62822176|FG002|Overall Study|Withdrawal by Subject|0|||
33446674|NCT00237042|62822190|FG000|Treatment|Became ineligible post-randomization|0|||
33446675|NCT00237042|62822191|FG001|Treatment|Became ineligible post-randomization|1|||
33446676|NCT00237042|62822192|FG002|Treatment|Became ineligible post-randomization|16|||
33446677|NCT00237042|62822190|FG000|Treatment|Moved out of state|1|||
33446678|NCT00237042|62822191|FG001|Treatment|Moved out of state|1|||
33446679|NCT00237042|62822192|FG002|Treatment|Moved out of state|1|||
33446680|NCT00237042|62822190|FG000|Treatment|Completed no treatment|5|||
33446681|NCT00237042|62822191|FG001|Treatment|Completed no treatment|5|||
33446682|NCT00237042|62822192|FG002|Treatment|Completed no treatment|21|||
33446683|NCT00237042|62822190|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
33446684|NCT00237042|62822191|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
33494714|NCT00075725|62873375|FG003|Overall Study|specimen(s) not submitted|0|||
33494715|NCT00075725|62873376|FG004|Overall Study|specimen(s) not submitted|0|||
33446685|NCT00237042|62822192|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
33494716|NCT00075725|62873377|FG005|Overall Study|specimen(s) not submitted|0|||
33446686|NCT00237042|62822190|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
33446687|NCT00237042|62822191|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
33446688|NCT00237042|62822192|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
33446689|NCT00465647|62822204|FG000|Overall Study|Administrative|2|||
33446690|NCT00465647|62822205|FG001|Overall Study|Administrative|2|||
33446691|NCT00465647|62822206|FG002|Overall Study|Administrative|3|||
33446692|NCT00465647|62822207|FG003|Overall Study|Administrative|2|||
33446693|NCT00465647|62822204|FG000|Overall Study|Adverse Event|2|||
33446694|NCT00465647|62822205|FG001|Overall Study|Adverse Event|0|||
33446695|NCT00465647|62822206|FG002|Overall Study|Adverse Event|3|||
33446696|NCT00465647|62822207|FG003|Overall Study|Adverse Event|2|||
33446697|NCT00465647|62822204|FG000|Overall Study|Withdrawal by Subject|1|||
33446698|NCT00465647|62822205|FG001|Overall Study|Withdrawal by Subject|2|||
33446699|NCT00465647|62822206|FG002|Overall Study|Withdrawal by Subject|2|||
33446700|NCT00465647|62822207|FG003|Overall Study|Withdrawal by Subject|7|||
33446701|NCT00465647|62822204|FG000|Overall Study|"The other reasons included loss of IV"|8|||
33446702|NCT00465647|62822205|FG001|Overall Study|"The other reasons included loss of IV"|4|||
33446703|NCT00465647|62822206|FG002|Overall Study|"The other reasons included loss of IV"|3|||
33446704|NCT00465647|62822207|FG003|Overall Study|"The other reasons included loss of IV"|2|||
33446705|NCT00465569|62822229|FG000|Overall Study|persistent eczema during dose escalation|1|||
33446706|NCT00465569|62822230|FG001|Overall Study|persistent eczema during dose escalation|0|||
33446707|NCT00090766|62822239|FG000|Overall Study|Nephrectomy Planned|0|||
33446708|NCT00090766|62822240|FG001|Overall Study|Nephrectomy Planned|0|||
33446709|NCT00090766|62822241|FG002|Overall Study|Nephrectomy Planned|1|||
33446710|NCT00090766|62822239|FG000|Overall Study|Death|1|||
33446711|NCT00090766|62822240|FG001|Overall Study|Death|0|||
33446712|NCT00090766|62822241|FG002|Overall Study|Death|0|||
33446713|NCT00090766|62822239|FG000|Overall Study|Admin|0|||
33446714|NCT00090766|62822240|FG001|Overall Study|Admin|2|||
33446715|NCT00090766|62822241|FG002|Overall Study|Admin|0|||
33446716|NCT00090766|62822239|FG000|Overall Study|Lost to Follow-up|2|||
33446717|NCT00090766|62822240|FG001|Overall Study|Lost to Follow-up|0|||
33446718|NCT00090766|62822241|FG002|Overall Study|Lost to Follow-up|2|||
33446719|NCT00465179|62822251|FG000|Overall Study|Adverse Event|4|||
33446720|NCT00465179|62822251|FG000|Overall Study|Withdrawal by Subject|2|||
33446721|NCT00465179|62822251|FG000|Overall Study|Progression of Disease|47|||
33446722|NCT00465101|62822255|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
33446723|NCT00465101|62822255|FG000|Overall Study|Change in health precluded follow up|4|||
33446724|NCT00465101|62822255|FG000|Overall Study|Did not meet study criteria|4|||
33446725|NCT00465101|62822255|FG000|Overall Study|Lost to Follow-up|5|||
33446726|NCT00465101|62822255|FG000|Overall Study|Other|6|||
33446727|NCT00465101|62822255|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
33446728|NCT00465101|62822255|FG000|Overall Study|Patient postponed procedure|1|||
33446729|NCT00465101|62822255|FG000|Overall Study|Site closed due to IRB expiration|1|||
33446730|NCT00465101|62822255|FG000|Overall Study|Unable to obtain IRB approval|1|||
33446731|NCT00465101|62822255|FG000|Overall Study|Death|3|||
33446732|NCT00465101|62822255|FG000|Overall Study|Withdrawal by Subject|25|||
33446733|NCT00465101|62822255|FG000|Overall Study|Physician Decision|1|||
33446734|NCT00465101|62822255|FG000|Overall Study|Withdrew consent prior to procedure|3|||
33446735|NCT00084136|62822284|FG000|PI Comparison|Death|10|||
33446736|NCT00084136|62822285|FG001|PI Comparison|Death|9|||
33446737|NCT00084136|62822286|FG002|PI Comparison|Death|0|||
33446738|NCT00084136|62822284|FG000|PI Comparison|Lost to Follow-up|11|||
33446739|NCT00084136|62822285|FG001|PI Comparison|Lost to Follow-up|8|||
33446740|NCT00084136|62822286|FG002|PI Comparison|Lost to Follow-up|0|||
33446741|NCT00084136|62822284|FG000|PI Comparison|Withdrawal by Subject|33|||
33446742|NCT00084136|62822285|FG001|PI Comparison|Withdrawal by Subject|30|||
33446743|NCT00084136|62822286|FG002|PI Comparison|Withdrawal by Subject|0|||
33446744|NCT00084136|62822284|FG000|PI Comparison|Clinic site closed|1|||
33446745|NCT00084136|62822285|FG001|PI Comparison|Clinic site closed|0|||
33494717|NCT00075725|62873378|FG006|Overall Study|specimen(s) not submitted|0|||
33494718|NCT00075725|62873379|FG007|Overall Study|specimen(s) not submitted|0|||
33607323|NCT01728454|63007429|FG002|Stage 1 and 2|Lost to Follow-up|0|||
33607324|NCT01728454|63007427|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
33446746|NCT00084136|62822286|FG002|PI Comparison|Clinic site closed|0|||
33446747|NCT00084136|62822284|FG000|NRTI Comparison|Death|20|||
33446748|NCT00084136|62822285|FG001|NRTI Comparison|Death|0|||
33446749|NCT00084136|62822286|FG002|NRTI Comparison|Death|18|||
33446750|NCT00084136|62822284|FG000|NRTI Comparison|Lost to Follow-up|14|||
33446751|NCT00084136|62822285|FG001|NRTI Comparison|Lost to Follow-up|0|||
33446752|NCT00084136|62822286|FG002|NRTI Comparison|Lost to Follow-up|12|||
33446753|NCT00084136|62822284|FG000|NRTI Comparison|Withdrawal by Subject|54|||
33446754|NCT00084136|62822285|FG001|NRTI Comparison|Withdrawal by Subject|0|||
33446755|NCT00084136|62822286|FG002|NRTI Comparison|Withdrawal by Subject|38|||
33446756|NCT00084136|62822284|FG000|NRTI Comparison|Clinic site closed|12|||
33446757|NCT00084136|62822285|FG001|NRTI Comparison|Clinic site closed|0|||
33446758|NCT00084136|62822286|FG002|NRTI Comparison|Clinic site closed|14|||
33446759|NCT00084136|62822284|FG000|NRTI Comparison|Not reason above|1|||
33446760|NCT00084136|62822285|FG001|NRTI Comparison|Not reason above|0|||
33494719|NCT00075725|62873380|FG008|Overall Study|specimen(s) not submitted|0|||
33494720|NCT00075725|62873381|FG009|Overall Study|specimen(s) not submitted|0|||
33494721|NCT00075725|62873382|FG010|Overall Study|specimen(s) not submitted|0|||
33494722|NCT00075725|62873383|FG011|Overall Study|specimen(s) not submitted|0|||
33494723|NCT00075725|62873372|FG000|Overall Study|Pt went to transplant|0|||
33494724|NCT00075725|62873373|FG001|Overall Study|Pt went to transplant|0|||
33607325|NCT01728454|63007428|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
33607326|NCT01728454|63007429|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
33607327|NCT01728454|63007427|FG000|Stage 3|Reason Missing|0|||
33607328|NCT01728454|63007428|FG001|Stage 3|Reason Missing|0|||
33607329|NCT01728454|63007429|FG002|Stage 3|Reason Missing|1|||
33607330|NCT01728454|63007427|FG000|Stage 3|Subject Required Other Treatment|0|||
33607331|NCT01728454|63007428|FG001|Stage 3|Subject Required Other Treatment|1|||
33607332|NCT01728454|63007429|FG002|Stage 3|Subject Required Other Treatment|0|||
33607333|NCT01728454|63007427|FG000|Stage 3|Pregnancy|1|||
33607334|NCT01728454|63007428|FG001|Stage 3|Pregnancy|0|||
33607335|NCT01728454|63007429|FG002|Stage 3|Pregnancy|0|||
33607336|NCT01728454|63007427|FG000|Stage 3|Withdrew Consent|1|||
33607337|NCT01728454|63007428|FG001|Stage 3|Withdrew Consent|0|||
33446761|NCT00084136|62822286|FG002|NRTI Comparison|Not reason above|0|||
33446762|NCT03812380|62822297|FG000|Overall Study|Protocol Violation|3|||
33446763|NCT03812380|62822298|FG001|Overall Study|Protocol Violation|3|||
33446764|NCT03812380|62822297|FG000|Overall Study|Withdrawal by Subject|5|||
33446765|NCT03812380|62822298|FG001|Overall Study|Withdrawal by Subject|4|||
33446766|NCT03812380|62822297|FG000|Overall Study|Early termination of study|14|||
33446767|NCT03812380|62822298|FG001|Overall Study|Early termination of study|14|||
33446768|NCT00464945|62822306|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
33446769|NCT00464945|62822307|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
33446770|NCT00464945|62822306|FG000|Infant Series|Protocol Violation|1|||
33446771|NCT00464945|62822307|FG001|Infant Series|Protocol Violation|0|||
33446772|NCT00464945|62822306|FG000|Infant Series|Lost to Follow-up|1|||
33446773|NCT00464945|62822307|FG001|Infant Series|Lost to Follow-up|0|||
33446774|NCT00464945|62822306|FG000|After Infant Series|Withdrawal by Subject|0|||
33446775|NCT00464945|62822307|FG001|After Infant Series|Withdrawal by Subject|2|||
33446776|NCT00464945|62822306|FG000|Toddler Dose|Lost to Follow-up|0|||
33446777|NCT00464945|62822307|FG001|Toddler Dose|Lost to Follow-up|1|||
33446778|NCT00464087|62822332|FG000|Overall Study|No PCI per inclusion criteria|0|||
33446779|NCT00464087|62822333|FG001|Overall Study|No PCI per inclusion criteria|0|||
33446780|NCT00464087|62822334|FG002|Overall Study|No PCI per inclusion criteria|29|||
33446781|NCT00452699|62822344|FG000|Overall Study|Adverse Event|10|||
33446782|NCT00452699|62822345|FG001|Overall Study|Adverse Event|3|||
33446783|NCT00452699|62822344|FG000|Overall Study|Lack of Efficacy|6|||
33446784|NCT00452699|62822345|FG001|Overall Study|Lack of Efficacy|4|||
33446785|NCT00452699|62822344|FG000|Overall Study|Lost to Follow-up|6|||
33446786|NCT00452699|62822345|FG001|Overall Study|Lost to Follow-up|9|||
33446787|NCT00452699|62822344|FG000|Overall Study|Protocol Violation|21|||
33446788|NCT00452699|62822345|FG001|Overall Study|Protocol Violation|25|||
33446789|NCT00452699|62822344|FG000|Overall Study|Withdrawal by Subject|26|||
33494725|NCT00075725|62873374|FG002|Overall Study|Pt went to transplant|0|||
33607338|NCT01728454|63007429|FG002|Stage 3|Withdrew Consent|1|||
33446790|NCT00452699|62822345|FG001|Overall Study|Withdrawal by Subject|25|||
33446791|NCT00452699|62822344|FG000|Overall Study|Other|12|||
33446792|NCT00452699|62822345|FG001|Overall Study|Other|7|||
33446793|NCT00069784|62822353|FG000|Overall Study|Adverse Event|105|||
33446794|NCT00069784|62822354|FG001|Overall Study|Adverse Event|0|||
33446795|NCT00069784|62822353|FG000|Overall Study|Withdrawal by Subject|1090|||
33607339|NCT01728454|63007427|FG000|Stage 3|Non-compliance with Protocol|0|||
33607340|NCT01728454|63007428|FG001|Stage 3|Non-compliance with Protocol|0|||
33607341|NCT01728454|63007429|FG002|Stage 3|Non-compliance with Protocol|1|||
33607342|NCT01728454|63007427|FG000|Stage 3|Lost to Follow-up|0|||
33607343|NCT01728454|63007428|FG001|Stage 3|Lost to Follow-up|3|||
33607344|NCT01728454|63007429|FG002|Stage 3|Lost to Follow-up|1|||
33607345|NCT01728454|63007427|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
33607346|NCT01728454|63007428|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
33607347|NCT01728454|63007429|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
33607348|NCT01636687|63007443|FG000|Induction Period|Withdrawal by Subject|1|||
33446796|NCT00069784|62822354|FG001|Overall Study|Withdrawal by Subject|0|||
33446797|NCT00069784|62822353|FG000|Overall Study|Other|17|||
33446798|NCT00069784|62822354|FG001|Overall Study|Other|0|||
33494726|NCT00075725|62873375|FG003|Overall Study|Pt went to transplant|1|||
33494727|NCT00075725|62873376|FG004|Overall Study|Pt went to transplant|0|||
33494728|NCT00075725|62873377|FG005|Overall Study|Pt went to transplant|1|||
33494729|NCT00075725|62873378|FG006|Overall Study|Pt went to transplant|0|||
33494730|NCT00075725|62873379|FG007|Overall Study|Pt went to transplant|0|||
33494731|NCT00075725|62873380|FG008|Overall Study|Pt went to transplant|0|||
33494732|NCT00075725|62873381|FG009|Overall Study|Pt went to transplant|0|||
33494733|NCT00075725|62873382|FG010|Overall Study|Pt went to transplant|0|||
33494734|NCT00075725|62873383|FG011|Overall Study|Pt went to transplant|0|||
33494735|NCT00075725|62873372|FG000|Overall Study|Pt received additional steroids|0|||
33494736|NCT00075725|62873373|FG001|Overall Study|Pt received additional steroids|0|||
33494737|NCT00075725|62873374|FG002|Overall Study|Pt received additional steroids|0|||
33494738|NCT00075725|62873375|FG003|Overall Study|Pt received additional steroids|1|||
33494739|NCT00075725|62873376|FG004|Overall Study|Pt received additional steroids|0|||
33494740|NCT00075725|62873377|FG005|Overall Study|Pt received additional steroids|0|||
33494741|NCT00075725|62873378|FG006|Overall Study|Pt received additional steroids|0|||
33494742|NCT00075725|62873379|FG007|Overall Study|Pt received additional steroids|0|||
33494743|NCT00075725|62873380|FG008|Overall Study|Pt received additional steroids|0|||
33494744|NCT00075725|62873381|FG009|Overall Study|Pt received additional steroids|0|||
33494745|NCT00075725|62873382|FG010|Overall Study|Pt received additional steroids|0|||
33494746|NCT00075725|62873383|FG011|Overall Study|Pt received additional steroids|0|||
33494747|NCT00075725|62873372|FG000|Overall Study|Pt relocated|0|||
33494748|NCT00075725|62873373|FG001|Overall Study|Pt relocated|0|||
33494749|NCT00075725|62873374|FG002|Overall Study|Pt relocated|0|||
33494750|NCT00075725|62873375|FG003|Overall Study|Pt relocated|2|||
33446799|NCT03811834|62822360|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
33446800|NCT00090610|62822375|FG000|Overall Study|Withdrawal by Subject|1|||
33446801|NCT00090610|62822376|FG001|Overall Study|Withdrawal by Subject|1|||
33446802|NCT00463385|62822386|FG000|Overall Study|Other|4|||
33446803|NCT00463385|62822387|FG001|Overall Study|Other|3|||
33446804|NCT00463385|62822388|FG002|Overall Study|Other|6|||
33446805|NCT00463385|62822389|FG003|Overall Study|Other|4|||
33446806|NCT00463385|62822386|FG000|Overall Study|Adverse Event|5|||
33446807|NCT00463385|62822387|FG001|Overall Study|Adverse Event|8|||
33446808|NCT00463385|62822388|FG002|Overall Study|Adverse Event|4|||
33446809|NCT00463385|62822389|FG003|Overall Study|Adverse Event|2|||
33446810|NCT00463385|62822386|FG000|Overall Study|Lack of Efficacy|6|||
33446811|NCT00463385|62822387|FG001|Overall Study|Lack of Efficacy|6|||
33446812|NCT00463385|62822388|FG002|Overall Study|Lack of Efficacy|7|||
33446813|NCT00463385|62822389|FG003|Overall Study|Lack of Efficacy|9|||
33446814|NCT00463385|62822386|FG000|Overall Study|Withdrawal by Subject|3|||
33446815|NCT00463385|62822387|FG001|Overall Study|Withdrawal by Subject|3|||
33446816|NCT00463385|62822388|FG002|Overall Study|Withdrawal by Subject|3|||
33446817|NCT00463385|62822389|FG003|Overall Study|Withdrawal by Subject|4|||
33446818|NCT00463385|62822386|FG000|Overall Study|Lost to Follow-up|0|||
33446819|NCT00463385|62822387|FG001|Overall Study|Lost to Follow-up|0|||
33446820|NCT00463385|62822388|FG002|Overall Study|Lost to Follow-up|0|||
33446821|NCT00463385|62822389|FG003|Overall Study|Lost to Follow-up|1|||
33446822|NCT00463385|62822386|FG000|Overall Study|Death|2|||
33446823|NCT00463385|62822387|FG001|Overall Study|Death|1|||
33607349|NCT01636687|63007444|FG001|Induction Period|Withdrawal by Subject|0|||
33446824|NCT00463385|62822388|FG002|Overall Study|Death|2|||
33446825|NCT00463385|62822389|FG003|Overall Study|Death|0|||
33446826|NCT00463385|62822386|FG000|Overall Study|Missing|2|||
33494751|NCT00075725|62873376|FG004|Overall Study|Pt relocated|0|||
33494752|NCT00075725|62873377|FG005|Overall Study|Pt relocated|1|||
33494753|NCT00075725|62873378|FG006|Overall Study|Pt relocated|1|||
33494754|NCT00075725|62873379|FG007|Overall Study|Pt relocated|2|||
33607350|NCT01636687|63007445|FG002|Induction Period|Withdrawal by Subject|0|||
33446827|NCT00463385|62822387|FG001|Overall Study|Missing|0|||
33446828|NCT00463385|62822388|FG002|Overall Study|Missing|0|||
33494755|NCT00075725|62873380|FG008|Overall Study|Pt relocated|1|||
33494756|NCT00075725|62873381|FG009|Overall Study|Pt relocated|0|||
33494757|NCT00075725|62873382|FG010|Overall Study|Pt relocated|0|||
33446829|NCT00463385|62822389|FG003|Overall Study|Missing|2|||
33446830|NCT00463385|62822386|FG000|Overall Study|1 participant received commercial drug|0|||
33494758|NCT00075725|62873383|FG011|Overall Study|Pt relocated|0|||
33607351|NCT01636687|63007446|FG003|Induction Period|Withdrawal by Subject|0|||
33446831|NCT00463385|62822387|FG001|Overall Study|1 participant received commercial drug|1|||
33446832|NCT00463385|62822388|FG002|Overall Study|1 participant received commercial drug|0|||
33446833|NCT00463385|62822389|FG003|Overall Study|1 participant received commercial drug|0|||
33446834|NCT00463229|62822409|FG000|Overall Study|Lost to Follow-up|5|||
33446835|NCT00463229|62822410|FG001|Overall Study|Lost to Follow-up|7|||
33446836|NCT00463229|62822409|FG000|Overall Study|Death|4|||
33446837|NCT00463229|62822410|FG001|Overall Study|Death|3|||
33446838|NCT03839693|62822420|FG000|Overall Study|Lost to Follow-up|0|||
33446839|NCT03839693|62822421|FG001|Overall Study|Lost to Follow-up|2|||
33446840|NCT03839693|62822422|FG002|Overall Study|Lost to Follow-up|2|||
33494759|NCT00075725|62873372|FG000|Overall Study|Institution Terminated|0|||
33494760|NCT00075725|62873373|FG001|Overall Study|Institution Terminated|0|||
33494761|NCT00075725|62873374|FG002|Overall Study|Institution Terminated|0|||
33494762|NCT00075725|62873375|FG003|Overall Study|Institution Terminated|0|||
33494763|NCT00075725|62873376|FG004|Overall Study|Institution Terminated|1|||
33494764|NCT00075725|62873377|FG005|Overall Study|Institution Terminated|0|||
33494765|NCT00075725|62873378|FG006|Overall Study|Institution Terminated|0|||
33494766|NCT00075725|62873379|FG007|Overall Study|Institution Terminated|3|||
33494767|NCT00075725|62873380|FG008|Overall Study|Institution Terminated|0|||
33494768|NCT00075725|62873381|FG009|Overall Study|Institution Terminated|0|||
33494769|NCT00075725|62873382|FG010|Overall Study|Institution Terminated|0|||
33494770|NCT00075725|62873383|FG011|Overall Study|Institution Terminated|0|||
33494771|NCT00075725|62873372|FG000|Overall Study|Study Closure|1|||
33494772|NCT00075725|62873373|FG001|Overall Study|Study Closure|0|||
33494773|NCT00075725|62873374|FG002|Overall Study|Study Closure|0|||
33494774|NCT00075725|62873375|FG003|Overall Study|Study Closure|0|||
33494775|NCT00075725|62873376|FG004|Overall Study|Study Closure|1|||
33494776|NCT00075725|62873377|FG005|Overall Study|Study Closure|3|||
33494777|NCT00075725|62873378|FG006|Overall Study|Study Closure|0|||
33494778|NCT00075725|62873379|FG007|Overall Study|Study Closure|1|||
33494779|NCT00075725|62873380|FG008|Overall Study|Study Closure|0|||
33494780|NCT00075725|62873381|FG009|Overall Study|Study Closure|0|||
33494781|NCT00075725|62873382|FG010|Overall Study|Study Closure|0|||
33494782|NCT00075725|62873383|FG011|Overall Study|Study Closure|0|||
33494783|NCT00075725|62873372|FG000|Overall Study|Other complications|0|||
33494784|NCT00075725|62873373|FG001|Overall Study|Other complications|0|||
33494785|NCT00075725|62873374|FG002|Overall Study|Other complications|0|||
33494786|NCT00075725|62873375|FG003|Overall Study|Other complications|0|||
33494787|NCT00075725|62873376|FG004|Overall Study|Other complications|0|||
33494788|NCT00075725|62873377|FG005|Overall Study|Other complications|1|||
33494789|NCT00075725|62873378|FG006|Overall Study|Other complications|0|||
33494790|NCT00075725|62873379|FG007|Overall Study|Other complications|0|||
33494791|NCT00075725|62873380|FG008|Overall Study|Other complications|0|||
33494792|NCT00075725|62873381|FG009|Overall Study|Other complications|0|||
33494793|NCT00075725|62873382|FG010|Overall Study|Other complications|0|||
33494794|NCT00075725|62873383|FG011|Overall Study|Other complications|0|||
33494795|NCT00075725|62873372|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
33446841|NCT03839693|62822420|FG000|Overall Study|Withdrawal by Subject|1|||
33446842|NCT03839693|62822421|FG001|Overall Study|Withdrawal by Subject|0|||
33446843|NCT03839693|62822422|FG002|Overall Study|Withdrawal by Subject|2|||
33446844|NCT03839693|62822420|FG000|Overall Study|subject moved out of the area|1|||
33446845|NCT03839693|62822421|FG001|Overall Study|subject moved out of the area|0|||
33446846|NCT03839693|62822422|FG002|Overall Study|subject moved out of the area|0|||
33494796|NCT00075725|62873373|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
33494797|NCT00075725|62873374|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
33494798|NCT00075725|62873375|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
33494799|NCT00075725|62873376|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
33494800|NCT00075725|62873377|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
33494801|NCT00075725|62873378|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
33494802|NCT00075725|62873379|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
33494803|NCT00075725|62873380|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
33494804|NCT00075725|62873381|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
33494805|NCT00075725|62873382|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
33494806|NCT00075725|62873383|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
33494807|NCT00075725|62873372|FG000|Overall Study|Pt incarcerated|0|||
33494808|NCT00075725|62873373|FG001|Overall Study|Pt incarcerated|0|||
33494809|NCT00075725|62873374|FG002|Overall Study|Pt incarcerated|0|||
33494810|NCT00075725|62873375|FG003|Overall Study|Pt incarcerated|0|||
33446847|NCT00068692|62822435|FG000|Step 1: Registration|Disese progression/relapse|5|||
33446848|NCT00068692|62822436|FG001|Step 1: Registration|Disese progression/relapse|0|||
33446849|NCT00068692|62822437|FG002|Step 1: Registration|Disese progression/relapse|0|||
33446850|NCT00068692|62822438|FG003|Step 1: Registration|Disese progression/relapse|0|||
33446851|NCT00068692|62822439|FG004|Step 1: Registration|Disese progression/relapse|0|||
33446852|NCT00068692|62822440|FG005|Step 1: Registration|Disese progression/relapse|0|||
33446853|NCT00068692|62822441|FG006|Step 1: Registration|Disese progression/relapse|0|||
33446854|NCT00068692|62822442|FG007|Step 1: Registration|Disese progression/relapse|0|||
33446855|NCT00068692|62822435|FG000|Step 1: Registration|Adverse Event|7|||
33446856|NCT00068692|62822436|FG001|Step 1: Registration|Adverse Event|0|||
33446857|NCT00068692|62822437|FG002|Step 1: Registration|Adverse Event|0|||
33446858|NCT00068692|62822438|FG003|Step 1: Registration|Adverse Event|0|||
33446859|NCT00068692|62822439|FG004|Step 1: Registration|Adverse Event|0|||
33446860|NCT00068692|62822440|FG005|Step 1: Registration|Adverse Event|0|||
33446861|NCT00068692|62822441|FG006|Step 1: Registration|Adverse Event|0|||
33446862|NCT00068692|62822442|FG007|Step 1: Registration|Adverse Event|0|||
33494811|NCT00075725|62873376|FG004|Overall Study|Pt incarcerated|0|||
33494812|NCT00075725|62873377|FG005|Overall Study|Pt incarcerated|0|||
33446863|NCT00068692|62822435|FG000|Step 1: Registration|Death|1|||
33494813|NCT00075725|62873378|FG006|Overall Study|Pt incarcerated|0|||
33494814|NCT00075725|62873379|FG007|Overall Study|Pt incarcerated|1|||
33494815|NCT00075725|62873380|FG008|Overall Study|Pt incarcerated|0|||
33494816|NCT00075725|62873381|FG009|Overall Study|Pt incarcerated|0|||
33494817|NCT00075725|62873382|FG010|Overall Study|Pt incarcerated|0|||
33494818|NCT00075725|62873383|FG011|Overall Study|Pt incarcerated|0|||
33494819|NCT02953782|62873422|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
33494820|NCT02953782|62873423|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
33494821|NCT02953782|62873424|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
33494822|NCT02953782|62873425|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
33494823|NCT02953782|62873426|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
33494824|NCT02953782|62873427|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
33494825|NCT02953782|62873428|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
33494826|NCT02953782|62873429|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
33494827|NCT02953782|62873422|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
33494828|NCT02953782|62873423|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
33494829|NCT02953782|62873424|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
33494830|NCT02953782|62873425|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
33494831|NCT02953782|62873426|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
33494832|NCT02953782|62873427|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
33494833|NCT02953782|62873428|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
33494834|NCT02953782|62873429|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
33494835|NCT02953782|62873422|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
33494836|NCT02953782|62873423|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
33494837|NCT02953782|62873424|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
33494838|NCT02953782|62873425|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
33494839|NCT02953782|62873426|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
33494840|NCT02953782|62873427|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
33494841|NCT02953782|62873428|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
33494842|NCT02953782|62873429|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
33494843|NCT02953782|62873422|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
33494844|NCT02953782|62873423|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
33494845|NCT02953782|62873424|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
33494846|NCT02953782|62873425|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
33494847|NCT02953782|62873426|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
33494848|NCT02953782|62873427|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
33494849|NCT02953782|62873428|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
33446864|NCT00068692|62822436|FG001|Step 1: Registration|Death|0|||
33446865|NCT00068692|62822437|FG002|Step 1: Registration|Death|0|||
33494850|NCT02953782|62873429|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
33494851|NCT02953782|62873422|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
33494852|NCT02953782|62873423|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
33494853|NCT02953782|62873424|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
33494854|NCT02953782|62873425|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
33607352|NCT01636687|63007447|FG004|Induction Period|Withdrawal by Subject|0|||
33446866|NCT00068692|62822438|FG003|Step 1: Registration|Death|0|||
33446867|NCT00068692|62822439|FG004|Step 1: Registration|Death|0|||
33494855|NCT02953782|62873426|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
33494856|NCT02953782|62873427|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
33494857|NCT02953782|62873428|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
33494858|NCT02953782|62873429|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
33494859|NCT02953782|62873422|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
33494860|NCT02953782|62873423|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
33494861|NCT02953782|62873424|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
33494862|NCT02953782|62873425|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
33494863|NCT02953782|62873426|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
33494864|NCT02953782|62873427|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
33494865|NCT02953782|62873428|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
33494866|NCT02953782|62873429|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
33494867|NCT02953782|62873422|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
33494868|NCT02953782|62873423|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
33494869|NCT02953782|62873424|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
33494870|NCT02953782|62873425|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
33494871|NCT02953782|62873426|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
33494872|NCT02953782|62873427|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
33494873|NCT02953782|62873428|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
33494874|NCT02953782|62873429|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
33494875|NCT02953782|62873422|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
33494876|NCT02953782|62873423|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
33494877|NCT02953782|62873424|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
33494878|NCT02953782|62873425|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
33494879|NCT02953782|62873426|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
33494880|NCT02953782|62873427|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
33494881|NCT02953782|62873428|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
33494882|NCT02953782|62873429|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
33494883|NCT03760081|62873452|FG000|Overall Study|Miscellaneous|0|||
33494884|NCT03760081|62873453|FG001|Overall Study|Miscellaneous|1|||
33494885|NCT03760081|62873452|FG000|Overall Study|Progressive Disease|5|||
33494886|NCT03760081|62873453|FG001|Overall Study|Progressive Disease|10|||
33494887|NCT03760081|62873452|FG000|Overall Study|Death|1|||
33494888|NCT03760081|62873453|FG001|Overall Study|Death|1|||
33607353|NCT01636687|63007443|FG000|Induction Period|Adverse Event|1|||
33607354|NCT01636687|63007444|FG001|Induction Period|Adverse Event|0|||
33607355|NCT01636687|63007445|FG002|Induction Period|Adverse Event|0|||
33607356|NCT01636687|63007446|FG003|Induction Period|Adverse Event|0|||
33607357|NCT01636687|63007447|FG004|Induction Period|Adverse Event|1|||
33607358|NCT01636687|63007443|FG000|Induction Period|Lack of Efficacy|0|||
33607359|NCT01636687|63007444|FG001|Induction Period|Lack of Efficacy|0|||
33607360|NCT01636687|63007445|FG002|Induction Period|Lack of Efficacy|0|||
33607361|NCT01636687|63007446|FG003|Induction Period|Lack of Efficacy|0|||
33607362|NCT01636687|63007447|FG004|Induction Period|Lack of Efficacy|1|||
33607363|NCT01636687|63007443|FG000|Induction Period|Physician Decision|1|||
33607364|NCT01636687|63007444|FG001|Induction Period|Physician Decision|0|||
33607365|NCT01636687|63007445|FG002|Induction Period|Physician Decision|0|||
33446868|NCT00068692|62822440|FG005|Step 1: Registration|Death|0|||
33446869|NCT00068692|62822441|FG006|Step 1: Registration|Death|0|||
33446870|NCT00068692|62822442|FG007|Step 1: Registration|Death|0|||
33446871|NCT00068692|62822435|FG000|Step 1: Registration|Withdrawal by Subject|11|||
33446872|NCT00068692|62822436|FG001|Step 1: Registration|Withdrawal by Subject|0|||
33446873|NCT00068692|62822437|FG002|Step 1: Registration|Withdrawal by Subject|0|||
33446874|NCT00068692|62822438|FG003|Step 1: Registration|Withdrawal by Subject|0|||
33446875|NCT00068692|62822439|FG004|Step 1: Registration|Withdrawal by Subject|0|||
33446876|NCT00068692|62822440|FG005|Step 1: Registration|Withdrawal by Subject|0|||
33446877|NCT00068692|62822441|FG006|Step 1: Registration|Withdrawal by Subject|0|||
33446878|NCT00068692|62822442|FG007|Step 1: Registration|Withdrawal by Subject|0|||
33446879|NCT00068692|62822435|FG000|Step 1: Registration|Alternative therapy|2|||
33446880|NCT00068692|62822436|FG001|Step 1: Registration|Alternative therapy|0|||
33446881|NCT00068692|62822437|FG002|Step 1: Registration|Alternative therapy|0|||
33446882|NCT00068692|62822438|FG003|Step 1: Registration|Alternative therapy|0|||
33607366|NCT01636687|63007446|FG003|Induction Period|Physician Decision|0|||
33607367|NCT01636687|63007447|FG004|Induction Period|Physician Decision|0|||
33446883|NCT00068692|62822439|FG004|Step 1: Registration|Alternative therapy|0|||
33494889|NCT03422172|62873461|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
33494890|NCT03422172|62873461|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
33494891|NCT03422172|62873461|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
33494892|NCT00057863|62873470|FG000|Overall Study|Death|1|||
33494893|NCT00057863|62873470|FG000|Overall Study|Withdrawal by Subject|2|||
33494894|NCT00075023|62873476|FG000|Pilot Study|Physician Decision|1|||
33494895|NCT00075023|62873477|FG001|Pilot Study|Physician Decision|2|||
33494896|NCT00075023|62873476|FG000|Pilot Study|Withdrawal by Subject|1|||
33494897|NCT00075023|62873477|FG001|Pilot Study|Withdrawal by Subject|0|||
33494898|NCT00074711|62873486|FG000|Overall Study|Withdrawal by Subject|1|||
33494899|NCT00074711|62873487|FG001|Overall Study|Withdrawal by Subject|1|||
33494900|NCT00074711|62873486|FG000|Overall Study|Lost to Follow-up|10|||
33494901|NCT00074711|62873487|FG001|Overall Study|Lost to Follow-up|8|||
33494902|NCT00074711|62873486|FG000|Overall Study|Participant stopped study drug|4|||
33494903|NCT00074711|62873487|FG001|Overall Study|Participant stopped study drug|6|||
33494904|NCT03420300|62873493|FG000|Overall Study|Death|2|||
33494905|NCT03419598|62873497|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
33494906|NCT03407430|62873505|FG000|Washout|Protocol Violation|1|||
33494907|NCT03407430|62873506|FG001|Washout|Protocol Violation|0|||
33494908|NCT03407118|62873519|FG000|Period 2|Withdrawal by Subject|1|||
33494909|NCT03407118|62873520|FG001|Period 2|Withdrawal by Subject|0|||
33494910|NCT03406962|62873526|FG000|Overall Study|Death|2|||
33494911|NCT03406962|62873526|FG000|Overall Study|Adverse Event|1|||
33494912|NCT03406260|62873537|FG000|Period 1|Adverse Event|0|||
33494913|NCT03406260|62873538|FG001|Period 1|Adverse Event|0|||
33494914|NCT03406260|62873539|FG002|Period 1|Adverse Event|0|||
33494915|NCT03406260|62873540|FG003|Period 1|Adverse Event|0|||
33494916|NCT03406260|62873541|FG004|Period 1|Adverse Event|1|||
33494917|NCT03406260|62873542|FG005|Period 1|Adverse Event|0|||
33494918|NCT03419364|62873555|FG000|Overall Study|Delivery due to maternal condition|2|||
33494919|NCT03419364|62873556|FG001|Overall Study|Delivery due to maternal condition|0|||
33494920|NCT03419364|62873557|FG002|Overall Study|Delivery due to maternal condition|0|||
33494921|NCT02954172|62873567|FG000|Overall Study|Protocol Violation|3|||
33494922|NCT02954172|62873568|FG001|Overall Study|Protocol Violation|0|||
33494923|NCT02954172|62873567|FG000|Overall Study|allergic reaction|2|||
33494924|NCT02954172|62873568|FG001|Overall Study|allergic reaction|1|||
33494925|NCT02954172|62873567|FG000|Overall Study|non-measurable lesions at baseline|1|||
33494926|NCT02954172|62873568|FG001|Overall Study|non-measurable lesions at baseline|2|||
33494927|NCT02953938|62873577|FG000|Overall Study|Adverse Event|0|||
33494928|NCT02953938|62873578|FG001|Overall Study|Adverse Event|1|||
33494929|NCT02953938|62873577|FG000|Overall Study|Withdrawal by Subject|1|||
33494930|NCT02953938|62873578|FG001|Overall Study|Withdrawal by Subject|1|||
33607368|NCT01636687|63007443|FG000|Maintenance Period|Withdrawal by Subject|2|||
33607369|NCT01636687|63007444|FG001|Maintenance Period|Withdrawal by Subject|0|||
33494931|NCT03758443|62873589|FG000|Induction Period|Adverse Event|2|||
33494932|NCT03758443|62873590|FG001|Induction Period|Adverse Event|4|||
33494933|NCT03758443|62873591|FG002|Induction Period|Adverse Event|2|||
33494934|NCT03758443|62873592|FG003|Induction Period|Adverse Event|3|||
33494935|NCT03758443|62873589|FG000|Induction Period|Physician Decision|1|||
33494936|NCT03758443|62873590|FG001|Induction Period|Physician Decision|1|||
33494937|NCT03758443|62873591|FG002|Induction Period|Physician Decision|3|||
33494938|NCT03758443|62873592|FG003|Induction Period|Physician Decision|0|||
33494939|NCT03758443|62873589|FG000|Induction Period|Protocol Violation|0|||
33607370|NCT01636687|63007445|FG002|Maintenance Period|Withdrawal by Subject|2|||
33494940|NCT03758443|62873590|FG001|Induction Period|Protocol Violation|0|||
33494941|NCT03758443|62873591|FG002|Induction Period|Protocol Violation|0|||
33607371|NCT01636687|63007446|FG003|Maintenance Period|Withdrawal by Subject|0|||
33607372|NCT01636687|63007447|FG004|Maintenance Period|Withdrawal by Subject|0|||
33494942|NCT03758443|62873592|FG003|Induction Period|Protocol Violation|1|||
33494943|NCT03758443|62873589|FG000|Induction Period|Withdrawal by Subject|3|||
33494944|NCT03758443|62873590|FG001|Induction Period|Withdrawal by Subject|2|||
33607373|NCT01636687|63007443|FG000|Maintenance Period|Adverse Event|1|||
33494945|NCT03758443|62873591|FG002|Induction Period|Withdrawal by Subject|2|||
33494946|NCT03758443|62873592|FG003|Induction Period|Withdrawal by Subject|4|||
33494947|NCT03758443|62873589|FG000|Extended Induction Period|Adverse Event|1|||
33607374|NCT01636687|63007444|FG001|Maintenance Period|Adverse Event|0|||
33494948|NCT03758443|62873590|FG001|Extended Induction Period|Adverse Event|1|||
33494949|NCT03758443|62873591|FG002|Extended Induction Period|Adverse Event|0|||
33494950|NCT03758443|62873592|FG003|Extended Induction Period|Adverse Event|1|||
33446884|NCT00068692|62822440|FG005|Step 1: Registration|Alternative therapy|0|||
33446885|NCT00068692|62822441|FG006|Step 1: Registration|Alternative therapy|0|||
33446886|NCT00068692|62822442|FG007|Step 1: Registration|Alternative therapy|0|||
33446887|NCT00068692|62822435|FG000|Step 1: Registration|Complicating disease|2|||
33446888|NCT00068692|62822436|FG001|Step 1: Registration|Complicating disease|0|||
33446889|NCT00068692|62822437|FG002|Step 1: Registration|Complicating disease|0|||
33446890|NCT00068692|62822438|FG003|Step 1: Registration|Complicating disease|0|||
33446891|NCT00068692|62822439|FG004|Step 1: Registration|Complicating disease|0|||
33446892|NCT00068692|62822440|FG005|Step 1: Registration|Complicating disease|0|||
33446893|NCT00068692|62822441|FG006|Step 1: Registration|Complicating disease|0|||
33446894|NCT00068692|62822442|FG007|Step 1: Registration|Complicating disease|0|||
33494951|NCT03758443|62873589|FG000|Extended Induction Period|Lost to Follow-up|1|||
33494952|NCT03758443|62873590|FG001|Extended Induction Period|Lost to Follow-up|0|||
33494953|NCT03758443|62873591|FG002|Extended Induction Period|Lost to Follow-up|0|||
33494954|NCT03758443|62873592|FG003|Extended Induction Period|Lost to Follow-up|0|||
33494955|NCT03758443|62873589|FG000|Extended Induction Period|Physician Decision|2|||
33494956|NCT03758443|62873590|FG001|Extended Induction Period|Physician Decision|1|||
33494957|NCT03758443|62873591|FG002|Extended Induction Period|Physician Decision|2|||
33494958|NCT03758443|62873592|FG003|Extended Induction Period|Physician Decision|2|||
33494959|NCT03758443|62873589|FG000|Extended Induction Period|Protocol Violation|0|||
33494960|NCT03758443|62873590|FG001|Extended Induction Period|Protocol Violation|0|||
33494961|NCT03758443|62873591|FG002|Extended Induction Period|Protocol Violation|0|||
33494962|NCT03758443|62873592|FG003|Extended Induction Period|Protocol Violation|1|||
33494963|NCT03758443|62873589|FG000|Extended Induction Period|Withdrawal by Subject|8|||
33494964|NCT03758443|62873590|FG001|Extended Induction Period|Withdrawal by Subject|1|||
33494965|NCT03758443|62873591|FG002|Extended Induction Period|Withdrawal by Subject|7|||
33494966|NCT03758443|62873592|FG003|Extended Induction Period|Withdrawal by Subject|3|||
33494967|NCT03758443|62873589|FG000|Extended Induction Period|Miscellaneous|1|||
33494968|NCT03758443|62873590|FG001|Extended Induction Period|Miscellaneous|0|||
33494969|NCT03758443|62873591|FG002|Extended Induction Period|Miscellaneous|0|||
33494970|NCT03758443|62873592|FG003|Extended Induction Period|Miscellaneous|0|||
33494971|NCT03758443|62873589|FG000|Maintenance Period|Adverse Event|1|||
33494972|NCT03758443|62873590|FG001|Maintenance Period|Adverse Event|2|||
33494973|NCT03758443|62873591|FG002|Maintenance Period|Adverse Event|0|||
33494974|NCT03758443|62873592|FG003|Maintenance Period|Adverse Event|0|||
33494975|NCT03758443|62873589|FG000|Maintenance Period|Lost to Follow-up|0|||
33494976|NCT03758443|62873590|FG001|Maintenance Period|Lost to Follow-up|0|||
33494977|NCT03758443|62873591|FG002|Maintenance Period|Lost to Follow-up|0|||
33494978|NCT03758443|62873592|FG003|Maintenance Period|Lost to Follow-up|1|||
33494979|NCT03758443|62873589|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
33494980|NCT03758443|62873590|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
33494981|NCT03758443|62873591|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
33494982|NCT03758443|62873592|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
33494983|NCT03758443|62873589|FG000|Maintenance Period|Protocol Violation|0|||
33494984|NCT03758443|62873590|FG001|Maintenance Period|Protocol Violation|1|||
33494985|NCT03758443|62873591|FG002|Maintenance Period|Protocol Violation|0|||
33494986|NCT03758443|62873592|FG003|Maintenance Period|Protocol Violation|0|||
33494987|NCT03758443|62873589|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
33494988|NCT03758443|62873590|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
33494989|NCT03758443|62873591|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
33494990|NCT03758443|62873592|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
33494991|NCT03758443|62873589|FG000|Maintenance Period|Withdrawal by Subject|1|||
33494992|NCT03758443|62873590|FG001|Maintenance Period|Withdrawal by Subject|0|||
33494993|NCT03758443|62873591|FG002|Maintenance Period|Withdrawal by Subject|1|||
33494994|NCT03758443|62873592|FG003|Maintenance Period|Withdrawal by Subject|1|||
33494995|NCT03758443|62873589|FG000|Maintenance Period|Miscellaneous|0|||
33494996|NCT03758443|62873590|FG001|Maintenance Period|Miscellaneous|0|||
33494997|NCT03758443|62873591|FG002|Maintenance Period|Miscellaneous|1|||
33494998|NCT03758443|62873592|FG003|Maintenance Period|Miscellaneous|0|||
33494999|NCT03442764|62873614|FG000|Overall Study|Adverse Event|1|||
33495000|NCT03442764|62873615|FG001|Overall Study|Adverse Event|0|||
33495001|NCT03442764|62873616|FG002|Overall Study|Adverse Event|0|||
33495002|NCT03442296|62873627|FG000|3 Month Follow-up|Death|3|||
33495003|NCT03442296|62873628|FG001|3 Month Follow-up|Death|1|||
33495004|NCT03442296|62873627|FG000|3 Month Follow-up|Lost to Follow-up|1|||
33495005|NCT03442296|62873628|FG001|3 Month Follow-up|Lost to Follow-up|1|||
33495006|NCT03442296|62873627|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
33495007|NCT03442296|62873628|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
33495008|NCT03442296|62873627|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
33495009|NCT03442296|62873628|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
33495010|NCT03442296|62873627|FG000|12 Month Follow-up|Incomplete measurement|1|||
33495011|NCT03442296|62873628|FG001|12 Month Follow-up|Incomplete measurement|1|||
33495012|NCT03441984|62873636|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33495013|NCT03441984|62873637|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33495014|NCT03441984|62873638|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
33495015|NCT03441984|62873639|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33495016|NCT03441984|62873640|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33495017|NCT03441984|62873641|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33495018|NCT03441984|62873642|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33495019|NCT03441984|62873643|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33495020|NCT03441984|62873644|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33495021|NCT03441984|62873645|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33495022|NCT03441984|62873646|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33495023|NCT03441984|62873647|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33495024|NCT03441360|62873665|FG000|Overall Study|Radiological disease progression|5|||
33495025|NCT03441360|62873666|FG001|Overall Study|Radiological disease progression|6|||
33495026|NCT03441360|62873667|FG002|Overall Study|Radiological disease progression|4|||
33495027|NCT03441360|62873665|FG000|Overall Study|Clinical disease progression|2|||
33495028|NCT03441360|62873666|FG001|Overall Study|Clinical disease progression|2|||
33495029|NCT03441360|62873667|FG002|Overall Study|Clinical disease progression|0|||
33495030|NCT03441360|62873665|FG000|Overall Study|Adverse Event|1|||
33495031|NCT03441360|62873666|FG001|Overall Study|Adverse Event|0|||
33495032|NCT03441360|62873667|FG002|Overall Study|Adverse Event|1|||
33495033|NCT01347840|62873675|FG000|Overall Study|Withdrawal by Subject|1|||
33495034|NCT01347762|62873683|FG000|Overall Study|Lost to Follow-up|0|||
33495035|NCT01347762|62873684|FG001|Overall Study|Lost to Follow-up|1|||
33495036|NCT01347762|62873685|FG002|Overall Study|Lost to Follow-up|6|||
33495037|NCT01347762|62873686|FG003|Overall Study|Lost to Follow-up|5|||
33495038|NCT01347762|62873683|FG000|Overall Study|Withdrawal by Subject|4|||
33495039|NCT01347762|62873684|FG001|Overall Study|Withdrawal by Subject|1|||
33495040|NCT01347762|62873685|FG002|Overall Study|Withdrawal by Subject|3|||
33495041|NCT01347762|62873686|FG003|Overall Study|Withdrawal by Subject|3|||
33495042|NCT03438396|62873696|FG000|Overall Study|Reason Not Specified|9|||
33495043|NCT03438396|62873696|FG000|Overall Study|Withdrawal by Subject|5|||
33495044|NCT03438396|62873696|FG000|Overall Study|Lost to Follow-up|2|||
33495045|NCT03438396|62873696|FG000|Overall Study|Death|85|||
33495046|NCT03438396|62873696|FG000|Overall Study|Not treated|1|||
33495047|NCT00073307|62873702|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
33495048|NCT00073307|62873703|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
33495049|NCT00073307|62873704|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
33495050|NCT00073307|62873702|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
33495051|NCT00073307|62873703|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
33495052|NCT00073307|62873704|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
33495053|NCT00073307|62873702|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
33495054|NCT00073307|62873703|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
33495055|NCT00073307|62873704|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
33495056|NCT00073307|62873702|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
33495057|NCT00073307|62873703|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
33495058|NCT00073307|62873704|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
33495059|NCT00073307|62873702|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
33495060|NCT00073307|62873703|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
33495061|NCT00073307|62873704|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
33495062|NCT00073307|62873702|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
33495063|NCT00073307|62873703|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
33495064|NCT00073307|62873704|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
33495065|NCT00073307|62873702|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
33495066|NCT00073307|62873703|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
33495067|NCT00073307|62873704|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
33544005|NCT03034967|62934799|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
33544006|NCT03021187|62934822|FG000|Overall Study|Death|0|||
33544007|NCT03021187|62934823|FG001|Overall Study|Death|0|||
33544008|NCT03021187|62934824|FG002|Overall Study|Death|3|||
33544009|NCT03021187|62934825|FG003|Overall Study|Death|0|||
33323877|NCT01122264|62700301|FG002|Overall Study|Lost to Follow-up|13|||
33544010|NCT03021187|62934822|FG000|Overall Study|Withdrawal by Subject|0|||
33495068|NCT00073307|62873702|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
33495069|NCT00073307|62873703|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
33495070|NCT00073307|62873704|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
33495071|NCT00073307|62873702|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
33607375|NCT01636687|63007445|FG002|Maintenance Period|Adverse Event|0|||
33607376|NCT01636687|63007446|FG003|Maintenance Period|Adverse Event|0|||
33607377|NCT01636687|63007447|FG004|Maintenance Period|Adverse Event|0|||
33607378|NCT01636687|63007443|FG000|Maintenance Period|Lack of Efficacy|4|||
33607379|NCT01636687|63007444|FG001|Maintenance Period|Lack of Efficacy|1|||
33607380|NCT01636687|63007445|FG002|Maintenance Period|Lack of Efficacy|0|||
33607381|NCT01636687|63007446|FG003|Maintenance Period|Lack of Efficacy|0|||
33607382|NCT01636687|63007447|FG004|Maintenance Period|Lack of Efficacy|0|||
33607383|NCT01636687|63007443|FG000|Maintenance Period|Lost to Follow-up|1|||
33607384|NCT01636687|63007444|FG001|Maintenance Period|Lost to Follow-up|1|||
33607385|NCT01636687|63007445|FG002|Maintenance Period|Lost to Follow-up|0|||
33607386|NCT01636687|63007446|FG003|Maintenance Period|Lost to Follow-up|0|||
33607387|NCT01636687|63007447|FG004|Maintenance Period|Lost to Follow-up|1|||
33607388|NCT01636687|63007443|FG000|Maintenance Period|Physician Decision|0|||
33607389|NCT01636687|63007444|FG001|Maintenance Period|Physician Decision|0|||
33607390|NCT01636687|63007445|FG002|Maintenance Period|Physician Decision|0|||
33607391|NCT01636687|63007446|FG003|Maintenance Period|Physician Decision|0|||
33607392|NCT01636687|63007447|FG004|Maintenance Period|Physician Decision|1|||
33607393|NCT01636687|63007443|FG000|Extension Period|technical problems|0|||
33607394|NCT01636687|63007444|FG001|Extension Period|technical problems|1|||
33607395|NCT01636687|63007445|FG002|Extension Period|technical problems|2|||
33607396|NCT01636687|63007446|FG003|Extension Period|technical problems|1|||
33607397|NCT01636687|63007447|FG004|Extension Period|technical problems|0|||
33607398|NCT01636687|63007443|FG000|Extension Period|Adverse Event|4|||
33607399|NCT01636687|63007444|FG001|Extension Period|Adverse Event|3|||
33607400|NCT01636687|63007445|FG002|Extension Period|Adverse Event|2|||
33607401|NCT01636687|63007446|FG003|Extension Period|Adverse Event|1|||
33607402|NCT01636687|63007447|FG004|Extension Period|Adverse Event|0|||
33607403|NCT01636687|63007443|FG000|Extension Period|Lack of Efficacy|7|||
33607404|NCT01636687|63007444|FG001|Extension Period|Lack of Efficacy|0|||
33607405|NCT01636687|63007445|FG002|Extension Period|Lack of Efficacy|2|||
33607406|NCT01636687|63007446|FG003|Extension Period|Lack of Efficacy|1|||
33607407|NCT01636687|63007447|FG004|Extension Period|Lack of Efficacy|0|||
33607408|NCT01636687|63007443|FG000|Extension Period|Lost to Follow-up|1|||
33607409|NCT01636687|63007444|FG001|Extension Period|Lost to Follow-up|0|||
33607410|NCT01636687|63007445|FG002|Extension Period|Lost to Follow-up|1|||
33607411|NCT01636687|63007446|FG003|Extension Period|Lost to Follow-up|0|||
33607412|NCT01636687|63007447|FG004|Extension Period|Lost to Follow-up|0|||
33607413|NCT01636687|63007443|FG000|Extension Period|Physician Decision|1|||
33607414|NCT01636687|63007444|FG001|Extension Period|Physician Decision|0|||
33607415|NCT01636687|63007445|FG002|Extension Period|Physician Decision|0|||
33607416|NCT01636687|63007446|FG003|Extension Period|Physician Decision|1|||
33607417|NCT01636687|63007447|FG004|Extension Period|Physician Decision|0|||
33607418|NCT01636687|63007443|FG000|Extension Period|study terminated by sponsor|33|||
33607419|NCT01636687|63007444|FG001|Extension Period|study terminated by sponsor|50|||
33607420|NCT01636687|63007445|FG002|Extension Period|study terminated by sponsor|17|||
33607421|NCT01636687|63007446|FG003|Extension Period|study terminated by sponsor|23|||
33607422|NCT01636687|63007447|FG004|Extension Period|study terminated by sponsor|0|||
33607423|NCT01636687|63007443|FG000|Extension Period|Withdrawal by Subject|1|||
33607424|NCT01636687|63007444|FG001|Extension Period|Withdrawal by Subject|0|||
33607425|NCT01636687|63007445|FG002|Extension Period|Withdrawal by Subject|1|||
33607426|NCT01636687|63007446|FG003|Extension Period|Withdrawal by Subject|1|||
33607427|NCT01636687|63007447|FG004|Extension Period|Withdrawal by Subject|0|||
33495072|NCT00073307|62873703|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
33495073|NCT00073307|62873704|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
33495074|NCT00073307|62873702|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
33495075|NCT00073307|62873703|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
33495076|NCT00073307|62873704|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
33495077|NCT00073307|62873702|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
33495078|NCT00073307|62873703|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
33495079|NCT00073307|62873704|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
33495080|NCT00073307|62873702|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
33495081|NCT00073307|62873703|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
33495082|NCT00073307|62873704|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
33495083|NCT00073307|62873702|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
33495084|NCT00073307|62873703|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
33495085|NCT00073307|62873704|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
33607428|NCT01636687|63007443|FG000|Follow-up Period|Withdrawal by Subject|1|||
33607429|NCT01636687|63007444|FG001|Follow-up Period|Withdrawal by Subject|0|||
33607430|NCT01636687|63007445|FG002|Follow-up Period|Withdrawal by Subject|0|||
33607431|NCT01636687|63007446|FG003|Follow-up Period|Withdrawal by Subject|0|||
33607432|NCT01636687|63007447|FG004|Follow-up Period|Withdrawal by Subject|1|||
33607433|NCT01634659|63007467|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
33607434|NCT01634659|63007468|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
33607435|NCT01634659|63007467|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
33607436|NCT01634659|63007468|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
33607437|NCT04863248|63007480|FG000|Overall Study|Sponsor Terminated|4|||
33607438|NCT04863248|63007481|FG001|Overall Study|Sponsor Terminated|1|||
33607439|NCT04863248|63007480|FG000|Overall Study|Death|0|||
33607440|NCT04863248|63007481|FG001|Overall Study|Death|1|||
33607441|NCT04863248|63007480|FG000|Overall Study|Withdrawal by Subject|0|||
33607442|NCT04863248|63007481|FG001|Overall Study|Withdrawal by Subject|1|||
33607443|NCT04498832|63007489|FG000|Overall Study|Adverse Event|1|||
33607444|NCT04498832|63007490|FG001|Overall Study|Adverse Event|3|||
33607445|NCT04498832|63007489|FG000|Overall Study|Withdrawal by Subject|0|||
33607446|NCT04498832|63007490|FG001|Overall Study|Withdrawal by Subject|1|||
33607447|NCT04285229|63007498|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
33607448|NCT04285229|63007499|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33607449|NCT04285229|63007500|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33607450|NCT04285229|63007501|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33607451|NCT04285229|63007502|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33607452|NCT04285229|63007503|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33607453|NCT04285229|63007498|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
33607454|NCT04285229|63007499|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
33607455|NCT04285229|63007500|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
33607456|NCT04285229|63007501|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
33607457|NCT04285229|63007502|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
33607458|NCT04285229|63007503|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
33607459|NCT04285229|63007498|FG000|Extended Treatment Period|Adverse Event|0|||
33607460|NCT04285229|63007499|FG001|Extended Treatment Period|Adverse Event|0|||
33607461|NCT04285229|63007500|FG002|Extended Treatment Period|Adverse Event|0|||
33607462|NCT04285229|63007501|FG003|Extended Treatment Period|Adverse Event|1|||
33607463|NCT04285229|63007502|FG004|Extended Treatment Period|Adverse Event|0|||
33495086|NCT00073307|62873702|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
33495087|NCT00073307|62873703|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
33495088|NCT00073307|62873704|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
33495089|NCT00073307|62873702|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
33495090|NCT00073307|62873703|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
33495091|NCT00073307|62873704|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
33495092|NCT00073307|62873702|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
33495093|NCT00073307|62873703|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
33495094|NCT00073307|62873704|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
33495095|NCT00073307|62873702|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
33495096|NCT00073307|62873703|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
33607464|NCT04285229|63007503|FG005|Extended Treatment Period|Adverse Event|0|||
33607465|NCT04285229|63007498|FG000|Extended Treatment Period|Physician Decision|0|||
33607466|NCT04285229|63007499|FG001|Extended Treatment Period|Physician Decision|0|||
33607467|NCT04285229|63007500|FG002|Extended Treatment Period|Physician Decision|1|||
33607468|NCT04285229|63007501|FG003|Extended Treatment Period|Physician Decision|0|||
33607469|NCT04285229|63007502|FG004|Extended Treatment Period|Physician Decision|0|||
33607470|NCT04285229|63007503|FG005|Extended Treatment Period|Physician Decision|0|||
33607471|NCT04285229|63007498|FG000|Follow-up Period|Adverse Event|0|||
33323878|NCT01122264|62700299|FG000|Overall Study|Entry Criteria Not Met|1|||
33495097|NCT00073307|62873704|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
33495098|NCT00073307|62873702|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
33495099|NCT00073307|62873703|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
33495100|NCT00073307|62873704|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
33495101|NCT00073307|62873702|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
33495102|NCT00073307|62873703|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
33495103|NCT00073307|62873704|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
33495104|NCT03388164|62873715|FG000|Overall Study|Withdrawal by Subject|3|||
33495105|NCT03388164|62873716|FG001|Overall Study|Withdrawal by Subject|1|||
33495106|NCT03403374|62873722|FG000|Overall Study|Lost to Follow-up|1|||
33495107|NCT03387462|62873726|FG000|Overall Study|Lost to Follow-up|1|||
33607472|NCT04285229|63007499|FG001|Follow-up Period|Adverse Event|0|||
33607473|NCT04285229|63007500|FG002|Follow-up Period|Adverse Event|0|||
33607474|NCT04285229|63007501|FG003|Follow-up Period|Adverse Event|0|||
33607475|NCT04285229|63007502|FG004|Follow-up Period|Adverse Event|1|||
33607476|NCT04285229|63007503|FG005|Follow-up Period|Adverse Event|4|||
33607477|NCT04285229|63007498|FG000|Follow-up Period|Withdrawal by Subject|0|||
33607478|NCT04285229|63007499|FG001|Follow-up Period|Withdrawal by Subject|0|||
33607479|NCT04285229|63007500|FG002|Follow-up Period|Withdrawal by Subject|0|||
33607480|NCT04285229|63007501|FG003|Follow-up Period|Withdrawal by Subject|0|||
33607481|NCT04285229|63007502|FG004|Follow-up Period|Withdrawal by Subject|0|||
33607482|NCT04285229|63007503|FG005|Follow-up Period|Withdrawal by Subject|5|||
33446895|NCT00068692|62822435|FG000|Step 1: Registration|Protocol Violation|1|||
33446896|NCT00068692|62822436|FG001|Step 1: Registration|Protocol Violation|0|||
33446897|NCT00068692|62822437|FG002|Step 1: Registration|Protocol Violation|0|||
33446898|NCT00068692|62822438|FG003|Step 1: Registration|Protocol Violation|0|||
33446899|NCT00068692|62822439|FG004|Step 1: Registration|Protocol Violation|0|||
33446900|NCT00068692|62822440|FG005|Step 1: Registration|Protocol Violation|0|||
33446901|NCT00068692|62822441|FG006|Step 1: Registration|Protocol Violation|0|||
33446902|NCT00068692|62822442|FG007|Step 1: Registration|Protocol Violation|0|||
33446903|NCT00068692|62822435|FG000|Step 1: Registration|Not eligible|6|||
33446904|NCT00068692|62822436|FG001|Step 1: Registration|Not eligible|0|||
33446905|NCT00068692|62822437|FG002|Step 1: Registration|Not eligible|0|||
33446906|NCT00068692|62822438|FG003|Step 1: Registration|Not eligible|0|||
33446907|NCT00068692|62822439|FG004|Step 1: Registration|Not eligible|0|||
33446908|NCT00068692|62822440|FG005|Step 1: Registration|Not eligible|0|||
33446909|NCT00068692|62822441|FG006|Step 1: Registration|Not eligible|0|||
33446910|NCT00068692|62822442|FG007|Step 1: Registration|Not eligible|0|||
33446911|NCT00068692|62822435|FG000|Step 1: Registration|Other|2|||
33446912|NCT00068692|62822436|FG001|Step 1: Registration|Other|0|||
33446913|NCT00068692|62822437|FG002|Step 1: Registration|Other|0|||
33446914|NCT00068692|62822438|FG003|Step 1: Registration|Other|0|||
33495108|NCT03756883|62873733|FG000|Overall Study|Adverse Event|2|||
33495109|NCT03756883|62873734|FG001|Overall Study|Adverse Event|2|||
33495110|NCT03756883|62873735|FG002|Overall Study|Adverse Event|2|||
33495111|NCT03756883|62873733|FG000|Overall Study|Lack of Efficacy|0|||
33495112|NCT03756883|62873734|FG001|Overall Study|Lack of Efficacy|1|||
33495113|NCT03756883|62873735|FG002|Overall Study|Lack of Efficacy|2|||
33495114|NCT03756883|62873733|FG000|Overall Study|Lost to Follow-up|3|||
33495115|NCT03756883|62873734|FG001|Overall Study|Lost to Follow-up|3|||
33495116|NCT03756883|62873735|FG002|Overall Study|Lost to Follow-up|0|||
33495117|NCT03756883|62873733|FG000|Overall Study|Protocol Violation|2|||
33495118|NCT03756883|62873734|FG001|Overall Study|Protocol Violation|0|||
33495119|NCT03756883|62873735|FG002|Overall Study|Protocol Violation|1|||
33495120|NCT03756883|62873733|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
33495121|NCT03756883|62873734|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
33495122|NCT03756883|62873735|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
33495123|NCT03756883|62873733|FG000|Overall Study|Withdrawal by Subject|4|||
33495124|NCT03756883|62873734|FG001|Overall Study|Withdrawal by Subject|1|||
33495125|NCT03756883|62873735|FG002|Overall Study|Withdrawal by Subject|0|||
33495126|NCT03756883|62873733|FG000|Overall Study|Other Reasons|2|||
33495127|NCT03756883|62873734|FG001|Overall Study|Other Reasons|4|||
33495128|NCT03756883|62873735|FG002|Overall Study|Other Reasons|0|||
33495129|NCT03386994|62873746|FG000|Overall Study|Lung transplant|1|||
33495130|NCT03386994|62873746|FG000|Overall Study|Adverse Event|14|||
33495131|NCT03386994|62873746|FG000|Overall Study|Lost to Follow-up|4|||
33495132|NCT03386994|62873746|FG000|Overall Study|Withdrawal by Subject|3|||
33495133|NCT03386994|62873746|FG000|Overall Study|Death|16|||
33607483|NCT04285229|63007498|FG000|Follow-up Period|Covid-19|0|||
33607484|NCT04285229|63007499|FG001|Follow-up Period|Covid-19|0|||
33607485|NCT04285229|63007500|FG002|Follow-up Period|Covid-19|0|||
33495134|NCT03756571|62873763|FG000|Overall Study|Lost to Follow-up|1|||
33495135|NCT03756571|62873764|FG001|Overall Study|Lost to Follow-up|1|||
33495136|NCT03386448|62873772|FG000|Overall Study|Adverse Event|0|||
33495137|NCT03386448|62873773|FG001|Overall Study|Adverse Event|2|||
33495138|NCT02951988|62873782|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
33495139|NCT02951988|62873783|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
33495140|NCT02951988|62873784|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
33495141|NCT02951988|62873785|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
33495142|NCT02951988|62873782|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
33495143|NCT02951988|62873783|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
33495144|NCT02951988|62873784|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
33495145|NCT02951988|62873785|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
33495146|NCT02951988|62873782|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
33495147|NCT02951988|62873783|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
33495148|NCT02951988|62873784|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
33495149|NCT02951988|62873785|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
33495150|NCT02951988|62873782|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
33495151|NCT02951988|62873783|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
33495152|NCT02951988|62873784|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
33495153|NCT02951988|62873785|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
33495154|NCT02951988|62873782|FG000|Open-Label Treatment Period|Protocol Violation|22|||
33495155|NCT02951988|62873783|FG001|Open-Label Treatment Period|Protocol Violation|0|||
33495156|NCT02951988|62873784|FG002|Open-Label Treatment Period|Protocol Violation|0|||
33495157|NCT02951988|62873785|FG003|Open-Label Treatment Period|Protocol Violation|0|||
33495158|NCT02951988|62873782|FG000|Open-Label Treatment Period|Pregnancy|2|||
33495159|NCT02951988|62873783|FG001|Open-Label Treatment Period|Pregnancy|0|||
33495160|NCT02951988|62873784|FG002|Open-Label Treatment Period|Pregnancy|0|||
33495161|NCT02951988|62873785|FG003|Open-Label Treatment Period|Pregnancy|0|||
33495162|NCT02951988|62873782|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
33495163|NCT02951988|62873783|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
33495164|NCT02951988|62873784|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
33495165|NCT02951988|62873785|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
33495166|NCT02951988|62873782|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
33495167|NCT02951988|62873783|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
33495168|NCT02951988|62873784|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
33495169|NCT02951988|62873785|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
33495170|NCT02951988|62873782|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
33495171|NCT02951988|62873783|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
33495172|NCT02951988|62873784|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
33495173|NCT02951988|62873785|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
33495174|NCT02951988|62873782|FG000|Open-Label Treatment Period|Adverse Event|45|||
33495175|NCT02951988|62873783|FG001|Open-Label Treatment Period|Adverse Event|0|||
33495176|NCT02951988|62873784|FG002|Open-Label Treatment Period|Adverse Event|0|||
33495177|NCT02951988|62873785|FG003|Open-Label Treatment Period|Adverse Event|0|||
33495178|NCT02951988|62873782|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
33495179|NCT02951988|62873783|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
33495180|NCT02951988|62873784|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
33495181|NCT02951988|62873785|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
33495182|NCT02951988|62873782|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
33495183|NCT02951988|62873783|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
33495184|NCT02951988|62873784|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
33495185|NCT02951988|62873785|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
33495186|NCT02951988|62873782|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
33495187|NCT02951988|62873783|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
33495188|NCT02951988|62873784|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
33495189|NCT02951988|62873785|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
33495190|NCT02951988|62873782|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
33495191|NCT02951988|62873783|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
33495192|NCT02951988|62873784|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
33495193|NCT02951988|62873785|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
33495194|NCT02951988|62873782|FG000|Double-Blind Treatment Period|Pregnancy|0|||
33607486|NCT04285229|63007501|FG003|Follow-up Period|Covid-19|0|||
33607487|NCT04285229|63007502|FG004|Follow-up Period|Covid-19|0|||
33607488|NCT04285229|63007503|FG005|Follow-up Period|Covid-19|2|||
33607489|NCT04285229|63007498|FG000|Follow-up Period|Physician Decision|0|||
33607490|NCT04285229|63007499|FG001|Follow-up Period|Physician Decision|0|||
33607491|NCT04285229|63007500|FG002|Follow-up Period|Physician Decision|0|||
33607492|NCT04285229|63007501|FG003|Follow-up Period|Physician Decision|0|||
33607493|NCT04285229|63007502|FG004|Follow-up Period|Physician Decision|0|||
33607494|NCT04285229|63007503|FG005|Follow-up Period|Physician Decision|1|||
33607495|NCT04263454|63007520|FG000|Overall Study|Adverse Event|0|||
33607496|NCT04263454|63007521|FG001|Overall Study|Adverse Event|2|||
33607497|NCT04263454|63007520|FG000|Overall Study|Physician Decision|3|||
33607498|NCT04263454|63007521|FG001|Overall Study|Physician Decision|5|||
33607499|NCT04263454|63007520|FG000|Overall Study|Poor Data Quality|0|||
33607500|NCT04263454|63007521|FG001|Overall Study|Poor Data Quality|1|||
33607501|NCT04155463|63007531|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
33607502|NCT04155463|63007532|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
33607503|NCT04056611|63007538|FG000|Overall Study|Physician Decision|1|||
33607504|NCT04001803|63007542|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
33607505|NCT04001803|63007542|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
33607506|NCT04001803|63007542|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
33607507|NCT04001803|63007542|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
33607508|NCT04001803|63007542|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
33607509|NCT04001803|63007542|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
33607510|NCT04001803|63007542|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
33607511|NCT04001803|63007542|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
33607512|NCT04001803|63007542|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
33607513|NCT04001803|63007542|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
33607514|NCT03768427|63007551|FG000|Overall Study|Death|0|||
33607515|NCT03768427|63007552|FG001|Overall Study|Death|0|||
33607516|NCT03768427|63007553|FG002|Overall Study|Death|1|||
33607517|NCT03768427|63007554|FG003|Overall Study|Death|0|||
33607518|NCT03768427|63007551|FG000|Overall Study|Lost to Follow-up|2|||
33446915|NCT00068692|62822439|FG004|Step 1: Registration|Other|0|||
33446916|NCT00068692|62822440|FG005|Step 1: Registration|Other|0|||
33446917|NCT00068692|62822441|FG006|Step 1: Registration|Other|0|||
33446918|NCT00068692|62822442|FG007|Step 1: Registration|Other|0|||
33446919|NCT00068692|62822435|FG000|Step 1: Registration|Not start protocol therapy|3|||
33446920|NCT00068692|62822436|FG001|Step 1: Registration|Not start protocol therapy|0|||
33446921|NCT00068692|62822437|FG002|Step 1: Registration|Not start protocol therapy|0|||
33446922|NCT00068692|62822438|FG003|Step 1: Registration|Not start protocol therapy|0|||
33446923|NCT00068692|62822439|FG004|Step 1: Registration|Not start protocol therapy|0|||
33446924|NCT00068692|62822440|FG005|Step 1: Registration|Not start protocol therapy|0|||
33446925|NCT00068692|62822441|FG006|Step 1: Registration|Not start protocol therapy|0|||
33446926|NCT00068692|62822442|FG007|Step 1: Registration|Not start protocol therapy|0|||
33446927|NCT00068692|62822435|FG000|Step 1: Registration|Registered but not randomized|0|||
33446928|NCT00068692|62822436|FG001|Step 1: Registration|Registered but not randomized|1|||
33446929|NCT00068692|62822437|FG002|Step 1: Registration|Registered but not randomized|0|||
33446930|NCT00068692|62822438|FG003|Step 1: Registration|Registered but not randomized|0|||
33446931|NCT00068692|62822439|FG004|Step 1: Registration|Registered but not randomized|0|||
33607519|NCT03768427|63007552|FG001|Overall Study|Lost to Follow-up|0|||
33607520|NCT03768427|63007553|FG002|Overall Study|Lost to Follow-up|0|||
33607521|NCT03768427|63007554|FG003|Overall Study|Lost to Follow-up|0|||
33495195|NCT02951988|62873783|FG001|Double-Blind Treatment Period|Pregnancy|1|||
33495196|NCT02951988|62873784|FG002|Double-Blind Treatment Period|Pregnancy|1|||
33495197|NCT02951988|62873785|FG003|Double-Blind Treatment Period|Pregnancy|0|||
33495198|NCT02951988|62873782|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33495199|NCT02951988|62873783|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
33495200|NCT02951988|62873784|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
33495201|NCT02951988|62873785|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
33495202|NCT02951988|62873782|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33495203|NCT02951988|62873783|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
33495204|NCT02951988|62873784|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
33495205|NCT02951988|62873785|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
33495206|NCT02951988|62873782|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33495207|NCT02951988|62873783|FG001|Double-Blind Treatment Period|Adverse Event|8|||
33495208|NCT02951988|62873784|FG002|Double-Blind Treatment Period|Adverse Event|3|||
33495209|NCT02951988|62873785|FG003|Double-Blind Treatment Period|Adverse Event|6|||
33495210|NCT02951988|62873782|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
33495211|NCT02951988|62873783|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
33495212|NCT02951988|62873784|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
33495213|NCT02951988|62873785|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
33495214|NCT00009737|62873797|FG000|Overall Study|Adverse Event|112|||
33495215|NCT00009737|62873798|FG001|Overall Study|Adverse Event|75|||
33495216|NCT00009737|62873797|FG000|Overall Study|Death|4|||
33495217|NCT00009737|62873798|FG001|Overall Study|Death|6|||
33495218|NCT00009737|62873797|FG000|Overall Study|Lack of Efficacy|17|||
33495219|NCT00009737|62873798|FG001|Overall Study|Lack of Efficacy|15|||
33495220|NCT00009737|62873797|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
33495221|NCT00009737|62873798|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
33495222|NCT00009737|62873797|FG000|Overall Study|Other Protocol Violation|1|||
33607522|NCT03768427|63007551|FG000|Overall Study|Physician Decision|3|||
33607523|NCT03768427|63007552|FG001|Overall Study|Physician Decision|2|||
33495223|NCT00009737|62873798|FG001|Overall Study|Other Protocol Violation|0|||
33495224|NCT00009737|62873797|FG000|Overall Study|Refused Treatment|15|||
33495225|NCT00009737|62873798|FG001|Overall Study|Refused Treatment|16|||
33495226|NCT00009737|62873797|FG000|Overall Study|Lost to Follow-up|1|||
33495227|NCT00009737|62873798|FG001|Overall Study|Lost to Follow-up|1|||
33495228|NCT00009737|62873797|FG000|Overall Study|Administrative/Other Reasons|7|||
33495229|NCT00009737|62873798|FG001|Overall Study|Administrative/Other Reasons|1|||
33495230|NCT03417102|62873806|FG000|Overall Study|Adverse Event|0|||
33495231|NCT03417102|62873807|FG001|Overall Study|Adverse Event|1|||
33495232|NCT03417102|62873806|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
33495233|NCT03417102|62873807|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
33495234|NCT03417102|62873806|FG000|Overall Study|Other|0|||
33495235|NCT03417102|62873807|FG001|Overall Study|Other|1|||
33495236|NCT03417024|62873813|FG000|Overall Study|Study Termination prior to follow-up|11|||
33495237|NCT03417024|62873813|FG000|Overall Study|Physician Decision|2|||
33495238|NCT00028769|62873817|FG000|Overall Study|Adverse Event|2|||
33607524|NCT03768427|63007553|FG002|Overall Study|Physician Decision|4|||
33607525|NCT03768427|63007554|FG003|Overall Study|Physician Decision|4|||
33495239|NCT00028769|62873817|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
33495240|NCT00028769|62873817|FG000|Overall Study|Progression or Death|31|||
33495241|NCT00028769|62873817|FG000|Overall Study|Other - Not Protocol Specified|1|||
33495242|NCT00028769|62873817|FG000|Overall Study|Ineligible|5|||
33495243|NCT00028769|62873817|FG000|Overall Study|Not Analyzable|1|||
33495244|NCT02953314|62873823|FG000|Overall Study|Adverse Event|0|||
33495245|NCT02953314|62873824|FG001|Overall Study|Adverse Event|1|||
33495246|NCT02953314|62873823|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
33495247|NCT02953314|62873824|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
33495248|NCT03402750|62873832|FG000|Overall Study|Lost to Follow-up|2|||
33607526|NCT03768427|63007551|FG000|Overall Study|Withdrawal by Subject|7|||
33495249|NCT03402750|62873833|FG001|Overall Study|Lost to Follow-up|1|||
33495250|NCT00007475|62873842|FG000|Overall Study|Withdrawal by Subject|1|||
33495251|NCT00007475|62873843|FG001|Overall Study|Withdrawal by Subject|0|||
33607527|NCT03768427|63007552|FG001|Overall Study|Withdrawal by Subject|2|||
33607528|NCT03768427|63007553|FG002|Overall Study|Withdrawal by Subject|6|||
33607529|NCT03768427|63007554|FG003|Overall Study|Withdrawal by Subject|7|||
33607530|NCT03595228|63007568|FG000|Overall Study|Death|2|||
33446932|NCT00068692|62822440|FG005|Step 1: Registration|Registered but not randomized|0|||
33446933|NCT00068692|62822441|FG006|Step 1: Registration|Registered but not randomized|0|||
33446934|NCT00068692|62822442|FG007|Step 1: Registration|Registered but not randomized|0|||
33446935|NCT00068692|62822435|FG000|Step 2: Randomization|Disesae progression/replase|0|||
33446936|NCT00068692|62822436|FG001|Step 2: Randomization|Disesae progression/replase|0|||
33446937|NCT00068692|62822437|FG002|Step 2: Randomization|Disesae progression/replase|1|||
33607531|NCT03595228|63007568|FG000|Overall Study|Lack of Efficacy|13|||
33607532|NCT03595228|63007568|FG000|Overall Study|Withdrawal by Subject|3|||
33607533|NCT03595228|63007568|FG000|Overall Study|Withdrawal by Sponsor|1|||
33607534|NCT03572933|63007574|FG000|Overall Study|Adverse Event|4|||
33607535|NCT03572933|63007575|FG001|Overall Study|Adverse Event|1|||
33607536|NCT03572933|63007574|FG000|Overall Study|Withdrawal by Subject|0|||
33607537|NCT03572933|63007575|FG001|Overall Study|Withdrawal by Subject|1|||
33607538|NCT03558152|63007586|FG000|Overall Study|Adverse Event|0|||
33607539|NCT03558152|63007587|FG001|Overall Study|Adverse Event|0|||
33446938|NCT00068692|62822438|FG003|Step 2: Randomization|Disesae progression/replase|1|||
33446939|NCT00068692|62822439|FG004|Step 2: Randomization|Disesae progression/replase|0|||
33446940|NCT00068692|62822440|FG005|Step 2: Randomization|Disesae progression/replase|0|||
33446941|NCT00068692|62822441|FG006|Step 2: Randomization|Disesae progression/replase|0|||
33446942|NCT00068692|62822442|FG007|Step 2: Randomization|Disesae progression/replase|0|||
33446943|NCT00068692|62822435|FG000|Step 2: Randomization|Adverse Event|0|||
33446944|NCT00068692|62822436|FG001|Step 2: Randomization|Adverse Event|0|||
33446945|NCT00068692|62822437|FG002|Step 2: Randomization|Adverse Event|4|||
33446946|NCT00068692|62822438|FG003|Step 2: Randomization|Adverse Event|2|||
33446947|NCT00068692|62822439|FG004|Step 2: Randomization|Adverse Event|2|||
33446948|NCT00068692|62822440|FG005|Step 2: Randomization|Adverse Event|3|||
33446949|NCT00068692|62822441|FG006|Step 2: Randomization|Adverse Event|4|||
33446950|NCT00068692|62822442|FG007|Step 2: Randomization|Adverse Event|4|||
33446951|NCT00068692|62822435|FG000|Step 2: Randomization|Death|0|||
33446952|NCT00068692|62822436|FG001|Step 2: Randomization|Death|0|||
33446953|NCT00068692|62822437|FG002|Step 2: Randomization|Death|0|||
33446954|NCT00068692|62822438|FG003|Step 2: Randomization|Death|0|||
33446955|NCT00068692|62822439|FG004|Step 2: Randomization|Death|1|||
33446956|NCT00068692|62822440|FG005|Step 2: Randomization|Death|0|||
33446957|NCT00068692|62822441|FG006|Step 2: Randomization|Death|0|||
33446958|NCT00068692|62822442|FG007|Step 2: Randomization|Death|1|||
33446959|NCT00068692|62822435|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
33446960|NCT00068692|62822436|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
33446961|NCT00068692|62822437|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
33446962|NCT00068692|62822438|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
33446963|NCT00068692|62822439|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
33446964|NCT00068692|62822440|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
33446965|NCT00068692|62822441|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
33446966|NCT00068692|62822442|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
33446967|NCT00068692|62822435|FG000|Step 2: Randomization|alternative therapy|0|||
33446968|NCT00068692|62822436|FG001|Step 2: Randomization|alternative therapy|0|||
33446969|NCT00068692|62822437|FG002|Step 2: Randomization|alternative therapy|0|||
33446970|NCT00068692|62822438|FG003|Step 2: Randomization|alternative therapy|1|||
33446971|NCT00068692|62822439|FG004|Step 2: Randomization|alternative therapy|1|||
33446972|NCT00068692|62822440|FG005|Step 2: Randomization|alternative therapy|0|||
33446973|NCT00068692|62822441|FG006|Step 2: Randomization|alternative therapy|0|||
33446974|NCT00068692|62822442|FG007|Step 2: Randomization|alternative therapy|0|||
33446975|NCT00068692|62822435|FG000|Step 2: Randomization|Physician Decision|0|||
33446976|NCT00068692|62822436|FG001|Step 2: Randomization|Physician Decision|0|||
33607540|NCT03558152|63007588|FG002|Overall Study|Adverse Event|1|||
33607541|NCT03558152|63007589|FG003|Overall Study|Adverse Event|1|||
33607542|NCT03558152|63007590|FG004|Overall Study|Adverse Event|2|||
33495252|NCT00007475|62873844|FG002|Overall Study|Withdrawal by Subject|0|||
33495253|NCT00007475|62873845|FG003|Overall Study|Withdrawal by Subject|0|||
33495254|NCT00007475|62873842|FG000|Overall Study|Adverse Event|3|||
33495255|NCT00007475|62873843|FG001|Overall Study|Adverse Event|0|||
33495256|NCT00007475|62873844|FG002|Overall Study|Adverse Event|0|||
33495257|NCT00007475|62873845|FG003|Overall Study|Adverse Event|0|||
33446977|NCT00068692|62822437|FG002|Step 2: Randomization|Physician Decision|0|||
33446978|NCT00068692|62822438|FG003|Step 2: Randomization|Physician Decision|1|||
33446979|NCT00068692|62822439|FG004|Step 2: Randomization|Physician Decision|1|||
33446980|NCT00068692|62822440|FG005|Step 2: Randomization|Physician Decision|0|||
33446981|NCT00068692|62822441|FG006|Step 2: Randomization|Physician Decision|0|||
33446982|NCT00068692|62822442|FG007|Step 2: Randomization|Physician Decision|0|||
33446983|NCT00068692|62822435|FG000|Step 2: Randomization|Other|0|||
33446984|NCT00068692|62822436|FG001|Step 2: Randomization|Other|0|||
33446985|NCT00068692|62822437|FG002|Step 2: Randomization|Other|0|||
33446986|NCT00068692|62822438|FG003|Step 2: Randomization|Other|1|||
33446987|NCT00068692|62822439|FG004|Step 2: Randomization|Other|0|||
33446988|NCT00068692|62822440|FG005|Step 2: Randomization|Other|1|||
33446989|NCT00068692|62822441|FG006|Step 2: Randomization|Other|0|||
33446990|NCT00068692|62822442|FG007|Step 2: Randomization|Other|0|||
33607543|NCT03558152|63007591|FG005|Overall Study|Adverse Event|1|||
33446991|NCT00068692|62822435|FG000|Step 2: Randomization|never start protocol therapy|0|||
33446992|NCT00068692|62822436|FG001|Step 2: Randomization|never start protocol therapy|0|||
33446993|NCT00068692|62822437|FG002|Step 2: Randomization|never start protocol therapy|1|||
33446994|NCT00068692|62822438|FG003|Step 2: Randomization|never start protocol therapy|0|||
33446995|NCT00068692|62822439|FG004|Step 2: Randomization|never start protocol therapy|1|||
33446996|NCT00068692|62822440|FG005|Step 2: Randomization|never start protocol therapy|0|||
33446997|NCT00068692|62822441|FG006|Step 2: Randomization|never start protocol therapy|0|||
33446998|NCT00068692|62822442|FG007|Step 2: Randomization|never start protocol therapy|0|||
33446999|NCT00463151|62822459|FG000|Overall Study|Adverse Event|0|||
33447000|NCT00463151|62822460|FG001|Overall Study|Adverse Event|0|||
33447001|NCT00463151|62822461|FG002|Overall Study|Adverse Event|1|||
33447002|NCT00463151|62822462|FG003|Overall Study|Adverse Event|0|||
33495258|NCT00025883|62873857|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
33495259|NCT00025883|62873857|FG000|Overall Study|no baseline data|1|||
33495260|NCT00025883|62873857|FG000|Overall Study|Death|1|||
33495261|NCT00025883|62873857|FG000|Overall Study|Adverse Event|1|||
33495262|NCT00025883|62873857|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
33495263|NCT00072293|62873864|FG000|Overall Study|Lost to Follow-up|1|||
33495264|NCT00072293|62873865|FG001|Overall Study|Lost to Follow-up|1|||
33447003|NCT00463151|62822459|FG000|Overall Study|Lack of Efficacy|2|||
33495265|NCT00072293|62873864|FG000|Overall Study|Withdrawal by Subject|0|||
33495266|NCT00072293|62873865|FG001|Overall Study|Withdrawal by Subject|1|||
33495267|NCT03753763|62873873|FG000|Overall Study|Adverse Event|2|||
33447004|NCT00463151|62822460|FG001|Overall Study|Lack of Efficacy|5|||
33447005|NCT00463151|62822461|FG002|Overall Study|Lack of Efficacy|2|||
33447006|NCT00463151|62822462|FG003|Overall Study|Lack of Efficacy|5|||
33447007|NCT00463151|62822459|FG000|Overall Study|Protocol Violation|0|||
33447008|NCT00463151|62822460|FG001|Overall Study|Protocol Violation|0|||
33447009|NCT00463151|62822461|FG002|Overall Study|Protocol Violation|0|||
33447010|NCT00463151|62822462|FG003|Overall Study|Protocol Violation|1|||
33495268|NCT03753763|62873874|FG001|Overall Study|Adverse Event|0|||
33495269|NCT03753763|62873873|FG000|Overall Study|Withdrawal by Subject|3|||
33495270|NCT03753763|62873874|FG001|Overall Study|Withdrawal by Subject|1|||
33607544|NCT03558152|63007592|FG006|Overall Study|Adverse Event|1|||
33607545|NCT03558152|63007593|FG007|Overall Study|Adverse Event|0|||
33607546|NCT03558152|63007586|FG000|Overall Study|Death|0|||
33607547|NCT03558152|63007587|FG001|Overall Study|Death|0|||
33607548|NCT03558152|63007588|FG002|Overall Study|Death|0|||
33607549|NCT03558152|63007589|FG003|Overall Study|Death|0|||
33607550|NCT03558152|63007590|FG004|Overall Study|Death|1|||
33607551|NCT03558152|63007591|FG005|Overall Study|Death|0|||
33607552|NCT03558152|63007592|FG006|Overall Study|Death|0|||
33607553|NCT03558152|63007593|FG007|Overall Study|Death|0|||
33607554|NCT03558152|63007586|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
33607555|NCT03558152|63007587|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
33607556|NCT03558152|63007588|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
33607557|NCT03558152|63007589|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
33607558|NCT03558152|63007590|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
33607559|NCT03558152|63007591|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
33607560|NCT03558152|63007592|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
33607561|NCT03558152|63007593|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
33607562|NCT03558152|63007586|FG000|Overall Study|Miscalculation in mmcs|0|||
33607563|NCT03558152|63007587|FG001|Overall Study|Miscalculation in mmcs|0|||
33607564|NCT03558152|63007588|FG002|Overall Study|Miscalculation in mmcs|0|||
33607565|NCT03558152|63007589|FG003|Overall Study|Miscalculation in mmcs|0|||
33447011|NCT00463151|62822459|FG000|Overall Study|Withdrawal by Subject|0|||
33447012|NCT00463151|62822460|FG001|Overall Study|Withdrawal by Subject|0|||
33447013|NCT00463151|62822461|FG002|Overall Study|Withdrawal by Subject|0|||
33447014|NCT00463151|62822462|FG003|Overall Study|Withdrawal by Subject|1|||
33447015|NCT00068380|62822472|FG000|Overall Study|Withdrawal by Subject|3|||
33447016|NCT00068380|62822472|FG000|Overall Study|Adverse Event|2|||
33447017|NCT00067990|62822478|FG000|Overall Study|Death|5|||
33447018|NCT00067990|62822479|FG001|Overall Study|Death|7|||
33447019|NCT00067990|62822478|FG000|Overall Study|ESRD, Non IF/TA|1|||
33447020|NCT00067990|62822479|FG001|Overall Study|ESRD, Non IF/TA|3|||
33447021|NCT00067990|62822478|FG000|Overall Study|Withdrawal by Subject|4|||
33447022|NCT00067990|62822479|FG001|Overall Study|Withdrawal by Subject|12|||
33447023|NCT00090220|62822487|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
33447024|NCT00090220|62822488|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
33447025|NCT00090220|62822489|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
33447026|NCT00090220|62822490|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
33447027|NCT00090220|62822491|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
33447028|NCT00090220|62822492|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
33447029|NCT00090220|62822487|FG000|Base Study Vaccination Period|Adverse Event|6|||
33447030|NCT00090220|62822488|FG001|Base Study Vaccination Period|Adverse Event|1|||
33447031|NCT00090220|62822489|FG002|Base Study Vaccination Period|Adverse Event|0|||
33447032|NCT00090220|62822490|FG003|Base Study Vaccination Period|Adverse Event|0|||
33495271|NCT03753763|62873873|FG000|Overall Study|clinical deterioration|1|||
33495272|NCT03753763|62873874|FG001|Overall Study|clinical deterioration|0|||
33495273|NCT03384966|62873883|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
33495274|NCT03384966|62873884|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
33495275|NCT03384966|62873885|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
33495276|NCT03384966|62873883|FG000|Follow-up Period|Adverse Event|1|||
33495277|NCT03384966|62873884|FG001|Follow-up Period|Adverse Event|0|||
33495278|NCT03384966|62873885|FG002|Follow-up Period|Adverse Event|0|||
33495279|NCT03402126|62873902|FG000|Overall Study|Lost to Follow-up|6|||
33495280|NCT03402126|62873902|FG000|Overall Study|Protocol Violation|10|||
33495281|NCT03402126|62873902|FG000|Overall Study|Sponsor request/Study termination|29|||
33495282|NCT03402126|62873902|FG000|Overall Study|Study product no longer in use|1|||
33495283|NCT03402126|62873902|FG000|Overall Study|Technical problems|1|||
33495284|NCT03402126|62873902|FG000|Overall Study|Withdrawal by Subject|6|||
33607566|NCT03558152|63007590|FG004|Overall Study|Miscalculation in mmcs|0|||
33447033|NCT00090220|62822491|FG004|Base Study Vaccination Period|Adverse Event|0|||
33607567|NCT03558152|63007591|FG005|Overall Study|Miscalculation in mmcs|0|||
33447034|NCT00090220|62822492|FG005|Base Study Vaccination Period|Adverse Event|0|||
33447035|NCT00090220|62822487|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
33495285|NCT03402126|62873902|FG000|Overall Study|Physician Decision|2|||
33495286|NCT03402126|62873902|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
33495287|NCT03402126|62873902|FG000|Overall Study|Death|4|||
33495288|NCT03355326|62873908|FG000|Overall Study|Protocol Violation|3|||
33495289|NCT03355326|62873909|FG001|Overall Study|Protocol Violation|3|||
33495290|NCT03353220|62873915|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
33495291|NCT03353220|62873916|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
33495292|NCT03751657|62873924|FG000|Overall Study|Physician Decision|0|||
33495293|NCT03751657|62873925|FG001|Overall Study|Physician Decision|1|||
33495294|NCT03751657|62873924|FG000|Overall Study|Withdrawal by Subject|1|||
33495295|NCT03751657|62873925|FG001|Overall Study|Withdrawal by Subject|1|||
33495296|NCT03751657|62873924|FG000|Overall Study|Lost to Follow-up|2|||
33495297|NCT03751657|62873925|FG001|Overall Study|Lost to Follow-up|1|||
33495298|NCT00025259|62873938|FG000|Overall Study|Death|1|||
33495299|NCT00025259|62873939|FG001|Overall Study|Death|3|||
33495300|NCT00025259|62873940|FG002|Overall Study|Death|0|||
33495301|NCT00025259|62873941|FG003|Overall Study|Death|3|||
33495302|NCT00025259|62873942|FG004|Overall Study|Death|0|||
33607568|NCT03558152|63007592|FG006|Overall Study|Miscalculation in mmcs|1|||
33607569|NCT03558152|63007593|FG007|Overall Study|Miscalculation in mmcs|0|||
33607570|NCT03558152|63007586|FG000|Overall Study|Mistake in calculation|0|||
33607571|NCT03558152|63007587|FG001|Overall Study|Mistake in calculation|0|||
33607572|NCT03558152|63007588|FG002|Overall Study|Mistake in calculation|0|||
33607573|NCT03558152|63007589|FG003|Overall Study|Mistake in calculation|1|||
33607574|NCT03558152|63007590|FG004|Overall Study|Mistake in calculation|0|||
33607575|NCT03558152|63007591|FG005|Overall Study|Mistake in calculation|0|||
33495303|NCT00025259|62873943|FG005|Overall Study|Death|1|||
33495304|NCT00025259|62873944|FG006|Overall Study|Death|2|||
33495305|NCT00025259|62873938|FG000|Overall Study|Lack of Efficacy|2|||
33495306|NCT00025259|62873939|FG001|Overall Study|Lack of Efficacy|46|||
33495307|NCT00025259|62873940|FG002|Overall Study|Lack of Efficacy|60|||
33495308|NCT00025259|62873941|FG003|Overall Study|Lack of Efficacy|78|||
33495309|NCT00025259|62873942|FG004|Overall Study|Lack of Efficacy|11|||
33495310|NCT00025259|62873943|FG005|Overall Study|Lack of Efficacy|30|||
33495311|NCT00025259|62873944|FG006|Overall Study|Lack of Efficacy|38|||
33495312|NCT00025259|62873938|FG000|Overall Study|Lost to Follow-up|2|||
33495313|NCT00025259|62873939|FG001|Overall Study|Lost to Follow-up|9|||
33495314|NCT00025259|62873940|FG002|Overall Study|Lost to Follow-up|13|||
33495315|NCT00025259|62873941|FG003|Overall Study|Lost to Follow-up|13|||
33495316|NCT00025259|62873942|FG004|Overall Study|Lost to Follow-up|1|||
33495317|NCT00025259|62873943|FG005|Overall Study|Lost to Follow-up|3|||
33495318|NCT00025259|62873944|FG006|Overall Study|Lost to Follow-up|1|||
33495319|NCT00025259|62873938|FG000|Overall Study|Physician Decision|12|||
33495320|NCT00025259|62873939|FG001|Overall Study|Physician Decision|1|||
33495321|NCT00025259|62873940|FG002|Overall Study|Physician Decision|0|||
33495322|NCT00025259|62873941|FG003|Overall Study|Physician Decision|5|||
33495323|NCT00025259|62873942|FG004|Overall Study|Physician Decision|4|||
33495324|NCT00025259|62873943|FG005|Overall Study|Physician Decision|2|||
33495325|NCT00025259|62873944|FG006|Overall Study|Physician Decision|1|||
33495326|NCT00025259|62873938|FG000|Overall Study|Protocol Violation|3|||
33495327|NCT00025259|62873939|FG001|Overall Study|Protocol Violation|2|||
33495328|NCT00025259|62873940|FG002|Overall Study|Protocol Violation|2|||
33495329|NCT00025259|62873941|FG003|Overall Study|Protocol Violation|1|||
33495330|NCT00025259|62873942|FG004|Overall Study|Protocol Violation|2|||
33495331|NCT00025259|62873943|FG005|Overall Study|Protocol Violation|1|||
33495332|NCT00025259|62873944|FG006|Overall Study|Protocol Violation|3|||
33495333|NCT00025259|62873938|FG000|Overall Study|Withdrawal by Subject|9|||
33495334|NCT00025259|62873939|FG001|Overall Study|Withdrawal by Subject|27|||
33495335|NCT00025259|62873940|FG002|Overall Study|Withdrawal by Subject|6|||
33495336|NCT00025259|62873941|FG003|Overall Study|Withdrawal by Subject|14|||
33495337|NCT00025259|62873942|FG004|Overall Study|Withdrawal by Subject|11|||
33495338|NCT00025259|62873943|FG005|Overall Study|Withdrawal by Subject|8|||
33495339|NCT00025259|62873944|FG006|Overall Study|Withdrawal by Subject|3|||
33607576|NCT03558152|63007592|FG006|Overall Study|Mistake in calculation|0|||
33607577|NCT03558152|63007593|FG007|Overall Study|Mistake in calculation|0|||
33495340|NCT00025259|62873938|FG000|Overall Study|Ineligible|14|||
33495341|NCT00025259|62873939|FG001|Overall Study|Ineligible|1|||
33495342|NCT00025259|62873940|FG002|Overall Study|Ineligible|0|||
33607578|NCT03558152|63007586|FG000|Overall Study|Mistake in evaluation of disease status|0|||
33607579|NCT03558152|63007587|FG001|Overall Study|Mistake in evaluation of disease status|0|||
33495343|NCT00025259|62873941|FG003|Overall Study|Ineligible|0|||
33495344|NCT00025259|62873942|FG004|Overall Study|Ineligible|6|||
33495345|NCT00025259|62873943|FG005|Overall Study|Ineligible|0|||
33495346|NCT00025259|62873944|FG006|Overall Study|Ineligible|1|||
33495347|NCT00025259|62873938|FG000|Overall Study|Randomization error|1|||
33607580|NCT03558152|63007588|FG002|Overall Study|Mistake in evaluation of disease status|0|||
33495348|NCT00025259|62873939|FG001|Overall Study|Randomization error|0|||
33607581|NCT03558152|63007589|FG003|Overall Study|Mistake in evaluation of disease status|0|||
33495349|NCT00025259|62873940|FG002|Overall Study|Randomization error|0|||
33495350|NCT00025259|62873941|FG003|Overall Study|Randomization error|0|||
33495351|NCT00025259|62873942|FG004|Overall Study|Randomization error|1|||
33495352|NCT00025259|62873943|FG005|Overall Study|Randomization error|7|||
33495353|NCT00025259|62873944|FG006|Overall Study|Randomization error|2|||
33495354|NCT00025259|62873938|FG000|Overall Study|Adverse Event|1|||
33495355|NCT00025259|62873939|FG001|Overall Study|Adverse Event|0|||
33495356|NCT00025259|62873940|FG002|Overall Study|Adverse Event|0|||
33495357|NCT00025259|62873941|FG003|Overall Study|Adverse Event|0|||
33447036|NCT00090220|62822488|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
33447037|NCT00090220|62822489|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
33447038|NCT00090220|62822490|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
33447039|NCT00090220|62822491|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
33447040|NCT00090220|62822492|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
33447041|NCT00090220|62822487|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
33447042|NCT00090220|62822488|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
33447043|NCT00090220|62822489|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
33447044|NCT00090220|62822490|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
33447045|NCT00090220|62822491|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
33447046|NCT00090220|62822492|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
33447047|NCT00090220|62822487|FG000|Base Study Vaccination Period|Patient Moved|6|||
33495358|NCT00025259|62873942|FG004|Overall Study|Adverse Event|0|||
33495359|NCT00025259|62873943|FG005|Overall Study|Adverse Event|0|||
33495360|NCT00025259|62873944|FG006|Overall Study|Adverse Event|0|||
33495361|NCT03351738|62873969|FG000|Overall Study|Withdrawal by Subject|0|||
33447048|NCT00090220|62822488|FG001|Base Study Vaccination Period|Patient Moved|2|||
33447049|NCT00090220|62822489|FG002|Base Study Vaccination Period|Patient Moved|0|||
33447050|NCT00090220|62822490|FG003|Base Study Vaccination Period|Patient Moved|0|||
33447051|NCT00090220|62822491|FG004|Base Study Vaccination Period|Patient Moved|0|||
33447052|NCT00090220|62822492|FG005|Base Study Vaccination Period|Patient Moved|0|||
33447053|NCT00090220|62822487|FG000|Base Study Vaccination Period|Other|4|||
33447054|NCT00090220|62822488|FG001|Base Study Vaccination Period|Other|4|||
33447055|NCT00090220|62822489|FG002|Base Study Vaccination Period|Other|0|||
33447056|NCT00090220|62822490|FG003|Base Study Vaccination Period|Other|0|||
33447057|NCT00090220|62822491|FG004|Base Study Vaccination Period|Other|0|||
33447058|NCT00090220|62822492|FG005|Base Study Vaccination Period|Other|0|||
33447059|NCT00090220|62822487|FG000|Base Study Follow-up Period|Adverse Event|6|||
33447060|NCT00090220|62822488|FG001|Base Study Follow-up Period|Adverse Event|1|||
33447061|NCT00090220|62822489|FG002|Base Study Follow-up Period|Adverse Event|0|||
33447062|NCT00090220|62822490|FG003|Base Study Follow-up Period|Adverse Event|0|||
33447063|NCT00090220|62822491|FG004|Base Study Follow-up Period|Adverse Event|0|||
33447064|NCT00090220|62822492|FG005|Base Study Follow-up Period|Adverse Event|0|||
33447065|NCT00090220|62822487|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
33447066|NCT00090220|62822488|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
33447067|NCT00090220|62822489|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
33447068|NCT00090220|62822490|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
33447069|NCT00090220|62822491|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
33447070|NCT00090220|62822492|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
33447071|NCT00090220|62822487|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
33447072|NCT00090220|62822488|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
33447073|NCT00090220|62822489|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
33447074|NCT00090220|62822490|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
33447075|NCT00090220|62822491|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
33447076|NCT00090220|62822492|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
33447077|NCT00090220|62822487|FG000|Base Study Follow-up Period|Patient Moved|20|||
33447078|NCT00090220|62822488|FG001|Base Study Follow-up Period|Patient Moved|28|||
33495362|NCT03351738|62873970|FG001|Overall Study|Withdrawal by Subject|1|||
33495363|NCT03351738|62873971|FG002|Overall Study|Withdrawal by Subject|0|||
33447079|NCT00090220|62822489|FG002|Base Study Follow-up Period|Patient Moved|0|||
33447080|NCT00090220|62822490|FG003|Base Study Follow-up Period|Patient Moved|0|||
33447081|NCT00090220|62822491|FG004|Base Study Follow-up Period|Patient Moved|0|||
33447082|NCT00090220|62822492|FG005|Base Study Follow-up Period|Patient Moved|0|||
33447083|NCT00090220|62822487|FG000|Base Study Follow-up Period|Other|19|||
33495364|NCT03351738|62873972|FG003|Overall Study|Withdrawal by Subject|1|||
33447084|NCT00090220|62822488|FG001|Base Study Follow-up Period|Other|21|||
33447085|NCT00090220|62822489|FG002|Base Study Follow-up Period|Other|0|||
33447086|NCT00090220|62822490|FG003|Base Study Follow-up Period|Other|0|||
33447087|NCT00090220|62822491|FG004|Base Study Follow-up Period|Other|0|||
33447088|NCT00090220|62822492|FG005|Base Study Follow-up Period|Other|0|||
33447089|NCT00090220|62822487|FG000|Extension 1 (EXT1)|Adverse Event|0|||
33447090|NCT00090220|62822488|FG001|Extension 1 (EXT1)|Adverse Event|0|||
33447091|NCT00090220|62822489|FG002|Extension 1 (EXT1)|Adverse Event|4|||
33447092|NCT00090220|62822490|FG003|Extension 1 (EXT1)|Adverse Event|0|||
33447093|NCT00090220|62822491|FG004|Extension 1 (EXT1)|Adverse Event|0|||
33447094|NCT00090220|62822492|FG005|Extension 1 (EXT1)|Adverse Event|0|||
33495365|NCT03351738|62873973|FG004|Overall Study|Withdrawal by Subject|0|||
33495366|NCT03351738|62873974|FG005|Overall Study|Withdrawal by Subject|0|||
33495367|NCT03351114|62873993|FG000|Overall Study|Withdrawal by Subject|1|||
33495368|NCT03350256|62873997|FG000|Overall Study|Inclusion/exclusion violation|4|||
33495369|NCT03350256|62873997|FG000|Overall Study|Recommended for other therapies|2|||
33495370|NCT03350256|62873997|FG000|Overall Study|Protocol Violation|3|||
33495371|NCT03350256|62873997|FG000|Overall Study|Non compliance|2|||
33495372|NCT03350256|62873997|FG000|Overall Study|Denial by insurance|1|||
33495373|NCT03350256|62873997|FG000|Overall Study|Adverse Event|2|||
33495374|NCT03350256|62873997|FG000|Overall Study|Trial failure|12|||
33495375|NCT03350256|62873997|FG000|Overall Study|Did not proceed to permanent implant|3|||
33495376|NCT03350256|62873997|FG000|Overall Study|Withdrawal by Subject|3|||
33495377|NCT03350256|62873997|FG000|Overall Study|Subject moving out of state|1|||
33495378|NCT03350256|62873997|FG000|Overall Study|Lost to Follow-up|1|||
33495379|NCT03350256|62873997|FG000|Overall Study|Lack of Efficacy|2|||
33495380|NCT00024167|62874004|FG000|Overall Study|Death|53|||
33495381|NCT00024167|62874005|FG001|Overall Study|Death|47|||
33495382|NCT00022763|62874014|FG000|Overall Study|Adverse Event|1|||
33495383|NCT00022763|62874015|FG001|Overall Study|Adverse Event|2|||
33495384|NCT00022763|62874014|FG000|Overall Study|Injection Site Reactions|0|||
33607582|NCT03558152|63007590|FG004|Overall Study|Mistake in evaluation of disease status|0|||
33607583|NCT03558152|63007591|FG005|Overall Study|Mistake in evaluation of disease status|0|||
33607584|NCT03558152|63007592|FG006|Overall Study|Mistake in evaluation of disease status|0|||
33447095|NCT00090220|62822487|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
33447096|NCT00090220|62822488|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
33607585|NCT03558152|63007593|FG007|Overall Study|Mistake in evaluation of disease status|1|||
33607586|NCT03558152|63007586|FG000|Overall Study|Physician Decision|0|||
33607587|NCT03558152|63007587|FG001|Overall Study|Physician Decision|0|||
33447097|NCT00090220|62822489|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
33447098|NCT00090220|62822490|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
33495385|NCT00022763|62874015|FG001|Overall Study|Injection Site Reactions|2|||
33495386|NCT00022763|62874014|FG000|Overall Study|Death|0|||
33495387|NCT00022763|62874015|FG001|Overall Study|Death|1|||
33495388|NCT00022763|62874014|FG000|Overall Study|Lost to Follow-up|0|||
33495389|NCT00022763|62874015|FG001|Overall Study|Lost to Follow-up|3|||
33495390|NCT00022763|62874014|FG000|Overall Study|Withdrawal by Subject|4|||
33495391|NCT00022763|62874015|FG001|Overall Study|Withdrawal by Subject|7|||
33495392|NCT00022763|62874014|FG000|Overall Study|Insufficient Therapy|1|||
33495393|NCT00022763|62874015|FG001|Overall Study|Insufficient Therapy|0|||
33495394|NCT00022763|62874014|FG000|Overall Study|Admin|3|||
33495395|NCT00022763|62874015|FG001|Overall Study|Admin|2|||
33495396|NCT00071513|62874022|FG000|Intervention Component|Withdrawal by Subject|2|||
33495397|NCT00071513|62874023|FG001|Intervention Component|Withdrawal by Subject|3|||
33495398|NCT00071513|62874022|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
33495399|NCT00071513|62874023|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
33495400|NCT00006389|62874031|FG000|Overall Study|Adverse Event|1|||
33495401|NCT00006305|62874040|FG000|Overall Study|Withdrawal by Subject|17|||
33495402|NCT00006305|62874041|FG001|Overall Study|Withdrawal by Subject|10|||
33495403|NCT00006305|62874042|FG002|Overall Study|Withdrawal by Subject|15|||
33495404|NCT00006305|62874043|FG003|Overall Study|Withdrawal by Subject|14|||
33495405|NCT03529773|62874093|FG000|Overall Study|Adverse Event|0|||
33495406|NCT03529773|62874094|FG001|Overall Study|Adverse Event|0|||
33495407|NCT03529773|62874095|FG002|Overall Study|Adverse Event|0|||
33607588|NCT03558152|63007588|FG002|Overall Study|Physician Decision|0|||
33447099|NCT00090220|62822491|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
33447100|NCT00090220|62822492|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
33447101|NCT00090220|62822487|FG000|Extension 1 (EXT1)|Moved|0|||
33495408|NCT03529773|62874096|FG003|Overall Study|Adverse Event|0|||
33607589|NCT03558152|63007589|FG003|Overall Study|Physician Decision|0|||
33447102|NCT00090220|62822488|FG001|Extension 1 (EXT1)|Moved|0|||
33495409|NCT03529773|62874097|FG004|Overall Study|Adverse Event|0|||
33495410|NCT03529773|62874098|FG005|Overall Study|Adverse Event|0|||
33495411|NCT03529773|62874099|FG006|Overall Study|Adverse Event|0|||
33495412|NCT03529773|62874100|FG007|Overall Study|Adverse Event|0|||
33495413|NCT03529773|62874101|FG008|Overall Study|Adverse Event|0|||
33495414|NCT03529773|62874102|FG009|Overall Study|Adverse Event|0|||
33495415|NCT03529773|62874103|FG010|Overall Study|Adverse Event|0|||
33607590|NCT03558152|63007590|FG004|Overall Study|Physician Decision|0|||
33607591|NCT03558152|63007591|FG005|Overall Study|Physician Decision|0|||
33607592|NCT03558152|63007592|FG006|Overall Study|Physician Decision|1|||
33607593|NCT03558152|63007593|FG007|Overall Study|Physician Decision|0|||
33607594|NCT03558152|63007586|FG000|Overall Study|Withdrawal by Subject|2|||
33607595|NCT03558152|63007587|FG001|Overall Study|Withdrawal by Subject|3|||
33607596|NCT03558152|63007588|FG002|Overall Study|Withdrawal by Subject|2|||
33607597|NCT03558152|63007589|FG003|Overall Study|Withdrawal by Subject|1|||
33607598|NCT03558152|63007590|FG004|Overall Study|Withdrawal by Subject|1|||
33607599|NCT03558152|63007591|FG005|Overall Study|Withdrawal by Subject|1|||
33607600|NCT03558152|63007592|FG006|Overall Study|Withdrawal by Subject|3|||
33607601|NCT03558152|63007593|FG007|Overall Study|Withdrawal by Subject|2|||
33607602|NCT03558152|63007586|FG000|Overall Study|Lack of Efficacy|11|||
33607603|NCT03558152|63007587|FG001|Overall Study|Lack of Efficacy|11|||
33607604|NCT03558152|63007588|FG002|Overall Study|Lack of Efficacy|10|||
33607605|NCT03558152|63007589|FG003|Overall Study|Lack of Efficacy|11|||
33607606|NCT03558152|63007590|FG004|Overall Study|Lack of Efficacy|14|||
33607607|NCT03558152|63007591|FG005|Overall Study|Lack of Efficacy|12|||
33607608|NCT03558152|63007592|FG006|Overall Study|Lack of Efficacy|14|||
33607609|NCT03558152|63007593|FG007|Overall Study|Lack of Efficacy|13|||
33607610|NCT03558152|63007586|FG000|Overall Study|Protocol Violation|1|||
33607611|NCT03558152|63007587|FG001|Overall Study|Protocol Violation|1|||
33607612|NCT03558152|63007588|FG002|Overall Study|Protocol Violation|0|||
33607613|NCT03558152|63007589|FG003|Overall Study|Protocol Violation|1|||
33607614|NCT03558152|63007590|FG004|Overall Study|Protocol Violation|1|||
33323879|NCT01122264|62700300|FG001|Overall Study|Entry Criteria Not Met|0|||
33323880|NCT01122264|62700301|FG002|Overall Study|Entry Criteria Not Met|0|||
33323881|NCT01122264|62700299|FG000|Overall Study|Protocol Violation|7|||
33323882|NCT01122264|62700300|FG001|Overall Study|Protocol Violation|7|||
33323883|NCT01122264|62700301|FG002|Overall Study|Protocol Violation|9|||
33323884|NCT01122264|62700299|FG000|Overall Study|Withdrawal by Subject|6|||
33323885|NCT01122264|62700300|FG001|Overall Study|Withdrawal by Subject|6|||
33323886|NCT01122264|62700301|FG002|Overall Study|Withdrawal by Subject|16|||
33323887|NCT01122264|62700299|FG000|Overall Study|Physician Decision|3|||
33323888|NCT01122264|62700300|FG001|Overall Study|Physician Decision|1|||
33323889|NCT01122264|62700301|FG002|Overall Study|Physician Decision|1|||
33323890|NCT01122264|62700299|FG000|Overall Study|Lack of Efficacy|3|||
33447103|NCT00090220|62822489|FG002|Extension 1 (EXT1)|Moved|2|||
33447104|NCT00090220|62822490|FG003|Extension 1 (EXT1)|Moved|1|||
33447105|NCT00090220|62822491|FG004|Extension 1 (EXT1)|Moved|0|||
33447106|NCT00090220|62822492|FG005|Extension 1 (EXT1)|Moved|0|||
33447107|NCT00090220|62822487|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
33447108|NCT00090220|62822488|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
33495416|NCT03529773|62874104|FG011|Overall Study|Adverse Event|0|||
33495417|NCT03529773|62874105|FG012|Overall Study|Adverse Event|0|||
33495418|NCT03529773|62874106|FG013|Overall Study|Adverse Event|0|||
33495419|NCT03529773|62874107|FG014|Overall Study|Adverse Event|0|||
33495420|NCT03529773|62874108|FG015|Overall Study|Adverse Event|0|||
33495421|NCT03529773|62874109|FG016|Overall Study|Adverse Event|0|||
33495422|NCT03529773|62874110|FG017|Overall Study|Adverse Event|0|||
33495423|NCT03529773|62874111|FG018|Overall Study|Adverse Event|0|||
33447109|NCT00090220|62822489|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
33447110|NCT00090220|62822490|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
33447111|NCT00090220|62822491|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
33495424|NCT03529773|62874112|FG019|Overall Study|Adverse Event|0|||
33495425|NCT03529773|62874113|FG020|Overall Study|Adverse Event|0|||
33495426|NCT03529773|62874114|FG021|Overall Study|Adverse Event|0|||
33495427|NCT03529773|62874115|FG022|Overall Study|Adverse Event|0|||
33495428|NCT03529773|62874116|FG023|Overall Study|Adverse Event|0|||
33495429|NCT03529773|62874117|FG024|Overall Study|Adverse Event|0|||
33495430|NCT03529773|62874118|FG025|Overall Study|Adverse Event|0|||
33323891|NCT01122264|62700300|FG001|Overall Study|Lack of Efficacy|1|||
33323892|NCT01122264|62700301|FG002|Overall Study|Lack of Efficacy|1|||
33323893|NCT00920218|62700317|FG000|Overall Study|Serious Adverse Event|2|||
33323894|NCT00920218|62700318|FG001|Overall Study|Serious Adverse Event|0|||
33323895|NCT00920218|62700319|FG002|Overall Study|Serious Adverse Event|2|||
33323896|NCT00920218|62700320|FG003|Overall Study|Serious Adverse Event|1|||
33323897|NCT00920218|62700317|FG000|Overall Study|Withdrawal by Subject|0|||
33323898|NCT00920218|62700318|FG001|Overall Study|Withdrawal by Subject|3|||
33447112|NCT00090220|62822492|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
33447113|NCT00090220|62822487|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
33495431|NCT03529773|62874119|FG026|Overall Study|Adverse Event|0|||
33495432|NCT03529773|62874120|FG027|Overall Study|Adverse Event|0|||
33495433|NCT03529773|62874121|FG028|Overall Study|Adverse Event|0|||
33495434|NCT03529773|62874122|FG029|Overall Study|Adverse Event|0|||
33495435|NCT03529773|62874123|FG030|Overall Study|Adverse Event|1|||
33607615|NCT03558152|63007591|FG005|Overall Study|Protocol Violation|0|||
33607616|NCT03558152|63007592|FG006|Overall Study|Protocol Violation|2|||
33607617|NCT03558152|63007593|FG007|Overall Study|Protocol Violation|0|||
33607618|NCT03461406|63007633|FG000|Overall Study|Death|1|||
33447114|NCT00090220|62822488|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
33447115|NCT00090220|62822489|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
33495436|NCT03529773|62874124|FG031|Overall Study|Adverse Event|0|||
33495437|NCT03529773|62874125|FG032|Overall Study|Adverse Event|0|||
33495438|NCT03529773|62874126|FG033|Overall Study|Adverse Event|0|||
33607619|NCT03461406|63007634|FG001|Overall Study|Death|2|||
33607620|NCT03461406|63007633|FG000|Overall Study|Consent Withdrawn by Participant|0|||
33607621|NCT03461406|63007634|FG001|Overall Study|Consent Withdrawn by Participant|1|||
33607622|NCT03461406|63007633|FG000|Overall Study|Screen Failure|3|||
33607623|NCT03461406|63007634|FG001|Overall Study|Screen Failure|1|||
33607624|NCT03461406|63007633|FG000|Overall Study|Reason not Specified|1|||
33607625|NCT03461406|63007634|FG001|Overall Study|Reason not Specified|3|||
33607626|NCT03461406|63007633|FG000|Overall Study|Lost to Follow-up|3|||
33607627|NCT03461406|63007634|FG001|Overall Study|Lost to Follow-up|0|||
33607628|NCT03408899|63007649|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
33495439|NCT03529773|62874127|FG034|Overall Study|Adverse Event|0|||
33495440|NCT03529773|62874128|FG035|Overall Study|Adverse Event|1|||
33495441|NCT03529773|62874129|FG036|Overall Study|Adverse Event|0|||
33495442|NCT03529773|62874130|FG037|Overall Study|Adverse Event|0|||
33495443|NCT03529773|62874131|FG038|Overall Study|Adverse Event|1|||
33495444|NCT03529773|62874132|FG039|Overall Study|Adverse Event|1|||
33495445|NCT03529773|62874093|FG000|Overall Study|Death|0|||
33495446|NCT03529773|62874094|FG001|Overall Study|Death|0|||
33495447|NCT03529773|62874095|FG002|Overall Study|Death|0|||
33495448|NCT03529773|62874096|FG003|Overall Study|Death|0|||
33607629|NCT02528643|63007670|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
33447116|NCT00090220|62822490|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
33447117|NCT00090220|62822491|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
33607630|NCT02528643|63007671|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
33607631|NCT02528643|63007670|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
33607632|NCT02528643|63007671|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
33607633|NCT02528643|63007670|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
33607634|NCT02528643|63007671|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
33607635|NCT02528643|63007670|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
33607636|NCT02528643|63007671|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
33607637|NCT02528643|63007670|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
33607638|NCT02528643|63007671|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
33607639|NCT02528643|63007670|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
33607640|NCT02528643|63007671|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
33607641|NCT02528643|63007670|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
33607642|NCT02528643|63007671|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
33607643|NCT02175680|63007701|FG000|Overall Study|non-compliance|1|||
33607644|NCT02175680|63007701|FG000|Overall Study|other non-medical reason|1|||
33607645|NCT01983462|63007715|FG000|Overall Study|Adverse Event|1|||
33607646|NCT01983462|63007716|FG001|Overall Study|Adverse Event|0|||
33607647|NCT01983462|63007717|FG002|Overall Study|Adverse Event|0|||
33607648|NCT01559935|63007748|FG000|Car Phase|Toxicity|4|||
33607649|NCT01559935|63007748|FG000|Car Phase|Death|1|||
33607650|NCT01559935|63007748|FG000|Car Phase|Lack of Efficacy|2|||
33607651|NCT01559935|63007748|FG000|Car Phase|Lost to Follow-up|1|||
33607652|NCT01559935|63007748|FG000|Car Phase|Physician Decision|1|||
33607653|NCT01559935|63007748|FG000|Car Phase|Withdrawal by Subject|2|||
33607654|NCT01559935|63007748|FG000|Car Phase|Per protocol|1|||
33607655|NCT01559935|63007748|FG000|Car Phase|Insurance|1|||
33607656|NCT01559935|63007748|FG000|Car Phase|non-compliance|1|||
33447118|NCT00090220|62822492|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
33447119|NCT00090220|62822487|FG000|Extension 1 (EXT1)|Other reason|0|||
33447120|NCT00090220|62822488|FG001|Extension 1 (EXT1)|Other reason|0|||
33447121|NCT00090220|62822489|FG002|Extension 1 (EXT1)|Other reason|2|||
33447122|NCT00090220|62822490|FG003|Extension 1 (EXT1)|Other reason|0|||
33447123|NCT00090220|62822491|FG004|Extension 1 (EXT1)|Other reason|0|||
33447124|NCT00090220|62822492|FG005|Extension 1 (EXT1)|Other reason|0|||
33447125|NCT00090220|62822487|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33447126|NCT00090220|62822488|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33447127|NCT00090220|62822489|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33447128|NCT00090220|62822490|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33447129|NCT00090220|62822491|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
33607657|NCT01559935|63007748|FG000|BiRD Phase|Toxicity|1|||
33607658|NCT01559935|63007748|FG000|BiRD Phase|Lack of Efficacy|1|||
33607659|NCT01559935|63007748|FG000|BiRD Phase|Withdrawal by Subject|2|||
33447130|NCT00090220|62822492|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
33447131|NCT00090220|62822487|FG000|Long-term Follow-up (EXT2)|Death|0|||
33495449|NCT03529773|62874097|FG004|Overall Study|Death|0|||
33495450|NCT03529773|62874098|FG005|Overall Study|Death|0|||
33447132|NCT00090220|62822488|FG001|Long-term Follow-up (EXT2)|Death|0|||
33607660|NCT01559935|63007748|FG000|Maintenance Phase|Remains on study|28|||
33607661|NCT01559935|63007748|FG000|Maintenance Phase|Toxicity|1|||
33607662|NCT01559935|63007748|FG000|Maintenance Phase|Lack of Efficacy|18|||
33607663|NCT01559935|63007748|FG000|Maintenance Phase|Withdrawal by Subject|5|||
33607664|NCT01559935|63007748|FG000|Maintenance Phase|Non-compliance|2|||
33607665|NCT00981058|63007754|FG000|Overall Study|Adverse Event|1|||
33607666|NCT00981058|63007755|FG001|Overall Study|Adverse Event|1|||
33607667|NCT00981058|63007754|FG000|Overall Study|Progressive Disease|61|||
33607668|NCT00981058|63007755|FG001|Overall Study|Progressive Disease|49|||
33607669|NCT00981058|63007754|FG000|Overall Study|Lost to Follow-up|16|||
33607670|NCT00981058|63007755|FG001|Overall Study|Lost to Follow-up|15|||
33607671|NCT00981058|63007754|FG000|Overall Study|New Anticancer Therapy|6|||
33607672|NCT00981058|63007755|FG001|Overall Study|New Anticancer Therapy|6|||
33607673|NCT00981058|63007754|FG000|Overall Study|Noncompliance|1|||
33607674|NCT00981058|63007755|FG001|Overall Study|Noncompliance|0|||
33607675|NCT00981058|63007754|FG000|Overall Study|Radiologist Error|0|||
33607676|NCT00981058|63007755|FG001|Overall Study|Radiologist Error|1|||
33607677|NCT00981058|63007754|FG000|Overall Study|Randomization Error|1|||
33607678|NCT00981058|63007755|FG001|Overall Study|Randomization Error|2|||
33607679|NCT00981058|63007754|FG000|Overall Study|Withdrawal by Subject|25|||
33607680|NCT00981058|63007755|FG001|Overall Study|Withdrawal by Subject|23|||
33607681|NCT00981058|63007754|FG000|Overall Study|On study treatment at conclusion|9|||
33607682|NCT00981058|63007755|FG001|Overall Study|On study treatment at conclusion|0|||
33607683|NCT00565851|63007769|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
33607684|NCT00565851|63007770|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
33607685|NCT00565851|63007771|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
33607686|NCT00565851|63007772|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
33607687|NCT00565851|63007773|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
33607688|NCT00565851|63007774|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
33607689|NCT00565851|63007775|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
33607690|NCT00565851|63007776|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
33607691|NCT00565851|63007769|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
33607692|NCT00565851|63007770|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
33607693|NCT00565851|63007771|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
33607694|NCT00565851|63007772|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
33607695|NCT00565851|63007773|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
33607696|NCT00565851|63007774|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
33607697|NCT00565851|63007775|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
33607698|NCT00565851|63007776|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
33447133|NCT00090220|62822489|FG002|Long-term Follow-up (EXT2)|Death|0|||
33495451|NCT03529773|62874099|FG006|Overall Study|Death|0|||
33495452|NCT03529773|62874100|FG007|Overall Study|Death|0|||
33495453|NCT03529773|62874101|FG008|Overall Study|Death|0|||
33495454|NCT03529773|62874102|FG009|Overall Study|Death|0|||
33495455|NCT03529773|62874103|FG010|Overall Study|Death|0|||
33495456|NCT03529773|62874104|FG011|Overall Study|Death|0|||
33495457|NCT03529773|62874105|FG012|Overall Study|Death|1|||
33495458|NCT03529773|62874106|FG013|Overall Study|Death|0|||
33495459|NCT03529773|62874107|FG014|Overall Study|Death|0|||
33495460|NCT03529773|62874108|FG015|Overall Study|Death|0|||
33495461|NCT03529773|62874109|FG016|Overall Study|Death|0|||
33495462|NCT03529773|62874110|FG017|Overall Study|Death|0|||
33495463|NCT03529773|62874111|FG018|Overall Study|Death|0|||
33495464|NCT03529773|62874112|FG019|Overall Study|Death|1|||
33495465|NCT03529773|62874113|FG020|Overall Study|Death|0|||
33495466|NCT03529773|62874114|FG021|Overall Study|Death|0|||
33495467|NCT03529773|62874115|FG022|Overall Study|Death|1|||
33495468|NCT03529773|62874116|FG023|Overall Study|Death|0|||
33495469|NCT03529773|62874117|FG024|Overall Study|Death|0|||
33495470|NCT03529773|62874118|FG025|Overall Study|Death|0|||
33495471|NCT03529773|62874119|FG026|Overall Study|Death|0|||
33495472|NCT03529773|62874120|FG027|Overall Study|Death|0|||
33495473|NCT03529773|62874121|FG028|Overall Study|Death|0|||
33495474|NCT03529773|62874122|FG029|Overall Study|Death|0|||
33495475|NCT03529773|62874123|FG030|Overall Study|Death|0|||
33495476|NCT03529773|62874124|FG031|Overall Study|Death|0|||
33495477|NCT03529773|62874125|FG032|Overall Study|Death|0|||
33495478|NCT03529773|62874126|FG033|Overall Study|Death|1|||
33495479|NCT03529773|62874127|FG034|Overall Study|Death|1|||
33495480|NCT03529773|62874128|FG035|Overall Study|Death|0|||
33495481|NCT03529773|62874129|FG036|Overall Study|Death|1|||
33495482|NCT03529773|62874130|FG037|Overall Study|Death|0|||
33495483|NCT03529773|62874131|FG038|Overall Study|Death|0|||
33495484|NCT03529773|62874132|FG039|Overall Study|Death|0|||
33495485|NCT03529773|62874093|FG000|Overall Study|Lost to Follow-up|0|||
33495486|NCT03529773|62874094|FG001|Overall Study|Lost to Follow-up|0|||
33495487|NCT03529773|62874095|FG002|Overall Study|Lost to Follow-up|1|||
33495488|NCT03529773|62874096|FG003|Overall Study|Lost to Follow-up|0|||
33495489|NCT03529773|62874097|FG004|Overall Study|Lost to Follow-up|1|||
33447134|NCT00090220|62822490|FG003|Long-term Follow-up (EXT2)|Death|0|||
33447135|NCT00090220|62822491|FG004|Long-term Follow-up (EXT2)|Death|1|||
33447136|NCT00090220|62822492|FG005|Long-term Follow-up (EXT2)|Death|1|||
33447137|NCT00090220|62822487|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33447138|NCT00090220|62822488|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33447139|NCT00090220|62822489|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33447140|NCT00090220|62822490|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33447141|NCT00090220|62822491|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
33447142|NCT00090220|62822492|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
33447143|NCT00090220|62822487|FG000|Long-term Follow-up (EXT2)|Other|0|||
33447144|NCT00090220|62822488|FG001|Long-term Follow-up (EXT2)|Other|0|||
33447145|NCT00090220|62822489|FG002|Long-term Follow-up (EXT2)|Other|0|||
33447146|NCT00090220|62822490|FG003|Long-term Follow-up (EXT2)|Other|0|||
33447147|NCT00090220|62822491|FG004|Long-term Follow-up (EXT2)|Other|1|||
33447148|NCT00090220|62822492|FG005|Long-term Follow-up (EXT2)|Other|0|||
33447149|NCT00263328|62822512|FG000|Overall Study|Death|0|||
33447150|NCT00263328|62822513|FG001|Overall Study|Death|0|||
33447151|NCT00263328|62822514|FG002|Overall Study|Death|1|||
33447152|NCT00263328|62822512|FG000|Overall Study|Lost to Follow-up|1|||
33447153|NCT00263328|62822513|FG001|Overall Study|Lost to Follow-up|1|||
33447154|NCT00263328|62822514|FG002|Overall Study|Lost to Follow-up|0|||
33447155|NCT00263328|62822512|FG000|Overall Study|Withdrawal by Subject|3|||
33447156|NCT00263328|62822513|FG001|Overall Study|Withdrawal by Subject|0|||
33447157|NCT00263328|62822514|FG002|Overall Study|Withdrawal by Subject|1|||
33447158|NCT00263328|62822512|FG000|Overall Study|Other|3|||
33447159|NCT00263328|62822513|FG001|Overall Study|Other|0|||
33495490|NCT03529773|62874098|FG005|Overall Study|Lost to Follow-up|1|||
33495491|NCT03529773|62874099|FG006|Overall Study|Lost to Follow-up|0|||
33495492|NCT03529773|62874100|FG007|Overall Study|Lost to Follow-up|0|||
33495493|NCT03529773|62874101|FG008|Overall Study|Lost to Follow-up|0|||
33495494|NCT03529773|62874102|FG009|Overall Study|Lost to Follow-up|0|||
33495495|NCT03529773|62874103|FG010|Overall Study|Lost to Follow-up|0|||
33495496|NCT03529773|62874104|FG011|Overall Study|Lost to Follow-up|0|||
33495497|NCT03529773|62874105|FG012|Overall Study|Lost to Follow-up|0|||
33447160|NCT00263328|62822514|FG002|Overall Study|Other|1|||
33447161|NCT00263328|62822512|FG000|Overall Study|Adverse Event|1|||
33447162|NCT00263328|62822513|FG001|Overall Study|Adverse Event|1|||
33495498|NCT03529773|62874106|FG013|Overall Study|Lost to Follow-up|1|||
33495499|NCT03529773|62874107|FG014|Overall Study|Lost to Follow-up|4|||
33495500|NCT03529773|62874108|FG015|Overall Study|Lost to Follow-up|1|||
33495501|NCT03529773|62874109|FG016|Overall Study|Lost to Follow-up|1|||
33495502|NCT03529773|62874110|FG017|Overall Study|Lost to Follow-up|0|||
33495503|NCT03529773|62874111|FG018|Overall Study|Lost to Follow-up|1|||
33495504|NCT03529773|62874112|FG019|Overall Study|Lost to Follow-up|1|||
33495505|NCT03529773|62874113|FG020|Overall Study|Lost to Follow-up|2|||
33495506|NCT03529773|62874114|FG021|Overall Study|Lost to Follow-up|4|||
33495507|NCT03529773|62874115|FG022|Overall Study|Lost to Follow-up|3|||
33495508|NCT03529773|62874116|FG023|Overall Study|Lost to Follow-up|4|||
33495509|NCT03529773|62874117|FG024|Overall Study|Lost to Follow-up|3|||
33495510|NCT03529773|62874118|FG025|Overall Study|Lost to Follow-up|5|||
33495511|NCT03529773|62874119|FG026|Overall Study|Lost to Follow-up|5|||
33447163|NCT00263328|62822514|FG002|Overall Study|Adverse Event|4|||
33447164|NCT00262860|62822524|FG000|Overall Study|Adverse Event|2|||
33447165|NCT00236184|62822530|FG000|Overall Study|Adverse Event|5|||
33447166|NCT00236184|62822531|FG001|Overall Study|Adverse Event|2|||
33447167|NCT00236184|62822530|FG000|Overall Study|Lack of Efficacy|0|||
33447168|NCT00236184|62822531|FG001|Overall Study|Lack of Efficacy|1|||
33447169|NCT00236184|62822530|FG000|Overall Study|Lost to Follow-up|3|||
33447170|NCT00236184|62822531|FG001|Overall Study|Lost to Follow-up|4|||
33447171|NCT00236184|62822530|FG000|Overall Study|Physician Decision|1|||
33447172|NCT00236184|62822531|FG001|Overall Study|Physician Decision|1|||
33447173|NCT00236184|62822530|FG000|Overall Study|Withdrawal by Subject|3|||
33447174|NCT00236184|62822531|FG001|Overall Study|Withdrawal by Subject|0|||
33447175|NCT00236184|62822530|FG000|Overall Study|Protocol Violation|3|||
33447176|NCT00236184|62822531|FG001|Overall Study|Protocol Violation|0|||
33447177|NCT00236184|62822530|FG000|Overall Study|non-compliance with study drug|2|||
33447178|NCT00236184|62822531|FG001|Overall Study|non-compliance with study drug|1|||
33495512|NCT03529773|62874120|FG027|Overall Study|Lost to Follow-up|0|||
33495513|NCT03529773|62874121|FG028|Overall Study|Lost to Follow-up|0|||
33495514|NCT03529773|62874122|FG029|Overall Study|Lost to Follow-up|0|||
33495515|NCT03529773|62874123|FG030|Overall Study|Lost to Follow-up|1|||
33495516|NCT03529773|62874124|FG031|Overall Study|Lost to Follow-up|0|||
33495517|NCT03529773|62874125|FG032|Overall Study|Lost to Follow-up|0|||
33495518|NCT03529773|62874126|FG033|Overall Study|Lost to Follow-up|1|||
33495519|NCT03529773|62874127|FG034|Overall Study|Lost to Follow-up|1|||
33495520|NCT03529773|62874128|FG035|Overall Study|Lost to Follow-up|0|||
33495521|NCT03529773|62874129|FG036|Overall Study|Lost to Follow-up|0|||
33495522|NCT03529773|62874130|FG037|Overall Study|Lost to Follow-up|3|||
33495523|NCT03529773|62874131|FG038|Overall Study|Lost to Follow-up|1|||
33495524|NCT03529773|62874132|FG039|Overall Study|Lost to Follow-up|1|||
33495525|NCT03529773|62874093|FG000|Overall Study|No longer meets eligibility criteria|0|||
33495526|NCT03529773|62874094|FG001|Overall Study|No longer meets eligibility criteria|0|||
33495527|NCT03529773|62874095|FG002|Overall Study|No longer meets eligibility criteria|0|||
33495528|NCT03529773|62874096|FG003|Overall Study|No longer meets eligibility criteria|0|||
33495529|NCT03529773|62874097|FG004|Overall Study|No longer meets eligibility criteria|0|||
33495530|NCT03529773|62874098|FG005|Overall Study|No longer meets eligibility criteria|0|||
33447179|NCT00236184|62822530|FG000|Overall Study|other|1|||
33447180|NCT00236184|62822531|FG001|Overall Study|other|2|||
33447181|NCT00296504|62822545|FG000|Interim Analysis|Withdrawal by Subject|8|||
33447182|NCT00296504|62822546|FG001|Interim Analysis|Withdrawal by Subject|0|||
33447183|NCT00296504|62822547|FG002|Interim Analysis|Withdrawal by Subject|12|||
33447184|NCT00296504|62822548|FG003|Interim Analysis|Withdrawal by Subject|0|||
33447185|NCT00296504|62822549|FG004|Interim Analysis|Withdrawal by Subject|5|||
33447186|NCT00296504|62822550|FG005|Interim Analysis|Withdrawal by Subject|5|||
33495531|NCT03529773|62874099|FG006|Overall Study|No longer meets eligibility criteria|0|||
33495532|NCT03529773|62874100|FG007|Overall Study|No longer meets eligibility criteria|0|||
33495533|NCT03529773|62874101|FG008|Overall Study|No longer meets eligibility criteria|0|||
33495534|NCT03529773|62874102|FG009|Overall Study|No longer meets eligibility criteria|0|||
33495535|NCT03529773|62874103|FG010|Overall Study|No longer meets eligibility criteria|0|||
33495536|NCT03529773|62874104|FG011|Overall Study|No longer meets eligibility criteria|0|||
33495537|NCT03529773|62874105|FG012|Overall Study|No longer meets eligibility criteria|0|||
33495538|NCT03529773|62874106|FG013|Overall Study|No longer meets eligibility criteria|0|||
33495539|NCT03529773|62874107|FG014|Overall Study|No longer meets eligibility criteria|0|||
33495540|NCT03529773|62874108|FG015|Overall Study|No longer meets eligibility criteria|0|||
33495541|NCT03529773|62874109|FG016|Overall Study|No longer meets eligibility criteria|0|||
33495542|NCT03529773|62874110|FG017|Overall Study|No longer meets eligibility criteria|0|||
33495543|NCT03529773|62874111|FG018|Overall Study|No longer meets eligibility criteria|0|||
33495544|NCT03529773|62874112|FG019|Overall Study|No longer meets eligibility criteria|0|||
33495545|NCT03529773|62874113|FG020|Overall Study|No longer meets eligibility criteria|0|||
33495546|NCT03529773|62874114|FG021|Overall Study|No longer meets eligibility criteria|0|||
33447187|NCT00296504|62822551|FG006|Interim Analysis|Withdrawal by Subject|9|||
33447188|NCT00296504|62822552|FG007|Interim Analysis|Withdrawal by Subject|3|||
33447189|NCT00296504|62822553|FG008|Interim Analysis|Withdrawal by Subject|0|||
33447190|NCT00296504|62822545|FG000|Interim Analysis|Lost to Follow-up|13|||
33495547|NCT03529773|62874115|FG022|Overall Study|No longer meets eligibility criteria|1|||
33495548|NCT03529773|62874116|FG023|Overall Study|No longer meets eligibility criteria|0|||
33495549|NCT03529773|62874117|FG024|Overall Study|No longer meets eligibility criteria|0|||
33495550|NCT03529773|62874118|FG025|Overall Study|No longer meets eligibility criteria|0|||
33495551|NCT03529773|62874119|FG026|Overall Study|No longer meets eligibility criteria|0|||
33495552|NCT03529773|62874120|FG027|Overall Study|No longer meets eligibility criteria|0|||
33495553|NCT03529773|62874121|FG028|Overall Study|No longer meets eligibility criteria|0|||
33495554|NCT03529773|62874122|FG029|Overall Study|No longer meets eligibility criteria|0|||
33495555|NCT03529773|62874123|FG030|Overall Study|No longer meets eligibility criteria|0|||
33495556|NCT03529773|62874124|FG031|Overall Study|No longer meets eligibility criteria|0|||
33495557|NCT03529773|62874125|FG032|Overall Study|No longer meets eligibility criteria|0|||
33495558|NCT03529773|62874126|FG033|Overall Study|No longer meets eligibility criteria|0|||
33495559|NCT03529773|62874127|FG034|Overall Study|No longer meets eligibility criteria|0|||
33495560|NCT03529773|62874128|FG035|Overall Study|No longer meets eligibility criteria|0|||
33447191|NCT00296504|62822546|FG001|Interim Analysis|Lost to Follow-up|3|||
33447192|NCT00296504|62822547|FG002|Interim Analysis|Lost to Follow-up|26|||
33447193|NCT00296504|62822548|FG003|Interim Analysis|Lost to Follow-up|8|||
33447194|NCT00296504|62822549|FG004|Interim Analysis|Lost to Follow-up|14|||
33447195|NCT00296504|62822550|FG005|Interim Analysis|Lost to Follow-up|4|||
33447196|NCT00296504|62822551|FG006|Interim Analysis|Lost to Follow-up|11|||
33495561|NCT03529773|62874129|FG036|Overall Study|No longer meets eligibility criteria|0|||
33495562|NCT03529773|62874130|FG037|Overall Study|No longer meets eligibility criteria|0|||
33495563|NCT03529773|62874131|FG038|Overall Study|No longer meets eligibility criteria|1|||
33495564|NCT03529773|62874132|FG039|Overall Study|No longer meets eligibility criteria|0|||
33447197|NCT00296504|62822552|FG007|Interim Analysis|Lost to Follow-up|4|||
33447198|NCT00296504|62822553|FG008|Interim Analysis|Lost to Follow-up|0|||
33447199|NCT00296504|62822545|FG000|Interim Analysis|Clinical Progression|1|||
33447200|NCT00296504|62822546|FG001|Interim Analysis|Clinical Progression|0|||
33495565|NCT03529773|62874093|FG000|Overall Study|Other|0|||
33495566|NCT03529773|62874094|FG001|Overall Study|Other|0|||
33495567|NCT03529773|62874095|FG002|Overall Study|Other|0|||
33495568|NCT03529773|62874096|FG003|Overall Study|Other|0|||
33495569|NCT03529773|62874097|FG004|Overall Study|Other|0|||
33495570|NCT03529773|62874098|FG005|Overall Study|Other|0|||
33495571|NCT03529773|62874099|FG006|Overall Study|Other|0|||
33607699|NCT00305227|63007800|FG000|Overall Study|Lost to Follow-up|7|||
33607700|NCT00305227|63007801|FG001|Overall Study|Lost to Follow-up|6|||
33607701|NCT01599793|63007809|FG000|Overall Study|Adverse Event|2|||
33607702|NCT01755598|63007824|FG000|Overall Study|Other|109|||
33607703|NCT01755598|63007825|FG001|Overall Study|Other|109|||
33607704|NCT01755598|63007824|FG000|Overall Study|Lost to Follow-up|32|||
33607705|NCT01755598|63007825|FG001|Overall Study|Lost to Follow-up|43|||
33607706|NCT01755598|63007824|FG000|Overall Study|Migrated/moved from study area|76|||
33607707|NCT01755598|63007825|FG001|Overall Study|Migrated/moved from study area|65|||
33607708|NCT01755598|63007824|FG000|Overall Study|Withdrawal by Subject|22|||
33607709|NCT01755598|63007825|FG001|Overall Study|Withdrawal by Subject|31|||
33607710|NCT01755598|63007824|FG000|Overall Study|Protocol Violation|7|||
33607711|NCT01755598|63007825|FG001|Overall Study|Protocol Violation|7|||
33607712|NCT01755598|63007824|FG000|Overall Study|Adverse Event|19|||
33607713|NCT01755598|63007825|FG001|Overall Study|Adverse Event|28|||
33607714|NCT01606306|63007837|FG000|Overall Study|Lack of Efficacy|2|||
33607715|NCT01606306|63007838|FG001|Overall Study|Lack of Efficacy|1|||
33607716|NCT01606306|63007839|FG002|Overall Study|Lack of Efficacy|4|||
33607717|NCT01606306|63007840|FG003|Overall Study|Lack of Efficacy|4|||
33607718|NCT01606306|63007841|FG004|Overall Study|Lack of Efficacy|1|||
33607719|NCT01606306|63007842|FG005|Overall Study|Lack of Efficacy|2|||
33447201|NCT00296504|62822547|FG002|Interim Analysis|Clinical Progression|1|||
33447202|NCT00296504|62822548|FG003|Interim Analysis|Clinical Progression|1|||
33447203|NCT00296504|62822549|FG004|Interim Analysis|Clinical Progression|0|||
33495572|NCT03529773|62874100|FG007|Overall Study|Other|0|||
33495573|NCT03529773|62874101|FG008|Overall Study|Other|0|||
33495574|NCT03529773|62874102|FG009|Overall Study|Other|0|||
33495575|NCT03529773|62874103|FG010|Overall Study|Other|0|||
33495576|NCT03529773|62874104|FG011|Overall Study|Other|0|||
33495577|NCT03529773|62874105|FG012|Overall Study|Other|1|||
33607720|NCT01606306|63007837|FG000|Overall Study|Adverse Event|1|||
33607721|NCT01606306|63007838|FG001|Overall Study|Adverse Event|0|||
33607722|NCT01606306|63007839|FG002|Overall Study|Adverse Event|1|||
33607723|NCT01606306|63007840|FG003|Overall Study|Adverse Event|1|||
33607724|NCT01606306|63007841|FG004|Overall Study|Adverse Event|2|||
33607725|NCT01606306|63007842|FG005|Overall Study|Adverse Event|0|||
33495578|NCT03529773|62874106|FG013|Overall Study|Other|0|||
33495579|NCT03529773|62874107|FG014|Overall Study|Other|2|||
33495580|NCT03529773|62874108|FG015|Overall Study|Other|0|||
33495581|NCT03529773|62874109|FG016|Overall Study|Other|0|||
33495582|NCT03529773|62874110|FG017|Overall Study|Other|3|||
33495583|NCT03529773|62874111|FG018|Overall Study|Other|0|||
33495584|NCT03529773|62874112|FG019|Overall Study|Other|0|||
33495585|NCT03529773|62874113|FG020|Overall Study|Other|1|||
33607726|NCT01606306|63007837|FG000|Overall Study|Lost to Follow-up|7|||
33607727|NCT01606306|63007838|FG001|Overall Study|Lost to Follow-up|4|||
33607728|NCT01606306|63007839|FG002|Overall Study|Lost to Follow-up|5|||
33607729|NCT01606306|63007840|FG003|Overall Study|Lost to Follow-up|4|||
33607730|NCT01606306|63007841|FG004|Overall Study|Lost to Follow-up|3|||
33607731|NCT01606306|63007842|FG005|Overall Study|Lost to Follow-up|5|||
33607732|NCT01606306|63007837|FG000|Overall Study|Withdrawal by Subject|4|||
33607733|NCT01606306|63007838|FG001|Overall Study|Withdrawal by Subject|3|||
33607734|NCT01606306|63007839|FG002|Overall Study|Withdrawal by Subject|4|||
33607735|NCT01606306|63007840|FG003|Overall Study|Withdrawal by Subject|4|||
33607736|NCT01606306|63007841|FG004|Overall Study|Withdrawal by Subject|5|||
33607737|NCT01606306|63007842|FG005|Overall Study|Withdrawal by Subject|4|||
33607738|NCT01606306|63007837|FG000|Overall Study|Physician Decision|1|||
33607739|NCT01606306|63007838|FG001|Overall Study|Physician Decision|2|||
33607740|NCT01606306|63007839|FG002|Overall Study|Physician Decision|0|||
33607741|NCT01606306|63007840|FG003|Overall Study|Physician Decision|0|||
33607742|NCT01606306|63007841|FG004|Overall Study|Physician Decision|0|||
33607743|NCT01606306|63007842|FG005|Overall Study|Physician Decision|0|||
33607744|NCT01754194|63007850|FG000|Overall Study|Lost to Follow-up|39|||
33607745|NCT01754194|63007851|FG001|Overall Study|Lost to Follow-up|14|||
33607746|NCT01754194|63007850|FG000|Overall Study|Withdrawal by Subject|4|||
33607747|NCT01754194|63007851|FG001|Overall Study|Withdrawal by Subject|5|||
33607748|NCT01754194|63007850|FG000|Overall Study|Other|9|||
33607749|NCT01754194|63007851|FG001|Overall Study|Other|8|||
33607750|NCT01753570|63007862|FG000|Overall Study|Adverse Event|1|||
33607751|NCT01753570|63007863|FG001|Overall Study|Adverse Event|0|||
33607752|NCT01753570|63007864|FG002|Overall Study|Adverse Event|1|||
33607753|NCT01753570|63007862|FG000|Overall Study|Physician Decision|0|||
33607754|NCT01753570|63007863|FG001|Overall Study|Physician Decision|1|||
33607755|NCT01753570|63007864|FG002|Overall Study|Physician Decision|0|||
33447204|NCT00296504|62822550|FG005|Interim Analysis|Clinical Progression|2|||
33447205|NCT00296504|62822551|FG006|Interim Analysis|Clinical Progression|1|||
33447206|NCT00296504|62822552|FG007|Interim Analysis|Clinical Progression|2|||
33447207|NCT00296504|62822553|FG008|Interim Analysis|Clinical Progression|0|||
33447208|NCT00296504|62822545|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
33607756|NCT01753570|63007862|FG000|Overall Study|Withdrawal by Subject|1|||
33607757|NCT01753570|63007863|FG001|Overall Study|Withdrawal by Subject|4|||
33607758|NCT01753570|63007864|FG002|Overall Study|Withdrawal by Subject|0|||
33607759|NCT01753336|63007873|FG000|Overall Study|Patient decision|12|||
33607760|NCT01753336|63007873|FG000|Overall Study|Lost to Follow-up|3|||
33607761|NCT01753336|63007873|FG000|Overall Study|Physician Decision|2|||
33607762|NCT01753336|63007873|FG000|Overall Study|Sponsor's decision|2|||
33607763|NCT01753336|63007873|FG000|Overall Study|Withdrawal by Subject|1|||
33607764|NCT01777282|63007882|FG000|Overall Study|Persistent Hyperglycemia|0|||
33607765|NCT01777282|63007883|FG001|Overall Study|Persistent Hyperglycemia|0|||
33607766|NCT01777282|63007884|FG002|Overall Study|Persistent Hyperglycemia|1|||
33607767|NCT01777282|63007885|FG003|Overall Study|Persistent Hyperglycemia|0|||
33607768|NCT01777282|63007886|FG004|Overall Study|Persistent Hyperglycemia|0|||
33607769|NCT01777282|63007882|FG000|Overall Study|New Antidiabetic Medication|0|||
33447209|NCT00296504|62822546|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
33447210|NCT00296504|62822547|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
33607770|NCT01777282|63007883|FG001|Overall Study|New Antidiabetic Medication|0|||
33607771|NCT01777282|63007884|FG002|Overall Study|New Antidiabetic Medication|1|||
33607772|NCT01777282|63007885|FG003|Overall Study|New Antidiabetic Medication|0|||
33607773|NCT01777282|63007886|FG004|Overall Study|New Antidiabetic Medication|0|||
33607774|NCT01777282|63007882|FG000|Overall Study|Adverse Event|4|||
33607775|NCT01777282|63007883|FG001|Overall Study|Adverse Event|4|||
33607776|NCT01777282|63007884|FG002|Overall Study|Adverse Event|2|||
33607777|NCT01777282|63007885|FG003|Overall Study|Adverse Event|1|||
33607778|NCT01777282|63007886|FG004|Overall Study|Adverse Event|3|||
33607779|NCT01777282|63007882|FG000|Overall Study|Withdrawal by Subject|4|||
33607780|NCT01777282|63007883|FG001|Overall Study|Withdrawal by Subject|0|||
33607781|NCT01777282|63007884|FG002|Overall Study|Withdrawal by Subject|0|||
33607782|NCT01777282|63007885|FG003|Overall Study|Withdrawal by Subject|1|||
33607783|NCT01777282|63007886|FG004|Overall Study|Withdrawal by Subject|2|||
33607784|NCT01777282|63007882|FG000|Overall Study|Protocol Violation|2|||
33607785|NCT01777282|63007883|FG001|Overall Study|Protocol Violation|0|||
33607786|NCT01777282|63007884|FG002|Overall Study|Protocol Violation|1|||
33607787|NCT01777282|63007885|FG003|Overall Study|Protocol Violation|0|||
33607788|NCT01777282|63007886|FG004|Overall Study|Protocol Violation|2|||
33607789|NCT01777282|63007882|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
33607790|NCT01777282|63007883|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
33607791|NCT01777282|63007884|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
33607792|NCT01777282|63007885|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
33607793|NCT01777282|63007886|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
33607794|NCT01975389|63007900|FG000|Overall Study|Adverse Event|10|||
33607795|NCT01975389|63007901|FG001|Overall Study|Adverse Event|6|||
33607796|NCT01975389|63007900|FG000|Overall Study|Death|61|||
33607797|NCT01975389|63007901|FG001|Overall Study|Death|54|||
33607798|NCT01975389|63007900|FG000|Overall Study|Lost to Follow-up|81|||
33607799|NCT01975389|63007901|FG001|Overall Study|Lost to Follow-up|86|||
33607800|NCT01975389|63007900|FG000|Overall Study|Withdrawal by Subject|90|||
33607801|NCT01975389|63007901|FG001|Overall Study|Withdrawal by Subject|76|||
33607802|NCT01975389|63007900|FG000|Overall Study|Other|6|||
33607803|NCT01975389|63007901|FG001|Overall Study|Other|9|||
33607804|NCT01975389|63007900|FG000|Overall Study|Randomized, not treated|4|||
33607805|NCT01975389|63007901|FG001|Overall Study|Randomized, not treated|5|||
33607806|NCT01974141|63007909|FG000|Overall Study|Other Reasons|28|||
33607807|NCT01974141|63007910|FG001|Overall Study|Other Reasons|18|||
33607808|NCT01974141|63007909|FG000|Overall Study|Protocol Violation|2|||
33607809|NCT01974141|63007910|FG001|Overall Study|Protocol Violation|6|||
33607810|NCT01974141|63007909|FG000|Overall Study|Personal Reasons|21|||
33607811|NCT01974141|63007910|FG001|Overall Study|Personal Reasons|20|||
33607812|NCT01974141|63007909|FG000|Overall Study|Lost to Follow-up|38|||
33607813|NCT01974141|63007910|FG001|Overall Study|Lost to Follow-up|29|||
33607814|NCT01974141|63007909|FG000|Overall Study|Pregnancy|3|||
33607815|NCT01974141|63007910|FG001|Overall Study|Pregnancy|3|||
33607816|NCT01974141|63007909|FG000|Overall Study|Lack of Efficacy|0|||
33607817|NCT01974141|63007910|FG001|Overall Study|Lack of Efficacy|1|||
33607818|NCT01974141|63007909|FG000|Overall Study|Adverse Event|4|||
33607819|NCT01974141|63007910|FG001|Overall Study|Adverse Event|5|||
33607820|NCT01945593|63007920|FG000|Overall Study|Adverse Event|0|||
33607821|NCT01945593|63007921|FG001|Overall Study|Adverse Event|0|||
33607822|NCT01945593|63007922|FG002|Overall Study|Adverse Event|0|||
33607823|NCT01945593|63007923|FG003|Overall Study|Adverse Event|5|||
33607824|NCT01945593|63007920|FG000|Overall Study|Physician Decision|0|||
33607825|NCT01945593|63007921|FG001|Overall Study|Physician Decision|0|||
33607826|NCT01945593|63007922|FG002|Overall Study|Physician Decision|1|||
33607827|NCT01945593|63007923|FG003|Overall Study|Physician Decision|1|||
33607828|NCT01945593|63007920|FG000|Overall Study|Withdrawal by Subject|0|||
33607829|NCT01945593|63007921|FG001|Overall Study|Withdrawal by Subject|2|||
33607830|NCT01945593|63007922|FG002|Overall Study|Withdrawal by Subject|0|||
33607831|NCT01945593|63007923|FG003|Overall Study|Withdrawal by Subject|4|||
33607832|NCT01945593|63007920|FG000|Overall Study|Protocol Violation|0|||
33607833|NCT01945593|63007921|FG001|Overall Study|Protocol Violation|2|||
33607834|NCT01945593|63007922|FG002|Overall Study|Protocol Violation|1|||
33607835|NCT01945593|63007923|FG003|Overall Study|Protocol Violation|3|||
33607836|NCT01945593|63007920|FG000|Overall Study|Death|0|||
33607837|NCT01945593|63007921|FG001|Overall Study|Death|0|||
33607838|NCT01945593|63007922|FG002|Overall Study|Death|1|||
33607839|NCT01945593|63007923|FG003|Overall Study|Death|0|||
33607840|NCT01945593|63007920|FG000|Overall Study|Other: Terminated|0|||
33607841|NCT01945593|63007921|FG001|Overall Study|Other: Terminated|0|||
33607842|NCT01945593|63007922|FG002|Overall Study|Other: Terminated|0|||
33607843|NCT01945593|63007923|FG003|Overall Study|Other: Terminated|1|||
33607844|NCT01945593|63007920|FG000|Overall Study|Other: Surgical Procedure|0|||
33607845|NCT01945593|63007921|FG001|Overall Study|Other: Surgical Procedure|2|||
33607846|NCT01945593|63007922|FG002|Overall Study|Other: Surgical Procedure|0|||
33607847|NCT01945593|63007923|FG003|Overall Study|Other: Surgical Procedure|6|||
33607848|NCT01945593|63007920|FG000|Overall Study|Other: Screen Failure|0|||
33607849|NCT01945593|63007921|FG001|Overall Study|Other: Screen Failure|2|||
33607850|NCT01945593|63007922|FG002|Overall Study|Other: Screen Failure|0|||
33607851|NCT01945593|63007923|FG003|Overall Study|Other: Screen Failure|0|||
33607852|NCT01945281|63007940|FG000|Overall Study|Adverse Event|1|||
33607853|NCT01945281|63007941|FG001|Overall Study|Adverse Event|0|||
33607854|NCT01945281|63007940|FG000|Overall Study|Death|3|||
33607855|NCT01945281|63007941|FG001|Overall Study|Death|3|||
33607856|NCT01945281|63007940|FG000|Overall Study|Physician Decision|1|||
33607857|NCT01945281|63007941|FG001|Overall Study|Physician Decision|1|||
33607858|NCT01945281|63007940|FG000|Overall Study|Technical Problems|1|||
33607859|NCT01945281|63007941|FG001|Overall Study|Technical Problems|0|||
33607860|NCT01961349|63007950|FG000|Overall Study|Withdrawal by Subject|1|||
33607861|NCT01961349|63007951|FG001|Overall Study|Withdrawal by Subject|4|||
33607862|NCT01961349|63007952|FG002|Overall Study|Withdrawal by Subject|0|||
33607863|NCT01961349|63007950|FG000|Overall Study|Adverse Event|0|||
33607864|NCT01961349|63007951|FG001|Overall Study|Adverse Event|0|||
33607865|NCT01961349|63007952|FG002|Overall Study|Adverse Event|1|||
33607866|NCT01961349|63007950|FG000|Overall Study|registration error, personal reason etc|2|||
33607867|NCT01961349|63007951|FG001|Overall Study|registration error, personal reason etc|2|||
33607868|NCT01961349|63007952|FG002|Overall Study|registration error, personal reason etc|1|||
33607869|NCT01973595|63007964|FG000|Washout|Withdrawal by Subject|1|||
33607870|NCT01973595|63007965|FG001|Washout|Withdrawal by Subject|0|||
33607871|NCT01973595|63007966|FG002|Washout|Withdrawal by Subject|1|||
33607872|NCT01973595|63007967|FG003|Washout|Withdrawal by Subject|0|||
33607873|NCT01944969|63007978|FG000|Overall Study|Adverse Event|1|||
33607874|NCT01944969|63007978|FG000|Overall Study|Lack of Efficacy|1|||
33607875|NCT01944969|63007978|FG000|Overall Study|Non-compliance with IMP|1|||
33323899|NCT00920218|62700319|FG002|Overall Study|Withdrawal by Subject|2|||
33323900|NCT00920218|62700320|FG003|Overall Study|Withdrawal by Subject|0|||
33323901|NCT00920218|62700317|FG000|Overall Study|Migrated/moved from study area|0|||
33323902|NCT00920218|62700318|FG001|Overall Study|Migrated/moved from study area|0|||
33323903|NCT00920218|62700319|FG002|Overall Study|Migrated/moved from study area|1|||
33323904|NCT00920218|62700320|FG003|Overall Study|Migrated/moved from study area|0|||
33323905|NCT00920218|62700317|FG000|Overall Study|Lost to Follow-up|0|||
33323906|NCT00920218|62700318|FG001|Overall Study|Lost to Follow-up|1|||
33323907|NCT00920218|62700319|FG002|Overall Study|Lost to Follow-up|0|||
33323908|NCT00920218|62700320|FG003|Overall Study|Lost to Follow-up|3|||
33323909|NCT00920218|62700317|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
33323910|NCT00920218|62700318|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
33323911|NCT00920218|62700319|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
33323912|NCT00920218|62700320|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
33323913|NCT00920218|62700317|FG000|Overall Study|Other|0|||
33323914|NCT00920218|62700318|FG001|Overall Study|Other|0|||
33323915|NCT00920218|62700319|FG002|Overall Study|Other|1|||
33323916|NCT00920218|62700320|FG003|Overall Study|Other|0|||
33323917|NCT01121562|62700334|FG000|Overall Study|Objective progression or relapse|8|||
33323918|NCT01121562|62700334|FG000|Overall Study|Withdrawal by Subject|1|||
33323919|NCT01121562|62700334|FG000|Overall Study|Adverse Event|1|||
33323920|NCT01121562|62700334|FG000|Overall Study|Sponsor Decision|1|||
33323921|NCT01121562|62700334|FG000|Overall Study|Met study discontinuation criteria|1|||
33323922|NCT01121484|62700340|FG000|Overall Study|Adverse Event|12|||
33323923|NCT01121484|62700341|FG001|Overall Study|Adverse Event|5|||
33323924|NCT01121484|62700340|FG000|Overall Study|Lack of Efficacy|3|||
33323925|NCT01121484|62700341|FG001|Overall Study|Lack of Efficacy|11|||
33323926|NCT01121484|62700340|FG000|Overall Study|Lost to Follow-up|5|||
33323927|NCT01121484|62700341|FG001|Overall Study|Lost to Follow-up|9|||
33323928|NCT01121484|62700340|FG000|Overall Study|Physician Decision|0|||
33607876|NCT01944969|63007978|FG000|Overall Study|Administrative or other reasons|23|||
33607877|NCT01961115|63007987|FG000|Overall Study|Disease Progression|1|||
33607878|NCT01961115|63007988|FG001|Overall Study|Disease Progression|0|||
33607879|NCT01961115|63007989|FG002|Overall Study|Disease Progression|3|||
33607880|NCT01961115|63007987|FG000|Overall Study|Adverse Event|1|||
33607881|NCT01961115|63007988|FG001|Overall Study|Adverse Event|0|||
33323929|NCT01121484|62700341|FG001|Overall Study|Physician Decision|3|||
33323930|NCT01121484|62700340|FG000|Overall Study|Protocol Violation|1|||
33323931|NCT01121484|62700341|FG001|Overall Study|Protocol Violation|0|||
33323932|NCT01121484|62700340|FG000|Overall Study|Withdrawal by Subject|8|||
33607882|NCT01961115|63007989|FG002|Overall Study|Adverse Event|1|||
33607883|NCT01973439|63007997|FG000|Overall Study|Lost samples from one PK Day|2|||
33607884|NCT01973439|63007997|FG000|Overall Study|Vomiting after commencing once daily|1|||
33607885|NCT01973439|63007997|FG000|Overall Study|PK curve incomplete|2|||
33607886|NCT01973283|63008001|FG000|Overall Study|Lost to Follow-up|4|||
33607887|NCT01943799|63008011|FG000|Overall Study|Lost to Follow-up|0|||
33447211|NCT00296504|62822548|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
33495586|NCT03529773|62874114|FG021|Overall Study|Other|0|||
33495587|NCT03529773|62874115|FG022|Overall Study|Other|1|||
33447212|NCT00296504|62822549|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
33447213|NCT00296504|62822550|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
33447214|NCT00296504|62822551|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
33447215|NCT00296504|62822552|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
33447216|NCT00296504|62822553|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
33447217|NCT00296504|62822545|FG000|Interim Analysis|Adverse Event|0|||
33495588|NCT03529773|62874116|FG023|Overall Study|Other|0|||
33495589|NCT03529773|62874117|FG024|Overall Study|Other|3|||
33495590|NCT03529773|62874118|FG025|Overall Study|Other|2|||
33495591|NCT03529773|62874119|FG026|Overall Study|Other|2|||
33495592|NCT03529773|62874120|FG027|Overall Study|Other|0|||
33495593|NCT03529773|62874121|FG028|Overall Study|Other|0|||
33495594|NCT03529773|62874122|FG029|Overall Study|Other|0|||
33495595|NCT03529773|62874123|FG030|Overall Study|Other|0|||
33495596|NCT03529773|62874124|FG031|Overall Study|Other|0|||
33607888|NCT01943799|63008012|FG001|Overall Study|Lost to Follow-up|1|||
33495597|NCT03529773|62874125|FG032|Overall Study|Other|0|||
33495598|NCT03529773|62874126|FG033|Overall Study|Other|0|||
33495599|NCT03529773|62874127|FG034|Overall Study|Other|1|||
33495600|NCT03529773|62874128|FG035|Overall Study|Other|1|||
33495601|NCT03529773|62874129|FG036|Overall Study|Other|0|||
33495602|NCT03529773|62874130|FG037|Overall Study|Other|0|||
33495603|NCT03529773|62874131|FG038|Overall Study|Other|0|||
33495604|NCT03529773|62874132|FG039|Overall Study|Other|0|||
33495605|NCT03529773|62874093|FG000|Overall Study|Physician Decision|0|||
33495606|NCT03529773|62874094|FG001|Overall Study|Physician Decision|0|||
33495607|NCT03529773|62874095|FG002|Overall Study|Physician Decision|0|||
33495608|NCT03529773|62874096|FG003|Overall Study|Physician Decision|0|||
33495609|NCT03529773|62874097|FG004|Overall Study|Physician Decision|0|||
33495610|NCT03529773|62874098|FG005|Overall Study|Physician Decision|0|||
33495611|NCT03529773|62874099|FG006|Overall Study|Physician Decision|0|||
33495612|NCT03529773|62874100|FG007|Overall Study|Physician Decision|0|||
33495613|NCT03529773|62874101|FG008|Overall Study|Physician Decision|0|||
33495614|NCT03529773|62874102|FG009|Overall Study|Physician Decision|0|||
33495615|NCT03529773|62874103|FG010|Overall Study|Physician Decision|0|||
33495616|NCT03529773|62874104|FG011|Overall Study|Physician Decision|0|||
33607889|NCT01943799|63008013|FG002|Overall Study|Lost to Follow-up|1|||
33607890|NCT01943799|63008014|FG003|Overall Study|Lost to Follow-up|0|||
33607891|NCT01943799|63008011|FG000|Overall Study|Protocol Violation|1|||
33607892|NCT01943799|63008012|FG001|Overall Study|Protocol Violation|0|||
33447218|NCT00296504|62822546|FG001|Interim Analysis|Adverse Event|0|||
33447219|NCT00296504|62822547|FG002|Interim Analysis|Adverse Event|13|||
33447220|NCT00296504|62822548|FG003|Interim Analysis|Adverse Event|4|||
33447221|NCT00296504|62822549|FG004|Interim Analysis|Adverse Event|6|||
33447222|NCT00296504|62822550|FG005|Interim Analysis|Adverse Event|3|||
33447223|NCT00296504|62822551|FG006|Interim Analysis|Adverse Event|4|||
33447224|NCT00296504|62822552|FG007|Interim Analysis|Adverse Event|5|||
33447225|NCT00296504|62822553|FG008|Interim Analysis|Adverse Event|0|||
33447226|NCT00296504|62822545|FG000|Interim Analysis|Protocol Violation|0|||
33447227|NCT00296504|62822546|FG001|Interim Analysis|Protocol Violation|0|||
33495617|NCT03529773|62874105|FG012|Overall Study|Physician Decision|0|||
33447228|NCT00296504|62822547|FG002|Interim Analysis|Protocol Violation|2|||
33495618|NCT03529773|62874106|FG013|Overall Study|Physician Decision|0|||
33495619|NCT03529773|62874107|FG014|Overall Study|Physician Decision|0|||
33495620|NCT03529773|62874108|FG015|Overall Study|Physician Decision|0|||
33495621|NCT03529773|62874109|FG016|Overall Study|Physician Decision|0|||
33495622|NCT03529773|62874110|FG017|Overall Study|Physician Decision|0|||
33607893|NCT01943799|63008013|FG002|Overall Study|Protocol Violation|0|||
33607894|NCT01943799|63008014|FG003|Overall Study|Protocol Violation|0|||
33607895|NCT01943799|63008011|FG000|Overall Study|Withdrawal by Subject|4|||
33607896|NCT01943799|63008012|FG001|Overall Study|Withdrawal by Subject|2|||
33607897|NCT01943799|63008013|FG002|Overall Study|Withdrawal by Subject|1|||
33607898|NCT01943799|63008014|FG003|Overall Study|Withdrawal by Subject|0|||
33607899|NCT01972659|63008026|FG000|Overall Study|Protocol Violation|2|||
33607900|NCT01972659|63008027|FG001|Overall Study|Protocol Violation|2|||
33607901|NCT01972659|63008026|FG000|Overall Study|problems realted to acceleromyograph|2|||
33607902|NCT01972659|63008027|FG001|Overall Study|problems realted to acceleromyograph|1|||
33607903|NCT01971723|63008035|FG000|Overall Study|Withdrawal by Subject|1|||
33607904|NCT01971723|63008036|FG001|Overall Study|Withdrawal by Subject|1|||
33607905|NCT01971723|63008035|FG000|Overall Study|Protocol Violation|1|||
33607906|NCT01971723|63008036|FG001|Overall Study|Protocol Violation|2|||
33607907|NCT01942785|63008042|FG000|Overall Study|Adverse Event|2|||
33607908|NCT01942785|63008042|FG000|Overall Study|Withdrawal by Subject|1|||
33607909|NCT01942785|63008042|FG000|Overall Study|Protocol Violation|1|||
33607910|NCT01774786|63008050|FG000|Overall Study|Death|300|||
33607911|NCT01774786|63008051|FG001|Overall Study|Death|319|||
33607912|NCT01774786|63008050|FG000|Overall Study|Lost to Follow-up|6|||
33607913|NCT01774786|63008051|FG001|Overall Study|Lost to Follow-up|7|||
33607914|NCT01774786|63008050|FG000|Overall Study|Withdrawal by Subject|18|||
33607915|NCT01774786|63008051|FG001|Overall Study|Withdrawal by Subject|14|||
33607916|NCT01774786|63008050|FG000|Overall Study|Physician Decision|2|||
33607917|NCT01774786|63008051|FG001|Overall Study|Physician Decision|0|||
33607918|NCT01774786|63008050|FG000|Overall Study|Non-compliance|0|||
33607919|NCT01774786|63008051|FG001|Overall Study|Non-compliance|1|||
33607920|NCT01774786|63008050|FG000|Overall Study|Reason Not Specified|2|||
33607921|NCT01774786|63008051|FG001|Overall Study|Reason Not Specified|5|||
33607922|NCT01960725|63008059|FG000|Overall Study|Lost to Follow-up|4|||
33607923|NCT01960725|63008060|FG001|Overall Study|Lost to Follow-up|3|||
33607924|NCT01960725|63008059|FG000|Overall Study|Withdrawal by Subject|1|||
33607925|NCT01960725|63008060|FG001|Overall Study|Withdrawal by Subject|0|||
33607926|NCT01960725|63008059|FG000|Overall Study|unable to obtain blood sample|1|||
33607927|NCT01960725|63008060|FG001|Overall Study|unable to obtain blood sample|2|||
33607928|NCT01942161|63008069|FG000|Overall Study|Adverse Event|1|||
33607929|NCT01942161|63008070|FG001|Overall Study|Adverse Event|2|||
33607930|NCT01942161|63008071|FG002|Overall Study|Adverse Event|5|||
33607931|NCT01942161|63008069|FG000|Overall Study|Physician Decision|3|||
33607932|NCT01942161|63008070|FG001|Overall Study|Physician Decision|1|||
33607933|NCT01942161|63008071|FG002|Overall Study|Physician Decision|0|||
33607934|NCT01942161|63008069|FG000|Overall Study|Protocol Violation|1|||
33607935|NCT01942161|63008070|FG001|Overall Study|Protocol Violation|0|||
33607936|NCT01942161|63008071|FG002|Overall Study|Protocol Violation|0|||
33607937|NCT01942161|63008069|FG000|Overall Study|Withdrawal by Subject|3|||
33607938|NCT01942161|63008070|FG001|Overall Study|Withdrawal by Subject|3|||
33607939|NCT01942161|63008071|FG002|Overall Study|Withdrawal by Subject|1|||
33607940|NCT01971645|63008082|FG000|Overall Study|Adverse Event|1|||
33607941|NCT01971645|63008083|FG001|Overall Study|Adverse Event|0|||
33607942|NCT01971645|63008084|FG002|Overall Study|Adverse Event|0|||
33607943|NCT01971645|63008082|FG000|Overall Study|Lost to Follow-up|1|||
33607944|NCT01971645|63008083|FG001|Overall Study|Lost to Follow-up|0|||
33607945|NCT01971645|63008084|FG002|Overall Study|Lost to Follow-up|1|||
33607946|NCT01971645|63008082|FG000|Overall Study|Protocol Violation|0|||
33607947|NCT01971645|63008083|FG001|Overall Study|Protocol Violation|0|||
33607948|NCT01971645|63008084|FG002|Overall Study|Protocol Violation|1|||
33447229|NCT00296504|62822548|FG003|Interim Analysis|Protocol Violation|0|||
33447230|NCT00296504|62822549|FG004|Interim Analysis|Protocol Violation|1|||
33447231|NCT00296504|62822550|FG005|Interim Analysis|Protocol Violation|0|||
33447232|NCT00296504|62822551|FG006|Interim Analysis|Protocol Violation|0|||
33447233|NCT00296504|62822552|FG007|Interim Analysis|Protocol Violation|1|||
33447234|NCT00296504|62822553|FG008|Interim Analysis|Protocol Violation|0|||
33607949|NCT01941537|63008094|FG000|Overall Study|Lack of Efficacy|1|||
33607950|NCT01941537|63008095|FG001|Overall Study|Lack of Efficacy|2|||
33607951|NCT01941537|63008094|FG000|Overall Study|Lost to Follow-up|1|||
33447235|NCT00296504|62822545|FG000|Interim Analysis|Insufficient CD4 Response|0|||
33447236|NCT00296504|62822546|FG001|Interim Analysis|Insufficient CD4 Response|0|||
33607952|NCT01941537|63008095|FG001|Overall Study|Lost to Follow-up|0|||
33607953|NCT01941537|63008094|FG000|Overall Study|Pregnancy|1|||
33607954|NCT01941537|63008095|FG001|Overall Study|Pregnancy|0|||
33607955|NCT01941537|63008094|FG000|Overall Study|Adverse Event|1|||
33607956|NCT01941537|63008095|FG001|Overall Study|Adverse Event|0|||
33607957|NCT01941537|63008094|FG000|Overall Study|Withdrawal by Subject|0|||
33607958|NCT01941537|63008095|FG001|Overall Study|Withdrawal by Subject|1|||
33607959|NCT01971567|63008104|FG000|Overall Study|Withdrawal by Subject|3|||
33607960|NCT01971567|63008105|FG001|Overall Study|Withdrawal by Subject|2|||
33607961|NCT01971567|63008104|FG000|Overall Study|Lost to Follow-up|1|||
33607962|NCT01971567|63008105|FG001|Overall Study|Lost to Follow-up|0|||
33607963|NCT01960413|63008113|FG000|Overall Study|Withdrawal by Subject|1|||
33607964|NCT01960413|63008114|FG001|Overall Study|Withdrawal by Subject|1|||
33607965|NCT01960413|63008113|FG000|Overall Study|Physician Decision|1|||
33447237|NCT00296504|62822547|FG002|Interim Analysis|Insufficient CD4 Response|0|||
33447238|NCT00296504|62822548|FG003|Interim Analysis|Insufficient CD4 Response|0|||
33447239|NCT00296504|62822549|FG004|Interim Analysis|Insufficient CD4 Response|1|||
33447240|NCT00296504|62822550|FG005|Interim Analysis|Insufficient CD4 Response|1|||
33447241|NCT00296504|62822551|FG006|Interim Analysis|Insufficient CD4 Response|0|||
33447242|NCT00296504|62822552|FG007|Interim Analysis|Insufficient CD4 Response|0|||
33447243|NCT00296504|62822553|FG008|Interim Analysis|Insufficient CD4 Response|0|||
33607966|NCT01960413|63008114|FG001|Overall Study|Physician Decision|0|||
33607967|NCT01960413|63008113|FG000|Overall Study|Lost to Follow-up|2|||
33447244|NCT00296504|62822545|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
33447245|NCT00296504|62822546|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
33447246|NCT00296504|62822547|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
33447247|NCT00296504|62822548|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
33447248|NCT00296504|62822549|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
33447249|NCT00296504|62822550|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
33447250|NCT00296504|62822551|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
33447251|NCT00296504|62822552|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
33447252|NCT00296504|62822553|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
33447253|NCT00296504|62822545|FG000|Interim Analysis|Pregnancy|4|||
33447254|NCT00296504|62822546|FG001|Interim Analysis|Pregnancy|1|||
33447255|NCT00296504|62822547|FG002|Interim Analysis|Pregnancy|4|||
33447256|NCT00296504|62822548|FG003|Interim Analysis|Pregnancy|2|||
33447257|NCT00296504|62822549|FG004|Interim Analysis|Pregnancy|0|||
33447258|NCT00296504|62822550|FG005|Interim Analysis|Pregnancy|1|||
33447259|NCT00296504|62822551|FG006|Interim Analysis|Pregnancy|1|||
33447260|NCT00296504|62822552|FG007|Interim Analysis|Pregnancy|1|||
33447261|NCT00296504|62822553|FG008|Interim Analysis|Pregnancy|0|||
33447262|NCT00296504|62822545|FG000|Interim Analysis|Death|1|||
33447263|NCT00296504|62822546|FG001|Interim Analysis|Death|0|||
33447264|NCT00296504|62822547|FG002|Interim Analysis|Death|3|||
33447265|NCT00296504|62822548|FG003|Interim Analysis|Death|0|||
33447266|NCT00296504|62822549|FG004|Interim Analysis|Death|0|||
33447267|NCT00296504|62822550|FG005|Interim Analysis|Death|0|||
33447268|NCT00296504|62822551|FG006|Interim Analysis|Death|0|||
33447269|NCT00296504|62822552|FG007|Interim Analysis|Death|0|||
33447270|NCT00296504|62822553|FG008|Interim Analysis|Death|0|||
33447271|NCT00296504|62822545|FG000|Interim Analysis|Participant Non-compliant|0|||
33447272|NCT00296504|62822546|FG001|Interim Analysis|Participant Non-compliant|1|||
33447273|NCT00296504|62822547|FG002|Interim Analysis|Participant Non-compliant|2|||
33447274|NCT00296504|62822548|FG003|Interim Analysis|Participant Non-compliant|1|||
33447275|NCT00296504|62822549|FG004|Interim Analysis|Participant Non-compliant|1|||
33447276|NCT00296504|62822550|FG005|Interim Analysis|Participant Non-compliant|3|||
33447277|NCT00296504|62822551|FG006|Interim Analysis|Participant Non-compliant|6|||
33447278|NCT00296504|62822552|FG007|Interim Analysis|Participant Non-compliant|2|||
33447279|NCT00296504|62822553|FG008|Interim Analysis|Participant Non-compliant|0|||
33447280|NCT00296504|62822545|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
33447281|NCT00296504|62822546|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
33447282|NCT00296504|62822547|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
33447283|NCT00296504|62822548|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
33447284|NCT00296504|62822549|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
33447285|NCT00296504|62822550|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
33447286|NCT00296504|62822551|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
33447287|NCT00296504|62822552|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
33447288|NCT00296504|62822553|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
33447289|NCT00296504|62822545|FG000|Interim Analysis|To Simplify Treatment|0|||
33447290|NCT00296504|62822546|FG001|Interim Analysis|To Simplify Treatment|0|||
33447291|NCT00296504|62822547|FG002|Interim Analysis|To Simplify Treatment|1|||
33447292|NCT00296504|62822548|FG003|Interim Analysis|To Simplify Treatment|0|||
33607968|NCT01960413|63008114|FG001|Overall Study|Lost to Follow-up|0|||
33607969|NCT01970475|63008122|FG000|Overall Study|Withdrawal by Subject|11|||
33607970|NCT01970475|63008123|FG001|Overall Study|Withdrawal by Subject|6|||
33607971|NCT01970475|63008122|FG000|Overall Study|Adverse Event|7|||
33607972|NCT01970475|63008123|FG001|Overall Study|Adverse Event|3|||
33607973|NCT01970475|63008122|FG000|Overall Study|Lost to Follow-up|2|||
33447293|NCT00296504|62822549|FG004|Interim Analysis|To Simplify Treatment|0|||
33495623|NCT03529773|62874111|FG018|Overall Study|Physician Decision|0|||
33495624|NCT03529773|62874112|FG019|Overall Study|Physician Decision|1|||
33495625|NCT03529773|62874113|FG020|Overall Study|Physician Decision|1|||
33495626|NCT03529773|62874114|FG021|Overall Study|Physician Decision|0|||
33495627|NCT03529773|62874115|FG022|Overall Study|Physician Decision|0|||
33495628|NCT03529773|62874116|FG023|Overall Study|Physician Decision|0|||
33495629|NCT03529773|62874117|FG024|Overall Study|Physician Decision|0|||
33495630|NCT03529773|62874118|FG025|Overall Study|Physician Decision|0|||
33495631|NCT03529773|62874119|FG026|Overall Study|Physician Decision|0|||
33495632|NCT03529773|62874120|FG027|Overall Study|Physician Decision|0|||
33495633|NCT03529773|62874121|FG028|Overall Study|Physician Decision|0|||
33495634|NCT03529773|62874122|FG029|Overall Study|Physician Decision|0|||
33495635|NCT03529773|62874123|FG030|Overall Study|Physician Decision|0|||
33495636|NCT03529773|62874124|FG031|Overall Study|Physician Decision|0|||
33495637|NCT03529773|62874125|FG032|Overall Study|Physician Decision|0|||
33495638|NCT03529773|62874126|FG033|Overall Study|Physician Decision|0|||
33495639|NCT03529773|62874127|FG034|Overall Study|Physician Decision|0|||
33495640|NCT03529773|62874128|FG035|Overall Study|Physician Decision|0|||
33495641|NCT03529773|62874129|FG036|Overall Study|Physician Decision|0|||
33495642|NCT03529773|62874130|FG037|Overall Study|Physician Decision|0|||
33495643|NCT03529773|62874131|FG038|Overall Study|Physician Decision|0|||
33495644|NCT03529773|62874132|FG039|Overall Study|Physician Decision|0|||
33495645|NCT03529773|62874093|FG000|Overall Study|Protocol Violation|0|||
33495646|NCT03529773|62874094|FG001|Overall Study|Protocol Violation|0|||
33495647|NCT03529773|62874095|FG002|Overall Study|Protocol Violation|0|||
33495648|NCT03529773|62874096|FG003|Overall Study|Protocol Violation|0|||
33495649|NCT03529773|62874097|FG004|Overall Study|Protocol Violation|0|||
33495650|NCT03529773|62874098|FG005|Overall Study|Protocol Violation|0|||
33495651|NCT03529773|62874099|FG006|Overall Study|Protocol Violation|0|||
33495652|NCT03529773|62874100|FG007|Overall Study|Protocol Violation|0|||
33495653|NCT03529773|62874101|FG008|Overall Study|Protocol Violation|0|||
33495654|NCT03529773|62874102|FG009|Overall Study|Protocol Violation|0|||
33495655|NCT03529773|62874103|FG010|Overall Study|Protocol Violation|0|||
33495656|NCT03529773|62874104|FG011|Overall Study|Protocol Violation|0|||
33495657|NCT03529773|62874105|FG012|Overall Study|Protocol Violation|0|||
33495658|NCT03529773|62874106|FG013|Overall Study|Protocol Violation|0|||
33495659|NCT03529773|62874107|FG014|Overall Study|Protocol Violation|0|||
33495660|NCT03529773|62874108|FG015|Overall Study|Protocol Violation|0|||
33495661|NCT03529773|62874109|FG016|Overall Study|Protocol Violation|0|||
33323933|NCT01121484|62700341|FG001|Overall Study|Withdrawal by Subject|7|||
33323934|NCT01121484|62700340|FG000|Overall Study|Discontinuation of study by sponsor|0|||
33323935|NCT01121484|62700341|FG001|Overall Study|Discontinuation of study by sponsor|1|||
33323936|NCT01121484|62700340|FG000|Overall Study|Other|3|||
33323937|NCT01121484|62700341|FG001|Overall Study|Other|3|||
33607974|NCT01970475|63008123|FG001|Overall Study|Lost to Follow-up|2|||
33607975|NCT01970475|63008122|FG000|Overall Study|Protocol Violation|1|||
33607976|NCT01970475|63008123|FG001|Overall Study|Protocol Violation|0|||
33607977|NCT01939977|63008131|FG000|Overall Study|Adverse Event|4|||
33607978|NCT01939977|63008132|FG001|Overall Study|Adverse Event|3|||
33607979|NCT01939977|63008131|FG000|Overall Study|Lack of Efficacy|3|||
33607980|NCT01939977|63008132|FG001|Overall Study|Lack of Efficacy|0|||
33607981|NCT01939977|63008131|FG000|Overall Study|Physician Decision|1|||
33323938|NCT01121484|62700340|FG000|Overall Study|Randomized, not treated|1|||
33323939|NCT01121484|62700341|FG001|Overall Study|Randomized, not treated|4|||
33447294|NCT00296504|62822550|FG005|Interim Analysis|To Simplify Treatment|0|||
33447295|NCT00296504|62822551|FG006|Interim Analysis|To Simplify Treatment|2|||
33447296|NCT00296504|62822552|FG007|Interim Analysis|To Simplify Treatment|0|||
33447297|NCT00296504|62822553|FG008|Interim Analysis|To Simplify Treatment|0|||
33447298|NCT00296504|62822545|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
33447299|NCT00296504|62822546|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
33447300|NCT00296504|62822547|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
33447301|NCT00296504|62822548|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
33447302|NCT00296504|62822549|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
33447303|NCT00296504|62822550|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
33323940|NCT01169675|62700352|FG000|Overall Study|Progressive disease|13|||
33323941|NCT01169675|62700353|FG001|Overall Study|Progressive disease|2|||
33323942|NCT01169675|62700354|FG002|Overall Study|Progressive disease|5|||
33323943|NCT01169675|62700355|FG003|Overall Study|Progressive disease|15|||
33495662|NCT03529773|62874110|FG017|Overall Study|Protocol Violation|0|||
33607982|NCT01939977|63008132|FG001|Overall Study|Physician Decision|1|||
33607983|NCT01939977|63008131|FG000|Overall Study|Withdrawal by Subject|0|||
33323944|NCT01169675|62700356|FG004|Overall Study|Progressive disease|1|||
33495663|NCT03529773|62874111|FG018|Overall Study|Protocol Violation|0|||
33495664|NCT03529773|62874112|FG019|Overall Study|Protocol Violation|0|||
33495665|NCT03529773|62874113|FG020|Overall Study|Protocol Violation|0|||
33495666|NCT03529773|62874114|FG021|Overall Study|Protocol Violation|0|||
33495667|NCT03529773|62874115|FG022|Overall Study|Protocol Violation|0|||
33607984|NCT01939977|63008132|FG001|Overall Study|Withdrawal by Subject|2|||
33323945|NCT01169675|62700352|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
33607985|NCT01939977|63008131|FG000|Overall Study|Did not meet inclusion criteria|1|||
33607986|NCT01939977|63008132|FG001|Overall Study|Did not meet inclusion criteria|0|||
33607987|NCT01939977|63008131|FG000|Overall Study|Did not receive study medication|0|||
33607988|NCT01939977|63008132|FG001|Overall Study|Did not receive study medication|1|||
33607989|NCT01939899|63008143|FG000|Lead-in Dose Finding Phase|Death|0|||
33607990|NCT01939899|63008144|FG001|Lead-in Dose Finding Phase|Death|3|||
33607991|NCT01939899|63008145|FG002|Lead-in Dose Finding Phase|Death|1|||
33607992|NCT01939899|63008146|FG003|Lead-in Dose Finding Phase|Death|0|||
33607993|NCT01939899|63008147|FG004|Lead-in Dose Finding Phase|Death|0|||
33607994|NCT01939899|63008143|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
33607995|NCT01939899|63008144|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
33607996|NCT01939899|63008145|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
33607997|NCT01939899|63008146|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
33607998|NCT01939899|63008147|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
33607999|NCT01939899|63008143|FG000|Lead-in Dose Finding Phase|Other|0|||
33608000|NCT01939899|63008144|FG001|Lead-in Dose Finding Phase|Other|0|||
33608001|NCT01939899|63008145|FG002|Lead-in Dose Finding Phase|Other|1|||
33608002|NCT01939899|63008146|FG003|Lead-in Dose Finding Phase|Other|0|||
33608003|NCT01939899|63008147|FG004|Lead-in Dose Finding Phase|Other|0|||
33608004|NCT01939899|63008143|FG000|Phase 2|Withdrawal by Subject|0|||
33608005|NCT01939899|63008144|FG001|Phase 2|Withdrawal by Subject|0|||
33608006|NCT01939899|63008145|FG002|Phase 2|Withdrawal by Subject|0|||
33608007|NCT01939899|63008146|FG003|Phase 2|Withdrawal by Subject|2|||
33608008|NCT01939899|63008147|FG004|Phase 2|Withdrawal by Subject|0|||
33608009|NCT01939899|63008143|FG000|Phase 2|Disease Progression|0|||
33608010|NCT01939899|63008144|FG001|Phase 2|Disease Progression|0|||
33495668|NCT03529773|62874116|FG023|Overall Study|Protocol Violation|0|||
33495669|NCT03529773|62874117|FG024|Overall Study|Protocol Violation|0|||
33495670|NCT03529773|62874118|FG025|Overall Study|Protocol Violation|0|||
33495671|NCT03529773|62874119|FG026|Overall Study|Protocol Violation|0|||
33495672|NCT03529773|62874120|FG027|Overall Study|Protocol Violation|0|||
33495673|NCT03529773|62874121|FG028|Overall Study|Protocol Violation|0|||
33495674|NCT03529773|62874122|FG029|Overall Study|Protocol Violation|0|||
33495675|NCT03529773|62874123|FG030|Overall Study|Protocol Violation|1|||
33495676|NCT03529773|62874124|FG031|Overall Study|Protocol Violation|0|||
33495677|NCT03529773|62874125|FG032|Overall Study|Protocol Violation|0|||
33495678|NCT03529773|62874126|FG033|Overall Study|Protocol Violation|0|||
33495679|NCT03529773|62874127|FG034|Overall Study|Protocol Violation|0|||
33495680|NCT03529773|62874128|FG035|Overall Study|Protocol Violation|0|||
33495681|NCT03529773|62874129|FG036|Overall Study|Protocol Violation|0|||
33495682|NCT03529773|62874130|FG037|Overall Study|Protocol Violation|0|||
33495683|NCT03529773|62874131|FG038|Overall Study|Protocol Violation|0|||
33495684|NCT03529773|62874132|FG039|Overall Study|Protocol Violation|0|||
33495685|NCT03529773|62874093|FG000|Overall Study|Withdrawal by Subject|0|||
33495686|NCT03529773|62874094|FG001|Overall Study|Withdrawal by Subject|0|||
33495687|NCT03529773|62874095|FG002|Overall Study|Withdrawal by Subject|0|||
33495688|NCT03529773|62874096|FG003|Overall Study|Withdrawal by Subject|0|||
33495689|NCT03529773|62874097|FG004|Overall Study|Withdrawal by Subject|0|||
33495690|NCT03529773|62874098|FG005|Overall Study|Withdrawal by Subject|0|||
33495691|NCT03529773|62874099|FG006|Overall Study|Withdrawal by Subject|0|||
33495692|NCT03529773|62874100|FG007|Overall Study|Withdrawal by Subject|1|||
33495693|NCT03529773|62874101|FG008|Overall Study|Withdrawal by Subject|0|||
33495694|NCT03529773|62874102|FG009|Overall Study|Withdrawal by Subject|1|||
33495695|NCT03529773|62874103|FG010|Overall Study|Withdrawal by Subject|1|||
33495696|NCT03529773|62874104|FG011|Overall Study|Withdrawal by Subject|0|||
33495697|NCT03529773|62874105|FG012|Overall Study|Withdrawal by Subject|0|||
33495698|NCT03529773|62874106|FG013|Overall Study|Withdrawal by Subject|0|||
33495699|NCT03529773|62874107|FG014|Overall Study|Withdrawal by Subject|0|||
33608011|NCT01939899|63008145|FG002|Phase 2|Disease Progression|0|||
33608012|NCT01939899|63008146|FG003|Phase 2|Disease Progression|9|||
33608013|NCT01939899|63008147|FG004|Phase 2|Disease Progression|1|||
33608014|NCT01970397|63008167|FG000|Overall Study|Adverse Event|0|||
33608015|NCT01970397|63008168|FG001|Overall Study|Adverse Event|1|||
33447304|NCT00296504|62822551|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
33447305|NCT00296504|62822552|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
33447306|NCT00296504|62822553|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
33447307|NCT00296504|62822545|FG000|Interim Analysis|Participant Moved|1|||
33447308|NCT00296504|62822546|FG001|Interim Analysis|Participant Moved|0|||
33447309|NCT00296504|62822547|FG002|Interim Analysis|Participant Moved|1|||
33447310|NCT00296504|62822548|FG003|Interim Analysis|Participant Moved|0|||
33447311|NCT00296504|62822549|FG004|Interim Analysis|Participant Moved|0|||
33447312|NCT00296504|62822550|FG005|Interim Analysis|Participant Moved|1|||
33495700|NCT03529773|62874108|FG015|Overall Study|Withdrawal by Subject|3|||
33608016|NCT01970397|63008167|FG000|Overall Study|Lost to Follow-up|0|||
33608017|NCT01970397|63008168|FG001|Overall Study|Lost to Follow-up|1|||
33608018|NCT01970397|63008167|FG000|Overall Study|Personal Reasons|1|||
33608019|NCT01970397|63008168|FG001|Overall Study|Personal Reasons|2|||
33495701|NCT03529773|62874109|FG016|Overall Study|Withdrawal by Subject|0|||
33495702|NCT03529773|62874110|FG017|Overall Study|Withdrawal by Subject|2|||
33495703|NCT03529773|62874111|FG018|Overall Study|Withdrawal by Subject|3|||
33495704|NCT03529773|62874112|FG019|Overall Study|Withdrawal by Subject|1|||
33495705|NCT03529773|62874113|FG020|Overall Study|Withdrawal by Subject|3|||
33495706|NCT03529773|62874114|FG021|Overall Study|Withdrawal by Subject|1|||
33495707|NCT03529773|62874115|FG022|Overall Study|Withdrawal by Subject|1|||
33495708|NCT03529773|62874116|FG023|Overall Study|Withdrawal by Subject|2|||
33495709|NCT03529773|62874117|FG024|Overall Study|Withdrawal by Subject|2|||
33495710|NCT03529773|62874118|FG025|Overall Study|Withdrawal by Subject|4|||
33495711|NCT03529773|62874119|FG026|Overall Study|Withdrawal by Subject|2|||
33495712|NCT03529773|62874120|FG027|Overall Study|Withdrawal by Subject|1|||
33495713|NCT03529773|62874121|FG028|Overall Study|Withdrawal by Subject|1|||
33495714|NCT03529773|62874122|FG029|Overall Study|Withdrawal by Subject|0|||
33495715|NCT03529773|62874123|FG030|Overall Study|Withdrawal by Subject|0|||
33495716|NCT03529773|62874124|FG031|Overall Study|Withdrawal by Subject|0|||
33495717|NCT03529773|62874125|FG032|Overall Study|Withdrawal by Subject|0|||
33495718|NCT03529773|62874126|FG033|Overall Study|Withdrawal by Subject|0|||
33495719|NCT03529773|62874127|FG034|Overall Study|Withdrawal by Subject|1|||
33495720|NCT03529773|62874128|FG035|Overall Study|Withdrawal by Subject|2|||
33495721|NCT03529773|62874129|FG036|Overall Study|Withdrawal by Subject|0|||
33495722|NCT03529773|62874130|FG037|Overall Study|Withdrawal by Subject|2|||
33495723|NCT03529773|62874131|FG038|Overall Study|Withdrawal by Subject|1|||
33495724|NCT03529773|62874132|FG039|Overall Study|Withdrawal by Subject|1|||
33495725|NCT03529773|62874093|FG000|Overall Study|Screen Failure|0|||
33495726|NCT03529773|62874094|FG001|Overall Study|Screen Failure|0|||
33495727|NCT03529773|62874095|FG002|Overall Study|Screen Failure|0|||
33495728|NCT03529773|62874096|FG003|Overall Study|Screen Failure|0|||
33495729|NCT03529773|62874097|FG004|Overall Study|Screen Failure|0|||
33495730|NCT03529773|62874098|FG005|Overall Study|Screen Failure|0|||
33495731|NCT03529773|62874099|FG006|Overall Study|Screen Failure|0|||
33495732|NCT03529773|62874100|FG007|Overall Study|Screen Failure|0|||
33495733|NCT03529773|62874101|FG008|Overall Study|Screen Failure|0|||
33495734|NCT03529773|62874102|FG009|Overall Study|Screen Failure|0|||
33495735|NCT03529773|62874103|FG010|Overall Study|Screen Failure|0|||
33495736|NCT03529773|62874104|FG011|Overall Study|Screen Failure|0|||
33495737|NCT03529773|62874105|FG012|Overall Study|Screen Failure|0|||
33495738|NCT03529773|62874106|FG013|Overall Study|Screen Failure|0|||
33495739|NCT03529773|62874107|FG014|Overall Study|Screen Failure|0|||
33495740|NCT03529773|62874108|FG015|Overall Study|Screen Failure|0|||
33495741|NCT03529773|62874109|FG016|Overall Study|Screen Failure|0|||
33495742|NCT03529773|62874110|FG017|Overall Study|Screen Failure|0|||
33495743|NCT03529773|62874111|FG018|Overall Study|Screen Failure|0|||
33495744|NCT03529773|62874112|FG019|Overall Study|Screen Failure|0|||
33495745|NCT03529773|62874113|FG020|Overall Study|Screen Failure|0|||
33495746|NCT03529773|62874114|FG021|Overall Study|Screen Failure|0|||
33495747|NCT03529773|62874115|FG022|Overall Study|Screen Failure|0|||
33495748|NCT03529773|62874116|FG023|Overall Study|Screen Failure|0|||
33495749|NCT03529773|62874117|FG024|Overall Study|Screen Failure|0|||
33495750|NCT03529773|62874118|FG025|Overall Study|Screen Failure|0|||
33495751|NCT03529773|62874119|FG026|Overall Study|Screen Failure|0|||
33495752|NCT03529773|62874120|FG027|Overall Study|Screen Failure|0|||
33495753|NCT03529773|62874121|FG028|Overall Study|Screen Failure|0|||
33495754|NCT03529773|62874122|FG029|Overall Study|Screen Failure|0|||
33495755|NCT03529773|62874123|FG030|Overall Study|Screen Failure|0|||
33495756|NCT03529773|62874124|FG031|Overall Study|Screen Failure|0|||
33495757|NCT03529773|62874125|FG032|Overall Study|Screen Failure|0|||
33495758|NCT03529773|62874126|FG033|Overall Study|Screen Failure|0|||
33495759|NCT03529773|62874127|FG034|Overall Study|Screen Failure|0|||
33447313|NCT00296504|62822551|FG006|Interim Analysis|Participant Moved|1|||
33447314|NCT00296504|62822552|FG007|Interim Analysis|Participant Moved|0|||
33447315|NCT00296504|62822553|FG008|Interim Analysis|Participant Moved|0|||
33447316|NCT00296504|62822545|FG000|Interim Analysis|Participant Was Incarcerated|2|||
33447317|NCT00296504|62822546|FG001|Interim Analysis|Participant Was Incarcerated|0|||
33447318|NCT00296504|62822547|FG002|Interim Analysis|Participant Was Incarcerated|1|||
33447319|NCT00296504|62822548|FG003|Interim Analysis|Participant Was Incarcerated|0|||
33447320|NCT00296504|62822549|FG004|Interim Analysis|Participant Was Incarcerated|0|||
33447321|NCT00296504|62822550|FG005|Interim Analysis|Participant Was Incarcerated|0|||
33447322|NCT00296504|62822551|FG006|Interim Analysis|Participant Was Incarcerated|0|||
33495760|NCT03529773|62874128|FG035|Overall Study|Screen Failure|0|||
33447323|NCT00296504|62822552|FG007|Interim Analysis|Participant Was Incarcerated|0|||
33495761|NCT03529773|62874129|FG036|Overall Study|Screen Failure|1|||
33495762|NCT03529773|62874130|FG037|Overall Study|Screen Failure|1|||
33495763|NCT03529773|62874131|FG038|Overall Study|Screen Failure|0|||
33495764|NCT03529773|62874132|FG039|Overall Study|Screen Failure|1|||
33495765|NCT03529773|62874093|FG000|Overall Study|Randomized but not vaccinated|0|||
33495766|NCT03529773|62874094|FG001|Overall Study|Randomized but not vaccinated|0|||
33495767|NCT03529773|62874095|FG002|Overall Study|Randomized but not vaccinated|0|||
33495768|NCT03529773|62874096|FG003|Overall Study|Randomized but not vaccinated|0|||
33495769|NCT03529773|62874097|FG004|Overall Study|Randomized but not vaccinated|0|||
33495770|NCT03529773|62874098|FG005|Overall Study|Randomized but not vaccinated|0|||
33495771|NCT03529773|62874099|FG006|Overall Study|Randomized but not vaccinated|0|||
33495772|NCT03529773|62874100|FG007|Overall Study|Randomized but not vaccinated|0|||
33495773|NCT03529773|62874101|FG008|Overall Study|Randomized but not vaccinated|0|||
33495774|NCT03529773|62874102|FG009|Overall Study|Randomized but not vaccinated|0|||
33495775|NCT03529773|62874103|FG010|Overall Study|Randomized but not vaccinated|0|||
33495776|NCT03529773|62874104|FG011|Overall Study|Randomized but not vaccinated|0|||
33495777|NCT03529773|62874105|FG012|Overall Study|Randomized but not vaccinated|0|||
33495778|NCT03529773|62874106|FG013|Overall Study|Randomized but not vaccinated|0|||
33495779|NCT03529773|62874107|FG014|Overall Study|Randomized but not vaccinated|0|||
33495780|NCT03529773|62874108|FG015|Overall Study|Randomized but not vaccinated|0|||
33495781|NCT03529773|62874109|FG016|Overall Study|Randomized but not vaccinated|0|||
33495782|NCT03529773|62874110|FG017|Overall Study|Randomized but not vaccinated|1|||
33495783|NCT03529773|62874111|FG018|Overall Study|Randomized but not vaccinated|0|||
33495784|NCT03529773|62874112|FG019|Overall Study|Randomized but not vaccinated|0|||
33495785|NCT03529773|62874113|FG020|Overall Study|Randomized but not vaccinated|0|||
33495786|NCT03529773|62874114|FG021|Overall Study|Randomized but not vaccinated|0|||
33495787|NCT03529773|62874115|FG022|Overall Study|Randomized but not vaccinated|0|||
33495788|NCT03529773|62874116|FG023|Overall Study|Randomized but not vaccinated|0|||
33495789|NCT03529773|62874117|FG024|Overall Study|Randomized but not vaccinated|0|||
33495790|NCT03529773|62874118|FG025|Overall Study|Randomized but not vaccinated|0|||
33495791|NCT03529773|62874119|FG026|Overall Study|Randomized but not vaccinated|0|||
33495792|NCT03529773|62874120|FG027|Overall Study|Randomized but not vaccinated|1|||
33495793|NCT03529773|62874121|FG028|Overall Study|Randomized but not vaccinated|0|||
33495794|NCT03529773|62874122|FG029|Overall Study|Randomized but not vaccinated|0|||
33495795|NCT03529773|62874123|FG030|Overall Study|Randomized but not vaccinated|0|||
33495796|NCT03529773|62874124|FG031|Overall Study|Randomized but not vaccinated|0|||
33495797|NCT03529773|62874125|FG032|Overall Study|Randomized but not vaccinated|0|||
33495798|NCT03529773|62874126|FG033|Overall Study|Randomized but not vaccinated|0|||
33495799|NCT03529773|62874127|FG034|Overall Study|Randomized but not vaccinated|0|||
33495800|NCT03529773|62874128|FG035|Overall Study|Randomized but not vaccinated|0|||
33495801|NCT03529773|62874129|FG036|Overall Study|Randomized but not vaccinated|0|||
33495802|NCT03529773|62874130|FG037|Overall Study|Randomized but not vaccinated|0|||
33495803|NCT03529773|62874131|FG038|Overall Study|Randomized but not vaccinated|0|||
33495804|NCT03529773|62874132|FG039|Overall Study|Randomized but not vaccinated|0|||
33495805|NCT03799211|62874237|FG000|Overall Study|Lost to Follow-up|2|||
33495806|NCT03799211|62874238|FG001|Overall Study|Lost to Follow-up|13|||
33495807|NCT03799211|62874237|FG000|Overall Study|Withdrawal by Subject|2|||
33495808|NCT03799211|62874238|FG001|Overall Study|Withdrawal by Subject|0|||
33495809|NCT03349710|62874250|FG000|Treatment Period|Death|0|||
33495810|NCT03349710|62874251|FG001|Treatment Period|Death|0|||
33495811|NCT03349710|62874252|FG002|Treatment Period|Death|1|||
33495812|NCT03349710|62874253|FG003|Treatment Period|Death|0|||
33495813|NCT03349710|62874250|FG000|Treatment Period|Disease Progression|0|||
33495814|NCT03349710|62874251|FG001|Treatment Period|Disease Progression|2|||
33495815|NCT03349710|62874252|FG002|Treatment Period|Disease Progression|0|||
33495816|NCT03349710|62874253|FG003|Treatment Period|Disease Progression|1|||
33495817|NCT03349710|62874250|FG000|Treatment Period|Study Drug Toxicity|1|||
33495818|NCT03349710|62874251|FG001|Treatment Period|Study Drug Toxicity|0|||
33495819|NCT03349710|62874252|FG002|Treatment Period|Study Drug Toxicity|1|||
33495820|NCT03349710|62874253|FG003|Treatment Period|Study Drug Toxicity|1|||
33495821|NCT03349710|62874250|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
33447324|NCT00296504|62822553|FG008|Interim Analysis|Participant Was Incarcerated|0|||
33447325|NCT00296504|62822545|FG000|Interim Analysis|Resistance to FPV|0|||
33447326|NCT00296504|62822546|FG001|Interim Analysis|Resistance to FPV|0|||
33447327|NCT00296504|62822547|FG002|Interim Analysis|Resistance to FPV|1|||
33447328|NCT00296504|62822548|FG003|Interim Analysis|Resistance to FPV|0|||
33447329|NCT00296504|62822549|FG004|Interim Analysis|Resistance to FPV|0|||
33447330|NCT00296504|62822550|FG005|Interim Analysis|Resistance to FPV|0|||
33447331|NCT00296504|62822551|FG006|Interim Analysis|Resistance to FPV|0|||
33447332|NCT00296504|62822552|FG007|Interim Analysis|Resistance to FPV|0|||
33447333|NCT00296504|62822553|FG008|Interim Analysis|Resistance to FPV|0|||
33447334|NCT00296504|62822545|FG000|Interim Analysis|Physician Decision|0|||
33447335|NCT00296504|62822546|FG001|Interim Analysis|Physician Decision|0|||
33447336|NCT00296504|62822547|FG002|Interim Analysis|Physician Decision|1|||
33447337|NCT00296504|62822548|FG003|Interim Analysis|Physician Decision|0|||
33447338|NCT00296504|62822549|FG004|Interim Analysis|Physician Decision|0|||
33447339|NCT00296504|62822550|FG005|Interim Analysis|Physician Decision|0|||
33447340|NCT00296504|62822551|FG006|Interim Analysis|Physician Decision|0|||
33447341|NCT00296504|62822552|FG007|Interim Analysis|Physician Decision|0|||
33495822|NCT03349710|62874251|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
33495823|NCT03349710|62874252|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
33495824|NCT03349710|62874253|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
33495825|NCT03349710|62874250|FG000|Treatment Period|admin reason by sponsor|0|||
33495826|NCT03349710|62874251|FG001|Treatment Period|admin reason by sponsor|7|||
33495827|NCT03349710|62874252|FG002|Treatment Period|admin reason by sponsor|0|||
33495828|NCT03349710|62874253|FG003|Treatment Period|admin reason by sponsor|19|||
33495829|NCT03349710|62874250|FG000|Treatment Period|Other Reason|2|||
33495830|NCT03349710|62874251|FG001|Treatment Period|Other Reason|0|||
33495831|NCT03349710|62874252|FG002|Treatment Period|Other Reason|2|||
33495832|NCT03349710|62874253|FG003|Treatment Period|Other Reason|1|||
33495833|NCT03349710|62874250|FG000|Treatment Period|completed|6|||
33495834|NCT03349710|62874251|FG001|Treatment Period|completed|0|||
33495835|NCT03349710|62874252|FG002|Treatment Period|completed|18|||
33495836|NCT03349710|62874253|FG003|Treatment Period|completed|1|||
33495837|NCT03349710|62874250|FG000|Treatment Period|participant request to discontinue|0|||
33495838|NCT03349710|62874251|FG001|Treatment Period|participant request to discontinue|0|||
33495839|NCT03349710|62874252|FG002|Treatment Period|participant request to discontinue|4|||
33495840|NCT03349710|62874253|FG003|Treatment Period|participant request to discontinue|0|||
33495841|NCT03349710|62874250|FG000|Treatment Period|participant withdrew consent|1|||
33495842|NCT03349710|62874251|FG001|Treatment Period|participant withdrew consent|0|||
33495843|NCT03349710|62874252|FG002|Treatment Period|participant withdrew consent|0|||
33495844|NCT03349710|62874253|FG003|Treatment Period|participant withdrew consent|0|||
33495845|NCT03511053|62874263|FG000|Overall Study|Withdrawal by Subject|1|||
33495846|NCT03377634|62874269|FG000|Study Period|Adverse Event|1|||
33495847|NCT03377634|62874270|FG001|Study Period|Adverse Event|0|||
33495848|NCT03377634|62874269|FG000|Study Period|Withdrawal by Subject|1|||
33495849|NCT03377634|62874270|FG001|Study Period|Withdrawal by Subject|0|||
33495850|NCT03528369|62874279|FG000|Overall Study|Withdrawal by Subject|2|||
33495851|NCT03528369|62874280|FG001|Overall Study|Withdrawal by Subject|0|||
33495852|NCT03528369|62874281|FG002|Overall Study|Withdrawal by Subject|0|||
33495853|NCT03528369|62874279|FG000|Overall Study|Lost to Follow-up|1|||
33495854|NCT03528369|62874280|FG001|Overall Study|Lost to Follow-up|0|||
33495855|NCT03528369|62874281|FG002|Overall Study|Lost to Follow-up|0|||
33495856|NCT03528369|62874279|FG000|Overall Study|Adverse Event|0|||
33495857|NCT03528369|62874280|FG001|Overall Study|Adverse Event|1|||
33495858|NCT03528369|62874281|FG002|Overall Study|Adverse Event|0|||
33495859|NCT00006011|62874292|FG000|Overall Study|Disease progression|13|||
33495860|NCT00006011|62874293|FG001|Overall Study|Disease progression|6|||
33495861|NCT00006011|62874294|FG002|Overall Study|Disease progression|26|||
33495862|NCT00006011|62874292|FG000|Overall Study|Refused further treatment|15|||
33495863|NCT00006011|62874293|FG001|Overall Study|Refused further treatment|13|||
33495864|NCT00006011|62874294|FG002|Overall Study|Refused further treatment|26|||
33495865|NCT00006011|62874292|FG000|Overall Study|Adverse Event|15|||
33495866|NCT00006011|62874293|FG001|Overall Study|Adverse Event|39|||
33495867|NCT00006011|62874294|FG002|Overall Study|Adverse Event|5|||
33495868|NCT00006011|62874292|FG000|Overall Study|Death|0|||
33495869|NCT00006011|62874293|FG001|Overall Study|Death|1|||
33495870|NCT00006011|62874294|FG002|Overall Study|Death|2|||
33495871|NCT00006011|62874292|FG000|Overall Study|Other|4|||
33495872|NCT00006011|62874293|FG001|Overall Study|Other|2|||
33495873|NCT00006011|62874294|FG002|Overall Study|Other|5|||
33495874|NCT00006011|62874292|FG000|Overall Study|Ineligible|18|||
33495875|NCT00006011|62874293|FG001|Overall Study|Ineligible|16|||
33495876|NCT00006011|62874294|FG002|Overall Study|Ineligible|9|||
33495877|NCT03377556|62874300|FG000|Overall Study|Adverse Event|5|||
33495878|NCT03377556|62874300|FG000|Overall Study|Refusal unrelated to adverse events|1|||
33495879|NCT03377556|62874300|FG000|Overall Study|Progression/relapse|38|||
33495880|NCT03377556|62874300|FG000|Overall Study|Death|3|||
33495881|NCT03750955|62874306|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
33495882|NCT03750955|62874307|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
33495883|NCT03750955|62874306|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
33495884|NCT03750955|62874307|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
33495885|NCT00005879|62874317|FG000|Overall Study|Withdrawal by Subject|8|||
33495886|NCT00005879|62874318|FG001|Overall Study|Withdrawal by Subject|10|||
33495887|NCT03583359|62874326|FG000|Overall Study|Withdrawal by Subject|15|||
33495888|NCT03583359|62874327|FG001|Overall Study|Withdrawal by Subject|6|||
33495889|NCT03583359|62874326|FG000|Overall Study|Lost to Follow-up|12|||
33495890|NCT03583359|62874327|FG001|Overall Study|Lost to Follow-up|3|||
33495891|NCT03583359|62874326|FG000|Overall Study|Adverse Event|0|||
33495892|NCT03583359|62874327|FG001|Overall Study|Adverse Event|1|||
33495893|NCT03583359|62874326|FG000|Overall Study|Protocol Violation|0|||
33495894|NCT03583359|62874327|FG001|Overall Study|Protocol Violation|1|||
33495895|NCT03583359|62874326|FG000|Overall Study|Other|2|||
33495896|NCT03583359|62874327|FG001|Overall Study|Other|1|||
33495897|NCT03510663|62874341|FG000|Overall Study|Withdrawal by Subject|0|||
33495898|NCT03510663|62874342|FG001|Overall Study|Withdrawal by Subject|1|||
33495899|NCT03510663|62874343|FG002|Overall Study|Withdrawal by Subject|0|||
33495900|NCT03510663|62874344|FG003|Overall Study|Withdrawal by Subject|0|||
33495901|NCT03510663|62874345|FG004|Overall Study|Withdrawal by Subject|0|||
33495902|NCT03510663|62874346|FG005|Overall Study|Withdrawal by Subject|0|||
33495903|NCT03510663|62874347|FG006|Overall Study|Withdrawal by Subject|0|||
33495904|NCT03510663|62874348|FG007|Overall Study|Withdrawal by Subject|0|||
33495905|NCT03510273|62874358|FG000|Overall Study|Withdrawal by Subject|2|||
33495906|NCT03510273|62874358|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
33495907|NCT03510273|62874358|FG000|Overall Study|Moved away from study area|4|||
33495908|NCT03582813|62874368|FG000|Overall Study|Lost to Follow-up|18|||
33495909|NCT03582813|62874369|FG001|Overall Study|Lost to Follow-up|21|||
33495910|NCT03582813|62874368|FG000|Overall Study|Withdrawal by Subject|1|||
33495911|NCT03582813|62874369|FG001|Overall Study|Withdrawal by Subject|0|||
33495912|NCT03480009|62874379|FG000|Overall Study|Lost to Follow-up|4|||
33495913|NCT03480009|62874380|FG001|Overall Study|Lost to Follow-up|5|||
33495914|NCT03480009|62874381|FG002|Overall Study|Lost to Follow-up|4|||
33495915|NCT03480009|62874382|FG003|Overall Study|Lost to Follow-up|0|||
33495916|NCT03399786|62874397|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
33495917|NCT03399786|62874398|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
33495918|NCT03399786|62874399|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
33495919|NCT03399786|62874400|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
33495920|NCT03399786|62874397|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
33495921|NCT03399786|62874398|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
33495922|NCT03399786|62874399|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
33495923|NCT03399786|62874400|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
33495924|NCT03399786|62874397|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
33495925|NCT03399786|62874398|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
33495926|NCT03399786|62874399|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
33495927|NCT03399786|62874400|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
33495928|NCT03505593|62874408|FG000|Overall Study|Withdrawal by Subject|1|||
33495929|NCT03505593|62874408|FG000|Overall Study|Died before procedure|1|||
33495930|NCT03505593|62874408|FG000|Overall Study|Anatomical abnormality|1|||
33495931|NCT03505593|62874408|FG000|Overall Study|Unable to pass through esophagus|1|||
33495932|NCT03505593|62874408|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
33495933|NCT03504189|62874412|FG000|Overall Study|Withdrawal by Subject|1|||
33495934|NCT03504189|62874412|FG000|Overall Study|Screening Failure|1|||
33495935|NCT03504189|62874412|FG000|Overall Study|Device Failure|2|||
33495936|NCT03374358|62874423|FG000|Overall Study|Withdrawal by Subject|0|||
33495937|NCT03374358|62874424|FG001|Overall Study|Withdrawal by Subject|2|||
33495938|NCT03372096|62874430|FG000|Overall Study|Study Closed|8|||
33495939|NCT00004859|62874439|FG000|Overall Study|Lack of Efficacy|43|||
33495940|NCT00004859|62874440|FG001|Overall Study|Lack of Efficacy|113|||
33495941|NCT00004859|62874439|FG000|Overall Study|Adverse Event|31|||
33495942|NCT00004859|62874440|FG001|Overall Study|Adverse Event|93|||
33495943|NCT00004859|62874439|FG000|Overall Study|Death|5|||
33495944|NCT00004859|62874440|FG001|Overall Study|Death|5|||
33495945|NCT00004859|62874439|FG000|Overall Study|Withdrawal by Subject|7|||
33495946|NCT00004859|62874440|FG001|Overall Study|Withdrawal by Subject|33|||
33495947|NCT00004859|62874439|FG000|Overall Study|Protocol Violation|2|||
33495948|NCT00004859|62874440|FG001|Overall Study|Protocol Violation|2|||
33495949|NCT00004859|62874439|FG000|Overall Study|other disease|0|||
33495950|NCT00004859|62874440|FG001|Overall Study|other disease|3|||
33495951|NCT00004859|62874439|FG000|Overall Study|error|3|||
33495952|NCT00004859|62874440|FG001|Overall Study|error|1|||
33495953|NCT00004859|62874439|FG000|Overall Study|missing data|14|||
33495954|NCT00004859|62874440|FG001|Overall Study|missing data|11|||
33495955|NCT00004859|62874439|FG000|Overall Study|Other|13|||
33495956|NCT00004859|62874440|FG001|Overall Study|Other|21|||
33495957|NCT03500679|62874450|FG000|Overall Study|Lost to Follow-up|6|||
33495958|NCT03500679|62874451|FG001|Overall Study|Lost to Follow-up|3|||
33495959|NCT03500679|62874450|FG000|Overall Study|Withdrawal by Subject|3|||
33495960|NCT03500679|62874451|FG001|Overall Study|Withdrawal by Subject|0|||
33608020|NCT01970397|63008167|FG000|Overall Study|Protocol Violation|1|||
33495961|NCT03348930|62874457|FG000|Washout (1 Week)|Lost to Follow-up|1|||
33495962|NCT03348930|62874458|FG001|Washout (1 Week)|Lost to Follow-up|1|||
33495963|NCT03500211|62874466|FG000|Overall Study|Withdrawal by Subject|1|||
33495964|NCT03500211|62874467|FG001|Overall Study|Withdrawal by Subject|1|||
33495965|NCT03478683|62874475|FG000|Overall Study|Adverse Event|5|||
33495966|NCT03478683|62874476|FG001|Overall Study|Adverse Event|3|||
33608021|NCT01970397|63008168|FG001|Overall Study|Protocol Violation|1|||
33608022|NCT01970241|63008176|FG000|Overall Study|Withdrawal by Subject|2|||
33495967|NCT03478683|62874475|FG000|Overall Study|Lost to Follow-up|0|||
33495968|NCT03478683|62874476|FG001|Overall Study|Lost to Follow-up|5|||
33608023|NCT01970241|63008177|FG001|Overall Study|Withdrawal by Subject|0|||
33495969|NCT03478683|62874475|FG000|Overall Study|Physician Decision|1|||
33495970|NCT03478683|62874476|FG001|Overall Study|Physician Decision|3|||
33495971|NCT03478683|62874475|FG000|Overall Study|Withdrawal by Subject|7|||
33495972|NCT03478683|62874476|FG001|Overall Study|Withdrawal by Subject|7|||
33495973|NCT03478371|62874482|FG000|Overall Study|non-compliance|1|||
33495974|NCT03478371|62874482|FG000|Overall Study|Lost to Follow-up|4|||
33495975|NCT03477903|62874492|FG000|Overall Study|Study Terminated by Sponsor|1|||
33495976|NCT03475875|62874496|FG000|Period 1|Lost to Follow-up|1|||
33495977|NCT03475875|62874497|FG001|Period 1|Lost to Follow-up|0|||
33495978|NCT03475875|62874496|FG000|Period 1|Adverse Event|2|||
33495979|NCT03475875|62874497|FG001|Period 1|Adverse Event|1|||
33495980|NCT03475875|62874496|FG000|Period 2|Adverse Event|3|||
33495981|NCT03475875|62874497|FG001|Period 2|Adverse Event|0|||
33495982|NCT03475875|62874496|FG000|Period 2|Protocol Violation|0|||
33495983|NCT03475875|62874497|FG001|Period 2|Protocol Violation|1|||
33495984|NCT03474081|62874505|FG000|Overall Study|Adverse Event|6|||
33495985|NCT03474081|62874506|FG001|Overall Study|Adverse Event|3|||
33495986|NCT03474081|62874505|FG000|Overall Study|Lost to Follow-up|2|||
33495987|NCT03474081|62874506|FG001|Overall Study|Lost to Follow-up|1|||
33495988|NCT03474081|62874505|FG000|Overall Study|Physician Decision|3|||
33495989|NCT03474081|62874506|FG001|Overall Study|Physician Decision|2|||
33495990|NCT03474081|62874505|FG000|Overall Study|Withdrawal by Subject|5|||
33495991|NCT03474081|62874506|FG001|Overall Study|Withdrawal by Subject|7|||
33495992|NCT03474081|62874505|FG000|Overall Study|Investigator site closed|1|||
33495993|NCT03474081|62874506|FG001|Overall Study|Investigator site closed|0|||
33495994|NCT03346434|62874518|FG000|Overall Study|Randomized in Error|0|||
33495995|NCT03346434|62874519|FG001|Overall Study|Randomized in Error|0|||
33495996|NCT03346434|62874520|FG002|Overall Study|Randomized in Error|0|||
33495997|NCT03346434|62874521|FG003|Overall Study|Randomized in Error|0|||
33608024|NCT01970241|63008176|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
33608025|NCT01970241|63008177|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
33608026|NCT01939353|63008185|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
33608027|NCT01939353|63008185|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
33608028|NCT01939353|63008185|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
33323946|NCT01169675|62700353|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33323947|NCT01169675|62700354|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33323948|NCT01169675|62700355|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33323949|NCT01169675|62700356|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
33447342|NCT00296504|62822553|FG008|Interim Analysis|Physician Decision|0|||
33447343|NCT00296504|62822545|FG000|Interim Analysis|Principle Investigator Discretion|2|||
33447344|NCT00296504|62822546|FG001|Interim Analysis|Principle Investigator Discretion|0|||
33447345|NCT00296504|62822547|FG002|Interim Analysis|Principle Investigator Discretion|1|||
33447346|NCT00296504|62822548|FG003|Interim Analysis|Principle Investigator Discretion|1|||
33447347|NCT00296504|62822549|FG004|Interim Analysis|Principle Investigator Discretion|0|||
33447348|NCT00296504|62822550|FG005|Interim Analysis|Principle Investigator Discretion|0|||
33447349|NCT00296504|62822551|FG006|Interim Analysis|Principle Investigator Discretion|0|||
33447350|NCT00296504|62822552|FG007|Interim Analysis|Principle Investigator Discretion|0|||
33447351|NCT00296504|62822553|FG008|Interim Analysis|Principle Investigator Discretion|0|||
33447352|NCT00296504|62822545|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
33447353|NCT00296504|62822546|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
33447354|NCT00296504|62822547|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
33447355|NCT00296504|62822548|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
33447356|NCT00296504|62822549|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
33447357|NCT00296504|62822550|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
33447358|NCT00296504|62822551|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
33323950|NCT01169675|62700352|FG000|Overall Study|Adverse Event|5|||
33323951|NCT01169675|62700353|FG001|Overall Study|Adverse Event|1|||
33323952|NCT01169675|62700354|FG002|Overall Study|Adverse Event|2|||
33323953|NCT01169675|62700355|FG003|Overall Study|Adverse Event|0|||
33447359|NCT00296504|62822552|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
33447360|NCT00296504|62822553|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
33447361|NCT00296504|62822545|FG000|Interim Analysis|Non-adherence|2|||
33495998|NCT03346434|62874522|FG004|Overall Study|Randomized in Error|1|||
33495999|NCT03346434|62874523|FG005|Overall Study|Randomized in Error|0|||
33496000|NCT03346434|62874518|FG000|Overall Study|Withdrawal by Subject|0|||
33496001|NCT03346434|62874519|FG001|Overall Study|Withdrawal by Subject|0|||
33496002|NCT03346434|62874520|FG002|Overall Study|Withdrawal by Subject|1|||
33496003|NCT03346434|62874521|FG003|Overall Study|Withdrawal by Subject|0|||
33496004|NCT03346434|62874522|FG004|Overall Study|Withdrawal by Subject|1|||
33496005|NCT03346434|62874523|FG005|Overall Study|Withdrawal by Subject|0|||
33323954|NCT01169675|62700356|FG004|Overall Study|Adverse Event|0|||
33323955|NCT01169675|62700352|FG000|Overall Study|Withdrawal by Subject|1|||
33323956|NCT01169675|62700353|FG001|Overall Study|Withdrawal by Subject|0|||
33323957|NCT01169675|62700354|FG002|Overall Study|Withdrawal by Subject|0|||
33323958|NCT01169675|62700355|FG003|Overall Study|Withdrawal by Subject|1|||
33323959|NCT01169675|62700356|FG004|Overall Study|Withdrawal by Subject|2|||
33323960|NCT01169675|62700352|FG000|Overall Study|Other Reason Not Defined Above|0|||
33323961|NCT01169675|62700353|FG001|Overall Study|Other Reason Not Defined Above|0|||
33323962|NCT01169675|62700354|FG002|Overall Study|Other Reason Not Defined Above|0|||
33323963|NCT01169675|62700355|FG003|Overall Study|Other Reason Not Defined Above|1|||
33323964|NCT01169675|62700356|FG004|Overall Study|Other Reason Not Defined Above|1|||
33323965|NCT00924664|62700370|FG000|Overall Study|Adverse Event|23|||
33323966|NCT00924664|62700371|FG001|Overall Study|Adverse Event|39|||
33323967|NCT00924664|62700370|FG000|Overall Study|Lack of Efficacy|10|||
33447362|NCT00296504|62822546|FG001|Interim Analysis|Non-adherence|0|||
33447363|NCT00296504|62822547|FG002|Interim Analysis|Non-adherence|0|||
33447364|NCT00296504|62822548|FG003|Interim Analysis|Non-adherence|0|||
33496006|NCT03346434|62874518|FG000|Overall Study|Lost to Follow-up|0|||
33496007|NCT03346434|62874519|FG001|Overall Study|Lost to Follow-up|0|||
33496008|NCT03346434|62874520|FG002|Overall Study|Lost to Follow-up|0|||
33496009|NCT03346434|62874521|FG003|Overall Study|Lost to Follow-up|0|||
33496010|NCT03346434|62874522|FG004|Overall Study|Lost to Follow-up|1|||
33496011|NCT03346434|62874523|FG005|Overall Study|Lost to Follow-up|1|||
33496012|NCT03346434|62874518|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
33496013|NCT03346434|62874519|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
33496014|NCT03346434|62874520|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
33496015|NCT03346434|62874521|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
33496016|NCT03346434|62874522|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
33496017|NCT03346434|62874523|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
33496018|NCT03393000|62874541|FG000|Overall Study|Death|11|||
33496019|NCT03393000|62874541|FG000|Overall Study|Withdrawal by Subject|2|||
33496020|NCT03393000|62874541|FG000|Overall Study|Physician Decision|1|||
33496021|NCT03370770|62874545|FG000|Overall Study|Patient was followed in another hospital center|1|||
33608029|NCT01939353|63008185|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
33608030|NCT01939353|63008185|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
33608031|NCT01970007|63008189|FG000|Overall Study|Death|5|||
33608032|NCT01970007|63008189|FG000|Overall Study|Withdrawal by Subject|23|||
33608033|NCT01970007|63008189|FG000|Overall Study|Lost to Follow-up|24|||
33608034|NCT01970007|63008189|FG000|Overall Study|"Other endpoint"|3|||
33608035|NCT01728376|63008199|FG000|Overall Study|Adverse Event|1|||
33323968|NCT00924664|62700371|FG001|Overall Study|Lack of Efficacy|15|||
33323969|NCT00924664|62700370|FG000|Overall Study|Lost to Follow-up|10|||
33323970|NCT00924664|62700371|FG001|Overall Study|Lost to Follow-up|12|||
33447365|NCT00296504|62822549|FG004|Interim Analysis|Non-adherence|1|||
33447366|NCT00296504|62822550|FG005|Interim Analysis|Non-adherence|0|||
33447367|NCT00296504|62822551|FG006|Interim Analysis|Non-adherence|0|||
33447368|NCT00296504|62822552|FG007|Interim Analysis|Non-adherence|1|||
33447369|NCT00296504|62822553|FG008|Interim Analysis|Non-adherence|0|||
33447370|NCT00296504|62822545|FG000|Interim Analysis|Site Closing|1|||
33447371|NCT00296504|62822546|FG001|Interim Analysis|Site Closing|0|||
33447372|NCT00296504|62822547|FG002|Interim Analysis|Site Closing|0|||
33447373|NCT00296504|62822548|FG003|Interim Analysis|Site Closing|0|||
33447374|NCT00296504|62822549|FG004|Interim Analysis|Site Closing|0|||
33447375|NCT00296504|62822550|FG005|Interim Analysis|Site Closing|1|||
33447376|NCT00296504|62822551|FG006|Interim Analysis|Site Closing|2|||
33447377|NCT00296504|62822552|FG007|Interim Analysis|Site Closing|0|||
33447378|NCT00296504|62822553|FG008|Interim Analysis|Site Closing|0|||
33447379|NCT00296504|62822545|FG000|Interim Analysis|Lack of Personnel at Site|1|||
33447380|NCT00296504|62822546|FG001|Interim Analysis|Lack of Personnel at Site|0|||
33447381|NCT00296504|62822547|FG002|Interim Analysis|Lack of Personnel at Site|0|||
33447382|NCT00296504|62822548|FG003|Interim Analysis|Lack of Personnel at Site|0|||
33447383|NCT00296504|62822549|FG004|Interim Analysis|Lack of Personnel at Site|0|||
33447384|NCT00296504|62822550|FG005|Interim Analysis|Lack of Personnel at Site|0|||
33447385|NCT00296504|62822551|FG006|Interim Analysis|Lack of Personnel at Site|0|||
33447386|NCT00296504|62822552|FG007|Interim Analysis|Lack of Personnel at Site|0|||
33447387|NCT00296504|62822553|FG008|Interim Analysis|Lack of Personnel at Site|0|||
33447388|NCT00296504|62822545|FG000|Interim Analysis|Missed Schedule Date|1|||
33447389|NCT00296504|62822546|FG001|Interim Analysis|Missed Schedule Date|0|||
33447390|NCT00296504|62822547|FG002|Interim Analysis|Missed Schedule Date|0|||
33447391|NCT00296504|62822548|FG003|Interim Analysis|Missed Schedule Date|0|||
33447392|NCT00296504|62822549|FG004|Interim Analysis|Missed Schedule Date|0|||
33496022|NCT03370770|62874545|FG000|Overall Study|Progressive Disease|98|||
33608036|NCT01728376|63008200|FG001|Overall Study|Adverse Event|1|||
33608037|NCT01728376|63008201|FG002|Overall Study|Adverse Event|1|||
33323971|NCT00924664|62700370|FG000|Overall Study|Withdrawal by Subject|47|||
33323972|NCT00924664|62700371|FG001|Overall Study|Withdrawal by Subject|71|||
33447393|NCT00296504|62822550|FG005|Interim Analysis|Missed Schedule Date|0|||
33496023|NCT03370770|62874545|FG000|Overall Study|Adverse Event|2|||
33496024|NCT03370770|62874545|FG000|Overall Study|Death|5|||
33496025|NCT03473301|62874552|FG000|Overall Study|Protocol Violation|4|||
33496026|NCT03473301|62874553|FG001|Overall Study|Protocol Violation|0|||
33496027|NCT03473301|62874554|FG002|Overall Study|Protocol Violation|0|||
33496028|NCT03473301|62874552|FG000|Overall Study|Withdrawal by Subject|0|||
33496029|NCT03473301|62874553|FG001|Overall Study|Withdrawal by Subject|1|||
33496030|NCT03473301|62874554|FG002|Overall Study|Withdrawal by Subject|0|||
33496031|NCT03473301|62874552|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
33496032|NCT03473301|62874553|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
33496033|NCT03473301|62874554|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
33496034|NCT03390426|62874566|FG000|Overall Study|Protocol Violation|0|||
33496035|NCT03390426|62874567|FG001|Overall Study|Protocol Violation|1|||
33496036|NCT03472521|62874575|FG000|Overall Study|Lost to Follow-up|3|||
33496037|NCT03472521|62874576|FG001|Overall Study|Lost to Follow-up|2|||
33496038|NCT03472521|62874575|FG000|Overall Study|Discontinued intervention|3|||
33496039|NCT03472521|62874576|FG001|Overall Study|Discontinued intervention|1|||
33496040|NCT02906020|62874592|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
33496041|NCT02906020|62874593|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
33496042|NCT02906020|62874594|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
33496043|NCT02906020|62874595|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
33496044|NCT02906020|62874596|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
33496045|NCT02906020|62874597|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
33496046|NCT02906020|62874598|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
33496047|NCT02906020|62874599|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
33496048|NCT02906020|62874600|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
33496049|NCT02906020|62874601|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
33496050|NCT02906020|62874602|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
33496051|NCT02906020|62874603|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
33496052|NCT02906020|62874604|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
33496053|NCT02906020|62874605|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
33496054|NCT02906020|62874606|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
33496055|NCT02906020|62874607|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
33496056|NCT02906020|62874592|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33496057|NCT02906020|62874593|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33496058|NCT02906020|62874594|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33496059|NCT02906020|62874595|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33496060|NCT02906020|62874596|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33496061|NCT02906020|62874597|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33496062|NCT02906020|62874598|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33496063|NCT02906020|62874599|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33496064|NCT02906020|62874600|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
33496065|NCT02906020|62874601|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
33496066|NCT02906020|62874602|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33496067|NCT02906020|62874603|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33496068|NCT02906020|62874604|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33496069|NCT02906020|62874605|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33496070|NCT02906020|62874606|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33496071|NCT02906020|62874607|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33496072|NCT02906020|62874592|FG000|Part 2: Double-blind Treatment Period|Other|0|||
33496073|NCT02906020|62874593|FG001|Part 2: Double-blind Treatment Period|Other|0|||
33496074|NCT02906020|62874594|FG002|Part 2: Double-blind Treatment Period|Other|0|||
33496075|NCT02906020|62874595|FG003|Part 2: Double-blind Treatment Period|Other|0|||
33496076|NCT02906020|62874596|FG004|Part 2: Double-blind Treatment Period|Other|0|||
33496077|NCT02906020|62874597|FG005|Part 2: Double-blind Treatment Period|Other|0|||
33496078|NCT02906020|62874598|FG006|Part 2: Double-blind Treatment Period|Other|0|||
33496079|NCT02906020|62874599|FG007|Part 2: Double-blind Treatment Period|Other|0|||
33496080|NCT02906020|62874600|FG008|Part 2: Double-blind Treatment Period|Other|6|||
33496081|NCT02906020|62874601|FG009|Part 2: Double-blind Treatment Period|Other|10|||
33496082|NCT02906020|62874602|FG010|Part 2: Double-blind Treatment Period|Other|0|||
33496083|NCT02906020|62874603|FG011|Part 2: Double-blind Treatment Period|Other|0|||
33496084|NCT02906020|62874604|FG012|Part 2: Double-blind Treatment Period|Other|0|||
33496085|NCT02906020|62874605|FG013|Part 2: Double-blind Treatment Period|Other|0|||
33496086|NCT02906020|62874606|FG014|Part 2: Double-blind Treatment Period|Other|0|||
33496087|NCT02906020|62874607|FG015|Part 2: Double-blind Treatment Period|Other|0|||
33608038|NCT01728376|63008202|FG003|Overall Study|Adverse Event|1|||
33496088|NCT02906020|62874592|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33496089|NCT02906020|62874593|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33608039|NCT01728376|63008203|FG004|Overall Study|Adverse Event|1|||
33447394|NCT00296504|62822551|FG006|Interim Analysis|Missed Schedule Date|0|||
33447395|NCT00296504|62822552|FG007|Interim Analysis|Missed Schedule Date|0|||
33447396|NCT00296504|62822553|FG008|Interim Analysis|Missed Schedule Date|0|||
33447397|NCT00296504|62822545|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
33447398|NCT00296504|62822546|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
33447399|NCT00296504|62822547|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
33447400|NCT00296504|62822548|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
33447401|NCT00296504|62822549|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
33608040|NCT01728376|63008204|FG005|Overall Study|Adverse Event|0|||
33608041|NCT01728376|63008199|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
33608042|NCT01728376|63008200|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
33608043|NCT01728376|63008201|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
33608044|NCT01728376|63008202|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
33608045|NCT01728376|63008203|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
33608046|NCT01728376|63008204|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
33608047|NCT01728376|63008199|FG000|Overall Study|No relevant bacteria|2|||
33608048|NCT01728376|63008200|FG001|Overall Study|No relevant bacteria|0|||
33447402|NCT00296504|62822550|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
33496090|NCT02906020|62874594|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33447403|NCT00296504|62822551|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
33447404|NCT00296504|62822552|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
33447405|NCT00296504|62822553|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
33447406|NCT00296504|62822545|FG000|Interim Analysis|Participant Stopped|0|||
33447407|NCT00296504|62822546|FG001|Interim Analysis|Participant Stopped|0|||
33447408|NCT00296504|62822547|FG002|Interim Analysis|Participant Stopped|0|||
33447409|NCT00296504|62822548|FG003|Interim Analysis|Participant Stopped|0|||
33447410|NCT00296504|62822549|FG004|Interim Analysis|Participant Stopped|1|||
33496091|NCT02906020|62874595|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33496092|NCT02906020|62874596|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33608049|NCT01728376|63008201|FG002|Overall Study|No relevant bacteria|0|||
33608050|NCT01728376|63008202|FG003|Overall Study|No relevant bacteria|0|||
33608051|NCT01728376|63008203|FG004|Overall Study|No relevant bacteria|1|||
33608052|NCT01728376|63008204|FG005|Overall Study|No relevant bacteria|1|||
33608053|NCT01728376|63008199|FG000|Overall Study|Did not receive treatment|0|||
33608054|NCT01728376|63008200|FG001|Overall Study|Did not receive treatment|1|||
33608055|NCT01728376|63008201|FG002|Overall Study|Did not receive treatment|0|||
33608056|NCT01728376|63008202|FG003|Overall Study|Did not receive treatment|0|||
33608057|NCT01728376|63008203|FG004|Overall Study|Did not receive treatment|0|||
33608058|NCT01728376|63008204|FG005|Overall Study|Did not receive treatment|0|||
33496093|NCT02906020|62874597|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33496094|NCT02906020|62874598|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33496095|NCT02906020|62874599|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33496096|NCT02906020|62874600|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33496097|NCT02906020|62874601|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33496098|NCT02906020|62874602|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33496099|NCT02906020|62874603|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33496100|NCT02906020|62874604|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
33496101|NCT02906020|62874605|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
33496102|NCT02906020|62874606|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33496103|NCT02906020|62874607|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33496104|NCT02906020|62874592|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33496105|NCT02906020|62874593|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33496106|NCT02906020|62874594|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33496107|NCT02906020|62874595|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33496108|NCT02906020|62874596|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33496109|NCT02906020|62874597|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33496110|NCT02906020|62874598|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33496111|NCT02906020|62874599|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33496112|NCT02906020|62874600|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33496113|NCT02906020|62874601|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33496114|NCT02906020|62874602|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33496115|NCT02906020|62874603|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33496116|NCT02906020|62874604|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
33496117|NCT02906020|62874605|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
33496118|NCT02906020|62874606|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33496119|NCT02906020|62874607|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
33496120|NCT02906020|62874592|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33496121|NCT02906020|62874593|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33496122|NCT02906020|62874594|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33496123|NCT02906020|62874595|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33496124|NCT02906020|62874596|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33496125|NCT02906020|62874597|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33496126|NCT02906020|62874598|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33496127|NCT02906020|62874599|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33496128|NCT02906020|62874600|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33496129|NCT02906020|62874601|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33496130|NCT02906020|62874602|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33496131|NCT02906020|62874603|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33608059|NCT01728376|63008199|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
33608060|NCT01728376|63008200|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
33608061|NCT01728376|63008201|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
33323973|NCT00924664|62700370|FG000|Overall Study|Protocol Violation|2|||
33608062|NCT01728376|63008202|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
33608063|NCT01728376|63008203|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
33323974|NCT00924664|62700371|FG001|Overall Study|Protocol Violation|5|||
33447411|NCT00296504|62822550|FG005|Interim Analysis|Participant Stopped|0|||
33496132|NCT02906020|62874604|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
33608064|NCT01728376|63008204|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
33496133|NCT02906020|62874605|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
33496134|NCT02906020|62874606|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33496135|NCT02906020|62874607|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33496136|NCT02906020|62874592|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33496137|NCT02906020|62874593|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33496138|NCT02906020|62874594|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33496139|NCT02906020|62874595|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33496140|NCT02906020|62874596|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33496141|NCT02906020|62874597|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33496142|NCT02906020|62874598|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33496143|NCT02906020|62874599|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33496144|NCT02906020|62874600|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33496145|NCT02906020|62874601|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33496146|NCT02906020|62874602|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33608065|NCT01708174|63008221|FG000|Treatment Period|Withdrawal by Subject|1|||
33608066|NCT01708174|63008222|FG001|Treatment Period|Withdrawal by Subject|0|||
33608067|NCT01708174|63008223|FG002|Treatment Period|Withdrawal by Subject|0|||
33608068|NCT01708174|63008221|FG000|Treatment Period|Progressive disease|0|||
33447412|NCT00296504|62822551|FG006|Interim Analysis|Participant Stopped|0|||
33447413|NCT00296504|62822552|FG007|Interim Analysis|Participant Stopped|0|||
33496147|NCT02906020|62874603|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33496148|NCT02906020|62874604|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
33496149|NCT02906020|62874605|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
33496150|NCT02906020|62874606|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33496151|NCT02906020|62874607|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33496152|NCT02906020|62874592|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33496153|NCT02906020|62874593|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33496154|NCT02906020|62874594|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33496155|NCT02906020|62874595|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33496156|NCT02906020|62874596|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33496157|NCT02906020|62874597|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33447414|NCT00296504|62822553|FG008|Interim Analysis|Participant Stopped|0|||
33447415|NCT00296504|62822545|FG000|Interim Analysis|Physician and Participant Decision|0|||
33447416|NCT00296504|62822546|FG001|Interim Analysis|Physician and Participant Decision|0|||
33496158|NCT02906020|62874598|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33496159|NCT02906020|62874599|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33496160|NCT02906020|62874600|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33496161|NCT02906020|62874601|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33496162|NCT02906020|62874602|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33496163|NCT02906020|62874603|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33496164|NCT02906020|62874604|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
33496165|NCT02906020|62874605|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
33496166|NCT02906020|62874606|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
33496167|NCT02906020|62874607|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
33496168|NCT02906020|62874592|FG000|Part 2: Long-term Follow-up Period|Other|0|||
33496169|NCT02906020|62874593|FG001|Part 2: Long-term Follow-up Period|Other|0|||
33496170|NCT02906020|62874594|FG002|Part 2: Long-term Follow-up Period|Other|0|||
33496171|NCT02906020|62874595|FG003|Part 2: Long-term Follow-up Period|Other|0|||
33496172|NCT02906020|62874596|FG004|Part 2: Long-term Follow-up Period|Other|0|||
33496173|NCT02906020|62874597|FG005|Part 2: Long-term Follow-up Period|Other|0|||
33447417|NCT00296504|62822547|FG002|Interim Analysis|Physician and Participant Decision|0|||
33447418|NCT00296504|62822548|FG003|Interim Analysis|Physician and Participant Decision|0|||
33323975|NCT00924664|62700370|FG000|Overall Study|Pregnancy|1|||
33447419|NCT00296504|62822549|FG004|Interim Analysis|Physician and Participant Decision|0|||
33447420|NCT00296504|62822550|FG005|Interim Analysis|Physician and Participant Decision|1|||
33447421|NCT00296504|62822551|FG006|Interim Analysis|Physician and Participant Decision|0|||
33447422|NCT00296504|62822552|FG007|Interim Analysis|Physician and Participant Decision|0|||
33447423|NCT00296504|62822553|FG008|Interim Analysis|Physician and Participant Decision|0|||
33447424|NCT00296504|62822545|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
33496174|NCT02906020|62874598|FG006|Part 2: Long-term Follow-up Period|Other|0|||
33496175|NCT02906020|62874599|FG007|Part 2: Long-term Follow-up Period|Other|0|||
33496176|NCT02906020|62874600|FG008|Part 2: Long-term Follow-up Period|Other|0|||
33496177|NCT02906020|62874601|FG009|Part 2: Long-term Follow-up Period|Other|0|||
33496178|NCT02906020|62874602|FG010|Part 2: Long-term Follow-up Period|Other|0|||
33496179|NCT02906020|62874603|FG011|Part 2: Long-term Follow-up Period|Other|0|||
33496180|NCT02906020|62874604|FG012|Part 2: Long-term Follow-up Period|Other|13|||
33496181|NCT02906020|62874605|FG013|Part 2: Long-term Follow-up Period|Other|8|||
33496182|NCT02906020|62874606|FG014|Part 2: Long-term Follow-up Period|Other|3|||
33496183|NCT02906020|62874607|FG015|Part 2: Long-term Follow-up Period|Other|2|||
33496184|NCT03499353|62874635|FG000|Treatment|Adverse Event|3|||
33496185|NCT03499353|62874635|FG000|Treatment|Progressive Disease|10|||
33496186|NCT03499353|62874635|FG000|Treatment|Other|1|||
33496187|NCT03499353|62874635|FG000|Treatment|Withdrawal by Subject|2|||
33496188|NCT03499353|62874635|FG000|Long-Term Follow-up|Death|2|||
33496189|NCT03499353|62874635|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
33496190|NCT03499353|62874635|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
33496191|NCT00004259|62874643|FG000|Overall Study|Protocol Violation|1|||
33496192|NCT00004259|62874644|FG001|Overall Study|Protocol Violation|2|||
33496193|NCT00004259|62874645|FG002|Overall Study|Protocol Violation|0|||
33496194|NCT00004259|62874646|FG003|Overall Study|Protocol Violation|0|||
33496195|NCT00004259|62874643|FG000|Overall Study|Withdrawal by Subject|0|||
33496196|NCT00004259|62874644|FG001|Overall Study|Withdrawal by Subject|2|||
33496197|NCT00004259|62874645|FG002|Overall Study|Withdrawal by Subject|0|||
33496198|NCT00004259|62874646|FG003|Overall Study|Withdrawal by Subject|0|||
33496199|NCT03365934|62874670|FG000|Overall Study|Adverse Event|1|||
33496200|NCT03365934|62874670|FG000|Overall Study|Withdrawal by Subject|1|||
33496201|NCT03468855|62874679|FG000|Overall Study|Adverse Event|2|||
33496202|NCT03468855|62874679|FG000|Overall Study|Lost to Follow-up|5|||
33496203|NCT03468855|62874679|FG000|Overall Study|Withdrawal by Subject|3|||
33447425|NCT00296504|62822546|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
33447426|NCT00296504|62822547|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
33447427|NCT00296504|62822548|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
33447428|NCT00296504|62822549|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
33447429|NCT00296504|62822550|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
33447430|NCT00296504|62822551|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
33447431|NCT00296504|62822552|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
33447432|NCT00296504|62822553|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
33496204|NCT03468855|62874679|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
33447433|NCT00296504|62822545|FG000|Interim Analysis|Study Ended|0|||
33496205|NCT03738865|62874685|FG000|Overall Study|Withdrawal by Subject|3|||
33447434|NCT00296504|62822546|FG001|Interim Analysis|Study Ended|0|||
33447435|NCT00296504|62822547|FG002|Interim Analysis|Study Ended|0|||
33447436|NCT00296504|62822548|FG003|Interim Analysis|Study Ended|0|||
33447437|NCT00296504|62822549|FG004|Interim Analysis|Study Ended|0|||
33447438|NCT00296504|62822550|FG005|Interim Analysis|Study Ended|0|||
33447439|NCT00296504|62822551|FG006|Interim Analysis|Study Ended|1|||
33447440|NCT00296504|62822552|FG007|Interim Analysis|Study Ended|0|||
33447441|NCT00296504|62822553|FG008|Interim Analysis|Study Ended|0|||
33447442|NCT00296504|62822545|FG000|Interim Analysis|Participant Needed Interferon|0|||
33447443|NCT00296504|62822546|FG001|Interim Analysis|Participant Needed Interferon|0|||
33496206|NCT03738865|62874686|FG001|Overall Study|Withdrawal by Subject|3|||
33496207|NCT03738865|62874685|FG000|Overall Study|Adverse Event|2|||
33496208|NCT03738865|62874686|FG001|Overall Study|Adverse Event|0|||
33496209|NCT03738865|62874685|FG000|Overall Study|Physician Decision|0|||
33496210|NCT03738865|62874686|FG001|Overall Study|Physician Decision|1|||
33447444|NCT00296504|62822547|FG002|Interim Analysis|Participant Needed Interferon|0|||
33447445|NCT00296504|62822548|FG003|Interim Analysis|Participant Needed Interferon|0|||
33496211|NCT03524157|62874695|FG000|Overall Study|cytology not readable|0|||
33608069|NCT01708174|63008222|FG001|Treatment Period|Progressive disease|1|||
33608070|NCT01708174|63008223|FG002|Treatment Period|Progressive disease|0|||
33608071|NCT01708174|63008221|FG000|Treatment Period|Death|0|||
33608072|NCT01708174|63008222|FG001|Treatment Period|Death|0|||
33447446|NCT00296504|62822549|FG004|Interim Analysis|Participant Needed Interferon|0|||
33447447|NCT00296504|62822550|FG005|Interim Analysis|Participant Needed Interferon|0|||
33447448|NCT00296504|62822551|FG006|Interim Analysis|Participant Needed Interferon|0|||
33496212|NCT03524157|62874696|FG001|Overall Study|cytology not readable|0|||
33496213|NCT03524157|62874697|FG002|Overall Study|cytology not readable|1|||
33496214|NCT03437733|62874711|FG000|Overall Study|Eligibility criteria not met|0|||
33496215|NCT03437733|62874712|FG001|Overall Study|Eligibility criteria not met|3|||
33496216|NCT03468543|62874720|FG000|Overall Study|Protocol stopping rules met|3|||
33496217|NCT03467763|62874724|FG000|Overall Study|Lost to Follow-up|1|||
33496218|NCT03467763|62874724|FG000|Overall Study|Protocol Violation|2|||
33496219|NCT00004031|62874732|FG000|Overall Study|Adverse Event|5|||
33496220|NCT00004031|62874733|FG001|Overall Study|Adverse Event|0|||
33496221|NCT00004031|62874732|FG000|Overall Study|Refusal unrelated to adverse events|2|||
33447449|NCT00296504|62822552|FG007|Interim Analysis|Participant Needed Interferon|1|||
33447450|NCT00296504|62822553|FG008|Interim Analysis|Participant Needed Interferon|0|||
33447451|NCT00296504|62822545|FG000|Interim Analysis|Ongoing|32|||
33447452|NCT00296504|62822546|FG001|Interim Analysis|Ongoing|12|||
33447453|NCT00296504|62822547|FG002|Interim Analysis|Ongoing|16|||
33447454|NCT00296504|62822548|FG003|Interim Analysis|Ongoing|22|||
33447455|NCT00296504|62822549|FG004|Interim Analysis|Ongoing|0|||
33447456|NCT00296504|62822550|FG005|Interim Analysis|Ongoing|0|||
33447457|NCT00296504|62822551|FG006|Interim Analysis|Ongoing|30|||
33447458|NCT00296504|62822552|FG007|Interim Analysis|Ongoing|1|||
33447459|NCT00296504|62822553|FG008|Interim Analysis|Ongoing|0|||
33447460|NCT00296504|62822545|FG000|Final Analysis|Withdrawal by Subject|0|||
33447461|NCT00296504|62822546|FG001|Final Analysis|Withdrawal by Subject|0|||
33447462|NCT00296504|62822547|FG002|Final Analysis|Withdrawal by Subject|0|||
33447463|NCT00296504|62822548|FG003|Final Analysis|Withdrawal by Subject|0|||
33447464|NCT00296504|62822549|FG004|Final Analysis|Withdrawal by Subject|0|||
33447465|NCT00296504|62822550|FG005|Final Analysis|Withdrawal by Subject|0|||
33447466|NCT00296504|62822551|FG006|Final Analysis|Withdrawal by Subject|0|||
33447467|NCT00296504|62822552|FG007|Final Analysis|Withdrawal by Subject|0|||
33447468|NCT00296504|62822553|FG008|Final Analysis|Withdrawal by Subject|1|||
33447469|NCT00296504|62822545|FG000|Final Analysis|Lost to Follow-up|0|||
33447470|NCT00296504|62822546|FG001|Final Analysis|Lost to Follow-up|0|||
33447471|NCT00296504|62822547|FG002|Final Analysis|Lost to Follow-up|0|||
33447472|NCT00296504|62822548|FG003|Final Analysis|Lost to Follow-up|0|||
33447473|NCT00296504|62822549|FG004|Final Analysis|Lost to Follow-up|0|||
33447474|NCT00296504|62822550|FG005|Final Analysis|Lost to Follow-up|0|||
33447475|NCT00296504|62822551|FG006|Final Analysis|Lost to Follow-up|0|||
33447476|NCT00296504|62822552|FG007|Final Analysis|Lost to Follow-up|0|||
33447477|NCT00296504|62822553|FG008|Final Analysis|Lost to Follow-up|5|||
33447478|NCT00296504|62822545|FG000|Final Analysis|Insufficient Viral Load Response|0|||
33447479|NCT00296504|62822546|FG001|Final Analysis|Insufficient Viral Load Response|0|||
33447480|NCT00296504|62822547|FG002|Final Analysis|Insufficient Viral Load Response|0|||
33447481|NCT00296504|62822548|FG003|Final Analysis|Insufficient Viral Load Response|0|||
33447482|NCT00296504|62822549|FG004|Final Analysis|Insufficient Viral Load Response|0|||
33447483|NCT00296504|62822550|FG005|Final Analysis|Insufficient Viral Load Response|0|||
33447484|NCT00296504|62822551|FG006|Final Analysis|Insufficient Viral Load Response|0|||
33447485|NCT00296504|62822552|FG007|Final Analysis|Insufficient Viral Load Response|0|||
33447486|NCT00296504|62822553|FG008|Final Analysis|Insufficient Viral Load Response|6|||
33447487|NCT00296504|62822545|FG000|Final Analysis|Adverse Event|0|||
33447488|NCT00296504|62822546|FG001|Final Analysis|Adverse Event|0|||
33447489|NCT00296504|62822547|FG002|Final Analysis|Adverse Event|0|||
33447490|NCT00296504|62822548|FG003|Final Analysis|Adverse Event|0|||
33447491|NCT00296504|62822549|FG004|Final Analysis|Adverse Event|0|||
33447492|NCT00296504|62822550|FG005|Final Analysis|Adverse Event|0|||
33447493|NCT00296504|62822551|FG006|Final Analysis|Adverse Event|0|||
33447494|NCT00296504|62822552|FG007|Final Analysis|Adverse Event|0|||
33447495|NCT00296504|62822553|FG008|Final Analysis|Adverse Event|2|||
33447496|NCT00296504|62822545|FG000|Final Analysis|Pregnancy|0|||
33447497|NCT00296504|62822546|FG001|Final Analysis|Pregnancy|0|||
33447498|NCT00296504|62822547|FG002|Final Analysis|Pregnancy|0|||
33447499|NCT00296504|62822548|FG003|Final Analysis|Pregnancy|0|||
33447500|NCT00296504|62822549|FG004|Final Analysis|Pregnancy|0|||
33447501|NCT00296504|62822550|FG005|Final Analysis|Pregnancy|0|||
33447502|NCT00296504|62822551|FG006|Final Analysis|Pregnancy|0|||
33447503|NCT00296504|62822552|FG007|Final Analysis|Pregnancy|0|||
33447504|NCT00296504|62822553|FG008|Final Analysis|Pregnancy|4|||
33447505|NCT00296504|62822545|FG000|Final Analysis|Tuberculosis|0|||
33447506|NCT00296504|62822546|FG001|Final Analysis|Tuberculosis|0|||
33447507|NCT00296504|62822547|FG002|Final Analysis|Tuberculosis|0|||
33447508|NCT00296504|62822548|FG003|Final Analysis|Tuberculosis|0|||
33447509|NCT00296504|62822549|FG004|Final Analysis|Tuberculosis|0|||
33447510|NCT00296504|62822550|FG005|Final Analysis|Tuberculosis|0|||
33447511|NCT00296504|62822551|FG006|Final Analysis|Tuberculosis|0|||
33447512|NCT00296504|62822552|FG007|Final Analysis|Tuberculosis|0|||
33447513|NCT00296504|62822553|FG008|Final Analysis|Tuberculosis|1|||
33447514|NCT00296504|62822545|FG000|Final Analysis|Participant Moved to Another Country|0|||
33447515|NCT00296504|62822546|FG001|Final Analysis|Participant Moved to Another Country|0|||
33447516|NCT00296504|62822547|FG002|Final Analysis|Participant Moved to Another Country|0|||
33447517|NCT00296504|62822548|FG003|Final Analysis|Participant Moved to Another Country|0|||
33447518|NCT00296504|62822549|FG004|Final Analysis|Participant Moved to Another Country|0|||
33447519|NCT00296504|62822550|FG005|Final Analysis|Participant Moved to Another Country|0|||
33447520|NCT00296504|62822551|FG006|Final Analysis|Participant Moved to Another Country|0|||
33447521|NCT00296504|62822552|FG007|Final Analysis|Participant Moved to Another Country|0|||
33447522|NCT00296504|62822553|FG008|Final Analysis|Participant Moved to Another Country|1|||
33447523|NCT00296504|62822545|FG000|Final Analysis|Poor Adherence|0|||
33447524|NCT00296504|62822546|FG001|Final Analysis|Poor Adherence|0|||
33447525|NCT00296504|62822547|FG002|Final Analysis|Poor Adherence|0|||
33447526|NCT00296504|62822548|FG003|Final Analysis|Poor Adherence|0|||
33447527|NCT00296504|62822549|FG004|Final Analysis|Poor Adherence|0|||
33447528|NCT00296504|62822550|FG005|Final Analysis|Poor Adherence|0|||
33447529|NCT00296504|62822551|FG006|Final Analysis|Poor Adherence|0|||
33447530|NCT00296504|62822552|FG007|Final Analysis|Poor Adherence|0|||
33447531|NCT00296504|62822553|FG008|Final Analysis|Poor Adherence|1|||
33447532|NCT00313820|62822580|FG000|Assigned to Treatment|Other|1|||
33447533|NCT00313820|62822581|FG001|Assigned to Treatment|Other|0|||
33447534|NCT00313820|62822580|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
33447535|NCT00313820|62822581|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
33447536|NCT00313820|62822580|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
33447537|NCT00313820|62822581|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
33447538|NCT00313820|62822580|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
33447539|NCT00313820|62822581|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
33447540|NCT00313820|62822580|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
33447541|NCT00313820|62822581|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
33447542|NCT00313820|62822580|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
33447543|NCT00313820|62822581|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
33447544|NCT00462761|62822587|FG000|Overall Study|Adverse Event|6|||
33447545|NCT00462761|62822587|FG000|Overall Study|Withdrawal by Subject|9|||
33447546|NCT00462761|62822587|FG000|Overall Study|Physician Decision|5|||
33447547|NCT00462761|62822587|FG000|Overall Study|Disease progression|43|||
33447548|NCT00462761|62822587|FG000|Overall Study|Death|12|||
33447549|NCT00462761|62822587|FG000|Overall Study|Other|1|||
33447550|NCT00235872|62822619|FG000|Overall Study|Adverse Event|34|||
33447551|NCT00235872|62822619|FG000|Overall Study|Death|1|||
33447552|NCT00235872|62822619|FG000|Overall Study|Lost to Follow-up|1|||
33447553|NCT00235872|62822619|FG000|Overall Study|Withdrawal by Subject|50|||
33447554|NCT00235872|62822619|FG000|Overall Study|Administrative reason|61|||
33447555|NCT00461981|62822625|FG000|Overall Study|Lost to Follow-up|9|||
33447556|NCT00461981|62822626|FG001|Overall Study|Lost to Follow-up|6|||
33447557|NCT00461981|62822625|FG000|Overall Study|Withdrawal by Subject|2|||
33447558|NCT00461981|62822626|FG001|Overall Study|Withdrawal by Subject|3|||
33447559|NCT00296036|62822634|FG000|Overall Study|Withdrawal by Subject|1|||
33447560|NCT00296036|62822635|FG001|Overall Study|Withdrawal by Subject|0|||
33447561|NCT00296036|62822636|FG002|Overall Study|Withdrawal by Subject|2|||
33447562|NCT00296036|62822637|FG003|Overall Study|Withdrawal by Subject|1|||
33447563|NCT00296036|62822638|FG004|Overall Study|Withdrawal by Subject|2|||
33447564|NCT00296036|62822639|FG005|Overall Study|Withdrawal by Subject|1|||
33447565|NCT00296036|62822634|FG000|Overall Study|Protocol Violation|0|||
33447566|NCT00296036|62822635|FG001|Overall Study|Protocol Violation|0|||
33447567|NCT00296036|62822636|FG002|Overall Study|Protocol Violation|0|||
33447568|NCT00296036|62822637|FG003|Overall Study|Protocol Violation|0|||
33447569|NCT00296036|62822638|FG004|Overall Study|Protocol Violation|0|||
33447570|NCT00296036|62822639|FG005|Overall Study|Protocol Violation|3|||
33447571|NCT00089674|62822658|FG000|Overall Study|Physician Decision|4|||
33447572|NCT00089674|62822659|FG001|Overall Study|Physician Decision|2|||
33447573|NCT00089674|62822658|FG000|Overall Study|Adverse Event|23|||
33447574|NCT00089674|62822659|FG001|Overall Study|Adverse Event|29|||
33447575|NCT00089674|62822658|FG000|Overall Study|Withdrawal by Subject|143|||
33496222|NCT00004031|62874733|FG001|Overall Study|Refusal unrelated to adverse events|11|||
33496223|NCT00004031|62874732|FG000|Overall Study|Progression/relapse|9|||
33496224|NCT00004031|62874733|FG001|Overall Study|Progression/relapse|4|||
33496225|NCT00004031|62874732|FG000|Overall Study|Death|3|||
33496226|NCT00004031|62874733|FG001|Overall Study|Death|1|||
33496227|NCT00004031|62874732|FG000|Overall Study|Other- not protocol specified|3|||
33496228|NCT00004031|62874733|FG001|Overall Study|Other- not protocol specified|3|||
33496229|NCT00004031|62874732|FG000|Overall Study|Reason under review|3|||
33496230|NCT00004031|62874733|FG001|Overall Study|Reason under review|2|||
33496231|NCT03467217|62874743|FG000|Overall Study|Trial stopped early|5|||
33496232|NCT03467217|62874744|FG001|Overall Study|Trial stopped early|2|||
33608073|NCT01708174|63008223|FG002|Treatment Period|Death|1|||
33608074|NCT01708174|63008221|FG000|Treatment Period|Adverse Event|0|||
33447576|NCT00089674|62822659|FG001|Overall Study|Withdrawal by Subject|127|||
33447577|NCT00089674|62822658|FG000|Overall Study|Death|43|||
33608075|NCT01708174|63008222|FG001|Treatment Period|Adverse Event|1|||
33447578|NCT00089674|62822659|FG001|Overall Study|Death|43|||
33496233|NCT03467217|62874743|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
33608076|NCT01708174|63008223|FG002|Treatment Period|Adverse Event|0|||
33447579|NCT00089674|62822658|FG000|Overall Study|Disease progression|21|||
33496234|NCT03467217|62874744|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
33496235|NCT03467217|62874743|FG000|Overall Study|Lost to Follow-up|0|||
33447580|NCT00089674|62822659|FG001|Overall Study|Disease progression|23|||
33447581|NCT00089674|62822658|FG000|Overall Study|Ineligibility determined|8|||
33447582|NCT00089674|62822659|FG001|Overall Study|Ineligibility determined|10|||
33447583|NCT00089674|62822658|FG000|Overall Study|Lost to Follow-up|21|||
33496236|NCT03467217|62874744|FG001|Overall Study|Lost to Follow-up|2|||
33608077|NCT02488759|63008238|FG000|Overall Study|Disease progression|74|||
33496237|NCT00003875|62874750|FG000|Overall Study|Screen Failed|1|||
33496238|NCT03495453|62874756|FG000|Overall Study|Withdrawal by Subject|0|||
33496239|NCT03495453|62874757|FG001|Overall Study|Withdrawal by Subject|1|||
33496240|NCT03364686|62874763|FG000|Overall Study|Physician Decision|2|||
33496241|NCT03437577|62874770|FG000|Pre-Randomization|Withdrawal by Subject|0|||
33496242|NCT03437577|62874771|FG001|Pre-Randomization|Withdrawal by Subject|0|||
33496243|NCT03437577|62874772|FG002|Pre-Randomization|Withdrawal by Subject|10|||
33496244|NCT03437577|62874770|FG000|Post-Randomization|Physician Decision|0|||
33496245|NCT03437577|62874771|FG001|Post-Randomization|Physician Decision|2|||
33496246|NCT03437577|62874772|FG002|Post-Randomization|Physician Decision|0|||
33496247|NCT03336528|62874780|FG000|Overall Study|Protocol Violation|1|||
33447584|NCT00089674|62822659|FG001|Overall Study|Lost to Follow-up|17|||
33447585|NCT00089674|62822658|FG000|Overall Study|Noncompliance|7|||
33447586|NCT00089674|62822659|FG001|Overall Study|Noncompliance|3|||
33447587|NCT00089674|62822658|FG000|Overall Study|Other|5|||
33447588|NCT00089674|62822659|FG001|Overall Study|Other|9|||
33447589|NCT00089674|62822658|FG000|Overall Study|Requirement for alternative therapy|14|||
33447590|NCT00089674|62822659|FG001|Overall Study|Requirement for alternative therapy|4|||
33447591|NCT00313586|62822669|FG000|Overall Study|Disease progression|14|||
33447592|NCT00313586|62822670|FG001|Overall Study|Disease progression|19|||
33496248|NCT03336528|62874781|FG001|Overall Study|Protocol Violation|1|||
33496249|NCT03336528|62874780|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
33496250|NCT03336528|62874781|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
33496251|NCT03336528|62874780|FG000|Overall Study|Did not receive study medication|1|||
33496252|NCT03336528|62874781|FG001|Overall Study|Did not receive study medication|2|||
33496253|NCT03364608|62874789|FG000|Overall Study|Withdrawal by Subject|4|||
33496254|NCT03364608|62874789|FG000|Overall Study|Protocol Violation|2|||
33496255|NCT03364608|62874789|FG000|Overall Study|Lost to Follow-up|2|||
33496256|NCT00003869|62874803|FG000|Overall Study|Adverse Event|14|||
33496257|NCT00003869|62874804|FG001|Overall Study|Adverse Event|3|||
33496258|NCT00003869|62874803|FG000|Overall Study|Withdrawal by Subject|21|||
33496259|NCT00003869|62874804|FG001|Overall Study|Withdrawal by Subject|3|||
33496260|NCT00003869|62874803|FG000|Overall Study|Death|1|||
33496261|NCT00003869|62874804|FG001|Overall Study|Death|2|||
33496262|NCT00003869|62874803|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
33496263|NCT00003869|62874804|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
33496264|NCT03344640|62874812|FG000|Overall Study|Adverse Event|1|||
33496265|NCT03344640|62874813|FG001|Overall Study|Adverse Event|0|||
33496266|NCT03344640|62874812|FG000|Overall Study|Physician Decision|1|||
33496267|NCT03344640|62874813|FG001|Overall Study|Physician Decision|1|||
33496268|NCT03344640|62874812|FG000|Overall Study|Withdrawal by Subject|1|||
33496269|NCT03344640|62874813|FG001|Overall Study|Withdrawal by Subject|2|||
33496270|NCT03344640|62874812|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
33496271|NCT03344640|62874813|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
33496272|NCT03344562|62874821|FG000|Overall Study|Withdrawal by Subject|2|||
33496273|NCT03344562|62874822|FG001|Overall Study|Withdrawal by Subject|0|||
33496274|NCT00003659|62874828|FG000|Overall Study|Withdrawal by Subject|3|||
33496275|NCT03494985|62874836|FG000|Overall Study|Adverse Event|3|||
33496276|NCT03494985|62874837|FG001|Overall Study|Adverse Event|2|||
33496277|NCT03494985|62874838|FG002|Overall Study|Adverse Event|3|||
33496278|NCT03494985|62874839|FG003|Overall Study|Adverse Event|0|||
33496279|NCT03494985|62874836|FG000|Overall Study|Other (Withdrawal of consent)|2|||
33496280|NCT03494985|62874837|FG001|Overall Study|Other (Withdrawal of consent)|3|||
33496281|NCT03494985|62874838|FG002|Overall Study|Other (Withdrawal of consent)|2|||
33496282|NCT03494985|62874839|FG003|Overall Study|Other (Withdrawal of consent)|5|||
33496283|NCT03494985|62874836|FG000|Overall Study|Other (Not specified)|0|||
33496284|NCT03494985|62874837|FG001|Overall Study|Other (Not specified)|1|||
33496285|NCT03494985|62874838|FG002|Overall Study|Other (Not specified)|1|||
33496286|NCT03494985|62874839|FG003|Overall Study|Other (Not specified)|0|||
33496287|NCT03437265|62874849|FG000|Overall Study|Protocol Violation|6|||
33496288|NCT00003509|62874853|FG000|Overall Study|Not evaluable|5|||
33496289|NCT03344172|62874859|FG000|Overall Study|Received <1 dose of treatment|1|||
33447593|NCT00313586|62822671|FG002|Overall Study|Disease progression|10|||
33496290|NCT03344172|62874860|FG001|Overall Study|Received <1 dose of treatment|0|||
33496291|NCT03465891|62874868|FG000|Overall Study|Withdrawal by Subject|0|||
33496292|NCT03465891|62874869|FG001|Overall Study|Withdrawal by Subject|1|||
33496293|NCT03465891|62874868|FG000|Overall Study|Disease progression|1|||
33496294|NCT03465891|62874869|FG001|Overall Study|Disease progression|0|||
33496295|NCT03363906|62874875|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
33496296|NCT03363906|62874876|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
33447594|NCT00313586|62822672|FG003|Overall Study|Disease progression|3|||
33496297|NCT03363906|62874875|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
33496298|NCT03363906|62874876|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
33496299|NCT03363906|62874875|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
33496300|NCT03363906|62874876|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
33447595|NCT00313586|62822669|FG000|Overall Study|Adverse Event|12|||
33496301|NCT03363906|62874875|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
33496302|NCT03363906|62874876|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
33496303|NCT00003473|62874882|FG000|Overall Study|Three patients were not evaluable.|3|||
33496304|NCT03343626|62874894|FG000|Overall Study|Lost to Follow-up|4|||
33496305|NCT03343626|62874895|FG001|Overall Study|Lost to Follow-up|3|||
33496306|NCT03343626|62874896|FG002|Overall Study|Lost to Follow-up|2|||
33496307|NCT03343626|62874897|FG003|Overall Study|Lost to Follow-up|5|||
33496308|NCT03343626|62874898|FG004|Overall Study|Lost to Follow-up|4|||
33496309|NCT03343626|62874899|FG005|Overall Study|Lost to Follow-up|4|||
33496310|NCT03343626|62874900|FG006|Overall Study|Lost to Follow-up|4|||
33496311|NCT03343626|62874901|FG007|Overall Study|Lost to Follow-up|7|||
33496312|NCT03343626|62874894|FG000|Overall Study|Withdrawal of Consent|2|||
33496313|NCT03343626|62874895|FG001|Overall Study|Withdrawal of Consent|1|||
33496314|NCT03343626|62874896|FG002|Overall Study|Withdrawal of Consent|0|||
33496315|NCT03343626|62874897|FG003|Overall Study|Withdrawal of Consent|3|||
33496316|NCT03343626|62874898|FG004|Overall Study|Withdrawal of Consent|3|||
33496317|NCT03343626|62874899|FG005|Overall Study|Withdrawal of Consent|1|||
33496318|NCT03343626|62874900|FG006|Overall Study|Withdrawal of Consent|1|||
33496319|NCT03343626|62874901|FG007|Overall Study|Withdrawal of Consent|2|||
33496320|NCT03343626|62874894|FG000|Overall Study|Reason not Specified|0|||
33496321|NCT03343626|62874895|FG001|Overall Study|Reason not Specified|1|||
33496322|NCT03343626|62874896|FG002|Overall Study|Reason not Specified|0|||
33496323|NCT03343626|62874897|FG003|Overall Study|Reason not Specified|0|||
33496324|NCT03343626|62874898|FG004|Overall Study|Reason not Specified|0|||
33496325|NCT03343626|62874899|FG005|Overall Study|Reason not Specified|0|||
33496326|NCT03343626|62874900|FG006|Overall Study|Reason not Specified|0|||
33496327|NCT03343626|62874901|FG007|Overall Study|Reason not Specified|1|||
33496328|NCT03343626|62874894|FG000|Overall Study|Data Entry Error|0|||
33496329|NCT03343626|62874895|FG001|Overall Study|Data Entry Error|0|||
33496330|NCT03343626|62874896|FG002|Overall Study|Data Entry Error|0|||
33496331|NCT03343626|62874897|FG003|Overall Study|Data Entry Error|0|||
33496332|NCT03343626|62874898|FG004|Overall Study|Data Entry Error|0|||
33496333|NCT03343626|62874899|FG005|Overall Study|Data Entry Error|0|||
33496334|NCT03343626|62874900|FG006|Overall Study|Data Entry Error|0|||
33496335|NCT03343626|62874901|FG007|Overall Study|Data Entry Error|1|||
33496336|NCT03334422|62874926|FG000|Overall Study|Adverse Event|1|||
33496337|NCT03334422|62874927|FG001|Overall Study|Adverse Event|3|||
33496338|NCT03334422|62874928|FG002|Overall Study|Adverse Event|2|||
33496339|NCT03334422|62874929|FG003|Overall Study|Adverse Event|2|||
33496340|NCT03334422|62874926|FG000|Overall Study|Lack of Efficacy|10|||
33496341|NCT03334422|62874927|FG001|Overall Study|Lack of Efficacy|2|||
33496342|NCT03334422|62874928|FG002|Overall Study|Lack of Efficacy|7|||
33496343|NCT03334422|62874929|FG003|Overall Study|Lack of Efficacy|3|||
33496344|NCT03334422|62874926|FG000|Overall Study|Withdrawal by Subject|8|||
33496345|NCT03334422|62874927|FG001|Overall Study|Withdrawal by Subject|3|||
33496346|NCT03334422|62874928|FG002|Overall Study|Withdrawal by Subject|1|||
33496347|NCT03334422|62874929|FG003|Overall Study|Withdrawal by Subject|0|||
33496348|NCT03334422|62874926|FG000|Overall Study|Lost to Follow-up|0|||
33496349|NCT03334422|62874927|FG001|Overall Study|Lost to Follow-up|0|||
33496350|NCT03334422|62874928|FG002|Overall Study|Lost to Follow-up|0|||
33496351|NCT03334422|62874929|FG003|Overall Study|Lost to Follow-up|1|||
33496352|NCT03334422|62874926|FG000|Overall Study|Inability to obtain laboratory samples|0|||
33496353|NCT03334422|62874927|FG001|Overall Study|Inability to obtain laboratory samples|1|||
33496354|NCT03334422|62874928|FG002|Overall Study|Inability to obtain laboratory samples|0|||
33496355|NCT03334422|62874929|FG003|Overall Study|Inability to obtain laboratory samples|0|||
33496356|NCT03334422|62874926|FG000|Overall Study|Pregnancy|0|||
33496357|NCT03334422|62874927|FG001|Overall Study|Pregnancy|1|||
33496358|NCT03334422|62874928|FG002|Overall Study|Pregnancy|0|||
33496359|NCT03334422|62874929|FG003|Overall Study|Pregnancy|0|||
33496360|NCT03362190|62874948|FG000|Overall Study|Adverse Event|0|||
33496361|NCT03362190|62874949|FG001|Overall Study|Adverse Event|0|||
33496362|NCT03362190|62874950|FG002|Overall Study|Adverse Event|0|||
33496363|NCT03362190|62874951|FG003|Overall Study|Adverse Event|1|||
33496364|NCT03362190|62874948|FG000|Overall Study|Withdrawal by Subject|0|||
33496365|NCT03362190|62874949|FG001|Overall Study|Withdrawal by Subject|0|||
33608078|NCT02488759|63008239|FG001|Overall Study|Disease progression|110|||
33496366|NCT03362190|62874950|FG002|Overall Study|Withdrawal by Subject|0|||
33496367|NCT03362190|62874951|FG003|Overall Study|Withdrawal by Subject|1|||
33496368|NCT02323126|62874967|FG000|Overall Study|Patient / guardian decision|0|||
33608079|NCT02488759|63008240|FG002|Overall Study|Disease progression|62|||
33496369|NCT02323126|62874968|FG001|Overall Study|Patient / guardian decision|1|||
33496370|NCT02323126|62874969|FG002|Overall Study|Patient / guardian decision|2|||
33496371|NCT02323126|62874967|FG000|Overall Study|Progressive disease|14|||
33496372|NCT02323126|62874968|FG001|Overall Study|Progressive disease|8|||
33496373|NCT02323126|62874969|FG002|Overall Study|Progressive disease|14|||
33496374|NCT02323126|62874967|FG000|Overall Study|Physician Decision|0|||
33608080|NCT02488759|63008241|FG003|Overall Study|Disease progression|7|||
33496375|NCT02323126|62874968|FG001|Overall Study|Physician Decision|1|||
33496376|NCT02323126|62874969|FG002|Overall Study|Physician Decision|3|||
33496377|NCT02323126|62874967|FG000|Overall Study|Death|1|||
33608081|NCT02488759|63008242|FG004|Overall Study|Disease progression|4|||
33608082|NCT02488759|63008243|FG005|Overall Study|Disease progression|2|||
33608083|NCT02488759|63008238|FG000|Overall Study|Study drug toxicity|11|||
33496378|NCT02323126|62874968|FG001|Overall Study|Death|1|||
33496379|NCT02323126|62874969|FG002|Overall Study|Death|4|||
33496380|NCT02323126|62874967|FG000|Overall Study|Adverse Event|3|||
33496381|NCT02323126|62874968|FG001|Overall Study|Adverse Event|5|||
33496382|NCT02323126|62874969|FG002|Overall Study|Adverse Event|7|||
33496383|NCT03491553|62874986|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
33496384|NCT03491553|62874987|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
33496385|NCT03491553|62874988|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
33496386|NCT03491553|62874989|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
33496387|NCT03491553|62874990|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
33496388|NCT03491553|62874991|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
33496389|NCT03491553|62874986|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
33496390|NCT03491553|62874987|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
33496391|NCT03491553|62874988|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
33496392|NCT03491553|62874989|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
33496393|NCT03491553|62874990|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
33496394|NCT03491553|62874991|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
33496395|NCT00003377|62875012|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
33496396|NCT00003377|62875013|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
33496397|NCT00003377|62875014|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
33496398|NCT00003377|62875015|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
33496399|NCT00003377|62875016|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
33496400|NCT00003377|62875012|FG000|Period II|Ureteral stent complications|0|||
33496401|NCT00003377|62875013|FG001|Period II|Ureteral stent complications|0|||
33496402|NCT00003377|62875014|FG002|Period II|Ureteral stent complications|0|||
33496403|NCT00003377|62875015|FG003|Period II|Ureteral stent complications|0|||
33496404|NCT00003377|62875016|FG004|Period II|Ureteral stent complications|1|||
33496405|NCT00651742|62875029|FG000|Overall Study|Objective Disease Progression|22|||
33496406|NCT00651742|62875029|FG000|Overall Study|Toxicity|3|||
33608084|NCT02488759|63008239|FG001|Overall Study|Study drug toxicity|33|||
33608085|NCT02488759|63008240|FG002|Overall Study|Study drug toxicity|31|||
33608086|NCT02488759|63008241|FG003|Overall Study|Study drug toxicity|0|||
33608087|NCT02488759|63008242|FG004|Overall Study|Study drug toxicity|0|||
33608088|NCT02488759|63008243|FG005|Overall Study|Study drug toxicity|2|||
33608089|NCT02488759|63008238|FG000|Overall Study|Adverse event unrelated to study drug|9|||
33608090|NCT02488759|63008239|FG001|Overall Study|Adverse event unrelated to study drug|11|||
33608091|NCT02488759|63008240|FG002|Overall Study|Adverse event unrelated to study drug|7|||
33608092|NCT02488759|63008241|FG003|Overall Study|Adverse event unrelated to study drug|0|||
33608093|NCT02488759|63008242|FG004|Overall Study|Adverse event unrelated to study drug|1|||
33608094|NCT02488759|63008243|FG005|Overall Study|Adverse event unrelated to study drug|0|||
33608095|NCT02488759|63008238|FG000|Overall Study|Participant request to discontinue study treatment|7|||
33608096|NCT02488759|63008239|FG001|Overall Study|Participant request to discontinue study treatment|8|||
33608097|NCT02488759|63008240|FG002|Overall Study|Participant request to discontinue study treatment|4|||
33608098|NCT02488759|63008241|FG003|Overall Study|Participant request to discontinue study treatment|0|||
33608099|NCT02488759|63008242|FG004|Overall Study|Participant request to discontinue study treatment|0|||
33608100|NCT02488759|63008243|FG005|Overall Study|Participant request to discontinue study treatment|0|||
33608101|NCT02488759|63008238|FG000|Overall Study|Withdrawal by Subject|2|||
33608102|NCT02488759|63008239|FG001|Overall Study|Withdrawal by Subject|0|||
33323976|NCT00924664|62700371|FG001|Overall Study|Pregnancy|1|||
33323977|NCT00924664|62700370|FG000|Overall Study|Death|0|||
33323978|NCT00924664|62700371|FG001|Overall Study|Death|2|||
33447596|NCT00313586|62822670|FG001|Overall Study|Adverse Event|18|||
33447597|NCT00313586|62822671|FG002|Overall Study|Adverse Event|3|||
33447598|NCT00313586|62822672|FG003|Overall Study|Adverse Event|10|||
33447599|NCT00313586|62822669|FG000|Overall Study|Death|11|||
33447600|NCT00313586|62822670|FG001|Overall Study|Death|8|||
33447601|NCT00313586|62822671|FG002|Overall Study|Death|1|||
33447602|NCT00313586|62822672|FG003|Overall Study|Death|7|||
33447603|NCT00313586|62822669|FG000|Overall Study|Withdrawal by Subject|13|||
33447604|NCT00313586|62822670|FG001|Overall Study|Withdrawal by Subject|6|||
33447605|NCT00313586|62822671|FG002|Overall Study|Withdrawal by Subject|6|||
33447606|NCT00313586|62822672|FG003|Overall Study|Withdrawal by Subject|2|||
33447607|NCT00313586|62822669|FG000|Overall Study|Alternative therapy|3|||
33447608|NCT00313586|62822670|FG001|Overall Study|Alternative therapy|6|||
33447609|NCT00313586|62822671|FG002|Overall Study|Alternative therapy|2|||
33447610|NCT00313586|62822672|FG003|Overall Study|Alternative therapy|0|||
33447611|NCT00313586|62822669|FG000|Overall Study|Other complicating disease|2|||
33447612|NCT00313586|62822670|FG001|Overall Study|Other complicating disease|2|||
33447613|NCT00313586|62822671|FG002|Overall Study|Other complicating disease|0|||
33447614|NCT00313586|62822672|FG003|Overall Study|Other complicating disease|0|||
33496407|NCT00651742|62875029|FG000|Overall Study|Investigator Judgment|1|||
33496408|NCT00651742|62875029|FG000|Overall Study|Withdrawal of Consent|1|||
33496409|NCT00651742|62875029|FG000|Overall Study|Enrolled but not treated|1|||
33496410|NCT00002651|62875035|FG000|Induction|Adverse Event|44|||
33496411|NCT00002651|62875036|FG001|Induction|Adverse Event|0|||
33496412|NCT00002651|62875037|FG002|Induction|Adverse Event|0|||
33496413|NCT00002651|62875035|FG000|Induction|Refusal unrelated to adverse event|50|||
33496414|NCT00002651|62875036|FG001|Induction|Refusal unrelated to adverse event|0|||
33496415|NCT00002651|62875037|FG002|Induction|Refusal unrelated to adverse event|0|||
33496416|NCT00002651|62875035|FG000|Induction|Progression/relapse|274|||
33496417|NCT00002651|62875036|FG001|Induction|Progression/relapse|0|||
33496418|NCT00002651|62875037|FG002|Induction|Progression/relapse|0|||
33496419|NCT00002651|62875035|FG000|Induction|Death|62|||
33496420|NCT00002651|62875036|FG001|Induction|Death|0|||
33496421|NCT00002651|62875037|FG002|Induction|Death|0|||
33496422|NCT00002651|62875035|FG000|Induction|Other|823|||
33496423|NCT00002651|62875036|FG001|Induction|Other|0|||
33496424|NCT00002651|62875037|FG002|Induction|Other|0|||
33496425|NCT00002651|62875035|FG000|Induction|not eligible|90|||
33496426|NCT00002651|62875036|FG001|Induction|not eligible|0|||
33496427|NCT00002651|62875037|FG002|Induction|not eligible|0|||
33496428|NCT00002651|62875035|FG000|Consolidation and Randomization|Adverse Event|0|||
33496429|NCT00002651|62875036|FG001|Consolidation and Randomization|Adverse Event|36|||
33496430|NCT00002651|62875037|FG002|Consolidation and Randomization|Adverse Event|14|||
33496431|NCT00002651|62875035|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
33496432|NCT00002651|62875036|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
33496433|NCT00002651|62875037|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
33496434|NCT00002651|62875035|FG000|Consolidation and Randomization|Progression/relapse|0|||
33496435|NCT00002651|62875036|FG001|Consolidation and Randomization|Progression/relapse|295|||
33496436|NCT00002651|62875037|FG002|Consolidation and Randomization|Progression/relapse|298|||
33496437|NCT00002651|62875035|FG000|Consolidation and Randomization|Death|0|||
33496438|NCT00002651|62875036|FG001|Consolidation and Randomization|Death|38|||
33496439|NCT00002651|62875037|FG002|Consolidation and Randomization|Death|48|||
33496440|NCT00002651|62875035|FG000|Consolidation and Randomization|Other|0|||
33496441|NCT00002651|62875036|FG001|Consolidation and Randomization|Other|314|||
33496442|NCT00002651|62875037|FG002|Consolidation and Randomization|Other|313|||
33496443|NCT00002651|62875035|FG000|Consolidation and Randomization|not eligible|0|||
33496444|NCT00002651|62875036|FG001|Consolidation and Randomization|not eligible|102|||
33496445|NCT00002651|62875037|FG002|Consolidation and Randomization|not eligible|112|||
33496446|NCT00002597|62875047|FG000|Overall Study|Protocol Violation|19|||
33608103|NCT02488759|63008240|FG002|Overall Study|Withdrawal by Subject|3|||
33496447|NCT00002597|62875048|FG001|Overall Study|Protocol Violation|17|||
33496448|NCT00002597|62875047|FG000|Overall Study|Withdrawal by Subject|7|||
33496449|NCT00002597|62875048|FG001|Overall Study|Withdrawal by Subject|6|||
33496450|NCT03435081|62875057|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
33496451|NCT03435081|62875058|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
33496452|NCT03435081|62875059|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
33608104|NCT02488759|63008241|FG003|Overall Study|Withdrawal by Subject|0|||
33608105|NCT02488759|63008242|FG004|Overall Study|Withdrawal by Subject|0|||
33608106|NCT02488759|63008243|FG005|Overall Study|Withdrawal by Subject|2|||
33608107|NCT02488759|63008238|FG000|Overall Study|Lost to Follow-up|0|||
33608108|NCT02488759|63008239|FG001|Overall Study|Lost to Follow-up|1|||
33608109|NCT02488759|63008240|FG002|Overall Study|Lost to Follow-up|2|||
33608110|NCT02488759|63008241|FG003|Overall Study|Lost to Follow-up|0|||
33608111|NCT02488759|63008242|FG004|Overall Study|Lost to Follow-up|0|||
33608112|NCT02488759|63008243|FG005|Overall Study|Lost to Follow-up|0|||
33608113|NCT02488759|63008238|FG000|Overall Study|Maximum clinical benefit|3|||
33608114|NCT02488759|63008239|FG001|Overall Study|Maximum clinical benefit|0|||
33608115|NCT02488759|63008240|FG002|Overall Study|Maximum clinical benefit|1|||
33608116|NCT02488759|63008241|FG003|Overall Study|Maximum clinical benefit|0|||
33608117|NCT02488759|63008242|FG004|Overall Study|Maximum clinical benefit|0|||
33496453|NCT03435081|62875057|FG000|Week 0 to Week 16|Adverse Event|2|||
33496454|NCT03435081|62875058|FG001|Week 0 to Week 16|Adverse Event|2|||
33496455|NCT03435081|62875059|FG002|Week 0 to Week 16|Adverse Event|2|||
33496456|NCT03435081|62875057|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
33496457|NCT03435081|62875058|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
33496458|NCT03435081|62875059|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
33496459|NCT03435081|62875057|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
33496460|NCT03435081|62875058|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
33496461|NCT03435081|62875059|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
33608118|NCT02488759|63008243|FG005|Overall Study|Maximum clinical benefit|0|||
33496462|NCT03435081|62875057|FG000|Week 0 to Week 16|Pregnancy|1|||
33608119|NCT02488759|63008238|FG000|Overall Study|Completed treatment|0|||
33608120|NCT02488759|63008239|FG001|Overall Study|Completed treatment|0|||
33608121|NCT02488759|63008240|FG002|Overall Study|Completed treatment|0|||
33496463|NCT03435081|62875058|FG001|Week 0 to Week 16|Pregnancy|0|||
33608122|NCT02488759|63008241|FG003|Overall Study|Completed treatment|0|||
33496464|NCT03435081|62875059|FG002|Week 0 to Week 16|Pregnancy|0|||
33496465|NCT03435081|62875057|FG000|Week 0 to Week 16|Non-compliance|1|||
33496466|NCT03435081|62875058|FG001|Week 0 to Week 16|Non-compliance|0|||
33608123|NCT02488759|63008242|FG004|Overall Study|Completed treatment|0|||
33608124|NCT02488759|63008243|FG005|Overall Study|Completed treatment|116|||
33608125|NCT02488759|63008238|FG000|Overall Study|Other reasons|5|||
33608126|NCT02488759|63008239|FG001|Overall Study|Other reasons|32|||
33608127|NCT02488759|63008240|FG002|Overall Study|Other reasons|21|||
33608128|NCT02488759|63008241|FG003|Overall Study|Other reasons|1|||
33608129|NCT02488759|63008242|FG004|Overall Study|Other reasons|1|||
33608130|NCT02488759|63008243|FG005|Overall Study|Other reasons|1|||
33608131|NCT01605916|63008262|FG000|Overall Study|Adverse Event|1|||
33608132|NCT01605916|63008263|FG001|Overall Study|Adverse Event|0|||
33608133|NCT01605916|63008264|FG002|Overall Study|Adverse Event|0|||
33608134|NCT01605916|63008265|FG003|Overall Study|Adverse Event|1|||
33608135|NCT01605916|63008266|FG004|Overall Study|Adverse Event|0|||
33608136|NCT01605916|63008262|FG000|Overall Study|Lack of Efficacy|2|||
33496467|NCT03435081|62875059|FG002|Week 0 to Week 16|Non-compliance|2|||
33496468|NCT03435081|62875057|FG000|Week 0 to Week 16|Inadequate Response|0|||
33496469|NCT03435081|62875058|FG001|Week 0 to Week 16|Inadequate Response|1|||
33496470|NCT03435081|62875059|FG002|Week 0 to Week 16|Inadequate Response|0|||
33496471|NCT03435081|62875057|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
33496472|NCT03435081|62875058|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
33496473|NCT03435081|62875059|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
33496474|NCT03435081|62875057|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
33496475|NCT03435081|62875058|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
33496476|NCT03435081|62875059|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
33496477|NCT03435081|62875057|FG000|Week 16 to Week 104|Adverse Event|1|||
33496478|NCT03435081|62875058|FG001|Week 16 to Week 104|Adverse Event|0|||
33447615|NCT00313586|62822669|FG000|Overall Study|Did not achieve HI-major/better response|10|||
33447616|NCT00313586|62822670|FG001|Overall Study|Did not achieve HI-major/better response|7|||
33447617|NCT00313586|62822671|FG002|Overall Study|Did not achieve HI-major/better response|2|||
33447618|NCT00313586|62822672|FG003|Overall Study|Did not achieve HI-major/better response|1|||
33447619|NCT00313586|62822669|FG000|Overall Study|Physician Decision|2|||
33447620|NCT00313586|62822670|FG001|Overall Study|Physician Decision|1|||
33496479|NCT03435081|62875059|FG002|Week 16 to Week 104|Adverse Event|2|||
33496480|NCT03435081|62875057|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
33496481|NCT03435081|62875058|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
33496482|NCT03435081|62875059|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
33496483|NCT03435081|62875057|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
33496484|NCT03435081|62875058|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
33447621|NCT00313586|62822671|FG002|Overall Study|Physician Decision|0|||
33447622|NCT00313586|62822672|FG003|Overall Study|Physician Decision|0|||
33447623|NCT00313586|62822669|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
33447624|NCT00313586|62822670|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
33447625|NCT00313586|62822671|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
33447626|NCT00313586|62822672|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
33496485|NCT03435081|62875059|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
33496486|NCT03435081|62875057|FG000|Week 16 to Week 104|Non--Compliance|0|||
33447627|NCT00313586|62822669|FG000|Overall Study|Lost insurance|0|||
33447628|NCT00313586|62822670|FG001|Overall Study|Lost insurance|1|||
33447629|NCT00313586|62822671|FG002|Overall Study|Lost insurance|0|||
33447630|NCT00313586|62822672|FG003|Overall Study|Lost insurance|0|||
33447631|NCT00313586|62822669|FG000|Overall Study|Moved|0|||
33447632|NCT00313586|62822670|FG001|Overall Study|Moved|1|||
33447633|NCT00313586|62822671|FG002|Overall Study|Moved|0|||
33447634|NCT00313586|62822672|FG003|Overall Study|Moved|0|||
33447635|NCT00313586|62822669|FG000|Overall Study|Death before starting treatment|1|||
33447636|NCT00313586|62822670|FG001|Overall Study|Death before starting treatment|0|||
33447637|NCT00313586|62822671|FG002|Overall Study|Death before starting treatment|0|||
33447638|NCT00313586|62822672|FG003|Overall Study|Death before starting treatment|0|||
33447639|NCT00312572|62822682|FG000|Overall Study|Adverse Event|10|||
33608137|NCT01605916|63008263|FG001|Overall Study|Lack of Efficacy|3|||
33608138|NCT01605916|63008264|FG002|Overall Study|Lack of Efficacy|3|||
33447640|NCT00312572|62822683|FG001|Overall Study|Adverse Event|16|||
33447641|NCT00312572|62822682|FG000|Overall Study|Lost to Follow-up|1|||
33496487|NCT03435081|62875058|FG001|Week 16 to Week 104|Non--Compliance|0|||
33496488|NCT03435081|62875059|FG002|Week 16 to Week 104|Non--Compliance|1|||
33496489|NCT02738008|62875074|FG000|Overall Study|Study Terminated by Sponsor|1|||
33608139|NCT01605916|63008265|FG003|Overall Study|Lack of Efficacy|5|||
33608140|NCT01605916|63008266|FG004|Overall Study|Lack of Efficacy|4|||
33496490|NCT02738008|62875075|FG001|Overall Study|Study Terminated by Sponsor|5|||
33496491|NCT02738008|62875076|FG002|Overall Study|Study Terminated by Sponsor|3|||
33496492|NCT02738008|62875074|FG000|Overall Study|Adverse Event|0|||
33447642|NCT00312572|62822683|FG001|Overall Study|Lost to Follow-up|1|||
33447643|NCT00312572|62822682|FG000|Overall Study|Administrative|4|||
33447644|NCT00312572|62822683|FG001|Overall Study|Administrative|2|||
33447645|NCT00312572|62822682|FG000|Overall Study|Lack of Efficacy|1|||
33447646|NCT00312572|62822683|FG001|Overall Study|Lack of Efficacy|2|||
33447647|NCT00290888|62822693|FG000|Overall Study|Physician Decision|3|||
33447648|NCT00290888|62822694|FG001|Overall Study|Physician Decision|1|||
33447649|NCT00290732|62822703|FG000|Overall Study|Inability to instill drug intraductally.|0|||
33447650|NCT00290732|62822704|FG001|Overall Study|Inability to instill drug intraductally.|1|||
33447651|NCT00290732|62822705|FG002|Overall Study|Inability to instill drug intraductally.|1|||
33447652|NCT00290732|62822706|FG003|Overall Study|Inability to instill drug intraductally.|0|||
33447653|NCT00290732|62822707|FG004|Overall Study|Inability to instill drug intraductally.|0|||
33447654|NCT00312494|62822723|FG000|Overall Study|Randomized; not treated with study drug|9|||
33496493|NCT02738008|62875075|FG001|Overall Study|Adverse Event|1|||
33496494|NCT02738008|62875076|FG002|Overall Study|Adverse Event|2|||
33496495|NCT03489369|62875088|FG000|Overall Study|Documented Progressive Disease|3|||
33496496|NCT03489369|62875089|FG001|Overall Study|Documented Progressive Disease|2|||
33496497|NCT03489369|62875090|FG002|Overall Study|Documented Progressive Disease|3|||
33496498|NCT03489369|62875091|FG003|Overall Study|Documented Progressive Disease|6|||
33496499|NCT03489369|62875088|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
33496500|NCT03489369|62875089|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
33496501|NCT03489369|62875090|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
33496502|NCT03489369|62875091|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
33496503|NCT03257254|62875101|FG000|Overall Study|Withdrawal by Subject|7|||
33496504|NCT03257254|62875101|FG000|Overall Study|Lost to Follow-up|9|||
33496505|NCT03257254|62875101|FG000|Overall Study|Study discontinued by sponsor|5|||
33496506|NCT03738475|62875107|FG000|Overall Study|Participant Non-Compliance|1|||
33496507|NCT03738475|62875108|FG001|Overall Study|Participant Non-Compliance|0|||
33496508|NCT03084718|62875119|FG000|Overall Study|Withdrawal by Subject|4|||
33496509|NCT03084718|62875120|FG001|Overall Study|Withdrawal by Subject|3|||
33496510|NCT03084718|62875121|FG002|Overall Study|Withdrawal by Subject|4|||
33496511|NCT03084718|62875122|FG003|Overall Study|Withdrawal by Subject|0|||
33496512|NCT03084718|62875123|FG004|Overall Study|Withdrawal by Subject|0|||
33496513|NCT03084718|62875119|FG000|Overall Study|Physician Decision|1|||
33496514|NCT03084718|62875120|FG001|Overall Study|Physician Decision|0|||
33496515|NCT03084718|62875121|FG002|Overall Study|Physician Decision|0|||
33496516|NCT03084718|62875122|FG003|Overall Study|Physician Decision|0|||
33496517|NCT03084718|62875123|FG004|Overall Study|Physician Decision|0|||
33496518|NCT03084718|62875119|FG000|Overall Study|Adverse Event|3|||
33496519|NCT03084718|62875120|FG001|Overall Study|Adverse Event|5|||
33496520|NCT03084718|62875121|FG002|Overall Study|Adverse Event|5|||
33447655|NCT00312494|62822724|FG001|Overall Study|Randomized; not treated with study drug|10|||
33447656|NCT00312494|62822725|FG002|Overall Study|Randomized; not treated with study drug|5|||
33496521|NCT03084718|62875122|FG003|Overall Study|Adverse Event|8|||
33496522|NCT03084718|62875123|FG004|Overall Study|Adverse Event|2|||
33496523|NCT03084718|62875119|FG000|Overall Study|Lack of Efficacy|2|||
33496524|NCT03084718|62875120|FG001|Overall Study|Lack of Efficacy|0|||
33496525|NCT03084718|62875121|FG002|Overall Study|Lack of Efficacy|1|||
33496526|NCT03084718|62875122|FG003|Overall Study|Lack of Efficacy|4|||
33496527|NCT03084718|62875123|FG004|Overall Study|Lack of Efficacy|0|||
33496528|NCT03084718|62875119|FG000|Overall Study|Lost to Follow-up|0|||
33496529|NCT03084718|62875120|FG001|Overall Study|Lost to Follow-up|1|||
33496530|NCT03084718|62875121|FG002|Overall Study|Lost to Follow-up|0|||
33496531|NCT03084718|62875122|FG003|Overall Study|Lost to Follow-up|0|||
33496532|NCT03084718|62875123|FG004|Overall Study|Lost to Follow-up|2|||
33447657|NCT00312494|62822723|FG000|Overall Study|Adverse Event|33|||
33447658|NCT00312494|62822724|FG001|Overall Study|Adverse Event|15|||
33496533|NCT03084718|62875119|FG000|Overall Study|Protocol Violation|0|||
33496534|NCT03084718|62875120|FG001|Overall Study|Protocol Violation|0|||
33496535|NCT03084718|62875121|FG002|Overall Study|Protocol Violation|1|||
33496536|NCT03084718|62875122|FG003|Overall Study|Protocol Violation|0|||
33496537|NCT03084718|62875123|FG004|Overall Study|Protocol Violation|0|||
33496538|NCT03084718|62875119|FG000|Overall Study|Death|0|||
33496539|NCT03084718|62875120|FG001|Overall Study|Death|1|||
33496540|NCT03084718|62875121|FG002|Overall Study|Death|0|||
33496541|NCT03084718|62875122|FG003|Overall Study|Death|0|||
33496542|NCT03084718|62875123|FG004|Overall Study|Death|0|||
33496543|NCT03084718|62875119|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
33496544|NCT03084718|62875120|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
33496545|NCT03084718|62875121|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
33496546|NCT03084718|62875122|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
33496547|NCT03084718|62875123|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
33496548|NCT04321252|62875147|FG000|Overall Study|Withdrawal by Subject|0|||
33496549|NCT04321252|62875148|FG001|Overall Study|Withdrawal by Subject|0|||
33496550|NCT04321252|62875149|FG002|Overall Study|Withdrawal by Subject|0|||
33496551|NCT04321252|62875150|FG003|Overall Study|Withdrawal by Subject|0|||
33447659|NCT00312494|62822725|FG002|Overall Study|Adverse Event|11|||
33447660|NCT00312494|62822723|FG000|Overall Study|Lack of Efficacy|4|||
33447661|NCT00312494|62822724|FG001|Overall Study|Lack of Efficacy|6|||
33447662|NCT00312494|62822725|FG002|Overall Study|Lack of Efficacy|8|||
33447663|NCT00312494|62822723|FG000|Overall Study|Laboratory abnormality|1|||
33447664|NCT00312494|62822724|FG001|Overall Study|Laboratory abnormality|0|||
33496552|NCT04321252|62875151|FG004|Overall Study|Withdrawal by Subject|0|||
33496553|NCT04321252|62875152|FG005|Overall Study|Withdrawal by Subject|1|||
33496554|NCT04321252|62875153|FG006|Overall Study|Withdrawal by Subject|0|||
33496555|NCT04321252|62875154|FG007|Overall Study|Withdrawal by Subject|0|||
33496556|NCT04321252|62875155|FG008|Overall Study|Withdrawal by Subject|0|||
33496557|NCT03433677|62875187|FG000|Period 1|Protocol Violation|1|||
33496558|NCT03433677|62875188|FG001|Period 1|Protocol Violation|0|||
33496559|NCT03433677|62875187|FG000|Period 2|Withdrawal by Subject|1|||
33496560|NCT03433677|62875188|FG001|Period 2|Withdrawal by Subject|1|||
33496561|NCT02492711|62875198|FG000|Overall Study|Adverse Event|9|||
33496562|NCT02492711|62875199|FG001|Overall Study|Adverse Event|9|||
33496563|NCT02492711|62875200|FG002|Overall Study|Adverse Event|2|||
33496564|NCT02492711|62875198|FG000|Overall Study|Death|3|||
33496565|NCT02492711|62875199|FG001|Overall Study|Death|3|||
33496566|NCT02492711|62875200|FG002|Overall Study|Death|0|||
33496567|NCT02492711|62875198|FG000|Overall Study|Withdrawal by Subject|10|||
33496568|NCT02492711|62875199|FG001|Overall Study|Withdrawal by Subject|16|||
33496569|NCT02492711|62875200|FG002|Overall Study|Withdrawal by Subject|5|||
33496570|NCT02492711|62875198|FG000|Overall Study|Physician Decision|10|||
33608141|NCT01605916|63008262|FG000|Overall Study|Withdrawal by Subject|1|||
33608142|NCT01605916|63008263|FG001|Overall Study|Withdrawal by Subject|1|||
33608143|NCT01605916|63008264|FG002|Overall Study|Withdrawal by Subject|0|||
33608144|NCT01605916|63008265|FG003|Overall Study|Withdrawal by Subject|0|||
33608145|NCT01605916|63008266|FG004|Overall Study|Withdrawal by Subject|2|||
33608146|NCT01635283|63008279|FG000|Overall Study|Tumor Progression|3|||
33608147|NCT01635283|63008279|FG000|Overall Study|Lost to Follow-up|1|||
33608148|NCT01707004|63008286|FG000|Overall Study|Physician Decision|3|||
33608149|NCT01939197|63008298|FG000|Overall Study|Withdrawal by Subject|1|||
33608150|NCT01939197|63008299|FG001|Overall Study|Withdrawal by Subject|0|||
33608151|NCT01939197|63008300|FG002|Overall Study|Withdrawal by Subject|0|||
33608152|NCT01939197|63008301|FG003|Overall Study|Withdrawal by Subject|0|||
33608153|NCT01939197|63008302|FG004|Overall Study|Withdrawal by Subject|1|||
33608154|NCT01939197|63008303|FG005|Overall Study|Withdrawal by Subject|0|||
33608155|NCT01939197|63008304|FG006|Overall Study|Withdrawal by Subject|0|||
33608156|NCT01939197|63008298|FG000|Overall Study|Lost to Follow-up|0|||
33608157|NCT01939197|63008299|FG001|Overall Study|Lost to Follow-up|1|||
33447665|NCT00312494|62822725|FG002|Overall Study|Laboratory abnormality|0|||
33447666|NCT00312494|62822723|FG000|Overall Study|Lost to Follow-up|8|||
33447667|NCT00312494|62822724|FG001|Overall Study|Lost to Follow-up|8|||
33447668|NCT00312494|62822725|FG002|Overall Study|Lost to Follow-up|8|||
33447669|NCT00312494|62822723|FG000|Overall Study|Withdrawal by Subject|6|||
33447670|NCT00312494|62822724|FG001|Overall Study|Withdrawal by Subject|9|||
33447671|NCT00312494|62822725|FG002|Overall Study|Withdrawal by Subject|10|||
33447672|NCT00312494|62822723|FG000|Overall Study|Other|10|||
33447673|NCT00312494|62822724|FG001|Overall Study|Other|10|||
33447674|NCT00312494|62822725|FG002|Overall Study|Other|1|||
33608158|NCT01939197|63008300|FG002|Overall Study|Lost to Follow-up|0|||
33608159|NCT01939197|63008301|FG003|Overall Study|Lost to Follow-up|1|||
33447675|NCT00312338|62822735|FG000|Overall Study|Adverse Event|7|||
33447676|NCT00312338|62822736|FG001|Overall Study|Adverse Event|2|||
33447677|NCT00312338|62822735|FG000|Overall Study|Lost to Follow-up|9|||
33496571|NCT02492711|62875199|FG001|Overall Study|Physician Decision|6|||
33496572|NCT02492711|62875200|FG002|Overall Study|Physician Decision|4|||
33496573|NCT02492711|62875198|FG000|Overall Study|Lost to Follow-up|0|||
33496574|NCT02492711|62875199|FG001|Overall Study|Lost to Follow-up|0|||
33496575|NCT02492711|62875200|FG002|Overall Study|Lost to Follow-up|1|||
33608160|NCT01939197|63008302|FG004|Overall Study|Lost to Follow-up|3|||
33447678|NCT00312338|62822736|FG001|Overall Study|Lost to Follow-up|1|||
33608161|NCT01939197|63008303|FG005|Overall Study|Lost to Follow-up|1|||
33608162|NCT01939197|63008304|FG006|Overall Study|Lost to Follow-up|2|||
33608163|NCT01969851|63008337|FG000|Overall Study|Adverse Event|0|||
33608164|NCT01969851|63008338|FG001|Overall Study|Adverse Event|0|||
33608165|NCT01969851|63008339|FG002|Overall Study|Adverse Event|3|||
33608166|NCT01969851|63008337|FG000|Overall Study|Lack of Efficacy|0|||
33608167|NCT01969851|63008338|FG001|Overall Study|Lack of Efficacy|3|||
33608168|NCT01969851|63008339|FG002|Overall Study|Lack of Efficacy|1|||
33608169|NCT01969851|63008337|FG000|Overall Study|Withdrawal by Subject|1|||
33496576|NCT02492711|62875198|FG000|Overall Study|study treatment delay|2|||
33496577|NCT02492711|62875199|FG001|Overall Study|study treatment delay|1|||
33496578|NCT02492711|62875200|FG002|Overall Study|study treatment delay|0|||
33496579|NCT02492711|62875198|FG000|Overall Study|change in chemotherapy|0|||
33496580|NCT02492711|62875199|FG001|Overall Study|change in chemotherapy|1|||
33496581|NCT02492711|62875200|FG002|Overall Study|change in chemotherapy|0|||
33496582|NCT02492711|62875198|FG000|Overall Study|never treated|2|||
33496583|NCT02492711|62875199|FG001|Overall Study|never treated|4|||
33496584|NCT02492711|62875200|FG002|Overall Study|never treated|0|||
33496585|NCT02492711|62875198|FG000|Overall Study|Other|0|||
33496586|NCT02492711|62875199|FG001|Overall Study|Other|0|||
33496587|NCT02492711|62875200|FG002|Overall Study|Other|1|||
33496588|NCT01147822|62875215|FG000|Overall Study|Death|66|||
33496589|NCT01147822|62875216|FG001|Overall Study|Death|59|||
33496590|NCT01147822|62875215|FG000|Overall Study|Protocol Violation|0|||
33496591|NCT01147822|62875216|FG001|Overall Study|Protocol Violation|1|||
33496592|NCT01147822|62875215|FG000|Overall Study|Lost to Follow-up|3|||
33496593|NCT01147822|62875216|FG001|Overall Study|Lost to Follow-up|2|||
33496594|NCT01147822|62875215|FG000|Overall Study|Physician Decision|0|||
33496595|NCT01147822|62875216|FG001|Overall Study|Physician Decision|2|||
33496596|NCT01147822|62875215|FG000|Overall Study|Withdrawal by Subject|8|||
33496597|NCT01147822|62875216|FG001|Overall Study|Withdrawal by Subject|13|||
33496598|NCT01147822|62875215|FG000|Overall Study|Not Completed/Ongoing|111|||
33496599|NCT01147822|62875216|FG001|Overall Study|Not Completed/Ongoing|102|||
33496600|NCT03431337|62875224|FG000|Overall Study|Lost to Follow-up|21|||
33496601|NCT03431337|62875225|FG001|Overall Study|Lost to Follow-up|19|||
33496602|NCT03431337|62875224|FG000|Overall Study|Withdrawal by Subject|8|||
33496603|NCT03431337|62875225|FG001|Overall Study|Withdrawal by Subject|3|||
33496604|NCT03738241|62875245|FG000|Overall Study|Withdrawal by Subject|0|||
33496605|NCT03738241|62875246|FG001|Overall Study|Withdrawal by Subject|0|||
33496606|NCT03738241|62875247|FG002|Overall Study|Withdrawal by Subject|0|||
33496607|NCT03738241|62875248|FG003|Overall Study|Withdrawal by Subject|0|||
33496608|NCT03738241|62875249|FG004|Overall Study|Withdrawal by Subject|0|||
33496609|NCT03738241|62875250|FG005|Overall Study|Withdrawal by Subject|0|||
33496610|NCT03738241|62875251|FG006|Overall Study|Withdrawal by Subject|0|||
33496611|NCT03738241|62875252|FG007|Overall Study|Withdrawal by Subject|0|||
33496612|NCT03738241|62875253|FG008|Overall Study|Withdrawal by Subject|0|||
33496613|NCT03738241|62875254|FG009|Overall Study|Withdrawal by Subject|1|||
33496614|NCT03738241|62875245|FG000|Overall Study|Physician Decision|0|||
33496615|NCT03738241|62875246|FG001|Overall Study|Physician Decision|0|||
33496616|NCT03738241|62875247|FG002|Overall Study|Physician Decision|0|||
33496617|NCT03738241|62875248|FG003|Overall Study|Physician Decision|0|||
33496618|NCT03738241|62875249|FG004|Overall Study|Physician Decision|0|||
33496619|NCT03738241|62875250|FG005|Overall Study|Physician Decision|0|||
33608170|NCT01969851|63008338|FG001|Overall Study|Withdrawal by Subject|0|||
33608171|NCT01969851|63008339|FG002|Overall Study|Withdrawal by Subject|1|||
33608172|NCT01969851|63008337|FG000|Overall Study|No effective dose in Titration period|0|||
33608173|NCT01969851|63008338|FG001|Overall Study|No effective dose in Titration period|0|||
33496620|NCT03738241|62875251|FG006|Overall Study|Physician Decision|0|||
33496621|NCT03738241|62875252|FG007|Overall Study|Physician Decision|0|||
33496622|NCT03738241|62875253|FG008|Overall Study|Physician Decision|1|||
33496623|NCT03738241|62875254|FG009|Overall Study|Physician Decision|0|||
33496624|NCT03738241|62875245|FG000|Overall Study|Adverse Event|1|||
33496625|NCT03738241|62875246|FG001|Overall Study|Adverse Event|0|||
33496626|NCT03738241|62875247|FG002|Overall Study|Adverse Event|0|||
33496627|NCT03738241|62875248|FG003|Overall Study|Adverse Event|0|||
33608174|NCT01969851|63008339|FG002|Overall Study|No effective dose in Titration period|1|||
33608175|NCT01969851|63008337|FG000|Overall Study|Sponsor decision|0|||
33608176|NCT01969851|63008338|FG001|Overall Study|Sponsor decision|0|||
33608177|NCT01969851|63008339|FG002|Overall Study|Sponsor decision|1|||
33608178|NCT01938573|63008347|FG000|Overall Study|Lack of Efficacy|1|||
33608179|NCT01938573|63008348|FG001|Overall Study|Lack of Efficacy|0|||
33608180|NCT01938573|63008347|FG000|Overall Study|Operation at other hospital|1|||
33608181|NCT01938573|63008348|FG001|Overall Study|Operation at other hospital|0|||
33608182|NCT01937871|63008356|FG000|Overall Study|Adverse Event|6|||
33608183|NCT01937871|63008357|FG001|Overall Study|Adverse Event|6|||
33608184|NCT01937871|63008358|FG002|Overall Study|Adverse Event|2|||
33608185|NCT01937871|63008356|FG000|Overall Study|Lost to Follow-up|8|||
33608186|NCT01937871|63008357|FG001|Overall Study|Lost to Follow-up|2|||
33608187|NCT01937871|63008358|FG002|Overall Study|Lost to Follow-up|4|||
33608188|NCT01937871|63008356|FG000|Overall Study|Withdrawal by Subject|9|||
33608189|NCT01937871|63008357|FG001|Overall Study|Withdrawal by Subject|6|||
33608190|NCT01937871|63008358|FG002|Overall Study|Withdrawal by Subject|4|||
33608191|NCT01937871|63008356|FG000|Overall Study|Physician Decision|0|||
33608192|NCT01937871|63008357|FG001|Overall Study|Physician Decision|1|||
33608193|NCT01937871|63008358|FG002|Overall Study|Physician Decision|0|||
33608194|NCT01937871|63008356|FG000|Overall Study|Entry Criteria Not Met|1|||
33608195|NCT01937871|63008357|FG001|Overall Study|Entry Criteria Not Met|2|||
33608196|NCT01937871|63008358|FG002|Overall Study|Entry Criteria Not Met|1|||
33608197|NCT01269463|63008369|FG000|First Intervention|Withdrawal by Subject|1|||
33608198|NCT01269463|63008370|FG001|First Intervention|Withdrawal by Subject|0|||
33608199|NCT01269463|63008369|FG000|First Intervention|Adverse Event|1|||
33608200|NCT01269463|63008370|FG001|First Intervention|Adverse Event|0|||
33608201|NCT01269463|63008369|FG000|First Intervention|Lack of Efficacy|0|||
33608202|NCT01269463|63008370|FG001|First Intervention|Lack of Efficacy|1|||
33608203|NCT01269463|63008369|FG000|First Intervention|Physician Decision|0|||
33608204|NCT01269463|63008370|FG001|First Intervention|Physician Decision|1|||
33608205|NCT01706926|63008385|FG000|Overall Study|Lost to Follow-up|0|||
33608206|NCT01706926|63008386|FG001|Overall Study|Lost to Follow-up|0|||
33608207|NCT01706926|63008387|FG002|Overall Study|Lost to Follow-up|1|||
33608208|NCT01706926|63008388|FG003|Overall Study|Lost to Follow-up|0|||
33608209|NCT01706926|63008385|FG000|Overall Study|Withdrawal by Subject|2|||
33608210|NCT01706926|63008386|FG001|Overall Study|Withdrawal by Subject|0|||
33608211|NCT01706926|63008387|FG002|Overall Study|Withdrawal by Subject|1|||
33608212|NCT01706926|63008388|FG003|Overall Study|Withdrawal by Subject|2|||
33608213|NCT01706926|63008385|FG000|Overall Study|Other|4|||
33608214|NCT01706926|63008386|FG001|Overall Study|Other|4|||
33608215|NCT01706926|63008387|FG002|Overall Study|Other|4|||
33608216|NCT01706926|63008388|FG003|Overall Study|Other|3|||
33608217|NCT01634113|63008404|FG000|Overall Study|Not treated|0|||
33608218|NCT01634113|63008405|FG001|Overall Study|Not treated|0|||
33608219|NCT01634113|63008406|FG002|Overall Study|Not treated|1|||
33608220|NCT01706770|63008416|FG000|Overall Study|Lost to Follow-up|1|||
33608221|NCT01706770|63008417|FG001|Overall Study|Lost to Follow-up|0|||
33608222|NCT01706770|63008416|FG000|Overall Study|Physician Decision|1|||
33608223|NCT01706770|63008417|FG001|Overall Study|Physician Decision|0|||
33608224|NCT01937715|63008428|FG000|Overall Study|Death|0|||
33608225|NCT01937715|63008429|FG001|Overall Study|Death|0|||
33608226|NCT01937715|63008430|FG002|Overall Study|Death|0|||
33608227|NCT01937715|63008431|FG003|Overall Study|Death|1|||
33608228|NCT01937715|63008432|FG004|Overall Study|Death|0|||
33608229|NCT01937715|63008428|FG000|Overall Study|Withdrawal by Subject|0|||
33608230|NCT01937715|63008429|FG001|Overall Study|Withdrawal by Subject|1|||
33608231|NCT01937715|63008430|FG002|Overall Study|Withdrawal by Subject|0|||
33608232|NCT01937715|63008431|FG003|Overall Study|Withdrawal by Subject|0|||
33323979|NCT00924664|62700370|FG000|Overall Study|Study terminated by sponsor|199|||
33608233|NCT01937715|63008432|FG004|Overall Study|Withdrawal by Subject|2|||
33323980|NCT00924664|62700371|FG001|Overall Study|Study terminated by sponsor|330|||
33323981|NCT00924664|62700370|FG000|Overall Study|Other|29|||
33447679|NCT00312338|62822735|FG000|Overall Study|Withdrawal by Subject|4|||
33447680|NCT00312338|62822736|FG001|Overall Study|Withdrawal by Subject|0|||
33447681|NCT00312338|62822735|FG000|Overall Study|Subsequent infection|2|||
33447682|NCT00312338|62822736|FG001|Overall Study|Subsequent infection|0|||
33447683|NCT00290498|62822744|FG000|Overall Study|Death|2|||
33447684|NCT00290498|62822745|FG001|Overall Study|Death|0|||
33447685|NCT00290498|62822744|FG000|Overall Study|Physician Decision|1|||
33447686|NCT00290498|62822745|FG001|Overall Study|Physician Decision|0|||
33447687|NCT00290498|62822744|FG000|Overall Study|Withdrawal by Subject|1|||
33447688|NCT00290498|62822745|FG001|Overall Study|Withdrawal by Subject|0|||
33608234|NCT01937715|63008428|FG000|Overall Study|Other|0|||
33608235|NCT01937715|63008429|FG001|Overall Study|Other|0|||
33608236|NCT01937715|63008430|FG002|Overall Study|Other|0|||
33608237|NCT01937715|63008431|FG003|Overall Study|Other|3|||
33608238|NCT01937715|63008432|FG004|Overall Study|Other|0|||
33608239|NCT01937559|63008447|FG000|Overall Study|Physician Decision|3|||
33608240|NCT01937559|63008448|FG001|Overall Study|Physician Decision|3|||
33608241|NCT01937559|63008449|FG002|Overall Study|Physician Decision|0|||
33608242|NCT01937559|63008447|FG000|Overall Study|Withdrawal by Subject|6|||
33608243|NCT01937559|63008448|FG001|Overall Study|Withdrawal by Subject|4|||
33608244|NCT01937559|63008449|FG002|Overall Study|Withdrawal by Subject|0|||
33608245|NCT01937559|63008447|FG000|Overall Study|screen fail|2|||
33608246|NCT01937559|63008448|FG001|Overall Study|screen fail|4|||
33608247|NCT01937559|63008449|FG002|Overall Study|screen fail|0|||
33608248|NCT01960257|63008461|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
33608249|NCT01960257|63008462|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
33608250|NCT01960257|63008463|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
33608251|NCT01960257|63008461|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
33608252|NCT01960257|63008462|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
33608253|NCT01960257|63008463|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
33608254|NCT01960257|63008461|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
33608255|NCT01960257|63008462|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
33608256|NCT01960257|63008463|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
33608257|NCT01918371|63008475|FG000|Overall Study|Missing Data|1|||
33608258|NCT01918371|63008476|FG001|Overall Study|Missing Data|1|||
33608259|NCT01917747|63008484|FG000|Overall Study|Withdrawal by Subject|1|||
33496628|NCT03738241|62875249|FG004|Overall Study|Adverse Event|0|||
33496629|NCT03738241|62875250|FG005|Overall Study|Adverse Event|0|||
33496630|NCT03738241|62875251|FG006|Overall Study|Adverse Event|0|||
33608260|NCT01917747|63008485|FG001|Overall Study|Withdrawal by Subject|2|||
33608261|NCT01917747|63008484|FG000|Overall Study|Lost to Follow-up|18|||
33608262|NCT01917747|63008485|FG001|Overall Study|Lost to Follow-up|9|||
33608263|NCT01597791|63008497|FG000|Overall Study|Physician Decision|2|||
33608264|NCT01597791|63008498|FG001|Overall Study|Physician Decision|1|||
33608265|NCT01597791|63008497|FG000|Overall Study|Cesarean Section|6|||
33608266|NCT01597791|63008498|FG001|Overall Study|Cesarean Section|7|||
33608267|NCT01597791|63008497|FG000|Overall Study|Subject withdrawal|0|||
33608268|NCT01597791|63008498|FG001|Overall Study|Subject withdrawal|1|||
33608269|NCT01597791|63008497|FG000|Overall Study|Protocol Violation|0|||
33608270|NCT01597791|63008498|FG001|Overall Study|Protocol Violation|1|||
33608271|NCT01916967|63008507|FG000|Overall Study|Adverse Event|0|||
33608272|NCT01916967|63008508|FG001|Overall Study|Adverse Event|0|||
33608273|NCT01916967|63008509|FG002|Overall Study|Adverse Event|2|||
33608274|NCT01916967|63008507|FG000|Overall Study|Lack of Efficacy|0|||
33608275|NCT01916967|63008508|FG001|Overall Study|Lack of Efficacy|0|||
33608276|NCT01916967|63008509|FG002|Overall Study|Lack of Efficacy|6|||
33608277|NCT01916967|63008507|FG000|Overall Study|Physician Decision|0|||
33496631|NCT03738241|62875252|FG007|Overall Study|Adverse Event|0|||
33496632|NCT03738241|62875253|FG008|Overall Study|Adverse Event|0|||
33496633|NCT03738241|62875254|FG009|Overall Study|Adverse Event|0|||
33496634|NCT03430245|62875276|FG000|Overall Study|Withdrawal by Subject|6|||
33496635|NCT03430245|62875276|FG000|Overall Study|Lost to Follow-up|1|||
33496636|NCT03461289|62875280|FG000|Overall Study|Death|1|||
33496637|NCT03452943|62875286|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
33496638|NCT03452943|62875287|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
33496639|NCT03452943|62875286|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
33496640|NCT03452943|62875287|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
33496641|NCT03452943|62875286|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
33496642|NCT03452943|62875287|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
33496643|NCT03452943|62875286|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
33496644|NCT03452943|62875287|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
33496645|NCT03452943|62875286|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
33496646|NCT03452943|62875287|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
33496647|NCT03452943|62875286|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
33496648|NCT03452943|62875287|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
33496649|NCT03481725|62875295|FG000|Overall Study|Withdrawal by Subject|1|||
33608278|NCT01916967|63008508|FG001|Overall Study|Physician Decision|0|||
33608279|NCT01916967|63008509|FG002|Overall Study|Physician Decision|1|||
33608280|NCT01916967|63008507|FG000|Overall Study|Protocol Violation|0|||
33608281|NCT01916967|63008508|FG001|Overall Study|Protocol Violation|1|||
33608282|NCT01916967|63008509|FG002|Overall Study|Protocol Violation|0|||
33496650|NCT03481725|62875296|FG001|Overall Study|Withdrawal by Subject|0|||
33496651|NCT03480243|62875304|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
33608283|NCT01936623|63008521|FG000|Overall Study|Lost to Follow-up|0|||
33608284|NCT01936623|63008522|FG001|Overall Study|Lost to Follow-up|5|||
33608285|NCT01959243|63008530|FG000|Overall Study|Investigator Decision|3|||
33608286|NCT01959243|63008531|FG001|Overall Study|Investigator Decision|0|||
33608287|NCT01959243|63008530|FG000|Overall Study|Adverse Event|5|||
33608288|NCT01959243|63008531|FG001|Overall Study|Adverse Event|2|||
33608289|NCT01959243|63008530|FG000|Overall Study|Administrative reasons|2|||
33608290|NCT01959243|63008531|FG001|Overall Study|Administrative reasons|1|||
33608291|NCT01959243|63008530|FG000|Overall Study|Lost to Follow-up|3|||
33608292|NCT01959243|63008531|FG001|Overall Study|Lost to Follow-up|1|||
33608293|NCT01959165|63008541|FG000|Overall Study|Adverse Event|0|||
33608294|NCT01959165|63008542|FG001|Overall Study|Adverse Event|0|||
33608295|NCT01959165|63008543|FG002|Overall Study|Adverse Event|0|||
33608296|NCT01959165|63008544|FG003|Overall Study|Adverse Event|1|||
33608297|NCT01959165|63008541|FG000|Overall Study|Lack of Efficacy|1|||
33608298|NCT01959165|63008542|FG001|Overall Study|Lack of Efficacy|0|||
33608299|NCT01959165|63008543|FG002|Overall Study|Lack of Efficacy|0|||
33608300|NCT01959165|63008544|FG003|Overall Study|Lack of Efficacy|0|||
33608301|NCT01959165|63008541|FG000|Overall Study|overdose|0|||
33608302|NCT01959165|63008542|FG001|Overall Study|overdose|0|||
33608303|NCT01959165|63008543|FG002|Overall Study|overdose|0|||
33608304|NCT01959165|63008544|FG003|Overall Study|overdose|1|||
33608305|NCT01959165|63008541|FG000|Overall Study|Welfare recipient|0|||
33608306|NCT01959165|63008542|FG001|Overall Study|Welfare recipient|1|||
33608307|NCT01959165|63008543|FG002|Overall Study|Welfare recipient|0|||
33608308|NCT01959165|63008544|FG003|Overall Study|Welfare recipient|0|||
33608309|NCT01916109|63008554|FG000|Overall Study|Withdrawal by Subject|1|||
33608310|NCT01915095|63008565|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
33608311|NCT01915095|63008566|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
33608312|NCT01915095|63008567|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
33608313|NCT01915095|63008568|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
33608314|NCT01915095|63008569|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
33608315|NCT01958619|63008594|FG000|Overall Study|Protocol Violation|2|||
33608316|NCT01958619|63008595|FG001|Overall Study|Protocol Violation|0|||
33608317|NCT01958619|63008596|FG002|Overall Study|Protocol Violation|1|||
33608318|NCT01958619|63008597|FG003|Overall Study|Protocol Violation|0|||
33608319|NCT01752634|63008613|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
33608320|NCT01752634|63008614|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
33608321|NCT01752634|63008615|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
33608322|NCT01752634|63008616|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
33608323|NCT01752634|63008617|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
33447689|NCT00290498|62822744|FG000|Overall Study|Ineligible|3|||
33447690|NCT00290498|62822745|FG001|Overall Study|Ineligible|0|||
33447691|NCT00290498|62822744|FG000|Overall Study|Non-Compliance|1|||
33447692|NCT00290498|62822745|FG001|Overall Study|Non-Compliance|0|||
33447693|NCT00451451|62822756|FG000|Overall Study|Adverse Event|11|||
33447694|NCT00451451|62822757|FG001|Overall Study|Adverse Event|21|||
33447695|NCT00451451|62822758|FG002|Overall Study|Adverse Event|26|||
33447696|NCT00451451|62822759|FG003|Overall Study|Adverse Event|10|||
33447697|NCT00451451|62822756|FG000|Overall Study|Lost to Follow-up|11|||
33447698|NCT00451451|62822757|FG001|Overall Study|Lost to Follow-up|9|||
33496652|NCT03480243|62875304|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
33496653|NCT03426345|62875319|FG000|Overall Study|Adverse Event|4|||
33496654|NCT03426345|62875320|FG001|Overall Study|Adverse Event|4|||
33447699|NCT00451451|62822758|FG002|Overall Study|Lost to Follow-up|8|||
33447700|NCT00451451|62822759|FG003|Overall Study|Lost to Follow-up|11|||
33447701|NCT00451451|62822756|FG000|Overall Study|Consent Withdrawn|14|||
33447702|NCT00451451|62822757|FG001|Overall Study|Consent Withdrawn|9|||
33447703|NCT00451451|62822758|FG002|Overall Study|Consent Withdrawn|17|||
33447704|NCT00451451|62822759|FG003|Overall Study|Consent Withdrawn|17|||
33447705|NCT00451451|62822756|FG000|Overall Study|Investigator Decision|6|||
33447706|NCT00451451|62822757|FG001|Overall Study|Investigator Decision|2|||
33447707|NCT00451451|62822758|FG002|Overall Study|Investigator Decision|1|||
33447708|NCT00451451|62822759|FG003|Overall Study|Investigator Decision|2|||
33496655|NCT03426345|62875319|FG000|Overall Study|Lack of Efficacy|1|||
33496656|NCT03426345|62875320|FG001|Overall Study|Lack of Efficacy|0|||
33496657|NCT03426345|62875319|FG000|Overall Study|Withdrawal by Subject|5|||
33496658|NCT03426345|62875320|FG001|Overall Study|Withdrawal by Subject|6|||
33496659|NCT03426345|62875319|FG000|Overall Study|Lost to Follow-up|3|||
33608324|NCT01752634|63008618|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
33608325|NCT01752634|63008613|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
33608326|NCT01752634|63008614|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
33608327|NCT01752634|63008615|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
33608328|NCT01752634|63008616|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
33608329|NCT01752634|63008617|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
33608330|NCT01752634|63008618|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
33496660|NCT03426345|62875320|FG001|Overall Study|Lost to Follow-up|1|||
33447709|NCT00451451|62822756|FG000|Overall Study|Subject Non-Compliance|8|||
33496661|NCT03426345|62875319|FG000|Overall Study|Protocol Deviation|3|||
33447710|NCT00451451|62822757|FG001|Overall Study|Subject Non-Compliance|4|||
33447711|NCT00451451|62822758|FG002|Overall Study|Subject Non-Compliance|3|||
33447712|NCT00451451|62822759|FG003|Overall Study|Subject Non-Compliance|3|||
33447713|NCT00451451|62822756|FG000|Overall Study|Death|1|||
33447714|NCT00451451|62822757|FG001|Overall Study|Death|0|||
33447715|NCT00451451|62822758|FG002|Overall Study|Death|0|||
33447716|NCT00451451|62822759|FG003|Overall Study|Death|1|||
33447717|NCT00451451|62822756|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
33447718|NCT00451451|62822757|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
33447719|NCT00451451|62822758|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
33447720|NCT00451451|62822759|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
33447721|NCT03824912|62822774|FG000|Overall Study|Lost to Follow-up|18|||
33447722|NCT03824912|62822775|FG001|Overall Study|Lost to Follow-up|15|||
33447723|NCT03824912|62822776|FG002|Overall Study|Lost to Follow-up|8|||
33447724|NCT03824912|62822774|FG000|Overall Study|Negative Baseline Culture Result|118|||
33447725|NCT03824912|62822775|FG001|Overall Study|Negative Baseline Culture Result|112|||
33447726|NCT03824912|62822776|FG002|Overall Study|Negative Baseline Culture Result|57|||
33447727|NCT03824912|62822774|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33447728|NCT03824912|62822775|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33447729|NCT03824912|62822776|FG002|Overall Study|Non-Compliance with Study Drug|1|||
33447730|NCT03824912|62822774|FG000|Overall Study|Protocol Violation|1|||
33496662|NCT03426345|62875320|FG001|Overall Study|Protocol Deviation|4|||
33496663|NCT03426345|62875319|FG000|Overall Study|Reason Not Specified|1|||
33496664|NCT03426345|62875320|FG001|Overall Study|Reason Not Specified|2|||
33496665|NCT03426345|62875319|FG000|Overall Study|Missing Completion Status|1|||
33323982|NCT00924664|62700371|FG001|Overall Study|Other|52|||
33323983|NCT00924664|62700370|FG000|Overall Study|Randomized but not Treated|1|||
33608331|NCT01752634|63008613|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
33608332|NCT01752634|63008614|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
33447731|NCT03824912|62822775|FG001|Overall Study|Protocol Violation|4|||
33447732|NCT03824912|62822776|FG002|Overall Study|Protocol Violation|1|||
33447733|NCT03824912|62822774|FG000|Overall Study|Withdrawal by Subject|3|||
33323984|NCT00924664|62700371|FG001|Overall Study|Randomized but not Treated|0|||
33496666|NCT03426345|62875320|FG001|Overall Study|Missing Completion Status|0|||
33496667|NCT03426267|62875329|FG000|Overall Study|Physician Decision|1|||
33496668|NCT03426267|62875330|FG001|Overall Study|Physician Decision|4|||
33496669|NCT03426267|62875329|FG000|Overall Study|Lost to Follow-up|1|||
33496670|NCT03426267|62875330|FG001|Overall Study|Lost to Follow-up|0|||
33496671|NCT03426267|62875329|FG000|Overall Study|Withdrawal by Subject|4|||
33496672|NCT03426267|62875330|FG001|Overall Study|Withdrawal by Subject|10|||
33496673|NCT03426267|62875329|FG000|Overall Study|Protocol Violation|1|||
33496674|NCT03426267|62875330|FG001|Overall Study|Protocol Violation|3|||
33496675|NCT03426267|62875329|FG000|Overall Study|Adverse Event|9|||
33496676|NCT03426267|62875330|FG001|Overall Study|Adverse Event|27|||
33496677|NCT03426267|62875329|FG000|Overall Study|Prohibited Treatment Intake|2|||
33496678|NCT03426267|62875330|FG001|Overall Study|Prohibited Treatment Intake|3|||
33496679|NCT03426267|62875329|FG000|Overall Study|Lack of Efficacy|0|||
33496680|NCT03426267|62875330|FG001|Overall Study|Lack of Efficacy|25|||
33496681|NCT03426267|62875329|FG000|Overall Study|other|3|||
33496682|NCT03426267|62875330|FG001|Overall Study|other|0|||
33496683|NCT03412929|62875336|FG000|Overall Study|Protocol Violation|3|||
33496684|NCT03451773|62875342|FG000|Overall Study|Death on study|1|||
33496685|NCT03451773|62875343|FG001|Overall Study|Death on study|5|||
33496686|NCT03451773|62875342|FG000|Overall Study|Death during follow-up period|0|||
33496687|NCT03451773|62875343|FG001|Overall Study|Death during follow-up period|1|||
33496688|NCT03425253|62875350|FG000|Overall Study|Adverse Event|2|||
33496689|NCT03425253|62875350|FG000|Overall Study|Lost to Follow-up|3|||
33496690|NCT03425253|62875350|FG000|Overall Study|Withdrew Consent|6|||
33496691|NCT03425253|62875350|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
33496692|NCT03424239|62875355|FG000|Overall Study|Withdrawal by Subject|2|||
33496693|NCT03451071|62875359|FG000|First Vaccine|Withdrawal by Subject|1|||
33496694|NCT03451071|62875359|FG000|Second Vaccine|Lost to Follow-up|19|||
33496695|NCT03451071|62875359|FG000|Third Vaccine|Lost to Follow-up|22|||
33496696|NCT03451071|62875359|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
33496697|NCT03449979|62875367|FG000|Overall Study|Technical difficulty|0|||
33608333|NCT01752634|63008615|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
33323985|NCT00600067|62700379|FG000|Overall Study|Adverse Event|0|||
33447734|NCT03824912|62822775|FG001|Overall Study|Withdrawal by Subject|2|||
33496698|NCT03449979|62875368|FG001|Overall Study|Technical difficulty|0|||
33496699|NCT03449979|62875369|FG002|Overall Study|Technical difficulty|0|||
33496700|NCT03449979|62875370|FG003|Overall Study|Technical difficulty|1|||
33496701|NCT03449199|62875383|FG000|Overall Study|Lost to Follow-up|1|||
33496702|NCT03449199|62875384|FG001|Overall Study|Lost to Follow-up|1|||
33323986|NCT00600067|62700380|FG001|Overall Study|Adverse Event|1|||
33447735|NCT03824912|62822776|FG002|Overall Study|Withdrawal by Subject|1|||
33447736|NCT03824912|62822774|FG000|Overall Study|Participation in another study|0|||
33496703|NCT03449199|62875385|FG002|Overall Study|Lost to Follow-up|0|||
33496704|NCT03449199|62875383|FG000|Overall Study|Protocol Deviation|0|||
33496705|NCT03449199|62875384|FG001|Overall Study|Protocol Deviation|0|||
33496706|NCT03449199|62875385|FG002|Overall Study|Protocol Deviation|1|||
33496707|NCT03449199|62875383|FG000|Overall Study|Withdrawal by Subject|0|||
33496708|NCT03449199|62875384|FG001|Overall Study|Withdrawal by Subject|0|||
33496709|NCT03449199|62875385|FG002|Overall Study|Withdrawal by Subject|1|||
33496710|NCT03421431|62875399|FG000|Overall Study|Adverse Event|2|||
33496711|NCT03421431|62875400|FG001|Overall Study|Adverse Event|1|||
33496712|NCT03421431|62875401|FG002|Overall Study|Adverse Event|12|||
33496713|NCT03421431|62875399|FG000|Overall Study|Lost to Follow-up|1|||
33496714|NCT03421431|62875400|FG001|Overall Study|Lost to Follow-up|1|||
33496715|NCT03421431|62875401|FG002|Overall Study|Lost to Follow-up|1|||
33496716|NCT03421431|62875399|FG000|Overall Study|Withdrawal by Subject|3|||
33496717|NCT03421431|62875400|FG001|Overall Study|Withdrawal by Subject|2|||
33496718|NCT03421431|62875401|FG002|Overall Study|Withdrawal by Subject|1|||
33496719|NCT03421431|62875399|FG000|Overall Study|Protocol Violation|0|||
33496720|NCT03421431|62875400|FG001|Overall Study|Protocol Violation|1|||
33496721|NCT03421431|62875401|FG002|Overall Study|Protocol Violation|0|||
33496722|NCT03421431|62875399|FG000|Overall Study|Participant met Stopping Rules|0|||
33496723|NCT03421431|62875400|FG001|Overall Study|Participant met Stopping Rules|1|||
33496724|NCT03421431|62875401|FG002|Overall Study|Participant met Stopping Rules|0|||
33496725|NCT03448419|62875413|FG000|Overall Study|Adverse Event|10|||
33496726|NCT03448419|62875414|FG001|Overall Study|Adverse Event|9|||
33496727|NCT03448419|62875413|FG000|Overall Study|Lost to Follow-up|0|||
33496728|NCT03448419|62875414|FG001|Overall Study|Lost to Follow-up|2|||
33496729|NCT03448419|62875413|FG000|Overall Study|Withdrawal by Subject|3|||
33496730|NCT03448419|62875414|FG001|Overall Study|Withdrawal by Subject|1|||
33496731|NCT03448419|62875413|FG000|Overall Study|Not treated|0|||
33496732|NCT03448419|62875414|FG001|Overall Study|Not treated|1|||
33496733|NCT03448419|62875413|FG000|Overall Study|Patient did not attend all visits|0|||
33496734|NCT03448419|62875414|FG001|Overall Study|Patient did not attend all visits|2|||
33496735|NCT03448419|62875413|FG000|Overall Study|Withdrawn by Sponsor|0|||
33496736|NCT03448419|62875414|FG001|Overall Study|Withdrawn by Sponsor|1|||
33496737|NCT03419403|62875425|FG000|Overall Study|Withdrawal by Subject|5|||
33496738|NCT03419403|62875426|FG001|Overall Study|Withdrawal by Subject|2|||
33608334|NCT01752634|63008616|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
33608335|NCT01752634|63008617|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
33608336|NCT01752634|63008618|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
33447737|NCT03824912|62822775|FG001|Overall Study|Participation in another study|1|||
33447738|NCT03824912|62822776|FG002|Overall Study|Participation in another study|0|||
33447739|NCT00461123|62822786|FG000|Overall Study|Adverse Event|1|||
33447740|NCT00461123|62822787|FG001|Overall Study|Adverse Event|0|||
33447741|NCT00461123|62822786|FG000|Overall Study|Lost to Follow-up|1|||
33447742|NCT00461123|62822787|FG001|Overall Study|Lost to Follow-up|1|||
33447743|NCT00461123|62822786|FG000|Overall Study|Protocol Violation|3|||
33447744|NCT00461123|62822787|FG001|Overall Study|Protocol Violation|2|||
33447745|NCT00461123|62822786|FG000|Overall Study|Withdrawal by Subject|1|||
33447746|NCT00461123|62822787|FG001|Overall Study|Withdrawal by Subject|3|||
33447747|NCT00290342|62822795|FG000|Overall Study|Other|0|||
33447748|NCT00290342|62822796|FG001|Overall Study|Other|1|||
33447749|NCT00290342|62822795|FG000|Overall Study|Withdrawal by Subject|6|||
33447750|NCT00290342|62822796|FG001|Overall Study|Withdrawal by Subject|4|||
33447751|NCT00290342|62822795|FG000|Overall Study|Lost to Follow-up|1|||
33447752|NCT00290342|62822796|FG001|Overall Study|Lost to Follow-up|0|||
33447753|NCT00460811|62822807|FG000|Overall Study|Adverse Event|4|||
33447754|NCT00460811|62822808|FG001|Overall Study|Adverse Event|6|||
33447755|NCT00460811|62822809|FG002|Overall Study|Adverse Event|3|||
33447756|NCT00460811|62822810|FG003|Overall Study|Adverse Event|10|||
33447757|NCT00460811|62822811|FG004|Overall Study|Adverse Event|2|||
33447758|NCT00460811|62822807|FG000|Overall Study|Noncompliance|1|||
33447759|NCT00460811|62822808|FG001|Overall Study|Noncompliance|0|||
33447760|NCT00460811|62822809|FG002|Overall Study|Noncompliance|0|||
33447761|NCT00460811|62822810|FG003|Overall Study|Noncompliance|2|||
33447762|NCT00460811|62822811|FG004|Overall Study|Noncompliance|1|||
33447763|NCT00460811|62822807|FG000|Overall Study|Withdrawal by Subject|7|||
33447764|NCT00460811|62822808|FG001|Overall Study|Withdrawal by Subject|7|||
33496739|NCT03419403|62875427|FG002|Overall Study|Withdrawal by Subject|5|||
33496740|NCT03419403|62875428|FG003|Overall Study|Withdrawal by Subject|1|||
33496741|NCT03419403|62875425|FG000|Overall Study|Progressive disease (per protocol)|0|||
33496742|NCT03419403|62875426|FG001|Overall Study|Progressive disease (per protocol)|2|||
33496743|NCT03419403|62875427|FG002|Overall Study|Progressive disease (per protocol)|2|||
33496744|NCT03419403|62875428|FG003|Overall Study|Progressive disease (per protocol)|0|||
33447765|NCT00460811|62822809|FG002|Overall Study|Withdrawal by Subject|6|||
33447766|NCT00460811|62822810|FG003|Overall Study|Withdrawal by Subject|3|||
33447767|NCT00460811|62822811|FG004|Overall Study|Withdrawal by Subject|11|||
33496745|NCT03419403|62875425|FG000|Overall Study|Other, not specified|6|||
33496746|NCT03419403|62875426|FG001|Overall Study|Other, not specified|4|||
33496747|NCT03419403|62875427|FG002|Overall Study|Other, not specified|5|||
33496748|NCT03419403|62875428|FG003|Overall Study|Other, not specified|1|||
33496749|NCT03419403|62875425|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
33608337|NCT01752634|63008613|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
33608338|NCT01752634|63008614|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
33496750|NCT03419403|62875426|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
33496751|NCT03419403|62875427|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
33496752|NCT03419403|62875428|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
33496753|NCT03447249|62875438|FG000|Overall Study|Adverse Event|1|||
33496754|NCT03447249|62875439|FG001|Overall Study|Adverse Event|0|||
33496755|NCT03447249|62875438|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
33496756|NCT03447249|62875439|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
33496757|NCT03447249|62875438|FG000|Overall Study|Other|3|||
33496758|NCT03447249|62875439|FG001|Overall Study|Other|0|||
33496759|NCT03418545|62875449|FG000|Overall Study|Withdrawal by Participant|2|||
33608339|NCT01752634|63008615|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
33608340|NCT01752634|63008616|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
33608341|NCT01752634|63008617|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
33608342|NCT01752634|63008618|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
33496760|NCT03418545|62875450|FG001|Overall Study|Withdrawal by Participant|4|||
33496761|NCT03418545|62875449|FG000|Overall Study|Lost to Follow-up|3|||
33496762|NCT03418545|62875450|FG001|Overall Study|Lost to Follow-up|5|||
33496763|NCT03418545|62875449|FG000|Overall Study|Reason Not Specified|0|||
33608343|NCT01752634|63008613|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
33608344|NCT01752634|63008614|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
33608345|NCT01752634|63008615|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
33608346|NCT01752634|63008616|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
33608347|NCT01752634|63008617|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
33608348|NCT01752634|63008618|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
33496764|NCT03418545|62875450|FG001|Overall Study|Reason Not Specified|1|||
33608349|NCT01752634|63008613|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
33608350|NCT01752634|63008614|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
33608351|NCT01752634|63008615|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
33608352|NCT01752634|63008616|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
33608353|NCT01752634|63008617|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
33608354|NCT01752634|63008618|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
33608355|NCT01752634|63008613|FG000|Week 24 to Week 260|Physician Decision|1|||
33608356|NCT01752634|63008614|FG001|Week 24 to Week 260|Physician Decision|2|||
33608357|NCT01752634|63008615|FG002|Week 24 to Week 260|Physician Decision|4|||
33608358|NCT01752634|63008616|FG003|Week 24 to Week 260|Physician Decision|2|||
33608359|NCT01752634|63008617|FG004|Week 24 to Week 260|Physician Decision|1|||
33608360|NCT01752634|63008618|FG005|Week 24 to Week 260|Physician Decision|0|||
33608361|NCT01752634|63008613|FG000|Week 24 to Week 260|Death|0|||
33323987|NCT00600067|62700379|FG000|Overall Study|Lost to Follow-up|2|||
33496765|NCT03418545|62875449|FG000|Overall Study|Missing Completion Status|0|||
33496766|NCT03418545|62875450|FG001|Overall Study|Missing Completion Status|1|||
33496767|NCT03446781|62875461|FG000|Overall Study|Lost to Follow-up|11|||
33496768|NCT03446781|62875462|FG001|Overall Study|Lost to Follow-up|5|||
33496769|NCT03446781|62875461|FG000|Overall Study|Withdrawal by Subject|9|||
33608362|NCT01752634|63008614|FG001|Week 24 to Week 260|Death|1|||
33608363|NCT01752634|63008615|FG002|Week 24 to Week 260|Death|0|||
33608364|NCT01752634|63008616|FG003|Week 24 to Week 260|Death|0|||
33608365|NCT01752634|63008617|FG004|Week 24 to Week 260|Death|0|||
33608366|NCT01752634|63008618|FG005|Week 24 to Week 260|Death|0|||
33608367|NCT01752634|63008613|FG000|Week 24 to Week 260|Pregnancy|0|||
33608368|NCT01752634|63008614|FG001|Week 24 to Week 260|Pregnancy|0|||
33608369|NCT01752634|63008615|FG002|Week 24 to Week 260|Pregnancy|1|||
33608370|NCT01752634|63008616|FG003|Week 24 to Week 260|Pregnancy|0|||
33608371|NCT01752634|63008617|FG004|Week 24 to Week 260|Pregnancy|0|||
33608372|NCT01752634|63008618|FG005|Week 24 to Week 260|Pregnancy|0|||
33608373|NCT01752634|63008613|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
33496770|NCT03446781|62875462|FG001|Overall Study|Withdrawal by Subject|7|||
33496771|NCT03446781|62875461|FG000|Overall Study|Adverse Event|8|||
33496772|NCT03446781|62875462|FG001|Overall Study|Adverse Event|2|||
33496773|NCT03446781|62875461|FG000|Overall Study|Protocol Violation|0|||
33496774|NCT03446781|62875462|FG001|Overall Study|Protocol Violation|3|||
33496775|NCT03445065|62875494|FG000|Overall Study|Withdrawal by Subject|3|||
33496776|NCT03445065|62875495|FG001|Overall Study|Withdrawal by Subject|6|||
33496777|NCT03445065|62875496|FG002|Overall Study|Withdrawal by Subject|2|||
33496778|NCT03445065|62875497|FG003|Overall Study|Withdrawal by Subject|2|||
33496779|NCT03445065|62875494|FG000|Overall Study|Other|4|||
33496780|NCT03445065|62875495|FG001|Overall Study|Other|3|||
33496781|NCT03445065|62875496|FG002|Overall Study|Other|3|||
33496782|NCT03445065|62875497|FG003|Overall Study|Other|1|||
33496783|NCT01224106|62875522|FG000|Double-Blind Treatment Phase|Death|3|||
33496784|NCT01224106|62875523|FG001|Double-Blind Treatment Phase|Death|0|||
33496785|NCT01224106|62875524|FG002|Double-Blind Treatment Phase|Death|0|||
33496786|NCT01224106|62875525|FG003|Double-Blind Treatment Phase|Death|0|||
33496787|NCT01224106|62875526|FG004|Double-Blind Treatment Phase|Death|0|||
33496788|NCT01224106|62875522|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
33496789|NCT01224106|62875523|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
33496790|NCT01224106|62875524|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
33496791|NCT01224106|62875525|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
33496792|NCT01224106|62875526|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
33496793|NCT01224106|62875522|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
33496794|NCT01224106|62875523|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
33496795|NCT01224106|62875524|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
33496796|NCT01224106|62875525|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
33496797|NCT01224106|62875526|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
33496798|NCT01224106|62875522|FG000|Double-Blind Treatment Phase|Other|0|||
33496799|NCT01224106|62875523|FG001|Double-Blind Treatment Phase|Other|0|||
33496800|NCT01224106|62875524|FG002|Double-Blind Treatment Phase|Other|1|||
33496801|NCT01224106|62875525|FG003|Double-Blind Treatment Phase|Other|0|||
33496802|NCT01224106|62875526|FG004|Double-Blind Treatment Phase|Other|0|||
33496803|NCT01224106|62875522|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
33496804|NCT01224106|62875523|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
33496805|NCT01224106|62875524|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
33496806|NCT01224106|62875525|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
33496807|NCT01224106|62875526|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
33496808|NCT01224106|62875522|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
33496809|NCT01224106|62875523|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
33496810|NCT01224106|62875524|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
33496811|NCT01224106|62875525|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
33496812|NCT01224106|62875526|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
33496813|NCT01224106|62875522|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
33496814|NCT01224106|62875523|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33496815|NCT01224106|62875524|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
33496816|NCT01224106|62875525|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33496817|NCT01224106|62875526|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33496818|NCT01224106|62875522|FG000|Open-Label Extension (OLE) Phase|Death|0|||
33608374|NCT01752634|63008614|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
33496819|NCT01224106|62875523|FG001|Open-Label Extension (OLE) Phase|Death|0|||
33496820|NCT01224106|62875524|FG002|Open-Label Extension (OLE) Phase|Death|0|||
33608375|NCT01752634|63008615|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
33608376|NCT01752634|63008616|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
33608377|NCT01752634|63008617|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
33496821|NCT01224106|62875525|FG003|Open-Label Extension (OLE) Phase|Death|1|||
33496822|NCT01224106|62875526|FG004|Open-Label Extension (OLE) Phase|Death|3|||
33496823|NCT01224106|62875522|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
33496824|NCT01224106|62875523|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
33496825|NCT01224106|62875524|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
33496826|NCT01224106|62875525|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
33496827|NCT01224106|62875526|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
33496828|NCT01224106|62875522|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
33496829|NCT01224106|62875523|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
33496830|NCT01224106|62875524|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
33496831|NCT01224106|62875525|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
33496832|NCT01224106|62875526|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
33496833|NCT01224106|62875522|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
33496834|NCT01224106|62875523|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
33496835|NCT01224106|62875524|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
33496836|NCT01224106|62875525|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
33496837|NCT01224106|62875526|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
33496838|NCT01224106|62875522|FG000|Open-Label Extension (OLE) Phase|Other|0|||
33496839|NCT01224106|62875523|FG001|Open-Label Extension (OLE) Phase|Other|0|||
33496840|NCT01224106|62875524|FG002|Open-Label Extension (OLE) Phase|Other|0|||
33496841|NCT01224106|62875525|FG003|Open-Label Extension (OLE) Phase|Other|5|||
33496842|NCT01224106|62875526|FG004|Open-Label Extension (OLE) Phase|Other|3|||
33496843|NCT03409107|62875546|FG000|Overall Study|Withdrawal by Subject|4|||
33496844|NCT03409107|62875547|FG001|Overall Study|Withdrawal by Subject|2|||
33496845|NCT03409107|62875546|FG000|Overall Study|Physician Decision|1|||
33496846|NCT03409107|62875547|FG001|Overall Study|Physician Decision|0|||
33496847|NCT03409107|62875546|FG000|Overall Study|Lost to Follow-up|7|||
33496848|NCT03409107|62875547|FG001|Overall Study|Lost to Follow-up|2|||
33496849|NCT03409107|62875546|FG000|Overall Study|Adverse Event|5|||
33496850|NCT03409107|62875547|FG001|Overall Study|Adverse Event|3|||
33496851|NCT03408873|62875561|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
33496852|NCT03408873|62875561|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
33496853|NCT03408873|62875561|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
33496854|NCT03408873|62875561|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
33496855|NCT03408873|62875561|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
33496856|NCT03408873|62875561|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
33496857|NCT03780959|62875568|FG000|Part 1|Adverse Event|1|||
33496858|NCT03780959|62875569|FG001|Part 1|Adverse Event|0|||
33496859|NCT03780959|62875570|FG002|Part 1|Adverse Event|0|||
33496860|NCT03780959|62875568|FG000|Part 1|Withdrawal by Subject|1|||
33496861|NCT03780959|62875569|FG001|Part 1|Withdrawal by Subject|0|||
33496862|NCT03780959|62875570|FG002|Part 1|Withdrawal by Subject|0|||
33496863|NCT03780959|62875568|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
33496864|NCT03780959|62875569|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
33496865|NCT03780959|62875570|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
33496866|NCT03780959|62875568|FG000|Part 1|Response Status|2|||
33496867|NCT03780959|62875569|FG001|Part 1|Response Status|0|||
33496868|NCT03780959|62875570|FG002|Part 1|Response Status|0|||
33496869|NCT03780959|62875568|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
33496870|NCT03780959|62875569|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
33496871|NCT03780959|62875570|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
33496872|NCT03780959|62875568|FG000|Part 2|Response Status|0|||
33496873|NCT03780959|62875569|FG001|Part 2|Response Status|18|||
33496874|NCT03780959|62875570|FG002|Part 2|Response Status|6|||
33496875|NCT03408639|62875582|FG000|Overall Study|Death|5|||
33496876|NCT03408639|62875583|FG001|Overall Study|Death|5|||
33496877|NCT03408639|62875582|FG000|Overall Study|Lost to Follow-up|1|||
33496878|NCT03408639|62875583|FG001|Overall Study|Lost to Follow-up|4|||
33496879|NCT03408639|62875582|FG000|Overall Study|Withdrawal by Subject|2|||
33496880|NCT03408639|62875583|FG001|Overall Study|Withdrawal by Subject|7|||
33496881|NCT03408639|62875582|FG000|Overall Study|Physician Decision|3|||
33496882|NCT03408639|62875583|FG001|Overall Study|Physician Decision|6|||
33608378|NCT01752634|63008618|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
33608379|NCT01752634|63008613|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
33608380|NCT01752634|63008614|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
33496883|NCT03810235|62875591|FG000|Overall Study|Withdrawal by Subject|2|||
33496884|NCT03810235|62875592|FG001|Overall Study|Withdrawal by Subject|0|||
33496885|NCT03408483|62875601|FG000|Overall Study|Physician Decision|3|||
33496886|NCT03408483|62875602|FG001|Overall Study|Physician Decision|3|||
33608381|NCT01752634|63008615|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
33608382|NCT01752634|63008616|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
33496887|NCT03408483|62875601|FG000|Overall Study|Lost to Follow-up|3|||
33496888|NCT03408483|62875602|FG001|Overall Study|Lost to Follow-up|0|||
33496889|NCT03777917|62875610|FG000|Overall Study|Withdrawal by Subject|1|||
33496890|NCT03777917|62875611|FG001|Overall Study|Withdrawal by Subject|0|||
33496891|NCT03777917|62875610|FG000|Overall Study|Physician Decision|1|||
33496892|NCT03777917|62875611|FG001|Overall Study|Physician Decision|0|||
33496893|NCT03777917|62875610|FG000|Overall Study|Lost to Follow-up|6|||
33496894|NCT03777917|62875611|FG001|Overall Study|Lost to Follow-up|2|||
33496895|NCT03777917|62875610|FG000|Overall Study|Other|1|||
33496896|NCT03777917|62875611|FG001|Overall Study|Other|0|||
33496897|NCT03777059|62875622|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
33496898|NCT03777059|62875623|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
33496899|NCT03777059|62875624|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
33496900|NCT03777059|62875625|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
33496901|NCT03777059|62875622|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
33496902|NCT03777059|62875623|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
33496903|NCT03777059|62875624|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
33496904|NCT03777059|62875625|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
33496905|NCT03777059|62875622|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
33496906|NCT03777059|62875623|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
33496907|NCT03777059|62875624|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
33496908|NCT03777059|62875625|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
33496909|NCT03777059|62875622|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
33496910|NCT03777059|62875623|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
33496911|NCT03777059|62875624|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
33496912|NCT03777059|62875625|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
33496913|NCT03777059|62875622|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
33496914|NCT03777059|62875623|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
33496915|NCT03777059|62875624|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
33496916|NCT03777059|62875625|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
33496917|NCT03777059|62875622|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
33496918|NCT03777059|62875623|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
33608383|NCT01752634|63008617|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
33608384|NCT01752634|63008618|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
33608385|NCT01752634|63008613|FG000|Week 24 to Week 260|Adverse Event|4|||
33608386|NCT01752634|63008614|FG001|Week 24 to Week 260|Adverse Event|8|||
33608387|NCT01752634|63008615|FG002|Week 24 to Week 260|Adverse Event|8|||
33608388|NCT01752634|63008616|FG003|Week 24 to Week 260|Adverse Event|4|||
33608389|NCT01752634|63008617|FG004|Week 24 to Week 260|Adverse Event|2|||
33608390|NCT01752634|63008618|FG005|Week 24 to Week 260|Adverse Event|0|||
33608391|NCT01933113|63008628|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
33608392|NCT01726270|63008632|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
33496919|NCT03777059|62875624|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
33496920|NCT03777059|62875625|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
33496921|NCT03777059|62875622|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
33496922|NCT03777059|62875623|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
33496923|NCT03777059|62875624|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
33496924|NCT03777059|62875625|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
33496925|NCT03777059|62875622|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
33496926|NCT03777059|62875623|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
33496927|NCT03777059|62875624|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
33496928|NCT03777059|62875625|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
33496929|NCT03777059|62875622|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
33496930|NCT03777059|62875623|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
33496931|NCT03777059|62875624|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
33496932|NCT03777059|62875625|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
33496933|NCT03777059|62875622|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
33496934|NCT03777059|62875623|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
33496935|NCT03777059|62875624|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
33496936|NCT03777059|62875625|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
33496937|NCT03777059|62875622|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
33608393|NCT01726270|63008632|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
33608394|NCT01726270|63008632|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
33608395|NCT01726270|63008632|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
33447768|NCT00460811|62822807|FG000|Overall Study|Physician Decision|1|||
33447769|NCT00460811|62822808|FG001|Overall Study|Physician Decision|0|||
33447770|NCT00460811|62822809|FG002|Overall Study|Physician Decision|0|||
33447771|NCT00460811|62822810|FG003|Overall Study|Physician Decision|0|||
33447772|NCT00460811|62822811|FG004|Overall Study|Physician Decision|0|||
33447773|NCT00460811|62822807|FG000|Overall Study|Lost to Follow-up|3|||
33447774|NCT00460811|62822808|FG001|Overall Study|Lost to Follow-up|2|||
33447775|NCT00460811|62822809|FG002|Overall Study|Lost to Follow-up|5|||
33447776|NCT00460811|62822810|FG003|Overall Study|Lost to Follow-up|3|||
33447777|NCT00460811|62822811|FG004|Overall Study|Lost to Follow-up|6|||
33447778|NCT00290186|62822830|FG000|Overall Study|Adverse Event|1|||
33447779|NCT00290186|62822831|FG001|Overall Study|Adverse Event|1|||
33447780|NCT00290186|62822830|FG000|Overall Study|Lost to Follow-up|3|||
33447781|NCT00290186|62822831|FG001|Overall Study|Lost to Follow-up|2|||
33447782|NCT00290186|62822830|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
33496938|NCT03777059|62875623|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
33496939|NCT03777059|62875624|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
33496940|NCT03777059|62875625|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
33496941|NCT03100058|62875644|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
33496942|NCT03100058|62875645|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
33496943|NCT03100058|62875646|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
33496944|NCT03100058|62875647|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
33496945|NCT03100058|62875648|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
33496946|NCT03100058|62875649|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
33496947|NCT03100058|62875650|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
33496948|NCT03100058|62875651|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
33496949|NCT03100058|62875652|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
33496950|NCT03100058|62875653|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
33496951|NCT03100058|62875654|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
33496952|NCT03100058|62875655|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
33496953|NCT03100058|62875656|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
33496954|NCT03100058|62875644|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
33496955|NCT03100058|62875645|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
33496956|NCT03100058|62875646|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
33496957|NCT03100058|62875647|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
33496958|NCT03100058|62875648|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
33496959|NCT03100058|62875649|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
33496960|NCT03100058|62875650|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
33496961|NCT03100058|62875651|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
33496962|NCT03100058|62875652|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
33496963|NCT03100058|62875653|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
33496964|NCT03100058|62875654|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
33496965|NCT03100058|62875655|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
33496966|NCT03100058|62875656|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
33496967|NCT03100058|62875644|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33496968|NCT03100058|62875645|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
33496969|NCT03100058|62875646|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
33496970|NCT03100058|62875647|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33496971|NCT03100058|62875648|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33496972|NCT03100058|62875649|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
33496973|NCT03100058|62875650|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
33496974|NCT03100058|62875651|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33496975|NCT03100058|62875652|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33496976|NCT03100058|62875653|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33496977|NCT03100058|62875654|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33496978|NCT03100058|62875655|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33496979|NCT03100058|62875656|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33496980|NCT03100058|62875644|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33496981|NCT03100058|62875645|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
33496982|NCT03100058|62875646|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
33496983|NCT03100058|62875647|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33496984|NCT03100058|62875648|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33496985|NCT03100058|62875649|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33496986|NCT03100058|62875650|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
33496987|NCT03100058|62875651|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33496988|NCT03100058|62875652|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
33496989|NCT03100058|62875653|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33496990|NCT03100058|62875654|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33496991|NCT03100058|62875655|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33496992|NCT03100058|62875656|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33496993|NCT03100058|62875644|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33496994|NCT03100058|62875645|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33496995|NCT03100058|62875646|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33496996|NCT03100058|62875647|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
33496997|NCT03100058|62875648|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33496998|NCT03100058|62875649|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33496999|NCT03100058|62875650|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33497000|NCT03100058|62875651|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
33497001|NCT03100058|62875652|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33497002|NCT03100058|62875653|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33497003|NCT03100058|62875654|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33497004|NCT03100058|62875655|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33497005|NCT03100058|62875656|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33497006|NCT03100058|62875644|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33497007|NCT03100058|62875645|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33497008|NCT03100058|62875646|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33497009|NCT03100058|62875647|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
33497010|NCT03100058|62875648|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33497011|NCT03100058|62875649|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33497012|NCT03100058|62875650|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
33497013|NCT03100058|62875651|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33497014|NCT03100058|62875652|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33497015|NCT03100058|62875653|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33497016|NCT03100058|62875654|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33497017|NCT03100058|62875655|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33497018|NCT03100058|62875656|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33497019|NCT03100058|62875644|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33497020|NCT03100058|62875645|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
33497021|NCT03100058|62875646|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33497022|NCT03100058|62875647|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33497023|NCT03100058|62875648|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33497024|NCT03100058|62875649|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33497025|NCT03100058|62875650|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33497026|NCT03100058|62875651|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33497027|NCT03100058|62875652|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33497028|NCT03100058|62875653|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33497029|NCT03100058|62875654|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33497030|NCT03100058|62875655|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33497031|NCT03100058|62875656|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33497032|NCT03100058|62875644|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
33497033|NCT03100058|62875645|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33497034|NCT03100058|62875646|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33497035|NCT03100058|62875647|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33497036|NCT03100058|62875648|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33497037|NCT03100058|62875649|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33497038|NCT03100058|62875650|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33497039|NCT03100058|62875651|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33497040|NCT03100058|62875652|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33497041|NCT03100058|62875653|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33497042|NCT03100058|62875654|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33497043|NCT03100058|62875655|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33497044|NCT03100058|62875656|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33497045|NCT03100058|62875644|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33497046|NCT03100058|62875645|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33497047|NCT03100058|62875646|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33497048|NCT03100058|62875647|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33497049|NCT03100058|62875648|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33497050|NCT03100058|62875649|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33497051|NCT03100058|62875650|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
33497052|NCT03100058|62875651|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33497053|NCT03100058|62875652|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33497054|NCT03100058|62875653|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33497055|NCT03100058|62875654|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33497056|NCT03100058|62875655|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33497057|NCT03100058|62875656|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33497058|NCT03100058|62875644|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33497059|NCT03100058|62875645|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33497060|NCT03100058|62875646|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33497061|NCT03100058|62875647|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33497062|NCT03100058|62875648|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33497063|NCT03100058|62875649|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33497064|NCT03100058|62875650|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33497065|NCT03100058|62875651|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33497066|NCT03100058|62875652|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33497067|NCT03100058|62875653|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33497068|NCT03100058|62875654|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
33497069|NCT03100058|62875655|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
33497070|NCT03100058|62875656|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
33608396|NCT01726270|63008632|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
33608397|NCT01726270|63008632|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
33497071|NCT03100058|62875644|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33497072|NCT03100058|62875645|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33497073|NCT03100058|62875646|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33497074|NCT03100058|62875647|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33497075|NCT03100058|62875648|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33497076|NCT03100058|62875649|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33497077|NCT03100058|62875650|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33497078|NCT03100058|62875651|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33497079|NCT03100058|62875652|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33497080|NCT03100058|62875653|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33497081|NCT03100058|62875654|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
33497082|NCT03100058|62875655|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
33497083|NCT03100058|62875656|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33497084|NCT03100058|62875644|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33497085|NCT03100058|62875645|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33497086|NCT03100058|62875646|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33323988|NCT00600067|62700380|FG001|Overall Study|Lost to Follow-up|3|||
33323989|NCT00600067|62700379|FG000|Overall Study|protocol non-compliance|0|||
33447783|NCT00290186|62822831|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
33447784|NCT00290186|62822830|FG000|Overall Study|Withdrawal by Subject|0|||
33447785|NCT00290186|62822831|FG001|Overall Study|Withdrawal by Subject|1|||
33447786|NCT00460655|62822841|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
33447787|NCT00460655|62822842|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33447788|NCT00460655|62822843|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33447789|NCT00460655|62822844|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33447790|NCT00460655|62822841|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
33447791|NCT00460655|62822842|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33447792|NCT00460655|62822843|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33447793|NCT00460655|62822844|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33447794|NCT00460655|62822841|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
33447795|NCT00460655|62822842|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
33497087|NCT03100058|62875647|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33497088|NCT03100058|62875648|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33497089|NCT03100058|62875649|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33497090|NCT03100058|62875650|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33497091|NCT03100058|62875651|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33497092|NCT03100058|62875652|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33497093|NCT03100058|62875653|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
33497094|NCT03100058|62875654|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
33497095|NCT03100058|62875655|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33497096|NCT03100058|62875656|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
33497097|NCT03100058|62875644|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33497098|NCT03100058|62875645|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33497099|NCT03100058|62875646|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33497100|NCT03100058|62875647|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33497101|NCT03100058|62875648|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33497102|NCT03100058|62875649|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33497103|NCT03100058|62875650|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33497104|NCT03100058|62875651|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33497105|NCT03100058|62875652|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33497106|NCT03100058|62875653|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33497107|NCT03100058|62875654|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
33497108|NCT03100058|62875655|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33608398|NCT00942331|63008640|FG000|Overall Study|Did not start treatment|15|||
33497109|NCT03100058|62875656|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33497110|NCT03100058|62875644|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33497111|NCT03100058|62875645|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33497112|NCT03100058|62875646|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33497113|NCT03100058|62875647|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33497114|NCT03100058|62875648|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33497115|NCT03100058|62875649|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33497116|NCT03100058|62875650|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33447796|NCT00460655|62822843|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
33497117|NCT03100058|62875651|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33497118|NCT03100058|62875652|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33497119|NCT03100058|62875653|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33497120|NCT03100058|62875654|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33497121|NCT03100058|62875655|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33497122|NCT03100058|62875656|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
33497123|NCT03100058|62875644|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33497124|NCT03100058|62875645|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33497125|NCT03100058|62875646|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33497126|NCT03100058|62875647|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33497127|NCT03100058|62875648|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33497128|NCT03100058|62875649|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33497129|NCT03100058|62875650|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33497130|NCT03100058|62875651|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33608399|NCT00942331|63008641|FG001|Overall Study|Did not start treatment|22|||
33608400|NCT01914393|63008650|FG000|Overall Study|Protocol Violation|11|||
33608401|NCT01914393|63008651|FG001|Overall Study|Protocol Violation|3|||
33608402|NCT01914393|63008652|FG002|Overall Study|Protocol Violation|19|||
33608403|NCT01914393|63008650|FG000|Overall Study|Lack of Efficacy|11|||
33608404|NCT01914393|63008651|FG001|Overall Study|Lack of Efficacy|16|||
33608405|NCT01914393|63008652|FG002|Overall Study|Lack of Efficacy|5|||
33447797|NCT00460655|62822844|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
33447798|NCT00460655|62822841|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
33447799|NCT00460655|62822842|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
33447800|NCT00460655|62822843|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
33447801|NCT00460655|62822844|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
33447802|NCT00460655|62822841|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33447803|NCT00460655|62822842|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33447804|NCT00460655|62822843|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
33447805|NCT00460655|62822844|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
33447806|NCT00460655|62822841|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
33447807|NCT00460655|62822842|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
33447808|NCT00460655|62822843|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
33447809|NCT00460655|62822844|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
33447810|NCT00460577|62822856|FG000|Overall Study|Protocol Violation|2|||
33447811|NCT00460577|62822857|FG001|Overall Study|Protocol Violation|6|||
33447812|NCT00289016|62822863|FG000|Overall Study|Disease Progression|29|||
33447813|NCT00289016|62822863|FG000|Overall Study|Death|2|||
33608406|NCT01914393|63008650|FG000|Overall Study|no reason given|14|||
33497131|NCT03100058|62875652|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33497132|NCT03100058|62875653|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
33497133|NCT03100058|62875654|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33497134|NCT03100058|62875655|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33497135|NCT03100058|62875656|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33497136|NCT02871778|62875702|FG000|Part A: Treatment Period 1|Adverse Event|1|||
33497137|NCT02871778|62875703|FG001|Part A: Treatment Period 1|Adverse Event|1|||
33497138|NCT02871778|62875704|FG002|Part A: Treatment Period 1|Adverse Event|1|||
33497139|NCT02871778|62875705|FG003|Part A: Treatment Period 1|Adverse Event|0|||
33497140|NCT02871778|62875706|FG004|Part A: Treatment Period 1|Adverse Event|0|||
33497141|NCT02871778|62875707|FG005|Part A: Treatment Period 1|Adverse Event|0|||
33497142|NCT02871778|62875708|FG006|Part A: Treatment Period 1|Adverse Event|0|||
33497143|NCT02871778|62875709|FG007|Part A: Treatment Period 1|Adverse Event|0|||
33497144|NCT02871778|62875702|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
33497145|NCT02871778|62875703|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
33497146|NCT02871778|62875704|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
33497147|NCT02871778|62875705|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
33608407|NCT01914393|63008651|FG001|Overall Study|no reason given|8|||
33608408|NCT01914393|63008652|FG002|Overall Study|no reason given|16|||
33608409|NCT01914393|63008650|FG000|Overall Study|Adverse Event|29|||
33608410|NCT01914393|63008651|FG001|Overall Study|Adverse Event|18|||
33608411|NCT01914393|63008652|FG002|Overall Study|Adverse Event|31|||
33608412|NCT01914393|63008650|FG000|Overall Study|Withdrawal by Subject|38|||
33608413|NCT01914393|63008651|FG001|Overall Study|Withdrawal by Subject|20|||
33608414|NCT01914393|63008652|FG002|Overall Study|Withdrawal by Subject|47|||
33608415|NCT01914393|63008650|FG000|Overall Study|Lost to Follow-up|12|||
33608416|NCT01914393|63008651|FG001|Overall Study|Lost to Follow-up|6|||
33608417|NCT01914393|63008652|FG002|Overall Study|Lost to Follow-up|19|||
33608418|NCT01914393|63008650|FG000|Overall Study|subject never dosed|0|||
33608419|NCT01914393|63008651|FG001|Overall Study|subject never dosed|0|||
33608420|NCT01914393|63008652|FG002|Overall Study|subject never dosed|1|||
33608421|NCT01931865|63008664|FG000|Overall Study|Lost to Follow-up|2|||
33608422|NCT01931865|63008664|FG000|Overall Study|Withdrawal by Subject|2|||
33608423|NCT01617447|63008671|FG000|Overall Study|Adverse Event|0|||
33608424|NCT01617447|63008672|FG001|Overall Study|Adverse Event|1|||
33608425|NCT01617447|63008671|FG000|Overall Study|Physician Decision|0|||
33608426|NCT01617447|63008672|FG001|Overall Study|Physician Decision|2|||
33608427|NCT00432679|63008680|FG000|Overall Study|Adverse Event|2|||
33608428|NCT00432679|63008681|FG001|Overall Study|Adverse Event|1|||
33608429|NCT00432679|63008680|FG000|Overall Study|Withdrawal by Subject|3|||
33608430|NCT00432679|63008681|FG001|Overall Study|Withdrawal by Subject|2|||
33608431|NCT01600105|63008689|FG000|Total Participants|Withdrawal by Subject|1|||
33608432|NCT01600105|63008690|FG001|Total Participants|Withdrawal by Subject|0|||
33608433|NCT01600105|63008689|FG000|Total Participants|No images in PACS|10|||
33608434|NCT01600105|63008690|FG001|Total Participants|No images in PACS|0|||
33608435|NCT01600105|63008689|FG000|Total Participants|Insufficient image quality|30|||
33608436|NCT01600105|63008690|FG001|Total Participants|Insufficient image quality|10|||
33608437|NCT01600105|63008689|FG000|Sub Study I|Insufficient image quality|0|||
33608438|NCT01600105|63008690|FG001|Sub Study I|Insufficient image quality|10|||
33608439|NCT01600105|63008689|FG000|Sub Study II|Withdrawal by Subject|1|||
33608440|NCT01600105|63008690|FG001|Sub Study II|Withdrawal by Subject|0|||
33608441|NCT01600105|63008689|FG000|Sub Study II|No images in PACS|1|||
33608442|NCT01600105|63008690|FG001|Sub Study II|No images in PACS|0|||
33608443|NCT01600105|63008689|FG000|Sub Study II|Insufficient image quality|3|||
33608444|NCT01600105|63008690|FG001|Sub Study II|Insufficient image quality|0|||
33608445|NCT01600105|63008689|FG000|Sub Study III|Insufficient image quality|5|||
33608446|NCT01600105|63008690|FG001|Sub Study III|Insufficient image quality|0|||
33608447|NCT01600105|63008689|FG000|Sub Study V|Poor Image Quality|2|||
33608448|NCT01600105|63008690|FG001|Sub Study V|Poor Image Quality|0|||
33608449|NCT02246647|63008702|FG000|Overall Study|Withdrawal by Subject|1|||
33608450|NCT02246647|63008703|FG001|Overall Study|Withdrawal by Subject|1|||
33608451|NCT02244619|63008725|FG000|Overall Study|Did not receive study intervention|8|||
33608452|NCT02244619|63008726|FG001|Overall Study|Did not receive study intervention|21|||
33608453|NCT02243371|63008734|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
33608454|NCT02243371|63008735|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
33608455|NCT02243371|63008734|FG000|Overall Study|Death (unrelated)|2|||
33608456|NCT02243371|63008735|FG001|Overall Study|Death (unrelated)|4|||
33608457|NCT02243371|63008734|FG000|Overall Study|Adverse Event (unrelated)|0|||
33608458|NCT02243371|63008735|FG001|Overall Study|Adverse Event (unrelated)|1|||
33608459|NCT02243371|63008734|FG000|Overall Study|Lack of Clinical Benefit|0|||
33608460|NCT02243371|63008735|FG001|Overall Study|Lack of Clinical Benefit|1|||
33608461|NCT02243371|63008734|FG000|Overall Study|Withdrawal by Subject|0|||
33608462|NCT02243371|63008735|FG001|Overall Study|Withdrawal by Subject|2|||
33608463|NCT01931475|63008743|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
33608464|NCT01931475|63008744|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
33608465|NCT01931475|63008743|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
33608466|NCT01931475|63008744|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
33608467|NCT01931475|63008743|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
33608468|NCT01931475|63008744|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
33608469|NCT01931475|63008743|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
33608470|NCT01931475|63008744|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
33608471|NCT01931475|63008743|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
33608472|NCT01931475|63008744|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
33608473|NCT01931475|63008743|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
33608474|NCT01931475|63008744|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
33608475|NCT01931475|63008743|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
33608476|NCT01931475|63008744|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
33608477|NCT01931475|63008743|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
33608478|NCT01931475|63008744|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
33608479|NCT01931475|63008743|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
33608480|NCT01931475|63008744|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
33608481|NCT01931475|63008743|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
33608482|NCT01931475|63008744|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
33497148|NCT02871778|62875706|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
33497149|NCT02871778|62875707|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
33497150|NCT02871778|62875708|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
33497151|NCT02871778|62875709|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
33497152|NCT02871778|62875702|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
33497153|NCT02871778|62875703|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
33497154|NCT02871778|62875704|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
33497155|NCT02871778|62875705|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
33497156|NCT02871778|62875706|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
33497157|NCT02871778|62875707|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
33608483|NCT01931475|63008743|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
33608484|NCT01931475|63008744|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
33608485|NCT01931397|63008755|FG000|Overall Study|Physician Decision|2|||
33608486|NCT01931397|63008755|FG000|Overall Study|Withdrawal by Subject|8|||
33608487|NCT01931397|63008755|FG000|Overall Study|moved out of state|1|||
33608488|NCT01929993|63008765|FG000|Overall Study|Protocol Violation|4|||
33447814|NCT00289016|62822863|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
33447815|NCT00289016|62822863|FG000|Overall Study|Withdrawal by Subject|2|||
33447816|NCT00289016|62822863|FG000|Overall Study|Adverse Event|1|||
33447817|NCT00289016|62822863|FG000|Overall Study|Other|1|||
33447818|NCT00288860|62822869|FG000|Overall Study|Did not complete intake|4|||
33447819|NCT00288860|62822870|FG001|Overall Study|Did not complete intake|8|||
33447820|NCT00288860|62822869|FG000|Overall Study|Death|4|||
33447821|NCT00288860|62822870|FG001|Overall Study|Death|3|||
33447822|NCT00288860|62822869|FG000|Overall Study|Withdrawal by Subject|20|||
33447823|NCT00288860|62822870|FG001|Overall Study|Withdrawal by Subject|15|||
33447824|NCT00288860|62822869|FG000|Overall Study|Lost to Follow-up|74|||
33447825|NCT00288860|62822870|FG001|Overall Study|Lost to Follow-up|71|||
33447826|NCT00288704|62822882|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
33447827|NCT00288704|62822883|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
33447828|NCT00288704|62822884|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
33447829|NCT00288704|62822882|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
33447830|NCT00288704|62822883|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
33447831|NCT00288704|62822884|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
33447832|NCT00288704|62822882|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
33447833|NCT00288704|62822883|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
33447834|NCT00288704|62822884|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
33447835|NCT00288704|62822882|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
33447836|NCT00288704|62822883|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
33447837|NCT00288704|62822884|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
33447838|NCT00288704|62822882|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
33447839|NCT00288704|62822883|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
33608489|NCT01929993|63008766|FG001|Overall Study|Protocol Violation|6|||
33608490|NCT01929993|63008765|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
33608491|NCT01929993|63008766|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
33608492|NCT01912599|63008774|FG000|Overall Study|Withdrawal by Subject|0|||
33608493|NCT01912599|63008775|FG001|Overall Study|Withdrawal by Subject|1|||
33608494|NCT01929681|63008783|FG000|Overall Study|Withdrawal by Subject|1|||
33608495|NCT01929681|63008784|FG001|Overall Study|Withdrawal by Subject|0|||
33608496|NCT01929681|63008783|FG000|Overall Study|Physician Decision|1|||
33608497|NCT01929681|63008784|FG001|Overall Study|Physician Decision|1|||
33608498|NCT01646177|63008794|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
33608499|NCT01646177|63008795|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
33608500|NCT01646177|63008796|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
33608501|NCT01646177|63008797|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
33608502|NCT01646177|63008798|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33608503|NCT01646177|63008799|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33608504|NCT01646177|63008800|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33608505|NCT01646177|63008801|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33608506|NCT01646177|63008802|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33608507|NCT01646177|63008803|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33497158|NCT02871778|62875708|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
33323990|NCT00600067|62700380|FG001|Overall Study|protocol non-compliance|3|||
33323991|NCT00600067|62700379|FG000|Overall Study|Lack of Efficacy|1|||
33323992|NCT00600067|62700380|FG001|Overall Study|Lack of Efficacy|0|||
33497159|NCT02871778|62875709|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
33497160|NCT02871778|62875702|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
33497161|NCT02871778|62875703|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
33497162|NCT02871778|62875704|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
33497163|NCT02871778|62875705|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
33323993|NCT00970593|62700394|FG000|Overall Study|Adverse Event|1|||
33323994|NCT00970593|62700395|FG001|Overall Study|Adverse Event|1|||
33323995|NCT00970593|62700396|FG002|Overall Study|Adverse Event|0|||
33608508|NCT01646177|63008804|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33323996|NCT00970593|62700397|FG003|Overall Study|Adverse Event|0|||
33497164|NCT02871778|62875706|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
33497165|NCT02871778|62875707|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
33497166|NCT02871778|62875708|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
33497167|NCT02871778|62875709|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
33497168|NCT02871778|62875702|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
33497169|NCT02871778|62875703|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
33497170|NCT02871778|62875704|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
33497171|NCT02871778|62875705|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
33497172|NCT02871778|62875706|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
33497173|NCT02871778|62875707|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
33497174|NCT02871778|62875708|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
33497175|NCT02871778|62875709|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
33497176|NCT02871778|62875702|FG000|Part A: Treatment Period 2|Adverse Event|2|||
33497177|NCT02871778|62875703|FG001|Part A: Treatment Period 2|Adverse Event|2|||
33497178|NCT02871778|62875704|FG002|Part A: Treatment Period 2|Adverse Event|0|||
33497179|NCT02871778|62875705|FG003|Part A: Treatment Period 2|Adverse Event|0|||
33608509|NCT01646177|63008805|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33497180|NCT02871778|62875706|FG004|Part A: Treatment Period 2|Adverse Event|0|||
33497181|NCT02871778|62875707|FG005|Part A: Treatment Period 2|Adverse Event|0|||
33497182|NCT02871778|62875708|FG006|Part A: Treatment Period 2|Adverse Event|0|||
33497183|NCT02871778|62875709|FG007|Part A: Treatment Period 2|Adverse Event|0|||
33497184|NCT02871778|62875702|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
33497185|NCT02871778|62875703|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
33497186|NCT02871778|62875704|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
33497187|NCT02871778|62875705|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
33608510|NCT01646177|63008794|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
33608511|NCT01646177|63008795|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
33608512|NCT01646177|63008796|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
33608513|NCT01646177|63008797|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
33608514|NCT01646177|63008798|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33608515|NCT01646177|63008799|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33608516|NCT01646177|63008800|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33497188|NCT02871778|62875706|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
33497189|NCT02871778|62875707|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
33497190|NCT02871778|62875708|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
33497191|NCT02871778|62875709|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
33497192|NCT02871778|62875702|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
33497193|NCT02871778|62875703|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
33497194|NCT02871778|62875704|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
33497195|NCT02871778|62875705|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
33497196|NCT02871778|62875706|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
33497197|NCT02871778|62875707|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
33497198|NCT02871778|62875708|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
33497199|NCT02871778|62875709|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
33497200|NCT02871778|62875702|FG000|Part B: Treatment Period 3|Adverse Event|0|||
33497201|NCT02871778|62875703|FG001|Part B: Treatment Period 3|Adverse Event|0|||
33497202|NCT02871778|62875704|FG002|Part B: Treatment Period 3|Adverse Event|0|||
33497203|NCT02871778|62875705|FG003|Part B: Treatment Period 3|Adverse Event|0|||
33497204|NCT02871778|62875706|FG004|Part B: Treatment Period 3|Adverse Event|1|||
33497205|NCT02871778|62875707|FG005|Part B: Treatment Period 3|Adverse Event|1|||
33497206|NCT02871778|62875708|FG006|Part B: Treatment Period 3|Adverse Event|1|||
33497207|NCT02871778|62875709|FG007|Part B: Treatment Period 3|Adverse Event|0|||
33497208|NCT01471444|62875742|FG000|Overall Study|Physician Decision|3|||
33497209|NCT01471444|62875743|FG001|Overall Study|Physician Decision|2|||
33497210|NCT01471444|62875742|FG000|Overall Study|Withdrawal by Subject|0|||
33497211|NCT01471444|62875743|FG001|Overall Study|Withdrawal by Subject|1|||
33497212|NCT03443427|62875761|FG000|Overall Study|Adverse Event|2|||
33497213|NCT03443427|62875762|FG001|Overall Study|Adverse Event|3|||
33497214|NCT03443427|62875761|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
33497215|NCT03443427|62875762|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
33497216|NCT03443427|62875761|FG000|Overall Study|Other|4|||
33497217|NCT03443427|62875762|FG001|Overall Study|Other|6|||
33497218|NCT03417219|62875770|FG000|Overall Study|Lost to Follow-up|0|||
33497219|NCT03417219|62875771|FG001|Overall Study|Lost to Follow-up|3|||
33497220|NCT02953821|62875779|FG000|Overall Study|Adverse Event|0|||
33497221|NCT02953821|62875780|FG001|Overall Study|Adverse Event|4|||
33497222|NCT02953821|62875779|FG000|Overall Study|Death|1|||
33497223|NCT02953821|62875780|FG001|Overall Study|Death|0|||
33497224|NCT02953821|62875779|FG000|Overall Study|Progressive Disease|5|||
33497225|NCT02953821|62875780|FG001|Overall Study|Progressive Disease|1|||
33497226|NCT02953821|62875779|FG000|Overall Study|Lost to Follow-up|2|||
33497227|NCT02953821|62875780|FG001|Overall Study|Lost to Follow-up|0|||
33497228|NCT02953821|62875779|FG000|Overall Study|Physician Decision|1|||
33497229|NCT02953821|62875780|FG001|Overall Study|Physician Decision|1|||
33497230|NCT02953821|62875779|FG000|Overall Study|Withdrawal by Subject|3|||
33497231|NCT02953821|62875780|FG001|Overall Study|Withdrawal by Subject|3|||
33497232|NCT02953821|62875779|FG000|Overall Study|Change of address|0|||
33497233|NCT02953821|62875780|FG001|Overall Study|Change of address|1|||
33447840|NCT00288704|62822884|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
33447841|NCT00288704|62822882|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
33447842|NCT00288704|62822883|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
33447843|NCT00288704|62822884|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
33447844|NCT00288704|62822882|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
33447845|NCT00288704|62822883|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
33447846|NCT00288704|62822884|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
33447847|NCT00288626|62822891|FG000|Overall Study|Death|3|||
33447848|NCT00288626|62822891|FG000|Overall Study|Withdrawal by Subject|4|||
33447849|NCT00087490|62822899|FG000|Overall Study|Death|6|||
33447850|NCT00087490|62822900|FG001|Overall Study|Death|4|||
33447851|NCT00087490|62822899|FG000|Overall Study|Adverse Event|3|||
33447852|NCT00087490|62822900|FG001|Overall Study|Adverse Event|8|||
33447853|NCT00087490|62822899|FG000|Overall Study|Lack of Efficacy|0|||
33447854|NCT00087490|62822900|FG001|Overall Study|Lack of Efficacy|2|||
33447855|NCT00087490|62822899|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
33447856|NCT00087490|62822900|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
33447857|NCT00087490|62822899|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
33447858|NCT00087490|62822900|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
33447859|NCT00087490|62822899|FG000|Overall Study|Randomized but not treated|7|||
33447860|NCT00087490|62822900|FG001|Overall Study|Randomized but not treated|18|||
33447861|NCT00087178|62822908|FG000|Overall Study|No follow up data|5|||
33447862|NCT00087178|62822909|FG001|Overall Study|No follow up data|15|||
33447863|NCT00087178|62822908|FG000|Overall Study|No clinical assessment|1|||
33447864|NCT00087178|62822909|FG001|Overall Study|No clinical assessment|2|||
33497234|NCT02953821|62875779|FG000|Overall Study|Lack of Efficacy|1|||
33447865|NCT00087178|62822908|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
33497235|NCT02953821|62875780|FG001|Overall Study|Lack of Efficacy|0|||
33497236|NCT02953821|62875779|FG000|Overall Study|Out of state for indeterminate time|0|||
33447866|NCT00087178|62822909|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
33497237|NCT02953821|62875780|FG001|Overall Study|Out of state for indeterminate time|1|||
33497238|NCT02953821|62875779|FG000|Overall Study|No improvement|0|||
33497239|NCT02953821|62875780|FG001|Overall Study|No improvement|1|||
33497240|NCT02953821|62875779|FG000|Overall Study|Refused follow-up visit|2|||
33497241|NCT02953821|62875780|FG001|Overall Study|Refused follow-up visit|1|||
33497242|NCT03783923|62875790|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
33497243|NCT03783923|62875791|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
33497244|NCT03783923|62875790|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
33447867|NCT00288080|62822917|FG000|Overall Study|Withdrawal by Subject|1|||
33497245|NCT03783923|62875791|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
33497246|NCT03783923|62875790|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
33497247|NCT03783923|62875791|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
33497248|NCT03783923|62875790|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
33497249|NCT03783923|62875791|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
33608517|NCT01646177|63008801|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33608518|NCT01646177|63008802|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33608519|NCT01646177|63008803|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33608520|NCT01646177|63008804|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33608521|NCT01646177|63008805|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33608522|NCT01646177|63008794|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
33608523|NCT01646177|63008795|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
33608524|NCT01646177|63008796|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
33497250|NCT03783923|62875790|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
33497251|NCT03783923|62875791|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
33497252|NCT03417141|62875795|FG000|Overall Study|Withdrawal by Subject|1|||
33497253|NCT03417141|62875795|FG000|Overall Study|Protocol Violation|3|||
33497254|NCT03724981|62875803|FG000|First Device|Protocol Violation|1|||
33497255|NCT03724981|62875804|FG001|First Device|Protocol Violation|1|||
33497256|NCT03442569|62875812|FG000|Overall Study|Subject was ineligible after enrollment|1|||
33497257|NCT01347879|62875818|FG000|Overall Study|Adverse Event|0|||
33497258|NCT01347879|62875819|FG001|Overall Study|Adverse Event|12|||
33497259|NCT01347879|62875818|FG000|Overall Study|Lost to Follow-up|2|||
33497260|NCT01347879|62875819|FG001|Overall Study|Lost to Follow-up|0|||
33497261|NCT01347879|62875818|FG000|Overall Study|Withdrawal by Subject|3|||
33497262|NCT01347879|62875819|FG001|Overall Study|Withdrawal by Subject|2|||
33497263|NCT01347879|62875818|FG000|Overall Study|Other|2|||
33497264|NCT01347879|62875819|FG001|Overall Study|Other|3|||
33497265|NCT03441789|62875836|FG000|Overall Study|Withdrawal by Subject|1|||
33497266|NCT03441789|62875837|FG001|Overall Study|Withdrawal by Subject|1|||
33497267|NCT03441789|62875836|FG000|Overall Study|Adverse Event|0|||
33497268|NCT03441789|62875837|FG001|Overall Study|Adverse Event|1|||
33497269|NCT03441789|62875836|FG000|Overall Study|Protocol Violation|0|||
33497270|NCT03441789|62875837|FG001|Overall Study|Protocol Violation|1|||
33497271|NCT03441789|62875836|FG000|Overall Study|Lost to Follow-up|0|||
33497272|NCT03441789|62875837|FG001|Overall Study|Lost to Follow-up|1|||
33497273|NCT03387735|62875849|FG000|Overall Study|Lost to Follow-up|4|||
33447868|NCT00288080|62822918|FG001|Overall Study|Withdrawal by Subject|3|||
33497274|NCT03387735|62875850|FG001|Overall Study|Lost to Follow-up|8|||
33497275|NCT03387735|62875849|FG000|Overall Study|Death|4|||
33497276|NCT03387735|62875850|FG001|Overall Study|Death|8|||
33497277|NCT03439137|62875858|FG000|Overall Study|Adverse Event|16|||
33323997|NCT00970593|62700398|FG004|Overall Study|Adverse Event|0|||
33323998|NCT00970593|62700399|FG005|Overall Study|Adverse Event|0|||
33447869|NCT00288080|62822917|FG000|Overall Study|Protocol Violation|25|||
33447870|NCT00288080|62822918|FG001|Overall Study|Protocol Violation|20|||
33447871|NCT00287690|62822926|FG000|Overall Study|Protocol Violation|20|||
33447872|NCT00287690|62822927|FG001|Overall Study|Protocol Violation|26|||
33447873|NCT00286754|62822936|FG000|Overall Study|Adverse Event|2|||
33497278|NCT03439137|62875859|FG001|Overall Study|Adverse Event|12|||
33497279|NCT03439137|62875858|FG000|Overall Study|Physician Decision|0|||
33497280|NCT03439137|62875859|FG001|Overall Study|Physician Decision|5|||
33497281|NCT03439137|62875858|FG000|Overall Study|Withdrawal by Subject|14|||
33497282|NCT03439137|62875859|FG001|Overall Study|Withdrawal by Subject|4|||
33497283|NCT03439137|62875858|FG000|Overall Study|Conducting rescue therapy|2|||
33447874|NCT00286754|62822937|FG001|Overall Study|Adverse Event|2|||
33497284|NCT03439137|62875859|FG001|Overall Study|Conducting rescue therapy|1|||
33497285|NCT03439137|62875858|FG000|Overall Study|Difficult to control Hb|10|||
33497286|NCT03439137|62875859|FG001|Overall Study|Difficult to control Hb|2|||
33497287|NCT03439137|62875858|FG000|Overall Study|Initiation of a renal transplant|0|||
33497288|NCT03439137|62875859|FG001|Overall Study|Initiation of a renal transplant|2|||
33323999|NCT00970593|62700400|FG006|Overall Study|Adverse Event|0|||
33447875|NCT00286754|62822938|FG002|Overall Study|Adverse Event|3|||
33447876|NCT00286754|62822936|FG000|Overall Study|Withdrawal by Subject|6|||
33447877|NCT00286754|62822937|FG001|Overall Study|Withdrawal by Subject|2|||
33447878|NCT00286754|62822938|FG002|Overall Study|Withdrawal by Subject|0|||
33447879|NCT00286754|62822936|FG000|Overall Study|Lost to Follow-up|12|||
33447880|NCT00286754|62822937|FG001|Overall Study|Lost to Follow-up|14|||
33447881|NCT00286754|62822938|FG002|Overall Study|Lost to Follow-up|6|||
33447882|NCT00286754|62822936|FG000|Overall Study|Moved out of state|0|||
33447883|NCT00286754|62822937|FG001|Overall Study|Moved out of state|0|||
33447884|NCT00286754|62822938|FG002|Overall Study|Moved out of state|1|||
33608525|NCT01646177|63008797|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
33608526|NCT01646177|63008798|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33608527|NCT01646177|63008799|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33608528|NCT01646177|63008800|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33447885|NCT00066742|62822952|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
33447886|NCT00066742|62822952|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
33447887|NCT00066742|62822952|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
33497289|NCT04055090|62875867|FG000|Overall Study|screen failure|1|||
33497290|NCT04055090|62875868|FG001|Overall Study|screen failure|0|||
33497291|NCT04055090|62875867|FG000|Overall Study|Withdrawal by Subject|1|||
33497292|NCT04055090|62875868|FG001|Overall Study|Withdrawal by Subject|0|||
33497293|NCT03403413|62875891|FG000|Overall Study|Lack of Efficacy|2|||
33324000|NCT00970593|62700394|FG000|Overall Study|Discontinuation of study by sponsor|0|||
33447888|NCT00066742|62822952|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
33497294|NCT03354663|62875906|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
33497295|NCT03354663|62875906|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
33497296|NCT03354663|62875906|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
33497297|NCT03354663|62875906|FG000|Completed 30-day Visit|Missed Visit|1|||
33497298|NCT03721705|62875916|FG000|Overall Study|Adverse Event|2|||
33497299|NCT03721705|62875917|FG001|Overall Study|Adverse Event|0|||
33497300|NCT03721705|62875916|FG000|Overall Study|Withdrawal by Subject|4|||
33497301|NCT03721705|62875917|FG001|Overall Study|Withdrawal by Subject|10|||
33497302|NCT03721705|62875916|FG000|Overall Study|No Suitable Study Partner|1|||
33497303|NCT03721705|62875917|FG001|Overall Study|No Suitable Study Partner|0|||
33497304|NCT03721705|62875916|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
33497305|NCT03721705|62875917|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
33497306|NCT03721705|62875916|FG000|Overall Study|Death|0|||
33497307|NCT03721705|62875917|FG001|Overall Study|Death|1|||
33497308|NCT03720847|62875923|FG000|Washout|Physician Decision|1|||
33497309|NCT03720847|62875924|FG001|Washout|Physician Decision|2|||
33497310|NCT02631070|62875933|FG000|Overall Study|Withdrawal by Subject|35|||
33497311|NCT02631070|62875934|FG001|Overall Study|Withdrawal by Subject|13|||
33497312|NCT02631070|62875933|FG000|Overall Study|Death|45|||
33497313|NCT02631070|62875934|FG001|Overall Study|Death|24|||
33497314|NCT02631070|62875933|FG000|Overall Study|Lost to Follow-up|5|||
33497315|NCT02631070|62875934|FG001|Overall Study|Lost to Follow-up|1|||
33497316|NCT02631070|62875933|FG000|Overall Study|Transition to rollover protocol|52|||
33497317|NCT02631070|62875934|FG001|Overall Study|Transition to rollover protocol|21|||
33497318|NCT02631070|62875933|FG000|Overall Study|Other reasons|12|||
33608529|NCT01646177|63008801|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33608530|NCT01646177|63008802|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33608531|NCT01646177|63008803|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33447889|NCT00066742|62822952|FG000|Induction Chemoradiotherapy|Ineligible|3|||
33497319|NCT02631070|62875934|FG001|Overall Study|Other reasons|5|||
33497320|NCT00741988|62875942|FG000|Overall Study|Adverse Event|2|||
33497321|NCT00741988|62875943|FG001|Overall Study|Adverse Event|4|||
33497322|NCT00741988|62875942|FG000|Overall Study|Lack of Efficacy|2|||
33497323|NCT00741988|62875943|FG001|Overall Study|Lack of Efficacy|0|||
33497324|NCT03354429|62875951|FG000|Overall Study|Withdrawal by Subject|8|||
33497325|NCT03354429|62875952|FG001|Overall Study|Withdrawal by Subject|7|||
33497326|NCT03354429|62875951|FG000|Overall Study|Lost to Follow-up|1|||
33497327|NCT03354429|62875952|FG001|Overall Study|Lost to Follow-up|0|||
33497328|NCT03352713|62875958|FG000|Overall Study|Lost to Follow-up|8|||
33497329|NCT03352713|62875958|FG000|Overall Study|Withdrawn by investigator|5|||
33497330|NCT03352713|62875958|FG000|Overall Study|Completed 0 EMAs|8|||
33497331|NCT03352713|62875958|FG000|Overall Study|Device incompatible/stolen|5|||
33497332|NCT03901144|62875962|FG000|Overall Study|Lost to Follow-up|1|||
33497333|NCT03901144|62875963|FG001|Overall Study|Lost to Follow-up|1|||
33497334|NCT03901144|62875964|FG002|Overall Study|Lost to Follow-up|1|||
33497335|NCT03901144|62875965|FG003|Overall Study|Lost to Follow-up|1|||
33497336|NCT02952261|62875977|FG000|Overall Study|Withdrawal by Subject|4|||
33497337|NCT02952261|62875978|FG001|Overall Study|Withdrawal by Subject|5|||
33497338|NCT02952261|62875977|FG000|Overall Study|Protocol Violation|1|||
33497339|NCT02952261|62875978|FG001|Overall Study|Protocol Violation|0|||
33497340|NCT03384693|62875984|FG000|Overall Study|Adverse Event|3|||
33497341|NCT03718429|62875996|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
33497342|NCT03718429|62875997|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
33497343|NCT03718429|62875998|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
33497344|NCT03718429|62875999|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
33497345|NCT01285102|62876019|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
33497346|NCT03382899|62876053|FG000|Overall Study|Ineligibility Determined|0|||
33497347|NCT03382899|62876054|FG001|Overall Study|Ineligibility Determined|1|||
33497348|NCT03382899|62876053|FG000|Overall Study|Lost to Follow-up|0|||
33497349|NCT03382899|62876054|FG001|Overall Study|Lost to Follow-up|1|||
33497350|NCT03382899|62876053|FG000|Overall Study|Sponsor's decision|31|||
33497351|NCT03382899|62876054|FG001|Overall Study|Sponsor's decision|28|||
33497352|NCT03382899|62876053|FG000|Overall Study|Withdrawal by Subject|0|||
33497353|NCT03382899|62876054|FG001|Overall Study|Withdrawal by Subject|5|||
33497354|NCT00709852|62876060|FG000|Period 1|Adverse Event|2|||
33497355|NCT00709852|62876061|FG001|Period 1|Adverse Event|0|||
33497356|NCT00709852|62876060|FG000|Period 1|Withdrawal by Subject|4|||
33497357|NCT00709852|62876061|FG001|Period 1|Withdrawal by Subject|2|||
33497358|NCT00709852|62876060|FG000|Period 1|Protocol Violation|1|||
33497359|NCT00709852|62876061|FG001|Period 1|Protocol Violation|0|||
33497360|NCT00709852|62876060|FG000|Period 1|Defective scanner|0|||
33497361|NCT00709852|62876061|FG001|Period 1|Defective scanner|1|||
33608532|NCT01646177|63008804|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33497362|NCT00709852|62876060|FG000|Period 1|Lost to Follow-up|1|||
33497363|NCT00709852|62876061|FG001|Period 1|Lost to Follow-up|0|||
33497364|NCT00709852|62876060|FG000|Period 2|Protocol Violation|4|||
33608533|NCT01646177|63008805|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33608534|NCT01646177|63008794|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
33497365|NCT00709852|62876061|FG001|Period 2|Protocol Violation|1|||
33497366|NCT00709852|62876060|FG000|Period 2|Adverse Event|1|||
33497367|NCT00709852|62876061|FG001|Period 2|Adverse Event|1|||
33497368|NCT00709852|62876060|FG000|Period 2|Lost to Follow-up|1|||
33497369|NCT00709852|62876061|FG001|Period 2|Lost to Follow-up|0|||
33497370|NCT00709852|62876060|FG000|Period 2|No 72-hour follow-up|3|||
33497371|NCT00709852|62876061|FG001|Period 2|No 72-hour follow-up|0|||
33497372|NCT03382041|62876078|FG000|Overall Study|Consent Form Lost|2|||
33497373|NCT03382041|62876079|FG001|Overall Study|Consent Form Lost|1|||
33608535|NCT01646177|63008795|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
33608536|NCT01646177|63008796|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
33497374|NCT03382041|62876078|FG000|Overall Study|Withdrawal by Subject|1|||
33497375|NCT03382041|62876079|FG001|Overall Study|Withdrawal by Subject|4|||
33497376|NCT03382041|62876078|FG000|Overall Study|Lost to Follow-up|1|||
33497377|NCT03382041|62876079|FG001|Overall Study|Lost to Follow-up|4|||
33608537|NCT01646177|63008797|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
33608538|NCT01646177|63008798|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33608539|NCT01646177|63008799|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33608540|NCT01646177|63008800|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33608541|NCT01646177|63008801|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33497378|NCT03351231|62876085|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
33608542|NCT01646177|63008802|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33608543|NCT01646177|63008803|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33608544|NCT01646177|63008804|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33608545|NCT01646177|63008805|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33608546|NCT01646177|63008794|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33497379|NCT03351231|62876085|FG000|Combination Therapy Period|Disease progression|2|||
33497380|NCT03351231|62876085|FG000|Combination Therapy Period|Study drug toxicity|1|||
33497381|NCT03351231|62876085|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
33497382|NCT03351231|62876085|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
33497383|NCT03351231|62876085|FG000|Safety Follow-Up Period|Other reason|2|||
33497384|NCT03381339|62876091|FG000|Overall Study|Protocol Violation|4|||
33497385|NCT03381339|62876092|FG001|Overall Study|Protocol Violation|3|||
33497386|NCT03381339|62876091|FG000|Overall Study|Lost to Follow-up|0|||
33497387|NCT03381339|62876092|FG001|Overall Study|Lost to Follow-up|1|||
33497388|NCT03401229|62876100|FG000|Overall Study|Lost to Follow-up|2|||
33497389|NCT03401229|62876101|FG001|Overall Study|Lost to Follow-up|1|||
33497390|NCT03401229|62876100|FG000|Overall Study|Other|1|||
33497391|NCT03401229|62876101|FG001|Overall Study|Other|3|||
33497392|NCT03401229|62876100|FG000|Overall Study|Adverse Event|8|||
33497393|NCT03401229|62876101|FG001|Overall Study|Adverse Event|6|||
33497394|NCT03401229|62876100|FG000|Overall Study|Withdrawal by Subject|29|||
33497395|NCT03401229|62876101|FG001|Overall Study|Withdrawal by Subject|26|||
33497396|NCT03401229|62876100|FG000|Overall Study|COVID-19|0|||
33497397|NCT03401229|62876101|FG001|Overall Study|COVID-19|1|||
33497398|NCT03349515|62876109|FG000|Overall Study|Lack of Efficacy|2|||
33497399|NCT03349515|62876110|FG001|Overall Study|Lack of Efficacy|0|||
33497400|NCT03349515|62876109|FG000|Overall Study|Physician Decision|3|||
33497401|NCT03349515|62876110|FG001|Overall Study|Physician Decision|1|||
33497402|NCT03349437|62876116|FG000|Screening|Screen Fail|4|||
33497403|NCT03349437|62876117|FG001|Screening|Screen Fail|0|||
33497404|NCT03349437|62876118|FG002|Screening|Screen Fail|0|||
33497405|NCT03349437|62876116|FG000|Screening|Withdrawn|1|||
33497406|NCT03349437|62876117|FG001|Screening|Withdrawn|0|||
33497407|NCT03349437|62876118|FG002|Screening|Withdrawn|0|||
33497408|NCT03380091|62876127|FG000|Overall Study|Withdrawal by Subject|2|||
33497409|NCT03380091|62876128|FG001|Overall Study|Withdrawal by Subject|1|||
33497410|NCT03379233|62876138|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
33497411|NCT03379233|62876139|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
33497412|NCT01377922|62876147|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
33497413|NCT01377922|62876148|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
33497414|NCT03372603|62876154|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
33497415|NCT03372603|62876155|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
33497416|NCT03372603|62876154|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
33497417|NCT03372603|62876155|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
33497418|NCT01377844|62876163|FG000|Overall Study|Withdrawal by Subject|25|||
33497419|NCT01377844|62876164|FG001|Overall Study|Withdrawal by Subject|28|||
33497420|NCT01377844|62876163|FG000|Overall Study|Protocol Violation|2|||
33497421|NCT01377844|62876164|FG001|Overall Study|Protocol Violation|3|||
33497422|NCT01377844|62876163|FG000|Overall Study|Adverse Event|3|||
33608547|NCT01646177|63008795|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33497423|NCT01377844|62876164|FG001|Overall Study|Adverse Event|0|||
33497424|NCT01377844|62876163|FG000|Overall Study|Physician Decision|6|||
33608548|NCT01646177|63008796|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
33497425|NCT01377844|62876164|FG001|Overall Study|Physician Decision|3|||
33497426|NCT01377844|62876163|FG000|Overall Study|Study terminated by Sponsor|0|||
33497427|NCT01377844|62876164|FG001|Overall Study|Study terminated by Sponsor|1|||
33497428|NCT03372369|62876173|FG000|Qualification Period|Withdrawal by Subject|16|||
33497429|NCT03372369|62876174|FG001|Qualification Period|Withdrawal by Subject|13|||
33497430|NCT03372369|62876173|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
33497431|NCT03372369|62876174|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
33497432|NCT03372369|62876173|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
33497433|NCT03372369|62876174|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
33324001|NCT00970593|62700395|FG001|Overall Study|Discontinuation of study by sponsor|0|||
33447890|NCT00066742|62822952|FG000|Consolidation Chemotherapy|not protocol specified|1|||
33497434|NCT03371355|62876184|FG000|Overall Study|Investigator judgment|0|||
33497435|NCT03371355|62876185|FG001|Overall Study|Investigator judgment|0|||
33497436|NCT03371355|62876186|FG002|Overall Study|Investigator judgment|1|||
33497437|NCT03371355|62876187|FG003|Overall Study|Investigator judgment|1|||
33608549|NCT01646177|63008797|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
33608550|NCT01646177|63008798|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33608551|NCT01646177|63008799|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33447891|NCT00066742|62822952|FG000|Consolidation Chemotherapy|Ineligible|2|||
33447892|NCT00460265|62822960|FG000|Overall Study|Lost to Follow-up|14|||
33447893|NCT00460265|62822961|FG001|Overall Study|Lost to Follow-up|15|||
33447894|NCT00460265|62822960|FG000|Overall Study|Physician Decision|1|||
33447895|NCT00460265|62822961|FG001|Overall Study|Physician Decision|2|||
33447896|NCT00460265|62822960|FG000|Overall Study|Withdrawal by Subject|10|||
33447897|NCT00460265|62822961|FG001|Overall Study|Withdrawal by Subject|25|||
33447898|NCT00460265|62822960|FG000|Overall Study|Ongoing|60|||
33447899|NCT00460265|62822961|FG001|Overall Study|Ongoing|47|||
33447900|NCT00460109|62822967|FG000|Overall Study|Death|1|||
33447901|NCT00065260|62822973|FG000|Overall Study|Death|0|||
33447902|NCT00065260|62822974|FG001|Overall Study|Death|1|||
33447903|NCT00460031|62822980|FG000|Overall Study|Adverse Event|5|||
33447904|NCT00460031|62822980|FG000|Overall Study|Withdrawal by Subject|5|||
33447905|NCT00460031|62822980|FG000|Overall Study|Death|1|||
33447906|NCT00451217|62822988|FG000|Overall Study|Lost to Follow-up|0|||
33447907|NCT00451217|62822989|FG001|Overall Study|Lost to Follow-up|1|||
33447908|NCT00451217|62822990|FG002|Overall Study|Lost to Follow-up|1|||
33447909|NCT00451217|62822991|FG003|Overall Study|Lost to Follow-up|1|||
33447910|NCT00451217|62822988|FG000|Overall Study|Withdrawal by Subject|1|||
33447911|NCT00451217|62822989|FG001|Overall Study|Withdrawal by Subject|0|||
33447912|NCT00451217|62822990|FG002|Overall Study|Withdrawal by Subject|0|||
33447913|NCT00451217|62822991|FG003|Overall Study|Withdrawal by Subject|0|||
33447914|NCT00451217|62822988|FG000|Overall Study|Not Treated|1|||
33497438|NCT03371355|62876184|FG000|Overall Study|Voluntary withdrawal|1|||
33608552|NCT01646177|63008800|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33447915|NCT00451217|62822989|FG001|Overall Study|Not Treated|1|||
33447916|NCT00451217|62822990|FG002|Overall Study|Not Treated|3|||
33447917|NCT00451217|62822991|FG003|Overall Study|Not Treated|4|||
33447918|NCT00459953|62823003|FG000|Overall Study|not analyzed-household member in study|1|||
33497439|NCT03371355|62876185|FG001|Overall Study|Voluntary withdrawal|0|||
33497440|NCT03371355|62876186|FG002|Overall Study|Voluntary withdrawal|1|||
33497441|NCT03371355|62876187|FG003|Overall Study|Voluntary withdrawal|2|||
33497442|NCT03371355|62876184|FG000|Overall Study|Adverse Event|0|||
33497443|NCT03371355|62876185|FG001|Overall Study|Adverse Event|1|||
33497444|NCT03371355|62876186|FG002|Overall Study|Adverse Event|2|||
33608553|NCT01646177|63008801|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33608554|NCT01646177|63008802|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33608555|NCT01646177|63008803|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33608556|NCT01646177|63008804|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33447919|NCT00459953|62823004|FG001|Overall Study|not analyzed-household member in study|1|||
33447920|NCT00459875|62823010|FG000|Overall Study|Ineligible participant|1|||
33447921|NCT00459875|62823010|FG000|Overall Study|Adverse Event|2|||
33447922|NCT00311402|62823016|FG000|Overall Study|Adverse Event|118|||
33447923|NCT00311402|62823017|FG001|Overall Study|Adverse Event|105|||
33447924|NCT00311402|62823016|FG000|Overall Study|Lost to Follow-up|0|||
33447925|NCT00311402|62823017|FG001|Overall Study|Lost to Follow-up|3|||
33447926|NCT00311402|62823016|FG000|Overall Study|Withdrawal by Subject|17|||
33447927|NCT00311402|62823017|FG001|Overall Study|Withdrawal by Subject|18|||
33447928|NCT00311402|62823016|FG000|Overall Study|Lack of Efficacy|58|||
33447929|NCT00311402|62823017|FG001|Overall Study|Lack of Efficacy|42|||
33447930|NCT00311402|62823016|FG000|Overall Study|Protocol Violation|7|||
33447931|NCT00311402|62823017|FG001|Overall Study|Protocol Violation|6|||
33447932|NCT00311402|62823016|FG000|Overall Study|IRB's rejection etc.|10|||
33447933|NCT00311402|62823017|FG001|Overall Study|IRB's rejection etc.|3|||
33447934|NCT00450749|62823026|FG000|Overall Study|Withdrawal by Subject|0|||
33447935|NCT00450749|62823027|FG001|Overall Study|Withdrawal by Subject|0|||
33447936|NCT00450749|62823028|FG002|Overall Study|Withdrawal by Subject|2|||
33447937|NCT00450749|62823026|FG000|Overall Study|Noncompliant|0|||
33447938|NCT00450749|62823027|FG001|Overall Study|Noncompliant|1|||
33447939|NCT00450749|62823028|FG002|Overall Study|Noncompliant|0|||
33447940|NCT00292370|62823039|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
33447941|NCT00292370|62823040|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
33447942|NCT00292370|62823041|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
33447943|NCT00292370|62823039|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
33447944|NCT00292370|62823040|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
33447945|NCT00292370|62823041|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
33447946|NCT00292370|62823039|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
33447947|NCT00292370|62823040|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
33447948|NCT00292370|62823041|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
33447949|NCT00292370|62823039|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
33447950|NCT00292370|62823040|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
33447951|NCT00292370|62823041|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
33447952|NCT00292370|62823039|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
33447953|NCT00292370|62823040|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
33497445|NCT03371355|62876187|FG003|Overall Study|Adverse Event|3|||
33447954|NCT00292370|62823041|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
33447955|NCT00292370|62823039|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
33447956|NCT00292370|62823040|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
33447957|NCT00292370|62823041|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
33447958|NCT00065182|62823050|FG000|Overall Study|Adverse Event|24|||
33447959|NCT00065182|62823051|FG001|Overall Study|Adverse Event|17|||
33447960|NCT00065182|62823050|FG000|Overall Study|Lost to Follow-up|0|||
33447961|NCT00065182|62823051|FG001|Overall Study|Lost to Follow-up|4|||
33447962|NCT00065182|62823050|FG000|Overall Study|Protocol Violation|3|||
33447963|NCT00065182|62823051|FG001|Overall Study|Protocol Violation|4|||
33447964|NCT00065182|62823050|FG000|Overall Study|Serious adverse events (SAE)|1|||
33447965|NCT00065182|62823051|FG001|Overall Study|Serious adverse events (SAE)|0|||
33447966|NCT00065182|62823050|FG000|Overall Study|Sponsor Decision|11|||
33447967|NCT00065182|62823051|FG001|Overall Study|Sponsor Decision|7|||
33447968|NCT00065182|62823050|FG000|Overall Study|Withdrawal by Subject|8|||
33447969|NCT00065182|62823051|FG001|Overall Study|Withdrawal by Subject|3|||
33447970|NCT00065182|62823050|FG000|Overall Study|No clinical benefit|1|||
33447971|NCT00065182|62823051|FG001|Overall Study|No clinical benefit|0|||
33497446|NCT03371355|62876184|FG000|Overall Study|Reason not Specified|0|||
33497447|NCT03371355|62876185|FG001|Overall Study|Reason not Specified|1|||
33497448|NCT03371355|62876186|FG002|Overall Study|Reason not Specified|0|||
33497449|NCT03371355|62876187|FG003|Overall Study|Reason not Specified|1|||
33497450|NCT03370419|62876201|FG000|Overall Study|Lost to Follow-up|16|||
33497451|NCT03369951|62876209|FG000|Overall Study|Withdrawal by Subject|3|||
33497452|NCT03369951|62876209|FG000|Overall Study|Death|1|||
33447972|NCT00065182|62823050|FG000|Overall Study|Death|0|||
33447973|NCT00065182|62823051|FG001|Overall Study|Death|1|||
33447974|NCT00065182|62823050|FG000|Overall Study|Decline in Status|0|||
33447975|NCT00065182|62823051|FG001|Overall Study|Decline in Status|1|||
33447976|NCT00064792|62823059|FG000|Overall Study|Withdrawal by Subject|2|||
33447977|NCT00064792|62823060|FG001|Overall Study|Withdrawal by Subject|0|||
33447978|NCT00064792|62823059|FG000|Overall Study|Adverse Event|3|||
33447979|NCT00064792|62823060|FG001|Overall Study|Adverse Event|0|||
33447980|NCT00450437|62823068|FG000|Overall Study|Withdrawal by Subject|10|||
33447981|NCT00450437|62823069|FG001|Overall Study|Withdrawal by Subject|2|||
33447982|NCT00450437|62823070|FG002|Overall Study|Withdrawal by Subject|0|||
33447983|NCT00450437|62823071|FG003|Overall Study|Withdrawal by Subject|1|||
33447984|NCT00450437|62823068|FG000|Overall Study|Lost to Follow-up|31|||
33447985|NCT00450437|62823069|FG001|Overall Study|Lost to Follow-up|12|||
33497453|NCT03369951|62876209|FG000|Overall Study|Lost to Follow-up|1|||
33497454|NCT03369951|62876209|FG000|Overall Study|Protocol Violation|1|||
33497455|NCT04040192|62876213|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
33608557|NCT01646177|63008805|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33608558|NCT01646177|63008794|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
33447986|NCT00450437|62823070|FG002|Overall Study|Lost to Follow-up|19|||
33447987|NCT00450437|62823071|FG003|Overall Study|Lost to Follow-up|9|||
33447988|NCT00450437|62823068|FG000|Overall Study|Protocol Violation|0|||
33447989|NCT00450437|62823069|FG001|Overall Study|Protocol Violation|1|||
33497456|NCT04040192|62876214|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
33497457|NCT04040192|62876215|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
33608559|NCT01646177|63008795|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
33447990|NCT00450437|62823070|FG002|Overall Study|Protocol Violation|0|||
33447991|NCT00450437|62823071|FG003|Overall Study|Protocol Violation|1|||
33497458|NCT04040192|62876213|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
33497459|NCT04040192|62876214|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
33497460|NCT04040192|62876215|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
33447992|NCT00450437|62823068|FG000|Overall Study|Inappropriate enrollment|4|||
33497461|NCT04040192|62876213|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
33497462|NCT04040192|62876214|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
33497463|NCT04040192|62876215|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
33497464|NCT04040192|62876213|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
33497465|NCT04040192|62876214|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
33497466|NCT04040192|62876215|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
33497467|NCT04040192|62876213|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
33497468|NCT04040192|62876214|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
33497469|NCT04040192|62876215|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
33497470|NCT04040192|62876213|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
33497471|NCT04040192|62876214|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
33497472|NCT04040192|62876215|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
33497473|NCT04040192|62876213|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
33497474|NCT04040192|62876214|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
33608560|NCT01646177|63008796|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
33608561|NCT01646177|63008797|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33608562|NCT01646177|63008798|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33608563|NCT01646177|63008799|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33447993|NCT00450437|62823069|FG001|Overall Study|Inappropriate enrollment|1|||
33447994|NCT00450437|62823070|FG002|Overall Study|Inappropriate enrollment|3|||
33447995|NCT00450437|62823071|FG003|Overall Study|Inappropriate enrollment|0|||
33447996|NCT00450437|62823068|FG000|Overall Study|Administrative reason|0|||
33447997|NCT00450437|62823069|FG001|Overall Study|Administrative reason|0|||
33447998|NCT00450437|62823070|FG002|Overall Study|Administrative reason|1|||
33447999|NCT00450437|62823071|FG003|Overall Study|Administrative reason|0|||
33497475|NCT04040192|62876215|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
33497476|NCT04040192|62876213|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
33497477|NCT04040192|62876214|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
33497478|NCT04040192|62876215|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
33497479|NCT04040192|62876213|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
33497480|NCT04040192|62876214|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
33608564|NCT01646177|63008800|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33608565|NCT01646177|63008801|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33608566|NCT01646177|63008802|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33608567|NCT01646177|63008803|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33608568|NCT01646177|63008804|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33608569|NCT01646177|63008805|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33608570|NCT01646177|63008794|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33608571|NCT01646177|63008795|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33608572|NCT01646177|63008796|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33608573|NCT01646177|63008797|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33608574|NCT01646177|63008798|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
33608575|NCT01646177|63008799|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
33608576|NCT01646177|63008800|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
33608577|NCT01646177|63008801|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
33608578|NCT01646177|63008802|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33608579|NCT01646177|63008803|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33608580|NCT01646177|63008804|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33608581|NCT01646177|63008805|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33608582|NCT01646177|63008794|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33608583|NCT01646177|63008795|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33608584|NCT01646177|63008796|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33608585|NCT01646177|63008797|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33608586|NCT01646177|63008798|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
33608587|NCT01646177|63008799|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
33608588|NCT01646177|63008800|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
33608589|NCT01646177|63008801|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
33608590|NCT01646177|63008802|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33608591|NCT01646177|63008803|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33608592|NCT01646177|63008804|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33608593|NCT01646177|63008805|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33608594|NCT01646177|63008794|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33608595|NCT01646177|63008795|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33608596|NCT01646177|63008796|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33324002|NCT00970593|62700396|FG002|Overall Study|Discontinuation of study by sponsor|5|||
33448000|NCT00450437|62823068|FG000|Overall Study|Unable to Classify|1|||
33497481|NCT04040192|62876215|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
33497482|NCT04040192|62876213|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
33497483|NCT04040192|62876214|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
33497484|NCT04040192|62876215|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
33497485|NCT04040192|62876213|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
33497486|NCT04040192|62876214|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
33497487|NCT04040192|62876215|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
33497488|NCT04040192|62876213|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
33497489|NCT04040192|62876214|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
33497490|NCT04040192|62876215|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
33497491|NCT04040192|62876213|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
33448001|NCT00450437|62823069|FG001|Overall Study|Unable to Classify|0|||
33448002|NCT00450437|62823070|FG002|Overall Study|Unable to Classify|1|||
33448003|NCT00450437|62823071|FG003|Overall Study|Unable to Classify|0|||
33448004|NCT00286442|62823088|FG000|Overall Study|Hyperglycemic Rescue|19|||
33448005|NCT00286442|62823089|FG001|Overall Study|Hyperglycemic Rescue|17|||
33448006|NCT00286442|62823090|FG002|Overall Study|Hyperglycemic Rescue|25|||
33448007|NCT00286442|62823088|FG000|Overall Study|Adverse Event|7|||
33448008|NCT00286442|62823089|FG001|Overall Study|Adverse Event|6|||
33448009|NCT00286442|62823090|FG002|Overall Study|Adverse Event|1|||
33448010|NCT00286442|62823088|FG000|Overall Study|Protocol Violation|2|||
33448011|NCT00286442|62823089|FG001|Overall Study|Protocol Violation|4|||
33448012|NCT00286442|62823090|FG002|Overall Study|Protocol Violation|2|||
33448013|NCT00286442|62823088|FG000|Overall Study|Lost to Follow-up|5|||
33497492|NCT04040192|62876214|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
33497493|NCT04040192|62876215|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
33608597|NCT01646177|63008797|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33608598|NCT01646177|63008798|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
33608599|NCT01646177|63008799|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
33608600|NCT01646177|63008800|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
33608601|NCT01646177|63008801|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
33608602|NCT01646177|63008802|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33608603|NCT01646177|63008803|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33608604|NCT01646177|63008804|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33608605|NCT01646177|63008805|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33608606|NCT01646177|63008794|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33608607|NCT01646177|63008795|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33608608|NCT01646177|63008796|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33608609|NCT01646177|63008797|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33608610|NCT01646177|63008798|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
33608611|NCT01646177|63008799|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
33497494|NCT04040192|62876213|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
33497495|NCT04040192|62876214|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
33497496|NCT04040192|62876215|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
33497497|NCT04040192|62876213|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
33497498|NCT04040192|62876214|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
33497499|NCT04040192|62876215|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
33497500|NCT04040192|62876213|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
33497501|NCT04040192|62876214|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
33497502|NCT04040192|62876215|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
33497503|NCT04040192|62876213|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
33497504|NCT04040192|62876214|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
33497505|NCT04040192|62876215|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
33497506|NCT03368859|62876239|FG000|Overall Study|Withdrew Consent|5|||
33497507|NCT03368859|62876240|FG001|Overall Study|Withdrew Consent|4|||
33497508|NCT03368859|62876239|FG000|Overall Study|Death|12|||
33497509|NCT03368859|62876240|FG001|Overall Study|Death|6|||
33497510|NCT03368859|62876239|FG000|Overall Study|Study terminated by Sponsor|18|||
33497511|NCT03368859|62876240|FG001|Overall Study|Study terminated by Sponsor|23|||
33497512|NCT03368859|62876239|FG000|Overall Study|Other|1|||
33497513|NCT03368859|62876240|FG001|Overall Study|Other|1|||
33497514|NCT03096314|62876254|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
33497515|NCT03096314|62876255|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
33497516|NCT03335163|62876261|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
33497517|NCT03335163|62876261|FG000|Overall Study|Withdrawal by Subject|18|||
33448014|NCT00286442|62823089|FG001|Overall Study|Lost to Follow-up|2|||
33448015|NCT00286442|62823090|FG002|Overall Study|Lost to Follow-up|1|||
33448016|NCT00286442|62823088|FG000|Overall Study|Physician Decision|1|||
33497518|NCT03364335|62876287|FG000|Overall Study|Adverse Event|3|||
33497519|NCT03364335|62876288|FG001|Overall Study|Adverse Event|4|||
33497520|NCT03364335|62876289|FG002|Overall Study|Adverse Event|1|||
33497521|NCT03364335|62876290|FG003|Overall Study|Adverse Event|2|||
33497522|NCT03364335|62876291|FG004|Overall Study|Adverse Event|0|||
33497523|NCT03364335|62876287|FG000|Overall Study|Lost to Follow-up|7|||
33497524|NCT03364335|62876288|FG001|Overall Study|Lost to Follow-up|7|||
33497525|NCT03364335|62876289|FG002|Overall Study|Lost to Follow-up|10|||
33497526|NCT03364335|62876290|FG003|Overall Study|Lost to Follow-up|11|||
33608612|NCT01646177|63008800|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
33608613|NCT01646177|63008801|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
33448017|NCT00286442|62823089|FG001|Overall Study|Physician Decision|1|||
33448018|NCT00286442|62823090|FG002|Overall Study|Physician Decision|1|||
33448019|NCT00286442|62823088|FG000|Overall Study|Administrative Error|1|||
33448020|NCT00286442|62823089|FG001|Overall Study|Administrative Error|1|||
33497527|NCT03364335|62876291|FG004|Overall Study|Lost to Follow-up|11|||
33497528|NCT03334695|62876314|FG000|Overall Study|Lost to Follow-up|3|||
33497529|NCT03334695|62876315|FG001|Overall Study|Lost to Follow-up|3|||
33497530|NCT03334695|62876314|FG000|Overall Study|Physician Decision|1|||
33497531|NCT03334695|62876315|FG001|Overall Study|Physician Decision|2|||
33497532|NCT03334695|62876314|FG000|Overall Study|Protocol Violation|0|||
33497533|NCT03334695|62876315|FG001|Overall Study|Protocol Violation|1|||
33448021|NCT00286442|62823090|FG002|Overall Study|Administrative Error|0|||
33497534|NCT03364023|62876323|FG000|Overall Study|Lost to Follow-up|3|||
33497535|NCT03364023|62876323|FG000|Overall Study|Death|14|||
33497536|NCT03764813|62876347|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
33497537|NCT03764813|62876348|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
33497538|NCT03764813|62876349|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
33497539|NCT03764813|62876350|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
33497540|NCT03363321|62876371|FG000|Overall Study|Withdrawal by Subject|0|||
33497541|NCT03363321|62876372|FG001|Overall Study|Withdrawal by Subject|1|||
33497542|NCT03363321|62876373|FG002|Overall Study|Withdrawal by Subject|0|||
33497543|NCT03363321|62876374|FG003|Overall Study|Withdrawal by Subject|1|||
33497544|NCT03363321|62876375|FG004|Overall Study|Withdrawal by Subject|0|||
33497545|NCT03361605|62876388|FG000|Overall Study|Analyzable data not available|3|||
33497546|NCT03829046|62876394|FG000|Overall Study|Withdrawal by Subject|1|||
33497547|NCT03829046|62876395|FG001|Overall Study|Withdrawal by Subject|0|||
33497548|NCT03361293|62876403|FG000|Overall Study|Lost to Follow-up|0|||
33497549|NCT03361293|62876404|FG001|Overall Study|Lost to Follow-up|2|||
33497550|NCT03361293|62876403|FG000|Overall Study|Withdrawal by Subject|1|||
33497551|NCT03361293|62876404|FG001|Overall Study|Withdrawal by Subject|3|||
33497552|NCT03361137|62876415|FG000|Overall Study|Reason not specified|1|||
33497553|NCT03361137|62876416|FG001|Overall Study|Reason not specified|0|||
33497554|NCT03361137|62876417|FG002|Overall Study|Reason not specified|0|||
33497555|NCT03361137|62876418|FG003|Overall Study|Reason not specified|0|||
33497556|NCT03361137|62876419|FG004|Overall Study|Reason not specified|0|||
33497557|NCT03360747|62876433|FG000|Overall Study|Voluntary Withdrawal|1|||
33497558|NCT03359811|62876439|FG000|Overall Study|Protocol Violation|2|||
33497559|NCT03359811|62876440|FG001|Overall Study|Protocol Violation|0|||
33497560|NCT03728426|62876447|FG000|Overall Study|Death|3|||
33497561|NCT02095678|62876453|FG000|Overall Study|Withdrawal by Subject|0|||
33497562|NCT02095678|62876454|FG001|Overall Study|Withdrawal by Subject|1|||
33497563|NCT02095678|62876453|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
33497564|NCT02095678|62876454|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
33497565|NCT02095678|62876453|FG000|Overall Study|lesion impacted by previous treatment|1|||
33497566|NCT02095678|62876454|FG001|Overall Study|lesion impacted by previous treatment|1|||
33497567|NCT02095678|62876453|FG000|Overall Study|No Confirmed Diagnosis|0|||
33497568|NCT02095678|62876454|FG001|Overall Study|No Confirmed Diagnosis|3|||
33497569|NCT02095678|62876453|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
33497570|NCT02095678|62876454|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
33497571|NCT02095678|62876453|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
33497572|NCT02095678|62876454|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
33497573|NCT03763877|62876467|FG000|Overall Study|Withdrawal by Subject|3|||
33497574|NCT03763877|62876468|FG001|Overall Study|Withdrawal by Subject|1|||
33497575|NCT03763877|62876469|FG002|Overall Study|Withdrawal by Subject|3|||
33497576|NCT03763877|62876470|FG003|Overall Study|Withdrawal by Subject|4|||
33497577|NCT03763877|62876467|FG000|Overall Study|Adverse Event|1|||
33497578|NCT03763877|62876468|FG001|Overall Study|Adverse Event|1|||
33497579|NCT03763877|62876469|FG002|Overall Study|Adverse Event|3|||
33497580|NCT03763877|62876470|FG003|Overall Study|Adverse Event|1|||
33497581|NCT03763877|62876467|FG000|Overall Study|Protocol Violation|1|||
33497582|NCT03763877|62876468|FG001|Overall Study|Protocol Violation|1|||
33497583|NCT03763877|62876469|FG002|Overall Study|Protocol Violation|0|||
33497584|NCT03763877|62876470|FG003|Overall Study|Protocol Violation|0|||
33608614|NCT01646177|63008802|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33608615|NCT01646177|63008803|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33608616|NCT01646177|63008804|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33608617|NCT01646177|63008805|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33608618|NCT01646177|63008794|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33608619|NCT01646177|63008795|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33608620|NCT01646177|63008796|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33448022|NCT00286442|62823088|FG000|Overall Study|Withdrawal by Subject|2|||
33448023|NCT00286442|62823089|FG001|Overall Study|Withdrawal by Subject|14|||
33448024|NCT00286442|62823090|FG002|Overall Study|Withdrawal by Subject|2|||
33448025|NCT00063934|62823098|FG000|Overall Study|Ineligible|1|||
33448026|NCT00458783|62823104|FG000|Overall Study|Protocol Violation|1228|||
33448027|NCT00458783|62823105|FG001|Overall Study|Protocol Violation|1220|||
33448028|NCT00063154|62823111|FG000|Overall Study|Disease progression|27|||
33448029|NCT00063154|62823111|FG000|Overall Study|Adverse Event|2|||
33448030|NCT00063154|62823111|FG000|Overall Study|Physician Decision|10|||
33448031|NCT00063154|62823111|FG000|Overall Study|Death|3|||
33448032|NCT00063154|62823111|FG000|Overall Study|Reason unspecified|1|||
33448033|NCT00063154|62823111|FG000|Overall Study|Did not receive treatment|8|||
33497585|NCT03763877|62876467|FG000|Overall Study|Lost to Follow-up|0|||
33497586|NCT03763877|62876468|FG001|Overall Study|Lost to Follow-up|1|||
33497587|NCT03763877|62876469|FG002|Overall Study|Lost to Follow-up|1|||
33608621|NCT01646177|63008797|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33608622|NCT01646177|63008798|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
33608623|NCT01646177|63008799|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
33448034|NCT00311168|62823117|FG000|First Intervention|Withdrawal by Subject|2|||
33497588|NCT03763877|62876470|FG003|Overall Study|Lost to Follow-up|0|||
33497589|NCT03358407|62876503|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33497590|NCT03358407|62876504|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33497591|NCT03358407|62876505|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
33497592|NCT03358407|62876506|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33497593|NCT03358407|62876507|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33497594|NCT03358407|62876508|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33497595|NCT03358407|62876509|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33497596|NCT03358407|62876510|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33497597|NCT03358407|62876511|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33497598|NCT03358407|62876512|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33497599|NCT03358407|62876503|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497600|NCT03358407|62876504|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497601|NCT03358407|62876505|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497602|NCT03358407|62876506|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497603|NCT03358407|62876507|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
33497604|NCT03358407|62876508|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497605|NCT03358407|62876509|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497606|NCT03358407|62876510|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497607|NCT03358407|62876511|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497608|NCT03358407|62876512|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497609|NCT03358407|62876503|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33497610|NCT03358407|62876504|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33497611|NCT03358407|62876505|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33497612|NCT03358407|62876506|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33497613|NCT03358407|62876507|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33497614|NCT03358407|62876508|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
33497615|NCT03358407|62876509|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33497616|NCT03358407|62876510|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
33497617|NCT03358407|62876511|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33497618|NCT03358407|62876512|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33497619|NCT03358407|62876503|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33497620|NCT03358407|62876504|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33497621|NCT03358407|62876505|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33497622|NCT03358407|62876506|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33497623|NCT03358407|62876507|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33497624|NCT03358407|62876508|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
33497625|NCT03358407|62876509|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33497626|NCT03358407|62876510|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
33497627|NCT03358407|62876511|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33497628|NCT03358407|62876512|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33497629|NCT03358407|62876503|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497630|NCT03358407|62876504|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497631|NCT03358407|62876505|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33448035|NCT00311168|62823118|FG001|First Intervention|Withdrawal by Subject|2|||
33448036|NCT00311168|62823117|FG000|First Intervention|Lost to Follow-up|1|||
33448037|NCT00311168|62823118|FG001|First Intervention|Lost to Follow-up|1|||
33448038|NCT00311168|62823117|FG000|First Intervention|Protocol Violation|1|||
33448039|NCT00311168|62823118|FG001|First Intervention|Protocol Violation|1|||
33448040|NCT00311168|62823117|FG000|First Intervention|Adverse Event|1|||
33448041|NCT00311168|62823118|FG001|First Intervention|Adverse Event|0|||
33448042|NCT00311168|62823117|FG000|First Intervention|Other|2|||
33448043|NCT00311168|62823118|FG001|First Intervention|Other|2|||
33448044|NCT00311168|62823117|FG000|Second Intervention|Lost to Follow-up|9|||
33448045|NCT00311168|62823118|FG001|Second Intervention|Lost to Follow-up|2|||
33448046|NCT00311168|62823117|FG000|Second Intervention|Withdrawal by Subject|0|||
33448047|NCT00311168|62823118|FG001|Second Intervention|Withdrawal by Subject|1|||
33448048|NCT00311168|62823117|FG000|Second Intervention|Other|1|||
33497632|NCT03358407|62876506|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497633|NCT03358407|62876507|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497634|NCT03358407|62876508|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
33497635|NCT03358407|62876509|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
33497636|NCT03358407|62876510|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497637|NCT03358407|62876511|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497638|NCT03358407|62876512|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33497639|NCT03358407|62876503|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
33497640|NCT03358407|62876504|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
33497641|NCT03358407|62876505|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
33497642|NCT03358407|62876506|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
33497643|NCT03358407|62876507|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
33497644|NCT03358407|62876508|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
33497645|NCT03358407|62876509|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
33497646|NCT03358407|62876510|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
33497647|NCT03358407|62876511|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
33497648|NCT03358407|62876512|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
33497649|NCT02950545|62876554|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
33497650|NCT02950545|62876555|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
33497651|NCT02950545|62876556|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
33497652|NCT02950545|62876557|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
33497653|NCT02950545|62876558|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
33497654|NCT02950545|62876559|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
33497655|NCT02950545|62876554|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
33497656|NCT02950545|62876555|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
33497657|NCT02950545|62876556|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
33497658|NCT02950545|62876557|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
33497659|NCT02950545|62876558|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
33497660|NCT02950545|62876559|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
33497661|NCT02950545|62876554|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
33497662|NCT02950545|62876555|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
33497663|NCT02950545|62876556|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
33497664|NCT02950545|62876557|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
33497665|NCT02950545|62876558|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
33497666|NCT02950545|62876559|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
33497667|NCT02950545|62876554|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
33497668|NCT02950545|62876555|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
33497669|NCT02950545|62876556|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
33497670|NCT02950545|62876557|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
33497671|NCT02950545|62876558|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
33497672|NCT02950545|62876559|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
33497673|NCT02950545|62876554|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
33497674|NCT02950545|62876555|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
33497675|NCT02950545|62876556|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
33497676|NCT02950545|62876557|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
33497677|NCT02950545|62876558|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
33497678|NCT02950545|62876559|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
33497679|NCT03358329|62876565|FG000|Overall Study|Lost to Follow-up|2|||
33497680|NCT03358329|62876565|FG000|Overall Study|Withdrawal by Subject|2|||
33497681|NCT03357471|62876581|FG000|Overall Study|Adverse Event|1|||
33497682|NCT03357471|62876582|FG001|Overall Study|Adverse Event|0|||
33497683|NCT03357471|62876581|FG000|Overall Study|Lost to Follow-up|1|||
33497684|NCT03357471|62876582|FG001|Overall Study|Lost to Follow-up|0|||
33497685|NCT03356145|62876590|FG000|Overall Study|Withdrawal by Subject|2|||
33497686|NCT03356145|62876591|FG001|Overall Study|Withdrawal by Subject|1|||
33448049|NCT00311168|62823118|FG001|Second Intervention|Other|1|||
33448050|NCT00458705|62823126|FG000|Overall Study|Adverse Event|4|||
33448051|NCT00458705|62823126|FG000|Overall Study|Not Treated|1|||
33448052|NCT00062374|62823130|FG000|Overall Study|Not treated|12|||
33448053|NCT00285818|62823136|FG000|Overall Study|Withdrawal by Subject|3|||
33448054|NCT00285818|62823137|FG001|Overall Study|Withdrawal by Subject|2|||
33448055|NCT00285818|62823136|FG000|Overall Study|Lost to Follow-up|1|||
33448056|NCT00285818|62823137|FG001|Overall Study|Lost to Follow-up|0|||
33448057|NCT00285584|62823145|FG000|Month 3|Lost to Follow-up|3|||
33448058|NCT00285584|62823146|FG001|Month 3|Lost to Follow-up|3|||
33448059|NCT00285584|62823145|FG000|Month 3|Withdrawal by Subject|1|||
33448060|NCT00285584|62823146|FG001|Month 3|Withdrawal by Subject|0|||
33448061|NCT00285584|62823145|FG000|Month 6|Lost to Follow-up|0|||
33448062|NCT00285584|62823146|FG001|Month 6|Lost to Follow-up|1|||
33448063|NCT03807700|62823158|FG000|Overall Study|Withdrawal by Subject|2|||
33448064|NCT03807700|62823159|FG001|Overall Study|Withdrawal by Subject|1|||
33448065|NCT00291668|62823169|FG000|Overall Study|Lack of Efficacy|1|||
33448066|NCT00291668|62823170|FG001|Overall Study|Lack of Efficacy|0|||
33608624|NCT01646177|63008800|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
33608625|NCT01646177|63008801|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
33608626|NCT01646177|63008802|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33608627|NCT01646177|63008803|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33608628|NCT01646177|63008804|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33608629|NCT01646177|63008805|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33448067|NCT00291668|62823171|FG002|Overall Study|Lack of Efficacy|0|||
33448068|NCT00291668|62823169|FG000|Overall Study|SAE, non-fatal|1|||
33448069|NCT00291668|62823170|FG001|Overall Study|SAE, non-fatal|1|||
33448070|NCT00291668|62823171|FG002|Overall Study|SAE, non-fatal|1|||
33448071|NCT00291668|62823169|FG000|Overall Study|AE, non-serious non-fatal|1|||
33448072|NCT00291668|62823170|FG001|Overall Study|AE, non-serious non-fatal|0|||
33448073|NCT00291668|62823171|FG002|Overall Study|AE, non-serious non-fatal|0|||
33448074|NCT00291668|62823169|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33448075|NCT00291668|62823170|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
33448076|NCT00291668|62823171|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
33448077|NCT00458393|62823181|FG000|Overall Study|Withdrawal by Subject|67|||
33448078|NCT00458393|62823182|FG001|Overall Study|Withdrawal by Subject|80|||
33448079|NCT00458393|62823181|FG000|Overall Study|Physician Decision|31|||
33448080|NCT00458393|62823182|FG001|Overall Study|Physician Decision|22|||
33448081|NCT00458393|62823181|FG000|Overall Study|Relocated|77|||
33448082|NCT00458393|62823182|FG001|Overall Study|Relocated|81|||
33448083|NCT00458393|62823181|FG000|Overall Study|Lost to Follow-up|115|||
33448084|NCT00458393|62823182|FG001|Overall Study|Lost to Follow-up|92|||
33448085|NCT00458393|62823181|FG000|Overall Study|Sites marked other on the form.|19|||
33448086|NCT00458393|62823182|FG001|Overall Study|Sites marked other on the form.|20|||
33448087|NCT00310856|62823193|FG000|Overall Study|Withdrawal by Subject|2|||
33448088|NCT00310856|62823194|FG001|Overall Study|Withdrawal by Subject|2|||
33448089|NCT00310856|62823195|FG002|Overall Study|Withdrawal by Subject|2|||
33448090|NCT00310856|62823193|FG000|Overall Study|Lost to Follow-up|1|||
33448091|NCT00310856|62823194|FG001|Overall Study|Lost to Follow-up|2|||
33448092|NCT00310856|62823195|FG002|Overall Study|Lost to Follow-up|6|||
33608630|NCT01646177|63008794|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33608631|NCT01646177|63008795|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33448093|NCT00310856|62823193|FG000|Overall Study|Inappropriate enrollment|1|||
33497687|NCT03356145|62876590|FG000|Overall Study|Did not meet inclusion criteria|1|||
33497688|NCT03356145|62876591|FG001|Overall Study|Did not meet inclusion criteria|0|||
33497689|NCT03342963|62876601|FG000|Overall Study|Adverse Event|1|||
33497690|NCT03342963|62876602|FG001|Overall Study|Adverse Event|2|||
33497691|NCT03342963|62876603|FG002|Overall Study|Adverse Event|0|||
33497692|NCT03342963|62876604|FG003|Overall Study|Adverse Event|0|||
33497693|NCT03342963|62876601|FG000|Overall Study|Withdrawal by Subject|1|||
33497694|NCT03342963|62876602|FG001|Overall Study|Withdrawal by Subject|0|||
33497695|NCT03342963|62876603|FG002|Overall Study|Withdrawal by Subject|0|||
33497696|NCT03342963|62876604|FG003|Overall Study|Withdrawal by Subject|0|||
33497697|NCT03361956|62876619|FG000|Overall Study|Adverse Event|1|||
33497698|NCT03361956|62876620|FG001|Overall Study|Adverse Event|0|||
33497699|NCT03361956|62876621|FG002|Overall Study|Adverse Event|1|||
33497700|NCT03361956|62876622|FG003|Overall Study|Adverse Event|1|||
33497701|NCT03361956|62876623|FG004|Overall Study|Adverse Event|0|||
33497702|NCT03361956|62876619|FG000|Overall Study|Other|0|||
33497703|NCT03361956|62876620|FG001|Overall Study|Other|0|||
33497704|NCT03361956|62876621|FG002|Overall Study|Other|0|||
33497705|NCT03361956|62876622|FG003|Overall Study|Other|1|||
33448094|NCT00310856|62823194|FG001|Overall Study|Inappropriate enrollment|1|||
33448095|NCT00310856|62823195|FG002|Overall Study|Inappropriate enrollment|0|||
33448096|NCT00310856|62823193|FG000|Overall Study|Unable to classify|1|||
33497706|NCT03361956|62876623|FG004|Overall Study|Other|0|||
33497707|NCT03361956|62876619|FG000|Overall Study|Withdrawal by Subject|2|||
33497708|NCT03361956|62876620|FG001|Overall Study|Withdrawal by Subject|2|||
33497709|NCT03361956|62876621|FG002|Overall Study|Withdrawal by Subject|2|||
33497710|NCT03361956|62876622|FG003|Overall Study|Withdrawal by Subject|0|||
33497711|NCT03361956|62876623|FG004|Overall Study|Withdrawal by Subject|3|||
33497712|NCT03361956|62876619|FG000|Overall Study|Disease Relapse|0|||
33497713|NCT03361956|62876620|FG001|Overall Study|Disease Relapse|0|||
33497714|NCT03361956|62876621|FG002|Overall Study|Disease Relapse|1|||
33497715|NCT03361956|62876622|FG003|Overall Study|Disease Relapse|0|||
33497716|NCT03361956|62876623|FG004|Overall Study|Disease Relapse|0|||
33497717|NCT03361956|62876619|FG000|Overall Study|Physician Decision|0|||
33497718|NCT03361956|62876620|FG001|Overall Study|Physician Decision|2|||
33497719|NCT03361956|62876621|FG002|Overall Study|Physician Decision|0|||
33497720|NCT03361956|62876622|FG003|Overall Study|Physician Decision|1|||
33497721|NCT03361956|62876623|FG004|Overall Study|Physician Decision|0|||
33497722|NCT03361956|62876619|FG000|Overall Study|Lost to Follow-up|0|||
33497723|NCT03361956|62876620|FG001|Overall Study|Lost to Follow-up|0|||
33497724|NCT03361956|62876621|FG002|Overall Study|Lost to Follow-up|1|||
33497725|NCT03361956|62876622|FG003|Overall Study|Lost to Follow-up|1|||
33497726|NCT03361956|62876623|FG004|Overall Study|Lost to Follow-up|2|||
33497727|NCT03361176|62876694|FG000|Overall Study|Lost to Follow-up|1|||
33497728|NCT03361176|62876695|FG001|Overall Study|Lost to Follow-up|2|||
33497729|NCT03361176|62876694|FG000|Overall Study|Adverse Event|0|||
33497730|NCT03361176|62876695|FG001|Overall Study|Adverse Event|2|||
33497731|NCT03361176|62876694|FG000|Overall Study|Withdrawal by Subject|0|||
33497732|NCT03361176|62876695|FG001|Overall Study|Withdrawal by Subject|1|||
33497733|NCT05283499|62876703|FG000|Overall Study|Did not receive intervention|1|||
33497734|NCT05283499|62876704|FG001|Overall Study|Did not receive intervention|2|||
33497735|NCT05271175|62876713|FG000|One Week Follow up|Lost to Follow-up|10|||
33448097|NCT00310856|62823194|FG001|Overall Study|Unable to classify|0|||
33448098|NCT00310856|62823195|FG002|Overall Study|Unable to classify|0|||
33448099|NCT00283712|62823206|FG000|Overall Study|Death|0|||
33448100|NCT00283712|62823207|FG001|Overall Study|Death|1|||
33448101|NCT00048724|62823215|FG000|Overall Study|Adverse Event|53|||
33497736|NCT05271175|62876714|FG001|One Week Follow up|Lost to Follow-up|7|||
33497737|NCT05271175|62876715|FG002|One Week Follow up|Lost to Follow-up|5|||
33497738|NCT05271175|62876713|FG000|One Month Follow up|Lost to Follow-up|12|||
33497739|NCT05271175|62876714|FG001|One Month Follow up|Lost to Follow-up|7|||
33608632|NCT01646177|63008796|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33448102|NCT00048724|62823216|FG001|Overall Study|Adverse Event|12|||
33448103|NCT00048724|62823215|FG000|Overall Study|Withdrawal by Subject|34|||
33497740|NCT05271175|62876715|FG002|One Month Follow up|Lost to Follow-up|9|||
33497741|NCT05271175|62876713|FG000|Six Months Follow up|Lost to Follow-up|8|||
33497742|NCT05271175|62876714|FG001|Six Months Follow up|Lost to Follow-up|2|||
33497743|NCT05271175|62876715|FG002|Six Months Follow up|Lost to Follow-up|2|||
33497744|NCT03098030|62876727|FG000|Overall Study|Death|10|||
33497745|NCT03098030|62876728|FG001|Overall Study|Death|156|||
33497746|NCT03098030|62876729|FG002|Overall Study|Death|156|||
33497747|NCT03098030|62876730|FG003|Overall Study|Death|82|||
33497748|NCT03098030|62876727|FG000|Overall Study|Withdrawal by Subject|0|||
33497749|NCT03098030|62876728|FG001|Overall Study|Withdrawal by Subject|7|||
33497750|NCT03098030|62876729|FG002|Overall Study|Withdrawal by Subject|8|||
33497751|NCT03098030|62876730|FG003|Overall Study|Withdrawal by Subject|2|||
33497752|NCT03098030|62876727|FG000|Overall Study|Lost to Follow-up|0|||
33497753|NCT03098030|62876728|FG001|Overall Study|Lost to Follow-up|0|||
33497754|NCT03098030|62876729|FG002|Overall Study|Lost to Follow-up|2|||
33497755|NCT03098030|62876730|FG003|Overall Study|Lost to Follow-up|1|||
33497756|NCT03341637|62876741|FG000|Overall Study|Lost to Follow-up|1|||
33497757|NCT03341637|62876742|FG001|Overall Study|Lost to Follow-up|0|||
33497758|NCT03341637|62876741|FG000|Overall Study|Withdrawal by Subject|3|||
33497759|NCT03341637|62876742|FG001|Overall Study|Withdrawal by Subject|3|||
33497760|NCT03341637|62876741|FG000|Overall Study|Reason not Specified|1|||
33497761|NCT03341637|62876742|FG001|Overall Study|Reason not Specified|1|||
33497762|NCT01378858|62876750|FG000|Overall Study|Withdrawal by Subject|4|||
33497763|NCT01378858|62876751|FG001|Overall Study|Withdrawal by Subject|4|||
33497764|NCT02891850|62876759|FG000|Overall Study|Adverse Event|3|||
33497765|NCT02891850|62876760|FG001|Overall Study|Adverse Event|0|||
33497766|NCT02891850|62876759|FG000|Overall Study|Death|0|||
33497767|NCT02891850|62876760|FG001|Overall Study|Death|4|||
33497768|NCT02891850|62876759|FG000|Overall Study|Physician Decision|1|||
33497769|NCT02891850|62876760|FG001|Overall Study|Physician Decision|0|||
33497770|NCT02891850|62876759|FG000|Overall Study|Pregnancy|1|||
33497771|NCT02891850|62876760|FG001|Overall Study|Pregnancy|0|||
33497772|NCT02891850|62876759|FG000|Overall Study|Withdrawal by Subject|2|||
33497773|NCT02891850|62876760|FG001|Overall Study|Withdrawal by Subject|3|||
33497774|NCT05594173|62876766|FG000|Overall Study|Adverse Event|1|||
33497775|NCT05594173|62876766|FG000|Overall Study|COVID-19 Pandemic|2|||
33497776|NCT03339999|62876779|FG000|Overall Study|Adverse Event|1|||
33497777|NCT03339999|62876780|FG001|Overall Study|Adverse Event|2|||
33497778|NCT03339999|62876781|FG002|Overall Study|Adverse Event|2|||
33497779|NCT03339999|62876782|FG003|Overall Study|Adverse Event|1|||
33497780|NCT03339999|62876779|FG000|Overall Study|Lack of Efficacy|0|||
33497781|NCT03339999|62876780|FG001|Overall Study|Lack of Efficacy|1|||
33497782|NCT03339999|62876781|FG002|Overall Study|Lack of Efficacy|0|||
33497783|NCT03339999|62876782|FG003|Overall Study|Lack of Efficacy|0|||
33497784|NCT03339999|62876779|FG000|Overall Study|Lost to Follow-up|0|||
33497785|NCT03339999|62876780|FG001|Overall Study|Lost to Follow-up|0|||
33497786|NCT03339999|62876781|FG002|Overall Study|Lost to Follow-up|0|||
33497787|NCT03339999|62876782|FG003|Overall Study|Lost to Follow-up|1|||
33497788|NCT03339999|62876779|FG000|Overall Study|Study Terminated by Sponsor|6|||
33497789|NCT03339999|62876780|FG001|Overall Study|Study Terminated by Sponsor|3|||
33497790|NCT03339999|62876781|FG002|Overall Study|Study Terminated by Sponsor|4|||
33497791|NCT03339999|62876782|FG003|Overall Study|Study Terminated by Sponsor|3|||
33497792|NCT03339453|62876795|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
33497793|NCT03339453|62876796|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
33497794|NCT03359850|62876840|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
33497795|NCT03359850|62876841|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
33497796|NCT03359850|62876840|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
33497797|NCT03359850|62876841|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
33497798|NCT03359850|62876840|FG000|Extension Phase (Up to 28 Months)|Death|2|||
33497799|NCT03359850|62876841|FG001|Extension Phase (Up to 28 Months)|Death|4|||
33497800|NCT03359850|62876840|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
33497801|NCT03359850|62876841|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
33497802|NCT03359850|62876840|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
33497803|NCT03359850|62876841|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
33497804|NCT00114140|62876860|FG000|Overall Study|Protocol Violation|7|||
33497805|NCT03712345|62876874|FG000|Overall Study|Failure to meet randomization criteria|0|||
33497806|NCT03712345|62876875|FG001|Overall Study|Failure to meet randomization criteria|0|||
33497807|NCT03712345|62876876|FG002|Overall Study|Failure to meet randomization criteria|1|||
33497808|NCT03358290|62876889|FG000|Overall Study|Study discontinued by Sponsor|0|||
33497809|NCT03358290|62876890|FG001|Overall Study|Study discontinued by Sponsor|1|||
33497810|NCT03358290|62876891|FG002|Overall Study|Study discontinued by Sponsor|1|||
33497811|NCT03358290|62876892|FG003|Overall Study|Study discontinued by Sponsor|0|||
33497812|NCT03358290|62876893|FG004|Overall Study|Study discontinued by Sponsor|0|||
33497813|NCT03358290|62876889|FG000|Overall Study|Adverse Event|0|||
33497814|NCT03358290|62876890|FG001|Overall Study|Adverse Event|0|||
33497815|NCT03358290|62876891|FG002|Overall Study|Adverse Event|1|||
33497816|NCT03358290|62876892|FG003|Overall Study|Adverse Event|2|||
33497817|NCT03358290|62876893|FG004|Overall Study|Adverse Event|0|||
33497818|NCT03358290|62876889|FG000|Overall Study|Withdrawal by Subject|0|||
33497819|NCT03358290|62876890|FG001|Overall Study|Withdrawal by Subject|0|||
33497820|NCT03358290|62876891|FG002|Overall Study|Withdrawal by Subject|0|||
33497821|NCT03358290|62876892|FG003|Overall Study|Withdrawal by Subject|0|||
33497822|NCT03358290|62876893|FG004|Overall Study|Withdrawal by Subject|1|||
33497823|NCT03089216|62876909|FG000|Overall Study|Adverse Event|0|||
33497824|NCT03089216|62876910|FG001|Overall Study|Adverse Event|0|||
33497825|NCT03089216|62876911|FG002|Overall Study|Adverse Event|0|||
33497826|NCT03089216|62876912|FG003|Overall Study|Adverse Event|1|||
33497827|NCT03339726|62876929|FG000|Overall Study|Withdrawal by Subject|1|||
33497828|NCT03339726|62876930|FG001|Overall Study|Withdrawal by Subject|0|||
33497829|NCT03339726|62876931|FG002|Overall Study|Withdrawal by Subject|0|||
33497830|NCT03339726|62876929|FG000|Overall Study|Lost to Follow-up|0|||
33497831|NCT03339726|62876930|FG001|Overall Study|Lost to Follow-up|1|||
33497832|NCT03339726|62876931|FG002|Overall Study|Lost to Follow-up|0|||
33497833|NCT03339297|62876941|FG000|Overall Study|Relapse of Hematologic Disease|1|||
33497834|NCT03339297|62876942|FG001|Overall Study|Relapse of Hematologic Disease|0|||
33497835|NCT03339297|62876941|FG000|Overall Study|Death|10|||
33497836|NCT03339297|62876942|FG001|Overall Study|Death|7|||
33497837|NCT03339297|62876941|FG000|Overall Study|Hepatic Candidosis|1|||
33497838|NCT03339297|62876942|FG001|Overall Study|Hepatic Candidosis|0|||
33497839|NCT03339297|62876941|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
33497840|NCT03339297|62876942|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
33497841|NCT03339297|62876941|FG000|Overall Study|Consent Withdrawn by Participant|3|||
33497842|NCT03339297|62876942|FG001|Overall Study|Consent Withdrawn by Participant|3|||
33497843|NCT03339297|62876941|FG000|Overall Study|Disease Relapse|2|||
33497844|NCT03339297|62876942|FG001|Overall Study|Disease Relapse|0|||
33497845|NCT03339297|62876941|FG000|Overall Study|Physician Decision|1|||
33497846|NCT03339297|62876942|FG001|Overall Study|Physician Decision|1|||
33497847|NCT03339297|62876941|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
33497848|NCT03339297|62876942|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
33497849|NCT03339297|62876941|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
33497850|NCT03339297|62876942|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
33497851|NCT03339297|62876941|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
33497852|NCT03339297|62876942|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
33497853|NCT03339297|62876941|FG000|Overall Study|Adverse Event, Non-fatal|1|||
33497854|NCT03339297|62876942|FG001|Overall Study|Adverse Event, Non-fatal|0|||
33497855|NCT03339297|62876941|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
33497856|NCT03339297|62876942|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
33497857|NCT03339297|62876941|FG000|Overall Study|Patient Was Not Eligible|1|||
33497858|NCT03339297|62876942|FG001|Overall Study|Patient Was Not Eligible|0|||
33497859|NCT03713281|62876968|FG000|Overall Study|Lens handling difficuluties|2|||
33497860|NCT03713281|62876968|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
33497861|NCT03339219|62876972|FG000|Overall Study|Death|12|||
33497862|NCT03339219|62876972|FG000|Overall Study|Site Terminated by Sponsor|22|||
33497863|NCT03339219|62876972|FG000|Overall Study|Withdrawal by Subject|1|||
33497864|NCT03338673|62876978|FG000|Overall Study|Lost to Follow-up|1|||
33497865|NCT03338673|62876979|FG001|Overall Study|Lost to Follow-up|1|||
33497866|NCT02949024|62876987|FG000|Overall Study|Withdrawal by Subject|0|||
33497867|NCT02949024|62876988|FG001|Overall Study|Withdrawal by Subject|1|||
33497868|NCT03093428|62876998|FG000|Overall Study|Not eligible for treatment|2|||
33608633|NCT01646177|63008797|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33608634|NCT01646177|63008798|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
33608635|NCT01646177|63008799|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
33608636|NCT01646177|63008800|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33608637|NCT01646177|63008801|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
33608638|NCT01646177|63008802|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33497869|NCT03093428|62876999|FG001|Overall Study|Not eligible for treatment|1|||
33497870|NCT03093428|62876998|FG000|Overall Study|Progression|14|||
33497871|NCT03093428|62876999|FG001|Overall Study|Progression|4|||
33497872|NCT03093428|62876998|FG000|Overall Study|Death|1|||
33608639|NCT01646177|63008803|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33608640|NCT01646177|63008804|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33608641|NCT01646177|63008805|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33497873|NCT03093428|62876999|FG001|Overall Study|Death|0|||
33497874|NCT03093428|62876998|FG000|Overall Study|Adverse Event|1|||
33497875|NCT03093428|62876999|FG001|Overall Study|Adverse Event|0|||
33497876|NCT03093428|62876998|FG000|Overall Study|Withdrawal by Subject|1|||
33497877|NCT03093428|62876999|FG001|Overall Study|Withdrawal by Subject|1|||
33497878|NCT02735980|62877008|FG000|Overall Study|Adverse Event|0|||
33497879|NCT02735980|62877009|FG001|Overall Study|Adverse Event|4|||
33497880|NCT02735980|62877010|FG002|Overall Study|Adverse Event|1|||
33497881|NCT02735980|62877008|FG000|Overall Study|Death|5|||
33497882|NCT02735980|62877009|FG001|Overall Study|Death|4|||
33497883|NCT02735980|62877010|FG002|Overall Study|Death|0|||
33497884|NCT02735980|62877008|FG000|Overall Study|Physician Decision|3|||
33497885|NCT02735980|62877009|FG001|Overall Study|Physician Decision|1|||
33497886|NCT02735980|62877010|FG002|Overall Study|Physician Decision|0|||
33497887|NCT02735980|62877008|FG000|Overall Study|Screen failure|1|||
33497888|NCT02735980|62877009|FG001|Overall Study|Screen failure|0|||
33497889|NCT02735980|62877010|FG002|Overall Study|Screen failure|0|||
33497890|NCT02735980|62877008|FG000|Overall Study|Withdrawal by Subject|1|||
33497891|NCT02735980|62877009|FG001|Overall Study|Withdrawal by Subject|2|||
33497892|NCT02735980|62877010|FG002|Overall Study|Withdrawal by Subject|0|||
33497893|NCT03338400|62877025|FG000|Overall Study|Lost to Follow-up|1|||
33497894|NCT03338400|62877026|FG001|Overall Study|Lost to Follow-up|2|||
33497895|NCT03337113|62877044|FG000|Overall Study|Adverse Event|1|||
33497896|NCT03337113|62877045|FG001|Overall Study|Adverse Event|1|||
33497897|NCT03337113|62877046|FG002|Overall Study|Adverse Event|0|||
33497898|NCT03337113|62877047|FG003|Overall Study|Adverse Event|1|||
33497899|NCT03337113|62877044|FG000|Overall Study|Physician Decision|0|||
33497900|NCT03337113|62877045|FG001|Overall Study|Physician Decision|2|||
33497901|NCT03337113|62877046|FG002|Overall Study|Physician Decision|0|||
33497902|NCT03337113|62877047|FG003|Overall Study|Physician Decision|1|||
33497903|NCT03337113|62877044|FG000|Overall Study|Withdrawal by Subject|0|||
33497904|NCT03337113|62877045|FG001|Overall Study|Withdrawal by Subject|0|||
33497905|NCT03337113|62877046|FG002|Overall Study|Withdrawal by Subject|1|||
33497906|NCT03337113|62877047|FG003|Overall Study|Withdrawal by Subject|0|||
33608642|NCT01646177|63008794|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33608643|NCT01646177|63008795|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33608644|NCT01646177|63008796|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33608645|NCT01646177|63008797|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33608646|NCT01646177|63008798|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
33608647|NCT01646177|63008799|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
33608648|NCT01646177|63008800|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
33608649|NCT01646177|63008801|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
33608650|NCT01646177|63008802|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33608651|NCT01646177|63008803|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33608652|NCT01646177|63008804|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33608653|NCT01646177|63008805|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33608654|NCT01646177|63008794|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
33608655|NCT01646177|63008795|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
33608656|NCT01646177|63008796|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
33324003|NCT00970593|62700397|FG003|Overall Study|Discontinuation of study by sponsor|0|||
33324004|NCT00970593|62700398|FG004|Overall Study|Discontinuation of study by sponsor|0|||
33608657|NCT01646177|63008797|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
33608658|NCT01646177|63008798|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
33608659|NCT01646177|63008799|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
33608660|NCT01646177|63008800|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
33608661|NCT01646177|63008801|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
33608662|NCT01646177|63008802|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
33608663|NCT01646177|63008803|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
33608664|NCT01646177|63008804|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
33608665|NCT01646177|63008805|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
33608666|NCT01646177|63008794|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33324005|NCT00970593|62700399|FG005|Overall Study|Discontinuation of study by sponsor|0|||
33448104|NCT00048724|62823216|FG001|Overall Study|Withdrawal by Subject|54|||
33448105|NCT00048724|62823215|FG000|Overall Study|Lost to Follow-up|5|||
33448106|NCT00048724|62823216|FG001|Overall Study|Lost to Follow-up|5|||
33448107|NCT00048724|62823215|FG000|Overall Study|Protocol-defined Clinical Event|17|||
33448108|NCT00048724|62823216|FG001|Overall Study|Protocol-defined Clinical Event|32|||
33448109|NCT00048724|62823215|FG000|Overall Study|Noncompliance With Protocol|4|||
33448110|NCT00048724|62823216|FG001|Overall Study|Noncompliance With Protocol|12|||
33448111|NCT00048724|62823215|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
33497907|NCT03092726|62877059|FG000|Overall Study|Adverse Event|3|||
33497908|NCT03092726|62877060|FG001|Overall Study|Adverse Event|10|||
33608667|NCT01646177|63008795|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33608668|NCT01646177|63008796|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33608669|NCT01646177|63008797|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33448112|NCT00048724|62823216|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
33497909|NCT03092726|62877059|FG000|Overall Study|Lack of Efficacy|0|||
33497910|NCT03092726|62877060|FG001|Overall Study|Lack of Efficacy|1|||
33497911|NCT03092726|62877059|FG000|Overall Study|Lost to Follow-up|1|||
33497912|NCT03092726|62877060|FG001|Overall Study|Lost to Follow-up|0|||
33608670|NCT01646177|63008798|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
33608671|NCT01646177|63008799|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
33608672|NCT01646177|63008800|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
33608673|NCT01646177|63008801|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
33608674|NCT01646177|63008802|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33608675|NCT01646177|63008803|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33608676|NCT01646177|63008804|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33608677|NCT01646177|63008805|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33608678|NCT01646177|63008794|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33608679|NCT01646177|63008795|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33608680|NCT01646177|63008796|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33448113|NCT00048724|62823215|FG000|Overall Study|Administrative|1|||
33608681|NCT01646177|63008797|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33608682|NCT01646177|63008798|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33608683|NCT01646177|63008799|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33608684|NCT01646177|63008800|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33608685|NCT01646177|63008801|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
33448114|NCT00048724|62823216|FG001|Overall Study|Administrative|1|||
33608686|NCT01646177|63008802|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33608687|NCT01646177|63008803|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33608688|NCT01646177|63008804|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33608689|NCT01646177|63008805|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33608690|NCT01646177|63008794|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33608691|NCT01646177|63008795|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33608692|NCT01646177|63008796|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33608693|NCT01646177|63008797|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33608694|NCT01646177|63008798|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33608695|NCT01646177|63008799|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
33608696|NCT01646177|63008800|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
33608697|NCT01646177|63008801|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
33608698|NCT01646177|63008802|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33608699|NCT01646177|63008803|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33608700|NCT01646177|63008804|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33608701|NCT01646177|63008805|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33608702|NCT01646177|63008794|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33608703|NCT01646177|63008795|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33608704|NCT01646177|63008796|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33608705|NCT01646177|63008797|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33608706|NCT01646177|63008798|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33608707|NCT01646177|63008799|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33608708|NCT01646177|63008800|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33608709|NCT01646177|63008801|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33608710|NCT01646177|63008802|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
33608711|NCT01646177|63008803|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
33608712|NCT01646177|63008804|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
33608713|NCT01646177|63008805|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
33608714|NCT01646177|63008794|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33608715|NCT01646177|63008795|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33608716|NCT01646177|63008796|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33608717|NCT01646177|63008797|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33608718|NCT01646177|63008798|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33608719|NCT01646177|63008799|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33448115|NCT00449033|62823224|FG000|Treatment Period|Adverse Event|117|||
33448116|NCT00449033|62823225|FG001|Treatment Period|Adverse Event|83|||
33448117|NCT00449033|62823224|FG000|Treatment Period|Death|21|||
33448118|NCT00449033|62823225|FG001|Treatment Period|Death|12|||
33448119|NCT00449033|62823224|FG000|Treatment Period|Lost to Follow-up|0|||
33448120|NCT00449033|62823225|FG001|Treatment Period|Lost to Follow-up|2|||
33448121|NCT00449033|62823224|FG000|Treatment Period|Physician Decision|4|||
33448122|NCT00449033|62823225|FG001|Treatment Period|Physician Decision|5|||
33448123|NCT00449033|62823224|FG000|Treatment Period|Protocol Violation|8|||
33448124|NCT00449033|62823225|FG001|Treatment Period|Protocol Violation|7|||
33448125|NCT00449033|62823224|FG000|Treatment Period|Disease Progression|231|||
33448126|NCT00449033|62823225|FG001|Treatment Period|Disease Progression|288|||
33497913|NCT03092726|62877059|FG000|Overall Study|Withdrawal by Subject|5|||
33497914|NCT03092726|62877060|FG001|Overall Study|Withdrawal by Subject|3|||
33497915|NCT03338010|62877068|FG000|Overall Study|Withdrawal by Subject|14|||
33497916|NCT03338010|62877069|FG001|Overall Study|Withdrawal by Subject|8|||
33497917|NCT03338010|62877068|FG000|Overall Study|Lost to Follow-up|4|||
33497918|NCT03338010|62877069|FG001|Overall Study|Lost to Follow-up|2|||
33497919|NCT03338010|62877068|FG000|Overall Study|Adverse Event|3|||
33497920|NCT03338010|62877069|FG001|Overall Study|Adverse Event|2|||
33497921|NCT03338010|62877068|FG000|Overall Study|Physician Decision|2|||
33497922|NCT03338010|62877069|FG001|Overall Study|Physician Decision|2|||
33497923|NCT03338010|62877068|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33497924|NCT03338010|62877069|FG001|Overall Study|Non-Compliance with Study Drug|3|||
33497925|NCT03338010|62877068|FG000|Overall Study|Protocol Violation|0|||
33497926|NCT03338010|62877069|FG001|Overall Study|Protocol Violation|1|||
33497927|NCT03337542|62877075|FG000|Overall Study|Withdrew Consent|17|||
33497928|NCT03337542|62877075|FG000|Overall Study|Allergic Adverse Event|1|||
33497929|NCT03337542|62877075|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
33497930|NCT03337542|62877075|FG000|Overall Study|Lost to Follow-up|1|||
33497931|NCT03337542|62877075|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
33497932|NCT01328548|62877082|FG000|Overall Study|Death|3|||
33497933|NCT01328548|62877083|FG001|Overall Study|Death|0|||
33497934|NCT01328548|62877082|FG000|Overall Study|Protocol Violation|1|||
33497935|NCT01328548|62877083|FG001|Overall Study|Protocol Violation|0|||
33497936|NCT03337308|62877121|FG000|Overall Study|Adverse Event|2|||
33497937|NCT03337308|62877122|FG001|Overall Study|Adverse Event|3|||
33497938|NCT03337308|62877123|FG002|Overall Study|Adverse Event|3|||
33497939|NCT03337308|62877124|FG003|Overall Study|Adverse Event|1|||
33608720|NCT01646177|63008800|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33608721|NCT01646177|63008801|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33608722|NCT01646177|63008802|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
33497940|NCT03337308|62877121|FG000|Overall Study|Lost to Follow-up|1|||
33497941|NCT03337308|62877122|FG001|Overall Study|Lost to Follow-up|2|||
33497942|NCT03337308|62877123|FG002|Overall Study|Lost to Follow-up|0|||
33497943|NCT03337308|62877124|FG003|Overall Study|Lost to Follow-up|0|||
33497944|NCT03337308|62877121|FG000|Overall Study|Withdrawal by Subject|2|||
33497945|NCT03337308|62877122|FG001|Overall Study|Withdrawal by Subject|1|||
33497946|NCT03337308|62877123|FG002|Overall Study|Withdrawal by Subject|2|||
33497947|NCT03337308|62877124|FG003|Overall Study|Withdrawal by Subject|1|||
33497948|NCT03337308|62877121|FG000|Overall Study|Protocol Violation|0|||
33497949|NCT03337308|62877122|FG001|Overall Study|Protocol Violation|1|||
33497950|NCT03337308|62877123|FG002|Overall Study|Protocol Violation|0|||
33497951|NCT03337308|62877124|FG003|Overall Study|Protocol Violation|0|||
33497952|NCT03337152|62877136|FG000|Overall Study|Physician Decision|1|||
33497953|NCT03337152|62877137|FG001|Overall Study|Physician Decision|0|||
33497954|NCT03337152|62877136|FG000|Overall Study|Lost to Follow-up|1|||
33497955|NCT03337152|62877137|FG001|Overall Study|Lost to Follow-up|3|||
33497956|NCT03337152|62877136|FG000|Overall Study|Adverse Event|3|||
33497957|NCT03337152|62877137|FG001|Overall Study|Adverse Event|1|||
33497958|NCT03337152|62877136|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
33497959|NCT03337152|62877137|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
33497960|NCT03091400|62877151|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
33497961|NCT03091400|62877152|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
33497962|NCT01318993|62877158|FG000|Overall Study|Adverse Event|53|||
33497963|NCT01318993|62877158|FG000|Overall Study|Lack of Efficacy|121|||
33497964|NCT01318993|62877158|FG000|Overall Study|Protocol Violation|3|||
33497965|NCT01318993|62877158|FG000|Overall Study|Protocol based stopping criteria|6|||
33497966|NCT01318993|62877158|FG000|Overall Study|Study closed or terminated|174|||
33497967|NCT01318993|62877158|FG000|Overall Study|Lost to Follow-up|4|||
33497968|NCT01318993|62877158|FG000|Overall Study|Physician Decision|13|||
33497969|NCT01318993|62877158|FG000|Overall Study|Withdrawal by Subject|24|||
33497970|NCT03090152|62877165|FG000|Overall Study|Withdrawal by Subject|0|||
33497971|NCT03090152|62877166|FG001|Overall Study|Withdrawal by Subject|2|||
33497972|NCT03090152|62877167|FG002|Overall Study|Withdrawal by Subject|1|||
33497973|NCT03090152|62877165|FG000|Overall Study|Surgery Canceled|1|||
33497974|NCT03090152|62877166|FG001|Overall Study|Surgery Canceled|0|||
33497975|NCT03090152|62877167|FG002|Overall Study|Surgery Canceled|0|||
33497976|NCT03090152|62877165|FG000|Overall Study|Epidural catheter could not be placed|0|||
33497977|NCT03090152|62877166|FG001|Overall Study|Epidural catheter could not be placed|2|||
33497978|NCT03090152|62877167|FG002|Overall Study|Epidural catheter could not be placed|0|||
33497979|NCT04252287|62877186|FG000|Overall Study|Death|5|||
33497980|NCT04252287|62877187|FG001|Overall Study|Death|3|||
33497981|NCT04252287|62877186|FG000|Overall Study|Lost to Follow-up|4|||
33497982|NCT04252287|62877187|FG001|Overall Study|Lost to Follow-up|6|||
33497983|NCT04252287|62877186|FG000|Overall Study|Withdrawal by Subject|19|||
33497984|NCT04252287|62877187|FG001|Overall Study|Withdrawal by Subject|16|||
33497985|NCT04252287|62877186|FG000|Overall Study|Protocol Violation|3|||
33497986|NCT04252287|62877187|FG001|Overall Study|Protocol Violation|4|||
33497987|NCT02735200|62877199|FG000|Overall Study|Lost to Follow-up|0|||
33497988|NCT02735200|62877200|FG001|Overall Study|Lost to Follow-up|5|||
33497989|NCT02735200|62877199|FG000|Overall Study|Withdrawal by Subject|8|||
33497990|NCT02735200|62877200|FG001|Overall Study|Withdrawal by Subject|0|||
33497991|NCT02946918|62877208|FG000|Overall Study|Patient unblinded himself|1|||
33497992|NCT02946918|62877209|FG001|Overall Study|Patient unblinded himself|0|||
33497993|NCT02946918|62877208|FG000|Overall Study|Physician Decision|0|||
33497994|NCT02946918|62877209|FG001|Overall Study|Physician Decision|2|||
33497995|NCT02946918|62877208|FG000|Overall Study|Ran out of study medication|0|||
33497996|NCT02946918|62877209|FG001|Overall Study|Ran out of study medication|1|||
33497997|NCT02734810|62877230|FG000|Overall Study|Adverse Event|1|||
33497998|NCT02734810|62877231|FG001|Overall Study|Adverse Event|0|||
33497999|NCT02734810|62877230|FG000|Overall Study|Lack of Efficacy|1|||
33498000|NCT02734810|62877231|FG001|Overall Study|Lack of Efficacy|0|||
33498001|NCT03656068|62877256|FG000|Overall Study|Withdrawal by Subject|4|||
33498002|NCT03656068|62877256|FG000|Overall Study|Adverse Event|1|||
33498003|NCT02944383|62877263|FG000|Overall Study|Lost to Follow-up|0|||
33498004|NCT02944383|62877264|FG001|Overall Study|Lost to Follow-up|0|||
33498005|NCT02944383|62877265|FG002|Overall Study|Lost to Follow-up|1|||
33498006|NCT02944383|62877263|FG000|Overall Study|Withdrawal by Subject|1|||
33498007|NCT02944383|62877264|FG001|Overall Study|Withdrawal by Subject|0|||
33498008|NCT02944383|62877265|FG002|Overall Study|Withdrawal by Subject|0|||
33498009|NCT03768089|62877293|FG000|Part A|Lost to Follow-up|0|||
33498010|NCT03768089|62877294|FG001|Part A|Lost to Follow-up|0|||
33498011|NCT03768089|62877295|FG002|Part A|Lost to Follow-up|0|||
33498012|NCT03768089|62877296|FG003|Part A|Lost to Follow-up|0|||
33498013|NCT03768089|62877297|FG004|Part A|Lost to Follow-up|1|||
33498014|NCT03768089|62877298|FG005|Part A|Lost to Follow-up|0|||
33498015|NCT03768089|62877299|FG006|Part A|Lost to Follow-up|0|||
33498016|NCT03768089|62877300|FG007|Part A|Lost to Follow-up|0|||
33498017|NCT03768089|62877301|FG008|Part A|Lost to Follow-up|0|||
33498018|NCT03768089|62877302|FG009|Part A|Lost to Follow-up|0|||
33498019|NCT03768089|62877303|FG010|Part A|Lost to Follow-up|0|||
33498020|NCT03768089|62877304|FG011|Part A|Lost to Follow-up|0|||
33498021|NCT03768089|62877305|FG012|Part A|Lost to Follow-up|0|||
33498022|NCT03768089|62877306|FG013|Part A|Lost to Follow-up|0|||
33498023|NCT03768089|62877307|FG014|Part A|Lost to Follow-up|0|||
33498024|NCT03768089|62877308|FG015|Part A|Lost to Follow-up|0|||
33498025|NCT03768089|62877309|FG016|Part A|Lost to Follow-up|0|||
33498026|NCT03768089|62877310|FG017|Part A|Lost to Follow-up|0|||
33498027|NCT03768089|62877293|FG000|Part C|Randomized, Never Dosed|0|||
33498028|NCT03768089|62877294|FG001|Part C|Randomized, Never Dosed|0|||
33498029|NCT03768089|62877295|FG002|Part C|Randomized, Never Dosed|0|||
33498030|NCT03768089|62877296|FG003|Part C|Randomized, Never Dosed|0|||
33498031|NCT03768089|62877297|FG004|Part C|Randomized, Never Dosed|0|||
33498032|NCT03768089|62877298|FG005|Part C|Randomized, Never Dosed|0|||
33448127|NCT00449033|62823224|FG000|Treatment Period|Consent Withdrawn|36|||
33448128|NCT00449033|62823225|FG001|Treatment Period|Consent Withdrawn|20|||
33448129|NCT00449033|62823224|FG000|Treatment Period|Amended Protocol Criteria|22|||
33448130|NCT00449033|62823225|FG001|Treatment Period|Amended Protocol Criteria|18|||
33448131|NCT00449033|62823224|FG000|Treatment Period|Non-compliance|7|||
33448132|NCT00449033|62823225|FG001|Treatment Period|Non-compliance|8|||
33448133|NCT00449033|62823224|FG000|Treatment Period|Second Malignancy|0|||
33448134|NCT00449033|62823225|FG001|Treatment Period|Second Malignancy|1|||
33448135|NCT00449033|62823224|FG000|Treatment Period|Reason Missing|0|||
33448136|NCT00449033|62823225|FG001|Treatment Period|Reason Missing|4|||
33448137|NCT00449033|62823224|FG000|Treatment Period|Treatment Ongoing|6|||
33448138|NCT00449033|62823225|FG001|Treatment Period|Treatment Ongoing|4|||
33448139|NCT00449033|62823224|FG000|Follow-up Period|Death|299|||
33448140|NCT00449033|62823225|FG001|Follow-up Period|Death|311|||
33448141|NCT00449033|62823224|FG000|Follow-up Period|Lost to Follow-up|6|||
33448142|NCT00449033|62823225|FG001|Follow-up Period|Lost to Follow-up|10|||
33498033|NCT03768089|62877299|FG006|Part C|Randomized, Never Dosed|0|||
33498034|NCT03768089|62877300|FG007|Part C|Randomized, Never Dosed|0|||
33498035|NCT03768089|62877301|FG008|Part C|Randomized, Never Dosed|0|||
33498036|NCT03768089|62877302|FG009|Part C|Randomized, Never Dosed|0|||
33498037|NCT03768089|62877303|FG010|Part C|Randomized, Never Dosed|0|||
33498038|NCT03768089|62877304|FG011|Part C|Randomized, Never Dosed|0|||
33498039|NCT03768089|62877305|FG012|Part C|Randomized, Never Dosed|0|||
33498040|NCT03768089|62877306|FG013|Part C|Randomized, Never Dosed|0|||
33498041|NCT03768089|62877307|FG014|Part C|Randomized, Never Dosed|1|||
33498042|NCT03768089|62877308|FG015|Part C|Randomized, Never Dosed|0|||
33498043|NCT03768089|62877309|FG016|Part C|Randomized, Never Dosed|0|||
33498044|NCT03768089|62877310|FG017|Part C|Randomized, Never Dosed|0|||
33498045|NCT03548584|62877368|FG000|Overall Study|Lost to Follow-up|0|||
33498046|NCT03548584|62877369|FG001|Overall Study|Lost to Follow-up|0|||
33498047|NCT03548584|62877370|FG002|Overall Study|Lost to Follow-up|1|||
33498048|NCT03548584|62877368|FG000|Overall Study|Adverse Event|1|||
33498049|NCT03548584|62877369|FG001|Overall Study|Adverse Event|11|||
33498050|NCT03548584|62877370|FG002|Overall Study|Adverse Event|5|||
33498051|NCT03548584|62877368|FG000|Overall Study|Site Terminated by Sponsor|1|||
33498052|NCT03548584|62877369|FG001|Overall Study|Site Terminated by Sponsor|3|||
33498053|NCT03548584|62877370|FG002|Overall Study|Site Terminated by Sponsor|2|||
33498054|NCT03548584|62877368|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
33498055|NCT03548584|62877369|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
33498056|NCT03548584|62877370|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
33498057|NCT03548584|62877368|FG000|Overall Study|Lack of Efficacy|0|||
33498058|NCT03548584|62877369|FG001|Overall Study|Lack of Efficacy|1|||
33498059|NCT03548584|62877370|FG002|Overall Study|Lack of Efficacy|0|||
33498060|NCT03548584|62877368|FG000|Overall Study|Non-compliance with Study Drug|0|||
33498061|NCT03548584|62877369|FG001|Overall Study|Non-compliance with Study Drug|1|||
33498062|NCT03548584|62877370|FG002|Overall Study|Non-compliance with Study Drug|0|||
33498063|NCT03548584|62877368|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
33498064|NCT03548584|62877369|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
33498065|NCT03548584|62877370|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
33498066|NCT03086330|62877383|FG000|Overall Study|Withdrawal by Subject|3|||
33498067|NCT03086330|62877384|FG001|Overall Study|Withdrawal by Subject|2|||
33498068|NCT03086330|62877383|FG000|Overall Study|Lost to Follow-up|1|||
33498069|NCT03086330|62877384|FG001|Overall Study|Lost to Follow-up|2|||
33498070|NCT02943993|62877416|FG000|Overall Study|Withdrawal by Subject|52|||
33498071|NCT02943993|62877416|FG000|Overall Study|Transfer to another institution|6|||
33498072|NCT02943993|62877416|FG000|Overall Study|Lost to Follow-up|135|||
33498073|NCT02943993|62877416|FG000|Overall Study|Death|98|||
33498074|NCT02943993|62877416|FG000|Overall Study|Other reason for premature termination|32|||
33498075|NCT02943993|62877416|FG000|Overall Study|Missing reason for termination|7|||
33498076|NCT02943447|62877440|FG000|Blinded Study Phase|Withdrew Consent|1|||
33498077|NCT02943447|62877441|FG001|Blinded Study Phase|Withdrew Consent|2|||
33498078|NCT02943447|62877442|FG002|Blinded Study Phase|Withdrew Consent|1|||
33498079|NCT02943447|62877440|FG000|Blinded Study Phase|Adverse Event|3|||
33498080|NCT02943447|62877441|FG001|Blinded Study Phase|Adverse Event|0|||
33498081|NCT02943447|62877442|FG002|Blinded Study Phase|Adverse Event|0|||
33498082|NCT02943447|62877440|FG000|Blinded Study Phase|Investigator's discretion|1|||
33498083|NCT02943447|62877441|FG001|Blinded Study Phase|Investigator's discretion|0|||
33498084|NCT02943447|62877442|FG002|Blinded Study Phase|Investigator's discretion|0|||
33498085|NCT02943447|62877440|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
33498086|NCT02943447|62877441|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
33498087|NCT02943447|62877442|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
33498088|NCT02943447|62877440|FG000|Open-Label Extension Phase|Adverse Event|4|||
33498089|NCT02943447|62877441|FG001|Open-Label Extension Phase|Adverse Event|7|||
33498090|NCT02943447|62877442|FG002|Open-Label Extension Phase|Adverse Event|3|||
33498091|NCT02943447|62877440|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
33498092|NCT02943447|62877441|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
33498093|NCT02943447|62877442|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
33498094|NCT02943447|62877440|FG000|Open-Label Extension Phase|Withdrew consent|1|||
33498095|NCT02943447|62877441|FG001|Open-Label Extension Phase|Withdrew consent|1|||
33498096|NCT02943447|62877442|FG002|Open-Label Extension Phase|Withdrew consent|1|||
33498097|NCT02943447|62877440|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
33498098|NCT02943447|62877441|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
33498099|NCT02943447|62877442|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
33498100|NCT02844777|62877471|FG000|Overall Study|Withdrawal by Subject|2|||
33498101|NCT02844777|62877472|FG001|Overall Study|Withdrawal by Subject|0|||
33498102|NCT02844777|62877473|FG002|Overall Study|Withdrawal by Subject|0|||
33498103|NCT02612337|62877483|FG000|Overall Study|Lack of Efficacy|1|||
33498104|NCT02612337|62877484|FG001|Overall Study|Lack of Efficacy|0|||
33498105|NCT02612337|62877483|FG000|Overall Study|Withdrawal by Subject|2|||
33498106|NCT02612337|62877484|FG001|Overall Study|Withdrawal by Subject|2|||
33498107|NCT02612337|62877483|FG000|Overall Study|Did not receive study drug|0|||
33498108|NCT02612337|62877484|FG001|Overall Study|Did not receive study drug|1|||
33498109|NCT03532451|62877498|FG000|Overall Study|Withdrawal by Subject|0|||
33498110|NCT03532451|62877499|FG001|Overall Study|Withdrawal by Subject|1|||
33498111|NCT03532451|62877498|FG000|Overall Study|Progression prior to the surgery|1|||
33498112|NCT03532451|62877499|FG001|Overall Study|Progression prior to the surgery|0|||
33498113|NCT03085238|62877505|FG000|Overall Study|Adverse Event|2|||
33498114|NCT03085238|62877505|FG000|Overall Study|Death|2|||
33498115|NCT03383666|62877518|FG000|Overall Study|Withdrawal by Subject|2|||
33498116|NCT03383666|62877518|FG000|Overall Study|Lost to Follow-up|2|||
33498117|NCT03086018|62877522|FG000|Final Testing for End of Trial|Adverse Event|1|||
33498118|NCT03086018|62877522|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
33498119|NCT03319953|62877532|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
33498120|NCT03319953|62877533|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
33498121|NCT03319953|62877534|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
33498122|NCT03319953|62877535|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
33498123|NCT03319953|62877532|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
33498124|NCT03319953|62877533|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
33498125|NCT03319953|62877534|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
33498126|NCT03319953|62877535|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
33498127|NCT02927834|62877546|FG000|Overall Study|Lost to Follow-up|1|||
33498128|NCT02927834|62877547|FG001|Overall Study|Lost to Follow-up|2|||
33498129|NCT02927834|62877548|FG002|Overall Study|Lost to Follow-up|2|||
33498130|NCT01964547|62877562|FG000|Overall Study|Adverse Event|8|||
33498131|NCT01964547|62877563|FG001|Overall Study|Adverse Event|2|||
33498132|NCT01964547|62877562|FG000|Overall Study|Withdrawal by Subject|4|||
33498133|NCT01964547|62877563|FG001|Overall Study|Withdrawal by Subject|7|||
33498134|NCT01964547|62877562|FG000|Overall Study|Lost to Follow-up|0|||
33498135|NCT01964547|62877563|FG001|Overall Study|Lost to Follow-up|1|||
33498136|NCT01964547|62877562|FG000|Overall Study|Withdrawal by Investigator|0|||
33498137|NCT01964547|62877563|FG001|Overall Study|Withdrawal by Investigator|1|||
33498138|NCT03319719|62877569|FG000|Overall Study|Lost to Follow-up|1|||
33498139|NCT03318783|62877577|FG000|Overall Study|Withdrawal by Subject|0|||
33498140|NCT03318783|62877578|FG001|Overall Study|Withdrawal by Subject|1|||
33498141|NCT03318783|62877577|FG000|Overall Study|Death|0|||
33498142|NCT03318783|62877578|FG001|Overall Study|Death|1|||
33498143|NCT01313689|62877589|FG000|24-Week Randomization 1|Adverse Event|10|||
33498144|NCT01313689|62877590|FG001|24-Week Randomization 1|Adverse Event|5|||
33498145|NCT01313689|62877591|FG002|24-Week Randomization 1|Adverse Event|0|||
33498146|NCT01313689|62877592|FG003|24-Week Randomization 1|Adverse Event|0|||
33498147|NCT01313689|62877593|FG004|24-Week Randomization 1|Adverse Event|0|||
33498148|NCT01313689|62877589|FG000|24-Week Randomization 1|Physician Decision|4|||
33498149|NCT01313689|62877590|FG001|24-Week Randomization 1|Physician Decision|5|||
33498150|NCT01313689|62877591|FG002|24-Week Randomization 1|Physician Decision|0|||
33498151|NCT01313689|62877592|FG003|24-Week Randomization 1|Physician Decision|0|||
33498152|NCT01313689|62877593|FG004|24-Week Randomization 1|Physician Decision|0|||
33498153|NCT01313689|62877589|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
33498154|NCT01313689|62877590|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
33498155|NCT01313689|62877591|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
33498156|NCT01313689|62877592|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
33498157|NCT01313689|62877593|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
33498158|NCT01313689|62877589|FG000|24-Week Randomization 2|Adverse Event|0|||
33498159|NCT01313689|62877590|FG001|24-Week Randomization 2|Adverse Event|0|||
33498160|NCT01313689|62877591|FG002|24-Week Randomization 2|Adverse Event|2|||
33498161|NCT01313689|62877592|FG003|24-Week Randomization 2|Adverse Event|0|||
33498162|NCT01313689|62877593|FG004|24-Week Randomization 2|Adverse Event|8|||
33498163|NCT01313689|62877589|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
33498164|NCT01313689|62877590|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
33498165|NCT01313689|62877591|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
33498166|NCT01313689|62877592|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
33498167|NCT01313689|62877593|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
33498168|NCT01313689|62877589|FG000|24-Week Randomization 2|Physician Decision|0|||
33498169|NCT01313689|62877590|FG001|24-Week Randomization 2|Physician Decision|0|||
33498170|NCT01313689|62877591|FG002|24-Week Randomization 2|Physician Decision|0|||
33498171|NCT01313689|62877592|FG003|24-Week Randomization 2|Physician Decision|0|||
33498172|NCT01313689|62877593|FG004|24-Week Randomization 2|Physician Decision|4|||
33498173|NCT03318315|62877615|FG000|Overall Study|Lost to Follow-up|3|||
33498174|NCT03318315|62877616|FG001|Overall Study|Lost to Follow-up|2|||
33498175|NCT03318315|62877617|FG002|Overall Study|Lost to Follow-up|1|||
33498176|NCT03318315|62877615|FG000|Overall Study|Protocol Violation|1|||
33498177|NCT03318315|62877616|FG001|Overall Study|Protocol Violation|1|||
33498178|NCT03318315|62877617|FG002|Overall Study|Protocol Violation|1|||
33498179|NCT03318315|62877615|FG000|Overall Study|Withdrawal by Subject|0|||
33498180|NCT03318315|62877616|FG001|Overall Study|Withdrawal by Subject|0|||
33498181|NCT03318315|62877617|FG002|Overall Study|Withdrawal by Subject|2|||
33498182|NCT04460183|62877628|FG000|Overall Study|Lost to Follow-up|3|||
33498183|NCT04460183|62877629|FG001|Overall Study|Lost to Follow-up|1|||
33498184|NCT04460183|62877628|FG000|Overall Study|Withdrawal by Subject|1|||
33448143|NCT00449033|62823224|FG000|Follow-up Period|Reason Missing|120|||
33448144|NCT00449033|62823225|FG001|Follow-up Period|Reason Missing|113|||
33448145|NCT00448019|62823231|FG000|Overall Study|Withdrawal by Subject|3|||
33448146|NCT00448019|62823231|FG000|Overall Study|Disease progression|1|||
33448147|NCT00448019|62823231|FG000|Overall Study|Death|2|||
33448148|NCT00448019|62823231|FG000|Overall Study|Insurance Issues|1|||
33448149|NCT00457691|62823237|FG000|Overall Study|Adverse Event|4|||
33448150|NCT00457691|62823238|FG001|Overall Study|Adverse Event|1|||
33448151|NCT00457691|62823237|FG000|Overall Study|Death|163|||
33448152|NCT00457691|62823238|FG001|Overall Study|Death|148|||
33448153|NCT00457691|62823237|FG000|Overall Study|Protocol Violation|1|||
33448154|NCT00457691|62823238|FG001|Overall Study|Protocol Violation|3|||
33448155|NCT00457691|62823237|FG000|Overall Study|Lost to Follow-up|23|||
33448156|NCT00457691|62823238|FG001|Overall Study|Lost to Follow-up|14|||
33448157|NCT00457691|62823237|FG000|Overall Study|Study terminated by Sponsor|1|||
33448158|NCT00457691|62823238|FG001|Overall Study|Study terminated by Sponsor|1|||
33448159|NCT00457691|62823237|FG000|Overall Study|Subject refused (reason other than AE)|14|||
33448160|NCT00457691|62823238|FG001|Overall Study|Subject refused (reason other than AE)|19|||
33448161|NCT00457691|62823237|FG000|Overall Study|Disease progression, study terminated|180|||
33448162|NCT00457691|62823238|FG001|Overall Study|Disease progression, study terminated|196|||
33448163|NCT00457301|62823246|FG000|Overall Study|Withdrawal by Subject|3|||
33448164|NCT00457301|62823247|FG001|Overall Study|Withdrawal by Subject|3|||
33448165|NCT00457301|62823246|FG000|Overall Study|Censored out of the study|15|||
33448166|NCT00457301|62823247|FG001|Overall Study|Censored out of the study|14|||
33448167|NCT00457301|62823246|FG000|Overall Study|Death|5|||
33448168|NCT00457301|62823247|FG001|Overall Study|Death|7|||
33448169|NCT00456755|62823255|FG000|Overall Study|Lost to Follow-up|2|||
33448170|NCT00456755|62823256|FG001|Overall Study|Lost to Follow-up|1|||
33448171|NCT00447005|62823262|FG000|Overall Study|Adverse Event|1|||
33448172|NCT00447005|62823262|FG000|Overall Study|Lack of Efficacy|11|||
33448173|NCT00446849|62823266|FG000|Acute Phase|Lack of Efficacy|64|||
33448174|NCT00446849|62823266|FG000|Acute Phase|Protocol Violation|10|||
33448175|NCT00446849|62823266|FG000|Acute Phase|Consent withdrawn|4|||
33448176|NCT00446849|62823266|FG000|Acute Phase|Lost to Follow-up|2|||
33448177|NCT00446849|62823266|FG000|Acute Phase|Physician Decision|1|||
33448178|NCT00446849|62823266|FG000|Acute Phase|noncompliance|1|||
33448179|NCT00446849|62823266|FG000|Maintenance Phase|Lack of Efficacy|40|||
33448180|NCT00446849|62823266|FG000|Maintenance Phase|Protocol Violation|7|||
33448181|NCT00446849|62823266|FG000|Maintenance Phase|Adverse Event|6|||
33448182|NCT00446849|62823266|FG000|Maintenance Phase|Consent withdrawn|5|||
33448183|NCT00446849|62823266|FG000|Maintenance Phase|Lost to Follow-up|3|||
33448184|NCT00446849|62823266|FG000|Maintenance Phase|Pregnancy|1|||
33448185|NCT00446849|62823266|FG000|Maintenance Phase|noncompliance|2|||
33448186|NCT00446849|62823266|FG000|Maintenance Phase|prohibited medication use|2|||
33448187|NCT00446849|62823266|FG000|Maintenance Phase|antibiotic use|1|||
33448188|NCT00446849|62823266|FG000|Maintenance Phase|study closure|1|||
33448189|NCT00446849|62823266|FG000|Maintenance Phase|hydrocodone use|1|||
33448190|NCT00446849|62823266|FG000|Maintenance Phase|concomitant medication use|1|||
33498185|NCT04460183|62877629|FG001|Overall Study|Withdrawal by Subject|0|||
33448191|NCT00446459|62823271|FG000|8 Months|Protocol Violation|12|||
33448192|NCT00446459|62823271|FG000|12 Months|Protocol Violation|4|||
33448193|NCT00446459|62823271|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
33448194|NCT00456599|62823275|FG000|Overall Study|Non-compliance|1|||
33448195|NCT00456599|62823275|FG000|Overall Study|Withdrawal by Subject|2|||
33448196|NCT00456521|62823281|FG000|Overall Study|Adverse Event|150|||
33448197|NCT00456521|62823282|FG001|Overall Study|Adverse Event|25|||
33448198|NCT00456521|62823281|FG000|Overall Study|Withdrawal by Subject|43|||
33448199|NCT00456521|62823282|FG001|Overall Study|Withdrawal by Subject|24|||
33448200|NCT00456521|62823281|FG000|Overall Study|Lost to Follow-up|22|||
33448201|NCT00456521|62823282|FG001|Overall Study|Lost to Follow-up|17|||
33448202|NCT00456521|62823281|FG000|Overall Study|Lack of Efficacy|3|||
33448203|NCT00456521|62823282|FG001|Overall Study|Lack of Efficacy|6|||
33448204|NCT00456521|62823281|FG000|Overall Study|Protocol Violation|4|||
33448205|NCT00456521|62823282|FG001|Overall Study|Protocol Violation|0|||
33448206|NCT00456521|62823281|FG000|Overall Study|Pregnancy|1|||
33448207|NCT00456521|62823282|FG001|Overall Study|Pregnancy|1|||
33448208|NCT00456521|62823281|FG000|Overall Study|Drug non-compliance, moved, other|26|||
33448209|NCT00456521|62823282|FG001|Overall Study|Drug non-compliance, moved, other|11|||
33448210|NCT00456365|62823291|FG000|Overall Study|Lost to Follow-up|1|||
33448211|NCT00456365|62823292|FG001|Overall Study|Lost to Follow-up|3|||
33448212|NCT00456365|62823291|FG000|Overall Study|Withdrawal by Subject|4|||
33448213|NCT00456365|62823292|FG001|Overall Study|Withdrawal by Subject|7|||
33448214|NCT00456365|62823291|FG000|Overall Study|Pregnancy|1|||
33448215|NCT00456365|62823292|FG001|Overall Study|Pregnancy|1|||
33448216|NCT00456365|62823291|FG000|Overall Study|oncologic diagnosis|1|||
33448217|NCT00456365|62823292|FG001|Overall Study|oncologic diagnosis|1|||
33448218|NCT00455741|62823302|FG000|Overall Study|Physician Decision|0|||
33448219|NCT00455741|62823303|FG001|Overall Study|Physician Decision|1|||
33448220|NCT00445679|62823323|FG000|Overall Study|Adverse Event|22|||
33448221|NCT00445679|62823324|FG001|Overall Study|Adverse Event|12|||
33448222|NCT00445679|62823325|FG002|Overall Study|Adverse Event|30|||
33448223|NCT00445679|62823326|FG003|Overall Study|Adverse Event|19|||
33448224|NCT00445679|62823323|FG000|Overall Study|Failed to return|1|||
33448225|NCT00445679|62823324|FG001|Overall Study|Failed to return|3|||
33448226|NCT00445679|62823325|FG002|Overall Study|Failed to return|2|||
33448227|NCT00445679|62823326|FG003|Overall Study|Failed to return|2|||
33448228|NCT00445679|62823323|FG000|Overall Study|Physician Decision|0|||
33448229|NCT00445679|62823324|FG001|Overall Study|Physician Decision|0|||
33448230|NCT00445679|62823325|FG002|Overall Study|Physician Decision|1|||
33448231|NCT00445679|62823326|FG003|Overall Study|Physician Decision|0|||
33448232|NCT00445679|62823323|FG000|Overall Study|Lost to Follow-up|10|||
33608723|NCT01646177|63008803|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
33608724|NCT01646177|63008804|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
33608725|NCT01646177|63008805|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
33448233|NCT00445679|62823324|FG001|Overall Study|Lost to Follow-up|6|||
33608726|NCT01646177|63008794|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33448234|NCT00445679|62823325|FG002|Overall Study|Lost to Follow-up|6|||
33448235|NCT00445679|62823326|FG003|Overall Study|Lost to Follow-up|5|||
33448236|NCT00445679|62823323|FG000|Overall Study|Compliance|3|||
33448237|NCT00445679|62823324|FG001|Overall Study|Compliance|2|||
33448238|NCT00445679|62823325|FG002|Overall Study|Compliance|1|||
33448239|NCT00445679|62823326|FG003|Overall Study|Compliance|2|||
33448240|NCT00445679|62823323|FG000|Overall Study|Withdrawal of Informed Consent|0|||
33448241|NCT00445679|62823324|FG001|Overall Study|Withdrawal of Informed Consent|0|||
33448242|NCT00445679|62823325|FG002|Overall Study|Withdrawal of Informed Consent|1|||
33448243|NCT00445679|62823326|FG003|Overall Study|Withdrawal of Informed Consent|0|||
33498186|NCT03710083|62877635|FG000|Overall Study|Withdrawal by Subject|2|||
33498187|NCT03710083|62877635|FG000|Overall Study|Unsuccessful Procedure|1|||
33498188|NCT03318003|62877641|FG000|Overall Study|Withdrawal by Subject|1|||
33498189|NCT03318003|62877642|FG001|Overall Study|Withdrawal by Subject|1|||
33498190|NCT03318003|62877641|FG000|Overall Study|fetal loss|0|||
33498191|NCT03318003|62877642|FG001|Overall Study|fetal loss|1|||
33498192|NCT03317379|62877651|FG000|Overall Study|Lost to Follow-up|0|||
33498193|NCT03317379|62877652|FG001|Overall Study|Lost to Follow-up|3|||
33498194|NCT03317379|62877653|FG002|Overall Study|Lost to Follow-up|2|||
33498195|NCT03316911|62877663|FG000|Overall Study|Lost to Follow-up|33|||
33498196|NCT03316911|62877664|FG001|Overall Study|Lost to Follow-up|29|||
33498197|NCT01106391|62877670|FG000|Overall Study|Death|12|||
33498198|NCT01106391|62877670|FG000|Overall Study|Withdrawal by Subject|7|||
33498199|NCT03316131|62877674|FG000|Treatment Period 2|Protocol deviation|1|||
33498200|NCT03316131|62877675|FG001|Treatment Period 2|Protocol deviation|0|||
33498201|NCT03301415|62877681|FG000|Overall Study|Lost to Follow-up|2|||
33498202|NCT03301415|62877681|FG000|Overall Study|Unable to comply with visit schedule|2|||
33498203|NCT02732938|62877687|FG000|Overall Study|Death|0|||
33498204|NCT02732938|62877688|FG001|Overall Study|Death|11|||
33498205|NCT02732938|62877689|FG002|Overall Study|Death|0|||
33498206|NCT02732938|62877687|FG000|Overall Study|Randomized but did not receive treatment|0|||
33498207|NCT02732938|62877688|FG001|Overall Study|Randomized but did not receive treatment|1|||
33498208|NCT02732938|62877689|FG002|Overall Study|Randomized but did not receive treatment|0|||
33498209|NCT02732938|62877687|FG000|Overall Study|Refused further follow-up|1|||
33498210|NCT02732938|62877688|FG001|Overall Study|Refused further follow-up|0|||
33498211|NCT02732938|62877689|FG002|Overall Study|Refused further follow-up|0|||
33498212|NCT02732938|62877687|FG000|Overall Study|Study terminated by sponsor|3|||
33498213|NCT02732938|62877688|FG001|Overall Study|Study terminated by sponsor|6|||
33498214|NCT02732938|62877689|FG002|Overall Study|Study terminated by sponsor|0|||
33498215|NCT04647721|62877697|FG000|Overall Study|Withdrawal by Subject|0|||
33498216|NCT04647721|62877698|FG001|Overall Study|Withdrawal by Subject|2|||
33324006|NCT00970593|62700400|FG006|Overall Study|Discontinuation of study by sponsor|2|||
33498217|NCT04647721|62877697|FG000|Overall Study|Lost to Follow-up|2|||
33498218|NCT04647721|62877698|FG001|Overall Study|Lost to Follow-up|0|||
33498219|NCT03718000|62877719|FG000|Overall Study|Relocation|2|||
33498220|NCT03718000|62877720|FG001|Overall Study|Relocation|4|||
33608727|NCT01646177|63008795|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33608728|NCT01646177|63008796|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33608729|NCT01646177|63008797|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33608730|NCT01646177|63008798|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33608731|NCT01646177|63008799|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33608732|NCT01646177|63008800|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33608733|NCT01646177|63008801|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33608734|NCT01646177|63008802|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
33608735|NCT01646177|63008803|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
33608736|NCT01646177|63008804|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
33608737|NCT01646177|63008805|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
33608738|NCT01646177|63008794|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33608739|NCT01646177|63008795|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33608740|NCT01646177|63008796|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33608741|NCT01646177|63008797|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33608742|NCT01646177|63008798|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33608743|NCT01646177|63008799|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33608744|NCT01646177|63008800|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33498221|NCT03718000|62877719|FG000|Overall Study|Pregnancy|0|||
33498222|NCT03718000|62877720|FG001|Overall Study|Pregnancy|1|||
33498223|NCT03063203|62877727|FG000|Overall Study|Chose alternative therapy|3|||
33498224|NCT03063203|62877727|FG000|Overall Study|Death|2|||
33498225|NCT03063203|62877727|FG000|Overall Study|Disease progression|4|||
33498226|NCT03063203|62877727|FG000|Overall Study|Physician Decision|5|||
33498227|NCT02891226|62877746|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
33498228|NCT02891226|62877747|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
33498229|NCT02891226|62877748|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
33498230|NCT02891226|62877749|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33498231|NCT02891226|62877750|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33498232|NCT02891226|62877751|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33498233|NCT02891226|62877752|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33498234|NCT02891226|62877753|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33608745|NCT01646177|63008801|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33498235|NCT02891226|62877754|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33498236|NCT02891226|62877755|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33498237|NCT02891226|62877756|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33498238|NCT02891226|62877757|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33498239|NCT02891226|62877758|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33498240|NCT02891226|62877759|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33498241|NCT02891226|62877760|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33498242|NCT02891226|62877761|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33498243|NCT02891226|62877746|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
33498244|NCT02891226|62877747|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
33498245|NCT02891226|62877748|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33498246|NCT02891226|62877749|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33498247|NCT02891226|62877750|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33498248|NCT02891226|62877751|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33498249|NCT02891226|62877752|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33498250|NCT02891226|62877753|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33498251|NCT02891226|62877754|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33498252|NCT02891226|62877755|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33498253|NCT02891226|62877756|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33498254|NCT02891226|62877757|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33498255|NCT02891226|62877758|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33498256|NCT02891226|62877759|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33498257|NCT02891226|62877760|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33498258|NCT02891226|62877761|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33498259|NCT02891226|62877746|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33498260|NCT02891226|62877747|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33498261|NCT02891226|62877748|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33498262|NCT02891226|62877749|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
33498263|NCT02891226|62877750|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33498264|NCT02891226|62877751|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33498265|NCT02891226|62877752|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33498266|NCT02891226|62877753|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33498267|NCT02891226|62877754|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33498268|NCT02891226|62877755|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33498269|NCT02891226|62877756|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33498270|NCT02891226|62877757|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33498271|NCT02891226|62877758|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33498272|NCT02891226|62877759|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33498273|NCT02891226|62877760|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33498274|NCT02891226|62877761|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33498275|NCT02891226|62877746|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33498276|NCT02891226|62877747|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33498277|NCT02891226|62877748|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
33498278|NCT02891226|62877749|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33498279|NCT02891226|62877750|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33608746|NCT01646177|63008802|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
33608747|NCT01646177|63008803|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
33498280|NCT02891226|62877751|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33498281|NCT02891226|62877752|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33498282|NCT02891226|62877753|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33498283|NCT02891226|62877754|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33498284|NCT02891226|62877755|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33498285|NCT02891226|62877756|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33498286|NCT02891226|62877757|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33498287|NCT02891226|62877758|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33498288|NCT02891226|62877759|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33608748|NCT01646177|63008804|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
33498289|NCT02891226|62877760|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33498290|NCT02891226|62877761|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33498291|NCT02891226|62877746|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33498292|NCT02891226|62877747|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33498293|NCT02891226|62877748|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33498294|NCT02891226|62877749|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
33498295|NCT02891226|62877750|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33498296|NCT02891226|62877751|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33498297|NCT02891226|62877752|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33498298|NCT02891226|62877753|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33498299|NCT02891226|62877754|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33498300|NCT02891226|62877755|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33498301|NCT02891226|62877756|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33498302|NCT02891226|62877757|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33498303|NCT02891226|62877758|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33498304|NCT02891226|62877759|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33498305|NCT02891226|62877760|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33498306|NCT02891226|62877761|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33498307|NCT02891226|62877746|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33498308|NCT02891226|62877747|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33498309|NCT02891226|62877748|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33498310|NCT02891226|62877749|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
33498311|NCT02891226|62877750|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33498312|NCT02891226|62877751|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33498313|NCT02891226|62877752|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33498314|NCT02891226|62877753|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33498315|NCT02891226|62877754|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33498316|NCT02891226|62877755|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33498317|NCT02891226|62877756|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33498318|NCT02891226|62877757|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33498319|NCT02891226|62877758|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33498320|NCT02891226|62877759|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33498321|NCT02891226|62877760|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33498322|NCT02891226|62877761|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33498323|NCT02891226|62877746|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33498324|NCT02891226|62877747|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33498325|NCT02891226|62877748|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33498326|NCT02891226|62877749|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33498327|NCT02891226|62877750|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33498328|NCT02891226|62877751|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33498329|NCT02891226|62877752|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
33498330|NCT02891226|62877753|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
33498331|NCT02891226|62877754|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
33498332|NCT02891226|62877755|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
33498333|NCT02891226|62877756|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33498334|NCT02891226|62877757|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33498335|NCT02891226|62877758|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33498336|NCT02891226|62877759|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33448244|NCT00445679|62823323|FG000|Overall Study|Protocol Violation|2|||
33448245|NCT00445679|62823324|FG001|Overall Study|Protocol Violation|3|||
33448246|NCT00445679|62823325|FG002|Overall Study|Protocol Violation|3|||
33448247|NCT00445679|62823326|FG003|Overall Study|Protocol Violation|1|||
33448248|NCT00445679|62823323|FG000|Overall Study|Withdrawal by Subject|8|||
33448249|NCT00445679|62823324|FG001|Overall Study|Withdrawal by Subject|14|||
33448250|NCT00445679|62823325|FG002|Overall Study|Withdrawal by Subject|20|||
33498337|NCT02891226|62877760|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33498338|NCT02891226|62877761|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33498339|NCT02891226|62877746|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33448251|NCT00445679|62823326|FG003|Overall Study|Withdrawal by Subject|18|||
33498340|NCT02891226|62877747|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33498341|NCT02891226|62877748|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33498342|NCT02891226|62877749|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33498343|NCT02891226|62877750|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33498344|NCT02891226|62877751|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
33498345|NCT02891226|62877752|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33498346|NCT02891226|62877753|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33498347|NCT02891226|62877754|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33498348|NCT02891226|62877755|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
33498349|NCT02891226|62877756|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33498350|NCT02891226|62877757|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33498351|NCT02891226|62877758|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33498352|NCT02891226|62877759|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33498353|NCT02891226|62877760|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33498354|NCT02891226|62877761|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33498355|NCT02891226|62877746|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33498356|NCT02891226|62877747|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33498357|NCT02891226|62877748|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33498358|NCT02891226|62877749|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33498359|NCT02891226|62877750|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33498360|NCT02891226|62877751|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33498361|NCT02891226|62877752|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
33498362|NCT02891226|62877753|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
33498363|NCT02891226|62877754|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
33498364|NCT02891226|62877755|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
33498365|NCT02891226|62877756|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33498366|NCT02891226|62877757|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33498367|NCT02891226|62877758|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33498368|NCT02891226|62877759|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33498369|NCT02891226|62877760|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33498370|NCT02891226|62877761|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33498371|NCT02891226|62877746|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33498372|NCT02891226|62877747|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33498373|NCT02891226|62877748|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33498374|NCT02891226|62877749|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33498375|NCT02891226|62877750|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
33498376|NCT02891226|62877751|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33498377|NCT02891226|62877752|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33498378|NCT02891226|62877753|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33498379|NCT02891226|62877754|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33498380|NCT02891226|62877755|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33498381|NCT02891226|62877756|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33498382|NCT02891226|62877757|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33498383|NCT02891226|62877758|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33498384|NCT02891226|62877759|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33498385|NCT02891226|62877760|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33498386|NCT02891226|62877761|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33608749|NCT01646177|63008805|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
33608750|NCT01646177|63008794|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33608751|NCT01646177|63008795|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33608752|NCT01646177|63008796|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33498387|NCT02891226|62877746|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33498388|NCT02891226|62877747|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33498389|NCT02891226|62877748|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33498390|NCT02891226|62877749|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33498391|NCT02891226|62877750|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33498392|NCT02891226|62877751|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33498393|NCT02891226|62877752|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
33608753|NCT01646177|63008797|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33608754|NCT01646177|63008798|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33608755|NCT01646177|63008799|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33498394|NCT02891226|62877753|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33498395|NCT02891226|62877754|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33498396|NCT02891226|62877755|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33498397|NCT02891226|62877756|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33498398|NCT02891226|62877757|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33498399|NCT02891226|62877758|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33498400|NCT02891226|62877759|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33498401|NCT02891226|62877760|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33498402|NCT02891226|62877761|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33498403|NCT02891226|62877746|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33498404|NCT02891226|62877747|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33498405|NCT02891226|62877748|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33498406|NCT02891226|62877749|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33498407|NCT02891226|62877750|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33498408|NCT02891226|62877751|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33498409|NCT02891226|62877752|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33498410|NCT02891226|62877753|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
33498411|NCT02891226|62877754|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
33498412|NCT02891226|62877755|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
33498413|NCT02891226|62877756|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33498414|NCT02891226|62877757|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33498415|NCT02891226|62877758|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33498416|NCT02891226|62877759|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33498417|NCT02891226|62877760|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33498418|NCT02891226|62877761|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33498419|NCT02891226|62877746|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33498420|NCT02891226|62877747|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33498421|NCT02891226|62877748|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33498422|NCT02891226|62877749|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33498423|NCT02891226|62877750|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33498424|NCT02891226|62877751|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33498425|NCT02891226|62877752|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33498426|NCT02891226|62877753|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
33498427|NCT02891226|62877754|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33498428|NCT02891226|62877755|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33498429|NCT02891226|62877756|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33498430|NCT02891226|62877757|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33498431|NCT02891226|62877758|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33498432|NCT02891226|62877759|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33498433|NCT02891226|62877760|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33498434|NCT02891226|62877761|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33498435|NCT02891226|62877746|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33498436|NCT02891226|62877747|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33498437|NCT02891226|62877748|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33498438|NCT02891226|62877749|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33498439|NCT02891226|62877750|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33498440|NCT02891226|62877751|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33498441|NCT02891226|62877752|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33498442|NCT02891226|62877753|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33498443|NCT02891226|62877754|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
33498444|NCT02891226|62877755|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33498445|NCT02891226|62877756|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33498446|NCT02891226|62877757|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33498447|NCT02891226|62877758|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33498448|NCT02891226|62877759|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33498449|NCT02891226|62877760|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33498450|NCT02891226|62877761|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33498451|NCT02891226|62877746|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33498452|NCT02891226|62877747|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33498453|NCT02891226|62877748|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33498454|NCT02891226|62877749|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33544011|NCT03021187|62934823|FG001|Overall Study|Withdrawal by Subject|6|||
33544012|NCT03021187|62934824|FG002|Overall Study|Withdrawal by Subject|2|||
33498455|NCT02891226|62877750|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33498456|NCT02891226|62877751|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33498457|NCT02891226|62877752|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33498458|NCT02891226|62877753|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33498459|NCT02891226|62877754|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33498460|NCT02891226|62877755|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
33498461|NCT02891226|62877756|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33498462|NCT02891226|62877757|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33498463|NCT02891226|62877758|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33498464|NCT02891226|62877759|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33498465|NCT02891226|62877760|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33498466|NCT02891226|62877761|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33498467|NCT02891226|62877746|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33498468|NCT02891226|62877747|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33498469|NCT02891226|62877748|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33498470|NCT02891226|62877749|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33498471|NCT02891226|62877750|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33498472|NCT02891226|62877751|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33498473|NCT02891226|62877752|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33498474|NCT02891226|62877753|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33498475|NCT02891226|62877754|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33498476|NCT02891226|62877755|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
33498477|NCT02891226|62877756|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33498478|NCT02891226|62877757|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33498479|NCT02891226|62877758|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33498480|NCT02891226|62877759|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33498481|NCT02891226|62877760|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33498482|NCT02891226|62877761|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33498483|NCT02891226|62877746|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33498484|NCT02891226|62877747|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33498485|NCT02891226|62877748|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33498486|NCT02891226|62877749|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33498487|NCT02891226|62877750|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33498488|NCT02891226|62877751|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33498489|NCT02891226|62877752|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33498490|NCT02891226|62877753|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33498491|NCT02891226|62877754|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33498492|NCT02891226|62877755|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33498493|NCT02891226|62877756|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
33498494|NCT02891226|62877757|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33498495|NCT02891226|62877758|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33498496|NCT02891226|62877759|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33498497|NCT02891226|62877760|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33498498|NCT02891226|62877761|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33498499|NCT02891226|62877746|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33498500|NCT02891226|62877747|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33498501|NCT02891226|62877748|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33498502|NCT02891226|62877749|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33498503|NCT02891226|62877750|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33498504|NCT02891226|62877751|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33498505|NCT02891226|62877752|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33498506|NCT02891226|62877753|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33498507|NCT02891226|62877754|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33498508|NCT02891226|62877755|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33498509|NCT02891226|62877756|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
33498510|NCT02891226|62877757|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33498511|NCT02891226|62877758|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33498512|NCT02891226|62877759|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33498513|NCT02891226|62877760|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33498514|NCT02891226|62877761|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33498515|NCT02891226|62877746|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33498516|NCT02891226|62877747|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33498517|NCT02891226|62877748|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33498518|NCT02891226|62877749|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33498519|NCT02891226|62877750|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33498520|NCT02891226|62877751|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33498521|NCT02891226|62877752|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33608756|NCT01646177|63008800|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33498522|NCT02891226|62877753|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33498523|NCT02891226|62877754|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33498524|NCT02891226|62877755|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33498525|NCT02891226|62877756|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
33498526|NCT02891226|62877757|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33498527|NCT02891226|62877758|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33498528|NCT02891226|62877759|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33498529|NCT02891226|62877760|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33498530|NCT02891226|62877761|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33498531|NCT02891226|62877746|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33498532|NCT02891226|62877747|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33498533|NCT02891226|62877748|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33498534|NCT02891226|62877749|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33498535|NCT02891226|62877750|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33498536|NCT02891226|62877751|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33498537|NCT02891226|62877752|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33498538|NCT02891226|62877753|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33498539|NCT02891226|62877754|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33498540|NCT02891226|62877755|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33498541|NCT02891226|62877756|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
33498542|NCT02891226|62877757|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33498543|NCT02891226|62877758|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33498544|NCT02891226|62877759|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33498545|NCT02891226|62877760|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33498546|NCT02891226|62877761|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33498547|NCT02891226|62877746|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33498548|NCT02891226|62877747|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33608757|NCT01646177|63008801|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33608758|NCT01646177|63008802|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
33608759|NCT01646177|63008803|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
33608760|NCT01646177|63008804|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
33608761|NCT01646177|63008805|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
33608762|NCT01646177|63008794|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33608763|NCT01646177|63008795|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33608764|NCT01646177|63008796|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33608765|NCT01646177|63008797|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33608766|NCT01646177|63008798|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33608767|NCT01646177|63008799|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33608768|NCT01646177|63008800|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33608769|NCT01646177|63008801|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33608770|NCT01646177|63008802|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
33608771|NCT01646177|63008803|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
33608772|NCT01646177|63008804|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
33608773|NCT01646177|63008805|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
33608774|NCT01646177|63008794|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33608775|NCT01646177|63008795|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33608776|NCT01646177|63008796|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33608777|NCT01646177|63008797|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33498549|NCT02891226|62877748|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33498550|NCT02891226|62877749|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33498551|NCT02891226|62877750|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33498552|NCT02891226|62877751|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33498553|NCT02891226|62877752|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33498554|NCT02891226|62877753|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33498555|NCT02891226|62877754|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33498556|NCT02891226|62877755|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33498557|NCT02891226|62877756|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
33498558|NCT02891226|62877757|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33498559|NCT02891226|62877758|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33498560|NCT02891226|62877759|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33498561|NCT02891226|62877760|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33498562|NCT02891226|62877761|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33608778|NCT01646177|63008798|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33498563|NCT02891226|62877746|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33498564|NCT02891226|62877747|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33498565|NCT02891226|62877748|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33498566|NCT02891226|62877749|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33498567|NCT02891226|62877750|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33498568|NCT02891226|62877751|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33498569|NCT02891226|62877752|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33498570|NCT02891226|62877753|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33498571|NCT02891226|62877754|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33498572|NCT02891226|62877755|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33498573|NCT02891226|62877756|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
33498574|NCT02891226|62877757|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33498575|NCT02891226|62877758|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33498576|NCT02891226|62877759|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33498577|NCT02891226|62877760|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33498578|NCT02891226|62877761|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33498579|NCT02891226|62877746|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33498580|NCT02891226|62877747|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33498581|NCT02891226|62877748|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33498582|NCT02891226|62877749|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33498583|NCT02891226|62877750|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33498584|NCT02891226|62877751|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33498585|NCT02891226|62877752|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33498586|NCT02891226|62877753|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33498587|NCT02891226|62877754|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33498588|NCT02891226|62877755|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33498589|NCT02891226|62877756|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
33498590|NCT02891226|62877757|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33498591|NCT02891226|62877758|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33498592|NCT02891226|62877759|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33498593|NCT02891226|62877760|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33498594|NCT02891226|62877761|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33498595|NCT02891226|62877746|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33498596|NCT02891226|62877747|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33498597|NCT02891226|62877748|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33498598|NCT02891226|62877749|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33498599|NCT02891226|62877750|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33498600|NCT02891226|62877751|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33498601|NCT02891226|62877752|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33498602|NCT02891226|62877753|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33498603|NCT02891226|62877754|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33498604|NCT02891226|62877755|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33498605|NCT02891226|62877756|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
33498606|NCT02891226|62877757|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33498607|NCT02891226|62877758|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33498608|NCT02891226|62877759|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33498609|NCT02891226|62877760|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33498610|NCT02891226|62877761|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33498611|NCT02891226|62877746|FG000|Follow-up Period|Withdrawal by Subject|0|||
33498612|NCT02891226|62877747|FG001|Follow-up Period|Withdrawal by Subject|0|||
33498613|NCT02891226|62877748|FG002|Follow-up Period|Withdrawal by Subject|0|||
33498614|NCT02891226|62877749|FG003|Follow-up Period|Withdrawal by Subject|0|||
33498615|NCT02891226|62877750|FG004|Follow-up Period|Withdrawal by Subject|0|||
33498616|NCT02891226|62877751|FG005|Follow-up Period|Withdrawal by Subject|0|||
33498617|NCT02891226|62877752|FG006|Follow-up Period|Withdrawal by Subject|0|||
33498618|NCT02891226|62877753|FG007|Follow-up Period|Withdrawal by Subject|0|||
33498619|NCT02891226|62877754|FG008|Follow-up Period|Withdrawal by Subject|0|||
33498620|NCT02891226|62877755|FG009|Follow-up Period|Withdrawal by Subject|0|||
33498621|NCT02891226|62877756|FG010|Follow-up Period|Withdrawal by Subject|0|||
33498622|NCT02891226|62877757|FG011|Follow-up Period|Withdrawal by Subject|1|||
33498623|NCT02891226|62877758|FG012|Follow-up Period|Withdrawal by Subject|0|||
33498624|NCT02891226|62877759|FG013|Follow-up Period|Withdrawal by Subject|0|||
33324007|NCT00970593|62700394|FG000|Overall Study|Withdrawal by Subject|0|||
33498625|NCT02891226|62877760|FG014|Follow-up Period|Withdrawal by Subject|1|||
33498626|NCT02891226|62877761|FG015|Follow-up Period|Withdrawal by Subject|1|||
33498627|NCT03612856|62877788|FG000|Pre-dose Period|Physician Decision|0|||
33498628|NCT03612856|62877789|FG001|Pre-dose Period|Physician Decision|1|||
33498629|NCT03612856|62877790|FG002|Pre-dose Period|Physician Decision|1|||
33498630|NCT03612856|62877788|FG000|Pre-dose Period|Withdrawal by Subject|0|||
33498631|NCT03612856|62877789|FG001|Pre-dose Period|Withdrawal by Subject|1|||
33498632|NCT03612856|62877790|FG002|Pre-dose Period|Withdrawal by Subject|0|||
33498633|NCT03333837|62877803|FG000|Overall Study|Adverse Event|2|||
33498634|NCT03333837|62877804|FG001|Overall Study|Adverse Event|1|||
33498635|NCT03333837|62877805|FG002|Overall Study|Adverse Event|1|||
33498636|NCT03333837|62877806|FG003|Overall Study|Adverse Event|1|||
33498637|NCT03333837|62877807|FG004|Overall Study|Adverse Event|0|||
33498638|NCT03333837|62877803|FG000|Overall Study|Caregiver withdrew|0|||
33498639|NCT03333837|62877804|FG001|Overall Study|Caregiver withdrew|2|||
33498640|NCT03333837|62877805|FG002|Overall Study|Caregiver withdrew|1|||
33498641|NCT03333837|62877806|FG003|Overall Study|Caregiver withdrew|0|||
33498642|NCT03333837|62877807|FG004|Overall Study|Caregiver withdrew|0|||
33498643|NCT03333837|62877803|FG000|Overall Study|Withdrawal by Subject|0|||
33498644|NCT03333837|62877804|FG001|Overall Study|Withdrawal by Subject|0|||
33608779|NCT01646177|63008799|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33608780|NCT01646177|63008800|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33608781|NCT01646177|63008801|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33608782|NCT01646177|63008802|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33608783|NCT01646177|63008803|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
33608784|NCT01646177|63008804|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
33608785|NCT01646177|63008805|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
33608786|NCT01646177|63008794|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33608787|NCT01646177|63008795|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33608788|NCT01646177|63008796|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33608789|NCT01646177|63008797|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33608790|NCT01646177|63008798|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33608791|NCT01646177|63008799|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33608792|NCT01646177|63008800|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33608793|NCT01646177|63008801|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33498645|NCT03333837|62877805|FG002|Overall Study|Withdrawal by Subject|1|||
33498646|NCT03333837|62877806|FG003|Overall Study|Withdrawal by Subject|1|||
33498647|NCT03333837|62877807|FG004|Overall Study|Withdrawal by Subject|3|||
33498648|NCT03333837|62877803|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
33498649|NCT03333837|62877804|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
33498650|NCT03333837|62877805|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
33498651|NCT03333837|62877806|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
33498652|NCT03333837|62877807|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
33498653|NCT03708211|62877825|FG000|Overall Study|Progressive Disease|10|||
33498654|NCT03708211|62877826|FG001|Overall Study|Progressive Disease|7|||
33498655|NCT03708211|62877825|FG000|Overall Study|Withdrawal by Subject|0|||
33498656|NCT03708211|62877826|FG001|Overall Study|Withdrawal by Subject|1|||
33608794|NCT01646177|63008802|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33608795|NCT01646177|63008803|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
33608796|NCT01646177|63008804|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
33608797|NCT01646177|63008805|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
33608798|NCT01646177|63008794|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33608799|NCT01646177|63008795|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33498657|NCT03708211|62877825|FG000|Overall Study|Other|2|||
33498658|NCT03708211|62877826|FG001|Overall Study|Other|0|||
33498659|NCT02948634|62877836|FG000|Overall Study|Lack of efficacy and study suspended|10|||
33498660|NCT02948634|62877837|FG001|Overall Study|Lack of efficacy and study suspended|2|||
33498661|NCT02945046|62877846|FG000|Overall Study|Adverse Event|1|||
33498662|NCT02945046|62877847|FG001|Overall Study|Adverse Event|0|||
33498663|NCT02945046|62877848|FG002|Overall Study|Adverse Event|2|||
33498664|NCT02945046|62877846|FG000|Overall Study|Withdrawal by Subject|3|||
33498665|NCT02945046|62877847|FG001|Overall Study|Withdrawal by Subject|3|||
33608800|NCT01646177|63008796|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33608801|NCT01646177|63008797|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33608802|NCT01646177|63008798|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33498666|NCT02945046|62877848|FG002|Overall Study|Withdrawal by Subject|3|||
33498667|NCT02945046|62877846|FG000|Overall Study|Protocol Violation|2|||
33498668|NCT02945046|62877847|FG001|Overall Study|Protocol Violation|3|||
33498669|NCT02945046|62877848|FG002|Overall Study|Protocol Violation|2|||
33608803|NCT01646177|63008799|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33608804|NCT01646177|63008800|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33498670|NCT02945046|62877846|FG000|Overall Study|Lost to Follow-up|1|||
33498671|NCT02945046|62877847|FG001|Overall Study|Lost to Follow-up|1|||
33498672|NCT02945046|62877848|FG002|Overall Study|Lost to Follow-up|0|||
33498673|NCT02945046|62877846|FG000|Overall Study|Lack of Efficacy|1|||
33498674|NCT02945046|62877847|FG001|Overall Study|Lack of Efficacy|2|||
33498675|NCT02945046|62877848|FG002|Overall Study|Lack of Efficacy|1|||
33498676|NCT02945046|62877846|FG000|Overall Study|Other than specified|5|||
33498677|NCT02945046|62877847|FG001|Overall Study|Other than specified|4|||
33498678|NCT02945046|62877848|FG002|Overall Study|Other than specified|7|||
33498679|NCT03705793|62877858|FG000|Overall Study|Lost to Follow-up|3|||
33498680|NCT03705793|62877859|FG001|Overall Study|Lost to Follow-up|4|||
33498681|NCT03705793|62877858|FG000|Overall Study|Withdrawal by Subject|2|||
33498682|NCT03705793|62877859|FG001|Overall Study|Withdrawal by Subject|1|||
33498683|NCT02944968|62877878|FG000|Overall Study|Subject excluded before study procedure|1|||
33498684|NCT02944968|62877878|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
33498685|NCT03761797|62877882|FG000|Overall Study|Changing hospital|11|||
33608805|NCT01646177|63008801|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33608806|NCT01646177|63008802|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
33608807|NCT01646177|63008803|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33608808|NCT01646177|63008804|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
33608809|NCT01646177|63008805|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
33608810|NCT01646177|63008794|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33498686|NCT03761797|62877882|FG000|Overall Study|Improvement/remission|6|||
33498687|NCT03761797|62877882|FG000|Overall Study|Withdrawal by Subject|19|||
33498688|NCT03761797|62877882|FG000|Overall Study|Lost to Follow-up|33|||
33498689|NCT03761797|62877882|FG000|Overall Study|Adverse Event|37|||
33498690|NCT03761797|62877882|FG000|Overall Study|Case report form (CRF) not collected|5|||
33498691|NCT03761797|62877882|FG000|Overall Study|No patient visit after entry|13|||
33498692|NCT03761797|62877882|FG000|Overall Study|Switch to other diabetes medication|10|||
33498693|NCT03761797|62877882|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
33498694|NCT03761797|62877882|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
33498695|NCT03761797|62877882|FG000|Overall Study|Insufficient effectives|2|||
33498696|NCT03761797|62877882|FG000|Overall Study|Excessive alcohol intake|1|||
33498697|NCT02944656|62877888|FG000|Overall Study|No longer eligible|3|||
33498698|NCT02944656|62877889|FG001|Overall Study|No longer eligible|0|||
33498699|NCT02944656|62877888|FG000|Overall Study|Lost to Follow-up|7|||
33498700|NCT02944656|62877889|FG001|Overall Study|Lost to Follow-up|10|||
33498701|NCT02713529|62877902|FG000|Overall Study|Withdrawal by Subject|3|||
33498702|NCT02713529|62877903|FG001|Overall Study|Withdrawal by Subject|1|||
33498703|NCT02713529|62877904|FG002|Overall Study|Withdrawal by Subject|4|||
33498704|NCT02713529|62877905|FG003|Overall Study|Withdrawal by Subject|2|||
33498705|NCT02713529|62877906|FG004|Overall Study|Withdrawal by Subject|0|||
33498706|NCT02713529|62877907|FG005|Overall Study|Withdrawal by Subject|1|||
33498707|NCT02713529|62877908|FG006|Overall Study|Withdrawal by Subject|1|||
33498708|NCT02713529|62877902|FG000|Overall Study|Lost to Follow-up|1|||
33498709|NCT02713529|62877903|FG001|Overall Study|Lost to Follow-up|0|||
33498710|NCT02713529|62877904|FG002|Overall Study|Lost to Follow-up|1|||
33498711|NCT02713529|62877905|FG003|Overall Study|Lost to Follow-up|0|||
33498712|NCT02713529|62877906|FG004|Overall Study|Lost to Follow-up|0|||
33498713|NCT02713529|62877907|FG005|Overall Study|Lost to Follow-up|0|||
33498714|NCT02713529|62877908|FG006|Overall Study|Lost to Follow-up|0|||
33498715|NCT02713529|62877902|FG000|Overall Study|Death|3|||
33498716|NCT02713529|62877903|FG001|Overall Study|Death|3|||
33608811|NCT01646177|63008795|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33608812|NCT01646177|63008796|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33608813|NCT01646177|63008797|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33608814|NCT01646177|63008798|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33608815|NCT01646177|63008799|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33608816|NCT01646177|63008800|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33608817|NCT01646177|63008801|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33608818|NCT01646177|63008802|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33608819|NCT01646177|63008803|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33498717|NCT02713529|62877904|FG002|Overall Study|Death|26|||
33498718|NCT02713529|62877905|FG003|Overall Study|Death|27|||
33498719|NCT02713529|62877906|FG004|Overall Study|Death|3|||
33498720|NCT02713529|62877907|FG005|Overall Study|Death|13|||
33498721|NCT02713529|62877908|FG006|Overall Study|Death|3|||
33498722|NCT03707821|62877934|FG000|Overall Study|Protocol Violation|0|||
33498723|NCT03707821|62877935|FG001|Overall Study|Protocol Violation|1|||
33498724|NCT03707821|62877934|FG000|Overall Study|Unsatisfactory Visual Response|1|||
33498725|NCT03707821|62877935|FG001|Overall Study|Unsatisfactory Visual Response|0|||
33498726|NCT03707821|62877934|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
33324008|NCT00970593|62700395|FG001|Overall Study|Withdrawal by Subject|0|||
33498727|NCT03707821|62877935|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
33498728|NCT04546581|62877943|FG000|Overall Study|Adverse Event|9|||
33498729|NCT04546581|62877944|FG001|Overall Study|Adverse Event|3|||
33498730|NCT04546581|62877943|FG000|Overall Study|Physician Decision|0|||
33498731|NCT04546581|62877944|FG001|Overall Study|Physician Decision|1|||
33498732|NCT04546581|62877943|FG000|Overall Study|Protocol Violation|1|||
33498733|NCT04546581|62877944|FG001|Overall Study|Protocol Violation|2|||
33498734|NCT04546581|62877943|FG000|Overall Study|Withdrawal by Subject|3|||
33498735|NCT04546581|62877944|FG001|Overall Study|Withdrawal by Subject|7|||
33498736|NCT03707587|62877952|FG000|Overall Study|Death|0|||
33498737|NCT03707587|62877953|FG001|Overall Study|Death|1|||
33498738|NCT03312933|62877963|FG000|Overall Study|Protocol Violation|15|||
33498739|NCT03312933|62877963|FG000|Overall Study|Lost to Follow-up|36|||
33498740|NCT03312933|62877963|FG000|Overall Study|Withdrawal by Subject|3|||
33448252|NCT00445679|62823323|FG000|Overall Study|Lack of Efficacy|2|||
33448253|NCT00445679|62823324|FG001|Overall Study|Lack of Efficacy|6|||
33498741|NCT02561273|62877969|FG000|Overall Study|Protocol Violation|1|||
33498742|NCT02561273|62877970|FG001|Overall Study|Protocol Violation|0|||
33498743|NCT03312543|62877980|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
33498744|NCT03312543|62877981|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
33498745|NCT03312543|62877980|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
33498746|NCT03312543|62877981|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
33498747|NCT03312543|62877980|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
33498748|NCT03312543|62877981|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
33498749|NCT03312543|62877980|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
33498750|NCT03312543|62877981|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
33498751|NCT03312543|62877980|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
33498752|NCT03312543|62877981|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
33498753|NCT03312543|62877980|FG000|Regression (Week 12 to Week 24)|Death|0|||
33498754|NCT03312543|62877981|FG001|Regression (Week 12 to Week 24)|Death|1|||
33498755|NCT02392559|62878010|FG000|Overall Study|Withdrawal by Subject|0|||
33498756|NCT02392559|62878011|FG001|Overall Study|Withdrawal by Subject|1|||
33498757|NCT03332589|62878025|FG000|Overall Study|Lack of Efficacy|2|||
33498758|NCT03332589|62878026|FG001|Overall Study|Lack of Efficacy|0|||
33498759|NCT03332589|62878027|FG002|Overall Study|Lack of Efficacy|0|||
33498760|NCT03332589|62878025|FG000|Overall Study|Adverse Event|1|||
33498761|NCT03332589|62878026|FG001|Overall Study|Adverse Event|0|||
33498762|NCT03332589|62878027|FG002|Overall Study|Adverse Event|0|||
33498763|NCT03332589|62878025|FG000|Overall Study|Death|1|||
33498764|NCT03332589|62878026|FG001|Overall Study|Death|0|||
33498765|NCT03332589|62878027|FG002|Overall Study|Death|0|||
33498766|NCT00458003|62878037|FG000|Overall Study|Non protocol spinal anesthesia|1|||
33498767|NCT00458003|62878038|FG001|Overall Study|Non protocol spinal anesthesia|1|||
33498768|NCT02061293|62878048|FG000|Overall Study|Elevated Blood Pressure|1|||
33608820|NCT01646177|63008804|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
33608821|NCT01646177|63008805|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
33448254|NCT00445679|62823325|FG002|Overall Study|Lack of Efficacy|2|||
33448255|NCT00445679|62823326|FG003|Overall Study|Lack of Efficacy|0|||
33448256|NCT00455429|62823340|FG000|Overall Study|Study Terminated by Sponsor|0|||
33448257|NCT00455429|62823341|FG001|Overall Study|Study Terminated by Sponsor|0|||
33448258|NCT00455429|62823342|FG002|Overall Study|Study Terminated by Sponsor|0|||
33448259|NCT00455429|62823343|FG003|Overall Study|Study Terminated by Sponsor|3|||
33448260|NCT00455429|62823340|FG000|Overall Study|Lost to Follow-up|1|||
33448261|NCT00455429|62823341|FG001|Overall Study|Lost to Follow-up|0|||
33448262|NCT00455429|62823342|FG002|Overall Study|Lost to Follow-up|0|||
33448263|NCT00455429|62823343|FG003|Overall Study|Lost to Follow-up|3|||
33448264|NCT00455429|62823340|FG000|Overall Study|Withdrawal by Subject|0|||
33448265|NCT00455429|62823341|FG001|Overall Study|Withdrawal by Subject|1|||
33448266|NCT00455429|62823342|FG002|Overall Study|Withdrawal by Subject|1|||
33448267|NCT00455429|62823343|FG003|Overall Study|Withdrawal by Subject|0|||
33448268|NCT00455429|62823340|FG000|Overall Study|Lack of Efficacy|0|||
33448269|NCT00455429|62823341|FG001|Overall Study|Lack of Efficacy|1|||
33448270|NCT00455429|62823342|FG002|Overall Study|Lack of Efficacy|0|||
33448271|NCT00455429|62823343|FG003|Overall Study|Lack of Efficacy|1|||
33498769|NCT02061293|62878049|FG001|Overall Study|Elevated Blood Pressure|1|||
33498770|NCT02913612|62878059|FG000|Overall Study|Lost to Follow-up|6|||
33498771|NCT02913612|62878060|FG001|Overall Study|Lost to Follow-up|5|||
33498772|NCT02913612|62878061|FG002|Overall Study|Lost to Follow-up|2|||
33498773|NCT02913612|62878062|FG003|Overall Study|Lost to Follow-up|0|||
33448272|NCT00455429|62823340|FG000|Overall Study|Adverse Event|0|||
33448273|NCT00455429|62823341|FG001|Overall Study|Adverse Event|1|||
33448274|NCT00455429|62823342|FG002|Overall Study|Adverse Event|0|||
33448275|NCT00455429|62823343|FG003|Overall Study|Adverse Event|3|||
33448276|NCT00455429|62823340|FG000|Overall Study|Randomly assigned but not treated|0|||
33448277|NCT00455429|62823341|FG001|Overall Study|Randomly assigned but not treated|0|||
33608822|NCT01912287|63008828|FG000|Overall Study|Ineligible|1|||
33608823|NCT01912287|63008829|FG001|Overall Study|Ineligible|0|||
33608824|NCT01912287|63008830|FG002|Overall Study|Ineligible|1|||
33498774|NCT02913612|62878059|FG000|Overall Study|Physician Decision|1|||
33608825|NCT01912287|63008828|FG000|Overall Study|No-show|0|||
33608826|NCT01912287|63008829|FG001|Overall Study|No-show|0|||
33608827|NCT01912287|63008830|FG002|Overall Study|No-show|1|||
33608828|NCT01912287|63008828|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
33608829|NCT01912287|63008829|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
33608830|NCT01912287|63008830|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
33608831|NCT01912287|63008828|FG000|Overall Study|Felt treatment no longer needed|0|||
33608832|NCT01912287|63008829|FG001|Overall Study|Felt treatment no longer needed|1|||
33608833|NCT01912287|63008830|FG002|Overall Study|Felt treatment no longer needed|0|||
33608834|NCT01912287|63008828|FG000|Overall Study|Life circumstances|4|||
33608835|NCT01912287|63008829|FG001|Overall Study|Life circumstances|2|||
33608836|NCT01912287|63008830|FG002|Overall Study|Life circumstances|0|||
33608837|NCT01912287|63008828|FG000|Overall Study|Lost Interest|1|||
33608838|NCT01912287|63008829|FG001|Overall Study|Lost Interest|0|||
33608839|NCT01912287|63008830|FG002|Overall Study|Lost Interest|0|||
33608840|NCT01912287|63008828|FG000|Overall Study|Uknown reason - subject drop out|5|||
33608841|NCT01912287|63008829|FG001|Overall Study|Uknown reason - subject drop out|7|||
33608842|NCT01912287|63008830|FG002|Overall Study|Uknown reason - subject drop out|3|||
33608843|NCT01912287|63008828|FG000|Overall Study|Missed Assesment|1|||
33608844|NCT01912287|63008829|FG001|Overall Study|Missed Assesment|1|||
33608845|NCT01912287|63008830|FG002|Overall Study|Missed Assesment|1|||
33608846|NCT01912287|63008828|FG000|Overall Study|Scheduling/change in availability|17|||
33608847|NCT01912287|63008829|FG001|Overall Study|Scheduling/change in availability|10|||
33608848|NCT01912287|63008830|FG002|Overall Study|Scheduling/change in availability|8|||
33608849|NCT01929135|63008840|FG000|Overall Study|Lost to Follow-up|1|||
33608850|NCT01929135|63008841|FG001|Overall Study|Lost to Follow-up|1|||
33608851|NCT01911819|63008852|FG000|Overall Study|Adverse Event|0|||
33608852|NCT01911819|63008853|FG001|Overall Study|Adverse Event|1|||
33608853|NCT01911819|63008854|FG002|Overall Study|Adverse Event|0|||
33608854|NCT01911819|63008852|FG000|Overall Study|Withdrawal by Subject|1|||
33608855|NCT01911819|63008853|FG001|Overall Study|Withdrawal by Subject|1|||
33498775|NCT02913612|62878060|FG001|Overall Study|Physician Decision|4|||
33498776|NCT02913612|62878061|FG002|Overall Study|Physician Decision|1|||
33498777|NCT02913612|62878062|FG003|Overall Study|Physician Decision|0|||
33498778|NCT02913612|62878059|FG000|Overall Study|Withdrawal by Subject|2|||
33498779|NCT02913612|62878060|FG001|Overall Study|Withdrawal by Subject|4|||
33498780|NCT02913612|62878061|FG002|Overall Study|Withdrawal by Subject|0|||
33498781|NCT02913612|62878062|FG003|Overall Study|Withdrawal by Subject|0|||
33498782|NCT02913612|62878059|FG000|Overall Study|Hemangioma resolved|1|||
33498783|NCT02913612|62878060|FG001|Overall Study|Hemangioma resolved|0|||
33498784|NCT02913612|62878061|FG002|Overall Study|Hemangioma resolved|0|||
33498785|NCT02913612|62878062|FG003|Overall Study|Hemangioma resolved|0|||
33498786|NCT02913612|62878059|FG000|Overall Study|Local IRB decision|1|||
33498787|NCT02913612|62878060|FG001|Overall Study|Local IRB decision|0|||
33498788|NCT02913612|62878061|FG002|Overall Study|Local IRB decision|0|||
33498789|NCT02913612|62878062|FG003|Overall Study|Local IRB decision|0|||
33498790|NCT02913612|62878059|FG000|Overall Study|Study drug non-compliance|1|||
33498791|NCT02913612|62878060|FG001|Overall Study|Study drug non-compliance|1|||
33498792|NCT02913612|62878061|FG002|Overall Study|Study drug non-compliance|0|||
33498793|NCT02913612|62878062|FG003|Overall Study|Study drug non-compliance|0|||
33498794|NCT02913612|62878059|FG000|Overall Study|Insurance issues|0|||
33498795|NCT02913612|62878060|FG001|Overall Study|Insurance issues|1|||
33498796|NCT02913612|62878061|FG002|Overall Study|Insurance issues|0|||
33498797|NCT02913612|62878062|FG003|Overall Study|Insurance issues|0|||
33498798|NCT02913612|62878059|FG000|Overall Study|Needed to treat second hemangioma|0|||
33498799|NCT02913612|62878060|FG001|Overall Study|Needed to treat second hemangioma|1|||
33498800|NCT02913612|62878061|FG002|Overall Study|Needed to treat second hemangioma|0|||
33498801|NCT02913612|62878062|FG003|Overall Study|Needed to treat second hemangioma|0|||
33498802|NCT02913612|62878059|FG000|Overall Study|Study completion criteria not met|0|||
33498803|NCT02913612|62878060|FG001|Overall Study|Study completion criteria not met|1|||
33498804|NCT02913612|62878061|FG002|Overall Study|Study completion criteria not met|0|||
33498805|NCT02913612|62878062|FG003|Overall Study|Study completion criteria not met|0|||
33498806|NCT02913612|62878059|FG000|Overall Study|Ineligible|0|||
33498807|NCT02913612|62878060|FG001|Overall Study|Ineligible|1|||
33498808|NCT02913612|62878061|FG002|Overall Study|Ineligible|0|||
33498809|NCT02913612|62878062|FG003|Overall Study|Ineligible|0|||
33498810|NCT03312231|62878076|FG000|Overall Study|Lost to Follow-up|2|||
33498811|NCT03312231|62878077|FG001|Overall Study|Lost to Follow-up|6|||
33498812|NCT03312231|62878078|FG002|Overall Study|Lost to Follow-up|1|||
33498813|NCT03312231|62878079|FG003|Overall Study|Lost to Follow-up|3|||
33498814|NCT03312231|62878080|FG004|Overall Study|Lost to Follow-up|1|||
33498815|NCT03312231|62878076|FG000|Overall Study|Withdrawal by Subject|0|||
33498816|NCT03312231|62878077|FG001|Overall Study|Withdrawal by Subject|3|||
33498817|NCT03312231|62878078|FG002|Overall Study|Withdrawal by Subject|1|||
33498818|NCT03312231|62878079|FG003|Overall Study|Withdrawal by Subject|0|||
33498819|NCT03312231|62878080|FG004|Overall Study|Withdrawal by Subject|0|||
33498820|NCT03312231|62878076|FG000|Overall Study|Death|0|||
33498821|NCT03312231|62878077|FG001|Overall Study|Death|1|||
33498822|NCT03312231|62878078|FG002|Overall Study|Death|1|||
33498823|NCT03312231|62878079|FG003|Overall Study|Death|0|||
33498824|NCT03312231|62878080|FG004|Overall Study|Death|0|||
33498825|NCT03312231|62878076|FG000|Overall Study|Study Vaccination not Received|1|||
33498826|NCT03312231|62878077|FG001|Overall Study|Study Vaccination not Received|1|||
33498827|NCT03312231|62878078|FG002|Overall Study|Study Vaccination not Received|1|||
33498828|NCT03312231|62878079|FG003|Overall Study|Study Vaccination not Received|0|||
33498829|NCT03312231|62878080|FG004|Overall Study|Study Vaccination not Received|0|||
33498830|NCT03323736|62878095|FG000|Overall Study|Screen Failure|14|||
33498831|NCT03323736|62878096|FG001|Overall Study|Screen Failure|9|||
33498832|NCT03323736|62878097|FG002|Overall Study|Screen Failure|1|||
33498833|NCT03323736|62878095|FG000|Overall Study|Withdrawal Before Treatment|3|||
33498834|NCT03323736|62878096|FG001|Overall Study|Withdrawal Before Treatment|1|||
33498835|NCT03323736|62878097|FG002|Overall Study|Withdrawal Before Treatment|1|||
33608856|NCT01911819|63008854|FG002|Overall Study|Withdrawal by Subject|0|||
33498836|NCT03323736|62878095|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
33498837|NCT03323736|62878096|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
33498838|NCT03323736|62878097|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
33498839|NCT03311841|62878112|FG000|14-day Wash-out|Adverse Event|0|||
33498840|NCT03311841|62878113|FG001|14-day Wash-out|Adverse Event|1|||
33498841|NCT03311841|62878114|FG002|14-day Wash-out|Adverse Event|0|||
33498842|NCT03311841|62878115|FG003|14-day Wash-out|Adverse Event|0|||
33608857|NCT02280863|63008864|FG000|Integrated Platform|Met stopping criteria|0|||
33608858|NCT02280863|63008865|FG001|Integrated Platform|Met stopping criteria|1|||
33608859|NCT01911429|63008878|FG000|Overall Study|Adverse Event|5|||
33608860|NCT01911429|63008879|FG001|Overall Study|Adverse Event|3|||
33608861|NCT01911429|63008880|FG002|Overall Study|Adverse Event|9|||
33608862|NCT01911429|63008878|FG000|Overall Study|Lack of Efficacy|1|||
33608863|NCT01911429|63008879|FG001|Overall Study|Lack of Efficacy|2|||
33608864|NCT01911429|63008880|FG002|Overall Study|Lack of Efficacy|4|||
33608865|NCT01911429|63008878|FG000|Overall Study|Lost to Follow-up|0|||
33608866|NCT01911429|63008879|FG001|Overall Study|Lost to Follow-up|0|||
33608867|NCT01911429|63008880|FG002|Overall Study|Lost to Follow-up|1|||
33608868|NCT01911429|63008878|FG000|Overall Study|Protocol Violation|0|||
33608869|NCT01911429|63008879|FG001|Overall Study|Protocol Violation|0|||
33608870|NCT01911429|63008880|FG002|Overall Study|Protocol Violation|1|||
33608871|NCT01911429|63008878|FG000|Overall Study|Withdrawal by Subject|5|||
33608872|NCT01911429|63008879|FG001|Overall Study|Withdrawal by Subject|5|||
33608873|NCT01911429|63008880|FG002|Overall Study|Withdrawal by Subject|4|||
33608874|NCT01911429|63008878|FG000|Overall Study|Accidental randomization|0|||
33608875|NCT01911429|63008879|FG001|Overall Study|Accidental randomization|0|||
33608876|NCT01911429|63008880|FG002|Overall Study|Accidental randomization|1|||
33608877|NCT01911429|63008878|FG000|Overall Study|subject left study|1|||
33608878|NCT01911429|63008879|FG001|Overall Study|subject left study|0|||
33608879|NCT01911429|63008880|FG002|Overall Study|subject left study|0|||
33608880|NCT02324465|63008890|FG000|Overall Study|device failure|0|||
33608881|NCT02324465|63008891|FG001|Overall Study|device failure|1|||
33608882|NCT02324153|63008899|FG000|Overall Study|Withdrawal by Subject|4|||
33608883|NCT02324153|63008900|FG001|Overall Study|Withdrawal by Subject|1|||
33608884|NCT02324153|63008899|FG000|Overall Study|Surgery postponed after randomization|3|||
33448278|NCT00455429|62823342|FG002|Overall Study|Randomly assigned but not treated|0|||
33448279|NCT00455429|62823343|FG003|Overall Study|Randomly assigned but not treated|2|||
33448280|NCT00455429|62823340|FG000|Overall Study|Personal Reason|1|||
33448281|NCT00455429|62823341|FG001|Overall Study|Personal Reason|0|||
33448282|NCT00455429|62823342|FG002|Overall Study|Personal Reason|0|||
33448283|NCT00455429|62823343|FG003|Overall Study|Personal Reason|0|||
33448284|NCT00455429|62823340|FG000|Overall Study|Non-compliance|0|||
33448285|NCT00455429|62823341|FG001|Overall Study|Non-compliance|0|||
33448286|NCT00455429|62823342|FG002|Overall Study|Non-compliance|0|||
33448287|NCT00455429|62823343|FG003|Overall Study|Non-compliance|1|||
33448288|NCT00455429|62823340|FG000|Overall Study|Other|0|||
33448289|NCT00455429|62823341|FG001|Overall Study|Other|2|||
33448290|NCT00455429|62823342|FG002|Overall Study|Other|0|||
33448291|NCT00455429|62823343|FG003|Overall Study|Other|1|||
33448292|NCT00445601|62823358|FG000|Overall Study|Withdrawal by Subject|11|||
33448293|NCT00445601|62823359|FG001|Overall Study|Withdrawal by Subject|11|||
33448294|NCT00445601|62823358|FG000|Overall Study|TURBT Complication|12|||
33448295|NCT00445601|62823359|FG001|Overall Study|TURBT Complication|8|||
33448296|NCT00445601|62823358|FG000|Overall Study|Incorrect Disease Status|6|||
33448297|NCT00445601|62823359|FG001|Overall Study|Incorrect Disease Status|6|||
33448298|NCT00445601|62823358|FG000|Overall Study|Drug Delivery Issue|2|||
33448299|NCT00445601|62823359|FG001|Overall Study|Drug Delivery Issue|2|||
33448300|NCT00445601|62823358|FG000|Overall Study|Adverse Event|2|||
33448301|NCT00445601|62823359|FG001|Overall Study|Adverse Event|0|||
33448302|NCT00445601|62823358|FG000|Overall Study|Death prior to TURBT|0|||
33448303|NCT00445601|62823359|FG001|Overall Study|Death prior to TURBT|1|||
33448304|NCT00444587|62823371|FG000|Overall Study|Death|2|||
33448305|NCT00444587|62823372|FG001|Overall Study|Death|1|||
33448306|NCT00444587|62823371|FG000|Overall Study|Progression of the disease|73|||
33448307|NCT00444587|62823372|FG001|Overall Study|Progression of the disease|8|||
33448308|NCT00444587|62823371|FG000|Overall Study|Refused treatment/did not cooperate|4|||
33448309|NCT00444587|62823372|FG001|Overall Study|Refused treatment/did not cooperate|1|||
33498843|NCT03311841|62878116|FG004|14-day Wash-out|Adverse Event|0|||
33608885|NCT02324153|63008900|FG001|Overall Study|Surgery postponed after randomization|0|||
33608886|NCT02324153|63008899|FG000|Overall Study|Developed delirium preoperatively|1|||
33608887|NCT02324153|63008900|FG001|Overall Study|Developed delirium preoperatively|0|||
33448310|NCT00444587|62823371|FG000|Overall Study|Investigator decision|3|||
33448311|NCT00444587|62823372|FG001|Overall Study|Investigator decision|0|||
33448312|NCT00444587|62823371|FG000|Overall Study|Protocol Violation|1|||
33448313|NCT00444587|62823372|FG001|Overall Study|Protocol Violation|0|||
33448314|NCT00444587|62823371|FG000|Overall Study|Missing|0|||
33608888|NCT02280473|63008908|FG000|Overall Study|Adverse Event|1|||
33608889|NCT02280473|63008909|FG001|Overall Study|Adverse Event|1|||
33498844|NCT03311841|62878112|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
33498845|NCT03311841|62878113|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
33498846|NCT03311841|62878114|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
33498847|NCT03311841|62878115|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
33498848|NCT03311841|62878116|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
33498849|NCT03311373|62878149|FG000|Overall Study|Adverse Event|1|||
33498850|NCT03311373|62878149|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
33498851|NCT03311373|62878149|FG000|Overall Study|Lost to Follow-up|1|||
33498852|NCT03311373|62878149|FG000|Overall Study|Physician Decision|1|||
33498853|NCT03311373|62878149|FG000|Overall Study|Withdrawal by Subject|3|||
33498854|NCT01155375|62878161|FG000|Overall Study|Adverse Event|1|||
33498855|NCT01155375|62878162|FG001|Overall Study|Adverse Event|0|||
33498856|NCT00628095|62878180|FG000|Overall Study|Adverse Event|5|||
33498857|NCT00628095|62878181|FG001|Overall Study|Adverse Event|3|||
33498858|NCT00628095|62878180|FG000|Overall Study|Lack of Efficacy|0|||
33498859|NCT00628095|62878181|FG001|Overall Study|Lack of Efficacy|3|||
33498860|NCT00628095|62878180|FG000|Overall Study|Withdrawal by Subject|2|||
33498861|NCT00628095|62878181|FG001|Overall Study|Withdrawal by Subject|0|||
33498862|NCT00628095|62878180|FG000|Overall Study|Other|0|||
33498863|NCT00628095|62878181|FG001|Overall Study|Other|1|||
33498864|NCT02889861|62878189|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
33498865|NCT03325881|62878200|FG000|Overall Study|Protocol Violation|0|||
33498866|NCT03325881|62878201|FG001|Overall Study|Protocol Violation|1|||
33498867|NCT03325881|62878200|FG000|Overall Study|Withdrawal by Subject|0|||
33498868|NCT03325881|62878201|FG001|Overall Study|Withdrawal by Subject|2|||
33498869|NCT03325881|62878200|FG000|Overall Study|Lack of Efficacy|2|||
33498870|NCT03325881|62878201|FG001|Overall Study|Lack of Efficacy|0|||
33498871|NCT03325881|62878200|FG000|Overall Study|Not treated|1|||
33498872|NCT03325881|62878201|FG001|Overall Study|Not treated|0|||
33498873|NCT02887989|62878211|FG000|Overall Study|Withdrawal by Subject|8|||
33498874|NCT02887989|62878212|FG001|Overall Study|Withdrawal by Subject|11|||
33498875|NCT02887989|62878211|FG000|Overall Study|Death|1|||
33608890|NCT02280473|63008908|FG000|Overall Study|Lack of Efficacy|0|||
33608891|NCT02280473|63008909|FG001|Overall Study|Lack of Efficacy|1|||
33608892|NCT02280473|63008908|FG000|Overall Study|Lost to Follow-up|0|||
33608893|NCT02280473|63008909|FG001|Overall Study|Lost to Follow-up|1|||
33608894|NCT01911273|63008917|FG000|Overall Study|Progression of Disease|1|||
33608895|NCT01911273|63008918|FG001|Overall Study|Progression of Disease|0|||
33608896|NCT01911273|63008917|FG000|Overall Study|Withdrawal by Subject|0|||
33608897|NCT01911273|63008918|FG001|Overall Study|Withdrawal by Subject|2|||
33608898|NCT02308007|63008927|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
33608899|NCT02308007|63008928|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
33608900|NCT02308007|63008929|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
33608901|NCT02308007|63008927|FG000|Overall Study|Positive for STD at Baseline|7|||
33608902|NCT02308007|63008928|FG001|Overall Study|Positive for STD at Baseline|11|||
33608903|NCT02308007|63008929|FG002|Overall Study|Positive for STD at Baseline|7|||
33608904|NCT02308007|63008927|FG000|Overall Study|Lost to Follow-up|3|||
33608905|NCT02308007|63008928|FG001|Overall Study|Lost to Follow-up|0|||
33608906|NCT02308007|63008929|FG002|Overall Study|Lost to Follow-up|1|||
33608907|NCT02278367|63008939|FG000|Overall Study|Physician Decision|5|||
33608908|NCT02278367|63008940|FG001|Overall Study|Physician Decision|0|||
33608909|NCT02278367|63008939|FG000|Overall Study|Withdrawal by Subject|5|||
33608910|NCT02278367|63008940|FG001|Overall Study|Withdrawal by Subject|0|||
33608911|NCT01910181|63008946|FG000|Overall Study|Death|37|||
33608912|NCT01910181|63008946|FG000|Overall Study|Lost to Follow-up|3|||
33498876|NCT02887989|62878212|FG001|Overall Study|Death|0|||
33498877|NCT02887521|62878220|FG000|Overall Study|Withdrawal by Subject|0|||
33498878|NCT02887521|62878221|FG001|Overall Study|Withdrawal by Subject|3|||
33498879|NCT03305055|62878229|FG000|Overall Study|Withdrawal by Subject|0|||
33498880|NCT03305055|62878230|FG001|Overall Study|Withdrawal by Subject|1|||
33498881|NCT03305055|62878229|FG000|Overall Study|Adverse Event|1|||
33498882|NCT03305055|62878230|FG001|Overall Study|Adverse Event|1|||
33498883|NCT02763189|62878238|FG000|Overall Study|Device failure|0|||
33498884|NCT02763189|62878239|FG001|Overall Study|Device failure|2|||
33498885|NCT03273387|62878247|FG000|Overall Study|Death|2|||
33498886|NCT03273387|62878248|FG001|Overall Study|Death|2|||
33498887|NCT03273387|62878247|FG000|Overall Study|Withdrawal by Subject|1|||
33498888|NCT03273387|62878248|FG001|Overall Study|Withdrawal by Subject|1|||
33498889|NCT01328080|62878254|FG000|Overall Study|Lost to Follow-up|5|||
33498890|NCT02649946|62878273|FG000|Overall Study|Withdrawal by Subject|1|||
33498891|NCT02649946|62878274|FG001|Overall Study|Withdrawal by Subject|1|||
33608913|NCT01910181|63008946|FG000|Overall Study|Study Terminated by Sponsor|6|||
33608914|NCT01957215|63008953|FG000|Overall Study|Adverse Event|2|||
33608915|NCT01957215|63008954|FG001|Overall Study|Adverse Event|2|||
33608916|NCT01957215|63008953|FG000|Overall Study|Lost to Follow-up|3|||
33498892|NCT02649946|62878273|FG000|Overall Study|Death|7|||
33498893|NCT02649946|62878274|FG001|Overall Study|Death|9|||
33498894|NCT02649946|62878273|FG000|Overall Study|Physician Decision|1|||
33608917|NCT01957215|63008954|FG001|Overall Study|Lost to Follow-up|3|||
33608918|NCT01957215|63008953|FG000|Overall Study|Protocol Violation|1|||
33608919|NCT01957215|63008954|FG001|Overall Study|Protocol Violation|2|||
33608920|NCT01957215|63008953|FG000|Overall Study|Withdrawal by Subject|7|||
33608921|NCT01957215|63008954|FG001|Overall Study|Withdrawal by Subject|5|||
33498895|NCT02649946|62878274|FG001|Overall Study|Physician Decision|0|||
33498896|NCT02649946|62878273|FG000|Overall Study|Lost to Follow-up|2|||
33498897|NCT02649946|62878274|FG001|Overall Study|Lost to Follow-up|1|||
33498898|NCT02649946|62878273|FG000|Overall Study|Erroneously enrolled|1|||
33498899|NCT02649946|62878274|FG001|Overall Study|Erroneously enrolled|0|||
33498900|NCT02649946|62878273|FG000|Overall Study|Missed 6-month follow-up visit|0|||
33498901|NCT02649946|62878274|FG001|Overall Study|Missed 6-month follow-up visit|4|||
33498902|NCT03273153|62878282|FG000|Overall Study|Adverse Event|1|||
33498903|NCT03273153|62878283|FG001|Overall Study|Adverse Event|2|||
33498904|NCT03273153|62878282|FG000|Overall Study|Missing|0|||
33608922|NCT02322749|63008964|FG000|Period 2|Adverse Event|0|||
33608923|NCT02322749|63008965|FG001|Period 2|Adverse Event|0|||
33608924|NCT02322749|63008966|FG002|Period 2|Adverse Event|0|||
33608925|NCT02322749|63008967|FG003|Period 2|Adverse Event|1|||
33608926|NCT02322749|63008968|FG004|Period 2|Adverse Event|0|||
33608927|NCT02322749|63008969|FG005|Period 2|Adverse Event|0|||
33608928|NCT02322749|63008964|FG000|Period 2|Withdrawal by Subject|0|||
33608929|NCT02322749|63008965|FG001|Period 2|Withdrawal by Subject|0|||
33498905|NCT03273153|62878283|FG001|Overall Study|Missing|2|||
33498906|NCT03273153|62878282|FG000|Overall Study|Other|3|||
33498907|NCT03273153|62878283|FG001|Overall Study|Other|2|||
33498908|NCT03273153|62878282|FG000|Overall Study|Symptomatic Deterioration|0|||
33498909|NCT03273153|62878283|FG001|Overall Study|Symptomatic Deterioration|1|||
33498910|NCT03273153|62878282|FG000|Overall Study|Progressive Disease|6|||
33498911|NCT03273153|62878283|FG001|Overall Study|Progressive Disease|5|||
33498912|NCT03273153|62878282|FG000|Overall Study|Physician Decision|1|||
33498913|NCT03273153|62878283|FG001|Overall Study|Physician Decision|3|||
33498914|NCT03273153|62878282|FG000|Overall Study|Study Terminated by Sponsor|112|||
33498915|NCT03273153|62878283|FG001|Overall Study|Study Terminated by Sponsor|102|||
33498916|NCT03273153|62878282|FG000|Overall Study|Withdrawal by Subject|26|||
33608930|NCT02322749|63008966|FG002|Period 2|Withdrawal by Subject|0|||
33608931|NCT02322749|63008967|FG003|Period 2|Withdrawal by Subject|1|||
33608932|NCT02322749|63008968|FG004|Period 2|Withdrawal by Subject|0|||
33448315|NCT00444587|62823372|FG001|Overall Study|Missing|5|||
33448316|NCT00455195|62823382|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
33448317|NCT00455195|62823383|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
33448318|NCT00455195|62823382|FG000|Double-blind Study AGLU02704|Death|1|||
33448319|NCT00455195|62823383|FG001|Double-blind Study AGLU02704|Death|0|||
33448320|NCT00455195|62823382|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
33448321|NCT00455195|62823383|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
33448322|NCT00455195|62823382|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
33448323|NCT00455195|62823383|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
33448324|NCT00235716|62823393|FG000|Overall Study|Death|26|||
33448325|NCT00235716|62823394|FG001|Overall Study|Death|39|||
33448326|NCT00235716|62823395|FG002|Overall Study|Death|32|||
33448327|NCT00235716|62823396|FG003|Overall Study|Death|31|||
33448328|NCT00235716|62823393|FG000|Overall Study|Withdrawal by Subject|23|||
33448329|NCT00235716|62823394|FG001|Overall Study|Withdrawal by Subject|19|||
33448330|NCT00235716|62823395|FG002|Overall Study|Withdrawal by Subject|17|||
33448331|NCT00235716|62823396|FG003|Overall Study|Withdrawal by Subject|18|||
33448332|NCT00235716|62823393|FG000|Overall Study|Lost to Follow-up|12|||
33448333|NCT00235716|62823394|FG001|Overall Study|Lost to Follow-up|7|||
33448334|NCT00235716|62823395|FG002|Overall Study|Lost to Follow-up|14|||
33448335|NCT00235716|62823396|FG003|Overall Study|Lost to Follow-up|10|||
33448336|NCT00235716|62823393|FG000|Overall Study|Adverse Event|1|||
33448337|NCT00235716|62823394|FG001|Overall Study|Adverse Event|1|||
33448338|NCT00235716|62823395|FG002|Overall Study|Adverse Event|1|||
33448339|NCT00235716|62823396|FG003|Overall Study|Adverse Event|0|||
33448340|NCT00235716|62823393|FG000|Overall Study|Physician Decision|0|||
33498917|NCT03273153|62878283|FG001|Overall Study|Withdrawal by Subject|25|||
33498918|NCT03273153|62878282|FG000|Overall Study|Protocol Deviation|3|||
33498919|NCT03273153|62878283|FG001|Overall Study|Protocol Deviation|0|||
33498920|NCT03273153|62878282|FG000|Overall Study|Lost to Follow-up|6|||
33498921|NCT03273153|62878283|FG001|Overall Study|Lost to Follow-up|11|||
33608933|NCT02322749|63008969|FG005|Period 2|Withdrawal by Subject|0|||
33448341|NCT00235716|62823394|FG001|Overall Study|Physician Decision|1|||
33448342|NCT00235716|62823395|FG002|Overall Study|Physician Decision|1|||
33448343|NCT00235716|62823396|FG003|Overall Study|Physician Decision|3|||
33448344|NCT00274742|62823412|FG000|Overall Study|Adverse Event|0|||
33448345|NCT00274742|62823413|FG001|Overall Study|Adverse Event|4|||
33448346|NCT00274742|62823414|FG002|Overall Study|Adverse Event|1|||
33498922|NCT03273153|62878282|FG000|Overall Study|Death|66|||
33608934|NCT02322749|63008964|FG000|Period 3|Withdrawal by Subject|0|||
33608935|NCT02322749|63008965|FG001|Period 3|Withdrawal by Subject|0|||
33608936|NCT02322749|63008966|FG002|Period 3|Withdrawal by Subject|1|||
33608937|NCT02322749|63008967|FG003|Period 3|Withdrawal by Subject|0|||
33608938|NCT02322749|63008968|FG004|Period 3|Withdrawal by Subject|0|||
33608939|NCT02322749|63008969|FG005|Period 3|Withdrawal by Subject|0|||
33608940|NCT01957137|63008978|FG000|Randomized Portion|Adverse Event|1|||
33608941|NCT01957137|63008978|FG000|Randomized Portion|Withdrawal by Subject|1|||
33608942|NCT01928433|63008993|FG000|Overall Study|Adverse Event|5|||
33608943|NCT01928433|63008994|FG001|Overall Study|Adverse Event|2|||
33608944|NCT01928433|63008995|FG002|Overall Study|Adverse Event|5|||
33608945|NCT01928433|63008993|FG000|Overall Study|Protocol Violation|0|||
33608946|NCT01928433|63008994|FG001|Overall Study|Protocol Violation|0|||
33608947|NCT01928433|63008995|FG002|Overall Study|Protocol Violation|2|||
33608948|NCT01928433|63008993|FG000|Overall Study|Lack of Efficacy|5|||
33608949|NCT01928433|63008994|FG001|Overall Study|Lack of Efficacy|4|||
33608950|NCT01928433|63008995|FG002|Overall Study|Lack of Efficacy|4|||
33608951|NCT01928433|63008993|FG000|Overall Study|Withdrawal by Subject|0|||
33608952|NCT01928433|63008994|FG001|Overall Study|Withdrawal by Subject|4|||
33608953|NCT01928433|63008995|FG002|Overall Study|Withdrawal by Subject|0|||
33608954|NCT01928433|63008993|FG000|Overall Study|Negative screening urine culture|7|||
33608955|NCT01928433|63008994|FG001|Overall Study|Negative screening urine culture|6|||
33608956|NCT01928433|63008995|FG002|Overall Study|Negative screening urine culture|10|||
33608957|NCT01928433|63008993|FG000|Overall Study|Lost to Follow-up|0|||
33608958|NCT01928433|63008994|FG001|Overall Study|Lost to Follow-up|2|||
33608959|NCT01928433|63008995|FG002|Overall Study|Lost to Follow-up|3|||
33608960|NCT01928433|63008993|FG000|Overall Study|Other reasons|3|||
33608961|NCT01928433|63008994|FG001|Overall Study|Other reasons|3|||
33608962|NCT01928433|63008995|FG002|Overall Study|Other reasons|4|||
33608963|NCT02322281|63009009|FG000|Overall Study|Progressive Disease|42|||
33608964|NCT02322281|63009010|FG001|Overall Study|Progressive Disease|14|||
33608965|NCT02322281|63009011|FG002|Overall Study|Progressive Disease|49|||
33608966|NCT02322281|63009009|FG000|Overall Study|Adverse Event|3|||
33608967|NCT02322281|63009010|FG001|Overall Study|Adverse Event|4|||
33608968|NCT02322281|63009011|FG002|Overall Study|Adverse Event|6|||
33608969|NCT02322281|63009009|FG000|Overall Study|Death|3|||
33608970|NCT02322281|63009010|FG001|Overall Study|Death|3|||
33608971|NCT02322281|63009011|FG002|Overall Study|Death|3|||
33608972|NCT02322281|63009009|FG000|Overall Study|Withdrawal by Subject|1|||
33608973|NCT02322281|63009010|FG001|Overall Study|Withdrawal by Subject|1|||
33608974|NCT02322281|63009011|FG002|Overall Study|Withdrawal by Subject|6|||
33608975|NCT02322281|63009009|FG000|Overall Study|Physician Decision|2|||
33608976|NCT02322281|63009010|FG001|Overall Study|Physician Decision|0|||
33608977|NCT02322281|63009011|FG002|Overall Study|Physician Decision|5|||
33608978|NCT02322281|63009009|FG000|Overall Study|Study Terminated by Sponsor|2|||
33608979|NCT02322281|63009010|FG001|Overall Study|Study Terminated by Sponsor|0|||
33608980|NCT02322281|63009011|FG002|Overall Study|Study Terminated by Sponsor|0|||
33608981|NCT02322281|63009009|FG000|Overall Study|Missing|0|||
33608982|NCT02322281|63009010|FG001|Overall Study|Missing|0|||
33608983|NCT02322281|63009011|FG002|Overall Study|Missing|1|||
33608984|NCT02322281|63009009|FG000|Overall Study|Miscellaneous|0|||
33608985|NCT02322281|63009010|FG001|Overall Study|Miscellaneous|0|||
33608986|NCT02322281|63009011|FG002|Overall Study|Miscellaneous|4|||
33608987|NCT02322125|63009021|FG000|Overall Study|Withdrawal by Subject|2|||
33608988|NCT02243293|63009042|FG000|Overall Study|Adverse Event|1|||
33608989|NCT02243293|63009043|FG001|Overall Study|Adverse Event|0|||
33608990|NCT02243293|63009044|FG002|Overall Study|Adverse Event|0|||
33608991|NCT02243293|63009045|FG003|Overall Study|Adverse Event|0|||
33608992|NCT02243293|63009046|FG004|Overall Study|Adverse Event|0|||
33608993|NCT02243293|63009047|FG005|Overall Study|Adverse Event|0|||
33608994|NCT02243293|63009048|FG006|Overall Study|Adverse Event|0|||
33608995|NCT02243293|63009049|FG007|Overall Study|Adverse Event|0|||
33448347|NCT00274742|62823415|FG003|Overall Study|Adverse Event|4|||
33448348|NCT00274742|62823416|FG004|Overall Study|Adverse Event|12|||
33448349|NCT00274742|62823417|FG005|Overall Study|Adverse Event|3|||
33448350|NCT00274742|62823412|FG000|Overall Study|Lost to Follow-up|0|||
33448351|NCT00274742|62823413|FG001|Overall Study|Lost to Follow-up|0|||
33448352|NCT00274742|62823414|FG002|Overall Study|Lost to Follow-up|0|||
33448353|NCT00274742|62823415|FG003|Overall Study|Lost to Follow-up|0|||
33448354|NCT00274742|62823416|FG004|Overall Study|Lost to Follow-up|1|||
33448355|NCT00274742|62823417|FG005|Overall Study|Lost to Follow-up|0|||
33448356|NCT00274742|62823412|FG000|Overall Study|End of Study|0|||
33448357|NCT00274742|62823413|FG001|Overall Study|End of Study|0|||
33448358|NCT00274742|62823414|FG002|Overall Study|End of Study|0|||
33448359|NCT00274742|62823415|FG003|Overall Study|End of Study|1|||
33448360|NCT00274742|62823416|FG004|Overall Study|End of Study|0|||
33448361|NCT00274742|62823417|FG005|Overall Study|End of Study|0|||
33448362|NCT00274742|62823412|FG000|Overall Study|Disease Progression|0|||
33608996|NCT02243293|63009050|FG008|Overall Study|Adverse Event|0|||
33608997|NCT02243293|63009051|FG009|Overall Study|Adverse Event|0|||
33498923|NCT03273153|62878283|FG001|Overall Study|Death|69|||
33498924|NCT03323034|62878295|FG000|Overall Study|Lack of Efficacy|5|||
33498925|NCT03323034|62878296|FG001|Overall Study|Lack of Efficacy|5|||
33498926|NCT03323034|62878297|FG002|Overall Study|Lack of Efficacy|6|||
33498927|NCT03323034|62878298|FG003|Overall Study|Lack of Efficacy|5|||
33498928|NCT03323034|62878299|FG004|Overall Study|Lack of Efficacy|5|||
33498929|NCT03323034|62878295|FG000|Overall Study|Physician Decision|0|||
33498930|NCT03323034|62878296|FG001|Overall Study|Physician Decision|0|||
33498931|NCT03323034|62878297|FG002|Overall Study|Physician Decision|0|||
33498932|NCT03323034|62878298|FG003|Overall Study|Physician Decision|0|||
33498933|NCT03323034|62878299|FG004|Overall Study|Physician Decision|1|||
33498934|NCT03323034|62878295|FG000|Overall Study|Withdrawal by Subject|1|||
33498935|NCT03323034|62878296|FG001|Overall Study|Withdrawal by Subject|1|||
33498936|NCT03323034|62878297|FG002|Overall Study|Withdrawal by Subject|0|||
33498937|NCT03323034|62878298|FG003|Overall Study|Withdrawal by Subject|1|||
33498938|NCT03323034|62878299|FG004|Overall Study|Withdrawal by Subject|0|||
33498939|NCT03270657|62878330|FG000|Overall Study|Withdrawal by Subject|1|||
33498940|NCT03303417|62878334|FG000|Overall Study|Withdrawal by Subject|1|||
33498941|NCT03303417|62878335|FG001|Overall Study|Withdrawal by Subject|1|||
33498942|NCT02943564|62878353|FG000|Overall Study|Miscellaneous Reasons|0|||
33498943|NCT02943564|62878354|FG001|Overall Study|Miscellaneous Reasons|0|||
33498944|NCT02943564|62878355|FG002|Overall Study|Miscellaneous Reasons|3|||
33498945|NCT02943564|62878353|FG000|Overall Study|Site terminated by sponsor|0|||
33498946|NCT02943564|62878354|FG001|Overall Study|Site terminated by sponsor|1|||
33498947|NCT02943564|62878355|FG002|Overall Study|Site terminated by sponsor|0|||
33498948|NCT02943564|62878353|FG000|Overall Study|Non-compliance with study drug|0|||
33498949|NCT02943564|62878354|FG001|Overall Study|Non-compliance with study drug|1|||
33498950|NCT02943564|62878355|FG002|Overall Study|Non-compliance with study drug|0|||
33498951|NCT02943564|62878353|FG000|Overall Study|Pregnancy|0|||
33498952|NCT02943564|62878354|FG001|Overall Study|Pregnancy|1|||
33498953|NCT02943564|62878355|FG002|Overall Study|Pregnancy|1|||
33498954|NCT02943564|62878353|FG000|Overall Study|Protocol Violation|2|||
33498955|NCT02943564|62878354|FG001|Overall Study|Protocol Violation|2|||
33498956|NCT02943564|62878355|FG002|Overall Study|Protocol Violation|2|||
33498957|NCT02943564|62878353|FG000|Overall Study|Lost to Follow-up|1|||
33498958|NCT02943564|62878354|FG001|Overall Study|Lost to Follow-up|0|||
33498959|NCT02943564|62878355|FG002|Overall Study|Lost to Follow-up|0|||
33498960|NCT02943564|62878353|FG000|Overall Study|Withdrawal by Subject|6|||
33498961|NCT02943564|62878354|FG001|Overall Study|Withdrawal by Subject|5|||
33498962|NCT02943564|62878355|FG002|Overall Study|Withdrawal by Subject|2|||
33498963|NCT02943564|62878353|FG000|Overall Study|Adverse Event|1|||
33498964|NCT02943564|62878354|FG001|Overall Study|Adverse Event|2|||
33498965|NCT02943564|62878355|FG002|Overall Study|Adverse Event|1|||
33498966|NCT02943564|62878353|FG000|Overall Study|Lack of Efficacy|0|||
33498967|NCT02943564|62878354|FG001|Overall Study|Lack of Efficacy|1|||
33498968|NCT02943564|62878355|FG002|Overall Study|Lack of Efficacy|0|||
33498969|NCT03268941|62878367|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
33498970|NCT03268941|62878368|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
33498971|NCT03268941|62878369|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
33498972|NCT03268941|62878370|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
33498973|NCT03268941|62878371|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
33498974|NCT03268941|62878372|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
33498975|NCT03268941|62878373|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
33498976|NCT03268941|62878367|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
33498977|NCT03268941|62878368|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
33498978|NCT03268941|62878369|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
33498979|NCT03268941|62878370|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
33498980|NCT03268941|62878371|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
33498981|NCT03268941|62878372|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
33498982|NCT03268941|62878373|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
33498983|NCT03268941|62878367|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
33498984|NCT03268941|62878368|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
33498985|NCT03268941|62878369|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
33498986|NCT03268941|62878370|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
33498987|NCT03268941|62878371|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
33498988|NCT03268941|62878372|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
33498989|NCT03268941|62878373|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
33608998|NCT02243293|63009052|FG010|Overall Study|Adverse Event|0|||
33608999|NCT02243293|63009053|FG011|Overall Study|Adverse Event|0|||
33498990|NCT03268941|62878367|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
33498991|NCT03268941|62878368|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
33498992|NCT03268941|62878369|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
33498993|NCT03268941|62878370|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
33498994|NCT03268941|62878371|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
33609000|NCT02243293|63009054|FG012|Overall Study|Adverse Event|0|||
33498995|NCT03268941|62878372|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
33498996|NCT03268941|62878373|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
33498997|NCT03268941|62878367|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
33498998|NCT03268941|62878368|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
33498999|NCT03268941|62878369|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
33499000|NCT03268941|62878370|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
33499001|NCT03268941|62878371|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
33499002|NCT03268941|62878372|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
33499003|NCT03268941|62878373|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
33499004|NCT03245619|62878450|FG000|Part A (Up to Day 22)|Physician Decision|4|||
33499005|NCT03245619|62878451|FG001|Part A (Up to Day 22)|Physician Decision|6|||
33499006|NCT03245619|62878452|FG002|Part A (Up to Day 22)|Physician Decision|6|||
33499007|NCT03245619|62878453|FG003|Part A (Up to Day 22)|Physician Decision|0|||
33499008|NCT03245619|62878454|FG004|Part A (Up to Day 22)|Physician Decision|0|||
33499009|NCT03245619|62878455|FG005|Part A (Up to Day 22)|Physician Decision|0|||
33499010|NCT03245619|62878456|FG006|Part A (Up to Day 22)|Physician Decision|0|||
33499011|NCT03245619|62878457|FG007|Part A (Up to Day 22)|Physician Decision|0|||
33499012|NCT03245619|62878458|FG008|Part A (Up to Day 22)|Physician Decision|0|||
33499013|NCT03245619|62878459|FG009|Part A (Up to Day 22)|Physician Decision|0|||
33499014|NCT03245619|62878460|FG010|Part A (Up to Day 22)|Physician Decision|0|||
33499015|NCT03245619|62878461|FG011|Part A (Up to Day 22)|Physician Decision|0|||
33499016|NCT03245619|62878462|FG012|Part A (Up to Day 22)|Physician Decision|0|||
33499017|NCT03245619|62878463|FG013|Part A (Up to Day 22)|Physician Decision|0|||
33499018|NCT03245619|62878464|FG014|Part A (Up to Day 22)|Physician Decision|0|||
33499019|NCT03245619|62878465|FG015|Part A (Up to Day 22)|Physician Decision|0|||
33499020|NCT03245619|62878466|FG016|Part A (Up to Day 22)|Physician Decision|0|||
33499021|NCT04472650|62878527|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
33499022|NCT04472650|62878528|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
33499023|NCT02606461|62878540|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
33499024|NCT02606461|62878541|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
33499025|NCT02606461|62878542|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
33499026|NCT02606461|62878543|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
33499027|NCT02606461|62878544|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
33499028|NCT02606461|62878545|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
33499029|NCT03321396|62878560|FG000|Overall Study|Physician Decision|1|||
33499030|NCT03244917|62878566|FG000|Overall Study|Lost to Follow-up|2|||
33499031|NCT03244917|62878567|FG001|Overall Study|Lost to Follow-up|2|||
33499032|NCT03321006|62878575|FG000|Overall Study|Death|1|||
33499033|NCT03321006|62878576|FG001|Overall Study|Death|0|||
33499034|NCT03321006|62878575|FG000|Overall Study|Lack of Efficacy|1|||
33499035|NCT03321006|62878576|FG001|Overall Study|Lack of Efficacy|0|||
33499036|NCT02593123|62878593|FG000|Overall Study|Physician Decision|2|||
33499037|NCT02593123|62878594|FG001|Overall Study|Physician Decision|1|||
33499038|NCT02593123|62878593|FG000|Overall Study|Relapse|1|||
33499039|NCT02593123|62878594|FG001|Overall Study|Relapse|1|||
33499040|NCT03302559|62878602|FG000|Overall Study|Adverse Event|2|||
33499041|NCT03302559|62878602|FG000|Overall Study|Lost to Follow-up|1|||
33499042|NCT03302559|62878602|FG000|Overall Study|Withdrew Consent|3|||
33609001|NCT02243293|63009055|FG013|Overall Study|Adverse Event|0|||
33609002|NCT02243293|63009056|FG014|Overall Study|Adverse Event|0|||
33609003|NCT02243293|63009057|FG015|Overall Study|Adverse Event|1|||
33609004|NCT02243293|63009058|FG016|Overall Study|Adverse Event|0|||
33609005|NCT02243293|63009059|FG017|Overall Study|Adverse Event|0|||
33609006|NCT02243293|63009060|FG018|Overall Study|Adverse Event|0|||
33448363|NCT00274742|62823413|FG001|Overall Study|Disease Progression|1|||
33448364|NCT00274742|62823414|FG002|Overall Study|Disease Progression|1|||
33448365|NCT00274742|62823415|FG003|Overall Study|Disease Progression|0|||
33448366|NCT00274742|62823416|FG004|Overall Study|Disease Progression|1|||
33448367|NCT00274742|62823417|FG005|Overall Study|Disease Progression|0|||
33448368|NCT00274742|62823412|FG000|Overall Study|Other|0|||
33448369|NCT00274742|62823413|FG001|Overall Study|Other|3|||
33448370|NCT00274742|62823414|FG002|Overall Study|Other|0|||
33448371|NCT00274742|62823415|FG003|Overall Study|Other|0|||
33448372|NCT00274742|62823416|FG004|Overall Study|Other|2|||
33448373|NCT00274742|62823417|FG005|Overall Study|Other|0|||
33448374|NCT00262314|62823437|FG000|Overall Study|Changing physicians|38|||
33448375|NCT00262314|62823437|FG000|Overall Study|Death|12|||
33448376|NCT00262314|62823437|FG000|Overall Study|Patient's decision|92|||
33448377|NCT00262314|62823437|FG000|Overall Study|Other|95|||
33448378|NCT00262314|62823437|FG000|Overall Study|Lost to Follow-up|70|||
33448379|NCT00262314|62823437|FG000|Overall Study|Administrative withdrawal|30|||
33448380|NCT00283400|62823445|FG000|Overall Study|Withdrawal by Subject|1|||
33448381|NCT00283400|62823446|FG001|Overall Study|Withdrawal by Subject|1|||
33448382|NCT00283400|62823447|FG002|Overall Study|Withdrawal by Subject|0|||
33448383|NCT00283400|62823448|FG003|Overall Study|Withdrawal by Subject|0|||
33448384|NCT00283400|62823445|FG000|Overall Study|Death|1|||
33499043|NCT03302247|62878606|FG000|Overall Study|the study has closed prematurely|2|||
33499044|NCT03302247|62878606|FG000|Overall Study|Death|1|||
33499045|NCT04993339|62878612|FG000|Overall Study|Lost to Follow-up|0|||
33499046|NCT04993339|62878613|FG001|Overall Study|Lost to Follow-up|1|||
33499047|NCT04993339|62878612|FG000|Overall Study|no MRI scan|3|||
33499048|NCT04993339|62878613|FG001|Overall Study|no MRI scan|1|||
33499049|NCT04974697|62878621|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
33499050|NCT04974697|62878621|FG000|Overall Study|Lens discomfort|1|||
33499051|NCT03265119|62878629|FG000|Overall Study|Adverse Event|2|||
33499052|NCT03265119|62878630|FG001|Overall Study|Adverse Event|1|||
33499053|NCT03265119|62878629|FG000|Overall Study|Lack of Efficacy|3|||
33499054|NCT03265119|62878630|FG001|Overall Study|Lack of Efficacy|0|||
33499055|NCT03265119|62878629|FG000|Overall Study|Protocol Violation|1|||
33499056|NCT03265119|62878630|FG001|Overall Study|Protocol Violation|2|||
33499057|NCT03265119|62878629|FG000|Overall Study|Withdrawal by Subject|2|||
33499058|NCT03265119|62878630|FG001|Overall Study|Withdrawal by Subject|4|||
33499059|NCT03265119|62878629|FG000|Overall Study|Lost to Follow-up|1|||
33499060|NCT03265119|62878630|FG001|Overall Study|Lost to Follow-up|0|||
33499061|NCT03265119|62878629|FG000|Overall Study|Lack of Compliance|1|||
33609007|NCT02243293|63009061|FG019|Overall Study|Adverse Event|0|||
33609008|NCT02243293|63009062|FG020|Overall Study|Adverse Event|1|||
33609009|NCT02243293|63009063|FG021|Overall Study|Adverse Event|0|||
33609010|NCT02243293|63009042|FG000|Overall Study|Withdrawal by Subject|1|||
33609011|NCT02243293|63009043|FG001|Overall Study|Withdrawal by Subject|0|||
33609012|NCT02243293|63009044|FG002|Overall Study|Withdrawal by Subject|0|||
33609013|NCT02243293|63009045|FG003|Overall Study|Withdrawal by Subject|0|||
33609014|NCT02243293|63009046|FG004|Overall Study|Withdrawal by Subject|0|||
33609015|NCT02243293|63009047|FG005|Overall Study|Withdrawal by Subject|0|||
33609016|NCT02243293|63009048|FG006|Overall Study|Withdrawal by Subject|0|||
33609017|NCT02243293|63009049|FG007|Overall Study|Withdrawal by Subject|0|||
33609018|NCT02243293|63009050|FG008|Overall Study|Withdrawal by Subject|0|||
33448385|NCT00283400|62823446|FG001|Overall Study|Death|0|||
33448386|NCT00283400|62823447|FG002|Overall Study|Death|1|||
33448387|NCT00283400|62823448|FG003|Overall Study|Death|0|||
33448388|NCT00444275|62823461|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
33448389|NCT00444275|62823462|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
33448390|NCT00444275|62823463|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
33448391|NCT00444275|62823464|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
33448392|NCT00444275|62823465|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
33448393|NCT00444275|62823461|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
33448394|NCT00444275|62823462|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
33448395|NCT00444275|62823463|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
33448396|NCT00444275|62823464|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
33448397|NCT00444275|62823465|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
33448398|NCT00444275|62823461|FG000|Maintenance Treatment Phase|Adverse Event|0|||
33448399|NCT00444275|62823462|FG001|Maintenance Treatment Phase|Adverse Event|0|||
33448400|NCT00444275|62823463|FG002|Maintenance Treatment Phase|Adverse Event|3|||
33448401|NCT00444275|62823464|FG003|Maintenance Treatment Phase|Adverse Event|2|||
33448402|NCT00444275|62823465|FG004|Maintenance Treatment Phase|Adverse Event|13|||
33448403|NCT00444275|62823461|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
33448404|NCT00444275|62823462|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
33448405|NCT00444275|62823463|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
33448406|NCT00444275|62823464|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
33448407|NCT00444275|62823465|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
33448408|NCT00444275|62823461|FG000|Maintenance Treatment Phase|Patient's wish|0|||
33448409|NCT00444275|62823462|FG001|Maintenance Treatment Phase|Patient's wish|0|||
33448410|NCT00444275|62823463|FG002|Maintenance Treatment Phase|Patient's wish|19|||
33448411|NCT00444275|62823464|FG003|Maintenance Treatment Phase|Patient's wish|9|||
33448412|NCT00444275|62823465|FG004|Maintenance Treatment Phase|Patient's wish|20|||
33448413|NCT00444275|62823461|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
33448414|NCT00444275|62823462|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
33448415|NCT00444275|62823463|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
33448416|NCT00444275|62823464|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
33448417|NCT00444275|62823465|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
33448418|NCT00444275|62823461|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
33448419|NCT00444275|62823462|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
33448420|NCT00444275|62823463|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
33448421|NCT00444275|62823464|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
33448422|NCT00444275|62823465|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
33448423|NCT00454805|62823482|FG000|Overall Study|Withdrawal by Subject|9|||
33499062|NCT03265119|62878630|FG001|Overall Study|Lack of Compliance|0|||
33499063|NCT04952701|62878636|FG000|Control Lens|Physician Decision|4|||
33499064|NCT04952701|62878636|FG000|Test Lens|Physician Decision|1|||
33499065|NCT04723173|62878642|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
33499066|NCT04919317|62878656|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
33499067|NCT04919317|62878657|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
33499068|NCT04919317|62878656|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
33499069|NCT04919317|62878657|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
33499070|NCT04919161|62878665|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
33499071|NCT04919161|62878666|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
33499072|NCT04919161|62878665|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
33609019|NCT02243293|63009051|FG009|Overall Study|Withdrawal by Subject|1|||
33609020|NCT02243293|63009052|FG010|Overall Study|Withdrawal by Subject|0|||
33499073|NCT04919161|62878666|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
33499074|NCT04919161|62878665|FG000|Overall Study|Acute ankle sprain after session 1|0|||
33499075|NCT04919161|62878666|FG001|Overall Study|Acute ankle sprain after session 1|1|||
33499076|NCT03262389|62878694|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
33499077|NCT03262389|62878694|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
33499078|NCT03262389|62878694|FG000|Overall Study|opted out of PET/MR|1|||
33499079|NCT03262233|62878702|FG000|Overall Study|Withdrawal by Subject|12|||
33499080|NCT03262233|62878703|FG001|Overall Study|Withdrawal by Subject|8|||
33499081|NCT03262233|62878704|FG002|Overall Study|Withdrawal by Subject|21|||
33499082|NCT03262233|62878705|FG003|Overall Study|Withdrawal by Subject|13|||
33324009|NCT00970593|62700396|FG002|Overall Study|Withdrawal by Subject|1|||
33324010|NCT00970593|62700397|FG003|Overall Study|Withdrawal by Subject|0|||
33324011|NCT00970593|62700398|FG004|Overall Study|Withdrawal by Subject|0|||
33324012|NCT00970593|62700399|FG005|Overall Study|Withdrawal by Subject|0|||
33324013|NCT00970593|62700400|FG006|Overall Study|Withdrawal by Subject|0|||
33324014|NCT00962013|62700420|FG000|Overall Study|Did not have surgery|1|||
33324015|NCT00962013|62700420|FG000|Overall Study|Death|8|||
33324016|NCT00962013|62700420|FG000|Overall Study|Lost to Follow-up|12|||
33324017|NCT00962013|62700420|FG000|Overall Study|Unable/Unwilling to return|6|||
33324018|NCT00962013|62700420|FG000|Overall Study|Withdrawal by Subject|8|||
33324019|NCT00962013|62700420|FG000|Overall Study|Removal of study device|3|||
33448424|NCT00454805|62823483|FG001|Overall Study|Withdrawal by Subject|2|||
33448425|NCT00454805|62823482|FG000|Overall Study|Death|0|||
33448426|NCT00454805|62823483|FG001|Overall Study|Death|2|||
33499083|NCT03262233|62878702|FG000|Overall Study|Declined due to shock|1|||
33499084|NCT03262233|62878703|FG001|Overall Study|Declined due to shock|2|||
33499085|NCT03262233|62878704|FG002|Overall Study|Declined due to shock|2|||
33499086|NCT03262233|62878705|FG003|Overall Study|Declined due to shock|3|||
33499087|NCT03262233|62878702|FG000|Overall Study|Protocol Violation|5|||
33499088|NCT03262233|62878703|FG001|Overall Study|Protocol Violation|10|||
33499089|NCT03262233|62878704|FG002|Overall Study|Protocol Violation|2|||
33499090|NCT03262233|62878705|FG003|Overall Study|Protocol Violation|13|||
33499091|NCT03262233|62878702|FG000|Overall Study|data collection artifact|0|||
33499092|NCT03262233|62878703|FG001|Overall Study|data collection artifact|1|||
33499093|NCT03262233|62878704|FG002|Overall Study|data collection artifact|0|||
33499094|NCT03262233|62878705|FG003|Overall Study|data collection artifact|0|||
33499095|NCT03261531|62878716|FG000|Overall Study|Withdrawal by Subject|4|||
33499096|NCT04151290|62878720|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
33499097|NCT03260205|62878739|FG000|Overall Study|Adverse Event|2|||
33499098|NCT03260205|62878740|FG001|Overall Study|Adverse Event|0|||
33499099|NCT03260205|62878741|FG002|Overall Study|Adverse Event|2|||
33499100|NCT03260205|62878742|FG003|Overall Study|Adverse Event|2|||
33499101|NCT03260205|62878743|FG004|Overall Study|Adverse Event|4|||
33499102|NCT03260205|62878739|FG000|Overall Study|Lost to Follow-up|2|||
33499103|NCT03260205|62878740|FG001|Overall Study|Lost to Follow-up|2|||
33499104|NCT03260205|62878741|FG002|Overall Study|Lost to Follow-up|1|||
33499105|NCT03260205|62878742|FG003|Overall Study|Lost to Follow-up|1|||
33499106|NCT03260205|62878743|FG004|Overall Study|Lost to Follow-up|5|||
33448427|NCT00454805|62823482|FG000|Overall Study|Disease progression|16|||
33448428|NCT00454805|62823483|FG001|Overall Study|Disease progression|19|||
33448429|NCT00454805|62823482|FG000|Overall Study|In order to begin radiotherapy|1|||
33448430|NCT00454805|62823483|FG001|Overall Study|In order to begin radiotherapy|0|||
33448431|NCT00283244|62823492|FG000|Overall Study|Adverse Event|0|||
33448432|NCT00283244|62823493|FG001|Overall Study|Adverse Event|8|||
33448433|NCT00283244|62823494|FG002|Overall Study|Adverse Event|11|||
33448434|NCT00283244|62823492|FG000|Overall Study|Death|4|||
33448435|NCT00283244|62823493|FG001|Overall Study|Death|3|||
33448436|NCT00283244|62823494|FG002|Overall Study|Death|2|||
33448437|NCT00283244|62823492|FG000|Overall Study|Lack of Efficacy|8|||
33324020|NCT00962013|62700420|FG000|Overall Study|Site Termination|24|||
33324021|NCT00962013|62700420|FG000|Overall Study|No 5 year evaluation|6|||
33324022|NCT00970359|62700424|FG000|Overall Study|Not Treated|4|||
33448438|NCT00283244|62823493|FG001|Overall Study|Lack of Efficacy|32|||
33448439|NCT00283244|62823494|FG002|Overall Study|Lack of Efficacy|26|||
33448440|NCT00283244|62823492|FG000|Overall Study|Withdrawal by Subject|1|||
33499107|NCT03260205|62878739|FG000|Overall Study|Protocol Violation|0|||
33499108|NCT03260205|62878740|FG001|Overall Study|Protocol Violation|0|||
33499109|NCT03260205|62878741|FG002|Overall Study|Protocol Violation|2|||
33499110|NCT03260205|62878742|FG003|Overall Study|Protocol Violation|0|||
33499111|NCT03260205|62878743|FG004|Overall Study|Protocol Violation|1|||
33499112|NCT03260205|62878739|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
33499113|NCT03260205|62878740|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
33499114|NCT03260205|62878741|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
33499115|NCT03260205|62878742|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
33499116|NCT03260205|62878743|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
33499117|NCT03260205|62878739|FG000|Overall Study|Other: Unspecified|0|||
33499118|NCT03260205|62878740|FG001|Overall Study|Other: Unspecified|0|||
33499119|NCT03260205|62878741|FG002|Overall Study|Other: Unspecified|3|||
33499120|NCT03260205|62878742|FG003|Overall Study|Other: Unspecified|1|||
33499121|NCT03260205|62878743|FG004|Overall Study|Other: Unspecified|1|||
33499122|NCT03260205|62878739|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
33499123|NCT03260205|62878740|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
33499124|NCT03260205|62878741|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
33499125|NCT03260205|62878742|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
33499126|NCT03260205|62878743|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
33499127|NCT04666441|62878768|FG000|Overall Study|Lost to Follow-up|1|||
33499128|NCT04666441|62878769|FG001|Overall Study|Lost to Follow-up|4|||
33499129|NCT04666441|62878770|FG002|Overall Study|Lost to Follow-up|1|||
33499130|NCT04666441|62878771|FG003|Overall Study|Lost to Follow-up|3|||
33499131|NCT04666441|62878772|FG004|Overall Study|Lost to Follow-up|0|||
33499132|NCT04666441|62878773|FG005|Overall Study|Lost to Follow-up|2|||
33499133|NCT04666441|62878774|FG006|Overall Study|Lost to Follow-up|2|||
33499134|NCT04666441|62878775|FG007|Overall Study|Lost to Follow-up|2|||
33499135|NCT04666441|62878768|FG000|Overall Study|Subject Decision|1|||
33499136|NCT04666441|62878769|FG001|Overall Study|Subject Decision|1|||
33499137|NCT04666441|62878770|FG002|Overall Study|Subject Decision|3|||
33499138|NCT04666441|62878771|FG003|Overall Study|Subject Decision|1|||
33499139|NCT04666441|62878772|FG004|Overall Study|Subject Decision|0|||
33499140|NCT04666441|62878773|FG005|Overall Study|Subject Decision|1|||
33499141|NCT04666441|62878774|FG006|Overall Study|Subject Decision|3|||
33499142|NCT04666441|62878775|FG007|Overall Study|Subject Decision|2|||
33499143|NCT03320850|62878812|FG000|Overall Study|Lost to Follow-up|0|||
33499144|NCT03320850|62878813|FG001|Overall Study|Lost to Follow-up|0|||
33499145|NCT03320850|62878814|FG002|Overall Study|Lost to Follow-up|0|||
33609021|NCT02243293|63009053|FG011|Overall Study|Withdrawal by Subject|1|||
33609022|NCT02243293|63009054|FG012|Overall Study|Withdrawal by Subject|0|||
33499146|NCT03320850|62878815|FG003|Overall Study|Lost to Follow-up|0|||
33499147|NCT03320850|62878816|FG004|Overall Study|Lost to Follow-up|1|||
33499148|NCT03320850|62878817|FG005|Overall Study|Lost to Follow-up|2|||
33499149|NCT03320850|62878818|FG006|Overall Study|Lost to Follow-up|2|||
33499150|NCT03320850|62878819|FG007|Overall Study|Lost to Follow-up|0|||
33499151|NCT03320850|62878820|FG008|Overall Study|Lost to Follow-up|6|||
33499152|NCT03320850|62878821|FG009|Overall Study|Lost to Follow-up|4|||
33499153|NCT03320850|62878812|FG000|Overall Study|Withdrawal by Subject|0|||
33499154|NCT03320850|62878813|FG001|Overall Study|Withdrawal by Subject|0|||
33499155|NCT03320850|62878814|FG002|Overall Study|Withdrawal by Subject|0|||
33499156|NCT03320850|62878815|FG003|Overall Study|Withdrawal by Subject|0|||
33499157|NCT03320850|62878816|FG004|Overall Study|Withdrawal by Subject|1|||
33499158|NCT03320850|62878817|FG005|Overall Study|Withdrawal by Subject|2|||
33609023|NCT02243293|63009055|FG013|Overall Study|Withdrawal by Subject|0|||
33499159|NCT03320850|62878818|FG006|Overall Study|Withdrawal by Subject|4|||
33499160|NCT03320850|62878819|FG007|Overall Study|Withdrawal by Subject|5|||
33609024|NCT02243293|63009056|FG014|Overall Study|Withdrawal by Subject|0|||
33609025|NCT02243293|63009057|FG015|Overall Study|Withdrawal by Subject|0|||
33609026|NCT02243293|63009058|FG016|Overall Study|Withdrawal by Subject|0|||
33609027|NCT02243293|63009059|FG017|Overall Study|Withdrawal by Subject|0|||
33609028|NCT02243293|63009060|FG018|Overall Study|Withdrawal by Subject|0|||
33609029|NCT02243293|63009061|FG019|Overall Study|Withdrawal by Subject|0|||
33499161|NCT03320850|62878820|FG008|Overall Study|Withdrawal by Subject|2|||
33499162|NCT03320850|62878821|FG009|Overall Study|Withdrawal by Subject|1|||
33499163|NCT03320850|62878812|FG000|Overall Study|Lack of Efficacy|0|||
33499164|NCT03320850|62878813|FG001|Overall Study|Lack of Efficacy|0|||
33499165|NCT03320850|62878814|FG002|Overall Study|Lack of Efficacy|0|||
33609030|NCT02243293|63009062|FG020|Overall Study|Withdrawal by Subject|0|||
33609031|NCT02243293|63009063|FG021|Overall Study|Withdrawal by Subject|1|||
33499166|NCT03320850|62878815|FG003|Overall Study|Lack of Efficacy|1|||
33499167|NCT03320850|62878816|FG004|Overall Study|Lack of Efficacy|0|||
33499168|NCT03320850|62878817|FG005|Overall Study|Lack of Efficacy|1|||
33499169|NCT03320850|62878818|FG006|Overall Study|Lack of Efficacy|0|||
33499170|NCT03320850|62878819|FG007|Overall Study|Lack of Efficacy|2|||
33499171|NCT03320850|62878820|FG008|Overall Study|Lack of Efficacy|0|||
33499172|NCT03320850|62878821|FG009|Overall Study|Lack of Efficacy|3|||
33499173|NCT03320850|62878812|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
33499174|NCT03320850|62878813|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
33499175|NCT03320850|62878814|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
33499176|NCT03320850|62878815|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
33499177|NCT03320850|62878816|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
33499178|NCT03320850|62878817|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
33499179|NCT03320850|62878818|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
33609032|NCT02243293|63009042|FG000|Overall Study|Lost to Follow-up|0|||
33609033|NCT02243293|63009043|FG001|Overall Study|Lost to Follow-up|1|||
33609034|NCT02243293|63009044|FG002|Overall Study|Lost to Follow-up|1|||
33609035|NCT02243293|63009045|FG003|Overall Study|Lost to Follow-up|1|||
33609036|NCT02243293|63009046|FG004|Overall Study|Lost to Follow-up|0|||
33609037|NCT02243293|63009047|FG005|Overall Study|Lost to Follow-up|0|||
33609038|NCT02243293|63009048|FG006|Overall Study|Lost to Follow-up|3|||
33609039|NCT02243293|63009049|FG007|Overall Study|Lost to Follow-up|0|||
33609040|NCT02243293|63009050|FG008|Overall Study|Lost to Follow-up|0|||
33609041|NCT02243293|63009051|FG009|Overall Study|Lost to Follow-up|0|||
33609042|NCT02243293|63009052|FG010|Overall Study|Lost to Follow-up|0|||
33609043|NCT02243293|63009053|FG011|Overall Study|Lost to Follow-up|2|||
33609044|NCT02243293|63009054|FG012|Overall Study|Lost to Follow-up|0|||
33609045|NCT02243293|63009055|FG013|Overall Study|Lost to Follow-up|0|||
33499180|NCT03320850|62878819|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
33499181|NCT03320850|62878820|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
33499182|NCT03320850|62878821|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
33499183|NCT03320850|62878812|FG000|Overall Study|Adverse Event|0|||
33324023|NCT01121406|62700430|FG000|Overall Study|Progressive disease RECIST|44|||
33448441|NCT00283244|62823493|FG001|Overall Study|Withdrawal by Subject|2|||
33448442|NCT00283244|62823494|FG002|Overall Study|Withdrawal by Subject|2|||
33448443|NCT00283244|62823492|FG000|Overall Study|Physician Decision|0|||
33448444|NCT00283244|62823493|FG001|Overall Study|Physician Decision|0|||
33448445|NCT00283244|62823494|FG002|Overall Study|Physician Decision|1|||
33499184|NCT03320850|62878813|FG001|Overall Study|Adverse Event|0|||
33499185|NCT03320850|62878814|FG002|Overall Study|Adverse Event|0|||
33499186|NCT03320850|62878815|FG003|Overall Study|Adverse Event|0|||
33499187|NCT03320850|62878816|FG004|Overall Study|Adverse Event|0|||
33499188|NCT03320850|62878817|FG005|Overall Study|Adverse Event|2|||
33499189|NCT03320850|62878818|FG006|Overall Study|Adverse Event|1|||
33499190|NCT03320850|62878819|FG007|Overall Study|Adverse Event|0|||
33499191|NCT03320850|62878820|FG008|Overall Study|Adverse Event|2|||
33499192|NCT03320850|62878821|FG009|Overall Study|Adverse Event|0|||
33499193|NCT03320850|62878812|FG000|Overall Study|Reason Not Specified|0|||
33499194|NCT03320850|62878813|FG001|Overall Study|Reason Not Specified|0|||
33499195|NCT03320850|62878814|FG002|Overall Study|Reason Not Specified|0|||
33499196|NCT03320850|62878815|FG003|Overall Study|Reason Not Specified|0|||
33499197|NCT03320850|62878816|FG004|Overall Study|Reason Not Specified|0|||
33499198|NCT03320850|62878817|FG005|Overall Study|Reason Not Specified|1|||
33499199|NCT03320850|62878818|FG006|Overall Study|Reason Not Specified|0|||
33499200|NCT03320850|62878819|FG007|Overall Study|Reason Not Specified|0|||
33499201|NCT03320850|62878820|FG008|Overall Study|Reason Not Specified|0|||
33609046|NCT02243293|63009056|FG014|Overall Study|Lost to Follow-up|0|||
33448446|NCT00283244|62823492|FG000|Overall Study|Medical illness (other complicating dz)|4|||
33448447|NCT00283244|62823493|FG001|Overall Study|Medical illness (other complicating dz)|3|||
33448448|NCT00283244|62823494|FG002|Overall Study|Medical illness (other complicating dz)|6|||
33448449|NCT00283244|62823492|FG000|Overall Study|Clinical deterioration|1|||
33448450|NCT00283244|62823493|FG001|Overall Study|Clinical deterioration|3|||
33448451|NCT00283244|62823494|FG002|Overall Study|Clinical deterioration|3|||
33448452|NCT00282464|62823505|FG000|Overall Study|Adverse Event|26|||
33448453|NCT00282464|62823506|FG001|Overall Study|Adverse Event|20|||
33448454|NCT00282464|62823505|FG000|Overall Study|Lack of Efficacy|8|||
33448455|NCT00282464|62823506|FG001|Overall Study|Lack of Efficacy|8|||
33448456|NCT00282464|62823505|FG000|Overall Study|Lost to Follow-up|10|||
33448457|NCT00282464|62823506|FG001|Overall Study|Lost to Follow-up|10|||
33448458|NCT00282464|62823505|FG000|Overall Study|Withdrawal by Subject|24|||
33448459|NCT00282464|62823506|FG001|Overall Study|Withdrawal by Subject|10|||
33448460|NCT00282464|62823505|FG000|Overall Study|laboratory abnormality|1|||
33448461|NCT00282464|62823506|FG001|Overall Study|laboratory abnormality|2|||
33448462|NCT00282464|62823505|FG000|Overall Study|Protocol Violation|0|||
33448463|NCT00282464|62823506|FG001|Overall Study|Protocol Violation|7|||
33448464|NCT00282464|62823505|FG000|Overall Study|Patient moved|1|||
33448465|NCT00282464|62823506|FG001|Overall Study|Patient moved|0|||
33499202|NCT03320850|62878821|FG009|Overall Study|Reason Not Specified|1|||
33609047|NCT02243293|63009057|FG015|Overall Study|Lost to Follow-up|0|||
33609048|NCT02243293|63009058|FG016|Overall Study|Lost to Follow-up|3|||
33448466|NCT00282464|62823505|FG000|Overall Study|patient non-compliant|3|||
33448467|NCT00282464|62823506|FG001|Overall Study|patient non-compliant|0|||
33448468|NCT00282464|62823505|FG000|Overall Study|patient no show|0|||
33448469|NCT00282464|62823506|FG001|Overall Study|patient no show|1|||
33499203|NCT03301623|62878850|FG000|Overall Study|Death|3|||
33499204|NCT03301623|62878851|FG001|Overall Study|Death|1|||
33499205|NCT03301623|62878850|FG000|Overall Study|Withdrawal by Subject|11|||
33609049|NCT02243293|63009059|FG017|Overall Study|Lost to Follow-up|1|||
33609050|NCT02243293|63009060|FG018|Overall Study|Lost to Follow-up|0|||
33609051|NCT02243293|63009061|FG019|Overall Study|Lost to Follow-up|0|||
33448470|NCT00282464|62823505|FG000|Overall Study|patient incarcerated|0|||
33448471|NCT00282464|62823506|FG001|Overall Study|patient incarcerated|1|||
33499206|NCT03301623|62878851|FG001|Overall Study|Withdrawal by Subject|13|||
33499207|NCT03301623|62878850|FG000|Overall Study|Lost to Follow-up|3|||
33499208|NCT03301623|62878851|FG001|Overall Study|Lost to Follow-up|1|||
33609052|NCT02243293|63009062|FG020|Overall Study|Lost to Follow-up|1|||
33609053|NCT02243293|63009063|FG021|Overall Study|Lost to Follow-up|2|||
33609054|NCT02243293|63009042|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
33609055|NCT02243293|63009043|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
33609056|NCT02243293|63009044|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
33609057|NCT02243293|63009045|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
33609058|NCT02243293|63009046|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
33609059|NCT02243293|63009047|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
33609060|NCT02243293|63009048|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
33609061|NCT02243293|63009049|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
33609062|NCT02243293|63009050|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
33609063|NCT02243293|63009051|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
33609064|NCT02243293|63009052|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
33609065|NCT02243293|63009053|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
33609066|NCT02243293|63009054|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
33609067|NCT02243293|63009055|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
33609068|NCT02243293|63009056|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
33609069|NCT02243293|63009057|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
33609070|NCT02243293|63009058|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
33609071|NCT02243293|63009059|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
33499209|NCT03319212|62878859|FG000|Overall Study|Discontinued as moving out of local area|0|||
33499210|NCT03319212|62878860|FG001|Overall Study|Discontinued as moving out of local area|1|||
33499211|NCT03319212|62878859|FG000|Overall Study|Adverse Event|2|||
33499212|NCT03319212|62878860|FG001|Overall Study|Adverse Event|2|||
33609072|NCT02243293|63009060|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
33609073|NCT02243293|63009061|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
33609074|NCT02243293|63009062|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
33448472|NCT00282464|62823505|FG000|Overall Study|family crisis|0|||
33499213|NCT03319212|62878859|FG000|Overall Study|Withdrawal by Subject|0|||
33499214|NCT03319212|62878860|FG001|Overall Study|Withdrawal by Subject|1|||
33499215|NCT03319212|62878859|FG000|Overall Study|Lost to Follow-up|0|||
33499216|NCT03319212|62878860|FG001|Overall Study|Lost to Follow-up|1|||
33499217|NCT03319212|62878859|FG000|Overall Study|Physician Decision|1|||
33499218|NCT03319212|62878860|FG001|Overall Study|Physician Decision|0|||
33499219|NCT04656691|62878865|FG000|Overall Study|Adverse Event|1|||
33499220|NCT03301155|62878871|FG000|Overall Study|Сompliance with exclusion criteria|8|||
33499221|NCT03301155|62878872|FG001|Overall Study|Сompliance with exclusion criteria|7|||
33499222|NCT01952730|62878878|FG000|Overall Study|FDA shut down core lab used by study|1|||
33499223|NCT03316170|62878884|FG000|Overall Study|Death|1|||
33499224|NCT03316170|62878885|FG001|Overall Study|Death|0|||
33499225|NCT03316170|62878884|FG000|Overall Study|Lost to Follow-up|6|||
33499226|NCT03316170|62878885|FG001|Overall Study|Lost to Follow-up|7|||
33499227|NCT03257865|62878894|FG000|Overall Study|Adverse Event|4|||
33499228|NCT03257865|62878895|FG001|Overall Study|Adverse Event|8|||
33499229|NCT03257865|62878894|FG000|Overall Study|Lack of Efficacy|1|||
33499230|NCT03257865|62878895|FG001|Overall Study|Lack of Efficacy|2|||
33499231|NCT03257865|62878894|FG000|Overall Study|Non-compliance with Study Drug|0|||
33499232|NCT03257865|62878895|FG001|Overall Study|Non-compliance with Study Drug|2|||
33448473|NCT00282464|62823506|FG001|Overall Study|family crisis|1|||
33448474|NCT00282464|62823505|FG000|Overall Study|dispensed wrong kit|0|||
33448475|NCT00282464|62823506|FG001|Overall Study|dispensed wrong kit|1|||
33448476|NCT00282464|62823505|FG000|Overall Study|dropped due to missed visits|0|||
33448477|NCT00282464|62823506|FG001|Overall Study|dropped due to missed visits|1|||
33448478|NCT00273182|62823512|FG000|Overall Study|Death|450|||
33448479|NCT00273182|62823512|FG000|Overall Study|Lost to Follow-up|88|||
33448480|NCT00273182|62823512|FG000|Overall Study|Withdrawal by Subject|257|||
33499233|NCT03257865|62878894|FG000|Overall Study|Withdrawal by Subject|23|||
33499234|NCT03257865|62878895|FG001|Overall Study|Withdrawal by Subject|17|||
33499235|NCT03257865|62878894|FG000|Overall Study|Physician Decision|3|||
33499236|NCT03257865|62878895|FG001|Overall Study|Physician Decision|1|||
33499237|NCT03257865|62878894|FG000|Overall Study|Other|0|||
33609075|NCT02243293|63009063|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
33609076|NCT02243293|63009042|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
33609077|NCT02243293|63009043|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
33448481|NCT00273182|62823512|FG000|Overall Study|Device/System Explant|154|||
33448482|NCT00273182|62823512|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
33499238|NCT03257865|62878895|FG001|Overall Study|Other|1|||
33609078|NCT02243293|63009044|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
33609079|NCT02243293|63009045|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
33499239|NCT03257865|62878894|FG000|Overall Study|Lost to Follow-up|4|||
33499240|NCT03257865|62878895|FG001|Overall Study|Lost to Follow-up|4|||
33499241|NCT04617847|62878903|FG000|Overall Study|Withdrawal by Subject|1|||
33499242|NCT04617847|62878904|FG001|Overall Study|Withdrawal by Subject|0|||
33499243|NCT04617847|62878903|FG000|Overall Study|Adverse Event|0|||
33499244|NCT04617847|62878904|FG001|Overall Study|Adverse Event|2|||
33499245|NCT04617847|62878903|FG000|Overall Study|Death|0|||
33499246|NCT04617847|62878904|FG001|Overall Study|Death|1|||
33499247|NCT04617847|62878903|FG000|Overall Study|Termination of Study by Sponsor|2|||
33499248|NCT04617847|62878904|FG001|Overall Study|Termination of Study by Sponsor|21|||
33499249|NCT04615507|62878914|FG000|Period 1|Covid-19 exposure|2|||
33499250|NCT04615507|62878915|FG001|Period 1|Covid-19 exposure|1|||
33499251|NCT04615507|62878914|FG000|Period 2|Covid-19 exposure|0|||
33499252|NCT04615507|62878915|FG001|Period 2|Covid-19 exposure|1|||
33499253|NCT04615507|62878914|FG000|Period 2|Protocol Violation|1|||
33499254|NCT04615507|62878915|FG001|Period 2|Protocol Violation|0|||
33499255|NCT04615507|62878914|FG000|Period 2|Withdrawal by Subject|1|||
33499256|NCT04615507|62878915|FG001|Period 2|Withdrawal by Subject|0|||
33499257|NCT04615507|62878914|FG000|Period 2|Adverse Event|0|||
33499258|NCT04615507|62878915|FG001|Period 2|Adverse Event|1|||
33499259|NCT04615507|62878914|FG000|Period 3|Covid-19 exposure|0|||
33499260|NCT04615507|62878915|FG001|Period 3|Covid-19 exposure|1|||
33324024|NCT01121406|62700431|FG001|Overall Study|Progressive disease RECIST|28|||
33324025|NCT01121406|62700430|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
33324026|NCT01121406|62700431|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
33324027|NCT01121406|62700430|FG000|Overall Study|Other AE|3|||
33324028|NCT01121406|62700431|FG001|Overall Study|Other AE|10|||
33324029|NCT01121406|62700430|FG000|Overall Study|Non-compliant with protocol|0|||
33324030|NCT01121406|62700431|FG001|Overall Study|Non-compliant with protocol|2|||
33448483|NCT00209274|62823519|FG000|Overall Study|Missed visit|3|||
33448484|NCT00209274|62823520|FG001|Overall Study|Missed visit|2|||
33499261|NCT04120233|62878927|FG000|Overall Study|Adverse Event|0|||
33499262|NCT04120233|62878928|FG001|Overall Study|Adverse Event|0|||
33499263|NCT04120233|62878929|FG002|Overall Study|Adverse Event|0|||
33499264|NCT04120233|62878930|FG003|Overall Study|Adverse Event|0|||
33499265|NCT04120233|62878931|FG004|Overall Study|Adverse Event|1|||
33499266|NCT04120233|62878932|FG005|Overall Study|Adverse Event|0|||
33499267|NCT01610700|62878948|FG000|Overall Study|Adverse Event|3|||
33609080|NCT02243293|63009046|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
33609081|NCT02243293|63009047|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
33609082|NCT02243293|63009048|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
33609083|NCT02243293|63009049|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
33609084|NCT02243293|63009050|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
33448485|NCT00209274|62823519|FG000|Overall Study|Death|32|||
33448486|NCT00209274|62823520|FG001|Overall Study|Death|15|||
33448487|NCT00209274|62823519|FG000|Overall Study|Withdrawal by Subject|30|||
33448488|NCT00209274|62823520|FG001|Overall Study|Withdrawal by Subject|15|||
33448489|NCT00209274|62823519|FG000|Overall Study|Randomized not treated (RNT)|6|||
33448490|NCT00209274|62823520|FG001|Overall Study|Randomized not treated (RNT)|15|||
33448491|NCT03841331|62823528|FG000|Overall Study|Withdrawal by Subject|4|||
33448492|NCT03841331|62823529|FG001|Overall Study|Withdrawal by Subject|9|||
33448493|NCT03841331|62823528|FG000|Overall Study|Lost to Follow-up|5|||
33448494|NCT03841331|62823529|FG001|Overall Study|Lost to Follow-up|1|||
33448495|NCT00262080|62823538|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
33448496|NCT00262080|62823539|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
33448497|NCT00262080|62823540|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
33448498|NCT00262080|62823538|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
33448499|NCT00262080|62823539|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
33448500|NCT00262080|62823540|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
33499268|NCT01610700|62878949|FG001|Overall Study|Adverse Event|1|||
33448501|NCT00262080|62823538|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
33499269|NCT01610700|62878948|FG000|Overall Study|Withdrawal by Subject|0|||
33324031|NCT01121406|62700430|FG000|Overall Study|Lost to Follow-up|0|||
33448502|NCT00262080|62823539|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
33448503|NCT00262080|62823540|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
33499270|NCT01610700|62878949|FG001|Overall Study|Withdrawal by Subject|1|||
33499271|NCT01610700|62878948|FG000|Overall Study|subject took one dose of street cannabis|0|||
33499272|NCT01610700|62878949|FG001|Overall Study|subject took one dose of street cannabis|1|||
33499273|NCT03256851|62878958|FG000|Overall Study|Withdrawal by Subject|1|||
33499274|NCT03256851|62878959|FG001|Overall Study|Withdrawal by Subject|0|||
33499275|NCT04837807|62878965|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
33499276|NCT04837807|62878966|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
33499277|NCT03256695|62878972|FG000|Overall Study|Adverse Event|8|||
33499278|NCT03256695|62878972|FG000|Overall Study|Death|2|||
33499279|NCT03256695|62878972|FG000|Overall Study|Withdrawal by Subject|14|||
33499280|NCT03256695|62878972|FG000|Overall Study|Non-compliance with study drug|1|||
33499281|NCT03256695|62878972|FG000|Overall Study|Lost to Follow-up|3|||
33448504|NCT00262080|62823538|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
33448505|NCT00262080|62823539|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
33448506|NCT00262080|62823540|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
33448507|NCT00262080|62823538|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
33499282|NCT03256695|62878972|FG000|Overall Study|Lack of Efficacy|3|||
33499283|NCT03256695|62878972|FG000|Overall Study|Protocol Violation|5|||
33499284|NCT03256695|62878972|FG000|Overall Study|Other than specified|3|||
33448508|NCT00262080|62823539|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
33448509|NCT00262080|62823540|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
33448510|NCT00262080|62823538|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
33448511|NCT00262080|62823539|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
33499285|NCT03305016|62878976|FG000|Overall Study|Withdrawal by Subject|2|||
33499286|NCT03297021|62878983|FG000|Overall Study|Incomplete/illegible data sheet|4|||
33499287|NCT03297021|62878984|FG001|Overall Study|Incomplete/illegible data sheet|2|||
33499288|NCT03297021|62878985|FG002|Overall Study|Incomplete/illegible data sheet|3|||
33499289|NCT03297021|62878983|FG000|Overall Study|Missing Post-Op Data|1|||
33499290|NCT03297021|62878984|FG001|Overall Study|Missing Post-Op Data|2|||
33499291|NCT03297021|62878985|FG002|Overall Study|Missing Post-Op Data|1|||
33499292|NCT04820491|62878995|FG000|Overall Study|Withdrawal by Subject|1|||
33499293|NCT04820491|62878996|FG001|Overall Study|Withdrawal by Subject|0|||
33499294|NCT01988571|62879004|FG000|Overall Study|Death|3|||
33499295|NCT01988571|62879005|FG001|Overall Study|Death|1|||
33499296|NCT01988571|62879004|FG000|Overall Study|Physician Decision|2|||
33499297|NCT01988571|62879005|FG001|Overall Study|Physician Decision|1|||
33499298|NCT01988571|62879004|FG000|Overall Study|Lost to Follow-up|3|||
33499299|NCT01988571|62879005|FG001|Overall Study|Lost to Follow-up|0|||
33499300|NCT01988571|62879004|FG000|Overall Study|Withdrawal by Subject|31|||
33499301|NCT01988571|62879005|FG001|Overall Study|Withdrawal by Subject|33|||
33499302|NCT04794751|62879011|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
33499303|NCT04794751|62879012|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
33499304|NCT04794751|62879011|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
33499305|NCT04794751|62879012|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
33499306|NCT04794751|62879011|FG000|Period 1|Protocol Violation|0|||
33499307|NCT04794751|62879012|FG001|Period 1|Protocol Violation|2|||
33499308|NCT04794751|62879011|FG000|Period 1|Withdrawal by Subject|0|||
33499309|NCT04794751|62879012|FG001|Period 1|Withdrawal by Subject|1|||
33499310|NCT04794751|62879011|FG000|Period 2|Withdrawal by Subject|0|||
33499311|NCT04794751|62879012|FG001|Period 2|Withdrawal by Subject|1|||
33499312|NCT04794751|62879011|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
33499313|NCT04794751|62879012|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
33499314|NCT04794751|62879011|FG000|Period 2|Protocol Violation|1|||
33499315|NCT04794751|62879012|FG001|Period 2|Protocol Violation|0|||
33499316|NCT04578457|62879018|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
33448512|NCT00262080|62823540|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
33448513|NCT00282308|62823550|FG000|Treatment Period|Lost to Follow-up|1|||
33448514|NCT00282308|62823551|FG001|Treatment Period|Lost to Follow-up|0|||
33448515|NCT00282308|62823552|FG002|Treatment Period|Lost to Follow-up|0|||
33448516|NCT00282308|62823550|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
33448517|NCT00282308|62823551|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
33499317|NCT04578457|62879018|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
33448518|NCT00282308|62823552|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
33499318|NCT04578457|62879018|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
33499319|NCT04578457|62879018|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
33499320|NCT03334188|62879028|FG000|Overall Study|Withdrawal by Subject|0|||
33499321|NCT03334188|62879029|FG001|Overall Study|Withdrawal by Subject|1|||
33609085|NCT02243293|63009051|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
33499322|NCT03334188|62879028|FG000|Overall Study|Death|1|||
33499323|NCT03334188|62879029|FG001|Overall Study|Death|0|||
33499324|NCT03334188|62879028|FG000|Overall Study|Never had qualifying clinic visit|7|||
33499325|NCT03334188|62879029|FG001|Overall Study|Never had qualifying clinic visit|7|||
33499326|NCT03333876|62879038|FG000|Screening Period|Screen Failure|4|||
33499327|NCT03333876|62879038|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
33499328|NCT03333876|62879038|FG000|Mandibular Advancement|Adverse Event|2|||
33499329|NCT03333876|62879038|FG000|Mandibular Advancement|Product Damage|2|||
33499330|NCT03294681|62879051|FG000|Overall Study|Withdrawal by Subject|1|||
33499331|NCT01140867|62879055|FG000|Overall Study|Adverse Event|22|||
33499332|NCT01140867|62879055|FG000|Overall Study|Lack of Efficacy|3|||
33499333|NCT01140867|62879055|FG000|Overall Study|Lost to Follow-up|2|||
33499334|NCT01140867|62879055|FG000|Overall Study|Withdrawal by Subject|1|||
33499335|NCT01140867|62879055|FG000|Overall Study|Protocol Violation|1|||
33499336|NCT01140867|62879055|FG000|Overall Study|Uncooperative patient|2|||
33499337|NCT01140867|62879055|FG000|Overall Study|Medication Noncompliance|2|||
33499338|NCT04572997|62879059|FG000|Overall Study|Adverse Event|1|||
33499339|NCT02943096|62879069|FG000|Overall Study|Lack of Efficacy|0|||
33499340|NCT02943096|62879070|FG001|Overall Study|Lack of Efficacy|1|||
33499341|NCT04571515|62879081|FG000|Overall Study|Physician Decision|0|||
33499342|NCT04571515|62879082|FG001|Overall Study|Physician Decision|0|||
33499343|NCT04571515|62879083|FG002|Overall Study|Physician Decision|0|||
33499344|NCT04571515|62879084|FG003|Overall Study|Physician Decision|0|||
33499345|NCT04571515|62879085|FG004|Overall Study|Physician Decision|1|||
33499346|NCT04571515|62879081|FG000|Overall Study|Withdrawal by Subject|0|||
33499347|NCT04571515|62879082|FG001|Overall Study|Withdrawal by Subject|0|||
33499348|NCT04571515|62879083|FG002|Overall Study|Withdrawal by Subject|0|||
33499349|NCT04571515|62879084|FG003|Overall Study|Withdrawal by Subject|0|||
33499350|NCT04571515|62879085|FG004|Overall Study|Withdrawal by Subject|1|||
33499351|NCT04571515|62879081|FG000|Overall Study|insufficient pain|1|||
33499352|NCT04571515|62879082|FG001|Overall Study|insufficient pain|0|||
33499353|NCT04571515|62879083|FG002|Overall Study|insufficient pain|0|||
33499354|NCT04571515|62879084|FG003|Overall Study|insufficient pain|0|||
33499355|NCT04571515|62879085|FG004|Overall Study|insufficient pain|1|||
33499356|NCT03292653|62879100|FG000|Overall Study|Adverse Event|0|||
33499357|NCT03292653|62879101|FG001|Overall Study|Adverse Event|0|||
33499358|NCT03292653|62879102|FG002|Overall Study|Adverse Event|1|||
33499359|NCT03292653|62879100|FG000|Overall Study|Did not Receive Treatment|1|||
33499360|NCT03292653|62879101|FG001|Overall Study|Did not Receive Treatment|0|||
33499361|NCT03292653|62879102|FG002|Overall Study|Did not Receive Treatment|0|||
33448519|NCT00282308|62823550|FG000|Treatment Period|Adverse Event|0|||
33448520|NCT00282308|62823551|FG001|Treatment Period|Adverse Event|2|||
33448521|NCT00282308|62823552|FG002|Treatment Period|Adverse Event|0|||
33448522|NCT00282308|62823550|FG000|Treatment Period|Not Treated with Study Drug|1|||
33448523|NCT00282308|62823551|FG001|Treatment Period|Not Treated with Study Drug|0|||
33448524|NCT00282308|62823552|FG002|Treatment Period|Not Treated with Study Drug|0|||
33448525|NCT00282308|62823550|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
33448526|NCT00282308|62823551|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
33448527|NCT00282308|62823552|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
33448528|NCT00282308|62823550|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
33448529|NCT00282308|62823551|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
33448530|NCT00282308|62823552|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
33448531|NCT00282308|62823550|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
33448532|NCT00282308|62823551|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
33448533|NCT00282308|62823552|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
33448534|NCT00282308|62823550|FG000|Safety Follow-up Period|Adverse Event|0|||
33448535|NCT00282308|62823551|FG001|Safety Follow-up Period|Adverse Event|0|||
33448536|NCT00282308|62823552|FG002|Safety Follow-up Period|Adverse Event|1|||
33448537|NCT00282308|62823550|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
33448538|NCT00282308|62823551|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
33448539|NCT00282308|62823552|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
33448540|NCT00282308|62823550|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
33448541|NCT00282308|62823551|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
33499362|NCT03858634|62879113|FG000|Overall Study|Withdrawal by Subject|1|||
33499363|NCT03858634|62879114|FG001|Overall Study|Withdrawal by Subject|0|||
33499364|NCT03858634|62879113|FG000|Overall Study|Adverse Event|1|||
33499365|NCT03858634|62879114|FG001|Overall Study|Adverse Event|0|||
33499366|NCT03858634|62879113|FG000|Overall Study|Lost to Follow-up|0|||
33499367|NCT03858634|62879114|FG001|Overall Study|Lost to Follow-up|1|||
33499368|NCT03858634|62879113|FG000|Overall Study|Other, Not Specified|1|||
33448542|NCT00282308|62823552|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
33499369|NCT03858634|62879114|FG001|Overall Study|Other, Not Specified|1|||
33499370|NCT02891070|62879130|FG000|Overall Study|Adverse Event|1|||
33499371|NCT02891070|62879131|FG001|Overall Study|Adverse Event|0|||
33499372|NCT02891070|62879130|FG000|Overall Study|Physician Decision|0|||
33609086|NCT02243293|63009052|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
33609087|NCT02243293|63009053|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
33609088|NCT02243293|63009054|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
33609089|NCT02243293|63009055|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
33609090|NCT02243293|63009056|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
33609091|NCT02243293|63009057|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
33609092|NCT02243293|63009058|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
33609093|NCT02243293|63009059|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
33609094|NCT02243293|63009060|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
33609095|NCT02243293|63009061|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
33609096|NCT02243293|63009062|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
33609097|NCT02243293|63009063|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
33609098|NCT02322047|63009104|FG000|Overall Study|Physician Decision|1|||
33609099|NCT02322047|63009105|FG001|Overall Study|Physician Decision|0|||
33609100|NCT02322047|63009106|FG002|Overall Study|Physician Decision|0|||
33609101|NCT02322047|63009107|FG003|Overall Study|Physician Decision|0|||
33609102|NCT02322047|63009104|FG000|Overall Study|Withdrawal by Subject|1|||
33609103|NCT02322047|63009105|FG001|Overall Study|Withdrawal by Subject|0|||
33448543|NCT00282308|62823550|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
33448544|NCT00282308|62823551|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
33448545|NCT00282308|62823552|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
33448546|NCT00282152|62823564|FG000|Overall Study|Withdrawal by Subject|1|||
33448547|NCT00282152|62823565|FG001|Overall Study|Withdrawal by Subject|0|||
33448548|NCT00281840|62823572|FG000|Overall Study|Adverse Event|12|||
33448549|NCT00281840|62823572|FG000|Overall Study|Physician Decision|6|||
33448550|NCT00281840|62823572|FG000|Overall Study|Withdrawal by Subject|3|||
33448551|NCT00281840|62823572|FG000|Overall Study|Disease Progression|2|||
33448552|NCT00281840|62823572|FG000|Overall Study|exceed maximum delay in treatment|1|||
33448553|NCT00281840|62823572|FG000|Overall Study|Complicating Disease|1|||
33448554|NCT00281684|62823581|FG000|Overall Study|Lost to Follow-up|0|||
33448555|NCT00281684|62823582|FG001|Overall Study|Lost to Follow-up|0|||
33448556|NCT00281684|62823583|FG002|Overall Study|Lost to Follow-up|1|||
33448557|NCT00281684|62823584|FG003|Overall Study|Lost to Follow-up|0|||
33448558|NCT00281684|62823581|FG000|Overall Study|Withdrawal by Subject|1|||
33448559|NCT00281684|62823582|FG001|Overall Study|Withdrawal by Subject|0|||
33448560|NCT00281684|62823583|FG002|Overall Study|Withdrawal by Subject|0|||
33448561|NCT00281684|62823584|FG003|Overall Study|Withdrawal by Subject|0|||
33448562|NCT00272792|62823598|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
33609104|NCT02322047|63009106|FG002|Overall Study|Withdrawal by Subject|0|||
33609105|NCT02322047|63009107|FG003|Overall Study|Withdrawal by Subject|1|||
33609106|NCT02322047|63009104|FG000|Overall Study|Adverse Event|0|||
33609107|NCT02322047|63009105|FG001|Overall Study|Adverse Event|1|||
33609108|NCT02322047|63009106|FG002|Overall Study|Adverse Event|0|||
33609109|NCT02322047|63009107|FG003|Overall Study|Adverse Event|0|||
33609110|NCT02322047|63009104|FG000|Overall Study|Lost to Follow-up|0|||
33609111|NCT02322047|63009105|FG001|Overall Study|Lost to Follow-up|0|||
33609112|NCT02322047|63009106|FG002|Overall Study|Lost to Follow-up|1|||
33609113|NCT02322047|63009107|FG003|Overall Study|Lost to Follow-up|1|||
33609114|NCT02254291|63009120|FG000|Overall Study|Withdrawal by Subject|0|||
33448563|NCT00272792|62823599|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
33448564|NCT00272792|62823598|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
33448565|NCT00272792|62823599|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
33609115|NCT02254291|63009121|FG001|Overall Study|Withdrawal by Subject|3|||
33609116|NCT02254291|63009122|FG002|Overall Study|Withdrawal by Subject|1|||
33609117|NCT02254291|63009120|FG000|Overall Study|Missing follow-up information|0|||
33609118|NCT02254291|63009121|FG001|Overall Study|Missing follow-up information|0|||
33499373|NCT02891070|62879131|FG001|Overall Study|Physician Decision|1|||
33499374|NCT02891070|62879130|FG000|Overall Study|Lost to Follow-up|4|||
33499375|NCT02891070|62879131|FG001|Overall Study|Lost to Follow-up|4|||
33499376|NCT02891070|62879130|FG000|Overall Study|Other|1|||
33499377|NCT02891070|62879131|FG001|Overall Study|Other|0|||
33499378|NCT02891070|62879130|FG000|Overall Study|Protocol Violation|0|||
33499379|NCT02891070|62879131|FG001|Overall Study|Protocol Violation|1|||
33499380|NCT02891070|62879130|FG000|Overall Study|Withdrawal by Subject|1|||
33499381|NCT02891070|62879131|FG001|Overall Study|Withdrawal by Subject|2|||
33499382|NCT02891070|62879130|FG000|Overall Study|Death|3|||
33499383|NCT02891070|62879131|FG001|Overall Study|Death|0|||
33499384|NCT03255291|62879143|FG000|Overall Study|Determined to be ineligible|10|||
33499385|NCT03255291|62879144|FG001|Overall Study|Determined to be ineligible|12|||
33499386|NCT03255291|62879145|FG002|Overall Study|Determined to be ineligible|6|||
33499387|NCT03255291|62879146|FG003|Overall Study|Determined to be ineligible|6|||
33499388|NCT03255291|62879147|FG004|Overall Study|Determined to be ineligible|5|||
33499389|NCT03255291|62879148|FG005|Overall Study|Determined to be ineligible|10|||
33499390|NCT03255291|62879143|FG000|Overall Study|Baseline data collection issues|3|||
33499391|NCT03255291|62879144|FG001|Overall Study|Baseline data collection issues|0|||
33499392|NCT03255291|62879145|FG002|Overall Study|Baseline data collection issues|0|||
33499393|NCT03255291|62879146|FG003|Overall Study|Baseline data collection issues|0|||
33499394|NCT03255291|62879147|FG004|Overall Study|Baseline data collection issues|2|||
33499395|NCT03255291|62879148|FG005|Overall Study|Baseline data collection issues|0|||
33499396|NCT00381381|62879166|FG000|Overall Study|Adverse Event|3|||
33499397|NCT00381381|62879166|FG000|Overall Study|Lost to Follow-up|52|||
33499398|NCT00381381|62879166|FG000|Overall Study|Withdrawal by Subject|9|||
33499399|NCT02939937|62879172|FG000|Overall Study|Adverse Event|5|||
33499400|NCT02939937|62879173|FG001|Overall Study|Adverse Event|0|||
33499401|NCT02939937|62879172|FG000|Overall Study|Lost to Follow-up|1|||
33499402|NCT02939937|62879173|FG001|Overall Study|Lost to Follow-up|3|||
33499403|NCT02939079|62879181|FG000|Overall Study|Adverse Event|2|||
33499404|NCT02939079|62879182|FG001|Overall Study|Adverse Event|1|||
33499405|NCT02939079|62879181|FG000|Overall Study|Lost to Follow-up|0|||
33499406|NCT02939079|62879182|FG001|Overall Study|Lost to Follow-up|2|||
33499407|NCT02939079|62879181|FG000|Overall Study|Protocol Violation|1|||
33499408|NCT02939079|62879182|FG001|Overall Study|Protocol Violation|0|||
33609119|NCT02254291|63009122|FG002|Overall Study|Missing follow-up information|1|||
33609120|NCT02253433|63009132|FG000|Overall Study|Unable to Contact|9|||
33609121|NCT02253433|63009133|FG001|Overall Study|Unable to Contact|16|||
33609122|NCT02253433|63009132|FG000|Overall Study|Death|1|||
33499409|NCT02939079|62879181|FG000|Overall Study|Withdrawal by Subject|0|||
33499410|NCT02939079|62879182|FG001|Overall Study|Withdrawal by Subject|1|||
33499411|NCT02939079|62879181|FG000|Overall Study|relapse during the study|1|||
33499412|NCT02939079|62879182|FG001|Overall Study|relapse during the study|1|||
33499413|NCT04562155|62879192|FG000|Overall Study|COVID-19 pandemic|0|||
33499414|NCT04562155|62879193|FG001|Overall Study|COVID-19 pandemic|0|||
33499415|NCT04562155|62879194|FG002|Overall Study|COVID-19 pandemic|0|||
33499416|NCT04562155|62879195|FG003|Overall Study|COVID-19 pandemic|1|||
33499417|NCT04562155|62879192|FG000|Overall Study|Adverse Event|7|||
33499418|NCT04562155|62879193|FG001|Overall Study|Adverse Event|3|||
33499419|NCT04562155|62879194|FG002|Overall Study|Adverse Event|8|||
33499420|NCT04562155|62879195|FG003|Overall Study|Adverse Event|1|||
33499421|NCT04562155|62879192|FG000|Overall Study|Withdrawal by Subject|3|||
33499422|NCT04562155|62879193|FG001|Overall Study|Withdrawal by Subject|6|||
33499423|NCT04562155|62879194|FG002|Overall Study|Withdrawal by Subject|3|||
33499424|NCT04562155|62879195|FG003|Overall Study|Withdrawal by Subject|3|||
33448566|NCT00272792|62823598|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
33499425|NCT04562155|62879192|FG000|Overall Study|Participant personal reason|1|||
33499426|NCT04562155|62879193|FG001|Overall Study|Participant personal reason|0|||
33609123|NCT02253433|63009133|FG001|Overall Study|Death|1|||
33609124|NCT02253433|63009132|FG000|Overall Study|No Longer Interested|3|||
33609125|NCT02253433|63009133|FG001|Overall Study|No Longer Interested|15|||
33448567|NCT00272792|62823599|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
33448568|NCT00272792|62823598|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
33448569|NCT00272792|62823599|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
33448570|NCT00048568|62823607|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
33448571|NCT00048568|62823608|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
33448572|NCT00048568|62823609|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
33609126|NCT02253433|63009132|FG000|Overall Study|Out of Study Area|2|||
33499427|NCT04562155|62879194|FG002|Overall Study|Participant personal reason|2|||
33499428|NCT04562155|62879195|FG003|Overall Study|Participant personal reason|1|||
33499429|NCT03313050|62879209|FG000|Stage 2: 12 Months|Adverse Event|0|||
33499430|NCT03313050|62879210|FG001|Stage 2: 12 Months|Adverse Event|0|||
33499431|NCT03313050|62879211|FG002|Stage 2: 12 Months|Adverse Event|0|||
33499432|NCT03313050|62879212|FG003|Stage 2: 12 Months|Adverse Event|1|||
33499433|NCT03313050|62879209|FG000|Stage 2: 12 Months|Death|0|||
33499434|NCT03313050|62879210|FG001|Stage 2: 12 Months|Death|0|||
33499435|NCT03313050|62879211|FG002|Stage 2: 12 Months|Death|3|||
33499436|NCT03313050|62879212|FG003|Stage 2: 12 Months|Death|0|||
33499437|NCT03313050|62879209|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
33499438|NCT03313050|62879210|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
33499439|NCT03313050|62879211|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
33499440|NCT03313050|62879212|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
33499441|NCT03313050|62879209|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
33499442|NCT03313050|62879210|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
33499443|NCT03313050|62879211|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
33499444|NCT03313050|62879212|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
33499445|NCT03313050|62879209|FG000|Stage 2: 12 Months|Protocol deviation|0|||
33499446|NCT03313050|62879210|FG001|Stage 2: 12 Months|Protocol deviation|0|||
33499447|NCT03313050|62879211|FG002|Stage 2: 12 Months|Protocol deviation|7|||
33499448|NCT03313050|62879212|FG003|Stage 2: 12 Months|Protocol deviation|7|||
33499449|NCT03313050|62879209|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
33499450|NCT03313050|62879210|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
33499451|NCT03313050|62879211|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
33499452|NCT03313050|62879212|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
33499453|NCT03313050|62879209|FG000|Stage 2: 12 Months|Other|0|||
33499454|NCT03313050|62879210|FG001|Stage 2: 12 Months|Other|0|||
33499455|NCT03313050|62879211|FG002|Stage 2: 12 Months|Other|0|||
33499456|NCT03313050|62879212|FG003|Stage 2: 12 Months|Other|1|||
33499457|NCT04755595|62879231|FG000|Overall Study|Lost to Follow-up|1|||
33499458|NCT04749745|62879236|FG000|Overall Study|Withdrawal by Subject|1|||
33499459|NCT04749745|62879237|FG001|Overall Study|Withdrawal by Subject|0|||
33499460|NCT03257436|62879243|FG000|Overall Study|Withdrawal by Subject|76|||
33499461|NCT03257436|62879243|FG000|Overall Study|Death|19|||
33499462|NCT04748341|62879249|FG000|Overall Study|Lost to Follow-up|1|||
33499463|NCT04748341|62879250|FG001|Overall Study|Lost to Follow-up|1|||
33499464|NCT01328002|62879256|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
33499465|NCT01328002|62879257|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
33499466|NCT01328002|62879256|FG000|Open-Label Period|Adverse Event|8|||
33499467|NCT01328002|62879257|FG001|Open-Label Period|Adverse Event|0|||
33499468|NCT01328002|62879256|FG000|Open-Label Period|Lack of Efficacy|3|||
33499469|NCT01328002|62879257|FG001|Open-Label Period|Lack of Efficacy|0|||
33499470|NCT01328002|62879256|FG000|Open-Label Period|Protocol Violation|2|||
33499471|NCT01328002|62879257|FG001|Open-Label Period|Protocol Violation|0|||
33499472|NCT01328002|62879256|FG000|Open-Label Period|Withdrawal by Subject|9|||
33499473|NCT01328002|62879257|FG001|Open-Label Period|Withdrawal by Subject|0|||
33499474|NCT01328002|62879256|FG000|Open-Label Period|Lost to Follow-up|6|||
33499475|NCT01328002|62879257|FG001|Open-Label Period|Lost to Follow-up|0|||
33499476|NCT01328002|62879256|FG000|Open-Label Period|Other Reason|2|||
33499477|NCT01328002|62879257|FG001|Open-Label Period|Other Reason|0|||
33499478|NCT01328002|62879256|FG000|Double-Blind Period|Adverse Event|1|||
33499479|NCT01328002|62879257|FG001|Double-Blind Period|Adverse Event|0|||
33499480|NCT01328002|62879256|FG000|Double-Blind Period|Lack of Efficacy|1|||
33499481|NCT01328002|62879257|FG001|Double-Blind Period|Lack of Efficacy|0|||
33499482|NCT02579265|62879266|FG000|Overall Study|Weaned off earlier than 28 days|44|||
33499483|NCT02579265|62879267|FG001|Overall Study|Weaned off earlier than 28 days|43|||
33499484|NCT02579265|62879266|FG000|Overall Study|Adverse Event|2|||
33499485|NCT02579265|62879267|FG001|Overall Study|Adverse Event|0|||
33499486|NCT02579265|62879266|FG000|Overall Study|Any other reason not specified|0|||
33499487|NCT02579265|62879267|FG001|Overall Study|Any other reason not specified|2|||
33499488|NCT02579265|62879266|FG000|Overall Study|Withdrawal by Subject|2|||
33499489|NCT02579265|62879267|FG001|Overall Study|Withdrawal by Subject|0|||
33499490|NCT02579265|62879266|FG000|Overall Study|Physician Decision|1|||
33499491|NCT02579265|62879267|FG001|Overall Study|Physician Decision|0|||
33499492|NCT02579265|62879266|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
33499493|NCT02579265|62879267|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
33499494|NCT03289533|62879273|FG000|Overall Study|Death|12|||
33499495|NCT03289533|62879273|FG000|Overall Study|Terminated from study by sponsor|10|||
33499496|NCT04727749|62879279|FG000|Overall Study|Lost to Follow-up|10|||
33499497|NCT04727749|62879280|FG001|Overall Study|Lost to Follow-up|3|||
33499498|NCT04547023|62879290|FG000|Overall Study|Did Not Receive Intervention|3|||
33499499|NCT04547023|62879291|FG001|Overall Study|Did Not Receive Intervention|2|||
33499500|NCT04547023|62879290|FG000|Overall Study|Lost to Follow-up|1|||
33499501|NCT04547023|62879291|FG001|Overall Study|Lost to Follow-up|1|||
33499502|NCT03697993|62879301|FG000|Overall Study|Became Ineligible after Enrollment|1|||
33499503|NCT03697993|62879302|FG001|Overall Study|Became Ineligible after Enrollment|3|||
33499504|NCT03697993|62879301|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
33499505|NCT03697993|62879302|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
33499506|NCT03697993|62879301|FG000|Overall Study|Lost to Follow-up|3|||
33499507|NCT03697993|62879302|FG001|Overall Study|Lost to Follow-up|0|||
33499508|NCT03697993|62879301|FG000|Overall Study|Physician Decision|4|||
33499509|NCT03697993|62879302|FG001|Overall Study|Physician Decision|0|||
33499510|NCT03697993|62879301|FG000|Overall Study|Initial Urine Culture Negative|0|||
33499511|NCT03697993|62879302|FG001|Overall Study|Initial Urine Culture Negative|1|||
33499512|NCT03289455|62879312|FG000|Overall Study|Death|1|||
33499513|NCT03289455|62879313|FG001|Overall Study|Death|0|||
33499514|NCT03289455|62879314|FG002|Overall Study|Death|0|||
33499515|NCT03289455|62879312|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
33499516|NCT03289455|62879313|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
33499517|NCT03289455|62879314|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
33499518|NCT03289455|62879312|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
33499519|NCT03289455|62879313|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
33609127|NCT02253433|63009133|FG001|Overall Study|Out of Study Area|7|||
33609128|NCT02253433|63009132|FG000|Overall Study|Uncomfortable with home visitors|0|||
33609129|NCT02253433|63009133|FG001|Overall Study|Uncomfortable with home visitors|3|||
33609130|NCT02253433|63009132|FG000|Overall Study|Unstable Housing/Homeless|0|||
33609131|NCT02253433|63009133|FG001|Overall Study|Unstable Housing/Homeless|7|||
33609132|NCT02253433|63009132|FG000|Overall Study|Too Busy|0|||
33609133|NCT02253433|63009133|FG001|Overall Study|Too Busy|4|||
33609134|NCT02253433|63009132|FG000|Overall Study|Medical or Other Concerns|1|||
33609135|NCT02253433|63009133|FG001|Overall Study|Medical or Other Concerns|2|||
33609136|NCT02242981|63009140|FG000|Overall Study|Withdrawal by Subject|1|||
33609137|NCT02277743|63009147|FG000|Overall Study|Protocol Violation|1|||
33609138|NCT02277743|63009148|FG001|Overall Study|Protocol Violation|1|||
33609139|NCT02277743|63009149|FG002|Overall Study|Protocol Violation|1|||
33609140|NCT02277743|63009147|FG000|Overall Study|Adverse Event|10|||
33609141|NCT02277743|63009148|FG001|Overall Study|Adverse Event|6|||
33609142|NCT02277743|63009149|FG002|Overall Study|Adverse Event|6|||
33609143|NCT02277743|63009147|FG000|Overall Study|Lack of Efficacy|11|||
33609144|NCT02277743|63009148|FG001|Overall Study|Lack of Efficacy|4|||
33609145|NCT02277743|63009149|FG002|Overall Study|Lack of Efficacy|3|||
33609146|NCT02277743|63009147|FG000|Overall Study|Other than specified above|18|||
33609147|NCT02277743|63009148|FG001|Overall Study|Other than specified above|5|||
33609148|NCT02277743|63009149|FG002|Overall Study|Other than specified above|16|||
33609149|NCT02242903|63009164|FG000|Overall Study|Withdrawal by Subject|1|||
33609150|NCT02242903|63009165|FG001|Overall Study|Withdrawal by Subject|0|||
33448573|NCT00048568|62823607|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
33448574|NCT00048568|62823608|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
33448575|NCT00048568|62823609|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
33448576|NCT00048568|62823607|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
33448577|NCT00048568|62823608|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
33448578|NCT00048568|62823609|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
33448579|NCT00048568|62823607|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
33448580|NCT00048568|62823608|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
33448581|NCT00048568|62823609|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
33448582|NCT00048568|62823607|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
33448583|NCT00048568|62823608|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
33448584|NCT00048568|62823609|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
33448585|NCT00048568|62823607|FG000|Double-Blind Period Days 170 to 365|Death|1|||
33448586|NCT00048568|62823608|FG001|Double-Blind Period Days 170 to 365|Death|1|||
33448587|NCT00048568|62823609|FG002|Double-Blind Period Days 170 to 365|Death|0|||
33448588|NCT00048568|62823607|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
33448589|NCT00048568|62823608|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
33448590|NCT00048568|62823609|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
33448591|NCT00048568|62823607|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
33448592|NCT00048568|62823608|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
33448593|NCT00048568|62823609|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
33448594|NCT00048568|62823607|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
33448595|NCT00048568|62823608|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
33609151|NCT02242903|63009166|FG002|Overall Study|Withdrawal by Subject|0|||
33609152|NCT02242903|63009167|FG003|Overall Study|Withdrawal by Subject|0|||
33609153|NCT02242903|63009168|FG004|Overall Study|Withdrawal by Subject|0|||
33609154|NCT02242903|63009169|FG005|Overall Study|Withdrawal by Subject|0|||
33609155|NCT02242903|63009170|FG006|Overall Study|Withdrawal by Subject|0|||
33609156|NCT02320721|63009194|FG000|Overall Study|Adverse Event|6|||
33609157|NCT02320721|63009195|FG001|Overall Study|Adverse Event|6|||
33499520|NCT03289455|62879314|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
33499521|NCT03289455|62879312|FG000|Overall Study|Progressive disease|3|||
33499522|NCT03289455|62879313|FG001|Overall Study|Progressive disease|4|||
33499523|NCT03289455|62879314|FG002|Overall Study|Progressive disease|5|||
33499524|NCT04484857|62879323|FG000|Overall Study|Adverse Event|2|||
33499525|NCT04484857|62879323|FG000|Overall Study|Death|10|||
33499526|NCT04484857|62879323|FG000|Overall Study|Withdrawal by Subject|3|||
33499527|NCT04484857|62879323|FG000|Overall Study|Transferred/Relocation|5|||
33499528|NCT04484857|62879323|FG000|Overall Study|Kidney Transplant|7|||
33499529|NCT04484857|62879323|FG000|Overall Study|Other than specified|4|||
33499530|NCT04484857|62879323|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
33499531|NCT04095793|62879327|FG000|Overall Study|Adverse Event|3|||
33499532|NCT04095793|62879327|FG000|Overall Study|Study Terminated by Sponsor|103|||
33499533|NCT04095793|62879327|FG000|Overall Study|Withdrawal by Subject|4|||
33499534|NCT04482439|62879331|FG000|Overall Study|Lost to Follow-up|1|||
33499535|NCT04482439|62879331|FG000|Overall Study|Unrelated illness|1|||
33499536|NCT04535947|62879338|FG000|Overall Study|Adverse Event|1|||
33499537|NCT04535947|62879339|FG001|Overall Study|Adverse Event|4|||
33499538|NCT04535947|62879338|FG000|Overall Study|Other reasons not specified|2|||
33499539|NCT04535947|62879339|FG001|Overall Study|Other reasons not specified|0|||
33499540|NCT04535947|62879338|FG000|Overall Study|Withdrawal by Subject|1|||
33499541|NCT04535947|62879339|FG001|Overall Study|Withdrawal by Subject|1|||
33499542|NCT04474405|62879351|FG000|Overall Study|Withdrawal by Subject|0|||
33499543|NCT04474405|62879352|FG001|Overall Study|Withdrawal by Subject|0|||
33499544|NCT04474405|62879353|FG002|Overall Study|Withdrawal by Subject|1|||
33499545|NCT04474405|62879354|FG003|Overall Study|Withdrawal by Subject|0|||
33499546|NCT04474405|62879355|FG004|Overall Study|Withdrawal by Subject|1|||
33499547|NCT04474405|62879356|FG005|Overall Study|Withdrawal by Subject|0|||
33499548|NCT04474405|62879351|FG000|Overall Study|Other|0|||
33499549|NCT04474405|62879352|FG001|Overall Study|Other|0|||
33499550|NCT04474405|62879353|FG002|Overall Study|Other|0|||
33499551|NCT04474405|62879354|FG003|Overall Study|Other|0|||
33499552|NCT04474405|62879355|FG004|Overall Study|Other|3|||
33499553|NCT04474405|62879356|FG005|Overall Study|Other|0|||
33609158|NCT02320721|63009194|FG000|Overall Study|Lack of Efficacy|2|||
33609159|NCT02320721|63009195|FG001|Overall Study|Lack of Efficacy|0|||
33609160|NCT02320721|63009194|FG000|Overall Study|Poor compliance to protocol|3|||
33499554|NCT04531813|62879370|FG000|Overall Study|Protocol Violation|1|||
33499555|NCT04531813|62879370|FG000|Overall Study|Withdrawal by Subject|1|||
33499556|NCT03538444|62879376|FG000|Overall Study|opioid withdrawal|1|||
33499557|NCT03538444|62879377|FG001|Overall Study|opioid withdrawal|0|||
33499558|NCT01199302|62879387|FG000|Overall Study|Adverse Event|1|||
33499559|NCT01199302|62879388|FG001|Overall Study|Adverse Event|1|||
33499560|NCT01199302|62879389|FG002|Overall Study|Adverse Event|2|||
33499561|NCT01199302|62879390|FG003|Overall Study|Adverse Event|0|||
33499562|NCT01199302|62879387|FG000|Overall Study|Withdrawal by Subject|2|||
33499563|NCT01199302|62879388|FG001|Overall Study|Withdrawal by Subject|2|||
33499564|NCT01199302|62879389|FG002|Overall Study|Withdrawal by Subject|3|||
33499565|NCT01199302|62879390|FG003|Overall Study|Withdrawal by Subject|0|||
33499566|NCT01199302|62879387|FG000|Overall Study|Disease Progression|3|||
33499567|NCT01199302|62879388|FG001|Overall Study|Disease Progression|4|||
33499568|NCT01199302|62879389|FG002|Overall Study|Disease Progression|4|||
33499569|NCT01199302|62879390|FG003|Overall Study|Disease Progression|2|||
33499570|NCT01199302|62879387|FG000|Overall Study|Study Termination|13|||
33499571|NCT01199302|62879388|FG001|Overall Study|Study Termination|8|||
33499572|NCT01199302|62879389|FG002|Overall Study|Study Termination|11|||
33499573|NCT01199302|62879390|FG003|Overall Study|Study Termination|9|||
33499574|NCT01199302|62879387|FG000|Overall Study|Lost to Follow-up|0|||
33499575|NCT01199302|62879388|FG001|Overall Study|Lost to Follow-up|1|||
33499576|NCT01199302|62879389|FG002|Overall Study|Lost to Follow-up|0|||
33499577|NCT01199302|62879390|FG003|Overall Study|Lost to Follow-up|0|||
33499578|NCT01199302|62879387|FG000|Overall Study|Other|1|||
33609161|NCT02320721|63009195|FG001|Overall Study|Poor compliance to protocol|7|||
33448596|NCT00048568|62823609|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
33609162|NCT02320721|63009194|FG000|Overall Study|Randomized but not treated|0|||
33448597|NCT00048568|62823607|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
33448598|NCT00048568|62823608|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
33448599|NCT00048568|62823609|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
33448600|NCT00048568|62823607|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
33448601|NCT00048568|62823608|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
33448602|NCT00048568|62823609|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
33448603|NCT00048568|62823607|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
33448604|NCT00048568|62823608|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
33499579|NCT01199302|62879388|FG001|Overall Study|Other|0|||
33499580|NCT01199302|62879389|FG002|Overall Study|Other|0|||
33499581|NCT01199302|62879390|FG003|Overall Study|Other|0|||
33609163|NCT02320721|63009195|FG001|Overall Study|Randomized but not treated|1|||
33499582|NCT03332784|62879417|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499583|NCT03332784|62879418|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
33499584|NCT03332784|62879419|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499585|NCT03332784|62879420|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499586|NCT03332784|62879421|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499587|NCT03332784|62879422|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499588|NCT03332784|62879423|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499589|NCT03332784|62879424|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499590|NCT03332784|62879425|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499591|NCT03332784|62879426|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499592|NCT03332784|62879427|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499593|NCT03332784|62879428|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499594|NCT03332784|62879429|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499595|NCT03332784|62879430|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499596|NCT03332784|62879431|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
33499597|NCT03332784|62879432|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499598|NCT03332784|62879433|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499599|NCT03332784|62879434|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499600|NCT03332784|62879435|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499601|NCT03332784|62879436|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33499602|NCT04465357|62879500|FG000|Overall Study|Adverse Event|2|||
33499603|NCT04465357|62879500|FG000|Overall Study|Lack of Efficacy|1|||
33499604|NCT04465357|62879500|FG000|Overall Study|Lost to Follow-up|2|||
33499605|NCT04465357|62879500|FG000|Overall Study|Withdrawal by Subject|6|||
33499606|NCT04465357|62879500|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
33499607|NCT03332628|62879504|FG000|Overall Study|Physician Decision|2|||
33499608|NCT04516759|62879511|FG000|Overall Study|Withdrawal by Subject|1|||
33499609|NCT04516759|62879512|FG001|Overall Study|Withdrawal by Subject|1|||
33499610|NCT04516759|62879511|FG000|Overall Study|Other|0|||
33499611|NCT04516759|62879512|FG001|Overall Study|Other|1|||
33499612|NCT03332160|62879520|FG000|Overall Study|Withdrawal by Subject|1|||
33499613|NCT03332160|62879521|FG001|Overall Study|Withdrawal by Subject|1|||
33499614|NCT03332160|62879520|FG000|Overall Study|Adverse Event|0|||
33499615|NCT03332160|62879521|FG001|Overall Study|Adverse Event|1|||
33499616|NCT03332160|62879520|FG000|Overall Study|Developed Exclusion Criteria|0|||
33499617|NCT03332160|62879521|FG001|Overall Study|Developed Exclusion Criteria|1|||
33499618|NCT03332160|62879520|FG000|Overall Study|Non-adherence to treatment|0|||
33499619|NCT03332160|62879521|FG001|Overall Study|Non-adherence to treatment|2|||
33499620|NCT03312114|62879528|FG000|Overall Study|All the five enrolled dropped out of the|5|||
33609164|NCT02320721|63009194|FG000|Overall Study|Hypoglycemia|1|||
33609165|NCT02320721|63009195|FG001|Overall Study|Hypoglycemia|0|||
33448605|NCT00048568|62823609|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
33448606|NCT00048568|62823607|FG000|Open-Label Period|Death|0|||
33448607|NCT00048568|62823608|FG001|Open-Label Period|Death|0|||
33448608|NCT00048568|62823609|FG002|Open-Label Period|Death|13|||
33448609|NCT00048568|62823607|FG000|Open-Label Period|Adverse Event|0|||
33448610|NCT00048568|62823608|FG001|Open-Label Period|Adverse Event|0|||
33448611|NCT00048568|62823609|FG002|Open-Label Period|Adverse Event|49|||
33448612|NCT00048568|62823607|FG000|Open-Label Period|Lack of Efficacy|0|||
33448613|NCT00048568|62823608|FG001|Open-Label Period|Lack of Efficacy|0|||
33448614|NCT00048568|62823609|FG002|Open-Label Period|Lack of Efficacy|32|||
33448615|NCT00048568|62823607|FG000|Open-Label Period|Withdrawal by Subject|0|||
33448616|NCT00048568|62823608|FG001|Open-Label Period|Withdrawal by Subject|0|||
33448617|NCT00048568|62823609|FG002|Open-Label Period|Withdrawal by Subject|26|||
33448618|NCT00048568|62823607|FG000|Open-Label Period|Pregnancy|0|||
33499621|NCT03694327|62879535|FG000|Overall Study|Lost to Follow-up|13|||
33499622|NCT03694327|62879536|FG001|Overall Study|Lost to Follow-up|23|||
33499623|NCT03330288|62879544|FG000|Overall Study|Other reason|1|||
33499624|NCT03330288|62879545|FG001|Overall Study|Other reason|1|||
33499625|NCT03330288|62879544|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
33609166|NCT02320721|63009194|FG000|Overall Study|Other than specified above|15|||
33448619|NCT00048568|62823608|FG001|Open-Label Period|Pregnancy|0|||
33448620|NCT00048568|62823609|FG002|Open-Label Period|Pregnancy|5|||
33448621|NCT00048568|62823607|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
33448622|NCT00048568|62823608|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
33499626|NCT03330288|62879545|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
33499627|NCT03330288|62879544|FG000|Overall Study|Adverse Event|1|||
33499628|NCT03330288|62879545|FG001|Overall Study|Adverse Event|0|||
33499629|NCT03330288|62879544|FG000|Overall Study|Withdrawal by Subject|1|||
33499630|NCT03330288|62879545|FG001|Overall Study|Withdrawal by Subject|0|||
33499631|NCT03330288|62879544|FG000|Overall Study|Lost to Follow-up|26|||
33499632|NCT03330288|62879545|FG001|Overall Study|Lost to Follow-up|7|||
33499633|NCT03084536|62879554|FG000|Overall Study|Determined to be ineligible|0|||
33499634|NCT03084536|62879555|FG001|Overall Study|Determined to be ineligible|0|||
33499635|NCT03084536|62879556|FG002|Overall Study|Determined to be ineligible|16|||
33499636|NCT03084536|62879554|FG000|Overall Study|Withdrawal by Subject|0|||
33499637|NCT03084536|62879555|FG001|Overall Study|Withdrawal by Subject|0|||
33499638|NCT03084536|62879556|FG002|Overall Study|Withdrawal by Subject|4|||
33499639|NCT03084536|62879554|FG000|Overall Study|Physician Decision|0|||
33499640|NCT03084536|62879555|FG001|Overall Study|Physician Decision|0|||
33499641|NCT03084536|62879556|FG002|Overall Study|Physician Decision|3|||
33499642|NCT03084536|62879554|FG000|Overall Study|Death|0|||
33499643|NCT03084536|62879555|FG001|Overall Study|Death|0|||
33499644|NCT03084536|62879556|FG002|Overall Study|Death|1|||
33499645|NCT03084536|62879554|FG000|Overall Study|Lost to Follow-up|0|||
33499646|NCT03084536|62879555|FG001|Overall Study|Lost to Follow-up|0|||
33499647|NCT03084536|62879556|FG002|Overall Study|Lost to Follow-up|1|||
33499648|NCT03084536|62879554|FG000|Overall Study|Protocol Violation|0|||
33499649|NCT03084536|62879555|FG001|Overall Study|Protocol Violation|0|||
33499650|NCT03084536|62879556|FG002|Overall Study|Protocol Violation|1|||
33499651|NCT03084536|62879554|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
33499652|NCT03084536|62879555|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
33499653|NCT03084536|62879556|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
33499654|NCT05291936|62879563|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
33499655|NCT05291936|62879564|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
33499656|NCT05291936|62879563|FG000|Period 1|Withdrew Consent during study|1|||
33499657|NCT05291936|62879564|FG001|Period 1|Withdrew Consent during study|0|||
33499658|NCT05291936|62879563|FG000|Period 2|Adverse Event|0|||
33499659|NCT05291936|62879564|FG001|Period 2|Adverse Event|1|||
33499660|NCT05291936|62879563|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
33499661|NCT05291936|62879564|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
33499662|NCT03289143|62879574|FG000|Overall Study|Caregiver Unavailability|1|||
33499663|NCT03289143|62879575|FG001|Overall Study|Caregiver Unavailability|1|||
33499664|NCT03289143|62879576|FG002|Overall Study|Caregiver Unavailability|0|||
33499665|NCT03289143|62879577|FG003|Overall Study|Caregiver Unavailability|0|||
33499666|NCT03289143|62879574|FG000|Overall Study|Research Department Closure|0|||
33499667|NCT03289143|62879575|FG001|Overall Study|Research Department Closure|0|||
33499668|NCT03289143|62879576|FG002|Overall Study|Research Department Closure|1|||
33499669|NCT03289143|62879577|FG003|Overall Study|Research Department Closure|0|||
33499670|NCT03289143|62879574|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
33499671|NCT03289143|62879575|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
33499672|NCT03289143|62879576|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
33499673|NCT03289143|62879577|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
33499674|NCT03289143|62879574|FG000|Overall Study|Medical Monitor Decision|1|||
33499675|NCT03289143|62879575|FG001|Overall Study|Medical Monitor Decision|0|||
33499676|NCT03289143|62879576|FG002|Overall Study|Medical Monitor Decision|0|||
33499677|NCT03289143|62879577|FG003|Overall Study|Medical Monitor Decision|0|||
33609167|NCT02320721|63009195|FG001|Overall Study|Other than specified above|20|||
33609168|NCT02320487|63009201|FG000|Overall Study|Reason not Specified|1|||
33609169|NCT02320487|63009201|FG000|Overall Study|Physician Decision|5|||
33609170|NCT02320487|63009201|FG000|Overall Study|Withdrawal by Subject|1|||
33609171|NCT02320487|63009201|FG000|Overall Study|Death|3|||
33609172|NCT02320487|63009201|FG000|Overall Study|Adverse Event|11|||
33609173|NCT02277119|63009208|FG000|Overall Study|Lack of Efficacy|1|||
33609174|NCT02277119|63009209|FG001|Overall Study|Lack of Efficacy|1|||
33609175|NCT02277119|63009210|FG002|Overall Study|Lack of Efficacy|1|||
33609176|NCT02277119|63009208|FG000|Overall Study|Protocol Violation|2|||
33609177|NCT02277119|63009209|FG001|Overall Study|Protocol Violation|3|||
33609178|NCT02277119|63009210|FG002|Overall Study|Protocol Violation|7|||
33609179|NCT02320253|63009221|FG000|Overall Study|Withdrawal by Subject|3|||
33499678|NCT03289143|62879574|FG000|Overall Study|Participant Non-Compliance|0|||
33499679|NCT03289143|62879575|FG001|Overall Study|Participant Non-Compliance|0|||
33499680|NCT03289143|62879576|FG002|Overall Study|Participant Non-Compliance|1|||
33609180|NCT02320253|63009222|FG001|Overall Study|Withdrawal by Subject|0|||
33609181|NCT02320253|63009223|FG002|Overall Study|Withdrawal by Subject|0|||
33499681|NCT03289143|62879577|FG003|Overall Study|Participant Non-Compliance|0|||
33499682|NCT03289143|62879574|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
33499683|NCT03289143|62879575|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
33499684|NCT03289143|62879576|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
33499685|NCT03289143|62879577|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
33499686|NCT03289143|62879574|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
33499687|NCT03289143|62879575|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
33499688|NCT03289143|62879576|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
33499689|NCT03289143|62879577|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
33499690|NCT03289143|62879574|FG000|Overall Study|Caregiver Passed Away|1|||
33499691|NCT03289143|62879575|FG001|Overall Study|Caregiver Passed Away|0|||
33499692|NCT03289143|62879576|FG002|Overall Study|Caregiver Passed Away|0|||
33499693|NCT03289143|62879577|FG003|Overall Study|Caregiver Passed Away|0|||
33499694|NCT03289143|62879574|FG000|Overall Study|Physician Decision|0|||
33499695|NCT03289143|62879575|FG001|Overall Study|Physician Decision|2|||
33499696|NCT03289143|62879576|FG002|Overall Study|Physician Decision|2|||
33499697|NCT03289143|62879577|FG003|Overall Study|Physician Decision|2|||
33499698|NCT03289143|62879574|FG000|Overall Study|Protocol Deviation|2|||
33499699|NCT03289143|62879575|FG001|Overall Study|Protocol Deviation|1|||
33499700|NCT03289143|62879576|FG002|Overall Study|Protocol Deviation|3|||
33499701|NCT03289143|62879577|FG003|Overall Study|Protocol Deviation|1|||
33499702|NCT03289143|62879574|FG000|Overall Study|Study Terminated By Sponsor|101|||
33499703|NCT03289143|62879575|FG001|Overall Study|Study Terminated By Sponsor|75|||
33499704|NCT03289143|62879576|FG002|Overall Study|Study Terminated By Sponsor|100|||
33499705|NCT03289143|62879577|FG003|Overall Study|Study Terminated By Sponsor|69|||
33499706|NCT03289143|62879574|FG000|Overall Study|Withdrawal by Subject|14|||
33499707|NCT03289143|62879575|FG001|Overall Study|Withdrawal by Subject|6|||
33499708|NCT03289143|62879576|FG002|Overall Study|Withdrawal by Subject|14|||
33499709|NCT03289143|62879577|FG003|Overall Study|Withdrawal by Subject|12|||
33499710|NCT03289143|62879574|FG000|Overall Study|Adverse Event|10|||
33499711|NCT03289143|62879575|FG001|Overall Study|Adverse Event|7|||
33499712|NCT03289143|62879576|FG002|Overall Study|Adverse Event|6|||
33499713|NCT03289143|62879577|FG003|Overall Study|Adverse Event|5|||
33499714|NCT03289143|62879574|FG000|Overall Study|Death|2|||
33499715|NCT03289143|62879575|FG001|Overall Study|Death|0|||
33499716|NCT03289143|62879576|FG002|Overall Study|Death|2|||
33499717|NCT03289143|62879577|FG003|Overall Study|Death|1|||
33499718|NCT03289143|62879574|FG000|Overall Study|Lost to Follow-up|2|||
33499719|NCT03289143|62879575|FG001|Overall Study|Lost to Follow-up|1|||
33499720|NCT03289143|62879576|FG002|Overall Study|Lost to Follow-up|1|||
33499721|NCT03289143|62879577|FG003|Overall Study|Lost to Follow-up|0|||
33499722|NCT03289143|62879574|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
33499723|NCT03289143|62879575|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
33499724|NCT03289143|62879576|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
33609182|NCT02320253|63009221|FG000|Overall Study|Lost to Follow-up|2|||
33609183|NCT02320253|63009222|FG001|Overall Study|Lost to Follow-up|2|||
33609184|NCT02320253|63009223|FG002|Overall Study|Lost to Follow-up|1|||
33609185|NCT02320253|63009221|FG000|Overall Study|Death|1|||
33609186|NCT02320253|63009222|FG001|Overall Study|Death|0|||
33609187|NCT02320253|63009223|FG002|Overall Study|Death|1|||
33609188|NCT02276807|63009233|FG000|Overall Study|Withdrawal by Subject|8|||
33609189|NCT02276807|63009234|FG001|Overall Study|Withdrawal by Subject|7|||
33609190|NCT02276807|63009233|FG000|Overall Study|Lost to Follow-up|10|||
33609191|NCT02276807|63009234|FG001|Overall Study|Lost to Follow-up|10|||
33609192|NCT02252965|63009242|FG000|Overall Study|Adverse Event|9|||
33609193|NCT02252965|63009243|FG001|Overall Study|Adverse Event|14|||
33609194|NCT02252965|63009242|FG000|Overall Study|Lost to Follow-up|16|||
33609195|NCT02252965|63009243|FG001|Overall Study|Lost to Follow-up|8|||
33609196|NCT02252965|63009242|FG000|Overall Study|Protocol Violation|4|||
33609197|NCT02252965|63009243|FG001|Overall Study|Protocol Violation|5|||
33609198|NCT02252965|63009242|FG000|Overall Study|Lack of Efficacy|0|||
33609199|NCT02252965|63009243|FG001|Overall Study|Lack of Efficacy|2|||
33609200|NCT02252965|63009242|FG000|Overall Study|Withdrawal by Subject|7|||
33609201|NCT02252965|63009243|FG001|Overall Study|Withdrawal by Subject|9|||
33609202|NCT02252965|63009242|FG000|Overall Study|Other|4|||
33609203|NCT02252965|63009243|FG001|Overall Study|Other|5|||
33609204|NCT02242435|63009253|FG000|Overall Study|Lost to Follow-up|3|||
33609205|NCT02242435|63009254|FG001|Overall Study|Lost to Follow-up|4|||
33609206|NCT02242435|63009253|FG000|Overall Study|Adverse Event|3|||
33499725|NCT03289143|62879577|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
33499726|NCT03289143|62879574|FG000|Overall Study|Withdrawal by Caregiver|0|||
33499727|NCT03289143|62879575|FG001|Overall Study|Withdrawal by Caregiver|1|||
33499728|NCT03289143|62879576|FG002|Overall Study|Withdrawal by Caregiver|0|||
33499729|NCT03289143|62879577|FG003|Overall Study|Withdrawal by Caregiver|0|||
33499730|NCT03289143|62879574|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
33499731|NCT03289143|62879575|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
33499732|NCT03289143|62879576|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
33609207|NCT02242435|63009254|FG001|Overall Study|Adverse Event|2|||
33609208|NCT02242435|63009253|FG000|Overall Study|Withdrawal by Subject|13|||
33609209|NCT02242435|63009254|FG001|Overall Study|Withdrawal by Subject|8|||
33609210|NCT02242435|63009253|FG000|Overall Study|Death|0|||
33609211|NCT02242435|63009254|FG001|Overall Study|Death|1|||
33609212|NCT02242435|63009253|FG000|Overall Study|Protocol Violation|1|||
33609213|NCT02242435|63009254|FG001|Overall Study|Protocol Violation|0|||
33609214|NCT02242435|63009253|FG000|Overall Study|Physician Decision|0|||
33609215|NCT02242435|63009254|FG001|Overall Study|Physician Decision|1|||
33609216|NCT02251717|63009262|FG000|Overall Study|Adverse Event|0|||
33609217|NCT02251717|63009263|FG001|Overall Study|Adverse Event|1|||
33609218|NCT02251717|63009262|FG000|Overall Study|Withdrew Consent|1|||
33609219|NCT02251717|63009263|FG001|Overall Study|Withdrew Consent|0|||
33609220|NCT02242201|63009272|FG000|Overall Study|preoperative identified neuropathy|2|||
33609221|NCT02242201|63009273|FG001|Overall Study|preoperative identified neuropathy|0|||
33609222|NCT02242201|63009274|FG002|Overall Study|preoperative identified neuropathy|0|||
33499733|NCT03289143|62879577|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
33499734|NCT03289143|62879574|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
33499735|NCT03289143|62879575|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
33499736|NCT03289143|62879576|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
33499737|NCT03289143|62879577|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
33499738|NCT03311724|62879596|FG000|Overall Study|Physician Decision|0|||
33499739|NCT03311724|62879597|FG001|Overall Study|Physician Decision|0|||
33499740|NCT03311724|62879598|FG002|Overall Study|Physician Decision|0|||
33499741|NCT03311724|62879599|FG003|Overall Study|Physician Decision|1|||
33609223|NCT02242201|63009272|FG000|Overall Study|planned post-op anticoagulation|1|||
33609224|NCT02242201|63009273|FG001|Overall Study|planned post-op anticoagulation|0|||
33609225|NCT02242201|63009274|FG002|Overall Study|planned post-op anticoagulation|0|||
33609226|NCT02242201|63009272|FG000|Overall Study|changed surgical procedure|1|||
33499742|NCT03311724|62879596|FG000|Overall Study|Protocol Violation|1|||
33499743|NCT03311724|62879597|FG001|Overall Study|Protocol Violation|0|||
33609227|NCT02242201|63009273|FG001|Overall Study|changed surgical procedure|0|||
33609228|NCT02242201|63009274|FG002|Overall Study|changed surgical procedure|0|||
33609229|NCT02242201|63009272|FG000|Overall Study|postponed surgery|0|||
33609230|NCT02242201|63009273|FG001|Overall Study|postponed surgery|0|||
33609231|NCT02242201|63009274|FG002|Overall Study|postponed surgery|1|||
33609232|NCT02242201|63009272|FG000|Overall Study|preoperative opioid consumption|0|||
33609233|NCT02242201|63009273|FG001|Overall Study|preoperative opioid consumption|1|||
33609234|NCT02242201|63009274|FG002|Overall Study|preoperative opioid consumption|0|||
33609235|NCT02242045|63009282|FG000|Overall Study|Investigator's Discretion|1|||
33609236|NCT02242045|63009282|FG000|Overall Study|Progressive Disease|2|||
33609237|NCT02242045|63009282|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
33609238|NCT02242045|63009282|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
33448623|NCT00048568|62823609|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
33448624|NCT00048568|62823607|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
33448625|NCT00048568|62823608|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
33448626|NCT00048568|62823609|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
33448627|NCT00048568|62823607|FG000|Open-Label Period|Unknown Reasons|0|||
33448628|NCT00048568|62823608|FG001|Open-Label Period|Unknown Reasons|0|||
33448629|NCT00048568|62823609|FG002|Open-Label Period|Unknown Reasons|25|||
33448630|NCT00048568|62823607|FG000|Open-Label Period|Lost to Follow-up|0|||
33448631|NCT00048568|62823608|FG001|Open-Label Period|Lost to Follow-up|0|||
33448632|NCT00048568|62823609|FG002|Open-Label Period|Lost to Follow-up|7|||
33448633|NCT00262002|62823637|FG000|Overall Study|Adverse Event|2|||
33448634|NCT00262002|62823638|FG001|Overall Study|Adverse Event|1|||
33448635|NCT00262002|62823639|FG002|Overall Study|Adverse Event|0|||
33448636|NCT00262002|62823640|FG003|Overall Study|Adverse Event|0|||
33448637|NCT00262002|62823641|FG004|Overall Study|Adverse Event|0|||
33448638|NCT00262002|62823642|FG005|Overall Study|Adverse Event|1|||
33448639|NCT00262002|62823643|FG006|Overall Study|Adverse Event|0|||
33448640|NCT00262002|62823637|FG000|Overall Study|Withdrawal by Subject|4|||
33448641|NCT00262002|62823638|FG001|Overall Study|Withdrawal by Subject|2|||
33448642|NCT00262002|62823639|FG002|Overall Study|Withdrawal by Subject|0|||
33448643|NCT00262002|62823640|FG003|Overall Study|Withdrawal by Subject|1|||
33499744|NCT03311724|62879598|FG002|Overall Study|Protocol Violation|1|||
33499745|NCT03311724|62879599|FG003|Overall Study|Protocol Violation|0|||
33499746|NCT03311724|62879596|FG000|Overall Study|Withdrawal by Subject|1|||
33499747|NCT03311724|62879597|FG001|Overall Study|Withdrawal by Subject|1|||
33609239|NCT02241889|63009286|FG000|Overall Study|device issues|0|||
33609240|NCT02241889|63009287|FG001|Overall Study|device issues|0|||
33609241|NCT02241889|63009288|FG002|Overall Study|device issues|1|||
33609242|NCT02241889|63009289|FG003|Overall Study|device issues|0|||
33609243|NCT02241889|63009290|FG004|Overall Study|device issues|0|||
33609244|NCT02241889|63009291|FG005|Overall Study|device issues|0|||
33609245|NCT02241889|63009286|FG000|Overall Study|Withdrawal by Subject|0|||
33609246|NCT02241889|63009287|FG001|Overall Study|Withdrawal by Subject|0|||
33609247|NCT02241889|63009288|FG002|Overall Study|Withdrawal by Subject|0|||
33609248|NCT02241889|63009289|FG003|Overall Study|Withdrawal by Subject|0|||
33609249|NCT02241889|63009290|FG004|Overall Study|Withdrawal by Subject|0|||
33609250|NCT02241889|63009291|FG005|Overall Study|Withdrawal by Subject|1|||
33609251|NCT02241733|63009301|FG000|Overall Study|Lost to Follow-up|9|||
33609252|NCT02241733|63009302|FG001|Overall Study|Lost to Follow-up|4|||
33609253|NCT02241733|63009301|FG000|Overall Study|Physician Decision|6|||
33609254|NCT02241733|63009302|FG001|Overall Study|Physician Decision|2|||
33609255|NCT02241733|63009301|FG000|Overall Study|Withdrawal by Subject|0|||
33609256|NCT02241733|63009302|FG001|Overall Study|Withdrawal by Subject|2|||
33609257|NCT02241733|63009301|FG000|Overall Study|Death|0|||
33609258|NCT02241733|63009302|FG001|Overall Study|Death|2|||
33609259|NCT02241343|63009308|FG000|Overall Study|Adverse Event|1|||
33609260|NCT02241187|63009313|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
33609261|NCT02249767|63009320|FG000|Overall Study|Did not use medication|8|||
33609262|NCT02249767|63009321|FG001|Overall Study|Did not use medication|9|||
33609263|NCT02249767|63009322|FG002|Overall Study|Did not use medication|8|||
33609264|NCT02239939|63009332|FG000|Overall Study|Adverse Event|1|||
33609265|NCT02239939|63009333|FG001|Overall Study|Adverse Event|0|||
33609266|NCT02239939|63009332|FG000|Overall Study|Withdrawal by Subject|1|||
33609267|NCT02239939|63009333|FG001|Overall Study|Withdrawal by Subject|1|||
33609268|NCT02239939|63009332|FG000|Overall Study|Lost to Follow-up|0|||
33609269|NCT02239939|63009333|FG001|Overall Study|Lost to Follow-up|1|||
33609270|NCT02248675|63009343|FG000|Overall Study|Lost to Follow-up|3|||
33609271|NCT02248675|63009344|FG001|Overall Study|Lost to Follow-up|1|||
33609272|NCT02238379|63009352|FG000|Overall Study|Lost to Follow-up|1|||
33609273|NCT02238379|63009353|FG001|Overall Study|Lost to Follow-up|0|||
33609274|NCT02238067|63009359|FG000|Overall Study|Not completed survey at Month 6|45|||
33609275|NCT02237911|63009366|FG000|Overall Study|Withdrawal by Subject|4|||
33609276|NCT02237911|63009367|FG001|Overall Study|Withdrawal by Subject|7|||
33448644|NCT00262002|62823641|FG004|Overall Study|Withdrawal by Subject|2|||
33448645|NCT00262002|62823642|FG005|Overall Study|Withdrawal by Subject|2|||
33499748|NCT03311724|62879598|FG002|Overall Study|Withdrawal by Subject|0|||
33499749|NCT03311724|62879599|FG003|Overall Study|Withdrawal by Subject|0|||
33499750|NCT03311724|62879596|FG000|Overall Study|Lost to Follow-up|1|||
33499751|NCT03311724|62879597|FG001|Overall Study|Lost to Follow-up|0|||
33499752|NCT03311724|62879598|FG002|Overall Study|Lost to Follow-up|0|||
33499753|NCT03311724|62879599|FG003|Overall Study|Lost to Follow-up|0|||
33499754|NCT03311724|62879596|FG000|Overall Study|Sponsor Decision|0|||
33499755|NCT03311724|62879597|FG001|Overall Study|Sponsor Decision|0|||
33499756|NCT03311724|62879598|FG002|Overall Study|Sponsor Decision|1|||
33499757|NCT03311724|62879599|FG003|Overall Study|Sponsor Decision|0|||
33499758|NCT03311646|62879621|FG000|Overall Study|Physician Decision|1|||
33499759|NCT03311646|62879621|FG000|Overall Study|Withdrawal by Subject|5|||
33499760|NCT03311646|62879621|FG000|Overall Study|Lost to Follow-up|5|||
33499761|NCT03311646|62879621|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
33499762|NCT01672892|62879628|FG000|Overall Study|Protocol Violation|7|||
33499763|NCT01672892|62879629|FG001|Overall Study|Protocol Violation|3|||
33499764|NCT03288987|62879640|FG000|Overall Study|Protocol Violation|10|||
33499765|NCT03288987|62879641|FG001|Overall Study|Protocol Violation|4|||
33499766|NCT02939781|62879647|FG000|Overall Study|Protocol Violation|8|||
33499767|NCT02939781|62879647|FG000|Overall Study|Withdrawal by Subject|1|||
33499768|NCT03083990|62879663|FG000|Overall Study|Adverse Event|1|||
33499769|NCT03083990|62879664|FG001|Overall Study|Adverse Event|0|||
33609277|NCT02237911|63009368|FG002|Overall Study|Withdrawal by Subject|2|||
33609278|NCT02237911|63009366|FG000|Overall Study|Lost to Follow-up|3|||
33609279|NCT02237911|63009367|FG001|Overall Study|Lost to Follow-up|1|||
33609280|NCT02237911|63009368|FG002|Overall Study|Lost to Follow-up|1|||
33609281|NCT02234479|63009378|FG000|Overall Study|Withdrawal by Subject|1|||
33448646|NCT00262002|62823643|FG006|Overall Study|Withdrawal by Subject|2|||
33448647|NCT00262002|62823637|FG000|Overall Study|Lost to Follow-up|2|||
33448648|NCT00262002|62823638|FG001|Overall Study|Lost to Follow-up|0|||
33448649|NCT00262002|62823639|FG002|Overall Study|Lost to Follow-up|0|||
33448650|NCT00262002|62823640|FG003|Overall Study|Lost to Follow-up|2|||
33448651|NCT00262002|62823641|FG004|Overall Study|Lost to Follow-up|0|||
33448652|NCT00262002|62823642|FG005|Overall Study|Lost to Follow-up|1|||
33499770|NCT03252015|62879682|FG000|Overall Study|Withdrawal by Subject|0|||
33609282|NCT02234479|63009379|FG001|Overall Study|Withdrawal by Subject|3|||
33609283|NCT02207491|63009387|FG000|Overall Study|Adverse Event|20|||
33609284|NCT02207491|63009388|FG001|Overall Study|Adverse Event|4|||
33609285|NCT02207491|63009387|FG000|Overall Study|Withdrawal by Subject|3|||
33499771|NCT03252015|62879683|FG001|Overall Study|Withdrawal by Subject|1|||
33448653|NCT00262002|62823643|FG006|Overall Study|Lost to Follow-up|0|||
33448654|NCT00262002|62823637|FG000|Overall Study|Inapropriate enrollment|0|||
33499772|NCT03252015|62879684|FG002|Overall Study|Withdrawal by Subject|1|||
33499773|NCT03252015|62879685|FG003|Overall Study|Withdrawal by Subject|0|||
33499774|NCT03252015|62879682|FG000|Overall Study|Adverse Event|1|||
33499775|NCT03252015|62879683|FG001|Overall Study|Adverse Event|0|||
33499776|NCT03252015|62879684|FG002|Overall Study|Adverse Event|0|||
33499777|NCT03252015|62879685|FG003|Overall Study|Adverse Event|1|||
33499778|NCT03083132|62879711|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
33499779|NCT03083132|62879712|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
33499780|NCT03083132|62879711|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
33499781|NCT03083132|62879712|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
33499782|NCT03083132|62879711|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
33499783|NCT03083132|62879712|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
33499784|NCT03683823|62879720|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
33499785|NCT03683823|62879721|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
33499786|NCT03683823|62879720|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
33499787|NCT03683823|62879721|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
33499788|NCT03683823|62879720|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
33499789|NCT03683823|62879721|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
33499790|NCT03285711|62879729|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
33499791|NCT03285711|62879730|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
33499792|NCT03285711|62879731|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
33499793|NCT03285711|62879732|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
33499794|NCT03285711|62879729|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
33499795|NCT03285711|62879730|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
33499796|NCT03285711|62879731|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
33499797|NCT03285711|62879732|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
33499798|NCT03285711|62879729|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
33609286|NCT02207491|63009388|FG001|Overall Study|Withdrawal by Subject|2|||
33609287|NCT02207491|63009387|FG000|Overall Study|Non-compliant|0|||
33609288|NCT02207491|63009388|FG001|Overall Study|Non-compliant|1|||
33499799|NCT03285711|62879730|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
33499800|NCT03285711|62879731|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
33499801|NCT03285711|62879732|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
33499802|NCT03285711|62879729|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
33499803|NCT03285711|62879730|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
33499804|NCT03285711|62879731|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
33609289|NCT02207491|63009387|FG000|Overall Study|Lost to Follow-up|0|||
33609290|NCT02207491|63009388|FG001|Overall Study|Lost to Follow-up|1|||
33609291|NCT02207491|63009387|FG000|Overall Study|Lack of Efficacy|3|||
33324032|NCT01121406|62700431|FG001|Overall Study|Lost to Follow-up|1|||
33324033|NCT01121406|62700430|FG000|Overall Study|Refused continuation of study med.|1|||
33448655|NCT00262002|62823638|FG001|Overall Study|Inapropriate enrollment|1|||
33448656|NCT00262002|62823639|FG002|Overall Study|Inapropriate enrollment|0|||
33448657|NCT00262002|62823640|FG003|Overall Study|Inapropriate enrollment|0|||
33448658|NCT00262002|62823641|FG004|Overall Study|Inapropriate enrollment|0|||
33448659|NCT00262002|62823642|FG005|Overall Study|Inapropriate enrollment|0|||
33448660|NCT00262002|62823643|FG006|Overall Study|Inapropriate enrollment|0|||
33448661|NCT00262002|62823637|FG000|Overall Study|Protocol Violation|3|||
33448662|NCT00262002|62823638|FG001|Overall Study|Protocol Violation|2|||
33448663|NCT00262002|62823639|FG002|Overall Study|Protocol Violation|0|||
33448664|NCT00262002|62823640|FG003|Overall Study|Protocol Violation|2|||
33448665|NCT00262002|62823641|FG004|Overall Study|Protocol Violation|5|||
33609292|NCT02207491|63009388|FG001|Overall Study|Lack of Efficacy|0|||
33609293|NCT02207491|63009387|FG000|Overall Study|Physician Decision|2|||
33609294|NCT02207491|63009388|FG001|Overall Study|Physician Decision|0|||
33324034|NCT01121406|62700431|FG001|Overall Study|Refused continuation of study med.|2|||
33448666|NCT00262002|62823642|FG005|Overall Study|Protocol Violation|3|||
33448667|NCT00262002|62823643|FG006|Overall Study|Protocol Violation|2|||
33499805|NCT03285711|62879732|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
33499806|NCT02927366|62879744|FG000|Overall Study|Adverse Event|1|||
33499807|NCT02927366|62879745|FG001|Overall Study|Adverse Event|0|||
33499808|NCT02927366|62879744|FG000|Overall Study|Patient schedule|1|||
33499809|NCT02927366|62879745|FG001|Overall Study|Patient schedule|0|||
33499810|NCT03249909|62879754|FG000|Overall Study|Withdrawal by Subject|3|||
33499811|NCT03249909|62879755|FG001|Overall Study|Withdrawal by Subject|0|||
33499812|NCT03249909|62879756|FG002|Overall Study|Withdrawal by Subject|0|||
33609295|NCT02207491|63009387|FG000|Overall Study|Protocol Violation|3|||
33499813|NCT03249909|62879754|FG000|Overall Study|Adverse Event|3|||
33499814|NCT03249909|62879755|FG001|Overall Study|Adverse Event|0|||
33499815|NCT03249909|62879756|FG002|Overall Study|Adverse Event|0|||
33499816|NCT03249909|62879754|FG000|Overall Study|Lost to Follow-up|0|||
33499817|NCT03249909|62879755|FG001|Overall Study|Lost to Follow-up|1|||
33609296|NCT02207491|63009388|FG001|Overall Study|Protocol Violation|5|||
33609297|NCT02315066|63009408|FG000|Overall Study|Lost to Follow-up|0|||
33609298|NCT02315066|63009409|FG001|Overall Study|Lost to Follow-up|1|||
33609299|NCT02315066|63009410|FG002|Overall Study|Lost to Follow-up|1|||
33609300|NCT02315066|63009411|FG003|Overall Study|Lost to Follow-up|0|||
33609301|NCT02315066|63009412|FG004|Overall Study|Lost to Follow-up|1|||
33609302|NCT02315066|63009413|FG005|Overall Study|Lost to Follow-up|0|||
33609303|NCT02315066|63009414|FG006|Overall Study|Lost to Follow-up|2|||
33609304|NCT02315066|63009415|FG007|Overall Study|Lost to Follow-up|1|||
33609305|NCT02315066|63009416|FG008|Overall Study|Lost to Follow-up|0|||
33609306|NCT02315066|63009417|FG009|Overall Study|Lost to Follow-up|0|||
33609307|NCT02315066|63009418|FG010|Overall Study|Lost to Follow-up|1|||
33609308|NCT02315066|63009419|FG011|Overall Study|Lost to Follow-up|2|||
33609309|NCT02315066|63009420|FG012|Overall Study|Lost to Follow-up|0|||
33609310|NCT02315066|63009421|FG013|Overall Study|Lost to Follow-up|4|||
33609311|NCT02315066|63009408|FG000|Overall Study|Death|2|||
33609312|NCT02315066|63009409|FG001|Overall Study|Death|7|||
33609313|NCT02315066|63009410|FG002|Overall Study|Death|6|||
33609314|NCT02315066|63009411|FG003|Overall Study|Death|11|||
33609315|NCT02315066|63009412|FG004|Overall Study|Death|10|||
33609316|NCT02315066|63009413|FG005|Overall Study|Death|3|||
33609317|NCT02315066|63009414|FG006|Overall Study|Death|9|||
33609318|NCT02315066|63009415|FG007|Overall Study|Death|9|||
33448668|NCT00262002|62823637|FG000|Overall Study|Unable to classify|0|||
33448669|NCT00262002|62823638|FG001|Overall Study|Unable to classify|0|||
33448670|NCT00262002|62823639|FG002|Overall Study|Unable to classify|0|||
33448671|NCT00262002|62823640|FG003|Overall Study|Unable to classify|0|||
33448672|NCT00262002|62823641|FG004|Overall Study|Unable to classify|0|||
33448673|NCT00262002|62823642|FG005|Overall Study|Unable to classify|0|||
33448674|NCT00262002|62823643|FG006|Overall Study|Unable to classify|2|||
33448675|NCT00281528|62823711|FG000|Overall Study|Progressive Disease|28|||
33448676|NCT00281528|62823712|FG001|Overall Study|Progressive Disease|18|||
33448677|NCT00281528|62823713|FG002|Overall Study|Progressive Disease|27|||
33448678|NCT00281528|62823711|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
33448679|NCT00281528|62823712|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
33448680|NCT00281528|62823713|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
33448681|NCT00281528|62823711|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
33448682|NCT00281528|62823712|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
33448683|NCT00281528|62823713|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
33448684|NCT00281528|62823711|FG000|Overall Study|Physician Decision|11|||
33448685|NCT00281528|62823712|FG001|Overall Study|Physician Decision|4|||
33448686|NCT00281528|62823713|FG002|Overall Study|Physician Decision|5|||
33448687|NCT00281528|62823711|FG000|Overall Study|Protocol Violation|1|||
33448688|NCT00281528|62823712|FG001|Overall Study|Protocol Violation|0|||
33448689|NCT00281528|62823713|FG002|Overall Study|Protocol Violation|1|||
33448690|NCT00281528|62823711|FG000|Overall Study|Withdrawal by Subject|5|||
33448691|NCT00281528|62823712|FG001|Overall Study|Withdrawal by Subject|5|||
33448692|NCT00281528|62823713|FG002|Overall Study|Withdrawal by Subject|7|||
33448693|NCT00281528|62823711|FG000|Overall Study|Other|6|||
33448694|NCT00281528|62823712|FG001|Overall Study|Other|3|||
33448695|NCT00281528|62823713|FG002|Overall Study|Other|5|||
33448696|NCT00280748|62823721|FG000|Overall Study|Decline in performance|3|||
33448697|NCT00280748|62823721|FG000|Overall Study|Extra-cranial disease progression|1|||
33448698|NCT00271856|62823727|FG000|Overall Study|Withdrawal by Subject|1|||
33448699|NCT00271856|62823728|FG001|Overall Study|Withdrawal by Subject|7|||
33448700|NCT00271856|62823727|FG000|Overall Study|Lost to Follow-up|10|||
33448701|NCT00271856|62823728|FG001|Overall Study|Lost to Follow-up|11|||
33448702|NCT00061048|62823734|FG000|Overall Study|Adverse Event|2|||
33448703|NCT00061048|62823734|FG000|Overall Study|disease progression|20|||
33448704|NCT00270998|62823741|FG000|3 Month Follow-up|Adverse Event|1|||
33499818|NCT03249909|62879756|FG002|Overall Study|Lost to Follow-up|0|||
33499819|NCT03081884|62879767|FG000|Overall Study|deferred prostate cancer treatment|1|||
33499820|NCT03081884|62879767|FG000|Overall Study|metastasis managed with systemic therapy|3|||
33499821|NCT03077438|62879774|FG000|Overall Study|Protocol Violation|3|||
33499822|NCT03077438|62879775|FG001|Overall Study|Protocol Violation|5|||
33499823|NCT03077438|62879774|FG000|Overall Study|Withdrawal by Subject|3|||
33499824|NCT03077438|62879775|FG001|Overall Study|Withdrawal by Subject|6|||
33499825|NCT03077438|62879774|FG000|Overall Study|Lost to Follow-up|6|||
33499826|NCT03077438|62879775|FG001|Overall Study|Lost to Follow-up|3|||
33499827|NCT03076970|62879785|FG000|Washout Period 2|Adverse Event|0|||
33499828|NCT03076970|62879786|FG001|Washout Period 2|Adverse Event|0|||
33499829|NCT03076970|62879787|FG002|Washout Period 2|Adverse Event|0|||
33499830|NCT03076970|62879788|FG003|Washout Period 2|Adverse Event|0|||
33499831|NCT03076970|62879789|FG004|Washout Period 2|Adverse Event|1|||
33499832|NCT03076970|62879790|FG005|Washout Period 2|Adverse Event|0|||
33499833|NCT03076970|62879785|FG000|Period 3|Withdrawal by Subject|0|||
33499834|NCT03076970|62879786|FG001|Period 3|Withdrawal by Subject|0|||
33499835|NCT03076970|62879787|FG002|Period 3|Withdrawal by Subject|0|||
33499836|NCT03076970|62879788|FG003|Period 3|Withdrawal by Subject|0|||
33499837|NCT03076970|62879789|FG004|Period 3|Withdrawal by Subject|0|||
33499838|NCT03076970|62879790|FG005|Period 3|Withdrawal by Subject|1|||
33499839|NCT03076970|62879785|FG000|Period 3|Failure to meet I/E criteria|0|||
33499840|NCT03076970|62879786|FG001|Period 3|Failure to meet I/E criteria|0|||
33499841|NCT03076970|62879787|FG002|Period 3|Failure to meet I/E criteria|0|||
33499842|NCT03076970|62879788|FG003|Period 3|Failure to meet I/E criteria|0|||
33499843|NCT03076970|62879789|FG004|Period 3|Failure to meet I/E criteria|1|||
33499844|NCT03076970|62879790|FG005|Period 3|Failure to meet I/E criteria|0|||
33499845|NCT00726596|62879803|FG000|Overall Study|Adverse Event|2|||
33499846|NCT00726596|62879804|FG001|Overall Study|Adverse Event|1|||
33499847|NCT00726596|62879803|FG000|Overall Study|Withdrawal by Subject|3|||
33499848|NCT00726596|62879804|FG001|Overall Study|Withdrawal by Subject|3|||
33499849|NCT02890992|62879827|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
33499850|NCT02890992|62879828|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
33499851|NCT02890992|62879829|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
33499852|NCT02890992|62879830|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
33499853|NCT02890992|62879831|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
33499854|NCT02890992|62879832|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
33499855|NCT02890992|62879833|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
33499856|NCT02890992|62879834|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
33499857|NCT02890992|62879827|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
33499858|NCT02890992|62879828|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
33499859|NCT02890992|62879829|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
33499860|NCT02890992|62879830|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
33499861|NCT02890992|62879831|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
33499862|NCT02890992|62879832|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
33499863|NCT02890992|62879833|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
33499864|NCT02890992|62879834|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
33499865|NCT02890992|62879827|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
33499866|NCT02890992|62879828|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
33499867|NCT02890992|62879829|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
33499868|NCT02890992|62879830|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
33499869|NCT02890992|62879831|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
33499870|NCT02890992|62879832|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
33499871|NCT02890992|62879833|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
33499872|NCT02890992|62879834|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
33499873|NCT03076190|62879879|FG000|Overall Study|Lost to Follow-up|9|||
33499874|NCT03076190|62879880|FG001|Overall Study|Lost to Follow-up|34|||
33499875|NCT03076190|62879879|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
33499876|NCT03076190|62879880|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
33499877|NCT03329196|62879891|FG000|Overall Study|Adverse Event|10|||
33499878|NCT03329196|62879892|FG001|Overall Study|Adverse Event|5|||
33499879|NCT03329196|62879891|FG000|Overall Study|Physician Decision|2|||
33499880|NCT03329196|62879892|FG001|Overall Study|Physician Decision|2|||
33499881|NCT03329196|62879891|FG000|Overall Study|Withdrawal by Subject|11|||
33499882|NCT03329196|62879892|FG001|Overall Study|Withdrawal by Subject|3|||
33499883|NCT03329196|62879891|FG000|Overall Study|Hepatic function abnormalities|0|||
33499884|NCT03329196|62879892|FG001|Overall Study|Hepatic function abnormalities|1|||
33499885|NCT03329196|62879891|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
33499886|NCT03329196|62879892|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
33499887|NCT03329196|62879891|FG000|Overall Study|Difficult to control Hb|2|||
33609319|NCT02315066|63009416|FG008|Overall Study|Death|10|||
33609320|NCT02315066|63009417|FG009|Overall Study|Death|8|||
33499888|NCT03329196|62879892|FG001|Overall Study|Difficult to control Hb|3|||
33499889|NCT03329196|62879891|FG000|Overall Study|Dialysis or renal transplant|13|||
33499890|NCT03329196|62879892|FG001|Overall Study|Dialysis or renal transplant|15|||
33499891|NCT03328182|62879898|FG000|Overall Study|Withdrawal by Subject|1|||
33499892|NCT03328182|62879898|FG000|Overall Study|Protocol Violation|2|||
33499893|NCT03328182|62879898|FG000|Overall Study|No Product Evaluated|1|||
33499894|NCT03327402|62879902|FG000|Overall Study|Withdrawal by Subject|1|||
33499895|NCT03327402|62879902|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
33499896|NCT03075878|62879906|FG000|Overall Study|Physician Decision|1|||
33499897|NCT03326856|62879915|FG000|Overall Study|Lost to Follow-up|1|||
33499898|NCT03326856|62879916|FG001|Overall Study|Lost to Follow-up|1|||
33499899|NCT03326856|62879917|FG002|Overall Study|Lost to Follow-up|0|||
33499900|NCT03326856|62879918|FG003|Overall Study|Lost to Follow-up|0|||
33499901|NCT03326856|62879919|FG004|Overall Study|Lost to Follow-up|0|||
33499902|NCT03309696|62879933|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
33499903|NCT03309696|62879934|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
33499904|NCT03309696|62879935|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
33499905|NCT03309696|62879936|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
33499906|NCT03075644|62879950|FG000|Overall Study|Withdrawal by Subject|1|||
33499907|NCT03075644|62879951|FG001|Overall Study|Withdrawal by Subject|1|||
33499908|NCT03075410|62879967|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
33499909|NCT03075410|62879968|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
33499910|NCT03075410|62879969|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
33499911|NCT03075410|62879970|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
33499912|NCT03075410|62879971|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
33499913|NCT03075410|62879972|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
33499914|NCT03075410|62879973|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
33499915|NCT03075410|62879974|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
33499916|NCT03075410|62879975|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
33499917|NCT03075410|62879967|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
33499918|NCT03075410|62879968|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33499919|NCT03075410|62879969|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33499920|NCT03075410|62879970|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33499921|NCT03075410|62879971|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33499922|NCT03075410|62879972|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33499923|NCT03075410|62879973|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33499924|NCT03075410|62879974|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33499925|NCT03075410|62879975|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33499926|NCT03071276|62880017|FG000|Overall Study|Adverse Event|1|||
33499927|NCT03071276|62880017|FG000|Overall Study|Lack of Efficacy|14|||
33499928|NCT03074162|62880027|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
33499929|NCT03074162|62880028|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
33499930|NCT03074162|62880029|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
33499931|NCT03074162|62880030|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
33499932|NCT03074162|62880031|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
33499933|NCT03074162|62880032|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
33499934|NCT03074162|62880027|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
33499935|NCT03074162|62880028|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
33499936|NCT03074162|62880029|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
33499937|NCT03074162|62880030|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
33499938|NCT03074162|62880031|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
33499939|NCT03074162|62880032|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
33499940|NCT03074162|62880027|FG000|Period 3|Withdrawal by Subject|1|||
33499941|NCT03074162|62880028|FG001|Period 3|Withdrawal by Subject|0|||
33499942|NCT03074162|62880029|FG002|Period 3|Withdrawal by Subject|0|||
33499943|NCT03074162|62880030|FG003|Period 3|Withdrawal by Subject|0|||
33499944|NCT03074162|62880031|FG004|Period 3|Withdrawal by Subject|1|||
33499945|NCT03074162|62880032|FG005|Period 3|Withdrawal by Subject|0|||
33499946|NCT03070964|62880040|FG000|Overall Study|Progressive disease|8|||
33499947|NCT03070964|62880040|FG000|Overall Study|Treatment-unrelated adverse event|2|||
33499948|NCT03070964|62880040|FG000|Overall Study|Never treated|1|||
33499949|NCT03070964|62880040|FG000|Overall Study|Physician Decision|1|||
33499950|NCT03070964|62880040|FG000|Overall Study|Withdrawal by Subject|1|||
33499951|NCT03070964|62880040|FG000|Overall Study|Adverse Event|1|||
33609321|NCT02315066|63009418|FG010|Overall Study|Death|10|||
33609322|NCT02315066|63009419|FG011|Overall Study|Death|7|||
33609323|NCT02315066|63009420|FG012|Overall Study|Death|8|||
33609324|NCT02315066|63009421|FG013|Overall Study|Death|21|||
33609325|NCT02315066|63009408|FG000|Overall Study|Other|0|||
33609326|NCT02315066|63009409|FG001|Overall Study|Other|0|||
33609327|NCT02315066|63009410|FG002|Overall Study|Other|0|||
33609328|NCT02315066|63009411|FG003|Overall Study|Other|0|||
33609329|NCT02315066|63009412|FG004|Overall Study|Other|0|||
33609330|NCT02315066|63009413|FG005|Overall Study|Other|0|||
33609331|NCT02315066|63009414|FG006|Overall Study|Other|0|||
33609332|NCT02315066|63009415|FG007|Overall Study|Other|1|||
33609333|NCT02315066|63009416|FG008|Overall Study|Other|1|||
33609334|NCT02315066|63009417|FG009|Overall Study|Other|2|||
33609335|NCT02315066|63009418|FG010|Overall Study|Other|0|||
33609336|NCT02315066|63009419|FG011|Overall Study|Other|0|||
33609337|NCT02315066|63009420|FG012|Overall Study|Other|0|||
33609338|NCT02315066|63009421|FG013|Overall Study|Other|0|||
33609339|NCT02315066|63009408|FG000|Overall Study|Subject refused further follow-up|0|||
33609340|NCT02315066|63009409|FG001|Overall Study|Subject refused further follow-up|2|||
33609341|NCT02315066|63009410|FG002|Overall Study|Subject refused further follow-up|2|||
33609342|NCT02315066|63009411|FG003|Overall Study|Subject refused further follow-up|0|||
33609343|NCT02315066|63009412|FG004|Overall Study|Subject refused further follow-up|0|||
33609344|NCT02315066|63009413|FG005|Overall Study|Subject refused further follow-up|0|||
33609345|NCT02315066|63009414|FG006|Overall Study|Subject refused further follow-up|2|||
33609346|NCT02315066|63009415|FG007|Overall Study|Subject refused further follow-up|3|||
33609347|NCT02315066|63009416|FG008|Overall Study|Subject refused further follow-up|0|||
33609348|NCT02315066|63009417|FG009|Overall Study|Subject refused further follow-up|1|||
33609349|NCT02315066|63009418|FG010|Overall Study|Subject refused further follow-up|1|||
33609350|NCT02315066|63009419|FG011|Overall Study|Subject refused further follow-up|2|||
33499952|NCT04065074|62880044|FG000|Overall Study|Adverse Event|1|||
33499953|NCT04065074|62880044|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
33499954|NCT02888106|62880054|FG000|Overall Study|Withdrawal by Subject|1|||
33499955|NCT02888106|62880055|FG001|Overall Study|Withdrawal by Subject|2|||
33499956|NCT02888106|62880056|FG002|Overall Study|Withdrawal by Subject|0|||
33499957|NCT02888106|62880057|FG003|Overall Study|Withdrawal by Subject|1|||
33499958|NCT02888106|62880058|FG004|Overall Study|Withdrawal by Subject|0|||
33499959|NCT02888106|62880059|FG005|Overall Study|Withdrawal by Subject|0|||
33499960|NCT02888106|62880054|FG000|Overall Study|Lost to Follow-up|1|||
33499961|NCT02888106|62880055|FG001|Overall Study|Lost to Follow-up|0|||
33499962|NCT02888106|62880056|FG002|Overall Study|Lost to Follow-up|0|||
33499963|NCT02888106|62880057|FG003|Overall Study|Lost to Follow-up|1|||
33499964|NCT02888106|62880058|FG004|Overall Study|Lost to Follow-up|0|||
33499965|NCT02888106|62880059|FG005|Overall Study|Lost to Follow-up|1|||
33499966|NCT02888106|62880054|FG000|Overall Study|Adverse Event|2|||
33499967|NCT02888106|62880055|FG001|Overall Study|Adverse Event|0|||
33499968|NCT02888106|62880056|FG002|Overall Study|Adverse Event|0|||
33499969|NCT02888106|62880057|FG003|Overall Study|Adverse Event|0|||
33499970|NCT02888106|62880058|FG004|Overall Study|Adverse Event|0|||
33499971|NCT02888106|62880059|FG005|Overall Study|Adverse Event|0|||
33499972|NCT02888106|62880054|FG000|Overall Study|Withdrawal of consent|0|||
33499973|NCT02888106|62880055|FG001|Overall Study|Withdrawal of consent|0|||
33499974|NCT02888106|62880056|FG002|Overall Study|Withdrawal of consent|0|||
33609351|NCT02315066|63009420|FG012|Overall Study|Subject refused further follow-up|2|||
33609352|NCT02315066|63009421|FG013|Overall Study|Subject refused further follow-up|4|||
33609353|NCT02315066|63009408|FG000|Overall Study|Study ongoing at date of cut-off|0|||
33609354|NCT02315066|63009409|FG001|Overall Study|Study ongoing at date of cut-off|0|||
33609355|NCT02315066|63009410|FG002|Overall Study|Study ongoing at date of cut-off|0|||
33609356|NCT02315066|63009411|FG003|Overall Study|Study ongoing at date of cut-off|0|||
33609357|NCT02315066|63009412|FG004|Overall Study|Study ongoing at date of cut-off|0|||
33448705|NCT00270998|62823742|FG001|3 Month Follow-up|Adverse Event|0|||
33448706|NCT00270998|62823743|FG002|3 Month Follow-up|Adverse Event|0|||
33448707|NCT00270998|62823741|FG000|3 Month Follow-up|Lack of Efficacy|1|||
33448708|NCT00270998|62823742|FG001|3 Month Follow-up|Lack of Efficacy|2|||
33448709|NCT00270998|62823743|FG002|3 Month Follow-up|Lack of Efficacy|1|||
33448710|NCT00270998|62823741|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
33448711|NCT00270998|62823742|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
33448712|NCT00270998|62823743|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
33448713|NCT00270998|62823741|FG000|3 Month Follow-up|Pessary did not fit|12|||
33448714|NCT00270998|62823742|FG001|3 Month Follow-up|Pessary did not fit|0|||
33448715|NCT00270998|62823743|FG002|3 Month Follow-up|Pessary did not fit|0|||
33448716|NCT00270998|62823741|FG000|3 Month Follow-up|Personal/family health|1|||
33448717|NCT00270998|62823742|FG001|3 Month Follow-up|Personal/family health|1|||
33448718|NCT00270998|62823743|FG002|3 Month Follow-up|Personal/family health|0|||
33448719|NCT00270998|62823741|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
33448720|NCT00270998|62823742|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
33499975|NCT02888106|62880057|FG003|Overall Study|Withdrawal of consent|0|||
33499976|NCT02888106|62880058|FG004|Overall Study|Withdrawal of consent|1|||
33499977|NCT02888106|62880059|FG005|Overall Study|Withdrawal of consent|0|||
33499978|NCT02888106|62880054|FG000|Overall Study|Pregnancy|1|||
33499979|NCT02888106|62880055|FG001|Overall Study|Pregnancy|0|||
33499980|NCT02888106|62880056|FG002|Overall Study|Pregnancy|0|||
33499981|NCT02888106|62880057|FG003|Overall Study|Pregnancy|0|||
33499982|NCT02888106|62880058|FG004|Overall Study|Pregnancy|0|||
33499983|NCT02888106|62880059|FG005|Overall Study|Pregnancy|0|||
33499984|NCT03793010|62880081|FG000|Overall Study|Withdrawal by Subject|5|||
33499985|NCT03793010|62880082|FG001|Overall Study|Withdrawal by Subject|7|||
33499986|NCT03793010|62880081|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
33499987|NCT03793010|62880082|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
33499988|NCT03793010|62880081|FG000|Overall Study|Lost to Follow-up|1|||
33499989|NCT03793010|62880082|FG001|Overall Study|Lost to Follow-up|2|||
33499990|NCT03793010|62880081|FG000|Overall Study|Patient couldn't sit still for injection|1|||
33499991|NCT03793010|62880082|FG001|Overall Study|Patient couldn't sit still for injection|0|||
33499992|NCT03793010|62880081|FG000|Overall Study|Withdrew to pursue other treatment|1|||
33499993|NCT03793010|62880082|FG001|Overall Study|Withdrew to pursue other treatment|0|||
33499994|NCT03793010|62880081|FG000|Overall Study|Did not meet eligibility criteria|1|||
33499995|NCT03793010|62880082|FG001|Overall Study|Did not meet eligibility criteria|0|||
33499996|NCT03304626|62880090|FG000|Overall Study|Adverse Event|1|||
33499997|NCT03304626|62880091|FG001|Overall Study|Adverse Event|0|||
33499998|NCT03304626|62880090|FG000|Overall Study|Lack of Efficacy|1|||
33499999|NCT03304626|62880091|FG001|Overall Study|Lack of Efficacy|1|||
33500000|NCT03274986|62880100|FG000|Overall Study|Withdrawal by Subject|0|||
33609358|NCT02315066|63009413|FG005|Overall Study|Study ongoing at date of cut-off|0|||
33609359|NCT02315066|63009414|FG006|Overall Study|Study ongoing at date of cut-off|0|||
33609360|NCT02315066|63009415|FG007|Overall Study|Study ongoing at date of cut-off|0|||
33609361|NCT02315066|63009416|FG008|Overall Study|Study ongoing at date of cut-off|0|||
33500001|NCT03274986|62880101|FG001|Overall Study|Withdrawal by Subject|1|||
33500002|NCT03274986|62880100|FG000|Overall Study|Lost to Follow-up|0|||
33500003|NCT03274986|62880101|FG001|Overall Study|Lost to Follow-up|1|||
33500004|NCT02919306|62880116|FG000|Overall Study|Withdrawal by Subject|1|||
33500005|NCT02919306|62880117|FG001|Overall Study|Withdrawal by Subject|0|||
33500006|NCT02919306|62880116|FG000|Overall Study|Protocol Violation|1|||
33500007|NCT02919306|62880117|FG001|Overall Study|Protocol Violation|0|||
33500008|NCT03274440|62880123|FG000|Overall Study|Time commitment too great|1|||
33500009|NCT03274440|62880124|FG001|Overall Study|Time commitment too great|0|||
33500010|NCT03274440|62880125|FG002|Overall Study|Time commitment too great|0|||
33500011|NCT03274440|62880126|FG003|Overall Study|Time commitment too great|1|||
33500012|NCT03274440|62880127|FG004|Overall Study|Time commitment too great|0|||
33500013|NCT03274440|62880128|FG005|Overall Study|Time commitment too great|0|||
33500014|NCT03268746|62880136|FG000|Overall Study|Withdrawal by Subject|1|||
33609362|NCT02315066|63009417|FG009|Overall Study|Study ongoing at date of cut-off|0|||
33609363|NCT02315066|63009418|FG010|Overall Study|Study ongoing at date of cut-off|0|||
33609364|NCT02315066|63009419|FG011|Overall Study|Study ongoing at date of cut-off|0|||
33609365|NCT02315066|63009420|FG012|Overall Study|Study ongoing at date of cut-off|0|||
33609366|NCT02315066|63009421|FG013|Overall Study|Study ongoing at date of cut-off|1|||
33500015|NCT03268590|62880147|FG000|Overall Study|Previously unknown exclusion criteria|1|||
33500016|NCT03267576|62880156|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
33500017|NCT03267576|62880157|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
33609367|NCT02207413|63009457|FG000|Overall Study|Withdrawal by Subject|1|||
33500018|NCT03267576|62880156|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
33500019|NCT03267576|62880157|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
33500020|NCT03267264|62880167|FG000|Overall Study|Withdrawal by Subject|1|||
33500021|NCT03267264|62880168|FG001|Overall Study|Withdrawal by Subject|0|||
33500022|NCT03267264|62880169|FG002|Overall Study|Withdrawal by Subject|2|||
33500023|NCT03267264|62880170|FG003|Overall Study|Withdrawal by Subject|4|||
33500024|NCT03244800|62880187|FG000|Overall Study|Adverse Event|0|||
33500025|NCT03244800|62880188|FG001|Overall Study|Adverse Event|1|||
33609368|NCT02207413|63009458|FG001|Overall Study|Withdrawal by Subject|0|||
33609369|NCT02207413|63009459|FG002|Overall Study|Withdrawal by Subject|0|||
33609370|NCT02207413|63009460|FG003|Overall Study|Withdrawal by Subject|0|||
33609371|NCT02207413|63009461|FG004|Overall Study|Withdrawal by Subject|3|||
33609372|NCT02207413|63009462|FG005|Overall Study|Withdrawal by Subject|7|||
33609373|NCT02207413|63009457|FG000|Overall Study|Lost to Follow-up|0|||
33609374|NCT02207413|63009458|FG001|Overall Study|Lost to Follow-up|0|||
33609375|NCT02207413|63009459|FG002|Overall Study|Lost to Follow-up|0|||
33609376|NCT02207413|63009460|FG003|Overall Study|Lost to Follow-up|1|||
33609377|NCT02207413|63009461|FG004|Overall Study|Lost to Follow-up|1|||
33609378|NCT02207413|63009462|FG005|Overall Study|Lost to Follow-up|5|||
33609379|NCT02207413|63009457|FG000|Overall Study|Adverse Event|0|||
33609380|NCT02207413|63009458|FG001|Overall Study|Adverse Event|0|||
33609381|NCT02207413|63009459|FG002|Overall Study|Adverse Event|0|||
33609382|NCT02207413|63009460|FG003|Overall Study|Adverse Event|0|||
33609383|NCT02207413|63009461|FG004|Overall Study|Adverse Event|2|||
33609384|NCT02207413|63009462|FG005|Overall Study|Adverse Event|1|||
33609385|NCT02207413|63009457|FG000|Overall Study|Migrated/moved from study area|0|||
33609386|NCT02207413|63009458|FG001|Overall Study|Migrated/moved from study area|0|||
33609387|NCT02207413|63009459|FG002|Overall Study|Migrated/moved from study area|0|||
33609388|NCT02207413|63009460|FG003|Overall Study|Migrated/moved from study area|0|||
33609389|NCT02207413|63009461|FG004|Overall Study|Migrated/moved from study area|1|||
33609390|NCT02207413|63009462|FG005|Overall Study|Migrated/moved from study area|0|||
33609391|NCT02309372|63009484|FG000|Overall Study|Lost to Follow-up|3|||
33609392|NCT02309372|63009485|FG001|Overall Study|Lost to Follow-up|2|||
33609393|NCT02276027|63009495|FG000|Overall Study|Death|1|||
33609394|NCT02276027|63009496|FG001|Overall Study|Death|0|||
33609395|NCT02276027|63009497|FG002|Overall Study|Death|0|||
33609396|NCT02276027|63009498|FG003|Overall Study|Death|2|||
33609397|NCT02276027|63009495|FG000|Overall Study|Physician Decision|0|||
33609398|NCT02276027|63009496|FG001|Overall Study|Physician Decision|0|||
33609399|NCT02276027|63009497|FG002|Overall Study|Physician Decision|0|||
33609400|NCT02276027|63009498|FG003|Overall Study|Physician Decision|1|||
33500026|NCT03244800|62880189|FG002|Overall Study|Adverse Event|0|||
33500027|NCT03244800|62880190|FG003|Overall Study|Adverse Event|1|||
33500028|NCT03244800|62880187|FG000|Overall Study|Withdrew treatment|0|||
33500029|NCT03244800|62880188|FG001|Overall Study|Withdrew treatment|0|||
33500030|NCT03244800|62880189|FG002|Overall Study|Withdrew treatment|0|||
33500031|NCT03244800|62880190|FG003|Overall Study|Withdrew treatment|1|||
33500032|NCT04516291|62880211|FG000|Treatment Period (24 Weeks)|Other|1|||
33500033|NCT04516291|62880212|FG001|Treatment Period (24 Weeks)|Other|0|||
33500034|NCT04516291|62880213|FG002|Treatment Period (24 Weeks)|Other|0|||
33500035|NCT04516291|62880214|FG003|Treatment Period (24 Weeks)|Other|2|||
33500036|NCT04516291|62880215|FG004|Treatment Period (24 Weeks)|Other|2|||
33500037|NCT04516291|62880216|FG005|Treatment Period (24 Weeks)|Other|4|||
33500038|NCT04516291|62880217|FG006|Treatment Period (24 Weeks)|Other|2|||
33500039|NCT04516291|62880218|FG007|Treatment Period (24 Weeks)|Other|0|||
33500040|NCT04516291|62880211|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33500041|NCT04516291|62880212|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
33500042|NCT04516291|62880213|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
33500043|NCT04516291|62880214|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33500044|NCT04516291|62880215|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
33500045|NCT04516291|62880216|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33609401|NCT02276027|63009495|FG000|Overall Study|Progressive disease|1|||
33609402|NCT02276027|63009496|FG001|Overall Study|Progressive disease|13|||
33609403|NCT02276027|63009497|FG002|Overall Study|Progressive disease|12|||
33609404|NCT02276027|63009498|FG003|Overall Study|Progressive disease|14|||
33609405|NCT02276027|63009495|FG000|Overall Study|Subject/guardian decision|0|||
33500046|NCT04516291|62880217|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33500047|NCT04516291|62880218|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33500048|NCT04516291|62880211|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
33500049|NCT04516291|62880212|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
33500050|NCT04516291|62880213|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
33500051|NCT04516291|62880214|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
33500052|NCT04516291|62880215|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
33609406|NCT02276027|63009496|FG001|Overall Study|Subject/guardian decision|1|||
33609407|NCT02276027|63009497|FG002|Overall Study|Subject/guardian decision|0|||
33609408|NCT02276027|63009498|FG003|Overall Study|Subject/guardian decision|3|||
33609409|NCT02276027|63009495|FG000|Overall Study|Adverse Event|0|||
33500053|NCT04516291|62880216|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
33500054|NCT04516291|62880217|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
33500055|NCT04516291|62880218|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
33500056|NCT04516291|62880211|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33500057|NCT04516291|62880212|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
33500058|NCT04516291|62880213|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33500059|NCT04516291|62880214|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33500060|NCT04516291|62880215|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33500061|NCT04516291|62880216|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33500062|NCT04516291|62880217|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33500063|NCT04516291|62880218|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33500064|NCT04516291|62880211|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
33500065|NCT04516291|62880212|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
33500066|NCT04516291|62880213|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
33500067|NCT04516291|62880214|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
33500068|NCT04516291|62880215|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
33500069|NCT04516291|62880216|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
33500070|NCT04516291|62880217|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
33500071|NCT04516291|62880218|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
33500072|NCT04516291|62880211|FG000|Follow-up Period (12 Weeks)|Other|0|||
33500073|NCT04516291|62880212|FG001|Follow-up Period (12 Weeks)|Other|1|||
33500074|NCT04516291|62880213|FG002|Follow-up Period (12 Weeks)|Other|0|||
33500075|NCT04516291|62880214|FG003|Follow-up Period (12 Weeks)|Other|2|||
33500076|NCT04516291|62880215|FG004|Follow-up Period (12 Weeks)|Other|0|||
33500077|NCT04516291|62880216|FG005|Follow-up Period (12 Weeks)|Other|0|||
33500078|NCT04516291|62880217|FG006|Follow-up Period (12 Weeks)|Other|0|||
33500079|NCT04516291|62880218|FG007|Follow-up Period (12 Weeks)|Other|0|||
33500080|NCT04516291|62880211|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33500081|NCT04516291|62880212|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33500082|NCT04516291|62880213|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33500083|NCT04516291|62880214|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33500084|NCT04516291|62880215|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
33500085|NCT04516291|62880216|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33500086|NCT04516291|62880217|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33500087|NCT04516291|62880218|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33500088|NCT04516291|62880211|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
33500089|NCT04516291|62880212|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
33500090|NCT04516291|62880213|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
33500091|NCT04516291|62880214|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
33500092|NCT04516291|62880215|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
33500093|NCT04516291|62880216|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
33500094|NCT04516291|62880217|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
33500095|NCT04516291|62880218|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
33500096|NCT03243630|62880236|FG000|Overall Study|Protocol Violation|1|||
33500097|NCT03243630|62880236|FG000|Overall Study|Physician Decision|1|||
33500098|NCT04450381|62880244|FG000|Overall Study|Protocol Violation|4|||
33500099|NCT04450381|62880244|FG000|Overall Study|Wrong device setting|2|||
33500100|NCT03068468|62880250|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
33500101|NCT03068468|62880251|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
33500102|NCT03068468|62880252|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
33500103|NCT03068468|62880253|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
33500104|NCT03068468|62880250|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
33500105|NCT03068468|62880251|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
33500106|NCT03068468|62880252|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
33500107|NCT03068468|62880253|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
33500108|NCT03068468|62880250|FG000|Placebo-Controlled Period|Adverse Event|16|||
33500109|NCT03068468|62880251|FG001|Placebo-Controlled Period|Adverse Event|21|||
33500110|NCT03068468|62880252|FG002|Placebo-Controlled Period|Adverse Event|0|||
33500111|NCT03068468|62880253|FG003|Placebo-Controlled Period|Adverse Event|0|||
33500112|NCT03068468|62880250|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
33500113|NCT03068468|62880251|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
33500114|NCT03068468|62880252|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
33500115|NCT03068468|62880253|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
33500116|NCT03068468|62880250|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
33500117|NCT03068468|62880251|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
33500118|NCT03068468|62880252|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33500119|NCT03068468|62880253|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33500120|NCT03068468|62880250|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
33500121|NCT03068468|62880251|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
33609410|NCT02276027|63009496|FG001|Overall Study|Adverse Event|2|||
33609411|NCT02276027|63009497|FG002|Overall Study|Adverse Event|8|||
33609412|NCT02276027|63009498|FG003|Overall Study|Adverse Event|2|||
33609413|NCT02309294|63009508|FG000|Overall Study|Withdrawal by Subject|2|||
33609414|NCT02233543|63009512|FG000|Period 1|Withdrawal by Subject|1|||
33609415|NCT02233543|63009513|FG001|Period 1|Withdrawal by Subject|0|||
33609416|NCT02233543|63009512|FG000|Period 1|Participants required other treatment.|2|||
33609417|NCT02233543|63009513|FG001|Period 1|Participants required other treatment.|3|||
33609418|NCT02233543|63009512|FG000|Period 2|Adverse Event|1|||
33609419|NCT02233543|63009513|FG001|Period 2|Adverse Event|0|||
33609420|NCT02233543|63009512|FG000|Period 2|Participant required other treatment.|0|||
33609421|NCT02233543|63009513|FG001|Period 2|Participant required other treatment.|1|||
33609422|NCT02233543|63009512|FG000|Period 2|COPD exacerbation|1|||
33609423|NCT02233543|63009513|FG001|Period 2|COPD exacerbation|0|||
33609424|NCT02309138|63009521|FG000|Overall Study|Withdrawal by Subject|44|||
33609425|NCT02309138|63009522|FG001|Overall Study|Withdrawal by Subject|15|||
33609426|NCT02309138|63009521|FG000|Overall Study|Protocol Violation|4|||
33609427|NCT02309138|63009522|FG001|Overall Study|Protocol Violation|2|||
33609428|NCT02309138|63009521|FG000|Overall Study|delivered before visit 2|0|||
33609429|NCT02309138|63009522|FG001|Overall Study|delivered before visit 2|1|||
33609430|NCT02233309|63009538|FG000|Overall Study|Physician Decision|5|||
33609431|NCT02204917|63009542|FG000|Overall Study|Protocol Violation|1|||
33609432|NCT02280044|63009551|FG000|Overall Study|Planned alternate|0|||
33609433|NCT02280044|63009552|FG001|Overall Study|Planned alternate|2|||
33609434|NCT02308748|63009558|FG000|Period 1|Withdrawal by Subject|0|||
33609435|NCT02308748|63009559|FG001|Period 1|Withdrawal by Subject|0|||
33609436|NCT02308748|63009560|FG002|Period 1|Withdrawal by Subject|1|||
33609437|NCT02308748|63009561|FG003|Period 1|Withdrawal by Subject|0|||
33609438|NCT02308748|63009562|FG004|Period 1|Withdrawal by Subject|0|||
33609439|NCT02308748|63009563|FG005|Period 1|Withdrawal by Subject|0|||
33609440|NCT02308748|63009564|FG006|Period 1|Withdrawal by Subject|0|||
33609441|NCT02308748|63009565|FG007|Period 1|Withdrawal by Subject|0|||
33609442|NCT02308748|63009566|FG008|Period 1|Withdrawal by Subject|0|||
33609443|NCT02308748|63009567|FG009|Period 1|Withdrawal by Subject|0|||
33609444|NCT02308748|63009558|FG000|Period 2|Adverse Event|0|||
33609445|NCT02308748|63009559|FG001|Period 2|Adverse Event|0|||
33609446|NCT02308748|63009560|FG002|Period 2|Adverse Event|0|||
33609447|NCT02308748|63009561|FG003|Period 2|Adverse Event|0|||
33609448|NCT02308748|63009562|FG004|Period 2|Adverse Event|0|||
33609449|NCT02308748|63009563|FG005|Period 2|Adverse Event|0|||
33609450|NCT02308748|63009564|FG006|Period 2|Adverse Event|0|||
33609451|NCT02308748|63009565|FG007|Period 2|Adverse Event|1|||
33609452|NCT02308748|63009566|FG008|Period 2|Adverse Event|0|||
33609453|NCT02308748|63009567|FG009|Period 2|Adverse Event|0|||
33609454|NCT02308748|63009558|FG000|Period 3|Protocol Violation|0|||
33609455|NCT02308748|63009559|FG001|Period 3|Protocol Violation|0|||
33609456|NCT02308748|63009560|FG002|Period 3|Protocol Violation|0|||
33609457|NCT02308748|63009561|FG003|Period 3|Protocol Violation|0|||
33609458|NCT02308748|63009562|FG004|Period 3|Protocol Violation|0|||
33609459|NCT02308748|63009563|FG005|Period 3|Protocol Violation|0|||
33609460|NCT02308748|63009564|FG006|Period 3|Protocol Violation|0|||
33609461|NCT02308748|63009565|FG007|Period 3|Protocol Violation|0|||
33609462|NCT02308748|63009566|FG008|Period 3|Protocol Violation|0|||
33609463|NCT02308748|63009567|FG009|Period 3|Protocol Violation|1|||
33609464|NCT02308748|63009558|FG000|Period 5|Adverse Event|1|||
33609465|NCT02308748|63009559|FG001|Period 5|Adverse Event|0|||
33609466|NCT02308748|63009560|FG002|Period 5|Adverse Event|0|||
33609467|NCT02308748|63009561|FG003|Period 5|Adverse Event|0|||
33609468|NCT02308748|63009562|FG004|Period 5|Adverse Event|0|||
33609469|NCT02308748|63009563|FG005|Period 5|Adverse Event|0|||
33609470|NCT02308748|63009564|FG006|Period 5|Adverse Event|0|||
33609471|NCT02308748|63009565|FG007|Period 5|Adverse Event|0|||
33609472|NCT02308748|63009566|FG008|Period 5|Adverse Event|1|||
33609473|NCT02308748|63009567|FG009|Period 5|Adverse Event|0|||
33324035|NCT01121406|62700430|FG000|Overall Study|Reason other than specified above|2|||
33500122|NCT03068468|62880252|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
33500123|NCT03068468|62880253|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
33500124|NCT03068468|62880250|FG000|Placebo-Controlled Period|Death|0|||
33609474|NCT01646216|63009581|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
33609475|NCT01646216|63009582|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
33609476|NCT01646216|63009581|FG000|Overall Study|Did not complete training|0|||
33609477|NCT01646216|63009582|FG001|Overall Study|Did not complete training|2|||
33609478|NCT01646216|63009581|FG000|Overall Study|Investigator decision|1|||
33609479|NCT01646216|63009582|FG001|Overall Study|Investigator decision|1|||
33609480|NCT02308124|63009595|FG000|Overall Study|Lost to Follow-up|6|||
33609481|NCT02308124|63009596|FG001|Overall Study|Lost to Follow-up|6|||
33609482|NCT02308124|63009597|FG002|Overall Study|Lost to Follow-up|6|||
33609483|NCT02308124|63009595|FG000|Overall Study|Adverse Event|0|||
33609484|NCT02308124|63009596|FG001|Overall Study|Adverse Event|2|||
33609485|NCT02308124|63009597|FG002|Overall Study|Adverse Event|2|||
33609486|NCT02232061|63009605|FG000|Overall Study|Administrative problems|1|||
33609487|NCT02232061|63009605|FG000|Overall Study|Withdrawal by Subject|1|||
33609488|NCT02275481|63009611|FG000|Overall Study|Death|2|||
33609489|NCT02275481|63009612|FG001|Overall Study|Death|1|||
33609490|NCT02275481|63009611|FG000|Overall Study|Lost to Follow-up|2|||
33609491|NCT02275481|63009612|FG001|Overall Study|Lost to Follow-up|0|||
33609492|NCT02275481|63009611|FG000|Overall Study|Withdrawal by Subject|3|||
33609493|NCT02275481|63009612|FG001|Overall Study|Withdrawal by Subject|0|||
33324036|NCT01121406|62700431|FG001|Overall Study|Reason other than specified above|6|||
33609494|NCT02275481|63009611|FG000|Overall Study|all other reasons combined|2|||
33609495|NCT02275481|63009612|FG001|Overall Study|all other reasons combined|1|||
33609496|NCT02275481|63009611|FG000|Overall Study|Physician Decision|0|||
33609497|NCT02275481|63009612|FG001|Overall Study|Physician Decision|1|||
33609498|NCT02204449|63009620|FG000|Overall Study|Lost to Follow-up|7|||
33609499|NCT02204449|63009621|FG001|Overall Study|Lost to Follow-up|9|||
33609500|NCT02204449|63009620|FG000|Overall Study|Death|0|||
33609501|NCT02204449|63009621|FG001|Overall Study|Death|1|||
33609502|NCT02204449|63009620|FG000|Overall Study|Withdrawal by Subject|0|||
33609503|NCT02204449|63009621|FG001|Overall Study|Withdrawal by Subject|1|||
33609504|NCT02308046|63009629|FG000|Overall Study|Negative yeast culture at Baseline|32|||
33609505|NCT02308046|63009630|FG001|Overall Study|Negative yeast culture at Baseline|33|||
33609506|NCT02308046|63009629|FG000|Overall Study|Positive for STD at Baseline|1|||
33609507|NCT02308046|63009630|FG001|Overall Study|Positive for STD at Baseline|2|||
33609508|NCT02308046|63009629|FG000|Overall Study|Lost to Follow-up|1|||
33609509|NCT02308046|63009630|FG001|Overall Study|Lost to Follow-up|3|||
33609510|NCT02318693|63009638|FG000|Overall Study|Protocol Violation|0|||
33609511|NCT02318693|63009639|FG001|Overall Study|Protocol Violation|1|||
33609512|NCT02230891|63009648|FG000|Baseline|Did not meet inclusion|0|||
33609513|NCT02230891|63009649|FG001|Baseline|Did not meet inclusion|1|||
33609514|NCT02230891|63009650|FG002|Baseline|Did not meet inclusion|1|||
33609515|NCT02230891|63009648|FG000|2 Week|Withdrawal by Subject|2|||
33324037|NCT01121406|62700430|FG000|Overall Study|Not treated|1|||
33500125|NCT03068468|62880251|FG001|Placebo-Controlled Period|Death|1|||
33500126|NCT03068468|62880252|FG002|Placebo-Controlled Period|Death|0|||
33500127|NCT03068468|62880253|FG003|Placebo-Controlled Period|Death|0|||
33500128|NCT03068468|62880250|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
33500129|NCT03068468|62880251|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
33500130|NCT03068468|62880252|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
33500131|NCT03068468|62880253|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
33500132|NCT03068468|62880250|FG000|Open-Label Extension Period|Adverse Event|0|||
33500133|NCT03068468|62880251|FG001|Open-Label Extension Period|Adverse Event|0|||
33500134|NCT03068468|62880252|FG002|Open-Label Extension Period|Adverse Event|13|||
33500135|NCT03068468|62880253|FG003|Open-Label Extension Period|Adverse Event|17|||
33500136|NCT03068468|62880250|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
33500137|NCT03068468|62880251|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
33500138|NCT03068468|62880252|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
33500139|NCT03068468|62880253|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
33500140|NCT03068468|62880250|FG000|Open-Label Extension Period|Death|0|||
33500141|NCT03068468|62880251|FG001|Open-Label Extension Period|Death|0|||
33500142|NCT03068468|62880252|FG002|Open-Label Extension Period|Death|0|||
33500143|NCT03068468|62880253|FG003|Open-Label Extension Period|Death|1|||
33500144|NCT03068468|62880250|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
33500145|NCT03068468|62880251|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
33500146|NCT03068468|62880252|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
33500147|NCT03068468|62880253|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
33500148|NCT03068468|62880250|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
33500149|NCT03068468|62880251|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
33500150|NCT03068468|62880252|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
33500151|NCT03068468|62880253|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
33500152|NCT03068468|62880250|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
33500153|NCT03068468|62880251|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
33500154|NCT03068468|62880252|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
33500155|NCT03068468|62880253|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
33500156|NCT03068468|62880250|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
33500157|NCT03068468|62880251|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
33500158|NCT03068468|62880252|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
33500159|NCT03068468|62880253|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
33609516|NCT02230891|63009649|FG001|2 Week|Withdrawal by Subject|2|||
33609517|NCT02230891|63009650|FG002|2 Week|Withdrawal by Subject|0|||
33609518|NCT02230891|63009648|FG000|2 Week|Consent withdrawn|1|||
33609519|NCT02230891|63009649|FG001|2 Week|Consent withdrawn|0|||
33609520|NCT02230891|63009650|FG002|2 Week|Consent withdrawn|0|||
33609521|NCT02230891|63009648|FG000|6 Month|Withdrawal by Subject|1|||
33609522|NCT02230891|63009649|FG001|6 Month|Withdrawal by Subject|1|||
33500160|NCT03068468|62880250|FG000|Open-Label Extension Period|Reason not Specified|0|||
33500161|NCT03068468|62880251|FG001|Open-Label Extension Period|Reason not Specified|0|||
33500162|NCT03068468|62880252|FG002|Open-Label Extension Period|Reason not Specified|1|||
33500163|NCT03068468|62880253|FG003|Open-Label Extension Period|Reason not Specified|4|||
33500164|NCT04512001|62880263|FG000|Week 0 to Week 24|Adverse Event|14|||
33500165|NCT04512001|62880264|FG001|Week 0 to Week 24|Adverse Event|10|||
33500166|NCT04512001|62880265|FG002|Week 0 to Week 24|Adverse Event|0|||
33500167|NCT04512001|62880266|FG003|Week 0 to Week 24|Adverse Event|0|||
33609523|NCT02230891|63009650|FG002|6 Month|Withdrawal by Subject|1|||
33609524|NCT02230891|63009648|FG000|6 Month|Physician Decision|0|||
33609525|NCT02230891|63009649|FG001|6 Month|Physician Decision|2|||
33609526|NCT02230891|63009650|FG002|6 Month|Physician Decision|0|||
33609527|NCT02230891|63009648|FG000|12 Month|Death|1|||
33609528|NCT02230891|63009649|FG001|12 Month|Death|0|||
33609529|NCT02230891|63009650|FG002|12 Month|Death|0|||
33609530|NCT02230891|63009648|FG000|12 Month|Lost to Follow-up|0|||
33609531|NCT02230891|63009649|FG001|12 Month|Lost to Follow-up|1|||
33609532|NCT02230891|63009650|FG002|12 Month|Lost to Follow-up|0|||
33609533|NCT02230891|63009648|FG000|12 Month|Withdrawal by Subject|0|||
33609534|NCT02230891|63009649|FG001|12 Month|Withdrawal by Subject|2|||
33609535|NCT02230891|63009650|FG002|12 Month|Withdrawal by Subject|0|||
33609536|NCT02230891|63009648|FG000|18 Month End of Study|Death|0|||
33609537|NCT02230891|63009649|FG001|18 Month End of Study|Death|0|||
33609538|NCT02230891|63009650|FG002|18 Month End of Study|Death|1|||
33609539|NCT02230891|63009648|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
33609540|NCT02230891|63009649|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
33609541|NCT02230891|63009650|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
33609542|NCT01646138|63009665|FG000|Overall Study|Lost to Follow-up|0|||
33609543|NCT01646138|63009666|FG001|Overall Study|Lost to Follow-up|0|||
33609544|NCT01646138|63009667|FG002|Overall Study|Lost to Follow-up|0|||
33609545|NCT01646138|63009668|FG003|Overall Study|Lost to Follow-up|0|||
33609546|NCT01646138|63009669|FG004|Overall Study|Lost to Follow-up|2|||
33609547|NCT02204371|63009681|FG000|Overall Study|Adverse Event|1|||
33609548|NCT02274857|63009687|FG000|Overall Study|Adverse Event|1|||
33609549|NCT02274857|63009688|FG001|Overall Study|Adverse Event|0|||
33609550|NCT02274857|63009687|FG000|Overall Study|Death|1|||
33609551|NCT02274857|63009688|FG001|Overall Study|Death|2|||
33609552|NCT02274857|63009687|FG000|Overall Study|Lost to Follow-up|3|||
33609553|NCT02274857|63009688|FG001|Overall Study|Lost to Follow-up|0|||
33500168|NCT04512001|62880267|FG004|Week 0 to Week 24|Adverse Event|0|||
33500169|NCT04512001|62880263|FG000|Week 0 to Week 24|Death|0|||
33500170|NCT04512001|62880264|FG001|Week 0 to Week 24|Death|2|||
33500171|NCT04512001|62880265|FG002|Week 0 to Week 24|Death|0|||
33500172|NCT04512001|62880266|FG003|Week 0 to Week 24|Death|0|||
33500173|NCT04512001|62880267|FG004|Week 0 to Week 24|Death|0|||
33500174|NCT04512001|62880263|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
33500175|NCT04512001|62880264|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
33500176|NCT04512001|62880265|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
33500177|NCT04512001|62880266|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
33500178|NCT04512001|62880267|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
33500179|NCT04512001|62880263|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
33500180|NCT04512001|62880264|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
33500181|NCT04512001|62880265|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
33500182|NCT04512001|62880266|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
33500183|NCT04512001|62880267|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
33500184|NCT04512001|62880263|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
33500185|NCT04512001|62880264|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
33500186|NCT04512001|62880265|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
33500187|NCT04512001|62880266|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
33500188|NCT04512001|62880267|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
33500189|NCT04512001|62880263|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
33500190|NCT04512001|62880264|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
33500191|NCT04512001|62880265|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
33500192|NCT04512001|62880266|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
33500193|NCT04512001|62880267|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
33609554|NCT02274857|63009687|FG000|Overall Study|Physician Decision|2|||
33609555|NCT02274857|63009688|FG001|Overall Study|Physician Decision|0|||
33500194|NCT04512001|62880263|FG000|Week 24 to Week 63|Adverse Event|0|||
33500195|NCT04512001|62880264|FG001|Week 24 to Week 63|Adverse Event|0|||
33609556|NCT02274857|63009687|FG000|Overall Study|Trial screen failure|0|||
33609557|NCT02274857|63009688|FG001|Overall Study|Trial screen failure|2|||
33609558|NCT02274857|63009687|FG000|Overall Study|Withdrawal by Subject|11|||
33609559|NCT02274857|63009688|FG001|Overall Study|Withdrawal by Subject|2|||
33609560|NCT02274857|63009687|FG000|Overall Study|Other|2|||
33609561|NCT02274857|63009688|FG001|Overall Study|Other|0|||
33609562|NCT02302859|63009697|FG000|Overall Study|Lost Phone|1|||
33500196|NCT04512001|62880265|FG002|Week 24 to Week 63|Adverse Event|13|||
33500197|NCT04512001|62880266|FG003|Week 24 to Week 63|Adverse Event|8|||
33500198|NCT04512001|62880267|FG004|Week 24 to Week 63|Adverse Event|6|||
33500199|NCT04512001|62880263|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
33500200|NCT04512001|62880264|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
33500201|NCT04512001|62880265|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
33500202|NCT04512001|62880266|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
33500203|NCT04512001|62880267|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
33500204|NCT04512001|62880263|FG000|Week 24 to Week 63|Death|0|||
33500205|NCT04512001|62880264|FG001|Week 24 to Week 63|Death|0|||
33500206|NCT04512001|62880265|FG002|Week 24 to Week 63|Death|0|||
33500207|NCT04512001|62880266|FG003|Week 24 to Week 63|Death|1|||
33500208|NCT04512001|62880267|FG004|Week 24 to Week 63|Death|1|||
33500209|NCT04512001|62880263|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
33500210|NCT04512001|62880264|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
33500211|NCT04512001|62880265|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
33500212|NCT04512001|62880266|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
33500213|NCT04512001|62880267|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
33500214|NCT04512001|62880263|FG000|Week 24 to Week 63|Miscellaneous|0|||
33500215|NCT04512001|62880264|FG001|Week 24 to Week 63|Miscellaneous|0|||
33500216|NCT04512001|62880265|FG002|Week 24 to Week 63|Miscellaneous|3|||
33500217|NCT04512001|62880266|FG003|Week 24 to Week 63|Miscellaneous|2|||
33609563|NCT02302859|63009698|FG001|Overall Study|Lost Phone|1|||
33609564|NCT02302859|63009697|FG000|Overall Study|Withdrawal by Subject|0|||
33609565|NCT02302859|63009698|FG001|Overall Study|Withdrawal by Subject|1|||
33609566|NCT02274311|63009704|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
33609567|NCT02316353|63009712|FG000|Overall Study|Pregnancy|1|||
33609568|NCT02316353|63009713|FG001|Overall Study|Pregnancy|3|||
33609569|NCT02316353|63009712|FG000|Overall Study|Adverse Event|1|||
33609570|NCT02316353|63009713|FG001|Overall Study|Adverse Event|3|||
33609571|NCT02316353|63009712|FG000|Overall Study|Withdrawal by Subject|6|||
33609572|NCT02316353|63009713|FG001|Overall Study|Withdrawal by Subject|2|||
33609573|NCT02273141|63009724|FG000|Overall Study|Adverse Event|0|||
33448721|NCT00270998|62823743|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
33448722|NCT00270998|62823741|FG000|12 Month Follow-up|Lack of Efficacy|5|||
33448723|NCT00270998|62823742|FG001|12 Month Follow-up|Lack of Efficacy|4|||
33448724|NCT00270998|62823743|FG002|12 Month Follow-up|Lack of Efficacy|3|||
33448725|NCT00270998|62823741|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
33448726|NCT00270998|62823742|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
33448727|NCT00270998|62823743|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
33448728|NCT00270998|62823741|FG000|12 Month Follow-up|Pessary did not fit|1|||
33448729|NCT00270998|62823742|FG001|12 Month Follow-up|Pessary did not fit|0|||
33448730|NCT00270998|62823743|FG002|12 Month Follow-up|Pessary did not fit|0|||
33609574|NCT02273141|63009725|FG001|Overall Study|Adverse Event|1|||
33609575|NCT02273141|63009724|FG000|Overall Study|Lost to Follow-up|1|||
33609576|NCT02273141|63009725|FG001|Overall Study|Lost to Follow-up|3|||
33609577|NCT02273141|63009724|FG000|Overall Study|Withdrawal by Subject|10|||
33609578|NCT02273141|63009725|FG001|Overall Study|Withdrawal by Subject|15|||
33609579|NCT02273141|63009724|FG000|Overall Study|Various|6|||
33609580|NCT02273141|63009725|FG001|Overall Study|Various|6|||
33609581|NCT02314052|63009731|FG000|Cycle One|Adverse Event|0|||
33609582|NCT02314052|63009732|FG001|Cycle One|Adverse Event|0|||
33609583|NCT02314052|63009733|FG002|Cycle One|Adverse Event|0|||
33609584|NCT02314052|63009734|FG003|Cycle One|Adverse Event|1|||
33609585|NCT02314052|63009735|FG004|Cycle One|Adverse Event|0|||
33500218|NCT04512001|62880267|FG004|Week 24 to Week 63|Miscellaneous|1|||
33500219|NCT04447417|62880282|FG000|Overall Study|Withdrawal by Subject|1|||
33500220|NCT04447417|62880283|FG001|Overall Study|Withdrawal by Subject|0|||
33500221|NCT04447417|62880282|FG000|Overall Study|Failure to meet inclusion criteria|1|||
33500222|NCT04447417|62880283|FG001|Overall Study|Failure to meet inclusion criteria|0|||
33609586|NCT02314052|63009736|FG005|Cycle One|Adverse Event|0|||
33609587|NCT02279732|63009752|FG000|Overall Study|Death|23|||
33609588|NCT02279732|63009753|FG001|Overall Study|Death|20|||
33609589|NCT02279732|63009752|FG000|Overall Study|Disease Progression|13|||
33500223|NCT04447417|62880282|FG000|Overall Study|Lost to Follow-up|1|||
33500224|NCT04447417|62880283|FG001|Overall Study|Lost to Follow-up|0|||
33500225|NCT02787044|62880291|FG000|Overall Study|Lost to Follow-up|15|||
33500226|NCT02787044|62880292|FG001|Overall Study|Lost to Follow-up|19|||
33500227|NCT01345019|62880304|FG000|Blinded Treatment Phase|Death|147|||
33500228|NCT01345019|62880305|FG001|Blinded Treatment Phase|Death|137|||
33500229|NCT01345019|62880304|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
33500230|NCT01345019|62880305|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
33609590|NCT02279732|63009753|FG001|Overall Study|Disease Progression|3|||
33609591|NCT02279732|63009752|FG000|Overall Study|Withdrawal by Subject|2|||
33609592|NCT02279732|63009753|FG001|Overall Study|Withdrawal by Subject|7|||
33609593|NCT02279732|63009752|FG000|Overall Study|Adverse Event|1|||
33609594|NCT02279732|63009753|FG001|Overall Study|Adverse Event|2|||
33609595|NCT02279732|63009752|FG000|Overall Study|Administrative Reason By Sponsor|0|||
33609596|NCT02279732|63009753|FG001|Overall Study|Administrative Reason By Sponsor|2|||
33609597|NCT02279732|63009752|FG000|Overall Study|Study Drug Toxicity|2|||
33609598|NCT02279732|63009753|FG001|Overall Study|Study Drug Toxicity|0|||
33609599|NCT02279732|63009752|FG000|Overall Study|Lost to Follow-up|0|||
33609600|NCT02279732|63009753|FG001|Overall Study|Lost to Follow-up|1|||
33609601|NCT02279732|63009752|FG000|Overall Study|Maximum Clinical Benefit|1|||
33609602|NCT02279732|63009753|FG001|Overall Study|Maximum Clinical Benefit|0|||
33609603|NCT02279732|63009752|FG000|Overall Study|Subject Requested to Discontinue|0|||
33609604|NCT02279732|63009753|FG001|Overall Study|Subject Requested to Discontinue|1|||
33609605|NCT02279732|63009752|FG000|Overall Study|Other|53|||
33609606|NCT02279732|63009753|FG001|Overall Study|Other|67|||
33609607|NCT02279732|63009752|FG000|Overall Study|Other|3|||
33609608|NCT02279732|63009753|FG001|Overall Study|Other|3|||
33609609|NCT02279498|63009761|FG000|Overall Study|Adverse Event|3|||
33609610|NCT02279498|63009762|FG001|Overall Study|Adverse Event|0|||
33609611|NCT02279498|63009761|FG000|Overall Study|Lack of Efficacy|4|||
33609612|NCT02279498|63009762|FG001|Overall Study|Lack of Efficacy|0|||
33448731|NCT00270998|62823741|FG000|12 Month Follow-up|Personal/family health|0|||
33448732|NCT00270998|62823742|FG001|12 Month Follow-up|Personal/family health|5|||
33448733|NCT00270998|62823743|FG002|12 Month Follow-up|Personal/family health|1|||
33448734|NCT00270998|62823741|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
33448735|NCT00270998|62823742|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
33448736|NCT00270998|62823743|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
33448737|NCT00279812|62823759|FG000|Overall Study|Protocol Violation|1|||
33448738|NCT00279812|62823760|FG001|Overall Study|Protocol Violation|1|||
33448739|NCT00279812|62823761|FG002|Overall Study|Protocol Violation|0|||
33448740|NCT00279812|62823762|FG003|Overall Study|Protocol Violation|0|||
33448741|NCT00279812|62823763|FG004|Overall Study|Protocol Violation|1|||
33448742|NCT00279812|62823764|FG005|Overall Study|Protocol Violation|0|||
33448743|NCT00279812|62823759|FG000|Overall Study|Withdrawal by Subject|0|||
33448744|NCT00279812|62823760|FG001|Overall Study|Withdrawal by Subject|4|||
33448745|NCT00279812|62823761|FG002|Overall Study|Withdrawal by Subject|2|||
33448746|NCT00279812|62823762|FG003|Overall Study|Withdrawal by Subject|0|||
33448747|NCT00279812|62823763|FG004|Overall Study|Withdrawal by Subject|0|||
33500231|NCT01345019|62880304|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
33500232|NCT01345019|62880305|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
33609613|NCT02279498|63009761|FG000|Overall Study|Lost to Follow-up|0|||
33448748|NCT00279812|62823764|FG005|Overall Study|Withdrawal by Subject|0|||
33448749|NCT00279812|62823759|FG000|Overall Study|Adverse Event|0|||
33448750|NCT00279812|62823760|FG001|Overall Study|Adverse Event|1|||
33448751|NCT00279812|62823761|FG002|Overall Study|Adverse Event|1|||
33500233|NCT01345019|62880304|FG000|Blinded Treatment Phase|Disease Progression|12|||
33500234|NCT01345019|62880305|FG001|Blinded Treatment Phase|Disease Progression|10|||
33500235|NCT01345019|62880304|FG000|Blinded Treatment Phase|Adverse Event|6|||
33500236|NCT01345019|62880305|FG001|Blinded Treatment Phase|Adverse Event|13|||
33500237|NCT01345019|62880304|FG000|Blinded Treatment Phase|Administrative Decision|10|||
33500238|NCT01345019|62880305|FG001|Blinded Treatment Phase|Administrative Decision|8|||
33500239|NCT01345019|62880304|FG000|Blinded Treatment Phase|Noncompliance|5|||
33500240|NCT01345019|62880305|FG001|Blinded Treatment Phase|Noncompliance|3|||
33500241|NCT01345019|62880304|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
33500242|NCT01345019|62880305|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
33500243|NCT01345019|62880304|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
33500244|NCT01345019|62880305|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
33500245|NCT01345019|62880304|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
33500246|NCT01345019|62880305|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
33500247|NCT01345019|62880304|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
33500248|NCT01345019|62880305|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
33500249|NCT01345019|62880304|FG000|Open Label Treatment Phase|Death|49|||
33500250|NCT01345019|62880305|FG001|Open Label Treatment Phase|Death|48|||
33500251|NCT01345019|62880304|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
33500252|NCT01345019|62880305|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
33500253|NCT01345019|62880304|FG000|Open Label Treatment Phase|Adverse Event|30|||
33500254|NCT01345019|62880305|FG001|Open Label Treatment Phase|Adverse Event|51|||
33500255|NCT01345019|62880304|FG000|Open Label Treatment Phase|Administrative Decision|30|||
33500256|NCT01345019|62880305|FG001|Open Label Treatment Phase|Administrative Decision|15|||
33500257|NCT01345019|62880304|FG000|Open Label Treatment Phase|Disease Progression|17|||
33500258|NCT01345019|62880305|FG001|Open Label Treatment Phase|Disease Progression|18|||
33500259|NCT01345019|62880304|FG000|Open Label Treatment Phase|Noncompliance|5|||
33500260|NCT01345019|62880305|FG001|Open Label Treatment Phase|Noncompliance|4|||
33500261|NCT01345019|62880304|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
33500262|NCT01345019|62880305|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
33500263|NCT01345019|62880304|FG000|Open Label Treatment Phase|Pregnancy|1|||
33500264|NCT01345019|62880305|FG001|Open Label Treatment Phase|Pregnancy|0|||
33500265|NCT01345019|62880304|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
33500266|NCT01345019|62880305|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
33500267|NCT01345019|62880304|FG000|Open Label Treatment Phase|Protocol Violation|0|||
33500268|NCT01345019|62880305|FG001|Open Label Treatment Phase|Protocol Violation|1|||
33500269|NCT04507867|62880315|FG000|Overall Study|Death|7|||
33500270|NCT04507867|62880316|FG001|Overall Study|Death|1|||
33500271|NCT03069716|62880340|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
33500272|NCT03069716|62880341|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
33500273|NCT03069716|62880342|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
33500274|NCT03069716|62880340|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
33500275|NCT03069716|62880341|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
33500276|NCT03069716|62880342|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
33500277|NCT03069716|62880340|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
33500278|NCT03069716|62880341|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
33500279|NCT03069716|62880342|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
33500280|NCT03069716|62880340|FG000|Randomized Treatment|Withdrawal by Subject|0|||
33500281|NCT03069716|62880341|FG001|Randomized Treatment|Withdrawal by Subject|2|||
33500282|NCT03069716|62880342|FG002|Randomized Treatment|Withdrawal by Subject|0|||
33500283|NCT03693625|62880355|FG000|Overall Study|Adverse Event|2|||
33500284|NCT03693625|62880356|FG001|Overall Study|Adverse Event|0|||
33500285|NCT03693625|62880355|FG000|Overall Study|Study Terminated By Sponsor|20|||
33500286|NCT03693625|62880356|FG001|Overall Study|Study Terminated By Sponsor|7|||
33500287|NCT03693625|62880355|FG000|Overall Study|Withdrawal by Subject|1|||
33500288|NCT03693625|62880356|FG001|Overall Study|Withdrawal by Subject|1|||
33500289|NCT01265537|62880364|FG000|Overall Study|Adverse Event|2|||
33500290|NCT01265537|62880365|FG001|Overall Study|Adverse Event|1|||
33500291|NCT01265537|62880364|FG000|Overall Study|Physician Decision|0|||
33500292|NCT01265537|62880365|FG001|Overall Study|Physician Decision|1|||
33500293|NCT04396639|62880371|FG000|Overall Study|Withdrawal by Subject|1|||
33500294|NCT04396639|62880371|FG000|Overall Study|Other|1|||
33448752|NCT00279812|62823762|FG003|Overall Study|Adverse Event|0|||
33448753|NCT00279812|62823763|FG004|Overall Study|Adverse Event|2|||
33448754|NCT00279812|62823764|FG005|Overall Study|Adverse Event|1|||
33448755|NCT00207714|62823783|FG000|Overall Study|Adverse Event|6|||
33448756|NCT00207714|62823784|FG001|Overall Study|Adverse Event|2|||
33448757|NCT00207714|62823785|FG002|Overall Study|Adverse Event|4|||
33448758|NCT00207714|62823786|FG003|Overall Study|Adverse Event|3|||
33448759|NCT00207714|62823787|FG004|Overall Study|Adverse Event|1|||
33448760|NCT00207714|62823783|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
33448761|NCT00207714|62823784|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33500295|NCT04432298|62880377|FG000|Overall Study|Other than specified|1|||
33500296|NCT04432298|62880378|FG001|Overall Study|Other than specified|0|||
33500297|NCT04432298|62880377|FG000|Overall Study|Lost to Follow-up|0|||
33500298|NCT04432298|62880378|FG001|Overall Study|Lost to Follow-up|1|||
33500299|NCT04432298|62880377|FG000|Overall Study|Death|3|||
33500300|NCT04432298|62880378|FG001|Overall Study|Death|2|||
33500301|NCT04432298|62880377|FG000|Overall Study|Withdrawal by Subject|2|||
33500302|NCT04432298|62880378|FG001|Overall Study|Withdrawal by Subject|0|||
33500303|NCT04167085|62880386|FG000|Baseline|Withdrawal by Subject|2|||
33500304|NCT04167085|62880387|FG001|Baseline|Withdrawal by Subject|1|||
33500305|NCT04167085|62880386|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
33500306|NCT04167085|62880387|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
33500307|NCT04162795|62880393|FG000|Overall Study|Other|16|||
33500308|NCT04162795|62880393|FG000|Overall Study|Screen failures|10|||
33500309|NCT03069482|62880399|FG000|Overall Study|Lost to Follow-up|0|||
33500310|NCT03069482|62880400|FG001|Overall Study|Lost to Follow-up|1|||
33500311|NCT03069482|62880399|FG000|Overall Study|Physician Decision|1|||
33500312|NCT03069482|62880400|FG001|Overall Study|Physician Decision|0|||
33500313|NCT03266172|62880412|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
33500314|NCT03266172|62880413|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
33500315|NCT03266172|62880414|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
33500316|NCT03266172|62880412|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
33500317|NCT03266172|62880413|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
33500318|NCT03266172|62880414|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
33500319|NCT03266172|62880412|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
33500320|NCT03266172|62880413|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
33500321|NCT03266172|62880414|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
33500322|NCT03266172|62880412|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
33500323|NCT03266172|62880413|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
33500324|NCT03266172|62880414|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
33500325|NCT03266172|62880412|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
33500326|NCT03266172|62880413|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
33500327|NCT03266172|62880414|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
33500328|NCT03266172|62880412|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
33500329|NCT03266172|62880413|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
33500330|NCT03266172|62880414|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
33500331|NCT04356937|62880466|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
33500332|NCT04356937|62880467|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
33500333|NCT03301740|62880479|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
33500334|NCT03301740|62880480|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
33500335|NCT03301740|62880479|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
33500336|NCT03301740|62880480|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
33500337|NCT04355767|62880488|FG000|Overall Study|Withdrawal by Subject|2|||
33500338|NCT04355767|62880489|FG001|Overall Study|Withdrawal by Subject|2|||
33500339|NCT04355767|62880488|FG000|Overall Study|Death|5|||
33500340|NCT04355767|62880489|FG001|Overall Study|Death|1|||
33500341|NCT00882050|62880498|FG000|Overall Study|Physician Decision|1|||
33500342|NCT00882050|62880499|FG001|Overall Study|Physician Decision|0|||
33500343|NCT00882050|62880500|FG002|Overall Study|Physician Decision|0|||
33324038|NCT01121406|62700431|FG001|Overall Study|Not treated|0|||
33500344|NCT03266094|62880508|FG000|Overall Study|Lost to Follow-up|1|||
33324039|NCT00960687|62700440|FG000|Washout Period of 7 Days|Adverse Event|3|||
33500345|NCT03266094|62880508|FG000|Overall Study|Withdrawal by Subject|1|||
33500346|NCT04161079|62880514|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
33609614|NCT02279498|63009762|FG001|Overall Study|Lost to Follow-up|1|||
33609615|NCT02279498|63009761|FG000|Overall Study|Withdrawal by Subject|9|||
33609616|NCT02279498|63009762|FG001|Overall Study|Withdrawal by Subject|2|||
33609617|NCT02279498|63009761|FG000|Overall Study|Undefined|2|||
33609618|NCT02279498|63009762|FG001|Overall Study|Undefined|1|||
33609619|NCT02307266|63009772|FG000|Overall Study|Adverse Event|3|||
33609620|NCT02307266|63009773|FG001|Overall Study|Adverse Event|1|||
33609621|NCT02307266|63009774|FG002|Overall Study|Adverse Event|5|||
33609622|NCT02307266|63009772|FG000|Overall Study|Withdrawal by Subject|2|||
33609623|NCT02307266|63009773|FG001|Overall Study|Withdrawal by Subject|0|||
33500347|NCT03243084|62880524|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
33500348|NCT03243084|62880525|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
33500349|NCT04353817|62880534|FG000|Overall Study|Adverse Event|0|||
33500350|NCT04353817|62880535|FG001|Overall Study|Adverse Event|1|||
33500351|NCT00159588|62880544|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
33500352|NCT00159588|62880545|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
33500353|NCT00159588|62880546|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
33500354|NCT03265938|62880557|FG000|Overall Study|Withdrawal by Subject|1|||
33500355|NCT03265938|62880557|FG000|Overall Study|Physician Decision|1|||
33500356|NCT03265938|62880557|FG000|Overall Study|friable mass|6|||
33500357|NCT04353037|62880566|FG000|Overall Study|Lost to Follow-up|0|||
33500358|NCT04353037|62880567|FG001|Overall Study|Lost to Follow-up|1|||
33500359|NCT04353037|62880568|FG002|Overall Study|Lost to Follow-up|2|||
33500360|NCT04353037|62880569|FG003|Overall Study|Lost to Follow-up|3|||
33500361|NCT04353037|62880566|FG000|Overall Study|Withdrawal by Subject|0|||
33500362|NCT04353037|62880567|FG001|Overall Study|Withdrawal by Subject|2|||
33500363|NCT04353037|62880568|FG002|Overall Study|Withdrawal by Subject|3|||
33500364|NCT04353037|62880569|FG003|Overall Study|Withdrawal by Subject|5|||
33500365|NCT04353037|62880566|FG000|Overall Study|Adverse Event|0|||
33500366|NCT04353037|62880567|FG001|Overall Study|Adverse Event|0|||
33500367|NCT04353037|62880568|FG002|Overall Study|Adverse Event|2|||
33500368|NCT04353037|62880569|FG003|Overall Study|Adverse Event|0|||
33500369|NCT04353037|62880566|FG000|Overall Study|Exposure Change|0|||
33500370|NCT04353037|62880567|FG001|Overall Study|Exposure Change|0|||
33500371|NCT04353037|62880568|FG002|Overall Study|Exposure Change|0|||
33500372|NCT04353037|62880569|FG003|Overall Study|Exposure Change|2|||
33500373|NCT04349917|62880583|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
33500374|NCT04349917|62880584|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
33609624|NCT02307266|63009774|FG002|Overall Study|Withdrawal by Subject|1|||
33609625|NCT02307266|63009772|FG000|Overall Study|Lost to Follow-up|3|||
33609626|NCT02307266|63009773|FG001|Overall Study|Lost to Follow-up|0|||
33609627|NCT02307266|63009774|FG002|Overall Study|Lost to Follow-up|0|||
33609628|NCT02279420|63009782|FG000|Overall Study|Lost to Follow-up|23|||
33609629|NCT02278952|63009786|FG000|Overall Study|Insufficient Sample|6|||
33609630|NCT02278328|63009796|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
33609631|NCT02278328|63009797|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
33609632|NCT02278328|63009798|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
33609633|NCT02278328|63009796|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
33609634|NCT02278328|63009797|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
33609635|NCT02278328|63009798|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
33609636|NCT02278328|63009796|FG000|Neuropsych Screening|incomplete consent|0|||
33609637|NCT02278328|63009797|FG001|Neuropsych Screening|incomplete consent|0|||
33609638|NCT02278328|63009798|FG002|Neuropsych Screening|incomplete consent|2|||
33609639|NCT02314637|63009806|FG000|Overall Study|Adverse Event|4|||
33609640|NCT02314637|63009807|FG001|Overall Study|Adverse Event|8|||
33500375|NCT04349917|62880583|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
33500376|NCT04349917|62880584|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
33500377|NCT04156399|62880591|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
33500378|NCT04156399|62880591|FG000|Overall Study|study suspension due to COVID pandemic|3|||
33500379|NCT03300570|62880597|FG000|Overall Study|Adverse Event|0|||
33500380|NCT03300570|62880598|FG001|Overall Study|Adverse Event|1|||
33500381|NCT03300570|62880597|FG000|Overall Study|Withdrawal by Subject|1|||
33500382|NCT03300570|62880598|FG001|Overall Study|Withdrawal by Subject|0|||
33500383|NCT03300570|62880597|FG000|Overall Study|Inadequate bowel prep|1|||
33500384|NCT03300570|62880598|FG001|Overall Study|Inadequate bowel prep|0|||
33500385|NCT04154605|62880607|FG000|Overall Study|Procedure Canceled|1|||
33500386|NCT04154605|62880608|FG001|Overall Study|Procedure Canceled|1|||
33500387|NCT04154605|62880607|FG000|Overall Study|Missed follow up|1|||
33500388|NCT04154605|62880608|FG001|Overall Study|Missed follow up|1|||
33609641|NCT02314637|63009806|FG000|Overall Study|Lack of Efficacy|1|||
33609642|NCT02314637|63009807|FG001|Overall Study|Lack of Efficacy|0|||
33609643|NCT02314637|63009806|FG000|Overall Study|Physician Decision|5|||
33609644|NCT02314637|63009807|FG001|Overall Study|Physician Decision|2|||
33609645|NCT02314637|63009806|FG000|Overall Study|Withdrawal by Subject|5|||
33500389|NCT04154605|62880607|FG000|Overall Study|Withdrawal by Subject|1|||
33500390|NCT04154605|62880608|FG001|Overall Study|Withdrawal by Subject|0|||
33500391|NCT03264456|62880614|FG000|Overall Study|Withdrawal by Subject|3|||
33500392|NCT03264456|62880614|FG000|Overall Study|Lost to Follow-up|1|||
33500393|NCT03853694|62880621|FG000|Overall Study|Protocol Violation|3|||
33500394|NCT03853694|62880622|FG001|Overall Study|Protocol Violation|5|||
33500395|NCT03853694|62880623|FG002|Overall Study|Protocol Violation|3|||
33500396|NCT03853694|62880621|FG000|Overall Study|Delivered early|0|||
33609646|NCT02314637|63009807|FG001|Overall Study|Withdrawal by Subject|4|||
33609647|NCT02314637|63009806|FG000|Overall Study|Other Reason|1|||
33609648|NCT02314637|63009807|FG001|Overall Study|Other Reason|0|||
33609649|NCT01646645|63009813|FG000|Overall Study|No Treated|1|||
33609650|NCT01646645|63009813|FG000|Overall Study|Inevaluable Donor|29|||
33609651|NCT02272985|63009817|FG000|Overall Study|Withdrawal by Subject|1|||
33609652|NCT02272985|63009817|FG000|Overall Study|hip fracture|1|||
33609653|NCT02272985|63009817|FG000|Overall Study|kidney transplantation|1|||
33500397|NCT03853694|62880622|FG001|Overall Study|Delivered early|1|||
33500398|NCT03853694|62880623|FG002|Overall Study|Delivered early|0|||
33500399|NCT03853694|62880621|FG000|Overall Study|not suitable to proceed|0|||
33500400|NCT03853694|62880622|FG001|Overall Study|not suitable to proceed|1|||
33500401|NCT03853694|62880623|FG002|Overall Study|not suitable to proceed|0|||
33500402|NCT03853694|62880621|FG000|Overall Study|difficult surgery|0|||
33500403|NCT03853694|62880622|FG001|Overall Study|difficult surgery|0|||
33500404|NCT03853694|62880623|FG002|Overall Study|difficult surgery|1|||
33500405|NCT03853694|62880621|FG000|Overall Study|Lost to Follow-up|0|||
33500406|NCT03853694|62880622|FG001|Overall Study|Lost to Follow-up|1|||
33500407|NCT03853694|62880623|FG002|Overall Study|Lost to Follow-up|0|||
33500408|NCT03853694|62880621|FG000|Overall Study|Withdrawal by Subject|0|||
33500409|NCT03853694|62880622|FG001|Overall Study|Withdrawal by Subject|1|||
33500410|NCT03853694|62880623|FG002|Overall Study|Withdrawal by Subject|0|||
33500411|NCT04154293|62880634|FG000|Overall Study|Withdrawal by Subject|2|||
33500412|NCT04154293|62880635|FG001|Overall Study|Withdrawal by Subject|3|||
33500413|NCT04154293|62880636|FG002|Overall Study|Withdrawal by Subject|1|||
33500414|NCT04154293|62880634|FG000|Overall Study|Physician Decision|0|||
33500415|NCT04154293|62880635|FG001|Overall Study|Physician Decision|0|||
33500416|NCT04154293|62880636|FG002|Overall Study|Physician Decision|1|||
33500417|NCT04342897|62880646|FG000|Overall Study|Death|7|||
33500418|NCT04342897|62880647|FG001|Overall Study|Death|4|||
33500419|NCT04342897|62880646|FG000|Overall Study|Lost to Follow-up|6|||
33500420|NCT04342897|62880647|FG001|Overall Study|Lost to Follow-up|6|||
33500421|NCT04342897|62880646|FG000|Overall Study|Withdrawal by Subject|1|||
33500422|NCT04342897|62880647|FG001|Overall Study|Withdrawal by Subject|2|||
33609654|NCT01644149|63009824|FG000|Overall Study|Withdrawal by Subject|1|||
33609655|NCT01644149|63009825|FG001|Overall Study|Withdrawal by Subject|0|||
33609656|NCT01644149|63009824|FG000|Overall Study|Lost to Follow-up|3|||
33609657|NCT01644149|63009825|FG001|Overall Study|Lost to Follow-up|1|||
33609658|NCT02313233|63009834|FG000|Overall Study|Withdrawal by Subject|1|||
33609659|NCT02313233|63009835|FG001|Overall Study|Withdrawal by Subject|2|||
33500423|NCT04340557|62880655|FG000|Overall Study|Transferred to ICU and/or death|1|||
33500424|NCT04340557|62880656|FG001|Overall Study|Transferred to ICU and/or death|2|||
33500425|NCT04382053|62880664|FG000|Overall Study|Death|6|||
33500426|NCT04382053|62880665|FG001|Overall Study|Death|8|||
33609660|NCT02313233|63009834|FG000|Overall Study|Administrative reason|1|||
33609661|NCT02313233|63009835|FG001|Overall Study|Administrative reason|1|||
33609662|NCT02305238|63009846|FG000|Overall Study|Death|2|||
33609663|NCT02305238|63009847|FG001|Overall Study|Death|1|||
33609664|NCT02305238|63009848|FG002|Overall Study|Death|0|||
33500427|NCT04382053|62880664|FG000|Overall Study|Lost to Follow-up|0|||
33500428|NCT04382053|62880665|FG001|Overall Study|Lost to Follow-up|2|||
33500429|NCT04382053|62880664|FG000|Overall Study|Protocol Deviation|1|||
33500430|NCT04382053|62880665|FG001|Overall Study|Protocol Deviation|2|||
33609665|NCT02305238|63009846|FG000|Overall Study|Progressive disease|4|||
33609666|NCT02305238|63009847|FG001|Overall Study|Progressive disease|4|||
33500431|NCT04382053|62880664|FG000|Overall Study|Withdrawal by Subject|2|||
33500432|NCT04382053|62880665|FG001|Overall Study|Withdrawal by Subject|1|||
33500433|NCT03066830|62880674|FG000|Overall Study|At the Participant's own Request|16|||
33500434|NCT03066830|62880675|FG001|Overall Study|At the Participant's own Request|17|||
33500435|NCT03066830|62880674|FG000|Overall Study|Other|3|||
33500436|NCT03066830|62880675|FG001|Overall Study|Other|0|||
33500437|NCT03066830|62880674|FG000|Overall Study|Poor Compliance to Protocol|1|||
33500438|NCT03066830|62880675|FG001|Overall Study|Poor Compliance to Protocol|0|||
33500439|NCT03066830|62880674|FG000|Overall Study|Adverse Event|2|||
33500440|NCT03066830|62880675|FG001|Overall Study|Adverse Event|2|||
33500441|NCT03066830|62880674|FG000|Overall Study|Lost to Follow-up|11|||
33500442|NCT03066830|62880675|FG001|Overall Study|Lost to Follow-up|3|||
33500443|NCT04380961|62880684|FG000|Overall Study|Lost to Follow-up|17|||
33500444|NCT04380961|62880685|FG001|Overall Study|Lost to Follow-up|11|||
33500445|NCT04380961|62880684|FG000|Overall Study|Withdrawal by Subject|3|||
33500446|NCT04380961|62880685|FG001|Overall Study|Withdrawal by Subject|0|||
33500447|NCT04380961|62880684|FG000|Overall Study|Death|22|||
33500448|NCT04380961|62880685|FG001|Overall Study|Death|16|||
33500449|NCT04380961|62880684|FG000|Overall Study|Other|1|||
33500450|NCT04380961|62880685|FG001|Overall Study|Other|0|||
33500451|NCT04380961|62880684|FG000|Overall Study|Randomized but Not Treated|1|||
33500452|NCT04380961|62880685|FG001|Overall Study|Randomized but Not Treated|2|||
33500453|NCT04331899|62880695|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
33500454|NCT04331899|62880696|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
33500455|NCT03063632|62880704|FG000|Overall Study|Death|4|||
33500456|NCT03063632|62880705|FG001|Overall Study|Death|6|||
33500457|NCT03063632|62880704|FG000|Overall Study|Lost to Follow-up|0|||
33500458|NCT03063632|62880705|FG001|Overall Study|Lost to Follow-up|1|||
33500459|NCT03063632|62880704|FG000|Overall Study|Withdrawal by Subject|0|||
33500460|NCT03063632|62880705|FG001|Overall Study|Withdrawal by Subject|2|||
33500461|NCT03063632|62880704|FG000|Overall Study|Physician Decision|2|||
33500462|NCT03063632|62880705|FG001|Overall Study|Physician Decision|0|||
33500463|NCT03063632|62880704|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
33500464|NCT03063632|62880705|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
33500465|NCT04328467|62880716|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
33500466|NCT04328467|62880717|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
33500467|NCT04328467|62880718|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
33500468|NCT04328077|62880730|FG000|Overall Study|Lost to Follow-up|0|||
33500469|NCT04328077|62880731|FG001|Overall Study|Lost to Follow-up|1|||
33500470|NCT04328077|62880732|FG002|Overall Study|Lost to Follow-up|0|||
33500471|NCT04328077|62880733|FG003|Overall Study|Lost to Follow-up|0|||
33500472|NCT04328077|62880730|FG000|Overall Study|Withdrawal by Subject|0|||
33500473|NCT04328077|62880731|FG001|Overall Study|Withdrawal by Subject|1|||
33500474|NCT04328077|62880732|FG002|Overall Study|Withdrawal by Subject|1|||
33500475|NCT04328077|62880733|FG003|Overall Study|Withdrawal by Subject|3|||
33500476|NCT03691831|62880751|FG000|Overall Study|Lost to Follow-up|16|||
33500477|NCT03691831|62880752|FG001|Overall Study|Lost to Follow-up|12|||
33500478|NCT03691831|62880751|FG000|Overall Study|Withdrawal by Subject|9|||
33500479|NCT03691831|62880752|FG001|Overall Study|Withdrawal by Subject|17|||
33500480|NCT03691831|62880751|FG000|Overall Study|Investigator Decision|2|||
33500481|NCT03691831|62880752|FG001|Overall Study|Investigator Decision|2|||
33500482|NCT04320745|62880769|FG000|Overall Study|Adverse Event|26|||
33500483|NCT04320745|62880769|FG000|Overall Study|Withdrawal by Subject|4|||
33500484|NCT04320745|62880769|FG000|Overall Study|Lost to Follow-up|12|||
33500485|NCT04320745|62880769|FG000|Overall Study|Protocol Deviation|2|||
33500486|NCT04320745|62880769|FG000|Overall Study|Non-compliance With Study Drug|2|||
33500487|NCT04320745|62880769|FG000|Overall Study|Reason Not Specified|1|||
33500488|NCT03063086|62880773|FG000|Overall Study|technical problems|1|||
33500489|NCT03063086|62880774|FG001|Overall Study|technical problems|0|||
33500490|NCT03063086|62880775|FG002|Overall Study|technical problems|0|||
33500491|NCT03063086|62880776|FG003|Overall Study|technical problems|0|||
33500492|NCT03063086|62880777|FG004|Overall Study|technical problems|0|||
33500493|NCT03063086|62880778|FG005|Overall Study|technical problems|0|||
33500494|NCT03063086|62880773|FG000|Overall Study|Adverse Event|1|||
33500495|NCT03063086|62880774|FG001|Overall Study|Adverse Event|1|||
33500496|NCT03063086|62880775|FG002|Overall Study|Adverse Event|1|||
33500497|NCT03063086|62880776|FG003|Overall Study|Adverse Event|1|||
33500498|NCT03063086|62880777|FG004|Overall Study|Adverse Event|0|||
33500499|NCT03063086|62880778|FG005|Overall Study|Adverse Event|0|||
33500500|NCT03063086|62880773|FG000|Overall Study|subject/guardian decision|1|||
33609667|NCT02305238|63009848|FG002|Overall Study|Progressive disease|0|||
33500501|NCT03063086|62880774|FG001|Overall Study|subject/guardian decision|0|||
33500502|NCT03063086|62880775|FG002|Overall Study|subject/guardian decision|0|||
33500503|NCT03063086|62880776|FG003|Overall Study|subject/guardian decision|0|||
33500504|NCT03063086|62880777|FG004|Overall Study|subject/guardian decision|0|||
33500505|NCT03063086|62880778|FG005|Overall Study|subject/guardian decision|0|||
33609668|NCT02305238|63009846|FG000|Overall Study|Logistical difficulties|1|||
33500506|NCT03063086|62880773|FG000|Overall Study|Non-compliance with study treatment|0|||
33500507|NCT03063086|62880774|FG001|Overall Study|Non-compliance with study treatment|0|||
33500508|NCT03063086|62880775|FG002|Overall Study|Non-compliance with study treatment|0|||
33500509|NCT03063086|62880776|FG003|Overall Study|Non-compliance with study treatment|1|||
33500510|NCT03063086|62880777|FG004|Overall Study|Non-compliance with study treatment|0|||
33500511|NCT03063086|62880778|FG005|Overall Study|Non-compliance with study treatment|1|||
33500512|NCT03063086|62880773|FG000|Overall Study|Physician Decision|0|||
33500513|NCT03063086|62880774|FG001|Overall Study|Physician Decision|0|||
33500514|NCT03063086|62880775|FG002|Overall Study|Physician Decision|0|||
33500515|NCT03063086|62880776|FG003|Overall Study|Physician Decision|1|||
33500516|NCT03063086|62880777|FG004|Overall Study|Physician Decision|0|||
33500517|NCT03063086|62880778|FG005|Overall Study|Physician Decision|0|||
33500518|NCT04128007|62880789|FG000|Overall Study|Withdrawal by Subject|9|||
33500519|NCT04128007|62880790|FG001|Overall Study|Withdrawal by Subject|6|||
33500520|NCT04128007|62880789|FG000|Overall Study|Protocol Violation|1|||
33500521|NCT04128007|62880790|FG001|Overall Study|Protocol Violation|0|||
33500522|NCT04128007|62880789|FG000|Overall Study|Lost to Follow-up|8|||
33500523|NCT04128007|62880790|FG001|Overall Study|Lost to Follow-up|7|||
33500524|NCT04128007|62880789|FG000|Overall Study|Adverse Event|5|||
33500525|NCT04128007|62880790|FG001|Overall Study|Adverse Event|2|||
33500526|NCT04128007|62880789|FG000|Overall Study|Not reported|0|||
33500527|NCT04128007|62880790|FG001|Overall Study|Not reported|2|||
33500528|NCT04318093|62880798|FG000|Overall Study|Adverse Event|2|||
33500529|NCT04318093|62880799|FG001|Overall Study|Adverse Event|2|||
33500530|NCT04318093|62880798|FG000|Overall Study|Participant withdrew consent|1|||
33500531|NCT04318093|62880799|FG001|Overall Study|Participant withdrew consent|0|||
33500532|NCT04318093|62880798|FG000|Overall Study|Other reasons|0|||
33500533|NCT04318093|62880799|FG001|Overall Study|Other reasons|1|||
33500534|NCT04123405|62880810|FG000|Overall Study|Adverse Event|1|||
33500535|NCT04123405|62880811|FG001|Overall Study|Adverse Event|2|||
33500536|NCT04123405|62880812|FG002|Overall Study|Adverse Event|3|||
33500537|NCT04123405|62880813|FG003|Overall Study|Adverse Event|3|||
33500538|NCT04123405|62880810|FG000|Overall Study|Exclusion criteria met|1|||
33500539|NCT04123405|62880811|FG001|Overall Study|Exclusion criteria met|2|||
33500540|NCT04123405|62880812|FG002|Overall Study|Exclusion criteria met|0|||
33448762|NCT00207714|62823785|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
33448763|NCT00207714|62823786|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
33448764|NCT00207714|62823787|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
33448765|NCT00207714|62823783|FG000|Overall Study|Other|3|||
33448766|NCT00207714|62823784|FG001|Overall Study|Other|2|||
33448767|NCT00207714|62823785|FG002|Overall Study|Other|5|||
33448768|NCT00207714|62823786|FG003|Overall Study|Other|1|||
33448769|NCT00207714|62823787|FG004|Overall Study|Other|0|||
33448770|NCT00207090|62823806|FG000|Overall Study|Study drug toxicity|3|||
33448771|NCT00207090|62823806|FG000|Overall Study|Chest wall mass larger|1|||
33448772|NCT00207090|62823806|FG000|Overall Study|Disease progression/relapse|2|||
33448773|NCT00207090|62823806|FG000|Overall Study|Physician Decision|1|||
33448774|NCT00059332|62823817|FG000|Overall Study|Withdrawal by Subject|2|||
33448775|NCT00059332|62823818|FG001|Overall Study|Withdrawal by Subject|1|||
33448776|NCT00059332|62823817|FG000|Overall Study|Lost to Follow-up|1|||
33448777|NCT00059332|62823818|FG001|Overall Study|Lost to Follow-up|1|||
33448778|NCT00233454|62823824|FG000|Overall Study|Death|6|||
33448779|NCT00047320|62823828|FG000|Overall Study|Lack of Efficacy|8|||
33448780|NCT00047320|62823828|FG000|Overall Study|Lost to Follow-up|1|||
33448781|NCT00047320|62823828|FG000|Overall Study|Physician Decision|8|||
33448782|NCT00047320|62823828|FG000|Overall Study|Withdrawal by Subject|9|||
33448783|NCT00047320|62823828|FG000|Overall Study|Ineligible|2|||
33448784|NCT00233064|62823834|FG000|Overall Study|Lost to Follow-up|7|||
33448785|NCT00233064|62823835|FG001|Overall Study|Lost to Follow-up|7|||
33448786|NCT00233064|62823834|FG000|Overall Study|Withdrawal by Subject|5|||
33500541|NCT04123405|62880813|FG003|Overall Study|Exclusion criteria met|2|||
33448787|NCT00233064|62823835|FG001|Overall Study|Withdrawal by Subject|3|||
33500542|NCT04123405|62880810|FG000|Overall Study|Withdrawal by Subject|1|||
33500543|NCT04123405|62880811|FG001|Overall Study|Withdrawal by Subject|3|||
33500544|NCT04123405|62880812|FG002|Overall Study|Withdrawal by Subject|0|||
33500545|NCT04123405|62880813|FG003|Overall Study|Withdrawal by Subject|2|||
33500546|NCT04123405|62880810|FG000|Overall Study|Contact to subject lost|0|||
33500547|NCT04123405|62880811|FG001|Overall Study|Contact to subject lost|0|||
33500548|NCT04123405|62880812|FG002|Overall Study|Contact to subject lost|0|||
33448788|NCT00233064|62823834|FG000|Overall Study|Death|0|||
33448789|NCT00233064|62823835|FG001|Overall Study|Death|1|||
33448790|NCT00233064|62823834|FG000|Overall Study|Relocation|0|||
33448791|NCT00233064|62823835|FG001|Overall Study|Relocation|1|||
33448792|NCT00233064|62823834|FG000|Overall Study|Protocol Violation|1|||
33448793|NCT00233064|62823835|FG001|Overall Study|Protocol Violation|0|||
33448794|NCT00233064|62823834|FG000|Overall Study|Moved to Dom. Republic|1|||
33448795|NCT00233064|62823835|FG001|Overall Study|Moved to Dom. Republic|0|||
33500549|NCT04123405|62880813|FG003|Overall Study|Contact to subject lost|1|||
33500550|NCT04123405|62880810|FG000|Overall Study|screening failure|1|||
33500551|NCT04123405|62880811|FG001|Overall Study|screening failure|0|||
33500552|NCT04123405|62880812|FG002|Overall Study|screening failure|0|||
33500553|NCT04123405|62880813|FG003|Overall Study|screening failure|0|||
33500554|NCT04314037|62880842|FG000|Treatment Period 2|Adverse Event|1|||
33500555|NCT04314037|62880843|FG001|Treatment Period 2|Adverse Event|0|||
33500556|NCT04314037|62880842|FG000|Treatment Period 3|Protocol Violation|1|||
33500557|NCT04314037|62880843|FG001|Treatment Period 3|Protocol Violation|0|||
33500558|NCT04314037|62880842|FG000|Treatment Period 3|Adverse Event|0|||
33500559|NCT04314037|62880843|FG001|Treatment Period 3|Adverse Event|1|||
33500560|NCT03056300|62880859|FG000|Overall Study|Surgical reason per study protocol|3|||
33500561|NCT03061214|62880866|FG000|Overall Study|Withdrawal by Subject|21|||
33500562|NCT03061214|62880867|FG001|Overall Study|Withdrawal by Subject|26|||
33500563|NCT03061214|62880868|FG002|Overall Study|Withdrawal by Subject|9|||
33500564|NCT03061214|62880866|FG000|Overall Study|Lost to Follow-up|3|||
33500565|NCT03061214|62880867|FG001|Overall Study|Lost to Follow-up|1|||
33500566|NCT03061214|62880868|FG002|Overall Study|Lost to Follow-up|1|||
33500567|NCT03061214|62880866|FG000|Overall Study|Death|1|||
33500568|NCT03061214|62880867|FG001|Overall Study|Death|1|||
33500569|NCT03061214|62880868|FG002|Overall Study|Death|0|||
33500570|NCT04115839|62880879|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
33500571|NCT04115839|62880880|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
33500572|NCT04115839|62880881|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
33500573|NCT04115839|62880882|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
33500574|NCT04115839|62880883|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
33500575|NCT04115839|62880884|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
33500576|NCT04115839|62880885|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
33500577|NCT04115839|62880879|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
33500578|NCT04115839|62880880|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
33500579|NCT04115839|62880881|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
33500580|NCT04115839|62880882|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
33500581|NCT04115839|62880883|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
33500582|NCT04115839|62880884|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
33500583|NCT04115839|62880885|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
33500584|NCT04115839|62880879|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
33500585|NCT04115839|62880880|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
33500586|NCT04115839|62880881|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
33500587|NCT04115839|62880882|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
33609669|NCT02305238|63009847|FG001|Overall Study|Logistical difficulties|3|||
33609670|NCT02305238|63009848|FG002|Overall Study|Logistical difficulties|0|||
33609671|NCT02305238|63009846|FG000|Overall Study|Protocol Violation|0|||
33609672|NCT02305238|63009847|FG001|Overall Study|Protocol Violation|3|||
33609673|NCT02305238|63009848|FG002|Overall Study|Protocol Violation|0|||
33609674|NCT02305238|63009846|FG000|Overall Study|Physician Decision|2|||
33609675|NCT02305238|63009847|FG001|Overall Study|Physician Decision|1|||
33609676|NCT02305238|63009848|FG002|Overall Study|Physician Decision|0|||
33448796|NCT00268892|62823845|FG000|Overall Study|Adverse Event|14|||
33448797|NCT00268892|62823846|FG001|Overall Study|Adverse Event|17|||
33448798|NCT00268892|62823847|FG002|Overall Study|Adverse Event|20|||
33448799|NCT00268892|62823845|FG000|Overall Study|Lack of Efficacy|1|||
33448800|NCT00268892|62823846|FG001|Overall Study|Lack of Efficacy|3|||
33448801|NCT00268892|62823847|FG002|Overall Study|Lack of Efficacy|0|||
33448802|NCT00268892|62823845|FG000|Overall Study|Withdrawal by Subject|14|||
33448803|NCT00268892|62823846|FG001|Overall Study|Withdrawal by Subject|15|||
33500588|NCT04115839|62880883|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
33609677|NCT02305238|63009846|FG000|Overall Study|Adverse Event|4|||
33609678|NCT02305238|63009847|FG001|Overall Study|Adverse Event|2|||
33609679|NCT02305238|63009848|FG002|Overall Study|Adverse Event|0|||
33609680|NCT02305238|63009846|FG000|Overall Study|Withdrawal by Subject|3|||
33324040|NCT00960687|62700441|FG001|Washout Period of 7 Days|Adverse Event|2|||
33324041|NCT00960687|62700440|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
33324042|NCT00960687|62700441|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33500589|NCT04115839|62880884|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
33500590|NCT04115839|62880885|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
33500591|NCT04115839|62880879|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
33609681|NCT02305238|63009847|FG001|Overall Study|Withdrawal by Subject|4|||
33609682|NCT02305238|63009848|FG002|Overall Study|Withdrawal by Subject|0|||
33324043|NCT00920140|62700452|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
33448804|NCT00268892|62823847|FG002|Overall Study|Withdrawal by Subject|13|||
33448805|NCT00268892|62823845|FG000|Overall Study|Physician Decision|0|||
33448806|NCT00268892|62823846|FG001|Overall Study|Physician Decision|1|||
33500592|NCT04115839|62880880|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
33609683|NCT02305238|63009846|FG000|Overall Study|Randomized failure|0|||
33609684|NCT02305238|63009847|FG001|Overall Study|Randomized failure|0|||
33609685|NCT02305238|63009848|FG002|Overall Study|Randomized failure|8|||
33609686|NCT02305238|63009846|FG000|Overall Study|Required procedure failed|0|||
33609687|NCT02305238|63009847|FG001|Overall Study|Required procedure failed|1|||
33609688|NCT02305238|63009848|FG002|Overall Study|Required procedure failed|0|||
33609689|NCT02313155|63009857|FG000|Overall Study|Lost to Follow-up|0|||
33609690|NCT02313155|63009858|FG001|Overall Study|Lost to Follow-up|1|||
33609691|NCT02204293|63009866|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
33609692|NCT02204293|63009867|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
33609693|NCT02204293|63009868|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
33609694|NCT02204293|63009869|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
33609695|NCT02204293|63009870|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
33609696|NCT02204293|63009871|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
33609697|NCT02204293|63009866|FG000|Core Study Part I|Adverse Event|1|||
33609698|NCT02204293|63009867|FG001|Core Study Part I|Adverse Event|0|||
33609699|NCT02204293|63009868|FG002|Core Study Part I|Adverse Event|0|||
33500593|NCT04115839|62880881|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
33500594|NCT04115839|62880882|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
33500595|NCT04115839|62880883|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
33500596|NCT04115839|62880884|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
33500597|NCT04115839|62880885|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
33500598|NCT04115839|62880879|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
33500599|NCT04115839|62880880|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
33500600|NCT04115839|62880881|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
33500601|NCT04115839|62880882|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
33500602|NCT04115839|62880883|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
33500603|NCT04115839|62880884|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
33500604|NCT04115839|62880885|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
33500605|NCT04115839|62880879|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
33500606|NCT04115839|62880880|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
33500607|NCT04115839|62880881|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
33500608|NCT04115839|62880882|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
33500609|NCT04115839|62880883|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
33500610|NCT04115839|62880884|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
33500611|NCT04115839|62880885|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
33500612|NCT01561430|62880914|FG000|Overall Study|Adverse Event|0|||
33500613|NCT01561430|62880915|FG001|Overall Study|Adverse Event|0|||
33500614|NCT01561430|62880916|FG002|Overall Study|Adverse Event|3|||
33500615|NCT01561430|62880917|FG003|Overall Study|Adverse Event|1|||
33500616|NCT01561430|62880914|FG000|Overall Study|Withdrawal by Subject|0|||
33500617|NCT01561430|62880915|FG001|Overall Study|Withdrawal by Subject|0|||
33500618|NCT01561430|62880916|FG002|Overall Study|Withdrawal by Subject|1|||
33500619|NCT01561430|62880917|FG003|Overall Study|Withdrawal by Subject|0|||
33500620|NCT01561430|62880914|FG000|Overall Study|Physician Decision|0|||
33500621|NCT01561430|62880915|FG001|Overall Study|Physician Decision|1|||
33500622|NCT01561430|62880916|FG002|Overall Study|Physician Decision|0|||
33500623|NCT01561430|62880917|FG003|Overall Study|Physician Decision|0|||
33500624|NCT01561430|62880914|FG000|Overall Study|Sponsor Decision|1|||
33500625|NCT01561430|62880915|FG001|Overall Study|Sponsor Decision|14|||
33500626|NCT01561430|62880916|FG002|Overall Study|Sponsor Decision|13|||
33500627|NCT01561430|62880917|FG003|Overall Study|Sponsor Decision|12|||
33500628|NCT03000530|62880953|FG000|Overall Study|Adverse Event|0|||
33500629|NCT03000530|62880954|FG001|Overall Study|Adverse Event|0|||
33500630|NCT03000530|62880955|FG002|Overall Study|Adverse Event|2|||
33500631|NCT03000530|62880953|FG000|Overall Study|Lost to Follow-up|0|||
33500632|NCT03000530|62880954|FG001|Overall Study|Lost to Follow-up|3|||
33500633|NCT03000530|62880955|FG002|Overall Study|Lost to Follow-up|1|||
33500634|NCT03000530|62880953|FG000|Overall Study|Withdrawal by Subject|0|||
33609700|NCT02204293|63009869|FG003|Core Study Part I|Adverse Event|0|||
33609701|NCT02204293|63009870|FG004|Core Study Part I|Adverse Event|0|||
33609702|NCT02204293|63009871|FG005|Core Study Part I|Adverse Event|0|||
33609703|NCT02204293|63009866|FG000|Core Study Part I|Physician Decision|0|||
33609704|NCT02204293|63009867|FG001|Core Study Part I|Physician Decision|3|||
33609705|NCT02204293|63009868|FG002|Core Study Part I|Physician Decision|0|||
33324044|NCT00920140|62700453|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
33609706|NCT02204293|63009869|FG003|Core Study Part I|Physician Decision|0|||
33609707|NCT02204293|63009870|FG004|Core Study Part I|Physician Decision|0|||
33609708|NCT02204293|63009871|FG005|Core Study Part I|Physician Decision|0|||
33609709|NCT02204293|63009866|FG000|LTE Phase|Study Suspended|0|||
33609710|NCT02204293|63009867|FG001|LTE Phase|Study Suspended|0|||
33609711|NCT02204293|63009868|FG002|LTE Phase|Study Suspended|0|||
33609712|NCT02204293|63009869|FG003|LTE Phase|Study Suspended|0|||
33609713|NCT02204293|63009870|FG004|LTE Phase|Study Suspended|0|||
33609714|NCT02204293|63009871|FG005|LTE Phase|Study Suspended|7|||
33609715|NCT02304926|63009887|FG000|Overall Study|Lost to Follow-up|2|||
33609716|NCT02304926|63009888|FG001|Overall Study|Lost to Follow-up|1|||
33609717|NCT01646255|63009898|FG000|Overall Study|Adverse Event|7|||
33609718|NCT01646255|63009899|FG001|Overall Study|Adverse Event|8|||
33609719|NCT01646255|63009898|FG000|Overall Study|Lack of Efficacy|2|||
33609720|NCT01646255|63009899|FG001|Overall Study|Lack of Efficacy|0|||
33609721|NCT01646255|63009898|FG000|Overall Study|Withdrawal by Subject|10|||
33609722|NCT01646255|63009899|FG001|Overall Study|Withdrawal by Subject|6|||
33609723|NCT01646255|63009898|FG000|Overall Study|Compliance is not well|1|||
33609724|NCT01646255|63009899|FG001|Overall Study|Compliance is not well|0|||
33609725|NCT01646255|63009898|FG000|Overall Study|Inclusion Criteria Deviation|1|||
33609726|NCT01646255|63009899|FG001|Overall Study|Inclusion Criteria Deviation|0|||
33609727|NCT02304380|63009912|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
33609728|NCT02304380|63009913|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
33609729|NCT02304380|63009914|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
33609730|NCT02304380|63009915|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
33609731|NCT02304380|63009916|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
33609732|NCT02304380|63009917|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
33609733|NCT02203591|63009939|FG000|Overall Study|Did not meet treatment day baseline|147|||
33609734|NCT02203591|63009940|FG001|Overall Study|Did not meet treatment day baseline|141|||
33609735|NCT02203591|63009941|FG002|Overall Study|Did not meet treatment day baseline|150|||
33609736|NCT02203591|63009942|FG003|Overall Study|Did not meet treatment day baseline|45|||
33609737|NCT02203591|63009943|FG004|Overall Study|Did not meet treatment day baseline|33|||
33609738|NCT02203591|63009944|FG005|Overall Study|Did not meet treatment day baseline|35|||
33609739|NCT02203591|63009945|FG006|Overall Study|Did not meet treatment day baseline|29|||
33609740|NCT02203591|63009946|FG007|Overall Study|Did not meet treatment day baseline|12|||
33609741|NCT02203591|63009939|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
33609742|NCT02203591|63009940|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
33609743|NCT02203591|63009941|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
33609744|NCT02203591|63009942|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
33609745|NCT02203591|63009943|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
33609746|NCT02203591|63009944|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
33609747|NCT02203591|63009945|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
33324045|NCT00920140|62700454|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
33324046|NCT00920140|62700455|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
33324047|NCT00920140|62700456|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
33324048|NCT00920140|62700452|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
33324049|NCT00920140|62700453|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
33324050|NCT00920140|62700454|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
33324051|NCT00920140|62700455|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
33324052|NCT00920140|62700456|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
33324053|NCT00920140|62700452|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
33609748|NCT02203591|63009946|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
33609749|NCT01642277|63009970|FG000|Overall Study|Adverse Event|10|||
33609750|NCT01642277|63009971|FG001|Overall Study|Adverse Event|0|||
33609751|NCT01642277|63009970|FG000|Overall Study|Physician Decision|2|||
33609752|NCT01642277|63009971|FG001|Overall Study|Physician Decision|0|||
33609753|NCT01642277|63009970|FG000|Overall Study|Protocol Violation|1|||
33609754|NCT01642277|63009971|FG001|Overall Study|Protocol Violation|0|||
33609755|NCT01642277|63009970|FG000|Overall Study|Withdrawal by Subject|11|||
33609756|NCT01642277|63009971|FG001|Overall Study|Withdrawal by Subject|0|||
33609757|NCT02230189|63009981|FG000|Overall Study|Withdrawal by Subject|3|||
33609758|NCT02230189|63009982|FG001|Overall Study|Withdrawal by Subject|0|||
33609759|NCT02230189|63009983|FG002|Overall Study|Withdrawal by Subject|1|||
33609760|NCT02230189|63009981|FG000|Overall Study|Lost to Follow-up|1|||
33609761|NCT02230189|63009982|FG001|Overall Study|Lost to Follow-up|0|||
33609762|NCT02230189|63009983|FG002|Overall Study|Lost to Follow-up|0|||
33609763|NCT02230189|63009981|FG000|Overall Study|Physician Decision|1|||
33609764|NCT02230189|63009982|FG001|Overall Study|Physician Decision|0|||
33609765|NCT02230189|63009983|FG002|Overall Study|Physician Decision|0|||
33609766|NCT02304302|63009994|FG000|Overall Study|Adverse Event|2|||
33609767|NCT02304302|63009995|FG001|Overall Study|Adverse Event|3|||
33609768|NCT02304302|63009994|FG000|Overall Study|Lost to Follow-up|1|||
33609769|NCT02304302|63009995|FG001|Overall Study|Lost to Follow-up|4|||
33609770|NCT02304302|63009994|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
33609771|NCT02304302|63009995|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
33609772|NCT02276612|63010007|FG000|Overall Study|Death|1|||
33609773|NCT02276612|63010008|FG001|Overall Study|Death|0|||
33609774|NCT02276612|63010007|FG000|Overall Study|Pregnancy|1|||
33609775|NCT02276612|63010008|FG001|Overall Study|Pregnancy|0|||
33609776|NCT02276612|63010007|FG000|Overall Study|Withdrew Consent|1|||
33324054|NCT00920140|62700453|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
33609777|NCT02276612|63010008|FG001|Overall Study|Withdrew Consent|0|||
33609778|NCT02276612|63010007|FG000|Overall Study|Lost to Follow-up|1|||
33609779|NCT02276612|63010008|FG001|Overall Study|Lost to Follow-up|0|||
33609780|NCT02301143|63010014|FG000|Induction Period|Enrolled But Not Treated|1|||
33500635|NCT03000530|62880954|FG001|Overall Study|Withdrawal by Subject|2|||
33500636|NCT03000530|62880955|FG002|Overall Study|Withdrawal by Subject|1|||
33500637|NCT03060512|62880968|FG000|Overall Study|Adverse Event|4|||
33500638|NCT03060512|62880969|FG001|Overall Study|Adverse Event|6|||
33500639|NCT03060512|62880968|FG000|Overall Study|Lost to Follow-up|1|||
33500640|NCT03060512|62880969|FG001|Overall Study|Lost to Follow-up|1|||
33500641|NCT03060512|62880968|FG000|Overall Study|Withdrawal by Subject|1|||
33500642|NCT03060512|62880969|FG001|Overall Study|Withdrawal by Subject|0|||
33500643|NCT03060512|62880968|FG000|Overall Study|Non-compliance with study medication|1|||
33500644|NCT03060512|62880969|FG001|Overall Study|Non-compliance with study medication|2|||
33500645|NCT02539160|62881057|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
33500646|NCT02539160|62881058|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
33609781|NCT02301143|63010015|FG001|Induction Period|Enrolled But Not Treated|0|||
33609782|NCT02301143|63010014|FG000|Induction Period|Death|1|||
33609783|NCT02301143|63010015|FG001|Induction Period|Death|0|||
33609784|NCT02301143|63010014|FG000|Induction Period|Adverse Event|22|||
33609785|NCT02301143|63010015|FG001|Induction Period|Adverse Event|0|||
33609786|NCT02301143|63010014|FG000|Induction Period|Progressive Disease|8|||
33609787|NCT02301143|63010015|FG001|Induction Period|Progressive Disease|0|||
33609788|NCT02301143|63010014|FG000|Induction Period|Withdrawal by Subject|3|||
33609789|NCT02301143|63010015|FG001|Induction Period|Withdrawal by Subject|0|||
33609790|NCT02301143|63010014|FG000|Induction Period|Noncompliance with Study Drug|1|||
33609791|NCT02301143|63010015|FG001|Induction Period|Noncompliance with Study Drug|0|||
33609792|NCT02301143|63010014|FG000|Induction Period|Physician Decision|4|||
33609793|NCT02301143|63010015|FG001|Induction Period|Physician Decision|0|||
33609794|NCT02301143|63010014|FG000|Induction Period|Symptomatic Deterioration|2|||
33609795|NCT02301143|63010015|FG001|Induction Period|Symptomatic Deterioration|0|||
33609796|NCT02301143|63010014|FG000|Induction Period|Protocol Violation|2|||
33609797|NCT02301143|63010015|FG001|Induction Period|Protocol Violation|0|||
33609798|NCT02301143|63010014|FG000|Induction Period|Other|1|||
33609799|NCT02301143|63010015|FG001|Induction Period|Other|0|||
33609800|NCT02301143|63010014|FG000|Investigator's Choice|Adverse Event|0|||
33609801|NCT02301143|63010015|FG001|Investigator's Choice|Adverse Event|3|||
33609802|NCT02301143|63010014|FG000|Investigator's Choice|Progressive Disease|0|||
33609803|NCT02301143|63010015|FG001|Investigator's Choice|Progressive Disease|3|||
33609804|NCT02301143|63010014|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
33609805|NCT02301143|63010015|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
33609806|NCT02301143|63010014|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
33609807|NCT02301143|63010015|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
33609808|NCT02301143|63010014|FG000|Investigator's Choice|Other|0|||
33609809|NCT02301143|63010015|FG001|Investigator's Choice|Other|1|||
33609810|NCT02301143|63010014|FG000|Investigator's Choice|Unresectable Surgery|0|||
33609811|NCT02301143|63010015|FG001|Investigator's Choice|Unresectable Surgery|1|||
33609812|NCT02276222|63010028|FG000|Overall Study|Adverse Event|62|||
33609813|NCT02276222|63010029|FG001|Overall Study|Adverse Event|11|||
33609814|NCT02276222|63010028|FG000|Overall Study|Death|3|||
33609815|NCT02276222|63010029|FG001|Overall Study|Death|4|||
33609816|NCT02276222|63010028|FG000|Overall Study|Lack of Efficacy|13|||
33609817|NCT02276222|63010029|FG001|Overall Study|Lack of Efficacy|3|||
33609818|NCT02276222|63010028|FG000|Overall Study|Protocol Violation|3|||
33609819|NCT02276222|63010029|FG001|Overall Study|Protocol Violation|2|||
33609820|NCT02276222|63010028|FG000|Overall Study|Withdrawal by Subject|79|||
33609821|NCT02276222|63010029|FG001|Overall Study|Withdrawal by Subject|33|||
33609822|NCT02276222|63010028|FG000|Overall Study|non compliance with study medication|6|||
33609823|NCT02276222|63010029|FG001|Overall Study|non compliance with study medication|2|||
33609824|NCT02276222|63010028|FG000|Overall Study|sponsor decision|0|||
33609825|NCT02276222|63010029|FG001|Overall Study|sponsor decision|3|||
33609826|NCT02276222|63010028|FG000|Overall Study|Lost to Follow-up|15|||
33324055|NCT00920140|62700454|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
33324056|NCT00920140|62700455|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
33609827|NCT02276222|63010029|FG001|Overall Study|Lost to Follow-up|5|||
33609828|NCT02276222|63010028|FG000|Overall Study|Physician Decision|2|||
33324057|NCT00920140|62700456|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
33609829|NCT02276222|63010029|FG001|Overall Study|Physician Decision|1|||
33324058|NCT00920140|62700452|FG000|Phase 2|Adverse Event|0|||
33500647|NCT02539160|62881059|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
33500648|NCT02539160|62881060|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
33609830|NCT02276222|63010028|FG000|Overall Study|sheduling conflict|1|||
33609831|NCT02276222|63010029|FG001|Overall Study|sheduling conflict|0|||
33609832|NCT02276222|63010028|FG000|Overall Study|subject withdrew after randomization|1|||
33609833|NCT02276222|63010029|FG001|Overall Study|subject withdrew after randomization|0|||
33609834|NCT02275364|63010035|FG000|Period 1|Withdrawal by Subject|1|||
33500649|NCT02539160|62881057|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
33500650|NCT02539160|62881058|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
33324059|NCT00920140|62700453|FG001|Phase 2|Adverse Event|0|||
33500651|NCT02539160|62881059|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
33500652|NCT02539160|62881060|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
33324060|NCT00920140|62700454|FG002|Phase 2|Adverse Event|14|||
33448807|NCT00268892|62823847|FG002|Overall Study|Physician Decision|0|||
33500653|NCT02539160|62881057|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
33500654|NCT02539160|62881058|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
33500655|NCT02539160|62881059|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
33500656|NCT02539160|62881060|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
33500657|NCT04292899|62881074|FG000|Overall Study|Death|21|||
33500658|NCT04292899|62881075|FG001|Overall Study|Death|28|||
33500659|NCT04292899|62881076|FG002|Overall Study|Death|188|||
33500660|NCT04292899|62881077|FG003|Overall Study|Death|371|||
33500661|NCT04292899|62881074|FG000|Overall Study|Lost to Follow-up|8|||
33500662|NCT04292899|62881075|FG001|Overall Study|Lost to Follow-up|4|||
33609835|NCT02275364|63010036|FG001|Period 1|Withdrawal by Subject|0|||
33609836|NCT02275364|63010035|FG000|Period 1|Other reason|1|||
33609837|NCT02275364|63010036|FG001|Period 1|Other reason|0|||
33609838|NCT02275052|63010053|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33609839|NCT02275052|63010054|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
33609840|NCT02275052|63010055|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33609841|NCT02275052|63010056|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33609842|NCT02275052|63010053|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
33609843|NCT02275052|63010054|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
33609844|NCT02275052|63010055|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
33609845|NCT02275052|63010056|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
33609846|NCT02275052|63010053|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
33609847|NCT02275052|63010054|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
33609848|NCT02275052|63010055|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33500663|NCT04292899|62881076|FG002|Overall Study|Lost to Follow-up|22|||
33609849|NCT02275052|63010056|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33609850|NCT02275052|63010053|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
33448808|NCT00268892|62823845|FG000|Overall Study|Lost to Follow-up|5|||
33448809|NCT00268892|62823846|FG001|Overall Study|Lost to Follow-up|2|||
33448810|NCT00268892|62823847|FG002|Overall Study|Lost to Follow-up|4|||
33448811|NCT00268892|62823845|FG000|Overall Study|Protocol Violation|0|||
33448812|NCT00268892|62823846|FG001|Overall Study|Protocol Violation|1|||
33448813|NCT00268892|62823847|FG002|Overall Study|Protocol Violation|0|||
33448814|NCT00268892|62823845|FG000|Overall Study|Disease Progression|1|||
33448815|NCT00268892|62823846|FG001|Overall Study|Disease Progression|1|||
33448816|NCT00268892|62823847|FG002|Overall Study|Disease Progression|0|||
33448817|NCT00268892|62823845|FG000|Overall Study|Trial Site Closed|4|||
33500664|NCT04292899|62881077|FG003|Overall Study|Lost to Follow-up|235|||
33500665|NCT04292899|62881074|FG000|Overall Study|Withdrew consent|1|||
33609851|NCT02275052|63010054|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
33609852|NCT02275052|63010055|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
33448818|NCT00268892|62823846|FG001|Overall Study|Trial Site Closed|2|||
33448819|NCT00268892|62823847|FG002|Overall Study|Trial Site Closed|2|||
33448820|NCT00206076|62823857|FG000|Overall Study|Physician Decision|2|||
33500666|NCT04292899|62881075|FG001|Overall Study|Withdrew consent|0|||
33500667|NCT04292899|62881076|FG002|Overall Study|Withdrew consent|11|||
33500668|NCT04292899|62881077|FG003|Overall Study|Withdrew consent|32|||
33500669|NCT04292899|62881074|FG000|Overall Study|Adverse Event|2|||
33500670|NCT04292899|62881075|FG001|Overall Study|Adverse Event|1|||
33500671|NCT04292899|62881076|FG002|Overall Study|Adverse Event|2|||
33500672|NCT04292899|62881077|FG003|Overall Study|Adverse Event|2|||
33500673|NCT04292899|62881074|FG000|Overall Study|Investigator's Discretion|0|||
33500674|NCT04292899|62881075|FG001|Overall Study|Investigator's Discretion|0|||
33500675|NCT04292899|62881076|FG002|Overall Study|Investigator's Discretion|0|||
33500676|NCT04292899|62881077|FG003|Overall Study|Investigator's Discretion|3|||
33500677|NCT04292899|62881074|FG000|Overall Study|Non-compliance With Study Drug|0|||
33500678|NCT04292899|62881075|FG001|Overall Study|Non-compliance With Study Drug|0|||
33500679|NCT04292899|62881076|FG002|Overall Study|Non-compliance With Study Drug|0|||
33500680|NCT04292899|62881077|FG003|Overall Study|Non-compliance With Study Drug|1|||
33500681|NCT04292899|62881074|FG000|Overall Study|Protocol Violation|0|||
33500682|NCT04292899|62881075|FG001|Overall Study|Protocol Violation|0|||
33500683|NCT04292899|62881076|FG002|Overall Study|Protocol Violation|0|||
33500684|NCT04292899|62881077|FG003|Overall Study|Protocol Violation|1|||
33500685|NCT03241173|62881096|FG000|Overall Study|Death|3|||
33500686|NCT03241173|62881097|FG001|Overall Study|Death|2|||
33500687|NCT03241173|62881098|FG002|Overall Study|Death|4|||
33500688|NCT03241173|62881099|FG003|Overall Study|Death|4|||
33500689|NCT03241173|62881100|FG004|Overall Study|Death|2|||
33500690|NCT03241173|62881101|FG005|Overall Study|Death|2|||
33500691|NCT03241173|62881102|FG006|Overall Study|Death|3|||
33500692|NCT03241173|62881103|FG007|Overall Study|Death|1|||
33500693|NCT03241173|62881104|FG008|Overall Study|Death|0|||
33500694|NCT03241173|62881105|FG009|Overall Study|Death|5|||
33500695|NCT03241173|62881106|FG010|Overall Study|Death|4|||
33500696|NCT03241173|62881107|FG011|Overall Study|Death|3|||
33500697|NCT03241173|62881108|FG012|Overall Study|Death|0|||
33500698|NCT03241173|62881109|FG013|Overall Study|Death|0|||
33500699|NCT03241173|62881110|FG014|Overall Study|Death|0|||
33500700|NCT03241173|62881096|FG000|Overall Study|Withdrawal by Subject|0|||
33500701|NCT03241173|62881097|FG001|Overall Study|Withdrawal by Subject|0|||
33500702|NCT03241173|62881098|FG002|Overall Study|Withdrawal by Subject|1|||
33500703|NCT03241173|62881099|FG003|Overall Study|Withdrawal by Subject|0|||
33500704|NCT03241173|62881100|FG004|Overall Study|Withdrawal by Subject|0|||
33500705|NCT03241173|62881101|FG005|Overall Study|Withdrawal by Subject|1|||
33500706|NCT03241173|62881102|FG006|Overall Study|Withdrawal by Subject|0|||
33500707|NCT03241173|62881103|FG007|Overall Study|Withdrawal by Subject|0|||
33500708|NCT03241173|62881104|FG008|Overall Study|Withdrawal by Subject|0|||
33500709|NCT03241173|62881105|FG009|Overall Study|Withdrawal by Subject|0|||
33500710|NCT03241173|62881106|FG010|Overall Study|Withdrawal by Subject|0|||
33500711|NCT03241173|62881107|FG011|Overall Study|Withdrawal by Subject|0|||
33500712|NCT03241173|62881108|FG012|Overall Study|Withdrawal by Subject|0|||
33500713|NCT03241173|62881109|FG013|Overall Study|Withdrawal by Subject|0|||
33500714|NCT03241173|62881110|FG014|Overall Study|Withdrawal by Subject|0|||
33500715|NCT03241173|62881096|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
33500716|NCT03241173|62881097|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
33500717|NCT03241173|62881098|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
33500718|NCT03241173|62881099|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
33500719|NCT03241173|62881100|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
33500720|NCT03241173|62881101|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
33500721|NCT03241173|62881102|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
33500722|NCT03241173|62881103|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
33500723|NCT03241173|62881104|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
33500724|NCT03241173|62881105|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
33544013|NCT03021187|62934825|FG003|Overall Study|Withdrawal by Subject|5|||
33544014|NCT03021187|62934822|FG000|Overall Study|Lost to Follow-up|10|||
33544015|NCT03021187|62934823|FG001|Overall Study|Lost to Follow-up|3|||
33544016|NCT03021187|62934824|FG002|Overall Study|Lost to Follow-up|1|||
33544017|NCT03021187|62934825|FG003|Overall Study|Lost to Follow-up|4|||
33544018|NCT03014479|62934837|FG000|Overall Study|Adverse Event|0|||
33544019|NCT03014479|62934838|FG001|Overall Study|Adverse Event|1|||
33544020|NCT03014479|62934837|FG000|Overall Study|Voluntary Withdrawal|0|||
33544021|NCT03014479|62934838|FG001|Overall Study|Voluntary Withdrawal|2|||
33544022|NCT03014479|62934837|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
33544023|NCT03014479|62934838|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
33544024|NCT04766333|62934846|FG000|Overall Study|Lost to Follow-up|40|||
33544025|NCT04766333|62934847|FG001|Overall Study|Lost to Follow-up|826|||
33544026|NCT03020641|62934855|FG000|Overall Study|Lost to Follow-up|0|||
33544027|NCT03020641|62934856|FG001|Overall Study|Lost to Follow-up|1|||
33500725|NCT03241173|62881106|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
33500726|NCT03241173|62881107|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
33500727|NCT03241173|62881108|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
33500728|NCT03241173|62881109|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
33500729|NCT03241173|62881110|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
33500730|NCT03241173|62881096|FG000|Overall Study|Lost to Follow-up|0|||
33500731|NCT03241173|62881097|FG001|Overall Study|Lost to Follow-up|0|||
33500732|NCT03241173|62881098|FG002|Overall Study|Lost to Follow-up|0|||
33500733|NCT03241173|62881099|FG003|Overall Study|Lost to Follow-up|0|||
33500734|NCT03241173|62881100|FG004|Overall Study|Lost to Follow-up|1|||
33500735|NCT03241173|62881101|FG005|Overall Study|Lost to Follow-up|0|||
33500736|NCT03241173|62881102|FG006|Overall Study|Lost to Follow-up|0|||
33500737|NCT03241173|62881103|FG007|Overall Study|Lost to Follow-up|0|||
33500738|NCT03241173|62881104|FG008|Overall Study|Lost to Follow-up|0|||
33500739|NCT03241173|62881105|FG009|Overall Study|Lost to Follow-up|1|||
33500740|NCT03241173|62881106|FG010|Overall Study|Lost to Follow-up|0|||
33500741|NCT03241173|62881107|FG011|Overall Study|Lost to Follow-up|0|||
33500742|NCT03241173|62881108|FG012|Overall Study|Lost to Follow-up|0|||
33609853|NCT02275052|63010056|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
33609854|NCT02275052|63010053|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
33609855|NCT02275052|63010054|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
33609856|NCT02275052|63010055|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
33609857|NCT02275052|63010056|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
33609858|NCT02275052|63010053|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
33609859|NCT02275052|63010054|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
33609860|NCT02275052|63010055|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
33609861|NCT02275052|63010056|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
33500743|NCT03241173|62881109|FG013|Overall Study|Lost to Follow-up|0|||
33500744|NCT03241173|62881110|FG014|Overall Study|Lost to Follow-up|0|||
33500745|NCT03264066|62881144|FG000|Overall Study|Adverse Event|1|||
33500746|NCT03264066|62881145|FG001|Overall Study|Adverse Event|1|||
33500747|NCT03264066|62881146|FG002|Overall Study|Adverse Event|0|||
33500748|NCT03264066|62881147|FG003|Overall Study|Adverse Event|0|||
33500749|NCT03264066|62881148|FG004|Overall Study|Adverse Event|0|||
33500750|NCT03264066|62881149|FG005|Overall Study|Adverse Event|0|||
33500751|NCT03264066|62881144|FG000|Overall Study|Death|12|||
33500752|NCT03264066|62881145|FG001|Overall Study|Death|12|||
33500753|NCT03264066|62881146|FG002|Overall Study|Death|8|||
33500754|NCT03264066|62881147|FG003|Overall Study|Death|10|||
33500755|NCT03264066|62881148|FG004|Overall Study|Death|6|||
33500756|NCT03264066|62881149|FG005|Overall Study|Death|1|||
33500757|NCT03264066|62881144|FG000|Overall Study|Lost to Follow-up|1|||
33500758|NCT03264066|62881145|FG001|Overall Study|Lost to Follow-up|0|||
33500759|NCT03264066|62881146|FG002|Overall Study|Lost to Follow-up|0|||
33500760|NCT03264066|62881147|FG003|Overall Study|Lost to Follow-up|0|||
33500761|NCT03264066|62881148|FG004|Overall Study|Lost to Follow-up|0|||
33500762|NCT03264066|62881149|FG005|Overall Study|Lost to Follow-up|0|||
33500763|NCT03264066|62881144|FG000|Overall Study|Progressive Disease|0|||
33500764|NCT03264066|62881145|FG001|Overall Study|Progressive Disease|2|||
33500765|NCT03264066|62881146|FG002|Overall Study|Progressive Disease|1|||
33500766|NCT03264066|62881147|FG003|Overall Study|Progressive Disease|0|||
33500767|NCT03264066|62881148|FG004|Overall Study|Progressive Disease|0|||
33500768|NCT03264066|62881149|FG005|Overall Study|Progressive Disease|0|||
33500769|NCT03264066|62881144|FG000|Overall Study|Study Terminated by Sponsor|5|||
33500770|NCT03264066|62881145|FG001|Overall Study|Study Terminated by Sponsor|5|||
33500771|NCT03264066|62881146|FG002|Overall Study|Study Terminated by Sponsor|8|||
33500772|NCT03264066|62881147|FG003|Overall Study|Study Terminated by Sponsor|5|||
33500773|NCT03264066|62881148|FG004|Overall Study|Study Terminated by Sponsor|1|||
33500774|NCT03264066|62881149|FG005|Overall Study|Study Terminated by Sponsor|2|||
33500775|NCT03264066|62881144|FG000|Overall Study|Withdrawal by Subject|1|||
33500776|NCT03264066|62881145|FG001|Overall Study|Withdrawal by Subject|0|||
33609862|NCT02275052|63010053|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
33500777|NCT03264066|62881146|FG002|Overall Study|Withdrawal by Subject|0|||
33500778|NCT03264066|62881147|FG003|Overall Study|Withdrawal by Subject|5|||
33500779|NCT03264066|62881148|FG004|Overall Study|Withdrawal by Subject|0|||
33609863|NCT02275052|63010054|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
33500780|NCT03264066|62881149|FG005|Overall Study|Withdrawal by Subject|0|||
33500781|NCT03759041|62881167|FG000|Overall Study|Withdrawal by Subject|4|||
33500782|NCT03759041|62881168|FG001|Overall Study|Withdrawal by Subject|10|||
33500783|NCT03759041|62881169|FG002|Overall Study|Withdrawal by Subject|10|||
33500784|NCT03759041|62881167|FG000|Overall Study|Adverse Event|1|||
33500785|NCT03759041|62881168|FG001|Overall Study|Adverse Event|3|||
33500786|NCT03759041|62881169|FG002|Overall Study|Adverse Event|4|||
33500787|NCT03759041|62881167|FG000|Overall Study|Lack of Efficacy|0|||
33500788|NCT03759041|62881168|FG001|Overall Study|Lack of Efficacy|0|||
33500789|NCT03759041|62881169|FG002|Overall Study|Lack of Efficacy|1|||
33500790|NCT03759041|62881167|FG000|Overall Study|Study Terminated by Sponsor|15|||
33500791|NCT03759041|62881168|FG001|Overall Study|Study Terminated by Sponsor|16|||
33500792|NCT03759041|62881169|FG002|Overall Study|Study Terminated by Sponsor|10|||
33500793|NCT03759041|62881167|FG000|Overall Study|Other reason for discontinuation|0|||
33500794|NCT03759041|62881168|FG001|Overall Study|Other reason for discontinuation|2|||
33500795|NCT03759041|62881169|FG002|Overall Study|Other reason for discontinuation|1|||
33500796|NCT03759041|62881167|FG000|Overall Study|Lost to Follow-up|7|||
33500797|NCT03759041|62881168|FG001|Overall Study|Lost to Follow-up|2|||
33500798|NCT03759041|62881169|FG002|Overall Study|Lost to Follow-up|2|||
33500799|NCT03759041|62881167|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
33500800|NCT03759041|62881168|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
33609864|NCT02275052|63010055|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
33609865|NCT02275052|63010056|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
33609866|NCT02275052|63010053|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
33609867|NCT02275052|63010054|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
33609868|NCT02275052|63010055|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
33609869|NCT02275052|63010056|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
33609870|NCT02275052|63010053|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33609871|NCT02275052|63010054|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33500801|NCT03759041|62881169|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
33500802|NCT04110145|62881182|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
33500803|NCT04110145|62881183|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
33500804|NCT04110145|62881184|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
33500805|NCT04110145|62881185|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
33500806|NCT04110145|62881186|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
33500807|NCT02477618|62881200|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
33500808|NCT02477618|62881201|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
33500809|NCT02477618|62881200|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
33500810|NCT02477618|62881201|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
33500811|NCT02477618|62881200|FG000|Overall Study|Adverse Event|1|||
33500812|NCT02477618|62881201|FG001|Overall Study|Adverse Event|1|||
33500813|NCT02477618|62881200|FG000|Overall Study|Transferred Away from Study Site|1|||
33500814|NCT02477618|62881201|FG001|Overall Study|Transferred Away from Study Site|0|||
33500815|NCT02477618|62881200|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
33500816|NCT02477618|62881201|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
33609872|NCT02275052|63010055|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33448821|NCT00206076|62823858|FG001|Overall Study|Physician Decision|0|||
33448822|NCT00206076|62823857|FG000|Overall Study|Withdrawal by Subject|1|||
33448823|NCT00206076|62823858|FG001|Overall Study|Withdrawal by Subject|1|||
33448824|NCT00278954|62823866|FG000|Overall Study|Adverse Event|3|||
33448825|NCT00278954|62823866|FG000|Overall Study|Lost to Follow-up|1|||
33448826|NCT00278954|62823866|FG000|Overall Study|Withdrawal by Subject|1|||
33448827|NCT00278564|62823870|FG000|Overall Study|Lack of Efficacy|4|||
33448828|NCT00268346|62823876|FG000|Overall Study|Adverse Event|0|||
33448829|NCT00268346|62823877|FG001|Overall Study|Adverse Event|1|||
33448830|NCT00268346|62823876|FG000|Overall Study|Death|0|||
33448831|NCT00268346|62823877|FG001|Overall Study|Death|1|||
33448832|NCT00268346|62823876|FG000|Overall Study|Withdrawal by Subject|0|||
33448833|NCT00268346|62823877|FG001|Overall Study|Withdrawal by Subject|1|||
33448834|NCT00203892|62823886|FG000|Overall Study|Physician Decision|1|||
33448835|NCT00203892|62823887|FG001|Overall Study|Physician Decision|2|||
33500817|NCT04102501|62881209|FG000|Overall Study|Withdrawal by Subject|7|||
33500818|NCT04102501|62881210|FG001|Overall Study|Withdrawal by Subject|9|||
33448836|NCT00203892|62823888|FG002|Overall Study|Physician Decision|0|||
33448837|NCT00203892|62823886|FG000|Overall Study|Death|1|||
33448838|NCT00203892|62823887|FG001|Overall Study|Death|0|||
33448839|NCT00203892|62823888|FG002|Overall Study|Death|0|||
33500819|NCT04102501|62881209|FG000|Overall Study|Adverse Event|1|||
33500820|NCT04102501|62881210|FG001|Overall Study|Adverse Event|3|||
33500821|NCT03285477|62881220|FG000|Treatment and Response Assessment Period|Death|1|||
33500822|NCT03285477|62881221|FG001|Treatment and Response Assessment Period|Death|0|||
33500823|NCT03285477|62881220|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
33500824|NCT03285477|62881221|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
33500825|NCT03285477|62881220|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
33500826|NCT03285477|62881221|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
33500827|NCT03285477|62881220|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
33500828|NCT03285477|62881221|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
33500829|NCT03285477|62881220|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
33500830|NCT03285477|62881221|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
33500831|NCT04289623|62881238|FG000|Wave 1 Emails|Email was not delivered|268|||
33500832|NCT04289623|62881239|FG001|Wave 1 Emails|Email was not delivered|257|||
33500833|NCT04289623|62881240|FG002|Wave 1 Emails|Email was not delivered|0|||
33500834|NCT04289623|62881241|FG003|Wave 1 Emails|Email was not delivered|0|||
33500835|NCT04289623|62881242|FG004|Wave 1 Emails|Email was not delivered|0|||
33500836|NCT04289623|62881243|FG005|Wave 1 Emails|Email was not delivered|0|||
33500837|NCT03248037|62881259|FG000|Overall Study|Withdrawal by Subject|6|||
33500838|NCT03248037|62881260|FG001|Overall Study|Withdrawal by Subject|9|||
33500839|NCT03248037|62881259|FG000|Overall Study|Adverse Event|15|||
33500840|NCT03248037|62881260|FG001|Overall Study|Adverse Event|0|||
33500841|NCT04287517|62881275|FG000|Overall Study|Withdrawal by Subject|1|||
33500842|NCT04287517|62881276|FG001|Overall Study|Withdrawal by Subject|1|||
33500843|NCT03284229|62881282|FG000|Overall Study|Lost to Follow-up|3|||
33500844|NCT03242928|62881289|FG000|Overall Study|Adverse Event|2|||
33500845|NCT03242928|62881290|FG001|Overall Study|Adverse Event|1|||
33500846|NCT03242928|62881289|FG000|Overall Study|Lost to Follow-up|2|||
33500847|NCT03242928|62881290|FG001|Overall Study|Lost to Follow-up|0|||
33500848|NCT03242928|62881289|FG000|Overall Study|Physician Decision|0|||
33500849|NCT03242928|62881290|FG001|Overall Study|Physician Decision|1|||
33500850|NCT03242928|62881289|FG000|Overall Study|Withdrawal by Subject|5|||
33500851|NCT03242928|62881290|FG001|Overall Study|Withdrawal by Subject|3|||
33448840|NCT00250718|62823896|FG000|Overall Study|Death|1|||
33448841|NCT00250718|62823896|FG000|Overall Study|Adverse Event|1|||
33448842|NCT00250718|62823896|FG000|Overall Study|Withdrawal by Subject|1|||
33448843|NCT00276614|62823900|FG000|Overall Study|Progression of disease under study|3|||
33448844|NCT00276458|62823906|FG000|Overall Study|Adverse Event|0|||
33448845|NCT00276458|62823907|FG001|Overall Study|Adverse Event|2|||
33448846|NCT00276458|62823906|FG000|Overall Study|Lost to Follow-up|2|||
33448847|NCT00276458|62823907|FG001|Overall Study|Lost to Follow-up|2|||
33448848|NCT00276458|62823906|FG000|Overall Study|Protocol Violation|4|||
33448849|NCT00276458|62823907|FG001|Overall Study|Protocol Violation|3|||
33448850|NCT00276380|62823915|FG000|Overall Study|Adverse Event|5|||
33448851|NCT00276380|62823916|FG001|Overall Study|Adverse Event|3|||
33448852|NCT00276380|62823915|FG000|Overall Study|Lost to Follow-up|1|||
33448853|NCT00276380|62823916|FG001|Overall Study|Lost to Follow-up|1|||
33448854|NCT00276380|62823915|FG000|Overall Study|Withdrawal by Subject|3|||
33448855|NCT00276380|62823916|FG001|Overall Study|Withdrawal by Subject|6|||
33448856|NCT00276380|62823915|FG000|Overall Study|Death|5|||
33448857|NCT00276380|62823916|FG001|Overall Study|Death|3|||
33448858|NCT00276380|62823915|FG000|Overall Study|Abnormal aPPT Levels|0|||
33448859|NCT00276380|62823916|FG001|Overall Study|Abnormal aPPT Levels|1|||
33448860|NCT00267956|62823925|FG000|Controlled Period|Adverse Event|4|||
33448861|NCT00267956|62823926|FG001|Controlled Period|Adverse Event|1|||
33448862|NCT00267956|62823927|FG002|Controlled Period|Adverse Event|0|||
33448863|NCT00267956|62823928|FG003|Controlled Period|Adverse Event|0|||
33448864|NCT00267956|62823925|FG000|Controlled Period|Lack of Efficacy|4|||
33448865|NCT00267956|62823926|FG001|Controlled Period|Lack of Efficacy|2|||
33448866|NCT00267956|62823927|FG002|Controlled Period|Lack of Efficacy|0|||
33448867|NCT00267956|62823928|FG003|Controlled Period|Lack of Efficacy|0|||
33448868|NCT00267956|62823925|FG000|Controlled Period|Lost to Follow-up|2|||
33448869|NCT00267956|62823926|FG001|Controlled Period|Lost to Follow-up|0|||
33448870|NCT00267956|62823927|FG002|Controlled Period|Lost to Follow-up|0|||
33448871|NCT00267956|62823928|FG003|Controlled Period|Lost to Follow-up|0|||
33448872|NCT00267956|62823925|FG000|Controlled Period|Withdrew consent|3|||
33448873|NCT00267956|62823926|FG001|Controlled Period|Withdrew consent|1|||
33448874|NCT00267956|62823927|FG002|Controlled Period|Withdrew consent|0|||
33448875|NCT00267956|62823928|FG003|Controlled Period|Withdrew consent|0|||
33448876|NCT00267956|62823925|FG000|After Controlled Period|Adverse Event|0|||
33448877|NCT00267956|62823926|FG001|After Controlled Period|Adverse Event|0|||
33448878|NCT00267956|62823927|FG002|After Controlled Period|Adverse Event|2|||
33448879|NCT00267956|62823928|FG003|After Controlled Period|Adverse Event|1|||
33448880|NCT00267956|62823925|FG000|After Controlled Period|Lack of Efficacy|0|||
33448881|NCT00267956|62823926|FG001|After Controlled Period|Lack of Efficacy|0|||
33448882|NCT00267956|62823927|FG002|After Controlled Period|Lack of Efficacy|1|||
33500852|NCT03300024|62881298|FG000|Overall Study|Physician Decision|4|||
33500853|NCT03300024|62881299|FG001|Overall Study|Physician Decision|6|||
33500854|NCT04276207|62881307|FG000|Period 1|Withdrawal by Subject|0|||
33500855|NCT04276207|62881308|FG001|Period 1|Withdrawal by Subject|1|||
33500856|NCT03282357|62881314|FG000|Overall Study|Lost to Follow-up|3|||
33500857|NCT03282357|62881314|FG000|Overall Study|Withdrawal by Subject|4|||
33609873|NCT02275052|63010056|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
33609874|NCT02275052|63010053|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
33609875|NCT02275052|63010054|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
33609876|NCT02275052|63010055|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
33609877|NCT02275052|63010056|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
33609878|NCT02275052|63010053|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33609879|NCT02275052|63010054|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33609880|NCT02275052|63010055|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33500858|NCT03282357|62881314|FG000|Overall Study|Adverse Event|1|||
33500859|NCT03282357|62881314|FG000|Overall Study|Other|9|||
33500860|NCT04272775|62881321|FG000|Overall Study|Study Terminated by Sponsor|1|||
33500861|NCT04272775|62881322|FG001|Overall Study|Study Terminated by Sponsor|0|||
33500862|NCT04272775|62881321|FG000|Overall Study|Protocol Violation|0|||
33609881|NCT02275052|63010056|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
33609882|NCT02274038|63010062|FG000|Overall Study|Death|1|||
33609883|NCT02300558|63010068|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
33609884|NCT02300558|63010068|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
33609885|NCT02300558|63010068|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
33609886|NCT02300558|63010068|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
33609887|NCT02273960|63010080|FG000|Short Term Period|Lost to Follow-up|1|||
33609888|NCT02273960|63010081|FG001|Short Term Period|Lost to Follow-up|0|||
33609889|NCT02273960|63010082|FG002|Short Term Period|Lost to Follow-up|0|||
33609890|NCT02273960|63010083|FG003|Short Term Period|Lost to Follow-up|0|||
33609891|NCT02273960|63010080|FG000|Short Term Period|Lack of Efficacy|0|||
33609892|NCT02273960|63010081|FG001|Short Term Period|Lack of Efficacy|0|||
33609893|NCT02273960|63010082|FG002|Short Term Period|Lack of Efficacy|0|||
33609894|NCT02273960|63010083|FG003|Short Term Period|Lack of Efficacy|1|||
33609895|NCT02273960|63010080|FG000|Short Term Period|ST complete, not entering LTE|4|||
33609896|NCT02273960|63010081|FG001|Short Term Period|ST complete, not entering LTE|6|||
33609897|NCT02273960|63010082|FG002|Short Term Period|ST complete, not entering LTE|4|||
33609898|NCT02273960|63010083|FG003|Short Term Period|ST complete, not entering LTE|5|||
33609899|NCT02273960|63010080|FG000|Long Term Extension|Death|0|||
33609900|NCT02273960|63010081|FG001|Long Term Extension|Death|0|||
33609901|NCT02273960|63010082|FG002|Long Term Extension|Death|0|||
33609902|NCT02273960|63010083|FG003|Long Term Extension|Death|1|||
33609903|NCT01646021|63010095|FG000|Overall Study|Death|77|||
33609904|NCT01646021|63010096|FG001|Overall Study|Death|83|||
33609905|NCT01646021|63010095|FG000|Overall Study|Study Terminated by Sponsor|50|||
33609906|NCT01646021|63010096|FG001|Overall Study|Study Terminated by Sponsor|41|||
33609907|NCT01646021|63010095|FG000|Overall Study|Lost to Follow-up|2|||
33609908|NCT01646021|63010096|FG001|Overall Study|Lost to Follow-up|2|||
33609909|NCT01646021|63010095|FG000|Overall Study|Withdrawal by Subject|10|||
33609910|NCT01646021|63010096|FG001|Overall Study|Withdrawal by Subject|15|||
33609911|NCT01750918|63010113|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
33609912|NCT01750918|63010114|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
33609913|NCT01750918|63010115|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
33609914|NCT01750918|63010116|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
33500863|NCT04272775|62881322|FG001|Overall Study|Protocol Violation|1|||
33500864|NCT04272775|62881321|FG000|Overall Study|Symptomatic Deterioration|1|||
33500865|NCT04272775|62881322|FG001|Overall Study|Symptomatic Deterioration|1|||
33500866|NCT04272775|62881321|FG000|Overall Study|Withdrawal by Subject|1|||
33500867|NCT04272775|62881322|FG001|Overall Study|Withdrawal by Subject|2|||
33500868|NCT04272775|62881321|FG000|Overall Study|Adverse Event|1|||
33500869|NCT04272775|62881322|FG001|Overall Study|Adverse Event|2|||
33500870|NCT04272775|62881321|FG000|Overall Study|Progressive Disease|3|||
33500871|NCT04272775|62881322|FG001|Overall Study|Progressive Disease|1|||
33500872|NCT03232983|62881328|FG000|Period 1|Physician Decision|0|||
33500873|NCT03232983|62881329|FG001|Period 1|Physician Decision|0|||
33500874|NCT03232983|62881330|FG002|Period 1|Physician Decision|1|||
33500875|NCT03232983|62881331|FG003|Period 1|Physician Decision|0|||
33500876|NCT03232983|62881328|FG000|Washout Period 2|Physician Decision|0|||
33500877|NCT03232983|62881329|FG001|Washout Period 2|Physician Decision|0|||
33500878|NCT03232983|62881330|FG002|Washout Period 2|Physician Decision|1|||
33500879|NCT03232983|62881331|FG003|Washout Period 2|Physician Decision|0|||
33500880|NCT03232983|62881328|FG000|Washout Period 2|Withdrawal by Subject|0|||
33500881|NCT03232983|62881329|FG001|Washout Period 2|Withdrawal by Subject|0|||
33500882|NCT03232983|62881330|FG002|Washout Period 2|Withdrawal by Subject|0|||
33500883|NCT03232983|62881331|FG003|Washout Period 2|Withdrawal by Subject|1|||
33500884|NCT03232983|62881328|FG000|Period 4|Withdrawal by Subject|1|||
33500885|NCT03232983|62881329|FG001|Period 4|Withdrawal by Subject|0|||
33500886|NCT03232983|62881330|FG002|Period 4|Withdrawal by Subject|0|||
33500887|NCT03232983|62881331|FG003|Period 4|Withdrawal by Subject|0|||
33500888|NCT04102345|62881345|FG000|Overall Study|Withdrawal by Subject|1|||
33500889|NCT04102345|62881346|FG001|Overall Study|Withdrawal by Subject|0|||
33500890|NCT04271605|62881352|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
33500891|NCT03299244|62881358|FG000|Overall Study|Withdrawal by Subject|34|||
33500892|NCT03299244|62881359|FG001|Overall Study|Withdrawal by Subject|29|||
33500893|NCT03299244|62881358|FG000|Overall Study|Decision by Sponsor|4|||
33500894|NCT03299244|62881359|FG001|Overall Study|Decision by Sponsor|5|||
33500895|NCT03299244|62881358|FG000|Overall Study|Death|9|||
33500896|NCT03299244|62881359|FG001|Overall Study|Death|4|||
33500897|NCT03757715|62881368|FG000|Overall Study|Lost to Follow-up|4|||
33609915|NCT01750918|63010117|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
33500898|NCT03757715|62881369|FG001|Overall Study|Lost to Follow-up|9|||
33500899|NCT03757715|62881368|FG000|Overall Study|Withdrawal by Subject|1|||
33500900|NCT03757715|62881369|FG001|Overall Study|Withdrawal by Subject|1|||
33500901|NCT03281577|62881379|FG000|Overall Study|Adverse Event|0|||
33500902|NCT03281577|62881380|FG001|Overall Study|Adverse Event|0|||
33500903|NCT03281577|62881381|FG002|Overall Study|Adverse Event|0|||
33500904|NCT03281577|62881382|FG003|Overall Study|Adverse Event|1|||
33500905|NCT03281577|62881379|FG000|Overall Study|Withdrawal by Subject|1|||
33500906|NCT03281577|62881380|FG001|Overall Study|Withdrawal by Subject|0|||
33500907|NCT03281577|62881381|FG002|Overall Study|Withdrawal by Subject|0|||
33500908|NCT03281577|62881382|FG003|Overall Study|Withdrawal by Subject|0|||
33500909|NCT04098367|62881398|FG000|Overall Study|Adverse Event|0|||
33500910|NCT04098367|62881399|FG001|Overall Study|Adverse Event|0|||
33500911|NCT04098367|62881400|FG002|Overall Study|Adverse Event|1|||
33500912|NCT04098367|62881398|FG000|Overall Study|Lost to Follow-up|1|||
33500913|NCT04098367|62881399|FG001|Overall Study|Lost to Follow-up|5|||
33500914|NCT04098367|62881400|FG002|Overall Study|Lost to Follow-up|2|||
33500915|NCT04098367|62881398|FG000|Overall Study|Withdrawal by Subject|0|||
33609916|NCT01750918|63010118|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
33500916|NCT04098367|62881399|FG001|Overall Study|Withdrawal by Subject|0|||
33500917|NCT04098367|62881400|FG002|Overall Study|Withdrawal by Subject|1|||
33500918|NCT04098367|62881398|FG000|Overall Study|Sick . Could not attend visit|1|||
33500919|NCT04098367|62881399|FG001|Overall Study|Sick . Could not attend visit|0|||
33500920|NCT04098367|62881400|FG002|Overall Study|Sick . Could not attend visit|0|||
33500921|NCT03759587|62881415|FG000|Overall Study|Ongoing|19|||
33500922|NCT04091659|62881421|FG000|Overall Study|Protocol Violation|3|||
33500923|NCT04091659|62881422|FG001|Overall Study|Protocol Violation|0|||
33500924|NCT04091659|62881421|FG000|Overall Study|Lost to Follow-up|0|||
33500925|NCT04091659|62881422|FG001|Overall Study|Lost to Follow-up|1|||
33500926|NCT04256785|62881459|FG000|Overall Study|Adverse Event|8|||
33500927|NCT04256785|62881460|FG001|Overall Study|Adverse Event|6|||
33500928|NCT04256785|62881459|FG000|Overall Study|Lack of Efficacy|3|||
33500929|NCT04256785|62881460|FG001|Overall Study|Lack of Efficacy|4|||
33500930|NCT04256785|62881459|FG000|Overall Study|Lost to Follow-up|7|||
33500931|NCT04256785|62881460|FG001|Overall Study|Lost to Follow-up|7|||
33500932|NCT04256785|62881459|FG000|Overall Study|Protocol Violation|1|||
33500933|NCT04256785|62881460|FG001|Overall Study|Protocol Violation|0|||
33500934|NCT04256785|62881459|FG000|Overall Study|Withdrawal by Subject|4|||
33500935|NCT04256785|62881460|FG001|Overall Study|Withdrawal by Subject|1|||
33500936|NCT04256785|62881459|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
33500937|NCT04256785|62881460|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
33500938|NCT02959918|62881482|FG000|Overall Study|Adverse Event|1|||
33500939|NCT02959918|62881483|FG001|Overall Study|Adverse Event|1|||
33500940|NCT02959918|62881484|FG002|Overall Study|Adverse Event|2|||
33500941|NCT02959918|62881485|FG003|Overall Study|Adverse Event|0|||
33500942|NCT02959918|62881486|FG004|Overall Study|Adverse Event|0|||
33609917|NCT01750918|63010119|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
33500943|NCT02959918|62881487|FG005|Overall Study|Adverse Event|2|||
33500944|NCT02959918|62881488|FG006|Overall Study|Adverse Event|2|||
33500945|NCT02959918|62881489|FG007|Overall Study|Adverse Event|1|||
33500946|NCT02959918|62881490|FG008|Overall Study|Adverse Event|2|||
33500947|NCT02959918|62881491|FG009|Overall Study|Adverse Event|1|||
33500948|NCT02959918|62881492|FG010|Overall Study|Adverse Event|1|||
33500949|NCT02959918|62881493|FG011|Overall Study|Adverse Event|3|||
33500950|NCT02959918|62881494|FG012|Overall Study|Adverse Event|2|||
33500951|NCT02959918|62881495|FG013|Overall Study|Adverse Event|4|||
33500952|NCT02959918|62881482|FG000|Overall Study|Lost to Follow-up|0|||
33500953|NCT02959918|62881483|FG001|Overall Study|Lost to Follow-up|0|||
33500954|NCT02959918|62881484|FG002|Overall Study|Lost to Follow-up|0|||
33500955|NCT02959918|62881485|FG003|Overall Study|Lost to Follow-up|0|||
33500956|NCT02959918|62881486|FG004|Overall Study|Lost to Follow-up|0|||
33500957|NCT02959918|62881487|FG005|Overall Study|Lost to Follow-up|0|||
33500958|NCT02959918|62881488|FG006|Overall Study|Lost to Follow-up|0|||
33500959|NCT02959918|62881489|FG007|Overall Study|Lost to Follow-up|0|||
33500960|NCT02959918|62881490|FG008|Overall Study|Lost to Follow-up|0|||
33500961|NCT02959918|62881491|FG009|Overall Study|Lost to Follow-up|1|||
33500962|NCT02959918|62881492|FG010|Overall Study|Lost to Follow-up|0|||
33500963|NCT02959918|62881493|FG011|Overall Study|Lost to Follow-up|0|||
33500964|NCT02959918|62881494|FG012|Overall Study|Lost to Follow-up|1|||
33500965|NCT02959918|62881495|FG013|Overall Study|Lost to Follow-up|0|||
33500966|NCT02959918|62881482|FG000|Overall Study|Withdrawal by Subject|0|||
33500967|NCT02959918|62881483|FG001|Overall Study|Withdrawal by Subject|0|||
33500968|NCT02959918|62881484|FG002|Overall Study|Withdrawal by Subject|1|||
33500969|NCT02959918|62881485|FG003|Overall Study|Withdrawal by Subject|2|||
33500970|NCT02959918|62881486|FG004|Overall Study|Withdrawal by Subject|0|||
33500971|NCT02959918|62881487|FG005|Overall Study|Withdrawal by Subject|0|||
33500972|NCT02959918|62881488|FG006|Overall Study|Withdrawal by Subject|1|||
33500973|NCT02959918|62881489|FG007|Overall Study|Withdrawal by Subject|0|||
33500974|NCT02959918|62881490|FG008|Overall Study|Withdrawal by Subject|1|||
33500975|NCT02959918|62881491|FG009|Overall Study|Withdrawal by Subject|1|||
33500976|NCT02959918|62881492|FG010|Overall Study|Withdrawal by Subject|2|||
33324061|NCT00920140|62700455|FG003|Phase 2|Adverse Event|2|||
33324062|NCT00920140|62700456|FG004|Phase 2|Adverse Event|3|||
33324063|NCT00920140|62700452|FG000|Phase 2|Lack of Efficacy|0|||
33324064|NCT00920140|62700453|FG001|Phase 2|Lack of Efficacy|0|||
33324065|NCT00920140|62700454|FG002|Phase 2|Lack of Efficacy|29|||
33324066|NCT00920140|62700455|FG003|Phase 2|Lack of Efficacy|14|||
33324067|NCT00920140|62700456|FG004|Phase 2|Lack of Efficacy|5|||
33324068|NCT00920140|62700452|FG000|Phase 2|Lost to Follow-up|0|||
33324069|NCT00920140|62700453|FG001|Phase 2|Lost to Follow-up|0|||
33500977|NCT02959918|62881493|FG011|Overall Study|Withdrawal by Subject|3|||
33500978|NCT02959918|62881494|FG012|Overall Study|Withdrawal by Subject|1|||
33500979|NCT02959918|62881495|FG013|Overall Study|Withdrawal by Subject|1|||
33500980|NCT02959918|62881482|FG000|Overall Study|Protocol Violation|0|||
33500981|NCT02959918|62881483|FG001|Overall Study|Protocol Violation|0|||
33324070|NCT00920140|62700454|FG002|Phase 2|Lost to Follow-up|0|||
33500982|NCT02959918|62881484|FG002|Overall Study|Protocol Violation|1|||
33500983|NCT02959918|62881485|FG003|Overall Study|Protocol Violation|0|||
33500984|NCT02959918|62881486|FG004|Overall Study|Protocol Violation|0|||
33500985|NCT02959918|62881487|FG005|Overall Study|Protocol Violation|1|||
33500986|NCT02959918|62881488|FG006|Overall Study|Protocol Violation|0|||
33500987|NCT02959918|62881489|FG007|Overall Study|Protocol Violation|0|||
33500988|NCT02959918|62881490|FG008|Overall Study|Protocol Violation|2|||
33500989|NCT02959918|62881491|FG009|Overall Study|Protocol Violation|1|||
33500990|NCT02959918|62881492|FG010|Overall Study|Protocol Violation|0|||
33500991|NCT02959918|62881493|FG011|Overall Study|Protocol Violation|1|||
33609918|NCT01750918|63010120|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
33609919|NCT01750918|63010113|FG000|Overall Study|Lost to Follow-up|0|||
33500992|NCT02959918|62881494|FG012|Overall Study|Protocol Violation|1|||
33500993|NCT02959918|62881495|FG013|Overall Study|Protocol Violation|0|||
33500994|NCT02959918|62881482|FG000|Overall Study|Stopping Rule Met|1|||
33500995|NCT02959918|62881483|FG001|Overall Study|Stopping Rule Met|0|||
33500996|NCT02959918|62881484|FG002|Overall Study|Stopping Rule Met|3|||
33500997|NCT02959918|62881485|FG003|Overall Study|Stopping Rule Met|4|||
33500998|NCT02959918|62881486|FG004|Overall Study|Stopping Rule Met|5|||
33609920|NCT01750918|63010114|FG001|Overall Study|Lost to Follow-up|0|||
33324071|NCT00920140|62700455|FG003|Phase 2|Lost to Follow-up|1|||
33324072|NCT00920140|62700456|FG004|Phase 2|Lost to Follow-up|0|||
33324073|NCT00920140|62700452|FG000|Phase 2|Physician Decision|0|||
33500999|NCT02959918|62881487|FG005|Overall Study|Stopping Rule Met|3|||
33501000|NCT02959918|62881488|FG006|Overall Study|Stopping Rule Met|2|||
33501001|NCT02959918|62881489|FG007|Overall Study|Stopping Rule Met|4|||
33501002|NCT02959918|62881490|FG008|Overall Study|Stopping Rule Met|1|||
33501003|NCT02959918|62881491|FG009|Overall Study|Stopping Rule Met|1|||
33501004|NCT02959918|62881492|FG010|Overall Study|Stopping Rule Met|3|||
33501005|NCT02959918|62881493|FG011|Overall Study|Stopping Rule Met|5|||
33501006|NCT02959918|62881494|FG012|Overall Study|Stopping Rule Met|2|||
33501007|NCT02959918|62881495|FG013|Overall Study|Stopping Rule Met|1|||
33501008|NCT02959918|62881482|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
33501009|NCT02959918|62881483|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
33501010|NCT02959918|62881484|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
33501011|NCT02959918|62881485|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
33501012|NCT02959918|62881486|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33501013|NCT02959918|62881487|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33501014|NCT02959918|62881488|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33501015|NCT02959918|62881489|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33501016|NCT02959918|62881490|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33501017|NCT02959918|62881491|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33501018|NCT02959918|62881492|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33501019|NCT02959918|62881493|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33501020|NCT02959918|62881494|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33501021|NCT02959918|62881495|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33501022|NCT02959918|62881482|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33501023|NCT02959918|62881483|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33501024|NCT02959918|62881484|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33501025|NCT02959918|62881485|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33501026|NCT02959918|62881486|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33501027|NCT02959918|62881487|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33501028|NCT02959918|62881488|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33501029|NCT02959918|62881489|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
33501030|NCT02959918|62881490|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33501031|NCT02959918|62881491|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33501032|NCT02959918|62881492|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33501033|NCT02959918|62881493|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33501034|NCT02959918|62881494|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33501035|NCT02959918|62881495|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33501036|NCT02959918|62881482|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33609921|NCT01750918|63010115|FG002|Overall Study|Lost to Follow-up|2|||
33609922|NCT01750918|63010116|FG003|Overall Study|Lost to Follow-up|2|||
33609923|NCT01750918|63010117|FG004|Overall Study|Lost to Follow-up|0|||
33609924|NCT01750918|63010118|FG005|Overall Study|Lost to Follow-up|0|||
33448883|NCT00267956|62823928|FG003|After Controlled Period|Lack of Efficacy|1|||
33448884|NCT00267956|62823925|FG000|After Controlled Period|Lost to Follow-up|0|||
33448885|NCT00267956|62823926|FG001|After Controlled Period|Lost to Follow-up|0|||
33448886|NCT00267956|62823927|FG002|After Controlled Period|Lost to Follow-up|1|||
33448887|NCT00267956|62823928|FG003|After Controlled Period|Lost to Follow-up|0|||
33448888|NCT00267956|62823925|FG000|After Controlled Period|Withdrew consent|0|||
33448889|NCT00267956|62823926|FG001|After Controlled Period|Withdrew consent|0|||
33448890|NCT00267956|62823927|FG002|After Controlled Period|Withdrew consent|1|||
33448891|NCT00267956|62823928|FG003|After Controlled Period|Withdrew consent|0|||
33448892|NCT00267488|62823936|FG000|Overall Study|Sponsor Terminated Study|9|||
33448893|NCT00267488|62823936|FG000|Overall Study|Protocol Violation|1|||
33448894|NCT00267488|62823936|FG000|Overall Study|Other (Disease Progression)|1|||
33501037|NCT02959918|62881483|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33448895|NCT00058552|62823942|FG000|Overall Study|Died prior to receiving treatment|4|||
33448896|NCT00058552|62823943|FG001|Overall Study|Died prior to receiving treatment|2|||
33448897|NCT00058552|62823942|FG000|Overall Study|Disease progression|52|||
33501038|NCT02959918|62881484|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33501039|NCT02959918|62881485|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33501040|NCT02959918|62881486|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33501041|NCT02959918|62881487|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33501042|NCT02959918|62881488|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33501043|NCT02959918|62881489|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33501044|NCT02959918|62881490|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
33501045|NCT02959918|62881491|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33501046|NCT02959918|62881492|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33501047|NCT02959918|62881493|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33501048|NCT02959918|62881494|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33501049|NCT02959918|62881495|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33501050|NCT02959918|62881482|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33501051|NCT02959918|62881483|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33501052|NCT02959918|62881484|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33501053|NCT02959918|62881485|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33501054|NCT02959918|62881486|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33501055|NCT02959918|62881487|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33501056|NCT02959918|62881488|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33501057|NCT02959918|62881489|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33501058|NCT02959918|62881490|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33501059|NCT02959918|62881491|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
33501060|NCT02959918|62881492|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33501061|NCT02959918|62881493|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33501062|NCT02959918|62881494|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33609925|NCT01750918|63010119|FG006|Overall Study|Lost to Follow-up|0|||
33609926|NCT01750918|63010120|FG007|Overall Study|Lost to Follow-up|1|||
33609927|NCT01750918|63010113|FG000|Overall Study|Withdrawal by Subject|0|||
33609928|NCT01750918|63010114|FG001|Overall Study|Withdrawal by Subject|0|||
33609929|NCT01750918|63010115|FG002|Overall Study|Withdrawal by Subject|1|||
33609930|NCT01750918|63010116|FG003|Overall Study|Withdrawal by Subject|2|||
33609931|NCT01750918|63010117|FG004|Overall Study|Withdrawal by Subject|1|||
33609932|NCT01750918|63010118|FG005|Overall Study|Withdrawal by Subject|1|||
33609933|NCT01750918|63010119|FG006|Overall Study|Withdrawal by Subject|2|||
33609934|NCT01750918|63010120|FG007|Overall Study|Withdrawal by Subject|2|||
33609935|NCT02300987|63010152|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
33609936|NCT02300987|63010153|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
33609937|NCT02300987|63010152|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
33609938|NCT02300987|63010153|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
33609939|NCT02300987|63010152|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
33609940|NCT02300987|63010153|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
33609941|NCT02300987|63010152|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
33609942|NCT02300987|63010153|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
33609943|NCT02300987|63010152|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
33609944|NCT02300987|63010153|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
33609945|NCT01750840|63010160|FG000|Overall Study|Lost to Follow-up|4|||
33448898|NCT00058552|62823943|FG001|Overall Study|Disease progression|44|||
33609946|NCT01606228|63010165|FG000|Overall Study|Lost to Follow-up|20|||
33609947|NCT01606228|63010165|FG000|Overall Study|Withdrawal by Subject|3|||
33609948|NCT01606228|63010165|FG000|Overall Study|Non-compliant|3|||
33609949|NCT01606228|63010165|FG000|Overall Study|Lack of Efficacy|2|||
33609950|NCT01606228|63010165|FG000|Overall Study|Adverse Event|1|||
33609951|NCT01706536|63010174|FG000|Overall Study|Withdrawal by Subject|1|||
33609952|NCT01706536|63010175|FG001|Overall Study|Withdrawal by Subject|0|||
33609953|NCT01706536|63010176|FG002|Overall Study|Withdrawal by Subject|1|||
33609954|NCT01706536|63010177|FG003|Overall Study|Withdrawal by Subject|0|||
33609955|NCT01706536|63010178|FG004|Overall Study|Withdrawal by Subject|0|||
33609956|NCT01706536|63010174|FG000|Overall Study|Adverse Event|2|||
33448899|NCT00058552|62823942|FG000|Overall Study|Adverse Event|4|||
33448900|NCT00058552|62823943|FG001|Overall Study|Adverse Event|2|||
33448901|NCT00058552|62823942|FG000|Overall Study|Withdrawal by Subject|3|||
33448902|NCT00058552|62823943|FG001|Overall Study|Withdrawal by Subject|5|||
33448903|NCT00058552|62823942|FG000|Overall Study|Physician Decision|2|||
33448904|NCT00058552|62823943|FG001|Overall Study|Physician Decision|5|||
33448905|NCT00058552|62823942|FG000|Overall Study|Clinical disease progression|0|||
33448906|NCT00058552|62823943|FG001|Overall Study|Clinical disease progression|4|||
33448907|NCT00044512|62823951|FG000|Follow Up|Lost to Follow-up|2|||
33448908|NCT03805438|62823955|FG000|Overall Study|Lack of Efficacy|1|||
33448909|NCT03805438|62823955|FG000|Overall Study|Protocol Violation|1|||
33609957|NCT01706536|63010175|FG001|Overall Study|Adverse Event|3|||
33609958|NCT01706536|63010176|FG002|Overall Study|Adverse Event|4|||
33609959|NCT01706536|63010177|FG003|Overall Study|Adverse Event|3|||
33609960|NCT01706536|63010178|FG004|Overall Study|Adverse Event|2|||
33609961|NCT01706536|63010174|FG000|Overall Study|Lack of Efficacy|1|||
33609962|NCT01706536|63010175|FG001|Overall Study|Lack of Efficacy|0|||
33609963|NCT01706536|63010176|FG002|Overall Study|Lack of Efficacy|0|||
33609964|NCT01706536|63010177|FG003|Overall Study|Lack of Efficacy|1|||
33609965|NCT01706536|63010178|FG004|Overall Study|Lack of Efficacy|0|||
33609966|NCT01706536|63010174|FG000|Overall Study|non compliance|0|||
33609967|NCT01706536|63010175|FG001|Overall Study|non compliance|1|||
33609968|NCT01706536|63010176|FG002|Overall Study|non compliance|0|||
33609969|NCT01706536|63010177|FG003|Overall Study|non compliance|0|||
33609970|NCT01706536|63010178|FG004|Overall Study|non compliance|0|||
33609971|NCT02269943|63010193|FG000|Treatment Period|Death|0|||
33609972|NCT02269943|63010194|FG001|Treatment Period|Death|1|||
33609973|NCT02269943|63010193|FG000|Treatment Period|Adverse Event|1|||
33609974|NCT02269943|63010194|FG001|Treatment Period|Adverse Event|10|||
33609975|NCT02269943|63010193|FG000|Treatment Period|Progressive Disease|5|||
33609976|NCT02269943|63010194|FG001|Treatment Period|Progressive Disease|17|||
33609977|NCT02269943|63010193|FG000|Treatment Period|Symptomatic Deterioration|0|||
33609978|NCT02269943|63010194|FG001|Treatment Period|Symptomatic Deterioration|2|||
33609979|NCT02269943|63010193|FG000|Follow-Up Survival Period|Death|3|||
33609980|NCT02269943|63010194|FG001|Follow-Up Survival Period|Death|16|||
33609981|NCT02269943|63010193|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
33609982|NCT02269943|63010194|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
33609983|NCT02269943|63010193|FG000|Follow-Up Survival Period|Alive|2|||
33501063|NCT02959918|62881495|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33501064|NCT03263442|62881530|FG000|Inpatient Phase|Death|1|||
33501065|NCT03263442|62881531|FG001|Inpatient Phase|Death|0|||
33501066|NCT03263442|62881530|FG000|Inpatient Phase|Withdrawal by Subject|1|||
33501067|NCT03263442|62881531|FG001|Inpatient Phase|Withdrawal by Subject|0|||
33609984|NCT02269943|63010194|FG001|Follow-Up Survival Period|Alive|8|||
33609985|NCT01706458|63010202|FG000|Overall Study|Physician Decision|3|||
33324074|NCT00920140|62700453|FG001|Phase 2|Physician Decision|0|||
33324075|NCT00920140|62700454|FG002|Phase 2|Physician Decision|3|||
33324076|NCT00920140|62700455|FG003|Phase 2|Physician Decision|3|||
33324077|NCT00920140|62700456|FG004|Phase 2|Physician Decision|2|||
33324078|NCT00920140|62700452|FG000|Phase 2|Withdrawal by Subject|0|||
33324079|NCT00920140|62700453|FG001|Phase 2|Withdrawal by Subject|0|||
33324080|NCT00920140|62700454|FG002|Phase 2|Withdrawal by Subject|4|||
33324081|NCT00920140|62700455|FG003|Phase 2|Withdrawal by Subject|2|||
33324082|NCT00920140|62700456|FG004|Phase 2|Withdrawal by Subject|1|||
33324083|NCT01120782|62700469|FG000|Overall Study|Test article shipping error|11|||
33324084|NCT01120626|62700475|FG000|Overall Study|Withdrawal by Subject|1|||
33609986|NCT01706458|63010203|FG001|Overall Study|Physician Decision|4|||
33609987|NCT02269787|63010211|FG000|Overall Study|Lost to Follow-up|20|||
33609988|NCT02269787|63010212|FG001|Overall Study|Lost to Follow-up|6|||
33609989|NCT02269787|63010211|FG000|Overall Study|Death|2|||
33609990|NCT02269787|63010212|FG001|Overall Study|Death|3|||
33609991|NCT02269787|63010211|FG000|Overall Study|Incapacitated|0|||
33324085|NCT01120626|62700476|FG001|Overall Study|Withdrawal by Subject|0|||
33324086|NCT00924508|62700482|FG000|Overall Study|Withdrawal by Subject|3|||
33324087|NCT01139658|62700491|FG000|Overall Study|Adverse Event|10|||
33324088|NCT01139658|62700492|FG001|Overall Study|Adverse Event|27|||
33324089|NCT01139658|62700491|FG000|Overall Study|Lack of Efficacy|15|||
33324090|NCT01139658|62700492|FG001|Overall Study|Lack of Efficacy|7|||
33324091|NCT01139658|62700491|FG000|Overall Study|Withdrawal by Subject|2|||
33609992|NCT02269787|63010212|FG001|Overall Study|Incapacitated|1|||
33609993|NCT01605370|63010220|FG000|Overall Study|Adverse Event|1|||
33324092|NCT01139658|62700492|FG001|Overall Study|Withdrawal by Subject|4|||
33324093|NCT01139658|62700491|FG000|Overall Study|No documentation of treatment|1|||
33609994|NCT01605370|63010221|FG001|Overall Study|Adverse Event|0|||
33609995|NCT02269709|63010227|FG000|Time of Enrollment|Withdrawal by Subject|3|||
33609996|NCT02269709|63010227|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
33324094|NCT01139658|62700492|FG001|Overall Study|No documentation of treatment|0|||
33324095|NCT01139658|62700491|FG000|Overall Study|Other|28|||
33324096|NCT01139658|62700492|FG001|Overall Study|Other|75|||
33501068|NCT03263442|62881530|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
33501069|NCT03263442|62881531|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
33501070|NCT03263442|62881530|FG000|1-month Follow-Up|Lost to Follow-up|1|||
33501071|NCT03263442|62881531|FG001|1-month Follow-Up|Lost to Follow-up|0|||
33501072|NCT03263442|62881530|FG000|3-month Follow-Up|Lost to Follow-up|1|||
33501073|NCT03263442|62881531|FG001|3-month Follow-Up|Lost to Follow-up|3|||
33501074|NCT03263442|62881530|FG000|6-month Follow-Up|Lost to Follow-up|2|||
33501075|NCT03263442|62881531|FG001|6-month Follow-Up|Lost to Follow-up|2|||
33501076|NCT04245709|62881539|FG000|Overall Study|Adverse Event|13|||
33501077|NCT04245709|62881539|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
33501078|NCT04091581|62881545|FG000|Overall Study|Lost to Follow-up|0|||
33501079|NCT04091581|62881546|FG001|Overall Study|Lost to Follow-up|1|||
33501080|NCT02940522|62881554|FG000|Overall Study|Lost to Follow-up|1|||
33501081|NCT02940522|62881555|FG001|Overall Study|Lost to Follow-up|2|||
33501082|NCT02940522|62881554|FG000|Overall Study|Withdrawal by Subject|1|||
33501083|NCT02940522|62881555|FG001|Overall Study|Withdrawal by Subject|0|||
33501084|NCT03262038|62881563|FG000|Overall Study|Withdrawal by Subject|0|||
33501085|NCT03262038|62881564|FG001|Overall Study|Withdrawal by Subject|1|||
33501086|NCT02472964|62881572|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
33501087|NCT02472964|62881573|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
33501088|NCT02472964|62881572|FG000|Part 1 (up to Week 24)|disease progression|58|||
33501089|NCT02472964|62881573|FG001|Part 1 (up to Week 24)|disease progression|47|||
33501090|NCT02472964|62881572|FG000|Part 1 (up to Week 24)|Death|3|||
33501091|NCT02472964|62881573|FG001|Part 1 (up to Week 24)|Death|6|||
33501092|NCT02472964|62881572|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
33501093|NCT02472964|62881573|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
33501094|NCT02472964|62881572|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
33501095|NCT02472964|62881573|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
33501096|NCT02472964|62881572|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
33501097|NCT02472964|62881573|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
33501098|NCT02472964|62881572|FG000|Part 1 (up to Week 24)|Other|2|||
33501099|NCT02472964|62881573|FG001|Part 1 (up to Week 24)|Other|1|||
33501100|NCT02472964|62881572|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
33324097|NCT01139580|62700500|FG000|Overall Study|Adverse Event|5|||
33501101|NCT02472964|62881573|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
33501102|NCT02472964|62881572|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
33501103|NCT02472964|62881573|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
33501104|NCT02472964|62881572|FG000|Part 2 (Week 24-week 48)|Death|0|||
33501105|NCT02472964|62881573|FG001|Part 2 (Week 24-week 48)|Death|1|||
33501106|NCT02472964|62881572|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
33501107|NCT02472964|62881573|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
33501108|NCT02472964|62881572|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
33501109|NCT02472964|62881573|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
33501110|NCT02472964|62881572|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
33501111|NCT02472964|62881573|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
33501112|NCT02472964|62881572|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
33501113|NCT02472964|62881573|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
33501114|NCT04079803|62881586|FG000|Overall Study|Withdrawal by Subject|0|||
33501115|NCT04079803|62881587|FG001|Overall Study|Withdrawal by Subject|0|||
33501116|NCT04079803|62881588|FG002|Overall Study|Withdrawal by Subject|1|||
33501117|NCT03278613|62881616|FG000|Overall Study|Lost to Follow-up|3|||
33501118|NCT03278613|62881617|FG001|Overall Study|Lost to Follow-up|1|||
33501119|NCT03761147|62881625|FG000|Overall Study|Withdrawal by Subject|6|||
33501120|NCT03761147|62881626|FG001|Overall Study|Withdrawal by Subject|1|||
33501121|NCT03761147|62881625|FG000|Overall Study|Adverse Event|1|||
33501122|NCT03761147|62881626|FG001|Overall Study|Adverse Event|3|||
33501123|NCT04076917|62881632|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
33501124|NCT04076917|62881632|FG000|Overall Study|Study closure|13|||
33324098|NCT01139580|62700501|FG001|Overall Study|Adverse Event|4|||
33501125|NCT04076917|62881632|FG000|Overall Study|Physician Decision|3|||
33609997|NCT02269709|63010227|FG000|Six Month Follow-up|Lost to Follow-up|12|||
33609998|NCT02269475|63010234|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
33609999|NCT02269475|63010235|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
33501126|NCT04076917|62881632|FG000|Overall Study|Death|1|||
33501127|NCT04076917|62881632|FG000|Overall Study|Lost to Follow-up|1|||
33501128|NCT04076917|62881632|FG000|Overall Study|Withdrawal by Subject|1|||
33501129|NCT04076917|62881632|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
33501130|NCT04222699|62881636|FG000|Overall Study|Lost to Follow-up|2|||
33501131|NCT02731690|62881649|FG000|Overall Study|Adverse Event|1|||
33501132|NCT02731690|62881649|FG000|Overall Study|Withdrawal by Subject|3|||
33501133|NCT02731690|62881649|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
33501134|NCT04075513|62881655|FG000|Overall Study|Withdrawal by Subject|2|||
33501135|NCT04075513|62881656|FG001|Overall Study|Withdrawal by Subject|2|||
33501136|NCT04075513|62881655|FG000|Overall Study|Lack of Efficacy|1|||
33501137|NCT04075513|62881656|FG001|Overall Study|Lack of Efficacy|0|||
33501138|NCT04075513|62881655|FG000|Overall Study|Lost to Follow-up|4|||
33501139|NCT04075513|62881656|FG001|Overall Study|Lost to Follow-up|2|||
33501140|NCT04075513|62881655|FG000|Overall Study|Switch to insulin pump|1|||
33501141|NCT04075513|62881656|FG001|Overall Study|Switch to insulin pump|0|||
33501142|NCT04073407|62881664|FG000|Part 1|Withdrawal by Subject|1|||
33501143|NCT04073407|62881665|FG001|Part 1|Withdrawal by Subject|0|||
33501144|NCT04073407|62881664|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
33501145|NCT04073407|62881665|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
33501146|NCT04073407|62881664|FG000|Part 2|Withdrawal by Subject|0|||
33501147|NCT04073407|62881665|FG001|Part 2|Withdrawal by Subject|1|||
33501148|NCT02778204|62881675|FG000|Overall Study|Adverse Event|1|||
33501149|NCT02778204|62881676|FG001|Overall Study|Adverse Event|0|||
33501150|NCT02778204|62881677|FG002|Overall Study|Adverse Event|0|||
33501151|NCT02778204|62881678|FG003|Overall Study|Adverse Event|0|||
33501152|NCT02778204|62881675|FG000|Overall Study|Withdrawal by Subject|0|||
33501153|NCT02778204|62881676|FG001|Overall Study|Withdrawal by Subject|0|||
33501154|NCT02778204|62881677|FG002|Overall Study|Withdrawal by Subject|1|||
33501155|NCT02778204|62881678|FG003|Overall Study|Withdrawal by Subject|2|||
33501156|NCT02778204|62881675|FG000|Overall Study|Lost to Follow-up|1|||
33501157|NCT02778204|62881676|FG001|Overall Study|Lost to Follow-up|0|||
33501158|NCT02778204|62881677|FG002|Overall Study|Lost to Follow-up|2|||
33501159|NCT02778204|62881678|FG003|Overall Study|Lost to Follow-up|1|||
33501160|NCT02778204|62881675|FG000|Overall Study|Protocol Violation|0|||
33501161|NCT02778204|62881676|FG001|Overall Study|Protocol Violation|0|||
33501162|NCT02778204|62881677|FG002|Overall Study|Protocol Violation|1|||
33501163|NCT02778204|62881678|FG003|Overall Study|Protocol Violation|0|||
33501164|NCT02778204|62881675|FG000|Overall Study|Eligibility Violation|0|||
33501165|NCT02778204|62881676|FG001|Overall Study|Eligibility Violation|0|||
33501166|NCT02778204|62881677|FG002|Overall Study|Eligibility Violation|0|||
33501167|NCT02778204|62881678|FG003|Overall Study|Eligibility Violation|1|||
33501168|NCT04072159|62881692|FG000|Overall Study|Lost to Follow-up|6|||
33501169|NCT04072159|62881693|FG001|Overall Study|Lost to Follow-up|6|||
33501170|NCT04072159|62881692|FG000|Overall Study|Withdrawal by Subject|2|||
33501171|NCT04072159|62881693|FG001|Overall Study|Withdrawal by Subject|0|||
33501172|NCT03232281|62881703|FG000|Overall Study|Adverse Event|1|||
33501173|NCT03232281|62881704|FG001|Overall Study|Adverse Event|1|||
33501174|NCT03232281|62881703|FG000|Overall Study|Withdrawal by Subject|5|||
33501175|NCT03232281|62881704|FG001|Overall Study|Withdrawal by Subject|4|||
33501176|NCT03232281|62881703|FG000|Overall Study|Protocol Deviation|1|||
33501177|NCT03232281|62881704|FG001|Overall Study|Protocol Deviation|1|||
33501178|NCT04071301|62881710|FG000|Overall Study|Withdrawal by Subject|6|||
33501179|NCT04071301|62881710|FG000|Overall Study|Death|1|||
33501180|NCT03261336|62881714|FG000|Overall Study|Adverse Event|1|||
33501181|NCT00462748|62881721|FG000|Overall Study|Adverse Event|7|||
33501182|NCT00462748|62881722|FG001|Overall Study|Adverse Event|5|||
33501183|NCT00462748|62881723|FG002|Overall Study|Adverse Event|9|||
33501184|NCT00462748|62881721|FG000|Overall Study|Protocol Violation|0|||
33501185|NCT00462748|62881722|FG001|Overall Study|Protocol Violation|2|||
33501186|NCT00462748|62881723|FG002|Overall Study|Protocol Violation|1|||
33501187|NCT00462748|62881721|FG000|Overall Study|Withdrew consent|3|||
33501188|NCT00462748|62881722|FG001|Overall Study|Withdrew consent|3|||
33501189|NCT00462748|62881723|FG002|Overall Study|Withdrew consent|0|||
33501190|NCT00462748|62881721|FG000|Overall Study|Lost to Follow-up|1|||
33501191|NCT00462748|62881722|FG001|Overall Study|Lost to Follow-up|1|||
33501192|NCT00462748|62881723|FG002|Overall Study|Lost to Follow-up|1|||
33501193|NCT00462748|62881721|FG000|Overall Study|Discontinued after 41 days Rx|1|||
33501194|NCT00462748|62881722|FG001|Overall Study|Discontinued after 41 days Rx|0|||
33448910|NCT00147537|62823963|FG000|Phase 1b|Death|0|||
33501195|NCT00462748|62881723|FG002|Overall Study|Discontinued after 41 days Rx|0|||
33501196|NCT04206085|62881734|FG000|Overall Study|Lost to Follow-up|0|||
33501197|NCT04206085|62881735|FG001|Overall Study|Lost to Follow-up|1|||
33501198|NCT04206085|62881736|FG002|Overall Study|Lost to Follow-up|0|||
33501199|NCT04206085|62881734|FG000|Overall Study|Lost to Follow-up|0|||
33501200|NCT04206085|62881735|FG001|Overall Study|Lost to Follow-up|0|||
33501201|NCT04206085|62881736|FG002|Overall Study|Lost to Follow-up|1|||
33501202|NCT04202497|62881744|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
33501203|NCT04202497|62881745|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
33501204|NCT04202497|62881746|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
33448911|NCT00147537|62823964|FG001|Phase 1b|Death|1|||
33448912|NCT00147537|62823965|FG002|Phase 1b|Death|2|||
33448913|NCT00147537|62823966|FG003|Phase 1b|Death|1|||
33501205|NCT04202497|62881747|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
33501206|NCT03297294|62881763|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
33501207|NCT03297294|62881764|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
33501208|NCT03297294|62881765|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33501209|NCT03297294|62881766|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33501210|NCT03297294|62881767|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33501211|NCT03297294|62881763|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
33501212|NCT03297294|62881764|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
33501213|NCT03297294|62881765|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33501214|NCT03297294|62881766|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33501215|NCT03297294|62881767|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33501216|NCT03297294|62881763|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
33501217|NCT03297294|62881764|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
33448914|NCT00147537|62823967|FG004|Phase 1b|Death|2|||
33448915|NCT00147537|62823968|FG005|Phase 1b|Death|2|||
33448916|NCT00147537|62823969|FG006|Phase 1b|Death|1|||
33448917|NCT00147537|62823970|FG007|Phase 1b|Death|3|||
33448918|NCT00147537|62823971|FG008|Phase 1b|Death|9|||
33448919|NCT00147537|62823972|FG009|Phase 1b|Death|0|||
33501218|NCT03297294|62881765|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33501219|NCT03297294|62881766|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33501220|NCT03297294|62881767|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33501221|NCT03297294|62881763|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
33501222|NCT03297294|62881764|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
33501223|NCT03297294|62881765|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33501224|NCT03297294|62881766|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33501225|NCT03297294|62881767|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33448920|NCT00147537|62823973|FG010|Phase 1b|Death|0|||
33448921|NCT00147537|62823963|FG000|Phase 1b|Lost to Follow-up|2|||
33448922|NCT00147537|62823964|FG001|Phase 1b|Lost to Follow-up|1|||
33448923|NCT00147537|62823965|FG002|Phase 1b|Lost to Follow-up|0|||
33501226|NCT03297294|62881763|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
33501227|NCT03297294|62881764|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
33501228|NCT03297294|62881765|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
33501229|NCT03297294|62881766|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
33501230|NCT03297294|62881767|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
33501231|NCT03238911|62881781|FG000|Overall Study|Withdrawal by Subject|1|||
33501232|NCT03238911|62881782|FG001|Overall Study|Withdrawal by Subject|2|||
33501233|NCT03238911|62881781|FG000|Overall Study|Lost to Follow-up|2|||
33501234|NCT03238911|62881782|FG001|Overall Study|Lost to Follow-up|1|||
33501235|NCT00418834|62881791|FG000|Overall Study|Adverse Event|16|||
33501236|NCT00418834|62881792|FG001|Overall Study|Adverse Event|9|||
33501237|NCT00418834|62881791|FG000|Overall Study|Lost to Follow-up|0|||
33501238|NCT00418834|62881792|FG001|Overall Study|Lost to Follow-up|1|||
33501239|NCT00418834|62881791|FG000|Overall Study|Protocol Violation|4|||
33501240|NCT00418834|62881792|FG001|Overall Study|Protocol Violation|3|||
33501241|NCT00418834|62881791|FG000|Overall Study|Withdrawal by Subject|3|||
33501242|NCT00418834|62881792|FG001|Overall Study|Withdrawal by Subject|7|||
33501243|NCT03276975|62881800|FG000|Overall Study|Withdrawal by Subject|1|||
33501244|NCT03276975|62881801|FG001|Overall Study|Withdrawal by Subject|0|||
33501245|NCT03297216|62881809|FG000|Overall Study|Death|0|||
33501246|NCT03297216|62881810|FG001|Overall Study|Death|1|||
33501247|NCT03297216|62881809|FG000|Overall Study|Miscarriage|0|||
33501248|NCT03297216|62881810|FG001|Overall Study|Miscarriage|2|||
33501249|NCT03297216|62881809|FG000|Overall Study|Lost to Follow-up|3|||
33501250|NCT03297216|62881810|FG001|Overall Study|Lost to Follow-up|2|||
33501251|NCT03260868|62881825|FG000|Overall Study|Poor Compliance to Protocol|0|||
33501252|NCT03260868|62881826|FG001|Overall Study|Poor Compliance to Protocol|2|||
33501253|NCT03260868|62881825|FG000|Overall Study|Study Terminated By Sponsor|2|||
33501254|NCT03260868|62881826|FG001|Overall Study|Study Terminated By Sponsor|1|||
33501255|NCT03260868|62881825|FG000|Overall Study|Other than specified above|1|||
33501256|NCT03260868|62881826|FG001|Overall Study|Other than specified above|0|||
33501257|NCT03293394|62881834|FG000|Follow-up (6 Months)|Adverse Event|4|||
33501258|NCT03293394|62881835|FG001|Follow-up (6 Months)|Adverse Event|2|||
33501259|NCT03259308|62881844|FG000|Overall Study|Adverse Event|5|||
33501260|NCT03259308|62881845|FG001|Overall Study|Adverse Event|4|||
33501261|NCT03259308|62881846|FG002|Overall Study|Adverse Event|1|||
33501262|NCT03259308|62881844|FG000|Overall Study|Withdrawal by Subject|2|||
33448924|NCT00147537|62823966|FG003|Phase 1b|Lost to Follow-up|0|||
33448925|NCT00147537|62823967|FG004|Phase 1b|Lost to Follow-up|0|||
33448926|NCT00147537|62823968|FG005|Phase 1b|Lost to Follow-up|0|||
33448927|NCT00147537|62823969|FG006|Phase 1b|Lost to Follow-up|2|||
33448928|NCT00147537|62823970|FG007|Phase 1b|Lost to Follow-up|0|||
33448929|NCT00147537|62823971|FG008|Phase 1b|Lost to Follow-up|1|||
33448930|NCT00147537|62823972|FG009|Phase 1b|Lost to Follow-up|0|||
33448931|NCT00147537|62823973|FG010|Phase 1b|Lost to Follow-up|0|||
33448932|NCT00147537|62823963|FG000|Phase 1b|Other|0|||
33448933|NCT00147537|62823964|FG001|Phase 1b|Other|0|||
33448934|NCT00147537|62823965|FG002|Phase 1b|Other|2|||
33501263|NCT03259308|62881845|FG001|Overall Study|Withdrawal by Subject|1|||
33501264|NCT03259308|62881846|FG002|Overall Study|Withdrawal by Subject|3|||
33501265|NCT03259308|62881844|FG000|Overall Study|Lost to Follow-up|0|||
33501266|NCT03259308|62881845|FG001|Overall Study|Lost to Follow-up|0|||
33501267|NCT03259308|62881846|FG002|Overall Study|Lost to Follow-up|1|||
33501268|NCT03259308|62881844|FG000|Overall Study|Pregnancy|0|||
33501269|NCT03259308|62881845|FG001|Overall Study|Pregnancy|0|||
33501270|NCT03259308|62881846|FG002|Overall Study|Pregnancy|1|||
33501271|NCT03259308|62881844|FG000|Overall Study|Protocol Deviation|0|||
33501272|NCT03259308|62881845|FG001|Overall Study|Protocol Deviation|3|||
33501273|NCT03259308|62881846|FG002|Overall Study|Protocol Deviation|0|||
33501274|NCT03259308|62881844|FG000|Overall Study|Lack of Efficacy|0|||
33501275|NCT03259308|62881845|FG001|Overall Study|Lack of Efficacy|0|||
33501276|NCT03259308|62881846|FG002|Overall Study|Lack of Efficacy|1|||
33501277|NCT03258762|62881856|FG000|Overall Study|Lost to Follow-up|0|||
33501278|NCT03258762|62881857|FG001|Overall Study|Lost to Follow-up|1|||
33501279|NCT04502589|62881866|FG000|Overall Study|Physician Decision|1|||
33501280|NCT04502589|62881867|FG001|Overall Study|Physician Decision|0|||
33501281|NCT03291288|62881873|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
33501282|NCT03291288|62881874|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
33501283|NCT03291288|62881873|FG000|Drug-drug Interaction Phase|Disease progression|1|||
33501284|NCT03291288|62881874|FG001|Drug-drug Interaction Phase|Disease progression|0|||
33501285|NCT03291288|62881873|FG000|Drug-drug Interaction Phase|Other|3|||
33501286|NCT03291288|62881874|FG001|Drug-drug Interaction Phase|Other|0|||
33501287|NCT03291288|62881873|FG000|Pexidartinib Only|Ongoing|0|||
33501288|NCT03291288|62881874|FG001|Pexidartinib Only|Ongoing|2|||
33448935|NCT00147537|62823966|FG003|Phase 1b|Other|1|||
33448936|NCT00147537|62823967|FG004|Phase 1b|Other|1|||
33448937|NCT00147537|62823968|FG005|Phase 1b|Other|1|||
33448938|NCT00147537|62823969|FG006|Phase 1b|Other|14|||
33448939|NCT00147537|62823970|FG007|Phase 1b|Other|4|||
33448940|NCT00147537|62823971|FG008|Phase 1b|Other|4|||
33448941|NCT00147537|62823972|FG009|Phase 1b|Other|0|||
33448942|NCT00147537|62823973|FG010|Phase 1b|Other|0|||
33448943|NCT00147537|62823963|FG000|Phase 1b|Withdrawal by Subject|0|||
33448944|NCT00147537|62823964|FG001|Phase 1b|Withdrawal by Subject|0|||
33448945|NCT00147537|62823965|FG002|Phase 1b|Withdrawal by Subject|0|||
33448946|NCT00147537|62823966|FG003|Phase 1b|Withdrawal by Subject|0|||
33448947|NCT00147537|62823967|FG004|Phase 1b|Withdrawal by Subject|0|||
33448948|NCT00147537|62823968|FG005|Phase 1b|Withdrawal by Subject|0|||
33448949|NCT00147537|62823969|FG006|Phase 1b|Withdrawal by Subject|0|||
33448950|NCT00147537|62823970|FG007|Phase 1b|Withdrawal by Subject|0|||
33448951|NCT00147537|62823971|FG008|Phase 1b|Withdrawal by Subject|2|||
33448952|NCT00147537|62823972|FG009|Phase 1b|Withdrawal by Subject|0|||
33448953|NCT00147537|62823973|FG010|Phase 1b|Withdrawal by Subject|0|||
33448954|NCT00147537|62823963|FG000|Phase 1b|Randomized but not treated|0|||
33448955|NCT00147537|62823964|FG001|Phase 1b|Randomized but not treated|0|||
33448956|NCT00147537|62823965|FG002|Phase 1b|Randomized but not treated|0|||
33448957|NCT00147537|62823966|FG003|Phase 1b|Randomized but not treated|0|||
33448958|NCT00147537|62823967|FG004|Phase 1b|Randomized but not treated|0|||
33448959|NCT00147537|62823968|FG005|Phase 1b|Randomized but not treated|0|||
33448960|NCT00147537|62823969|FG006|Phase 1b|Randomized but not treated|1|||
33501289|NCT03257358|62881899|FG000|Overall Study|Adverse Event|25|||
33501290|NCT03257358|62881900|FG001|Overall Study|Adverse Event|12|||
33448961|NCT00147537|62823970|FG007|Phase 1b|Randomized but not treated|0|||
33448962|NCT00147537|62823971|FG008|Phase 1b|Randomized but not treated|1|||
33448963|NCT00147537|62823972|FG009|Phase 1b|Randomized but not treated|0|||
33448964|NCT00147537|62823973|FG010|Phase 1b|Randomized but not treated|0|||
33448965|NCT00147537|62823963|FG000|Phase 2|Death|0|||
33501291|NCT03257358|62881899|FG000|Overall Study|Lack of Efficacy|1|||
33501292|NCT03257358|62881900|FG001|Overall Study|Lack of Efficacy|1|||
33448966|NCT00147537|62823964|FG001|Phase 2|Death|0|||
33448967|NCT00147537|62823965|FG002|Phase 2|Death|0|||
33448968|NCT00147537|62823966|FG003|Phase 2|Death|0|||
33501293|NCT03257358|62881899|FG000|Overall Study|Lost to Follow-up|12|||
33501294|NCT03257358|62881900|FG001|Overall Study|Lost to Follow-up|4|||
33501295|NCT03257358|62881899|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
33501296|NCT03257358|62881900|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
33501297|NCT03257358|62881899|FG000|Overall Study|Physician Decision|2|||
33501298|NCT03257358|62881900|FG001|Overall Study|Physician Decision|2|||
33501299|NCT03257358|62881899|FG000|Overall Study|Protocol Violation|5|||
33501300|NCT03257358|62881900|FG001|Overall Study|Protocol Violation|3|||
33501301|NCT03257358|62881899|FG000|Overall Study|Technical problems|4|||
33501302|NCT03257358|62881900|FG001|Overall Study|Technical problems|1|||
33501303|NCT03257358|62881899|FG000|Overall Study|Withdrawal by Subject|8|||
33501304|NCT03257358|62881900|FG001|Overall Study|Withdrawal by Subject|3|||
33501305|NCT03257358|62881899|FG000|Overall Study|Withdrawal of informed consent|9|||
33501306|NCT03257358|62881900|FG001|Overall Study|Withdrawal of informed consent|5|||
33501307|NCT03257358|62881899|FG000|Overall Study|New therapy for study indication|1|||
33501308|NCT03257358|62881900|FG001|Overall Study|New therapy for study indication|0|||
33448969|NCT00147537|62823967|FG004|Phase 2|Death|0|||
33448970|NCT00147537|62823968|FG005|Phase 2|Death|0|||
33448971|NCT00147537|62823969|FG006|Phase 2|Death|0|||
33501309|NCT03257358|62881899|FG000|Overall Study|No longer requires treatment|0|||
33501310|NCT03257358|62881900|FG001|Overall Study|No longer requires treatment|1|||
33501311|NCT02936037|62881908|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
33610000|NCT02269475|63010234|FG000|Overall Study|Withdrawal by Subject|0|||
33610001|NCT02269475|63010235|FG001|Overall Study|Withdrawal by Subject|1|||
33610002|NCT01605136|63010244|FG000|Study Period|Withdrawal by Subject|2|||
33610003|NCT01605136|63010245|FG001|Study Period|Withdrawal by Subject|0|||
33610004|NCT01605136|63010244|FG000|Study Period|Physician Decision|1|||
33610005|NCT01605136|63010245|FG001|Study Period|Physician Decision|1|||
33610006|NCT01605136|63010244|FG000|Study Period|Lost to Follow-up|0|||
33610007|NCT01605136|63010245|FG001|Study Period|Lost to Follow-up|2|||
33610008|NCT01605136|63010244|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
33610009|NCT01605136|63010245|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
33610010|NCT01706146|63010251|FG000|Overall Study|Withdrawal by Subject|1|||
33448972|NCT00147537|62823970|FG007|Phase 2|Death|0|||
33448973|NCT00147537|62823971|FG008|Phase 2|Death|0|||
33448974|NCT00147537|62823972|FG009|Phase 2|Death|85|||
33448975|NCT00147537|62823973|FG010|Phase 2|Death|31|||
33448976|NCT00147537|62823963|FG000|Phase 2|Lost to Follow-up|0|||
33501312|NCT02936037|62881909|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
33501313|NCT02936037|62881908|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
33501314|NCT02936037|62881909|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
33501315|NCT02936037|62881908|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
33501316|NCT02936037|62881909|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
33501317|NCT02936037|62881908|FG000|Double-Blind Treatment Period|Death|0|||
33501318|NCT02936037|62881909|FG001|Double-Blind Treatment Period|Death|1|||
33501319|NCT02936037|62881908|FG000|Double-Blind Treatment Period|Adverse Event|11|||
33610011|NCT01706146|63010251|FG000|Overall Study|Adverse Event|3|||
33448977|NCT00147537|62823964|FG001|Phase 2|Lost to Follow-up|0|||
33448978|NCT00147537|62823965|FG002|Phase 2|Lost to Follow-up|0|||
33501320|NCT02936037|62881909|FG001|Double-Blind Treatment Period|Adverse Event|11|||
33501321|NCT02936037|62881908|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
33501322|NCT02936037|62881909|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
33501323|NCT02936037|62881908|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33501324|NCT02936037|62881909|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
33501325|NCT02936037|62881908|FG000|Open Label Extension|Adverse Event|0|||
33501326|NCT02936037|62881909|FG001|Open Label Extension|Adverse Event|3|||
33501327|NCT02936037|62881908|FG000|Open Label Extension|Other|0|||
33501328|NCT02936037|62881909|FG001|Open Label Extension|Other|3|||
33501329|NCT02936037|62881908|FG000|Open Label Extension|Withdrawal by Subject|0|||
33501330|NCT02936037|62881909|FG001|Open Label Extension|Withdrawal by Subject|4|||
33501331|NCT03288714|62881917|FG000|Overall Study|Lost to Follow-up|2|||
33501332|NCT03288714|62881918|FG001|Overall Study|Lost to Follow-up|1|||
33324099|NCT01139580|62700500|FG000|Overall Study|Lost to Follow-up|9|||
33448979|NCT00147537|62823966|FG003|Phase 2|Lost to Follow-up|0|||
33448980|NCT00147537|62823967|FG004|Phase 2|Lost to Follow-up|0|||
33448981|NCT00147537|62823968|FG005|Phase 2|Lost to Follow-up|0|||
33448982|NCT00147537|62823969|FG006|Phase 2|Lost to Follow-up|0|||
33448983|NCT00147537|62823970|FG007|Phase 2|Lost to Follow-up|0|||
33448984|NCT00147537|62823971|FG008|Phase 2|Lost to Follow-up|0|||
33448985|NCT00147537|62823972|FG009|Phase 2|Lost to Follow-up|12|||
33448986|NCT00147537|62823973|FG010|Phase 2|Lost to Follow-up|4|||
33448987|NCT00147537|62823963|FG000|Phase 2|Other|0|||
33448988|NCT00147537|62823964|FG001|Phase 2|Other|0|||
33448989|NCT00147537|62823965|FG002|Phase 2|Other|0|||
33448990|NCT00147537|62823966|FG003|Phase 2|Other|0|||
33448991|NCT00147537|62823967|FG004|Phase 2|Other|0|||
33448992|NCT00147537|62823968|FG005|Phase 2|Other|0|||
33324100|NCT01139580|62700501|FG001|Overall Study|Lost to Follow-up|1|||
33324101|NCT01139580|62700500|FG000|Overall Study|Lack of Efficacy|0|||
33324102|NCT01139580|62700501|FG001|Overall Study|Lack of Efficacy|2|||
33324103|NCT01139580|62700500|FG000|Overall Study|Withdrawal by Subject|6|||
33324104|NCT01139580|62700501|FG001|Overall Study|Withdrawal by Subject|9|||
33324105|NCT01139580|62700500|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
33324106|NCT01139580|62700501|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
33324107|NCT01139580|62700500|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
33324108|NCT01139580|62700501|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
33324109|NCT01139580|62700500|FG000|Overall Study|Misrandomized|1|||
33324110|NCT01139580|62700501|FG001|Overall Study|Misrandomized|0|||
33324111|NCT01139580|62700500|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
33324112|NCT01139580|62700501|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
33324113|NCT01139580|62700500|FG000|Overall Study|Participant Randomization in Error|0|||
33448993|NCT00147537|62823969|FG006|Phase 2|Other|0|||
33448994|NCT00147537|62823970|FG007|Phase 2|Other|0|||
33448995|NCT00147537|62823971|FG008|Phase 2|Other|0|||
33448996|NCT00147537|62823972|FG009|Phase 2|Other|47|||
33448997|NCT00147537|62823973|FG010|Phase 2|Other|12|||
33448998|NCT00147537|62823963|FG000|Phase 2|Withdrawal by Subject|0|||
33448999|NCT00147537|62823964|FG001|Phase 2|Withdrawal by Subject|0|||
33449000|NCT00147537|62823965|FG002|Phase 2|Withdrawal by Subject|0|||
33449001|NCT00147537|62823966|FG003|Phase 2|Withdrawal by Subject|0|||
33449002|NCT00147537|62823967|FG004|Phase 2|Withdrawal by Subject|0|||
33449003|NCT00147537|62823968|FG005|Phase 2|Withdrawal by Subject|0|||
33449004|NCT00147537|62823969|FG006|Phase 2|Withdrawal by Subject|0|||
33449005|NCT00147537|62823970|FG007|Phase 2|Withdrawal by Subject|0|||
33501333|NCT03288714|62881917|FG000|Overall Study|Non-compliance with study schedule|2|||
33501334|NCT03288714|62881918|FG001|Overall Study|Non-compliance with study schedule|0|||
33501335|NCT03288714|62881917|FG000|Overall Study|Withdrawal by Subject|3|||
33324114|NCT01139580|62700501|FG001|Overall Study|Participant Randomization in Error|1|||
33449006|NCT00147537|62823971|FG008|Phase 2|Withdrawal by Subject|0|||
33449007|NCT00147537|62823972|FG009|Phase 2|Withdrawal by Subject|16|||
33449008|NCT00147537|62823973|FG010|Phase 2|Withdrawal by Subject|4|||
33449009|NCT00147537|62823963|FG000|Phase 2|Randomized but not treated|0|||
33449010|NCT00147537|62823964|FG001|Phase 2|Randomized but not treated|0|||
33501336|NCT03288714|62881918|FG001|Overall Study|Withdrawal by Subject|1|||
33501337|NCT03288714|62881917|FG000|Overall Study|Clinical Worsening|2|||
33501338|NCT03288714|62881918|FG001|Overall Study|Clinical Worsening|1|||
33501339|NCT03288714|62881917|FG000|Overall Study|Adverse Event|1|||
33501340|NCT03288714|62881918|FG001|Overall Study|Adverse Event|0|||
33501341|NCT04068181|62881930|FG000|Overall Study|Withdrawal by Subject|2|||
33501342|NCT04068181|62881931|FG001|Overall Study|Withdrawal by Subject|0|||
33501343|NCT04068181|62881932|FG002|Overall Study|Withdrawal by Subject|0|||
33501344|NCT04068181|62881933|FG003|Overall Study|Withdrawal by Subject|0|||
33501345|NCT04068181|62881930|FG000|Overall Study|Lost to Follow-up|1|||
33324115|NCT00917644|62700507|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
33324116|NCT00917644|62700508|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
33501346|NCT04068181|62881931|FG001|Overall Study|Lost to Follow-up|0|||
33501347|NCT04068181|62881932|FG002|Overall Study|Lost to Follow-up|0|||
33610012|NCT01706146|63010251|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
33610013|NCT02269241|63010255|FG000|Overall Study|Lost to Follow-up|269|||
33610014|NCT02269241|63010255|FG000|Overall Study|Withdrawal by Subject|155|||
33610015|NCT02269241|63010255|FG000|Overall Study|Protocol Violation|1|||
33449011|NCT00147537|62823965|FG002|Phase 2|Randomized but not treated|0|||
33449012|NCT00147537|62823966|FG003|Phase 2|Randomized but not treated|0|||
33449013|NCT00147537|62823967|FG004|Phase 2|Randomized but not treated|0|||
33449014|NCT00147537|62823968|FG005|Phase 2|Randomized but not treated|0|||
33449015|NCT00147537|62823969|FG006|Phase 2|Randomized but not treated|0|||
33449016|NCT00147537|62823970|FG007|Phase 2|Randomized but not treated|0|||
33449017|NCT00147537|62823971|FG008|Phase 2|Randomized but not treated|0|||
33449018|NCT00147537|62823972|FG009|Phase 2|Randomized but not treated|1|||
33449019|NCT00147537|62823973|FG010|Phase 2|Randomized but not treated|1|||
33449020|NCT00222729|62824018|FG000|Overall Study|Adverse Event|3|||
33449021|NCT00147225|62824028|FG000|Overall Study|Withdrawal by Subject|1|||
33449022|NCT00147225|62824029|FG001|Overall Study|Withdrawal by Subject|0|||
33449023|NCT00147225|62824030|FG002|Overall Study|Withdrawal by Subject|1|||
33501348|NCT04068181|62881933|FG003|Overall Study|Lost to Follow-up|0|||
33610016|NCT02269241|63010255|FG000|Overall Study|Physician Decision|7|||
33610017|NCT02269241|63010255|FG000|Overall Study|Pregnancy|15|||
33610018|NCT02269241|63010255|FG000|Overall Study|Wish for pregnancy|5|||
33610019|NCT02269241|63010255|FG000|Overall Study|Development of an exclusion criteria|16|||
33610020|NCT02269241|63010255|FG000|Overall Study|Adverse Event|113|||
33610021|NCT02269241|63010255|FG000|Overall Study|At the specific request of the sponsor|20|||
33610022|NCT02269241|63010255|FG000|Overall Study|Several reasons not classified|53|||
33610023|NCT02269241|63010255|FG000|Overall Study|Screening failures|546|||
33610024|NCT01750684|63010262|FG000|Overall Study|Death|1|||
33610025|NCT01750684|63010263|FG001|Overall Study|Death|0|||
33610026|NCT01750684|63010262|FG000|Overall Study|Non-compliance with Study Drug|0|||
33610027|NCT01750684|63010263|FG001|Overall Study|Non-compliance with Study Drug|1|||
33610028|NCT01750684|63010262|FG000|Overall Study|Withdrawn by Sponsor|0|||
33610029|NCT01750684|63010263|FG001|Overall Study|Withdrawn by Sponsor|1|||
33610030|NCT01750684|63010262|FG000|Overall Study|Protocol Violation|1|||
33610031|NCT01750684|63010263|FG001|Overall Study|Protocol Violation|0|||
33610032|NCT01750294|63010270|FG000|Overall Study|Withdrawal by Subject|1|||
33610033|NCT01750294|63010270|FG000|Overall Study|Safety Endpoint|1|||
33610034|NCT01749982|63010278|FG000|Overall Study|Physician Decision|0|||
33610035|NCT01749982|63010279|FG001|Overall Study|Physician Decision|0|||
33449024|NCT00147225|62824031|FG003|Overall Study|Withdrawal by Subject|0|||
33449025|NCT00147225|62824032|FG004|Overall Study|Withdrawal by Subject|0|||
33449026|NCT00147225|62824033|FG005|Overall Study|Withdrawal by Subject|1|||
33449027|NCT00147225|62824028|FG000|Overall Study|Adverse Event|0|||
33449028|NCT00147225|62824029|FG001|Overall Study|Adverse Event|0|||
33449029|NCT00147225|62824030|FG002|Overall Study|Adverse Event|1|||
33449030|NCT00147225|62824031|FG003|Overall Study|Adverse Event|1|||
33449031|NCT00147225|62824032|FG004|Overall Study|Adverse Event|0|||
33610036|NCT01749982|63010280|FG002|Overall Study|Physician Decision|0|||
33610037|NCT01749982|63010281|FG003|Overall Study|Physician Decision|1|||
33610038|NCT01749982|63010278|FG000|Overall Study|Lost to Follow-up|0|||
33610039|NCT01749982|63010279|FG001|Overall Study|Lost to Follow-up|0|||
33610040|NCT01749982|63010280|FG002|Overall Study|Lost to Follow-up|0|||
33501349|NCT04068181|62881930|FG000|Overall Study|Death|8|||
33501350|NCT04068181|62881931|FG001|Overall Study|Death|8|||
33501351|NCT04068181|62881932|FG002|Overall Study|Death|4|||
33501352|NCT04068181|62881933|FG003|Overall Study|Death|2|||
33501353|NCT04068181|62881930|FG000|Overall Study|Continuing Study|16|||
33501354|NCT04068181|62881931|FG001|Overall Study|Continuing Study|7|||
33501355|NCT04068181|62881932|FG002|Overall Study|Continuing Study|11|||
33501356|NCT04068181|62881933|FG003|Overall Study|Continuing Study|13|||
33501357|NCT03256578|62881945|FG000|Overall Study|Excluded Post Randomization|66|||
33501358|NCT03256578|62881946|FG001|Overall Study|Excluded Post Randomization|56|||
33501359|NCT03227445|62881952|FG000|Period 1 (28 Days)|Adverse Event|1|||
33501360|NCT03227445|62881953|FG001|Period 1 (28 Days)|Adverse Event|2|||
33501361|NCT03227445|62881954|FG002|Period 1 (28 Days)|Adverse Event|0|||
33501362|NCT03227445|62881955|FG003|Period 1 (28 Days)|Adverse Event|1|||
33501363|NCT03227445|62881952|FG000|Period 1 (28 Days)|Protocol Violation|1|||
33501364|NCT03227445|62881953|FG001|Period 1 (28 Days)|Protocol Violation|0|||
33501365|NCT03227445|62881954|FG002|Period 1 (28 Days)|Protocol Violation|0|||
33501366|NCT03227445|62881955|FG003|Period 1 (28 Days)|Protocol Violation|0|||
33501367|NCT03227445|62881952|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
33501368|NCT03227445|62881953|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
33501369|NCT03227445|62881954|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
33501370|NCT03227445|62881955|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
33501371|NCT03227445|62881952|FG000|Period 2 (28 Days)|Adverse Event|1|||
33501372|NCT03227445|62881953|FG001|Period 2 (28 Days)|Adverse Event|0|||
33501373|NCT03227445|62881954|FG002|Period 2 (28 Days)|Adverse Event|2|||
33501374|NCT03227445|62881955|FG003|Period 2 (28 Days)|Adverse Event|1|||
33501375|NCT03227445|62881952|FG000|Period 2 (28 Days)|Protocol Violation|0|||
33501376|NCT03227445|62881953|FG001|Period 2 (28 Days)|Protocol Violation|0|||
33501377|NCT03227445|62881954|FG002|Period 2 (28 Days)|Protocol Violation|0|||
33501378|NCT03227445|62881955|FG003|Period 2 (28 Days)|Protocol Violation|1|||
33501379|NCT03227445|62881952|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
33501380|NCT03227445|62881953|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
33501381|NCT03227445|62881954|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
33501382|NCT03227445|62881955|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
33501383|NCT04067401|62881966|FG000|Overall Study|Withdrawal by Subject|7|||
33501384|NCT04067401|62881967|FG001|Overall Study|Withdrawal by Subject|0|||
33501385|NCT04067401|62881966|FG000|Overall Study|no data provided|1|||
33501386|NCT04067401|62881967|FG001|Overall Study|no data provided|0|||
33501387|NCT04194151|62881979|FG000|Overall Study|Physician Decision|1|||
33501388|NCT04194151|62881980|FG001|Overall Study|Physician Decision|1|||
33501389|NCT04194151|62881981|FG002|Overall Study|Physician Decision|1|||
33501390|NCT04194151|62881982|FG003|Overall Study|Physician Decision|1|||
33501391|NCT04194151|62881983|FG004|Overall Study|Physician Decision|0|||
33501392|NCT04194151|62881984|FG005|Overall Study|Physician Decision|1|||
33610041|NCT01749982|63010281|FG003|Overall Study|Lost to Follow-up|1|||
33324117|NCT00917644|62700507|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
33324118|NCT00917644|62700508|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
33324119|NCT00917644|62700507|FG000|Period 2: Second Intervention|family emergency|1|||
33324120|NCT00917644|62700508|FG001|Period 2: Second Intervention|family emergency|0|||
33324121|NCT01137786|62700516|FG000|Overall Study|Lost to Follow-up|0|||
33324122|NCT01137786|62700517|FG001|Overall Study|Lost to Follow-up|2|||
33324123|NCT01137786|62700516|FG000|Overall Study|Withdrawal by Subject|1|||
33324124|NCT01137786|62700517|FG001|Overall Study|Withdrawal by Subject|1|||
33324125|NCT00599755|62700525|FG000|Overall Study|Adverse Event|11|||
33324126|NCT00599755|62700525|FG000|Overall Study|Withdrawal by Subject|2|||
33449032|NCT00147225|62824033|FG005|Overall Study|Adverse Event|0|||
33449033|NCT00147225|62824028|FG000|Overall Study|Screen Failure|0|||
33449034|NCT00147225|62824029|FG001|Overall Study|Screen Failure|0|||
33449035|NCT00147225|62824030|FG002|Overall Study|Screen Failure|0|||
33449036|NCT00147225|62824031|FG003|Overall Study|Screen Failure|0|||
33449037|NCT00147225|62824032|FG004|Overall Study|Screen Failure|1|||
33449038|NCT00147225|62824033|FG005|Overall Study|Screen Failure|0|||
33449039|NCT00147225|62824028|FG000|Overall Study|Chemotherapy Changed|0|||
33501393|NCT04194151|62881979|FG000|Overall Study|Monitorization problem|0|||
33501394|NCT04194151|62881980|FG001|Overall Study|Monitorization problem|1|||
33324127|NCT00599755|62700525|FG000|Overall Study|Progression of Disease|3|||
33449040|NCT00147225|62824029|FG001|Overall Study|Chemotherapy Changed|0|||
33449041|NCT00147225|62824030|FG002|Overall Study|Chemotherapy Changed|0|||
33449042|NCT00147225|62824031|FG003|Overall Study|Chemotherapy Changed|0|||
33449043|NCT00147225|62824032|FG004|Overall Study|Chemotherapy Changed|0|||
33449044|NCT00147225|62824033|FG005|Overall Study|Chemotherapy Changed|1|||
33449045|NCT00222105|62824047|FG000|Overall Study|Removed due to wrong diagnosis|1|||
33501395|NCT04194151|62881981|FG002|Overall Study|Monitorization problem|0|||
33501396|NCT04194151|62881982|FG003|Overall Study|Monitorization problem|0|||
33610042|NCT01749982|63010278|FG000|Overall Study|Withdrawal by Subject|0|||
33610043|NCT01749982|63010279|FG001|Overall Study|Withdrawal by Subject|0|||
33610044|NCT01749982|63010280|FG002|Overall Study|Withdrawal by Subject|0|||
33610045|NCT01749982|63010281|FG003|Overall Study|Withdrawal by Subject|1|||
33610046|NCT02269163|63010293|FG000|Overall Study|Lost to Follow-up|1|||
33610047|NCT02269163|63010294|FG001|Overall Study|Lost to Follow-up|0|||
33610048|NCT02269163|63010293|FG000|Overall Study|Major protocol violation|0|||
33324128|NCT00599755|62700525|FG000|Overall Study|Other Reason|2|||
33324129|NCT00599755|62700525|FG000|Overall Study|No data available|1|||
33324130|NCT00600613|62700529|FG000|Overall Study|Protocol Deviation|1|||
33324131|NCT01125930|62700535|FG000|Overall Study|Adverse Event|0|||
33324132|NCT01125930|62700536|FG001|Overall Study|Adverse Event|1|||
33324133|NCT01125930|62700535|FG000|Overall Study|Withdrawal by Subject|1|||
33324134|NCT01125930|62700536|FG001|Overall Study|Withdrawal by Subject|6|||
33324135|NCT01125930|62700535|FG000|Overall Study|Protocol Violation|0|||
33324136|NCT01125930|62700536|FG001|Overall Study|Protocol Violation|1|||
33324137|NCT01125930|62700535|FG000|Overall Study|Lost to Follow-up|0|||
33324138|NCT01125930|62700536|FG001|Overall Study|Lost to Follow-up|2|||
33324139|NCT00918346|62700567|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
33610049|NCT02269163|63010294|FG001|Overall Study|Major protocol violation|1|||
33610050|NCT02269163|63010293|FG000|Overall Study|Other|2|||
33610051|NCT02269163|63010294|FG001|Overall Study|Other|2|||
33324140|NCT00918346|62700568|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
33324141|NCT00913978|62700579|FG000|Overall Study|Surgeon choice|1|||
33324142|NCT00913978|62700580|FG001|Overall Study|Surgeon choice|3|||
33449046|NCT00222105|62824047|FG000|Overall Study|Withdrawal by Subject|1|||
33449047|NCT00222105|62824047|FG000|Overall Study|Adverse Event|8|||
33449048|NCT00222105|62824047|FG000|Overall Study|Treatment delays|2|||
33501397|NCT04194151|62881983|FG004|Overall Study|Monitorization problem|0|||
33501398|NCT04194151|62881984|FG005|Overall Study|Monitorization problem|0|||
33501399|NCT03820323|62882000|FG000|Overall Study|Lost to Follow-up|2|||
33501400|NCT03820323|62882001|FG001|Overall Study|Lost to Follow-up|1|||
33501401|NCT03820323|62882000|FG000|Overall Study|Missed 12-month visit|22|||
33501402|NCT03820323|62882001|FG001|Overall Study|Missed 12-month visit|14|||
33501403|NCT03820323|62882000|FG000|Overall Study|Death|2|||
33501404|NCT03820323|62882001|FG001|Overall Study|Death|1|||
33449049|NCT00222105|62824047|FG000|Overall Study|Death|2|||
33449050|NCT00146757|62824051|FG000|Overall Study|Death|1|||
33449051|NCT00146757|62824052|FG001|Overall Study|Death|0|||
33449052|NCT00146757|62824051|FG000|Overall Study|Adverse Event|1|||
33449053|NCT00146757|62824052|FG001|Overall Study|Adverse Event|0|||
33449054|NCT00267098|62824066|FG000|Overall Study|Death|0|||
33449055|NCT00267098|62824067|FG001|Overall Study|Death|0|||
33449056|NCT00267098|62824068|FG002|Overall Study|Death|57|||
33449057|NCT00267098|62824069|FG003|Overall Study|Death|66|||
33449058|NCT00267098|62824070|FG004|Overall Study|Death|14|||
33449059|NCT00267098|62824071|FG005|Overall Study|Death|23|||
33449060|NCT00267098|62824072|FG006|Overall Study|Death|28|||
33449061|NCT00267098|62824073|FG007|Overall Study|Death|9|||
33449062|NCT00267098|62824066|FG000|Overall Study|Lost to Follow-up|0|||
33449063|NCT00267098|62824067|FG001|Overall Study|Lost to Follow-up|0|||
33449064|NCT00267098|62824068|FG002|Overall Study|Lost to Follow-up|6|||
33449065|NCT00267098|62824069|FG003|Overall Study|Lost to Follow-up|5|||
33449066|NCT00267098|62824070|FG004|Overall Study|Lost to Follow-up|2|||
33449067|NCT00267098|62824071|FG005|Overall Study|Lost to Follow-up|3|||
33449068|NCT00267098|62824072|FG006|Overall Study|Lost to Follow-up|1|||
33449069|NCT00267098|62824073|FG007|Overall Study|Lost to Follow-up|1|||
33449070|NCT00267098|62824066|FG000|Overall Study|Withdrawal by Subject|8|||
33449071|NCT00267098|62824067|FG001|Overall Study|Withdrawal by Subject|0|||
33449072|NCT00267098|62824068|FG002|Overall Study|Withdrawal by Subject|24|||
33449073|NCT00267098|62824069|FG003|Overall Study|Withdrawal by Subject|21|||
33449074|NCT00267098|62824070|FG004|Overall Study|Withdrawal by Subject|12|||
33449075|NCT00267098|62824071|FG005|Overall Study|Withdrawal by Subject|9|||
33449076|NCT00267098|62824072|FG006|Overall Study|Withdrawal by Subject|12|||
33501405|NCT03820323|62882000|FG000|Overall Study|Transferred out|13|||
33501406|NCT03820323|62882001|FG001|Overall Study|Transferred out|11|||
33610052|NCT02269163|63010293|FG000|Overall Study|Withdrawal by Subject|0|||
33324143|NCT01137474|62700590|FG000|Overall Study|Adverse Event|3|||
33324144|NCT01137474|62700591|FG001|Overall Study|Adverse Event|5|||
33324145|NCT01137474|62700592|FG002|Overall Study|Adverse Event|1|||
33324146|NCT01137474|62700593|FG003|Overall Study|Adverse Event|3|||
33449077|NCT00267098|62824073|FG007|Overall Study|Withdrawal by Subject|5|||
33449078|NCT00267098|62824066|FG000|Overall Study|Physician Decision|5|||
33501407|NCT03820323|62882000|FG000|Overall Study|Terminated|0|||
33501408|NCT03820323|62882001|FG001|Overall Study|Terminated|3|||
33449079|NCT00267098|62824067|FG001|Overall Study|Physician Decision|0|||
33449080|NCT00267098|62824068|FG002|Overall Study|Physician Decision|7|||
33449081|NCT00267098|62824069|FG003|Overall Study|Physician Decision|11|||
33610053|NCT02269163|63010294|FG001|Overall Study|Withdrawal by Subject|3|||
33610054|NCT02269163|63010293|FG000|Overall Study|Physician Decision|0|||
33501409|NCT03820323|62882000|FG000|Overall Study|Withdrawal by Subject|1|||
33501410|NCT03820323|62882001|FG001|Overall Study|Withdrawal by Subject|6|||
33501411|NCT03287622|62882016|FG000|Overall Study|Withdrawal by Subject|1|||
33501412|NCT03287622|62882017|FG001|Overall Study|Withdrawal by Subject|0|||
33501413|NCT03287622|62882016|FG000|Overall Study|Lost to Follow-up|27|||
33501414|NCT03287622|62882017|FG001|Overall Study|Lost to Follow-up|15|||
33501415|NCT03287622|62882016|FG000|Overall Study|No prescripion after surgery|28|||
33501416|NCT03287622|62882017|FG001|Overall Study|No prescripion after surgery|31|||
33501417|NCT03287622|62882016|FG000|Overall Study|prolonged Length of stay|2|||
33501418|NCT03287622|62882017|FG001|Overall Study|prolonged Length of stay|0|||
33501419|NCT03287622|62882016|FG000|Overall Study|surgery related|0|||
33501420|NCT03287622|62882017|FG001|Overall Study|surgery related|2|||
33501421|NCT04063657|62882032|FG000|Overall Study|Lost to Follow-up|1|||
33501422|NCT04063657|62882033|FG001|Overall Study|Lost to Follow-up|0|||
33501423|NCT04058353|62882050|FG000|Overall Study|Adverse Event|2|||
33501424|NCT04058353|62882051|FG001|Overall Study|Adverse Event|1|||
33501425|NCT04058353|62882050|FG000|Overall Study|Physician Decision|1|||
33501426|NCT04058353|62882051|FG001|Overall Study|Physician Decision|0|||
33501427|NCT04058353|62882050|FG000|Overall Study|Other|1|||
33501428|NCT04058353|62882051|FG001|Overall Study|Other|0|||
33501429|NCT03226353|62882058|FG000|Overall Study|Withdrawal by Subject|1|||
33501430|NCT03226353|62882058|FG000|Overall Study|Screen Failure|5|||
33610055|NCT02269163|63010294|FG001|Overall Study|Physician Decision|1|||
33610056|NCT01749826|63010304|FG000|Overall Study|Study Terminated|20|||
33610057|NCT01749826|63010305|FG001|Overall Study|Study Terminated|0|||
33610058|NCT02300129|63010311|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
33610059|NCT02300129|63010312|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
33610060|NCT02300129|63010313|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
33610061|NCT02300129|63010314|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
33610062|NCT02300129|63010311|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
33610063|NCT02300129|63010312|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
33610064|NCT02300129|63010313|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
33610065|NCT02300129|63010314|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
33610066|NCT02300129|63010311|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
33501431|NCT02730598|62882067|FG000|Overall Study|Withdrawal by Subject|3|||
33501432|NCT02730598|62882068|FG001|Overall Study|Withdrawal by Subject|3|||
33610067|NCT02300129|63010312|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
33610068|NCT02300129|63010313|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
33501433|NCT02730598|62882067|FG000|Overall Study|Protocol Violation|0|||
33501434|NCT02730598|62882068|FG001|Overall Study|Protocol Violation|1|||
33501435|NCT02730598|62882067|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
33501436|NCT02730598|62882068|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
33501437|NCT03226275|62882078|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
33501438|NCT03226275|62882079|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
33501439|NCT03226275|62882080|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
33501440|NCT03226275|62882081|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
33501441|NCT03226275|62882078|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
33501442|NCT03226275|62882079|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
33501443|NCT03226275|62882080|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
33501444|NCT03226275|62882081|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
33501445|NCT04189081|62882094|FG000|Overall Study|Lost to Follow-up|1|||
33501446|NCT04189081|62882095|FG001|Overall Study|Lost to Follow-up|0|||
33501447|NCT04189081|62882096|FG002|Overall Study|Lost to Follow-up|0|||
33501448|NCT04189081|62882094|FG000|Overall Study|Withdrawal by Subject|0|||
33501449|NCT04189081|62882095|FG001|Overall Study|Withdrawal by Subject|0|||
33501450|NCT04189081|62882096|FG002|Overall Study|Withdrawal by Subject|1|||
33501451|NCT04187989|62882106|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
33501452|NCT04187989|62882107|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
33501453|NCT04187989|62882106|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
33501454|NCT04187989|62882107|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
33501455|NCT01150890|62882117|FG000|Overall Study|Other|0|||
33501456|NCT01150890|62882118|FG001|Overall Study|Other|1|||
33501457|NCT01150890|62882119|FG002|Overall Study|Other|0|||
33501458|NCT01150890|62882120|FG003|Overall Study|Other|2|||
33501459|NCT01150890|62882117|FG000|Overall Study|Pregnancy|0|||
33501460|NCT01150890|62882118|FG001|Overall Study|Pregnancy|0|||
33501461|NCT01150890|62882119|FG002|Overall Study|Pregnancy|0|||
33610069|NCT02300129|63010314|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
33324147|NCT01137474|62700590|FG000|Overall Study|Withdrawal by Subject|7|||
33501462|NCT01150890|62882120|FG003|Overall Study|Pregnancy|1|||
33501463|NCT01150890|62882117|FG000|Overall Study|Administrative Decision|4|||
33501464|NCT01150890|62882118|FG001|Overall Study|Administrative Decision|4|||
33501465|NCT01150890|62882119|FG002|Overall Study|Administrative Decision|5|||
33501466|NCT01150890|62882120|FG003|Overall Study|Administrative Decision|6|||
33501467|NCT01150890|62882117|FG000|Overall Study|Ineligibility determined|0|||
33501468|NCT01150890|62882118|FG001|Overall Study|Ineligibility determined|1|||
33501469|NCT01150890|62882119|FG002|Overall Study|Ineligibility determined|0|||
33501470|NCT01150890|62882120|FG003|Overall Study|Ineligibility determined|0|||
33501471|NCT01150890|62882117|FG000|Overall Study|Adverse Event|0|||
33501472|NCT01150890|62882118|FG001|Overall Study|Adverse Event|0|||
33501473|NCT01150890|62882119|FG002|Overall Study|Adverse Event|2|||
33501474|NCT01150890|62882120|FG003|Overall Study|Adverse Event|0|||
33501475|NCT01150890|62882117|FG000|Overall Study|Withdrawal by Subject|0|||
33501476|NCT01150890|62882118|FG001|Overall Study|Withdrawal by Subject|0|||
33501477|NCT01150890|62882119|FG002|Overall Study|Withdrawal by Subject|2|||
33501478|NCT01150890|62882120|FG003|Overall Study|Withdrawal by Subject|1|||
33501479|NCT01150890|62882117|FG000|Overall Study|Disease progression|0|||
33501480|NCT01150890|62882118|FG001|Overall Study|Disease progression|7|||
33501481|NCT01150890|62882119|FG002|Overall Study|Disease progression|3|||
33501482|NCT01150890|62882120|FG003|Overall Study|Disease progression|7|||
33501483|NCT04057573|62882135|FG000|24-Week Double-Blind Period|Adverse Event|2|||
33501484|NCT04057573|62882136|FG001|24-Week Double-Blind Period|Adverse Event|0|||
33501485|NCT04057573|62882137|FG002|24-Week Double-Blind Period|Adverse Event|0|||
33501486|NCT04057573|62882138|FG003|24-Week Double-Blind Period|Adverse Event|0|||
33501487|NCT04057573|62882135|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
33501488|NCT04057573|62882136|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
33501489|NCT04057573|62882137|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
33501490|NCT04057573|62882138|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
33501491|NCT04057573|62882135|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
33501492|NCT04057573|62882136|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
33501493|NCT04057573|62882137|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
33501494|NCT04057573|62882138|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
33501495|NCT04057573|62882135|FG000|24-Week Double-Blind Period|Physician Decision|1|||
33501496|NCT04057573|62882136|FG001|24-Week Double-Blind Period|Physician Decision|0|||
33501497|NCT04057573|62882137|FG002|24-Week Double-Blind Period|Physician Decision|0|||
33501498|NCT04057573|62882138|FG003|24-Week Double-Blind Period|Physician Decision|0|||
33501499|NCT04057573|62882135|FG000|24-Week Double-Blind Period|Pregnancy|1|||
33501500|NCT04057573|62882136|FG001|24-Week Double-Blind Period|Pregnancy|0|||
33501501|NCT04057573|62882137|FG002|24-Week Double-Blind Period|Pregnancy|0|||
33501502|NCT04057573|62882138|FG003|24-Week Double-Blind Period|Pregnancy|0|||
33501503|NCT04057573|62882135|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
33501504|NCT04057573|62882136|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
33501505|NCT04057573|62882137|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
33501506|NCT04057573|62882138|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
33501507|NCT04057573|62882135|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
33501508|NCT04057573|62882136|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
33501509|NCT04057573|62882137|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
33501510|NCT04057573|62882138|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
33501511|NCT04057573|62882135|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
33501512|NCT04057573|62882136|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
33501513|NCT04057573|62882137|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
33501514|NCT04057573|62882138|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
33501515|NCT04057573|62882135|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
33449082|NCT00267098|62824070|FG004|Overall Study|Physician Decision|5|||
33449083|NCT00267098|62824071|FG005|Overall Study|Physician Decision|4|||
33449084|NCT00267098|62824072|FG006|Overall Study|Physician Decision|3|||
33449085|NCT00267098|62824073|FG007|Overall Study|Physician Decision|0|||
33449086|NCT00267098|62824066|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
33449087|NCT00267098|62824067|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33449088|NCT00267098|62824068|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33449089|NCT00267098|62824069|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33449090|NCT00267098|62824070|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
33449091|NCT00267098|62824071|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33449092|NCT00267098|62824072|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33449093|NCT00267098|62824073|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33449094|NCT00267098|62824066|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
33449095|NCT00267098|62824067|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
33449096|NCT00267098|62824068|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
33449097|NCT00267098|62824069|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
33501516|NCT04057573|62882136|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
33501517|NCT04057573|62882137|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
33501518|NCT04057573|62882138|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
33501519|NCT04057573|62882135|FG000|24-Week Double-Blind Period|Not Treated|1|||
33501520|NCT04057573|62882136|FG001|24-Week Double-Blind Period|Not Treated|0|||
33501521|NCT04057573|62882137|FG002|24-Week Double-Blind Period|Not Treated|0|||
33501522|NCT04057573|62882138|FG003|24-Week Double-Blind Period|Not Treated|0|||
33501523|NCT04057573|62882135|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
33501524|NCT04057573|62882136|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
33501525|NCT04057573|62882137|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
33501526|NCT04057573|62882138|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
33501527|NCT04057573|62882135|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
33501528|NCT04057573|62882136|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
33501529|NCT04057573|62882137|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
33501530|NCT04057573|62882138|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
33501531|NCT04057573|62882135|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
33501532|NCT04057573|62882136|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
33501533|NCT04057573|62882137|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
33501534|NCT04057573|62882138|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
33501535|NCT04057573|62882135|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
33501536|NCT04057573|62882136|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
33501537|NCT04057573|62882137|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
33501538|NCT04057573|62882138|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
33501539|NCT04057573|62882135|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
33501540|NCT04057573|62882136|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
33501541|NCT04057573|62882137|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
33501542|NCT04057573|62882138|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
33501543|NCT04054765|62882151|FG000|Baseline|Withdrawal by Subject|5|||
33501544|NCT04054765|62882152|FG001|Baseline|Withdrawal by Subject|3|||
33501545|NCT04054765|62882151|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
33501546|NCT04054765|62882152|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
33501547|NCT04054765|62882151|FG000|3-month Follow up|Withdrawal by Subject|0|||
33501548|NCT04054765|62882152|FG001|3-month Follow up|Withdrawal by Subject|3|||
33501549|NCT04054765|62882151|FG000|6-month Follow up|Lost to Follow-up|32|||
33501550|NCT04054765|62882152|FG001|6-month Follow up|Lost to Follow-up|32|||
33501551|NCT04179721|62882160|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
33501552|NCT04179721|62882161|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
33501553|NCT04179721|62882160|FG000|Overall Study|Lost to Follow-up|0|||
33501554|NCT04179721|62882161|FG001|Overall Study|Lost to Follow-up|1|||
33501555|NCT03286218|62882167|FG000|Qualification Phase Period 1|Adverse Event|1|||
33501556|NCT03286218|62882168|FG001|Qualification Phase Period 1|Adverse Event|0|||
33501557|NCT03286218|62882169|FG002|Qualification Phase Period 1|Adverse Event|0|||
33501558|NCT03286218|62882170|FG003|Qualification Phase Period 1|Adverse Event|0|||
33501559|NCT03286218|62882171|FG004|Qualification Phase Period 1|Adverse Event|0|||
33501560|NCT03286218|62882172|FG005|Qualification Phase Period 1|Adverse Event|0|||
33501561|NCT03286218|62882173|FG006|Qualification Phase Period 1|Adverse Event|0|||
33501562|NCT03286218|62882174|FG007|Qualification Phase Period 1|Adverse Event|0|||
33324148|NCT01137474|62700591|FG001|Overall Study|Withdrawal by Subject|2|||
33324149|NCT01137474|62700592|FG002|Overall Study|Withdrawal by Subject|6|||
33324150|NCT01137474|62700593|FG003|Overall Study|Withdrawal by Subject|9|||
33324151|NCT01137474|62700590|FG000|Overall Study|No longer met study criteria|6|||
33324152|NCT01137474|62700591|FG001|Overall Study|No longer met study criteria|1|||
33324153|NCT01137474|62700592|FG002|Overall Study|No longer met study criteria|0|||
33449098|NCT00267098|62824070|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
33449099|NCT00267098|62824071|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
33449100|NCT00267098|62824072|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
33449101|NCT00267098|62824073|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
33449102|NCT00267098|62824066|FG000|Overall Study|Site closure|0|||
33449103|NCT00267098|62824067|FG001|Overall Study|Site closure|0|||
33449104|NCT00267098|62824068|FG002|Overall Study|Site closure|0|||
33449105|NCT00267098|62824069|FG003|Overall Study|Site closure|1|||
33449106|NCT00267098|62824070|FG004|Overall Study|Site closure|0|||
33449107|NCT00267098|62824071|FG005|Overall Study|Site closure|1|||
33449108|NCT00267098|62824072|FG006|Overall Study|Site closure|1|||
33449109|NCT00267098|62824073|FG007|Overall Study|Site closure|0|||
33449110|NCT00267098|62824066|FG000|Overall Study|Explanted Medtronic device|0|||
33501563|NCT03286218|62882175|FG008|Qualification Phase Period 1|Adverse Event|0|||
33501564|NCT03286218|62882176|FG009|Qualification Phase Period 1|Adverse Event|0|||
33501565|NCT03286218|62882177|FG010|Qualification Phase Period 1|Adverse Event|0|||
33449111|NCT00267098|62824067|FG001|Overall Study|Explanted Medtronic device|0|||
33449112|NCT00267098|62824068|FG002|Overall Study|Explanted Medtronic device|0|||
33501566|NCT03286218|62882178|FG011|Qualification Phase Period 1|Adverse Event|0|||
33501567|NCT03286218|62882167|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
33501568|NCT03286218|62882168|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
33501569|NCT03286218|62882169|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
33501570|NCT03286218|62882170|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
33501571|NCT03286218|62882171|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
33501572|NCT03286218|62882172|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
33501573|NCT03286218|62882173|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
33501574|NCT03286218|62882174|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
33501575|NCT03286218|62882175|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
33501576|NCT03286218|62882176|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
33501577|NCT03286218|62882177|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
33501578|NCT03286218|62882178|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
33501579|NCT03286218|62882167|FG000|Qualification Phase Period 2|Adverse Event|0|||
33501580|NCT03286218|62882168|FG001|Qualification Phase Period 2|Adverse Event|1|||
33501581|NCT03286218|62882169|FG002|Qualification Phase Period 2|Adverse Event|0|||
33501582|NCT03286218|62882170|FG003|Qualification Phase Period 2|Adverse Event|0|||
33501583|NCT03286218|62882171|FG004|Qualification Phase Period 2|Adverse Event|0|||
33501584|NCT03286218|62882172|FG005|Qualification Phase Period 2|Adverse Event|0|||
33501585|NCT03286218|62882173|FG006|Qualification Phase Period 2|Adverse Event|0|||
33501586|NCT03286218|62882174|FG007|Qualification Phase Period 2|Adverse Event|0|||
33501587|NCT03286218|62882175|FG008|Qualification Phase Period 2|Adverse Event|0|||
33501588|NCT03286218|62882176|FG009|Qualification Phase Period 2|Adverse Event|0|||
33501589|NCT03286218|62882177|FG010|Qualification Phase Period 2|Adverse Event|0|||
33501590|NCT03286218|62882178|FG011|Qualification Phase Period 2|Adverse Event|0|||
33501591|NCT03286218|62882167|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
33501592|NCT03286218|62882168|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
33501593|NCT03286218|62882169|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33501594|NCT03286218|62882170|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33501595|NCT03286218|62882171|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33610070|NCT02267135|63010326|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
33610071|NCT02267135|63010327|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
33610072|NCT02267135|63010326|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
33610073|NCT02267135|63010327|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
33610074|NCT02267135|63010326|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
33610075|NCT02267135|63010327|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
33610076|NCT02267135|63010326|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
33610077|NCT02267135|63010327|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
33610078|NCT02267135|63010326|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
33610079|NCT02267135|63010327|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
33610080|NCT02299427|63010338|FG000|Overall Study|Withdrawal by Subject|1|||
33610081|NCT02299427|63010339|FG001|Overall Study|Withdrawal by Subject|0|||
33610082|NCT02299427|63010338|FG000|Overall Study|Lost to Follow-up|1|||
33610083|NCT02299427|63010339|FG001|Overall Study|Lost to Follow-up|3|||
33610084|NCT02299427|63010338|FG000|Overall Study|not adherent to dog website use|21|||
33610085|NCT02299427|63010339|FG001|Overall Study|not adherent to dog website use|0|||
33610086|NCT01724866|63010349|FG000|Overall Study|Adverse Event|0|||
33610087|NCT01724866|63010350|FG001|Overall Study|Adverse Event|0|||
33610088|NCT01724866|63010351|FG002|Overall Study|Adverse Event|1|||
33610089|NCT01724866|63010352|FG003|Overall Study|Adverse Event|1|||
33610090|NCT01724866|63010349|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
33610091|NCT01724866|63010350|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
33610092|NCT01724866|63010351|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
33610093|NCT01724866|63010352|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
33610094|NCT01724866|63010349|FG000|Overall Study|Investigator's Discretion|0|||
33610095|NCT01724866|63010350|FG001|Overall Study|Investigator's Discretion|1|||
33610096|NCT01724866|63010351|FG002|Overall Study|Investigator's Discretion|1|||
33610097|NCT01724866|63010352|FG003|Overall Study|Investigator's Discretion|0|||
33324154|NCT01137474|62700593|FG003|Overall Study|No longer met study criteria|5|||
33449113|NCT00267098|62824069|FG003|Overall Study|Explanted Medtronic device|1|||
33449114|NCT00267098|62824070|FG004|Overall Study|Explanted Medtronic device|0|||
33449115|NCT00267098|62824071|FG005|Overall Study|Explanted Medtronic device|0|||
33449116|NCT00267098|62824072|FG006|Overall Study|Explanted Medtronic device|0|||
33449117|NCT00267098|62824073|FG007|Overall Study|Explanted Medtronic device|0|||
33449118|NCT00267098|62824066|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
33449119|NCT00267098|62824067|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
33449120|NCT00267098|62824068|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
33449121|NCT00267098|62824069|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
33610098|NCT01724866|63010349|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
33610099|NCT01724866|63010350|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
33501596|NCT03286218|62882172|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33501597|NCT03286218|62882173|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33501598|NCT03286218|62882174|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33501599|NCT03286218|62882175|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33501600|NCT03286218|62882176|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33501601|NCT03286218|62882177|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33501602|NCT03286218|62882178|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33501603|NCT03286218|62882167|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
33501604|NCT03286218|62882168|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
33501605|NCT03286218|62882169|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
33501606|NCT03286218|62882170|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
33501607|NCT03286218|62882171|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
33501608|NCT03286218|62882172|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
33501609|NCT03286218|62882173|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
33501610|NCT03286218|62882174|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
33501611|NCT03286218|62882175|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
33501612|NCT03286218|62882176|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
33501613|NCT03286218|62882177|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
33501614|NCT03286218|62882178|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
33501615|NCT03286218|62882167|FG000|Qualification Phase Period 2|Protocol Violation|2|||
33501616|NCT03286218|62882168|FG001|Qualification Phase Period 2|Protocol Violation|0|||
33501617|NCT03286218|62882169|FG002|Qualification Phase Period 2|Protocol Violation|0|||
33501618|NCT03286218|62882170|FG003|Qualification Phase Period 2|Protocol Violation|0|||
33501619|NCT03286218|62882171|FG004|Qualification Phase Period 2|Protocol Violation|0|||
33501620|NCT03286218|62882172|FG005|Qualification Phase Period 2|Protocol Violation|0|||
33501621|NCT03286218|62882173|FG006|Qualification Phase Period 2|Protocol Violation|0|||
33501622|NCT03286218|62882174|FG007|Qualification Phase Period 2|Protocol Violation|0|||
33501623|NCT03286218|62882175|FG008|Qualification Phase Period 2|Protocol Violation|0|||
33501624|NCT03286218|62882176|FG009|Qualification Phase Period 2|Protocol Violation|0|||
33501625|NCT03286218|62882177|FG010|Qualification Phase Period 2|Protocol Violation|0|||
33501626|NCT03286218|62882178|FG011|Qualification Phase Period 2|Protocol Violation|0|||
33501627|NCT03286218|62882167|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
33501628|NCT03286218|62882168|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
33501629|NCT03286218|62882169|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
33501630|NCT03286218|62882170|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
33501631|NCT03286218|62882171|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
33501632|NCT03286218|62882172|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
33501633|NCT03286218|62882173|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
33501634|NCT03286218|62882174|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
33501635|NCT03286218|62882175|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
33501636|NCT03286218|62882176|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
33501637|NCT03286218|62882177|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
33501638|NCT03286218|62882178|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
33501639|NCT03286218|62882167|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
33501640|NCT03286218|62882168|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
33501641|NCT03286218|62882169|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
33501642|NCT03286218|62882170|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
33501643|NCT03286218|62882171|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
33501644|NCT03286218|62882172|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
33501645|NCT03286218|62882173|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
33501646|NCT03286218|62882174|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
33501647|NCT03286218|62882175|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
33501648|NCT03286218|62882176|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
33651423|NCT01746901|63062906|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33501649|NCT03286218|62882177|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
33501650|NCT03286218|62882178|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
33501651|NCT03286218|62882167|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
33501652|NCT03286218|62882168|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
33501653|NCT03286218|62882169|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
33501654|NCT03286218|62882170|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
33501655|NCT03286218|62882171|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
33501656|NCT03286218|62882172|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
33501657|NCT03286218|62882173|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
33501658|NCT03286218|62882174|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
33501659|NCT03286218|62882175|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
33501660|NCT03286218|62882176|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
33501661|NCT03286218|62882177|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
33501662|NCT03286218|62882178|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
33501663|NCT03224325|62882212|FG000|Overall Study|Adverse Event|1|||
33501664|NCT03224325|62882213|FG001|Overall Study|Adverse Event|0|||
33501665|NCT03224325|62882214|FG002|Overall Study|Adverse Event|0|||
33501666|NCT03224325|62882215|FG003|Overall Study|Adverse Event|0|||
33501667|NCT03224325|62882216|FG004|Overall Study|Adverse Event|0|||
33501668|NCT03224325|62882217|FG005|Overall Study|Adverse Event|0|||
33501669|NCT03224325|62882218|FG006|Overall Study|Adverse Event|1|||
33501670|NCT03224325|62882212|FG000|Overall Study|Withdrawal by Subject|0|||
33501671|NCT03224325|62882213|FG001|Overall Study|Withdrawal by Subject|0|||
33501672|NCT03224325|62882214|FG002|Overall Study|Withdrawal by Subject|0|||
33501673|NCT03224325|62882215|FG003|Overall Study|Withdrawal by Subject|1|||
33501674|NCT03224325|62882216|FG004|Overall Study|Withdrawal by Subject|0|||
33501675|NCT03224325|62882217|FG005|Overall Study|Withdrawal by Subject|0|||
33501676|NCT03224325|62882218|FG006|Overall Study|Withdrawal by Subject|0|||
33501677|NCT04016779|62882242|FG000|Overall Study|Adverse Event|9|||
33501678|NCT04016779|62882243|FG001|Overall Study|Adverse Event|17|||
33501679|NCT04016779|62882242|FG000|Overall Study|Lack of Efficacy|4|||
33501680|NCT04016779|62882243|FG001|Overall Study|Lack of Efficacy|1|||
33501681|NCT04016779|62882242|FG000|Overall Study|Lost to Follow-up|5|||
33501682|NCT04016779|62882243|FG001|Overall Study|Lost to Follow-up|14|||
33501683|NCT04016779|62882242|FG000|Overall Study|Physician Decision|1|||
33501684|NCT04016779|62882243|FG001|Overall Study|Physician Decision|3|||
33501685|NCT04016779|62882242|FG000|Overall Study|Withdrawal by Subject|6|||
33501686|NCT04016779|62882243|FG001|Overall Study|Withdrawal by Subject|8|||
33501687|NCT04016779|62882242|FG000|Overall Study|Non-compliance with Study Drug|2|||
33501688|NCT04016779|62882243|FG001|Overall Study|Non-compliance with Study Drug|3|||
33501689|NCT04016779|62882242|FG000|Overall Study|Other, Multiple categories|17|||
33501690|NCT04016779|62882243|FG001|Overall Study|Other, Multiple categories|17|||
33501691|NCT02857426|62882253|FG000|Overall Study|Disease progression|34|||
33501692|NCT02857426|62882254|FG001|Overall Study|Disease progression|13|||
33501693|NCT02857426|62882253|FG000|Overall Study|Study drug toxicity|4|||
33501694|NCT02857426|62882254|FG001|Overall Study|Study drug toxicity|1|||
33501695|NCT02857426|62882253|FG000|Overall Study|Death|1|||
33501696|NCT02857426|62882254|FG001|Overall Study|Death|0|||
33501697|NCT02857426|62882253|FG000|Overall Study|Adverse event unrelated to study drug|6|||
33501698|NCT02857426|62882254|FG001|Overall Study|Adverse event unrelated to study drug|2|||
33501699|NCT02857426|62882253|FG000|Overall Study|Participant withdrew consent|1|||
33501700|NCT02857426|62882254|FG001|Overall Study|Participant withdrew consent|1|||
33501701|NCT02857426|62882253|FG000|Overall Study|Maximum clinical benefit|1|||
33501702|NCT02857426|62882254|FG001|Overall Study|Maximum clinical benefit|0|||
33501703|NCT02857426|62882253|FG000|Overall Study|Completed treatment|0|||
33501704|NCT02857426|62882254|FG001|Overall Study|Completed treatment|2|||
33501705|NCT01127256|62882262|FG000|Overall Study|Adverse Event|13|||
33501706|NCT01127256|62882263|FG001|Overall Study|Adverse Event|13|||
33501707|NCT01127256|62882262|FG000|Overall Study|Lack of Efficacy|4|||
33501708|NCT01127256|62882263|FG001|Overall Study|Lack of Efficacy|0|||
33501709|NCT01127256|62882262|FG000|Overall Study|Lost to Follow-up|16|||
33501710|NCT01127256|62882263|FG001|Overall Study|Lost to Follow-up|17|||
33501711|NCT01127256|62882262|FG000|Overall Study|Withdrawal by Subject|5|||
33501712|NCT01127256|62882263|FG001|Overall Study|Withdrawal by Subject|9|||
33501713|NCT01127256|62882262|FG000|Overall Study|Protocol Violation|1|||
33501714|NCT01127256|62882263|FG001|Overall Study|Protocol Violation|0|||
33501715|NCT04016311|62882271|FG000|Overall Study|Withdrawal by Subject|1|||
33501716|NCT04016311|62882272|FG001|Overall Study|Withdrawal by Subject|0|||
33501717|NCT04052425|62882282|FG000|24-Week Double-blind Period|Adverse Event|0|||
33501718|NCT04052425|62882283|FG001|24-Week Double-blind Period|Adverse Event|1|||
33501719|NCT04052425|62882284|FG002|24-Week Double-blind Period|Adverse Event|0|||
33501720|NCT04052425|62882285|FG003|24-Week Double-blind Period|Adverse Event|0|||
33501721|NCT04052425|62882282|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
33501722|NCT04052425|62882283|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
33501723|NCT04052425|62882284|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
33501724|NCT04052425|62882285|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
33501725|NCT04052425|62882282|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
33501726|NCT04052425|62882283|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
33501727|NCT04052425|62882284|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
33501728|NCT04052425|62882285|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
33501729|NCT04052425|62882282|FG000|24-Week Double-blind Period|Physician Decision|1|||
33501730|NCT04052425|62882283|FG001|24-Week Double-blind Period|Physician Decision|0|||
33501731|NCT04052425|62882284|FG002|24-Week Double-blind Period|Physician Decision|0|||
33501732|NCT04052425|62882285|FG003|24-Week Double-blind Period|Physician Decision|0|||
33501733|NCT04052425|62882282|FG000|24-Week Double-blind Period|Protocol Violation|1|||
33501734|NCT04052425|62882283|FG001|24-Week Double-blind Period|Protocol Violation|0|||
33501735|NCT04052425|62882284|FG002|24-Week Double-blind Period|Protocol Violation|0|||
33501736|NCT04052425|62882285|FG003|24-Week Double-blind Period|Protocol Violation|0|||
33501737|NCT04052425|62882282|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
33501738|NCT04052425|62882283|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
33501739|NCT04052425|62882284|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
33501740|NCT04052425|62882285|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
33501741|NCT04052425|62882282|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
33501742|NCT04052425|62882283|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
33501743|NCT04052425|62882284|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
33501744|NCT04052425|62882285|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
33501745|NCT04052425|62882282|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
33501746|NCT04052425|62882283|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
33501747|NCT04052425|62882284|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
33501748|NCT04052425|62882285|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
33501749|NCT04052425|62882282|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
33501750|NCT04052425|62882283|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
33501751|NCT04052425|62882284|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
33501752|NCT04052425|62882285|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
33501753|NCT04052425|62882282|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
33501754|NCT04052425|62882283|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
33501755|NCT04052425|62882284|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
33501756|NCT04052425|62882285|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
33501757|NCT04052425|62882282|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
33610100|NCT01724866|63010351|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
33610101|NCT01724866|63010352|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
33501758|NCT04052425|62882283|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
33501759|NCT04052425|62882284|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
33501760|NCT04052425|62882285|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
33501761|NCT04052425|62882282|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
33501762|NCT04052425|62882283|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
33501763|NCT04052425|62882284|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
33501764|NCT04052425|62882285|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
33501765|NCT04052425|62882282|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
33501766|NCT04052425|62882283|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
33501767|NCT04052425|62882284|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
33501768|NCT04052425|62882285|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
33501769|NCT04052425|62882282|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
33501770|NCT04052425|62882283|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
33501771|NCT04052425|62882284|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
33501772|NCT04052425|62882285|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
33501773|NCT03235089|62882295|FG000|Overall Study|Lost to Follow-up|1|||
33610102|NCT01724866|63010349|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
33610103|NCT01724866|63010350|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
33610104|NCT01724866|63010351|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
33501774|NCT03235089|62882296|FG001|Overall Study|Lost to Follow-up|1|||
33501775|NCT03235089|62882295|FG000|Overall Study|Physician Decision|2|||
33501776|NCT03235089|62882296|FG001|Overall Study|Physician Decision|2|||
33501777|NCT04013191|62882305|FG000|Overall Study|Adverse Event|1|||
33501778|NCT04013191|62882306|FG001|Overall Study|Adverse Event|0|||
33501779|NCT03285594|62882319|FG000|Overall Study|At the Participant's Own Request|10|||
33501780|NCT03285594|62882320|FG001|Overall Study|At the Participant's Own Request|5|||
33501781|NCT03285594|62882321|FG002|Overall Study|At the Participant's Own Request|21|||
33501782|NCT03285594|62882319|FG000|Overall Study|Adverse Event|2|||
33501783|NCT03285594|62882320|FG001|Overall Study|Adverse Event|2|||
33501784|NCT03285594|62882321|FG002|Overall Study|Adverse Event|6|||
33501785|NCT03285594|62882319|FG000|Overall Study|Poor Compliance to Protocol|0|||
33501786|NCT03285594|62882320|FG001|Overall Study|Poor Compliance to Protocol|0|||
33501787|NCT03285594|62882321|FG002|Overall Study|Poor Compliance to Protocol|1|||
33501788|NCT03285594|62882319|FG000|Overall Study|Lost to Follow-up|0|||
33501789|NCT03285594|62882320|FG001|Overall Study|Lost to Follow-up|0|||
33501790|NCT03285594|62882321|FG002|Overall Study|Lost to Follow-up|1|||
33501791|NCT03285594|62882319|FG000|Overall Study|Reason Not Specified|3|||
33501792|NCT03285594|62882320|FG001|Overall Study|Reason Not Specified|4|||
33501793|NCT03285594|62882321|FG002|Overall Study|Reason Not Specified|8|||
33501794|NCT03234465|62882332|FG000|Overall Study|Adverse Event|4|||
33501795|NCT03234465|62882333|FG001|Overall Study|Adverse Event|2|||
33501796|NCT03234465|62882332|FG000|Overall Study|Death|0|||
33501797|NCT03234465|62882333|FG001|Overall Study|Death|1|||
33501798|NCT03234465|62882332|FG000|Overall Study|Lost to Follow-up|1|||
33501799|NCT03234465|62882333|FG001|Overall Study|Lost to Follow-up|1|||
33501800|NCT03234465|62882332|FG000|Overall Study|Withdrawal by Subject|12|||
33501801|NCT03234465|62882333|FG001|Overall Study|Withdrawal by Subject|27|||
33501802|NCT03234465|62882332|FG000|Overall Study|Symptomatic deterioration|0|||
33501803|NCT03234465|62882333|FG001|Overall Study|Symptomatic deterioration|1|||
33501804|NCT03234465|62882332|FG000|Overall Study|Non-compliance|2|||
33501805|NCT03234465|62882333|FG001|Overall Study|Non-compliance|0|||
33501806|NCT03234465|62882332|FG000|Overall Study|Other|14|||
33501807|NCT03234465|62882333|FG001|Overall Study|Other|8|||
33501808|NCT03290131|62882342|FG000|Overall Study|Adverse Event|22|||
33501809|NCT03290131|62882343|FG001|Overall Study|Adverse Event|57|||
33501810|NCT03290131|62882344|FG002|Overall Study|Adverse Event|11|||
33501811|NCT03290131|62882342|FG000|Overall Study|Withdrawal by Subject|18|||
33501812|NCT03290131|62882343|FG001|Overall Study|Withdrawal by Subject|13|||
33501813|NCT03290131|62882344|FG002|Overall Study|Withdrawal by Subject|8|||
33501814|NCT03290131|62882342|FG000|Overall Study|MS Relapse|2|||
33610105|NCT01724866|63010352|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
33610106|NCT02266433|63010364|FG000|Overall Study|Lost to Follow-up|54|||
33610107|NCT02266433|63010365|FG001|Overall Study|Lost to Follow-up|46|||
33610108|NCT02266433|63010364|FG000|Overall Study|Withdrawal by Subject|5|||
33610109|NCT02266433|63010365|FG001|Overall Study|Withdrawal by Subject|7|||
33610110|NCT01748890|63010372|FG000|Overall Study|Insufficient recruitment for analysis|4|||
33610111|NCT01747876|63010379|FG000|Overall Study|Adverse Event|1|||
33610112|NCT01747876|63010380|FG001|Overall Study|Adverse Event|0|||
33610113|NCT01747876|63010381|FG002|Overall Study|Adverse Event|2|||
33610114|NCT01747876|63010379|FG000|Overall Study|Withdrawal by Subject|0|||
33610115|NCT01747876|63010380|FG001|Overall Study|Withdrawal by Subject|1|||
33610116|NCT01747876|63010381|FG002|Overall Study|Withdrawal by Subject|1|||
33324155|NCT01137474|62700590|FG000|Overall Study|Lost to Follow-up|5|||
33501815|NCT03290131|62882343|FG001|Overall Study|MS Relapse|1|||
33501816|NCT03290131|62882344|FG002|Overall Study|MS Relapse|0|||
33501817|NCT03290131|62882342|FG000|Overall Study|Unknown reason|0|||
33501818|NCT03290131|62882343|FG001|Overall Study|Unknown reason|1|||
33501819|NCT03290131|62882344|FG002|Overall Study|Unknown reason|0|||
33501820|NCT04050865|62882355|FG000|Overall Study|Adverse Event|1|||
33501821|NCT04050865|62882356|FG001|Overall Study|Adverse Event|0|||
33501822|NCT04050865|62882355|FG000|Overall Study|no insert|1|||
33501823|NCT04050865|62882356|FG001|Overall Study|no insert|0|||
33610117|NCT01747876|63010379|FG000|Overall Study|Disease progression|4|||
33501824|NCT04050865|62882355|FG000|Overall Study|Only 1 insert|2|||
33501825|NCT04050865|62882356|FG001|Overall Study|Only 1 insert|3|||
33501826|NCT04050865|62882355|FG000|Overall Study|Physician Decision|0|||
33501827|NCT04050865|62882356|FG001|Overall Study|Physician Decision|1|||
33501828|NCT04050865|62882355|FG000|Overall Study|Withdrawal by Subject|0|||
33501829|NCT04050865|62882356|FG001|Overall Study|Withdrawal by Subject|1|||
33449122|NCT00267098|62824070|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
33449123|NCT00267098|62824071|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
33449124|NCT00267098|62824072|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
33449125|NCT00267098|62824073|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
33449126|NCT00267098|62824066|FG000|Overall Study|Subject listed for heart transplant|0|||
33449127|NCT00267098|62824067|FG001|Overall Study|Subject listed for heart transplant|0|||
33449128|NCT00267098|62824068|FG002|Overall Study|Subject listed for heart transplant|0|||
33449129|NCT00267098|62824069|FG003|Overall Study|Subject listed for heart transplant|0|||
33449130|NCT00267098|62824070|FG004|Overall Study|Subject listed for heart transplant|0|||
33449131|NCT00267098|62824071|FG005|Overall Study|Subject listed for heart transplant|0|||
33501830|NCT03283566|62882364|FG000|Overall Study|Lost to Follow-up|1|||
33501831|NCT03283566|62882365|FG001|Overall Study|Lost to Follow-up|2|||
33501832|NCT03210519|62882373|FG000|Overall Study|Adverse Event|2|||
33501833|NCT03210519|62882374|FG001|Overall Study|Adverse Event|0|||
33501834|NCT04048681|62882380|FG000|Overall Study|family emergency|0|||
33501835|NCT04048681|62882381|FG001|Overall Study|family emergency|0|||
33501836|NCT04048681|62882382|FG002|Overall Study|family emergency|0|||
33501837|NCT04048681|62882383|FG003|Overall Study|family emergency|1|||
33501838|NCT04048681|62882384|FG004|Overall Study|family emergency|0|||
33501839|NCT04007107|62882392|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
33501840|NCT04007107|62882393|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
33501841|NCT04007107|62882394|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
33324156|NCT01137474|62700591|FG001|Overall Study|Lost to Follow-up|1|||
33324157|NCT01137474|62700592|FG002|Overall Study|Lost to Follow-up|0|||
33324158|NCT01137474|62700593|FG003|Overall Study|Lost to Follow-up|2|||
33324159|NCT01137474|62700590|FG000|Overall Study|Lack of Efficacy|0|||
33324160|NCT01137474|62700591|FG001|Overall Study|Lack of Efficacy|0|||
33324161|NCT01137474|62700592|FG002|Overall Study|Lack of Efficacy|0|||
33324162|NCT01137474|62700593|FG003|Overall Study|Lack of Efficacy|2|||
33324163|NCT01137474|62700590|FG000|Overall Study|Other|3|||
33324164|NCT01137474|62700591|FG001|Overall Study|Other|1|||
33324165|NCT01137474|62700592|FG002|Overall Study|Other|0|||
33501842|NCT04007107|62882395|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
33501843|NCT04046341|62882400|FG000|Overall Study|Lost to Follow-up|2|||
33501844|NCT04046341|62882400|FG000|Overall Study|Withdrawal by Subject|1|||
33501845|NCT03233529|62882404|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
33501846|NCT03233529|62882404|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
33501847|NCT04006171|62882414|FG000|Overall Study|Withdrawal by Subject|8|||
33501848|NCT04006171|62882415|FG001|Overall Study|Withdrawal by Subject|7|||
33501849|NCT04006171|62882414|FG000|Overall Study|missing serum samples|2|||
33501850|NCT04006171|62882415|FG001|Overall Study|missing serum samples|2|||
33501851|NCT04006171|62882414|FG000|Overall Study|insufficient sample volume|2|||
33501852|NCT04006171|62882415|FG001|Overall Study|insufficient sample volume|3|||
33501853|NCT04043143|62882428|FG000|Overall Study|Lost to Follow-up|5|||
33501854|NCT04043143|62882429|FG001|Overall Study|Lost to Follow-up|5|||
33501855|NCT04043143|62882428|FG000|Overall Study|screen failure|1|||
33501856|NCT04043143|62882429|FG001|Overall Study|screen failure|0|||
33501857|NCT03283098|62882437|FG000|Overall Study|Withdrawal by Subject|0|||
33501858|NCT03283098|62882438|FG001|Overall Study|Withdrawal by Subject|1|||
33501859|NCT03655951|62882446|FG000|Overall Study|Lost to Follow-up|39|||
33501860|NCT03655951|62882447|FG001|Overall Study|Lost to Follow-up|20|||
33501861|NCT03655951|62882446|FG000|Overall Study|Withdrawal by Subject|0|||
33610118|NCT01747876|63010380|FG001|Overall Study|Disease progression|13|||
33324166|NCT01137474|62700593|FG003|Overall Study|Other|0|||
33324167|NCT01137474|62700590|FG000|Overall Study|Pregnancy|0|||
33449132|NCT00267098|62824072|FG006|Overall Study|Subject listed for heart transplant|1|||
33501862|NCT03655951|62882447|FG001|Overall Study|Withdrawal by Subject|1|||
33501863|NCT02527798|62882459|FG000|Overall Study|Physician Decision|1|||
33501864|NCT02527798|62882460|FG001|Overall Study|Physician Decision|0|||
33501865|NCT02527798|62882461|FG002|Overall Study|Physician Decision|1|||
33610119|NCT01747876|63010381|FG002|Overall Study|Disease progression|8|||
33501866|NCT02527798|62882462|FG003|Overall Study|Physician Decision|1|||
33501867|NCT02527798|62882463|FG004|Overall Study|Physician Decision|0|||
33501868|NCT02527798|62882464|FG005|Overall Study|Physician Decision|0|||
33501869|NCT02527798|62882459|FG000|Overall Study|Death|0|||
33501870|NCT02527798|62882460|FG001|Overall Study|Death|0|||
33501871|NCT02527798|62882461|FG002|Overall Study|Death|1|||
33501872|NCT02527798|62882462|FG003|Overall Study|Death|0|||
33501873|NCT02527798|62882463|FG004|Overall Study|Death|0|||
33501874|NCT02527798|62882464|FG005|Overall Study|Death|0|||
33501875|NCT02527798|62882459|FG000|Overall Study|Withdrawal by Subject|0|||
33501876|NCT02527798|62882460|FG001|Overall Study|Withdrawal by Subject|1|||
33501877|NCT02527798|62882461|FG002|Overall Study|Withdrawal by Subject|2|||
33501878|NCT02527798|62882462|FG003|Overall Study|Withdrawal by Subject|0|||
33501879|NCT02527798|62882463|FG004|Overall Study|Withdrawal by Subject|0|||
33501880|NCT02527798|62882464|FG005|Overall Study|Withdrawal by Subject|0|||
33501881|NCT02527798|62882459|FG000|Overall Study|Reason undisclosed|1|||
33501882|NCT02527798|62882460|FG001|Overall Study|Reason undisclosed|0|||
33501883|NCT02527798|62882461|FG002|Overall Study|Reason undisclosed|1|||
33501884|NCT02527798|62882462|FG003|Overall Study|Reason undisclosed|0|||
33501885|NCT02527798|62882463|FG004|Overall Study|Reason undisclosed|0|||
33501886|NCT02527798|62882464|FG005|Overall Study|Reason undisclosed|0|||
33501887|NCT02527798|62882459|FG000|Overall Study|Did not receive intervention|1|||
33501888|NCT02527798|62882460|FG001|Overall Study|Did not receive intervention|1|||
33501889|NCT02527798|62882461|FG002|Overall Study|Did not receive intervention|0|||
33501890|NCT02527798|62882462|FG003|Overall Study|Did not receive intervention|0|||
33501891|NCT02527798|62882463|FG004|Overall Study|Did not receive intervention|0|||
33501892|NCT02527798|62882464|FG005|Overall Study|Did not receive intervention|0|||
33501893|NCT03188991|62882495|FG000|Overall Study|Withdrawal by Subject|0|||
33449133|NCT00267098|62824073|FG007|Overall Study|Subject listed for heart transplant|0|||
33449134|NCT00267098|62824066|FG000|Overall Study|Sponsor withdrew subject|0|||
33449135|NCT00267098|62824067|FG001|Overall Study|Sponsor withdrew subject|0|||
33449136|NCT00267098|62824068|FG002|Overall Study|Sponsor withdrew subject|0|||
33449137|NCT00267098|62824069|FG003|Overall Study|Sponsor withdrew subject|1|||
33449138|NCT00267098|62824070|FG004|Overall Study|Sponsor withdrew subject|0|||
33449139|NCT00267098|62824071|FG005|Overall Study|Sponsor withdrew subject|0|||
33449140|NCT00267098|62824072|FG006|Overall Study|Sponsor withdrew subject|0|||
33449141|NCT00267098|62824073|FG007|Overall Study|Sponsor withdrew subject|0|||
33449142|NCT00247676|62824096|FG000|Overall Study|Death|5|||
33449143|NCT00247676|62824096|FG000|Overall Study|Adverse Event|11|||
33501894|NCT03188991|62882496|FG001|Overall Study|Withdrawal by Subject|0|||
33501895|NCT03188991|62882497|FG002|Overall Study|Withdrawal by Subject|0|||
33501896|NCT03188991|62882498|FG003|Overall Study|Withdrawal by Subject|1|||
33501897|NCT03857542|62882510|FG000|Overall Study|Adverse Event|1|||
33501898|NCT03857542|62882511|FG001|Overall Study|Adverse Event|3|||
33501899|NCT03857542|62882510|FG000|Overall Study|Withdrawal by Subject|2|||
33449144|NCT00247676|62824096|FG000|Overall Study|Lack of Efficacy|15|||
33449145|NCT00247676|62824096|FG000|Overall Study|Other|3|||
33449146|NCT00247676|62824096|FG000|Overall Study|Withdrawal by Subject|2|||
33501900|NCT03857542|62882511|FG001|Overall Study|Withdrawal by Subject|1|||
33501901|NCT03857542|62882510|FG000|Overall Study|Lost to Follow-up|2|||
33501902|NCT03857542|62882511|FG001|Overall Study|Lost to Follow-up|1|||
33501903|NCT03857542|62882510|FG000|Overall Study|Reason not Specified|1|||
33501904|NCT03857542|62882511|FG001|Overall Study|Reason not Specified|0|||
33501905|NCT03209973|62882518|FG000|Overall Study|Withdrawal by Subject|7|||
33501906|NCT03209973|62882518|FG000|Overall Study|Lost to Follow-up|2|||
33501907|NCT03209973|62882518|FG000|Overall Study|Death|8|||
33501908|NCT03209973|62882518|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
33501909|NCT03209973|62882518|FG000|Overall Study|Sponsor Decision|18|||
33501910|NCT03209973|62882518|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
33501911|NCT03209973|62882518|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
33501912|NCT03751631|62882524|FG000|Overall Study|Withdrawal by Subject|0|||
33501913|NCT03751631|62882525|FG001|Overall Study|Withdrawal by Subject|0|||
33501914|NCT03751631|62882526|FG002|Overall Study|Withdrawal by Subject|1|||
33501915|NCT03751631|62882527|FG003|Overall Study|Withdrawal by Subject|1|||
33501916|NCT03751631|62882528|FG004|Overall Study|Withdrawal by Subject|0|||
33501917|NCT03751631|62882529|FG005|Overall Study|Withdrawal by Subject|0|||
33501918|NCT03688711|62882542|FG000|Overall Study|Withdrawal by Subject|0|||
33501919|NCT03688711|62882543|FG001|Overall Study|Withdrawal by Subject|1|||
33501920|NCT03188055|62882551|FG000|Overall Study|Unavailable for training|0|||
33501921|NCT03188055|62882552|FG001|Overall Study|Unavailable for training|0|||
33501922|NCT03188055|62882553|FG002|Overall Study|Unavailable for training|19|||
33501923|NCT03188055|62882554|FG003|Overall Study|Unavailable for training|0|||
33501924|NCT03188055|62882555|FG004|Overall Study|Unavailable for training|0|||
33501925|NCT03188055|62882556|FG005|Overall Study|Unavailable for training||||
33501926|NCT03188055|62882551|FG000|Overall Study|Lost to Follow-up|0|||
33501927|NCT03188055|62882552|FG001|Overall Study|Lost to Follow-up|18|||
33501928|NCT03188055|62882553|FG002|Overall Study|Lost to Follow-up|0|||
33501929|NCT03188055|62882554|FG003|Overall Study|Lost to Follow-up|11|||
33501930|NCT03188055|62882555|FG004|Overall Study|Lost to Follow-up|0|||
33501931|NCT03188055|62882556|FG005|Overall Study|Lost to Follow-up||||
33501932|NCT03188055|62882551|FG000|Overall Study|Withdrawal by Subject|0|||
33501933|NCT03188055|62882552|FG001|Overall Study|Withdrawal by Subject|1|||
33501934|NCT03188055|62882553|FG002|Overall Study|Withdrawal by Subject|0|||
33501935|NCT03188055|62882554|FG003|Overall Study|Withdrawal by Subject|1|||
33501936|NCT03188055|62882555|FG004|Overall Study|Withdrawal by Subject|0|||
33501937|NCT03188055|62882556|FG005|Overall Study|Withdrawal by Subject||||
33501938|NCT04035577|62882567|FG000|Overall Study|Lost to Follow-up|1|||
33501939|NCT04035577|62882567|FG000|Overall Study|Withdrawal by Subject|1|||
33501940|NCT03655717|62882595|FG000|Overall Study|Withdrawal by Subject|4|||
33501941|NCT03655717|62882596|FG001|Overall Study|Withdrawal by Subject|8|||
33501942|NCT03655717|62882597|FG002|Overall Study|Withdrawal by Subject|1|||
33501943|NCT03655717|62882598|FG003|Overall Study|Withdrawal by Subject|0|||
33501944|NCT03655717|62882599|FG004|Overall Study|Withdrawal by Subject|0|||
33501945|NCT03655717|62882600|FG005|Overall Study|Withdrawal by Subject|1|||
33501946|NCT03655717|62882601|FG006|Overall Study|Withdrawal by Subject|3|||
33501947|NCT03655717|62882602|FG007|Overall Study|Withdrawal by Subject|1|||
33501948|NCT03655717|62882603|FG008|Overall Study|Withdrawal by Subject|2|||
33501949|NCT03655717|62882604|FG009|Overall Study|Withdrawal by Subject|0|||
33501950|NCT03655717|62882605|FG010|Overall Study|Withdrawal by Subject|0|||
33501951|NCT03655717|62882606|FG011|Overall Study|Withdrawal by Subject|1|||
33501952|NCT03655717|62882607|FG012|Overall Study|Withdrawal by Subject|0|||
33501953|NCT03655717|62882608|FG013|Overall Study|Withdrawal by Subject|3|||
33501954|NCT03655717|62882609|FG014|Overall Study|Withdrawal by Subject|0|||
33501955|NCT03655717|62882610|FG015|Overall Study|Withdrawal by Subject|1|||
33501956|NCT03655717|62882611|FG016|Overall Study|Withdrawal by Subject|0|||
33501957|NCT03655717|62882612|FG017|Overall Study|Withdrawal by Subject|0|||
33501958|NCT03655717|62882613|FG018|Overall Study|Withdrawal by Subject|1|||
33501959|NCT03655717|62882614|FG019|Overall Study|Withdrawal by Subject|0|||
33501960|NCT03655717|62882615|FG020|Overall Study|Withdrawal by Subject|0|||
33501961|NCT03655717|62882616|FG021|Overall Study|Withdrawal by Subject|1|||
33501962|NCT03655717|62882617|FG022|Overall Study|Withdrawal by Subject|2|||
33501963|NCT03655717|62882618|FG023|Overall Study|Withdrawal by Subject|1|||
33501964|NCT03655717|62882619|FG024|Overall Study|Withdrawal by Subject|1|||
33501965|NCT03655717|62882620|FG025|Overall Study|Withdrawal by Subject|0|||
33501966|NCT03655717|62882595|FG000|Overall Study|Physician Decision|3|||
33501967|NCT03655717|62882596|FG001|Overall Study|Physician Decision|3|||
33501968|NCT03655717|62882597|FG002|Overall Study|Physician Decision|0|||
33501969|NCT03655717|62882598|FG003|Overall Study|Physician Decision|0|||
33501970|NCT03655717|62882599|FG004|Overall Study|Physician Decision|0|||
33610120|NCT01747876|63010379|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
33610121|NCT01747876|63010380|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
33610122|NCT01747876|63010381|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
33610123|NCT02273726|63010394|FG000|Overall Study|Death|70|||
33610124|NCT02273726|63010395|FG001|Overall Study|Death|62|||
33610125|NCT02273726|63010394|FG000|Overall Study|Withdrawal by Subject|41|||
33610126|NCT02273726|63010395|FG001|Overall Study|Withdrawal by Subject|29|||
33610127|NCT02273726|63010394|FG000|Overall Study|Kidney transplant|31|||
33610128|NCT02273726|63010395|FG001|Overall Study|Kidney transplant|39|||
33610129|NCT02273726|63010394|FG000|Overall Study|Physician Decision|30|||
33610130|NCT02273726|63010395|FG001|Overall Study|Physician Decision|15|||
33610131|NCT02273726|63010394|FG000|Overall Study|Adverse Event|27|||
33610132|NCT02273726|63010395|FG001|Overall Study|Adverse Event|9|||
33610133|NCT02273726|63010394|FG000|Overall Study|Lost to Follow-up|6|||
33610134|NCT02273726|63010395|FG001|Overall Study|Lost to Follow-up|3|||
33610135|NCT02273726|63010394|FG000|Overall Study|Lack of Efficacy|6|||
33610136|NCT02273726|63010395|FG001|Overall Study|Lack of Efficacy|1|||
33610137|NCT02273726|63010394|FG000|Overall Study|Protocol Violation|4|||
33610138|NCT02273726|63010395|FG001|Overall Study|Protocol Violation|0|||
33610139|NCT02273726|63010394|FG000|Overall Study|Other than specified|28|||
33610140|NCT02273726|63010395|FG001|Overall Study|Other than specified|30|||
33610141|NCT01723228|63010403|FG000|Overall Study|Adverse Event|2|||
33610142|NCT01723228|63010404|FG001|Overall Study|Adverse Event|6|||
33610143|NCT01723228|63010403|FG000|Overall Study|Withdrawal by Subject|2|||
33610144|NCT01723228|63010404|FG001|Overall Study|Withdrawal by Subject|1|||
33610145|NCT01723228|63010403|FG000|Overall Study|Protocol Violation|0|||
33610146|NCT01723228|63010404|FG001|Overall Study|Protocol Violation|2|||
33610147|NCT01723228|63010403|FG000|Overall Study|Lost to Follow-up|2|||
33610148|NCT01723228|63010404|FG001|Overall Study|Lost to Follow-up|1|||
33610149|NCT01723228|63010403|FG000|Overall Study|Other|2|||
33610150|NCT01723228|63010404|FG001|Overall Study|Other|1|||
33610151|NCT02273180|63010412|FG000|Overall Study|Adverse Event|2|||
33610152|NCT02273180|63010413|FG001|Overall Study|Adverse Event|2|||
33610153|NCT02273180|63010412|FG000|Overall Study|Lack of Efficacy|1|||
33610154|NCT02273180|63010413|FG001|Overall Study|Lack of Efficacy|0|||
33610155|NCT02273180|63010412|FG000|Overall Study|Protocol Violation|1|||
33610156|NCT02273180|63010413|FG001|Overall Study|Protocol Violation|7|||
33610157|NCT02273180|63010412|FG000|Overall Study|Randomized but not treated|1|||
33610158|NCT02273180|63010413|FG001|Overall Study|Randomized but not treated|0|||
33610159|NCT02273180|63010412|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
33610160|NCT02273180|63010413|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
33610161|NCT02273180|63010412|FG000|Overall Study|Other than specified above|21|||
33610162|NCT02273180|63010413|FG001|Overall Study|Other than specified above|10|||
33610163|NCT01746862|63010421|FG000|Overall Study|Withdrawal by Subject|1|||
33501971|NCT03655717|62882600|FG005|Overall Study|Physician Decision|0|||
33610164|NCT01746862|63010422|FG001|Overall Study|Withdrawal by Subject|1|||
33501972|NCT03655717|62882601|FG006|Overall Study|Physician Decision|0|||
33501973|NCT03655717|62882602|FG007|Overall Study|Physician Decision|0|||
33501974|NCT03655717|62882603|FG008|Overall Study|Physician Decision|0|||
33501975|NCT03655717|62882604|FG009|Overall Study|Physician Decision|1|||
33501976|NCT03655717|62882605|FG010|Overall Study|Physician Decision|0|||
33501977|NCT03655717|62882606|FG011|Overall Study|Physician Decision|0|||
33501978|NCT03655717|62882607|FG012|Overall Study|Physician Decision|0|||
33501979|NCT03655717|62882608|FG013|Overall Study|Physician Decision|0|||
33501980|NCT03655717|62882609|FG014|Overall Study|Physician Decision|0|||
33501981|NCT03655717|62882610|FG015|Overall Study|Physician Decision|0|||
33501982|NCT03655717|62882611|FG016|Overall Study|Physician Decision|0|||
33501983|NCT03655717|62882612|FG017|Overall Study|Physician Decision|0|||
33610165|NCT01746862|63010421|FG000|Overall Study|Protocol Violation|1|||
33610166|NCT01746862|63010422|FG001|Overall Study|Protocol Violation|0|||
33610167|NCT01746862|63010421|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
33610168|NCT01746862|63010422|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
33610169|NCT01746862|63010421|FG000|Overall Study|Entered puberty during the study|1|||
33501984|NCT03655717|62882613|FG018|Overall Study|Physician Decision|0|||
33610170|NCT01746862|63010422|FG001|Overall Study|Entered puberty during the study|0|||
33610171|NCT01745848|63010429|FG000|Overall Study|Adverse Event|6|||
33610172|NCT01745380|63010435|FG000|Overall Study|Lost to Follow-up|1|||
33610173|NCT01745380|63010436|FG001|Overall Study|Lost to Follow-up|0|||
33501985|NCT03655717|62882614|FG019|Overall Study|Physician Decision|1|||
33501986|NCT03655717|62882615|FG020|Overall Study|Physician Decision|0|||
33501987|NCT03655717|62882616|FG021|Overall Study|Physician Decision|0|||
33501988|NCT03655717|62882617|FG022|Overall Study|Physician Decision|0|||
33501989|NCT03655717|62882618|FG023|Overall Study|Physician Decision|1|||
33501990|NCT03655717|62882619|FG024|Overall Study|Physician Decision|0|||
33501991|NCT03655717|62882620|FG025|Overall Study|Physician Decision|0|||
33501992|NCT03655717|62882595|FG000|Overall Study|Lost to Follow-up|3|||
33501993|NCT03655717|62882596|FG001|Overall Study|Lost to Follow-up|1|||
33501994|NCT03655717|62882597|FG002|Overall Study|Lost to Follow-up|0|||
33501995|NCT03655717|62882598|FG003|Overall Study|Lost to Follow-up|1|||
33501996|NCT03655717|62882599|FG004|Overall Study|Lost to Follow-up|0|||
33501997|NCT03655717|62882600|FG005|Overall Study|Lost to Follow-up|1|||
33501998|NCT03655717|62882601|FG006|Overall Study|Lost to Follow-up|0|||
33501999|NCT03655717|62882602|FG007|Overall Study|Lost to Follow-up|0|||
33502000|NCT03655717|62882603|FG008|Overall Study|Lost to Follow-up|0|||
33502001|NCT03655717|62882604|FG009|Overall Study|Lost to Follow-up|0|||
33502002|NCT03655717|62882605|FG010|Overall Study|Lost to Follow-up|0|||
33502003|NCT03655717|62882606|FG011|Overall Study|Lost to Follow-up|1|||
33502004|NCT03655717|62882607|FG012|Overall Study|Lost to Follow-up|0|||
33502005|NCT03655717|62882608|FG013|Overall Study|Lost to Follow-up|0|||
33502006|NCT03655717|62882609|FG014|Overall Study|Lost to Follow-up|0|||
33502007|NCT03655717|62882610|FG015|Overall Study|Lost to Follow-up|0|||
33502008|NCT03655717|62882611|FG016|Overall Study|Lost to Follow-up|0|||
33502009|NCT03655717|62882612|FG017|Overall Study|Lost to Follow-up|0|||
33502010|NCT03655717|62882613|FG018|Overall Study|Lost to Follow-up|0|||
33502011|NCT03655717|62882614|FG019|Overall Study|Lost to Follow-up|0|||
33502012|NCT03655717|62882615|FG020|Overall Study|Lost to Follow-up|0|||
33502013|NCT03655717|62882616|FG021|Overall Study|Lost to Follow-up|0|||
33502014|NCT03655717|62882617|FG022|Overall Study|Lost to Follow-up|0|||
33502015|NCT03655717|62882618|FG023|Overall Study|Lost to Follow-up|0|||
33502016|NCT03655717|62882619|FG024|Overall Study|Lost to Follow-up|0|||
33502017|NCT03655717|62882620|FG025|Overall Study|Lost to Follow-up|0|||
33502018|NCT04032613|62882636|FG000|Overall Study|Did not complete post-program assessment|5|||
33502019|NCT04032613|62882637|FG001|Overall Study|Did not complete post-program assessment|2|||
33502020|NCT04000165|62882643|FG000|Overall Study|Physician Decision|1|||
33502021|NCT04000165|62882643|FG000|Overall Study|Withdrawal by Subject|1|||
33502022|NCT03187197|62882650|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
33502023|NCT03187197|62882651|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
33502024|NCT03187197|62882652|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
33502025|NCT03187197|62882650|FG000|Overall Study|Withdrawal by Subject|8|||
33502026|NCT03187197|62882651|FG001|Overall Study|Withdrawal by Subject|63|||
33502027|NCT03187197|62882652|FG002|Overall Study|Withdrawal by Subject|4|||
33502028|NCT03187197|62882650|FG000|Overall Study|Lost to Follow-up|1|||
33502029|NCT03187197|62882651|FG001|Overall Study|Lost to Follow-up|60|||
33502030|NCT03187197|62882652|FG002|Overall Study|Lost to Follow-up|7|||
33502031|NCT03187197|62882650|FG000|Overall Study|Adverse Event|6|||
33502032|NCT03187197|62882651|FG001|Overall Study|Adverse Event|29|||
33449147|NCT00267020|62824102|FG000|Overall Study|Adverse Event|22|||
33449148|NCT00267020|62824103|FG001|Overall Study|Adverse Event|5|||
33449149|NCT00267020|62824102|FG000|Overall Study|Death|2|||
33449150|NCT00267020|62824103|FG001|Overall Study|Death|1|||
33449151|NCT00267020|62824102|FG000|Overall Study|Withdrawal by Subject|17|||
33449152|NCT00267020|62824103|FG001|Overall Study|Withdrawal by Subject|7|||
33449153|NCT00267020|62824102|FG000|Overall Study|Physician Decision|3|||
33449154|NCT00267020|62824103|FG001|Overall Study|Physician Decision|2|||
33449155|NCT00267020|62824102|FG000|Overall Study|Disease Progression|39|||
33449156|NCT00267020|62824103|FG001|Overall Study|Disease Progression|25|||
33449157|NCT00267020|62824102|FG000|Overall Study|Unrelated Complication|1|||
33449158|NCT00267020|62824103|FG001|Overall Study|Unrelated Complication|1|||
33449159|NCT00267020|62824102|FG000|Overall Study|Sponsor Request|1|||
33449160|NCT00267020|62824103|FG001|Overall Study|Sponsor Request|0|||
33449161|NCT00267020|62824102|FG000|Overall Study|Other|1|||
33449162|NCT00267020|62824103|FG001|Overall Study|Other|2|||
33449163|NCT00242216|62824111|FG000|Overall Study|Lost to Follow-up|12|||
33502033|NCT03187197|62882652|FG002|Overall Study|Adverse Event|0|||
33502034|NCT03187197|62882650|FG000|Overall Study|Death|0|||
33502035|NCT03187197|62882651|FG001|Overall Study|Death|11|||
33502036|NCT03187197|62882652|FG002|Overall Study|Death|0|||
33502037|NCT03187197|62882650|FG000|Overall Study|Administrative problem|1|||
33502038|NCT03187197|62882651|FG001|Overall Study|Administrative problem|1|||
33502039|NCT03187197|62882652|FG002|Overall Study|Administrative problem|0|||
33502040|NCT03187197|62882650|FG000|Overall Study|Reason not listed|2|||
33502041|NCT03187197|62882651|FG001|Overall Study|Reason not listed|54|||
33449164|NCT00242216|62824112|FG001|Overall Study|Lost to Follow-up|17|||
33449165|NCT00242216|62824111|FG000|Overall Study|Death|4|||
33449166|NCT00242216|62824112|FG001|Overall Study|Death|2|||
33449167|NCT00242216|62824111|FG000|Overall Study|Lack of Efficacy|1|||
33449168|NCT00242216|62824112|FG001|Overall Study|Lack of Efficacy|2|||
33502042|NCT03187197|62882652|FG002|Overall Study|Reason not listed|1|||
33502043|NCT03187197|62882650|FG000|Overall Study|Missing|1|||
33502044|NCT03187197|62882651|FG001|Overall Study|Missing|32|||
33502045|NCT03187197|62882652|FG002|Overall Study|Missing|3|||
33502046|NCT03187197|62882650|FG000|Overall Study|Status missing|2|||
33502047|NCT03187197|62882651|FG001|Overall Study|Status missing|33|||
33502048|NCT03187197|62882652|FG002|Overall Study|Status missing|3|||
33502049|NCT03187197|62882650|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
33502050|NCT03187197|62882651|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
33502051|NCT03187197|62882652|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
33502052|NCT04000009|62882660|FG000|Overall Study|Adverse Event|13|||
33502053|NCT04000009|62882660|FG000|Overall Study|Lack of Efficacy|7|||
33502054|NCT04000009|62882660|FG000|Overall Study|Lost to Follow-up|8|||
33502055|NCT04000009|62882660|FG000|Overall Study|Noncompliance with study drug|4|||
33502056|NCT04000009|62882660|FG000|Overall Study|Physician Decision|1|||
33502057|NCT04000009|62882660|FG000|Overall Study|Use of prohibited medication|3|||
33502058|NCT04000009|62882660|FG000|Overall Study|Pregnancy|1|||
33502059|NCT04000009|62882660|FG000|Overall Study|Withdrawal by Subject|22|||
33502060|NCT04000009|62882660|FG000|Overall Study|Study terminated by sponsor|98|||
33502061|NCT04000009|62882660|FG000|Overall Study|Not further specified|8|||
33502062|NCT03282240|62882667|FG000|Overall Study|Adverse Event|2|||
33502063|NCT03282240|62882668|FG001|Overall Study|Adverse Event|2|||
33502064|NCT03282240|62882669|FG002|Overall Study|Adverse Event|0|||
33502065|NCT03282240|62882667|FG000|Overall Study|Lost to Follow-up|3|||
33502066|NCT03282240|62882668|FG001|Overall Study|Lost to Follow-up|0|||
33502067|NCT03282240|62882669|FG002|Overall Study|Lost to Follow-up|0|||
33502068|NCT03282240|62882667|FG000|Overall Study|Protocol Deviation|4|||
33502069|NCT03282240|62882668|FG001|Overall Study|Protocol Deviation|1|||
33502070|NCT03282240|62882669|FG002|Overall Study|Protocol Deviation|2|||
33502071|NCT03282240|62882667|FG000|Overall Study|Withdrawal by Subject|1|||
33502072|NCT03282240|62882668|FG001|Overall Study|Withdrawal by Subject|0|||
33502073|NCT03282240|62882669|FG002|Overall Study|Withdrawal by Subject|1|||
33502074|NCT03185949|62882682|FG000|ITT Analysis|Withdrawal by Subject|4|||
33502075|NCT03185949|62882683|FG001|ITT Analysis|Withdrawal by Subject|3|||
33502076|NCT03185949|62882682|FG000|PP Analysis|Protocol Violation|2|||
33502077|NCT03185949|62882683|FG001|PP Analysis|Protocol Violation|2|||
33502078|NCT03185949|62882682|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
33502079|NCT03185949|62882683|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
33502080|NCT03655405|62882693|FG000|Overall Study|Death after initial data collection|4|||
33502081|NCT03655405|62882694|FG001|Overall Study|Death after initial data collection|2|||
33502082|NCT03655405|62882693|FG000|Overall Study|Died before initial data collection|1|||
33502083|NCT03655405|62882694|FG001|Overall Study|Died before initial data collection|2|||
33502084|NCT03655405|62882693|FG000|Overall Study|Protocol Violation|0|||
33610174|NCT01745380|63010435|FG000|Overall Study|Lack of Efficacy|0|||
33610175|NCT01745380|63010436|FG001|Overall Study|Lack of Efficacy|1|||
33610176|NCT01745146|63010444|FG000|Overall Study|Withdrawal by Subject|1|||
33610177|NCT01745146|63010445|FG001|Overall Study|Withdrawal by Subject|3|||
33610178|NCT01745146|63010444|FG000|Overall Study|Lost to Follow-up|2|||
33610179|NCT01745146|63010445|FG001|Overall Study|Lost to Follow-up|0|||
33610180|NCT02203513|63010457|FG000|Overall Study|Refused further treatment|2|||
33610181|NCT02203513|63010458|FG001|Overall Study|Refused further treatment|0|||
33610182|NCT02203513|63010459|FG002|Overall Study|Refused further treatment|1|||
33610183|NCT02203513|63010460|FG003|Overall Study|Refused further treatment|0|||
33610184|NCT02203513|63010461|FG004|Overall Study|Refused further treatment|0|||
33610185|NCT02203513|63010457|FG000|Overall Study|Switched to alternative treatment|3|||
33610186|NCT02203513|63010458|FG001|Overall Study|Switched to alternative treatment|4|||
33610187|NCT02203513|63010459|FG002|Overall Study|Switched to alternative treatment|0|||
33610188|NCT02203513|63010460|FG003|Overall Study|Switched to alternative treatment|0|||
33502085|NCT03655405|62882694|FG001|Overall Study|Protocol Violation|1|||
33502086|NCT03510598|62882700|FG000|Overall Study|Withdrawal by Subject|1|||
33610189|NCT02203513|63010461|FG004|Overall Study|Switched to alternative treatment|4|||
33610190|NCT02203513|63010457|FG000|Overall Study|Did not receive investigational product (IP)|0|||
33610191|NCT02203513|63010458|FG001|Overall Study|Did not receive investigational product (IP)|1|||
33610192|NCT02203513|63010459|FG002|Overall Study|Did not receive investigational product (IP)|0|||
33502087|NCT03222141|62882704|FG000|Overall Study|Death|15|||
33502088|NCT03222141|62882704|FG000|Overall Study|Lost to Follow-up|3|||
33502089|NCT04029961|62882711|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
33502090|NCT04029961|62882712|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
33502091|NCT04029961|62882711|FG000|Overall Study|Change in Treatment Course|0|||
33502092|NCT04029961|62882712|FG001|Overall Study|Change in Treatment Course|1|||
33610193|NCT02203513|63010460|FG003|Overall Study|Did not receive investigational product (IP)|0|||
33610194|NCT02203513|63010461|FG004|Overall Study|Did not receive investigational product (IP)|0|||
33610195|NCT02203513|63010457|FG000|Overall Study|Death (unrelated to study therapy)|1|||
33610196|NCT02203513|63010458|FG001|Overall Study|Death (unrelated to study therapy)|3|||
33610197|NCT02203513|63010459|FG002|Overall Study|Death (unrelated to study therapy)|1|||
33502093|NCT03997825|62882718|FG000|Overall Study|Death|3|||
33502094|NCT03997825|62882718|FG000|Overall Study|Lost to Follow-up|10|||
33502095|NCT03997825|62882718|FG000|Overall Study|Withdrawal by Subject|3|||
33502096|NCT03997825|62882718|FG000|Overall Study|Refused participation|1|||
33502097|NCT04024891|62882724|FG000|Overall Study|Pregnancy|0|||
33502098|NCT04024891|62882725|FG001|Overall Study|Pregnancy|1|||
33502099|NCT03250182|62882731|FG000|Overall Study|Withdrawal by Subject|1|||
33502100|NCT03993379|62882739|FG000|Overall Study|The study was terminated early due to business decision.|0|||
33502101|NCT03993379|62882740|FG001|Overall Study|The study was terminated early due to business decision.|2|||
33502102|NCT03993379|62882741|FG002|Overall Study|The study was terminated early due to business decision.|0|||
33502103|NCT03993379|62882742|FG003|Overall Study|The study was terminated early due to business decision.|0|||
33502104|NCT03993379|62882739|FG000|Overall Study|Withdrawal by Subject|0|||
33502105|NCT03993379|62882740|FG001|Overall Study|Withdrawal by Subject|1|||
33502106|NCT03993379|62882741|FG002|Overall Study|Withdrawal by Subject|0|||
33502107|NCT03993379|62882742|FG003|Overall Study|Withdrawal by Subject|0|||
33502108|NCT03370120|62882752|FG000|Overall Study|Adverse event, non-fatal|24|||
33502109|NCT03370120|62882752|FG000|Overall Study|Withdrawal by Subject|6|||
33502110|NCT03370120|62882752|FG000|Overall Study|Lost to Follow-up|1|||
33502111|NCT03370120|62882752|FG000|Overall Study|Lack of Efficacy|37|||
33502112|NCT03370120|62882752|FG000|Overall Study|Per sponsor's instructions|1|||
33502113|NCT03370120|62882752|FG000|Overall Study|Study was terminated by parent company UCB|2|||
33502114|NCT03370120|62882752|FG000|Overall Study|The study was ended by the promoter|3|||
33502115|NCT03370120|62882752|FG000|Overall Study|Discontinuation of drug development|3|||
33502116|NCT03370120|62882752|FG000|Overall Study|End of project|2|||
33502117|NCT03370120|62882752|FG000|Overall Study|Premature study closure|2|||
33502118|NCT03370120|62882752|FG000|Overall Study|Premature program termination|1|||
33502119|NCT03370120|62882752|FG000|Overall Study|Premature study termination|7|||
33502120|NCT03370120|62882752|FG000|Overall Study|Trial terminated by sponsor|2|||
33502121|NCT03370120|62882752|FG000|Overall Study|Trial discontinued by sponsor|2|||
33502122|NCT03370120|62882752|FG000|Overall Study|Study ended|15|||
33502123|NCT03370120|62882752|FG000|Overall Study|Clinical trial has been cancelled|1|||
33502124|NCT03370120|62882752|FG000|Overall Study|End of study per sponsor decision|2|||
33502125|NCT03370120|62882752|FG000|Overall Study|Promoter's decision|2|||
33502126|NCT03370120|62882752|FG000|Overall Study|The trial has been suspended|3|||
33502127|NCT03370120|62882752|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
33502128|NCT03370120|62882752|FG000|Overall Study|Early termination by order of sponsor|2|||
33502129|NCT03370120|62882752|FG000|Overall Study|Discontinuation of the study|5|||
33502130|NCT03370120|62882752|FG000|Overall Study|End of clinical trial discontinuation|1|||
33502131|NCT03370120|62882752|FG000|Overall Study|Because the clinical trial ended halfway|4|||
33502132|NCT03370120|62882752|FG000|Overall Study|Development discontinued|5|||
33502133|NCT03370120|62882752|FG000|Overall Study|Padsenovil program closed|3|||
33502134|NCT03370120|62882752|FG000|Overall Study|End of project|2|||
33610198|NCT02203513|63010460|FG003|Overall Study|Death (unrelated to study therapy)|0|||
33502135|NCT03370120|62882752|FG000|Overall Study|Termination of project|1|||
33502136|NCT03370120|62882752|FG000|Overall Study|The study was interrupted by sponsor|4|||
33610199|NCT02203513|63010461|FG004|Overall Study|Death (unrelated to study therapy)|2|||
33610200|NCT02203513|63010457|FG000|Overall Study|Lost to Follow-up|0|||
33324168|NCT01137474|62700591|FG001|Overall Study|Pregnancy|1|||
33324169|NCT01137474|62700592|FG002|Overall Study|Pregnancy|0|||
33449169|NCT00242216|62824111|FG000|Overall Study|no medicaiton dispensed|1|||
33502137|NCT03370120|62882752|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
33502138|NCT03370120|62882752|FG000|Overall Study|End of sponsor decision|1|||
33502139|NCT03370120|62882752|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
33502140|NCT03370120|62882752|FG000|Overall Study|Early termination of studies|5|||
33502141|NCT03370120|62882752|FG000|Overall Study|This study is ended early|1|||
33502142|NCT03370120|62882752|FG000|Overall Study|End of padsevonil program|2|||
33610201|NCT02203513|63010458|FG001|Overall Study|Lost to Follow-up|0|||
33449170|NCT00242216|62824112|FG001|Overall Study|no medicaiton dispensed|1|||
33449171|NCT00240110|62824120|FG000|Overall Study|Lost to Follow-up|6|||
33449172|NCT00240110|62824121|FG001|Overall Study|Lost to Follow-up|7|||
33449173|NCT00239720|62824131|FG000|Overall Study|Adverse Event|1|||
33449174|NCT00239720|62824132|FG001|Overall Study|Adverse Event|0|||
33449175|NCT00239720|62824131|FG000|Overall Study|Lost to Follow-up|0|||
33449176|NCT00239720|62824132|FG001|Overall Study|Lost to Follow-up|1|||
33449177|NCT00266864|62824140|FG000|Overall Study|Lost to Follow-up|4|||
33449178|NCT00266864|62824141|FG001|Overall Study|Lost to Follow-up|1|||
33449179|NCT00266864|62824140|FG000|Overall Study|Withdrawal by Subject|1|||
33449180|NCT00266864|62824141|FG001|Overall Study|Withdrawal by Subject|1|||
33449181|NCT00266708|62824149|FG000|Overall Study|No renal function|1|||
33449182|NCT00266708|62824150|FG001|Overall Study|No renal function|1|||
33449183|NCT00266708|62824149|FG000|Overall Study|Refused biopsy|3|||
33449184|NCT00266708|62824150|FG001|Overall Study|Refused biopsy|6|||
33449185|NCT00266708|62824149|FG000|Overall Study|Asthma|0|||
33449186|NCT00266708|62824150|FG001|Overall Study|Asthma|2|||
33324170|NCT01137474|62700593|FG003|Overall Study|Pregnancy|0|||
33449187|NCT00266630|62824158|FG000|Overall Study|Adverse Event|8|||
33502143|NCT03370120|62882752|FG000|Overall Study|Decision of sponsor|6|||
33502144|NCT03370120|62882752|FG000|Overall Study|Asked by the sponsor|3|||
33502145|NCT03370120|62882752|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
33502146|NCT03370120|62882752|FG000|Overall Study|PI decision poor compliance from participant|1|||
33502147|NCT03370120|62882752|FG000|Overall Study|Promoter ended the study|3|||
33502148|NCT03370120|62882752|FG000|Overall Study|Premature study close by sponsor's decision|4|||
33502149|NCT03370120|62882752|FG000|Overall Study|Study terminated by sponsor|33|||
33502150|NCT03370120|62882752|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
33502151|NCT03370120|62882752|FG000|Overall Study|Sponsor decision to terminate study|63|||
33502152|NCT03370120|62882752|FG000|Overall Study|Program closure|3|||
33502153|NCT03370120|62882752|FG000|Overall Study|Study ended prematurely|1|||
33502154|NCT03370120|62882752|FG000|Overall Study|Study stopped by sponsor|2|||
33502155|NCT03370120|62882752|FG000|Overall Study|Program termination|55|||
33502156|NCT03370120|62882752|FG000|Overall Study|Sponsor decision|62|||
33502157|NCT03370120|62882752|FG000|Overall Study|Sponsor study closure|10|||
33502158|NCT03247686|62882760|FG000|Overall Study|Withdrawal by Subject|1|||
33502159|NCT03247686|62882761|FG001|Overall Study|Withdrawal by Subject|2|||
33502160|NCT03990649|62882772|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
33502161|NCT03990649|62882773|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
33502162|NCT03990649|62882774|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
33610202|NCT02203513|63010459|FG002|Overall Study|Lost to Follow-up|1|||
33610203|NCT02203513|63010460|FG003|Overall Study|Lost to Follow-up|1|||
33610204|NCT02203513|63010461|FG004|Overall Study|Lost to Follow-up|0|||
33610205|NCT02299934|63010475|FG000|Overall Study|Termination of study|13|||
33610206|NCT01703260|63010482|FG000|Overall Study|Adverse Event|1|||
33610207|NCT01703260|63010483|FG001|Overall Study|Adverse Event|2|||
33610208|NCT01703260|63010484|FG002|Overall Study|Adverse Event|2|||
33610209|NCT01703260|63010482|FG000|Overall Study|Lost to Follow-up|1|||
33610210|NCT01703260|63010483|FG001|Overall Study|Lost to Follow-up|0|||
33610211|NCT01703260|63010484|FG002|Overall Study|Lost to Follow-up|0|||
33610212|NCT01703260|63010482|FG000|Overall Study|Withdrawal by Subject|0|||
33610213|NCT01703260|63010483|FG001|Overall Study|Withdrawal by Subject|0|||
33610214|NCT01703260|63010484|FG002|Overall Study|Withdrawal by Subject|1|||
33610215|NCT01703260|63010482|FG000|Overall Study|Study Termination|1|||
33610216|NCT01703260|63010483|FG001|Overall Study|Study Termination|2|||
33610217|NCT01703260|63010484|FG002|Overall Study|Study Termination|0|||
33610218|NCT02203357|63010495|FG000|Overall Study|Lost to Follow-up|58|||
33610219|NCT02203357|63010496|FG001|Overall Study|Lost to Follow-up|66|||
33610220|NCT02203357|63010497|FG002|Overall Study|Lost to Follow-up|70|||
33610221|NCT02299388|63010510|FG000|Overall Study|Withdrawal by Subject|0|||
33610222|NCT02299388|63010511|FG001|Overall Study|Withdrawal by Subject|1|||
33610223|NCT02202577|63010519|FG000|Overall Study|Lost to Follow-up|6|||
33610224|NCT02202577|63010520|FG001|Overall Study|Lost to Follow-up|16|||
33449188|NCT00266630|62824159|FG001|Overall Study|Adverse Event|6|||
33449189|NCT00266630|62824158|FG000|Overall Study|Lack of Efficacy|1|||
33449190|NCT00266630|62824159|FG001|Overall Study|Lack of Efficacy|4|||
33449191|NCT00266630|62824158|FG000|Overall Study|Entry Criteria not met|1|||
33449192|NCT00266630|62824159|FG001|Overall Study|Entry Criteria not met|0|||
33449193|NCT00266630|62824158|FG000|Overall Study|Protocol Violation|1|||
33449194|NCT00266630|62824159|FG001|Overall Study|Protocol Violation|3|||
33449195|NCT00266630|62824158|FG000|Overall Study|Physician Decision|1|||
33449196|NCT00266630|62824159|FG001|Overall Study|Physician Decision|2|||
33449197|NCT00266630|62824158|FG000|Overall Study|Withdrawal by Subject|10|||
33449198|NCT00266630|62824159|FG001|Overall Study|Withdrawal by Subject|2|||
33449199|NCT00266630|62824158|FG000|Overall Study|Lost to Follow-up|1|||
33449200|NCT00266630|62824159|FG001|Overall Study|Lost to Follow-up|0|||
33449201|NCT00266630|62824158|FG000|Overall Study|Other|19|||
33449202|NCT00266630|62824159|FG001|Overall Study|Other|11|||
33449203|NCT00129129|62824170|FG000|Primary Phase|Adverse Event|2|||
33449204|NCT00129129|62824171|FG001|Primary Phase|Adverse Event|1|||
33449205|NCT00129129|62824172|FG002|Primary Phase|Adverse Event|0|||
33449206|NCT00129129|62824173|FG003|Primary Phase|Adverse Event|0|||
33449207|NCT00129129|62824174|FG004|Primary Phase|Adverse Event|0|||
33449208|NCT00129129|62824170|FG000|Primary Phase|Withdrawal by Subject|12|||
33502163|NCT03990649|62882772|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
33502164|NCT03990649|62882773|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
33502165|NCT03990649|62882774|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
33502166|NCT03990649|62882772|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
33502167|NCT03990649|62882773|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
33502168|NCT03990649|62882774|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
33502169|NCT03990649|62882772|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
33502170|NCT03990649|62882773|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
33502171|NCT03990649|62882774|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
33610225|NCT02202577|63010519|FG000|Overall Study|Protocol Violation|7|||
33610226|NCT02202577|63010520|FG001|Overall Study|Protocol Violation|3|||
33610227|NCT02299076|63010528|FG000|Overall Study|Fraudulent Entries|20|||
33502172|NCT03990649|62882772|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
33502173|NCT03990649|62882773|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
33502174|NCT03990649|62882774|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
33502175|NCT03990649|62882772|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
33502176|NCT03990649|62882773|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
33502177|NCT03990649|62882774|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
33502178|NCT03990649|62882772|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
33502179|NCT03990649|62882773|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
33324171|NCT01137474|62700590|FG000|Overall Study|Administrative reason by sponsor|0|||
33324172|NCT01137474|62700591|FG001|Overall Study|Administrative reason by sponsor|1|||
33502180|NCT03990649|62882774|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
33502181|NCT03185481|62882781|FG000|Overall Study|Adverse Event|1|||
33502182|NCT03185481|62882781|FG000|Overall Study|Study Terminated by Sponsor|4|||
33502183|NCT03652675|62882787|FG000|Overall Study|Lost to Follow-up|4|||
33502184|NCT03652675|62882788|FG001|Overall Study|Lost to Follow-up|4|||
33502185|NCT03241368|62882794|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
33502186|NCT03241368|62882794|FG000|Overall Study|Lost to Follow-up|1|||
33502187|NCT03241368|62882794|FG000|Overall Study|Physician Decision|6|||
33502188|NCT03241368|62882794|FG000|Overall Study|Withdrawal by Subject|6|||
33502189|NCT03241368|62882794|FG000|Overall Study|Protocol Violation|1|||
33502190|NCT03220581|62882801|FG000|Overall Study|Withdrawal by Subject|0|||
33502191|NCT03220581|62882802|FG001|Overall Study|Withdrawal by Subject|1|||
33502192|NCT03220581|62882801|FG000|Overall Study|Lost to Follow-up|3|||
33502193|NCT03220581|62882802|FG001|Overall Study|Lost to Follow-up|6|||
33502194|NCT02954575|62882810|FG000|Overall Study|Withdrawal by Subject|2|||
33502195|NCT02954575|62882810|FG000|Overall Study|Adverse Event|1|||
33502196|NCT03184701|62882818|FG000|Overall Study|Death|3|||
33502197|NCT03184701|62882818|FG000|Overall Study|Physician Decision|3|||
33502198|NCT03184701|62882818|FG000|Overall Study|Withdrawal by Subject|6|||
33502199|NCT03184701|62882818|FG000|Overall Study|Lost to Follow-up|5|||
33502200|NCT03247530|62882825|FG000|Overall Study|Withdrawal by caregiver|19|||
33502201|NCT03247530|62882826|FG001|Overall Study|Withdrawal by caregiver|8|||
33502202|NCT03247530|62882827|FG002|Overall Study|Withdrawal by caregiver|10|||
33502203|NCT03247530|62882825|FG000|Overall Study|Lost to Follow-up|3|||
33502204|NCT03247530|62882826|FG001|Overall Study|Lost to Follow-up|9|||
33502205|NCT03247530|62882827|FG002|Overall Study|Lost to Follow-up|6|||
33502206|NCT03247530|62882825|FG000|Overall Study|Adverse Event|2|||
33502207|NCT03247530|62882826|FG001|Overall Study|Adverse Event|5|||
33502208|NCT03247530|62882827|FG002|Overall Study|Adverse Event|2|||
33502209|NCT03247530|62882825|FG000|Overall Study|Failure to follow procedure|1|||
33502210|NCT03247530|62882826|FG001|Overall Study|Failure to follow procedure|1|||
33502211|NCT03247530|62882827|FG002|Overall Study|Failure to follow procedure|1|||
33502212|NCT03247530|62882825|FG000|Overall Study|Withdrawal by Subject|1|||
33502213|NCT03247530|62882826|FG001|Overall Study|Withdrawal by Subject|1|||
33502214|NCT03247530|62882827|FG002|Overall Study|Withdrawal by Subject|0|||
33610228|NCT02299076|63010529|FG001|Overall Study|Fraudulent Entries|14|||
33502215|NCT03247530|62882825|FG000|Overall Study|Study medication misuse|0|||
33502216|NCT03247530|62882826|FG001|Overall Study|Study medication misuse|1|||
33610229|NCT01723072|63010537|FG000|Overall Study|Withdrawal by Subject|7|||
33610230|NCT01723072|63010538|FG001|Overall Study|Withdrawal by Subject|13|||
33610231|NCT01723072|63010537|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
33610232|NCT01723072|63010538|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
33610233|NCT01723072|63010537|FG000|Overall Study|Other|4|||
33502217|NCT03247530|62882827|FG002|Overall Study|Study medication misuse|0|||
33502218|NCT03247530|62882825|FG000|Overall Study|Other, multiple categories|1|||
33610234|NCT01723072|63010538|FG001|Overall Study|Other|3|||
33610235|NCT01722994|63010546|FG000|Overall Study|Missing data|25|||
33610236|NCT01722994|63010547|FG001|Overall Study|Missing data|17|||
33610237|NCT02228395|63010555|FG000|First Intervention Period|No longer willing to participate|1|||
33610238|NCT02228395|63010556|FG001|First Intervention Period|No longer willing to participate|0|||
33610239|NCT02228395|63010557|FG002|First Intervention Period|No longer willing to participate|0|||
33610240|NCT02228395|63010555|FG000|First Intervention Period|Unable to comply with study dates|0|||
33610241|NCT02228395|63010556|FG001|First Intervention Period|Unable to comply with study dates|1|||
33610242|NCT02228395|63010557|FG002|First Intervention Period|Unable to comply with study dates|1|||
33502219|NCT03247530|62882826|FG001|Overall Study|Other, multiple categories|3|||
33502220|NCT03247530|62882827|FG002|Overall Study|Other, multiple categories|1|||
33502221|NCT03246672|62882838|FG000|Overall Study|Lost to Follow-up|2|||
33502222|NCT03983317|62882842|FG000|Overall Study|Physician Decision|5|||
33502223|NCT03207243|62882848|FG000|Overall Study|Adverse Event|2|||
33502224|NCT03207243|62882849|FG001|Overall Study|Adverse Event|2|||
33502225|NCT03207243|62882848|FG000|Overall Study|Loss of Asthma Control|47|||
33502226|NCT03207243|62882849|FG001|Overall Study|Loss of Asthma Control|31|||
33502227|NCT03207243|62882848|FG000|Overall Study|Withdrawal by Subject|2|||
33502228|NCT03207243|62882849|FG001|Overall Study|Withdrawal by Subject|4|||
33502229|NCT03207243|62882848|FG000|Overall Study|Physician Decision|1|||
33502230|NCT03207243|62882849|FG001|Overall Study|Physician Decision|1|||
33502231|NCT03207243|62882848|FG000|Overall Study|Lost to Follow-up|0|||
33502232|NCT03207243|62882849|FG001|Overall Study|Lost to Follow-up|1|||
33502233|NCT03207243|62882848|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
33502234|NCT03207243|62882849|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
33502235|NCT03207243|62882848|FG000|Overall Study|Protocol Violation|0|||
33502236|NCT03207243|62882849|FG001|Overall Study|Protocol Violation|3|||
33502237|NCT03982069|62882860|FG000|Overall Study|Lost to Follow-up|5|||
33502238|NCT03982069|62882861|FG001|Overall Study|Lost to Follow-up|5|||
33502239|NCT03982069|62882862|FG002|Overall Study|Lost to Follow-up|3|||
33502240|NCT03982069|62882863|FG003|Overall Study|Lost to Follow-up|5|||
33502241|NCT03982069|62882860|FG000|Overall Study|Physician Decision|0|||
33502242|NCT03982069|62882861|FG001|Overall Study|Physician Decision|1|||
33610243|NCT02170051|63010569|FG000|Overall Study|Withdrawal by Subject|10|||
33610244|NCT02170051|63010570|FG001|Overall Study|Withdrawal by Subject|10|||
33610245|NCT02170051|63010569|FG000|Overall Study|Lost to Follow-up|1|||
33610246|NCT02170051|63010570|FG001|Overall Study|Lost to Follow-up|3|||
33610247|NCT02169739|63010578|FG000|Overall Study|Lost to Follow-up|0|||
33610248|NCT02169739|63010579|FG001|Overall Study|Lost to Follow-up|4|||
33610249|NCT02169505|63010586|FG000|Overall Study|Withdrawal by Subject|1|||
33610250|NCT01909791|63010593|FG000|Overall Study|Death|9|||
33610251|NCT01909791|63010594|FG001|Overall Study|Death|8|||
33610252|NCT01909791|63010595|FG002|Overall Study|Death|4|||
33610253|NCT01909791|63010593|FG000|Overall Study|Withdrawal by Subject|5|||
33610254|NCT01909791|63010594|FG001|Overall Study|Withdrawal by Subject|9|||
33449209|NCT00129129|62824171|FG001|Primary Phase|Withdrawal by Subject|10|||
33449210|NCT00129129|62824172|FG002|Primary Phase|Withdrawal by Subject|0|||
33449211|NCT00129129|62824173|FG003|Primary Phase|Withdrawal by Subject|0|||
33449212|NCT00129129|62824174|FG004|Primary Phase|Withdrawal by Subject|0|||
33449213|NCT00129129|62824170|FG000|Primary Phase|Migration from study area|1|||
33449214|NCT00129129|62824171|FG001|Primary Phase|Migration from study area|3|||
33449215|NCT00129129|62824172|FG002|Primary Phase|Migration from study area|0|||
33449216|NCT00129129|62824173|FG003|Primary Phase|Migration from study area|0|||
33449217|NCT00129129|62824174|FG004|Primary Phase|Migration from study area|0|||
33449218|NCT00129129|62824170|FG000|Primary Phase|Lost to Follow-up|8|||
33449219|NCT00129129|62824171|FG001|Primary Phase|Lost to Follow-up|6|||
33449220|NCT00129129|62824172|FG002|Primary Phase|Lost to Follow-up|0|||
33449221|NCT00129129|62824173|FG003|Primary Phase|Lost to Follow-up|0|||
33502243|NCT03982069|62882862|FG002|Overall Study|Physician Decision|0|||
33449222|NCT00129129|62824174|FG004|Primary Phase|Lost to Follow-up|0|||
33502244|NCT03982069|62882863|FG003|Overall Study|Physician Decision|0|||
33502245|NCT03982069|62882860|FG000|Overall Study|Withdrawal by Subject|2|||
33502246|NCT03982069|62882861|FG001|Overall Study|Withdrawal by Subject|1|||
33502247|NCT03982069|62882862|FG002|Overall Study|Withdrawal by Subject|5|||
33502248|NCT03982069|62882863|FG003|Overall Study|Withdrawal by Subject|2|||
33610255|NCT01909791|63010595|FG002|Overall Study|Withdrawal by Subject|13|||
33610256|NCT01909791|63010593|FG000|Overall Study|Lost to Follow-up|5|||
33610257|NCT01909791|63010594|FG001|Overall Study|Lost to Follow-up|11|||
33610258|NCT01909791|63010595|FG002|Overall Study|Lost to Follow-up|10|||
33610259|NCT01909791|63010593|FG000|Overall Study|Missed Visit|2|||
33610260|NCT01909791|63010594|FG001|Overall Study|Missed Visit|0|||
33610261|NCT01909791|63010595|FG002|Overall Study|Missed Visit|1|||
33610262|NCT02202499|63010611|FG000|Overall Study|Cancer diagnosis|0|||
33502249|NCT03982069|62882860|FG000|Overall Study|Specimen loss|3|||
33502250|NCT03982069|62882861|FG001|Overall Study|Specimen loss|3|||
33502251|NCT03982069|62882862|FG002|Overall Study|Specimen loss|1|||
33502252|NCT03982069|62882863|FG003|Overall Study|Specimen loss|1|||
33502253|NCT02937870|62882871|FG000|Overall Study|Adverse Event|1|||
33502254|NCT02937870|62882871|FG000|Overall Study|Protocol Deviation|2|||
33502255|NCT03629041|62882885|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
33502256|NCT03629041|62882886|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
33502257|NCT03629041|62882887|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
33502258|NCT03629041|62882888|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
33502259|NCT03219723|62882906|FG000|Overall Study|Case Report Forms Uncollected|6|||
33502260|NCT03219723|62882906|FG000|Overall Study|Protocol Deviation|4|||
33502261|NCT03628417|62882910|FG000|Overall Study|Death|1|||
33502262|NCT03628417|62882911|FG001|Overall Study|Death|1|||
33502263|NCT03184077|62882923|FG000|Overall Study|Lost to Follow-up|21|||
33502264|NCT03184077|62882924|FG001|Overall Study|Lost to Follow-up|21|||
33502265|NCT03245736|62882930|FG000|Overall Study|Adverse Event|1|||
33502266|NCT03245736|62882930|FG000|Overall Study|Progressive Disease|4|||
33502267|NCT02954887|62882934|FG000|Overall Study|Withdrawal by Subject|3|||
33502268|NCT02954887|62882934|FG000|Overall Study|Lack of Efficacy|3|||
33502269|NCT02954887|62882934|FG000|Overall Study|Other|1|||
33502270|NCT03183063|62882941|FG000|Overall Study|Withdrawal by Subject|2|||
33502271|NCT03183063|62882942|FG001|Overall Study|Withdrawal by Subject|0|||
33502272|NCT03183063|62882943|FG002|Overall Study|Withdrawal by Subject|0|||
33502273|NCT03183063|62882941|FG000|Overall Study|Physician Decision|3|||
33502274|NCT03183063|62882942|FG001|Overall Study|Physician Decision|4|||
33502275|NCT03183063|62882943|FG002|Overall Study|Physician Decision|4|||
33502276|NCT03182829|62882959|FG000|Overall Study|Protocol Violation|12|||
33502277|NCT03182829|62882960|FG001|Overall Study|Protocol Violation|12|||
33502278|NCT03182829|62882959|FG000|Overall Study|Other|4|||
33502279|NCT03182829|62882960|FG001|Overall Study|Other|3|||
33502280|NCT03278028|62882968|FG000|Overall Study|Lost to Follow-up|1|||
33502281|NCT03278028|62882969|FG001|Overall Study|Lost to Follow-up|0|||
33502282|NCT03278028|62882968|FG000|Overall Study|Withdrawal by Subject|3|||
33502283|NCT03278028|62882969|FG001|Overall Study|Withdrawal by Subject|1|||
33502284|NCT03278028|62882968|FG000|Overall Study|Pregnancy|0|||
33502285|NCT03278028|62882969|FG001|Overall Study|Pregnancy|1|||
33502286|NCT03181503|62882977|FG000|Overall Study|Adverse Event|2|||
33502287|NCT03181503|62882978|FG001|Overall Study|Adverse Event|2|||
33502288|NCT03181503|62882977|FG000|Overall Study|Protocol Violation|1|||
33502289|NCT03181503|62882978|FG001|Overall Study|Protocol Violation|0|||
33502290|NCT03181503|62882977|FG000|Overall Study|Withdrawal by Subject|3|||
33502291|NCT03181503|62882978|FG001|Overall Study|Withdrawal by Subject|0|||
33502292|NCT03181503|62882977|FG000|Overall Study|Lost to Follow-up|1|||
33610263|NCT02202499|63010612|FG001|Overall Study|Cancer diagnosis|0|||
33610264|NCT02202499|63010613|FG002|Overall Study|Cancer diagnosis|1|||
33610265|NCT02202499|63010611|FG000|Overall Study|Moved from area|0|||
33610266|NCT02202499|63010612|FG001|Overall Study|Moved from area|0|||
33610267|NCT02202499|63010613|FG002|Overall Study|Moved from area|1|||
33610268|NCT02202499|63010611|FG000|Overall Study|Declined before randomization|1|||
33610269|NCT02202499|63010612|FG001|Overall Study|Declined before randomization|0|||
33502293|NCT03181503|62882978|FG001|Overall Study|Lost to Follow-up|1|||
33502294|NCT03277794|62882989|FG000|Overall Study|Lost to Follow-up|2|||
33502295|NCT03277794|62882990|FG001|Overall Study|Lost to Follow-up|4|||
33502296|NCT03277794|62882989|FG000|Overall Study|Withdrew due to high acuity|1|||
33502297|NCT03277794|62882990|FG001|Overall Study|Withdrew due to high acuity|0|||
33610270|NCT02202499|63010613|FG002|Overall Study|Declined before randomization|0|||
33610271|NCT02202499|63010611|FG000|Overall Study|Auto accident|1|||
33610272|NCT02202499|63010612|FG001|Overall Study|Auto accident|0|||
33610273|NCT02202499|63010613|FG002|Overall Study|Auto accident|0|||
33502298|NCT03276078|62882997|FG000|Overall Study|Adverse Event|1|||
33502299|NCT03180801|62883004|FG000|Overall Study|Physician Decision|3|||
33610274|NCT02202109|63010628|FG000|Overall Study|Lost to Follow-up|88|||
33502300|NCT03180801|62883005|FG001|Overall Study|Physician Decision|3|||
33502301|NCT03180801|62883006|FG002|Overall Study|Physician Decision|1|||
33502302|NCT03180801|62883004|FG000|Overall Study|Non-compliance|1|||
33502303|NCT03180801|62883005|FG001|Overall Study|Non-compliance|4|||
33502304|NCT03180801|62883006|FG002|Overall Study|Non-compliance|0|||
33502305|NCT03180801|62883004|FG000|Overall Study|Inoculation Target Reached|1|||
33502306|NCT03180801|62883005|FG001|Overall Study|Inoculation Target Reached|1|||
33502307|NCT03180801|62883006|FG002|Overall Study|Inoculation Target Reached|3|||
33502308|NCT03180801|62883004|FG000|Overall Study|Adverse Event|1|||
33502309|NCT03180801|62883005|FG001|Overall Study|Adverse Event|0|||
33502310|NCT03180801|62883006|FG002|Overall Study|Adverse Event|2|||
33502311|NCT03180801|62883004|FG000|Overall Study|Withdrawal by Subject|2|||
33502312|NCT03180801|62883005|FG001|Overall Study|Withdrawal by Subject|2|||
33502313|NCT03180801|62883006|FG002|Overall Study|Withdrawal by Subject|1|||
33502314|NCT03180801|62883004|FG000|Overall Study|Lost to Follow-up|0|||
33502315|NCT03180801|62883005|FG001|Overall Study|Lost to Follow-up|2|||
33502316|NCT03180801|62883006|FG002|Overall Study|Lost to Follow-up|3|||
33502317|NCT03742271|62883017|FG000|Overall Study|Unsatisfactory Visual Response|1|||
33502318|NCT03742271|62883017|FG000|Overall Study|Withdrawal by Subject|3|||
33502319|NCT03742271|62883017|FG000|Overall Study|Lost to Follow-up|4|||
33502320|NCT03742271|62883017|FG000|Overall Study|Failed Insertion & removal|3|||
33502321|NCT03742271|62883017|FG000|Overall Study|Protocol Violation|1|||
33502322|NCT03214224|62883021|FG000|Overall Study|Protocol Violation|1|||
33502323|NCT03214224|62883021|FG000|Overall Study|Withdrawal by Subject|2|||
33502324|NCT03214224|62883021|FG000|Overall Study|Practice controls or therapists|6|||
33502325|NCT03180645|62883028|FG000|Overall Study|Adverse Event|0|||
33502326|NCT03180645|62883029|FG001|Overall Study|Adverse Event|1|||
33502327|NCT03180645|62883030|FG002|Overall Study|Adverse Event|2|||
33502328|NCT03750695|62883042|FG000|Overall Study|Lost to Follow-up|0|||
33502329|NCT03750695|62883043|FG001|Overall Study|Lost to Follow-up|1|||
33502330|NCT03231228|62883056|FG000|Overall Study|Lost to Follow-up|2|||
33502331|NCT03231228|62883057|FG001|Overall Study|Lost to Follow-up|0|||
33502332|NCT03231228|62883056|FG000|Overall Study|Physician Decision|1|||
33502333|NCT03231228|62883057|FG001|Overall Study|Physician Decision|0|||
33502334|NCT03213366|62883065|FG000|Overall Study|Lost to Follow-up|9|||
33502335|NCT03213366|62883066|FG001|Overall Study|Lost to Follow-up|4|||
33502336|NCT03213210|62883072|FG000|Overall Study|Lost to Follow-up|2|||
33502337|NCT03213210|62883072|FG000|Overall Study|Study termination|3|||
33502338|NCT02932878|62883078|FG000|Overall Study|Due to Lab Results|2|||
33610275|NCT02202109|63010629|FG001|Overall Study|Lost to Follow-up|87|||
33610276|NCT02202109|63010628|FG000|Overall Study|Withdrawal by Subject|2|||
33324173|NCT01137474|62700592|FG002|Overall Study|Administrative reason by sponsor|0|||
33502339|NCT02932878|62883079|FG001|Overall Study|Due to Lab Results|1|||
33610277|NCT02202109|63010629|FG001|Overall Study|Withdrawal by Subject|0|||
33502340|NCT03230292|62883085|FG000|Overall Study|Adverse Event|1|||
33502341|NCT03230292|62883085|FG000|Overall Study|Protocol Violation|1|||
33502342|NCT03230292|62883085|FG000|Overall Study|Lost to Follow-up|1|||
33502343|NCT03230292|62883085|FG000|Overall Study|Withdrawal by Subject|3|||
33502344|NCT03228420|62883093|FG000|Overall Study|Lost to Follow-up|5|||
33502345|NCT03228420|62883094|FG001|Overall Study|Lost to Follow-up|3|||
33502346|NCT03228420|62883093|FG000|Overall Study|Withdrawal by Subject|10|||
33502347|NCT03228420|62883094|FG001|Overall Study|Withdrawal by Subject|0|||
33502348|NCT03228420|62883093|FG000|Overall Study|Adverse Event|5|||
33502349|NCT03228420|62883094|FG001|Overall Study|Adverse Event|2|||
33502350|NCT03117049|62883102|FG000|Overall Study|Continued the follow-up period|109|||
33502351|NCT03117049|62883103|FG001|Overall Study|Continued the follow-up period|129|||
33502352|NCT03117049|62883102|FG000|Overall Study|Died|82|||
33502353|NCT03117049|62883103|FG001|Overall Study|Died|93|||
33502354|NCT03117049|62883102|FG000|Overall Study|Consent withdrawal|7|||
33502355|NCT03117049|62883103|FG001|Overall Study|Consent withdrawal|6|||
33502356|NCT03117049|62883102|FG000|Overall Study|Missing contact|3|||
33502357|NCT03117049|62883103|FG001|Overall Study|Missing contact|3|||
33502358|NCT03746483|62883111|FG000|Overall Study|Adverse Event|0|||
33502359|NCT03746483|62883112|FG001|Overall Study|Adverse Event|1|||
33502360|NCT03746483|62883111|FG000|Overall Study|Lack of Efficacy|3|||
33502361|NCT03746483|62883112|FG001|Overall Study|Lack of Efficacy|2|||
33502362|NCT03746483|62883111|FG000|Overall Study|Lost to Follow-up|1|||
33502363|NCT03746483|62883112|FG001|Overall Study|Lost to Follow-up|0|||
33502364|NCT03746483|62883111|FG000|Overall Study|Protocol Violation|2|||
33502365|NCT03746483|62883112|FG001|Overall Study|Protocol Violation|0|||
33502366|NCT03746405|62883122|FG000|Overall Study|Withdrawal by Subject|3|||
33502367|NCT03746405|62883123|FG001|Overall Study|Withdrawal by Subject|0|||
33502368|NCT03746405|62883122|FG000|Overall Study|technical difficulties|0|||
33502369|NCT03746405|62883123|FG001|Overall Study|technical difficulties|2|||
33502370|NCT03226392|62883131|FG000|Overall Study|Protocol Deviation|1|||
33502371|NCT03226392|62883132|FG001|Overall Study|Protocol Deviation|0|||
33610278|NCT02227849|63010635|FG000|Overall Study|Adverse Event|4|||
33610279|NCT02227849|63010635|FG000|Overall Study|Physician Decision|1|||
33502372|NCT03226392|62883131|FG000|Overall Study|Physician Decision|1|||
33502373|NCT03226392|62883132|FG001|Overall Study|Physician Decision|0|||
33502374|NCT03226392|62883131|FG000|Overall Study|Lost to Follow-up|1|||
33502375|NCT03226392|62883132|FG001|Overall Study|Lost to Follow-up|0|||
33610280|NCT02227849|63010635|FG000|Overall Study|Withdrawal by Subject|3|||
33610281|NCT01927497|63010641|FG000|Overall Study|Death|0|||
33610282|NCT01927497|63010642|FG001|Overall Study|Death|1|||
33610283|NCT01927497|63010641|FG000|Overall Study|Protocol Violation|2|||
33610284|NCT01927497|63010642|FG001|Overall Study|Protocol Violation|0|||
33610285|NCT02169271|63010650|FG000|Overall Study|Protocol Violation|1|||
33610286|NCT02169271|63010651|FG001|Overall Study|Protocol Violation|2|||
33610287|NCT02202031|63010659|FG000|Overall Study|Lost to Follow-up|1|||
33610288|NCT02202031|63010660|FG001|Overall Study|Lost to Follow-up|0|||
33610289|NCT02202031|63010659|FG000|Overall Study|Too Busy|1|||
33610290|NCT02202031|63010660|FG001|Overall Study|Too Busy|3|||
33610291|NCT02202031|63010659|FG000|Overall Study|Illness/Medical Reason|0|||
33610292|NCT02202031|63010660|FG001|Overall Study|Illness/Medical Reason|2|||
33610293|NCT02202031|63010659|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
33610294|NCT02202031|63010660|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
33610295|NCT01644188|63010668|FG000|Overall Study|Adverse Event|44|||
33610296|NCT01644188|63010669|FG001|Overall Study|Adverse Event|20|||
33610297|NCT01644188|63010668|FG000|Overall Study|Poor compliance to protocol|26|||
33610298|NCT01644188|63010669|FG001|Overall Study|Poor compliance to protocol|14|||
33610299|NCT01644188|63010668|FG000|Overall Study|Physician Decision|1|||
33610300|NCT01644188|63010669|FG001|Overall Study|Physician Decision|3|||
33610301|NCT01644188|63010668|FG000|Overall Study|Participant moved|7|||
33502376|NCT03226392|62883131|FG000|Overall Study|Adverse Event|1|||
33502377|NCT03226392|62883132|FG001|Overall Study|Adverse Event|0|||
33502378|NCT03226392|62883131|FG000|Overall Study|Technical Problems|0|||
33502379|NCT03226392|62883132|FG001|Overall Study|Technical Problems|2|||
33502380|NCT03226392|62883131|FG000|Overall Study|Subject/Guardian Decision|7|||
33502381|NCT03226392|62883132|FG001|Overall Study|Subject/Guardian Decision|6|||
33502382|NCT03205371|62883150|FG000|Overall Study|Withdrawal by Subject|4|||
33502383|NCT03205371|62883151|FG001|Overall Study|Withdrawal by Subject|1|||
33502384|NCT03205371|62883152|FG002|Overall Study|Withdrawal by Subject|0|||
33610302|NCT01644188|63010669|FG001|Overall Study|Participant moved|2|||
33502385|NCT03205371|62883153|FG003|Overall Study|Withdrawal by Subject|0|||
33502386|NCT03205371|62883154|FG004|Overall Study|Withdrawal by Subject|0|||
33610303|NCT01644188|63010668|FG000|Overall Study|Related to auto-injector administration|2|||
33610304|NCT01644188|63010669|FG001|Overall Study|Related to auto-injector administration|2|||
33610305|NCT01644188|63010668|FG000|Overall Study|Consent withdrawn by participant|14|||
33610306|NCT01644188|63010669|FG001|Overall Study|Consent withdrawn by participant|7|||
33610307|NCT01644188|63010668|FG000|Overall Study|Selection criteria finally not met|2|||
33610308|NCT01644188|63010669|FG001|Overall Study|Selection criteria finally not met|0|||
33502387|NCT03205371|62883155|FG005|Overall Study|Withdrawal by Subject|0|||
33502388|NCT03205371|62883156|FG006|Overall Study|Withdrawal by Subject|4|||
33502389|NCT03205371|62883157|FG007|Overall Study|Withdrawal by Subject|0|||
33502390|NCT03205371|62883158|FG008|Overall Study|Withdrawal by Subject|2|||
33502391|NCT03205371|62883159|FG009|Overall Study|Withdrawal by Subject|0|||
33502392|NCT03205371|62883160|FG010|Overall Study|Withdrawal by Subject|0|||
33502393|NCT03205371|62883161|FG011|Overall Study|Withdrawal by Subject|1|||
33610309|NCT01644188|63010668|FG000|Overall Study|Lost to Follow-up|1|||
33610310|NCT01644188|63010669|FG001|Overall Study|Lost to Follow-up|0|||
33610311|NCT01644188|63010668|FG000|Overall Study|Death|4|||
33610312|NCT01644188|63010669|FG001|Overall Study|Death|3|||
33610313|NCT01644188|63010668|FG000|Overall Study|Last visit outside protocol visit window|14|||
33610314|NCT01644188|63010669|FG001|Overall Study|Last visit outside protocol visit window|16|||
33610315|NCT01644188|63010668|FG000|Overall Study|Site closure|1|||
33610316|NCT01644188|63010669|FG001|Overall Study|Site closure|1|||
33610317|NCT01644188|63010668|FG000|Overall Study|Other than specified above|6|||
33610318|NCT01644188|63010669|FG001|Overall Study|Other than specified above|7|||
33610319|NCT02201953|63010677|FG000|Overall Study|Randomized but Never Treated|1|||
33610320|NCT02201953|63010678|FG001|Overall Study|Randomized but Never Treated|5|||
33610321|NCT02201953|63010677|FG000|Overall Study|Lack of Efficacy|9|||
33610322|NCT02201953|63010678|FG001|Overall Study|Lack of Efficacy|30|||
33610323|NCT02201953|63010677|FG000|Overall Study|Lost to Follow-up|8|||
33449223|NCT00129129|62824170|FG000|Primary Phase|Other|2|||
33449224|NCT00129129|62824171|FG001|Primary Phase|Other|5|||
33449225|NCT00129129|62824172|FG002|Primary Phase|Other|0|||
33449226|NCT00129129|62824173|FG003|Primary Phase|Other|0|||
33449227|NCT00129129|62824174|FG004|Primary Phase|Other|0|||
33449228|NCT00129129|62824170|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
33449229|NCT00129129|62824171|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
33449230|NCT00129129|62824172|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
33449231|NCT00129129|62824173|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
33449232|NCT00129129|62824174|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
33449233|NCT00129129|62824170|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
33449234|NCT00129129|62824171|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
33449235|NCT00129129|62824172|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
33449236|NCT00129129|62824173|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
33449237|NCT00129129|62824174|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
33449238|NCT00129129|62824170|FG000|Fourth Dose Phase|Migration from study area|0|||
33449239|NCT00129129|62824171|FG001|Fourth Dose Phase|Migration from study area|0|||
33449240|NCT00129129|62824172|FG002|Fourth Dose Phase|Migration from study area|0|||
33449241|NCT00129129|62824173|FG003|Fourth Dose Phase|Migration from study area|0|||
33449242|NCT00129129|62824174|FG004|Fourth Dose Phase|Migration from study area|2|||
33449243|NCT00129129|62824170|FG000|Fourth Dose Phase|Other|0|||
33449244|NCT00129129|62824171|FG001|Fourth Dose Phase|Other|0|||
33449245|NCT00129129|62824172|FG002|Fourth Dose Phase|Other|0|||
33449246|NCT00129129|62824173|FG003|Fourth Dose Phase|Other|1|||
33449247|NCT00129129|62824174|FG004|Fourth Dose Phase|Other|1|||
33449248|NCT00129129|62824170|FG000|Fourth Dose Phase|Protocol Violation|0|||
33449249|NCT00129129|62824171|FG001|Fourth Dose Phase|Protocol Violation|0|||
33449250|NCT00129129|62824172|FG002|Fourth Dose Phase|Protocol Violation|0|||
33449251|NCT00129129|62824173|FG003|Fourth Dose Phase|Protocol Violation|1|||
33449252|NCT00129129|62824174|FG004|Fourth Dose Phase|Protocol Violation|0|||
33449253|NCT00221403|62824197|FG000|Overall Study|Protocol Violation|1|||
33449254|NCT00221403|62824198|FG001|Overall Study|Protocol Violation|0|||
33449255|NCT00221403|62824199|FG002|Overall Study|Protocol Violation|0|||
33449256|NCT00221403|62824197|FG000|Overall Study|Physician Decision|1|||
33449257|NCT00221403|62824198|FG001|Overall Study|Physician Decision|0|||
33449258|NCT00221403|62824199|FG002|Overall Study|Physician Decision|0|||
33449259|NCT00221403|62824197|FG000|Overall Study|Withdrawal by Subject|0|||
33449260|NCT00221403|62824198|FG001|Overall Study|Withdrawal by Subject|3|||
33449261|NCT00221403|62824199|FG002|Overall Study|Withdrawal by Subject|0|||
33449262|NCT00221403|62824197|FG000|Overall Study|Lack of Efficacy|0|||
33449263|NCT00221403|62824198|FG001|Overall Study|Lack of Efficacy|1|||
33502394|NCT03205371|62883150|FG000|Overall Study|Lost to Follow-up|0|||
33610324|NCT02201953|63010678|FG001|Overall Study|Lost to Follow-up|8|||
33449264|NCT00221403|62824199|FG002|Overall Study|Lack of Efficacy|0|||
33449265|NCT00221403|62824197|FG000|Overall Study|Adverse Event|0|||
33449266|NCT00221403|62824198|FG001|Overall Study|Adverse Event|1|||
33449267|NCT00221403|62824199|FG002|Overall Study|Adverse Event|0|||
33449268|NCT00145977|62824209|FG000|Overall Study|Lack of Efficacy|0|||
33610325|NCT02201953|63010677|FG000|Overall Study|Withdrew Consent|2|||
33610326|NCT02201953|63010678|FG001|Overall Study|Withdrew Consent|5|||
33610327|NCT02201953|63010677|FG000|Overall Study|Adverse Event|0|||
33610328|NCT02201953|63010678|FG001|Overall Study|Adverse Event|5|||
33610329|NCT02201953|63010677|FG000|Overall Study|Death|0|||
33610330|NCT02201953|63010678|FG001|Overall Study|Death|3|||
33449269|NCT00145977|62824210|FG001|Overall Study|Lack of Efficacy|4|||
33449270|NCT00145977|62824209|FG000|Overall Study|Lost to Follow-up|1|||
33502395|NCT03205371|62883151|FG001|Overall Study|Lost to Follow-up|0|||
33502396|NCT03205371|62883152|FG002|Overall Study|Lost to Follow-up|0|||
33502397|NCT03205371|62883153|FG003|Overall Study|Lost to Follow-up|0|||
33502398|NCT03205371|62883154|FG004|Overall Study|Lost to Follow-up|0|||
33502399|NCT03205371|62883155|FG005|Overall Study|Lost to Follow-up|0|||
33502400|NCT03205371|62883156|FG006|Overall Study|Lost to Follow-up|5|||
33502401|NCT03205371|62883157|FG007|Overall Study|Lost to Follow-up|2|||
33502402|NCT03205371|62883158|FG008|Overall Study|Lost to Follow-up|3|||
33502403|NCT03205371|62883159|FG009|Overall Study|Lost to Follow-up|0|||
33502404|NCT03205371|62883160|FG010|Overall Study|Lost to Follow-up|0|||
33502405|NCT03205371|62883161|FG011|Overall Study|Lost to Follow-up|0|||
33502406|NCT03205371|62883150|FG000|Overall Study|Protocol Violation|0|||
33502407|NCT03205371|62883151|FG001|Overall Study|Protocol Violation|0|||
33502408|NCT03205371|62883152|FG002|Overall Study|Protocol Violation|0|||
33502409|NCT03205371|62883153|FG003|Overall Study|Protocol Violation|0|||
33502410|NCT03205371|62883154|FG004|Overall Study|Protocol Violation|0|||
33502411|NCT03205371|62883155|FG005|Overall Study|Protocol Violation|0|||
33502412|NCT03205371|62883156|FG006|Overall Study|Protocol Violation|1|||
33502413|NCT03205371|62883157|FG007|Overall Study|Protocol Violation|0|||
33502414|NCT03205371|62883158|FG008|Overall Study|Protocol Violation|0|||
33502415|NCT03205371|62883159|FG009|Overall Study|Protocol Violation|0|||
33502416|NCT03205371|62883160|FG010|Overall Study|Protocol Violation|0|||
33502417|NCT03205371|62883161|FG011|Overall Study|Protocol Violation|0|||
33502418|NCT03205371|62883150|FG000|Overall Study|Adverse Event|0|||
33502419|NCT03205371|62883151|FG001|Overall Study|Adverse Event|0|||
33502420|NCT03205371|62883152|FG002|Overall Study|Adverse Event|0|||
33502421|NCT03205371|62883153|FG003|Overall Study|Adverse Event|0|||
33502422|NCT03205371|62883154|FG004|Overall Study|Adverse Event|0|||
33502423|NCT03205371|62883155|FG005|Overall Study|Adverse Event|0|||
33502424|NCT03205371|62883156|FG006|Overall Study|Adverse Event|0|||
33502425|NCT03205371|62883157|FG007|Overall Study|Adverse Event|1|||
33502426|NCT03205371|62883158|FG008|Overall Study|Adverse Event|0|||
33502427|NCT03205371|62883159|FG009|Overall Study|Adverse Event|0|||
33502428|NCT03205371|62883160|FG010|Overall Study|Adverse Event|0|||
33502429|NCT03205371|62883161|FG011|Overall Study|Adverse Event|0|||
33502430|NCT03682705|62883213|FG000|Overall Study|Adverse Event|1|||
33502431|NCT03682705|62883214|FG001|Overall Study|Adverse Event|1|||
33502432|NCT03682705|62883215|FG002|Overall Study|Adverse Event|1|||
33502433|NCT03682705|62883216|FG003|Overall Study|Adverse Event|0|||
33502434|NCT03682705|62883217|FG004|Overall Study|Adverse Event|1|||
33502435|NCT03682705|62883218|FG005|Overall Study|Adverse Event|1|||
33502436|NCT03682705|62883213|FG000|Overall Study|Withdrawal by Subject|1|||
33502437|NCT03682705|62883214|FG001|Overall Study|Withdrawal by Subject|3|||
33502438|NCT03682705|62883215|FG002|Overall Study|Withdrawal by Subject|2|||
33449271|NCT00145977|62824210|FG001|Overall Study|Lost to Follow-up|0|||
33449272|NCT00145977|62824209|FG000|Overall Study|Withdrawal by Subject|1|||
33449273|NCT00145977|62824210|FG001|Overall Study|Withdrawal by Subject|0|||
33449274|NCT00238238|62824219|FG000|Overall Study|Withdrawal by Subject|0|||
33449275|NCT00238238|62824220|FG001|Overall Study|Withdrawal by Subject|3|||
33449276|NCT00238238|62824221|FG002|Overall Study|Withdrawal by Subject|0|||
33449277|NCT00128661|62824231|FG000|Overall Study|Adverse Event|14|||
33449278|NCT00128661|62824232|FG001|Overall Study|Adverse Event|11|||
33449279|NCT00128661|62824231|FG000|Overall Study|Lost to Follow-up|10|||
33449280|NCT00128661|62824232|FG001|Overall Study|Lost to Follow-up|7|||
33449281|NCT00128661|62824231|FG000|Overall Study|Withdrawal by Subject|243|||
33449282|NCT00128661|62824232|FG001|Overall Study|Withdrawal by Subject|232|||
33449283|NCT00128661|62824231|FG000|Overall Study|Other|7|||
33449284|NCT00128661|62824232|FG001|Overall Study|Other|8|||
33449285|NCT00145509|62824240|FG000|Overall Study|Adverse Event|10|||
33449286|NCT00145509|62824241|FG001|Overall Study|Adverse Event|3|||
33449287|NCT00145509|62824240|FG000|Overall Study|Lack of Efficacy|3|||
33449288|NCT00145509|62824241|FG001|Overall Study|Lack of Efficacy|1|||
33449289|NCT00145509|62824240|FG000|Overall Study|Lost to Follow-up|5|||
33502439|NCT03682705|62883216|FG003|Overall Study|Withdrawal by Subject|4|||
33502440|NCT03682705|62883217|FG004|Overall Study|Withdrawal by Subject|0|||
33502441|NCT03682705|62883218|FG005|Overall Study|Withdrawal by Subject|1|||
33449290|NCT00145509|62824241|FG001|Overall Study|Lost to Follow-up|9|||
33449291|NCT00145509|62824240|FG000|Overall Study|Withdrew Consent|2|||
33449292|NCT00145509|62824241|FG001|Overall Study|Withdrew Consent|7|||
33502442|NCT03682705|62883213|FG000|Overall Study|Other, not specified|0|||
33502443|NCT03682705|62883214|FG001|Overall Study|Other, not specified|0|||
33502444|NCT03682705|62883215|FG002|Overall Study|Other, not specified|0|||
33502445|NCT03682705|62883216|FG003|Overall Study|Other, not specified|1|||
33502446|NCT03682705|62883217|FG004|Overall Study|Other, not specified|2|||
33502447|NCT03682705|62883218|FG005|Overall Study|Other, not specified|0|||
33502448|NCT03682705|62883213|FG000|Overall Study|Lost to Follow-up|0|||
33502449|NCT03682705|62883214|FG001|Overall Study|Lost to Follow-up|0|||
33502450|NCT03682705|62883215|FG002|Overall Study|Lost to Follow-up|0|||
33502451|NCT03682705|62883216|FG003|Overall Study|Lost to Follow-up|0|||
33502452|NCT03682705|62883217|FG004|Overall Study|Lost to Follow-up|3|||
33502453|NCT03682705|62883218|FG005|Overall Study|Lost to Follow-up|0|||
33610331|NCT02271854|63010684|FG000|Overall Study|Withdrawal by Subject|2|||
33610332|NCT02271854|63010684|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
33610333|NCT02271854|63010684|FG000|Overall Study|Lost to Follow-up|1|||
33610334|NCT02296892|63010692|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
33610335|NCT02296892|63010693|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
33610336|NCT02296892|63010694|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
33610337|NCT02296892|63010692|FG000|Overall Study|Lost to Follow-up|5|||
33610338|NCT02296892|63010693|FG001|Overall Study|Lost to Follow-up|0|||
33610339|NCT02296892|63010694|FG002|Overall Study|Lost to Follow-up|1|||
33610340|NCT02270684|63010704|FG000|Overall Study|Lost to Follow-up|0|||
33610341|NCT02270684|63010705|FG001|Overall Study|Lost to Follow-up|3|||
33610342|NCT02270684|63010704|FG000|Overall Study|Study terminated|1|||
33610343|NCT02270684|63010705|FG001|Overall Study|Study terminated|0|||
33610344|NCT02168803|63010714|FG000|Overall Study|Lost to Follow-up|1|||
33610345|NCT02168803|63010715|FG001|Overall Study|Lost to Follow-up|0|||
33610346|NCT02168803|63010716|FG002|Overall Study|Lost to Follow-up|1|||
33610347|NCT02168803|63010714|FG000|Overall Study|Withdrawal by Subject|1|||
33502454|NCT03179787|62883232|FG000|Overall Study|Lost to Follow-up|15|||
33502455|NCT03179787|62883232|FG000|Overall Study|Case report failures|2|||
33502456|NCT03179787|62883232|FG000|Overall Study|Treatment not administered|1|||
33502457|NCT03745937|62883240|FG000|Overall Study|Withdrawal by Subject|0|||
33502458|NCT03745937|62883241|FG001|Overall Study|Withdrawal by Subject|0|||
33502459|NCT03745937|62883242|FG002|Overall Study|Withdrawal by Subject|0|||
33502460|NCT03745937|62883243|FG003|Overall Study|Withdrawal by Subject|1|||
33502461|NCT03745937|62883240|FG000|Overall Study|Not-specifed|0|||
33502462|NCT03745937|62883241|FG001|Overall Study|Not-specifed|1|||
33502463|NCT03745937|62883242|FG002|Overall Study|Not-specifed|0|||
33502464|NCT03745937|62883243|FG003|Overall Study|Not-specifed|1|||
33502465|NCT02956057|62883260|FG000|Overall Study|Discontinued intervention|14|||
33502466|NCT02956057|62883261|FG001|Overall Study|Discontinued intervention|10|||
33502467|NCT02956057|62883262|FG002|Overall Study|Discontinued intervention|7|||
33502468|NCT02956057|62883263|FG003|Overall Study|Discontinued intervention|14|||
33502469|NCT02956057|62883264|FG004|Overall Study|Discontinued intervention|4|||
33502470|NCT02956057|62883265|FG005|Overall Study|Discontinued intervention|17|||
33502471|NCT02956057|62883260|FG000|Overall Study|Lost to Follow-up|0|||
33502472|NCT02956057|62883261|FG001|Overall Study|Lost to Follow-up|2|||
33502473|NCT02956057|62883262|FG002|Overall Study|Lost to Follow-up|1|||
33502474|NCT02956057|62883263|FG003|Overall Study|Lost to Follow-up|1|||
33502475|NCT02956057|62883264|FG004|Overall Study|Lost to Follow-up|1|||
33502476|NCT02956057|62883265|FG005|Overall Study|Lost to Follow-up|0|||
33502477|NCT03179319|62883281|FG000|Overall Study|Lost to Follow-up|6|||
33502478|NCT03179319|62883282|FG001|Overall Study|Lost to Follow-up|0|||
33502479|NCT03627091|62883291|FG000|Overall Study|Adverse Event|0|||
33502480|NCT03627091|62883292|FG001|Overall Study|Adverse Event|0|||
33502481|NCT03627091|62883293|FG002|Overall Study|Adverse Event|2|||
33502482|NCT03627091|62883291|FG000|Overall Study|Withdrawal by Subject|2|||
33502483|NCT03627091|62883292|FG001|Overall Study|Withdrawal by Subject|0|||
33502484|NCT03627091|62883293|FG002|Overall Study|Withdrawal by Subject|2|||
33502485|NCT03627091|62883291|FG000|Overall Study|Physician Decision|2|||
33502486|NCT03627091|62883292|FG001|Overall Study|Physician Decision|0|||
33502487|NCT03627091|62883293|FG002|Overall Study|Physician Decision|0|||
33502488|NCT03627091|62883291|FG000|Overall Study|Site terminated by sponsor|0|||
33502489|NCT03627091|62883292|FG001|Overall Study|Site terminated by sponsor|1|||
33502490|NCT03627091|62883293|FG002|Overall Study|Site terminated by sponsor|0|||
33502491|NCT03627091|62883291|FG000|Overall Study|Disease relapse|7|||
33502492|NCT03627091|62883292|FG001|Overall Study|Disease relapse|5|||
33502493|NCT03627091|62883293|FG002|Overall Study|Disease relapse|1|||
33502494|NCT03627091|62883291|FG000|Overall Study|Other|1|||
33502495|NCT03627091|62883292|FG001|Overall Study|Other|0|||
33610348|NCT02168803|63010715|FG001|Overall Study|Withdrawal by Subject|1|||
33610349|NCT02168803|63010716|FG002|Overall Study|Withdrawal by Subject|2|||
33502496|NCT03627091|62883293|FG002|Overall Study|Other|0|||
33502497|NCT04237584|62883306|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
33502498|NCT04237584|62883307|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
33502499|NCT04237584|62883308|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
33502500|NCT04237584|62883309|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
33502501|NCT04237584|62883306|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
33610350|NCT02168803|63010714|FG000|Overall Study|Physician Decision|0|||
33610351|NCT02168803|63010715|FG001|Overall Study|Physician Decision|1|||
33502502|NCT04237584|62883307|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
33502503|NCT04237584|62883308|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
33502504|NCT04237584|62883309|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
33502505|NCT04237584|62883306|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
33502506|NCT04237584|62883307|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
33502507|NCT04237584|62883308|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
33502508|NCT04237584|62883309|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
33502509|NCT04237584|62883306|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
33502510|NCT04237584|62883307|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
33502511|NCT04237584|62883308|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
33502512|NCT04237584|62883309|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
33502513|NCT04237584|62883306|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
33502514|NCT04237584|62883307|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
33502515|NCT04237584|62883308|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
33502516|NCT04237584|62883309|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
33502517|NCT03224598|62883326|FG000|Overall Study|Lost to Follow-up|0|||
33502518|NCT03224598|62883327|FG001|Overall Study|Lost to Follow-up|2|||
33502519|NCT03224598|62883328|FG002|Overall Study|Lost to Follow-up|0|||
33502520|NCT03224598|62883326|FG000|Overall Study|Other|0|||
33502521|NCT03224598|62883327|FG001|Overall Study|Other|1|||
33502522|NCT03224598|62883328|FG002|Overall Study|Other|0|||
33502523|NCT03681691|62883338|FG000|Overall Study|COVID|1|||
33502524|NCT03681691|62883339|FG001|Overall Study|COVID|0|||
33502525|NCT03681691|62883338|FG000|Overall Study|prolonged bleeding|1|||
33502526|NCT03681691|62883339|FG001|Overall Study|prolonged bleeding|0|||
33502527|NCT03681691|62883338|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
33502528|NCT03681691|62883339|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
33502529|NCT02935842|62883351|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
33502530|NCT02935842|62883352|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
33502531|NCT02935842|62883353|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
33502532|NCT02935842|62883354|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
33502533|NCT02935842|62883351|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
33502534|NCT02935842|62883352|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
33502535|NCT02935842|62883353|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
33502536|NCT02935842|62883354|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
33502537|NCT02935842|62883351|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
33502538|NCT02935842|62883352|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
33502539|NCT02935842|62883353|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
33502540|NCT02935842|62883354|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
33502541|NCT02935842|62883351|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
33502542|NCT02935842|62883352|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
33502543|NCT02935842|62883353|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
33502544|NCT02935842|62883354|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
33502545|NCT02935842|62883351|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
33502546|NCT02935842|62883352|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
33502547|NCT02935842|62883353|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
33502548|NCT02935842|62883354|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
33502549|NCT01064479|62883373|FG000|Overall Study|Death|10|||
33502550|NCT01064479|62883374|FG001|Overall Study|Death|11|||
33502551|NCT01064479|62883373|FG000|Overall Study|Withdrawal by Subject|2|||
33502552|NCT01064479|62883374|FG001|Overall Study|Withdrawal by Subject|2|||
33502553|NCT01064479|62883373|FG000|Overall Study|Disease progression|1|||
33502554|NCT01064479|62883374|FG001|Overall Study|Disease progression|1|||
33502555|NCT01064479|62883373|FG000|Overall Study|Toxicity|1|||
33502556|NCT01064479|62883374|FG001|Overall Study|Toxicity|1|||
33502557|NCT01064479|62883373|FG000|Overall Study|Other|1|||
33502558|NCT01064479|62883374|FG001|Overall Study|Other|2|||
33502559|NCT03680911|62883382|FG000|At Home Treatment|Study Termination|3|||
33502560|NCT03680911|62883383|FG001|At Home Treatment|Study Termination|0|||
33502561|NCT03680911|62883382|FG000|At Home Treatment|Lost to Follow-up|0|||
33502562|NCT03680911|62883383|FG001|At Home Treatment|Lost to Follow-up|1|||
33502563|NCT03680911|62883382|FG000|At Home Treatment|Withdrawal by Subject|0|||
33502564|NCT03680911|62883383|FG001|At Home Treatment|Withdrawal by Subject|2|||
33502565|NCT03680911|62883382|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
33502566|NCT03680911|62883383|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
33502567|NCT03224130|62883391|FG000|Overall Study|consent issue|0|||
33502568|NCT03224130|62883392|FG001|Overall Study|consent issue|1|||
33502569|NCT03680521|62883400|FG000|Overall Study|Ongoing in long-term follow up|7|||
33502570|NCT03680521|62883401|FG001|Overall Study|Ongoing in long-term follow up|11|||
33610352|NCT02168803|63010716|FG002|Overall Study|Physician Decision|0|||
33502571|NCT03679741|62883410|FG000|Period 1|No longer meet eligibility criteria|1|||
33502572|NCT03679741|62883411|FG001|Period 1|No longer meet eligibility criteria|0|||
33502573|NCT03679741|62883410|FG000|Period 1|Lost to Follow-up|0|||
33502574|NCT03679741|62883411|FG001|Period 1|Lost to Follow-up|1|||
33502575|NCT03679741|62883410|FG000|Period 1|Adverse Event|1|||
33324174|NCT01137474|62700593|FG003|Overall Study|Administrative reason by sponsor|0|||
33502576|NCT03679741|62883411|FG001|Period 1|Adverse Event|1|||
33502577|NCT03679741|62883410|FG000|Period 1|Withdrawal by Subject|0|||
33502578|NCT03679741|62883411|FG001|Period 1|Withdrawal by Subject|1|||
33502579|NCT03679741|62883410|FG000|Period 2|Adverse Event|2|||
33502580|NCT03679741|62883411|FG001|Period 2|Adverse Event|1|||
33502581|NCT03679741|62883410|FG000|Period 2|Withdrawal by Subject|1|||
33502582|NCT03679741|62883411|FG001|Period 2|Withdrawal by Subject|1|||
33502583|NCT03678103|62883417|FG000|Overall Study|Withdrawn prior to completion|4|||
33502584|NCT03649477|62883424|FG000|Overall Study|Adverse Event|2|||
33502585|NCT03649477|62883425|FG001|Overall Study|Adverse Event|0|||
33502586|NCT03649477|62883426|FG002|Overall Study|Adverse Event|0|||
33502587|NCT03677869|62883434|FG000|Overall Study|Withdrawal by Subject|1|||
33502588|NCT03677401|62883440|FG000|Overall Study|Adverse Event|4|||
33502589|NCT03677401|62883441|FG001|Overall Study|Adverse Event|14|||
33502590|NCT03677401|62883440|FG000|Overall Study|Lack of Efficacy|3|||
33502591|NCT03677401|62883441|FG001|Overall Study|Lack of Efficacy|1|||
33502592|NCT03677401|62883440|FG000|Overall Study|Withdrawal by Subject|2|||
33502593|NCT03677401|62883441|FG001|Overall Study|Withdrawal by Subject|2|||
33502594|NCT03677401|62883440|FG000|Overall Study|Sponsor decision|0|||
33502595|NCT03677401|62883441|FG001|Overall Study|Sponsor decision|1|||
33502596|NCT03677401|62883440|FG000|Overall Study|Reason Unspecified|1|||
33502597|NCT03677401|62883441|FG001|Overall Study|Reason Unspecified|0|||
33502598|NCT03218787|62883447|FG000|Overall Study|Lost to Follow-up|12|||
33502599|NCT03218787|62883447|FG000|Overall Study|Withdrawal by Subject|72|||
33502600|NCT03218787|62883447|FG000|Overall Study|Physician Decision|11|||
33502601|NCT03218787|62883447|FG000|Overall Study|Death|111|||
33502602|NCT01348087|62883451|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
33502603|NCT01348087|62883451|FG000|Overall Study|Administrative problems|79|||
33502604|NCT01348087|62883451|FG000|Overall Study|protocol deviation|1|||
33502605|NCT01348087|62883451|FG000|Overall Study|Lost to Follow-up|1|||
33502606|NCT01348087|62883451|FG000|Overall Study|Subject withdrew consent|7|||
33502607|NCT01348087|62883451|FG000|Overall Study|Adverse Event|25|||
33502608|NCT01347931|62883465|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
33502609|NCT03645421|62883475|FG000|Overall Study|Adverse Event|0|||
33502610|NCT03645421|62883476|FG001|Overall Study|Adverse Event|0|||
33502611|NCT03645421|62883477|FG002|Overall Study|Adverse Event|4|||
33502612|NCT03645421|62883478|FG003|Overall Study|Adverse Event|1|||
33502613|NCT03645421|62883475|FG000|Overall Study|Withdrawal by patient|0|||
33502614|NCT03645421|62883476|FG001|Overall Study|Withdrawal by patient|0|||
33502615|NCT03645421|62883477|FG002|Overall Study|Withdrawal by patient|0|||
33502616|NCT03645421|62883478|FG003|Overall Study|Withdrawal by patient|3|||
33502617|NCT03645421|62883475|FG000|Overall Study|Study specific withdrawal criteria|0|||
33502618|NCT03645421|62883476|FG001|Overall Study|Study specific withdrawal criteria|0|||
33502619|NCT03645421|62883477|FG002|Overall Study|Study specific withdrawal criteria|1|||
33502620|NCT03645421|62883478|FG003|Overall Study|Study specific withdrawal criteria|0|||
33502621|NCT03207750|62883493|FG000|Overall Study|Adverse Event|3|||
33502622|NCT03207750|62883494|FG001|Overall Study|Adverse Event|2|||
33502623|NCT03207750|62883493|FG000|Overall Study|Lost to Follow-up|21|||
33502624|NCT03207750|62883494|FG001|Overall Study|Lost to Follow-up|29|||
33502625|NCT03207750|62883493|FG000|Overall Study|Protocol Violation|0|||
33502626|NCT03207750|62883494|FG001|Overall Study|Protocol Violation|1|||
33502627|NCT03207750|62883493|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
33502628|NCT03207750|62883494|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
33502629|NCT03207750|62883493|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
33502630|NCT03207750|62883494|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
33502631|NCT03207750|62883493|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
33502632|NCT03207750|62883494|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
33502633|NCT03207750|62883493|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
33502634|NCT03207750|62883494|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
33502635|NCT03207750|62883493|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
33502636|NCT03207750|62883494|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
33502637|NCT03674281|62883503|FG000|Overall Study|screen failure|2|||
33502638|NCT03674281|62883504|FG001|Overall Study|screen failure|0|||
33502639|NCT03674281|62883505|FG002|Overall Study|screen failure|0|||
33502640|NCT03674281|62883503|FG000|Overall Study|Withdrawal by Subject|1|||
33502641|NCT03674281|62883504|FG001|Overall Study|Withdrawal by Subject|3|||
33502642|NCT03674281|62883505|FG002|Overall Study|Withdrawal by Subject|3|||
33502643|NCT03673345|62883529|FG000|Overall Study|Lost to Follow-up|1|||
33502644|NCT03673345|62883530|FG001|Overall Study|Lost to Follow-up|0|||
33502645|NCT03673345|62883531|FG002|Overall Study|Lost to Follow-up|3|||
33502646|NCT03673345|62883532|FG003|Overall Study|Lost to Follow-up|3|||
33502647|NCT03673345|62883533|FG004|Overall Study|Lost to Follow-up|2|||
33502648|NCT03673345|62883534|FG005|Overall Study|Lost to Follow-up|1|||
33502649|NCT03673345|62883535|FG006|Overall Study|Lost to Follow-up|0|||
33502650|NCT03673345|62883536|FG007|Overall Study|Lost to Follow-up|0|||
33502651|NCT03673345|62883529|FG000|Overall Study|Withdrawal by Subject|1|||
33502652|NCT03673345|62883530|FG001|Overall Study|Withdrawal by Subject|0|||
33502653|NCT03673345|62883531|FG002|Overall Study|Withdrawal by Subject|4|||
33502654|NCT03673345|62883532|FG003|Overall Study|Withdrawal by Subject|2|||
33502655|NCT03673345|62883533|FG004|Overall Study|Withdrawal by Subject|0|||
33502656|NCT03673345|62883534|FG005|Overall Study|Withdrawal by Subject|0|||
33502657|NCT03673345|62883535|FG006|Overall Study|Withdrawal by Subject|0|||
33502658|NCT03673345|62883536|FG007|Overall Study|Withdrawal by Subject|0|||
33502659|NCT03673345|62883529|FG000|Overall Study|Physician Decision|0|||
33449293|NCT00145509|62824240|FG000|Overall Study|Reason not provided|2|||
33449294|NCT00145509|62824241|FG001|Overall Study|Reason not provided|1|||
33449295|NCT00145119|62824247|FG000|Overall Study|Death|45|||
33449296|NCT00220779|62824254|FG000|Overall Study|Adverse Event|1|||
33449297|NCT00220779|62824255|FG001|Overall Study|Adverse Event|0|||
33449298|NCT00220779|62824256|FG002|Overall Study|Adverse Event|0|||
33449299|NCT00220779|62824254|FG000|Overall Study|Withdrawal by Subject|1|||
33449300|NCT00220779|62824255|FG001|Overall Study|Withdrawal by Subject|4|||
33449301|NCT00220779|62824256|FG002|Overall Study|Withdrawal by Subject|1|||
33449302|NCT00220779|62824254|FG000|Overall Study|Non-compliance|1|||
33449303|NCT00220779|62824255|FG001|Overall Study|Non-compliance|0|||
33449304|NCT00220779|62824256|FG002|Overall Study|Non-compliance|0|||
33449305|NCT00220779|62824254|FG000|Overall Study|Too time consuming|1|||
33449306|NCT00220779|62824255|FG001|Overall Study|Too time consuming|0|||
33449307|NCT00220779|62824256|FG002|Overall Study|Too time consuming|0|||
33449308|NCT00220779|62824254|FG000|Overall Study|Pregnancy|0|||
33449309|NCT00220779|62824255|FG001|Overall Study|Pregnancy|0|||
33449310|NCT00220779|62824256|FG002|Overall Study|Pregnancy|2|||
33449311|NCT00220779|62824254|FG000|Overall Study|Lack of Efficacy|3|||
33449312|NCT00220779|62824255|FG001|Overall Study|Lack of Efficacy|0|||
33449313|NCT00220779|62824256|FG002|Overall Study|Lack of Efficacy|1|||
33449314|NCT00207740|62824268|FG000|Overall Study|Adverse Event|4|||
33449315|NCT00207740|62824269|FG001|Overall Study|Adverse Event|14|||
33449316|NCT00207740|62824270|FG002|Overall Study|Adverse Event|14|||
33449317|NCT00207740|62824271|FG003|Overall Study|Adverse Event|11|||
33449318|NCT00207740|62824268|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33449319|NCT00207740|62824269|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33449320|NCT00207740|62824270|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
33449321|NCT00207740|62824271|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
33449322|NCT00207740|62824268|FG000|Overall Study|Lost to Follow-up|0|||
33449323|NCT00207740|62824269|FG001|Overall Study|Lost to Follow-up|2|||
33449324|NCT00207740|62824270|FG002|Overall Study|Lost to Follow-up|1|||
33502660|NCT03673345|62883530|FG001|Overall Study|Physician Decision|0|||
33449325|NCT00207740|62824271|FG003|Overall Study|Lost to Follow-up|1|||
33449326|NCT00207740|62824268|FG000|Overall Study|Death|0|||
33502661|NCT03673345|62883531|FG002|Overall Study|Physician Decision|2|||
33502662|NCT03673345|62883532|FG003|Overall Study|Physician Decision|0|||
33502663|NCT03673345|62883533|FG004|Overall Study|Physician Decision|0|||
33449327|NCT00207740|62824269|FG001|Overall Study|Death|0|||
33449328|NCT00207740|62824270|FG002|Overall Study|Death|0|||
33449329|NCT00207740|62824271|FG003|Overall Study|Death|1|||
33502664|NCT03673345|62883534|FG005|Overall Study|Physician Decision|0|||
33502665|NCT03673345|62883535|FG006|Overall Study|Physician Decision|0|||
33502666|NCT03673345|62883536|FG007|Overall Study|Physician Decision|0|||
33502667|NCT03223662|62883554|FG000|Overall Study|Physician Decision|1|||
33502668|NCT03223662|62883554|FG000|Overall Study|Study closure|1|||
33502669|NCT03672097|62883558|FG000|Period 1|Withdrawal by Subject|2|||
33502670|NCT03672097|62883558|FG000|Period 1|Adverse Event|1|||
33502671|NCT03672097|62883558|FG000|Period 1|Did not receive treatment|1|||
33502672|NCT03672097|62883558|FG000|Period 2|Withdrawal by Subject|3|||
33502673|NCT03672097|62883558|FG000|Period 2|Other|1|||
33502674|NCT03847896|62883567|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
33502675|NCT03847896|62883568|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
33502676|NCT03847896|62883569|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
33502677|NCT03847896|62883570|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
33502678|NCT03847896|62883571|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
33502679|NCT03847896|62883567|FG000|Overall Study|Withdrawal by Subject|2|||
33502680|NCT03847896|62883568|FG001|Overall Study|Withdrawal by Subject|10|||
33502681|NCT03847896|62883569|FG002|Overall Study|Withdrawal by Subject|5|||
33502682|NCT03847896|62883570|FG003|Overall Study|Withdrawal by Subject|9|||
33502683|NCT03847896|62883571|FG004|Overall Study|Withdrawal by Subject|8|||
33502684|NCT03847896|62883567|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33502685|NCT03847896|62883568|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33502686|NCT03847896|62883569|FG002|Overall Study|Withdrawal by parent/guardian|1|||
33502687|NCT03847896|62883570|FG003|Overall Study|Withdrawal by parent/guardian|0|||
33502688|NCT03847896|62883571|FG004|Overall Study|Withdrawal by parent/guardian|0|||
33502689|NCT03847896|62883567|FG000|Overall Study|Adverse Event|2|||
33502690|NCT03847896|62883568|FG001|Overall Study|Adverse Event|1|||
33502691|NCT03847896|62883569|FG002|Overall Study|Adverse Event|3|||
33502692|NCT03847896|62883570|FG003|Overall Study|Adverse Event|2|||
33502693|NCT03847896|62883571|FG004|Overall Study|Adverse Event|4|||
33502694|NCT03847896|62883567|FG000|Overall Study|A severe exacerbation event|0|||
33449330|NCT00207740|62824268|FG000|Overall Study|Sponsor Directive|22|||
33449331|NCT00207740|62824269|FG001|Overall Study|Sponsor Directive|15|||
33449332|NCT00207740|62824270|FG002|Overall Study|Sponsor Directive|16|||
33449333|NCT00207740|62824271|FG003|Overall Study|Sponsor Directive|21|||
33449334|NCT00207740|62824268|FG000|Overall Study|Other|2|||
33502695|NCT03847896|62883568|FG001|Overall Study|A severe exacerbation event|0|||
33502696|NCT03847896|62883569|FG002|Overall Study|A severe exacerbation event|0|||
33502697|NCT03847896|62883570|FG003|Overall Study|A severe exacerbation event|0|||
33502698|NCT03847896|62883571|FG004|Overall Study|A severe exacerbation event|3|||
33502699|NCT03847896|62883567|FG000|Overall Study|Protocol Violation|0|||
33502700|NCT03847896|62883568|FG001|Overall Study|Protocol Violation|2|||
33502701|NCT03847896|62883569|FG002|Overall Study|Protocol Violation|1|||
33502702|NCT03847896|62883570|FG003|Overall Study|Protocol Violation|0|||
33502703|NCT03847896|62883571|FG004|Overall Study|Protocol Violation|2|||
33502704|NCT03847896|62883567|FG000|Overall Study|Lost to Follow-up|0|||
33502705|NCT03847896|62883568|FG001|Overall Study|Lost to Follow-up|0|||
33449335|NCT00207740|62824269|FG001|Overall Study|Other|10|||
33449336|NCT00207740|62824270|FG002|Overall Study|Other|7|||
33449337|NCT00207740|62824271|FG003|Overall Study|Other|5|||
33449338|NCT00265382|62824285|FG000|Overall Study|Adverse Event|21|||
33449339|NCT00265382|62824285|FG000|Overall Study|Laboratory Abnormality|1|||
33449340|NCT00265382|62824285|FG000|Overall Study|Lost to Follow-up|3|||
33449341|NCT00265382|62824285|FG000|Overall Study|Lack of Efficacy|6|||
33449342|NCT00265382|62824285|FG000|Overall Study|Miscellaneous|6|||
33449343|NCT00265382|62824285|FG000|Overall Study|Withdrawal by Subject|13|||
33449344|NCT00265382|62824285|FG000|Overall Study|Study terminated by sponsor|94|||
33449345|NCT00265382|62824285|FG000|Overall Study|Death|1|||
33449346|NCT00206726|62824289|FG000|Overall Study|Delayed recovery of blood counts|1|||
33449347|NCT00206726|62824289|FG000|Overall Study|Progressive disease or relapsed disease|18|||
33449348|NCT00206726|62824289|FG000|Overall Study|Placed on new protocol|1|||
33449349|NCT00206726|62824289|FG000|Overall Study|Bone marrow transplant|1|||
33449350|NCT00206726|62824289|FG000|Overall Study|Adverse Event|17|||
33502706|NCT03847896|62883569|FG002|Overall Study|Lost to Follow-up|0|||
33502707|NCT03847896|62883570|FG003|Overall Study|Lost to Follow-up|1|||
33502708|NCT03847896|62883571|FG004|Overall Study|Lost to Follow-up|0|||
33610353|NCT02168803|63010714|FG000|Overall Study|Adverse Event|0|||
33449351|NCT00206726|62824289|FG000|Overall Study|Death|4|||
33449352|NCT00206726|62824289|FG000|Overall Study|Protocol Violation|1|||
33449353|NCT00206726|62824289|FG000|Overall Study|Withdrawal by Subject|8|||
33449354|NCT00237692|62824297|FG000|Overall Study|Lost to Follow-up|9|||
33449355|NCT00237692|62824298|FG001|Overall Study|Lost to Follow-up|3|||
33449356|NCT00237692|62824299|FG002|Overall Study|Lost to Follow-up|5|||
33449357|NCT00237692|62824300|FG003|Overall Study|Lost to Follow-up|3|||
33449358|NCT00237692|62824297|FG000|Overall Study|Death|1|||
33449359|NCT00237692|62824298|FG001|Overall Study|Death|2|||
33449360|NCT00237692|62824299|FG002|Overall Study|Death|2|||
33449361|NCT00237692|62824300|FG003|Overall Study|Death|3|||
33449362|NCT00237692|62824297|FG000|Overall Study|Excluded - did not meet criteria|4|||
33449363|NCT00237692|62824298|FG001|Overall Study|Excluded - did not meet criteria|3|||
33449364|NCT00237692|62824299|FG002|Overall Study|Excluded - did not meet criteria|5|||
33449365|NCT00237692|62824300|FG003|Overall Study|Excluded - did not meet criteria|9|||
33449366|NCT00237692|62824297|FG000|Overall Study|Withdrawal by Subject|4|||
33449367|NCT00237692|62824298|FG001|Overall Study|Withdrawal by Subject|6|||
33449368|NCT00237692|62824299|FG002|Overall Study|Withdrawal by Subject|10|||
33449369|NCT00237692|62824300|FG003|Overall Study|Withdrawal by Subject|4|||
33449370|NCT00237458|62824310|FG000|Overall Study|Lack of Efficacy|1|||
33449371|NCT00237458|62824310|FG000|Overall Study|Adverse Event|1|||
33449372|NCT00237458|62824310|FG000|Overall Study|Withdrawal by Subject|1|||
33502709|NCT03847896|62883567|FG000|Overall Study|Condition under investigation worsened|0|||
33502710|NCT03847896|62883568|FG001|Overall Study|Condition under investigation worsened|0|||
33502711|NCT03847896|62883569|FG002|Overall Study|Condition under investigation worsened|0|||
33502712|NCT03847896|62883570|FG003|Overall Study|Condition under investigation worsened|1|||
33502713|NCT03847896|62883571|FG004|Overall Study|Condition under investigation worsened|1|||
33324175|NCT01168973|62700605|FG000|Overall Study|Progressive Disease|341|||
33324176|NCT01168973|62700606|FG001|Overall Study|Progressive Disease|429|||
33502714|NCT03847896|62883567|FG000|Overall Study|Lack of Efficacy|0|||
33502715|NCT03847896|62883568|FG001|Overall Study|Lack of Efficacy|0|||
33502716|NCT03847896|62883569|FG002|Overall Study|Lack of Efficacy|0|||
33502717|NCT03847896|62883570|FG003|Overall Study|Lack of Efficacy|2|||
33502718|NCT03847896|62883571|FG004|Overall Study|Lack of Efficacy|2|||
33502719|NCT03847896|62883567|FG000|Overall Study|Other reasons|3|||
33502720|NCT03847896|62883568|FG001|Overall Study|Other reasons|3|||
33502721|NCT03847896|62883569|FG002|Overall Study|Other reasons|1|||
33502722|NCT03847896|62883570|FG003|Overall Study|Other reasons|2|||
33502723|NCT03847896|62883571|FG004|Overall Study|Other reasons|1|||
33502724|NCT03670537|62883583|FG000|Overall Study|Protocol Violation|1|||
33502725|NCT03619837|62883587|FG000|Screening|received organs from HCV-negative donors|47|||
33502726|NCT03619837|62883587|FG000|Screening|died on the wait-list|2|||
33502727|NCT03619837|62883587|FG000|Screening|remained on the wait list|40|||
33502728|NCT03619837|62883587|FG000|Screening|didn't meet eligibility criteria|3|||
33502729|NCT03619837|62883587|FG000|Screening|withdrew consent|2|||
33502730|NCT03619837|62883587|FG000|Screening|never listed for HCV-viremic donor|1|||
33502731|NCT03619837|62883587|FG000|Screening|developed exclusion criteria|2|||
33502732|NCT03619837|62883587|FG000|Screening|excluded by the investigator due to non-compliance|1|||
33502733|NCT03206970|62883591|FG000|Overall Study|Death|21|||
33502734|NCT03206970|62883591|FG000|Overall Study|Withdrawal by Subject|13|||
33502735|NCT03206970|62883591|FG000|Overall Study|Lost to Follow-up|3|||
33502736|NCT03206970|62883591|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
33502737|NCT03644173|62883595|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
33502738|NCT03644173|62883595|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
33324177|NCT01168973|62700605|FG000|Overall Study|Adverse Event|94|||
33449373|NCT00265148|62824316|FG000|Overall Study|Adverse Event|2|||
33449374|NCT00265148|62824317|FG001|Overall Study|Adverse Event|2|||
33449375|NCT00265148|62824316|FG000|Overall Study|Lack of Efficacy|0|||
33502739|NCT03644173|62883595|FG000|Participants at the 1-month Follow up|Death|2|||
33502740|NCT03644173|62883595|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
33502741|NCT03178851|62883603|FG000|Overall Study|Death|48|||
33502742|NCT03178851|62883604|FG001|Overall Study|Death|2|||
33502743|NCT03178851|62883605|FG002|Overall Study|Death|25|||
33502744|NCT03178851|62883603|FG000|Overall Study|Withdrawal by Subject|8|||
33502745|NCT03178851|62883604|FG001|Overall Study|Withdrawal by Subject|0|||
33502746|NCT03178851|62883605|FG002|Overall Study|Withdrawal by Subject|0|||
33502747|NCT03178851|62883603|FG000|Overall Study|Lost to Follow-up|5|||
33502748|NCT03178851|62883604|FG001|Overall Study|Lost to Follow-up|2|||
33502749|NCT03178851|62883605|FG002|Overall Study|Lost to Follow-up|0|||
33502750|NCT03178851|62883603|FG000|Overall Study|Adverse Event|0|||
33449376|NCT00265148|62824317|FG001|Overall Study|Lack of Efficacy|2|||
33449377|NCT00265148|62824316|FG000|Overall Study|Protocol Violation|3|||
33449378|NCT00265148|62824317|FG001|Overall Study|Protocol Violation|2|||
33449379|NCT00265148|62824316|FG000|Overall Study|Lost to Follow-up|0|||
33502751|NCT03178851|62883604|FG001|Overall Study|Adverse Event|0|||
33502752|NCT03178851|62883605|FG002|Overall Study|Adverse Event|1|||
33502753|NCT03178851|62883603|FG000|Overall Study|Study Termination by Sponsor|31|||
33502754|NCT03178851|62883604|FG001|Overall Study|Study Termination by Sponsor|7|||
33502755|NCT03178851|62883605|FG002|Overall Study|Study Termination by Sponsor|26|||
33502756|NCT03643159|62883616|FG000|Overall Study|Adverse Event|1|||
33502757|NCT03643159|62883616|FG000|Overall Study|Withdrawal by Subject|1|||
33502758|NCT03205566|62883623|FG000|Phase 1|Protocol Violation|1|||
33502759|NCT03205566|62883624|FG001|Phase 1|Protocol Violation|1|||
33502760|NCT02935452|62883636|FG000|Overall Study|work and life commintment|3|||
33502761|NCT02935452|62883637|FG001|Overall Study|work and life commintment|1|||
33502762|NCT03178773|62883645|FG000|Overall Study|Death|0|||
33502763|NCT03178773|62883646|FG001|Overall Study|Death|1|||
33502764|NCT03178773|62883645|FG000|Overall Study|Lost to Follow-up|29|||
33502765|NCT03178773|62883646|FG001|Overall Study|Lost to Follow-up|25|||
33502766|NCT03178773|62883645|FG000|Overall Study|Withdrawal by Subject|10|||
33502767|NCT03178773|62883646|FG001|Overall Study|Withdrawal by Subject|14|||
33502768|NCT03713034|62883655|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
33502769|NCT03713034|62883656|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
33502770|NCT03218397|62883666|FG000|Overall Study|Prior positive blood culture|8|||
33502771|NCT03218397|62883667|FG001|Overall Study|Prior positive blood culture|13|||
33502772|NCT03218397|62883666|FG000|Overall Study|Comfort care|8|||
33502773|NCT03218397|62883667|FG001|Overall Study|Comfort care|5|||
33502774|NCT03218397|62883666|FG000|Overall Study|Comfort care and positive blood culture|1|||
33502775|NCT03218397|62883667|FG001|Overall Study|Comfort care and positive blood culture|0|||
33502776|NCT03218397|62883666|FG000|Overall Study|Comfort care and mixed culture|0|||
33502777|NCT03218397|62883667|FG001|Overall Study|Comfort care and mixed culture|1|||
33502778|NCT03218397|62883666|FG000|Overall Study|Mixed culture|2|||
33502779|NCT03218397|62883667|FG001|Overall Study|Mixed culture|2|||
33502780|NCT03218397|62883666|FG000|Overall Study|Inaccessible hospital records|2|||
33502781|NCT03218397|62883667|FG001|Overall Study|Inaccessible hospital records|5|||
33502782|NCT03218397|62883666|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
33502783|NCT03218397|62883667|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
33502784|NCT03218397|62883666|FG000|Overall Study|Randomized during laboratory off hours|2|||
33610354|NCT02168803|63010715|FG001|Overall Study|Adverse Event|1|||
33610355|NCT02168803|63010716|FG002|Overall Study|Adverse Event|1|||
33610356|NCT02168803|63010714|FG000|Overall Study|Death|0|||
33610357|NCT02168803|63010715|FG001|Overall Study|Death|0|||
33610358|NCT02168803|63010716|FG002|Overall Study|Death|1|||
33610359|NCT02168803|63010714|FG000|Overall Study|Sponsor Decision|0|||
33502785|NCT03218397|62883667|FG001|Overall Study|Randomized during laboratory off hours|1|||
33610360|NCT02168803|63010715|FG001|Overall Study|Sponsor Decision|0|||
33610361|NCT02168803|63010716|FG002|Overall Study|Sponsor Decision|1|||
33610362|NCT02201329|63010731|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
33610363|NCT02201329|63010731|FG000|Overall Study|Withdrawal by Subject|2|||
33449380|NCT00265148|62824317|FG001|Overall Study|Lost to Follow-up|1|||
33449381|NCT00265148|62824316|FG000|Overall Study|Withdrawal by Subject|2|||
33449382|NCT00265148|62824317|FG001|Overall Study|Withdrawal by Subject|1|||
33449383|NCT00265148|62824316|FG000|Overall Study|Physician Decision|1|||
33449384|NCT00265148|62824317|FG001|Overall Study|Physician Decision|0|||
33449385|NCT00265148|62824316|FG000|Overall Study|Increasing frailty|0|||
33449386|NCT00265148|62824317|FG001|Overall Study|Increasing frailty|1|||
33449387|NCT00265148|62824316|FG000|Overall Study|Subject chose to change of the dose|1|||
33449388|NCT00265148|62824317|FG001|Overall Study|Subject chose to change of the dose|0|||
33449389|NCT00043186|62824333|FG000|Overall Study|Physician Decision|0|||
33449390|NCT00043186|62824334|FG001|Overall Study|Physician Decision|0|||
33449391|NCT00043186|62824335|FG002|Overall Study|Physician Decision|3|||
33449392|NCT00043186|62824336|FG003|Overall Study|Physician Decision|0|||
33449393|NCT00043186|62824337|FG004|Overall Study|Physician Decision|1|||
33449394|NCT00043186|62824338|FG005|Overall Study|Physician Decision|0|||
33449395|NCT00043186|62824339|FG006|Overall Study|Physician Decision|0|||
33449396|NCT00043186|62824340|FG007|Overall Study|Physician Decision|1|||
33449397|NCT00043186|62824341|FG008|Overall Study|Physician Decision|1|||
33449398|NCT00043186|62824333|FG000|Overall Study|Adverse Event|2|||
33449399|NCT00043186|62824334|FG001|Overall Study|Adverse Event|2|||
33502786|NCT03618823|62883675|FG000|Overall Study|Lost to Follow-up|63|||
33502787|NCT03618823|62883676|FG001|Overall Study|Lost to Follow-up|61|||
33502788|NCT03640507|62883688|FG000|Overall Study|Withdrawal by Subject|0|||
33502789|NCT03640507|62883689|FG001|Overall Study|Withdrawal by Subject|0|||
33502790|NCT03640507|62883690|FG002|Overall Study|Withdrawal by Subject|1|||
33502791|NCT02937636|62883700|FG000|Overall Study|Other (Not specified)|3|||
33610364|NCT01927419|63010737|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33449400|NCT00043186|62824335|FG002|Overall Study|Adverse Event|2|||
33610365|NCT01927419|63010738|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
33449401|NCT00043186|62824336|FG003|Overall Study|Adverse Event|3|||
33610366|NCT01927419|63010737|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
33610367|NCT01927419|63010738|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
33610368|NCT01927419|63010737|FG000|Treatment Period|Disease progression|17|||
33610369|NCT01927419|63010738|FG001|Treatment Period|Disease progression|20|||
33610370|NCT01927419|63010737|FG000|Treatment Period|Study drug toxicity|48|||
33610371|NCT01927419|63010738|FG001|Treatment Period|Study drug toxicity|10|||
33610372|NCT01927419|63010737|FG000|Treatment Period|Death|0|||
33610373|NCT01927419|63010738|FG001|Treatment Period|Death|1|||
33610374|NCT01927419|63010737|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
33610375|NCT01927419|63010738|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
33610376|NCT01927419|63010737|FG000|Treatment Period|Participant request to discontinue|12|||
33610377|NCT01927419|63010738|FG001|Treatment Period|Participant request to discontinue|4|||
33610378|NCT01927419|63010737|FG000|Treatment Period|Withdrawal by Subject|1|||
33610379|NCT01927419|63010738|FG001|Treatment Period|Withdrawal by Subject|1|||
33610380|NCT01927419|63010737|FG000|Treatment Period|Maximum Clinical Benefit|6|||
33610381|NCT01927419|63010738|FG001|Treatment Period|Maximum Clinical Benefit|2|||
33610382|NCT01927419|63010737|FG000|Treatment Period|Other reasons|3|||
33610383|NCT01927419|63010738|FG001|Treatment Period|Other reasons|4|||
33610384|NCT01927419|63010737|FG000|Treatment Period|Not Reported|1|||
33610385|NCT01927419|63010738|FG001|Treatment Period|Not Reported|1|||
33610386|NCT02168491|63010744|FG000|Overall Study|Withdrawal by Subject|1|||
33610387|NCT02225743|63010748|FG000|Overall Study|Withdrawal by Subject|18|||
33610388|NCT01721746|63010754|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
33610389|NCT01721746|63010755|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
33610390|NCT01721746|63010754|FG000|Pre-Treatment|Withdrawal by Subject|1|||
33610391|NCT01721746|63010755|FG001|Pre-Treatment|Withdrawal by Subject|16|||
33610392|NCT01721746|63010754|FG000|Pre-Treatment|Poor/Non-compliance|1|||
33610393|NCT01721746|63010755|FG001|Pre-Treatment|Poor/Non-compliance|0|||
33610394|NCT01721746|63010754|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
33610395|NCT01721746|63010755|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
33610396|NCT01721746|63010754|FG000|Treatment|Disease Progression|192|||
33610397|NCT01721746|63010755|FG001|Treatment|Disease Progression|74|||
33610398|NCT01721746|63010754|FG000|Treatment|Study Drug Toxicity|19|||
33610399|NCT01721746|63010755|FG001|Treatment|Study Drug Toxicity|11|||
33610400|NCT01721746|63010754|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
33610401|NCT01721746|63010755|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
33610402|NCT01721746|63010754|FG000|Treatment|Participant request to discontinue Study treatment|26|||
33610403|NCT01721746|63010755|FG001|Treatment|Participant request to discontinue Study treatment|7|||
33610404|NCT01721746|63010754|FG000|Treatment|Participant withdrew consent|4|||
33610405|NCT01721746|63010755|FG001|Treatment|Participant withdrew consent|2|||
33610406|NCT01721746|63010754|FG000|Treatment|Maximum Clinical Benefit|9|||
33610407|NCT01721746|63010755|FG001|Treatment|Maximum Clinical Benefit|3|||
33610408|NCT01721746|63010754|FG000|Treatment|Poor/Non-compliance|2|||
33610409|NCT01721746|63010755|FG001|Treatment|Poor/Non-compliance|0|||
33610410|NCT01721746|63010754|FG000|Treatment|Participant no longer met Study criteria|4|||
33610411|NCT01721746|63010755|FG001|Treatment|Participant no longer met Study criteria|0|||
33610412|NCT01721746|63010754|FG000|Treatment|Other reasons|6|||
33610413|NCT01721746|63010755|FG001|Treatment|Other reasons|2|||
33610414|NCT02225665|63010764|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
33610415|NCT02225665|63010765|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
33610416|NCT02225665|63010764|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
33610417|NCT02225665|63010765|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
33610418|NCT01721200|63010773|FG000|Overall Study|Lost to Follow-up|3|||
33610419|NCT01721200|63010774|FG001|Overall Study|Lost to Follow-up|5|||
33610420|NCT02225587|63010787|FG000|Overall Study|Adverse Event|5|||
33610421|NCT02225587|63010788|FG001|Overall Study|Adverse Event|5|||
33610422|NCT02225587|63010787|FG000|Overall Study|Lost to Follow-up|5|||
33610423|NCT02225587|63010788|FG001|Overall Study|Lost to Follow-up|5|||
33610424|NCT02225587|63010787|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33610425|NCT02225587|63010788|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33610426|NCT02225587|63010787|FG000|Overall Study|Physician Decision|2|||
33610427|NCT02225587|63010788|FG001|Overall Study|Physician Decision|0|||
33610428|NCT02225587|63010787|FG000|Overall Study|Protocol Violation|1|||
33610429|NCT02225587|63010788|FG001|Overall Study|Protocol Violation|0|||
33610430|NCT02225587|63010787|FG000|Overall Study|Participant Moved|1|||
33610431|NCT02225587|63010788|FG001|Overall Study|Participant Moved|0|||
33610432|NCT02225587|63010787|FG000|Overall Study|Withdrawal by Subject|13|||
33610433|NCT02225587|63010788|FG001|Overall Study|Withdrawal by Subject|28|||
33610434|NCT02296424|63010796|FG000|Part 1|New therapy for study indication|0|||
33610435|NCT02296424|63010797|FG001|Part 1|New therapy for study indication|1|||
33610436|NCT02296424|63010798|FG002|Part 1|New therapy for study indication|0|||
33610437|NCT02296424|63010799|FG003|Part 1|New therapy for study indication|0|||
33610438|NCT02296424|63010796|FG000|Part 1|Protocol Violation|0|||
33610439|NCT02296424|63010797|FG001|Part 1|Protocol Violation|1|||
33610440|NCT02296424|63010798|FG002|Part 1|Protocol Violation|0|||
33610441|NCT02296424|63010799|FG003|Part 1|Protocol Violation|0|||
33610442|NCT02296424|63010796|FG000|Part 1|Withdrawal by Subject|0|||
33610443|NCT02296424|63010797|FG001|Part 1|Withdrawal by Subject|2|||
33502792|NCT02937636|62883701|FG001|Overall Study|Other (Not specified)|2|||
33502793|NCT03638635|62883710|FG000|Initial Hospitalization|Study terminated prematurely|0|||
33502794|NCT03638635|62883711|FG001|Initial Hospitalization|Study terminated prematurely|1|||
33502795|NCT03638635|62883710|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
33502796|NCT03638635|62883711|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
33502797|NCT03638635|62883710|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
33502798|NCT03638635|62883711|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
33502799|NCT03204981|62883717|FG000|Overall Study|Physician Decision|2|||
33502800|NCT03204981|62883717|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
33502801|NCT03205488|62883726|FG000|Overall Study|Adverse Event|1|||
33449402|NCT00043186|62824337|FG004|Overall Study|Adverse Event|2|||
33449403|NCT00043186|62824338|FG005|Overall Study|Adverse Event|1|||
33449404|NCT00043186|62824339|FG006|Overall Study|Adverse Event|2|||
33449405|NCT00043186|62824340|FG007|Overall Study|Adverse Event|1|||
33449406|NCT00043186|62824341|FG008|Overall Study|Adverse Event|3|||
33449407|NCT00043186|62824333|FG000|Overall Study|Withdrawal by Subject|11|||
33449408|NCT00043186|62824334|FG001|Overall Study|Withdrawal by Subject|8|||
33449409|NCT00043186|62824335|FG002|Overall Study|Withdrawal by Subject|11|||
33449410|NCT00043186|62824336|FG003|Overall Study|Withdrawal by Subject|13|||
33449411|NCT00043186|62824337|FG004|Overall Study|Withdrawal by Subject|14|||
33449412|NCT00043186|62824338|FG005|Overall Study|Withdrawal by Subject|6|||
33449413|NCT00043186|62824339|FG006|Overall Study|Withdrawal by Subject|12|||
33449414|NCT00043186|62824340|FG007|Overall Study|Withdrawal by Subject|9|||
33449415|NCT00043186|62824341|FG008|Overall Study|Withdrawal by Subject|10|||
33502802|NCT03205488|62883727|FG001|Overall Study|Adverse Event|2|||
33502803|NCT03205488|62883728|FG002|Overall Study|Adverse Event|4|||
33502804|NCT03205488|62883726|FG000|Overall Study|Protocol Violation|0|||
33502805|NCT03205488|62883727|FG001|Overall Study|Protocol Violation|0|||
33502806|NCT03205488|62883728|FG002|Overall Study|Protocol Violation|1|||
33502807|NCT03204279|62883742|FG000|Overall Study|Withdrawal by Subject|0|||
33502808|NCT03204279|62883743|FG001|Overall Study|Withdrawal by Subject|1|||
33502809|NCT03173547|62883752|FG000|Overall Study|Adverse Event|2|||
33502810|NCT03173547|62883753|FG001|Overall Study|Adverse Event|0|||
33502811|NCT03173547|62883752|FG000|Overall Study|Withdrawal by Subject|2|||
33502812|NCT03173547|62883753|FG001|Overall Study|Withdrawal by Subject|2|||
33502813|NCT02954653|62883761|FG000|Overall Study|Death|3|||
33502814|NCT02954653|62883762|FG001|Overall Study|Death|1|||
33502815|NCT02954653|62883763|FG002|Overall Study|Death|0|||
33502816|NCT02954653|62883764|FG003|Overall Study|Death|0|||
33502817|NCT02954653|62883765|FG004|Overall Study|Death|0|||
33502818|NCT02954653|62883766|FG005|Overall Study|Death|0|||
33502819|NCT02954653|62883767|FG006|Overall Study|Death|0|||
33502820|NCT02954653|62883768|FG007|Overall Study|Death|0|||
33502821|NCT02954653|62883769|FG008|Overall Study|Death|0|||
33502822|NCT02954653|62883761|FG000|Overall Study|Randomized but did not receive treatment|1|||
33502823|NCT02954653|62883762|FG001|Overall Study|Randomized but did not receive treatment|0|||
33502824|NCT02954653|62883763|FG002|Overall Study|Randomized but did not receive treatment|0|||
33502825|NCT02954653|62883764|FG003|Overall Study|Randomized but did not receive treatment|0|||
33502826|NCT02954653|62883765|FG004|Overall Study|Randomized but did not receive treatment|0|||
33502827|NCT02954653|62883766|FG005|Overall Study|Randomized but did not receive treatment|0|||
33502828|NCT02954653|62883767|FG006|Overall Study|Randomized but did not receive treatment|0|||
33502829|NCT02954653|62883768|FG007|Overall Study|Randomized but did not receive treatment|0|||
33502830|NCT02954653|62883769|FG008|Overall Study|Randomized but did not receive treatment|0|||
33502831|NCT02954653|62883761|FG000|Overall Study|Started another anti-cancer therapy|0|||
33502832|NCT02954653|62883762|FG001|Overall Study|Started another anti-cancer therapy|1|||
33502833|NCT02954653|62883763|FG002|Overall Study|Started another anti-cancer therapy|0|||
33610444|NCT02296424|63010798|FG002|Part 1|Withdrawal by Subject|0|||
33610445|NCT02296424|63010799|FG003|Part 1|Withdrawal by Subject|0|||
33610446|NCT02296424|63010796|FG000|Part 1|Study terminated by sponsor|0|||
33502834|NCT02954653|62883764|FG003|Overall Study|Started another anti-cancer therapy|0|||
33502835|NCT02954653|62883765|FG004|Overall Study|Started another anti-cancer therapy|0|||
33502836|NCT02954653|62883766|FG005|Overall Study|Started another anti-cancer therapy|0|||
33502837|NCT02954653|62883767|FG006|Overall Study|Started another anti-cancer therapy|0|||
33610447|NCT02296424|63010797|FG001|Part 1|Study terminated by sponsor|1|||
33449416|NCT00043186|62824333|FG000|Overall Study|Death|0|||
33449417|NCT00043186|62824334|FG001|Overall Study|Death|0|||
33449418|NCT00043186|62824335|FG002|Overall Study|Death|1|||
33502838|NCT02954653|62883768|FG007|Overall Study|Started another anti-cancer therapy|0|||
33610448|NCT02296424|63010798|FG002|Part 1|Study terminated by sponsor|0|||
33610449|NCT02296424|63010799|FG003|Part 1|Study terminated by sponsor|0|||
33502839|NCT02954653|62883769|FG008|Overall Study|Started another anti-cancer therapy|0|||
33502840|NCT02954653|62883761|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
33324178|NCT01168973|62700606|FG001|Overall Study|Adverse Event|55|||
33449419|NCT00043186|62824336|FG003|Overall Study|Death|0|||
33449420|NCT00043186|62824337|FG004|Overall Study|Death|0|||
33449421|NCT00043186|62824338|FG005|Overall Study|Death|0|||
33449422|NCT00043186|62824339|FG006|Overall Study|Death|2|||
33449423|NCT00043186|62824340|FG007|Overall Study|Death|0|||
33449424|NCT00043186|62824341|FG008|Overall Study|Death|0|||
33449425|NCT00043186|62824333|FG000|Overall Study|Disease progression|1|||
33449426|NCT00043186|62824334|FG001|Overall Study|Disease progression|0|||
33449427|NCT00043186|62824335|FG002|Overall Study|Disease progression|0|||
33449428|NCT00043186|62824336|FG003|Overall Study|Disease progression|3|||
33449429|NCT00043186|62824337|FG004|Overall Study|Disease progression|0|||
33449430|NCT00043186|62824338|FG005|Overall Study|Disease progression|0|||
33449431|NCT00043186|62824339|FG006|Overall Study|Disease progression|0|||
33449432|NCT00043186|62824340|FG007|Overall Study|Disease progression|4|||
33449433|NCT00043186|62824341|FG008|Overall Study|Disease progression|0|||
33449434|NCT00043186|62824333|FG000|Overall Study|Ineligibility determined|0|||
33449435|NCT00043186|62824334|FG001|Overall Study|Ineligibility determined|0|||
33449436|NCT00043186|62824335|FG002|Overall Study|Ineligibility determined|0|||
33449437|NCT00043186|62824336|FG003|Overall Study|Ineligibility determined|0|||
33449438|NCT00043186|62824337|FG004|Overall Study|Ineligibility determined|0|||
33449439|NCT00043186|62824338|FG005|Overall Study|Ineligibility determined|0|||
33449440|NCT00043186|62824339|FG006|Overall Study|Ineligibility determined|0|||
33449441|NCT00043186|62824340|FG007|Overall Study|Ineligibility determined|0|||
33449442|NCT00043186|62824341|FG008|Overall Study|Ineligibility determined|1|||
33449443|NCT00043186|62824333|FG000|Overall Study|Lost to Follow-up|3|||
33449444|NCT00043186|62824334|FG001|Overall Study|Lost to Follow-up|5|||
33449445|NCT00043186|62824335|FG002|Overall Study|Lost to Follow-up|1|||
33449446|NCT00043186|62824336|FG003|Overall Study|Lost to Follow-up|1|||
33449447|NCT00043186|62824337|FG004|Overall Study|Lost to Follow-up|1|||
33449448|NCT00043186|62824338|FG005|Overall Study|Lost to Follow-up|1|||
33449449|NCT00043186|62824339|FG006|Overall Study|Lost to Follow-up|1|||
33449450|NCT00043186|62824340|FG007|Overall Study|Lost to Follow-up|1|||
33449451|NCT00043186|62824341|FG008|Overall Study|Lost to Follow-up|2|||
33449452|NCT00043186|62824333|FG000|Overall Study|Noncompliance|0|||
33449453|NCT00043186|62824334|FG001|Overall Study|Noncompliance|0|||
33449454|NCT00043186|62824335|FG002|Overall Study|Noncompliance|1|||
33449455|NCT00043186|62824336|FG003|Overall Study|Noncompliance|1|||
33449456|NCT00043186|62824337|FG004|Overall Study|Noncompliance|0|||
33449457|NCT00043186|62824338|FG005|Overall Study|Noncompliance|0|||
33449458|NCT00043186|62824339|FG006|Overall Study|Noncompliance|0|||
33449459|NCT00043186|62824340|FG007|Overall Study|Noncompliance|0|||
33449460|NCT00043186|62824341|FG008|Overall Study|Noncompliance|0|||
33449461|NCT00043186|62824333|FG000|Overall Study|Other|0|||
33449462|NCT00043186|62824334|FG001|Overall Study|Other|0|||
33449463|NCT00043186|62824335|FG002|Overall Study|Other|1|||
33449464|NCT00043186|62824336|FG003|Overall Study|Other|1|||
33449465|NCT00043186|62824337|FG004|Overall Study|Other|0|||
33449466|NCT00043186|62824338|FG005|Overall Study|Other|0|||
33449467|NCT00043186|62824339|FG006|Overall Study|Other|0|||
33449468|NCT00043186|62824340|FG007|Overall Study|Other|0|||
33449469|NCT00043186|62824341|FG008|Overall Study|Other|0|||
33449470|NCT00041470|62824362|FG000|Overall Study|Loss of Funding|38|||
33449471|NCT00206102|62824368|FG000|Overall Study|Adverse Event|119|||
33502841|NCT02954653|62883762|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
33324179|NCT01168973|62700605|FG000|Overall Study|Withdrawal by Subject|90|||
33324180|NCT01168973|62700606|FG001|Overall Study|Withdrawal by Subject|53|||
33324181|NCT01168973|62700605|FG000|Overall Study|Death|42|||
33324182|NCT01168973|62700606|FG001|Overall Study|Death|45|||
33324183|NCT01168973|62700605|FG000|Overall Study|Physician Decision|37|||
33324184|NCT01168973|62700606|FG001|Overall Study|Physician Decision|19|||
33324185|NCT01168973|62700605|FG000|Overall Study|Sponsor Decision|2|||
33324186|NCT01168973|62700606|FG001|Overall Study|Sponsor Decision|1|||
33324187|NCT01168973|62700605|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
33324188|NCT01168973|62700606|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
33324189|NCT03918109|62700616|FG000|Overall Study|Withdrawal by Subject|0|||
33324190|NCT03918109|62700617|FG001|Overall Study|Withdrawal by Subject|0|||
33324191|NCT03918109|62700618|FG002|Overall Study|Withdrawal by Subject|2|||
33324192|NCT03918109|62700619|FG003|Overall Study|Withdrawal by Subject|1|||
33449472|NCT00206102|62824369|FG001|Overall Study|Adverse Event|82|||
33449473|NCT00206102|62824368|FG000|Overall Study|Protocol Violation|0|||
33449474|NCT00206102|62824369|FG001|Overall Study|Protocol Violation|2|||
33449475|NCT00206102|62824368|FG000|Overall Study|Lack of therapeutic response|16|||
33449476|NCT00206102|62824369|FG001|Overall Study|Lack of therapeutic response|11|||
33449477|NCT00206102|62824368|FG000|Overall Study|Lost to Follow-up|95|||
33449478|NCT00206102|62824369|FG001|Overall Study|Lost to Follow-up|66|||
33324193|NCT03918109|62700616|FG000|Overall Study|Lost to Follow-up|0|||
33449479|NCT00206102|62824368|FG000|Overall Study|Withdrawal by Subject|118|||
33502842|NCT02954653|62883763|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
33502843|NCT02954653|62883764|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
33502844|NCT02954653|62883765|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
33610450|NCT02296424|63010796|FG000|Part 1|Adverse Event|2|||
33610451|NCT02296424|63010797|FG001|Part 1|Adverse Event|11|||
33502845|NCT02954653|62883766|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
33502846|NCT02954653|62883767|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
33502847|NCT02954653|62883768|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
33502848|NCT02954653|62883769|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
33502849|NCT03173313|62883783|FG000|Overall Study|Lost to Follow-up|2|||
33502850|NCT03173313|62883784|FG001|Overall Study|Lost to Follow-up|3|||
33502851|NCT03173313|62883783|FG000|Overall Study|Withdrawal by Subject|0|||
33502852|NCT03173313|62883784|FG001|Overall Study|Withdrawal by Subject|1|||
33502853|NCT03173313|62883783|FG000|Overall Study|Death|5|||
33502854|NCT03173313|62883784|FG001|Overall Study|Death|0|||
33502855|NCT03173313|62883783|FG000|Overall Study|Physician Decision|1|||
33502856|NCT03173313|62883784|FG001|Overall Study|Physician Decision|0|||
33502857|NCT03173313|62883783|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
33502858|NCT03173313|62883784|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
33502859|NCT03173313|62883783|FG000|Overall Study|Bone Fracture|1|||
33502860|NCT03173313|62883784|FG001|Overall Study|Bone Fracture|0|||
33502861|NCT03215667|62883790|FG000|Overall Study|Physician Decision|4|||
33610452|NCT02296424|63010798|FG002|Part 1|Adverse Event|0|||
33610453|NCT02296424|63010799|FG003|Part 1|Adverse Event|0|||
33610454|NCT02296424|63010796|FG000|Part 1|Lack of Efficacy|5|||
33610455|NCT02296424|63010797|FG001|Part 1|Lack of Efficacy|17|||
33610456|NCT02296424|63010798|FG002|Part 1|Lack of Efficacy|0|||
33610457|NCT02296424|63010799|FG003|Part 1|Lack of Efficacy|0|||
33502862|NCT03634579|62883794|FG000|Overall Study|study termination|9|||
33502863|NCT02730208|62883800|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
33502864|NCT02730208|62883801|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
33502865|NCT01291511|62883809|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
33502866|NCT01291511|62883810|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
33610458|NCT02296424|63010796|FG000|Part 1|16 directly started part II|16|||
33610459|NCT02296424|63010797|FG001|Part 1|16 directly started part II|0|||
33610460|NCT02296424|63010798|FG002|Part 1|16 directly started part II|0|||
33610461|NCT02296424|63010799|FG003|Part 1|16 directly started part II|0|||
33324194|NCT03918109|62700617|FG001|Overall Study|Lost to Follow-up|0|||
33324195|NCT03918109|62700618|FG002|Overall Study|Lost to Follow-up|0|||
33324196|NCT03918109|62700619|FG003|Overall Study|Lost to Follow-up|1|||
33324197|NCT01168427|62700629|FG000|Overall Study|Patient exited prior to implant|1|||
33324198|NCT01124916|62700635|FG000|Overall Study|Lost to Follow-up|3|||
33324199|NCT01124916|62700636|FG001|Overall Study|Lost to Follow-up|2|||
33610462|NCT02296424|63010796|FG000|Part 2|Lack of Efficacy|0|||
33610463|NCT02296424|63010797|FG001|Part 2|Lack of Efficacy|0|||
33610464|NCT02296424|63010798|FG002|Part 2|Lack of Efficacy|1|||
33610465|NCT02296424|63010799|FG003|Part 2|Lack of Efficacy|0|||
33610466|NCT02296424|63010796|FG000|Part 2|Adverse Event|0|||
33610467|NCT02296424|63010797|FG001|Part 2|Adverse Event|0|||
33324200|NCT00916006|62700644|FG000|Overall Study|Adverse Event|1|||
33324201|NCT00916006|62700645|FG001|Overall Study|Adverse Event|1|||
33324202|NCT00916006|62700644|FG000|Overall Study|Withdrawal by Subject|2|||
33449480|NCT00206102|62824369|FG001|Overall Study|Withdrawal by Subject|101|||
33449481|NCT00206102|62824368|FG000|Overall Study|Study-specific discontinuation criteria|18|||
33449482|NCT00206102|62824369|FG001|Overall Study|Study-specific discontinuation criteria|17|||
33449483|NCT00206102|62824368|FG000|Overall Study|None of those categories|42|||
33449484|NCT00206102|62824369|FG001|Overall Study|None of those categories|36|||
33449485|NCT00041080|62824377|FG000|Overall Study|Adverse Event|21|||
33449486|NCT00041080|62824378|FG001|Overall Study|Adverse Event|1|||
33449487|NCT00041080|62824377|FG000|Overall Study|Withdrawal by Subject|6|||
33449488|NCT00041080|62824378|FG001|Overall Study|Withdrawal by Subject|6|||
33449489|NCT00041080|62824377|FG000|Overall Study|Concommitant Illness/Other|1|||
33449490|NCT00041080|62824378|FG001|Overall Study|Concommitant Illness/Other|2|||
33449491|NCT00041080|62824377|FG000|Overall Study|Did not start therapy|1|||
33449492|NCT00041080|62824378|FG001|Overall Study|Did not start therapy|1|||
33449493|NCT00041080|62824377|FG000|Overall Study|Ineligible|1|||
33449494|NCT00041080|62824378|FG001|Overall Study|Ineligible|0|||
33502867|NCT01291511|62883809|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
33502868|NCT01291511|62883810|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
33502869|NCT01291511|62883809|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
33502870|NCT01291511|62883810|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
33324203|NCT00916006|62700645|FG001|Overall Study|Withdrawal by Subject|5|||
33449495|NCT00205712|62824386|FG000|Overall Study|Lost to Follow-up|0|||
33610468|NCT02296424|63010798|FG002|Part 2|Adverse Event|1|||
33610469|NCT02296424|63010799|FG003|Part 2|Adverse Event|0|||
33610470|NCT02296424|63010796|FG000|Part 2|Lost to Follow-up|0|||
33610471|NCT02296424|63010797|FG001|Part 2|Lost to Follow-up|0|||
33449496|NCT00205712|62824387|FG001|Overall Study|Lost to Follow-up|1|||
33449497|NCT00203294|62824397|FG000|Overall Study|Withdrawal by Subject|8|||
33449498|NCT00203294|62824398|FG001|Overall Study|Withdrawal by Subject|13|||
33449499|NCT00264290|62824406|FG000|Intervention (8 Weeks)|Adverse Event|1|||
33449500|NCT00264290|62824407|FG001|Intervention (8 Weeks)|Adverse Event|0|||
33449501|NCT00234494|62824417|FG000|Overall Study|Protocol Violation|2|||
33502871|NCT01291511|62883809|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
33502872|NCT01291511|62883810|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
33502873|NCT01291511|62883809|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
33502874|NCT01291511|62883810|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
33449502|NCT00234104|62824425|FG000|Overall Study|Adverse Event|4|||
33449503|NCT00234104|62824426|FG001|Overall Study|Adverse Event|0|||
33449504|NCT00234104|62824427|FG002|Overall Study|Adverse Event|3|||
33449505|NCT00234104|62824428|FG003|Overall Study|Adverse Event|5|||
33449506|NCT00234104|62824425|FG000|Overall Study|Protocol Violation|0|||
33449507|NCT00234104|62824426|FG001|Overall Study|Protocol Violation|0|||
33449508|NCT00234104|62824427|FG002|Overall Study|Protocol Violation|0|||
33449509|NCT00234104|62824428|FG003|Overall Study|Protocol Violation|1|||
33449510|NCT00234104|62824425|FG000|Overall Study|Physician Decision|0|||
33449511|NCT00234104|62824426|FG001|Overall Study|Physician Decision|1|||
33449512|NCT00234104|62824427|FG002|Overall Study|Physician Decision|2|||
33449513|NCT00234104|62824428|FG003|Overall Study|Physician Decision|2|||
33449514|NCT00263666|62824440|FG000|Overall Study|Adverse Event|6|||
33449515|NCT00263666|62824441|FG001|Overall Study|Adverse Event|8|||
33502875|NCT01291511|62883809|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
33502876|NCT01291511|62883810|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
33502877|NCT01291511|62883809|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
33502878|NCT01291511|62883810|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
33502879|NCT01291511|62883809|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
33502880|NCT01291511|62883810|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
33502881|NCT01291511|62883809|FG000|Cross-Titration and Stabilization Phase|Death|1|||
33502882|NCT01291511|62883810|FG001|Cross-Titration and Stabilization Phase|Death|0|||
33502883|NCT01291511|62883809|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
33502884|NCT01291511|62883810|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
33502885|NCT01291511|62883809|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
33502886|NCT01291511|62883810|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
33502887|NCT01291511|62883809|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
33502888|NCT01291511|62883810|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
33502889|NCT01291511|62883809|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
33502890|NCT01291511|62883810|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
33449516|NCT00263666|62824440|FG000|Overall Study|Lost to Follow-up|1|||
33449517|NCT00263666|62824441|FG001|Overall Study|Lost to Follow-up|2|||
33502891|NCT01291511|62883809|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
33449518|NCT00263666|62824440|FG000|Overall Study|Withdrawal by Subject|0|||
33449519|NCT00263666|62824441|FG001|Overall Study|Withdrawal by Subject|1|||
33449520|NCT00195338|62824447|FG000|Overall Study|Lost to Follow-up|2|||
33449521|NCT00195338|62824447|FG000|Overall Study|Adverse Event|5|||
33449522|NCT00195338|62824447|FG000|Overall Study|Lack of Efficacy|1|||
33502892|NCT01291511|62883810|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
33502893|NCT01291511|62883809|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
33502894|NCT01291511|62883810|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
33502895|NCT01291511|62883809|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
33502896|NCT01291511|62883810|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
33502897|NCT01291511|62883809|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
33502898|NCT01291511|62883810|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
33502899|NCT01291511|62883809|FG000|Double-blind Relapse Prevention Phase|Death|1|||
33502900|NCT01291511|62883810|FG001|Double-blind Relapse Prevention Phase|Death|0|||
33502901|NCT03170349|62883817|FG000|At 30 Days Follow-up|Death|1|||
33502902|NCT03170349|62883817|FG000|At 6 Months Follow-up|Death|3|||
33502903|NCT03170349|62883817|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
33502904|NCT03170349|62883817|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
33502905|NCT03170349|62883817|FG000|At 1 Year Follow-up|Death|6|||
33502906|NCT03170349|62883817|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
33502907|NCT03201900|62883821|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
33502908|NCT03201900|62883821|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
33502909|NCT03201900|62883821|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
33502910|NCT03201900|62883821|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
33502911|NCT03201900|62883821|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
33502912|NCT03201900|62883821|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
33502913|NCT03201900|62883821|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
33502914|NCT03201900|62883821|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
33502915|NCT03201900|62883821|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
33502916|NCT03201900|62883821|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
33502917|NCT03201900|62883821|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
33502918|NCT03201900|62883821|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
33502919|NCT03201900|62883821|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
33502920|NCT03170271|62883836|FG000|Overall Study|Adverse Event|7|||
33502921|NCT03170271|62883837|FG001|Overall Study|Adverse Event|2|||
33502922|NCT03170271|62883836|FG000|Overall Study|Lost to Follow-up|0|||
33502923|NCT03170271|62883837|FG001|Overall Study|Lost to Follow-up|1|||
33502924|NCT03170271|62883836|FG000|Overall Study|Physician Decision|1|||
33502925|NCT03170271|62883837|FG001|Overall Study|Physician Decision|0|||
33502926|NCT03170271|62883836|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
33449523|NCT00195338|62824447|FG000|Overall Study|Early closure of the site|4|||
33449524|NCT00035932|62824454|FG000|Overall Study|Adverse Event|10|||
33449525|NCT00035932|62824455|FG001|Overall Study|Adverse Event|9|||
33449526|NCT00035932|62824456|FG002|Overall Study|Adverse Event|9|||
33449527|NCT00035932|62824454|FG000|Overall Study|Death|0|||
33502927|NCT03170271|62883837|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
33502928|NCT03170271|62883836|FG000|Overall Study|Withdrawal by Subject|17|||
33502929|NCT03170271|62883837|FG001|Overall Study|Withdrawal by Subject|5|||
33502930|NCT03170271|62883836|FG000|Overall Study|Other|2|||
33502931|NCT03170271|62883837|FG001|Overall Study|Other|2|||
33502932|NCT03170271|62883836|FG000|Overall Study|Randomized in error|4|||
33502933|NCT03170271|62883837|FG001|Overall Study|Randomized in error|0|||
33502934|NCT03613129|62883847|FG000|Pre-treatment Assessment|Protocol Violation|2|||
33502935|NCT03613129|62883848|FG001|Pre-treatment Assessment|Protocol Violation|0|||
33502936|NCT03613129|62883849|FG002|Pre-treatment Assessment|Protocol Violation|0|||
33502937|NCT03613129|62883850|FG003|Pre-treatment Assessment|Protocol Violation|0|||
33502938|NCT03613129|62883851|FG004|Pre-treatment Assessment|Protocol Violation|0|||
33502939|NCT03613129|62883847|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
33502940|NCT03613129|62883848|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
33502941|NCT03613129|62883849|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
33502942|NCT03613129|62883850|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
33502943|NCT03613129|62883851|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
33502944|NCT03235284|62883866|FG000|Overall Study|Adverse Event|1|||
33502945|NCT03235284|62883867|FG001|Overall Study|Adverse Event|2|||
33502946|NCT03235284|62883868|FG002|Overall Study|Adverse Event|1|||
33502947|NCT03170193|62883883|FG000|Overall Study|Withdrawal by Subject|0|||
33502948|NCT03170193|62883884|FG001|Overall Study|Withdrawal by Subject|0|||
33502949|NCT03170193|62883885|FG002|Overall Study|Withdrawal by Subject|0|||
33502950|NCT03170193|62883886|FG003|Overall Study|Withdrawal by Subject|1|||
33502951|NCT03170193|62883887|FG004|Overall Study|Withdrawal by Subject|0|||
33502952|NCT03170193|62883888|FG005|Overall Study|Withdrawal by Subject|0|||
33502953|NCT03170193|62883889|FG006|Overall Study|Withdrawal by Subject|0|||
33502954|NCT03170193|62883883|FG000|Overall Study|Lost to Follow-up|1|||
33502955|NCT03170193|62883884|FG001|Overall Study|Lost to Follow-up|1|||
33502956|NCT03170193|62883885|FG002|Overall Study|Lost to Follow-up|0|||
33502957|NCT03170193|62883886|FG003|Overall Study|Lost to Follow-up|0|||
33502958|NCT03170193|62883887|FG004|Overall Study|Lost to Follow-up|0|||
33502959|NCT03170193|62883888|FG005|Overall Study|Lost to Follow-up|0|||
33502960|NCT03170193|62883889|FG006|Overall Study|Lost to Follow-up|0|||
33502961|NCT03633331|62883911|FG000|Overall Study|Withdrawal by Subject|1|||
33502962|NCT03201003|62883917|FG000|Overall Study|Adverse Event|14|||
33502963|NCT03201003|62883918|FG001|Overall Study|Adverse Event|1|||
33502964|NCT03201003|62883917|FG000|Overall Study|Other reasons|5|||
33502965|NCT03201003|62883918|FG001|Overall Study|Other reasons|1|||
33502966|NCT03201003|62883917|FG000|Overall Study|Withdrawal by Subject|4|||
33502967|NCT03201003|62883918|FG001|Overall Study|Withdrawal by Subject|1|||
33502968|NCT03201003|62883917|FG000|Overall Study|Lost to Follow-up|2|||
33502969|NCT03201003|62883918|FG001|Overall Study|Lost to Follow-up|0|||
33502970|NCT03201003|62883917|FG000|Overall Study|Protocol Violation|1|||
33502971|NCT03201003|62883918|FG001|Overall Study|Protocol Violation|0|||
33502972|NCT03166215|62883926|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
33502973|NCT03166215|62883927|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
33502974|NCT03166215|62883928|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
33502975|NCT03166215|62883926|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
33449528|NCT00035932|62824455|FG001|Overall Study|Death|0|||
33449529|NCT00035932|62824456|FG002|Overall Study|Death|1|||
33449530|NCT00035932|62824454|FG000|Overall Study|Disease Progression / Relapse|1|||
33449531|NCT00035932|62824455|FG001|Overall Study|Disease Progression / Relapse|1|||
33449532|NCT00035932|62824456|FG002|Overall Study|Disease Progression / Relapse|0|||
33449533|NCT00035932|62824454|FG000|Overall Study|Lost to Follow-up|4|||
33449534|NCT00035932|62824455|FG001|Overall Study|Lost to Follow-up|4|||
33449535|NCT00035932|62824456|FG002|Overall Study|Lost to Follow-up|3|||
33449536|NCT00035932|62824454|FG000|Overall Study|Noncompliance|6|||
33449537|NCT00035932|62824455|FG001|Overall Study|Noncompliance|7|||
33449538|NCT00035932|62824456|FG002|Overall Study|Noncompliance|6|||
33449539|NCT00035932|62824454|FG000|Overall Study|Protocol Violation While on Study|0|||
33449540|NCT00035932|62824455|FG001|Overall Study|Protocol Violation While on Study|1|||
33449541|NCT00035932|62824456|FG002|Overall Study|Protocol Violation While on Study|2|||
33449542|NCT00035932|62824454|FG000|Overall Study|Withdrawal by Subject|1|||
33449543|NCT00035932|62824455|FG001|Overall Study|Withdrawal by Subject|5|||
33449544|NCT00035932|62824456|FG002|Overall Study|Withdrawal by Subject|0|||
33449545|NCT00035932|62824454|FG000|Overall Study|Study Termination by Sponsor|1|||
33449546|NCT00035932|62824455|FG001|Overall Study|Study Termination by Sponsor|0|||
33449547|NCT00035932|62824456|FG002|Overall Study|Study Termination by Sponsor|0|||
33449548|NCT00035932|62824454|FG000|Overall Study|Lack of Efficacy|33|||
33502976|NCT03166215|62883927|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
33502977|NCT03166215|62883928|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
33449549|NCT00035932|62824455|FG001|Overall Study|Lack of Efficacy|33|||
33449550|NCT00035932|62824456|FG002|Overall Study|Lack of Efficacy|28|||
33449551|NCT00022516|62824471|FG000|Overall Study|Adverse Event|0|||
33449552|NCT00022516|62824472|FG001|Overall Study|Adverse Event|59|||
33449553|NCT00022516|62824471|FG000|Overall Study|Lack of Efficacy|0|||
33502978|NCT03168711|62883950|FG000|Overall Study|Adverse Event|2|||
33502979|NCT03168711|62883951|FG001|Overall Study|Adverse Event|0|||
33502980|NCT03168711|62883950|FG000|Overall Study|Withdrawal by Subject|0|||
33502981|NCT03168711|62883951|FG001|Overall Study|Withdrawal by Subject|1|||
33449554|NCT00022516|62824472|FG001|Overall Study|Lack of Efficacy|27|||
33449555|NCT00022516|62824471|FG000|Overall Study|Physician Decision|0|||
33502982|NCT03168711|62883950|FG000|Overall Study|Death|0|||
33502983|NCT03168711|62883951|FG001|Overall Study|Death|1|||
33502984|NCT03738215|62883960|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
33502985|NCT03738215|62883961|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
33502986|NCT03738215|62883962|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
33502987|NCT03738215|62883960|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
33502988|NCT03738215|62883961|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
33502989|NCT03738215|62883962|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33502990|NCT03738215|62883960|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
33502991|NCT03738215|62883961|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
33502992|NCT03738215|62883962|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
33502993|NCT03738215|62883960|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
33502994|NCT03738215|62883961|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
33502995|NCT03738215|62883962|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
33502996|NCT03738215|62883960|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
33502997|NCT03738215|62883961|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
33502998|NCT03738215|62883962|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
33502999|NCT03738215|62883960|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
33503000|NCT03738215|62883961|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
33503001|NCT03738215|62883962|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
33503002|NCT03738215|62883960|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
33503003|NCT03738215|62883961|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
33503004|NCT03738215|62883962|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
33503005|NCT03738215|62883960|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
33503006|NCT03738215|62883961|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
33503007|NCT03738215|62883962|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
33503008|NCT03738215|62883960|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
33503009|NCT03738215|62883961|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
33503010|NCT03738215|62883962|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
33503011|NCT03738215|62883960|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
33503012|NCT03738215|62883961|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
33503013|NCT03738215|62883962|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
33503014|NCT03199911|62883972|FG000|Overall Study|Lost to Follow-up|5|||
33503015|NCT03199911|62883973|FG001|Overall Study|Lost to Follow-up|5|||
33503016|NCT03199911|62883972|FG000|Overall Study|Did not proceed with surgery|2|||
33503017|NCT03199911|62883973|FG001|Overall Study|Did not proceed with surgery|1|||
33503018|NCT03736967|62883983|FG000|Overall Study|Withdrawal by Subject|26|||
33503019|NCT03736967|62883984|FG001|Overall Study|Withdrawal by Subject|25|||
33503020|NCT03736967|62883985|FG002|Overall Study|Withdrawal by Subject|23|||
33449556|NCT00022516|62824472|FG001|Overall Study|Physician Decision|1|||
33449557|NCT00022516|62824471|FG000|Overall Study|Protocol Violation|1|||
33449558|NCT00022516|62824472|FG001|Overall Study|Protocol Violation|3|||
33449559|NCT00022516|62824471|FG000|Overall Study|Withdrawal by Subject|2|||
33449560|NCT00022516|62824472|FG001|Overall Study|Withdrawal by Subject|113|||
33449561|NCT00022516|62824471|FG000|Overall Study|Incomplete documentation|0|||
33503021|NCT03736967|62883986|FG003|Overall Study|Withdrawal by Subject|26|||
33503022|NCT03736967|62883983|FG000|Overall Study|Lost to Follow-up|3|||
33503023|NCT03736967|62883984|FG001|Overall Study|Lost to Follow-up|2|||
33503024|NCT03736967|62883985|FG002|Overall Study|Lost to Follow-up|1|||
33503025|NCT03736967|62883986|FG003|Overall Study|Lost to Follow-up|1|||
33503026|NCT03736967|62883983|FG000|Overall Study|Physician Decision|1|||
33503027|NCT03736967|62883984|FG001|Overall Study|Physician Decision|0|||
33503028|NCT03736967|62883985|FG002|Overall Study|Physician Decision|0|||
33503029|NCT03736967|62883986|FG003|Overall Study|Physician Decision|1|||
33449562|NCT00022516|62824472|FG001|Overall Study|Incomplete documentation|27|||
33449563|NCT00033514|62824480|FG000|Overall Study|Lost to Follow-up|1|||
33449564|NCT00033514|62824481|FG001|Overall Study|Lost to Follow-up|1|||
33449565|NCT00033514|62824480|FG000|Overall Study|Withdrawal by Subject|0|||
33449566|NCT00033514|62824481|FG001|Overall Study|Withdrawal by Subject|3|||
33503030|NCT03736967|62883983|FG000|Overall Study|Adverse Event|0|||
33503031|NCT03736967|62883984|FG001|Overall Study|Adverse Event|1|||
33503032|NCT03736967|62883985|FG002|Overall Study|Adverse Event|0|||
33503033|NCT03736967|62883986|FG003|Overall Study|Adverse Event|1|||
33449567|NCT00006916|62824488|FG000|Overall Study|Device not inserted|4|||
33449568|NCT00006916|62824488|FG000|Overall Study|Complication of device insertion|1|||
33503034|NCT03736967|62883983|FG000|Overall Study|Death|0|||
33503035|NCT03736967|62883984|FG001|Overall Study|Death|0|||
33503036|NCT03736967|62883985|FG002|Overall Study|Death|0|||
33503037|NCT03736967|62883986|FG003|Overall Study|Death|1|||
33503038|NCT03736967|62883983|FG000|Overall Study|Randomized but never treated|1|||
33503039|NCT03736967|62883984|FG001|Overall Study|Randomized but never treated|0|||
33503040|NCT03736967|62883985|FG002|Overall Study|Randomized but never treated|0|||
33503041|NCT03736967|62883986|FG003|Overall Study|Randomized but never treated|0|||
33449569|NCT00454649|62824502|FG000|Overall Study|Lack of Efficacy|2|||
33449570|NCT00454649|62824503|FG001|Overall Study|Lack of Efficacy|2|||
33449571|NCT00454649|62824504|FG002|Overall Study|Lack of Efficacy|10|||
33449572|NCT00454649|62824505|FG003|Overall Study|Lack of Efficacy|3|||
33449573|NCT00454649|62824506|FG004|Overall Study|Lack of Efficacy|0|||
33449574|NCT00454649|62824507|FG005|Overall Study|Lack of Efficacy|4|||
33449575|NCT00454649|62824508|FG006|Overall Study|Lack of Efficacy|5|||
33449576|NCT00454649|62824509|FG007|Overall Study|Lack of Efficacy|13|||
33449577|NCT00454649|62824510|FG008|Overall Study|Lack of Efficacy|10|||
33449578|NCT00454649|62824511|FG009|Overall Study|Lack of Efficacy|2|||
33449579|NCT00454649|62824502|FG000|Overall Study|Adverse Event|0|||
33449580|NCT00454649|62824503|FG001|Overall Study|Adverse Event|1|||
33449581|NCT00454649|62824504|FG002|Overall Study|Adverse Event|3|||
33503042|NCT03168555|62883999|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
33503043|NCT03168555|62883999|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
33503044|NCT03168555|62883999|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
33610472|NCT02296424|63010798|FG002|Part 2|Lost to Follow-up|1|||
33610473|NCT02296424|63010799|FG003|Part 2|Lost to Follow-up|0|||
33610474|NCT02296190|63010813|FG000|Overall Study|Lost to Follow-up|0|||
33610475|NCT02296190|63010814|FG001|Overall Study|Lost to Follow-up|0|||
33503045|NCT03168555|62883999|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
33503046|NCT03235050|62884011|FG000|Overall Study|Adverse Event|0|||
33503047|NCT03235050|62884012|FG001|Overall Study|Adverse Event|0|||
33503048|NCT03235050|62884013|FG002|Overall Study|Adverse Event|1|||
33503049|NCT03235050|62884014|FG003|Overall Study|Adverse Event|4|||
33503050|NCT03235050|62884015|FG004|Overall Study|Adverse Event|1|||
33503051|NCT03235050|62884011|FG000|Overall Study|Death|0|||
33503052|NCT03235050|62884012|FG001|Overall Study|Death|0|||
33503053|NCT03235050|62884013|FG002|Overall Study|Death|0|||
33503054|NCT03235050|62884014|FG003|Overall Study|Death|2|||
33503055|NCT03235050|62884015|FG004|Overall Study|Death|1|||
33503056|NCT03235050|62884011|FG000|Overall Study|Lost to Follow-up|1|||
33503057|NCT03235050|62884012|FG001|Overall Study|Lost to Follow-up|2|||
33503058|NCT03235050|62884013|FG002|Overall Study|Lost to Follow-up|1|||
33503059|NCT03235050|62884014|FG003|Overall Study|Lost to Follow-up|2|||
33503060|NCT03235050|62884015|FG004|Overall Study|Lost to Follow-up|0|||
33503061|NCT03235050|62884011|FG000|Overall Study|Withdrawal by Subject|3|||
33503062|NCT03235050|62884012|FG001|Overall Study|Withdrawal by Subject|2|||
33503063|NCT03235050|62884013|FG002|Overall Study|Withdrawal by Subject|2|||
33503064|NCT03235050|62884014|FG003|Overall Study|Withdrawal by Subject|5|||
33503065|NCT03235050|62884015|FG004|Overall Study|Withdrawal by Subject|7|||
33503066|NCT03235050|62884011|FG000|Overall Study|Other reasons|0|||
33503067|NCT03235050|62884012|FG001|Overall Study|Other reasons|1|||
33503068|NCT03235050|62884013|FG002|Overall Study|Other reasons|0|||
33503069|NCT03235050|62884014|FG003|Overall Study|Other reasons|1|||
33503070|NCT03235050|62884015|FG004|Overall Study|Other reasons|2|||
33503071|NCT04502212|62884044|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
33503072|NCT04502212|62884044|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
33503073|NCT03167619|62884051|FG000|Overall Study|Death|11|||
33503074|NCT03167619|62884052|FG001|Overall Study|Death|8|||
33503075|NCT03167619|62884051|FG000|Overall Study|Withdrawal by Subject|1|||
33503076|NCT03167619|62884052|FG001|Overall Study|Withdrawal by Subject|2|||
33503077|NCT03167619|62884051|FG000|Overall Study|Physician Decision|0|||
33610476|NCT02296190|63010815|FG002|Overall Study|Lost to Follow-up|0|||
33610477|NCT02296190|63010816|FG003|Overall Study|Lost to Follow-up|0|||
33503078|NCT03167619|62884052|FG001|Overall Study|Physician Decision|1|||
33503079|NCT03578809|62884062|FG000|Overall Study|Death|0|||
33503080|NCT03578809|62884063|FG001|Overall Study|Death|2|||
33503081|NCT03578809|62884064|FG002|Overall Study|Death|0|||
33449582|NCT00454649|62824505|FG003|Overall Study|Adverse Event|0|||
33449583|NCT00454649|62824506|FG004|Overall Study|Adverse Event|1|||
33449584|NCT00454649|62824507|FG005|Overall Study|Adverse Event|2|||
33503082|NCT03578809|62884065|FG003|Overall Study|Death|1|||
33503083|NCT03578809|62884062|FG000|Overall Study|Lost to Follow-up|0|||
33503084|NCT03578809|62884063|FG001|Overall Study|Lost to Follow-up|1|||
33610478|NCT02296190|63010817|FG004|Overall Study|Lost to Follow-up|1|||
33503085|NCT03578809|62884064|FG002|Overall Study|Lost to Follow-up|0|||
33503086|NCT03578809|62884065|FG003|Overall Study|Lost to Follow-up|0|||
33503087|NCT03578809|62884062|FG000|Overall Study|Withdrawal by Subject|3|||
33503088|NCT03578809|62884063|FG001|Overall Study|Withdrawal by Subject|5|||
33610479|NCT02296190|63010818|FG005|Overall Study|Lost to Follow-up|0|||
33610480|NCT02296190|63010813|FG000|Overall Study|Failure to induce PSVT|6|||
33503089|NCT03578809|62884064|FG002|Overall Study|Withdrawal by Subject|2|||
33503090|NCT03578809|62884065|FG003|Overall Study|Withdrawal by Subject|0|||
33503091|NCT03578809|62884062|FG000|Overall Study|Other|3|||
33503092|NCT03578809|62884063|FG001|Overall Study|Other|6|||
33503093|NCT03578809|62884064|FG002|Overall Study|Other|2|||
33503094|NCT03578809|62884065|FG003|Overall Study|Other|8|||
33503095|NCT03198507|62884080|FG000|Overall Study|Withdrawal by Subject|1|||
33503096|NCT03198507|62884081|FG001|Overall Study|Withdrawal by Subject|0|||
33503097|NCT03610165|62884089|FG000|Overall Study|Device didn't work|0|||
33503098|NCT03610165|62884090|FG001|Overall Study|Device didn't work|1|||
33503099|NCT03609619|62884098|FG000|Overall Study|Adverse Event|1|||
33503100|NCT03609619|62884099|FG001|Overall Study|Adverse Event|0|||
33503101|NCT03609619|62884098|FG000|Overall Study|Lack of Efficacy|1|||
33503102|NCT03609619|62884099|FG001|Overall Study|Lack of Efficacy|2|||
33503103|NCT03609619|62884098|FG000|Overall Study|Protocol Violation|5|||
33503104|NCT03609619|62884099|FG001|Overall Study|Protocol Violation|0|||
33503105|NCT03609619|62884098|FG000|Overall Study|Withdrawal by Subject|2|||
33610481|NCT02296190|63010814|FG001|Overall Study|Failure to induce PSVT|10|||
33610482|NCT02296190|63010815|FG002|Overall Study|Failure to induce PSVT|5|||
33610483|NCT02296190|63010816|FG003|Overall Study|Failure to induce PSVT|13|||
33610484|NCT02296190|63010817|FG004|Overall Study|Failure to induce PSVT|8|||
33610485|NCT02296190|63010818|FG005|Overall Study|Failure to induce PSVT|0|||
33610486|NCT02296190|63010813|FG000|Overall Study|Physician Decision|1|||
33610487|NCT02296190|63010814|FG001|Overall Study|Physician Decision|1|||
33610488|NCT02296190|63010815|FG002|Overall Study|Physician Decision|0|||
33610489|NCT02296190|63010816|FG003|Overall Study|Physician Decision|1|||
33610490|NCT02296190|63010817|FG004|Overall Study|Physician Decision|2|||
33610491|NCT02296190|63010818|FG005|Overall Study|Physician Decision|0|||
33610492|NCT02296190|63010813|FG000|Overall Study|Withdrawal by Subject|0|||
33610493|NCT02296190|63010814|FG001|Overall Study|Withdrawal by Subject|1|||
33610494|NCT02296190|63010815|FG002|Overall Study|Withdrawal by Subject|0|||
33610495|NCT02296190|63010816|FG003|Overall Study|Withdrawal by Subject|0|||
33610496|NCT02296190|63010817|FG004|Overall Study|Withdrawal by Subject|0|||
33610497|NCT02296190|63010818|FG005|Overall Study|Withdrawal by Subject|0|||
33610498|NCT02296190|63010813|FG000|Overall Study|PSVT < 5 minutes|5|||
33610499|NCT02296190|63010814|FG001|Overall Study|PSVT < 5 minutes|6|||
33449585|NCT00454649|62824508|FG006|Overall Study|Adverse Event|3|||
33449586|NCT00454649|62824509|FG007|Overall Study|Adverse Event|4|||
33449587|NCT00454649|62824510|FG008|Overall Study|Adverse Event|6|||
33449588|NCT00454649|62824511|FG009|Overall Study|Adverse Event|2|||
33449589|NCT00454649|62824502|FG000|Overall Study|Lost to Follow-up|0|||
33449590|NCT00454649|62824503|FG001|Overall Study|Lost to Follow-up|0|||
33449591|NCT00454649|62824504|FG002|Overall Study|Lost to Follow-up|1|||
33449592|NCT00454649|62824505|FG003|Overall Study|Lost to Follow-up|0|||
33449593|NCT00454649|62824506|FG004|Overall Study|Lost to Follow-up|0|||
33449594|NCT00454649|62824507|FG005|Overall Study|Lost to Follow-up|0|||
33449595|NCT00454649|62824508|FG006|Overall Study|Lost to Follow-up|1|||
33449596|NCT00454649|62824509|FG007|Overall Study|Lost to Follow-up|0|||
33449597|NCT00454649|62824510|FG008|Overall Study|Lost to Follow-up|0|||
33503106|NCT03609619|62884099|FG001|Overall Study|Withdrawal by Subject|3|||
33610500|NCT02296190|63010815|FG002|Overall Study|PSVT < 5 minutes|6|||
33610501|NCT02296190|63010816|FG003|Overall Study|PSVT < 5 minutes|6|||
33610502|NCT02296190|63010817|FG004|Overall Study|PSVT < 5 minutes|5|||
33610503|NCT02296190|63010818|FG005|Overall Study|PSVT < 5 minutes|0|||
33449598|NCT00454649|62824511|FG009|Overall Study|Lost to Follow-up|0|||
33503107|NCT03609619|62884098|FG000|Overall Study|Lost to Follow-up|1|||
33503108|NCT03609619|62884099|FG001|Overall Study|Lost to Follow-up|1|||
33503109|NCT03167151|62884108|FG000|Overall Study|Withdrawal by Subject|1|||
33503110|NCT03167151|62884109|FG001|Overall Study|Withdrawal by Subject|0|||
33503111|NCT03167151|62884110|FG002|Overall Study|Withdrawal by Subject|0|||
33610504|NCT02296190|63010813|FG000|Overall Study|Patient was given Propofol|0|||
33503112|NCT03167151|62884108|FG000|Overall Study|No evidence of tumour at surgery|0|||
33610505|NCT02296190|63010814|FG001|Overall Study|Patient was given Propofol|1|||
33610506|NCT02296190|63010815|FG002|Overall Study|Patient was given Propofol|0|||
33610507|NCT02296190|63010816|FG003|Overall Study|Patient was given Propofol|1|||
33610508|NCT02296190|63010817|FG004|Overall Study|Patient was given Propofol|0|||
33503113|NCT03167151|62884109|FG001|Overall Study|No evidence of tumour at surgery|1|||
33503114|NCT03167151|62884110|FG002|Overall Study|No evidence of tumour at surgery|1|||
33503115|NCT03660943|62884120|FG000|Overall Study|Adverse Event|5|||
33503116|NCT03660943|62884121|FG001|Overall Study|Adverse Event|3|||
33503117|NCT03660943|62884120|FG000|Overall Study|Death|0|||
33503118|NCT03660943|62884121|FG001|Overall Study|Death|2|||
33503119|NCT03660943|62884120|FG000|Overall Study|Lost to Follow-up|7|||
33503120|NCT03660943|62884121|FG001|Overall Study|Lost to Follow-up|3|||
33449599|NCT00454649|62824502|FG000|Overall Study|Other|1|||
33449600|NCT00454649|62824503|FG001|Overall Study|Other|1|||
33503121|NCT03660943|62884120|FG000|Overall Study|Protocol Violation|3|||
33503122|NCT03660943|62884121|FG001|Overall Study|Protocol Violation|5|||
33503123|NCT03660943|62884120|FG000|Overall Study|Withdrawal by Subject|8|||
33503124|NCT03660943|62884121|FG001|Overall Study|Withdrawal by Subject|15|||
33503125|NCT03660943|62884120|FG000|Overall Study|Lack of Efficacy|9|||
33503126|NCT03660943|62884121|FG001|Overall Study|Lack of Efficacy|12|||
33503127|NCT03660943|62884120|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
33503128|NCT03660943|62884121|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
33503129|NCT03167073|62884129|FG000|Overall Study|Stillbirth|1|||
33503130|NCT03167073|62884130|FG001|Overall Study|Stillbirth|0|||
33610509|NCT02296190|63010818|FG005|Overall Study|Patient was given Propofol|0|||
33449601|NCT00454649|62824504|FG002|Overall Study|Other|5|||
33503131|NCT03657277|62884136|FG000|Overall Study|Physician Decision|2|||
33503132|NCT03657277|62884136|FG000|Overall Study|Lost to Follow-up|1|||
33503133|NCT03657277|62884136|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
33503134|NCT03197883|62884142|FG000|Overall Study|Adverse Event|1|||
33503135|NCT03197883|62884143|FG001|Overall Study|Adverse Event|1|||
33503136|NCT03197883|62884142|FG000|Overall Study|Lost to Follow-up|1|||
33503137|NCT03197883|62884143|FG001|Overall Study|Lost to Follow-up|0|||
33503138|NCT03197883|62884142|FG000|Overall Study|Protocol Violation|1|||
33503139|NCT03197883|62884143|FG001|Overall Study|Protocol Violation|0|||
33503140|NCT03197883|62884142|FG000|Overall Study|Other (Not Specified)|0|||
33503141|NCT03197883|62884143|FG001|Overall Study|Other (Not Specified)|5|||
33503142|NCT03234036|62884152|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
33503143|NCT03234036|62884153|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
33610510|NCT02296190|63010813|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
33449602|NCT00454649|62824505|FG003|Overall Study|Other|3|||
33449603|NCT00454649|62824506|FG004|Overall Study|Other|0|||
33449604|NCT00454649|62824507|FG005|Overall Study|Other|0|||
33449605|NCT00454649|62824508|FG006|Overall Study|Other|0|||
33449606|NCT00454649|62824509|FG007|Overall Study|Other|0|||
33449607|NCT00454649|62824510|FG008|Overall Study|Other|3|||
33449608|NCT00454649|62824511|FG009|Overall Study|Other|1|||
33449609|NCT00454649|62824502|FG000|Overall Study|Withdrawal by Subject|0|||
33449610|NCT00454649|62824503|FG001|Overall Study|Withdrawal by Subject|0|||
33449611|NCT00454649|62824504|FG002|Overall Study|Withdrawal by Subject|0|||
33449612|NCT00454649|62824505|FG003|Overall Study|Withdrawal by Subject|0|||
33449613|NCT00454649|62824506|FG004|Overall Study|Withdrawal by Subject|0|||
33449614|NCT00454649|62824507|FG005|Overall Study|Withdrawal by Subject|1|||
33449615|NCT00454649|62824508|FG006|Overall Study|Withdrawal by Subject|0|||
33449616|NCT00454649|62824509|FG007|Overall Study|Withdrawal by Subject|2|||
33449617|NCT00454649|62824510|FG008|Overall Study|Withdrawal by Subject|1|||
33449618|NCT00454649|62824511|FG009|Overall Study|Withdrawal by Subject|0|||
33449619|NCT00454571|62824554|FG000|Overall Study|Adverse Event|2|||
33503144|NCT03234036|62884154|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
33503145|NCT03234036|62884155|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
33503146|NCT03606109|62884173|FG000|Overall Study|Lost to Follow-up|2|||
33503147|NCT03606109|62884174|FG001|Overall Study|Lost to Follow-up|1|||
33610511|NCT02296190|63010814|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
33610512|NCT02296190|63010815|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
33449620|NCT00454571|62824555|FG001|Overall Study|Adverse Event|0|||
33449621|NCT00454571|62824554|FG000|Overall Study|Physician Decision|0|||
33449622|NCT00454571|62824555|FG001|Overall Study|Physician Decision|1|||
33449623|NCT00454571|62824554|FG000|Overall Study|Protocol Violation|1|||
33449624|NCT00454571|62824555|FG001|Overall Study|Protocol Violation|0|||
33449625|NCT00454571|62824554|FG000|Overall Study|Withdrawal by Subject|10|||
33449626|NCT00454571|62824555|FG001|Overall Study|Withdrawal by Subject|5|||
33503148|NCT03768336|62884180|FG000|Overall Study|Lost to Follow-up|3|||
33503149|NCT03768336|62884181|FG001|Overall Study|Lost to Follow-up|2|||
33503150|NCT03768336|62884180|FG000|Overall Study|Became Ineligible|2|||
33503151|NCT03768336|62884181|FG001|Overall Study|Became Ineligible|0|||
33503152|NCT03768336|62884180|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
33503153|NCT03768336|62884181|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
33503154|NCT03768336|62884180|FG000|Overall Study|Missed final survey (post-treatment|0|||
33503155|NCT03768336|62884181|FG001|Overall Study|Missed final survey (post-treatment|1|||
33503156|NCT02729896|62884191|FG000|Overall Study|Death|0|||
33503157|NCT02729896|62884192|FG001|Overall Study|Death|2|||
33503158|NCT02729896|62884193|FG002|Overall Study|Death|13|||
33503159|NCT02729896|62884191|FG000|Overall Study|Lost to Follow-up|0|||
33503160|NCT02729896|62884192|FG001|Overall Study|Lost to Follow-up|2|||
33503161|NCT02729896|62884193|FG002|Overall Study|Lost to Follow-up|3|||
33610513|NCT02296190|63010816|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
33610514|NCT02296190|63010817|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
33610515|NCT02296190|63010818|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
33610516|NCT02296190|63010813|FG000|Overall Study|Blood pressure <100 after sedation|0|||
33610517|NCT02296190|63010814|FG001|Overall Study|Blood pressure <100 after sedation|0|||
33610518|NCT02296190|63010815|FG002|Overall Study|Blood pressure <100 after sedation|0|||
33449627|NCT03837743|62824561|FG000|Overall Study|Adverse Event|1|||
33449628|NCT03837743|62824561|FG000|Overall Study|Withdrawal by Subject|2|||
33503162|NCT02729896|62884191|FG000|Overall Study|Other|0|||
33503163|NCT02729896|62884192|FG001|Overall Study|Other|2|||
33503164|NCT02729896|62884193|FG002|Overall Study|Other|0|||
33503165|NCT02729896|62884191|FG000|Overall Study|Physician Decision|1|||
33503166|NCT02729896|62884192|FG001|Overall Study|Physician Decision|2|||
33503167|NCT02729896|62884193|FG002|Overall Study|Physician Decision|3|||
33503168|NCT02729896|62884191|FG000|Overall Study|Progressive Disease|0|||
33503169|NCT02729896|62884192|FG001|Overall Study|Progressive Disease|1|||
33503170|NCT02729896|62884193|FG002|Overall Study|Progressive Disease|0|||
33503171|NCT02729896|62884191|FG000|Overall Study|Withdrawal by Subject|1|||
33503172|NCT02729896|62884192|FG001|Overall Study|Withdrawal by Subject|0|||
33503173|NCT02729896|62884193|FG002|Overall Study|Withdrawal by Subject|3|||
33503174|NCT03575065|62884204|FG000|Overall Study|Death|31|||
33503175|NCT03575065|62884205|FG001|Overall Study|Death|12|||
33503176|NCT03575065|62884204|FG000|Overall Study|Sponsor's Decision|28|||
33503177|NCT03575065|62884205|FG001|Overall Study|Sponsor's Decision|13|||
33449629|NCT03836729|62824569|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
33449630|NCT00443729|62824579|FG000|Overall Study|Never Treated|0|||
33449631|NCT00443729|62824580|FG001|Overall Study|Never Treated|1|||
33449632|NCT00443729|62824579|FG000|Overall Study|Lack of Efficacy|4|||
33449633|NCT00443729|62824580|FG001|Overall Study|Lack of Efficacy|2|||
33449634|NCT00443729|62824579|FG000|Overall Study|Lost to Follow-up|0|||
33449635|NCT00443729|62824580|FG001|Overall Study|Lost to Follow-up|1|||
33449636|NCT00443729|62824579|FG000|Overall Study|Physician Decision|2|||
33449637|NCT00443729|62824580|FG001|Overall Study|Physician Decision|1|||
33449638|NCT00443729|62824579|FG000|Overall Study|Protocol Violation|1|||
33449639|NCT00443729|62824580|FG001|Overall Study|Protocol Violation|1|||
33449640|NCT00443729|62824579|FG000|Overall Study|Withdrawal by Subject|3|||
33449641|NCT00443729|62824580|FG001|Overall Study|Withdrawal by Subject|1|||
33449642|NCT00443651|62824588|FG000|Overall Study|Death|1|||
33449643|NCT00443651|62824589|FG001|Overall Study|Death|5|||
33449644|NCT00443651|62824588|FG000|Overall Study|Adverse Event|5|||
33503178|NCT03575065|62884204|FG000|Overall Study|Withdrawal by Subject|2|||
33503179|NCT03575065|62884205|FG001|Overall Study|Withdrawal by Subject|1|||
33503180|NCT03575065|62884204|FG000|Overall Study|Lost to Follow-up|1|||
33503181|NCT03575065|62884205|FG001|Overall Study|Lost to Follow-up|0|||
33503182|NCT03514134|62884214|FG000|Overall Study|Lost to Follow-up|0|||
33610519|NCT02296190|63010816|FG003|Overall Study|Blood pressure <100 after sedation|1|||
33610520|NCT02296190|63010817|FG004|Overall Study|Blood pressure <100 after sedation|0|||
33449645|NCT00443651|62824589|FG001|Overall Study|Adverse Event|6|||
33449646|NCT00443651|62824588|FG000|Overall Study|Lost to Follow-up|18|||
33610521|NCT02296190|63010818|FG005|Overall Study|Blood pressure <100 after sedation|0|||
33449647|NCT00443651|62824589|FG001|Overall Study|Lost to Follow-up|12|||
33503183|NCT03514134|62884215|FG001|Overall Study|Lost to Follow-up|1|||
33503184|NCT03188718|62884221|FG000|Overall Study|Participant noncompliance|4|||
33503185|NCT03188718|62884221|FG000|Overall Study|Withdrawal by Subject|1|||
33503186|NCT03188718|62884221|FG000|Overall Study|Device failure|3|||
33503187|NCT03574753|62884225|FG000|Overall Study|Adverse Event|3|||
33503188|NCT03574753|62884225|FG000|Overall Study|Progression/relapse|19|||
33503189|NCT03574753|62884225|FG000|Overall Study|Death|1|||
33503190|NCT03573505|62884232|FG000|Overall Study|Adverse Event|1|||
33503191|NCT03573505|62884233|FG001|Overall Study|Adverse Event|1|||
33503192|NCT03573505|62884232|FG000|Overall Study|Consent withdrawn|0|||
33503193|NCT03573505|62884233|FG001|Overall Study|Consent withdrawn|1|||
33503194|NCT03573505|62884232|FG000|Overall Study|Disease progression|0|||
33503195|NCT03573505|62884233|FG001|Overall Study|Disease progression|1|||
33503196|NCT03573505|62884232|FG000|Overall Study|Site Terminated by Sponsor|1|||
33503197|NCT03573505|62884233|FG001|Overall Study|Site Terminated by Sponsor|1|||
33503198|NCT03573505|62884232|FG000|Overall Study|Study terminated by sponsor|50|||
33503199|NCT03573505|62884233|FG001|Overall Study|Study terminated by sponsor|45|||
33503200|NCT03573505|62884232|FG000|Overall Study|Reason not specified|0|||
33503201|NCT03573505|62884233|FG001|Overall Study|Reason not specified|1|||
33503202|NCT03573505|62884232|FG000|Overall Study|Death|0|||
33503203|NCT03573505|62884233|FG001|Overall Study|Death|4|||
33503204|NCT01376908|62884242|FG000|Overall Study|Protocol Violation|1|||
33503205|NCT01376908|62884243|FG001|Overall Study|Protocol Violation|1|||
33503206|NCT01376908|62884242|FG000|Overall Study|Withdrawal by Subject|1|||
33503207|NCT01376908|62884243|FG001|Overall Study|Withdrawal by Subject|2|||
33503208|NCT02668653|62884258|FG000|Overall Study|Refractory disease|41|||
33503209|NCT02668653|62884259|FG001|Overall Study|Refractory disease|70|||
33503210|NCT02668653|62884258|FG000|Overall Study|Relapse|44|||
33503211|NCT02668653|62884259|FG001|Overall Study|Relapse|65|||
33503212|NCT02668653|62884258|FG000|Overall Study|Adverse Event|58|||
33503213|NCT02668653|62884259|FG001|Overall Study|Adverse Event|23|||
33503214|NCT02668653|62884258|FG000|Overall Study|Subject decision to stop study drug|25|||
33503215|NCT02668653|62884259|FG001|Overall Study|Subject decision to stop study drug|23|||
33503216|NCT02668653|62884258|FG000|Overall Study|Other reasons not specified|16|||
33503217|NCT02668653|62884259|FG001|Overall Study|Other reasons not specified|11|||
33503218|NCT02668653|62884258|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
33503219|NCT02668653|62884259|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
33503220|NCT02668653|62884258|FG000|Overall Study|Investigator decision|10|||
33503221|NCT02668653|62884259|FG001|Overall Study|Investigator decision|7|||
33503222|NCT02668653|62884258|FG000|Overall Study|Failure to meet continuation criteria|5|||
33503223|NCT02668653|62884259|FG001|Overall Study|Failure to meet continuation criteria|12|||
33503224|NCT02668653|62884258|FG000|Overall Study|Lost to Follow-up|1|||
33503225|NCT02668653|62884259|FG001|Overall Study|Lost to Follow-up|0|||
33503226|NCT02668653|62884258|FG000|Overall Study|Pregnancy|0|||
33503227|NCT02668653|62884259|FG001|Overall Study|Pregnancy|1|||
33503228|NCT02668653|62884258|FG000|Overall Study|Death|0|||
33503229|NCT02668653|62884259|FG001|Overall Study|Death|1|||
33503230|NCT03736031|62884267|FG000|Overall Study|Death|2|||
33503231|NCT03736031|62884268|FG001|Overall Study|Death|4|||
33503232|NCT03736031|62884267|FG000|Overall Study|Lost to Follow-up|21|||
33503233|NCT03736031|62884268|FG001|Overall Study|Lost to Follow-up|2|||
33503234|NCT03736031|62884267|FG000|Overall Study|Withdrawal by Subject|9|||
33503235|NCT03736031|62884268|FG001|Overall Study|Withdrawal by Subject|0|||
33503236|NCT03602053|62884277|FG000|Overall Study|Withdrawal by Subject|7|||
33503237|NCT03602053|62884278|FG001|Overall Study|Withdrawal by Subject|9|||
33503238|NCT03602053|62884279|FG002|Overall Study|Withdrawal by Subject|7|||
33503239|NCT03602053|62884277|FG000|Overall Study|Lost to Follow-up|5|||
33503240|NCT03602053|62884278|FG001|Overall Study|Lost to Follow-up|6|||
33503241|NCT03602053|62884279|FG002|Overall Study|Lost to Follow-up|0|||
33503242|NCT03602053|62884277|FG000|Overall Study|Protocol Violation|3|||
33503243|NCT03602053|62884278|FG001|Overall Study|Protocol Violation|0|||
33503244|NCT03602053|62884279|FG002|Overall Study|Protocol Violation|4|||
33503245|NCT03602053|62884277|FG000|Overall Study|Physician Decision|1|||
33503246|NCT03602053|62884278|FG001|Overall Study|Physician Decision|0|||
33503247|NCT03602053|62884279|FG002|Overall Study|Physician Decision|0|||
33503248|NCT03602053|62884277|FG000|Overall Study|migration|2|||
33503249|NCT03602053|62884278|FG001|Overall Study|migration|3|||
33610522|NCT02296190|63010813|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
33503250|NCT03602053|62884279|FG002|Overall Study|migration|0|||
33503251|NCT03602053|62884277|FG000|Overall Study|Other|1|||
33324204|NCT00916006|62700644|FG000|Overall Study|Protocol Violation|0|||
33503252|NCT03602053|62884278|FG001|Overall Study|Other|0|||
33503253|NCT03602053|62884279|FG002|Overall Study|Other|0|||
33503254|NCT04831515|62884291|FG000|First Intervention|Adverse Event|0|||
33503255|NCT04831515|62884292|FG001|First Intervention|Adverse Event|1|||
33503256|NCT03554629|62884298|FG000|Overall Study|Inadequate data|6|||
33503257|NCT03196791|62884328|FG000|Overall Study|Protocol Violation|7|||
33503258|NCT03196791|62884329|FG001|Overall Study|Protocol Violation|3|||
33610523|NCT02296190|63010814|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
33503259|NCT03196791|62884328|FG000|Overall Study|Withdrawal by Subject|3|||
33503260|NCT03196791|62884329|FG001|Overall Study|Withdrawal by Subject|2|||
33503261|NCT03196635|62884335|FG000|Overall Study|Withdrawal by Subject|1|||
33503262|NCT03194217|62884357|FG000|Overall Study|Adverse Event|0|||
33503263|NCT03194217|62884358|FG001|Overall Study|Adverse Event|2|||
33503264|NCT03194217|62884359|FG002|Overall Study|Adverse Event|3|||
33503265|NCT03194217|62884360|FG003|Overall Study|Adverse Event|3|||
33503266|NCT03194217|62884357|FG000|Overall Study|Failure to meet randomisation criteria|0|||
33503267|NCT03194217|62884358|FG001|Overall Study|Failure to meet randomisation criteria|0|||
33503268|NCT03194217|62884359|FG002|Overall Study|Failure to meet randomisation criteria|0|||
33503269|NCT03194217|62884360|FG003|Overall Study|Failure to meet randomisation criteria|1|||
33503270|NCT03194217|62884357|FG000|Overall Study|Other|0|||
33503271|NCT03194217|62884358|FG001|Overall Study|Other|1|||
33610524|NCT02296190|63010815|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
33610525|NCT02296190|63010816|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
33610526|NCT02296190|63010817|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
33610527|NCT02296190|63010818|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
33610528|NCT02296190|63010813|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
33610529|NCT02296190|63010814|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
33503272|NCT03194217|62884359|FG002|Overall Study|Other|1|||
33503273|NCT03194217|62884360|FG003|Overall Study|Other|0|||
33503274|NCT00709618|62884370|FG000|Overall Study|Withdrawal by Subject|4|||
33503275|NCT00709618|62884370|FG000|Overall Study|Lost to Follow-up|1|||
33503276|NCT00709618|62884370|FG000|Overall Study|Study Closed/Terminated|25|||
33503277|NCT03193047|62884376|FG000|Overall Study|Physician Decision|1|||
33503278|NCT03193047|62884377|FG001|Overall Study|Physician Decision|0|||
33503279|NCT03193047|62884376|FG000|Overall Study|Participant Left State|1|||
33503280|NCT03193047|62884377|FG001|Overall Study|Participant Left State|0|||
33503281|NCT02918019|62884389|FG000|Overall Study|Death|0|||
33503282|NCT02918019|62884390|FG001|Overall Study|Death|0|||
33503283|NCT02918019|62884391|FG002|Overall Study|Death|1|||
33503284|NCT02918019|62884392|FG003|Overall Study|Death|0|||
33503285|NCT02918019|62884389|FG000|Overall Study|Lost to Follow-up|1|||
33503286|NCT02918019|62884390|FG001|Overall Study|Lost to Follow-up|1|||
33503287|NCT02918019|62884391|FG002|Overall Study|Lost to Follow-up|0|||
33503288|NCT02918019|62884392|FG003|Overall Study|Lost to Follow-up|1|||
33503289|NCT02918019|62884389|FG000|Overall Study|Principal investigator request|0|||
33503290|NCT02918019|62884390|FG001|Overall Study|Principal investigator request|0|||
33503291|NCT02918019|62884391|FG002|Overall Study|Principal investigator request|0|||
33503292|NCT02918019|62884392|FG003|Overall Study|Principal investigator request|1|||
33503293|NCT02918019|62884389|FG000|Overall Study|Physician Decision|1|||
33503294|NCT02918019|62884390|FG001|Overall Study|Physician Decision|3|||
33503295|NCT02918019|62884391|FG002|Overall Study|Physician Decision|2|||
33503296|NCT02918019|62884392|FG003|Overall Study|Physician Decision|0|||
33610530|NCT02296190|63010815|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
33610531|NCT02296190|63010816|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
33610532|NCT02296190|63010817|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
33503297|NCT02918019|62884389|FG000|Overall Study|Protocol deviation|1|||
33503298|NCT02918019|62884390|FG001|Overall Study|Protocol deviation|1|||
33503299|NCT02918019|62884391|FG002|Overall Study|Protocol deviation|0|||
33503300|NCT02918019|62884392|FG003|Overall Study|Protocol deviation|2|||
33503301|NCT02918019|62884389|FG000|Overall Study|Withdrawal by Subject|3|||
33503302|NCT02918019|62884390|FG001|Overall Study|Withdrawal by Subject|4|||
33503303|NCT02918019|62884391|FG002|Overall Study|Withdrawal by Subject|6|||
33503304|NCT02918019|62884392|FG003|Overall Study|Withdrawal by Subject|4|||
33503305|NCT02918019|62884389|FG000|Overall Study|Adverse Event|0|||
33503306|NCT02918019|62884390|FG001|Overall Study|Adverse Event|1|||
33503307|NCT02918019|62884391|FG002|Overall Study|Adverse Event|0|||
33503308|NCT02918019|62884392|FG003|Overall Study|Adverse Event|1|||
33503309|NCT03055988|62884410|FG000|Period 1|Adverse Event|0|||
33503310|NCT03055988|62884411|FG001|Period 1|Adverse Event|1|||
33503311|NCT03055988|62884410|FG000|Period 1|Lost to Follow-up|1|||
33503312|NCT03055988|62884411|FG001|Period 1|Lost to Follow-up|0|||
33503313|NCT03055988|62884410|FG000|Period 1|Withdrawal by Subject|0|||
33503314|NCT03055988|62884411|FG001|Period 1|Withdrawal by Subject|4|||
33503315|NCT03055988|62884410|FG000|Period 2|Adverse Event|0|||
33503316|NCT03055988|62884411|FG001|Period 2|Adverse Event|1|||
33503317|NCT03055988|62884410|FG000|Period 2|Other than listed|1|||
33503318|NCT03055988|62884411|FG001|Period 2|Other than listed|1|||
33503319|NCT01250912|62884417|FG000|Overall Study|Lost to Follow-up|1|||
33503320|NCT03733301|62884427|FG000|Overall Study|Screen Fail|1|||
33503321|NCT03733301|62884428|FG001|Overall Study|Screen Fail|0|||
33503322|NCT03733301|62884429|FG002|Overall Study|Screen Fail|0|||
33503323|NCT03733301|62884427|FG000|Overall Study|Non-compliance|1|||
33503324|NCT03733301|62884428|FG001|Overall Study|Non-compliance|0|||
33503325|NCT03733301|62884429|FG002|Overall Study|Non-compliance|0|||
33503326|NCT03733301|62884427|FG000|Overall Study|Lack of Efficacy|2|||
33503327|NCT03733301|62884428|FG001|Overall Study|Lack of Efficacy|3|||
33503328|NCT03733301|62884429|FG002|Overall Study|Lack of Efficacy|0|||
33503329|NCT03733301|62884427|FG000|Overall Study|Adverse Event|0|||
33503330|NCT03733301|62884428|FG001|Overall Study|Adverse Event|1|||
33503331|NCT03733301|62884429|FG002|Overall Study|Adverse Event|3|||
33503332|NCT03733301|62884427|FG000|Overall Study|Withdrawal by Subject|3|||
33503333|NCT03733301|62884428|FG001|Overall Study|Withdrawal by Subject|5|||
33503334|NCT03733301|62884429|FG002|Overall Study|Withdrawal by Subject|1|||
33503335|NCT02871297|62884438|FG000|Overall Study|Adverse Event|34|||
33503336|NCT02871297|62884438|FG000|Overall Study|Lack of Efficacy|10|||
33503337|NCT02871297|62884438|FG000|Overall Study|Non-compliance with study drug|15|||
33503338|NCT02871297|62884438|FG000|Overall Study|Protocol Violation|3|||
33503339|NCT02871297|62884438|FG000|Overall Study|Withdrawal by Subject|20|||
33503340|NCT02871297|62884438|FG000|Overall Study|Lost to Follow-up|13|||
33503341|NCT02871297|62884438|FG000|Overall Study|Rolled over to 13546A|2|||
33503342|NCT02871297|62884438|FG000|Overall Study|Other than specified|39|||
33503343|NCT03554005|62884448|FG000|Overall Study|Not in participant's best interest|0|||
33503344|NCT03554005|62884449|FG001|Overall Study|Not in participant's best interest|0|||
33503345|NCT03554005|62884450|FG002|Overall Study|Not in participant's best interest|0|||
33503346|NCT03554005|62884451|FG003|Overall Study|Not in participant's best interest|0|||
33503347|NCT03554005|62884452|FG004|Overall Study|Not in participant's best interest|0|||
33503348|NCT03554005|62884453|FG005|Overall Study|Not in participant's best interest|1|||
33503349|NCT03554005|62884448|FG000|Overall Study|Disease Progression|1|||
33503350|NCT03554005|62884449|FG001|Overall Study|Disease Progression|1|||
33503351|NCT03554005|62884450|FG002|Overall Study|Disease Progression|1|||
33503352|NCT03554005|62884451|FG003|Overall Study|Disease Progression|1|||
33503353|NCT03554005|62884452|FG004|Overall Study|Disease Progression|5|||
33503354|NCT03554005|62884453|FG005|Overall Study|Disease Progression|6|||
33503355|NCT03554005|62884448|FG000|Overall Study|Adverse Event|0|||
33503356|NCT03554005|62884449|FG001|Overall Study|Adverse Event|0|||
33503357|NCT03554005|62884450|FG002|Overall Study|Adverse Event|0|||
33503358|NCT03554005|62884451|FG003|Overall Study|Adverse Event|0|||
33610533|NCT02296190|63010818|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
33610534|NCT02296190|63010813|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
33503359|NCT03554005|62884452|FG004|Overall Study|Adverse Event|0|||
33503360|NCT03554005|62884453|FG005|Overall Study|Adverse Event|3|||
33503361|NCT03554005|62884448|FG000|Overall Study|Physician Decision|0|||
33503362|NCT03554005|62884449|FG001|Overall Study|Physician Decision|0|||
33503363|NCT03554005|62884450|FG002|Overall Study|Physician Decision|0|||
33503364|NCT03554005|62884451|FG003|Overall Study|Physician Decision|0|||
33503365|NCT03554005|62884452|FG004|Overall Study|Physician Decision|1|||
33503366|NCT03554005|62884453|FG005|Overall Study|Physician Decision|0|||
33503367|NCT03554005|62884448|FG000|Overall Study|Other|0|||
33503368|NCT03554005|62884449|FG001|Overall Study|Other|0|||
33503369|NCT03554005|62884450|FG002|Overall Study|Other|0|||
33503370|NCT03554005|62884451|FG003|Overall Study|Other|0|||
33503371|NCT03554005|62884452|FG004|Overall Study|Other|0|||
33503372|NCT03554005|62884453|FG005|Overall Study|Other|1|||
33503373|NCT00709228|62884467|FG000|Overall Study|Not treated|14|||
33503374|NCT00709228|62884467|FG000|Overall Study|Eligibility criteria not met|281|||
33503375|NCT00709228|62884467|FG000|Overall Study|Adverse events|2|||
33503376|NCT00709228|62884467|FG000|Overall Study|Discontinued treatment|14|||
33503377|NCT00709228|62884467|FG000|Overall Study|Did not enter follow-up|4|||
33610535|NCT02296190|63010814|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
33610536|NCT02296190|63010815|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
33610537|NCT02296190|63010816|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
33610538|NCT02296190|63010817|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
33610539|NCT02296190|63010818|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
33610540|NCT02296190|63010813|FG000|Overall Study|Lab result not available in time|1|||
33610541|NCT02296190|63010814|FG001|Overall Study|Lab result not available in time|0|||
33610542|NCT02296190|63010815|FG002|Overall Study|Lab result not available in time|0|||
33610543|NCT02296190|63010816|FG003|Overall Study|Lab result not available in time|0|||
33503378|NCT00709228|62884467|FG000|Overall Study|Discontinued follow-up|5|||
33503379|NCT00709228|62884467|FG000|Overall Study|Disease progression|1|||
33503380|NCT00709228|62884467|FG000|Overall Study|Lost to Follow-up|6|||
33503381|NCT00709228|62884467|FG000|Overall Study|Non-compliance|5|||
33503382|NCT03219372|62884473|FG000|Overall Study|Withdrawal by Subject|1|||
33503383|NCT03219372|62884474|FG001|Overall Study|Withdrawal by Subject|0|||
33503384|NCT03056690|62884489|FG000|Overall Study|Adverse Event|3|||
33503385|NCT03056690|62884490|FG001|Overall Study|Adverse Event|2|||
33503386|NCT03056690|62884489|FG000|Overall Study|Lack of Efficacy|1|||
33503387|NCT03056690|62884490|FG001|Overall Study|Lack of Efficacy|2|||
33503388|NCT03056690|62884489|FG000|Overall Study|Lost to Follow-up|3|||
33503389|NCT03056690|62884490|FG001|Overall Study|Lost to Follow-up|2|||
33503390|NCT03056690|62884489|FG000|Overall Study|Protocol Violation|2|||
33503391|NCT03056690|62884490|FG001|Overall Study|Protocol Violation|2|||
33503392|NCT03056690|62884489|FG000|Overall Study|Withdrawal by Subject|3|||
33503393|NCT03056690|62884490|FG001|Overall Study|Withdrawal by Subject|6|||
33610544|NCT02296190|63010817|FG004|Overall Study|Lab result not available in time|0|||
33610545|NCT02296190|63010818|FG005|Overall Study|Lab result not available in time|0|||
33610546|NCT02296112|63010831|FG000|Overall Study|Disease progression|7|||
33610547|NCT02296112|63010831|FG000|Overall Study|Toxicity|1|||
33610548|NCT02296112|63010831|FG000|Overall Study|Began an alternate therapy|1|||
33610549|NCT02295644|63010844|FG000|Overall Study|Did not meet inclusion criterion|0|||
33610550|NCT02295644|63010845|FG001|Overall Study|Did not meet inclusion criterion|0|||
33610551|NCT02295644|63010846|FG002|Overall Study|Did not meet inclusion criterion|1|||
33610552|NCT02295644|63010847|FG003|Overall Study|Did not meet inclusion criterion|2|||
33610553|NCT02269670|63010857|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
33610554|NCT02225353|63010864|FG000|Overall Study|Lost to Follow-up|0|||
33610555|NCT02225353|63010865|FG001|Overall Study|Lost to Follow-up|1|||
33610556|NCT02225353|63010866|FG002|Overall Study|Lost to Follow-up|3|||
33610557|NCT02225353|63010864|FG000|Overall Study|Protocol Violation|4|||
33610558|NCT02225353|63010865|FG001|Overall Study|Protocol Violation|5|||
33610559|NCT02225353|63010866|FG002|Overall Study|Protocol Violation|12|||
33610560|NCT01641926|63010881|FG000|Overall Study|Adverse Event|5|||
33610561|NCT01641926|63010882|FG001|Overall Study|Adverse Event|2|||
33610562|NCT01641926|63010883|FG002|Overall Study|Adverse Event|3|||
33610563|NCT01641926|63010884|FG003|Overall Study|Adverse Event|1|||
33610564|NCT01641926|63010881|FG000|Overall Study|Lost to Follow-up|2|||
33610565|NCT01641926|63010882|FG001|Overall Study|Lost to Follow-up|2|||
33610566|NCT01641926|63010883|FG002|Overall Study|Lost to Follow-up|1|||
33610567|NCT01641926|63010884|FG003|Overall Study|Lost to Follow-up|0|||
33610568|NCT01641926|63010881|FG000|Overall Study|Physician Decision|6|||
33610569|NCT01641926|63010882|FG001|Overall Study|Physician Decision|5|||
33610570|NCT01641926|63010883|FG002|Overall Study|Physician Decision|0|||
33610571|NCT01641926|63010884|FG003|Overall Study|Physician Decision|1|||
33610572|NCT01641926|63010881|FG000|Overall Study|Protocol Violation|1|||
33610573|NCT01641926|63010882|FG001|Overall Study|Protocol Violation|0|||
33610574|NCT01641926|63010883|FG002|Overall Study|Protocol Violation|0|||
33610575|NCT01641926|63010884|FG003|Overall Study|Protocol Violation|1|||
33610576|NCT01641926|63010881|FG000|Overall Study|Withdrawal by Subject|13|||
33610577|NCT01641926|63010882|FG001|Overall Study|Withdrawal by Subject|5|||
33610578|NCT01641926|63010883|FG002|Overall Study|Withdrawal by Subject|6|||
33610579|NCT01641926|63010884|FG003|Overall Study|Withdrawal by Subject|1|||
33610580|NCT01641926|63010881|FG000|Overall Study|Not Treated|1|||
33610581|NCT01641926|63010882|FG001|Overall Study|Not Treated|1|||
33610582|NCT01641926|63010883|FG002|Overall Study|Not Treated|1|||
33610583|NCT01641926|63010884|FG003|Overall Study|Not Treated|0|||
33610584|NCT02295020|63010896|FG000|Overall Study|Adverse Event|0|||
33610585|NCT02295020|63010897|FG001|Overall Study|Adverse Event|1|||
33610586|NCT02295020|63010896|FG000|Overall Study|Withdrawal by Subject|3|||
33610587|NCT02295020|63010897|FG001|Overall Study|Withdrawal by Subject|2|||
33449648|NCT00443651|62824588|FG000|Overall Study|Patient's/Guardian's Decision|58|||
33449649|NCT00443651|62824589|FG001|Overall Study|Patient's/Guardian's Decision|30|||
33449650|NCT00443651|62824588|FG000|Overall Study|Physician Decision|13|||
33449651|NCT00443651|62824589|FG001|Overall Study|Physician Decision|4|||
33449652|NCT00443651|62824588|FG000|Overall Study|Pregnancy|0|||
33449653|NCT00443651|62824589|FG001|Overall Study|Pregnancy|1|||
33449654|NCT00443261|62824595|FG000|Overall Study|Death|1|||
33449655|NCT00439517|62824601|FG000|Overall Study|Subject on treatment|1|||
33449656|NCT00439517|62824602|FG001|Overall Study|Subject on treatment|0|||
33449657|NCT00439517|62824601|FG000|Overall Study|Subject in survival follow-up|1|||
33449658|NCT00439517|62824602|FG001|Overall Study|Subject in survival follow-up|0|||
33449659|NCT00438815|62824608|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
33449660|NCT00438815|62824608|FG000|Overall Study|3-month follow-up no longer required|12|||
33449661|NCT00438815|62824608|FG000|Overall Study|Noncompliance with protocol requirements|9|||
33610588|NCT02200939|63010911|FG000|Overall Study|Participant withdrew consent|0|||
33449662|NCT00438815|62824608|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
33449663|NCT00438815|62824608|FG000|Overall Study|Lost to Follow-up|6|||
33610589|NCT02200939|63010912|FG001|Overall Study|Participant withdrew consent|1|||
33610590|NCT02200939|63010911|FG000|Overall Study|Lost to Follow-up|2|||
33610591|NCT02200939|63010912|FG001|Overall Study|Lost to Follow-up|9|||
33610592|NCT02200939|63010911|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
33610593|NCT02200939|63010912|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
33610594|NCT02294786|63010924|FG000|Overall Study|Withdrawal by Subject|0|||
33503394|NCT03056690|62884489|FG000|Overall Study|Non-compliance with Study Drug|1|||
33503395|NCT03056690|62884490|FG001|Overall Study|Non-compliance with Study Drug|0|||
33503396|NCT03056690|62884489|FG000|Overall Study|Miscellaneous|1|||
33503397|NCT03056690|62884490|FG001|Overall Study|Miscellaneous|2|||
33503398|NCT03191799|62884496|FG000|Overall Study|Withdrawal by Subject|4|||
33503399|NCT03191799|62884496|FG000|Overall Study|Physician Decision|2|||
33503400|NCT03191799|62884496|FG000|Overall Study|Lost to Follow-up|1|||
33503401|NCT03191799|62884496|FG000|Overall Study|Death|2|||
33610595|NCT02294786|63010925|FG001|Overall Study|Withdrawal by Subject|1|||
33610596|NCT02294786|63010924|FG000|Overall Study|Physician Decision|6|||
33610597|NCT02294786|63010925|FG001|Overall Study|Physician Decision|7|||
33610598|NCT02294786|63010924|FG000|Overall Study|Lost to Follow-up|1|||
33610599|NCT02294786|63010925|FG001|Overall Study|Lost to Follow-up|2|||
33610600|NCT02294786|63010924|FG000|Overall Study|Protocol Violation|1|||
33610601|NCT02294786|63010925|FG001|Overall Study|Protocol Violation|0|||
33610602|NCT02294786|63010924|FG000|Overall Study|Adverse Event|1|||
33610603|NCT02294786|63010925|FG001|Overall Study|Adverse Event|1|||
33610604|NCT02294786|63010924|FG000|Overall Study|Death|2|||
33610605|NCT02294786|63010925|FG001|Overall Study|Death|3|||
33610606|NCT02269124|63010934|FG000|Overall Study|Lost to Follow-up|1|||
33503402|NCT00708916|62884500|FG000|Overall Study|Subject Noncompliance|2|||
33503403|NCT00708916|62884500|FG000|Overall Study|Adverse Event|2|||
33503404|NCT02352753|62884505|FG000|6-Month Dosing Period|Decision by sponsor|2|||
33503405|NCT02352753|62884505|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
33503406|NCT02352753|62884505|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
33503407|NCT02352753|62884505|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
33503408|NCT02352753|62884505|FG000|3-Month Dosing Period|Decision by sponsor|14|||
33503409|NCT02352753|62884505|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
33503410|NCT04532294|62884516|FG000|Overall Study|Withdrawal by Subject|0|||
33503411|NCT04532294|62884517|FG001|Overall Study|Withdrawal by Subject|0|||
33503412|NCT04532294|62884518|FG002|Overall Study|Withdrawal by Subject|1|||
33503413|NCT04532294|62884516|FG000|Overall Study|Participants Not Dosed|0|||
33503414|NCT04532294|62884517|FG001|Overall Study|Participants Not Dosed|0|||
33503415|NCT04532294|62884518|FG002|Overall Study|Participants Not Dosed|2|||
33503416|NCT03197766|62884530|FG000|Overall Study|Withdrawal by Subject|2|||
33503417|NCT03197766|62884531|FG001|Overall Study|Withdrawal by Subject|0|||
33503418|NCT03738332|62884537|FG000|Overall Study|Withdrawal by Subject|1|||
33503419|NCT03173456|62884547|FG000|Baseline|Medication dispensing system malfunction'|0|||
33503420|NCT03173456|62884548|FG001|Baseline|Medication dispensing system malfunction'|1|||
33503421|NCT03173456|62884549|FG002|Baseline|Medication dispensing system malfunction'|0|||
33503422|NCT03173456|62884550|FG003|Baseline|Medication dispensing system malfunction'|0|||
33503423|NCT03173456|62884551|FG004|Baseline|Medication dispensing system malfunction'|2|||
33503424|NCT03173456|62884547|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
33503425|NCT03173456|62884548|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
33503426|NCT03173456|62884549|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
33503427|NCT03173456|62884550|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
33503428|NCT03173456|62884551|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
33610607|NCT02269124|63010935|FG001|Overall Study|Lost to Follow-up|0|||
33610608|NCT02269124|63010934|FG000|Overall Study|Withdrawal by Subject|0|||
33503429|NCT03197376|62884574|FG000|Primary and Booster Phase|Adverse Event|0|||
33503430|NCT03197376|62884575|FG001|Primary and Booster Phase|Adverse Event|0|||
33503431|NCT03197376|62884576|FG002|Primary and Booster Phase|Adverse Event|0|||
33503432|NCT03197376|62884577|FG003|Primary and Booster Phase|Adverse Event|1|||
33503433|NCT03197376|62884574|FG000|Primary and Booster Phase|Death|1|||
33610609|NCT02269124|63010935|FG001|Overall Study|Withdrawal by Subject|2|||
33610610|NCT01927341|63010947|FG000|Phase 1b|Lost to Follow-up|1|||
33610611|NCT01927341|63010948|FG001|Phase 1b|Lost to Follow-up|0|||
33324205|NCT00916006|62700645|FG001|Overall Study|Protocol Violation|1|||
33503434|NCT03197376|62884575|FG001|Primary and Booster Phase|Death|0|||
33503435|NCT03197376|62884576|FG002|Primary and Booster Phase|Death|0|||
33503436|NCT03197376|62884577|FG003|Primary and Booster Phase|Death|2|||
33503437|NCT03197376|62884574|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
33503438|NCT03197376|62884575|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
33503439|NCT03197376|62884576|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
33503440|NCT03197376|62884577|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
33503441|NCT03197376|62884574|FG000|Primary and Booster Phase|Physician Decision|1|||
33503442|NCT03197376|62884575|FG001|Primary and Booster Phase|Physician Decision|0|||
33503443|NCT03197376|62884576|FG002|Primary and Booster Phase|Physician Decision|1|||
33503444|NCT03197376|62884577|FG003|Primary and Booster Phase|Physician Decision|3|||
33503445|NCT03197376|62884574|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
33503446|NCT03197376|62884575|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
33503447|NCT03197376|62884576|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
33503448|NCT03197376|62884577|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
33503449|NCT03197376|62884574|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
33503450|NCT03197376|62884575|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
33503451|NCT03197376|62884576|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
33503452|NCT03197376|62884577|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
33503453|NCT03197376|62884574|FG000|Primary and Booster Phase|Not vaccine related|1|||
33503454|NCT03197376|62884575|FG001|Primary and Booster Phase|Not vaccine related|2|||
33503455|NCT03197376|62884576|FG002|Primary and Booster Phase|Not vaccine related|0|||
33503456|NCT03197376|62884577|FG003|Primary and Booster Phase|Not vaccine related|6|||
33503457|NCT03197376|62884574|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
33503458|NCT03197376|62884575|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
33503459|NCT03197376|62884576|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
33503460|NCT03197376|62884577|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
33610612|NCT01927341|63010949|FG002|Phase 1b|Lost to Follow-up|0|||
33610613|NCT01927341|63010950|FG003|Phase 1b|Lost to Follow-up|0|||
33610614|NCT01927341|63010951|FG004|Phase 1b|Lost to Follow-up|0|||
33610615|NCT01927341|63010947|FG000|Phase 1b|Death|2|||
33610616|NCT01927341|63010948|FG001|Phase 1b|Death|0|||
33610617|NCT01927341|63010949|FG002|Phase 1b|Death|0|||
33610618|NCT01927341|63010950|FG003|Phase 1b|Death|0|||
33610619|NCT01927341|63010951|FG004|Phase 1b|Death|0|||
33503461|NCT03197376|62884574|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
33503462|NCT03197376|62884575|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
33503463|NCT03197376|62884576|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
33503464|NCT03197376|62884577|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
33503465|NCT03197376|62884574|FG000|Immune Persistence Phase|Not vaccine related|1|||
33503466|NCT03197376|62884575|FG001|Immune Persistence Phase|Not vaccine related|0|||
33503467|NCT03197376|62884576|FG002|Immune Persistence Phase|Not vaccine related|1|||
33503468|NCT03197376|62884577|FG003|Immune Persistence Phase|Not vaccine related|1|||
33503469|NCT03600805|62884614|FG000|Overall Study|Adverse Event|2|||
33503470|NCT03600805|62884615|FG001|Overall Study|Adverse Event|1|||
33503471|NCT03600805|62884616|FG002|Overall Study|Adverse Event|1|||
33503472|NCT03600805|62884617|FG003|Overall Study|Adverse Event|7|||
33503473|NCT03600805|62884614|FG000|Overall Study|Lack of Efficacy|2|||
33503474|NCT03600805|62884615|FG001|Overall Study|Lack of Efficacy|1|||
33503475|NCT03600805|62884616|FG002|Overall Study|Lack of Efficacy|0|||
33503476|NCT03600805|62884617|FG003|Overall Study|Lack of Efficacy|0|||
33503477|NCT03600805|62884614|FG000|Overall Study|Withdrawal by Subject|1|||
33503478|NCT03600805|62884615|FG001|Overall Study|Withdrawal by Subject|0|||
33503479|NCT03600805|62884616|FG002|Overall Study|Withdrawal by Subject|0|||
33503480|NCT03600805|62884617|FG003|Overall Study|Withdrawal by Subject|1|||
33503481|NCT03600805|62884614|FG000|Overall Study|Other unspecified|14|||
33503482|NCT03600805|62884615|FG001|Overall Study|Other unspecified|6|||
33503483|NCT03600805|62884616|FG002|Overall Study|Other unspecified|7|||
33503484|NCT03600805|62884617|FG003|Overall Study|Other unspecified|11|||
33503485|NCT02729740|62884629|FG000|Overall Study|Early Termination|130|||
33503486|NCT02729740|62884629|FG000|Overall Study|Other|1|||
33503487|NCT03196284|62884639|FG000|Main Part|Withdrawal by Subject|0|||
33503488|NCT03196284|62884640|FG001|Main Part|Withdrawal by Subject|1|||
33503489|NCT03196284|62884641|FG002|Main Part|Withdrawal by Subject|0|||
33503490|NCT03196284|62884639|FG000|Extension Part|Lack of Efficacy|0|||
33503491|NCT03196284|62884640|FG001|Extension Part|Lack of Efficacy|0|||
33503492|NCT03196284|62884641|FG002|Extension Part|Lack of Efficacy|1|||
33503493|NCT03196284|62884639|FG000|Extension Part|Withdrawal by Subject|0|||
33503494|NCT03196284|62884640|FG001|Extension Part|Withdrawal by Subject|0|||
33503495|NCT03196284|62884641|FG002|Extension Part|Withdrawal by Subject|1|||
33610620|NCT01927341|63010947|FG000|Phase 1b|Follow-up completed|7|||
33503496|NCT03196284|62884639|FG000|Extension Part|Physician Decision|0|||
33503497|NCT03196284|62884640|FG001|Extension Part|Physician Decision|0|||
33610621|NCT01927341|63010948|FG001|Phase 1b|Follow-up completed|0|||
33503498|NCT03196284|62884641|FG002|Extension Part|Physician Decision|1|||
33503499|NCT03730961|62884663|FG000|Overall Study|Adverse Event|0|||
33503500|NCT03730961|62884664|FG001|Overall Study|Adverse Event|1|||
33503501|NCT01078454|62884672|FG000|Overall Study|Adverse Event|1|||
33503502|NCT01078454|62884673|FG001|Overall Study|Adverse Event|1|||
33503503|NCT01078454|62884672|FG000|Overall Study|Death|0|||
33503504|NCT01078454|62884673|FG001|Overall Study|Death|1|||
33503505|NCT03345004|62884690|FG000|Overall Study|Physician Decision|1|||
33503506|NCT03345004|62884691|FG001|Overall Study|Physician Decision|0|||
33503507|NCT03345004|62884690|FG000|Overall Study|Withdrawal by Subject|0|||
33503508|NCT03345004|62884691|FG001|Overall Study|Withdrawal by Subject|1|||
33503509|NCT03552757|62884702|FG000|Overall Study|Withdrawal by Subject|10|||
33503510|NCT03552757|62884703|FG001|Overall Study|Withdrawal by Subject|5|||
33503511|NCT03552757|62884704|FG002|Overall Study|Withdrawal by Subject|12|||
33503512|NCT03552757|62884702|FG000|Overall Study|Lost to Follow-up|2|||
33503513|NCT03552757|62884703|FG001|Overall Study|Lost to Follow-up|7|||
33503514|NCT03552757|62884704|FG002|Overall Study|Lost to Follow-up|7|||
33503515|NCT03552757|62884702|FG000|Overall Study|Death|1|||
33503516|NCT03552757|62884703|FG001|Overall Study|Death|1|||
33503517|NCT03552757|62884704|FG002|Overall Study|Death|1|||
33503518|NCT03730103|62884717|FG000|Overall Study|Did not meet inclusion criteria|0|||
33503519|NCT03730103|62884718|FG001|Overall Study|Did not meet inclusion criteria|5|||
33503520|NCT03727841|62884726|FG000|Overall Study|Physician Decision|3|||
33503521|NCT03727841|62884727|FG001|Overall Study|Physician Decision|1|||
33503522|NCT03552523|62884733|FG000|Overall Study|Withdrawal by Subject|1|||
33503523|NCT03552523|62884734|FG001|Overall Study|Withdrawal by Subject|1|||
33503524|NCT03345550|62884742|FG000|Overall Study|Withdrawal by Subject|1|||
33503525|NCT03345550|62884743|FG001|Overall Study|Withdrawal by Subject|0|||
33503526|NCT03345550|62884742|FG000|Overall Study|Lost to Follow-up|4|||
33503527|NCT03345550|62884743|FG001|Overall Study|Lost to Follow-up|5|||
33503528|NCT03186378|62884751|FG000|Overall Study|Lost to Follow-up|1|||
33503529|NCT03186378|62884752|FG001|Overall Study|Lost to Follow-up|0|||
33503530|NCT00687596|62884760|FG000|Overall Study|Adverse Event (AE)|10|||
33503531|NCT00687596|62884761|FG001|Overall Study|Adverse Event (AE)|3|||
33503532|NCT00687596|62884760|FG000|Overall Study|Radiological Disease Progression|6|||
33503533|NCT00687596|62884761|FG001|Overall Study|Radiological Disease Progression|2|||
33503534|NCT00687596|62884760|FG000|Overall Study|Clinical Disease Progression|1|||
33503535|NCT00687596|62884761|FG001|Overall Study|Clinical Disease Progression|3|||
33503536|NCT00687596|62884760|FG000|Overall Study|Investigator Discretion|3|||
33503537|NCT00687596|62884761|FG001|Overall Study|Investigator Discretion|1|||
33503538|NCT00687596|62884760|FG000|Overall Study|Sponsor Terminated Study|6|||
33503539|NCT00687596|62884761|FG001|Overall Study|Sponsor Terminated Study|17|||
33503540|NCT02892409|62884769|FG000|Overall Study|Adverse Event|1|||
33503541|NCT02892409|62884770|FG001|Overall Study|Adverse Event|0|||
33503542|NCT02892409|62884769|FG000|Overall Study|Withdrawal by Subject|2|||
33503543|NCT02892409|62884770|FG001|Overall Study|Withdrawal by Subject|1|||
33503544|NCT03219216|62884778|FG000|Overall Study|Lost to Follow-up|0|||
33503545|NCT03219216|62884779|FG001|Overall Study|Lost to Follow-up|1|||
33503546|NCT03195660|62884793|FG000|Overall Study|The study was terminated|2|||
33503547|NCT03194490|62884799|FG000|Overall Study|Lost to Follow-up|1|||
33503548|NCT03194490|62884800|FG001|Overall Study|Lost to Follow-up|3|||
33503549|NCT03194490|62884799|FG000|Overall Study|participant developed specific neck pain|1|||
33503550|NCT03194490|62884800|FG001|Overall Study|participant developed specific neck pain|0|||
33503551|NCT03217968|62884807|FG000|Overall Study|Withdrawal by Subject|4|||
33503552|NCT03217968|62884807|FG000|Overall Study|Lost to Follow-up|1|||
33503553|NCT03217968|62884807|FG000|Overall Study|Protocol Violation|6|||
33503554|NCT03192306|62884813|FG000|Overall Study|Did not treat cold sore during study|149|||
33503555|NCT03192306|62884814|FG001|Overall Study|Did not treat cold sore during study|143|||
33503556|NCT03192306|62884813|FG000|Overall Study|Withdrawal by Subject|1|||
33503557|NCT03192306|62884814|FG001|Overall Study|Withdrawal by Subject|1|||
33503558|NCT03192306|62884813|FG000|Overall Study|Lost to Follow-up|1|||
33503559|NCT03192306|62884814|FG001|Overall Study|Lost to Follow-up|0|||
33503560|NCT03192306|62884813|FG000|Overall Study|Protocol Violation|1|||
33503561|NCT03192306|62884814|FG001|Overall Study|Protocol Violation|1|||
33503562|NCT03216954|62884837|FG000|Overall Study|Adverse Event|0|||
33503563|NCT03216954|62884838|FG001|Overall Study|Adverse Event|0|||
33503564|NCT03216954|62884839|FG002|Overall Study|Adverse Event|1|||
33503565|NCT03216954|62884840|FG003|Overall Study|Adverse Event|0|||
33503566|NCT03216954|62884841|FG004|Overall Study|Adverse Event|1|||
33503567|NCT03216954|62884837|FG000|Overall Study|Withdrawal by Subject|2|||
33503568|NCT03216954|62884838|FG001|Overall Study|Withdrawal by Subject|0|||
33503569|NCT03216954|62884839|FG002|Overall Study|Withdrawal by Subject|0|||
33503570|NCT03216954|62884840|FG003|Overall Study|Withdrawal by Subject|0|||
33503571|NCT03216954|62884841|FG004|Overall Study|Withdrawal by Subject|0|||
33503572|NCT03216954|62884837|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
33503573|NCT03216954|62884838|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
33610622|NCT01927341|63010949|FG002|Phase 1b|Follow-up completed|0|||
33503574|NCT03216954|62884839|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
33503575|NCT03216954|62884840|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
33503576|NCT03216954|62884841|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
33503577|NCT03599089|62884853|FG000|Overall Study|Lost to Follow-up|1|||
33503578|NCT03599089|62884854|FG001|Overall Study|Lost to Follow-up|0|||
33503579|NCT03599089|62884855|FG002|Overall Study|Lost to Follow-up|0|||
33503580|NCT03599089|62884856|FG003|Overall Study|Lost to Follow-up|0|||
33503581|NCT03599089|62884853|FG000|Overall Study|Withdrawal by Subject|2|||
33503582|NCT03599089|62884854|FG001|Overall Study|Withdrawal by Subject|1|||
33503583|NCT03599089|62884855|FG002|Overall Study|Withdrawal by Subject|0|||
33503584|NCT03599089|62884856|FG003|Overall Study|Withdrawal by Subject|0|||
33503585|NCT03599089|62884853|FG000|Overall Study|Lack of Efficacy|0|||
33503586|NCT03599089|62884854|FG001|Overall Study|Lack of Efficacy|0|||
33503587|NCT03599089|62884855|FG002|Overall Study|Lack of Efficacy|1|||
33503588|NCT03599089|62884856|FG003|Overall Study|Lack of Efficacy|2|||
33503589|NCT03192150|62884868|FG000|Overall Study|Adverse Event|14|||
33503590|NCT03192150|62884869|FG001|Overall Study|Adverse Event|12|||
33503591|NCT03192150|62884868|FG000|Overall Study|Lack of Efficacy|23|||
33503592|NCT03192150|62884869|FG001|Overall Study|Lack of Efficacy|30|||
33503593|NCT03192150|62884868|FG000|Overall Study|Lost to Follow-up|1|||
33503594|NCT03192150|62884869|FG001|Overall Study|Lost to Follow-up|1|||
33503595|NCT03192150|62884868|FG000|Overall Study|Withdrawal by Subject|4|||
33503596|NCT03192150|62884869|FG001|Overall Study|Withdrawal by Subject|2|||
33503597|NCT03192150|62884868|FG000|Overall Study|Protocol Violation|5|||
33610623|NCT01927341|63010950|FG003|Phase 1b|Follow-up completed|0|||
33610624|NCT01927341|63010951|FG004|Phase 1b|Follow-up completed|0|||
33610625|NCT01927341|63010947|FG000|Phase 2|Lost to Follow-up|0|||
33610626|NCT01927341|63010948|FG001|Phase 2|Lost to Follow-up|1|||
33610627|NCT01927341|63010949|FG002|Phase 2|Lost to Follow-up|0|||
33610628|NCT01927341|63010950|FG003|Phase 2|Lost to Follow-up|0|||
33610629|NCT01927341|63010951|FG004|Phase 2|Lost to Follow-up|0|||
33610630|NCT01927341|63010947|FG000|Phase 2|Participant withdrew consent|0|||
33503598|NCT03192150|62884869|FG001|Overall Study|Protocol Violation|2|||
33503599|NCT03192150|62884868|FG000|Overall Study|Surgery Canceled|6|||
33503600|NCT03192150|62884869|FG001|Overall Study|Surgery Canceled|2|||
33503601|NCT03192150|62884868|FG000|Overall Study|Other-Various Administrative Reasons|2|||
33610631|NCT01927341|63010948|FG001|Phase 2|Participant withdrew consent|2|||
33503602|NCT03192150|62884869|FG001|Overall Study|Other-Various Administrative Reasons|5|||
33503603|NCT03597529|62884877|FG000|Overall Study|Lost to Follow-up|10|||
33503604|NCT03597529|62884878|FG001|Overall Study|Lost to Follow-up|12|||
33503605|NCT03597529|62884877|FG000|Overall Study|Physician Decision|3|||
33503606|NCT03597529|62884878|FG001|Overall Study|Physician Decision|1|||
33503607|NCT03597529|62884877|FG000|Overall Study|Withdrawal by Subject|6|||
33503608|NCT03597529|62884878|FG001|Overall Study|Withdrawal by Subject|3|||
33503609|NCT03597529|62884877|FG000|Overall Study|Non-compliant with study activities|1|||
33503610|NCT03597529|62884878|FG001|Overall Study|Non-compliant with study activities|2|||
33503611|NCT03180528|62884884|FG000|Overall Study|Adverse Event|1|||
33610632|NCT01927341|63010949|FG002|Phase 2|Participant withdrew consent|1|||
33610633|NCT01927341|63010950|FG003|Phase 2|Participant withdrew consent|2|||
33610634|NCT01927341|63010951|FG004|Phase 2|Participant withdrew consent|3|||
33610635|NCT01927341|63010947|FG000|Phase 2|Death|0|||
33610636|NCT01927341|63010948|FG001|Phase 2|Death|4|||
33610637|NCT01927341|63010949|FG002|Phase 2|Death|0|||
33610638|NCT01927341|63010950|FG003|Phase 2|Death|3|||
33449664|NCT00438815|62824608|FG000|Overall Study|Withdrawal by Subject|6|||
33449665|NCT00438815|62824608|FG000|Overall Study|Death|1|||
33449666|NCT00438659|62824614|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
33449667|NCT00438659|62824615|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
33449668|NCT00438659|62824614|FG000|Overall Study|Cancel|5|||
33449669|NCT00438659|62824615|FG001|Overall Study|Cancel|2|||
33449670|NCT00437645|62824624|FG000|Overall Study|Adverse Event|15|||
33449671|NCT00437645|62824625|FG001|Overall Study|Adverse Event|84|||
33503612|NCT03180528|62884884|FG000|Overall Study|Withdrawal by Subject|1|||
33503613|NCT03180528|62884884|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
33610639|NCT01927341|63010951|FG004|Phase 2|Death|2|||
33610640|NCT01927341|63010947|FG000|Phase 2|New cancer therapy|0|||
33449672|NCT00437645|62824624|FG000|Overall Study|Withdrawal by Subject|10|||
33449673|NCT00437645|62824625|FG001|Overall Study|Withdrawal by Subject|22|||
33449674|NCT00437645|62824624|FG000|Overall Study|Protocol Violation|3|||
33449675|NCT00437645|62824625|FG001|Overall Study|Protocol Violation|3|||
33503614|NCT03597295|62884888|FG000|Overall Study|Death|70|||
33503615|NCT03597295|62884888|FG000|Overall Study|Lost to Follow-up|7|||
33610641|NCT01927341|63010948|FG001|Phase 2|New cancer therapy|1|||
33610642|NCT01927341|63010949|FG002|Phase 2|New cancer therapy|0|||
33449676|NCT00437645|62824624|FG000|Overall Study|Lost to Follow-up|2|||
33503616|NCT03180138|62884895|FG000|Overall Study|Mobile-phone could not be verified|2|||
33610643|NCT01927341|63010950|FG003|Phase 2|New cancer therapy|4|||
33610644|NCT01927341|63010951|FG004|Phase 2|New cancer therapy|1|||
33610645|NCT01927341|63010947|FG000|Phase 2|Disease progression|0|||
33610646|NCT01927341|63010948|FG001|Phase 2|Disease progression|1|||
33503617|NCT03180138|62884896|FG001|Overall Study|Mobile-phone could not be verified|13|||
33503618|NCT03180138|62884897|FG002|Overall Study|Mobile-phone could not be verified|15|||
33503619|NCT03180138|62884895|FG000|Overall Study|No prior immunization records|17|||
33503620|NCT03180138|62884896|FG001|Overall Study|No prior immunization records|0|||
33503621|NCT03180138|62884897|FG002|Overall Study|No prior immunization records|6|||
33503622|NCT03180138|62884895|FG000|Overall Study|Found to be >24 mon after randomization|3|||
33503623|NCT03180138|62884896|FG001|Overall Study|Found to be >24 mon after randomization|0|||
33503624|NCT03180138|62884897|FG002|Overall Study|Found to be >24 mon after randomization|3|||
33503625|NCT03597139|62884907|FG000|Overall Study|Adverse Event|3|||
33503626|NCT03597139|62884908|FG001|Overall Study|Adverse Event|0|||
33503627|NCT03597139|62884907|FG000|Overall Study|Protocol Non-compliance|1|||
33610647|NCT01927341|63010949|FG002|Phase 2|Disease progression|1|||
33610648|NCT01927341|63010950|FG003|Phase 2|Disease progression|1|||
33610649|NCT01927341|63010951|FG004|Phase 2|Disease progression|0|||
33610650|NCT01927341|63010947|FG000|Phase 2|Follow-up completed|0|||
33610651|NCT01927341|63010948|FG001|Phase 2|Follow-up completed|6|||
33610652|NCT01927341|63010949|FG002|Phase 2|Follow-up completed|3|||
33610653|NCT01927341|63010950|FG003|Phase 2|Follow-up completed|5|||
33610654|NCT01927341|63010951|FG004|Phase 2|Follow-up completed|2|||
33610655|NCT02294474|63010969|FG000|Overall Study|Adverse Event|7|||
33610656|NCT02294474|63010970|FG001|Overall Study|Adverse Event|7|||
33610657|NCT02294474|63010969|FG000|Overall Study|Lack of Efficacy|2|||
33610658|NCT02294474|63010970|FG001|Overall Study|Lack of Efficacy|1|||
33610659|NCT02294474|63010969|FG000|Overall Study|Protocol Violation|4|||
33449677|NCT00437645|62824625|FG001|Overall Study|Lost to Follow-up|3|||
33449678|NCT00437645|62824624|FG000|Overall Study|Administrative problems|2|||
33449679|NCT00437645|62824625|FG001|Overall Study|Administrative problems|1|||
33449680|NCT00437645|62824624|FG000|Overall Study|Lack of Efficacy|2|||
33449681|NCT00437645|62824625|FG001|Overall Study|Lack of Efficacy|1|||
33449682|NCT00437645|62824624|FG000|Overall Study|Condition no longer requires study drug|1|||
33449683|NCT00437645|62824625|FG001|Overall Study|Condition no longer requires study drug|1|||
33449684|NCT00437489|62824633|FG000|Overall Study|Study terminated by sponsor|23|||
33449685|NCT00437489|62824634|FG001|Overall Study|Study terminated by sponsor|21|||
33449686|NCT00437489|62824633|FG000|Overall Study|Lost to Follow-up|0|||
33449687|NCT00437489|62824634|FG001|Overall Study|Lost to Follow-up|1|||
33503628|NCT03597139|62884908|FG001|Overall Study|Protocol Non-compliance|0|||
33503629|NCT03179202|62884914|FG000|Overall Study|Screen Failure|67|||
33503630|NCT03179202|62884914|FG000|Overall Study|Subject Lost to Follow Up|12|||
33503631|NCT03179202|62884914|FG000|Overall Study|Withdrawal by Subject|7|||
33503632|NCT03179202|62884914|FG000|Overall Study|Adverse Event|3|||
33503633|NCT03179202|62884914|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
33503634|NCT03179202|62884914|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
33503635|NCT00708214|62884923|FG000|Overall Study|Other Adverse Event|3|||
33503636|NCT00708214|62884924|FG001|Overall Study|Other Adverse Event|6|||
33503637|NCT00708214|62884925|FG002|Overall Study|Other Adverse Event|2|||
33503638|NCT00708214|62884923|FG000|Overall Study|Other|0|||
33503639|NCT00708214|62884924|FG001|Overall Study|Other|1|||
33503640|NCT00708214|62884925|FG002|Overall Study|Other|1|||
33503641|NCT00708214|62884923|FG000|Overall Study|Progressive Disease|4|||
33503642|NCT00708214|62884924|FG001|Overall Study|Progressive Disease|6|||
33503643|NCT00708214|62884925|FG002|Overall Study|Progressive Disease|5|||
33503644|NCT03570697|62884940|FG000|Overall Study|Lost to Follow-up|0|||
33503645|NCT03570697|62884941|FG001|Overall Study|Lost to Follow-up|1|||
33503646|NCT03570697|62884940|FG000|Overall Study|Death|2|||
33503647|NCT03570697|62884941|FG001|Overall Study|Death|0|||
33610660|NCT02294474|63010970|FG001|Overall Study|Protocol Violation|2|||
33610661|NCT02294474|63010969|FG000|Overall Study|Other than specified above|12|||
33503648|NCT03570697|62884940|FG000|Overall Study|Withdrawal by Subject|4|||
33503649|NCT03570697|62884941|FG001|Overall Study|Withdrawal by Subject|2|||
33503650|NCT03569371|62884958|FG000|Overall Study|Lack of Efficacy|1|||
33503651|NCT03569371|62884958|FG000|Overall Study|Lost to Follow-up|1|||
33503652|NCT03569371|62884958|FG000|Overall Study|Adverse Event|1|||
33503653|NCT01318070|62884965|FG000|Overall Study|Adverse Event|1|||
33503654|NCT01318070|62884966|FG001|Overall Study|Adverse Event|1|||
33503655|NCT01318070|62884967|FG002|Overall Study|Adverse Event|5|||
33610662|NCT02294474|63010970|FG001|Overall Study|Other than specified above|12|||
33610663|NCT02168101|63010980|FG000|Overall Study|Death|2|||
33610664|NCT02168101|63010981|FG001|Overall Study|Death|2|||
33610665|NCT02168101|63010982|FG002|Overall Study|Death|1|||
33610666|NCT02298179|63011003|FG000|Overall Study|Lost to Follow-up|0|||
33610667|NCT02298179|63011004|FG001|Overall Study|Lost to Follow-up|0|||
33610668|NCT02298179|63011005|FG002|Overall Study|Lost to Follow-up|1|||
33610669|NCT02298179|63011006|FG003|Overall Study|Lost to Follow-up|0|||
33610670|NCT02298179|63011007|FG004|Overall Study|Lost to Follow-up|0|||
33610671|NCT02298179|63011008|FG005|Overall Study|Lost to Follow-up|0|||
33610672|NCT02298179|63011009|FG006|Overall Study|Lost to Follow-up|0|||
33610673|NCT02298179|63011010|FG007|Overall Study|Lost to Follow-up|1|||
33610674|NCT02298179|63011011|FG008|Overall Study|Lost to Follow-up|0|||
33610675|NCT02298179|63011012|FG009|Overall Study|Lost to Follow-up|0|||
33610676|NCT02298179|63011013|FG010|Overall Study|Lost to Follow-up|0|||
33610677|NCT02298179|63011014|FG011|Overall Study|Lost to Follow-up|0|||
33503656|NCT01318070|62884965|FG000|Overall Study|Withdrawal by Subject|0|||
33610678|NCT02298023|63011043|FG000|Overall Study|Withdrawal by Subject|1|||
33610679|NCT02298023|63011044|FG001|Overall Study|Withdrawal by Subject|0|||
33610680|NCT02298023|63011045|FG002|Overall Study|Withdrawal by Subject|0|||
33610681|NCT02296931|63011058|FG000|Overall Study|Protocol Violation|0|||
33610682|NCT02296931|63011059|FG001|Overall Study|Protocol Violation|2|||
33610683|NCT02166697|63011065|FG000|Overall Study|Protocol Violation|347|||
33610684|NCT01909479|63011071|FG000|From Baseline to Week 26|Adverse Event|3|||
33610685|NCT01909479|63011072|FG001|From Baseline to Week 26|Adverse Event|2|||
33610686|NCT01909479|63011071|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
33610687|NCT01909479|63011072|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
33610688|NCT01909479|63011071|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
33610689|NCT01909479|63011072|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
33610690|NCT01909479|63011071|FG000|26 - 52 Weeks|Adverse Event|0|||
33610691|NCT01909479|63011072|FG001|26 - 52 Weeks|Adverse Event|1|||
33610692|NCT01909479|63011071|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
33610693|NCT01909479|63011072|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
33610694|NCT01909479|63011071|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
33610695|NCT01909479|63011072|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
33610696|NCT01909479|63011071|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
33610697|NCT01909479|63011072|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
33610698|NCT01909479|63011071|FG000|52 Weeks to End of Study|Adverse Event|2|||
33610699|NCT01909479|63011072|FG001|52 Weeks to End of Study|Adverse Event|1|||
33503657|NCT01318070|62884966|FG001|Overall Study|Withdrawal by Subject|1|||
33503658|NCT01318070|62884967|FG002|Overall Study|Withdrawal by Subject|1|||
33503659|NCT01318070|62884965|FG000|Overall Study|Lack of Efficacy|0|||
33503660|NCT01318070|62884966|FG001|Overall Study|Lack of Efficacy|0|||
33503661|NCT01318070|62884967|FG002|Overall Study|Lack of Efficacy|1|||
33503662|NCT01318070|62884965|FG000|Overall Study|Principal Investigator Discretion|1|||
33503663|NCT01318070|62884966|FG001|Overall Study|Principal Investigator Discretion|0|||
33503664|NCT01318070|62884967|FG002|Overall Study|Principal Investigator Discretion|0|||
33503665|NCT02895295|62884978|FG000|Overall Study|Survey Non-response|71|||
33503666|NCT02895295|62884979|FG001|Overall Study|Survey Non-response|94|||
33503667|NCT02895295|62884980|FG002|Overall Study|Survey Non-response|92|||
33503668|NCT00245960|62884990|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
33503669|NCT00245960|62884991|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
33503670|NCT00245960|62884990|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
33503671|NCT00245960|62884991|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
33503672|NCT00245960|62884990|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
33503673|NCT00245960|62884991|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
33503674|NCT00245960|62884990|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
33610700|NCT01909479|63011071|FG000|52 Weeks to End of Study|Death|0|||
33610701|NCT01909479|63011072|FG001|52 Weeks to End of Study|Death|1|||
33610702|NCT01909479|63011071|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
33610703|NCT01909479|63011072|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
33610704|NCT01909479|63011071|FG000|52 Weeks to End of Study|Protocol Violation|1|||
33610705|NCT01909479|63011072|FG001|52 Weeks to End of Study|Protocol Violation|0|||
33610706|NCT01909479|63011071|FG000|52 Weeks to End of Study|Progressive disease|1|||
33503675|NCT00245960|62884991|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
33610707|NCT01909479|63011072|FG001|52 Weeks to End of Study|Progressive disease|1|||
33610708|NCT01909479|63011071|FG000|52 Weeks to End of Study|Personal reasons|2|||
33610709|NCT01909479|63011072|FG001|52 Weeks to End of Study|Personal reasons|1|||
33610710|NCT01909479|63011071|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
33610711|NCT01909479|63011072|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
33610712|NCT01909479|63011071|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
33610713|NCT01909479|63011072|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
33610714|NCT01909479|63011071|FG000|52 Weeks to End of Study|Lack of contact|1|||
33610715|NCT01909479|63011072|FG001|52 Weeks to End of Study|Lack of contact|0|||
33610716|NCT01909479|63011071|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
33610717|NCT01909479|63011072|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
33610718|NCT01909479|63011071|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
33610719|NCT01909479|63011072|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
33610720|NCT01955733|63011085|FG000|Period 1|Lost to Follow-up|1|||
33610721|NCT01955733|63011086|FG001|Period 1|Lost to Follow-up|0|||
33610722|NCT01955733|63011087|FG002|Period 1|Lost to Follow-up|0|||
33610723|NCT01955733|63011085|FG000|Period 2|Adverse Event|1|||
33610724|NCT01955733|63011086|FG001|Period 2|Adverse Event|0|||
33610725|NCT01955733|63011087|FG002|Period 2|Adverse Event|0|||
33610726|NCT01955733|63011085|FG000|Period 2|Physician Decision|0|||
33610727|NCT01955733|63011086|FG001|Period 2|Physician Decision|0|||
33610728|NCT01955733|63011087|FG002|Period 2|Physician Decision|1|||
33610729|NCT01955733|63011085|FG000|Period 2|Withdrawal by Subject|1|||
33610730|NCT01955733|63011086|FG001|Period 2|Withdrawal by Subject|3|||
33610731|NCT01955733|63011087|FG002|Period 2|Withdrawal by Subject|2|||
33610732|NCT01955733|63011085|FG000|Period 2|Study terminated by sponsor|8|||
33610733|NCT01955733|63011086|FG001|Period 2|Study terminated by sponsor|14|||
33610734|NCT01955733|63011087|FG002|Period 2|Study terminated by sponsor|16|||
33610735|NCT01955733|63011085|FG000|Period 2|Lost to Follow-up|2|||
33610736|NCT01955733|63011086|FG001|Period 2|Lost to Follow-up|0|||
33610737|NCT01955733|63011087|FG002|Period 2|Lost to Follow-up|0|||
33610738|NCT01955733|63011085|FG000|Period 2|Other not defined above|0|||
33610739|NCT01955733|63011086|FG001|Period 2|Other not defined above|2|||
33610740|NCT01955733|63011087|FG002|Period 2|Other not defined above|2|||
33610741|NCT02197897|63011095|FG000|Overall Study|not eligible|1|||
33610742|NCT02223793|63011102|FG000|Overall Study|Lost to Follow-up|10|||
33610743|NCT02223793|63011103|FG001|Overall Study|Lost to Follow-up|1|||
33610744|NCT02223793|63011104|FG002|Overall Study|Lost to Follow-up|2|||
33610745|NCT02223793|63011102|FG000|Overall Study|Withdrawal by Subject|3|||
33449688|NCT00442559|62824642|FG000|Overall Study|Lost to Follow-up|32|||
33449689|NCT00442559|62824643|FG001|Overall Study|Lost to Follow-up|34|||
33449690|NCT00442559|62824642|FG000|Overall Study|Protocol Violation|1|||
33449691|NCT00442559|62824643|FG001|Overall Study|Protocol Violation|1|||
33449692|NCT00442559|62824642|FG000|Overall Study|Withdrawal by Subject|1|||
33449693|NCT00442559|62824643|FG001|Overall Study|Withdrawal by Subject|0|||
33449694|NCT00441701|62824665|FG000|Overall Study|Adverse Event|3|||
33449695|NCT00441701|62824666|FG001|Overall Study|Adverse Event|2|||
33449696|NCT00441701|62824667|FG002|Overall Study|Adverse Event|1|||
33610746|NCT02223793|63011103|FG001|Overall Study|Withdrawal by Subject|2|||
33610747|NCT02223793|63011104|FG002|Overall Study|Withdrawal by Subject|3|||
33610748|NCT02223793|63011102|FG000|Overall Study|Moved/studycenter unable to participate|4|||
33610749|NCT02223793|63011103|FG001|Overall Study|Moved/studycenter unable to participate|6|||
33610750|NCT02223793|63011104|FG002|Overall Study|Moved/studycenter unable to participate|8|||
33610751|NCT01926015|63011114|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33610752|NCT01926015|63011115|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33610753|NCT01926015|63011114|FG000|Overall Study|Randomized not treated|2|||
33610754|NCT01926015|63011115|FG001|Overall Study|Randomized not treated|0|||
33610755|NCT02223715|63011121|FG000|Overall Study|Death|31|||
33610756|NCT02223715|63011121|FG000|Overall Study|Lost to Follow-up|73|||
33610757|NCT02196259|63011131|FG000|Overall Study|Researcher choice|0|||
33610758|NCT02196259|63011132|FG001|Overall Study|Researcher choice|0|||
33610759|NCT02196259|63011133|FG002|Overall Study|Researcher choice|1|||
33610760|NCT02196259|63011131|FG000|Overall Study|Partial data analysis|0|||
33610761|NCT02196259|63011132|FG001|Overall Study|Partial data analysis|3|||
33610762|NCT02196259|63011133|FG002|Overall Study|Partial data analysis|0|||
33610763|NCT02294396|63011144|FG000|Overall Study|Adverse Event|26|||
33610764|NCT02294396|63011145|FG001|Overall Study|Adverse Event|25|||
33610765|NCT02294396|63011146|FG002|Overall Study|Adverse Event|21|||
33610766|NCT02294396|63011147|FG003|Overall Study|Adverse Event|24|||
33610767|NCT02294396|63011144|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
33610768|NCT02294396|63011145|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
33610769|NCT02294396|63011146|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
33610770|NCT02294396|63011147|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
33610771|NCT02294396|63011144|FG000|Overall Study|Withdrawal by Subject|8|||
33610772|NCT02294396|63011145|FG001|Overall Study|Withdrawal by Subject|6|||
33610773|NCT02294396|63011146|FG002|Overall Study|Withdrawal by Subject|6|||
33610774|NCT02294396|63011147|FG003|Overall Study|Withdrawal by Subject|8|||
33610775|NCT02294396|63011144|FG000|Overall Study|Lost to Follow-up|0|||
33610776|NCT02294396|63011145|FG001|Overall Study|Lost to Follow-up|0|||
33610777|NCT02294396|63011146|FG002|Overall Study|Lost to Follow-up|1|||
33610778|NCT02294396|63011147|FG003|Overall Study|Lost to Follow-up|1|||
33610779|NCT02294396|63011144|FG000|Overall Study|Protocol Deviation|3|||
33610780|NCT02294396|63011145|FG001|Overall Study|Protocol Deviation|2|||
33610781|NCT02294396|63011146|FG002|Overall Study|Protocol Deviation|2|||
33449697|NCT00441701|62824668|FG003|Overall Study|Adverse Event|0|||
33449698|NCT00441701|62824669|FG004|Overall Study|Adverse Event|2|||
33449699|NCT00441701|62824670|FG005|Overall Study|Adverse Event|2|||
33449700|NCT00441701|62824671|FG006|Overall Study|Adverse Event|0|||
33449701|NCT00441701|62824672|FG007|Overall Study|Adverse Event|0|||
33449702|NCT00441701|62824673|FG008|Overall Study|Adverse Event|0|||
33449703|NCT00441701|62824674|FG009|Overall Study|Adverse Event|0|||
33449704|NCT00441701|62824665|FG000|Overall Study|Lack of Efficacy|2|||
33449705|NCT00441701|62824666|FG001|Overall Study|Lack of Efficacy|0|||
33449706|NCT00441701|62824667|FG002|Overall Study|Lack of Efficacy|2|||
33449707|NCT00441701|62824668|FG003|Overall Study|Lack of Efficacy|2|||
33449708|NCT00441701|62824669|FG004|Overall Study|Lack of Efficacy|0|||
33449709|NCT00441701|62824670|FG005|Overall Study|Lack of Efficacy|1|||
33449710|NCT00441701|62824671|FG006|Overall Study|Lack of Efficacy|0|||
33449711|NCT00441701|62824672|FG007|Overall Study|Lack of Efficacy|0|||
33449712|NCT00441701|62824673|FG008|Overall Study|Lack of Efficacy|0|||
33449713|NCT00441701|62824674|FG009|Overall Study|Lack of Efficacy|0|||
33449714|NCT00441701|62824665|FG000|Overall Study|Withdrawal by Subject|0|||
33449715|NCT00441701|62824666|FG001|Overall Study|Withdrawal by Subject|2|||
33503676|NCT00245960|62884990|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
33610782|NCT02294396|63011147|FG003|Overall Study|Protocol Deviation|1|||
33610783|NCT02294396|63011144|FG000|Overall Study|Miscellaneous|2|||
33610784|NCT02294396|63011145|FG001|Overall Study|Miscellaneous|0|||
33610785|NCT02294396|63011146|FG002|Overall Study|Miscellaneous|5|||
33610786|NCT02294396|63011147|FG003|Overall Study|Miscellaneous|2|||
33610787|NCT01721044|63011160|FG000|Treatment Period|Adverse Event|7|||
33610788|NCT01721044|63011161|FG001|Treatment Period|Adverse Event|7|||
33610789|NCT01721044|63011162|FG002|Treatment Period|Adverse Event|10|||
33610790|NCT01721044|63011160|FG000|Treatment Period|Death|0|||
33610791|NCT01721044|63011161|FG001|Treatment Period|Death|0|||
33610792|NCT01721044|63011162|FG002|Treatment Period|Death|1|||
33610793|NCT01721044|63011160|FG000|Treatment Period|Lack of Efficacy|16|||
33449716|NCT00441701|62824667|FG002|Overall Study|Withdrawal by Subject|1|||
33503677|NCT00245960|62884991|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
33503678|NCT00245960|62884990|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
33503679|NCT00245960|62884991|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
33503680|NCT00245960|62884990|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
33503681|NCT00245960|62884991|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
33503682|NCT00245960|62884990|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
33503683|NCT00245960|62884991|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
33503684|NCT00245960|62884990|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
33503685|NCT00245960|62884991|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
33503686|NCT00245960|62884990|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
33503687|NCT00245960|62884991|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
33503688|NCT00245960|62884990|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
33503689|NCT00245960|62884991|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
33503690|NCT00245960|62884990|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
33503691|NCT00245960|62884991|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
33503692|NCT02729194|62884997|FG000|Overall Study|Withdrawal by Subject|3|||
33503693|NCT03178266|62885003|FG000|Overall Study|Death|0|||
33610794|NCT01721044|63011161|FG001|Treatment Period|Lack of Efficacy|4|||
33610795|NCT01721044|63011162|FG002|Treatment Period|Lack of Efficacy|4|||
33610796|NCT01721044|63011160|FG000|Treatment Period|Lost to Follow-up|0|||
33610797|NCT01721044|63011161|FG001|Treatment Period|Lost to Follow-up|0|||
33610798|NCT01721044|63011162|FG002|Treatment Period|Lost to Follow-up|1|||
33610799|NCT01721044|63011160|FG000|Treatment Period|Physician Decision|1|||
33449717|NCT00441701|62824668|FG003|Overall Study|Withdrawal by Subject|1|||
33449718|NCT00441701|62824669|FG004|Overall Study|Withdrawal by Subject|0|||
33449719|NCT00441701|62824670|FG005|Overall Study|Withdrawal by Subject|0|||
33449720|NCT00441701|62824671|FG006|Overall Study|Withdrawal by Subject|0|||
33449721|NCT00441701|62824672|FG007|Overall Study|Withdrawal by Subject|0|||
33449722|NCT00441701|62824673|FG008|Overall Study|Withdrawal by Subject|0|||
33449723|NCT00441701|62824674|FG009|Overall Study|Withdrawal by Subject|0|||
33449724|NCT00441545|62824692|FG000|First Intervention|Adverse Event|6|||
33449725|NCT00441545|62824693|FG001|First Intervention|Adverse Event|5|||
33449726|NCT00441545|62824692|FG000|First Intervention|Protocol Violation|2|||
33449727|NCT00441545|62824693|FG001|First Intervention|Protocol Violation|2|||
33449728|NCT00441545|62824692|FG000|First Intervention|Withdrawal by Subject|3|||
33449729|NCT00441545|62824693|FG001|First Intervention|Withdrawal by Subject|3|||
33449730|NCT00441545|62824692|FG000|First Intervention|Kidney transplant|1|||
33449731|NCT00441545|62824693|FG001|First Intervention|Kidney transplant|1|||
33449732|NCT00441545|62824692|FG000|First Intervention|Lack of Efficacy|2|||
33449733|NCT00441545|62824693|FG001|First Intervention|Lack of Efficacy|0|||
33449734|NCT00441545|62824692|FG000|First Intervention|Subject exceeded safety criteria|0|||
33449735|NCT00441545|62824693|FG001|First Intervention|Subject exceeded safety criteria|1|||
33449736|NCT00441545|62824692|FG000|First Intervention|Subject met an exclusionary criteria|1|||
33449737|NCT00441545|62824693|FG001|First Intervention|Subject met an exclusionary criteria|0|||
33449738|NCT00441545|62824692|FG000|First Intervention|Extended hospitalization|1|||
33449739|NCT00441545|62824693|FG001|First Intervention|Extended hospitalization|0|||
33449740|NCT00441545|62824692|FG000|First Intervention|Site error|1|||
33449741|NCT00441545|62824693|FG001|First Intervention|Site error|0|||
33449742|NCT00441545|62824692|FG000|First Intervention|Sponsor's request|1|||
33449743|NCT00441545|62824693|FG001|First Intervention|Sponsor's request|0|||
33449744|NCT00441545|62824692|FG000|Second Intervention|Adverse Event|5|||
33449745|NCT00441545|62824693|FG001|Second Intervention|Adverse Event|2|||
33449746|NCT00441545|62824692|FG000|Second Intervention|Protocol Violation|4|||
33449747|NCT00441545|62824693|FG001|Second Intervention|Protocol Violation|1|||
33449748|NCT00441545|62824692|FG000|Second Intervention|Withdrawal by Subject|1|||
33449749|NCT00441545|62824693|FG001|Second Intervention|Withdrawal by Subject|1|||
33449750|NCT00441545|62824692|FG000|Second Intervention|Kidney Transplant|1|||
33449751|NCT00441545|62824693|FG001|Second Intervention|Kidney Transplant|1|||
33449752|NCT00441545|62824692|FG000|Second Intervention|Lack of Efficacy|0|||
33449753|NCT00441545|62824693|FG001|Second Intervention|Lack of Efficacy|1|||
33449754|NCT00441545|62824692|FG000|Second Intervention|Subject exceeded safety criteria|1|||
33449755|NCT00441545|62824693|FG001|Second Intervention|Subject exceeded safety criteria|0|||
33449756|NCT00441545|62824692|FG000|Second Intervention|Subject moved|0|||
33449757|NCT00441545|62824693|FG001|Second Intervention|Subject moved|1|||
33449758|NCT00436553|62824702|FG000|Overall Study|Adverse Event|4|||
33449759|NCT00436553|62824703|FG001|Overall Study|Adverse Event|3|||
33449760|NCT00436553|62824704|FG002|Overall Study|Adverse Event|4|||
33449761|NCT00436553|62824702|FG000|Overall Study|Death|3|||
33449762|NCT00436553|62824703|FG001|Overall Study|Death|1|||
33449763|NCT00436553|62824704|FG002|Overall Study|Death|3|||
33449764|NCT00436553|62824702|FG000|Overall Study|Lost to Follow-up|0|||
33449765|NCT00436553|62824703|FG001|Overall Study|Lost to Follow-up|2|||
33449766|NCT00436553|62824704|FG002|Overall Study|Lost to Follow-up|0|||
33503694|NCT03178266|62885004|FG001|Overall Study|Death|1|||
33503695|NCT03178266|62885003|FG000|Overall Study|Disont. Early|0|||
33503696|NCT03178266|62885004|FG001|Overall Study|Disont. Early|1|||
33503697|NCT03178266|62885003|FG000|Overall Study|Withdrawal by Subject|0|||
33503698|NCT03178266|62885004|FG001|Overall Study|Withdrawal by Subject|2|||
33503699|NCT03548935|62885012|FG000|Overall Study|Withdrawal by Subject|26|||
33503700|NCT03548935|62885013|FG001|Overall Study|Withdrawal by Subject|17|||
33503701|NCT03548935|62885012|FG000|Overall Study|Lost to Follow-up|39|||
33503702|NCT03548935|62885013|FG001|Overall Study|Lost to Follow-up|28|||
33503703|NCT03548935|62885012|FG000|Overall Study|Death|1|||
33503704|NCT03548935|62885013|FG001|Overall Study|Death|1|||
33503705|NCT03547687|62885019|FG000|Overall Study|Withdrawal by Subject|1|||
33503706|NCT03547687|62885019|FG000|Overall Study|Death|1|||
33503707|NCT03547531|62885025|FG000|Overall Study|not coming in data collection : sick|2|||
33503708|NCT03547531|62885026|FG001|Overall Study|not coming in data collection : sick|2|||
33503709|NCT03547531|62885025|FG000|Overall Study|having family occasion|0|||
33503710|NCT03547531|62885026|FG001|Overall Study|having family occasion|2|||
33503711|NCT03566485|62885034|FG000|Overall Study|Disease progression|5|||
33503712|NCT03566485|62885035|FG001|Overall Study|Disease progression|4|||
33503713|NCT03566485|62885034|FG000|Overall Study|Clinical progression|0|||
33503714|NCT03566485|62885035|FG001|Overall Study|Clinical progression|1|||
33503715|NCT03566485|62885034|FG000|Overall Study|Toxicity|0|||
33610800|NCT01721044|63011161|FG001|Treatment Period|Physician Decision|0|||
33610801|NCT01721044|63011162|FG002|Treatment Period|Physician Decision|2|||
33503716|NCT03566485|62885035|FG001|Overall Study|Toxicity|2|||
33503717|NCT03176238|62885043|FG000|Overall Study|Unacceptable AEs|15|||
33503718|NCT03176238|62885044|FG001|Overall Study|Unacceptable AEs|8|||
33503719|NCT03176238|62885043|FG000|Overall Study|Abnormal lab value(s)|2|||
33610802|NCT01721044|63011160|FG000|Treatment Period|Protocol Violation|1|||
33610803|NCT01721044|63011161|FG001|Treatment Period|Protocol Violation|0|||
33610804|NCT01721044|63011162|FG002|Treatment Period|Protocol Violation|0|||
33610805|NCT01721044|63011160|FG000|Treatment Period|Withdrawal by Subject|7|||
33610806|NCT01721044|63011161|FG001|Treatment Period|Withdrawal by Subject|6|||
33610807|NCT01721044|63011162|FG002|Treatment Period|Withdrawal by Subject|1|||
33610808|NCT02164981|63011184|FG000|Started|Withdrawal by Subject|2|||
33610809|NCT02164981|63011185|FG001|Started|Withdrawal by Subject|1|||
33610810|NCT02164981|63011186|FG002|Started|Withdrawal by Subject|0|||
33610811|NCT02164981|63011184|FG000|Started|Protocol Violation|2|||
33610812|NCT02164981|63011185|FG001|Started|Protocol Violation|0|||
33610813|NCT02164981|63011186|FG002|Started|Protocol Violation|0|||
33610814|NCT02164981|63011184|FG000|Started|Adverse Event|1|||
33610815|NCT02164981|63011185|FG001|Started|Adverse Event|2|||
33610816|NCT02164981|63011186|FG002|Started|Adverse Event|0|||
33610817|NCT02164981|63011184|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
33610818|NCT02164981|63011185|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
33610819|NCT02164981|63011186|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
33610820|NCT02164981|63011184|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
33610821|NCT02164981|63011185|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
33610822|NCT02164981|63011186|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
33610823|NCT02164981|63011184|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
33610824|NCT02164981|63011185|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
33610825|NCT02164981|63011186|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
33610826|NCT02195869|63011207|FG000|Overall Study|cGVHD Progression|5|||
33610827|NCT02195869|63011207|FG000|Overall Study|Malignancy Progression/relapse|2|||
33610828|NCT02195869|63011207|FG000|Overall Study|Adverse Event|15|||
33610829|NCT02195869|63011207|FG000|Overall Study|Withdrawal by Subject|7|||
33610830|NCT02195869|63011207|FG000|Overall Study|Physician Decision|4|||
33610831|NCT02195869|63011207|FG000|Overall Study|Study Terminated by Sponsor|7|||
33610832|NCT02195869|63011207|FG000|Overall Study|Noncompliance with study drug|2|||
33610833|NCT01908699|63011216|FG000|Overall Study|Adverse Event|8|||
33503720|NCT03176238|62885044|FG001|Overall Study|Abnormal lab value(s)|0|||
33503721|NCT03176238|62885043|FG000|Overall Study|Inter-current illness|0|||
33503722|NCT03176238|62885044|FG001|Overall Study|Inter-current illness|1|||
33503723|NCT03176238|62885043|FG000|Overall Study|Consent withdrawal|14|||
33503724|NCT03176238|62885044|FG001|Overall Study|Consent withdrawal|2|||
33503725|NCT03176238|62885043|FG000|Overall Study|Lost to Follow-up|3|||
33503726|NCT03176238|62885044|FG001|Overall Study|Lost to Follow-up|0|||
33503727|NCT03176238|62885043|FG000|Overall Study|Administrative problems|1|||
33610834|NCT01908699|63011217|FG001|Overall Study|Adverse Event|12|||
33610835|NCT01908699|63011216|FG000|Overall Study|Lack of Efficacy|2|||
33610836|NCT01908699|63011217|FG001|Overall Study|Lack of Efficacy|2|||
33610837|NCT01908699|63011216|FG000|Overall Study|Lost to Follow-up|2|||
33610838|NCT01908699|63011217|FG001|Overall Study|Lost to Follow-up|4|||
33503728|NCT03176238|62885044|FG001|Overall Study|Administrative problems|0|||
33503729|NCT03176238|62885043|FG000|Overall Study|Death|3|||
33610839|NCT01908699|63011216|FG000|Overall Study|Physician Decision|8|||
33610840|NCT01908699|63011217|FG001|Overall Study|Physician Decision|8|||
33610841|NCT01908699|63011216|FG000|Overall Study|Withdrawal by Subject|15|||
33610842|NCT01908699|63011217|FG001|Overall Study|Withdrawal by Subject|10|||
33610843|NCT01908699|63011216|FG000|Overall Study|Pregnancy|0|||
33610844|NCT01908699|63011217|FG001|Overall Study|Pregnancy|1|||
33610845|NCT01908699|63011216|FG000|Overall Study|Randomized in Error|1|||
33610846|NCT01908699|63011217|FG001|Overall Study|Randomized in Error|0|||
33610847|NCT01908699|63011216|FG000|Overall Study|Death|9|||
33610848|NCT01908699|63011217|FG001|Overall Study|Death|12|||
33610849|NCT01908699|63011216|FG000|Overall Study|Progressive Disease|30|||
33503730|NCT03176238|62885044|FG001|Overall Study|Death|0|||
33503731|NCT03176238|62885043|FG000|Overall Study|Disease Progression|133|||
33503732|NCT03176238|62885044|FG001|Overall Study|Disease Progression|22|||
33503733|NCT03176238|62885043|FG000|Overall Study|Tx duration completed per EAP|0|||
33503734|NCT03176238|62885044|FG001|Overall Study|Tx duration completed per EAP|1|||
33503735|NCT03176238|62885043|FG000|Overall Study|Patient is switched to commercial drug|16|||
33503736|NCT03176238|62885044|FG001|Overall Study|Patient is switched to commercial drug|1|||
33503737|NCT03176238|62885043|FG000|Overall Study|Protocol Violation|1|||
33503738|NCT03176238|62885044|FG001|Overall Study|Protocol Violation|0|||
33503739|NCT03176238|62885043|FG000|Overall Study|Changes in the patient's condition|2|||
33503740|NCT03176238|62885044|FG001|Overall Study|Changes in the patient's condition|1|||
33503741|NCT03176238|62885043|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
33503742|NCT03176238|62885044|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
33503743|NCT03565315|62885058|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
33503744|NCT03565315|62885059|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
33503745|NCT03565315|62885060|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
33503746|NCT03565315|62885061|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
33503747|NCT03565237|62885084|FG000|Overall Study|Non-compliance of Investigational Product|1|||
33503748|NCT03565237|62885084|FG000|Overall Study|Physician Decision|1|||
33503749|NCT01345682|62885090|FG000|Overall Study|Progressive disease per RECIST|226|||
33503750|NCT01345682|62885091|FG001|Overall Study|Progressive disease per RECIST|93|||
33503751|NCT01345682|62885090|FG000|Overall Study|Worsening of underlying cancer disease|23|||
33503752|NCT01345682|62885091|FG001|Overall Study|Worsening of underlying cancer disease|12|||
33503753|NCT01345682|62885090|FG000|Overall Study|Adverse Event|51|||
33610850|NCT01908699|63011217|FG001|Overall Study|Progressive Disease|29|||
33610851|NCT01599637|63011226|FG000|Overall Study|administrative problems|0|||
33610852|NCT01599637|63011227|FG001|Overall Study|administrative problems|2|||
33610853|NCT01599637|63011228|FG002|Overall Study|administrative problems|0|||
33324206|NCT01168349|62700662|FG000|Overall Study|Death|157|||
33324207|NCT01168349|62700662|FG000|Overall Study|Lost to Follow-up|34|||
33324208|NCT01168349|62700662|FG000|Overall Study|Withdrawal by Subject|9|||
33503754|NCT01345682|62885091|FG001|Overall Study|Adverse Event|41|||
33503755|NCT01345682|62885090|FG000|Overall Study|Non-compliance with protocol|0|||
33503756|NCT01345682|62885091|FG001|Overall Study|Non-compliance with protocol|1|||
33503757|NCT01345682|62885090|FG000|Overall Study|Lost to Follow-up|0|||
33503758|NCT01345682|62885091|FG001|Overall Study|Lost to Follow-up|1|||
33503759|NCT01345682|62885090|FG000|Overall Study|Refused to continue trial medication|16|||
33503760|NCT01345682|62885091|FG001|Overall Study|Refused to continue trial medication|9|||
33503761|NCT01345682|62885090|FG000|Overall Study|Not treated|2|||
33503762|NCT01345682|62885091|FG001|Overall Study|Not treated|1|||
33503763|NCT01345682|62885090|FG000|Overall Study|Reason other than those specified above|4|||
33503764|NCT01345682|62885091|FG001|Overall Study|Reason other than those specified above|3|||
33503765|NCT03562117|62885100|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
33503766|NCT03562117|62885101|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
33503767|NCT03562117|62885102|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
33503768|NCT03561883|62885112|FG000|Overall Study|Adverse Event|10|||
33503769|NCT03561883|62885113|FG001|Overall Study|Adverse Event|13|||
33503770|NCT03561883|62885112|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33503771|NCT03561883|62885113|FG001|Overall Study|Non-Compliance With Study Drug|2|||
33503772|NCT03561883|62885112|FG000|Overall Study|Protocol Violation|2|||
33503773|NCT03561883|62885113|FG001|Overall Study|Protocol Violation|3|||
33503774|NCT03561883|62885112|FG000|Overall Study|Withdrawal by Subject|14|||
33503775|NCT03561883|62885113|FG001|Overall Study|Withdrawal by Subject|6|||
33503776|NCT03561883|62885112|FG000|Overall Study|Lost to Follow-up|2|||
33503777|NCT03561883|62885113|FG001|Overall Study|Lost to Follow-up|6|||
33324209|NCT01168349|62700662|FG000|Overall Study|Kidney transplantation|3|||
33503778|NCT03561883|62885112|FG000|Overall Study|Study Terminated by Sponsor|12|||
33503779|NCT03561883|62885113|FG001|Overall Study|Study Terminated by Sponsor|11|||
33610854|NCT01599637|63011226|FG000|Overall Study|Adverse Event|1|||
33610855|NCT01599637|63011227|FG001|Overall Study|Adverse Event|0|||
33503780|NCT03561883|62885112|FG000|Overall Study|Physician Decision|1|||
33503781|NCT03561883|62885113|FG001|Overall Study|Physician Decision|0|||
33503782|NCT03561883|62885112|FG000|Overall Study|Randomized by Mistake|1|||
33503783|NCT03561883|62885113|FG001|Overall Study|Randomized by Mistake|0|||
33503784|NCT03561883|62885112|FG000|Overall Study|Other, Not Specified|3|||
33610856|NCT01599637|63011228|FG002|Overall Study|Adverse Event|0|||
33610857|NCT02264639|63011243|FG000|Overall Study|Death (after completing single-dose phase)|1|||
33503785|NCT03561883|62885113|FG001|Overall Study|Other, Not Specified|2|||
33503786|NCT03546907|62885121|FG000|Overall Study|Lack of Efficacy|1|||
33503787|NCT03546907|62885122|FG001|Overall Study|Lack of Efficacy|1|||
33503788|NCT03546907|62885121|FG000|Overall Study|Withdrawal by Subject|8|||
33503789|NCT03546907|62885122|FG001|Overall Study|Withdrawal by Subject|9|||
33503790|NCT03546907|62885121|FG000|Overall Study|Adverse events (AEs)|7|||
33503791|NCT03546907|62885122|FG001|Overall Study|Adverse events (AEs)|10|||
33503792|NCT03546907|62885121|FG000|Overall Study|Other-unspecified|1|||
33503793|NCT03546907|62885122|FG001|Overall Study|Other-unspecified|1|||
33503794|NCT01318382|62885128|FG000|Overall Study|Physician Decision|2|||
33503795|NCT01318382|62885128|FG000|Overall Study|Device Malfunction|10|||
33503796|NCT01318382|62885128|FG000|Overall Study|Protocol Violation|1|||
33503797|NCT03053180|62885146|FG000|Overall Study|Failure to Return|1|||
33503798|NCT03560869|62885150|FG000|Overall Study|Withdrawal by Subject|3|||
33503799|NCT03560869|62885151|FG001|Overall Study|Withdrawal by Subject|4|||
33503800|NCT03560869|62885150|FG000|Overall Study|Screening failure|4|||
33503801|NCT03560869|62885151|FG001|Overall Study|Screening failure|4|||
33503802|NCT03560869|62885150|FG000|Overall Study|Withdrawal by PI|0|||
33503803|NCT03560869|62885151|FG001|Overall Study|Withdrawal by PI|1|||
33503804|NCT03590743|62885159|FG000|Overall Study|Withdrawal by Subject|0|||
33503805|NCT03590743|62885160|FG001|Overall Study|Withdrawal by Subject|1|||
33503806|NCT03053102|62885166|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
33503807|NCT03053102|62885166|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
33503808|NCT03589885|62885174|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
33503809|NCT03589885|62885175|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
33503810|NCT03589885|62885176|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
33503811|NCT03589885|62885177|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
33324210|NCT01168349|62700662|FG000|Overall Study|Other|22|||
33449767|NCT00436553|62824702|FG000|Overall Study|Protocol Violation|1|||
33449768|NCT00436553|62824703|FG001|Overall Study|Protocol Violation|0|||
33449769|NCT00436553|62824704|FG002|Overall Study|Protocol Violation|0|||
33449770|NCT00436553|62824702|FG000|Overall Study|Withdrawal by Subject|5|||
33449771|NCT00436553|62824703|FG001|Overall Study|Withdrawal by Subject|6|||
33449772|NCT00436553|62824704|FG002|Overall Study|Withdrawal by Subject|3|||
33449773|NCT00441467|62824712|FG000|Overall Study|Adverse Event|6|||
33449774|NCT00441467|62824712|FG000|Overall Study|Withdrawal by Subject|3|||
33449775|NCT00441467|62824712|FG000|Overall Study|Progressive disease|9|||
33503812|NCT03589885|62885178|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
33503813|NCT03589885|62885174|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
33503814|NCT03589885|62885175|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
33503815|NCT03589885|62885176|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
33503816|NCT03589885|62885177|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
33503817|NCT03589885|62885178|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
33503818|NCT03589885|62885174|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
33503819|NCT03589885|62885175|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
33503820|NCT03589885|62885176|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
33503821|NCT03589885|62885177|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
33503822|NCT03589885|62885178|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
33503823|NCT03589885|62885174|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
33503824|NCT03589885|62885175|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
33503825|NCT03589885|62885176|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
33503826|NCT03589885|62885177|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
33503827|NCT03589885|62885178|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
33503828|NCT03589885|62885174|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
33503829|NCT03589885|62885175|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
33503830|NCT03589885|62885176|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
33503831|NCT03589885|62885177|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
33503832|NCT03589885|62885178|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
33503833|NCT03589885|62885174|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
33503834|NCT03589885|62885175|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
33503835|NCT03589885|62885176|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
33503836|NCT03589885|62885177|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
33503837|NCT03589885|62885178|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
33503838|NCT03589885|62885174|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
33503839|NCT03589885|62885175|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
33503840|NCT03589885|62885176|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
33503841|NCT03589885|62885177|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
33503842|NCT03589885|62885178|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
33503843|NCT03589885|62885174|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
33503844|NCT03589885|62885175|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
33324211|NCT01168349|62700662|FG000|Overall Study|Protocol Violation|76|||
33449776|NCT00436163|62824716|FG000|Overall Study|Lost to Follow-up|2|||
33610858|NCT02264639|63011244|FG001|Overall Study|Death (after completing single-dose phase)|0|||
33610859|NCT02264639|63011245|FG002|Overall Study|Death (after completing single-dose phase)|0|||
33610860|NCT02264639|63011246|FG003|Overall Study|Death (after completing single-dose phase)|0|||
33503845|NCT03589885|62885176|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
33503846|NCT03589885|62885177|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
33503847|NCT03589885|62885178|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
33503848|NCT03545503|62885198|FG000|Overall Study|Protocol Violation|14|||
33503849|NCT03545503|62885199|FG001|Overall Study|Protocol Violation|16|||
33503850|NCT03545113|62885207|FG000|Overall Study|Surgery Cancelled|1|||
33503851|NCT03545113|62885208|FG001|Overall Study|Surgery Cancelled|0|||
33503852|NCT03545113|62885207|FG000|Overall Study|Death|1|||
33503853|NCT03545113|62885208|FG001|Overall Study|Death|0|||
33503854|NCT03545113|62885207|FG000|Overall Study|Adverse Event|2|||
33503855|NCT03545113|62885208|FG001|Overall Study|Adverse Event|0|||
33503856|NCT03545113|62885207|FG000|Overall Study|Received different surgery|1|||
33503857|NCT03545113|62885208|FG001|Overall Study|Received different surgery|0|||
33503858|NCT03214380|62885220|FG000|Lead-in|Adverse Event|3|||
33503859|NCT03214380|62885221|FG001|Lead-in|Adverse Event|0|||
33503860|NCT03214380|62885222|FG002|Lead-in|Adverse Event|0|||
33503861|NCT03214380|62885223|FG003|Lead-in|Adverse Event|1|||
33503862|NCT03214380|62885224|FG004|Lead-in|Adverse Event|0|||
33503863|NCT03214380|62885225|FG005|Lead-in|Adverse Event|0|||
33503864|NCT03214380|62885220|FG000|Lead-in|Lost to Follow-up|4|||
33449777|NCT00436163|62824716|FG000|Overall Study|Adverse Event|1|||
33449778|NCT00006604|62824728|FG000|Overall Study|Met study objective - no further FU|1|||
33449779|NCT00006604|62824729|FG001|Overall Study|Met study objective - no further FU|0|||
33449780|NCT00006604|62824730|FG002|Overall Study|Met study objective - no further FU|0|||
33503865|NCT03214380|62885221|FG001|Lead-in|Lost to Follow-up|0|||
33503866|NCT03214380|62885222|FG002|Lead-in|Lost to Follow-up|0|||
33503867|NCT03214380|62885223|FG003|Lead-in|Lost to Follow-up|1|||
33503868|NCT03214380|62885224|FG004|Lead-in|Lost to Follow-up|0|||
33503869|NCT03214380|62885225|FG005|Lead-in|Lost to Follow-up|0|||
33503870|NCT03214380|62885220|FG000|Lead-in|Eligibility Criteria|3|||
33449781|NCT00006604|62824731|FG003|Overall Study|Met study objective - no further FU|0|||
33449782|NCT00006604|62824732|FG004|Overall Study|Met study objective - no further FU|0|||
33449783|NCT00006604|62824733|FG005|Overall Study|Met study objective - no further FU|0|||
33449784|NCT00006604|62824734|FG006|Overall Study|Met study objective - no further FU|0|||
33449785|NCT00006604|62824735|FG007|Overall Study|Met study objective - no further FU|0|||
33449786|NCT00006604|62824736|FG008|Overall Study|Met study objective - no further FU|0|||
33449787|NCT00006604|62824737|FG009|Overall Study|Met study objective - no further FU|0|||
33449788|NCT00006604|62824738|FG010|Overall Study|Met study objective - no further FU|0|||
33449789|NCT00006604|62824739|FG011|Overall Study|Met study objective - no further FU|0|||
33449790|NCT00006604|62824740|FG012|Overall Study|Met study objective - no further FU|0|||
33449791|NCT00006604|62824741|FG013|Overall Study|Met study objective - no further FU|0|||
33449792|NCT00006604|62824742|FG014|Overall Study|Met study objective - no further FU|1|||
33449793|NCT00006604|62824743|FG015|Overall Study|Met study objective - no further FU|1|||
33449794|NCT00006604|62824744|FG016|Overall Study|Met study objective - no further FU|0|||
33449795|NCT00006604|62824728|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
33449796|NCT00006604|62824729|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
33449797|NCT00006604|62824730|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
33449798|NCT00006604|62824731|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
33449799|NCT00006604|62824732|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
33449800|NCT00006604|62824733|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
33503871|NCT03214380|62885221|FG001|Lead-in|Eligibility Criteria|0|||
33503872|NCT03214380|62885222|FG002|Lead-in|Eligibility Criteria|0|||
33503873|NCT03214380|62885223|FG003|Lead-in|Eligibility Criteria|0|||
33503874|NCT03214380|62885224|FG004|Lead-in|Eligibility Criteria|0|||
33503875|NCT03214380|62885225|FG005|Lead-in|Eligibility Criteria|0|||
33503876|NCT03214380|62885220|FG000|Lead-in|Physician Decision|6|||
33503877|NCT03214380|62885221|FG001|Lead-in|Physician Decision|0|||
33503878|NCT03214380|62885222|FG002|Lead-in|Physician Decision|0|||
33503879|NCT03214380|62885223|FG003|Lead-in|Physician Decision|0|||
33503880|NCT03214380|62885224|FG004|Lead-in|Physician Decision|0|||
33610861|NCT02264639|63011247|FG004|Overall Study|Death (after completing single-dose phase)|0|||
33503881|NCT03214380|62885225|FG005|Lead-in|Physician Decision|0|||
33503882|NCT03214380|62885220|FG000|Lead-in|Protocol Deviation|7|||
33503883|NCT03214380|62885221|FG001|Lead-in|Protocol Deviation|0|||
33503884|NCT03214380|62885222|FG002|Lead-in|Protocol Deviation|0|||
33503885|NCT03214380|62885223|FG003|Lead-in|Protocol Deviation|3|||
33449801|NCT00006604|62824734|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
33449802|NCT00006604|62824735|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
33449803|NCT00006604|62824736|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
33449804|NCT00006604|62824737|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
33449805|NCT00006604|62824738|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
33449806|NCT00006604|62824739|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
33449807|NCT00006604|62824740|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
33449808|NCT00006604|62824741|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
33449809|NCT00006604|62824742|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
33449810|NCT00006604|62824743|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
33449811|NCT00006604|62824744|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
33449812|NCT00006604|62824728|FG000|Overall Study|Death|0|||
33449813|NCT00006604|62824729|FG001|Overall Study|Death|0|||
33449814|NCT00006604|62824730|FG002|Overall Study|Death|0|||
33449815|NCT00006604|62824731|FG003|Overall Study|Death|0|||
33449816|NCT00006604|62824732|FG004|Overall Study|Death|0|||
33449817|NCT00006604|62824733|FG005|Overall Study|Death|0|||
33449818|NCT00006604|62824734|FG006|Overall Study|Death|0|||
33449819|NCT00006604|62824735|FG007|Overall Study|Death|0|||
33449820|NCT00006604|62824736|FG008|Overall Study|Death|0|||
33449821|NCT00006604|62824737|FG009|Overall Study|Death|1|||
33503886|NCT03214380|62885224|FG004|Lead-in|Protocol Deviation|0|||
33503887|NCT03214380|62885225|FG005|Lead-in|Protocol Deviation|0|||
33503888|NCT03214380|62885220|FG000|Lead-in|Withdrawal by Subject|41|||
33449822|NCT00006604|62824738|FG010|Overall Study|Death|1|||
33449823|NCT00006604|62824739|FG011|Overall Study|Death|1|||
33503889|NCT03214380|62885221|FG001|Lead-in|Withdrawal by Subject|0|||
33503890|NCT03214380|62885222|FG002|Lead-in|Withdrawal by Subject|0|||
33503891|NCT03214380|62885223|FG003|Lead-in|Withdrawal by Subject|14|||
33503892|NCT03214380|62885224|FG004|Lead-in|Withdrawal by Subject|0|||
33503893|NCT03214380|62885225|FG005|Lead-in|Withdrawal by Subject|0|||
33503894|NCT03214380|62885220|FG000|Lead-in|Family Emergency|1|||
33503895|NCT03214380|62885221|FG001|Lead-in|Family Emergency|0|||
33503896|NCT03214380|62885222|FG002|Lead-in|Family Emergency|0|||
33503897|NCT03214380|62885223|FG003|Lead-in|Family Emergency|0|||
33503898|NCT03214380|62885224|FG004|Lead-in|Family Emergency|0|||
33503899|NCT03214380|62885225|FG005|Lead-in|Family Emergency|0|||
33503900|NCT03214380|62885220|FG000|Lead-in|Natural Disaster|9|||
33503901|NCT03214380|62885221|FG001|Lead-in|Natural Disaster|0|||
33503902|NCT03214380|62885222|FG002|Lead-in|Natural Disaster|0|||
33503903|NCT03214380|62885223|FG003|Lead-in|Natural Disaster|0|||
33503904|NCT03214380|62885224|FG004|Lead-in|Natural Disaster|0|||
33503905|NCT03214380|62885225|FG005|Lead-in|Natural Disaster|0|||
33503906|NCT03214380|62885220|FG000|Lead-in|Non Compliance|1|||
33503907|NCT03214380|62885221|FG001|Lead-in|Non Compliance|0|||
33503908|NCT03214380|62885222|FG002|Lead-in|Non Compliance|0|||
33503909|NCT03214380|62885223|FG003|Lead-in|Non Compliance|0|||
33503910|NCT03214380|62885224|FG004|Lead-in|Non Compliance|0|||
33503911|NCT03214380|62885225|FG005|Lead-in|Non Compliance|0|||
33503912|NCT03214380|62885220|FG000|Lead-in|Participant Schedule|2|||
33503913|NCT03214380|62885221|FG001|Lead-in|Participant Schedule|0|||
33503914|NCT03214380|62885222|FG002|Lead-in|Participant Schedule|0|||
33503915|NCT03214380|62885223|FG003|Lead-in|Participant Schedule|0|||
33503916|NCT03214380|62885224|FG004|Lead-in|Participant Schedule|0|||
33503917|NCT03214380|62885225|FG005|Lead-in|Participant Schedule|0|||
33503918|NCT03214380|62885220|FG000|Treatment Period|Adverse Event|0|||
33503919|NCT03214380|62885221|FG001|Treatment Period|Adverse Event|1|||
33610862|NCT02264639|63011243|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
33610863|NCT02264639|63011244|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
33324212|NCT00915772|62700685|FG000|Overall Study|Adverse Event|12|||
33324213|NCT00915772|62700686|FG001|Overall Study|Adverse Event|13|||
33324214|NCT00915772|62700687|FG002|Overall Study|Adverse Event|11|||
33324215|NCT00915772|62700685|FG000|Overall Study|Protocol Violation|4|||
33324216|NCT00915772|62700686|FG001|Overall Study|Protocol Violation|1|||
33324217|NCT00915772|62700687|FG002|Overall Study|Protocol Violation|2|||
33324218|NCT00915772|62700685|FG000|Overall Study|Lost to Follow-up|1|||
33324219|NCT00915772|62700686|FG001|Overall Study|Lost to Follow-up|2|||
33449824|NCT00006604|62824740|FG012|Overall Study|Death|0|||
33449825|NCT00006604|62824741|FG013|Overall Study|Death|0|||
33449826|NCT00006604|62824742|FG014|Overall Study|Death|0|||
33449827|NCT00006604|62824743|FG015|Overall Study|Death|0|||
33503920|NCT03214380|62885222|FG002|Treatment Period|Adverse Event|1|||
33503921|NCT03214380|62885223|FG003|Treatment Period|Adverse Event|0|||
33503922|NCT03214380|62885224|FG004|Treatment Period|Adverse Event|1|||
33503923|NCT03214380|62885225|FG005|Treatment Period|Adverse Event|0|||
33503924|NCT03214380|62885220|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
33503925|NCT03214380|62885221|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
33503926|NCT03214380|62885222|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
33503927|NCT03214380|62885223|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
33503928|NCT03214380|62885224|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
33610864|NCT02264639|63011245|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
33610865|NCT02264639|63011246|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
33503929|NCT03214380|62885225|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
33503930|NCT03214380|62885220|FG000|Treatment Period|Withdrawal by Subject|0|||
33503931|NCT03214380|62885221|FG001|Treatment Period|Withdrawal by Subject|10|||
33503932|NCT03214380|62885222|FG002|Treatment Period|Withdrawal by Subject|8|||
33503933|NCT03214380|62885223|FG003|Treatment Period|Withdrawal by Subject|0|||
33503934|NCT03214380|62885224|FG004|Treatment Period|Withdrawal by Subject|7|||
33503935|NCT03214380|62885225|FG005|Treatment Period|Withdrawal by Subject|11|||
33503936|NCT03214380|62885220|FG000|Treatment Period|Death|0|||
33503937|NCT03214380|62885221|FG001|Treatment Period|Death|1|||
33503938|NCT03214380|62885222|FG002|Treatment Period|Death|2|||
33503939|NCT03214380|62885223|FG003|Treatment Period|Death|0|||
33503940|NCT03214380|62885224|FG004|Treatment Period|Death|0|||
33503941|NCT03214380|62885225|FG005|Treatment Period|Death|0|||
33503942|NCT03214380|62885220|FG000|Treatment Period|Lost to Follow-up|0|||
33503943|NCT03214380|62885221|FG001|Treatment Period|Lost to Follow-up|6|||
33503944|NCT03214380|62885222|FG002|Treatment Period|Lost to Follow-up|3|||
33503945|NCT03214380|62885223|FG003|Treatment Period|Lost to Follow-up|0|||
33503946|NCT03214380|62885224|FG004|Treatment Period|Lost to Follow-up|0|||
33503947|NCT03214380|62885225|FG005|Treatment Period|Lost to Follow-up|0|||
33503948|NCT03214380|62885220|FG000|Treatment Period|Participant schedule|0|||
33503949|NCT03214380|62885221|FG001|Treatment Period|Participant schedule|0|||
33503950|NCT03214380|62885222|FG002|Treatment Period|Participant schedule|1|||
33503951|NCT03214380|62885223|FG003|Treatment Period|Participant schedule|0|||
33503952|NCT03214380|62885224|FG004|Treatment Period|Participant schedule|0|||
33503953|NCT03214380|62885225|FG005|Treatment Period|Participant schedule|0|||
33503954|NCT03214380|62885220|FG000|Treatment Period|Treatment Interruption|0|||
33503955|NCT03214380|62885221|FG001|Treatment Period|Treatment Interruption|0|||
33503956|NCT03214380|62885222|FG002|Treatment Period|Treatment Interruption|1|||
33503957|NCT03214380|62885223|FG003|Treatment Period|Treatment Interruption|0|||
33503958|NCT03214380|62885224|FG004|Treatment Period|Treatment Interruption|0|||
33503959|NCT03214380|62885225|FG005|Treatment Period|Treatment Interruption|0|||
33503960|NCT02674464|62885239|FG000|Overall Study|Death|10|||
33503961|NCT02674464|62885240|FG001|Overall Study|Death|21|||
33503962|NCT02674464|62885239|FG000|Overall Study|Withdrawal by Subject|24|||
33503963|NCT02674464|62885240|FG001|Overall Study|Withdrawal by Subject|44|||
33503964|NCT02674464|62885239|FG000|Overall Study|Lost to Follow-up|97|||
33503965|NCT02674464|62885240|FG001|Overall Study|Lost to Follow-up|92|||
33503966|NCT02674464|62885239|FG000|Overall Study|Outside survey window|6|||
33503967|NCT02674464|62885240|FG001|Overall Study|Outside survey window|3|||
33503968|NCT03172026|62885248|FG000|Overall Study|Withdrawal by Subject|1|||
33503969|NCT03172026|62885249|FG001|Overall Study|Withdrawal by Subject|0|||
33503970|NCT03172026|62885248|FG000|Overall Study|COVID restrictions|1|||
33503971|NCT03172026|62885249|FG001|Overall Study|COVID restrictions|0|||
33503972|NCT01343888|62885259|FG000|Overall Study|Adverse Event|12|||
33503973|NCT01343888|62885260|FG001|Overall Study|Adverse Event|22|||
33503974|NCT01343888|62885261|FG002|Overall Study|Adverse Event|5|||
33503975|NCT01343888|62885259|FG000|Overall Study|Lack of Efficacy|9|||
33503976|NCT01343888|62885260|FG001|Overall Study|Lack of Efficacy|9|||
33503977|NCT01343888|62885261|FG002|Overall Study|Lack of Efficacy|13|||
33503978|NCT01343888|62885259|FG000|Overall Study|Lost to Follow-up|0|||
33503979|NCT01343888|62885260|FG001|Overall Study|Lost to Follow-up|2|||
33503980|NCT01343888|62885261|FG002|Overall Study|Lost to Follow-up|1|||
33503981|NCT01343888|62885259|FG000|Overall Study|Protocol Violation|0|||
33503982|NCT01343888|62885260|FG001|Overall Study|Protocol Violation|2|||
33503983|NCT01343888|62885261|FG002|Overall Study|Protocol Violation|0|||
33503984|NCT01343888|62885259|FG000|Overall Study|Withdrawal by Subject|4|||
33503985|NCT01343888|62885260|FG001|Overall Study|Withdrawal by Subject|4|||
33610866|NCT02264639|63011247|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
33610867|NCT02264639|63011243|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
33610868|NCT02264639|63011244|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
33503986|NCT01343888|62885261|FG002|Overall Study|Withdrawal by Subject|2|||
33503987|NCT01343888|62885259|FG000|Overall Study|other than stated above|0|||
33503988|NCT01343888|62885260|FG001|Overall Study|other than stated above|0|||
33503989|NCT01343888|62885261|FG002|Overall Study|other than stated above|1|||
33503990|NCT03589807|62885275|FG000|Overall Study|Lost to Follow-up|0|||
33503991|NCT03589807|62885276|FG001|Overall Study|Lost to Follow-up|2|||
33503992|NCT03589807|62885277|FG002|Overall Study|Lost to Follow-up|2|||
33503993|NCT03589807|62885278|FG003|Overall Study|Lost to Follow-up|3|||
33503994|NCT03589807|62885279|FG004|Overall Study|Lost to Follow-up|1|||
33503995|NCT03589807|62885280|FG005|Overall Study|Lost to Follow-up|1|||
33503996|NCT03589807|62885275|FG000|Overall Study|Withdrawal by Subject|0|||
33503997|NCT03589807|62885276|FG001|Overall Study|Withdrawal by Subject|5|||
33503998|NCT03589807|62885277|FG002|Overall Study|Withdrawal by Subject|0|||
33503999|NCT03589807|62885278|FG003|Overall Study|Withdrawal by Subject|0|||
33504000|NCT03589807|62885279|FG004|Overall Study|Withdrawal by Subject|0|||
33504001|NCT03589807|62885280|FG005|Overall Study|Withdrawal by Subject|0|||
33504002|NCT03589807|62885275|FG000|Overall Study|Protocol Violation|0|||
33504003|NCT03589807|62885276|FG001|Overall Study|Protocol Violation|0|||
33504004|NCT03589807|62885277|FG002|Overall Study|Protocol Violation|0|||
33504005|NCT03589807|62885278|FG003|Overall Study|Protocol Violation|1|||
33504006|NCT03589807|62885279|FG004|Overall Study|Protocol Violation|0|||
33504007|NCT03589807|62885280|FG005|Overall Study|Protocol Violation|0|||
33504008|NCT03589807|62885275|FG000|Overall Study|Enrolled but treatment not administered|0|||
33504009|NCT03589807|62885276|FG001|Overall Study|Enrolled but treatment not administered|0|||
33504010|NCT03589807|62885277|FG002|Overall Study|Enrolled but treatment not administered|0|||
33504011|NCT03589807|62885278|FG003|Overall Study|Enrolled but treatment not administered|0|||
33504012|NCT03589807|62885279|FG004|Overall Study|Enrolled but treatment not administered|1|||
33504013|NCT03589807|62885280|FG005|Overall Study|Enrolled but treatment not administered|0|||
33504014|NCT03544333|62885299|FG000|Overall Study|Withdrawal by Subject|1|||
33504015|NCT03544333|62885300|FG001|Overall Study|Withdrawal by Subject|0|||
33504016|NCT03560245|62885308|FG000|Overall Study|Withdrawal by Subject|3|||
33504017|NCT03560245|62885309|FG001|Overall Study|Withdrawal by Subject|2|||
33504018|NCT03560245|62885308|FG000|Overall Study|Adverse Event|1|||
33504019|NCT03560245|62885309|FG001|Overall Study|Adverse Event|1|||
33504020|NCT03560245|62885308|FG000|Overall Study|Protocol Violation|1|||
33504021|NCT03560245|62885309|FG001|Overall Study|Protocol Violation|0|||
33504022|NCT03560245|62885308|FG000|Overall Study|Death|0|||
33504023|NCT03560245|62885309|FG001|Overall Study|Death|1|||
33504024|NCT03560245|62885308|FG000|Overall Study|Lost to Follow-up|0|||
33504025|NCT03560245|62885309|FG001|Overall Study|Lost to Follow-up|1|||
33504026|NCT03560245|62885308|FG000|Overall Study|Physician Decision|0|||
33504027|NCT03560245|62885309|FG001|Overall Study|Physician Decision|1|||
33504028|NCT03560245|62885308|FG000|Overall Study|Other|0|||
33504029|NCT03560245|62885309|FG001|Overall Study|Other|1|||
33504030|NCT00707434|62885317|FG000|Overall Study|Adverse Event|1|||
33504031|NCT03054428|62885324|FG000|Overall Study|Physician Decision|0|||
33504032|NCT03054428|62885325|FG001|Overall Study|Physician Decision|1|||
33610869|NCT02264639|63011245|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
33504033|NCT03054428|62885326|FG002|Overall Study|Physician Decision|1|||
33504034|NCT03054428|62885324|FG000|Overall Study|Lack of Efficacy|3|||
33504035|NCT03054428|62885325|FG001|Overall Study|Lack of Efficacy|1|||
33504036|NCT03054428|62885326|FG002|Overall Study|Lack of Efficacy|0|||
33504037|NCT03054428|62885324|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
33504038|NCT03054428|62885325|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
33504039|NCT03054428|62885326|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
33324220|NCT00915772|62700687|FG002|Overall Study|Lost to Follow-up|2|||
33324221|NCT00915772|62700685|FG000|Overall Study|Lack of Efficacy|9|||
33504040|NCT03054428|62885324|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
33504041|NCT03054428|62885325|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
33610870|NCT02264639|63011246|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
33324222|NCT00915772|62700686|FG001|Overall Study|Lack of Efficacy|15|||
33449828|NCT00006604|62824744|FG016|Overall Study|Death|0|||
33449829|NCT00006604|62824728|FG000|Overall Study|Severe debilitation, unable to continue|0|||
33449830|NCT00006604|62824729|FG001|Overall Study|Severe debilitation, unable to continue|0|||
33449831|NCT00006604|62824730|FG002|Overall Study|Severe debilitation, unable to continue|0|||
33449832|NCT00006604|62824731|FG003|Overall Study|Severe debilitation, unable to continue|0|||
33449833|NCT00006604|62824732|FG004|Overall Study|Severe debilitation, unable to continue|0|||
33449834|NCT00006604|62824733|FG005|Overall Study|Severe debilitation, unable to continue|0|||
33449835|NCT00006604|62824734|FG006|Overall Study|Severe debilitation, unable to continue|3|||
33449836|NCT00006604|62824735|FG007|Overall Study|Severe debilitation, unable to continue|0|||
33449837|NCT00006604|62824736|FG008|Overall Study|Severe debilitation, unable to continue|0|||
33449838|NCT00006604|62824737|FG009|Overall Study|Severe debilitation, unable to continue|5|||
33449839|NCT00006604|62824738|FG010|Overall Study|Severe debilitation, unable to continue|0|||
33449840|NCT00006604|62824739|FG011|Overall Study|Severe debilitation, unable to continue|2|||
33449841|NCT00006604|62824740|FG012|Overall Study|Severe debilitation, unable to continue|1|||
33449842|NCT00006604|62824741|FG013|Overall Study|Severe debilitation, unable to continue|0|||
33449843|NCT00006604|62824742|FG014|Overall Study|Severe debilitation, unable to continue|2|||
33449844|NCT00006604|62824743|FG015|Overall Study|Severe debilitation, unable to continue|0|||
33449845|NCT00006604|62824744|FG016|Overall Study|Severe debilitation, unable to continue|0|||
33449846|NCT00006604|62824728|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
33449847|NCT00006604|62824729|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
33449848|NCT00006604|62824730|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
33449849|NCT00006604|62824731|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
33504042|NCT03054428|62885326|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
33610871|NCT02264639|63011247|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
33610872|NCT02264639|63011243|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
33610873|NCT02264639|63011244|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
33504043|NCT03054428|62885324|FG000|Overall Study|Transitioned to OLE study|76|||
33504044|NCT03054428|62885325|FG001|Overall Study|Transitioned to OLE study|76|||
33504045|NCT03054428|62885326|FG002|Overall Study|Transitioned to OLE study|73|||
33504046|NCT03054428|62885324|FG000|Overall Study|Withdrawal by Subject|3|||
33504047|NCT03054428|62885325|FG001|Overall Study|Withdrawal by Subject|2|||
33504048|NCT03054428|62885326|FG002|Overall Study|Withdrawal by Subject|3|||
33504049|NCT03054428|62885324|FG000|Overall Study|Lost to Follow-up|0|||
33504050|NCT03054428|62885325|FG001|Overall Study|Lost to Follow-up|0|||
33504051|NCT03054428|62885326|FG002|Overall Study|Lost to Follow-up|1|||
33504052|NCT03558997|62885338|FG000|Overall Study|Adverse Event|0|||
33504053|NCT03558997|62885339|FG001|Overall Study|Adverse Event|2|||
33504054|NCT03558997|62885340|FG002|Overall Study|Adverse Event|5|||
33504055|NCT03558997|62885341|FG003|Overall Study|Adverse Event|1|||
33504056|NCT03558997|62885338|FG000|Overall Study|Physician Decision|0|||
33504057|NCT03558997|62885339|FG001|Overall Study|Physician Decision|0|||
33504058|NCT03558997|62885340|FG002|Overall Study|Physician Decision|1|||
33504059|NCT03558997|62885341|FG003|Overall Study|Physician Decision|0|||
33504060|NCT03558997|62885338|FG000|Overall Study|Withdrawal by Subject|1|||
33504061|NCT03558997|62885339|FG001|Overall Study|Withdrawal by Subject|0|||
33504062|NCT03558997|62885340|FG002|Overall Study|Withdrawal by Subject|1|||
33504063|NCT03558997|62885341|FG003|Overall Study|Withdrawal by Subject|1|||
33504064|NCT03558997|62885338|FG000|Overall Study|Lost to Follow-up|0|||
33504065|NCT03558997|62885339|FG001|Overall Study|Lost to Follow-up|0|||
33610874|NCT02264639|63011245|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
33610875|NCT02264639|63011246|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
33610876|NCT02264639|63011247|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
33610877|NCT01363011|63011264|FG000|Main Study|Adverse Event|2|||
33610878|NCT01363011|63011265|FG001|Main Study|Adverse Event|3|||
33610879|NCT01363011|63011264|FG000|Main Study|Investigator's Discretion|1|||
33610880|NCT01363011|63011265|FG001|Main Study|Investigator's Discretion|1|||
33610881|NCT01363011|63011264|FG000|Main Study|Withdrew Consent|1|||
33449850|NCT00006604|62824732|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
33449851|NCT00006604|62824733|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
33449852|NCT00006604|62824734|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
33449853|NCT00006604|62824735|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
33449854|NCT00006604|62824736|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
33449855|NCT00006604|62824737|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
33449856|NCT00006604|62824738|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
33449857|NCT00006604|62824739|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
33449858|NCT00006604|62824740|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
33449859|NCT00006604|62824741|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
33449860|NCT00006604|62824742|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
33449861|NCT00006604|62824743|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
33449862|NCT00006604|62824744|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
33449863|NCT00006604|62824728|FG000|Overall Study|Site closing|0|||
33449864|NCT00006604|62824729|FG001|Overall Study|Site closing|0|||
33449865|NCT00006604|62824730|FG002|Overall Study|Site closing|1|||
33449866|NCT00006604|62824731|FG003|Overall Study|Site closing|1|||
33449867|NCT00006604|62824732|FG004|Overall Study|Site closing|0|||
33449868|NCT00006604|62824733|FG005|Overall Study|Site closing|0|||
33449869|NCT00006604|62824734|FG006|Overall Study|Site closing|0|||
33449870|NCT00006604|62824735|FG007|Overall Study|Site closing|1|||
33449871|NCT00006604|62824736|FG008|Overall Study|Site closing|0|||
33449872|NCT00006604|62824737|FG009|Overall Study|Site closing|0|||
33449873|NCT00006604|62824738|FG010|Overall Study|Site closing|0|||
33449874|NCT00006604|62824739|FG011|Overall Study|Site closing|1|||
33449875|NCT00006604|62824740|FG012|Overall Study|Site closing|1|||
33449876|NCT00006604|62824741|FG013|Overall Study|Site closing|1|||
33449877|NCT00006604|62824742|FG014|Overall Study|Site closing|0|||
33449878|NCT00006604|62824743|FG015|Overall Study|Site closing|0|||
33449879|NCT00006604|62824744|FG016|Overall Study|Site closing|1|||
33449880|NCT00006604|62824728|FG000|Overall Study|Withdrawal by Subject|1|||
33449881|NCT00006604|62824729|FG001|Overall Study|Withdrawal by Subject|0|||
33449882|NCT00006604|62824730|FG002|Overall Study|Withdrawal by Subject|2|||
33449883|NCT00006604|62824731|FG003|Overall Study|Withdrawal by Subject|0|||
33449884|NCT00006604|62824732|FG004|Overall Study|Withdrawal by Subject|1|||
33449885|NCT00006604|62824733|FG005|Overall Study|Withdrawal by Subject|2|||
33504066|NCT03558997|62885340|FG002|Overall Study|Lost to Follow-up|1|||
33504067|NCT03558997|62885341|FG003|Overall Study|Lost to Follow-up|0|||
33504068|NCT03052400|62885356|FG000|Overall Study|Lost to Follow-up|1|||
33610882|NCT01363011|63011265|FG001|Main Study|Withdrew Consent|4|||
33610883|NCT01363011|63011264|FG000|Main Study|Protocol Violation|0|||
33610884|NCT01363011|63011265|FG001|Main Study|Protocol Violation|1|||
33610885|NCT01363011|63011264|FG000|Extension Phase|Adverse Event|1|||
33610886|NCT01363011|63011265|FG001|Extension Phase|Adverse Event|1|||
33610887|NCT01363011|63011264|FG000|Extension Phase|Lack of Efficacy|0|||
33610888|NCT01363011|63011265|FG001|Extension Phase|Lack of Efficacy|1|||
33610889|NCT01363011|63011264|FG000|Extension Phase|Investigator's Discretion|2|||
33504069|NCT03052400|62885357|FG001|Overall Study|Lost to Follow-up|0|||
33504070|NCT03052400|62885356|FG000|Overall Study|Withdrawal by Subject|0|||
33504071|NCT03052400|62885357|FG001|Overall Study|Withdrawal by Subject|1|||
33504072|NCT03538951|62885365|FG000|Overall Study|Withdrawal by Subject|1|||
33504073|NCT03538951|62885366|FG001|Overall Study|Withdrawal by Subject|2|||
33504074|NCT03052322|62885374|FG000|Overall Study|Other un-specified|1|||
33504075|NCT03052322|62885375|FG001|Overall Study|Other un-specified|2|||
33504076|NCT03052322|62885374|FG000|Overall Study|Withdrawal by Subject|10|||
33504077|NCT03052322|62885375|FG001|Overall Study|Withdrawal by Subject|9|||
33504078|NCT03052322|62885374|FG000|Overall Study|Death|0|||
33504079|NCT03052322|62885375|FG001|Overall Study|Death|2|||
33504080|NCT03052322|62885374|FG000|Overall Study|Lack of Efficacy|1|||
33504081|NCT03052322|62885375|FG001|Overall Study|Lack of Efficacy|2|||
33504082|NCT03052322|62885374|FG000|Overall Study|Protocol Violation|1|||
33504083|NCT03052322|62885375|FG001|Overall Study|Protocol Violation|0|||
33504084|NCT03052322|62885374|FG000|Overall Study|Lost to Follow-up|2|||
33504085|NCT03052322|62885375|FG001|Overall Study|Lost to Follow-up|4|||
33504086|NCT03052322|62885374|FG000|Overall Study|Adverse Event|6|||
33504087|NCT03052322|62885375|FG001|Overall Study|Adverse Event|13|||
33504088|NCT03521791|62885383|FG000|Overall Study|Protocol Violation|7|||
33504089|NCT03521791|62885384|FG001|Overall Study|Protocol Violation|17|||
33504090|NCT03521635|62885392|FG000|Overall Study|Adverse Event|1|||
33504091|NCT03521635|62885393|FG001|Overall Study|Adverse Event|1|||
33504092|NCT03521635|62885392|FG000|Overall Study|Refused to complete study visit|1|||
33610890|NCT01363011|63011265|FG001|Extension Phase|Investigator's Discretion|2|||
33610891|NCT01363011|63011264|FG000|Extension Phase|Withdrew Consent|0|||
33504093|NCT03521635|62885393|FG001|Overall Study|Refused to complete study visit|0|||
33504094|NCT03521635|62885392|FG000|Overall Study|Refused to continue trial medication|2|||
33504095|NCT03521635|62885393|FG001|Overall Study|Refused to continue trial medication|2|||
33610892|NCT01363011|63011265|FG001|Extension Phase|Withdrew Consent|1|||
33610893|NCT01363011|63011264|FG000|Extension Phase|Lost to Follow-up|0|||
33610894|NCT01363011|63011265|FG001|Extension Phase|Lost to Follow-up|2|||
33610895|NCT01363011|63011264|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
33610896|NCT01363011|63011265|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
33610897|NCT02263547|63011271|FG000|Overall Study|Adverse Event|1|||
33504096|NCT03521635|62885392|FG000|Overall Study|Lost to Follow-up|0|||
33504097|NCT03521635|62885393|FG001|Overall Study|Lost to Follow-up|1|||
33504098|NCT03521635|62885392|FG000|Overall Study|Meet exclusion criteria|0|||
33504099|NCT03521635|62885393|FG001|Overall Study|Meet exclusion criteria|1|||
33504100|NCT03521635|62885392|FG000|Overall Study|Patient not taken study medicine|0|||
33504101|NCT03521635|62885393|FG001|Overall Study|Patient not taken study medicine|1|||
33504102|NCT03170544|62885411|FG000|Part 1|Lost to Follow-up|1|||
33504103|NCT03170544|62885412|FG001|Part 1|Lost to Follow-up|0|||
33504104|NCT03170544|62885413|FG002|Part 1|Lost to Follow-up|0|||
33504105|NCT03170544|62885414|FG003|Part 1|Lost to Follow-up|0|||
33610898|NCT02263547|63011271|FG000|Overall Study|Lost to Follow-up|2|||
33610899|NCT01925703|63011275|FG000|Overall Study|Physician Decision|1|||
33610900|NCT01925703|63011275|FG000|Overall Study|Lost to Follow-up|2|||
33610901|NCT01925703|63011275|FG000|Overall Study|Discharge prior to full iron repletion|1|||
33610902|NCT02195011|63011281|FG000|Overall Study|Adverse Event|4|||
33610903|NCT02195011|63011282|FG001|Overall Study|Adverse Event|0|||
33610904|NCT02195011|63011281|FG000|Overall Study|Progressive Disease|18|||
33610905|NCT02195011|63011282|FG001|Overall Study|Progressive Disease|1|||
33610906|NCT02195011|63011281|FG000|Overall Study|Withdrawal by Subject|3|||
33610907|NCT02195011|63011282|FG001|Overall Study|Withdrawal by Subject|0|||
33610908|NCT01617681|63011292|FG000|Period 1 Double Blind|Adverse Event|2|||
33610909|NCT01617681|63011293|FG001|Period 1 Double Blind|Adverse Event|0|||
33610910|NCT01617681|63011294|FG002|Period 1 Double Blind|Adverse Event|0|||
33504106|NCT03170544|62885415|FG004|Part 1|Lost to Follow-up|0|||
33610911|NCT01617681|63011295|FG003|Period 1 Double Blind|Adverse Event|2|||
33610912|NCT01617681|63011296|FG004|Period 1 Double Blind|Adverse Event|0|||
33504107|NCT03170544|62885416|FG005|Part 1|Lost to Follow-up|0|||
33504108|NCT03170544|62885417|FG006|Part 1|Lost to Follow-up|0|||
33610913|NCT01617681|63011292|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
33610914|NCT01617681|63011293|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
33610915|NCT01617681|63011294|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
33504109|NCT03170544|62885418|FG007|Part 1|Lost to Follow-up|0|||
33504110|NCT03170544|62885419|FG008|Part 1|Lost to Follow-up|0|||
33504111|NCT03170544|62885420|FG009|Part 1|Lost to Follow-up|0|||
33504112|NCT03170544|62885421|FG010|Part 1|Lost to Follow-up|0|||
33504113|NCT03170544|62885422|FG011|Part 1|Lost to Follow-up|0|||
33504114|NCT03170544|62885411|FG000|Part 1|Not treated|0|||
33504115|NCT03170544|62885412|FG001|Part 1|Not treated|0|||
33504116|NCT03170544|62885413|FG002|Part 1|Not treated|0|||
33504117|NCT03170544|62885414|FG003|Part 1|Not treated|1|||
33610916|NCT01617681|63011295|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
33610917|NCT01617681|63011296|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
33504118|NCT03170544|62885415|FG004|Part 1|Not treated|0|||
33610918|NCT01617681|63011292|FG000|Period 2 Open Label|Adverse Event|0|||
33504119|NCT03170544|62885416|FG005|Part 1|Not treated|0|||
33504120|NCT03170544|62885417|FG006|Part 1|Not treated|0|||
33504121|NCT03170544|62885418|FG007|Part 1|Not treated|0|||
33504122|NCT03170544|62885419|FG008|Part 1|Not treated|0|||
33504123|NCT03170544|62885420|FG009|Part 1|Not treated|0|||
33504124|NCT03170544|62885421|FG010|Part 1|Not treated|0|||
33504125|NCT03170544|62885422|FG011|Part 1|Not treated|0|||
33504126|NCT03582943|62885507|FG000|Allocated to Groups|Withdrawal by Subject|1|||
33504127|NCT03582943|62885508|FG001|Allocated to Groups|Withdrawal by Subject|1|||
33504128|NCT03582943|62885507|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
33504129|NCT03582943|62885508|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
33504130|NCT03582943|62885507|FG000|Analyzed|Protocol Violation|4|||
33504131|NCT03582943|62885508|FG001|Analyzed|Protocol Violation|1|||
33504132|NCT03532009|62885516|FG000|Overall Study|Other|1|||
33504133|NCT03532009|62885517|FG001|Overall Study|Other|1|||
33504134|NCT03532009|62885516|FG000|Overall Study|Death|1|||
33504135|NCT03532009|62885517|FG001|Overall Study|Death|1|||
33504136|NCT03532009|62885516|FG000|Overall Study|Withdrawal by Patient|0|||
33504137|NCT03532009|62885517|FG001|Overall Study|Withdrawal by Patient|2|||
33504138|NCT03520387|62885528|FG000|Pre-Randomization|Withdrawal by Subject|1|||
33504139|NCT03520387|62885529|FG001|Pre-Randomization|Withdrawal by Subject|0|||
33504140|NCT03520387|62885530|FG002|Pre-Randomization|Withdrawal by Subject|0|||
33504141|NCT03520387|62885531|FG003|Pre-Randomization|Withdrawal by Subject|0|||
33504142|NCT03520387|62885532|FG004|Pre-Randomization|Withdrawal by Subject|0|||
33504143|NCT03520387|62885528|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
33504144|NCT03520387|62885529|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
33504145|NCT03520387|62885530|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
33504146|NCT03520387|62885531|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
33504147|NCT03520387|62885532|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
33504148|NCT03170232|62885545|FG000|Overall Study|Adverse Event|0|||
33504149|NCT03170232|62885546|FG001|Overall Study|Adverse Event|1|||
33504150|NCT03170232|62885545|FG000|Overall Study|Protocol Violation|0|||
33504151|NCT03170232|62885546|FG001|Overall Study|Protocol Violation|1|||
33504152|NCT03170232|62885545|FG000|Overall Study|Lack of Efficacy|0|||
33504153|NCT03170232|62885546|FG001|Overall Study|Lack of Efficacy|1|||
33610919|NCT01617681|63011293|FG001|Period 2 Open Label|Adverse Event|0|||
33610920|NCT01617681|63011294|FG002|Period 2 Open Label|Adverse Event|0|||
33610921|NCT01617681|63011295|FG003|Period 2 Open Label|Adverse Event|0|||
33449886|NCT00006604|62824734|FG006|Overall Study|Withdrawal by Subject|2|||
33449887|NCT00006604|62824735|FG007|Overall Study|Withdrawal by Subject|0|||
33449888|NCT00006604|62824736|FG008|Overall Study|Withdrawal by Subject|1|||
33449889|NCT00006604|62824737|FG009|Overall Study|Withdrawal by Subject|3|||
33449890|NCT00006604|62824738|FG010|Overall Study|Withdrawal by Subject|2|||
33449891|NCT00006604|62824739|FG011|Overall Study|Withdrawal by Subject|0|||
33449892|NCT00006604|62824740|FG012|Overall Study|Withdrawal by Subject|1|||
33449893|NCT00006604|62824741|FG013|Overall Study|Withdrawal by Subject|2|||
33449894|NCT00006604|62824742|FG014|Overall Study|Withdrawal by Subject|1|||
33449895|NCT00006604|62824743|FG015|Overall Study|Withdrawal by Subject|0|||
33449896|NCT00006604|62824744|FG016|Overall Study|Withdrawal by Subject|1|||
33449897|NCT00006604|62824728|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
33449898|NCT00006604|62824729|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
33504154|NCT03170232|62885545|FG000|Overall Study|Study closed/terminated|26|||
33504155|NCT03170232|62885546|FG001|Overall Study|Study closed/terminated|23|||
33504156|NCT03170232|62885545|FG000|Overall Study|Lost to Follow-up|1|||
33504157|NCT03170232|62885546|FG001|Overall Study|Lost to Follow-up|0|||
33504158|NCT03170232|62885545|FG000|Overall Study|Withdrawal by Subject|0|||
33610922|NCT01617681|63011296|FG004|Period 2 Open Label|Adverse Event|3|||
33449899|NCT00006604|62824730|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
33504159|NCT03170232|62885546|FG001|Overall Study|Withdrawal by Subject|1|||
33610923|NCT01617681|63011292|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
33504160|NCT03519919|62885552|FG000|Overall Study|Withdrawal by Subject|1|||
33504161|NCT03519919|62885552|FG000|Overall Study|Lack of Efficacy|1|||
33504162|NCT03519919|62885552|FG000|Overall Study|Screen Failure|1|||
33504163|NCT03478969|62885585|FG000|Overall Study|Withdrawal by Subject|4|||
33504164|NCT03478969|62885586|FG001|Overall Study|Withdrawal by Subject|7|||
33504165|NCT03478969|62885587|FG002|Overall Study|Withdrawal by Subject|6|||
33504166|NCT03478969|62885585|FG000|Overall Study|Adverse Event|2|||
33504167|NCT03478969|62885586|FG001|Overall Study|Adverse Event|0|||
33504168|NCT03478969|62885587|FG002|Overall Study|Adverse Event|1|||
33504169|NCT03478969|62885585|FG000|Overall Study|Pregnancy|1|||
33504170|NCT03478969|62885586|FG001|Overall Study|Pregnancy|0|||
33504171|NCT03478969|62885587|FG002|Overall Study|Pregnancy|0|||
33504172|NCT03478969|62885585|FG000|Overall Study|Personal Reasons|1|||
33504173|NCT03478969|62885586|FG001|Overall Study|Personal Reasons|0|||
33504174|NCT03478969|62885587|FG002|Overall Study|Personal Reasons|1|||
33504175|NCT03478969|62885585|FG000|Overall Study|Covid-19|1|||
33504176|NCT03478969|62885586|FG001|Overall Study|Covid-19|4|||
33504177|NCT03478969|62885587|FG002|Overall Study|Covid-19|3|||
33504178|NCT03478969|62885585|FG000|Overall Study|Multiple Reasons|0|||
33504179|NCT03478969|62885586|FG001|Overall Study|Multiple Reasons|1|||
33504180|NCT03478969|62885587|FG002|Overall Study|Multiple Reasons|1|||
33504181|NCT03478969|62885585|FG000|Overall Study|Eligibility Criteria|0|||
33504182|NCT03478969|62885586|FG001|Overall Study|Eligibility Criteria|0|||
33504183|NCT03478969|62885587|FG002|Overall Study|Eligibility Criteria|5|||
33504184|NCT03478969|62885585|FG000|Overall Study|Lost to Follow-up|0|||
33504185|NCT03478969|62885586|FG001|Overall Study|Lost to Follow-up|0|||
33504186|NCT03478969|62885587|FG002|Overall Study|Lost to Follow-up|1|||
33504187|NCT04823949|62885618|FG000|Overall Study|Withdrawal by Subject|0|||
33504188|NCT04823949|62885619|FG001|Overall Study|Withdrawal by Subject|4|||
33504189|NCT04823949|62885618|FG000|Overall Study|Physician Decision|0|||
33504190|NCT04823949|62885619|FG001|Overall Study|Physician Decision|1|||
33504191|NCT04499482|62885634|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
33504192|NCT04408794|62885653|FG000|Overall Study|Adverse Event|43|||
33504193|NCT04408794|62885653|FG000|Overall Study|Infrequent study drug usage|43|||
33504194|NCT04408794|62885653|FG000|Overall Study|Lack of Efficacy|61|||
33504195|NCT04408794|62885653|FG000|Overall Study|Lost to Follow-up|33|||
33504196|NCT04408794|62885653|FG000|Overall Study|Non-compliance|6|||
33504197|NCT04408794|62885653|FG000|Overall Study|Physician Decision|1|||
33504198|NCT04408794|62885653|FG000|Overall Study|Pregnancy|6|||
33504199|NCT04408794|62885653|FG000|Overall Study|Protocol Deviation|9|||
33504200|NCT04408794|62885653|FG000|Overall Study|Sheehan-STS Result|1|||
33504201|NCT04408794|62885653|FG000|Overall Study|Withdrawal by Subject|57|||
33504202|NCT04408794|62885653|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
33504203|NCT04408794|62885653|FG000|Overall Study|Never Treated Migraine|5|||
33504204|NCT04354168|62885686|FG000|Overall Study|Lost to Follow-up|22|||
33449900|NCT00006604|62824731|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
33449901|NCT00006604|62824732|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
33449902|NCT00006604|62824733|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
33449903|NCT00006604|62824734|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
33504205|NCT04305405|62885692|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33504206|NCT04305405|62885693|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33504207|NCT03543410|62885715|FG000|Overall Study|Adverse Event|10|||
33449904|NCT00006604|62824735|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
33449905|NCT00006604|62824736|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
33449906|NCT00006604|62824737|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
33449907|NCT00006604|62824738|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
33449908|NCT00006604|62824739|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
33449909|NCT00006604|62824740|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
33449910|NCT00006604|62824741|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
33449911|NCT00006604|62824742|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
33449912|NCT00006604|62824743|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
33449913|NCT00006604|62824744|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
33449914|NCT00006604|62824728|FG000|Overall Study|Lost to Follow-up|0|||
33504208|NCT03543410|62885716|FG001|Overall Study|Adverse Event|8|||
33449915|NCT00006604|62824729|FG001|Overall Study|Lost to Follow-up|0|||
33504209|NCT03543410|62885717|FG002|Overall Study|Adverse Event|2|||
33504210|NCT03543410|62885715|FG000|Overall Study|Lack of Efficacy|0|||
33504211|NCT03543410|62885716|FG001|Overall Study|Lack of Efficacy|1|||
33504212|NCT03543410|62885717|FG002|Overall Study|Lack of Efficacy|0|||
33504213|NCT03543410|62885715|FG000|Overall Study|Lost to Follow-up|0|||
33504214|NCT03543410|62885716|FG001|Overall Study|Lost to Follow-up|1|||
33504215|NCT03543410|62885717|FG002|Overall Study|Lost to Follow-up|0|||
33610924|NCT01617681|63011293|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
33610925|NCT01617681|63011294|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
33610926|NCT01617681|63011295|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
33610927|NCT01617681|63011296|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
33504216|NCT03543410|62885715|FG000|Overall Study|Withdrawal by Subject|5|||
33504217|NCT03543410|62885716|FG001|Overall Study|Withdrawal by Subject|2|||
33504218|NCT03543410|62885717|FG002|Overall Study|Withdrawal by Subject|8|||
33504219|NCT03543410|62885715|FG000|Overall Study|Protocol Violation|0|||
33504220|NCT03543410|62885716|FG001|Overall Study|Protocol Violation|1|||
33504221|NCT03543410|62885717|FG002|Overall Study|Protocol Violation|0|||
33504222|NCT03543410|62885715|FG000|Overall Study|Due to COVID-19|4|||
33504223|NCT03543410|62885716|FG001|Overall Study|Due to COVID-19|0|||
33504224|NCT03543410|62885717|FG002|Overall Study|Due to COVID-19|2|||
33504225|NCT03543410|62885715|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
33504226|NCT03543410|62885716|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
33504227|NCT03543410|62885717|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
33504228|NCT03543410|62885715|FG000|Overall Study|Not Due to COVID-19|2|||
33504229|NCT03543410|62885716|FG001|Overall Study|Not Due to COVID-19|0|||
33504230|NCT03543410|62885717|FG002|Overall Study|Not Due to COVID-19|1|||
33504231|NCT03294590|62885727|FG000|Overall Study|Lost to Follow-up|105|||
33504232|NCT03294590|62885728|FG001|Overall Study|Lost to Follow-up|107|||
33504233|NCT02908074|62885742|FG000|Overall Study|sponsor/ICON decision|0|||
33504234|NCT02908074|62885743|FG001|Overall Study|sponsor/ICON decision|0|||
33504235|NCT02908074|62885744|FG002|Overall Study|sponsor/ICON decision|1|||
33504236|NCT02908074|62885745|FG003|Overall Study|sponsor/ICON decision|0|||
33504237|NCT02908074|62885746|FG004|Overall Study|sponsor/ICON decision|0|||
33504238|NCT02908074|62885747|FG005|Overall Study|sponsor/ICON decision|0|||
33504239|NCT02908074|62885742|FG000|Overall Study|Protocol Violation|0|||
33504240|NCT02908074|62885743|FG001|Overall Study|Protocol Violation|1|||
33504241|NCT02908074|62885744|FG002|Overall Study|Protocol Violation|0|||
33504242|NCT02908074|62885745|FG003|Overall Study|Protocol Violation|0|||
33504243|NCT02908074|62885746|FG004|Overall Study|Protocol Violation|0|||
33504244|NCT02908074|62885747|FG005|Overall Study|Protocol Violation|0|||
33504245|NCT02908074|62885742|FG000|Overall Study|Adverse Event|5|||
33504246|NCT02908074|62885743|FG001|Overall Study|Adverse Event|2|||
33504247|NCT02908074|62885744|FG002|Overall Study|Adverse Event|0|||
33504248|NCT02908074|62885745|FG003|Overall Study|Adverse Event|0|||
33504249|NCT02908074|62885746|FG004|Overall Study|Adverse Event|1|||
33504250|NCT02908074|62885747|FG005|Overall Study|Adverse Event|0|||
33504251|NCT02908074|62885742|FG000|Overall Study|AESI|1|||
33504252|NCT02908074|62885743|FG001|Overall Study|AESI|0|||
33504253|NCT02908074|62885744|FG002|Overall Study|AESI|1|||
33504254|NCT02908074|62885745|FG003|Overall Study|AESI|0|||
33504255|NCT02908074|62885746|FG004|Overall Study|AESI|1|||
33504256|NCT02908074|62885747|FG005|Overall Study|AESI|0|||
33504257|NCT02908074|62885742|FG000|Overall Study|Discontinuation criteria per protocol|0|||
33504258|NCT02908074|62885743|FG001|Overall Study|Discontinuation criteria per protocol|0|||
33504259|NCT02908074|62885744|FG002|Overall Study|Discontinuation criteria per protocol|1|||
33504260|NCT02908074|62885745|FG003|Overall Study|Discontinuation criteria per protocol|0|||
33504261|NCT02908074|62885746|FG004|Overall Study|Discontinuation criteria per protocol|0|||
33504262|NCT02908074|62885747|FG005|Overall Study|Discontinuation criteria per protocol|1|||
33610928|NCT02263079|63011308|FG000|Overall Study|Physician Decision|1|||
33610929|NCT02263079|63011309|FG001|Overall Study|Physician Decision|0|||
33610930|NCT02263079|63011310|FG002|Overall Study|Physician Decision|0|||
33610931|NCT02263079|63011308|FG000|Overall Study|Withdrawal by Subject|2|||
33610932|NCT02263079|63011309|FG001|Overall Study|Withdrawal by Subject|8|||
33610933|NCT02263079|63011310|FG002|Overall Study|Withdrawal by Subject|0|||
33610934|NCT02295995|63011320|FG000|Overall Study|Lost to Follow-up|5|||
33610935|NCT02295995|63011321|FG001|Overall Study|Lost to Follow-up|1|||
33610936|NCT02294981|63011328|FG000|Overall Study|Lost to Follow-up|1|||
33610937|NCT02262377|63011334|FG000|Overall Study|Lost to Follow-up|5|||
33449916|NCT00006604|62824730|FG002|Overall Study|Lost to Follow-up|0|||
33449917|NCT00006604|62824731|FG003|Overall Study|Lost to Follow-up|0|||
33449918|NCT00006604|62824732|FG004|Overall Study|Lost to Follow-up|0|||
33449919|NCT00006604|62824733|FG005|Overall Study|Lost to Follow-up|0|||
33449920|NCT00006604|62824734|FG006|Overall Study|Lost to Follow-up|0|||
33449921|NCT00006604|62824735|FG007|Overall Study|Lost to Follow-up|1|||
33449922|NCT00006604|62824736|FG008|Overall Study|Lost to Follow-up|0|||
33449923|NCT00006604|62824737|FG009|Overall Study|Lost to Follow-up|2|||
33449924|NCT00006604|62824738|FG010|Overall Study|Lost to Follow-up|0|||
33449925|NCT00006604|62824739|FG011|Overall Study|Lost to Follow-up|0|||
33449926|NCT00006604|62824740|FG012|Overall Study|Lost to Follow-up|0|||
33449927|NCT00006604|62824741|FG013|Overall Study|Lost to Follow-up|0|||
33504263|NCT02908074|62885742|FG000|Overall Study|Withdrawal by Subject|3|||
33610938|NCT02262377|63011335|FG001|Overall Study|Lost to Follow-up|6|||
33610939|NCT02262377|63011334|FG000|Overall Study|Found ineligible after enrollment|3|||
33610940|NCT02262377|63011335|FG001|Overall Study|Found ineligible after enrollment|0|||
33610941|NCT02262377|63011334|FG000|Overall Study|Withdrawal by Subject|4|||
33610942|NCT02262377|63011335|FG001|Overall Study|Withdrawal by Subject|0|||
33610943|NCT02260817|63011344|FG000|Overall Study|Lost to Follow-up|0|||
33610944|NCT02260817|63011345|FG001|Overall Study|Lost to Follow-up|14|||
33610945|NCT02260817|63011344|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
33610946|NCT02260817|63011345|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
33504264|NCT02908074|62885743|FG001|Overall Study|Withdrawal by Subject|2|||
33504265|NCT02908074|62885744|FG002|Overall Study|Withdrawal by Subject|2|||
33504266|NCT02908074|62885745|FG003|Overall Study|Withdrawal by Subject|2|||
33504267|NCT02908074|62885746|FG004|Overall Study|Withdrawal by Subject|2|||
33504268|NCT02908074|62885747|FG005|Overall Study|Withdrawal by Subject|2|||
33504269|NCT02908074|62885742|FG000|Overall Study|Lost to Follow-up|0|||
33504270|NCT02908074|62885743|FG001|Overall Study|Lost to Follow-up|1|||
33504271|NCT02908074|62885744|FG002|Overall Study|Lost to Follow-up|1|||
33504272|NCT02908074|62885745|FG003|Overall Study|Lost to Follow-up|1|||
33504273|NCT02908074|62885746|FG004|Overall Study|Lost to Follow-up|0|||
33504274|NCT02908074|62885747|FG005|Overall Study|Lost to Follow-up|1|||
33504275|NCT02907359|62885766|FG000|Overall Study|Death|234|||
33504276|NCT02907359|62885767|FG001|Overall Study|Death|117|||
33504277|NCT02907359|62885766|FG000|Overall Study|Withdrawal by Subject|6|||
33504278|NCT02907359|62885767|FG001|Overall Study|Withdrawal by Subject|11|||
33504279|NCT02907359|62885766|FG000|Overall Study|Lost to Follow-up|1|||
33504280|NCT02907359|62885767|FG001|Overall Study|Lost to Follow-up|0|||
33504281|NCT02714205|62885775|FG000|Overall Study|Cannot tolerate medication|1|||
33504282|NCT02714205|62885776|FG001|Overall Study|Cannot tolerate medication|0|||
33504283|NCT02714205|62885775|FG000|Overall Study|Adverse Event|2|||
33504284|NCT02714205|62885776|FG001|Overall Study|Adverse Event|0|||
33504285|NCT02714205|62885775|FG000|Overall Study|Too busy|1|||
33504286|NCT02714205|62885776|FG001|Overall Study|Too busy|0|||
33504287|NCT02714205|62885775|FG000|Overall Study|Incomplete outcome data|0|||
33504288|NCT02714205|62885776|FG001|Overall Study|Incomplete outcome data|1|||
33504289|NCT00583752|62885800|FG000|Overall Study|Lost to Follow-up|5|||
33504290|NCT00583752|62885801|FG001|Overall Study|Lost to Follow-up|5|||
33504291|NCT02318784|62885808|FG000|Overall Study|Adverse Event|13|||
33504292|NCT02318784|62885808|FG000|Overall Study|Death|2|||
33504293|NCT02318784|62885808|FG000|Overall Study|Progressive Disease|37|||
33610947|NCT02260817|63011344|FG000|Overall Study|Observation, no biopsy|0|||
33449928|NCT00006604|62824742|FG014|Overall Study|Lost to Follow-up|0|||
33504294|NCT02318784|62885808|FG000|Overall Study|Withdrawal by Subject|10|||
33504295|NCT03170154|62885823|FG000|Overall Study|Lost to Follow-up|4|||
33504296|NCT03170154|62885823|FG000|Overall Study|Death|2|||
33504297|NCT03170154|62885823|FG000|Overall Study|Withdrawal by Subject|2|||
33504298|NCT03518125|62885838|FG000|Overall Study|Lost to Follow-up|0|||
33504299|NCT03518125|62885839|FG001|Overall Study|Lost to Follow-up|2|||
33504300|NCT03518125|62885840|FG002|Overall Study|Lost to Follow-up|0|||
33504301|NCT03518125|62885841|FG003|Overall Study|Lost to Follow-up|0|||
33504302|NCT03518125|62885842|FG004|Overall Study|Lost to Follow-up|3|||
33504303|NCT03518125|62885843|FG005|Overall Study|Lost to Follow-up|5|||
33504304|NCT03518125|62885838|FG000|Overall Study|Physician Decision|0|||
33504305|NCT03518125|62885839|FG001|Overall Study|Physician Decision|1|||
33504306|NCT03518125|62885840|FG002|Overall Study|Physician Decision|0|||
33504307|NCT03518125|62885841|FG003|Overall Study|Physician Decision|0|||
33504308|NCT03518125|62885842|FG004|Overall Study|Physician Decision|0|||
33504309|NCT03518125|62885843|FG005|Overall Study|Physician Decision|0|||
33504310|NCT03518125|62885838|FG000|Overall Study|Withdrawal by Subject|1|||
33504311|NCT03518125|62885839|FG001|Overall Study|Withdrawal by Subject|1|||
33449929|NCT00006604|62824743|FG015|Overall Study|Lost to Follow-up|1|||
33449930|NCT00006604|62824744|FG016|Overall Study|Lost to Follow-up|3|||
33449931|NCT00006604|62824728|FG000|Overall Study|Other Reason|0|||
33449932|NCT00006604|62824729|FG001|Overall Study|Other Reason|0|||
33449933|NCT00006604|62824730|FG002|Overall Study|Other Reason|0|||
33449934|NCT00006604|62824731|FG003|Overall Study|Other Reason|0|||
33449935|NCT00006604|62824732|FG004|Overall Study|Other Reason|0|||
33449936|NCT00006604|62824733|FG005|Overall Study|Other Reason|1|||
33449937|NCT00006604|62824734|FG006|Overall Study|Other Reason|0|||
33449938|NCT00006604|62824735|FG007|Overall Study|Other Reason|0|||
33504312|NCT03518125|62885840|FG002|Overall Study|Withdrawal by Subject|0|||
33504313|NCT03518125|62885841|FG003|Overall Study|Withdrawal by Subject|1|||
33504314|NCT03518125|62885842|FG004|Overall Study|Withdrawal by Subject|1|||
33504315|NCT03518125|62885843|FG005|Overall Study|Withdrawal by Subject|3|||
33449939|NCT00006604|62824736|FG008|Overall Study|Other Reason|0|||
33504316|NCT03518125|62885838|FG000|Overall Study|Missed Day 394 Visit|1|||
33504317|NCT03518125|62885839|FG001|Overall Study|Missed Day 394 Visit|0|||
33610948|NCT02260817|63011345|FG001|Overall Study|Observation, no biopsy|1|||
33610949|NCT02260817|63011344|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
33504318|NCT03518125|62885840|FG002|Overall Study|Missed Day 394 Visit|0|||
33504319|NCT03518125|62885841|FG003|Overall Study|Missed Day 394 Visit|0|||
33504320|NCT03518125|62885842|FG004|Overall Study|Missed Day 394 Visit|0|||
33504321|NCT03518125|62885843|FG005|Overall Study|Missed Day 394 Visit|0|||
33504322|NCT03169530|62885860|FG000|Overall Study|Study ended by NIH|15|||
33504323|NCT03169530|62885861|FG001|Overall Study|Study ended by NIH|17|||
33504324|NCT03478891|62885879|FG000|Overall Study|Enrolled, but product never administered|0|||
33504325|NCT03478891|62885880|FG001|Overall Study|Enrolled, but product never administered|0|||
33504326|NCT03478891|62885881|FG002|Overall Study|Enrolled, but product never administered|1|||
33504327|NCT03478891|62885879|FG000|Overall Study|Moved from area|0|||
33504328|NCT03478891|62885880|FG001|Overall Study|Moved from area|0|||
33504329|NCT03478891|62885881|FG002|Overall Study|Moved from area|1|||
33504330|NCT03478891|62885879|FG000|Overall Study|Lost to Follow-up|1|||
33504331|NCT03478891|62885880|FG001|Overall Study|Lost to Follow-up|0|||
33504332|NCT03478891|62885881|FG002|Overall Study|Lost to Follow-up|1|||
33504333|NCT01585103|62885893|FG000|Overall Study|Unable to swallow Cytosponge|6|||
33504334|NCT03168906|62885899|FG000|Overall Study|Lack of Efficacy|6|||
33504335|NCT03168906|62885900|FG001|Overall Study|Lack of Efficacy|6|||
33504336|NCT00706966|62885907|FG000|Overall Study|Adverse Event|1|||
33504337|NCT03478657|62885941|FG000|Overall Study|Withdrawal by Subject|0|||
33504338|NCT03478657|62885942|FG001|Overall Study|Withdrawal by Subject|1|||
33504339|NCT03515941|62885950|FG000|Overall Study|Adverse Event|1|||
33504340|NCT03515941|62885951|FG001|Overall Study|Adverse Event|0|||
33504341|NCT03011034|62885959|FG000|Overall Study|Adverse Event|1|||
33504342|NCT03011034|62885960|FG001|Overall Study|Adverse Event|0|||
33504343|NCT03515629|62885968|FG000|Overall Study|Death|0|||
33504344|NCT03515629|62885969|FG001|Overall Study|Death|1|||
33504345|NCT03515629|62885970|FG002|Overall Study|Death|1|||
33504346|NCT03515629|62885968|FG000|Overall Study|Progressive disease|0|||
33504347|NCT03515629|62885969|FG001|Overall Study|Progressive disease|1|||
33504348|NCT03515629|62885970|FG002|Overall Study|Progressive disease|0|||
33504349|NCT03512353|62885979|FG000|Overall Study|Sponsor Decision|3|||
33504350|NCT03512353|62885979|FG000|Overall Study|Death|1|||
33504351|NCT03512275|62885987|FG000|Overall Study|Withdrawal by Subject|1|||
33504352|NCT03512275|62885988|FG001|Overall Study|Withdrawal by Subject|3|||
33504353|NCT03512275|62885987|FG000|Overall Study|Physician Decision|0|||
33504354|NCT03512275|62885988|FG001|Overall Study|Physician Decision|1|||
33504355|NCT03512275|62885987|FG000|Overall Study|Lost to Follow-up|0|||
33504356|NCT03512275|62885988|FG001|Overall Study|Lost to Follow-up|3|||
33504357|NCT03512275|62885987|FG000|Overall Study|Other|1|||
33504358|NCT03512275|62885988|FG001|Overall Study|Other|0|||
33504359|NCT03473197|62885994|FG000|Overall Study|Adverse Event|4|||
33504360|NCT03473197|62885994|FG000|Overall Study|Lost to Follow-up|1|||
33504361|NCT03473197|62885994|FG000|Overall Study|Withdrawal by Subject|5|||
33504362|NCT03511105|62886000|FG000|Overall Study|Adverse Event|1|||
33504363|NCT03511105|62886001|FG001|Overall Study|Adverse Event|0|||
33504364|NCT03511105|62886000|FG000|Overall Study|Withdrew consent|1|||
33504365|NCT03511105|62886001|FG001|Overall Study|Withdrew consent|0|||
33504366|NCT03510715|62886021|FG000|Overall Study|Adverse Event|1|||
33504367|NCT03510715|62886022|FG001|Overall Study|Adverse Event|0|||
33504368|NCT03508843|62886029|FG000|Overall Study|Withdrawal by Subject|1|||
33504369|NCT03508843|62886029|FG000|Overall Study|technical difficulties|2|||
33504370|NCT03508609|62886033|FG000|Overall Study|Withdrawal by Subject|1|||
33504371|NCT03054350|62886043|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
33504372|NCT03054350|62886044|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
33504373|NCT03054350|62886045|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
33504374|NCT03054350|62886046|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
33449940|NCT00006604|62824737|FG009|Overall Study|Other Reason|1|||
33449941|NCT00006604|62824738|FG010|Overall Study|Other Reason|0|||
33449942|NCT00006604|62824739|FG011|Overall Study|Other Reason|0|||
33449943|NCT00006604|62824740|FG012|Overall Study|Other Reason|0|||
33449944|NCT00006604|62824741|FG013|Overall Study|Other Reason|0|||
33449945|NCT00006604|62824742|FG014|Overall Study|Other Reason|0|||
33449946|NCT00006604|62824743|FG015|Overall Study|Other Reason|0|||
33449947|NCT00006604|62824744|FG016|Overall Study|Other Reason|0|||
33504375|NCT03054350|62886047|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
33504376|NCT03054350|62886048|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
33610950|NCT02260817|63011345|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
33610951|NCT02260817|63011344|FG000|Overall Study|Protocol Violation|0|||
33449948|NCT00436007|62824770|FG000|Overall Study|Withdrawal by Subject|5|||
33504377|NCT03054350|62886043|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
33504378|NCT03054350|62886044|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
33504379|NCT03054350|62886045|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
33504380|NCT03054350|62886046|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
33610952|NCT02260817|63011345|FG001|Overall Study|Protocol Violation|14|||
33504381|NCT03054350|62886047|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
33504382|NCT03054350|62886048|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
33504383|NCT03054350|62886043|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
33504384|NCT03054350|62886044|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
33504385|NCT03054350|62886045|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
33504386|NCT03054350|62886046|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
33504387|NCT03054350|62886047|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
33504388|NCT03054350|62886048|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
33504389|NCT03054350|62886043|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
33504390|NCT03054350|62886044|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
33504391|NCT03054350|62886045|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
33504392|NCT03054350|62886046|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
33504393|NCT03054350|62886047|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
33504394|NCT03054350|62886048|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
33504395|NCT03528577|62886079|FG000|Sequence 1|Failed Spirometry|1|||
33504396|NCT03528577|62886079|FG000|Sequence 1|Restricted medication|1|||
33504397|NCT03528577|62886079|FG000|Sequence 2|Adverse Event|1|||
33504398|NCT03528577|62886079|FG000|Sequence 2|Withdrawal by Subject|1|||
33504399|NCT03528577|62886079|FG000|Sequence 2|Failed Spirometry|1|||
33504400|NCT03528577|62886079|FG000|Sequence 3|Failed Spirometry|1|||
33504401|NCT03528577|62886079|FG000|Sequence 4|Failed Spirometry|2|||
33504402|NCT03528577|62886079|FG000|Sequence 4|Adverse Event|1|||
33504403|NCT00706654|62886089|FG000|Conversion Phase|Lost to Follow-up|4|||
33504404|NCT00706654|62886090|FG001|Conversion Phase|Lost to Follow-up|0|||
33504405|NCT00706654|62886091|FG002|Conversion Phase|Lost to Follow-up|0|||
33504406|NCT00706654|62886092|FG003|Conversion Phase|Lost to Follow-up|0|||
33504407|NCT00706654|62886089|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
33504408|NCT00706654|62886090|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
33504409|NCT00706654|62886091|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
33504410|NCT00706654|62886092|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
33504411|NCT00706654|62886089|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
33504412|NCT00706654|62886090|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
33504413|NCT00706654|62886091|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
33504414|NCT00706654|62886092|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
33504415|NCT00706654|62886089|FG000|Conversion Phase|Withdrawn by Investigator|14|||
33504416|NCT00706654|62886090|FG001|Conversion Phase|Withdrawn by Investigator|0|||
33504417|NCT00706654|62886091|FG002|Conversion Phase|Withdrawn by Investigator|0|||
33504418|NCT00706654|62886092|FG003|Conversion Phase|Withdrawn by Investigator|0|||
33504419|NCT00706654|62886089|FG000|Conversion Phase|Withdrew Consent|38|||
33504420|NCT00706654|62886090|FG001|Conversion Phase|Withdrew Consent|0|||
33504421|NCT00706654|62886091|FG002|Conversion Phase|Withdrew Consent|0|||
33504422|NCT00706654|62886092|FG003|Conversion Phase|Withdrew Consent|0|||
33504423|NCT00706654|62886089|FG000|Conversion Phase|Adverse Event|18|||
33504424|NCT00706654|62886090|FG001|Conversion Phase|Adverse Event|0|||
33504425|NCT00706654|62886091|FG002|Conversion Phase|Adverse Event|0|||
33610953|NCT01642589|63011353|FG000|Overall Study|Withdrawal by Subject|1|||
33610954|NCT01642589|63011354|FG001|Overall Study|Withdrawal by Subject|1|||
33449949|NCT00436007|62824771|FG001|Overall Study|Withdrawal by Subject|3|||
33449950|NCT00436007|62824772|FG002|Overall Study|Withdrawal by Subject|4|||
33504426|NCT00706654|62886092|FG003|Conversion Phase|Adverse Event|0|||
33504427|NCT00706654|62886089|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
33504428|NCT00706654|62886090|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
33504429|NCT00706654|62886091|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
33610955|NCT02268812|63011364|FG000|Overall Study|Adverse Event|8|||
33449951|NCT00436007|62824770|FG000|Overall Study|Lost to Follow-up|14|||
33449952|NCT00436007|62824771|FG001|Overall Study|Lost to Follow-up|10|||
33449953|NCT00436007|62824772|FG002|Overall Study|Lost to Follow-up|13|||
33449954|NCT00436007|62824770|FG000|Overall Study|Physician Decision|0|||
33449955|NCT00436007|62824771|FG001|Overall Study|Physician Decision|0|||
33449956|NCT00436007|62824772|FG002|Overall Study|Physician Decision|2|||
33449957|NCT00436007|62824770|FG000|Overall Study|Death|0|||
33449958|NCT00436007|62824771|FG001|Overall Study|Death|1|||
33449959|NCT00436007|62824772|FG002|Overall Study|Death|3|||
33449960|NCT00436007|62824770|FG000|Overall Study|Other|0|||
33504430|NCT00706654|62886092|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
33504431|NCT00706654|62886089|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
33504432|NCT00706654|62886090|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
33504433|NCT00706654|62886091|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
33504434|NCT00706654|62886092|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
33610956|NCT02268812|63011365|FG001|Overall Study|Adverse Event|26|||
33449961|NCT00436007|62824771|FG001|Overall Study|Other|0|||
33449962|NCT00436007|62824772|FG002|Overall Study|Other|1|||
33449963|NCT00435461|62824788|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
33504435|NCT00706654|62886089|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
33504436|NCT00706654|62886090|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
33504437|NCT00706654|62886091|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
33504438|NCT00706654|62886092|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
33504439|NCT00706654|62886089|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
33504440|NCT00706654|62886090|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
33504441|NCT00706654|62886091|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
33504442|NCT00706654|62886092|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
33504443|NCT00706654|62886089|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
33504444|NCT00706654|62886090|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
33504445|NCT00706654|62886091|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
33504446|NCT00706654|62886092|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
33504447|NCT00706654|62886089|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
33504448|NCT00706654|62886090|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
33504449|NCT00706654|62886091|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
33504450|NCT00706654|62886092|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
33504451|NCT00706654|62886089|FG000|Oral Stabilization Phase|Withdrew consent|55|||
33504452|NCT00706654|62886090|FG001|Oral Stabilization Phase|Withdrew consent|0|||
33504453|NCT00706654|62886091|FG002|Oral Stabilization Phase|Withdrew consent|0|||
33504454|NCT00706654|62886092|FG003|Oral Stabilization Phase|Withdrew consent|0|||
33504455|NCT00706654|62886089|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
33504456|NCT00706654|62886090|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
33504457|NCT00706654|62886091|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
33504458|NCT00706654|62886092|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
33504459|NCT00706654|62886089|FG000|Oral Stabilization Phase|Adverse Event|21|||
33504460|NCT00706654|62886090|FG001|Oral Stabilization Phase|Adverse Event|0|||
33504461|NCT00706654|62886091|FG002|Oral Stabilization Phase|Adverse Event|0|||
33504462|NCT00706654|62886092|FG003|Oral Stabilization Phase|Adverse Event|0|||
33504463|NCT00706654|62886089|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
33504464|NCT00706654|62886090|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
33504465|NCT00706654|62886091|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
33504466|NCT00706654|62886092|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
33504467|NCT00706654|62886089|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
33504468|NCT00706654|62886090|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
33504469|NCT00706654|62886091|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
33504470|NCT00706654|62886092|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
33324223|NCT00915772|62700687|FG002|Overall Study|Lack of Efficacy|3|||
33324224|NCT00915772|62700685|FG000|Overall Study|Refused to continue trial medication|6|||
33324225|NCT00915772|62700686|FG001|Overall Study|Refused to continue trial medication|8|||
33324226|NCT00915772|62700687|FG002|Overall Study|Refused to continue trial medication|4|||
33324227|NCT00915772|62700685|FG000|Overall Study|Any other reason|4|||
33324228|NCT00915772|62700686|FG001|Overall Study|Any other reason|7|||
33324229|NCT00915772|62700687|FG002|Overall Study|Any other reason|7|||
33324230|NCT00912964|62700699|FG000|Overall Study|Eligibility criterion not met|1|||
33324231|NCT00912964|62700700|FG001|Overall Study|Eligibility criterion not met|1|||
33324232|NCT00912964|62700701|FG002|Overall Study|Eligibility criterion not met|0|||
33324233|NCT00912964|62700699|FG000|Overall Study|Adverse Event|15|||
33324234|NCT00912964|62700700|FG001|Overall Study|Adverse Event|18|||
33324235|NCT00912964|62700701|FG002|Overall Study|Adverse Event|12|||
33449964|NCT00435461|62824789|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
33449965|NCT00435461|62824790|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
33449966|NCT00435461|62824788|FG000|Overall Study|Protocol Violation|6|||
33449967|NCT00435461|62824789|FG001|Overall Study|Protocol Violation|9|||
33449968|NCT00435461|62824790|FG002|Overall Study|Protocol Violation|10|||
33449969|NCT00435461|62824788|FG000|Overall Study|Participant randomized(inadequate score)|1|||
33449970|NCT00435461|62824789|FG001|Overall Study|Participant randomized(inadequate score)|0|||
33449971|NCT00435461|62824790|FG002|Overall Study|Participant randomized(inadequate score)|0|||
33449972|NCT00435461|62824788|FG000|Overall Study|Compliance less than 80 percent|1|||
33324236|NCT00912964|62700699|FG000|Overall Study|Lack of Efficacy|11|||
33324237|NCT00912964|62700700|FG001|Overall Study|Lack of Efficacy|4|||
33324238|NCT00912964|62700701|FG002|Overall Study|Lack of Efficacy|3|||
33324239|NCT00912964|62700699|FG000|Overall Study|Withdrawal by Subject|20|||
33324240|NCT00912964|62700700|FG001|Overall Study|Withdrawal by Subject|12|||
33324241|NCT00912964|62700701|FG002|Overall Study|Withdrawal by Subject|18|||
33324242|NCT00912964|62700699|FG000|Overall Study|Lost to Follow-up|4|||
33324243|NCT00912964|62700700|FG001|Overall Study|Lost to Follow-up|3|||
33324244|NCT00912964|62700701|FG002|Overall Study|Lost to Follow-up|3|||
33324245|NCT00912964|62700699|FG000|Overall Study|Protocol Violation|5|||
33324246|NCT00912964|62700700|FG001|Overall Study|Protocol Violation|3|||
33324247|NCT00912964|62700701|FG002|Overall Study|Protocol Violation|8|||
33324248|NCT00912964|62700699|FG000|Overall Study|Taking exclusionary medications|7|||
33324249|NCT00912964|62700700|FG001|Overall Study|Taking exclusionary medications|4|||
33324250|NCT00912964|62700701|FG002|Overall Study|Taking exclusionary medications|8|||
33324251|NCT00912964|62700699|FG000|Overall Study|Medical History|1|||
33324252|NCT00912964|62700700|FG001|Overall Study|Medical History|0|||
33324253|NCT00912964|62700701|FG002|Overall Study|Medical History|0|||
33324254|NCT00912964|62700699|FG000|Overall Study|Non-compliance with study procedures|2|||
33324255|NCT00912964|62700700|FG001|Overall Study|Non-compliance with study procedures|0|||
33324256|NCT00912964|62700701|FG002|Overall Study|Non-compliance with study procedures|0|||
33324257|NCT00912964|62700699|FG000|Overall Study|Violation of exclusion criterion|0|||
33449973|NCT00435461|62824789|FG001|Overall Study|Compliance less than 80 percent|0|||
33504471|NCT00706654|62886089|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
33449974|NCT00435461|62824790|FG002|Overall Study|Compliance less than 80 percent|0|||
33449975|NCT00435461|62824788|FG000|Overall Study|In error, two study medications switched|1|||
33449976|NCT00435461|62824789|FG001|Overall Study|In error, two study medications switched|0|||
33449977|NCT00435461|62824790|FG002|Overall Study|In error, two study medications switched|0|||
33449978|NCT00435461|62824788|FG000|Overall Study|Lack of Efficacy|2|||
33449979|NCT00435461|62824789|FG001|Overall Study|Lack of Efficacy|1|||
33449980|NCT00435461|62824790|FG002|Overall Study|Lack of Efficacy|0|||
33449981|NCT00435461|62824788|FG000|Overall Study|Withdrawal by Subject|1|||
33449982|NCT00435461|62824789|FG001|Overall Study|Withdrawal by Subject|0|||
33449983|NCT00435461|62824790|FG002|Overall Study|Withdrawal by Subject|2|||
33449984|NCT00435461|62824788|FG000|Overall Study|Randomized in error|1|||
33449985|NCT00435461|62824789|FG001|Overall Study|Randomized in error|0|||
33449986|NCT00435461|62824790|FG002|Overall Study|Randomized in error|0|||
33449987|NCT00435461|62824788|FG000|Overall Study|Participant could not tolerate symptoms|0|||
33449988|NCT00435461|62824789|FG001|Overall Study|Participant could not tolerate symptoms|0|||
33449989|NCT00435461|62824790|FG002|Overall Study|Participant could not tolerate symptoms|1|||
33449990|NCT00435461|62824788|FG000|Overall Study|Participant could not swallow capsule|0|||
33449991|NCT00435461|62824789|FG001|Overall Study|Participant could not swallow capsule|0|||
33504472|NCT00706654|62886090|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
33504473|NCT00706654|62886091|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
33504474|NCT00706654|62886092|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
33504475|NCT00706654|62886089|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
33504476|NCT00706654|62886090|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
33504477|NCT00706654|62886091|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
33504478|NCT00706654|62886092|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
33504479|NCT00706654|62886089|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
33504480|NCT00706654|62886090|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
33504481|NCT00706654|62886091|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
33504482|NCT00706654|62886092|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
33504483|NCT00706654|62886089|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
33504484|NCT00706654|62886090|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
33504485|NCT00706654|62886091|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
33504486|NCT00706654|62886092|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
33504487|NCT00706654|62886089|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
33504488|NCT00706654|62886090|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
33504489|NCT00706654|62886091|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
33504490|NCT00706654|62886092|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
33504491|NCT00706654|62886089|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
33504492|NCT00706654|62886090|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
33504493|NCT00706654|62886091|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
33504494|NCT00706654|62886092|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
33504495|NCT00706654|62886089|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
33504496|NCT00706654|62886090|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
33504497|NCT00706654|62886091|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
33449992|NCT00435461|62824790|FG002|Overall Study|Participant could not swallow capsule|1|||
33449993|NCT00435461|62824788|FG000|Overall Study|Pregnancy|2|||
33504498|NCT00706654|62886092|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
33504499|NCT00706654|62886089|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
33504500|NCT00706654|62886090|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
33504501|NCT00706654|62886091|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
33504502|NCT00706654|62886092|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
33449994|NCT00435461|62824789|FG001|Overall Study|Pregnancy|0|||
33449995|NCT00435461|62824790|FG002|Overall Study|Pregnancy|0|||
33449996|NCT00435461|62824788|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
33449997|NCT00435461|62824789|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
33449998|NCT00435461|62824790|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
33504503|NCT03471871|62886104|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
33504504|NCT03471871|62886105|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
33504505|NCT03471871|62886106|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
33504506|NCT03471871|62886107|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
33504507|NCT03471871|62886108|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
33504508|NCT03471871|62886104|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
33504509|NCT03471871|62886105|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
33504510|NCT03471871|62886106|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
33504511|NCT03471871|62886107|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
33504512|NCT03471871|62886108|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
33504513|NCT03471871|62886104|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
33504514|NCT03471871|62886105|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
33504515|NCT03471871|62886106|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
33504516|NCT03471871|62886107|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
33504517|NCT03471871|62886108|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
33504518|NCT03471871|62886104|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
33504519|NCT03471871|62886105|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
33504520|NCT03471871|62886106|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
33504521|NCT03471871|62886107|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
33504522|NCT03471871|62886108|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
33504523|NCT03471871|62886104|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
33504524|NCT03471871|62886105|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
33504525|NCT03471871|62886106|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
33504526|NCT03471871|62886107|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
33504527|NCT03471871|62886108|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
33504528|NCT01957176|62886126|FG000|Overall Study|Adverse Event|2|||
33504529|NCT01957176|62886127|FG001|Overall Study|Adverse Event|0|||
33504530|NCT01957176|62886126|FG000|Overall Study|Physician Decision|2|||
33504531|NCT01957176|62886127|FG001|Overall Study|Physician Decision|1|||
33504532|NCT01957176|62886126|FG000|Overall Study|Withdrawal by Subject|1|||
33504533|NCT01957176|62886127|FG001|Overall Study|Withdrawal by Subject|0|||
33504534|NCT03527173|62886136|FG000|Overall Study|Lost to Follow-up|4|||
33504535|NCT03527173|62886137|FG001|Overall Study|Lost to Follow-up|2|||
33504536|NCT03527173|62886136|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
33504537|NCT03527173|62886137|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
33504538|NCT03527173|62886136|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
33504539|NCT03527173|62886137|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
33504540|NCT03527173|62886136|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
33504541|NCT03527173|62886137|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33504542|NCT00707980|62886143|FG000|Overall Study|Adverse Event|49|||
33504543|NCT00707980|62886143|FG000|Overall Study|Lack of Efficacy|35|||
33504544|NCT00707980|62886143|FG000|Overall Study|Non-Compliance with Study Drug|28|||
33504545|NCT00707980|62886143|FG000|Overall Study|Protocol Deviations|19|||
33504546|NCT00707980|62886143|FG000|Overall Study|Withdrawal of Consent|81|||
33504547|NCT00707980|62886143|FG000|Overall Study|Lost to Follow-up|59|||
33504548|NCT00707980|62886143|FG000|Overall Study|Other|39|||
33504549|NCT03506425|62886150|FG000|Overall Study|Adverse Event|1|||
33504550|NCT03506425|62886151|FG001|Overall Study|Adverse Event|3|||
33504551|NCT03506425|62886152|FG002|Overall Study|Adverse Event|0|||
33504552|NCT03506425|62886150|FG000|Overall Study|Death|1|||
33504553|NCT03506425|62886151|FG001|Overall Study|Death|0|||
33504554|NCT03506425|62886152|FG002|Overall Study|Death|0|||
33504555|NCT03506425|62886150|FG000|Overall Study|Withdrawal by Subject|0|||
33504556|NCT03506425|62886151|FG001|Overall Study|Withdrawal by Subject|0|||
33449999|NCT00435461|62824788|FG000|Overall Study|Participant ended study one day early|1|||
33450000|NCT00435461|62824789|FG001|Overall Study|Participant ended study one day early|0|||
33450001|NCT00435461|62824790|FG002|Overall Study|Participant ended study one day early|0|||
33450002|NCT00435461|62824788|FG000|Overall Study|Noncompliance with study requirements|1|||
33450003|NCT00435461|62824789|FG001|Overall Study|Noncompliance with study requirements|1|||
33450004|NCT00435461|62824790|FG002|Overall Study|Noncompliance with study requirements|1|||
33450005|NCT00435461|62824788|FG000|Overall Study|Adverse Event|1|||
33450006|NCT00435461|62824789|FG001|Overall Study|Adverse Event|2|||
33450007|NCT00435461|62824790|FG002|Overall Study|Adverse Event|6|||
33504557|NCT03506425|62886152|FG002|Overall Study|Withdrawal by Subject|1|||
33504558|NCT03051620|62886161|FG000|Overall Study|Lost to Follow-up|6|||
33504559|NCT03051620|62886161|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
33504560|NCT03053492|62886167|FG000|Overall Study|Adverse Event|1|||
33504561|NCT03053492|62886168|FG001|Overall Study|Adverse Event|1|||
33324258|NCT00912964|62700700|FG001|Overall Study|Violation of exclusion criterion|0|||
33324259|NCT00912964|62700701|FG002|Overall Study|Violation of exclusion criterion|2|||
33504562|NCT03053492|62886167|FG000|Overall Study|Withdrawal by Subject|7|||
33504563|NCT03053492|62886168|FG001|Overall Study|Withdrawal by Subject|5|||
33504564|NCT03801707|62886174|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
33504565|NCT04239872|62886178|FG000|Overall Study|Lost to Follow-up|0|||
33504566|NCT04239872|62886179|FG001|Overall Study|Lost to Follow-up|1|||
33504567|NCT03164772|62886187|FG000|Overall Study|Death|4|||
33504568|NCT03164772|62886188|FG001|Overall Study|Death|2|||
33504569|NCT03164772|62886187|FG000|Overall Study|Adverse Event|1|||
33504570|NCT03164772|62886188|FG001|Overall Study|Adverse Event|4|||
33504571|NCT03164772|62886187|FG000|Overall Study|Progressive Disease|11|||
33504572|NCT03164772|62886188|FG001|Overall Study|Progressive Disease|21|||
33504573|NCT03164772|62886187|FG000|Overall Study|Physician Decision|2|||
33610957|NCT02268812|63011366|FG002|Overall Study|Adverse Event|7|||
33610958|NCT02268812|63011367|FG003|Overall Study|Adverse Event|10|||
33610959|NCT02268812|63011364|FG000|Overall Study|Protocol deviation|0|||
33610960|NCT02268812|63011365|FG001|Overall Study|Protocol deviation|0|||
33610961|NCT02268812|63011366|FG002|Overall Study|Protocol deviation|1|||
33610962|NCT02268812|63011367|FG003|Overall Study|Protocol deviation|0|||
33610963|NCT02268812|63011364|FG000|Overall Study|Withdrawal by Subject|0|||
33610964|NCT02268812|63011365|FG001|Overall Study|Withdrawal by Subject|1|||
33610965|NCT02268812|63011366|FG002|Overall Study|Withdrawal by Subject|0|||
33610966|NCT02268812|63011367|FG003|Overall Study|Withdrawal by Subject|0|||
33610967|NCT02268812|63011364|FG000|Overall Study|Physician Decision|3|||
33610968|NCT02268812|63011365|FG001|Overall Study|Physician Decision|1|||
33610969|NCT02268812|63011366|FG002|Overall Study|Physician Decision|0|||
33610970|NCT02268812|63011367|FG003|Overall Study|Physician Decision|1|||
33610971|NCT02268812|63011364|FG000|Overall Study|Other|5|||
33610972|NCT02268812|63011365|FG001|Overall Study|Other|4|||
33610973|NCT02268812|63011366|FG002|Overall Study|Other|1|||
33610974|NCT02268812|63011367|FG003|Overall Study|Other|3|||
33610975|NCT01954251|63011379|FG000|Overall Study|Adverse Event|5|||
33610976|NCT01954251|63011380|FG001|Overall Study|Adverse Event|7|||
33610977|NCT01954251|63011379|FG000|Overall Study|Lost to Follow-up|6|||
33610978|NCT01954251|63011380|FG001|Overall Study|Lost to Follow-up|6|||
33610979|NCT01954251|63011379|FG000|Overall Study|Withdrawal by Subject|2|||
33610980|NCT01954251|63011380|FG001|Overall Study|Withdrawal by Subject|6|||
33610981|NCT01644617|63011390|FG000|Overall Study|Withdrawal by Subject|3|||
33610982|NCT01644617|63011391|FG001|Overall Study|Withdrawal by Subject|4|||
33610983|NCT01644617|63011392|FG002|Overall Study|Withdrawal by Subject|1|||
33610984|NCT01644617|63011390|FG000|Overall Study|Lost to Follow-up|0|||
33610985|NCT01644617|63011391|FG001|Overall Study|Lost to Follow-up|1|||
33610986|NCT01644617|63011392|FG002|Overall Study|Lost to Follow-up|0|||
33450008|NCT00435461|62824788|FG000|Overall Study|Non-Compliance of diary|2|||
33450009|NCT00435461|62824789|FG001|Overall Study|Non-Compliance of diary|0|||
33450010|NCT00435461|62824790|FG002|Overall Study|Non-Compliance of diary|1|||
33450011|NCT00435461|62824788|FG000|Overall Study|Lost to Follow-up|1|||
33450012|NCT00435461|62824789|FG001|Overall Study|Lost to Follow-up|1|||
33450013|NCT00435461|62824790|FG002|Overall Study|Lost to Follow-up|2|||
33450014|NCT00434759|62824800|FG000|Overall Study|Lack of Efficacy|5|||
33450015|NCT00434759|62824801|FG001|Overall Study|Lack of Efficacy|4|||
33450016|NCT00434759|62824800|FG000|Overall Study|Withdrawal by Subject|17|||
33450017|NCT00434759|62824801|FG001|Overall Study|Withdrawal by Subject|1|||
33450018|NCT00434759|62824800|FG000|Overall Study|family affairs|2|||
33450019|NCT00434759|62824801|FG001|Overall Study|family affairs|0|||
33450020|NCT00440999|62824811|FG000|Overall Study|Adverse Event|0|||
33450021|NCT00440999|62824812|FG001|Overall Study|Adverse Event|2|||
33504574|NCT03164772|62886188|FG001|Overall Study|Physician Decision|0|||
33504575|NCT03164772|62886187|FG000|Overall Study|Withdrawal by Subject|0|||
33504576|NCT03164772|62886188|FG001|Overall Study|Withdrawal by Subject|4|||
33504577|NCT03050450|62886211|FG000|Overall Study|Physician Decision|1|||
33504578|NCT03050450|62886212|FG001|Overall Study|Physician Decision|0|||
33504579|NCT03050450|62886213|FG002|Overall Study|Physician Decision|0|||
33504580|NCT03050450|62886214|FG003|Overall Study|Physician Decision|0|||
33504581|NCT03050450|62886215|FG004|Overall Study|Physician Decision|0|||
33504582|NCT03505021|62886229|FG000|Overall Study|Protocol Violation|1|||
33504583|NCT03505021|62886230|FG001|Overall Study|Protocol Violation|0|||
33504584|NCT03505021|62886229|FG000|Overall Study|Death|9|||
33504585|NCT03505021|62886230|FG001|Overall Study|Death|8|||
33504586|NCT03505021|62886229|FG000|Overall Study|Consent withdrawn by subject|6|||
33504587|NCT03505021|62886230|FG001|Overall Study|Consent withdrawn by subject|1|||
33504588|NCT03505021|62886229|FG000|Overall Study|Lost to Follow-up|5|||
33504589|NCT03505021|62886230|FG001|Overall Study|Lost to Follow-up|3|||
33610987|NCT01644617|63011390|FG000|Overall Study|Adverse Event|3|||
33610988|NCT01644617|63011391|FG001|Overall Study|Adverse Event|0|||
33610989|NCT01644617|63011392|FG002|Overall Study|Adverse Event|6|||
33610990|NCT02294318|63011402|FG000|Overall Study|Worsening of drinking|3|||
33610991|NCT02294318|63011403|FG001|Overall Study|Worsening of drinking|0|||
33610992|NCT02294318|63011402|FG000|Overall Study|Not exposed to intervention|0|||
33504590|NCT03505021|62886229|FG000|Overall Study|Adverse Event|26|||
33504591|NCT03505021|62886230|FG001|Overall Study|Adverse Event|9|||
33504592|NCT03505021|62886229|FG000|Overall Study|Disease progression|33|||
33504593|NCT03505021|62886230|FG001|Overall Study|Disease progression|17|||
33504594|NCT03505021|62886229|FG000|Overall Study|Other|11|||
33504595|NCT03505021|62886230|FG001|Overall Study|Other|5|||
33504596|NCT03505021|62886229|FG000|Overall Study|Personal reason|21|||
33504597|NCT03505021|62886230|FG001|Overall Study|Personal reason|12|||
33504598|NCT03050372|62886236|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
33504599|NCT03050372|62886237|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
33504600|NCT03050372|62886236|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
33504601|NCT03050372|62886237|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
33504602|NCT03470545|62886244|FG000|Overall Study|Death|0|||
33504603|NCT03470545|62886245|FG001|Overall Study|Death|1|||
33504604|NCT03470545|62886244|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
33504605|NCT03470545|62886245|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
33504606|NCT03470545|62886244|FG000|Overall Study|Adverse Event|2|||
33504607|NCT03470545|62886245|FG001|Overall Study|Adverse Event|0|||
33504608|NCT03470545|62886244|FG000|Overall Study|Withdrawal by Subject|1|||
33504609|NCT03470545|62886245|FG001|Overall Study|Withdrawal by Subject|1|||
33504610|NCT03470545|62886244|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
33504611|NCT03470545|62886245|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
33504612|NCT03163446|62886254|FG000|Overall Study|Unable to return for Day 180 visit|2|||
33504613|NCT03163446|62886255|FG001|Overall Study|Unable to return for Day 180 visit|0|||
33504614|NCT03163446|62886254|FG000|Overall Study|Withdrawal by Subject|2|||
33610993|NCT02294318|63011403|FG001|Overall Study|Not exposed to intervention|2|||
33504615|NCT03163446|62886255|FG001|Overall Study|Withdrawal by Subject|6|||
33504616|NCT03163446|62886254|FG000|Overall Study|Death|16|||
33504617|NCT03163446|62886255|FG001|Overall Study|Death|5|||
33504618|NCT03163446|62886254|FG000|Overall Study|Lost to Follow-up|6|||
33504619|NCT03163446|62886255|FG001|Overall Study|Lost to Follow-up|5|||
33504620|NCT03163446|62886254|FG000|Overall Study|Physician Decision|1|||
33504621|NCT03163446|62886255|FG001|Overall Study|Physician Decision|1|||
33504622|NCT03163446|62886254|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
33504623|NCT03163446|62886255|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
33504624|NCT03722485|62886269|FG000|Overall Study|Withdrawal by Subject|1|||
33504625|NCT03722485|62886270|FG001|Overall Study|Withdrawal by Subject|0|||
33504626|NCT03722485|62886269|FG000|Overall Study|Adverse Event|0|||
33504627|NCT03722485|62886270|FG001|Overall Study|Adverse Event|2|||
33504628|NCT03722485|62886269|FG000|Overall Study|subject discharged prior to study completion|1|||
33504629|NCT03722485|62886270|FG001|Overall Study|subject discharged prior to study completion|5|||
33324260|NCT00912964|62700699|FG000|Overall Study|Randomized but never received study drug|0|||
33324261|NCT00912964|62700700|FG001|Overall Study|Randomized but never received study drug|1|||
33324262|NCT00912964|62700701|FG002|Overall Study|Randomized but never received study drug|0|||
33324263|NCT00913744|62700711|FG000|Overall Study|Adverse Event|2|||
33504630|NCT03722485|62886269|FG000|Overall Study|eligibility criteria not met|2|||
33504631|NCT03722485|62886270|FG001|Overall Study|eligibility criteria not met|0|||
33504632|NCT03047720|62886300|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
33504633|NCT03047720|62886301|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
33504634|NCT03626168|62886326|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
33504635|NCT03626168|62886327|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
33504636|NCT03626168|62886326|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
33504637|NCT03626168|62886327|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
33504638|NCT03626168|62886326|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
33504639|NCT03626168|62886327|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
33504640|NCT02966873|62886335|FG000|Overall Study|Lost to Follow-up|16|||
33504641|NCT02966873|62886336|FG001|Overall Study|Lost to Follow-up|15|||
33504642|NCT01389024|62886344|FG000|Overall Study|Withdrawal by Subject|0|||
33504643|NCT01389024|62886345|FG001|Overall Study|Withdrawal by Subject|1|||
33504644|NCT01389024|62886344|FG000|Overall Study|Lost to Follow-up|1|||
33504645|NCT01389024|62886345|FG001|Overall Study|Lost to Follow-up|0|||
33504646|NCT03050060|62886355|FG000|Overall Study|Adverse Event|7|||
33504647|NCT03050060|62886355|FG000|Overall Study|Withdrawal by Subject|1|||
33324264|NCT00913744|62700712|FG001|Overall Study|Adverse Event|0|||
33504648|NCT03050060|62886355|FG000|Overall Study|Progression|7|||
33504649|NCT00706342|62886368|FG000|Overall Study|Adverse Event|3|||
33504650|NCT00706342|62886368|FG000|Overall Study|Not responding to treatment|2|||
33324265|NCT00913744|62700711|FG000|Overall Study|Withdrawal by Subject|2|||
33504651|NCT00706342|62886368|FG000|Overall Study|Withdrawn due to failure to respond|1|||
33651424|NCT01746901|63062907|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33504652|NCT00706342|62886368|FG000|Overall Study|Death|1|||
33504653|NCT00706342|62886368|FG000|Overall Study|Withdrew from the study on his own.|1|||
33504654|NCT00706342|62886368|FG000|Overall Study|Investigator discretion|2|||
33504655|NCT00706342|62886368|FG000|Overall Study|Non-responder Week 12|1|||
33504656|NCT00706342|62886368|FG000|Overall Study|Ongoing|6|||
33504657|NCT00706342|62886368|FG000|Overall Study|WIthdrawal of consent|1|||
33504658|NCT03049748|62886374|FG000|Overall Study|Lost to Follow-up|1|||
33504659|NCT03049748|62886375|FG001|Overall Study|Lost to Follow-up|0|||
33504660|NCT03049748|62886374|FG000|Overall Study|Death|3|||
33504661|NCT03049748|62886375|FG001|Overall Study|Death|0|||
33504662|NCT03049748|62886374|FG000|Overall Study|Withdrawal by Subject|0|||
33504663|NCT03049748|62886375|FG001|Overall Study|Withdrawal by Subject|3|||
33504664|NCT03049748|62886374|FG000|Overall Study|Protocol Violation|0|||
33504665|NCT03049748|62886375|FG001|Overall Study|Protocol Violation|2|||
33504666|NCT03049748|62886374|FG000|Overall Study|Moved out of state (relocation)|0|||
33504667|NCT03049748|62886375|FG001|Overall Study|Moved out of state (relocation)|1|||
33504668|NCT03501277|62886389|FG000|Intervention Period 1 (4 Days)|Other|0|||
33504669|NCT03501277|62886390|FG001|Intervention Period 1 (4 Days)|Other|0|||
33504670|NCT03501277|62886391|FG002|Intervention Period 1 (4 Days)|Other|1|||
33504671|NCT03501277|62886392|FG003|Intervention Period 1 (4 Days)|Other|0|||
33504672|NCT03501277|62886389|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
33504673|NCT03501277|62886390|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
33450022|NCT00440999|62824811|FG000|Overall Study|Lack of Efficacy|6|||
33450023|NCT00440999|62824812|FG001|Overall Study|Lack of Efficacy|7|||
33450024|NCT00440999|62824811|FG000|Overall Study|Lost to Follow-up|19|||
33450025|NCT00440999|62824812|FG001|Overall Study|Lost to Follow-up|12|||
33450026|NCT00440999|62824811|FG000|Overall Study|Protocol Violation|1|||
33450027|NCT00440999|62824812|FG001|Overall Study|Protocol Violation|0|||
33450028|NCT00440999|62824811|FG000|Overall Study|Withdrawal by Subject|2|||
33450029|NCT00440999|62824812|FG001|Overall Study|Withdrawal by Subject|5|||
33450030|NCT00440999|62824811|FG000|Overall Study|Subjets missed the visit|1|||
33450031|NCT00440999|62824812|FG001|Overall Study|Subjets missed the visit|0|||
33504674|NCT03501277|62886391|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
33504675|NCT03501277|62886392|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
33504676|NCT03501277|62886389|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
33504677|NCT03501277|62886390|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
33504678|NCT03501277|62886391|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
33504679|NCT03501277|62886392|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
33504680|NCT03501277|62886389|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
33610994|NCT02293499|63011412|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
33610995|NCT02293499|63011413|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
33610996|NCT02293499|63011414|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
33610997|NCT02293499|63011412|FG000|Intervention - Camp|Withdrawal by Subject|3|||
33610998|NCT02293499|63011413|FG001|Intervention - Camp|Withdrawal by Subject|6|||
33610999|NCT02293499|63011414|FG002|Intervention - Camp|Withdrawal by Subject|2|||
33611000|NCT02293499|63011412|FG000|Intervention - Camp|these are those not showing up at camp|24|||
33450032|NCT00440999|62824811|FG000|Overall Study|Mixed infection at entry|1|||
33450033|NCT00440999|62824812|FG001|Overall Study|Mixed infection at entry|0|||
33450034|NCT00440999|62824811|FG000|Overall Study|P. falciparum malaria|5|||
33450035|NCT00440999|62824812|FG001|Overall Study|P. falciparum malaria|14|||
33450036|NCT00440999|62824811|FG000|Overall Study|Subj left hosp without inform staff|0|||
33450037|NCT00440999|62824812|FG001|Overall Study|Subj left hosp without inform staff|1|||
33450038|NCT00434213|62824820|FG000|Overall Study|Adverse Event|12|||
33611001|NCT02293499|63011413|FG001|Intervention - Camp|these are those not showing up at camp|28|||
33611002|NCT02293499|63011414|FG002|Intervention - Camp|these are those not showing up at camp|4|||
33611003|NCT02293499|63011412|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
33611004|NCT02293499|63011413|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
33611005|NCT02293499|63011414|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
33611006|NCT02293499|63011412|FG000|3 Month Follow Up|Lost to Follow-up|14|||
33611007|NCT02293499|63011413|FG001|3 Month Follow Up|Lost to Follow-up|15|||
33611008|NCT02293499|63011414|FG002|3 Month Follow Up|Lost to Follow-up|6|||
33611009|NCT02293499|63011412|FG000|6 Month Follow Up|Lost to Follow-up|17|||
33611010|NCT02293499|63011413|FG001|6 Month Follow Up|Lost to Follow-up|27|||
33450039|NCT00434213|62824820|FG000|Overall Study|Lack of Efficacy|9|||
33450040|NCT00434213|62824820|FG000|Overall Study|Lost to Follow-up|14|||
33504681|NCT03501277|62886390|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
33450041|NCT00434213|62824820|FG000|Overall Study|Withdrawal by Subject|7|||
33450042|NCT00434213|62824820|FG000|Overall Study|Protocol Violation|3|||
33450043|NCT00434213|62824820|FG000|Overall Study|Unable to comply with study visit window|2|||
33450044|NCT00434213|62824820|FG000|Overall Study|Application site reaction|1|||
33450045|NCT00434213|62824820|FG000|Overall Study|Non-compliant to study schedule|1|||
33450046|NCT00006184|62824826|FG000|Overall Study|Death|1|||
33504682|NCT03501277|62886391|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
33611011|NCT02293499|63011414|FG002|6 Month Follow Up|Lost to Follow-up|6|||
33611012|NCT02293499|63011412|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
33611013|NCT02293499|63011413|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
33611014|NCT02293499|63011414|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
33611015|NCT02293499|63011412|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
33611016|NCT02293499|63011413|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
33450047|NCT00006184|62824827|FG001|Overall Study|Death|0|||
33450048|NCT00434057|62824833|FG000|Overall Study|Withdrawal by Subject|1|||
33324266|NCT00913744|62700712|FG001|Overall Study|Withdrawal by Subject|1|||
33324267|NCT00913744|62700711|FG000|Overall Study|Death|1|||
33324268|NCT00913744|62700712|FG001|Overall Study|Death|0|||
33611017|NCT02293499|63011414|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
33611018|NCT02293499|63011412|FG000|9 Month Follow Up|Lost to Follow-up|24|||
33324269|NCT00912808|62700720|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
33324270|NCT00912808|62700721|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
33324271|NCT00912808|62700720|FG000|Washout|Withdrawal by Subject|0|||
33324272|NCT00912808|62700721|FG001|Washout|Withdrawal by Subject|1|||
33324273|NCT00912808|62700720|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
33324274|NCT00912808|62700721|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
33324275|NCT00912808|62700720|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
33324276|NCT00912808|62700721|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
33450049|NCT00433199|62824839|FG000|Double-Blind Period|Adverse Event|0|||
33450050|NCT00433199|62824840|FG001|Double-Blind Period|Adverse Event|25|||
33450051|NCT00433199|62824839|FG000|Double-Blind Period|Lack of Efficacy|0|||
33450052|NCT00433199|62824840|FG001|Double-Blind Period|Lack of Efficacy|2|||
33450053|NCT00433199|62824839|FG000|Double-Blind Period|Lost to Follow-up|2|||
33450054|NCT00433199|62824840|FG001|Double-Blind Period|Lost to Follow-up|5|||
33450055|NCT00433199|62824839|FG000|Double-Blind Period|Withdrawal by Subject|8|||
33450056|NCT00433199|62824840|FG001|Double-Blind Period|Withdrawal by Subject|19|||
33450057|NCT00433199|62824839|FG000|Double-Blind Period|Protocol Violation|1|||
33450058|NCT00433199|62824840|FG001|Double-Blind Period|Protocol Violation|10|||
33450059|NCT00433199|62824839|FG000|Double-Blind Period|Administrative|1|||
33450060|NCT00433199|62824840|FG001|Double-Blind Period|Administrative|5|||
33450061|NCT00433199|62824839|FG000|Open-Label Period|Adverse Event|0|||
33450062|NCT00433199|62824840|FG001|Open-Label Period|Adverse Event|19|||
33450063|NCT00433199|62824839|FG000|Open-Label Period|Lack of Efficacy|0|||
33450064|NCT00433199|62824840|FG001|Open-Label Period|Lack of Efficacy|2|||
33450065|NCT00433199|62824839|FG000|Open-Label Period|Lost to Follow-up|0|||
33450066|NCT00433199|62824840|FG001|Open-Label Period|Lost to Follow-up|3|||
33450067|NCT00433199|62824839|FG000|Open-Label Period|Withdrawal by Subject|0|||
33450068|NCT00433199|62824840|FG001|Open-Label Period|Withdrawal by Subject|7|||
33450069|NCT00433199|62824839|FG000|Open-Label Period|Protocol Violation|0|||
33450070|NCT00433199|62824840|FG001|Open-Label Period|Protocol Violation|2|||
33450071|NCT00433199|62824839|FG000|Open-Label Period|Administrative|0|||
33450072|NCT00433199|62824840|FG001|Open-Label Period|Administrative|1|||
33450073|NCT00006046|62824856|FG000|Overall Study|Adverse Event|3|||
33450074|NCT00006046|62824857|FG001|Overall Study|Adverse Event|0|||
33450075|NCT00006046|62824858|FG002|Overall Study|Adverse Event|0|||
33450076|NCT00006046|62824859|FG003|Overall Study|Adverse Event|0|||
33450077|NCT00006046|62824860|FG004|Overall Study|Adverse Event|0|||
33450078|NCT00006046|62824856|FG000|Overall Study|Disease Progression|2|||
33450079|NCT00006046|62824857|FG001|Overall Study|Disease Progression|0|||
33450080|NCT00006046|62824858|FG002|Overall Study|Disease Progression|0|||
33450081|NCT00006046|62824859|FG003|Overall Study|Disease Progression|0|||
33450082|NCT00006046|62824860|FG004|Overall Study|Disease Progression|0|||
33450083|NCT00005908|62824872|FG000|Overall Study|Withdrawal by Subject|1|||
33450084|NCT00005908|62824873|FG001|Overall Study|Withdrawal by Subject|0|||
33450085|NCT00432965|62824884|FG000|Overall Study|Lost to Follow-up|22|||
33450086|NCT00432965|62824885|FG001|Overall Study|Lost to Follow-up|19|||
33450087|NCT00432965|62824884|FG000|Overall Study|Withdrawal by Subject|13|||
33450088|NCT00432965|62824885|FG001|Overall Study|Withdrawal by Subject|13|||
33450089|NCT00432965|62824884|FG000|Overall Study|Physician Decision|14|||
33450090|NCT00432965|62824885|FG001|Overall Study|Physician Decision|13|||
33450091|NCT00432965|62824884|FG000|Overall Study|Lack of Efficacy|8|||
33450092|NCT00432965|62824885|FG001|Overall Study|Lack of Efficacy|13|||
33450093|NCT00432965|62824884|FG000|Overall Study|Non-compliance|7|||
33450094|NCT00432965|62824885|FG001|Overall Study|Non-compliance|0|||
33450095|NCT00432965|62824884|FG000|Overall Study|Adverse Event|22|||
33450096|NCT00432965|62824885|FG001|Overall Study|Adverse Event|19|||
33450097|NCT00432965|62824884|FG000|Overall Study|Death|3|||
33450098|NCT00432965|62824885|FG001|Overall Study|Death|4|||
33450099|NCT00432965|62824884|FG000|Overall Study|Exclusionary Methods|1|||
33450100|NCT00432965|62824885|FG001|Overall Study|Exclusionary Methods|2|||
33504683|NCT03501277|62886392|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
33504684|NCT03500419|62886404|FG000|Overall Study|Withdrawal by Subject|2|||
33504685|NCT03500419|62886405|FG001|Overall Study|Withdrawal by Subject|25|||
33504686|NCT03500341|62886411|FG000|Overall Study|Withdrawn prior to Completion|2|||
33504687|NCT01316900|62886432|FG000|Overall Study|Adverse Event|10|||
33504688|NCT01316900|62886433|FG001|Overall Study|Adverse Event|10|||
33504689|NCT01316900|62886434|FG002|Overall Study|Adverse Event|15|||
33504690|NCT01316900|62886435|FG003|Overall Study|Adverse Event|9|||
33504691|NCT01316900|62886432|FG000|Overall Study|Lack of Efficacy|17|||
33504692|NCT01316900|62886433|FG001|Overall Study|Lack of Efficacy|9|||
33504693|NCT01316900|62886434|FG002|Overall Study|Lack of Efficacy|5|||
33504694|NCT01316900|62886435|FG003|Overall Study|Lack of Efficacy|7|||
33504695|NCT01316900|62886432|FG000|Overall Study|Protocol Violation|7|||
33504696|NCT01316900|62886433|FG001|Overall Study|Protocol Violation|1|||
33504697|NCT01316900|62886434|FG002|Overall Study|Protocol Violation|4|||
33504698|NCT01316900|62886435|FG003|Overall Study|Protocol Violation|0|||
33504699|NCT01316900|62886432|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
33504700|NCT01316900|62886433|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
33504701|NCT01316900|62886434|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
33504702|NCT01316900|62886435|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
33504703|NCT01316900|62886432|FG000|Overall Study|Lost to Follow-up|1|||
33504704|NCT01316900|62886433|FG001|Overall Study|Lost to Follow-up|0|||
33504705|NCT01316900|62886434|FG002|Overall Study|Lost to Follow-up|1|||
33504706|NCT01316900|62886435|FG003|Overall Study|Lost to Follow-up|1|||
33504707|NCT01316900|62886432|FG000|Overall Study|Withdrawal by Subject|7|||
33504708|NCT01316900|62886433|FG001|Overall Study|Withdrawal by Subject|8|||
33504709|NCT01316900|62886434|FG002|Overall Study|Withdrawal by Subject|6|||
33504710|NCT01316900|62886435|FG003|Overall Study|Withdrawal by Subject|9|||
33504711|NCT00936390|62886447|FG000|Overall Study|Protocol Violation|21|||
33504712|NCT00936390|62886448|FG001|Overall Study|Protocol Violation|25|||
33504713|NCT03499873|62886459|FG000|Overall Study|Withdrawal by Subject|4|||
33504714|NCT03499873|62886460|FG001|Overall Study|Withdrawal by Subject|6|||
33504715|NCT03499873|62886461|FG002|Overall Study|Withdrawal by Subject|1|||
33504716|NCT03499873|62886459|FG000|Overall Study|Subjects condition worsened|0|||
33504717|NCT03499873|62886460|FG001|Overall Study|Subjects condition worsened|3|||
33504718|NCT03499873|62886461|FG002|Overall Study|Subjects condition worsened|11|||
33504719|NCT03499873|62886459|FG000|Overall Study|Adverse Event|8|||
33504720|NCT03499873|62886460|FG001|Overall Study|Adverse Event|3|||
33504721|NCT03499873|62886461|FG002|Overall Study|Adverse Event|6|||
33504722|NCT03499873|62886459|FG000|Overall Study|Physician Decision|1|||
33504723|NCT03499873|62886460|FG001|Overall Study|Physician Decision|0|||
33504724|NCT03499873|62886461|FG002|Overall Study|Physician Decision|0|||
33504725|NCT03499873|62886459|FG000|Overall Study|Administrative reasons|0|||
33504726|NCT03499873|62886460|FG001|Overall Study|Administrative reasons|1|||
33504727|NCT03499873|62886461|FG002|Overall Study|Administrative reasons|0|||
33504728|NCT03499873|62886459|FG000|Overall Study|Concomitant therapy|5|||
33504729|NCT03499873|62886460|FG001|Overall Study|Concomitant therapy|4|||
33504730|NCT03499873|62886461|FG002|Overall Study|Concomitant therapy|7|||
33504731|NCT03499873|62886459|FG000|Overall Study|Miscellaneous|1|||
33504732|NCT03499873|62886460|FG001|Overall Study|Miscellaneous|2|||
33504733|NCT03499873|62886461|FG002|Overall Study|Miscellaneous|2|||
33611019|NCT02293499|63011413|FG001|9 Month Follow Up|Lost to Follow-up|28|||
33450101|NCT00432965|62824884|FG000|Overall Study|Incomplete Data|4|||
33450102|NCT00432965|62824885|FG001|Overall Study|Incomplete Data|3|||
33450103|NCT00440297|62824893|FG000|Overall Study|Adverse Event|8|||
33450104|NCT00440297|62824894|FG001|Overall Study|Adverse Event|5|||
33450105|NCT00440297|62824893|FG000|Overall Study|Lost to Follow-up|1|||
33450106|NCT00440297|62824894|FG001|Overall Study|Lost to Follow-up|0|||
33450107|NCT00440297|62824893|FG000|Overall Study|Physician Decision|1|||
33450108|NCT00440297|62824894|FG001|Overall Study|Physician Decision|0|||
33324277|NCT00960531|62700738|FG000|Overall Study|Lack of Efficacy|1|||
33324278|NCT00960531|62700739|FG001|Overall Study|Lack of Efficacy|0|||
33324279|NCT00960531|62700740|FG002|Overall Study|Lack of Efficacy|0|||
33324280|NCT00960531|62700741|FG003|Overall Study|Lack of Efficacy|0|||
33324281|NCT00960531|62700742|FG004|Overall Study|Lack of Efficacy|0|||
33504734|NCT03499873|62886459|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
33504735|NCT03499873|62886460|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
33504736|NCT03499873|62886461|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
33504737|NCT03467971|62886471|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33504738|NCT03467971|62886472|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33504739|NCT03049280|62886488|FG000|Overall Study|Physician Decision|1|||
33504740|NCT03048500|62886494|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
33504741|NCT03048500|62886494|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
33611020|NCT02293499|63011414|FG002|9 Month Follow Up|Lost to Follow-up|4|||
33504742|NCT03048500|62886494|FG000|Reached 1st Response/Continued Treatment|Death|1|||
33504743|NCT03048500|62886494|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
33611021|NCT02293499|63011412|FG000|12 Month Follow Up|Lost to Follow-up|26|||
33504744|NCT03048500|62886494|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
33504745|NCT03048500|62886494|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
33504746|NCT03048500|62886494|FG000|Follow up for 3 Years|Death|12|||
33504747|NCT00908076|62886500|FG000|Overall Study|Lack of Efficacy|1|||
33504748|NCT00908076|62886501|FG001|Overall Study|Lack of Efficacy|1|||
33504749|NCT03467425|62886509|FG000|Overall Study|Adverse Event|9|||
33504750|NCT03467425|62886510|FG001|Overall Study|Adverse Event|9|||
33504751|NCT03467425|62886509|FG000|Overall Study|Lack of Efficacy|3|||
33504752|NCT03467425|62886510|FG001|Overall Study|Lack of Efficacy|1|||
33504753|NCT03467425|62886509|FG000|Overall Study|Protocol Violation|0|||
33504754|NCT03467425|62886510|FG001|Overall Study|Protocol Violation|1|||
33504755|NCT03467425|62886509|FG000|Overall Study|Lost to Follow-up|18|||
33504756|NCT03467425|62886510|FG001|Overall Study|Lost to Follow-up|25|||
33504757|NCT03467425|62886509|FG000|Overall Study|Physician Decision|2|||
33504758|NCT03467425|62886510|FG001|Overall Study|Physician Decision|1|||
33504759|NCT03467425|62886509|FG000|Overall Study|Withdrawal by Subject|15|||
33504760|NCT03467425|62886510|FG001|Overall Study|Withdrawal by Subject|17|||
33504761|NCT02886702|62886519|FG000|Overall Study|Other|4|||
33504762|NCT02886702|62886520|FG001|Overall Study|Other|3|||
33504763|NCT02886702|62886521|FG002|Overall Study|Other|9|||
33504764|NCT02886702|62886519|FG000|Overall Study|Withdrawal by Subject|24|||
33504765|NCT02886702|62886520|FG001|Overall Study|Withdrawal by Subject|18|||
33504766|NCT02886702|62886521|FG002|Overall Study|Withdrawal by Subject|22|||
33504767|NCT02886702|62886519|FG000|Overall Study|Significant Worsening of Condition|0|||
33504768|NCT02886702|62886520|FG001|Overall Study|Significant Worsening of Condition|1|||
33504769|NCT02886702|62886521|FG002|Overall Study|Significant Worsening of Condition|0|||
33504770|NCT02886702|62886519|FG000|Overall Study|Protocol Violation|2|||
33504771|NCT02886702|62886520|FG001|Overall Study|Protocol Violation|2|||
33504772|NCT02886702|62886521|FG002|Overall Study|Protocol Violation|1|||
33504773|NCT02886702|62886519|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33504774|NCT02886702|62886520|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33504775|NCT02886702|62886521|FG002|Overall Study|Non-Compliance With Study Drug|4|||
33504776|NCT02886702|62886519|FG000|Overall Study|Lost to Follow-up|11|||
33504777|NCT02886702|62886520|FG001|Overall Study|Lost to Follow-up|13|||
33504778|NCT02886702|62886521|FG002|Overall Study|Lost to Follow-up|8|||
33504779|NCT02886702|62886519|FG000|Overall Study|Lack of Efficacy|3|||
33504780|NCT02886702|62886520|FG001|Overall Study|Lack of Efficacy|4|||
33504781|NCT02886702|62886521|FG002|Overall Study|Lack of Efficacy|5|||
33504782|NCT02886702|62886519|FG000|Overall Study|Adverse Event|4|||
33504783|NCT02886702|62886520|FG001|Overall Study|Adverse Event|9|||
33504784|NCT02886702|62886521|FG002|Overall Study|Adverse Event|3|||
33504785|NCT02886702|62886519|FG000|Overall Study|Administrative Reasons|0|||
33504786|NCT02886702|62886520|FG001|Overall Study|Administrative Reasons|0|||
33504787|NCT02886702|62886521|FG002|Overall Study|Administrative Reasons|1|||
33504788|NCT03498313|62886535|FG000|Experimental Period 1|Adverse Event|1|||
33504789|NCT03498313|62886536|FG001|Experimental Period 1|Adverse Event|0|||
33504790|NCT03498313|62886537|FG002|Experimental Period 1|Adverse Event|0|||
33504791|NCT03498313|62886538|FG003|Experimental Period 1|Adverse Event|1|||
33504792|NCT03498313|62886539|FG004|Experimental Period 1|Adverse Event|0|||
33504793|NCT03498313|62886540|FG005|Experimental Period 1|Adverse Event|0|||
33504794|NCT03498313|62886535|FG000|Experimental Period 1|Withdrawal by Subject|0|||
33504795|NCT03498313|62886536|FG001|Experimental Period 1|Withdrawal by Subject|1|||
33504796|NCT03498313|62886537|FG002|Experimental Period 1|Withdrawal by Subject|0|||
33504797|NCT03498313|62886538|FG003|Experimental Period 1|Withdrawal by Subject|0|||
33504798|NCT03498313|62886539|FG004|Experimental Period 1|Withdrawal by Subject|0|||
33504799|NCT03498313|62886540|FG005|Experimental Period 1|Withdrawal by Subject|0|||
33504800|NCT03498313|62886535|FG000|Washout Period 1|Anovulation|1|||
33504801|NCT03498313|62886536|FG001|Washout Period 1|Anovulation|0|||
33504802|NCT03498313|62886537|FG002|Washout Period 1|Anovulation|0|||
33504803|NCT03498313|62886538|FG003|Washout Period 1|Anovulation|0|||
33504804|NCT03498313|62886539|FG004|Washout Period 1|Anovulation|0|||
33504805|NCT03498313|62886540|FG005|Washout Period 1|Anovulation|0|||
33504806|NCT03498313|62886535|FG000|Washout Period 1|Withdrawal by Subject|0|||
33504807|NCT03498313|62886536|FG001|Washout Period 1|Withdrawal by Subject|3|||
33504808|NCT03498313|62886537|FG002|Washout Period 1|Withdrawal by Subject|0|||
33504809|NCT03498313|62886538|FG003|Washout Period 1|Withdrawal by Subject|1|||
33504810|NCT03498313|62886539|FG004|Washout Period 1|Withdrawal by Subject|0|||
33504811|NCT03498313|62886540|FG005|Washout Period 1|Withdrawal by Subject|1|||
33504812|NCT03498313|62886535|FG000|Experimental Period 2|Adverse Event|0|||
33504813|NCT03498313|62886536|FG001|Experimental Period 2|Adverse Event|0|||
33504814|NCT03498313|62886537|FG002|Experimental Period 2|Adverse Event|0|||
33504815|NCT03498313|62886538|FG003|Experimental Period 2|Adverse Event|0|||
33504816|NCT03498313|62886539|FG004|Experimental Period 2|Adverse Event|1|||
33504817|NCT03498313|62886540|FG005|Experimental Period 2|Adverse Event|2|||
33504818|NCT03498313|62886535|FG000|Washout Period 2|Physician Decision|1|||
33504819|NCT03498313|62886536|FG001|Washout Period 2|Physician Decision|0|||
33504820|NCT03498313|62886537|FG002|Washout Period 2|Physician Decision|0|||
33504821|NCT03498313|62886538|FG003|Washout Period 2|Physician Decision|1|||
33504822|NCT03498313|62886539|FG004|Washout Period 2|Physician Decision|0|||
33504823|NCT03498313|62886540|FG005|Washout Period 2|Physician Decision|1|||
33504824|NCT03498313|62886535|FG000|Washout Period 2|Withdrawal by Subject|3|||
33504825|NCT03498313|62886536|FG001|Washout Period 2|Withdrawal by Subject|2|||
33504826|NCT03498313|62886537|FG002|Washout Period 2|Withdrawal by Subject|0|||
33504827|NCT03498313|62886538|FG003|Washout Period 2|Withdrawal by Subject|0|||
33504828|NCT03498313|62886539|FG004|Washout Period 2|Withdrawal by Subject|2|||
33504829|NCT03498313|62886540|FG005|Washout Period 2|Withdrawal by Subject|0|||
33504830|NCT03498313|62886535|FG000|Washout Period 2|Anovulation|0|||
33504831|NCT03498313|62886536|FG001|Washout Period 2|Anovulation|0|||
33504832|NCT03498313|62886537|FG002|Washout Period 2|Anovulation|0|||
33504833|NCT03498313|62886538|FG003|Washout Period 2|Anovulation|0|||
33504834|NCT03498313|62886539|FG004|Washout Period 2|Anovulation|0|||
33611022|NCT02293499|63011413|FG001|12 Month Follow Up|Lost to Follow-up|25|||
33611023|NCT02293499|63011414|FG002|12 Month Follow Up|Lost to Follow-up|6|||
33611024|NCT02293499|63011412|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
33611025|NCT02293499|63011413|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
33611026|NCT02293499|63011414|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
33611027|NCT02293499|63011412|FG000|15 Month Follow Up|Lost to Follow-up|22|||
33611028|NCT02293499|63011413|FG001|15 Month Follow Up|Lost to Follow-up|22|||
33611029|NCT02293499|63011414|FG002|15 Month Follow Up|Lost to Follow-up|7|||
33504835|NCT03498313|62886540|FG005|Washout Period 2|Anovulation|1|||
33504836|NCT02601014|62886550|FG000|Overall Study|Adverse Event|3|||
33504837|NCT02601014|62886551|FG001|Overall Study|Adverse Event|3|||
33504838|NCT02601014|62886550|FG000|Overall Study|Death|3|||
33504839|NCT02601014|62886551|FG001|Overall Study|Death|1|||
33504840|NCT02601014|62886550|FG000|Overall Study|Disease progression|4|||
33504841|NCT02601014|62886551|FG001|Overall Study|Disease progression|8|||
33504842|NCT01307046|62886559|FG000|Overall Study|Adverse Event|3|||
33611030|NCT02257385|63011425|FG000|Overall Study|Adverse Event|12|||
33611031|NCT02257385|63011426|FG001|Overall Study|Adverse Event|8|||
33611032|NCT02257385|63011425|FG000|Overall Study|Lack of Efficacy|1|||
33611033|NCT02257385|63011426|FG001|Overall Study|Lack of Efficacy|2|||
33611034|NCT02257385|63011425|FG000|Overall Study|Protocol Violation|5|||
33611035|NCT02257385|63011426|FG001|Overall Study|Protocol Violation|7|||
33611036|NCT02257385|63011425|FG000|Overall Study|Lost to Follow-up|0|||
33611037|NCT02257385|63011426|FG001|Overall Study|Lost to Follow-up|1|||
33611038|NCT02257385|63011425|FG000|Overall Study|Withdrawal by Subject|4|||
33611039|NCT02257385|63011426|FG001|Overall Study|Withdrawal by Subject|4|||
33611040|NCT01629667|63011435|FG000|Overall Study|Lost to Follow-up|0|||
33611041|NCT01629667|63011436|FG001|Overall Study|Lost to Follow-up|1|||
33611042|NCT01629667|63011437|FG002|Overall Study|Lost to Follow-up|1|||
33611043|NCT01629667|63011435|FG000|Overall Study|Withdrawal by Subject|31|||
33324282|NCT00960531|62700743|FG005|Overall Study|Lack of Efficacy|0|||
33324283|NCT00960531|62700744|FG006|Overall Study|Lack of Efficacy|0|||
33324284|NCT00960531|62700745|FG007|Overall Study|Lack of Efficacy|0|||
33324285|NCT00960531|62700746|FG008|Overall Study|Lack of Efficacy|0|||
33324286|NCT00960531|62700747|FG009|Overall Study|Lack of Efficacy|0|||
33324287|NCT00960531|62700738|FG000|Overall Study|Withdrawal by Subject|1|||
33324288|NCT00960531|62700739|FG001|Overall Study|Withdrawal by Subject|0|||
33324289|NCT00960531|62700740|FG002|Overall Study|Withdrawal by Subject|5|||
33450109|NCT00440297|62824893|FG000|Overall Study|Protocol Violation|11|||
33450110|NCT00440297|62824894|FG001|Overall Study|Protocol Violation|7|||
33450111|NCT00440297|62824893|FG000|Overall Study|Withdrawal by Subject|1|||
33450112|NCT00440297|62824894|FG001|Overall Study|Withdrawal by Subject|6|||
33450113|NCT00440297|62824893|FG000|Overall Study|Randomized by mistake|1|||
33450114|NCT00440297|62824894|FG001|Overall Study|Randomized by mistake|0|||
33450115|NCT00432809|62824903|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
33450116|NCT00432809|62824904|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
33450117|NCT00432809|62824905|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
33450118|NCT00432809|62824903|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
33450119|NCT00432809|62824904|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
33450120|NCT00432809|62824905|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
33450121|NCT00431951|62824917|FG000|Overall Study|Inability to follow study procedures|1|||
33450122|NCT00431951|62824918|FG001|Overall Study|Inability to follow study procedures|0|||
33450123|NCT00431951|62824919|FG002|Overall Study|Inability to follow study procedures|1|||
33450124|NCT00431951|62824920|FG003|Overall Study|Inability to follow study procedures|2|||
33450125|NCT00431951|62824917|FG000|Overall Study|Lost to Follow-up|0|||
33450126|NCT00431951|62824918|FG001|Overall Study|Lost to Follow-up|1|||
33450127|NCT00431951|62824919|FG002|Overall Study|Lost to Follow-up|0|||
33450128|NCT00431951|62824920|FG003|Overall Study|Lost to Follow-up|0|||
33450129|NCT00431951|62824917|FG000|Overall Study|Withdrawal by Subject|0|||
33450130|NCT00431951|62824918|FG001|Overall Study|Withdrawal by Subject|1|||
33450131|NCT00431951|62824919|FG002|Overall Study|Withdrawal by Subject|0|||
33450132|NCT00431951|62824920|FG003|Overall Study|Withdrawal by Subject|0|||
33450133|NCT00431951|62824917|FG000|Overall Study|Adverse Event|0|||
33450134|NCT00431951|62824918|FG001|Overall Study|Adverse Event|0|||
33450135|NCT00431951|62824919|FG002|Overall Study|Adverse Event|1|||
33450136|NCT00431951|62824920|FG003|Overall Study|Adverse Event|0|||
33450137|NCT00004978|62824936|FG000|Overall Study|Death|107|||
33450138|NCT00004978|62824937|FG001|Overall Study|Death|116|||
33450139|NCT00004978|62824936|FG000|Overall Study|Lost to Follow-up|101|||
33450140|NCT00004978|62824937|FG001|Overall Study|Lost to Follow-up|108|||
33504843|NCT01307046|62886560|FG001|Overall Study|Adverse Event|3|||
33504844|NCT01307046|62886559|FG000|Overall Study|Lack of Efficacy|0|||
33504845|NCT01307046|62886560|FG001|Overall Study|Lack of Efficacy|2|||
33504846|NCT01307046|62886559|FG000|Overall Study|Physician Decision|2|||
33504847|NCT01307046|62886560|FG001|Overall Study|Physician Decision|0|||
33504848|NCT01307046|62886559|FG000|Overall Study|Withdrawal by Subject|1|||
33504849|NCT01307046|62886560|FG001|Overall Study|Withdrawal by Subject|1|||
33504850|NCT01307046|62886559|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
33504851|NCT01307046|62886560|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
33504852|NCT01307046|62886559|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
33504853|NCT01307046|62886560|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
33504854|NCT03495817|62886566|FG000|26 Week Open Label|Adverse Event|3|||
33504855|NCT03495817|62886566|FG000|26 Week Open Label|Withdrawal by Subject|4|||
33504856|NCT03495817|62886566|FG000|26 Week Open Label|Lost to Follow-up|1|||
33504857|NCT03495817|62886566|FG000|26 Week Extension|Lost to Follow-up|2|||
33504858|NCT02886624|62886570|FG000|12-week Post Treatment Follow-up|Death|1|||
33504859|NCT02886624|62886570|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
33504860|NCT02963766|62886577|FG000|Double-Blind Period|Adverse Event|1|||
33504861|NCT02963766|62886578|FG001|Double-Blind Period|Adverse Event|0|||
33504862|NCT02963766|62886579|FG002|Double-Blind Period|Adverse Event|1|||
33504863|NCT02963766|62886577|FG000|Double-Blind Period|Physician Decision|1|||
33504864|NCT02963766|62886578|FG001|Double-Blind Period|Physician Decision|0|||
33504865|NCT02963766|62886579|FG002|Double-Blind Period|Physician Decision|0|||
33504866|NCT02963766|62886577|FG000|Double-Blind Period|Withdrawal by Subject|1|||
33504867|NCT02963766|62886578|FG001|Double-Blind Period|Withdrawal by Subject|1|||
33504868|NCT02963766|62886579|FG002|Double-Blind Period|Withdrawal by Subject|0|||
33504869|NCT02963766|62886577|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
33504870|NCT02963766|62886578|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
33504871|NCT02963766|62886579|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
33504872|NCT02963766|62886577|FG000|Double-Blind Period|Protocol Violation|1|||
33504873|NCT02963766|62886578|FG001|Double-Blind Period|Protocol Violation|0|||
33504874|NCT02963766|62886579|FG002|Double-Blind Period|Protocol Violation|0|||
33504875|NCT02963766|62886577|FG000|Double-Blind Period|Lost to Follow-up|0|||
33504876|NCT02963766|62886578|FG001|Double-Blind Period|Lost to Follow-up|1|||
33504877|NCT02963766|62886579|FG002|Double-Blind Period|Lost to Follow-up|0|||
33504878|NCT02963766|62886577|FG000|Open Label Extension (OLE)|Physician Decision|1|||
33504879|NCT02963766|62886578|FG001|Open Label Extension (OLE)|Physician Decision|2|||
33504880|NCT02963766|62886579|FG002|Open Label Extension (OLE)|Physician Decision|2|||
33504881|NCT02963766|62886577|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
33504882|NCT02963766|62886578|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
33504883|NCT02963766|62886579|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
33504884|NCT04839965|62886599|FG000|Overall Study|Death|6|||
33504885|NCT04839965|62886600|FG001|Overall Study|Death|6|||
33504886|NCT04839965|62886599|FG000|Overall Study|Lost to Follow-up|1|||
33504887|NCT04839965|62886600|FG001|Overall Study|Lost to Follow-up|0|||
33504888|NCT03466099|62886609|FG000|Overall Study|Adverse Event|1|||
33504889|NCT03466099|62886610|FG001|Overall Study|Adverse Event|1|||
33504890|NCT03466099|62886611|FG002|Overall Study|Adverse Event|1|||
33611044|NCT01629667|63011436|FG001|Overall Study|Withdrawal by Subject|20|||
33611045|NCT01629667|63011437|FG002|Overall Study|Withdrawal by Subject|28|||
33611046|NCT01629667|63011435|FG000|Overall Study|Death|1|||
33611047|NCT01629667|63011436|FG001|Overall Study|Death|5|||
33611048|NCT01629667|63011437|FG002|Overall Study|Death|3|||
33611049|NCT01629667|63011435|FG000|Overall Study|Randomized, not treated|2|||
33611050|NCT01629667|63011436|FG001|Overall Study|Randomized, not treated|1|||
33611051|NCT01629667|63011437|FG002|Overall Study|Randomized, not treated|0|||
33611052|NCT01629667|63011435|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
33611053|NCT01629667|63011436|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
33611054|NCT01629667|63011437|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
33611055|NCT01629667|63011435|FG000|Overall Study|Requiring lung transplant|2|||
33611056|NCT01629667|63011436|FG001|Overall Study|Requiring lung transplant|1|||
33611057|NCT01629667|63011437|FG002|Overall Study|Requiring lung transplant|3|||
33611058|NCT01629667|63011435|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
33611059|NCT01629667|63011436|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
33611060|NCT01629667|63011437|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
33504891|NCT03466099|62886609|FG000|Overall Study|Withdrawal by Subject|2|||
33504892|NCT03466099|62886610|FG001|Overall Study|Withdrawal by Subject|3|||
33504893|NCT03466099|62886611|FG002|Overall Study|Withdrawal by Subject|1|||
33504894|NCT03466099|62886609|FG000|Overall Study|Use of rescue medication|8|||
33504895|NCT03466099|62886610|FG001|Overall Study|Use of rescue medication|9|||
33504896|NCT03466099|62886611|FG002|Overall Study|Use of rescue medication|13|||
33504897|NCT03466099|62886609|FG000|Overall Study|Rescued without meeting criteria|4|||
33504898|NCT03466099|62886610|FG001|Overall Study|Rescued without meeting criteria|1|||
33504899|NCT03466099|62886611|FG002|Overall Study|Rescued without meeting criteria|1|||
33504900|NCT03466099|62886609|FG000|Overall Study|Subject compliance|2|||
33504901|NCT03466099|62886610|FG001|Overall Study|Subject compliance|0|||
33504902|NCT03466099|62886611|FG002|Overall Study|Subject compliance|0|||
33504903|NCT03466099|62886609|FG000|Overall Study|Worsening disease|0|||
33504904|NCT03466099|62886610|FG001|Overall Study|Worsening disease|0|||
33504905|NCT03466099|62886611|FG002|Overall Study|Worsening disease|1|||
33504906|NCT00739674|62886621|FG000|Overall Study|Screening failures|19|||
33504907|NCT00739674|62886622|FG001|Overall Study|Screening failures|17|||
33504908|NCT00739674|62886621|FG000|Overall Study|Site 212 removal|19|||
33504909|NCT00739674|62886622|FG001|Overall Study|Site 212 removal|13|||
33504910|NCT00739674|62886621|FG000|Overall Study|No follow-up data|33|||
33504911|NCT00739674|62886622|FG001|Overall Study|No follow-up data|18|||
33504912|NCT00739674|62886621|FG000|Overall Study|Dietician consultation >30 days|1|||
33504913|NCT00739674|62886622|FG001|Overall Study|Dietician consultation >30 days|9|||
33504914|NCT00739674|62886621|FG000|Overall Study|Adverse Event|22|||
33504915|NCT00739674|62886622|FG001|Overall Study|Adverse Event|13|||
33504916|NCT00739674|62886621|FG000|Overall Study|Death|1|||
33504917|NCT00739674|62886622|FG001|Overall Study|Death|0|||
33504918|NCT00739674|62886621|FG000|Overall Study|Lack of Efficacy|1|||
33504919|NCT00739674|62886622|FG001|Overall Study|Lack of Efficacy|0|||
33504920|NCT00739674|62886621|FG000|Overall Study|Lost to Follow-up|52|||
33504921|NCT00739674|62886622|FG001|Overall Study|Lost to Follow-up|30|||
33504922|NCT00739674|62886621|FG000|Overall Study|Protocol Violation|5|||
33504923|NCT00739674|62886622|FG001|Overall Study|Protocol Violation|5|||
33504924|NCT00739674|62886621|FG000|Overall Study|Withdrawal by Subject|9|||
33504925|NCT00739674|62886622|FG001|Overall Study|Withdrawal by Subject|9|||
33504926|NCT00739674|62886621|FG000|Overall Study|Reason missing|2|||
33504927|NCT00739674|62886622|FG001|Overall Study|Reason missing|0|||
33504928|NCT00739674|62886621|FG000|Overall Study|Clinic closed|6|||
33504929|NCT00739674|62886622|FG001|Overall Study|Clinic closed|4|||
33504930|NCT00739674|62886621|FG000|Overall Study|Patient moved|3|||
33504931|NCT00739674|62886622|FG001|Overall Study|Patient moved|2|||
33504932|NCT00739674|62886621|FG000|Overall Study|Non compliant|4|||
33504933|NCT00739674|62886622|FG001|Overall Study|Non compliant|0|||
33504934|NCT00739674|62886621|FG000|Overall Study|Unable to attend visit|3|||
33504935|NCT00739674|62886622|FG001|Overall Study|Unable to attend visit|1|||
33504936|NCT00739674|62886621|FG000|Overall Study|Home monitoring off meds|1|||
33504937|NCT00739674|62886622|FG001|Overall Study|Home monitoring off meds|0|||
33504938|NCT00739674|62886621|FG000|Overall Study|Erectile dysfunction|0|||
33504939|NCT00739674|62886622|FG001|Overall Study|Erectile dysfunction|1|||
33504940|NCT03494725|62886630|FG000|Overall Study|Withdrawal by Subject|0|||
33504941|NCT03494725|62886631|FG001|Overall Study|Withdrawal by Subject|2|||
33504942|NCT03494725|62886630|FG000|Overall Study|Antibiotic use|1|||
33504943|NCT03494725|62886631|FG001|Overall Study|Antibiotic use|0|||
33504944|NCT00705718|62886645|FG000|Overall Study|Death|6|||
33504945|NCT00705718|62886646|FG001|Overall Study|Death|6|||
33504946|NCT00705718|62886645|FG000|Overall Study|Not due for Visit|0|||
33504947|NCT00705718|62886646|FG001|Overall Study|Not due for Visit|12|||
33504948|NCT00705718|62886645|FG000|Overall Study|Follow up not done|1|||
33504949|NCT00705718|62886646|FG001|Overall Study|Follow up not done|4|||
33504950|NCT03435211|62886661|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
33504951|NCT03465709|62886674|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
33504952|NCT03465709|62886674|FG000|Overall Study|Withdrawal by Subject|3|||
33504953|NCT03435055|62886680|FG000|Screening|Physician Decision|2|||
33504954|NCT03435055|62886680|FG000|Received Intervention|Did not complete nitrous administration|3|||
33504955|NCT03434977|62886693|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
33504956|NCT03434977|62886694|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
33504957|NCT03434119|62886702|FG000|Overall Study|Randomized but not treated|1|||
33504958|NCT03434119|62886703|FG001|Overall Study|Randomized but not treated|0|||
33504959|NCT03434119|62886702|FG000|Overall Study|Adverse Event|1|||
33504960|NCT03434119|62886703|FG001|Overall Study|Adverse Event|0|||
33504961|NCT03434119|62886702|FG000|Overall Study|Poor Compliance to Protocol|0|||
33504962|NCT03434119|62886703|FG001|Overall Study|Poor Compliance to Protocol|1|||
33504963|NCT03434119|62886702|FG000|Overall Study|Study Terminated by Sponsor|91|||
33504964|NCT03434119|62886703|FG001|Overall Study|Study Terminated by Sponsor|102|||
33504965|NCT03434119|62886702|FG000|Overall Study|Withdrawal by Subject|7|||
33504966|NCT03434119|62886703|FG001|Overall Study|Withdrawal by Subject|5|||
33504967|NCT03434119|62886702|FG000|Overall Study|Other than specified|7|||
33504968|NCT03434119|62886703|FG001|Overall Study|Other than specified|5|||
33504969|NCT00378378|62886712|FG000|Overall Study|Withdrawal by Subject|0|||
33504970|NCT00378378|62886713|FG001|Overall Study|Withdrawal by Subject|1|||
33504971|NCT00378378|62886714|FG002|Overall Study|Withdrawal by Subject|0|||
33504972|NCT00378378|62886712|FG000|Overall Study|Treatment Failure|0|||
33504973|NCT00378378|62886713|FG001|Overall Study|Treatment Failure|0|||
33504974|NCT00378378|62886714|FG002|Overall Study|Treatment Failure|1|||
33504975|NCT00378378|62886712|FG000|Overall Study|Non-compliance with protocol|0|||
33504976|NCT00378378|62886713|FG001|Overall Study|Non-compliance with protocol|0|||
33504977|NCT00378378|62886714|FG002|Overall Study|Non-compliance with protocol|1|||
33504978|NCT03490981|62886724|FG000|Overall Study|Lost to Follow-up|1|||
33504979|NCT03490981|62886725|FG001|Overall Study|Lost to Follow-up|2|||
33504980|NCT03160716|62886731|FG000|Overall Study|Lost to Follow-up|1|||
33504981|NCT03713021|62886735|FG000|Overall Study|Did not have CT sim scan available|6|||
33504982|NCT03713021|62886735|FG000|Overall Study|Not eligible|4|||
33504983|NCT03713021|62886735|FG000|Overall Study|Issues with TraceIT markers|5|||
33504984|NCT03160560|62886743|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
33504985|NCT03160560|62886744|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33504986|NCT03160560|62886745|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33504987|NCT03160560|62886746|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
33504988|NCT03160560|62886743|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
33504989|NCT03160560|62886744|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
33504990|NCT03160560|62886745|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
33504991|NCT03160560|62886746|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
33504992|NCT03489343|62886763|FG000|Overall Study|Documented progressive disease|1|||
33504993|NCT03489343|62886764|FG001|Overall Study|Documented progressive disease|0|||
33504994|NCT03489343|62886765|FG002|Overall Study|Documented progressive disease|3|||
33504995|NCT03489343|62886766|FG003|Overall Study|Documented progressive disease|1|||
33504996|NCT03489343|62886767|FG004|Overall Study|Documented progressive disease|3|||
33504997|NCT03489343|62886768|FG005|Overall Study|Documented progressive disease|5|||
33504998|NCT03489343|62886769|FG006|Overall Study|Documented progressive disease|4|||
33504999|NCT03489343|62886763|FG000|Overall Study|Adverse Event|0|||
33505000|NCT03489343|62886764|FG001|Overall Study|Adverse Event|1|||
33505001|NCT03489343|62886765|FG002|Overall Study|Adverse Event|0|||
33505002|NCT03489343|62886766|FG003|Overall Study|Adverse Event|0|||
33505003|NCT03489343|62886767|FG004|Overall Study|Adverse Event|0|||
33505004|NCT03489343|62886768|FG005|Overall Study|Adverse Event|1|||
33505005|NCT03489343|62886769|FG006|Overall Study|Adverse Event|0|||
33505006|NCT03489343|62886763|FG000|Overall Study|Withdrawal by Subject|0|||
33505007|NCT03489343|62886764|FG001|Overall Study|Withdrawal by Subject|0|||
33505008|NCT03489343|62886765|FG002|Overall Study|Withdrawal by Subject|0|||
33505009|NCT03489343|62886766|FG003|Overall Study|Withdrawal by Subject|1|||
33505010|NCT03489343|62886767|FG004|Overall Study|Withdrawal by Subject|0|||
33505011|NCT03489343|62886768|FG005|Overall Study|Withdrawal by Subject|1|||
33505012|NCT03489343|62886769|FG006|Overall Study|Withdrawal by Subject|1|||
33505013|NCT03489343|62886763|FG000|Overall Study|Clinical progression|0|||
33505014|NCT03489343|62886764|FG001|Overall Study|Clinical progression|0|||
33505015|NCT03489343|62886765|FG002|Overall Study|Clinical progression|0|||
33505016|NCT03489343|62886766|FG003|Overall Study|Clinical progression|1|||
33505017|NCT03489343|62886767|FG004|Overall Study|Clinical progression|0|||
33505018|NCT03489343|62886768|FG005|Overall Study|Clinical progression|0|||
33505019|NCT03489343|62886769|FG006|Overall Study|Clinical progression|1|||
33505020|NCT03489109|62886787|FG000|Overall Study|Lost to Follow-up|1|||
33505021|NCT03489109|62886788|FG001|Overall Study|Lost to Follow-up|2|||
33505022|NCT03709823|62886800|FG000|Overall Study|Adverse Event|0|||
33505023|NCT03709823|62886801|FG001|Overall Study|Adverse Event|0|||
33505024|NCT03709823|62886802|FG002|Overall Study|Adverse Event|1|||
33505025|NCT03709823|62886803|FG003|Overall Study|Adverse Event|0|||
33505026|NCT03709823|62886804|FG004|Overall Study|Adverse Event|0|||
33505027|NCT03709823|62886805|FG005|Overall Study|Adverse Event|0|||
33505028|NCT03709823|62886800|FG000|Overall Study|Lost to Follow-up|2|||
33505029|NCT03709823|62886801|FG001|Overall Study|Lost to Follow-up|2|||
33505030|NCT03709823|62886802|FG002|Overall Study|Lost to Follow-up|2|||
33505031|NCT03709823|62886803|FG003|Overall Study|Lost to Follow-up|1|||
33505032|NCT03709823|62886804|FG004|Overall Study|Lost to Follow-up|1|||
33505033|NCT03709823|62886805|FG005|Overall Study|Lost to Follow-up|0|||
33505034|NCT03709823|62886800|FG000|Overall Study|Withdrawal by Subject|1|||
33505035|NCT03709823|62886801|FG001|Overall Study|Withdrawal by Subject|3|||
33505036|NCT03709823|62886802|FG002|Overall Study|Withdrawal by Subject|0|||
33505037|NCT03709823|62886803|FG003|Overall Study|Withdrawal by Subject|0|||
33611061|NCT01629667|63011435|FG000|Overall Study|Started other medicine|1|||
33611062|NCT01629667|63011436|FG001|Overall Study|Started other medicine|0|||
33505038|NCT03709823|62886804|FG004|Overall Study|Withdrawal by Subject|0|||
33505039|NCT03709823|62886805|FG005|Overall Study|Withdrawal by Subject|0|||
33505040|NCT03709823|62886800|FG000|Overall Study|Other, Not Specified|0|||
33505041|NCT03709823|62886801|FG001|Overall Study|Other, Not Specified|0|||
33505042|NCT03709823|62886802|FG002|Overall Study|Other, Not Specified|0|||
33505043|NCT03709823|62886803|FG003|Overall Study|Other, Not Specified|1|||
33505044|NCT03709823|62886804|FG004|Overall Study|Other, Not Specified|0|||
33505045|NCT03709823|62886805|FG005|Overall Study|Other, Not Specified|0|||
33505046|NCT03488563|62886825|FG000|Overall Study|Lost to Follow-up|7|||
33505047|NCT03488563|62886826|FG001|Overall Study|Lost to Follow-up|6|||
33505048|NCT03488563|62886827|FG002|Overall Study|Lost to Follow-up|7|||
33505049|NCT03488563|62886825|FG000|Overall Study|Withdrawal by Subject|8|||
33505050|NCT03488563|62886826|FG001|Overall Study|Withdrawal by Subject|7|||
33505051|NCT03488563|62886827|FG002|Overall Study|Withdrawal by Subject|7|||
33505052|NCT03488563|62886825|FG000|Overall Study|Physician Decision|0|||
33505053|NCT03488563|62886826|FG001|Overall Study|Physician Decision|0|||
33505054|NCT03488563|62886827|FG002|Overall Study|Physician Decision|1|||
33505055|NCT03488563|62886825|FG000|Overall Study|Protocol Violation|3|||
33505056|NCT03488563|62886826|FG001|Overall Study|Protocol Violation|2|||
33505057|NCT03488563|62886827|FG002|Overall Study|Protocol Violation|6|||
33505058|NCT03488563|62886825|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
33505059|NCT03488563|62886826|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
33505060|NCT03488563|62886827|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
33505061|NCT03488563|62886825|FG000|Overall Study|Use of prohibited medication|2|||
33505062|NCT03488563|62886826|FG001|Overall Study|Use of prohibited medication|0|||
33505063|NCT03488563|62886827|FG002|Overall Study|Use of prohibited medication|0|||
33505064|NCT03488563|62886825|FG000|Overall Study|Adverse Event|1|||
33505065|NCT03488563|62886826|FG001|Overall Study|Adverse Event|0|||
33505066|NCT03488563|62886827|FG002|Overall Study|Adverse Event|1|||
33505067|NCT03488563|62886825|FG000|Overall Study|Subject returned for ET visit|0|||
33505068|NCT03488563|62886826|FG001|Overall Study|Subject returned for ET visit|1|||
33505069|NCT03488563|62886827|FG002|Overall Study|Subject returned for ET visit|0|||
33505070|NCT03488563|62886825|FG000|Overall Study|Sponsor's decision|0|||
33505071|NCT03488563|62886826|FG001|Overall Study|Sponsor's decision|0|||
33505072|NCT03488563|62886827|FG002|Overall Study|Sponsor's decision|1|||
33505073|NCT00706030|62886841|FG000|Overall Study|Disease Progression|4|||
33505074|NCT00706030|62886842|FG001|Overall Study|Disease Progression|6|||
33505075|NCT00706030|62886843|FG002|Overall Study|Disease Progression|46|||
33505076|NCT00706030|62886844|FG003|Overall Study|Disease Progression|12|||
33505077|NCT00706030|62886841|FG000|Overall Study|Adverse Event|1|||
33505078|NCT00706030|62886842|FG001|Overall Study|Adverse Event|0|||
33505079|NCT00706030|62886843|FG002|Overall Study|Adverse Event|4|||
33505080|NCT00706030|62886844|FG003|Overall Study|Adverse Event|2|||
33505081|NCT00706030|62886841|FG000|Overall Study|Withdrawal by Subject|1|||
33505082|NCT00706030|62886842|FG001|Overall Study|Withdrawal by Subject|0|||
33505083|NCT00706030|62886843|FG002|Overall Study|Withdrawal by Subject|2|||
33505084|NCT00706030|62886844|FG003|Overall Study|Withdrawal by Subject|0|||
33505085|NCT00706030|62886841|FG000|Overall Study|Physician Decision|0|||
33505086|NCT00706030|62886842|FG001|Overall Study|Physician Decision|0|||
33505087|NCT00706030|62886843|FG002|Overall Study|Physician Decision|2|||
33505088|NCT00706030|62886844|FG003|Overall Study|Physician Decision|0|||
33611063|NCT01629667|63011437|FG002|Overall Study|Started other medicine|1|||
33611064|NCT01629667|63011435|FG000|Overall Study|Site error in safety follow-up|0|||
33611065|NCT01629667|63011436|FG001|Overall Study|Site error in safety follow-up|0|||
33611066|NCT01629667|63011437|FG002|Overall Study|Site error in safety follow-up|1|||
33505089|NCT00706030|62886841|FG000|Overall Study|Not recorded|0|||
33505090|NCT00706030|62886842|FG001|Overall Study|Not recorded|0|||
33505091|NCT00706030|62886843|FG002|Overall Study|Not recorded|2|||
33611067|NCT01629667|63011435|FG000|Overall Study|Enrolled in another clinical study|0|||
33611068|NCT01629667|63011436|FG001|Overall Study|Enrolled in another clinical study|1|||
33611069|NCT01629667|63011437|FG002|Overall Study|Enrolled in another clinical study|0|||
33611070|NCT01629667|63011435|FG000|Overall Study|Code break|1|||
33611071|NCT01629667|63011436|FG001|Overall Study|Code break|0|||
33611072|NCT01629667|63011437|FG002|Overall Study|Code break|0|||
33611073|NCT01645280|63011452|FG000|Overall Study|Death|0|||
33611074|NCT01645280|63011453|FG001|Overall Study|Death|1|||
33611075|NCT01645280|63011454|FG002|Overall Study|Death|0|||
33611076|NCT01645280|63011455|FG003|Overall Study|Death|0|||
33611077|NCT01645280|63011456|FG004|Overall Study|Death|0|||
33611078|NCT01645280|63011452|FG000|Overall Study|Withdrawal by Subject|4|||
33611079|NCT01645280|63011453|FG001|Overall Study|Withdrawal by Subject|0|||
33505092|NCT00706030|62886844|FG003|Overall Study|Not recorded|0|||
33611080|NCT01645280|63011454|FG002|Overall Study|Withdrawal by Subject|2|||
33611081|NCT01645280|63011455|FG003|Overall Study|Withdrawal by Subject|4|||
33611082|NCT01645280|63011456|FG004|Overall Study|Withdrawal by Subject|5|||
33505093|NCT00706030|62886841|FG000|Overall Study|Protocol Violation|0|||
33611083|NCT01645280|63011452|FG000|Overall Study|Lost to Follow-up|0|||
33611084|NCT01645280|63011453|FG001|Overall Study|Lost to Follow-up|0|||
33505094|NCT00706030|62886842|FG001|Overall Study|Protocol Violation|0|||
33505095|NCT00706030|62886843|FG002|Overall Study|Protocol Violation|1|||
33505096|NCT00706030|62886844|FG003|Overall Study|Protocol Violation|1|||
33505097|NCT00706030|62886841|FG000|Overall Study|Failed to return|0|||
33505098|NCT00706030|62886842|FG001|Overall Study|Failed to return|0|||
33505099|NCT00706030|62886843|FG002|Overall Study|Failed to return|1|||
33611085|NCT01645280|63011454|FG002|Overall Study|Lost to Follow-up|0|||
33611086|NCT01645280|63011455|FG003|Overall Study|Lost to Follow-up|2|||
33505100|NCT00706030|62886844|FG003|Overall Study|Failed to return|0|||
33505101|NCT00706030|62886841|FG000|Overall Study|Symptomatic Deterioration|0|||
33505102|NCT00706030|62886842|FG001|Overall Study|Symptomatic Deterioration|0|||
33505103|NCT00706030|62886843|FG002|Overall Study|Symptomatic Deterioration|1|||
33505104|NCT00706030|62886844|FG003|Overall Study|Symptomatic Deterioration|0|||
33505105|NCT00706030|62886841|FG000|Overall Study|No treatment received|0|||
33505106|NCT00706030|62886842|FG001|Overall Study|No treatment received|0|||
33505107|NCT00706030|62886843|FG002|Overall Study|No treatment received|0|||
33505108|NCT00706030|62886844|FG003|Overall Study|No treatment received|1|||
33505109|NCT00706030|62886841|FG000|Overall Study|Death|0|||
33505110|NCT00706030|62886842|FG001|Overall Study|Death|0|||
33505111|NCT00706030|62886843|FG002|Overall Study|Death|1|||
33505112|NCT00706030|62886844|FG003|Overall Study|Death|0|||
33505113|NCT03488251|62886859|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
33505114|NCT03488251|62886860|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
33505115|NCT03488251|62886861|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
33505116|NCT03488251|62886862|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
33505117|NCT03488251|62886859|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
33505118|NCT03488251|62886860|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
33505119|NCT03488251|62886861|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
33505120|NCT03488251|62886862|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
33505121|NCT03488251|62886859|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
33505122|NCT03488251|62886860|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
33505123|NCT03488251|62886861|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
33505124|NCT03488251|62886862|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
33505125|NCT03488251|62886859|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
33505126|NCT03488251|62886860|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
33505127|NCT03488251|62886861|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
33505128|NCT03488251|62886862|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
33505129|NCT03488251|62886859|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
33505130|NCT03488251|62886860|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
33505131|NCT03488251|62886861|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
33505132|NCT03488251|62886862|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
33505133|NCT02727322|62886875|FG000|Overall Study|Withdrawal by Subject|1|||
33505134|NCT02727322|62886876|FG001|Overall Study|Withdrawal by Subject|1|||
33505135|NCT02727322|62886875|FG000|Overall Study|Protocol Violation|1|||
33505136|NCT02727322|62886876|FG001|Overall Study|Protocol Violation|0|||
33505137|NCT03431857|62886886|FG000|Overall Study|Death|6|||
33505138|NCT03431857|62886886|FG000|Overall Study|Lost to Follow-up|41|||
33505139|NCT03431857|62886886|FG000|Overall Study|Adverse Event|6|||
33505140|NCT03431857|62886886|FG000|Overall Study|Withdrawal by Subject|1|||
33505141|NCT03487549|62886892|FG000|Overall Study|Protocol Violation|0|||
33505142|NCT03487549|62886893|FG001|Overall Study|Protocol Violation|1|||
33505143|NCT03487549|62886892|FG000|Overall Study|Lost to Follow-up|2|||
33505144|NCT03487549|62886893|FG001|Overall Study|Lost to Follow-up|1|||
33505145|NCT03487549|62886892|FG000|Overall Study|Withdrawal by Subject|2|||
33505146|NCT03487549|62886893|FG001|Overall Study|Withdrawal by Subject|0|||
33505147|NCT03464383|62886902|FG000|Overall Study|Lost to Follow-up|1|||
33505148|NCT03464383|62886903|FG001|Overall Study|Lost to Follow-up|0|||
33505149|NCT03464383|62886904|FG002|Overall Study|Lost to Follow-up|0|||
33505150|NCT03464383|62886902|FG000|Overall Study|Withdrawal by Subject|0|||
33505151|NCT03464383|62886903|FG001|Overall Study|Withdrawal by Subject|1|||
33450141|NCT00004978|62824936|FG000|Overall Study|Withdrawal by Subject|17|||
33450142|NCT00004978|62824937|FG001|Overall Study|Withdrawal by Subject|26|||
33450143|NCT00004978|62824936|FG000|Overall Study|site closure - not in analysis cohort|19|||
33450144|NCT00004978|62824937|FG001|Overall Study|site closure - not in analysis cohort|20|||
33450145|NCT00430937|62824945|FG000|Overall Study|Adverse Event|3|||
33450146|NCT00430937|62824946|FG001|Overall Study|Adverse Event|8|||
33450147|NCT00430937|62824945|FG000|Overall Study|Death|0|||
33450148|NCT00430937|62824946|FG001|Overall Study|Death|1|||
33450149|NCT00430937|62824945|FG000|Overall Study|Lost to Follow-up|6|||
33450150|NCT00430937|62824946|FG001|Overall Study|Lost to Follow-up|6|||
33450151|NCT00430937|62824945|FG000|Overall Study|Withdrawal by Subject|5|||
33450152|NCT00430937|62824946|FG001|Overall Study|Withdrawal by Subject|2|||
33450153|NCT00430937|62824945|FG000|Overall Study|Protocol Violation|3|||
33450154|NCT00430937|62824946|FG001|Overall Study|Protocol Violation|2|||
33450155|NCT00430937|62824945|FG000|Overall Study|Lack of Efficacy|6|||
33450156|NCT00430937|62824946|FG001|Overall Study|Lack of Efficacy|5|||
33450157|NCT00430937|62824945|FG000|Overall Study|Inappropriate enrollment|2|||
33450158|NCT00430937|62824946|FG001|Overall Study|Inappropriate enrollment|1|||
33450159|NCT00430937|62824945|FG000|Overall Study|Administrative reasons|1|||
33611087|NCT01645280|63011456|FG004|Overall Study|Lost to Follow-up|1|||
33505152|NCT03464383|62886904|FG002|Overall Study|Withdrawal by Subject|0|||
33505153|NCT01444092|62886913|FG000|Overall Study|Adverse Event|8|||
33505154|NCT01444092|62886913|FG000|Overall Study|Protocol Violation|1|||
33505155|NCT01444092|62886913|FG000|Overall Study|Withdrawal by Subject|1|||
33505156|NCT01444092|62886913|FG000|Overall Study|Other Eligibility criteria|7|||
33505157|NCT01265784|62886920|FG000|Overall Study|Lost to Follow-up|5|||
33505158|NCT01265784|62886921|FG001|Overall Study|Lost to Follow-up|3|||
33505159|NCT01265784|62886922|FG002|Overall Study|Lost to Follow-up|2|||
33505160|NCT01265784|62886920|FG000|Overall Study|Withdrawal by Subject|0|||
33505161|NCT01265784|62886921|FG001|Overall Study|Withdrawal by Subject|5|||
33505162|NCT01265784|62886922|FG002|Overall Study|Withdrawal by Subject|0|||
33505163|NCT01265784|62886920|FG000|Overall Study|Physician Decision|1|||
33505164|NCT01265784|62886921|FG001|Overall Study|Physician Decision|0|||
33505165|NCT01265784|62886922|FG002|Overall Study|Physician Decision|1|||
33505166|NCT01265784|62886920|FG000|Overall Study|Adverse Event|1|||
33505167|NCT01265784|62886921|FG001|Overall Study|Adverse Event|0|||
33505168|NCT01265784|62886922|FG002|Overall Study|Adverse Event|0|||
33505169|NCT01265784|62886920|FG000|Overall Study|Death|3|||
33505170|NCT01265784|62886921|FG001|Overall Study|Death|0|||
33505171|NCT01265784|62886922|FG002|Overall Study|Death|0|||
33505172|NCT01265784|62886920|FG000|Overall Study|Protocol Violation|2|||
33505173|NCT01265784|62886921|FG001|Overall Study|Protocol Violation|0|||
33505174|NCT01265784|62886922|FG002|Overall Study|Protocol Violation|0|||
33505175|NCT01265784|62886920|FG000|Overall Study|Incorrectly Randomized|0|||
33505176|NCT01265784|62886921|FG001|Overall Study|Incorrectly Randomized|0|||
33505177|NCT01265784|62886922|FG002|Overall Study|Incorrectly Randomized|1|||
33505178|NCT03156504|62886930|FG000|Overall Study|Withdrawal by Subject|1|||
33505179|NCT03159468|62886940|FG000|Overall Study|Withdrawal by Subject|0|||
33505180|NCT03159468|62886941|FG001|Overall Study|Withdrawal by Subject|0|||
33505181|NCT03159468|62886942|FG002|Overall Study|Withdrawal by Subject|3|||
33505182|NCT03159468|62886943|FG003|Overall Study|Withdrawal by Subject|0|||
33505183|NCT03159468|62886944|FG004|Overall Study|Withdrawal by Subject|0|||
33505184|NCT03159468|62886945|FG005|Overall Study|Withdrawal by Subject|0|||
33505185|NCT03430063|62886962|FG000|Overall Study|Adverse Event|0|||
33505186|NCT03430063|62886963|FG001|Overall Study|Adverse Event|1|||
33505187|NCT03430063|62886964|FG002|Overall Study|Adverse Event|0|||
33505188|NCT03430063|62886962|FG000|Overall Study|Death|3|||
33505189|NCT03430063|62886963|FG001|Overall Study|Death|2|||
33505190|NCT03430063|62886964|FG002|Overall Study|Death|3|||
33505191|NCT03430063|62886962|FG000|Overall Study|Lost to Follow-up|0|||
33505192|NCT03430063|62886963|FG001|Overall Study|Lost to Follow-up|1|||
33505193|NCT03430063|62886964|FG002|Overall Study|Lost to Follow-up|0|||
33505194|NCT03430063|62886962|FG000|Overall Study|Withdrawal by Subject|0|||
33505195|NCT03430063|62886963|FG001|Overall Study|Withdrawal by Subject|0|||
33505196|NCT03430063|62886964|FG002|Overall Study|Withdrawal by Subject|1|||
33505197|NCT03430063|62886962|FG000|Overall Study|Withdrawal of consent|3|||
33505198|NCT03430063|62886963|FG001|Overall Study|Withdrawal of consent|1|||
33505199|NCT03430063|62886964|FG002|Overall Study|Withdrawal of consent|2|||
33505200|NCT03430063|62886962|FG000|Overall Study|Progressive disease|1|||
33505201|NCT03430063|62886963|FG001|Overall Study|Progressive disease|2|||
33505202|NCT03430063|62886964|FG002|Overall Study|Progressive disease|1|||
33505203|NCT03430063|62886962|FG000|Overall Study|Other un-specified|1|||
33505204|NCT03430063|62886963|FG001|Overall Study|Other un-specified|1|||
33505205|NCT03430063|62886964|FG002|Overall Study|Other un-specified|0|||
33505206|NCT03430063|62886962|FG000|Overall Study|Randomized, but never treated|0|||
33505207|NCT03430063|62886963|FG001|Overall Study|Randomized, but never treated|0|||
33505208|NCT03430063|62886964|FG002|Overall Study|Randomized, but never treated|1|||
33450160|NCT00430937|62824946|FG001|Overall Study|Administrative reasons|0|||
33450161|NCT00430937|62824945|FG000|Overall Study|Protocol discontinuation criteria met|1|||
33450162|NCT00430937|62824946|FG001|Overall Study|Protocol discontinuation criteria met|2|||
33450163|NCT00430937|62824945|FG000|Overall Study|Unable to classify|0|||
33450164|NCT00430937|62824946|FG001|Overall Study|Unable to classify|1|||
33450165|NCT00004888|62824954|FG000|Overall Study|Adverse Event|5|||
33450166|NCT00004888|62824955|FG001|Overall Study|Adverse Event|10|||
33450167|NCT00004888|62824954|FG000|Overall Study|Withdrawal by Subject|0|||
33450168|NCT00004888|62824955|FG001|Overall Study|Withdrawal by Subject|3|||
33450169|NCT00004888|62824954|FG000|Overall Study|Physician Decision|1|||
33505209|NCT03158220|62886975|FG000|Overall Study|Screen Failure|0|||
33505210|NCT03158220|62886976|FG001|Overall Study|Screen Failure|1|||
33505211|NCT03158220|62886975|FG000|Overall Study|Withdrawal by Subject|8|||
33450170|NCT00004888|62824955|FG001|Overall Study|Physician Decision|1|||
33505212|NCT03158220|62886976|FG001|Overall Study|Withdrawal by Subject|9|||
33505213|NCT03158220|62886975|FG000|Overall Study|Status unknown|0|||
33505214|NCT03158220|62886976|FG001|Overall Study|Status unknown|1|||
33505215|NCT03158220|62886975|FG000|Overall Study|Lost to Follow-up|8|||
33505216|NCT03158220|62886976|FG001|Overall Study|Lost to Follow-up|5|||
33505217|NCT03158220|62886975|FG000|Overall Study|Physician Decision|1|||
33505218|NCT03158220|62886976|FG001|Overall Study|Physician Decision|0|||
33611088|NCT01645280|63011452|FG000|Overall Study|Other|1|||
33505219|NCT03156270|62886982|FG000|Overall Study|Failed pre-treatment screening|1|||
33505220|NCT03156270|62886982|FG000|Overall Study|Lost to Follow-up|1|||
33505221|NCT03429049|62886990|FG000|Overall Study|Adverse Event|2|||
33505222|NCT03429049|62886991|FG001|Overall Study|Adverse Event|3|||
33505223|NCT03429049|62886990|FG000|Overall Study|Death|0|||
33505224|NCT03429049|62886991|FG001|Overall Study|Death|1|||
33505225|NCT03429049|62886990|FG000|Overall Study|Lack of Efficacy|4|||
33505226|NCT03429049|62886991|FG001|Overall Study|Lack of Efficacy|2|||
33505227|NCT03429049|62886990|FG000|Overall Study|Lost to Follow-up|9|||
33505228|NCT03429049|62886991|FG001|Overall Study|Lost to Follow-up|8|||
33505229|NCT03429049|62886990|FG000|Overall Study|Physician Decision|1|||
33505230|NCT03429049|62886991|FG001|Overall Study|Physician Decision|0|||
33505231|NCT03429049|62886990|FG000|Overall Study|Protocol Violation|3|||
33505232|NCT03429049|62886991|FG001|Overall Study|Protocol Violation|0|||
33505233|NCT03429049|62886990|FG000|Overall Study|Sponsor Decision|2|||
33505234|NCT03429049|62886991|FG001|Overall Study|Sponsor Decision|0|||
33505235|NCT03429049|62886990|FG000|Overall Study|Withdrawal by Subject|4|||
33505236|NCT03429049|62886991|FG001|Overall Study|Withdrawal by Subject|20|||
33505237|NCT03429049|62886990|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
33505238|NCT03429049|62886991|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
33505239|NCT03428815|62886999|FG000|Overall Study|Lost to Follow-up|2|||
33505240|NCT03428815|62887000|FG001|Overall Study|Lost to Follow-up|2|||
33505241|NCT03428815|62886999|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
33505242|NCT03428815|62887000|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
33505243|NCT03428815|62886999|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
33505244|NCT03428815|62887000|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
33505245|NCT03155724|62887006|FG000|Overall Study|Death|3|||
33505246|NCT03155724|62887006|FG000|Overall Study|Physician Decision|1|||
33505247|NCT03155724|62887006|FG000|Overall Study|Study closure|7|||
33505248|NCT03426787|62887010|FG000|Overall Study|Withdrawal by Subject|6|||
33505249|NCT03426787|62887010|FG000|Overall Study|Lost to Follow-up|7|||
33505250|NCT03426787|62887010|FG000|Overall Study|Unrelated to intervention death|1|||
33505251|NCT03426631|62887020|FG000|Overall Study|Lost to Follow-up|0|||
33505252|NCT03426631|62887021|FG001|Overall Study|Lost to Follow-up|1|||
33505253|NCT03484429|62887029|FG000|Overall Study|Withdrawal by Subject|1|||
33505254|NCT03484429|62887030|FG001|Overall Study|Withdrawal by Subject|0|||
33505255|NCT03484429|62887029|FG000|Overall Study|Adverse Event|2|||
33505256|NCT03484429|62887030|FG001|Overall Study|Adverse Event|0|||
33505257|NCT03484273|62887036|FG000|Overall Study|Equipment Malfunction|1|||
33505258|NCT03484273|62887036|FG000|Overall Study|Data excluded from analysis|1|||
33505259|NCT02724592|62887050|FG000|Overall Study|Lost to Follow-up|4|||
33505260|NCT02724592|62887051|FG001|Overall Study|Lost to Follow-up|1|||
33505261|NCT03154476|62887059|FG000|Overall Study|Lost to Follow-up|4|||
33505262|NCT03154476|62887060|FG001|Overall Study|Lost to Follow-up|4|||
33505263|NCT02726074|62887066|FG000|Overall Study|Withdrawal by Subject|4|||
33505264|NCT02726074|62887066|FG000|Overall Study|Adverse Event|14|||
33505265|NCT02726074|62887066|FG000|Overall Study|Protocol Violation|3|||
33505266|NCT02726074|62887066|FG000|Overall Study|Lost to Follow-up|2|||
33505267|NCT02726074|62887066|FG000|Overall Study|Others|3|||
33505268|NCT03482635|62887074|FG000|Overall Study|Lack of Efficacy|0|||
33505269|NCT03482635|62887075|FG001|Overall Study|Lack of Efficacy|0|||
33505270|NCT03482635|62887076|FG002|Overall Study|Lack of Efficacy|1|||
33505271|NCT03482635|62887077|FG003|Overall Study|Lack of Efficacy|3|||
33505272|NCT03482635|62887074|FG000|Overall Study|Adverse Event|2|||
33505273|NCT03482635|62887075|FG001|Overall Study|Adverse Event|2|||
33505274|NCT03482635|62887076|FG002|Overall Study|Adverse Event|0|||
33505275|NCT03482635|62887077|FG003|Overall Study|Adverse Event|3|||
33505276|NCT03482635|62887074|FG000|Overall Study|Withdrawal by Subject|2|||
33505277|NCT03482635|62887075|FG001|Overall Study|Withdrawal by Subject|1|||
33505278|NCT03482635|62887076|FG002|Overall Study|Withdrawal by Subject|0|||
33505279|NCT03482635|62887077|FG003|Overall Study|Withdrawal by Subject|1|||
33505280|NCT03482635|62887074|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
33505281|NCT03482635|62887075|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
33505282|NCT03482635|62887076|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
33505283|NCT03482635|62887077|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
33505284|NCT03482635|62887074|FG000|Overall Study|Not treated|0|||
33505285|NCT03482635|62887075|FG001|Overall Study|Not treated|0|||
33505286|NCT03482635|62887076|FG002|Overall Study|Not treated|0|||
33505287|NCT03482635|62887077|FG003|Overall Study|Not treated|1|||
33505288|NCT03712787|62887091|FG000|Overall Study|Adverse Event|2|||
33505289|NCT03712787|62887092|FG001|Overall Study|Adverse Event|3|||
33505290|NCT03712787|62887093|FG002|Overall Study|Adverse Event|0|||
33505291|NCT03712787|62887094|FG003|Overall Study|Adverse Event|4|||
33505292|NCT03712787|62887091|FG000|Overall Study|Withdrawal by Subject|4|||
33505293|NCT03712787|62887092|FG001|Overall Study|Withdrawal by Subject|14|||
33505294|NCT03712787|62887093|FG002|Overall Study|Withdrawal by Subject|12|||
33505295|NCT03712787|62887094|FG003|Overall Study|Withdrawal by Subject|8|||
33505296|NCT03712787|62887091|FG000|Overall Study|Lost to Follow-up|1|||
33505297|NCT03712787|62887092|FG001|Overall Study|Lost to Follow-up|1|||
33505298|NCT03712787|62887093|FG002|Overall Study|Lost to Follow-up|2|||
33505299|NCT03712787|62887094|FG003|Overall Study|Lost to Follow-up|1|||
33505300|NCT03712787|62887091|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
33505301|NCT03712787|62887092|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
33505302|NCT03712787|62887093|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
33611089|NCT01645280|63011453|FG001|Overall Study|Other|1|||
33611090|NCT01645280|63011454|FG002|Overall Study|Other|2|||
33611091|NCT01645280|63011455|FG003|Overall Study|Other|0|||
33611092|NCT01645280|63011456|FG004|Overall Study|Other|0|||
33611093|NCT01645280|63011452|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
33611094|NCT01645280|63011453|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
33611095|NCT01645280|63011454|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
33611096|NCT01645280|63011455|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
33611097|NCT01645280|63011456|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
33611098|NCT02256917|63011469|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
33611099|NCT02256917|63011469|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
33611100|NCT02256917|63011469|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
33611101|NCT02256917|63011469|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
33611102|NCT02256917|63011469|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
33611103|NCT01629589|63011482|FG000|Overall Study|Protocol Violation|4|||
33611104|NCT01629589|63011483|FG001|Overall Study|Protocol Violation|2|||
33611105|NCT01629589|63011482|FG000|Overall Study|Lost to Follow-up|2|||
33611106|NCT01629589|63011483|FG001|Overall Study|Lost to Follow-up|1|||
33611107|NCT01629589|63011482|FG000|Overall Study|Withdrawal by Subject|2|||
33611108|NCT01629589|63011483|FG001|Overall Study|Withdrawal by Subject|3|||
33505303|NCT03712787|62887094|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
33505304|NCT03712787|62887091|FG000|Overall Study|COVID-19 Infection|0|||
33450171|NCT00004888|62824954|FG000|Overall Study|Progressive Disease|4|||
33450172|NCT00004888|62824955|FG001|Overall Study|Progressive Disease|9|||
33450173|NCT00004888|62824954|FG000|Overall Study|Death without progressive disease|0|||
33450174|NCT00004888|62824955|FG001|Overall Study|Death without progressive disease|1|||
33450175|NCT00004888|62824954|FG000|Overall Study|Toxic death|1|||
33450176|NCT00004888|62824955|FG001|Overall Study|Toxic death|0|||
33450177|NCT00004732|62824963|FG000|Overall Study|Withdrawal by Subject|36|||
33450178|NCT00004732|62824964|FG001|Overall Study|Withdrawal by Subject|64|||
33450179|NCT00004732|62824963|FG000|Overall Study|Lost to Follow-up|33|||
33450180|NCT00004732|62824964|FG001|Overall Study|Lost to Follow-up|47|||
33450181|NCT00430781|62824975|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
33450182|NCT00430781|62824976|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
33505305|NCT03712787|62887092|FG001|Overall Study|COVID-19 Infection|1|||
33505306|NCT03712787|62887093|FG002|Overall Study|COVID-19 Infection|0|||
33505307|NCT03712787|62887094|FG003|Overall Study|COVID-19 Infection|0|||
33505308|NCT03712787|62887091|FG000|Overall Study|Other, Not Specified|79|||
33505309|NCT03712787|62887092|FG001|Overall Study|Other, Not Specified|77|||
33505310|NCT03712787|62887093|FG002|Overall Study|Other, Not Specified|74|||
33505311|NCT03712787|62887094|FG003|Overall Study|Other, Not Specified|78|||
33505312|NCT03048422|62887126|FG000|Overall Study|Death|1|||
33505313|NCT03048422|62887127|FG001|Overall Study|Death|0|||
33505314|NCT03048422|62887128|FG002|Overall Study|Death|0|||
33505315|NCT03048422|62887126|FG000|Overall Study|Lost to Follow-up|5|||
33505316|NCT03048422|62887127|FG001|Overall Study|Lost to Follow-up|0|||
33505317|NCT03048422|62887128|FG002|Overall Study|Lost to Follow-up|1|||
33505318|NCT03048422|62887126|FG000|Overall Study|Withdrawal by Subject|5|||
33505319|NCT03048422|62887127|FG001|Overall Study|Withdrawal by Subject|7|||
33505320|NCT03048422|62887128|FG002|Overall Study|Withdrawal by Subject|4|||
33505321|NCT03048422|62887126|FG000|Overall Study|Moved|3|||
33505322|NCT03048422|62887127|FG001|Overall Study|Moved|2|||
33505323|NCT03048422|62887128|FG002|Overall Study|Moved|2|||
33505324|NCT03048422|62887126|FG000|Overall Study|Noncompliant with Study Requirements|2|||
33505325|NCT03048422|62887127|FG001|Overall Study|Noncompliant with Study Requirements|1|||
33505326|NCT03048422|62887128|FG002|Overall Study|Noncompliant with Study Requirements|2|||
33505327|NCT03048422|62887126|FG000|Overall Study|Not Able to Get to Clinic|1|||
33505328|NCT03048422|62887127|FG001|Overall Study|Not Able to Get to Clinic|0|||
33505329|NCT03048422|62887128|FG002|Overall Study|Not Able to Get to Clinic|0|||
33505330|NCT04664855|62887148|FG000|Overall Study|Withdrawal by Subject|0|||
33505331|NCT04664855|62887149|FG001|Overall Study|Withdrawal by Subject|2|||
33611109|NCT01629589|63011482|FG000|Overall Study|Did not receive study vaccine|0|||
33611110|NCT01629589|63011483|FG001|Overall Study|Did not receive study vaccine|1|||
33611111|NCT02256839|63011491|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
33611112|NCT02256839|63011492|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
33611113|NCT02220907|63011498|FG000|Overall Study|Adverse Event|7|||
33611114|NCT02220907|63011498|FG000|Overall Study|Physician Decision|1|||
33611115|NCT02220907|63011498|FG000|Overall Study|Withdrawal by Subject|2|||
33505332|NCT04664153|62887159|FG000|Overall Study|Lack of Efficacy|0|||
33505333|NCT04664153|62887160|FG001|Overall Study|Lack of Efficacy|0|||
33505334|NCT04664153|62887161|FG002|Overall Study|Lack of Efficacy|1|||
33505335|NCT04664153|62887162|FG003|Overall Study|Lack of Efficacy|0|||
33505336|NCT04664153|62887159|FG000|Overall Study|Physician Decision|0|||
33505337|NCT04664153|62887160|FG001|Overall Study|Physician Decision|0|||
33505338|NCT04664153|62887161|FG002|Overall Study|Physician Decision|1|||
33505339|NCT04664153|62887162|FG003|Overall Study|Physician Decision|0|||
33505340|NCT04664153|62887159|FG000|Overall Study|Withdrawal by Subject|3|||
33505341|NCT04664153|62887160|FG001|Overall Study|Withdrawal by Subject|2|||
33505342|NCT04664153|62887161|FG002|Overall Study|Withdrawal by Subject|1|||
33505343|NCT04664153|62887162|FG003|Overall Study|Withdrawal by Subject|2|||
33505344|NCT04664153|62887159|FG000|Overall Study|Other|0|||
33611116|NCT02220907|63011498|FG000|Overall Study|Conflict with the stopping criteria|1|||
33611117|NCT02255981|63011502|FG000|Overall Study|Lost to Follow-up|3|||
33611118|NCT02255981|63011502|FG000|Overall Study|Withdrawal by Subject|1|||
33611119|NCT01601873|63011514|FG000|Overall Study|Lost to Follow-up|2|||
33611120|NCT01601873|63011515|FG001|Overall Study|Lost to Follow-up|3|||
33611121|NCT02194933|63011523|FG000|Overall Study|Lost to Follow-up|1|||
33611122|NCT02194933|63011524|FG001|Overall Study|Lost to Follow-up|2|||
33611123|NCT02194933|63011523|FG000|Overall Study|Participant met withdrawal criteria|1|||
33611124|NCT02194933|63011524|FG001|Overall Study|Participant met withdrawal criteria|3|||
33611125|NCT02194933|63011523|FG000|Overall Study|Withdrawal by Subject|0|||
33611126|NCT02194933|63011524|FG001|Overall Study|Withdrawal by Subject|2|||
33611127|NCT02194933|63011523|FG000|Overall Study|Lack of Efficacy|1|||
33611128|NCT02194933|63011524|FG001|Overall Study|Lack of Efficacy|2|||
33611129|NCT01644890|63011534|FG000|Overall Study|Adverse Event|7|||
33611130|NCT01644890|63011535|FG001|Overall Study|Adverse Event|20|||
33505345|NCT04664153|62887160|FG001|Overall Study|Other|1|||
33505346|NCT04664153|62887161|FG002|Overall Study|Other|0|||
33505347|NCT04664153|62887162|FG003|Overall Study|Other|0|||
33505348|NCT04664153|62887159|FG000|Overall Study|Adverse Event|4|||
33505349|NCT04664153|62887160|FG001|Overall Study|Adverse Event|0|||
33505350|NCT04664153|62887161|FG002|Overall Study|Adverse Event|1|||
33505351|NCT04664153|62887162|FG003|Overall Study|Adverse Event|0|||
33505352|NCT04663295|62887174|FG000|Run-in Period|Withdrawal by Subject|3|||
33505353|NCT04663295|62887174|FG000|Overall Study Period|Pregnancy|1|||
33505354|NCT04663295|62887174|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
33611131|NCT01644890|63011534|FG000|Overall Study|Death|1|||
33505355|NCT04228445|62887185|FG000|Overall Study|Lost to Follow-up|1|||
33505356|NCT04228445|62887186|FG001|Overall Study|Lost to Follow-up|1|||
33611132|NCT01644890|63011535|FG001|Overall Study|Death|3|||
33611133|NCT01644890|63011534|FG000|Overall Study|Physician Decision|3|||
33611134|NCT01644890|63011535|FG001|Overall Study|Physician Decision|9|||
33611135|NCT01644890|63011534|FG000|Overall Study|Protocol Violation|6|||
33611136|NCT01644890|63011535|FG001|Overall Study|Protocol Violation|7|||
33611137|NCT01644890|63011534|FG000|Overall Study|Withdrawal by Subject|19|||
33611138|NCT01644890|63011535|FG001|Overall Study|Withdrawal by Subject|27|||
33611139|NCT01644890|63011534|FG000|Overall Study|Progression Disease|160|||
33611140|NCT01644890|63011535|FG001|Overall Study|Progression Disease|131|||
33611141|NCT01644890|63011534|FG000|Overall Study|Clinical Progression|6|||
33611142|NCT01644890|63011535|FG001|Overall Study|Clinical Progression|6|||
33611143|NCT01644890|63011534|FG000|Overall Study|> 28 days since last dose of study drug|6|||
33611144|NCT01644890|63011535|FG001|Overall Study|> 28 days since last dose of study drug|3|||
33611145|NCT01644890|63011534|FG000|Overall Study|Other|8|||
33611146|NCT01644890|63011535|FG001|Overall Study|Other|9|||
33611147|NCT01628965|63011541|FG000|Overall Study|Adverse Event|30|||
33611148|NCT01628965|63011541|FG000|Overall Study|Lack of Efficacy|7|||
33611149|NCT01628965|63011541|FG000|Overall Study|Withdrawal by Subject|3|||
33611150|NCT01628965|63011541|FG000|Overall Study|Lost to Follow-up|1|||
33611151|NCT01628965|63011541|FG000|Overall Study|Discontinuation criteria|8|||
33611152|NCT01644734|63011545|FG000|Overall Study|Adverse Event|4|||
33611153|NCT01644734|63011545|FG000|Overall Study|Lost to Follow-up|17|||
33611154|NCT01644734|63011545|FG000|Overall Study|Reasons other than stated above|7|||
33611155|NCT01644734|63011545|FG000|Overall Study|Missing documentation|238|||
33611156|NCT02255279|63011551|FG000|Overall Study|Lost to Follow-up|2|||
33611157|NCT02255279|63011552|FG001|Overall Study|Lost to Follow-up|2|||
33611158|NCT02255279|63011551|FG000|Overall Study|Protocol Violation|0|||
33611159|NCT02255279|63011552|FG001|Overall Study|Protocol Violation|1|||
33611160|NCT02255279|63011551|FG000|Overall Study|Withdrawal by Subject|3|||
33611161|NCT02255279|63011552|FG001|Overall Study|Withdrawal by Subject|6|||
33611162|NCT01643798|63011572|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
33611163|NCT01643798|63011573|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
33611164|NCT02194699|63011586|FG000|Randomised|Did not receive treatment|1|||
33611165|NCT02194699|63011587|FG001|Randomised|Did not receive treatment|5|||
33611166|NCT02194699|63011586|FG000|Randomised|Without potential for 52 weeks of IP|5|||
33611167|NCT02194699|63011587|FG001|Randomised|Without potential for 52 weeks of IP|5|||
33611168|NCT02194699|63011586|FG000|Randomised|Duplicate patient|2|||
33611169|NCT02194699|63011587|FG001|Randomised|Duplicate patient|1|||
33611170|NCT02194699|63011586|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
33611171|NCT02194699|63011587|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
33611172|NCT02194699|63011586|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
33611173|NCT02194699|63011587|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
33611174|NCT02194699|63011586|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
33611175|NCT02194699|63011587|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
33611176|NCT02194699|63011586|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
33611177|NCT02194699|63011587|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
33611178|NCT02194699|63011586|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
33611179|NCT02194699|63011587|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
33611180|NCT02194699|63011586|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
33611181|NCT02194699|63011587|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
33611182|NCT02293538|63011603|FG000|Overall Study|Adverse Event|0|||
33611183|NCT02293538|63011604|FG001|Overall Study|Adverse Event|1|||
33611184|NCT02293538|63011603|FG000|Overall Study|Lost to Follow-up|1|||
33611185|NCT02293538|63011604|FG001|Overall Study|Lost to Follow-up|0|||
33611186|NCT02293538|63011603|FG000|Overall Study|Withdrawal by Subject|0|||
33611187|NCT02293538|63011604|FG001|Overall Study|Withdrawal by Subject|1|||
33611188|NCT02194621|63011614|FG000|Overall Study|6 withdrew prior to randomization|2|||
33611189|NCT02194621|63011615|FG001|Overall Study|6 withdrew prior to randomization|2|||
33611190|NCT02194621|63011616|FG002|Overall Study|6 withdrew prior to randomization|2|||
33611191|NCT02194621|63011614|FG000|Overall Study|Withdrawal by Subject|4|||
33611192|NCT02194621|63011615|FG001|Overall Study|Withdrawal by Subject|4|||
33611193|NCT02194621|63011616|FG002|Overall Study|Withdrawal by Subject|7|||
33611194|NCT02220205|63011626|FG000|Overall Study|Withdrawal by Subject|1|||
33611195|NCT02220205|63011627|FG001|Overall Study|Withdrawal by Subject|0|||
33611196|NCT02266706|63011642|FG000|Overall Study|Withdrawal by Subject|0|||
33611197|NCT02266706|63011643|FG001|Overall Study|Withdrawal by Subject|1|||
33611198|NCT02266706|63011644|FG002|Overall Study|Withdrawal by Subject|1|||
33611199|NCT02266706|63011645|FG003|Overall Study|Withdrawal by Subject|0|||
33611200|NCT02266706|63011646|FG004|Overall Study|Withdrawal by Subject|0|||
33611201|NCT02266706|63011647|FG005|Overall Study|Withdrawal by Subject|1|||
33611202|NCT02266706|63011648|FG006|Overall Study|Withdrawal by Subject|0|||
33611203|NCT02266706|63011649|FG007|Overall Study|Withdrawal by Subject|0|||
33611204|NCT02266706|63011650|FG008|Overall Study|Withdrawal by Subject|0|||
33611205|NCT02266706|63011642|FG000|Overall Study|Screen failure|0|||
33611206|NCT02266706|63011643|FG001|Overall Study|Screen failure|0|||
33611207|NCT02266706|63011644|FG002|Overall Study|Screen failure|0|||
33611208|NCT02266706|63011645|FG003|Overall Study|Screen failure|0|||
33611209|NCT02266706|63011646|FG004|Overall Study|Screen failure|0|||
33611210|NCT02266706|63011647|FG005|Overall Study|Screen failure|1|||
33611211|NCT02266706|63011648|FG006|Overall Study|Screen failure|1|||
33611212|NCT02266706|63011649|FG007|Overall Study|Screen failure|0|||
33611213|NCT02266706|63011650|FG008|Overall Study|Screen failure|0|||
33611214|NCT02266706|63011642|FG000|Overall Study|Enrollment in another study|0|||
33611215|NCT02266706|63011643|FG001|Overall Study|Enrollment in another study|0|||
33611216|NCT02266706|63011644|FG002|Overall Study|Enrollment in another study|0|||
33611217|NCT02266706|63011645|FG003|Overall Study|Enrollment in another study|1|||
33611218|NCT02266706|63011646|FG004|Overall Study|Enrollment in another study|0|||
33611219|NCT02266706|63011647|FG005|Overall Study|Enrollment in another study|0|||
33611220|NCT02266706|63011648|FG006|Overall Study|Enrollment in another study|0|||
33611221|NCT02266706|63011649|FG007|Overall Study|Enrollment in another study|0|||
33611222|NCT02266706|63011650|FG008|Overall Study|Enrollment in another study|0|||
33611223|NCT02293460|63011670|FG000|Overall Study|Protocol Violation|1|||
33611224|NCT02293460|63011670|FG000|Overall Study|Lack of Efficacy|2|||
33611225|NCT02293460|63011670|FG000|Overall Study|Adverse Event|2|||
33611226|NCT02293460|63011670|FG000|Overall Study|Withdrawal by Subject|1|||
33611227|NCT02266004|63011674|FG000|Overall Study|unrelated adverse event|1|||
33611228|NCT02266004|63011674|FG000|Overall Study|Physician Decision|1|||
33611229|NCT02292719|63011684|FG000|Overall Study|Withdrawal by Subject|0|||
33611230|NCT02292719|63011685|FG001|Overall Study|Withdrawal by Subject|0|||
33611231|NCT02292719|63011686|FG002|Overall Study|Withdrawal by Subject|0|||
33611232|NCT02292719|63011687|FG003|Overall Study|Withdrawal by Subject|1|||
33611233|NCT02292719|63011688|FG004|Overall Study|Withdrawal by Subject|1|||
33611234|NCT02292719|63011689|FG005|Overall Study|Withdrawal by Subject|0|||
33611235|NCT02292719|63011684|FG000|Overall Study|Subject enrolled in new study.|0|||
33611236|NCT02292719|63011685|FG001|Overall Study|Subject enrolled in new study.|0|||
33611237|NCT02292719|63011686|FG002|Overall Study|Subject enrolled in new study.|1|||
33611238|NCT02292719|63011687|FG003|Overall Study|Subject enrolled in new study.|0|||
33611239|NCT02292719|63011688|FG004|Overall Study|Subject enrolled in new study.|0|||
33611240|NCT02292719|63011689|FG005|Overall Study|Subject enrolled in new study.|0|||
33611241|NCT02291861|63011707|FG000|Overall Study|Adverse Event|2|||
33611242|NCT02291861|63011708|FG001|Overall Study|Adverse Event|4|||
33611243|NCT02291861|63011709|FG002|Overall Study|Adverse Event|1|||
33611244|NCT02291861|63011710|FG003|Overall Study|Adverse Event|2|||
33611245|NCT02291861|63011707|FG000|Overall Study|Death|0|||
33611246|NCT02291861|63011708|FG001|Overall Study|Death|0|||
33611247|NCT02291861|63011709|FG002|Overall Study|Death|1|||
33611248|NCT02291861|63011710|FG003|Overall Study|Death|1|||
33611249|NCT02291861|63011707|FG000|Overall Study|Protocol Violation|1|||
33611250|NCT02291861|63011708|FG001|Overall Study|Protocol Violation|0|||
33611251|NCT02291861|63011709|FG002|Overall Study|Protocol Violation|0|||
33611252|NCT02291861|63011710|FG003|Overall Study|Protocol Violation|1|||
33611253|NCT02291861|63011707|FG000|Overall Study|Withdrawal by Subject|1|||
33611254|NCT02291861|63011708|FG001|Overall Study|Withdrawal by Subject|2|||
33611255|NCT02291861|63011709|FG002|Overall Study|Withdrawal by Subject|1|||
33611256|NCT02291861|63011710|FG003|Overall Study|Withdrawal by Subject|4|||
33450183|NCT00430781|62824977|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
33450184|NCT00430781|62824975|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
33611257|NCT02291861|63011707|FG000|Overall Study|Noncompliance|1|||
33611258|NCT02291861|63011708|FG001|Overall Study|Noncompliance|1|||
33611259|NCT02291861|63011709|FG002|Overall Study|Noncompliance|2|||
33611260|NCT02291861|63011710|FG003|Overall Study|Noncompliance|1|||
33611261|NCT02291861|63011707|FG000|Overall Study|Lost to Follow-up|2|||
33611262|NCT02291861|63011708|FG001|Overall Study|Lost to Follow-up|1|||
33611263|NCT02291861|63011709|FG002|Overall Study|Lost to Follow-up|4|||
33611264|NCT02291861|63011710|FG003|Overall Study|Lost to Follow-up|0|||
33611265|NCT02291861|63011707|FG000|Overall Study|Other|0|||
33611266|NCT02291861|63011708|FG001|Overall Study|Other|0|||
33611267|NCT02291861|63011709|FG002|Overall Study|Other|0|||
33611268|NCT02291861|63011710|FG003|Overall Study|Other|1|||
33611269|NCT02291549|63011722|FG000|Overall Study|Lost to Follow-up|1|||
33611270|NCT02291549|63011723|FG001|Overall Study|Lost to Follow-up|0|||
33611271|NCT02291549|63011722|FG000|Overall Study|Withdrawal by Subject|0|||
33611272|NCT02291549|63011723|FG001|Overall Study|Withdrawal by Subject|1|||
33611273|NCT02264990|63011733|FG000|Overall Study|Death|255|||
33611274|NCT02264990|63011734|FG001|Overall Study|Death|250|||
33611275|NCT02264990|63011733|FG000|Overall Study|Withdrawal by Subject|4|||
33611276|NCT02264990|63011734|FG001|Overall Study|Withdrawal by Subject|5|||
33611277|NCT02264990|63011733|FG000|Overall Study|Lost to Follow-up|1|||
33611278|NCT02264990|63011734|FG001|Overall Study|Lost to Follow-up|3|||
33611279|NCT02264990|63011733|FG000|Overall Study|Other|0|||
33611280|NCT02264990|63011734|FG001|Overall Study|Other|1|||
33611281|NCT02291237|63011743|FG000|Overall Study|Study Terminated by Sponsor|72|||
33611282|NCT02291237|63011744|FG001|Overall Study|Study Terminated by Sponsor|67|||
33611283|NCT02291237|63011743|FG000|Overall Study|Adverse Event|1|||
33611284|NCT02291237|63011744|FG001|Overall Study|Adverse Event|3|||
33611285|NCT02291237|63011743|FG000|Overall Study|Investigator's Discretion|0|||
33611286|NCT02291237|63011744|FG001|Overall Study|Investigator's Discretion|3|||
33611287|NCT02291237|63011743|FG000|Overall Study|Withdrew Consent|11|||
33611288|NCT02291237|63011744|FG001|Overall Study|Withdrew Consent|11|||
33611289|NCT02291237|63011743|FG000|Overall Study|Lost to Follow-up|0|||
33611290|NCT02291237|63011744|FG001|Overall Study|Lost to Follow-up|2|||
33611291|NCT02291237|63011743|FG000|Overall Study|Subject Required Prohibited Medication|2|||
33611292|NCT02291237|63011744|FG001|Overall Study|Subject Required Prohibited Medication|0|||
33611293|NCT02292446|63011750|FG000|Overall Study|Adverse Event|12|||
33611294|NCT02292446|63011750|FG000|Overall Study|Death|1|||
33611295|NCT02292446|63011750|FG000|Overall Study|Disease progression|2|||
33611296|NCT02292446|63011750|FG000|Overall Study|Subject/guardian decision|2|||
33611297|NCT02292446|63011750|FG000|Overall Study|Withdrawal by Subject|3|||
33611298|NCT02290925|63011759|FG000|First Period of Three Months|Lost to Follow-up|2|||
33611299|NCT02290925|63011760|FG001|First Period of Three Months|Lost to Follow-up|1|||
33611300|NCT02290925|63011759|FG000|First Period of Three Months|Death|1|||
33611301|NCT02290925|63011760|FG001|First Period of Three Months|Death|0|||
33611302|NCT02290925|63011759|FG000|First Period of Three Months|Insulin Started|1|||
33611303|NCT02290925|63011760|FG001|First Period of Three Months|Insulin Started|1|||
33611304|NCT02290925|63011759|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
33611305|NCT02290925|63011760|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
33611306|NCT02290925|63011759|FG000|Second Period of 3 Months|insulin started|0|||
33611307|NCT02290925|63011760|FG001|Second Period of 3 Months|insulin started|1|||
33611308|NCT02290691|63011770|FG000|Overall Study|Noncompliance|0|||
33611309|NCT02290691|63011771|FG001|Overall Study|Noncompliance|1|||
33611310|NCT02290691|63011770|FG000|Overall Study|Withdrawal by Subject|1|||
33611311|NCT02290691|63011771|FG001|Overall Study|Withdrawal by Subject|1|||
33611312|NCT02290691|63011770|FG000|Overall Study|Lost to Follow-up|7|||
33611313|NCT02290691|63011771|FG001|Overall Study|Lost to Follow-up|7|||
33611314|NCT02292212|63011777|FG000|ViE Phase|Withdrawal by Subject|1|||
33611315|NCT02292212|63011777|FG000|ViE Phase|Protocol Violation|2|||
33611316|NCT02291510|63011792|FG000|Overall Study|Adverse Event|0|||
33611317|NCT02291510|63011793|FG001|Overall Study|Adverse Event|0|||
33611318|NCT02291510|63011794|FG002|Overall Study|Adverse Event|0|||
33611319|NCT02291510|63011795|FG003|Overall Study|Adverse Event|1|||
33611320|NCT02290223|63011807|FG000|6 Months|Lost to Follow-up|9|||
33611321|NCT02290223|63011808|FG001|6 Months|Lost to Follow-up|6|||
33611322|NCT02290223|63011807|FG000|6 Months|Withdrawal by Subject|5|||
33611323|NCT02290223|63011808|FG001|6 Months|Withdrawal by Subject|0|||
33611324|NCT02290223|63011807|FG000|6 Months|deceased (not related to study)|2|||
33611325|NCT02290223|63011808|FG001|6 Months|deceased (not related to study)|0|||
33611326|NCT02290223|63011807|FG000|12 Months|Lost to Follow-up|16|||
33611327|NCT02290223|63011808|FG001|12 Months|Lost to Follow-up|10|||
33611328|NCT02290223|63011807|FG000|12 Months|Refusal|0|||
33611329|NCT02290223|63011808|FG001|12 Months|Refusal|1|||
33611330|NCT02289833|63011816|FG000|Overall Study|Study discontinuation|0|||
33611331|NCT02289833|63011817|FG001|Overall Study|Study discontinuation|1|||
33611332|NCT02289833|63011816|FG000|Overall Study|Lost to Follow-up|4|||
33611333|NCT02289833|63011817|FG001|Overall Study|Lost to Follow-up|0|||
33611334|NCT02289833|63011816|FG000|Overall Study|Death|23|||
33611335|NCT02289833|63011817|FG001|Overall Study|Death|16|||
33611336|NCT01702558|63011830|FG000|Overall Study|Withdrawal by Subject|0|||
33611337|NCT01702558|63011831|FG001|Overall Study|Withdrawal by Subject|0|||
33611338|NCT01702558|63011832|FG002|Overall Study|Withdrawal by Subject|0|||
33611339|NCT01702558|63011833|FG003|Overall Study|Withdrawal by Subject|12|||
33611340|NCT01702558|63011834|FG004|Overall Study|Withdrawal by Subject|4|||
33611341|NCT01702558|63011830|FG000|Overall Study|Lost to Follow-up|0|||
33611342|NCT01702558|63011831|FG001|Overall Study|Lost to Follow-up|0|||
33611343|NCT01702558|63011832|FG002|Overall Study|Lost to Follow-up|0|||
33611344|NCT01702558|63011833|FG003|Overall Study|Lost to Follow-up|3|||
33611345|NCT01702558|63011834|FG004|Overall Study|Lost to Follow-up|0|||
33611346|NCT01702558|63011830|FG000|Overall Study|Death|4|||
33611347|NCT01702558|63011831|FG001|Overall Study|Death|3|||
33611348|NCT01702558|63011832|FG002|Overall Study|Death|3|||
33611349|NCT01702558|63011833|FG003|Overall Study|Death|16|||
33611350|NCT01702558|63011834|FG004|Overall Study|Death|20|||
33611351|NCT01702558|63011830|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
33611352|NCT01702558|63011831|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
33611353|NCT01702558|63011832|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
33611354|NCT01702558|63011833|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
33611355|NCT01702558|63011834|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
33611356|NCT01702558|63011830|FG000|Overall Study|Study Terminated by Sponsor|0|||
33611357|NCT01702558|63011831|FG001|Overall Study|Study Terminated by Sponsor|1|||
33611358|NCT01702558|63011832|FG002|Overall Study|Study Terminated by Sponsor|0|||
33611359|NCT01702558|63011833|FG003|Overall Study|Study Terminated by Sponsor|0|||
33611360|NCT01702558|63011834|FG004|Overall Study|Study Terminated by Sponsor|1|||
33611361|NCT01702558|63011830|FG000|Overall Study|Other|0|||
33611362|NCT01702558|63011831|FG001|Overall Study|Other|0|||
33611363|NCT01702558|63011832|FG002|Overall Study|Other|0|||
33611364|NCT01702558|63011833|FG003|Overall Study|Other|16|||
33611365|NCT01702558|63011834|FG004|Overall Study|Other|17|||
33611366|NCT02287883|63011849|FG000|Overall Study|Death|8|||
33611367|NCT02287883|63011850|FG001|Overall Study|Death|7|||
33611368|NCT02287883|63011849|FG000|Overall Study|No longer eligible|222|||
33611369|NCT02287883|63011850|FG001|Overall Study|No longer eligible|182|||
33611370|NCT02287883|63011849|FG000|Overall Study|Non-response to survey|229|||
33611371|NCT02287883|63011850|FG001|Overall Study|Non-response to survey|237|||
33611372|NCT01743040|63011856|FG000|Overall Study|Death|1|||
33611373|NCT01743040|63011856|FG000|Overall Study|Lost to Follow-up|66|||
33611374|NCT01743040|63011856|FG000|Overall Study|Physician Decision|40|||
33611375|NCT01743040|63011856|FG000|Overall Study|Protocol Violation|1|||
33611376|NCT01743040|63011856|FG000|Overall Study|Withdrawal by Subject|121|||
33611377|NCT02194465|63011867|FG000|Overall Study|Adverse Event|6|||
33611378|NCT02194465|63011868|FG001|Overall Study|Adverse Event|1|||
33611379|NCT02194465|63011869|FG002|Overall Study|Adverse Event|4|||
33611380|NCT02194465|63011870|FG003|Overall Study|Adverse Event|4|||
33611381|NCT02194465|63011871|FG004|Overall Study|Adverse Event|4|||
33611382|NCT02194465|63011872|FG005|Overall Study|Adverse Event|2|||
33611383|NCT02194465|63011873|FG006|Overall Study|Adverse Event|0|||
33611384|NCT02194465|63011867|FG000|Overall Study|Lost to Follow-up|0|||
33611385|NCT02194465|63011868|FG001|Overall Study|Lost to Follow-up|0|||
33611386|NCT02194465|63011869|FG002|Overall Study|Lost to Follow-up|0|||
33611387|NCT02194465|63011870|FG003|Overall Study|Lost to Follow-up|1|||
33611388|NCT02194465|63011871|FG004|Overall Study|Lost to Follow-up|0|||
33611389|NCT02194465|63011872|FG005|Overall Study|Lost to Follow-up|1|||
33611390|NCT02194465|63011873|FG006|Overall Study|Lost to Follow-up|0|||
33611391|NCT02194465|63011867|FG000|Overall Study|Physician Decision|1|||
33611392|NCT02194465|63011868|FG001|Overall Study|Physician Decision|0|||
33611393|NCT02194465|63011869|FG002|Overall Study|Physician Decision|0|||
33611394|NCT02194465|63011870|FG003|Overall Study|Physician Decision|0|||
33611395|NCT02194465|63011871|FG004|Overall Study|Physician Decision|0|||
33611396|NCT02194465|63011872|FG005|Overall Study|Physician Decision|0|||
33611397|NCT02194465|63011873|FG006|Overall Study|Physician Decision|0|||
33611398|NCT02194465|63011867|FG000|Overall Study|Protocol Violation|1|||
33611399|NCT02194465|63011868|FG001|Overall Study|Protocol Violation|1|||
33611400|NCT02194465|63011869|FG002|Overall Study|Protocol Violation|2|||
33611401|NCT02194465|63011870|FG003|Overall Study|Protocol Violation|1|||
33611402|NCT02194465|63011871|FG004|Overall Study|Protocol Violation|1|||
33450185|NCT00430781|62824976|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
33450186|NCT00430781|62824977|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
33611403|NCT02194465|63011872|FG005|Overall Study|Protocol Violation|0|||
33611404|NCT02194465|63011873|FG006|Overall Study|Protocol Violation|0|||
33611405|NCT02194465|63011867|FG000|Overall Study|Withdrawal by Subject|1|||
33611406|NCT02194465|63011868|FG001|Overall Study|Withdrawal by Subject|3|||
33611407|NCT02194465|63011869|FG002|Overall Study|Withdrawal by Subject|1|||
33611408|NCT02194465|63011870|FG003|Overall Study|Withdrawal by Subject|2|||
33611409|NCT02194465|63011871|FG004|Overall Study|Withdrawal by Subject|2|||
33611410|NCT02194465|63011872|FG005|Overall Study|Withdrawal by Subject|1|||
33611411|NCT02194465|63011873|FG006|Overall Study|Withdrawal by Subject|2|||
33611412|NCT02194465|63011867|FG000|Overall Study|Discontinued follow-up period|0|||
33611413|NCT02194465|63011868|FG001|Overall Study|Discontinued follow-up period|2|||
33611414|NCT02194465|63011869|FG002|Overall Study|Discontinued follow-up period|1|||
33611415|NCT02194465|63011870|FG003|Overall Study|Discontinued follow-up period|0|||
33611416|NCT02194465|63011871|FG004|Overall Study|Discontinued follow-up period|2|||
33611417|NCT02194465|63011872|FG005|Overall Study|Discontinued follow-up period|0|||
33611418|NCT02194465|63011873|FG006|Overall Study|Discontinued follow-up period|0|||
33611419|NCT02287025|63011895|FG000|Overall Study|Not treated|2|||
33611420|NCT02287025|63011896|FG001|Overall Study|Not treated|0|||
33611421|NCT02287025|63011895|FG000|Overall Study|Progression of disease|3|||
33611422|NCT02287025|63011896|FG001|Overall Study|Progression of disease|2|||
33611423|NCT02287025|63011895|FG000|Overall Study|Adverse Event|2|||
33611424|NCT02287025|63011896|FG001|Overall Study|Adverse Event|4|||
33611425|NCT02287025|63011895|FG000|Overall Study|Withdrawal by Subject|2|||
33611426|NCT02287025|63011896|FG001|Overall Study|Withdrawal by Subject|2|||
33611427|NCT02287025|63011895|FG000|Overall Study|Screening failed|1|||
33611428|NCT02287025|63011896|FG001|Overall Study|Screening failed|1|||
33611429|NCT01720264|63011900|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
33611430|NCT01720264|63011900|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
33611431|NCT01720264|63011900|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
33611432|NCT01702246|63011904|FG000|Overall Study|Lost to Follow-up|2|||
33611433|NCT01702246|63011904|FG000|Overall Study|Withdrawal by Subject|2|||
33611434|NCT01702246|63011904|FG000|Overall Study|Physician Decision|1|||
33611435|NCT01631227|63011913|FG000|Overall Study|withdrawn consent|27|||
33611436|NCT01631227|63011914|FG001|Overall Study|withdrawn consent|21|||
33611437|NCT01631227|63011913|FG000|Overall Study|Adverse Event|1|||
33611438|NCT01631227|63011914|FG001|Overall Study|Adverse Event|0|||
33611439|NCT01631227|63011913|FG000|Overall Study|administrative|2|||
33611440|NCT01631227|63011914|FG001|Overall Study|administrative|1|||
33611441|NCT01719172|63011920|FG000|Overall Study|Lost to Follow-up|1|||
33611442|NCT01719172|63011920|FG000|Overall Study|Death|1|||
33611443|NCT02286947|63011924|FG000|Overall Study|Withdrawal by Subject|2|||
33611444|NCT02286713|63011932|FG000|One Week Follow-Up|Death|1|||
33611445|NCT02286713|63011933|FG001|One Week Follow-Up|Death|0|||
33611446|NCT02286713|63011932|FG000|One Week Follow-Up|Lost to Follow-up|17|||
33611447|NCT02286713|63011933|FG001|One Week Follow-Up|Lost to Follow-up|21|||
33611448|NCT02286713|63011932|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
33611449|NCT02286713|63011933|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
33611450|NCT02286713|63011932|FG000|Three Month Follow-Up|Death|1|||
33611451|NCT02286713|63011933|FG001|Three Month Follow-Up|Death|1|||
33611452|NCT02286713|63011932|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
33611453|NCT02286713|63011933|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
33611454|NCT02286713|63011932|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
33611455|NCT02286713|63011933|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
33611456|NCT02286713|63011932|FG000|Six Month Follow-Up|Death|2|||
33611457|NCT02286713|63011933|FG001|Six Month Follow-Up|Death|0|||
33611458|NCT02286713|63011932|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
33611459|NCT02286713|63011933|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
33611460|NCT02285855|63011941|FG000|Overall Study|Withdrawal by Subject|2|||
33450187|NCT00430781|62824975|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
33450188|NCT00430781|62824976|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
33450189|NCT00430781|62824977|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
33450190|NCT00430781|62824975|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
33450191|NCT00430781|62824976|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
33450192|NCT00430781|62824977|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
33450193|NCT00430781|62824975|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
33450194|NCT00430781|62824976|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
33611461|NCT02285855|63011942|FG001|Overall Study|Withdrawal by Subject|1|||
33611462|NCT02285777|63011950|FG000|Overall Study|Withdrawal by Subject|1|||
33611463|NCT02285777|63011951|FG001|Overall Study|Withdrawal by Subject|1|||
33611464|NCT02285777|63011950|FG000|Overall Study|Lost to Follow-up|4|||
33450195|NCT00430781|62824977|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
33450196|NCT00430781|62824975|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
33450197|NCT00430781|62824976|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
33450198|NCT00430781|62824977|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
33450199|NCT00430781|62824975|FG000|Interim Analysis; 11 February 2008|Death|0|||
33450200|NCT00430781|62824976|FG001|Interim Analysis; 11 February 2008|Death|1|||
33450201|NCT00430781|62824977|FG002|Interim Analysis; 11 February 2008|Death|0|||
33450202|NCT00430781|62824975|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
33450203|NCT00430781|62824976|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
33450204|NCT00430781|62824977|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
33450205|NCT00430781|62824975|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
33450206|NCT00430781|62824976|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
33450207|NCT00430781|62824977|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
33450208|NCT00430781|62824975|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
33450209|NCT00430781|62824976|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
33450210|NCT00430781|62824977|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
33450211|NCT00430781|62824975|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
33450212|NCT00430781|62824976|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
33450213|NCT00430781|62824977|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
33611465|NCT02285777|63011951|FG001|Overall Study|Lost to Follow-up|2|||
33611466|NCT02285153|63011959|FG000|Overall Study|Adverse Event|1|||
33611467|NCT02285153|63011960|FG001|Overall Study|Adverse Event|0|||
33611468|NCT02284373|63011969|FG000|Overall Study|Withdrawal by Subject|0|||
33611469|NCT02284373|63011970|FG001|Overall Study|Withdrawal by Subject|1|||
33611470|NCT02284373|63011971|FG002|Overall Study|Withdrawal by Subject|0|||
33611471|NCT02284373|63011969|FG000|Overall Study|Other|0|||
33611472|NCT02284373|63011970|FG001|Overall Study|Other|1|||
33611473|NCT02284373|63011971|FG002|Overall Study|Other|0|||
33611474|NCT02284373|63011969|FG000|Overall Study|Lost to Follow-up|0|||
33611475|NCT02284373|63011970|FG001|Overall Study|Lost to Follow-up|1|||
33611476|NCT02284373|63011971|FG002|Overall Study|Lost to Follow-up|0|||
33611477|NCT01632241|63011981|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
33611478|NCT01632241|63011982|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
33611479|NCT01632241|63011981|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
33611480|NCT01632241|63011982|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
33611481|NCT01632241|63011981|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
33611482|NCT01632241|63011982|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
33611483|NCT01632241|63011981|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
33611484|NCT01632241|63011982|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
33611485|NCT01632241|63011981|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
33611486|NCT01632241|63011982|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
33611487|NCT01632241|63011981|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
33611488|NCT01632241|63011982|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
33611489|NCT01632241|63011981|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
33611490|NCT01632241|63011982|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
33611491|NCT01632241|63011981|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
33611492|NCT01632241|63011982|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
33611493|NCT01632241|63011981|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
33611494|NCT01632241|63011982|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
33611495|NCT01632241|63011981|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
33611496|NCT01632241|63011982|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
33611497|NCT01632241|63011981|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
33611498|NCT01632241|63011982|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
33611499|NCT01632241|63011981|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
33611500|NCT01632241|63011982|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
33611501|NCT01632241|63011981|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
33611502|NCT01632241|63011982|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
33611503|NCT01632241|63011981|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
33611504|NCT01632241|63011982|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
33611505|NCT02263508|63011997|FG000|Overall Study|Withdrawal by Subject|1|||
33611506|NCT02263508|63011998|FG001|Overall Study|Withdrawal by Subject|23|||
33611507|NCT02263508|63011999|FG002|Overall Study|Withdrawal by Subject|17|||
33611508|NCT02263508|63011997|FG000|Overall Study|Sponsor Decision|12|||
33611509|NCT02263508|63011998|FG001|Overall Study|Sponsor Decision|165|||
33611510|NCT02263508|63011999|FG002|Overall Study|Sponsor Decision|182|||
33611511|NCT02263508|63011997|FG000|Overall Study|Lost to Follow-up|2|||
33611512|NCT02263508|63011998|FG001|Overall Study|Lost to Follow-up|7|||
33611513|NCT02263508|63011999|FG002|Overall Study|Lost to Follow-up|7|||
33611514|NCT02263508|63011997|FG000|Overall Study|Death|6|||
33505357|NCT04228445|62887185|FG000|Overall Study|Physician Decision|1|||
33505358|NCT04228445|62887186|FG001|Overall Study|Physician Decision|2|||
33611515|NCT02263508|63011998|FG001|Overall Study|Death|151|||
33611516|NCT02263508|63011999|FG002|Overall Study|Death|140|||
33611517|NCT02291432|63012010|FG000|Overall Study|Withdrawal by Subject|2|||
33611518|NCT02290340|63012018|FG000|Overall Study|Lost to Follow-up|0|||
33611519|NCT02290340|63012019|FG001|Overall Study|Lost to Follow-up|0|||
33611520|NCT02290340|63012020|FG002|Overall Study|Lost to Follow-up|0|||
33611521|NCT02290340|63012021|FG003|Overall Study|Lost to Follow-up|1|||
33611522|NCT02290340|63012018|FG000|Overall Study|Withdrawal by Subject|1|||
33611523|NCT02290340|63012019|FG001|Overall Study|Withdrawal by Subject|0|||
33611524|NCT02290340|63012020|FG002|Overall Study|Withdrawal by Subject|0|||
33611525|NCT02290340|63012021|FG003|Overall Study|Withdrawal by Subject|0|||
33611526|NCT02290340|63012018|FG000|Overall Study|Other|1|||
33611527|NCT02290340|63012019|FG001|Overall Study|Other|0|||
33611528|NCT02290340|63012020|FG002|Overall Study|Other|0|||
33611529|NCT02290340|63012021|FG003|Overall Study|Other|1|||
33611530|NCT02290028|63012034|FG000|Overall Study|Death|217|||
33611531|NCT02290028|63012034|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
33611532|NCT02290028|63012034|FG000|Overall Study|No longer under care of study physician|76|||
33611533|NCT02290028|63012034|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
33611534|NCT02290028|63012034|FG000|Overall Study|Withdrawal by Subject|52|||
33611535|NCT02290028|63012034|FG000|Overall Study|Study site closure|44|||
33611536|NCT02290028|63012034|FG000|Overall Study|Lost to Follow-up|34|||
33611537|NCT02290028|63012034|FG000|Overall Study|Miscellaneous|10|||
33611538|NCT02290028|63012034|FG000|Overall Study|Transition to EP PASSION|1295|||
33611539|NCT02290028|63012034|FG000|Overall Study|Planned study completion at 12 months|257|||
33611540|NCT01741792|63012044|FG000|Overall Study|Death|6|||
33611541|NCT01741792|63012045|FG001|Overall Study|Death|1|||
33611542|NCT01741792|63012046|FG002|Overall Study|Death|12|||
33611543|NCT02289950|63012062|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
33611544|NCT02289950|63012063|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
33611545|NCT02289950|63012062|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
33611546|NCT02289950|63012063|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
33611547|NCT02289950|63012062|FG000|Overall Study|Lost to Follow-up|1|||
33611548|NCT02289950|63012063|FG001|Overall Study|Lost to Follow-up|0|||
33611549|NCT02289950|63012062|FG000|Overall Study|Physician Decision|9|||
33611550|NCT02289950|63012063|FG001|Overall Study|Physician Decision|3|||
33611551|NCT02289950|63012062|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
33611552|NCT02289950|63012063|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
33611553|NCT02289950|63012062|FG000|Overall Study|Withdrawal by Subject|1|||
33611554|NCT02289950|63012063|FG001|Overall Study|Withdrawal by Subject|3|||
33611555|NCT02289950|63012062|FG000|Overall Study|Test article held for greater than 28 days|0|||
33611556|NCT02289950|63012063|FG001|Overall Study|Test article held for greater than 28 days|1|||
33611557|NCT02289950|63012062|FG000|Overall Study|Adverse Event|11|||
33611558|NCT02289950|63012063|FG001|Overall Study|Adverse Event|3|||
33611559|NCT02289950|63012062|FG000|Overall Study|Death|1|||
33611560|NCT02289950|63012063|FG001|Overall Study|Death|1|||
33611561|NCT02289950|63012062|FG000|Overall Study|Other|5|||
33611562|NCT02289950|63012063|FG001|Overall Study|Other|2|||
33611563|NCT02289950|63012062|FG000|Overall Study|Not Treated|2|||
33611564|NCT02289950|63012063|FG001|Overall Study|Not Treated|1|||
33611565|NCT01741012|63012069|FG000|Overall Study|Lost to Follow-up|1|||
33611566|NCT01741012|63012069|FG000|Overall Study|Withdrawal by Subject|2|||
33611567|NCT02288312|63012077|FG000|Overall Study|Pregnancy|1|||
33611568|NCT02288312|63012078|FG001|Overall Study|Pregnancy|0|||
33611569|NCT02288312|63012079|FG002|Overall Study|Pregnancy|0|||
33611570|NCT01740388|63012089|FG000|Overall Study|Withdrawal by Subject|1|||
33611571|NCT01740388|63012090|FG001|Overall Study|Withdrawal by Subject|2|||
33611572|NCT01740388|63012089|FG000|Overall Study|Lost to Follow-up|2|||
33611573|NCT01740388|63012090|FG001|Overall Study|Lost to Follow-up|0|||
33611574|NCT01740388|63012089|FG000|Overall Study|Physician Decision|2|||
33611575|NCT01740388|63012090|FG001|Overall Study|Physician Decision|6|||
33611576|NCT01740388|63012089|FG000|Overall Study|Subjects missing data, completed|41|||
33611577|NCT01740388|63012090|FG001|Overall Study|Subjects missing data, completed|36|||
33611578|NCT01740154|63012096|FG000|Overall Study|Adverse Event|1|||
33611579|NCT02287922|63012104|FG000|Overall Study|Adverse Event|1|||
33611580|NCT02287922|63012105|FG001|Overall Study|Adverse Event|1|||
33611581|NCT02287922|63012106|FG002|Overall Study|Adverse Event|3|||
33611582|NCT02287922|63012107|FG003|Overall Study|Adverse Event|4|||
33611583|NCT02287922|63012104|FG000|Overall Study|Withdrawal by Subject|1|||
33611584|NCT02287922|63012105|FG001|Overall Study|Withdrawal by Subject|1|||
33450214|NCT00430781|62824975|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
33611585|NCT02287922|63012106|FG002|Overall Study|Withdrawal by Subject|1|||
33611586|NCT02287922|63012107|FG003|Overall Study|Withdrawal by Subject|2|||
33611587|NCT02287922|63012104|FG000|Overall Study|Lost to Follow-up|0|||
33611588|NCT02287922|63012105|FG001|Overall Study|Lost to Follow-up|0|||
33611589|NCT02287922|63012106|FG002|Overall Study|Lost to Follow-up|1|||
33611590|NCT02287922|63012107|FG003|Overall Study|Lost to Follow-up|0|||
33611591|NCT02287922|63012104|FG000|Overall Study|Sponsor's decision|0|||
33611592|NCT02287922|63012105|FG001|Overall Study|Sponsor's decision|0|||
33611593|NCT02287922|63012106|FG002|Overall Study|Sponsor's decision|0|||
33611594|NCT02287922|63012107|FG003|Overall Study|Sponsor's decision|1|||
33611595|NCT02287922|63012104|FG000|Overall Study|Other|1|||
33611596|NCT02287922|63012105|FG001|Overall Study|Other|0|||
33611597|NCT02287922|63012106|FG002|Overall Study|Other|2|||
33611598|NCT02287922|63012107|FG003|Overall Study|Other|0|||
33611599|NCT02287610|63012118|FG000|Overall Study|Lost to Follow-up|3|||
33611600|NCT02287610|63012118|FG000|Overall Study|Withdrawal by Subject|8|||
33611601|NCT02287610|63012118|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
33611602|NCT02262728|63012124|FG000|Follow-up Phase (3 Years)|Death|0|||
33611603|NCT02262728|63012125|FG001|Follow-up Phase (3 Years)|Death|1|||
33611604|NCT02262728|63012124|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
33611605|NCT02262728|63012125|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
33611606|NCT02262728|63012124|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
33611607|NCT02262728|63012125|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
33611608|NCT02262260|63012133|FG000|Overall Study|Adverse Event|4|||
33611609|NCT02262260|63012134|FG001|Overall Study|Adverse Event|1|||
33611610|NCT02262260|63012133|FG000|Overall Study|Withdrawal of consent|4|||
33611611|NCT02262260|63012134|FG001|Overall Study|Withdrawal of consent|2|||
33611612|NCT02262260|63012133|FG000|Overall Study|Lost to Follow-up|1|||
33611613|NCT02262260|63012134|FG001|Overall Study|Lost to Follow-up|2|||
33611614|NCT02262260|63012133|FG000|Overall Study|Protocol deviation|2|||
33611615|NCT02262260|63012134|FG001|Overall Study|Protocol deviation|5|||
33611616|NCT02285270|63012140|FG000|Overall Study|Lost to Follow-up|1|||
33611617|NCT02285270|63012140|FG000|Overall Study|Physician Decision|3|||
33611618|NCT02285270|63012140|FG000|Overall Study|Determined to be ineligible|1|||
33611619|NCT01717768|63012154|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33611620|NCT01717768|63012155|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
33611621|NCT01717768|63012156|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33611622|NCT01717768|63012157|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33611623|NCT01717768|63012158|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33611624|NCT01717768|63012159|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33611625|NCT01717768|63012160|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33611626|NCT01717768|63012161|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33611627|NCT01717768|63012162|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33611628|NCT01717768|63012163|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33611629|NCT01717768|63012164|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33611630|NCT01717768|63012165|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33611631|NCT01717768|63012154|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33611632|NCT01717768|63012155|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33611633|NCT01717768|63012156|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33611634|NCT01717768|63012157|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33611635|NCT01717768|63012158|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33611636|NCT01717768|63012159|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33611637|NCT01717768|63012160|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33611638|NCT01717768|63012161|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33611639|NCT01717768|63012162|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33611640|NCT01717768|63012163|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33611641|NCT01717768|63012164|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33611642|NCT01717768|63012165|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
33505359|NCT04228445|62887185|FG000|Overall Study|Withdrawal by Subject|0|||
33505360|NCT04228445|62887186|FG001|Overall Study|Withdrawal by Subject|1|||
33505361|NCT04228445|62887185|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
33505362|NCT04228445|62887186|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
33505363|NCT04641299|62887198|FG000|Overall Study|Adverse Event|0|||
33505364|NCT04641299|62887199|FG001|Overall Study|Adverse Event|0|||
33505365|NCT04641299|62887200|FG002|Overall Study|Adverse Event|2|||
33505366|NCT04641299|62887201|FG003|Overall Study|Adverse Event|0|||
33505367|NCT04641299|62887198|FG000|Overall Study|Lost to Follow-up|0|||
33505368|NCT04641299|62887199|FG001|Overall Study|Lost to Follow-up|1|||
33505369|NCT04641299|62887200|FG002|Overall Study|Lost to Follow-up|0|||
33505370|NCT04641299|62887201|FG003|Overall Study|Lost to Follow-up|0|||
33611643|NCT01717768|63012154|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33611644|NCT01717768|63012155|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33611645|NCT01717768|63012156|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33611646|NCT01717768|63012157|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33611647|NCT01717768|63012158|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33611648|NCT01717768|63012159|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33611649|NCT01717768|63012160|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33611650|NCT01717768|63012161|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
33611651|NCT01717768|63012162|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33611652|NCT01717768|63012163|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33611653|NCT01717768|63012164|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33611654|NCT01717768|63012165|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33611655|NCT01717768|63012154|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33611656|NCT01717768|63012155|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33611657|NCT01717768|63012156|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33611658|NCT01717768|63012157|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33611659|NCT01717768|63012158|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33611660|NCT01717768|63012159|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33611661|NCT01717768|63012160|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33611662|NCT01717768|63012161|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33611663|NCT01717768|63012162|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33611664|NCT01717768|63012163|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
33611665|NCT01717768|63012164|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33611666|NCT01717768|63012165|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33611667|NCT02260934|63012193|FG000|Overall Study|Lost to Follow-up|2|||
33611668|NCT02260934|63012194|FG001|Overall Study|Lost to Follow-up|1|||
33611669|NCT02260934|63012193|FG000|Overall Study|Withdrawal by Subject|0|||
33611670|NCT02260934|63012194|FG001|Overall Study|Withdrawal by Subject|2|||
33611671|NCT02260934|63012193|FG000|Overall Study|Participant Relocated|1|||
33611672|NCT02260934|63012194|FG001|Overall Study|Participant Relocated|0|||
33611673|NCT02260934|63012193|FG000|Overall Study|Site error|0|||
33611674|NCT02260934|63012194|FG001|Overall Study|Site error|1|||
33611675|NCT02260388|63012211|FG000|Overall Study|Lost to Follow-up|2|||
33611676|NCT02260388|63012212|FG001|Overall Study|Lost to Follow-up|8|||
33611677|NCT02260388|63012213|FG002|Overall Study|Lost to Follow-up|3|||
33611678|NCT02260388|63012214|FG003|Overall Study|Lost to Follow-up|4|||
33611679|NCT02260154|63012224|FG000|Overall Study|Screening failure|2|||
33611680|NCT02284178|63012231|FG000|Overall Study|Met exclusion criteria|49|||
33611681|NCT02284178|63012232|FG001|Overall Study|Met exclusion criteria|54|||
33611682|NCT01643408|63012238|FG000|Overall Study|Adverse Event|12|||
33611683|NCT01643408|63012238|FG000|Overall Study|Other|2|||
33611684|NCT02283788|63012246|FG000|Overall Study|Adverse Event|1|||
33611685|NCT02283788|63012247|FG001|Overall Study|Adverse Event|3|||
33611686|NCT02283788|63012248|FG002|Overall Study|Adverse Event|5|||
33611687|NCT02283788|63012249|FG003|Overall Study|Adverse Event|1|||
33611688|NCT02283788|63012246|FG000|Overall Study|Withdrawal by Subject|0|||
33611689|NCT02283788|63012247|FG001|Overall Study|Withdrawal by Subject|1|||
33611690|NCT02283788|63012248|FG002|Overall Study|Withdrawal by Subject|0|||
33611691|NCT02283788|63012249|FG003|Overall Study|Withdrawal by Subject|1|||
33611692|NCT01739764|63012262|FG000|Overall Study|Adverse Event|0|||
33611693|NCT01739764|63012263|FG001|Overall Study|Adverse Event|3|||
33611694|NCT01739764|63012264|FG002|Overall Study|Adverse Event|4|||
33611695|NCT01739764|63012262|FG000|Overall Study|Death|4|||
33611696|NCT01739764|63012263|FG001|Overall Study|Death|6|||
33611697|NCT01739764|63012264|FG002|Overall Study|Death|38|||
33611698|NCT01739764|63012262|FG000|Overall Study|Lost to Follow-up|0|||
33611699|NCT01739764|63012263|FG001|Overall Study|Lost to Follow-up|0|||
33611700|NCT01739764|63012264|FG002|Overall Study|Lost to Follow-up|5|||
33611701|NCT01739764|63012262|FG000|Overall Study|Non-Compliance|0|||
33611702|NCT01739764|63012263|FG001|Overall Study|Non-Compliance|0|||
33611703|NCT01739764|63012264|FG002|Overall Study|Non-Compliance|1|||
33611704|NCT01739764|63012262|FG000|Overall Study|Multiple Reasons|3|||
33611705|NCT01739764|63012263|FG001|Overall Study|Multiple Reasons|2|||
33611706|NCT01739764|63012264|FG002|Overall Study|Multiple Reasons|3|||
33611707|NCT01739764|63012262|FG000|Overall Study|Physician Decision|2|||
33611708|NCT01739764|63012263|FG001|Overall Study|Physician Decision|2|||
33611709|NCT01739764|63012264|FG002|Overall Study|Physician Decision|4|||
33611710|NCT01739764|63012262|FG000|Overall Study|Progressive Disease|3|||
33611711|NCT01739764|63012263|FG001|Overall Study|Progressive Disease|5|||
33611712|NCT01739764|63012264|FG002|Overall Study|Progressive Disease|16|||
33611713|NCT01739764|63012262|FG000|Overall Study|Protocol Violation|0|||
33611714|NCT01739764|63012263|FG001|Overall Study|Protocol Violation|0|||
33611715|NCT01739764|63012264|FG002|Overall Study|Protocol Violation|2|||
33611716|NCT01739764|63012262|FG000|Overall Study|Study Terminated by Sponsor|8|||
33611717|NCT01739764|63012263|FG001|Overall Study|Study Terminated by Sponsor|13|||
33611718|NCT01739764|63012264|FG002|Overall Study|Study Terminated by Sponsor|26|||
33611719|NCT01739764|63012262|FG000|Overall Study|Withdrawal by Subject|6|||
33611720|NCT01739764|63012263|FG001|Overall Study|Withdrawal by Subject|5|||
33611721|NCT01739764|63012264|FG002|Overall Study|Withdrawal by Subject|27|||
33611722|NCT01700530|63012275|FG000|Overall Study|Withdrawal by Subject|0|||
33611723|NCT01700530|63012276|FG001|Overall Study|Withdrawal by Subject|3|||
33611724|NCT01700530|63012277|FG002|Overall Study|Withdrawal by Subject|1|||
33611725|NCT01700140|63012288|FG000|Overall Study|Use of rescue drugs|3|||
33611726|NCT01700140|63012289|FG001|Overall Study|Use of rescue drugs|3|||
33505371|NCT04641299|62887198|FG000|Overall Study|Withdrawal by Subject|1|||
33505372|NCT04641299|62887199|FG001|Overall Study|Withdrawal by Subject|0|||
33505373|NCT04641299|62887200|FG002|Overall Study|Withdrawal by Subject|0|||
33611727|NCT01700140|63012290|FG002|Overall Study|Use of rescue drugs|1|||
33611728|NCT01700140|63012288|FG000|Overall Study|Discontinuation of radiotherapy|1|||
33611729|NCT01700140|63012289|FG001|Overall Study|Discontinuation of radiotherapy|0|||
33611730|NCT01700140|63012290|FG002|Overall Study|Discontinuation of radiotherapy|0|||
33611731|NCT01700140|63012288|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
33611732|NCT01700140|63012289|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
33611733|NCT01700140|63012290|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
33611734|NCT01700140|63012288|FG000|Overall Study|Aggravation of symptoms|1|||
33611735|NCT01700140|63012289|FG001|Overall Study|Aggravation of symptoms|0|||
33611736|NCT01700140|63012290|FG002|Overall Study|Aggravation of symptoms|0|||
33611737|NCT01700140|63012288|FG000|Overall Study|Adverse Event|0|||
33611738|NCT01700140|63012289|FG001|Overall Study|Adverse Event|1|||
33611739|NCT01700140|63012290|FG002|Overall Study|Adverse Event|0|||
33611740|NCT01700140|63012288|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
33611741|NCT01700140|63012289|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
33611742|NCT01700140|63012290|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
33611743|NCT01717456|63012303|FG000|End of Treatment|Physician Decision|0|||
33611744|NCT01717456|63012304|FG001|End of Treatment|Physician Decision|1|||
33611745|NCT01717456|63012303|FG000|End of Treatment|Lost to Follow-up|0|||
33611746|NCT01717456|63012304|FG001|End of Treatment|Lost to Follow-up|1|||
33611747|NCT01717456|63012303|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
33611748|NCT01717456|63012304|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
33611749|NCT01699750|63012313|FG000|Overall Study|Withdrew Consent|0|||
33611750|NCT01699750|63012314|FG001|Overall Study|Withdrew Consent|1|||
33611751|NCT01699750|63012313|FG000|Overall Study|Other|0|||
33611752|NCT01699750|63012314|FG001|Overall Study|Other|2|||
33611753|NCT01716754|63012328|FG000|Overall Study|Death|0|||
33611754|NCT01716754|63012329|FG001|Overall Study|Death|0|||
33611755|NCT01716754|63012330|FG002|Overall Study|Death|0|||
33611756|NCT01716754|63012331|FG003|Overall Study|Death|1|||
33611757|NCT01716754|63012328|FG000|Overall Study|Protocol deviation|0|||
33505374|NCT04641299|62887201|FG003|Overall Study|Withdrawal by Subject|0|||
33611758|NCT01716754|63012329|FG001|Overall Study|Protocol deviation|2|||
33611759|NCT01716754|63012330|FG002|Overall Study|Protocol deviation|7|||
33611760|NCT01716754|63012331|FG003|Overall Study|Protocol deviation|2|||
33611761|NCT01716754|63012328|FG000|Overall Study|Non-compliance with study treatment|0|||
33611762|NCT01716754|63012329|FG001|Overall Study|Non-compliance with study treatment|0|||
33611763|NCT01716754|63012330|FG002|Overall Study|Non-compliance with study treatment|1|||
33611764|NCT01716754|63012331|FG003|Overall Study|Non-compliance with study treatment|0|||
33611765|NCT01716754|63012328|FG000|Overall Study|Physician Decision|1|||
33611766|NCT01716754|63012329|FG001|Overall Study|Physician Decision|0|||
33611767|NCT01716754|63012330|FG002|Overall Study|Physician Decision|0|||
33505375|NCT04641299|62887198|FG000|Overall Study|Reason not given|1|||
33505376|NCT04641299|62887199|FG001|Overall Study|Reason not given|0|||
33505377|NCT04641299|62887200|FG002|Overall Study|Reason not given|0|||
33505378|NCT04641299|62887201|FG003|Overall Study|Reason not given|0|||
33611768|NCT01716754|63012331|FG003|Overall Study|Physician Decision|0|||
33611769|NCT01716754|63012328|FG000|Overall Study|Lost to Follow-up|1|||
33611770|NCT01716754|63012329|FG001|Overall Study|Lost to Follow-up|0|||
33611771|NCT01716754|63012330|FG002|Overall Study|Lost to Follow-up|0|||
33505379|NCT03703817|62887217|FG000|Overall Study|Not meeting eligibility criteria|7|||
33611772|NCT01716754|63012331|FG003|Overall Study|Lost to Follow-up|1|||
33611773|NCT01716754|63012328|FG000|Overall Study|Adverse Event|4|||
33611774|NCT01716754|63012329|FG001|Overall Study|Adverse Event|2|||
33611775|NCT01716754|63012330|FG002|Overall Study|Adverse Event|2|||
33611776|NCT01716754|63012331|FG003|Overall Study|Adverse Event|1|||
33611777|NCT01716754|63012328|FG000|Overall Study|Withdrawal by Subject|5|||
33611778|NCT01716754|63012329|FG001|Overall Study|Withdrawal by Subject|0|||
33611779|NCT01716754|63012330|FG002|Overall Study|Withdrawal by Subject|4|||
33611780|NCT01716754|63012331|FG003|Overall Study|Withdrawal by Subject|3|||
33611781|NCT01698814|63012342|FG000|Overall Study|Adverse Event|0|||
33611782|NCT01698814|63012343|FG001|Overall Study|Adverse Event|2|||
33611783|NCT01698814|63012342|FG000|Overall Study|Lost to Follow-up|0|||
33611784|NCT01698814|63012343|FG001|Overall Study|Lost to Follow-up|1|||
33611785|NCT01698814|63012342|FG000|Overall Study|Pregnancy|1|||
33611786|NCT01698814|63012343|FG001|Overall Study|Pregnancy|0|||
33611787|NCT01698814|63012342|FG000|Overall Study|Randomized in error|1|||
33611788|NCT01698814|63012343|FG001|Overall Study|Randomized in error|0|||
33611789|NCT01738984|63012351|FG000|Overall Study|Pregnancy|4|||
33611790|NCT01738984|63012352|FG001|Overall Study|Pregnancy|0|||
33611791|NCT01738984|63012351|FG000|Overall Study|Withdrawal by Subject|1|||
33611792|NCT01738984|63012352|FG001|Overall Study|Withdrawal by Subject|0|||
33611793|NCT01738984|63012351|FG000|Overall Study|Lost to Follow-up|59|||
33611794|NCT01738984|63012352|FG001|Overall Study|Lost to Follow-up|39|||
33611795|NCT01738594|63012361|FG000|Registration and Treatment Start|Adverse Event|0|||
33611796|NCT01738594|63012362|FG001|Registration and Treatment Start|Adverse Event|1|||
33611797|NCT01738594|63012363|FG002|Registration and Treatment Start|Adverse Event|0|||
33611798|NCT01738594|63012364|FG003|Registration and Treatment Start|Adverse Event|0|||
33611799|NCT01738594|63012365|FG004|Registration and Treatment Start|Adverse Event|0|||
33611800|NCT01738594|63012366|FG005|Registration and Treatment Start|Adverse Event|0|||
33611801|NCT01738594|63012367|FG006|Registration and Treatment Start|Adverse Event|0|||
33611802|NCT01738594|63012368|FG007|Registration and Treatment Start|Adverse Event|0|||
33611803|NCT01738594|63012361|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
33611804|NCT01738594|63012362|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
33611805|NCT01738594|63012363|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
33611806|NCT01738594|63012364|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
33611807|NCT01738594|63012365|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
33611808|NCT01738594|63012366|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
33611809|NCT01738594|63012367|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
33611810|NCT01738594|63012368|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
33611811|NCT01738594|63012361|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
33611812|NCT01738594|63012362|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
33611813|NCT01738594|63012363|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
33611814|NCT01738594|63012364|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
33611815|NCT01738594|63012365|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
33611816|NCT01738594|63012366|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
33611817|NCT01738594|63012367|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
33611818|NCT01738594|63012368|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
33611819|NCT01738594|63012361|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
33611820|NCT01738594|63012362|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
33611821|NCT01738594|63012363|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
33611822|NCT01738594|63012364|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
33611823|NCT01738594|63012365|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
33611824|NCT01738594|63012366|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
33611825|NCT01738594|63012367|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
33611826|NCT01738594|63012368|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
33611827|NCT01738594|63012361|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
33611828|NCT01738594|63012362|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
33611829|NCT01738594|63012363|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
33611830|NCT01738594|63012364|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
33611831|NCT01738594|63012365|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
33611832|NCT01738594|63012366|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
33611833|NCT01738594|63012367|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
33611834|NCT01738594|63012368|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
33611835|NCT01738594|63012361|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
33611836|NCT01738594|63012362|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
33324290|NCT00960531|62700741|FG003|Overall Study|Withdrawal by Subject|2|||
33611837|NCT01738594|63012363|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
33611838|NCT01738594|63012364|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
33611839|NCT01738594|63012365|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
33611840|NCT01738594|63012366|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
33611841|NCT01738594|63012367|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
33611842|NCT01738594|63012368|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
33505380|NCT03703817|62887218|FG001|Overall Study|Not meeting eligibility criteria|4|||
33505381|NCT03698591|62887226|FG000|Overall Study|Withdrawal by Subject|2|||
33505382|NCT03698591|62887227|FG001|Overall Study|Withdrawal by Subject|2|||
33505383|NCT03698591|62887226|FG000|Overall Study|Failed drug screen|1|||
33505384|NCT03698591|62887227|FG001|Overall Study|Failed drug screen|1|||
33505385|NCT03698591|62887226|FG000|Overall Study|Failed health screen|0|||
33505386|NCT03698591|62887227|FG001|Overall Study|Failed health screen|1|||
33505387|NCT03698591|62887226|FG000|Overall Study|Ineligible for financial compensation|1|||
33505388|NCT03698591|62887227|FG001|Overall Study|Ineligible for financial compensation|0|||
33505389|NCT03698591|62887226|FG000|Overall Study|Equipment Error|1|||
33505390|NCT03698591|62887227|FG001|Overall Study|Equipment Error|0|||
33505391|NCT03698591|62887226|FG000|Overall Study|Could not establish TMS dosage|0|||
33505392|NCT03698591|62887227|FG001|Overall Study|Could not establish TMS dosage|1|||
33505393|NCT04606199|62887233|FG000|Overall Study|Withdrawal by Subject|2|||
33505394|NCT05085665|62887239|FG000|Overall Study|Physician Decision|2|||
33505395|NCT05017493|62887245|FG000|Overall Study|Withdrawal by Subject|26|||
33505396|NCT05017493|62887246|FG001|Overall Study|Withdrawal by Subject|0|||
33505397|NCT05017493|62887245|FG000|Overall Study|Physician Decision|15|||
33505398|NCT05017493|62887246|FG001|Overall Study|Physician Decision|0|||
33505399|NCT05017493|62887245|FG000|Overall Study|Protocol Violation|81|||
33505400|NCT05017493|62887246|FG001|Overall Study|Protocol Violation|0|||
33505401|NCT04599803|62887252|FG000|Overall Study|Withdrawal by Subject|5|||
33505402|NCT04599803|62887252|FG000|Overall Study|Lost to Follow-up|26|||
33505403|NCT05002985|62887256|FG000|Overall Study|Withdrawal by Subject|1|||
33505404|NCT04580303|62887262|FG000|Overall Study|Adverse Event|0|||
33505405|NCT04580303|62887263|FG001|Overall Study|Adverse Event|1|||
33505406|NCT04580303|62887264|FG002|Overall Study|Adverse Event|0|||
33505407|NCT04580303|62887265|FG003|Overall Study|Adverse Event|0|||
33505408|NCT04580303|62887262|FG000|Overall Study|Withdrawal by Subject|0|||
33505409|NCT04580303|62887263|FG001|Overall Study|Withdrawal by Subject|0|||
33505410|NCT04580303|62887264|FG002|Overall Study|Withdrawal by Subject|1|||
33505411|NCT04580303|62887265|FG003|Overall Study|Withdrawal by Subject|0|||
33505412|NCT04577183|62887275|FG000|Overall Study|Death|1|||
33505413|NCT04577183|62887275|FG000|Overall Study|Withdrawal by Subject|3|||
33505414|NCT04577183|62887275|FG000|Overall Study|Early termination|2|||
33505415|NCT04574999|62887281|FG000|Overall Study|Adverse Event|1|||
33505416|NCT04574999|62887282|FG001|Overall Study|Adverse Event|0|||
33505417|NCT04574999|62887281|FG000|Overall Study|Lack of Efficacy|2|||
33505418|NCT04574999|62887282|FG001|Overall Study|Lack of Efficacy|3|||
33505419|NCT04574999|62887281|FG000|Overall Study|Protocol Violation|1|||
33505420|NCT04574999|62887282|FG001|Overall Study|Protocol Violation|0|||
33505421|NCT04574999|62887281|FG000|Overall Study|Withdrawal by Subject|2|||
33505422|NCT04574999|62887282|FG001|Overall Study|Withdrawal by Subject|2|||
33505423|NCT04574999|62887281|FG000|Overall Study|Lost to Follow-up|1|||
33505424|NCT04574999|62887282|FG001|Overall Study|Lost to Follow-up|0|||
33505425|NCT04574999|62887281|FG000|Overall Study|Personal problems|1|||
33505426|NCT04574999|62887282|FG001|Overall Study|Personal problems|0|||
33505427|NCT04574999|62887281|FG000|Overall Study|Previous planned surgery|1|||
33505428|NCT04574999|62887282|FG001|Overall Study|Previous planned surgery|0|||
33505429|NCT04565249|62887292|FG000|Overall Study|Death|0|||
33505430|NCT04565249|62887293|FG001|Overall Study|Death|0|||
33505431|NCT04565249|62887294|FG002|Overall Study|Death|0|||
33505432|NCT04565249|62887295|FG003|Overall Study|Death|1|||
33505433|NCT04942925|62887307|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
33505434|NCT04942925|62887308|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
33505435|NCT04942925|62887307|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
33505436|NCT04942925|62887308|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
33505437|NCT04854707|62887320|FG000|Overall Study|Lack of Efficacy|78|||
33505438|NCT04854707|62887321|FG001|Overall Study|Lack of Efficacy|59|||
33505439|NCT04854707|62887322|FG002|Overall Study|Lack of Efficacy|30|||
33505440|NCT04557371|62887337|FG000|Overall Study|Covid-19-related|0|||
33505441|NCT04557371|62887338|FG001|Overall Study|Covid-19-related|1|||
33505442|NCT04557371|62887339|FG002|Overall Study|Covid-19-related|0|||
33505443|NCT04557371|62887337|FG000|Overall Study|Withdrawal by Subject|0|||
33611843|NCT01738594|63012361|FG000|Follow up for 1 Year|Death|0|||
33505444|NCT04557371|62887338|FG001|Overall Study|Withdrawal by Subject|1|||
33505445|NCT04557371|62887339|FG002|Overall Study|Withdrawal by Subject|0|||
33505446|NCT04557371|62887337|FG000|Overall Study|Adverse Event|1|||
33505447|NCT04557371|62887338|FG001|Overall Study|Adverse Event|0|||
33505448|NCT04557371|62887339|FG002|Overall Study|Adverse Event|0|||
33505449|NCT04821245|62887347|FG000|Overall Study|Withdrawal by Subject|3|||
33505450|NCT04821245|62887347|FG000|Overall Study|Physician Decision|1|||
33505451|NCT04821245|62887347|FG000|Overall Study|Protocol Violation|5|||
33505452|NCT04539275|62887355|FG000|Overall Study|Death|2|||
33505453|NCT04539275|62887356|FG001|Overall Study|Death|4|||
33505454|NCT04539275|62887355|FG000|Overall Study|Lost to Follow-up|1|||
33611844|NCT01738594|63012362|FG001|Follow up for 1 Year|Death|0|||
33611845|NCT01738594|63012363|FG002|Follow up for 1 Year|Death|0|||
33611846|NCT01738594|63012364|FG003|Follow up for 1 Year|Death|0|||
33611847|NCT01738594|63012365|FG004|Follow up for 1 Year|Death|0|||
33611848|NCT01738594|63012366|FG005|Follow up for 1 Year|Death|1|||
33611849|NCT01738594|63012367|FG006|Follow up for 1 Year|Death|0|||
33611850|NCT01738594|63012368|FG007|Follow up for 1 Year|Death|0|||
33611851|NCT01738594|63012361|FG000|Follow up for 1 Year|Other|0|||
33611852|NCT01738594|63012362|FG001|Follow up for 1 Year|Other|0|||
33611853|NCT01738594|63012363|FG002|Follow up for 1 Year|Other|0|||
33611854|NCT01738594|63012364|FG003|Follow up for 1 Year|Other|0|||
33611855|NCT01738594|63012365|FG004|Follow up for 1 Year|Other|0|||
33611856|NCT01738594|63012366|FG005|Follow up for 1 Year|Other|2|||
33611857|NCT01738594|63012367|FG006|Follow up for 1 Year|Other|0|||
33611858|NCT01738594|63012368|FG007|Follow up for 1 Year|Other|0|||
33611859|NCT01738438|63012378|FG000|Overall Study|Disease Progression|32|||
33611860|NCT01738438|63012378|FG000|Overall Study|Adverse Event|3|||
33611861|NCT01716520|63012382|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
33505455|NCT04539275|62887356|FG001|Overall Study|Lost to Follow-up|1|||
33505456|NCT04539275|62887355|FG000|Overall Study|Withdrawal by Subject|3|||
33505457|NCT04539275|62887356|FG001|Overall Study|Withdrawal by Subject|0|||
33505458|NCT04784897|62887365|FG000|Overall Study|Death|4|||
33505459|NCT04784897|62887366|FG001|Overall Study|Death|2|||
33505460|NCT04784897|62887367|FG002|Overall Study|Death|1|||
33505461|NCT04784897|62887365|FG000|Overall Study|Withdrawal by Subject|0|||
33505462|NCT04784897|62887366|FG001|Overall Study|Withdrawal by Subject|0|||
33505463|NCT04784897|62887367|FG002|Overall Study|Withdrawal by Subject|1|||
33505464|NCT02780804|62887381|FG000|Overall Study|Death|1|||
33505465|NCT02780804|62887382|FG001|Overall Study|Death|0|||
33505466|NCT02780804|62887383|FG002|Overall Study|Death|0|||
33505467|NCT02780804|62887381|FG000|Overall Study|Lack of Efficacy|5|||
33505468|NCT02780804|62887382|FG001|Overall Study|Lack of Efficacy|8|||
33505469|NCT02780804|62887383|FG002|Overall Study|Lack of Efficacy|4|||
33505470|NCT02780804|62887381|FG000|Overall Study|Physician Decision|0|||
33505471|NCT02780804|62887382|FG001|Overall Study|Physician Decision|0|||
33505472|NCT02780804|62887383|FG002|Overall Study|Physician Decision|2|||
33505473|NCT02780804|62887381|FG000|Overall Study|Withdrawal by Subject|0|||
33505474|NCT02780804|62887382|FG001|Overall Study|Withdrawal by Subject|1|||
33505475|NCT02780804|62887383|FG002|Overall Study|Withdrawal by Subject|0|||
33505476|NCT04537949|62887400|FG000|Overall Study|personal reasons not related to the IMP|1|||
33505477|NCT04537949|62887401|FG001|Overall Study|personal reasons not related to the IMP|0|||
33505478|NCT04537949|62887402|FG002|Overall Study|personal reasons not related to the IMP|0|||
33505479|NCT04537949|62887403|FG003|Overall Study|personal reasons not related to the IMP|0|||
33505480|NCT04537949|62887404|FG004|Overall Study|personal reasons not related to the IMP|0|||
33505481|NCT04537949|62887405|FG005|Overall Study|personal reasons not related to the IMP|0|||
33505482|NCT04537949|62887406|FG006|Overall Study|personal reasons not related to the IMP|0|||
33505483|NCT04537949|62887407|FG007|Overall Study|personal reasons not related to the IMP|0|||
33505484|NCT04532099|62887428|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
33505485|NCT04532099|62887429|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
33505486|NCT04532099|62887430|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
33505487|NCT03041792|62887444|FG000|Overall Study|Adverse Event|4|||
33505488|NCT03041792|62887445|FG001|Overall Study|Adverse Event|0|||
33505489|NCT03041792|62887444|FG000|Overall Study|Death in the family|0|||
33505490|NCT03041792|62887445|FG001|Overall Study|Death in the family|2|||
33505491|NCT03041792|62887444|FG000|Overall Study|Randomized but not treated|0|||
33505492|NCT03041792|62887445|FG001|Overall Study|Randomized but not treated|1|||
33505493|NCT04507763|62887451|FG000|Overall Study|Participants did not meet entrance criteria|201|||
33611862|NCT01716520|63012383|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
33611863|NCT01716520|63012384|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
33611864|NCT01716520|63012385|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
33611865|NCT01716520|63012386|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
33505494|NCT03045302|62887458|FG000|Overall Study|Pre-treatment adverse event|1|||
33505495|NCT00705484|62887464|FG000|Overall Study|Adverse Event|28|||
33505496|NCT00705484|62887465|FG001|Overall Study|Adverse Event|27|||
33505497|NCT00705484|62887464|FG000|Overall Study|Lost to Follow-up|169|||
33505498|NCT00705484|62887465|FG001|Overall Study|Lost to Follow-up|250|||
33505499|NCT00705484|62887464|FG000|Overall Study|Withdrawal by Subject|96|||
33505500|NCT00705484|62887465|FG001|Overall Study|Withdrawal by Subject|72|||
33505501|NCT00705484|62887464|FG000|Overall Study|Administrative|89|||
33505502|NCT00705484|62887465|FG001|Overall Study|Administrative|59|||
33505503|NCT04523831|62887475|FG000|Overall Study|Lost to Follow-up|15|||
33505504|NCT04523831|62887476|FG001|Overall Study|Lost to Follow-up|17|||
33505505|NCT04523831|62887475|FG000|Overall Study|Death|0|||
33505506|NCT04523831|62887476|FG001|Overall Study|Death|3|||
33505507|NCT04523831|62887475|FG000|Overall Study|Adverse Event|2|||
33505508|NCT04523831|62887476|FG001|Overall Study|Adverse Event|0|||
33505509|NCT04707664|62887487|FG000|Overall Study|Adverse Event|2|||
33505510|NCT04707664|62887488|FG001|Overall Study|Adverse Event|0|||
33505511|NCT04707664|62887487|FG000|Overall Study|Death|1|||
33505512|NCT04707664|62887488|FG001|Overall Study|Death|2|||
33505513|NCT04707664|62887487|FG000|Overall Study|Withdrawal by Subject|13|||
33505514|NCT04707664|62887488|FG001|Overall Study|Withdrawal by Subject|21|||
33505515|NCT04707664|62887487|FG000|Overall Study|Lost to Follow-up|11|||
33505516|NCT04707664|62887488|FG001|Overall Study|Lost to Follow-up|13|||
33505517|NCT04707664|62887487|FG000|Overall Study|Not treated|2|||
33505518|NCT04707664|62887488|FG001|Overall Study|Not treated|0|||
33505519|NCT01316276|62887494|FG000|Overall Study|Death|1|||
33450215|NCT00430781|62824976|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
33450216|NCT00430781|62824977|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
33450217|NCT00430781|62824975|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
33450218|NCT00430781|62824976|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
33450219|NCT00430781|62824977|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
33450220|NCT00430781|62824975|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
33450221|NCT00430781|62824976|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
33450222|NCT00430781|62824977|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
33450223|NCT00430781|62824975|FG000|Final Analysis; 31 July 2008|Other|0|||
33450224|NCT00430781|62824976|FG001|Final Analysis; 31 July 2008|Other|1|||
33450225|NCT00430781|62824977|FG002|Final Analysis; 31 July 2008|Other|0|||
33450226|NCT00430781|62824975|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
33450227|NCT00430781|62824976|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
33450228|NCT00430781|62824977|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
33505520|NCT01316276|62887494|FG000|Overall Study|Adverse Event|19|||
33505521|NCT01316276|62887494|FG000|Overall Study|Withdrawal of consent|24|||
33505522|NCT01316276|62887494|FG000|Overall Study|Lost to Follow-up|1|||
33505523|NCT01316276|62887494|FG000|Overall Study|Other|22|||
33505524|NCT04668989|62887499|FG000|First Intervention|Covid-19 related self-isolation|0|||
33505525|NCT04668989|62887500|FG001|First Intervention|Covid-19 related self-isolation|1|||
33450229|NCT00430781|62824975|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
33450230|NCT00430781|62824976|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
33505526|NCT04668989|62887499|FG000|Second Intervention|Adverse Event|0|||
33505527|NCT04668989|62887500|FG001|Second Intervention|Adverse Event|1|||
33505528|NCT03700385|62887506|FG000|Overall Study|Lost to Follow-up|1|||
33505529|NCT04498403|62887512|FG000|Overall Study|Adverse Event|1|||
33505530|NCT04498403|62887513|FG001|Overall Study|Adverse Event|0|||
33505531|NCT04498403|62887512|FG000|Overall Study|Study Terminated By Sponsor|29|||
33505532|NCT04498403|62887513|FG001|Overall Study|Study Terminated By Sponsor|10|||
33505533|NCT04362137|62887521|FG000|Overall Study|Death|9|||
33505534|NCT04362137|62887522|FG001|Overall Study|Death|3|||
33505535|NCT04362137|62887521|FG000|Overall Study|Patient decision|6|||
33505536|NCT04362137|62887522|FG001|Overall Study|Patient decision|3|||
33505537|NCT04362137|62887521|FG000|Overall Study|Adverse Event|1|||
33505538|NCT04362137|62887522|FG001|Overall Study|Adverse Event|0|||
33505539|NCT04362137|62887521|FG000|Overall Study|Lost to Follow-up|1|||
33505540|NCT04362137|62887522|FG001|Overall Study|Lost to Follow-up|0|||
33505541|NCT04362137|62887521|FG000|Overall Study|Protocol deviation|1|||
33505542|NCT04362137|62887522|FG001|Overall Study|Protocol deviation|0|||
33505543|NCT05099380|62887530|FG000|Overall Study|Subject enrolled in error|1|||
33505544|NCT05099380|62887531|FG001|Overall Study|Subject enrolled in error|0|||
33505545|NCT05099380|62887530|FG000|Overall Study|Study Procedure|1|||
33505546|NCT05099380|62887531|FG001|Overall Study|Study Procedure|0|||
33505547|NCT05099380|62887530|FG000|Overall Study|Protocol Violation|1|||
33505548|NCT05099380|62887531|FG001|Overall Study|Protocol Violation|0|||
33505549|NCT05099380|62887530|FG000|Overall Study|Adverse Event|1|||
33505550|NCT05099380|62887531|FG001|Overall Study|Adverse Event|1|||
33505551|NCT05099380|62887530|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
33505552|NCT05099380|62887531|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
33505553|NCT03614728|62887541|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
33505554|NCT03614728|62887542|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
33505555|NCT03614728|62887543|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
33505556|NCT03614728|62887544|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
33505557|NCT03614728|62887541|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
33505558|NCT03614728|62887542|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
33505559|NCT03614728|62887543|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
33505560|NCT03614728|62887544|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
33505561|NCT03154086|62887567|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33505562|NCT03154086|62887568|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33505563|NCT03154086|62887569|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33505564|NCT03154086|62887570|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
33505565|NCT03154086|62887571|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33505566|NCT03154086|62887572|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33505567|NCT03154086|62887573|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33505568|NCT03154086|62887574|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33505569|NCT03154086|62887575|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33450231|NCT00430781|62824977|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
33450232|NCT00430781|62824975|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
33450233|NCT00430781|62824976|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
33450234|NCT00430781|62824977|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
33450235|NCT00430781|62824975|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
33450236|NCT00430781|62824976|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
33450237|NCT00430781|62824977|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
33505570|NCT03154086|62887576|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33505571|NCT03154086|62887577|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33505572|NCT03154086|62887578|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33505573|NCT03154086|62887579|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33505574|NCT03154086|62887580|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33505575|NCT03154086|62887581|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33505576|NCT03154086|62887567|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33505577|NCT03154086|62887568|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
33505578|NCT03154086|62887569|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33505579|NCT03154086|62887570|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33505580|NCT03154086|62887571|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33505581|NCT03154086|62887572|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33505582|NCT03154086|62887573|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33505583|NCT03154086|62887574|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33505584|NCT03154086|62887575|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33505585|NCT03154086|62887576|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33505586|NCT03154086|62887577|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33505587|NCT03154086|62887578|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33505588|NCT03154086|62887579|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33505589|NCT03154086|62887580|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33505590|NCT03154086|62887581|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33505591|NCT03154086|62887567|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33505592|NCT03154086|62887568|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33505593|NCT03154086|62887569|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
33505594|NCT03154086|62887570|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33505595|NCT03154086|62887571|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33505596|NCT03154086|62887572|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33505597|NCT03154086|62887573|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33505598|NCT03154086|62887574|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33505599|NCT03154086|62887575|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33505600|NCT03154086|62887576|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33505601|NCT03154086|62887577|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33505602|NCT03154086|62887578|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33505603|NCT03154086|62887579|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33505604|NCT03154086|62887580|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33505605|NCT03154086|62887581|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33505606|NCT03154086|62887567|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
33505607|NCT03154086|62887568|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33505608|NCT03154086|62887569|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33505609|NCT03154086|62887570|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33505610|NCT03154086|62887571|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33505611|NCT03154086|62887572|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33505612|NCT03154086|62887573|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33505613|NCT03154086|62887574|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33505614|NCT03154086|62887575|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33505615|NCT03154086|62887576|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33505616|NCT03154086|62887577|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33505617|NCT03154086|62887578|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33505618|NCT03154086|62887579|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33505619|NCT03154086|62887580|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33505620|NCT03154086|62887581|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33505621|NCT03154086|62887567|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33505622|NCT03154086|62887568|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33505623|NCT03154086|62887569|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33505624|NCT03154086|62887570|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33505625|NCT03154086|62887571|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33505626|NCT03154086|62887572|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33505627|NCT03154086|62887573|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33505628|NCT03154086|62887574|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33505629|NCT03154086|62887575|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
33505630|NCT03154086|62887576|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33505631|NCT03154086|62887577|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33505632|NCT03154086|62887578|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33611866|NCT01716520|63012387|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
33505633|NCT03154086|62887579|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33505634|NCT03154086|62887580|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33611867|NCT01716520|63012382|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
33611868|NCT01716520|63012383|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
33611869|NCT01716520|63012384|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
33611870|NCT01716520|63012385|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
33611871|NCT01716520|63012386|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
33611872|NCT01716520|63012387|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
33611873|NCT01716520|63012382|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33611874|NCT01716520|63012383|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33611875|NCT01716520|63012384|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33611876|NCT01716520|63012385|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33611877|NCT01716520|63012386|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33611878|NCT01716520|63012387|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33611879|NCT01716520|63012382|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
33611880|NCT01716520|63012383|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
33611881|NCT01716520|63012384|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
33611882|NCT01716520|63012385|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
33611883|NCT01716520|63012386|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
33611884|NCT01716520|63012387|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
33611885|NCT01716520|63012382|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33611886|NCT01716520|63012383|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33611887|NCT01716520|63012384|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33611888|NCT01716520|63012385|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33611889|NCT01716520|63012386|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33611890|NCT01716520|63012387|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
33611891|NCT01716520|63012382|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
33611892|NCT01716520|63012383|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
33611893|NCT01716520|63012384|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
33611894|NCT01716520|63012385|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
33611895|NCT01716520|63012386|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
33611896|NCT01716520|63012387|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
33611897|NCT01716520|63012382|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
33611898|NCT01716520|63012383|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
33611899|NCT01716520|63012384|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
33611900|NCT01716520|63012385|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
33611901|NCT01716520|63012386|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
33505635|NCT03154086|62887581|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33505636|NCT03154086|62887567|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33505637|NCT03154086|62887568|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33505638|NCT03154086|62887569|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33505639|NCT03154086|62887570|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33505640|NCT03154086|62887571|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33505641|NCT03154086|62887572|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33611902|NCT01716520|63012387|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
33611903|NCT01716520|63012382|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33611904|NCT01716520|63012383|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33611905|NCT01716520|63012384|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33611906|NCT01716520|63012385|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33611907|NCT01716520|63012386|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
33611908|NCT01716520|63012387|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33611909|NCT01716520|63012382|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
33611910|NCT01716520|63012383|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
33611911|NCT01716520|63012384|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
33611912|NCT01716520|63012385|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
33611913|NCT01716520|63012386|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
33611914|NCT01716520|63012387|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
33611915|NCT01716520|63012382|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
33611916|NCT01716520|63012383|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
33611917|NCT01716520|63012384|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
33611918|NCT01716520|63012385|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
33611919|NCT01716520|63012386|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
33611920|NCT01716520|63012387|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
33611921|NCT01716520|63012382|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
33611922|NCT01716520|63012383|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
33611923|NCT01716520|63012384|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
33611924|NCT01716520|63012385|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
33611925|NCT01716520|63012386|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
33611926|NCT01716520|63012387|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
33611927|NCT01716520|63012382|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
33611928|NCT01716520|63012383|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
33611929|NCT01716520|63012384|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
33611930|NCT01716520|63012385|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
33611931|NCT01716520|63012386|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
33611932|NCT01716520|63012387|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
33611933|NCT01716520|63012382|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
33611934|NCT01716520|63012383|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
33611935|NCT01716520|63012384|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
33611936|NCT01716520|63012385|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
33611937|NCT01716520|63012386|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
33611938|NCT01716520|63012387|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
33611939|NCT01716520|63012382|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33611940|NCT01716520|63012383|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33611941|NCT01716520|63012384|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33611942|NCT01716520|63012385|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33611943|NCT01716520|63012386|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33611944|NCT01716520|63012387|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
33505642|NCT03154086|62887573|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33505643|NCT03154086|62887574|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
33505644|NCT03154086|62887575|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33505645|NCT03154086|62887576|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33505646|NCT03154086|62887577|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33505647|NCT03154086|62887578|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33505648|NCT03154086|62887579|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33505649|NCT03154086|62887580|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33505650|NCT03154086|62887581|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33505651|NCT03154086|62887567|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
33505652|NCT03154086|62887568|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
33505653|NCT03154086|62887569|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
33505654|NCT03154086|62887570|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
33505655|NCT03154086|62887571|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
33505656|NCT03154086|62887572|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
33505657|NCT03154086|62887573|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
33505658|NCT03154086|62887574|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
33505659|NCT03154086|62887575|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
33505660|NCT03154086|62887576|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
33505661|NCT03154086|62887577|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
33505662|NCT03154086|62887578|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
33505663|NCT03154086|62887579|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
33505664|NCT03154086|62887580|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
33505665|NCT03154086|62887581|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
33505666|NCT02723344|62887639|FG000|Overall Study|Lost to Follow-up|0|||
33505667|NCT02723344|62887640|FG001|Overall Study|Lost to Follow-up|4|||
33505668|NCT02723188|62887649|FG000|Overall Study|Withdrawal by Subject|1|||
33505669|NCT02723188|62887650|FG001|Overall Study|Withdrawal by Subject|0|||
33505670|NCT02723188|62887651|FG002|Overall Study|Withdrawal by Subject|0|||
33505671|NCT00705406|62887661|FG000|Overall Study|Lost to Follow-up|3|||
33505672|NCT00705406|62887662|FG001|Overall Study|Lost to Follow-up|3|||
33505673|NCT00705406|62887661|FG000|Overall Study|Did not receive study drug|1|||
33505674|NCT00705406|62887662|FG001|Overall Study|Did not receive study drug|2|||
33505675|NCT03155178|62887673|FG000|Overall Study|Did not meet treatment day baseline|7|||
33505676|NCT03155178|62887674|FG001|Overall Study|Did not meet treatment day baseline|7|||
33505677|NCT03155178|62887675|FG002|Overall Study|Did not meet treatment day baseline|7|||
33505678|NCT03155178|62887676|FG003|Overall Study|Did not meet treatment day baseline|7|||
33505679|NCT00705250|62887700|FG000|Overall Study|Withdrawal by Subject|1|||
33505680|NCT00705250|62887700|FG000|Overall Study|Patient died in car accident|1|||
33505681|NCT03078192|62887706|FG000|Overall Study|Withdrawal by Subject|2|||
33505682|NCT03078192|62887707|FG001|Overall Study|Withdrawal by Subject|1|||
33505683|NCT03078192|62887706|FG000|Overall Study|screen failure|0|||
33505684|NCT03078192|62887707|FG001|Overall Study|screen failure|3|||
33505685|NCT00703846|62887713|FG000|Overall Study|Adverse Event|8|||
33611945|NCT01716520|63012382|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33505686|NCT00703846|62887713|FG000|Overall Study|Lost to Follow-up|55|||
33505687|NCT00703846|62887713|FG000|Overall Study|Lack of Efficacy|15|||
33505688|NCT00703846|62887713|FG000|Overall Study|Noncompliance with Study Treatment|2|||
33505689|NCT00703846|62887713|FG000|Overall Study|Withdrawal by Subject|40|||
33505690|NCT00703846|62887713|FG000|Overall Study|Death|1|||
33505691|NCT00703846|62887713|FG000|Overall Study|Other|14|||
33505692|NCT00703846|62887713|FG000|Overall Study|Did Not Receive Study Drug|2|||
33505693|NCT01314872|62887728|FG000|Treatment Period 1|Protocol Violation|2|||
33505694|NCT01314872|62887729|FG001|Treatment Period 1|Protocol Violation|1|||
33505695|NCT01314872|62887730|FG002|Treatment Period 1|Protocol Violation|1|||
33505696|NCT01314872|62887731|FG003|Treatment Period 1|Protocol Violation|0|||
33505697|NCT01314872|62887732|FG004|Treatment Period 1|Protocol Violation|1|||
33505698|NCT01314872|62887733|FG005|Treatment Period 1|Protocol Violation|0|||
33505699|NCT01314872|62887734|FG006|Treatment Period 1|Protocol Violation|0|||
33505700|NCT01314872|62887735|FG007|Treatment Period 1|Protocol Violation|0|||
33505701|NCT01314872|62887736|FG008|Treatment Period 1|Protocol Violation|0|||
33505702|NCT01314872|62887737|FG009|Treatment Period 1|Protocol Violation|1|||
33505703|NCT01314872|62887738|FG010|Treatment Period 1|Protocol Violation|1|||
33505704|NCT01314872|62887739|FG011|Treatment Period 1|Protocol Violation|0|||
33505705|NCT01314872|62887740|FG012|Treatment Period 1|Protocol Violation|0|||
33505706|NCT01314872|62887741|FG013|Treatment Period 1|Protocol Violation|0|||
33505707|NCT01314872|62887742|FG014|Treatment Period 1|Protocol Violation|0|||
33505708|NCT01314872|62887728|FG000|Treatment Period 1|Physician Decision|0|||
33505709|NCT01314872|62887729|FG001|Treatment Period 1|Physician Decision|1|||
33505710|NCT01314872|62887730|FG002|Treatment Period 1|Physician Decision|0|||
33505711|NCT01314872|62887731|FG003|Treatment Period 1|Physician Decision|1|||
33505712|NCT01314872|62887732|FG004|Treatment Period 1|Physician Decision|0|||
33505713|NCT01314872|62887733|FG005|Treatment Period 1|Physician Decision|0|||
33505714|NCT01314872|62887734|FG006|Treatment Period 1|Physician Decision|0|||
33505715|NCT01314872|62887735|FG007|Treatment Period 1|Physician Decision|0|||
33505716|NCT01314872|62887736|FG008|Treatment Period 1|Physician Decision|0|||
33505717|NCT01314872|62887737|FG009|Treatment Period 1|Physician Decision|1|||
33505718|NCT01314872|62887738|FG010|Treatment Period 1|Physician Decision|0|||
33505719|NCT01314872|62887739|FG011|Treatment Period 1|Physician Decision|0|||
33505720|NCT01314872|62887740|FG012|Treatment Period 1|Physician Decision|0|||
33505721|NCT01314872|62887741|FG013|Treatment Period 1|Physician Decision|0|||
33505722|NCT01314872|62887742|FG014|Treatment Period 1|Physician Decision|0|||
33505723|NCT01314872|62887728|FG000|Treatment Period 1|Lack of Efficacy|1|||
33505724|NCT01314872|62887729|FG001|Treatment Period 1|Lack of Efficacy|0|||
33505725|NCT01314872|62887730|FG002|Treatment Period 1|Lack of Efficacy|0|||
33505726|NCT01314872|62887731|FG003|Treatment Period 1|Lack of Efficacy|0|||
33505727|NCT01314872|62887732|FG004|Treatment Period 1|Lack of Efficacy|0|||
33505728|NCT01314872|62887733|FG005|Treatment Period 1|Lack of Efficacy|1|||
33505729|NCT01314872|62887734|FG006|Treatment Period 1|Lack of Efficacy|0|||
33505730|NCT01314872|62887735|FG007|Treatment Period 1|Lack of Efficacy|2|||
33505731|NCT01314872|62887736|FG008|Treatment Period 1|Lack of Efficacy|0|||
33505732|NCT01314872|62887737|FG009|Treatment Period 1|Lack of Efficacy|0|||
33505733|NCT01314872|62887738|FG010|Treatment Period 1|Lack of Efficacy|0|||
33505734|NCT01314872|62887739|FG011|Treatment Period 1|Lack of Efficacy|0|||
33505735|NCT01314872|62887740|FG012|Treatment Period 1|Lack of Efficacy|0|||
33505736|NCT01314872|62887741|FG013|Treatment Period 1|Lack of Efficacy|0|||
33505737|NCT01314872|62887742|FG014|Treatment Period 1|Lack of Efficacy|0|||
33505738|NCT01314872|62887728|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
33505739|NCT01314872|62887729|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
33505740|NCT01314872|62887730|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
33505741|NCT01314872|62887731|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
33505742|NCT01314872|62887732|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
33505743|NCT01314872|62887733|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
33505744|NCT01314872|62887734|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
33505745|NCT01314872|62887735|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
33505746|NCT01314872|62887736|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
33505747|NCT01314872|62887737|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
33505748|NCT01314872|62887738|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
33505749|NCT01314872|62887739|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
33505750|NCT01314872|62887740|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
33505751|NCT01314872|62887741|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
33505752|NCT01314872|62887742|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
33505753|NCT01314872|62887728|FG000|Treatment Period 1|Withdrawal by Subject|3|||
33505754|NCT01314872|62887729|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33505755|NCT01314872|62887730|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33505756|NCT01314872|62887731|FG003|Treatment Period 1|Withdrawal by Subject|2|||
33505757|NCT01314872|62887732|FG004|Treatment Period 1|Withdrawal by Subject|3|||
33505758|NCT01314872|62887733|FG005|Treatment Period 1|Withdrawal by Subject|1|||
33505759|NCT01314872|62887734|FG006|Treatment Period 1|Withdrawal by Subject|3|||
33505760|NCT01314872|62887735|FG007|Treatment Period 1|Withdrawal by Subject|2|||
33505761|NCT01314872|62887736|FG008|Treatment Period 1|Withdrawal by Subject|2|||
33505762|NCT01314872|62887737|FG009|Treatment Period 1|Withdrawal by Subject|2|||
33505763|NCT01314872|62887738|FG010|Treatment Period 1|Withdrawal by Subject|1|||
33505764|NCT01314872|62887739|FG011|Treatment Period 1|Withdrawal by Subject|0|||
33505765|NCT01314872|62887740|FG012|Treatment Period 1|Withdrawal by Subject|0|||
33505766|NCT01314872|62887741|FG013|Treatment Period 1|Withdrawal by Subject|0|||
33505767|NCT01314872|62887742|FG014|Treatment Period 1|Withdrawal by Subject|0|||
33505768|NCT01314872|62887728|FG000|Treatment Period 1|Lost to Follow-up|0|||
33505769|NCT01314872|62887729|FG001|Treatment Period 1|Lost to Follow-up|1|||
33505770|NCT01314872|62887730|FG002|Treatment Period 1|Lost to Follow-up|2|||
33505771|NCT01314872|62887731|FG003|Treatment Period 1|Lost to Follow-up|2|||
33505772|NCT01314872|62887732|FG004|Treatment Period 1|Lost to Follow-up|1|||
33505773|NCT01314872|62887733|FG005|Treatment Period 1|Lost to Follow-up|1|||
33505774|NCT01314872|62887734|FG006|Treatment Period 1|Lost to Follow-up|1|||
33505775|NCT01314872|62887735|FG007|Treatment Period 1|Lost to Follow-up|1|||
33505776|NCT01314872|62887736|FG008|Treatment Period 1|Lost to Follow-up|1|||
33505777|NCT01314872|62887737|FG009|Treatment Period 1|Lost to Follow-up|0|||
33505778|NCT01314872|62887738|FG010|Treatment Period 1|Lost to Follow-up|0|||
33505779|NCT01314872|62887739|FG011|Treatment Period 1|Lost to Follow-up|0|||
33505780|NCT01314872|62887740|FG012|Treatment Period 1|Lost to Follow-up|0|||
33505781|NCT01314872|62887741|FG013|Treatment Period 1|Lost to Follow-up|0|||
33505782|NCT01314872|62887742|FG014|Treatment Period 1|Lost to Follow-up|0|||
33505783|NCT01314872|62887728|FG000|Period 2|Protocol Violation|0|||
33505784|NCT01314872|62887729|FG001|Period 2|Protocol Violation|0|||
33505785|NCT01314872|62887730|FG002|Period 2|Protocol Violation|0|||
33505786|NCT01314872|62887731|FG003|Period 2|Protocol Violation|0|||
33505787|NCT01314872|62887732|FG004|Period 2|Protocol Violation|0|||
33505788|NCT01314872|62887733|FG005|Period 2|Protocol Violation|0|||
33505789|NCT01314872|62887734|FG006|Period 2|Protocol Violation|0|||
33505790|NCT01314872|62887735|FG007|Period 2|Protocol Violation|0|||
33505791|NCT01314872|62887736|FG008|Period 2|Protocol Violation|0|||
33505792|NCT01314872|62887737|FG009|Period 2|Protocol Violation|0|||
33505793|NCT01314872|62887738|FG010|Period 2|Protocol Violation|0|||
33505794|NCT01314872|62887739|FG011|Period 2|Protocol Violation|3|||
33505795|NCT01314872|62887740|FG012|Period 2|Protocol Violation|3|||
33505796|NCT01314872|62887741|FG013|Period 2|Protocol Violation|2|||
33450238|NCT00430781|62824975|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
33450239|NCT00430781|62824976|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
33450240|NCT00430781|62824977|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
33450241|NCT00430781|62824975|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
33450242|NCT00430781|62824976|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
33450243|NCT00430781|62824977|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
33450244|NCT00430781|62824975|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
33450245|NCT00430781|62824976|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
33450246|NCT00430781|62824977|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
33450247|NCT00429299|62824991|FG000|Overall Study|Disease Progression|1|||
33450248|NCT00429299|62824992|FG001|Overall Study|Disease Progression|1|||
33450249|NCT00429299|62824993|FG002|Overall Study|Disease Progression|0|||
33450250|NCT00429299|62824991|FG000|Overall Study|Adverse Event|2|||
33450251|NCT00429299|62824992|FG001|Overall Study|Adverse Event|5|||
33450252|NCT00429299|62824993|FG002|Overall Study|Adverse Event|1|||
33450253|NCT00429299|62824991|FG000|Overall Study|Protocol Violation|1|||
33450254|NCT00429299|62824992|FG001|Overall Study|Protocol Violation|0|||
33450255|NCT00429299|62824993|FG002|Overall Study|Protocol Violation|0|||
33450256|NCT00429299|62824991|FG000|Overall Study|Withdrawal by Subject|0|||
33450257|NCT00429299|62824992|FG001|Overall Study|Withdrawal by Subject|1|||
33450258|NCT00429299|62824993|FG002|Overall Study|Withdrawal by Subject|3|||
33450259|NCT00428597|62825003|FG000|Overall Study|Randomized but not treated|3|||
33450260|NCT00428597|62825004|FG001|Overall Study|Randomized but not treated|3|||
33450261|NCT00428597|62825003|FG000|Overall Study|Objective Progression or Relapse|19|||
33450262|NCT00428597|62825004|FG001|Overall Study|Objective Progression or Relapse|47|||
33450263|NCT00428597|62825003|FG000|Overall Study|Study Terminated by Sponsor|41|||
33450264|NCT00428597|62825004|FG001|Overall Study|Study Terminated by Sponsor|16|||
33450265|NCT00428597|62825003|FG000|Overall Study|Adverse Event|15|||
33450266|NCT00428597|62825004|FG001|Overall Study|Adverse Event|7|||
33505797|NCT01314872|62887742|FG014|Period 2|Protocol Violation|0|||
33611946|NCT01716520|63012383|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33450267|NCT00428597|62825003|FG000|Overall Study|Global Deterioration of Health Status|1|||
33505798|NCT01314872|62887728|FG000|Period 2|Non-compliance with study drug|0|||
33505799|NCT01314872|62887729|FG001|Period 2|Non-compliance with study drug|0|||
33505800|NCT01314872|62887730|FG002|Period 2|Non-compliance with study drug|0|||
33505801|NCT01314872|62887731|FG003|Period 2|Non-compliance with study drug|0|||
33505802|NCT01314872|62887732|FG004|Period 2|Non-compliance with study drug|0|||
33505803|NCT01314872|62887733|FG005|Period 2|Non-compliance with study drug|0|||
33505804|NCT01314872|62887734|FG006|Period 2|Non-compliance with study drug|0|||
33505805|NCT01314872|62887735|FG007|Period 2|Non-compliance with study drug|0|||
33505806|NCT01314872|62887736|FG008|Period 2|Non-compliance with study drug|0|||
33505807|NCT01314872|62887737|FG009|Period 2|Non-compliance with study drug|0|||
33505808|NCT01314872|62887738|FG010|Period 2|Non-compliance with study drug|0|||
33505809|NCT01314872|62887739|FG011|Period 2|Non-compliance with study drug|3|||
33505810|NCT01314872|62887740|FG012|Period 2|Non-compliance with study drug|3|||
33505811|NCT01314872|62887741|FG013|Period 2|Non-compliance with study drug|1|||
33505812|NCT01314872|62887742|FG014|Period 2|Non-compliance with study drug|2|||
33505813|NCT01314872|62887728|FG000|Period 2|Lack of Efficacy|0|||
33505814|NCT01314872|62887729|FG001|Period 2|Lack of Efficacy|0|||
33505815|NCT01314872|62887730|FG002|Period 2|Lack of Efficacy|0|||
33505816|NCT01314872|62887731|FG003|Period 2|Lack of Efficacy|0|||
33505817|NCT01314872|62887732|FG004|Period 2|Lack of Efficacy|0|||
33505818|NCT01314872|62887733|FG005|Period 2|Lack of Efficacy|0|||
33505819|NCT01314872|62887734|FG006|Period 2|Lack of Efficacy|0|||
33505820|NCT01314872|62887735|FG007|Period 2|Lack of Efficacy|0|||
33505821|NCT01314872|62887736|FG008|Period 2|Lack of Efficacy|0|||
33505822|NCT01314872|62887737|FG009|Period 2|Lack of Efficacy|0|||
33611947|NCT01716520|63012384|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
33505823|NCT01314872|62887738|FG010|Period 2|Lack of Efficacy|0|||
33505824|NCT01314872|62887739|FG011|Period 2|Lack of Efficacy|7|||
33505825|NCT01314872|62887740|FG012|Period 2|Lack of Efficacy|12|||
33505826|NCT01314872|62887741|FG013|Period 2|Lack of Efficacy|9|||
33505827|NCT01314872|62887742|FG014|Period 2|Lack of Efficacy|2|||
33505828|NCT01314872|62887728|FG000|Period 2|Pregnancy|0|||
33505829|NCT01314872|62887729|FG001|Period 2|Pregnancy|0|||
33505830|NCT01314872|62887730|FG002|Period 2|Pregnancy|0|||
33505831|NCT01314872|62887731|FG003|Period 2|Pregnancy|0|||
33505832|NCT01314872|62887732|FG004|Period 2|Pregnancy|0|||
33505833|NCT01314872|62887733|FG005|Period 2|Pregnancy|0|||
33505834|NCT01314872|62887734|FG006|Period 2|Pregnancy|0|||
33505835|NCT01314872|62887735|FG007|Period 2|Pregnancy|0|||
33505836|NCT01314872|62887736|FG008|Period 2|Pregnancy|0|||
33505837|NCT01314872|62887737|FG009|Period 2|Pregnancy|0|||
33505838|NCT01314872|62887738|FG010|Period 2|Pregnancy|0|||
33505839|NCT01314872|62887739|FG011|Period 2|Pregnancy|0|||
33505840|NCT01314872|62887740|FG012|Period 2|Pregnancy|0|||
33505841|NCT01314872|62887741|FG013|Period 2|Pregnancy|0|||
33611948|NCT01716520|63012385|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33611949|NCT01716520|63012386|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33611950|NCT01716520|63012387|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33611951|NCT01698268|63012397|FG000|Overall Study|Physician Decision|2|||
33611952|NCT01698268|63012398|FG001|Overall Study|Physician Decision|1|||
33611953|NCT01697956|63012406|FG000|Overall Study|Protocol Violation|1|||
33611954|NCT01697956|63012407|FG001|Overall Study|Protocol Violation|1|||
33505842|NCT01314872|62887742|FG014|Period 2|Pregnancy|1|||
33505843|NCT01314872|62887728|FG000|Period 2|Study terminated by Sponsor|0|||
33505844|NCT01314872|62887729|FG001|Period 2|Study terminated by Sponsor|0|||
33505845|NCT01314872|62887730|FG002|Period 2|Study terminated by Sponsor|0|||
33505846|NCT01314872|62887731|FG003|Period 2|Study terminated by Sponsor|0|||
33505847|NCT01314872|62887732|FG004|Period 2|Study terminated by Sponsor|0|||
33505848|NCT01314872|62887733|FG005|Period 2|Study terminated by Sponsor|0|||
33505849|NCT01314872|62887734|FG006|Period 2|Study terminated by Sponsor|0|||
33505850|NCT01314872|62887735|FG007|Period 2|Study terminated by Sponsor|0|||
33505851|NCT01314872|62887736|FG008|Period 2|Study terminated by Sponsor|0|||
33505852|NCT01314872|62887737|FG009|Period 2|Study terminated by Sponsor|0|||
33505853|NCT01314872|62887738|FG010|Period 2|Study terminated by Sponsor|0|||
33505854|NCT01314872|62887739|FG011|Period 2|Study terminated by Sponsor|2|||
33505855|NCT01314872|62887740|FG012|Period 2|Study terminated by Sponsor|2|||
33505856|NCT01314872|62887741|FG013|Period 2|Study terminated by Sponsor|3|||
33505857|NCT01314872|62887742|FG014|Period 2|Study terminated by Sponsor|0|||
33505858|NCT01314872|62887728|FG000|Period 2|Adverse event, non-fatal|0|||
33505859|NCT01314872|62887729|FG001|Period 2|Adverse event, non-fatal|0|||
33505860|NCT01314872|62887730|FG002|Period 2|Adverse event, non-fatal|0|||
33505861|NCT01314872|62887731|FG003|Period 2|Adverse event, non-fatal|0|||
33611955|NCT01697800|63012421|FG000|Overall Study|Death|0|||
33611956|NCT01697800|63012422|FG001|Overall Study|Death|1|||
33505862|NCT01314872|62887732|FG004|Period 2|Adverse event, non-fatal|0|||
33505863|NCT01314872|62887733|FG005|Period 2|Adverse event, non-fatal|0|||
33505864|NCT01314872|62887734|FG006|Period 2|Adverse event, non-fatal|0|||
33505865|NCT01314872|62887735|FG007|Period 2|Adverse event, non-fatal|0|||
33505866|NCT01314872|62887736|FG008|Period 2|Adverse event, non-fatal|0|||
33505867|NCT01314872|62887737|FG009|Period 2|Adverse event, non-fatal|0|||
33505868|NCT01314872|62887738|FG010|Period 2|Adverse event, non-fatal|0|||
33505869|NCT01314872|62887739|FG011|Period 2|Adverse event, non-fatal|13|||
33505870|NCT01314872|62887740|FG012|Period 2|Adverse event, non-fatal|16|||
33505871|NCT01314872|62887741|FG013|Period 2|Adverse event, non-fatal|24|||
33505872|NCT01314872|62887742|FG014|Period 2|Adverse event, non-fatal|9|||
33505873|NCT01314872|62887728|FG000|Period 2|Withdrawal by Subject|0|||
33505874|NCT01314872|62887729|FG001|Period 2|Withdrawal by Subject|0|||
33505875|NCT01314872|62887730|FG002|Period 2|Withdrawal by Subject|0|||
33505876|NCT01314872|62887731|FG003|Period 2|Withdrawal by Subject|0|||
33505877|NCT01314872|62887732|FG004|Period 2|Withdrawal by Subject|0|||
33505878|NCT01314872|62887733|FG005|Period 2|Withdrawal by Subject|0|||
33505879|NCT01314872|62887734|FG006|Period 2|Withdrawal by Subject|0|||
33505880|NCT01314872|62887735|FG007|Period 2|Withdrawal by Subject|0|||
33505881|NCT01314872|62887736|FG008|Period 2|Withdrawal by Subject|0|||
33505882|NCT01314872|62887737|FG009|Period 2|Withdrawal by Subject|0|||
33505883|NCT01314872|62887738|FG010|Period 2|Withdrawal by Subject|0|||
33505884|NCT01314872|62887739|FG011|Period 2|Withdrawal by Subject|14|||
33505885|NCT01314872|62887740|FG012|Period 2|Withdrawal by Subject|17|||
33505886|NCT01314872|62887741|FG013|Period 2|Withdrawal by Subject|12|||
33505887|NCT01314872|62887742|FG014|Period 2|Withdrawal by Subject|4|||
33505888|NCT01314872|62887728|FG000|Period 2|Lost to Follow-up|0|||
33505889|NCT01314872|62887729|FG001|Period 2|Lost to Follow-up|0|||
33505890|NCT01314872|62887730|FG002|Period 2|Lost to Follow-up|0|||
33505891|NCT01314872|62887731|FG003|Period 2|Lost to Follow-up|0|||
33505892|NCT01314872|62887732|FG004|Period 2|Lost to Follow-up|0|||
33505893|NCT01314872|62887733|FG005|Period 2|Lost to Follow-up|0|||
33505894|NCT01314872|62887734|FG006|Period 2|Lost to Follow-up|0|||
33505895|NCT01314872|62887735|FG007|Period 2|Lost to Follow-up|0|||
33505896|NCT01314872|62887736|FG008|Period 2|Lost to Follow-up|0|||
33505897|NCT01314872|62887737|FG009|Period 2|Lost to Follow-up|0|||
33505898|NCT01314872|62887738|FG010|Period 2|Lost to Follow-up|0|||
33505899|NCT01314872|62887739|FG011|Period 2|Lost to Follow-up|6|||
33505900|NCT01314872|62887740|FG012|Period 2|Lost to Follow-up|7|||
33505901|NCT01314872|62887741|FG013|Period 2|Lost to Follow-up|2|||
33505902|NCT01314872|62887742|FG014|Period 2|Lost to Follow-up|6|||
33505903|NCT00703924|62887776|FG000|Overall Study|Withdrawal by Subject|1|||
33505904|NCT00703924|62887777|FG001|Overall Study|Withdrawal by Subject|1|||
33505905|NCT03152526|62887789|FG000|Overall Study|Withdrawal by Subject|0|||
33505906|NCT03152526|62887790|FG001|Overall Study|Withdrawal by Subject|1|||
33505907|NCT03149328|62887798|FG000|Overall Study|Withdrawal by Subject|30|||
33505908|NCT03149328|62887799|FG001|Overall Study|Withdrawal by Subject|26|||
33505909|NCT03149328|62887798|FG000|Overall Study|Changed Dialysis Modality|18|||
33505910|NCT03149328|62887799|FG001|Overall Study|Changed Dialysis Modality|1|||
33505911|NCT03149328|62887798|FG000|Overall Study|Transplant|9|||
33505912|NCT03149328|62887799|FG001|Overall Study|Transplant|1|||
33505913|NCT03149328|62887798|FG000|Overall Study|Lost to Follow-up|25|||
33505914|NCT03149328|62887799|FG001|Overall Study|Lost to Follow-up|16|||
33505915|NCT03149328|62887798|FG000|Overall Study|Left Study Site|1|||
33505916|NCT03149328|62887799|FG001|Overall Study|Left Study Site|2|||
33505917|NCT03149328|62887798|FG000|Overall Study|Language Barrier|1|||
33505918|NCT03149328|62887799|FG001|Overall Study|Language Barrier|0|||
33505919|NCT04296942|62887848|FG000|Overall Study|Study closure by sponsor|1|||
33505920|NCT04296942|62887849|FG001|Overall Study|Study closure by sponsor|0|||
33505921|NCT04296942|62887850|FG002|Overall Study|Study closure by sponsor|0|||
33505922|NCT01315028|62887906|FG000|Overall Study|Lost to Follow-up|1|||
33505923|NCT01315028|62887907|FG001|Overall Study|Lost to Follow-up|0|||
33505924|NCT01315028|62887906|FG000|Overall Study|Death|0|||
33505925|NCT01315028|62887907|FG001|Overall Study|Death|1|||
33505926|NCT02720536|62887913|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
33505927|NCT02720536|62887913|FG000|Overall Study|PR - pregnancy|2|||
33505928|NCT02720536|62887913|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
33505929|NCT02720536|62887913|FG000|Overall Study|PR - death|1|||
33505930|NCT02720536|62887913|FG000|Overall Study|PR - adverse event|1|||
33505931|NCT02720536|62887913|FG000|Overall Study|PR - abnormal lab value(s)|1|||
33505932|NCT02720536|62887913|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
33505933|NCT03168438|62887925|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
33505934|NCT03168438|62887926|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
33505935|NCT03137784|62887933|FG000|Overall Study|Adverse Event|1|||
33505936|NCT03137784|62887934|FG001|Overall Study|Adverse Event|1|||
33505937|NCT03137784|62887935|FG002|Overall Study|Adverse Event|0|||
33505938|NCT03137784|62887936|FG003|Overall Study|Adverse Event|0|||
33505939|NCT03137784|62887937|FG004|Overall Study|Adverse Event|0|||
33505940|NCT03137784|62887938|FG005|Overall Study|Adverse Event|0|||
33505941|NCT03137784|62887933|FG000|Overall Study|Subject/guardian decision|1|||
33505942|NCT03137784|62887934|FG001|Overall Study|Subject/guardian decision|0|||
33505943|NCT03137784|62887935|FG002|Overall Study|Subject/guardian decision|0|||
33505944|NCT03137784|62887936|FG003|Overall Study|Subject/guardian decision|0|||
33505945|NCT03137784|62887937|FG004|Overall Study|Subject/guardian decision|0|||
33505946|NCT03137784|62887938|FG005|Overall Study|Subject/guardian decision|0|||
33505947|NCT03137784|62887933|FG000|Overall Study|Non-compliance with study treatment|0|||
33505948|NCT03137784|62887934|FG001|Overall Study|Non-compliance with study treatment|0|||
33505949|NCT03137784|62887935|FG002|Overall Study|Non-compliance with study treatment|0|||
33505950|NCT03137784|62887936|FG003|Overall Study|Non-compliance with study treatment|0|||
33505951|NCT03137784|62887937|FG004|Overall Study|Non-compliance with study treatment|1|||
33505952|NCT03137784|62887938|FG005|Overall Study|Non-compliance with study treatment|0|||
33505953|NCT01314716|62887948|FG000|Double-Blind Phase|Randomized but not treated|1|||
33505954|NCT01314716|62887949|FG001|Double-Blind Phase|Randomized but not treated|1|||
33505955|NCT01314716|62887948|FG000|Double-Blind Phase|Adverse Event|10|||
33505956|NCT01314716|62887949|FG001|Double-Blind Phase|Adverse Event|4|||
33505957|NCT01314716|62887948|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
33505958|NCT01314716|62887949|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
33505959|NCT01314716|62887948|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33505960|NCT01314716|62887949|FG001|Double-Blind Phase|Lost to Follow-up|1|||
33505961|NCT01314716|62887948|FG000|Double-Blind Phase|Sponsor request|1|||
33505962|NCT01314716|62887949|FG001|Double-Blind Phase|Sponsor request|2|||
33505963|NCT01314716|62887948|FG000|Double-Blind Phase|Physician Decision|0|||
33505964|NCT01314716|62887949|FG001|Double-Blind Phase|Physician Decision|1|||
33505965|NCT01314716|62887948|FG000|Open-Label Phase|Adverse Event|4|||
33505966|NCT01314716|62887949|FG001|Open-Label Phase|Adverse Event|6|||
33505967|NCT01314716|62887948|FG000|Open-Label Phase|Withdrawal by Subject|1|||
33505968|NCT01314716|62887949|FG001|Open-Label Phase|Withdrawal by Subject|2|||
33505969|NCT01314716|62887948|FG000|Open-Label Phase|Physician Decision|5|||
33505970|NCT01314716|62887949|FG001|Open-Label Phase|Physician Decision|4|||
33505971|NCT03144180|62887959|FG000|Overall Study|STAT Delivery|1|||
33505972|NCT03144180|62887960|FG001|Overall Study|STAT Delivery|1|||
33505973|NCT03144180|62887959|FG000|Overall Study|Provider forgot to fill out forms|1|||
33505974|NCT03144180|62887960|FG001|Overall Study|Provider forgot to fill out forms|3|||
33505975|NCT03144180|62887959|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
33505976|NCT03144180|62887960|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
33505977|NCT03144180|62887959|FG000|Overall Study|Scrub tech removed tube cap|0|||
33505978|NCT03144180|62887960|FG001|Overall Study|Scrub tech removed tube cap|1|||
33505979|NCT01465334|62887970|FG000|Overall Study|Disease Progression|1|||
33505980|NCT01465334|62887971|FG001|Overall Study|Disease Progression|0|||
33505981|NCT01465334|62887970|FG000|Overall Study|Adverse Event|1|||
33505982|NCT01465334|62887971|FG001|Overall Study|Adverse Event|0|||
33505983|NCT01465334|62887970|FG000|Overall Study|Richter's transformation|0|||
33505984|NCT01465334|62887971|FG001|Overall Study|Richter's transformation|3|||
33505985|NCT01465334|62887970|FG000|Overall Study|Refractory Disease|0|||
33505986|NCT01465334|62887971|FG001|Overall Study|Refractory Disease|3|||
33505987|NCT00702208|62887977|FG000|Overall Study|Lost to Follow-up|28|||
33505988|NCT00702208|62887977|FG000|Overall Study|Did not self-lavage|1|||
33505989|NCT00702208|62887977|FG000|Overall Study|Unsatisfactory colposcopy|2|||
33505990|NCT02718898|62887994|FG000|Blinded Treatment Period|Adverse Event|5|||
33505991|NCT02718898|62887995|FG001|Blinded Treatment Period|Adverse Event|1|||
33505992|NCT02718898|62887996|FG002|Blinded Treatment Period|Adverse Event|0|||
33505993|NCT02718898|62887997|FG003|Blinded Treatment Period|Adverse Event|0|||
33505994|NCT02718898|62887998|FG004|Blinded Treatment Period|Adverse Event|0|||
33505995|NCT02718898|62887999|FG005|Blinded Treatment Period|Adverse Event|0|||
33505996|NCT02718898|62888000|FG006|Blinded Treatment Period|Adverse Event|0|||
33505997|NCT02718898|62887994|FG000|Blinded Treatment Period|Physician Decision|1|||
33505998|NCT02718898|62887995|FG001|Blinded Treatment Period|Physician Decision|0|||
33505999|NCT02718898|62887996|FG002|Blinded Treatment Period|Physician Decision|0|||
33506000|NCT02718898|62887997|FG003|Blinded Treatment Period|Physician Decision|0|||
33506001|NCT02718898|62887998|FG004|Blinded Treatment Period|Physician Decision|0|||
33506002|NCT02718898|62887999|FG005|Blinded Treatment Period|Physician Decision|0|||
33506003|NCT02718898|62888000|FG006|Blinded Treatment Period|Physician Decision|0|||
33506004|NCT02718898|62887994|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
33506005|NCT02718898|62887995|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
33506006|NCT02718898|62887996|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
33611957|NCT01644500|63012431|FG000|Overall Study|Adverse Event|6|||
33611958|NCT01644500|63012432|FG001|Overall Study|Adverse Event|1|||
33611959|NCT01644500|63012433|FG002|Overall Study|Adverse Event|2|||
33611960|NCT01644500|63012431|FG000|Overall Study|Death|0|||
33611961|NCT01644500|63012432|FG001|Overall Study|Death|1|||
33611962|NCT01644500|63012433|FG002|Overall Study|Death|0|||
33611963|NCT01644500|63012431|FG000|Overall Study|Lost to Follow-up|3|||
33611964|NCT01644500|63012432|FG001|Overall Study|Lost to Follow-up|8|||
33611965|NCT01644500|63012433|FG002|Overall Study|Lost to Follow-up|0|||
33506007|NCT02718898|62887997|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
33611966|NCT01644500|63012431|FG000|Overall Study|Protocol Violation|1|||
33506008|NCT02718898|62887998|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
33506009|NCT02718898|62887999|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
33506010|NCT02718898|62888000|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
33506011|NCT02718898|62887994|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
33611967|NCT01644500|63012432|FG001|Overall Study|Protocol Violation|1|||
33611968|NCT01644500|63012433|FG002|Overall Study|Protocol Violation|0|||
33611969|NCT01644500|63012431|FG000|Overall Study|Withdrawal by Subject|11|||
33611970|NCT01644500|63012432|FG001|Overall Study|Withdrawal by Subject|12|||
33611971|NCT01644500|63012433|FG002|Overall Study|Withdrawal by Subject|12|||
33506012|NCT02718898|62887995|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
33506013|NCT02718898|62887996|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
33506014|NCT02718898|62887997|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
33506015|NCT02718898|62887998|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
33506016|NCT02718898|62887999|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
33506017|NCT02718898|62888000|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
33506018|NCT02718898|62887994|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
33611972|NCT01644500|63012431|FG000|Overall Study|Physician Decision|1|||
33611973|NCT01644500|63012432|FG001|Overall Study|Physician Decision|1|||
33506019|NCT02718898|62887995|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
33506020|NCT02718898|62887996|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
33506021|NCT02718898|62887997|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
33506022|NCT02718898|62887998|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
33506023|NCT02718898|62887999|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
33506024|NCT02718898|62888000|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
33506025|NCT02718898|62887994|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
33506026|NCT02718898|62887995|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
33506027|NCT02718898|62887996|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
33506028|NCT02718898|62887997|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
33506029|NCT02718898|62887998|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
33506030|NCT02718898|62887999|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
33506031|NCT02718898|62888000|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
33506032|NCT02718898|62887994|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33506033|NCT02718898|62887995|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33506034|NCT02718898|62887996|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
33506035|NCT02718898|62887997|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
33506036|NCT02718898|62887998|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33506037|NCT02718898|62887999|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33506038|NCT02718898|62888000|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33506039|NCT02718898|62887994|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
33506040|NCT02718898|62887995|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
33506041|NCT02718898|62887996|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
33506042|NCT02718898|62887997|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
33506043|NCT02718898|62887998|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
33506044|NCT02718898|62887999|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
33506045|NCT02718898|62888000|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
33506046|NCT02718898|62887994|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
33506047|NCT02718898|62887995|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
33506048|NCT02718898|62887996|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
33506049|NCT02718898|62887997|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
33506050|NCT02718898|62887998|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
33506051|NCT02718898|62887999|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
33506052|NCT02718898|62888000|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
33450268|NCT00428597|62825004|FG001|Overall Study|Global Deterioration of Health Status|5|||
33450269|NCT00428597|62825003|FG000|Overall Study|Protocol Violation|2|||
33450270|NCT00428597|62825004|FG001|Overall Study|Protocol Violation|1|||
33450271|NCT00428597|62825003|FG000|Overall Study|Withdrawal by Subject|2|||
33450272|NCT00428597|62825004|FG001|Overall Study|Withdrawal by Subject|1|||
33450273|NCT00428597|62825003|FG000|Overall Study|Other|1|||
33450274|NCT00428597|62825004|FG001|Overall Study|Other|1|||
33450275|NCT00428597|62825003|FG000|Overall Study|Lost to Follow-up|0|||
33450276|NCT00428597|62825004|FG001|Overall Study|Lost to Follow-up|1|||
33450277|NCT00428597|62825003|FG000|Overall Study|Pregnancy|1|||
33450278|NCT00428597|62825004|FG001|Overall Study|Pregnancy|0|||
33450279|NCT00428597|62825003|FG000|Overall Study|Death|1|||
33450280|NCT00428597|62825004|FG001|Overall Study|Death|3|||
33450281|NCT00428441|62825010|FG000|Overall Study|Lost to Follow-up|1|||
33450282|NCT00144339|62825016|FG000|Overall Study|Adverse Event|746|||
33450283|NCT00144339|62825017|FG001|Overall Study|Adverse Event|627|||
33450284|NCT00144339|62825016|FG000|Overall Study|Protocol Violation|75|||
33450285|NCT00144339|62825017|FG001|Overall Study|Protocol Violation|48|||
33450286|NCT00144339|62825016|FG000|Overall Study|Withdrawal by Subject|403|||
33450287|NCT00144339|62825017|FG001|Overall Study|Withdrawal by Subject|300|||
33450288|NCT00144339|62825016|FG000|Overall Study|Lost to Follow-up|76|||
33450289|NCT00144339|62825017|FG001|Overall Study|Lost to Follow-up|64|||
33450290|NCT00144339|62825016|FG000|Overall Study|Other|58|||
33450291|NCT00144339|62825017|FG001|Overall Study|Other|60|||
33450292|NCT00144027|62825025|FG000|Overall Study|Lost to Follow-up|1|||
33450293|NCT00144027|62825026|FG001|Overall Study|Lost to Follow-up|3|||
33450294|NCT00144027|62825025|FG000|Overall Study|Withdrawal by Subject|2|||
33450295|NCT00144027|62825026|FG001|Overall Study|Withdrawal by Subject|2|||
33450296|NCT00144027|62825025|FG000|Overall Study|did not complete baseline assessment|0|||
33450297|NCT00144027|62825026|FG001|Overall Study|did not complete baseline assessment|6|||
33450298|NCT00127803|62825036|FG000|Overall Study|Adverse Event|2|||
33450299|NCT00127803|62825037|FG001|Overall Study|Adverse Event|0|||
33450300|NCT00127803|62825038|FG002|Overall Study|Adverse Event|0|||
33450301|NCT00127803|62825039|FG003|Overall Study|Adverse Event|0|||
33450302|NCT00127803|62825036|FG000|Overall Study|Withdrawal by Subject|1|||
33450303|NCT00127803|62825037|FG001|Overall Study|Withdrawal by Subject|0|||
33506053|NCT02718898|62887994|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
33506054|NCT02718898|62887995|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
33506055|NCT02718898|62887996|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
33506056|NCT02718898|62887997|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
33506057|NCT02718898|62887998|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
33506058|NCT02718898|62887999|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
33506059|NCT02718898|62888000|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
33506060|NCT02718898|62887994|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
33506061|NCT02718898|62887995|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
33506062|NCT02718898|62887996|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
33506063|NCT02718898|62887997|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
33506064|NCT02718898|62887998|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
33506065|NCT02718898|62887999|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
33506066|NCT02718898|62888000|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
33506067|NCT02718898|62887994|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
33506068|NCT02718898|62887995|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
33506069|NCT02718898|62887996|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
33506070|NCT02718898|62887997|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
33506071|NCT02718898|62887998|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
33506072|NCT02718898|62887999|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
33506073|NCT02718898|62888000|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
33506074|NCT02718898|62887994|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33506075|NCT02718898|62887995|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33506076|NCT02718898|62887996|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33450304|NCT00127803|62825038|FG002|Overall Study|Withdrawal by Subject|0|||
33450305|NCT00127803|62825039|FG003|Overall Study|Withdrawal by Subject|0|||
33450306|NCT00127803|62825036|FG000|Overall Study|Lost to Follow-up|0|||
33450307|NCT00127803|62825037|FG001|Overall Study|Lost to Follow-up|0|||
33450308|NCT00127803|62825038|FG002|Overall Study|Lost to Follow-up|0|||
33450309|NCT00127803|62825039|FG003|Overall Study|Lost to Follow-up|1|||
33450310|NCT00127413|62825053|FG000|Overall Study|Lost to Follow-up|6|||
33450311|NCT00127413|62825054|FG001|Overall Study|Lost to Follow-up|4|||
33450312|NCT00127413|62825055|FG002|Overall Study|Lost to Follow-up|8|||
33450313|NCT00127413|62825056|FG003|Overall Study|Lost to Follow-up|2|||
33450314|NCT00143403|62825068|FG000|Overall Study|Adverse Event|3|||
33450315|NCT00143403|62825069|FG001|Overall Study|Adverse Event|8|||
33450316|NCT00143403|62825068|FG000|Overall Study|Death|1|||
33450317|NCT00143403|62825069|FG001|Overall Study|Death|0|||
33450318|NCT00143403|62825068|FG000|Overall Study|Withdrawal by Subject|3|||
33450319|NCT00143403|62825069|FG001|Overall Study|Withdrawal by Subject|12|||
33450320|NCT00143403|62825068|FG000|Overall Study|Relapse|15|||
33450321|NCT00143403|62825069|FG001|Overall Study|Relapse|7|||
33450322|NCT00143403|62825068|FG000|Overall Study|Protocol Violation|2|||
33506077|NCT02718898|62887997|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33506078|NCT02718898|62887998|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33506079|NCT02718898|62887999|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
33506080|NCT02718898|62888000|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
33506081|NCT03143166|62888017|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
33506082|NCT02879994|62888023|FG000|Overall Study|off treatment early|7|||
33506083|NCT02879994|62888023|FG000|Overall Study|Adverse Event|2|||
33506084|NCT02879994|62888023|FG000|Overall Study|Death|2|||
33506085|NCT03142932|62888029|FG000|Overall Study|Lost to Follow-up|2|||
33506086|NCT03142932|62888030|FG001|Overall Study|Lost to Follow-up|11|||
33506087|NCT00702052|62888036|FG000|Overall Study|Adverse Event|23|||
33506088|NCT00702052|62888036|FG000|Overall Study|Disease Progression|30|||
33506089|NCT00702052|62888036|FG000|Overall Study|Withdrawal by Subject|5|||
33506090|NCT03140280|62888040|FG000|Overall Study|Physician Decision|5|||
33506091|NCT03136380|62888046|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
33506092|NCT03136380|62888047|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
33506093|NCT03136380|62888048|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
33506094|NCT03136380|62888049|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
33506095|NCT03136380|62888050|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
33506096|NCT03136068|62888070|FG000|Overall Study|Lost to Follow-up|1|||
33506097|NCT03136068|62888071|FG001|Overall Study|Lost to Follow-up|1|||
33506098|NCT03136068|62888070|FG000|Overall Study|Protocol Violation|1|||
33506099|NCT03136068|62888071|FG001|Overall Study|Protocol Violation|0|||
33450323|NCT00143403|62825069|FG001|Overall Study|Protocol Violation|2|||
33450324|NCT00143403|62825068|FG000|Overall Study|specified by site|4|||
33450325|NCT00143403|62825069|FG001|Overall Study|specified by site|9|||
33450326|NCT00143403|62825068|FG000|Overall Study|Randomized Not Treated|7|||
33450327|NCT00143403|62825069|FG001|Overall Study|Randomized Not Treated|8|||
33450328|NCT00220701|62825077|FG000|Overall Study|Lost to Follow-up|5|||
33506100|NCT02585232|62888079|FG000|Overall Study|Lost to Follow-up|8|||
33506101|NCT02585232|62888080|FG001|Overall Study|Lost to Follow-up|8|||
33611974|NCT01644500|63012433|FG002|Overall Study|Physician Decision|1|||
33611975|NCT01604824|63012445|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
33611976|NCT01604824|63012446|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
33611977|NCT01604824|63012447|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
33450329|NCT00220701|62825078|FG001|Overall Study|Lost to Follow-up|4|||
33450330|NCT00127101|62825090|FG000|Base Protocol|Adverse Event|0|||
33450331|NCT00127101|62825091|FG001|Base Protocol|Adverse Event|2|||
33450332|NCT00127101|62825092|FG002|Base Protocol|Adverse Event|1|||
33450333|NCT00127101|62825093|FG003|Base Protocol|Adverse Event|0|||
33450334|NCT00127101|62825094|FG004|Base Protocol|Adverse Event|0|||
33450335|NCT00127101|62825095|FG005|Base Protocol|Adverse Event|0|||
33450336|NCT00127101|62825090|FG000|Base Protocol|Lack of Efficacy|1|||
33450337|NCT00127101|62825091|FG001|Base Protocol|Lack of Efficacy|0|||
33450338|NCT00127101|62825092|FG002|Base Protocol|Lack of Efficacy|0|||
33450339|NCT00127101|62825093|FG003|Base Protocol|Lack of Efficacy|0|||
33450340|NCT00127101|62825094|FG004|Base Protocol|Lack of Efficacy|2|||
33450341|NCT00127101|62825095|FG005|Base Protocol|Lack of Efficacy|0|||
33450342|NCT00127101|62825090|FG000|Base Protocol|Withdrawal by Subject|1|||
33450343|NCT00127101|62825091|FG001|Base Protocol|Withdrawal by Subject|2|||
33450344|NCT00127101|62825092|FG002|Base Protocol|Withdrawal by Subject|1|||
33450345|NCT00127101|62825093|FG003|Base Protocol|Withdrawal by Subject|0|||
33450346|NCT00127101|62825094|FG004|Base Protocol|Withdrawal by Subject|0|||
33450347|NCT00127101|62825095|FG005|Base Protocol|Withdrawal by Subject|1|||
33450348|NCT00127101|62825090|FG000|Continuation Phase|Adverse Event|0|||
33450349|NCT00127101|62825091|FG001|Continuation Phase|Adverse Event|0|||
33450350|NCT00127101|62825092|FG002|Continuation Phase|Adverse Event|0|||
33450351|NCT00127101|62825093|FG003|Continuation Phase|Adverse Event|0|||
33450352|NCT00127101|62825094|FG004|Continuation Phase|Adverse Event|1|||
33450353|NCT00127101|62825095|FG005|Continuation Phase|Adverse Event|1|||
33450354|NCT00127101|62825090|FG000|Continuation Phase|Lack of Efficacy|0|||
33450355|NCT00127101|62825091|FG001|Continuation Phase|Lack of Efficacy|0|||
33450356|NCT00127101|62825092|FG002|Continuation Phase|Lack of Efficacy|0|||
33450357|NCT00127101|62825093|FG003|Continuation Phase|Lack of Efficacy|0|||
33450358|NCT00127101|62825094|FG004|Continuation Phase|Lack of Efficacy|0|||
33450359|NCT00127101|62825095|FG005|Continuation Phase|Lack of Efficacy|1|||
33450360|NCT00127101|62825090|FG000|Continuation Phase|Withdrawal by Subject|0|||
33450361|NCT00127101|62825091|FG001|Continuation Phase|Withdrawal by Subject|0|||
33450362|NCT00127101|62825092|FG002|Continuation Phase|Withdrawal by Subject|1|||
33450363|NCT00127101|62825093|FG003|Continuation Phase|Withdrawal by Subject|0|||
33450364|NCT00127101|62825094|FG004|Continuation Phase|Withdrawal by Subject|2|||
33450365|NCT00127101|62825095|FG005|Continuation Phase|Withdrawal by Subject|1|||
33450366|NCT00126555|62825109|FG000|Overall Study|Withdrawal by Subject|1|||
33450367|NCT00126555|62825109|FG000|Overall Study|Adverse Event|2|||
33450368|NCT00126555|62825109|FG000|Overall Study|Progressive Disease|3|||
33450369|NCT00004228|62825132|FG000|Overall Study|Adverse Event|0|||
33450370|NCT00004228|62825133|FG001|Overall Study|Adverse Event|1|||
33450371|NCT00004228|62825134|FG002|Overall Study|Adverse Event|0|||
33450372|NCT00004228|62825135|FG003|Overall Study|Adverse Event|0|||
33450373|NCT00004228|62825136|FG004|Overall Study|Adverse Event|1|||
33450374|NCT00004228|62825137|FG005|Overall Study|Adverse Event|0|||
33506102|NCT02585232|62888079|FG000|Overall Study|Withdrawal by Subject|4|||
33506103|NCT02585232|62888080|FG001|Overall Study|Withdrawal by Subject|8|||
33506104|NCT03377790|62888109|FG000|Overall Study|Withdrawal by Subject|1|||
33506105|NCT03377790|62888110|FG001|Overall Study|Withdrawal by Subject|0|||
33506106|NCT03377790|62888109|FG000|Overall Study|Adverse Event|1|||
33506107|NCT03377790|62888110|FG001|Overall Study|Adverse Event|0|||
33506108|NCT03377790|62888109|FG000|Overall Study|Lost to Follow-up|0|||
33506109|NCT03377790|62888110|FG001|Overall Study|Lost to Follow-up|2|||
33506110|NCT03377790|62888109|FG000|Overall Study|Randomized but not treated|1|||
33506111|NCT03377790|62888110|FG001|Overall Study|Randomized but not treated|0|||
33506112|NCT03377790|62888109|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
33506113|NCT03377790|62888110|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
33506114|NCT02717494|62888119|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
33450375|NCT00004228|62825138|FG006|Overall Study|Adverse Event|0|||
33450376|NCT00004228|62825132|FG000|Overall Study|Death|0|||
33450377|NCT00004228|62825133|FG001|Overall Study|Death|1|||
33450378|NCT00004228|62825134|FG002|Overall Study|Death|2|||
33450379|NCT00004228|62825135|FG003|Overall Study|Death|0|||
33450380|NCT00004228|62825136|FG004|Overall Study|Death|1|||
33450381|NCT00004228|62825137|FG005|Overall Study|Death|0|||
33450382|NCT00004228|62825138|FG006|Overall Study|Death|0|||
33450383|NCT00004228|62825132|FG000|Overall Study|Lack of Efficacy|1|||
33450384|NCT00004228|62825133|FG001|Overall Study|Lack of Efficacy|6|||
33450385|NCT00004228|62825134|FG002|Overall Study|Lack of Efficacy|5|||
33506115|NCT02717494|62888120|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
33506116|NCT02717494|62888121|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
33506117|NCT02717494|62888119|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
33506118|NCT02717494|62888120|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
33506119|NCT02717494|62888121|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
33506120|NCT02717494|62888119|FG000|First Intervention (Step 1)|Death|0|||
33506121|NCT02717494|62888120|FG001|First Intervention (Step 1)|Death|0|||
33506122|NCT02717494|62888121|FG002|First Intervention (Step 1)|Death|1|||
33506123|NCT02717494|62888119|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
33506124|NCT02717494|62888120|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
33506125|NCT02717494|62888121|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
33506126|NCT01844856|62888149|FG000|Overall Study|Lost to Follow-up|15|||
33506127|NCT01844856|62888150|FG001|Overall Study|Lost to Follow-up|3|||
33506128|NCT01844856|62888149|FG000|Overall Study|Adverse Event|3|||
33506129|NCT01844856|62888150|FG001|Overall Study|Adverse Event|6|||
33506130|NCT01844856|62888149|FG000|Overall Study|Withdrawal by Subject|3|||
33506131|NCT01844856|62888150|FG001|Overall Study|Withdrawal by Subject|2|||
33506132|NCT01844856|62888149|FG000|Overall Study|Noncompliance|2|||
33506133|NCT01844856|62888150|FG001|Overall Study|Noncompliance|3|||
33506134|NCT01844856|62888149|FG000|Overall Study|Enterococcus Resistant|0|||
33506135|NCT01844856|62888150|FG001|Overall Study|Enterococcus Resistant|1|||
33506136|NCT01844856|62888149|FG000|Overall Study|Inadvertently Not Scheduled|1|||
33506137|NCT01844856|62888150|FG001|Overall Study|Inadvertently Not Scheduled|0|||
33506138|NCT01844856|62888149|FG000|Overall Study|Randomized but was a Screen Failure|0|||
33506139|NCT01844856|62888150|FG001|Overall Study|Randomized but was a Screen Failure|1|||
33506140|NCT03135210|62888186|FG000|Overall Study|Death|0|||
33506141|NCT03135210|62888187|FG001|Overall Study|Death|1|||
33506142|NCT00701662|62888193|FG000|Overall Study|Lack of Efficacy|1|||
33611978|NCT01604824|63012448|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
33611979|NCT01604824|63012449|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
33611980|NCT01604824|63012450|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
33611981|NCT01604824|63012445|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
33611982|NCT01604824|63012446|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
33611983|NCT01604824|63012447|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
33506143|NCT02878590|62888197|FG000|Overall Study|Withdrawal by Subject|2|||
33506144|NCT04634409|62888228|FG000|Overall Study|Death|0|||
33506145|NCT04634409|62888229|FG001|Overall Study|Death|0|||
33506146|NCT04634409|62888230|FG002|Overall Study|Death|0|||
33506147|NCT04634409|62888231|FG003|Overall Study|Death|0|||
33506148|NCT04634409|62888232|FG004|Overall Study|Death|0|||
33506149|NCT04634409|62888233|FG005|Overall Study|Death|0|||
33506150|NCT04634409|62888234|FG006|Overall Study|Death|0|||
33506151|NCT04634409|62888235|FG007|Overall Study|Death|0|||
33506152|NCT04634409|62888236|FG008|Overall Study|Death|0|||
33611984|NCT01604824|63012448|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
33611985|NCT01604824|63012449|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
33611986|NCT01604824|63012450|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
33611987|NCT01716052|63012464|FG000|Overall Study|Withdrawal of funding|1|||
33611988|NCT01716052|63012465|FG001|Overall Study|Withdrawal of funding|1|||
33506153|NCT04634409|62888237|FG009|Overall Study|Death|0|||
33506154|NCT04634409|62888238|FG010|Overall Study|Death|1|||
33506155|NCT04634409|62888239|FG011|Overall Study|Death|0|||
33506156|NCT04634409|62888240|FG012|Overall Study|Death|1|||
33506157|NCT04634409|62888241|FG013|Overall Study|Death|0|||
33506158|NCT04634409|62888242|FG014|Overall Study|Death|0|||
33506159|NCT04634409|62888243|FG015|Overall Study|Death|0|||
33506160|NCT04634409|62888244|FG016|Overall Study|Death|0|||
33506161|NCT04634409|62888245|FG017|Overall Study|Death|0|||
33506162|NCT04634409|62888246|FG018|Overall Study|Death|0|||
33506163|NCT04634409|62888247|FG019|Overall Study|Death|0|||
33506164|NCT04634409|62888248|FG020|Overall Study|Death|0|||
33506165|NCT04634409|62888249|FG021|Overall Study|Death|0|||
33506166|NCT04634409|62888250|FG022|Overall Study|Death|0|||
33506167|NCT04634409|62888251|FG023|Overall Study|Death|0|||
33506168|NCT04634409|62888252|FG024|Overall Study|Death|0|||
33506169|NCT04634409|62888253|FG025|Overall Study|Death|0|||
33506170|NCT04634409|62888254|FG026|Overall Study|Death|0|||
33506171|NCT04634409|62888228|FG000|Overall Study|Adverse Event|0|||
33506172|NCT04634409|62888229|FG001|Overall Study|Adverse Event|0|||
33506173|NCT04634409|62888230|FG002|Overall Study|Adverse Event|1|||
33506174|NCT04634409|62888231|FG003|Overall Study|Adverse Event|0|||
33506175|NCT04634409|62888232|FG004|Overall Study|Adverse Event|0|||
33506176|NCT04634409|62888233|FG005|Overall Study|Adverse Event|1|||
33611989|NCT01641692|63012471|FG000|Treatment Period 1|Adverse Event|1|||
33324291|NCT00960531|62700742|FG004|Overall Study|Withdrawal by Subject|0|||
33324292|NCT00960531|62700743|FG005|Overall Study|Withdrawal by Subject|0|||
33506177|NCT04634409|62888234|FG006|Overall Study|Adverse Event|0|||
33506178|NCT04634409|62888235|FG007|Overall Study|Adverse Event|0|||
33506179|NCT04634409|62888236|FG008|Overall Study|Adverse Event|0|||
33506180|NCT04634409|62888237|FG009|Overall Study|Adverse Event|0|||
33506181|NCT04634409|62888238|FG010|Overall Study|Adverse Event|0|||
33506182|NCT04634409|62888239|FG011|Overall Study|Adverse Event|0|||
33506183|NCT04634409|62888240|FG012|Overall Study|Adverse Event|0|||
33506184|NCT04634409|62888241|FG013|Overall Study|Adverse Event|0|||
33506185|NCT04634409|62888242|FG014|Overall Study|Adverse Event|0|||
33506186|NCT04634409|62888243|FG015|Overall Study|Adverse Event|0|||
33506187|NCT04634409|62888244|FG016|Overall Study|Adverse Event|0|||
33506188|NCT04634409|62888245|FG017|Overall Study|Adverse Event|0|||
33506189|NCT04634409|62888246|FG018|Overall Study|Adverse Event|0|||
33506190|NCT04634409|62888247|FG019|Overall Study|Adverse Event|0|||
33506191|NCT04634409|62888248|FG020|Overall Study|Adverse Event|0|||
33506192|NCT04634409|62888249|FG021|Overall Study|Adverse Event|0|||
33506193|NCT04634409|62888250|FG022|Overall Study|Adverse Event|0|||
33506194|NCT04634409|62888251|FG023|Overall Study|Adverse Event|0|||
33506195|NCT04634409|62888252|FG024|Overall Study|Adverse Event|0|||
33506196|NCT04634409|62888253|FG025|Overall Study|Adverse Event|0|||
33506197|NCT04634409|62888254|FG026|Overall Study|Adverse Event|0|||
33506198|NCT04634409|62888228|FG000|Overall Study|Lost to Follow-up|3|||
33506199|NCT04634409|62888229|FG001|Overall Study|Lost to Follow-up|1|||
33506200|NCT04634409|62888230|FG002|Overall Study|Lost to Follow-up|1|||
33506201|NCT04634409|62888231|FG003|Overall Study|Lost to Follow-up|3|||
33506202|NCT04634409|62888232|FG004|Overall Study|Lost to Follow-up|1|||
33506203|NCT04634409|62888233|FG005|Overall Study|Lost to Follow-up|1|||
33506204|NCT04634409|62888234|FG006|Overall Study|Lost to Follow-up|1|||
33506205|NCT04634409|62888235|FG007|Overall Study|Lost to Follow-up|3|||
33506206|NCT04634409|62888236|FG008|Overall Study|Lost to Follow-up|3|||
33506207|NCT04634409|62888237|FG009|Overall Study|Lost to Follow-up|11|||
33506208|NCT04634409|62888238|FG010|Overall Study|Lost to Follow-up|8|||
33506209|NCT04634409|62888239|FG011|Overall Study|Lost to Follow-up|15|||
33611990|NCT01641692|63012472|FG001|Treatment Period 1|Adverse Event|0|||
33611991|NCT01641692|63012473|FG002|Treatment Period 1|Adverse Event|0|||
33611992|NCT01641692|63012474|FG003|Treatment Period 1|Adverse Event|0|||
33611993|NCT01641692|63012475|FG004|Treatment Period 1|Adverse Event|0|||
33611994|NCT01641692|63012476|FG005|Treatment Period 1|Adverse Event|0|||
33611995|NCT01641692|63012477|FG006|Treatment Period 1|Adverse Event|0|||
33611996|NCT01641692|63012478|FG007|Treatment Period 1|Adverse Event|0|||
33611997|NCT01641692|63012471|FG000|Treatment Period 1|Lack of Efficacy|0|||
33611998|NCT01641692|63012472|FG001|Treatment Period 1|Lack of Efficacy|0|||
33611999|NCT01641692|63012473|FG002|Treatment Period 1|Lack of Efficacy|0|||
33612000|NCT01641692|63012474|FG003|Treatment Period 1|Lack of Efficacy|0|||
33612001|NCT01641692|63012475|FG004|Treatment Period 1|Lack of Efficacy|0|||
33612002|NCT01641692|63012476|FG005|Treatment Period 1|Lack of Efficacy|0|||
33612003|NCT01641692|63012477|FG006|Treatment Period 1|Lack of Efficacy|0|||
33612004|NCT01641692|63012478|FG007|Treatment Period 1|Lack of Efficacy|1|||
33612005|NCT01641692|63012471|FG000|Treatment Period 1|Protocol Violation|1|||
33612006|NCT01641692|63012472|FG001|Treatment Period 1|Protocol Violation|0|||
33450386|NCT00004228|62825135|FG003|Overall Study|Lack of Efficacy|3|||
33450387|NCT00004228|62825136|FG004|Overall Study|Lack of Efficacy|9|||
33450388|NCT00004228|62825137|FG005|Overall Study|Lack of Efficacy|8|||
33450389|NCT00004228|62825138|FG006|Overall Study|Lack of Efficacy|4|||
33450390|NCT00004228|62825132|FG000|Overall Study|Lost to Follow-up|0|||
33506210|NCT04634409|62888240|FG012|Overall Study|Lost to Follow-up|3|||
33506211|NCT04634409|62888241|FG013|Overall Study|Lost to Follow-up|2|||
33506212|NCT04634409|62888242|FG014|Overall Study|Lost to Follow-up|7|||
33506213|NCT04634409|62888243|FG015|Overall Study|Lost to Follow-up|0|||
33506214|NCT04634409|62888244|FG016|Overall Study|Lost to Follow-up|0|||
33506215|NCT04634409|62888245|FG017|Overall Study|Lost to Follow-up|0|||
33450391|NCT00004228|62825133|FG001|Overall Study|Lost to Follow-up|0|||
33450392|NCT00004228|62825134|FG002|Overall Study|Lost to Follow-up|1|||
33450393|NCT00004228|62825135|FG003|Overall Study|Lost to Follow-up|0|||
33450394|NCT00004228|62825136|FG004|Overall Study|Lost to Follow-up|0|||
33450395|NCT00004228|62825137|FG005|Overall Study|Lost to Follow-up|0|||
33506216|NCT04634409|62888246|FG018|Overall Study|Lost to Follow-up|0|||
33506217|NCT04634409|62888247|FG019|Overall Study|Lost to Follow-up|0|||
33506218|NCT04634409|62888248|FG020|Overall Study|Lost to Follow-up|0|||
33506219|NCT04634409|62888249|FG021|Overall Study|Lost to Follow-up|0|||
33506220|NCT04634409|62888250|FG022|Overall Study|Lost to Follow-up|0|||
33506221|NCT04634409|62888251|FG023|Overall Study|Lost to Follow-up|0|||
33506222|NCT04634409|62888252|FG024|Overall Study|Lost to Follow-up|0|||
33612007|NCT01641692|63012473|FG002|Treatment Period 1|Protocol Violation|0|||
33450396|NCT00004228|62825138|FG006|Overall Study|Lost to Follow-up|0|||
33450397|NCT00004228|62825132|FG000|Overall Study|Physician Decision|1|||
33506223|NCT04634409|62888253|FG025|Overall Study|Lost to Follow-up|0|||
33506224|NCT04634409|62888254|FG026|Overall Study|Lost to Follow-up|0|||
33506225|NCT04634409|62888228|FG000|Overall Study|Withdrawal by Subject|3|||
33612008|NCT01641692|63012474|FG003|Treatment Period 1|Protocol Violation|0|||
33612009|NCT01641692|63012475|FG004|Treatment Period 1|Protocol Violation|2|||
33506226|NCT04634409|62888229|FG001|Overall Study|Withdrawal by Subject|1|||
33506227|NCT04634409|62888230|FG002|Overall Study|Withdrawal by Subject|6|||
33506228|NCT04634409|62888231|FG003|Overall Study|Withdrawal by Subject|4|||
33506229|NCT04634409|62888232|FG004|Overall Study|Withdrawal by Subject|2|||
33506230|NCT04634409|62888233|FG005|Overall Study|Withdrawal by Subject|0|||
33506231|NCT04634409|62888234|FG006|Overall Study|Withdrawal by Subject|0|||
33506232|NCT04634409|62888235|FG007|Overall Study|Withdrawal by Subject|2|||
33506233|NCT04634409|62888236|FG008|Overall Study|Withdrawal by Subject|3|||
33506234|NCT04634409|62888237|FG009|Overall Study|Withdrawal by Subject|2|||
33506235|NCT04634409|62888238|FG010|Overall Study|Withdrawal by Subject|3|||
33506236|NCT04634409|62888239|FG011|Overall Study|Withdrawal by Subject|2|||
33506237|NCT04634409|62888240|FG012|Overall Study|Withdrawal by Subject|2|||
33506238|NCT04634409|62888241|FG013|Overall Study|Withdrawal by Subject|1|||
33506239|NCT04634409|62888242|FG014|Overall Study|Withdrawal by Subject|5|||
33506240|NCT04634409|62888243|FG015|Overall Study|Withdrawal by Subject|0|||
33506241|NCT04634409|62888244|FG016|Overall Study|Withdrawal by Subject|0|||
33506242|NCT04634409|62888245|FG017|Overall Study|Withdrawal by Subject|1|||
33506243|NCT04634409|62888246|FG018|Overall Study|Withdrawal by Subject|0|||
33506244|NCT04634409|62888247|FG019|Overall Study|Withdrawal by Subject|0|||
33506245|NCT04634409|62888248|FG020|Overall Study|Withdrawal by Subject|0|||
33506246|NCT04634409|62888249|FG021|Overall Study|Withdrawal by Subject|0|||
33506247|NCT04634409|62888250|FG022|Overall Study|Withdrawal by Subject|0|||
33450398|NCT00004228|62825133|FG001|Overall Study|Physician Decision|0|||
33450399|NCT00004228|62825134|FG002|Overall Study|Physician Decision|3|||
33450400|NCT00004228|62825135|FG003|Overall Study|Physician Decision|2|||
33450401|NCT00004228|62825136|FG004|Overall Study|Physician Decision|1|||
33450402|NCT00004228|62825137|FG005|Overall Study|Physician Decision|1|||
33450403|NCT00004228|62825138|FG006|Overall Study|Physician Decision|1|||
33450404|NCT00004228|62825132|FG000|Overall Study|Protocol Violation|0|||
33450405|NCT00004228|62825133|FG001|Overall Study|Protocol Violation|5|||
33450406|NCT00004228|62825134|FG002|Overall Study|Protocol Violation|2|||
33450407|NCT00004228|62825135|FG003|Overall Study|Protocol Violation|1|||
33450408|NCT00004228|62825136|FG004|Overall Study|Protocol Violation|1|||
33450409|NCT00004228|62825137|FG005|Overall Study|Protocol Violation|2|||
33450410|NCT00004228|62825138|FG006|Overall Study|Protocol Violation|0|||
33450411|NCT00004228|62825132|FG000|Overall Study|Withdrawal by Subject|3|||
33450412|NCT00004228|62825133|FG001|Overall Study|Withdrawal by Subject|0|||
33450413|NCT00004228|62825134|FG002|Overall Study|Withdrawal by Subject|1|||
33450414|NCT00004228|62825135|FG003|Overall Study|Withdrawal by Subject|0|||
33450415|NCT00004228|62825136|FG004|Overall Study|Withdrawal by Subject|2|||
33450416|NCT00004228|62825137|FG005|Overall Study|Withdrawal by Subject|1|||
33450417|NCT00004228|62825138|FG006|Overall Study|Withdrawal by Subject|2|||
33450418|NCT00004228|62825132|FG000|Overall Study|Other|0|||
33450419|NCT00004228|62825133|FG001|Overall Study|Other|0|||
33450420|NCT00004228|62825134|FG002|Overall Study|Other|1|||
33450421|NCT00004228|62825135|FG003|Overall Study|Other|0|||
33450422|NCT00004228|62825136|FG004|Overall Study|Other|0|||
33450423|NCT00004228|62825137|FG005|Overall Study|Other|0|||
33450424|NCT00004228|62825138|FG006|Overall Study|Other|0|||
33450425|NCT00004228|62825132|FG000|Overall Study|ineligible|4|||
33450426|NCT00004228|62825133|FG001|Overall Study|ineligible|2|||
33450427|NCT00004228|62825134|FG002|Overall Study|ineligible|4|||
33450428|NCT00004228|62825135|FG003|Overall Study|ineligible|1|||
33450429|NCT00004228|62825136|FG004|Overall Study|ineligible|1|||
33450430|NCT00004228|62825137|FG005|Overall Study|ineligible|2|||
33450431|NCT00004228|62825138|FG006|Overall Study|ineligible|5|||
33450432|NCT00003526|62825155|FG000|Overall Study|Not evaluable|6|||
33450433|NCT00195260|62825161|FG000|Part 1: Dose Escalation|Adverse Event|0|||
33450434|NCT00195260|62825162|FG001|Part 1: Dose Escalation|Adverse Event|1|||
33450435|NCT00195260|62825163|FG002|Part 1: Dose Escalation|Adverse Event|0|||
33450436|NCT00195260|62825164|FG003|Part 1: Dose Escalation|Adverse Event|1|||
33450437|NCT00195260|62825165|FG004|Part 1: Dose Escalation|Adverse Event|1|||
33450438|NCT00195260|62825166|FG005|Part 1: Dose Escalation|Adverse Event|0|||
33450439|NCT00195260|62825167|FG006|Part 1: Dose Escalation|Adverse Event|3|||
33506248|NCT04634409|62888251|FG023|Overall Study|Withdrawal by Subject|1|||
33506249|NCT04634409|62888252|FG024|Overall Study|Withdrawal by Subject|0|||
33450440|NCT00195260|62825168|FG007|Part 1: Dose Escalation|Adverse Event|0|||
33450441|NCT00195260|62825169|FG008|Part 1: Dose Escalation|Adverse Event|0|||
33450442|NCT00195260|62825170|FG009|Part 1: Dose Escalation|Adverse Event|0|||
33450443|NCT00195260|62825171|FG010|Part 1: Dose Escalation|Adverse Event|0|||
33450444|NCT00195260|62825161|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33450445|NCT00195260|62825162|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33450446|NCT00195260|62825163|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33450447|NCT00195260|62825164|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33506250|NCT04634409|62888253|FG025|Overall Study|Withdrawal by Subject|0|||
33506251|NCT04634409|62888254|FG026|Overall Study|Withdrawal by Subject|0|||
33506252|NCT04634409|62888228|FG000|Overall Study|Other - As reported by Investigator|1|||
33506253|NCT04634409|62888229|FG001|Overall Study|Other - As reported by Investigator|0|||
33506254|NCT04634409|62888230|FG002|Overall Study|Other - As reported by Investigator|0|||
33506255|NCT04634409|62888231|FG003|Overall Study|Other - As reported by Investigator|0|||
33506256|NCT04634409|62888232|FG004|Overall Study|Other - As reported by Investigator|0|||
33506257|NCT04634409|62888233|FG005|Overall Study|Other - As reported by Investigator|0|||
33506258|NCT04634409|62888234|FG006|Overall Study|Other - As reported by Investigator|0|||
33506259|NCT04634409|62888235|FG007|Overall Study|Other - As reported by Investigator|6|||
33506260|NCT04634409|62888236|FG008|Overall Study|Other - As reported by Investigator|4|||
33506261|NCT04634409|62888237|FG009|Overall Study|Other - As reported by Investigator|0|||
33506262|NCT04634409|62888238|FG010|Overall Study|Other - As reported by Investigator|1|||
33506263|NCT04634409|62888239|FG011|Overall Study|Other - As reported by Investigator|2|||
33506264|NCT04634409|62888240|FG012|Overall Study|Other - As reported by Investigator|2|||
33506265|NCT04634409|62888241|FG013|Overall Study|Other - As reported by Investigator|1|||
33506266|NCT04634409|62888242|FG014|Overall Study|Other - As reported by Investigator|0|||
33506267|NCT04634409|62888243|FG015|Overall Study|Other - As reported by Investigator|0|||
33506268|NCT04634409|62888244|FG016|Overall Study|Other - As reported by Investigator|0|||
33506269|NCT04634409|62888245|FG017|Overall Study|Other - As reported by Investigator|0|||
33506270|NCT04634409|62888246|FG018|Overall Study|Other - As reported by Investigator|0|||
33506271|NCT04634409|62888247|FG019|Overall Study|Other - As reported by Investigator|0|||
33506272|NCT04634409|62888248|FG020|Overall Study|Other - As reported by Investigator|0|||
33506273|NCT04634409|62888249|FG021|Overall Study|Other - As reported by Investigator|0|||
33506274|NCT04634409|62888250|FG022|Overall Study|Other - As reported by Investigator|0|||
33506275|NCT04634409|62888251|FG023|Overall Study|Other - As reported by Investigator|0|||
33506276|NCT04634409|62888252|FG024|Overall Study|Other - As reported by Investigator|0|||
33506277|NCT04634409|62888253|FG025|Overall Study|Other - As reported by Investigator|0|||
33506278|NCT04634409|62888254|FG026|Overall Study|Other - As reported by Investigator|0|||
33506279|NCT00005780|62888332|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
33450448|NCT00195260|62825165|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
33450449|NCT00195260|62825166|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33450450|NCT00195260|62825167|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33450451|NCT00195260|62825168|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
33450452|NCT00195260|62825169|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33450453|NCT00195260|62825170|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33450454|NCT00195260|62825171|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33450455|NCT00195260|62825161|FG000|Part 1: Dose Escalation|Death|0|||
33450456|NCT00195260|62825162|FG001|Part 1: Dose Escalation|Death|0|||
33450457|NCT00195260|62825163|FG002|Part 1: Dose Escalation|Death|0|||
33450458|NCT00195260|62825164|FG003|Part 1: Dose Escalation|Death|0|||
33450459|NCT00195260|62825165|FG004|Part 1: Dose Escalation|Death|0|||
33450460|NCT00195260|62825166|FG005|Part 1: Dose Escalation|Death|0|||
33450461|NCT00195260|62825167|FG006|Part 1: Dose Escalation|Death|0|||
33450462|NCT00195260|62825168|FG007|Part 1: Dose Escalation|Death|1|||
33450463|NCT00195260|62825169|FG008|Part 1: Dose Escalation|Death|0|||
33450464|NCT00195260|62825170|FG009|Part 1: Dose Escalation|Death|0|||
33450465|NCT00195260|62825171|FG010|Part 1: Dose Escalation|Death|0|||
33450466|NCT00195260|62825161|FG000|Part 1: Dose Escalation|Disease Progression|3|||
33450467|NCT00195260|62825162|FG001|Part 1: Dose Escalation|Disease Progression|2|||
33450468|NCT00195260|62825163|FG002|Part 1: Dose Escalation|Disease Progression|5|||
33450469|NCT00195260|62825164|FG003|Part 1: Dose Escalation|Disease Progression|6|||
33450470|NCT00195260|62825165|FG004|Part 1: Dose Escalation|Disease Progression|4|||
33450471|NCT00195260|62825166|FG005|Part 1: Dose Escalation|Disease Progression|6|||
33450472|NCT00195260|62825167|FG006|Part 1: Dose Escalation|Disease Progression|7|||
33450473|NCT00195260|62825168|FG007|Part 1: Dose Escalation|Disease Progression|4|||
33450474|NCT00195260|62825169|FG008|Part 1: Dose Escalation|Disease Progression|0|||
33450475|NCT00195260|62825170|FG009|Part 1: Dose Escalation|Disease Progression|0|||
33450476|NCT00195260|62825171|FG010|Part 1: Dose Escalation|Disease Progression|0|||
33450477|NCT00195260|62825161|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
33450478|NCT00195260|62825162|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
33450479|NCT00195260|62825163|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
33450480|NCT00195260|62825164|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
33450481|NCT00195260|62825165|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
33450482|NCT00195260|62825166|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
33450483|NCT00195260|62825167|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
33450484|NCT00195260|62825168|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
33450485|NCT00195260|62825169|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
33506280|NCT01978938|62888341|FG000|Overall Study|Lost to Follow-up|12|||
33506281|NCT01978938|62888342|FG001|Overall Study|Lost to Follow-up|6|||
33506282|NCT01978938|62888341|FG000|Overall Study|Withdrawal by Subject|8|||
33506283|NCT01978938|62888342|FG001|Overall Study|Withdrawal by Subject|4|||
33450486|NCT00195260|62825170|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
33450487|NCT00195260|62825171|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
33450488|NCT00195260|62825161|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33506284|NCT01978938|62888341|FG000|Overall Study|Adverse Event, non-fatal|2|||
33506285|NCT01978938|62888342|FG001|Overall Study|Adverse Event, non-fatal|1|||
33506286|NCT01978938|62888341|FG000|Overall Study|Participant noncompliance|1|||
33506287|NCT01978938|62888342|FG001|Overall Study|Participant noncompliance|1|||
33506288|NCT01978938|62888341|FG000|Overall Study|Did not meet inclusion criteria|0|||
33506289|NCT01978938|62888342|FG001|Overall Study|Did not meet inclusion criteria|1|||
33506290|NCT01978938|62888341|FG000|Overall Study|Previously scheduled procedure|0|||
33506291|NCT01978938|62888342|FG001|Overall Study|Previously scheduled procedure|1|||
33506292|NCT03041090|62888350|FG000|Overall Study|technical error|0|||
33506293|NCT03041090|62888351|FG001|Overall Study|technical error|3|||
33506294|NCT00116142|62888359|FG000|Overall Study|Adverse Event|8|||
33506295|NCT00116142|62888360|FG001|Overall Study|Adverse Event|7|||
33506296|NCT00116142|62888359|FG000|Overall Study|Protocol Violation|2|||
33506297|NCT00116142|62888360|FG001|Overall Study|Protocol Violation|1|||
33506298|NCT00116142|62888359|FG000|Overall Study|Withdrawal by Subject|5|||
33506299|NCT00116142|62888360|FG001|Overall Study|Withdrawal by Subject|5|||
33506300|NCT00116142|62888359|FG000|Overall Study|Physician Decision|3|||
33506301|NCT00116142|62888360|FG001|Overall Study|Physician Decision|1|||
33506302|NCT00116142|62888359|FG000|Overall Study|Delayed Radiation Therapy|1|||
33506303|NCT00116142|62888360|FG001|Overall Study|Delayed Radiation Therapy|0|||
33506304|NCT00116142|62888359|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
33506305|NCT00116142|62888360|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
33506306|NCT00116142|62888359|FG000|Overall Study|Patient stopped due to depression|0|||
33506307|NCT00116142|62888360|FG001|Overall Study|Patient stopped due to depression|1|||
33506308|NCT00116142|62888359|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
33506309|NCT00116142|62888360|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
33506310|NCT00116142|62888359|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
33506311|NCT00116142|62888360|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
33506312|NCT00116142|62888359|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
33506313|NCT00116142|62888360|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
33506314|NCT03135522|62888371|FG000|Overall Study|Adverse Event|1|||
33506315|NCT03135522|62888372|FG001|Overall Study|Adverse Event|0|||
33506316|NCT02875080|62888395|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
33506317|NCT02875080|62888396|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
33506318|NCT02875080|62888397|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
33506319|NCT03129360|62888408|FG000|Overall Study|Did not meet entry criteria|0|||
33506320|NCT03129360|62888409|FG001|Overall Study|Did not meet entry criteria|2|||
33506321|NCT03129360|62888410|FG002|Overall Study|Did not meet entry criteria|1|||
33506322|NCT03129360|62888408|FG000|Overall Study|Excluded due to motion in scanner|1|||
33506323|NCT03129360|62888409|FG001|Overall Study|Excluded due to motion in scanner|0|||
33506324|NCT03129360|62888410|FG002|Overall Study|Excluded due to motion in scanner|0|||
33506325|NCT03165045|62888418|FG000|Visit 1|No registration after visit 1|9|||
33506326|NCT03165045|62888418|FG000|Visit 1|No treatment documented|10|||
33506327|NCT03165045|62888418|FG000|Visit 1|No visit 1|10|||
33506328|NCT03165045|62888418|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
33506329|NCT03165045|62888418|FG000|Visit 2|No available total CCQ score at all|29|||
33450489|NCT00195260|62825162|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33450490|NCT00195260|62825163|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33450491|NCT00195260|62825164|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33450492|NCT00195260|62825165|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33450493|NCT00195260|62825166|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33450494|NCT00195260|62825167|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33450495|NCT00195260|62825168|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33450496|NCT00195260|62825169|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
33450497|NCT00195260|62825170|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
33450498|NCT00195260|62825171|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
33450499|NCT00195260|62825161|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33450500|NCT00195260|62825162|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33450501|NCT00195260|62825163|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33450502|NCT00195260|62825164|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33450503|NCT00195260|62825165|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33450504|NCT00195260|62825166|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33450505|NCT00195260|62825167|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33450506|NCT00195260|62825168|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33506330|NCT03165045|62888418|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
33506331|NCT01928199|62888426|FG000|Overall Study|Lost to Follow-up|2|||
33506332|NCT01928199|62888427|FG001|Overall Study|Lost to Follow-up|1|||
33506333|NCT01928199|62888426|FG000|Overall Study|Withdrawal by Subject|3|||
33506334|NCT01928199|62888427|FG001|Overall Study|Withdrawal by Subject|5|||
33506335|NCT03128892|62888433|FG000|Overall Study|Withdrawal by Subject|2|||
33612010|NCT01641692|63012476|FG005|Treatment Period 1|Protocol Violation|0|||
33612011|NCT01641692|63012477|FG006|Treatment Period 1|Protocol Violation|0|||
33612012|NCT01641692|63012478|FG007|Treatment Period 1|Protocol Violation|0|||
33612013|NCT01641692|63012471|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
33612014|NCT01641692|63012472|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
33612015|NCT01641692|63012473|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
33612016|NCT01641692|63012474|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
33612017|NCT01641692|63012475|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
33612018|NCT01641692|63012476|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
33612019|NCT01641692|63012477|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
33612020|NCT01641692|63012478|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
33612021|NCT01641692|63012471|FG000|Treatment Period 1|Lost to Follow-up|0|||
33612022|NCT01641692|63012472|FG001|Treatment Period 1|Lost to Follow-up|0|||
33612023|NCT01641692|63012473|FG002|Treatment Period 1|Lost to Follow-up|1|||
33612024|NCT01641692|63012474|FG003|Treatment Period 1|Lost to Follow-up|0|||
33612025|NCT01641692|63012475|FG004|Treatment Period 1|Lost to Follow-up|0|||
33506336|NCT03128892|62888433|FG000|Overall Study|Physician Decision|1|||
33506337|NCT03039686|62888449|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
33506338|NCT03039686|62888450|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
33506339|NCT03039686|62888451|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
33506340|NCT03039686|62888449|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
33506341|NCT03039686|62888450|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
33506342|NCT03039686|62888451|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
33506343|NCT03039686|62888449|FG000|Double-blind Period|Withdrawal by Subject|2|||
33506344|NCT03039686|62888450|FG001|Double-blind Period|Withdrawal by Subject|2|||
33450507|NCT00195260|62825169|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
33450508|NCT00195260|62825170|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
33450509|NCT00195260|62825171|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
33450510|NCT00195260|62825161|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33450511|NCT00195260|62825162|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33450512|NCT00195260|62825163|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33450513|NCT00195260|62825164|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33450514|NCT00195260|62825165|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33450515|NCT00195260|62825166|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33450516|NCT00195260|62825167|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33506345|NCT03039686|62888451|FG002|Double-blind Period|Withdrawal by Subject|1|||
33324293|NCT00960531|62700744|FG006|Overall Study|Withdrawal by Subject|2|||
33324294|NCT00960531|62700745|FG007|Overall Study|Withdrawal by Subject|0|||
33450517|NCT00195260|62825168|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33324295|NCT00960531|62700746|FG008|Overall Study|Withdrawal by Subject|1|||
33450518|NCT00195260|62825169|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
33450519|NCT00195260|62825170|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
33506346|NCT03039686|62888449|FG000|Double-blind Period|Death|0|||
33506347|NCT03039686|62888450|FG001|Double-blind Period|Death|0|||
33506348|NCT03039686|62888451|FG002|Double-blind Period|Death|1|||
33506349|NCT03039686|62888449|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
33506350|NCT03039686|62888450|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
33506351|NCT03039686|62888451|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
33506352|NCT03039686|62888449|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
33506353|NCT03039686|62888450|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
33506354|NCT03039686|62888451|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
33506355|NCT03039686|62888449|FG000|Open Label Period|Withdrawal by Subject|0|||
33506356|NCT03039686|62888450|FG001|Open Label Period|Withdrawal by Subject|3|||
33506357|NCT03039686|62888451|FG002|Open Label Period|Withdrawal by Subject|1|||
33506358|NCT01822275|62888469|FG000|Overall Study|Withdrawal by Subject|3|||
33506359|NCT01822275|62888469|FG000|Overall Study|Adverse Event|3|||
33506360|NCT01822275|62888469|FG000|Overall Study|Progression|14|||
33506361|NCT01822275|62888469|FG000|Overall Study|Physician Decision|2|||
33506362|NCT01656434|62888481|FG000|Overall Study|Adverse Event|199|||
33506363|NCT01656434|62888482|FG001|Overall Study|Adverse Event|63|||
33506364|NCT01656434|62888481|FG000|Overall Study|Enrollment terminated at trial site|2|||
33506365|NCT01656434|62888482|FG001|Overall Study|Enrollment terminated at trial site|0|||
33506366|NCT01656434|62888481|FG000|Overall Study|Lost to Follow-up|309|||
33506367|NCT01656434|62888482|FG001|Overall Study|Lost to Follow-up|76|||
33506368|NCT01656434|62888481|FG000|Overall Study|Site discontinued study participation|24|||
33506369|NCT01656434|62888482|FG001|Overall Study|Site discontinued study participation|9|||
33506370|NCT01656434|62888481|FG000|Overall Study|Screen failure|2|||
33506371|NCT01656434|62888482|FG001|Overall Study|Screen failure|0|||
33506372|NCT01656434|62888481|FG000|Overall Study|Protocol Violation|7|||
33506373|NCT01656434|62888482|FG001|Overall Study|Protocol Violation|0|||
33506374|NCT01656434|62888481|FG000|Overall Study|Pregnancy wish|18|||
33506375|NCT01656434|62888482|FG001|Overall Study|Pregnancy wish|6|||
33506376|NCT01656434|62888481|FG000|Overall Study|Pregnancy|45|||
33506377|NCT01656434|62888482|FG001|Overall Study|Pregnancy|10|||
33506378|NCT01656434|62888481|FG000|Overall Study|Physician Decision|7|||
33506379|NCT01656434|62888482|FG001|Overall Study|Physician Decision|2|||
33506380|NCT01656434|62888481|FG000|Overall Study|Non-compliance with study drug|48|||
33506381|NCT01656434|62888482|FG001|Overall Study|Non-compliance with study drug|9|||
33506382|NCT01656434|62888481|FG000|Overall Study|Study terminated by sponsor|1501|||
33506383|NCT01656434|62888482|FG001|Overall Study|Study terminated by sponsor|348|||
33506384|NCT01656434|62888481|FG000|Overall Study|Participant discontinued; drug related|13|||
33506385|NCT01656434|62888482|FG001|Overall Study|Participant discontinued; drug related|4|||
33506386|NCT01656434|62888481|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
33506387|NCT01656434|62888482|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
33506388|NCT01656434|62888481|FG000|Overall Study|Non-compliance with protocol|39|||
33506389|NCT01656434|62888482|FG001|Overall Study|Non-compliance with protocol|15|||
33506390|NCT01656434|62888481|FG000|Overall Study|Participant moved|40|||
33506391|NCT01656434|62888482|FG001|Overall Study|Participant moved|12|||
33506392|NCT01656434|62888481|FG000|Overall Study|Participant withdrew consent|28|||
33506393|NCT01656434|62888482|FG001|Overall Study|Participant withdrew consent|9|||
33450520|NCT00195260|62825171|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
33506394|NCT01656434|62888481|FG000|Overall Study|Withdrawal by Subject|64|||
33450521|NCT00195260|62825161|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33450522|NCT00195260|62825162|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33450523|NCT00195260|62825163|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33450524|NCT00195260|62825164|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33450525|NCT00195260|62825165|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33450526|NCT00195260|62825166|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33450527|NCT00195260|62825167|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33450528|NCT00195260|62825168|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33450529|NCT00195260|62825169|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
33506395|NCT01656434|62888482|FG001|Overall Study|Withdrawal by Subject|7|||
33506396|NCT02931396|62888490|FG000|Overall Study|Lost to Follow-up|3|||
33506397|NCT02931396|62888491|FG001|Overall Study|Lost to Follow-up|0|||
33506398|NCT02931396|62888490|FG000|Overall Study|Withdrawal by Subject|2|||
33506399|NCT02931396|62888491|FG001|Overall Study|Withdrawal by Subject|0|||
33450530|NCT00195260|62825170|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
33450531|NCT00195260|62825171|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
33450532|NCT00031486|62825201|FG000|Overall Study|Adverse Event|1|||
33450533|NCT00031486|62825202|FG001|Overall Study|Adverse Event|0|||
33450534|NCT00031486|62825201|FG000|Overall Study|Lost to Follow-up|0|||
33450535|NCT00031486|62825202|FG001|Overall Study|Lost to Follow-up|1|||
33450536|NCT00031486|62825201|FG000|Overall Study|Withdrawal by Subject|3|||
33450537|NCT00031486|62825202|FG001|Overall Study|Withdrawal by Subject|2|||
33450538|NCT00031486|62825201|FG000|Overall Study|Death|0|||
33450539|NCT00031486|62825202|FG001|Overall Study|Death|3|||
33450540|NCT00031486|62825201|FG000|Overall Study|Non-compliant|0|||
33450541|NCT00031486|62825202|FG001|Overall Study|Non-compliant|4|||
33450542|NCT00031486|62825201|FG000|Overall Study|Did not meet eligibility requirement|2|||
33450543|NCT00031486|62825202|FG001|Overall Study|Did not meet eligibility requirement|1|||
33450544|NCT00031486|62825201|FG000|Overall Study|Other|1|||
33450545|NCT00031486|62825202|FG001|Overall Study|Other|1|||
33450546|NCT00003508|62825210|FG000|Overall Study|Not evaluable|5|||
33450547|NCT00003472|62825214|FG000|Overall Study|Not evaluable|3|||
33450548|NCT00003298|62825218|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
33450549|NCT00003298|62825218|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
33450550|NCT00003298|62825218|FG000|Surgery|Unresectable at surgery|3|||
33450551|NCT00003298|62825218|FG000|Surgery|Progression before surgery|2|||
33450552|NCT00003298|62825218|FG000|Surgery|Unevaluable and off study|2|||
33450553|NCT00003298|62825218|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
33450554|NCT00003298|62825218|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
33450555|NCT00003298|62825218|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
33450556|NCT00003298|62825218|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
33450557|NCT00003298|62825218|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
33450558|NCT00003298|62825218|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
33450559|NCT00003298|62825218|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
33450560|NCT00003298|62825218|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
33450561|NCT00003298|62825218|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
33450562|NCT00003298|62825218|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
33450563|NCT00002842|62825223|FG000|Overall Study|ineligible for surgical resection|27|||
33450564|NCT00143247|62825227|FG000|Overall Study|Death|8|||
33450565|NCT00143247|62825227|FG000|Overall Study|Adverse Event|19|||
33450566|NCT00143247|62825227|FG000|Overall Study|Lack of Efficacy|3|||
33450567|NCT00143247|62825227|FG000|Overall Study|Withdrawal by Subject|55|||
33450568|NCT00143247|62825227|FG000|Overall Study|Study terminated by sponsor|31|||
33450569|NCT00143247|62825227|FG000|Overall Study|Protocol Violation|15|||
33506400|NCT03037580|62888499|FG000|Overall Study|Withdrawal by Subject|3|||
33506401|NCT03037580|62888500|FG001|Overall Study|Withdrawal by Subject|0|||
33506402|NCT03037580|62888499|FG000|Overall Study|Adverse Event|1|||
33506403|NCT03037580|62888500|FG001|Overall Study|Adverse Event|0|||
33506404|NCT03037580|62888499|FG000|Overall Study|Study Terminated by Sponsor|12|||
33506405|NCT03037580|62888500|FG001|Overall Study|Study Terminated by Sponsor|15|||
33506406|NCT03037580|62888499|FG000|Overall Study|Death|0|||
33506407|NCT03037580|62888500|FG001|Overall Study|Death|1|||
33544028|NCT03020641|62934855|FG000|Overall Study|Converted to open surgery|2|||
33544029|NCT03020641|62934856|FG001|Overall Study|Converted to open surgery|1|||
33544030|NCT03020641|62934855|FG000|Overall Study|for surgery not performed|0|||
33544031|NCT03020641|62934856|FG001|Overall Study|for surgery not performed|1|||
33544032|NCT03020407|62934867|FG000|Overall Study|Withdrawal by Subject|2|||
33544033|NCT03020407|62934868|FG001|Overall Study|Withdrawal by Subject|1|||
33544034|NCT03020407|62934867|FG000|Overall Study|Lost to Follow-up|2|||
33544035|NCT03020407|62934868|FG001|Overall Study|Lost to Follow-up|3|||
33544036|NCT03020407|62934867|FG000|Overall Study|Protocol Violation|0|||
33544037|NCT03020407|62934868|FG001|Overall Study|Protocol Violation|1|||
33544038|NCT02536846|62934874|FG000|Overall Study|Withdrawal by Subject|1|||
33544039|NCT03014011|62934879|FG000|First Intervention|Withdrawal by Subject|1|||
33544040|NCT03014011|62934880|FG001|First Intervention|Withdrawal by Subject|0|||
33544041|NCT03014011|62934879|FG000|Washout|Withdrawal by Subject|1|||
33544042|NCT03014011|62934880|FG001|Washout|Withdrawal by Subject|0|||
33544043|NCT03012841|62934895|FG000|Overall Study|Protocol Violation|0|||
33544044|NCT03012841|62934896|FG001|Overall Study|Protocol Violation|10|||
33544045|NCT03012841|62934895|FG000|Overall Study|Lost to Follow-up|6|||
33544046|NCT03012841|62934896|FG001|Overall Study|Lost to Follow-up|1|||
33544047|NCT03012841|62934895|FG000|Overall Study|Withdrawal by Subject|6|||
33544048|NCT03012841|62934896|FG001|Overall Study|Withdrawal by Subject|0|||
33544049|NCT03012841|62934895|FG000|Overall Study|Unable to complete 12 month visit|6|||
33544050|NCT03012841|62934896|FG001|Overall Study|Unable to complete 12 month visit|0|||
33544051|NCT03012841|62934895|FG000|Overall Study|Subject relocation|1|||
33544052|NCT03012841|62934896|FG001|Overall Study|Subject relocation|0|||
33544053|NCT03012841|62934895|FG000|Overall Study|Seasonal winter travel|1|||
33544054|NCT03012841|62934896|FG001|Overall Study|Seasonal winter travel|0|||
33544055|NCT03012841|62934895|FG000|Overall Study|Physician Decision|0|||
33544056|NCT03012841|62934896|FG001|Overall Study|Physician Decision|2|||
33544057|NCT03012841|62934895|FG000|Overall Study|No ablation performed|0|||
33544058|NCT03012841|62934896|FG001|Overall Study|No ablation performed|2|||
33544059|NCT03012841|62934895|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
33544060|NCT03012841|62934896|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
33544061|NCT03012841|62934895|FG000|Overall Study|Insurance change|0|||
33544062|NCT03012841|62934896|FG001|Overall Study|Insurance change|1|||
33544063|NCT02359864|62934903|FG000|Overall Study|Withdrawal by Subject|1|||
33544064|NCT02359864|62934904|FG001|Overall Study|Withdrawal by Subject|0|||
33544065|NCT02533258|62934910|FG000|Overall Study|Adverse Event|1|||
33544066|NCT02533258|62934910|FG000|Overall Study|Death|2|||
33544067|NCT02533258|62934910|FG000|Overall Study|Other|1|||
33544068|NCT02533258|62934910|FG000|Overall Study|Economic factor|1|||
33544069|NCT02533258|62934910|FG000|Overall Study|Progression of pleural effusion|1|||
33544070|NCT02533258|62934910|FG000|Overall Study|Lack of Efficacy|2|||
33544071|NCT03019627|62934929|FG000|Overall Study|Adverse Event|8|||
33544072|NCT03019627|62934930|FG001|Overall Study|Adverse Event|0|||
33544073|NCT03019627|62934929|FG000|Overall Study|Unrelated to adverse event|1|||
33544074|NCT03019627|62934930|FG001|Overall Study|Unrelated to adverse event|3|||
33544075|NCT03019627|62934929|FG000|Overall Study|Lost to Follow-up|2|||
33544076|NCT03019627|62934930|FG001|Overall Study|Lost to Follow-up|1|||
33544077|NCT03019627|62934929|FG000|Overall Study|not compliance|2|||
33544078|NCT03019627|62934930|FG001|Overall Study|not compliance|2|||
33544079|NCT03019627|62934929|FG000|Overall Study|Other|2|||
33544080|NCT03019627|62934930|FG001|Overall Study|Other|2|||
33544081|NCT01661140|62934936|FG000|Open-Label Period|Adverse Event|44|||
33544082|NCT01661140|62934937|FG001|Open-Label Period|Adverse Event|0|||
33544083|NCT01661140|62934938|FG002|Open-Label Period|Adverse Event|0|||
33544084|NCT01661140|62934936|FG000|Open-Label Period|Protocol Violation|3|||
33544085|NCT01661140|62934937|FG001|Open-Label Period|Protocol Violation|0|||
33544086|NCT01661140|62934938|FG002|Open-Label Period|Protocol Violation|0|||
33544087|NCT01661140|62934936|FG000|Open-Label Period|Withdrawal by Subject|5|||
33544088|NCT01661140|62934937|FG001|Open-Label Period|Withdrawal by Subject|0|||
33544089|NCT01661140|62934938|FG002|Open-Label Period|Withdrawal by Subject|0|||
33544090|NCT01661140|62934936|FG000|Open-Label Period|Investigator Decision|3|||
33544091|NCT01661140|62934937|FG001|Open-Label Period|Investigator Decision|0|||
33544092|NCT01661140|62934938|FG002|Open-Label Period|Investigator Decision|0|||
33612026|NCT01641692|63012476|FG005|Treatment Period 1|Lost to Follow-up|0|||
33544093|NCT01661140|62934936|FG000|Open-Label Period|Death|1|||
33544094|NCT01661140|62934937|FG001|Open-Label Period|Death|0|||
33544095|NCT01661140|62934938|FG002|Open-Label Period|Death|0|||
33544096|NCT01661140|62934936|FG000|Open-Label Period|Administrative/Other|1|||
33544097|NCT01661140|62934937|FG001|Open-Label Period|Administrative/Other|0|||
33506408|NCT01755195|62888506|FG000|Overall Study|Participant noncompliance|2|||
33324296|NCT00960531|62700747|FG009|Overall Study|Withdrawal by Subject|0|||
33450570|NCT00143247|62825227|FG000|Overall Study|Lost to Follow-up|12|||
33506409|NCT01755195|62888506|FG000|Overall Study|Switched to alternative treatment|4|||
33506410|NCT01755195|62888506|FG000|Overall Study|Withdrawal by Subject|1|||
33506411|NCT01755195|62888506|FG000|Overall Study|Participant refused to start treatment|1|||
33506412|NCT01755195|62888506|FG000|Overall Study|Participant has been consented for another trial|1|||
33506413|NCT01755195|62888506|FG000|Overall Study|Refused further treatment|3|||
33506414|NCT01755195|62888506|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
33506415|NCT00897104|62888513|FG000|Overall Study|Lost to Follow-up|12|||
33506416|NCT00897104|62888514|FG001|Overall Study|Lost to Follow-up|17|||
33506417|NCT00897104|62888515|FG002|Overall Study|Lost to Follow-up|2|||
33506418|NCT00897104|62888513|FG000|Overall Study|Pregnancy|0|||
33506419|NCT00897104|62888514|FG001|Overall Study|Pregnancy|1|||
33506420|NCT00897104|62888515|FG002|Overall Study|Pregnancy|0|||
33506421|NCT00897104|62888513|FG000|Overall Study|Protocol Violation|0|||
33506422|NCT00897104|62888514|FG001|Overall Study|Protocol Violation|1|||
33506423|NCT00897104|62888515|FG002|Overall Study|Protocol Violation|0|||
33612027|NCT01641692|63012477|FG006|Treatment Period 1|Lost to Follow-up|0|||
33612028|NCT01641692|63012478|FG007|Treatment Period 1|Lost to Follow-up|0|||
33612029|NCT01641692|63012471|FG000|Treatment Period 1|Physician Decision|0|||
33612030|NCT01641692|63012472|FG001|Treatment Period 1|Physician Decision|0|||
33612031|NCT01641692|63012473|FG002|Treatment Period 1|Physician Decision|0|||
33612032|NCT01641692|63012474|FG003|Treatment Period 1|Physician Decision|0|||
33612033|NCT01641692|63012475|FG004|Treatment Period 1|Physician Decision|1|||
33612034|NCT01641692|63012476|FG005|Treatment Period 1|Physician Decision|0|||
33612035|NCT01641692|63012477|FG006|Treatment Period 1|Physician Decision|0|||
33612036|NCT01641692|63012478|FG007|Treatment Period 1|Physician Decision|0|||
33612037|NCT01641692|63012471|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33450571|NCT00143247|62825227|FG000|Overall Study|following inaccurate lab adverse event|1|||
33450572|NCT00143247|62825227|FG000|Overall Study|Other|12|||
33450573|NCT00125853|62825231|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
33450574|NCT00125853|62825232|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
33450575|NCT00219141|62825241|FG000|Overall Study|Adverse Event|4|||
33450576|NCT00219141|62825242|FG001|Overall Study|Adverse Event|10|||
33450577|NCT00219141|62825243|FG002|Overall Study|Adverse Event|5|||
33450578|NCT00219141|62825241|FG000|Overall Study|Lack of Efficacy|3|||
33450579|NCT00219141|62825242|FG001|Overall Study|Lack of Efficacy|2|||
33450580|NCT00219141|62825243|FG002|Overall Study|Lack of Efficacy|0|||
33450581|NCT00219141|62825241|FG000|Overall Study|Administrative problems|0|||
33450582|NCT00219141|62825242|FG001|Overall Study|Administrative problems|1|||
33450583|NCT00219141|62825243|FG002|Overall Study|Administrative problems|0|||
33450584|NCT00219141|62825241|FG000|Overall Study|Lost to Follow-up|2|||
33450585|NCT00219141|62825242|FG001|Overall Study|Lost to Follow-up|4|||
33450586|NCT00219141|62825243|FG002|Overall Study|Lost to Follow-up|1|||
33450587|NCT00219141|62825241|FG000|Overall Study|Protocol Violation|3|||
33450588|NCT00219141|62825242|FG001|Overall Study|Protocol Violation|1|||
33450589|NCT00219141|62825243|FG002|Overall Study|Protocol Violation|1|||
33450590|NCT00219141|62825241|FG000|Overall Study|Withdrawal by Subject|1|||
33450591|NCT00219141|62825242|FG001|Overall Study|Withdrawal by Subject|3|||
33450592|NCT00219141|62825243|FG002|Overall Study|Withdrawal by Subject|5|||
33450593|NCT00219141|62825241|FG000|Overall Study|Condition no longer requires study drug|1|||
33450594|NCT00219141|62825242|FG001|Overall Study|Condition no longer requires study drug|0|||
33450595|NCT00219141|62825243|FG002|Overall Study|Condition no longer requires study drug|0|||
33450596|NCT00142935|62825254|FG000|Overall Study|Other reason|1|||
33450597|NCT00142935|62825255|FG001|Overall Study|Other reason|1|||
33450598|NCT00142935|62825256|FG002|Overall Study|Other reason|1|||
33450599|NCT00142935|62825254|FG000|Overall Study|Lost to Follow-up|2|||
33450600|NCT00142935|62825255|FG001|Overall Study|Lost to Follow-up|5|||
33506424|NCT00897104|62888513|FG000|Overall Study|Withdrawal by Subject|23|||
33506425|NCT00897104|62888514|FG001|Overall Study|Withdrawal by Subject|27|||
33506426|NCT00897104|62888515|FG002|Overall Study|Withdrawal by Subject|3|||
33506427|NCT00897104|62888513|FG000|Overall Study|Abnormal Prestudy Labs|2|||
33506428|NCT00897104|62888514|FG001|Overall Study|Abnormal Prestudy Labs|0|||
33506429|NCT00897104|62888515|FG002|Overall Study|Abnormal Prestudy Labs|0|||
33506430|NCT00897104|62888513|FG000|Overall Study|Abnormal Baseline ECG|2|||
33506431|NCT00897104|62888514|FG001|Overall Study|Abnormal Baseline ECG|2|||
33506432|NCT00897104|62888515|FG002|Overall Study|Abnormal Baseline ECG|0|||
33506433|NCT00897104|62888513|FG000|Overall Study|Need for Concom. Med.|0|||
33506434|NCT00897104|62888514|FG001|Overall Study|Need for Concom. Med.|1|||
33506435|NCT00897104|62888515|FG002|Overall Study|Need for Concom. Med.|1|||
33506436|NCT00897104|62888513|FG000|Overall Study|Lack of Migraine Attack|20|||
33506437|NCT00897104|62888514|FG001|Overall Study|Lack of Migraine Attack|22|||
33506438|NCT00897104|62888515|FG002|Overall Study|Lack of Migraine Attack|1|||
33506439|NCT00897104|62888513|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
33506440|NCT00897104|62888514|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33506441|NCT00897104|62888515|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33506442|NCT00897104|62888513|FG000|Overall Study|Other|3|||
33506443|NCT00897104|62888514|FG001|Overall Study|Other|0|||
33506444|NCT00897104|62888515|FG002|Overall Study|Other|0|||
33506445|NCT00897104|62888513|FG000|Overall Study|Protocol Violation|1|||
33506446|NCT00897104|62888514|FG001|Overall Study|Protocol Violation|0|||
33506447|NCT00897104|62888515|FG002|Overall Study|Protocol Violation|0|||
33506448|NCT00897104|62888513|FG000|Overall Study|Withdrawal by Subject|0|||
33506449|NCT00897104|62888514|FG001|Overall Study|Withdrawal by Subject|0|||
33506450|NCT00897104|62888515|FG002|Overall Study|Withdrawal by Subject|1|||
33506451|NCT01339689|62888525|FG000|Overall Study|Adverse Event|1|||
33506452|NCT01339689|62888526|FG001|Overall Study|Adverse Event|2|||
33506453|NCT01339689|62888525|FG000|Overall Study|Lost to Follow-up|9|||
33506454|NCT01339689|62888526|FG001|Overall Study|Lost to Follow-up|3|||
33506455|NCT01339689|62888525|FG000|Overall Study|Withdrawal by Subject|3|||
33506456|NCT01339689|62888526|FG001|Overall Study|Withdrawal by Subject|0|||
33506457|NCT01339689|62888525|FG000|Overall Study|Noncompliance|1|||
33506458|NCT01339689|62888526|FG001|Overall Study|Noncompliance|0|||
33506459|NCT01339689|62888525|FG000|Overall Study|Relocated out of area|0|||
33506460|NCT01339689|62888526|FG001|Overall Study|Relocated out of area|1|||
33506461|NCT01339689|62888525|FG000|Overall Study|Other|2|||
33506462|NCT01339689|62888526|FG001|Overall Study|Other|2|||
33506463|NCT01339689|62888525|FG000|Overall Study|multiple reasons|1|||
33506464|NCT01339689|62888526|FG001|Overall Study|multiple reasons|1|||
33506465|NCT03038126|62888534|FG000|Overall Study|Death|1|||
33506466|NCT03038126|62888535|FG001|Overall Study|Death|1|||
33506467|NCT03038126|62888534|FG000|Overall Study|Withdrawal by Subject|5|||
33506468|NCT03038126|62888535|FG001|Overall Study|Withdrawal by Subject|0|||
33506469|NCT03038126|62888534|FG000|Overall Study|Lost to Follow-up|0|||
33506470|NCT03038126|62888535|FG001|Overall Study|Lost to Follow-up|1|||
33506471|NCT03038126|62888534|FG000|Overall Study|Long Term Hospitalization|2|||
33506472|NCT03038126|62888535|FG001|Overall Study|Long Term Hospitalization|0|||
33506473|NCT03038126|62888534|FG000|Overall Study|Too Ill to Participate|1|||
33506474|NCT03038126|62888535|FG001|Overall Study|Too Ill to Participate|2|||
33506475|NCT00696878|62888553|FG000|Overall Study|Adverse Event|8|||
33506476|NCT00696878|62888553|FG000|Overall Study|Withdrawal by Subject|87|||
33506477|NCT00696878|62888553|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
33506478|NCT00696878|62888553|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
33506479|NCT00696878|62888553|FG000|Overall Study|Trial stopped|32|||
33506480|NCT00696878|62888553|FG000|Overall Study|Other reason (not specified)|55|||
33506481|NCT00696800|62888559|FG000|Overall Study|Adverse Event|16|||
33506482|NCT00696800|62888560|FG001|Overall Study|Adverse Event|3|||
33506483|NCT00696800|62888559|FG000|Overall Study|Insufficient compliance with medication|2|||
33506484|NCT00696800|62888560|FG001|Overall Study|Insufficient compliance with medication|1|||
33506485|NCT00696800|62888559|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
33506486|NCT00696800|62888560|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
33506487|NCT00696800|62888559|FG000|Overall Study|Insufficient ovarian response|4|||
33506488|NCT00696800|62888560|FG001|Overall Study|Insufficient ovarian response|1|||
33506489|NCT00696800|62888559|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
33506490|NCT00696800|62888560|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
33506491|NCT00696800|62888559|FG000|Overall Study|Too high ovarian response|6|||
33506492|NCT00696800|62888560|FG001|Overall Study|Too high ovarian response|1|||
33506493|NCT00696800|62888559|FG000|Overall Study|No/too few/bad quality oocytes|4|||
33506494|NCT00696800|62888560|FG001|Overall Study|No/too few/bad quality oocytes|3|||
33506495|NCT00696800|62888559|FG000|Overall Study|No/abnormal fertilization|11|||
33506496|NCT00696800|62888560|FG001|Overall Study|No/abnormal fertilization|13|||
33506497|NCT00696800|62888559|FG000|Overall Study|No/too few/bad quality embryos|24|||
33506498|NCT00696800|62888560|FG001|Overall Study|No/too few/bad quality embryos|18|||
33506499|NCT00696800|62888559|FG000|Overall Study|Other Reasons|5|||
33506500|NCT00696800|62888560|FG001|Overall Study|Other Reasons|3|||
33506501|NCT00696800|62888559|FG000|Overall Study|Not treated|1|||
33506502|NCT00696800|62888560|FG001|Overall Study|Not treated|2|||
33506503|NCT00289874|62888568|FG000|Overall Study|Adverse Event|1|||
33506504|NCT00289874|62888569|FG001|Overall Study|Adverse Event|5|||
33506505|NCT00289874|62888568|FG000|Overall Study|Lost to Follow-up|1|||
33506506|NCT00289874|62888569|FG001|Overall Study|Lost to Follow-up|1|||
33506507|NCT00289874|62888568|FG000|Overall Study|Protocol Violation|3|||
33506508|NCT00289874|62888569|FG001|Overall Study|Protocol Violation|2|||
33506509|NCT00289874|62888568|FG000|Overall Study|Did not meet eligibility|1|||
33506510|NCT00289874|62888569|FG001|Overall Study|Did not meet eligibility|0|||
33506511|NCT00245570|62888575|FG000|Washout Between Periods III and IV|Adverse Event|0|||
33506512|NCT00245570|62888576|FG001|Washout Between Periods III and IV|Adverse Event|1|||
33506513|NCT00245570|62888577|FG002|Washout Between Periods III and IV|Adverse Event|0|||
33506514|NCT00245570|62888578|FG003|Washout Between Periods III and IV|Adverse Event|0|||
33506515|NCT00245570|62888579|FG004|Washout Between Periods III and IV|Adverse Event|0|||
33506516|NCT00245570|62888580|FG005|Washout Between Periods III and IV|Adverse Event|0|||
33506517|NCT04638660|62888626|FG000|Overall Study|Withdrawal by Subject|2|||
33506518|NCT04638660|62888627|FG001|Overall Study|Withdrawal by Subject|0|||
33506519|NCT04638660|62888626|FG000|Overall Study|Lost to Follow-up|1|||
33506520|NCT04638660|62888627|FG001|Overall Study|Lost to Follow-up|0|||
33506521|NCT04367480|62888636|FG000|Overall Study|Adverse Event|1|||
33506522|NCT04367480|62888637|FG001|Overall Study|Adverse Event|1|||
33506523|NCT04367480|62888636|FG000|Overall Study|Death|1|||
33506524|NCT04367480|62888637|FG001|Overall Study|Death|0|||
33506525|NCT04367480|62888636|FG000|Overall Study|Lost to Follow-up|1|||
33506526|NCT04367480|62888637|FG001|Overall Study|Lost to Follow-up|1|||
33506527|NCT04367480|62888636|FG000|Overall Study|Withdrawal by Subject|0|||
33506528|NCT04367480|62888637|FG001|Overall Study|Withdrawal by Subject|3|||
33506529|NCT04367480|62888636|FG000|Overall Study|App glitch during the study|1|||
33506530|NCT04367480|62888637|FG001|Overall Study|App glitch during the study|0|||
33506531|NCT04367480|62888636|FG000|Overall Study|Device Distribution Error|0|||
33506532|NCT04367480|62888637|FG001|Overall Study|Device Distribution Error|2|||
33506533|NCT04367480|62888636|FG000|Overall Study|Ineligible after Randomization|0|||
33506534|NCT04367480|62888637|FG001|Overall Study|Ineligible after Randomization|1|||
33506535|NCT04367480|62888636|FG000|Overall Study|Other Medical Reasons|0|||
33506536|NCT04367480|62888637|FG001|Overall Study|Other Medical Reasons|2|||
33506537|NCT04137731|62888660|FG000|Overall Study|Surgery Cancellation|1|||
33506538|NCT04137731|62888661|FG001|Overall Study|Surgery Cancellation|2|||
33506539|NCT04137731|62888660|FG000|Overall Study|Withdrawal by Subject|2|||
33506540|NCT04137731|62888661|FG001|Overall Study|Withdrawal by Subject|0|||
33506541|NCT04137731|62888660|FG000|Overall Study|Protocol Violation|0|||
33506542|NCT04137731|62888661|FG001|Overall Study|Protocol Violation|1|||
33506543|NCT04088760|62888676|FG000|Overall Study|Physician Decision|1|||
33506544|NCT03905694|62888779|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
33506545|NCT03813238|62888798|FG000|Overall Study|Adverse Event|0|||
33506546|NCT03813238|62888799|FG001|Overall Study|Adverse Event|6|||
33506547|NCT03813238|62888798|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33506548|NCT03813238|62888799|FG001|Overall Study|Withdrawal by parent/guardian|2|||
33506549|NCT03813238|62888798|FG000|Overall Study|Lost to Follow-up|0|||
33506550|NCT03813238|62888799|FG001|Overall Study|Lost to Follow-up|1|||
33506551|NCT03813238|62888798|FG000|Overall Study|Other than specified|1|||
33506552|NCT03813238|62888799|FG001|Overall Study|Other than specified|2|||
33506553|NCT03737240|62888807|FG000|Overall Study|Lost to Follow-up|16|||
33506554|NCT03737240|62888808|FG001|Overall Study|Lost to Follow-up|15|||
33324297|NCT00960531|62700738|FG000|Overall Study|Caregiver Request|2|||
33506555|NCT03681184|62888816|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
33450601|NCT00142935|62825256|FG002|Overall Study|Lost to Follow-up|5|||
33450602|NCT00142935|62825254|FG000|Overall Study|Death|0|||
33450603|NCT00142935|62825255|FG001|Overall Study|Death|2|||
33450604|NCT00142935|62825256|FG002|Overall Study|Death|1|||
33450605|NCT00233948|62825270|FG000|Overall Study|Adverse Event|1|||
33450606|NCT00233948|62825271|FG001|Overall Study|Adverse Event|0|||
33450607|NCT00233948|62825272|FG002|Overall Study|Adverse Event|0|||
33450608|NCT00233948|62825273|FG003|Overall Study|Adverse Event|0|||
33450609|NCT00233948|62825274|FG004|Overall Study|Adverse Event|0|||
33450610|NCT00233948|62825275|FG005|Overall Study|Adverse Event|0|||
33450611|NCT00233480|62825292|FG000|Overall Study|Underwent status II heart transplant|0|||
33450612|NCT00233480|62825293|FG001|Overall Study|Underwent status II heart transplant|1|||
33450613|NCT03801928|62825307|FG000|Overall Study|Adverse Event|1|||
33450614|NCT03801928|62825308|FG001|Overall Study|Adverse Event|0|||
33450615|NCT03801928|62825309|FG002|Overall Study|Adverse Event|1|||
33450616|NCT03801928|62825310|FG003|Overall Study|Adverse Event|2|||
33506556|NCT03681184|62888817|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
33506557|NCT03681184|62888816|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12|||
33506558|NCT03681184|62888817|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23|||
33506559|NCT03681184|62888816|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
33506560|NCT03681184|62888817|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
33506561|NCT03532178|62888825|FG000|First Period|Withdrawal by Subject|1|||
33506562|NCT03532178|62888826|FG001|First Period|Withdrawal by Subject|3|||
33506563|NCT03532178|62888825|FG000|First Period|technical issues in data collection Technical issues|0|||
33506564|NCT03532178|62888826|FG001|First Period|technical issues in data collection Technical issues|1|||
33506565|NCT03532178|62888825|FG000|Second Period|Withdrawal by Subject|1|||
33506566|NCT03532178|62888826|FG001|Second Period|Withdrawal by Subject|1|||
33506567|NCT03532178|62888825|FG000|Second Period|Technical issues|0|||
33506568|NCT03532178|62888826|FG001|Second Period|Technical issues|1|||
33506569|NCT03526549|62888834|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
33506570|NCT03526549|62888835|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
33506571|NCT03526549|62888834|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
33506572|NCT03526549|62888835|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
33506573|NCT03526549|62888834|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
33506574|NCT03526549|62888835|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
33450617|NCT03801928|62825311|FG004|Overall Study|Adverse Event|0|||
33506575|NCT03526549|62888834|FG000|Open-label Phase|Adverse Event|4|||
33506576|NCT03526549|62888835|FG001|Open-label Phase|Adverse Event|0|||
33506577|NCT03526549|62888834|FG000|Open-label Phase|Withdrawal by Subject|54|||
33506578|NCT03526549|62888835|FG001|Open-label Phase|Withdrawal by Subject|0|||
33506579|NCT03526549|62888834|FG000|Open-label Phase|Lost to Follow-up|35|||
33506580|NCT03526549|62888835|FG001|Open-label Phase|Lost to Follow-up|0|||
33506581|NCT03526549|62888834|FG000|Open-label Phase|Other than Specified|5|||
33506582|NCT03526549|62888835|FG001|Open-label Phase|Other than Specified|0|||
33506583|NCT03449901|62888849|FG000|Overall Study|Progression|57|||
33506584|NCT03449901|62888850|FG001|Overall Study|Progression|12|||
33506585|NCT03449901|62888849|FG000|Overall Study|Adverse Event|3|||
33506586|NCT03449901|62888850|FG001|Overall Study|Adverse Event|0|||
33506587|NCT03449901|62888849|FG000|Overall Study|Death|6|||
33506588|NCT03449901|62888850|FG001|Overall Study|Death|2|||
33506589|NCT03449901|62888849|FG000|Overall Study|Withdrawal by Subject|12|||
33506590|NCT03449901|62888850|FG001|Overall Study|Withdrawal by Subject|1|||
33506591|NCT03449901|62888849|FG000|Overall Study|Physician Decision|1|||
33506592|NCT03449901|62888850|FG001|Overall Study|Physician Decision|0|||
33506593|NCT03449901|62888849|FG000|Overall Study|Patient elected for surgical intervention|1|||
33506594|NCT03449901|62888850|FG001|Overall Study|Patient elected for surgical intervention|0|||
33506595|NCT03449901|62888849|FG000|Overall Study|Patient off for other complicating disease|1|||
33506596|NCT03449901|62888850|FG001|Overall Study|Patient off for other complicating disease|0|||
33506597|NCT03435380|62888865|FG000|Overall Study|Death|1|||
33506598|NCT03435380|62888866|FG001|Overall Study|Death|2|||
33506599|NCT03435380|62888867|FG002|Overall Study|Death|1|||
33506600|NCT03435380|62888865|FG000|Overall Study|Lost to Follow-up|12|||
33506601|NCT03435380|62888866|FG001|Overall Study|Lost to Follow-up|8|||
33506602|NCT03435380|62888867|FG002|Overall Study|Lost to Follow-up|6|||
33506603|NCT03435380|62888865|FG000|Overall Study|Physician Decision|1|||
33506604|NCT03435380|62888866|FG001|Overall Study|Physician Decision|0|||
33506605|NCT03435380|62888867|FG002|Overall Study|Physician Decision|0|||
33506606|NCT03435380|62888865|FG000|Overall Study|Withdrawal by Subject|0|||
33506607|NCT03435380|62888866|FG001|Overall Study|Withdrawal by Subject|1|||
33506608|NCT03435380|62888867|FG002|Overall Study|Withdrawal by Subject|1|||
33506609|NCT03435380|62888865|FG000|Overall Study|Ineligible|0|||
33506610|NCT03435380|62888866|FG001|Overall Study|Ineligible|1|||
33506611|NCT03435380|62888867|FG002|Overall Study|Ineligible|1|||
33506612|NCT03363659|62888875|FG000|Overall Study|Adverse Event|1|||
33506613|NCT03363659|62888875|FG000|Overall Study|Screen fail|1|||
33506614|NCT03363659|62888875|FG000|Overall Study|Withdrawal by Subject|1|||
33506615|NCT03299166|62888881|FG000|Overall Study|Adverse Event|9|||
33506616|NCT03299166|62888882|FG001|Overall Study|Adverse Event|4|||
33506617|NCT03299166|62888881|FG000|Overall Study|Withdrawal by Subject|6|||
33506618|NCT03299166|62888882|FG001|Overall Study|Withdrawal by Subject|5|||
33506619|NCT03299166|62888881|FG000|Overall Study|Physician Decision|1|||
33506620|NCT03299166|62888882|FG001|Overall Study|Physician Decision|1|||
33506621|NCT03299166|62888881|FG000|Overall Study|Sponsor Decision|3|||
33506622|NCT03299166|62888882|FG001|Overall Study|Sponsor Decision|0|||
33506623|NCT03299166|62888881|FG000|Overall Study|Lost to Follow-up|2|||
33506624|NCT03299166|62888882|FG001|Overall Study|Lost to Follow-up|4|||
33506625|NCT03299166|62888881|FG000|Overall Study|Randomization Error|0|||
33506626|NCT03299166|62888882|FG001|Overall Study|Randomization Error|1|||
33506627|NCT03299166|62888881|FG000|Overall Study|Subject unable to return due to COVID|1|||
33506628|NCT03299166|62888882|FG001|Overall Study|Subject unable to return due to COVID|0|||
33506629|NCT03299166|62888881|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
33506630|NCT03299166|62888882|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
33506631|NCT03204812|62888888|FG000|Overall Study|Adverse Event|3|||
33506632|NCT03201250|62888895|FG000|Overall Study|screen failures|3|||
33506633|NCT03201250|62888896|FG001|Overall Study|screen failures|0|||
33506634|NCT03201250|62888897|FG002|Overall Study|screen failures|0|||
33506635|NCT03164616|62888909|FG000|Overall Study|Death|250|||
33506636|NCT03164616|62888910|FG001|Overall Study|Death|264|||
33506637|NCT03164616|62888911|FG002|Overall Study|Death|279|||
33506638|NCT03164616|62888909|FG000|Overall Study|Lost to Follow-up|2|||
33506639|NCT03164616|62888910|FG001|Overall Study|Lost to Follow-up|2|||
33506640|NCT03164616|62888911|FG002|Overall Study|Lost to Follow-up|2|||
33506641|NCT03164616|62888909|FG000|Overall Study|Withdrawal by Subject|6|||
33506642|NCT03164616|62888910|FG001|Overall Study|Withdrawal by Subject|7|||
33506643|NCT03164616|62888911|FG002|Overall Study|Withdrawal by Subject|16|||
33506644|NCT03149029|62888923|FG000|Overall Study|Adverse Event|2|||
33506645|NCT03149029|62888924|FG001|Overall Study|Adverse Event|0|||
33506646|NCT02853305|62888934|FG000|Overall Study|Death|287|||
33506647|NCT02853305|62888935|FG001|Overall Study|Death|249|||
33506648|NCT02853305|62888936|FG002|Overall Study|Death|300|||
33506649|NCT02853305|62888934|FG000|Overall Study|Withdrawal by Subject|2|||
33506650|NCT02853305|62888935|FG001|Overall Study|Withdrawal by Subject|8|||
33506651|NCT02853305|62888936|FG002|Overall Study|Withdrawal by Subject|3|||
33506652|NCT02853305|62888934|FG000|Overall Study|Transferred to Extension Study|46|||
33506653|NCT02853305|62888935|FG001|Overall Study|Transferred to Extension Study|30|||
33506654|NCT02853305|62888936|FG002|Overall Study|Transferred to Extension Study|25|||
33506655|NCT02853305|62888934|FG000|Overall Study|Did Not Continue on Extension Study|16|||
33506656|NCT02853305|62888935|FG001|Overall Study|Did Not Continue on Extension Study|20|||
33506657|NCT02853305|62888936|FG002|Overall Study|Did Not Continue on Extension Study|24|||
33506658|NCT02524275|62888946|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
33506659|NCT02499120|62888952|FG000|Overall Study|Death|52|||
33506660|NCT02499120|62888953|FG001|Overall Study|Death|43|||
33506661|NCT02499120|62888952|FG000|Overall Study|Lost to Follow-up|1|||
33506662|NCT02499120|62888953|FG001|Overall Study|Lost to Follow-up|2|||
33506663|NCT02499120|62888952|FG000|Overall Study|Participant refused further follow-up|1|||
33506664|NCT02499120|62888953|FG001|Overall Study|Participant refused further follow-up|0|||
33506665|NCT02499120|62888952|FG000|Overall Study|Withdrawal by Subject|2|||
33506666|NCT02499120|62888953|FG001|Overall Study|Withdrawal by Subject|5|||
33506667|NCT02499120|62888952|FG000|Overall Study|Other|9|||
33506668|NCT02499120|62888953|FG001|Overall Study|Other|10|||
33506669|NCT02227992|62888961|FG000|Overall Study|Lost to Follow-up|1|||
33506670|NCT02227992|62888962|FG001|Overall Study|Lost to Follow-up|1|||
33506671|NCT02101775|62888971|FG000|Overall Study|Adverse Event|4|||
33506672|NCT02101775|62888972|FG001|Overall Study|Adverse Event|0|||
33506673|NCT02101775|62888973|FG002|Overall Study|Adverse Event|0|||
33506674|NCT02101775|62888971|FG000|Overall Study|Admission to Hospital|0|||
33506675|NCT02101775|62888972|FG001|Overall Study|Admission to Hospital|1|||
33506676|NCT02101775|62888973|FG002|Overall Study|Admission to Hospital|0|||
33506677|NCT01027143|62888993|FG000|Overall Study|Lost to Follow-up|9|||
33506678|NCT01027143|62888994|FG001|Overall Study|Lost to Follow-up|4|||
33506679|NCT00981656|62889000|FG000|Overall Study|Protocol Violation|1|||
33506680|NCT00981656|62889000|FG000|Overall Study|Did not start protocol treatment|2|||
33506681|NCT00895622|62889007|FG000|Overall Study|Protocol Violation|5|||
33506682|NCT00895622|62889008|FG001|Overall Study|Protocol Violation|4|||
33506683|NCT00895622|62889009|FG002|Overall Study|Protocol Violation|4|||
33506684|NCT00847535|62889025|FG000|Overall Study|Withdrawal by Subject|2|||
33506685|NCT00847535|62889026|FG001|Overall Study|Withdrawal by Subject|1|||
33506686|NCT00847535|62889027|FG002|Overall Study|Withdrawal by Subject|1|||
33506687|NCT00847535|62889025|FG000|Overall Study|Lost to Follow-up|0|||
33506688|NCT00847535|62889026|FG001|Overall Study|Lost to Follow-up|1|||
33506689|NCT00847535|62889027|FG002|Overall Study|Lost to Follow-up|0|||
33506690|NCT00539591|62889039|FG000|Overall Study|Toxicity|3|||
33506691|NCT00539591|62889040|FG001|Overall Study|Toxicity|0|||
33506692|NCT00539591|62889041|FG002|Overall Study|Toxicity|0|||
33506693|NCT00539591|62889039|FG000|Overall Study|Disease progression|2|||
33506694|NCT00539591|62889040|FG001|Overall Study|Disease progression|2|||
33506695|NCT00539591|62889041|FG002|Overall Study|Disease progression|3|||
33506696|NCT03512210|62889081|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
33506697|NCT03512210|62889081|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
33506698|NCT03512210|62889081|FG000|Step 2:Post-MINMON|Death|2|||
33506699|NCT03512210|62889081|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
33506700|NCT03512210|62889081|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
33506701|NCT00383721|62889090|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
33506702|NCT00383721|62889091|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
33324298|NCT00960531|62700739|FG001|Overall Study|Caregiver Request|0|||
33450618|NCT03801928|62825312|FG005|Overall Study|Adverse Event|2|||
33450619|NCT03801928|62825307|FG000|Overall Study|Lack of Efficacy|0|||
33450620|NCT03801928|62825308|FG001|Overall Study|Lack of Efficacy|0|||
33450621|NCT03801928|62825309|FG002|Overall Study|Lack of Efficacy|1|||
33450622|NCT03801928|62825310|FG003|Overall Study|Lack of Efficacy|0|||
33450623|NCT03801928|62825311|FG004|Overall Study|Lack of Efficacy|0|||
33450624|NCT03801928|62825312|FG005|Overall Study|Lack of Efficacy|0|||
33450625|NCT03801928|62825307|FG000|Overall Study|Lost to Follow-up|5|||
33450626|NCT03801928|62825308|FG001|Overall Study|Lost to Follow-up|1|||
33450627|NCT03801928|62825309|FG002|Overall Study|Lost to Follow-up|1|||
33450628|NCT03801928|62825310|FG003|Overall Study|Lost to Follow-up|4|||
33450629|NCT03801928|62825311|FG004|Overall Study|Lost to Follow-up|4|||
33450630|NCT03801928|62825312|FG005|Overall Study|Lost to Follow-up|2|||
33450631|NCT03801928|62825307|FG000|Overall Study|Withdrawal by Subject|0|||
33450632|NCT03801928|62825308|FG001|Overall Study|Withdrawal by Subject|0|||
33506703|NCT00383721|62889092|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
33506704|NCT00383721|62889093|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
33506705|NCT00383721|62889094|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
33450633|NCT03801928|62825309|FG002|Overall Study|Withdrawal by Subject|2|||
33506706|NCT00383721|62889090|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
33506707|NCT00383721|62889091|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
33506708|NCT00383721|62889092|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
33506709|NCT00383721|62889093|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
33506710|NCT00383721|62889094|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
33506711|NCT00383721|62889090|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
33506712|NCT00383721|62889091|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
33506713|NCT00383721|62889092|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
33506714|NCT00383721|62889093|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
33506715|NCT00383721|62889094|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
33506716|NCT00383721|62889090|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
33506717|NCT00383721|62889091|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
33506718|NCT00383721|62889092|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
33506719|NCT00383721|62889093|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
33506720|NCT00383721|62889094|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
33506721|NCT00383721|62889090|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
33506722|NCT00383721|62889091|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
33506723|NCT00383721|62889092|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
33506724|NCT00383721|62889093|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
33506725|NCT00383721|62889094|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
33506726|NCT00383721|62889090|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
33506727|NCT00383721|62889091|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
33506728|NCT00383721|62889092|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
33506729|NCT00383721|62889093|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
33506730|NCT00383721|62889094|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
33506731|NCT00383721|62889090|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
33506732|NCT00383721|62889091|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
33506733|NCT00383721|62889092|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
33506734|NCT00383721|62889093|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
33506735|NCT00383721|62889094|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
33506736|NCT00383721|62889090|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
33506737|NCT00383721|62889091|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
33506738|NCT00383721|62889092|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
33506739|NCT00383721|62889093|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
33506740|NCT00383721|62889094|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
33506741|NCT00383721|62889090|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
33506742|NCT00383721|62889091|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
33506743|NCT00383721|62889092|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
33506744|NCT00383721|62889093|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
33506745|NCT00383721|62889094|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
33506746|NCT00383721|62889090|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
33506747|NCT00383721|62889091|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
33506748|NCT00383721|62889092|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
33506749|NCT00383721|62889093|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
33506750|NCT00383721|62889094|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
33506751|NCT00383721|62889090|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
33506752|NCT00383721|62889091|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
33506753|NCT00383721|62889092|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
33506754|NCT00383721|62889093|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
33506755|NCT00383721|62889094|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
33506756|NCT00383721|62889090|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
33506757|NCT00383721|62889091|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
33506758|NCT00383721|62889092|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
33506759|NCT00383721|62889093|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
33506760|NCT00383721|62889094|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
33506761|NCT00383721|62889090|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
33506762|NCT00383721|62889091|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
33506763|NCT00383721|62889092|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
33506764|NCT00383721|62889093|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
33506765|NCT00383721|62889094|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
33506766|NCT00383721|62889090|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
33506767|NCT00383721|62889091|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
33612038|NCT01641692|63012472|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33612039|NCT01641692|63012473|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33612040|NCT01641692|63012474|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33612041|NCT01641692|63012475|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33450634|NCT03801928|62825310|FG003|Overall Study|Withdrawal by Subject|1|||
33450635|NCT03801928|62825311|FG004|Overall Study|Withdrawal by Subject|0|||
33612042|NCT01641692|63012476|FG005|Treatment Period 1|Withdrawal by Subject|2|||
33612043|NCT01641692|63012477|FG006|Treatment Period 1|Withdrawal by Subject|0|||
33612044|NCT01641692|63012478|FG007|Treatment Period 1|Withdrawal by Subject|1|||
33612045|NCT01641692|63012471|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
33612046|NCT01641692|63012472|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
33612047|NCT01641692|63012473|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
33612048|NCT01641692|63012474|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
33612049|NCT01641692|63012475|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
33612050|NCT01641692|63012476|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
33612051|NCT01641692|63012477|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
33612052|NCT01641692|63012478|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
33612053|NCT01641692|63012471|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33612054|NCT01641692|63012472|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33612055|NCT01641692|63012473|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33612056|NCT01641692|63012474|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33612057|NCT01641692|63012475|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33612058|NCT01641692|63012476|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33612059|NCT01641692|63012477|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
33612060|NCT01641692|63012478|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33612061|NCT01641692|63012471|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
33612062|NCT01641692|63012472|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33612063|NCT01641692|63012473|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
33612064|NCT01641692|63012474|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
33612065|NCT01641692|63012475|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
33612066|NCT01641692|63012476|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33612067|NCT01641692|63012477|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33612068|NCT01641692|63012478|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
33612069|NCT01641692|63012471|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
33612070|NCT01641692|63012472|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
33612071|NCT01641692|63012473|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33612072|NCT01641692|63012474|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
33612073|NCT01641692|63012475|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
33612074|NCT01641692|63012476|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33612075|NCT01641692|63012477|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
33612076|NCT01641692|63012478|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33612077|NCT01641692|63012471|FG000|Treatment Period 2|Lack of Efficacy|1|||
33612078|NCT01641692|63012472|FG001|Treatment Period 2|Lack of Efficacy|0|||
33612079|NCT01641692|63012473|FG002|Treatment Period 2|Lack of Efficacy|0|||
33612080|NCT01641692|63012474|FG003|Treatment Period 2|Lack of Efficacy|0|||
33612081|NCT01641692|63012475|FG004|Treatment Period 2|Lack of Efficacy|0|||
33612082|NCT01641692|63012476|FG005|Treatment Period 2|Lack of Efficacy|0|||
33612083|NCT01641692|63012477|FG006|Treatment Period 2|Lack of Efficacy|0|||
33612084|NCT01641692|63012478|FG007|Treatment Period 2|Lack of Efficacy|0|||
33612085|NCT01641692|63012471|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
33612086|NCT01641692|63012472|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33612087|NCT01641692|63012473|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33612088|NCT01641692|63012474|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33612089|NCT01641692|63012475|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33612090|NCT01641692|63012476|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33612091|NCT01641692|63012477|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33612092|NCT01641692|63012478|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33612093|NCT01641692|63012471|FG000|Treatment Period 2|Lost to Follow-up|0|||
33612094|NCT01641692|63012472|FG001|Treatment Period 2|Lost to Follow-up|0|||
33612095|NCT01641692|63012473|FG002|Treatment Period 2|Lost to Follow-up|0|||
33612096|NCT01641692|63012474|FG003|Treatment Period 2|Lost to Follow-up|0|||
33612097|NCT01641692|63012475|FG004|Treatment Period 2|Lost to Follow-up|0|||
33612098|NCT01641692|63012476|FG005|Treatment Period 2|Lost to Follow-up|1|||
33612099|NCT01641692|63012477|FG006|Treatment Period 2|Lost to Follow-up|0|||
33612100|NCT01641692|63012478|FG007|Treatment Period 2|Lost to Follow-up|0|||
33612101|NCT01641692|63012471|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33612102|NCT01641692|63012472|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33612103|NCT01641692|63012473|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33612104|NCT01641692|63012474|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33612105|NCT01641692|63012475|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33612106|NCT01641692|63012476|FG005|Treatment Period 2|Withdrawal by Subject|1|||
33612107|NCT01641692|63012477|FG006|Treatment Period 2|Withdrawal by Subject|0|||
33612108|NCT01641692|63012478|FG007|Treatment Period 2|Withdrawal by Subject|1|||
33612109|NCT01641692|63012471|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33612110|NCT01641692|63012472|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33612111|NCT01641692|63012473|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33612112|NCT01641692|63012474|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33612113|NCT01641692|63012475|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
33612114|NCT01641692|63012476|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33612115|NCT01641692|63012477|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
33612116|NCT01641692|63012478|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33612117|NCT01641692|63012471|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33612118|NCT01641692|63012472|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33612119|NCT01641692|63012473|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
33612120|NCT01641692|63012474|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33612121|NCT01641692|63012475|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33612122|NCT01641692|63012476|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
33612123|NCT01641692|63012477|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33612124|NCT01641692|63012478|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
33612125|NCT01641692|63012471|FG000|Treatment Period 3|Adverse Event|0|||
33612126|NCT01641692|63012472|FG001|Treatment Period 3|Adverse Event|0|||
33612127|NCT01641692|63012473|FG002|Treatment Period 3|Adverse Event|0|||
33612128|NCT01641692|63012474|FG003|Treatment Period 3|Adverse Event|0|||
33612129|NCT01641692|63012475|FG004|Treatment Period 3|Adverse Event|0|||
33612130|NCT01641692|63012476|FG005|Treatment Period 3|Adverse Event|0|||
33612131|NCT01641692|63012477|FG006|Treatment Period 3|Adverse Event|1|||
33612132|NCT01641692|63012478|FG007|Treatment Period 3|Adverse Event|0|||
33612133|NCT01641692|63012471|FG000|Treatment Period 3|Protocol Violation|0|||
33612134|NCT01641692|63012472|FG001|Treatment Period 3|Protocol Violation|0|||
33612135|NCT01641692|63012473|FG002|Treatment Period 3|Protocol Violation|1|||
33612136|NCT01641692|63012474|FG003|Treatment Period 3|Protocol Violation|0|||
33612137|NCT01641692|63012475|FG004|Treatment Period 3|Protocol Violation|0|||
33612138|NCT01641692|63012476|FG005|Treatment Period 3|Protocol Violation|0|||
33612139|NCT01641692|63012477|FG006|Treatment Period 3|Protocol Violation|0|||
33612140|NCT01641692|63012478|FG007|Treatment Period 3|Protocol Violation|0|||
33612141|NCT01641692|63012471|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33612142|NCT01641692|63012472|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33612143|NCT01641692|63012473|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33612144|NCT01641692|63012474|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33612145|NCT01641692|63012475|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33612146|NCT01641692|63012476|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33612147|NCT01641692|63012477|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
33612148|NCT01641692|63012478|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33612149|NCT01641692|63012471|FG000|Treatment Period 3|Lost to Follow-up|0|||
33612150|NCT01641692|63012472|FG001|Treatment Period 3|Lost to Follow-up|1|||
33612151|NCT01641692|63012473|FG002|Treatment Period 3|Lost to Follow-up|0|||
33612152|NCT01641692|63012474|FG003|Treatment Period 3|Lost to Follow-up|0|||
33612153|NCT01641692|63012475|FG004|Treatment Period 3|Lost to Follow-up|0|||
33612154|NCT01641692|63012476|FG005|Treatment Period 3|Lost to Follow-up|0|||
33612155|NCT01641692|63012477|FG006|Treatment Period 3|Lost to Follow-up|0|||
33612156|NCT01641692|63012478|FG007|Treatment Period 3|Lost to Follow-up|0|||
33612157|NCT01641692|63012471|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
33612158|NCT01641692|63012472|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
33450636|NCT03801928|62825312|FG005|Overall Study|Withdrawal by Subject|0|||
33450637|NCT03801928|62825307|FG000|Overall Study|Other|0|||
33450638|NCT03801928|62825308|FG001|Overall Study|Other|2|||
33450639|NCT03801928|62825309|FG002|Overall Study|Other|0|||
33450640|NCT03801928|62825310|FG003|Overall Study|Other|1|||
33450641|NCT03801928|62825311|FG004|Overall Study|Other|0|||
33450642|NCT03801928|62825312|FG005|Overall Study|Other|1|||
33450643|NCT00263588|62825331|FG000|Overall Study|Death|54|||
33450644|NCT00263588|62825332|FG001|Overall Study|Death|90|||
33450645|NCT00263588|62825331|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
33450646|NCT00263588|62825332|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
33450647|NCT00263588|62825331|FG000|Overall Study|Lost to Follow-up|7|||
33450648|NCT00263588|62825332|FG001|Overall Study|Lost to Follow-up|10|||
33450649|NCT00263588|62825331|FG000|Overall Study|Withdrawal by Subject|3|||
33450650|NCT00263588|62825332|FG001|Overall Study|Withdrawal by Subject|4|||
33450651|NCT00263588|62825331|FG000|Overall Study|Protocol Violation|0|||
33612159|NCT01641692|63012473|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
33612160|NCT01641692|63012474|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
33612161|NCT01641692|63012475|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
33612162|NCT01641692|63012476|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
33612163|NCT01641692|63012477|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
33612164|NCT01641692|63012478|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
33612165|NCT01641692|63012471|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
33612166|NCT01641692|63012472|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
33612167|NCT01641692|63012473|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
33612168|NCT01641692|63012474|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
33612169|NCT01641692|63012475|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
33612170|NCT01641692|63012476|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
33612171|NCT01641692|63012477|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
33612172|NCT01641692|63012478|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
33612173|NCT01682512|63012500|FG000|Overall Study|Adverse Event|6|||
33612174|NCT01682512|63012501|FG001|Overall Study|Adverse Event|5|||
33612175|NCT01682512|63012502|FG002|Overall Study|Adverse Event|2|||
33612176|NCT01682512|63012500|FG000|Overall Study|Withdrawal by Subject|2|||
33612177|NCT01682512|63012501|FG001|Overall Study|Withdrawal by Subject|6|||
33612178|NCT01682512|63012502|FG002|Overall Study|Withdrawal by Subject|3|||
33612179|NCT01682512|63012500|FG000|Overall Study|Physician Decision|0|||
33612180|NCT01682512|63012501|FG001|Overall Study|Physician Decision|2|||
33612181|NCT01682512|63012502|FG002|Overall Study|Physician Decision|0|||
33612182|NCT01682512|63012500|FG000|Overall Study|Study terminated by sponsor|46|||
33612183|NCT01682512|63012501|FG001|Overall Study|Study terminated by sponsor|43|||
33612184|NCT01682512|63012502|FG002|Overall Study|Study terminated by sponsor|0|||
33612185|NCT01682512|63012500|FG000|Overall Study|Lost to Follow-up|3|||
33612186|NCT01682512|63012501|FG001|Overall Study|Lost to Follow-up|0|||
33612187|NCT01682512|63012502|FG002|Overall Study|Lost to Follow-up|2|||
33612188|NCT01682512|63012500|FG000|Overall Study|Protocol Violation|2|||
33612189|NCT01682512|63012501|FG001|Overall Study|Protocol Violation|3|||
33612190|NCT01682512|63012502|FG002|Overall Study|Protocol Violation|2|||
33612191|NCT01682512|63012500|FG000|Overall Study|Primary lack of efficacy|10|||
33612192|NCT01682512|63012501|FG001|Overall Study|Primary lack of efficacy|7|||
33612193|NCT01682512|63012502|FG002|Overall Study|Primary lack of efficacy|7|||
33612194|NCT01682512|63012500|FG000|Overall Study|Secondary lack of efficacy|1|||
33612195|NCT01682512|63012501|FG001|Overall Study|Secondary lack of efficacy|1|||
33612196|NCT01682512|63012502|FG002|Overall Study|Secondary lack of efficacy|0|||
33612197|NCT01682512|63012500|FG000|Overall Study|Other than stated above|2|||
33612198|NCT01682512|63012501|FG001|Overall Study|Other than stated above|4|||
33612199|NCT01682512|63012502|FG002|Overall Study|Other than stated above|2|||
33612200|NCT02256488|63012514|FG000|Overall Study|Lost to Follow-up|6|||
33612201|NCT02256488|63012515|FG001|Overall Study|Lost to Follow-up|6|||
33612202|NCT02256488|63012516|FG002|Overall Study|Lost to Follow-up|9|||
33612203|NCT02256488|63012517|FG003|Overall Study|Lost to Follow-up|3|||
33612204|NCT02256488|63012514|FG000|Overall Study|OTHER|1|||
33612205|NCT02256488|63012515|FG001|Overall Study|OTHER|0|||
33612206|NCT02256488|63012516|FG002|Overall Study|OTHER|1|||
33612207|NCT02256488|63012517|FG003|Overall Study|OTHER|1|||
33612208|NCT02256488|63012514|FG000|Overall Study|Withdrawal by Subject|1|||
33612209|NCT02256488|63012515|FG001|Overall Study|Withdrawal by Subject|0|||
33612210|NCT02256488|63012516|FG002|Overall Study|Withdrawal by Subject|0|||
33612211|NCT02256488|63012517|FG003|Overall Study|Withdrawal by Subject|2|||
33612212|NCT01715896|63012530|FG000|Overall Study|Lost to Follow-up|0|||
33612213|NCT01715896|63012531|FG001|Overall Study|Lost to Follow-up|2|||
33612214|NCT01715896|63012530|FG000|Overall Study|Withdrawal by Subject|1|||
33612215|NCT01715896|63012531|FG001|Overall Study|Withdrawal by Subject|4|||
33612216|NCT01715896|63012530|FG000|Overall Study|Other|2|||
33612217|NCT01715896|63012531|FG001|Overall Study|Other|5|||
33612218|NCT02255552|63012540|FG000|Overall Study|Participants enrolled into another study|0|||
33612219|NCT02255552|63012541|FG001|Overall Study|Participants enrolled into another study|11|||
33612220|NCT02255552|63012540|FG000|Overall Study|Withdrawal by Subject|1|||
33612221|NCT02255552|63012541|FG001|Overall Study|Withdrawal by Subject|4|||
33612222|NCT01714726|63012549|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
33612223|NCT01714726|63012550|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
33612224|NCT01714726|63012551|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
33612225|NCT01714726|63012552|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
33612226|NCT01714726|63012549|FG000|Double-Blinded Induction Period|Adverse Event|0|||
33612227|NCT01714726|63012550|FG001|Double-Blinded Induction Period|Adverse Event|1|||
33612228|NCT01714726|63012551|FG002|Double-Blinded Induction Period|Adverse Event|0|||
33612229|NCT01714726|63012552|FG003|Double-Blinded Induction Period|Adverse Event|0|||
33612230|NCT01714726|63012549|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
33612231|NCT01714726|63012550|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
33612232|NCT01714726|63012551|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
33612233|NCT01714726|63012552|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
33612234|NCT01714726|63012549|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
33612235|NCT01714726|63012550|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
33612236|NCT01714726|63012551|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
33612237|NCT01714726|63012552|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
33612238|NCT01714726|63012549|FG000|Open-Label Period|Other|0|||
33612239|NCT01714726|63012550|FG001|Open-Label Period|Other|0|||
33612240|NCT01714726|63012551|FG002|Open-Label Period|Other|1|||
33612241|NCT01714726|63012552|FG003|Open-Label Period|Other|3|||
33612242|NCT01714726|63012549|FG000|Open-Label Period|Adverse Event|0|||
33612243|NCT01714726|63012550|FG001|Open-Label Period|Adverse Event|0|||
33612244|NCT01714726|63012551|FG002|Open-Label Period|Adverse Event|1|||
33612245|NCT01714726|63012552|FG003|Open-Label Period|Adverse Event|0|||
33612246|NCT01714726|63012549|FG000|Open-Label Period|Withdrawal by Subject|0|||
33612247|NCT01714726|63012550|FG001|Open-Label Period|Withdrawal by Subject|0|||
33612248|NCT01714726|63012551|FG002|Open-Label Period|Withdrawal by Subject|9|||
33612249|NCT01714726|63012552|FG003|Open-Label Period|Withdrawal by Subject|19|||
33612250|NCT01714726|63012549|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
33612251|NCT01714726|63012550|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
33612252|NCT01714726|63012551|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
33612253|NCT01714726|63012552|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
33612254|NCT01714726|63012549|FG000|Open-Label Period|Lost to Follow-up|0|||
33612255|NCT01714726|63012550|FG001|Open-Label Period|Lost to Follow-up|0|||
33612256|NCT01714726|63012551|FG002|Open-Label Period|Lost to Follow-up|3|||
33612257|NCT01714726|63012552|FG003|Open-Label Period|Lost to Follow-up|4|||
33612258|NCT02255474|63012565|FG000|Overall Study|Lost to Follow-up|1|||
33612259|NCT02255474|63012566|FG001|Overall Study|Lost to Follow-up|1|||
33612260|NCT02255474|63012567|FG002|Overall Study|Lost to Follow-up|3|||
33612261|NCT02255474|63012565|FG000|Overall Study|Withdrawal by Subject|1|||
33612262|NCT02255474|63012566|FG001|Overall Study|Withdrawal by Subject|1|||
33612263|NCT02255474|63012567|FG002|Overall Study|Withdrawal by Subject|0|||
33612264|NCT02254772|63012576|FG000|Overall Study|Ineligible|1|||
33612265|NCT02254772|63012576|FG000|Overall Study|Withdrawal by Subject|1|||
33612266|NCT02254460|63012580|FG000|Overall Study|Adverse Event|1|||
33612267|NCT02254460|63012581|FG001|Overall Study|Adverse Event|0|||
33612268|NCT01682044|63012587|FG000|Overall Study|Death|1|||
33612269|NCT01682044|63012587|FG000|Overall Study|Progression|3|||
33612270|NCT01696942|63012593|FG000|Overall Study|Withdrawal by Subject|1|||
33612271|NCT01696942|63012594|FG001|Overall Study|Withdrawal by Subject|0|||
33612272|NCT01696942|63012593|FG000|Overall Study|Protocol Violation|1|||
33612273|NCT01696942|63012594|FG001|Overall Study|Protocol Violation|2|||
33612274|NCT01696942|63012593|FG000|Overall Study|screen failure|0|||
33612275|NCT01696942|63012594|FG001|Overall Study|screen failure|1|||
33450652|NCT00263588|62825332|FG001|Overall Study|Protocol Violation|1|||
33450653|NCT00263588|62825331|FG000|Overall Study|Investigator decision|7|||
33450654|NCT00263588|62825332|FG001|Overall Study|Investigator decision|15|||
33450655|NCT00263588|62825331|FG000|Overall Study|Sponsor terminated study|0|||
33450656|NCT00263588|62825332|FG001|Overall Study|Sponsor terminated study|1|||
33450657|NCT00213135|62825342|FG000|Overall Study|Adverse Event|9|||
33450658|NCT00213135|62825343|FG001|Overall Study|Adverse Event|5|||
33450659|NCT00213135|62825344|FG002|Overall Study|Adverse Event|5|||
33450660|NCT00213135|62825342|FG000|Overall Study|Lost to Follow-up|11|||
33450661|NCT00213135|62825343|FG001|Overall Study|Lost to Follow-up|8|||
33450662|NCT00213135|62825344|FG002|Overall Study|Lost to Follow-up|4|||
33450663|NCT00213135|62825342|FG000|Overall Study|Protocol Violation|4|||
33450664|NCT00213135|62825343|FG001|Overall Study|Protocol Violation|4|||
33450665|NCT00213135|62825344|FG002|Overall Study|Protocol Violation|10|||
33450666|NCT00213135|62825342|FG000|Overall Study|Death|1|||
33450667|NCT00213135|62825343|FG001|Overall Study|Death|1|||
33450668|NCT00213135|62825344|FG002|Overall Study|Death|2|||
33450669|NCT00213135|62825342|FG000|Overall Study|Disease progression|4|||
33450670|NCT00213135|62825343|FG001|Overall Study|Disease progression|5|||
33450671|NCT00213135|62825344|FG002|Overall Study|Disease progression|21|||
33450672|NCT00213135|62825342|FG000|Overall Study|Other|21|||
33450673|NCT00213135|62825343|FG001|Overall Study|Other|12|||
33612276|NCT01640366|63012600|FG000|Overall Study|Withdrawal by Subject|1|||
33450674|NCT00213135|62825344|FG002|Overall Study|Other|15|||
33612277|NCT01640366|63012600|FG000|Overall Study|Protocol Violation|16|||
33450675|NCT00077974|62825352|FG000|Overall Study|Adverse Event|22|||
33450676|NCT00077974|62825352|FG000|Overall Study|Protocol Violation|1|||
33450677|NCT00077974|62825352|FG000|Overall Study|Withdrawal by Subject|3|||
33450678|NCT00077974|62825352|FG000|Overall Study|Lack of Efficacy|76|||
33612278|NCT01640366|63012600|FG000|Overall Study|Lost to Follow-up|5|||
33612279|NCT01640288|63012608|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
33612280|NCT01640288|63012609|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
33612281|NCT01640288|63012608|FG000|Overall Study|Screen Failure|20|||
33612282|NCT01640288|63012609|FG001|Overall Study|Screen Failure|18|||
33612283|NCT01640288|63012608|FG000|Overall Study|Withdrawn by PI|5|||
33612284|NCT01640288|63012609|FG001|Overall Study|Withdrawn by PI|0|||
33612285|NCT01640288|63012608|FG000|Overall Study|Withdrawal by Subject|1|||
33612286|NCT01640288|63012609|FG001|Overall Study|Withdrawal by Subject|0|||
33612287|NCT01639040|63012618|FG000|Overall Study|Adverse Event|1|||
33612288|NCT01639040|63012619|FG001|Overall Study|Adverse Event|0|||
33612289|NCT01640054|63012628|FG000|Overall Study|Study-specific disc criteria|1|||
33612290|NCT01640054|63012628|FG000|Overall Study|Lack of Efficacy|3|||
33612291|NCT01640054|63012628|FG000|Overall Study|Adverse Event|2|||
33612292|NCT01600586|63012634|FG000|Overall Study|Physician Decision|3|||
33612293|NCT01600586|63012635|FG001|Overall Study|Physician Decision|3|||
33612294|NCT01639742|63012648|FG000|Overall Study|Study Ongoing|17|||
33612295|NCT01639742|63012648|FG000|Overall Study|Lost to Follow-up|1|||
33612296|NCT02164513|63012655|FG000|Overall Study|Adverse Event|162|||
33612297|NCT02164513|63012656|FG001|Overall Study|Adverse Event|180|||
33612298|NCT02164513|63012657|FG002|Overall Study|Adverse Event|111|||
33612299|NCT02164513|63012655|FG000|Overall Study|Other: Study Closed or terminated|5|||
33612300|NCT02164513|63012656|FG001|Overall Study|Other: Study Closed or terminated|2|||
33612301|NCT02164513|63012657|FG002|Overall Study|Other: Study Closed or terminated|4|||
33612302|NCT02164513|63012655|FG000|Overall Study|Lost to Follow-up|30|||
33612303|NCT02164513|63012656|FG001|Overall Study|Lost to Follow-up|36|||
33612304|NCT02164513|63012657|FG002|Overall Study|Lost to Follow-up|22|||
33612305|NCT02164513|63012655|FG000|Overall Study|Physician Decision|47|||
33612306|NCT02164513|63012656|FG001|Overall Study|Physician Decision|57|||
33612307|NCT02164513|63012657|FG002|Overall Study|Physician Decision|28|||
33612308|NCT02164513|63012655|FG000|Overall Study|Withdrawal by Subject|192|||
33612309|NCT02164513|63012656|FG001|Overall Study|Withdrawal by Subject|261|||
33612310|NCT02164513|63012657|FG002|Overall Study|Withdrawal by Subject|130|||
33612311|NCT02164513|63012655|FG000|Overall Study|Other: Reason not provided by site|1|||
33612312|NCT02164513|63012656|FG001|Overall Study|Other: Reason not provided by site|0|||
33612313|NCT02164513|63012657|FG002|Overall Study|Other: Reason not provided by site|0|||
33612314|NCT02218489|63012677|FG000|Overall Study|Withdrawal by Subject|4|||
33612315|NCT02218489|63012678|FG001|Overall Study|Withdrawal by Subject|3|||
33612316|NCT02218489|63012677|FG000|Overall Study|Lost to Follow-up|1|||
33612317|NCT02218489|63012678|FG001|Overall Study|Lost to Follow-up|0|||
33612318|NCT02192905|63012685|FG000|Overall Study|Lost to Follow-up|1|||
33612319|NCT01713946|63012693|FG000|Overall Study|Death|0|||
33612320|NCT01713946|63012694|FG001|Overall Study|Death|2|||
33612321|NCT01713946|63012695|FG002|Overall Study|Death|2|||
33612322|NCT01713946|63012693|FG000|Overall Study|Adverse Event|19|||
33612323|NCT01713946|63012694|FG001|Overall Study|Adverse Event|14|||
33612324|NCT01713946|63012695|FG002|Overall Study|Adverse Event|13|||
33612325|NCT01713946|63012693|FG000|Overall Study|Withdrawal by Subject|12|||
33612326|NCT01713946|63012694|FG001|Overall Study|Withdrawal by Subject|12|||
33612327|NCT01713946|63012695|FG002|Overall Study|Withdrawal by Subject|8|||
33612328|NCT01713946|63012693|FG000|Overall Study|Lack of Efficacy|8|||
33612329|NCT01713946|63012694|FG001|Overall Study|Lack of Efficacy|8|||
33612330|NCT01713946|63012695|FG002|Overall Study|Lack of Efficacy|14|||
33612331|NCT01713946|63012693|FG000|Overall Study|Protocol Violation|2|||
33612332|NCT01713946|63012694|FG001|Overall Study|Protocol Violation|4|||
33612333|NCT01713946|63012695|FG002|Overall Study|Protocol Violation|1|||
33612334|NCT01713946|63012693|FG000|Overall Study|Lost to Follow-up|0|||
33612335|NCT01713946|63012694|FG001|Overall Study|Lost to Follow-up|0|||
33612336|NCT01713946|63012695|FG002|Overall Study|Lost to Follow-up|1|||
33612337|NCT01713946|63012693|FG000|Overall Study|Administrative problems|1|||
33612338|NCT01713946|63012694|FG001|Overall Study|Administrative problems|0|||
33612339|NCT01713946|63012695|FG002|Overall Study|Administrative problems|0|||
33612340|NCT01713946|63012693|FG000|Overall Study|Did not continue in Ext|0|||
33612341|NCT01713946|63012694|FG001|Overall Study|Did not continue in Ext|3|||
33612342|NCT01713946|63012695|FG002|Overall Study|Did not continue in Ext|0|||
33612343|NCT01713946|63012693|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
33612344|NCT01713946|63012694|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
33612345|NCT01713946|63012695|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
33612346|NCT01713946|63012693|FG000|Overall Study|Patients never switched to everolimus|0|||
33450679|NCT00077974|62825352|FG000|Overall Study|Decision of Sponsor|2|||
33612347|NCT01713946|63012694|FG001|Overall Study|Patients never switched to everolimus|0|||
33612348|NCT01713946|63012695|FG002|Overall Study|Patients never switched to everolimus|5|||
33450680|NCT00124917|62825356|FG000|Overall Study|Physician Decision|3|||
33612349|NCT02163499|63012721|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
33612350|NCT02163499|63012721|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
33612351|NCT02163499|63012721|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
33612352|NCT02163499|63012721|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
33612353|NCT02163499|63012721|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
33612354|NCT02163499|63012721|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
33612355|NCT02163499|63012721|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
33612356|NCT02163499|63012721|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
33612357|NCT02163499|63012721|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
33612358|NCT02163499|63012721|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
33612359|NCT02163499|63012721|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
33612360|NCT02163499|63012721|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
33612361|NCT02163499|63012721|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
33612362|NCT02163499|63012721|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
33612363|NCT02163499|63012721|FG000|Extended Dosing Phase: ZS|Death|8|||
33612364|NCT02163499|63012721|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
33612365|NCT02163499|63012721|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
33612366|NCT02163499|63012721|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
33612367|NCT02163187|63012731|FG000|Overall Study|Device removed|1|||
33612368|NCT02163187|63012732|FG001|Overall Study|Device removed|0|||
33612369|NCT02163187|63012731|FG000|Overall Study|Progressive disease|1|||
33612370|NCT02163187|63012732|FG001|Overall Study|Progressive disease|0|||
33612371|NCT02191579|63012740|FG000|Treatment 1|Multiple Reasons Specified|27|||
33612372|NCT02191579|63012741|FG001|Treatment 1|Multiple Reasons Specified|58|||
33612373|NCT02191579|63012740|FG000|Treatment 2|Multiple Reasons Specified|0|||
33612374|NCT02191579|63012741|FG001|Treatment 2|Multiple Reasons Specified|25|||
33612375|NCT01363700|63012750|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
33612376|NCT01363700|63012751|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
33612377|NCT01363700|63012752|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
33612378|NCT01363700|63012753|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
33612379|NCT01363700|63012754|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
33612380|NCT01637402|63012765|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
33612381|NCT01637402|63012766|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
33612382|NCT01637402|63012765|FG000|Standard Dose Regimen|Adverse Event|1|||
33612383|NCT01637402|63012766|FG001|Standard Dose Regimen|Adverse Event|0|||
33612384|NCT01637402|63012765|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
33612385|NCT01637402|63012766|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
33612386|NCT01637402|63012765|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
33612387|NCT01637402|63012766|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
33612388|NCT01637402|63012765|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
33612389|NCT01637402|63012766|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
33612390|NCT01637402|63012765|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
33612391|NCT01637402|63012766|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
33612392|NCT02217475|63012794|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
33612393|NCT02217475|63012795|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
33612394|NCT02217475|63012796|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
33612395|NCT02217475|63012794|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
33612396|NCT02217475|63012795|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
33612397|NCT02217475|63012796|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
33612398|NCT02217475|63012794|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
33612399|NCT02217475|63012795|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
33450681|NCT00141921|62825361|FG000|Overall Study|Remain on Study|28|||
33450682|NCT00141921|62825361|FG000|Overall Study|Withdrawal by Subject|42|||
33450683|NCT00141921|62825361|FG000|Overall Study|Lost to Follow-up|19|||
33450684|NCT00141921|62825361|FG000|Overall Study|Noncompliance|17|||
33450685|NCT00141921|62825361|FG000|Overall Study|Disease Progression|7|||
33450686|NCT00141921|62825361|FG000|Overall Study|Protocol Deviation|7|||
33450687|NCT00141921|62825361|FG000|Overall Study|Adverse Event|5|||
33612400|NCT02217475|63012796|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
33612401|NCT02217475|63012794|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
33612402|NCT02217475|63012795|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
33612403|NCT02217475|63012796|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
33612404|NCT02217475|63012794|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
33612405|NCT02217475|63012795|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
33450688|NCT00141921|62825361|FG000|Overall Study|Administrative Decision|2|||
33450689|NCT00141921|62825361|FG000|Overall Study|Pregnancy|4|||
33450690|NCT00141921|62825361|FG000|Overall Study|Ineligibility Determined|2|||
33450691|NCT00141921|62825361|FG000|Overall Study|Other|8|||
33450692|NCT00029146|62825367|FG000|Overall Study|Lost to Follow-up|2|||
33450693|NCT00029146|62825368|FG001|Overall Study|Lost to Follow-up|1|||
33612406|NCT02217475|63012796|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
33612407|NCT02217475|63012794|FG000|Discontinued After Period 1|Adverse Event|1|||
33612408|NCT02217475|63012795|FG001|Discontinued After Period 1|Adverse Event|2|||
33612409|NCT02217475|63012796|FG002|Discontinued After Period 1|Adverse Event|0|||
33612410|NCT02217475|63012794|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
33612411|NCT02217475|63012795|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
33612412|NCT02217475|63012796|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
33612413|NCT02217475|63012794|FG000|Discontinued After Period 1|Physician Decision|0|||
33612414|NCT02217475|63012795|FG001|Discontinued After Period 1|Physician Decision|0|||
33612415|NCT02217475|63012796|FG002|Discontinued After Period 1|Physician Decision|1|||
33612416|NCT02217475|63012794|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
33612417|NCT02217475|63012795|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
33612418|NCT02217475|63012796|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
33612419|NCT02217475|63012794|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
33612420|NCT02217475|63012795|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
33612421|NCT02217475|63012796|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
33450694|NCT00026494|62825378|FG000|Overall Study|Withdrawal by Subject|1|||
33450695|NCT00026494|62825379|FG001|Overall Study|Withdrawal by Subject|0|||
33450696|NCT00026494|62825380|FG002|Overall Study|Withdrawal by Subject|1|||
33506768|NCT00383721|62889092|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
33506769|NCT00383721|62889093|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
33506770|NCT00383721|62889094|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
33506771|NCT00383721|62889090|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
33506772|NCT00383721|62889091|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
33506773|NCT00383721|62889092|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
33506774|NCT00383721|62889093|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
33506775|NCT00383721|62889094|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
33506776|NCT00383721|62889090|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
33506777|NCT00383721|62889091|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
33506778|NCT00383721|62889092|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
33506779|NCT00383721|62889093|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
33506780|NCT00383721|62889094|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
33506781|NCT00383721|62889090|FG000|26-Week Treatment Safety Extension|Administrative|1|||
33506782|NCT00383721|62889091|FG001|26-Week Treatment Safety Extension|Administrative|2|||
33506783|NCT00383721|62889092|FG002|26-Week Treatment Safety Extension|Administrative|3|||
33506784|NCT00383721|62889093|FG003|26-Week Treatment Safety Extension|Administrative|1|||
33506785|NCT00383721|62889094|FG004|26-Week Treatment Safety Extension|Administrative|0|||
33506786|NCT03035942|62889122|FG000|Overall Study|Adverse Event|8|||
33506787|NCT03035942|62889123|FG001|Overall Study|Adverse Event|4|||
33506788|NCT03035942|62889124|FG002|Overall Study|Adverse Event|5|||
33506789|NCT02616146|62889136|FG000|Overall Study|Adverse Event|64|||
33506790|NCT02616146|62889137|FG001|Overall Study|Adverse Event|24|||
33506791|NCT02616146|62889136|FG000|Overall Study|Lost to Follow-up|23|||
33506792|NCT02616146|62889137|FG001|Overall Study|Lost to Follow-up|13|||
33506793|NCT02616146|62889136|FG000|Overall Study|Non-compliance with study protocol|2|||
33506794|NCT02616146|62889137|FG001|Overall Study|Non-compliance with study protocol|0|||
33506795|NCT02616146|62889136|FG000|Overall Study|Non-compliance with study drug|4|||
33506796|NCT02616146|62889137|FG001|Overall Study|Non-compliance with study drug|2|||
33506797|NCT02616146|62889136|FG000|Overall Study|Pregnancy|2|||
33506798|NCT02616146|62889137|FG001|Overall Study|Pregnancy|2|||
33506799|NCT02616146|62889136|FG000|Overall Study|Pregnancy wish|3|||
33506800|NCT02616146|62889137|FG001|Overall Study|Pregnancy wish|0|||
33612422|NCT02217475|63012794|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
33612423|NCT02217475|63012795|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
33506801|NCT02616146|62889136|FG000|Overall Study|Protocol Violation|6|||
33506802|NCT02616146|62889137|FG001|Overall Study|Protocol Violation|3|||
33506803|NCT02616146|62889136|FG000|Overall Study|Study terminated by sponsor|1372|||
33506804|NCT02616146|62889137|FG001|Overall Study|Study terminated by sponsor|432|||
33506805|NCT02616146|62889136|FG000|Overall Study|Participant moved|4|||
33506806|NCT02616146|62889137|FG001|Overall Study|Participant moved|3|||
33506807|NCT02616146|62889136|FG000|Overall Study|Withdrawal by Subject|30|||
33506808|NCT02616146|62889137|FG001|Overall Study|Withdrawal by Subject|24|||
33506809|NCT02616146|62889136|FG000|Overall Study|Physician Decision|2|||
33506810|NCT02616146|62889137|FG001|Overall Study|Physician Decision|1|||
33506811|NCT04850313|62889145|FG000|Overall Study|Withdrawal by Subject|0|||
33506812|NCT04850313|62889146|FG001|Overall Study|Withdrawal by Subject|1|||
33506813|NCT03035864|62889154|FG000|Treatment Period|Adverse Event|1|||
33506814|NCT03035864|62889155|FG001|Treatment Period|Adverse Event|0|||
33506815|NCT03035864|62889154|FG000|Treatment Period|Other|3|||
33506816|NCT03035864|62889155|FG001|Treatment Period|Other|1|||
33506817|NCT03035864|62889154|FG000|Follow-up Period|Adverse Event|1|||
33506818|NCT03035864|62889155|FG001|Follow-up Period|Adverse Event|0|||
33506819|NCT03035864|62889154|FG000|Follow-up Period|Lost to Follow-up|6|||
33506820|NCT03035864|62889155|FG001|Follow-up Period|Lost to Follow-up|2|||
33506821|NCT03035864|62889154|FG000|Follow-up Period|Physician Decision|1|||
33506822|NCT03035864|62889155|FG001|Follow-up Period|Physician Decision|0|||
33506823|NCT03035864|62889154|FG000|Follow-up Period|Other|3|||
33506824|NCT03035864|62889155|FG001|Follow-up Period|Other|2|||
33506825|NCT02885181|62889173|FG000|Overall Study|Investigator's Discretion|0|||
33506826|NCT02885181|62889174|FG001|Overall Study|Investigator's Discretion|1|||
33506827|NCT02885181|62889175|FG002|Overall Study|Investigator's Discretion|0|||
33506828|NCT02885181|62889176|FG003|Overall Study|Investigator's Discretion|1|||
33506829|NCT02885181|62889173|FG000|Overall Study|Adverse Event|0|||
33506830|NCT02885181|62889174|FG001|Overall Study|Adverse Event|0|||
33506831|NCT02885181|62889175|FG002|Overall Study|Adverse Event|0|||
33506832|NCT02885181|62889176|FG003|Overall Study|Adverse Event|1|||
33506833|NCT02885181|62889173|FG000|Overall Study|Withdrawal by Subject|0|||
33506834|NCT02885181|62889174|FG001|Overall Study|Withdrawal by Subject|0|||
33506835|NCT02885181|62889175|FG002|Overall Study|Withdrawal by Subject|0|||
33506836|NCT02885181|62889176|FG003|Overall Study|Withdrawal by Subject|1|||
33450697|NCT00026494|62825381|FG003|Overall Study|Withdrawal by Subject|0|||
33450698|NCT00026494|62825378|FG000|Overall Study|Patient non-compliance|1|||
33450699|NCT00026494|62825379|FG001|Overall Study|Patient non-compliance|0|||
33450700|NCT00026494|62825380|FG002|Overall Study|Patient non-compliance|0|||
33450701|NCT00026494|62825381|FG003|Overall Study|Patient non-compliance|0|||
33450702|NCT00026494|62825378|FG000|Overall Study|Patient not treated|0|||
33450703|NCT00026494|62825379|FG001|Overall Study|Patient not treated|0|||
33450704|NCT00026494|62825380|FG002|Overall Study|Patient not treated|2|||
33450705|NCT00026494|62825381|FG003|Overall Study|Patient not treated|0|||
33450706|NCT00026494|62825378|FG000|Overall Study|Clinical progression|0|||
33450707|NCT00026494|62825379|FG001|Overall Study|Clinical progression|0|||
33450708|NCT00026494|62825380|FG002|Overall Study|Clinical progression|3|||
33450709|NCT00026494|62825381|FG003|Overall Study|Clinical progression|0|||
33450710|NCT00023764|62825391|FG000|Overall Study|Other|1|||
33450711|NCT00023764|62825391|FG000|Overall Study|Adverse Event|4|||
33450712|NCT00023764|62825391|FG000|Overall Study|Withdrawal by Subject|1|||
33450713|NCT00023764|62825391|FG000|Overall Study|Progression of disease|6|||
33450714|NCT00023764|62825391|FG000|Overall Study|patient received other treatment|1|||
33450715|NCT00023764|62825391|FG000|Overall Study|delay in obtaining staging images|1|||
33450716|NCT00189488|62825398|FG000|Overall Study|Ineligibility determined|1|||
33506837|NCT02884089|62889190|FG000|Period 1|Dosing error|2|||
33506838|NCT02884089|62889191|FG001|Period 1|Dosing error|2|||
33506839|NCT02884089|62889192|FG002|Period 1|Dosing error|0|||
33506840|NCT02884089|62889193|FG003|Period 1|Dosing error|0|||
33506841|NCT02884089|62889190|FG000|Washout Period 1|Lost to Follow-up|0|||
33506842|NCT02884089|62889191|FG001|Washout Period 1|Lost to Follow-up|1|||
33506843|NCT02884089|62889192|FG002|Washout Period 1|Lost to Follow-up|0|||
33506844|NCT02884089|62889193|FG003|Washout Period 1|Lost to Follow-up|1|||
33506845|NCT02884089|62889190|FG000|Washout Period 1|Withdrawal by Subject|0|||
33506846|NCT02884089|62889191|FG001|Washout Period 1|Withdrawal by Subject|1|||
33506847|NCT02884089|62889192|FG002|Washout Period 1|Withdrawal by Subject|0|||
33506848|NCT02884089|62889193|FG003|Washout Period 1|Withdrawal by Subject|0|||
33506849|NCT02884089|62889190|FG000|Period 2|Adverse Event|1|||
33506850|NCT02884089|62889191|FG001|Period 2|Adverse Event|0|||
33506851|NCT02884089|62889192|FG002|Period 2|Adverse Event|0|||
33506852|NCT02884089|62889193|FG003|Period 2|Adverse Event|0|||
33506853|NCT02884089|62889190|FG000|Period 3|Withdrawal by Subject|0|||
33506854|NCT02884089|62889191|FG001|Period 3|Withdrawal by Subject|0|||
33506855|NCT02884089|62889192|FG002|Period 3|Withdrawal by Subject|1|||
33506856|NCT02884089|62889193|FG003|Period 3|Withdrawal by Subject|0|||
33506857|NCT02884089|62889190|FG000|Washout Period 3|Withdrawal by Subject|0|||
33506858|NCT02884089|62889191|FG001|Washout Period 3|Withdrawal by Subject|0|||
33506859|NCT02884089|62889192|FG002|Washout Period 3|Withdrawal by Subject|1|||
33506860|NCT02884089|62889193|FG003|Washout Period 3|Withdrawal by Subject|0|||
33506861|NCT02884089|62889190|FG000|Washout Period 3|Lost to Follow-up|0|||
33506862|NCT02884089|62889191|FG001|Washout Period 3|Lost to Follow-up|0|||
33506863|NCT02884089|62889192|FG002|Washout Period 3|Lost to Follow-up|0|||
33506864|NCT02884089|62889193|FG003|Washout Period 3|Lost to Follow-up|1|||
33506865|NCT02884089|62889190|FG000|Period 4|Withdrawal by Subject|0|||
33506866|NCT02884089|62889191|FG001|Period 4|Withdrawal by Subject|1|||
33506867|NCT02884089|62889192|FG002|Period 4|Withdrawal by Subject|0|||
33506868|NCT02884089|62889193|FG003|Period 4|Withdrawal by Subject|0|||
33506869|NCT02884089|62889190|FG000|Period 4|Lost to Follow-up|1|||
33506870|NCT02884089|62889191|FG001|Period 4|Lost to Follow-up|0|||
33506871|NCT02884089|62889192|FG002|Period 4|Lost to Follow-up|0|||
33506872|NCT02884089|62889193|FG003|Period 4|Lost to Follow-up|0|||
33506873|NCT02884089|62889190|FG000|Follow-up Visit|Withdrawal by Subject|1|||
33506874|NCT02884089|62889191|FG001|Follow-up Visit|Withdrawal by Subject|0|||
33506875|NCT02884089|62889192|FG002|Follow-up Visit|Withdrawal by Subject|0|||
33506876|NCT02884089|62889193|FG003|Follow-up Visit|Withdrawal by Subject|1|||
33506877|NCT02809677|62889203|FG000|Overall Study|Withdrawal by Subject|8|||
33506878|NCT02881047|62889208|FG000|Overall Study|Adverse Event|1|||
33506879|NCT02881047|62889208|FG000|Overall Study|Withdrawal by Subject|1|||
33506880|NCT03157089|62889214|FG000|Overall Study|Treated only with pembrolizumab|1|||
33506881|NCT03157089|62889215|FG001|Overall Study|Treated only with pembrolizumab|0|||
33506882|NCT03157089|62889214|FG000|Overall Study|Adverse Event|5|||
33450717|NCT00189488|62825399|FG001|Overall Study|Ineligibility determined|0|||
33450718|NCT00189488|62825398|FG000|Overall Study|Protocol deviation|2|||
33450719|NCT00189488|62825399|FG001|Overall Study|Protocol deviation|1|||
33450720|NCT00189488|62825398|FG000|Overall Study|Adverse Event|2|||
33450721|NCT00189488|62825399|FG001|Overall Study|Adverse Event|1|||
33450722|NCT00189488|62825398|FG000|Overall Study|Withdrawal by Subject|2|||
33450723|NCT00189488|62825399|FG001|Overall Study|Withdrawal by Subject|6|||
33450724|NCT00189488|62825398|FG000|Overall Study|Disease progression|2|||
33450725|NCT00189488|62825399|FG001|Overall Study|Disease progression|4|||
33450726|NCT00189488|62825398|FG000|Overall Study|Administrative Decision|0|||
33450727|NCT00189488|62825399|FG001|Overall Study|Administrative Decision|2|||
33450728|NCT00189488|62825398|FG000|Overall Study|Death|5|||
33450729|NCT00189488|62825399|FG001|Overall Study|Death|8|||
33450730|NCT00189488|62825398|FG000|Overall Study|Other|1|||
33450731|NCT00189488|62825399|FG001|Overall Study|Other|0|||
33450732|NCT00233402|62825408|FG000|Overall Study|No pathology data|12|||
33450733|NCT00233402|62825409|FG001|Overall Study|No pathology data|9|||
33450734|NCT00233402|62825408|FG000|Overall Study|No Ta/T1|89|||
33450735|NCT00233402|62825409|FG001|Overall Study|No Ta/T1|94|||
33450736|NCT00233402|62825408|FG000|Overall Study|Lost to follow up etc|3|||
33450737|NCT00233402|62825409|FG001|Overall Study|Lost to follow up etc|21|||
33506883|NCT03157089|62889215|FG001|Overall Study|Adverse Event|4|||
33506884|NCT03157089|62889214|FG000|Overall Study|Progressive disease|6|||
33506885|NCT03157089|62889215|FG001|Overall Study|Progressive disease|8|||
33506886|NCT03158727|62889224|FG000|Overall Study|Withdrawal by Subject|2|||
33506887|NCT03158727|62889225|FG001|Overall Study|Withdrawal by Subject|6|||
33506888|NCT03158727|62889224|FG000|Overall Study|Death|11|||
33506889|NCT03158727|62889225|FG001|Overall Study|Death|12|||
33506890|NCT03158727|62889224|FG000|Overall Study|Lost to Follow-up|1|||
33506891|NCT03158727|62889225|FG001|Overall Study|Lost to Follow-up|0|||
33506892|NCT03158727|62889224|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
33450738|NCT00233324|62825421|FG000|Main Study|Death|68|||
33450739|NCT00233324|62825422|FG001|Main Study|Death|60|||
33450740|NCT00233324|62825423|FG002|Main Study|Death|62|||
33544098|NCT01661140|62934938|FG002|Open-Label Period|Administrative/Other|0|||
33506893|NCT03158727|62889225|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
33506894|NCT03158727|62889224|FG000|Overall Study|Visit 11 not done by mistake|0|||
33506895|NCT03158727|62889225|FG001|Overall Study|Visit 11 not done by mistake|1|||
33506896|NCT03158727|62889224|FG000|Overall Study|Enrolled, not treated|1|||
33506897|NCT03158727|62889225|FG001|Overall Study|Enrolled, not treated|0|||
33506898|NCT00089895|62889233|FG000|Overall Study|Consent Withdrawn|11|||
33506899|NCT00089895|62889234|FG001|Overall Study|Consent Withdrawn|14|||
33506900|NCT00089895|62889233|FG000|Overall Study|Technical reason|7|||
33506901|NCT00089895|62889234|FG001|Overall Study|Technical reason|2|||
33506902|NCT00089895|62889233|FG000|Overall Study|Surgery|0|||
33506903|NCT00089895|62889234|FG001|Overall Study|Surgery|1|||
33506904|NCT00089895|62889233|FG000|Overall Study|Bleeding|0|||
33506905|NCT00089895|62889234|FG001|Overall Study|Bleeding|2|||
33506906|NCT00089895|62889233|FG000|Overall Study|Physician Decision|3|||
33506907|NCT00089895|62889234|FG001|Overall Study|Physician Decision|7|||
33506908|NCT00089895|62889233|FG000|Overall Study|Exclusion criteria met|6|||
33506909|NCT00089895|62889234|FG001|Overall Study|Exclusion criteria met|6|||
33506910|NCT00089895|62889233|FG000|Overall Study|Not otherwise specified|4|||
33506911|NCT00089895|62889234|FG001|Overall Study|Not otherwise specified|8|||
33506912|NCT00089895|62889233|FG000|Overall Study|Missing|4|||
33506913|NCT00089895|62889234|FG001|Overall Study|Missing|2|||
33506914|NCT02714218|62889243|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33506915|NCT02714218|62889244|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
33506916|NCT02714218|62889245|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33506917|NCT02714218|62889243|FG000|Pre-Treatment Period|Other reasons|0|||
33506918|NCT02714218|62889244|FG001|Pre-Treatment Period|Other reasons|1|||
33612424|NCT02217475|63012796|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
33612425|NCT02217475|63012794|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
33612426|NCT02217475|63012795|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
33506919|NCT02714218|62889245|FG002|Pre-Treatment Period|Other reasons|0|||
33506920|NCT02714218|62889243|FG000|Treatment Period|Disease Progression|55|||
33506921|NCT02714218|62889244|FG001|Treatment Period|Disease Progression|52|||
33506922|NCT02714218|62889245|FG002|Treatment Period|Disease Progression|14|||
33506923|NCT02714218|62889243|FG000|Treatment Period|Study drug toxicity|46|||
33506924|NCT02714218|62889244|FG001|Treatment Period|Study drug toxicity|70|||
33506925|NCT02714218|62889245|FG002|Treatment Period|Study drug toxicity|6|||
33506926|NCT02714218|62889243|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
33506927|NCT02714218|62889244|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
33506928|NCT02714218|62889245|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
33506929|NCT02714218|62889243|FG000|Treatment Period|Request to discontinue treatment|1|||
33506930|NCT02714218|62889244|FG001|Treatment Period|Request to discontinue treatment|4|||
33506931|NCT02714218|62889245|FG002|Treatment Period|Request to discontinue treatment|1|||
33612427|NCT02217475|63012796|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
33612428|NCT02217475|63012794|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
33612429|NCT02217475|63012795|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
33612430|NCT02217475|63012796|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
33612431|NCT02191267|63012816|FG000|Overall Study|Withdrawal by Subject|1|||
33612432|NCT02191267|63012817|FG001|Overall Study|Withdrawal by Subject|0|||
33612433|NCT02191267|63012818|FG002|Overall Study|Withdrawal by Subject|0|||
33612434|NCT02189941|63012826|FG000|Overall Study|Non-compliance|0|||
33612435|NCT02189941|63012827|FG001|Overall Study|Non-compliance|0|||
33450741|NCT00233324|62825424|FG003|Main Study|Death|47|||
33450742|NCT00233324|62825421|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
33450743|NCT00233324|62825422|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
33450744|NCT00233324|62825423|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
33450745|NCT00233324|62825424|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
33450746|NCT00233324|62825421|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
33450747|NCT00233324|62825422|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
33506932|NCT02714218|62889243|FG000|Treatment Period|Participant withdrew consent|2|||
33506933|NCT02714218|62889244|FG001|Treatment Period|Participant withdrew consent|2|||
33506934|NCT02714218|62889245|FG002|Treatment Period|Participant withdrew consent|0|||
33506935|NCT02714218|62889243|FG000|Treatment Period|Maximum clinical benefit|4|||
33506936|NCT02714218|62889244|FG001|Treatment Period|Maximum clinical benefit|2|||
33506937|NCT02714218|62889245|FG002|Treatment Period|Maximum clinical benefit|0|||
33506938|NCT02714218|62889243|FG000|Treatment Period|Administrative reason by sponsor|2|||
33506939|NCT02714218|62889244|FG001|Treatment Period|Administrative reason by sponsor|1|||
33506940|NCT02714218|62889245|FG002|Treatment Period|Administrative reason by sponsor|0|||
33506941|NCT02714218|62889243|FG000|Treatment Period|Other reasons|6|||
33506942|NCT02714218|62889244|FG001|Treatment Period|Other reasons|6|||
33506943|NCT02714218|62889245|FG002|Treatment Period|Other reasons|0|||
33506944|NCT02714218|62889243|FG000|Treatment Period|Completed treatment as per protocol|36|||
33506945|NCT02714218|62889244|FG001|Treatment Period|Completed treatment as per protocol|27|||
33506946|NCT02714218|62889245|FG002|Treatment Period|Completed treatment as per protocol|3|||
33506947|NCT02714218|62889243|FG000|Treatment Period|Not reported|9|||
33506948|NCT02714218|62889244|FG001|Treatment Period|Not reported|6|||
33506949|NCT02714218|62889245|FG002|Treatment Period|Not reported|0|||
33506950|NCT03154047|62889252|FG000|Overall Study|Death|1|||
33506951|NCT03154047|62889252|FG000|Overall Study|Study terminated by sponsor|76|||
33506952|NCT03154047|62889252|FG000|Overall Study|Withdrawal by Subject|3|||
33506953|NCT03156621|62889258|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
33506954|NCT03156621|62889259|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
33506955|NCT03156621|62889258|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33506956|NCT03156621|62889259|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
33506957|NCT03156543|62889270|FG000|Overall Study|Withdrawal by Subject|1|||
33506958|NCT03156543|62889271|FG001|Overall Study|Withdrawal by Subject|0|||
33506959|NCT02713594|62889279|FG000|Overall Study|Withdrawal by Subject|32|||
33506960|NCT02713594|62889280|FG001|Overall Study|Withdrawal by Subject|22|||
33506961|NCT02713594|62889279|FG000|Overall Study|Lost to Follow-up|358|||
33506962|NCT02713594|62889280|FG001|Overall Study|Lost to Follow-up|374|||
33506963|NCT03152019|62889290|FG000|Overall Study|Adverse Event|0|||
33506964|NCT03152019|62889291|FG001|Overall Study|Adverse Event|1|||
33506965|NCT02714062|62889304|FG000|Overall Study|Adverse Event|0|||
33506966|NCT02714062|62889305|FG001|Overall Study|Adverse Event|0|||
33506967|NCT02714062|62889306|FG002|Overall Study|Adverse Event|2|||
33506968|NCT02714062|62889304|FG000|Overall Study|Withdrawal by Subject|1|||
33506969|NCT02714062|62889305|FG001|Overall Study|Withdrawal by Subject|0|||
33506970|NCT02714062|62889306|FG002|Overall Study|Withdrawal by Subject|1|||
33506971|NCT02714062|62889304|FG000|Overall Study|Protocol Violation|0|||
33506972|NCT02714062|62889305|FG001|Overall Study|Protocol Violation|1|||
33506973|NCT02714062|62889306|FG002|Overall Study|Protocol Violation|0|||
33506974|NCT03151395|62889316|FG000|Overall Study|Adverse Event|2|||
33506975|NCT03151395|62889316|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
33506976|NCT03151395|62889316|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
33506977|NCT03151395|62889316|FG000|Overall Study|Unspecified reason|4|||
33506978|NCT02713828|62889322|FG000|Overall Study|Death|2|||
33506979|NCT02713828|62889323|FG001|Overall Study|Death|0|||
33506980|NCT02713828|62889322|FG000|Overall Study|Withdrawal by Subject|1|||
33506981|NCT02713828|62889323|FG001|Overall Study|Withdrawal by Subject|0|||
33506982|NCT02713828|62889322|FG000|Overall Study|study terminated but patient allowed to|2|||
33506983|NCT02713828|62889323|FG001|Overall Study|study terminated but patient allowed to|0|||
33506984|NCT02876328|62889352|FG000|Overall Study|Death|2|||
33450748|NCT00233324|62825423|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
33450749|NCT00233324|62825424|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
33450750|NCT00023452|62825443|FG000|Overall Study|Ineligible for Study|163|||
33450751|NCT00023452|62825444|FG001|Overall Study|Ineligible for Study|159|||
33450752|NCT00023452|62825443|FG000|Overall Study|Out of Window|129|||
33450753|NCT00023452|62825444|FG001|Overall Study|Out of Window|69|||
33450754|NCT00023452|62825443|FG000|Overall Study|Death|2|||
33450755|NCT00023452|62825444|FG001|Overall Study|Death|0|||
33450756|NCT00023452|62825443|FG000|Overall Study|Withdrawal by Subject|66|||
33450757|NCT00023452|62825444|FG001|Overall Study|Withdrawal by Subject|54|||
33450758|NCT00023452|62825443|FG000|Overall Study|Adverse Event|139|||
33450759|NCT00023452|62825444|FG001|Overall Study|Adverse Event|196|||
33450760|NCT00023452|62825443|FG000|Overall Study|Lost to Follow-up|293|||
33450761|NCT00023452|62825444|FG001|Overall Study|Lost to Follow-up|60|||
33450762|NCT00023452|62825443|FG000|Overall Study|Physician Decision|49|||
33450763|NCT00023452|62825444|FG001|Overall Study|Physician Decision|21|||
33450764|NCT00023452|62825443|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
33450765|NCT00023452|62825444|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
33450766|NCT00023452|62825443|FG000|Overall Study|Pregnant|53|||
33450767|NCT00023452|62825444|FG001|Overall Study|Pregnant|20|||
33450768|NCT00023452|62825443|FG000|Overall Study|Other|204|||
33450769|NCT00023452|62825444|FG001|Overall Study|Other|69|||
33450770|NCT00022672|62825456|FG000|Main Phase: 24 Months|Adverse Event|6|||
33450771|NCT00022672|62825457|FG001|Main Phase: 24 Months|Adverse Event|0|||
33450772|NCT00022672|62825456|FG000|Main Phase: 24 Months|Death|0|||
33450773|NCT00022672|62825457|FG001|Main Phase: 24 Months|Death|3|||
33450774|NCT00022672|62825456|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
33450775|NCT00022672|62825457|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
33450776|NCT00022672|62825456|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
33450777|NCT00022672|62825457|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
33450778|NCT00022672|62825456|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
33450779|NCT00022672|62825457|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
33450780|NCT00022672|62825456|FG000|Main Phase: 24 Months|Refused Treatment|3|||
33450781|NCT00022672|62825457|FG001|Main Phase: 24 Months|Refused Treatment|4|||
33450782|NCT00022672|62825456|FG000|Main Phase: 24 Months|Failure to Return|1|||
33450783|NCT00022672|62825457|FG001|Main Phase: 24 Months|Failure to Return|1|||
33450784|NCT00022672|62825456|FG000|Main Phase: 24 Months|Other|1|||
33450785|NCT00022672|62825457|FG001|Main Phase: 24 Months|Other|0|||
33450786|NCT00022672|62825456|FG000|Extension Phase|Adverse Event|1|||
33450787|NCT00022672|62825457|FG001|Extension Phase|Adverse Event|3|||
33450788|NCT00022672|62825456|FG000|Extension Phase|Death|0|||
33450789|NCT00022672|62825457|FG001|Extension Phase|Death|1|||
33450790|NCT00022672|62825456|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
33450791|NCT00022672|62825457|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
33450792|NCT00022672|62825456|FG000|Extension Phase|Refused Treatment|0|||
33450793|NCT00022672|62825457|FG001|Extension Phase|Refused Treatment|2|||
33450794|NCT00022672|62825456|FG000|Extension Phase|Other|1|||
33450795|NCT00022672|62825457|FG001|Extension Phase|Other|1|||
33450796|NCT00076804|62825466|FG000|Overall Study|Death|9|||
33506985|NCT02876328|62889353|FG001|Overall Study|Death|1|||
33506986|NCT02876328|62889354|FG002|Overall Study|Death|3|||
33506987|NCT02876328|62889355|FG003|Overall Study|Death|0|||
33506988|NCT02876328|62889356|FG004|Overall Study|Death|0|||
33506989|NCT02876328|62889357|FG005|Overall Study|Death|0|||
33506990|NCT02876328|62889358|FG006|Overall Study|Death|1|||
33506991|NCT02876328|62889359|FG007|Overall Study|Death|3|||
33506992|NCT02876328|62889360|FG008|Overall Study|Death|0|||
33506993|NCT02876328|62889361|FG009|Overall Study|Death|1|||
33506994|NCT02876328|62889362|FG010|Overall Study|Death|1|||
33506995|NCT02876328|62889363|FG011|Overall Study|Death|0|||
33506996|NCT02876328|62889364|FG012|Overall Study|Death|0|||
33506997|NCT02876328|62889365|FG013|Overall Study|Death|0|||
33506998|NCT02876328|62889366|FG014|Overall Study|Death|0|||
33506999|NCT02876328|62889367|FG015|Overall Study|Death|0|||
33507000|NCT02876328|62889368|FG016|Overall Study|Death|1|||
33507001|NCT02876328|62889369|FG017|Overall Study|Death|1|||
33507002|NCT02876328|62889370|FG018|Overall Study|Death|0|||
33507003|NCT02876328|62889371|FG019|Overall Study|Death|0|||
33507004|NCT02876328|62889372|FG020|Overall Study|Death|0|||
33507005|NCT02876328|62889373|FG021|Overall Study|Death|1|||
33507006|NCT02876328|62889374|FG022|Overall Study|Death|0|||
33507007|NCT02876328|62889375|FG023|Overall Study|Death|0|||
33507008|NCT02876328|62889352|FG000|Overall Study|Withdrawal by Subject|0|||
33507009|NCT02876328|62889353|FG001|Overall Study|Withdrawal by Subject|2|||
33507010|NCT02876328|62889354|FG002|Overall Study|Withdrawal by Subject|3|||
33507011|NCT02876328|62889355|FG003|Overall Study|Withdrawal by Subject|3|||
33507012|NCT02876328|62889356|FG004|Overall Study|Withdrawal by Subject|0|||
33507013|NCT02876328|62889357|FG005|Overall Study|Withdrawal by Subject|1|||
33507014|NCT02876328|62889358|FG006|Overall Study|Withdrawal by Subject|0|||
33507015|NCT02876328|62889359|FG007|Overall Study|Withdrawal by Subject|1|||
33507016|NCT02876328|62889360|FG008|Overall Study|Withdrawal by Subject|1|||
33507017|NCT02876328|62889361|FG009|Overall Study|Withdrawal by Subject|2|||
33507018|NCT02876328|62889362|FG010|Overall Study|Withdrawal by Subject|0|||
33507019|NCT02876328|62889363|FG011|Overall Study|Withdrawal by Subject|0|||
33507020|NCT02876328|62889364|FG012|Overall Study|Withdrawal by Subject|0|||
33507021|NCT02876328|62889365|FG013|Overall Study|Withdrawal by Subject|0|||
33507022|NCT02876328|62889366|FG014|Overall Study|Withdrawal by Subject|0|||
33507023|NCT02876328|62889367|FG015|Overall Study|Withdrawal by Subject|0|||
33507024|NCT02876328|62889368|FG016|Overall Study|Withdrawal by Subject|1|||
33507025|NCT02876328|62889369|FG017|Overall Study|Withdrawal by Subject|3|||
33507026|NCT02876328|62889370|FG018|Overall Study|Withdrawal by Subject|0|||
33507027|NCT02876328|62889371|FG019|Overall Study|Withdrawal by Subject|0|||
33507028|NCT02876328|62889372|FG020|Overall Study|Withdrawal by Subject|1|||
33507029|NCT02876328|62889373|FG021|Overall Study|Withdrawal by Subject|0|||
33507030|NCT02876328|62889374|FG022|Overall Study|Withdrawal by Subject|0|||
33507031|NCT02876328|62889375|FG023|Overall Study|Withdrawal by Subject|0|||
33507032|NCT02876328|62889352|FG000|Overall Study|Missed 12 Month Visit|15|||
33507033|NCT02876328|62889353|FG001|Overall Study|Missed 12 Month Visit|10|||
33507034|NCT02876328|62889354|FG002|Overall Study|Missed 12 Month Visit|11|||
33507035|NCT02876328|62889355|FG003|Overall Study|Missed 12 Month Visit|6|||
33507036|NCT02876328|62889356|FG004|Overall Study|Missed 12 Month Visit|10|||
33507037|NCT02876328|62889357|FG005|Overall Study|Missed 12 Month Visit|14|||
33507038|NCT02876328|62889358|FG006|Overall Study|Missed 12 Month Visit|3|||
33507039|NCT02876328|62889359|FG007|Overall Study|Missed 12 Month Visit|8|||
33507040|NCT02876328|62889360|FG008|Overall Study|Missed 12 Month Visit|9|||
33507041|NCT02876328|62889361|FG009|Overall Study|Missed 12 Month Visit|5|||
33507042|NCT02876328|62889362|FG010|Overall Study|Missed 12 Month Visit|4|||
33507043|NCT02876328|62889363|FG011|Overall Study|Missed 12 Month Visit|1|||
33507044|NCT02876328|62889364|FG012|Overall Study|Missed 12 Month Visit|5|||
33507045|NCT02876328|62889365|FG013|Overall Study|Missed 12 Month Visit|4|||
33507046|NCT02876328|62889366|FG014|Overall Study|Missed 12 Month Visit|4|||
33507047|NCT02876328|62889367|FG015|Overall Study|Missed 12 Month Visit|4|||
33507048|NCT02876328|62889368|FG016|Overall Study|Missed 12 Month Visit|3|||
33507049|NCT02876328|62889369|FG017|Overall Study|Missed 12 Month Visit|6|||
33507050|NCT02876328|62889370|FG018|Overall Study|Missed 12 Month Visit|2|||
33507051|NCT02876328|62889371|FG019|Overall Study|Missed 12 Month Visit|2|||
33507052|NCT02876328|62889372|FG020|Overall Study|Missed 12 Month Visit|11|||
33507053|NCT02876328|62889373|FG021|Overall Study|Missed 12 Month Visit|7|||
33507054|NCT02876328|62889374|FG022|Overall Study|Missed 12 Month Visit|1|||
33507055|NCT02876328|62889375|FG023|Overall Study|Missed 12 Month Visit|0|||
33507056|NCT02875860|62889403|FG000|Overall Study|Withdrawal by Subject|0|||
33507057|NCT02875860|62889404|FG001|Overall Study|Withdrawal by Subject|1|||
33507058|NCT02875392|62889412|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
33507059|NCT02875392|62889413|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
33507060|NCT03127644|62889422|FG000|Overall Study|Study-specific withdrawal criteria|0|||
33507061|NCT03127644|62889423|FG001|Overall Study|Study-specific withdrawal criteria|0|||
33507062|NCT03127644|62889424|FG002|Overall Study|Study-specific withdrawal criteria|2|||
33507063|NCT03965962|62889438|FG000|Overall Study|Adverse Event|1|||
33507064|NCT03965962|62889439|FG001|Overall Study|Adverse Event|0|||
33507065|NCT03965962|62889440|FG002|Overall Study|Adverse Event|0|||
33507066|NCT03965962|62889441|FG003|Overall Study|Adverse Event|0|||
33507067|NCT03965962|62889438|FG000|Overall Study|Protocol Violation|21|||
33507068|NCT03965962|62889439|FG001|Overall Study|Protocol Violation|4|||
33507069|NCT03965962|62889440|FG002|Overall Study|Protocol Violation|10|||
33507070|NCT03965962|62889441|FG003|Overall Study|Protocol Violation|5|||
33507071|NCT03965962|62889438|FG000|Overall Study|Lost to Follow-up|0|||
33507072|NCT03965962|62889439|FG001|Overall Study|Lost to Follow-up|1|||
33507073|NCT03965962|62889440|FG002|Overall Study|Lost to Follow-up|0|||
33507074|NCT03965962|62889441|FG003|Overall Study|Lost to Follow-up|0|||
33507075|NCT03965962|62889438|FG000|Overall Study|Withdrawal by Subject|3|||
33507076|NCT03965962|62889439|FG001|Overall Study|Withdrawal by Subject|0|||
33507077|NCT03965962|62889440|FG002|Overall Study|Withdrawal by Subject|0|||
33507078|NCT03965962|62889441|FG003|Overall Study|Withdrawal by Subject|1|||
33507079|NCT03151551|62889453|FG000|Open-Label Treatment Period|Adverse Event|0|||
33507080|NCT03151551|62889454|FG001|Open-Label Treatment Period|Adverse Event|2|||
33507081|NCT03151551|62889453|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
33507082|NCT03151551|62889454|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
33507083|NCT03151551|62889453|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
33507084|NCT03151551|62889454|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
33507085|NCT03151551|62889453|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
33507086|NCT03151551|62889454|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
33507087|NCT03151551|62889453|FG000|Open-Label Treatment Period|Physician Decision|3|||
33507088|NCT03151551|62889454|FG001|Open-Label Treatment Period|Physician Decision|0|||
33507089|NCT03151551|62889453|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
33507090|NCT03151551|62889454|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
33507091|NCT03151551|62889453|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
33507092|NCT03151551|62889454|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
33507093|NCT03151551|62889453|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
33507094|NCT03151551|62889454|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
33450797|NCT00076804|62825467|FG001|Overall Study|Death|20|||
33450798|NCT00076804|62825466|FG000|Overall Study|Lost to Follow-up|9|||
33507095|NCT03151551|62889453|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
33507096|NCT03151551|62889454|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
33450799|NCT00076804|62825467|FG001|Overall Study|Lost to Follow-up|9|||
33450800|NCT00076804|62825466|FG000|Overall Study|Withdrawal by Subject|10|||
33450801|NCT00076804|62825467|FG001|Overall Study|Withdrawal by Subject|8|||
33450802|NCT00076804|62825466|FG000|Overall Study|Early study Closure|32|||
33450803|NCT00076804|62825467|FG001|Overall Study|Early study Closure|32|||
33450804|NCT00141453|62825475|FG000|Overall Study|Protocol Violation|6|||
33450805|NCT00141453|62825476|FG001|Overall Study|Protocol Violation|5|||
33450806|NCT00076570|62825484|FG000|Overall Study|Drug intolerance|8|||
33450807|NCT00076570|62825485|FG001|Overall Study|Drug intolerance|8|||
33450808|NCT00124449|62825493|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
33450809|NCT00124449|62825494|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
33450810|NCT00124449|62825493|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
33507097|NCT03151551|62889453|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
33507098|NCT03151551|62889454|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
33507099|NCT03147495|62889464|FG000|Overall Study|Physician Decision|0|||
33507100|NCT03147495|62889465|FG001|Overall Study|Physician Decision|6|||
33507101|NCT03126786|62889473|FG000|Overall Study|Adverse Event|3|||
33507102|NCT03126786|62889474|FG001|Overall Study|Adverse Event|0|||
33507103|NCT03126786|62889473|FG000|Overall Study|Lost to Follow-up|0|||
33507104|NCT03126786|62889474|FG001|Overall Study|Lost to Follow-up|1|||
33507105|NCT03126786|62889473|FG000|Overall Study|Withdrawal by Subject|3|||
33507106|NCT03126786|62889474|FG001|Overall Study|Withdrawal by Subject|1|||
33507107|NCT03146403|62889482|FG000|Overall Study|Withdrawal by Subject|0|||
33507108|NCT03146403|62889483|FG001|Overall Study|Withdrawal by Subject|3|||
33507109|NCT03146403|62889482|FG000|Overall Study|Lost to Follow-up|2|||
33507110|NCT03146403|62889483|FG001|Overall Study|Lost to Follow-up|0|||
33507111|NCT02713204|62889492|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
33507112|NCT02713204|62889493|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
33507113|NCT02713204|62889494|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
33507114|NCT02713204|62889495|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
33612436|NCT02189941|63012828|FG002|Overall Study|Non-compliance|1|||
33612437|NCT02216773|63012838|FG000|Overall Study|Disease progression|4|||
33507115|NCT02713204|62889496|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
33507116|NCT02713204|62889497|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
33507117|NCT02713204|62889498|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
33507118|NCT02713204|62889499|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
33507119|NCT02713204|62889492|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33507120|NCT02713204|62889493|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33507121|NCT02713204|62889494|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
33507122|NCT02713204|62889495|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33507123|NCT02713204|62889496|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33507124|NCT02713204|62889497|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33507125|NCT02713204|62889498|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33507126|NCT02713204|62889499|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33507127|NCT02713204|62889492|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33507128|NCT02713204|62889493|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
33507129|NCT02713204|62889494|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33507130|NCT02713204|62889495|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33507131|NCT02713204|62889496|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33507132|NCT02713204|62889497|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33507133|NCT02713204|62889498|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33507134|NCT02713204|62889499|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33507135|NCT02713204|62889492|FG000|From Week 12 up to Week 36|Adverse Event|1|||
33507136|NCT02713204|62889493|FG001|From Week 12 up to Week 36|Adverse Event|0|||
33507137|NCT02713204|62889494|FG002|From Week 12 up to Week 36|Adverse Event|0|||
33507138|NCT02713204|62889495|FG003|From Week 12 up to Week 36|Adverse Event|1|||
33507139|NCT02713204|62889496|FG004|From Week 12 up to Week 36|Adverse Event|1|||
33507140|NCT02713204|62889497|FG005|From Week 12 up to Week 36|Adverse Event|0|||
33507141|NCT02713204|62889498|FG006|From Week 12 up to Week 36|Adverse Event|2|||
33507142|NCT02713204|62889499|FG007|From Week 12 up to Week 36|Adverse Event|1|||
33507143|NCT02713204|62889492|FG000|From Week 12 up to Week 36|Death|0|||
33507144|NCT02713204|62889493|FG001|From Week 12 up to Week 36|Death|0|||
33507145|NCT02713204|62889494|FG002|From Week 12 up to Week 36|Death|0|||
33507146|NCT02713204|62889495|FG003|From Week 12 up to Week 36|Death|1|||
33507147|NCT02713204|62889496|FG004|From Week 12 up to Week 36|Death|0|||
33507148|NCT02713204|62889497|FG005|From Week 12 up to Week 36|Death|1|||
33507149|NCT02713204|62889498|FG006|From Week 12 up to Week 36|Death|0|||
33507150|NCT02713204|62889499|FG007|From Week 12 up to Week 36|Death|3|||
33507151|NCT02713204|62889492|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
33507152|NCT02713204|62889493|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
33507153|NCT02713204|62889494|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
33507154|NCT02713204|62889495|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
33507155|NCT02713204|62889496|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
33507156|NCT02713204|62889497|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
33507157|NCT02713204|62889498|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
33612438|NCT02216773|63012839|FG001|Overall Study|Disease progression|2|||
33507158|NCT02713204|62889499|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
33507159|NCT02713204|62889492|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
33507160|NCT02713204|62889493|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
33507161|NCT02713204|62889494|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
33507162|NCT02713204|62889495|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
33507163|NCT02713204|62889496|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
33507164|NCT02713204|62889497|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
33507165|NCT02713204|62889498|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
33612439|NCT02216773|63012838|FG000|Overall Study|Insufficient FLRV|4|||
33507166|NCT02713204|62889499|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
33507167|NCT03695172|62889519|FG000|Overall Study|Withdrawal by Subject|1|||
33507168|NCT03695172|62889520|FG001|Overall Study|Withdrawal by Subject|1|||
33507169|NCT03695172|62889521|FG002|Overall Study|Withdrawal by Subject|0|||
33507170|NCT03721107|62889533|FG000|Overall Study|Adverse Event|1|||
33507171|NCT03721107|62889534|FG001|Overall Study|Adverse Event|1|||
33507172|NCT03721107|62889535|FG002|Overall Study|Adverse Event|6|||
33507173|NCT03721107|62889536|FG003|Overall Study|Adverse Event|5|||
33507174|NCT03721107|62889533|FG000|Overall Study|Lost to Follow-up|2|||
33507175|NCT03721107|62889534|FG001|Overall Study|Lost to Follow-up|0|||
33507176|NCT03721107|62889535|FG002|Overall Study|Lost to Follow-up|3|||
33507177|NCT03721107|62889536|FG003|Overall Study|Lost to Follow-up|0|||
33507178|NCT03721107|62889533|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
33507179|NCT03721107|62889534|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
33507180|NCT03721107|62889535|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
33507181|NCT03721107|62889536|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
33507182|NCT03721107|62889533|FG000|Overall Study|Physician Decision|0|||
33507183|NCT03721107|62889534|FG001|Overall Study|Physician Decision|1|||
33507184|NCT03721107|62889535|FG002|Overall Study|Physician Decision|0|||
33507185|NCT03721107|62889536|FG003|Overall Study|Physician Decision|0|||
33507186|NCT03721107|62889533|FG000|Overall Study|Pregnancy|0|||
33507187|NCT03721107|62889534|FG001|Overall Study|Pregnancy|0|||
33507188|NCT03721107|62889535|FG002|Overall Study|Pregnancy|1|||
33507189|NCT03721107|62889536|FG003|Overall Study|Pregnancy|0|||
33507190|NCT03721107|62889533|FG000|Overall Study|Withdrawal by Subject|1|||
33450811|NCT00124449|62825494|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
33450812|NCT00124449|62825493|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
33450813|NCT00124449|62825494|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
33450814|NCT00124449|62825493|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
33450815|NCT00124449|62825494|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
33450816|NCT00124449|62825493|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
33450817|NCT00124449|62825494|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
33450818|NCT00124449|62825493|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
33450819|NCT00124449|62825494|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
33450820|NCT00124449|62825493|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
33450821|NCT00124449|62825494|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
33450822|NCT00124449|62825493|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
33450823|NCT00124449|62825494|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
33450824|NCT00124449|62825493|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
33450825|NCT00124449|62825494|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
33450826|NCT00124449|62825493|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
33450827|NCT00124449|62825494|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
33450828|NCT00124449|62825493|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
33450829|NCT00124449|62825494|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
33450830|NCT00124449|62825493|FG000|18-Month Untreated Observation Period|Relocated|1|||
33450831|NCT00124449|62825494|FG001|18-Month Untreated Observation Period|Relocated|0|||
33450832|NCT00076336|62825503|FG000|Overall Study|Death|13|||
33450833|NCT00076336|62825504|FG001|Overall Study|Death|17|||
33450834|NCT00076336|62825503|FG000|Overall Study|Adverse Event|4|||
33450835|NCT00076336|62825504|FG001|Overall Study|Adverse Event|4|||
33450836|NCT00076336|62825503|FG000|Overall Study|Lost to Follow-up|4|||
33450837|NCT00076336|62825504|FG001|Overall Study|Lost to Follow-up|4|||
33450838|NCT00076336|62825503|FG000|Overall Study|Non-Compliance|2|||
33450839|NCT00076336|62825504|FG001|Overall Study|Non-Compliance|0|||
33450840|NCT00076336|62825503|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
33450841|NCT00076336|62825504|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
33450842|NCT00076336|62825503|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
33450843|NCT00076336|62825504|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
33450844|NCT00076336|62825503|FG000|Overall Study|Liver Transplantation|3|||
33450845|NCT00076336|62825504|FG001|Overall Study|Liver Transplantation|3|||
33450846|NCT00076336|62825503|FG000|Overall Study|Virologic Breakthrough|14|||
33450847|NCT00076336|62825504|FG001|Overall Study|Virologic Breakthrough|16|||
33450848|NCT00076336|62825503|FG000|Overall Study|Treatment failure|4|||
33450849|NCT00076336|62825504|FG001|Overall Study|Treatment failure|5|||
33507191|NCT03721107|62889534|FG001|Overall Study|Withdrawal by Subject|1|||
33507192|NCT03721107|62889535|FG002|Overall Study|Withdrawal by Subject|5|||
33507193|NCT03721107|62889536|FG003|Overall Study|Withdrawal by Subject|5|||
33450850|NCT00185588|62825514|FG000|Overall Study|Adverse Event|3|||
33450851|NCT00185588|62825515|FG001|Overall Study|Adverse Event|1|||
33450852|NCT00185588|62825516|FG002|Overall Study|Adverse Event|4|||
33450853|NCT00185588|62825517|FG003|Overall Study|Adverse Event|2|||
33507194|NCT03721107|62889533|FG000|Overall Study|Other|1|||
33507195|NCT03721107|62889534|FG001|Overall Study|Other|0|||
33507196|NCT03721107|62889535|FG002|Overall Study|Other|0|||
33612440|NCT02216773|63012839|FG001|Overall Study|Insufficient FLRV|0|||
33612441|NCT02216773|63012838|FG000|Overall Study|Abandoned|4|||
33612442|NCT02216773|63012839|FG001|Overall Study|Abandoned|3|||
33612443|NCT01601132|63012845|FG000|Overall Study|Patient withdrew consent|1|||
33612444|NCT01601132|63012845|FG000|Overall Study|Protocol deviation|1|||
33612445|NCT02162719|63012854|FG000|Overall Study|Death|41|||
33450854|NCT00185588|62825514|FG000|Overall Study|Lost to Follow-up|0|||
33450855|NCT00185588|62825515|FG001|Overall Study|Lost to Follow-up|0|||
33450856|NCT00185588|62825516|FG002|Overall Study|Lost to Follow-up|1|||
33450857|NCT00185588|62825517|FG003|Overall Study|Lost to Follow-up|2|||
33450858|NCT00185588|62825514|FG000|Overall Study|Withdrawal by Subject|0|||
33450859|NCT00185588|62825515|FG001|Overall Study|Withdrawal by Subject|1|||
33450860|NCT00185588|62825516|FG002|Overall Study|Withdrawal by Subject|0|||
33450861|NCT00185588|62825517|FG003|Overall Study|Withdrawal by Subject|0|||
33450862|NCT00185588|62825514|FG000|Overall Study|Physician Decision|0|||
33450863|NCT00185588|62825515|FG001|Overall Study|Physician Decision|0|||
33450864|NCT00185588|62825516|FG002|Overall Study|Physician Decision|1|||
33450865|NCT00185588|62825517|FG003|Overall Study|Physician Decision|0|||
33450866|NCT00232544|62825529|FG000|Overall Study|Lost to Follow-up|20|||
33450867|NCT00232544|62825530|FG001|Overall Study|Lost to Follow-up|15|||
33450868|NCT00231842|62825536|FG000|Overall Study|Withdrawal by Subject|3|||
33450869|NCT00231842|62825536|FG000|Overall Study|Did not complete the last 3 cycle|8|||
33450870|NCT00076102|62825541|FG000|Overall Study|Clinical progression|1|||
33450871|NCT00076102|62825541|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
33450872|NCT00076102|62825541|FG000|Overall Study|plexiform neurofibroma surgery|1|||
33450873|NCT00076102|62825541|FG000|Overall Study|refusal of further therapy|2|||
33450874|NCT00231062|62825555|FG000|Overall Study|Physician Decision|6|||
33450875|NCT00184028|62825559|FG000|Overall Study|Death|1|||
33450876|NCT00184028|62825559|FG000|Overall Study|Lack of Efficacy|4|||
33450877|NCT00184028|62825559|FG000|Overall Study|Adverse Event|2|||
33450878|NCT00184028|62825559|FG000|Overall Study|Withdrawal by Subject|1|||
33450879|NCT00184028|62825559|FG000|Overall Study|Non-compliance|2|||
33450880|NCT00183872|62825564|FG000|Overall Study|Death|3|||
33450881|NCT00183872|62825564|FG000|Overall Study|Adverse Event|9|||
33450882|NCT00183872|62825564|FG000|Overall Study|Withdrawal by Subject|2|||
33450883|NCT00183872|62825564|FG000|Overall Study|Drug delayed more than 28 days|2|||
33450884|NCT03815175|62825568|FG000|Overall Study|Subject Lost to Follow-up|6|||
33450885|NCT03815175|62825568|FG000|Overall Study|Subject Withdrew Consent|48|||
33450886|NCT03815175|62825568|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
33450887|NCT03815175|62825568|FG000|Overall Study|Death|86|||
33450888|NCT03815175|62825568|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
33450889|NCT03815175|62825568|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
33450890|NCT03815175|62825568|FG000|Overall Study|Other Status Change Reason|1|||
33450891|NCT03815175|62825568|FG000|Overall Study|Missed Visit|12|||
33450892|NCT00262028|62825581|FG000|Overall Study|Withdrawal by Subject|6|||
33450893|NCT00262028|62825582|FG001|Overall Study|Withdrawal by Subject|3|||
33450894|NCT00262028|62825583|FG002|Overall Study|Withdrawal by Subject|6|||
33450895|NCT00262028|62825584|FG003|Overall Study|Withdrawal by Subject|5|||
33450896|NCT00262028|62825585|FG004|Overall Study|Withdrawal by Subject|2|||
33450897|NCT00262028|62825586|FG005|Overall Study|Withdrawal by Subject|3|||
33450898|NCT00262028|62825587|FG006|Overall Study|Withdrawal by Subject|5|||
33450899|NCT00262028|62825588|FG007|Overall Study|Withdrawal by Subject|7|||
33450900|NCT00262028|62825589|FG008|Overall Study|Withdrawal by Subject|2|||
33450901|NCT00262028|62825581|FG000|Overall Study|Lost to Follow-up|7|||
33612446|NCT02162719|63012855|FG001|Overall Study|Death|46|||
33450902|NCT00262028|62825582|FG001|Overall Study|Lost to Follow-up|7|||
33450903|NCT00262028|62825583|FG002|Overall Study|Lost to Follow-up|5|||
33450904|NCT00262028|62825584|FG003|Overall Study|Lost to Follow-up|5|||
33450905|NCT00262028|62825585|FG004|Overall Study|Lost to Follow-up|4|||
33450906|NCT00262028|62825586|FG005|Overall Study|Lost to Follow-up|3|||
33450907|NCT00262028|62825587|FG006|Overall Study|Lost to Follow-up|3|||
33450908|NCT00262028|62825588|FG007|Overall Study|Lost to Follow-up|5|||
33612447|NCT02162719|63012854|FG000|Overall Study|Lost to Follow-up|1|||
33507197|NCT03721107|62889536|FG003|Overall Study|Other|1|||
33507198|NCT03052920|62889555|FG000|Overall Study|Withdrawal by Subject|1|||
33507199|NCT02930226|62889565|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
33507200|NCT02930226|62889566|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
33507201|NCT02930226|62889567|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
33507202|NCT02930226|62889568|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
33507203|NCT02930226|62889569|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
33507204|NCT02930226|62889570|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
33507205|NCT02722434|62889607|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
33507206|NCT02722434|62889608|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
33507207|NCT02722434|62889607|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
33507208|NCT02722434|62889608|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
33507209|NCT03539601|62889618|FG000|Overall Study|Withdraw by parent/guardian|1|||
33507210|NCT03539601|62889619|FG001|Overall Study|Withdraw by parent/guardian|0|||
33507211|NCT03539601|62889620|FG002|Overall Study|Withdraw by parent/guardian|1|||
33507212|NCT03539601|62889621|FG003|Overall Study|Withdraw by parent/guardian|0|||
33507213|NCT03539601|62889618|FG000|Overall Study|Adverse Event|0|||
33507214|NCT03539601|62889619|FG001|Overall Study|Adverse Event|2|||
33507215|NCT03539601|62889620|FG002|Overall Study|Adverse Event|0|||
33507216|NCT03539601|62889621|FG003|Overall Study|Adverse Event|0|||
33507217|NCT03539601|62889618|FG000|Overall Study|Lost to Follow-up|2|||
33324299|NCT00960531|62700740|FG002|Overall Study|Caregiver Request|6|||
33450909|NCT00262028|62825589|FG008|Overall Study|Lost to Follow-up|6|||
33450910|NCT00262028|62825581|FG000|Overall Study|Administrative Reason|11|||
33450911|NCT00262028|62825582|FG001|Overall Study|Administrative Reason|14|||
33450912|NCT00262028|62825583|FG002|Overall Study|Administrative Reason|9|||
33450913|NCT00262028|62825584|FG003|Overall Study|Administrative Reason|12|||
33450914|NCT00262028|62825585|FG004|Overall Study|Administrative Reason|6|||
33450915|NCT00262028|62825586|FG005|Overall Study|Administrative Reason|7|||
33450916|NCT00262028|62825587|FG006|Overall Study|Administrative Reason|4|||
33450917|NCT00262028|62825588|FG007|Overall Study|Administrative Reason|6|||
33450918|NCT00262028|62825589|FG008|Overall Study|Administrative Reason|10|||
33450919|NCT00262028|62825581|FG000|Overall Study|Protocol Violation|0|||
33450920|NCT00262028|62825582|FG001|Overall Study|Protocol Violation|0|||
33450921|NCT00262028|62825583|FG002|Overall Study|Protocol Violation|0|||
33450922|NCT00262028|62825584|FG003|Overall Study|Protocol Violation|1|||
33450923|NCT00262028|62825585|FG004|Overall Study|Protocol Violation|0|||
33450924|NCT00262028|62825586|FG005|Overall Study|Protocol Violation|0|||
33450925|NCT00262028|62825587|FG006|Overall Study|Protocol Violation|0|||
33450926|NCT00262028|62825588|FG007|Overall Study|Protocol Violation|0|||
33450927|NCT00262028|62825589|FG008|Overall Study|Protocol Violation|0|||
33450928|NCT00262028|62825581|FG000|Overall Study|Unable to classify|0|||
33450929|NCT00262028|62825582|FG001|Overall Study|Unable to classify|3|||
33450930|NCT00262028|62825583|FG002|Overall Study|Unable to classify|0|||
33450931|NCT00262028|62825584|FG003|Overall Study|Unable to classify|0|||
33450932|NCT00262028|62825585|FG004|Overall Study|Unable to classify|0|||
33450933|NCT00262028|62825586|FG005|Overall Study|Unable to classify|0|||
33450934|NCT00262028|62825587|FG006|Overall Study|Unable to classify|0|||
33450935|NCT00262028|62825588|FG007|Overall Study|Unable to classify|0|||
33450936|NCT00262028|62825589|FG008|Overall Study|Unable to classify|1|||
33450937|NCT00183248|62825633|FG000|Overall Study|Lost to Follow-up|0|||
33450938|NCT00183248|62825634|FG001|Overall Study|Lost to Follow-up|1|||
33450939|NCT00183248|62825633|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
33450940|NCT00183248|62825634|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
33450941|NCT00183170|62825642|FG000|First Intervention|Did not complete study|1|||
33450942|NCT00183170|62825643|FG001|First Intervention|Did not complete study|0|||
33450943|NCT00183170|62825642|FG000|First Intervention|Did not meet targeted BrAC|1|||
33450944|NCT00183170|62825643|FG001|First Intervention|Did not meet targeted BrAC|0|||
33450945|NCT00183170|62825642|FG000|Washout 1 Week|Did not complete study|6|||
33450946|NCT00183170|62825643|FG001|Washout 1 Week|Did not complete study|8|||
33450947|NCT00183170|62825642|FG000|Second Intervention|Did not complete study|1|||
33450948|NCT00183170|62825643|FG001|Second Intervention|Did not complete study|0|||
33507218|NCT03539601|62889619|FG001|Overall Study|Lost to Follow-up|4|||
33507219|NCT03539601|62889620|FG002|Overall Study|Lost to Follow-up|5|||
33507220|NCT03539601|62889621|FG003|Overall Study|Lost to Follow-up|0|||
33507221|NCT03539601|62889618|FG000|Overall Study|Withdrawal by Subject|2|||
33507222|NCT03539601|62889619|FG001|Overall Study|Withdrawal by Subject|0|||
33507223|NCT03539601|62889620|FG002|Overall Study|Withdrawal by Subject|0|||
33507224|NCT03539601|62889621|FG003|Overall Study|Withdrawal by Subject|1|||
33507225|NCT03539601|62889618|FG000|Overall Study|Randomized but not treated|1|||
33507226|NCT03539601|62889619|FG001|Overall Study|Randomized but not treated|1|||
33507227|NCT03539601|62889620|FG002|Overall Study|Randomized but not treated|0|||
33507228|NCT03539601|62889621|FG003|Overall Study|Randomized but not treated|0|||
33612448|NCT02162719|63012855|FG001|Overall Study|Lost to Follow-up|3|||
33612449|NCT02162719|63012854|FG000|Overall Study|Disease Progression|2|||
33612450|NCT02162719|63012855|FG001|Overall Study|Disease Progression|1|||
33612451|NCT02162719|63012854|FG000|Overall Study|Withdrawal by Subject|8|||
33507229|NCT00700804|62889641|FG000|Overall Study|Withdrawal by Subject|1|||
33612452|NCT02162719|63012855|FG001|Overall Study|Withdrawal by Subject|2|||
33450949|NCT00183170|62825642|FG000|Second Intervention|Did not meet targeted BrAC|0|||
33450950|NCT00183170|62825643|FG001|Second Intervention|Did not meet targeted BrAC|2|||
33450951|NCT00230282|62825649|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
33450952|NCT00230282|62825649|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
33450953|NCT00230282|62825649|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
33450954|NCT00230282|62825649|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
33450955|NCT00261950|62825653|FG000|Overall Study|Lost to Follow-up|2|||
33450956|NCT00261950|62825653|FG000|Overall Study|Death|6|||
33450957|NCT00261950|62825653|FG000|Overall Study|Withdrawal by Subject|5|||
33450958|NCT00261950|62825653|FG000|Overall Study|Other|1|||
33450959|NCT00261950|62825653|FG000|Overall Study|Physician Decision|1|||
33450960|NCT00261950|62825653|FG000|Overall Study|Protocol specified Criteria|11|||
33450961|NCT00230048|62825659|FG000|Overall Study|Lost to Follow-up|13|||
33450962|NCT00230048|62825660|FG001|Overall Study|Lost to Follow-up|18|||
33450963|NCT00229658|62825670|FG000|Overall Study|Administrative|2|||
33450964|NCT00229658|62825671|FG001|Overall Study|Administrative|1|||
33450965|NCT00229658|62825670|FG000|Overall Study|Investigator decision|13|||
33450966|NCT00229658|62825671|FG001|Overall Study|Investigator decision|10|||
33450967|NCT00229658|62825670|FG000|Overall Study|Other|80|||
33450968|NCT00229658|62825671|FG001|Overall Study|Other|60|||
33450969|NCT00229658|62825670|FG000|Overall Study|Lost to Follow-up|82|||
33450970|NCT00229658|62825671|FG001|Overall Study|Lost to Follow-up|55|||
33450971|NCT00229658|62825670|FG000|Overall Study|Serious Adverse Event|2|||
33450972|NCT00229658|62825671|FG001|Overall Study|Serious Adverse Event|2|||
33450973|NCT00229658|62825670|FG000|Overall Study|Withdrawal of consent|46|||
33450974|NCT00229658|62825671|FG001|Overall Study|Withdrawal of consent|39|||
33450975|NCT00182078|62825679|FG000|Overall Study|Withdrawal by Subject|1|||
33450976|NCT00182078|62825680|FG001|Overall Study|Withdrawal by Subject|0|||
33450977|NCT00181844|62825686|FG000|Signed Consent|Withdrawal by Subject|5|||
33450978|NCT00181844|62825686|FG000|Signed Consent|Did not meet entrance criteria|7|||
33450979|NCT00181844|62825686|FG000|Exposed to Study Medication|Adverse Event|10|||
33450980|NCT00181844|62825686|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
33450981|NCT00181844|62825686|FG000|Exposed to Study Medication|Non-compliance|2|||
33450982|NCT00181844|62825686|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
33450983|NCT00181844|62825686|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
33450984|NCT00181766|62825690|FG000|Overall Study|Lost to Follow-up|6|||
33450985|NCT00181766|62825690|FG000|Overall Study|Adverse Event|4|||
33450986|NCT00181766|62825690|FG000|Overall Study|non-compliance|2|||
33450987|NCT00180674|62825694|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
33450988|NCT00180674|62825694|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
33450989|NCT00076024|62825705|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
33450990|NCT00076024|62825706|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
33450991|NCT00076024|62825707|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
33450992|NCT00076024|62825708|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
33450993|NCT00076024|62825705|FG000|Phase 1, Lead-in|Adverse Event|1|||
33450994|NCT00076024|62825706|FG001|Phase 1, Lead-in|Adverse Event|0|||
33507230|NCT00700804|62889642|FG001|Overall Study|Withdrawal by Subject|2|||
33507231|NCT00700804|62889641|FG000|Overall Study|Protocol Violation|1|||
33507232|NCT00700804|62889642|FG001|Overall Study|Protocol Violation|1|||
33507233|NCT00700804|62889641|FG000|Overall Study|Loose Stools|1|||
33507234|NCT00700804|62889642|FG001|Overall Study|Loose Stools|1|||
33507235|NCT02903823|62889648|FG000|Overall Study|Physician Decision|5|||
33507236|NCT02903823|62889648|FG000|Overall Study|Could not advance catheter|1|||
33507237|NCT02903823|62889648|FG000|Overall Study|Catheter dislodgement|1|||
33507238|NCT00832455|62889677|FG000|Overall Study|Adverse Event|13|||
33507239|NCT00832455|62889677|FG000|Overall Study|Lost to Follow-up|26|||
33507240|NCT00832455|62889677|FG000|Overall Study|Protocol Violation|4|||
33507241|NCT00832455|62889677|FG000|Overall Study|Withdrawal by Subject|17|||
33507242|NCT00832455|62889677|FG000|Overall Study|Screening Failure|2|||
33507243|NCT00832455|62889677|FG000|Overall Study|Stopped Medication|4|||
33507244|NCT00832455|62889677|FG000|Overall Study|Parent misunderstood study|1|||
33507245|NCT00832455|62889677|FG000|Overall Study|Parent dissatisfied|1|||
33507246|NCT00832455|62889677|FG000|Overall Study|No improvement|3|||
33507247|NCT00832455|62889677|FG000|Overall Study|Patient moved|1|||
33507248|NCT00687531|62889690|FG000|Overall Study|Did not meet protocol eligibility|104|||
33507249|NCT00687531|62889690|FG000|Overall Study|Adverse Event|5|||
33507250|NCT00687531|62889690|FG000|Overall Study|Lost to Follow-up|26|||
33507251|NCT00423579|62889696|FG000|Overall Study|Lost to Follow-up|3|||
33507252|NCT00423579|62889697|FG001|Overall Study|Lost to Follow-up|0|||
33507253|NCT00423579|62889696|FG000|Overall Study|Protocol Violation|1|||
33507254|NCT00423579|62889697|FG001|Overall Study|Protocol Violation|3|||
33507255|NCT00423579|62889696|FG000|Overall Study|Diagnosis of diabetes|0|||
33507256|NCT00423579|62889697|FG001|Overall Study|Diagnosis of diabetes|1|||
33507257|NCT03268005|62889705|FG000|Overall Study|Death|2|||
33507258|NCT03268005|62889706|FG001|Overall Study|Death|1|||
33507259|NCT03268005|62889705|FG000|Overall Study|Lost to Follow-up|2|||
33612453|NCT02162719|63012854|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
33612454|NCT02162719|63012855|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
33612455|NCT02161549|63012863|FG000|Overall Study|Physician Decision|6|||
33612456|NCT02161549|63012864|FG001|Overall Study|Physician Decision|2|||
33612457|NCT02189863|63012870|FG000|First 2 Weeks|Motion Sickness|4|||
33612458|NCT02189863|63012871|FG001|First 2 Weeks|Motion Sickness|2|||
33612459|NCT02189473|63012882|FG000|Overall Study|Death|22|||
33612460|NCT02189473|63012883|FG001|Overall Study|Death|23|||
33612461|NCT02189473|63012882|FG000|Overall Study|Lost to Follow-up|1|||
33612462|NCT02189473|63012883|FG001|Overall Study|Lost to Follow-up|2|||
33612463|NCT02188849|63012891|FG000|Overall Study|Lost to Follow-up|3|||
33612464|NCT02188849|63012892|FG001|Overall Study|Lost to Follow-up|8|||
33612465|NCT01636076|63012900|FG000|Overall Study|Terminated by sponsor|1|||
33612466|NCT01636076|63012901|FG001|Overall Study|Terminated by sponsor|1|||
33612467|NCT01636076|63012900|FG000|Overall Study|Lack of Efficacy|0|||
33612468|NCT01636076|63012901|FG001|Overall Study|Lack of Efficacy|1|||
33612469|NCT01636076|63012900|FG000|Overall Study|Lost to Follow-up|1|||
33612470|NCT01636076|63012901|FG001|Overall Study|Lost to Follow-up|0|||
33612471|NCT01636076|63012900|FG000|Overall Study|Physician Decision|1|||
33612472|NCT01636076|63012901|FG001|Overall Study|Physician Decision|1|||
33612473|NCT01636076|63012900|FG000|Overall Study|Non-compliance with study treatment|1|||
33612474|NCT01636076|63012901|FG001|Overall Study|Non-compliance with study treatment|1|||
33450995|NCT00076024|62825707|FG002|Phase 1, Lead-in|Adverse Event|0|||
33450996|NCT00076024|62825708|FG003|Phase 1, Lead-in|Adverse Event|0|||
33450997|NCT00076024|62825705|FG000|Phase 1, Lead-in|Clinical progression|1|||
33450998|NCT00076024|62825706|FG001|Phase 1, Lead-in|Clinical progression|0|||
33450999|NCT00076024|62825707|FG002|Phase 1, Lead-in|Clinical progression|0|||
33451000|NCT00076024|62825708|FG003|Phase 1, Lead-in|Clinical progression|0|||
33451001|NCT00076024|62825705|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
33612475|NCT01636076|63012900|FG000|Overall Study|Adverse Event|6|||
33612476|NCT01636076|63012901|FG001|Overall Study|Adverse Event|11|||
33612477|NCT01636076|63012900|FG000|Overall Study|Withdrawal by Subject|7|||
33451002|NCT00076024|62825706|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
33451003|NCT00076024|62825707|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
33451004|NCT00076024|62825708|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
33451005|NCT00076024|62825705|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
33451006|NCT00076024|62825706|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
33451007|NCT00076024|62825707|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
33451008|NCT00076024|62825708|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
33507260|NCT03268005|62889706|FG001|Overall Study|Lost to Follow-up|2|||
33507261|NCT03268005|62889705|FG000|Overall Study|Withdrawal by Subject|11|||
33507262|NCT03268005|62889706|FG001|Overall Study|Withdrawal by Subject|11|||
33507263|NCT03149055|62889712|FG000|Overall Study|Not treated|4|||
33612478|NCT01636076|63012901|FG001|Overall Study|Withdrawal by Subject|10|||
33612479|NCT01635998|63012916|FG000|Overall Study|Death|1|||
33612480|NCT01635998|63012917|FG001|Overall Study|Death|1|||
33612481|NCT01635998|63012916|FG000|Overall Study|Lost to Follow-up|2|||
33612482|NCT01635998|63012917|FG001|Overall Study|Lost to Follow-up|1|||
33612483|NCT01635998|63012916|FG000|Overall Study|Withdrawal by Subject|1|||
33612484|NCT01635998|63012917|FG001|Overall Study|Withdrawal by Subject|5|||
33612485|NCT01635920|63012925|FG000|Overall Study|Adverse Event|1|||
33612486|NCT01635920|63012926|FG001|Overall Study|Adverse Event|0|||
33612487|NCT01635920|63012925|FG000|Overall Study|Lost to Follow-up|0|||
33612488|NCT01635920|63012926|FG001|Overall Study|Lost to Follow-up|1|||
33612489|NCT01635920|63012925|FG000|Overall Study|Subject decision|2|||
33612490|NCT01635920|63012926|FG001|Overall Study|Subject decision|0|||
33612491|NCT02160145|63012943|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
33612492|NCT02160145|63012944|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
33612493|NCT02160145|63012945|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
33612494|NCT02160145|63012943|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
33612495|NCT02160145|63012944|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
33507264|NCT03137121|62889727|FG000|Overall Study|Withdrawal by Subject|0|||
33507265|NCT03137121|62889728|FG001|Overall Study|Withdrawal by Subject|1|||
33507266|NCT00700570|62889771|FG000|Overall Study|Adverse Event|2|||
33507267|NCT00700570|62889772|FG001|Overall Study|Adverse Event|6|||
33507268|NCT00700570|62889771|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
33507269|NCT00700570|62889772|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
33507270|NCT00700570|62889771|FG000|Overall Study|Disease Progression|8|||
33507271|NCT00700570|62889772|FG001|Overall Study|Disease Progression|11|||
33507272|NCT00700570|62889771|FG000|Overall Study|Withdrawal by Subject|1|||
33507273|NCT00700570|62889772|FG001|Overall Study|Withdrawal by Subject|6|||
33507274|NCT02874924|62889790|FG000|Overall Study|Adverse Event|2|||
33507275|NCT02874924|62889791|FG001|Overall Study|Adverse Event|0|||
33507276|NCT02874924|62889792|FG002|Overall Study|Adverse Event|0|||
33507277|NCT02874924|62889790|FG000|Overall Study|Withdrawal by Subject|1|||
33507278|NCT02874924|62889791|FG001|Overall Study|Withdrawal by Subject|0|||
33507279|NCT02874924|62889792|FG002|Overall Study|Withdrawal by Subject|0|||
33507280|NCT04425863|62889803|FG000|Overall Study|Death|0|||
33507281|NCT04425863|62889804|FG001|Overall Study|Death|0|||
33507282|NCT04425863|62889805|FG002|Overall Study|Death|1|||
33507283|NCT04360187|62889827|FG000|Double-Blind Treatment|Adverse Event|9|||
33507284|NCT04360187|62889828|FG001|Double-Blind Treatment|Adverse Event|11|||
33507285|NCT04360187|62889827|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
33507286|NCT04360187|62889828|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
33507287|NCT04360187|62889827|FG000|Double-Blind Treatment|Physician Decision|1|||
33507288|NCT04360187|62889828|FG001|Double-Blind Treatment|Physician Decision|0|||
33507289|NCT04360187|62889827|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
33507290|NCT04360187|62889828|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
33507291|NCT04360187|62889827|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
33507292|NCT04360187|62889828|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
33507293|NCT04360187|62889827|FG000|Follow-Up|Lost to Follow-up|1|||
33507294|NCT04360187|62889828|FG001|Follow-Up|Lost to Follow-up|0|||
33507295|NCT04498169|62889836|FG000|Study Completion|Adverse Event|1|||
33507296|NCT04498169|62889837|FG001|Study Completion|Adverse Event|1|||
33507297|NCT03695393|62889845|FG000|Overall Study|Death|3|||
33507298|NCT03695393|62889846|FG001|Overall Study|Death|1|||
33507299|NCT03695393|62889845|FG000|Overall Study|Lost to Follow-up|0|||
33507300|NCT03695393|62889846|FG001|Overall Study|Lost to Follow-up|1|||
33507301|NCT03694925|62889855|FG000|Overall Study|Inadequate laboratory testing|0|||
33507302|NCT03694925|62889856|FG001|Overall Study|Inadequate laboratory testing|3|||
33507303|NCT03694925|62889857|FG002|Overall Study|Inadequate laboratory testing|0|||
33507304|NCT04258020|62889869|FG000|Overall Study|Withdrawal by Subject|1|||
33507305|NCT04258020|62889870|FG001|Overall Study|Withdrawal by Subject|0|||
33507306|NCT04495283|62889879|FG000|Overall Study|Physician Decision|0|||
33507307|NCT04495283|62889880|FG001|Overall Study|Physician Decision|0|||
33507308|NCT04495283|62889881|FG002|Overall Study|Physician Decision|1|||
33507309|NCT04495283|62889879|FG000|Overall Study|Withdrawal by Subject|0|||
33612496|NCT02160145|63012945|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
33612497|NCT02160145|63012943|FG000|Randomized Double-blind Period|Subject decision|0|||
33612498|NCT02160145|63012944|FG001|Randomized Double-blind Period|Subject decision|21|||
33612499|NCT02160145|63012945|FG002|Randomized Double-blind Period|Subject decision|20|||
33507310|NCT04495283|62889880|FG001|Overall Study|Withdrawal by Subject|1|||
33507311|NCT04495283|62889881|FG002|Overall Study|Withdrawal by Subject|1|||
33507312|NCT04495283|62889879|FG000|Overall Study|Other|1|||
33507313|NCT04495283|62889880|FG001|Overall Study|Other|0|||
33507314|NCT04495283|62889881|FG002|Overall Study|Other|1|||
33507315|NCT03117738|62889894|FG000|Overall Study|Withdrawal by Subject|3|||
33507316|NCT03117738|62889895|FG001|Overall Study|Withdrawal by Subject|1|||
33507317|NCT03117738|62889894|FG000|Overall Study|Lost to Follow-up|1|||
33507318|NCT03117738|62889895|FG001|Overall Study|Lost to Follow-up|4|||
33612500|NCT02160145|63012943|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
33612501|NCT02160145|63012944|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
33507319|NCT04234464|62889903|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
33507320|NCT04234464|62889904|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
33507321|NCT03123588|62889912|FG000|Overall Study|Study Terminated by Sponsor|2|||
33507322|NCT03123588|62889913|FG001|Overall Study|Study Terminated by Sponsor|5|||
33507323|NCT03123588|62889912|FG000|Overall Study|Withdrawal by Subject|1|||
33507324|NCT03123588|62889913|FG001|Overall Study|Withdrawal by Subject|0|||
33507325|NCT03123588|62889912|FG000|Overall Study|Adverse Event|1|||
33507326|NCT03123588|62889913|FG001|Overall Study|Adverse Event|0|||
33507327|NCT03123588|62889912|FG000|Overall Study|Physician Decision|2|||
33507328|NCT03123588|62889913|FG001|Overall Study|Physician Decision|1|||
33507329|NCT03123354|62889920|FG000|Overall Study|Physician Decision|6|||
33507330|NCT04421027|62889926|FG000|Treatment Period|Adverse Event|5|||
33507331|NCT04421027|62889927|FG001|Treatment Period|Adverse Event|3|||
33507332|NCT04421027|62889928|FG002|Treatment Period|Adverse Event|0|||
33507333|NCT04421027|62889929|FG003|Treatment Period|Adverse Event|0|||
33507334|NCT04421027|62889926|FG000|Treatment Period|Death|98|||
33507335|NCT04421027|62889927|FG001|Treatment Period|Death|61|||
33507336|NCT04421027|62889928|FG002|Treatment Period|Death|0|||
33507337|NCT04421027|62889929|FG003|Treatment Period|Death|0|||
33507338|NCT04421027|62889926|FG000|Treatment Period|Lost to Follow-up|22|||
33507339|NCT04421027|62889927|FG001|Treatment Period|Lost to Follow-up|20|||
33507340|NCT04421027|62889928|FG002|Treatment Period|Lost to Follow-up|0|||
33507341|NCT04421027|62889929|FG003|Treatment Period|Lost to Follow-up|0|||
33507342|NCT04421027|62889926|FG000|Treatment Period|Other-Unknown|15|||
33507343|NCT04421027|62889927|FG001|Treatment Period|Other-Unknown|9|||
33507344|NCT04421027|62889928|FG002|Treatment Period|Other-Unknown|0|||
33507345|NCT04421027|62889929|FG003|Treatment Period|Other-Unknown|0|||
33507346|NCT04421027|62889926|FG000|Treatment Period|Physician Decision|1|||
33507347|NCT04421027|62889927|FG001|Treatment Period|Physician Decision|1|||
33451009|NCT00076024|62825705|FG000|Phase 2, Double-blind|Adverse Event|0|||
33451010|NCT00076024|62825706|FG001|Phase 2, Double-blind|Adverse Event|25|||
33451011|NCT00076024|62825707|FG002|Phase 2, Double-blind|Adverse Event|6|||
33451012|NCT00076024|62825708|FG003|Phase 2, Double-blind|Adverse Event|0|||
33451013|NCT00076024|62825705|FG000|Phase 2, Double-blind|Un-specified|0|||
33451014|NCT00076024|62825706|FG001|Phase 2, Double-blind|Un-specified|14|||
33451015|NCT00076024|62825707|FG002|Phase 2, Double-blind|Un-specified|6|||
33451016|NCT00076024|62825708|FG003|Phase 2, Double-blind|Un-specified|0|||
33451017|NCT00076024|62825705|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
33451018|NCT00076024|62825706|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
33451019|NCT00076024|62825707|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
33451020|NCT00076024|62825708|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
33451021|NCT00076024|62825705|FG000|Phase 2, Open-label|Adverse Event|0|||
33451022|NCT00076024|62825706|FG001|Phase 2, Open-label|Adverse Event|0|||
33451023|NCT00076024|62825707|FG002|Phase 2, Open-label|Adverse Event|0|||
33451024|NCT00076024|62825708|FG003|Phase 2, Open-label|Adverse Event|2|||
33451025|NCT00076024|62825705|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
33451026|NCT00076024|62825706|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
33451027|NCT00076024|62825707|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
33507348|NCT04421027|62889928|FG002|Treatment Period|Physician Decision|0|||
33507349|NCT04421027|62889929|FG003|Treatment Period|Physician Decision|0|||
33507350|NCT04421027|62889926|FG000|Treatment Period|Withdrawal by Subject|7|||
33507351|NCT04421027|62889927|FG001|Treatment Period|Withdrawal by Subject|12|||
33507352|NCT04421027|62889928|FG002|Treatment Period|Withdrawal by Subject|0|||
33612502|NCT02160145|63012945|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
33507353|NCT04421027|62889929|FG003|Treatment Period|Withdrawal by Subject|0|||
33507354|NCT04421027|62889926|FG000|Treatment Period|Randomized Not Dosed|9|||
33507355|NCT04421027|62889927|FG001|Treatment Period|Randomized Not Dosed|14|||
33507356|NCT04421027|62889928|FG002|Treatment Period|Randomized Not Dosed|0|||
33507357|NCT04421027|62889929|FG003|Treatment Period|Randomized Not Dosed|0|||
33507358|NCT04421027|62889926|FG000|Follow-Up Period|Adverse Event|0|||
33507359|NCT04421027|62889927|FG001|Follow-Up Period|Adverse Event|0|||
33507360|NCT04421027|62889928|FG002|Follow-Up Period|Adverse Event|0|||
33507361|NCT04421027|62889929|FG003|Follow-Up Period|Adverse Event|3|||
33324300|NCT00960531|62700741|FG003|Overall Study|Caregiver Request|5|||
33324301|NCT00960531|62700742|FG004|Overall Study|Caregiver Request|0|||
33507362|NCT04421027|62889926|FG000|Follow-Up Period|Death|0|||
33324302|NCT00960531|62700743|FG005|Overall Study|Caregiver Request|2|||
33507363|NCT04421027|62889927|FG001|Follow-Up Period|Death|0|||
33324303|NCT00960531|62700744|FG006|Overall Study|Caregiver Request|3|||
33324304|NCT00960531|62700745|FG007|Overall Study|Caregiver Request|1|||
33324305|NCT00960531|62700746|FG008|Overall Study|Caregiver Request|3|||
33324306|NCT00960531|62700747|FG009|Overall Study|Caregiver Request|0|||
33507364|NCT04421027|62889928|FG002|Follow-Up Period|Death|16|||
33451028|NCT00076024|62825708|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
33451029|NCT00076024|62825705|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
33451030|NCT00076024|62825706|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
33612503|NCT02160145|63012943|FG000|Randomized Double-blind Period|Physician Decision|0|||
33324307|NCT00960531|62700738|FG000|Overall Study|Investigator Request|0|||
33612504|NCT02160145|63012944|FG001|Randomized Double-blind Period|Physician Decision|7|||
33612505|NCT02160145|63012945|FG002|Randomized Double-blind Period|Physician Decision|5|||
33451031|NCT00076024|62825707|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
33451032|NCT00076024|62825708|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
33451033|NCT00076024|62825705|FG000|Phase 2, Open-label|Other|0|||
33451034|NCT00076024|62825706|FG001|Phase 2, Open-label|Other|0|||
33451035|NCT00076024|62825707|FG002|Phase 2, Open-label|Other|0|||
33451036|NCT00076024|62825708|FG003|Phase 2, Open-label|Other|2|||
33451037|NCT00075478|62825719|FG000|Overall Study|not eligible|1|||
33451038|NCT00075478|62825720|FG001|Overall Study|not eligible|0|||
33507365|NCT04421027|62889929|FG003|Follow-Up Period|Death|17|||
33507366|NCT04421027|62889926|FG000|Follow-Up Period|Lost to Follow-up|0|||
33507367|NCT04421027|62889927|FG001|Follow-Up Period|Lost to Follow-up|0|||
33507368|NCT04421027|62889928|FG002|Follow-Up Period|Lost to Follow-up|7|||
33507369|NCT04421027|62889929|FG003|Follow-Up Period|Lost to Follow-up|7|||
33451039|NCT00075478|62825719|FG000|Overall Study|Physician Decision|0|||
33451040|NCT00075478|62825720|FG001|Overall Study|Physician Decision|1|||
33451041|NCT00175916|62825726|FG000|Overall Study|Death|19|||
33451042|NCT00175916|62825726|FG000|Overall Study|Adverse Event|81|||
33451043|NCT00175916|62825726|FG000|Overall Study|Lack of Efficacy|354|||
33451044|NCT00175916|62825726|FG000|Overall Study|Lost to Follow-up|17|||
33451045|NCT00175916|62825726|FG000|Overall Study|Subject Choice|98|||
33451046|NCT00175916|62825726|FG000|Overall Study|Lack of compliance|8|||
33451047|NCT00175916|62825726|FG000|Overall Study|Patient cannot record seizures|1|||
33451048|NCT00175916|62825726|FG000|Overall Study|Sponsor decision|17|||
33451049|NCT00175916|62825726|FG000|Overall Study|Vigabatrin intake|1|||
33451050|NCT00175916|62825726|FG000|Overall Study|Suicidal behaviour|1|||
33451051|NCT00175916|62825726|FG000|Overall Study|Withdrawal by Subject|1|||
33451052|NCT00175916|62825726|FG000|Overall Study|Seizure - free|4|||
33451053|NCT00175916|62825726|FG000|Overall Study|Administrative reason|1|||
33451054|NCT00175916|62825726|FG000|Overall Study|Pregnancy|1|||
33451055|NCT00175916|62825726|FG000|Overall Study|Patient's request|2|||
33451056|NCT00175916|62825726|FG000|Overall Study|Treating physiciant's choice|1|||
33451057|NCT00175916|62825726|FG000|Overall Study|Moved overseas|1|||
33451058|NCT00175916|62825726|FG000|Overall Study|Loss of job and economic burden|1|||
33451059|NCT00175916|62825726|FG000|Overall Study|Site was closed|9|||
33451060|NCT00175916|62825726|FG000|Overall Study|Patient went to prison|1|||
33451061|NCT00075400|62825731|FG000|Overall Study|Ineligible: wrong primary|1|||
33451062|NCT00075400|62825731|FG000|Overall Study|Never treated|2|||
33451063|NCT00228566|62825740|FG000|Overall Study|Adverse Event|31|||
33451064|NCT00228566|62825740|FG000|Overall Study|Lack of Efficacy|14|||
33451065|NCT00228566|62825740|FG000|Overall Study|Lost to Follow-up|16|||
33451066|NCT00228566|62825740|FG000|Overall Study|Physician Decision|5|||
33451067|NCT00228566|62825740|FG000|Overall Study|Withdrawal by Subject|4|||
33451068|NCT00228566|62825740|FG000|Overall Study|Miscellaneous|1|||
33451069|NCT00074152|62825746|FG000|Overall Study|Death|21|||
33507370|NCT04421027|62889926|FG000|Follow-Up Period|Protocol Deviation|0|||
33507371|NCT04421027|62889927|FG001|Follow-Up Period|Protocol Deviation|0|||
33507372|NCT04421027|62889928|FG002|Follow-Up Period|Protocol Deviation|1|||
33507373|NCT04421027|62889929|FG003|Follow-Up Period|Protocol Deviation|0|||
33507374|NCT04421027|62889926|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
33507375|NCT04421027|62889927|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
33507376|NCT04421027|62889928|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
33507377|NCT04421027|62889929|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
33507378|NCT04421027|62889926|FG000|Follow-Up Period|Left message, participant did not call back|0|||
33507379|NCT04421027|62889927|FG001|Follow-Up Period|Left message, participant did not call back|0|||
33507380|NCT04421027|62889928|FG002|Follow-Up Period|Left message, participant did not call back|0|||
33507381|NCT04421027|62889929|FG003|Follow-Up Period|Left message, participant did not call back|1|||
33507382|NCT04421027|62889926|FG000|Follow-Up Period|Participant died|0|||
33507383|NCT04421027|62889927|FG001|Follow-Up Period|Participant died|0|||
33507384|NCT04421027|62889928|FG002|Follow-Up Period|Participant died|0|||
33507385|NCT04421027|62889929|FG003|Follow-Up Period|Participant died|1|||
33507386|NCT04421027|62889926|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
33507387|NCT04421027|62889927|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
33507388|NCT04421027|62889928|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
33507389|NCT04421027|62889929|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
33507390|NCT04419311|62889939|FG000|Overall Study|Lost to Follow-up|1|||
33507391|NCT04419311|62889940|FG001|Overall Study|Lost to Follow-up|0|||
33507392|NCT04411667|62889950|FG000|Overall Study|Physician Decision|1|||
33507393|NCT04411667|62889951|FG001|Overall Study|Physician Decision|0|||
33507394|NCT04358549|62889959|FG000|Overall Study|Adverse Event|0|||
33507395|NCT04358549|62889960|FG001|Overall Study|Adverse Event|1|||
33612506|NCT01696396|63012956|FG000|Overall Study|Withdrawal by Subject|19|||
33612507|NCT01696396|63012957|FG001|Overall Study|Withdrawal by Subject|5|||
33612508|NCT01696396|63012958|FG002|Overall Study|Withdrawal by Subject|19|||
33507396|NCT04358549|62889959|FG000|Overall Study|Death|1|||
33507397|NCT04358549|62889960|FG001|Overall Study|Death|0|||
33507398|NCT04358549|62889959|FG000|Overall Study|Lost to Follow-up|2|||
33507399|NCT04358549|62889960|FG001|Overall Study|Lost to Follow-up|1|||
33507400|NCT04358549|62889959|FG000|Overall Study|Withdrawal by Subject|6|||
33507401|NCT04358549|62889960|FG001|Overall Study|Withdrawal by Subject|6|||
33507402|NCT04358549|62889959|FG000|Overall Study|Start remdesivir|1|||
33507403|NCT04358549|62889960|FG001|Overall Study|Start remdesivir|0|||
33507404|NCT00700180|62889968|FG000|Overall Study|Death|99|||
33507405|NCT00700180|62889969|FG001|Overall Study|Death|114|||
33507406|NCT00700180|62889968|FG000|Overall Study|Alive on treatment|5|||
33507407|NCT00700180|62889969|FG001|Overall Study|Alive on treatment|3|||
33507408|NCT00700180|62889968|FG000|Overall Study|Alive in follow-up|46|||
33507409|NCT00700180|62889969|FG001|Overall Study|Alive in follow-up|27|||
33507410|NCT00700180|62889968|FG000|Overall Study|Lost to Follow-up|4|||
33507411|NCT00700180|62889969|FG001|Overall Study|Lost to Follow-up|5|||
33507412|NCT00238420|62889977|FG000|Overall Study|Protocol Violation|1|||
33507413|NCT00238420|62889978|FG001|Overall Study|Protocol Violation|1|||
33507414|NCT04492475|62889986|FG000|Overall Study|Enrolled but not treated|8|||
33507415|NCT04492475|62889987|FG001|Overall Study|Enrolled but not treated|8|||
33507416|NCT04492475|62889986|FG000|Overall Study|Withdrawal by Subject|4|||
33507417|NCT04492475|62889987|FG001|Overall Study|Withdrawal by Subject|0|||
33612509|NCT01696396|63012959|FG003|Overall Study|Withdrawal by Subject|11|||
33612510|NCT01696396|63012956|FG000|Overall Study|Decision by Sponsor|3|||
33612511|NCT01696396|63012957|FG001|Overall Study|Decision by Sponsor|1|||
33612512|NCT01696396|63012958|FG002|Overall Study|Decision by Sponsor|2|||
33612513|NCT01696396|63012959|FG003|Overall Study|Decision by Sponsor|2|||
33612514|NCT01696396|63012956|FG000|Overall Study|Lost to Follow-up|9|||
33324308|NCT00960531|62700739|FG001|Overall Study|Investigator Request|0|||
33324309|NCT00960531|62700740|FG002|Overall Study|Investigator Request|1|||
33451070|NCT00074152|62825747|FG001|Overall Study|Death|9|||
33451071|NCT00074152|62825746|FG000|Overall Study|Lack of Efficacy|34|||
33451072|NCT00074152|62825747|FG001|Overall Study|Lack of Efficacy|24|||
33451073|NCT00261846|62825763|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
33451074|NCT00261846|62825764|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
33451075|NCT00261846|62825765|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
33451076|NCT00261846|62825766|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33451077|NCT00261846|62825767|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33451078|NCT00261846|62825768|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33451079|NCT00261846|62825769|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33451080|NCT00261846|62825770|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33451081|NCT00261846|62825771|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33451082|NCT00261846|62825772|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33451083|NCT00261846|62825773|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33507418|NCT04492475|62889986|FG000|Overall Study|Became ineligible after enrollment|2|||
33507419|NCT04492475|62889987|FG001|Overall Study|Became ineligible after enrollment|0|||
33507420|NCT04486235|62890002|FG000|Overall Study|Pregnancy|1|||
33507421|NCT04486235|62890003|FG001|Overall Study|Pregnancy|0|||
33507422|NCT04486235|62890002|FG000|Overall Study|Lost to Follow-up|1|||
33507423|NCT04486235|62890003|FG001|Overall Study|Lost to Follow-up|0|||
33507424|NCT04358081|62890013|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
33507425|NCT04358081|62890014|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
33507426|NCT04358081|62890015|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
33507427|NCT04358081|62890013|FG000|Treatment Phase of Study|Adverse Event|1|||
33507428|NCT04358081|62890014|FG001|Treatment Phase of Study|Adverse Event|0|||
33507429|NCT04358081|62890015|FG002|Treatment Phase of Study|Adverse Event|1|||
33507430|NCT04358081|62890013|FG000|Treatment Phase of Study|Physician Decision|2|||
33507431|NCT04358081|62890014|FG001|Treatment Phase of Study|Physician Decision|0|||
33507432|NCT04358081|62890015|FG002|Treatment Phase of Study|Physician Decision|1|||
33507433|NCT04358081|62890013|FG000|Treatment Phase of Study|Protocol Violation|1|||
33507434|NCT04358081|62890014|FG001|Treatment Phase of Study|Protocol Violation|0|||
33507435|NCT04358081|62890015|FG002|Treatment Phase of Study|Protocol Violation|0|||
33507436|NCT04358081|62890013|FG000|Study Completion Phase|Death|0|||
33507437|NCT04358081|62890014|FG001|Study Completion Phase|Death|0|||
33507438|NCT04358081|62890015|FG002|Study Completion Phase|Death|1|||
33507439|NCT04358081|62890013|FG000|Study Completion Phase|Lost to Follow-up|1|||
33507440|NCT04358081|62890014|FG001|Study Completion Phase|Lost to Follow-up|0|||
33507441|NCT04358081|62890015|FG002|Study Completion Phase|Lost to Follow-up|1|||
33507442|NCT04355663|62890028|FG000|Overall Study|Physician Decision|2|||
33507443|NCT04355663|62890029|FG001|Overall Study|Physician Decision|7|||
33507444|NCT04355663|62890030|FG002|Overall Study|Physician Decision|0|||
33507445|NCT04355663|62890028|FG000|Overall Study|Adverse Event|0|||
33507446|NCT04355663|62890029|FG001|Overall Study|Adverse Event|0|||
33507447|NCT04355663|62890030|FG002|Overall Study|Adverse Event|1|||
33507448|NCT04355663|62890028|FG000|Overall Study|Withdrawal by Subject|0|||
33507449|NCT04355663|62890029|FG001|Overall Study|Withdrawal by Subject|8|||
33507450|NCT04355663|62890030|FG002|Overall Study|Withdrawal by Subject|3|||
33507451|NCT04345367|62890040|FG000|Overall Study|Other|3|||
33507452|NCT04345367|62890041|FG001|Overall Study|Other|4|||
33507453|NCT04345367|62890040|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
33507454|NCT04345367|62890041|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
33507455|NCT04345367|62890040|FG000|Overall Study|Withdrawal by Subject|11|||
33507456|NCT04345367|62890041|FG001|Overall Study|Withdrawal by Subject|11|||
33507457|NCT04345367|62890040|FG000|Overall Study|Protocol Violation|4|||
33507458|NCT04345367|62890041|FG001|Overall Study|Protocol Violation|3|||
33507459|NCT04345367|62890040|FG000|Overall Study|Lost to Follow-up|2|||
33507460|NCT04345367|62890041|FG001|Overall Study|Lost to Follow-up|4|||
33507461|NCT04345367|62890040|FG000|Overall Study|Lack of Efficacy|2|||
33507462|NCT04345367|62890041|FG001|Overall Study|Lack of Efficacy|0|||
33507463|NCT04345367|62890040|FG000|Overall Study|Death|2|||
33507464|NCT04345367|62890041|FG001|Overall Study|Death|0|||
33507465|NCT04345367|62890040|FG000|Overall Study|Adverse Event|10|||
33507466|NCT04345367|62890041|FG001|Overall Study|Adverse Event|9|||
33507467|NCT04404725|62890047|FG000|First Intervention|Withdrawal by Subject|0|||
33507468|NCT04404725|62890048|FG001|First Intervention|Withdrawal by Subject|2|||
33507469|NCT04404725|62890047|FG000|Second Intervention|Adverse Event|1|||
33507470|NCT04404725|62890048|FG001|Second Intervention|Adverse Event|1|||
33507471|NCT04404725|62890047|FG000|Second Intervention|Withdrawal by Subject|0|||
33507472|NCT04404725|62890048|FG001|Second Intervention|Withdrawal by Subject|1|||
33507473|NCT04343261|62890054|FG000|Overall Study|Adverse Event|1|||
33507474|NCT04343261|62890054|FG000|Overall Study|received inadequate amount of antibodies|7|||
33507475|NCT04336475|62890060|FG000|Overall Study|pain|1|||
33507476|NCT04336475|62890061|FG001|Overall Study|pain|0|||
33507477|NCT04336475|62890060|FG000|Overall Study|upper respiratory infection|1|||
33507478|NCT04336475|62890061|FG001|Overall Study|upper respiratory infection|0|||
33507479|NCT04336475|62890060|FG000|Overall Study|Lost to Follow-up|0|||
33507480|NCT04336475|62890061|FG001|Overall Study|Lost to Follow-up|2|||
33507481|NCT04335929|62890067|FG000|Overall Study|Lost to Follow-up|10|||
33507482|NCT04333199|62890074|FG000|Evaluated Patients|Lost to Follow-up|0|||
33507483|NCT04333199|62890075|FG001|Evaluated Patients|Lost to Follow-up|1|||
33507484|NCT04333199|62890076|FG002|Evaluated Patients|Lost to Follow-up|2|||
33507485|NCT04332419|62890085|FG000|Overall Study|Withdrawal by Subject|1|||
33507486|NCT04330157|62890089|FG000|Overall Study|Protocol Violation|4|||
33507487|NCT04330157|62890089|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
33507488|NCT04329923|62890104|FG000|Overall Study|Withdrawal by Subject|1|||
33507489|NCT04329923|62890105|FG001|Overall Study|Withdrawal by Subject|4|||
33507490|NCT04329923|62890106|FG002|Overall Study|Withdrawal by Subject|1|||
33507491|NCT04329923|62890107|FG003|Overall Study|Withdrawal by Subject|1|||
33507492|NCT04329923|62890108|FG004|Overall Study|Withdrawal by Subject|1|||
33507493|NCT04329923|62890109|FG005|Overall Study|Withdrawal by Subject|1|||
33507494|NCT04329923|62890104|FG000|Overall Study|early termination of study|0|||
33507495|NCT04329923|62890105|FG001|Overall Study|early termination of study|0|||
33507496|NCT04329923|62890106|FG002|Overall Study|early termination of study|0|||
33507497|NCT04329923|62890107|FG003|Overall Study|early termination of study|0|||
33612515|NCT01696396|63012957|FG001|Overall Study|Lost to Follow-up|1|||
33612516|NCT01696396|63012958|FG002|Overall Study|Lost to Follow-up|4|||
33612517|NCT01696396|63012959|FG003|Overall Study|Lost to Follow-up|1|||
33612518|NCT01696396|63012956|FG000|Overall Study|Death|0|||
33507498|NCT04329923|62890108|FG004|Overall Study|early termination of study|1|||
33507499|NCT04329923|62890109|FG005|Overall Study|early termination of study|2|||
33507500|NCT04329923|62890104|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
33507501|NCT04329923|62890105|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
33507502|NCT04329923|62890106|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
33507503|NCT04329923|62890107|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
33612519|NCT01696396|63012957|FG001|Overall Study|Death|0|||
33612520|NCT01696396|63012958|FG002|Overall Study|Death|1|||
33612521|NCT01696396|63012959|FG003|Overall Study|Death|0|||
33612522|NCT02216071|63012975|FG000|Overall Study|Withdrawal by Subject|7|||
33612523|NCT02216071|63012976|FG001|Overall Study|Withdrawal by Subject|2|||
33507504|NCT04329923|62890108|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
33507505|NCT04329923|62890109|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
33507506|NCT04403399|62890125|FG000|Period 2|Physician Decision|0|||
33507507|NCT04403399|62890126|FG001|Period 2|Physician Decision|1|||
33507508|NCT04401293|62890134|FG000|Overall Study|Withdrawal by Subject|1|||
33507509|NCT04401293|62890135|FG001|Overall Study|Withdrawal by Subject|3|||
33507510|NCT04319159|62890143|FG000|Overall Study|Screening failure|13|||
33507511|NCT04319159|62890143|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
33507512|NCT04319159|62890143|FG000|Overall Study|Withdrawal by Subject|1|||
33507513|NCT04318535|62890149|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
33507514|NCT04318535|62890150|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
33507515|NCT04318535|62890151|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
33507516|NCT04454567|62890162|FG000|Overall Study|Study Terminated by Sponsor|1|||
33507517|NCT04454567|62890163|FG001|Overall Study|Study Terminated by Sponsor|1|||
33507518|NCT04449341|62890171|FG000|Overall Study|Protocol Violation|1|||
33507519|NCT04449341|62890172|FG001|Overall Study|Protocol Violation|0|||
33507520|NCT04448561|62890180|FG000|Overall Study|Noncompliance|1|||
33507521|NCT04448561|62890181|FG001|Overall Study|Noncompliance|0|||
33507522|NCT04308239|62890197|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
33507523|NCT04308239|62890198|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
33507524|NCT04308239|62890197|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
33507525|NCT04308239|62890198|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
33507526|NCT04308239|62890197|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
33507527|NCT04308239|62890198|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
33507528|NCT04308239|62890197|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
33507529|NCT04308239|62890198|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
33507530|NCT04302545|62890210|FG000|Overall Study|Lost to Follow-up|3|||
33507531|NCT04302545|62890211|FG001|Overall Study|Lost to Follow-up|4|||
33507532|NCT04297241|62890228|FG000|Overall Study|Withdrawal by Subject|1|||
33507533|NCT04297241|62890228|FG000|Overall Study|Adverse Event|1|||
33507534|NCT04297241|62890228|FG000|Overall Study|Physician Decision|3|||
33507535|NCT04292171|62890244|FG000|Overall Study|Pharmacy error|2|||
33507536|NCT04292171|62890245|FG001|Overall Study|Pharmacy error|0|||
33507537|NCT04292171|62890244|FG000|Overall Study|Delivered prior to procedure|0|||
33507538|NCT04292171|62890245|FG001|Overall Study|Delivered prior to procedure|1|||
33507539|NCT04393493|62890253|FG000|First 4 Days of Intervention|Early improvement|5|||
33507540|NCT04393493|62890254|FG001|First 4 Days of Intervention|Early improvement|7|||
33507541|NCT04280705|62890264|FG000|Overall Study|Enrolled but not treated|4|||
33507542|NCT04280705|62890265|FG001|Overall Study|Enrolled but not treated|10|||
33507543|NCT04280705|62890264|FG000|Overall Study|Physician Decision|1|||
33507544|NCT04280705|62890265|FG001|Overall Study|Physician Decision|0|||
33507545|NCT04280705|62890264|FG000|Overall Study|Withdrawal by Subject|7|||
33507546|NCT04280705|62890265|FG001|Overall Study|Withdrawal by Subject|9|||
33507547|NCT04280705|62890264|FG000|Overall Study|Adverse Event|0|||
33507548|NCT04280705|62890265|FG001|Overall Study|Adverse Event|4|||
33612524|NCT02216071|63012975|FG000|Overall Study|Lost to Follow-up|3|||
33612525|NCT02216071|63012976|FG001|Overall Study|Lost to Follow-up|3|||
33612526|NCT02216071|63012975|FG000|Overall Study|Protocol Violation|3|||
33507549|NCT04280705|62890264|FG000|Overall Study|Transferred to another hospital|1|||
33612527|NCT02216071|63012976|FG001|Overall Study|Protocol Violation|5|||
33612528|NCT02216071|63012975|FG000|Overall Study|Other|2|||
33612529|NCT02216071|63012976|FG001|Overall Study|Other|2|||
33507550|NCT04280705|62890265|FG001|Overall Study|Transferred to another hospital|1|||
33507551|NCT02077166|62890278|FG000|Overall Study|Death|6|||
33507552|NCT02077166|62890279|FG001|Overall Study|Death|7|||
33324310|NCT00960531|62700741|FG003|Overall Study|Investigator Request|0|||
33324311|NCT00960531|62700742|FG004|Overall Study|Investigator Request|0|||
33324312|NCT00960531|62700743|FG005|Overall Study|Investigator Request|0|||
33507553|NCT02077166|62890280|FG002|Overall Study|Death|5|||
33507554|NCT02077166|62890281|FG003|Overall Study|Death|6|||
33507555|NCT02077166|62890282|FG004|Overall Study|Death|4|||
33507556|NCT02077166|62890283|FG005|Overall Study|Death|32|||
33507557|NCT02077166|62890284|FG006|Overall Study|Death|22|||
33507558|NCT02077166|62890278|FG000|Overall Study|Study Closure by Sponsor|3|||
33507559|NCT02077166|62890279|FG001|Overall Study|Study Closure by Sponsor|0|||
33507560|NCT02077166|62890280|FG002|Overall Study|Study Closure by Sponsor|2|||
33507561|NCT02077166|62890281|FG003|Overall Study|Study Closure by Sponsor|2|||
33507562|NCT02077166|62890282|FG004|Overall Study|Study Closure by Sponsor|2|||
33507563|NCT02077166|62890283|FG005|Overall Study|Study Closure by Sponsor|12|||
33507564|NCT02077166|62890284|FG006|Overall Study|Study Closure by Sponsor|4|||
33507565|NCT02077166|62890278|FG000|Overall Study|Lost to Follow-up|0|||
33507566|NCT02077166|62890279|FG001|Overall Study|Lost to Follow-up|0|||
33507567|NCT02077166|62890280|FG002|Overall Study|Lost to Follow-up|0|||
33507568|NCT02077166|62890281|FG003|Overall Study|Lost to Follow-up|0|||
33507569|NCT02077166|62890282|FG004|Overall Study|Lost to Follow-up|0|||
33507570|NCT02077166|62890283|FG005|Overall Study|Lost to Follow-up|1|||
33507571|NCT02077166|62890284|FG006|Overall Study|Lost to Follow-up|0|||
33507572|NCT02077166|62890278|FG000|Overall Study|Withdrawal by Subject|3|||
33507573|NCT02077166|62890279|FG001|Overall Study|Withdrawal by Subject|0|||
33507574|NCT02077166|62890280|FG002|Overall Study|Withdrawal by Subject|1|||
33507575|NCT02077166|62890281|FG003|Overall Study|Withdrawal by Subject|1|||
33507576|NCT02077166|62890282|FG004|Overall Study|Withdrawal by Subject|1|||
33507577|NCT02077166|62890283|FG005|Overall Study|Withdrawal by Subject|3|||
33507578|NCT02077166|62890284|FG006|Overall Study|Withdrawal by Subject|0|||
33507579|NCT02077166|62890278|FG000|Overall Study|Other, Not Specified|0|||
33507580|NCT02077166|62890279|FG001|Overall Study|Other, Not Specified|0|||
33612530|NCT01681576|63012984|FG000|Period 1|Adverse Event|1|||
33612531|NCT01681576|63012985|FG001|Period 1|Adverse Event|0|||
33612532|NCT01681576|63012984|FG000|Period 1|Protocol Deviation|1|||
33612533|NCT01681576|63012985|FG001|Period 1|Protocol Deviation|0|||
33612534|NCT01681576|63012984|FG000|Period 2|subject/guardian decision|3|||
33612535|NCT01681576|63012985|FG001|Period 2|subject/guardian decision|1|||
33612536|NCT01681576|63012984|FG000|Period 2|Non-compliance with study treatment|1|||
33612537|NCT01681576|63012985|FG001|Period 2|Non-compliance with study treatment|0|||
33612538|NCT02188459|63012995|FG000|Overall Study|Lost to Follow-up|3|||
33612539|NCT02188459|63012996|FG001|Overall Study|Lost to Follow-up|4|||
33612540|NCT02188459|63012995|FG000|Overall Study|Early Termination|0|||
33612541|NCT02188459|63012996|FG001|Overall Study|Early Termination|3|||
33612542|NCT02214121|63013018|FG000|Part A|Patient decision|2|||
33612543|NCT02214121|63013019|FG001|Part A|Patient decision|0|||
33612544|NCT02214121|63013020|FG002|Part A|Patient decision|0|||
33612545|NCT02214121|63013018|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
33507581|NCT02077166|62890280|FG002|Overall Study|Other, Not Specified|1|||
33507582|NCT02077166|62890281|FG003|Overall Study|Other, Not Specified|0|||
33507583|NCT02077166|62890282|FG004|Overall Study|Other, Not Specified|1|||
33507584|NCT02077166|62890283|FG005|Overall Study|Other, Not Specified|7|||
33507585|NCT02077166|62890284|FG006|Overall Study|Other, Not Specified|8|||
33612546|NCT02214121|63013019|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
33612547|NCT02214121|63013020|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
33612548|NCT02214121|63013018|FG000|Part A|Other|1|||
33612549|NCT02214121|63013019|FG001|Part A|Other|0|||
33612550|NCT02214121|63013020|FG002|Part A|Other|0|||
33612551|NCT02214121|63013018|FG000|Part B|Patient decision|0|||
33612552|NCT02214121|63013019|FG001|Part B|Patient decision|1|||
33612553|NCT02214121|63013020|FG002|Part B|Patient decision|0|||
33612554|NCT02214121|63013018|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
33324313|NCT00960531|62700744|FG006|Overall Study|Investigator Request|0|||
33324314|NCT00960531|62700745|FG007|Overall Study|Investigator Request|0|||
33324315|NCT00960531|62700746|FG008|Overall Study|Investigator Request|0|||
33324316|NCT00960531|62700747|FG009|Overall Study|Investigator Request|0|||
33507586|NCT04273217|62890311|FG000|Overall Study|Lost to Follow-up|0|||
33507587|NCT04273217|62890312|FG001|Overall Study|Lost to Follow-up|0|||
33507588|NCT04273217|62890313|FG002|Overall Study|Lost to Follow-up|0|||
33507589|NCT04273217|62890314|FG003|Overall Study|Lost to Follow-up|0|||
33507590|NCT04273217|62890315|FG004|Overall Study|Lost to Follow-up|0|||
33507591|NCT04273217|62890316|FG005|Overall Study|Lost to Follow-up|1|||
33612555|NCT02214121|63013019|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
33612556|NCT02214121|63013020|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
33507592|NCT04273217|62890311|FG000|Overall Study|Participant non-compliance|0|||
33612557|NCT02214121|63013018|FG000|Part B|Lost to Follow-up|0|||
33612558|NCT02214121|63013019|FG001|Part B|Lost to Follow-up|0|||
33612559|NCT02214121|63013020|FG002|Part B|Lost to Follow-up|1|||
33612560|NCT01681186|63013048|FG000|Washout Period From Second Intervention|Adverse Event|0|||
33612561|NCT01681186|63013049|FG001|Washout Period From Second Intervention|Adverse Event|0|||
33612562|NCT01681186|63013050|FG002|Washout Period From Second Intervention|Adverse Event|0|||
33612563|NCT01681186|63013051|FG003|Washout Period From Second Intervention|Adverse Event|0|||
33612564|NCT01681186|63013052|FG004|Washout Period From Second Intervention|Adverse Event|0|||
33612565|NCT01681186|63013053|FG005|Washout Period From Second Intervention|Adverse Event|0|||
33612566|NCT01681186|63013054|FG006|Washout Period From Second Intervention|Adverse Event|1|||
33612567|NCT01681186|63013055|FG007|Washout Period From Second Intervention|Adverse Event|0|||
33612568|NCT01681186|63013048|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
33612569|NCT01681186|63013049|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
33612570|NCT01681186|63013050|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
33612571|NCT01681186|63013051|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
33612572|NCT01681186|63013052|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
33612573|NCT01681186|63013053|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
33612574|NCT01681186|63013054|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
33612575|NCT01681186|63013055|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
33612576|NCT01681186|63013048|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
33612577|NCT01681186|63013049|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
33612578|NCT01681186|63013050|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
33612579|NCT01681186|63013051|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
33612580|NCT01681186|63013052|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
33612581|NCT01681186|63013053|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
33507593|NCT04273217|62890312|FG001|Overall Study|Participant non-compliance|0|||
33507594|NCT04273217|62890313|FG002|Overall Study|Participant non-compliance|0|||
33507595|NCT04273217|62890314|FG003|Overall Study|Participant non-compliance|0|||
33507596|NCT04273217|62890315|FG004|Overall Study|Participant non-compliance|1|||
33507597|NCT04273217|62890316|FG005|Overall Study|Participant non-compliance|0|||
33507598|NCT04273217|62890311|FG000|Overall Study|Positive urine drug screen|1|||
33451084|NCT00261846|62825774|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33451085|NCT00261846|62825763|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33451086|NCT00261846|62825764|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33451087|NCT00261846|62825765|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33451088|NCT00261846|62825766|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
33451089|NCT00261846|62825767|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33451090|NCT00261846|62825768|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33507599|NCT04273217|62890312|FG001|Overall Study|Positive urine drug screen|0|||
33507600|NCT04273217|62890313|FG002|Overall Study|Positive urine drug screen|1|||
33612582|NCT01681186|63013054|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
33612583|NCT01681186|63013055|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
33612584|NCT01681186|63013048|FG000|Fourth Intervention|Protocol Violation|0|||
33612585|NCT01681186|63013049|FG001|Fourth Intervention|Protocol Violation|0|||
33612586|NCT01681186|63013050|FG002|Fourth Intervention|Protocol Violation|0|||
33612587|NCT01681186|63013051|FG003|Fourth Intervention|Protocol Violation|0|||
33612588|NCT01681186|63013052|FG004|Fourth Intervention|Protocol Violation|0|||
33612589|NCT01681186|63013053|FG005|Fourth Intervention|Protocol Violation|0|||
33612590|NCT01681186|63013054|FG006|Fourth Intervention|Protocol Violation|0|||
33612591|NCT01681186|63013055|FG007|Fourth Intervention|Protocol Violation|1|||
33612592|NCT03597464|63013087|FG000|Overall Study|Withdrawal by Subject|4|||
33612593|NCT03597464|63013088|FG001|Overall Study|Withdrawal by Subject|5|||
33612594|NCT03597464|63013087|FG000|Overall Study|Lost to Follow-up|3|||
33451091|NCT00261846|62825769|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33451092|NCT00261846|62825770|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33451093|NCT00261846|62825771|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
33507601|NCT04273217|62890314|FG003|Overall Study|Positive urine drug screen|0|||
33507602|NCT04273217|62890315|FG004|Overall Study|Positive urine drug screen|0|||
33507603|NCT04273217|62890316|FG005|Overall Study|Positive urine drug screen|1|||
33612595|NCT03597464|63013088|FG001|Overall Study|Lost to Follow-up|1|||
33612596|NCT03597464|63013087|FG000|Overall Study|Pregnancy|3|||
33612597|NCT03597464|63013088|FG001|Overall Study|Pregnancy|1|||
33612598|NCT03597464|63013087|FG000|Overall Study|Lack of Efficacy|2|||
33612599|NCT03597464|63013088|FG001|Overall Study|Lack of Efficacy|0|||
33612600|NCT03597464|63013087|FG000|Overall Study|Physician Decision|2|||
33612601|NCT03597464|63013088|FG001|Overall Study|Physician Decision|2|||
33612602|NCT03597464|63013087|FG000|Overall Study|Protocol Violation|1|||
33612603|NCT03597464|63013088|FG001|Overall Study|Protocol Violation|1|||
33507604|NCT04384523|62890336|FG000|Overall Study|Lost to Follow-up|0|||
33507605|NCT04384523|62890337|FG001|Overall Study|Lost to Follow-up|0|||
33612604|NCT03597464|63013087|FG000|Overall Study|Adverse Event|0|||
33612605|NCT03597464|63013088|FG001|Overall Study|Adverse Event|2|||
33612606|NCT03597464|63013087|FG000|Overall Study|Death|0|||
33612607|NCT03597464|63013088|FG001|Overall Study|Death|3|||
33612608|NCT01695772|63013096|FG000|Overall Study|Withdrawal by Subject|18|||
33612609|NCT01695772|63013096|FG000|Overall Study|Progressive Disease|8|||
33612610|NCT01695772|63013096|FG000|Overall Study|Investigator Decision|5|||
33612611|NCT01695772|63013096|FG000|Overall Study|Lost to Follow-up|4|||
33612612|NCT01695772|63013096|FG000|Overall Study|Protocol Violation|2|||
33612613|NCT01695772|63013096|FG000|Overall Study|Unspecified Reason|1|||
33612614|NCT02159521|63013100|FG000|Overall Study|Enrolled but not treated|3|||
33612615|NCT02159521|63013100|FG000|Overall Study|Withdrawal by Subject|7|||
33612616|NCT02159521|63013100|FG000|Overall Study|Lost to Follow-up|6|||
33612617|NCT02159521|63013100|FG000|Overall Study|Death|1|||
33612618|NCT02159521|63013100|FG000|Overall Study|Other than specified|1|||
33612619|NCT01636934|63013106|FG000|Overall Study|Withdrawal by Subject|3|||
33612620|NCT01636934|63013107|FG001|Overall Study|Withdrawal by Subject|2|||
33612621|NCT01636934|63013106|FG000|Overall Study|Chemo cancel|1|||
33612622|NCT01636934|63013107|FG001|Overall Study|Chemo cancel|0|||
33612623|NCT01636934|63013106|FG000|Overall Study|Too ill to continue|1|||
33612624|NCT01636934|63013107|FG001|Overall Study|Too ill to continue|0|||
33612625|NCT01636934|63013106|FG000|Overall Study|Never started study medication|1|||
33612626|NCT01636934|63013107|FG001|Overall Study|Never started study medication|1|||
33612627|NCT01712854|63013113|FG000|Overall Study|Physician Decision|1|||
33612628|NCT01693120|63013117|FG000|Enrollment|Lost to Follow-up|1|||
33612629|NCT01693120|63013117|FG000|Enrollment|Withdrawal by Subject|10|||
33612630|NCT01693120|63013117|FG000|Enrollment|Protocol Violation|46|||
33612631|NCT01693120|63013117|FG000|Enrollment|Physician Decision|3|||
33612632|NCT01693120|63013117|FG000|Enrollment|Adverse Event|1|||
33612633|NCT01693120|63013117|FG000|Enrollment|Study closed|8|||
33612634|NCT01693120|63013117|FG000|Enrollment|Other|1|||
33612635|NCT01693120|63013117|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
33612636|NCT01693120|63013117|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
33612637|NCT01693120|63013117|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
33612638|NCT01693120|63013117|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
33612639|NCT01693120|63013117|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
33612640|NCT02159365|63013121|FG000|Overall Study|Disease Progression|23|||
33612641|NCT02159365|63013121|FG000|Overall Study|Other reasons|11|||
33612642|NCT02159365|63013121|FG000|Overall Study|Administrative reason by Sponsor|9|||
33612643|NCT02159365|63013121|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
33612644|NCT02159365|63013121|FG000|Overall Study|Study drug toxicity|7|||
33612645|NCT02159365|63013121|FG000|Overall Study|Maximum clinical benefit|3|||
33612646|NCT02159365|63013121|FG000|Overall Study|Subject request to discontinue treatment|3|||
33612647|NCT02159365|63013121|FG000|Overall Study|Subject withdrew consent|3|||
33612648|NCT02159365|63013121|FG000|Overall Study|Death|1|||
33612649|NCT02159365|63013121|FG000|Overall Study|Lost to Follow-up|1|||
33612650|NCT01712074|63013128|FG000|Placebo Run-in Period|Adverse Event|2|||
33612651|NCT01712074|63013129|FG001|Placebo Run-in Period|Adverse Event|0|||
33612652|NCT01712074|63013130|FG002|Placebo Run-in Period|Adverse Event|0|||
33612653|NCT01712074|63013128|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
33612654|NCT01712074|63013129|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
33612655|NCT01712074|63013130|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
33612656|NCT01712074|63013128|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
33612657|NCT01712074|63013129|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
33612658|NCT01712074|63013130|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
33612659|NCT01712074|63013128|FG000|Placebo Run-in Period|Other|1|||
33612660|NCT01712074|63013129|FG001|Placebo Run-in Period|Other|0|||
33612661|NCT01712074|63013130|FG002|Placebo Run-in Period|Other|0|||
33612662|NCT01712074|63013128|FG000|Placebo Run-in Period|No longer willing to participate|1|||
33612663|NCT01712074|63013129|FG001|Placebo Run-in Period|No longer willing to participate|0|||
33612664|NCT01712074|63013130|FG002|Placebo Run-in Period|No longer willing to participate|0|||
33612665|NCT01712074|63013128|FG000|Double Blind Period|Adverse Event|0|||
33612666|NCT01712074|63013129|FG001|Double Blind Period|Adverse Event|2|||
33612667|NCT01712074|63013130|FG002|Double Blind Period|Adverse Event|1|||
33612668|NCT01712074|63013128|FG000|Double Blind Period|No longer willing to participate|0|||
33612669|NCT01712074|63013129|FG001|Double Blind Period|No longer willing to participate|2|||
33451094|NCT00261846|62825772|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33451095|NCT00261846|62825773|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33451096|NCT00261846|62825774|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33451097|NCT00261846|62825763|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
33451098|NCT00261846|62825764|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
33451099|NCT00261846|62825765|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
33612670|NCT01712074|63013130|FG002|Double Blind Period|No longer willing to participate|4|||
33451100|NCT00261846|62825766|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
33507606|NCT04384523|62890338|FG002|Overall Study|Lost to Follow-up|0|||
33507607|NCT04384523|62890339|FG003|Overall Study|Lost to Follow-up|0|||
33507608|NCT04384523|62890340|FG004|Overall Study|Lost to Follow-up|0|||
33507609|NCT04384523|62890341|FG005|Overall Study|Lost to Follow-up|1|||
33507610|NCT04384523|62890336|FG000|Overall Study|Protocol Violation|0|||
33507611|NCT04384523|62890337|FG001|Overall Study|Protocol Violation|1|||
33507612|NCT04384523|62890338|FG002|Overall Study|Protocol Violation|0|||
33507613|NCT04384523|62890339|FG003|Overall Study|Protocol Violation|0|||
33507614|NCT04384523|62890340|FG004|Overall Study|Protocol Violation|0|||
33507615|NCT04384523|62890341|FG005|Overall Study|Protocol Violation|0|||
33507616|NCT04384523|62890336|FG000|Overall Study|Withdrawal by Subject|1|||
33507617|NCT04384523|62890337|FG001|Overall Study|Withdrawal by Subject|0|||
33507618|NCT04384523|62890338|FG002|Overall Study|Withdrawal by Subject|0|||
33507619|NCT04384523|62890339|FG003|Overall Study|Withdrawal by Subject|0|||
33507620|NCT04384523|62890340|FG004|Overall Study|Withdrawal by Subject|0|||
33507621|NCT04384523|62890341|FG005|Overall Study|Withdrawal by Subject|0|||
33507622|NCT04382651|62890376|FG000|Overall Study|Death|26|||
33507623|NCT04382651|62890377|FG001|Overall Study|Death|23|||
33507624|NCT04382651|62890376|FG000|Overall Study|Lost to Follow-up|3|||
33507625|NCT04382651|62890377|FG001|Overall Study|Lost to Follow-up|4|||
33507626|NCT04382651|62890376|FG000|Overall Study|Withdrawal by Subject|2|||
33507627|NCT04382651|62890377|FG001|Overall Study|Withdrawal by Subject|0|||
33507628|NCT04382651|62890376|FG000|Overall Study|Physician Decision|0|||
33507629|NCT04382651|62890377|FG001|Overall Study|Physician Decision|1|||
33507630|NCT04238663|62890392|FG000|Overall Study|Lost to Follow-up|0|||
33507631|NCT04238663|62890393|FG001|Overall Study|Lost to Follow-up|1|||
33507632|NCT04238663|62890394|FG002|Overall Study|Lost to Follow-up|0|||
33507633|NCT03442088|62890402|FG000|Overall Study|Adverse Event|1|||
33507634|NCT03442088|62890402|FG000|Overall Study|Lack of Efficacy|2|||
33507635|NCT03442088|62890402|FG000|Overall Study|Lost to Follow-up|2|||
33507636|NCT04223687|62890408|FG000|Overall Study|Missing primary outcome|1|||
33507637|NCT04223687|62890409|FG001|Overall Study|Missing primary outcome|0|||
33507638|NCT03722576|62890415|FG000|Overall Study|Withdrawal by Subject|3|||
33507639|NCT03722576|62890415|FG000|Overall Study|Adverse Event|2|||
33507640|NCT03722576|62890415|FG000|Overall Study|Physician Decision|1|||
33507641|NCT03722576|62890415|FG000|Overall Study|Lost to Follow-up|1|||
33507642|NCT03693989|62890421|FG000|Overall Study|Protocol Violation|3|||
33507643|NCT03693989|62890422|FG001|Overall Study|Protocol Violation|4|||
33507644|NCT04206293|62890428|FG000|Overall Study|Consent withdrawal|1|||
33507645|NCT02727998|62890435|FG000|Overall Study|Lost to Follow-up|3|||
33507646|NCT02727998|62890436|FG001|Overall Study|Lost to Follow-up|3|||
33507647|NCT02727998|62890435|FG000|Overall Study|Withdrawal by Subject|0|||
33507648|NCT02727998|62890436|FG001|Overall Study|Withdrawal by Subject|1|||
33507649|NCT04366349|62890448|FG000|Overall Study|Withdrawal by Subject|1|||
33507650|NCT04366349|62890449|FG001|Overall Study|Withdrawal by Subject|0|||
33507651|NCT04366349|62890450|FG002|Overall Study|Withdrawal by Subject|0|||
33507652|NCT04366349|62890451|FG003|Overall Study|Withdrawal by Subject|0|||
33507653|NCT04366349|62890452|FG004|Overall Study|Withdrawal by Subject|0|||
33507654|NCT04366349|62890453|FG005|Overall Study|Withdrawal by Subject|0|||
33612671|NCT01712074|63013128|FG000|Double Blind Period|Death|0|||
33451101|NCT00261846|62825767|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
33451102|NCT00261846|62825768|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
33451103|NCT00261846|62825769|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
33451104|NCT00261846|62825770|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
33451105|NCT00261846|62825771|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
33451106|NCT00261846|62825772|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
33451107|NCT00261846|62825773|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
33507655|NCT04179461|62890471|FG000|Overall Study|Lost to Follow-up|4|||
33507656|NCT04017611|62890475|FG000|Overall Study|Withdrawn prior to completion|1|||
33507657|NCT04172831|62890490|FG000|Overall Study|Adverse Event|21|||
33507658|NCT04172831|62890491|FG001|Overall Study|Adverse Event|9|||
33507659|NCT04172831|62890490|FG000|Overall Study|Lack of Efficacy|2|||
33451108|NCT00261846|62825774|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
33451109|NCT00261846|62825763|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
33507660|NCT04172831|62890491|FG001|Overall Study|Lack of Efficacy|8|||
33507661|NCT04172831|62890490|FG000|Overall Study|Physician Decision|0|||
33507662|NCT04172831|62890491|FG001|Overall Study|Physician Decision|1|||
33507663|NCT04172831|62890490|FG000|Overall Study|Withdrawal by Subject|12|||
33507664|NCT04172831|62890491|FG001|Overall Study|Withdrawal by Subject|11|||
33507665|NCT04172831|62890490|FG000|Overall Study|Lost to Follow-up|4|||
33507666|NCT04172831|62890491|FG001|Overall Study|Lost to Follow-up|9|||
33507667|NCT04172831|62890490|FG000|Overall Study|COVID-19 related crisis|3|||
33507668|NCT04172831|62890491|FG001|Overall Study|COVID-19 related crisis|3|||
33507669|NCT04172831|62890490|FG000|Overall Study|Subject non-compliance|1|||
33507670|NCT04172831|62890491|FG001|Overall Study|Subject non-compliance|1|||
33507671|NCT04172831|62890490|FG000|Overall Study|Family emergency|1|||
33451110|NCT00261846|62825764|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
33451111|NCT00261846|62825765|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
33507672|NCT04172831|62890491|FG001|Overall Study|Family emergency|0|||
33507673|NCT04165031|62890508|FG000|Overall Study|Adverse Event|1|||
33507674|NCT04165031|62890509|FG001|Overall Study|Adverse Event|1|||
33507675|NCT04165031|62890510|FG002|Overall Study|Adverse Event|0|||
33507676|NCT04165031|62890511|FG003|Overall Study|Adverse Event|0|||
33507677|NCT04165031|62890512|FG004|Overall Study|Adverse Event|0|||
33507678|NCT04165031|62890513|FG005|Overall Study|Adverse Event|0|||
33507679|NCT04165031|62890508|FG000|Overall Study|Withdrawal by Subject|0|||
33507680|NCT04165031|62890509|FG001|Overall Study|Withdrawal by Subject|0|||
33507681|NCT04165031|62890510|FG002|Overall Study|Withdrawal by Subject|1|||
33507682|NCT04165031|62890511|FG003|Overall Study|Withdrawal by Subject|0|||
33507683|NCT04165031|62890512|FG004|Overall Study|Withdrawal by Subject|0|||
33507684|NCT04165031|62890513|FG005|Overall Study|Withdrawal by Subject|0|||
33507685|NCT02712424|62890530|FG000|Overall Study|Lost to Follow-up|34|||
33507686|NCT02712424|62890531|FG001|Overall Study|Lost to Follow-up|32|||
33507687|NCT02968004|62890539|FG000|Overall Study|Adverse Event|1|||
33507688|NCT02968004|62890540|FG001|Overall Study|Adverse Event|0|||
33507689|NCT02968004|62890539|FG000|Overall Study|Withdrawal by Subject|0|||
33507690|NCT02968004|62890540|FG001|Overall Study|Withdrawal by Subject|1|||
33507691|NCT03034772|62890548|FG000|Overall Study|Adverse Event|0|||
33507692|NCT03034772|62890549|FG001|Overall Study|Adverse Event|1|||
33507693|NCT03034772|62890548|FG000|Overall Study|Withdrawal by Subject|0|||
33507694|NCT03034772|62890549|FG001|Overall Study|Withdrawal by Subject|1|||
33507695|NCT03032198|62890555|FG000|Overall Study|Screen Fail|1|||
33507696|NCT02431364|62890564|FG000|Overall Study|Adverse Event|0|||
33507697|NCT02431364|62890565|FG001|Overall Study|Adverse Event|1|||
33507698|NCT02431364|62890566|FG002|Overall Study|Adverse Event|0|||
33507699|NCT02431364|62890567|FG003|Overall Study|Adverse Event|0|||
33507700|NCT02431364|62890568|FG004|Overall Study|Adverse Event|0|||
33507701|NCT02431364|62890564|FG000|Overall Study|Randomized but never treated|0|||
33507702|NCT02431364|62890565|FG001|Overall Study|Randomized but never treated|0|||
33507703|NCT02431364|62890566|FG002|Overall Study|Randomized but never treated|0|||
33507704|NCT02431364|62890567|FG003|Overall Study|Randomized but never treated|1|||
33507705|NCT02431364|62890568|FG004|Overall Study|Randomized but never treated|0|||
33507706|NCT03034460|62890586|FG000|Overall Study|Adverse Event|0|||
33507707|NCT03034460|62890587|FG001|Overall Study|Adverse Event|1|||
33612672|NCT01712074|63013129|FG001|Double Blind Period|Death|1|||
33612673|NCT01712074|63013130|FG002|Double Blind Period|Death|0|||
33451112|NCT00261846|62825766|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
33451113|NCT00261846|62825767|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
33451114|NCT00261846|62825768|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
33451115|NCT00261846|62825769|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
33451116|NCT00261846|62825770|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
33451117|NCT00261846|62825771|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
33451118|NCT00261846|62825772|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
33507708|NCT03034460|62890586|FG000|Overall Study|Withdrawal by Subject|2|||
33507709|NCT03034460|62890587|FG001|Overall Study|Withdrawal by Subject|2|||
33507710|NCT03034460|62890586|FG000|Overall Study|Personal Reasons|1|||
33507711|NCT03034460|62890587|FG001|Overall Study|Personal Reasons|0|||
33507712|NCT04162769|62890600|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
33612674|NCT01712074|63013128|FG000|Double Blind Period|Lost to Follow-up|0|||
33451119|NCT00261846|62825773|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
33507713|NCT04162769|62890601|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
33507714|NCT04162769|62890602|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
33507715|NCT04162769|62890603|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
33507716|NCT04162769|62890600|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
33507717|NCT04162769|62890601|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
33612675|NCT01712074|63013129|FG001|Double Blind Period|Lost to Follow-up|2|||
33507718|NCT04162769|62890602|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
33507719|NCT04162769|62890603|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
33507720|NCT04162769|62890600|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
33507721|NCT04162769|62890601|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
33507722|NCT04162769|62890602|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
33507723|NCT04162769|62890603|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
33507724|NCT04162769|62890600|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
33507725|NCT04162769|62890601|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
33507726|NCT04162769|62890602|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
33507727|NCT04162769|62890603|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
33507728|NCT04162769|62890600|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
33612676|NCT01712074|63013130|FG002|Double Blind Period|Lost to Follow-up|1|||
33612677|NCT01712074|63013128|FG000|Double Blind Period|Other|0|||
33612678|NCT01712074|63013129|FG001|Double Blind Period|Other|4|||
33612679|NCT01712074|63013130|FG002|Double Blind Period|Other|1|||
33612680|NCT01712074|63013128|FG000|Double Blind Period|Protocol Violation|0|||
33612681|NCT01712074|63013129|FG001|Double Blind Period|Protocol Violation|0|||
33451120|NCT00261846|62825774|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
33451121|NCT00261846|62825763|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
33451122|NCT00261846|62825764|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
33451123|NCT00261846|62825765|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
33451124|NCT00261846|62825766|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
33451125|NCT00261846|62825767|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
33451126|NCT00261846|62825768|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
33451127|NCT00261846|62825769|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
33451128|NCT00261846|62825770|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
33451129|NCT00261846|62825771|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
33451130|NCT00261846|62825772|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
33451131|NCT00261846|62825773|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
33451132|NCT00261846|62825774|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
33451133|NCT00261846|62825763|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
33451134|NCT00261846|62825764|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
33451135|NCT00261846|62825765|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
33451136|NCT00261846|62825766|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
33451137|NCT00261846|62825767|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
33451138|NCT00261846|62825768|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
33451139|NCT00261846|62825769|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
33451140|NCT00261846|62825770|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
33451141|NCT00261846|62825771|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
33451142|NCT00261846|62825772|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
33451143|NCT00261846|62825773|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
33451144|NCT00261846|62825774|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
33451145|NCT00261846|62825763|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
33451146|NCT00261846|62825764|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
33451147|NCT00261846|62825765|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
33451148|NCT00261846|62825766|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
33451149|NCT00261846|62825767|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
33451150|NCT00261846|62825768|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
33451151|NCT00261846|62825769|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
33451152|NCT00261846|62825770|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
33451153|NCT00261846|62825771|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
33451154|NCT00261846|62825772|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
33451155|NCT00261846|62825773|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
33451156|NCT00261846|62825774|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
33451157|NCT00169442|62825819|FG000|Overall Study|Withdrawal by Subject|0|||
33451158|NCT00169442|62825820|FG001|Overall Study|Withdrawal by Subject|0|||
33451159|NCT00169442|62825821|FG002|Overall Study|Withdrawal by Subject|1|||
33451160|NCT00169442|62825822|FG003|Overall Study|Withdrawal by Subject|0|||
33451161|NCT00169442|62825823|FG004|Overall Study|Withdrawal by Subject|0|||
33451162|NCT00169442|62825824|FG005|Overall Study|Withdrawal by Subject|0|||
33451163|NCT00169442|62825819|FG000|Overall Study|Migrated/moved from study area|0|||
33451164|NCT00169442|62825820|FG001|Overall Study|Migrated/moved from study area|0|||
33451165|NCT00169442|62825821|FG002|Overall Study|Migrated/moved from study area|0|||
33451166|NCT00169442|62825822|FG003|Overall Study|Migrated/moved from study area|0|||
33451167|NCT00169442|62825823|FG004|Overall Study|Migrated/moved from study area|0|||
33451168|NCT00169442|62825824|FG005|Overall Study|Migrated/moved from study area|2|||
33451169|NCT00169442|62825819|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
33451170|NCT00169442|62825820|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
33451171|NCT00169442|62825821|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
33451172|NCT00169442|62825822|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
33451173|NCT00169442|62825823|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
33451174|NCT00169442|62825824|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
33451175|NCT00169442|62825819|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
33507729|NCT04162769|62890601|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
33507730|NCT04162769|62890602|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
33507731|NCT04162769|62890603|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
33507732|NCT04162769|62890600|FG000|Double-blind Treatment (12-Week)|Other|0|||
33507733|NCT04162769|62890601|FG001|Double-blind Treatment (12-Week)|Other|1|||
33507734|NCT04162769|62890602|FG002|Double-blind Treatment (12-Week)|Other|1|||
33507735|NCT04162769|62890603|FG003|Double-blind Treatment (12-Week)|Other|0|||
33507736|NCT04162769|62890600|FG000|OLE Period (52-Week)|Adverse Event|0|||
33507737|NCT04162769|62890601|FG001|OLE Period (52-Week)|Adverse Event|0|||
33507738|NCT04162769|62890602|FG002|OLE Period (52-Week)|Adverse Event|0|||
33507739|NCT04162769|62890603|FG003|OLE Period (52-Week)|Adverse Event|5|||
33507740|NCT04162769|62890600|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
33507741|NCT04162769|62890601|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
33507742|NCT04162769|62890602|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
33507743|NCT04162769|62890603|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
33612682|NCT01712074|63013130|FG002|Double Blind Period|Protocol Violation|1|||
33612683|NCT01712074|63013128|FG000|Double Blind Period|No longer met eligibility criteria|0|||
33612684|NCT01712074|63013129|FG001|Double Blind Period|No longer met eligibility criteria|3|||
33612685|NCT01712074|63013130|FG002|Double Blind Period|No longer met eligibility criteria|0|||
33507744|NCT04162769|62890600|FG000|OLE Period (52-Week)|Physician Decision|0|||
33507745|NCT04162769|62890601|FG001|OLE Period (52-Week)|Physician Decision|0|||
33507746|NCT04162769|62890602|FG002|OLE Period (52-Week)|Physician Decision|0|||
33507747|NCT04162769|62890603|FG003|OLE Period (52-Week)|Physician Decision|1|||
33507748|NCT04162769|62890600|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
33507749|NCT04162769|62890601|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
33507750|NCT04162769|62890602|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
33507751|NCT04162769|62890603|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
33612686|NCT01711216|63013145|FG000|Overall Study|Adverse Event|4|||
33612687|NCT01711216|63013145|FG000|Overall Study|Pregnancy|56|||
33612688|NCT01711216|63013145|FG000|Overall Study|Withdrawal by Subject|6|||
33612689|NCT01711216|63013145|FG000|Overall Study|Lost to Follow-up|46|||
33612690|NCT01711216|63013145|FG000|Overall Study|variety of other minor reasons|83|||
33612691|NCT01711216|63013145|FG000|Overall Study|no reason specified|22|||
33451176|NCT00169442|62825820|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
33507752|NCT04162769|62890600|FG000|OLE Period (52-Week)|Protocol deviation|0|||
33507753|NCT04162769|62890601|FG001|OLE Period (52-Week)|Protocol deviation|0|||
33507754|NCT04162769|62890602|FG002|OLE Period (52-Week)|Protocol deviation|0|||
33507755|NCT04162769|62890603|FG003|OLE Period (52-Week)|Protocol deviation|2|||
33507756|NCT04161131|62890614|FG000|Overall Study|Ineligible|2|||
33507757|NCT04161131|62890614|FG000|Overall Study|Lost to Follow-up|4|||
33507758|NCT04155047|62890620|FG000|Overall Study|Adverse Event|1|||
33507759|NCT04155047|62890621|FG001|Overall Study|Adverse Event|0|||
33507760|NCT04155047|62890620|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
33507761|NCT04155047|62890621|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
33507762|NCT04152083|62890629|FG000|Overall Study|Lost to Follow-up|2|||
33507763|NCT04152083|62890630|FG001|Overall Study|Lost to Follow-up|1|||
33507764|NCT04152083|62890629|FG000|Overall Study|Adverse Event|1|||
33507765|NCT04152083|62890630|FG001|Overall Study|Adverse Event|0|||
33507766|NCT04152083|62890629|FG000|Overall Study|Randomized but not treated|3|||
33507767|NCT04152083|62890630|FG001|Overall Study|Randomized but not treated|2|||
33507768|NCT02711956|62890651|FG000|Overall Study|Adverse Event|0|||
33507769|NCT02711956|62890652|FG001|Overall Study|Adverse Event|0|||
33507770|NCT02711956|62890653|FG002|Overall Study|Adverse Event|0|||
33507771|NCT02711956|62890654|FG003|Overall Study|Adverse Event|1|||
33507772|NCT02711956|62890655|FG004|Overall Study|Adverse Event|2|||
33507773|NCT02711956|62890656|FG005|Overall Study|Adverse Event|0|||
33507774|NCT02711956|62890657|FG006|Overall Study|Adverse Event|0|||
33507775|NCT02711956|62890658|FG007|Overall Study|Adverse Event|1|||
33507776|NCT02711956|62890659|FG008|Overall Study|Adverse Event|1|||
33507777|NCT02711956|62890660|FG009|Overall Study|Adverse Event|1|||
33507778|NCT02711956|62890661|FG010|Overall Study|Adverse Event|1|||
33507779|NCT02711956|62890662|FG011|Overall Study|Adverse Event|0|||
33612692|NCT01692730|63013155|FG000|Overall Study|Lost to Follow-up|225|||
33451177|NCT00169442|62825821|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
33451178|NCT00169442|62825822|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
33451179|NCT00169442|62825823|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
33451180|NCT00169442|62825824|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
33451181|NCT00261716|62825842|FG000|Overall Study|Withdrawal by Subject|6|||
33451182|NCT00261716|62825843|FG001|Overall Study|Withdrawal by Subject|8|||
33507780|NCT02711956|62890663|FG012|Overall Study|Adverse Event|0|||
33507781|NCT02711956|62890664|FG013|Overall Study|Adverse Event|0|||
33507782|NCT02711956|62890665|FG014|Overall Study|Adverse Event|2|||
33507783|NCT02711956|62890651|FG000|Overall Study|Physician Decision|0|||
33507784|NCT02711956|62890652|FG001|Overall Study|Physician Decision|0|||
33612693|NCT01692730|63013156|FG001|Overall Study|Lost to Follow-up|227|||
33507785|NCT02711956|62890653|FG002|Overall Study|Physician Decision|0|||
33507786|NCT02711956|62890654|FG003|Overall Study|Physician Decision|2|||
33507787|NCT02711956|62890655|FG004|Overall Study|Physician Decision|0|||
33507788|NCT02711956|62890656|FG005|Overall Study|Physician Decision|0|||
33507789|NCT02711956|62890657|FG006|Overall Study|Physician Decision|0|||
33507790|NCT02711956|62890658|FG007|Overall Study|Physician Decision|0|||
33507791|NCT02711956|62890659|FG008|Overall Study|Physician Decision|0|||
33507792|NCT02711956|62890660|FG009|Overall Study|Physician Decision|0|||
33507793|NCT02711956|62890661|FG010|Overall Study|Physician Decision|0|||
33507794|NCT02711956|62890662|FG011|Overall Study|Physician Decision|0|||
33507795|NCT02711956|62890663|FG012|Overall Study|Physician Decision|0|||
33507796|NCT02711956|62890664|FG013|Overall Study|Physician Decision|0|||
33507797|NCT02711956|62890665|FG014|Overall Study|Physician Decision|0|||
33507798|NCT02711956|62890651|FG000|Overall Study|Withdrawal by Subject|0|||
33507799|NCT02711956|62890652|FG001|Overall Study|Withdrawal by Subject|0|||
33507800|NCT02711956|62890653|FG002|Overall Study|Withdrawal by Subject|0|||
33507801|NCT02711956|62890654|FG003|Overall Study|Withdrawal by Subject|0|||
33507802|NCT02711956|62890655|FG004|Overall Study|Withdrawal by Subject|0|||
33612694|NCT01691794|63013165|FG000|Overall Study|Poor/Non-Compliance|1|||
33612695|NCT01691794|63013166|FG001|Overall Study|Poor/Non-Compliance|4|||
33612696|NCT01691794|63013167|FG002|Overall Study|Poor/Non-Compliance|1|||
33612697|NCT01691794|63013165|FG000|Overall Study|Death|0|||
33612698|NCT01691794|63013166|FG001|Overall Study|Death|0|||
33612699|NCT01691794|63013167|FG002|Overall Study|Death|1|||
33612700|NCT01691794|63013165|FG000|Overall Study|Lack of Efficacy|0|||
33612701|NCT01691794|63013166|FG001|Overall Study|Lack of Efficacy|7|||
33612702|NCT01691794|63013167|FG002|Overall Study|Lack of Efficacy|1|||
33612703|NCT01691794|63013165|FG000|Overall Study|Participant request to discontinue|0|||
33612704|NCT01691794|63013166|FG001|Overall Study|Participant request to discontinue|1|||
33612705|NCT01691794|63013167|FG002|Overall Study|Participant request to discontinue|0|||
33507803|NCT02711956|62890656|FG005|Overall Study|Withdrawal by Subject|0|||
33507804|NCT02711956|62890657|FG006|Overall Study|Withdrawal by Subject|1|||
33507805|NCT02711956|62890658|FG007|Overall Study|Withdrawal by Subject|0|||
33507806|NCT02711956|62890659|FG008|Overall Study|Withdrawal by Subject|0|||
33507807|NCT02711956|62890660|FG009|Overall Study|Withdrawal by Subject|0|||
33507808|NCT02711956|62890661|FG010|Overall Study|Withdrawal by Subject|0|||
33507809|NCT02711956|62890662|FG011|Overall Study|Withdrawal by Subject|1|||
33507810|NCT02711956|62890663|FG012|Overall Study|Withdrawal by Subject|6|||
33507811|NCT02711956|62890664|FG013|Overall Study|Withdrawal by Subject|0|||
33507812|NCT02711956|62890665|FG014|Overall Study|Withdrawal by Subject|1|||
33507813|NCT02711956|62890651|FG000|Overall Study|Clinical progression|1|||
33507814|NCT02711956|62890652|FG001|Overall Study|Clinical progression|0|||
33507815|NCT02711956|62890653|FG002|Overall Study|Clinical progression|0|||
33507816|NCT02711956|62890654|FG003|Overall Study|Clinical progression|0|||
33507817|NCT02711956|62890655|FG004|Overall Study|Clinical progression|0|||
33507818|NCT02711956|62890656|FG005|Overall Study|Clinical progression|0|||
33507819|NCT02711956|62890657|FG006|Overall Study|Clinical progression|1|||
33507820|NCT02711956|62890658|FG007|Overall Study|Clinical progression|0|||
33507821|NCT02711956|62890659|FG008|Overall Study|Clinical progression|1|||
33507822|NCT02711956|62890660|FG009|Overall Study|Clinical progression|0|||
33507823|NCT02711956|62890661|FG010|Overall Study|Clinical progression|0|||
33507824|NCT02711956|62890662|FG011|Overall Study|Clinical progression|2|||
33507825|NCT02711956|62890663|FG012|Overall Study|Clinical progression|4|||
33507826|NCT02711956|62890664|FG013|Overall Study|Clinical progression|1|||
33507827|NCT02711956|62890665|FG014|Overall Study|Clinical progression|1|||
33507828|NCT02711956|62890651|FG000|Overall Study|Radiographic progression|1|||
33507829|NCT02711956|62890652|FG001|Overall Study|Radiographic progression|1|||
33507830|NCT02711956|62890653|FG002|Overall Study|Radiographic progression|2|||
33507831|NCT02711956|62890654|FG003|Overall Study|Radiographic progression|0|||
33507832|NCT02711956|62890655|FG004|Overall Study|Radiographic progression|1|||
33507833|NCT02711956|62890656|FG005|Overall Study|Radiographic progression|0|||
33507834|NCT02711956|62890657|FG006|Overall Study|Radiographic progression|0|||
33507835|NCT02711956|62890658|FG007|Overall Study|Radiographic progression|0|||
33507836|NCT02711956|62890659|FG008|Overall Study|Radiographic progression|2|||
33507837|NCT02711956|62890660|FG009|Overall Study|Radiographic progression|1|||
33612706|NCT01691794|63013165|FG000|Overall Study|Adverse Event|0|||
33612707|NCT01691794|63013166|FG001|Overall Study|Adverse Event|1|||
33507838|NCT02711956|62890661|FG010|Overall Study|Radiographic progression|0|||
33507839|NCT02711956|62890662|FG011|Overall Study|Radiographic progression|5|||
33507840|NCT02711956|62890663|FG012|Overall Study|Radiographic progression|3|||
33507841|NCT02711956|62890664|FG013|Overall Study|Radiographic progression|0|||
33507842|NCT02711956|62890665|FG014|Overall Study|Radiographic progression|1|||
33507843|NCT02711956|62890651|FG000|Overall Study|PSA progression with clinical progression|0|||
33507844|NCT02711956|62890652|FG001|Overall Study|PSA progression with clinical progression|0|||
33507845|NCT02711956|62890653|FG002|Overall Study|PSA progression with clinical progression|0|||
33612708|NCT01691794|63013167|FG002|Overall Study|Adverse Event|1|||
33507846|NCT02711956|62890654|FG003|Overall Study|PSA progression with clinical progression|0|||
33507847|NCT02711956|62890655|FG004|Overall Study|PSA progression with clinical progression|1|||
33507848|NCT02711956|62890656|FG005|Overall Study|PSA progression with clinical progression|0|||
33507849|NCT02711956|62890657|FG006|Overall Study|PSA progression with clinical progression|0|||
33507850|NCT02711956|62890658|FG007|Overall Study|PSA progression with clinical progression|0|||
33507851|NCT02711956|62890659|FG008|Overall Study|PSA progression with clinical progression|0|||
33507852|NCT02711956|62890660|FG009|Overall Study|PSA progression with clinical progression|0|||
33507853|NCT02711956|62890661|FG010|Overall Study|PSA progression with clinical progression|0|||
33507854|NCT02711956|62890662|FG011|Overall Study|PSA progression with clinical progression|0|||
33507855|NCT02711956|62890663|FG012|Overall Study|PSA progression with clinical progression|1|||
33507856|NCT02711956|62890664|FG013|Overall Study|PSA progression with clinical progression|1|||
33507857|NCT02711956|62890665|FG014|Overall Study|PSA progression with clinical progression|0|||
33507858|NCT02711956|62890651|FG000|Overall Study|PSA progression with radiographic progression|0|||
33507859|NCT02711956|62890652|FG001|Overall Study|PSA progression with radiographic progression|1|||
33507860|NCT02711956|62890653|FG002|Overall Study|PSA progression with radiographic progression|0|||
33507861|NCT02711956|62890654|FG003|Overall Study|PSA progression with radiographic progression|0|||
33507862|NCT02711956|62890655|FG004|Overall Study|PSA progression with radiographic progression|0|||
33507863|NCT02711956|62890656|FG005|Overall Study|PSA progression with radiographic progression|2|||
33507864|NCT02711956|62890657|FG006|Overall Study|PSA progression with radiographic progression|2|||
33507865|NCT02711956|62890658|FG007|Overall Study|PSA progression with radiographic progression|1|||
33507866|NCT02711956|62890659|FG008|Overall Study|PSA progression with radiographic progression|0|||
33507867|NCT02711956|62890660|FG009|Overall Study|PSA progression with radiographic progression|1|||
33507868|NCT02711956|62890661|FG010|Overall Study|PSA progression with radiographic progression|0|||
33507869|NCT02711956|62890662|FG011|Overall Study|PSA progression with radiographic progression|1|||
33507870|NCT02711956|62890663|FG012|Overall Study|PSA progression with radiographic progression|2|||
33507871|NCT02711956|62890664|FG013|Overall Study|PSA progression with radiographic progression|3|||
33507872|NCT02711956|62890665|FG014|Overall Study|PSA progression with radiographic progression|3|||
33507873|NCT04149353|62890706|FG000|Overall Study|Study terminated|1|||
33507874|NCT02711800|62890711|FG000|Overall Study|Lost to Follow-up|1|||
33507875|NCT02711800|62890711|FG000|Overall Study|Withdrawal by Subject|1|||
33507876|NCT03031496|62890715|FG000|Period 1|Adverse Event|2|||
33507877|NCT03031496|62890716|FG001|Period 1|Adverse Event|0|||
33507878|NCT03031496|62890715|FG000|Period 1|Withdrawal by Subject|0|||
33507879|NCT03031496|62890716|FG001|Period 1|Withdrawal by Subject|2|||
33507880|NCT02659020|62890729|FG000|Overall Study|Adverse Event|0|||
33507881|NCT02659020|62890730|FG001|Overall Study|Adverse Event|0|||
33612709|NCT01691794|63013165|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
33507882|NCT02659020|62890731|FG002|Overall Study|Adverse Event|0|||
33507883|NCT02659020|62890732|FG003|Overall Study|Adverse Event|2|||
33507884|NCT02659020|62890733|FG004|Overall Study|Adverse Event|0|||
33507885|NCT02659020|62890734|FG005|Overall Study|Adverse Event|0|||
33507886|NCT02659020|62890735|FG006|Overall Study|Adverse Event|2|||
33507887|NCT02659020|62890729|FG000|Overall Study|Lost to Follow-up|1|||
33507888|NCT02659020|62890730|FG001|Overall Study|Lost to Follow-up|2|||
33507889|NCT02659020|62890731|FG002|Overall Study|Lost to Follow-up|1|||
33507890|NCT02659020|62890732|FG003|Overall Study|Lost to Follow-up|6|||
33507891|NCT02659020|62890733|FG004|Overall Study|Lost to Follow-up|1|||
33507892|NCT02659020|62890734|FG005|Overall Study|Lost to Follow-up|5|||
33507893|NCT02659020|62890735|FG006|Overall Study|Lost to Follow-up|0|||
33507894|NCT02659020|62890729|FG000|Overall Study|Physician Decision|0|||
33507895|NCT02659020|62890730|FG001|Overall Study|Physician Decision|0|||
33507896|NCT02659020|62890731|FG002|Overall Study|Physician Decision|0|||
33507897|NCT02659020|62890732|FG003|Overall Study|Physician Decision|1|||
33507898|NCT02659020|62890733|FG004|Overall Study|Physician Decision|1|||
33507899|NCT02659020|62890734|FG005|Overall Study|Physician Decision|0|||
33507900|NCT02659020|62890735|FG006|Overall Study|Physician Decision|1|||
33507901|NCT02659020|62890729|FG000|Overall Study|Withdrawal by Subject|2|||
33507902|NCT02659020|62890730|FG001|Overall Study|Withdrawal by Subject|1|||
33507903|NCT02659020|62890731|FG002|Overall Study|Withdrawal by Subject|0|||
33612710|NCT01691794|63013166|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
33612711|NCT01691794|63013167|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
33507904|NCT02659020|62890732|FG003|Overall Study|Withdrawal by Subject|3|||
33507905|NCT02659020|62890733|FG004|Overall Study|Withdrawal by Subject|3|||
33507906|NCT02659020|62890734|FG005|Overall Study|Withdrawal by Subject|6|||
33507907|NCT02659020|62890735|FG006|Overall Study|Withdrawal by Subject|3|||
33507908|NCT02659020|62890729|FG000|Overall Study|Progressive Disease|0|||
33507909|NCT02659020|62890730|FG001|Overall Study|Progressive Disease|0|||
33507910|NCT02659020|62890731|FG002|Overall Study|Progressive Disease|0|||
33507911|NCT02659020|62890732|FG003|Overall Study|Progressive Disease|4|||
33507912|NCT02659020|62890733|FG004|Overall Study|Progressive Disease|1|||
33507913|NCT02659020|62890734|FG005|Overall Study|Progressive Disease|0|||
33507914|NCT02659020|62890735|FG006|Overall Study|Progressive Disease|2|||
33507915|NCT03482011|62890760|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
33507916|NCT03482011|62890761|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
33507917|NCT03482011|62890762|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
33507918|NCT03482011|62890763|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
33507919|NCT03482011|62890764|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
33507920|NCT03482011|62890765|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
33507921|NCT03482011|62890766|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
33507922|NCT03482011|62890767|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
33507923|NCT03482011|62890760|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
33612712|NCT01691794|63013165|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
33612713|NCT01691794|63013166|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
33612714|NCT01691794|63013167|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
33612715|NCT01710514|63013177|FG000|Overall Study|Adverse Event|6|||
33612716|NCT01710514|63013178|FG001|Overall Study|Adverse Event|7|||
33612717|NCT01710514|63013177|FG000|Overall Study|Withdrawal by Subject|1|||
33612718|NCT01710514|63013178|FG001|Overall Study|Withdrawal by Subject|0|||
33612719|NCT01592344|63013189|FG000|Overall Study|Adverse Event|1|||
33507924|NCT03482011|62890761|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
33507925|NCT03482011|62890762|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33507926|NCT03482011|62890763|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33507927|NCT03482011|62890764|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33507928|NCT03482011|62890765|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33507929|NCT03482011|62890766|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33507930|NCT03482011|62890767|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33507931|NCT03482011|62890760|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
33507932|NCT03482011|62890761|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
33507933|NCT03482011|62890762|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
33507934|NCT03482011|62890763|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
33507935|NCT03482011|62890764|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
33507936|NCT03482011|62890765|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
33507937|NCT03482011|62890766|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
33507938|NCT03482011|62890767|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
33507939|NCT03482011|62890760|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
33507940|NCT03482011|62890761|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
33507941|NCT03482011|62890762|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
33507942|NCT03482011|62890763|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
33507943|NCT03482011|62890764|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
33507944|NCT03482011|62890765|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
33507945|NCT03482011|62890766|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
33507946|NCT03482011|62890767|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
33507947|NCT03482011|62890760|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
33507948|NCT03482011|62890761|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
33507949|NCT03482011|62890762|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33612720|NCT01592344|63013190|FG001|Overall Study|Adverse Event|1|||
33507950|NCT03482011|62890763|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33507951|NCT03482011|62890764|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33507952|NCT03482011|62890765|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33507953|NCT03482011|62890766|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33507954|NCT03482011|62890767|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33612721|NCT01592344|63013189|FG000|Overall Study|Lack of Efficacy|1|||
33507955|NCT03482011|62890760|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
33507956|NCT03482011|62890761|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
33507957|NCT03482011|62890762|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
33507958|NCT03482011|62890763|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
33612722|NCT01592344|63013190|FG001|Overall Study|Lack of Efficacy|0|||
33612723|NCT01592344|63013189|FG000|Overall Study|not available at primary outcome visit|2|||
33507959|NCT03482011|62890764|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
33507960|NCT03482011|62890765|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
33507961|NCT03482011|62890766|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
33507962|NCT03482011|62890767|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
33507963|NCT03482011|62890760|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
33324317|NCT00960531|62700738|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
33324318|NCT00960531|62700739|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
33324319|NCT00960531|62700740|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
33324320|NCT00960531|62700741|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
33324321|NCT00960531|62700742|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
33324322|NCT00960531|62700743|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
33324323|NCT00960531|62700744|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
33324324|NCT00960531|62700745|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
33324325|NCT00960531|62700746|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
33324326|NCT00960531|62700747|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
33324327|NCT00960531|62700738|FG000|Overall Study|Lost to Follow-up|0|||
33324328|NCT00960531|62700739|FG001|Overall Study|Lost to Follow-up|0|||
33324329|NCT00960531|62700740|FG002|Overall Study|Lost to Follow-up|1|||
33324330|NCT00960531|62700741|FG003|Overall Study|Lost to Follow-up|0|||
33324331|NCT00960531|62700742|FG004|Overall Study|Lost to Follow-up|0|||
33324332|NCT00960531|62700743|FG005|Overall Study|Lost to Follow-up|0|||
33324333|NCT00960531|62700744|FG006|Overall Study|Lost to Follow-up|1|||
33324334|NCT00960531|62700745|FG007|Overall Study|Lost to Follow-up|0|||
33324335|NCT00960531|62700746|FG008|Overall Study|Lost to Follow-up|0|||
33324336|NCT00960531|62700747|FG009|Overall Study|Lost to Follow-up|0|||
33324337|NCT00960531|62700738|FG000|Overall Study|Failed to Return|2|||
33324338|NCT00960531|62700739|FG001|Overall Study|Failed to Return|0|||
33324339|NCT00960531|62700740|FG002|Overall Study|Failed to Return|0|||
33324340|NCT00960531|62700741|FG003|Overall Study|Failed to Return|0|||
33324341|NCT00960531|62700742|FG004|Overall Study|Failed to Return|0|||
33324342|NCT00960531|62700743|FG005|Overall Study|Failed to Return|0|||
33324343|NCT00960531|62700744|FG006|Overall Study|Failed to Return|0|||
33324344|NCT00960531|62700745|FG007|Overall Study|Failed to Return|2|||
33324345|NCT00960531|62700746|FG008|Overall Study|Failed to Return|0|||
33324346|NCT00960531|62700747|FG009|Overall Study|Failed to Return|0|||
33324347|NCT00960531|62700738|FG000|Overall Study|Adverse Event (AE)|2|||
33324348|NCT00960531|62700739|FG001|Overall Study|Adverse Event (AE)|0|||
33324349|NCT00960531|62700740|FG002|Overall Study|Adverse Event (AE)|0|||
33324350|NCT00960531|62700741|FG003|Overall Study|Adverse Event (AE)|0|||
33324351|NCT00960531|62700742|FG004|Overall Study|Adverse Event (AE)|0|||
33324352|NCT00960531|62700743|FG005|Overall Study|Adverse Event (AE)|1|||
33324353|NCT00960531|62700744|FG006|Overall Study|Adverse Event (AE)|2|||
33324354|NCT00960531|62700745|FG007|Overall Study|Adverse Event (AE)|0|||
33507964|NCT03482011|62890761|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
33507965|NCT03482011|62890762|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
33507966|NCT03482011|62890763|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
33507967|NCT03482011|62890764|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
33507968|NCT03482011|62890765|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
33507969|NCT03482011|62890766|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
33507970|NCT03482011|62890767|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
33507971|NCT03482011|62890760|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33507972|NCT03482011|62890761|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33507973|NCT03482011|62890762|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33507974|NCT03482011|62890763|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33507975|NCT03482011|62890764|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
33507976|NCT03482011|62890765|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33507977|NCT03482011|62890766|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33507978|NCT03482011|62890767|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
33507979|NCT03482011|62890760|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
33507980|NCT03482011|62890761|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
33507981|NCT03482011|62890762|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
33507982|NCT03482011|62890763|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
33507983|NCT03482011|62890764|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
33507984|NCT03482011|62890765|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
33507985|NCT03482011|62890766|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
33507986|NCT03482011|62890767|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
33507987|NCT03482011|62890760|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33324355|NCT00960531|62700746|FG008|Overall Study|Adverse Event (AE)|2|||
33324356|NCT00960531|62700747|FG009|Overall Study|Adverse Event (AE)|0|||
33324357|NCT00960531|62700738|FG000|Overall Study|Reason not Specified|2|||
33324358|NCT00960531|62700739|FG001|Overall Study|Reason not Specified|1|||
33324359|NCT00960531|62700740|FG002|Overall Study|Reason not Specified|13|||
33324360|NCT00960531|62700741|FG003|Overall Study|Reason not Specified|1|||
33324361|NCT00960531|62700742|FG004|Overall Study|Reason not Specified|2|||
33612724|NCT01592344|63013190|FG001|Overall Study|not available at primary outcome visit|4|||
33612725|NCT01636778|63013196|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
33612726|NCT01636778|63013197|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
33612727|NCT01636778|63013198|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
33612728|NCT01636778|63013196|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
33612729|NCT01636778|63013197|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
33612730|NCT01636778|63013198|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
33612731|NCT01636778|63013196|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
33612732|NCT01636778|63013197|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
33612733|NCT01636778|63013198|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
33612734|NCT01636778|63013196|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
33612735|NCT01636778|63013197|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
33612736|NCT01636778|63013198|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
33612737|NCT01636778|63013196|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
33612738|NCT01636778|63013197|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
33612739|NCT01636778|63013198|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
33612740|NCT01636778|63013196|FG000|Follow-up Period After Part 2|Other|0|||
33612741|NCT01636778|63013197|FG001|Follow-up Period After Part 2|Other|0|||
33612742|NCT01636778|63013198|FG002|Follow-up Period After Part 2|Other|1|||
33612743|NCT01636778|63013196|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
33612744|NCT01636778|63013197|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
33612745|NCT01636778|63013198|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
33612746|NCT01636778|63013196|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
33612747|NCT01636778|63013197|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
33612748|NCT01636778|63013198|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
33451183|NCT00261716|62825842|FG000|Overall Study|Lost to Follow-up|0|||
33451184|NCT00261716|62825843|FG001|Overall Study|Lost to Follow-up|2|||
33451185|NCT03809104|62825853|FG000|Overall Study|Withdrawal by Subject|3|||
33451186|NCT00203502|62825857|FG000|Overall Study|Death|1|||
33451187|NCT03799198|62825863|FG000|Overall Study|Lost to Follow-up|4|||
33451188|NCT03799198|62825864|FG001|Overall Study|Lost to Follow-up|8|||
33451189|NCT03799198|62825863|FG000|Overall Study|Death|0|||
33451190|NCT03799198|62825864|FG001|Overall Study|Death|1|||
33451191|NCT00232596|62825872|FG000|6-Week Titration Phase|Adverse Event|6|||
33451192|NCT00232596|62825873|FG001|6-Week Titration Phase|Adverse Event|19|||
33451193|NCT00232596|62825872|FG000|6-Week Titration Phase|Failed to Return|2|||
33451194|NCT00232596|62825873|FG001|6-Week Titration Phase|Failed to Return|1|||
33451195|NCT00232596|62825872|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
33451196|NCT00232596|62825873|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
33451197|NCT00232596|62825872|FG000|6-Week Titration Phase|Protocol Violation|1|||
33451198|NCT00232596|62825873|FG001|6-Week Titration Phase|Protocol Violation|3|||
33451199|NCT00232596|62825872|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
33451200|NCT00232596|62825873|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
33451201|NCT00232596|62825872|FG000|6-Week Titration Phase|Other|3|||
33451202|NCT00232596|62825873|FG001|6-Week Titration Phase|Other|3|||
33451203|NCT00232596|62825872|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
33451204|NCT00232596|62825873|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
33451205|NCT00232596|62825872|FG000|12-Week Maintenance Phase|Adverse Event|7|||
33451206|NCT00232596|62825873|FG001|12-Week Maintenance Phase|Adverse Event|22|||
33451207|NCT00232596|62825872|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
33451208|NCT00232596|62825873|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
33451209|NCT00232596|62825872|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
33451210|NCT00232596|62825873|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
33451211|NCT00232596|62825872|FG000|12-Week Maintenance Phase|Other|1|||
33451212|NCT00232596|62825873|FG001|12-Week Maintenance Phase|Other|3|||
33451213|NCT00073918|62825891|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
33451214|NCT00073918|62825891|FG000|Overall Study|Rapid disease progression|2|||
33451215|NCT00073918|62825891|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
33451216|NCT00231894|62825897|FG000|Overall Study|Withdrawal by Subject|1|||
33451217|NCT00231894|62825898|FG001|Overall Study|Withdrawal by Subject|1|||
33451218|NCT00203424|62825910|FG000|Treatment Period|Withdrawal by Subject|4|||
33451219|NCT00203424|62825910|FG000|Treatment Period|Adverse Event|5|||
33451220|NCT00203424|62825910|FG000|Treatment Period|progressive disease|2|||
33451221|NCT00203424|62825910|FG000|Follow-up Period|Withdrawal by Subject|1|||
33612749|NCT02159053|63013209|FG000|Overall Study|Death|2|||
33451222|NCT00203424|62825910|FG000|Follow-up Period|progressive disease|4|||
33451223|NCT00203424|62825910|FG000|Follow-up Period|Lost to Follow-up|1|||
33451224|NCT00203268|62825914|FG000|Early Treatment|only treated one headache|2|||
33451225|NCT00203268|62825914|FG000|Early Treatment|Lost to Follow-up|1|||
33451226|NCT00203268|62825914|FG000|Early Treatment|Withdrawal by Subject|1|||
33507988|NCT03482011|62890761|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33507989|NCT03482011|62890762|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33507990|NCT03482011|62890763|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
33507991|NCT03482011|62890764|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
33612750|NCT02159053|63013210|FG001|Overall Study|Death|0|||
33612751|NCT02159053|63013211|FG002|Overall Study|Death|1|||
33612752|NCT02159053|63013209|FG000|Overall Study|Physician Decision|0|||
33612753|NCT02159053|63013210|FG001|Overall Study|Physician Decision|1|||
33612754|NCT02159053|63013211|FG002|Overall Study|Physician Decision|1|||
33612755|NCT02159053|63013209|FG000|Overall Study|Lack of Efficacy|3|||
33612756|NCT02159053|63013210|FG001|Overall Study|Lack of Efficacy|4|||
33612757|NCT02159053|63013211|FG002|Overall Study|Lack of Efficacy|7|||
33612758|NCT02159053|63013209|FG000|Overall Study|Adverse Event|7|||
33507992|NCT03482011|62890765|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
33507993|NCT03482011|62890766|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
33507994|NCT03482011|62890767|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
33507995|NCT03482011|62890760|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33507996|NCT03482011|62890761|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33507997|NCT03482011|62890762|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33324362|NCT00960531|62700743|FG005|Overall Study|Reason not Specified|0|||
33324363|NCT00960531|62700744|FG006|Overall Study|Reason not Specified|16|||
33324364|NCT00960531|62700745|FG007|Overall Study|Reason not Specified|0|||
33324365|NCT00960531|62700746|FG008|Overall Study|Reason not Specified|8|||
33324366|NCT00960531|62700747|FG009|Overall Study|Reason not Specified|1|||
33324367|NCT00960375|62700775|FG000|Overall Study|Lost to Follow-up|20|||
33324368|NCT00960375|62700776|FG001|Overall Study|Lost to Follow-up|22|||
33324369|NCT00957801|62700795|FG000|Overall Study|Withdrawal by Subject|0|||
33324370|NCT00957801|62700796|FG001|Overall Study|Withdrawal by Subject|0|||
33324371|NCT00957801|62700797|FG002|Overall Study|Withdrawal by Subject|0|||
33324372|NCT00957801|62700798|FG003|Overall Study|Withdrawal by Subject|1|||
33324373|NCT00957723|62700808|FG000|Overall Study|Death|3|||
33324374|NCT00957723|62700808|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
33324375|NCT00957723|62700808|FG000|Overall Study|Lost to Follow-up|8|||
33324376|NCT00957723|62700808|FG000|Overall Study|Withdrawal by Subject|24|||
33324377|NCT00957723|62700808|FG000|Overall Study|Investigative Site Terminated|61|||
33324378|NCT00957723|62700808|FG000|Overall Study|Intercurrent Illness|2|||
33507998|NCT03482011|62890763|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
33507999|NCT03482011|62890764|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33508000|NCT03482011|62890765|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
33508001|NCT03482011|62890766|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
33508002|NCT03482011|62890767|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
33508003|NCT03482011|62890760|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
33508004|NCT03482011|62890761|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
33508005|NCT03482011|62890762|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
33508006|NCT03482011|62890763|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
33508007|NCT03482011|62890764|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
33508008|NCT03482011|62890765|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
33508009|NCT03482011|62890766|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
33508010|NCT03482011|62890767|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
33508011|NCT03482011|62890760|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
33508012|NCT03482011|62890761|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
33508013|NCT03482011|62890762|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
33508014|NCT03482011|62890763|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
33508015|NCT03482011|62890764|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
33508016|NCT03482011|62890765|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
33508017|NCT03482011|62890766|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
33508018|NCT03482011|62890767|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
33508019|NCT03482011|62890760|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
33508020|NCT03482011|62890761|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
33508021|NCT03482011|62890762|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
33508022|NCT03482011|62890763|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
33508023|NCT03482011|62890764|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
33508024|NCT03482011|62890765|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
33612759|NCT02159053|63013210|FG001|Overall Study|Adverse Event|6|||
33324379|NCT00957723|62700808|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
33324380|NCT03778021|62700816|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
33508025|NCT03482011|62890766|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
33612760|NCT02159053|63013211|FG002|Overall Study|Adverse Event|5|||
33612761|NCT02159053|63013209|FG000|Overall Study|Participants/guardian decision|8|||
33324381|NCT03778021|62700817|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
33324382|NCT00911170|62700826|FG000|Treatment Period|Randomized in error|1|||
33508026|NCT03482011|62890767|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
33612762|NCT02159053|63013210|FG001|Overall Study|Participants/guardian decision|10|||
33508027|NCT03482011|62890760|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33508028|NCT03482011|62890761|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33508029|NCT03482011|62890762|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33508030|NCT03482011|62890763|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33612763|NCT02159053|63013211|FG002|Overall Study|Participants/guardian decision|6|||
33612764|NCT02158975|63013221|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
33508031|NCT03482011|62890764|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33508032|NCT03482011|62890765|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33508033|NCT03482011|62890766|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33508034|NCT03482011|62890767|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
33508035|NCT03481309|62890798|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
33508036|NCT03481309|62890799|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
33508037|NCT03481309|62890800|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
33508038|NCT03481309|62890801|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
33508039|NCT03481309|62890802|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
33508040|NCT03481309|62890803|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
33508041|NCT03480841|62890811|FG000|Overall Study|Lost to Follow-up|2|||
33508042|NCT02709538|62890818|FG000|Overall Study|Adverse Event|13|||
33508043|NCT02709538|62890819|FG001|Overall Study|Adverse Event|2|||
33508044|NCT02709538|62890820|FG002|Overall Study|Adverse Event|3|||
33508045|NCT02709538|62890818|FG000|Overall Study|Lack of Efficacy|1|||
33508046|NCT02709538|62890819|FG001|Overall Study|Lack of Efficacy|0|||
33508047|NCT02709538|62890820|FG002|Overall Study|Lack of Efficacy|0|||
33508048|NCT02709538|62890818|FG000|Overall Study|Lost to Follow-up|24|||
33508049|NCT02709538|62890819|FG001|Overall Study|Lost to Follow-up|8|||
33508050|NCT02709538|62890820|FG002|Overall Study|Lost to Follow-up|4|||
33508051|NCT02709538|62890818|FG000|Overall Study|Physician Decision|1|||
33508052|NCT02709538|62890819|FG001|Overall Study|Physician Decision|0|||
33508053|NCT02709538|62890820|FG002|Overall Study|Physician Decision|0|||
33508054|NCT02709538|62890818|FG000|Overall Study|Withdrawal by Subject|40|||
33508055|NCT02709538|62890819|FG001|Overall Study|Withdrawal by Subject|7|||
33508056|NCT02709538|62890820|FG002|Overall Study|Withdrawal by Subject|4|||
33612765|NCT02158663|63013228|FG000|Overall Study|Withdrawal by Subject|5|||
33612766|NCT02158663|63013229|FG001|Overall Study|Withdrawal by Subject|4|||
33612767|NCT02158039|63013237|FG000|Overall Study|Withdrawal by Subject|1|||
33612768|NCT02158039|63013237|FG000|Overall Study|Screen Failure|9|||
33612769|NCT01635764|63013255|FG000|Overall Study|Adverse Event|46|||
33612770|NCT01635764|63013255|FG000|Overall Study|Lack of Efficacy|76|||
33612771|NCT01635764|63013255|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
33612772|NCT01635764|63013255|FG000|Overall Study|Protocol Deviation|1|||
33612773|NCT01635764|63013255|FG000|Overall Study|Withdrew Consent|67|||
33612774|NCT01635764|63013255|FG000|Overall Study|Lost to Follow-up|53|||
33612775|NCT01635764|63013255|FG000|Overall Study|Other|28|||
33612776|NCT03432260|63013271|FG000|Overall Study|Lost to Follow-up|1|||
33612777|NCT03432260|63013272|FG001|Overall Study|Lost to Follow-up|1|||
33612778|NCT03432260|63013273|FG002|Overall Study|Lost to Follow-up|0|||
33612779|NCT03432260|63013274|FG003|Overall Study|Lost to Follow-up|0|||
33612780|NCT03432260|63013275|FG004|Overall Study|Lost to Follow-up|1|||
33612781|NCT01634360|63013289|FG000|Overall Study|Adverse Event|10|||
33612782|NCT01634360|63013290|FG001|Overall Study|Adverse Event|34|||
33612783|NCT01634360|63013289|FG000|Overall Study|subject withdrew consent|13|||
33612784|NCT01634360|63013290|FG001|Overall Study|subject withdrew consent|23|||
33612785|NCT01634360|63013289|FG000|Overall Study|Protocol Violation|1|||
33612786|NCT01634360|63013290|FG001|Overall Study|Protocol Violation|1|||
33612787|NCT01634360|63013289|FG000|Overall Study|Lack of Efficacy|4|||
33612788|NCT01634360|63013290|FG001|Overall Study|Lack of Efficacy|14|||
33612789|NCT01634360|63013289|FG000|Overall Study|Other|3|||
33612790|NCT01634360|63013290|FG001|Overall Study|Other|20|||
33612791|NCT01634360|63013289|FG000|Overall Study|Study termination by sponsor|18|||
33612792|NCT01634360|63013290|FG001|Overall Study|Study termination by sponsor|44|||
33612793|NCT01635218|63013307|FG000|Overall Study|Lost to Follow-up|3|||
33612794|NCT01635218|63013308|FG001|Overall Study|Lost to Follow-up|7|||
33612795|NCT01635218|63013309|FG002|Overall Study|Lost to Follow-up|6|||
33508057|NCT02709538|62890818|FG000|Overall Study|Non-compliance with study procedures|5|||
33508058|NCT02709538|62890819|FG001|Overall Study|Non-compliance with study procedures|0|||
33612796|NCT02049866|63013317|FG000|Overall Study|Withdrawal by Subject|1|||
33508059|NCT02709538|62890820|FG002|Overall Study|Non-compliance with study procedures|0|||
33508060|NCT02709538|62890818|FG000|Overall Study|Non-compliance with study drug|2|||
33508061|NCT02709538|62890819|FG001|Overall Study|Non-compliance with study drug|0|||
33508062|NCT02709538|62890820|FG002|Overall Study|Non-compliance with study drug|0|||
33508063|NCT02709538|62890818|FG000|Overall Study|Protocol deviation|10|||
33612797|NCT04274894|63013321|FG000|Overall Study|Adverse Event|7|||
33612798|NCT04274894|63013321|FG000|Overall Study|Withdrew consent|5|||
33612799|NCT04274894|63013321|FG000|Overall Study|Lost to Follow-up|9|||
33612800|NCT04274894|63013321|FG000|Overall Study|COVID-19 infection|1|||
33612801|NCT04274894|63013321|FG000|Overall Study|Other, not specified|20|||
33612802|NCT02213263|63013327|FG000|Overall Study|Insufficient clinical response|4|||
33612803|NCT02213263|63013328|FG001|Overall Study|Insufficient clinical response|3|||
33612804|NCT02213263|63013327|FG000|Overall Study|Lost to Follow-up|0|||
33612805|NCT02213263|63013328|FG001|Overall Study|Lost to Follow-up|1|||
33612806|NCT02213263|63013327|FG000|Overall Study|No longer willing to participate|3|||
33612807|NCT02213263|63013328|FG001|Overall Study|No longer willing to participate|4|||
33612808|NCT02213263|63013327|FG000|Overall Study|Progressive disease|20|||
33612809|NCT02213263|63013328|FG001|Overall Study|Progressive disease|14|||
33508064|NCT02709538|62890819|FG001|Overall Study|Protocol deviation|4|||
33508065|NCT02709538|62890820|FG002|Overall Study|Protocol deviation|4|||
33612810|NCT02213263|63013327|FG000|Overall Study|Protocol Violation|0|||
33612811|NCT02213263|63013328|FG001|Overall Study|Protocol Violation|1|||
33612812|NCT02213263|63013327|FG000|Overall Study|Adverse Event|1|||
33612813|NCT02213263|63013328|FG001|Overall Study|Adverse Event|3|||
33612814|NCT02211313|63013336|FG000|Overall Study|Treatment Failure|5|||
33612815|NCT02211313|63013337|FG001|Overall Study|Treatment Failure|2|||
33612816|NCT02211313|63013336|FG000|Overall Study|No Follow up Questionnaires|1|||
33508066|NCT02709538|62890818|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
33508067|NCT02709538|62890819|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
33508068|NCT02709538|62890820|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
33508069|NCT02709538|62890818|FG000|Overall Study|Other|16|||
33508070|NCT02709538|62890819|FG001|Overall Study|Other|7|||
33508071|NCT02709538|62890820|FG002|Overall Study|Other|5|||
33508072|NCT03789318|62890833|FG000|Overall Study|Adverse Event|0|||
33508073|NCT03789318|62890834|FG001|Overall Study|Adverse Event|0|||
33508074|NCT03789318|62890835|FG002|Overall Study|Adverse Event|1|||
33508075|NCT03789318|62890836|FG003|Overall Study|Adverse Event|1|||
33508076|NCT03789318|62890837|FG004|Overall Study|Adverse Event|0|||
33508077|NCT03789318|62890833|FG000|Overall Study|Lost to Follow-up|0|||
33508078|NCT03789318|62890834|FG001|Overall Study|Lost to Follow-up|0|||
33508079|NCT03789318|62890835|FG002|Overall Study|Lost to Follow-up|1|||
33508080|NCT03789318|62890836|FG003|Overall Study|Lost to Follow-up|0|||
33508081|NCT03789318|62890837|FG004|Overall Study|Lost to Follow-up|0|||
33508082|NCT03789318|62890833|FG000|Overall Study|Withdrawal by Subject|0|||
33508083|NCT03789318|62890834|FG001|Overall Study|Withdrawal by Subject|0|||
33508084|NCT03789318|62890835|FG002|Overall Study|Withdrawal by Subject|1|||
33508085|NCT03789318|62890836|FG003|Overall Study|Withdrawal by Subject|0|||
33508086|NCT03789318|62890837|FG004|Overall Study|Withdrawal by Subject|0|||
33508087|NCT00511134|62890855|FG000|Overall Study|Withdrawal by Subject|0|||
33508088|NCT00511134|62890856|FG001|Overall Study|Withdrawal by Subject|2|||
33508089|NCT01372384|62890862|FG000|Overall Study|Progression of disease|3|||
33508090|NCT03115476|62890869|FG000|LP0084-1369|Death|1|||
33508091|NCT03115476|62890870|FG001|LP0084-1369|Death|0|||
33508092|NCT03115476|62890871|FG002|LP0084-1369|Death|2|||
33508093|NCT03115476|62890869|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
33508094|NCT03115476|62890870|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
33508095|NCT03115476|62890871|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
33508096|NCT03480763|62890881|FG000|Overall Study|Withdrawal by Subject|18|||
33508097|NCT03480763|62890882|FG001|Overall Study|Withdrawal by Subject|10|||
33508098|NCT03480763|62890881|FG000|Overall Study|Lost to Follow-up|4|||
33508099|NCT03480763|62890882|FG001|Overall Study|Lost to Follow-up|7|||
33508100|NCT03480763|62890881|FG000|Overall Study|non-study pneumococcal vaccine|1|||
33508101|NCT03480763|62890882|FG001|Overall Study|non-study pneumococcal vaccine|0|||
33508102|NCT03480763|62890881|FG000|Overall Study|oncological treatment|0|||
33508103|NCT03480763|62890882|FG001|Overall Study|oncological treatment|2|||
33508104|NCT03480763|62890881|FG000|Overall Study|pain with vaccination|1|||
33508105|NCT03480763|62890882|FG001|Overall Study|pain with vaccination|0|||
33508106|NCT03123120|62890896|FG000|Overall Study|Lost to Follow-up|0|||
33508107|NCT03123120|62890897|FG001|Overall Study|Lost to Follow-up|1|||
33508108|NCT03123120|62890896|FG000|Overall Study|Withdrawal by Subject|0|||
33612817|NCT02211313|63013337|FG001|Overall Study|No Follow up Questionnaires|1|||
33612818|NCT02210689|63013346|FG000|Overall Study|Withdrawal by Subject|7|||
33612819|NCT02210689|63013347|FG001|Overall Study|Withdrawal by Subject|4|||
33612820|NCT02210689|63013348|FG002|Overall Study|Withdrawal by Subject|2|||
33612821|NCT02210689|63013346|FG000|Overall Study|Adverse Event|0|||
33612822|NCT02210689|63013347|FG001|Overall Study|Adverse Event|1|||
33612823|NCT02210689|63013348|FG002|Overall Study|Adverse Event|0|||
33508109|NCT03123120|62890897|FG001|Overall Study|Withdrawal by Subject|1|||
33508110|NCT01319994|62890907|FG000|Overall Study|Protocol Violation|7|||
33508111|NCT01319994|62890908|FG001|Overall Study|Protocol Violation|6|||
33508112|NCT03453151|62890918|FG000|Overall Study|Withdrawal by Subject|1|||
33508113|NCT03453151|62890918|FG000|Overall Study|Physician Decision|3|||
33508114|NCT02887248|62890922|FG000|Overall Study|Withdrawal by Subject|1|||
33508115|NCT02887248|62890922|FG000|Overall Study|Adverse Event|1|||
33508116|NCT02887248|62890922|FG000|Overall Study|Progressive Disease|1|||
33508117|NCT03452527|62890928|FG000|Overall Study|Withdrawal by Subject|1|||
33508118|NCT03452527|62890929|FG001|Overall Study|Withdrawal by Subject|1|||
33612824|NCT02210689|63013346|FG000|Overall Study|Protocol Violation|1|||
33508119|NCT03452527|62890928|FG000|Overall Study|Study Terminated|2|||
33508120|NCT03452527|62890929|FG001|Overall Study|Study Terminated|3|||
33508121|NCT03028142|62890935|FG000|Overall Study|Adverse Event|1|||
33612825|NCT02210689|63013347|FG001|Overall Study|Protocol Violation|0|||
33612826|NCT02210689|63013348|FG002|Overall Study|Protocol Violation|0|||
33612827|NCT02210689|63013346|FG000|Overall Study|Lost to Follow-up|11|||
33612828|NCT02210689|63013347|FG001|Overall Study|Lost to Follow-up|9|||
33612829|NCT02210689|63013348|FG002|Overall Study|Lost to Follow-up|5|||
33612830|NCT02210689|63013346|FG000|Overall Study|Pregnancy|0|||
33508122|NCT03028142|62890936|FG001|Overall Study|Adverse Event|1|||
33508123|NCT03028142|62890937|FG002|Overall Study|Adverse Event|0|||
33508124|NCT03028142|62890938|FG003|Overall Study|Adverse Event|0|||
33508125|NCT03028142|62890939|FG004|Overall Study|Adverse Event|0|||
33508126|NCT03028142|62890940|FG005|Overall Study|Adverse Event|1|||
33508127|NCT03028142|62890935|FG000|Overall Study|Withdrawal by Subject|0|||
33508128|NCT03028142|62890936|FG001|Overall Study|Withdrawal by Subject|0|||
33508129|NCT03028142|62890937|FG002|Overall Study|Withdrawal by Subject|0|||
33508130|NCT03028142|62890938|FG003|Overall Study|Withdrawal by Subject|0|||
33508131|NCT03028142|62890939|FG004|Overall Study|Withdrawal by Subject|1|||
33508132|NCT03028142|62890940|FG005|Overall Study|Withdrawal by Subject|0|||
33508133|NCT02708524|62890953|FG000|Overall Study|Adverse Event|0|||
33508134|NCT02708524|62890954|FG001|Overall Study|Adverse Event|1|||
33508135|NCT02708524|62890955|FG002|Overall Study|Adverse Event|0|||
33508136|NCT02708524|62890956|FG003|Overall Study|Adverse Event|0|||
33508137|NCT02708524|62890953|FG000|Overall Study|Lens Discomfort|1|||
33508138|NCT02708524|62890954|FG001|Overall Study|Lens Discomfort|0|||
33508139|NCT02708524|62890955|FG002|Overall Study|Lens Discomfort|1|||
33508140|NCT02708524|62890956|FG003|Overall Study|Lens Discomfort|0|||
33508141|NCT02708524|62890953|FG000|Overall Study|Lost to Follow-up|1|||
33508142|NCT02708524|62890954|FG001|Overall Study|Lost to Follow-up|1|||
33508143|NCT02708524|62890955|FG002|Overall Study|Lost to Follow-up|1|||
33508144|NCT02708524|62890956|FG003|Overall Study|Lost to Follow-up|0|||
33508145|NCT02708524|62890953|FG000|Overall Study|Protocol Violation|0|||
33612831|NCT02210689|63013347|FG001|Overall Study|Pregnancy|1|||
33612832|NCT02210689|63013348|FG002|Overall Study|Pregnancy|0|||
33612833|NCT02210689|63013346|FG000|Overall Study|Lack of Efficacy|0|||
33612834|NCT02210689|63013347|FG001|Overall Study|Lack of Efficacy|1|||
33612835|NCT02210689|63013348|FG002|Overall Study|Lack of Efficacy|5|||
33612836|NCT02210689|63013346|FG000|Overall Study|Prohibited medication|2|||
33612837|NCT02210689|63013347|FG001|Overall Study|Prohibited medication|8|||
33612838|NCT02210689|63013348|FG002|Overall Study|Prohibited medication|1|||
33612839|NCT02210689|63013346|FG000|Overall Study|Negative Nugent score at baseline|6|||
33612840|NCT02210689|63013347|FG001|Overall Study|Negative Nugent score at baseline|2|||
33508146|NCT02708524|62890954|FG001|Overall Study|Protocol Violation|1|||
33508147|NCT02708524|62890955|FG002|Overall Study|Protocol Violation|0|||
33508148|NCT02708524|62890956|FG003|Overall Study|Protocol Violation|0|||
33508149|NCT02708524|62890953|FG000|Overall Study|Withdrawal by Subject|1|||
33508150|NCT02708524|62890954|FG001|Overall Study|Withdrawal by Subject|1|||
33508151|NCT02708524|62890955|FG002|Overall Study|Withdrawal by Subject|0|||
33508152|NCT02708524|62890956|FG003|Overall Study|Withdrawal by Subject|0|||
33612841|NCT02210689|63013348|FG002|Overall Study|Negative Nugent score at baseline|2|||
33451227|NCT00168818|62825923|FG000|Overall Study|Adverse Event|23|||
33451228|NCT00168818|62825924|FG001|Overall Study|Adverse Event|29|||
33451229|NCT00168818|62825925|FG002|Overall Study|Adverse Event|31|||
33451230|NCT00168818|62825923|FG000|Overall Study|Protocol Violation|16|||
33451231|NCT00168818|62825924|FG001|Overall Study|Protocol Violation|11|||
33451232|NCT00168818|62825925|FG002|Overall Study|Protocol Violation|11|||
33451233|NCT00168818|62825923|FG000|Overall Study|Lost to Follow-up|13|||
33451234|NCT00168818|62825924|FG001|Overall Study|Lost to Follow-up|4|||
33508153|NCT02708524|62890953|FG000|Overall Study|Dispensed incorrect study lens|0|||
33508154|NCT02708524|62890954|FG001|Overall Study|Dispensed incorrect study lens|1|||
33508155|NCT02708524|62890955|FG002|Overall Study|Dispensed incorrect study lens|1|||
33508156|NCT02708524|62890956|FG003|Overall Study|Dispensed incorrect study lens|0|||
33612842|NCT02210689|63013346|FG000|Overall Study|Other|25|||
33612843|NCT02210689|63013347|FG001|Overall Study|Other|21|||
33508157|NCT02708524|62890953|FG000|Overall Study|Did not wear lens at final visit|0|||
33508158|NCT02708524|62890954|FG001|Overall Study|Did not wear lens at final visit|1|||
33508159|NCT02708524|62890955|FG002|Overall Study|Did not wear lens at final visit|0|||
33508160|NCT02708524|62890956|FG003|Overall Study|Did not wear lens at final visit|0|||
33508161|NCT02708524|62890953|FG000|Overall Study|Subject lost study lens|1|||
33612844|NCT02210689|63013348|FG002|Overall Study|Other|8|||
33451235|NCT00168818|62825925|FG002|Overall Study|Lost to Follow-up|15|||
33451236|NCT00168818|62825923|FG000|Overall Study|Withdrawal by Subject|43|||
33508162|NCT02708524|62890954|FG001|Overall Study|Subject lost study lens|0|||
33508163|NCT02708524|62890955|FG002|Overall Study|Subject lost study lens|0|||
33508164|NCT02708524|62890956|FG003|Overall Study|Subject lost study lens|0|||
33508165|NCT03418675|62890968|FG000|Overall Study|Lost to Follow-up|13|||
33508166|NCT03418675|62890969|FG001|Overall Study|Lost to Follow-up|10|||
33508167|NCT03418675|62890968|FG000|Overall Study|Adverse Event|2|||
33612845|NCT02209597|63013356|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
33612846|NCT02209597|63013356|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
33451237|NCT00168818|62825924|FG001|Overall Study|Withdrawal by Subject|41|||
33612847|NCT02209597|63013356|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
33612848|NCT02209597|63013356|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
33612849|NCT02188303|63013385|FG000|Overall Study|Adverse Event|0|||
33612850|NCT02188303|63013386|FG001|Overall Study|Adverse Event|0|||
33612851|NCT02188303|63013387|FG002|Overall Study|Adverse Event|0|||
33612852|NCT02188303|63013388|FG003|Overall Study|Adverse Event|0|||
33612853|NCT02188303|63013389|FG004|Overall Study|Adverse Event|0|||
33612854|NCT02188303|63013390|FG005|Overall Study|Adverse Event|2|||
33451238|NCT00168818|62825925|FG002|Overall Study|Withdrawal by Subject|37|||
33451239|NCT00168818|62825923|FG000|Overall Study|Other|22|||
33451240|NCT00168818|62825924|FG001|Overall Study|Other|24|||
33451241|NCT00168818|62825925|FG002|Overall Study|Other|30|||
33451242|NCT00168818|62825923|FG000|Treatment|Adverse Event|77|||
33451243|NCT00168818|62825924|FG001|Treatment|Adverse Event|89|||
33451244|NCT00168818|62825925|FG002|Treatment|Adverse Event|68|||
33451245|NCT00168818|62825923|FG000|Treatment|Protocol Violation|8|||
33451246|NCT00168818|62825924|FG001|Treatment|Protocol Violation|11|||
33451247|NCT00168818|62825925|FG002|Treatment|Protocol Violation|11|||
33451248|NCT00168818|62825923|FG000|Treatment|Lost to Follow-up|0|||
33451249|NCT00168818|62825924|FG001|Treatment|Lost to Follow-up|2|||
33451250|NCT00168818|62825925|FG002|Treatment|Lost to Follow-up|1|||
33451251|NCT00168818|62825923|FG000|Treatment|Withdrawal by Subject|25|||
33451252|NCT00168818|62825924|FG001|Treatment|Withdrawal by Subject|20|||
33451253|NCT00168818|62825925|FG002|Treatment|Withdrawal by Subject|22|||
33451254|NCT00168818|62825923|FG000|Treatment|Other|23|||
33451255|NCT00168818|62825924|FG001|Treatment|Other|29|||
33451256|NCT00168818|62825925|FG002|Treatment|Other|31|||
33451257|NCT00260832|62825935|FG000|Overall Study|Adverse Event|26|||
33451258|NCT00260832|62825936|FG001|Overall Study|Adverse Event|19|||
33451259|NCT00260832|62825935|FG000|Overall Study|Progression|116|||
33451260|NCT00260832|62825936|FG001|Overall Study|Progression|96|||
33451261|NCT00260832|62825935|FG000|Overall Study|Withdrawal by Subject|15|||
33508168|NCT03418675|62890969|FG001|Overall Study|Adverse Event|0|||
33612855|NCT02188303|63013391|FG006|Overall Study|Adverse Event|0|||
33451262|NCT00260832|62825936|FG001|Overall Study|Withdrawal by Subject|17|||
33451263|NCT00260832|62825935|FG000|Overall Study|Physician Decision|15|||
33451264|NCT00260832|62825936|FG001|Overall Study|Physician Decision|9|||
33451265|NCT00260832|62825935|FG000|Overall Study|Death|43|||
33508169|NCT03417505|62890986|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
33508170|NCT03417505|62890987|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
33612856|NCT02188303|63013392|FG007|Overall Study|Adverse Event|2|||
33451266|NCT00260832|62825936|FG001|Overall Study|Death|62|||
33451267|NCT00260832|62825935|FG000|Overall Study|Other|10|||
33451268|NCT00260832|62825936|FG001|Overall Study|Other|7|||
33508171|NCT02953639|62890996|FG000|Overall Study|Adverse Event|2|||
33508172|NCT02953639|62890997|FG001|Overall Study|Adverse Event|0|||
33508173|NCT02953639|62890998|FG002|Overall Study|Adverse Event|1|||
33508174|NCT02953639|62890996|FG000|Overall Study|Lost to Follow-up|8|||
33508175|NCT02953639|62890997|FG001|Overall Study|Lost to Follow-up|4|||
33508176|NCT02953639|62890998|FG002|Overall Study|Lost to Follow-up|3|||
33508177|NCT02953639|62890996|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33508178|NCT02953639|62890997|FG001|Overall Study|Non-Compliance With Study Drug|2|||
33508179|NCT02953639|62890998|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33508180|NCT02953639|62890996|FG000|Overall Study|Multiple Reasons|1|||
33508181|NCT02953639|62890997|FG001|Overall Study|Multiple Reasons|0|||
33508182|NCT02953639|62890998|FG002|Overall Study|Multiple Reasons|1|||
33508183|NCT02953639|62890996|FG000|Overall Study|Physician Decision|1|||
33508184|NCT02953639|62890997|FG001|Overall Study|Physician Decision|0|||
33508185|NCT02953639|62890998|FG002|Overall Study|Physician Decision|0|||
33508186|NCT02953639|62890996|FG000|Overall Study|Withdrawal by Subject|7|||
33508187|NCT02953639|62890997|FG001|Overall Study|Withdrawal by Subject|8|||
33508188|NCT02953639|62890998|FG002|Overall Study|Withdrawal by Subject|10|||
33508189|NCT02953639|62890996|FG000|Overall Study|Completed or Discontinued information is missing|1|||
33508190|NCT02953639|62890997|FG001|Overall Study|Completed or Discontinued information is missing|0|||
33508191|NCT02953639|62890998|FG002|Overall Study|Completed or Discontinued information is missing|0|||
33508192|NCT04147715|62891020|FG000|Overall Study|Adverse Event|0|||
33508193|NCT04147715|62891021|FG001|Overall Study|Adverse Event|0|||
33508194|NCT04147715|62891022|FG002|Overall Study|Adverse Event|0|||
33508195|NCT04147715|62891023|FG003|Overall Study|Adverse Event|0|||
33508196|NCT04147715|62891024|FG004|Overall Study|Adverse Event|0|||
33508197|NCT04147715|62891025|FG005|Overall Study|Adverse Event|0|||
33508198|NCT04147715|62891026|FG006|Overall Study|Adverse Event|0|||
33508199|NCT04147715|62891027|FG007|Overall Study|Adverse Event|2|||
33508200|NCT04147715|62891028|FG008|Overall Study|Adverse Event|1|||
33508201|NCT04147715|62891029|FG009|Overall Study|Adverse Event|0|||
33508202|NCT04147715|62891030|FG010|Overall Study|Adverse Event|0|||
33508203|NCT04147715|62891031|FG011|Overall Study|Adverse Event|0|||
33508204|NCT02452554|62891118|FG000|Overall Study|Death|2|||
33508205|NCT02452554|62891119|FG001|Overall Study|Death|1|||
33508206|NCT02452554|62891120|FG002|Overall Study|Death|0|||
33508207|NCT02452554|62891121|FG003|Overall Study|Death|0|||
33508208|NCT02452554|62891122|FG004|Overall Study|Death|0|||
33508209|NCT02452554|62891123|FG005|Overall Study|Death|0|||
33451269|NCT00260832|62825935|FG000|Overall Study|Protocol Violation|3|||
33451270|NCT00260832|62825936|FG001|Overall Study|Protocol Violation|1|||
33508210|NCT02452554|62891118|FG000|Overall Study|Lack of Efficacy|13|||
33508211|NCT02452554|62891119|FG001|Overall Study|Lack of Efficacy|14|||
33508212|NCT02452554|62891120|FG002|Overall Study|Lack of Efficacy|9|||
33508213|NCT02452554|62891121|FG003|Overall Study|Lack of Efficacy|1|||
33508214|NCT02452554|62891122|FG004|Overall Study|Lack of Efficacy|5|||
33451271|NCT00168038|62825942|FG000|Overall Study|Adverse Event|1|||
33451272|NCT00168038|62825942|FG000|Overall Study|Therapy failure|1|||
33451273|NCT00167414|62825946|FG000|Overall Study|Death|10|||
33451274|NCT00166712|62825952|FG000|Overall Study|Death|0|||
33451275|NCT00166712|62825953|FG001|Overall Study|Death|1|||
33451276|NCT00166712|62825952|FG000|Overall Study|Adverse Event|1|||
33451277|NCT00166712|62825953|FG001|Overall Study|Adverse Event|0|||
33451278|NCT00166712|62825952|FG000|Overall Study|Withdrawal by Subject|1|||
33451279|NCT00166712|62825953|FG001|Overall Study|Withdrawal by Subject|2|||
33451280|NCT00166712|62825952|FG000|Overall Study|Physician Decision|0|||
33451281|NCT00166712|62825953|FG001|Overall Study|Physician Decision|2|||
33451282|NCT00073528|62825965|FG000|Overall Study|Death|488|||
33451283|NCT00073528|62825966|FG001|Overall Study|Death|473|||
33451284|NCT00073528|62825965|FG000|Overall Study|Lost to Follow-up|52|||
33451285|NCT00073528|62825966|FG001|Overall Study|Lost to Follow-up|45|||
33508215|NCT02452554|62891123|FG005|Overall Study|Lack of Efficacy|8|||
33508216|NCT02452554|62891118|FG000|Overall Study|Physician Decision|0|||
33508217|NCT02452554|62891119|FG001|Overall Study|Physician Decision|1|||
33451286|NCT00073528|62825965|FG000|Overall Study|Withdrawal by Subject|50|||
33508218|NCT02452554|62891120|FG002|Overall Study|Physician Decision|0|||
33508219|NCT02452554|62891121|FG003|Overall Study|Physician Decision|0|||
33508220|NCT02452554|62891122|FG004|Overall Study|Physician Decision|0|||
33508221|NCT02452554|62891123|FG005|Overall Study|Physician Decision|0|||
33508222|NCT02452554|62891118|FG000|Overall Study|Withdrawal by Subject|1|||
33508223|NCT02452554|62891119|FG001|Overall Study|Withdrawal by Subject|0|||
33508224|NCT02452554|62891120|FG002|Overall Study|Withdrawal by Subject|2|||
33508225|NCT02452554|62891121|FG003|Overall Study|Withdrawal by Subject|0|||
33451287|NCT00073528|62825966|FG001|Overall Study|Withdrawal by Subject|45|||
33451288|NCT00073528|62825965|FG000|Overall Study|Study terminated by Sponsor|10|||
33451289|NCT00073528|62825966|FG001|Overall Study|Study terminated by Sponsor|29|||
33508226|NCT02452554|62891122|FG004|Overall Study|Withdrawal by Subject|0|||
33508227|NCT02452554|62891123|FG005|Overall Study|Withdrawal by Subject|1|||
33451290|NCT00073528|62825965|FG000|Overall Study|Other|18|||
33508228|NCT02452554|62891118|FG000|Overall Study|Ineligible|0|||
33612857|NCT02188303|63013385|FG000|Overall Study|Dose Termination Criteria Met|0|||
33612858|NCT02188303|63013386|FG001|Overall Study|Dose Termination Criteria Met|0|||
33612859|NCT02188303|63013387|FG002|Overall Study|Dose Termination Criteria Met|0|||
33612860|NCT02188303|63013388|FG003|Overall Study|Dose Termination Criteria Met|0|||
33612861|NCT02188303|63013389|FG004|Overall Study|Dose Termination Criteria Met|0|||
33612862|NCT02188303|63013390|FG005|Overall Study|Dose Termination Criteria Met|0|||
33612863|NCT02188303|63013391|FG006|Overall Study|Dose Termination Criteria Met|2|||
33612864|NCT02188303|63013392|FG007|Overall Study|Dose Termination Criteria Met|4|||
33612865|NCT04867382|63013428|FG000|Overall Study|Did not complete the survey|2|||
33612866|NCT04867382|63013429|FG001|Overall Study|Did not complete the survey|1|||
33612867|NCT02187055|63013438|FG000|Overall Study|Lack of Efficacy|10|||
33612868|NCT02187055|63013439|FG001|Overall Study|Lack of Efficacy|3|||
33612869|NCT02187055|63013440|FG002|Overall Study|Lack of Efficacy|7|||
33612870|NCT02187055|63013438|FG000|Overall Study|Lost to Follow-up|2|||
33612871|NCT02187055|63013439|FG001|Overall Study|Lost to Follow-up|7|||
33612872|NCT02187055|63013440|FG002|Overall Study|Lost to Follow-up|3|||
33612873|NCT02187055|63013438|FG000|Overall Study|No longer meets eligibility criteria|0|||
33612874|NCT02187055|63013439|FG001|Overall Study|No longer meets eligibility criteria|2|||
33612875|NCT02187055|63013440|FG002|Overall Study|No longer meets eligibility criteria|0|||
33612876|NCT02187055|63013438|FG000|Overall Study|No longer willing to participate|6|||
33612877|NCT02187055|63013439|FG001|Overall Study|No longer willing to participate|8|||
33612878|NCT02187055|63013440|FG002|Overall Study|No longer willing to participate|10|||
33612879|NCT02187055|63013438|FG000|Overall Study|Other|5|||
33612880|NCT02187055|63013439|FG001|Overall Study|Other|6|||
33612881|NCT02187055|63013440|FG002|Overall Study|Other|3|||
33612882|NCT02187055|63013438|FG000|Overall Study|Protocol Violation|9|||
33612883|NCT02187055|63013439|FG001|Overall Study|Protocol Violation|9|||
33612884|NCT02187055|63013440|FG002|Overall Study|Protocol Violation|4|||
33612885|NCT02187055|63013438|FG000|Overall Study|Pregnancy|3|||
33612886|NCT02187055|63013439|FG001|Overall Study|Pregnancy|1|||
33612887|NCT02187055|63013440|FG002|Overall Study|Pregnancy|0|||
33612888|NCT02187055|63013438|FG000|Overall Study|Withdrawal by Subject|11|||
33612889|NCT02187055|63013439|FG001|Overall Study|Withdrawal by Subject|11|||
33612890|NCT02187055|63013440|FG002|Overall Study|Withdrawal by Subject|11|||
33612891|NCT02187055|63013438|FG000|Overall Study|Adverse Event|21|||
33612892|NCT02187055|63013439|FG001|Overall Study|Adverse Event|26|||
33612893|NCT02187055|63013440|FG002|Overall Study|Adverse Event|36|||
33612894|NCT02187055|63013438|FG000|Overall Study|Death|2|||
33612895|NCT02187055|63013439|FG001|Overall Study|Death|0|||
33612896|NCT02187055|63013440|FG002|Overall Study|Death|0|||
33612897|NCT02246660|63013480|FG000|Overall Study|Withdrawal by Subject|0|||
33612898|NCT02246660|63013481|FG001|Overall Study|Withdrawal by Subject|1|||
33612899|NCT02246660|63013482|FG002|Overall Study|Withdrawal by Subject|0|||
33612900|NCT02246660|63013480|FG000|Overall Study|Death|0|||
33612901|NCT02246660|63013481|FG001|Overall Study|Death|0|||
33612902|NCT02246660|63013482|FG002|Overall Study|Death|1|||
33612903|NCT02246582|63013490|FG000|Overall Study|Withdrawal by Subject|3|||
33612904|NCT02246582|63013491|FG001|Overall Study|Withdrawal by Subject|4|||
33612905|NCT02137369|63013497|FG000|Overall Study|Withdrawal by Subject|3|||
33612906|NCT02137369|63013498|FG001|Overall Study|Withdrawal by Subject|2|||
33612907|NCT02137369|63013497|FG000|Overall Study|Adverse Event|2|||
33612908|NCT02137369|63013498|FG001|Overall Study|Adverse Event|0|||
33612909|NCT02137369|63013497|FG000|Overall Study|Lost to Follow-up|1|||
33612910|NCT02137369|63013498|FG001|Overall Study|Lost to Follow-up|0|||
33612911|NCT02137369|63013497|FG000|Overall Study|Moved away|2|||
33612912|NCT02137369|63013498|FG001|Overall Study|Moved away|0|||
33612913|NCT02155309|63013507|FG000|Overall Study|Protocol Violation|0|||
33612914|NCT02155309|63013508|FG001|Overall Study|Protocol Violation|0|||
33612915|NCT02155309|63013509|FG002|Overall Study|Protocol Violation|1|||
33612916|NCT02186821|63013516|FG000|Overall Study|Adverse Event|9|||
33612917|NCT02186821|63013516|FG000|Overall Study|Death|2|||
33612918|NCT02186821|63013516|FG000|Overall Study|Disease progression|32|||
33612919|NCT02186821|63013516|FG000|Overall Study|Protocol Violation|1|||
33612920|NCT02186821|63013516|FG000|Overall Study|Physician Decision|1|||
33612921|NCT02186821|63013516|FG000|Overall Study|Study terminated by sponsor|2|||
33612922|NCT01710358|63013523|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
33612923|NCT01710358|63013524|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
33612924|NCT01710358|63013525|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
33612925|NCT01710358|63013523|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
33612926|NCT01710358|63013524|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
33612927|NCT01710358|63013525|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
33612928|NCT01710358|63013523|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
33612929|NCT01710358|63013524|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
33612930|NCT01710358|63013525|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
33612931|NCT01710358|63013523|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
33508229|NCT02452554|62891119|FG001|Overall Study|Ineligible|1|||
33508230|NCT02452554|62891120|FG002|Overall Study|Ineligible|0|||
33508231|NCT02452554|62891121|FG003|Overall Study|Ineligible|0|||
33508232|NCT02452554|62891122|FG004|Overall Study|Ineligible|0|||
33508233|NCT02452554|62891123|FG005|Overall Study|Ineligible|0|||
33508234|NCT02452554|62891118|FG000|Overall Study|Never Received Treatment|1|||
33508235|NCT02452554|62891119|FG001|Overall Study|Never Received Treatment|0|||
33508236|NCT02452554|62891120|FG002|Overall Study|Never Received Treatment|0|||
33508237|NCT02452554|62891121|FG003|Overall Study|Never Received Treatment|0|||
33508238|NCT02452554|62891122|FG004|Overall Study|Never Received Treatment|0|||
33508239|NCT02452554|62891123|FG005|Overall Study|Never Received Treatment|0|||
33508240|NCT04009577|62891142|FG000|Core Study|Adverse Event|1|||
33508241|NCT04009577|62891143|FG001|Core Study|Adverse Event|0|||
33508242|NCT04009577|62891144|FG002|Core Study|Adverse Event|2|||
33508243|NCT04009577|62891145|FG003|Core Study|Adverse Event|4|||
33508244|NCT04009577|62891142|FG000|Core Study|Withdrawal by Subject|0|||
33508245|NCT04009577|62891143|FG001|Core Study|Withdrawal by Subject|0|||
33508246|NCT04009577|62891144|FG002|Core Study|Withdrawal by Subject|2|||
33508247|NCT04009577|62891145|FG003|Core Study|Withdrawal by Subject|0|||
33508248|NCT04009577|62891142|FG000|Core Study|Other|0|||
33508249|NCT04009577|62891143|FG001|Core Study|Other|0|||
33508250|NCT04009577|62891144|FG002|Core Study|Other|0|||
33508251|NCT04009577|62891145|FG003|Core Study|Other|1|||
33508252|NCT04009577|62891142|FG000|Extension Phase|Adverse Event|0|||
33508253|NCT04009577|62891143|FG001|Extension Phase|Adverse Event|0|||
33508254|NCT04009577|62891144|FG002|Extension Phase|Adverse Event|0|||
33508255|NCT04009577|62891145|FG003|Extension Phase|Adverse Event|1|||
33508256|NCT04009577|62891142|FG000|Extension Phase|Inadequate therapeutic effect|0|||
33508257|NCT04009577|62891143|FG001|Extension Phase|Inadequate therapeutic effect|0|||
33508258|NCT04009577|62891144|FG002|Extension Phase|Inadequate therapeutic effect|1|||
33508259|NCT04009577|62891145|FG003|Extension Phase|Inadequate therapeutic effect|0|||
33508260|NCT04009577|62891142|FG000|Extension Phase|Withdrawal by Subject|0|||
33508261|NCT04009577|62891143|FG001|Extension Phase|Withdrawal by Subject|0|||
33508262|NCT04009577|62891144|FG002|Extension Phase|Withdrawal by Subject|1|||
33508263|NCT04009577|62891145|FG003|Extension Phase|Withdrawal by Subject|0|||
33508264|NCT04009577|62891142|FG000|Extension Phase|Not Treated|0|||
33508265|NCT04009577|62891143|FG001|Extension Phase|Not Treated|0|||
33508266|NCT04009577|62891144|FG002|Extension Phase|Not Treated|2|||
33508267|NCT04009577|62891145|FG003|Extension Phase|Not Treated|0|||
33508268|NCT04146467|62891173|FG000|Overall Study|Adverse Event|0|||
33508269|NCT04146467|62891174|FG001|Overall Study|Adverse Event|1|||
33508270|NCT04146467|62891173|FG000|Overall Study|Lost to Follow-up|0|||
33508271|NCT04146467|62891174|FG001|Overall Study|Lost to Follow-up|2|||
33508272|NCT02705716|62891185|FG000|Overall Study|Adverse Event|0|||
33508273|NCT02705716|62891186|FG001|Overall Study|Adverse Event|1|||
33508274|NCT02705716|62891185|FG000|Overall Study|Protocol Violation|3|||
33508275|NCT02705716|62891186|FG001|Overall Study|Protocol Violation|0|||
33508276|NCT02705716|62891185|FG000|Overall Study|Withdrawal of Consent|1|||
33451291|NCT00073528|62825966|FG001|Overall Study|Other|19|||
33451292|NCT00073528|62825965|FG000|Overall Study|Other|9|||
33451293|NCT00073528|62825966|FG001|Overall Study|Other|12|||
33451294|NCT00073528|62825965|FG000|Overall Study|Protocol Violation|3|||
33451295|NCT00073528|62825966|FG001|Overall Study|Protocol Violation|5|||
33451296|NCT03801148|62825976|FG000|Period 1 (2 Days)|Adverse Event|1|||
33451297|NCT03801148|62825977|FG001|Period 1 (2 Days)|Adverse Event|1|||
33451298|NCT03801148|62825978|FG002|Period 1 (2 Days)|Adverse Event|0|||
33451299|NCT03801148|62825979|FG003|Period 1 (2 Days)|Adverse Event|0|||
33508277|NCT02705716|62891186|FG001|Overall Study|Withdrawal of Consent|1|||
33508278|NCT04138043|62891194|FG000|Overall Study|Withdrawal by Subject|0|||
33508279|NCT04138043|62891195|FG001|Overall Study|Withdrawal by Subject|1|||
33508280|NCT03443713|62891214|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
33508281|NCT03443713|62891215|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
33508282|NCT03443713|62891216|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
33508283|NCT04133519|62891230|FG000|Overall Study|Withdrawal by Subject|5|||
33508284|NCT04133519|62891231|FG001|Overall Study|Withdrawal by Subject|4|||
33451300|NCT03801148|62825976|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
33508285|NCT04133519|62891230|FG000|Overall Study|Protocol Violation|0|||
33508286|NCT04133519|62891231|FG001|Overall Study|Protocol Violation|1|||
33508287|NCT04133519|62891230|FG000|Overall Study|Never started treatment|1|||
33508288|NCT04133519|62891231|FG001|Overall Study|Never started treatment|1|||
33508289|NCT04007159|62891237|FG000|Induction Phase|(missed study visits)|16|||
33508290|NCT04007159|62891237|FG000|Induction Phase|Withdrawal by Subject|4|||
33508291|NCT04007159|62891237|FG000|Induction Phase|Adverse Event|2|||
33508292|NCT04007159|62891237|FG000|Challenge Phase|missed study visits|3|||
33508293|NCT03119688|62891248|FG000|Overall Study|Adverse Event|4|||
33508294|NCT03389893|62891267|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
33508295|NCT03389893|62891268|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
33508296|NCT03389893|62891269|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
33508297|NCT03389893|62891270|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
33508298|NCT03389893|62891267|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
33508299|NCT03389893|62891268|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
33508300|NCT03389893|62891269|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
33508301|NCT03389893|62891270|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
33508302|NCT03389893|62891267|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
33508303|NCT03389893|62891268|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
33508304|NCT03389893|62891269|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
33508305|NCT03389893|62891270|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
33508306|NCT03389893|62891267|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
33508307|NCT03389893|62891268|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
33508308|NCT03389893|62891269|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
33508309|NCT03389893|62891270|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
33508310|NCT04128293|62891280|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
33508311|NCT04128293|62891281|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
33508312|NCT04128293|62891282|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
33508313|NCT04128293|62891283|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
33508314|NCT00787176|62891302|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
33508315|NCT00787176|62891303|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
33508316|NCT00787176|62891304|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
33508317|NCT00787176|62891305|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
33508318|NCT03691571|62891318|FG000|Overall Study|Withdrawal by Subject|9|||
33508319|NCT03691571|62891319|FG001|Overall Study|Withdrawal by Subject|2|||
33508320|NCT03113916|62891328|FG000|Overall Study|Withdrawal by Subject|9|||
33508321|NCT03113916|62891329|FG001|Overall Study|Withdrawal by Subject|7|||
33508322|NCT03113916|62891328|FG000|Overall Study|Pregnancy|1|||
33508323|NCT03113916|62891329|FG001|Overall Study|Pregnancy|3|||
33508324|NCT03113916|62891328|FG000|Overall Study|Lost to Follow-up|1|||
33508325|NCT03113916|62891329|FG001|Overall Study|Lost to Follow-up|2|||
33508326|NCT02925494|62891344|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
33508327|NCT02925494|62891345|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
33508328|NCT02925494|62891346|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
33508329|NCT02925494|62891347|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
33508330|NCT02925494|62891344|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
33508331|NCT02925494|62891345|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
33508332|NCT02925494|62891346|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
33508333|NCT02925494|62891347|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
33508334|NCT02925494|62891344|FG000|Post-Treatment Follow-Up Period|Other|1|||
33508335|NCT02925494|62891345|FG001|Post-Treatment Follow-Up Period|Other|4|||
33508336|NCT02925494|62891346|FG002|Post-Treatment Follow-Up Period|Other|3|||
33508337|NCT02925494|62891347|FG003|Post-Treatment Follow-Up Period|Other|6|||
33544099|NCT01661140|62934936|FG000|Open-Label Period|Sponsor termination|16|||
33544100|NCT01661140|62934937|FG001|Open-Label Period|Sponsor termination|0|||
33544101|NCT01661140|62934938|FG002|Open-Label Period|Sponsor termination|0|||
33544102|NCT01661140|62934936|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
33544103|NCT01661140|62934937|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
33508338|NCT02925494|62891344|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
33612932|NCT01710358|63013524|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
33612933|NCT01710358|63013525|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
33612934|NCT01710358|63013523|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
33612935|NCT01710358|63013524|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
33612936|NCT01710358|63013525|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
33612937|NCT01710358|63013523|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
33612938|NCT01710358|63013524|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
33612939|NCT01710358|63013525|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
33508339|NCT02925494|62891345|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
33508340|NCT02925494|62891346|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
33508341|NCT02925494|62891347|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
33508342|NCT02925494|62891344|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
33508343|NCT02925494|62891345|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
33508344|NCT02925494|62891346|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
33508345|NCT02925494|62891347|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
33508346|NCT02925494|62891344|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
33508347|NCT02925494|62891345|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
33508348|NCT02925494|62891346|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
33508349|NCT02925494|62891347|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
33508350|NCT02925494|62891344|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
33508351|NCT02925494|62891345|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
33508352|NCT02925494|62891346|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
33508353|NCT02925494|62891347|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
33508354|NCT04006145|62891360|FG000|Overall Study|Lost to Follow-up|0|||
33508355|NCT04006145|62891361|FG001|Overall Study|Lost to Follow-up|1|||
33508356|NCT04006145|62891360|FG000|Overall Study|Other|1|||
33508357|NCT04006145|62891361|FG001|Overall Study|Other|2|||
33508358|NCT03386773|62891369|FG000|Overall Study|Lost to Follow-up|24|||
33508359|NCT03386773|62891370|FG001|Overall Study|Lost to Follow-up|33|||
33508360|NCT03386773|62891369|FG000|Overall Study|Withdrawal by Subject|3|||
33508361|NCT03386773|62891370|FG001|Overall Study|Withdrawal by Subject|2|||
33508362|NCT04126343|62891382|FG000|Overall Study|Adverse Event|0|||
33612940|NCT01710358|63013523|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
33612941|NCT01710358|63013524|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
33612942|NCT01710358|63013525|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
33612943|NCT01710358|63013523|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
33612944|NCT01710358|63013524|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
33612945|NCT01710358|63013525|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
33612946|NCT01710358|63013523|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
33612947|NCT01710358|63013524|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
33451301|NCT03801148|62825977|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
33451302|NCT03801148|62825978|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
33451303|NCT03801148|62825979|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
33451304|NCT03801148|62825976|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33451305|NCT03801148|62825977|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33451306|NCT03801148|62825978|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
33451307|NCT03801148|62825979|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33451308|NCT03801148|62825976|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
33451309|NCT03801148|62825977|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
33451310|NCT03801148|62825978|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
33451311|NCT03801148|62825979|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
33451312|NCT00072280|62825991|FG000|Treatment|Found ineligible|1|||
33451313|NCT00072280|62825992|FG001|Treatment|Found ineligible|2|||
33451314|NCT00072280|62825991|FG000|Follow-up|Early termination of study|2|||
33451315|NCT00072280|62825992|FG001|Follow-up|Early termination of study|2|||
33451316|NCT00071812|62826001|FG000|24-Week Double-Blind Period|Adverse Event|2|||
33451317|NCT00071812|62826002|FG001|24-Week Double-Blind Period|Adverse Event|3|||
33451318|NCT00071812|62826003|FG002|24-Week Double-Blind Period|Adverse Event|4|||
33451319|NCT00071812|62826004|FG003|24-Week Double-Blind Period|Adverse Event|4|||
33451320|NCT00071812|62826001|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
33451321|NCT00071812|62826002|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
33451322|NCT00071812|62826003|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
33451323|NCT00071812|62826004|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
33451324|NCT00071812|62826001|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
33508363|NCT04126343|62891383|FG001|Overall Study|Adverse Event|0|||
33508364|NCT04126343|62891384|FG002|Overall Study|Adverse Event|0|||
33508365|NCT04126343|62891385|FG003|Overall Study|Adverse Event|0|||
33508366|NCT04126343|62891386|FG004|Overall Study|Adverse Event|0|||
33508367|NCT04126343|62891387|FG005|Overall Study|Adverse Event|1|||
33508368|NCT04126343|62891382|FG000|Overall Study|Withdrawal by Subject|0|||
33508369|NCT04126343|62891383|FG001|Overall Study|Withdrawal by Subject|0|||
33508370|NCT04126343|62891384|FG002|Overall Study|Withdrawal by Subject|0|||
33508371|NCT04126343|62891385|FG003|Overall Study|Withdrawal by Subject|1|||
33508372|NCT04126343|62891386|FG004|Overall Study|Withdrawal by Subject|0|||
33508373|NCT04126343|62891387|FG005|Overall Study|Withdrawal by Subject|0|||
33508374|NCT04126343|62891382|FG000|Overall Study|Related to COVID-19 pandemic|3|||
33508375|NCT04126343|62891383|FG001|Overall Study|Related to COVID-19 pandemic|4|||
33508376|NCT04126343|62891384|FG002|Overall Study|Related to COVID-19 pandemic|3|||
33508377|NCT04126343|62891385|FG003|Overall Study|Related to COVID-19 pandemic|3|||
33508378|NCT04126343|62891386|FG004|Overall Study|Related to COVID-19 pandemic|3|||
33508379|NCT04126343|62891387|FG005|Overall Study|Related to COVID-19 pandemic|3|||
33508380|NCT02952313|62891402|FG000|Primary Endpoint|Lost to Follow-up|4|||
33508381|NCT02952313|62891402|FG000|Primary Endpoint|Withdrawal by Subject|1|||
33508382|NCT02952313|62891402|FG000|Primary Endpoint|Lack of Efficacy|1|||
33508383|NCT02952313|62891402|FG000|Primary Endpoint|Missed visit|1|||
33508384|NCT02952313|62891402|FG000|Long-term Follow-up|Lost to Follow-up|12|||
33508385|NCT02952313|62891402|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
33508386|NCT02952313|62891402|FG000|Long-term Follow-up|Lack of Efficacy|6|||
33508387|NCT02952313|62891402|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
33508388|NCT02952313|62891402|FG000|Long-term Follow-up|Physician Decision|1|||
33508389|NCT02952313|62891402|FG000|Long-term Follow-up|Death|1|||
33508390|NCT03119610|62891409|FG000|Overall Study|Adverse Event|1|||
33508391|NCT03119610|62891410|FG001|Overall Study|Adverse Event|0|||
33508392|NCT03119610|62891409|FG000|Overall Study|Lost to Follow-up|0|||
33612948|NCT01710358|63013525|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
33612949|NCT01710358|63013523|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
33612950|NCT01710358|63013524|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
33612951|NCT01710358|63013525|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
33612952|NCT01710358|63013523|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
33612953|NCT01710358|63013524|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
33612954|NCT01710358|63013525|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
33612955|NCT01710358|63013523|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
33612956|NCT01710358|63013524|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
33612957|NCT01710358|63013525|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
33612958|NCT01710358|63013523|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
33612959|NCT01710358|63013524|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
33612960|NCT01710358|63013525|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
33612961|NCT01710358|63013523|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
33612962|NCT01710358|63013524|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
33508393|NCT03119610|62891410|FG001|Overall Study|Lost to Follow-up|1|||
33508394|NCT04005755|62891416|FG000|Overall Study|Adverse Event|6|||
33508395|NCT04005755|62891416|FG000|Overall Study|Physician Decision|3|||
33508396|NCT04005755|62891416|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
33508397|NCT04005755|62891416|FG000|Overall Study|Withdrawal by Subject|3|||
33508398|NCT04005755|62891416|FG000|Overall Study|Lost to Follow-up|1|||
33508399|NCT03442777|62891423|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
33508400|NCT03442777|62891424|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
33508401|NCT03442777|62891425|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
33508402|NCT03401749|62891434|FG000|Overall Study|Lost to Follow-up|20|||
33508403|NCT03401749|62891435|FG001|Overall Study|Lost to Follow-up|16|||
33508404|NCT03401749|62891436|FG002|Overall Study|Lost to Follow-up|26|||
33508405|NCT03029624|62891444|FG000|Overall Study|Adverse Event|1|||
33508406|NCT03029624|62891444|FG000|Overall Study|Withdrawal by Subject|1|||
33508407|NCT03029624|62891444|FG000|Overall Study|Lack of Efficacy|1|||
33508408|NCT03029624|62891444|FG000|Overall Study|MRI need|2|||
33508409|NCT02952001|62891452|FG000|Overall Study|Adverse Event|3|||
33508410|NCT02952001|62891453|FG001|Overall Study|Adverse Event|0|||
33508411|NCT02952001|62891452|FG000|Overall Study|Prohibited therapy|10|||
33508412|NCT02952001|62891453|FG001|Overall Study|Prohibited therapy|3|||
33508413|NCT02952001|62891452|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
33508414|NCT02952001|62891453|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
33508415|NCT04123067|62891462|FG000|Overall Study|Lost to Follow-up|0|||
33508416|NCT04123067|62891463|FG001|Overall Study|Lost to Follow-up|1|||
33508417|NCT04117607|62891472|FG000|Overall Study|Early Termination|0|||
33508418|NCT04117607|62891473|FG001|Overall Study|Early Termination|1|||
33508419|NCT04117607|62891474|FG002|Overall Study|Early Termination|0|||
33508420|NCT04117607|62891475|FG003|Overall Study|Early Termination|0|||
33508421|NCT04117607|62891476|FG004|Overall Study|Early Termination|0|||
33508422|NCT04117607|62891477|FG005|Overall Study|Early Termination|0|||
33612963|NCT01710358|63013525|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
33612964|NCT01710358|63013523|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
33612965|NCT01710358|63013524|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
33612966|NCT01710358|63013525|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
33612967|NCT01710358|63013523|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
33612968|NCT01710358|63013524|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
33612969|NCT01710358|63013525|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
33612970|NCT01710358|63013523|FG000|Rescue Period|Adverse Event|0|||
33612971|NCT01710358|63013524|FG001|Rescue Period|Adverse Event|15|||
33612972|NCT01710358|63013525|FG002|Rescue Period|Adverse Event|0|||
33612973|NCT01710358|63013523|FG000|Rescue Period|Death|0|||
33612974|NCT01710358|63013524|FG001|Rescue Period|Death|1|||
33612975|NCT01710358|63013525|FG002|Rescue Period|Death|0|||
33612976|NCT01710358|63013523|FG000|Rescue Period|Lack of Efficacy|0|||
33612977|NCT01710358|63013524|FG001|Rescue Period|Lack of Efficacy|7|||
33612978|NCT01710358|63013525|FG002|Rescue Period|Lack of Efficacy|0|||
33612979|NCT01710358|63013523|FG000|Rescue Period|Withdrawal by Subject|0|||
33612980|NCT01710358|63013524|FG001|Rescue Period|Withdrawal by Subject|8|||
33612981|NCT01710358|63013525|FG002|Rescue Period|Withdrawal by Subject|0|||
33612982|NCT01633112|63013549|FG000|Overall Study|Lack of Efficacy|1|||
33612983|NCT01633112|63013550|FG001|Overall Study|Lack of Efficacy|6|||
33612984|NCT01633112|63013551|FG002|Overall Study|Lack of Efficacy|13|||
33612985|NCT01633112|63013549|FG000|Overall Study|Abnormal laboratory value(s)|3|||
33508423|NCT04117607|62891478|FG006|Overall Study|Early Termination|1|||
33508424|NCT04117607|62891479|FG007|Overall Study|Early Termination|0|||
33508425|NCT04117607|62891480|FG008|Overall Study|Early Termination|0|||
33508426|NCT04117607|62891481|FG009|Overall Study|Early Termination|0|||
33508427|NCT04117607|62891482|FG010|Overall Study|Early Termination|0|||
33508428|NCT04117607|62891483|FG011|Overall Study|Early Termination|0|||
33508429|NCT04117607|62891484|FG012|Overall Study|Early Termination|0|||
33508430|NCT04117607|62891485|FG013|Overall Study|Early Termination|0|||
33508431|NCT04112303|62891501|FG000|Overall Study|Death|1|||
33508432|NCT03998189|62891507|FG000|Overall Study|Lack of Efficacy|0|||
33508433|NCT03998189|62891508|FG001|Overall Study|Lack of Efficacy|1|||
33508434|NCT04099277|62891514|FG000|Overall Study|Physician Decision|1|||
33508435|NCT04099277|62891514|FG000|Overall Study|Withdrawal by Subject|1|||
33508436|NCT03990389|62891520|FG000|Overall Study|Lost to Follow-up|3|||
33508437|NCT03990389|62891521|FG001|Overall Study|Lost to Follow-up|0|||
33508438|NCT03988907|62891529|FG000|Overall Study|Unable to complete visit|0|||
33508439|NCT03988907|62891530|FG001|Overall Study|Unable to complete visit|1|||
33508440|NCT03987191|62891544|FG000|Overall Study|COVID-19 related research disruption|0|||
33508441|NCT03987191|62891545|FG001|Overall Study|COVID-19 related research disruption|2|||
33508442|NCT04098809|62891553|FG000|Overall Study|Withdrawal by Subject|1|||
33508443|NCT04098809|62891554|FG001|Overall Study|Withdrawal by Subject|3|||
33508444|NCT04098809|62891553|FG000|Overall Study|Physician Decision|2|||
33508445|NCT04098809|62891554|FG001|Overall Study|Physician Decision|1|||
33508446|NCT03122184|62891562|FG000|Overall Study|Lost to Follow-up|4|||
33508447|NCT03122184|62891563|FG001|Overall Study|Lost to Follow-up|6|||
33508448|NCT03122184|62891562|FG000|Overall Study|Withdrawal by Subject|3|||
33508449|NCT03122184|62891563|FG001|Overall Study|Withdrawal by Subject|0|||
33508450|NCT03122184|62891562|FG000|Overall Study|Terminated due to cognitive problem|1|||
33508451|NCT03122184|62891563|FG001|Overall Study|Terminated due to cognitive problem|0|||
33508452|NCT04091087|62891588|FG000|Overall Study|Not treated|1|||
33508453|NCT04091087|62891589|FG001|Overall Study|Not treated|0|||
33508454|NCT04091087|62891588|FG000|Overall Study|Adverse Event|4|||
33508455|NCT04091087|62891589|FG001|Overall Study|Adverse Event|4|||
33508456|NCT04091087|62891588|FG000|Overall Study|Protocol Violation|0|||
33508457|NCT04091087|62891589|FG001|Overall Study|Protocol Violation|1|||
33508458|NCT04091087|62891588|FG000|Overall Study|Withdrawal by Subject|5|||
33508459|NCT04091087|62891589|FG001|Overall Study|Withdrawal by Subject|2|||
33508460|NCT03400033|62891607|FG000|Overall Study|Withdrawal by Subject|1|||
33508461|NCT03400033|62891608|FG001|Overall Study|Withdrawal by Subject|2|||
33508462|NCT04089761|62891623|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
33508463|NCT04089761|62891623|FG000|"Run In Phase"|Lost to Follow-up|1|||
33508464|NCT04089761|62891623|FG000|"Treatment Phase"|No evaluable data|5|||
33508465|NCT04089761|62891623|FG000|"Treatment Phase"|Lost to Follow-up|1|||
33508466|NCT03118518|62891629|FG000|Overall Study|Early Exit after treatment|2|||
33508467|NCT03118518|62891630|FG001|Overall Study|Early Exit after treatment|8|||
33508468|NCT03118518|62891629|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
33508469|NCT03118518|62891630|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
33508470|NCT03984305|62891638|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
33612986|NCT01633112|63013550|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33612987|NCT01633112|63013551|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33612988|NCT01633112|63013549|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33508471|NCT03984305|62891639|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
33508472|NCT03984305|62891638|FG000|Overall Study|Withdrawal by Subject|3|||
33508473|NCT03984305|62891639|FG001|Overall Study|Withdrawal by Subject|3|||
33508474|NCT03984305|62891638|FG000|Overall Study|Lost to Follow-up|1|||
33508475|NCT03984305|62891639|FG001|Overall Study|Lost to Follow-up|0|||
33508476|NCT03397771|62891647|FG000|Overall Study|2 erroneously randomized, never treated|3|||
33508477|NCT03397771|62891648|FG001|Overall Study|2 erroneously randomized, never treated|1|||
33508478|NCT03397771|62891647|FG000|Overall Study|Withdrawal by Subject|1|||
33508479|NCT03397771|62891648|FG001|Overall Study|Withdrawal by Subject|3|||
33508480|NCT03397771|62891647|FG000|Overall Study|Protocol Violation|2|||
33508481|NCT03397771|62891648|FG001|Overall Study|Protocol Violation|2|||
33508482|NCT03397771|62891647|FG000|Overall Study|Adverse Event|2|||
33508483|NCT03397771|62891648|FG001|Overall Study|Adverse Event|1|||
33508484|NCT02876835|62891656|FG000|Treatment Period (51.1 Month)|Other|1|||
33508485|NCT02876835|62891657|FG001|Treatment Period (51.1 Month)|Other|0|||
33508486|NCT02876835|62891656|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
33508487|NCT02876835|62891657|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
33508488|NCT02876835|62891656|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
33508489|NCT02876835|62891657|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
33508490|NCT02876835|62891656|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
33508491|NCT02876835|62891657|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
33508492|NCT04086641|62891666|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
33508493|NCT04086641|62891667|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
33508494|NCT03503318|62891676|FG000|Overall Study|Death|1|||
33508495|NCT03503318|62891677|FG001|Overall Study|Death|0|||
33508496|NCT03503318|62891678|FG002|Overall Study|Death|4|||
33508497|NCT03503318|62891676|FG000|Overall Study|Adverse Event|3|||
33508498|NCT03503318|62891677|FG001|Overall Study|Adverse Event|4|||
33508499|NCT03503318|62891678|FG002|Overall Study|Adverse Event|2|||
33508500|NCT03503318|62891676|FG000|Overall Study|Withdrawal by Subject|12|||
33508501|NCT03503318|62891677|FG001|Overall Study|Withdrawal by Subject|17|||
33508502|NCT03503318|62891678|FG002|Overall Study|Withdrawal by Subject|16|||
33508503|NCT03503318|62891676|FG000|Overall Study|Protocol Violation|5|||
33508504|NCT03503318|62891677|FG001|Overall Study|Protocol Violation|0|||
33508505|NCT03503318|62891678|FG002|Overall Study|Protocol Violation|3|||
33508506|NCT03503318|62891676|FG000|Overall Study|Lost to Follow-up|17|||
33508507|NCT03503318|62891677|FG001|Overall Study|Lost to Follow-up|15|||
33508508|NCT03503318|62891678|FG002|Overall Study|Lost to Follow-up|12|||
33508509|NCT03503318|62891676|FG000|Overall Study|Other than specified|1|||
33508510|NCT03503318|62891677|FG001|Overall Study|Other than specified|3|||
33508511|NCT03503318|62891678|FG002|Overall Study|Other than specified|3|||
33508512|NCT03396913|62891688|FG000|Overall Study|Lost to Follow-up|0|||
33508513|NCT03396913|62891689|FG001|Overall Study|Lost to Follow-up|6|||
33508514|NCT03982433|62891695|FG000|Overall Study|Lost to Follow-up|1|||
33508515|NCT03396835|62891699|FG000|Overall Study|Withdrawn prior to completion|1|||
33508516|NCT03396835|62891699|FG000|Overall Study|Did not meet criteria for data analysis|1|||
33508517|NCT03121950|62891705|FG000|Overall Study|Withdrawal by Subject|11|||
33508518|NCT03121950|62891706|FG001|Overall Study|Withdrawal by Subject|2|||
33508519|NCT03395353|62891714|FG000|Overall Study|Adverse Event|20|||
33508520|NCT03395353|62891714|FG000|Overall Study|Protocol Violation|1|||
33508521|NCT03395353|62891714|FG000|Overall Study|Lack of Efficacy|3|||
33508522|NCT03395353|62891714|FG000|Overall Study|Withdrawal by Subject|24|||
33508523|NCT03395353|62891714|FG000|Overall Study|Discontinued visit|1|||
33508524|NCT03395353|62891714|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
33508525|NCT03395353|62891714|FG000|Overall Study|Physician Decision|4|||
33508526|NCT03395353|62891714|FG000|Overall Study|Early termination of overall study|33|||
33508527|NCT04082663|62891722|FG000|Overall Study|Adverse Event|6|||
33451325|NCT00071812|62826002|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
33451326|NCT00071812|62826003|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
33451327|NCT00071812|62826004|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
33451328|NCT00071812|62826001|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
33451329|NCT00071812|62826002|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
33451330|NCT00071812|62826003|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
33451331|NCT00071812|62826004|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
33451332|NCT00071812|62826001|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
33451333|NCT00071812|62826002|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
33451334|NCT00071812|62826003|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
33451335|NCT00071812|62826004|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
33451336|NCT00071812|62826001|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
33451337|NCT00071812|62826002|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
33451338|NCT00071812|62826003|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
33451339|NCT00071812|62826004|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
33508528|NCT04082663|62891722|FG000|Overall Study|Lost to Follow-up|1|||
33508529|NCT03682367|62891728|FG000|Overall Study|Protocol Violation|2|||
33508530|NCT03682367|62891729|FG001|Overall Study|Protocol Violation|1|||
33508531|NCT03682367|62891728|FG000|Overall Study|Closed Study Early|0|||
33508532|NCT03682367|62891729|FG001|Overall Study|Closed Study Early|3|||
33508533|NCT03681353|62891735|FG000|Overall Study|Lost to Follow-up|2|||
33508534|NCT03681353|62891735|FG000|Overall Study|Withdrawal by Subject|3|||
33508535|NCT03681353|62891735|FG000|Overall Study|withdrawn by PI|2|||
33508536|NCT03394885|62891739|FG000|Overall Study|Adverse Event|4|||
33508537|NCT03394885|62891739|FG000|Overall Study|Lack of Efficacy|1|||
33508538|NCT03394885|62891739|FG000|Overall Study|Physician Decision|1|||
33508539|NCT03394885|62891739|FG000|Overall Study|Withdrawal by Subject|8|||
33508540|NCT03394885|62891739|FG000|Overall Study|Alternative Therapy|1|||
33508541|NCT02877927|62891745|FG000|Overall Study|Adverse Event|1|||
33508542|NCT02877927|62891746|FG001|Overall Study|Adverse Event|0|||
33508543|NCT02877927|62891745|FG000|Overall Study|Lost to Follow-up|37|||
33508544|NCT02877927|62891746|FG001|Overall Study|Lost to Follow-up|38|||
33508545|NCT02877927|62891745|FG000|Overall Study|Withdrawal by Subject|11|||
33508546|NCT02877927|62891746|FG001|Overall Study|Withdrawal by Subject|12|||
33508547|NCT02877927|62891745|FG000|Overall Study|Physician Decision|0|||
33508548|NCT02877927|62891746|FG001|Overall Study|Physician Decision|1|||
33508549|NCT02877927|62891745|FG000|Overall Study|Missed EOT/PTE Visit|5|||
33508550|NCT02877927|62891746|FG001|Overall Study|Missed EOT/PTE Visit|6|||
33508551|NCT02706886|62891761|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
33508552|NCT02706886|62891762|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
33508553|NCT02706886|62891763|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
33508554|NCT02706886|62891764|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
33508555|NCT02706886|62891765|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
33508556|NCT02706886|62891766|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
33508557|NCT02706886|62891767|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
33508558|NCT02706886|62891768|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
33508559|NCT02706886|62891769|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
33508560|NCT04069715|62891823|FG000|Overall Study|Lost to Follow-up|1|||
33508561|NCT04069715|62891824|FG001|Overall Study|Lost to Follow-up|1|||
33508562|NCT04069715|62891823|FG000|Overall Study|Physician Decision|1|||
33508563|NCT04069715|62891824|FG001|Overall Study|Physician Decision|1|||
33508564|NCT04069715|62891823|FG000|Overall Study|Withdrawal by Subject|3|||
33508565|NCT04069715|62891824|FG001|Overall Study|Withdrawal by Subject|3|||
33508566|NCT03681119|62891832|FG000|Overall Study|No specific reason|4|||
33508567|NCT03681119|62891833|FG001|Overall Study|No specific reason|0|||
33508568|NCT03681119|62891832|FG000|Overall Study|Sickness|2|||
33508569|NCT03681119|62891833|FG001|Overall Study|Sickness|0|||
33508570|NCT03111108|62891839|FG000|Overall Study|Death|0|||
33508571|NCT03111108|62891840|FG001|Overall Study|Death|1|||
33451340|NCT00071812|62826001|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
33451341|NCT00071812|62826002|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
33451342|NCT00071812|62826003|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
33451343|NCT00071812|62826004|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
33451344|NCT00071812|62826001|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
33451345|NCT00071812|62826002|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
33451346|NCT00071812|62826003|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
33451347|NCT00071812|62826004|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
33451348|NCT00071812|62826001|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
33451349|NCT00071812|62826002|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
33451350|NCT00071812|62826003|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
33451351|NCT00071812|62826004|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
33451352|NCT00071812|62826001|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
33451353|NCT00071812|62826002|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
33451354|NCT00071812|62826003|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
33508572|NCT03111108|62891839|FG000|Overall Study|Withdrawal by Subject|1|||
33508573|NCT03111108|62891840|FG001|Overall Study|Withdrawal by Subject|0|||
33508574|NCT03677375|62891846|FG000|Overall Study|Incomplete procedure|8|||
33508575|NCT03677375|62891846|FG000|Overall Study|Adverse Event|3|||
33508576|NCT03677375|62891846|FG000|Overall Study|Physician Decision|1|||
33508577|NCT00702520|62891852|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
33508578|NCT00702520|62891853|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
33508579|NCT00702520|62891854|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
33508580|NCT00702520|62891855|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
33508581|NCT00702520|62891852|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
33508582|NCT00702520|62891853|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
33508583|NCT00702520|62891854|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
33508584|NCT00702520|62891855|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
33508585|NCT00702520|62891852|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
33508586|NCT00702520|62891853|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
33508587|NCT00702520|62891854|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
33508588|NCT00702520|62891855|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
33508589|NCT04067141|62891865|FG000|First Intervention|Withdrawal by Subject|0|||
33508590|NCT04067141|62891866|FG001|First Intervention|Withdrawal by Subject|1|||
33508591|NCT04067141|62891865|FG000|Second Intervention|Adverse Event|0|||
33508592|NCT04067141|62891866|FG001|Second Intervention|Adverse Event|2|||
33508593|NCT02876601|62891876|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
33508594|NCT02876601|62891877|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
33508595|NCT02876601|62891878|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
33508596|NCT02876601|62891879|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
33508597|NCT04054193|62891924|FG000|Cycle 1|Physician Decision|1|||
33508598|NCT04054193|62891924|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
33508599|NCT04054193|62891924|FG000|Cycle 1|Allocated but not treated|3|||
33508600|NCT04054193|62891924|FG000|Cycles 2-3|Physician Decision|2|||
33508601|NCT04054193|62891924|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
33508602|NCT04054193|62891924|FG000|Cycles 2-3|Various reasons|17|||
33508603|NCT03394027|62891932|FG000|Overall Study|Ineligible|3|||
33508604|NCT03394027|62891933|FG001|Overall Study|Ineligible|1|||
33508605|NCT03394027|62891934|FG002|Overall Study|Ineligible|3|||
33508606|NCT03394027|62891932|FG000|Overall Study|Participant declined to participate before treatment started|0|||
33508607|NCT03394027|62891933|FG001|Overall Study|Participant declined to participate before treatment started|0|||
33508608|NCT03394027|62891934|FG002|Overall Study|Participant declined to participate before treatment started|1|||
33508609|NCT03136107|62891960|FG000|Overall Study|Other (Not specified)|1|||
33508610|NCT02916056|62891968|FG000|Overall Study|Adverse Event|6|||
33508611|NCT02916056|62891968|FG000|Overall Study|Lost to Follow-up|1|||
33508612|NCT02916056|62891968|FG000|Overall Study|Other|12|||
33508613|NCT02916056|62891968|FG000|Overall Study|Protocol Violation|1|||
33508614|NCT02916056|62891968|FG000|Overall Study|Withdrawal by Subject|8|||
33508615|NCT02916056|62891968|FG000|Overall Study|Study Terminated by Sponsor|269|||
33508616|NCT04854642|62891972|FG000|Overall Study|Adverse Event|1|||
33508617|NCT04854642|62891973|FG001|Overall Study|Adverse Event|2|||
33508618|NCT04854642|62891972|FG000|Overall Study|Withdrawal by Subject|0|||
33508619|NCT04854642|62891973|FG001|Overall Study|Withdrawal by Subject|1|||
33508620|NCT03689712|62891983|FG000|Overall Study|Adverse Event|1|||
33508621|NCT03689712|62891984|FG001|Overall Study|Adverse Event|0|||
33508622|NCT03689712|62891983|FG000|Overall Study|Death|20|||
33508623|NCT03689712|62891984|FG001|Overall Study|Death|10|||
33508624|NCT03689712|62891983|FG000|Overall Study|Lost to Follow-up|6|||
33508625|NCT03689712|62891984|FG001|Overall Study|Lost to Follow-up|6|||
33508626|NCT03689712|62891983|FG000|Overall Study|Other|1|||
33508627|NCT03689712|62891984|FG001|Overall Study|Other|0|||
33508628|NCT03689712|62891983|FG000|Overall Study|Patient Non-Compliance|0|||
33508629|NCT03689712|62891984|FG001|Overall Study|Patient Non-Compliance|1|||
33508630|NCT03689712|62891983|FG000|Overall Study|Withdrawal by Subject|20|||
33508631|NCT03689712|62891984|FG001|Overall Study|Withdrawal by Subject|4|||
33508632|NCT03689712|62891983|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
33508633|NCT03689712|62891984|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
33508634|NCT03689712|62891983|FG000|Overall Study|Randomized but not Treated|13|||
33508635|NCT03689712|62891984|FG001|Overall Study|Randomized but not Treated|7|||
33508636|NCT03689712|62891983|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
33508637|NCT03689712|62891984|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
33508638|NCT03384745|62891996|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
33508639|NCT03384745|62891997|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
33612989|NCT01633112|63013550|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33508640|NCT03384745|62891998|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
33508641|NCT03384745|62891999|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
33508642|NCT03384745|62892000|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
33508643|NCT03384745|62892001|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
33508644|NCT03384745|62891996|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
33508645|NCT03384745|62891997|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
33508646|NCT03384745|62891998|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
33508647|NCT03384745|62891999|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
33508648|NCT03384745|62892000|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
33612990|NCT01633112|63013551|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33451355|NCT00071812|62826004|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
33451356|NCT00071110|62826018|FG000|Overall Study|Protocol Violation|0|||
33451357|NCT00071110|62826019|FG001|Overall Study|Protocol Violation|4|||
33451358|NCT00071032|62826027|FG000|Overall Study|Lost to Follow-up|1|||
33451359|NCT00071032|62826028|FG001|Overall Study|Lost to Follow-up|1|||
33451360|NCT00071032|62826027|FG000|Overall Study|Withdrawal by Subject|8|||
33451361|NCT00071032|62826028|FG001|Overall Study|Withdrawal by Subject|6|||
33451362|NCT00071032|62826027|FG000|Overall Study|Missing Primary Outcome|0|||
33451363|NCT00071032|62826028|FG001|Overall Study|Missing Primary Outcome|1|||
33451364|NCT00259610|62826039|FG000|Overall Study|Withdrawal by Subject|33|||
33451365|NCT00259610|62826040|FG001|Overall Study|Withdrawal by Subject|25|||
33451366|NCT00259610|62826041|FG002|Overall Study|Withdrawal by Subject|29|||
33451367|NCT00259610|62826042|FG003|Overall Study|Withdrawal by Subject|19|||
33451368|NCT00259610|62826039|FG000|Overall Study|Lost to Follow-up|19|||
33451369|NCT00259610|62826040|FG001|Overall Study|Lost to Follow-up|8|||
33451370|NCT00259610|62826041|FG002|Overall Study|Lost to Follow-up|18|||
33451371|NCT00259610|62826042|FG003|Overall Study|Lost to Follow-up|15|||
33451372|NCT00259610|62826039|FG000|Overall Study|Physician Decision|6|||
33451373|NCT00259610|62826040|FG001|Overall Study|Physician Decision|4|||
33451374|NCT00259610|62826041|FG002|Overall Study|Physician Decision|7|||
33451375|NCT00259610|62826042|FG003|Overall Study|Physician Decision|2|||
33451376|NCT00259610|62826039|FG000|Overall Study|Death|1|||
33451377|NCT00259610|62826040|FG001|Overall Study|Death|1|||
33451378|NCT00259610|62826041|FG002|Overall Study|Death|2|||
33451379|NCT00259610|62826042|FG003|Overall Study|Death|0|||
33451380|NCT00259610|62826039|FG000|Overall Study|non medical reason|6|||
33451381|NCT00259610|62826040|FG001|Overall Study|non medical reason|2|||
33451382|NCT00259610|62826041|FG002|Overall Study|non medical reason|10|||
33451383|NCT00259610|62826042|FG003|Overall Study|non medical reason|3|||
33451384|NCT00259610|62826039|FG000|Overall Study|Adverse Event|3|||
33451385|NCT00259610|62826040|FG001|Overall Study|Adverse Event|4|||
33451386|NCT00259610|62826041|FG002|Overall Study|Adverse Event|5|||
33451387|NCT00259610|62826042|FG003|Overall Study|Adverse Event|2|||
33451388|NCT00259610|62826039|FG000|Overall Study|Serious Adverse Event|8|||
33451389|NCT00259610|62826040|FG001|Overall Study|Serious Adverse Event|2|||
33451390|NCT00259610|62826041|FG002|Overall Study|Serious Adverse Event|2|||
33451391|NCT00259610|62826042|FG003|Overall Study|Serious Adverse Event|2|||
33451392|NCT00165776|62826056|FG000|Overall Study|Lack of Efficacy|0|||
33451393|NCT00165776|62826057|FG001|Overall Study|Lack of Efficacy|0|||
33451394|NCT00165776|62826058|FG002|Overall Study|Lack of Efficacy|0|||
33451395|NCT00165776|62826059|FG003|Overall Study|Lack of Efficacy|1|||
33612991|NCT01633112|63013549|FG000|Overall Study|Administrative problems|1|||
33612992|NCT01633112|63013550|FG001|Overall Study|Administrative problems|2|||
33612993|NCT01633112|63013551|FG002|Overall Study|Administrative problems|5|||
33612994|NCT01633112|63013549|FG000|Overall Study|Adverse Event|16|||
33612995|NCT01633112|63013550|FG001|Overall Study|Adverse Event|18|||
33612996|NCT01633112|63013551|FG002|Overall Study|Adverse Event|20|||
33612997|NCT01633112|63013549|FG000|Overall Study|Lost to Follow-up|7|||
33612998|NCT01633112|63013550|FG001|Overall Study|Lost to Follow-up|19|||
33612999|NCT01633112|63013551|FG002|Overall Study|Lost to Follow-up|6|||
33613000|NCT01633112|63013549|FG000|Overall Study|Protocol Violation|4|||
33613001|NCT01633112|63013550|FG001|Overall Study|Protocol Violation|0|||
33451396|NCT00165776|62826056|FG000|Overall Study|Withdrawal by Subject|4|||
33451397|NCT00165776|62826057|FG001|Overall Study|Withdrawal by Subject|1|||
33451398|NCT00165776|62826058|FG002|Overall Study|Withdrawal by Subject|2|||
33613002|NCT01633112|63013551|FG002|Overall Study|Protocol Violation|2|||
33613003|NCT01633112|63013549|FG000|Overall Study|Subject no longer requires study drug|0|||
33613004|NCT01633112|63013550|FG001|Overall Study|Subject no longer requires study drug|0|||
33613005|NCT01633112|63013551|FG002|Overall Study|Subject no longer requires study drug|1|||
33508649|NCT03384745|62892001|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
33508650|NCT03384745|62891996|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
33508651|NCT03384745|62891997|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
33508652|NCT03384745|62891998|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
33508653|NCT03384745|62891999|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
33508654|NCT03384745|62892000|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
33508655|NCT03384745|62892001|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
33508656|NCT03384745|62891996|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
33508657|NCT03384745|62891997|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
33508658|NCT03384745|62891998|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
33508659|NCT03384745|62891999|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
33508660|NCT03384745|62892000|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
33508661|NCT03384745|62892001|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
33508662|NCT03384745|62891996|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
33508663|NCT03384745|62891997|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
33508664|NCT03384745|62891998|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
33508665|NCT03384745|62891999|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
33508666|NCT03384745|62892000|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
33508667|NCT03384745|62892001|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
33508668|NCT03384745|62891996|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
33508669|NCT03384745|62891997|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
33508670|NCT03384745|62891998|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
33508671|NCT03384745|62891999|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
33508672|NCT03384745|62892000|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
33508673|NCT03384745|62892001|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
33508674|NCT03384745|62891996|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
33508675|NCT03384745|62891997|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
33508676|NCT03384745|62891998|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
33508677|NCT03384745|62891999|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
33508678|NCT03384745|62892000|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
33508679|NCT03384745|62892001|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
33508680|NCT03384745|62891996|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
33508681|NCT03384745|62891997|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
33508682|NCT03384745|62891998|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
33508683|NCT03384745|62891999|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
33508684|NCT03384745|62892000|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
33613006|NCT01633112|63013549|FG000|Overall Study|Withdrawal by Subject|20|||
33451399|NCT00165776|62826059|FG003|Overall Study|Withdrawal by Subject|0|||
33451400|NCT00165776|62826056|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
33451401|NCT00165776|62826057|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
33451402|NCT00165776|62826058|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
33451403|NCT00165776|62826059|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
33451404|NCT00165698|62826071|FG000|Overall Study|Adverse Event|2|||
33451405|NCT00165698|62826072|FG001|Overall Study|Adverse Event|10|||
33451406|NCT00165698|62826071|FG000|Overall Study|Lost to Follow-up|2|||
33451407|NCT00165698|62826072|FG001|Overall Study|Lost to Follow-up|2|||
33508685|NCT03384745|62892001|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
33508686|NCT03384745|62891996|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
33508687|NCT03384745|62891997|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
33508688|NCT03384745|62891998|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
33508689|NCT03384745|62891999|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
33508690|NCT03384745|62892000|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
33508691|NCT03384745|62892001|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
33508692|NCT03384745|62891996|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
33508693|NCT03384745|62891997|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
33508694|NCT03384745|62891998|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
33508695|NCT03384745|62891999|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
33508696|NCT03384745|62892000|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
33508697|NCT03384745|62892001|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
33508698|NCT03384745|62891996|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
33508699|NCT03384745|62891997|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
33508700|NCT03384745|62891998|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
33508701|NCT03384745|62891999|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
33508702|NCT03384745|62892000|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
33508703|NCT03384745|62892001|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
33508704|NCT03383887|62892021|FG000|Overall Study|Lost to Follow-up|0|||
33508705|NCT03383887|62892022|FG001|Overall Study|Lost to Follow-up|1|||
33508706|NCT03379753|62892030|FG000|Overall Study|Withdrawal by Subject|2|||
33508707|NCT03379753|62892031|FG001|Overall Study|Withdrawal by Subject|1|||
33508708|NCT03379753|62892030|FG000|Overall Study|not having correct procedure|1|||
33508709|NCT03379753|62892031|FG001|Overall Study|not having correct procedure|2|||
33508710|NCT03379753|62892030|FG000|Overall Study|No primary outcome|12|||
33508711|NCT03379753|62892031|FG001|Overall Study|No primary outcome|22|||
33508712|NCT03379675|62892040|FG000|Overall Study|Lost to Follow-up|0|||
33508713|NCT03379675|62892041|FG001|Overall Study|Lost to Follow-up|1|||
33508714|NCT03379675|62892042|FG002|Overall Study|Lost to Follow-up|0|||
33451408|NCT00165698|62826071|FG000|Overall Study|Withdrawal by Subject|2|||
33451409|NCT00165698|62826072|FG001|Overall Study|Withdrawal by Subject|1|||
33451410|NCT00165698|62826071|FG000|Overall Study|Protocol Violation|1|||
33451411|NCT00165698|62826072|FG001|Overall Study|Protocol Violation|0|||
33451412|NCT00165698|62826071|FG000|Overall Study|Not Taken/Lost the medicine|1|||
33451413|NCT00165698|62826072|FG001|Overall Study|Not Taken/Lost the medicine|2|||
33451414|NCT00225758|62826078|FG000|Overall Study|Adverse Event|4|||
33451415|NCT00259298|62826084|FG000|Overall Study|Withdrawal by Subject|1|||
33451416|NCT00259298|62826084|FG000|Overall Study|Physician Decision|2|||
33451417|NCT03789292|62826094|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
33451418|NCT03789292|62826095|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
33451419|NCT03789292|62826096|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
33451420|NCT03789292|62826094|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
33451421|NCT03789292|62826095|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
33451422|NCT03789292|62826096|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
33451423|NCT03789292|62826094|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
33451424|NCT03789292|62826095|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
33451425|NCT03789292|62826096|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
33451426|NCT03789292|62826094|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
33451427|NCT03789292|62826095|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
33451428|NCT03789292|62826096|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
33451429|NCT03789292|62826094|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
33451430|NCT03789292|62826095|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
33451431|NCT03789292|62826096|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
33451432|NCT03789292|62826094|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
33451433|NCT03789292|62826095|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
33451434|NCT03789292|62826096|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
33451435|NCT03789292|62826094|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
33451436|NCT03789292|62826095|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
33508715|NCT03379675|62892040|FG000|Overall Study|Adverse Event|2|||
33508716|NCT03379675|62892041|FG001|Overall Study|Adverse Event|0|||
33451437|NCT03789292|62826096|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
33451438|NCT03789292|62826094|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
33451439|NCT03789292|62826095|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
33508717|NCT03379675|62892042|FG002|Overall Study|Adverse Event|0|||
33508718|NCT03379675|62892040|FG000|Overall Study|Withdrawal by Subject|2|||
33508719|NCT03379675|62892041|FG001|Overall Study|Withdrawal by Subject|1|||
33508720|NCT03379675|62892042|FG002|Overall Study|Withdrawal by Subject|2|||
33508721|NCT02930889|62892050|FG000|Overall Study|Lost to Follow-up|2|||
33508722|NCT02930889|62892050|FG000|Overall Study|Withdrawal by Subject|6|||
33508723|NCT02930889|62892050|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
33508724|NCT02875977|62892056|FG000|Overall Study|Lost to Follow-up|42|||
33508725|NCT02875977|62892057|FG001|Overall Study|Lost to Follow-up|29|||
33508726|NCT02703532|62892076|FG000|Overall Study|Withdrawal by Subject|0|||
33508727|NCT02703532|62892077|FG001|Overall Study|Withdrawal by Subject|1|||
33508728|NCT02703532|62892078|FG002|Overall Study|Withdrawal by Subject|0|||
33508729|NCT02703532|62892079|FG003|Overall Study|Withdrawal by Subject|1|||
33508730|NCT02703532|62892076|FG000|Overall Study|Lost to Follow-up|2|||
33508731|NCT02703532|62892077|FG001|Overall Study|Lost to Follow-up|0|||
33508732|NCT02703532|62892078|FG002|Overall Study|Lost to Follow-up|2|||
33508733|NCT02703532|62892079|FG003|Overall Study|Lost to Follow-up|0|||
33508734|NCT02930343|62892112|FG000|Overall Study|Lost to Follow-up|9|||
33508735|NCT02930343|62892113|FG001|Overall Study|Lost to Follow-up|7|||
33508736|NCT02703454|62892121|FG000|Overall Study|Not treated|1|||
33508737|NCT02703454|62892122|FG001|Overall Study|Not treated|3|||
33508738|NCT02703454|62892121|FG000|Overall Study|Withdrawal by Subject|4|||
33508739|NCT02703454|62892122|FG001|Overall Study|Withdrawal by Subject|3|||
33508740|NCT02703454|62892121|FG000|Overall Study|Lost to Follow-up|1|||
33508741|NCT02703454|62892122|FG001|Overall Study|Lost to Follow-up|2|||
33508742|NCT02703454|62892121|FG000|Overall Study|Study discontinuation|5|||
33508743|NCT02703454|62892122|FG001|Overall Study|Study discontinuation|8|||
33508744|NCT03103542|62892128|FG000|Overall Study|Physician Decision|2|||
33508745|NCT03103542|62892128|FG000|Overall Study|Adverse Event|2|||
33508746|NCT03103542|62892128|FG000|Overall Study|Other|2|||
33508747|NCT03103542|62892128|FG000|Overall Study|Withdrawal by Subject|1|||
33508748|NCT03376321|62892155|FG000|Overall Study|Other|5|||
33508749|NCT03376321|62892156|FG001|Overall Study|Other|1|||
33508750|NCT03376321|62892155|FG000|Overall Study|Withdrawal by Subject|8|||
33508751|NCT03376321|62892156|FG001|Overall Study|Withdrawal by Subject|14|||
33508752|NCT03376321|62892155|FG000|Overall Study|Lost to Follow-up|1|||
33508753|NCT03376321|62892156|FG001|Overall Study|Lost to Follow-up|7|||
33508754|NCT03376321|62892155|FG000|Overall Study|Death|4|||
33508755|NCT03376321|62892156|FG001|Overall Study|Death|0|||
33508756|NCT03376321|62892155|FG000|Overall Study|Randomized, not treated|5|||
33508757|NCT03376321|62892156|FG001|Overall Study|Randomized, not treated|3|||
33508758|NCT03374995|62892164|FG000|Overall Study|Withdrawal by Subject|0|||
33508759|NCT03374995|62892165|FG001|Overall Study|Withdrawal by Subject|1|||
33508760|NCT02828982|62892171|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33508761|NCT02828982|62892172|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33508762|NCT03133767|62892182|FG000|Overall Study|Lost to Follow-up|38|||
33508763|NCT03133767|62892183|FG001|Overall Study|Lost to Follow-up|24|||
33508764|NCT03133767|62892182|FG000|Overall Study|Protocol Violation|0|||
33508765|NCT03133767|62892183|FG001|Overall Study|Protocol Violation|1|||
33508766|NCT03391765|62892193|FG000|Overall Study|Adverse Event|2|||
33508767|NCT03391765|62892194|FG001|Overall Study|Adverse Event|0|||
33508768|NCT03391765|62892195|FG002|Overall Study|Adverse Event|0|||
33508769|NCT03391765|62892196|FG003|Overall Study|Adverse Event|2|||
33508770|NCT03391765|62892193|FG000|Overall Study|Withdrew consent|5|||
33508771|NCT03391765|62892194|FG001|Overall Study|Withdrew consent|7|||
33508772|NCT03391765|62892195|FG002|Overall Study|Withdrew consent|2|||
33508773|NCT03391765|62892196|FG003|Overall Study|Withdrew consent|5|||
33508774|NCT03391765|62892193|FG000|Overall Study|Other, not specified|44|||
33508775|NCT03391765|62892194|FG001|Overall Study|Other, not specified|38|||
33508776|NCT03391765|62892195|FG002|Overall Study|Other, not specified|21|||
33508777|NCT03391765|62892196|FG003|Overall Study|Other, not specified|16|||
33508778|NCT02802228|62892208|FG000|Overall Study|Withdrawal by Subject|2|||
33508779|NCT02802228|62892209|FG001|Overall Study|Withdrawal by Subject|0|||
33508780|NCT02802228|62892208|FG000|Overall Study|Lost to Follow-up|1|||
33613007|NCT01633112|63013550|FG001|Overall Study|Withdrawal by Subject|12|||
33508781|NCT02802228|62892209|FG001|Overall Study|Lost to Follow-up|0|||
33508782|NCT02802228|62892208|FG000|Overall Study|Adverse Event|1|||
33508783|NCT02802228|62892209|FG001|Overall Study|Adverse Event|0|||
33508784|NCT02802228|62892208|FG000|Overall Study|Physician Decision|1|||
33508785|NCT02802228|62892209|FG001|Overall Study|Physician Decision|0|||
33508786|NCT03130257|62892218|FG000|Overall Study|Withdrawal by Subject|1|||
33508787|NCT03130257|62892219|FG001|Overall Study|Withdrawal by Subject|0|||
33508788|NCT03130257|62892220|FG002|Overall Study|Withdrawal by Subject|2|||
33508789|NCT03674177|62892232|FG000|Overall Study|Lost to Follow-up|2|||
33508790|NCT03674177|62892233|FG001|Overall Study|Lost to Follow-up|1|||
33508791|NCT03674177|62892234|FG002|Overall Study|Lost to Follow-up|0|||
33508792|NCT03674177|62892235|FG003|Overall Study|Lost to Follow-up|2|||
33508793|NCT03354637|62892261|FG000|Double-blind Period|Protocol Violation|2|||
33508794|NCT03354637|62892262|FG001|Double-blind Period|Protocol Violation|0|||
33508795|NCT03354637|62892263|FG002|Double-blind Period|Protocol Violation|0|||
33508796|NCT03354637|62892261|FG000|Double-blind Period|Adverse Event|1|||
33508797|NCT03354637|62892262|FG001|Double-blind Period|Adverse Event|2|||
33508798|NCT03354637|62892263|FG002|Double-blind Period|Adverse Event|0|||
33508799|NCT03354637|62892261|FG000|Double-blind Period|Lost to Follow-up|3|||
33508800|NCT03354637|62892262|FG001|Double-blind Period|Lost to Follow-up|4|||
33508801|NCT03354637|62892263|FG002|Double-blind Period|Lost to Follow-up|3|||
33508802|NCT03354637|62892261|FG000|Double-blind Period|Withdrawal by Subject|10|||
33508803|NCT03354637|62892262|FG001|Double-blind Period|Withdrawal by Subject|6|||
33508804|NCT03354637|62892263|FG002|Double-blind Period|Withdrawal by Subject|4|||
33508805|NCT03354637|62892261|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
33508806|NCT03354637|62892262|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
33508807|NCT03354637|62892263|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
33508808|NCT03354637|62892261|FG000|Open Label Extension|Adverse Event|0|||
33508809|NCT03354637|62892262|FG001|Open Label Extension|Adverse Event|0|||
33508810|NCT03354637|62892263|FG002|Open Label Extension|Adverse Event|1|||
33508811|NCT03354637|62892261|FG000|Open Label Extension|Lost to Follow-up|0|||
33508812|NCT03354637|62892262|FG001|Open Label Extension|Lost to Follow-up|0|||
33508813|NCT03354637|62892263|FG002|Open Label Extension|Lost to Follow-up|2|||
33508814|NCT03354637|62892261|FG000|Open Label Extension|Withdrawal by Subject|0|||
33508815|NCT03354637|62892262|FG001|Open Label Extension|Withdrawal by Subject|0|||
33508816|NCT03354637|62892263|FG002|Open Label Extension|Withdrawal by Subject|5|||
33508817|NCT03354637|62892261|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
33508818|NCT03354637|62892262|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
33508819|NCT03354637|62892263|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
33508820|NCT03354637|62892261|FG000|Open Label Extension|Subject Noncompliance|0|||
33508821|NCT03354637|62892262|FG001|Open Label Extension|Subject Noncompliance|0|||
33508822|NCT03354637|62892263|FG002|Open Label Extension|Subject Noncompliance|1|||
33508823|NCT03354637|62892261|FG000|Open Label Extension|Lack of Efficacy|0|||
33508824|NCT03354637|62892262|FG001|Open Label Extension|Lack of Efficacy|0|||
33508825|NCT03354637|62892263|FG002|Open Label Extension|Lack of Efficacy|1|||
33508826|NCT03354637|62892261|FG000|Open Label Extension|Physician Decision|0|||
33508827|NCT03354637|62892262|FG001|Open Label Extension|Physician Decision|0|||
33508828|NCT03354637|62892263|FG002|Open Label Extension|Physician Decision|1|||
33508829|NCT04053023|62892274|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
33508830|NCT04053023|62892275|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
33508831|NCT03352453|62892287|FG000|Overall Study|Miscellaneous Reasons|1|||
33508832|NCT03352453|62892288|FG001|Overall Study|Miscellaneous Reasons|2|||
33508833|NCT03352453|62892287|FG000|Overall Study|Lack of Efficacy|1|||
33508834|NCT03352453|62892288|FG001|Overall Study|Lack of Efficacy|0|||
33508835|NCT03352453|62892287|FG000|Overall Study|Withdrawal by Subject|8|||
33508836|NCT03352453|62892288|FG001|Overall Study|Withdrawal by Subject|14|||
33508837|NCT03352453|62892287|FG000|Overall Study|Study Terminated by Sponsor|2|||
33508838|NCT03352453|62892288|FG001|Overall Study|Study Terminated by Sponsor|1|||
33451440|NCT03789292|62826096|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
33451441|NCT03789292|62826094|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
33451442|NCT03789292|62826095|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
33508839|NCT03352453|62892287|FG000|Overall Study|Protocol Deviation|1|||
33508840|NCT03352453|62892288|FG001|Overall Study|Protocol Deviation|0|||
33508841|NCT03352453|62892287|FG000|Overall Study|Lost to Follow-up|7|||
33508842|NCT03352453|62892288|FG001|Overall Study|Lost to Follow-up|6|||
33508843|NCT03352453|62892287|FG000|Overall Study|Adverse Event|2|||
33508844|NCT03352453|62892288|FG001|Overall Study|Adverse Event|9|||
33508845|NCT03128931|62892294|FG000|Overall Study|Physician Decision|1|||
33508846|NCT03128931|62892294|FG000|Overall Study|Equipment Issues|3|||
33508847|NCT03107052|62892301|FG000|Overall Study|Adverse Event|6|||
33508848|NCT03107052|62892302|FG001|Overall Study|Adverse Event|1|||
33508849|NCT03107052|62892303|FG002|Overall Study|Adverse Event|2|||
33508850|NCT03107052|62892301|FG000|Overall Study|Withdrawal by Subject|9|||
33508851|NCT03107052|62892302|FG001|Overall Study|Withdrawal by Subject|5|||
33451443|NCT03789292|62826096|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
33451444|NCT03789292|62826094|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
33451445|NCT03789292|62826095|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
33451446|NCT03789292|62826096|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
33451447|NCT03789292|62826094|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
33451448|NCT03789292|62826095|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
33451449|NCT03789292|62826096|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
33451450|NCT03789292|62826094|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
33451451|NCT03789292|62826095|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
33451452|NCT03789292|62826096|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
33451453|NCT03789292|62826094|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
33451454|NCT03789292|62826095|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
33451455|NCT03789292|62826096|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
33451456|NCT03781336|62826112|FG000|Overall Study|Withdrawal by Subject|2|||
33451457|NCT03781336|62826113|FG001|Overall Study|Withdrawal by Subject|2|||
33451458|NCT03780400|62826119|FG000|Overall Study|Lost to Follow-up|5|||
33451459|NCT03780400|62826119|FG000|Overall Study|Withdrawal by Subject|2|||
33451460|NCT03780244|62826125|FG000|Overall Study|Lost to Follow-up|1|||
33451461|NCT03780244|62826126|FG001|Overall Study|Lost to Follow-up|0|||
33451462|NCT03785548|62826134|FG000|Overall Study|age > 80|1|||
33451463|NCT03785548|62826135|FG001|Overall Study|age > 80|0|||
33451464|NCT03785548|62826134|FG000|Overall Study|no Postop queries|1|||
33451465|NCT03785548|62826135|FG001|Overall Study|no Postop queries|0|||
33451466|NCT00141297|62826143|FG000|Overall Study|Adverse Event|0|||
33451467|NCT00141297|62826144|FG001|Overall Study|Adverse Event|0|||
33613008|NCT01633112|63013551|FG002|Overall Study|Withdrawal by Subject|41|||
33613009|NCT01633112|63013549|FG000|Overall Study|missing Study Completion CRF|1|||
33613010|NCT01633112|63013550|FG001|Overall Study|missing Study Completion CRF|1|||
33613011|NCT01633112|63013551|FG002|Overall Study|missing Study Completion CRF|4|||
33613012|NCT01691482|63013560|FG000|Treatment Period 2|Adverse Event|0|||
33613013|NCT01691482|63013561|FG001|Treatment Period 2|Adverse Event|1|||
33613014|NCT01691482|63013560|FG000|Treatment Period 2|Protocol Violation|1|||
33613015|NCT01691482|63013561|FG001|Treatment Period 2|Protocol Violation|1|||
33613016|NCT02246114|63013570|FG000|Overall Study|miscarriage|1|||
33613017|NCT02246114|63013571|FG001|Overall Study|miscarriage|0|||
33613018|NCT01710046|63013579|FG000|Overall Study|Lost to Follow-up|1|||
33613019|NCT01710046|63013580|FG001|Overall Study|Lost to Follow-up|0|||
33613020|NCT02154529|63013590|FG000|Overall Study|Death|1|||
33613021|NCT02154529|63013591|FG001|Overall Study|Death|1|||
33613022|NCT02154529|63013592|FG002|Overall Study|Death|5|||
33613023|NCT02154529|63013593|FG003|Overall Study|Death|1|||
33613024|NCT02154529|63013590|FG000|Overall Study|Termination of study by sponsor|2|||
33613025|NCT02154529|63013591|FG001|Overall Study|Termination of study by sponsor|2|||
33613026|NCT02154529|63013592|FG002|Overall Study|Termination of study by sponsor|3|||
33613027|NCT02154529|63013593|FG003|Overall Study|Termination of study by sponsor|1|||
33613028|NCT02154529|63013590|FG000|Overall Study|Lost to Follow-up|1|||
33613029|NCT02154529|63013591|FG001|Overall Study|Lost to Follow-up|0|||
33613030|NCT02154529|63013592|FG002|Overall Study|Lost to Follow-up|0|||
33613031|NCT02154529|63013593|FG003|Overall Study|Lost to Follow-up|0|||
33451468|NCT00141297|62826145|FG002|Overall Study|Adverse Event|1|||
33451469|NCT00141297|62826146|FG003|Overall Study|Adverse Event|0|||
33613032|NCT01954017|63013608|FG000|Overall Study|Adverse Event|0|||
33613033|NCT01954017|63013609|FG001|Overall Study|Adverse Event|0|||
33613034|NCT01954017|63013610|FG002|Overall Study|Adverse Event|1|||
33613035|NCT01954017|63013608|FG000|Overall Study|Death|2|||
33613036|NCT01954017|63013609|FG001|Overall Study|Death|1|||
33451470|NCT00141297|62826147|FG004|Overall Study|Adverse Event|1|||
33451471|NCT00141297|62826148|FG005|Overall Study|Adverse Event|1|||
33451472|NCT00141297|62826149|FG006|Overall Study|Adverse Event|0|||
33451473|NCT00141297|62826150|FG007|Overall Study|Adverse Event|1|||
33451474|NCT00141297|62826151|FG008|Overall Study|Adverse Event|1|||
33508852|NCT03107052|62892303|FG002|Overall Study|Withdrawal by Subject|8|||
33508853|NCT03107052|62892301|FG000|Overall Study|Protocol Violation|6|||
33508854|NCT03107052|62892302|FG001|Overall Study|Protocol Violation|0|||
33508855|NCT03107052|62892303|FG002|Overall Study|Protocol Violation|3|||
33508856|NCT03107052|62892301|FG000|Overall Study|Lost to Follow-up|4|||
33508857|NCT03107052|62892302|FG001|Overall Study|Lost to Follow-up|0|||
33613037|NCT01954017|63013610|FG002|Overall Study|Death|1|||
33613038|NCT01954017|63013608|FG000|Overall Study|Withdrawal by Subject|0|||
33613039|NCT01954017|63013609|FG001|Overall Study|Withdrawal by Subject|1|||
33451475|NCT00141297|62826152|FG009|Overall Study|Adverse Event|0|||
33451476|NCT00141297|62826143|FG000|Overall Study|Death|1|||
33451477|NCT00141297|62826144|FG001|Overall Study|Death|0|||
33451478|NCT00141297|62826145|FG002|Overall Study|Death|0|||
33508858|NCT03107052|62892303|FG002|Overall Study|Lost to Follow-up|1|||
33508859|NCT03107052|62892301|FG000|Overall Study|Lack of Efficacy|23|||
33613040|NCT01954017|63013610|FG002|Overall Study|Withdrawal by Subject|0|||
33613041|NCT01954017|63013608|FG000|Overall Study|Protocol Violation|0|||
33613042|NCT01954017|63013609|FG001|Overall Study|Protocol Violation|3|||
33613043|NCT01954017|63013610|FG002|Overall Study|Protocol Violation|2|||
33613044|NCT01954017|63013608|FG000|Overall Study|Necrotizing enterocolitis|1|||
33613045|NCT01954017|63013609|FG001|Overall Study|Necrotizing enterocolitis|0|||
33613046|NCT01954017|63013610|FG002|Overall Study|Necrotizing enterocolitis|1|||
33613047|NCT01954017|63013608|FG000|Overall Study|Enteral intake stopped >7 days|0|||
33613048|NCT01954017|63013609|FG001|Overall Study|Enteral intake stopped >7 days|1|||
33613049|NCT01954017|63013610|FG002|Overall Study|Enteral intake stopped >7 days|1|||
33613050|NCT01954017|63013608|FG000|Overall Study|All other reasons|2|||
33613051|NCT01954017|63013609|FG001|Overall Study|All other reasons|2|||
33613052|NCT01954017|63013610|FG002|Overall Study|All other reasons|7|||
33613053|NCT02154139|63013644|FG000|Overall Study|Injection not administered|2|||
33613054|NCT02154139|63013644|FG000|Overall Study|Other|2|||
33613055|NCT02154139|63013644|FG000|Overall Study|Investigator transferred|3|||
33613056|NCT02245568|63013648|FG000|Overall Study|Study terminated by Sponsor|346|||
33613057|NCT02245568|63013648|FG000|Overall Study|Adverse Event|144|||
33613058|NCT02245568|63013648|FG000|Overall Study|Lack of Efficacy|98|||
33613059|NCT02245568|63013648|FG000|Overall Study|Withdrawal by Caregiver|85|||
33613060|NCT02245568|63013648|FG000|Overall Study|Withdrawal by Subject|77|||
33613061|NCT02245568|63013648|FG000|Overall Study|Withdrawal by Legal Representative|31|||
33613062|NCT02245568|63013648|FG000|Overall Study|Missing (Site closure)|16|||
33613063|NCT02245568|63013648|FG000|Overall Study|Physician Decision|14|||
33613064|NCT02245568|63013648|FG000|Overall Study|Non-compliance with study drug|11|||
33613065|NCT02245568|63013648|FG000|Overall Study|Death|9|||
33613066|NCT02245568|63013648|FG000|Overall Study|Blue staining|6|||
33613067|NCT02245568|63013648|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
33613068|NCT02245568|63013648|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
33613069|NCT02245568|63013648|FG000|Overall Study|Lost to Follow-up|5|||
33613070|NCT02154061|63013654|FG000|Overall Study|Pregnancy|1|||
33613071|NCT02154061|63013655|FG001|Overall Study|Pregnancy|0|||
33613072|NCT02154061|63013654|FG000|Overall Study|enrolled but not vaccinated|1|||
33613073|NCT02154061|63013655|FG001|Overall Study|enrolled but not vaccinated|0|||
33508860|NCT03107052|62892302|FG001|Overall Study|Lack of Efficacy|7|||
33508861|NCT03107052|62892303|FG002|Overall Study|Lack of Efficacy|4|||
33613074|NCT01907217|63013663|FG000|Overall Study|Withdrawal by Subject|0|||
33613075|NCT01907217|63013664|FG001|Overall Study|Withdrawal by Subject|2|||
33613076|NCT01953783|63013672|FG000|Overall Study|Progressive disease|2|||
33613077|NCT02134015|63013678|FG000|Overall Study|Protocol Violation|0|||
33613078|NCT02134015|63013679|FG001|Overall Study|Protocol Violation|1|||
33613079|NCT02134015|63013678|FG000|Overall Study|Death|2|||
33508862|NCT03107052|62892301|FG000|Overall Study|Other than specified|4|||
33508863|NCT03107052|62892302|FG001|Overall Study|Other than specified|2|||
33508864|NCT03107052|62892303|FG002|Overall Study|Other than specified|0|||
33508865|NCT03107052|62892301|FG000|Overall Study|Study terminated due to futility|67|||
33508866|NCT03107052|62892302|FG001|Overall Study|Study terminated due to futility|31|||
33508867|NCT03107052|62892303|FG002|Overall Study|Study terminated due to futility|23|||
33508868|NCT04050371|62892313|FG000|Overall Study|Withdrawal by Subject|1|||
33508869|NCT04050371|62892314|FG001|Overall Study|Withdrawal by Subject|0|||
33508870|NCT04447287|62892323|FG000|Period 1: Run-in Period|Adverse Event|3|||
33508871|NCT04447287|62892324|FG001|Period 1: Run-in Period|Adverse Event|0|||
33508872|NCT04447287|62892325|FG002|Period 1: Run-in Period|Adverse Event|0|||
33508873|NCT04447287|62892323|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
33613080|NCT02134015|63013679|FG001|Overall Study|Death|1|||
33613081|NCT02134015|63013678|FG000|Overall Study|Reason not provided|1|||
33613082|NCT02134015|63013679|FG001|Overall Study|Reason not provided|2|||
33613083|NCT02134015|63013678|FG000|Overall Study|Clinical progression|14|||
33613084|NCT02134015|63013679|FG001|Overall Study|Clinical progression|7|||
33613085|NCT02134015|63013678|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
33613086|NCT02134015|63013679|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
33613087|NCT02134015|63013678|FG000|Overall Study|Study terminated by sponsor|2|||
33613088|NCT02134015|63013679|FG001|Overall Study|Study terminated by sponsor|3|||
33613089|NCT02134015|63013678|FG000|Overall Study|Adverse Event|9|||
33451479|NCT00141297|62826146|FG003|Overall Study|Death|0|||
33451480|NCT00141297|62826147|FG004|Overall Study|Death|0|||
33451481|NCT00141297|62826148|FG005|Overall Study|Death|0|||
33451482|NCT00141297|62826149|FG006|Overall Study|Death|0|||
33451483|NCT00141297|62826150|FG007|Overall Study|Death|0|||
33451484|NCT00141297|62826151|FG008|Overall Study|Death|1|||
33451485|NCT00141297|62826152|FG009|Overall Study|Death|0|||
33451486|NCT00141297|62826143|FG000|Overall Study|Withdrawal by Subject|0|||
33451487|NCT00141297|62826144|FG001|Overall Study|Withdrawal by Subject|0|||
33451488|NCT00141297|62826145|FG002|Overall Study|Withdrawal by Subject|0|||
33451489|NCT00141297|62826146|FG003|Overall Study|Withdrawal by Subject|0|||
33451490|NCT00141297|62826147|FG004|Overall Study|Withdrawal by Subject|0|||
33451491|NCT00141297|62826148|FG005|Overall Study|Withdrawal by Subject|0|||
33451492|NCT00141297|62826149|FG006|Overall Study|Withdrawal by Subject|0|||
33451493|NCT00141297|62826150|FG007|Overall Study|Withdrawal by Subject|0|||
33451494|NCT00141297|62826151|FG008|Overall Study|Withdrawal by Subject|1|||
33451495|NCT00141297|62826152|FG009|Overall Study|Withdrawal by Subject|0|||
33451496|NCT00141297|62826143|FG000|Overall Study|Other|0|||
33451497|NCT00141297|62826144|FG001|Overall Study|Other|0|||
33451498|NCT00141297|62826145|FG002|Overall Study|Other|0|||
33451499|NCT00141297|62826146|FG003|Overall Study|Other|1|||
33508874|NCT04447287|62892324|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
33508875|NCT04447287|62892325|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
33508876|NCT04447287|62892323|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
33508877|NCT04447287|62892324|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
33508878|NCT04447287|62892325|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
33508879|NCT01879319|62892346|FG000|Overall Study|Withdrawal by Subject|1|||
33508880|NCT01879319|62892347|FG001|Overall Study|Withdrawal by Subject|0|||
33508881|NCT01879319|62892346|FG000|Overall Study|Lost to Follow-up|1|||
33508882|NCT01879319|62892347|FG001|Overall Study|Lost to Follow-up|5|||
33508883|NCT03102918|62892355|FG000|Overall Study|Protocol Violation|1|||
33508884|NCT03102918|62892356|FG001|Overall Study|Protocol Violation|0|||
33508885|NCT03128307|62892362|FG000|Overall Study|Lost to Follow-up|29|||
33508886|NCT03128307|62892362|FG000|Overall Study|Withdrawal by Subject|5|||
33508887|NCT03102762|62892368|FG000|Overall Study|Lost to Follow-up|1|||
33508888|NCT03102762|62892369|FG001|Overall Study|Lost to Follow-up|0|||
33508889|NCT01346475|62892382|FG000|First Intervention|Lost to Follow-up|4|||
33508890|NCT01346475|62892383|FG001|First Intervention|Lost to Follow-up|3|||
33508891|NCT01338636|62892389|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
33508892|NCT00322218|62892395|FG000|Overall Study|Death|3|||
33508893|NCT00322218|62892396|FG001|Overall Study|Death|6|||
33508894|NCT02873754|62892402|FG000|Overall Study|Lost to Follow-up|5|||
33508895|NCT02873754|62892402|FG000|Overall Study|Couldn't complete study procedures|1|||
33508896|NCT03287414|62892408|FG000|Treatment Epoch|Adverse Event|0|||
33508897|NCT03287414|62892409|FG001|Treatment Epoch|Adverse Event|1|||
33508898|NCT03287414|62892408|FG000|Treatment Epoch|Study terminated by sponsor|2|||
33508899|NCT03287414|62892409|FG001|Treatment Epoch|Study terminated by sponsor|2|||
33508900|NCT03287414|62892408|FG000|Treatment Epoch|Subject/Guardian decision|4|||
33508901|NCT03287414|62892409|FG001|Treatment Epoch|Subject/Guardian decision|0|||
33508902|NCT03287414|62892408|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
33508903|NCT03287414|62892409|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
33508904|NCT03287414|62892408|FG000|Treatment Epoch|Withdrawal by Subject|1|||
33508905|NCT03287414|62892409|FG001|Treatment Epoch|Withdrawal by Subject|0|||
33508906|NCT03287414|62892408|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
33508907|NCT03287414|62892409|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
33508908|NCT03287414|62892408|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
33508909|NCT03287414|62892409|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
33508910|NCT03101592|62892439|FG000|Overall Study|participant files could not be located|111|||
33508911|NCT03101592|62892440|FG001|Overall Study|participant files could not be located|170|||
33508912|NCT03101592|62892441|FG002|Overall Study|participant files could not be located|118|||
33508913|NCT04046939|62892459|FG000|Primary Assessment Period|Adverse Event|1|||
33508914|NCT04046939|62892460|FG001|Primary Assessment Period|Adverse Event|0|||
33508915|NCT04046939|62892461|FG002|Primary Assessment Period|Adverse Event|0|||
33508916|NCT04046939|62892462|FG003|Primary Assessment Period|Adverse Event|0|||
33508917|NCT04046939|62892459|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
33508918|NCT04046939|62892460|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
33508919|NCT04046939|62892461|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
33508920|NCT04046939|62892462|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
33508921|NCT04046939|62892459|FG000|Primary Assessment Period|Physician Decision|0|||
33508922|NCT04046939|62892460|FG001|Primary Assessment Period|Physician Decision|0|||
33508923|NCT04046939|62892461|FG002|Primary Assessment Period|Physician Decision|1|||
33508924|NCT04046939|62892462|FG003|Primary Assessment Period|Physician Decision|0|||
33508925|NCT04046939|62892459|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
33508926|NCT04046939|62892460|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
33508927|NCT04046939|62892461|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
33508928|NCT04046939|62892462|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
33508929|NCT04042103|62892478|FG000|Overall Study|Lost to Follow-up|1|||
33508930|NCT04042103|62892478|FG000|Overall Study|Withdrawal by Subject|1|||
33508931|NCT02955797|62892486|FG000|Overall Study|Protocol Violation|1|||
33508932|NCT02955797|62892487|FG001|Overall Study|Protocol Violation|0|||
33508933|NCT02955797|62892488|FG002|Overall Study|Protocol Violation|0|||
33508934|NCT02955797|62892489|FG003|Overall Study|Protocol Violation|1|||
33508935|NCT02955797|62892486|FG000|Overall Study|Withdrawal by Subject|2|||
33508936|NCT02955797|62892487|FG001|Overall Study|Withdrawal by Subject|2|||
33508937|NCT02955797|62892488|FG002|Overall Study|Withdrawal by Subject|0|||
33508938|NCT02955797|62892489|FG003|Overall Study|Withdrawal by Subject|1|||
33508939|NCT02955797|62892486|FG000|Overall Study|Lost to Follow-up|0|||
33508940|NCT02955797|62892487|FG001|Overall Study|Lost to Follow-up|1|||
33508941|NCT02955797|62892488|FG002|Overall Study|Lost to Follow-up|0|||
33508942|NCT02955797|62892489|FG003|Overall Study|Lost to Follow-up|0|||
33508943|NCT03101514|62892502|FG000|Overall Study|Withdrawal by Subject|4|||
33508944|NCT03101514|62892502|FG000|Overall Study|Protocol Violation|2|||
33613090|NCT02134015|63013679|FG001|Overall Study|Adverse Event|10|||
33508945|NCT03101514|62892502|FG000|Overall Study|patient's information was incomplete|1|||
33508946|NCT02702518|62892508|FG000|Overall Study|Lost to Follow-up|3|||
33508947|NCT02702518|62892509|FG001|Overall Study|Lost to Follow-up|4|||
33508948|NCT04039503|62892519|FG000|Overall Study|Adverse Event|3|||
33508949|NCT04039503|62892520|FG001|Overall Study|Adverse Event|0|||
33508950|NCT04039503|62892521|FG002|Overall Study|Adverse Event|2|||
33508951|NCT04039503|62892522|FG003|Overall Study|Adverse Event|0|||
33508952|NCT04039503|62892519|FG000|Overall Study|Lost to Follow-up|0|||
33508953|NCT04039503|62892520|FG001|Overall Study|Lost to Follow-up|0|||
33508954|NCT04039503|62892521|FG002|Overall Study|Lost to Follow-up|1|||
33508955|NCT04039503|62892522|FG003|Overall Study|Lost to Follow-up|0|||
33508956|NCT04039503|62892519|FG000|Overall Study|Protocol Violation|0|||
33508957|NCT04039503|62892520|FG001|Overall Study|Protocol Violation|1|||
33508958|NCT04039503|62892521|FG002|Overall Study|Protocol Violation|2|||
33508959|NCT04039503|62892522|FG003|Overall Study|Protocol Violation|1|||
33508960|NCT04039503|62892519|FG000|Overall Study|Withdrawal by Subject|4|||
33508961|NCT04039503|62892520|FG001|Overall Study|Withdrawal by Subject|3|||
33508962|NCT04039503|62892521|FG002|Overall Study|Withdrawal by Subject|5|||
33508963|NCT04039503|62892522|FG003|Overall Study|Withdrawal by Subject|2|||
33508964|NCT03131895|62892559|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
33508965|NCT03131895|62892560|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
33508966|NCT03131895|62892561|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
33508967|NCT03131895|62892562|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
33508968|NCT03131895|62892559|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
33508969|NCT03131895|62892560|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
33508970|NCT03131895|62892561|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
33508971|NCT03131895|62892562|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
33508972|NCT03131895|62892559|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33508973|NCT03131895|62892560|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
33508974|NCT03131895|62892561|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33508975|NCT03131895|62892562|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
33508976|NCT03131895|62892559|FG000|Washout Period (at Least 5 Days)|Other|0|||
33508977|NCT03131895|62892560|FG001|Washout Period (at Least 5 Days)|Other|0|||
33508978|NCT03131895|62892561|FG002|Washout Period (at Least 5 Days)|Other|2|||
33508979|NCT03131895|62892562|FG003|Washout Period (at Least 5 Days)|Other|0|||
33508980|NCT03131895|62892559|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
33508981|NCT03131895|62892560|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
33508982|NCT03131895|62892561|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
33508983|NCT03131895|62892562|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
33508984|NCT03131895|62892559|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
33508985|NCT03131895|62892560|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
33508986|NCT03131895|62892561|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
33508987|NCT03131895|62892562|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
33508988|NCT04039919|62892577|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33508989|NCT04039919|62892578|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33508990|NCT04039919|62892579|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33508991|NCT04039919|62892580|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33508992|NCT04039919|62892581|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33508993|NCT04039919|62892577|FG000|Treatment Period 1|Sponsor's decision|0|||
33508994|NCT04039919|62892578|FG001|Treatment Period 1|Sponsor's decision|0|||
33508995|NCT04039919|62892579|FG002|Treatment Period 1|Sponsor's decision|0|||
33508996|NCT04039919|62892580|FG003|Treatment Period 1|Sponsor's decision|0|||
33508997|NCT04039919|62892581|FG004|Treatment Period 1|Sponsor's decision|16|||
33508998|NCT04039919|62892577|FG000|Treatment Period 5|Withdrawal by Subject|1|||
33508999|NCT04039919|62892578|FG001|Treatment Period 5|Withdrawal by Subject|0|||
33509000|NCT04039919|62892579|FG002|Treatment Period 5|Withdrawal by Subject|0|||
33613091|NCT02134015|63013678|FG000|Overall Study|Withdrawal by Subject|3|||
33509001|NCT04039919|62892580|FG003|Treatment Period 5|Withdrawal by Subject|0|||
33509002|NCT04039919|62892581|FG004|Treatment Period 5|Withdrawal by Subject|0|||
33509003|NCT04035473|62892617|FG000|Screening/Baseline|Death|0|||
33509004|NCT04035473|62892618|FG001|Screening/Baseline|Death|1|||
33509005|NCT04035473|62892617|FG000|Screening/Baseline|Adverse Event|0|||
33509006|NCT04035473|62892618|FG001|Screening/Baseline|Adverse Event|1|||
33509007|NCT04035473|62892617|FG000|Follow-up Period|Adverse Event|2|||
33509008|NCT04035473|62892618|FG001|Follow-up Period|Adverse Event|0|||
33509009|NCT04032977|62892626|FG000|Overall Study|Withdrawal by Subject|6|||
33509010|NCT04032977|62892627|FG001|Overall Study|Withdrawal by Subject|1|||
33509011|NCT04032977|62892626|FG000|Overall Study|Lost to Follow-up|2|||
33509012|NCT04032977|62892627|FG001|Overall Study|Lost to Follow-up|7|||
33509013|NCT04032977|62892626|FG000|Overall Study|Pregnancy|1|||
33613092|NCT02134015|63013679|FG001|Overall Study|Withdrawal by Subject|7|||
33613093|NCT01924845|63013685|FG000|Overall Study|Adverse Event|3|||
33509014|NCT04032977|62892627|FG001|Overall Study|Pregnancy|0|||
33509015|NCT04030247|62892633|FG000|Overall Study|Withdrawal by Subject|4|||
33509016|NCT04030247|62892633|FG000|Overall Study|Lost to Follow-up|13|||
33509017|NCT02915978|62892640|FG000|Overall Study|Adverse Event|2|||
33509018|NCT02915978|62892641|FG001|Overall Study|Adverse Event|1|||
33509019|NCT02915978|62892642|FG002|Overall Study|Adverse Event|0|||
33509020|NCT02701192|62892650|FG000|Overall Study|Protocol Violation|2|||
33509021|NCT02701192|62892650|FG000|Overall Study|Lost to Follow-up|4|||
33509022|NCT03101358|62892658|FG000|Overall Study|Non-compliance with study schedule|1|||
33509023|NCT03101358|62892659|FG001|Overall Study|Non-compliance with study schedule|0|||
33509024|NCT03101358|62892660|FG002|Overall Study|Non-compliance with study schedule|0|||
33509025|NCT03101358|62892661|FG003|Overall Study|Non-compliance with study schedule|1|||
33509026|NCT03101358|62892658|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
33509027|NCT03101358|62892659|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
33509028|NCT03101358|62892660|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
33509029|NCT03101358|62892661|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
33509030|NCT03101358|62892658|FG000|Overall Study|Physician Decision|1|||
33509031|NCT03101358|62892659|FG001|Overall Study|Physician Decision|0|||
33509032|NCT03101358|62892660|FG002|Overall Study|Physician Decision|0|||
33509033|NCT03101358|62892661|FG003|Overall Study|Physician Decision|3|||
33509034|NCT03101358|62892658|FG000|Overall Study|Adverse Event|0|||
33509035|NCT03101358|62892659|FG001|Overall Study|Adverse Event|0|||
33509036|NCT03101358|62892660|FG002|Overall Study|Adverse Event|1|||
33509037|NCT03101358|62892661|FG003|Overall Study|Adverse Event|0|||
33509038|NCT03101358|62892658|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
33509039|NCT03101358|62892659|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
33509040|NCT03101358|62892660|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
33509041|NCT03101358|62892661|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
33509042|NCT03101358|62892658|FG000|Overall Study|Lost to Follow-up|1|||
33509043|NCT03101358|62892659|FG001|Overall Study|Lost to Follow-up|0|||
33509044|NCT03101358|62892660|FG002|Overall Study|Lost to Follow-up|0|||
33509045|NCT03101358|62892661|FG003|Overall Study|Lost to Follow-up|1|||
33509046|NCT03657095|62892674|FG000|Overall Study|Withdrawal by Subject|1|||
33509047|NCT03657095|62892675|FG001|Overall Study|Withdrawal by Subject|1|||
33509048|NCT03657095|62892674|FG000|Overall Study|Adverse Event|0|||
33509049|NCT03657095|62892675|FG001|Overall Study|Adverse Event|3|||
33509050|NCT03657095|62892674|FG000|Overall Study|Study Terminated by Sponsor|58|||
33509051|NCT03657095|62892675|FG001|Overall Study|Study Terminated by Sponsor|49|||
33509052|NCT03100344|62892685|FG000|Overall Study|Adverse Event|0|||
33509053|NCT03100344|62892686|FG001|Overall Study|Adverse Event|3|||
33509054|NCT03100344|62892687|FG002|Overall Study|Adverse Event|2|||
33509055|NCT03100344|62892688|FG003|Overall Study|Adverse Event|3|||
33509056|NCT03100344|62892685|FG000|Overall Study|Lack of Efficacy|2|||
33509057|NCT03100344|62892686|FG001|Overall Study|Lack of Efficacy|0|||
33509058|NCT03100344|62892687|FG002|Overall Study|Lack of Efficacy|0|||
33509059|NCT03100344|62892688|FG003|Overall Study|Lack of Efficacy|0|||
33509060|NCT03100344|62892685|FG000|Overall Study|Protocol Violation|1|||
33509061|NCT03100344|62892686|FG001|Overall Study|Protocol Violation|0|||
33509062|NCT03100344|62892687|FG002|Overall Study|Protocol Violation|0|||
33509063|NCT03100344|62892688|FG003|Overall Study|Protocol Violation|0|||
33509064|NCT03100344|62892685|FG000|Overall Study|Withdrawal by Subject|10|||
33451500|NCT00141297|62826147|FG004|Overall Study|Other|5|||
33509065|NCT03100344|62892686|FG001|Overall Study|Withdrawal by Subject|7|||
33509066|NCT03100344|62892687|FG002|Overall Study|Withdrawal by Subject|4|||
33509067|NCT03100344|62892688|FG003|Overall Study|Withdrawal by Subject|8|||
33509068|NCT03100344|62892685|FG000|Overall Study|Lost to Follow-up|1|||
33509069|NCT03100344|62892686|FG001|Overall Study|Lost to Follow-up|1|||
33509070|NCT03100344|62892687|FG002|Overall Study|Lost to Follow-up|1|||
33509071|NCT03100344|62892688|FG003|Overall Study|Lost to Follow-up|1|||
33509072|NCT02951533|62892701|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
33509073|NCT02951533|62892702|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
33509074|NCT02951533|62892703|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
33509075|NCT02951533|62892701|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
33451501|NCT00141297|62826148|FG005|Overall Study|Other|0|||
33451502|NCT00141297|62826149|FG006|Overall Study|Other|0|||
33451503|NCT00141297|62826150|FG007|Overall Study|Other|0|||
33451504|NCT00141297|62826151|FG008|Overall Study|Other|2|||
33509076|NCT02951533|62892702|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
33451505|NCT00141297|62826152|FG009|Overall Study|Other|0|||
33451506|NCT00141297|62826143|FG000|Overall Study|Progressive Disease|2|||
33451507|NCT00141297|62826144|FG001|Overall Study|Progressive Disease|3|||
33451508|NCT00141297|62826145|FG002|Overall Study|Progressive Disease|6|||
33451509|NCT00141297|62826146|FG003|Overall Study|Progressive Disease|2|||
33451510|NCT00141297|62826147|FG004|Overall Study|Progressive Disease|15|||
33451511|NCT00141297|62826148|FG005|Overall Study|Progressive Disease|2|||
33613094|NCT01924845|63013685|FG000|Overall Study|Withdrawal by Subject|2|||
33613095|NCT01924845|63013685|FG000|Overall Study|Protocol Violation|1|||
33613096|NCT01630135|63013691|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
33613097|NCT01630135|63013692|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
33613098|NCT01691248|63013700|FG000|Overall Study|Protocol Violation|43|||
33613099|NCT01691248|63013701|FG001|Overall Study|Protocol Violation|27|||
33613100|NCT01691248|63013700|FG000|Overall Study|Adverse Event|24|||
33613101|NCT01691248|63013701|FG001|Overall Study|Adverse Event|22|||
33613102|NCT01691248|63013700|FG000|Overall Study|Withdrawal by Subject|20|||
33613103|NCT01691248|63013701|FG001|Overall Study|Withdrawal by Subject|18|||
33613104|NCT01691248|63013700|FG000|Overall Study|Confirmed CDAD|14|||
33613105|NCT01691248|63013701|FG001|Overall Study|Confirmed CDAD|31|||
33613106|NCT01691248|63013700|FG000|Overall Study|Lost to Follow-up|2|||
33613107|NCT01691248|63013701|FG001|Overall Study|Lost to Follow-up|5|||
33613108|NCT01691248|63013700|FG000|Overall Study|Reason not provided|4|||
33613109|NCT01691248|63013701|FG001|Overall Study|Reason not provided|4|||
33613110|NCT01691248|63013700|FG000|Overall Study|Not Treated|4|||
33613111|NCT01691248|63013701|FG001|Overall Study|Not Treated|7|||
33613112|NCT01924767|63013712|FG000|Overall Study|Adverse Event|1|||
33613113|NCT01924767|63013713|FG001|Overall Study|Adverse Event|0|||
33613114|NCT01924767|63013714|FG002|Overall Study|Adverse Event|1|||
33613115|NCT01924767|63013715|FG003|Overall Study|Adverse Event|0|||
33613116|NCT01924767|63013716|FG004|Overall Study|Adverse Event|0|||
33613117|NCT01691092|63013733|FG000|Overall Study|Lost to Follow-up|10|||
33613118|NCT01691092|63013733|FG000|Overall Study|Physician Decision|4|||
33613119|NCT01691092|63013733|FG000|Overall Study|Withdrawal by Subject|3|||
33613120|NCT01691092|63013733|FG000|Overall Study|non-compliance|3|||
33613121|NCT01691092|63013733|FG000|Overall Study|used for different study|2|||
33613122|NCT01691092|63013733|FG000|Overall Study|screen fail|19|||
33613123|NCT02133001|63013739|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
33613124|NCT02133001|63013740|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
33613125|NCT02133001|63013739|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
33613126|NCT02133001|63013740|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
33613127|NCT02133001|63013739|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
33613128|NCT02133001|63013740|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
33613129|NCT02133001|63013739|FG000|Double Blind (Day 1-25)|Other|2|||
33613130|NCT02133001|63013740|FG001|Double Blind (Day 1-25)|Other|2|||
33613131|NCT02133001|63013739|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
33613132|NCT02133001|63013740|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
33613133|NCT02133001|63013739|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
33613134|NCT02133001|63013740|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
33613135|NCT02133001|63013739|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
33613136|NCT02133001|63013740|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
33613137|NCT02133001|63013739|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
33613138|NCT02133001|63013740|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
33613139|NCT01709578|63013751|FG000|Overall Study|Rescued and entered in long term safety|63|||
33613140|NCT01709578|63013752|FG001|Overall Study|Rescued and entered in long term safety|25|||
33613141|NCT01709578|63013753|FG002|Overall Study|Rescued and entered in long term safety|26|||
33613142|NCT01709578|63013751|FG000|Overall Study|Adverse Event|9|||
33613143|NCT01709578|63013752|FG001|Overall Study|Adverse Event|18|||
33613144|NCT01709578|63013753|FG002|Overall Study|Adverse Event|17|||
33613145|NCT01709578|63013751|FG000|Overall Study|Lack of Efficacy|5|||
33613146|NCT01709578|63013752|FG001|Overall Study|Lack of Efficacy|4|||
33613147|NCT01709578|63013753|FG002|Overall Study|Lack of Efficacy|2|||
33613148|NCT01709578|63013751|FG000|Overall Study|Poor compliance to protocol|1|||
33613149|NCT01709578|63013752|FG001|Overall Study|Poor compliance to protocol|2|||
33613150|NCT01709578|63013753|FG002|Overall Study|Poor compliance to protocol|1|||
33613151|NCT01709578|63013751|FG000|Overall Study|Other, not related to safety or efficacy|2|||
33613152|NCT01709578|63013752|FG001|Overall Study|Other, not related to safety or efficacy|7|||
33613153|NCT01709578|63013753|FG002|Overall Study|Other, not related to safety or efficacy|5|||
33613154|NCT02132767|63013763|FG000|Overall Study|Death|3|||
33613155|NCT02132767|63013764|FG001|Overall Study|Death|2|||
33613156|NCT02132767|63013763|FG000|Overall Study|Withdrawal by Subject|10|||
33613157|NCT02132767|63013764|FG001|Overall Study|Withdrawal by Subject|9|||
33613158|NCT02132767|63013763|FG000|Overall Study|Lost to Follow-up|4|||
33613159|NCT02132767|63013764|FG001|Overall Study|Lost to Follow-up|4|||
33613160|NCT02153905|63013772|FG000|Overall Study|Death|1|||
33451512|NCT00141297|62826149|FG006|Overall Study|Progressive Disease|3|||
33613161|NCT02153905|63013773|FG001|Overall Study|Death|0|||
33613162|NCT02153827|63013781|FG000|Overall Study|Lost to Follow-up|3|||
33613163|NCT02153827|63013782|FG001|Overall Study|Lost to Follow-up|9|||
33613164|NCT02153359|63013788|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
33613165|NCT02153359|63013789|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
33613166|NCT01691014|63013802|FG000|Overall Study|Premature Termination|1|||
33613167|NCT01691014|63013803|FG001|Overall Study|Premature Termination|6|||
33613168|NCT01691014|63013804|FG002|Overall Study|Premature Termination|0|||
33613169|NCT01691014|63013805|FG003|Overall Study|Premature Termination|3|||
33613170|NCT01691014|63013802|FG000|Overall Study|Other|0|||
33613171|NCT01691014|63013803|FG001|Overall Study|Other|0|||
33613172|NCT01691014|63013804|FG002|Overall Study|Other|2|||
33613173|NCT01691014|63013805|FG003|Overall Study|Other|0|||
33613174|NCT01691014|63013802|FG000|Overall Study|Withdrawal by Subject|0|||
33613175|NCT01691014|63013803|FG001|Overall Study|Withdrawal by Subject|1|||
33613176|NCT01691014|63013804|FG002|Overall Study|Withdrawal by Subject|1|||
33613177|NCT01691014|63013805|FG003|Overall Study|Withdrawal by Subject|1|||
33613178|NCT01691014|63013802|FG000|Overall Study|Adverse Event|0|||
33613179|NCT01691014|63013803|FG001|Overall Study|Adverse Event|5|||
33613180|NCT01691014|63013804|FG002|Overall Study|Adverse Event|1|||
33613181|NCT01691014|63013805|FG003|Overall Study|Adverse Event|1|||
33613182|NCT01691014|63013802|FG000|Overall Study|Lack of Efficacy|2|||
33613183|NCT01691014|63013803|FG001|Overall Study|Lack of Efficacy|3|||
33509077|NCT02951533|62892703|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
33509078|NCT02951533|62892701|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
33509079|NCT02951533|62892702|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
33509080|NCT02951533|62892703|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
33509081|NCT02951533|62892701|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
33509082|NCT02951533|62892702|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
33509083|NCT02951533|62892703|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
33509084|NCT02951533|62892701|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
33509085|NCT02951533|62892702|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
33509086|NCT02951533|62892703|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
33509087|NCT02951533|62892701|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
33509088|NCT02951533|62892702|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
33509089|NCT02951533|62892703|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
33509090|NCT02951533|62892701|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
33509091|NCT02951533|62892702|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
33509092|NCT02951533|62892703|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
33509093|NCT02951533|62892701|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
33509094|NCT02951533|62892702|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
33509095|NCT02951533|62892703|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
33509096|NCT02951533|62892701|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
33509097|NCT02951533|62892702|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
33509098|NCT02951533|62892703|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
33509099|NCT02951533|62892701|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
33509100|NCT02951533|62892702|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
33509101|NCT02951533|62892703|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
33509102|NCT02951533|62892701|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
33509103|NCT02951533|62892702|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
33509104|NCT02951533|62892703|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
33509105|NCT02700412|62892720|FG000|Overall Study|Adverse Event|6|||
33509106|NCT02700412|62892720|FG000|Overall Study|Death|1|||
33613184|NCT01691014|63013804|FG002|Overall Study|Lack of Efficacy|7|||
33613185|NCT01691014|63013805|FG003|Overall Study|Lack of Efficacy|0|||
33613186|NCT02245412|63013818|FG000|Treatment Period|Death|1|||
33613187|NCT02245412|63013819|FG001|Treatment Period|Death|1|||
33613188|NCT02245412|63013820|FG002|Treatment Period|Death|0|||
33613189|NCT02245412|63013818|FG000|Treatment Period|Physician Decision|1|||
33613190|NCT02245412|63013819|FG001|Treatment Period|Physician Decision|1|||
33613191|NCT02245412|63013820|FG002|Treatment Period|Physician Decision|0|||
33509107|NCT02700412|62892720|FG000|Overall Study|Lack of Efficacy|19|||
33509108|NCT02700412|62892720|FG000|Overall Study|Protocol Violation|5|||
33509109|NCT02700412|62892720|FG000|Overall Study|Withdrawal by Subject|2|||
33509110|NCT03665441|62892726|FG000|Overall Study|survival follow up ongoing|23|||
33509111|NCT03665441|62892727|FG001|Overall Study|survival follow up ongoing|0|||
33509112|NCT03665441|62892726|FG000|Overall Study|Patients ongoing on treatment|9|||
33509113|NCT03665441|62892727|FG001|Overall Study|Patients ongoing on treatment|6|||
33509114|NCT03665441|62892726|FG000|Overall Study|Randomized but not treated|7|||
33509115|NCT03665441|62892727|FG001|Overall Study|Randomized but not treated|11|||
33509116|NCT02699866|62892733|FG000|Overall Study|Withdrawal by Subject|3|||
33509117|NCT02699866|62892733|FG000|Overall Study|Physician Decision|2|||
33509118|NCT02699866|62892733|FG000|Overall Study|Adverse Event|3|||
33509119|NCT03663569|62892737|FG000|Overall Study|Discontinuation of study|11|||
33613192|NCT02245412|63013818|FG000|Treatment Period|Withdrawal by Subject|2|||
33613193|NCT02245412|63013819|FG001|Treatment Period|Withdrawal by Subject|1|||
33613194|NCT02245412|63013820|FG002|Treatment Period|Withdrawal by Subject|0|||
33509120|NCT03663569|62892737|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
33509121|NCT03663569|62892737|FG000|Overall Study|Deceased patient|6|||
33509122|NCT03663569|62892737|FG000|Overall Study|Lost to Follow-up|18|||
33509123|NCT03663569|62892737|FG000|Overall Study|Withdrawal of consent|5|||
33509124|NCT03663569|62892737|FG000|Overall Study|Patient's request|11|||
33509125|NCT03663569|62892737|FG000|Overall Study|Adverse Event|4|||
33509126|NCT03663569|62892737|FG000|Overall Study|Not come to second visit|3|||
33509127|NCT03663569|62892737|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
33509128|NCT03663569|62892737|FG000|Overall Study|Serious adverse event|1|||
33509129|NCT03596762|62892746|FG000|Overall Study|Protocol Violation|0|||
33509130|NCT03596762|62892747|FG001|Overall Study|Protocol Violation|0|||
33509131|NCT03596762|62892748|FG002|Overall Study|Protocol Violation|0|||
33509132|NCT03596762|62892749|FG003|Overall Study|Protocol Violation|0|||
33509133|NCT03596762|62892750|FG004|Overall Study|Protocol Violation|1|||
33509134|NCT03596762|62892746|FG000|Overall Study|Adverse Event|2|||
33509135|NCT03596762|62892747|FG001|Overall Study|Adverse Event|0|||
33509136|NCT03596762|62892748|FG002|Overall Study|Adverse Event|1|||
33509137|NCT03596762|62892749|FG003|Overall Study|Adverse Event|0|||
33509138|NCT03596762|62892750|FG004|Overall Study|Adverse Event|5|||
33509139|NCT03596762|62892746|FG000|Overall Study|Withdrawal by Subject|2|||
33509140|NCT03596762|62892747|FG001|Overall Study|Withdrawal by Subject|1|||
33509141|NCT03596762|62892748|FG002|Overall Study|Withdrawal by Subject|0|||
33509142|NCT03596762|62892749|FG003|Overall Study|Withdrawal by Subject|1|||
33509143|NCT03596762|62892750|FG004|Overall Study|Withdrawal by Subject|1|||
33509144|NCT03663179|62892768|FG000|Overall Study|Withdrawal by Subject|2|||
33509145|NCT03663179|62892769|FG001|Overall Study|Withdrawal by Subject|0|||
33509146|NCT03663179|62892768|FG000|Overall Study|Lost to Follow-up|1|||
33509147|NCT03663179|62892769|FG001|Overall Study|Lost to Follow-up|1|||
33509148|NCT03663179|62892768|FG000|Overall Study|Revealed exclusionary condition|1|||
33509149|NCT03663179|62892769|FG001|Overall Study|Revealed exclusionary condition|0|||
33509150|NCT03662789|62892777|FG000|Overall Study|Lost to Follow-up|1|||
33509151|NCT03662789|62892778|FG001|Overall Study|Lost to Follow-up|2|||
33509152|NCT03662789|62892777|FG000|Overall Study|Could not perform treadmill test|4|||
33509153|NCT03662789|62892778|FG001|Overall Study|Could not perform treadmill test|4|||
33613195|NCT02245412|63013818|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
33613196|NCT02245412|63013819|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
33509154|NCT03662789|62892777|FG000|Overall Study|Death|0|||
33509155|NCT03662789|62892778|FG001|Overall Study|Death|1|||
33509156|NCT03658889|62892786|FG000|Overall Study|Protocol Violation|2|||
33509157|NCT03658889|62892787|FG001|Overall Study|Protocol Violation|0|||
33509158|NCT03655691|62892795|FG000|Overall Study|Adverse Event|0|||
33509159|NCT03655691|62892796|FG001|Overall Study|Adverse Event|0|||
33509160|NCT03655691|62892797|FG002|Overall Study|Adverse Event|1|||
33509161|NCT03655691|62892795|FG000|Overall Study|Lost to Follow-up|1|||
33509162|NCT03655691|62892796|FG001|Overall Study|Lost to Follow-up|1|||
33509163|NCT03655691|62892797|FG002|Overall Study|Lost to Follow-up|2|||
33509164|NCT03655691|62892795|FG000|Overall Study|Protocol Violation|0|||
33509165|NCT03655691|62892796|FG001|Overall Study|Protocol Violation|1|||
33509166|NCT03655691|62892797|FG002|Overall Study|Protocol Violation|0|||
33509167|NCT03655691|62892795|FG000|Overall Study|Withdrawal by Subject|1|||
33509168|NCT03655691|62892796|FG001|Overall Study|Withdrawal by Subject|1|||
33509169|NCT03655691|62892797|FG002|Overall Study|Withdrawal by Subject|0|||
33509170|NCT03658811|62892805|FG000|Overall Study|Lost to Follow-up|3|||
33509171|NCT03631355|62892815|FG000|Overall Study|Lost to Follow-up|1|||
33509172|NCT03631355|62892816|FG001|Overall Study|Lost to Follow-up|2|||
33509173|NCT03629249|62892825|FG000|Overall Study|Study terminated by sponsor|197|||
33509174|NCT03629249|62892826|FG001|Overall Study|Study terminated by sponsor|197|||
33509175|NCT03629249|62892827|FG002|Overall Study|Study terminated by sponsor|194|||
33509176|NCT03629249|62892825|FG000|Overall Study|Protocol deviation|0|||
33509177|NCT03629249|62892826|FG001|Overall Study|Protocol deviation|2|||
33509178|NCT03629249|62892827|FG002|Overall Study|Protocol deviation|5|||
33451513|NCT00141297|62826150|FG007|Overall Study|Progressive Disease|3|||
33451514|NCT00141297|62826151|FG008|Overall Study|Progressive Disease|15|||
33451515|NCT00141297|62826152|FG009|Overall Study|Progressive Disease|6|||
33451516|NCT00141297|62826143|FG000|Overall Study|Transitioned|0|||
33451517|NCT00141297|62826144|FG001|Overall Study|Transitioned|0|||
33451518|NCT00141297|62826145|FG002|Overall Study|Transitioned|0|||
33509179|NCT03629249|62892825|FG000|Overall Study|Subject decision|1|||
33509180|NCT03629249|62892826|FG001|Overall Study|Subject decision|1|||
33509181|NCT03629249|62892827|FG002|Overall Study|Subject decision|3|||
33509182|NCT03629249|62892825|FG000|Overall Study|Adverse Event|1|||
33509183|NCT03629249|62892826|FG001|Overall Study|Adverse Event|1|||
33509184|NCT03629249|62892827|FG002|Overall Study|Adverse Event|0|||
33509185|NCT03629249|62892825|FG000|Overall Study|Death|1|||
33509186|NCT03629249|62892826|FG001|Overall Study|Death|0|||
33509187|NCT03629249|62892827|FG002|Overall Study|Death|0|||
33451519|NCT00141297|62826146|FG003|Overall Study|Transitioned|0|||
33451520|NCT00141297|62826147|FG004|Overall Study|Transitioned|1|||
33451521|NCT00141297|62826148|FG005|Overall Study|Transitioned|0|||
33451522|NCT00141297|62826149|FG006|Overall Study|Transitioned|0|||
33451523|NCT00141297|62826150|FG007|Overall Study|Transitioned|0|||
33509188|NCT03629249|62892825|FG000|Overall Study|Physician Decision|1|||
33509189|NCT03629249|62892826|FG001|Overall Study|Physician Decision|0|||
33509190|NCT03629249|62892827|FG002|Overall Study|Physician Decision|0|||
33613197|NCT02245412|63013820|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
33509191|NCT03628781|62892837|FG000|Overall Study|Lost to Follow-up|16|||
33509192|NCT03628781|62892838|FG001|Overall Study|Lost to Follow-up|8|||
33509193|NCT03628781|62892837|FG000|Overall Study|Withdrawal by Subject|16|||
33509194|NCT03628781|62892838|FG001|Overall Study|Withdrawal by Subject|1|||
33509195|NCT03371251|62892850|FG000|Overall Study|Withdrawal by Subject|1|||
33509196|NCT03371251|62892851|FG001|Overall Study|Withdrawal by Subject|0|||
33509197|NCT03371251|62892852|FG002|Overall Study|Withdrawal by Subject|1|||
33509198|NCT03371251|62892853|FG003|Overall Study|Withdrawal by Subject|0|||
33509199|NCT03371251|62892854|FG004|Overall Study|Withdrawal by Subject|2|||
33509200|NCT03371251|62892855|FG005|Overall Study|Withdrawal by Subject|2|||
33509201|NCT03371251|62892850|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
33509202|NCT03371251|62892851|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
33509203|NCT03371251|62892852|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
33509204|NCT03371251|62892853|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
33509205|NCT03371251|62892854|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
33509206|NCT03371251|62892855|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
33509207|NCT03371251|62892850|FG000|Overall Study|Adverse Event|0|||
33509208|NCT03371251|62892851|FG001|Overall Study|Adverse Event|0|||
33509209|NCT03371251|62892852|FG002|Overall Study|Adverse Event|0|||
33509210|NCT03371251|62892853|FG003|Overall Study|Adverse Event|0|||
33613198|NCT02245412|63013818|FG000|Follow-Up Period|Death|4|||
33613199|NCT02245412|63013819|FG001|Follow-Up Period|Death|2|||
33509211|NCT03371251|62892854|FG004|Overall Study|Adverse Event|1|||
33509212|NCT03371251|62892855|FG005|Overall Study|Adverse Event|0|||
33509213|NCT03371251|62892850|FG000|Overall Study|Decision by Sponsor|0|||
33509214|NCT03371251|62892851|FG001|Overall Study|Decision by Sponsor|0|||
33509215|NCT03371251|62892852|FG002|Overall Study|Decision by Sponsor|0|||
33509216|NCT03371251|62892853|FG003|Overall Study|Decision by Sponsor|0|||
33509217|NCT03371251|62892854|FG004|Overall Study|Decision by Sponsor|2|||
33509218|NCT03371251|62892855|FG005|Overall Study|Decision by Sponsor|0|||
33509219|NCT03370471|62892874|FG000|Overall Study|Withdrawal by Subject|6|||
33509220|NCT03370471|62892875|FG001|Overall Study|Withdrawal by Subject|1|||
33509221|NCT03370471|62892874|FG000|Overall Study|Unable to access veins for blood draw|0|||
33509222|NCT03370471|62892875|FG001|Overall Study|Unable to access veins for blood draw|1|||
33509223|NCT03370471|62892874|FG000|Overall Study|Screen fail|1|||
33509224|NCT03370471|62892875|FG001|Overall Study|Screen fail|0|||
33509225|NCT03349645|62892883|FG000|Overall Study|Sponsor Terminated Study|75|||
33509226|NCT03349645|62892883|FG000|Overall Study|Withdrawal by Subject|4|||
33509227|NCT03349645|62892883|FG000|Overall Study|Protocol Violation|1|||
33509228|NCT03349645|62892883|FG000|Overall Study|Other|2|||
33509229|NCT03349333|62892887|FG000|Overall Study|Progression of Disease|36|||
33509230|NCT03349333|62892887|FG000|Overall Study|Adverse Event|11|||
33509231|NCT03349333|62892887|FG000|Overall Study|Other|6|||
33509232|NCT03349333|62892887|FG000|Overall Study|Withdrawal by Subject|5|||
33509233|NCT03349333|62892887|FG000|Overall Study|Conditions interfere with participation|2|||
33509234|NCT03349333|62892887|FG000|Overall Study|Physician Decision|2|||
33509235|NCT03349333|62892887|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
33509236|NCT03349333|62892887|FG000|Overall Study|Patients in treatment less than 24 month|8|||
33509237|NCT03349099|62892893|FG000|Overall Study|Physician Decision|3|||
33509238|NCT03349099|62892894|FG001|Overall Study|Physician Decision|4|||
33509239|NCT03349099|62892893|FG000|Overall Study|Stone migrated from the kidney|1|||
33509240|NCT03349099|62892894|FG001|Overall Study|Stone migrated from the kidney|0|||
33509241|NCT03348163|62892902|FG000|Overall Study|Withdrawal by Subject|2|||
33509242|NCT03348163|62892903|FG001|Overall Study|Withdrawal by Subject|0|||
33509243|NCT03347695|62892911|FG000|Overall Study|Death|0|||
33509244|NCT03347695|62892912|FG001|Overall Study|Death|4|||
33613200|NCT02245412|63013820|FG002|Follow-Up Period|Death|1|||
33613201|NCT02245412|63013818|FG000|Follow-Up Period|Physician Decision|1|||
33451524|NCT00141297|62826151|FG008|Overall Study|Transitioned|0|||
33451525|NCT00141297|62826152|FG009|Overall Study|Transitioned|0|||
33451526|NCT00141219|62826187|FG000|Overall Study|Protocol violations|5|||
33451527|NCT00141219|62826188|FG001|Overall Study|Protocol violations|4|||
33451528|NCT00141219|62826187|FG000|Overall Study|Adverse Event|8|||
33451529|NCT00141219|62826188|FG001|Overall Study|Adverse Event|6|||
33451530|NCT00141219|62826187|FG000|Overall Study|Lack of Efficacy|5|||
33451531|NCT00141219|62826188|FG001|Overall Study|Lack of Efficacy|4|||
33451532|NCT00141219|62826187|FG000|Overall Study|Withdrawal by Subject|6|||
33509245|NCT03347695|62892911|FG000|Overall Study|Lost to Follow-up|0|||
33509246|NCT03347695|62892912|FG001|Overall Study|Lost to Follow-up|1|||
33509247|NCT02892019|62892922|FG000|Overall Study|randomized but not treated|0|||
33509248|NCT02892019|62892923|FG001|Overall Study|randomized but not treated|1|||
33509249|NCT02892019|62892922|FG000|Overall Study|Withdrawal by Subject|0|||
33451533|NCT00141219|62826188|FG001|Overall Study|Withdrawal by Subject|2|||
33451534|NCT00162266|62826197|FG000|Double-Blind Period|Adverse Event|5|||
33509250|NCT02892019|62892923|FG001|Overall Study|Withdrawal by Subject|1|||
33509251|NCT02892019|62892922|FG000|Overall Study|Adverse Event|1|||
33509252|NCT02892019|62892923|FG001|Overall Study|Adverse Event|1|||
33509253|NCT03365791|62892929|FG000|Overall Study|Adverse Event|5|||
33509254|NCT03365791|62892929|FG000|Overall Study|Death|1|||
33509255|NCT03365791|62892929|FG000|Overall Study|Lost to Follow-up|1|||
33509256|NCT03365791|62892929|FG000|Overall Study|Physician Decision|9|||
33509257|NCT03365791|62892929|FG000|Overall Study|Progressive disease|51|||
33509258|NCT03365791|62892929|FG000|Overall Study|Subject/guardian decision|5|||
33613202|NCT02245412|63013819|FG001|Follow-Up Period|Physician Decision|0|||
33613203|NCT02245412|63013820|FG002|Follow-Up Period|Physician Decision|0|||
33613204|NCT02245412|63013818|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
33613205|NCT02245412|63013819|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
33451535|NCT00162266|62826198|FG001|Double-Blind Period|Adverse Event|9|||
33451536|NCT00162266|62826199|FG002|Double-Blind Period|Adverse Event|11|||
33451537|NCT00162266|62826200|FG003|Double-Blind Period|Adverse Event|0|||
33451538|NCT00162266|62826197|FG000|Double-Blind Period|Death|0|||
33451539|NCT00162266|62826198|FG001|Double-Blind Period|Death|1|||
33451540|NCT00162266|62826199|FG002|Double-Blind Period|Death|0|||
33451541|NCT00162266|62826200|FG003|Double-Blind Period|Death|0|||
33451542|NCT00162266|62826197|FG000|Double-Blind Period|Lost to Follow-up|1|||
33451543|NCT00162266|62826198|FG001|Double-Blind Period|Lost to Follow-up|2|||
33451544|NCT00162266|62826199|FG002|Double-Blind Period|Lost to Follow-up|0|||
33451545|NCT00162266|62826200|FG003|Double-Blind Period|Lost to Follow-up|0|||
33451546|NCT00162266|62826197|FG000|Double-Blind Period|Other Reason|1|||
33451547|NCT00162266|62826198|FG001|Double-Blind Period|Other Reason|0|||
33451548|NCT00162266|62826199|FG002|Double-Blind Period|Other Reason|1|||
33451549|NCT00162266|62826200|FG003|Double-Blind Period|Other Reason|0|||
33451550|NCT00162266|62826197|FG000|Double-Blind Period|Lack of Efficacy|13|||
33451551|NCT00162266|62826198|FG001|Double-Blind Period|Lack of Efficacy|17|||
33451552|NCT00162266|62826199|FG002|Double-Blind Period|Lack of Efficacy|30|||
33451553|NCT00162266|62826200|FG003|Double-Blind Period|Lack of Efficacy|0|||
33451554|NCT00162266|62826197|FG000|Double-Blind Period|Withdrawal by Subject|5|||
33451555|NCT00162266|62826198|FG001|Double-Blind Period|Withdrawal by Subject|2|||
33451556|NCT00162266|62826199|FG002|Double-Blind Period|Withdrawal by Subject|6|||
33451557|NCT00162266|62826200|FG003|Double-Blind Period|Withdrawal by Subject|0|||
33451558|NCT00162266|62826197|FG000|Open-Label Period|Death|0|||
33451559|NCT00162266|62826198|FG001|Open-Label Period|Death|0|||
33451560|NCT00162266|62826199|FG002|Open-Label Period|Death|0|||
33451561|NCT00162266|62826200|FG003|Open-Label Period|Death|7|||
33613206|NCT02245412|63013820|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
33613207|NCT02244944|63013828|FG000|Overall Study|Withdrawal by Subject|1|||
33451562|NCT00162266|62826197|FG000|Open-Label Period|Adverse Event|0|||
33451563|NCT00162266|62826198|FG001|Open-Label Period|Adverse Event|0|||
33451564|NCT00162266|62826199|FG002|Open-Label Period|Adverse Event|0|||
33451565|NCT00162266|62826200|FG003|Open-Label Period|Adverse Event|46|||
33451566|NCT00162266|62826197|FG000|Open-Label Period|Lack of Efficacy|0|||
33451567|NCT00162266|62826198|FG001|Open-Label Period|Lack of Efficacy|0|||
33451568|NCT00162266|62826199|FG002|Open-Label Period|Lack of Efficacy|0|||
33451569|NCT00162266|62826200|FG003|Open-Label Period|Lack of Efficacy|26|||
33451570|NCT00162266|62826197|FG000|Open-Label Period|Lost to Follow-up|0|||
33451571|NCT00162266|62826198|FG001|Open-Label Period|Lost to Follow-up|0|||
33451572|NCT00162266|62826199|FG002|Open-Label Period|Lost to Follow-up|0|||
33451573|NCT00162266|62826200|FG003|Open-Label Period|Lost to Follow-up|3|||
33451574|NCT00162266|62826197|FG000|Open-Label Period|Withdrawal by Subject|0|||
33451575|NCT00162266|62826198|FG001|Open-Label Period|Withdrawal by Subject|0|||
33451576|NCT00162266|62826199|FG002|Open-Label Period|Withdrawal by Subject|0|||
33451577|NCT00162266|62826200|FG003|Open-Label Period|Withdrawal by Subject|31|||
33451578|NCT00162266|62826197|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
33451579|NCT00162266|62826198|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
33451580|NCT00162266|62826199|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
33451581|NCT00162266|62826200|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
33509259|NCT03365011|62892936|FG000|Overall Study|Withdrawal by Subject|1|||
33451582|NCT00162266|62826197|FG000|Open-Label Period|Other Reasons|0|||
33451583|NCT00162266|62826198|FG001|Open-Label Period|Other Reasons|0|||
33451584|NCT00162266|62826199|FG002|Open-Label Period|Other Reasons|0|||
33451585|NCT00162266|62826200|FG003|Open-Label Period|Other Reasons|15|||
33451586|NCT00225212|62826252|FG000|Overall Study|Disease progression|2|||
33509260|NCT03365011|62892937|FG001|Overall Study|Withdrawal by Subject|2|||
33613208|NCT02244944|63013828|FG000|Overall Study|Study Terminated|1|||
33451587|NCT00225212|62826252|FG000|Overall Study|Death|1|||
33451588|NCT00225212|62826252|FG000|Overall Study|Adverse Event|2|||
33451589|NCT00225212|62826252|FG000|Overall Study|Intercurrent illness|1|||
33451590|NCT00162032|62826258|FG000|Overall Study|Lost to Follow-up|4|||
33613209|NCT01689532|63013834|FG000|Overall Study|Adverse Event|9|||
33451591|NCT00162032|62826259|FG001|Overall Study|Lost to Follow-up|2|||
33451592|NCT00162032|62826258|FG000|Overall Study|Reason not specified|1|||
33451593|NCT00162032|62826259|FG001|Overall Study|Reason not specified|0|||
33451594|NCT00258674|62826273|FG000|Overall Study|Death|32|||
33451595|NCT00258674|62826274|FG001|Overall Study|Death|53|||
33509261|NCT03627767|62892946|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
33613210|NCT01689532|63013835|FG001|Overall Study|Adverse Event|5|||
33613211|NCT01689532|63013834|FG000|Overall Study|Lack of Efficacy|2|||
33613212|NCT01689532|63013835|FG001|Overall Study|Lack of Efficacy|2|||
33613213|NCT01689532|63013834|FG000|Overall Study|Withdrawal by Subject|1|||
33613214|NCT01689532|63013835|FG001|Overall Study|Withdrawal by Subject|2|||
33613215|NCT01689532|63013834|FG000|Overall Study|Physician Decision|2|||
33613216|NCT01689532|63013835|FG001|Overall Study|Physician Decision|0|||
33613217|NCT01924689|63013847|FG000|Overall Study|Death|0|||
33613218|NCT01924689|63013848|FG001|Overall Study|Death|1|||
33613219|NCT01924689|63013849|FG002|Overall Study|Death|0|||
33613220|NCT01924689|63013850|FG003|Overall Study|Death|1|||
33613221|NCT01924689|63013851|FG004|Overall Study|Death|0|||
33613222|NCT01924689|63013852|FG005|Overall Study|Death|0|||
33613223|NCT01924689|63013847|FG000|Overall Study|Disease progression|0|||
33613224|NCT01924689|63013848|FG001|Overall Study|Disease progression|0|||
33509262|NCT03627767|62892947|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
33509263|NCT03627767|62892948|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
33509264|NCT03627767|62892949|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
33613225|NCT01924689|63013849|FG002|Overall Study|Disease progression|2|||
33613226|NCT01924689|63013850|FG003|Overall Study|Disease progression|0|||
33613227|NCT01924689|63013851|FG004|Overall Study|Disease progression|3|||
33613228|NCT01924689|63013852|FG005|Overall Study|Disease progression|2|||
33613229|NCT01924689|63013847|FG000|Overall Study|New therapy or study|3|||
33613230|NCT01924689|63013848|FG001|Overall Study|New therapy or study|2|||
33509265|NCT03627767|62892950|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
33509266|NCT03627767|62892946|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
33509267|NCT03627767|62892947|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
33509268|NCT03627767|62892948|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
33509269|NCT03627767|62892949|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
33509270|NCT03627767|62892950|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
33509271|NCT03627767|62892946|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
33509272|NCT03627767|62892947|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
33509273|NCT03627767|62892948|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
33509274|NCT03627767|62892949|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
33509275|NCT03627767|62892950|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
33509276|NCT03627767|62892946|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
33509277|NCT03627767|62892947|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
33509278|NCT03627767|62892948|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
33509279|NCT03627767|62892949|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
33509280|NCT03627767|62892950|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
33509281|NCT03627767|62892946|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
33509282|NCT03627767|62892947|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
33509283|NCT03627767|62892948|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
33509284|NCT03627767|62892949|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
33509285|NCT03627767|62892950|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
33509286|NCT03627767|62892946|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
33509287|NCT03627767|62892947|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
33509288|NCT03627767|62892948|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
33613231|NCT01924689|63013849|FG002|Overall Study|New therapy or study|1|||
33613232|NCT01924689|63013850|FG003|Overall Study|New therapy or study|4|||
33613233|NCT01924689|63013851|FG004|Overall Study|New therapy or study|2|||
33613234|NCT01924689|63013852|FG005|Overall Study|New therapy or study|0|||
33613235|NCT01924689|63013847|FG000|Overall Study|Withdrawal of consent|0|||
33613236|NCT01924689|63013848|FG001|Overall Study|Withdrawal of consent|0|||
33613237|NCT01924689|63013849|FG002|Overall Study|Withdrawal of consent|1|||
33613238|NCT01924689|63013850|FG003|Overall Study|Withdrawal of consent|1|||
33613239|NCT01924689|63013851|FG004|Overall Study|Withdrawal of consent|0|||
33613240|NCT01924689|63013852|FG005|Overall Study|Withdrawal of consent|0|||
33613241|NCT01924689|63013847|FG000|Overall Study|Other|0|||
33613242|NCT01924689|63013848|FG001|Overall Study|Other|0|||
33613243|NCT01924689|63013849|FG002|Overall Study|Other|0|||
33613244|NCT01924689|63013850|FG003|Overall Study|Other|0|||
33613245|NCT01924689|63013851|FG004|Overall Study|Other|1|||
33451596|NCT00258674|62826275|FG002|Overall Study|Death|34|||
33451597|NCT00258440|62826286|FG000|Overall Study|Withdrawal by Subject|0|||
33451598|NCT00258440|62826287|FG001|Overall Study|Withdrawal by Subject|0|||
33451599|NCT00258440|62826288|FG002|Overall Study|Withdrawal by Subject|1|||
33451600|NCT00224120|62826298|FG000|Overall Study|Adverse Event|10|||
33451601|NCT00224120|62826299|FG001|Overall Study|Adverse Event|4|||
33613246|NCT01924689|63013852|FG005|Overall Study|Other|0|||
33613247|NCT01591330|63013870|FG000|Period 1|Adverse Event|1|||
33613248|NCT01591330|63013871|FG001|Period 1|Adverse Event|0|||
33613249|NCT01591330|63013872|FG002|Period 1|Adverse Event|0|||
33613250|NCT01591330|63013873|FG003|Period 1|Adverse Event|0|||
33613251|NCT01591330|63013870|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
33613252|NCT01591330|63013871|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
33613253|NCT01591330|63013872|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
33509289|NCT03627767|62892949|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
33613254|NCT01591330|63013873|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
33613255|NCT01591330|63013870|FG000|Period 2|Adverse Event|1|||
33509290|NCT03627767|62892950|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
33509291|NCT03627767|62892946|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
33509292|NCT03627767|62892947|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
33509293|NCT03627767|62892948|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
33509294|NCT03627767|62892949|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
33509295|NCT03627767|62892950|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
33509296|NCT03627767|62892946|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
33509297|NCT03627767|62892947|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
33509298|NCT03627767|62892948|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
33509299|NCT03627767|62892949|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
33509300|NCT03627767|62892950|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
33509301|NCT03627767|62892946|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
33509302|NCT03627767|62892947|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
33509303|NCT03627767|62892948|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
33509304|NCT03627767|62892949|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
33509305|NCT03627767|62892950|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
33509306|NCT03627767|62892946|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
33509307|NCT03627767|62892947|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
33509308|NCT03627767|62892948|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
33509309|NCT03627767|62892949|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
33509310|NCT03627767|62892950|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
33509311|NCT03627767|62892946|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
33509312|NCT03627767|62892947|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
33509313|NCT03627767|62892948|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
33509314|NCT03627767|62892949|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
33509315|NCT03627767|62892950|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
33509316|NCT03627767|62892946|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
33509317|NCT03627767|62892947|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
33509318|NCT03627767|62892948|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
33509319|NCT03627767|62892949|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
33509320|NCT03627767|62892950|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
33509321|NCT03627767|62892946|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
33509322|NCT03627767|62892947|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
33509323|NCT03627767|62892948|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
33509324|NCT03627767|62892949|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
33509325|NCT03627767|62892950|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
33509326|NCT03627767|62892946|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
33509327|NCT03627767|62892947|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
33509328|NCT03627767|62892948|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
33509329|NCT03627767|62892949|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
33613256|NCT01591330|63013871|FG001|Period 2|Adverse Event|0|||
33613257|NCT01591330|63013872|FG002|Period 2|Adverse Event|0|||
33613258|NCT01591330|63013873|FG003|Period 2|Adverse Event|0|||
33613259|NCT01591096|63013883|FG000|Overall Study|Adverse Event|1|||
33613260|NCT01953003|63013889|FG000|Overall Study|Not treated|0|||
33613261|NCT01953003|63013890|FG001|Overall Study|Not treated|1|||
33613262|NCT01953003|63013889|FG000|Overall Study|Progressive disease|35|||
33451602|NCT00224120|62826298|FG000|Overall Study|Protocol Violation|1|||
33451603|NCT00224120|62826299|FG001|Overall Study|Protocol Violation|0|||
33451604|NCT00224120|62826298|FG000|Overall Study|Withdrawal by Subject|5|||
33451605|NCT00224120|62826299|FG001|Overall Study|Withdrawal by Subject|10|||
33451606|NCT00224120|62826298|FG000|Overall Study|Lack of Efficacy|0|||
33451607|NCT00224120|62826299|FG001|Overall Study|Lack of Efficacy|2|||
33451608|NCT00224120|62826298|FG000|Overall Study|Lost to Follow-up|2|||
33451609|NCT00224120|62826299|FG001|Overall Study|Lost to Follow-up|3|||
33509330|NCT03627767|62892950|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
33509331|NCT03627767|62892946|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
33509332|NCT03627767|62892947|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
33509333|NCT03627767|62892948|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
33509334|NCT03627767|62892949|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
33509335|NCT03627767|62892950|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
33509336|NCT03627767|62892946|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
33509337|NCT03627767|62892947|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
33509338|NCT03627767|62892948|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
33509339|NCT03627767|62892949|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
33509340|NCT03627767|62892950|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
33509341|NCT03627767|62892946|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
33509342|NCT03627767|62892947|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
33509343|NCT03627767|62892948|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
33509344|NCT03627767|62892949|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
33509345|NCT03627767|62892950|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
33509346|NCT03627767|62892946|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
33509347|NCT03627767|62892947|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
33509348|NCT03627767|62892948|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
33509349|NCT03627767|62892949|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
33509350|NCT03627767|62892950|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
33509351|NCT03627767|62892946|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
33509352|NCT03627767|62892947|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
33509353|NCT03627767|62892948|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
33509354|NCT03627767|62892949|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
33509355|NCT03627767|62892950|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
33509356|NCT03627767|62892946|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
33509357|NCT03627767|62892947|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
33509358|NCT03627767|62892948|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
33509359|NCT03627767|62892949|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
33509360|NCT03627767|62892950|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
33509361|NCT03627065|62892961|FG000|Overall Study|Study Terminated by sponsor|1|||
33509362|NCT03627065|62892961|FG000|Overall Study|Withdrawal by Subject|2|||
33509363|NCT02142738|62892967|FG000|Overall Study|Adverse Event|13|||
33509364|NCT02142738|62892968|FG001|Overall Study|Adverse Event|9|||
33509365|NCT02142738|62892967|FG000|Overall Study|Death|92|||
33509366|NCT02142738|62892968|FG001|Overall Study|Death|112|||
33509367|NCT02142738|62892967|FG000|Overall Study|Lost to Follow-up|0|||
33509368|NCT02142738|62892968|FG001|Overall Study|Lost to Follow-up|3|||
33509369|NCT02142738|62892967|FG000|Overall Study|Withdrawal by Subject|6|||
33509370|NCT02142738|62892968|FG001|Overall Study|Withdrawal by Subject|7|||
33509371|NCT02142738|62892967|FG000|Overall Study|Follow up ended by sponsor|43|||
33509372|NCT02142738|62892968|FG001|Overall Study|Follow up ended by sponsor|20|||
33509373|NCT03617861|62892979|FG000|Second Intervention (1 Day)|Adverse Event|0|||
33509374|NCT03617861|62892980|FG001|Second Intervention (1 Day)|Adverse Event|0|||
33509375|NCT03617861|62892981|FG002|Second Intervention (1 Day)|Adverse Event|1|||
33509376|NCT03617861|62892982|FG003|Second Intervention (1 Day)|Adverse Event|0|||
33509377|NCT03614975|62892994|FG000|Overall Study|Physician Decision|7|||
33509378|NCT03614975|62892995|FG001|Overall Study|Physician Decision|5|||
33509379|NCT03614975|62892994|FG000|Overall Study|Withdrawal by Subject|2|||
33509380|NCT03614975|62892995|FG001|Overall Study|Withdrawal by Subject|2|||
33509381|NCT03614975|62892994|FG000|Overall Study|Specimens not in lab batch shipment|1|||
33509382|NCT03614975|62892995|FG001|Overall Study|Specimens not in lab batch shipment|1|||
33509383|NCT03613649|62893013|FG000|Second Treatment|Lost to Follow-up|0|||
33509384|NCT03613649|62893014|FG001|Second Treatment|Lost to Follow-up|0|||
33509385|NCT03613649|62893015|FG002|Second Treatment|Lost to Follow-up|1|||
33509386|NCT03613649|62893016|FG003|Second Treatment|Lost to Follow-up|0|||
33509387|NCT03613649|62893017|FG004|Second Treatment|Lost to Follow-up|0|||
33613263|NCT01953003|63013890|FG001|Overall Study|Progressive disease|45|||
33613264|NCT01953003|63013889|FG000|Overall Study|Related Adverse events|7|||
33613265|NCT01953003|63013890|FG001|Overall Study|Related Adverse events|2|||
33613266|NCT01953003|63013889|FG000|Overall Study|Non-related adverse events|0|||
33613267|NCT01953003|63013890|FG001|Overall Study|Non-related adverse events|2|||
33509388|NCT03613649|62893018|FG005|Second Treatment|Lost to Follow-up|0|||
33509389|NCT03613649|62893019|FG006|Second Treatment|Lost to Follow-up|0|||
33509390|NCT03613649|62893020|FG007|Second Treatment|Lost to Follow-up|0|||
33509391|NCT03613649|62893021|FG008|Second Treatment|Lost to Follow-up|0|||
33509392|NCT03613649|62893022|FG009|Second Treatment|Lost to Follow-up|0|||
33509393|NCT03613649|62893023|FG010|Second Treatment|Lost to Follow-up|0|||
33509394|NCT03613649|62893024|FG011|Second Treatment|Lost to Follow-up|0|||
33613268|NCT01953003|63013889|FG000|Overall Study|Protocol Violation|0|||
33613269|NCT01953003|63013890|FG001|Overall Study|Protocol Violation|1|||
33613270|NCT01953003|63013889|FG000|Overall Study|Withdrawal by Subject|14|||
33613271|NCT01953003|63013890|FG001|Overall Study|Withdrawal by Subject|4|||
33613272|NCT01952691|63013896|FG000|Overall Study|Lost to Follow-up|2|||
33613273|NCT01709500|63013902|FG000|Overall Study|Randomized but not treated|0|||
33509395|NCT03613649|62893013|FG000|Second Treatment|Withdrawal by Subject|0|||
33509396|NCT03613649|62893014|FG001|Second Treatment|Withdrawal by Subject|0|||
33613274|NCT01709500|63013903|FG001|Overall Study|Randomized but not treated|1|||
33613275|NCT01709500|63013902|FG000|Overall Study|Adverse Event|5|||
33613276|NCT01709500|63013903|FG001|Overall Study|Adverse Event|1|||
33613277|NCT01709500|63013902|FG000|Overall Study|Poor compliance to protocol|2|||
33613278|NCT01709500|63013903|FG001|Overall Study|Poor compliance to protocol|1|||
33613279|NCT01709500|63013902|FG000|Overall Study|Other|3|||
33613280|NCT01709500|63013903|FG001|Overall Study|Other|1|||
33613281|NCT01709500|63013902|FG000|Overall Study|Related to IMP administration|1|||
33613282|NCT01709500|63013903|FG001|Overall Study|Related to IMP administration|0|||
33613283|NCT01709500|63013902|FG000|Overall Study|Treatment ongoing|156|||
33613284|NCT01709500|63013903|FG001|Overall Study|Treatment ongoing|78|||
33613285|NCT01599806|63013911|FG000|Overall Study|Lost to Follow-up|20|||
33509397|NCT03613649|62893015|FG002|Second Treatment|Withdrawal by Subject|0|||
33509398|NCT03613649|62893016|FG003|Second Treatment|Withdrawal by Subject|0|||
33509399|NCT03613649|62893017|FG004|Second Treatment|Withdrawal by Subject|1|||
33509400|NCT03613649|62893018|FG005|Second Treatment|Withdrawal by Subject|0|||
33509401|NCT03613649|62893019|FG006|Second Treatment|Withdrawal by Subject|0|||
33509402|NCT03613649|62893020|FG007|Second Treatment|Withdrawal by Subject|0|||
33509403|NCT03613649|62893021|FG008|Second Treatment|Withdrawal by Subject|0|||
33509404|NCT03613649|62893022|FG009|Second Treatment|Withdrawal by Subject|0|||
33509405|NCT03613649|62893023|FG010|Second Treatment|Withdrawal by Subject|0|||
33509406|NCT03613649|62893024|FG011|Second Treatment|Withdrawal by Subject|0|||
33509407|NCT03613649|62893013|FG000|Third Treatment|Lost to Follow-up|0|||
33509408|NCT03613649|62893014|FG001|Third Treatment|Lost to Follow-up|0|||
33509409|NCT03613649|62893015|FG002|Third Treatment|Lost to Follow-up|0|||
33509410|NCT03613649|62893016|FG003|Third Treatment|Lost to Follow-up|0|||
33509411|NCT03613649|62893017|FG004|Third Treatment|Lost to Follow-up|1|||
33509412|NCT03613649|62893018|FG005|Third Treatment|Lost to Follow-up|0|||
33509413|NCT03613649|62893019|FG006|Third Treatment|Lost to Follow-up|0|||
33509414|NCT03613649|62893020|FG007|Third Treatment|Lost to Follow-up|0|||
33509415|NCT03613649|62893021|FG008|Third Treatment|Lost to Follow-up|0|||
33509416|NCT03613649|62893022|FG009|Third Treatment|Lost to Follow-up|0|||
33509417|NCT03613649|62893023|FG010|Third Treatment|Lost to Follow-up|0|||
33509418|NCT03613649|62893024|FG011|Third Treatment|Lost to Follow-up|1|||
33509419|NCT03613649|62893013|FG000|Third Treatment|Protocol Violation|0|||
33509420|NCT03613649|62893014|FG001|Third Treatment|Protocol Violation|0|||
33509421|NCT03613649|62893015|FG002|Third Treatment|Protocol Violation|0|||
33509422|NCT03613649|62893016|FG003|Third Treatment|Protocol Violation|0|||
33509423|NCT03613649|62893017|FG004|Third Treatment|Protocol Violation|0|||
33509424|NCT03613649|62893018|FG005|Third Treatment|Protocol Violation|0|||
33509425|NCT03613649|62893019|FG006|Third Treatment|Protocol Violation|1|||
33509426|NCT03613649|62893020|FG007|Third Treatment|Protocol Violation|0|||
33509427|NCT03613649|62893021|FG008|Third Treatment|Protocol Violation|0|||
33509428|NCT03613649|62893022|FG009|Third Treatment|Protocol Violation|0|||
33509429|NCT03613649|62893023|FG010|Third Treatment|Protocol Violation|0|||
33509430|NCT03613649|62893024|FG011|Third Treatment|Protocol Violation|1|||
33509431|NCT03613649|62893013|FG000|Fourth Treatment|Protocol Violation|1|||
33509432|NCT03613649|62893014|FG001|Fourth Treatment|Protocol Violation|0|||
33509433|NCT03613649|62893015|FG002|Fourth Treatment|Protocol Violation|0|||
33509434|NCT03613649|62893016|FG003|Fourth Treatment|Protocol Violation|0|||
33509435|NCT03613649|62893017|FG004|Fourth Treatment|Protocol Violation|1|||
33509436|NCT03613649|62893018|FG005|Fourth Treatment|Protocol Violation|0|||
33509437|NCT03613649|62893019|FG006|Fourth Treatment|Protocol Violation|0|||
33509438|NCT03613649|62893020|FG007|Fourth Treatment|Protocol Violation|0|||
33509439|NCT03613649|62893021|FG008|Fourth Treatment|Protocol Violation|0|||
33509440|NCT03613649|62893022|FG009|Fourth Treatment|Protocol Violation|0|||
33509441|NCT03613649|62893023|FG010|Fourth Treatment|Protocol Violation|0|||
33509442|NCT03613649|62893024|FG011|Fourth Treatment|Protocol Violation|0|||
33509443|NCT03613649|62893013|FG000|Fourth Treatment|Physician Decision|0|||
33509444|NCT03613649|62893014|FG001|Fourth Treatment|Physician Decision|0|||
33509445|NCT03613649|62893015|FG002|Fourth Treatment|Physician Decision|0|||
33613286|NCT01599806|63013912|FG001|Overall Study|Lost to Follow-up|20|||
33613287|NCT01599806|63013911|FG000|Overall Study|Withdrawal by Subject|12|||
33613288|NCT01599806|63013912|FG001|Overall Study|Withdrawal by Subject|12|||
33613289|NCT01599806|63013911|FG000|Overall Study|Other Eligibility criteria|11|||
33509446|NCT03613649|62893016|FG003|Fourth Treatment|Physician Decision|0|||
33509447|NCT03613649|62893017|FG004|Fourth Treatment|Physician Decision|0|||
33509448|NCT03613649|62893018|FG005|Fourth Treatment|Physician Decision|0|||
33509449|NCT03613649|62893019|FG006|Fourth Treatment|Physician Decision|1|||
33509450|NCT03613649|62893020|FG007|Fourth Treatment|Physician Decision|0|||
33613290|NCT01599806|63013912|FG001|Overall Study|Other Eligibility criteria|9|||
33509451|NCT03613649|62893021|FG008|Fourth Treatment|Physician Decision|0|||
33509452|NCT03613649|62893022|FG009|Fourth Treatment|Physician Decision|0|||
33509453|NCT03613649|62893023|FG010|Fourth Treatment|Physician Decision|0|||
33509454|NCT03613649|62893024|FG011|Fourth Treatment|Physician Decision|0|||
33509455|NCT03096288|62893046|FG000|Overall Study|Withdrawal by Subject|0|||
33509456|NCT03096288|62893047|FG001|Overall Study|Withdrawal by Subject|1|||
33509457|NCT03096288|62893048|FG002|Overall Study|Withdrawal by Subject|0|||
33509458|NCT03096288|62893049|FG003|Overall Study|Withdrawal by Subject|1|||
33509459|NCT03611075|62893068|FG000|Overall Study|Physician Decision|0|||
33509460|NCT03611075|62893069|FG001|Overall Study|Physician Decision|1|||
33509461|NCT03611075|62893070|FG002|Overall Study|Physician Decision|1|||
33509462|NCT03611075|62893071|FG003|Overall Study|Physician Decision|0|||
33509463|NCT03611075|62893072|FG004|Overall Study|Physician Decision|0|||
33509464|NCT03611075|62893073|FG005|Overall Study|Physician Decision|0|||
33509465|NCT03611075|62893074|FG006|Overall Study|Physician Decision|0|||
33509466|NCT03611075|62893075|FG007|Overall Study|Physician Decision|0|||
33509467|NCT03611075|62893076|FG008|Overall Study|Physician Decision|0|||
33509468|NCT03611075|62893068|FG000|Overall Study|Lost to Follow-up|1|||
33509469|NCT03611075|62893069|FG001|Overall Study|Lost to Follow-up|0|||
33509470|NCT03611075|62893070|FG002|Overall Study|Lost to Follow-up|0|||
33509471|NCT03611075|62893071|FG003|Overall Study|Lost to Follow-up|2|||
33509472|NCT03611075|62893072|FG004|Overall Study|Lost to Follow-up|0|||
33509473|NCT03611075|62893073|FG005|Overall Study|Lost to Follow-up|0|||
33509474|NCT03611075|62893074|FG006|Overall Study|Lost to Follow-up|0|||
33509475|NCT03611075|62893075|FG007|Overall Study|Lost to Follow-up|0|||
33509476|NCT03611075|62893076|FG008|Overall Study|Lost to Follow-up|0|||
33509477|NCT03611075|62893068|FG000|Overall Study|Withdrawal by Subject|0|||
33509478|NCT03611075|62893069|FG001|Overall Study|Withdrawal by Subject|1|||
33509479|NCT03611075|62893070|FG002|Overall Study|Withdrawal by Subject|1|||
33613291|NCT01599325|63013918|FG000|Primary Parent Phase|Adverse Event|5|||
33613292|NCT01599325|63013918|FG000|Primary Parent Phase|Disease Progression|7|||
33613293|NCT01599325|63013918|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
33613294|NCT01599325|63013918|FG000|Primary Parent Phase|Death|13|||
33613295|NCT01599325|63013918|FG000|Primary Parent Phase|Protocol Violation|1|||
33613296|NCT01599325|63013918|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
33509480|NCT03611075|62893071|FG003|Overall Study|Withdrawal by Subject|1|||
33509481|NCT03611075|62893072|FG004|Overall Study|Withdrawal by Subject|0|||
33509482|NCT03611075|62893073|FG005|Overall Study|Withdrawal by Subject|0|||
33509483|NCT03611075|62893074|FG006|Overall Study|Withdrawal by Subject|1|||
33509484|NCT03611075|62893075|FG007|Overall Study|Withdrawal by Subject|0|||
33509485|NCT03611075|62893076|FG008|Overall Study|Withdrawal by Subject|0|||
33509486|NCT03611075|62893068|FG000|Overall Study|Reason unknown|0|||
33509487|NCT03611075|62893069|FG001|Overall Study|Reason unknown|0|||
33509488|NCT03611075|62893070|FG002|Overall Study|Reason unknown|0|||
33509489|NCT03611075|62893071|FG003|Overall Study|Reason unknown|1|||
33509490|NCT03611075|62893072|FG004|Overall Study|Reason unknown|0|||
33509491|NCT03611075|62893073|FG005|Overall Study|Reason unknown|0|||
33509492|NCT03611075|62893074|FG006|Overall Study|Reason unknown|1|||
33509493|NCT03611075|62893075|FG007|Overall Study|Reason unknown|0|||
33509494|NCT03611075|62893076|FG008|Overall Study|Reason unknown|0|||
33509495|NCT03095508|62893121|FG000|Overall Study|Adverse Event|0|||
33509496|NCT03095508|62893122|FG001|Overall Study|Adverse Event|1|||
33509497|NCT03607487|62893132|FG000|Overall Study|Withdrawal by Subject|2|||
33509498|NCT03607487|62893133|FG001|Overall Study|Withdrawal by Subject|0|||
33509499|NCT03607487|62893134|FG002|Overall Study|Withdrawal by Subject|0|||
33509500|NCT03607487|62893135|FG003|Overall Study|Withdrawal by Subject|1|||
33509501|NCT03605693|62893149|FG000|Overall Study|Lost to Follow-up|4|||
33509502|NCT03605693|62893150|FG001|Overall Study|Lost to Follow-up|0|||
33509503|NCT03605693|62893149|FG000|Overall Study|Physician Decision|1|||
33509504|NCT03605693|62893150|FG001|Overall Study|Physician Decision|0|||
33509505|NCT03605303|62893156|FG000|Period 1|Study Terminated|2|||
33509506|NCT03605303|62893157|FG001|Period 1|Study Terminated|1|||
33613297|NCT01599325|63013918|FG000|Primary Parent Phase|Other|2|||
33613298|NCT01599325|63013918|FG000|Extension Phase|Study Closure|1|||
33613299|NCT01599325|63013918|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
33613300|NCT01599325|63013918|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
33509507|NCT03604523|62893165|FG000|Overall Study|Physician Decision|1|||
33509508|NCT03604523|62893166|FG001|Overall Study|Physician Decision|0|||
33509509|NCT03602339|62893172|FG000|Overall Study|Withdrawal by Subject|9|||
33509510|NCT03602339|62893172|FG000|Overall Study|Physician Decision|2|||
33509511|NCT03602339|62893172|FG000|Overall Study|Other reason|4|||
33509512|NCT03653429|62893181|FG000|Overall Study|Physician Decision|4|||
33509513|NCT03653429|62893182|FG001|Overall Study|Physician Decision|10|||
33509514|NCT03601715|62893191|FG000|Second Intervention|Lost to Follow-up|1|||
33509515|NCT03601715|62893192|FG001|Second Intervention|Lost to Follow-up|1|||
33509516|NCT03601715|62893193|FG002|Second Intervention|Lost to Follow-up|0|||
33509517|NCT03594227|62893209|FG000|Overall Study|Adverse Event|2|||
33509518|NCT03594227|62893210|FG001|Overall Study|Adverse Event|1|||
33509519|NCT03594227|62893211|FG002|Overall Study|Adverse Event|0|||
33509520|NCT03594227|62893212|FG003|Overall Study|Adverse Event|2|||
33509521|NCT03594227|62893209|FG000|Overall Study|Lost to Follow-up|1|||
33509522|NCT03594227|62893210|FG001|Overall Study|Lost to Follow-up|1|||
33509523|NCT03594227|62893211|FG002|Overall Study|Lost to Follow-up|1|||
33509524|NCT03594227|62893212|FG003|Overall Study|Lost to Follow-up|0|||
33613301|NCT01599325|63013918|FG000|Extension Phase|Disease Progression|1|||
33613302|NCT01599325|63013918|FG000|Extension Phase|Withdrawal by Subject|8|||
33613303|NCT01924299|63013925|FG000|Period 2|Withdrawal by Subject|1|||
33613304|NCT01924299|63013926|FG001|Period 2|Withdrawal by Subject|0|||
33613305|NCT01924299|63013925|FG000|Period 2|Adverse Event|0|||
33613306|NCT01924299|63013926|FG001|Period 2|Adverse Event|1|||
33613307|NCT02182999|63013940|FG000|Overall Study|Adverse Event|4|||
33613308|NCT02182999|63013941|FG001|Overall Study|Adverse Event|3|||
33613309|NCT02182999|63013940|FG000|Overall Study|Physician Decision|1|||
33509525|NCT03594227|62893209|FG000|Overall Study|Withdrawal by Subject|1|||
33509526|NCT03594227|62893210|FG001|Overall Study|Withdrawal by Subject|1|||
33509527|NCT03594227|62893211|FG002|Overall Study|Withdrawal by Subject|1|||
33509528|NCT03594227|62893212|FG003|Overall Study|Withdrawal by Subject|1|||
33509529|NCT03594227|62893209|FG000|Overall Study|Pregnancy|0|||
33509530|NCT03594227|62893210|FG001|Overall Study|Pregnancy|1|||
33509531|NCT03594227|62893211|FG002|Overall Study|Pregnancy|0|||
33509532|NCT03594227|62893212|FG003|Overall Study|Pregnancy|0|||
33509533|NCT03594227|62893209|FG000|Overall Study|Sponsor Decision|0|||
33509534|NCT03594227|62893210|FG001|Overall Study|Sponsor Decision|0|||
33509535|NCT03594227|62893211|FG002|Overall Study|Sponsor Decision|0|||
33509536|NCT03594227|62893212|FG003|Overall Study|Sponsor Decision|1|||
33509537|NCT03594227|62893209|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
33509538|NCT03594227|62893210|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
33509539|NCT03594227|62893211|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
33509540|NCT03594227|62893212|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
33509541|NCT03098550|62893236|FG000|Overall Study|Disease Progression|30|||
33509542|NCT03098550|62893237|FG001|Overall Study|Disease Progression|19|||
33509543|NCT03098550|62893238|FG002|Overall Study|Disease Progression|41|||
33509544|NCT03098550|62893236|FG000|Overall Study|Study Drug Toxicity|2|||
33509545|NCT03098550|62893237|FG001|Overall Study|Study Drug Toxicity|1|||
33509546|NCT03098550|62893238|FG002|Overall Study|Study Drug Toxicity|0|||
33509547|NCT03098550|62893236|FG000|Overall Study|Death|1|||
33509548|NCT03098550|62893237|FG001|Overall Study|Death|0|||
33509549|NCT03098550|62893238|FG002|Overall Study|Death|0|||
33509550|NCT03098550|62893236|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
33509551|NCT03098550|62893237|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
33509552|NCT03098550|62893238|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
33509553|NCT03098550|62893236|FG000|Overall Study|Administrative reason by sponsor|0|||
33509554|NCT03098550|62893237|FG001|Overall Study|Administrative reason by sponsor|0|||
33509555|NCT03098550|62893238|FG002|Overall Study|Administrative reason by sponsor|1|||
33509556|NCT03098550|62893236|FG000|Overall Study|Other reasons|2|||
33509557|NCT03098550|62893237|FG001|Overall Study|Other reasons|0|||
33509558|NCT03098550|62893238|FG002|Overall Study|Other reasons|0|||
33509559|NCT03095118|62893250|FG000|Overall Study|Adverse Event|1|||
33509560|NCT03095118|62893250|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
33509561|NCT03594071|62893254|FG000|Overall Study|Re-operation|3|||
33509562|NCT03594071|62893254|FG000|Overall Study|Missed visit|2|||
33509563|NCT02696902|62893261|FG000|Overall Study|Lost to Follow-up|0|||
33509564|NCT02696902|62893262|FG001|Overall Study|Lost to Follow-up|1|||
33509565|NCT02696902|62893263|FG002|Overall Study|Lost to Follow-up|1|||
33451610|NCT00224120|62826298|FG000|Overall Study|Other|4|||
33451611|NCT00224120|62826299|FG001|Overall Study|Other|5|||
33451612|NCT00257660|62826307|FG000|Overall Study|Lack of Efficacy|5|||
33451613|NCT00257660|62826308|FG001|Overall Study|Lack of Efficacy|23|||
33451614|NCT00257660|62826307|FG000|Overall Study|Withdrawal by Subject|2|||
33451615|NCT00257660|62826308|FG001|Overall Study|Withdrawal by Subject|0|||
33451616|NCT00257660|62826307|FG000|Overall Study|Lost to Follow-up|1|||
33451617|NCT00257660|62826308|FG001|Overall Study|Lost to Follow-up|0|||
33451618|NCT00257660|62826307|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
33509566|NCT02696902|62893261|FG000|Overall Study|Withdrawal by Subject|0|||
33509567|NCT02696902|62893262|FG001|Overall Study|Withdrawal by Subject|0|||
33509568|NCT02696902|62893263|FG002|Overall Study|Withdrawal by Subject|1|||
33509569|NCT02696902|62893261|FG000|Overall Study|Death|19|||
33509570|NCT02696902|62893262|FG001|Overall Study|Death|3|||
33451619|NCT00257660|62826308|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
33451620|NCT00257660|62826307|FG000|Overall Study|No longer wanted to do blood draws|1|||
33509571|NCT02696902|62893263|FG002|Overall Study|Death|24|||
33509572|NCT02696902|62893261|FG000|Overall Study|Participant not fit post-randomization|0|||
33509573|NCT02696902|62893262|FG001|Overall Study|Participant not fit post-randomization|0|||
33509574|NCT02696902|62893263|FG002|Overall Study|Participant not fit post-randomization|1|||
33613310|NCT02182999|63013941|FG001|Overall Study|Physician Decision|0|||
33613311|NCT02243696|63013947|FG000|Overall Study|Death|282|||
33509575|NCT02696902|62893261|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
33509576|NCT02696902|62893262|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
33509577|NCT02696902|62893263|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
33509578|NCT02696902|62893261|FG000|Overall Study|Principal investigator's decision|1|||
33509579|NCT02696902|62893262|FG001|Overall Study|Principal investigator's decision|0|||
33509580|NCT02696902|62893263|FG002|Overall Study|Principal investigator's decision|0|||
33509581|NCT02696902|62893261|FG000|Overall Study|Sponsor's decision|1|||
33509582|NCT02696902|62893262|FG001|Overall Study|Sponsor's decision|0|||
33509583|NCT02696902|62893263|FG002|Overall Study|Sponsor's decision|0|||
33509584|NCT02696902|62893261|FG000|Overall Study|Transferred to other hospital|1|||
33509585|NCT02696902|62893262|FG001|Overall Study|Transferred to other hospital|0|||
33509586|NCT02696902|62893263|FG002|Overall Study|Transferred to other hospital|0|||
33451621|NCT00257660|62826308|FG001|Overall Study|No longer wanted to do blood draws|0|||
33509587|NCT02694562|62893273|FG000|Overall Study|Death|8|||
33509588|NCT02694562|62893273|FG000|Overall Study|Protocol Violation|4|||
33509589|NCT02694562|62893273|FG000|Overall Study|Lost to Follow-up|3|||
33509590|NCT02694562|62893273|FG000|Overall Study|Screen Failure|2|||
33509591|NCT02694562|62893273|FG000|Overall Study|Physician Decision|1|||
33509592|NCT02874534|62893279|FG000|Overall Study|Withdrawal by Subject|5|||
33509593|NCT02874534|62893280|FG001|Overall Study|Withdrawal by Subject|8|||
33509594|NCT02874534|62893279|FG000|Overall Study|Lost to Follow-up|2|||
33509595|NCT02874534|62893280|FG001|Overall Study|Lost to Follow-up|2|||
33509596|NCT02874534|62893279|FG000|Overall Study|Ongoing in study|1|||
33509597|NCT02874534|62893280|FG001|Overall Study|Ongoing in study|1|||
33509598|NCT03097614|62893286|FG000|Overall Study|Adverse Event|3|||
33451622|NCT00224042|62826316|FG000|Overall Study|Adverse Event|2|||
33509599|NCT03364309|62893293|FG000|Induction Period|Adverse Event|4|||
33509600|NCT03364309|62893294|FG001|Induction Period|Adverse Event|0|||
33509601|NCT03364309|62893295|FG002|Induction Period|Adverse Event|1|||
33509602|NCT03364309|62893296|FG003|Induction Period|Adverse Event|0|||
33509603|NCT03364309|62893297|FG004|Induction Period|Adverse Event|0|||
33509604|NCT03364309|62893298|FG005|Induction Period|Adverse Event|0|||
33509605|NCT03364309|62893299|FG006|Induction Period|Adverse Event|0|||
33509606|NCT03364309|62893300|FG007|Induction Period|Adverse Event|0|||
33509607|NCT03364309|62893301|FG008|Induction Period|Adverse Event|0|||
33509608|NCT03364309|62893302|FG009|Induction Period|Adverse Event|0|||
33509609|NCT03364309|62893303|FG010|Induction Period|Adverse Event|0|||
33509610|NCT03364309|62893304|FG011|Induction Period|Adverse Event|0|||
33509611|NCT03364309|62893305|FG012|Induction Period|Adverse Event|0|||
33509612|NCT03364309|62893306|FG013|Induction Period|Adverse Event|0|||
33509613|NCT03364309|62893307|FG014|Induction Period|Adverse Event|0|||
33509614|NCT03364309|62893308|FG015|Induction Period|Adverse Event|0|||
33509615|NCT03364309|62893309|FG016|Induction Period|Adverse Event|0|||
33509616|NCT03364309|62893310|FG017|Induction Period|Adverse Event|0|||
33509617|NCT03364309|62893311|FG018|Induction Period|Adverse Event|0|||
33509618|NCT03364309|62893293|FG000|Induction Period|Withdrawal by Subject|1|||
33509619|NCT03364309|62893294|FG001|Induction Period|Withdrawal by Subject|3|||
33509620|NCT03364309|62893295|FG002|Induction Period|Withdrawal by Subject|0|||
33509621|NCT03364309|62893296|FG003|Induction Period|Withdrawal by Subject|0|||
33509622|NCT03364309|62893297|FG004|Induction Period|Withdrawal by Subject|0|||
33509623|NCT03364309|62893298|FG005|Induction Period|Withdrawal by Subject|0|||
33509624|NCT03364309|62893299|FG006|Induction Period|Withdrawal by Subject|0|||
33451623|NCT00224042|62826317|FG001|Overall Study|Adverse Event|1|||
33451624|NCT00224042|62826316|FG000|Overall Study|Protocol Violation|0|||
33451625|NCT00224042|62826317|FG001|Overall Study|Protocol Violation|1|||
33451626|NCT00224042|62826316|FG000|Overall Study|Physician Decision|0|||
33451627|NCT00224042|62826317|FG001|Overall Study|Physician Decision|1|||
33451628|NCT00224042|62826316|FG000|Overall Study|Did not meet lab incusion criteria|2|||
33451629|NCT00224042|62826317|FG001|Overall Study|Did not meet lab incusion criteria|3|||
33451630|NCT00224042|62826316|FG000|Overall Study|Other|2|||
33451631|NCT00224042|62826317|FG001|Overall Study|Other|0|||
33451632|NCT00160706|62826323|FG000|Overall Study|Adverse Event|53|||
33509625|NCT03364309|62893300|FG007|Induction Period|Withdrawal by Subject|0|||
33509626|NCT03364309|62893301|FG008|Induction Period|Withdrawal by Subject|0|||
33509627|NCT03364309|62893302|FG009|Induction Period|Withdrawal by Subject|0|||
33509628|NCT03364309|62893303|FG010|Induction Period|Withdrawal by Subject|0|||
33509629|NCT03364309|62893304|FG011|Induction Period|Withdrawal by Subject|0|||
33509630|NCT03364309|62893305|FG012|Induction Period|Withdrawal by Subject|0|||
33509631|NCT03364309|62893306|FG013|Induction Period|Withdrawal by Subject|0|||
33613312|NCT02243696|63013947|FG000|Overall Study|Withdrawal by Subject|79|||
33451633|NCT00160706|62826323|FG000|Overall Study|Adverse Event and Other Reason|105|||
33509632|NCT03364309|62893307|FG014|Induction Period|Withdrawal by Subject|0|||
33509633|NCT03364309|62893308|FG015|Induction Period|Withdrawal by Subject|0|||
33509634|NCT03364309|62893309|FG016|Induction Period|Withdrawal by Subject|0|||
33509635|NCT03364309|62893310|FG017|Induction Period|Withdrawal by Subject|0|||
33509636|NCT03364309|62893311|FG018|Induction Period|Withdrawal by Subject|0|||
33509637|NCT03364309|62893293|FG000|Induction Period|Lost to Follow-up|1|||
33509638|NCT03364309|62893294|FG001|Induction Period|Lost to Follow-up|0|||
33509639|NCT03364309|62893295|FG002|Induction Period|Lost to Follow-up|0|||
33509640|NCT03364309|62893296|FG003|Induction Period|Lost to Follow-up|0|||
33509641|NCT03364309|62893297|FG004|Induction Period|Lost to Follow-up|0|||
33509642|NCT03364309|62893298|FG005|Induction Period|Lost to Follow-up|0|||
33509643|NCT03364309|62893299|FG006|Induction Period|Lost to Follow-up|0|||
33509644|NCT03364309|62893300|FG007|Induction Period|Lost to Follow-up|0|||
33509645|NCT03364309|62893301|FG008|Induction Period|Lost to Follow-up|0|||
33509646|NCT03364309|62893302|FG009|Induction Period|Lost to Follow-up|0|||
33509647|NCT03364309|62893303|FG010|Induction Period|Lost to Follow-up|0|||
33509648|NCT03364309|62893304|FG011|Induction Period|Lost to Follow-up|0|||
33509649|NCT03364309|62893305|FG012|Induction Period|Lost to Follow-up|0|||
33509650|NCT03364309|62893306|FG013|Induction Period|Lost to Follow-up|0|||
33509651|NCT03364309|62893307|FG014|Induction Period|Lost to Follow-up|0|||
33509652|NCT03364309|62893308|FG015|Induction Period|Lost to Follow-up|0|||
33509653|NCT03364309|62893309|FG016|Induction Period|Lost to Follow-up|0|||
33509654|NCT03364309|62893310|FG017|Induction Period|Lost to Follow-up|0|||
33509655|NCT03364309|62893311|FG018|Induction Period|Lost to Follow-up|0|||
33509656|NCT03364309|62893293|FG000|Induction Period|Physician Decision|0|||
33509657|NCT03364309|62893294|FG001|Induction Period|Physician Decision|1|||
33509658|NCT03364309|62893295|FG002|Induction Period|Physician Decision|0|||
33613313|NCT02243696|63013947|FG000|Overall Study|Lost to Follow-up|57|||
33613314|NCT02243696|63013947|FG000|Overall Study|Subject No Longer has Study System|42|||
33613315|NCT02243696|63013947|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
33324383|NCT00911170|62700827|FG001|Treatment Period|Randomized in error|1|||
33509659|NCT03364309|62893296|FG003|Induction Period|Physician Decision|0|||
33509660|NCT03364309|62893297|FG004|Induction Period|Physician Decision|0|||
33509661|NCT03364309|62893298|FG005|Induction Period|Physician Decision|0|||
33509662|NCT03364309|62893299|FG006|Induction Period|Physician Decision|0|||
33509663|NCT03364309|62893300|FG007|Induction Period|Physician Decision|0|||
33509664|NCT03364309|62893301|FG008|Induction Period|Physician Decision|0|||
33509665|NCT03364309|62893302|FG009|Induction Period|Physician Decision|0|||
33509666|NCT03364309|62893303|FG010|Induction Period|Physician Decision|0|||
33509667|NCT03364309|62893304|FG011|Induction Period|Physician Decision|0|||
33509668|NCT03364309|62893305|FG012|Induction Period|Physician Decision|0|||
33509669|NCT03364309|62893306|FG013|Induction Period|Physician Decision|0|||
33509670|NCT03364309|62893307|FG014|Induction Period|Physician Decision|0|||
33509671|NCT03364309|62893308|FG015|Induction Period|Physician Decision|0|||
33509672|NCT03364309|62893309|FG016|Induction Period|Physician Decision|0|||
33509673|NCT03364309|62893310|FG017|Induction Period|Physician Decision|0|||
33509674|NCT03364309|62893311|FG018|Induction Period|Physician Decision|0|||
33509675|NCT03364309|62893293|FG000|Maintenance Period|Withdrawal by Subject|0|||
33509676|NCT03364309|62893294|FG001|Maintenance Period|Withdrawal by Subject|0|||
33509677|NCT03364309|62893295|FG002|Maintenance Period|Withdrawal by Subject|0|||
33509678|NCT03364309|62893296|FG003|Maintenance Period|Withdrawal by Subject|1|||
33509679|NCT03364309|62893297|FG004|Maintenance Period|Withdrawal by Subject|3|||
33509680|NCT03364309|62893298|FG005|Maintenance Period|Withdrawal by Subject|1|||
33509681|NCT03364309|62893299|FG006|Maintenance Period|Withdrawal by Subject|3|||
33509682|NCT03364309|62893300|FG007|Maintenance Period|Withdrawal by Subject|0|||
33509683|NCT03364309|62893301|FG008|Maintenance Period|Withdrawal by Subject|1|||
33509684|NCT03364309|62893302|FG009|Maintenance Period|Withdrawal by Subject|1|||
33324384|NCT00911170|62700826|FG000|Treatment Period|Ineligibility determined|1|||
33324385|NCT00911170|62700827|FG001|Treatment Period|Ineligibility determined|3|||
33324386|NCT00911170|62700826|FG000|Treatment Period|Protocol deviation|1|||
33324387|NCT00911170|62700827|FG001|Treatment Period|Protocol deviation|2|||
33324388|NCT00911170|62700826|FG000|Treatment Period|Adverse Event|9|||
33324389|NCT00911170|62700827|FG001|Treatment Period|Adverse Event|10|||
33324390|NCT00911170|62700826|FG000|Treatment Period|Withdrawal by Subject|4|||
33324391|NCT00911170|62700827|FG001|Treatment Period|Withdrawal by Subject|4|||
33324392|NCT00911170|62700826|FG000|Treatment Period|Disease progression|0|||
33324393|NCT00911170|62700827|FG001|Treatment Period|Disease progression|2|||
33324394|NCT00911170|62700826|FG000|Treatment Period|Physician Decision|5|||
33324395|NCT00911170|62700827|FG001|Treatment Period|Physician Decision|5|||
33324396|NCT00911170|62700826|FG000|Treatment Period|Lost to Follow-up|0|||
33324397|NCT00911170|62700827|FG001|Treatment Period|Lost to Follow-up|1|||
33324398|NCT00911170|62700826|FG000|Treatment Period|Death|6|||
33324399|NCT00911170|62700827|FG001|Treatment Period|Death|9|||
33324400|NCT00911170|62700826|FG000|Long Term Follow-Up|Continuing in study|274|||
33509685|NCT03364309|62893303|FG010|Maintenance Period|Withdrawal by Subject|2|||
33509686|NCT03364309|62893304|FG011|Maintenance Period|Withdrawal by Subject|0|||
33509687|NCT03364309|62893305|FG012|Maintenance Period|Withdrawal by Subject|0|||
33509688|NCT03364309|62893306|FG013|Maintenance Period|Withdrawal by Subject|0|||
33509689|NCT03364309|62893307|FG014|Maintenance Period|Withdrawal by Subject|0|||
33509690|NCT03364309|62893308|FG015|Maintenance Period|Withdrawal by Subject|0|||
33509691|NCT03364309|62893309|FG016|Maintenance Period|Withdrawal by Subject|0|||
33509692|NCT03364309|62893310|FG017|Maintenance Period|Withdrawal by Subject|0|||
33509693|NCT03364309|62893311|FG018|Maintenance Period|Withdrawal by Subject|0|||
33509694|NCT03364309|62893293|FG000|Maintenance Period|Adverse Event|0|||
33509695|NCT03364309|62893294|FG001|Maintenance Period|Adverse Event|0|||
33509696|NCT03364309|62893295|FG002|Maintenance Period|Adverse Event|0|||
33509697|NCT03364309|62893296|FG003|Maintenance Period|Adverse Event|0|||
33509698|NCT03364309|62893297|FG004|Maintenance Period|Adverse Event|2|||
33509699|NCT03364309|62893298|FG005|Maintenance Period|Adverse Event|0|||
33509700|NCT03364309|62893299|FG006|Maintenance Period|Adverse Event|3|||
33509701|NCT03364309|62893300|FG007|Maintenance Period|Adverse Event|0|||
33509702|NCT03364309|62893301|FG008|Maintenance Period|Adverse Event|1|||
33509703|NCT03364309|62893302|FG009|Maintenance Period|Adverse Event|0|||
33509704|NCT03364309|62893303|FG010|Maintenance Period|Adverse Event|2|||
33509705|NCT03364309|62893304|FG011|Maintenance Period|Adverse Event|0|||
33509706|NCT03364309|62893305|FG012|Maintenance Period|Adverse Event|0|||
33509707|NCT03364309|62893306|FG013|Maintenance Period|Adverse Event|0|||
33509708|NCT03364309|62893307|FG014|Maintenance Period|Adverse Event|0|||
33509709|NCT03364309|62893308|FG015|Maintenance Period|Adverse Event|0|||
33509710|NCT03364309|62893309|FG016|Maintenance Period|Adverse Event|0|||
33509711|NCT03364309|62893310|FG017|Maintenance Period|Adverse Event|0|||
33509712|NCT03364309|62893311|FG018|Maintenance Period|Adverse Event|0|||
33509713|NCT03364309|62893293|FG000|Maintenance Period|Relapsed|0|||
33509714|NCT03364309|62893294|FG001|Maintenance Period|Relapsed|0|||
33509715|NCT03364309|62893295|FG002|Maintenance Period|Relapsed|0|||
33509716|NCT03364309|62893296|FG003|Maintenance Period|Relapsed|43|||
33509717|NCT03364309|62893297|FG004|Maintenance Period|Relapsed|7|||
33509718|NCT03364309|62893298|FG005|Maintenance Period|Relapsed|45|||
33509719|NCT03364309|62893299|FG006|Maintenance Period|Relapsed|10|||
33509720|NCT03364309|62893300|FG007|Maintenance Period|Relapsed|2|||
33509721|NCT03364309|62893301|FG008|Maintenance Period|Relapsed|0|||
33509722|NCT03364309|62893302|FG009|Maintenance Period|Relapsed|0|||
33509723|NCT03364309|62893303|FG010|Maintenance Period|Relapsed|0|||
33509724|NCT03364309|62893304|FG011|Maintenance Period|Relapsed|0|||
33509725|NCT03364309|62893305|FG012|Maintenance Period|Relapsed|0|||
33509726|NCT03364309|62893306|FG013|Maintenance Period|Relapsed|0|||
33509727|NCT03364309|62893307|FG014|Maintenance Period|Relapsed|0|||
33509728|NCT03364309|62893308|FG015|Maintenance Period|Relapsed|0|||
33509729|NCT03364309|62893309|FG016|Maintenance Period|Relapsed|0|||
33509730|NCT03364309|62893310|FG017|Maintenance Period|Relapsed|0|||
33509731|NCT03364309|62893311|FG018|Maintenance Period|Relapsed|0|||
33613316|NCT02243696|63013947|FG000|Overall Study|Study Terminated for EP PASSION|961|||
33613317|NCT01598311|63013953|FG000|Overall Study|Physician Decision|4|||
33613318|NCT01598311|63013954|FG001|Overall Study|Physician Decision|5|||
33613319|NCT01598311|63013953|FG000|Overall Study|Adverse Event|9|||
33613320|NCT01598311|63013954|FG001|Overall Study|Adverse Event|13|||
33613321|NCT01598311|63013953|FG000|Overall Study|Lost to Follow-up|7|||
33613322|NCT01598311|63013954|FG001|Overall Study|Lost to Follow-up|12|||
33613323|NCT01598311|63013953|FG000|Overall Study|Withdrawal by Subject|9|||
33613324|NCT01598311|63013954|FG001|Overall Study|Withdrawal by Subject|13|||
33613325|NCT01598311|63013953|FG000|Overall Study|No reason provided.|0|||
33451634|NCT00160706|62826323|FG000|Overall Study|Protocol Violation|3|||
33451635|NCT00160706|62826323|FG000|Overall Study|Withdrawal by Subject|41|||
33451636|NCT00160706|62826323|FG000|Overall Study|Withdrawal by Subject and Other|12|||
33451637|NCT00160706|62826323|FG000|Overall Study|Physician Decision|10|||
33451638|NCT00160706|62826323|FG000|Overall Study|Physician Decision and Other|3|||
33451639|NCT00160706|62826323|FG000|Overall Study|Lost to Follow-up|4|||
33451640|NCT00160706|62826323|FG000|Overall Study|Lost to Follow-up and Other|1|||
33451641|NCT00160706|62826323|FG000|Overall Study|Lack of Efficacy|42|||
33509732|NCT03364309|62893293|FG000|Maintenance Period|Lack of Efficacy|0|||
33509733|NCT03364309|62893294|FG001|Maintenance Period|Lack of Efficacy|0|||
33509734|NCT03364309|62893295|FG002|Maintenance Period|Lack of Efficacy|0|||
33509735|NCT03364309|62893296|FG003|Maintenance Period|Lack of Efficacy|0|||
33509736|NCT03364309|62893297|FG004|Maintenance Period|Lack of Efficacy|0|||
33613326|NCT01598311|63013954|FG001|Overall Study|No reason provided.|5|||
33613327|NCT01598311|63013953|FG000|Overall Study|Randomized but never treated|8|||
33451642|NCT00160706|62826323|FG000|Overall Study|Lack of Efficacy and Other|1|||
33613328|NCT01598311|63013954|FG001|Overall Study|Randomized but never treated|5|||
33613329|NCT01598311|63013953|FG000|Overall Study|Treated but no confirmed CDAD|9|||
33509737|NCT03364309|62893298|FG005|Maintenance Period|Lack of Efficacy|0|||
33509738|NCT03364309|62893299|FG006|Maintenance Period|Lack of Efficacy|0|||
33509739|NCT03364309|62893300|FG007|Maintenance Period|Lack of Efficacy|0|||
33613330|NCT01598311|63013954|FG001|Overall Study|Treated but no confirmed CDAD|8|||
33509740|NCT03364309|62893301|FG008|Maintenance Period|Lack of Efficacy|1|||
33509741|NCT03364309|62893302|FG009|Maintenance Period|Lack of Efficacy|3|||
33613331|NCT01598311|63013953|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
33509742|NCT03364309|62893303|FG010|Maintenance Period|Lack of Efficacy|2|||
33509743|NCT03364309|62893304|FG011|Maintenance Period|Lack of Efficacy|0|||
33509744|NCT03364309|62893305|FG012|Maintenance Period|Lack of Efficacy|0|||
33509745|NCT03364309|62893306|FG013|Maintenance Period|Lack of Efficacy|0|||
33509746|NCT03364309|62893307|FG014|Maintenance Period|Lack of Efficacy|0|||
33509747|NCT03364309|62893308|FG015|Maintenance Period|Lack of Efficacy|0|||
33509748|NCT03364309|62893309|FG016|Maintenance Period|Lack of Efficacy|0|||
33509749|NCT03364309|62893310|FG017|Maintenance Period|Lack of Efficacy|0|||
33509750|NCT03364309|62893311|FG018|Maintenance Period|Lack of Efficacy|0|||
33509751|NCT03364309|62893293|FG000|Maintenance Period|Death|0|||
33509752|NCT03364309|62893294|FG001|Maintenance Period|Death|0|||
33509753|NCT03364309|62893295|FG002|Maintenance Period|Death|0|||
33509754|NCT03364309|62893296|FG003|Maintenance Period|Death|0|||
33509755|NCT03364309|62893297|FG004|Maintenance Period|Death|0|||
33613332|NCT01598311|63013954|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
33613333|NCT02182843|63013960|FG000|Overall Study|Withdrawal by Subject|7|||
33613334|NCT02182843|63013960|FG000|Overall Study|Lost to Follow-up|2|||
33613335|NCT02182843|63013960|FG000|Overall Study|Adverse Event|1|||
33509756|NCT03364309|62893298|FG005|Maintenance Period|Death|0|||
33509757|NCT03364309|62893299|FG006|Maintenance Period|Death|0|||
33509758|NCT03364309|62893300|FG007|Maintenance Period|Death|0|||
33509759|NCT03364309|62893301|FG008|Maintenance Period|Death|1|||
33509760|NCT03364309|62893302|FG009|Maintenance Period|Death|0|||
33509761|NCT03364309|62893303|FG010|Maintenance Period|Death|0|||
33509762|NCT03364309|62893304|FG011|Maintenance Period|Death|0|||
33509763|NCT03364309|62893305|FG012|Maintenance Period|Death|0|||
33613336|NCT02208050|63013966|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
33613337|NCT02208050|63013967|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
33613338|NCT02978222|63013989|FG000|Overall Study|Withdrawal by Subject|2|||
33613339|NCT02978222|63013990|FG001|Overall Study|Withdrawal by Subject|2|||
33613340|NCT02978222|63013989|FG000|Overall Study|Physician Decision|2|||
33613341|NCT02978222|63013990|FG001|Overall Study|Physician Decision|0|||
33613342|NCT02978222|63013989|FG000|Overall Study|Adverse Event|0|||
33613343|NCT02978222|63013990|FG001|Overall Study|Adverse Event|1|||
33613344|NCT02978222|63013989|FG000|Overall Study|Death|1|||
33613345|NCT02978222|63013990|FG001|Overall Study|Death|0|||
33613346|NCT02978222|63013989|FG000|Overall Study|Disease Progression|32|||
33613347|NCT02978222|63013990|FG001|Overall Study|Disease Progression|32|||
33613348|NCT02978222|63013989|FG000|Overall Study|Early Study Termination|24|||
33613349|NCT02978222|63013990|FG001|Overall Study|Early Study Termination|21|||
33451643|NCT00160706|62826323|FG000|Overall Study|Other Reason|11|||
33451644|NCT00257192|62826329|FG000|Overall Study|Adverse Event|21|||
33509764|NCT03364309|62893306|FG013|Maintenance Period|Death|0|||
33509765|NCT03364309|62893307|FG014|Maintenance Period|Death|0|||
33613350|NCT02181673|63013998|FG000|Up to Week 24|Adverse Event|2|||
33613351|NCT02181673|63013999|FG001|Up to Week 24|Adverse Event|0|||
33613352|NCT02181673|63014000|FG002|Up to Week 24|Adverse Event|3|||
33451645|NCT00257192|62826330|FG001|Overall Study|Adverse Event|10|||
33451646|NCT00257192|62826329|FG000|Overall Study|Laboratory abnormality|1|||
33451647|NCT00257192|62826330|FG001|Overall Study|Laboratory abnormality|1|||
33451648|NCT00257192|62826329|FG000|Overall Study|Lost to Follow-up|3|||
33451649|NCT00257192|62826330|FG001|Overall Study|Lost to Follow-up|3|||
33451650|NCT00257192|62826329|FG000|Overall Study|Insufficient clinical response|18|||
33451651|NCT00257192|62826330|FG001|Overall Study|Insufficient clinical response|18|||
33451652|NCT00257192|62826329|FG000|Overall Study|Withdrawal by Subject|14|||
33451653|NCT00257192|62826330|FG001|Overall Study|Withdrawal by Subject|2|||
33451654|NCT00257192|62826329|FG000|Overall Study|Randomized but not treated|0|||
33451655|NCT00257192|62826330|FG001|Overall Study|Randomized but not treated|1|||
33451656|NCT00257192|62826329|FG000|Overall Study|Study terminated by sponsor|1|||
33451657|NCT00257192|62826330|FG001|Overall Study|Study terminated by sponsor|0|||
33451658|NCT00257192|62826329|FG000|Overall Study|Miscellaneous|0|||
33451659|NCT00257192|62826330|FG001|Overall Study|Miscellaneous|4|||
33451660|NCT00256724|62826338|FG000|Overall Study|Physician Decision|2|||
33451661|NCT00256724|62826339|FG001|Overall Study|Physician Decision|5|||
33451662|NCT00256724|62826338|FG000|Overall Study|Protocol Violation|3|||
33451663|NCT00256724|62826339|FG001|Overall Study|Protocol Violation|3|||
33451664|NCT00157820|62826348|FG000|Randomized|Physician Decision|4|||
33509766|NCT03364309|62893308|FG015|Maintenance Period|Death|0|||
33509767|NCT03364309|62893309|FG016|Maintenance Period|Death|0|||
33613353|NCT02181673|63013998|FG000|Up to Week 24|Death|1|||
33451665|NCT00157820|62826349|FG001|Randomized|Physician Decision|2|||
33613354|NCT02181673|63013999|FG001|Up to Week 24|Death|0|||
33613355|NCT02181673|63014000|FG002|Up to Week 24|Death|0|||
33451666|NCT00157820|62826350|FG002|Randomized|Physician Decision|3|||
33509768|NCT03364309|62893310|FG017|Maintenance Period|Death|0|||
33509769|NCT03364309|62893311|FG018|Maintenance Period|Death|0|||
33509770|NCT03364309|62893293|FG000|Maintenance Period|Lost to Follow-up|0|||
33509771|NCT03364309|62893294|FG001|Maintenance Period|Lost to Follow-up|0|||
33509772|NCT03364309|62893295|FG002|Maintenance Period|Lost to Follow-up|0|||
33509773|NCT03364309|62893296|FG003|Maintenance Period|Lost to Follow-up|0|||
33509774|NCT03364309|62893297|FG004|Maintenance Period|Lost to Follow-up|0|||
33509775|NCT03364309|62893298|FG005|Maintenance Period|Lost to Follow-up|0|||
33509776|NCT03364309|62893299|FG006|Maintenance Period|Lost to Follow-up|0|||
33509777|NCT03364309|62893300|FG007|Maintenance Period|Lost to Follow-up|0|||
33509778|NCT03364309|62893301|FG008|Maintenance Period|Lost to Follow-up|1|||
33509779|NCT03364309|62893302|FG009|Maintenance Period|Lost to Follow-up|0|||
33509780|NCT03364309|62893303|FG010|Maintenance Period|Lost to Follow-up|0|||
33509781|NCT03364309|62893304|FG011|Maintenance Period|Lost to Follow-up|0|||
33509782|NCT03364309|62893305|FG012|Maintenance Period|Lost to Follow-up|0|||
33509783|NCT03364309|62893306|FG013|Maintenance Period|Lost to Follow-up|0|||
33509784|NCT03364309|62893307|FG014|Maintenance Period|Lost to Follow-up|0|||
33509785|NCT03364309|62893308|FG015|Maintenance Period|Lost to Follow-up|0|||
33509786|NCT03364309|62893309|FG016|Maintenance Period|Lost to Follow-up|0|||
33509787|NCT03364309|62893310|FG017|Maintenance Period|Lost to Follow-up|0|||
33509788|NCT03364309|62893311|FG018|Maintenance Period|Lost to Follow-up|0|||
33509789|NCT03364309|62893293|FG000|Maintenance Period|Miscellaneous|0|||
33509790|NCT03364309|62893294|FG001|Maintenance Period|Miscellaneous|0|||
33509791|NCT03364309|62893295|FG002|Maintenance Period|Miscellaneous|0|||
33509792|NCT03364309|62893296|FG003|Maintenance Period|Miscellaneous|0|||
33509793|NCT03364309|62893297|FG004|Maintenance Period|Miscellaneous|0|||
33509794|NCT03364309|62893298|FG005|Maintenance Period|Miscellaneous|0|||
33509795|NCT03364309|62893299|FG006|Maintenance Period|Miscellaneous|0|||
33509796|NCT03364309|62893300|FG007|Maintenance Period|Miscellaneous|0|||
33509797|NCT03364309|62893301|FG008|Maintenance Period|Miscellaneous|1|||
33509798|NCT03364309|62893302|FG009|Maintenance Period|Miscellaneous|0|||
33509799|NCT03364309|62893303|FG010|Maintenance Period|Miscellaneous|0|||
33451667|NCT00157820|62826348|FG000|Randomized|Withdrawal by Subject|1|||
33451668|NCT00157820|62826349|FG001|Randomized|Withdrawal by Subject|2|||
33451669|NCT00157820|62826350|FG002|Randomized|Withdrawal by Subject|3|||
33451670|NCT00157820|62826348|FG000|Randomized|Protocol Violation|2|||
33451671|NCT00157820|62826349|FG001|Randomized|Protocol Violation|1|||
33451672|NCT00157820|62826350|FG002|Randomized|Protocol Violation|2|||
33451673|NCT00157820|62826348|FG000|1st 8 Month|Death|7|||
33451674|NCT00157820|62826349|FG001|1st 8 Month|Death|8|||
33451675|NCT00157820|62826350|FG002|1st 8 Month|Death|3|||
33451676|NCT00157820|62826348|FG000|1st 8 Month|Lost to Follow-up|1|||
33451677|NCT00157820|62826349|FG001|1st 8 Month|Lost to Follow-up|2|||
33451678|NCT00157820|62826350|FG002|1st 8 Month|Lost to Follow-up|1|||
33451679|NCT00157820|62826348|FG000|1st 8 Month|Premature cross-over|0|||
33451680|NCT00157820|62826349|FG001|1st 8 Month|Premature cross-over|2|||
33451681|NCT00157820|62826350|FG002|1st 8 Month|Premature cross-over|2|||
33451682|NCT00157820|62826348|FG000|2nd 8 Months|Death|3|||
33509800|NCT03364309|62893304|FG011|Maintenance Period|Miscellaneous|0|||
33509801|NCT03364309|62893305|FG012|Maintenance Period|Miscellaneous|0|||
33509802|NCT03364309|62893306|FG013|Maintenance Period|Miscellaneous|0|||
33509803|NCT03364309|62893307|FG014|Maintenance Period|Miscellaneous|0|||
33509804|NCT03364309|62893308|FG015|Maintenance Period|Miscellaneous|0|||
33509805|NCT03364309|62893309|FG016|Maintenance Period|Miscellaneous|0|||
33509806|NCT03364309|62893310|FG017|Maintenance Period|Miscellaneous|0|||
33451683|NCT00157820|62826349|FG001|2nd 8 Months|Death|1|||
33451684|NCT00157820|62826350|FG002|2nd 8 Months|Death|3|||
33451685|NCT00157820|62826348|FG000|2nd 8 Months|Lost to Follow-up|1|||
33451686|NCT00157820|62826349|FG001|2nd 8 Months|Lost to Follow-up|5|||
33451687|NCT00157820|62826350|FG002|2nd 8 Months|Lost to Follow-up|2|||
33451688|NCT00157820|62826348|FG000|2nd 8 Months|Premature cross-over|1|||
33451689|NCT00157820|62826349|FG001|2nd 8 Months|Premature cross-over|7|||
33451690|NCT00157820|62826350|FG002|2nd 8 Months|Premature cross-over|9|||
33451691|NCT00223808|62826362|FG000|Overall Study|<5 hrs therapy before discharge|3|||
33451692|NCT00223808|62826363|FG001|Overall Study|<5 hrs therapy before discharge|5|||
33451693|NCT00223808|62826364|FG002|Overall Study|<5 hrs therapy before discharge|5|||
33451694|NCT00154310|62826374|FG000|Overall Study|Adverse Event|19|||
33509807|NCT03364309|62893311|FG018|Maintenance Period|Miscellaneous|0|||
33509808|NCT03364309|62893293|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33509809|NCT03364309|62893294|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33509810|NCT03364309|62893295|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33509811|NCT03364309|62893296|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33509812|NCT03364309|62893297|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33451695|NCT00154310|62826375|FG001|Overall Study|Adverse Event|9|||
33451696|NCT00154310|62826374|FG000|Overall Study|Lack of Efficacy|5|||
33451697|NCT00154310|62826375|FG001|Overall Study|Lack of Efficacy|4|||
33451698|NCT00154310|62826374|FG000|Overall Study|Protocol Violation|4|||
33509813|NCT03364309|62893298|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33509814|NCT03364309|62893299|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33509815|NCT03364309|62893300|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33509816|NCT03364309|62893301|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33509817|NCT03364309|62893302|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33509818|NCT03364309|62893303|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33509819|NCT03364309|62893304|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33509820|NCT03364309|62893305|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33509821|NCT03364309|62893306|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
33509822|NCT03364309|62893307|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
33509823|NCT03364309|62893308|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
33509824|NCT03364309|62893309|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33509825|NCT03364309|62893310|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33509826|NCT03364309|62893311|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33509827|NCT03364309|62893293|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509828|NCT03364309|62893294|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509829|NCT03364309|62893295|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509830|NCT03364309|62893296|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509831|NCT03364309|62893297|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509832|NCT03364309|62893298|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509833|NCT03364309|62893299|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509834|NCT03364309|62893300|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509835|NCT03364309|62893301|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509836|NCT03364309|62893302|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509837|NCT03364309|62893303|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509838|NCT03364309|62893304|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509839|NCT03364309|62893305|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509840|NCT03364309|62893306|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509841|NCT03364309|62893307|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
33509842|NCT03364309|62893308|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509843|NCT03364309|62893309|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509844|NCT03364309|62893310|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509845|NCT03364309|62893311|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
33509846|NCT03364309|62893293|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
33509847|NCT03364309|62893294|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
33509848|NCT03364309|62893295|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
33509849|NCT03364309|62893296|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
33509850|NCT03364309|62893297|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
33509851|NCT03364309|62893298|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
33509852|NCT03364309|62893299|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
33509853|NCT03364309|62893300|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
33509854|NCT03364309|62893301|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
33509855|NCT03364309|62893302|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
33451699|NCT00154310|62826375|FG001|Overall Study|Protocol Violation|2|||
33451700|NCT00154310|62826374|FG000|Overall Study|Withdrawal by Subject|9|||
33451701|NCT00154310|62826375|FG001|Overall Study|Withdrawal by Subject|3|||
33451702|NCT00154310|62826374|FG000|Overall Study|Lost to Follow-up|0|||
33451703|NCT00154310|62826375|FG001|Overall Study|Lost to Follow-up|8|||
33451704|NCT00154310|62826374|FG000|Overall Study|Administrative problems|0|||
33451705|NCT00154310|62826375|FG001|Overall Study|Administrative problems|1|||
33451706|NCT00154310|62826374|FG000|Overall Study|Death|0|||
33451707|NCT00154310|62826375|FG001|Overall Study|Death|1|||
33451708|NCT03771664|62826383|FG000|Overall Study|Adverse Event|1|||
33451709|NCT03771664|62826384|FG001|Overall Study|Adverse Event|0|||
33451710|NCT03771664|62826383|FG000|Overall Study|Lost to Follow-up|1|||
33451711|NCT03771664|62826384|FG001|Overall Study|Lost to Follow-up|0|||
33451712|NCT03771664|62826383|FG000|Overall Study|Withdrawal by Participant|1|||
33451713|NCT03771664|62826384|FG001|Overall Study|Withdrawal by Participant|4|||
33451714|NCT03771664|62826383|FG000|Overall Study|Randomized but not Treated|0|||
33451715|NCT03771664|62826384|FG001|Overall Study|Randomized but not Treated|1|||
33451716|NCT03771352|62826390|FG000|Overall Study|Screen failure|2|||
33451717|NCT03771352|62826390|FG000|Overall Study|Withdrawal by Subject|2|||
33451718|NCT03770728|62826398|FG000|Overall Study|Adverse Event|1|||
33451719|NCT03770728|62826399|FG001|Overall Study|Adverse Event|0|||
33451720|NCT03770728|62826400|FG002|Overall Study|Adverse Event|1|||
33451721|NCT03770728|62826401|FG003|Overall Study|Adverse Event|0|||
33451722|NCT03770728|62826398|FG000|Overall Study|Poor compliance to protocol|0|||
33451723|NCT03770728|62826399|FG001|Overall Study|Poor compliance to protocol|0|||
33451724|NCT03770728|62826400|FG002|Overall Study|Poor compliance to protocol|1|||
33451725|NCT03770728|62826401|FG003|Overall Study|Poor compliance to protocol|0|||
33451726|NCT03770728|62826398|FG000|Overall Study|Withdrawal by Subject|13|||
33451727|NCT03770728|62826399|FG001|Overall Study|Withdrawal by Subject|8|||
33451728|NCT03770728|62826400|FG002|Overall Study|Withdrawal by Subject|9|||
33509856|NCT03364309|62893303|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
33509857|NCT03364309|62893304|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
33509858|NCT03364309|62893305|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
33509859|NCT03364309|62893306|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
33509860|NCT03364309|62893307|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
33509861|NCT03364309|62893308|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
33509862|NCT03364309|62893309|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
33509863|NCT03364309|62893310|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
33509864|NCT03364309|62893311|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
33509865|NCT03364309|62893293|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509866|NCT03364309|62893294|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509867|NCT03364309|62893295|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509868|NCT03364309|62893296|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509869|NCT03364309|62893297|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509870|NCT03364309|62893298|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509871|NCT03364309|62893299|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509872|NCT03364309|62893300|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509873|NCT03364309|62893301|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509874|NCT03364309|62893302|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509875|NCT03364309|62893303|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509876|NCT03364309|62893304|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509877|NCT03364309|62893305|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509878|NCT03364309|62893306|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509879|NCT03364309|62893307|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509880|NCT03364309|62893308|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33509881|NCT03364309|62893309|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
33509882|NCT03364309|62893310|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
33509883|NCT03364309|62893311|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
33509884|NCT03364309|62893293|FG000|Post-Treatment Followup Period|Adverse Event|0|||
33509885|NCT03364309|62893294|FG001|Post-Treatment Followup Period|Adverse Event|0|||
33509886|NCT03364309|62893295|FG002|Post-Treatment Followup Period|Adverse Event|0|||
33509887|NCT03364309|62893296|FG003|Post-Treatment Followup Period|Adverse Event|0|||
33509888|NCT03364309|62893297|FG004|Post-Treatment Followup Period|Adverse Event|0|||
33509889|NCT03364309|62893298|FG005|Post-Treatment Followup Period|Adverse Event|0|||
33509890|NCT03364309|62893299|FG006|Post-Treatment Followup Period|Adverse Event|0|||
33509891|NCT03364309|62893300|FG007|Post-Treatment Followup Period|Adverse Event|0|||
33509892|NCT03364309|62893301|FG008|Post-Treatment Followup Period|Adverse Event|0|||
33509893|NCT03364309|62893302|FG009|Post-Treatment Followup Period|Adverse Event|0|||
33509894|NCT03364309|62893303|FG010|Post-Treatment Followup Period|Adverse Event|0|||
33509895|NCT03364309|62893304|FG011|Post-Treatment Followup Period|Adverse Event|0|||
33509896|NCT03364309|62893305|FG012|Post-Treatment Followup Period|Adverse Event|0|||
33509897|NCT03364309|62893306|FG013|Post-Treatment Followup Period|Adverse Event|0|||
33509898|NCT03364309|62893307|FG014|Post-Treatment Followup Period|Adverse Event|0|||
33509899|NCT03364309|62893308|FG015|Post-Treatment Followup Period|Adverse Event|0|||
33613356|NCT02181673|63013998|FG000|Up to Week 24|Lack of Efficacy|1|||
33613357|NCT02181673|63013999|FG001|Up to Week 24|Lack of Efficacy|0|||
33613358|NCT02181673|63014000|FG002|Up to Week 24|Lack of Efficacy|0|||
33613359|NCT02181673|63013998|FG000|Up to Week 24|Lost to Follow-up|1|||
33451729|NCT03770728|62826401|FG003|Overall Study|Withdrawal by Subject|13|||
33451730|NCT03770728|62826398|FG000|Overall Study|Other than specified|24|||
33451731|NCT03770728|62826399|FG001|Overall Study|Other than specified|23|||
33451732|NCT03770728|62826400|FG002|Overall Study|Other than specified|21|||
33451733|NCT03770728|62826401|FG003|Overall Study|Other than specified|22|||
33451734|NCT03769090|62826416|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
33451735|NCT03769090|62826417|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
33451736|NCT03769090|62826418|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
33451737|NCT03769090|62826416|FG000|Overall Study|Withdrawal by Subject|52|||
33509900|NCT03364309|62893309|FG016|Post-Treatment Followup Period|Adverse Event|2|||
33509901|NCT03364309|62893310|FG017|Post-Treatment Followup Period|Adverse Event|6|||
33509902|NCT03364309|62893311|FG018|Post-Treatment Followup Period|Adverse Event|1|||
33509903|NCT03364309|62893293|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509904|NCT03364309|62893294|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509905|NCT03364309|62893295|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509906|NCT03364309|62893296|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509907|NCT03364309|62893297|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509908|NCT03364309|62893298|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
33613360|NCT02181673|63013999|FG001|Up to Week 24|Lost to Follow-up|0|||
33451738|NCT03769090|62826417|FG001|Overall Study|Withdrawal by Subject|62|||
33451739|NCT03769090|62826418|FG002|Overall Study|Withdrawal by Subject|74|||
33451740|NCT03769090|62826416|FG000|Overall Study|Death|4|||
33509909|NCT03364309|62893299|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509910|NCT03364309|62893300|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509911|NCT03364309|62893301|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509912|NCT03364309|62893302|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509913|NCT03364309|62893303|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509914|NCT03364309|62893304|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
33613361|NCT02181673|63014000|FG002|Up to Week 24|Lost to Follow-up|0|||
33613362|NCT02181673|63013998|FG000|Up to Week 24|Physician Decision|0|||
33613363|NCT02181673|63013999|FG001|Up to Week 24|Physician Decision|0|||
33613364|NCT02181673|63014000|FG002|Up to Week 24|Physician Decision|3|||
33613365|NCT02181673|63013998|FG000|Up to Week 24|Withdrawal by Subject|10|||
33509915|NCT03364309|62893305|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509916|NCT03364309|62893306|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509917|NCT03364309|62893307|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509918|NCT03364309|62893308|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509919|NCT03364309|62893309|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509920|NCT03364309|62893310|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
33509921|NCT03364309|62893311|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
33509922|NCT03364309|62893293|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
33509923|NCT03364309|62893294|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
33509924|NCT03364309|62893295|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
33509925|NCT03364309|62893296|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
33509926|NCT03364309|62893297|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
33509927|NCT03364309|62893298|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
33509928|NCT03364309|62893299|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
33613366|NCT02181673|63013999|FG001|Up to Week 24|Withdrawal by Subject|0|||
33613367|NCT02181673|63014000|FG002|Up to Week 24|Withdrawal by Subject|1|||
33509929|NCT03364309|62893300|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
33509930|NCT03364309|62893301|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
33509931|NCT03364309|62893302|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
33509932|NCT03364309|62893303|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
33509933|NCT03364309|62893304|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
33509934|NCT03364309|62893305|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
33509935|NCT03364309|62893306|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
33509936|NCT03364309|62893307|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
33509937|NCT03364309|62893308|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
33509938|NCT03364309|62893309|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
33509939|NCT03364309|62893310|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
33509940|NCT03364309|62893311|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
33509941|NCT03334903|62893337|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
33509942|NCT03334903|62893338|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
33509943|NCT03334903|62893337|FG000|Overall Study|Protocol Violation|1|||
33509944|NCT03334903|62893338|FG001|Overall Study|Protocol Violation|3|||
33509945|NCT03334903|62893337|FG000|Overall Study|Surgery postponed|1|||
33509946|NCT03334903|62893338|FG001|Overall Study|Surgery postponed|0|||
33509947|NCT03334903|62893337|FG000|Overall Study|Adverse Event|1|||
33509948|NCT03334903|62893338|FG001|Overall Study|Adverse Event|1|||
33509949|NCT03334903|62893337|FG000|Overall Study|Withdrawal by Subject|0|||
33509950|NCT03334903|62893338|FG001|Overall Study|Withdrawal by Subject|1|||
33509951|NCT01353664|62893344|FG000|Overall Study|Other|3|||
33509952|NCT01353664|62893344|FG000|Overall Study|Disease Progression|16|||
33509953|NCT02694328|62893350|FG000|Overall Study|Adverse Event|27|||
33509954|NCT02694328|62893351|FG001|Overall Study|Adverse Event|33|||
33509955|NCT02694328|62893350|FG000|Overall Study|Withdrawal by Subject|27|||
33509956|NCT02694328|62893351|FG001|Overall Study|Withdrawal by Subject|23|||
33509957|NCT02694328|62893350|FG000|Overall Study|Lost to Follow-up|26|||
33509958|NCT02694328|62893351|FG001|Overall Study|Lost to Follow-up|22|||
33613368|NCT02181673|63013998|FG000|Up to Week 24|Other|2|||
33613369|NCT02181673|63013999|FG001|Up to Week 24|Other|0|||
33613370|NCT02181673|63014000|FG002|Up to Week 24|Other|3|||
33613371|NCT02181673|63013998|FG000|Up to Week 24|Randomized not Treated|0|||
33613372|NCT02181673|63013999|FG001|Up to Week 24|Randomized not Treated|0|||
33613373|NCT02181673|63014000|FG002|Up to Week 24|Randomized not Treated|1|||
33613374|NCT02181673|63013998|FG000|Week 24-Week 60|Adverse Event|0|||
33613375|NCT02181673|63013999|FG001|Week 24-Week 60|Adverse Event|4|||
33613376|NCT02181673|63014000|FG002|Week 24-Week 60|Adverse Event|10|||
33509959|NCT02694328|62893350|FG000|Overall Study|Noncompliant with study drug|11|||
33509960|NCT02694328|62893351|FG001|Overall Study|Noncompliant with study drug|8|||
33613377|NCT02181673|63013998|FG000|Week 24-Week 60|Other|0|||
33613378|NCT02181673|63013999|FG001|Week 24-Week 60|Other|2|||
33613379|NCT02181673|63014000|FG002|Week 24-Week 60|Other|1|||
33613380|NCT02181673|63013998|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
33613381|NCT02181673|63013999|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
33613382|NCT02181673|63014000|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
33509961|NCT02694328|62893350|FG000|Overall Study|Incarceration|1|||
33509962|NCT02694328|62893351|FG001|Overall Study|Incarceration|1|||
33509963|NCT02694328|62893350|FG000|Overall Study|Lack of Efficacy|1|||
33613383|NCT02181673|63013998|FG000|Week 24-Week 60|Pregnancy|0|||
33613384|NCT02181673|63013999|FG001|Week 24-Week 60|Pregnancy|0|||
33509964|NCT02694328|62893351|FG001|Overall Study|Lack of Efficacy|2|||
33509965|NCT02694328|62893350|FG000|Overall Study|Pregnancy|1|||
33509966|NCT02694328|62893351|FG001|Overall Study|Pregnancy|1|||
33509967|NCT02694328|62893350|FG000|Overall Study|Protocol Violation|6|||
33509968|NCT02694328|62893351|FG001|Overall Study|Protocol Violation|5|||
33509969|NCT02694328|62893350|FG000|Overall Study|Abnormal Laboratory Value|0|||
33509970|NCT02694328|62893351|FG001|Overall Study|Abnormal Laboratory Value|3|||
33509971|NCT03334747|62893366|FG000|Treatment Phase|Technical problems|0|||
33509972|NCT03334747|62893367|FG001|Treatment Phase|Technical problems|0|||
33509973|NCT03334747|62893368|FG002|Treatment Phase|Technical problems|0|||
33509974|NCT03334747|62893369|FG003|Treatment Phase|Technical problems|0|||
33509975|NCT03334747|62893370|FG004|Treatment Phase|Technical problems|1|||
33509976|NCT03334747|62893371|FG005|Treatment Phase|Technical problems|0|||
33509977|NCT03334747|62893372|FG006|Treatment Phase|Technical problems|0|||
33509978|NCT03334747|62893373|FG007|Treatment Phase|Technical problems|0|||
33509979|NCT03334747|62893374|FG008|Treatment Phase|Technical problems|0|||
33509980|NCT03334747|62893366|FG000|Treatment Phase|Subject/guardian decision|1|||
33509981|NCT03334747|62893367|FG001|Treatment Phase|Subject/guardian decision|0|||
33509982|NCT03334747|62893368|FG002|Treatment Phase|Subject/guardian decision|0|||
33509983|NCT03334747|62893369|FG003|Treatment Phase|Subject/guardian decision|0|||
33509984|NCT03334747|62893370|FG004|Treatment Phase|Subject/guardian decision|0|||
33509985|NCT03334747|62893371|FG005|Treatment Phase|Subject/guardian decision|1|||
33509986|NCT03334747|62893372|FG006|Treatment Phase|Subject/guardian decision|0|||
33509987|NCT03334747|62893373|FG007|Treatment Phase|Subject/guardian decision|0|||
33613385|NCT02181673|63014000|FG002|Week 24-Week 60|Pregnancy|1|||
33613386|NCT02181673|63013998|FG000|Week 24-Week 60|Lack of Efficacy|0|||
33613387|NCT02181673|63013999|FG001|Week 24-Week 60|Lack of Efficacy|0|||
33613388|NCT02181673|63014000|FG002|Week 24-Week 60|Lack of Efficacy|1|||
33613389|NCT02181673|63013998|FG000|Week 24-Week 60|Lost to Follow-up|0|||
33613390|NCT02181673|63013999|FG001|Week 24-Week 60|Lost to Follow-up|0|||
33613391|NCT02181673|63014000|FG002|Week 24-Week 60|Lost to Follow-up|1|||
33613392|NCT02181673|63013998|FG000|Week 24-Week 60|Physician Decision|0|||
33613393|NCT02181673|63013999|FG001|Week 24-Week 60|Physician Decision|0|||
33613394|NCT02181673|63014000|FG002|Week 24-Week 60|Physician Decision|1|||
33613395|NCT02131129|63014009|FG000|Overall Study|Withdrawal by Subject|1|||
33613396|NCT02131129|63014010|FG001|Overall Study|Withdrawal by Subject|0|||
33613397|NCT02152345|63014018|FG000|Overall Study|Case Cancellations|2|||
33613398|NCT02152345|63014019|FG001|Overall Study|Case Cancellations|4|||
33613399|NCT02152345|63014018|FG000|Overall Study|Withdrawal by Subject|2|||
33613400|NCT02152345|63014019|FG001|Overall Study|Withdrawal by Subject|1|||
33613401|NCT02180659|63014027|FG000|Overall Study|Adverse Event|1|||
33613402|NCT02180659|63014028|FG001|Overall Study|Adverse Event|0|||
33613403|NCT02180659|63014027|FG000|Overall Study|Lost to Follow-up|4|||
33613404|NCT02180659|63014028|FG001|Overall Study|Lost to Follow-up|2|||
33613405|NCT02180659|63014027|FG000|Overall Study|Subject incarcerated during conduct|1|||
33613406|NCT02180659|63014028|FG001|Overall Study|Subject incarcerated during conduct|0|||
33613407|NCT02180659|63014027|FG000|Overall Study|Withdrawal by Subject|0|||
33613408|NCT02180659|63014028|FG001|Overall Study|Withdrawal by Subject|2|||
33613409|NCT02180659|63014027|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
33613410|NCT02180659|63014028|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
33613411|NCT02130427|63014034|FG000|Overall Study|Imaging results not interpretable|30|||
33613412|NCT02207816|63014041|FG000|Overall Study|Serious Adverse Event|0|||
33613413|NCT02207816|63014042|FG001|Overall Study|Serious Adverse Event|5|||
33613414|NCT02207816|63014043|FG002|Overall Study|Serious Adverse Event|2|||
33613415|NCT02207816|63014041|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
33613416|NCT02207816|63014042|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
33613417|NCT02207816|63014043|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
33613418|NCT02207816|63014041|FG000|Overall Study|Withdrawal by Subject|4|||
33613419|NCT02207816|63014042|FG001|Overall Study|Withdrawal by Subject|9|||
33613420|NCT02207816|63014043|FG002|Overall Study|Withdrawal by Subject|7|||
33509988|NCT03334747|62893374|FG008|Treatment Phase|Subject/guardian decision|0|||
33613421|NCT02207816|63014041|FG000|Overall Study|Migrated/Moved From Study Area|41|||
33613422|NCT02207816|63014042|FG001|Overall Study|Migrated/Moved From Study Area|60|||
33613423|NCT02207816|63014043|FG002|Overall Study|Migrated/Moved From Study Area|51|||
33613424|NCT02207816|63014041|FG000|Overall Study|Lost to Follow-up|3|||
33613425|NCT02207816|63014042|FG001|Overall Study|Lost to Follow-up|9|||
33613426|NCT02207816|63014043|FG002|Overall Study|Lost to Follow-up|1|||
33613427|NCT02207816|63014041|FG000|Overall Study|Other|1|||
33613428|NCT02207816|63014042|FG001|Overall Study|Other|2|||
33509989|NCT03334747|62893366|FG000|Follow-Up Phase|Subject/guardian decision|0|||
33509990|NCT03334747|62893367|FG001|Follow-Up Phase|Subject/guardian decision|0|||
33509991|NCT03334747|62893368|FG002|Follow-Up Phase|Subject/guardian decision|0|||
33613429|NCT02207816|63014043|FG002|Overall Study|Other|4|||
33613430|NCT02241512|63014056|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
33613431|NCT02241512|63014057|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
33613432|NCT02205476|63014065|FG000|Overall Study|Study termination by Sponsor|7|||
33613433|NCT02205476|63014066|FG001|Overall Study|Study termination by Sponsor|3|||
33613434|NCT01709110|63014080|FG000|Overall Study|Adverse Event|56|||
33451741|NCT03769090|62826417|FG001|Overall Study|Death|2|||
33509992|NCT03334747|62893369|FG003|Follow-Up Phase|Subject/guardian decision|0|||
33509993|NCT03334747|62893370|FG004|Follow-Up Phase|Subject/guardian decision|0|||
33509994|NCT03334747|62893371|FG005|Follow-Up Phase|Subject/guardian decision|0|||
33509995|NCT03334747|62893372|FG006|Follow-Up Phase|Subject/guardian decision|1|||
33509996|NCT03334747|62893373|FG007|Follow-Up Phase|Subject/guardian decision|0|||
33509997|NCT03334747|62893374|FG008|Follow-Up Phase|Subject/guardian decision|1|||
33509998|NCT03346759|62893396|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
33509999|NCT03346759|62893397|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
33510000|NCT03346759|62893396|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
33510001|NCT03346759|62893397|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
33510002|NCT03346759|62893396|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
33510003|NCT03346759|62893397|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
33510004|NCT03361423|62893406|FG000|Overall Study|Withdrawal by Subject|4|||
33510005|NCT03361423|62893407|FG001|Overall Study|Withdrawal by Subject|3|||
33510006|NCT03361423|62893406|FG000|Overall Study|Did not treat|19|||
33510007|NCT03361423|62893407|FG001|Overall Study|Did not treat|18|||
33510008|NCT03361423|62893406|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
33510009|NCT03361423|62893407|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
33510010|NCT03361423|62893406|FG000|Overall Study|Missing data|4|||
33613435|NCT01709110|63014081|FG001|Overall Study|Adverse Event|48|||
33613436|NCT01709110|63014080|FG000|Overall Study|Death|14|||
33613437|NCT01709110|63014081|FG001|Overall Study|Death|6|||
33324401|NCT00911170|62700827|FG001|Long Term Follow-Up|Continuing in study|269|||
33324402|NCT00911170|62700826|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
33324403|NCT00911170|62700827|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
33451742|NCT03769090|62826418|FG002|Overall Study|Death|2|||
33451743|NCT03769090|62826416|FG000|Overall Study|Adverse Event|7|||
33451744|NCT03769090|62826417|FG001|Overall Study|Adverse Event|7|||
33451745|NCT03769090|62826418|FG002|Overall Study|Adverse Event|8|||
33451746|NCT03769090|62826416|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
33451747|NCT03769090|62826417|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
33451748|NCT03769090|62826418|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
33451749|NCT03769090|62826416|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
33451750|NCT03769090|62826417|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
33451751|NCT03769090|62826418|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
33451752|NCT03769090|62826416|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
33451753|NCT03769090|62826417|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
33451754|NCT03769090|62826418|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
33451755|NCT03769090|62826416|FG000|Overall Study|Protocol Violation|5|||
33451756|NCT03769090|62826417|FG001|Overall Study|Protocol Violation|6|||
33451757|NCT03769090|62826418|FG002|Overall Study|Protocol Violation|8|||
33451758|NCT03769090|62826416|FG000|Overall Study|Pregnancy|1|||
33451759|NCT03769090|62826417|FG001|Overall Study|Pregnancy|0|||
33451760|NCT03769090|62826418|FG002|Overall Study|Pregnancy|3|||
33451761|NCT03769090|62826416|FG000|Overall Study|Lost to Follow-up|19|||
33451762|NCT03769090|62826417|FG001|Overall Study|Lost to Follow-up|25|||
33451763|NCT03769090|62826418|FG002|Overall Study|Lost to Follow-up|21|||
33451764|NCT03769090|62826416|FG000|Overall Study|Condition under investigation worsened|2|||
33451765|NCT03769090|62826417|FG001|Overall Study|Condition under investigation worsened|0|||
33451766|NCT03769090|62826418|FG002|Overall Study|Condition under investigation worsened|1|||
33451767|NCT03769090|62826416|FG000|Overall Study|Lack of Efficacy|1|||
33451768|NCT03769090|62826417|FG001|Overall Study|Lack of Efficacy|2|||
33451769|NCT03769090|62826418|FG002|Overall Study|Lack of Efficacy|2|||
33451770|NCT03769090|62826416|FG000|Overall Study|Other reasons|8|||
33451771|NCT03769090|62826417|FG001|Overall Study|Other reasons|12|||
33451772|NCT03769090|62826418|FG002|Overall Study|Other reasons|15|||
33451773|NCT03559270|62826442|FG000|Overall Study|Adverse Event|6|||
33451774|NCT03559270|62826443|FG001|Overall Study|Adverse Event|5|||
33451775|NCT03559270|62826444|FG002|Overall Study|Adverse Event|3|||
33510011|NCT03361423|62893407|FG001|Overall Study|Missing data|1|||
33510012|NCT02693002|62893415|FG000|Overall Study|Withdrawal by Subject|1|||
33510013|NCT02693002|62893416|FG001|Overall Study|Withdrawal by Subject|0|||
33510014|NCT03093870|62893425|FG000|Overall Study|Withdrawal by Subject|2|||
33510015|NCT03093870|62893426|FG001|Overall Study|Withdrawal by Subject|6|||
33510016|NCT03093870|62893427|FG002|Overall Study|Withdrawal by Subject|5|||
33510017|NCT03093870|62893425|FG000|Overall Study|Death|1|||
33510018|NCT03093870|62893426|FG001|Overall Study|Death|35|||
33510019|NCT03093870|62893427|FG002|Overall Study|Death|35|||
33510020|NCT03093870|62893425|FG000|Overall Study|Radiographic disease progression|10|||
33510021|NCT03093870|62893426|FG001|Overall Study|Radiographic disease progression|0|||
33510022|NCT03093870|62893427|FG002|Overall Study|Radiographic disease progression|0|||
33510023|NCT03093870|62893425|FG000|Overall Study|Clinical disease progression|1|||
33510024|NCT03093870|62893426|FG001|Overall Study|Clinical disease progression|0|||
33510025|NCT03093870|62893427|FG002|Overall Study|Clinical disease progression|0|||
33510026|NCT03093870|62893425|FG000|Overall Study|Physician Decision|2|||
33510027|NCT03093870|62893426|FG001|Overall Study|Physician Decision|0|||
33510028|NCT03093870|62893427|FG002|Overall Study|Physician Decision|0|||
33510029|NCT03093870|62893425|FG000|Overall Study|Adverse Event|7|||
33510030|NCT03093870|62893426|FG001|Overall Study|Adverse Event|0|||
33510031|NCT03093870|62893427|FG002|Overall Study|Adverse Event|0|||
33510032|NCT03093870|62893425|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
33510033|NCT03093870|62893426|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
33510034|NCT03093870|62893427|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
33510035|NCT03093870|62893425|FG000|Overall Study|Lost to Follow-up|0|||
33510036|NCT03093870|62893426|FG001|Overall Study|Lost to Follow-up|0|||
33510037|NCT03093870|62893427|FG002|Overall Study|Lost to Follow-up|1|||
33510038|NCT03346057|62893450|FG000|Overall Study|Death|1|||
33510039|NCT03346057|62893451|FG001|Overall Study|Death|2|||
33510040|NCT03346057|62893452|FG002|Overall Study|Death|0|||
33510041|NCT03346057|62893453|FG003|Overall Study|Death|0|||
33510042|NCT03346057|62893450|FG000|Overall Study|Lost to Follow-up|0|||
33510043|NCT03346057|62893451|FG001|Overall Study|Lost to Follow-up|2|||
33510044|NCT03346057|62893452|FG002|Overall Study|Lost to Follow-up|1|||
33510045|NCT03346057|62893453|FG003|Overall Study|Lost to Follow-up|0|||
33510046|NCT03346057|62893450|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
33510047|NCT03346057|62893451|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
33510048|NCT03346057|62893452|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
33510049|NCT03346057|62893453|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
33510050|NCT03346057|62893450|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
33510051|NCT03346057|62893451|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
33510052|NCT03346057|62893452|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
33510053|NCT03346057|62893453|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
33510054|NCT03346057|62893450|FG000|Overall Study|Physician Decision|3|||
33510055|NCT03346057|62893451|FG001|Overall Study|Physician Decision|2|||
33510056|NCT03346057|62893452|FG002|Overall Study|Physician Decision|0|||
33510057|NCT03346057|62893453|FG003|Overall Study|Physician Decision|2|||
33613438|NCT01709110|63014080|FG000|Overall Study|Lost to Follow-up|7|||
33613439|NCT01709110|63014081|FG001|Overall Study|Lost to Follow-up|5|||
33510058|NCT03346057|62893450|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
33510059|NCT03346057|62893451|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
33510060|NCT03346057|62893452|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
33510061|NCT03346057|62893453|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
33510062|NCT03346057|62893450|FG000|Overall Study|Withdrawal by Subject|1|||
33613440|NCT01709110|63014080|FG000|Overall Study|Protocol Violation|4|||
33613441|NCT01709110|63014081|FG001|Overall Study|Protocol Violation|6|||
33613442|NCT01709110|63014080|FG000|Overall Study|Withdrawal by Subject|96|||
33510063|NCT03346057|62893451|FG001|Overall Study|Withdrawal by Subject|0|||
33510064|NCT03346057|62893452|FG002|Overall Study|Withdrawal by Subject|0|||
33510065|NCT03346057|62893453|FG003|Overall Study|Withdrawal by Subject|0|||
33510066|NCT03345979|62893465|FG000|Overall Study|Withdrawal by Subject|20|||
33510067|NCT03345979|62893466|FG001|Overall Study|Withdrawal by Subject|31|||
33510068|NCT03345979|62893465|FG000|Overall Study|Adverse Event|10|||
33510069|NCT03345979|62893466|FG001|Overall Study|Adverse Event|11|||
33510070|NCT03345979|62893465|FG000|Overall Study|Lost to Follow-up|8|||
33510071|NCT03345979|62893466|FG001|Overall Study|Lost to Follow-up|9|||
33510072|NCT03345979|62893465|FG000|Overall Study|Lack of Efficacy|4|||
33510073|NCT03345979|62893466|FG001|Overall Study|Lack of Efficacy|2|||
33510074|NCT03345979|62893465|FG000|Overall Study|Protocol Violation|1|||
33510075|NCT03345979|62893466|FG001|Overall Study|Protocol Violation|3|||
33510076|NCT03345979|62893465|FG000|Overall Study|Physician Decision|0|||
33510077|NCT03345979|62893466|FG001|Overall Study|Physician Decision|2|||
33510078|NCT02696434|62893474|FG000|Overall Study|Adverse Event|3|||
33510079|NCT02696434|62893475|FG001|Overall Study|Adverse Event|1|||
33510080|NCT02696434|62893474|FG000|Overall Study|Lost to Follow-up|5|||
33510081|NCT02696434|62893475|FG001|Overall Study|Lost to Follow-up|4|||
33510082|NCT02696434|62893474|FG000|Overall Study|Withdrawal by Subject|14|||
33510083|NCT02696434|62893475|FG001|Overall Study|Withdrawal by Subject|12|||
33510084|NCT02696434|62893474|FG000|Overall Study|Physician Decision|0|||
33510085|NCT02696434|62893475|FG001|Overall Study|Physician Decision|1|||
33510086|NCT03345901|62893481|FG000|Overall Study|The study was terminated|18|||
33510087|NCT02950831|62893486|FG000|Overall Study|Lost to Follow-up|1|||
33510088|NCT02950831|62893486|FG000|Overall Study|Withdrawal by Subject|3|||
33510089|NCT02950831|62893486|FG000|Overall Study|stimulation trail failure|5|||
33510090|NCT03593915|62893496|FG000|Overall Study|Adverse Event|0|||
33510091|NCT03593915|62893497|FG001|Overall Study|Adverse Event|0|||
33613443|NCT01709110|63014081|FG001|Overall Study|Withdrawal by Subject|89|||
33613444|NCT01709110|63014080|FG000|Overall Study|Physician Decision|4|||
33613445|NCT01709110|63014081|FG001|Overall Study|Physician Decision|10|||
33613446|NCT01709110|63014080|FG000|Overall Study|Sponsor Decision|2|||
33613447|NCT01709110|63014081|FG001|Overall Study|Sponsor Decision|2|||
33613448|NCT01709110|63014080|FG000|Overall Study|Lack of Efficacy|1|||
33613449|NCT01709110|63014081|FG001|Overall Study|Lack of Efficacy|1|||
33613450|NCT01709110|63014080|FG000|Overall Study|Caregiver Decision|1|||
33510092|NCT03593915|62893498|FG002|Overall Study|Adverse Event|0|||
33510093|NCT03593915|62893499|FG003|Overall Study|Adverse Event|1|||
33510094|NCT03593915|62893500|FG004|Overall Study|Adverse Event|0|||
33510095|NCT03593915|62893501|FG005|Overall Study|Adverse Event|0|||
33510096|NCT03593915|62893496|FG000|Overall Study|Physician Decision|0|||
33510097|NCT03593915|62893497|FG001|Overall Study|Physician Decision|0|||
33510098|NCT03593915|62893498|FG002|Overall Study|Physician Decision|0|||
33613451|NCT01709110|63014081|FG001|Overall Study|Caregiver Decision|1|||
33613452|NCT02240108|63014089|FG000|Overall Study|Other than specified|8|||
33613453|NCT02240108|63014090|FG001|Overall Study|Other than specified|6|||
33510099|NCT03593915|62893499|FG003|Overall Study|Physician Decision|0|||
33613454|NCT02240108|63014089|FG000|Overall Study|Adverse Event|1|||
33613455|NCT02240108|63014090|FG001|Overall Study|Adverse Event|9|||
33510100|NCT03593915|62893500|FG004|Overall Study|Physician Decision|0|||
33510101|NCT03593915|62893501|FG005|Overall Study|Physician Decision|1|||
33510102|NCT03593681|62893515|FG000|Overall Study|Inadequate sample collected|12|||
33613456|NCT02240108|63014089|FG000|Overall Study|Pregnancy|1|||
33510103|NCT03593681|62893515|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
33510104|NCT03593681|62893515|FG000|Overall Study|Protocol Violation|3|||
33510105|NCT03593681|62893515|FG000|Overall Study|Withdrawal by Subject|3|||
33510106|NCT03593681|62893515|FG000|Overall Study|Procedure not attempted|3|||
33510107|NCT03593681|62893515|FG000|Overall Study|Adverse Event|2|||
33510108|NCT03593681|62893515|FG000|Overall Study|Physician Decision|1|||
33510109|NCT03592745|62893538|FG000|Overall Study|Adverse Event|0|||
33510110|NCT03592745|62893539|FG001|Overall Study|Adverse Event|2|||
33510111|NCT03592745|62893538|FG000|Overall Study|Lost to Follow-up|2|||
33510112|NCT03592745|62893539|FG001|Overall Study|Lost to Follow-up|0|||
33510113|NCT03592745|62893538|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
33510114|NCT03592745|62893539|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
33510115|NCT03592277|62893547|FG000|Overall Study|Withdrawal by Subject|6|||
33510116|NCT03592277|62893548|FG001|Overall Study|Withdrawal by Subject|8|||
33510117|NCT03401112|62893559|FG000|Overall Study|Adverse Event|1|||
33510118|NCT03401112|62893560|FG001|Overall Study|Adverse Event|2|||
33510119|NCT03401112|62893561|FG002|Overall Study|Adverse Event|3|||
33510120|NCT03401112|62893562|FG003|Overall Study|Adverse Event|2|||
33510121|NCT03401112|62893563|FG004|Overall Study|Adverse Event|0|||
33510122|NCT03401112|62893559|FG000|Overall Study|Lost to Follow-up|1|||
33510123|NCT03401112|62893560|FG001|Overall Study|Lost to Follow-up|0|||
33510124|NCT03401112|62893561|FG002|Overall Study|Lost to Follow-up|0|||
33510125|NCT03401112|62893562|FG003|Overall Study|Lost to Follow-up|0|||
33510126|NCT03401112|62893563|FG004|Overall Study|Lost to Follow-up|0|||
33510127|NCT03401112|62893559|FG000|Overall Study|Noncompliance|1|||
33510128|NCT03401112|62893560|FG001|Overall Study|Noncompliance|2|||
33510129|NCT03401112|62893561|FG002|Overall Study|Noncompliance|3|||
33510130|NCT03401112|62893562|FG003|Overall Study|Noncompliance|0|||
33613457|NCT02240108|63014090|FG001|Overall Study|Pregnancy|0|||
33613458|NCT02240108|63014089|FG000|Overall Study|Withdrawal by Subject|4|||
33324404|NCT00911170|62700826|FG000|Long Term Follow-Up|Physician Decision|5|||
33324405|NCT00911170|62700827|FG001|Long Term Follow-Up|Physician Decision|4|||
33510131|NCT03401112|62893563|FG004|Overall Study|Noncompliance|0|||
33510132|NCT03401112|62893559|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
33510133|NCT03401112|62893560|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
33510134|NCT03401112|62893561|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
33510135|NCT03401112|62893562|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
33510136|NCT03401112|62893563|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
33510137|NCT03401112|62893559|FG000|Overall Study|Withdrawal by Subject|0|||
33510138|NCT03401112|62893560|FG001|Overall Study|Withdrawal by Subject|3|||
33510139|NCT03401112|62893561|FG002|Overall Study|Withdrawal by Subject|2|||
33510140|NCT03401112|62893562|FG003|Overall Study|Withdrawal by Subject|1|||
33510141|NCT03401112|62893563|FG004|Overall Study|Withdrawal by Subject|0|||
33510142|NCT03401112|62893559|FG000|Overall Study|Physician Decision|0|||
33510143|NCT03401112|62893560|FG001|Overall Study|Physician Decision|0|||
33510144|NCT03401112|62893561|FG002|Overall Study|Physician Decision|0|||
33510145|NCT03401112|62893562|FG003|Overall Study|Physician Decision|2|||
33510146|NCT03401112|62893563|FG004|Overall Study|Physician Decision|0|||
33510147|NCT03401112|62893559|FG000|Overall Study|Study was Terminated by Sponsor|0|||
33613459|NCT02240108|63014090|FG001|Overall Study|Withdrawal by Subject|9|||
33324406|NCT00911170|62700826|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
33324407|NCT00911170|62700827|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
33324408|NCT00911170|62700826|FG000|Long Term Follow-Up|Death|116|||
33324409|NCT00911170|62700827|FG001|Long Term Follow-Up|Death|121|||
33324410|NCT01167881|62700835|FG000|Overall Study|Adverse Event|47|||
33324411|NCT01167881|62700836|FG001|Overall Study|Adverse Event|51|||
33324412|NCT01167881|62700835|FG000|Overall Study|Lack of Efficacy|4|||
33451776|NCT03559270|62826445|FG003|Overall Study|Adverse Event|0|||
33324413|NCT01167881|62700836|FG001|Overall Study|Lack of Efficacy|7|||
33451777|NCT03559270|62826442|FG000|Overall Study|Lack of Efficacy|34|||
33451778|NCT03559270|62826443|FG001|Overall Study|Lack of Efficacy|52|||
33451779|NCT03559270|62826444|FG002|Overall Study|Lack of Efficacy|37|||
33451780|NCT03559270|62826445|FG003|Overall Study|Lack of Efficacy|2|||
33451781|NCT03559270|62826442|FG000|Overall Study|Death|0|||
33451782|NCT03559270|62826443|FG001|Overall Study|Death|2|||
33451783|NCT03559270|62826444|FG002|Overall Study|Death|0|||
33451784|NCT03559270|62826445|FG003|Overall Study|Death|0|||
33451785|NCT03559270|62826442|FG000|Overall Study|Lost to Follow-up|16|||
33510148|NCT03401112|62893560|FG001|Overall Study|Study was Terminated by Sponsor|0|||
33510149|NCT03401112|62893561|FG002|Overall Study|Study was Terminated by Sponsor|0|||
33510150|NCT03401112|62893562|FG003|Overall Study|Study was Terminated by Sponsor|1|||
33510151|NCT03401112|62893563|FG004|Overall Study|Study was Terminated by Sponsor|0|||
33510152|NCT03401112|62893559|FG000|Overall Study|Day 1 Assessment not Done|1|||
33510153|NCT03401112|62893560|FG001|Overall Study|Day 1 Assessment not Done|0|||
33510154|NCT03401112|62893561|FG002|Overall Study|Day 1 Assessment not Done|0|||
33510155|NCT03401112|62893562|FG003|Overall Study|Day 1 Assessment not Done|0|||
33510156|NCT03401112|62893563|FG004|Overall Study|Day 1 Assessment not Done|0|||
33510157|NCT03401112|62893559|FG000|Overall Study|Not Dosed|0|||
33510158|NCT03401112|62893560|FG001|Overall Study|Not Dosed|0|||
33510159|NCT03401112|62893561|FG002|Overall Study|Not Dosed|1|||
33510160|NCT03401112|62893562|FG003|Overall Study|Not Dosed|0|||
33510161|NCT03401112|62893563|FG004|Overall Study|Not Dosed|0|||
33510162|NCT03401112|62893559|FG000|Overall Study|Missed Clinical Visit|0|||
33510163|NCT03401112|62893560|FG001|Overall Study|Missed Clinical Visit|0|||
33510164|NCT03401112|62893561|FG002|Overall Study|Missed Clinical Visit|1|||
33510165|NCT03401112|62893562|FG003|Overall Study|Missed Clinical Visit|0|||
33510166|NCT03401112|62893563|FG004|Overall Study|Missed Clinical Visit|0|||
33510167|NCT03401112|62893559|FG000|Overall Study|Missed Doses|0|||
33510168|NCT03401112|62893560|FG001|Overall Study|Missed Doses|0|||
33510169|NCT03401112|62893561|FG002|Overall Study|Missed Doses|1|||
33510170|NCT03401112|62893562|FG003|Overall Study|Missed Doses|0|||
33510171|NCT03401112|62893563|FG004|Overall Study|Missed Doses|0|||
33510172|NCT02697916|62893592|FG000|Overall Study|Death|357|||
33510173|NCT02697916|62893593|FG001|Overall Study|Death|315|||
33510174|NCT02697916|62893592|FG000|Overall Study|Withdrawal by Subject|221|||
33510175|NCT02697916|62893593|FG001|Overall Study|Withdrawal by Subject|393|||
33510176|NCT03650387|62893599|FG000|Overall Study|Withdrawal by Subject|13|||
33510177|NCT03650387|62893599|FG000|Overall Study|Lost to Follow-up|12|||
33510178|NCT03650387|62893599|FG000|Overall Study|Adverse Event (Not related)|1|||
33510179|NCT03650387|62893599|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
33510180|NCT03359473|62893625|FG000|Overall Study|Adverse Event|0|||
33510181|NCT03359473|62893626|FG001|Overall Study|Adverse Event|2|||
33510182|NCT03359473|62893627|FG002|Overall Study|Adverse Event|5|||
33510183|NCT03359473|62893628|FG003|Overall Study|Adverse Event|3|||
33510184|NCT03359473|62893625|FG000|Overall Study|Lost to Follow-up|0|||
33510185|NCT03359473|62893626|FG001|Overall Study|Lost to Follow-up|1|||
33510186|NCT03359473|62893627|FG002|Overall Study|Lost to Follow-up|0|||
33510187|NCT03359473|62893628|FG003|Overall Study|Lost to Follow-up|0|||
33510188|NCT03359473|62893625|FG000|Overall Study|Physician Decision|0|||
33510189|NCT03359473|62893626|FG001|Overall Study|Physician Decision|1|||
33510190|NCT03359473|62893627|FG002|Overall Study|Physician Decision|0|||
33510191|NCT03359473|62893628|FG003|Overall Study|Physician Decision|1|||
33510192|NCT03359473|62893625|FG000|Overall Study|Withdrawal by Subject|1|||
33510193|NCT03359473|62893626|FG001|Overall Study|Withdrawal by Subject|2|||
33510194|NCT03359473|62893627|FG002|Overall Study|Withdrawal by Subject|1|||
33510195|NCT03359473|62893628|FG003|Overall Study|Withdrawal by Subject|0|||
33510196|NCT03359473|62893625|FG000|Overall Study|Protocol-defined stopping criteria|1|||
33510197|NCT03359473|62893626|FG001|Overall Study|Protocol-defined stopping criteria|0|||
33510198|NCT03359473|62893627|FG002|Overall Study|Protocol-defined stopping criteria|0|||
33510199|NCT03359473|62893628|FG003|Overall Study|Protocol-defined stopping criteria|1|||
33510200|NCT03589469|62893641|FG000|Overall Study|Withdrawal by Subject|8|||
33613460|NCT02240108|63014089|FG000|Overall Study|StudyTerminated by Sponsor|0|||
33613461|NCT02240108|63014090|FG001|Overall Study|StudyTerminated by Sponsor|1|||
33613462|NCT02239640|63014096|FG000|Overall Study|Withdrawal by Subject|3|||
33613463|NCT02239640|63014096|FG000|Overall Study|Lost to Follow-up|72|||
33613464|NCT02239640|63014096|FG000|Overall Study|Death|142|||
33613465|NCT01590628|63014108|FG000|Overall Study|Death|2|||
33613466|NCT01590628|63014109|FG001|Overall Study|Death|0|||
33613467|NCT02130193|63014121|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
33613468|NCT02130193|63014122|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
33613469|NCT02130193|63014123|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
33613470|NCT02130193|63014121|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
33613471|NCT02130193|63014122|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
33613472|NCT02130193|63014123|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
33451786|NCT03559270|62826443|FG001|Overall Study|Lost to Follow-up|4|||
33451787|NCT03559270|62826444|FG002|Overall Study|Lost to Follow-up|12|||
33451788|NCT03559270|62826445|FG003|Overall Study|Lost to Follow-up|3|||
33451789|NCT03559270|62826442|FG000|Overall Study|Sponsor Decision|38|||
33451790|NCT03559270|62826443|FG001|Overall Study|Sponsor Decision|31|||
33451791|NCT03559270|62826444|FG002|Overall Study|Sponsor Decision|35|||
33451792|NCT03559270|62826445|FG003|Overall Study|Sponsor Decision|18|||
33451793|NCT03559270|62826442|FG000|Overall Study|Withdrawal by Subject|19|||
33451794|NCT03559270|62826443|FG001|Overall Study|Withdrawal by Subject|21|||
33451795|NCT03559270|62826444|FG002|Overall Study|Withdrawal by Subject|18|||
33451796|NCT03559270|62826445|FG003|Overall Study|Withdrawal by Subject|7|||
33451797|NCT03559270|62826442|FG000|Overall Study|Physician Decision|3|||
33451798|NCT03559270|62826443|FG001|Overall Study|Physician Decision|2|||
33510201|NCT03589469|62893641|FG000|Overall Study|Physician Decision|20|||
33510202|NCT03589469|62893641|FG000|Overall Study|Death|97|||
33510203|NCT03589469|62893641|FG000|Overall Study|Lost to Follow-up|8|||
33510204|NCT03589469|62893641|FG000|Overall Study|Miscellaneous|1|||
33510205|NCT03359395|62893647|FG000|First Intervention A / B|Withdrawal by Subject|1|||
33510206|NCT03359395|62893648|FG001|First Intervention A / B|Withdrawal by Subject|0|||
33510207|NCT03359395|62893647|FG000|First Intervention A / B|Lost to Follow-up|2|||
33510208|NCT03359395|62893648|FG001|First Intervention A / B|Lost to Follow-up|3|||
33510209|NCT03359395|62893647|FG000|Second Intervention B/A|Exclusion criteria|0|||
33510210|NCT03359395|62893648|FG001|Second Intervention B/A|Exclusion criteria|1|||
33510211|NCT03359395|62893647|FG000|Second Intervention B/A|Lost to Follow-up|3|||
33510212|NCT03359395|62893648|FG001|Second Intervention B/A|Lost to Follow-up|2|||
33510213|NCT03586427|62893659|FG000|Overall Study|Lost to Follow-up|0|||
33510214|NCT03586427|62893660|FG001|Overall Study|Lost to Follow-up|3|||
33510215|NCT03586427|62893661|FG002|Overall Study|Lost to Follow-up|1|||
33510216|NCT03586427|62893662|FG003|Overall Study|Lost to Follow-up|3|||
33510217|NCT03586427|62893663|FG004|Overall Study|Lost to Follow-up|3|||
33510218|NCT03586427|62893659|FG000|Overall Study|Withdrawal by Subject|0|||
33510219|NCT03586427|62893660|FG001|Overall Study|Withdrawal by Subject|1|||
33510220|NCT03586427|62893661|FG002|Overall Study|Withdrawal by Subject|2|||
33510221|NCT03586427|62893662|FG003|Overall Study|Withdrawal by Subject|1|||
33510222|NCT03586427|62893663|FG004|Overall Study|Withdrawal by Subject|1|||
33510223|NCT03586427|62893659|FG000|Overall Study|Adverse Event|0|||
33510224|NCT03586427|62893660|FG001|Overall Study|Adverse Event|0|||
33510225|NCT03586427|62893661|FG002|Overall Study|Adverse Event|1|||
33510226|NCT03586427|62893662|FG003|Overall Study|Adverse Event|0|||
33510227|NCT03586427|62893663|FG004|Overall Study|Adverse Event|0|||
33510228|NCT03586427|62893659|FG000|Overall Study|Protocol Violation|0|||
33510229|NCT03586427|62893660|FG001|Overall Study|Protocol Violation|0|||
33510230|NCT03586427|62893661|FG002|Overall Study|Protocol Violation|1|||
33510231|NCT03586427|62893662|FG003|Overall Study|Protocol Violation|0|||
33510232|NCT03586427|62893663|FG004|Overall Study|Protocol Violation|1|||
33510233|NCT03586427|62893659|FG000|Overall Study|Noncompliance with study drug|0|||
33510234|NCT03586427|62893660|FG001|Overall Study|Noncompliance with study drug|0|||
33510235|NCT03586427|62893661|FG002|Overall Study|Noncompliance with study drug|1|||
33510236|NCT03586427|62893662|FG003|Overall Study|Noncompliance with study drug|0|||
33510237|NCT03586427|62893663|FG004|Overall Study|Noncompliance with study drug|0|||
33510238|NCT03648983|62893680|FG000|Overall Study|Study was terminated due to PI departure|95|||
33510239|NCT02695420|62893689|FG000|Overall Study|Death|0|||
33510240|NCT02695420|62893690|FG001|Overall Study|Death|1|||
33510241|NCT02695420|62893691|FG002|Overall Study|Death|0|||
33510242|NCT02695420|62893692|FG003|Overall Study|Death|0|||
33510243|NCT03358147|62893710|FG000|Overall Study|Withdrawal by Subject|13|||
33510244|NCT03358147|62893711|FG001|Overall Study|Withdrawal by Subject|19|||
33510245|NCT03358147|62893712|FG002|Overall Study|Withdrawal by Subject|16|||
33510246|NCT03358147|62893713|FG003|Overall Study|Withdrawal by Subject|10|||
33510247|NCT03358147|62893714|FG004|Overall Study|Withdrawal by Subject|5|||
33510248|NCT03358147|62893710|FG000|Overall Study|Adverse Event|3|||
33510249|NCT03358147|62893711|FG001|Overall Study|Adverse Event|9|||
33510250|NCT03358147|62893712|FG002|Overall Study|Adverse Event|7|||
33510251|NCT03358147|62893713|FG003|Overall Study|Adverse Event|5|||
33510252|NCT03358147|62893714|FG004|Overall Study|Adverse Event|2|||
33510253|NCT03358147|62893710|FG000|Overall Study|Lost to Follow-up|4|||
33613473|NCT02130193|63014121|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
33613474|NCT02130193|63014122|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
33613475|NCT02130193|63014123|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
33613476|NCT02130193|63014121|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
33613477|NCT02130193|63014122|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
33613478|NCT02130193|63014123|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
33613479|NCT01590082|63014134|FG000|Overall Study|Withdrawal by Subject|1|||
33613480|NCT01590082|63014135|FG001|Overall Study|Withdrawal by Subject|0|||
33613481|NCT01590082|63014134|FG000|Overall Study|Ineligible|1|||
33613482|NCT01590082|63014135|FG001|Overall Study|Ineligible|0|||
33613483|NCT01631474|63014146|FG000|Overall Study|Lost to Follow-up|8|||
33613484|NCT01631474|63014147|FG001|Overall Study|Lost to Follow-up|5|||
33613485|NCT01631474|63014148|FG002|Overall Study|Lost to Follow-up|7|||
33613486|NCT01631474|63014149|FG003|Overall Study|Lost to Follow-up|5|||
33613487|NCT01631474|63014150|FG004|Overall Study|Lost to Follow-up|5|||
33613488|NCT01631474|63014146|FG000|Overall Study|Withdrawal by Subject|4|||
33613489|NCT01631474|63014147|FG001|Overall Study|Withdrawal by Subject|4|||
33613490|NCT01631474|63014148|FG002|Overall Study|Withdrawal by Subject|2|||
33613491|NCT01631474|63014149|FG003|Overall Study|Withdrawal by Subject|6|||
33613492|NCT01631474|63014150|FG004|Overall Study|Withdrawal by Subject|5|||
33613493|NCT01631474|63014146|FG000|Overall Study|Lack of Efficacy|2|||
33613494|NCT01631474|63014147|FG001|Overall Study|Lack of Efficacy|2|||
33613495|NCT01631474|63014148|FG002|Overall Study|Lack of Efficacy|0|||
33613496|NCT01631474|63014149|FG003|Overall Study|Lack of Efficacy|0|||
33510254|NCT03358147|62893711|FG001|Overall Study|Lost to Follow-up|3|||
33510255|NCT03358147|62893712|FG002|Overall Study|Lost to Follow-up|7|||
33510256|NCT03358147|62893713|FG003|Overall Study|Lost to Follow-up|6|||
33510257|NCT03358147|62893714|FG004|Overall Study|Lost to Follow-up|4|||
33510258|NCT03358147|62893710|FG000|Overall Study|Major Protocol Deviation|11|||
33510259|NCT03358147|62893711|FG001|Overall Study|Major Protocol Deviation|3|||
33510260|NCT03358147|62893712|FG002|Overall Study|Major Protocol Deviation|2|||
33613497|NCT01631474|63014150|FG004|Overall Study|Lack of Efficacy|2|||
33613498|NCT01631474|63014146|FG000|Overall Study|Noncompliance with Study Drug|0|||
33613499|NCT01631474|63014147|FG001|Overall Study|Noncompliance with Study Drug|0|||
33613500|NCT01631474|63014148|FG002|Overall Study|Noncompliance with Study Drug|0|||
33613501|NCT01631474|63014149|FG003|Overall Study|Noncompliance with Study Drug|0|||
33613502|NCT01631474|63014150|FG004|Overall Study|Noncompliance with Study Drug|1|||
33613503|NCT01631474|63014146|FG000|Overall Study|Adverse Event|0|||
33613504|NCT01631474|63014147|FG001|Overall Study|Adverse Event|1|||
33613505|NCT01631474|63014148|FG002|Overall Study|Adverse Event|0|||
33613506|NCT01631474|63014149|FG003|Overall Study|Adverse Event|0|||
33613507|NCT01631474|63014150|FG004|Overall Study|Adverse Event|0|||
33613508|NCT02203916|63014165|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
33613509|NCT02203916|63014166|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
33613510|NCT02203916|63014167|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
33613511|NCT02203916|63014165|FG000|Overall Study|Major Protocol Deviation|1|||
33613512|NCT02203916|63014166|FG001|Overall Study|Major Protocol Deviation|1|||
33613513|NCT02203916|63014167|FG002|Overall Study|Major Protocol Deviation|0|||
33613514|NCT02203916|63014165|FG000|Overall Study|Lost to Follow-up|0|||
33613515|NCT02203916|63014166|FG001|Overall Study|Lost to Follow-up|1|||
33613516|NCT02203916|63014167|FG002|Overall Study|Lost to Follow-up|0|||
33613517|NCT02203916|63014165|FG000|Overall Study|Voluntary Withdrawal|3|||
33613518|NCT02203916|63014166|FG001|Overall Study|Voluntary Withdrawal|3|||
33613519|NCT02203916|63014167|FG002|Overall Study|Voluntary Withdrawal|8|||
33613520|NCT02203916|63014165|FG000|Overall Study|Lack of Efficacy|3|||
33613521|NCT02203916|63014166|FG001|Overall Study|Lack of Efficacy|0|||
33613522|NCT02203916|63014167|FG002|Overall Study|Lack of Efficacy|0|||
33613523|NCT02203916|63014165|FG000|Overall Study|Reason Not Specified|0|||
33613524|NCT02203916|63014166|FG001|Overall Study|Reason Not Specified|2|||
33613525|NCT02203916|63014167|FG002|Overall Study|Reason Not Specified|1|||
33613526|NCT02179177|63014191|FG000|Overall Study|Lost to Follow-up|1|||
33613527|NCT02179177|63014192|FG001|Overall Study|Lost to Follow-up|1|||
33613528|NCT02179177|63014191|FG000|Overall Study|Withdrawal by Subject|1|||
33613529|NCT02179177|63014192|FG001|Overall Study|Withdrawal by Subject|1|||
33451799|NCT03559270|62826444|FG002|Overall Study|Physician Decision|1|||
33451800|NCT03559270|62826445|FG003|Overall Study|Physician Decision|0|||
33451801|NCT03559270|62826442|FG000|Overall Study|Pregnancy|0|||
33451802|NCT03559270|62826443|FG001|Overall Study|Pregnancy|1|||
33451803|NCT03559270|62826444|FG002|Overall Study|Pregnancy|0|||
33451804|NCT03559270|62826445|FG003|Overall Study|Pregnancy|0|||
33451805|NCT03559270|62826442|FG000|Overall Study|Protocol Violation|1|||
33451806|NCT03559270|62826443|FG001|Overall Study|Protocol Violation|0|||
33451807|NCT03559270|62826444|FG002|Overall Study|Protocol Violation|2|||
33451808|NCT03559270|62826445|FG003|Overall Study|Protocol Violation|0|||
33451809|NCT00114777|62826500|FG000|Randomization to Month 36|Death|10|||
33451810|NCT00114777|62826501|FG001|Randomization to Month 36|Death|4|||
33451811|NCT00114777|62826502|FG002|Randomization to Month 36|Death|3|||
33451812|NCT00114777|62826500|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
33451813|NCT00114777|62826501|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
33451814|NCT00114777|62826502|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
33451815|NCT00114777|62826500|FG000|Randomization to Month 36|Lack of Efficacy|19|||
33451816|NCT00114777|62826501|FG001|Randomization to Month 36|Lack of Efficacy|15|||
33451817|NCT00114777|62826502|FG002|Randomization to Month 36|Lack of Efficacy|17|||
33451818|NCT00114777|62826500|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
33451819|NCT00114777|62826501|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
33451820|NCT00114777|62826502|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
33451821|NCT00114777|62826500|FG000|Randomization to Month 36|Adverse Event|34|||
33451822|NCT00114777|62826501|FG001|Randomization to Month 36|Adverse Event|35|||
33451823|NCT00114777|62826502|FG002|Randomization to Month 36|Adverse Event|44|||
33451824|NCT00114777|62826500|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
33451825|NCT00114777|62826501|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
33451826|NCT00114777|62826502|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
33451827|NCT00114777|62826500|FG000|Randomization to Month 36|Other|9|||
33451828|NCT00114777|62826501|FG001|Randomization to Month 36|Other|3|||
33451829|NCT00114777|62826502|FG002|Randomization to Month 36|Other|12|||
33451830|NCT00114777|62826500|FG000|Long-Term Extension to Month 84|Death|8|||
33451831|NCT00114777|62826501|FG001|Long-Term Extension to Month 84|Death|13|||
33451832|NCT00114777|62826502|FG002|Long-Term Extension to Month 84|Death|7|||
33451833|NCT00114777|62826500|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
33451834|NCT00114777|62826501|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
33451835|NCT00114777|62826502|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
33451836|NCT00114777|62826500|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
33451837|NCT00114777|62826501|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
33451838|NCT00114777|62826502|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
33613530|NCT02239328|63014198|FG000|Overall Study|Benign disease noted at time of surgery|6|||
33613531|NCT02239328|63014198|FG000|Overall Study|Equipment or website malfunction|2|||
33510261|NCT03358147|62893713|FG003|Overall Study|Major Protocol Deviation|3|||
33510262|NCT03358147|62893714|FG004|Overall Study|Major Protocol Deviation|1|||
33510263|NCT03358147|62893710|FG000|Overall Study|Protocol specified criteria|2|||
33510264|NCT03358147|62893711|FG001|Overall Study|Protocol specified criteria|3|||
33510265|NCT03358147|62893712|FG002|Overall Study|Protocol specified criteria|0|||
33510266|NCT03358147|62893713|FG003|Overall Study|Protocol specified criteria|3|||
33510267|NCT03358147|62893714|FG004|Overall Study|Protocol specified criteria|1|||
33510268|NCT03358147|62893710|FG000|Overall Study|Physician Decision|1|||
33510269|NCT03358147|62893711|FG001|Overall Study|Physician Decision|0|||
33510270|NCT03358147|62893712|FG002|Overall Study|Physician Decision|1|||
33510271|NCT03358147|62893713|FG003|Overall Study|Physician Decision|6|||
33510272|NCT03358147|62893714|FG004|Overall Study|Physician Decision|1|||
33510273|NCT03358147|62893710|FG000|Overall Study|Administrative reasons|0|||
33510274|NCT03358147|62893711|FG001|Overall Study|Administrative reasons|1|||
33510275|NCT03358147|62893712|FG002|Overall Study|Administrative reasons|0|||
33510276|NCT03358147|62893713|FG003|Overall Study|Administrative reasons|3|||
33510277|NCT03358147|62893714|FG004|Overall Study|Administrative reasons|0|||
33510278|NCT03358147|62893710|FG000|Overall Study|Lack of Efficacy|0|||
33510279|NCT03358147|62893711|FG001|Overall Study|Lack of Efficacy|1|||
33510280|NCT03358147|62893712|FG002|Overall Study|Lack of Efficacy|1|||
33510281|NCT03358147|62893713|FG003|Overall Study|Lack of Efficacy|0|||
33510282|NCT03358147|62893714|FG004|Overall Study|Lack of Efficacy|0|||
33510283|NCT03093402|62893730|FG000|Overall Study|Lost to Follow-up|1|||
33510284|NCT03093402|62893731|FG001|Overall Study|Lost to Follow-up|0|||
33510285|NCT03093402|62893732|FG002|Overall Study|Lost to Follow-up|0|||
33510286|NCT03093402|62893733|FG003|Overall Study|Lost to Follow-up|0|||
33510287|NCT03093402|62893730|FG000|Overall Study|Withdrawal by Subject|3|||
33510288|NCT03093402|62893731|FG001|Overall Study|Withdrawal by Subject|3|||
33510289|NCT03093402|62893732|FG002|Overall Study|Withdrawal by Subject|0|||
33510290|NCT03093402|62893733|FG003|Overall Study|Withdrawal by Subject|1|||
33510291|NCT03093402|62893730|FG000|Overall Study|Withdrew prior to dosing|2|||
33510292|NCT03093402|62893731|FG001|Overall Study|Withdrew prior to dosing|1|||
33510293|NCT03093402|62893732|FG002|Overall Study|Withdrew prior to dosing|2|||
33510294|NCT03093402|62893733|FG003|Overall Study|Withdrew prior to dosing|3|||
33510295|NCT03093402|62893730|FG000|Overall Study|Ineligible for study|1|||
33510296|NCT03093402|62893731|FG001|Overall Study|Ineligible for study|0|||
33510297|NCT03093402|62893732|FG002|Overall Study|Ineligible for study|0|||
33510298|NCT03093402|62893733|FG003|Overall Study|Ineligible for study|0|||
33510299|NCT03093402|62893730|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
33510300|NCT03093402|62893731|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
33510301|NCT03093402|62893732|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
33510302|NCT03093402|62893733|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
33510303|NCT03585959|62893743|FG000|Overall Study|Physician Decision|1|||
33510304|NCT03585959|62893743|FG000|Overall Study|Unsuccessful Procedure|2|||
33510305|NCT03584789|62893752|FG000|Overall Study|refused EHR permission|19|||
33510306|NCT03584789|62893753|FG001|Overall Study|refused EHR permission|28|||
33510307|NCT03584789|62893754|FG002|Overall Study|refused EHR permission|23|||
33510308|NCT03584789|62893752|FG000|Overall Study|patients tied to a provider who retired|0|||
33613532|NCT02129803|63014204|FG000|Overall Study|Protocol Violation|4|||
33613533|NCT02129803|63014205|FG001|Overall Study|Protocol Violation|0|||
33613534|NCT02129803|63014204|FG000|Overall Study|Physician Decision|0|||
33613535|NCT02129803|63014205|FG001|Overall Study|Physician Decision|1|||
33613536|NCT02129803|63014204|FG000|Overall Study|Difficulty sleeping|1|||
33613537|NCT02129803|63014205|FG001|Overall Study|Difficulty sleeping|0|||
33613538|NCT02129803|63014204|FG000|Overall Study|Morning headache|0|||
33613539|NCT02129803|63014205|FG001|Overall Study|Morning headache|1|||
33613540|NCT02129803|63014204|FG000|Overall Study|Withdrawal by Subject|1|||
33613541|NCT02129803|63014205|FG001|Overall Study|Withdrawal by Subject|1|||
33613542|NCT02239094|63014211|FG000|Overall Study|Withdrawal by Subject|1|||
33613543|NCT02239094|63014211|FG000|Overall Study|Remitted before started|1|||
33613544|NCT02129647|63014215|FG000|Overall Study|Adverse Event|2|||
33510309|NCT03584789|62893753|FG001|Overall Study|patients tied to a provider who retired|0|||
33510310|NCT03584789|62893754|FG002|Overall Study|patients tied to a provider who retired|3|||
33510311|NCT03343639|62893764|FG000|Overall Study|Withdrawal by Subject|10|||
33510312|NCT03343639|62893765|FG001|Overall Study|Withdrawal by Subject|6|||
33613545|NCT02129647|63014215|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
33510313|NCT03343639|62893764|FG000|Overall Study|Lost to Follow-up|4|||
33510314|NCT03343639|62893765|FG001|Overall Study|Lost to Follow-up|5|||
33510315|NCT03343639|62893764|FG000|Overall Study|Protocol Violation|0|||
33613546|NCT02238626|63014223|FG000|Overall Study|Adverse Event|3|||
33510316|NCT03343639|62893765|FG001|Overall Study|Protocol Violation|1|||
33510317|NCT03647267|62893773|FG000|Overall Study|Lost to Follow-up|1|||
33613547|NCT02238626|63014224|FG001|Overall Study|Adverse Event|5|||
33613548|NCT02238626|63014225|FG002|Overall Study|Adverse Event|0|||
33613549|NCT02238626|63014226|FG003|Overall Study|Adverse Event|3|||
33613550|NCT02238626|63014223|FG000|Overall Study|Lost to Follow-up|2|||
33613551|NCT02238626|63014224|FG001|Overall Study|Lost to Follow-up|4|||
33613552|NCT02238626|63014225|FG002|Overall Study|Lost to Follow-up|2|||
33613553|NCT02238626|63014226|FG003|Overall Study|Lost to Follow-up|2|||
33613554|NCT02238626|63014223|FG000|Overall Study|Withdrawal by Subject|0|||
33613555|NCT02238626|63014224|FG001|Overall Study|Withdrawal by Subject|3|||
33613556|NCT02238626|63014225|FG002|Overall Study|Withdrawal by Subject|0|||
33613557|NCT02238626|63014226|FG003|Overall Study|Withdrawal by Subject|1|||
33613558|NCT02238626|63014223|FG000|Overall Study|Death|0|||
33613559|NCT02238626|63014224|FG001|Overall Study|Death|0|||
33613560|NCT02238626|63014225|FG002|Overall Study|Death|1|||
33613561|NCT02238626|63014226|FG003|Overall Study|Death|1|||
33613562|NCT02238626|63014223|FG000|Overall Study|Other|0|||
33613563|NCT02238626|63014224|FG001|Overall Study|Other|2|||
33613564|NCT02238626|63014225|FG002|Overall Study|Other|0|||
33613565|NCT02238626|63014226|FG003|Overall Study|Other|0|||
33613566|NCT02151643|63014252|FG000|Overall Study|Adverse Event|2|||
33613567|NCT02151643|63014253|FG001|Overall Study|Adverse Event|0|||
33613568|NCT02151643|63014254|FG002|Overall Study|Adverse Event|1|||
33613569|NCT02151643|63014255|FG003|Overall Study|Adverse Event|4|||
33613570|NCT02151643|63014256|FG004|Overall Study|Adverse Event|0|||
33613571|NCT02151643|63014252|FG000|Overall Study|Withdrawal by Subject|0|||
33613572|NCT02151643|63014253|FG001|Overall Study|Withdrawal by Subject|1|||
33613573|NCT02151643|63014254|FG002|Overall Study|Withdrawal by Subject|1|||
33613574|NCT02151643|63014255|FG003|Overall Study|Withdrawal by Subject|1|||
33613575|NCT02151643|63014256|FG004|Overall Study|Withdrawal by Subject|1|||
33613576|NCT02151643|63014252|FG000|Overall Study|Hyperphosphataemia|1|||
33613577|NCT02151643|63014253|FG001|Overall Study|Hyperphosphataemia|0|||
33613578|NCT02151643|63014254|FG002|Overall Study|Hyperphosphataemia|0|||
33613579|NCT02151643|63014255|FG003|Overall Study|Hyperphosphataemia|0|||
33613580|NCT02151643|63014256|FG004|Overall Study|Hyperphosphataemia|1|||
33613581|NCT02151643|63014252|FG000|Overall Study|High Ferritin levels|3|||
33613582|NCT02151643|63014253|FG001|Overall Study|High Ferritin levels|3|||
33613583|NCT02151643|63014254|FG002|Overall Study|High Ferritin levels|2|||
33613584|NCT02151643|63014255|FG003|Overall Study|High Ferritin levels|2|||
33613585|NCT02151643|63014256|FG004|Overall Study|High Ferritin levels|1|||
33613586|NCT02203838|63014272|FG000|Overall Study|Lack of Efficacy|7|||
33613587|NCT02203838|63014273|FG001|Overall Study|Lack of Efficacy|0|||
33613588|NCT02203838|63014274|FG002|Overall Study|Lack of Efficacy|1|||
33613589|NCT02203838|63014275|FG003|Overall Study|Lack of Efficacy|1|||
33613590|NCT02203838|63014272|FG000|Overall Study|Adverse Event|46|||
33613591|NCT02203838|63014273|FG001|Overall Study|Adverse Event|6|||
33613592|NCT02203838|63014274|FG002|Overall Study|Adverse Event|3|||
33613593|NCT02203838|63014275|FG003|Overall Study|Adverse Event|2|||
33613594|NCT02203838|63014272|FG000|Overall Study|Lost to Follow-up|39|||
33613595|NCT02203838|63014273|FG001|Overall Study|Lost to Follow-up|3|||
33613596|NCT02203838|63014274|FG002|Overall Study|Lost to Follow-up|2|||
33613597|NCT02203838|63014275|FG003|Overall Study|Lost to Follow-up|1|||
33613598|NCT02203838|63014272|FG000|Overall Study|Protocol Violation|7|||
33613599|NCT02203838|63014273|FG001|Overall Study|Protocol Violation|3|||
33510318|NCT03647267|62893774|FG001|Overall Study|Lost to Follow-up|0|||
33510319|NCT03356977|62893782|FG000|Overall Study|Lost to Follow-up|3|||
33510320|NCT03356977|62893782|FG000|Overall Study|Withdrawal by parent/guardian|2|||
33510321|NCT02690974|62893786|FG000|Overall Study|Adverse Event|16|||
33510322|NCT02690974|62893786|FG000|Overall Study|Death|9|||
33510323|NCT02690974|62893786|FG000|Overall Study|Subject/guardian decision|4|||
33510324|NCT02690974|62893786|FG000|Overall Study|Lost to Follow-up|3|||
33510325|NCT02690974|62893786|FG000|Overall Study|Withdrawal of Informed Consent|3|||
33510326|NCT02690974|62893786|FG000|Overall Study|Physician Decision|2|||
33510327|NCT02690974|62893786|FG000|Overall Study|Non-compliance with study treatment|1|||
33510328|NCT02690974|62893786|FG000|Overall Study|Protocol-defined stopping criteria|1|||
33510329|NCT02690974|62893786|FG000|Overall Study|Protocol Deviation|1|||
33613600|NCT02203838|63014274|FG002|Overall Study|Protocol Violation|0|||
33613601|NCT02203838|63014275|FG003|Overall Study|Protocol Violation|0|||
33613602|NCT02203838|63014272|FG000|Overall Study|Withdrawal by Subject|83|||
33613603|NCT02203838|63014273|FG001|Overall Study|Withdrawal by Subject|10|||
33613604|NCT02203838|63014274|FG002|Overall Study|Withdrawal by Subject|8|||
33613605|NCT02203838|63014275|FG003|Overall Study|Withdrawal by Subject|11|||
33613606|NCT02203838|63014272|FG000|Overall Study|Physician Decision|27|||
33613607|NCT02203838|63014273|FG001|Overall Study|Physician Decision|0|||
33510330|NCT03093324|62893792|FG000|Overall Study|Adverse Event|4|||
33510331|NCT03093324|62893793|FG001|Overall Study|Adverse Event|15|||
33510332|NCT03093324|62893792|FG000|Overall Study|Lost to Follow-up|1|||
33613608|NCT02203838|63014274|FG002|Overall Study|Physician Decision|2|||
33613609|NCT02203838|63014275|FG003|Overall Study|Physician Decision|3|||
33613610|NCT02203838|63014272|FG000|Overall Study|Other|1|||
33510333|NCT03093324|62893793|FG001|Overall Study|Lost to Follow-up|0|||
33510334|NCT03093324|62893792|FG000|Overall Study|Protocol Deviation|2|||
33510335|NCT03093324|62893793|FG001|Overall Study|Protocol Deviation|2|||
33510336|NCT03093324|62893792|FG000|Overall Study|Withdrawal by Subject|2|||
33510337|NCT03093324|62893793|FG001|Overall Study|Withdrawal by Subject|2|||
33510338|NCT03584009|62893801|FG000|Overall Study|Death|25|||
33510339|NCT03584009|62893802|FG001|Overall Study|Death|18|||
33510340|NCT03584009|62893801|FG000|Overall Study|Lost to Follow-up|0|||
33510341|NCT03584009|62893802|FG001|Overall Study|Lost to Follow-up|1|||
33510342|NCT03584009|62893801|FG000|Overall Study|Physician Decision|1|||
33510343|NCT03584009|62893802|FG001|Overall Study|Physician Decision|1|||
33510344|NCT03584009|62893801|FG000|Overall Study|Study Terminated by Sponsor|22|||
33510345|NCT03584009|62893802|FG001|Overall Study|Study Terminated by Sponsor|30|||
33510346|NCT03584009|62893801|FG000|Overall Study|Withdrawal by Subject|3|||
33510347|NCT03584009|62893802|FG001|Overall Study|Withdrawal by Subject|2|||
33510348|NCT04167462|62893813|FG000|Overall Study|Other reasons|3|||
33510349|NCT04167462|62893814|FG001|Overall Study|Other reasons|2|||
33510350|NCT04167462|62893813|FG000|Overall Study|Withdrawal by Subject|6|||
33510351|NCT04167462|62893814|FG001|Overall Study|Withdrawal by Subject|7|||
33510352|NCT04167462|62893813|FG000|Overall Study|Adverse Event|4|||
33510353|NCT04167462|62893814|FG001|Overall Study|Adverse Event|0|||
33510354|NCT04167462|62893813|FG000|Overall Study|Pregnancy|1|||
33510355|NCT04167462|62893814|FG001|Overall Study|Pregnancy|0|||
33510356|NCT04167462|62893813|FG000|Overall Study|Lack of Efficacy|0|||
33510357|NCT04167462|62893814|FG001|Overall Study|Lack of Efficacy|1|||
33613611|NCT02203838|63014273|FG001|Overall Study|Other|0|||
33613612|NCT02203838|63014274|FG002|Overall Study|Other|0|||
33613613|NCT02203838|63014275|FG003|Overall Study|Other|0|||
33613614|NCT02178787|63014287|FG000|Overall Study|Lost to Follow-up|1|||
33451839|NCT00114777|62826500|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
33451840|NCT00114777|62826501|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
33451841|NCT00114777|62826502|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
33451842|NCT00114777|62826500|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
33451843|NCT00114777|62826501|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
33451844|NCT00114777|62826502|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
33451845|NCT00114777|62826500|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
33451846|NCT00114777|62826501|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
33451847|NCT00114777|62826502|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
33451848|NCT00114777|62826500|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
33451849|NCT00114777|62826501|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
33451850|NCT00114777|62826502|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
33451851|NCT00114777|62826500|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
33451852|NCT00114777|62826501|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
33451853|NCT00114777|62826502|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
33451854|NCT00114777|62826500|FG000|Long-Term Extension to Month 84|Other|2|||
33451855|NCT00114777|62826501|FG001|Long-Term Extension to Month 84|Other|0|||
33451856|NCT00114777|62826502|FG002|Long-Term Extension to Month 84|Other|2|||
33451857|NCT00139737|62826511|FG000|Overall Study|Withdrawal by Subject|190|||
33451858|NCT00139737|62826511|FG000|Overall Study|Adverse Event|58|||
33451859|NCT00139737|62826511|FG000|Overall Study|Lack of Efficacy|40|||
33451860|NCT00139737|62826511|FG000|Overall Study|Lost to Follow-up|8|||
33451861|NCT00139737|62826511|FG000|Overall Study|Death|3|||
33451862|NCT00139737|62826511|FG000|Overall Study|Laboratory Abnormality|2|||
33451863|NCT00139737|62826511|FG000|Overall Study|Protocol Violation|18|||
33451864|NCT00139737|62826511|FG000|Overall Study|Withdrew During Screening Phase|8|||
33451865|NCT00139737|62826511|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
33451866|NCT00139737|62826511|FG000|Overall Study|Screened, Not Treated|13|||
33451867|NCT00122187|62826517|FG000|Overall Study|Withdrew because of resource limitations|2|||
33451868|NCT00122187|62826518|FG001|Overall Study|Withdrew because of resource limitations|2|||
33451869|NCT00139659|62826528|FG000|Overall Study|Adverse Event|12|||
33451870|NCT00139659|62826529|FG001|Overall Study|Adverse Event|1|||
33451871|NCT00139659|62826528|FG000|Overall Study|Lack of Efficacy|1|||
33451872|NCT00139659|62826529|FG001|Overall Study|Lack of Efficacy|1|||
33451873|NCT00139659|62826528|FG000|Overall Study|Lost to Follow-up|7|||
33451874|NCT00139659|62826529|FG001|Overall Study|Lost to Follow-up|3|||
33451875|NCT00139659|62826528|FG000|Overall Study|Reason not Specified|6|||
33510358|NCT03583385|62893821|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33510359|NCT03583385|62893822|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33510360|NCT03583385|62893821|FG000|Treatment Period 2|Adverse Event|1|||
33510361|NCT03583385|62893822|FG001|Treatment Period 2|Adverse Event|0|||
33510362|NCT04350372|62893828|FG000|Overall Study|Death|1|||
33510363|NCT02949973|62893832|FG000|Overall Study|Physician Decision|1|||
33510364|NCT02948959|62893838|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
33510365|NCT02948959|62893839|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
33510366|NCT02948959|62893838|FG000|52 Weeks Treatment Period|Adverse Event|2|||
33510367|NCT02948959|62893839|FG001|52 Weeks Treatment Period|Adverse Event|5|||
33510368|NCT02948959|62893838|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
33510369|NCT02948959|62893839|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
33510370|NCT02948959|62893838|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
33510371|NCT02948959|62893839|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
33510372|NCT02948959|62893838|FG000|52 Weeks Treatment Period|Randomized by error|0|||
33510373|NCT02948959|62893839|FG001|52 Weeks Treatment Period|Randomized by error|5|||
33510374|NCT02948959|62893838|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
33510375|NCT02948959|62893839|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
33510376|NCT02948959|62893838|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
33510377|NCT02948959|62893839|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
33510378|NCT02948959|62893838|FG000|52 Weeks Treatment Period|Change of residence location|0|||
33510379|NCT02948959|62893839|FG001|52 Weeks Treatment Period|Change of residence location|1|||
33510380|NCT02948959|62893838|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
33510381|NCT02948959|62893839|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
33510382|NCT02948959|62893838|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
33510383|NCT02948959|62893839|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
33510384|NCT02948959|62893838|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
33510385|NCT02948959|62893839|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
33510386|NCT02948959|62893838|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
33510387|NCT02948959|62893839|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
33510388|NCT02948959|62893838|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
33510389|NCT02948959|62893839|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
33510390|NCT02948959|62893838|FG000|12 Weeks Follow-up Period|Study site closure|1|||
33510391|NCT02948959|62893839|FG001|12 Weeks Follow-up Period|Study site closure|0|||
33510392|NCT03582215|62893861|FG000|Overall Study|Adverse Event|1|||
33510393|NCT03582215|62893862|FG001|Overall Study|Adverse Event|0|||
33510394|NCT03582215|62893863|FG002|Overall Study|Adverse Event|0|||
33510395|NCT03582215|62893864|FG003|Overall Study|Adverse Event|0|||
33510396|NCT03582215|62893865|FG004|Overall Study|Adverse Event|0|||
33510397|NCT03582215|62893866|FG005|Overall Study|Adverse Event|0|||
33510398|NCT03582215|62893867|FG006|Overall Study|Adverse Event|2|||
33510399|NCT03582215|62893868|FG007|Overall Study|Adverse Event|2|||
33510400|NCT03089580|62893897|FG000|Overall Study|Lost to Follow-up|2|||
33510401|NCT03645395|62893907|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
33510402|NCT03645395|62893908|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
33510403|NCT03645395|62893909|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
33510404|NCT03645395|62893910|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
33510405|NCT03645395|62893907|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
33510406|NCT03645395|62893908|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
33510407|NCT03645395|62893909|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
33510408|NCT03645395|62893910|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
33510409|NCT03645395|62893907|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
33510410|NCT03645395|62893908|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
33510411|NCT03645395|62893909|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
33510412|NCT03645395|62893910|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
33510413|NCT03645395|62893907|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
33510414|NCT03645395|62893908|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
33510415|NCT03645395|62893909|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
33510416|NCT03645395|62893910|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
33510417|NCT03342469|62893923|FG000|Overall Study|Withdrawal by Subject|0|||
33510418|NCT03342469|62893924|FG001|Overall Study|Withdrawal by Subject|1|||
33510419|NCT03342469|62893925|FG002|Overall Study|Withdrawal by Subject|0|||
33510420|NCT03342469|62893926|FG003|Overall Study|Withdrawal by Subject|0|||
33510421|NCT03581825|62893937|FG000|Period 1|Lens Discomfort|1|||
33510422|NCT03581825|62893938|FG001|Period 1|Lens Discomfort|0|||
33510423|NCT03581825|62893937|FG000|Period 2|Unsatisfactory Vision to Test|0|||
33510424|NCT03581825|62893938|FG001|Period 2|Unsatisfactory Vision to Test|1|||
33510425|NCT03342001|62893944|FG000|Overall Study|Adverse Event|1|||
33510426|NCT03342001|62893944|FG000|Overall Study|Lost to Follow-up|1|||
33510427|NCT03341923|62893948|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
33510428|NCT03341923|62893949|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
33510429|NCT03579719|62893957|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
33510430|NCT03341533|62893963|FG000|Overall Study|Withdrawal by Subject|1|||
33510431|NCT03341533|62893964|FG001|Overall Study|Withdrawal by Subject|1|||
33510432|NCT03341533|62893963|FG000|Overall Study|Not eligible after randomization|2|||
33510433|NCT03341533|62893964|FG001|Overall Study|Not eligible after randomization|1|||
33510434|NCT02688088|62893970|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
33510435|NCT02688088|62893971|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
33510436|NCT02688088|62893972|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
33510437|NCT02688088|62893973|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
33510438|NCT02688088|62893974|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
33510439|NCT02688088|62893970|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
33510440|NCT02688088|62893971|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
33510441|NCT02688088|62893972|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
33510442|NCT02688088|62893973|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
33510443|NCT02688088|62893974|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
33510444|NCT02688088|62893970|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
33510445|NCT02688088|62893971|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
33613615|NCT02178787|63014288|FG001|Overall Study|Lost to Follow-up|0|||
33613616|NCT02178787|63014287|FG000|Overall Study|Withdrawal by Subject|0|||
33613617|NCT02178787|63014288|FG001|Overall Study|Withdrawal by Subject|2|||
33613618|NCT02178787|63014287|FG000|Overall Study|No TCD window|3|||
33613619|NCT02178787|63014288|FG001|Overall Study|No TCD window|7|||
33613620|NCT02178787|63014287|FG000|Overall Study|Physician Decision|1|||
33613621|NCT02178787|63014288|FG001|Overall Study|Physician Decision|0|||
33613622|NCT02178709|63014296|FG000|Overall Study|Adverse Event|5|||
33613623|NCT02178709|63014296|FG000|Overall Study|Death|2|||
33613624|NCT02178709|63014296|FG000|Overall Study|Withdrawal by Subject|2|||
33613625|NCT02178709|63014296|FG000|Overall Study|Physician Decision|2|||
33613626|NCT02178709|63014296|FG000|Overall Study|Disease Progression|5|||
33613627|NCT02238080|63014300|FG000|Overall Study|Death|13|||
33613628|NCT02238080|63014300|FG000|Overall Study|Treatment interrupted|6|||
33613629|NCT02238080|63014300|FG000|Overall Study|Withdrawal by Subject|2|||
33613630|NCT02238080|63014300|FG000|Overall Study|Other|4|||
33613631|NCT02150863|63014307|FG000|Overall Study|Lost to Follow-up|0|||
33613632|NCT02150863|63014308|FG001|Overall Study|Lost to Follow-up|1|||
33613633|NCT02150863|63014309|FG002|Overall Study|Lost to Follow-up|0|||
33613634|NCT02178553|63014319|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
33613635|NCT02178553|63014320|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
33613636|NCT02178553|63014319|FG000|Overall Study|Physician Decision|0|||
33510446|NCT02688088|62893972|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
33510447|NCT02688088|62893973|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
33510448|NCT02688088|62893974|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
33510449|NCT02688088|62893970|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
33510450|NCT02688088|62893971|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
33510451|NCT02688088|62893972|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
33510452|NCT02688088|62893973|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
33510453|NCT02688088|62893974|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
33510454|NCT02688088|62893970|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
33613637|NCT02178553|63014320|FG001|Overall Study|Physician Decision|4|||
33613638|NCT02178553|63014319|FG000|Overall Study|Technical problem with injection|1|||
33510455|NCT02688088|62893971|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
33510456|NCT02688088|62893972|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
33510457|NCT02688088|62893973|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
33510458|NCT02688088|62893974|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
33324414|NCT01167881|62700835|FG000|Overall Study|Non compliant with protocol|9|||
33324415|NCT01167881|62700836|FG001|Overall Study|Non compliant with protocol|18|||
33451876|NCT00139659|62826529|FG001|Overall Study|Reason not Specified|3|||
33451877|NCT00139659|62826528|FG000|Overall Study|Withdrawal by Subject|14|||
33451878|NCT00139659|62826529|FG001|Overall Study|Withdrawal by Subject|10|||
33451879|NCT00137631|62826541|FG000|Overall Study|Lost to Follow-up|37|||
33451880|NCT00137631|62826542|FG001|Overall Study|Lost to Follow-up|41|||
33451881|NCT00114231|62826550|FG000|Overall Study|No consent|2|||
33451882|NCT00114231|62826551|FG001|Overall Study|No consent|0|||
33451883|NCT00114231|62826550|FG000|Overall Study|QARC requirement not met|1|||
33451884|NCT00114231|62826551|FG001|Overall Study|QARC requirement not met|0|||
33451885|NCT00114231|62826550|FG000|Overall Study|Suspected metastatic disease|1|||
33451886|NCT00114231|62826551|FG001|Overall Study|Suspected metastatic disease|0|||
33324416|NCT01167881|62700835|FG000|Overall Study|Lost to Follow-up|19|||
33510459|NCT02688088|62893970|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
33510460|NCT02688088|62893971|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
33510461|NCT02688088|62893972|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
33510462|NCT02688088|62893973|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
33510463|NCT02688088|62893974|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
33510464|NCT02688088|62893970|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
33510465|NCT02688088|62893971|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
33510466|NCT02688088|62893972|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
33510467|NCT02688088|62893973|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
33510468|NCT02688088|62893974|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
33510469|NCT02688088|62893970|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
33510470|NCT02688088|62893971|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
33510471|NCT02688088|62893972|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
33510472|NCT02688088|62893973|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
33510473|NCT02688088|62893974|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
33510474|NCT02688088|62893970|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
33510475|NCT02688088|62893971|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
33510476|NCT02688088|62893972|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
33510477|NCT02688088|62893973|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
33510478|NCT02688088|62893974|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
33510479|NCT03641651|62893999|FG000|Overall Study|organizational issues at one study site|1|||
33510480|NCT03341299|62894003|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
33510481|NCT03341299|62894004|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
33510482|NCT03341299|62894005|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
33510483|NCT03341299|62894006|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
33510484|NCT02949271|62894020|FG000|Overall Study|Lack of Efficacy|5|||
33510485|NCT02949271|62894021|FG001|Overall Study|Lack of Efficacy|4|||
33510486|NCT02949271|62894020|FG000|Overall Study|Lost to Follow-up|3|||
33510487|NCT02949271|62894021|FG001|Overall Study|Lost to Follow-up|6|||
33510488|NCT02949271|62894020|FG000|Overall Study|Physician Decision|5|||
33510489|NCT02949271|62894021|FG001|Overall Study|Physician Decision|5|||
33510490|NCT02949271|62894020|FG000|Overall Study|Protocol Violation|6|||
33510491|NCT02949271|62894021|FG001|Overall Study|Protocol Violation|3|||
33510492|NCT02949271|62894020|FG000|Overall Study|Withdrawal by Subject|1|||
33510493|NCT02949271|62894021|FG001|Overall Study|Withdrawal by Subject|0|||
33510494|NCT02949271|62894020|FG000|Overall Study|Delivered prior to intervention|7|||
33510495|NCT02949271|62894021|FG001|Overall Study|Delivered prior to intervention|9|||
33510496|NCT02949271|62894020|FG000|Overall Study|Outside the window for cervical dilation|2|||
33510497|NCT02949271|62894021|FG001|Overall Study|Outside the window for cervical dilation|3|||
33510498|NCT03640559|62894029|FG000|Overall Study|Physician Decision|1|||
33510499|NCT03640559|62894030|FG001|Overall Study|Physician Decision|1|||
33451887|NCT00114231|62826550|FG000|Overall Study|No adenocarcinoma|1|||
33451888|NCT00114231|62826551|FG001|Overall Study|No adenocarcinoma|0|||
33451889|NCT00114231|62826550|FG000|Overall Study|Low creatinine clearance|0|||
33451890|NCT00114231|62826551|FG001|Overall Study|Low creatinine clearance|1|||
33451891|NCT00114231|62826550|FG000|Overall Study|Tumor size > 4cm|1|||
33451892|NCT00114231|62826551|FG001|Overall Study|Tumor size > 4cm|0|||
33451893|NCT00114231|62826550|FG000|Overall Study|Tumor fixed on digital exam|0|||
33451894|NCT00114231|62826551|FG001|Overall Study|Tumor fixed on digital exam|1|||
33451895|NCT00114231|62826550|FG000|Overall Study|No Absolute Neutrophil Count|2|||
33451896|NCT00114231|62826551|FG001|Overall Study|No Absolute Neutrophil Count|0|||
33451897|NCT00114231|62826550|FG000|Overall Study|Biopsy done after registration|1|||
33451898|NCT00114231|62826551|FG001|Overall Study|Biopsy done after registration|0|||
33451899|NCT00113919|62826556|FG000|Overall Study|Physician Decision|8|||
33451900|NCT00113919|62826556|FG000|Overall Study|Death|6|||
33451901|NCT00113841|62826562|FG000|Overall Study|Disease progression|0|||
33451902|NCT00113841|62826563|FG001|Overall Study|Disease progression|2|||
33451903|NCT00113841|62826562|FG000|Overall Study|Non-compliant|1|||
33451904|NCT00113841|62826563|FG001|Overall Study|Non-compliant|0|||
33451905|NCT00113607|62826571|FG000|Overall Study|Adverse Event|40|||
33451906|NCT00113607|62826572|FG001|Overall Study|Adverse Event|71|||
33451907|NCT00113607|62826571|FG000|Overall Study|Death|8|||
33451908|NCT00113607|62826572|FG001|Overall Study|Death|8|||
33510500|NCT03640559|62894029|FG000|Overall Study|Withdrawal by Subject|1|||
33510501|NCT03640559|62894030|FG001|Overall Study|Withdrawal by Subject|0|||
33510502|NCT03339583|62894038|FG000|First Intervention (14 Days)|Adverse Event|1|||
33510503|NCT03339583|62894039|FG001|First Intervention (14 Days)|Adverse Event|0|||
33510504|NCT03339583|62894038|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
33510505|NCT03339583|62894039|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
33510506|NCT03339583|62894038|FG000|Second Intervention (14 Days)|Adverse Event|0|||
33510507|NCT03339583|62894039|FG001|Second Intervention (14 Days)|Adverse Event|1|||
33510508|NCT03339583|62894038|FG000|Follow-up (14 Days)|Physician Decision|6|||
33510509|NCT03339583|62894039|FG001|Follow-up (14 Days)|Physician Decision|3|||
33510510|NCT03639779|62894047|FG000|Overall Study|Lost to Follow-up|1|||
33510511|NCT03575975|62894056|FG000|Overall Study|Lost to Follow-up|1|||
33510512|NCT03575975|62894057|FG001|Overall Study|Lost to Follow-up|0|||
33510513|NCT03575975|62894058|FG002|Overall Study|Lost to Follow-up|0|||
33510514|NCT03636893|62894066|FG000|Overall Study|Death|0|||
33510515|NCT03636893|62894067|FG001|Overall Study|Death|1|||
33510516|NCT03636893|62894066|FG000|Overall Study|Protocol Violation|0|||
33510517|NCT03636893|62894067|FG001|Overall Study|Protocol Violation|3|||
33510518|NCT03636893|62894066|FG000|Overall Study|Withdrawal by Subject|1|||
33613639|NCT02178553|63014320|FG001|Overall Study|Technical problem with injection|3|||
33613640|NCT01627327|63014328|FG000|Overall Study|Adverse Event|6|||
33613641|NCT01627327|63014329|FG001|Overall Study|Adverse Event|12|||
33613642|NCT01627327|63014328|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
33613643|NCT01627327|63014329|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
33613644|NCT01627327|63014328|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
33613645|NCT01627327|63014329|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
33613646|NCT01627327|63014328|FG000|Overall Study|Protocol Violation|4|||
33613647|NCT01627327|63014329|FG001|Overall Study|Protocol Violation|10|||
33613648|NCT01627327|63014328|FG000|Overall Study|Lost to Follow-up|1|||
33613649|NCT01627327|63014329|FG001|Overall Study|Lost to Follow-up|3|||
33613650|NCT01627327|63014328|FG000|Overall Study|Physician Decision|1|||
33613651|NCT01627327|63014329|FG001|Overall Study|Physician Decision|0|||
33613652|NCT01627327|63014328|FG000|Overall Study|Withdrawal by Subject|3|||
33613653|NCT01627327|63014329|FG001|Overall Study|Withdrawal by Subject|3|||
33451909|NCT00113607|62826571|FG000|Overall Study|Withdrawal by Subject|50|||
33451910|NCT00113607|62826572|FG001|Overall Study|Withdrawal by Subject|58|||
33451911|NCT00113607|62826571|FG000|Overall Study|Lost to Follow-up|0|||
33451912|NCT00113607|62826572|FG001|Overall Study|Lost to Follow-up|2|||
33451913|NCT00113607|62826571|FG000|Overall Study|Disease Progression|180|||
33451914|NCT00113607|62826572|FG001|Overall Study|Disease Progression|142|||
33451915|NCT00113607|62826571|FG000|Overall Study|Complete Response (Confirmed)|14|||
33451916|NCT00113607|62826572|FG001|Overall Study|Complete Response (Confirmed)|24|||
33451917|NCT00113607|62826571|FG000|Overall Study|Other|43|||
33451918|NCT00113607|62826572|FG001|Overall Study|Other|32|||
33451919|NCT00113529|62826579|FG000|Overall Study|Adverse Event|4|||
33451920|NCT00113529|62826579|FG000|Overall Study|Lack of Efficacy|20|||
33451921|NCT00113529|62826579|FG000|Overall Study|Decision of sponsor|6|||
33451922|NCT00113529|62826579|FG000|Overall Study|Withdrawal by Subject|4|||
33510519|NCT03636893|62894067|FG001|Overall Study|Withdrawal by Subject|2|||
33510520|NCT03636893|62894066|FG000|Overall Study|Refusal to surgery|4|||
33510521|NCT03636893|62894067|FG001|Overall Study|Refusal to surgery|3|||
33451923|NCT00134901|62826585|FG000|Overall Study|Lost to Follow-up|5|||
33451924|NCT00134901|62826586|FG001|Overall Study|Lost to Follow-up|5|||
33451925|NCT00134901|62826585|FG000|Overall Study|discontinued intervention|12|||
33510522|NCT03636893|62894066|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
33510523|NCT03636893|62894067|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
33510524|NCT03636893|62894066|FG000|Overall Study|Adverse Event|1|||
33510525|NCT03636893|62894067|FG001|Overall Study|Adverse Event|1|||
33613654|NCT01627249|63014338|FG000|Overall Study|Death|3|||
33613655|NCT01627249|63014339|FG001|Overall Study|Death|5|||
33613656|NCT01627249|63014340|FG002|Overall Study|Death|3|||
33510526|NCT01353586|62894075|FG000|Overall Study|Procedure terminated prior to ablation|3|||
33510527|NCT01353586|62894076|FG001|Overall Study|Procedure terminated prior to ablation|0|||
33510528|NCT01353586|62894075|FG000|Overall Study|Never had insertion of study catheter|4|||
33510529|NCT01353586|62894076|FG001|Overall Study|Never had insertion of study catheter|1|||
33510530|NCT01353586|62894075|FG000|Overall Study|Neurological exam not done|0|||
33510531|NCT01353586|62894076|FG001|Overall Study|Neurological exam not done|1|||
33510532|NCT03091920|62894088|FG000|Overall Study|Adverse Event|0|||
33510533|NCT03091920|62894089|FG001|Overall Study|Adverse Event|1|||
33510534|NCT03091920|62894090|FG002|Overall Study|Adverse Event|0|||
33510535|NCT03338569|62894106|FG000|Overall Study|Physician Decision|8|||
33510536|NCT03338569|62894107|FG001|Overall Study|Physician Decision|3|||
33510537|NCT03338569|62894106|FG000|Overall Study|Withdrawal by Subject|0|||
33613657|NCT01627249|63014338|FG000|Overall Study|Withdrawal by Subject|12|||
33613658|NCT01627249|63014339|FG001|Overall Study|Withdrawal by Subject|6|||
33613659|NCT01627249|63014340|FG002|Overall Study|Withdrawal by Subject|9|||
33613660|NCT01627249|63014338|FG000|Overall Study|Missed Visit|1|||
33613661|NCT01627249|63014339|FG001|Overall Study|Missed Visit|1|||
33613662|NCT01627249|63014340|FG002|Overall Study|Missed Visit|0|||
33613663|NCT01688830|63014369|FG000|Overall Study|Lost to Follow-up|0|||
33613664|NCT01688830|63014370|FG001|Overall Study|Lost to Follow-up|0|||
33613665|NCT01688830|63014371|FG002|Overall Study|Lost to Follow-up|0|||
33613666|NCT01688830|63014372|FG003|Overall Study|Lost to Follow-up|0|||
33613667|NCT01688830|63014373|FG004|Overall Study|Lost to Follow-up|0|||
33613668|NCT01688830|63014374|FG005|Overall Study|Lost to Follow-up|0|||
33613669|NCT01688830|63014375|FG006|Overall Study|Lost to Follow-up|0|||
33613670|NCT01688830|63014376|FG007|Overall Study|Lost to Follow-up|0|||
33613671|NCT01688830|63014377|FG008|Overall Study|Lost to Follow-up|0|||
33451926|NCT00134901|62826586|FG001|Overall Study|discontinued intervention|10|||
33451927|NCT00122109|62826596|FG000|Overall Study|Did not meet criteria|6|||
33451928|NCT00122109|62826597|FG001|Overall Study|Did not meet criteria|7|||
33451929|NCT00113373|62826606|FG000|Overall Study|Ineligible: wrong primary|1|||
33451930|NCT00113373|62826606|FG000|Overall Study|Ineligible: second primary|1|||
33510538|NCT03338569|62894107|FG001|Overall Study|Withdrawal by Subject|1|||
33510539|NCT03338569|62894106|FG000|Overall Study|Lost to Follow-up|0|||
33510540|NCT03338569|62894107|FG001|Overall Study|Lost to Follow-up|1|||
33510541|NCT03338023|62894115|FG000|Overall Study|Withdrawal by Subject|3|||
33510542|NCT03338023|62894116|FG001|Overall Study|Withdrawal by Subject|4|||
33510543|NCT03338023|62894115|FG000|Overall Study|Protocol Violation|3|||
33451931|NCT00113373|62826606|FG000|Overall Study|Never Treated|1|||
33451932|NCT00113295|62826617|FG000|Overall Study|Adverse Event|4|||
33451933|NCT00113295|62826618|FG001|Overall Study|Adverse Event|1|||
33451934|NCT00113295|62826617|FG000|Overall Study|Unrelated Medical Illness|1|||
33451935|NCT00113295|62826618|FG001|Overall Study|Unrelated Medical Illness|0|||
33451936|NCT00112905|62826626|FG000|Overall Study|Adverse Event|4|||
33451937|NCT00112905|62826626|FG000|Overall Study|Death|1|||
33451938|NCT00112905|62826626|FG000|Overall Study|Ineligibility|5|||
33451939|NCT00112905|62826626|FG000|Overall Study|Alternative treatment|1|||
33451940|NCT00112905|62826626|FG000|Overall Study|performance status was deteiorating|1|||
33451941|NCT00427895|62826634|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
33451942|NCT00427895|62826635|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
33451943|NCT00427895|62826636|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
33451944|NCT00427895|62826637|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
33451945|NCT00427895|62826638|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
33510544|NCT03338023|62894116|FG001|Overall Study|Protocol Violation|3|||
33510545|NCT03338023|62894115|FG000|Overall Study|Lost to Follow-up|2|||
33510546|NCT03338023|62894116|FG001|Overall Study|Lost to Follow-up|1|||
33451946|NCT00427895|62826639|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
33510547|NCT03338023|62894115|FG000|Overall Study|Physician Decision|1|||
33510548|NCT03338023|62894116|FG001|Overall Study|Physician Decision|2|||
33510549|NCT03337477|62894124|FG000|Overall Study|not categorized into the listed ones|11|||
33510550|NCT03337477|62894125|FG001|Overall Study|not categorized into the listed ones|9|||
33510551|NCT03337477|62894124|FG000|Overall Study|Withdrawal by Subject|0|||
33510552|NCT03337477|62894125|FG001|Overall Study|Withdrawal by Subject|1|||
33510553|NCT03337477|62894124|FG000|Overall Study|Death|0|||
33510554|NCT03337477|62894125|FG001|Overall Study|Death|1|||
33510555|NCT03337477|62894124|FG000|Overall Study|Lost to Follow-up|0|||
33613672|NCT01688830|63014378|FG009|Overall Study|Lost to Follow-up|0|||
33613673|NCT01688830|63014379|FG010|Overall Study|Lost to Follow-up|1|||
33613674|NCT01688830|63014380|FG011|Overall Study|Lost to Follow-up|0|||
33510556|NCT03337477|62894125|FG001|Overall Study|Lost to Follow-up|2|||
33613675|NCT01688830|63014381|FG012|Overall Study|Lost to Follow-up|0|||
33613676|NCT01688830|63014382|FG013|Overall Study|Lost to Follow-up|0|||
33613677|NCT01688830|63014383|FG014|Overall Study|Lost to Follow-up|0|||
33613678|NCT01688830|63014384|FG015|Overall Study|Lost to Follow-up|0|||
33510557|NCT02687542|62894138|FG000|Overall Study|Medication error without associated AEs|0|||
33510558|NCT02687542|62894139|FG001|Overall Study|Medication error without associated AEs|0|||
33510559|NCT02687542|62894140|FG002|Overall Study|Medication error without associated AEs|0|||
33510560|NCT02687542|62894141|FG003|Overall Study|Medication error without associated AEs|0|||
33510561|NCT02687542|62894142|FG004|Overall Study|Medication error without associated AEs|1|||
33510562|NCT02687542|62894138|FG000|Overall Study|Lost to Follow-up|0|||
33510563|NCT02687542|62894139|FG001|Overall Study|Lost to Follow-up|0|||
33613679|NCT01688830|63014385|FG016|Overall Study|Lost to Follow-up|0|||
33613680|NCT01688830|63014386|FG017|Overall Study|Lost to Follow-up|0|||
33510564|NCT02687542|62894140|FG002|Overall Study|Lost to Follow-up|0|||
33510565|NCT02687542|62894141|FG003|Overall Study|Lost to Follow-up|0|||
33510566|NCT02687542|62894142|FG004|Overall Study|Lost to Follow-up|1|||
33510567|NCT02687542|62894138|FG000|Overall Study|Protocol Violation|0|||
33510568|NCT02687542|62894139|FG001|Overall Study|Protocol Violation|1|||
33510569|NCT02687542|62894140|FG002|Overall Study|Protocol Violation|0|||
33510570|NCT02687542|62894141|FG003|Overall Study|Protocol Violation|0|||
33510571|NCT02687542|62894142|FG004|Overall Study|Protocol Violation|0|||
33510572|NCT02687542|62894138|FG000|Overall Study|Other|5|||
33510573|NCT02687542|62894139|FG001|Overall Study|Other|9|||
33510574|NCT02687542|62894140|FG002|Overall Study|Other|10|||
33510575|NCT02687542|62894141|FG003|Overall Study|Other|6|||
33510576|NCT02687542|62894142|FG004|Overall Study|Other|5|||
33510577|NCT02687542|62894138|FG000|Overall Study|Adverse Event|3|||
33510578|NCT02687542|62894139|FG001|Overall Study|Adverse Event|1|||
33510579|NCT02687542|62894140|FG002|Overall Study|Adverse Event|3|||
33510580|NCT02687542|62894141|FG003|Overall Study|Adverse Event|2|||
33510581|NCT02687542|62894142|FG004|Overall Study|Adverse Event|9|||
33510582|NCT02687542|62894138|FG000|Overall Study|Withdrawal by Subject|0|||
33510583|NCT02687542|62894139|FG001|Overall Study|Withdrawal by Subject|1|||
33510584|NCT02687542|62894140|FG002|Overall Study|Withdrawal by Subject|1|||
33510585|NCT02687542|62894141|FG003|Overall Study|Withdrawal by Subject|2|||
33510586|NCT02687542|62894142|FG004|Overall Study|Withdrawal by Subject|4|||
33324417|NCT01167881|62700836|FG001|Overall Study|Lost to Follow-up|20|||
33451947|NCT00427895|62826640|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
33451948|NCT00427895|62826641|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
33451949|NCT00427895|62826634|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
33451950|NCT00427895|62826635|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
33451951|NCT00427895|62826636|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
33451952|NCT00427895|62826637|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
33451953|NCT00427895|62826638|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
33451954|NCT00427895|62826639|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
33451955|NCT00427895|62826640|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
33451956|NCT00427895|62826641|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
33451957|NCT00427895|62826634|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
33451958|NCT00427895|62826635|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
33451959|NCT00427895|62826636|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
33451960|NCT00427895|62826637|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
33451961|NCT00427895|62826638|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
33451962|NCT00427895|62826639|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
33451963|NCT00427895|62826640|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
33451964|NCT00427895|62826641|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
33451965|NCT00427895|62826634|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
33451966|NCT00427895|62826635|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
33451967|NCT00427895|62826636|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
33451968|NCT00427895|62826637|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
33451969|NCT00427895|62826638|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
33451970|NCT00427895|62826639|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
33451971|NCT00427895|62826640|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
33451972|NCT00427895|62826641|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
33451973|NCT00427895|62826634|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
33451974|NCT00427895|62826635|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
33510587|NCT03336619|62894156|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
33510588|NCT03336619|62894157|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
33510589|NCT03336619|62894156|FG000|Overall Study|Withdrawal by Subject|17|||
33510590|NCT03336619|62894157|FG001|Overall Study|Withdrawal by Subject|16|||
33510591|NCT03336619|62894156|FG000|Overall Study|Adverse Event|2|||
33510592|NCT03336619|62894157|FG001|Overall Study|Adverse Event|5|||
33510593|NCT03336619|62894156|FG000|Overall Study|Physician Decision|3|||
33510594|NCT03336619|62894157|FG001|Overall Study|Physician Decision|0|||
33613681|NCT01688830|63014387|FG018|Overall Study|Lost to Follow-up|0|||
33510595|NCT01353508|62894179|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
33510596|NCT01353508|62894180|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
33510597|NCT01353508|62894181|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
33510598|NCT01353508|62894182|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
33510599|NCT01353508|62894179|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
33510600|NCT01353508|62894180|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
33510601|NCT01353508|62894181|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
33510602|NCT01353508|62894182|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
33510603|NCT03636269|62894194|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
33510604|NCT03636269|62894195|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
33613682|NCT01688830|63014388|FG019|Overall Study|Lost to Follow-up|0|||
33613683|NCT01688830|63014389|FG020|Overall Study|Lost to Follow-up|0|||
33613684|NCT02178475|63014473|FG000|Overall Study|Withdrawal by Subject|7|||
33613685|NCT02178475|63014473|FG000|Overall Study|Lost to Follow-up|10|||
33613686|NCT02178475|63014473|FG000|Overall Study|Death|13|||
33613687|NCT02178475|63014473|FG000|Overall Study|Protocol-specified Criteria|99|||
33613688|NCT01569022|63014477|FG000|First Intervention|Lost to Follow-up|2|||
33613689|NCT01569022|63014478|FG001|First Intervention|Lost to Follow-up|1|||
33613690|NCT01569022|63014477|FG000|Second Intervention|Lost to Follow-up|2|||
33613691|NCT01569022|63014478|FG001|Second Intervention|Lost to Follow-up|2|||
33613692|NCT01629823|63014489|FG000|Trial Period|Missed visit|11|||
33613693|NCT01629823|63014490|FG001|Trial Period|Missed visit|9|||
33613694|NCT01629823|63014491|FG002|Trial Period|Missed visit|8|||
33613695|NCT01629823|63014489|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
33613696|NCT01629823|63014490|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
33613697|NCT01629823|63014491|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
33613698|NCT01629823|63014489|FG000|Trial Period|Pregnancy|1|||
33613699|NCT01629823|63014490|FG001|Trial Period|Pregnancy|0|||
33613700|NCT01629823|63014491|FG002|Trial Period|Pregnancy|0|||
33613701|NCT01629823|63014489|FG000|Trial Period|Adverse Event|0|||
33613702|NCT01629823|63014490|FG001|Trial Period|Adverse Event|1|||
33613703|NCT01629823|63014491|FG002|Trial Period|Adverse Event|0|||
33613704|NCT01629823|63014489|FG000|Trial Period|Out-of-window visit|0|||
33613705|NCT01629823|63014490|FG001|Trial Period|Out-of-window visit|2|||
33613706|NCT01629823|63014491|FG002|Trial Period|Out-of-window visit|0|||
33613707|NCT01629823|63014489|FG000|Trial Period|Failed to hold medication|0|||
33613708|NCT01629823|63014490|FG001|Trial Period|Failed to hold medication|0|||
33613709|NCT01629823|63014491|FG002|Trial Period|Failed to hold medication|1|||
33451975|NCT00427895|62826636|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
33451976|NCT00427895|62826637|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
33451977|NCT00427895|62826638|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
33510605|NCT03636269|62894196|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
33510606|NCT03636269|62894194|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
33510607|NCT03636269|62894195|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
33510608|NCT03636269|62894196|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
33510609|NCT03636269|62894194|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
33510610|NCT03636269|62894195|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
33510611|NCT03636269|62894196|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
33510612|NCT03636269|62894194|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
33510613|NCT03636269|62894195|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
33510614|NCT03636269|62894196|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
33510615|NCT03636269|62894194|FG000|Period 1: Double-blind Phase|Other|6|||
33510616|NCT03636269|62894195|FG001|Period 1: Double-blind Phase|Other|3|||
33510617|NCT03636269|62894196|FG002|Period 1: Double-blind Phase|Other|0|||
33510618|NCT03636269|62894194|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
33510619|NCT03636269|62894195|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
33510620|NCT03636269|62894196|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
33510621|NCT03636269|62894194|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
33451978|NCT00427895|62826639|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
33451979|NCT00427895|62826640|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
33451980|NCT00427895|62826641|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
33451981|NCT00427895|62826634|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
33510622|NCT03636269|62894195|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
33510623|NCT03636269|62894196|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
33510624|NCT03636269|62894194|FG000|Period 2: Open-label Phase|Adverse Event|0|||
33510625|NCT03636269|62894195|FG001|Period 2: Open-label Phase|Adverse Event|0|||
33613710|NCT01629823|63014489|FG000|Washout Period|Safety|2|||
33613711|NCT01629823|63014490|FG001|Washout Period|Safety|5|||
33613712|NCT01629823|63014491|FG002|Washout Period|Safety|0|||
33613713|NCT01629823|63014489|FG000|Washout Period|Pregnancy|1|||
33613714|NCT01629823|63014490|FG001|Washout Period|Pregnancy|0|||
33613715|NCT01629823|63014491|FG002|Washout Period|Pregnancy|0|||
33613716|NCT01629823|63014489|FG000|Washout Period|Protocol Violation|0|||
33510626|NCT03636269|62894196|FG002|Period 2: Open-label Phase|Adverse Event|21|||
33510627|NCT03636269|62894194|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
33510628|NCT03636269|62894195|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
33510629|NCT03636269|62894196|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
33510630|NCT03636269|62894194|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
33510631|NCT03636269|62894195|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
33510632|NCT03636269|62894196|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
33510633|NCT03636269|62894194|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
33510634|NCT03636269|62894195|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
33510635|NCT03636269|62894196|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
33510636|NCT03636269|62894194|FG000|Period 2: Open-label Phase|Administrative|0|||
33510637|NCT03636269|62894195|FG001|Period 2: Open-label Phase|Administrative|0|||
33510638|NCT03636269|62894196|FG002|Period 2: Open-label Phase|Administrative|36|||
33510639|NCT03636269|62894194|FG000|Period 2: Open-label Phase|Other|0|||
33510640|NCT03636269|62894195|FG001|Period 2: Open-label Phase|Other|0|||
33510641|NCT03636269|62894196|FG002|Period 2: Open-label Phase|Other|9|||
33510642|NCT03636269|62894194|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
33510643|NCT03636269|62894195|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
33510644|NCT03636269|62894196|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
33510645|NCT02685202|62894205|FG000|Overall Study|Lost to Follow-up|9|||
33510646|NCT03087786|62894211|FG000|Overall Study|Withdrawal by Subject|2|||
33510647|NCT03087786|62894212|FG001|Overall Study|Withdrawal by Subject|0|||
33510648|NCT03635957|62894218|FG000|Run-In Period|Lost to Follow-up|1|||
33510649|NCT03635957|62894218|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
33510650|NCT01353274|62894223|FG000|Overall Study|No case report form (CRF) collected|28|||
33510651|NCT02690194|62894230|FG000|Overall Study|Withdrawal by Subject|1|||
33510652|NCT02690194|62894231|FG001|Overall Study|Withdrawal by Subject|4|||
33510653|NCT02690194|62894232|FG002|Overall Study|Withdrawal by Subject|0|||
33510654|NCT02684344|62894242|FG000|Overall Study|Withdrawal by Subject|0|||
33510655|NCT02684344|62894243|FG001|Overall Study|Withdrawal by Subject|1|||
33510656|NCT02683876|62894251|FG000|Overall Study|samples damaged during shipping|2|||
33510657|NCT02683876|62894252|FG001|Overall Study|samples damaged during shipping|0|||
33510658|NCT03974100|62894262|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
33510659|NCT03974100|62894263|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
33510660|NCT03974100|62894264|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
33510661|NCT03974100|62894265|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
33510662|NCT03974100|62894266|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
33510663|NCT03974100|62894262|FG000|TP1 - Day 1 to Week 52|Death|1|||
33510664|NCT03974100|62894263|FG001|TP1 - Day 1 to Week 52|Death|0|||
33510665|NCT03974100|62894264|FG002|TP1 - Day 1 to Week 52|Death|0|||
33510666|NCT03974100|62894265|FG003|TP1 - Day 1 to Week 52|Death|0|||
33510667|NCT03974100|62894266|FG004|TP1 - Day 1 to Week 52|Death|0|||
33510668|NCT03974100|62894262|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
33613717|NCT01629823|63014490|FG001|Washout Period|Protocol Violation|1|||
33613718|NCT01629823|63014491|FG002|Washout Period|Protocol Violation|0|||
33613719|NCT01688050|63014499|FG000|Overall Study|Death|7|||
33613720|NCT01688050|63014499|FG000|Overall Study|Conversion to open repair|1|||
33613721|NCT01688050|63014499|FG000|Overall Study|Lost to Follow-up|13|||
33613722|NCT01688050|63014499|FG000|Overall Study|Withdrawal by Subject|10|||
33613723|NCT01604278|63014505|FG000|Overall Study|Lack of Efficacy|0|||
33613724|NCT01604278|63014506|FG001|Overall Study|Lack of Efficacy|1|||
33451982|NCT00427895|62826635|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
33451983|NCT00427895|62826636|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
33451984|NCT00427895|62826637|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
33451985|NCT00427895|62826638|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
33451986|NCT00427895|62826639|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
33451987|NCT00427895|62826640|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
33451988|NCT00427895|62826641|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
33451989|NCT00427895|62826634|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
33451990|NCT00427895|62826635|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
33451991|NCT00427895|62826636|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
33451992|NCT00427895|62826637|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
33451993|NCT00427895|62826638|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
33451994|NCT00427895|62826639|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
33510669|NCT03974100|62894263|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
33510670|NCT03974100|62894264|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
33510671|NCT03974100|62894265|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
33510672|NCT03974100|62894266|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
33510673|NCT03974100|62894262|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
33510674|NCT03974100|62894263|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
33613725|NCT01604278|63014505|FG000|Overall Study|Lost to Follow-up|1|||
33613726|NCT01604278|63014506|FG001|Overall Study|Lost to Follow-up|0|||
33613727|NCT01604278|63014505|FG000|Overall Study|Administrative problems|2|||
33510675|NCT03974100|62894264|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
33510676|NCT03974100|62894265|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
33510677|NCT03974100|62894266|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
33510678|NCT03974100|62894262|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
33510679|NCT03974100|62894263|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
33510680|NCT03974100|62894264|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
33510681|NCT03974100|62894265|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
33510682|NCT03974100|62894266|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
33510683|NCT03974100|62894262|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
33510684|NCT03974100|62894263|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
33510685|NCT03974100|62894264|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
33510686|NCT03974100|62894265|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
33510687|NCT03974100|62894266|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
33510688|NCT03974100|62894262|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
33510689|NCT03974100|62894263|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
33510690|NCT03974100|62894264|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
33510691|NCT03974100|62894265|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
33510692|NCT03974100|62894266|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
33510693|NCT02689804|62894280|FG000|Overall Study|Withdrawal by Subject|2|||
33510694|NCT02689804|62894281|FG001|Overall Study|Withdrawal by Subject|0|||
33510695|NCT02946931|62894290|FG000|Overall Study|Did not require collection of CRFs|588|||
33510696|NCT02946931|62894290|FG000|Overall Study|Other than listed|37|||
33510697|NCT02946931|62894290|FG000|Overall Study|Discharge from hospital|118|||
33510698|NCT02946931|62894290|FG000|Overall Study|Adverse Event|81|||
33510699|NCT02946931|62894290|FG000|Overall Study|CRFs not valid|1|||
33510700|NCT02946931|62894290|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
33510701|NCT02689492|62894294|FG000|Overall Study|Lost to Follow-up|61|||
33510702|NCT02689492|62894294|FG000|Overall Study|Withdrawal by Subject|11|||
33510703|NCT02689492|62894294|FG000|Overall Study|Death|9|||
33510704|NCT02689492|62894294|FG000|Overall Study|Physician Decision|2|||
33510705|NCT02689492|62894294|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
33510706|NCT02689492|62894294|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
33510707|NCT02689492|62894294|FG000|Overall Study|Other than listed|1|||
33510708|NCT01374568|62894312|FG000|Overall Study|Lab unable to analyze BTM|0|||
33510709|NCT01374568|62894313|FG001|Overall Study|Lab unable to analyze BTM|2|||
33510710|NCT02682784|62894323|FG000|Overall Study|Withdrawal by Subject|0|||
33510711|NCT02682784|62894324|FG001|Overall Study|Withdrawal by Subject|2|||
33510712|NCT02682784|62894325|FG002|Overall Study|Withdrawal by Subject|1|||
33510713|NCT02682784|62894326|FG003|Overall Study|Withdrawal by Subject|2|||
33510714|NCT02682784|62894323|FG000|Overall Study|Physician Decision|1|||
33510715|NCT02682784|62894324|FG001|Overall Study|Physician Decision|0|||
33510716|NCT02682784|62894325|FG002|Overall Study|Physician Decision|1|||
33510717|NCT02682784|62894326|FG003|Overall Study|Physician Decision|1|||
33510718|NCT03387852|62894340|FG000|Overall Study|Adverse event (AE)|3|||
33510719|NCT03387852|62894341|FG001|Overall Study|Adverse event (AE)|0|||
33510720|NCT03387852|62894342|FG002|Overall Study|Adverse event (AE)|2|||
33510721|NCT03387852|62894343|FG003|Overall Study|Adverse event (AE)|0|||
33510722|NCT03387852|62894340|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
33510723|NCT03387852|62894341|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
33510724|NCT03387852|62894342|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
33510725|NCT03387852|62894343|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
33510726|NCT03387852|62894340|FG000|Overall Study|Withdrawal by participant|1|||
33510727|NCT03387852|62894341|FG001|Overall Study|Withdrawal by participant|1|||
33510728|NCT03387852|62894342|FG002|Overall Study|Withdrawal by participant|3|||
33510729|NCT03387852|62894343|FG003|Overall Study|Withdrawal by participant|2|||
33510730|NCT03387852|62894340|FG000|Overall Study|Other- Unspecified|1|||
33510731|NCT03387852|62894341|FG001|Overall Study|Other- Unspecified|1|||
33510732|NCT03387852|62894342|FG002|Overall Study|Other- Unspecified|2|||
33510733|NCT03387852|62894343|FG003|Overall Study|Other- Unspecified|1|||
33510734|NCT03387852|62894340|FG000|Overall Study|Poor compliance to protocol|0|||
33510735|NCT03387852|62894341|FG001|Overall Study|Poor compliance to protocol|0|||
33510736|NCT03387852|62894342|FG002|Overall Study|Poor compliance to protocol|0|||
33510737|NCT03387852|62894343|FG003|Overall Study|Poor compliance to protocol|1|||
33510738|NCT03387852|62894340|FG000|Overall Study|Randomized and not treated|0|||
33510739|NCT03387852|62894341|FG001|Overall Study|Randomized and not treated|0|||
33510740|NCT03387852|62894342|FG002|Overall Study|Randomized and not treated|0|||
33510741|NCT03387852|62894343|FG003|Overall Study|Randomized and not treated|1|||
33510742|NCT02679274|62894356|FG000|Overall Study|Withdrawal by Subject|1|||
33510743|NCT02679274|62894357|FG001|Overall Study|Withdrawal by Subject|0|||
33544104|NCT01661140|62934938|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
33544105|NCT01661140|62934936|FG000|Open-Label Period|Lost to Follow-up|2|||
33544106|NCT01661140|62934937|FG001|Open-Label Period|Lost to Follow-up|0|||
33544107|NCT01661140|62934938|FG002|Open-Label Period|Lost to Follow-up|0|||
33544108|NCT01661140|62934936|FG000|Double-Blind Period|Refused Treatment|0|||
33510744|NCT04969861|62894365|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
33510745|NCT04969861|62894366|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
33510746|NCT02678416|62894374|FG000|Part 1|Withdrawal by Subject|1|||
33510747|NCT02678416|62894374|FG000|Part 2|Adverse Event|2|||
33510748|NCT02678416|62894374|FG000|Part 2|Withdrawal by Subject|1|||
33510749|NCT02680834|62894394|FG000|Overall Study|Physician Decision|5|||
33510750|NCT02680834|62894395|FG001|Overall Study|Physician Decision|2|||
33510751|NCT02680834|62894394|FG000|Overall Study|Withdrawal by Subject|6|||
33510752|NCT02680834|62894395|FG001|Overall Study|Withdrawal by Subject|0|||
33510753|NCT02680834|62894394|FG000|Overall Study|Lost to Follow-up|0|||
33510754|NCT02680834|62894395|FG001|Overall Study|Lost to Follow-up|1|||
33510755|NCT03343704|62894403|FG000|Overall Study|Refused to complete follow up|0|||
33510756|NCT03343704|62894404|FG001|Overall Study|Refused to complete follow up|1|||
33510757|NCT03343704|62894403|FG000|Overall Study|Death|0|||
33510758|NCT03343704|62894404|FG001|Overall Study|Death|1|||
33510759|NCT03343704|62894403|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
33510760|NCT03343704|62894404|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
33510761|NCT02680756|62894414|FG000|Overall Study|Adverse Event|10|||
33510762|NCT02680756|62894415|FG001|Overall Study|Adverse Event|2|||
33510763|NCT02680756|62894414|FG000|Overall Study|Lost to Follow-up|7|||
33510764|NCT02680756|62894415|FG001|Overall Study|Lost to Follow-up|6|||
33510765|NCT02680756|62894414|FG000|Overall Study|Withdrawal by Subject|5|||
33510766|NCT02680756|62894415|FG001|Overall Study|Withdrawal by Subject|5|||
33510767|NCT02680756|62894414|FG000|Overall Study|Physician Decision|4|||
33510768|NCT02680756|62894415|FG001|Overall Study|Physician Decision|1|||
33510769|NCT02680756|62894414|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
33510770|NCT02680756|62894415|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
33510771|NCT02680756|62894414|FG000|Overall Study|Blood transfusion for any reason|0|||
33510772|NCT02680756|62894415|FG001|Overall Study|Blood transfusion for any reason|1|||
33451995|NCT00427895|62826640|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
33451996|NCT00427895|62826641|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
33451997|NCT00427895|62826634|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
33451998|NCT00427895|62826635|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
33451999|NCT00427895|62826636|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
33452000|NCT00427895|62826637|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
33452001|NCT00427895|62826638|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
33452002|NCT00427895|62826639|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
33452003|NCT00427895|62826640|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
33452004|NCT00427895|62826641|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
33452005|NCT00427895|62826634|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
33452006|NCT00427895|62826635|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
33452007|NCT00427895|62826636|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
33452008|NCT00427895|62826637|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
33452009|NCT00427895|62826638|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
33452010|NCT00427895|62826639|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
33452011|NCT00427895|62826640|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
33452012|NCT00427895|62826641|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
33452013|NCT00427895|62826634|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
33452014|NCT00427895|62826635|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
33452015|NCT00427895|62826636|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
33452016|NCT00427895|62826637|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
33452017|NCT00427895|62826638|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
33510773|NCT02680756|62894414|FG000|Overall Study|Death|1|||
33510774|NCT02680756|62894415|FG001|Overall Study|Death|0|||
33510775|NCT02680756|62894414|FG000|Overall Study|Protocol Violation|1|||
33510776|NCT02680756|62894415|FG001|Overall Study|Protocol Violation|0|||
33613728|NCT01604278|63014506|FG001|Overall Study|Administrative problems|1|||
33510777|NCT02680756|62894414|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
33510778|NCT02680756|62894415|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
33510779|NCT02680756|62894414|FG000|Overall Study|None of above or not recorded|3|||
33510780|NCT02680756|62894415|FG001|Overall Study|None of above or not recorded|2|||
33510781|NCT03086460|62894421|FG000|Study Participants|Lost to Follow-up|2|||
33510782|NCT03086460|62894421|FG000|Study Participants|Protocol Violation|1|||
33510783|NCT03086460|62894421|FG000|Study Participants|Withdrawal by Subject|6|||
33510784|NCT03086460|62894421|FG000|Treatment A|Lost to Follow-up|1|||
33510785|NCT03086460|62894421|FG000|Treatment A|Protocol Violation|1|||
33613729|NCT01604278|63014505|FG000|Overall Study|Withdrawal by Subject|3|||
33613730|NCT01604278|63014506|FG001|Overall Study|Withdrawal by Subject|3|||
33613731|NCT01604278|63014505|FG000|Overall Study|Adverse Event|3|||
33613732|NCT01604278|63014506|FG001|Overall Study|Adverse Event|5|||
33613733|NCT01604278|63014505|FG000|Overall Study|Protocol Deviation|5|||
33452018|NCT00427895|62826639|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
33452019|NCT00427895|62826640|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
33510786|NCT03086460|62894421|FG000|Treatment A|Withdrawal by Subject|2|||
33510787|NCT03086460|62894421|FG000|Treatment C|Withdrawal by Subject|2|||
33510788|NCT03086460|62894421|FG000|Treatment E|Lost to Follow-up|1|||
33510789|NCT03086460|62894421|FG000|Treatment E|Withdrawal by Subject|3|||
33510790|NCT02677714|62894447|FG000|Overall Study|Withdrawal by Subject|2|||
33510791|NCT02677714|62894448|FG001|Overall Study|Withdrawal by Subject|0|||
33510792|NCT02677324|62894454|FG000|Overall Study|Disease Progression|6|||
33510793|NCT02677324|62894454|FG000|Overall Study|Inability to Swallow pills|1|||
33510794|NCT02677324|62894454|FG000|Overall Study|Non-compliance|1|||
33510795|NCT02677324|62894454|FG000|Overall Study|Lack of Efficacy|1|||
33510796|NCT02677324|62894454|FG000|Overall Study|Medical insurance coverage|1|||
33510797|NCT02677324|62894454|FG000|Overall Study|Adverse Event|1|||
33510798|NCT02677324|62894454|FG000|Overall Study|IgM Myeloma diagnosis|1|||
33510799|NCT01971008|62894462|FG000|Overall Study|Protocol Violation|2|||
33510800|NCT01971008|62894463|FG001|Overall Study|Protocol Violation|1|||
33510801|NCT01374178|62894472|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
33510802|NCT01374178|62894473|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
33510803|NCT01374178|62894472|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
33510804|NCT01374178|62894473|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
33510805|NCT03025542|62894481|FG000|Overall Study|Adverse Event|0|||
33510806|NCT03025542|62894482|FG001|Overall Study|Adverse Event|2|||
33510807|NCT03025542|62894481|FG000|Overall Study|Lost to Follow-up|1|||
33510808|NCT03025542|62894482|FG001|Overall Study|Lost to Follow-up|0|||
33510809|NCT03025542|62894481|FG000|Overall Study|Withdrawal by Subject|1|||
33510810|NCT03025542|62894482|FG001|Overall Study|Withdrawal by Subject|0|||
33510811|NCT03022370|62894496|FG000|Overall Study|Death|6|||
33510812|NCT03022370|62894497|FG001|Overall Study|Death|12|||
33510813|NCT03022370|62894496|FG000|Overall Study|Lost to Follow-up|174|||
33510814|NCT03022370|62894497|FG001|Overall Study|Lost to Follow-up|109|||
33510815|NCT03021668|62894509|FG000|Overall Study|Physician Decision|0|||
33510816|NCT03021668|62894510|FG001|Overall Study|Physician Decision|1|||
33510817|NCT03020888|62894516|FG000|Overall Study|Physician Decision|4|||
33510818|NCT03020888|62894516|FG000|Overall Study|Withdrawal by Subject|6|||
33510819|NCT03020888|62894516|FG000|Overall Study|Insurance coverage|2|||
33452020|NCT00427895|62826641|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
33452021|NCT00427895|62826634|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
33452022|NCT00427895|62826635|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
33452023|NCT00427895|62826636|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
33452024|NCT00427895|62826637|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
33452025|NCT00427895|62826638|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
33452026|NCT00427895|62826639|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
33452027|NCT00427895|62826640|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
33452028|NCT00427895|62826641|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
33452029|NCT00427895|62826634|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
33452030|NCT00427895|62826635|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
33452031|NCT00427895|62826636|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
33452032|NCT00427895|62826637|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
33452033|NCT00427895|62826638|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
33452034|NCT00427895|62826639|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
33510820|NCT03020888|62894516|FG000|Overall Study|Lost to Follow-up|1|||
33510821|NCT02250300|62894524|FG000|Expansion Phase|Death|6|||
33510822|NCT02250300|62894525|FG001|Expansion Phase|Death|7|||
33510823|NCT02250300|62894526|FG002|Expansion Phase|Death|0|||
33510824|NCT02250300|62894527|FG003|Expansion Phase|Death|0|||
33510825|NCT03020966|62894540|FG000|Overall Study|Withdrawal by Subject|2|||
33510826|NCT03020966|62894541|FG001|Overall Study|Withdrawal by Subject|0|||
33510827|NCT03020576|62894549|FG000|Overall Study|Withdrawal by Subject|1|||
33510828|NCT03020576|62894550|FG001|Overall Study|Withdrawal by Subject|2|||
33510829|NCT03017612|62894556|FG000|Overall Study|Adverse Event|2|||
33510830|NCT03635099|62894568|FG000|Period 1|Adverse Event|1|||
33613734|NCT01604278|63014506|FG001|Overall Study|Protocol Deviation|3|||
33510831|NCT03635099|62894569|FG001|Period 1|Adverse Event|0|||
33510832|NCT03635099|62894570|FG002|Period 1|Adverse Event|0|||
33510833|NCT03635099|62894571|FG003|Period 1|Adverse Event|1|||
33510834|NCT03635099|62894572|FG004|Period 1|Adverse Event|0|||
33510835|NCT03635099|62894573|FG005|Period 1|Adverse Event|0|||
33510836|NCT03635099|62894574|FG006|Period 1|Adverse Event|0|||
33510837|NCT03635099|62894575|FG007|Period 1|Adverse Event|0|||
33510838|NCT03635099|62894568|FG000|Period 1|Protocol Violation|0|||
33510839|NCT03635099|62894569|FG001|Period 1|Protocol Violation|0|||
33510840|NCT03635099|62894570|FG002|Period 1|Protocol Violation|1|||
33510841|NCT03635099|62894571|FG003|Period 1|Protocol Violation|0|||
33510842|NCT03635099|62894572|FG004|Period 1|Protocol Violation|0|||
33613735|NCT01687270|63014512|FG000|Overall Study|Lack of Efficacy|11|||
33613736|NCT01687270|63014512|FG000|Overall Study|Lost to Follow-up|1|||
33613737|NCT01589770|63014518|FG000|Overall Study|EGFR <60ml/min|6|||
33613738|NCT01589770|63014519|FG001|Overall Study|EGFR <60ml/min|4|||
33613739|NCT01589770|63014518|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
33613740|NCT01589770|63014519|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
33613741|NCT01588990|63014525|FG000|Phase A|Withdrawal by Subject|5|||
33613742|NCT01588990|63014525|FG000|Phase A|Physician Decision|11|||
33613743|NCT01588990|63014525|FG000|Phase A|Other|14|||
33613744|NCT01588990|63014525|FG000|Phase A|Lost to Follow-up|1|||
33613745|NCT01588990|63014525|FG000|Phase A|Death|5|||
33452035|NCT00427895|62826640|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
33452036|NCT00427895|62826641|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
33452037|NCT00427895|62826634|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
33452038|NCT00427895|62826635|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
33452039|NCT00427895|62826636|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
33452040|NCT00427895|62826637|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
33452041|NCT00427895|62826638|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
33452042|NCT00427895|62826639|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
33452043|NCT00427895|62826640|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
33452044|NCT00427895|62826641|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
33452045|NCT00427895|62826634|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
33452046|NCT00427895|62826635|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
33452047|NCT00427895|62826636|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
33452048|NCT00427895|62826637|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
33452049|NCT00427895|62826638|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
33452050|NCT00427895|62826639|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
33452051|NCT00427895|62826640|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
33452052|NCT00427895|62826641|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
33452053|NCT00427895|62826634|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
33452054|NCT00427895|62826635|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
33452055|NCT00427895|62826636|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
33452056|NCT00427895|62826637|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
33452057|NCT00427895|62826638|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
33452058|NCT00427895|62826639|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
33452059|NCT00427895|62826640|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
33452060|NCT00427895|62826641|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
33510843|NCT03635099|62894573|FG005|Period 1|Protocol Violation|0|||
33510844|NCT03635099|62894574|FG006|Period 1|Protocol Violation|0|||
33510845|NCT03635099|62894575|FG007|Period 1|Protocol Violation|0|||
33510846|NCT03635099|62894568|FG000|Period 1|Lost to Follow-up|0|||
33510847|NCT03635099|62894569|FG001|Period 1|Lost to Follow-up|0|||
33510848|NCT03635099|62894570|FG002|Period 1|Lost to Follow-up|1|||
33613746|NCT01588990|63014525|FG000|Phase A|Adverse Event|28|||
33613747|NCT01588990|63014525|FG000|Phase A|Still on therapy at end of study|6|||
33613748|NCT01588990|63014525|FG000|Phase B|Adverse Event|2|||
33510849|NCT03635099|62894571|FG003|Period 1|Lost to Follow-up|2|||
33510850|NCT03635099|62894572|FG004|Period 1|Lost to Follow-up|1|||
33510851|NCT03635099|62894573|FG005|Period 1|Lost to Follow-up|0|||
33510852|NCT03635099|62894574|FG006|Period 1|Lost to Follow-up|1|||
33510853|NCT03635099|62894575|FG007|Period 1|Lost to Follow-up|2|||
33510854|NCT03635099|62894568|FG000|Period 1|Withdrawal by Subject|3|||
33510855|NCT03635099|62894569|FG001|Period 1|Withdrawal by Subject|3|||
33510856|NCT03635099|62894570|FG002|Period 1|Withdrawal by Subject|5|||
33510857|NCT03635099|62894571|FG003|Period 1|Withdrawal by Subject|2|||
33510858|NCT03635099|62894572|FG004|Period 1|Withdrawal by Subject|2|||
33510859|NCT03635099|62894573|FG005|Period 1|Withdrawal by Subject|0|||
33510860|NCT03635099|62894574|FG006|Period 1|Withdrawal by Subject|3|||
33510861|NCT03635099|62894575|FG007|Period 1|Withdrawal by Subject|0|||
33510862|NCT03635099|62894568|FG000|Period 1|History of suicidal ideation|0|||
33510863|NCT03635099|62894569|FG001|Period 1|History of suicidal ideation|0|||
33510864|NCT03635099|62894570|FG002|Period 1|History of suicidal ideation|1|||
33510865|NCT03635099|62894571|FG003|Period 1|History of suicidal ideation|0|||
33510866|NCT03635099|62894572|FG004|Period 1|History of suicidal ideation|0|||
33510867|NCT03635099|62894573|FG005|Period 1|History of suicidal ideation|0|||
33510868|NCT03635099|62894574|FG006|Period 1|History of suicidal ideation|0|||
33510869|NCT03635099|62894575|FG007|Period 1|History of suicidal ideation|0|||
33510870|NCT03635099|62894568|FG000|Period 1|pursue other treatment options|0|||
33510871|NCT03635099|62894569|FG001|Period 1|pursue other treatment options|0|||
33510872|NCT03635099|62894570|FG002|Period 1|pursue other treatment options|0|||
33510873|NCT03635099|62894571|FG003|Period 1|pursue other treatment options|0|||
33510874|NCT03635099|62894572|FG004|Period 1|pursue other treatment options|0|||
33510875|NCT03635099|62894573|FG005|Period 1|pursue other treatment options|1|||
33510876|NCT03635099|62894574|FG006|Period 1|pursue other treatment options|0|||
33510877|NCT03635099|62894575|FG007|Period 1|pursue other treatment options|0|||
33510878|NCT03635099|62894568|FG000|Not Eligible for Period 2|Pregnancy|0|||
33510879|NCT03635099|62894569|FG001|Not Eligible for Period 2|Pregnancy|0|||
33510880|NCT03635099|62894570|FG002|Not Eligible for Period 2|Pregnancy|0|||
33510881|NCT03635099|62894571|FG003|Not Eligible for Period 2|Pregnancy|1|||
33510882|NCT03635099|62894572|FG004|Not Eligible for Period 2|Pregnancy|0|||
33510883|NCT03635099|62894573|FG005|Not Eligible for Period 2|Pregnancy|0|||
33510884|NCT03635099|62894574|FG006|Not Eligible for Period 2|Pregnancy|0|||
33452061|NCT00427895|62826634|FG000|Vax 1/Year 1 Follow-up|Death|1|||
33452062|NCT00427895|62826635|FG001|Vax 1/Year 1 Follow-up|Death|0|||
33452063|NCT00427895|62826636|FG002|Vax 1/Year 1 Follow-up|Death|0|||
33452064|NCT00427895|62826637|FG003|Vax 1/Year 1 Follow-up|Death|0|||
33452065|NCT00427895|62826638|FG004|Vax 1/Year 1 Follow-up|Death|0|||
33452066|NCT00427895|62826639|FG005|Vax 1/Year 1 Follow-up|Death|0|||
33452067|NCT00427895|62826640|FG006|Vax 1/Year 1 Follow-up|Death|0|||
33452068|NCT00427895|62826641|FG007|Vax 1/Year 1 Follow-up|Death|0|||
33452069|NCT00427895|62826634|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
33452070|NCT00427895|62826635|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
33452071|NCT00427895|62826636|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
33452072|NCT00427895|62826637|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
33452073|NCT00427895|62826638|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
33452074|NCT00427895|62826639|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
33452075|NCT00427895|62826640|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
33452076|NCT00427895|62826641|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
33452077|NCT00427895|62826634|FG000|Vax 1/Year 1 Follow-up|Other|0|||
33452078|NCT00427895|62826635|FG001|Vax 1/Year 1 Follow-up|Other|0|||
33452079|NCT00427895|62826636|FG002|Vax 1/Year 1 Follow-up|Other|0|||
33452080|NCT00427895|62826637|FG003|Vax 1/Year 1 Follow-up|Other|2|||
33452081|NCT00427895|62826638|FG004|Vax 1/Year 1 Follow-up|Other|0|||
33452082|NCT00427895|62826639|FG005|Vax 1/Year 1 Follow-up|Other|0|||
33452083|NCT00427895|62826640|FG006|Vax 1/Year 1 Follow-up|Other|0|||
33452084|NCT00427895|62826641|FG007|Vax 1/Year 1 Follow-up|Other|0|||
33452085|NCT00427895|62826634|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
33452086|NCT00427895|62826635|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
33452087|NCT00427895|62826636|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
33510885|NCT03635099|62894575|FG007|Not Eligible for Period 2|Pregnancy|0|||
33510886|NCT03635099|62894568|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
33510887|NCT03635099|62894569|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
33510888|NCT03635099|62894570|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
33510889|NCT03635099|62894571|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
33510890|NCT03635099|62894572|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
33510891|NCT03635099|62894573|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
33510892|NCT03635099|62894574|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
33613749|NCT01588990|63014525|FG000|Phase B|Still on therapy at end of study|5|||
33613750|NCT01588990|63014525|FG000|Phase B|Withdrawal by Subject|3|||
33613751|NCT01588990|63014525|FG000|Phase B|Physician Decision|4|||
33613752|NCT01588990|63014525|FG000|Phase B|Other|2|||
33613753|NCT02176525|63014541|FG000|Overall Study|Adverse Event|0|||
33613754|NCT02176525|63014542|FG001|Overall Study|Adverse Event|0|||
33613755|NCT02176525|63014543|FG002|Overall Study|Adverse Event|0|||
33613756|NCT02176525|63014544|FG003|Overall Study|Adverse Event|1|||
33613757|NCT02176525|63014545|FG004|Overall Study|Adverse Event|1|||
33613758|NCT02176525|63014546|FG005|Overall Study|Adverse Event|0|||
33613759|NCT02176525|63014547|FG006|Overall Study|Adverse Event|1|||
33613760|NCT02176525|63014548|FG007|Overall Study|Adverse Event|0|||
33613761|NCT02176525|63014541|FG000|Overall Study|not treated|1|||
33613762|NCT02176525|63014542|FG001|Overall Study|not treated|0|||
33613763|NCT02176525|63014543|FG002|Overall Study|not treated|0|||
33510893|NCT03635099|62894575|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
33510894|NCT03635099|62894568|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
33510895|NCT03635099|62894569|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
33510896|NCT03635099|62894570|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
33510897|NCT03635099|62894571|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
33510898|NCT03635099|62894572|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
33510899|NCT03635099|62894573|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
33510900|NCT03635099|62894574|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
33510901|NCT03635099|62894575|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
33510902|NCT03635099|62894568|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
33510903|NCT03635099|62894569|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
33510904|NCT03635099|62894570|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
33613764|NCT02176525|63014544|FG003|Overall Study|not treated|0|||
33613765|NCT02176525|63014545|FG004|Overall Study|not treated|0|||
33613766|NCT02176525|63014546|FG005|Overall Study|not treated|1|||
33613767|NCT02176525|63014547|FG006|Overall Study|not treated|0|||
33613768|NCT02176525|63014548|FG007|Overall Study|not treated|0|||
33613769|NCT02127931|63014574|FG000|Overall Study|Glitch in Game|1|||
33613770|NCT02127307|63014579|FG000|Overall Study|Protocol Violation|36|||
33613771|NCT02127307|63014579|FG000|Overall Study|Lost to Follow-up|2|||
33613772|NCT02127307|63014579|FG000|Overall Study|Death|101|||
33613773|NCT02127307|63014579|FG000|Overall Study|Other than specified above|169|||
33613774|NCT02126839|63014585|FG000|Overall Study|Adverse Event|0|||
33613775|NCT02126839|63014586|FG001|Overall Study|Adverse Event|1|||
33613776|NCT02126839|63014585|FG000|Overall Study|Withdrawal by Subject|1|||
33613777|NCT02126839|63014586|FG001|Overall Study|Withdrawal by Subject|0|||
33613778|NCT02126839|63014585|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33613779|NCT02126839|63014586|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33613780|NCT02126839|63014585|FG000|Overall Study|Protocol Violation|2|||
33613781|NCT02126839|63014586|FG001|Overall Study|Protocol Violation|3|||
33452088|NCT00427895|62826637|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
33452089|NCT00427895|62826638|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
33452090|NCT00427895|62826639|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
33452091|NCT00427895|62826640|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
33452092|NCT00427895|62826641|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
33452093|NCT00425945|62826682|FG000|Overall Study|Concern about Supplement|2|||
33452094|NCT00425945|62826683|FG001|Overall Study|Concern about Supplement|0|||
33452095|NCT00425945|62826682|FG000|Overall Study|Inconvenience|0|||
33452096|NCT00425945|62826683|FG001|Overall Study|Inconvenience|2|||
33452097|NCT00425945|62826682|FG000|Overall Study|Lost to Follow-up|0|||
33452098|NCT00425945|62826683|FG001|Overall Study|Lost to Follow-up|2|||
33452099|NCT00425945|62826682|FG000|Overall Study|Began hypertension medication|1|||
33452100|NCT00425945|62826683|FG001|Overall Study|Began hypertension medication|0|||
33452101|NCT00425945|62826682|FG000|Overall Study|Began cancer treatments|1|||
33613782|NCT02126839|63014585|FG000|Overall Study|Sponsor request|0|||
33613783|NCT02126839|63014586|FG001|Overall Study|Sponsor request|1|||
33613784|NCT02126839|63014585|FG000|Overall Study|Lost to Follow-up|1|||
33452102|NCT00425945|62826683|FG001|Overall Study|Began cancer treatments|0|||
33613785|NCT02126839|63014586|FG001|Overall Study|Lost to Follow-up|4|||
33613786|NCT02126839|63014585|FG000|Overall Study|Other|5|||
33613787|NCT02126839|63014586|FG001|Overall Study|Other|5|||
33510905|NCT03635099|62894571|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
33510906|NCT03635099|62894572|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
33510907|NCT03635099|62894573|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
33510908|NCT03635099|62894574|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
33510909|NCT03635099|62894575|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
33510910|NCT03635099|62894568|FG000|Period 2|Adverse Event|0|||
33510911|NCT03635099|62894569|FG001|Period 2|Adverse Event|0|||
33510912|NCT03635099|62894570|FG002|Period 2|Adverse Event|1|||
33510913|NCT03635099|62894571|FG003|Period 2|Adverse Event|0|||
33510914|NCT03635099|62894572|FG004|Period 2|Adverse Event|1|||
33324418|NCT01167881|62700835|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
33324419|NCT01167881|62700836|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
33324420|NCT01167881|62700835|FG000|Overall Study|Not treated|4|||
33324421|NCT01167881|62700836|FG001|Overall Study|Not treated|0|||
33324422|NCT01167881|62700835|FG000|Overall Study|Other not defined above|31|||
33324423|NCT01167881|62700836|FG001|Overall Study|Other not defined above|55|||
33324424|NCT00960063|62700845|FG000|Overall Study|Adverse Event|1|||
33324425|NCT00960063|62700846|FG001|Overall Study|Adverse Event|0|||
33324426|NCT00960063|62700847|FG002|Overall Study|Adverse Event|0|||
33324427|NCT00960063|62700845|FG000|Overall Study|Progression of Disease|0|||
33324428|NCT00960063|62700846|FG001|Overall Study|Progression of Disease|0|||
33324429|NCT00960063|62700847|FG002|Overall Study|Progression of Disease|3|||
33452103|NCT00425945|62826682|FG000|Overall Study|Moved from area|0|||
33452104|NCT00425945|62826683|FG001|Overall Study|Moved from area|1|||
33510915|NCT03635099|62894573|FG005|Period 2|Adverse Event|0|||
33510916|NCT03635099|62894574|FG006|Period 2|Adverse Event|0|||
33510917|NCT03635099|62894575|FG007|Period 2|Adverse Event|0|||
33510918|NCT03635099|62894568|FG000|Period 2|Lost to Follow-up|0|||
33510919|NCT03635099|62894569|FG001|Period 2|Lost to Follow-up|0|||
33510920|NCT03635099|62894570|FG002|Period 2|Lost to Follow-up|1|||
33510921|NCT03635099|62894571|FG003|Period 2|Lost to Follow-up|0|||
33510922|NCT03635099|62894572|FG004|Period 2|Lost to Follow-up|4|||
33510923|NCT03635099|62894573|FG005|Period 2|Lost to Follow-up|0|||
33510924|NCT03635099|62894574|FG006|Period 2|Lost to Follow-up|0|||
33510925|NCT03635099|62894575|FG007|Period 2|Lost to Follow-up|0|||
33510926|NCT03635099|62894568|FG000|Period 2|Withdrawal by Subject|0|||
33510927|NCT03635099|62894569|FG001|Period 2|Withdrawal by Subject|0|||
33510928|NCT03635099|62894570|FG002|Period 2|Withdrawal by Subject|7|||
33510929|NCT03635099|62894571|FG003|Period 2|Withdrawal by Subject|4|||
33510930|NCT03635099|62894572|FG004|Period 2|Withdrawal by Subject|7|||
33510931|NCT03635099|62894573|FG005|Period 2|Withdrawal by Subject|0|||
33510932|NCT03635099|62894574|FG006|Period 2|Withdrawal by Subject|0|||
33510933|NCT03635099|62894575|FG007|Period 2|Withdrawal by Subject|0|||
33510934|NCT02108652|62894601|FG000|Overall Study|Death|226|||
33510935|NCT02108652|62894601|FG000|Overall Study|Lost to Follow-up|2|||
33510936|NCT02108652|62894601|FG000|Overall Study|Withdrawal by Subject|8|||
33510937|NCT02108652|62894601|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74|||
33510938|NCT03634085|62894607|FG000|Overall Study|Adverse Event|1|||
33510939|NCT03634085|62894608|FG001|Overall Study|Adverse Event|0|||
33510940|NCT03634085|62894607|FG000|Overall Study|Withdrawal by Subject|0|||
33510941|NCT03634085|62894608|FG001|Overall Study|Withdrawal by Subject|2|||
33510942|NCT02676778|62894624|FG000|Overall Study|Disease Progression|7|||
33510943|NCT02676778|62894625|FG001|Overall Study|Disease Progression|3|||
33324430|NCT00959907|62700857|FG000|Overall Study|Protocol Violation|0|||
33452105|NCT00416195|62826693|FG000|Overall Study|Adverse Event|1|||
33452106|NCT00416195|62826694|FG001|Overall Study|Adverse Event|2|||
33452107|NCT00416195|62826693|FG000|Overall Study|Protocol Violation|1|||
33452108|NCT00416195|62826694|FG001|Overall Study|Protocol Violation|1|||
33452109|NCT00416195|62826693|FG000|Overall Study|Other|0|||
33452110|NCT00416195|62826694|FG001|Overall Study|Other|1|||
33324431|NCT00959907|62700858|FG001|Overall Study|Protocol Violation|1|||
33452111|NCT00121641|62826704|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
33452112|NCT00121641|62826705|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
33510944|NCT02676778|62894626|FG002|Overall Study|Disease Progression|1|||
33510945|NCT02676778|62894624|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
33510946|NCT02676778|62894625|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
33510947|NCT02676778|62894626|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
33510948|NCT02676778|62894624|FG000|Overall Study|Withdrawal by Subject|3|||
33510949|NCT02676778|62894625|FG001|Overall Study|Withdrawal by Subject|2|||
33510950|NCT02676778|62894626|FG002|Overall Study|Withdrawal by Subject|0|||
33510951|NCT02676778|62894624|FG000|Overall Study|Other|4|||
33324432|NCT00959907|62700857|FG000|Overall Study|Adverse Event|1|||
33324433|NCT00959907|62700858|FG001|Overall Study|Adverse Event|0|||
33452113|NCT00121641|62826706|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
33510952|NCT02676778|62894625|FG001|Overall Study|Other|3|||
33510953|NCT02676778|62894626|FG002|Overall Study|Other|0|||
33613788|NCT02125279|63014592|FG000|Overall Study|Lack of Efficacy|2|||
33613789|NCT02125279|63014592|FG000|Overall Study|Withdrawal by Subject|6|||
33613790|NCT02125279|63014592|FG000|Overall Study|Protocol Violation|1|||
33613791|NCT02125279|63014592|FG000|Overall Study|Lost to Follow-up|4|||
33613792|NCT02124811|63014600|FG000|Overall Study|Early termination|2|||
33613793|NCT02124811|63014601|FG001|Overall Study|Early termination|2|||
33613794|NCT02124811|63014600|FG000|Overall Study|Withdrawal by Subject|1|||
33613795|NCT02124811|63014601|FG001|Overall Study|Withdrawal by Subject|0|||
33613796|NCT02148445|63014609|FG000|Overall Study|Death|1|||
33613797|NCT02148445|63014610|FG001|Overall Study|Death|3|||
33613798|NCT02148211|63014618|FG000|Overall Study|Lost to Follow-up|352|||
33613799|NCT02147587|63014624|FG000|Overall Study|Adverse Event|9|||
33613800|NCT02147587|63014625|FG001|Overall Study|Adverse Event|4|||
33613801|NCT02147587|63014624|FG000|Overall Study|Lack of Efficacy|2|||
33613802|NCT02147587|63014625|FG001|Overall Study|Lack of Efficacy|1|||
33613803|NCT02147353|63014633|FG000|Overall Study|Lost to Follow-up|2|||
33613804|NCT02147353|63014634|FG001|Overall Study|Lost to Follow-up|0|||
33613805|NCT02147353|63014633|FG000|Overall Study|unable to make visits|4|||
33613806|NCT02147353|63014634|FG001|Overall Study|unable to make visits|0|||
33613807|NCT02147353|63014633|FG000|Overall Study|medication noncompliance|3|||
33613808|NCT02147353|63014634|FG001|Overall Study|medication noncompliance|0|||
33613809|NCT02147197|63014643|FG000|Overall Study|Adverse Event|1|||
33613810|NCT02147197|63014644|FG001|Overall Study|Adverse Event|0|||
33613811|NCT02147197|63014645|FG002|Overall Study|Adverse Event|0|||
33613812|NCT02147197|63014643|FG000|Overall Study|Withdrawal of Consent|4|||
33613813|NCT02147197|63014644|FG001|Overall Study|Withdrawal of Consent|3|||
33324434|NCT00959907|62700857|FG000|Overall Study|Withdrawal by Subject|2|||
33324435|NCT00959907|62700858|FG001|Overall Study|Withdrawal by Subject|0|||
33324436|NCT00912340|62700867|FG000|Overall Study|Adverse Event|2|||
33324437|NCT00912340|62700868|FG001|Overall Study|Adverse Event|4|||
33324438|NCT00912340|62700869|FG002|Overall Study|Adverse Event|0|||
33452114|NCT00121641|62826707|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
33452115|NCT00121641|62826708|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
33452116|NCT00121641|62826704|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
33452117|NCT00121641|62826705|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
33452118|NCT00121641|62826706|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
33452119|NCT00121641|62826707|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
33452120|NCT00121641|62826708|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
33452121|NCT00121641|62826704|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
33452122|NCT00121641|62826705|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
33452123|NCT00121641|62826706|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
33452124|NCT00121641|62826707|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
33452125|NCT00121641|62826708|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
33452126|NCT00121641|62826704|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
33452127|NCT00121641|62826705|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
33452128|NCT00121641|62826706|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
33452129|NCT00121641|62826707|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
33452130|NCT00121641|62826708|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
33452131|NCT00121641|62826704|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
33452132|NCT00121641|62826705|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
33452133|NCT00121641|62826706|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
33452134|NCT00121641|62826707|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
33452135|NCT00121641|62826708|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
33452136|NCT00121641|62826704|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
33452137|NCT00121641|62826705|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
33452138|NCT00121641|62826706|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
33452139|NCT00121641|62826707|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
33452140|NCT00121641|62826708|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
33452141|NCT00121641|62826704|FG000|24-week Short-term Treatment Period|Other Reason|1|||
33452142|NCT00121641|62826705|FG001|24-week Short-term Treatment Period|Other Reason|0|||
33452143|NCT00121641|62826706|FG002|24-week Short-term Treatment Period|Other Reason|0|||
33452144|NCT00121641|62826707|FG003|24-week Short-term Treatment Period|Other Reason|0|||
33452145|NCT00121641|62826708|FG004|24-week Short-term Treatment Period|Other Reason|0|||
33452146|NCT00121641|62826704|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
33452147|NCT00121641|62826705|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
33452148|NCT00121641|62826706|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
33452149|NCT00121641|62826707|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
33613814|NCT02147197|63014645|FG002|Overall Study|Withdrawal of Consent|2|||
33613815|NCT02147197|63014643|FG000|Overall Study|Lost to Follow-up|2|||
33510954|NCT02676778|62894624|FG000|Overall Study|Adverse Event|2|||
33510955|NCT02676778|62894625|FG001|Overall Study|Adverse Event|3|||
33510956|NCT02676778|62894626|FG002|Overall Study|Adverse Event|0|||
33510957|NCT02946385|62894641|FG000|Overall Study|Lost to Follow-up|0|||
33510958|NCT02946385|62894642|FG001|Overall Study|Lost to Follow-up|0|||
33510959|NCT02946385|62894643|FG002|Overall Study|Lost to Follow-up|3|||
33510960|NCT02946385|62894644|FG003|Overall Study|Lost to Follow-up|0|||
33510961|NCT02946385|62894645|FG004|Overall Study|Lost to Follow-up|2|||
33510962|NCT02946385|62894646|FG005|Overall Study|Lost to Follow-up|1|||
33510963|NCT02694718|62894666|FG000|Overall Study|Death|1|||
33510964|NCT02694718|62894666|FG000|Overall Study|Withdrawal by Subject|1|||
33510965|NCT02944513|62894672|FG000|Overall Study|Withdrawal by Subject|4|||
33510966|NCT02944513|62894673|FG001|Overall Study|Withdrawal by Subject|1|||
33510967|NCT03018938|62894701|FG000|Overall Study|Death|0|||
33510968|NCT03018938|62894702|FG001|Overall Study|Death|1|||
33510969|NCT03018938|62894701|FG000|Overall Study|Lost to Follow-up|21|||
33510970|NCT03018938|62894702|FG001|Overall Study|Lost to Follow-up|32|||
33613816|NCT02147197|63014644|FG001|Overall Study|Lost to Follow-up|3|||
33613817|NCT02147197|63014645|FG002|Overall Study|Lost to Follow-up|1|||
33613818|NCT02147197|63014643|FG000|Overall Study|Protocol Violation|1|||
33452150|NCT00121641|62826708|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
33452151|NCT00121641|62826704|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
33452152|NCT00121641|62826705|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
33452153|NCT00121641|62826706|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
33452154|NCT00121641|62826707|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
33452155|NCT00121641|62826708|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
33452156|NCT00121641|62826704|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
33452157|NCT00121641|62826705|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
33452158|NCT00121641|62826706|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
33452159|NCT00121641|62826707|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
33452160|NCT00121641|62826708|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
33452161|NCT00121641|62826704|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
33452162|NCT00121641|62826705|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
33510971|NCT03018938|62894701|FG000|Overall Study|Withdrawal by Subject|38|||
33510972|NCT03018938|62894702|FG001|Overall Study|Withdrawal by Subject|45|||
33510973|NCT03018938|62894701|FG000|Overall Study|Physician Decision|3|||
33510974|NCT03018938|62894702|FG001|Overall Study|Physician Decision|2|||
33510975|NCT03018938|62894701|FG000|Overall Study|Sponsor Decision|0|||
33510976|NCT03018938|62894702|FG001|Overall Study|Sponsor Decision|1|||
33510977|NCT03018938|62894701|FG000|Overall Study|Screen failure-After randomization|4|||
33613819|NCT02147197|63014644|FG001|Overall Study|Protocol Violation|0|||
33613820|NCT02147197|63014645|FG002|Overall Study|Protocol Violation|3|||
33613821|NCT02147197|63014643|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33613822|NCT02147197|63014644|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33613823|NCT02147197|63014645|FG002|Overall Study|Other Miscellaneous Reasons|3|||
33613824|NCT02176291|63014655|FG000|Overall Study|Death|1|||
33613825|NCT02176291|63014656|FG001|Overall Study|Death|0|||
33613826|NCT02176291|63014655|FG000|Overall Study|non compliance with protocol|2|||
33613827|NCT02176291|63014656|FG001|Overall Study|non compliance with protocol|0|||
33613828|NCT02176291|63014655|FG000|Overall Study|Withdrawal by Subject|2|||
33613829|NCT02176291|63014656|FG001|Overall Study|Withdrawal by Subject|0|||
33613830|NCT02175745|63014662|FG000|Overall Study|Not Eligible|1|||
33613831|NCT02175277|63014666|FG000|Overall Study|Protocol-specified Criteria|1|||
33510978|NCT03018938|62894702|FG001|Overall Study|Screen failure-After randomization|2|||
33510979|NCT03018938|62894701|FG000|Overall Study|Not recorded|0|||
33613832|NCT02124265|63014670|FG000|Overall Study|Adverse Event|1|||
33613833|NCT02146105|63014674|FG000|Overall Study|Adverse Event|1|||
33613834|NCT02146105|63014674|FG000|Overall Study|Withdrawal by Subject|5|||
33613835|NCT02175199|63014680|FG000|Overall Study|Withdrawal by Subject|1|||
33613836|NCT02175199|63014681|FG001|Overall Study|Withdrawal by Subject|5|||
33452163|NCT00121641|62826706|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
33452164|NCT00121641|62826707|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
33452165|NCT00121641|62826708|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
33510980|NCT03018938|62894702|FG001|Overall Study|Not recorded|2|||
33510981|NCT02943577|62894710|FG000|Overall Study|Protocol Violation|0|||
33510982|NCT02943577|62894711|FG001|Overall Study|Protocol Violation|1|||
33510983|NCT02943577|62894710|FG000|Overall Study|Adverse Event|3|||
33510984|NCT02943577|62894711|FG001|Overall Study|Adverse Event|2|||
33510985|NCT02943577|62894710|FG000|Overall Study|Lost to Follow-up|0|||
33510986|NCT02943577|62894711|FG001|Overall Study|Lost to Follow-up|1|||
33613837|NCT02175199|63014680|FG000|Overall Study|Randomized in Error|1|||
33510987|NCT02943577|62894710|FG000|Overall Study|Withdrawal by Subject|1|||
33510988|NCT02943577|62894711|FG001|Overall Study|Withdrawal by Subject|1|||
33613838|NCT02175199|63014681|FG001|Overall Study|Randomized in Error|0|||
33510989|NCT02943577|62894710|FG000|Overall Study|Pregnancy|1|||
33510990|NCT02943577|62894711|FG001|Overall Study|Pregnancy|0|||
33510991|NCT03016598|62894719|FG000|Overall Study|Lost to Follow-up|0|||
33510992|NCT03016598|62894720|FG001|Overall Study|Lost to Follow-up|2|||
33510993|NCT03017846|62894726|FG000|Overall Study|Lost to Follow-up|3|||
33510994|NCT03017846|62894726|FG000|Overall Study|Adverse Event|2|||
33510995|NCT03014180|62894732|FG000|Overall Study|Protocol Violation|2|||
33510996|NCT03011840|62894742|FG000|Overall Study|Not received PIL in post PIL phase|0|||
33510997|NCT03011840|62894743|FG001|Overall Study|Not received PIL in post PIL phase|21|||
33510998|NCT02942485|62894751|FG000|Overall Study|Lost to Follow-up|1|||
33510999|NCT02942485|62894752|FG001|Overall Study|Lost to Follow-up|0|||
33511000|NCT02942407|62894760|FG000|Overall Study|Lost to Follow-up|3|||
33511001|NCT02942407|62894761|FG001|Overall Study|Lost to Follow-up|2|||
33511002|NCT02942407|62894760|FG000|Overall Study|Withdrawal by Subject|7|||
33511003|NCT02942407|62894761|FG001|Overall Study|Withdrawal by Subject|9|||
33511004|NCT02942407|62894760|FG000|Overall Study|Death|16|||
33511005|NCT02942407|62894761|FG001|Overall Study|Death|13|||
33511006|NCT03009344|62894775|FG000|Overall Study|Lack of Efficacy|5|||
33511007|NCT03009344|62894775|FG000|Overall Study|Withdrawal by Subject|1|||
33511008|NCT03009344|62894775|FG000|Overall Study|Adverse Event|1|||
33511009|NCT03322423|62894779|FG000|Period 1|Subject no longer eligible|0|||
33511010|NCT03322423|62894780|FG001|Period 1|Subject no longer eligible|1|||
33511011|NCT03322423|62894779|FG000|Period 1|Withdrawal by Subject|0|||
33511012|NCT03322423|62894780|FG001|Period 1|Withdrawal by Subject|1|||
33511013|NCT03322423|62894779|FG000|Period 1|Incorrect Lens Dispensed|1|||
33511014|NCT03322423|62894780|FG001|Period 1|Incorrect Lens Dispensed|0|||
33511015|NCT03322423|62894779|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
33511016|NCT03322423|62894780|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
33511017|NCT03322423|62894779|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
33511018|NCT03322423|62894780|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
33511019|NCT03322423|62894779|FG000|Period 2|Protocol Violation|1|||
33511020|NCT03322423|62894780|FG001|Period 2|Protocol Violation|0|||
33511021|NCT03322423|62894779|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
33511022|NCT03322423|62894780|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
33613839|NCT02175199|63014680|FG000|Overall Study|Sponsor Decision|1|||
33511023|NCT03007472|62894786|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
33511024|NCT03007472|62894786|FG000|Overall Study|Death|2|||
33511025|NCT03007472|62894786|FG000|Overall Study|Loss to Follow Up|1|||
33511026|NCT03321721|62894793|FG000|Overall Study|Lost to Follow-up|4|||
33511027|NCT03321721|62894794|FG001|Overall Study|Lost to Follow-up|8|||
33511028|NCT03321721|62894795|FG002|Overall Study|Lost to Follow-up|11|||
33511029|NCT03015116|62894807|FG000|Overall Study|Lost to Follow-up|3|||
33511030|NCT03015116|62894808|FG001|Overall Study|Lost to Follow-up|0|||
33511031|NCT03015116|62894809|FG002|Overall Study|Lost to Follow-up|2|||
33511032|NCT03015116|62894807|FG000|Overall Study|Withdrawal by Subject|3|||
33511033|NCT03015116|62894808|FG001|Overall Study|Withdrawal by Subject|1|||
33511034|NCT03015116|62894809|FG002|Overall Study|Withdrawal by Subject|0|||
33511035|NCT03015116|62894807|FG000|Overall Study|Subject has New Medical Status|1|||
33511036|NCT03015116|62894808|FG001|Overall Study|Subject has New Medical Status|0|||
33511037|NCT03015116|62894809|FG002|Overall Study|Subject has New Medical Status|0|||
33613840|NCT02175199|63014681|FG001|Overall Study|Sponsor Decision|0|||
33511038|NCT03015116|62894807|FG000|Overall Study|Physician Decision|0|||
33511039|NCT03015116|62894808|FG001|Overall Study|Physician Decision|1|||
33511040|NCT03015116|62894809|FG002|Overall Study|Physician Decision|0|||
33511041|NCT03006458|62894819|FG000|First Intervention|Unsatisfied Vision|0|||
33511042|NCT03006458|62894820|FG001|First Intervention|Unsatisfied Vision|3|||
33511043|NCT03320941|62894831|FG000|Overall Study|subject/guardian decision|0|||
33511044|NCT03320941|62894832|FG001|Overall Study|subject/guardian decision|0|||
33511045|NCT03320941|62894833|FG002|Overall Study|subject/guardian decision|0|||
33511046|NCT03320941|62894834|FG003|Overall Study|subject/guardian decision|1|||
33452166|NCT00121641|62826704|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
33452167|NCT00121641|62826705|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
33452168|NCT00121641|62826706|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
33452169|NCT00121641|62826707|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
33452170|NCT00121641|62826708|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
33452171|NCT00121641|62826704|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
33452172|NCT00121641|62826705|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
33452173|NCT00121641|62826706|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
33452174|NCT00121641|62826707|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
33452175|NCT00121641|62826708|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
33452176|NCT00121641|62826704|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
33452177|NCT00121641|62826705|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
33452178|NCT00121641|62826706|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
33452179|NCT00121641|62826707|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
33452180|NCT00121641|62826708|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
33452181|NCT00121641|62826704|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
33511047|NCT03320941|62894835|FG004|Overall Study|subject/guardian decision|0|||
33511048|NCT03005288|62894849|FG000|Overall Study|Withdrawal by Subject|7|||
33511049|NCT03005288|62894850|FG001|Overall Study|Withdrawal by Subject|5|||
33511050|NCT03005288|62894849|FG000|Overall Study|Lost to Follow-up|0|||
33511051|NCT03005288|62894850|FG001|Overall Study|Lost to Follow-up|1|||
33511052|NCT03005288|62894849|FG000|Overall Study|Adverse Event|5|||
33511053|NCT03005288|62894850|FG001|Overall Study|Adverse Event|0|||
33511054|NCT03005288|62894849|FG000|Overall Study|Protocol deviation|0|||
33511055|NCT03005288|62894850|FG001|Overall Study|Protocol deviation|1|||
33511056|NCT03005288|62894849|FG000|Overall Study|Physician Decision|0|||
33511057|NCT03005288|62894850|FG001|Overall Study|Physician Decision|1|||
33511058|NCT03003494|62894856|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
33511059|NCT03559699|62894860|FG000|Overall Study|Withdrawal by Subject|6|||
33511060|NCT03559699|62894860|FG000|Overall Study|Lost to Follow-up|1|||
33511061|NCT03085758|62894867|FG000|Overall Study|Death|26|||
33511062|NCT03085758|62894868|FG001|Overall Study|Death|24|||
33511063|NCT03085758|62894869|FG002|Overall Study|Death|53|||
33511064|NCT03085758|62894867|FG000|Overall Study|Lost to Follow-up|1|||
33511065|NCT03085758|62894868|FG001|Overall Study|Lost to Follow-up|1|||
33511066|NCT03085758|62894869|FG002|Overall Study|Lost to Follow-up|1|||
33511067|NCT03085758|62894867|FG000|Overall Study|Withdrawal by Subject|2|||
33511068|NCT03085758|62894868|FG001|Overall Study|Withdrawal by Subject|2|||
33511069|NCT03085758|62894869|FG002|Overall Study|Withdrawal by Subject|1|||
33511070|NCT03085758|62894867|FG000|Overall Study|Refusal to recall it up to day 90|0|||
33511071|NCT03085758|62894868|FG001|Overall Study|Refusal to recall it up to day 90|0|||
33511072|NCT03085758|62894869|FG002|Overall Study|Refusal to recall it up to day 90|1|||
33511073|NCT03085758|62894867|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
33511074|NCT03085758|62894868|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
33511075|NCT03085758|62894869|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
33511076|NCT03935880|62894893|FG000|Overall Study|Lost to Follow-up|0|||
33511077|NCT03935880|62894894|FG001|Overall Study|Lost to Follow-up|1|||
33511078|NCT03315793|62894902|FG000|Overall Study|Adverse Event|4|||
33511079|NCT03315793|62894903|FG001|Overall Study|Adverse Event|2|||
33511080|NCT03315793|62894902|FG000|Overall Study|Protocol Deviation|1|||
33511081|NCT03315793|62894903|FG001|Overall Study|Protocol Deviation|0|||
33511082|NCT03315793|62894902|FG000|Overall Study|Difficult for regular visit|0|||
33511083|NCT03315793|62894903|FG001|Overall Study|Difficult for regular visit|1|||
33511084|NCT02676466|62894919|FG000|Overall Study|Death|0|||
33511085|NCT02676466|62894920|FG001|Overall Study|Death|2|||
33511086|NCT02676466|62894921|FG002|Overall Study|Death|1|||
33511087|NCT02676466|62894922|FG003|Overall Study|Death|0|||
33511088|NCT02676466|62894923|FG004|Overall Study|Death|0|||
33511089|NCT02676466|62894924|FG005|Overall Study|Death|0|||
33511090|NCT02676466|62894925|FG006|Overall Study|Death|0|||
33511091|NCT02676466|62894926|FG007|Overall Study|Death|0|||
33511092|NCT02676466|62894919|FG000|Overall Study|Withdrawal by Subject|4|||
33511093|NCT02676466|62894920|FG001|Overall Study|Withdrawal by Subject|3|||
33511094|NCT02676466|62894921|FG002|Overall Study|Withdrawal by Subject|1|||
33511095|NCT02676466|62894922|FG003|Overall Study|Withdrawal by Subject|0|||
33511096|NCT02676466|62894923|FG004|Overall Study|Withdrawal by Subject|3|||
33511097|NCT02676466|62894924|FG005|Overall Study|Withdrawal by Subject|1|||
33511098|NCT02676466|62894925|FG006|Overall Study|Withdrawal by Subject|1|||
33511099|NCT02676466|62894926|FG007|Overall Study|Withdrawal by Subject|1|||
33511100|NCT03633695|62894950|FG000|Overall Study|Lost to Follow-up|4|||
33511101|NCT03633695|62894951|FG001|Overall Study|Lost to Follow-up|5|||
33511102|NCT03633695|62894950|FG000|Overall Study|Discontinued|8|||
33511103|NCT03633695|62894951|FG001|Overall Study|Discontinued|4|||
33511104|NCT03314233|62894973|FG000|Overall Study|No longer eligible at time of delivery|1|||
33511105|NCT02675998|62894981|FG000|8-Week Treatment Period|Adverse Event|6|||
33511106|NCT02675998|62894982|FG001|8-Week Treatment Period|Adverse Event|5|||
33511107|NCT02675998|62894983|FG002|8-Week Treatment Period|Adverse Event|6|||
33511108|NCT02675998|62894984|FG003|8-Week Treatment Period|Adverse Event|0|||
33511109|NCT02675998|62894981|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
33511110|NCT02675998|62894982|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
33511111|NCT02675998|62894983|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
33511112|NCT02675998|62894984|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
33511113|NCT02675998|62894981|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
33511114|NCT02675998|62894982|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
33511115|NCT02675998|62894983|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
33511116|NCT02675998|62894984|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
33511117|NCT02675998|62894981|FG000|8-Week Treatment Period|Physician Decision|1|||
33511118|NCT02675998|62894982|FG001|8-Week Treatment Period|Physician Decision|0|||
33511119|NCT02675998|62894983|FG002|8-Week Treatment Period|Physician Decision|2|||
33511120|NCT02675998|62894984|FG003|8-Week Treatment Period|Physician Decision|0|||
33511121|NCT02675998|62894981|FG000|8-Week Treatment Period|GI side Effects|1|||
33511122|NCT02675998|62894982|FG001|8-Week Treatment Period|GI side Effects|4|||
33511123|NCT02675998|62894983|FG002|8-Week Treatment Period|GI side Effects|2|||
33511124|NCT02675998|62894984|FG003|8-Week Treatment Period|GI side Effects|0|||
33511125|NCT02675998|62894981|FG000|8-Week Treatment Period|Protocol Violation|1|||
33511126|NCT02675998|62894982|FG001|8-Week Treatment Period|Protocol Violation|1|||
33511127|NCT02675998|62894983|FG002|8-Week Treatment Period|Protocol Violation|1|||
33511128|NCT02675998|62894984|FG003|8-Week Treatment Period|Protocol Violation|0|||
33511129|NCT02675998|62894981|FG000|8-Week Treatment Period|Other|3|||
33511130|NCT02675998|62894982|FG001|8-Week Treatment Period|Other|1|||
33511131|NCT02675998|62894983|FG002|8-Week Treatment Period|Other|2|||
33511132|NCT02675998|62894984|FG003|8-Week Treatment Period|Other|0|||
33511133|NCT02675998|62894981|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
33511134|NCT02675998|62894982|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
33511135|NCT02675998|62894983|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
33511136|NCT02675998|62894984|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
33511137|NCT02675998|62894981|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
33511138|NCT02675998|62894982|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
33511139|NCT02675998|62894983|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
33511140|NCT02675998|62894984|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
33511141|NCT02675998|62894981|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
33511142|NCT02675998|62894982|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
33511143|NCT02675998|62894983|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
33511144|NCT02675998|62894984|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
33511145|NCT02675998|62894981|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
33511146|NCT02675998|62894982|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
33511147|NCT02675998|62894983|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
33511148|NCT02675998|62894984|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
33511149|NCT02675998|62894981|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
33511150|NCT02675998|62894982|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
33511151|NCT02675998|62894983|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
33511152|NCT02675998|62894984|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
33511153|NCT02674204|62895000|FG000|Overall Study|Adverse Event|1|||
33511154|NCT02674204|62895001|FG001|Overall Study|Adverse Event|0|||
33511155|NCT02941627|62895007|FG000|Overall Study|Death|1|||
33511156|NCT02941627|62895007|FG000|Overall Study|Surgical failure|1|||
33511157|NCT02941627|62895007|FG000|Overall Study|cholesteatoma prevented implantation|1|||
33511158|NCT03521934|62895019|FG000|Overall Study|Death|65|||
33511159|NCT03521934|62895020|FG001|Overall Study|Death|73|||
33511160|NCT03521934|62895019|FG000|Overall Study|Withdrawal by Subject|18|||
33511161|NCT03521934|62895020|FG001|Overall Study|Withdrawal by Subject|23|||
33511162|NCT03521934|62895019|FG000|Overall Study|Site Terminated by Sponsor|39|||
33511163|NCT03521934|62895020|FG001|Overall Study|Site Terminated by Sponsor|35|||
33511164|NCT03521934|62895019|FG000|Overall Study|Study Terminated by Sponsor|483|||
33511165|NCT03521934|62895020|FG001|Overall Study|Study Terminated by Sponsor|477|||
33511166|NCT03521934|62895019|FG000|Overall Study|Reason not Specified|3|||
33511167|NCT03521934|62895020|FG001|Overall Study|Reason not Specified|6|||
33511168|NCT03434353|62895031|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
33511169|NCT03434353|62895032|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
33511170|NCT03434353|62895033|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
33613841|NCT02123797|63014690|FG000|Baseline Intervention|Death|9|||
33613842|NCT02123797|63014691|FG001|Baseline Intervention|Death|16|||
33613843|NCT02123797|63014692|FG002|Baseline Intervention|Death|0|||
33613844|NCT02123797|63014693|FG003|Baseline Intervention|Death|0|||
33613845|NCT02123797|63014694|FG004|Baseline Intervention|Death|0|||
33613846|NCT02123797|63014690|FG000|Baseline Intervention|Withdrawal by Subject|2|||
33613847|NCT02123797|63014691|FG001|Baseline Intervention|Withdrawal by Subject|8|||
33613848|NCT02123797|63014692|FG002|Baseline Intervention|Withdrawal by Subject|0|||
33613849|NCT02123797|63014693|FG003|Baseline Intervention|Withdrawal by Subject|0|||
33511171|NCT03434353|62895034|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
33511172|NCT03434353|62895035|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
33613850|NCT02123797|63014694|FG004|Baseline Intervention|Withdrawal by Subject|0|||
33613851|NCT02123797|63014690|FG000|Baseline Intervention|Relocation|2|||
33613852|NCT02123797|63014691|FG001|Baseline Intervention|Relocation|0|||
33613853|NCT02123797|63014692|FG002|Baseline Intervention|Relocation|0|||
33613854|NCT02123797|63014693|FG003|Baseline Intervention|Relocation|0|||
33613855|NCT02123797|63014694|FG004|Baseline Intervention|Relocation|0|||
33613856|NCT02123797|63014690|FG000|Baseline Intervention|Out of window for initial survey|6|||
33613857|NCT02123797|63014691|FG001|Baseline Intervention|Out of window for initial survey|13|||
33613858|NCT02123797|63014692|FG002|Baseline Intervention|Out of window for initial survey|0|||
33613859|NCT02123797|63014693|FG003|Baseline Intervention|Out of window for initial survey|0|||
33613860|NCT02123797|63014694|FG004|Baseline Intervention|Out of window for initial survey|0|||
33613861|NCT02123797|63014690|FG000|Baseline Intervention|Lost to Follow-up|0|||
33613862|NCT02123797|63014691|FG001|Baseline Intervention|Lost to Follow-up|5|||
33511173|NCT03434353|62895031|FG000|Overall Study|Withdrew consent|1|||
33511174|NCT03434353|62895032|FG001|Overall Study|Withdrew consent|0|||
33511175|NCT03434353|62895033|FG002|Overall Study|Withdrew consent|3|||
33511176|NCT03434353|62895034|FG003|Overall Study|Withdrew consent|0|||
33511177|NCT03434353|62895035|FG004|Overall Study|Withdrew consent|0|||
33511178|NCT03434353|62895031|FG000|Overall Study|Adverse Event|1|||
33511179|NCT03434353|62895032|FG001|Overall Study|Adverse Event|0|||
33511180|NCT03434353|62895033|FG002|Overall Study|Adverse Event|0|||
33511181|NCT03434353|62895034|FG003|Overall Study|Adverse Event|0|||
33511182|NCT03434353|62895035|FG004|Overall Study|Adverse Event|1|||
33511183|NCT03434353|62895031|FG000|Overall Study|Lost to Follow-up|2|||
33511184|NCT03434353|62895032|FG001|Overall Study|Lost to Follow-up|0|||
33511185|NCT03434353|62895033|FG002|Overall Study|Lost to Follow-up|0|||
33511186|NCT03434353|62895034|FG003|Overall Study|Lost to Follow-up|0|||
33511187|NCT03434353|62895035|FG004|Overall Study|Lost to Follow-up|0|||
33511188|NCT02914184|62895051|FG000|Overall Study|Lost to Follow-up|7|||
33511189|NCT02914184|62895052|FG001|Overall Study|Lost to Follow-up|10|||
33511190|NCT02914184|62895053|FG002|Overall Study|Lost to Follow-up|8|||
33511191|NCT02914184|62895054|FG003|Overall Study|Lost to Follow-up|7|||
33511192|NCT02914184|62895051|FG000|Overall Study|Withdrawal by Subject|4|||
33511193|NCT02914184|62895052|FG001|Overall Study|Withdrawal by Subject|2|||
33511194|NCT02914184|62895053|FG002|Overall Study|Withdrawal by Subject|7|||
33511195|NCT02914184|62895054|FG003|Overall Study|Withdrawal by Subject|3|||
33511196|NCT02914184|62895051|FG000|Overall Study|Other|1|||
33511197|NCT02914184|62895052|FG001|Overall Study|Other|0|||
33511198|NCT02914184|62895053|FG002|Overall Study|Other|0|||
33511199|NCT02914184|62895054|FG003|Overall Study|Other|0|||
33511200|NCT02914184|62895051|FG000|Overall Study|Migrated/moved from the study area|2|||
33511201|NCT02914184|62895052|FG001|Overall Study|Migrated/moved from the study area|1|||
33511202|NCT02914184|62895053|FG002|Overall Study|Migrated/moved from the study area|2|||
33511203|NCT02914184|62895054|FG003|Overall Study|Migrated/moved from the study area|1|||
33511204|NCT03633227|62895068|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
33511205|NCT03633227|62895069|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
33511206|NCT03633227|62895068|FG000|Double Blind (DB), up to Week 48|Death|2|||
33511207|NCT03633227|62895069|FG001|Double Blind (DB), up to Week 48|Death|1|||
33511208|NCT03633227|62895068|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
33511209|NCT03633227|62895069|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
33511210|NCT03633227|62895068|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
33613863|NCT02123797|63014692|FG002|Baseline Intervention|Lost to Follow-up|0|||
33613864|NCT02123797|63014693|FG003|Baseline Intervention|Lost to Follow-up|0|||
33613865|NCT02123797|63014694|FG004|Baseline Intervention|Lost to Follow-up|0|||
33613866|NCT02123797|63014690|FG000|Baseline Intervention|Other Disease|3|||
33511211|NCT03633227|62895069|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
33511212|NCT03633227|62895068|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
33511213|NCT03633227|62895069|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
33511214|NCT03633227|62895068|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
33511215|NCT03633227|62895069|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
33511216|NCT03633227|62895068|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
33511217|NCT03633227|62895069|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
33511218|NCT03633227|62895068|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
33511219|NCT03633227|62895069|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
33511220|NCT03633227|62895068|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
33511221|NCT03633227|62895069|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
33511222|NCT03633227|62895068|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
33511223|NCT03633227|62895069|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
33511224|NCT03633227|62895068|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
33511225|NCT03633227|62895069|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
33511226|NCT03633227|62895068|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
33511227|NCT03633227|62895069|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
33511228|NCT02913326|62895082|FG000|Overall Study|Reason not listed|0|||
33511229|NCT02913326|62895083|FG001|Overall Study|Reason not listed|1|||
33511230|NCT02913326|62895082|FG000|Overall Study|Lost to Follow-up|0|||
33511231|NCT02913326|62895083|FG001|Overall Study|Lost to Follow-up|1|||
33511232|NCT02913326|62895082|FG000|Overall Study|Adverse Event|1|||
33511233|NCT02913326|62895083|FG001|Overall Study|Adverse Event|0|||
33324439|NCT00912340|62700867|FG000|Overall Study|Protocol revised to remove arm|0|||
33452182|NCT00121641|62826705|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
33452183|NCT00121641|62826706|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
33452184|NCT00121641|62826707|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
33452185|NCT00121641|62826708|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
33452186|NCT00121641|62826704|FG000|48-month Short Term + Long Term Period|Death|0|||
33452187|NCT00121641|62826705|FG001|48-month Short Term + Long Term Period|Death|0|||
33452188|NCT00121641|62826706|FG002|48-month Short Term + Long Term Period|Death|0|||
33511234|NCT02912468|62895091|FG000|Overall Study|Adverse Event|3|||
33511235|NCT02912468|62895092|FG001|Overall Study|Adverse Event|2|||
33511236|NCT02912468|62895091|FG000|Overall Study|Withdrawal by Subject|6|||
33511237|NCT02912468|62895092|FG001|Overall Study|Withdrawal by Subject|2|||
33511238|NCT02912468|62895091|FG000|Overall Study|Randomized and not treated|0|||
33511239|NCT02912468|62895092|FG001|Overall Study|Randomized and not treated|1|||
33511240|NCT04438499|62895099|FG000|Overall Study|Lack of Efficacy|2|||
33511241|NCT00002874|62895105|FG000|Overall Study|Withdrawal by Subject|1|||
33511242|NCT00002874|62895106|FG001|Overall Study|Withdrawal by Subject|1|||
33511243|NCT00002874|62895105|FG000|Overall Study|Protocol Violation|44|||
33511244|NCT00002874|62895106|FG001|Overall Study|Protocol Violation|34|||
33511245|NCT03001076|62895114|FG000|Overall Study|Withdrawal by patient|2|||
33511246|NCT03001076|62895115|FG001|Overall Study|Withdrawal by patient|0|||
33511247|NCT03001076|62895114|FG000|Overall Study|Other|1|||
33511248|NCT03001076|62895115|FG001|Overall Study|Other|0|||
33511249|NCT03001076|62895114|FG000|Overall Study|Adverse Event|3|||
33511250|NCT03001076|62895115|FG001|Overall Study|Adverse Event|3|||
33511251|NCT03001076|62895114|FG000|Overall Study|Sponsor decision|1|||
33511252|NCT03001076|62895115|FG001|Overall Study|Sponsor decision|0|||
33511253|NCT03001076|62895114|FG000|Overall Study|Lost to Follow-up|0|||
33511254|NCT03001076|62895115|FG001|Overall Study|Lost to Follow-up|2|||
33511255|NCT03555305|62895121|FG000|Period 1|Physician Decision|0|||
33511256|NCT03555305|62895122|FG001|Period 1|Physician Decision|1|||
33511257|NCT03555305|62895121|FG000|Period 1|Adverse Event|0|||
33511258|NCT03555305|62895122|FG001|Period 1|Adverse Event|1|||
33511259|NCT03553823|62895130|FG000|Overall Study|Physician Decision|0|||
33511260|NCT03553823|62895131|FG001|Overall Study|Physician Decision|1|||
33511261|NCT03000686|62895139|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
33511262|NCT03000686|62895140|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
33613867|NCT02123797|63014691|FG001|Baseline Intervention|Other Disease|0|||
33613868|NCT02123797|63014692|FG002|Baseline Intervention|Other Disease|0|||
33613869|NCT02123797|63014693|FG003|Baseline Intervention|Other Disease|0|||
33613870|NCT02123797|63014694|FG004|Baseline Intervention|Other Disease|0|||
33613871|NCT02123797|63014690|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
33613872|NCT02123797|63014691|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
33613873|NCT02123797|63014692|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
33613874|NCT02123797|63014693|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
33613875|NCT02123797|63014694|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
33613876|NCT02123797|63014690|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
33324440|NCT00912340|62700868|FG001|Overall Study|Protocol revised to remove arm|0|||
33324441|NCT00912340|62700869|FG002|Overall Study|Protocol revised to remove arm|4|||
33452189|NCT00121641|62826707|FG003|48-month Short Term + Long Term Period|Death|1|||
33452190|NCT00121641|62826708|FG004|48-month Short Term + Long Term Period|Death|0|||
33452191|NCT00121641|62826704|FG000|48-month Short Term + Long Term Period|Missing|0|||
33452192|NCT00121641|62826705|FG001|48-month Short Term + Long Term Period|Missing|0|||
33452193|NCT00121641|62826706|FG002|48-month Short Term + Long Term Period|Missing|1|||
33452194|NCT00121641|62826707|FG003|48-month Short Term + Long Term Period|Missing|0|||
33452195|NCT00121641|62826708|FG004|48-month Short Term + Long Term Period|Missing|0|||
33452196|NCT00121641|62826704|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
33452197|NCT00121641|62826705|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
33452198|NCT00121641|62826706|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
33452199|NCT00121641|62826707|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
33452200|NCT00121641|62826708|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
33452201|NCT00425555|62826724|FG000|Overall Study|Withdrawal by Subject|11|||
33452202|NCT00425555|62826725|FG001|Overall Study|Withdrawal by Subject|8|||
33452203|NCT00425555|62826724|FG000|Overall Study|Lost to Follow-up|0|||
33452204|NCT00425555|62826725|FG001|Overall Study|Lost to Follow-up|1|||
33452205|NCT00425555|62826724|FG000|Overall Study|Administrative problems|3|||
33452206|NCT00425555|62826725|FG001|Overall Study|Administrative problems|0|||
33452207|NCT00425555|62826724|FG000|Overall Study|Death|1|||
33452208|NCT00425555|62826725|FG001|Overall Study|Death|2|||
33452209|NCT00425555|62826724|FG000|Overall Study|New cancer therapy|2|||
33452210|NCT00425555|62826725|FG001|Overall Study|New cancer therapy|1|||
33452211|NCT00425555|62826724|FG000|Overall Study|Disease progression|36|||
33452212|NCT00425555|62826725|FG001|Overall Study|Disease progression|33|||
33452213|NCT00425555|62826724|FG000|Overall Study|Adverse Event|25|||
33452214|NCT00425555|62826725|FG001|Overall Study|Adverse Event|15|||
33452215|NCT00425555|62826724|FG000|Overall Study|Protocol Violation|1|||
33452216|NCT00425555|62826725|FG001|Overall Study|Protocol Violation|0|||
33452217|NCT00424775|62826734|FG000|Overall Study|Adverse Event|2|||
33452218|NCT00424775|62826735|FG001|Overall Study|Adverse Event|0|||
33452219|NCT00424775|62826734|FG000|Overall Study|Lack of Efficacy|1|||
33452220|NCT00424775|62826735|FG001|Overall Study|Lack of Efficacy|0|||
33452221|NCT00121485|62826741|FG000|Overall Study|Not implanted|1|||
33452222|NCT00121485|62826742|FG001|Overall Study|Not implanted|5|||
33452223|NCT00121485|62826741|FG000|Overall Study|Crossover|0|||
33452224|NCT00121485|62826742|FG001|Overall Study|Crossover|2|||
33452225|NCT01763866|62826773|FG000|Overall Study|Withdrawal by Subject|2|||
33452226|NCT01763866|62826774|FG001|Overall Study|Withdrawal by Subject|1|||
33452227|NCT01763866|62826775|FG002|Overall Study|Withdrawal by Subject|4|||
33452228|NCT01763866|62826776|FG003|Overall Study|Withdrawal by Subject|0|||
33452229|NCT01763866|62826777|FG004|Overall Study|Withdrawal by Subject|0|||
33511263|NCT03000686|62895141|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
33511264|NCT03000686|62895142|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
33452230|NCT01763866|62826778|FG005|Overall Study|Withdrawal by Subject|3|||
33452231|NCT01763866|62826779|FG006|Overall Study|Withdrawal by Subject|4|||
33452232|NCT01763866|62826780|FG007|Overall Study|Withdrawal by Subject|0|||
33452233|NCT01763866|62826781|FG008|Overall Study|Withdrawal by Subject|1|||
33452234|NCT01763866|62826782|FG009|Overall Study|Withdrawal by Subject|1|||
33511265|NCT02493660|62895160|FG000|Overall Study|Physician Decision|0|||
33613877|NCT02123797|63014691|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
33324442|NCT01167257|62700879|FG000|Overall Study|Lost to Follow-up|2|||
33452235|NCT01763866|62826783|FG010|Overall Study|Withdrawal by Subject|2|||
33452236|NCT01763866|62826784|FG011|Overall Study|Withdrawal by Subject|2|||
33452237|NCT01763866|62826785|FG012|Overall Study|Withdrawal by Subject|2|||
33511266|NCT02493660|62895161|FG001|Overall Study|Physician Decision|1|||
33511267|NCT02493660|62895160|FG000|Overall Study|Adverse Event|4|||
33511268|NCT02493660|62895161|FG001|Overall Study|Adverse Event|2|||
33452238|NCT01763866|62826786|FG013|Overall Study|Withdrawal by Subject|0|||
33452239|NCT01763866|62826787|FG014|Overall Study|Withdrawal by Subject|6|||
33452240|NCT01763866|62826788|FG015|Overall Study|Withdrawal by Subject|3|||
33452241|NCT01763866|62826789|FG016|Overall Study|Withdrawal by Subject|0|||
33452242|NCT01763866|62826790|FG017|Overall Study|Withdrawal by Subject|1|||
33452243|NCT01763866|62826791|FG018|Overall Study|Withdrawal by Subject|1|||
33511269|NCT02493660|62895160|FG000|Overall Study|Withdrawal by Subject|2|||
33511270|NCT02493660|62895161|FG001|Overall Study|Withdrawal by Subject|3|||
33511271|NCT02493660|62895160|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
33511272|NCT02493660|62895161|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
33511273|NCT02493660|62895160|FG000|Overall Study|Protocol Violation|0|||
33511274|NCT02493660|62895161|FG001|Overall Study|Protocol Violation|1|||
33511275|NCT02493660|62895160|FG000|Overall Study|Death|0|||
33511276|NCT02493660|62895161|FG001|Overall Study|Death|1|||
33511277|NCT02493660|62895160|FG000|Overall Study|Lost to Follow-up|2|||
33511278|NCT02493660|62895161|FG001|Overall Study|Lost to Follow-up|4|||
33511279|NCT03552029|62895171|FG000|Overall Study|Death|3|||
33511280|NCT03552029|62895172|FG001|Overall Study|Death|0|||
33511281|NCT03552029|62895171|FG000|Overall Study|Adverse Event|1|||
33511282|NCT03552029|62895172|FG001|Overall Study|Adverse Event|0|||
33511283|NCT03552029|62895171|FG000|Overall Study|Lack of Efficacy|0|||
33511284|NCT03552029|62895172|FG001|Overall Study|Lack of Efficacy|2|||
33511285|NCT03552029|62895171|FG000|Overall Study|Physician Decision|0|||
33511286|NCT03552029|62895172|FG001|Overall Study|Physician Decision|1|||
33511287|NCT03552029|62895171|FG000|Overall Study|Study terminated by Sponsor|0|||
33511288|NCT03552029|62895172|FG001|Overall Study|Study terminated by Sponsor|1|||
33511289|NCT03552029|62895171|FG000|Overall Study|Other|0|||
33511290|NCT03552029|62895172|FG001|Overall Study|Other|2|||
33511291|NCT03521141|62895181|FG000|Overall Study|Death|1|||
33511292|NCT03521141|62895182|FG001|Overall Study|Death|0|||
33511293|NCT03521141|62895183|FG002|Overall Study|Death|1|||
33511294|NCT02997176|62895195|FG000|Overall Study|Adverse Event|0|||
33511295|NCT02997176|62895196|FG001|Overall Study|Adverse Event|0|||
33511296|NCT02997176|62895197|FG002|Overall Study|Adverse Event|0|||
33511297|NCT02997176|62895198|FG003|Overall Study|Adverse Event|8|||
33511298|NCT02997176|62895195|FG000|Overall Study|Progressive Disease|1|||
33511299|NCT02997176|62895196|FG001|Overall Study|Progressive Disease|0|||
33511300|NCT02997176|62895197|FG002|Overall Study|Progressive Disease|1|||
33511301|NCT02997176|62895198|FG003|Overall Study|Progressive Disease|1|||
33511302|NCT02997176|62895195|FG000|Overall Study|Death|0|||
33511303|NCT02997176|62895196|FG001|Overall Study|Death|0|||
33452244|NCT01763866|62826792|FG019|Overall Study|Withdrawal by Subject|1|||
33511304|NCT02997176|62895197|FG002|Overall Study|Death|1|||
33511305|NCT02997176|62895198|FG003|Overall Study|Death|1|||
33452245|NCT01763866|62826793|FG020|Overall Study|Withdrawal by Subject|2|||
33452246|NCT01763866|62826794|FG021|Overall Study|Withdrawal by Subject|1|||
33452247|NCT01763866|62826795|FG022|Overall Study|Withdrawal by Subject|2|||
33452248|NCT01763866|62826796|FG023|Overall Study|Withdrawal by Subject|1|||
33452249|NCT01763866|62826773|FG000|Overall Study|Decision by sponsor|0|||
33452250|NCT01763866|62826774|FG001|Overall Study|Decision by sponsor|0|||
33452251|NCT01763866|62826775|FG002|Overall Study|Decision by sponsor|1|||
33452252|NCT01763866|62826776|FG003|Overall Study|Decision by sponsor|0|||
33452253|NCT01763866|62826777|FG004|Overall Study|Decision by sponsor|2|||
33452254|NCT01763866|62826778|FG005|Overall Study|Decision by sponsor|0|||
33452255|NCT01763866|62826779|FG006|Overall Study|Decision by sponsor|2|||
33452256|NCT01763866|62826780|FG007|Overall Study|Decision by sponsor|0|||
33452257|NCT01763866|62826781|FG008|Overall Study|Decision by sponsor|2|||
33511306|NCT02997176|62895195|FG000|Overall Study|Withdrawal by Subject|0|||
33511307|NCT02997176|62895196|FG001|Overall Study|Withdrawal by Subject|2|||
33511308|NCT02997176|62895197|FG002|Overall Study|Withdrawal by Subject|0|||
33511309|NCT02997176|62895198|FG003|Overall Study|Withdrawal by Subject|1|||
33511310|NCT03000452|62895208|FG000|Treatment Period|Death|1|||
33511311|NCT03000452|62895208|FG000|Treatment Period|Progressive Disease (PD)|14|||
33511312|NCT03000452|62895208|FG000|Treatment Period|Physician Decision|1|||
33452258|NCT01763866|62826782|FG009|Overall Study|Decision by sponsor|0|||
33452259|NCT01763866|62826783|FG010|Overall Study|Decision by sponsor|6|||
33452260|NCT01763866|62826784|FG011|Overall Study|Decision by sponsor|0|||
33452261|NCT01763866|62826785|FG012|Overall Study|Decision by sponsor|1|||
33511313|NCT03000452|62895208|FG000|Treatment Period|Miscellaneous|2|||
33511314|NCT03000452|62895208|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
33511315|NCT03000452|62895208|FG000|Follow-Up Period|Death|3|||
33511316|NCT03000452|62895208|FG000|Follow-Up Period|Withdrawal by Subject|3|||
33511317|NCT01373164|62895217|FG000|Overall Study|Lost to Follow-up|0|||
33511318|NCT01373164|62895218|FG001|Overall Study|Lost to Follow-up|0|||
33511319|NCT01373164|62895219|FG002|Overall Study|Lost to Follow-up|1|||
33511320|NCT01373164|62895220|FG003|Overall Study|Lost to Follow-up|2|||
33511321|NCT01373164|62895221|FG004|Overall Study|Lost to Follow-up|0|||
33511322|NCT01373164|62895217|FG000|Overall Study|Withdrawal by Subject|0|||
33511323|NCT01373164|62895218|FG001|Overall Study|Withdrawal by Subject|1|||
33511324|NCT01373164|62895219|FG002|Overall Study|Withdrawal by Subject|0|||
33511325|NCT01373164|62895220|FG003|Overall Study|Withdrawal by Subject|10|||
33511326|NCT01373164|62895221|FG004|Overall Study|Withdrawal by Subject|2|||
33511327|NCT02999984|62895236|FG000|Overall Study|Treatment Failure|1|||
33324443|NCT01167257|62700880|FG001|Overall Study|Lost to Follow-up|2|||
33324444|NCT01167257|62700879|FG000|Overall Study|Withdrew consent|1|||
33511328|NCT03550313|62895243|FG000|Overall Study|Adverse Event|0|||
33511329|NCT03550313|62895244|FG001|Overall Study|Adverse Event|1|||
33511330|NCT03550313|62895245|FG002|Overall Study|Adverse Event|0|||
33511331|NCT03550313|62895243|FG000|Overall Study|Lost to Follow-up|5|||
33511332|NCT03550313|62895244|FG001|Overall Study|Lost to Follow-up|7|||
33511333|NCT03550313|62895245|FG002|Overall Study|Lost to Follow-up|12|||
33511334|NCT03550313|62895243|FG000|Overall Study|Study terminated by sponsor|44|||
33511335|NCT03550313|62895244|FG001|Overall Study|Study terminated by sponsor|37|||
33511336|NCT03550313|62895245|FG002|Overall Study|Study terminated by sponsor|48|||
33511337|NCT03550313|62895243|FG000|Overall Study|No longer met eligibility criteria|3|||
33511338|NCT03550313|62895244|FG001|Overall Study|No longer met eligibility criteria|5|||
33511339|NCT03550313|62895245|FG002|Overall Study|No longer met eligibility criteria|6|||
33511340|NCT03550313|62895243|FG000|Overall Study|Withdrawal by parent/guardian|20|||
33511341|NCT03550313|62895244|FG001|Overall Study|Withdrawal by parent/guardian|18|||
33511342|NCT03550313|62895245|FG002|Overall Study|Withdrawal by parent/guardian|26|||
33511343|NCT03550313|62895243|FG000|Overall Study|Other|4|||
33511344|NCT03550313|62895244|FG001|Overall Study|Other|2|||
33452262|NCT01763866|62826786|FG013|Overall Study|Decision by sponsor|0|||
33452263|NCT01763866|62826787|FG014|Overall Study|Decision by sponsor|5|||
33511345|NCT03550313|62895245|FG002|Overall Study|Other|2|||
33511346|NCT03550313|62895243|FG000|Overall Study|Randomized but not vaccinated|3|||
33511347|NCT03550313|62895244|FG001|Overall Study|Randomized but not vaccinated|23|||
33511348|NCT03550313|62895245|FG002|Overall Study|Randomized but not vaccinated|2|||
33511349|NCT03550313|62895243|FG000|Overall Study|Sites terminated due to quality issues|18|||
33511350|NCT03550313|62895244|FG001|Overall Study|Sites terminated due to quality issues|17|||
33511351|NCT03550313|62895245|FG002|Overall Study|Sites terminated due to quality issues|18|||
33511352|NCT03312907|62895257|FG000|Overall Study|Adverse Event|1|||
33511353|NCT03312907|62895258|FG001|Overall Study|Adverse Event|6|||
33511354|NCT03312907|62895259|FG002|Overall Study|Adverse Event|1|||
33511355|NCT03312907|62895257|FG000|Overall Study|Protocol Violation|2|||
33511356|NCT03312907|62895258|FG001|Overall Study|Protocol Violation|3|||
33511357|NCT03312907|62895259|FG002|Overall Study|Protocol Violation|4|||
33511358|NCT03312907|62895257|FG000|Overall Study|Lost to Follow-up|2|||
33613878|NCT02123797|63014692|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
33452264|NCT01763866|62826788|FG015|Overall Study|Decision by sponsor|0|||
33452265|NCT01763866|62826789|FG016|Overall Study|Decision by sponsor|0|||
33452266|NCT01763866|62826790|FG017|Overall Study|Decision by sponsor|0|||
33452267|NCT01763866|62826791|FG018|Overall Study|Decision by sponsor|4|||
33452268|NCT01763866|62826792|FG019|Overall Study|Decision by sponsor|0|||
33452269|NCT01763866|62826793|FG020|Overall Study|Decision by sponsor|2|||
33452270|NCT01763866|62826794|FG021|Overall Study|Decision by sponsor|0|||
33452271|NCT01763866|62826795|FG022|Overall Study|Decision by sponsor|1|||
33452272|NCT01763866|62826796|FG023|Overall Study|Decision by sponsor|0|||
33452273|NCT01763866|62826773|FG000|Overall Study|Lost to Follow-up|0|||
33511359|NCT03312907|62895258|FG001|Overall Study|Lost to Follow-up|3|||
33511360|NCT03312907|62895259|FG002|Overall Study|Lost to Follow-up|2|||
33511361|NCT03312907|62895257|FG000|Overall Study|Physician Decision|3|||
33511362|NCT03312907|62895258|FG001|Overall Study|Physician Decision|4|||
33613879|NCT02123797|63014693|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
33511363|NCT03312907|62895259|FG002|Overall Study|Physician Decision|2|||
33511364|NCT03312907|62895257|FG000|Overall Study|Withdrawal by Subject|9|||
33452274|NCT01763866|62826774|FG001|Overall Study|Lost to Follow-up|0|||
33452275|NCT01763866|62826775|FG002|Overall Study|Lost to Follow-up|0|||
33511365|NCT03312907|62895258|FG001|Overall Study|Withdrawal by Subject|14|||
33511366|NCT03312907|62895259|FG002|Overall Study|Withdrawal by Subject|10|||
33511367|NCT02999672|62895269|FG000|Overall Study|Death|0|||
33452276|NCT01763866|62826776|FG003|Overall Study|Lost to Follow-up|0|||
33452277|NCT01763866|62826777|FG004|Overall Study|Lost to Follow-up|0|||
33511368|NCT02999672|62895270|FG001|Overall Study|Death|1|||
33511369|NCT02999672|62895269|FG000|Overall Study|Study Terminated by Sponsor|0|||
33511370|NCT02999672|62895270|FG001|Overall Study|Study Terminated by Sponsor|1|||
33511371|NCT02999672|62895269|FG000|Overall Study|Progressive Disease|9|||
33511372|NCT02999672|62895270|FG001|Overall Study|Progressive Disease|5|||
33511373|NCT02999672|62895269|FG000|Overall Study|Adverse Event|4|||
33511374|NCT02999672|62895270|FG001|Overall Study|Adverse Event|0|||
33511375|NCT01911676|62895280|FG000|Period 1 of Study|Withdrawal by Subject|4|||
33511376|NCT01911676|62895281|FG001|Period 1 of Study|Withdrawal by Subject|2|||
33511377|NCT01911676|62895282|FG002|Period 1 of Study|Withdrawal by Subject|1|||
33511378|NCT01911676|62895283|FG003|Period 1 of Study|Withdrawal by Subject|2|||
33511379|NCT01911676|62895280|FG000|Period 1 of Study|Physician Decision|2|||
33511380|NCT01911676|62895281|FG001|Period 1 of Study|Physician Decision|0|||
33511381|NCT01911676|62895282|FG002|Period 1 of Study|Physician Decision|0|||
33613880|NCT02123797|63014694|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
33613881|NCT02123797|63014690|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
33613882|NCT02123797|63014691|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
33613883|NCT02123797|63014692|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
33613884|NCT02123797|63014693|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
33613885|NCT02123797|63014694|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
33613886|NCT02123797|63014690|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
33613887|NCT02123797|63014691|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
33613888|NCT02123797|63014692|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
33613889|NCT02123797|63014693|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
33511382|NCT01911676|62895283|FG003|Period 1 of Study|Physician Decision|1|||
33511383|NCT01911676|62895280|FG000|Period 2 of Study|Physician Decision|2|||
33511384|NCT01911676|62895281|FG001|Period 2 of Study|Physician Decision|0|||
33511385|NCT01911676|62895282|FG002|Period 2 of Study|Physician Decision|0|||
33511386|NCT01911676|62895283|FG003|Period 2 of Study|Physician Decision|1|||
33511387|NCT01911676|62895280|FG000|Period 2 of Study|Lost to Follow-up|0|||
33511388|NCT01911676|62895281|FG001|Period 2 of Study|Lost to Follow-up|0|||
33511389|NCT01911676|62895282|FG002|Period 2 of Study|Lost to Follow-up|0|||
33511390|NCT01911676|62895283|FG003|Period 2 of Study|Lost to Follow-up|1|||
33511391|NCT03573323|62895300|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
33511392|NCT03573323|62895301|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
33511393|NCT03573323|62895300|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
33511394|NCT03573323|62895301|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
33613890|NCT02123797|63014694|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
33613891|NCT02123797|63014690|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
33613892|NCT02123797|63014691|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
33613893|NCT02123797|63014692|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
33452278|NCT01763866|62826778|FG005|Overall Study|Lost to Follow-up|0|||
33452279|NCT01763866|62826779|FG006|Overall Study|Lost to Follow-up|1|||
33452280|NCT01763866|62826780|FG007|Overall Study|Lost to Follow-up|0|||
33452281|NCT01763866|62826781|FG008|Overall Study|Lost to Follow-up|0|||
33452282|NCT01763866|62826782|FG009|Overall Study|Lost to Follow-up|0|||
33452283|NCT01763866|62826783|FG010|Overall Study|Lost to Follow-up|0|||
33452284|NCT01763866|62826784|FG011|Overall Study|Lost to Follow-up|0|||
33452285|NCT01763866|62826785|FG012|Overall Study|Lost to Follow-up|1|||
33452286|NCT01763866|62826786|FG013|Overall Study|Lost to Follow-up|0|||
33452287|NCT01763866|62826787|FG014|Overall Study|Lost to Follow-up|1|||
33452288|NCT01763866|62826788|FG015|Overall Study|Lost to Follow-up|0|||
33452289|NCT01763866|62826789|FG016|Overall Study|Lost to Follow-up|0|||
33452290|NCT01763866|62826790|FG017|Overall Study|Lost to Follow-up|0|||
33452291|NCT01763866|62826791|FG018|Overall Study|Lost to Follow-up|1|||
33452292|NCT01763866|62826792|FG019|Overall Study|Lost to Follow-up|1|||
33452293|NCT01763866|62826793|FG020|Overall Study|Lost to Follow-up|0|||
33452294|NCT01763866|62826794|FG021|Overall Study|Lost to Follow-up|0|||
33452295|NCT01763866|62826795|FG022|Overall Study|Lost to Follow-up|0|||
33452296|NCT01763866|62826796|FG023|Overall Study|Lost to Follow-up|1|||
33511395|NCT03573323|62895300|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
33511396|NCT03573323|62895301|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
33511397|NCT03573323|62895300|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
33511398|NCT03573323|62895301|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
33613894|NCT02123797|63014693|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
33613895|NCT02123797|63014694|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
33452297|NCT01763866|62826773|FG000|Overall Study|Death|0|||
33452298|NCT01763866|62826774|FG001|Overall Study|Death|0|||
33452299|NCT01763866|62826775|FG002|Overall Study|Death|0|||
33452300|NCT01763866|62826776|FG003|Overall Study|Death|0|||
33452301|NCT01763866|62826777|FG004|Overall Study|Death|0|||
33452302|NCT01763866|62826778|FG005|Overall Study|Death|0|||
33452303|NCT01763866|62826779|FG006|Overall Study|Death|0|||
33511399|NCT03573323|62895300|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
33511400|NCT03573323|62895301|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
33511401|NCT03573323|62895300|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
33511402|NCT03573323|62895301|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
33511403|NCT03573323|62895300|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
33511404|NCT03573323|62895301|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
33511405|NCT03573323|62895300|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
33511406|NCT03573323|62895301|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
33511407|NCT03573323|62895300|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
33511408|NCT03573323|62895301|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
33511409|NCT03573323|62895300|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
33511410|NCT03573323|62895301|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
33613896|NCT02123797|63014690|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
33613897|NCT02123797|63014691|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
33613898|NCT02123797|63014692|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
33613899|NCT02123797|63014693|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
33452304|NCT01763866|62826780|FG007|Overall Study|Death|0|||
33452305|NCT01763866|62826781|FG008|Overall Study|Death|0|||
33511411|NCT03573323|62895300|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
33511412|NCT03573323|62895301|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
33511413|NCT03573323|62895300|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
33511414|NCT03573323|62895301|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
33511415|NCT03573323|62895300|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
33511416|NCT03573323|62895301|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
33511417|NCT03573323|62895300|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
33511418|NCT03573323|62895301|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
33511419|NCT03573323|62895300|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
33511420|NCT03573323|62895301|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
33511421|NCT03573323|62895300|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
33511422|NCT03573323|62895301|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
33511423|NCT03573323|62895300|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
33511424|NCT03573323|62895301|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
33511425|NCT03573323|62895300|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
33511426|NCT03573323|62895301|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
33511427|NCT03573323|62895300|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
33511428|NCT03573323|62895301|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
33511429|NCT03306043|62895327|FG000|Overall Study|Adverse Event|1|||
33511430|NCT03306043|62895327|FG000|Overall Study|Lost to Follow-up|1|||
33511431|NCT03306043|62895327|FG000|Overall Study|Withdrawal by Subject|2|||
33511432|NCT01069172|62895331|FG000|Overall Study|Withdrawal by Subject|1|||
33511433|NCT01069172|62895332|FG001|Overall Study|Withdrawal by Subject|0|||
33511434|NCT02911688|62895341|FG000|Washout|Lost to Follow-up|1|||
33511435|NCT02911688|62895342|FG001|Washout|Lost to Follow-up|1|||
33511436|NCT02911688|62895341|FG000|Washout|Withdrawal by Subject|0|||
33511437|NCT02911688|62895342|FG001|Washout|Withdrawal by Subject|1|||
33511438|NCT02670928|62895352|FG000|Overall Study|Adverse Event|3|||
33511439|NCT02670928|62895353|FG001|Overall Study|Adverse Event|1|||
33511440|NCT02670928|62895352|FG000|Overall Study|Withdrawal by Subject|4|||
33511441|NCT02670928|62895353|FG001|Overall Study|Withdrawal by Subject|0|||
33511442|NCT02670928|62895352|FG000|Overall Study|Lost to Follow-up|1|||
33613900|NCT02123797|63014694|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
33452306|NCT01763866|62826782|FG009|Overall Study|Death|0|||
33452307|NCT01763866|62826783|FG010|Overall Study|Death|0|||
33452308|NCT01763866|62826784|FG011|Overall Study|Death|0|||
33452309|NCT01763866|62826785|FG012|Overall Study|Death|0|||
33452310|NCT01763866|62826786|FG013|Overall Study|Death|0|||
33452311|NCT01763866|62826787|FG014|Overall Study|Death|0|||
33452312|NCT01763866|62826788|FG015|Overall Study|Death|0|||
33452313|NCT01763866|62826789|FG016|Overall Study|Death|1|||
33452314|NCT01763866|62826790|FG017|Overall Study|Death|0|||
33452315|NCT01763866|62826791|FG018|Overall Study|Death|0|||
33452316|NCT01763866|62826792|FG019|Overall Study|Death|0|||
33452317|NCT01763866|62826793|FG020|Overall Study|Death|0|||
33511443|NCT02670928|62895353|FG001|Overall Study|Lost to Follow-up|0|||
33511444|NCT02670928|62895352|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
33452318|NCT01763866|62826794|FG021|Overall Study|Death|0|||
33452319|NCT01763866|62826795|FG022|Overall Study|Death|0|||
33452320|NCT01763866|62826796|FG023|Overall Study|Death|0|||
33452321|NCT00132873|62826846|FG000|Overall Study|Adverse Event|3|||
33452322|NCT00132873|62826846|FG000|Overall Study|Lost to Follow-up|1|||
33452323|NCT00132873|62826846|FG000|Overall Study|Lack of Efficacy|1|||
33452324|NCT00132873|62826846|FG000|Overall Study|Withdrawal by Subject|3|||
33511445|NCT02670928|62895353|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
33511446|NCT03305809|62895363|FG000|Overall Study|Adverse Event|2|||
33511447|NCT03305809|62895364|FG001|Overall Study|Adverse Event|2|||
33511448|NCT03305809|62895365|FG002|Overall Study|Adverse Event|6|||
33511449|NCT03305809|62895366|FG003|Overall Study|Adverse Event|6|||
33511450|NCT03305809|62895363|FG000|Overall Study|Death|0|||
33511451|NCT03305809|62895364|FG001|Overall Study|Death|0|||
33511452|NCT03305809|62895365|FG002|Overall Study|Death|1|||
33511453|NCT03305809|62895366|FG003|Overall Study|Death|1|||
33511454|NCT03305809|62895363|FG000|Overall Study|Lost to Follow-up|1|||
33511455|NCT03305809|62895364|FG001|Overall Study|Lost to Follow-up|2|||
33511456|NCT03305809|62895365|FG002|Overall Study|Lost to Follow-up|0|||
33511457|NCT03305809|62895366|FG003|Overall Study|Lost to Follow-up|0|||
33511458|NCT03305809|62895363|FG000|Overall Study|Sponsor Decision|1|||
33511459|NCT03305809|62895364|FG001|Overall Study|Sponsor Decision|0|||
33511460|NCT03305809|62895365|FG002|Overall Study|Sponsor Decision|1|||
33511461|NCT03305809|62895366|FG003|Overall Study|Sponsor Decision|8|||
33511462|NCT03305809|62895363|FG000|Overall Study|Physician Decision|0|||
33511463|NCT03305809|62895364|FG001|Overall Study|Physician Decision|0|||
33511464|NCT03305809|62895365|FG002|Overall Study|Physician Decision|2|||
33511465|NCT03305809|62895366|FG003|Overall Study|Physician Decision|4|||
33511466|NCT03305809|62895363|FG000|Overall Study|Progressive Disease|0|||
33511467|NCT03305809|62895364|FG001|Overall Study|Progressive Disease|0|||
33511468|NCT03305809|62895365|FG002|Overall Study|Progressive Disease|1|||
33511469|NCT03305809|62895366|FG003|Overall Study|Progressive Disease|0|||
33511470|NCT03305809|62895363|FG000|Overall Study|Protocol Violation|1|||
33511471|NCT03305809|62895364|FG001|Overall Study|Protocol Violation|0|||
33511472|NCT03305809|62895365|FG002|Overall Study|Protocol Violation|2|||
33511473|NCT03305809|62895366|FG003|Overall Study|Protocol Violation|3|||
33511474|NCT03305809|62895363|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
33511475|NCT03305809|62895364|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
33511476|NCT03305809|62895365|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
33511477|NCT03305809|62895366|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
33511478|NCT03305809|62895363|FG000|Overall Study|Withdrawal by Subject|2|||
33452325|NCT00132873|62826846|FG000|Overall Study|Planned Pregnancy|1|||
33452326|NCT00120627|62826852|FG000|Overall Study|Withdrawal by Subject|5|||
33452327|NCT00120627|62826853|FG001|Overall Study|Withdrawal by Subject|5|||
33511479|NCT03305809|62895364|FG001|Overall Study|Withdrawal by Subject|4|||
33511480|NCT03305809|62895365|FG002|Overall Study|Withdrawal by Subject|5|||
33511481|NCT03305809|62895366|FG003|Overall Study|Withdrawal by Subject|2|||
33511482|NCT03305809|62895363|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
33511483|NCT03305809|62895364|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
33511484|NCT03305809|62895365|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
33511485|NCT03305809|62895366|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
33511486|NCT02994056|62895379|FG000|Overall Study|Death|8|||
33511487|NCT02994056|62895379|FG000|Overall Study|Withdrew Consent|1|||
33511488|NCT03548051|62895398|FG000|Overall Study|Death|1|||
33511489|NCT03548051|62895399|FG001|Overall Study|Death|1|||
33511490|NCT03548051|62895398|FG000|Overall Study|Withdrawal by Subject|1|||
33613901|NCT02123797|63014690|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
33452328|NCT03762616|62826868|FG000|Overall Study|Protocol Violation|2|||
33511491|NCT03548051|62895399|FG001|Overall Study|Withdrawal by Subject|0|||
33511492|NCT03305731|62895405|FG000|Overall Study|Protocol Violation|1|||
33511493|NCT03305575|62895411|FG000|Overall Study|Physician Decision|1|||
33511494|NCT03305575|62895412|FG001|Overall Study|Physician Decision|0|||
33511495|NCT02993822|62895422|FG000|Overall Study|Lack of Efficacy|1|||
33511496|NCT02993822|62895423|FG001|Overall Study|Lack of Efficacy|1|||
33511497|NCT02993822|62895424|FG002|Overall Study|Lack of Efficacy|0|||
33511498|NCT02993822|62895425|FG003|Overall Study|Lack of Efficacy|0|||
33511499|NCT02993822|62895422|FG000|Overall Study|Protocol Violation|1|||
33511500|NCT02993822|62895423|FG001|Overall Study|Protocol Violation|0|||
33511501|NCT02993822|62895424|FG002|Overall Study|Protocol Violation|0|||
33452329|NCT04246996|62826876|FG000|Overall Study|Physician Decision|1|||
33452330|NCT04246996|62826877|FG001|Overall Study|Physician Decision|1|||
33452331|NCT04246996|62826876|FG000|Overall Study|Did not meet eligibility criteria|1|||
33452332|NCT04246996|62826877|FG001|Overall Study|Did not meet eligibility criteria|4|||
33452333|NCT00424463|62826886|FG000|Overall Study|Adverse Event|2|||
33511502|NCT02993822|62895425|FG003|Overall Study|Protocol Violation|0|||
33452334|NCT00424463|62826887|FG001|Overall Study|Adverse Event|3|||
33511503|NCT02993822|62895422|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
33511504|NCT02993822|62895423|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
33452335|NCT00424463|62826888|FG002|Overall Study|Adverse Event|2|||
33511505|NCT02993822|62895424|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
33511506|NCT02993822|62895425|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
33511507|NCT02993822|62895422|FG000|Overall Study|Adverse Event|3|||
33511508|NCT02993822|62895423|FG001|Overall Study|Adverse Event|1|||
33511509|NCT02993822|62895424|FG002|Overall Study|Adverse Event|7|||
33511510|NCT02993822|62895425|FG003|Overall Study|Adverse Event|0|||
33511511|NCT02993822|62895422|FG000|Overall Study|Withdrawal by Subject|4|||
33511512|NCT02993822|62895423|FG001|Overall Study|Withdrawal by Subject|2|||
33511513|NCT02993822|62895424|FG002|Overall Study|Withdrawal by Subject|2|||
33613902|NCT02123797|63014691|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
33613903|NCT02123797|63014692|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
33613904|NCT02123797|63014693|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
33613905|NCT02123797|63014694|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
33613906|NCT02123797|63014690|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
33613907|NCT02123797|63014691|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
33613908|NCT02123797|63014692|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
33613909|NCT02123797|63014693|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
33613910|NCT02123797|63014694|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
33613911|NCT02123797|63014690|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
33613912|NCT02123797|63014691|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
33613913|NCT02123797|63014692|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
33511514|NCT02993822|62895425|FG003|Overall Study|Withdrawal by Subject|3|||
33511515|NCT02993822|62895422|FG000|Overall Study|Lost to Follow-up|1|||
33511516|NCT02993822|62895423|FG001|Overall Study|Lost to Follow-up|0|||
33511517|NCT02993822|62895424|FG002|Overall Study|Lost to Follow-up|1|||
33511518|NCT02993822|62895425|FG003|Overall Study|Lost to Follow-up|0|||
33511519|NCT01068860|62895445|FG000|Overall Study|Withdrawal by Subject|0|||
33511520|NCT01068860|62895446|FG001|Overall Study|Withdrawal by Subject|0|||
33511521|NCT01068860|62895447|FG002|Overall Study|Withdrawal by Subject|0|||
33511522|NCT01068860|62895448|FG003|Overall Study|Withdrawal by Subject|0|||
33511523|NCT01068860|62895449|FG004|Overall Study|Withdrawal by Subject|0|||
33511524|NCT01068860|62895450|FG005|Overall Study|Withdrawal by Subject|2|||
33511525|NCT01068860|62895451|FG006|Overall Study|Withdrawal by Subject|0|||
33511526|NCT01068860|62895452|FG007|Overall Study|Withdrawal by Subject|0|||
33511527|NCT01068860|62895453|FG008|Overall Study|Withdrawal by Subject|0|||
33511528|NCT01068860|62895454|FG009|Overall Study|Withdrawal by Subject|3|||
33511529|NCT01068860|62895445|FG000|Overall Study|Administrative problems; misrandomized|0|||
33511530|NCT01068860|62895446|FG001|Overall Study|Administrative problems; misrandomized|0|||
33511531|NCT01068860|62895447|FG002|Overall Study|Administrative problems; misrandomized|0|||
33511532|NCT01068860|62895448|FG003|Overall Study|Administrative problems; misrandomized|1|||
33511533|NCT01068860|62895449|FG004|Overall Study|Administrative problems; misrandomized|0|||
33511534|NCT01068860|62895450|FG005|Overall Study|Administrative problems; misrandomized|0|||
33511535|NCT01068860|62895451|FG006|Overall Study|Administrative problems; misrandomized|0|||
33511536|NCT01068860|62895452|FG007|Overall Study|Administrative problems; misrandomized|0|||
33511537|NCT01068860|62895453|FG008|Overall Study|Administrative problems; misrandomized|0|||
33511538|NCT01068860|62895454|FG009|Overall Study|Administrative problems; misrandomized|1|||
33511539|NCT01068860|62895445|FG000|Overall Study|Lost to Follow-up|0|||
33511540|NCT01068860|62895446|FG001|Overall Study|Lost to Follow-up|1|||
33511541|NCT01068860|62895447|FG002|Overall Study|Lost to Follow-up|0|||
33511542|NCT01068860|62895448|FG003|Overall Study|Lost to Follow-up|0|||
33511543|NCT01068860|62895449|FG004|Overall Study|Lost to Follow-up|0|||
33511544|NCT01068860|62895450|FG005|Overall Study|Lost to Follow-up|0|||
33511545|NCT01068860|62895451|FG006|Overall Study|Lost to Follow-up|0|||
33511546|NCT01068860|62895452|FG007|Overall Study|Lost to Follow-up|0|||
33511547|NCT01068860|62895453|FG008|Overall Study|Lost to Follow-up|0|||
33511548|NCT01068860|62895454|FG009|Overall Study|Lost to Follow-up|0|||
33511549|NCT02989610|62895476|FG000|Overall Study|Withdrawal/Other reasons|39|||
33511550|NCT01372774|62895482|FG000|Overall Study|Withdrawal prior to treatment|4|||
33511551|NCT01372774|62895483|FG001|Overall Study|Withdrawal prior to treatment|5|||
33511552|NCT02670538|62895494|FG000|Overall Study|Withdrawal of Consent|8|||
33511553|NCT02670538|62895495|FG001|Overall Study|Withdrawal of Consent|6|||
33511554|NCT02670538|62895496|FG002|Overall Study|Withdrawal of Consent|5|||
33511555|NCT02670538|62895494|FG000|Overall Study|Lost to Follow-up|8|||
33511556|NCT02670538|62895495|FG001|Overall Study|Lost to Follow-up|12|||
33511557|NCT02670538|62895496|FG002|Overall Study|Lost to Follow-up|7|||
33511558|NCT02670538|62895494|FG000|Overall Study|Adverse Event|5|||
33511559|NCT02670538|62895495|FG001|Overall Study|Adverse Event|5|||
33511560|NCT02670538|62895496|FG002|Overall Study|Adverse Event|11|||
33613914|NCT02123797|63014693|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
33613915|NCT02123797|63014694|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
33613916|NCT02175121|63014719|FG000|Overall Study|Lack of Efficacy|1|||
33613917|NCT02175121|63014720|FG001|Overall Study|Lack of Efficacy|0|||
33613918|NCT02175121|63014721|FG002|Overall Study|Lack of Efficacy|0|||
33613919|NCT02175121|63014722|FG003|Overall Study|Lack of Efficacy|0|||
33613920|NCT02175121|63014723|FG004|Overall Study|Lack of Efficacy|0|||
33613921|NCT02175121|63014719|FG000|Overall Study|Lost to Follow-up|0|||
33613922|NCT02175121|63014720|FG001|Overall Study|Lost to Follow-up|1|||
33613923|NCT02175121|63014721|FG002|Overall Study|Lost to Follow-up|0|||
33613924|NCT02175121|63014722|FG003|Overall Study|Lost to Follow-up|1|||
33613925|NCT02175121|63014723|FG004|Overall Study|Lost to Follow-up|0|||
33613926|NCT02175121|63014719|FG000|Overall Study|Personal emergency|0|||
33613927|NCT02175121|63014720|FG001|Overall Study|Personal emergency|0|||
33613928|NCT02175121|63014721|FG002|Overall Study|Personal emergency|0|||
33613929|NCT02175121|63014722|FG003|Overall Study|Personal emergency|0|||
33613930|NCT02175121|63014723|FG004|Overall Study|Personal emergency|1|||
33613931|NCT02175121|63014719|FG000|Overall Study|Schedule conflict|0|||
33613932|NCT02175121|63014720|FG001|Overall Study|Schedule conflict|0|||
33613933|NCT02175121|63014721|FG002|Overall Study|Schedule conflict|1|||
33613934|NCT02175121|63014722|FG003|Overall Study|Schedule conflict|0|||
33613935|NCT02175121|63014723|FG004|Overall Study|Schedule conflict|0|||
33613936|NCT02175121|63014719|FG000|Overall Study|Time issues|0|||
33613937|NCT02175121|63014720|FG001|Overall Study|Time issues|0|||
33613938|NCT02175121|63014721|FG002|Overall Study|Time issues|1|||
33613939|NCT02175121|63014722|FG003|Overall Study|Time issues|0|||
33511561|NCT02670538|62895494|FG000|Overall Study|Lack of Efficacy|7|||
33511562|NCT02670538|62895495|FG001|Overall Study|Lack of Efficacy|1|||
33511563|NCT02670538|62895496|FG002|Overall Study|Lack of Efficacy|2|||
33511564|NCT02670538|62895494|FG000|Overall Study|Protocol Violation|3|||
33511565|NCT02670538|62895495|FG001|Overall Study|Protocol Violation|4|||
33511566|NCT02670538|62895496|FG002|Overall Study|Protocol Violation|1|||
33511567|NCT02670538|62895494|FG000|Overall Study|Noncompliance with Study Drug|1|||
33511568|NCT02670538|62895495|FG001|Overall Study|Noncompliance with Study Drug|3|||
33511569|NCT02670538|62895496|FG002|Overall Study|Noncompliance with Study Drug|2|||
33511570|NCT02670538|62895494|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33511571|NCT02670538|62895495|FG001|Overall Study|Other Miscellaneous Reasons|1|||
33511572|NCT02670538|62895496|FG002|Overall Study|Other Miscellaneous Reasons|2|||
33511573|NCT03547583|62895507|FG000|Overall Study|Adverse Event|16|||
33511574|NCT03547583|62895508|FG001|Overall Study|Adverse Event|11|||
33511575|NCT03547583|62895509|FG002|Overall Study|Adverse Event|10|||
33613940|NCT02175121|63014723|FG004|Overall Study|Time issues|0|||
33613941|NCT01568866|63014741|FG000|Overall Study|Disease Progression|208|||
33613942|NCT01568866|63014742|FG001|Overall Study|Disease Progression|183|||
33511576|NCT03547583|62895507|FG000|Overall Study|Death|11|||
33511577|NCT03547583|62895508|FG001|Overall Study|Death|7|||
33511578|NCT03547583|62895509|FG002|Overall Study|Death|4|||
33511579|NCT03547583|62895507|FG000|Overall Study|Lost to Follow-up|1|||
33511580|NCT03547583|62895508|FG001|Overall Study|Lost to Follow-up|0|||
33511581|NCT03547583|62895509|FG002|Overall Study|Lost to Follow-up|0|||
33511582|NCT03547583|62895507|FG000|Overall Study|Non-compliance with study drug|0|||
33511583|NCT03547583|62895508|FG001|Overall Study|Non-compliance with study drug|0|||
33511584|NCT03547583|62895509|FG002|Overall Study|Non-compliance with study drug|1|||
33511585|NCT03547583|62895507|FG000|Overall Study|Physician Decision|1|||
33511586|NCT03547583|62895508|FG001|Overall Study|Physician Decision|0|||
33511587|NCT03547583|62895509|FG002|Overall Study|Physician Decision|3|||
33511588|NCT03547583|62895507|FG000|Overall Study|Protocol Violation|2|||
33511589|NCT03547583|62895508|FG001|Overall Study|Protocol Violation|1|||
33511590|NCT03547583|62895509|FG002|Overall Study|Protocol Violation|1|||
33613943|NCT01568866|63014741|FG000|Overall Study|Adverse Event|94|||
33613944|NCT01568866|63014742|FG001|Overall Study|Adverse Event|96|||
33613945|NCT01568866|63014741|FG000|Overall Study|Patient Request|55|||
33613946|NCT01568866|63014742|FG001|Overall Study|Patient Request|71|||
33613947|NCT01568866|63014741|FG000|Overall Study|Physician Decision|40|||
33613948|NCT01568866|63014742|FG001|Overall Study|Physician Decision|32|||
33613949|NCT01568866|63014741|FG000|Overall Study|Withdrawal by Subject|19|||
33613950|NCT01568866|63014742|FG001|Overall Study|Withdrawal by Subject|11|||
33511591|NCT03547583|62895507|FG000|Overall Study|Withdrawal by Subject|12|||
33511592|NCT03547583|62895508|FG001|Overall Study|Withdrawal by Subject|19|||
33511593|NCT03547583|62895509|FG002|Overall Study|Withdrawal by Subject|10|||
33511594|NCT03547583|62895507|FG000|Overall Study|Other|2|||
33511595|NCT03547583|62895508|FG001|Overall Study|Other|2|||
33511596|NCT03547583|62895509|FG002|Overall Study|Other|3|||
33511597|NCT02670382|62895520|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
33511598|NCT02670382|62895521|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
33511599|NCT02991482|62895531|FG000|Overall Study|Disease progression|56|||
33511600|NCT02991482|62895532|FG001|Overall Study|Disease progression|47|||
33511601|NCT02991482|62895531|FG000|Overall Study|Death|4|||
33511602|NCT02991482|62895532|FG001|Overall Study|Death|4|||
33511603|NCT02991482|62895531|FG000|Overall Study|Adverse Event|1|||
33511604|NCT02991482|62895532|FG001|Overall Study|Adverse Event|6|||
33511605|NCT02991482|62895531|FG000|Overall Study|Patient decision|1|||
33511606|NCT02991482|62895532|FG001|Overall Study|Patient decision|1|||
33613951|NCT01568866|63014741|FG000|Overall Study|Death|10|||
33613952|NCT01568866|63014742|FG001|Overall Study|Death|18|||
33613953|NCT01568866|63014741|FG000|Overall Study|Protocol Non-compliance|2|||
33613954|NCT01568866|63014742|FG001|Overall Study|Protocol Non-compliance|4|||
33613955|NCT01568866|63014741|FG000|Overall Study|Lost to Follow-up|1|||
33613956|NCT01568866|63014742|FG001|Overall Study|Lost to Follow-up|0|||
33613957|NCT01568866|63014741|FG000|Overall Study|Randomized but Not Dosed|9|||
33613958|NCT01568866|63014742|FG001|Overall Study|Randomized but Not Dosed|1|||
33613959|NCT01568320|63014748|FG000|Overall Study|Death|20|||
33613960|NCT01568320|63014748|FG000|Overall Study|Lost to Follow-up|9|||
33613961|NCT01568320|63014748|FG000|Overall Study|Withdrawal by Subject|10|||
33613962|NCT01568320|63014748|FG000|Overall Study|Conversion to open repair|1|||
33613963|NCT01568320|63014748|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
33613964|NCT01567852|63014754|FG000|Overall Study|Withdrawal by Subject|3|||
33613965|NCT01567852|63014755|FG001|Overall Study|Withdrawal by Subject|6|||
33613966|NCT01567852|63014754|FG000|Overall Study|ECT discontinued|1|||
33613967|NCT01567852|63014755|FG001|Overall Study|ECT discontinued|1|||
33613968|NCT01588366|63014766|FG000|Overall Study|Adverse Event|0|||
33613969|NCT01588366|63014767|FG001|Overall Study|Adverse Event|1|||
33613970|NCT01588366|63014768|FG002|Overall Study|Adverse Event|0|||
33613971|NCT01588366|63014769|FG003|Overall Study|Adverse Event|1|||
33613972|NCT01588366|63014770|FG004|Overall Study|Adverse Event|0|||
33511607|NCT02991482|62895531|FG000|Overall Study|Physician Decision|0|||
33511608|NCT02991482|62895532|FG001|Overall Study|Physician Decision|6|||
33511609|NCT02991482|62895531|FG000|Overall Study|Clinical deterioration|1|||
33511610|NCT02991482|62895532|FG001|Overall Study|Clinical deterioration|0|||
33511611|NCT02991482|62895531|FG000|Overall Study|Patient feeling too unwell|1|||
33511612|NCT02991482|62895532|FG001|Overall Study|Patient feeling too unwell|0|||
33511613|NCT02991482|62895531|FG000|Overall Study|Worsening of performance status|0|||
33511614|NCT02991482|62895532|FG001|Overall Study|Worsening of performance status|1|||
33511615|NCT02991482|62895531|FG000|Overall Study|Death prior to study drug initiation|1|||
33511616|NCT02991482|62895532|FG001|Overall Study|Death prior to study drug initiation|0|||
33511617|NCT02991482|62895531|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
33511618|NCT02991482|62895532|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
33511619|NCT02674750|62895541|FG000|Overall Study|Death|4|||
33511620|NCT02674750|62895542|FG001|Overall Study|Death|5|||
33511621|NCT02674750|62895543|FG002|Overall Study|Death|8|||
33511622|NCT02674750|62895541|FG000|Overall Study|Lost to Follow-up|0|||
33511623|NCT02674750|62895542|FG001|Overall Study|Lost to Follow-up|8|||
33511624|NCT02674750|62895543|FG002|Overall Study|Lost to Follow-up|0|||
33511625|NCT02674750|62895541|FG000|Overall Study|Lack of Efficacy|1|||
33511626|NCT02674750|62895542|FG001|Overall Study|Lack of Efficacy|17|||
33613973|NCT01588366|63014771|FG005|Overall Study|Adverse Event|2|||
33511627|NCT02674750|62895543|FG002|Overall Study|Lack of Efficacy|3|||
33511628|NCT02674750|62895541|FG000|Overall Study|Withdrawal by Subject|0|||
33511629|NCT02674750|62895542|FG001|Overall Study|Withdrawal by Subject|7|||
33511630|NCT02674750|62895543|FG002|Overall Study|Withdrawal by Subject|1|||
33511631|NCT02674750|62895541|FG000|Overall Study|Other|0|||
33511632|NCT02674750|62895542|FG001|Overall Study|Other|8|||
33511633|NCT02674750|62895543|FG002|Overall Study|Other|0|||
33511634|NCT02987972|62895572|FG000|Overall Study|Adverse Event|1|||
33511635|NCT02987972|62895573|FG001|Overall Study|Adverse Event|1|||
33511636|NCT02987972|62895574|FG002|Overall Study|Adverse Event|0|||
33613974|NCT01686958|63014787|FG000|Overall Study|Withdrawal by Subject|1|||
33613975|NCT01686568|63014794|FG000|Main Study|Withdrawal by Subject|1|||
33613976|NCT01686568|63014795|FG001|Main Study|Withdrawal by Subject|3|||
33613977|NCT01686568|63014794|FG000|Main Study|Noncompliance with protocol|0|||
33613978|NCT01686568|63014795|FG001|Main Study|Noncompliance with protocol|1|||
33613979|NCT01686568|63014794|FG000|Main Study|Liver enzymes above range of exclusion|1|||
33511637|NCT02987972|62895572|FG000|Overall Study|Death|1|||
33511638|NCT02987972|62895573|FG001|Overall Study|Death|0|||
33511639|NCT02987972|62895574|FG002|Overall Study|Death|0|||
33511640|NCT02987972|62895572|FG000|Overall Study|Lack of Efficacy|9|||
33511641|NCT02987972|62895573|FG001|Overall Study|Lack of Efficacy|12|||
33511642|NCT02987972|62895574|FG002|Overall Study|Lack of Efficacy|12|||
33511643|NCT02987972|62895572|FG000|Overall Study|Lost to Follow-up|7|||
33511644|NCT02987972|62895573|FG001|Overall Study|Lost to Follow-up|8|||
33511645|NCT02987972|62895574|FG002|Overall Study|Lost to Follow-up|4|||
33511646|NCT02987972|62895572|FG000|Overall Study|Physician Decision|1|||
33511647|NCT02987972|62895573|FG001|Overall Study|Physician Decision|6|||
33511648|NCT02987972|62895574|FG002|Overall Study|Physician Decision|0|||
33511649|NCT02987972|62895572|FG000|Overall Study|Protocol Violation|2|||
33511650|NCT02987972|62895573|FG001|Overall Study|Protocol Violation|1|||
33511651|NCT02987972|62895574|FG002|Overall Study|Protocol Violation|5|||
33511652|NCT02987972|62895572|FG000|Overall Study|Withdrawal by Subject|22|||
33511653|NCT02987972|62895573|FG001|Overall Study|Withdrawal by Subject|17|||
33511654|NCT02987972|62895574|FG002|Overall Study|Withdrawal by Subject|21|||
33511655|NCT03305419|62895590|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
33511656|NCT03305419|62895591|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
33511657|NCT03305419|62895592|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
33511658|NCT03305419|62895593|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
33511659|NCT03305419|62895594|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
33511660|NCT03305419|62895595|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
33511661|NCT03305419|62895596|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
33511662|NCT03305419|62895597|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
33511663|NCT03305419|62895590|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
33511664|NCT03305419|62895591|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
33511665|NCT03305419|62895592|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
33511666|NCT03305419|62895593|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
33511667|NCT03305419|62895594|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
33511668|NCT03305419|62895595|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
33452336|NCT00424463|62826886|FG000|Overall Study|Physician Decision|0|||
33452337|NCT00424463|62826887|FG001|Overall Study|Physician Decision|2|||
33452338|NCT00424463|62826888|FG002|Overall Study|Physician Decision|2|||
33452339|NCT00424463|62826886|FG000|Overall Study|Withdrawal by Subject|4|||
33452340|NCT00424463|62826887|FG001|Overall Study|Withdrawal by Subject|2|||
33452341|NCT00424463|62826888|FG002|Overall Study|Withdrawal by Subject|5|||
33452342|NCT00424463|62826886|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
33452343|NCT00424463|62826887|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
33452344|NCT00424463|62826888|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
33452345|NCT00424463|62826886|FG000|Overall Study|Patient's convenience|0|||
33452346|NCT00424463|62826887|FG001|Overall Study|Patient's convenience|0|||
33452347|NCT00424463|62826888|FG002|Overall Study|Patient's convenience|1|||
33452348|NCT00424385|62826896|FG000|Cohort 0|Withdrawal by Subject|5|||
33452349|NCT00424385|62826896|FG000|Cohort 0|Physician Decision|1|||
33452350|NCT00424385|62826896|FG000|Cohort 1|Withdrawal by Subject|1|||
33452351|NCT00423917|62826902|FG000|Overall Study|Cancel|2|||
33452352|NCT00423917|62826902|FG000|Overall Study|Ineligible|1|||
33452353|NCT00845026|62826908|FG000|Study Period III|Adverse Event|23|||
33452354|NCT00845026|62826909|FG001|Study Period III|Adverse Event|19|||
33452355|NCT00845026|62826908|FG000|Study Period III|Perceived lack of efficacy|27|||
33452356|NCT00845026|62826909|FG001|Study Period III|Perceived lack of efficacy|15|||
33452357|NCT00845026|62826908|FG000|Study Period III|Withdrawal by Subject|19|||
33452358|NCT00845026|62826909|FG001|Study Period III|Withdrawal by Subject|15|||
33452359|NCT00845026|62826908|FG000|Study Period III|Entry Criteria not met|8|||
33511669|NCT03305419|62895596|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
33452360|NCT00845026|62826909|FG001|Study Period III|Entry Criteria not met|11|||
33452361|NCT00845026|62826908|FG000|Study Period III|Lost to Follow-up|4|||
33452362|NCT00845026|62826909|FG001|Study Period III|Lost to Follow-up|5|||
33452363|NCT00845026|62826908|FG000|Study Period III|Protocol Violation|8|||
33452364|NCT00845026|62826909|FG001|Study Period III|Protocol Violation|1|||
33511670|NCT03305419|62895597|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
33511671|NCT03305419|62895590|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
33511672|NCT03305419|62895591|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
33511673|NCT03305419|62895592|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
33324445|NCT01167257|62700880|FG001|Overall Study|Withdrew consent|1|||
33511674|NCT03305419|62895593|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
33511675|NCT03305419|62895594|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
33511676|NCT03305419|62895595|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
33511677|NCT03305419|62895596|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
33511678|NCT03305419|62895597|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
33511679|NCT03305419|62895590|FG000|Part B (14 Days)|Adverse Event|0|||
33511680|NCT03305419|62895591|FG001|Part B (14 Days)|Adverse Event|0|||
33511681|NCT03305419|62895592|FG002|Part B (14 Days)|Adverse Event|0|||
33511682|NCT03305419|62895593|FG003|Part B (14 Days)|Adverse Event|0|||
33511683|NCT03305419|62895594|FG004|Part B (14 Days)|Adverse Event|1|||
33511684|NCT03305419|62895595|FG005|Part B (14 Days)|Adverse Event|2|||
33511685|NCT03305419|62895596|FG006|Part B (14 Days)|Adverse Event|4|||
33511686|NCT03305419|62895597|FG007|Part B (14 Days)|Adverse Event|0|||
33511687|NCT03305419|62895590|FG000|Part B (14 Days)|Physician Decision|0|||
33511688|NCT03305419|62895591|FG001|Part B (14 Days)|Physician Decision|0|||
33511689|NCT03305419|62895592|FG002|Part B (14 Days)|Physician Decision|0|||
33511690|NCT03305419|62895593|FG003|Part B (14 Days)|Physician Decision|0|||
33511691|NCT03305419|62895594|FG004|Part B (14 Days)|Physician Decision|2|||
33511692|NCT03305419|62895595|FG005|Part B (14 Days)|Physician Decision|8|||
33511693|NCT03305419|62895596|FG006|Part B (14 Days)|Physician Decision|1|||
33511694|NCT03305419|62895597|FG007|Part B (14 Days)|Physician Decision|0|||
33511695|NCT01372618|62895620|FG000|Overall Study|PI Died. Study Terminated|9|||
33511696|NCT03304873|62895626|FG000|Overall Study|Lost to Follow-up|1|||
33511697|NCT03304873|62895627|FG001|Overall Study|Lost to Follow-up|8|||
33613980|NCT01686568|63014795|FG001|Main Study|Liver enzymes above range of exclusion|0|||
33452365|NCT00845026|62826908|FG000|Study Period III|Scheduled conflict|3|||
33452366|NCT00845026|62826909|FG001|Study Period III|Scheduled conflict|1|||
33452367|NCT00845026|62826908|FG000|Study Period III|Subject is moving or has moved|2|||
33511698|NCT02669758|62895633|FG000|Overall Study|Withdrawal by Subject|43|||
33511699|NCT02669758|62895633|FG000|Overall Study|Lost to Follow-up|19|||
33511700|NCT02669758|62895633|FG000|Overall Study|Adverse Event|16|||
33511701|NCT02669758|62895633|FG000|Overall Study|Non-Compliance with Study Drug|8|||
33511702|NCT02669758|62895633|FG000|Overall Study|Lack of Efficacy|5|||
33511703|NCT02669758|62895633|FG000|Overall Study|Pregnancy|1|||
33511704|NCT02669758|62895633|FG000|Overall Study|Study noncompliance|1|||
33511705|NCT02669758|62895633|FG000|Overall Study|Protocol Violation|1|||
33511706|NCT02987660|62895639|FG000|Overall Study|Study terminated by sponsor|10|||
33511707|NCT02987660|62895640|FG001|Overall Study|Study terminated by sponsor|10|||
33511708|NCT04528069|62895646|FG000|Overall Study|Adverse Event|1|||
33511709|NCT04528069|62895646|FG000|Overall Study|Lost to Follow-up|1|||
33511710|NCT04528069|62895646|FG000|Overall Study|Patient Unable to Come|1|||
33511711|NCT04528069|62895646|FG000|Overall Study|Patient Unable to Attend|1|||
33511712|NCT03303469|62895662|FG000|Overall Study|Lost to Follow-up|2|||
33511713|NCT02990000|62895668|FG000|Overall Study|Failed to provide data beyond baseline|36|||
33511714|NCT02990000|62895669|FG001|Overall Study|Failed to provide data beyond baseline|34|||
33511715|NCT01068626|62895677|FG000|Overall Study|Adverse Event|3|||
33511716|NCT01068626|62895678|FG001|Overall Study|Adverse Event|0|||
33511717|NCT01068626|62895677|FG000|Overall Study|Withdrawal by Subject|0|||
33324446|NCT01119846|62700893|FG000|Overall Study|Adverse Event|1|||
33452368|NCT00845026|62826909|FG001|Study Period III|Subject is moving or has moved|4|||
33452369|NCT00845026|62826908|FG000|Study Period III|Transportation issues|1|||
33452370|NCT00845026|62826909|FG001|Study Period III|Transportation issues|1|||
33452371|NCT00845026|62826908|FG000|Study Period IV|Adverse Event|4|||
33452372|NCT00845026|62826909|FG001|Study Period IV|Adverse Event|0|||
33452373|NCT00845026|62826908|FG000|Study Period IV|Perceived lack of efficacy|2|||
33452374|NCT00845026|62826909|FG001|Study Period IV|Perceived lack of efficacy|1|||
33452375|NCT00845026|62826908|FG000|Study Period IV|Protocol Violation|3|||
33452376|NCT00845026|62826909|FG001|Study Period IV|Protocol Violation|1|||
33452377|NCT00845026|62826908|FG000|Study Period IV|Lost to Follow-up|1|||
33452378|NCT00845026|62826909|FG001|Study Period IV|Lost to Follow-up|0|||
33452379|NCT00845026|62826908|FG000|Study Period IV|Withdrawal by Subject|4|||
33452380|NCT00845026|62826909|FG001|Study Period IV|Withdrawal by Subject|1|||
33452381|NCT00845026|62826908|FG000|Study Period IV|Entry Criteria Not Met|1|||
33452382|NCT00845026|62826909|FG001|Study Period IV|Entry Criteria Not Met|0|||
33452383|NCT00845026|62826908|FG000|Study Period IV|Subject is moving or has moved|0|||
33452384|NCT00845026|62826909|FG001|Study Period IV|Subject is moving or has moved|1|||
33452385|NCT00845026|62826908|FG000|Study Period IV|Scheduling conflict|1|||
33511718|NCT01068626|62895678|FG001|Overall Study|Withdrawal by Subject|2|||
33511719|NCT02921750|62895686|FG000|Overall Study|Adverse Event|1|||
33511720|NCT02921750|62895687|FG001|Overall Study|Adverse Event|2|||
33511721|NCT02921750|62895686|FG000|Overall Study|Withdrawal by Subject|1|||
33511722|NCT02921750|62895687|FG001|Overall Study|Withdrawal by Subject|1|||
33511723|NCT02921750|62895686|FG000|Overall Study|Lost to Follow-up|3|||
33511724|NCT02921750|62895687|FG001|Overall Study|Lost to Follow-up|3|||
33511725|NCT02921750|62895686|FG000|Overall Study|Wound healed|3|||
33613981|NCT01686568|63014794|FG000|Sub-Study|Not consented for sub-study|2|||
33511726|NCT02921750|62895687|FG001|Overall Study|Wound healed|3|||
33511727|NCT02921750|62895686|FG000|Overall Study|Serious Adverse Event|1|||
33511728|NCT02921750|62895687|FG001|Overall Study|Serious Adverse Event|2|||
33511729|NCT02920970|62895696|FG000|First Intervention|Protocol Violation|0|||
33511730|NCT02920970|62895697|FG001|First Intervention|Protocol Violation|1|||
33511731|NCT02920970|62895696|FG000|First Intervention|Adverse Event|0|||
33511732|NCT02920970|62895697|FG001|First Intervention|Adverse Event|1|||
33511733|NCT02920970|62895696|FG000|Second Intervention|Poor Lens Fit|1|||
33511734|NCT02920970|62895697|FG001|Second Intervention|Poor Lens Fit|0|||
33511735|NCT01068158|62895707|FG000|Overall Study|Withdrawal by Subject|1|||
33511736|NCT01068158|62895708|FG001|Overall Study|Withdrawal by Subject|2|||
33511737|NCT01068158|62895707|FG000|Overall Study|Lost to Follow-up|7|||
33511738|NCT01068158|62895708|FG001|Overall Study|Lost to Follow-up|0|||
33511739|NCT01068158|62895707|FG000|Overall Study|Protocol Violation|0|||
33511740|NCT01068158|62895708|FG001|Overall Study|Protocol Violation|2|||
33511741|NCT03303079|62895717|FG000|Overall Study|Adverse Event|0|||
33511742|NCT03303079|62895718|FG001|Overall Study|Adverse Event|1|||
33613982|NCT01686568|63014795|FG001|Sub-Study|Not consented for sub-study|2|||
33613983|NCT01567462|63014803|FG000|Overall Study|Withdrawal by Subject|4|||
33613984|NCT01567462|63014804|FG001|Overall Study|Withdrawal by Subject|7|||
33613985|NCT01587898|63014814|FG000|Overall Study|Adverse Event|1|||
33452386|NCT00845026|62826909|FG001|Study Period IV|Scheduling conflict|0|||
33452387|NCT00691678|62826917|FG000|Overall Study|Adverse Event|5|||
33452388|NCT00691678|62826917|FG000|Overall Study|life events, pain|11|||
33452389|NCT00423605|62826921|FG000|Overall Study|Adverse Event|129|||
33452390|NCT00423605|62826921|FG000|Overall Study|Withdrawal by Subject|36|||
33452391|NCT00423605|62826921|FG000|Overall Study|Lost to Follow-up|15|||
33452392|NCT00423605|62826921|FG000|Overall Study|Lack of Efficacy|38|||
33452393|NCT00423605|62826921|FG000|Overall Study|Sponsor Decision|3|||
33452394|NCT00423605|62826921|FG000|Overall Study|Physician Decision|8|||
33452395|NCT00423605|62826921|FG000|Overall Study|Protocol Violation|7|||
33452396|NCT00423605|62826921|FG000|Overall Study|Not one of the pre-specified options|5|||
33452397|NCT00423449|62826925|FG000|Overall Study|Clinical Adverse Event|1|||
33452398|NCT00423449|62826926|FG001|Overall Study|Clinical Adverse Event|0|||
33452399|NCT00423449|62826927|FG002|Overall Study|Clinical Adverse Event|1|||
33452400|NCT00423449|62826928|FG003|Overall Study|Clinical Adverse Event|8|||
33452401|NCT00423449|62826929|FG004|Overall Study|Clinical Adverse Event|2|||
33452402|NCT00423449|62826925|FG000|Overall Study|Death|1|||
33452403|NCT00423449|62826926|FG001|Overall Study|Death|0|||
33452404|NCT00423449|62826927|FG002|Overall Study|Death|2|||
33452405|NCT00423449|62826928|FG003|Overall Study|Death|1|||
33452406|NCT00423449|62826929|FG004|Overall Study|Death|1|||
33452407|NCT00423449|62826925|FG000|Overall Study|Progressive Disease|1|||
33452408|NCT00423449|62826926|FG001|Overall Study|Progressive Disease|3|||
33452409|NCT00423449|62826927|FG002|Overall Study|Progressive Disease|8|||
33452410|NCT00423449|62826928|FG003|Overall Study|Progressive Disease|11|||
33452411|NCT00423449|62826929|FG004|Overall Study|Progressive Disease|4|||
33452412|NCT00423449|62826925|FG000|Overall Study|Laboratory Adverse Event|0|||
33452413|NCT00423449|62826926|FG001|Overall Study|Laboratory Adverse Event|1|||
33452414|NCT00423449|62826927|FG002|Overall Study|Laboratory Adverse Event|2|||
33452415|NCT00423449|62826928|FG003|Overall Study|Laboratory Adverse Event|0|||
33452416|NCT00423449|62826929|FG004|Overall Study|Laboratory Adverse Event|0|||
33452417|NCT00423449|62826925|FG000|Overall Study|Other|0|||
33452418|NCT00423449|62826926|FG001|Overall Study|Other|0|||
33452419|NCT00423449|62826927|FG002|Overall Study|Other|0|||
33452420|NCT00423449|62826928|FG003|Overall Study|Other|1|||
33452421|NCT00423449|62826929|FG004|Overall Study|Other|0|||
33452422|NCT00423449|62826925|FG000|Overall Study|Protocol Violation|0|||
33452423|NCT00423449|62826926|FG001|Overall Study|Protocol Violation|0|||
33452424|NCT00423449|62826927|FG002|Overall Study|Protocol Violation|2|||
33452425|NCT00423449|62826928|FG003|Overall Study|Protocol Violation|1|||
33452426|NCT00423449|62826929|FG004|Overall Study|Protocol Violation|0|||
33452427|NCT00423293|62826942|FG000|Overall Study|Ineligible / No protocol treatment|11|||
33324447|NCT01119846|62700894|FG001|Overall Study|Adverse Event|0|||
33452428|NCT00423137|62826950|FG000|Overall Study|Lost to Follow-up|0|||
33452429|NCT00423137|62826951|FG001|Overall Study|Lost to Follow-up|0|||
33452430|NCT00423137|62826952|FG002|Overall Study|Lost to Follow-up|1|||
33452431|NCT00423137|62826953|FG003|Overall Study|Lost to Follow-up|0|||
33452432|NCT00423137|62826950|FG000|Overall Study|Protocol Violation|0|||
33452433|NCT00423137|62826951|FG001|Overall Study|Protocol Violation|0|||
33452434|NCT00423137|62826952|FG002|Overall Study|Protocol Violation|0|||
33452435|NCT00423137|62826953|FG003|Overall Study|Protocol Violation|1|||
33452436|NCT00423137|62826950|FG000|Overall Study|Adverse Event Study disease worse|1|||
33511743|NCT03303079|62895719|FG002|Overall Study|Adverse Event|3|||
33511744|NCT03303079|62895717|FG000|Overall Study|Protocol Violation|5|||
33511745|NCT03303079|62895718|FG001|Overall Study|Protocol Violation|4|||
33511746|NCT03303079|62895719|FG002|Overall Study|Protocol Violation|7|||
33613986|NCT01587898|63014815|FG001|Overall Study|Adverse Event|1|||
33613987|NCT01587898|63014816|FG002|Overall Study|Adverse Event|0|||
33511747|NCT03303079|62895717|FG000|Overall Study|Withdrawal by Subject|2|||
33511748|NCT03303079|62895718|FG001|Overall Study|Withdrawal by Subject|4|||
33511749|NCT03303079|62895719|FG002|Overall Study|Withdrawal by Subject|2|||
33511750|NCT03303079|62895717|FG000|Overall Study|Other than specified|0|||
33511751|NCT03303079|62895718|FG001|Overall Study|Other than specified|2|||
33511752|NCT03303079|62895719|FG002|Overall Study|Other than specified|0|||
33511753|NCT01067846|62895729|FG000|Overall Study|Lost to Follow-up|17|||
33511754|NCT01067846|62895730|FG001|Overall Study|Lost to Follow-up|19|||
33511755|NCT01067846|62895729|FG000|Overall Study|Withdrawal by Subject|1|||
33511756|NCT01067846|62895730|FG001|Overall Study|Withdrawal by Subject|0|||
33511757|NCT01067846|62895729|FG000|Overall Study|participation in other tx study|1|||
33511758|NCT01067846|62895730|FG001|Overall Study|participation in other tx study|0|||
33511759|NCT03311659|62895736|FG000|Overall Study|Protocol Violation|1|||
33511760|NCT03874234|62895753|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33511761|NCT03874234|62895754|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33511762|NCT03874234|62895755|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33511763|NCT03874234|62895756|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
33511764|NCT03874234|62895757|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33511765|NCT03874234|62895758|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33511766|NCT03874234|62895759|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33511767|NCT03874234|62895760|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33324448|NCT01119846|62700895|FG002|Overall Study|Adverse Event|6|||
33511768|NCT03874234|62895761|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33511769|NCT03874234|62895762|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33511770|NCT03874234|62895763|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33511771|NCT03874234|62895764|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33511772|NCT03874234|62895765|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33511773|NCT03874234|62895753|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
33511774|NCT03874234|62895754|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33511775|NCT03874234|62895755|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33511776|NCT03874234|62895756|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33511777|NCT03874234|62895757|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33511778|NCT03874234|62895758|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33452437|NCT00423137|62826951|FG001|Overall Study|Adverse Event Study disease worse|0|||
33452438|NCT00423137|62826952|FG002|Overall Study|Adverse Event Study disease worse|3|||
33452439|NCT00423137|62826953|FG003|Overall Study|Adverse Event Study disease worse|1|||
33452440|NCT00423137|62826950|FG000|Overall Study|Adverse Event Other|0|||
33511779|NCT03874234|62895759|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33511780|NCT03874234|62895760|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33511781|NCT03874234|62895761|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33511782|NCT03874234|62895762|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33511783|NCT03874234|62895763|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33511784|NCT03874234|62895764|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33511785|NCT03874234|62895765|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33511786|NCT03874234|62895753|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33511787|NCT03874234|62895754|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33511788|NCT03874234|62895755|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33511789|NCT03874234|62895756|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
33511790|NCT03874234|62895757|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33511791|NCT03874234|62895758|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33511792|NCT03874234|62895759|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33511793|NCT03874234|62895760|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33511794|NCT03874234|62895761|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33511795|NCT03874234|62895762|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33511796|NCT03874234|62895763|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33511797|NCT03874234|62895764|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33511798|NCT03874234|62895765|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33511799|NCT03874234|62895753|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33511800|NCT03874234|62895754|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33511801|NCT03874234|62895755|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33511802|NCT03874234|62895756|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33613988|NCT01587898|63014817|FG003|Overall Study|Adverse Event|0|||
33324449|NCT01119846|62700893|FG000|Overall Study|Physician Decision|1|||
33452441|NCT00423137|62826951|FG001|Overall Study|Adverse Event Other|0|||
33452442|NCT00423137|62826952|FG002|Overall Study|Adverse Event Other|2|||
33452443|NCT00423137|62826953|FG003|Overall Study|Adverse Event Other|0|||
33452444|NCT00422903|62826968|FG000|Overall Study|Disease Progression|3|||
33452445|NCT00422903|62826969|FG001|Overall Study|Disease Progression|1|||
33511803|NCT03874234|62895757|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
33511804|NCT03874234|62895758|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33511805|NCT03874234|62895759|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33511806|NCT03874234|62895760|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33511807|NCT03874234|62895761|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33511808|NCT03874234|62895762|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33511809|NCT03874234|62895763|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33511810|NCT03874234|62895764|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33511811|NCT03874234|62895765|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33511812|NCT03874234|62895753|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33511813|NCT03874234|62895754|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33511814|NCT03874234|62895755|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33511815|NCT03874234|62895756|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33511816|NCT03874234|62895757|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33511817|NCT03874234|62895758|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33511818|NCT03874234|62895759|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33511819|NCT03874234|62895760|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
33511820|NCT03874234|62895761|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33511821|NCT03874234|62895762|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33511822|NCT03874234|62895763|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33511823|NCT03874234|62895764|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33511824|NCT03874234|62895765|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33511825|NCT03874234|62895753|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33511826|NCT03874234|62895754|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33511827|NCT03874234|62895755|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33511828|NCT03874234|62895756|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33511829|NCT03874234|62895757|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
33511830|NCT03874234|62895758|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
33511831|NCT03874234|62895759|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33511832|NCT03874234|62895760|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33511833|NCT03874234|62895761|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33511834|NCT03874234|62895762|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33511835|NCT03874234|62895763|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33511836|NCT03874234|62895764|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33511837|NCT03874234|62895765|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33511838|NCT03874234|62895753|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33511839|NCT03874234|62895754|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33511840|NCT03874234|62895755|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33511841|NCT03874234|62895756|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33511842|NCT03874234|62895757|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33511843|NCT03874234|62895758|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33511844|NCT03874234|62895759|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
33511845|NCT03874234|62895760|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33613989|NCT01587898|63014814|FG000|Overall Study|Protocol Violation|0|||
33511846|NCT03874234|62895761|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33511847|NCT03874234|62895762|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33511848|NCT03874234|62895763|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33511849|NCT03874234|62895764|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33511850|NCT03874234|62895765|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33511851|NCT03874234|62895753|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33511852|NCT03874234|62895754|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33511853|NCT03874234|62895755|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33511854|NCT03874234|62895756|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33511855|NCT03874234|62895757|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
33511856|NCT03874234|62895758|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33511857|NCT03874234|62895759|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33511858|NCT03874234|62895760|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33511859|NCT03874234|62895761|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33511860|NCT03874234|62895762|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33511861|NCT03874234|62895763|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33511862|NCT03874234|62895764|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33511863|NCT03874234|62895765|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33511864|NCT02985398|62895801|FG000|Overall Study|Adverse Event|1|||
33511865|NCT02985398|62895801|FG000|Overall Study|Lost to Follow-up|4|||
33511866|NCT02985398|62895801|FG000|Overall Study|Withdrawal by Subject|8|||
33511867|NCT02985398|62895801|FG000|Overall Study|Study Burden|9|||
33511868|NCT03310723|62895807|FG000|Overall Study|Withdrawal by Subject|0|||
33511869|NCT03310723|62895808|FG001|Overall Study|Withdrawal by Subject|1|||
33511870|NCT03310723|62895807|FG000|Overall Study|Protocol Violation|0|||
33511871|NCT03310723|62895808|FG001|Overall Study|Protocol Violation|2|||
33511872|NCT02663674|62895816|FG000|Overall Study|Lost to Follow-up|5|||
33511873|NCT02663674|62895817|FG001|Overall Study|Lost to Follow-up|4|||
33511874|NCT02663674|62895816|FG000|Overall Study|Withdrawal by Subject|1|||
33511875|NCT02663674|62895817|FG001|Overall Study|Withdrawal by Subject|4|||
33511876|NCT02663674|62895816|FG000|Overall Study|Physician Decision|1|||
33511877|NCT02663674|62895817|FG001|Overall Study|Physician Decision|1|||
33511878|NCT02663674|62895816|FG000|Overall Study|Other Event (Health Related)|0|||
33511879|NCT02663674|62895817|FG001|Overall Study|Other Event (Health Related)|1|||
33511880|NCT02908880|62895823|FG000|Overall Study|Lost to Follow-up|4|||
33511881|NCT02908880|62895823|FG000|Overall Study|Explantation of the device|1|||
33511882|NCT02908880|62895823|FG000|Overall Study|Withdrawal by Subject|17|||
33511883|NCT02908880|62895823|FG000|Overall Study|Death|5|||
33511884|NCT03310411|62895827|FG000|Period 1|Adverse Event|0|||
33511885|NCT03310411|62895828|FG001|Period 1|Adverse Event|0|||
33511886|NCT03310411|62895829|FG002|Period 1|Adverse Event|0|||
33511887|NCT03310411|62895830|FG003|Period 1|Adverse Event|1|||
33511888|NCT03301831|62895848|FG000|Overall Study|Lost to Follow-up|5|||
33613990|NCT01587898|63014815|FG001|Overall Study|Protocol Violation|2|||
33613991|NCT01587898|63014816|FG002|Overall Study|Protocol Violation|1|||
33613992|NCT01587898|63014817|FG003|Overall Study|Protocol Violation|1|||
33613993|NCT01587898|63014814|FG000|Overall Study|Lost to Follow-up|0|||
33613994|NCT01587898|63014815|FG001|Overall Study|Lost to Follow-up|0|||
33613995|NCT01587898|63014816|FG002|Overall Study|Lost to Follow-up|0|||
33613996|NCT01587898|63014817|FG003|Overall Study|Lost to Follow-up|1|||
33613997|NCT01587898|63014814|FG000|Overall Study|Withdrawal by Subject|2|||
33613998|NCT01587898|63014815|FG001|Overall Study|Withdrawal by Subject|1|||
33613999|NCT01587898|63014816|FG002|Overall Study|Withdrawal by Subject|0|||
33614000|NCT01587898|63014817|FG003|Overall Study|Withdrawal by Subject|0|||
33614001|NCT01587898|63014814|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
33511889|NCT03301831|62895849|FG001|Overall Study|Lost to Follow-up|3|||
33614002|NCT01587898|63014815|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
33324450|NCT01119846|62700894|FG001|Overall Study|Physician Decision|0|||
33324451|NCT01119846|62700895|FG002|Overall Study|Physician Decision|0|||
33324452|NCT01119846|62700893|FG000|Overall Study|Protocol Violation|0|||
33511890|NCT03301831|62895848|FG000|Overall Study|Protocol Violation|4|||
33511891|NCT03301831|62895849|FG001|Overall Study|Protocol Violation|0|||
33511892|NCT03301831|62895848|FG000|Overall Study|Withdrawal by Subject|11|||
33511893|NCT03301831|62895849|FG001|Overall Study|Withdrawal by Subject|0|||
33511894|NCT02909504|62895855|FG000|Overall Study|Adverse Event|2|||
33511895|NCT02909504|62895855|FG000|Overall Study|Lack of Efficacy|3|||
33614003|NCT01587898|63014816|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
33614004|NCT01587898|63014817|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
33614005|NCT01567306|63014836|FG000|Overall Study|Protocol Violation|2|||
33614006|NCT01567306|63014837|FG001|Overall Study|Protocol Violation|2|||
33614007|NCT01567306|63014838|FG002|Overall Study|Protocol Violation|0|||
33614008|NCT01567306|63014839|FG003|Overall Study|Protocol Violation|3|||
33614009|NCT01567306|63014840|FG004|Overall Study|Protocol Violation|1|||
33614010|NCT01567306|63014841|FG005|Overall Study|Protocol Violation|1|||
33614011|NCT01567306|63014836|FG000|Overall Study|Change site living|1|||
33614012|NCT01567306|63014837|FG001|Overall Study|Change site living|0|||
33614013|NCT01567306|63014838|FG002|Overall Study|Change site living|0|||
33614014|NCT01567306|63014839|FG003|Overall Study|Change site living|0|||
33614015|NCT01567306|63014840|FG004|Overall Study|Change site living|0|||
33614016|NCT01567306|63014841|FG005|Overall Study|Change site living|0|||
33452446|NCT00422903|62826968|FG000|Overall Study|Adverse Event|0|||
33452447|NCT00422903|62826969|FG001|Overall Study|Adverse Event|2|||
33452448|NCT00422903|62826968|FG000|Overall Study|Informed Consent Withdrawn|1|||
33452449|NCT00422903|62826969|FG001|Overall Study|Informed Consent Withdrawn|2|||
33452450|NCT00422669|62826978|FG000|Overall Study|The study was terminated early.|98|||
33511896|NCT02909504|62895855|FG000|Overall Study|Withdrawal by Subject|4|||
33511897|NCT02909504|62895855|FG000|Overall Study|Pregnancy|1|||
33511898|NCT02909504|62895855|FG000|Overall Study|Subject moved|1|||
33511899|NCT02909504|62895855|FG000|Overall Study|Lost to Follow-up|1|||
33511900|NCT02199691|62895864|FG000|Overall Study|Protocol Violation|3|||
33511901|NCT02199691|62895865|FG001|Overall Study|Protocol Violation|3|||
33511902|NCT02199691|62895866|FG002|Overall Study|Protocol Violation|6|||
33511903|NCT02199691|62895867|FG003|Overall Study|Protocol Violation|7|||
33511904|NCT02199691|62895864|FG000|Overall Study|Withdrawal by Subject|5|||
33511905|NCT02199691|62895865|FG001|Overall Study|Withdrawal by Subject|3|||
33452451|NCT00422669|62826979|FG001|Overall Study|The study was terminated early.|100|||
33452452|NCT00422669|62826980|FG002|Overall Study|The study was terminated early.|7|||
33452453|NCT00422591|62826986|FG000|Overall Study|Physician Decision|4|||
33511906|NCT02199691|62895866|FG002|Overall Study|Withdrawal by Subject|12|||
33511907|NCT02199691|62895867|FG003|Overall Study|Withdrawal by Subject|13|||
33511908|NCT02199691|62895864|FG000|Overall Study|Lost to Follow-up|2|||
33511909|NCT02199691|62895865|FG001|Overall Study|Lost to Follow-up|1|||
33511910|NCT02199691|62895866|FG002|Overall Study|Lost to Follow-up|9|||
33511911|NCT02199691|62895867|FG003|Overall Study|Lost to Follow-up|10|||
33511912|NCT03299881|62895881|FG000|Overall Study|Study Termination|17|||
33511913|NCT03299881|62895882|FG001|Overall Study|Study Termination|13|||
33511914|NCT03299101|62895888|FG000|Overall Study|Lost to Follow-up|1|||
33511915|NCT03299101|62895888|FG000|Overall Study|Withdrawal by Subject|5|||
33511916|NCT03299101|62895888|FG000|Overall Study|Surgery was changed|3|||
33511917|NCT03299101|62895888|FG000|Overall Study|Not enough time to complete prehab|1|||
33511918|NCT02663128|62895894|FG000|Period 2|Physician Decision|0|||
33511919|NCT02663128|62895895|FG001|Period 2|Physician Decision|0|||
33511920|NCT02663128|62895896|FG002|Period 2|Physician Decision|0|||
33511921|NCT02663128|62895897|FG003|Period 2|Physician Decision|0|||
33511922|NCT02663128|62895898|FG004|Period 2|Physician Decision|1|||
33511923|NCT02663128|62895899|FG005|Period 2|Physician Decision|0|||
33614017|NCT01567306|63014836|FG000|Overall Study|Adverse Event|0|||
33452454|NCT00422591|62826986|FG000|Overall Study|Withdrawal by Subject|2|||
33452455|NCT00422513|62826992|FG000|Overall Study|Lack of Efficacy|4|||
33452456|NCT00422513|62826993|FG001|Overall Study|Lack of Efficacy|5|||
33452457|NCT00422513|62826992|FG000|Overall Study|Protocol Violation|23|||
33452458|NCT00422513|62826993|FG001|Overall Study|Protocol Violation|7|||
33452459|NCT00422513|62826992|FG000|Overall Study|Refused Treatment|4|||
33452460|NCT00422513|62826993|FG001|Overall Study|Refused Treatment|2|||
33452461|NCT00422513|62826992|FG000|Overall Study|Withdrawal by Subject|2|||
33452462|NCT00422513|62826993|FG001|Overall Study|Withdrawal by Subject|1|||
33452463|NCT00422513|62826992|FG000|Overall Study|early termination of the study|67|||
33452464|NCT00422513|62826993|FG001|Overall Study|early termination of the study|80|||
33614018|NCT01567306|63014837|FG001|Overall Study|Adverse Event|0|||
33614019|NCT01567306|63014838|FG002|Overall Study|Adverse Event|0|||
33614020|NCT01567306|63014839|FG003|Overall Study|Adverse Event|2|||
33614021|NCT01567306|63014840|FG004|Overall Study|Adverse Event|4|||
33614022|NCT01567306|63014841|FG005|Overall Study|Adverse Event|1|||
33614023|NCT01567306|63014836|FG000|Overall Study|Lost to Follow-up|0|||
33614024|NCT01567306|63014837|FG001|Overall Study|Lost to Follow-up|0|||
33614025|NCT01567306|63014838|FG002|Overall Study|Lost to Follow-up|0|||
33452465|NCT00422513|62826992|FG000|Overall Study|Adverse Event|4|||
33452466|NCT00422513|62826993|FG001|Overall Study|Adverse Event|4|||
33452467|NCT00422513|62826992|FG000|Overall Study|Death|3|||
33452468|NCT00422513|62826993|FG001|Overall Study|Death|7|||
33452469|NCT00202878|62827001|FG000|Overall Study|Death|964|||
33452470|NCT00202878|62827002|FG001|Overall Study|Death|968|||
33511924|NCT03298867|62895910|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
33511925|NCT03298867|62895911|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
33511926|NCT03298867|62895910|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
33452471|NCT00202878|62827001|FG000|Overall Study|Only Vital Status Known|357|||
33614026|NCT01567306|63014839|FG003|Overall Study|Lost to Follow-up|0|||
33511927|NCT03298867|62895911|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
33511928|NCT03298867|62895910|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
33511929|NCT03298867|62895911|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
33511930|NCT03298867|62895910|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
33511931|NCT03298867|62895911|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
33511932|NCT03298867|62895910|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
33511933|NCT03298867|62895911|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
33511934|NCT03298867|62895910|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
33511935|NCT03298867|62895911|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
33511936|NCT03298867|62895910|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
33452472|NCT00202878|62827002|FG001|Overall Study|Only Vital Status Known|356|||
33452473|NCT00202878|62827001|FG000|Overall Study|Lost to Follow-up|44|||
33452474|NCT00202878|62827002|FG001|Overall Study|Lost to Follow-up|49|||
33452475|NCT00202878|62827001|FG000|Overall Study|Site Closure|39|||
33452476|NCT00202878|62827002|FG001|Overall Study|Site Closure|36|||
33452477|NCT00202878|62827001|FG000|Overall Study|Withdrawal by Subject|795|||
33452478|NCT00202878|62827002|FG001|Overall Study|Withdrawal by Subject|808|||
33452479|NCT00414011|62827008|FG000|Overall Study|Physician Decision|3|||
33452480|NCT00414011|62827008|FG000|Overall Study|Withdrawal by Subject|2|||
33452481|NCT00231816|62827015|FG000|Overall Study|Adverse Event|1|||
33452482|NCT00231816|62827016|FG001|Overall Study|Adverse Event|0|||
33452483|NCT00231816|62827015|FG000|Overall Study|Lost to Follow-up|8|||
33452484|NCT00231816|62827016|FG001|Overall Study|Lost to Follow-up|5|||
33452485|NCT00231816|62827015|FG000|Overall Study|Protocol Violation|2|||
33452486|NCT00231816|62827016|FG001|Overall Study|Protocol Violation|3|||
33452487|NCT00231816|62827015|FG000|Overall Study|Withdrawal by Subject|3|||
33452488|NCT00231816|62827016|FG001|Overall Study|Withdrawal by Subject|3|||
33452489|NCT00231816|62827015|FG000|Overall Study|Other|2|||
33452490|NCT00231816|62827016|FG001|Overall Study|Other|1|||
33452491|NCT00260208|62827025|FG000|Overall Study|Subject withdrew consent|11|||
33452492|NCT00260208|62827026|FG001|Overall Study|Subject withdrew consent|7|||
33452493|NCT00260208|62827025|FG000|Overall Study|Lost to Follow-up|6|||
33452494|NCT00260208|62827026|FG001|Overall Study|Lost to Follow-up|1|||
33452495|NCT00260208|62827025|FG000|Overall Study|Death|12|||
33452496|NCT00260208|62827026|FG001|Overall Study|Death|10|||
33452497|NCT00260208|62827025|FG000|Overall Study|Missing|18|||
33452498|NCT00260208|62827026|FG001|Overall Study|Missing|16|||
33452499|NCT00202644|62827034|FG000|Overall Study|Adverse Event|12|||
33452500|NCT00202644|62827035|FG001|Overall Study|Adverse Event|13|||
33452501|NCT00202644|62827034|FG000|Overall Study|Withdrawal by Subject|8|||
33452502|NCT00202644|62827035|FG001|Overall Study|Withdrawal by Subject|6|||
33452503|NCT00202644|62827034|FG000|Overall Study|Lack of Efficacy|6|||
33452504|NCT00202644|62827035|FG001|Overall Study|Lack of Efficacy|6|||
33452505|NCT00202644|62827034|FG000|Overall Study|Lost to Follow-up|0|||
33452506|NCT00202644|62827035|FG001|Overall Study|Lost to Follow-up|1|||
33452507|NCT00202644|62827034|FG000|Overall Study|Other|9|||
33452508|NCT00202644|62827035|FG001|Overall Study|Other|1|||
33452509|NCT01235962|62827045|FG000|Overall Study|Withdrawal by Subject|20|||
33452510|NCT01235962|62827046|FG001|Overall Study|Withdrawal by Subject|19|||
33452511|NCT01235962|62827047|FG002|Overall Study|Withdrawal by Subject|62|||
33452512|NCT01235962|62827048|FG003|Overall Study|Withdrawal by Subject|49|||
33452513|NCT01235962|62827045|FG000|Overall Study|Lost to Follow-up|21|||
33452514|NCT01235962|62827046|FG001|Overall Study|Lost to Follow-up|16|||
33452515|NCT01235962|62827047|FG002|Overall Study|Lost to Follow-up|47|||
33452516|NCT01235962|62827048|FG003|Overall Study|Lost to Follow-up|32|||
33452517|NCT01235962|62827045|FG000|Overall Study|Physician Decision|5|||
33452518|NCT01235962|62827046|FG001|Overall Study|Physician Decision|0|||
33511937|NCT03298867|62895911|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
33511938|NCT03298867|62895910|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
33511939|NCT03298867|62895911|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
33511940|NCT03298867|62895910|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
33511941|NCT03298867|62895911|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
33511942|NCT02906930|62895921|FG000|Overall Study|Withdrawal by Subject|0|||
33511943|NCT02906930|62895922|FG001|Overall Study|Withdrawal by Subject|5|||
33511944|NCT02906930|62895923|FG002|Overall Study|Withdrawal by Subject|5|||
33511945|NCT02906930|62895924|FG003|Overall Study|Withdrawal by Subject|4|||
33511946|NCT02906930|62895921|FG000|Overall Study|Lost to Follow-up|5|||
33511947|NCT02906930|62895922|FG001|Overall Study|Lost to Follow-up|7|||
33511948|NCT02906930|62895923|FG002|Overall Study|Lost to Follow-up|5|||
33511949|NCT02906930|62895924|FG003|Overall Study|Lost to Follow-up|2|||
33511950|NCT02906930|62895921|FG000|Overall Study|Death|0|||
33511951|NCT02906930|62895922|FG001|Overall Study|Death|0|||
33511952|NCT02906930|62895923|FG002|Overall Study|Death|1|||
33511953|NCT02906930|62895924|FG003|Overall Study|Death|0|||
33511954|NCT02906930|62895921|FG000|Overall Study|Other|1|||
33511955|NCT02906930|62895922|FG001|Overall Study|Other|2|||
33511956|NCT02906930|62895923|FG002|Overall Study|Other|1|||
33511957|NCT02906930|62895924|FG003|Overall Study|Other|2|||
33511958|NCT02983604|62895938|FG000|Overall Study|Enrolled but not Treated|0|||
33511959|NCT02983604|62895939|FG001|Overall Study|Enrolled but not Treated|0|||
33511960|NCT02983604|62895940|FG002|Overall Study|Enrolled but not Treated|1|||
33511961|NCT02983604|62895941|FG003|Overall Study|Enrolled but not Treated|0|||
33511962|NCT02662582|62895953|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
33511963|NCT02662582|62895954|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
33511964|NCT02662582|62895953|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
33511965|NCT02662582|62895954|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
33511966|NCT02662582|62895953|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
33511967|NCT02662582|62895954|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
33511968|NCT02662582|62895953|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33511969|NCT02662582|62895954|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33511970|NCT02908100|62895964|FG000|Overall Study|Adverse Event|7|||
33511971|NCT02908100|62895965|FG001|Overall Study|Adverse Event|6|||
33511972|NCT02908100|62895966|FG002|Overall Study|Adverse Event|9|||
33511973|NCT02908100|62895964|FG000|Overall Study|Death|2|||
33511974|NCT02908100|62895965|FG001|Overall Study|Death|0|||
33511975|NCT02908100|62895966|FG002|Overall Study|Death|0|||
33511976|NCT02908100|62895964|FG000|Overall Study|Lack of Efficacy|2|||
33511977|NCT02908100|62895965|FG001|Overall Study|Lack of Efficacy|3|||
33511978|NCT02908100|62895966|FG002|Overall Study|Lack of Efficacy|3|||
33511979|NCT02908100|62895964|FG000|Overall Study|Lost to Follow-up|0|||
33511980|NCT02908100|62895965|FG001|Overall Study|Lost to Follow-up|1|||
33614027|NCT01567306|63014840|FG004|Overall Study|Lost to Follow-up|2|||
33614028|NCT01567306|63014841|FG005|Overall Study|Lost to Follow-up|0|||
33614029|NCT01567306|63014836|FG000|Overall Study|Withdrawal by Subject|0|||
33614030|NCT01567306|63014837|FG001|Overall Study|Withdrawal by Subject|0|||
33614031|NCT01567306|63014838|FG002|Overall Study|Withdrawal by Subject|0|||
33614032|NCT01567306|63014839|FG003|Overall Study|Withdrawal by Subject|0|||
33614033|NCT01567306|63014840|FG004|Overall Study|Withdrawal by Subject|0|||
33614034|NCT01567306|63014841|FG005|Overall Study|Withdrawal by Subject|1|||
33614035|NCT01587274|63014858|FG000|Overall Study|Lost to Follow-up|4|||
33614036|NCT01587274|63014859|FG001|Overall Study|Lost to Follow-up|5|||
33614037|NCT01587274|63014860|FG002|Overall Study|Lost to Follow-up|3|||
33614038|NCT01587118|63014868|FG000|Overall Study|Adverse Event|3|||
33614039|NCT01587118|63014868|FG000|Overall Study|Lost to Follow-up|2|||
33614040|NCT01587118|63014868|FG000|Overall Study|Relocation|1|||
33614041|NCT01587118|63014868|FG000|Overall Study|nonresponse|1|||
33614042|NCT01905657|63014875|FG000|Overall Study|Adverse Event|23|||
33614043|NCT01905657|63014876|FG001|Overall Study|Adverse Event|17|||
33614044|NCT01905657|63014877|FG002|Overall Study|Adverse Event|18|||
33614045|NCT01905657|63014875|FG000|Overall Study|Clinical Progression|103|||
33511981|NCT02908100|62895966|FG002|Overall Study|Lost to Follow-up|2|||
33511982|NCT02908100|62895964|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33511983|NCT02908100|62895965|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33511984|NCT02908100|62895966|FG002|Overall Study|Non-Compliance With Study Drug|2|||
33511985|NCT02908100|62895964|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
33511986|NCT02908100|62895965|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
33511987|NCT02908100|62895966|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
33511988|NCT02908100|62895964|FG000|Overall Study|Physician Decision|0|||
33511989|NCT02908100|62895965|FG001|Overall Study|Physician Decision|1|||
33614046|NCT01905657|63014876|FG001|Overall Study|Clinical Progression|78|||
33614047|NCT01905657|63014877|FG002|Overall Study|Clinical Progression|59|||
33614048|NCT01905657|63014875|FG000|Overall Study|Death|40|||
33614049|NCT01905657|63014876|FG001|Overall Study|Death|43|||
33324453|NCT01119846|62700894|FG001|Overall Study|Protocol Violation|0|||
33324454|NCT01119846|62700895|FG002|Overall Study|Protocol Violation|1|||
33324455|NCT01119846|62700893|FG000|Overall Study|Withdrawal by Subject|0|||
33511990|NCT02908100|62895966|FG002|Overall Study|Physician Decision|0|||
33511991|NCT02908100|62895964|FG000|Overall Study|Pregnancy|1|||
33511992|NCT02908100|62895965|FG001|Overall Study|Pregnancy|2|||
33511993|NCT02908100|62895966|FG002|Overall Study|Pregnancy|0|||
33511994|NCT02908100|62895964|FG000|Overall Study|Withdrawal by Subject|8|||
33511995|NCT02908100|62895965|FG001|Overall Study|Withdrawal by Subject|7|||
33511996|NCT02908100|62895966|FG002|Overall Study|Withdrawal by Subject|5|||
33511997|NCT02908100|62895964|FG000|Overall Study|Randomised in Error|1|||
33511998|NCT02908100|62895965|FG001|Overall Study|Randomised in Error|0|||
33511999|NCT02908100|62895966|FG002|Overall Study|Randomised in Error|0|||
33512000|NCT02982590|62895990|FG000|Overall Study|Lost to Follow-up|0|||
33512001|NCT02982590|62895991|FG001|Overall Study|Lost to Follow-up|1|||
33512002|NCT02982590|62895990|FG000|Overall Study|Death|4|||
33512003|NCT02982590|62895991|FG001|Overall Study|Death|0|||
33512004|NCT03310021|62896017|FG000|Overall Study|Withdrawal by Subject|0|||
33512005|NCT03310021|62896018|FG001|Overall Study|Withdrawal by Subject|0|||
33512006|NCT03310021|62896019|FG002|Overall Study|Withdrawal by Subject|0|||
33512007|NCT03310021|62896020|FG003|Overall Study|Withdrawal by Subject|0|||
33512008|NCT03310021|62896021|FG004|Overall Study|Withdrawal by Subject|0|||
33512009|NCT03310021|62896022|FG005|Overall Study|Withdrawal by Subject|0|||
33512010|NCT03310021|62896023|FG006|Overall Study|Withdrawal by Subject|1|||
33512011|NCT03310021|62896024|FG007|Overall Study|Withdrawal by Subject|0|||
33512012|NCT03310021|62896025|FG008|Overall Study|Withdrawal by Subject|0|||
33512013|NCT03310021|62896026|FG009|Overall Study|Withdrawal by Subject|0|||
33512014|NCT03310021|62896027|FG010|Overall Study|Withdrawal by Subject|0|||
33512015|NCT03310021|62896028|FG011|Overall Study|Withdrawal by Subject|0|||
33512016|NCT03310021|62896029|FG012|Overall Study|Withdrawal by Subject|0|||
33512017|NCT03310021|62896030|FG013|Overall Study|Withdrawal by Subject|0|||
33512018|NCT03310021|62896031|FG014|Overall Study|Withdrawal by Subject|0|||
33512019|NCT03310021|62896032|FG015|Overall Study|Withdrawal by Subject|0|||
33512020|NCT03310021|62896033|FG016|Overall Study|Withdrawal by Subject|0|||
33512021|NCT03310021|62896034|FG017|Overall Study|Withdrawal by Subject|0|||
33512022|NCT03310021|62896035|FG018|Overall Study|Withdrawal by Subject|0|||
33512023|NCT03310021|62896036|FG019|Overall Study|Withdrawal by Subject|0|||
33512024|NCT03310021|62896017|FG000|Overall Study|Lost to Follow-up|0|||
33512025|NCT03310021|62896018|FG001|Overall Study|Lost to Follow-up|0|||
33512026|NCT03310021|62896019|FG002|Overall Study|Lost to Follow-up|0|||
33512027|NCT03310021|62896020|FG003|Overall Study|Lost to Follow-up|0|||
33512028|NCT03310021|62896021|FG004|Overall Study|Lost to Follow-up|0|||
33512029|NCT03310021|62896022|FG005|Overall Study|Lost to Follow-up|0|||
33512030|NCT03310021|62896023|FG006|Overall Study|Lost to Follow-up|0|||
33512031|NCT03310021|62896024|FG007|Overall Study|Lost to Follow-up|0|||
33512032|NCT03310021|62896025|FG008|Overall Study|Lost to Follow-up|0|||
33512033|NCT03310021|62896026|FG009|Overall Study|Lost to Follow-up|0|||
33512034|NCT03310021|62896027|FG010|Overall Study|Lost to Follow-up|1|||
33512035|NCT03310021|62896028|FG011|Overall Study|Lost to Follow-up|0|||
33512036|NCT03310021|62896029|FG012|Overall Study|Lost to Follow-up|0|||
33512037|NCT03310021|62896030|FG013|Overall Study|Lost to Follow-up|0|||
33512038|NCT03310021|62896031|FG014|Overall Study|Lost to Follow-up|0|||
33512039|NCT03310021|62896032|FG015|Overall Study|Lost to Follow-up|0|||
33512040|NCT03310021|62896033|FG016|Overall Study|Lost to Follow-up|0|||
33512041|NCT03310021|62896034|FG017|Overall Study|Lost to Follow-up|0|||
33512042|NCT03310021|62896035|FG018|Overall Study|Lost to Follow-up|0|||
33512043|NCT03310021|62896036|FG019|Overall Study|Lost to Follow-up|0|||
33512044|NCT03333109|62896081|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
33512045|NCT03333109|62896082|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
33512046|NCT03333109|62896083|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
33512047|NCT03333109|62896081|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33324456|NCT01119846|62700894|FG001|Overall Study|Withdrawal by Subject|0|||
33512048|NCT03333109|62896082|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33512049|NCT03333109|62896083|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
33512050|NCT03333109|62896081|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
33512051|NCT03333109|62896082|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
33512052|NCT03333109|62896083|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
33512053|NCT03333109|62896081|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
33512054|NCT03333109|62896082|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
33614050|NCT01905657|63014877|FG002|Overall Study|Death|47|||
33614051|NCT01905657|63014875|FG000|Overall Study|Excluded Medication|13|||
33512055|NCT03333109|62896083|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
33512056|NCT03333109|62896081|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
33512057|NCT03333109|62896082|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
33512058|NCT03333109|62896083|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
33512059|NCT03333109|62896081|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
33512060|NCT03333109|62896082|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
33512061|NCT03333109|62896083|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
33512062|NCT03333109|62896081|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
33512063|NCT03333109|62896082|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
33512064|NCT03333109|62896083|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
33512065|NCT03333109|62896081|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
33512066|NCT03333109|62896082|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
33512067|NCT03333109|62896083|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
33512068|NCT02940223|62896093|FG000|Overall Study|Failed Requirement|2|||
33512069|NCT02940223|62896094|FG001|Overall Study|Failed Requirement|0|||
33512070|NCT03295201|62896102|FG000|Overall Study|Lost to Follow-up|1|||
33512071|NCT03295201|62896103|FG001|Overall Study|Lost to Follow-up|1|||
33512072|NCT03295201|62896102|FG000|Overall Study|Hospital admission|0|||
33512073|NCT03295201|62896103|FG001|Overall Study|Hospital admission|1|||
33512074|NCT03293485|62896109|FG000|Overall Study|Death|1|||
33512075|NCT03293485|62896109|FG000|Overall Study|Screen Failure|2|||
33512076|NCT03293485|62896109|FG000|Overall Study|Withdrawal by Subject|2|||
33512077|NCT03309943|62896117|FG000|Overall Study|Withdrawal by Subject|0|||
33324457|NCT01119846|62700895|FG002|Overall Study|Withdrawal by Subject|4|||
33324458|NCT01167179|62700932|FG000|Overall Study|disease recurrence|4|||
33512078|NCT03309943|62896118|FG001|Overall Study|Withdrawal by Subject|1|||
33512079|NCT03309943|62896117|FG000|Overall Study|Inappropriate behavior towards staff|0|||
33512080|NCT03309943|62896118|FG001|Overall Study|Inappropriate behavior towards staff|1|||
33512081|NCT01732627|62896126|FG000|Overall Study|Withdrawal by Subject|1|||
33512082|NCT01732627|62896127|FG001|Overall Study|Withdrawal by Subject|0|||
33512083|NCT03307837|62896139|FG000|Overall Study|Withdrawal by Subject|0|||
33512084|NCT03307837|62896140|FG001|Overall Study|Withdrawal by Subject|0|||
33512085|NCT03307837|62896141|FG002|Overall Study|Withdrawal by Subject|1|||
33512086|NCT03307837|62896142|FG003|Overall Study|Withdrawal by Subject|0|||
33512087|NCT03307837|62896143|FG004|Overall Study|Withdrawal by Subject|0|||
33512088|NCT03307837|62896144|FG005|Overall Study|Withdrawal by Subject|1|||
33512089|NCT03307837|62896139|FG000|Overall Study|Lost to Follow-up|1|||
33512090|NCT03307837|62896140|FG001|Overall Study|Lost to Follow-up|1|||
33512091|NCT03307837|62896141|FG002|Overall Study|Lost to Follow-up|0|||
33512092|NCT03307837|62896142|FG003|Overall Study|Lost to Follow-up|0|||
33512093|NCT03307837|62896143|FG004|Overall Study|Lost to Follow-up|0|||
33512094|NCT03307837|62896144|FG005|Overall Study|Lost to Follow-up|1|||
33512095|NCT03331315|62896165|FG000|Overall Study|Physician Decision|18|||
33512096|NCT03331315|62896166|FG001|Overall Study|Physician Decision|14|||
33512097|NCT03329989|62896174|FG000|Overall Study|Withdrawal by Subject|9|||
33512098|NCT03329989|62896174|FG000|Overall Study|Lost to Follow-up|8|||
33512099|NCT03329989|62896174|FG000|Overall Study|Adverse Event|5|||
33614052|NCT01905657|63014876|FG001|Overall Study|Excluded Medication|16|||
33614053|NCT01905657|63014877|FG002|Overall Study|Excluded Medication|9|||
33512100|NCT03329989|62896174|FG000|Overall Study|Protocol Violation|1|||
33512101|NCT03287869|62896180|FG000|Overall Study|Adverse Event|14|||
33512102|NCT03287869|62896181|FG001|Overall Study|Adverse Event|12|||
33512103|NCT03287869|62896180|FG000|Overall Study|Lack of Efficacy|1|||
33512104|NCT03287869|62896181|FG001|Overall Study|Lack of Efficacy|0|||
33512105|NCT03287869|62896180|FG000|Overall Study|Lost to Follow-up|13|||
33512106|NCT03287869|62896181|FG001|Overall Study|Lost to Follow-up|19|||
33512107|NCT03287869|62896180|FG000|Overall Study|Non-Compliance With Study Drug|5|||
33512108|NCT03287869|62896181|FG001|Overall Study|Non-Compliance With Study Drug|9|||
33512109|NCT03287869|62896180|FG000|Overall Study|Progressive Disease|1|||
33512110|NCT03287869|62896181|FG001|Overall Study|Progressive Disease|0|||
33512111|NCT03287869|62896180|FG000|Overall Study|Protocol Deviation|2|||
33512112|NCT03287869|62896181|FG001|Overall Study|Protocol Deviation|1|||
33512113|NCT03287869|62896180|FG000|Overall Study|Withdrawal by Subject|36|||
33512114|NCT03287869|62896181|FG001|Overall Study|Withdrawal by Subject|43|||
33614054|NCT01905657|63014875|FG000|Overall Study|Lost to Follow-up|1|||
33614055|NCT01905657|63014876|FG001|Overall Study|Lost to Follow-up|2|||
33512115|NCT03287869|62896180|FG000|Overall Study|Early Closure of the Site|0|||
33512116|NCT03287869|62896181|FG001|Overall Study|Early Closure of the Site|1|||
33512117|NCT03287869|62896180|FG000|Overall Study|Physician Decision|5|||
33512118|NCT03287869|62896181|FG001|Overall Study|Physician Decision|5|||
33512119|NCT03287869|62896180|FG000|Overall Study|Reason not Specified|6|||
33512120|NCT03287869|62896181|FG001|Overall Study|Reason not Specified|3|||
33512121|NCT02661490|62896192|FG000|Overall Study|Lost to Follow-up|0|||
33512122|NCT02661490|62896193|FG001|Overall Study|Lost to Follow-up|1|||
33512123|NCT02661490|62896194|FG002|Overall Study|Lost to Follow-up|0|||
33512124|NCT02661490|62896195|FG003|Overall Study|Lost to Follow-up|0|||
33512125|NCT02661490|62896196|FG004|Overall Study|Lost to Follow-up|2|||
33512126|NCT02661490|62896192|FG000|Overall Study|Withdrawal by Subject|2|||
33512127|NCT02661490|62896193|FG001|Overall Study|Withdrawal by Subject|0|||
33512128|NCT02661490|62896194|FG002|Overall Study|Withdrawal by Subject|2|||
33512129|NCT02661490|62896195|FG003|Overall Study|Withdrawal by Subject|0|||
33512130|NCT02661490|62896196|FG004|Overall Study|Withdrawal by Subject|0|||
33512131|NCT02661490|62896192|FG000|Overall Study|Death|1|||
33512132|NCT02661490|62896193|FG001|Overall Study|Death|1|||
33512133|NCT02661490|62896194|FG002|Overall Study|Death|0|||
33512134|NCT02661490|62896195|FG003|Overall Study|Death|1|||
33512135|NCT02661490|62896196|FG004|Overall Study|Death|0|||
33512136|NCT02661490|62896192|FG000|Overall Study|Reason not Specified|0|||
33512137|NCT02661490|62896193|FG001|Overall Study|Reason not Specified|0|||
33512138|NCT02661490|62896194|FG002|Overall Study|Reason not Specified|0|||
33512139|NCT02661490|62896195|FG003|Overall Study|Reason not Specified|0|||
33512140|NCT02661490|62896196|FG004|Overall Study|Reason not Specified|1|||
33512141|NCT03287791|62896211|FG000|Overall Study|Insufficient Therapeutic Response|0|||
33512142|NCT03287791|62896212|FG001|Overall Study|Insufficient Therapeutic Response|0|||
33512143|NCT03287791|62896213|FG002|Overall Study|Insufficient Therapeutic Response|1|||
33512144|NCT03287791|62896211|FG000|Overall Study|Adverse Event|0|||
33512145|NCT03287791|62896212|FG001|Overall Study|Adverse Event|4|||
33512146|NCT03287791|62896213|FG002|Overall Study|Adverse Event|3|||
33512147|NCT03287791|62896211|FG000|Overall Study|Withdrawal by Subject|12|||
33512148|NCT03287791|62896212|FG001|Overall Study|Withdrawal by Subject|12|||
33512149|NCT03287791|62896213|FG002|Overall Study|Withdrawal by Subject|17|||
33512150|NCT03287791|62896211|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
33512151|NCT03287791|62896212|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
33512152|NCT03287791|62896213|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
33512153|NCT03287791|62896211|FG000|Overall Study|Lost to Follow-up|8|||
33512154|NCT03287791|62896212|FG001|Overall Study|Lost to Follow-up|14|||
33512155|NCT03287791|62896213|FG002|Overall Study|Lost to Follow-up|11|||
33512156|NCT03287791|62896211|FG000|Overall Study|Protocol Violation|7|||
33512157|NCT03287791|62896212|FG001|Overall Study|Protocol Violation|2|||
33512158|NCT03287791|62896213|FG002|Overall Study|Protocol Violation|1|||
33512159|NCT03287791|62896211|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
33512160|NCT03287791|62896212|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
33512161|NCT03287791|62896213|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
33512162|NCT03287791|62896211|FG000|Overall Study|Too much time between 2 visits|0|||
33512163|NCT03287791|62896212|FG001|Overall Study|Too much time between 2 visits|1|||
33512164|NCT03287791|62896213|FG002|Overall Study|Too much time between 2 visits|0|||
33512165|NCT03287791|62896211|FG000|Overall Study|Non-compliance|0|||
33512166|NCT03287791|62896212|FG001|Overall Study|Non-compliance|1|||
33512167|NCT03287791|62896213|FG002|Overall Study|Non-compliance|0|||
33512168|NCT03287791|62896211|FG000|Overall Study|Did not meet inclusion criteria|1|||
33512169|NCT03287791|62896212|FG001|Overall Study|Did not meet inclusion criteria|0|||
33512170|NCT03287791|62896213|FG002|Overall Study|Did not meet inclusion criteria|0|||
33512171|NCT03287635|62896221|FG000|Overall Study|Lost to Follow-up|5|||
33512172|NCT03287635|62896221|FG000|Overall Study|Withdrawal by Subject|1|||
33512173|NCT03287635|62896221|FG000|Overall Study|Physician Decision|1|||
33512174|NCT03287089|62896227|FG000|Overall Study|Lost to Follow-up|0|||
33512175|NCT03287089|62896228|FG001|Overall Study|Lost to Follow-up|2|||
33512176|NCT03287089|62896227|FG000|Overall Study|Physician Decision|0|||
33512177|NCT03287089|62896228|FG001|Overall Study|Physician Decision|2|||
33512178|NCT03287089|62896227|FG000|Overall Study|Withdrawal by Subject|0|||
33512179|NCT03287089|62896228|FG001|Overall Study|Withdrawal by Subject|2|||
33512180|NCT03286543|62896236|FG000|Consented|Screen failure before randomization|2|||
33512181|NCT03286543|62896237|FG001|Consented|Screen failure before randomization|0|||
33512182|NCT03286543|62896238|FG002|Consented|Screen failure before randomization|0|||
33512183|NCT03286543|62896236|FG000|Consented|Screen failure before enrollment|4|||
33512184|NCT03286543|62896237|FG001|Consented|Screen failure before enrollment|0|||
33512185|NCT03286543|62896238|FG002|Consented|Screen failure before enrollment|0|||
33614056|NCT01905657|63014877|FG002|Overall Study|Lost to Follow-up|1|||
33614057|NCT01905657|63014875|FG000|Overall Study|Physician Decision|5|||
33614058|NCT01905657|63014876|FG001|Overall Study|Physician Decision|8|||
33614059|NCT01905657|63014877|FG002|Overall Study|Physician Decision|12|||
33512186|NCT03286543|62896236|FG000|Consented|TKA cancelled after enrollment|1|||
33512187|NCT03286543|62896237|FG001|Consented|TKA cancelled after enrollment|0|||
33512188|NCT03286543|62896238|FG002|Consented|TKA cancelled after enrollment|0|||
33512189|NCT03286543|62896236|FG000|Consented|Withdrawn from study|12|||
33512190|NCT03286543|62896237|FG001|Consented|Withdrawn from study|0|||
33614060|NCT01905657|63014875|FG000|Overall Study|Protocol Violation|2|||
33614061|NCT01905657|63014876|FG001|Overall Study|Protocol Violation|1|||
33614062|NCT01905657|63014877|FG002|Overall Study|Protocol Violation|1|||
33614063|NCT01905657|63014875|FG000|Overall Study|Screen Failure|0|||
33614064|NCT01905657|63014876|FG001|Overall Study|Screen Failure|1|||
33614065|NCT01905657|63014877|FG002|Overall Study|Screen Failure|0|||
33614066|NCT01905657|63014875|FG000|Overall Study|Withdrawal by Subject|15|||
33614067|NCT01905657|63014876|FG001|Overall Study|Withdrawal by Subject|21|||
33614068|NCT01905657|63014877|FG002|Overall Study|Withdrawal by Subject|53|||
33614069|NCT01905657|63014875|FG000|Overall Study|Sponsor Decision|1|||
33324459|NCT01167179|62700933|FG001|Overall Study|disease recurrence|4|||
33324460|NCT01167179|62700932|FG000|Overall Study|Death|4|||
33324461|NCT01167179|62700933|FG001|Overall Study|Death|10|||
33512191|NCT03286543|62896238|FG002|Consented|Withdrawn from study|0|||
33512192|NCT03286543|62896236|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
33512193|NCT03286543|62896237|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
33512194|NCT03286543|62896238|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
33512195|NCT03286543|62896236|FG000|Study Enrollment|Withdrawn from study|0|||
33512196|NCT03286543|62896237|FG001|Study Enrollment|Withdrawn from study|6|||
33512197|NCT03286543|62896238|FG002|Study Enrollment|Withdrawn from study|6|||
33512198|NCT03306433|62896244|FG000|Overall Study|Lost to Follow-up|3|||
33452519|NCT01235962|62827047|FG002|Overall Study|Physician Decision|9|||
33452520|NCT01235962|62827048|FG003|Overall Study|Physician Decision|5|||
33512199|NCT03306433|62896244|FG000|Overall Study|Patient did not have teeth extracted|1|||
33512200|NCT03306433|62896244|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
33512201|NCT02940691|62896252|FG000|Overall Study|Lost to Follow-up|5|||
33512202|NCT02940691|62896252|FG000|Overall Study|Incarceration|1|||
33512203|NCT03306277|62896290|FG000|Overall Study|Death|1|||
33512204|NCT03306277|62896290|FG000|Overall Study|Adverse Event|1|||
33512205|NCT03306277|62896290|FG000|Overall Study|Withdrawal by Subject|1|||
33512206|NCT03130959|62896304|FG000|Overall Study|Disease progression|19|||
33512207|NCT03130959|62896305|FG001|Overall Study|Disease progression|7|||
33512208|NCT03130959|62896306|FG002|Overall Study|Disease progression|12|||
33512209|NCT03130959|62896307|FG003|Overall Study|Disease progression|7|||
33512210|NCT03130959|62896308|FG004|Overall Study|Disease progression|12|||
33512211|NCT03130959|62896309|FG005|Overall Study|Disease progression|3|||
33512212|NCT03130959|62896310|FG006|Overall Study|Disease progression|6|||
33512213|NCT03130959|62896311|FG007|Overall Study|Disease progression|3|||
33512214|NCT03130959|62896312|FG008|Overall Study|Disease progression|15|||
33512215|NCT03130959|62896313|FG009|Overall Study|Disease progression|8|||
33452521|NCT00259740|62827068|FG000|Overall Study|Physician Decision|1|||
33452522|NCT00259740|62827069|FG001|Overall Study|Physician Decision|1|||
33452523|NCT00259740|62827068|FG000|Overall Study|Adverse Event|0|||
33452524|NCT00259740|62827069|FG001|Overall Study|Adverse Event|2|||
33452525|NCT00259740|62827068|FG000|Overall Study|Withdrawal by Subject|2|||
33452526|NCT00259740|62827069|FG001|Overall Study|Withdrawal by Subject|6|||
33452527|NCT00259740|62827068|FG000|Overall Study|Death|1|||
33452528|NCT00259740|62827069|FG001|Overall Study|Death|1|||
33452529|NCT00259740|62827068|FG000|Overall Study|Disease progression|19|||
33452530|NCT00259740|62827069|FG001|Overall Study|Disease progression|36|||
33452531|NCT00259740|62827068|FG000|Overall Study|Ongoing|17|||
33452532|NCT00259740|62827069|FG001|Overall Study|Ongoing|3|||
33452533|NCT00259740|62827068|FG000|Overall Study|Other|3|||
33452534|NCT00259740|62827069|FG001|Overall Study|Other|0|||
33452535|NCT00259740|62827068|FG000|Overall Study|Requirement for alternative therapy|0|||
33452536|NCT00259740|62827069|FG001|Overall Study|Requirement for alternative therapy|4|||
33452537|NCT00201006|62827078|FG000|Overall Study|Withdrawal by Subject|7|||
33452538|NCT00201006|62827079|FG001|Overall Study|Withdrawal by Subject|2|||
33452539|NCT00201006|62827080|FG002|Overall Study|Withdrawal by Subject|3|||
33452540|NCT00201006|62827078|FG000|Overall Study|Adverse Event|1|||
33452541|NCT00201006|62827079|FG001|Overall Study|Adverse Event|0|||
33452542|NCT00201006|62827080|FG002|Overall Study|Adverse Event|1|||
33452543|NCT00200850|62827091|FG000|Overall Study|relocation|1|||
33512216|NCT03130959|62896304|FG000|Overall Study|Study drug toxicity|2|||
33512217|NCT03130959|62896305|FG001|Overall Study|Study drug toxicity|2|||
33512218|NCT03130959|62896306|FG002|Overall Study|Study drug toxicity|1|||
33512219|NCT03130959|62896307|FG003|Overall Study|Study drug toxicity|2|||
33512220|NCT03130959|62896308|FG004|Overall Study|Study drug toxicity|1|||
33614070|NCT01905657|63014876|FG001|Overall Study|Sponsor Decision|0|||
33614071|NCT01905657|63014877|FG002|Overall Study|Sponsor Decision|0|||
33452544|NCT00200850|62827092|FG001|Overall Study|relocation|0|||
33452545|NCT00200850|62827093|FG002|Overall Study|relocation|1|||
33452546|NCT00200850|62827091|FG000|Overall Study|too busy|1|||
33452547|NCT00200850|62827092|FG001|Overall Study|too busy|0|||
33452548|NCT00200850|62827093|FG002|Overall Study|too busy|0|||
33512221|NCT03130959|62896309|FG005|Overall Study|Study drug toxicity|1|||
33512222|NCT03130959|62896310|FG006|Overall Study|Study drug toxicity|3|||
33614072|NCT02202980|63014902|FG000|Overall Study|Lack of Efficacy|1|||
33614073|NCT02202980|63014903|FG001|Overall Study|Lack of Efficacy|0|||
33324462|NCT01167179|62700932|FG000|Overall Study|Withdrawal by Subject|1|||
33324463|NCT01167179|62700933|FG001|Overall Study|Withdrawal by Subject|2|||
33324464|NCT01167179|62700932|FG000|Overall Study|diverse|6|||
33324465|NCT01167179|62700933|FG001|Overall Study|diverse|5|||
33324466|NCT01167023|62701006|FG000|Overall Study|Lost to Follow-up|0|||
33324467|NCT01167023|62701007|FG001|Overall Study|Lost to Follow-up|1|||
33324468|NCT01167023|62701008|FG002|Overall Study|Lost to Follow-up|1|||
33324469|NCT01167023|62701006|FG000|Overall Study|Screen Failure|0|||
33324470|NCT01167023|62701007|FG001|Overall Study|Screen Failure|1|||
33324471|NCT01167023|62701008|FG002|Overall Study|Screen Failure|0|||
33324472|NCT01167023|62701006|FG000|Overall Study|Sponsor Decision|0|||
33324473|NCT01167023|62701007|FG001|Overall Study|Sponsor Decision|1|||
33324474|NCT01167023|62701008|FG002|Overall Study|Sponsor Decision|0|||
33324475|NCT01167023|62701006|FG000|Overall Study|Withdrawal by Subject|0|||
33324476|NCT01167023|62701007|FG001|Overall Study|Withdrawal by Subject|0|||
33324477|NCT01167023|62701008|FG002|Overall Study|Withdrawal by Subject|1|||
33452549|NCT00200850|62827091|FG000|Overall Study|Pregnancy|0|||
33452550|NCT00200850|62827092|FG001|Overall Study|Pregnancy|0|||
33452551|NCT00200850|62827093|FG002|Overall Study|Pregnancy|1|||
33452552|NCT00200850|62827091|FG000|Overall Study|Poor adherence|0|||
33614074|NCT02202980|63014904|FG002|Overall Study|Lack of Efficacy|7|||
33452553|NCT00200850|62827092|FG001|Overall Study|Poor adherence|0|||
33452554|NCT00200850|62827093|FG002|Overall Study|Poor adherence|1|||
33512223|NCT03130959|62896311|FG007|Overall Study|Study drug toxicity|0|||
33512224|NCT03130959|62896312|FG008|Overall Study|Study drug toxicity|3|||
33512225|NCT03130959|62896313|FG009|Overall Study|Study drug toxicity|3|||
33512226|NCT03130959|62896304|FG000|Overall Study|Other reasons|0|||
33512227|NCT03130959|62896305|FG001|Overall Study|Other reasons|0|||
33512228|NCT03130959|62896306|FG002|Overall Study|Other reasons|0|||
33512229|NCT03130959|62896307|FG003|Overall Study|Other reasons|0|||
33512230|NCT03130959|62896308|FG004|Overall Study|Other reasons|0|||
33452555|NCT00200850|62827091|FG000|Overall Study|optic neuritis|0|||
33452556|NCT00200850|62827092|FG001|Overall Study|optic neuritis|0|||
33452557|NCT00200850|62827093|FG002|Overall Study|optic neuritis|1|||
33452558|NCT00200850|62827091|FG000|Overall Study|Adverse Event|1|||
33452559|NCT00200850|62827092|FG001|Overall Study|Adverse Event|1|||
33452560|NCT00200850|62827093|FG002|Overall Study|Adverse Event|2|||
33452561|NCT03812224|62827103|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
33452562|NCT03812224|62827104|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
33452563|NCT03812224|62827103|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
33452564|NCT03812224|62827104|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
33452565|NCT03812224|62827103|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
33452566|NCT03812224|62827104|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
33452567|NCT03812224|62827103|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
33452568|NCT03812224|62827104|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
33452569|NCT00231114|62827113|FG000|Randomized|Withdrawal by Subject|6|||
33452570|NCT00231114|62827114|FG001|Randomized|Withdrawal by Subject|3|||
33452571|NCT00231114|62827113|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
33452572|NCT00231114|62827114|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
33452573|NCT00231114|62827113|FG000|Post-Treatment Period|Lost to Follow-up|6|||
33452574|NCT00231114|62827114|FG001|Post-Treatment Period|Lost to Follow-up|1|||
33452575|NCT00231114|62827113|FG000|Post-Treatment Period|Physician Decision|1|||
33452576|NCT00231114|62827114|FG001|Post-Treatment Period|Physician Decision|0|||
33452577|NCT00231114|62827113|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
33452578|NCT00231114|62827114|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
33452579|NCT03543046|62827124|FG000|Overall Study|Adverse Event|1|||
33452580|NCT03543046|62827125|FG001|Overall Study|Adverse Event|1|||
33452581|NCT03543046|62827124|FG000|Overall Study|Physician Decision|1|||
33452582|NCT03543046|62827125|FG001|Overall Study|Physician Decision|1|||
33512231|NCT03130959|62896309|FG005|Overall Study|Other reasons|1|||
33512232|NCT03130959|62896310|FG006|Overall Study|Other reasons|1|||
33512233|NCT03130959|62896311|FG007|Overall Study|Other reasons|0|||
33324478|NCT03484117|62701016|FG000|Overall Study|Lost to Follow-up|1|||
33324479|NCT03484117|62701017|FG001|Overall Study|Lost to Follow-up|3|||
33324480|NCT03484117|62701016|FG000|Overall Study|Declined participation in exit assess|1|||
33324481|NCT03484117|62701017|FG001|Overall Study|Declined participation in exit assess|1|||
33452583|NCT03543046|62827124|FG000|Overall Study|Protocol Violation|1|||
33452584|NCT03543046|62827125|FG001|Overall Study|Protocol Violation|0|||
33452585|NCT00259272|62827144|FG000|Overall Study|Adverse Event|2|||
33324482|NCT01166945|62701025|FG000|Randomized|diagnosed with Group A strep|4|||
33452586|NCT00259272|62827145|FG001|Overall Study|Adverse Event|1|||
33452587|NCT00259272|62827146|FG002|Overall Study|Adverse Event|0|||
33324483|NCT01166945|62701026|FG001|Randomized|diagnosed with Group A strep|4|||
33452588|NCT00259272|62827147|FG003|Overall Study|Adverse Event|3|||
33512234|NCT03130959|62896312|FG008|Overall Study|Other reasons|0|||
33512235|NCT03130959|62896313|FG009|Overall Study|Other reasons|0|||
33512236|NCT03130959|62896304|FG000|Overall Study|Subject request to discontinue therapy|0|||
33512237|NCT03130959|62896305|FG001|Overall Study|Subject request to discontinue therapy|0|||
33512238|NCT03130959|62896306|FG002|Overall Study|Subject request to discontinue therapy|1|||
33512239|NCT03130959|62896307|FG003|Overall Study|Subject request to discontinue therapy|1|||
33512240|NCT03130959|62896308|FG004|Overall Study|Subject request to discontinue therapy|0|||
33512241|NCT03130959|62896309|FG005|Overall Study|Subject request to discontinue therapy|0|||
33512242|NCT03130959|62896310|FG006|Overall Study|Subject request to discontinue therapy|1|||
33512243|NCT03130959|62896311|FG007|Overall Study|Subject request to discontinue therapy|1|||
33512244|NCT03130959|62896312|FG008|Overall Study|Subject request to discontinue therapy|0|||
33512245|NCT03130959|62896313|FG009|Overall Study|Subject request to discontinue therapy|0|||
33512246|NCT03130959|62896304|FG000|Overall Study|Not reported|0|||
33512247|NCT03130959|62896305|FG001|Overall Study|Not reported|0|||
33512248|NCT03130959|62896306|FG002|Overall Study|Not reported|0|||
33512249|NCT03130959|62896307|FG003|Overall Study|Not reported|1|||
33512250|NCT03130959|62896308|FG004|Overall Study|Not reported|0|||
33512251|NCT03130959|62896309|FG005|Overall Study|Not reported|1|||
33512252|NCT03130959|62896310|FG006|Overall Study|Not reported|0|||
33512253|NCT03130959|62896311|FG007|Overall Study|Not reported|0|||
33512254|NCT03130959|62896312|FG008|Overall Study|Not reported|0|||
33512255|NCT03130959|62896313|FG009|Overall Study|Not reported|1|||
33512256|NCT03130959|62896304|FG000|Overall Study|Adverse Event unrelated to drug|0|||
33512257|NCT03130959|62896305|FG001|Overall Study|Adverse Event unrelated to drug|0|||
33512258|NCT03130959|62896306|FG002|Overall Study|Adverse Event unrelated to drug|1|||
33512259|NCT03130959|62896307|FG003|Overall Study|Adverse Event unrelated to drug|1|||
33512260|NCT03130959|62896308|FG004|Overall Study|Adverse Event unrelated to drug|1|||
33512261|NCT03130959|62896309|FG005|Overall Study|Adverse Event unrelated to drug|0|||
33512262|NCT03130959|62896310|FG006|Overall Study|Adverse Event unrelated to drug|1|||
33512263|NCT03130959|62896311|FG007|Overall Study|Adverse Event unrelated to drug|0|||
33512264|NCT03130959|62896312|FG008|Overall Study|Adverse Event unrelated to drug|1|||
33512265|NCT03130959|62896313|FG009|Overall Study|Adverse Event unrelated to drug|1|||
33512266|NCT03130959|62896304|FG000|Overall Study|Participant withdrew consent|0|||
33512267|NCT03130959|62896305|FG001|Overall Study|Participant withdrew consent|1|||
33512268|NCT03130959|62896306|FG002|Overall Study|Participant withdrew consent|0|||
33512269|NCT03130959|62896307|FG003|Overall Study|Participant withdrew consent|2|||
33614075|NCT02202980|63014905|FG003|Overall Study|Lack of Efficacy|0|||
33614076|NCT02202980|63014906|FG004|Overall Study|Lack of Efficacy|3|||
33614077|NCT02202980|63014907|FG005|Overall Study|Lack of Efficacy|1|||
33614078|NCT02202980|63014908|FG006|Overall Study|Lack of Efficacy|11|||
33614079|NCT02202980|63014909|FG007|Overall Study|Lack of Efficacy|2|||
33614080|NCT02202980|63014910|FG008|Overall Study|Lack of Efficacy|2|||
33452589|NCT00259272|62827144|FG000|Overall Study|Lack of Efficacy|5|||
33452590|NCT00259272|62827145|FG001|Overall Study|Lack of Efficacy|1|||
33452591|NCT00259272|62827146|FG002|Overall Study|Lack of Efficacy|2|||
33452592|NCT00259272|62827147|FG003|Overall Study|Lack of Efficacy|6|||
33452593|NCT00259272|62827144|FG000|Overall Study|Physician Decision|1|||
33452594|NCT00259272|62827145|FG001|Overall Study|Physician Decision|2|||
33452595|NCT00259272|62827146|FG002|Overall Study|Physician Decision|1|||
33452596|NCT00259272|62827147|FG003|Overall Study|Physician Decision|3|||
33512270|NCT03130959|62896308|FG004|Overall Study|Participant withdrew consent|1|||
33512271|NCT03130959|62896309|FG005|Overall Study|Participant withdrew consent|0|||
33512272|NCT03130959|62896310|FG006|Overall Study|Participant withdrew consent|0|||
33512273|NCT03130959|62896311|FG007|Overall Study|Participant withdrew consent|0|||
33452597|NCT00259272|62827144|FG000|Overall Study|Protocol Violation|2|||
33452598|NCT00259272|62827145|FG001|Overall Study|Protocol Violation|0|||
33512274|NCT03130959|62896312|FG008|Overall Study|Participant withdrew consent|0|||
33614081|NCT02202980|63014911|FG009|Overall Study|Lack of Efficacy|0|||
33614082|NCT02202980|63014912|FG010|Overall Study|Lack of Efficacy|0|||
33614083|NCT02202980|63014913|FG011|Overall Study|Lack of Efficacy|3|||
33452599|NCT00259272|62827146|FG002|Overall Study|Protocol Violation|0|||
33614084|NCT02202980|63014914|FG012|Overall Study|Lack of Efficacy|10|||
33512275|NCT03130959|62896313|FG009|Overall Study|Participant withdrew consent|2|||
33512276|NCT03130959|62896304|FG000|Overall Study|Administrative reason by sponsor|1|||
33512277|NCT03130959|62896305|FG001|Overall Study|Administrative reason by sponsor|0|||
33512278|NCT03130959|62896306|FG002|Overall Study|Administrative reason by sponsor|1|||
33512279|NCT03130959|62896307|FG003|Overall Study|Administrative reason by sponsor|0|||
33512280|NCT03130959|62896308|FG004|Overall Study|Administrative reason by sponsor|0|||
33512281|NCT03130959|62896309|FG005|Overall Study|Administrative reason by sponsor|0|||
33512282|NCT03130959|62896310|FG006|Overall Study|Administrative reason by sponsor|0|||
33512283|NCT03130959|62896311|FG007|Overall Study|Administrative reason by sponsor|0|||
33512284|NCT03130959|62896312|FG008|Overall Study|Administrative reason by sponsor|0|||
33512285|NCT03130959|62896313|FG009|Overall Study|Administrative reason by sponsor|0|||
33512286|NCT03130959|62896304|FG000|Overall Study|Lost to Follow-up|1|||
33512287|NCT03130959|62896305|FG001|Overall Study|Lost to Follow-up|0|||
33512288|NCT03130959|62896306|FG002|Overall Study|Lost to Follow-up|0|||
33512289|NCT03130959|62896307|FG003|Overall Study|Lost to Follow-up|0|||
33512290|NCT03130959|62896308|FG004|Overall Study|Lost to Follow-up|0|||
33512291|NCT03130959|62896309|FG005|Overall Study|Lost to Follow-up|0|||
33512292|NCT03130959|62896310|FG006|Overall Study|Lost to Follow-up|0|||
33512293|NCT03130959|62896311|FG007|Overall Study|Lost to Follow-up|0|||
33512294|NCT03130959|62896312|FG008|Overall Study|Lost to Follow-up|0|||
33512295|NCT03130959|62896313|FG009|Overall Study|Lost to Follow-up|0|||
33512296|NCT03124407|62896352|FG000|Overall Study|Lost to Follow-up|1|||
33512297|NCT03124407|62896353|FG001|Overall Study|Lost to Follow-up|0|||
33512298|NCT03124407|62896354|FG002|Overall Study|Lost to Follow-up|0|||
33512299|NCT03124407|62896355|FG003|Overall Study|Lost to Follow-up|0|||
33512300|NCT03124407|62896352|FG000|Overall Study|Adverse Event|0|||
33512301|NCT03124407|62896353|FG001|Overall Study|Adverse Event|0|||
33512302|NCT03124407|62896354|FG002|Overall Study|Adverse Event|1|||
33512303|NCT03124407|62896355|FG003|Overall Study|Adverse Event|0|||
33512304|NCT02929407|62896369|FG000|Overall Study|Adverse Event|1|||
33512305|NCT03123939|62896373|FG000|Overall Study|Lack of Efficacy|6|||
33512306|NCT03123939|62896373|FG000|Overall Study|Death|5|||
33512307|NCT03123939|62896373|FG000|Overall Study|Physician Decision|2|||
33512308|NCT03123939|62896373|FG000|Overall Study|Subject/guardian decision|2|||
33512309|NCT03123939|62896373|FG000|Overall Study|Lost to Follow-up|1|||
33512310|NCT03123939|62896373|FG000|Overall Study|New therapy for study indication|1|||
33512311|NCT03123939|62896373|FG000|Overall Study|Protocol deviation|1|||
33512312|NCT03123939|62896373|FG000|Overall Study|Progressive disease|18|||
33512313|NCT03123939|62896373|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
33512314|NCT03123939|62896373|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
33512315|NCT03123861|62896388|FG000|Overall Study|Protocol Violation|1|||
33512316|NCT03123861|62896389|FG001|Overall Study|Protocol Violation|1|||
33512317|NCT03123861|62896388|FG000|Overall Study|Withdrawal by Subject|2|||
33512318|NCT03123861|62896389|FG001|Overall Study|Withdrawal by Subject|2|||
33512319|NCT03123471|62896397|FG000|Placebo-controlled Phase|Adverse Event|3|||
33512320|NCT03123471|62896398|FG001|Placebo-controlled Phase|Adverse Event|8|||
33512321|NCT03123471|62896397|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
33512322|NCT03123471|62896398|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
33512323|NCT03123471|62896397|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
33614085|NCT02202980|63014915|FG013|Overall Study|Lack of Efficacy|0|||
33614086|NCT02202980|63014902|FG000|Overall Study|Protocol Violation|0|||
33614087|NCT02202980|63014903|FG001|Overall Study|Protocol Violation|0|||
33614088|NCT02202980|63014904|FG002|Overall Study|Protocol Violation|0|||
33512324|NCT03123471|62896398|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
33512325|NCT03123471|62896397|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
33512326|NCT03123471|62896398|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
33512327|NCT03123471|62896397|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
33512328|NCT03123471|62896398|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
33512329|NCT03123471|62896397|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
33512330|NCT03123471|62896398|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
33512331|NCT03123471|62896397|FG000|Placebo-controlled Phase|Miscellaneous|0|||
33512332|NCT03123471|62896398|FG001|Placebo-controlled Phase|Miscellaneous|1|||
33512333|NCT03123471|62896397|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
33512334|NCT03123471|62896398|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
33512335|NCT03123471|62896397|FG000|Apremilast Extension Phase|Adverse Event|1|||
33512336|NCT03123471|62896398|FG001|Apremilast Extension Phase|Adverse Event|5|||
33512337|NCT03123471|62896397|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
33512338|NCT03123471|62896398|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
33512339|NCT03123471|62896397|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
33512340|NCT03123471|62896398|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
33614089|NCT02202980|63014905|FG003|Overall Study|Protocol Violation|3|||
33512341|NCT02661178|62896425|FG000|Part 1|Protocol Violation|1|||
33512342|NCT02661178|62896426|FG001|Part 1|Protocol Violation|0|||
33614090|NCT02202980|63014906|FG004|Overall Study|Protocol Violation|3|||
33512343|NCT02661178|62896427|FG002|Part 1|Protocol Violation|0|||
33614091|NCT02202980|63014907|FG005|Overall Study|Protocol Violation|0|||
33512344|NCT02661178|62896428|FG003|Part 1|Protocol Violation|0|||
33512345|NCT02661178|62896429|FG004|Part 1|Protocol Violation|0|||
33512346|NCT02661178|62896430|FG005|Part 1|Protocol Violation|0|||
33512347|NCT02661178|62896431|FG006|Part 1|Protocol Violation|0|||
33512348|NCT02661178|62896432|FG007|Part 1|Protocol Violation|0|||
33512349|NCT02661178|62896433|FG008|Part 1|Protocol Violation|0|||
33512350|NCT02661178|62896434|FG009|Part 1|Protocol Violation|0|||
33512351|NCT02661178|62896435|FG010|Part 1|Protocol Violation|0|||
33512352|NCT02661178|62896436|FG011|Part 1|Protocol Violation|0|||
33512353|NCT02661178|62896437|FG012|Part 1|Protocol Violation|0|||
33512354|NCT02661178|62896438|FG013|Part 1|Protocol Violation|0|||
33512355|NCT02661178|62896439|FG014|Part 1|Protocol Violation|0|||
33512356|NCT02660944|62896491|FG000|Overall Study|Adverse Event|3|||
33512357|NCT02660944|62896492|FG001|Overall Study|Adverse Event|4|||
33512358|NCT02660944|62896491|FG000|Overall Study|Physician Decision|3|||
33512359|NCT02660944|62896492|FG001|Overall Study|Physician Decision|1|||
33512360|NCT02660944|62896491|FG000|Overall Study|Withdrawal by Subject|5|||
33512361|NCT02660944|62896492|FG001|Overall Study|Withdrawal by Subject|3|||
33512362|NCT02660944|62896491|FG000|Overall Study|Lost to Follow-up|4|||
33512363|NCT02660944|62896492|FG001|Overall Study|Lost to Follow-up|1|||
33512364|NCT02660944|62896491|FG000|Overall Study|Subject schedule|0|||
33512365|NCT02660944|62896492|FG001|Overall Study|Subject schedule|1|||
33512366|NCT02660944|62896491|FG000|Overall Study|Exclusion criteria met|2|||
33512367|NCT02660944|62896492|FG001|Overall Study|Exclusion criteria met|0|||
33512368|NCT02975336|62896502|FG000|DBPC (52 Weeks)|Adverse Event|16|||
33512369|NCT02975336|62896503|FG001|DBPC (52 Weeks)|Adverse Event|17|||
33512370|NCT02975336|62896504|FG002|DBPC (52 Weeks)|Adverse Event|13|||
33512371|NCT02975336|62896505|FG003|DBPC (52 Weeks)|Adverse Event|18|||
33512372|NCT02975336|62896506|FG004|DBPC (52 Weeks)|Adverse Event|0|||
33512373|NCT02975336|62896507|FG005|DBPC (52 Weeks)|Adverse Event|0|||
33512374|NCT02975336|62896508|FG006|DBPC (52 Weeks)|Adverse Event|0|||
33512375|NCT02975336|62896509|FG007|DBPC (52 Weeks)|Adverse Event|0|||
33512376|NCT02975336|62896502|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
33512377|NCT02975336|62896503|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
33512378|NCT02975336|62896504|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
33512379|NCT02975336|62896505|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
33614092|NCT02202980|63014908|FG006|Overall Study|Protocol Violation|0|||
33614093|NCT02202980|63014909|FG007|Overall Study|Protocol Violation|0|||
33614094|NCT02202980|63014910|FG008|Overall Study|Protocol Violation|0|||
33614095|NCT02202980|63014911|FG009|Overall Study|Protocol Violation|0|||
33614096|NCT02202980|63014912|FG010|Overall Study|Protocol Violation|0|||
33614097|NCT02202980|63014913|FG011|Overall Study|Protocol Violation|0|||
33614098|NCT02202980|63014914|FG012|Overall Study|Protocol Violation|0|||
33614099|NCT02202980|63014915|FG013|Overall Study|Protocol Violation|0|||
33512380|NCT02975336|62896506|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
33512381|NCT02975336|62896507|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
33512382|NCT02975336|62896508|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
33512383|NCT02975336|62896509|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
33614100|NCT02202980|63014902|FG000|Overall Study|Lost to Follow-up|0|||
33614101|NCT02202980|63014903|FG001|Overall Study|Lost to Follow-up|1|||
33614102|NCT02202980|63014904|FG002|Overall Study|Lost to Follow-up|1|||
33614103|NCT02202980|63014905|FG003|Overall Study|Lost to Follow-up|1|||
33614104|NCT02202980|63014906|FG004|Overall Study|Lost to Follow-up|0|||
33614105|NCT02202980|63014907|FG005|Overall Study|Lost to Follow-up|0|||
33614106|NCT02202980|63014908|FG006|Overall Study|Lost to Follow-up|0|||
33614107|NCT02202980|63014909|FG007|Overall Study|Lost to Follow-up|1|||
33614108|NCT02202980|63014910|FG008|Overall Study|Lost to Follow-up|1|||
33614109|NCT02202980|63014911|FG009|Overall Study|Lost to Follow-up|0|||
33614110|NCT02202980|63014912|FG010|Overall Study|Lost to Follow-up|0|||
33614111|NCT02202980|63014913|FG011|Overall Study|Lost to Follow-up|0|||
33614112|NCT02202980|63014914|FG012|Overall Study|Lost to Follow-up|1|||
33614113|NCT02202980|63014915|FG013|Overall Study|Lost to Follow-up|0|||
33512384|NCT02975336|62896502|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
33512385|NCT02975336|62896503|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
33512386|NCT02975336|62896504|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
33512387|NCT02975336|62896505|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
33512388|NCT02975336|62896506|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
33512389|NCT02975336|62896507|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
33512390|NCT02975336|62896508|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
33614114|NCT02202980|63014902|FG000|Overall Study|Withdrew Consent|0|||
33614115|NCT02202980|63014903|FG001|Overall Study|Withdrew Consent|1|||
33614116|NCT02202980|63014904|FG002|Overall Study|Withdrew Consent|2|||
33614117|NCT02202980|63014905|FG003|Overall Study|Withdrew Consent|0|||
33324484|NCT01166945|62701025|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
33512391|NCT02975336|62896509|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
33512392|NCT02975336|62896502|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
33512393|NCT02975336|62896503|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
33614118|NCT02202980|63014906|FG004|Overall Study|Withdrew Consent|0|||
33614119|NCT02202980|63014907|FG005|Overall Study|Withdrew Consent|0|||
33614120|NCT02202980|63014908|FG006|Overall Study|Withdrew Consent|0|||
33614121|NCT02202980|63014909|FG007|Overall Study|Withdrew Consent|0|||
33512394|NCT02975336|62896504|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
33512395|NCT02975336|62896505|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
33512396|NCT02975336|62896506|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
33512397|NCT02975336|62896507|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
33512398|NCT02975336|62896508|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
33512399|NCT02975336|62896509|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
33512400|NCT02975336|62896502|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
33512401|NCT02975336|62896503|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
33512402|NCT02975336|62896504|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
33512403|NCT02975336|62896505|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
33512404|NCT02975336|62896506|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
33512405|NCT02975336|62896507|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
33512406|NCT02975336|62896508|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
33512407|NCT02975336|62896509|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
33512408|NCT02975336|62896502|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
33512409|NCT02975336|62896503|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
33512410|NCT02975336|62896504|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
33512411|NCT02975336|62896505|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
33512412|NCT02975336|62896506|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
33512413|NCT02975336|62896507|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
33512414|NCT02975336|62896508|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
33512415|NCT02975336|62896509|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
33512416|NCT02975336|62896502|FG000|LTE (104 Weeks)|Adverse Event|0|||
33512417|NCT02975336|62896503|FG001|LTE (104 Weeks)|Adverse Event|0|||
33512418|NCT02975336|62896504|FG002|LTE (104 Weeks)|Adverse Event|0|||
33512419|NCT02975336|62896505|FG003|LTE (104 Weeks)|Adverse Event|0|||
33614122|NCT02202980|63014910|FG008|Overall Study|Withdrew Consent|1|||
33614123|NCT02202980|63014911|FG009|Overall Study|Withdrew Consent|0|||
33614124|NCT02202980|63014912|FG010|Overall Study|Withdrew Consent|0|||
33614125|NCT02202980|63014913|FG011|Overall Study|Withdrew Consent|0|||
33614126|NCT02202980|63014914|FG012|Overall Study|Withdrew Consent|0|||
33614127|NCT02202980|63014915|FG013|Overall Study|Withdrew Consent|0|||
33614128|NCT01952145|63014947|FG000|Overall Study|Protocol Violation|2|||
33614129|NCT01952145|63014948|FG001|Overall Study|Protocol Violation|1|||
33614130|NCT01952145|63014947|FG000|Overall Study|Death|0|||
33614131|NCT01952145|63014948|FG001|Overall Study|Death|1|||
33614132|NCT01952145|63014947|FG000|Overall Study|Adverse Event|9|||
33614133|NCT01952145|63014948|FG001|Overall Study|Adverse Event|0|||
33614134|NCT01952145|63014947|FG000|Overall Study|Withdrawal Criteria|16|||
33614135|NCT01952145|63014948|FG001|Overall Study|Withdrawal Criteria|11|||
33614136|NCT01952145|63014947|FG000|Overall Study|Unclassified|1|||
33614137|NCT01952145|63014948|FG001|Overall Study|Unclassified|1|||
33614138|NCT01923363|63014954|FG000|Overall Study|Protocol Violation|1|||
33614139|NCT01905267|63014960|FG000|Overall Study|Physician Decision|2|||
33614140|NCT01905267|63014961|FG001|Overall Study|Physician Decision|2|||
33614141|NCT01923285|63014969|FG000|Overall Study|Withdrawal by Subject|7|||
33614142|NCT01923285|63014970|FG001|Overall Study|Withdrawal by Subject|6|||
33614143|NCT01904721|63014983|FG000|Overall Study|Other Reasons|0|||
33614144|NCT01904721|63014984|FG001|Overall Study|Other Reasons|0|||
33512420|NCT02975336|62896506|FG004|LTE (104 Weeks)|Adverse Event|7|||
33614145|NCT01904721|63014985|FG002|Overall Study|Other Reasons|1|||
33614146|NCT01904721|63014986|FG003|Overall Study|Other Reasons|1|||
33614147|NCT01904721|63014987|FG004|Overall Study|Other Reasons|2|||
33614148|NCT01904721|63014988|FG005|Overall Study|Other Reasons|2|||
33614149|NCT01904721|63014989|FG006|Overall Study|Other Reasons|2|||
33614150|NCT01904721|63014983|FG000|Overall Study|Personal Reasons|0|||
33614151|NCT01904721|63014984|FG001|Overall Study|Personal Reasons|0|||
33614152|NCT01904721|63014985|FG002|Overall Study|Personal Reasons|0|||
33614153|NCT01904721|63014986|FG003|Overall Study|Personal Reasons|0|||
33614154|NCT01904721|63014987|FG004|Overall Study|Personal Reasons|2|||
33614155|NCT01904721|63014988|FG005|Overall Study|Personal Reasons|3|||
33614156|NCT01904721|63014989|FG006|Overall Study|Personal Reasons|3|||
33512421|NCT02975336|62896507|FG005|LTE (104 Weeks)|Adverse Event|4|||
33512422|NCT02975336|62896508|FG006|LTE (104 Weeks)|Adverse Event|2|||
33512423|NCT02975336|62896509|FG007|LTE (104 Weeks)|Adverse Event|0|||
33512424|NCT02975336|62896502|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
33614157|NCT01904721|63014983|FG000|Overall Study|Lost to Follow-up|0|||
33614158|NCT01904721|63014984|FG001|Overall Study|Lost to Follow-up|0|||
33512425|NCT02975336|62896503|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
33512426|NCT02975336|62896504|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
33614159|NCT01904721|63014985|FG002|Overall Study|Lost to Follow-up|0|||
33614160|NCT01904721|63014986|FG003|Overall Study|Lost to Follow-up|0|||
33614161|NCT01904721|63014987|FG004|Overall Study|Lost to Follow-up|1|||
33614162|NCT01904721|63014988|FG005|Overall Study|Lost to Follow-up|3|||
33614163|NCT01904721|63014989|FG006|Overall Study|Lost to Follow-up|1|||
33512427|NCT02975336|62896505|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
33512428|NCT02975336|62896506|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
33512429|NCT02975336|62896507|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
33512430|NCT02975336|62896508|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
33512431|NCT02975336|62896509|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
33512432|NCT02975336|62896502|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
33512433|NCT02975336|62896503|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
33512434|NCT02975336|62896504|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
33512435|NCT02975336|62896505|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
33512436|NCT02975336|62896506|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
33512437|NCT02975336|62896507|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
33512438|NCT02975336|62896508|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
33512439|NCT02975336|62896509|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
33512440|NCT02975336|62896502|FG000|LTE (104 Weeks)|Other|0|||
33512441|NCT02975336|62896503|FG001|LTE (104 Weeks)|Other|0|||
33512442|NCT02975336|62896504|FG002|LTE (104 Weeks)|Other|0|||
33512443|NCT02975336|62896505|FG003|LTE (104 Weeks)|Other|0|||
33512444|NCT02975336|62896506|FG004|LTE (104 Weeks)|Other|55|||
33512445|NCT02975336|62896507|FG005|LTE (104 Weeks)|Other|63|||
33512446|NCT02975336|62896508|FG006|LTE (104 Weeks)|Other|76|||
33512447|NCT02975336|62896509|FG007|LTE (104 Weeks)|Other|72|||
33512448|NCT03124563|62896525|FG000|Overall Study|Lost to Follow-up|1|||
33512449|NCT03124563|62896526|FG001|Overall Study|Lost to Follow-up|1|||
33512450|NCT03124563|62896525|FG000|Overall Study|Withdrawal by Subject|1|||
33512451|NCT03124563|62896526|FG001|Overall Study|Withdrawal by Subject|1|||
33512452|NCT03079869|62896534|FG000|Overall Study|Adverse Event|6|||
33512453|NCT03079869|62896535|FG001|Overall Study|Adverse Event|8|||
33512454|NCT03079869|62896534|FG000|Overall Study|Withdrawal by Subject|4|||
33512455|NCT03079869|62896535|FG001|Overall Study|Withdrawal by Subject|1|||
33512456|NCT03079869|62896534|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
33512457|NCT03079869|62896535|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
33512458|NCT03085914|62896548|FG000|Overall Study|Death|6|||
33512459|NCT03085914|62896549|FG001|Overall Study|Death|6|||
33512460|NCT03085914|62896550|FG002|Overall Study|Death|4|||
33512461|NCT03085914|62896551|FG003|Overall Study|Death|1|||
33512462|NCT03085914|62896552|FG004|Overall Study|Death|5|||
33512463|NCT03085914|62896553|FG005|Overall Study|Death|2|||
33614164|NCT01904721|63014983|FG000|Overall Study|Lack of Efficacy|0|||
33614165|NCT01904721|63014984|FG001|Overall Study|Lack of Efficacy|0|||
33614166|NCT01904721|63014985|FG002|Overall Study|Lack of Efficacy|0|||
33614167|NCT01904721|63014986|FG003|Overall Study|Lack of Efficacy|0|||
33614168|NCT01904721|63014987|FG004|Overall Study|Lack of Efficacy|0|||
33614169|NCT01904721|63014988|FG005|Overall Study|Lack of Efficacy|0|||
33452600|NCT00259272|62827147|FG003|Overall Study|Protocol Violation|1|||
33452601|NCT00259272|62827144|FG000|Overall Study|Sponsor Decision|0|||
33452602|NCT00259272|62827145|FG001|Overall Study|Sponsor Decision|1|||
33452603|NCT00259272|62827146|FG002|Overall Study|Sponsor Decision|0|||
33452604|NCT00259272|62827147|FG003|Overall Study|Sponsor Decision|0|||
33452605|NCT00259272|62827144|FG000|Overall Study|Withdrawal by Subject|4|||
33452606|NCT00259272|62827145|FG001|Overall Study|Withdrawal by Subject|2|||
33452607|NCT00259272|62827146|FG002|Overall Study|Withdrawal by Subject|2|||
33452608|NCT00259272|62827147|FG003|Overall Study|Withdrawal by Subject|7|||
33452609|NCT00259272|62827144|FG000|Overall Study|Lost to Follow-up|1|||
33452610|NCT00259272|62827145|FG001|Overall Study|Lost to Follow-up|0|||
33452611|NCT00259272|62827146|FG002|Overall Study|Lost to Follow-up|0|||
33452612|NCT00259272|62827147|FG003|Overall Study|Lost to Follow-up|1|||
33452613|NCT00421889|62827180|FG000|Overall Study|Adverse Event|1|||
33452614|NCT00421889|62827181|FG001|Overall Study|Adverse Event|0|||
33452615|NCT00421889|62827182|FG002|Overall Study|Adverse Event|1|||
33452616|NCT00421889|62827183|FG003|Overall Study|Adverse Event|1|||
33452617|NCT00421889|62827184|FG004|Overall Study|Adverse Event|1|||
33452618|NCT00421889|62827185|FG005|Overall Study|Adverse Event|4|||
33452619|NCT00421889|62827186|FG006|Overall Study|Adverse Event|1|||
33452620|NCT00421889|62827187|FG007|Overall Study|Adverse Event|0|||
33452621|NCT00421889|62827188|FG008|Overall Study|Adverse Event|2|||
33452622|NCT00421889|62827180|FG000|Overall Study|Withdrawal by Subject|1|||
33452623|NCT00421889|62827181|FG001|Overall Study|Withdrawal by Subject|3|||
33512464|NCT03085914|62896554|FG006|Overall Study|Death|2|||
33512465|NCT03085914|62896548|FG000|Overall Study|Withdrawal by Subject|1|||
33512466|NCT03085914|62896549|FG001|Overall Study|Withdrawal by Subject|1|||
33512467|NCT03085914|62896550|FG002|Overall Study|Withdrawal by Subject|2|||
33452624|NCT00421889|62827182|FG002|Overall Study|Withdrawal by Subject|0|||
33512468|NCT03085914|62896551|FG003|Overall Study|Withdrawal by Subject|2|||
33512469|NCT03085914|62896552|FG004|Overall Study|Withdrawal by Subject|2|||
33614170|NCT01904721|63014989|FG006|Overall Study|Lack of Efficacy|1|||
33512470|NCT03085914|62896553|FG005|Overall Study|Withdrawal by Subject|0|||
33614171|NCT01904721|63014983|FG000|Overall Study|Adverse Event|0|||
33614172|NCT01904721|63014984|FG001|Overall Study|Adverse Event|0|||
33512471|NCT03085914|62896554|FG006|Overall Study|Withdrawal by Subject|1|||
33512472|NCT03085914|62896548|FG000|Overall Study|Lost to Follow-up|0|||
33512473|NCT03085914|62896549|FG001|Overall Study|Lost to Follow-up|0|||
33512474|NCT03085914|62896550|FG002|Overall Study|Lost to Follow-up|1|||
33512475|NCT03085914|62896551|FG003|Overall Study|Lost to Follow-up|0|||
33512476|NCT03085914|62896552|FG004|Overall Study|Lost to Follow-up|0|||
33512477|NCT03085914|62896553|FG005|Overall Study|Lost to Follow-up|1|||
33512478|NCT03085914|62896554|FG006|Overall Study|Lost to Follow-up|1|||
33512479|NCT03085914|62896548|FG000|Overall Study|Reason was not specified,|2|||
33512480|NCT03085914|62896549|FG001|Overall Study|Reason was not specified,|2|||
33512481|NCT03085914|62896550|FG002|Overall Study|Reason was not specified,|2|||
33512482|NCT03085914|62896551|FG003|Overall Study|Reason was not specified,|3|||
33512483|NCT03085914|62896552|FG004|Overall Study|Reason was not specified,|3|||
33512484|NCT03085914|62896553|FG005|Overall Study|Reason was not specified,|3|||
33512485|NCT03085914|62896554|FG006|Overall Study|Reason was not specified,|6|||
33512486|NCT03085914|62896548|FG000|Overall Study|Progressive Disease|0|||
33512487|NCT03085914|62896549|FG001|Overall Study|Progressive Disease|0|||
33512488|NCT03085914|62896550|FG002|Overall Study|Progressive Disease|2|||
33512489|NCT03085914|62896551|FG003|Overall Study|Progressive Disease|2|||
33512490|NCT03085914|62896552|FG004|Overall Study|Progressive Disease|1|||
33512491|NCT03085914|62896553|FG005|Overall Study|Progressive Disease|1|||
33512492|NCT03085914|62896554|FG006|Overall Study|Progressive Disease|1|||
33512493|NCT03085914|62896548|FG000|Overall Study|Study Terminated by the Sponsor|0|||
33512494|NCT03085914|62896549|FG001|Overall Study|Study Terminated by the Sponsor|0|||
33512495|NCT03085914|62896550|FG002|Overall Study|Study Terminated by the Sponsor|0|||
33512496|NCT03085914|62896551|FG003|Overall Study|Study Terminated by the Sponsor|1|||
33512497|NCT03085914|62896552|FG004|Overall Study|Study Terminated by the Sponsor|2|||
33512498|NCT03085914|62896553|FG005|Overall Study|Study Terminated by the Sponsor|1|||
33512499|NCT03085914|62896554|FG006|Overall Study|Study Terminated by the Sponsor|0|||
33512500|NCT03078582|62896582|FG000|Overall Study|Adverse Event|0|||
33324485|NCT01166945|62701026|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
33324486|NCT01166945|62701025|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
33512501|NCT03078582|62896583|FG001|Overall Study|Adverse Event|8|||
33512502|NCT03077724|62896591|FG000|Overall Study|Lost to Follow-up|5|||
33512503|NCT03077724|62896592|FG001|Overall Study|Lost to Follow-up|1|||
33512504|NCT03077724|62896591|FG000|Overall Study|Withdrawal by Subject|3|||
33512505|NCT03077724|62896592|FG001|Overall Study|Withdrawal by Subject|1|||
33512506|NCT00979212|62896600|FG000|Overall Study|Protocol Violation|1|||
33512507|NCT00979212|62896601|FG001|Overall Study|Protocol Violation|8|||
33512508|NCT00979212|62896600|FG000|Overall Study|No protocol therapy received|1|||
33512509|NCT00979212|62896601|FG001|Overall Study|No protocol therapy received|0|||
33512510|NCT03080454|62896607|FG000|Baseline|Adverse Event|2|||
33512511|NCT03080454|62896607|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
33512512|NCT03080454|62896607|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
33512513|NCT02981342|62896631|FG000|Overall Study|Adverse Event|0|||
33512514|NCT02981342|62896632|FG001|Overall Study|Adverse Event|0|||
33512515|NCT02981342|62896633|FG002|Overall Study|Adverse Event|0|||
33512516|NCT02981342|62896634|FG003|Overall Study|Adverse Event|1|||
33512517|NCT02981342|62896631|FG000|Overall Study|Death|0|||
33512518|NCT02981342|62896632|FG001|Overall Study|Death|9|||
33512519|NCT02981342|62896633|FG002|Overall Study|Death|9|||
33512520|NCT02981342|62896634|FG003|Overall Study|Death|4|||
33512521|NCT02981342|62896631|FG000|Overall Study|Withdrawal by Subject|0|||
33512522|NCT02981342|62896632|FG001|Overall Study|Withdrawal by Subject|0|||
33512523|NCT02981342|62896633|FG002|Overall Study|Withdrawal by Subject|3|||
33512524|NCT02981342|62896634|FG003|Overall Study|Withdrawal by Subject|1|||
33614173|NCT01904721|63014985|FG002|Overall Study|Adverse Event|0|||
33614174|NCT01904721|63014986|FG003|Overall Study|Adverse Event|0|||
33512525|NCT02981342|62896631|FG000|Overall Study|Study closed by sponsor|0|||
33512526|NCT02981342|62896632|FG001|Overall Study|Study closed by sponsor|0|||
33512527|NCT02981342|62896633|FG002|Overall Study|Study closed by sponsor|1|||
33512528|NCT02981342|62896634|FG003|Overall Study|Study closed by sponsor|1|||
33512529|NCT02981342|62896631|FG000|Overall Study|Randomized, Never Treated|0|||
33512530|NCT02981342|62896632|FG001|Overall Study|Randomized, Never Treated|1|||
33614175|NCT01904721|63014987|FG004|Overall Study|Adverse Event|3|||
33614176|NCT01904721|63014988|FG005|Overall Study|Adverse Event|1|||
33324487|NCT01166945|62701026|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
33324488|NCT01166945|62701025|FG000|Day 30|Lost to Follow-up|4|||
33512531|NCT02981342|62896633|FG002|Overall Study|Randomized, Never Treated|0|||
33512532|NCT02981342|62896634|FG003|Overall Study|Randomized, Never Treated|7|||
33512533|NCT02981342|62896631|FG000|Overall Study|Lost to Follow-up|0|||
33512534|NCT02981342|62896632|FG001|Overall Study|Lost to Follow-up|1|||
33512535|NCT02981342|62896633|FG002|Overall Study|Lost to Follow-up|0|||
33512536|NCT02981342|62896634|FG003|Overall Study|Lost to Follow-up|0|||
33512537|NCT02794246|62896646|FG000|Overall Study|Withdrawal by Subject|2|||
33512538|NCT02794246|62896646|FG000|Overall Study|Physician Decision|4|||
33512539|NCT03428100|62896654|FG000|Overall Study|Adverse Event|1|||
33512540|NCT03428100|62896655|FG001|Overall Study|Adverse Event|0|||
33512541|NCT03428100|62896656|FG002|Overall Study|Adverse Event|3|||
33512542|NCT03428100|62896657|FG003|Overall Study|Adverse Event|1|||
33512543|NCT03428100|62896654|FG000|Overall Study|Lack of Efficacy|16|||
33512544|NCT03428100|62896655|FG001|Overall Study|Lack of Efficacy|10|||
33512545|NCT03428100|62896656|FG002|Overall Study|Lack of Efficacy|7|||
33512546|NCT03428100|62896657|FG003|Overall Study|Lack of Efficacy|6|||
33512547|NCT03428100|62896654|FG000|Overall Study|Protocol Deviation|0|||
33512548|NCT03428100|62896655|FG001|Overall Study|Protocol Deviation|2|||
33614177|NCT01904721|63014989|FG006|Overall Study|Adverse Event|0|||
33614178|NCT01904019|63015001|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
33614179|NCT01904019|63015001|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
33614180|NCT01904019|63015001|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
33614181|NCT01904019|63015001|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
33614182|NCT01904019|63015001|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
33614183|NCT01904019|63015001|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
33614184|NCT01922895|63015007|FG000|Overall Study|Death|0|||
33614185|NCT01922895|63015008|FG001|Overall Study|Death|1|||
33614186|NCT01922895|63015007|FG000|Overall Study|Withdrawal by Subject|1|||
33614187|NCT01922895|63015008|FG001|Overall Study|Withdrawal by Subject|2|||
33452625|NCT00421889|62827183|FG003|Overall Study|Withdrawal by Subject|0|||
33452626|NCT00421889|62827184|FG004|Overall Study|Withdrawal by Subject|2|||
33452627|NCT00421889|62827185|FG005|Overall Study|Withdrawal by Subject|0|||
33452628|NCT00421889|62827186|FG006|Overall Study|Withdrawal by Subject|0|||
33452629|NCT00421889|62827187|FG007|Overall Study|Withdrawal by Subject|0|||
33452630|NCT00421889|62827188|FG008|Overall Study|Withdrawal by Subject|0|||
33452631|NCT00421889|62827180|FG000|Overall Study|Death|0|||
33452632|NCT00421889|62827181|FG001|Overall Study|Death|0|||
33452633|NCT00421889|62827182|FG002|Overall Study|Death|0|||
33452634|NCT00421889|62827183|FG003|Overall Study|Death|0|||
33452635|NCT00421889|62827184|FG004|Overall Study|Death|1|||
33452636|NCT00421889|62827185|FG005|Overall Study|Death|1|||
33452637|NCT00421889|62827186|FG006|Overall Study|Death|0|||
33452638|NCT00421889|62827187|FG007|Overall Study|Death|0|||
33452639|NCT00421889|62827188|FG008|Overall Study|Death|0|||
33452640|NCT00421889|62827180|FG000|Overall Study|Progressive disease|3|||
33452641|NCT00421889|62827181|FG001|Overall Study|Progressive disease|2|||
33452642|NCT00421889|62827182|FG002|Overall Study|Progressive disease|2|||
33452643|NCT00421889|62827183|FG003|Overall Study|Progressive disease|3|||
33452644|NCT00421889|62827184|FG004|Overall Study|Progressive disease|2|||
33452645|NCT00421889|62827185|FG005|Overall Study|Progressive disease|21|||
33452646|NCT00421889|62827186|FG006|Overall Study|Progressive disease|3|||
33452647|NCT00421889|62827187|FG007|Overall Study|Progressive disease|1|||
33452648|NCT00421889|62827188|FG008|Overall Study|Progressive disease|5|||
33452649|NCT00421889|62827180|FG000|Overall Study|Patient/Investigator request|0|||
33452650|NCT00421889|62827181|FG001|Overall Study|Patient/Investigator request|0|||
33452651|NCT00421889|62827182|FG002|Overall Study|Patient/Investigator request|0|||
33452652|NCT00421889|62827183|FG003|Overall Study|Patient/Investigator request|0|||
33324489|NCT01166945|62701026|FG001|Day 30|Lost to Follow-up|3|||
33324490|NCT00910000|62701040|FG000|Overall Study|Adverse Event|0|||
33452653|NCT00421889|62827184|FG004|Overall Study|Patient/Investigator request|0|||
33452654|NCT00421889|62827185|FG005|Overall Study|Patient/Investigator request|9|||
33452655|NCT00421889|62827186|FG006|Overall Study|Patient/Investigator request|0|||
33452656|NCT00421889|62827187|FG007|Overall Study|Patient/Investigator request|1|||
33512549|NCT03428100|62896656|FG002|Overall Study|Protocol Deviation|2|||
33512550|NCT03428100|62896657|FG003|Overall Study|Protocol Deviation|0|||
33512551|NCT03428100|62896654|FG000|Overall Study|Withdrawal by Subject|4|||
33512552|NCT03428100|62896655|FG001|Overall Study|Withdrawal by Subject|0|||
33614188|NCT01922895|63015007|FG000|Overall Study|Lost to Follow-up|5|||
33614189|NCT01922895|63015008|FG001|Overall Study|Lost to Follow-up|11|||
33614190|NCT01922739|63015016|FG000|Titration/Adjustment Period|Adverse Event|3|||
33614191|NCT01922739|63015016|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
33614192|NCT01922739|63015016|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
33614193|NCT01922739|63015016|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
33614194|NCT01922739|63015016|FG000|Open-label Treatment Period|Adverse Event|6|||
33614195|NCT01922739|63015016|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
33614196|NCT01922739|63015016|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
33614197|NCT01922739|63015016|FG000|Open-label Treatment Period|Protocol Violation|5|||
33614198|NCT01922739|63015016|FG000|Open-label Treatment Period|Pregnancy|1|||
33614199|NCT01922739|63015016|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
33614200|NCT01922739|63015016|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
33614201|NCT01922739|63015016|FG000|Open-label Treatment Period|Physician Decision|1|||
33512553|NCT03428100|62896656|FG002|Overall Study|Withdrawal by Subject|0|||
33512554|NCT03428100|62896657|FG003|Overall Study|Withdrawal by Subject|0|||
33512555|NCT03428100|62896654|FG000|Overall Study|Physician Decision|0|||
33512556|NCT03428100|62896655|FG001|Overall Study|Physician Decision|1|||
33512557|NCT03428100|62896656|FG002|Overall Study|Physician Decision|0|||
33512558|NCT03428100|62896657|FG003|Overall Study|Physician Decision|0|||
33512559|NCT02980874|62896679|FG000|Overall Study|Adverse Event|2|||
33512560|NCT02980874|62896680|FG001|Overall Study|Adverse Event|7|||
33512561|NCT02980874|62896679|FG000|Overall Study|Withdrawal by Subject|7|||
33512562|NCT02980874|62896680|FG001|Overall Study|Withdrawal by Subject|2|||
33512563|NCT02980874|62896679|FG000|Overall Study|Lost to Follow-up|5|||
33512564|NCT02980874|62896680|FG001|Overall Study|Lost to Follow-up|5|||
33512565|NCT02980874|62896679|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
33512566|NCT02980874|62896680|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
33512567|NCT02980874|62896679|FG000|Overall Study|Unknown study completion status|1|||
33512568|NCT02980874|62896680|FG001|Overall Study|Unknown study completion status|0|||
33512569|NCT01066052|62896688|FG000|Overall Study|Enrolled But Not Treated|3|||
33512570|NCT01066052|62896689|FG001|Overall Study|Enrolled But Not Treated|0|||
33512571|NCT03077646|62896697|FG000|Overall Study|Lost to Follow-up|29|||
33512572|NCT03077646|62896698|FG001|Overall Study|Lost to Follow-up|30|||
33512573|NCT03077646|62896699|FG002|Overall Study|Lost to Follow-up|31|||
33512574|NCT02892149|62896709|FG000|Overall Study|Death|262|||
33512575|NCT02892149|62896710|FG001|Overall Study|Death|278|||
33512576|NCT02892149|62896709|FG000|Overall Study|Withdrawal by Subject|53|||
33512577|NCT02892149|62896710|FG001|Overall Study|Withdrawal by Subject|47|||
33512578|NCT02892149|62896709|FG000|Overall Study|Lost to Follow-up|37|||
33512579|NCT02892149|62896710|FG001|Overall Study|Lost to Follow-up|31|||
33512580|NCT04187092|62896718|FG000|Overall Study|Lost to Follow-up|1|||
33512581|NCT04187092|62896719|FG001|Overall Study|Lost to Follow-up|1|||
33512582|NCT04187092|62896718|FG000|Overall Study|Withdrawal by Subject|1|||
33512583|NCT04187092|62896719|FG001|Overall Study|Withdrawal by Subject|1|||
33512584|NCT04187092|62896718|FG000|Overall Study|Adverse Event|0|||
33512585|NCT04187092|62896719|FG001|Overall Study|Adverse Event|1|||
33512586|NCT02896127|62896727|FG000|COMPLETED WEEK 52|Adverse Event|9|||
33512587|NCT02896127|62896728|FG001|COMPLETED WEEK 52|Adverse Event|2|||
33512588|NCT02896127|62896727|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
33512589|NCT02896127|62896728|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
33512590|NCT02896127|62896727|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
33512591|NCT02896127|62896728|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
33512592|NCT02896127|62896727|FG000|COMPLETED WEEK 52|Physician Decision|1|||
33512593|NCT02896127|62896728|FG001|COMPLETED WEEK 52|Physician Decision|1|||
33512594|NCT02896127|62896727|FG000|COMPLETED WEEK 52|Pregnancy|2|||
33512595|NCT02896127|62896728|FG001|COMPLETED WEEK 52|Pregnancy|0|||
33512596|NCT02896127|62896727|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
33512597|NCT02896127|62896728|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
33512598|NCT02896127|62896727|FG000|COMPLETED WEEK 52|Technical problems|1|||
33512599|NCT02896127|62896728|FG001|COMPLETED WEEK 52|Technical problems|0|||
33512600|NCT02896127|62896727|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
33512601|NCT02896127|62896728|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
33614202|NCT01922739|63015016|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
33614203|NCT02236988|63015036|FG000|Overall Study|Lost to Follow-up|0|||
33614204|NCT02236988|63015037|FG001|Overall Study|Lost to Follow-up|0|||
33614205|NCT02236988|63015038|FG002|Overall Study|Lost to Follow-up|0|||
33512602|NCT02896127|62896727|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
33512603|NCT02896127|62896728|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
33512604|NCT02896127|62896727|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
33512605|NCT02896127|62896728|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
33512606|NCT02896127|62896727|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
33512607|NCT02896127|62896728|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
33512608|NCT02896127|62896727|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
33512609|NCT02896127|62896728|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
33512610|NCT03546647|62896734|FG000|Overall Study|Adverse Event|1|||
33512611|NCT03546647|62896735|FG001|Overall Study|Adverse Event|0|||
33512612|NCT03077412|62896744|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
33512613|NCT03077412|62896745|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
33512614|NCT03077412|62896746|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
33512615|NCT03077412|62896744|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
33512616|NCT03077412|62896745|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
33512617|NCT03077412|62896746|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
33512618|NCT03077412|62896744|FG000|Overall Study|Adverse Event|1|||
33512619|NCT03077412|62896745|FG001|Overall Study|Adverse Event|2|||
33512620|NCT03077412|62896746|FG002|Overall Study|Adverse Event|2|||
33512621|NCT03077412|62896744|FG000|Overall Study|Investigator's Discretion|0|||
33512622|NCT03077412|62896745|FG001|Overall Study|Investigator's Discretion|1|||
33512623|NCT03077412|62896746|FG002|Overall Study|Investigator's Discretion|1|||
33512624|NCT03077412|62896744|FG000|Overall Study|Withdrew Consent|0|||
33512625|NCT03077412|62896745|FG001|Overall Study|Withdrew Consent|2|||
33512626|NCT03077412|62896746|FG002|Overall Study|Withdrew Consent|0|||
33512627|NCT03544229|62896758|FG000|Overall Study|Adverse Event|1|||
33512628|NCT03544229|62896759|FG001|Overall Study|Adverse Event|0|||
33512629|NCT03544229|62896760|FG002|Overall Study|Adverse Event|1|||
33512630|NCT03544229|62896761|FG003|Overall Study|Adverse Event|0|||
33512631|NCT03544229|62896758|FG000|Overall Study|Protocol Deviation|0|||
33512632|NCT03544229|62896759|FG001|Overall Study|Protocol Deviation|0|||
33512633|NCT03544229|62896760|FG002|Overall Study|Protocol Deviation|1|||
33512634|NCT03544229|62896761|FG003|Overall Study|Protocol Deviation|0|||
33512635|NCT03544229|62896758|FG000|Overall Study|Lost to Follow-up|3|||
33512636|NCT03544229|62896759|FG001|Overall Study|Lost to Follow-up|0|||
33512637|NCT03544229|62896760|FG002|Overall Study|Lost to Follow-up|0|||
33512638|NCT03544229|62896761|FG003|Overall Study|Lost to Follow-up|2|||
33512639|NCT03544229|62896758|FG000|Overall Study|Voluntary Withdrawal|2|||
33512640|NCT03544229|62896759|FG001|Overall Study|Voluntary Withdrawal|1|||
33512641|NCT03544229|62896760|FG002|Overall Study|Voluntary Withdrawal|3|||
33512642|NCT03544229|62896761|FG003|Overall Study|Voluntary Withdrawal|0|||
33512643|NCT03544229|62896758|FG000|Overall Study|Lack of Efficacy|0|||
33512644|NCT03544229|62896759|FG001|Overall Study|Lack of Efficacy|1|||
33512645|NCT03544229|62896760|FG002|Overall Study|Lack of Efficacy|0|||
33512646|NCT03544229|62896761|FG003|Overall Study|Lack of Efficacy|0|||
33512647|NCT03078816|62896771|FG000|Overall Study|Withdrawal by Subject|1|||
33512648|NCT03510455|62896775|FG000|Overall Study|Physician Decision|1|||
33512649|NCT03509675|62896783|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
33512650|NCT03509675|62896784|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
33512651|NCT03509675|62896783|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
33512652|NCT03509675|62896784|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
33512653|NCT03509675|62896783|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
33512654|NCT03509675|62896784|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
33512655|NCT03509675|62896783|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
33512656|NCT03509675|62896784|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
33512657|NCT03509207|62896790|FG000|Overall Study|Death|2|||
33512658|NCT03543137|62896794|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
33512659|NCT03543137|62896795|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
33512660|NCT03543137|62896794|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
33512661|NCT03543137|62896795|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
33614206|NCT02236988|63015039|FG003|Overall Study|Lost to Follow-up|1|||
33614207|NCT02236988|63015036|FG000|Overall Study|Unable to Comply with Study Visits|0|||
33452657|NCT00421889|62827188|FG008|Overall Study|Patient/Investigator request|3|||
33452658|NCT00421889|62827180|FG000|Overall Study|Lost to Follow-up|0|||
33452659|NCT00421889|62827181|FG001|Overall Study|Lost to Follow-up|0|||
33452660|NCT00421889|62827182|FG002|Overall Study|Lost to Follow-up|0|||
33452661|NCT00421889|62827183|FG003|Overall Study|Lost to Follow-up|0|||
33452662|NCT00421889|62827184|FG004|Overall Study|Lost to Follow-up|0|||
33452663|NCT00421889|62827185|FG005|Overall Study|Lost to Follow-up|0|||
33452664|NCT00421889|62827186|FG006|Overall Study|Lost to Follow-up|0|||
33452665|NCT00421889|62827187|FG007|Overall Study|Lost to Follow-up|0|||
33452666|NCT00421889|62827188|FG008|Overall Study|Lost to Follow-up|1|||
33452667|NCT00421733|62827215|FG000|Overall Study|Adverse Event|4|||
33452668|NCT00421733|62827216|FG001|Overall Study|Adverse Event|9|||
33512662|NCT03543137|62896794|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
33512663|NCT03543137|62896795|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
33512664|NCT02895347|62896805|FG000|Overall Study|Withdrawal by Subject|3|||
33512665|NCT02895347|62896806|FG001|Overall Study|Withdrawal by Subject|1|||
33512666|NCT03539549|62896813|FG000|Overall Study|Adverse Event|12|||
33512667|NCT03539549|62896813|FG000|Overall Study|Lost to Follow-up|1|||
33512668|NCT03539549|62896813|FG000|Overall Study|Death|2|||
33512669|NCT03539549|62896813|FG000|Overall Study|Progressive Disease|1|||
33512670|NCT03539549|62896813|FG000|Overall Study|Reason not Specified|1|||
33512671|NCT03506477|62896819|FG000|Overall Study|Withdrawal by Subject|1|||
33512672|NCT03506477|62896820|FG001|Overall Study|Withdrawal by Subject|0|||
33512673|NCT03073980|62896829|FG000|Overall Study|Lost to Follow-up|10|||
33512674|NCT03073980|62896830|FG001|Overall Study|Lost to Follow-up|2|||
33452669|NCT00421733|62827217|FG002|Overall Study|Adverse Event|2|||
33452670|NCT00421733|62827215|FG000|Overall Study|Lost to Follow-up|1|||
33452671|NCT00421733|62827216|FG001|Overall Study|Lost to Follow-up|2|||
33452672|NCT00421733|62827217|FG002|Overall Study|Lost to Follow-up|4|||
33452673|NCT00421733|62827215|FG000|Overall Study|Withdrawal by Subject|1|||
33452674|NCT00421733|62827216|FG001|Overall Study|Withdrawal by Subject|2|||
33452675|NCT00421733|62827217|FG002|Overall Study|Withdrawal by Subject|7|||
33452676|NCT00421733|62827215|FG000|Overall Study|Death|0|||
33452677|NCT00421733|62827216|FG001|Overall Study|Death|3|||
33452678|NCT00421733|62827217|FG002|Overall Study|Death|0|||
33452679|NCT00421733|62827215|FG000|Overall Study|Required dialysis|1|||
33452680|NCT00421733|62827216|FG001|Overall Study|Required dialysis|0|||
33452681|NCT00421733|62827217|FG002|Overall Study|Required dialysis|0|||
33452682|NCT00421733|62827215|FG000|Overall Study|Administrative|2|||
33452683|NCT00421733|62827216|FG001|Overall Study|Administrative|0|||
33452684|NCT00421733|62827217|FG002|Overall Study|Administrative|0|||
33452685|NCT00421733|62827215|FG000|Overall Study|Did not satisfy entry criteria|1|||
33512675|NCT03073980|62896831|FG002|Overall Study|Lost to Follow-up|9|||
33512676|NCT03073980|62896829|FG000|Overall Study|No post-procedure data|0|||
33512677|NCT03073980|62896830|FG001|Overall Study|No post-procedure data|0|||
33512678|NCT03073980|62896831|FG002|Overall Study|No post-procedure data|2|||
33512679|NCT03930186|62896843|FG000|Weeks 0 to 16|Adverse Event|6|||
33512680|NCT03930186|62896843|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
33512681|NCT03930186|62896843|FG000|Weeks 16 to 32|Adverse Event|1|||
33512682|NCT03930186|62896843|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
33512683|NCT03504917|62896849|FG000|Blinded Treatment Period|Protocol Violation|1|||
33512684|NCT03504917|62896850|FG001|Blinded Treatment Period|Protocol Violation|0|||
33512685|NCT03504917|62896849|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
33512686|NCT03504917|62896850|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
33512687|NCT03504917|62896849|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
33512688|NCT03504917|62896850|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
33512689|NCT03504917|62896849|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
33452686|NCT00421733|62827216|FG001|Overall Study|Did not satisfy entry criteria|3|||
33512690|NCT03504917|62896850|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
33512691|NCT03504917|62896849|FG000|Blinded Treatment Period|Adverse Event|4|||
33614208|NCT02236988|63015037|FG001|Overall Study|Unable to Comply with Study Visits|0|||
33614209|NCT02236988|63015038|FG002|Overall Study|Unable to Comply with Study Visits|0|||
33614210|NCT02236988|63015039|FG003|Overall Study|Unable to Comply with Study Visits|2|||
33614211|NCT02236598|63015092|FG000|Overall Study|Adverse Event|0|||
33614212|NCT02236598|63015093|FG001|Overall Study|Adverse Event|1|||
33614213|NCT02236598|63015092|FG000|Overall Study|Withdrawal by Subject|0|||
33512692|NCT03504917|62896850|FG001|Blinded Treatment Period|Adverse Event|4|||
33512693|NCT03504917|62896849|FG000|Blinded Treatment Period|Physician Decision|1|||
33512694|NCT03504917|62896850|FG001|Blinded Treatment Period|Physician Decision|0|||
33512695|NCT03504917|62896849|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
33512696|NCT03504917|62896850|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
33614214|NCT02236598|63015093|FG001|Overall Study|Withdrawal by Subject|1|||
33614215|NCT01922349|63015103|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
33614216|NCT01922349|63015104|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
33614217|NCT01922349|63015105|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
33614218|NCT01922349|63015106|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
33614219|NCT02236520|63015144|FG000|Overall Study|Physician Decision|0|||
33614220|NCT02236520|63015145|FG001|Overall Study|Physician Decision|5|||
33452687|NCT00421733|62827217|FG002|Overall Study|Did not satisfy entry criteria|2|||
33452688|NCT00421733|62827215|FG000|Overall Study|Sponsor request|1|||
33512697|NCT03504917|62896849|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
33512698|NCT03504917|62896850|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
33512699|NCT03504917|62896849|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
33512700|NCT03504917|62896850|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
33512701|NCT03504917|62896849|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
33614221|NCT02236520|63015146|FG002|Overall Study|Physician Decision|0|||
33614222|NCT02236520|63015147|FG003|Overall Study|Physician Decision|0|||
33452689|NCT00421733|62827216|FG001|Overall Study|Sponsor request|0|||
33452690|NCT00421733|62827217|FG002|Overall Study|Sponsor request|3|||
33452691|NCT00421733|62827215|FG000|Overall Study|Protocol deviation|4|||
33452692|NCT00421733|62827216|FG001|Overall Study|Protocol deviation|7|||
33452693|NCT00421733|62827217|FG002|Overall Study|Protocol deviation|2|||
33452694|NCT00421343|62827229|FG000|Overall Study|Death|1|||
33452695|NCT00421343|62827229|FG000|Overall Study|Withdrawal by Subject|2|||
33452696|NCT00421343|62827229|FG000|Overall Study|Lost to Follow-up|3|||
33452697|NCT00230178|62827236|FG000|Overall Study|Adverse Event|1|||
33452698|NCT00230178|62827237|FG001|Overall Study|Adverse Event|5|||
33452699|NCT00230178|62827238|FG002|Overall Study|Adverse Event|2|||
33452700|NCT00230178|62827236|FG000|Overall Study|Withdrawal by Subject|0|||
33452701|NCT00230178|62827237|FG001|Overall Study|Withdrawal by Subject|0|||
33614223|NCT02236520|63015144|FG000|Overall Study|Withdrawal by Subject|1|||
33614224|NCT02236520|63015145|FG001|Overall Study|Withdrawal by Subject|0|||
33452702|NCT00230178|62827238|FG002|Overall Study|Withdrawal by Subject|1|||
33452703|NCT00230178|62827236|FG000|Overall Study|Various other reasons|3|||
33452704|NCT00230178|62827237|FG001|Overall Study|Various other reasons|2|||
33614225|NCT02236520|63015146|FG002|Overall Study|Withdrawal by Subject|0|||
33614226|NCT02236520|63015147|FG003|Overall Study|Withdrawal by Subject|1|||
33614227|NCT02236520|63015144|FG000|Overall Study|Pregnancy|1|||
33614228|NCT02236520|63015145|FG001|Overall Study|Pregnancy|0|||
33614229|NCT02236520|63015146|FG002|Overall Study|Pregnancy|0|||
33452705|NCT00230178|62827238|FG002|Overall Study|Various other reasons|4|||
33452706|NCT00413777|62827248|FG000|Fixed-dose Period|Lost to Follow-up|1|||
33512702|NCT03504917|62896850|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
33512703|NCT03504917|62896849|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
33512704|NCT03504917|62896850|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
33512705|NCT03504917|62896849|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
33512706|NCT03504917|62896850|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
33512707|NCT03504917|62896849|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
33512708|NCT03504917|62896850|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
33512709|NCT03504917|62896849|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
33512710|NCT03504917|62896850|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
33512711|NCT03504917|62896849|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
33512712|NCT03504917|62896850|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
33512713|NCT03504917|62896849|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
33512714|NCT03504917|62896850|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
33512715|NCT03536663|62896862|FG000|Endexo|Protocol Violation|1|||
33512716|NCT03565211|62896871|FG000|Overall Study|Withdrawal by Subject|2|||
33512717|NCT03565211|62896871|FG000|Overall Study|Lost to Follow-up|1|||
33512718|NCT03565211|62896871|FG000|Overall Study|Adverse Event|44|||
33512719|NCT03565211|62896871|FG000|Overall Study|Personal issues|1|||
33512720|NCT03531905|62896878|FG000|Overall Study|Withdrawal by Subject|3|||
33512721|NCT03531905|62896879|FG001|Overall Study|Withdrawal by Subject|3|||
33512722|NCT03531905|62896880|FG002|Overall Study|Withdrawal by Subject|2|||
33512723|NCT03531905|62896878|FG000|Overall Study|Lost to Follow-up|2|||
33512724|NCT03531905|62896879|FG001|Overall Study|Lost to Follow-up|2|||
33512725|NCT03531905|62896880|FG002|Overall Study|Lost to Follow-up|1|||
33512726|NCT03531905|62896878|FG000|Overall Study|Participant was out of town|1|||
33512727|NCT03531905|62896879|FG001|Overall Study|Participant was out of town|0|||
33512728|NCT03531905|62896880|FG002|Overall Study|Participant was out of town|0|||
33512729|NCT03531905|62896878|FG000|Overall Study|Could not speak with the participant|1|||
33512730|NCT03531905|62896879|FG001|Overall Study|Could not speak with the participant|0|||
33512731|NCT03531905|62896880|FG002|Overall Study|Could not speak with the participant|0|||
33512732|NCT03531827|62896890|FG000|Overall Study|Adverse Event|2|||
33512733|NCT03531827|62896891|FG001|Overall Study|Adverse Event|0|||
33512734|NCT03531827|62896890|FG000|Overall Study|Progressive disease|1|||
33512735|NCT03531827|62896891|FG001|Overall Study|Progressive disease|0|||
33512736|NCT03530345|62896920|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
33512737|NCT03530345|62896921|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
33512738|NCT03530345|62896920|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
33512739|NCT03530345|62896921|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
33512740|NCT03530345|62896920|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
33512741|NCT03530345|62896921|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
33512742|NCT03530345|62896920|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
33512743|NCT03530345|62896921|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
33512744|NCT03500159|62896935|FG000|Overall Study|Study Terminated|2|||
33512745|NCT03500159|62896936|FG001|Overall Study|Study Terminated|1|||
33512746|NCT03785340|62896944|FG000|Overall Study|Lost to Follow-up|2|||
33512747|NCT03785340|62896945|FG001|Overall Study|Lost to Follow-up|0|||
33512748|NCT03785340|62896944|FG000|Overall Study|Adverse Event|1|||
33512749|NCT03785340|62896945|FG001|Overall Study|Adverse Event|0|||
33512750|NCT03499067|62896951|FG000|First Intervention|Physician Decision|2|||
33512751|NCT03499067|62896952|FG001|First Intervention|Physician Decision|1|||
33512752|NCT03499067|62896951|FG000|First Intervention|Withdrawal by Subject|3|||
33512753|NCT03499067|62896952|FG001|First Intervention|Withdrawal by Subject|6|||
33512754|NCT03562481|62896960|FG000|First Intervention|Lost to Follow-up|1|||
33512755|NCT03562481|62896961|FG001|First Intervention|Lost to Follow-up|0|||
33512756|NCT03529409|62896987|FG000|Randomized|Lost to Follow-up|0|||
33512757|NCT03529409|62896988|FG001|Randomized|Lost to Follow-up|0|||
33512758|NCT03529409|62896989|FG002|Randomized|Lost to Follow-up|4|||
33512759|NCT03529409|62896987|FG000|Randomized|Excluded|0|||
33512760|NCT03529409|62896988|FG001|Randomized|Excluded|0|||
33512761|NCT03529409|62896989|FG002|Randomized|Excluded|1|||
33512762|NCT03529409|62896987|FG000|Post-treatment Assessment|Death|1|||
33512763|NCT03529409|62896988|FG001|Post-treatment Assessment|Death|0|||
33512764|NCT03529409|62896989|FG002|Post-treatment Assessment|Death|0|||
33512765|NCT03529409|62896987|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
33512766|NCT03529409|62896988|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
33512767|NCT03529409|62896989|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
33512768|NCT03529409|62896987|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
33512769|NCT03529409|62896988|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
33512770|NCT03529409|62896989|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
33512771|NCT03529409|62896987|FG000|Follow-up Assessment|Death|1|||
33512772|NCT03529409|62896988|FG001|Follow-up Assessment|Death|0|||
33512773|NCT03529409|62896989|FG002|Follow-up Assessment|Death|0|||
33512774|NCT03529409|62896987|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
33512775|NCT03529409|62896988|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
33512776|NCT03529409|62896989|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
33512777|NCT03498287|62896998|FG000|Overall Study|Withdrawal by Subject|3|||
33512778|NCT03498287|62896999|FG001|Overall Study|Withdrawal by Subject|0|||
33512779|NCT03498287|62896998|FG000|Overall Study|Protocol Violation|0|||
33512780|NCT03498287|62896999|FG001|Overall Study|Protocol Violation|4|||
33512781|NCT03498287|62896998|FG000|Overall Study|Adverse Event|0|||
33512782|NCT03498287|62896999|FG001|Overall Study|Adverse Event|1|||
33512783|NCT03497429|62897007|FG000|Overall Study|Progressive disease|3|||
33512784|NCT03497429|62897008|FG001|Overall Study|Progressive disease|4|||
33512785|NCT03497429|62897007|FG000|Overall Study|Adverse Event|0|||
33512786|NCT03497429|62897008|FG001|Overall Study|Adverse Event|2|||
33512787|NCT03497039|62897016|FG000|Overall Study|Withdrawal by Subject|1|||
33512788|NCT03497039|62897017|FG001|Overall Study|Withdrawal by Subject|0|||
33614230|NCT02236520|63015147|FG003|Overall Study|Pregnancy|0|||
33614231|NCT01922271|63015159|FG000|WASHOUT Period|Withdrawal by Subject|1|||
33512789|NCT03497039|62897016|FG000|Overall Study|Protocol Violation|0|||
33512790|NCT03497039|62897017|FG001|Overall Study|Protocol Violation|1|||
33512791|NCT03495869|62897036|FG000|Overall Study|Lost to Follow-up|4|||
33512792|NCT03495869|62897037|FG001|Overall Study|Lost to Follow-up|17|||
33614232|NCT01922271|63015160|FG001|WASHOUT Period|Withdrawal by Subject|0|||
33614233|NCT02236130|63015168|FG000|Overall Study|Lost to Follow-up|7|||
33614234|NCT02236130|63015169|FG001|Overall Study|Lost to Follow-up|12|||
33324491|NCT00910000|62701041|FG001|Overall Study|Adverse Event|3|||
33324492|NCT00910000|62701042|FG002|Overall Study|Adverse Event|2|||
33324493|NCT00910000|62701043|FG003|Overall Study|Adverse Event|2|||
33324494|NCT00910000|62701044|FG004|Overall Study|Adverse Event|0|||
33324495|NCT00910000|62701045|FG005|Overall Study|Adverse Event|1|||
33324496|NCT00910000|62701040|FG000|Overall Study|Withdrawal by Subject|0|||
33512793|NCT03495869|62897038|FG002|Overall Study|Lost to Follow-up|8|||
33324497|NCT00910000|62701041|FG001|Overall Study|Withdrawal by Subject|0|||
33324498|NCT00910000|62701042|FG002|Overall Study|Withdrawal by Subject|1|||
33512794|NCT03495869|62897039|FG003|Overall Study|Lost to Follow-up|14|||
33512795|NCT03495869|62897036|FG000|Overall Study|Withdrawal by Subject|0|||
33512796|NCT03495869|62897037|FG001|Overall Study|Withdrawal by Subject|3|||
33512797|NCT03495869|62897038|FG002|Overall Study|Withdrawal by Subject|0|||
33512798|NCT03495869|62897039|FG003|Overall Study|Withdrawal by Subject|3|||
33512799|NCT03495869|62897036|FG000|Overall Study|Dropped from study|0|||
33512800|NCT03495869|62897037|FG001|Overall Study|Dropped from study|7|||
33512801|NCT03495869|62897038|FG002|Overall Study|Dropped from study|2|||
33512802|NCT03495869|62897039|FG003|Overall Study|Dropped from study|4|||
33512803|NCT03071094|62897060|FG000|Overall Study|Death|1|||
33512804|NCT03071094|62897061|FG001|Overall Study|Death|1|||
33512805|NCT03071094|62897060|FG000|Overall Study|Adverse Event|1|||
33512806|NCT03071094|62897061|FG001|Overall Study|Adverse Event|0|||
33512807|NCT03559517|62897070|FG000|Overall Study|Withdrawal by Subject|1|||
33512808|NCT03559517|62897071|FG001|Overall Study|Withdrawal by Subject|0|||
33512809|NCT03559517|62897072|FG002|Overall Study|Withdrawal by Subject|0|||
33512810|NCT02509494|62897089|FG000|Overall Study|Lost to Follow-up|8|||
33512811|NCT02509494|62897090|FG001|Overall Study|Lost to Follow-up|47|||
33512812|NCT02509494|62897091|FG002|Overall Study|Lost to Follow-up|19|||
33512813|NCT02509494|62897092|FG003|Overall Study|Lost to Follow-up|6|||
33512814|NCT02509494|62897093|FG004|Overall Study|Lost to Follow-up|3|||
33512815|NCT02509494|62897094|FG005|Overall Study|Lost to Follow-up|3|||
33512816|NCT02509494|62897095|FG006|Overall Study|Lost to Follow-up|1|||
33512817|NCT02509494|62897096|FG007|Overall Study|Lost to Follow-up|3|||
33512818|NCT02509494|62897097|FG008|Overall Study|Lost to Follow-up|1|||
33512819|NCT02509494|62897089|FG000|Overall Study|Physician Decision|2|||
33512820|NCT02509494|62897090|FG001|Overall Study|Physician Decision|1|||
33512821|NCT02509494|62897091|FG002|Overall Study|Physician Decision|0|||
33512822|NCT02509494|62897092|FG003|Overall Study|Physician Decision|0|||
33512823|NCT02509494|62897093|FG004|Overall Study|Physician Decision|0|||
33512824|NCT02509494|62897094|FG005|Overall Study|Physician Decision|0|||
33512825|NCT02509494|62897095|FG006|Overall Study|Physician Decision|0|||
33512826|NCT02509494|62897096|FG007|Overall Study|Physician Decision|0|||
33512827|NCT02509494|62897097|FG008|Overall Study|Physician Decision|0|||
33512828|NCT02509494|62897089|FG000|Overall Study|Withdrawal by Subject|4|||
33512829|NCT02509494|62897090|FG001|Overall Study|Withdrawal by Subject|17|||
33512830|NCT02509494|62897091|FG002|Overall Study|Withdrawal by Subject|7|||
33512831|NCT02509494|62897092|FG003|Overall Study|Withdrawal by Subject|5|||
33512832|NCT02509494|62897093|FG004|Overall Study|Withdrawal by Subject|0|||
33512833|NCT02509494|62897094|FG005|Overall Study|Withdrawal by Subject|6|||
33512834|NCT02509494|62897095|FG006|Overall Study|Withdrawal by Subject|1|||
33512835|NCT02509494|62897096|FG007|Overall Study|Withdrawal by Subject|2|||
33512836|NCT02509494|62897097|FG008|Overall Study|Withdrawal by Subject|1|||
33512837|NCT02509494|62897089|FG000|Overall Study|Death|0|||
33512838|NCT02509494|62897090|FG001|Overall Study|Death|1|||
33512839|NCT02509494|62897091|FG002|Overall Study|Death|0|||
33512840|NCT02509494|62897092|FG003|Overall Study|Death|0|||
33512841|NCT02509494|62897093|FG004|Overall Study|Death|1|||
33512842|NCT02509494|62897094|FG005|Overall Study|Death|0|||
33512843|NCT02509494|62897095|FG006|Overall Study|Death|0|||
33512844|NCT02509494|62897096|FG007|Overall Study|Death|1|||
33512845|NCT02509494|62897097|FG008|Overall Study|Death|0|||
33512846|NCT02509494|62897089|FG000|Overall Study|Other|0|||
33512847|NCT02509494|62897090|FG001|Overall Study|Other|4|||
33512848|NCT02509494|62897091|FG002|Overall Study|Other|5|||
33512849|NCT02509494|62897092|FG003|Overall Study|Other|0|||
33512850|NCT02509494|62897093|FG004|Overall Study|Other|0|||
33512851|NCT02509494|62897094|FG005|Overall Study|Other|0|||
33512852|NCT02509494|62897095|FG006|Overall Study|Other|0|||
33512853|NCT02509494|62897096|FG007|Overall Study|Other|0|||
33452707|NCT00413777|62827249|FG001|Fixed-dose Period|Lost to Follow-up|1|||
33452708|NCT00413777|62827248|FG000|Fixed-dose Period|Adverse Event|2|||
33452709|NCT00413777|62827249|FG001|Fixed-dose Period|Adverse Event|1|||
33452710|NCT00413777|62827248|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
33452711|NCT00413777|62827249|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
33452712|NCT00413777|62827248|FG000|Fixed-dose Period|Withdrew Consent|0|||
33452713|NCT00413777|62827249|FG001|Fixed-dose Period|Withdrew Consent|1|||
33452714|NCT00197028|62827257|FG000|Overall Study|Adverse Event|2|||
33452715|NCT00197028|62827258|FG001|Overall Study|Adverse Event|2|||
33452716|NCT00197028|62827257|FG000|Overall Study|Protocol Violation|2|||
33452717|NCT00197028|62827258|FG001|Overall Study|Protocol Violation|1|||
33452718|NCT00197028|62827257|FG000|Overall Study|Withdrawal by Subject|8|||
33614235|NCT02233946|63015177|FG000|Baseline|Withdrawal by Subject|2|||
33614236|NCT02233946|63015178|FG001|Baseline|Withdrawal by Subject|0|||
33452719|NCT00197028|62827258|FG001|Overall Study|Withdrawal by Subject|12|||
33452720|NCT00197028|62827257|FG000|Overall Study|Lost to Follow-up|1|||
33452721|NCT00197028|62827258|FG001|Overall Study|Lost to Follow-up|0|||
33452722|NCT00197028|62827257|FG000|Overall Study|Other|3|||
33452723|NCT00197028|62827258|FG001|Overall Study|Other|6|||
33452724|NCT00420641|62827267|FG000|Overall Study|Adverse Event|3|||
33452725|NCT00420641|62827268|FG001|Overall Study|Adverse Event|25|||
33614237|NCT02233946|63015177|FG000|3-months Follow-up|Lost to Follow-up|53|||
33614238|NCT02233946|63015178|FG001|3-months Follow-up|Lost to Follow-up|29|||
33614239|NCT02233946|63015177|FG000|6-months Follow-up|Lost to Follow-up|21|||
33614240|NCT02233946|63015178|FG001|6-months Follow-up|Lost to Follow-up|2|||
33614241|NCT02233946|63015177|FG000|9-month Follow-up|Lost to Follow-up|20|||
33614242|NCT02233946|63015178|FG001|9-month Follow-up|Lost to Follow-up|11|||
33614243|NCT02233946|63015177|FG000|12-month Follow-up|Lost to Follow-up|28|||
33614244|NCT02233946|63015178|FG001|12-month Follow-up|Lost to Follow-up|11|||
33614245|NCT02232698|63015186|FG000|Overall Study|Pregnancy|1|||
33614246|NCT02232698|63015187|FG001|Overall Study|Pregnancy|1|||
33614247|NCT02232698|63015186|FG000|Overall Study|Met exclusion criteria|1|||
33614248|NCT02232698|63015187|FG001|Overall Study|Met exclusion criteria|1|||
33614249|NCT02232698|63015186|FG000|Overall Study|Had device-associated symptoms|7|||
33614250|NCT02232698|63015187|FG001|Overall Study|Had device-associated symptoms|0|||
33614251|NCT02232698|63015186|FG000|Overall Study|Non-compliance with study device|1|||
33614252|NCT02232698|63015187|FG001|Overall Study|Non-compliance with study device|4|||
33614253|NCT02232698|63015186|FG000|Overall Study|Allocated to control group|0|||
33614254|NCT02232698|63015187|FG001|Overall Study|Allocated to control group|3|||
33614255|NCT02232698|63015186|FG000|Overall Study|Withdrawal by Subject|0|||
33614256|NCT02232698|63015187|FG001|Overall Study|Withdrawal by Subject|11|||
33614257|NCT01632878|63015195|FG000|Screening|Physician Decision|268|||
33614258|NCT01632878|63015195|FG000|Treatment|Lost to Follow-up|41|||
33614259|NCT01632878|63015195|FG000|Treatment|Withdrawal by Subject|36|||
33614260|NCT01632878|63015195|FG000|Treatment|Physician Decision|34|||
33614261|NCT01632878|63015195|FG000|Treatment|missing information|4|||
33614262|NCT01632878|63015195|FG000|Treatment|no information on study completion|43|||
33452726|NCT00420641|62827269|FG002|Overall Study|Adverse Event|10|||
33614263|NCT01632800|63015199|FG000|Overall Study|Subject did not fit in apparatus|1|||
33614264|NCT01641809|63015207|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
33452727|NCT00420641|62827267|FG000|Overall Study|Lost to Follow-up|2|||
33452728|NCT00420641|62827268|FG001|Overall Study|Lost to Follow-up|4|||
33452729|NCT00420641|62827269|FG002|Overall Study|Lost to Follow-up|2|||
33452730|NCT00420641|62827267|FG000|Overall Study|Protocol Violation|8|||
33452731|NCT00420641|62827268|FG001|Overall Study|Protocol Violation|8|||
33512854|NCT02509494|62897097|FG008|Overall Study|Other|0|||
33512855|NCT02509494|62897089|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33614265|NCT01641809|63015208|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
33452732|NCT00420641|62827269|FG002|Overall Study|Protocol Violation|7|||
33452733|NCT00420641|62827267|FG000|Overall Study|Withdrawal by Subject|15|||
33452734|NCT00420641|62827268|FG001|Overall Study|Withdrawal by Subject|21|||
33452735|NCT00420641|62827269|FG002|Overall Study|Withdrawal by Subject|14|||
33452736|NCT00420641|62827267|FG000|Overall Study|Lack of Efficacy|6|||
33452737|NCT00420641|62827268|FG001|Overall Study|Lack of Efficacy|5|||
33452738|NCT00420641|62827269|FG002|Overall Study|Lack of Efficacy|4|||
33452739|NCT00420641|62827267|FG000|Overall Study|Non-compliance|7|||
33452740|NCT00420641|62827268|FG001|Overall Study|Non-compliance|5|||
33452741|NCT00420641|62827269|FG002|Overall Study|Non-compliance|4|||
33452742|NCT00420641|62827267|FG000|Overall Study|Other|4|||
33452743|NCT00420641|62827268|FG001|Overall Study|Other|4|||
33614266|NCT01641809|63015209|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
33614267|NCT01641809|63015210|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
33614268|NCT01641809|63015207|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
33614269|NCT01641809|63015208|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
33614270|NCT01641809|63015209|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
33614271|NCT01641809|63015210|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
33614272|NCT01641809|63015207|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
33614273|NCT01641809|63015208|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
33614274|NCT01641809|63015209|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
33614275|NCT01641809|63015210|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
33452744|NCT00420641|62827269|FG002|Overall Study|Other|3|||
33452745|NCT00257556|62827279|FG000|Overall Study|Adverse Event|1|||
33452746|NCT00257556|62827280|FG001|Overall Study|Adverse Event|4|||
33452747|NCT00257556|62827279|FG000|Overall Study|Physician Decision|6|||
33452748|NCT00257556|62827280|FG001|Overall Study|Physician Decision|0|||
33452749|NCT00257556|62827279|FG000|Overall Study|Did not meet hCG criterion|3|||
33452750|NCT00257556|62827280|FG001|Overall Study|Did not meet hCG criterion|0|||
33452751|NCT00257556|62827279|FG000|Overall Study|other reason|4|||
33452752|NCT00257556|62827280|FG001|Overall Study|other reason|6|||
33452753|NCT00228384|62827288|FG000|Overall Study|Death|9|||
33452754|NCT00228384|62827289|FG001|Overall Study|Death|3|||
33452755|NCT00228384|62827288|FG000|Overall Study|Lost to Follow-up|6|||
33452756|NCT00228384|62827289|FG001|Overall Study|Lost to Follow-up|10|||
33452757|NCT00228384|62827288|FG000|Overall Study|Surgical Intervention (bypass)|5|||
33452758|NCT00228384|62827289|FG001|Overall Study|Surgical Intervention (bypass)|5|||
33452759|NCT00228384|62827288|FG000|Overall Study|Withdrawal by Subject|9|||
33452760|NCT00228384|62827289|FG001|Overall Study|Withdrawal by Subject|10|||
33452761|NCT00228384|62827288|FG000|Overall Study|Physician Decision|0|||
33452762|NCT00228384|62827289|FG001|Overall Study|Physician Decision|1|||
33452763|NCT00257166|62827297|FG000|Overall Study|Adverse Event|18|||
33452764|NCT00257166|62827298|FG001|Overall Study|Adverse Event|13|||
33452765|NCT00257166|62827297|FG000|Overall Study|Laboratory abnormality|1|||
33452766|NCT00257166|62827298|FG001|Overall Study|Laboratory abnormality|0|||
33452767|NCT00257166|62827297|FG000|Overall Study|Lost to Follow-up|8|||
33452768|NCT00257166|62827298|FG001|Overall Study|Lost to Follow-up|1|||
33452769|NCT00257166|62827297|FG000|Overall Study|Withdrawal by Subject|9|||
33452770|NCT00257166|62827298|FG001|Overall Study|Withdrawal by Subject|2|||
33452771|NCT00257166|62827297|FG000|Overall Study|Other|16|||
33452772|NCT00257166|62827298|FG001|Overall Study|Other|21|||
33452773|NCT00257166|62827297|FG000|Overall Study|Randomized, but not treated|1|||
33452774|NCT00257166|62827298|FG001|Overall Study|Randomized, but not treated|0|||
33452775|NCT00227370|62827306|FG000|Overall Study|Withdrawal by Subject|1|||
33452776|NCT00227370|62827307|FG001|Overall Study|Withdrawal by Subject|2|||
33452777|NCT00227370|62827306|FG000|Overall Study|Death|3|||
33452778|NCT00227370|62827307|FG001|Overall Study|Death|4|||
33452779|NCT00227370|62827306|FG000|Overall Study|Adverse Event|6|||
33452780|NCT00227370|62827307|FG001|Overall Study|Adverse Event|11|||
33452781|NCT00227370|62827306|FG000|Overall Study|Physician Decision|9|||
33452782|NCT00227370|62827307|FG001|Overall Study|Physician Decision|6|||
33452783|NCT00227370|62827306|FG000|Overall Study|Other reasons|2|||
33452784|NCT00227370|62827307|FG001|Overall Study|Other reasons|1|||
33452785|NCT00191100|62827315|FG000|Overall Study|Adverse Event|18|||
33452786|NCT00191100|62827316|FG001|Overall Study|Adverse Event|1|||
33452787|NCT00191100|62827315|FG000|Overall Study|Lost to Follow-up|2|||
33452788|NCT00191100|62827316|FG001|Overall Study|Lost to Follow-up|0|||
33452789|NCT00191100|62827315|FG000|Overall Study|Patient Moved|0|||
33452790|NCT00191100|62827316|FG001|Overall Study|Patient Moved|1|||
33452791|NCT00191100|62827315|FG000|Overall Study|Withdrawal by Subject|9|||
33452792|NCT00191100|62827316|FG001|Overall Study|Withdrawal by Subject|3|||
33452793|NCT00191100|62827315|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
33452794|NCT00191100|62827316|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
33452795|NCT00191100|62827315|FG000|Overall Study|Clinical Relapse|2|||
33452796|NCT00191100|62827316|FG001|Overall Study|Clinical Relapse|1|||
33452797|NCT00191100|62827315|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
33452798|NCT00191100|62827316|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
33452799|NCT00191100|62827315|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
33452800|NCT00191100|62827316|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
33452801|NCT00191100|62827315|FG000|Overall Study|Physician Decision|3|||
33452802|NCT00191100|62827316|FG001|Overall Study|Physician Decision|1|||
33452803|NCT00191100|62827315|FG000|Overall Study|Death from Study Drug Toxicity|2|||
33452804|NCT00191100|62827316|FG001|Overall Study|Death from Study Drug Toxicity|0|||
33452805|NCT00191100|62827315|FG000|Overall Study|Protocol Violation|1|||
33452806|NCT00191100|62827316|FG001|Overall Study|Protocol Violation|1|||
33452807|NCT00191100|62827315|FG000|Overall Study|Death from Other Cause|1|||
33452808|NCT00191100|62827316|FG001|Overall Study|Death from Other Cause|0|||
33452809|NCT00191100|62827315|FG000|Overall Study|Reason Not Specified|0|||
33452810|NCT00191100|62827316|FG001|Overall Study|Reason Not Specified|1|||
33452811|NCT00189540|62827324|FG000|Overall Study|Withdrawal by Subject|3|||
33452812|NCT00189540|62827325|FG001|Overall Study|Withdrawal by Subject|0|||
33452813|NCT00189540|62827324|FG000|Overall Study|Death|4|||
33452814|NCT00189540|62827325|FG001|Overall Study|Death|1|||
33452815|NCT00257010|62827331|FG000|Overall Study|Lack of Efficacy|11|||
33452816|NCT00257010|62827331|FG000|Overall Study|Lost to Follow-up|53|||
33614276|NCT01641809|63015207|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
33614277|NCT01641809|63015208|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
33614278|NCT01641809|63015209|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
33452817|NCT00257010|62827331|FG000|Overall Study|Withdrawal by Subject|34|||
33452818|NCT00257010|62827331|FG000|Overall Study|Adverse Event|10|||
33614279|NCT01641809|63015210|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
33614280|NCT01641809|63015207|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
33452819|NCT00257010|62827331|FG000|Overall Study|various|11|||
33452820|NCT00257010|62827331|FG000|Overall Study|no headache reported|9|||
33452821|NCT00256854|62827341|FG000|Overall Study|Withdrawal by Subject|2|||
33452822|NCT00256854|62827342|FG001|Overall Study|Withdrawal by Subject|3|||
33452823|NCT00256854|62827343|FG002|Overall Study|Withdrawal by Subject|0|||
33452824|NCT00256854|62827344|FG003|Overall Study|Withdrawal by Subject|0|||
33452825|NCT00256854|62827345|FG004|Overall Study|Withdrawal by Subject|0|||
33452826|NCT00256854|62827346|FG005|Overall Study|Withdrawal by Subject|0|||
33452827|NCT00256854|62827341|FG000|Overall Study|Lack of Efficacy|1|||
33452828|NCT00256854|62827342|FG001|Overall Study|Lack of Efficacy|0|||
33452829|NCT00256854|62827343|FG002|Overall Study|Lack of Efficacy|0|||
33452830|NCT00256854|62827344|FG003|Overall Study|Lack of Efficacy|0|||
33614281|NCT01641809|63015208|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
33614282|NCT01641809|63015209|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
33614283|NCT01641809|63015210|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
33614284|NCT01641809|63015207|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
33614285|NCT01641809|63015208|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
33614286|NCT01641809|63015209|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
33614287|NCT01641809|63015210|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
33452831|NCT00256854|62827345|FG004|Overall Study|Lack of Efficacy|0|||
33614288|NCT01641809|63015207|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
33452832|NCT00256854|62827346|FG005|Overall Study|Lack of Efficacy|0|||
33452833|NCT00256854|62827341|FG000|Overall Study|Protocol Violation|0|||
33452834|NCT00256854|62827342|FG001|Overall Study|Protocol Violation|1|||
33452835|NCT00256854|62827343|FG002|Overall Study|Protocol Violation|1|||
33452836|NCT00256854|62827344|FG003|Overall Study|Protocol Violation|1|||
33452837|NCT00256854|62827345|FG004|Overall Study|Protocol Violation|0|||
33452838|NCT00256854|62827346|FG005|Overall Study|Protocol Violation|0|||
33452839|NCT00256854|62827341|FG000|Overall Study|Adverse Event|0|||
33452840|NCT00256854|62827342|FG001|Overall Study|Adverse Event|0|||
33452841|NCT00256854|62827343|FG002|Overall Study|Adverse Event|2|||
33452842|NCT00256854|62827344|FG003|Overall Study|Adverse Event|2|||
33452843|NCT00256854|62827345|FG004|Overall Study|Adverse Event|0|||
33452844|NCT00256854|62827346|FG005|Overall Study|Adverse Event|1|||
33452845|NCT00256854|62827341|FG000|Overall Study|Not compliant with the study drug|0|||
33452846|NCT00256854|62827342|FG001|Overall Study|Not compliant with the study drug|0|||
33452847|NCT00256854|62827343|FG002|Overall Study|Not compliant with the study drug|0|||
33452848|NCT00256854|62827344|FG003|Overall Study|Not compliant with the study drug|0|||
33452849|NCT00256854|62827345|FG004|Overall Study|Not compliant with the study drug|1|||
33452850|NCT00256854|62827346|FG005|Overall Study|Not compliant with the study drug|0|||
33452851|NCT00189462|62827363|FG000|Overall Study|Lack of Efficacy|5|||
33452852|NCT00189462|62827364|FG001|Overall Study|Lack of Efficacy|1|||
33452853|NCT00189462|62827363|FG000|Overall Study|Lost to Follow-up|18|||
33452854|NCT00189462|62827364|FG001|Overall Study|Lost to Follow-up|20|||
33452855|NCT00256698|62827372|FG000|Overall Study|Withdrawal by Subject|7|||
33452856|NCT00256698|62827373|FG001|Overall Study|Withdrawal by Subject|7|||
33452857|NCT00256698|62827372|FG000|Overall Study|Adverse Event|13|||
33452858|NCT00256698|62827373|FG001|Overall Study|Adverse Event|6|||
33452859|NCT00256698|62827372|FG000|Overall Study|Protocol Violation|6|||
33452860|NCT00256698|62827373|FG001|Overall Study|Protocol Violation|5|||
33452861|NCT00256698|62827372|FG000|Overall Study|Lost to Follow-up|1|||
33452862|NCT00256698|62827373|FG001|Overall Study|Lost to Follow-up|3|||
33452863|NCT00256698|62827372|FG000|Overall Study|disease progression|97|||
33452864|NCT00256698|62827373|FG001|Overall Study|disease progression|105|||
33614289|NCT01641809|63015208|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
33614290|NCT01641809|63015209|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
33614291|NCT01641809|63015210|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
33614292|NCT01641809|63015207|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
33614293|NCT01641809|63015208|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
33614294|NCT01641809|63015209|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
33614295|NCT01641809|63015210|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
33614296|NCT01641809|63015207|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
33614297|NCT01641809|63015208|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
33614298|NCT01641809|63015209|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
33614299|NCT01641809|63015210|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
33614300|NCT01641809|63015207|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
33614301|NCT01641809|63015208|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
33614302|NCT01641809|63015209|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
33614303|NCT01641809|63015210|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
33614304|NCT01641809|63015207|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
33614305|NCT01641809|63015208|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
33614306|NCT01641809|63015209|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
33614307|NCT01641809|63015210|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
33614308|NCT01641809|63015207|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
33614309|NCT01641809|63015208|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
33452865|NCT00256698|62827372|FG000|Overall Study|still ongoing at data cut-off|41|||
33452866|NCT00256698|62827373|FG001|Overall Study|still ongoing at data cut-off|46|||
33452867|NCT00256698|62827372|FG000|Overall Study|withdrawn due to osteoporosis|1|||
33452868|NCT00256698|62827373|FG001|Overall Study|withdrawn due to osteoporosis|0|||
33452869|NCT00256698|62827372|FG000|Overall Study|Prematurely Discontinued|1|||
33452870|NCT00256698|62827373|FG001|Overall Study|Prematurely Discontinued|0|||
33452871|NCT00189306|62827379|FG000|Treatment Period|Withdrawal by Subject|2|||
33452872|NCT00189306|62827379|FG000|Treatment Period|Adverse Event|2|||
33452873|NCT00189306|62827379|FG000|Treatment Period|Protocol Violation|1|||
33452874|NCT00189306|62827379|FG000|Posttreatment Period|Death|1|||
33452875|NCT00189306|62827379|FG000|Posttreatment Period|Withdrawal by Subject|2|||
33452876|NCT00189306|62827379|FG000|Posttreatment Period|Noncompliance|1|||
33452877|NCT00189306|62827379|FG000|Posttreatment Period|Target lesion excised|1|||
33452878|NCT00189306|62827379|FG000|Posttreatment Period|Protocol Violation|1|||
33452879|NCT00189306|62827379|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
33452880|NCT00189306|62827379|FG000|Posttreatment Period|Local skin reaction/sign|1|||
33452881|NCT00189306|62827379|FG000|Long-Term Follow-up|Adverse Event|2|||
33452882|NCT00189306|62827379|FG000|Long-Term Follow-up|Death|4|||
33452883|NCT00189306|62827379|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
33452884|NCT00189306|62827379|FG000|Long-Term Follow-up|Intercurrent disease|2|||
33452885|NCT00189306|62827379|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
33452886|NCT00189306|62827379|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
33452887|NCT00187278|62827385|FG000|Overall Study|Protocol Violation|10|||
33452888|NCT00187278|62827386|FG001|Overall Study|Protocol Violation|13|||
33614310|NCT01641809|63015209|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
33614311|NCT01641809|63015210|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
33452889|NCT00256308|62827394|FG000|Overall Study|Death|2|||
33452890|NCT00255840|62827400|FG000|Overall Study|Lost to Follow-up|10|||
33452891|NCT00255840|62827401|FG001|Overall Study|Lost to Follow-up|14|||
33452892|NCT00255840|62827400|FG000|Overall Study|Discontinued intervention|53|||
33452893|NCT00255840|62827401|FG001|Overall Study|Discontinued intervention|56|||
33452894|NCT00224874|62827411|FG000|Overall Study|Withdrawal by Subject|0|||
33452895|NCT00224874|62827412|FG001|Overall Study|Withdrawal by Subject|0|||
33452896|NCT00224874|62827413|FG002|Overall Study|Withdrawal by Subject|1|||
33452897|NCT00224874|62827414|FG003|Overall Study|Withdrawal by Subject|0|||
33452898|NCT00186186|62827424|FG000|Overall Study|Lack of Efficacy|3|||
33452899|NCT00186186|62827424|FG000|Overall Study|Withdrawal by Subject|3|||
33452900|NCT00186186|62827424|FG000|Overall Study|Not reported as to reason|2|||
33452901|NCT00185640|62827429|FG000|Overall Study|Not Eligible|4|||
33452902|NCT00185640|62827429|FG000|Overall Study|Withdrawal by Subject|3|||
33452903|NCT00185640|62827429|FG000|Overall Study|Death|138|||
33452904|NCT03760666|62827436|FG000|Overall Study|Adverse Event|2|||
33452905|NCT03760666|62827437|FG001|Overall Study|Adverse Event|4|||
33452906|NCT03760666|62827438|FG002|Overall Study|Adverse Event|1|||
33452907|NCT03760666|62827436|FG000|Overall Study|AML Disease Progression|3|||
33452908|NCT03760666|62827437|FG001|Overall Study|AML Disease Progression|3|||
33452909|NCT03760666|62827438|FG002|Overall Study|AML Disease Progression|0|||
33452910|NCT03760666|62827436|FG000|Overall Study|Physician Decision|0|||
33452911|NCT03760666|62827437|FG001|Overall Study|Physician Decision|3|||
33452912|NCT03760666|62827438|FG002|Overall Study|Physician Decision|0|||
33452913|NCT03760666|62827436|FG000|Overall Study|Withdrawal by Subject|0|||
33452914|NCT03760666|62827437|FG001|Overall Study|Withdrawal by Subject|1|||
33452915|NCT03760666|62827438|FG002|Overall Study|Withdrawal by Subject|0|||
33452916|NCT03760510|62827451|FG000|Overall Study|Not ventilated for 24 hours|105|||
33452917|NCT03760510|62827452|FG001|Overall Study|Not ventilated for 24 hours|97|||
33452918|NCT00224484|62827461|FG000|Overall Study|Serious Adverse Event|1|||
33452919|NCT00224484|62827462|FG001|Overall Study|Serious Adverse Event|1|||
33452920|NCT00224484|62827463|FG002|Overall Study|Serious Adverse Event|0|||
33452921|NCT00224484|62827461|FG000|Overall Study|Non-Serious Adverse Event|5|||
33452922|NCT00224484|62827462|FG001|Overall Study|Non-Serious Adverse Event|7|||
33452923|NCT00224484|62827463|FG002|Overall Study|Non-Serious Adverse Event|3|||
33452924|NCT00224484|62827461|FG000|Overall Study|Protocol Violation|2|||
33452925|NCT00224484|62827462|FG001|Overall Study|Protocol Violation|2|||
33452926|NCT00224484|62827463|FG002|Overall Study|Protocol Violation|0|||
33452927|NCT00224484|62827461|FG000|Overall Study|Withdrawal by Subject|49|||
33452928|NCT00224484|62827462|FG001|Overall Study|Withdrawal by Subject|18|||
33452929|NCT00224484|62827463|FG002|Overall Study|Withdrawal by Subject|16|||
33452930|NCT00224484|62827461|FG000|Overall Study|Migrated/moved from study area|18|||
33452931|NCT00224484|62827462|FG001|Overall Study|Migrated/moved from study area|5|||
33452932|NCT00224484|62827463|FG002|Overall Study|Migrated/moved from study area|5|||
33452933|NCT00224484|62827461|FG000|Overall Study|Lost to Follow-up|66|||
33452934|NCT00224484|62827462|FG001|Overall Study|Lost to Follow-up|28|||
33452935|NCT00224484|62827463|FG002|Overall Study|Lost to Follow-up|36|||
33452936|NCT00224484|62827461|FG000|Overall Study|Reason not specified|5|||
33452937|NCT00224484|62827462|FG001|Overall Study|Reason not specified|4|||
33452938|NCT00224484|62827463|FG002|Overall Study|Reason not specified|2|||
33452939|NCT00254982|62827476|FG000|Overall Study|Other|2|||
33452940|NCT00254982|62827477|FG001|Overall Study|Other|1|||
33452941|NCT00254982|62827476|FG000|Overall Study|Lack of Efficacy|5|||
33452942|NCT00254982|62827477|FG001|Overall Study|Lack of Efficacy|3|||
33452943|NCT00254982|62827476|FG000|Overall Study|Lost to Follow-up|5|||
33452944|NCT00254982|62827477|FG001|Overall Study|Lost to Follow-up|3|||
33452945|NCT00254982|62827476|FG000|Overall Study|Adverse Event|18|||
33452946|NCT00254982|62827477|FG001|Overall Study|Adverse Event|16|||
33452947|NCT00254982|62827476|FG000|Overall Study|Withdrawal by Subject|1|||
33452948|NCT00254982|62827477|FG001|Overall Study|Withdrawal by Subject|1|||
33452949|NCT00254982|62827476|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
33452950|NCT00254982|62827477|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
33452951|NCT00254982|62827476|FG000|Overall Study|Protocol deviation|1|||
33452952|NCT00254982|62827477|FG001|Overall Study|Protocol deviation|1|||
33452953|NCT00254982|62827476|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
33452954|NCT00254982|62827477|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
33614312|NCT01641809|63015207|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
33614313|NCT01641809|63015208|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
33614314|NCT01641809|63015209|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
33614315|NCT01641809|63015210|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
33614316|NCT01641809|63015207|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
33614317|NCT01641809|63015208|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
33614318|NCT01641809|63015209|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
33614319|NCT01641809|63015210|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
33614320|NCT01641809|63015207|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
33614321|NCT01641809|63015208|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
33614322|NCT01641809|63015209|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
33614323|NCT01641809|63015210|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
33614324|NCT01641809|63015207|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
33614325|NCT01641809|63015208|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
33614326|NCT01641809|63015209|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
33614327|NCT01641809|63015210|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
33614328|NCT01641809|63015207|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
33614329|NCT01641809|63015208|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
33614330|NCT01641809|63015209|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
33614331|NCT01641809|63015210|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
33614332|NCT01641809|63015207|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
33614333|NCT01641809|63015208|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
33614334|NCT01641809|63015209|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
33614335|NCT01641809|63015210|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
33614336|NCT01632566|63015233|FG000|Overall Study|Withdrawal by Subject|0|||
33614337|NCT01632566|63015234|FG001|Overall Study|Withdrawal by Subject|1|||
33614338|NCT01632566|63015235|FG002|Overall Study|Withdrawal by Subject|0|||
33614339|NCT01632566|63015236|FG003|Overall Study|Withdrawal by Subject|0|||
33614340|NCT01632566|63015237|FG004|Overall Study|Withdrawal by Subject|0|||
33614341|NCT01632566|63015233|FG000|Overall Study|Sponsor Decision|0|||
33614342|NCT01632566|63015234|FG001|Overall Study|Sponsor Decision|2|||
33614343|NCT01632566|63015235|FG002|Overall Study|Sponsor Decision|9|||
33614344|NCT01632566|63015236|FG003|Overall Study|Sponsor Decision|2|||
33614345|NCT01632566|63015237|FG004|Overall Study|Sponsor Decision|2|||
33614346|NCT02254304|63015255|FG000|Overall Study|Adverse Event|2|||
33614347|NCT02254304|63015256|FG001|Overall Study|Adverse Event|1|||
33614348|NCT02254304|63015255|FG000|Overall Study|Lost to Follow-up|2|||
33614349|NCT02254304|63015256|FG001|Overall Study|Lost to Follow-up|2|||
33614350|NCT02254304|63015255|FG000|Overall Study|Protocol Violation|1|||
33614351|NCT02254304|63015256|FG001|Overall Study|Protocol Violation|0|||
33614352|NCT02254304|63015255|FG000|Overall Study|Withdrawal by Subject|3|||
33614353|NCT02254304|63015256|FG001|Overall Study|Withdrawal by Subject|0|||
33614354|NCT02254304|63015255|FG000|Overall Study|Injection site pain and Injection fear|1|||
33614355|NCT02254304|63015256|FG001|Overall Study|Injection site pain and Injection fear|0|||
33614356|NCT02254304|63015255|FG000|Overall Study|Personal causes|4|||
33614357|NCT02254304|63015256|FG001|Overall Study|Personal causes|1|||
33452955|NCT00254982|62827476|FG000|Overall Study|Malignancy|0|||
33452956|NCT00254982|62827477|FG001|Overall Study|Malignancy|2|||
33452957|NCT00254982|62827476|FG000|Overall Study|Opportunistic infection|1|||
33614358|NCT02254304|63015255|FG000|Overall Study|Personal decision|1|||
33614359|NCT02254304|63015256|FG001|Overall Study|Personal decision|0|||
33614360|NCT02174731|63015266|FG000|Overall Study|Participant decision|67|||
33452958|NCT00254982|62827477|FG001|Overall Study|Opportunistic infection|0|||
33452959|NCT00254982|62827476|FG000|Overall Study|Abnormal liver function tests|2|||
33452960|NCT00254982|62827477|FG001|Overall Study|Abnormal liver function tests|1|||
33452961|NCT03759340|62827483|FG000|Overall Study|Adverse Event|2|||
33452962|NCT03759340|62827483|FG000|Overall Study|Lost to Follow-up|1|||
33452963|NCT03759340|62827483|FG000|Overall Study|Withdrawal by Subject|15|||
33614361|NCT02174731|63015267|FG001|Overall Study|Participant decision|64|||
33614362|NCT02174731|63015266|FG000|Overall Study|Incorrect enrolment before randomization|0|||
33452964|NCT03759340|62827483|FG000|Overall Study|Study Terminated by Sponsor|38|||
33614363|NCT02174731|63015267|FG001|Overall Study|Incorrect enrolment before randomization|1|||
33614364|NCT02174731|63015266|FG000|Overall Study|Missing|2|||
33614365|NCT02174731|63015267|FG001|Overall Study|Missing|0|||
33614366|NCT01922037|63015275|FG000|Overall Study|Withdrawal by Subject|2|||
33614367|NCT01922037|63015276|FG001|Overall Study|Withdrawal by Subject|44|||
33614368|NCT01922037|63015275|FG000|Overall Study|Adverse Event|1|||
33614369|NCT01922037|63015276|FG001|Overall Study|Adverse Event|7|||
33614370|NCT01922037|63015275|FG000|Overall Study|Death|0|||
33614371|NCT01922037|63015276|FG001|Overall Study|Death|5|||
33614372|NCT01922037|63015275|FG000|Overall Study|Pregnancy|0|||
33452965|NCT00224016|62827489|FG000|Titration Period|Withdrawal by Subject|0|||
33452966|NCT00224016|62827490|FG001|Titration Period|Withdrawal by Subject|1|||
33452967|NCT00224016|62827489|FG000|Titration Period|Lost to Follow-up|1|||
33452968|NCT00224016|62827490|FG001|Titration Period|Lost to Follow-up|0|||
33452969|NCT00224016|62827489|FG000|Maintenance Period|Withdrawal by Subject|2|||
33452970|NCT00224016|62827490|FG001|Maintenance Period|Withdrawal by Subject|0|||
33452971|NCT00224016|62827489|FG000|Maintenance Period|Lost to Follow-up|0|||
33452972|NCT00224016|62827490|FG001|Maintenance Period|Lost to Follow-up|1|||
33452973|NCT03757234|62827501|FG000|Overall Study|Adverse Event|0|||
33452974|NCT03757234|62827502|FG001|Overall Study|Adverse Event|0|||
33452975|NCT03757234|62827503|FG002|Overall Study|Adverse Event|0|||
33452976|NCT03757234|62827504|FG003|Overall Study|Adverse Event|0|||
33452977|NCT03757234|62827505|FG004|Overall Study|Adverse Event|1|||
33452978|NCT03757234|62827501|FG000|Overall Study|Lost to Follow-up|1|||
33452979|NCT03757234|62827502|FG001|Overall Study|Lost to Follow-up|0|||
33452980|NCT03757234|62827503|FG002|Overall Study|Lost to Follow-up|0|||
33452981|NCT03757234|62827504|FG003|Overall Study|Lost to Follow-up|0|||
33452982|NCT03757234|62827505|FG004|Overall Study|Lost to Follow-up|1|||
33452983|NCT03757234|62827501|FG000|Overall Study|Withdrawal by Subject|1|||
33452984|NCT03757234|62827502|FG001|Overall Study|Withdrawal by Subject|1|||
33452985|NCT03757234|62827503|FG002|Overall Study|Withdrawal by Subject|0|||
33452986|NCT03757234|62827504|FG003|Overall Study|Withdrawal by Subject|1|||
33452987|NCT03757234|62827505|FG004|Overall Study|Withdrawal by Subject|2|||
33452988|NCT03757234|62827501|FG000|Overall Study|Other|1|||
33452989|NCT03757234|62827502|FG001|Overall Study|Other|1|||
33452990|NCT03757234|62827503|FG002|Overall Study|Other|0|||
33452991|NCT03757234|62827504|FG003|Overall Study|Other|0|||
33452992|NCT03757234|62827505|FG004|Overall Study|Other|0|||
33452993|NCT00223080|62827519|FG000|Overall Study|Withdrawal by Subject|253|||
33452994|NCT00223080|62827520|FG001|Overall Study|Withdrawal by Subject|232|||
33452995|NCT00223080|62827519|FG000|Overall Study|Required contraindicated med|0|||
33452996|NCT00223080|62827520|FG001|Overall Study|Required contraindicated med|1|||
33452997|NCT00223080|62827519|FG000|Overall Study|Non-compliant|7|||
33452998|NCT00223080|62827520|FG001|Overall Study|Non-compliant|7|||
33452999|NCT00223080|62827519|FG000|Overall Study|Moved from study area|37|||
33453000|NCT00223080|62827520|FG001|Overall Study|Moved from study area|47|||
33453001|NCT00223080|62827519|FG000|Overall Study|Lost to Follow-up|259|||
33453002|NCT00223080|62827520|FG001|Overall Study|Lost to Follow-up|284|||
33453003|NCT00223080|62827519|FG000|Overall Study|Death|85|||
33453004|NCT00223080|62827520|FG001|Overall Study|Death|74|||
33453005|NCT00223080|62827519|FG000|Overall Study|Other|14|||
33453006|NCT00223080|62827520|FG001|Overall Study|Other|11|||
33453007|NCT00223080|62827519|FG000|Overall Study|Reason not provided|141|||
33453008|NCT00223080|62827520|FG001|Overall Study|Reason not provided|140|||
33453009|NCT00223080|62827519|FG000|Overall Study|Adverse Event|0|||
33453010|NCT00223080|62827520|FG001|Overall Study|Adverse Event|1|||
33453011|NCT00220740|62827528|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
33453012|NCT00220740|62827529|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
33453013|NCT00220740|62827528|FG000|Efficacy Period|Adverse Event|1|||
33614373|NCT01922037|63015276|FG001|Overall Study|Pregnancy|2|||
33453014|NCT00220740|62827529|FG001|Efficacy Period|Adverse Event|1|||
33614374|NCT01922037|63015275|FG000|Overall Study|Participant non-compliance|4|||
33614375|NCT01922037|63015276|FG001|Overall Study|Participant non-compliance|46|||
33614376|NCT01922037|63015275|FG000|Overall Study|Investigator/Sponsor decision|1|||
33453015|NCT00220740|62827528|FG000|Efficacy Period|Withdrawal by Subject|1|||
33453016|NCT00220740|62827529|FG001|Efficacy Period|Withdrawal by Subject|0|||
33453017|NCT00220740|62827528|FG000|Efficacy Period|Protocol Violation|1|||
33453018|NCT00220740|62827529|FG001|Efficacy Period|Protocol Violation|0|||
33614377|NCT01922037|63015276|FG001|Overall Study|Investigator/Sponsor decision|4|||
33453019|NCT00220740|62827528|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
33453020|NCT00220740|62827529|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
33453021|NCT00184002|62827537|FG000|Overall Study|Adverse Event|9|||
33453022|NCT00184002|62827537|FG000|Overall Study|Death|3|||
33453023|NCT00184002|62827537|FG000|Overall Study|Physician Decision|1|||
33453024|NCT00184002|62827537|FG000|Overall Study|Withdrawal by Subject|4|||
33453025|NCT00165672|62827543|FG000|Overall Study|Adverse Event|0|||
33453026|NCT00165672|62827544|FG001|Overall Study|Adverse Event|1|||
33453027|NCT00180414|62827552|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
33453028|NCT00180414|62827553|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
33453029|NCT00174252|62827559|FG000|Overall Study|Protocol Violation|2|||
33453030|NCT00169104|62827567|FG000|Overall Study|Withdrawal by Subject|2|||
33453031|NCT00169104|62827568|FG001|Overall Study|Withdrawal by Subject|0|||
33453032|NCT00169104|62827567|FG000|Overall Study|Protocol Violation|0|||
33453033|NCT00169104|62827568|FG001|Overall Study|Protocol Violation|1|||
33453034|NCT00169104|62827567|FG000|Overall Study|Physician Decision|0|||
33453035|NCT00169104|62827568|FG001|Overall Study|Physician Decision|1|||
33453036|NCT00163020|62827577|FG000|Overall Study|Lost to Follow-up|0|||
33453037|NCT00163020|62827578|FG001|Overall Study|Lost to Follow-up|2|||
33453038|NCT00252720|62827588|FG000|Overall Study|Withdrawal by Subject|95|||
33453039|NCT00252720|62827589|FG001|Overall Study|Withdrawal by Subject|97|||
33453040|NCT00252720|62827588|FG000|Overall Study|Death|7|||
33453041|NCT00252720|62827589|FG001|Overall Study|Death|8|||
33453042|NCT00252720|62827588|FG000|Overall Study|Moving|23|||
33453043|NCT00252720|62827589|FG001|Overall Study|Moving|42|||
33453044|NCT00252720|62827588|FG000|Overall Study|Mainly patients lost to follow-up|7|||
33324499|NCT00910000|62701043|FG003|Overall Study|Withdrawal by Subject|0|||
33324500|NCT00910000|62701044|FG004|Overall Study|Withdrawal by Subject|1|||
33324501|NCT00910000|62701045|FG005|Overall Study|Withdrawal by Subject|0|||
33324502|NCT01119768|62701066|FG000|Treatment Period|Lack of Efficacy|18|||
33324503|NCT01119768|62701067|FG001|Treatment Period|Lack of Efficacy|25|||
33324504|NCT01165307|62701075|FG000|Overall Study|Lost to Follow-up|11|||
33324505|NCT01165307|62701076|FG001|Overall Study|Lost to Follow-up|3|||
33324506|NCT01165307|62701075|FG000|Overall Study|Withdrawal by Subject|2|||
33324507|NCT01165307|62701076|FG001|Overall Study|Withdrawal by Subject|0|||
33324508|NCT01165307|62701075|FG000|Overall Study|Subject not available for contact|1|||
33324509|NCT01165307|62701076|FG001|Overall Study|Subject not available for contact|0|||
33324510|NCT00960999|62701084|FG000|Overall Study|Withdrawal by Subject|1|||
33324511|NCT00960999|62701085|FG001|Overall Study|Withdrawal by Subject|0|||
33324512|NCT00960999|62701084|FG000|Overall Study|Protocol Violation|5|||
33614378|NCT01922037|63015275|FG000|Overall Study|Other unspecified|2|||
33614379|NCT01922037|63015276|FG001|Overall Study|Other unspecified|66|||
33614380|NCT02282813|63015287|FG000|Overall Study|Withdrawal by Subject|4|||
33614381|NCT02282813|63015288|FG001|Overall Study|Withdrawal by Subject|5|||
33614382|NCT02282813|63015289|FG002|Overall Study|Withdrawal by Subject|0|||
33614383|NCT02282813|63015287|FG000|Overall Study|Adverse Event|3|||
33614384|NCT02282813|63015288|FG001|Overall Study|Adverse Event|10|||
33614385|NCT02282813|63015289|FG002|Overall Study|Adverse Event|1|||
33614386|NCT02282813|63015287|FG000|Overall Study|Subject non-compliance|1|||
33614387|NCT02282813|63015288|FG001|Overall Study|Subject non-compliance|4|||
33614388|NCT02282813|63015289|FG002|Overall Study|Subject non-compliance|0|||
33614389|NCT02282813|63015287|FG000|Overall Study|Physician Decision|0|||
33614390|NCT02282813|63015288|FG001|Overall Study|Physician Decision|3|||
33614391|NCT02282813|63015289|FG002|Overall Study|Physician Decision|1|||
33614392|NCT02282813|63015287|FG000|Overall Study|Lost to Follow-up|2|||
33614393|NCT02282813|63015288|FG001|Overall Study|Lost to Follow-up|0|||
33614394|NCT02282813|63015289|FG002|Overall Study|Lost to Follow-up|1|||
33614395|NCT02282813|63015287|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
33614396|NCT02282813|63015288|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
33324513|NCT00960999|62701085|FG001|Overall Study|Protocol Violation|2|||
33324514|NCT00960999|62701084|FG000|Overall Study|RT dose constraints not met|2|||
33324515|NCT00960999|62701085|FG001|Overall Study|RT dose constraints not met|0|||
33324516|NCT01124838|62701093|FG000|Overall Study|Miscellaneous|4|||
33324517|NCT01124838|62701094|FG001|Overall Study|Miscellaneous|2|||
33324518|NCT01124838|62701093|FG000|Overall Study|Adverse Event|7|||
33614397|NCT02282813|63015289|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
33614398|NCT02282813|63015287|FG000|Overall Study|Lack of Efficacy|1|||
33614399|NCT02282813|63015288|FG001|Overall Study|Lack of Efficacy|0|||
33614400|NCT02282813|63015289|FG002|Overall Study|Lack of Efficacy|0|||
33614401|NCT02282813|63015287|FG000|Overall Study|Administrative reasons|0|||
33324519|NCT01124838|62701094|FG001|Overall Study|Adverse Event|11|||
33614402|NCT02282813|63015288|FG001|Overall Study|Administrative reasons|1|||
33614403|NCT02282813|63015289|FG002|Overall Study|Administrative reasons|0|||
33324520|NCT01124838|62701093|FG000|Overall Study|Lack of Efficacy|2|||
33324521|NCT01124838|62701094|FG001|Overall Study|Lack of Efficacy|0|||
33324522|NCT01124838|62701093|FG000|Overall Study|Withdrawal by Subject|3|||
33324523|NCT01124838|62701094|FG001|Overall Study|Withdrawal by Subject|2|||
33614404|NCT01903863|63015301|FG000|Overall Study|Physician Decision|2|||
33614405|NCT01903863|63015302|FG001|Overall Study|Physician Decision|0|||
33614406|NCT02123251|63015310|FG000|Overall Study|Death|1|||
33324524|NCT01124838|62701093|FG000|Overall Study|Lost to Follow-up|2|||
33324525|NCT01124838|62701094|FG001|Overall Study|Lost to Follow-up|0|||
33324526|NCT00959751|62701104|FG000|Overall Study|Lost to Follow-up|2|||
33324527|NCT00959751|62701105|FG001|Overall Study|Lost to Follow-up|3|||
33324528|NCT00959751|62701104|FG000|Overall Study|Consent Withdrawn|0|||
33324529|NCT00959751|62701105|FG001|Overall Study|Consent Withdrawn|1|||
33324530|NCT00959751|62701104|FG000|Overall Study|Non-compliance to Study Procedures|0|||
33324531|NCT00959751|62701105|FG001|Overall Study|Non-compliance to Study Procedures|1|||
33324532|NCT00959751|62701104|FG000|Overall Study|No migraine headache without aura|7|||
33324533|NCT00959751|62701105|FG001|Overall Study|No migraine headache without aura|7|||
33324534|NCT00910858|62701114|FG000|Pharmacokinetic Phase|Adverse Event|1|||
33324535|NCT00910858|62701115|FG001|Pharmacokinetic Phase|Adverse Event|0|||
33324536|NCT00910858|62701116|FG002|Pharmacokinetic Phase|Adverse Event|0|||
33324537|NCT00910858|62701114|FG000|Monotherapy Phase|Adverse Event|3|||
33324538|NCT00910858|62701115|FG001|Monotherapy Phase|Adverse Event|2|||
33324539|NCT00910858|62701116|FG002|Monotherapy Phase|Adverse Event|0|||
33324540|NCT00910858|62701114|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
33324541|NCT00910858|62701115|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
33324542|NCT00910858|62701116|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
33324543|NCT00910858|62701114|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
33324544|NCT00910858|62701115|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
33324545|NCT00910858|62701116|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
33324546|NCT00910858|62701114|FG000|Monotherapy Phase|Protocol Violation|1|||
33324547|NCT00910858|62701115|FG001|Monotherapy Phase|Protocol Violation|0|||
33324548|NCT00910858|62701116|FG002|Monotherapy Phase|Protocol Violation|0|||
33324549|NCT00910858|62701114|FG000|Monotherapy Phase|Other|3|||
33324550|NCT00910858|62701115|FG001|Monotherapy Phase|Other|4|||
33324551|NCT00910858|62701116|FG002|Monotherapy Phase|Other|2|||
33324552|NCT00910858|62701114|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
33324553|NCT00910858|62701115|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
33324554|NCT00910858|62701116|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
33324555|NCT00910858|62701114|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
33324556|NCT00910858|62701115|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
33324557|NCT00910858|62701116|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
33324558|NCT00910858|62701114|FG000|Combined Treatment Phase|Protocol Violation|1|||
33324559|NCT00910858|62701115|FG001|Combined Treatment Phase|Protocol Violation|0|||
33324560|NCT00910858|62701116|FG002|Combined Treatment Phase|Protocol Violation|0|||
33324561|NCT00910858|62701114|FG000|Combined Treatment Phase|Other|0|||
33324562|NCT00910858|62701115|FG001|Combined Treatment Phase|Other|2|||
33324563|NCT00910858|62701116|FG002|Combined Treatment Phase|Other|1|||
33324564|NCT00598975|62701134|FG000|Overall Study|Adverse Event|1|||
33324565|NCT00598975|62701135|FG001|Overall Study|Adverse Event|1|||
33324566|NCT00598975|62701134|FG000|Overall Study|Brain metastases|1|||
33324567|NCT00598975|62701135|FG001|Overall Study|Brain metastases|0|||
33324568|NCT00598975|62701134|FG000|Overall Study|Withdrawal by Subject|1|||
33324569|NCT00598975|62701135|FG001|Overall Study|Withdrawal by Subject|1|||
33324570|NCT00598975|62701134|FG000|Overall Study|Withdrawal of consent|0|||
33324571|NCT00598975|62701135|FG001|Overall Study|Withdrawal of consent|1|||
33324572|NCT00598975|62701134|FG000|Overall Study|Disease progression|8|||
33324573|NCT00598975|62701135|FG001|Overall Study|Disease progression|3|||
33324574|NCT00598975|62701134|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
33324575|NCT00598975|62701135|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
33324576|NCT00957021|62701143|FG000|Overall Study|Death|5|||
33324577|NCT00957021|62701143|FG000|Overall Study|Lost to Follow-up|8|||
33324578|NCT00957021|62701143|FG000|Overall Study|Withdrawal by Subject|34|||
33324579|NCT00957021|62701143|FG000|Overall Study|No 2 yr ROM data|35|||
33324580|NCT00957021|62701143|FG000|Overall Study|Revised study component by 2 yr visit|8|||
33324581|NCT00957021|62701143|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
33324582|NCT00957021|62701143|FG000|Overall Study|Surgery Cancelled|9|||
33324583|NCT00957021|62701143|FG000|Overall Study|Termination due to language issue|2|||
33324584|NCT01124604|62701150|FG000|Overall Study|Adverse Event|10|||
33324585|NCT01124604|62701151|FG001|Overall Study|Adverse Event|1|||
33614407|NCT02123251|63015311|FG001|Overall Study|Death|1|||
33324586|NCT01124604|62701150|FG000|Overall Study|Lack of Efficacy|1|||
33324587|NCT01124604|62701151|FG001|Overall Study|Lack of Efficacy|0|||
33324588|NCT01124604|62701150|FG000|Overall Study|Withdrawal by Subject|4|||
33324589|NCT01124604|62701151|FG001|Overall Study|Withdrawal by Subject|0|||
33324590|NCT01124604|62701150|FG000|Overall Study|Disease Progression|0|||
33324591|NCT01124604|62701151|FG001|Overall Study|Disease Progression|1|||
33324592|NCT00909844|62701157|FG000|Overall Study|Adverse Event|1|||
33324593|NCT00909844|62701157|FG000|Overall Study|Withdrawal by Subject|1|||
33324594|NCT00909844|62701157|FG000|Overall Study|Lost to Follow-up|2|||
33324595|NCT01124448|62701164|FG000|Overall Study|Lost to Follow-up|0|||
33324596|NCT01124448|62701165|FG001|Overall Study|Lost to Follow-up|3|||
33324597|NCT01124448|62701164|FG000|Overall Study|Protocol Violation|2|||
33324598|NCT01124448|62701165|FG001|Overall Study|Protocol Violation|0|||
33324599|NCT01124292|62701174|FG000|Overall Study|Lost to Follow-up|2|||
33324600|NCT01124292|62701175|FG001|Overall Study|Lost to Follow-up|4|||
33324601|NCT01124292|62701176|FG002|Overall Study|Lost to Follow-up|3|||
33324602|NCT01124292|62701174|FG000|Overall Study|Physician Decision|0|||
33324603|NCT01124292|62701175|FG001|Overall Study|Physician Decision|3|||
33324604|NCT01124292|62701176|FG002|Overall Study|Physician Decision|2|||
33324605|NCT01124292|62701174|FG000|Overall Study|Withdrawal by Subject|0|||
33324606|NCT01124292|62701175|FG001|Overall Study|Withdrawal by Subject|6|||
33324607|NCT01124292|62701176|FG002|Overall Study|Withdrawal by Subject|2|||
33512856|NCT02509494|62897090|FG001|Overall Study|Non-Compliance With Study Drug|11|||
33512857|NCT02509494|62897091|FG002|Overall Study|Non-Compliance With Study Drug|7|||
33512858|NCT02509494|62897092|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33512859|NCT02509494|62897093|FG004|Overall Study|Non-Compliance With Study Drug|1|||
33512860|NCT02509494|62897094|FG005|Overall Study|Non-Compliance With Study Drug|2|||
33512861|NCT02509494|62897095|FG006|Overall Study|Non-Compliance With Study Drug|1|||
33512862|NCT02509494|62897096|FG007|Overall Study|Non-Compliance With Study Drug|1|||
33512863|NCT02509494|62897097|FG008|Overall Study|Non-Compliance With Study Drug|0|||
33512864|NCT03493451|62897134|FG000|Overall Study|Death|11|||
33512865|NCT03493451|62897135|FG001|Overall Study|Death|26|||
33512866|NCT03493451|62897136|FG002|Overall Study|Death|3|||
33512867|NCT03493451|62897134|FG000|Overall Study|Lost to Follow-up|1|||
33512868|NCT03493451|62897135|FG001|Overall Study|Lost to Follow-up|4|||
33512869|NCT03493451|62897136|FG002|Overall Study|Lost to Follow-up|1|||
33512870|NCT03493451|62897134|FG000|Overall Study|Withdrawal by Subject|1|||
33512871|NCT03493451|62897135|FG001|Overall Study|Withdrawal by Subject|1|||
33512872|NCT03493451|62897136|FG002|Overall Study|Withdrawal by Subject|2|||
33512873|NCT03493451|62897134|FG000|Overall Study|Progressive Disease|1|||
33512874|NCT03493451|62897135|FG001|Overall Study|Progressive Disease|0|||
33512875|NCT03493451|62897136|FG002|Overall Study|Progressive Disease|0|||
33512876|NCT03493451|62897134|FG000|Overall Study|Transferred to long term extension study|8|||
33512877|NCT03493451|62897135|FG001|Overall Study|Transferred to long term extension study|13|||
33512878|NCT03493451|62897136|FG002|Overall Study|Transferred to long term extension study|5|||
33512879|NCT03492281|62897147|FG000|Overall Study|Withdrawal by Subject|21|||
33512880|NCT03492281|62897148|FG001|Overall Study|Withdrawal by Subject|14|||
33512881|NCT03492281|62897149|FG002|Overall Study|Withdrawal by Subject|13|||
33512882|NCT03492281|62897147|FG000|Overall Study|Lost to Follow-up|14|||
33512883|NCT03492281|62897148|FG001|Overall Study|Lost to Follow-up|15|||
33324608|NCT01124292|62701174|FG000|Overall Study|medical issue unrelated to the study|0|||
33324609|NCT01124292|62701175|FG001|Overall Study|medical issue unrelated to the study|0|||
33324610|NCT01124292|62701176|FG002|Overall Study|medical issue unrelated to the study|2|||
33324611|NCT01124292|62701174|FG000|Overall Study|piercing track closed|0|||
33324612|NCT01124292|62701175|FG001|Overall Study|piercing track closed|2|||
33324613|NCT01124292|62701176|FG002|Overall Study|piercing track closed|1|||
33512884|NCT03492281|62897149|FG002|Overall Study|Lost to Follow-up|10|||
33512885|NCT03492281|62897147|FG000|Overall Study|Adverse Event|6|||
33512886|NCT03492281|62897148|FG001|Overall Study|Adverse Event|8|||
33512887|NCT03492281|62897149|FG002|Overall Study|Adverse Event|13|||
33512888|NCT03492281|62897147|FG000|Overall Study|Lack of Efficacy|3|||
33512889|NCT03492281|62897148|FG001|Overall Study|Lack of Efficacy|0|||
33512890|NCT03492281|62897149|FG002|Overall Study|Lack of Efficacy|1|||
33512891|NCT03492281|62897147|FG000|Overall Study|Physician Decision|1|||
33512892|NCT03492281|62897148|FG001|Overall Study|Physician Decision|0|||
33512893|NCT03492281|62897149|FG002|Overall Study|Physician Decision|3|||
33512894|NCT03492281|62897147|FG000|Overall Study|Protocol Violation|0|||
33512895|NCT03492281|62897148|FG001|Overall Study|Protocol Violation|2|||
33512896|NCT03492281|62897149|FG002|Overall Study|Protocol Violation|1|||
33324614|NCT01136772|62701189|FG000|Overall Study|Adverse Event|15|||
33324615|NCT01136772|62701190|FG001|Overall Study|Adverse Event|14|||
33324616|NCT01136772|62701189|FG000|Overall Study|Lack of Efficacy|42|||
33324617|NCT01136772|62701190|FG001|Overall Study|Lack of Efficacy|39|||
33512897|NCT03492281|62897147|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
33512898|NCT03492281|62897148|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
33512899|NCT03492281|62897149|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
33512900|NCT03492281|62897147|FG000|Overall Study|Death|0|||
33324618|NCT01136772|62701189|FG000|Overall Study|Administrative|14|||
33324619|NCT01136772|62701190|FG001|Overall Study|Administrative|12|||
33324620|NCT01136772|62701189|FG000|Overall Study|Withdrawal by Subject|33|||
33324621|NCT01136772|62701190|FG001|Overall Study|Withdrawal by Subject|36|||
33324622|NCT01136772|62701189|FG000|Overall Study|Did not receive injection|10|||
33324623|NCT01136772|62701190|FG001|Overall Study|Did not receive injection|7|||
33324624|NCT01136772|62701189|FG000|Overall Study|Did not follow up after first injection|2|||
33324625|NCT01136772|62701190|FG001|Overall Study|Did not follow up after first injection|2|||
33324626|NCT00909532|62701198|FG000|Overall Study|Adverse Event|4|||
33324627|NCT00909532|62701199|FG001|Overall Study|Adverse Event|1|||
33324628|NCT00909532|62701198|FG000|Overall Study|Pregnancy|0|||
33324629|NCT00909532|62701199|FG001|Overall Study|Pregnancy|1|||
33324630|NCT00909532|62701198|FG000|Overall Study|Prohibited Medication|2|||
33324631|NCT00909532|62701199|FG001|Overall Study|Prohibited Medication|1|||
33512901|NCT03492281|62897148|FG001|Overall Study|Death|0|||
33512902|NCT03492281|62897149|FG002|Overall Study|Death|1|||
33512903|NCT03492281|62897147|FG000|Overall Study|Captured as Other in Database|8|||
33512904|NCT03492281|62897148|FG001|Overall Study|Captured as Other in Database|6|||
33512905|NCT03492281|62897149|FG002|Overall Study|Captured as Other in Database|3|||
33512906|NCT03070782|62897166|FG000|Overall Study|Adverse Event|3|||
33512907|NCT03070782|62897167|FG001|Overall Study|Adverse Event|0|||
33512908|NCT03070782|62897168|FG002|Overall Study|Adverse Event|3|||
33512909|NCT03070782|62897169|FG003|Overall Study|Adverse Event|1|||
33512910|NCT03070782|62897170|FG004|Overall Study|Adverse Event|6|||
33512911|NCT03070782|62897171|FG005|Overall Study|Adverse Event|2|||
33512912|NCT03070782|62897166|FG000|Overall Study|Withdrawal by Subject|2|||
33512913|NCT03070782|62897167|FG001|Overall Study|Withdrawal by Subject|1|||
33512914|NCT03070782|62897168|FG002|Overall Study|Withdrawal by Subject|1|||
33512915|NCT03070782|62897169|FG003|Overall Study|Withdrawal by Subject|0|||
33512916|NCT03070782|62897170|FG004|Overall Study|Withdrawal by Subject|4|||
33512917|NCT03070782|62897171|FG005|Overall Study|Withdrawal by Subject|3|||
33512918|NCT03070782|62897166|FG000|Overall Study|Reason Not Specified|2|||
33512919|NCT03070782|62897167|FG001|Overall Study|Reason Not Specified|0|||
33512920|NCT03070782|62897168|FG002|Overall Study|Reason Not Specified|0|||
33512921|NCT03070782|62897169|FG003|Overall Study|Reason Not Specified|1|||
33512922|NCT03070782|62897170|FG004|Overall Study|Reason Not Specified|2|||
33512923|NCT03070782|62897171|FG005|Overall Study|Reason Not Specified|1|||
33512924|NCT03070782|62897166|FG000|Overall Study|Ineligibility|0|||
33512925|NCT03070782|62897167|FG001|Overall Study|Ineligibility|0|||
33512926|NCT03070782|62897168|FG002|Overall Study|Ineligibility|0|||
33512927|NCT03070782|62897169|FG003|Overall Study|Ineligibility|1|||
33512928|NCT03070782|62897170|FG004|Overall Study|Ineligibility|0|||
33512929|NCT03070782|62897171|FG005|Overall Study|Ineligibility|1|||
33512930|NCT03070782|62897166|FG000|Overall Study|Pregnancy|0|||
33512931|NCT03070782|62897167|FG001|Overall Study|Pregnancy|0|||
33512932|NCT03070782|62897168|FG002|Overall Study|Pregnancy|0|||
33512933|NCT03070782|62897169|FG003|Overall Study|Pregnancy|1|||
33512934|NCT03070782|62897170|FG004|Overall Study|Pregnancy|0|||
33512935|NCT03070782|62897171|FG005|Overall Study|Pregnancy|0|||
33512936|NCT03070782|62897166|FG000|Overall Study|Investigator Judgement|0|||
33512937|NCT03070782|62897167|FG001|Overall Study|Investigator Judgement|0|||
33512938|NCT03070782|62897168|FG002|Overall Study|Investigator Judgement|0|||
33512939|NCT03070782|62897169|FG003|Overall Study|Investigator Judgement|1|||
33512940|NCT03070782|62897170|FG004|Overall Study|Investigator Judgement|0|||
33512941|NCT03070782|62897171|FG005|Overall Study|Investigator Judgement|0|||
33512942|NCT03525119|62897207|FG000|Overall Study|Adverse Event|0|||
33512943|NCT03525119|62897208|FG001|Overall Study|Adverse Event|1|||
33512944|NCT03525119|62897209|FG002|Overall Study|Adverse Event|0|||
33324632|NCT00909532|62701198|FG000|Overall Study|Withdrawal of Consent|1|||
33324633|NCT00909532|62701199|FG001|Overall Study|Withdrawal of Consent|1|||
33512945|NCT03525119|62897207|FG000|Overall Study|Lost to Follow-up|32|||
33324634|NCT00909532|62701198|FG000|Overall Study|Noncompliance with Study Requirements|0|||
33512946|NCT03525119|62897208|FG001|Overall Study|Lost to Follow-up|33|||
33512947|NCT03525119|62897209|FG002|Overall Study|Lost to Follow-up|37|||
33512948|NCT03525119|62897207|FG000|Overall Study|Withdrawal by Subject|5|||
33512949|NCT03525119|62897208|FG001|Overall Study|Withdrawal by Subject|4|||
33512950|NCT03525119|62897209|FG002|Overall Study|Withdrawal by Subject|2|||
33512951|NCT03525119|62897207|FG000|Overall Study|Reason not Specified|2|||
33512952|NCT03525119|62897208|FG001|Overall Study|Reason not Specified|1|||
33512953|NCT03525119|62897209|FG002|Overall Study|Reason not Specified|2|||
33512954|NCT03525119|62897207|FG000|Overall Study|Randomized but not Vaccinated|1|||
33512955|NCT03525119|62897208|FG001|Overall Study|Randomized but not Vaccinated|0|||
33512956|NCT03525119|62897209|FG002|Overall Study|Randomized but not Vaccinated|2|||
33512957|NCT03558503|62897217|FG000|Overall Study|Adverse Event|1|||
33512958|NCT03558503|62897217|FG000|Overall Study|Death|1|||
33512959|NCT03558503|62897217|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
33512960|NCT03489863|62897223|FG000|Overall Study|Withdrawal by Subject|0|||
33512961|NCT03489863|62897224|FG001|Overall Study|Withdrawal by Subject|1|||
33512962|NCT03489551|62897230|FG000|Overall Study|Withdrawal by Subject|2|||
33512963|NCT03557801|62897237|FG000|Overall Study|Protocol Violation|1|||
33512964|NCT03557801|62897238|FG001|Overall Study|Protocol Violation|0|||
33512965|NCT03557801|62897239|FG002|Overall Study|Protocol Violation|0|||
33512966|NCT03557801|62897237|FG000|Overall Study|Withdrawal by Subject|1|||
33512967|NCT03557801|62897238|FG001|Overall Study|Withdrawal by Subject|0|||
33512968|NCT03557801|62897239|FG002|Overall Study|Withdrawal by Subject|3|||
33512969|NCT03557801|62897237|FG000|Overall Study|Lost to Follow-up|0|||
33512970|NCT03557801|62897238|FG001|Overall Study|Lost to Follow-up|1|||
33512971|NCT03557801|62897239|FG002|Overall Study|Lost to Follow-up|0|||
33512972|NCT04210180|62897247|FG000|Overall Study|Withdrawal by Subject|2|||
33512973|NCT03523871|62897251|FG000|Overall Study|Death|1|||
33512974|NCT03523715|62897257|FG000|Overall Study|Lost to Follow-up|11|||
33512975|NCT03523715|62897258|FG001|Overall Study|Lost to Follow-up|14|||
33512976|NCT03523715|62897257|FG000|Overall Study|Did not meet inclusion criteria|1|||
33512977|NCT03523715|62897258|FG001|Overall Study|Did not meet inclusion criteria|0|||
33512978|NCT03523715|62897257|FG000|Overall Study|Internally inconsistent reporting|0|||
33512979|NCT03523715|62897258|FG001|Overall Study|Internally inconsistent reporting|2|||
33512980|NCT03980730|62897266|FG000|Overall Study|Study Terminated by Sponsor|0|||
33512981|NCT03980730|62897267|FG001|Overall Study|Study Terminated by Sponsor|3|||
33512982|NCT03980730|62897266|FG000|Overall Study|Adverse Event|2|||
33512983|NCT03980730|62897267|FG001|Overall Study|Adverse Event|0|||
33512984|NCT03980730|62897266|FG000|Overall Study|Sponsor Request|0|||
33512985|NCT03980730|62897267|FG001|Overall Study|Sponsor Request|1|||
33512986|NCT03523091|62897275|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
33512987|NCT03523091|62897276|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
33512988|NCT03523091|62897275|FG000|Overall Study|Withdrawal by Subject|0|||
33512989|NCT03523091|62897276|FG001|Overall Study|Withdrawal by Subject|3|||
33512990|NCT03523091|62897275|FG000|Overall Study|Increase Botox dose|0|||
33512991|NCT03523091|62897276|FG001|Overall Study|Increase Botox dose|1|||
33512992|NCT03438383|62897297|FG000|Overall Study|Protocol Violation|9|||
33512993|NCT03438383|62897298|FG001|Overall Study|Protocol Violation|3|||
33512994|NCT03478787|62897306|FG000|Overall Study|Adverse Event|5|||
33512995|NCT03478787|62897307|FG001|Overall Study|Adverse Event|1|||
33512996|NCT03478787|62897306|FG000|Overall Study|Protocol Violation|3|||
33512997|NCT03478787|62897307|FG001|Overall Study|Protocol Violation|0|||
33512998|NCT03478787|62897306|FG000|Overall Study|Lack of Efficacy|7|||
33512999|NCT03478787|62897307|FG001|Overall Study|Lack of Efficacy|1|||
33513000|NCT03478787|62897306|FG000|Overall Study|Lost to Follow-up|9|||
33513001|NCT03478787|62897307|FG001|Overall Study|Lost to Follow-up|5|||
33513002|NCT03478787|62897306|FG000|Overall Study|Withdrawal by Subject|2|||
33513003|NCT03478787|62897307|FG001|Overall Study|Withdrawal by Subject|6|||
33513004|NCT03478787|62897306|FG000|Overall Study|Other, Not Specified|3|||
33513005|NCT03478787|62897307|FG001|Overall Study|Other, Not Specified|0|||
33513006|NCT03488927|62897316|FG000|Overall Study|Withdrawal by Subject|44|||
33513007|NCT03488927|62897317|FG001|Overall Study|Withdrawal by Subject|118|||
33513008|NCT03488927|62897318|FG002|Overall Study|Withdrawal by Subject|217|||
33513009|NCT03488225|62897326|FG000|Overall Study|Off Protocol Therapy|2|||
33513010|NCT03488225|62897326|FG000|Overall Study|Stem Cell Transplant|2|||
33513011|NCT03437447|62897333|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33513012|NCT03437447|62897334|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33513013|NCT03437447|62897335|FG002|Treatment Period 1|Withdrawal by Subject|1|||
33513014|NCT03487445|62897358|FG000|Randomization|Not treated for administrative reasons|1|||
33513015|NCT03487445|62897359|FG001|Randomization|Not treated for administrative reasons|0|||
33513016|NCT02109172|62897365|FG000|Overall Study|Withdrawal by Subject|1|||
33513017|NCT02109172|62897366|FG001|Overall Study|Withdrawal by Subject|0|||
33513018|NCT02109172|62897367|FG002|Overall Study|Withdrawal by Subject|0|||
33513019|NCT02109172|62897368|FG003|Overall Study|Withdrawal by Subject|1|||
33513020|NCT02109172|62897369|FG004|Overall Study|Withdrawal by Subject|0|||
33513021|NCT02109172|62897370|FG005|Overall Study|Withdrawal by Subject|0|||
33513022|NCT02109172|62897365|FG000|Overall Study|Adverse Event|0|||
33513023|NCT02109172|62897366|FG001|Overall Study|Adverse Event|0|||
33513024|NCT02109172|62897367|FG002|Overall Study|Adverse Event|1|||
33513025|NCT02109172|62897368|FG003|Overall Study|Adverse Event|0|||
33513026|NCT02109172|62897369|FG004|Overall Study|Adverse Event|0|||
33513027|NCT02109172|62897370|FG005|Overall Study|Adverse Event|1|||
33513028|NCT02109172|62897365|FG000|Overall Study|Death|0|||
33513029|NCT02109172|62897366|FG001|Overall Study|Death|0|||
33513030|NCT02109172|62897367|FG002|Overall Study|Death|0|||
33513031|NCT02109172|62897368|FG003|Overall Study|Death|0|||
33513032|NCT02109172|62897369|FG004|Overall Study|Death|1|||
33513033|NCT02109172|62897370|FG005|Overall Study|Death|0|||
33513034|NCT02974868|62897381|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
33513035|NCT02974868|62897382|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
33513036|NCT02974868|62897383|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
33513037|NCT02974868|62897384|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
33513038|NCT02974868|62897381|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
33513039|NCT02974868|62897382|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
33513040|NCT02974868|62897383|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
33513041|NCT02974868|62897384|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
33513042|NCT02974868|62897381|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
33513043|NCT02974868|62897382|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
33513044|NCT02974868|62897383|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
33513045|NCT02974868|62897384|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
33513046|NCT02974868|62897381|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
33513047|NCT02974868|62897382|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
33513048|NCT02974868|62897383|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
33513049|NCT02974868|62897384|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
33513050|NCT03486899|62897429|FG000|Overall Study|Lost to Follow-up|4|||
33513051|NCT03486899|62897430|FG001|Overall Study|Lost to Follow-up|1|||
33513052|NCT03486899|62897431|FG002|Overall Study|Lost to Follow-up|4|||
33513053|NCT03486899|62897432|FG003|Overall Study|Lost to Follow-up|3|||
33513054|NCT03486899|62897429|FG000|Overall Study|Death|1|||
33513055|NCT03486899|62897430|FG001|Overall Study|Death|0|||
33513056|NCT03486899|62897431|FG002|Overall Study|Death|0|||
33513057|NCT03486899|62897432|FG003|Overall Study|Death|1|||
33513058|NCT03486899|62897429|FG000|Overall Study|Adverse Event|0|||
33513059|NCT03486899|62897430|FG001|Overall Study|Adverse Event|2|||
33513060|NCT03486899|62897431|FG002|Overall Study|Adverse Event|0|||
33513061|NCT03486899|62897432|FG003|Overall Study|Adverse Event|2|||
33513062|NCT03486899|62897429|FG000|Overall Study|Withdrawal by Subject|3|||
33513063|NCT03486899|62897430|FG001|Overall Study|Withdrawal by Subject|7|||
33513064|NCT03486899|62897431|FG002|Overall Study|Withdrawal by Subject|4|||
33513065|NCT03486899|62897432|FG003|Overall Study|Withdrawal by Subject|3|||
33513066|NCT03486899|62897429|FG000|Overall Study|Other Reasons|0|||
33513067|NCT03486899|62897430|FG001|Overall Study|Other Reasons|1|||
33513068|NCT03486899|62897431|FG002|Overall Study|Other Reasons|0|||
33513069|NCT03486899|62897432|FG003|Overall Study|Other Reasons|1|||
33513070|NCT02918552|62897444|FG000|Overall Study|Failed Pharmacokinetics|1|||
33513071|NCT02918552|62897445|FG001|Overall Study|Failed Pharmacokinetics|0|||
33513072|NCT02918552|62897444|FG000|Overall Study|Withdrawal by Subject|0|||
33513073|NCT02918552|62897445|FG001|Overall Study|Withdrawal by Subject|1|||
33513074|NCT02918552|62897444|FG000|Overall Study|Lost to Follow-up|0|||
33513075|NCT02918552|62897445|FG001|Overall Study|Lost to Follow-up|1|||
33513076|NCT03485495|62897453|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
33513077|NCT03485495|62897454|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
33513078|NCT01065818|62897460|FG000|Overall Study|Withdrawal by Subject|1|||
33513079|NCT01065818|62897460|FG000|Overall Study|Not a candidate for surgery|1|||
33513080|NCT03483623|62897464|FG000|Overall Study|43 complete sets achieved|1|||
33513081|NCT02318277|62897476|FG000|Overall Study|Physician Decision|0|||
33513082|NCT02318277|62897477|FG001|Overall Study|Physician Decision|0|||
33513083|NCT02318277|62897478|FG002|Overall Study|Physician Decision|0|||
33513084|NCT02318277|62897479|FG003|Overall Study|Physician Decision|0|||
33513085|NCT02318277|62897480|FG004|Overall Study|Physician Decision|0|||
33513086|NCT02318277|62897481|FG005|Overall Study|Physician Decision|0|||
33513087|NCT02318277|62897482|FG006|Overall Study|Physician Decision|0|||
33513088|NCT02318277|62897483|FG007|Overall Study|Physician Decision|1|||
33513089|NCT02318277|62897476|FG000|Overall Study|Other|0|||
33513090|NCT02318277|62897477|FG001|Overall Study|Other|0|||
33513091|NCT02318277|62897478|FG002|Overall Study|Other|0|||
33513092|NCT02318277|62897479|FG003|Overall Study|Other|0|||
33513093|NCT02318277|62897480|FG004|Overall Study|Other|0|||
33513094|NCT02318277|62897481|FG005|Overall Study|Other|0|||
33513095|NCT02318277|62897482|FG006|Overall Study|Other|1|||
33614408|NCT02123251|63015310|FG000|Overall Study|Withdrawal by Subject|0|||
33614409|NCT02123251|63015311|FG001|Overall Study|Withdrawal by Subject|3|||
33513096|NCT02318277|62897483|FG007|Overall Study|Other|0|||
33513097|NCT02318277|62897476|FG000|Overall Study|Withdrawal by Subject|0|||
33513098|NCT02318277|62897477|FG001|Overall Study|Withdrawal by Subject|0|||
33513099|NCT02318277|62897478|FG002|Overall Study|Withdrawal by Subject|1|||
33513100|NCT02318277|62897479|FG003|Overall Study|Withdrawal by Subject|0|||
33513101|NCT02318277|62897480|FG004|Overall Study|Withdrawal by Subject|1|||
33513102|NCT02318277|62897481|FG005|Overall Study|Withdrawal by Subject|1|||
33513103|NCT02318277|62897482|FG006|Overall Study|Withdrawal by Subject|6|||
33614410|NCT02123251|63015310|FG000|Overall Study|Lost Medicaid eligibility|29|||
33513104|NCT02318277|62897483|FG007|Overall Study|Withdrawal by Subject|14|||
33513105|NCT02318277|62897476|FG000|Overall Study|Participant trial terminated by sponsor|0|||
33513106|NCT02318277|62897477|FG001|Overall Study|Participant trial terminated by sponsor|0|||
33513107|NCT02318277|62897478|FG002|Overall Study|Participant trial terminated by sponsor|1|||
33513108|NCT02318277|62897479|FG003|Overall Study|Participant trial terminated by sponsor|0|||
33513109|NCT02318277|62897480|FG004|Overall Study|Participant trial terminated by sponsor|1|||
33513110|NCT02318277|62897481|FG005|Overall Study|Participant trial terminated by sponsor|2|||
33513111|NCT02318277|62897482|FG006|Overall Study|Participant trial terminated by sponsor|5|||
33513112|NCT02318277|62897483|FG007|Overall Study|Participant trial terminated by sponsor|16|||
33513113|NCT02318277|62897476|FG000|Overall Study|Lost to Follow-up|1|||
33513114|NCT02318277|62897477|FG001|Overall Study|Lost to Follow-up|0|||
33513115|NCT02318277|62897478|FG002|Overall Study|Lost to Follow-up|1|||
33513116|NCT02318277|62897479|FG003|Overall Study|Lost to Follow-up|0|||
33513117|NCT02318277|62897480|FG004|Overall Study|Lost to Follow-up|0|||
33513118|NCT02318277|62897481|FG005|Overall Study|Lost to Follow-up|0|||
33513119|NCT02318277|62897482|FG006|Overall Study|Lost to Follow-up|3|||
33513120|NCT02318277|62897483|FG007|Overall Study|Lost to Follow-up|4|||
33513121|NCT02318277|62897476|FG000|Overall Study|Death|5|||
33513122|NCT02318277|62897477|FG001|Overall Study|Death|3|||
33513123|NCT02318277|62897478|FG002|Overall Study|Death|1|||
33513124|NCT02318277|62897479|FG003|Overall Study|Death|4|||
33513125|NCT02318277|62897480|FG004|Overall Study|Death|6|||
33513126|NCT02318277|62897481|FG005|Overall Study|Death|5|||
33614411|NCT02123251|63015311|FG001|Overall Study|Lost Medicaid eligibility|22|||
33614412|NCT02123251|63015310|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
33614413|NCT02123251|63015311|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
33324635|NCT00909532|62701199|FG001|Overall Study|Noncompliance with Study Requirements|2|||
33324636|NCT00909532|62701198|FG000|Overall Study|Physician Decision|1|||
33513127|NCT02318277|62897482|FG006|Overall Study|Death|34|||
33513128|NCT02318277|62897483|FG007|Overall Study|Death|58|||
33513129|NCT02318277|62897476|FG000|Overall Study|Transitioned to Hospice|0|||
33513130|NCT02318277|62897477|FG001|Overall Study|Transitioned to Hospice|0|||
33513131|NCT02318277|62897478|FG002|Overall Study|Transitioned to Hospice|0|||
33513132|NCT02318277|62897479|FG003|Overall Study|Transitioned to Hospice|0|||
33513133|NCT02318277|62897480|FG004|Overall Study|Transitioned to Hospice|0|||
33513134|NCT02318277|62897481|FG005|Overall Study|Transitioned to Hospice|1|||
33513135|NCT02318277|62897482|FG006|Overall Study|Transitioned to Hospice|0|||
33513136|NCT02318277|62897483|FG007|Overall Study|Transitioned to Hospice|0|||
33513137|NCT01063868|62897528|FG000|Overall Study|Adverse Event|9|||
33513138|NCT01063868|62897529|FG001|Overall Study|Adverse Event|7|||
33513139|NCT01063868|62897528|FG000|Overall Study|Withdrawal by Subject|3|||
33513140|NCT01063868|62897529|FG001|Overall Study|Withdrawal by Subject|1|||
33513141|NCT01063868|62897528|FG000|Overall Study|Study Terminated By Sponsor|23|||
33513142|NCT01063868|62897529|FG001|Overall Study|Study Terminated By Sponsor|4|||
33513143|NCT02974088|62897537|FG000|Overall Study|Lost to Follow-up|0|||
33513144|NCT02974088|62897538|FG001|Overall Study|Lost to Follow-up|2|||
33513145|NCT02974088|62897537|FG000|Overall Study|Adverse Event|0|||
33513146|NCT02974088|62897538|FG001|Overall Study|Adverse Event|1|||
33513147|NCT02385045|62897544|FG000|Overall Study|Endoscopy could not be completed|4|||
33513148|NCT02974010|62897552|FG000|Overall Study|Lost to Follow-up|3|||
33513149|NCT02974010|62897553|FG001|Overall Study|Lost to Follow-up|1|||
33513150|NCT02974010|62897554|FG002|Overall Study|Lost to Follow-up|0|||
33513151|NCT02974010|62897555|FG003|Overall Study|Lost to Follow-up|0|||
33513152|NCT02974010|62897552|FG000|Overall Study|Withdrawal by Subject|2|||
33513153|NCT02974010|62897553|FG001|Overall Study|Withdrawal by Subject|1|||
33513154|NCT02974010|62897554|FG002|Overall Study|Withdrawal by Subject|0|||
33513155|NCT02974010|62897555|FG003|Overall Study|Withdrawal by Subject|0|||
33513156|NCT02974010|62897552|FG000|Overall Study|Adverse Event|0|||
33513157|NCT02974010|62897553|FG001|Overall Study|Adverse Event|1|||
33324637|NCT00909532|62701199|FG001|Overall Study|Physician Decision|0|||
33324638|NCT00909532|62701198|FG000|Overall Study|Wrong Genotype|1|||
33324639|NCT00909532|62701199|FG001|Overall Study|Wrong Genotype|0|||
33324640|NCT00909532|62701198|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
33324641|NCT00909532|62701199|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
33324642|NCT01136382|62701208|FG000|Overall Study|Other|8|||
33513158|NCT02974010|62897554|FG002|Overall Study|Adverse Event|0|||
33513159|NCT02974010|62897555|FG003|Overall Study|Adverse Event|0|||
33513160|NCT02974010|62897552|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
33513161|NCT02974010|62897553|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
33614414|NCT01902303|63015320|FG000|Overall Study|Adverse Event|0|||
33513162|NCT02974010|62897554|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
33513163|NCT02974010|62897555|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
33513164|NCT02974010|62897552|FG000|Overall Study|Lack of Efficacy|0|||
33513165|NCT02974010|62897553|FG001|Overall Study|Lack of Efficacy|0|||
33513166|NCT02974010|62897554|FG002|Overall Study|Lack of Efficacy|1|||
33513167|NCT02974010|62897555|FG003|Overall Study|Lack of Efficacy|0|||
33513168|NCT02030938|62897565|FG000|Overall Study|Lost to Follow-up|4|||
33513169|NCT02030938|62897565|FG000|Overall Study|Withdrawal by Subject|1|||
33513170|NCT03122535|62897573|FG000|Overall Study|Lost to Follow-up|68|||
33513171|NCT03122535|62897574|FG001|Overall Study|Lost to Follow-up|68|||
33513172|NCT03122535|62897573|FG000|Overall Study|Physician Decision|3|||
33513173|NCT03122535|62897574|FG001|Overall Study|Physician Decision|3|||
33513174|NCT03122535|62897573|FG000|Overall Study|Withdrawal by Subject|2|||
33513175|NCT03122535|62897574|FG001|Overall Study|Withdrawal by Subject|2|||
33513176|NCT01061606|62897580|FG000|Overall Study|Adverse Event|1|||
33513177|NCT01061606|62897580|FG000|Overall Study|Death|1|||
33513178|NCT01061606|62897580|FG000|Overall Study|Disease Progression|4|||
33614415|NCT01902303|63015321|FG001|Overall Study|Adverse Event|1|||
33614416|NCT01902303|63015320|FG000|Overall Study|Lost to Follow-up|0|||
33614417|NCT01902303|63015321|FG001|Overall Study|Lost to Follow-up|1|||
33324643|NCT01136382|62701209|FG001|Overall Study|Other|3|||
33324644|NCT01136382|62701208|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
33324645|NCT01136382|62701209|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
33324646|NCT01136382|62701208|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
33453045|NCT00252720|62827589|FG001|Overall Study|Mainly patients lost to follow-up|18|||
33453046|NCT00167778|62827595|FG000|Overall Study|Withdrawal by Subject|1|||
33453047|NCT00167310|62827602|FG000|Overall Study|Protocol Violation|5|||
33453048|NCT00167310|62827603|FG001|Overall Study|Protocol Violation|3|||
33453049|NCT00167310|62827602|FG000|Overall Study|Withdrawal by Subject|3|||
33453050|NCT00167310|62827603|FG001|Overall Study|Withdrawal by Subject|7|||
33453051|NCT03754582|62827609|FG000|Treatment Phase|Adverse Event|0|||
33453052|NCT03754582|62827610|FG001|Treatment Phase|Adverse Event|1|||
33453053|NCT03754582|62827611|FG002|Treatment Phase|Adverse Event|0|||
33453054|NCT03754582|62827609|FG000|Follow-up Phase|Other|0|||
33453055|NCT03754582|62827610|FG001|Follow-up Phase|Other|0|||
33453056|NCT03754582|62827611|FG002|Follow-up Phase|Other|1|||
33453057|NCT00161616|62827629|FG000|Overall Study|Withdrawal by Subject|6|||
33453058|NCT00161616|62827630|FG001|Overall Study|Withdrawal by Subject|5|||
33453059|NCT00161616|62827629|FG000|Overall Study|Physician Decision|1|||
33453060|NCT00161616|62827630|FG001|Overall Study|Physician Decision|0|||
33453061|NCT00161616|62827629|FG000|Overall Study|Death|1|||
33453062|NCT00161616|62827630|FG001|Overall Study|Death|1|||
33453063|NCT00161616|62827629|FG000|Overall Study|Lost to Follow-up|17|||
33453064|NCT00161616|62827630|FG001|Overall Study|Lost to Follow-up|13|||
33453065|NCT00161616|62827629|FG000|Overall Study|Protocol deviation|1|||
33453066|NCT00161616|62827630|FG001|Overall Study|Protocol deviation|0|||
33453067|NCT00252564|62827638|FG000|Overall Study|Adverse Event|17|||
33453068|NCT00252564|62827639|FG001|Overall Study|Adverse Event|13|||
33453069|NCT00252564|62827638|FG000|Overall Study|Unrelated Complication|2|||
33453070|NCT00252564|62827639|FG001|Overall Study|Unrelated Complication|1|||
33453071|NCT00252564|62827638|FG000|Overall Study|Disease Progression|14|||
33453072|NCT00252564|62827639|FG001|Overall Study|Disease Progression|20|||
33453073|NCT00252564|62827638|FG000|Overall Study|Death|0|||
33453074|NCT00252564|62827639|FG001|Overall Study|Death|3|||
33453075|NCT00252564|62827638|FG000|Overall Study|Physician Decision|1|||
33453076|NCT00252564|62827639|FG001|Overall Study|Physician Decision|0|||
33453077|NCT00252564|62827638|FG000|Overall Study|Lost to Follow-up|1|||
33453078|NCT00252564|62827639|FG001|Overall Study|Lost to Follow-up|0|||
33453079|NCT00252564|62827638|FG000|Overall Study|Patient Request|4|||
33453080|NCT00252564|62827639|FG001|Overall Study|Patient Request|5|||
33453081|NCT00252564|62827638|FG000|Overall Study|Withdrawal by Subject|0|||
33453082|NCT00252564|62827639|FG001|Overall Study|Withdrawal by Subject|2|||
33453083|NCT00166296|62827647|FG000|Overall Study|Withdrawal by Subject|1|||
33453084|NCT00166296|62827648|FG001|Overall Study|Withdrawal by Subject|3|||
33513179|NCT01061606|62897580|FG000|Overall Study|alternative therapy|2|||
33513180|NCT03122457|62897584|FG000|Overall Study|Withdrawal by Subject|6|||
33513181|NCT03482453|62897600|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33513182|NCT03482453|62897601|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33513183|NCT03482453|62897602|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33513184|NCT03482453|62897603|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33513185|NCT03482453|62897604|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33513186|NCT03482453|62897605|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33513187|NCT03482453|62897606|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33513188|NCT03482453|62897607|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33513189|NCT03482453|62897608|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33513190|NCT03482453|62897609|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33513191|NCT03482453|62897610|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
33513192|NCT03482453|62897611|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33513193|NCT03480425|62897647|FG000|Overall Study|Force transducer technical failure|1|||
33513194|NCT03472547|62897651|FG000|Overall Study|Withdrawal by Subject|30|||
33513195|NCT00799396|62897655|FG000|Clopidogrel Treatment|Adverse Event|6|||
33513196|NCT00799396|62897655|FG000|Clopidogrel Treatment|Physician Decision|5|||
33513197|NCT00799396|62897655|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
33513198|NCT00799396|62897655|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
33513199|NCT00799396|62897655|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
33513200|NCT03469349|62897661|FG000|Overall Study|Withdrawal by Subject|1|||
33513201|NCT03469349|62897662|FG001|Overall Study|Withdrawal by Subject|3|||
33513202|NCT03469349|62897661|FG000|Overall Study|Progressive Disease|0|||
33513203|NCT03469349|62897662|FG001|Overall Study|Progressive Disease|1|||
33513204|NCT03469349|62897661|FG000|Overall Study|Lost to Follow-up|2|||
33513205|NCT03469349|62897662|FG001|Overall Study|Lost to Follow-up|2|||
33513206|NCT03469349|62897661|FG000|Overall Study|Adverse Event|2|||
33513207|NCT03469349|62897662|FG001|Overall Study|Adverse Event|4|||
33513208|NCT03467945|62897672|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33513209|NCT03467945|62897673|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33513210|NCT03467945|62897674|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33513211|NCT03467945|62897675|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33513212|NCT03467945|62897672|FG000|Treatment Period 3|Withdrawal by Subject|1|||
33513213|NCT03467945|62897673|FG001|Treatment Period 3|Withdrawal by Subject|0|||
33513214|NCT03467945|62897674|FG002|Treatment Period 3|Withdrawal by Subject|2|||
33513215|NCT03467945|62897675|FG003|Treatment Period 3|Withdrawal by Subject|1|||
33513216|NCT00069238|62897686|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
33513217|NCT00069238|62897687|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
33513218|NCT00069238|62897688|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
33513219|NCT00069238|62897686|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
33513220|NCT00069238|62897687|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
33513221|NCT00069238|62897688|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
33513222|NCT00069238|62897686|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
33513223|NCT00069238|62897687|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
33513224|NCT00069238|62897688|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
33513225|NCT03435497|62897695|FG000|Overall Study|Lost to Follow-up|1|||
33513226|NCT03435497|62897696|FG001|Overall Study|Lost to Follow-up|0|||
33513227|NCT03435497|62897695|FG000|Overall Study|Death|1|||
33513228|NCT03435497|62897696|FG001|Overall Study|Death|0|||
33513229|NCT03435497|62897695|FG000|Overall Study|Withdrawal by Subject|0|||
33513230|NCT03435497|62897696|FG001|Overall Study|Withdrawal by Subject|4|||
33513231|NCT03435497|62897695|FG000|Overall Study|Wrong survey administered|0|||
33513232|NCT03435497|62897696|FG001|Overall Study|Wrong survey administered|2|||
33513233|NCT03073200|62897705|FG000|Double Blind Treatment Period|Protocol Violation|1|||
33513234|NCT03073200|62897706|FG001|Double Blind Treatment Period|Protocol Violation|0|||
33513235|NCT03073200|62897707|FG002|Double Blind Treatment Period|Protocol Violation|0|||
33513236|NCT03073200|62897708|FG003|Double Blind Treatment Period|Protocol Violation|0|||
33513237|NCT03073200|62897709|FG004|Double Blind Treatment Period|Protocol Violation|0|||
33513238|NCT03073200|62897710|FG005|Double Blind Treatment Period|Protocol Violation|0|||
33513239|NCT03073200|62897711|FG006|Double Blind Treatment Period|Protocol Violation|0|||
33513240|NCT03073200|62897712|FG007|Double Blind Treatment Period|Protocol Violation|0|||
33513241|NCT03073200|62897713|FG008|Double Blind Treatment Period|Protocol Violation|0|||
33513242|NCT03073200|62897714|FG009|Double Blind Treatment Period|Protocol Violation|0|||
33513243|NCT03073200|62897715|FG010|Double Blind Treatment Period|Protocol Violation|0|||
33513244|NCT03073200|62897716|FG011|Double Blind Treatment Period|Protocol Violation|0|||
33513245|NCT03073200|62897717|FG012|Double Blind Treatment Period|Protocol Violation|0|||
33513246|NCT03073200|62897718|FG013|Double Blind Treatment Period|Protocol Violation|0|||
33513247|NCT03073200|62897719|FG014|Double Blind Treatment Period|Protocol Violation|0|||
33614418|NCT01902303|63015320|FG000|Overall Study|Protocol Violation|2|||
33614419|NCT01902303|63015321|FG001|Overall Study|Protocol Violation|2|||
33614420|NCT01902303|63015320|FG000|Overall Study|subject lost investigational product|0|||
33614421|NCT01902303|63015321|FG001|Overall Study|subject lost investigational product|1|||
33614422|NCT01902303|63015320|FG000|Overall Study|Did not develop a cold sore|21|||
33614423|NCT01902303|63015321|FG001|Overall Study|Did not develop a cold sore|19|||
33614424|NCT02122783|63015331|FG000|Overall Study|Adverse Event|0|||
33614425|NCT02122783|63015332|FG001|Overall Study|Adverse Event|1|||
33614426|NCT01921257|63015341|FG000|Overall Study|Adverse Event|1|||
33614427|NCT01921257|63015341|FG000|Overall Study|Protocol Violation|1|||
33614428|NCT01921257|63015341|FG000|Overall Study|Withdrawal by Subject|1|||
33614429|NCT02121847|63015346|FG000|Overall Study|Administrative Reasons|1|||
33614430|NCT02121847|63015346|FG000|Overall Study|Adverse Event|2|||
33614431|NCT01921179|63015352|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
33614432|NCT01921179|63015353|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
33614433|NCT01921179|63015352|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
33614434|NCT01921179|63015353|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
33614435|NCT01587040|63015364|FG000|Overall Study|Protocol Violation|0|||
33614436|NCT01587040|63015365|FG001|Overall Study|Protocol Violation|0|||
33614437|NCT01587040|63015366|FG002|Overall Study|Protocol Violation|1|||
33614438|NCT01587040|63015367|FG003|Overall Study|Protocol Violation|0|||
33614439|NCT01587040|63015364|FG000|Overall Study|Adverse Event|0|||
33614440|NCT01587040|63015365|FG001|Overall Study|Adverse Event|1|||
33614441|NCT01587040|63015366|FG002|Overall Study|Adverse Event|10|||
33614442|NCT01587040|63015367|FG003|Overall Study|Adverse Event|0|||
33614443|NCT01587040|63015364|FG000|Overall Study|Disease progression|12|||
33614444|NCT01587040|63015365|FG001|Overall Study|Disease progression|1|||
33614445|NCT01587040|63015366|FG002|Overall Study|Disease progression|15|||
33614446|NCT01587040|63015367|FG003|Overall Study|Disease progression|3|||
33614447|NCT01587040|63015364|FG000|Overall Study|Other than specified|5|||
33614448|NCT01587040|63015365|FG001|Overall Study|Other than specified|1|||
33614449|NCT01587040|63015366|FG002|Overall Study|Other than specified|11|||
33614450|NCT01587040|63015367|FG003|Overall Study|Other than specified|1|||
33614451|NCT02144701|63015379|FG000|Overall Study|development of relapse, GVHD or death|9|||
33614452|NCT02144701|63015380|FG001|Overall Study|development of relapse, GVHD or death|3|||
33614453|NCT01921101|63015388|FG000|Overall Study|Death|16|||
33614454|NCT01921101|63015389|FG001|Overall Study|Death|6|||
33614455|NCT01586806|63015398|FG000|Overall Study|Protocol Violation|0|||
33614456|NCT01586806|63015399|FG001|Overall Study|Protocol Violation|1|||
33614457|NCT01586806|63015400|FG002|Overall Study|Protocol Violation|0|||
33614458|NCT01586806|63015398|FG000|Overall Study|Withdrawal by Subject|1|||
33614459|NCT01586806|63015399|FG001|Overall Study|Withdrawal by Subject|0|||
33614460|NCT01586806|63015400|FG002|Overall Study|Withdrawal by Subject|0|||
33614461|NCT01586806|63015398|FG000|Overall Study|Lost to Follow-up|2|||
33614462|NCT01586806|63015399|FG001|Overall Study|Lost to Follow-up|3|||
33614463|NCT01586806|63015400|FG002|Overall Study|Lost to Follow-up|2|||
33614464|NCT02144077|63015410|FG000|Overall Study|Withdrawal by Subject|3|||
33614465|NCT02144077|63015411|FG001|Overall Study|Withdrawal by Subject|3|||
33614466|NCT02144077|63015410|FG000|Overall Study|Adverse Event|2|||
33614467|NCT02144077|63015411|FG001|Overall Study|Adverse Event|3|||
33614468|NCT02144077|63015410|FG000|Overall Study|Lost to Follow-up|2|||
33614469|NCT02144077|63015411|FG001|Overall Study|Lost to Follow-up|2|||
33614470|NCT02144077|63015410|FG000|Overall Study|Protocol Violation|1|||
33614471|NCT02144077|63015411|FG001|Overall Study|Protocol Violation|2|||
33614472|NCT02144077|63015410|FG000|Overall Study|Death|0|||
33614473|NCT02144077|63015411|FG001|Overall Study|Death|1|||
33614474|NCT02144077|63015410|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
33614475|NCT02144077|63015411|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
33614476|NCT02172625|63015419|FG000|Overall Study|Adverse Event|0|||
33614477|NCT02172625|63015420|FG001|Overall Study|Adverse Event|1|||
33614478|NCT02172625|63015419|FG000|Overall Study|Pregnancy|0|||
33614479|NCT02172625|63015420|FG001|Overall Study|Pregnancy|1|||
33614480|NCT02172625|63015419|FG000|Overall Study|car accident|0|||
33614481|NCT02172625|63015420|FG001|Overall Study|car accident|1|||
33614482|NCT02143843|63015430|FG000|Overall Study|Adverse Event|8|||
33614483|NCT02143843|63015430|FG000|Overall Study|Lack of Efficacy|2|||
33614484|NCT02143843|63015430|FG000|Overall Study|Withdrawal by Subject|2|||
33614485|NCT02121535|63015436|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
33614486|NCT02121535|63015437|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
33614487|NCT02121535|63015436|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
33614488|NCT02121535|63015437|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
33614489|NCT01586338|63015444|FG000|Overall Study|Adverse Event|3|||
33614490|NCT01586338|63015444|FG000|Overall Study|Lost to Follow-up|1|||
33614491|NCT01586338|63015444|FG000|Overall Study|Withdrawal by participant|3|||
33614492|NCT01586338|63015444|FG000|Overall Study|Other|1|||
33614493|NCT02143141|63015450|FG000|Overall Study|pain scores at 24 hours not collected|1|||
33614494|NCT02143141|63015451|FG001|Overall Study|pain scores at 24 hours not collected|0|||
33614495|NCT02171065|63015460|FG000|Overall Study|Withdrawal by Subject|1|||
33614496|NCT02171065|63015461|FG001|Overall Study|Withdrawal by Subject|0|||
33614497|NCT02171065|63015462|FG002|Overall Study|Withdrawal by Subject|0|||
33614498|NCT02171065|63015460|FG000|Overall Study|Lost to Follow-up|0|||
33614499|NCT02171065|63015461|FG001|Overall Study|Lost to Follow-up|0|||
33614500|NCT02171065|63015462|FG002|Overall Study|Lost to Follow-up|1|||
33614501|NCT01566604|63015474|FG000|Overall Study|Patient's inability to use the device|1|||
33614502|NCT01566604|63015475|FG001|Overall Study|Patient's inability to use the device|0|||
33614503|NCT01566604|63015474|FG000|Overall Study|Administrative problems|1|||
33614504|NCT01566604|63015475|FG001|Overall Study|Administrative problems|0|||
33614505|NCT01566604|63015474|FG000|Overall Study|Lack of Efficacy|1|||
33614506|NCT01566604|63015475|FG001|Overall Study|Lack of Efficacy|2|||
33614507|NCT01566604|63015474|FG000|Overall Study|Protocol deviation|2|||
33614508|NCT01566604|63015475|FG001|Overall Study|Protocol deviation|0|||
33614509|NCT01566604|63015474|FG000|Overall Study|Abnormal laboratory value|2|||
33614510|NCT01566604|63015475|FG001|Overall Study|Abnormal laboratory value|0|||
33614511|NCT01566604|63015474|FG000|Overall Study|Death|4|||
33614512|NCT01566604|63015475|FG001|Overall Study|Death|1|||
33614513|NCT01566604|63015474|FG000|Overall Study|Adverse Event|4|||
33614514|NCT01566604|63015475|FG001|Overall Study|Adverse Event|2|||
33614515|NCT01566604|63015474|FG000|Overall Study|Withdrawal by Subject|9|||
33614516|NCT01566604|63015475|FG001|Overall Study|Withdrawal by Subject|6|||
33614517|NCT01684930|63015483|FG000|Overall Study|Withdrawal by Subject|3|||
33614518|NCT01684930|63015484|FG001|Overall Study|Withdrawal by Subject|1|||
33614519|NCT01566214|63015492|FG000|Overall Study|Lost to Follow-up|3|||
33614520|NCT01566214|63015493|FG001|Overall Study|Lost to Follow-up|0|||
33614521|NCT02253992|63015502|FG000|Overall Study|Study drug toxicity|1|||
33614522|NCT02253992|63015503|FG001|Overall Study|Study drug toxicity|0|||
33614523|NCT02253992|63015504|FG002|Overall Study|Study drug toxicity|10|||
33614524|NCT02253992|63015502|FG000|Overall Study|Disease progression|4|||
33614525|NCT02253992|63015503|FG001|Overall Study|Disease progression|3|||
33614526|NCT02253992|63015504|FG002|Overall Study|Disease progression|98|||
33614527|NCT02253992|63015502|FG000|Overall Study|Withdrawal by Subject|0|||
33614528|NCT02253992|63015503|FG001|Overall Study|Withdrawal by Subject|0|||
33614529|NCT02253992|63015504|FG002|Overall Study|Withdrawal by Subject|3|||
33614530|NCT02253992|63015502|FG000|Overall Study|Adverse Event|0|||
33614531|NCT02253992|63015503|FG001|Overall Study|Adverse Event|0|||
33614532|NCT02253992|63015504|FG002|Overall Study|Adverse Event|8|||
33614533|NCT02253992|63015502|FG000|Overall Study|Death|0|||
33614534|NCT02253992|63015503|FG001|Overall Study|Death|0|||
33614535|NCT02253992|63015504|FG002|Overall Study|Death|1|||
33614536|NCT02253992|63015502|FG000|Overall Study|Subject discontinued study drug|1|||
33614537|NCT02253992|63015503|FG001|Overall Study|Subject discontinued study drug|0|||
33614538|NCT02253992|63015504|FG002|Overall Study|Subject discontinued study drug|1|||
33614539|NCT02253992|63015502|FG000|Overall Study|Completed treatment as per protocol|0|||
33614540|NCT02253992|63015503|FG001|Overall Study|Completed treatment as per protocol|1|||
33614541|NCT02253992|63015504|FG002|Overall Study|Completed treatment as per protocol|22|||
33614542|NCT02253992|63015502|FG000|Overall Study|Other|0|||
33614543|NCT02253992|63015503|FG001|Overall Study|Other|0|||
33614544|NCT02253992|63015504|FG002|Overall Study|Other|1|||
33614545|NCT02252588|63015528|FG000|Overall Study|Withdrawal by Subject|4|||
33614546|NCT02252588|63015529|FG001|Overall Study|Withdrawal by Subject|0|||
33614547|NCT01585558|63015538|FG000|Overall Study|Withdrawal by Subject|4|||
33614548|NCT01585558|63015539|FG001|Overall Study|Withdrawal by Subject|5|||
33614549|NCT01585558|63015540|FG002|Overall Study|Withdrawal by Subject|8|||
33614550|NCT01585558|63015538|FG000|Overall Study|Lost to Follow-up|2|||
33614551|NCT01585558|63015539|FG001|Overall Study|Lost to Follow-up|0|||
33614552|NCT01585558|63015540|FG002|Overall Study|Lost to Follow-up|3|||
33614553|NCT01585558|63015538|FG000|Overall Study|Adverse Event|3|||
33614554|NCT01585558|63015539|FG001|Overall Study|Adverse Event|4|||
33614555|NCT01585558|63015540|FG002|Overall Study|Adverse Event|1|||
33453085|NCT00166296|62827647|FG000|Overall Study|Adverse Event|2|||
33453086|NCT00166296|62827648|FG001|Overall Study|Adverse Event|4|||
33614556|NCT01585558|63015538|FG000|Overall Study|Protocol Violation|4|||
33614557|NCT01585558|63015539|FG001|Overall Study|Protocol Violation|3|||
33614558|NCT01585558|63015540|FG002|Overall Study|Protocol Violation|2|||
33614559|NCT01585558|63015538|FG000|Overall Study|Lack of Efficacy|0|||
33614560|NCT01585558|63015539|FG001|Overall Study|Lack of Efficacy|0|||
33614561|NCT01585558|63015540|FG002|Overall Study|Lack of Efficacy|1|||
33614562|NCT01565980|63015550|FG000|Overall Study|Death|1|||
33614563|NCT01565980|63015551|FG001|Overall Study|Death|0|||
33324647|NCT01136382|62701209|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
33324648|NCT01136382|62701208|FG000|Overall Study|Withdrawal by Subject|4|||
33614564|NCT01565980|63015550|FG000|Overall Study|Lost to Follow-up|1|||
33614565|NCT01565980|63015551|FG001|Overall Study|Lost to Follow-up|0|||
33614566|NCT01565980|63015550|FG000|Overall Study|health complications|1|||
33614567|NCT01565980|63015551|FG001|Overall Study|health complications|1|||
33614568|NCT01565980|63015550|FG000|Overall Study|stopped medical treatment|1|||
33614569|NCT01565980|63015551|FG001|Overall Study|stopped medical treatment|0|||
33614570|NCT01565980|63015550|FG000|Overall Study|Withdrawal by Subject|0|||
33614571|NCT01565980|63015551|FG001|Overall Study|Withdrawal by Subject|3|||
33614572|NCT01585246|63015566|FG000|Overall Study|Lost to Follow-up|0|||
33614573|NCT01585246|63015567|FG001|Overall Study|Lost to Follow-up|0|||
33614574|NCT01585246|63015568|FG002|Overall Study|Lost to Follow-up|2|||
33614575|NCT01585246|63015569|FG003|Overall Study|Lost to Follow-up|1|||
33614576|NCT01585246|63015570|FG004|Overall Study|Lost to Follow-up|0|||
33614577|NCT01585246|63015566|FG000|Overall Study|Protocol Violation|0|||
33614578|NCT01585246|63015567|FG001|Overall Study|Protocol Violation|0|||
33614579|NCT01585246|63015568|FG002|Overall Study|Protocol Violation|0|||
33614580|NCT01585246|63015569|FG003|Overall Study|Protocol Violation|0|||
33614581|NCT01585246|63015570|FG004|Overall Study|Protocol Violation|1|||
33614582|NCT01585246|63015566|FG000|Overall Study|Withdrawal by Subject|0|||
33614583|NCT01585246|63015567|FG001|Overall Study|Withdrawal by Subject|0|||
33614584|NCT01585246|63015568|FG002|Overall Study|Withdrawal by Subject|1|||
33614585|NCT01585246|63015569|FG003|Overall Study|Withdrawal by Subject|2|||
33614586|NCT01585246|63015570|FG004|Overall Study|Withdrawal by Subject|1|||
33614587|NCT01585246|63015566|FG000|Overall Study|Other|0|||
33614588|NCT01585246|63015567|FG001|Overall Study|Other|1|||
33614589|NCT01585246|63015568|FG002|Overall Study|Other|1|||
33614590|NCT01585246|63015569|FG003|Overall Study|Other|1|||
33614591|NCT01585246|63015570|FG004|Overall Study|Other|0|||
33614592|NCT01585168|63015587|FG000|Overall Study|Lost to Follow-up|3|||
33614593|NCT01585168|63015588|FG001|Overall Study|Lost to Follow-up|1|||
33614594|NCT01585168|63015589|FG002|Overall Study|Lost to Follow-up|1|||
33614595|NCT01585168|63015590|FG003|Overall Study|Lost to Follow-up|1|||
33614596|NCT02232074|63015600|FG000|Overall Study|Withdrawal by Subject|5|||
33614597|NCT02232074|63015601|FG001|Overall Study|Withdrawal by Subject|3|||
33614598|NCT02232074|63015600|FG000|Overall Study|No legal concerns at baseline|36|||
33614599|NCT02232074|63015601|FG001|Overall Study|No legal concerns at baseline|41|||
33614600|NCT02232074|63015600|FG000|Overall Study|deemed ineligible|0|||
33614601|NCT02232074|63015601|FG001|Overall Study|deemed ineligible|1|||
33614602|NCT02142283|63015615|FG000|Overall Study|Death|20|||
33614603|NCT02142283|63015616|FG001|Overall Study|Death|18|||
33614604|NCT02142283|63015615|FG000|Overall Study|Withdrawal by Subject|1|||
33614605|NCT02142283|63015616|FG001|Overall Study|Withdrawal by Subject|3|||
33614606|NCT02231918|63015625|FG000|Overall Study|Withdrawal by Subject|0|||
33614607|NCT02231918|63015626|FG001|Overall Study|Withdrawal by Subject|1|||
33614608|NCT02231918|63015627|FG002|Overall Study|Withdrawal by Subject|0|||
33614609|NCT02231918|63015625|FG000|Overall Study|Adverse Event|0|||
33614610|NCT02231918|63015626|FG001|Overall Study|Adverse Event|0|||
33614611|NCT02231918|63015627|FG002|Overall Study|Adverse Event|1|||
33614612|NCT02199314|63015635|FG000|Overall Study|Withdrawal by Subject|6|||
33614613|NCT02199314|63015635|FG000|Overall Study|Physician Decision|10|||
33614614|NCT02199080|63015639|FG000|Overall Study|Protocol Violation|12|||
33614615|NCT02251652|63015645|FG000|Overall Study|Withdrawal by Subject|1|||
33614616|NCT02197520|63015651|FG000|Period 1|Withdrawal by Subject|1|||
33614617|NCT02197520|63015652|FG001|Period 1|Withdrawal by Subject|0|||
33614618|NCT02197520|63015651|FG000|Period 2|Adverse Event|0|||
33614619|NCT02197520|63015652|FG001|Period 2|Adverse Event|2|||
33614620|NCT02197520|63015651|FG000|Period 2|Withdrawal by Subject|1|||
33614621|NCT02197520|63015652|FG001|Period 2|Withdrawal by Subject|0|||
33614622|NCT02230904|63015662|FG000|Overall Study|Safety follow up could not take place|0|||
33614623|NCT02230904|63015663|FG001|Overall Study|Safety follow up could not take place|1|||
33614624|NCT02230670|63015673|FG000|Overall Study|Adverse Event|1|||
33614625|NCT02230670|63015674|FG001|Overall Study|Adverse Event|2|||
33614626|NCT02230670|63015673|FG000|Overall Study|Withdrawal by Subject|2|||
33614627|NCT02230670|63015674|FG001|Overall Study|Withdrawal by Subject|2|||
33614628|NCT02230670|63015673|FG000|Overall Study|Physician Decision|0|||
33614629|NCT02230670|63015674|FG001|Overall Study|Physician Decision|1|||
33614630|NCT02230670|63015673|FG000|Overall Study|Protocol Violation|0|||
33614631|NCT02230670|63015674|FG001|Overall Study|Protocol Violation|1|||
33614632|NCT02230670|63015673|FG000|Overall Study|Progression to Child-Pugh C|1|||
33614633|NCT02230670|63015674|FG001|Overall Study|Progression to Child-Pugh C|2|||
33614634|NCT02197130|63015683|FG000|Overall Study|Adverse Event|13|||
33614635|NCT02197130|63015684|FG001|Overall Study|Adverse Event|4|||
33614636|NCT02197130|63015685|FG002|Overall Study|Adverse Event|23|||
33614637|NCT02197130|63015683|FG000|Overall Study|Death|0|||
33614638|NCT02197130|63015684|FG001|Overall Study|Death|1|||
33614639|NCT02197130|63015685|FG002|Overall Study|Death|0|||
33614640|NCT02197130|63015683|FG000|Overall Study|Lost to Follow-up|2|||
33614641|NCT02197130|63015684|FG001|Overall Study|Lost to Follow-up|0|||
33614642|NCT02197130|63015685|FG002|Overall Study|Lost to Follow-up|1|||
33614643|NCT02197130|63015683|FG000|Overall Study|Does not meet entrance criteria|0|||
33614644|NCT02197130|63015684|FG001|Overall Study|Does not meet entrance criteria|0|||
33614645|NCT02197130|63015685|FG002|Overall Study|Does not meet entrance criteria|1|||
33614646|NCT02197130|63015683|FG000|Overall Study|Withdrawal by Subject|0|||
33614647|NCT02197130|63015684|FG001|Overall Study|Withdrawal by Subject|3|||
33614648|NCT02197130|63015685|FG002|Overall Study|Withdrawal by Subject|4|||
33614649|NCT02197130|63015683|FG000|Overall Study|Other|1|||
33614650|NCT02197130|63015684|FG001|Overall Study|Other|0|||
33614651|NCT02197130|63015685|FG002|Overall Study|Other|3|||
33614652|NCT02196506|63015695|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
33614653|NCT02196506|63015696|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
33614654|NCT02196506|63015697|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
33614655|NCT02196506|63015698|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
33614656|NCT02196506|63015695|FG000|Phase A|Withdrawal by Subject|34|||
33614657|NCT02196506|63015696|FG001|Phase A|Withdrawal by Subject|0|||
33614658|NCT02196506|63015697|FG002|Phase A|Withdrawal by Subject|0|||
33614659|NCT02196506|63015698|FG003|Phase A|Withdrawal by Subject|0|||
33614660|NCT02196506|63015695|FG000|Phase A|Adverse Event|22|||
33614661|NCT02196506|63015696|FG001|Phase A|Adverse Event|0|||
33614662|NCT02196506|63015697|FG002|Phase A|Adverse Event|0|||
33614663|NCT02196506|63015698|FG003|Phase A|Adverse Event|0|||
33614664|NCT02196506|63015695|FG000|Phase A|Lost to Follow-up|9|||
33614665|NCT02196506|63015696|FG001|Phase A|Lost to Follow-up|0|||
33614666|NCT02196506|63015697|FG002|Phase A|Lost to Follow-up|0|||
33614667|NCT02196506|63015698|FG003|Phase A|Lost to Follow-up|0|||
33614668|NCT02196506|63015695|FG000|Phase A|Protocol deviation|12|||
33614669|NCT02196506|63015696|FG001|Phase A|Protocol deviation|0|||
33614670|NCT02196506|63015697|FG002|Phase A|Protocol deviation|0|||
33614671|NCT02196506|63015698|FG003|Phase A|Protocol deviation|0|||
33614672|NCT02196506|63015695|FG000|Phase A|Participant withdrawn by investigator|10|||
33614673|NCT02196506|63015696|FG001|Phase A|Participant withdrawn by investigator|0|||
33614674|NCT02196506|63015697|FG002|Phase A|Participant withdrawn by investigator|0|||
33614675|NCT02196506|63015698|FG003|Phase A|Participant withdrawn by investigator|0|||
33614676|NCT02196506|63015695|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
33614677|NCT02196506|63015696|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
33614678|NCT02196506|63015697|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
33614679|NCT02196506|63015698|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
33614680|NCT02196506|63015695|FG000|Phase B|Lack of Efficacy|0|||
33614681|NCT02196506|63015696|FG001|Phase B|Lack of Efficacy|1|||
33614682|NCT02196506|63015697|FG002|Phase B|Lack of Efficacy|2|||
33614683|NCT02196506|63015698|FG003|Phase B|Lack of Efficacy|0|||
33614684|NCT02196506|63015695|FG000|Phase B|Withdrawal by Participant|0|||
33614685|NCT02196506|63015696|FG001|Phase B|Withdrawal by Participant|8|||
33614686|NCT02196506|63015697|FG002|Phase B|Withdrawal by Participant|1|||
33614687|NCT02196506|63015698|FG003|Phase B|Withdrawal by Participant|0|||
33614688|NCT02196506|63015695|FG000|Phase B|Adverse Event|0|||
33614689|NCT02196506|63015696|FG001|Phase B|Adverse Event|4|||
33614690|NCT02196506|63015697|FG002|Phase B|Adverse Event|1|||
33614691|NCT02196506|63015698|FG003|Phase B|Adverse Event|0|||
33614692|NCT02196506|63015695|FG000|Phase B|Lost to Follow-up|0|||
33614693|NCT02196506|63015696|FG001|Phase B|Lost to Follow-up|2|||
33614694|NCT02196506|63015697|FG002|Phase B|Lost to Follow-up|1|||
33614695|NCT02196506|63015698|FG003|Phase B|Lost to Follow-up|0|||
33614696|NCT02196506|63015695|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
33614697|NCT02196506|63015696|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
33614698|NCT02196506|63015697|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
33614699|NCT02196506|63015698|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
33614700|NCT02196506|63015695|FG000|Phase A+|Withdrawal by Participant|0|||
33614701|NCT02196506|63015696|FG001|Phase A+|Withdrawal by Participant|0|||
33614702|NCT02196506|63015697|FG002|Phase A+|Withdrawal by Participant|0|||
33614703|NCT02196506|63015698|FG003|Phase A+|Withdrawal by Participant|5|||
33614704|NCT02196506|63015695|FG000|Phase A+|Adverse Event|0|||
33614705|NCT02196506|63015696|FG001|Phase A+|Adverse Event|0|||
33614706|NCT02196506|63015697|FG002|Phase A+|Adverse Event|0|||
33614707|NCT02196506|63015698|FG003|Phase A+|Adverse Event|1|||
33453087|NCT00166296|62827647|FG000|Overall Study|Lost to Follow-up|4|||
33614708|NCT02196506|63015695|FG000|Phase A+|Lost to Follow-up|0|||
33614709|NCT02196506|63015696|FG001|Phase A+|Lost to Follow-up|0|||
33614710|NCT02196506|63015697|FG002|Phase A+|Lost to Follow-up|0|||
33453088|NCT00166296|62827648|FG001|Overall Study|Lost to Follow-up|2|||
33614711|NCT02196506|63015698|FG003|Phase A+|Lost to Follow-up|6|||
33614712|NCT02196506|63015695|FG000|Phase A+|Participant withdrawn by investigator|0|||
33614713|NCT02196506|63015696|FG001|Phase A+|Participant withdrawn by investigator|0|||
33614714|NCT02196506|63015697|FG002|Phase A+|Participant withdrawn by investigator|0|||
33614715|NCT02196506|63015698|FG003|Phase A+|Participant withdrawn by investigator|1|||
33614716|NCT02228720|63015704|FG000|Open Label - Day 30|Lost to Follow-up|1|||
33614717|NCT02228564|63015708|FG000|Overall Study|Withdrawal by Subject|10|||
33614718|NCT02228564|63015708|FG000|Overall Study|Death|11|||
33614719|NCT02228564|63015708|FG000|Overall Study|Physician Decision|5|||
33614720|NCT02228564|63015708|FG000|Overall Study|Lost to Follow-up|17|||
33614721|NCT02228564|63015708|FG000|Overall Study|Other|6|||
33614722|NCT01640951|63015720|FG000|Overall Study|Adverse Event|8|||
33614723|NCT01640951|63015721|FG001|Overall Study|Adverse Event|3|||
33614724|NCT01640951|63015722|FG002|Overall Study|Adverse Event|10|||
33614725|NCT01640951|63015723|FG003|Overall Study|Adverse Event|6|||
33614726|NCT01640951|63015724|FG004|Overall Study|Adverse Event|1|||
33614727|NCT01640951|63015725|FG005|Overall Study|Adverse Event|11|||
33614728|NCT01640951|63015726|FG006|Overall Study|Adverse Event|1|||
33614729|NCT01640951|63015727|FG007|Overall Study|Adverse Event|3|||
33614730|NCT01640951|63015720|FG000|Overall Study|Lack of Efficacy|20|||
33614731|NCT01640951|63015721|FG001|Overall Study|Lack of Efficacy|1|||
33614732|NCT01640951|63015722|FG002|Overall Study|Lack of Efficacy|7|||
33614733|NCT01640951|63015723|FG003|Overall Study|Lack of Efficacy|14|||
33614734|NCT01640951|63015724|FG004|Overall Study|Lack of Efficacy|0|||
33614735|NCT01640951|63015725|FG005|Overall Study|Lack of Efficacy|6|||
33614736|NCT01640951|63015726|FG006|Overall Study|Lack of Efficacy|5|||
33614737|NCT01640951|63015727|FG007|Overall Study|Lack of Efficacy|6|||
33614738|NCT01640951|63015720|FG000|Overall Study|Lost to Follow-up|1|||
33614739|NCT01640951|63015721|FG001|Overall Study|Lost to Follow-up|0|||
33614740|NCT01640951|63015722|FG002|Overall Study|Lost to Follow-up|6|||
33614741|NCT01640951|63015723|FG003|Overall Study|Lost to Follow-up|2|||
33614742|NCT01640951|63015724|FG004|Overall Study|Lost to Follow-up|2|||
33614743|NCT01640951|63015725|FG005|Overall Study|Lost to Follow-up|3|||
33614744|NCT01640951|63015726|FG006|Overall Study|Lost to Follow-up|1|||
33614745|NCT01640951|63015727|FG007|Overall Study|Lost to Follow-up|1|||
33614746|NCT01640951|63015720|FG000|Overall Study|Non-compliance with study treatment|0|||
33614747|NCT01640951|63015721|FG001|Overall Study|Non-compliance with study treatment|0|||
33614748|NCT01640951|63015722|FG002|Overall Study|Non-compliance with study treatment|1|||
33614749|NCT01640951|63015723|FG003|Overall Study|Non-compliance with study treatment|1|||
33614750|NCT01640951|63015724|FG004|Overall Study|Non-compliance with study treatment|1|||
33614751|NCT01640951|63015725|FG005|Overall Study|Non-compliance with study treatment|4|||
33614752|NCT01640951|63015726|FG006|Overall Study|Non-compliance with study treatment|1|||
33614753|NCT01640951|63015727|FG007|Overall Study|Non-compliance with study treatment|0|||
33614754|NCT01640951|63015720|FG000|Overall Study|Physician Decision|2|||
33614755|NCT01640951|63015721|FG001|Overall Study|Physician Decision|5|||
33614756|NCT01640951|63015722|FG002|Overall Study|Physician Decision|2|||
33513248|NCT03073200|62897705|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33513249|NCT03073200|62897706|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
33513250|NCT03073200|62897707|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33513251|NCT03073200|62897708|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33513252|NCT03073200|62897709|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33513253|NCT03073200|62897710|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33614757|NCT01640951|63015723|FG003|Overall Study|Physician Decision|2|||
33614758|NCT01640951|63015724|FG004|Overall Study|Physician Decision|2|||
33513254|NCT03073200|62897711|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33513255|NCT03073200|62897712|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33513256|NCT03073200|62897713|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33513257|NCT03073200|62897714|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33513258|NCT03073200|62897715|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33513259|NCT03073200|62897716|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33513260|NCT03073200|62897717|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33513261|NCT03073200|62897718|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33513262|NCT03073200|62897719|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33513263|NCT03073200|62897705|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
33513264|NCT03073200|62897706|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
33513265|NCT03073200|62897707|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
33513266|NCT03073200|62897708|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
33513267|NCT03073200|62897709|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
33513268|NCT03073200|62897710|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
33513269|NCT03073200|62897711|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
33513270|NCT03073200|62897712|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
33614759|NCT01640951|63015725|FG005|Overall Study|Physician Decision|3|||
33614760|NCT01640951|63015726|FG006|Overall Study|Physician Decision|3|||
33614761|NCT01640951|63015727|FG007|Overall Study|Physician Decision|0|||
33614762|NCT01640951|63015720|FG000|Overall Study|Pregnancy|3|||
33614763|NCT01640951|63015721|FG001|Overall Study|Pregnancy|0|||
33614764|NCT01640951|63015722|FG002|Overall Study|Pregnancy|0|||
33614765|NCT01640951|63015723|FG003|Overall Study|Pregnancy|4|||
33453089|NCT00252174|62827657|FG000|Overall Study|Withdrawal by Subject|0|||
33453090|NCT00252174|62827658|FG001|Overall Study|Withdrawal by Subject|1|||
33453091|NCT00252174|62827659|FG002|Overall Study|Withdrawal by Subject|0|||
33453092|NCT00165984|62827667|FG000|Overall Study|Death|15|||
33453093|NCT00160524|62827674|FG000|Overall Study|Adverse Event|119|||
33453094|NCT00160524|62827674|FG000|Overall Study|Adverse Event and Other|94|||
33453095|NCT00160524|62827674|FG000|Overall Study|Protocol Violation|16|||
33453096|NCT00160524|62827674|FG000|Overall Study|Protocol Violation and Other|2|||
33453097|NCT00160524|62827674|FG000|Overall Study|Withdrawal by Subject|141|||
33453098|NCT00160524|62827674|FG000|Overall Study|Withdrawal by Subject and Other|17|||
33453099|NCT00160524|62827674|FG000|Overall Study|Physician Decision|27|||
33453100|NCT00160524|62827674|FG000|Overall Study|Physician Decision and Other|6|||
33513271|NCT03073200|62897713|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
33513272|NCT03073200|62897714|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
33513273|NCT03073200|62897715|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
33513274|NCT03073200|62897716|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
33513275|NCT03073200|62897717|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
33614766|NCT01640951|63015724|FG004|Overall Study|Pregnancy|0|||
33513276|NCT03073200|62897718|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
33513277|NCT03073200|62897719|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
33513278|NCT03073200|62897705|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
33513279|NCT03073200|62897706|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
33513280|NCT03073200|62897707|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
33513281|NCT03073200|62897708|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
33513282|NCT03073200|62897709|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
33614767|NCT01640951|63015725|FG005|Overall Study|Pregnancy|0|||
33614768|NCT01640951|63015726|FG006|Overall Study|Pregnancy|2|||
33614769|NCT01640951|63015727|FG007|Overall Study|Pregnancy|0|||
33614770|NCT01640951|63015720|FG000|Overall Study|Protocol Deviation|0|||
33513283|NCT03073200|62897710|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
33513284|NCT03073200|62897711|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
33513285|NCT03073200|62897712|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
33513286|NCT03073200|62897713|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
33513287|NCT03073200|62897714|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
33513288|NCT03073200|62897715|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
33513289|NCT03073200|62897716|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
33513290|NCT03073200|62897717|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
33513291|NCT03073200|62897718|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
33513292|NCT03073200|62897719|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
33614771|NCT01640951|63015721|FG001|Overall Study|Protocol Deviation|1|||
33513293|NCT03073200|62897705|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
33513294|NCT03073200|62897706|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
33513295|NCT03073200|62897707|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
33513296|NCT03073200|62897708|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
33513297|NCT03073200|62897709|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
33513298|NCT03073200|62897710|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
33513299|NCT03073200|62897711|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
33513300|NCT03073200|62897712|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
33513301|NCT03073200|62897713|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
33513302|NCT03073200|62897714|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
33513303|NCT03073200|62897715|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
33513304|NCT03073200|62897716|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
33513305|NCT03073200|62897717|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
33513306|NCT03073200|62897718|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
33513307|NCT03073200|62897719|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
33513308|NCT03073200|62897705|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
33513309|NCT03073200|62897706|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
33513310|NCT03073200|62897707|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
33513311|NCT03073200|62897708|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
33513312|NCT03073200|62897709|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
33513313|NCT03073200|62897710|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
33513314|NCT03073200|62897711|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
33513315|NCT03073200|62897712|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
33513316|NCT03073200|62897713|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
33513317|NCT03073200|62897714|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
33513318|NCT03073200|62897715|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
33513319|NCT03073200|62897716|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
33614772|NCT01640951|63015722|FG002|Overall Study|Protocol Deviation|2|||
33614773|NCT01640951|63015723|FG003|Overall Study|Protocol Deviation|1|||
33614774|NCT01640951|63015724|FG004|Overall Study|Protocol Deviation|0|||
33614775|NCT01640951|63015725|FG005|Overall Study|Protocol Deviation|1|||
33614776|NCT01640951|63015726|FG006|Overall Study|Protocol Deviation|0|||
33614777|NCT01640951|63015727|FG007|Overall Study|Protocol Deviation|0|||
33614778|NCT01640951|63015720|FG000|Overall Study|Subject/Guardian decision|12|||
33614779|NCT01640951|63015721|FG001|Overall Study|Subject/Guardian decision|4|||
33614780|NCT01640951|63015722|FG002|Overall Study|Subject/Guardian decision|13|||
33614781|NCT01640951|63015723|FG003|Overall Study|Subject/Guardian decision|15|||
33614782|NCT01640951|63015724|FG004|Overall Study|Subject/Guardian decision|7|||
33614783|NCT01640951|63015725|FG005|Overall Study|Subject/Guardian decision|19|||
33614784|NCT01640951|63015726|FG006|Overall Study|Subject/Guardian decision|5|||
33614785|NCT01640951|63015727|FG007|Overall Study|Subject/Guardian decision|4|||
33614786|NCT01640951|63015720|FG000|Overall Study|Death|0|||
33614787|NCT01640951|63015721|FG001|Overall Study|Death|1|||
33614788|NCT01640951|63015722|FG002|Overall Study|Death|1|||
33614789|NCT01640951|63015723|FG003|Overall Study|Death|0|||
33614790|NCT01640951|63015724|FG004|Overall Study|Death|0|||
33614791|NCT01640951|63015725|FG005|Overall Study|Death|0|||
33614792|NCT01640951|63015726|FG006|Overall Study|Death|0|||
33614793|NCT01640951|63015727|FG007|Overall Study|Death|2|||
33614794|NCT02228096|63015749|FG000|Overall Study|Study terminated by Sponsor|24|||
33614795|NCT02228096|63015749|FG000|Overall Study|Lack of Efficacy|18|||
33614796|NCT02228096|63015749|FG000|Overall Study|Death|12|||
33614797|NCT02228096|63015749|FG000|Overall Study|Physician Decision|3|||
33614798|NCT02228096|63015749|FG000|Overall Study|Subject/guardian decision|2|||
33614799|NCT02228096|63015749|FG000|Overall Study|New therapy for study indication|1|||
33614800|NCT02228096|63015749|FG000|Overall Study|Enrolled, not infused|11|||
33614801|NCT01640873|63015769|FG000|Overall Study|Protocol Violation|2|||
33614802|NCT01640873|63015770|FG001|Overall Study|Protocol Violation|1|||
33614803|NCT01683994|63015781|FG000|Overall Study|Withdrawal by Subject|1|||
33614804|NCT01683994|63015782|FG001|Overall Study|Withdrawal by Subject|0|||
33614805|NCT01683994|63015783|FG002|Overall Study|Withdrawal by Subject|0|||
33614806|NCT01683994|63015784|FG003|Overall Study|Withdrawal by Subject|1|||
33614807|NCT01683994|63015785|FG004|Overall Study|Withdrawal by Subject|0|||
33614808|NCT01683994|63015781|FG000|Overall Study|Intercurrent illness|0|||
33614809|NCT01683994|63015782|FG001|Overall Study|Intercurrent illness|0|||
33614810|NCT01683994|63015783|FG002|Overall Study|Intercurrent illness|0|||
33614811|NCT01683994|63015784|FG003|Overall Study|Intercurrent illness|2|||
33614812|NCT01683994|63015785|FG004|Overall Study|Intercurrent illness|1|||
33614813|NCT02247440|63015803|FG000|Overall Study|Withdrawal by Subject|1|||
33614814|NCT02247440|63015803|FG000|Overall Study|Lack of Efficacy|3|||
33614815|NCT01683838|63015809|FG000|Overall Study|Adverse Event|12|||
33614816|NCT01683838|63015810|FG001|Overall Study|Adverse Event|2|||
33614817|NCT01683838|63015809|FG000|Overall Study|Protocol Violation|3|||
33614818|NCT01683838|63015810|FG001|Overall Study|Protocol Violation|1|||
33614819|NCT01683838|63015809|FG000|Overall Study|Withdrawal by Subject|6|||
33614820|NCT01683838|63015810|FG001|Overall Study|Withdrawal by Subject|5|||
33614821|NCT01683838|63015809|FG000|Overall Study|Lost to Follow-up|1|||
33614822|NCT01683838|63015810|FG001|Overall Study|Lost to Follow-up|1|||
33614823|NCT01683838|63015809|FG000|Overall Study|Other|4|||
33614824|NCT01683838|63015810|FG001|Overall Study|Other|3|||
33614825|NCT01683604|63015816|FG000|Overall Study|Adverse Event|2|||
33614826|NCT01683604|63015816|FG000|Overall Study|Lack of Efficacy|1|||
33614827|NCT01683604|63015816|FG000|Overall Study|Other|2|||
33614828|NCT02196038|63015827|FG000|Overall Study|Death|16|||
33614829|NCT02196038|63015828|FG001|Overall Study|Death|21|||
33614830|NCT02196038|63015827|FG000|Overall Study|Withdrawal by Subject|0|||
33614831|NCT02196038|63015828|FG001|Overall Study|Withdrawal by Subject|1|||
33614832|NCT02196038|63015827|FG000|Overall Study|Lost to Follow-up|1|||
33614833|NCT02196038|63015828|FG001|Overall Study|Lost to Follow-up|0|||
33614834|NCT02141659|63015840|FG000|Overall Study|Major Protocol Deviation|0|||
33453101|NCT00160524|62827674|FG000|Overall Study|Lost to Follow-up|13|||
33614835|NCT02141659|63015841|FG001|Overall Study|Major Protocol Deviation|1|||
33614836|NCT02141659|63015842|FG002|Overall Study|Major Protocol Deviation|0|||
33614837|NCT02141659|63015843|FG003|Overall Study|Major Protocol Deviation|0|||
33614838|NCT02141659|63015844|FG004|Overall Study|Major Protocol Deviation|0|||
33614839|NCT02141659|63015845|FG005|Overall Study|Major Protocol Deviation|0|||
33614840|NCT02141659|63015840|FG000|Overall Study|Lack of Efficacy|0|||
33614841|NCT02141659|63015841|FG001|Overall Study|Lack of Efficacy|0|||
33453102|NCT00160524|62827674|FG000|Overall Study|Lost to Follow-up and Other|1|||
33453103|NCT00160524|62827674|FG000|Overall Study|Lack of Efficacy|21|||
33453104|NCT00160524|62827674|FG000|Overall Study|Lack of Efficacy and Other|1|||
33453105|NCT00160524|62827674|FG000|Overall Study|Other|20|||
33453106|NCT00159822|62827678|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
33453107|NCT00159822|62827678|FG000|Voriconazole Treatment Period|Adverse Event|9|||
33453108|NCT00159822|62827678|FG000|Voriconazole Treatment Period|Death|4|||
33614842|NCT02141659|63015842|FG002|Overall Study|Lack of Efficacy|0|||
33614843|NCT02141659|63015843|FG003|Overall Study|Lack of Efficacy|0|||
33513320|NCT03073200|62897717|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
33513321|NCT03073200|62897718|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
33513322|NCT03073200|62897719|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
33513323|NCT03073200|62897705|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33513324|NCT03073200|62897706|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33513325|NCT03073200|62897707|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33513326|NCT03073200|62897708|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
33513327|NCT03073200|62897709|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
33513328|NCT03073200|62897710|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33513329|NCT03073200|62897711|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33513330|NCT03073200|62897712|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33513331|NCT03073200|62897713|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33513332|NCT03073200|62897714|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33513333|NCT03073200|62897715|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33513334|NCT03073200|62897716|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33513335|NCT03073200|62897717|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33513336|NCT03073200|62897718|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33513337|NCT03073200|62897719|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33513338|NCT03073200|62897705|FG000|Extension Period|Lost to Follow-up|0|||
33513339|NCT03073200|62897706|FG001|Extension Period|Lost to Follow-up|0|||
33513340|NCT03073200|62897707|FG002|Extension Period|Lost to Follow-up|0|||
33513341|NCT03073200|62897708|FG003|Extension Period|Lost to Follow-up|0|||
33513342|NCT03073200|62897709|FG004|Extension Period|Lost to Follow-up|0|||
33513343|NCT03073200|62897710|FG005|Extension Period|Lost to Follow-up|0|||
33513344|NCT03073200|62897711|FG006|Extension Period|Lost to Follow-up|1|||
33513345|NCT03073200|62897712|FG007|Extension Period|Lost to Follow-up|1|||
33513346|NCT03073200|62897713|FG008|Extension Period|Lost to Follow-up|0|||
33513347|NCT03073200|62897714|FG009|Extension Period|Lost to Follow-up|0|||
33513348|NCT03073200|62897715|FG010|Extension Period|Lost to Follow-up|0|||
33513349|NCT03073200|62897716|FG011|Extension Period|Lost to Follow-up|0|||
33513350|NCT03073200|62897717|FG012|Extension Period|Lost to Follow-up|0|||
33513351|NCT03073200|62897718|FG013|Extension Period|Lost to Follow-up|0|||
33513352|NCT03073200|62897719|FG014|Extension Period|Lost to Follow-up|0|||
33513353|NCT03073200|62897705|FG000|Extension Period|Sponsor Decision|0|||
33513354|NCT03073200|62897706|FG001|Extension Period|Sponsor Decision|0|||
33513355|NCT03073200|62897707|FG002|Extension Period|Sponsor Decision|0|||
33513356|NCT03073200|62897708|FG003|Extension Period|Sponsor Decision|0|||
33513357|NCT03073200|62897709|FG004|Extension Period|Sponsor Decision|0|||
33513358|NCT03073200|62897710|FG005|Extension Period|Sponsor Decision|0|||
33513359|NCT03073200|62897711|FG006|Extension Period|Sponsor Decision|0|||
33513360|NCT03073200|62897712|FG007|Extension Period|Sponsor Decision|0|||
33513361|NCT03073200|62897713|FG008|Extension Period|Sponsor Decision|1|||
33513362|NCT03073200|62897714|FG009|Extension Period|Sponsor Decision|0|||
33513363|NCT03073200|62897715|FG010|Extension Period|Sponsor Decision|0|||
33513364|NCT03073200|62897716|FG011|Extension Period|Sponsor Decision|0|||
33513365|NCT03073200|62897717|FG012|Extension Period|Sponsor Decision|0|||
33513366|NCT03073200|62897718|FG013|Extension Period|Sponsor Decision|0|||
33513367|NCT03073200|62897719|FG014|Extension Period|Sponsor Decision|0|||
33513368|NCT03073200|62897705|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
33513369|NCT03073200|62897706|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
33513370|NCT03073200|62897707|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
33513371|NCT03073200|62897708|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
33513372|NCT03073200|62897709|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
33513373|NCT03073200|62897710|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
33513374|NCT03073200|62897711|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
33513375|NCT03073200|62897712|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
33453109|NCT00159822|62827678|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
33453110|NCT00159822|62827678|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
33453111|NCT00159822|62827678|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
33453112|NCT00159822|62827678|FG000|Post-treatment Follow-up Period|Death|1|||
33453113|NCT00159822|62827678|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
33453114|NCT00159822|62827678|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
33453115|NCT00158262|62827684|FG000|Overall Study|Lost to Follow-up|1|||
33453116|NCT00158262|62827685|FG001|Overall Study|Lost to Follow-up|1|||
33453117|NCT00157950|62827693|FG000|Overall Study|Death|1|||
33453118|NCT00157950|62827694|FG001|Overall Study|Death|0|||
33453119|NCT03745768|62827702|FG000|Overall Study|discontinued study|2|||
33453120|NCT03745768|62827703|FG001|Overall Study|discontinued study|0|||
33453121|NCT03745222|62827712|FG000|Overall Study|Withdrawal by Subject|0|||
33453122|NCT03745222|62827713|FG001|Overall Study|Withdrawal by Subject|1|||
33453123|NCT03745222|62827714|FG002|Overall Study|Withdrawal by Subject|0|||
33453124|NCT03743038|62827722|FG000|Overall Study|Physician Decision|1|||
33453125|NCT00153816|62827734|FG000|Overall Study|Death|6|||
33513376|NCT03073200|62897713|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
33513377|NCT03073200|62897714|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
33513378|NCT03073200|62897715|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
33324649|NCT01136382|62701209|FG001|Overall Study|Withdrawal by Subject|1|||
33324650|NCT00912028|62701218|FG000|Overall Study|Lost to Follow-up|2|||
33453126|NCT00153816|62827735|FG001|Overall Study|Death|5|||
33513379|NCT03073200|62897716|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
33513380|NCT03073200|62897717|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
33513381|NCT03073200|62897718|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
33513382|NCT03073200|62897719|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
33513383|NCT03073200|62897705|FG000|Extension Period|Withdrawal by Subject|0|||
33513384|NCT03073200|62897706|FG001|Extension Period|Withdrawal by Subject|0|||
33513385|NCT03073200|62897707|FG002|Extension Period|Withdrawal by Subject|0|||
33513386|NCT03073200|62897708|FG003|Extension Period|Withdrawal by Subject|0|||
33513387|NCT03073200|62897709|FG004|Extension Period|Withdrawal by Subject|0|||
33513388|NCT03073200|62897710|FG005|Extension Period|Withdrawal by Subject|0|||
33513389|NCT03073200|62897711|FG006|Extension Period|Withdrawal by Subject|1|||
33513390|NCT03073200|62897712|FG007|Extension Period|Withdrawal by Subject|2|||
33513391|NCT03073200|62897713|FG008|Extension Period|Withdrawal by Subject|0|||
33513392|NCT03073200|62897714|FG009|Extension Period|Withdrawal by Subject|0|||
33513393|NCT03073200|62897715|FG010|Extension Period|Withdrawal by Subject|0|||
33513394|NCT03073200|62897716|FG011|Extension Period|Withdrawal by Subject|0|||
33513395|NCT03073200|62897717|FG012|Extension Period|Withdrawal by Subject|0|||
33513396|NCT03073200|62897718|FG013|Extension Period|Withdrawal by Subject|0|||
33513397|NCT03073200|62897719|FG014|Extension Period|Withdrawal by Subject|0|||
33513398|NCT03073200|62897705|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
33513399|NCT03073200|62897706|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
33513400|NCT03073200|62897707|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
33513401|NCT03073200|62897708|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
33513402|NCT03073200|62897709|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
33513403|NCT03073200|62897710|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
33513404|NCT03073200|62897711|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
33513405|NCT03073200|62897712|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
33513406|NCT03073200|62897713|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
33513407|NCT03073200|62897714|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
33513408|NCT03073200|62897715|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
33513409|NCT03073200|62897716|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
33513410|NCT03073200|62897717|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
33513411|NCT03073200|62897718|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
33513412|NCT03073200|62897719|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
33513413|NCT03073200|62897705|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33513414|NCT03073200|62897706|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33513415|NCT03073200|62897707|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33513416|NCT03073200|62897708|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33513417|NCT03073200|62897709|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33513418|NCT03073200|62897710|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33513419|NCT03073200|62897711|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33513420|NCT03073200|62897712|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33513421|NCT03073200|62897713|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33513422|NCT03073200|62897714|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33513423|NCT03073200|62897715|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33513424|NCT03073200|62897716|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
33513425|NCT03073200|62897717|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33513426|NCT03073200|62897718|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33513427|NCT03073200|62897719|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33513428|NCT03073200|62897705|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33453127|NCT00153816|62827736|FG002|Overall Study|Death|4|||
33453128|NCT00153816|62827737|FG003|Overall Study|Death|6|||
33453129|NCT00153816|62827738|FG004|Overall Study|Death|0|||
33453130|NCT00153816|62827739|FG005|Overall Study|Death|2|||
33453131|NCT00153816|62827734|FG000|Overall Study|Lost to Follow-up|7|||
33453132|NCT00153816|62827735|FG001|Overall Study|Lost to Follow-up|8|||
33453133|NCT00153816|62827736|FG002|Overall Study|Lost to Follow-up|5|||
33453134|NCT00153816|62827737|FG003|Overall Study|Lost to Follow-up|8|||
33453135|NCT00153816|62827738|FG004|Overall Study|Lost to Follow-up|7|||
33453136|NCT00153816|62827739|FG005|Overall Study|Lost to Follow-up|9|||
33453137|NCT00153816|62827734|FG000|Overall Study|Withdrawal by Subject|9|||
33453138|NCT00153816|62827735|FG001|Overall Study|Withdrawal by Subject|9|||
33513429|NCT03073200|62897706|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33453139|NCT00153816|62827736|FG002|Overall Study|Withdrawal by Subject|9|||
33453140|NCT00153816|62827737|FG003|Overall Study|Withdrawal by Subject|4|||
33513430|NCT03073200|62897707|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33513431|NCT03073200|62897708|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33513432|NCT03073200|62897709|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33513433|NCT03073200|62897710|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33513434|NCT03073200|62897711|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33513435|NCT03073200|62897712|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33513436|NCT03073200|62897713|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33513437|NCT03073200|62897714|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33513438|NCT03073200|62897715|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
33513439|NCT03073200|62897716|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
33513440|NCT03073200|62897717|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33513441|NCT03073200|62897718|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33513442|NCT03073200|62897719|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33513443|NCT03073200|62897705|FG000|Randomized Withdrawal Period|Adverse Event|0|||
33513444|NCT03073200|62897706|FG001|Randomized Withdrawal Period|Adverse Event|0|||
33513445|NCT03073200|62897707|FG002|Randomized Withdrawal Period|Adverse Event|0|||
33513446|NCT03073200|62897708|FG003|Randomized Withdrawal Period|Adverse Event|0|||
33513447|NCT03073200|62897709|FG004|Randomized Withdrawal Period|Adverse Event|0|||
33513448|NCT03073200|62897710|FG005|Randomized Withdrawal Period|Adverse Event|0|||
33513449|NCT03073200|62897711|FG006|Randomized Withdrawal Period|Adverse Event|0|||
33513450|NCT03073200|62897712|FG007|Randomized Withdrawal Period|Adverse Event|0|||
33513451|NCT03073200|62897713|FG008|Randomized Withdrawal Period|Adverse Event|0|||
33513452|NCT03073200|62897714|FG009|Randomized Withdrawal Period|Adverse Event|0|||
33513453|NCT03073200|62897715|FG010|Randomized Withdrawal Period|Adverse Event|1|||
33513454|NCT03073200|62897716|FG011|Randomized Withdrawal Period|Adverse Event|0|||
33513455|NCT03073200|62897717|FG012|Randomized Withdrawal Period|Adverse Event|0|||
33513456|NCT03073200|62897718|FG013|Randomized Withdrawal Period|Adverse Event|0|||
33513457|NCT03073200|62897719|FG014|Randomized Withdrawal Period|Adverse Event|0|||
33513458|NCT03073200|62897705|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
33513459|NCT03073200|62897706|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
33513460|NCT03073200|62897707|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
33513461|NCT03073200|62897708|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
33513462|NCT03073200|62897709|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
33513463|NCT03073200|62897710|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
33513464|NCT03073200|62897711|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
33614844|NCT02141659|63015844|FG004|Overall Study|Lack of Efficacy|0|||
33614845|NCT02141659|63015845|FG005|Overall Study|Lack of Efficacy|1|||
33614846|NCT02141659|63015840|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
33614847|NCT02141659|63015841|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
33614848|NCT02141659|63015842|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
33614849|NCT02141659|63015843|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
33614850|NCT02141659|63015844|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
33614851|NCT02141659|63015845|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
33614852|NCT01640249|63015866|FG000|Period 1|Withdrawal by Subject|1|||
33614853|NCT01640249|63015867|FG001|Period 1|Withdrawal by Subject|0|||
33614854|NCT01640249|63015868|FG002|Period 1|Withdrawal by Subject|0|||
33614855|NCT01640249|63015869|FG003|Period 1|Withdrawal by Subject|0|||
33614856|NCT01640249|63015870|FG004|Period 1|Withdrawal by Subject|0|||
33614857|NCT01640249|63015871|FG005|Period 1|Withdrawal by Subject|1|||
33614858|NCT01640249|63015872|FG006|Period 1|Withdrawal by Subject|0|||
33614859|NCT02121301|63015894|FG000|Overall Study|Protocol Violation|1|||
33614860|NCT02121301|63015895|FG001|Overall Study|Protocol Violation|4|||
33614861|NCT02121301|63015896|FG002|Overall Study|Protocol Violation|1|||
33614862|NCT02227862|63015906|FG000|Overall Study|Protocol Violation|7|||
33614863|NCT02227862|63015907|FG001|Overall Study|Protocol Violation|9|||
33614864|NCT02227862|63015906|FG000|Overall Study|Other|0|||
33614865|NCT02227862|63015907|FG001|Overall Study|Other|2|||
33614866|NCT02227862|63015906|FG000|Overall Study|Adverse Event|4|||
33614867|NCT02227862|63015907|FG001|Overall Study|Adverse Event|3|||
33614868|NCT02227862|63015906|FG000|Overall Study|Withdrawal by Subject|7|||
33324651|NCT00912028|62701219|FG001|Overall Study|Lost to Follow-up|3|||
33614869|NCT02227862|63015907|FG001|Overall Study|Withdrawal by Subject|6|||
33614870|NCT02227862|63015906|FG000|Overall Study|Lost to Follow-up|1|||
33614871|NCT02227862|63015907|FG001|Overall Study|Lost to Follow-up|2|||
33513465|NCT03073200|62897712|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
33614872|NCT02120833|63015915|FG000|Overall Study|Adverse Event|1|||
33324652|NCT00912028|62701220|FG002|Overall Study|Lost to Follow-up|0|||
33513466|NCT03073200|62897713|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
33513467|NCT03073200|62897714|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
33513468|NCT03073200|62897715|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
33614873|NCT02120833|63015916|FG001|Overall Study|Adverse Event|0|||
33614874|NCT02120833|63015915|FG000|Overall Study|Withdrawal by Subject|2|||
33614875|NCT02120833|63015916|FG001|Overall Study|Withdrawal by Subject|0|||
33614876|NCT02120833|63015915|FG000|Overall Study|Lost to Follow-up|1|||
33614877|NCT02120833|63015916|FG001|Overall Study|Lost to Follow-up|1|||
33614878|NCT02170207|63015922|FG000|Overall Study|Case report forms unavailable|5|||
33614879|NCT02227784|63015930|FG000|Double-Blind Phase|Adverse Event|3|||
33614880|NCT02227784|63015931|FG001|Double-Blind Phase|Adverse Event|2|||
33614881|NCT02227784|63015932|FG002|Double-Blind Phase|Adverse Event|1|||
33614882|NCT02227784|63015933|FG003|Double-Blind Phase|Adverse Event|3|||
33614883|NCT02227784|63015934|FG004|Double-Blind Phase|Adverse Event|0|||
33614884|NCT02227784|63015930|FG000|Double-Blind Phase|Physician Decision|1|||
33614885|NCT02227784|63015931|FG001|Double-Blind Phase|Physician Decision|0|||
33614886|NCT02227784|63015932|FG002|Double-Blind Phase|Physician Decision|0|||
33614887|NCT02227784|63015933|FG003|Double-Blind Phase|Physician Decision|1|||
33614888|NCT02227784|63015934|FG004|Double-Blind Phase|Physician Decision|0|||
33614889|NCT02227784|63015930|FG000|Double-Blind Phase|Protocol Violation|0|||
33614890|NCT02227784|63015931|FG001|Double-Blind Phase|Protocol Violation|0|||
33614891|NCT02227784|63015932|FG002|Double-Blind Phase|Protocol Violation|1|||
33614892|NCT02227784|63015933|FG003|Double-Blind Phase|Protocol Violation|1|||
33614893|NCT02227784|63015934|FG004|Double-Blind Phase|Protocol Violation|0|||
33614894|NCT02227784|63015930|FG000|Double-Blind Phase|Sponsor Decision|34|||
33614895|NCT02227784|63015931|FG001|Double-Blind Phase|Sponsor Decision|15|||
33614896|NCT02227784|63015932|FG002|Double-Blind Phase|Sponsor Decision|14|||
33614897|NCT02227784|63015933|FG003|Double-Blind Phase|Sponsor Decision|32|||
33614898|NCT02227784|63015934|FG004|Double-Blind Phase|Sponsor Decision|0|||
33614899|NCT02227784|63015930|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
33513469|NCT03073200|62897716|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
33513470|NCT03073200|62897717|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
33513471|NCT03073200|62897718|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
33513472|NCT03073200|62897719|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
33513473|NCT03073200|62897705|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33513474|NCT03073200|62897706|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33513475|NCT03073200|62897707|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33513476|NCT03073200|62897708|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33614900|NCT02227784|63015931|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
33614901|NCT02227784|63015932|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
33614902|NCT02227784|63015933|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
33453141|NCT00153816|62827738|FG004|Overall Study|Withdrawal by Subject|1|||
33453142|NCT00153816|62827739|FG005|Overall Study|Withdrawal by Subject|5|||
33453143|NCT00153816|62827734|FG000|Overall Study|Follow-up exam not done|8|||
33453144|NCT00153816|62827735|FG001|Overall Study|Follow-up exam not done|7|||
33453145|NCT00153816|62827736|FG002|Overall Study|Follow-up exam not done|11|||
33453146|NCT00153816|62827737|FG003|Overall Study|Follow-up exam not done|10|||
33453147|NCT00153816|62827738|FG004|Overall Study|Follow-up exam not done|8|||
33453148|NCT00153816|62827739|FG005|Overall Study|Follow-up exam not done|9|||
33453149|NCT00153816|62827734|FG000|Overall Study|Follow-up exam done, histology missing|2|||
33453150|NCT00153816|62827735|FG001|Overall Study|Follow-up exam done, histology missing|3|||
33453151|NCT00153816|62827736|FG002|Overall Study|Follow-up exam done, histology missing|3|||
33453152|NCT00153816|62827737|FG003|Overall Study|Follow-up exam done, histology missing|3|||
33614903|NCT02227784|63015934|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
33614904|NCT02227784|63015930|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
33614905|NCT02227784|63015931|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
33513477|NCT03073200|62897709|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33513478|NCT03073200|62897710|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33513479|NCT03073200|62897711|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33513480|NCT03073200|62897712|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33513481|NCT03073200|62897713|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33513482|NCT03073200|62897714|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33513483|NCT03073200|62897715|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33513484|NCT03073200|62897716|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33513485|NCT03073200|62897717|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33513486|NCT03073200|62897718|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
33513487|NCT03073200|62897719|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33513488|NCT03073200|62897705|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33513489|NCT03073200|62897706|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33513490|NCT03073200|62897707|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33513491|NCT03073200|62897708|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33513492|NCT03073200|62897709|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33513493|NCT03073200|62897710|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33513494|NCT03073200|62897711|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33513495|NCT03073200|62897712|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33513496|NCT03073200|62897713|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33513497|NCT03073200|62897714|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33513498|NCT03073200|62897715|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33513499|NCT03073200|62897716|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33513500|NCT03073200|62897717|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33513501|NCT03073200|62897718|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
33513502|NCT03073200|62897719|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33513503|NCT03073200|62897705|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33513504|NCT03073200|62897706|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33513505|NCT03073200|62897707|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33513506|NCT03073200|62897708|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33513507|NCT03073200|62897709|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33513508|NCT03073200|62897710|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33513509|NCT03073200|62897711|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33453153|NCT00153816|62827738|FG004|Overall Study|Follow-up exam done, histology missing|1|||
33453154|NCT00153816|62827739|FG005|Overall Study|Follow-up exam done, histology missing|2|||
33453155|NCT00151476|62827756|FG000|FAP Identified Subjects|Protocol Violation|0|||
33453156|NCT00151476|62827757|FG001|FAP Identified Subjects|Protocol Violation|1|||
33453157|NCT00151476|62827756|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
33453158|NCT00151476|62827757|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
33453159|NCT00151476|62827756|FG000|FAP Analyzed Subjects|Other study participation|0|||
33453160|NCT00151476|62827757|FG001|FAP Analyzed Subjects|Other study participation|1|||
33453161|NCT00149994|62827766|FG000|Overall Study|Administrative problems:|1|||
33453162|NCT00149994|62827767|FG001|Overall Study|Administrative problems:|0|||
33453163|NCT00149994|62827766|FG000|Overall Study|Protocol Violation|0|||
33453164|NCT00149994|62827767|FG001|Overall Study|Protocol Violation|1|||
33453165|NCT00149214|62827775|FG000|Overall Study|Adverse Event|12|||
33453166|NCT00149214|62827776|FG001|Overall Study|Adverse Event|9|||
33453167|NCT00149214|62827775|FG000|Overall Study|Withdrawal by Subject|4|||
33453168|NCT00149214|62827776|FG001|Overall Study|Withdrawal by Subject|1|||
33513510|NCT03073200|62897712|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33513511|NCT03073200|62897713|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33513512|NCT03073200|62897714|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33513513|NCT03073200|62897715|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33513514|NCT03073200|62897716|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33513515|NCT03073200|62897717|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33513516|NCT03073200|62897718|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
33513517|NCT03073200|62897719|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33513518|NCT03073200|62897705|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33513519|NCT03073200|62897706|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33513520|NCT03073200|62897707|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33513521|NCT03073200|62897708|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33513522|NCT03073200|62897709|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33513523|NCT03073200|62897710|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33513524|NCT03073200|62897711|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33513525|NCT03073200|62897712|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33513526|NCT03073200|62897713|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33513527|NCT03073200|62897714|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33513528|NCT03073200|62897715|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33513529|NCT03073200|62897716|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33513530|NCT03073200|62897717|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33513531|NCT03073200|62897718|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33513532|NCT03073200|62897719|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
33513533|NCT03073200|62897705|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33513534|NCT03073200|62897706|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33513535|NCT03073200|62897707|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33513536|NCT03073200|62897708|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33513537|NCT03073200|62897709|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33513538|NCT03073200|62897710|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33513539|NCT03073200|62897711|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33513540|NCT03073200|62897712|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33513541|NCT03073200|62897713|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33513542|NCT03073200|62897714|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33513543|NCT03073200|62897715|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33513544|NCT03073200|62897716|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33513545|NCT03073200|62897717|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33453169|NCT00149214|62827775|FG000|Overall Study|Physician Decision|3|||
33453170|NCT00149214|62827776|FG001|Overall Study|Physician Decision|3|||
33513546|NCT03073200|62897718|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
33513547|NCT03073200|62897719|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33513548|NCT03073200|62897705|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33513549|NCT03073200|62897706|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33513550|NCT03073200|62897707|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33513551|NCT03073200|62897708|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33453171|NCT00149214|62827775|FG000|Overall Study|Sponsor Decision|0|||
33453172|NCT00149214|62827776|FG001|Overall Study|Sponsor Decision|1|||
33453173|NCT00149214|62827775|FG000|Overall Study|Progressive Disease|7|||
33453174|NCT00149214|62827776|FG001|Overall Study|Progressive Disease|3|||
33453175|NCT00114972|62827793|FG000|Overall Study|Withdrawal by Subject|40|||
33453176|NCT00114972|62827794|FG001|Overall Study|Withdrawal by Subject|7|||
33453177|NCT00114972|62827793|FG000|Overall Study|Lost to Follow-up|8|||
33453178|NCT00114972|62827794|FG001|Overall Study|Lost to Follow-up|5|||
33453179|NCT00129402|62827802|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
33453180|NCT00129402|62827803|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
33453181|NCT00129402|62827804|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
33513552|NCT03073200|62897709|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33513553|NCT03073200|62897710|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33513554|NCT03073200|62897711|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33513555|NCT03073200|62897712|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33513556|NCT03073200|62897713|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33513557|NCT03073200|62897714|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33513558|NCT03073200|62897715|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33513559|NCT03073200|62897716|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33513560|NCT03073200|62897717|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33513561|NCT03073200|62897718|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
33513562|NCT03073200|62897719|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33513563|NCT03073200|62897705|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33513564|NCT03073200|62897706|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33513565|NCT03073200|62897707|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33513566|NCT03073200|62897708|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33513567|NCT03073200|62897709|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33513568|NCT03073200|62897710|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33513569|NCT03073200|62897711|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33513570|NCT03073200|62897712|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33513571|NCT03073200|62897713|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33513572|NCT03073200|62897714|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33513573|NCT03073200|62897715|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33614906|NCT02227784|63015932|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
33324653|NCT00912028|62701221|FG003|Overall Study|Lost to Follow-up|1|||
33453182|NCT00129402|62827805|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
33453183|NCT00129402|62827806|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
33453184|NCT00129402|62827807|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
33453185|NCT00129402|62827808|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
33453186|NCT00129402|62827802|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
33453187|NCT00129402|62827803|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
33453188|NCT00129402|62827804|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
33453189|NCT00129402|62827805|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
33453190|NCT00129402|62827806|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
33453191|NCT00129402|62827807|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
33453192|NCT00129402|62827808|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
33453193|NCT00129402|62827802|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
33453194|NCT00129402|62827803|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
33453195|NCT00129402|62827804|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
33453196|NCT00129402|62827805|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
33453197|NCT00129402|62827806|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
33453198|NCT00129402|62827807|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
33453199|NCT00129402|62827808|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
33453200|NCT00129402|62827802|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
33453201|NCT00129402|62827803|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
33453202|NCT00129402|62827804|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
33453203|NCT00129402|62827805|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
33453204|NCT00129402|62827806|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
33453205|NCT00129402|62827807|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
33453206|NCT00129402|62827808|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
33453207|NCT00129402|62827802|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
33453208|NCT00129402|62827803|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
33453209|NCT00129402|62827804|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
33453210|NCT00129402|62827805|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
33513574|NCT03073200|62897716|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33513575|NCT03073200|62897717|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33513576|NCT03073200|62897718|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
33513577|NCT03073200|62897719|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33513578|NCT03290781|62897748|FG000|Overall Study|Adverse Event|5|||
33513579|NCT03290781|62897749|FG001|Overall Study|Adverse Event|7|||
33513580|NCT03290781|62897750|FG002|Overall Study|Adverse Event|4|||
33513581|NCT03290781|62897751|FG003|Overall Study|Adverse Event|1|||
33513582|NCT03290781|62897752|FG004|Overall Study|Adverse Event|0|||
33513583|NCT03290781|62897753|FG005|Overall Study|Adverse Event|0|||
33513584|NCT03290781|62897754|FG006|Overall Study|Adverse Event|0|||
33513585|NCT03290781|62897748|FG000|Overall Study|Death|0|||
33513586|NCT03290781|62897749|FG001|Overall Study|Death|0|||
33513587|NCT03290781|62897750|FG002|Overall Study|Death|1|||
33513588|NCT03290781|62897751|FG003|Overall Study|Death|0|||
33513589|NCT03290781|62897752|FG004|Overall Study|Death|1|||
33513590|NCT03290781|62897753|FG005|Overall Study|Death|0|||
33614907|NCT02227784|63015933|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
33614908|NCT02227784|63015934|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
33614909|NCT02227784|63015930|FG000|Open-Label Extension Phase (OLE)|Death|0|||
33614910|NCT02227784|63015931|FG001|Open-Label Extension Phase (OLE)|Death|0|||
33614911|NCT02227784|63015932|FG002|Open-Label Extension Phase (OLE)|Death|0|||
33614912|NCT02227784|63015933|FG003|Open-Label Extension Phase (OLE)|Death|0|||
33614913|NCT02227784|63015934|FG004|Open-Label Extension Phase (OLE)|Death|1|||
33614914|NCT02227784|63015930|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
33614915|NCT02227784|63015931|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
33614916|NCT02227784|63015932|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
33614917|NCT02227784|63015933|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
33614918|NCT02227784|63015934|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
33614919|NCT02227784|63015930|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
33614920|NCT02227784|63015931|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
33513591|NCT03290781|62897754|FG006|Overall Study|Death|0|||
33513592|NCT03290781|62897748|FG000|Overall Study|Withdrawal by Subject|6|||
33513593|NCT03290781|62897749|FG001|Overall Study|Withdrawal by Subject|5|||
33513594|NCT03290781|62897750|FG002|Overall Study|Withdrawal by Subject|9|||
33513595|NCT03290781|62897751|FG003|Overall Study|Withdrawal by Subject|10|||
33513596|NCT03290781|62897752|FG004|Overall Study|Withdrawal by Subject|1|||
33513597|NCT03290781|62897753|FG005|Overall Study|Withdrawal by Subject|2|||
33513598|NCT03290781|62897754|FG006|Overall Study|Withdrawal by Subject|0|||
33513599|NCT03290781|62897748|FG000|Overall Study|Physician Decision|0|||
33513600|NCT03290781|62897749|FG001|Overall Study|Physician Decision|1|||
33513601|NCT03290781|62897750|FG002|Overall Study|Physician Decision|0|||
33513602|NCT03290781|62897751|FG003|Overall Study|Physician Decision|0|||
33513603|NCT03290781|62897752|FG004|Overall Study|Physician Decision|0|||
33513604|NCT03290781|62897753|FG005|Overall Study|Physician Decision|0|||
33513605|NCT03290781|62897754|FG006|Overall Study|Physician Decision|0|||
33513606|NCT03290781|62897748|FG000|Overall Study|Site Terminated by Sponsor|1|||
33513607|NCT03290781|62897749|FG001|Overall Study|Site Terminated by Sponsor|0|||
33513608|NCT03290781|62897750|FG002|Overall Study|Site Terminated by Sponsor|2|||
33614921|NCT02227784|63015932|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
33614922|NCT02227784|63015933|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
33614923|NCT02227784|63015934|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
33614924|NCT01565668|63015949|FG000|Overall Study|Death|2|||
33614925|NCT01565668|63015950|FG001|Overall Study|Death|1|||
33614926|NCT01565668|63015949|FG000|Overall Study|Lack of Efficacy|4|||
33614927|NCT01565668|63015950|FG001|Overall Study|Lack of Efficacy|2|||
33513609|NCT03290781|62897751|FG003|Overall Study|Site Terminated by Sponsor|1|||
33513610|NCT03290781|62897752|FG004|Overall Study|Site Terminated by Sponsor|0|||
33513611|NCT03290781|62897753|FG005|Overall Study|Site Terminated by Sponsor|0|||
33513612|NCT03290781|62897754|FG006|Overall Study|Site Terminated by Sponsor|0|||
33513613|NCT03290781|62897748|FG000|Overall Study|Lost to Follow-up|0|||
33513614|NCT03290781|62897749|FG001|Overall Study|Lost to Follow-up|0|||
33513615|NCT03290781|62897750|FG002|Overall Study|Lost to Follow-up|0|||
33513616|NCT03290781|62897751|FG003|Overall Study|Lost to Follow-up|1|||
33614928|NCT01565668|63015949|FG000|Overall Study|Participant went on Hospice Care|1|||
33614929|NCT01565668|63015950|FG001|Overall Study|Participant went on Hospice Care|0|||
33614930|NCT01565668|63015949|FG000|Overall Study|Adverse Event|6|||
33513617|NCT03290781|62897752|FG004|Overall Study|Lost to Follow-up|0|||
33513618|NCT03290781|62897753|FG005|Overall Study|Lost to Follow-up|0|||
33614931|NCT01565668|63015950|FG001|Overall Study|Adverse Event|1|||
33614932|NCT01565668|63015949|FG000|Overall Study|Randomized, but never received drug|0|||
33614933|NCT01565668|63015950|FG001|Overall Study|Randomized, but never received drug|2|||
33614934|NCT01565668|63015949|FG000|Overall Study|Progressive disease|13|||
33614935|NCT01565668|63015950|FG001|Overall Study|Progressive disease|14|||
33614936|NCT01565668|63015949|FG000|Overall Study|Withdrawal by Subject|1|||
33614937|NCT01565668|63015950|FG001|Overall Study|Withdrawal by Subject|3|||
33614938|NCT01565668|63015949|FG000|Overall Study|HSCT Transplant|11|||
33614939|NCT01565668|63015950|FG001|Overall Study|HSCT Transplant|15|||
33614940|NCT01683058|63015956|FG000|Overall Study|Lost to Follow-up|9|||
33513619|NCT03290781|62897754|FG006|Overall Study|Lost to Follow-up|0|||
33513620|NCT03290781|62897748|FG000|Overall Study|Protocol Deviation|2|||
33513621|NCT03290781|62897749|FG001|Overall Study|Protocol Deviation|0|||
33513622|NCT03290781|62897750|FG002|Overall Study|Protocol Deviation|0|||
33513623|NCT03290781|62897751|FG003|Overall Study|Protocol Deviation|1|||
33513624|NCT03290781|62897752|FG004|Overall Study|Protocol Deviation|0|||
33513625|NCT03290781|62897753|FG005|Overall Study|Protocol Deviation|0|||
33513626|NCT03290781|62897754|FG006|Overall Study|Protocol Deviation|0|||
33513627|NCT03290781|62897748|FG000|Overall Study|Disease Relapse|32|||
33513628|NCT03290781|62897749|FG001|Overall Study|Disease Relapse|5|||
33513629|NCT03290781|62897750|FG002|Overall Study|Disease Relapse|38|||
33513630|NCT03290781|62897751|FG003|Overall Study|Disease Relapse|7|||
33513631|NCT03290781|62897752|FG004|Overall Study|Disease Relapse|3|||
33513632|NCT03290781|62897753|FG005|Overall Study|Disease Relapse|1|||
33513633|NCT03290781|62897754|FG006|Overall Study|Disease Relapse|4|||
33513634|NCT03290781|62897748|FG000|Overall Study|Other|3|||
33614941|NCT01683058|63015956|FG000|Overall Study|Adverse Event|6|||
33513635|NCT03290781|62897749|FG001|Overall Study|Other|0|||
33513636|NCT03290781|62897750|FG002|Overall Study|Other|2|||
33513637|NCT03290781|62897751|FG003|Overall Study|Other|2|||
33513638|NCT03290781|62897752|FG004|Overall Study|Other|0|||
33513639|NCT03290781|62897753|FG005|Overall Study|Other|0|||
33513640|NCT03290781|62897754|FG006|Overall Study|Other|0|||
33513641|NCT03466073|62897783|FG000|Overall Study|Death|1|||
33513642|NCT03466073|62897784|FG001|Overall Study|Death|0|||
33614942|NCT01683058|63015956|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
33614943|NCT01683058|63015956|FG000|Overall Study|Withdrawal by Subject|7|||
33614944|NCT01683058|63015956|FG000|Overall Study|Lack of Efficacy|2|||
33614945|NCT01626859|63015964|FG000|Overall Study|Adverse Event|1|||
33453211|NCT00129402|62827806|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
33453212|NCT00129402|62827807|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
33453213|NCT00129402|62827808|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
33453214|NCT00129402|62827802|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
33614946|NCT01626859|63015965|FG001|Overall Study|Adverse Event|3|||
33614947|NCT01626859|63015966|FG002|Overall Study|Adverse Event|2|||
33614948|NCT01626859|63015964|FG000|Overall Study|Physician Decision|0|||
33614949|NCT01626859|63015965|FG001|Overall Study|Physician Decision|1|||
33614950|NCT01626859|63015966|FG002|Overall Study|Physician Decision|0|||
33614951|NCT01626859|63015964|FG000|Overall Study|Withdrawal by Subject|1|||
33614952|NCT01626859|63015965|FG001|Overall Study|Withdrawal by Subject|4|||
33614953|NCT01626859|63015966|FG002|Overall Study|Withdrawal by Subject|2|||
33614954|NCT02193776|63015978|FG000|Overall Study|Consent withdrawn|1|||
33614955|NCT02193776|63015979|FG001|Overall Study|Consent withdrawn|0|||
33614956|NCT02193776|63015980|FG002|Overall Study|Consent withdrawn|0|||
33614957|NCT02193776|63015981|FG003|Overall Study|Consent withdrawn|0|||
33614958|NCT02193776|63015978|FG000|Overall Study|Failure to comply with protocol|0|||
33614959|NCT02193776|63015979|FG001|Overall Study|Failure to comply with protocol|1|||
33614960|NCT02193776|63015980|FG002|Overall Study|Failure to comply with protocol|0|||
33614961|NCT02193776|63015981|FG003|Overall Study|Failure to comply with protocol|0|||
33614962|NCT02193776|63015978|FG000|Overall Study|Investigator/Sponsor decision|1|||
33614963|NCT02193776|63015979|FG001|Overall Study|Investigator/Sponsor decision|1|||
33453215|NCT00129402|62827803|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
33453216|NCT00129402|62827804|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
33453217|NCT00129402|62827805|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
33453218|NCT00129402|62827806|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
33453219|NCT00129402|62827807|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
33453220|NCT00129402|62827808|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
33453221|NCT00129402|62827802|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
33513643|NCT03466073|62897785|FG002|Overall Study|Death|0|||
33513644|NCT03466073|62897786|FG003|Overall Study|Death|0|||
33513645|NCT03466073|62897787|FG004|Overall Study|Death|0|||
33513646|NCT03466073|62897788|FG005|Overall Study|Death|1|||
33513647|NCT03412019|62897811|FG000|Overall Study|Withdrawal by Subject|1|||
33614964|NCT02193776|63015980|FG002|Overall Study|Investigator/Sponsor decision|0|||
33614965|NCT02193776|63015981|FG003|Overall Study|Investigator/Sponsor decision|0|||
33614966|NCT02193776|63015978|FG000|Overall Study|Death|1|||
33614967|NCT02193776|63015979|FG001|Overall Study|Death|0|||
33614968|NCT02193776|63015980|FG002|Overall Study|Death|0|||
33614969|NCT02193776|63015981|FG003|Overall Study|Death|0|||
33614970|NCT02193776|63015978|FG000|Overall Study|Adverse event/Specific toxicity|5|||
33614971|NCT02193776|63015979|FG001|Overall Study|Adverse event/Specific toxicity|5|||
33614972|NCT02193776|63015980|FG002|Overall Study|Adverse event/Specific toxicity|2|||
33453222|NCT00129402|62827803|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
33453223|NCT00129402|62827804|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
33453224|NCT00129402|62827805|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
33453225|NCT00129402|62827806|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
33453226|NCT00129402|62827807|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
33453227|NCT00129402|62827808|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
33453228|NCT00129402|62827802|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
33513648|NCT03412019|62897812|FG001|Overall Study|Withdrawal by Subject|1|||
33513649|NCT03070002|62897818|FG000|Follow up for 2 Years|Death|1|||
33513650|NCT02918318|62897826|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
33513651|NCT02918318|62897827|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
33513652|NCT02918318|62897828|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
33513653|NCT02918318|62897829|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
33513654|NCT02918318|62897830|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
33513655|NCT02918318|62897826|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
33513656|NCT02918318|62897827|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
33513657|NCT02918318|62897828|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
33513658|NCT02918318|62897829|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
33513659|NCT02918318|62897830|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
33513660|NCT02918318|62897826|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
33513661|NCT02918318|62897827|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
33513662|NCT02918318|62897828|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
33513663|NCT02918318|62897829|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
33513664|NCT02918318|62897830|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
33513665|NCT02918318|62897826|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
33513666|NCT02918318|62897827|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
33513667|NCT02918318|62897828|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
33513668|NCT02918318|62897829|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
33513669|NCT02918318|62897830|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
33513670|NCT02918318|62897826|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
33513671|NCT02918318|62897827|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
33513672|NCT02918318|62897828|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
33513673|NCT02918318|62897829|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
33513674|NCT02918318|62897830|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
33513675|NCT02918318|62897826|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
33513676|NCT02918318|62897827|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
33513677|NCT02918318|62897828|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
33513678|NCT02918318|62897829|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
33513679|NCT02918318|62897830|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
33513680|NCT02918318|62897826|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
33513681|NCT02918318|62897827|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
33513682|NCT02918318|62897828|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
33513683|NCT02918318|62897829|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
33513684|NCT02918318|62897830|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
33513685|NCT02918318|62897826|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
33513686|NCT02918318|62897827|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
33513687|NCT02918318|62897828|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
33513688|NCT02918318|62897829|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
33513689|NCT02918318|62897830|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
33513690|NCT02918318|62897826|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
33513691|NCT02918318|62897827|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
33513692|NCT02918318|62897828|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
33513693|NCT02918318|62897829|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
33614973|NCT02193776|63015981|FG003|Overall Study|Adverse event/Specific toxicity|2|||
33513694|NCT02918318|62897830|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
33513695|NCT02918318|62897826|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
33513696|NCT02918318|62897827|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
33513697|NCT02918318|62897828|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
33513698|NCT02918318|62897829|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
33513699|NCT02918318|62897830|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
33513700|NCT02918318|62897826|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
33513701|NCT02918318|62897827|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
33513702|NCT02918318|62897828|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
33513703|NCT02918318|62897829|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
33513704|NCT02918318|62897830|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
33513705|NCT02918318|62897826|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
33513706|NCT02918318|62897827|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
33513707|NCT02918318|62897828|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
33513708|NCT02918318|62897829|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
33513709|NCT02918318|62897830|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
33513710|NCT03411863|62897875|FG000|Overall Study|Withdrawal by Subject|3|||
33513711|NCT03411863|62897876|FG001|Overall Study|Withdrawal by Subject|1|||
33513712|NCT03411863|62897875|FG000|Overall Study|Physician Decision|0|||
33513713|NCT03411863|62897876|FG001|Overall Study|Physician Decision|1|||
33513714|NCT01065350|62897885|FG000|Overall Study|Received incorrect drug allocation|0|||
33513715|NCT01065350|62897886|FG001|Overall Study|Received incorrect drug allocation|1|||
33513716|NCT03434249|62897894|FG000|Overall Study|Adverse Event|1|||
33513717|NCT03434249|62897895|FG001|Overall Study|Adverse Event|0|||
33513718|NCT03434249|62897894|FG000|Overall Study|Lost to Follow-up|0|||
33513719|NCT03434249|62897895|FG001|Overall Study|Lost to Follow-up|1|||
33513720|NCT03434249|62897894|FG000|Overall Study|Non-compliance of family|2|||
33513721|NCT03434249|62897895|FG001|Overall Study|Non-compliance of family|1|||
33513722|NCT03434249|62897894|FG000|Overall Study|Difficulties in completing daily diary|2|||
33513723|NCT03434249|62897895|FG001|Overall Study|Difficulties in completing daily diary|1|||
33513724|NCT03114969|62897910|FG000|Overall Study|Lost to Follow-up|0|||
33513725|NCT03114969|62897911|FG001|Overall Study|Lost to Follow-up|0|||
33513726|NCT03114969|62897912|FG002|Overall Study|Lost to Follow-up|3|||
33513727|NCT03114969|62897913|FG003|Overall Study|Lost to Follow-up|2|||
33513728|NCT03114969|62897914|FG004|Overall Study|Lost to Follow-up|0|||
33614974|NCT02170064|63015994|FG000|Overall Study|Withdrawal by Subject|5|||
33614975|NCT02170064|63015995|FG001|Overall Study|Withdrawal by Subject|1|||
33614976|NCT02170064|63015996|FG002|Overall Study|Withdrawal by Subject|1|||
33614977|NCT02170064|63015994|FG000|Overall Study|Physician Decision|1|||
33614978|NCT02170064|63015995|FG001|Overall Study|Physician Decision|1|||
33614979|NCT02170064|63015996|FG002|Overall Study|Physician Decision|0|||
33614980|NCT02169830|63016007|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
33614981|NCT02169830|63016008|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
33614982|NCT02169830|63016009|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
33614983|NCT02169830|63016007|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
33614984|NCT02169830|63016008|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
33614985|NCT02169830|63016009|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
33614986|NCT02169830|63016007|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
33513729|NCT03114969|62897915|FG005|Overall Study|Lost to Follow-up|0|||
33513730|NCT03114969|62897916|FG006|Overall Study|Lost to Follow-up|0|||
33513731|NCT03114969|62897917|FG007|Overall Study|Lost to Follow-up|0|||
33513732|NCT03114969|62897918|FG008|Overall Study|Lost to Follow-up|0|||
33513733|NCT03114969|62897910|FG000|Overall Study|Adverse Event|0|||
33513734|NCT03114969|62897911|FG001|Overall Study|Adverse Event|0|||
33513735|NCT03114969|62897912|FG002|Overall Study|Adverse Event|1|||
33513736|NCT03114969|62897913|FG003|Overall Study|Adverse Event|0|||
33513737|NCT03114969|62897914|FG004|Overall Study|Adverse Event|0|||
33513738|NCT03114969|62897915|FG005|Overall Study|Adverse Event|1|||
33513739|NCT03114969|62897916|FG006|Overall Study|Adverse Event|1|||
33513740|NCT03114969|62897917|FG007|Overall Study|Adverse Event|0|||
33513741|NCT03114969|62897918|FG008|Overall Study|Adverse Event|2|||
33513742|NCT02046096|62897947|FG000|Overall Study|Death|28|||
33614987|NCT02169830|63016008|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
33614988|NCT02169830|63016009|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
33614989|NCT02169830|63016007|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
33614990|NCT02169830|63016008|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
33513743|NCT02046096|62897948|FG001|Overall Study|Death|45|||
33513744|NCT02046096|62897947|FG000|Overall Study|Lost to Follow-up|9|||
33513745|NCT02046096|62897948|FG001|Overall Study|Lost to Follow-up|20|||
33513746|NCT02046096|62897947|FG000|Overall Study|Withdrawal by Subject|5|||
33513747|NCT02046096|62897948|FG001|Overall Study|Withdrawal by Subject|17|||
33513748|NCT02046096|62897947|FG000|Overall Study|Other endpoint|2|||
33513749|NCT02046096|62897948|FG001|Overall Study|Other endpoint|19|||
33513750|NCT03463577|62897962|FG000|Overall Study|Lost to Follow-up|238|||
33513751|NCT03463577|62897963|FG001|Overall Study|Lost to Follow-up|435|||
33513752|NCT03463577|62897964|FG002|Overall Study|Lost to Follow-up|0|||
33513753|NCT03463577|62897965|FG003|Overall Study|Lost to Follow-up|0|||
33513754|NCT03463577|62897966|FG004|Overall Study|Lost to Follow-up|0|||
33513755|NCT03463577|62897967|FG005|Overall Study|Lost to Follow-up|0|||
33513756|NCT03463577|62897962|FG000|Overall Study|With unknown pregnancy outcome|0|||
33513757|NCT03463577|62897963|FG001|Overall Study|With unknown pregnancy outcome|5|||
33513758|NCT03463577|62897964|FG002|Overall Study|With unknown pregnancy outcome|0|||
33513759|NCT03463577|62897965|FG003|Overall Study|With unknown pregnancy outcome|0|||
33513760|NCT03463577|62897966|FG004|Overall Study|With unknown pregnancy outcome|0|||
33513761|NCT03463577|62897967|FG005|Overall Study|With unknown pregnancy outcome|0|||
33513762|NCT03463577|62897962|FG000|Overall Study|Maternal death|2|||
33513763|NCT03463577|62897963|FG001|Overall Study|Maternal death|0|||
33513764|NCT03463577|62897964|FG002|Overall Study|Maternal death|0|||
33513765|NCT03463577|62897965|FG003|Overall Study|Maternal death|0|||
33513766|NCT03463577|62897966|FG004|Overall Study|Maternal death|0|||
33614991|NCT02169830|63016009|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
33614992|NCT02169830|63016007|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
33614993|NCT02169830|63016008|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
33614994|NCT02169830|63016009|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
33614995|NCT02169674|63016019|FG000|Overall Study|Withdrawal by Subject|2|||
33614996|NCT02169674|63016020|FG001|Overall Study|Withdrawal by Subject|1|||
33513767|NCT03463577|62897967|FG005|Overall Study|Maternal death|0|||
33614997|NCT02169674|63016019|FG000|Overall Study|Seroprotected|30|||
33614998|NCT02169674|63016020|FG001|Overall Study|Seroprotected|76|||
33614999|NCT02169674|63016019|FG000|Overall Study|Lost to Follow-up|0|||
33615000|NCT02169674|63016020|FG001|Overall Study|Lost to Follow-up|1|||
33513768|NCT03463577|62897962|FG000|Overall Study|Neonatal death|0|||
33513769|NCT03463577|62897963|FG001|Overall Study|Neonatal death|0|||
33513770|NCT03463577|62897964|FG002|Overall Study|Neonatal death|0|||
33513771|NCT03463577|62897965|FG003|Overall Study|Neonatal death|15|||
33513772|NCT03463577|62897966|FG004|Overall Study|Neonatal death|17|||
33513773|NCT03463577|62897967|FG005|Overall Study|Neonatal death|0|||
33615001|NCT02169284|63016028|FG000|Overall Study|Physician Decision|0|||
33615002|NCT02169284|63016029|FG001|Overall Study|Physician Decision|1|||
33615003|NCT02119819|63016043|FG000|Overall Study|Adverse Event|3|||
33615004|NCT02119819|63016044|FG001|Overall Study|Adverse Event|1|||
33324654|NCT00912028|62701222|FG004|Overall Study|Lost to Follow-up|3|||
33513774|NCT03122145|62897983|FG000|Overall Study|Concurrent respiratory disease|3|||
33513775|NCT03122145|62897984|FG001|Overall Study|Concurrent respiratory disease|0|||
33513776|NCT03114657|62897992|FG000|Overall Study|Adverse Event|9|||
33513777|NCT03114657|62897993|FG001|Overall Study|Adverse Event|6|||
33513778|NCT03114657|62897992|FG000|Overall Study|Death|4|||
33324655|NCT00912028|62701218|FG000|Overall Study|Withdrawal by Subject|3|||
33513779|NCT03114657|62897993|FG001|Overall Study|Death|0|||
33513780|NCT03114657|62897992|FG000|Overall Study|Multiple Reasons|1|||
33513781|NCT03114657|62897993|FG001|Overall Study|Multiple Reasons|2|||
33513782|NCT03114657|62897992|FG000|Overall Study|Physician Decision|2|||
33513783|NCT03114657|62897993|FG001|Overall Study|Physician Decision|2|||
33513784|NCT03114657|62897992|FG000|Overall Study|Study Terminated By Sponsor|355|||
33513785|NCT03114657|62897993|FG001|Overall Study|Study Terminated By Sponsor|374|||
33513786|NCT03114657|62897992|FG000|Overall Study|Symptomatic Deterioration|0|||
33513787|NCT03114657|62897993|FG001|Overall Study|Symptomatic Deterioration|1|||
33513788|NCT03114657|62897992|FG000|Overall Study|Withdrawal by Subject|28|||
33513789|NCT03114657|62897993|FG001|Overall Study|Withdrawal by Subject|22|||
33513790|NCT02926950|62898002|FG000|Overall Study|Adverse Event|4|||
33513791|NCT02926950|62898003|FG001|Overall Study|Adverse Event|6|||
33513792|NCT02926950|62898002|FG000|Overall Study|At the participant's own request|21|||
33513793|NCT02926950|62898003|FG001|Overall Study|At the participant's own request|25|||
33615005|NCT02119819|63016045|FG002|Overall Study|Adverse Event|2|||
33615006|NCT02119819|63016046|FG003|Overall Study|Adverse Event|3|||
33615007|NCT02119819|63016047|FG004|Overall Study|Adverse Event|0|||
33615008|NCT02119819|63016048|FG005|Overall Study|Adverse Event|1|||
33513794|NCT02926950|62898002|FG000|Overall Study|Reason not Specified|17|||
33513795|NCT02926950|62898003|FG001|Overall Study|Reason not Specified|9|||
33513796|NCT02926950|62898002|FG000|Overall Study|Lost to Follow-up|7|||
33513797|NCT02926950|62898003|FG001|Overall Study|Lost to Follow-up|8|||
33513798|NCT03410693|62898012|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
33513799|NCT03410693|62898013|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
33513800|NCT03410693|62898012|FG000|Overall Study|Disc trt: Lost to follow up|0|||
33513801|NCT03410693|62898013|FG001|Overall Study|Disc trt: Lost to follow up|1|||
33513802|NCT03410693|62898012|FG000|Overall Study|Disc trt: radiological progression|58|||
33513803|NCT03410693|62898013|FG001|Overall Study|Disc trt: radiological progression|50|||
33513804|NCT03410693|62898012|FG000|Overall Study|Disc trt: Other|1|||
33513805|NCT03410693|62898013|FG001|Overall Study|Disc trt: Other|0|||
33513806|NCT03410693|62898012|FG000|Overall Study|Study drug never administered|1|||
33513807|NCT03410693|62898013|FG001|Overall Study|Study drug never administered|6|||
33513808|NCT03410693|62898012|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
33615009|NCT02119819|63016043|FG000|Overall Study|Lack of Efficacy|0|||
33615010|NCT02119819|63016044|FG001|Overall Study|Lack of Efficacy|0|||
33615011|NCT02119819|63016045|FG002|Overall Study|Lack of Efficacy|0|||
33615012|NCT02119819|63016046|FG003|Overall Study|Lack of Efficacy|0|||
33615013|NCT02119819|63016047|FG004|Overall Study|Lack of Efficacy|0|||
33615014|NCT02119819|63016048|FG005|Overall Study|Lack of Efficacy|1|||
33615015|NCT02119819|63016043|FG000|Overall Study|Lost to Follow-up|0|||
33615016|NCT02119819|63016044|FG001|Overall Study|Lost to Follow-up|0|||
33615017|NCT02119819|63016045|FG002|Overall Study|Lost to Follow-up|1|||
33615018|NCT02119819|63016046|FG003|Overall Study|Lost to Follow-up|2|||
33615019|NCT02119819|63016047|FG004|Overall Study|Lost to Follow-up|1|||
33615020|NCT02119819|63016048|FG005|Overall Study|Lost to Follow-up|2|||
33453229|NCT00129402|62827803|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
33513809|NCT03410693|62898013|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
33513810|NCT03410693|62898012|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
33513811|NCT03410693|62898013|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
33513812|NCT03410693|62898012|FG000|Overall Study|Disc trt: Physician decision|0|||
33513813|NCT03410693|62898013|FG001|Overall Study|Disc trt: Physician decision|5|||
33513814|NCT03410693|62898012|FG000|Overall Study|Disc trt: clinical progression|1|||
33513815|NCT03410693|62898013|FG001|Overall Study|Disc trt: clinical progression|5|||
33513816|NCT03410693|62898012|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
33513817|NCT03410693|62898013|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
33513818|NCT01064414|62898028|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
33615021|NCT02119819|63016043|FG000|Overall Study|Physician Decision|1|||
33453230|NCT00129402|62827804|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
33453231|NCT00129402|62827805|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
33453232|NCT00129402|62827806|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
33453233|NCT00129402|62827807|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
33453234|NCT00129402|62827808|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
33453235|NCT00129402|62827802|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
33453236|NCT00129402|62827803|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
33453237|NCT00129402|62827804|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
33453238|NCT00129402|62827805|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
33453239|NCT00129402|62827806|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
33453240|NCT00129402|62827807|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
33453241|NCT00129402|62827808|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
33453242|NCT00129402|62827802|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
33453243|NCT00129402|62827803|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
33453244|NCT00129402|62827804|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
33453245|NCT00129402|62827805|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
33453246|NCT00129402|62827806|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
33453247|NCT00129402|62827807|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
33453248|NCT00129402|62827808|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
33453249|NCT00129402|62827802|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
33453250|NCT00129402|62827803|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
33513819|NCT01064414|62898029|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
33513820|NCT01064414|62898030|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
33513821|NCT01064414|62898028|FG000|Core Period: Baseline to Week 26|Death|0|||
33615022|NCT02119819|63016044|FG001|Overall Study|Physician Decision|1|||
33615023|NCT02119819|63016045|FG002|Overall Study|Physician Decision|0|||
33615024|NCT02119819|63016046|FG003|Overall Study|Physician Decision|0|||
33513822|NCT01064414|62898029|FG001|Core Period: Baseline to Week 26|Death|1|||
33513823|NCT01064414|62898030|FG002|Core Period: Baseline to Week 26|Death|0|||
33513824|NCT01064414|62898028|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
33513825|NCT01064414|62898029|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
33513826|NCT01064414|62898030|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
33513827|NCT01064414|62898028|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
33513828|NCT01064414|62898029|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
33513829|NCT01064414|62898030|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
33513830|NCT01064414|62898028|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33513831|NCT01064414|62898029|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
33513832|NCT01064414|62898030|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33513833|NCT01064414|62898028|FG000|Core Period: Baseline to Week 26|Other|4|||
33513834|NCT01064414|62898029|FG001|Core Period: Baseline to Week 26|Other|7|||
33513835|NCT01064414|62898030|FG002|Core Period: Baseline to Week 26|Other|2|||
33513836|NCT01064414|62898028|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
33513837|NCT01064414|62898029|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
33513838|NCT01064414|62898030|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
33513839|NCT01064414|62898028|FG000|Extension Period: Week 26 to Week 52|Death|0|||
33513840|NCT01064414|62898029|FG001|Extension Period: Week 26 to Week 52|Death|1|||
33615025|NCT02119819|63016047|FG004|Overall Study|Physician Decision|0|||
33615026|NCT02119819|63016048|FG005|Overall Study|Physician Decision|1|||
33615027|NCT02119819|63016043|FG000|Overall Study|Withdrawal by Subject|5|||
33615028|NCT02119819|63016044|FG001|Overall Study|Withdrawal by Subject|3|||
33615029|NCT02119819|63016045|FG002|Overall Study|Withdrawal by Subject|0|||
33615030|NCT02119819|63016046|FG003|Overall Study|Withdrawal by Subject|0|||
33615031|NCT02119819|63016047|FG004|Overall Study|Withdrawal by Subject|6|||
33615032|NCT02119819|63016048|FG005|Overall Study|Withdrawal by Subject|10|||
33513841|NCT01064414|62898030|FG002|Extension Period: Week 26 to Week 52|Death|0|||
33513842|NCT01064414|62898028|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
33513843|NCT01064414|62898029|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33513844|NCT01064414|62898030|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33513845|NCT01064414|62898028|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
33513846|NCT01064414|62898029|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33513847|NCT01064414|62898030|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33513848|NCT01064414|62898028|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33513849|NCT01064414|62898029|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
33513850|NCT01064414|62898030|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33513851|NCT01064414|62898028|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
33513852|NCT01064414|62898029|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
33513853|NCT01064414|62898030|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
33513854|NCT01064414|62898028|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
33513855|NCT01064414|62898029|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
33513856|NCT01064414|62898030|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
33513857|NCT01064414|62898028|FG000|Extension Period: Week 26 to Week 52|Other|5|||
33513858|NCT01064414|62898029|FG001|Extension Period: Week 26 to Week 52|Other|2|||
33513859|NCT01064414|62898030|FG002|Extension Period: Week 26 to Week 52|Other|1|||
33513860|NCT03433703|62898041|FG000|Overall Study|Study terminated by Sponsor|2|||
33513861|NCT03463031|62898051|FG000|Overall Study|Withdrawal by Subject|4|||
33513862|NCT03463031|62898052|FG001|Overall Study|Withdrawal by Subject|2|||
33513863|NCT03463031|62898051|FG000|Overall Study|Investigator/Sponsor Decision|0|||
33513864|NCT03463031|62898052|FG001|Overall Study|Investigator/Sponsor Decision|1|||
33513865|NCT03463031|62898051|FG000|Overall Study|Lost to Follow-up|1|||
33615033|NCT02119819|63016043|FG000|Overall Study|Jury Duty|0|||
33615034|NCT02119819|63016044|FG001|Overall Study|Jury Duty|0|||
33615035|NCT02119819|63016045|FG002|Overall Study|Jury Duty|1|||
33615036|NCT02119819|63016046|FG003|Overall Study|Jury Duty|0|||
33615037|NCT02119819|63016047|FG004|Overall Study|Jury Duty|0|||
33615038|NCT02119819|63016048|FG005|Overall Study|Jury Duty|0|||
33615039|NCT02119819|63016043|FG000|Overall Study|Protocol Violation|0|||
33615040|NCT02119819|63016044|FG001|Overall Study|Protocol Violation|0|||
33513866|NCT03463031|62898052|FG001|Overall Study|Lost to Follow-up|1|||
33615041|NCT02119819|63016045|FG002|Overall Study|Protocol Violation|0|||
33615042|NCT02119819|63016046|FG003|Overall Study|Protocol Violation|1|||
33615043|NCT02119819|63016047|FG004|Overall Study|Protocol Violation|0|||
33615044|NCT02119819|63016048|FG005|Overall Study|Protocol Violation|0|||
33615045|NCT02119819|63016043|FG000|Overall Study|Left the city to get a job|0|||
33615046|NCT02119819|63016044|FG001|Overall Study|Left the city to get a job|0|||
33615047|NCT02119819|63016045|FG002|Overall Study|Left the city to get a job|0|||
33615048|NCT02119819|63016046|FG003|Overall Study|Left the city to get a job|1|||
33513867|NCT03463031|62898051|FG000|Overall Study|Adverse Event|4|||
33513868|NCT03463031|62898052|FG001|Overall Study|Adverse Event|1|||
33513869|NCT03463031|62898051|FG000|Overall Study|Use of prohibited medication by subject|1|||
33513870|NCT03463031|62898052|FG001|Overall Study|Use of prohibited medication by subject|0|||
33513871|NCT03462641|62898060|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
33513872|NCT03462641|62898061|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
33513873|NCT03462641|62898060|FG000|Visit 2|Withdrawal by Subject|0|||
33513874|NCT03462641|62898061|FG001|Visit 2|Withdrawal by Subject|1|||
33513875|NCT02974634|62898071|FG000|Overall Study|Advanced disease|12|||
33513876|NCT02974634|62898072|FG001|Overall Study|Advanced disease|3|||
33513877|NCT02974634|62898071|FG000|Overall Study|Noncompliance|3|||
33513878|NCT02974634|62898072|FG001|Overall Study|Noncompliance|7|||
33513879|NCT02974634|62898071|FG000|Overall Study|intervention technology related issues|5|||
33513880|NCT02974634|62898072|FG001|Overall Study|intervention technology related issues|0|||
33513881|NCT02974634|62898071|FG000|Overall Study|Death|8|||
33513882|NCT02974634|62898072|FG001|Overall Study|Death|11|||
33615049|NCT02119819|63016047|FG004|Overall Study|Left the city to get a job|0|||
33615050|NCT02119819|63016048|FG005|Overall Study|Left the city to get a job|0|||
33615051|NCT02168816|63016064|FG000|Overall Study|Lost to Follow-up|2|||
33615052|NCT02168816|63016065|FG001|Overall Study|Lost to Follow-up|2|||
33615053|NCT01584232|63016073|FG000|Overall Study|Adverse Event|3|||
33615054|NCT01584232|63016074|FG001|Overall Study|Adverse Event|1|||
33615055|NCT01584232|63016073|FG000|Overall Study|Withdrawal by Subject|2|||
33615056|NCT01584232|63016074|FG001|Overall Study|Withdrawal by Subject|1|||
33513883|NCT01060670|62898081|FG000|Run In|screen failure|0|||
33513884|NCT01060670|62898082|FG001|Run In|screen failure|238|||
33513885|NCT02971670|62898094|FG000|Overall Study|Withdrawal by Subject|4|||
33513886|NCT02971670|62898095|FG001|Overall Study|Withdrawal by Subject|1|||
33513887|NCT02971670|62898096|FG002|Overall Study|Withdrawal by Subject|1|||
33513888|NCT02971670|62898097|FG003|Overall Study|Withdrawal by Subject|2|||
33513889|NCT02971202|62898110|FG000|Overall Study|Pregnancy|1|||
33513890|NCT02971202|62898111|FG001|Overall Study|Pregnancy|0|||
33513891|NCT02971202|62898112|FG002|Overall Study|Pregnancy|0|||
33513892|NCT02971202|62898110|FG000|Overall Study|screen fail after consent|1|||
33513893|NCT02971202|62898111|FG001|Overall Study|screen fail after consent|0|||
33513894|NCT02971202|62898112|FG002|Overall Study|screen fail after consent|1|||
33513895|NCT02926638|62898122|FG000|Overall Study|Progression|2|||
33513896|NCT02926638|62898123|FG001|Overall Study|Progression|5|||
33615057|NCT01584232|63016073|FG000|Overall Study|Physician Decision|2|||
33615058|NCT01584232|63016074|FG001|Overall Study|Physician Decision|1|||
33615059|NCT01584232|63016073|FG000|Overall Study|Lost to Follow-up|1|||
33453251|NCT00129402|62827804|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
33453252|NCT00129402|62827805|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
33453253|NCT00129402|62827806|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
33453254|NCT00129402|62827807|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
33453255|NCT00129402|62827808|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
33453256|NCT00129402|62827802|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
33453257|NCT00129402|62827803|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
33453258|NCT00129402|62827804|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
33453259|NCT00129402|62827805|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
33453260|NCT00129402|62827806|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
33453261|NCT00129402|62827807|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
33453262|NCT00129402|62827808|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
33453263|NCT00129402|62827802|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
33513897|NCT02926638|62898122|FG000|Overall Study|Ineligible|1|||
33615060|NCT01584232|63016074|FG001|Overall Study|Lost to Follow-up|0|||
33615061|NCT01639703|63016080|FG000|Overall Study|Withdrawal by Subject|5|||
33615062|NCT01639703|63016080|FG000|Overall Study|Other reason|7|||
33513898|NCT02926638|62898123|FG001|Overall Study|Ineligible|0|||
33513899|NCT02926638|62898122|FG000|Overall Study|Not protocol specified|1|||
33513900|NCT02926638|62898123|FG001|Overall Study|Not protocol specified|0|||
33513901|NCT02903030|62898131|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
33513902|NCT02903030|62898132|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
33513903|NCT02969408|62898141|FG000|Overall Study|Adverse Event|2|||
33513904|NCT02969408|62898141|FG000|Overall Study|Withdrawal by Subject|8|||
33513905|NCT02969408|62898141|FG000|Overall Study|Lost to Follow-up|4|||
33513906|NCT02969408|62898141|FG000|Overall Study|Protocol Violation|1|||
33513907|NCT02969408|62898141|FG000|Overall Study|Other than specified|1|||
33513908|NCT03462563|62898147|FG000|Overall Study|Death|1|||
33513909|NCT03462563|62898148|FG001|Overall Study|Death|1|||
33513910|NCT03462563|62898147|FG000|Overall Study|Termination of study|2|||
33513911|NCT03462563|62898148|FG001|Overall Study|Termination of study|1|||
33513912|NCT03462563|62898147|FG000|Overall Study|Adverse Event|1|||
33513913|NCT03462563|62898148|FG001|Overall Study|Adverse Event|3|||
33513914|NCT03462563|62898147|FG000|Overall Study|Unspecified reason|10|||
33513915|NCT03462563|62898148|FG001|Overall Study|Unspecified reason|12|||
33513916|NCT03462563|62898147|FG000|Overall Study|Physician Decision|1|||
33513917|NCT03462563|62898148|FG001|Overall Study|Physician Decision|0|||
33513918|NCT01060124|62898154|FG000|Overall Study|Other|16|||
33513919|NCT01060124|62898154|FG000|Overall Study|Adverse Event|14|||
33513920|NCT01060124|62898154|FG000|Overall Study|Withdrawal by Subject|7|||
33513921|NCT03461003|62898160|FG000|Overall Study|Lost to Follow-up|2|||
33513922|NCT03461003|62898161|FG001|Overall Study|Lost to Follow-up|2|||
33513923|NCT03461003|62898160|FG000|Overall Study|Withdrawal by Subject|3|||
33513924|NCT03461003|62898161|FG001|Overall Study|Withdrawal by Subject|1|||
33513925|NCT02904902|62898167|FG000|Overall Study|Withdrawal by Subject|1|||
33513926|NCT04425720|62898173|FG000|Overall Study|Withdrawal by Subject|0|||
33513927|NCT04425720|62898174|FG001|Overall Study|Withdrawal by Subject|20|||
33513928|NCT02904512|62898183|FG000|Overall Study|Withdrawal by Subject|1|||
33513929|NCT02904512|62898184|FG001|Overall Study|Withdrawal by Subject|0|||
33513930|NCT02904512|62898183|FG000|Overall Study|Transferred to ICU|1|||
33513931|NCT02904512|62898184|FG001|Overall Study|Transferred to ICU|0|||
33615063|NCT02119663|63016098|FG000|Overall Study|Disease progression|26|||
33615064|NCT02119663|63016099|FG001|Overall Study|Disease progression|27|||
33615065|NCT02119663|63016098|FG000|Overall Study|Adverse Event|5|||
33615066|NCT02119663|63016099|FG001|Overall Study|Adverse Event|5|||
33615067|NCT02119663|63016098|FG000|Overall Study|Death|3|||
33324656|NCT00912028|62701219|FG001|Overall Study|Withdrawal by Subject|0|||
33324657|NCT00912028|62701220|FG002|Overall Study|Withdrawal by Subject|0|||
33453264|NCT00129402|62827803|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
33453265|NCT00129402|62827804|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
33453266|NCT00129402|62827805|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
33453267|NCT00129402|62827806|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
33453268|NCT00129402|62827807|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
33453269|NCT00129402|62827808|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
33453270|NCT03739528|62827818|FG000|Overall Study|Not treated|8|||
33453271|NCT03739528|62827819|FG001|Overall Study|Not treated|12|||
33453272|NCT03739528|62827818|FG000|Overall Study|Treatment and study discontinued|6|||
33453273|NCT03739528|62827819|FG001|Overall Study|Treatment and study discontinued|2|||
33453274|NCT03739528|62827818|FG000|Overall Study|Treatment discontinued + study completed|1|||
33453275|NCT03739528|62827819|FG001|Overall Study|Treatment discontinued + study completed|3|||
33453276|NCT00114738|62827828|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
33453277|NCT00114738|62827829|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
33453278|NCT00114738|62827830|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
33453279|NCT00114738|62827828|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
33453280|NCT00114738|62827829|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
33453281|NCT00114738|62827830|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
33453282|NCT00114738|62827828|FG000|Screening for Randomization|Neuropathy|17|||
33453283|NCT00114738|62827829|FG001|Screening for Randomization|Neuropathy|0|||
33453284|NCT00114738|62827830|FG002|Screening for Randomization|Neuropathy|0|||
33453285|NCT00114738|62827828|FG000|Screening for Randomization|Progressive disease|2|||
33453286|NCT00114738|62827829|FG001|Screening for Randomization|Progressive disease|0|||
33453287|NCT00114738|62827830|FG002|Screening for Randomization|Progressive disease|0|||
33453288|NCT00114738|62827828|FG000|Screening for Randomization|CNS Hemorrhage|1|||
33453289|NCT00114738|62827829|FG001|Screening for Randomization|CNS Hemorrhage|0|||
33453290|NCT00114738|62827830|FG002|Screening for Randomization|CNS Hemorrhage|0|||
33453291|NCT00114738|62827828|FG000|Screening for Randomization|Other|1|||
33453292|NCT00114738|62827829|FG001|Screening for Randomization|Other|0|||
33453293|NCT00114738|62827830|FG002|Screening for Randomization|Other|0|||
33513932|NCT02904512|62898183|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
33513933|NCT02904512|62898184|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
33513934|NCT02904200|62898190|FG000|Overall Study|Withdrawal by Subject|1|||
33615068|NCT02119663|63016099|FG001|Overall Study|Death|2|||
33615069|NCT02119663|63016098|FG000|Overall Study|Physician Decision|1|||
33615070|NCT02119663|63016099|FG001|Overall Study|Physician Decision|2|||
33513935|NCT02904200|62898191|FG001|Overall Study|Withdrawal by Subject|0|||
33513936|NCT03432533|62898197|FG000|Overall Study|Lost to Follow-up|1|||
33513937|NCT03432533|62898198|FG001|Overall Study|Lost to Follow-up|2|||
33513938|NCT03432533|62898197|FG000|Overall Study|Withdrawal by Subject|14|||
33513939|NCT03432533|62898198|FG001|Overall Study|Withdrawal by Subject|9|||
33513940|NCT02901548|62898204|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
33513941|NCT02903966|62898210|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
33513942|NCT02903966|62898211|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
33513943|NCT02903966|62898210|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
33513944|NCT02903966|62898211|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
33513945|NCT02903966|62898210|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
33513946|NCT02903966|62898211|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
33513947|NCT03457727|62898227|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
33513948|NCT03457727|62898228|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
33513949|NCT03457727|62898229|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
33513950|NCT03457727|62898230|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
33513951|NCT03431441|62898262|FG000|Overall Study|Withdrawal by Subject|2|||
33513952|NCT03431441|62898262|FG000|Overall Study|Adverse Event|2|||
33513953|NCT03431441|62898262|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
33513954|NCT03457103|62898268|FG000|Overall Study|illness/hospitalization|4|||
33513955|NCT03457103|62898269|FG001|Overall Study|illness/hospitalization|2|||
33513956|NCT03457103|62898268|FG000|Overall Study|Lost to Follow-up|2|||
33513957|NCT03457103|62898269|FG001|Overall Study|Lost to Follow-up|1|||
33513958|NCT03457103|62898268|FG000|Overall Study|Withdrawal by Subject|1|||
33513959|NCT03457103|62898269|FG001|Overall Study|Withdrawal by Subject|2|||
33513960|NCT03457103|62898268|FG000|Overall Study|financial/ insurance issues|1|||
33513961|NCT03457103|62898269|FG001|Overall Study|financial/ insurance issues|1|||
33513962|NCT03455543|62898277|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
33513963|NCT03455543|62898278|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
33513964|NCT03455543|62898279|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
33513965|NCT03455543|62898277|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
33513966|NCT03455543|62898278|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
33615071|NCT02119663|63016098|FG000|Overall Study|Other unspecified|2|||
33615072|NCT02119663|63016099|FG001|Overall Study|Other unspecified|0|||
33513967|NCT03455543|62898279|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
33513968|NCT03455543|62898277|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
33513969|NCT03455543|62898278|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
33513970|NCT03455543|62898279|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
33513971|NCT03455543|62898277|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
33513972|NCT03455543|62898278|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
33513973|NCT03455543|62898279|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
33513974|NCT03455543|62898277|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
33615073|NCT02119663|63016098|FG000|Overall Study|Subject decision|0|||
33615074|NCT02119663|63016099|FG001|Overall Study|Subject decision|1|||
33615075|NCT02119663|63016098|FG000|Overall Study|Study Terminated by the Sponsor|3|||
33615076|NCT02119663|63016099|FG001|Overall Study|Study Terminated by the Sponsor|4|||
33615077|NCT01639469|63016107|FG000|Overall Study|Death|4|||
33615078|NCT01639469|63016108|FG001|Overall Study|Death|2|||
33615079|NCT01639469|63016107|FG000|Overall Study|Lost to Follow-up|1|||
33615080|NCT01639469|63016108|FG001|Overall Study|Lost to Follow-up|1|||
33615081|NCT02193074|63016116|FG000|Overall Study|Withdrawal by Subject|1|||
33615082|NCT02193074|63016117|FG001|Overall Study|Withdrawal by Subject|2|||
33324658|NCT00912028|62701221|FG003|Overall Study|Withdrawal by Subject|0|||
33324659|NCT00912028|62701222|FG004|Overall Study|Withdrawal by Subject|0|||
33513975|NCT03455543|62898278|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
33513976|NCT03455543|62898279|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
33513977|NCT03455543|62898277|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
33513978|NCT03455543|62898278|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
33513979|NCT03455543|62898279|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
33513980|NCT03455543|62898277|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
33513981|NCT03455543|62898278|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
33513982|NCT03455543|62898279|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
33513983|NCT03455543|62898277|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
33513984|NCT03455543|62898278|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
33615083|NCT02193074|63016116|FG000|Overall Study|Adverse Event|16|||
33615084|NCT02193074|63016117|FG001|Overall Study|Adverse Event|13|||
33615085|NCT02192606|63016125|FG000|Overall Study|surgery type was changed|1|||
33615086|NCT02192606|63016126|FG001|Overall Study|surgery type was changed|1|||
33615087|NCT02192606|63016125|FG000|Overall Study|Physician Decision|1|||
33615088|NCT02192606|63016126|FG001|Overall Study|Physician Decision|2|||
33615089|NCT02192606|63016125|FG000|Overall Study|3D equipment rep unable to join|0|||
33513985|NCT03455543|62898279|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
33513986|NCT03455543|62898277|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
33513987|NCT03455543|62898278|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
33513988|NCT03455543|62898279|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
33513989|NCT03068754|62898289|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
33513990|NCT03068754|62898290|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
33513991|NCT03068754|62898291|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
33615090|NCT02192606|63016126|FG001|Overall Study|3D equipment rep unable to join|1|||
33615091|NCT01628107|63016132|FG000|Overall Study|Withdrawal by Subject|17|||
33615092|NCT01628107|63016132|FG000|Overall Study|Lost to Follow-up|4|||
33615093|NCT01628107|63016132|FG000|Overall Study|Adverse Event|33|||
33615094|NCT01628107|63016132|FG000|Overall Study|Physician Decision|2|||
33615095|NCT01628107|63016132|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
33615096|NCT01628107|63016132|FG000|Overall Study|Non-compliant with Study Procedures|10|||
33615097|NCT01628107|63016132|FG000|Overall Study|Not Treated|8|||
33615098|NCT01628107|63016132|FG000|Overall Study|Sponsor Decision|11|||
33615099|NCT01628107|63016132|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
33615100|NCT01628107|63016132|FG000|Overall Study|Relocated|8|||
33615101|NCT01628107|63016132|FG000|Overall Study|Kidney Transplant|9|||
33615102|NCT01628107|63016132|FG000|Overall Study|Use of Standard of Care|9|||
33615103|NCT01583530|63016142|FG000|Overall Study|Adverse Event|0|||
33615104|NCT01583530|63016143|FG001|Overall Study|Adverse Event|0|||
33615105|NCT01583530|63016144|FG002|Overall Study|Adverse Event|0|||
33615106|NCT01583530|63016145|FG003|Overall Study|Adverse Event|0|||
33615107|NCT01583530|63016146|FG004|Overall Study|Adverse Event|0|||
33615108|NCT01583530|63016147|FG005|Overall Study|Adverse Event|1|||
33615109|NCT01583530|63016142|FG000|Overall Study|Withdrawal by Subject|0|||
33615110|NCT01583530|63016143|FG001|Overall Study|Withdrawal by Subject|3|||
33615111|NCT01583530|63016144|FG002|Overall Study|Withdrawal by Subject|0|||
33615112|NCT01583530|63016145|FG003|Overall Study|Withdrawal by Subject|1|||
33615113|NCT01583530|63016146|FG004|Overall Study|Withdrawal by Subject|1|||
33615114|NCT01583530|63016147|FG005|Overall Study|Withdrawal by Subject|2|||
33615115|NCT01583530|63016142|FG000|Overall Study|Lost to Follow-up|0|||
33615116|NCT01583530|63016143|FG001|Overall Study|Lost to Follow-up|0|||
33615117|NCT01583530|63016144|FG002|Overall Study|Lost to Follow-up|0|||
33615118|NCT01583530|63016145|FG003|Overall Study|Lost to Follow-up|0|||
33615119|NCT01583530|63016146|FG004|Overall Study|Lost to Follow-up|3|||
33615120|NCT01583530|63016147|FG005|Overall Study|Lost to Follow-up|0|||
33615121|NCT01583530|63016142|FG000|Overall Study|Lack of compliance|0|||
33615122|NCT01583530|63016143|FG001|Overall Study|Lack of compliance|0|||
33615123|NCT01583530|63016144|FG002|Overall Study|Lack of compliance|0|||
33615124|NCT01583530|63016145|FG003|Overall Study|Lack of compliance|0|||
33615125|NCT01583530|63016146|FG004|Overall Study|Lack of compliance|1|||
33615126|NCT01583530|63016147|FG005|Overall Study|Lack of compliance|0|||
33615127|NCT01639001|63016166|FG000|Overall Study|Refused further follow-up|9|||
33615128|NCT01639001|63016167|FG001|Overall Study|Refused further follow-up|12|||
33513992|NCT03068754|62898292|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
33513993|NCT03068754|62898289|FG000|Randomized Treatment Period (RTP)|Death|2|||
33513994|NCT03068754|62898290|FG001|Randomized Treatment Period (RTP)|Death|2|||
33513995|NCT03068754|62898291|FG002|Randomized Treatment Period (RTP)|Death|0|||
33513996|NCT03068754|62898292|FG003|Randomized Treatment Period (RTP)|Death|0|||
33615129|NCT01639001|63016166|FG000|Overall Study|Lost to Follow-up|3|||
33615130|NCT01639001|63016167|FG001|Overall Study|Lost to Follow-up|0|||
33615131|NCT01639001|63016166|FG000|Overall Study|Death|62|||
33615132|NCT01639001|63016167|FG001|Overall Study|Death|61|||
33615133|NCT01639001|63016166|FG000|Overall Study|Randomized but not treated|0|||
33615134|NCT01639001|63016167|FG001|Overall Study|Randomized but not treated|2|||
33615135|NCT01639001|63016166|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
33615136|NCT01639001|63016167|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
33513997|NCT03068754|62898289|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
33513998|NCT03068754|62898290|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
33513999|NCT03068754|62898291|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
33514000|NCT03068754|62898292|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
33514001|NCT03068754|62898289|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
33514002|NCT03068754|62898290|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
33514003|NCT03068754|62898291|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
33514004|NCT03068754|62898292|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
33514005|NCT03068754|62898289|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
33514006|NCT03068754|62898290|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
33514007|NCT03068754|62898291|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
33453294|NCT00148122|62827837|FG000|Overall Study|Withdrawal by Subject|2|||
33514008|NCT03068754|62898292|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
33514009|NCT03068754|62898289|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
33514010|NCT03068754|62898290|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
33514011|NCT03068754|62898291|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
33514012|NCT03068754|62898292|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
33514013|NCT03068754|62898289|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
33514014|NCT03068754|62898290|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
33514015|NCT03068754|62898291|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
33514016|NCT03068754|62898292|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
33514017|NCT03068754|62898289|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
33514018|NCT03068754|62898290|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
33453295|NCT00147498|62827845|FG000|Overall Study|Adverse Event|1|||
33453296|NCT00147498|62827846|FG001|Overall Study|Adverse Event|6|||
33453297|NCT00147498|62827847|FG002|Overall Study|Adverse Event|7|||
33453298|NCT00147498|62827848|FG003|Overall Study|Adverse Event|3|||
33453299|NCT00147498|62827845|FG000|Overall Study|Lack of Efficacy|1|||
33453300|NCT00147498|62827846|FG001|Overall Study|Lack of Efficacy|1|||
33453301|NCT00147498|62827847|FG002|Overall Study|Lack of Efficacy|1|||
33453302|NCT00147498|62827848|FG003|Overall Study|Lack of Efficacy|8|||
33453303|NCT00147498|62827845|FG000|Overall Study|Laboratory abnormality|0|||
33453304|NCT00147498|62827846|FG001|Overall Study|Laboratory abnormality|0|||
33453305|NCT00147498|62827847|FG002|Overall Study|Laboratory abnormality|2|||
33453306|NCT00147498|62827848|FG003|Overall Study|Laboratory abnormality|0|||
33453307|NCT00147498|62827845|FG000|Overall Study|Participant defaulted|0|||
33453308|NCT00147498|62827846|FG001|Overall Study|Participant defaulted|1|||
33453309|NCT00147498|62827847|FG002|Overall Study|Participant defaulted|4|||
33453310|NCT00147498|62827848|FG003|Overall Study|Participant defaulted|3|||
33453311|NCT00147498|62827845|FG000|Overall Study|Other|1|||
33453312|NCT00147498|62827846|FG001|Overall Study|Other|1|||
33453313|NCT00147498|62827847|FG002|Overall Study|Other|3|||
33453314|NCT00147498|62827848|FG003|Overall Study|Other|3|||
33453315|NCT00113568|62827858|FG000|Overall Study|Adverse Event|97|||
33453316|NCT00113568|62827858|FG000|Overall Study|Death|1|||
33453317|NCT00113568|62827858|FG000|Overall Study|Lack of Efficacy|30|||
33514019|NCT03068754|62898291|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
33514020|NCT03068754|62898292|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
33514021|NCT03068754|62898289|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
33514022|NCT03068754|62898290|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
33514023|NCT03068754|62898291|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
33514024|NCT03068754|62898292|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
33514025|NCT03068754|62898289|FG000|Open Label Extension Period (OLE)|Death|0|||
33514026|NCT03068754|62898290|FG001|Open Label Extension Period (OLE)|Death|0|||
33514027|NCT03068754|62898291|FG002|Open Label Extension Period (OLE)|Death|0|||
33514028|NCT03068754|62898292|FG003|Open Label Extension Period (OLE)|Death|1|||
33514029|NCT03068754|62898289|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
33514030|NCT03068754|62898290|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
33514031|NCT03068754|62898291|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
33514032|NCT03068754|62898292|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
33514033|NCT03068754|62898289|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
33514034|NCT03068754|62898290|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
33514035|NCT03068754|62898291|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
33514036|NCT03068754|62898292|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
33514037|NCT03068754|62898289|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
33514038|NCT03068754|62898290|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
33514039|NCT03068754|62898291|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
33514040|NCT03068754|62898292|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
33514041|NCT03068754|62898289|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
33514042|NCT03068754|62898290|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
33514043|NCT03068754|62898291|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
33514044|NCT03068754|62898292|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
33514045|NCT02965820|62898302|FG000|Period 2, Second 30 Days|Adverse Event|1|||
33514046|NCT02965820|62898303|FG001|Period 2, Second 30 Days|Adverse Event|1|||
33514047|NCT03430895|62898309|FG000|Overall Study|Not Treated|2|||
33514048|NCT03452189|62898313|FG000|First Intervention (3 Months)|Adverse Event|1|||
33453318|NCT00113568|62827858|FG000|Overall Study|Lost to Follow-up|156|||
33514049|NCT03452189|62898314|FG001|First Intervention (3 Months)|Adverse Event|0|||
33514050|NCT03452189|62898313|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
33514051|NCT03452189|62898314|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
33514052|NCT03451721|62898320|FG000|Overall Study|Death|1|||
33514053|NCT00603954|62898326|FG000|Overall Study|Protocol Violation|1|||
33615137|NCT02224664|63016175|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
33615138|NCT02224664|63016176|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
33615139|NCT02224664|63016177|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
33453319|NCT00113568|62827858|FG000|Overall Study|Protocol Violation|32|||
33453320|NCT00113568|62827858|FG000|Overall Study|Withdrawal by Subject|117|||
33453321|NCT00113568|62827858|FG000|Overall Study|Other|112|||
33453322|NCT00113490|62827864|FG000|Overall Study|Withdrawal by Subject|1|||
33453323|NCT00113490|62827865|FG001|Overall Study|Withdrawal by Subject|3|||
33453324|NCT00113490|62827864|FG000|Overall Study|Lost to Follow-up|1|||
33453325|NCT00113490|62827865|FG001|Overall Study|Lost to Follow-up|0|||
33453326|NCT00146640|62827873|FG000|Overall Study|Adverse Event|12|||
33453327|NCT00146640|62827874|FG001|Overall Study|Adverse Event|10|||
33453328|NCT00146640|62827873|FG000|Overall Study|Medical Reasons|3|||
33453329|NCT00146640|62827874|FG001|Overall Study|Medical Reasons|0|||
33615140|NCT02224664|63016178|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
33615141|NCT02224664|63016179|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
33615142|NCT02224664|63016175|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
33615143|NCT02224664|63016176|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
33615144|NCT02224664|63016177|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
33615145|NCT02224664|63016178|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
33615146|NCT02224664|63016179|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
33453330|NCT00146640|62827873|FG000|Overall Study|Non-Medical Reasons|8|||
33453331|NCT00146640|62827874|FG001|Overall Study|Non-Medical Reasons|4|||
33453332|NCT00146328|62827892|FG000|Overall Study|Adverse Event|39|||
33514054|NCT00603954|62898327|FG001|Overall Study|Protocol Violation|2|||
33514055|NCT03427619|62898334|FG000|Overall Study|Physician Decision|3|||
33514056|NCT03427619|62898334|FG000|Overall Study|Withdrawal by Subject|4|||
33514057|NCT03427619|62898334|FG000|Overall Study|Lost to Follow-up|5|||
33514058|NCT03427619|62898334|FG000|Overall Study|Administrative|4|||
33514059|NCT03427619|62898334|FG000|Overall Study|Other|2|||
33453333|NCT00146328|62827893|FG001|Overall Study|Adverse Event|48|||
33453334|NCT00146328|62827894|FG002|Overall Study|Adverse Event|79|||
33453335|NCT00146328|62827892|FG000|Overall Study|Protocol Violation|11|||
33453336|NCT00146328|62827893|FG001|Overall Study|Protocol Violation|6|||
33453337|NCT00146328|62827894|FG002|Overall Study|Protocol Violation|12|||
33453338|NCT00146328|62827892|FG000|Overall Study|Lost to Follow-up|7|||
33453339|NCT00146328|62827893|FG001|Overall Study|Lost to Follow-up|4|||
33453340|NCT00146328|62827894|FG002|Overall Study|Lost to Follow-up|7|||
33453341|NCT00146328|62827892|FG000|Overall Study|Withdrawal by Subject|16|||
33453342|NCT00146328|62827893|FG001|Overall Study|Withdrawal by Subject|16|||
33453343|NCT00146328|62827894|FG002|Overall Study|Withdrawal by Subject|22|||
33453344|NCT00146328|62827892|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
33453345|NCT00146328|62827893|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
33453346|NCT00146328|62827894|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
33453347|NCT00146328|62827892|FG000|Overall Study|Trial ended/site closed|8|||
33453348|NCT00146328|62827893|FG001|Overall Study|Trial ended/site closed|2|||
33453349|NCT00146328|62827894|FG002|Overall Study|Trial ended/site closed|19|||
33514060|NCT03427619|62898334|FG000|Overall Study|Unknown or Missing Completion Status|48|||
33514061|NCT03407729|62898340|FG000|Overall Study|Lost to Follow-up|2|||
33514062|NCT03407729|62898341|FG001|Overall Study|Lost to Follow-up|0|||
33514063|NCT03407729|62898340|FG000|Overall Study|Unable to schedule|0|||
33514064|NCT03407729|62898341|FG001|Overall Study|Unable to schedule|3|||
33514065|NCT02435433|62898352|FG000|Overall Study|Withdrawal by Subject|2|||
33514066|NCT02435433|62898353|FG001|Overall Study|Withdrawal by Subject|3|||
33514067|NCT02435433|62898354|FG002|Overall Study|Withdrawal by Subject|1|||
33514068|NCT02435433|62898355|FG003|Overall Study|Withdrawal by Subject|0|||
33514069|NCT02435433|62898356|FG004|Overall Study|Withdrawal by Subject|0|||
33514070|NCT02435433|62898352|FG000|Overall Study|Lost to Follow-up|2|||
33514071|NCT02435433|62898353|FG001|Overall Study|Lost to Follow-up|2|||
33514072|NCT02435433|62898354|FG002|Overall Study|Lost to Follow-up|4|||
33514073|NCT02435433|62898355|FG003|Overall Study|Lost to Follow-up|1|||
33514074|NCT02435433|62898356|FG004|Overall Study|Lost to Follow-up|0|||
33514075|NCT03120351|62898369|FG000|Overall Study|Physician Decision|1|||
33514076|NCT03120351|62898370|FG001|Overall Study|Physician Decision|1|||
33514077|NCT02354703|62898380|FG000|Overall Study|Withdrawal by Subject|1|||
33514078|NCT02354703|62898381|FG001|Overall Study|Withdrawal by Subject|1|||
33514079|NCT02354703|62898382|FG002|Overall Study|Withdrawal by Subject|1|||
33514080|NCT02354703|62898383|FG003|Overall Study|Withdrawal by Subject|1|||
33514081|NCT02354703|62898380|FG000|Overall Study|Lost to Follow-up|2|||
33514082|NCT02354703|62898381|FG001|Overall Study|Lost to Follow-up|7|||
33615147|NCT02224664|63016175|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
33615148|NCT02224664|63016176|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
33615149|NCT02224664|63016177|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
33615150|NCT02224664|63016178|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
33615151|NCT02224664|63016179|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
33615152|NCT02168270|63016195|FG000|Overall Study|Lack of Efficacy|4|||
33615153|NCT02167256|63016201|FG000|Overall Study|Adverse Event|13|||
33615154|NCT02167256|63016202|FG001|Overall Study|Adverse Event|6|||
33615155|NCT02167256|63016201|FG000|Overall Study|Withdrawal by Subject|4|||
33615156|NCT02167256|63016202|FG001|Overall Study|Withdrawal by Subject|4|||
33615157|NCT02167256|63016201|FG000|Overall Study|non-compliance|3|||
33615158|NCT02167256|63016202|FG001|Overall Study|non-compliance|0|||
33615159|NCT02167256|63016201|FG000|Overall Study|Study partner unable to participate|1|||
33615160|NCT02167256|63016202|FG001|Overall Study|Study partner unable to participate|0|||
33615161|NCT02191046|63016210|FG000|Overall Study|low compliance|5|||
33615162|NCT02191046|63016211|FG001|Overall Study|low compliance|1|||
33615163|NCT02166476|63016219|FG000|Overall Study|Withdrawal by Subject|5|||
33514083|NCT02354703|62898382|FG002|Overall Study|Lost to Follow-up|9|||
33514084|NCT02354703|62898383|FG003|Overall Study|Lost to Follow-up|2|||
33514085|NCT02354703|62898380|FG000|Overall Study|Adverse Event|0|||
33514086|NCT02354703|62898381|FG001|Overall Study|Adverse Event|0|||
33514087|NCT02354703|62898382|FG002|Overall Study|Adverse Event|1|||
33514088|NCT02354703|62898383|FG003|Overall Study|Adverse Event|0|||
33514089|NCT00384111|62898399|FG000|Overall Study|Disease Progression|3|||
33514090|NCT00384111|62898399|FG000|Overall Study|Adverse Event|1|||
33514091|NCT00384111|62898399|FG000|Overall Study|Investigator Decision|3|||
33514092|NCT00384111|62898399|FG000|Overall Study|Study Terminated by the Sponsor|19|||
33514093|NCT03113409|62898403|FG000|Overall Study|Withdrawal by Subject|5|||
33514094|NCT03113409|62898404|FG001|Overall Study|Withdrawal by Subject|0|||
33514095|NCT03113409|62898405|FG002|Overall Study|Withdrawal by Subject|0|||
33514096|NCT01319877|62898411|FG000|Overall Study|Lost to Follow-up|100|||
33514097|NCT01319877|62898412|FG001|Overall Study|Lost to Follow-up|37|||
33514098|NCT01319877|62898411|FG000|Overall Study|Physician Decision|2|||
33514099|NCT01319877|62898412|FG001|Overall Study|Physician Decision|0|||
33514100|NCT01319877|62898411|FG000|Overall Study|Disease Progression|2|||
33514101|NCT01319877|62898412|FG001|Overall Study|Disease Progression|2|||
33514102|NCT01319877|62898411|FG000|Overall Study|Withdrawal by Subject|0|||
33514103|NCT01319877|62898412|FG001|Overall Study|Withdrawal by Subject|1|||
33514104|NCT01319877|62898411|FG000|Overall Study|Reason Not Specified|4|||
33514105|NCT01319877|62898412|FG001|Overall Study|Reason Not Specified|5|||
33514106|NCT03427073|62898425|FG000|Overall Study|Disease Progression|1|||
33514107|NCT03427073|62898426|FG001|Overall Study|Disease Progression|1|||
33615164|NCT02166476|63016220|FG001|Overall Study|Withdrawal by Subject|7|||
33615165|NCT02166476|63016219|FG000|Overall Study|Adverse Event|3|||
33615166|NCT02166476|63016220|FG001|Overall Study|Adverse Event|3|||
33514108|NCT03427073|62898427|FG002|Overall Study|Disease Progression|1|||
33514109|NCT03427073|62898428|FG003|Overall Study|Disease Progression|3|||
33514110|NCT03427073|62898429|FG004|Overall Study|Disease Progression|3|||
33514111|NCT03427073|62898430|FG005|Overall Study|Disease Progression|4|||
33514112|NCT03427073|62898431|FG006|Overall Study|Disease Progression|2|||
33615167|NCT02166476|63016219|FG000|Overall Study|Lost to Follow-up|5|||
33514113|NCT03427073|62898432|FG007|Overall Study|Disease Progression|3|||
33514114|NCT03427073|62898425|FG000|Overall Study|Physician Decision|0|||
33514115|NCT03427073|62898426|FG001|Overall Study|Physician Decision|0|||
33514116|NCT03427073|62898427|FG002|Overall Study|Physician Decision|0|||
33514117|NCT03427073|62898428|FG003|Overall Study|Physician Decision|0|||
33514118|NCT03427073|62898429|FG004|Overall Study|Physician Decision|0|||
33514119|NCT03427073|62898430|FG005|Overall Study|Physician Decision|0|||
33514120|NCT03427073|62898431|FG006|Overall Study|Physician Decision|1|||
33514121|NCT03427073|62898432|FG007|Overall Study|Physician Decision|1|||
33514122|NCT03066804|62898452|FG000|Overall Study|Physician Decision|0|||
33514123|NCT03066804|62898453|FG001|Overall Study|Physician Decision|4|||
33514124|NCT03066804|62898452|FG000|Overall Study|Death|23|||
33514125|NCT03066804|62898453|FG001|Overall Study|Death|17|||
33514126|NCT03066804|62898452|FG000|Overall Study|Withdrawal by Subject|19|||
33514127|NCT03066804|62898453|FG001|Overall Study|Withdrawal by Subject|25|||
33514128|NCT03066804|62898452|FG000|Overall Study|Lost to Follow-up|2|||
33514129|NCT03066804|62898453|FG001|Overall Study|Lost to Follow-up|0|||
33514130|NCT03066804|62898452|FG000|Overall Study|Adverse Event|2|||
33514131|NCT03066804|62898453|FG001|Overall Study|Adverse Event|3|||
33514132|NCT03066804|62898452|FG000|Overall Study|Technical problems|5|||
33514133|NCT03066804|62898453|FG001|Overall Study|Technical problems|1|||
33514134|NCT02954237|62898460|FG000|Overall Study|Withdrawal by Subject|25|||
33514135|NCT02954237|62898460|FG000|Overall Study|Missed visit|16|||
33514136|NCT02954237|62898460|FG000|Overall Study|Death|2|||
33514137|NCT04250337|62898466|FG000|Overall Study|Adverse Event|0|||
33514138|NCT04250337|62898467|FG001|Overall Study|Adverse Event|3|||
33514139|NCT04250337|62898466|FG000|Overall Study|Lack of Efficacy|1|||
33514140|NCT04250337|62898467|FG001|Overall Study|Lack of Efficacy|3|||
33514141|NCT04250337|62898466|FG000|Overall Study|Physician Decision|1|||
33514142|NCT04250337|62898467|FG001|Overall Study|Physician Decision|0|||
33514143|NCT04250337|62898466|FG000|Overall Study|Protocol Deviation|2|||
33514144|NCT04250337|62898467|FG001|Overall Study|Protocol Deviation|2|||
33514145|NCT04250337|62898466|FG000|Overall Study|Withdrawal by Subject|4|||
33514146|NCT04250337|62898467|FG001|Overall Study|Withdrawal by Subject|3|||
33514147|NCT03118947|62898474|FG000|Overall Study|Adverse Event|7|||
33514148|NCT03118947|62898474|FG000|Overall Study|Death|3|||
33514149|NCT03118947|62898474|FG000|Overall Study|Lack of Efficacy|4|||
33514150|NCT03118947|62898474|FG000|Overall Study|Non-compliance with study drug|1|||
33514151|NCT03118947|62898474|FG000|Overall Study|Protocol Violation|2|||
33514152|NCT03118947|62898474|FG000|Overall Study|Withdrawal by Subject|3|||
33615168|NCT02166476|63016220|FG001|Overall Study|Lost to Follow-up|10|||
33615169|NCT02166476|63016219|FG000|Overall Study|Physician Decision|1|||
33615170|NCT02166476|63016220|FG001|Overall Study|Physician Decision|0|||
33615171|NCT02166476|63016219|FG000|Overall Study|Unable to Come for Visit|0|||
33453350|NCT00146328|62827892|FG000|Overall Study|Patient decision to end|0|||
33453351|NCT00146328|62827893|FG001|Overall Study|Patient decision to end|1|||
33453352|NCT00146328|62827894|FG002|Overall Study|Patient decision to end|6|||
33453353|NCT00146328|62827892|FG000|Overall Study|Enroll into other trial|2|||
33453354|NCT00146328|62827893|FG001|Overall Study|Enroll into other trial|4|||
33453355|NCT00146328|62827894|FG002|Overall Study|Enroll into other trial|2|||
33453356|NCT00146328|62827892|FG000|Overall Study|Death|0|||
33453357|NCT00146328|62827893|FG001|Overall Study|Death|1|||
33453358|NCT00146328|62827894|FG002|Overall Study|Death|1|||
33453359|NCT00146328|62827892|FG000|Overall Study|Moved|2|||
33453360|NCT00146328|62827893|FG001|Overall Study|Moved|0|||
33453361|NCT00146328|62827894|FG002|Overall Study|Moved|0|||
33453362|NCT00146328|62827892|FG000|Overall Study|Interaction with other medication|2|||
33453363|NCT00146328|62827893|FG001|Overall Study|Interaction with other medication|0|||
33453364|NCT00146328|62827894|FG002|Overall Study|Interaction with other medication|1|||
33453365|NCT03733444|62827905|FG000|Overall Study|Adverse Event|8|||
33453366|NCT03733444|62827906|FG001|Overall Study|Adverse Event|10|||
33453367|NCT03733444|62827907|FG002|Overall Study|Adverse Event|5|||
33514153|NCT03118947|62898474|FG000|Overall Study|Withdrawal by caregiver|3|||
33514154|NCT03118947|62898474|FG000|Overall Study|Change in patient's living situation|4|||
33514155|NCT03118947|62898474|FG000|Overall Study|Lost to Follow-up|2|||
33514156|NCT03953079|62898481|FG000|Core Study|Withdrawal by Subject|1|||
33514157|NCT03953079|62898482|FG001|Core Study|Withdrawal by Subject|2|||
33514158|NCT03953079|62898483|FG002|Core Study|Withdrawal by Subject|1|||
33514159|NCT03953079|62898481|FG000|Core Study|COVID-19|0|||
33453368|NCT03733444|62827905|FG000|Overall Study|Death|20|||
33453369|NCT03733444|62827906|FG001|Overall Study|Death|19|||
33453370|NCT03733444|62827907|FG002|Overall Study|Death|11|||
33514160|NCT03953079|62898482|FG001|Core Study|COVID-19|1|||
33514161|NCT03953079|62898483|FG002|Core Study|COVID-19|0|||
33514162|NCT03953079|62898481|FG000|Core Study|Difficulties leaving the house|0|||
33514163|NCT03953079|62898482|FG001|Core Study|Difficulties leaving the house|1|||
33514164|NCT03953079|62898483|FG002|Core Study|Difficulties leaving the house|0|||
33514165|NCT03953079|62898481|FG000|Extension Study|Withdrawal by Subject|1|||
33514166|NCT03953079|62898482|FG001|Extension Study|Withdrawal by Subject|0|||
33514167|NCT03953079|62898483|FG002|Extension Study|Withdrawal by Subject|0|||
33514168|NCT03953079|62898481|FG000|Extension Study|Received Rescue Treatment|5|||
33514169|NCT03953079|62898482|FG001|Extension Study|Received Rescue Treatment|6|||
33514170|NCT03953079|62898483|FG002|Extension Study|Received Rescue Treatment|5|||
33514171|NCT03885999|62898496|FG000|Overall Study|Adverse Event|1|||
33615172|NCT02166476|63016220|FG001|Overall Study|Unable to Come for Visit|3|||
33615173|NCT02224274|63016231|FG000|Overall Study|Death|1|||
33514172|NCT03108027|62898510|FG000|Period 1|Subject/Guardian Decision|0|||
33514173|NCT03108027|62898511|FG001|Period 1|Subject/Guardian Decision|0|||
33514174|NCT03108027|62898512|FG002|Period 1|Subject/Guardian Decision|0|||
33514175|NCT03108027|62898513|FG003|Period 1|Subject/Guardian Decision|2|||
33514176|NCT03108027|62898514|FG004|Period 1|Subject/Guardian Decision|0|||
33514177|NCT03108027|62898515|FG005|Period 1|Subject/Guardian Decision|0|||
33514178|NCT03108027|62898510|FG000|Period 3|Adverse Event|0|||
33514179|NCT03108027|62898511|FG001|Period 3|Adverse Event|1|||
33514180|NCT03108027|62898512|FG002|Period 3|Adverse Event|0|||
33514181|NCT03108027|62898513|FG003|Period 3|Adverse Event|0|||
33514182|NCT03108027|62898514|FG004|Period 3|Adverse Event|0|||
33514183|NCT03108027|62898515|FG005|Period 3|Adverse Event|0|||
33514184|NCT03107715|62898531|FG000|Overall Study|did not deliver at the home hospital|4|||
33514185|NCT03107715|62898532|FG001|Overall Study|did not deliver at the home hospital|6|||
33514186|NCT03107715|62898531|FG000|Overall Study|infant stillborn|0|||
33514187|NCT03107715|62898532|FG001|Overall Study|infant stillborn|1|||
33514188|NCT03567057|62898541|FG000|Overall Study|Adverse Event|56|||
33514189|NCT03567057|62898542|FG001|Overall Study|Adverse Event|53|||
33514190|NCT03567057|62898543|FG002|Overall Study|Adverse Event|28|||
33514191|NCT03567057|62898541|FG000|Overall Study|Withdrawal by Subject|22|||
33514192|NCT03567057|62898542|FG001|Overall Study|Withdrawal by Subject|24|||
33514193|NCT03567057|62898543|FG002|Overall Study|Withdrawal by Subject|13|||
33514194|NCT03567057|62898541|FG000|Overall Study|Lost to Follow-up|3|||
33514195|NCT03567057|62898542|FG001|Overall Study|Lost to Follow-up|5|||
33514196|NCT03567057|62898543|FG002|Overall Study|Lost to Follow-up|2|||
33514197|NCT03567057|62898541|FG000|Overall Study|COVID-19 pandemic|4|||
33514198|NCT03567057|62898542|FG001|Overall Study|COVID-19 pandemic|3|||
33514199|NCT03567057|62898543|FG002|Overall Study|COVID-19 pandemic|0|||
33514200|NCT03567057|62898541|FG000|Overall Study|Non-compliance with study drug|4|||
33514201|NCT03567057|62898542|FG001|Overall Study|Non-compliance with study drug|2|||
33514202|NCT03567057|62898543|FG002|Overall Study|Non-compliance with study drug|0|||
33514203|NCT03567057|62898541|FG000|Overall Study|Lack of Efficacy|3|||
33514204|NCT03567057|62898542|FG001|Overall Study|Lack of Efficacy|0|||
33514205|NCT03567057|62898543|FG002|Overall Study|Lack of Efficacy|1|||
33514206|NCT03567057|62898541|FG000|Overall Study|Death|1|||
33514207|NCT03567057|62898542|FG001|Overall Study|Death|0|||
33514208|NCT03567057|62898543|FG002|Overall Study|Death|0|||
33514209|NCT03567057|62898541|FG000|Overall Study|Physician Decision|1|||
33615174|NCT02224274|63016232|FG001|Overall Study|Death|0|||
33615175|NCT02189252|63016246|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
33514210|NCT03567057|62898542|FG001|Overall Study|Physician Decision|0|||
33514211|NCT03567057|62898543|FG002|Overall Study|Physician Decision|0|||
33514212|NCT03567057|62898541|FG000|Overall Study|Unstable medical condition|1|||
33514213|NCT03567057|62898542|FG001|Overall Study|Unstable medical condition|0|||
33514214|NCT03567057|62898543|FG002|Overall Study|Unstable medical condition|0|||
33514215|NCT03567057|62898541|FG000|Overall Study|Medical history event|0|||
33514216|NCT03567057|62898542|FG001|Overall Study|Medical history event|0|||
33514217|NCT03567057|62898543|FG002|Overall Study|Medical history event|1|||
33514218|NCT03567057|62898541|FG000|Overall Study|Other|0|||
33615176|NCT02189252|63016247|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
33615177|NCT02189252|63016248|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
33453371|NCT03733444|62827905|FG000|Overall Study|Lost to Follow-up|3|||
33453372|NCT03733444|62827906|FG001|Overall Study|Lost to Follow-up|0|||
33453373|NCT03733444|62827907|FG002|Overall Study|Lost to Follow-up|1|||
33453374|NCT03733444|62827905|FG000|Overall Study|Lack of Efficacy|0|||
33453375|NCT03733444|62827906|FG001|Overall Study|Lack of Efficacy|1|||
33453376|NCT03733444|62827907|FG002|Overall Study|Lack of Efficacy|1|||
33453377|NCT03733444|62827905|FG000|Overall Study|Physician Decision|2|||
33453378|NCT03733444|62827906|FG001|Overall Study|Physician Decision|1|||
33514219|NCT03567057|62898542|FG001|Overall Study|Other|0|||
33514220|NCT03567057|62898543|FG002|Overall Study|Other|1|||
33514221|NCT04388787|62898551|FG000|Blinded Period|Patient could not follow instructions|1|||
33514222|NCT04388787|62898551|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
33514223|NCT03057600|62898563|FG000|Overall Study|Adverse Event|0|||
33514224|NCT03057600|62898564|FG001|Overall Study|Adverse Event|0|||
33514225|NCT03057600|62898565|FG002|Overall Study|Adverse Event|4|||
33514226|NCT03057600|62898566|FG003|Overall Study|Adverse Event|0|||
33514227|NCT03057600|62898563|FG000|Overall Study|Radiologic Disease Progression|8|||
33514228|NCT03057600|62898564|FG001|Overall Study|Radiologic Disease Progression|7|||
33514229|NCT03057600|62898565|FG002|Overall Study|Radiologic Disease Progression|13|||
33514230|NCT03057600|62898566|FG003|Overall Study|Radiologic Disease Progression|10|||
33514231|NCT03057600|62898563|FG000|Overall Study|Symptomatic Deterioration|0|||
33514232|NCT03057600|62898564|FG001|Overall Study|Symptomatic Deterioration|1|||
33514233|NCT03057600|62898565|FG002|Overall Study|Symptomatic Deterioration|1|||
33514234|NCT03057600|62898566|FG003|Overall Study|Symptomatic Deterioration|0|||
33615178|NCT02189252|63016249|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
33615179|NCT02189252|63016246|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
33615180|NCT02189252|63016247|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
33615181|NCT02189252|63016248|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
33615182|NCT02189252|63016249|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
33615183|NCT01583374|63016263|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
33615184|NCT01583374|63016264|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
33615185|NCT01583374|63016265|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
33453379|NCT03733444|62827907|FG002|Overall Study|Physician Decision|0|||
33453380|NCT03733444|62827905|FG000|Overall Study|Protocol Violation|2|||
33453381|NCT03733444|62827906|FG001|Overall Study|Protocol Violation|1|||
33453382|NCT03733444|62827907|FG002|Overall Study|Protocol Violation|0|||
33453383|NCT03733444|62827905|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
33453384|NCT03733444|62827906|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
33453385|NCT03733444|62827907|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
33453386|NCT03733444|62827905|FG000|Overall Study|Study Terminated by Sponsor|203|||
33453387|NCT03733444|62827906|FG001|Overall Study|Study Terminated by Sponsor|209|||
33453388|NCT03733444|62827907|FG002|Overall Study|Study Terminated by Sponsor|221|||
33453389|NCT03733444|62827905|FG000|Overall Study|Withdrawal by Subject|19|||
33453390|NCT03733444|62827906|FG001|Overall Study|Withdrawal by Subject|18|||
33453391|NCT03733444|62827907|FG002|Overall Study|Withdrawal by Subject|16|||
33453392|NCT03733444|62827905|FG000|Overall Study|Miscellaneous|1|||
33453393|NCT03733444|62827906|FG001|Overall Study|Miscellaneous|0|||
33453394|NCT03733444|62827907|FG002|Overall Study|Miscellaneous|1|||
33453395|NCT03733444|62827905|FG000|Overall Study|Not Treated|1|||
33453396|NCT03733444|62827906|FG001|Overall Study|Not Treated|2|||
33514235|NCT03057600|62898563|FG000|Overall Study|Investigator Decision|0|||
33514236|NCT03057600|62898564|FG001|Overall Study|Investigator Decision|0|||
33514237|NCT03057600|62898565|FG002|Overall Study|Investigator Decision|1|||
33514238|NCT03057600|62898566|FG003|Overall Study|Investigator Decision|0|||
33514239|NCT03057600|62898563|FG000|Overall Study|Study Termination by Sponsor|0|||
33514240|NCT03057600|62898564|FG001|Overall Study|Study Termination by Sponsor|0|||
33514241|NCT03057600|62898565|FG002|Overall Study|Study Termination by Sponsor|0|||
33514242|NCT03057600|62898566|FG003|Overall Study|Study Termination by Sponsor|2|||
33514243|NCT03057600|62898563|FG000|Overall Study|Withdrawal by Subject|0|||
33615186|NCT01583374|63016266|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33615187|NCT01583374|63016267|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33453397|NCT03733444|62827907|FG002|Overall Study|Not Treated|1|||
33514244|NCT03057600|62898564|FG001|Overall Study|Withdrawal by Subject|1|||
33514245|NCT03057600|62898565|FG002|Overall Study|Withdrawal by Subject|0|||
33514246|NCT03057600|62898566|FG003|Overall Study|Withdrawal by Subject|0|||
33514247|NCT03057600|62898563|FG000|Overall Study|Other, Not Specified|1|||
33514248|NCT03057600|62898564|FG001|Overall Study|Other, Not Specified|1|||
33514249|NCT03057600|62898565|FG002|Overall Study|Other, Not Specified|1|||
33514250|NCT03057600|62898566|FG003|Overall Study|Other, Not Specified|1|||
33514251|NCT03371823|62898596|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
33514252|NCT03371823|62898597|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
33514253|NCT02966301|62898612|FG000|Overall Study|Death|2|||
33514254|NCT02966301|62898612|FG000|Overall Study|Withdrawal by Subject|1|||
33514255|NCT03107091|62898616|FG000|Overall Study|Physician Decision|1|||
33514256|NCT03065400|62898630|FG000|Overall Study|Adverse Event|1|||
33514257|NCT03065400|62898630|FG000|Overall Study|Physician Decision|3|||
33514258|NCT03065400|62898630|FG000|Overall Study|Withdrawal by Subject|1|||
33514259|NCT03065400|62898630|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
33514260|NCT03085095|62898636|FG000|Overall Study|Adverse Event|23|||
33514261|NCT03085095|62898637|FG001|Overall Study|Adverse Event|8|||
33514262|NCT03085095|62898636|FG000|Overall Study|Protocol Violation|0|||
33514263|NCT03085095|62898637|FG001|Overall Study|Protocol Violation|1|||
33514264|NCT03085095|62898636|FG000|Overall Study|Lost to Follow-up|2|||
33514265|NCT03085095|62898637|FG001|Overall Study|Lost to Follow-up|1|||
33514266|NCT03085095|62898636|FG000|Overall Study|Withdrawal by Subject|17|||
33514267|NCT03085095|62898637|FG001|Overall Study|Withdrawal by Subject|6|||
33514268|NCT03085095|62898636|FG000|Overall Study|Physician Decision|9|||
33514269|NCT03085095|62898637|FG001|Overall Study|Physician Decision|3|||
33514270|NCT03085095|62898636|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
33514271|NCT03085095|62898637|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
33514272|NCT03085095|62898636|FG000|Overall Study|Did not Receive Study Drug|2|||
33514273|NCT03085095|62898637|FG001|Overall Study|Did not Receive Study Drug|2|||
33514274|NCT03085095|62898636|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
33514275|NCT03085095|62898637|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
33615188|NCT01583374|63016268|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33615189|NCT01583374|63016269|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33615190|NCT01583374|63016270|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33615191|NCT01583374|63016271|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33615192|NCT01583374|63016263|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
33324660|NCT02731729|62701234|FG000|Overall Study|Death|2|||
33324661|NCT02731729|62701235|FG001|Overall Study|Death|2|||
33514276|NCT04097301|62898646|FG000|Overall Study|Death|1|||
33615193|NCT01583374|63016264|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
33615194|NCT01583374|63016265|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
33615195|NCT01583374|63016266|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33324662|NCT02731729|62701234|FG000|Overall Study|Study terminated by Sponsor|6|||
33324663|NCT02731729|62701235|FG001|Overall Study|Study terminated by Sponsor|6|||
33453398|NCT03731182|62827927|FG000|Overall Study|Lost to Follow-up|2|||
33453399|NCT03731182|62827928|FG001|Overall Study|Lost to Follow-up|0|||
33453400|NCT03731182|62827927|FG000|Overall Study|Physician Decision|1|||
33453401|NCT03731182|62827928|FG001|Overall Study|Physician Decision|0|||
33453402|NCT03731182|62827927|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
33453403|NCT03731182|62827928|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
33453404|NCT03730012|62827937|FG000|Overall Study|Adverse Event|0|||
33453405|NCT03730012|62827938|FG001|Overall Study|Adverse Event|1|||
33453406|NCT03730012|62827937|FG000|Overall Study|Lack of Efficacy|1|||
33453407|NCT03730012|62827938|FG001|Overall Study|Lack of Efficacy|5|||
33453408|NCT03730012|62827937|FG000|Overall Study|Withdrawal by Subject|0|||
33453409|NCT03730012|62827938|FG001|Overall Study|Withdrawal by Subject|1|||
33453410|NCT03730012|62827937|FG000|Overall Study|Miscellaneous|2|||
33453411|NCT03730012|62827938|FG001|Overall Study|Miscellaneous|1|||
33453412|NCT03728140|62827949|FG000|Overall Study|Abnormal embryo transfer operation|10|||
33453413|NCT03728140|62827950|FG001|Overall Study|Abnormal embryo transfer operation|7|||
33453414|NCT03725722|62827975|FG000|Overall Study|Lack of Efficacy|2|||
33453415|NCT03725722|62827976|FG001|Overall Study|Lack of Efficacy|1|||
33453416|NCT03725722|62827977|FG002|Overall Study|Lack of Efficacy|2|||
33453417|NCT03725722|62827978|FG003|Overall Study|Lack of Efficacy|0|||
33453418|NCT03725722|62827979|FG004|Overall Study|Lack of Efficacy|2|||
33453419|NCT03725722|62827975|FG000|Overall Study|Adverse Event|2|||
33453420|NCT03725722|62827976|FG001|Overall Study|Adverse Event|2|||
33453421|NCT03725722|62827977|FG002|Overall Study|Adverse Event|1|||
33453422|NCT03725722|62827978|FG003|Overall Study|Adverse Event|0|||
33453423|NCT03725722|62827979|FG004|Overall Study|Adverse Event|6|||
33453424|NCT03725722|62827975|FG000|Overall Study|Withdrawal by Subject|4|||
33453425|NCT03725722|62827976|FG001|Overall Study|Withdrawal by Subject|1|||
33514277|NCT04097301|62898646|FG000|Overall Study|Withdrawal by Subject|1|||
33324664|NCT02731729|62701234|FG000|Overall Study|Withdrawal by Subject|1|||
33514278|NCT04097301|62898646|FG000|Overall Study|Screening Failure|5|||
33514279|NCT02649855|62898655|FG000|Overall Study|Refused further treatment|2|||
33615196|NCT01583374|63016267|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33615197|NCT01583374|63016268|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33514280|NCT02649855|62898656|FG001|Overall Study|Refused further treatment|1|||
33514281|NCT02649855|62898657|FG002|Overall Study|Refused further treatment|1|||
33514282|NCT02649855|62898655|FG000|Overall Study|Withdrew consent|0|||
33514283|NCT02649855|62898656|FG001|Overall Study|Withdrew consent|1|||
33514284|NCT02649855|62898657|FG002|Overall Study|Withdrew consent|0|||
33514285|NCT02649855|62898655|FG000|Overall Study|Switched to alternative treatment|0|||
33514286|NCT02649855|62898656|FG001|Overall Study|Switched to alternative treatment|1|||
33514287|NCT02649855|62898657|FG002|Overall Study|Switched to alternative treatment|1|||
33514288|NCT02649855|62898655|FG000|Overall Study|Principal investigator discretion|0|||
33514289|NCT02649855|62898656|FG001|Overall Study|Principal investigator discretion|1|||
33514290|NCT02649855|62898657|FG002|Overall Study|Principal investigator discretion|1|||
33514291|NCT02649855|62898655|FG000|Overall Study|No treatment, per protocol|1|||
33514292|NCT02649855|62898656|FG001|Overall Study|No treatment, per protocol|0|||
33514293|NCT02649855|62898657|FG002|Overall Study|No treatment, per protocol|0|||
33514294|NCT02649855|62898655|FG000|Overall Study|Initiate new treatment|1|||
33514295|NCT02649855|62898656|FG001|Overall Study|Initiate new treatment|0|||
33514296|NCT02649855|62898657|FG002|Overall Study|Initiate new treatment|0|||
33514297|NCT02276547|62898665|FG000|Overall Study|Death|2|||
33514298|NCT02276547|62898665|FG000|Overall Study|Explant|2|||
33514299|NCT02966834|62898675|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
33514300|NCT02966834|62898676|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
33514301|NCT02966834|62898677|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
33514302|NCT02966834|62898678|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
33514303|NCT02966834|62898679|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
33514304|NCT02966834|62898680|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
33514305|NCT02966834|62898675|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
33514306|NCT02966834|62898676|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33514307|NCT02966834|62898677|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33615198|NCT01583374|63016269|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33615199|NCT01583374|63016270|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33615200|NCT01583374|63016271|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33615201|NCT01583374|63016263|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
33615202|NCT01583374|63016264|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
33615203|NCT01583374|63016265|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33615204|NCT01583374|63016266|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33615205|NCT01583374|63016267|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33615206|NCT01583374|63016268|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33615207|NCT01583374|63016269|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33615208|NCT01583374|63016270|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33615209|NCT01583374|63016271|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33615210|NCT01583374|63016263|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
33615211|NCT01583374|63016264|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
33615212|NCT01583374|63016265|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
33615213|NCT01583374|63016266|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33615214|NCT01583374|63016267|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33615215|NCT01583374|63016268|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33615216|NCT01583374|63016269|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33615217|NCT01583374|63016270|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33615218|NCT01583374|63016271|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33615219|NCT01583374|63016263|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
33615220|NCT01583374|63016264|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
33615221|NCT01583374|63016265|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
33615222|NCT01583374|63016266|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
33615223|NCT01583374|63016267|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
33615224|NCT01583374|63016268|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
33615225|NCT01583374|63016269|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
33615226|NCT01583374|63016270|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
33615227|NCT01583374|63016271|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
33615228|NCT01583374|63016263|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33514308|NCT02966834|62898678|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33514309|NCT02966834|62898679|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33514310|NCT02966834|62898680|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33514311|NCT02966834|62898675|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
33514312|NCT02966834|62898676|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
33514313|NCT02966834|62898677|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
33514314|NCT02966834|62898678|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
33514315|NCT02966834|62898679|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
33514316|NCT02966834|62898680|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
33514317|NCT02966834|62898675|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
33514318|NCT02966834|62898676|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
33514319|NCT02966834|62898677|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
33514320|NCT02966834|62898678|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
33514321|NCT02966834|62898679|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
33514322|NCT02966834|62898680|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
33514323|NCT02966834|62898675|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
33514324|NCT02966834|62898676|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
33514325|NCT02966834|62898677|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
33514326|NCT02966834|62898678|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
33514327|NCT02966834|62898679|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
33514328|NCT02966834|62898680|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
33514329|NCT02966834|62898675|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
33514330|NCT02966834|62898676|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
33514331|NCT02966834|62898677|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
33514332|NCT02966834|62898678|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
33514333|NCT02966834|62898679|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
33514334|NCT02966834|62898680|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
33514335|NCT03106077|62898729|FG000|Overall Study|Screen Failure|94|||
33514336|NCT03106077|62898730|FG001|Overall Study|Screen Failure|0|||
33514337|NCT03105297|62898735|FG000|Baseline Phase (Day 1)|Other|21|||
33514338|NCT03105297|62898735|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
33514339|NCT03105297|62898735|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
33514340|NCT03426995|62898765|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514341|NCT03426995|62898766|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514342|NCT03426995|62898767|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
33514343|NCT03426995|62898768|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514344|NCT03426995|62898769|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514345|NCT03426995|62898770|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514346|NCT03426995|62898771|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514347|NCT03426995|62898772|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514348|NCT03426995|62898773|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514349|NCT03426995|62898774|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514350|NCT03426995|62898775|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33453426|NCT03725722|62827977|FG002|Overall Study|Withdrawal by Subject|0|||
33453427|NCT03725722|62827978|FG003|Overall Study|Withdrawal by Subject|4|||
33453428|NCT03725722|62827979|FG004|Overall Study|Withdrawal by Subject|4|||
33453429|NCT03725722|62827975|FG000|Overall Study|Lost to Follow-up|3|||
33453430|NCT03725722|62827976|FG001|Overall Study|Lost to Follow-up|1|||
33453431|NCT03725722|62827977|FG002|Overall Study|Lost to Follow-up|2|||
33453432|NCT03725722|62827978|FG003|Overall Study|Lost to Follow-up|2|||
33453433|NCT03725722|62827979|FG004|Overall Study|Lost to Follow-up|1|||
33453434|NCT03725722|62827975|FG000|Overall Study|Personal reasons|0|||
33453435|NCT03725722|62827976|FG001|Overall Study|Personal reasons|0|||
33453436|NCT03725722|62827977|FG002|Overall Study|Personal reasons|1|||
33514351|NCT03426995|62898776|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514352|NCT03426995|62898777|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514353|NCT03426995|62898778|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514354|NCT03426995|62898779|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514355|NCT03426995|62898780|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514356|NCT03426995|62898781|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514357|NCT03426995|62898782|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33453437|NCT03725722|62827978|FG003|Overall Study|Personal reasons|0|||
33453438|NCT03725722|62827979|FG004|Overall Study|Personal reasons|1|||
33453439|NCT03725722|62827975|FG000|Overall Study|COVID-19 situation|0|||
33453440|NCT03725722|62827976|FG001|Overall Study|COVID-19 situation|1|||
33453441|NCT03725722|62827977|FG002|Overall Study|COVID-19 situation|0|||
33514358|NCT03426995|62898783|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33514359|NCT03426995|62898765|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514360|NCT03426995|62898766|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33453442|NCT03725722|62827978|FG003|Overall Study|COVID-19 situation|0|||
33453443|NCT03725722|62827979|FG004|Overall Study|COVID-19 situation|0|||
33514361|NCT03426995|62898767|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514362|NCT03426995|62898768|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514363|NCT03426995|62898769|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514364|NCT03426995|62898770|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
33514365|NCT03426995|62898771|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514366|NCT03426995|62898772|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514367|NCT03426995|62898773|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514368|NCT03426995|62898774|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514369|NCT03426995|62898775|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514370|NCT03426995|62898776|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33615229|NCT01583374|63016264|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33615230|NCT01583374|63016265|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
33615231|NCT01583374|63016266|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33514371|NCT03426995|62898777|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514372|NCT03426995|62898778|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514373|NCT03426995|62898779|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514374|NCT03426995|62898780|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514375|NCT03426995|62898781|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514376|NCT03426995|62898782|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514377|NCT03426995|62898783|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33514378|NCT03426995|62898765|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514379|NCT03426995|62898766|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514380|NCT03426995|62898767|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514381|NCT03426995|62898768|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514382|NCT03426995|62898769|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
33514383|NCT03426995|62898770|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
33514384|NCT03426995|62898771|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514385|NCT03426995|62898772|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514386|NCT03426995|62898773|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514387|NCT03426995|62898774|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514388|NCT03426995|62898775|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514389|NCT03426995|62898776|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514390|NCT03426995|62898777|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514391|NCT03426995|62898778|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514392|NCT03426995|62898779|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514393|NCT03426995|62898780|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514394|NCT03426995|62898781|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514395|NCT03426995|62898782|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514396|NCT03426995|62898783|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33514397|NCT03426995|62898765|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514398|NCT03426995|62898766|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514399|NCT03426995|62898767|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514400|NCT03426995|62898768|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514401|NCT03426995|62898769|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514402|NCT03426995|62898770|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514403|NCT03426995|62898771|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514404|NCT03426995|62898772|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33615232|NCT01583374|63016267|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33615233|NCT01583374|63016268|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33324665|NCT02731729|62701235|FG001|Overall Study|Withdrawal by Subject|0|||
33453444|NCT02966314|62827993|FG000|Overall Study|Lost to Follow-up|1|||
33453445|NCT02966314|62827994|FG001|Overall Study|Lost to Follow-up|0|||
33453446|NCT03723070|62828000|FG000|Overall Study|Lost to Follow-up|2|||
33453447|NCT03723070|62828000|FG000|Overall Study|Physician Decision|1|||
33453448|NCT03723070|62828000|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
33453449|NCT03722524|62828008|FG000|Overall Study|Protocol Violation|86|||
33453450|NCT03722524|62828008|FG000|Overall Study|Adverse Event|7|||
33453451|NCT03722524|62828008|FG000|Overall Study|Lost to Follow-up|1|||
33453452|NCT03722524|62828008|FG000|Overall Study|Reason is not stated|1|||
33453453|NCT03722524|62828008|FG000|Overall Study|Physician Decision|1|||
33453454|NCT03722524|62828008|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
33514405|NCT03426995|62898773|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514406|NCT03426995|62898774|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514407|NCT03426995|62898775|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
33615234|NCT01583374|63016269|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33453455|NCT03722446|62828014|FG000|Overall Study|Protocol Violation|15|||
33453456|NCT03722446|62828015|FG001|Overall Study|Protocol Violation|2|||
33453457|NCT00146172|62828029|FG000|Overall Study|Adverse Event|0|||
33514408|NCT03426995|62898776|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514409|NCT03426995|62898777|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514410|NCT03426995|62898778|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514411|NCT03426995|62898779|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514412|NCT03426995|62898780|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514413|NCT03426995|62898781|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514414|NCT03426995|62898782|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514415|NCT03426995|62898783|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33514416|NCT03426995|62898765|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514417|NCT03426995|62898766|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514418|NCT03426995|62898767|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514419|NCT03426995|62898768|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514420|NCT03426995|62898769|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514421|NCT03426995|62898770|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33453458|NCT00146172|62828030|FG001|Overall Study|Adverse Event|0|||
33514422|NCT03426995|62898771|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514423|NCT03426995|62898772|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
33514424|NCT03426995|62898773|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514425|NCT03426995|62898774|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514426|NCT03426995|62898775|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514427|NCT03426995|62898776|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514428|NCT03426995|62898777|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514429|NCT03426995|62898778|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514430|NCT03426995|62898779|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514431|NCT03426995|62898780|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514432|NCT03426995|62898781|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514433|NCT03426995|62898782|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514434|NCT03426995|62898783|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33514435|NCT03426995|62898765|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33514436|NCT03426995|62898766|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33514437|NCT03426995|62898767|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33514438|NCT03426995|62898768|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33514439|NCT03426995|62898769|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33514440|NCT03426995|62898770|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33514441|NCT03426995|62898771|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33514442|NCT03426995|62898772|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33514443|NCT03426995|62898773|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33514444|NCT03426995|62898774|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33514445|NCT03426995|62898775|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33514446|NCT03426995|62898776|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33453459|NCT00146172|62828031|FG002|Overall Study|Adverse Event|1|||
33453460|NCT00146172|62828032|FG003|Overall Study|Adverse Event|1|||
33453461|NCT00146172|62828033|FG004|Overall Study|Adverse Event|0|||
33453462|NCT00146172|62828034|FG005|Overall Study|Adverse Event|2|||
33453463|NCT00146172|62828035|FG006|Overall Study|Adverse Event|3|||
33453464|NCT00146172|62828036|FG007|Overall Study|Adverse Event|10|||
33453465|NCT00146172|62828029|FG000|Overall Study|Lost to Follow-up|0|||
33453466|NCT00146172|62828030|FG001|Overall Study|Lost to Follow-up|0|||
33453467|NCT00146172|62828031|FG002|Overall Study|Lost to Follow-up|0|||
33453468|NCT00146172|62828032|FG003|Overall Study|Lost to Follow-up|0|||
33453469|NCT00146172|62828033|FG004|Overall Study|Lost to Follow-up|0|||
33453470|NCT00146172|62828034|FG005|Overall Study|Lost to Follow-up|0|||
33453471|NCT00146172|62828035|FG006|Overall Study|Lost to Follow-up|0|||
33453472|NCT00146172|62828036|FG007|Overall Study|Lost to Follow-up|1|||
33453473|NCT00146172|62828029|FG000|Overall Study|Disease Progression|2|||
33453474|NCT00146172|62828030|FG001|Overall Study|Disease Progression|4|||
33453475|NCT00146172|62828031|FG002|Overall Study|Disease Progression|2|||
33453476|NCT00146172|62828032|FG003|Overall Study|Disease Progression|5|||
33453477|NCT00146172|62828033|FG004|Overall Study|Disease Progression|2|||
33453478|NCT00146172|62828034|FG005|Overall Study|Disease Progression|2|||
33453479|NCT00146172|62828035|FG006|Overall Study|Disease Progression|1|||
33453480|NCT00146172|62828036|FG007|Overall Study|Disease Progression|22|||
33453481|NCT00146172|62828029|FG000|Overall Study|Death|0|||
33453482|NCT00146172|62828030|FG001|Overall Study|Death|0|||
33453483|NCT00146172|62828031|FG002|Overall Study|Death|0|||
33453484|NCT00146172|62828032|FG003|Overall Study|Death|0|||
33514447|NCT03426995|62898777|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33453485|NCT00146172|62828033|FG004|Overall Study|Death|0|||
33453486|NCT00146172|62828034|FG005|Overall Study|Death|0|||
33453487|NCT00146172|62828035|FG006|Overall Study|Death|1|||
33453488|NCT00146172|62828036|FG007|Overall Study|Death|0|||
33453489|NCT00146172|62828029|FG000|Overall Study|Physician Decision|0|||
33453490|NCT00146172|62828030|FG001|Overall Study|Physician Decision|0|||
33453491|NCT00146172|62828031|FG002|Overall Study|Physician Decision|0|||
33514448|NCT03426995|62898778|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33514449|NCT03426995|62898779|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
33514450|NCT03426995|62898780|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
33514451|NCT03426995|62898781|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33514452|NCT03426995|62898782|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33514453|NCT03426995|62898783|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33514454|NCT03426995|62898765|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514455|NCT03426995|62898766|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514456|NCT03426995|62898767|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514457|NCT03426995|62898768|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514458|NCT03426995|62898769|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514459|NCT03426995|62898770|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514460|NCT03426995|62898771|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514461|NCT03426995|62898772|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514462|NCT03426995|62898773|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514463|NCT03426995|62898774|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514464|NCT03426995|62898775|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514465|NCT03426995|62898776|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514466|NCT03426995|62898777|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514467|NCT03426995|62898778|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514468|NCT03426995|62898779|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
33514469|NCT03426995|62898780|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
33514470|NCT03426995|62898781|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514471|NCT03426995|62898782|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514472|NCT03426995|62898783|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33514473|NCT03424265|62898832|FG000|Overall Study|screening failure|1|||
33514474|NCT03424265|62898833|FG001|Overall Study|screening failure|0|||
33514475|NCT03424265|62898832|FG000|Overall Study|Withdrawal by Subject|0|||
33514476|NCT03424265|62898833|FG001|Overall Study|Withdrawal by Subject|2|||
33514477|NCT03322566|62898842|FG000|Overall Study|Death|34|||
33514478|NCT03322566|62898843|FG001|Overall Study|Death|35|||
33514479|NCT03322566|62898844|FG002|Overall Study|Death|23|||
33514480|NCT03322566|62898842|FG000|Overall Study|Physician Decision|6|||
33514481|NCT03322566|62898843|FG001|Overall Study|Physician Decision|7|||
33514482|NCT03322566|62898844|FG002|Overall Study|Physician Decision|2|||
33514483|NCT03322566|62898842|FG000|Overall Study|Withdrawal by Subject|4|||
33514484|NCT03322566|62898843|FG001|Overall Study|Withdrawal by Subject|3|||
33514485|NCT03322566|62898844|FG002|Overall Study|Withdrawal by Subject|6|||
33514486|NCT03322566|62898842|FG000|Overall Study|Lost to Follow-up|0|||
33514487|NCT03322566|62898843|FG001|Overall Study|Lost to Follow-up|0|||
33514488|NCT03322566|62898844|FG002|Overall Study|Lost to Follow-up|1|||
33514489|NCT03322566|62898842|FG000|Overall Study|Study terminated by sponsor|1|||
33514490|NCT03322566|62898843|FG001|Overall Study|Study terminated by sponsor|0|||
33514491|NCT03322566|62898844|FG002|Overall Study|Study terminated by sponsor|1|||
33514492|NCT02969018|62898860|FG000|Overall Study|Adverse Event|2|||
33514493|NCT02969018|62898861|FG001|Overall Study|Adverse Event|4|||
33514494|NCT02969018|62898862|FG002|Overall Study|Adverse Event|1|||
33514495|NCT02969018|62898863|FG003|Overall Study|Adverse Event|2|||
33514496|NCT02969018|62898864|FG004|Overall Study|Adverse Event|0|||
33514497|NCT02969018|62898865|FG005|Overall Study|Adverse Event|1|||
33514498|NCT02969018|62898866|FG006|Overall Study|Adverse Event|2|||
33514499|NCT02969018|62898867|FG007|Overall Study|Adverse Event|0|||
33514500|NCT02969018|62898860|FG000|Overall Study|Lack of Efficacy|0|||
33514501|NCT02969018|62898861|FG001|Overall Study|Lack of Efficacy|1|||
33514502|NCT02969018|62898862|FG002|Overall Study|Lack of Efficacy|0|||
33514503|NCT02969018|62898863|FG003|Overall Study|Lack of Efficacy|0|||
33514504|NCT02969018|62898864|FG004|Overall Study|Lack of Efficacy|1|||
33514505|NCT02969018|62898865|FG005|Overall Study|Lack of Efficacy|1|||
33514506|NCT02969018|62898866|FG006|Overall Study|Lack of Efficacy|1|||
33514507|NCT02969018|62898867|FG007|Overall Study|Lack of Efficacy|1|||
33514508|NCT02969018|62898860|FG000|Overall Study|Lost to Follow-up|1|||
33514509|NCT02969018|62898861|FG001|Overall Study|Lost to Follow-up|2|||
33514510|NCT02969018|62898862|FG002|Overall Study|Lost to Follow-up|2|||
33514511|NCT02969018|62898863|FG003|Overall Study|Lost to Follow-up|0|||
33514512|NCT02969018|62898864|FG004|Overall Study|Lost to Follow-up|1|||
33514513|NCT02969018|62898865|FG005|Overall Study|Lost to Follow-up|1|||
33514514|NCT02969018|62898866|FG006|Overall Study|Lost to Follow-up|0|||
33514515|NCT02969018|62898867|FG007|Overall Study|Lost to Follow-up|1|||
33514516|NCT02969018|62898860|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33514517|NCT02969018|62898861|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33514518|NCT02969018|62898862|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
33514519|NCT02969018|62898863|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
33514520|NCT02969018|62898864|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
33615235|NCT01583374|63016270|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33615236|NCT01583374|63016271|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33514521|NCT02969018|62898865|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
33514522|NCT02969018|62898866|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
33514523|NCT02969018|62898867|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
33514524|NCT02969018|62898860|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33514525|NCT02969018|62898861|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33514526|NCT02969018|62898862|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33514527|NCT02969018|62898863|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33514528|NCT02969018|62898864|FG004|Overall Study|Non-Compliance With Study Drug|0|||
33514529|NCT02969018|62898865|FG005|Overall Study|Non-Compliance With Study Drug|0|||
33514530|NCT02969018|62898866|FG006|Overall Study|Non-Compliance With Study Drug|0|||
33514531|NCT02969018|62898867|FG007|Overall Study|Non-Compliance With Study Drug|0|||
33514532|NCT02969018|62898860|FG000|Overall Study|Other|0|||
33514533|NCT02969018|62898861|FG001|Overall Study|Other|0|||
33514534|NCT02969018|62898862|FG002|Overall Study|Other|0|||
33514535|NCT02969018|62898863|FG003|Overall Study|Other|1|||
33514536|NCT02969018|62898864|FG004|Overall Study|Other|0|||
33514537|NCT02969018|62898865|FG005|Overall Study|Other|0|||
33514538|NCT02969018|62898866|FG006|Overall Study|Other|0|||
33514539|NCT02969018|62898867|FG007|Overall Study|Other|2|||
33514540|NCT02969018|62898860|FG000|Overall Study|Pregnancy|0|||
33514541|NCT02969018|62898861|FG001|Overall Study|Pregnancy|0|||
33514542|NCT02969018|62898862|FG002|Overall Study|Pregnancy|0|||
33514543|NCT02969018|62898863|FG003|Overall Study|Pregnancy|0|||
33514544|NCT02969018|62898864|FG004|Overall Study|Pregnancy|0|||
33514545|NCT02969018|62898865|FG005|Overall Study|Pregnancy|1|||
33514546|NCT02969018|62898866|FG006|Overall Study|Pregnancy|0|||
33514547|NCT02969018|62898867|FG007|Overall Study|Pregnancy|0|||
33514548|NCT02969018|62898860|FG000|Overall Study|Protocol Violation|0|||
33514549|NCT02969018|62898861|FG001|Overall Study|Protocol Violation|0|||
33514550|NCT02969018|62898862|FG002|Overall Study|Protocol Violation|1|||
33514551|NCT02969018|62898863|FG003|Overall Study|Protocol Violation|1|||
33514552|NCT02969018|62898864|FG004|Overall Study|Protocol Violation|0|||
33514553|NCT02969018|62898865|FG005|Overall Study|Protocol Violation|0|||
33514554|NCT02969018|62898866|FG006|Overall Study|Protocol Violation|0|||
33514555|NCT02969018|62898867|FG007|Overall Study|Protocol Violation|0|||
33514556|NCT02969018|62898860|FG000|Overall Study|Withdrawal by Subject|0|||
33514557|NCT02969018|62898861|FG001|Overall Study|Withdrawal by Subject|1|||
33514558|NCT02969018|62898862|FG002|Overall Study|Withdrawal by Subject|2|||
33514559|NCT02969018|62898863|FG003|Overall Study|Withdrawal by Subject|1|||
33514560|NCT02969018|62898864|FG004|Overall Study|Withdrawal by Subject|0|||
33514561|NCT02969018|62898865|FG005|Overall Study|Withdrawal by Subject|4|||
33514562|NCT02969018|62898866|FG006|Overall Study|Withdrawal by Subject|4|||
33514563|NCT02969018|62898867|FG007|Overall Study|Withdrawal by Subject|3|||
33514564|NCT01319721|62898890|FG000|Overall Study|Lost to Follow-up|1|||
33514565|NCT01319721|62898891|FG001|Overall Study|Lost to Follow-up|6|||
33514566|NCT02905032|62898900|FG000|Overall Study|Withdrawal by Subject|2|||
33514567|NCT02905032|62898901|FG001|Overall Study|Withdrawal by Subject|0|||
33514568|NCT02905032|62898902|FG002|Overall Study|Withdrawal by Subject|0|||
33514569|NCT02905032|62898900|FG000|Overall Study|Protocol Violation|6|||
33514570|NCT02905032|62898901|FG001|Overall Study|Protocol Violation|12|||
33514571|NCT02905032|62898902|FG002|Overall Study|Protocol Violation|0|||
33514572|NCT03259425|62898909|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
33514573|NCT03101241|62898915|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
33514574|NCT03101241|62898916|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
33514575|NCT03101241|62898915|FG000|Overall Study|Participant withdrew consent|3|||
33615237|NCT01583374|63016263|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
33514576|NCT03101241|62898916|FG001|Overall Study|Participant withdrew consent|1|||
33514577|NCT03101241|62898915|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
33514578|NCT03101241|62898916|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
33514579|NCT03101241|62898915|FG000|Overall Study|Lost to Follow-up|2|||
33514580|NCT03101241|62898916|FG001|Overall Study|Lost to Follow-up|0|||
33514581|NCT03101241|62898915|FG000|Overall Study|Lack of Efficacy|0|||
33514582|NCT03101241|62898916|FG001|Overall Study|Lack of Efficacy|1|||
33514583|NCT03101241|62898915|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
33514584|NCT03101241|62898916|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
33514585|NCT03061188|62898926|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
33514586|NCT03061188|62898927|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
33615238|NCT01583374|63016264|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
33615239|NCT01583374|63016265|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
33615240|NCT01583374|63016266|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
33615241|NCT01583374|63016267|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
33615242|NCT01583374|63016268|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
33615243|NCT01583374|63016269|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
33615244|NCT01583374|63016270|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
33615245|NCT01583374|63016271|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
33615246|NCT01583374|63016263|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33615247|NCT01583374|63016264|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33615248|NCT01583374|63016265|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33615249|NCT01583374|63016266|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33615250|NCT01583374|63016267|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33615251|NCT01583374|63016268|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33615252|NCT01583374|63016269|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33615253|NCT01583374|63016270|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
33615254|NCT01583374|63016271|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33615255|NCT01583374|63016263|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
33615256|NCT01583374|63016264|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
33615257|NCT01583374|63016265|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
33615258|NCT01583374|63016266|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
33615259|NCT01583374|63016267|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
33615260|NCT01583374|63016268|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
33615261|NCT01583374|63016269|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
33615262|NCT01583374|63016270|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
33615263|NCT01583374|63016271|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
33615264|NCT01583374|63016263|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
33615265|NCT01583374|63016264|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
33615266|NCT01583374|63016265|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
33615267|NCT01583374|63016266|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
33453492|NCT00146172|62828032|FG003|Overall Study|Physician Decision|0|||
33453493|NCT00146172|62828033|FG004|Overall Study|Physician Decision|0|||
33453494|NCT00146172|62828034|FG005|Overall Study|Physician Decision|0|||
33453495|NCT00146172|62828035|FG006|Overall Study|Physician Decision|0|||
33453496|NCT00146172|62828036|FG007|Overall Study|Physician Decision|1|||
33514587|NCT03061188|62898928|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
33514588|NCT03061188|62898929|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
33514589|NCT03061188|62898926|FG000|On Follow-up for 3 Years|Death|0|||
33514590|NCT03061188|62898927|FG001|On Follow-up for 3 Years|Death|3|||
33514591|NCT03061188|62898928|FG002|On Follow-up for 3 Years|Death|5|||
33514592|NCT03061188|62898929|FG003|On Follow-up for 3 Years|Death|2|||
33514593|NCT03061188|62898926|FG000|On Follow-up for 3 Years|Still in follow-up|0|||
33514594|NCT03061188|62898927|FG001|On Follow-up for 3 Years|Still in follow-up|0|||
33514595|NCT03061188|62898928|FG002|On Follow-up for 3 Years|Still in follow-up|0|||
33514596|NCT03061188|62898929|FG003|On Follow-up for 3 Years|Still in follow-up|3|||
33514597|NCT03449147|62898947|FG000|52-week Treatment Period|Death|0|||
33514598|NCT03449147|62898948|FG001|52-week Treatment Period|Death|1|||
33615268|NCT01583374|63016267|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
33615269|NCT01583374|63016268|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
33453497|NCT00146172|62828029|FG000|Overall Study|Withdrawal by Subject|0|||
33453498|NCT00146172|62828030|FG001|Overall Study|Withdrawal by Subject|0|||
33453499|NCT00146172|62828031|FG002|Overall Study|Withdrawal by Subject|0|||
33453500|NCT00146172|62828032|FG003|Overall Study|Withdrawal by Subject|0|||
33453501|NCT00146172|62828033|FG004|Overall Study|Withdrawal by Subject|0|||
33453502|NCT00146172|62828034|FG005|Overall Study|Withdrawal by Subject|1|||
33453503|NCT00146172|62828035|FG006|Overall Study|Withdrawal by Subject|1|||
33615270|NCT01583374|63016269|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
33615271|NCT01583374|63016270|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
33615272|NCT01583374|63016271|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
33453504|NCT00146172|62828036|FG007|Overall Study|Withdrawal by Subject|4|||
33453505|NCT00146172|62828029|FG000|Overall Study|Symptomatic Deterioration|1|||
33453506|NCT00146172|62828030|FG001|Overall Study|Symptomatic Deterioration|0|||
33514599|NCT03449147|62898949|FG002|52-week Treatment Period|Death|0|||
33514600|NCT03449147|62898947|FG000|52-week Treatment Period|Lost to Follow-up|6|||
33514601|NCT03449147|62898948|FG001|52-week Treatment Period|Lost to Follow-up|2|||
33615273|NCT01583374|63016263|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
33514602|NCT03449147|62898949|FG002|52-week Treatment Period|Lost to Follow-up|5|||
33514603|NCT03449147|62898947|FG000|52-week Treatment Period|Other|0|||
33514604|NCT03449147|62898948|FG001|52-week Treatment Period|Other|1|||
33514605|NCT03449147|62898949|FG002|52-week Treatment Period|Other|2|||
33514606|NCT03449147|62898947|FG000|52-week Treatment Period|Physician Decision|1|||
33514607|NCT03449147|62898948|FG001|52-week Treatment Period|Physician Decision|0|||
33514608|NCT03449147|62898949|FG002|52-week Treatment Period|Physician Decision|3|||
33514609|NCT03449147|62898947|FG000|52-week Treatment Period|Screen Failure|1|||
33514610|NCT03449147|62898948|FG001|52-week Treatment Period|Screen Failure|2|||
33514611|NCT03449147|62898949|FG002|52-week Treatment Period|Screen Failure|0|||
33514612|NCT03449147|62898947|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
33514613|NCT03449147|62898948|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
33514614|NCT03449147|62898949|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
33514615|NCT03449147|62898947|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
33514616|NCT03449147|62898948|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
33514617|NCT03449147|62898949|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
33514618|NCT03449147|62898947|FG000|12-Week Off-Treatment Durability Period|Other|0|||
33514619|NCT03449147|62898948|FG001|12-Week Off-Treatment Durability Period|Other|1|||
33514620|NCT03449147|62898949|FG002|12-Week Off-Treatment Durability Period|Other|0|||
33514621|NCT03423173|62898965|FG000|Overall Study|Randomized but not vaccinated|1|||
33514622|NCT03423173|62898966|FG001|Overall Study|Randomized but not vaccinated|0|||
33615274|NCT01583374|63016264|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
33615275|NCT01583374|63016265|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
33615276|NCT01583374|63016266|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
33615277|NCT01583374|63016267|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
33514623|NCT03423173|62898967|FG002|Overall Study|Randomized but not vaccinated|2|||
33514624|NCT03423173|62898968|FG003|Overall Study|Randomized but not vaccinated|1|||
33514625|NCT03423173|62898965|FG000|Overall Study|Adverse Event|1|||
33514626|NCT03423173|62898966|FG001|Overall Study|Adverse Event|1|||
33514627|NCT03423173|62898967|FG002|Overall Study|Adverse Event|1|||
33514628|NCT03423173|62898968|FG003|Overall Study|Adverse Event|1|||
33514629|NCT03423173|62898965|FG000|Overall Study|Lost to Follow-up|10|||
33514630|NCT03423173|62898966|FG001|Overall Study|Lost to Follow-up|19|||
33514631|NCT03423173|62898967|FG002|Overall Study|Lost to Follow-up|17|||
33514632|NCT03423173|62898968|FG003|Overall Study|Lost to Follow-up|22|||
33514633|NCT03423173|62898965|FG000|Overall Study|Withdrawal of consent|4|||
33514634|NCT03423173|62898966|FG001|Overall Study|Withdrawal of consent|10|||
33514635|NCT03423173|62898967|FG002|Overall Study|Withdrawal of consent|4|||
33514636|NCT03423173|62898968|FG003|Overall Study|Withdrawal of consent|5|||
33514637|NCT03423173|62898965|FG000|Overall Study|Death|1|||
33514638|NCT03423173|62898966|FG001|Overall Study|Death|0|||
33514639|NCT03423173|62898967|FG002|Overall Study|Death|0|||
33514640|NCT03423173|62898968|FG003|Overall Study|Death|0|||
33514641|NCT03423173|62898965|FG000|Overall Study|Reason not Specified|2|||
33514642|NCT03423173|62898966|FG001|Overall Study|Reason not Specified|5|||
33514643|NCT03423173|62898967|FG002|Overall Study|Reason not Specified|3|||
33514644|NCT03423173|62898968|FG003|Overall Study|Reason not Specified|1|||
33514645|NCT03447821|62898981|FG000|Overall Study|Withdrawal by Subject|1|||
33514646|NCT03447821|62898982|FG001|Overall Study|Withdrawal by Subject|1|||
33514647|NCT03447821|62898983|FG002|Overall Study|Withdrawal by Subject|0|||
33514648|NCT03447821|62898981|FG000|Overall Study|Lost to Follow-up|0|||
33514649|NCT03447821|62898982|FG001|Overall Study|Lost to Follow-up|0|||
33514650|NCT03447821|62898983|FG002|Overall Study|Lost to Follow-up|1|||
33514651|NCT03447353|62898997|FG000|Overall Study|Failure at Screening Visit|2|||
33514652|NCT03447353|62898997|FG000|Overall Study|Lost to Follow-up|4|||
33514653|NCT03447353|62898997|FG000|Overall Study|Scheduling Conflicts|3|||
33514654|NCT03447353|62898997|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
33324666|NCT01119066|62701245|FG000|Overall Study|Withdrawal by Subject|4|||
33514655|NCT03446885|62899007|FG000|Overall Study|Lost to Follow-up|1|||
33514656|NCT03446885|62899008|FG001|Overall Study|Lost to Follow-up|0|||
33615278|NCT01583374|63016268|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
33514657|NCT03446885|62899007|FG000|Overall Study|Did not complete entire visit|1|||
33514658|NCT03446885|62899008|FG001|Overall Study|Did not complete entire visit|0|||
33514659|NCT00710970|62899016|FG000|Overall Study|Never took drug|3|||
33514660|NCT03421379|62899022|FG000|Period 1|Withdrawal by Subject|0|||
33514661|NCT03421379|62899023|FG001|Period 1|Withdrawal by Subject|1|||
33514662|NCT03421379|62899022|FG000|Period 1|Physician Decision|1|||
33514663|NCT03421379|62899023|FG001|Period 1|Physician Decision|1|||
33514664|NCT03421379|62899022|FG000|Period 1|Did not receive treatment|1|||
33514665|NCT03421379|62899023|FG001|Period 1|Did not receive treatment|2|||
33514666|NCT02900378|62899031|FG000|Randomization (Visit 2)|Adverse Event|14|||
33514667|NCT02900378|62899032|FG001|Randomization (Visit 2)|Adverse Event|11|||
33514668|NCT02900378|62899031|FG000|Randomization (Visit 2)|Death|1|||
33514669|NCT02900378|62899032|FG001|Randomization (Visit 2)|Death|4|||
33514670|NCT02900378|62899031|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
33514671|NCT02900378|62899032|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
33514672|NCT02900378|62899031|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
33514673|NCT02900378|62899032|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
33514674|NCT02900378|62899031|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
33514675|NCT02900378|62899032|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
33514676|NCT02900378|62899031|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
33514677|NCT02900378|62899032|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
33514678|NCT02900378|62899031|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
33514679|NCT02900378|62899032|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
33514680|NCT03058692|62899040|FG000|Overall Study|Lost to Follow-up|2|||
33514681|NCT03058692|62899041|FG001|Overall Study|Lost to Follow-up|1|||
33514682|NCT03058692|62899040|FG000|Overall Study|Withdrawal by Subject|1|||
33514683|NCT03058692|62899041|FG001|Overall Study|Withdrawal by Subject|1|||
33514684|NCT02964338|62899051|FG000|Overall Study|Sponsor terminated study for futility|12|||
33514685|NCT02964338|62899052|FG001|Overall Study|Sponsor terminated study for futility|15|||
33514686|NCT02964338|62899053|FG002|Overall Study|Sponsor terminated study for futility|14|||
33514687|NCT02964338|62899051|FG000|Overall Study|Lack of Efficacy|0|||
33514688|NCT02964338|62899052|FG001|Overall Study|Lack of Efficacy|3|||
33514689|NCT02964338|62899053|FG002|Overall Study|Lack of Efficacy|0|||
33514690|NCT02964338|62899051|FG000|Overall Study|Lost to Follow-up|1|||
33514691|NCT02964338|62899052|FG001|Overall Study|Lost to Follow-up|0|||
33514692|NCT02964338|62899053|FG002|Overall Study|Lost to Follow-up|3|||
33514693|NCT02964338|62899051|FG000|Overall Study|Protocol Violation|0|||
33514694|NCT02964338|62899052|FG001|Overall Study|Protocol Violation|1|||
33514695|NCT02964338|62899053|FG002|Overall Study|Protocol Violation|0|||
33514696|NCT02964338|62899051|FG000|Overall Study|Withdrawal by Subject|1|||
33514697|NCT02964338|62899052|FG001|Overall Study|Withdrawal by Subject|3|||
33514698|NCT02964338|62899053|FG002|Overall Study|Withdrawal by Subject|1|||
33514699|NCT02964338|62899051|FG000|Overall Study|Adverse Event|2|||
33514700|NCT02964338|62899052|FG001|Overall Study|Adverse Event|1|||
33514701|NCT02964338|62899053|FG002|Overall Study|Adverse Event|1|||
33514702|NCT02964338|62899051|FG000|Overall Study|Non-compliant with e-diary|0|||
33514703|NCT02964338|62899052|FG001|Overall Study|Non-compliant with e-diary|1|||
33514704|NCT02964338|62899053|FG002|Overall Study|Non-compliant with e-diary|0|||
33514705|NCT02964338|62899051|FG000|Overall Study|Did not meet criteria|1|||
33514706|NCT02964338|62899052|FG001|Overall Study|Did not meet criteria|0|||
33514707|NCT02964338|62899053|FG002|Overall Study|Did not meet criteria|0|||
33514708|NCT03056352|62899061|FG000|Overall Study|Lost to Follow-up|1|||
33514709|NCT02898662|62899067|FG000|Overall Study|Adverse Event|1|||
33514710|NCT02898662|62899068|FG001|Overall Study|Adverse Event|0|||
33514711|NCT02898662|62899067|FG000|Overall Study|Loss of asthma control|23|||
33514712|NCT02898662|62899068|FG001|Overall Study|Loss of asthma control|24|||
33514713|NCT02898662|62899067|FG000|Overall Study|Withdrawal by Subject|4|||
33514714|NCT02898662|62899068|FG001|Overall Study|Withdrawal by Subject|1|||
33514715|NCT02898662|62899067|FG000|Overall Study|Technical issue|0|||
33514716|NCT02898662|62899068|FG001|Overall Study|Technical issue|1|||
33514717|NCT02898662|62899067|FG000|Overall Study|Randomized in error|0|||
33514718|NCT02898662|62899068|FG001|Overall Study|Randomized in error|1|||
33514719|NCT02898662|62899067|FG000|Overall Study|Subject decision|1|||
33514720|NCT02898662|62899068|FG001|Overall Study|Subject decision|0|||
33514721|NCT02898662|62899067|FG000|Overall Study|Other|0|||
33514722|NCT02898662|62899068|FG001|Overall Study|Other|1|||
33514723|NCT03055338|62899077|FG000|Overall Study|Lost to Follow-up|9|||
33514724|NCT03055338|62899078|FG001|Overall Study|Lost to Follow-up|2|||
33514725|NCT03055338|62899079|FG002|Overall Study|Lost to Follow-up|3|||
33514726|NCT03055338|62899077|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
33514727|NCT03055338|62899078|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
33514728|NCT03055338|62899079|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
33514729|NCT03055338|62899077|FG000|Overall Study|Physician Decision|0|||
33514730|NCT03055338|62899078|FG001|Overall Study|Physician Decision|0|||
33514731|NCT03055338|62899079|FG002|Overall Study|Physician Decision|2|||
33514732|NCT03055338|62899077|FG000|Overall Study|Withdrawal by Subject|9|||
33514733|NCT03055338|62899078|FG001|Overall Study|Withdrawal by Subject|8|||
33514734|NCT03055338|62899079|FG002|Overall Study|Withdrawal by Subject|7|||
33514735|NCT03913130|62899087|FG000|Overall Study|Sponsor Decision|1|||
33514736|NCT03419741|62899093|FG000|Overall Study|Adverse Event|1|||
33514737|NCT03419741|62899094|FG001|Overall Study|Adverse Event|0|||
33514738|NCT03419741|62899093|FG000|Overall Study|Withdrawal by Subject|1|||
33514739|NCT03419741|62899094|FG001|Overall Study|Withdrawal by Subject|2|||
33514740|NCT02896400|62899116|FG000|1 Month Follow-up|Lost to Follow-up|7|||
33514741|NCT02896400|62899117|FG001|1 Month Follow-up|Lost to Follow-up|7|||
33514742|NCT02896400|62899118|FG002|1 Month Follow-up|Lost to Follow-up|5|||
33514743|NCT02896400|62899119|FG003|1 Month Follow-up|Lost to Follow-up|8|||
33514744|NCT02896400|62899120|FG004|1 Month Follow-up|Lost to Follow-up|9|||
33514745|NCT02896400|62899121|FG005|1 Month Follow-up|Lost to Follow-up|6|||
33514746|NCT02896400|62899122|FG006|1 Month Follow-up|Lost to Follow-up|5|||
33514747|NCT02896400|62899123|FG007|1 Month Follow-up|Lost to Follow-up|6|||
33514748|NCT02896400|62899124|FG008|1 Month Follow-up|Lost to Follow-up|4|||
33514749|NCT02896400|62899125|FG009|1 Month Follow-up|Lost to Follow-up|7|||
33514750|NCT02896400|62899126|FG010|1 Month Follow-up|Lost to Follow-up|5|||
33514751|NCT02896400|62899127|FG011|1 Month Follow-up|Lost to Follow-up|5|||
33514752|NCT02896400|62899128|FG012|1 Month Follow-up|Lost to Follow-up|3|||
33514753|NCT02896400|62899129|FG013|1 Month Follow-up|Lost to Follow-up|4|||
33514754|NCT02896400|62899130|FG014|1 Month Follow-up|Lost to Follow-up|1|||
33514755|NCT02896400|62899131|FG015|1 Month Follow-up|Lost to Follow-up|2|||
33514756|NCT02896400|62899116|FG000|1 Month Follow-up|Death|0|||
33514757|NCT02896400|62899117|FG001|1 Month Follow-up|Death|0|||
33514758|NCT02896400|62899118|FG002|1 Month Follow-up|Death|0|||
33514759|NCT02896400|62899119|FG003|1 Month Follow-up|Death|0|||
33514760|NCT02896400|62899120|FG004|1 Month Follow-up|Death|0|||
33514761|NCT02896400|62899121|FG005|1 Month Follow-up|Death|0|||
33514762|NCT02896400|62899122|FG006|1 Month Follow-up|Death|0|||
33514763|NCT02896400|62899123|FG007|1 Month Follow-up|Death|0|||
33514764|NCT02896400|62899124|FG008|1 Month Follow-up|Death|0|||
33514765|NCT02896400|62899125|FG009|1 Month Follow-up|Death|0|||
33514766|NCT02896400|62899126|FG010|1 Month Follow-up|Death|0|||
33514767|NCT02896400|62899127|FG011|1 Month Follow-up|Death|0|||
33514768|NCT02896400|62899128|FG012|1 Month Follow-up|Death|0|||
33514769|NCT02896400|62899129|FG013|1 Month Follow-up|Death|0|||
33514770|NCT02896400|62899130|FG014|1 Month Follow-up|Death|0|||
33514771|NCT02896400|62899131|FG015|1 Month Follow-up|Death|1|||
33514772|NCT02896400|62899116|FG000|3 Month Follow-up|Lost to Follow-up|6|||
33514773|NCT02896400|62899117|FG001|3 Month Follow-up|Lost to Follow-up|3|||
33514774|NCT02896400|62899118|FG002|3 Month Follow-up|Lost to Follow-up|6|||
33514775|NCT02896400|62899119|FG003|3 Month Follow-up|Lost to Follow-up|11|||
33514776|NCT02896400|62899120|FG004|3 Month Follow-up|Lost to Follow-up|12|||
33514777|NCT02896400|62899121|FG005|3 Month Follow-up|Lost to Follow-up|6|||
33514778|NCT02896400|62899122|FG006|3 Month Follow-up|Lost to Follow-up|4|||
33514779|NCT02896400|62899123|FG007|3 Month Follow-up|Lost to Follow-up|3|||
33514780|NCT02896400|62899124|FG008|3 Month Follow-up|Lost to Follow-up|6|||
33514781|NCT02896400|62899125|FG009|3 Month Follow-up|Lost to Follow-up|5|||
33514782|NCT02896400|62899126|FG010|3 Month Follow-up|Lost to Follow-up|6|||
33514783|NCT02896400|62899127|FG011|3 Month Follow-up|Lost to Follow-up|6|||
33514784|NCT02896400|62899128|FG012|3 Month Follow-up|Lost to Follow-up|3|||
33514785|NCT02896400|62899129|FG013|3 Month Follow-up|Lost to Follow-up|5|||
33514786|NCT02896400|62899130|FG014|3 Month Follow-up|Lost to Follow-up|3|||
33514787|NCT02896400|62899131|FG015|3 Month Follow-up|Lost to Follow-up|2|||
33514788|NCT02896400|62899116|FG000|3 Month Follow-up|Death|0|||
33514789|NCT02896400|62899117|FG001|3 Month Follow-up|Death|0|||
33514790|NCT02896400|62899118|FG002|3 Month Follow-up|Death|0|||
33514791|NCT02896400|62899119|FG003|3 Month Follow-up|Death|0|||
33514792|NCT02896400|62899120|FG004|3 Month Follow-up|Death|0|||
33514793|NCT02896400|62899121|FG005|3 Month Follow-up|Death|0|||
33514794|NCT02896400|62899122|FG006|3 Month Follow-up|Death|0|||
33514795|NCT02896400|62899123|FG007|3 Month Follow-up|Death|0|||
33514796|NCT02896400|62899124|FG008|3 Month Follow-up|Death|0|||
33514797|NCT02896400|62899125|FG009|3 Month Follow-up|Death|0|||
33514798|NCT02896400|62899126|FG010|3 Month Follow-up|Death|0|||
33514799|NCT02896400|62899127|FG011|3 Month Follow-up|Death|0|||
33514800|NCT02896400|62899128|FG012|3 Month Follow-up|Death|0|||
33514801|NCT02896400|62899129|FG013|3 Month Follow-up|Death|1|||
33514802|NCT02896400|62899130|FG014|3 Month Follow-up|Death|1|||
33514803|NCT02896400|62899131|FG015|3 Month Follow-up|Death|0|||
33514804|NCT02896400|62899116|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33514805|NCT02896400|62899117|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
33514806|NCT02896400|62899118|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33514807|NCT02896400|62899119|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33514808|NCT02896400|62899120|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
33514809|NCT02896400|62899121|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33514810|NCT02896400|62899122|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
33514811|NCT02896400|62899123|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
33514812|NCT02896400|62899124|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33514813|NCT02896400|62899125|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33514814|NCT02896400|62899126|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
33514815|NCT02896400|62899127|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
33514816|NCT02896400|62899128|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33514817|NCT02896400|62899129|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
33514818|NCT02896400|62899130|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
33514819|NCT02896400|62899131|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33514820|NCT02896400|62899116|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
33514821|NCT02896400|62899117|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
33514822|NCT02896400|62899118|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
33514823|NCT02896400|62899119|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
33514824|NCT02896400|62899120|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
33514825|NCT02896400|62899121|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
33514826|NCT02896400|62899122|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
33514827|NCT02896400|62899123|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
33514828|NCT02896400|62899124|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
33615279|NCT01583374|63016269|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
33615280|NCT01583374|63016270|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
33615281|NCT01583374|63016271|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
33453507|NCT00146172|62828031|FG002|Overall Study|Symptomatic Deterioration|1|||
33453508|NCT00146172|62828032|FG003|Overall Study|Symptomatic Deterioration|0|||
33453509|NCT00146172|62828033|FG004|Overall Study|Symptomatic Deterioration|1|||
33453510|NCT00146172|62828034|FG005|Overall Study|Symptomatic Deterioration|2|||
33453511|NCT00146172|62828035|FG006|Overall Study|Symptomatic Deterioration|0|||
33453512|NCT00146172|62828036|FG007|Overall Study|Symptomatic Deterioration|2|||
33453513|NCT00145626|62828064|FG000|Overall Study|Did not have NK infusions|2|||
33453514|NCT00145626|62828064|FG000|Overall Study|Turned 2 years old before treatment|1|||
33453515|NCT00145626|62828064|FG000|Overall Study|Death|1|||
33453516|NCT00145626|62828064|FG000|Overall Study|Withdrawal by Subject|1|||
33453517|NCT00153062|62828088|FG000|Overall Study|Death|360|||
33615282|NCT01583374|63016263|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
33615283|NCT01583374|63016264|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
33615284|NCT01583374|63016265|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
33615285|NCT01583374|63016266|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
33615286|NCT01583374|63016267|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
33615287|NCT01583374|63016268|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
33514829|NCT02896400|62899125|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
33514830|NCT02896400|62899126|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
33514831|NCT02896400|62899127|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
33514832|NCT02896400|62899128|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
33514833|NCT02896400|62899129|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
33514834|NCT02896400|62899130|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
33514835|NCT02896400|62899131|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
33514836|NCT03405935|62899157|FG000|Overall Study|Adverse Event|3|||
33514837|NCT03405935|62899157|FG000|Overall Study|Death|2|||
33514838|NCT03405935|62899157|FG000|Overall Study|Withdrawal by Subject|1|||
33514839|NCT03405935|62899157|FG000|Overall Study|Lost to Follow-up|2|||
33514840|NCT03055260|62899163|FG000|Overall Study|Withdrawal by Subject|1|||
33514841|NCT03055260|62899164|FG001|Overall Study|Withdrawal by Subject|0|||
33514842|NCT03404843|62899172|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
33514843|NCT03404843|62899173|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
33514844|NCT03444155|62899197|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
33514845|NCT03444155|62899198|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
33514846|NCT02898116|62899204|FG000|Overall Study|Adverse Event|1|||
33514847|NCT02898116|62899204|FG000|Overall Study|Progressive disease|1|||
33514848|NCT03658304|62899208|FG000|Overall Study|participants still on follow up|8|||
33514849|NCT03422159|62899214|FG000|Overall Study|Exclusion due to terminal disease|2|||
33514850|NCT03422159|62899215|FG001|Overall Study|Exclusion due to terminal disease|1|||
33514851|NCT03403751|62899225|FG000|Overall Study|Death|5|||
33514852|NCT03403751|62899226|FG001|Overall Study|Death|6|||
33514853|NCT03403751|62899225|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
33514854|NCT03403751|62899226|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
33514855|NCT02297412|62899236|FG000|Overall Study|Canceled|1|||
33514856|NCT02297412|62899237|FG001|Overall Study|Canceled|1|||
33514857|NCT03418727|62899246|FG000|Overall Study|Adverse Event|1|||
33514858|NCT03418727|62899247|FG001|Overall Study|Adverse Event|2|||
33514859|NCT03418727|62899248|FG002|Overall Study|Adverse Event|0|||
33514860|NCT03418727|62899246|FG000|Overall Study|Withdrawal by Subject|0|||
33514861|NCT03418727|62899247|FG001|Overall Study|Withdrawal by Subject|0|||
33453518|NCT00153062|62828089|FG001|Overall Study|Death|352|||
33453519|NCT00153062|62828090|FG002|Overall Study|Death|369|||
33453520|NCT00153062|62828091|FG003|Overall Study|Death|365|||
33453521|NCT00153062|62828088|FG000|Overall Study|Withdrawal by Subject|14|||
33453522|NCT00153062|62828089|FG001|Overall Study|Withdrawal by Subject|30|||
33453523|NCT00153062|62828090|FG002|Overall Study|Withdrawal by Subject|27|||
33453524|NCT00153062|62828091|FG003|Overall Study|Withdrawal by Subject|28|||
33453525|NCT00153062|62828088|FG000|Overall Study|Lost to Follow-up|12|||
33453526|NCT00153062|62828089|FG001|Overall Study|Lost to Follow-up|20|||
33453527|NCT00153062|62828090|FG002|Overall Study|Lost to Follow-up|15|||
33453528|NCT00153062|62828091|FG003|Overall Study|Lost to Follow-up|16|||
33453529|NCT00153062|62828088|FG000|Overall Study|Adverse Event|0|||
33453530|NCT00153062|62828089|FG001|Overall Study|Adverse Event|1|||
33453531|NCT00153062|62828090|FG002|Overall Study|Adverse Event|1|||
33453532|NCT00153062|62828091|FG003|Overall Study|Adverse Event|0|||
33453533|NCT00153062|62828088|FG000|Overall Study|Protocol Violation|0|||
33453534|NCT00153062|62828089|FG001|Overall Study|Protocol Violation|2|||
33453535|NCT00153062|62828090|FG002|Overall Study|Protocol Violation|1|||
33453536|NCT00153062|62828091|FG003|Overall Study|Protocol Violation|1|||
33453537|NCT00153062|62828088|FG000|Overall Study|No disposition data available|1|||
33453538|NCT00153062|62828089|FG001|Overall Study|No disposition data available|1|||
33453539|NCT00153062|62828090|FG002|Overall Study|No disposition data available|1|||
33453540|NCT00153062|62828091|FG003|Overall Study|No disposition data available|1|||
33453541|NCT00153062|62828088|FG000|Overall Study|Other|0|||
33453542|NCT00153062|62828089|FG001|Overall Study|Other|0|||
33453543|NCT00153062|62828090|FG002|Overall Study|Other|1|||
33453544|NCT00153062|62828091|FG003|Overall Study|Other|0|||
33453545|NCT00145470|62828103|FG000|Overall Study|Adverse Event|19|||
33453546|NCT00145470|62828104|FG001|Overall Study|Adverse Event|25|||
33453547|NCT00145470|62828103|FG000|Overall Study|Lack of Efficacy|27|||
33453548|NCT00145470|62828104|FG001|Overall Study|Lack of Efficacy|13|||
33514862|NCT03418727|62899248|FG002|Overall Study|Withdrawal by Subject|2|||
33514863|NCT03418571|62899258|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
33514864|NCT03418571|62899259|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
33514865|NCT03402893|62899265|FG000|Overall Study|Withdrawal by Subject|1|||
33514866|NCT03442985|62899273|FG000|Overall Study|Sponsor Request|55|||
33514867|NCT03442985|62899274|FG001|Overall Study|Sponsor Request|60|||
33514868|NCT03442985|62899275|FG002|Overall Study|Sponsor Request|54|||
33514869|NCT03442985|62899273|FG000|Overall Study|Lost to Follow-up|5|||
33514870|NCT03442985|62899274|FG001|Overall Study|Lost to Follow-up|2|||
33514871|NCT03442985|62899275|FG002|Overall Study|Lost to Follow-up|7|||
33514872|NCT03442985|62899273|FG000|Overall Study|Withdrawal by Subject|2|||
33514873|NCT03442985|62899274|FG001|Overall Study|Withdrawal by Subject|3|||
33514874|NCT03442985|62899275|FG002|Overall Study|Withdrawal by Subject|4|||
33514875|NCT03442985|62899273|FG000|Overall Study|Adverse Event|0|||
33514876|NCT03442985|62899274|FG001|Overall Study|Adverse Event|1|||
33514877|NCT03442985|62899275|FG002|Overall Study|Adverse Event|0|||
33514878|NCT01318122|62899287|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33514879|NCT01318122|62899288|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33514880|NCT01318122|62899289|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
33514881|NCT01318122|62899290|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
33514882|NCT01318122|62899287|FG000|Enrolled - Long-Term Extension Study|Other|1|||
33514883|NCT01318122|62899288|FG001|Enrolled - Long-Term Extension Study|Other|0|||
33514884|NCT01318122|62899289|FG002|Enrolled - Long-Term Extension Study|Other|0|||
33514885|NCT01318122|62899290|FG003|Enrolled - Long-Term Extension Study|Other|0|||
33514886|NCT01318122|62899287|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
33514887|NCT01318122|62899288|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
33514888|NCT01318122|62899289|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
33514889|NCT01318122|62899290|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
33514890|NCT01318122|62899287|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
33514891|NCT01318122|62899288|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33514892|NCT01318122|62899289|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33514893|NCT01318122|62899290|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33514894|NCT01318122|62899287|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33514895|NCT01318122|62899288|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
33514896|NCT01318122|62899289|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33514897|NCT01318122|62899290|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
33514898|NCT01318122|62899287|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
33514899|NCT01318122|62899288|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
33514900|NCT01318122|62899289|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
33514901|NCT01318122|62899290|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
33514902|NCT02954159|62899298|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
33514903|NCT02954159|62899299|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
33514904|NCT02954159|62899298|FG000|Overall Study|Withdrawal by Subject|0|||
33514905|NCT02954159|62899299|FG001|Overall Study|Withdrawal by Subject|1|||
33514906|NCT03442829|62899307|FG000|Overall Study|Scheduling clash|3|||
33514907|NCT03442829|62899308|FG001|Overall Study|Scheduling clash|1|||
33514908|NCT03442829|62899307|FG000|Overall Study|Illness unrelated to study|1|||
33514909|NCT03442829|62899308|FG001|Overall Study|Illness unrelated to study|1|||
33514910|NCT03442595|62899316|FG000|Overall Study|Lost to Follow-up|94|||
33514911|NCT03442595|62899317|FG001|Overall Study|Lost to Follow-up|0|||
33514912|NCT03440411|62899326|FG000|Overall Study|Adverse Event|0|||
33514913|NCT03440411|62899327|FG001|Overall Study|Adverse Event|0|||
33514914|NCT03440411|62899328|FG002|Overall Study|Adverse Event|1|||
33514915|NCT03440411|62899329|FG003|Overall Study|Adverse Event|0|||
33514916|NCT03440411|62899326|FG000|Overall Study|PD|2|||
33514917|NCT03440411|62899327|FG001|Overall Study|PD|1|||
33514918|NCT03440411|62899328|FG002|Overall Study|PD|1|||
33514919|NCT03440411|62899329|FG003|Overall Study|PD|1|||
33514920|NCT03440411|62899326|FG000|Overall Study|Withdrawal by Subject|1|||
33514921|NCT03440411|62899327|FG001|Overall Study|Withdrawal by Subject|0|||
33514922|NCT03440411|62899328|FG002|Overall Study|Withdrawal by Subject|0|||
33514923|NCT03440411|62899329|FG003|Overall Study|Withdrawal by Subject|0|||
33514924|NCT03440411|62899326|FG000|Overall Study|Closed study by sponsor|0|||
33514925|NCT03440411|62899327|FG001|Overall Study|Closed study by sponsor|0|||
33514926|NCT03440411|62899328|FG002|Overall Study|Closed study by sponsor|0|||
33514927|NCT03440411|62899329|FG003|Overall Study|Closed study by sponsor|1|||
33514928|NCT03438539|62899350|FG000|Overall Study|Lost to Follow-up|8|||
33514929|NCT03438539|62899351|FG001|Overall Study|Lost to Follow-up|4|||
33514930|NCT03438539|62899352|FG002|Overall Study|Lost to Follow-up|10|||
33514931|NCT03438539|62899353|FG003|Overall Study|Lost to Follow-up|9|||
33514932|NCT03438539|62899354|FG004|Overall Study|Lost to Follow-up|3|||
33514933|NCT03438539|62899355|FG005|Overall Study|Lost to Follow-up|8|||
33514934|NCT03400787|62899371|FG000|Overall Study|Lost to Follow-up|1|||
33514935|NCT03400787|62899372|FG001|Overall Study|Lost to Follow-up|0|||
33514936|NCT03400787|62899371|FG000|Overall Study|Death|1|||
33514937|NCT03400787|62899372|FG001|Overall Study|Death|0|||
33514938|NCT03400787|62899371|FG000|Overall Study|Protocol Violation|0|||
33514939|NCT03400787|62899372|FG001|Overall Study|Protocol Violation|2|||
33514940|NCT03400787|62899371|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
33514941|NCT03400787|62899372|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
33514942|NCT03417245|62899380|FG000|Overall Study|Adverse Event|1|||
33514943|NCT03417245|62899381|FG001|Overall Study|Adverse Event|0|||
33514944|NCT03417245|62899380|FG000|Overall Study|Protocol Violation|1|||
33514945|NCT03417245|62899381|FG001|Overall Study|Protocol Violation|0|||
33514946|NCT03417245|62899380|FG000|Overall Study|Withdrawal by Subject|1|||
33514947|NCT03417245|62899381|FG001|Overall Study|Withdrawal by Subject|1|||
33514948|NCT03389555|62899389|FG000|Overall Study|Protocol Violation|1|||
33514949|NCT03389555|62899390|FG001|Overall Study|Protocol Violation|3|||
33514950|NCT03389555|62899389|FG000|Overall Study|Death|1|||
33514951|NCT03389555|62899390|FG001|Overall Study|Death|0|||
33514952|NCT03395639|62899398|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
33514953|NCT03395639|62899399|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
33514954|NCT03395639|62899400|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
33514955|NCT03395639|62899398|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
33514956|NCT03395639|62899399|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
33514957|NCT03395639|62899400|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
33514958|NCT03395639|62899398|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
33514959|NCT03395639|62899399|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
33514960|NCT03395639|62899400|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
33514961|NCT03395639|62899398|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
33514962|NCT03395639|62899399|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
33514963|NCT03395639|62899400|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
33514964|NCT03395639|62899398|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
33514965|NCT03395639|62899399|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
33514966|NCT03395639|62899400|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
33514967|NCT03353922|62899407|FG000|Overall Study|Withdrawal by Subject|1|||
33514968|NCT03353922|62899408|FG001|Overall Study|Withdrawal by Subject|0|||
33514969|NCT03353922|62899409|FG002|Overall Study|Withdrawal by Subject|1|||
33514970|NCT03353922|62899410|FG003|Overall Study|Withdrawal by Subject|1|||
33514971|NCT03353922|62899411|FG004|Overall Study|Withdrawal by Subject|0|||
33514972|NCT03353922|62899412|FG005|Overall Study|Withdrawal by Subject|0|||
33514973|NCT03353922|62899407|FG000|Overall Study|Adverse Event|0|||
33514974|NCT03353922|62899408|FG001|Overall Study|Adverse Event|1|||
33514975|NCT03353922|62899409|FG002|Overall Study|Adverse Event|0|||
33514976|NCT03353922|62899410|FG003|Overall Study|Adverse Event|0|||
33514977|NCT03353922|62899411|FG004|Overall Study|Adverse Event|0|||
33514978|NCT03353922|62899412|FG005|Overall Study|Adverse Event|0|||
33514979|NCT03395405|62899425|FG000|Overall Study|Death|0|||
33514980|NCT03395405|62899426|FG001|Overall Study|Death|2|||
33514981|NCT03395405|62899425|FG000|Overall Study|Lost to Follow-up|0|||
33514982|NCT03395405|62899426|FG001|Overall Study|Lost to Follow-up|1|||
33514983|NCT03395405|62899425|FG000|Overall Study|Protocol Violation|0|||
33514984|NCT03395405|62899426|FG001|Overall Study|Protocol Violation|1|||
33514985|NCT03395405|62899425|FG000|Overall Study|Withdrawal by Subject|3|||
33514986|NCT03395405|62899426|FG001|Overall Study|Withdrawal by Subject|1|||
33514987|NCT03395405|62899425|FG000|Overall Study|COVID-19 Pandemic|1|||
33514988|NCT03395405|62899426|FG001|Overall Study|COVID-19 Pandemic|0|||
33514989|NCT03387683|62899434|FG000|Overall Study|In receipt of disallowed medication|1|||
33514990|NCT03387683|62899435|FG001|Overall Study|In receipt of disallowed medication|0|||
33514991|NCT03387683|62899434|FG000|Overall Study|Did not receive treatment|1|||
33514992|NCT03387683|62899435|FG001|Overall Study|Did not receive treatment|0|||
33514993|NCT03387059|62899443|FG000|Overall Study|Study termination|5|||
33514994|NCT03387059|62899444|FG001|Overall Study|Study termination|4|||
33514995|NCT02942004|62899453|FG000|Overall Study|Withdrawal by Subject|0|||
33514996|NCT02942004|62899454|FG001|Overall Study|Withdrawal by Subject|2|||
33514997|NCT02942004|62899455|FG002|Overall Study|Withdrawal by Subject|3|||
33514998|NCT02942004|62899453|FG000|Overall Study|Lost to Follow-up|1|||
33514999|NCT02942004|62899454|FG001|Overall Study|Lost to Follow-up|1|||
33515000|NCT02942004|62899455|FG002|Overall Study|Lost to Follow-up|2|||
33515001|NCT02942004|62899453|FG000|Overall Study|Randomized but not dosed|3|||
33515002|NCT02942004|62899454|FG001|Overall Study|Randomized but not dosed|9|||
33515003|NCT02942004|62899455|FG002|Overall Study|Randomized but not dosed|4|||
33515004|NCT03394391|62899465|FG000|Overall Study|Lost to Follow-up|1|||
33515005|NCT03394391|62899466|FG001|Overall Study|Lost to Follow-up|2|||
33515006|NCT03386435|62899474|FG000|Overall Study|Protocol Violation|5|||
33515007|NCT03386435|62899475|FG001|Overall Study|Protocol Violation|7|||
33515008|NCT02726880|62899483|FG000|Overall Study|Withdrawal by Subject|2|||
33515009|NCT02726880|62899484|FG001|Overall Study|Withdrawal by Subject|0|||
33515010|NCT02726880|62899483|FG000|Overall Study|Lost to Follow-up|1|||
33515011|NCT02726880|62899484|FG001|Overall Study|Lost to Follow-up|3|||
33515012|NCT03275389|62899501|FG000|Overall Study|Lost to Follow-up|10|||
33515013|NCT03275389|62899502|FG001|Overall Study|Lost to Follow-up|10|||
33515014|NCT03275389|62899503|FG002|Overall Study|Lost to Follow-up|19|||
33515015|NCT03275389|62899504|FG003|Overall Study|Lost to Follow-up|12|||
33515016|NCT03275389|62899505|FG004|Overall Study|Lost to Follow-up|11|||
33615288|NCT01583374|63016269|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
33615289|NCT01583374|63016270|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
33615290|NCT01583374|63016271|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
33615291|NCT01583374|63016263|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
33615292|NCT01583374|63016264|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
33615293|NCT01583374|63016265|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
33615294|NCT01583374|63016266|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
33615295|NCT01583374|63016267|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
33615296|NCT01583374|63016268|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
33615297|NCT01583374|63016269|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
33615298|NCT01583374|63016270|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
33615299|NCT01583374|63016271|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
33615300|NCT01583374|63016263|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
33615301|NCT01583374|63016264|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
33615302|NCT01583374|63016265|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
33615303|NCT01583374|63016266|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
33615304|NCT01583374|63016267|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
33615305|NCT01583374|63016268|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
33615306|NCT01583374|63016269|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
33615307|NCT01583374|63016270|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
33615308|NCT01583374|63016271|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
33615309|NCT01583374|63016263|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
33615310|NCT01583374|63016264|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
33515017|NCT03275389|62899506|FG005|Overall Study|Lost to Follow-up|12|||
33515018|NCT03275389|62899507|FG006|Overall Study|Lost to Follow-up|21|||
33515019|NCT03275389|62899508|FG007|Overall Study|Lost to Follow-up|15|||
33515020|NCT03275389|62899509|FG008|Overall Study|Lost to Follow-up|12|||
33515021|NCT03275389|62899510|FG009|Overall Study|Lost to Follow-up|14|||
33615311|NCT01583374|63016265|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
33453549|NCT00145470|62828103|FG000|Overall Study|Withdrawal by Subject|36|||
33453550|NCT00145470|62828104|FG001|Overall Study|Withdrawal by Subject|34|||
33453551|NCT00145470|62828103|FG000|Overall Study|Lost to Follow-up|21|||
33453552|NCT00145470|62828104|FG001|Overall Study|Lost to Follow-up|17|||
33615312|NCT01583374|63016266|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
33615313|NCT01583374|63016267|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
33453553|NCT00145470|62828103|FG000|Overall Study|Reason Not Reported|9|||
33453554|NCT00145470|62828104|FG001|Overall Study|Reason Not Reported|9|||
33453555|NCT00152516|62828110|FG000|Overall Study|Adverse Event|18|||
33615314|NCT01583374|63016268|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
33615315|NCT01583374|63016269|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
33324667|NCT01119066|62701246|FG001|Overall Study|Withdrawal by Subject|6|||
33324668|NCT01119066|62701247|FG002|Overall Study|Withdrawal by Subject|0|||
33453556|NCT00152516|62828110|FG000|Overall Study|Lack and Loss of Efficacy|30|||
33453557|NCT00152516|62828110|FG000|Overall Study|Lost to Follow-up|5|||
33453558|NCT00152516|62828110|FG000|Overall Study|Withdrawal by Subject|8|||
33453559|NCT00152516|62828110|FG000|Overall Study|Protocol Violation|3|||
33453560|NCT00152516|62828110|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
33324669|NCT01119066|62701248|FG003|Overall Study|Withdrawal by Subject|0|||
33324670|NCT01119066|62701245|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
33324671|NCT01119066|62701246|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
33324672|NCT01119066|62701247|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
33324673|NCT01119066|62701248|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
33324674|NCT01119066|62701245|FG000|Overall Study|Relapse identified before transplant|1|||
33453561|NCT00152516|62828110|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
33453562|NCT00152516|62828110|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
33515022|NCT03275389|62899501|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33515023|NCT03275389|62899502|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33453563|NCT00152516|62828110|FG000|Overall Study|Other: Non-Compliance|2|||
33453564|NCT00152516|62828110|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
33453565|NCT00152516|62828110|FG000|Overall Study|Other: Moved Out Of State|1|||
33453566|NCT00152516|62828110|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
33453567|NCT00152516|62828110|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
33453568|NCT00145158|62828116|FG000|Overall Study|premature withdrawal|2|||
33453569|NCT00145158|62828117|FG001|Overall Study|premature withdrawal|3|||
33453570|NCT00150800|62828124|FG000|Overall Study|Adverse Event|89|||
33453571|NCT00150800|62828124|FG000|Overall Study|Death|18|||
33453572|NCT00150800|62828124|FG000|Overall Study|Lack of Efficacy|166|||
33453573|NCT00150800|62828124|FG000|Overall Study|Lost to Follow-up|58|||
33453574|NCT00150800|62828124|FG000|Overall Study|Subject's choice|90|||
33453575|NCT00150800|62828124|FG000|Overall Study|No compliance|18|||
33453576|NCT00150800|62828124|FG000|Overall Study|IP misshandling|1|||
33453577|NCT00150800|62828124|FG000|Overall Study|Site closure|24|||
33453578|NCT00150800|62828124|FG000|Overall Study|Protocol non-adherence|2|||
33515024|NCT03275389|62899503|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33515025|NCT03275389|62899504|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33515026|NCT03275389|62899505|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33515027|NCT03275389|62899506|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
33515028|NCT03275389|62899507|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33515029|NCT03275389|62899508|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33515030|NCT03275389|62899509|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33515031|NCT03275389|62899510|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
33515032|NCT03275389|62899501|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
33515033|NCT03275389|62899502|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33515034|NCT03275389|62899503|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33515035|NCT03275389|62899504|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
33515036|NCT03275389|62899505|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
33515037|NCT03275389|62899506|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
33515038|NCT03275389|62899507|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
33515039|NCT03275389|62899508|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
33515040|NCT03275389|62899509|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
33515041|NCT03275389|62899510|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
33515042|NCT03275389|62899501|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33515043|NCT03275389|62899502|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
33615316|NCT01583374|63016270|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
33615317|NCT01583374|63016271|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
33615318|NCT01583374|63016263|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
33615319|NCT01583374|63016264|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
33615320|NCT01583374|63016265|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
33615321|NCT01583374|63016266|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
33615322|NCT01583374|63016267|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
33615323|NCT01583374|63016268|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
33615324|NCT01583374|63016269|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
33615325|NCT01583374|63016270|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
33615326|NCT01583374|63016271|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
33615327|NCT01583374|63016263|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
33615328|NCT01583374|63016264|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
33615329|NCT01583374|63016265|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
33615330|NCT01583374|63016266|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
33615331|NCT01583374|63016267|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
33615332|NCT01583374|63016268|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
33453579|NCT00150800|62828124|FG000|Overall Study|Nobody to accompany patient|1|||
33453580|NCT00150800|62828124|FG000|Overall Study|Distance too long for patient|1|||
33453581|NCT00150800|62828124|FG000|Overall Study|Neurosurgery|2|||
33453582|NCT00150800|62828124|FG000|Overall Study|BRV monotherapy|1|||
33453583|NCT00150800|62828124|FG000|Overall Study|Visit refusal|3|||
33453584|NCT00150800|62828124|FG000|Overall Study|Sponsor's request|2|||
33453585|NCT00150800|62828124|FG000|Overall Study|Generalized Epilepsy|1|||
33453586|NCT00150800|62828124|FG000|Overall Study|Moved from area/country|8|||
33515044|NCT03275389|62899503|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33515045|NCT03275389|62899504|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
33453587|NCT00150800|62828124|FG000|Overall Study|PI retiring|2|||
33453588|NCT00150800|62828124|FG000|Overall Study|PI leaving site|2|||
33453589|NCT00150800|62828124|FG000|Overall Study|Patient insurance|1|||
33515046|NCT03275389|62899505|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33324675|NCT01119066|62701246|FG001|Overall Study|Relapse identified before transplant|0|||
33515047|NCT03275389|62899506|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33515048|NCT03275389|62899507|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33515049|NCT03275389|62899508|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33515050|NCT03275389|62899509|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33515051|NCT03275389|62899510|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33515052|NCT03275389|62899501|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33515053|NCT03275389|62899502|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33515054|NCT03275389|62899503|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
33515055|NCT03275389|62899504|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33515056|NCT03275389|62899505|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33515057|NCT03275389|62899506|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33515058|NCT03275389|62899507|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33515059|NCT03275389|62899508|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33515060|NCT03275389|62899509|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33515061|NCT03275389|62899510|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
33515062|NCT03275389|62899501|FG000|Overall Study|Other|0|||
33515063|NCT03275389|62899502|FG001|Overall Study|Other|4|||
33515064|NCT03275389|62899503|FG002|Overall Study|Other|3|||
33515065|NCT03275389|62899504|FG003|Overall Study|Other|2|||
33515066|NCT03275389|62899505|FG004|Overall Study|Other|2|||
33515067|NCT03275389|62899506|FG005|Overall Study|Other|2|||
33515068|NCT03275389|62899507|FG006|Overall Study|Other|0|||
33515069|NCT03275389|62899508|FG007|Overall Study|Other|0|||
33515070|NCT03275389|62899509|FG008|Overall Study|Other|1|||
33515071|NCT03275389|62899510|FG009|Overall Study|Other|0|||
33515072|NCT03414983|62899534|FG000|Pre-Treatment|Other reasons|1|||
33515073|NCT03414983|62899535|FG001|Pre-Treatment|Other reasons|0|||
33515074|NCT03414983|62899534|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
33515075|NCT03414983|62899535|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
33515076|NCT03414983|62899534|FG000|Pre-Treatment|Participant withdrew consent|1|||
33515077|NCT03414983|62899535|FG001|Pre-Treatment|Participant withdrew consent|3|||
33515078|NCT03414983|62899534|FG000|Treatment|Participant withdrew consent|4|||
33515079|NCT03414983|62899535|FG001|Treatment|Participant withdrew consent|3|||
33515080|NCT03414983|62899534|FG000|Treatment|Participant request to discontinue study treatment|8|||
33515081|NCT03414983|62899535|FG001|Treatment|Participant request to discontinue study treatment|10|||
33515082|NCT03414983|62899534|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
33515083|NCT03414983|62899535|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
33515084|NCT03414983|62899534|FG000|Treatment|Death|0|||
33453590|NCT00150800|62828124|FG000|Overall Study|Surgical intervention|4|||
33515085|NCT03414983|62899535|FG001|Treatment|Death|2|||
33515086|NCT03414983|62899534|FG000|Treatment|Study Drug Toxicity|11|||
33515087|NCT03414983|62899535|FG001|Treatment|Study Drug Toxicity|4|||
33515088|NCT03414983|62899534|FG000|Treatment|Disease Progression|72|||
33515089|NCT03414983|62899535|FG001|Treatment|Disease Progression|27|||
33515090|NCT03414983|62899534|FG000|Treatment|Not reported|1|||
33515091|NCT03414983|62899535|FG001|Treatment|Not reported|0|||
33615333|NCT01583374|63016269|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
33615334|NCT01583374|63016270|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
33453591|NCT00150800|62828124|FG000|Overall Study|Pregnancy planned|1|||
33453592|NCT00150800|62828124|FG000|Overall Study|PI discontinuation request|1|||
33453593|NCT00144300|62828131|FG000|Overall Study|Adverse Event|18|||
33453594|NCT00144300|62828132|FG001|Overall Study|Adverse Event|16|||
33453595|NCT00144300|62828131|FG000|Overall Study|Protocol Violation|1|||
33515092|NCT03414983|62899534|FG000|Treatment|Other reasons|3|||
33515093|NCT03414983|62899535|FG001|Treatment|Other reasons|2|||
33515094|NCT03414983|62899534|FG000|Treatment|Completed treatment as per protocol|8|||
33515095|NCT03414983|62899535|FG001|Treatment|Completed treatment as per protocol|0|||
33515096|NCT03414983|62899534|FG000|Treatment|Poor/non-compliance|2|||
33515097|NCT03414983|62899535|FG001|Treatment|Poor/non-compliance|0|||
33515098|NCT03414983|62899534|FG000|Treatment|Maximum clinical benefit|5|||
33453596|NCT00144300|62828132|FG001|Overall Study|Protocol Violation|3|||
33453597|NCT00144300|62828131|FG000|Overall Study|Lost to Follow-up|3|||
33453598|NCT00144300|62828132|FG001|Overall Study|Lost to Follow-up|0|||
33453599|NCT00144300|62828131|FG000|Overall Study|Withdrawal by Subject|6|||
33515099|NCT03414983|62899535|FG001|Treatment|Maximum clinical benefit|9|||
33515100|NCT03414983|62899534|FG000|Treatment|Lost to Follow-up|0|||
33515101|NCT03414983|62899535|FG001|Treatment|Lost to Follow-up|1|||
33515102|NCT03414359|62899543|FG000|Overall Study|Lack of Efficacy|1|||
33515103|NCT03414359|62899544|FG001|Overall Study|Lack of Efficacy|1|||
33515104|NCT03414359|62899543|FG000|Overall Study|Protocol Violation|0|||
33515105|NCT03414359|62899544|FG001|Overall Study|Protocol Violation|1|||
33515106|NCT03285295|62899555|FG000|Alinity s HBsAg|Protocol Violation|11|||
33515107|NCT03285295|62899556|FG001|Alinity s HBsAg|Protocol Violation|0|||
33515108|NCT03285295|62899557|FG002|Alinity s HBsAg|Protocol Violation|0|||
33515109|NCT03285295|62899558|FG003|Alinity s HBsAg|Protocol Violation|0|||
33515110|NCT03285295|62899559|FG004|Alinity s HBsAg|Protocol Violation|0|||
33515111|NCT03285295|62899555|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
33515112|NCT03285295|62899556|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
33515113|NCT03285295|62899557|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
33515114|NCT03285295|62899558|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
33515115|NCT03285295|62899559|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
33515116|NCT03285295|62899555|FG000|Alinity s HBsAg|No Results Generated|74|||
33515117|NCT03285295|62899556|FG001|Alinity s HBsAg|No Results Generated|6|||
33515118|NCT03285295|62899557|FG002|Alinity s HBsAg|No Results Generated|0|||
33515119|NCT03285295|62899558|FG003|Alinity s HBsAg|No Results Generated|0|||
33515120|NCT03285295|62899559|FG004|Alinity s HBsAg|No Results Generated|0|||
33515121|NCT03285295|62899555|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
33515122|NCT03285295|62899556|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
33515123|NCT03285295|62899557|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
33515124|NCT03285295|62899558|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
33515125|NCT03285295|62899559|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
33515126|NCT03285295|62899555|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
33515127|NCT03285295|62899556|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
33515128|NCT03285295|62899557|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
33515129|NCT03285295|62899558|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
33515130|NCT03285295|62899559|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
33515131|NCT03285295|62899555|FG000|Alinity s HTLV I/II|No Results Generated|70|||
33515132|NCT03285295|62899556|FG001|Alinity s HTLV I/II|No Results Generated|0|||
33515133|NCT03285295|62899557|FG002|Alinity s HTLV I/II|No Results Generated|0|||
33515134|NCT03285295|62899558|FG003|Alinity s HTLV I/II|No Results Generated|0|||
33515135|NCT03285295|62899559|FG004|Alinity s HTLV I/II|No Results Generated|0|||
33515136|NCT03285295|62899555|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
33515137|NCT03285295|62899556|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
33515138|NCT03285295|62899557|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
33515139|NCT03285295|62899558|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
33515140|NCT03285295|62899559|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
33515141|NCT03285295|62899555|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
33515142|NCT03285295|62899556|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
33515143|NCT03285295|62899557|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
33515144|NCT03285295|62899558|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
33515145|NCT03285295|62899559|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
33515146|NCT03285295|62899555|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
33515147|NCT03285295|62899556|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
33515148|NCT03285295|62899557|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
33515149|NCT03285295|62899558|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
33515150|NCT03285295|62899559|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
33515151|NCT03285295|62899555|FG000|Alinity s Anti-HCV|No Results Generated|71|||
33515152|NCT03285295|62899556|FG001|Alinity s Anti-HCV|No Results Generated|0|||
33615335|NCT01583374|63016271|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
33615336|NCT01583374|63016263|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
33615337|NCT01583374|63016264|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
33615338|NCT01583374|63016265|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
33615339|NCT01583374|63016266|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
33615340|NCT01583374|63016267|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
33615341|NCT01583374|63016268|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
33615342|NCT01583374|63016269|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
33615343|NCT01583374|63016270|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
33515153|NCT03285295|62899557|FG002|Alinity s Anti-HCV|No Results Generated|0|||
33515154|NCT03285295|62899558|FG003|Alinity s Anti-HCV|No Results Generated|0|||
33515155|NCT03285295|62899559|FG004|Alinity s Anti-HCV|No Results Generated|0|||
33515156|NCT03285295|62899555|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
33615344|NCT01583374|63016271|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
33615345|NCT01583374|63016263|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
33615346|NCT01583374|63016264|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
33615347|NCT01583374|63016265|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
33615348|NCT01583374|63016266|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
33615349|NCT01583374|63016267|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
33615350|NCT01583374|63016268|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
33615351|NCT01583374|63016269|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
33615352|NCT01583374|63016270|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
33615353|NCT01583374|63016271|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
33615354|NCT01583296|63016292|FG000|Overall Study|Withdrawal by Subject|11|||
33615355|NCT01583296|63016293|FG001|Overall Study|Withdrawal by Subject|10|||
33615356|NCT02222714|63016304|FG000|Overall Study|Death|0|||
33615357|NCT02222714|63016305|FG001|Overall Study|Death|2|||
33615358|NCT02222714|63016306|FG002|Overall Study|Death|3|||
33615359|NCT02222714|63016307|FG003|Overall Study|Death|4|||
33615360|NCT02222714|63016308|FG004|Overall Study|Death|6|||
33615361|NCT02222714|63016304|FG000|Overall Study|Withdrawal by Subject|0|||
33615362|NCT02222714|63016305|FG001|Overall Study|Withdrawal by Subject|0|||
33515157|NCT03285295|62899556|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
33515158|NCT03285295|62899557|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
33515159|NCT03285295|62899558|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
33515160|NCT03285295|62899559|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
33515161|NCT03285295|62899555|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
33515162|NCT03285295|62899556|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
33515163|NCT03285295|62899557|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
33515164|NCT03285295|62899558|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
33515165|NCT03285295|62899559|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
33515166|NCT03285295|62899555|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
33515167|NCT03285295|62899556|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
33515168|NCT03285295|62899557|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
33615363|NCT02222714|63016306|FG002|Overall Study|Withdrawal by Subject|1|||
33615364|NCT02222714|63016307|FG003|Overall Study|Withdrawal by Subject|0|||
33615365|NCT02222714|63016308|FG004|Overall Study|Withdrawal by Subject|1|||
33615366|NCT02164916|63016325|FG000|Overall Study|Adverse Event|3|||
33615367|NCT02164916|63016326|FG001|Overall Study|Adverse Event|8|||
33515169|NCT03285295|62899558|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
33515170|NCT03285295|62899559|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
33515171|NCT03285295|62899555|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
33515172|NCT03285295|62899556|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
33515173|NCT03285295|62899557|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
33515174|NCT03285295|62899558|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
33515175|NCT03285295|62899559|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
33515176|NCT03285295|62899555|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
33615368|NCT02164916|63016325|FG000|Overall Study|Death|1|||
33615369|NCT02164916|63016326|FG001|Overall Study|Death|1|||
33515177|NCT03285295|62899556|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
33515178|NCT03285295|62899557|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
33515179|NCT03285295|62899558|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
33515180|NCT03285295|62899559|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
33515181|NCT03285295|62899555|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
33515182|NCT03285295|62899556|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
33515183|NCT03285295|62899557|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
33515184|NCT03285295|62899558|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
33515185|NCT03285295|62899559|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
33515186|NCT03285295|62899555|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
33515187|NCT03285295|62899556|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
33515188|NCT03285295|62899557|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
33515189|NCT03285295|62899558|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
33515190|NCT03285295|62899559|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
33515191|NCT03285295|62899555|FG000|Alinity s Anti-HBc|No Results Generated|70|||
33515192|NCT03285295|62899556|FG001|Alinity s Anti-HBc|No Results Generated|0|||
33515193|NCT03285295|62899557|FG002|Alinity s Anti-HBc|No Results Generated|0|||
33515194|NCT03285295|62899558|FG003|Alinity s Anti-HBc|No Results Generated|0|||
33515195|NCT03285295|62899559|FG004|Alinity s Anti-HBc|No Results Generated|0|||
33515196|NCT03285295|62899555|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
33515197|NCT03285295|62899556|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
33515198|NCT03285295|62899557|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
33515199|NCT03285295|62899558|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
33515200|NCT03285295|62899559|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
33515201|NCT03285295|62899555|FG000|Alinity s Chagas|Protocol Violation|76|||
33515202|NCT03285295|62899556|FG001|Alinity s Chagas|Protocol Violation|0|||
33515203|NCT03285295|62899557|FG002|Alinity s Chagas|Protocol Violation|0|||
33515204|NCT03285295|62899558|FG003|Alinity s Chagas|Protocol Violation|0|||
33515205|NCT03285295|62899559|FG004|Alinity s Chagas|Protocol Violation|0|||
33515206|NCT03285295|62899555|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
33515207|NCT03285295|62899556|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
33515208|NCT03285295|62899557|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
33515209|NCT03285295|62899558|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
33515210|NCT03285295|62899559|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
33515211|NCT03285295|62899555|FG000|Alinity s Chagas|No Results Generated|105|||
33515212|NCT03285295|62899556|FG001|Alinity s Chagas|No Results Generated|0|||
33515213|NCT03285295|62899557|FG002|Alinity s Chagas|No Results Generated|0|||
33515214|NCT03285295|62899558|FG003|Alinity s Chagas|No Results Generated|0|||
33515215|NCT03285295|62899559|FG004|Alinity s Chagas|No Results Generated|0|||
33515216|NCT03285295|62899555|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
33515217|NCT03285295|62899556|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
33515218|NCT03285295|62899557|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
33515219|NCT03285295|62899558|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
33515220|NCT03285295|62899559|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
33515221|NCT02583048|62899591|FG000|Overall Study|Withdrawal by Subject|0|||
33515222|NCT02583048|62899592|FG001|Overall Study|Withdrawal by Subject|1|||
33515223|NCT02583048|62899593|FG002|Overall Study|Withdrawal by Subject|0|||
33515224|NCT02583048|62899591|FG000|Overall Study|Failed to meet eligibility criterion|0|||
33515225|NCT02583048|62899592|FG001|Overall Study|Failed to meet eligibility criterion|0|||
33515226|NCT02583048|62899593|FG002|Overall Study|Failed to meet eligibility criterion|1|||
33515227|NCT02939599|62899606|FG000|Overall Study|Adverse Event|1|||
33515228|NCT02939599|62899607|FG001|Overall Study|Adverse Event|0|||
33515229|NCT02939599|62899606|FG000|Overall Study|Study Terminated By Sponsor|2|||
33515230|NCT02939599|62899607|FG001|Overall Study|Study Terminated By Sponsor|2|||
33515231|NCT01318512|62899614|FG000|Maintenance Period (6 Months)|Death|2|||
33515232|NCT01318512|62899614|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
33515233|NCT03274687|62899635|FG000|Overall Study|Protocol Violation|1|||
33515234|NCT03274687|62899636|FG001|Overall Study|Protocol Violation|1|||
33515235|NCT04651218|62899642|FG000|Overall Study|Withdrawal by Subject|0|||
33515236|NCT04651218|62899643|FG001|Overall Study|Withdrawal by Subject|2|||
33515237|NCT03274453|62899653|FG000|Overall Study|Lost to Follow-up|2|||
33515238|NCT03274453|62899654|FG001|Overall Study|Lost to Follow-up|5|||
33515239|NCT03274453|62899655|FG002|Overall Study|Lost to Follow-up|4|||
33515240|NCT03274453|62899656|FG003|Overall Study|Lost to Follow-up|1|||
33515241|NCT03274453|62899653|FG000|Overall Study|Physician Decision|2|||
33515242|NCT03274453|62899654|FG001|Overall Study|Physician Decision|0|||
33515243|NCT03274453|62899655|FG002|Overall Study|Physician Decision|0|||
33515244|NCT03274453|62899656|FG003|Overall Study|Physician Decision|3|||
33515245|NCT03274453|62899653|FG000|Overall Study|Surgery Cancelled|0|||
33515246|NCT03274453|62899654|FG001|Overall Study|Surgery Cancelled|1|||
33515247|NCT03274453|62899655|FG002|Overall Study|Surgery Cancelled|0|||
33515248|NCT03274453|62899656|FG003|Overall Study|Surgery Cancelled|0|||
33515249|NCT03273907|62899666|FG000|Overall Study|Death|1|||
33515250|NCT03273907|62899666|FG000|Overall Study|Lost to Follow-up|4|||
33515251|NCT03273907|62899666|FG000|Overall Study|Withdrawal by Subject|2|||
33515252|NCT03273907|62899666|FG000|Overall Study|COVID 19|2|||
33515253|NCT00659646|62899688|FG000|Overall Study|Protocol Violation|12|||
33515254|NCT00659646|62899689|FG001|Overall Study|Protocol Violation|8|||
33515255|NCT00659646|62899688|FG000|Overall Study|Adverse Event|1|||
33515256|NCT00659646|62899689|FG001|Overall Study|Adverse Event|0|||
33515257|NCT00659646|62899688|FG000|Overall Study|Lost to Follow-up|1|||
33515258|NCT00659646|62899689|FG001|Overall Study|Lost to Follow-up|0|||
33515259|NCT00659646|62899688|FG000|Overall Study|protocol noncompliance after randomized|1|||
33515260|NCT00659646|62899689|FG001|Overall Study|protocol noncompliance after randomized|0|||
33515261|NCT02236572|62899697|FG000|Overall Study|Withdrawal by Subject|1|||
33515262|NCT02236572|62899697|FG000|Overall Study|Protocol Violation|1|||
33515263|NCT02236572|62899697|FG000|Overall Study|Lost to Follow-up|1|||
33515264|NCT03054870|62899701|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
33515265|NCT03054870|62899701|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
33515266|NCT03414047|62899720|FG000|Overall Study|Adverse Event|0|||
33515267|NCT03414047|62899721|FG001|Overall Study|Adverse Event|0|||
33515268|NCT03414047|62899722|FG002|Overall Study|Adverse Event|1|||
33515269|NCT03414047|62899723|FG003|Overall Study|Adverse Event|1|||
33515270|NCT03414047|62899720|FG000|Overall Study|Physician Decision|1|||
33515271|NCT03414047|62899721|FG001|Overall Study|Physician Decision|0|||
33515272|NCT03414047|62899722|FG002|Overall Study|Physician Decision|0|||
33515273|NCT03414047|62899723|FG003|Overall Study|Physician Decision|1|||
33515274|NCT03414047|62899720|FG000|Overall Study|Withdrawal by Subject|1|||
33515275|NCT03414047|62899721|FG001|Overall Study|Withdrawal by Subject|0|||
33515276|NCT03414047|62899722|FG002|Overall Study|Withdrawal by Subject|2|||
33515277|NCT03414047|62899723|FG003|Overall Study|Withdrawal by Subject|0|||
33515278|NCT03351335|62899737|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
33515279|NCT03351335|62899738|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
33515280|NCT03351335|62899739|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
33515281|NCT03055806|62899751|FG000|Overall Study|Adverse Event|0|||
33515282|NCT03055806|62899752|FG001|Overall Study|Adverse Event|0|||
33515283|NCT03055806|62899753|FG002|Overall Study|Adverse Event|1|||
33515284|NCT03055806|62899754|FG003|Overall Study|Adverse Event|1|||
33515285|NCT03055806|62899751|FG000|Overall Study|Lost to Follow-up|0|||
33515286|NCT03055806|62899752|FG001|Overall Study|Lost to Follow-up|3|||
33515287|NCT03055806|62899753|FG002|Overall Study|Lost to Follow-up|6|||
33515288|NCT03055806|62899754|FG003|Overall Study|Lost to Follow-up|7|||
33515289|NCT03055806|62899751|FG000|Overall Study|Physician Decision|1|||
33515290|NCT03055806|62899752|FG001|Overall Study|Physician Decision|0|||
33515291|NCT03055806|62899753|FG002|Overall Study|Physician Decision|0|||
33515292|NCT03055806|62899754|FG003|Overall Study|Physician Decision|1|||
33515293|NCT03055806|62899751|FG000|Overall Study|Protocol Violation|1|||
33515294|NCT03055806|62899752|FG001|Overall Study|Protocol Violation|0|||
33515295|NCT03055806|62899753|FG002|Overall Study|Protocol Violation|0|||
33515296|NCT03055806|62899754|FG003|Overall Study|Protocol Violation|0|||
33515297|NCT03055806|62899751|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
33515298|NCT03055806|62899752|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
33515299|NCT03055806|62899753|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
33515300|NCT03055806|62899754|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
33515301|NCT03055806|62899751|FG000|Overall Study|Withdrawal of consent to continue study|2|||
33515302|NCT03055806|62899752|FG001|Overall Study|Withdrawal of consent to continue study|3|||
33515303|NCT03055806|62899753|FG002|Overall Study|Withdrawal of consent to continue study|4|||
33515304|NCT03055806|62899754|FG003|Overall Study|Withdrawal of consent to continue study|6|||
33515305|NCT03055806|62899751|FG000|Overall Study|Partner not willing to try intercourse|1|||
33515306|NCT03055806|62899752|FG001|Overall Study|Partner not willing to try intercourse|0|||
33515307|NCT03055806|62899753|FG002|Overall Study|Partner not willing to try intercourse|0|||
33515308|NCT03055806|62899754|FG003|Overall Study|Partner not willing to try intercourse|0|||
33515309|NCT04620798|62899766|FG000|Overall Study|Lost to Follow-up|126|||
33515310|NCT04620798|62899767|FG001|Overall Study|Lost to Follow-up|138|||
33515311|NCT03052764|62899775|FG000|Double-Blind Treatment Period|Adverse Event|2|||
33515312|NCT03052764|62899776|FG001|Double-Blind Treatment Period|Adverse Event|0|||
33515313|NCT03052764|62899775|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
33515314|NCT03052764|62899776|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
33515315|NCT03052764|62899775|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
33515316|NCT03052764|62899776|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
33515317|NCT03052764|62899775|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
33515318|NCT03052764|62899776|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33515319|NCT03052764|62899775|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
33515320|NCT03052764|62899776|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
33515321|NCT02951819|62899786|FG000|Overall Study|Death|9|||
33515322|NCT02951819|62899787|FG001|Overall Study|Death|7|||
33515323|NCT02951819|62899786|FG000|Overall Study|Withdrawal by Subject|3|||
33515324|NCT02951819|62899787|FG001|Overall Study|Withdrawal by Subject|0|||
33515325|NCT02951819|62899786|FG000|Overall Study|Adverse Event|1|||
33515326|NCT02951819|62899787|FG001|Overall Study|Adverse Event|0|||
33515327|NCT02951819|62899786|FG000|Overall Study|Lack of Efficacy|4|||
33515328|NCT02951819|62899787|FG001|Overall Study|Lack of Efficacy|0|||
33515329|NCT02951819|62899786|FG000|Overall Study|Lost to Follow-up|1|||
33515330|NCT02951819|62899787|FG001|Overall Study|Lost to Follow-up|0|||
33515331|NCT02951819|62899786|FG000|Overall Study|Progressive Disease|1|||
33515332|NCT02951819|62899787|FG001|Overall Study|Progressive Disease|0|||
33515333|NCT02951819|62899786|FG000|Overall Study|Other|9|||
33515334|NCT02951819|62899787|FG001|Overall Study|Other|0|||
33515335|NCT03383783|62899793|FG000|Overall Study|Withdrawal by Subject|2|||
33515336|NCT03334721|62899811|FG000|Overall Study|Withdrawal by Subject|1|||
33515337|NCT03334721|62899812|FG001|Overall Study|Withdrawal by Subject|0|||
33515338|NCT03334721|62899811|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
33515339|NCT03334721|62899812|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
33515340|NCT03515551|62899825|FG000|Overall Study|Death|4|||
33515341|NCT03515551|62899826|FG001|Overall Study|Death|1|||
33515342|NCT03515551|62899827|FG002|Overall Study|Death|2|||
33515343|NCT03515551|62899828|FG003|Overall Study|Death|2|||
33515344|NCT03515551|62899829|FG004|Overall Study|Death|2|||
33515345|NCT03515551|62899830|FG005|Overall Study|Death|4|||
33515346|NCT03515551|62899831|FG006|Overall Study|Death|1|||
33515347|NCT03515551|62899825|FG000|Overall Study|Lost to Follow-up|0|||
33515348|NCT03515551|62899826|FG001|Overall Study|Lost to Follow-up|0|||
33515349|NCT03515551|62899827|FG002|Overall Study|Lost to Follow-up|1|||
33515350|NCT03515551|62899828|FG003|Overall Study|Lost to Follow-up|0|||
33515351|NCT03515551|62899829|FG004|Overall Study|Lost to Follow-up|0|||
33515352|NCT03515551|62899830|FG005|Overall Study|Lost to Follow-up|0|||
33515353|NCT03515551|62899831|FG006|Overall Study|Lost to Follow-up|0|||
33515354|NCT03515551|62899825|FG000|Overall Study|Withdrawal by Subject|0|||
33515355|NCT03515551|62899826|FG001|Overall Study|Withdrawal by Subject|1|||
33515356|NCT03515551|62899827|FG002|Overall Study|Withdrawal by Subject|0|||
33515357|NCT03515551|62899828|FG003|Overall Study|Withdrawal by Subject|0|||
33515358|NCT03515551|62899829|FG004|Overall Study|Withdrawal by Subject|0|||
33453600|NCT00144300|62828132|FG001|Overall Study|Withdrawal by Subject|6|||
33453601|NCT00144300|62828131|FG000|Overall Study|Other reason (not specified)|1|||
33453602|NCT00144300|62828132|FG001|Overall Study|Other reason (not specified)|3|||
33453603|NCT00149630|62828140|FG000|Overall Study|Incarceration|2|||
33453604|NCT00149630|62828141|FG001|Overall Study|Incarceration|0|||
33453605|NCT00149630|62828140|FG000|Overall Study|Treatment Programs|4|||
33453606|NCT00149630|62828141|FG001|Overall Study|Treatment Programs|5|||
33453607|NCT00149630|62828140|FG000|Overall Study|Adverse Event|2|||
33453608|NCT00149630|62828141|FG001|Overall Study|Adverse Event|0|||
33453609|NCT00127842|62828151|FG000|Overall Study|Adverse Event|15|||
33453610|NCT00127842|62828151|FG000|Overall Study|Withdrawal by Subject|3|||
33453611|NCT00127842|62828151|FG000|Overall Study|Lost to Follow-up|1|||
33453612|NCT00127842|62828151|FG000|Overall Study|Lack of Efficacy|12|||
33453613|NCT00127842|62828151|FG000|Overall Study|Noncompliance|2|||
33453614|NCT00127842|62828151|FG000|Overall Study|Protocol Violation|1|||
33453615|NCT00127842|62828151|FG000|Overall Study|Other|5|||
33453616|NCT03720652|62828157|FG000|Overall Study|Withdrawal by Subject|2|||
33453617|NCT03720652|62828158|FG001|Overall Study|Withdrawal by Subject|7|||
33453618|NCT03720652|62828157|FG000|Overall Study|Lost to Follow-up|0|||
33453619|NCT03720652|62828158|FG001|Overall Study|Lost to Follow-up|4|||
33453620|NCT00112866|62828168|FG000|Overall Study|Protocol Violation|1|||
33453621|NCT00112866|62828169|FG001|Overall Study|Protocol Violation|0|||
33453622|NCT00112866|62828168|FG000|Overall Study|did not start treatment post-op|1|||
33453623|NCT00112866|62828169|FG001|Overall Study|did not start treatment post-op|2|||
33453624|NCT00127608|62828183|FG000|Overall Study|VZV DNA negative|1|||
33453625|NCT00149396|62828187|FG000|Overall Study|Death|15|||
33453626|NCT00149396|62828187|FG000|Overall Study|Withdrawal by Subject|1|||
33453627|NCT00149396|62828187|FG000|Overall Study|Subject noncompliance|2|||
33453628|NCT00149396|62828187|FG000|Overall Study|other treatment|5|||
33453629|NCT00223496|62828198|FG000|Overall Study|screen failure|9|||
33515359|NCT03515551|62899830|FG005|Overall Study|Withdrawal by Subject|0|||
33515360|NCT03515551|62899831|FG006|Overall Study|Withdrawal by Subject|1|||
33453630|NCT00223496|62828198|FG000|Overall Study|Lost to Follow-up|4|||
33453631|NCT00223496|62828198|FG000|Overall Study|Lack of Efficacy|6|||
33453632|NCT00223496|62828198|FG000|Overall Study|Withdrawal by Subject|1|||
33453633|NCT00223496|62828198|FG000|Overall Study|Physician Decision|2|||
33453634|NCT00255944|62828204|FG000|Overall Study|Lost to Follow-up|797|||
33453635|NCT00255944|62828205|FG001|Overall Study|Lost to Follow-up|834|||
33515361|NCT03515551|62899825|FG000|Overall Study|Study ended by sponsor|0|||
33515362|NCT03515551|62899826|FG001|Overall Study|Study ended by sponsor|0|||
33515363|NCT03515551|62899827|FG002|Overall Study|Study ended by sponsor|2|||
33515364|NCT03515551|62899828|FG003|Overall Study|Study ended by sponsor|1|||
33515365|NCT03515551|62899829|FG004|Overall Study|Study ended by sponsor|3|||
33515366|NCT03515551|62899830|FG005|Overall Study|Study ended by sponsor|0|||
33515367|NCT03515551|62899831|FG006|Overall Study|Study ended by sponsor|3|||
33515368|NCT03515551|62899825|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
33515369|NCT03515551|62899826|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
33515370|NCT03515551|62899827|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
33615370|NCT02164916|63016325|FG000|Overall Study|Refusal unrelated to adverse event|3|||
33453636|NCT00143598|62828213|FG000|Overall Study|Lost to Follow-up|23|||
33453637|NCT00143598|62828214|FG001|Overall Study|Lost to Follow-up|21|||
33453638|NCT00143598|62828213|FG000|Overall Study|Withdrawal by Subject|33|||
33453639|NCT00143598|62828214|FG001|Overall Study|Withdrawal by Subject|37|||
33515371|NCT03515551|62899828|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
33515372|NCT03515551|62899829|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
33515373|NCT03515551|62899830|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
33515374|NCT03515551|62899831|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
33515375|NCT03380429|62899857|FG000|Overall Study|Physician Decision|0|||
33515376|NCT03380429|62899858|FG001|Overall Study|Physician Decision|1|||
33515377|NCT03380429|62899859|FG002|Overall Study|Physician Decision|0|||
33515378|NCT03380429|62899860|FG003|Overall Study|Physician Decision|1|||
33515379|NCT03380429|62899861|FG004|Overall Study|Physician Decision|1|||
33515380|NCT03380429|62899857|FG000|Overall Study|Withdrawal by Subject|3|||
33515381|NCT03380429|62899858|FG001|Overall Study|Withdrawal by Subject|3|||
33515382|NCT03380429|62899859|FG002|Overall Study|Withdrawal by Subject|5|||
33515383|NCT03380429|62899860|FG003|Overall Study|Withdrawal by Subject|2|||
33515384|NCT03380429|62899861|FG004|Overall Study|Withdrawal by Subject|1|||
33515385|NCT03380429|62899857|FG000|Overall Study|Lost to Follow-up|0|||
33515386|NCT03380429|62899858|FG001|Overall Study|Lost to Follow-up|2|||
33515387|NCT03380429|62899859|FG002|Overall Study|Lost to Follow-up|4|||
33515388|NCT03380429|62899860|FG003|Overall Study|Lost to Follow-up|3|||
33515389|NCT03380429|62899861|FG004|Overall Study|Lost to Follow-up|1|||
33515390|NCT03380429|62899857|FG000|Overall Study|Protocol Violation|1|||
33515391|NCT03380429|62899858|FG001|Overall Study|Protocol Violation|0|||
33515392|NCT03380429|62899859|FG002|Overall Study|Protocol Violation|1|||
33515393|NCT03380429|62899860|FG003|Overall Study|Protocol Violation|0|||
33515394|NCT03380429|62899861|FG004|Overall Study|Protocol Violation|1|||
33515395|NCT03380429|62899857|FG000|Overall Study|Lack of Efficacy|0|||
33515396|NCT03380429|62899858|FG001|Overall Study|Lack of Efficacy|0|||
33515397|NCT03380429|62899859|FG002|Overall Study|Lack of Efficacy|0|||
33515398|NCT03380429|62899860|FG003|Overall Study|Lack of Efficacy|2|||
33515399|NCT03380429|62899861|FG004|Overall Study|Lack of Efficacy|1|||
33515400|NCT03380429|62899857|FG000|Overall Study|Adverse Event|1|||
33515401|NCT03380429|62899858|FG001|Overall Study|Adverse Event|1|||
33515402|NCT03380429|62899859|FG002|Overall Study|Adverse Event|1|||
33515403|NCT03380429|62899860|FG003|Overall Study|Adverse Event|2|||
33515404|NCT03380429|62899861|FG004|Overall Study|Adverse Event|0|||
33515405|NCT03280615|62899880|FG000|Overall Study|Lost to Follow-up|1|||
33515406|NCT03280615|62899881|FG001|Overall Study|Lost to Follow-up|2|||
33515407|NCT03280615|62899880|FG000|Overall Study|Adverse Event|1|||
33515408|NCT03280615|62899881|FG001|Overall Study|Adverse Event|1|||
33515409|NCT03280615|62899880|FG000|Overall Study|Withdrawal by Subject|2|||
33515410|NCT03280615|62899881|FG001|Overall Study|Withdrawal by Subject|2|||
33515411|NCT03280537|62899889|FG000|Overall Study|Withdrawal by Subject|2|||
33515412|NCT03280537|62899890|FG001|Overall Study|Withdrawal by Subject|4|||
33453640|NCT00143598|62828213|FG000|Overall Study|Death|36|||
33453641|NCT00143598|62828214|FG001|Overall Study|Death|36|||
33453642|NCT00126672|62828220|FG000|Overall Study|Adverse Event|4|||
33453643|NCT00126672|62828220|FG000|Overall Study|Lost to Follow-up|4|||
33453644|NCT00145574|62828227|FG000|Double Blind|Adverse Event|0|||
33453645|NCT00145574|62828228|FG001|Double Blind|Adverse Event|3|||
33453646|NCT00145574|62828229|FG002|Double Blind|Adverse Event|1|||
33453647|NCT00145574|62828227|FG000|Double Blind|Withdrawal by Subject|1|||
33453648|NCT00145574|62828228|FG001|Double Blind|Withdrawal by Subject|1|||
33453649|NCT00145574|62828229|FG002|Double Blind|Withdrawal by Subject|1|||
33453650|NCT00145574|62828227|FG000|Double Blind|required restricted medicine|0|||
33453651|NCT00145574|62828228|FG001|Double Blind|required restricted medicine|1|||
33515413|NCT03280381|62899898|FG000|Overall Study|Physician Decision|0|||
33515414|NCT03280381|62899899|FG001|Overall Study|Physician Decision|2|||
33515415|NCT03270085|62899908|FG000|Overall Study|Withdrawal by Subject|1|||
33515416|NCT03270085|62899909|FG001|Overall Study|Withdrawal by Subject|0|||
33453652|NCT00145574|62828229|FG002|Double Blind|required restricted medicine|0|||
33453653|NCT00145574|62828227|FG000|Open Label Long-term Extension|Adverse Event|0|||
33453654|NCT00145574|62828228|FG001|Open Label Long-term Extension|Adverse Event|0|||
33515417|NCT03267511|62899919|FG000|Overall Study|Lost to Follow-up|0|||
33515418|NCT03267511|62899920|FG001|Overall Study|Lost to Follow-up|0|||
33515419|NCT03267511|62899921|FG002|Overall Study|Lost to Follow-up|0|||
33515420|NCT03267511|62899922|FG003|Overall Study|Lost to Follow-up|1|||
33515421|NCT03379259|62899949|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
33515422|NCT03379259|62899950|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
33515423|NCT03379259|62899951|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
33515424|NCT03379259|62899952|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
33515425|NCT03379259|62899953|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
33515426|NCT03379259|62899954|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
33515427|NCT03379259|62899949|FG000|Overall Study|Death|0|||
33515428|NCT03379259|62899950|FG001|Overall Study|Death|1|||
33515429|NCT03379259|62899951|FG002|Overall Study|Death|2|||
33515430|NCT03379259|62899952|FG003|Overall Study|Death|1|||
33515431|NCT03379259|62899953|FG004|Overall Study|Death|4|||
33515432|NCT03379259|62899954|FG005|Overall Study|Death|2|||
33515433|NCT03379259|62899949|FG000|Overall Study|Withdrawal by Subject|0|||
33515434|NCT03379259|62899950|FG001|Overall Study|Withdrawal by Subject|0|||
33515435|NCT03379259|62899951|FG002|Overall Study|Withdrawal by Subject|1|||
33515436|NCT03379259|62899952|FG003|Overall Study|Withdrawal by Subject|0|||
33515437|NCT03379259|62899953|FG004|Overall Study|Withdrawal by Subject|2|||
33515438|NCT03379259|62899954|FG005|Overall Study|Withdrawal by Subject|0|||
33515439|NCT03379259|62899949|FG000|Overall Study|Study terminated by sponsor|0|||
33515440|NCT03379259|62899950|FG001|Overall Study|Study terminated by sponsor|0|||
33515441|NCT03379259|62899951|FG002|Overall Study|Study terminated by sponsor|0|||
33515442|NCT03379259|62899952|FG003|Overall Study|Study terminated by sponsor|1|||
33515443|NCT03379259|62899953|FG004|Overall Study|Study terminated by sponsor|1|||
33515444|NCT03379259|62899954|FG005|Overall Study|Study terminated by sponsor|4|||
33615371|NCT02164916|63016326|FG001|Overall Study|Refusal unrelated to adverse event|7|||
33615372|NCT02164916|63016325|FG000|Overall Study|Progression|37|||
33615373|NCT02164916|63016326|FG001|Overall Study|Progression|26|||
33615374|NCT02164916|63016325|FG000|Overall Study|Not protocol specified|5|||
33615375|NCT02164916|63016326|FG001|Overall Study|Not protocol specified|1|||
33453655|NCT00145574|62828229|FG002|Open Label Long-term Extension|Adverse Event|5|||
33515445|NCT03379259|62899949|FG000|Overall Study|Disease progression|0|||
33515446|NCT03379259|62899950|FG001|Overall Study|Disease progression|0|||
33515447|NCT03379259|62899951|FG002|Overall Study|Disease progression|0|||
33515448|NCT03379259|62899952|FG003|Overall Study|Disease progression|1|||
33515449|NCT03379259|62899953|FG004|Overall Study|Disease progression|0|||
33515450|NCT03379259|62899954|FG005|Overall Study|Disease progression|1|||
33515451|NCT03379259|62899949|FG000|Overall Study|Lost to Follow-up|0|||
33515452|NCT03379259|62899950|FG001|Overall Study|Lost to Follow-up|0|||
33515453|NCT03379259|62899951|FG002|Overall Study|Lost to Follow-up|0|||
33515454|NCT03379259|62899952|FG003|Overall Study|Lost to Follow-up|0|||
33515455|NCT03379259|62899953|FG004|Overall Study|Lost to Follow-up|1|||
33515456|NCT03379259|62899954|FG005|Overall Study|Lost to Follow-up|0|||
33515457|NCT03379259|62899949|FG000|Overall Study|Deteriorating condition|0|||
33515458|NCT03379259|62899950|FG001|Overall Study|Deteriorating condition|0|||
33453656|NCT00145574|62828227|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
33453657|NCT00145574|62828228|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
33453658|NCT00145574|62828229|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
33453659|NCT00145574|62828227|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
33453660|NCT00145574|62828228|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
33453661|NCT00145574|62828229|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
33453662|NCT00145574|62828227|FG000|Open Label Long-term Extension|required restricted medicine|0|||
33453663|NCT00145574|62828228|FG001|Open Label Long-term Extension|required restricted medicine|0|||
33453664|NCT00145574|62828229|FG002|Open Label Long-term Extension|required restricted medicine|1|||
33453665|NCT00145496|62828244|FG000|Overall Study|Adverse Event|42|||
33453666|NCT00145496|62828245|FG001|Overall Study|Adverse Event|30|||
33453667|NCT00145496|62828244|FG000|Overall Study|Lack of Efficacy|12|||
33453668|NCT00145496|62828245|FG001|Overall Study|Lack of Efficacy|7|||
33453669|NCT00145496|62828244|FG000|Overall Study|Withdrawal by Subject|32|||
33453670|NCT00145496|62828245|FG001|Overall Study|Withdrawal by Subject|26|||
33453671|NCT00145496|62828244|FG000|Overall Study|Lost to Follow-up|12|||
33453672|NCT00145496|62828245|FG001|Overall Study|Lost to Follow-up|5|||
33453673|NCT00145496|62828244|FG000|Overall Study|Other|25|||
33453674|NCT00145496|62828245|FG001|Overall Study|Other|13|||
33453675|NCT00255164|62828254|FG000|Overall Study|Adverse Event|10|||
33453676|NCT00255164|62828255|FG001|Overall Study|Adverse Event|6|||
33453677|NCT00255164|62828256|FG002|Overall Study|Adverse Event|9|||
33515459|NCT03379259|62899951|FG002|Overall Study|Deteriorating condition|0|||
33515460|NCT03379259|62899952|FG003|Overall Study|Deteriorating condition|0|||
33615376|NCT02164916|63016325|FG000|Overall Study|Reason under review|1|||
33615377|NCT02164916|63016326|FG001|Overall Study|Reason under review|6|||
33615378|NCT02164916|63016325|FG000|Overall Study|Not eligible|2|||
33453678|NCT00255164|62828254|FG000|Overall Study|Lost to Follow-up|4|||
33515461|NCT03379259|62899953|FG004|Overall Study|Deteriorating condition|1|||
33515462|NCT03379259|62899954|FG005|Overall Study|Deteriorating condition|0|||
33515463|NCT03328897|62899974|FG000|Randomized-treatment Epoch|Adverse Event|4|||
33615379|NCT02164916|63016326|FG001|Overall Study|Not eligible|5|||
33453679|NCT00255164|62828255|FG001|Overall Study|Lost to Follow-up|3|||
33515464|NCT03328897|62899975|FG001|Randomized-treatment Epoch|Adverse Event|1|||
33515465|NCT03328897|62899976|FG002|Randomized-treatment Epoch|Adverse Event|1|||
33515466|NCT03328897|62899974|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
33515467|NCT03328897|62899975|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
33515468|NCT03328897|62899976|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
33515469|NCT03328897|62899974|FG000|Randomized-treatment Epoch|Pregnancy|3|||
33515470|NCT03328897|62899975|FG001|Randomized-treatment Epoch|Pregnancy|0|||
33515471|NCT03328897|62899976|FG002|Randomized-treatment Epoch|Pregnancy|0|||
33515472|NCT03328897|62899974|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
33515473|NCT03328897|62899975|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
33515474|NCT03328897|62899976|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
33515475|NCT03328897|62899974|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
33515476|NCT03328897|62899975|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
33515477|NCT03328897|62899976|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
33515478|NCT03328897|62899974|FG000|Follow-up Epoch|Adverse Event|4|||
33515479|NCT03328897|62899975|FG001|Follow-up Epoch|Adverse Event|0|||
33515480|NCT03328897|62899976|FG002|Follow-up Epoch|Adverse Event|1|||
33515481|NCT03328897|62899974|FG000|Follow-up Epoch|Lack of Efficacy|1|||
33515482|NCT03328897|62899975|FG001|Follow-up Epoch|Lack of Efficacy|1|||
33515483|NCT03328897|62899976|FG002|Follow-up Epoch|Lack of Efficacy|1|||
33515484|NCT03328897|62899974|FG000|Follow-up Epoch|Lost to Follow-up|0|||
33515485|NCT03328897|62899975|FG001|Follow-up Epoch|Lost to Follow-up|1|||
33515486|NCT03328897|62899976|FG002|Follow-up Epoch|Lost to Follow-up|0|||
33515487|NCT03328897|62899974|FG000|Follow-up Epoch|Pregnancy|1|||
33515488|NCT03328897|62899975|FG001|Follow-up Epoch|Pregnancy|0|||
33515489|NCT03328897|62899976|FG002|Follow-up Epoch|Pregnancy|0|||
33515490|NCT03328897|62899974|FG000|Follow-up Epoch|Patient/guardian decision|2|||
33515491|NCT03328897|62899975|FG001|Follow-up Epoch|Patient/guardian decision|1|||
33515492|NCT03328897|62899976|FG002|Follow-up Epoch|Patient/guardian decision|0|||
33515493|NCT03266107|62899984|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
33515494|NCT03266107|62899984|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
33515495|NCT03266107|62899984|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
33515496|NCT03266107|62899984|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
33515497|NCT03378635|62899993|FG000|Overall Study|Adverse Event|1|||
33515498|NCT03378635|62899994|FG001|Overall Study|Adverse Event|0|||
33515499|NCT03378635|62899995|FG002|Overall Study|Adverse Event|0|||
33515500|NCT03378635|62899993|FG000|Overall Study|Withdrawal by Subject|1|||
33515501|NCT03378635|62899994|FG001|Overall Study|Withdrawal by Subject|0|||
33515502|NCT03378635|62899995|FG002|Overall Study|Withdrawal by Subject|0|||
33515503|NCT03326869|62900006|FG000|Overall Study|Study data has been lost to natural disa|1|||
33515504|NCT03326869|62900007|FG001|Overall Study|Study data has been lost to natural disa|1|||
33515505|NCT03334409|62900019|FG000|Overall Study|Did not meet inclusion criteria|1|||
33515506|NCT03334409|62900020|FG001|Overall Study|Did not meet inclusion criteria|0|||
33515507|NCT02891915|62900028|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
33515508|NCT02891915|62900029|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
33515509|NCT02891915|62900028|FG000|Overall Study|Withdrawal by Subject|3|||
33515510|NCT02891915|62900029|FG001|Overall Study|Withdrawal by Subject|3|||
33515511|NCT02891915|62900028|FG000|Overall Study|Became Ineligible After Enrollment|2|||
33515512|NCT02891915|62900029|FG001|Overall Study|Became Ineligible After Enrollment|1|||
33515513|NCT02891915|62900028|FG000|Overall Study|Lost to Follow-up|1|||
33515514|NCT02891915|62900029|FG001|Overall Study|Lost to Follow-up|4|||
33515515|NCT02891915|62900028|FG000|Overall Study|Physician Decision|1|||
33515516|NCT02891915|62900029|FG001|Overall Study|Physician Decision|0|||
33515517|NCT02891681|62900038|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
33515518|NCT02891681|62900039|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
33515519|NCT02891681|62900040|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
33515520|NCT02891681|62900038|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
33515521|NCT02891681|62900039|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
33515522|NCT02891681|62900040|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
33515523|NCT02891681|62900038|FG000|Overall Study|Taken off study after first imaging appointment|1|||
33515524|NCT02891681|62900039|FG001|Overall Study|Taken off study after first imaging appointment|0|||
33515525|NCT02891681|62900040|FG002|Overall Study|Taken off study after first imaging appointment|0|||
33515526|NCT04671342|62900048|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
33515527|NCT04671342|62900048|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
33515528|NCT04671342|62900048|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
33515529|NCT04671342|62900048|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
33515530|NCT04671342|62900048|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
33515531|NCT04671342|62900048|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
33515532|NCT03046446|62900052|FG000|Overall Study|Lack of Efficacy|7|||
33515533|NCT03046446|62900052|FG000|Overall Study|Adverse Event|6|||
33515534|NCT03046446|62900052|FG000|Overall Study|Lost to Follow-up|3|||
33615380|NCT02222558|63016337|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
33615381|NCT02222558|63016338|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
33615382|NCT02222558|63016339|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
33615383|NCT02222558|63016340|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
33615384|NCT02222558|63016341|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
33615385|NCT02222558|63016342|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
33615386|NCT02222558|63016337|FG000|Period 3|Withdrawal by Subject|0|||
33615387|NCT02222558|63016338|FG001|Period 3|Withdrawal by Subject|0|||
33615388|NCT02222558|63016339|FG002|Period 3|Withdrawal by Subject|0|||
33615389|NCT02222558|63016340|FG003|Period 3|Withdrawal by Subject|0|||
33615390|NCT02222558|63016341|FG004|Period 3|Withdrawal by Subject|0|||
33615391|NCT02222558|63016342|FG005|Period 3|Withdrawal by Subject|1|||
33615392|NCT02188784|63016358|FG000|Overall Study|Death|3|||
33615393|NCT02188784|63016359|FG001|Overall Study|Death|1|||
33615394|NCT02188784|63016358|FG000|Overall Study|Lost to Follow-up|1|||
33615395|NCT02188784|63016359|FG001|Overall Study|Lost to Follow-up|0|||
33615396|NCT02188784|63016358|FG000|Overall Study|Withdrawal by Subject|3|||
33615397|NCT02188784|63016359|FG001|Overall Study|Withdrawal by Subject|9|||
33615398|NCT02188784|63016358|FG000|Overall Study|Physician Decision|2|||
33615399|NCT02188784|63016359|FG001|Overall Study|Physician Decision|3|||
33615400|NCT02222246|63016382|FG000|Overall Study|No Emergency Department Visits|27|||
33615401|NCT02222246|63016383|FG001|Overall Study|No Emergency Department Visits|26|||
33615402|NCT02222246|63016382|FG000|Overall Study|Physician Decision|0|||
33453680|NCT00255164|62828256|FG002|Overall Study|Lost to Follow-up|4|||
33453681|NCT00255164|62828254|FG000|Overall Study|Withdrawal by Subject|18|||
33453682|NCT00255164|62828255|FG001|Overall Study|Withdrawal by Subject|17|||
33453683|NCT00255164|62828256|FG002|Overall Study|Withdrawal by Subject|8|||
33453684|NCT00255164|62828254|FG000|Overall Study|Noncompliance|0|||
33453685|NCT00255164|62828255|FG001|Overall Study|Noncompliance|1|||
33453686|NCT00255164|62828256|FG002|Overall Study|Noncompliance|2|||
33453687|NCT00255164|62828254|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
33453688|NCT00255164|62828255|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
33453689|NCT00255164|62828256|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
33453690|NCT00255164|62828254|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
33453691|NCT00255164|62828255|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
33453692|NCT00255164|62828256|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
33453693|NCT00255164|62828254|FG000|Overall Study|Possible Barrett's Esophagus|1|||
33453694|NCT00255164|62828255|FG001|Overall Study|Possible Barrett's Esophagus|3|||
33453695|NCT00255164|62828256|FG002|Overall Study|Possible Barrett's Esophagus|8|||
33453696|NCT00255164|62828254|FG000|Overall Study|Esophageal Stricture|0|||
33453697|NCT00255164|62828255|FG001|Overall Study|Esophageal Stricture|0|||
33453698|NCT00255164|62828256|FG002|Overall Study|Esophageal Stricture|1|||
33453699|NCT00255164|62828254|FG000|Overall Study|Therapeutic Failure|11|||
33453700|NCT00255164|62828255|FG001|Overall Study|Therapeutic Failure|2|||
33453701|NCT00255164|62828256|FG002|Overall Study|Therapeutic Failure|3|||
33453702|NCT00126594|62828266|FG000|Overall Study|Ineligible|2|||
33453703|NCT00126594|62828267|FG001|Overall Study|Ineligible|0|||
33453704|NCT00126594|62828266|FG000|Overall Study|Withdrawal by Subject|0|||
33453705|NCT00126594|62828267|FG001|Overall Study|Withdrawal by Subject|4|||
33453706|NCT00126594|62828266|FG000|Overall Study|Physician Decision|1|||
33453707|NCT00126594|62828267|FG001|Overall Study|Physician Decision|3|||
33453708|NCT00126594|62828266|FG000|Overall Study|Adverse Event|7|||
33453709|NCT00126594|62828267|FG001|Overall Study|Adverse Event|5|||
33453710|NCT00126594|62828266|FG000|Overall Study|Non-compliance|0|||
33453711|NCT00126594|62828267|FG001|Overall Study|Non-compliance|1|||
33453712|NCT00126594|62828266|FG000|Overall Study|Disease Progression|29|||
33453713|NCT00126594|62828267|FG001|Overall Study|Disease Progression|24|||
33453714|NCT00126438|62828276|FG000|Overall Study|Withdrawal due to adverse event|1|||
33453715|NCT00126438|62828277|FG001|Overall Study|Withdrawal due to adverse event|0|||
33453716|NCT00126438|62828276|FG000|Overall Study|Lost to Follow-up|22|||
33453717|NCT00126438|62828277|FG001|Overall Study|Lost to Follow-up|0|||
33453718|NCT00126438|62828276|FG000|Overall Study|Protocol Violation|8|||
33453719|NCT00126438|62828277|FG001|Overall Study|Protocol Violation|8|||
33615403|NCT02222246|63016383|FG001|Overall Study|Physician Decision|1|||
33615404|NCT02188160|63016393|FG000|Overall Study|Adverse Event|1|||
33615405|NCT02188160|63016394|FG001|Overall Study|Adverse Event|0|||
33453720|NCT00126438|62828276|FG000|Overall Study|Withdrawal by Subject|3|||
33453721|NCT00126438|62828277|FG001|Overall Study|Withdrawal by Subject|2|||
33615406|NCT02188160|63016393|FG000|Overall Study|Use of an excluded medication|0|||
33515535|NCT03046446|62900052|FG000|Overall Study|Withdrawal by Subject|14|||
33515536|NCT03046446|62900052|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
33515537|NCT03046446|62900052|FG000|Overall Study|Disease Progression (see caveats)|25|||
33515538|NCT03046446|62900052|FG000|Overall Study|Non OA related knee surgery|1|||
33515539|NCT03051217|62900059|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
33515540|NCT03051217|62900060|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33515541|NCT03051217|62900061|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
33515542|NCT03051217|62900062|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33515543|NCT03051217|62900063|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33515544|NCT03051217|62900064|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33515545|NCT03051217|62900065|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33515546|NCT03051217|62900059|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
33515547|NCT03051217|62900060|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
33515548|NCT03051217|62900061|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
33515549|NCT03051217|62900062|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
33515550|NCT03051217|62900063|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
33515551|NCT03051217|62900064|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
33515552|NCT03051217|62900065|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
33515553|NCT03051217|62900059|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
33515554|NCT03051217|62900060|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
33515555|NCT03051217|62900061|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
33515556|NCT03051217|62900062|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33515557|NCT03051217|62900063|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33515558|NCT03051217|62900064|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33515559|NCT03051217|62900065|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33515560|NCT03051217|62900059|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
33515561|NCT03051217|62900060|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
33515562|NCT03051217|62900061|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
33515563|NCT03051217|62900062|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
33515564|NCT03051217|62900063|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
33515565|NCT03051217|62900064|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
33515566|NCT03051217|62900065|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
33515567|NCT03051217|62900059|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
33515568|NCT03051217|62900060|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
33515569|NCT03051217|62900061|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
33515570|NCT03051217|62900062|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
33515571|NCT03051217|62900063|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
33515572|NCT03051217|62900064|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
33515573|NCT03051217|62900065|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
33515574|NCT03051217|62900059|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
33515575|NCT03051217|62900060|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
33515576|NCT03051217|62900061|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
33515577|NCT03051217|62900062|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
33515578|NCT03051217|62900063|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
33515579|NCT03051217|62900064|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
33515580|NCT03051217|62900065|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
33515581|NCT03051217|62900059|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
33515582|NCT03051217|62900060|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
33515583|NCT03051217|62900061|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
33515584|NCT03051217|62900062|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
33515585|NCT03051217|62900063|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
33515586|NCT03051217|62900064|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
33515587|NCT03051217|62900065|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
33515588|NCT03051217|62900059|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
33515589|NCT03051217|62900060|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
33515590|NCT03051217|62900061|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
33515591|NCT03051217|62900062|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
33515592|NCT03051217|62900063|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
33515593|NCT03051217|62900064|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
33515594|NCT03051217|62900065|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
33515595|NCT03046056|62900091|FG000|Overall Study|Non-responder at Week 10|6|||
33515596|NCT03046056|62900092|FG001|Overall Study|Non-responder at Week 10|6|||
33515597|NCT03046056|62900093|FG002|Overall Study|Non-responder at Week 10|4|||
33515598|NCT03046056|62900091|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
33515599|NCT03046056|62900092|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
33515600|NCT03046056|62900093|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
33515601|NCT03046056|62900091|FG000|Overall Study|Adverse Event|1|||
33515602|NCT03046056|62900092|FG001|Overall Study|Adverse Event|5|||
33515603|NCT03046056|62900093|FG002|Overall Study|Adverse Event|0|||
33515604|NCT03046056|62900091|FG000|Overall Study|Non-compliance With Study Drug|0|||
33515605|NCT03046056|62900092|FG001|Overall Study|Non-compliance With Study Drug|0|||
33515606|NCT03046056|62900093|FG002|Overall Study|Non-compliance With Study Drug|2|||
33515607|NCT03046056|62900091|FG000|Overall Study|Protocol Violation|1|||
33515608|NCT03046056|62900092|FG001|Overall Study|Protocol Violation|1|||
33515609|NCT03046056|62900093|FG002|Overall Study|Protocol Violation|0|||
33515610|NCT03046056|62900091|FG000|Overall Study|Investigator's Discretion|0|||
33515611|NCT03046056|62900092|FG001|Overall Study|Investigator's Discretion|1|||
33515612|NCT03046056|62900093|FG002|Overall Study|Investigator's Discretion|0|||
33515613|NCT03046056|62900091|FG000|Overall Study|Withdrew Consent|1|||
33515614|NCT03046056|62900092|FG001|Overall Study|Withdrew Consent|0|||
33515615|NCT03046056|62900093|FG002|Overall Study|Withdrew Consent|0|||
33515616|NCT02849587|62900104|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
33515617|NCT02849587|62900105|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
33515618|NCT02849587|62900106|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
33515619|NCT02849587|62900104|FG000|Overall Study|Withdrawal by Subject|0|||
33515620|NCT02849587|62900105|FG001|Overall Study|Withdrawal by Subject|1|||
33515621|NCT02849587|62900106|FG002|Overall Study|Withdrawal by Subject|0|||
33515622|NCT03347279|62900120|FG000|Overall Study|Withdrawal by Subject|8|||
33515623|NCT03347279|62900121|FG001|Overall Study|Withdrawal by Subject|15|||
33515624|NCT03347279|62900120|FG000|Overall Study|Death|0|||
33515625|NCT03347279|62900121|FG001|Overall Study|Death|2|||
33515626|NCT03347279|62900120|FG000|Overall Study|Lost to Follow-up|5|||
33515627|NCT03347279|62900121|FG001|Overall Study|Lost to Follow-up|2|||
33515628|NCT03347279|62900120|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
33515629|NCT03347279|62900121|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
33515630|NCT03262441|62900127|FG000|Overall Study|Withdrawal by Subject|1|||
33515631|NCT04580394|62900131|FG000|First Intervention|Incorrectly Randomized|1|||
33515632|NCT04580394|62900131|FG000|First Intervention|Physician Decision|1|||
33515633|NCT04580394|62900131|FG000|First Intervention|Lost to Follow-up|1|||
33515634|NCT04580394|62900131|FG000|Washout (One Week)|Withdrawal by Subject|1|||
33515635|NCT04580394|62900131|FG000|Washout (One Week)|Adverse Event|1|||
33515636|NCT04580394|62900131|FG000|Washout (One Week)|Withdrawal by Subject|2|||
33515637|NCT04580394|62900131|FG000|Third Intervention|Adverse Event|1|||
33515638|NCT04580394|62900131|FG000|Third Intervention|Withdrawal by Subject|1|||
33515639|NCT04580394|62900131|FG000|Washout (One Week)|Withdrawal by Subject|2|||
33515640|NCT02781727|62900143|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
33515641|NCT02781727|62900144|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
33515642|NCT02781727|62900143|FG000|Treatment Period|Withdrawal by Subject|1|||
33515643|NCT02781727|62900144|FG001|Treatment Period|Withdrawal by Subject|0|||
33515644|NCT02781727|62900143|FG000|Treatment Period|Lost to Follow-up|0|||
33515645|NCT02781727|62900144|FG001|Treatment Period|Lost to Follow-up|1|||
33515646|NCT01343082|62900150|FG000|The run-in Period|Not meeting criteria|3|||
33515647|NCT01343082|62900151|FG001|The run-in Period|Not meeting criteria|4|||
33515648|NCT01343082|62900152|FG002|The run-in Period|Not meeting criteria|5|||
33515649|NCT01343082|62900150|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
33515650|NCT01343082|62900151|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
33515651|NCT01343082|62900152|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
33515652|NCT01343082|62900150|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
33515653|NCT01343082|62900151|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
33515654|NCT01343082|62900152|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
33515655|NCT01343082|62900150|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
33515656|NCT01343082|62900151|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
33515657|NCT01343082|62900152|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
33515658|NCT01343082|62900150|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
33515659|NCT01343082|62900151|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
33515660|NCT01343082|62900152|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
33515661|NCT03374189|62900158|FG000|Overall Study|Lost to Follow-up|1|||
33515662|NCT03374189|62900159|FG001|Overall Study|Lost to Follow-up|0|||
33515663|NCT03261037|62900169|FG000|Overall Study|Withdrawal by Subject|2|||
33515664|NCT03261037|62900170|FG001|Overall Study|Withdrawal by Subject|13|||
33615407|NCT02188160|63016394|FG001|Overall Study|Use of an excluded medication|1|||
33615408|NCT02220998|63016402|FG000|Overall Study|Randomized but Never Treated|1|||
33615409|NCT02220998|63016403|FG001|Overall Study|Randomized but Never Treated|2|||
33615410|NCT02220998|63016402|FG000|Overall Study|Death|2|||
33515665|NCT03261037|62900171|FG002|Overall Study|Withdrawal by Subject|0|||
33515666|NCT03261037|62900172|FG003|Overall Study|Withdrawal by Subject|18|||
33515667|NCT03261037|62900169|FG000|Overall Study|Non-compliance with study procedures|0|||
33515668|NCT03261037|62900170|FG001|Overall Study|Non-compliance with study procedures|2|||
33515669|NCT03261037|62900171|FG002|Overall Study|Non-compliance with study procedures|0|||
33515670|NCT03261037|62900172|FG003|Overall Study|Non-compliance with study procedures|6|||
33515671|NCT03261037|62900169|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
33515672|NCT03261037|62900170|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
33515673|NCT03261037|62900171|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
33515674|NCT03261037|62900172|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
33515675|NCT03261037|62900169|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
33515676|NCT03261037|62900170|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
33515677|NCT03261037|62900171|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
33515678|NCT03261037|62900172|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
33515679|NCT03261037|62900169|FG000|Overall Study|Diagnosed but protocol deviation|1|||
33515680|NCT03261037|62900170|FG001|Overall Study|Diagnosed but protocol deviation|0|||
33515681|NCT03261037|62900171|FG002|Overall Study|Diagnosed but protocol deviation|0|||
33515682|NCT03261037|62900172|FG003|Overall Study|Diagnosed but protocol deviation|0|||
33515683|NCT03261037|62900169|FG000|Overall Study|Participant did not want to continue the study|0|||
33515684|NCT03261037|62900170|FG001|Overall Study|Participant did not want to continue the study|1|||
33515685|NCT03261037|62900171|FG002|Overall Study|Participant did not want to continue the study|0|||
33515686|NCT03261037|62900172|FG003|Overall Study|Participant did not want to continue the study|0|||
33515687|NCT03261037|62900169|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
33515688|NCT03261037|62900170|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
33515689|NCT03261037|62900171|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
33615411|NCT02220998|63016403|FG001|Overall Study|Death|0|||
33515690|NCT03261037|62900172|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
33515691|NCT03261037|62900169|FG000|Overall Study|Participant presented clinical improvement|0|||
33515692|NCT03261037|62900170|FG001|Overall Study|Participant presented clinical improvement|2|||
33515693|NCT03261037|62900171|FG002|Overall Study|Participant presented clinical improvement|0|||
33515694|NCT03261037|62900172|FG003|Overall Study|Participant presented clinical improvement|0|||
33515695|NCT03261037|62900169|FG000|Overall Study|Technical difficulties|0|||
33515696|NCT03261037|62900170|FG001|Overall Study|Technical difficulties|0|||
33515697|NCT03261037|62900171|FG002|Overall Study|Technical difficulties|0|||
33515698|NCT03261037|62900172|FG003|Overall Study|Technical difficulties|1|||
33515699|NCT03261037|62900169|FG000|Overall Study|Equipment failed to work|0|||
33515700|NCT03261037|62900170|FG001|Overall Study|Equipment failed to work|0|||
33515701|NCT03261037|62900171|FG002|Overall Study|Equipment failed to work|0|||
33515702|NCT03261037|62900172|FG003|Overall Study|Equipment failed to work|1|||
33515703|NCT03261037|62900169|FG000|Overall Study|End of study for participant and no follow up|0|||
33615412|NCT02220998|63016402|FG000|Overall Study|Lack of Efficacy|0|||
33615413|NCT02220998|63016403|FG001|Overall Study|Lack of Efficacy|5|||
33615414|NCT02220998|63016402|FG000|Overall Study|Lost to Follow-up|4|||
33615415|NCT02220998|63016403|FG001|Overall Study|Lost to Follow-up|4|||
33615416|NCT02220920|63016411|FG000|Overall Study|Adverse Event|1|||
33615417|NCT02220920|63016412|FG001|Overall Study|Adverse Event|0|||
33615418|NCT02220920|63016411|FG000|Overall Study|Lack of Efficacy|0|||
33615419|NCT02220920|63016412|FG001|Overall Study|Lack of Efficacy|1|||
33615420|NCT02220920|63016411|FG000|Overall Study|Withdrawal by Subject|1|||
33615421|NCT02220920|63016412|FG001|Overall Study|Withdrawal by Subject|0|||
33615422|NCT02220920|63016411|FG000|Overall Study|Conflict with the stopping criteria|1|||
33615423|NCT02220920|63016412|FG001|Overall Study|Conflict with the stopping criteria|2|||
33615424|NCT03966053|63016418|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
33615425|NCT01634555|63016431|FG000|Overall Study|Adverse Event|3|||
33615426|NCT01634555|63016431|FG000|Overall Study|Physician Decision|1|||
33615427|NCT01634243|63016438|FG000|Overall Study|Adverse Event|5|||
33615428|NCT01634243|63016439|FG001|Overall Study|Adverse Event|5|||
33615429|NCT01634243|63016438|FG000|Overall Study|Lack of Efficacy|1|||
33615430|NCT01634243|63016439|FG001|Overall Study|Lack of Efficacy|0|||
33615431|NCT01542034|63016456|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
33615432|NCT01542034|63016457|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
33515704|NCT03261037|62900170|FG001|Overall Study|End of study for participant and no follow up|0|||
33515705|NCT03261037|62900171|FG002|Overall Study|End of study for participant and no follow up|0|||
33515706|NCT03261037|62900172|FG003|Overall Study|End of study for participant and no follow up|1|||
33515707|NCT03261037|62900169|FG000|Overall Study|Participant was too weak to continue in study|1|||
33515708|NCT03261037|62900170|FG001|Overall Study|Participant was too weak to continue in study|0|||
33515709|NCT03261037|62900171|FG002|Overall Study|Participant was too weak to continue in study|0|||
33515710|NCT03261037|62900172|FG003|Overall Study|Participant was too weak to continue in study|0|||
33515711|NCT03372551|62900183|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
33515712|NCT03372551|62900184|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
33515713|NCT03326323|62900197|FG000|Overall Study|Unable to receive ANH protocol|3|||
33515714|NCT03259789|62900208|FG000|Overall Study|Adverse Event|3|||
33515715|NCT03259789|62900209|FG001|Overall Study|Adverse Event|2|||
33515716|NCT03259789|62900210|FG002|Overall Study|Adverse Event|1|||
33515717|NCT03259789|62900208|FG000|Overall Study|Withdrawal by Subject|9|||
33515718|NCT03259789|62900209|FG001|Overall Study|Withdrawal by Subject|5|||
33515719|NCT03259789|62900210|FG002|Overall Study|Withdrawal by Subject|1|||
33515720|NCT03259789|62900208|FG000|Overall Study|Lost to Follow-up|5|||
33515721|NCT03259789|62900209|FG001|Overall Study|Lost to Follow-up|9|||
33515722|NCT03259789|62900210|FG002|Overall Study|Lost to Follow-up|4|||
33515723|NCT03259789|62900208|FG000|Overall Study|Physician Decision|0|||
33515724|NCT03259789|62900209|FG001|Overall Study|Physician Decision|1|||
33515725|NCT03259789|62900210|FG002|Overall Study|Physician Decision|0|||
33515726|NCT03259555|62900221|FG000|Overall Study|Adverse Event|6|||
33515727|NCT03259555|62900222|FG001|Overall Study|Adverse Event|4|||
33515728|NCT03259555|62900221|FG000|Overall Study|Lack of Efficacy|6|||
33515729|NCT03259555|62900222|FG001|Overall Study|Lack of Efficacy|4|||
33515730|NCT03259555|62900221|FG000|Overall Study|Lost to Follow-up|0|||
33515731|NCT03259555|62900222|FG001|Overall Study|Lost to Follow-up|2|||
33515732|NCT03259555|62900221|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33515733|NCT03259555|62900222|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33515734|NCT03259555|62900221|FG000|Overall Study|Progressive Disease|0|||
33515735|NCT03259555|62900222|FG001|Overall Study|Progressive Disease|2|||
33515736|NCT03259555|62900221|FG000|Overall Study|Withdrawal by Subject|19|||
33515737|NCT03259555|62900222|FG001|Overall Study|Withdrawal by Subject|16|||
33515738|NCT03259555|62900221|FG000|Overall Study|Physician Decision|1|||
33515739|NCT03259555|62900222|FG001|Overall Study|Physician Decision|2|||
33515740|NCT03259555|62900221|FG000|Overall Study|Other|1|||
33515741|NCT03259555|62900222|FG001|Overall Study|Other|0|||
33515742|NCT03259087|62900233|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
33515743|NCT03259087|62900234|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
33515744|NCT03259087|62900235|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
33515745|NCT03259087|62900236|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
33515746|NCT03259087|62900237|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
33515747|NCT03259087|62900233|FG000|Period 2 of Part 2|Adverse Event|0|||
33515748|NCT03259087|62900234|FG001|Period 2 of Part 2|Adverse Event|0|||
33515749|NCT03259087|62900235|FG002|Period 2 of Part 2|Adverse Event|0|||
33515750|NCT03259087|62900236|FG003|Period 2 of Part 2|Adverse Event|0|||
33515751|NCT03259087|62900237|FG004|Period 2 of Part 2|Adverse Event|1|||
33515752|NCT03257995|62900259|FG000|Overall Study|Adverse Event|0|||
33515753|NCT03257995|62900260|FG001|Overall Study|Adverse Event|1|||
33515754|NCT03257995|62900261|FG002|Overall Study|Adverse Event|0|||
33515755|NCT03257995|62900262|FG003|Overall Study|Adverse Event|0|||
33515756|NCT03257995|62900263|FG004|Overall Study|Adverse Event|0|||
33515757|NCT03257995|62900264|FG005|Overall Study|Adverse Event|0|||
33515758|NCT03257995|62900259|FG000|Overall Study|Protocol deviation|0|||
33515759|NCT03257995|62900260|FG001|Overall Study|Protocol deviation|0|||
33453722|NCT00142584|62828285|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
33453723|NCT00142584|62828286|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
33453724|NCT00142584|62828285|FG000|Overall Study|Withdrawal by Subject|30|||
33453725|NCT00142584|62828286|FG001|Overall Study|Withdrawal by Subject|16|||
33453726|NCT00142584|62828285|FG000|Overall Study|Lost to Follow-up|22|||
33453727|NCT00142584|62828286|FG001|Overall Study|Lost to Follow-up|12|||
33453728|NCT00142584|62828285|FG000|Overall Study|Adverse Event|14|||
33453729|NCT00142584|62828286|FG001|Overall Study|Adverse Event|5|||
33453730|NCT00142584|62828285|FG000|Overall Study|Protocol Violation|4|||
33515760|NCT03257995|62900261|FG002|Overall Study|Protocol deviation|0|||
33515761|NCT03257995|62900262|FG003|Overall Study|Protocol deviation|0|||
33515762|NCT03257995|62900263|FG004|Overall Study|Protocol deviation|0|||
33515763|NCT03257995|62900264|FG005|Overall Study|Protocol deviation|2|||
33515764|NCT03049488|62900282|FG000|Overall Study|Lost to Follow-up|1|||
33515765|NCT03049488|62900283|FG001|Overall Study|Lost to Follow-up|1|||
33515766|NCT03049488|62900284|FG002|Overall Study|Lost to Follow-up|0|||
33515767|NCT03049488|62900285|FG003|Overall Study|Lost to Follow-up|0|||
33515768|NCT03049488|62900286|FG004|Overall Study|Lost to Follow-up|0|||
33515769|NCT03049488|62900287|FG005|Overall Study|Lost to Follow-up|0|||
33515770|NCT03049488|62900282|FG000|Overall Study|Moved from Area|1|||
33515771|NCT03049488|62900283|FG001|Overall Study|Moved from Area|0|||
33515772|NCT03049488|62900284|FG002|Overall Study|Moved from Area|0|||
33515773|NCT03049488|62900285|FG003|Overall Study|Moved from Area|1|||
33515774|NCT03049488|62900286|FG004|Overall Study|Moved from Area|1|||
33515775|NCT03049488|62900287|FG005|Overall Study|Moved from Area|0|||
33515776|NCT03049488|62900282|FG000|Overall Study|Physician Decision|0|||
33515777|NCT03049488|62900283|FG001|Overall Study|Physician Decision|1|||
33515778|NCT03049488|62900284|FG002|Overall Study|Physician Decision|0|||
33515779|NCT03049488|62900285|FG003|Overall Study|Physician Decision|0|||
33515780|NCT03049488|62900286|FG004|Overall Study|Physician Decision|0|||
33515781|NCT03049488|62900287|FG005|Overall Study|Physician Decision|0|||
33515782|NCT03049488|62900282|FG000|Overall Study|Withdrawal by Subject|0|||
33515783|NCT03049488|62900283|FG001|Overall Study|Withdrawal by Subject|0|||
33515784|NCT03049488|62900284|FG002|Overall Study|Withdrawal by Subject|0|||
33515785|NCT03049488|62900285|FG003|Overall Study|Withdrawal by Subject|1|||
33515786|NCT03049488|62900286|FG004|Overall Study|Withdrawal by Subject|1|||
33515787|NCT03049488|62900287|FG005|Overall Study|Withdrawal by Subject|0|||
33515788|NCT03257371|62900302|FG000|Overall Study|Lost to Follow-up|1|||
33515789|NCT03242863|62900306|FG000|Study Week 1|Withdrawal by Subject|0|||
33515790|NCT03242863|62900307|FG001|Study Week 1|Withdrawal by Subject|1|||
33515791|NCT03242863|62900308|FG002|Study Week 1|Withdrawal by Subject|0|||
33515792|NCT03242863|62900309|FG003|Study Week 1|Withdrawal by Subject|0|||
33515793|NCT03242863|62900310|FG004|Study Week 1|Withdrawal by Subject|3|||
33515794|NCT03242863|62900311|FG005|Study Week 1|Withdrawal by Subject|0|||
33515795|NCT03044106|62900319|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
33515796|NCT03044106|62900320|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
33515797|NCT03043560|62900346|FG000|Overall Study|Discontinued Intervention|1|||
33515798|NCT03043560|62900347|FG001|Overall Study|Discontinued Intervention|2|||
33515799|NCT03043560|62900346|FG000|Overall Study|Lost to Follow-up|0|||
33515800|NCT03043560|62900347|FG001|Overall Study|Lost to Follow-up|1|||
33515801|NCT03255733|62900373|FG000|Overall Study|Lost to Follow-up|4|||
33515802|NCT03255655|62900379|FG000|Overall Study|Lost to Follow-up|7|||
33515803|NCT03255655|62900380|FG001|Overall Study|Lost to Follow-up|4|||
33515804|NCT02899988|62900390|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
33515805|NCT02899988|62900391|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
33515806|NCT02899988|62900392|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33515807|NCT02899988|62900393|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33515808|NCT02899988|62900394|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33515809|NCT02899988|62900395|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33515810|NCT02899988|62900396|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33615433|NCT01542034|63016456|FG000|Overall Study|Administrative decision|0|||
33615434|NCT01542034|63016457|FG001|Overall Study|Administrative decision|3|||
33615435|NCT01542034|63016456|FG000|Overall Study|Subject Noncompliance|1|||
33615436|NCT01542034|63016457|FG001|Overall Study|Subject Noncompliance|0|||
33615437|NCT01542034|63016456|FG000|Overall Study|Adverse Event|2|||
33615438|NCT01542034|63016457|FG001|Overall Study|Adverse Event|2|||
33615439|NCT01542034|63016456|FG000|Overall Study|Lost to Follow-up|7|||
33515811|NCT02899988|62900397|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33515812|NCT02899988|62900398|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33515813|NCT02899988|62900399|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33515814|NCT02899988|62900400|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33515815|NCT02899988|62900390|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
33515816|NCT02899988|62900391|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
33515817|NCT02899988|62900392|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
33515818|NCT02899988|62900393|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
33515819|NCT02899988|62900394|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
33515820|NCT02899988|62900395|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
33515821|NCT02899988|62900396|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
33515822|NCT02899988|62900397|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
33515823|NCT02899988|62900398|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
33615440|NCT01542034|63016457|FG001|Overall Study|Lost to Follow-up|6|||
33615441|NCT01564732|63016465|FG000|Overall Study|Early termination by the study sponsor|6|||
33615442|NCT01564732|63016466|FG001|Overall Study|Early termination by the study sponsor|5|||
33615443|NCT01541644|63016472|FG000|Overall Study|Withdrawal by Subject|3|||
33615444|NCT01582282|63016479|FG000|Overall Study|Adverse Event|1|||
33615445|NCT01582282|63016480|FG001|Overall Study|Adverse Event|1|||
33515824|NCT02899988|62900399|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
33515825|NCT02899988|62900400|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
33515826|NCT02899988|62900390|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
33515827|NCT02899988|62900391|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
33515828|NCT02899988|62900392|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
33515829|NCT02899988|62900393|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
33515830|NCT02899988|62900394|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
33515831|NCT02899988|62900395|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
33515832|NCT02899988|62900396|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
33615446|NCT01582282|63016481|FG002|Overall Study|Adverse Event|0|||
33515833|NCT02899988|62900397|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
33515834|NCT02899988|62900398|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
33515835|NCT02899988|62900399|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
33515836|NCT02899988|62900400|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
33515837|NCT02899988|62900390|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
33515838|NCT02899988|62900391|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
33515839|NCT02899988|62900392|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
33515840|NCT02899988|62900393|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
33515841|NCT02899988|62900394|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
33515842|NCT02899988|62900395|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
33515843|NCT02899988|62900396|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
33515844|NCT02899988|62900397|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
33515845|NCT02899988|62900398|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
33515846|NCT02899988|62900399|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
33515847|NCT02899988|62900400|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
33515848|NCT02899988|62900390|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33515849|NCT02899988|62900391|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33515850|NCT02899988|62900392|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33515851|NCT02899988|62900393|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33515852|NCT02899988|62900394|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33515853|NCT02899988|62900395|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
33515854|NCT02899988|62900396|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33515855|NCT02899988|62900397|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
33515856|NCT02899988|62900398|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33515857|NCT02899988|62900399|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33515858|NCT02899988|62900400|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33515859|NCT02899988|62900390|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
33324676|NCT01119066|62701247|FG002|Overall Study|Relapse identified before transplant|0|||
33515860|NCT02899988|62900391|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
33515861|NCT02899988|62900392|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
33515862|NCT02899988|62900393|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
33515863|NCT02899988|62900394|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
33515864|NCT02899988|62900395|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
33515865|NCT02899988|62900396|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
33515866|NCT02899988|62900397|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
33515867|NCT02899988|62900398|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
33515868|NCT02899988|62900399|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
33515869|NCT02899988|62900400|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
33515870|NCT02939131|62900434|FG000|Overall Study|Unable to get to clinic|6|||
33515871|NCT02939131|62900435|FG001|Overall Study|Unable to get to clinic|4|||
33515872|NCT02939131|62900434|FG000|Overall Study|Lost to Follow-up|2|||
33615447|NCT01582282|63016479|FG000|Overall Study|Lost to Follow-up|1|||
33615448|NCT01582282|63016480|FG001|Overall Study|Lost to Follow-up|0|||
33615449|NCT01582282|63016481|FG002|Overall Study|Lost to Follow-up|0|||
33615450|NCT01582282|63016479|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
33615451|NCT01582282|63016480|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
33615452|NCT01582282|63016481|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
33615453|NCT01599650|63016492|FG000|Overall Study|Administrative issue|1|||
33615454|NCT01599650|63016493|FG001|Overall Study|Administrative issue|0|||
33615455|NCT01599650|63016494|FG002|Overall Study|Administrative issue|1|||
33615456|NCT01599650|63016492|FG000|Overall Study|Physician Decision|2|||
33515873|NCT02939131|62900435|FG001|Overall Study|Lost to Follow-up|4|||
33515874|NCT02939131|62900434|FG000|Overall Study|severe debilitation|1|||
33615457|NCT01599650|63016493|FG001|Overall Study|Physician Decision|0|||
33615458|NCT01599650|63016494|FG002|Overall Study|Physician Decision|7|||
33615459|NCT01599650|63016492|FG000|Overall Study|Protocol Violation|0|||
33615460|NCT01599650|63016493|FG001|Overall Study|Protocol Violation|3|||
33615461|NCT01599650|63016494|FG002|Overall Study|Protocol Violation|0|||
33615462|NCT01599650|63016492|FG000|Overall Study|Death|2|||
33615463|NCT01599650|63016493|FG001|Overall Study|Death|1|||
33615464|NCT01599650|63016494|FG002|Overall Study|Death|2|||
33615465|NCT01599650|63016492|FG000|Overall Study|Lost to Follow-up|3|||
33615466|NCT01599650|63016493|FG001|Overall Study|Lost to Follow-up|3|||
33615467|NCT01599650|63016494|FG002|Overall Study|Lost to Follow-up|3|||
33615468|NCT01599650|63016492|FG000|Overall Study|Withdrawal by Subject|11|||
33615469|NCT01599650|63016493|FG001|Overall Study|Withdrawal by Subject|11|||
33615470|NCT01599650|63016494|FG002|Overall Study|Withdrawal by Subject|10|||
33615471|NCT01599650|63016492|FG000|Overall Study|Adverse Event|3|||
33615472|NCT01599650|63016493|FG001|Overall Study|Adverse Event|8|||
33615473|NCT01599650|63016494|FG002|Overall Study|Adverse Event|4|||
33615474|NCT01541254|63016504|FG000|Overall Study|Withdrawal by Subject|1|||
33615475|NCT01541254|63016504|FG000|Overall Study|excluded - metal allergy|1|||
33615476|NCT01541254|63016504|FG000|Overall Study|enrolled after study closed|1|||
33615477|NCT01541254|63016504|FG000|Overall Study|GI bleed prior to procedure|1|||
33615478|NCT01541254|63016504|FG000|Overall Study|stent not required|1|||
33615479|NCT01541254|63016504|FG000|Overall Study|alternate stent used|1|||
33615480|NCT02163902|63016510|FG000|Overall Study|Subject's Request|3|||
33515875|NCT02939131|62900435|FG001|Overall Study|severe debilitation|0|||
33515876|NCT02939131|62900434|FG000|Overall Study|Other|0|||
33515877|NCT02939131|62900435|FG001|Overall Study|Other|1|||
33615481|NCT02163902|63016511|FG001|Overall Study|Subject's Request|4|||
33615482|NCT02163902|63016510|FG000|Overall Study|Lost to Follow-up|6|||
33615483|NCT02163902|63016511|FG001|Overall Study|Lost to Follow-up|7|||
33615484|NCT02163902|63016510|FG000|Overall Study|Administrative Decision|2|||
33615485|NCT02163902|63016511|FG001|Overall Study|Administrative Decision|2|||
33615486|NCT01630616|63016523|FG000|Overall Study|Adverse Event|0|||
33615487|NCT01630616|63016524|FG001|Overall Study|Adverse Event|0|||
33615488|NCT01630616|63016525|FG002|Overall Study|Adverse Event|0|||
33615489|NCT01630616|63016526|FG003|Overall Study|Adverse Event|1|||
33615490|NCT01630616|63016527|FG004|Overall Study|Adverse Event|0|||
33515878|NCT02939131|62900434|FG000|Overall Study|not willing to adhere to protocol|2|||
33615491|NCT01630616|63016528|FG005|Overall Study|Adverse Event|0|||
33615492|NCT01630616|63016523|FG000|Overall Study|Withdrawal by Subject|0|||
33615493|NCT01630616|63016524|FG001|Overall Study|Withdrawal by Subject|0|||
33615494|NCT01630616|63016525|FG002|Overall Study|Withdrawal by Subject|0|||
33615495|NCT01630616|63016526|FG003|Overall Study|Withdrawal by Subject|2|||
33615496|NCT01630616|63016527|FG004|Overall Study|Withdrawal by Subject|0|||
33615497|NCT01630616|63016528|FG005|Overall Study|Withdrawal by Subject|0|||
33615498|NCT03774875|63016547|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
33615499|NCT03774875|63016548|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
33515879|NCT02939131|62900435|FG001|Overall Study|not willing to adhere to protocol|0|||
33515880|NCT03345407|62900449|FG000|Overall Study|Withdrawal by Subject|11|||
33515881|NCT03345407|62900450|FG001|Overall Study|Withdrawal by Subject|1|||
33515882|NCT03345407|62900451|FG002|Overall Study|Withdrawal by Subject|5|||
33515883|NCT03345407|62900452|FG003|Overall Study|Withdrawal by Subject|6|||
33515884|NCT03345407|62900453|FG004|Overall Study|Withdrawal by Subject|3|||
33515885|NCT03345407|62900454|FG005|Overall Study|Withdrawal by Subject|6|||
33515886|NCT03345407|62900455|FG006|Overall Study|Withdrawal by Subject|16|||
33515887|NCT03345407|62900449|FG000|Overall Study|Physician Decision|3|||
33515888|NCT03345407|62900450|FG001|Overall Study|Physician Decision|1|||
33515889|NCT03345407|62900451|FG002|Overall Study|Physician Decision|0|||
33515890|NCT03345407|62900452|FG003|Overall Study|Physician Decision|0|||
33515891|NCT03345407|62900453|FG004|Overall Study|Physician Decision|1|||
33515892|NCT03345407|62900454|FG005|Overall Study|Physician Decision|2|||
33515893|NCT03345407|62900455|FG006|Overall Study|Physician Decision|3|||
33515894|NCT03345407|62900449|FG000|Overall Study|Lost to Follow-up|2|||
33515895|NCT03345407|62900450|FG001|Overall Study|Lost to Follow-up|0|||
33515896|NCT03345407|62900451|FG002|Overall Study|Lost to Follow-up|1|||
33515897|NCT03345407|62900452|FG003|Overall Study|Lost to Follow-up|0|||
33515898|NCT03345407|62900453|FG004|Overall Study|Lost to Follow-up|1|||
33515899|NCT03345407|62900454|FG005|Overall Study|Lost to Follow-up|2|||
33515900|NCT03345407|62900455|FG006|Overall Study|Lost to Follow-up|3|||
33515901|NCT03345407|62900449|FG000|Overall Study|Protocol-defined stopping criteria|9|||
33515902|NCT03345407|62900450|FG001|Overall Study|Protocol-defined stopping criteria|0|||
33515903|NCT03345407|62900451|FG002|Overall Study|Protocol-defined stopping criteria|0|||
33515904|NCT03345407|62900452|FG003|Overall Study|Protocol-defined stopping criteria|0|||
33515905|NCT03345407|62900453|FG004|Overall Study|Protocol-defined stopping criteria|2|||
33515906|NCT03345407|62900454|FG005|Overall Study|Protocol-defined stopping criteria|1|||
33515907|NCT03345407|62900455|FG006|Overall Study|Protocol-defined stopping criteria|1|||
33515908|NCT03345407|62900449|FG000|Overall Study|Protocol Violation|2|||
33515909|NCT03345407|62900450|FG001|Overall Study|Protocol Violation|0|||
33515910|NCT03345407|62900451|FG002|Overall Study|Protocol Violation|0|||
33515911|NCT03345407|62900452|FG003|Overall Study|Protocol Violation|0|||
33515912|NCT03345407|62900453|FG004|Overall Study|Protocol Violation|1|||
33515913|NCT03345407|62900454|FG005|Overall Study|Protocol Violation|0|||
33515914|NCT03345407|62900455|FG006|Overall Study|Protocol Violation|3|||
33615500|NCT03774875|63016547|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
33515915|NCT03345407|62900449|FG000|Overall Study|Lack of Efficacy|1|||
33515916|NCT03345407|62900450|FG001|Overall Study|Lack of Efficacy|1|||
33615501|NCT03774875|63016548|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
33615502|NCT03774875|63016547|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
33515917|NCT03345407|62900451|FG002|Overall Study|Lack of Efficacy|1|||
33515918|NCT03345407|62900452|FG003|Overall Study|Lack of Efficacy|1|||
33515919|NCT03345407|62900453|FG004|Overall Study|Lack of Efficacy|1|||
33515920|NCT03345407|62900454|FG005|Overall Study|Lack of Efficacy|0|||
33515921|NCT03345407|62900455|FG006|Overall Study|Lack of Efficacy|3|||
33515922|NCT03345407|62900449|FG000|Overall Study|Adverse Event|4|||
33515923|NCT03345407|62900450|FG001|Overall Study|Adverse Event|0|||
33515924|NCT03345407|62900451|FG002|Overall Study|Adverse Event|5|||
33615503|NCT03774875|63016548|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
33615504|NCT03774875|63016547|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
33615505|NCT03774875|63016548|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
33615506|NCT03774875|63016547|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
33515925|NCT03345407|62900452|FG003|Overall Study|Adverse Event|4|||
33515926|NCT03345407|62900453|FG004|Overall Study|Adverse Event|6|||
33515927|NCT03345407|62900454|FG005|Overall Study|Adverse Event|5|||
33515928|NCT03345407|62900455|FG006|Overall Study|Adverse Event|16|||
33515929|NCT03255187|62900479|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
33515930|NCT03255187|62900480|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
33515931|NCT03255187|62900479|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
33515932|NCT03255187|62900480|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
33515933|NCT02929329|62900488|FG000|Overall Study|Withdrawal by Subject|24|||
33515934|NCT02929329|62900489|FG001|Overall Study|Withdrawal by Subject|21|||
33515935|NCT02929329|62900488|FG000|Overall Study|Lost to Follow-up|26|||
33515936|NCT02929329|62900489|FG001|Overall Study|Lost to Follow-up|20|||
33515937|NCT02929329|62900488|FG000|Overall Study|Death|1054|||
33515938|NCT02929329|62900489|FG001|Overall Study|Death|1051|||
33515939|NCT03240133|62900502|FG000|Overall Study|Withdrawal by Subject|0|||
33515940|NCT03240133|62900503|FG001|Overall Study|Withdrawal by Subject|1|||
33515941|NCT03240133|62900504|FG002|Overall Study|Withdrawal by Subject|0|||
33453731|NCT00142584|62828286|FG001|Overall Study|Protocol Violation|7|||
33453732|NCT00142584|62828285|FG000|Overall Study|Treatment Failure|2|||
33453733|NCT00142584|62828286|FG001|Overall Study|Treatment Failure|0|||
33453734|NCT00126126|62828296|FG000|Overall Study|Lost to Follow-up|0|||
33453735|NCT00126126|62828297|FG001|Overall Study|Lost to Follow-up|2|||
33453736|NCT00125268|62828305|FG000|Overall Study|Withdrawal by Subject|1|||
33453737|NCT00125268|62828306|FG001|Overall Study|Withdrawal by Subject|1|||
33453738|NCT00125190|62828312|FG000|Overall Study|Subject/Parent Decision|7|||
33453739|NCT00125190|62828312|FG000|Overall Study|Non-compliance|2|||
33453740|NCT00125190|62828312|FG000|Overall Study|Adverse Event|1|||
33515942|NCT03240133|62900502|FG000|Overall Study|Adverse Event|1|||
33515943|NCT03240133|62900503|FG001|Overall Study|Adverse Event|1|||
33515944|NCT03240133|62900504|FG002|Overall Study|Adverse Event|0|||
33515945|NCT03240133|62900502|FG000|Overall Study|Rash|1|||
33515946|NCT03240133|62900503|FG001|Overall Study|Rash|0|||
33615507|NCT03774875|63016548|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
33615508|NCT03774875|63016547|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
33515947|NCT03240133|62900504|FG002|Overall Study|Rash|0|||
33515948|NCT03240133|62900502|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
33515949|NCT03240133|62900503|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
33615509|NCT03774875|63016548|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
33615510|NCT03774875|63016547|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
33615511|NCT03774875|63016548|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
33453741|NCT00125190|62828312|FG000|Overall Study|Other|1|||
33515950|NCT03240133|62900504|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
33515951|NCT03240133|62900502|FG000|Overall Study|Intercurrent illness.|0|||
33515952|NCT03240133|62900503|FG001|Overall Study|Intercurrent illness.|1|||
33515953|NCT03240133|62900504|FG002|Overall Study|Intercurrent illness.|0|||
33453742|NCT00125190|62828312|FG000|Overall Study|Lost to Follow-up|4|||
33515954|NCT03240133|62900502|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
33515955|NCT03240133|62900503|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
33515956|NCT03240133|62900504|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
33515957|NCT03372083|62900528|FG000|Overall Study|Adverse Event|3|||
33515958|NCT03372083|62900528|FG000|Overall Study|Physician Decision|1|||
33515959|NCT03372083|62900528|FG000|Overall Study|Withdrawal by Subject|1|||
33515960|NCT03044886|62900535|FG000|Overall Study|Lost to Follow-up|15|||
33515961|NCT03044886|62900536|FG001|Overall Study|Lost to Follow-up|10|||
33515962|NCT03044886|62900537|FG002|Overall Study|Lost to Follow-up|12|||
33515963|NCT02961764|62900547|FG000|Overall Study|Protocol Violation|0|||
33515964|NCT02961764|62900548|FG001|Overall Study|Protocol Violation|1|||
33515965|NCT02961764|62900547|FG000|Overall Study|Death|2|||
33515966|NCT02961764|62900548|FG001|Overall Study|Death|0|||
33515967|NCT02961764|62900547|FG000|Overall Study|Lost to Follow-up|35|||
33515968|NCT02961764|62900548|FG001|Overall Study|Lost to Follow-up|24|||
33515969|NCT02961764|62900547|FG000|Overall Study|Withdrawal by Subject|2|||
33515970|NCT02961764|62900548|FG001|Overall Study|Withdrawal by Subject|0|||
33515971|NCT03371459|62900554|FG000|Washout|Lost to Follow-up|0|||
33515972|NCT03371459|62900555|FG001|Washout|Lost to Follow-up|1|||
33515973|NCT02961920|62900563|FG000|Overall Study|did not achive stydy protocol schedule|1|||
33515974|NCT02961920|62900564|FG001|Overall Study|did not achive stydy protocol schedule|1|||
33515975|NCT03371381|62900570|FG000|Overall Study|Death|5|||
33515976|NCT03371381|62900570|FG000|Overall Study|Study terminated by sponsor|3|||
33515977|NCT03371381|62900570|FG000|Overall Study|Other|4|||
33615512|NCT03774875|63016547|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
33615513|NCT03774875|63016548|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
33615514|NCT03774875|63016547|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
33615515|NCT03774875|63016548|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
33615516|NCT03774875|63016547|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
33615517|NCT03774875|63016548|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
33615518|NCT03774875|63016547|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
33615519|NCT03774875|63016548|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
33515978|NCT03044730|62900574|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
33515979|NCT03044730|62900574|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
33515980|NCT03044730|62900574|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
33515981|NCT03044730|62900574|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
33515982|NCT03044730|62900574|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
33515983|NCT03044730|62900574|FG000|Cycles 4 and Beyond|Adverse Event|1|||
33515984|NCT03044730|62900574|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
33515985|NCT03044730|62900574|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
33515986|NCT03044730|62900574|FG000|On Follow-up for 2 Years|Death|17|||
33515987|NCT02961374|62900579|FG000|Overall Study|Adverse Event|4|||
33515988|NCT02951429|62900585|FG000|Overall Study|Adverse Event|3|||
33515989|NCT02951429|62900586|FG001|Overall Study|Adverse Event|7|||
33615520|NCT03774875|63016547|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
33515990|NCT02951429|62900585|FG000|Overall Study|Death|28|||
33515991|NCT02951429|62900586|FG001|Overall Study|Death|36|||
33515992|NCT02951429|62900585|FG000|Overall Study|Lack of Efficacy|0|||
33515993|NCT02951429|62900586|FG001|Overall Study|Lack of Efficacy|1|||
33615521|NCT03774875|63016548|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
33615522|NCT03774875|63016547|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
33615523|NCT03774875|63016548|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
33615524|NCT02220764|63016561|FG000|Overall Study|Lost to Follow-up|3|||
33615525|NCT02220764|63016562|FG001|Overall Study|Lost to Follow-up|1|||
33615526|NCT02220764|63016561|FG000|Overall Study|Death|1|||
33515994|NCT02951429|62900585|FG000|Overall Study|Lost to Follow-up|0|||
33515995|NCT02951429|62900586|FG001|Overall Study|Lost to Follow-up|1|||
33515996|NCT02951429|62900585|FG000|Overall Study|Lung Transplantation|9|||
33515997|NCT02951429|62900586|FG001|Overall Study|Lung Transplantation|6|||
33515998|NCT02951429|62900585|FG000|Overall Study|Other|1|||
33515999|NCT02951429|62900586|FG001|Overall Study|Other|3|||
33516000|NCT02951429|62900585|FG000|Overall Study|Progressive Disease|1|||
33516001|NCT02951429|62900586|FG001|Overall Study|Progressive Disease|1|||
33516002|NCT02951429|62900585|FG000|Overall Study|Withdrawal by Subject|7|||
33516003|NCT02951429|62900586|FG001|Overall Study|Withdrawal by Subject|11|||
33516004|NCT02951429|62900585|FG000|Overall Study|Participant ongoing in the study|23|||
33516005|NCT02951429|62900586|FG001|Overall Study|Participant ongoing in the study|17|||
33516006|NCT03343067|62900599|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
33516007|NCT03343067|62900600|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
33516008|NCT03343067|62900601|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
33516009|NCT03103503|62900609|FG000|Overall Study|Death|64|||
33516010|NCT03103503|62900609|FG000|Overall Study|Physician Decision|57|||
33516011|NCT03103503|62900609|FG000|Overall Study|Withdrawal by Subject|10|||
33516012|NCT03103503|62900609|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
33516013|NCT03103503|62900609|FG000|Overall Study|Lost to Follow-up|3|||
33516014|NCT03103503|62900609|FG000|Overall Study|Study Closure|757|||
33516015|NCT02961218|62900615|FG000|Overall Study|Lost to Follow-up|0|||
33516016|NCT02961218|62900616|FG001|Overall Study|Lost to Follow-up|2|||
33516017|NCT02961218|62900615|FG000|Overall Study|Physician Decision|0|||
33516018|NCT02961218|62900616|FG001|Overall Study|Physician Decision|2|||
33516019|NCT02961218|62900615|FG000|Overall Study|Subject/Guardian Decision|3|||
33516020|NCT02961218|62900616|FG001|Overall Study|Subject/Guardian Decision|1|||
33516021|NCT02949947|62900626|FG000|Overall Study|Non Compliance|0|||
33516022|NCT02949947|62900627|FG001|Overall Study|Non Compliance|1|||
33516023|NCT02949947|62900626|FG000|Overall Study|Insurance change|1|||
33516024|NCT02949947|62900627|FG001|Overall Study|Insurance change|0|||
33516025|NCT03341507|62900633|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
33615527|NCT02220764|63016562|FG001|Overall Study|Death|0|||
33516026|NCT01345058|62900639|FG000|Overall Study|Withdrawal by Subject|1|||
33516027|NCT01345058|62900640|FG001|Overall Study|Withdrawal by Subject|0|||
33516028|NCT01345058|62900639|FG000|Overall Study|Participant Reported Increase in Events|1|||
33516029|NCT01345058|62900640|FG001|Overall Study|Participant Reported Increase in Events|0|||
33516030|NCT01345058|62900639|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
33516031|NCT01345058|62900640|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
33516032|NCT01345058|62900639|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
33516033|NCT01345058|62900640|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
33516034|NCT01345058|62900639|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
33516035|NCT01345058|62900640|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
33615528|NCT01563172|63016568|FG000|Overall Study|Adverse Event|5|||
33615529|NCT01563172|63016568|FG000|Overall Study|Lost to Follow-up|2|||
33615530|NCT01563172|63016568|FG000|Overall Study|Other (Protocol deviation)|5|||
33615531|NCT01563172|63016568|FG000|Overall Study|Other (Not specified)|1|||
33615532|NCT02161718|63016585|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
33615533|NCT02161718|63016586|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
33615534|NCT02161718|63016587|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
33615535|NCT02161718|63016585|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
33615536|NCT02161718|63016586|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
33615537|NCT02161718|63016587|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
33615538|NCT02161718|63016585|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
33615539|NCT02161718|63016586|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
33615540|NCT02161718|63016587|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
33615541|NCT02161718|63016585|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
33615542|NCT02161718|63016586|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
33615543|NCT02161718|63016587|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
33615544|NCT02161718|63016585|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
33615545|NCT02161718|63016586|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
33615546|NCT02161718|63016587|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
33615547|NCT02161718|63016585|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
33615548|NCT02161718|63016586|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
33615549|NCT02161718|63016587|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
33615550|NCT02161718|63016585|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
33615551|NCT02161718|63016586|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
33615552|NCT02161718|63016587|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
33615553|NCT02161718|63016585|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
33516036|NCT01345292|62900649|FG000|Overall Study|Withdrawal by Subject|2|||
33516037|NCT01345292|62900650|FG001|Overall Study|Withdrawal by Subject|0|||
33516038|NCT01345292|62900651|FG002|Overall Study|Withdrawal by Subject|1|||
33516039|NCT03340961|62900663|FG000|Overall Study|Adverse Event|1|||
33516040|NCT03340961|62900664|FG001|Overall Study|Adverse Event|3|||
33516041|NCT03340961|62900665|FG002|Overall Study|Adverse Event|2|||
33516042|NCT03340961|62900666|FG003|Overall Study|Adverse Event|4|||
33516043|NCT03340961|62900663|FG000|Overall Study|Lost to Follow-up|0|||
33516044|NCT03340961|62900664|FG001|Overall Study|Lost to Follow-up|1|||
33516045|NCT03340961|62900665|FG002|Overall Study|Lost to Follow-up|0|||
33516046|NCT03340961|62900666|FG003|Overall Study|Lost to Follow-up|1|||
33516047|NCT03340961|62900663|FG000|Overall Study|Withdrawal by Subject|3|||
33516048|NCT03340961|62900664|FG001|Overall Study|Withdrawal by Subject|2|||
33516049|NCT03340961|62900665|FG002|Overall Study|Withdrawal by Subject|4|||
33516050|NCT03340961|62900666|FG003|Overall Study|Withdrawal by Subject|7|||
33516051|NCT03340961|62900663|FG000|Overall Study|Use of prohibited treatment|0|||
33516052|NCT03340961|62900664|FG001|Overall Study|Use of prohibited treatment|3|||
33516053|NCT03340961|62900665|FG002|Overall Study|Use of prohibited treatment|2|||
33516054|NCT03340961|62900666|FG003|Overall Study|Use of prohibited treatment|4|||
33516055|NCT03340961|62900663|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
33516056|NCT03340961|62900664|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
33516057|NCT03340961|62900665|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
33615554|NCT02161718|63016586|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
33615555|NCT02161718|63016587|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
33615556|NCT02161718|63016585|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
33516058|NCT03340961|62900666|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
33516059|NCT03340961|62900663|FG000|Overall Study|Subject developed an exclusion criterion|0|||
33516060|NCT03340961|62900664|FG001|Overall Study|Subject developed an exclusion criterion|1|||
33516061|NCT03340961|62900665|FG002|Overall Study|Subject developed an exclusion criterion|0|||
33516062|NCT03340961|62900666|FG003|Overall Study|Subject developed an exclusion criterion|0|||
33516063|NCT03340961|62900663|FG000|Overall Study|Protocol Violation|1|||
33516064|NCT03340961|62900664|FG001|Overall Study|Protocol Violation|0|||
33516065|NCT03340961|62900665|FG002|Overall Study|Protocol Violation|1|||
33516066|NCT03340961|62900666|FG003|Overall Study|Protocol Violation|0|||
33516067|NCT03340961|62900663|FG000|Overall Study|Adverse Event|1|||
33516068|NCT03340961|62900664|FG001|Overall Study|Adverse Event|1|||
33516069|NCT03340961|62900665|FG002|Overall Study|Adverse Event|0|||
33516070|NCT03340961|62900666|FG003|Overall Study|Adverse Event|0|||
33516071|NCT03340961|62900663|FG000|Overall Study|Lack of Efficacy|0|||
33516072|NCT03340961|62900664|FG001|Overall Study|Lack of Efficacy|0|||
33516073|NCT03340961|62900665|FG002|Overall Study|Lack of Efficacy|0|||
33516074|NCT03340961|62900666|FG003|Overall Study|Lack of Efficacy|1|||
33516075|NCT03340025|62900678|FG000|Overall Study|Lost to Follow-up|2|||
33516076|NCT03340025|62900679|FG001|Overall Study|Lost to Follow-up|2|||
33516077|NCT03339713|62900687|FG000|Overall Study|Lost to Follow-up|2|||
33516078|NCT03339713|62900688|FG001|Overall Study|Lost to Follow-up|1|||
33516079|NCT03339713|62900687|FG000|Overall Study|Protocol Violation|1|||
33516080|NCT03339713|62900688|FG001|Overall Study|Protocol Violation|0|||
33516081|NCT03339713|62900687|FG000|Overall Study|Withdrawal by Subject|1|||
33516082|NCT03339713|62900688|FG001|Overall Study|Withdrawal by Subject|1|||
33516083|NCT03254485|62900700|FG000|Overall Study|Adverse Event|3|||
33516084|NCT03254485|62900701|FG001|Overall Study|Adverse Event|0|||
33516085|NCT03254485|62900702|FG002|Overall Study|Adverse Event|0|||
33516086|NCT03254485|62900703|FG003|Overall Study|Adverse Event|6|||
33516087|NCT03254485|62900700|FG000|Overall Study|Protocol Violation|6|||
33516088|NCT03254485|62900701|FG001|Overall Study|Protocol Violation|0|||
33516089|NCT03254485|62900702|FG002|Overall Study|Protocol Violation|0|||
33516090|NCT03254485|62900703|FG003|Overall Study|Protocol Violation|2|||
33516091|NCT03254485|62900700|FG000|Overall Study|Withdrawal by Subject|1|||
33516092|NCT03254485|62900701|FG001|Overall Study|Withdrawal by Subject|0|||
33516093|NCT03254485|62900702|FG002|Overall Study|Withdrawal by Subject|0|||
33516094|NCT03254485|62900703|FG003|Overall Study|Withdrawal by Subject|4|||
33516095|NCT03254485|62900700|FG000|Overall Study|Death|0|||
33516096|NCT03254485|62900701|FG001|Overall Study|Death|0|||
33516097|NCT03254485|62900702|FG002|Overall Study|Death|0|||
33615557|NCT02161718|63016586|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
33615558|NCT02161718|63016587|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
33516098|NCT03254485|62900703|FG003|Overall Study|Death|1|||
33516099|NCT03254485|62900700|FG000|Overall Study|Lost to Follow-up|1|||
33516100|NCT03254485|62900701|FG001|Overall Study|Lost to Follow-up|0|||
33516101|NCT03254485|62900702|FG002|Overall Study|Lost to Follow-up|0|||
33516102|NCT03254485|62900703|FG003|Overall Study|Lost to Follow-up|0|||
33453743|NCT00141726|62828317|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
33453744|NCT00111228|62828324|FG000|Overall Study|Withdrawal by Subject|5|||
33453745|NCT00111228|62828325|FG001|Overall Study|Withdrawal by Subject|1|||
33516103|NCT03254485|62900700|FG000|Overall Study|Other|1|||
33516104|NCT03254485|62900701|FG001|Overall Study|Other|0|||
33516105|NCT03254485|62900702|FG002|Overall Study|Other|0|||
33516106|NCT03254485|62900703|FG003|Overall Study|Other|2|||
33516107|NCT03339401|62900726|FG000|Overall Study|Death|2|||
33516108|NCT03339401|62900727|FG001|Overall Study|Death|1|||
33516109|NCT03339401|62900726|FG000|Overall Study|Withdrawal by Subject|2|||
33615559|NCT02161718|63016585|FG000|Post- Randomization Period|Lost to Follow-up|0|||
33615560|NCT02161718|63016586|FG001|Post- Randomization Period|Lost to Follow-up|9|||
33615561|NCT02161718|63016587|FG002|Post- Randomization Period|Lost to Follow-up|15|||
33453746|NCT00111228|62828326|FG002|Overall Study|Withdrawal by Subject|0|||
33453747|NCT00110994|62828336|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
33453748|NCT00110994|62828337|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
33453749|NCT00110994|62828336|FG000|Double-blind (DB) Treatment|Death|1|||
33453750|NCT00110994|62828337|FG001|Double-blind (DB) Treatment|Death|0|||
33453751|NCT00110994|62828336|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
33453752|NCT00110994|62828337|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
33516110|NCT03339401|62900727|FG001|Overall Study|Withdrawal by Subject|0|||
33516111|NCT03339401|62900726|FG000|Overall Study|Study terminated|4|||
33516112|NCT03339401|62900727|FG001|Overall Study|Study terminated|3|||
33516113|NCT03339401|62900726|FG000|Overall Study|Investigator Decision|1|||
33516114|NCT03339401|62900727|FG001|Overall Study|Investigator Decision|0|||
33615562|NCT02161718|63016585|FG000|Post- Randomization Period|Adverse Event|0|||
33453753|NCT00110994|62828336|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
33516115|NCT03370289|62900733|FG000|Overall Study|Screen Failure|1|||
33516116|NCT03370289|62900733|FG000|Overall Study|Sample Size Sufficient|4|||
33516117|NCT01344824|62900737|FG000|Overall Study|Adverse Event|15|||
33516118|NCT01344824|62900737|FG000|Overall Study|Withdrawal by Subject|6|||
33516119|NCT01344824|62900737|FG000|Overall Study|Other complicating disease|1|||
33516120|NCT01344824|62900737|FG000|Overall Study|Progression|15|||
33516121|NCT03339245|62900744|FG000|Overall Study|Adverse Event|1|||
33516122|NCT03339245|62900745|FG001|Overall Study|Adverse Event|1|||
33516123|NCT03339245|62900744|FG000|Overall Study|Withdrawal by Subject|1|||
33516124|NCT03339245|62900745|FG001|Overall Study|Withdrawal by Subject|0|||
33516125|NCT03044574|62900753|FG000|Overall Study|Lost to Follow-up|37|||
33516126|NCT03044574|62900754|FG001|Overall Study|Lost to Follow-up|45|||
33516127|NCT02959892|62900762|FG000|Overall Study|PET tracer synthesis failure|1|||
33516128|NCT02959892|62900763|FG001|Overall Study|PET tracer synthesis failure|0|||
33516129|NCT02959892|62900762|FG000|Overall Study|Study termination|0|||
33516130|NCT02959892|62900763|FG001|Overall Study|Study termination|1|||
33516131|NCT03252145|62900771|FG000|Overall Study|Withdrawal by Subject|1|||
33516132|NCT03252145|62900772|FG001|Overall Study|Withdrawal by Subject|0|||
33516133|NCT03252145|62900771|FG000|Overall Study|Complicating Disease|1|||
33615563|NCT02161718|63016586|FG001|Post- Randomization Period|Adverse Event|9|||
33615564|NCT02161718|63016587|FG002|Post- Randomization Period|Adverse Event|10|||
33453754|NCT00110994|62828337|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
33516134|NCT03252145|62900772|FG001|Overall Study|Complicating Disease|2|||
33516135|NCT02959814|62900778|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
33516136|NCT02959814|62900778|FG000|Overall Study|Excluded based on anatomical criteria|2|||
33516137|NCT02959814|62900778|FG000|Overall Study|Protocol Violation|7|||
33516138|NCT02959814|62900778|FG000|Overall Study|FFR not measured|2|||
33516139|NCT02959814|62900778|FG000|Overall Study|In-procedure QFR not computed|6|||
33516140|NCT02959814|62900778|FG000|Overall Study|Excluded by FFR core-lab|24|||
33516141|NCT03666624|62900785|FG000|Overall Study|participant grieving over recent death of parent|1|||
33516142|NCT03666624|62900786|FG001|Overall Study|participant grieving over recent death of parent|0|||
33516143|NCT03368807|62900792|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
33516144|NCT03368807|62900792|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
33516145|NCT03368807|62900792|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
33516146|NCT03368807|62900792|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
33516147|NCT03338855|62900800|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
33516148|NCT03338855|62900801|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
33516149|NCT03367793|62900813|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
33516150|NCT03367793|62900814|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
33516151|NCT03367793|62900815|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
33516152|NCT03367793|62900816|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
33516153|NCT03367793|62900817|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
33516154|NCT03367793|62900818|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
33516155|NCT01347307|62900840|FG000|Overall Study|Death|0|||
33516156|NCT01347307|62900841|FG001|Overall Study|Death|4|||
33516157|NCT01347307|62900840|FG000|Overall Study|Physician Decision|0|||
33516158|NCT01347307|62900841|FG001|Overall Study|Physician Decision|1|||
33516159|NCT03247543|62900898|FG000|Overall Study|Adverse Event|3|||
33516160|NCT03247543|62900899|FG001|Overall Study|Adverse Event|6|||
33516161|NCT03247543|62900900|FG002|Overall Study|Adverse Event|4|||
33516162|NCT03247543|62900898|FG000|Overall Study|Lost to Follow-up|10|||
33516163|NCT03247543|62900899|FG001|Overall Study|Lost to Follow-up|7|||
33516164|NCT03247543|62900900|FG002|Overall Study|Lost to Follow-up|8|||
33516165|NCT03247543|62900898|FG000|Overall Study|Consent withdrawn by caregiver|2|||
33516166|NCT03247543|62900899|FG001|Overall Study|Consent withdrawn by caregiver|2|||
33516167|NCT03247543|62900900|FG002|Overall Study|Consent withdrawn by caregiver|9|||
33516168|NCT03247543|62900898|FG000|Overall Study|Withdrawal by Subject|0|||
33516169|NCT03247543|62900899|FG001|Overall Study|Withdrawal by Subject|0|||
33516170|NCT03247543|62900900|FG002|Overall Study|Withdrawal by Subject|1|||
33516171|NCT03247543|62900898|FG000|Overall Study|Failure to Follow study procedures|1|||
33516172|NCT03247543|62900899|FG001|Overall Study|Failure to Follow study procedures|3|||
33516173|NCT03247543|62900900|FG002|Overall Study|Failure to Follow study procedures|1|||
33516174|NCT03247543|62900898|FG000|Overall Study|Lack of Efficacy|1|||
33516175|NCT03247543|62900899|FG001|Overall Study|Lack of Efficacy|0|||
33516176|NCT03247543|62900900|FG002|Overall Study|Lack of Efficacy|0|||
33516177|NCT03247543|62900898|FG000|Overall Study|Non-compliance with study visits|0|||
33516178|NCT03247543|62900899|FG001|Overall Study|Non-compliance with study visits|1|||
33516179|NCT03247543|62900900|FG002|Overall Study|Non-compliance with study visits|0|||
33516180|NCT01347073|62900910|FG000|Overall Study|Adverse Event|1|||
33516181|NCT01347073|62900910|FG000|Overall Study|Liver Transplant|1|||
33516182|NCT01315236|62900922|FG000|Double-blind Phase|Death|1|||
33615565|NCT02161718|63016585|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
33453755|NCT00110994|62828336|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
33453756|NCT00110994|62828337|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
33453757|NCT00110994|62828336|FG000|Double-blind (DB) Treatment|other reasons|2|||
33453758|NCT00110994|62828337|FG001|Double-blind (DB) Treatment|other reasons|3|||
33453759|NCT00110994|62828336|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
33453760|NCT00110994|62828337|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
33615566|NCT02161718|63016586|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
33516183|NCT01315236|62900923|FG001|Double-blind Phase|Death|0|||
33516184|NCT01315236|62900922|FG000|Double-blind Phase|Adverse Event|1|||
33516185|NCT01315236|62900923|FG001|Double-blind Phase|Adverse Event|0|||
33516186|NCT01315236|62900922|FG000|Double-blind Phase|Withdrawal of Consent|1|||
33516187|NCT01315236|62900923|FG001|Double-blind Phase|Withdrawal of Consent|0|||
33516188|NCT01315236|62900922|FG000|Double-blind Phase|Lost to Follow-up|1|||
33516189|NCT01315236|62900923|FG001|Double-blind Phase|Lost to Follow-up|0|||
33516190|NCT01315236|62900922|FG000|Open-label Phase|Death|1|||
33516191|NCT01315236|62900923|FG001|Open-label Phase|Death|0|||
33516192|NCT01315236|62900922|FG000|Open-label Phase|Adverse Event|0|||
33516193|NCT01315236|62900923|FG001|Open-label Phase|Adverse Event|1|||
33516194|NCT01315236|62900922|FG000|Open-label Phase|Other|0|||
33516195|NCT01315236|62900923|FG001|Open-label Phase|Other|1|||
33516196|NCT01315236|62900922|FG000|12-Month Follow-up Period|Death|0|||
33516197|NCT01315236|62900923|FG001|12-Month Follow-up Period|Death|1|||
33516198|NCT01315236|62900922|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
33516199|NCT01315236|62900923|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
33516200|NCT03232567|62900935|FG000|Overall Study|Withdrawal by Subject|0|||
33516201|NCT03232567|62900936|FG001|Overall Study|Withdrawal by Subject|1|||
33516202|NCT03232567|62900937|FG002|Overall Study|Withdrawal by Subject|0|||
33516203|NCT03232567|62900938|FG003|Overall Study|Withdrawal by Subject|0|||
33516204|NCT01348490|62900959|FG000|Overall Study|Death|1|||
33516205|NCT01348490|62900959|FG000|Overall Study|Adverse Event|3|||
33516206|NCT01348490|62900959|FG000|Overall Study|Consent withdrawn|7|||
33516207|NCT01348490|62900959|FG000|Overall Study|Disease progression|3|||
33516208|NCT01348490|62900959|FG000|Overall Study|Lost to Follow-up|1|||
33516209|NCT01348490|62900959|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
33516210|NCT01348490|62900959|FG000|Overall Study|Other Unspecified|8|||
33516211|NCT03040674|62900980|FG000|Overall Study|Lost to Follow-up|225|||
33516212|NCT03040674|62900980|FG000|Overall Study|Death|23|||
33516213|NCT03232333|62900985|FG000|Overall Study|Infection or Osteomyelitis|9|||
33516214|NCT03232333|62900985|FG000|Overall Study|Lost to Follow-up|4|||
33516215|NCT03232333|62900985|FG000|Overall Study|Withdrawal by Subject|2|||
33516216|NCT03364049|62900993|FG000|Overall Study|Death|6|||
33516217|NCT03364049|62900994|FG001|Overall Study|Death|4|||
33516218|NCT03364049|62900995|FG002|Overall Study|Death|5|||
33516219|NCT03364049|62900996|FG003|Overall Study|Death|14|||
33516220|NCT03364049|62900993|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
33516221|NCT03364049|62900994|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
33516222|NCT03364049|62900995|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
33516223|NCT03364049|62900996|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
33516224|NCT03364049|62900993|FG000|Overall Study|Withdrawal by Subject|0|||
33516225|NCT03364049|62900994|FG001|Overall Study|Withdrawal by Subject|1|||
33516226|NCT03364049|62900995|FG002|Overall Study|Withdrawal by Subject|1|||
33516227|NCT03364049|62900996|FG003|Overall Study|Withdrawal by Subject|1|||
33516228|NCT03238963|62901008|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
33516229|NCT03238963|62901009|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
33516230|NCT03238963|62901008|FG000|Overall Study|Withdrawal by Subject|1|||
33516231|NCT03238963|62901009|FG001|Overall Study|Withdrawal by Subject|1|||
33516232|NCT03238963|62901008|FG000|Overall Study|Lost to Follow-up|1|||
33516233|NCT03238963|62901009|FG001|Overall Study|Lost to Follow-up|0|||
33516234|NCT03238963|62901008|FG000|Overall Study|Protocol Violation|1|||
33516235|NCT03238963|62901009|FG001|Overall Study|Protocol Violation|1|||
33516236|NCT03238963|62901008|FG000|Overall Study|Adverse Event|1|||
33516237|NCT03238963|62901009|FG001|Overall Study|Adverse Event|0|||
33516238|NCT03337139|62901017|FG000|Phase I|Withdrawal by Subject|10|||
33516239|NCT03337139|62901018|FG001|Phase I|Withdrawal by Subject|0|||
33516240|NCT03042312|62901026|FG000|Overall Study|Administrative Reason|1|||
33516241|NCT03042312|62901027|FG001|Overall Study|Administrative Reason|1|||
33516242|NCT03042312|62901026|FG000|Overall Study|Adverse Event|0|||
33516243|NCT03042312|62901027|FG001|Overall Study|Adverse Event|1|||
33516244|NCT03042312|62901026|FG000|Overall Study|Lost to Follow-up|1|||
33516245|NCT03042312|62901027|FG001|Overall Study|Lost to Follow-up|3|||
33516246|NCT03042312|62901026|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
33516247|NCT03042312|62901027|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
33516248|NCT03042312|62901026|FG000|Overall Study|Withdrawal by Subject|4|||
33516249|NCT03042312|62901027|FG001|Overall Study|Withdrawal by Subject|5|||
33516250|NCT03360071|62901035|FG000|Overall Study|Lost to Follow-up|1|||
33516251|NCT03360071|62901036|FG001|Overall Study|Lost to Follow-up|0|||
33516252|NCT02949011|62901045|FG000|Overall Study|Adverse Event|6|||
33516253|NCT02949011|62901046|FG001|Overall Study|Adverse Event|7|||
33516254|NCT02949011|62901047|FG002|Overall Study|Adverse Event|3|||
33516255|NCT02949011|62901045|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
33516256|NCT02949011|62901046|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
33516257|NCT02949011|62901047|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
33516258|NCT02949011|62901045|FG000|Overall Study|Protocol Deviation|5|||
33516259|NCT02949011|62901046|FG001|Overall Study|Protocol Deviation|3|||
33516260|NCT02949011|62901047|FG002|Overall Study|Protocol Deviation|3|||
33516261|NCT02949011|62901045|FG000|Overall Study|Lack of Efficacy|0|||
33516262|NCT02949011|62901046|FG001|Overall Study|Lack of Efficacy|2|||
33516263|NCT02949011|62901047|FG002|Overall Study|Lack of Efficacy|0|||
33516264|NCT02949011|62901045|FG000|Overall Study|Withdrawal by Subject|13|||
33516265|NCT02949011|62901046|FG001|Overall Study|Withdrawal by Subject|13|||
33516266|NCT02949011|62901047|FG002|Overall Study|Withdrawal by Subject|21|||
33516267|NCT02949011|62901045|FG000|Overall Study|Lost to Follow-up|7|||
33516268|NCT02949011|62901046|FG001|Overall Study|Lost to Follow-up|5|||
33516269|NCT02949011|62901047|FG002|Overall Study|Lost to Follow-up|5|||
33516270|NCT02949011|62901045|FG000|Overall Study|Death|0|||
33516271|NCT02949011|62901046|FG001|Overall Study|Death|0|||
33516272|NCT02949011|62901047|FG002|Overall Study|Death|1|||
33516273|NCT02949011|62901045|FG000|Overall Study|Miscellaneous|2|||
33516274|NCT02949011|62901046|FG001|Overall Study|Miscellaneous|4|||
33516275|NCT02949011|62901047|FG002|Overall Study|Miscellaneous|6|||
33516276|NCT03357731|62901059|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
33516277|NCT03357731|62901060|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
33516278|NCT03357731|62901061|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
33516279|NCT03357731|62901062|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
33516280|NCT03357731|62901063|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
33516281|NCT03357731|62901064|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
33516282|NCT03357731|62901059|FG000|Overall Study|Acute bradycardia and hypotension|0|||
33516283|NCT03357731|62901060|FG001|Overall Study|Acute bradycardia and hypotension|0|||
33516284|NCT03357731|62901061|FG002|Overall Study|Acute bradycardia and hypotension|0|||
33516285|NCT03357731|62901062|FG003|Overall Study|Acute bradycardia and hypotension|1|||
33516286|NCT03357731|62901063|FG004|Overall Study|Acute bradycardia and hypotension|0|||
33516287|NCT03357731|62901064|FG005|Overall Study|Acute bradycardia and hypotension|0|||
33516288|NCT03357731|62901059|FG000|Overall Study|Adverse Event|0|||
33516289|NCT03357731|62901060|FG001|Overall Study|Adverse Event|0|||
33516290|NCT03357731|62901061|FG002|Overall Study|Adverse Event|0|||
33516291|NCT03357731|62901062|FG003|Overall Study|Adverse Event|0|||
33516292|NCT03357731|62901063|FG004|Overall Study|Adverse Event|0|||
33516293|NCT03357731|62901064|FG005|Overall Study|Adverse Event|1|||
33516294|NCT03357731|62901059|FG000|Overall Study|Hypotension|0|||
33516295|NCT03357731|62901060|FG001|Overall Study|Hypotension|0|||
33516296|NCT03357731|62901061|FG002|Overall Study|Hypotension|1|||
33516297|NCT03357731|62901062|FG003|Overall Study|Hypotension|1|||
33516298|NCT03357731|62901063|FG004|Overall Study|Hypotension|0|||
33516299|NCT03357731|62901064|FG005|Overall Study|Hypotension|0|||
33516300|NCT03357731|62901059|FG000|Overall Study|Lost to Follow-up|0|||
33516301|NCT03357731|62901060|FG001|Overall Study|Lost to Follow-up|0|||
33516302|NCT03357731|62901061|FG002|Overall Study|Lost to Follow-up|0|||
33516303|NCT03357731|62901062|FG003|Overall Study|Lost to Follow-up|1|||
33516304|NCT03357731|62901063|FG004|Overall Study|Lost to Follow-up|0|||
33516305|NCT03357731|62901064|FG005|Overall Study|Lost to Follow-up|0|||
33516306|NCT03357341|62901074|FG000|Overall Study|Withdrawal by Subject|3|||
33516307|NCT03357341|62901075|FG001|Overall Study|Withdrawal by Subject|6|||
33516308|NCT03357341|62901074|FG000|Overall Study|Lost to Follow-up|4|||
33516309|NCT03357341|62901075|FG001|Overall Study|Lost to Follow-up|5|||
33516310|NCT03357341|62901074|FG000|Overall Study|Death|0|||
33516311|NCT03357341|62901075|FG001|Overall Study|Death|1|||
33516312|NCT03039738|62901084|FG000|Overall Study|Incomplete data sets|54|||
33516313|NCT03039738|62901085|FG001|Overall Study|Incomplete data sets|0|||
33516314|NCT03036852|62901116|FG000|Overall Study|Death|2|||
33516315|NCT03036852|62901116|FG000|Overall Study|Lack of Efficacy|2|||
33516316|NCT03036852|62901116|FG000|Overall Study|Adverse Event|1|||
33516317|NCT03036852|62901116|FG000|Overall Study|Lost to Follow-up|1|||
33516318|NCT02945657|62901127|FG000|Overall Study|Adverse Event|1|||
33516319|NCT02945657|62901127|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
33516320|NCT02948777|62901132|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
33615567|NCT02161718|63016587|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
33324677|NCT01119066|62701248|FG003|Overall Study|Relapse identified before transplant|0|||
33516321|NCT03324581|62901140|FG000|Overall Study|Adverse Event|18|||
33516322|NCT03324581|62901141|FG001|Overall Study|Adverse Event|11|||
33516323|NCT03324581|62901142|FG002|Overall Study|Adverse Event|7|||
33516324|NCT03324581|62901140|FG000|Overall Study|Lack of Efficacy|0|||
33516325|NCT03324581|62901141|FG001|Overall Study|Lack of Efficacy|1|||
33615568|NCT02161718|63016585|FG000|Post- Randomization Period|Physician Decision|0|||
33615569|NCT02161718|63016586|FG001|Post- Randomization Period|Physician Decision|2|||
33516326|NCT03324581|62901142|FG002|Overall Study|Lack of Efficacy|0|||
33516327|NCT03324581|62901140|FG000|Overall Study|Lost to Follow-up|5|||
33516328|NCT03324581|62901141|FG001|Overall Study|Lost to Follow-up|3|||
33516329|NCT03324581|62901142|FG002|Overall Study|Lost to Follow-up|6|||
33516330|NCT03324581|62901140|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
33516331|NCT03324581|62901141|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
33516332|NCT03324581|62901142|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
33516333|NCT03324581|62901140|FG000|Overall Study|Physician Decision|0|||
33516334|NCT03324581|62901141|FG001|Overall Study|Physician Decision|1|||
33516335|NCT03324581|62901142|FG002|Overall Study|Physician Decision|2|||
33516336|NCT03324581|62901140|FG000|Overall Study|Protocol Deviation|8|||
33516337|NCT03324581|62901141|FG001|Overall Study|Protocol Deviation|9|||
33516338|NCT03324581|62901142|FG002|Overall Study|Protocol Deviation|4|||
33516339|NCT03324581|62901140|FG000|Overall Study|Withdrawal by Subject|6|||
33516340|NCT03324581|62901141|FG001|Overall Study|Withdrawal by Subject|8|||
33516341|NCT03324581|62901142|FG002|Overall Study|Withdrawal by Subject|6|||
33516342|NCT03324581|62901140|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
33516343|NCT03324581|62901141|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
33516344|NCT03324581|62901142|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
33516345|NCT02943473|62901150|FG000|Overall Study|enrolled but not dosed|1|||
33516346|NCT02943473|62901150|FG000|Overall Study|screen failure|1|||
33516347|NCT02943473|62901150|FG000|Overall Study|Physician Decision|4|||
33516348|NCT03320369|62901154|FG000|Overall Study|Adverse Event|1|||
33516349|NCT03320369|62901154|FG000|Overall Study|Withdrawal by Subject|2|||
33516350|NCT02650895|62901164|FG000|Overall Study|Withdrawal by Subject|0|||
33516351|NCT02650895|62901165|FG001|Overall Study|Withdrawal by Subject|1|||
33516352|NCT02650895|62901166|FG002|Overall Study|Withdrawal by Subject|0|||
33516353|NCT02650895|62901167|FG003|Overall Study|Withdrawal by Subject|0|||
33516354|NCT02650895|62901168|FG004|Overall Study|Withdrawal by Subject|0|||
33516355|NCT02650895|62901169|FG005|Overall Study|Withdrawal by Subject|0|||
33516356|NCT03320057|62901188|FG000|Overall Study|Lost to Follow-up|4|||
33516357|NCT03320057|62901189|FG001|Overall Study|Lost to Follow-up|17|||
33516358|NCT03320057|62901188|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
33516359|NCT03320057|62901189|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
33516360|NCT03316547|62901197|FG000|Overall Study|Death|3|||
33516361|NCT03316547|62901198|FG001|Overall Study|Death|1|||
33516362|NCT03316547|62901197|FG000|Overall Study|Lost to Follow-up|6|||
33516363|NCT03316547|62901198|FG001|Overall Study|Lost to Follow-up|6|||
33516364|NCT03316547|62901197|FG000|Overall Study|Withdrawal by Subject|3|||
33516365|NCT03316547|62901198|FG001|Overall Study|Withdrawal by Subject|2|||
33516366|NCT03316547|62901197|FG000|Overall Study|Transfer to another hospital|6|||
33516367|NCT03316547|62901198|FG001|Overall Study|Transfer to another hospital|4|||
33516368|NCT03315689|62901221|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
33516369|NCT03315689|62901222|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
33516370|NCT03315689|62901221|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
33516371|NCT03315689|62901222|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
33516372|NCT03315689|62901221|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
33516373|NCT03315689|62901222|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
33516374|NCT03314519|62901232|FG000|Overall Study|Protocol Violation|3|||
33516375|NCT03314519|62901233|FG001|Overall Study|Protocol Violation|2|||
33516376|NCT03313037|62901245|FG000|Overall Study|Protocol Violation|4|||
33516377|NCT03313037|62901246|FG001|Overall Study|Protocol Violation|1|||
33516378|NCT03313037|62901245|FG000|Overall Study|Other|1|||
33516379|NCT03313037|62901246|FG001|Overall Study|Other|1|||
33516380|NCT03313037|62901245|FG000|Overall Study|Withdrawal by Subject|4|||
33516381|NCT03313037|62901246|FG001|Overall Study|Withdrawal by Subject|3|||
33516382|NCT03313037|62901245|FG000|Overall Study|No longer meets eligibility criteria|1|||
33516383|NCT03313037|62901246|FG001|Overall Study|No longer meets eligibility criteria|7|||
33516384|NCT03313037|62901245|FG000|Overall Study|Lost to Follow-up|9|||
33516385|NCT03313037|62901246|FG001|Overall Study|Lost to Follow-up|8|||
33516386|NCT03313037|62901245|FG000|Overall Study|Randomized but not treated|1|||
33516387|NCT03313037|62901246|FG001|Overall Study|Randomized but not treated|0|||
33516388|NCT02420795|62901255|FG000|Overall Study|Withdrawal by Subject|1|||
33516389|NCT02420795|62901256|FG001|Overall Study|Withdrawal by Subject|0|||
33516390|NCT02420795|62901257|FG002|Overall Study|Withdrawal by Subject|0|||
33516391|NCT02420795|62901255|FG000|Overall Study|Adverse Event|1|||
33516392|NCT02420795|62901256|FG001|Overall Study|Adverse Event|0|||
33516393|NCT02420795|62901257|FG002|Overall Study|Adverse Event|0|||
33516394|NCT02420795|62901255|FG000|Overall Study|Progressive disease|2|||
33516395|NCT02420795|62901256|FG001|Overall Study|Progressive disease|2|||
33516396|NCT02420795|62901257|FG002|Overall Study|Progressive disease|4|||
33615570|NCT02161718|63016587|FG002|Post- Randomization Period|Physician Decision|4|||
33615571|NCT02161718|63016585|FG000|Post- Randomization Period|Protocol Violation|0|||
33516397|NCT02420795|62901255|FG000|Overall Study|Death|0|||
33516398|NCT02420795|62901256|FG001|Overall Study|Death|0|||
33516399|NCT02420795|62901257|FG002|Overall Study|Death|1|||
33615572|NCT02161718|63016586|FG001|Post- Randomization Period|Protocol Violation|2|||
33516400|NCT03334175|62901269|FG000|Overall Study|Lost to Follow-up|0|||
33453761|NCT00110994|62828336|FG000|Active Follow-up|Other reasons|0|||
33453762|NCT00110994|62828337|FG001|Active Follow-up|Other reasons|2|||
33453763|NCT00110994|62828336|FG000|Long Term Follow-up|Death|19|||
33453764|NCT00110994|62828337|FG001|Long Term Follow-up|Death|17|||
33453765|NCT00144170|62828345|FG000|Overall Study|Adverse Event|84|||
33453766|NCT00144170|62828346|FG001|Overall Study|Adverse Event|41|||
33453767|NCT00144170|62828345|FG000|Overall Study|Protocol Violation|23|||
33453768|NCT00144170|62828346|FG001|Overall Study|Protocol Violation|16|||
33453769|NCT00144170|62828345|FG000|Overall Study|Lost to Follow-up|5|||
33453770|NCT00144170|62828346|FG001|Overall Study|Lost to Follow-up|10|||
33453771|NCT00144170|62828345|FG000|Overall Study|Withdrawal by Subject|29|||
33453772|NCT00144170|62828346|FG001|Overall Study|Withdrawal by Subject|13|||
33453773|NCT00144170|62828345|FG000|Overall Study|Other reason not defined above|211|||
33453774|NCT00144170|62828346|FG001|Overall Study|Other reason not defined above|316|||
33453775|NCT00255086|62828354|FG000|Overall Study|Adverse Event|1|||
33453776|NCT00255086|62828355|FG001|Overall Study|Adverse Event|1|||
33453777|NCT00255086|62828354|FG000|Overall Study|Protocol Violation|1|||
33453778|NCT00255086|62828355|FG001|Overall Study|Protocol Violation|1|||
33453779|NCT00110214|62828364|FG000|Overall Study|Never started treatment|21|||
33453780|NCT00110214|62828365|FG001|Overall Study|Never started treatment|20|||
33453781|NCT00110214|62828364|FG000|Overall Study|Disease progression or death|260|||
33453782|NCT00110214|62828365|FG001|Overall Study|Disease progression or death|151|||
33453783|NCT00110214|62828364|FG000|Overall Study|Adverse Event|115|||
33453784|NCT00110214|62828365|FG001|Overall Study|Adverse Event|192|||
33453785|NCT00110214|62828364|FG000|Overall Study|Refused further treatment|52|||
33453786|NCT00110214|62828365|FG001|Overall Study|Refused further treatment|65|||
33453787|NCT00110214|62828364|FG000|Overall Study|Other (not specified)|61|||
33453788|NCT00110214|62828365|FG001|Overall Study|Other (not specified)|75|||
33453789|NCT00124020|62828373|FG000|Overall Study|Death|67|||
33453790|NCT00124020|62828374|FG001|Overall Study|Death|71|||
33453791|NCT00124020|62828373|FG000|Overall Study|Withdrawal by Subject|13|||
33453792|NCT00124020|62828374|FG001|Overall Study|Withdrawal by Subject|11|||
33453793|NCT00124020|62828373|FG000|Overall Study|Lost to Follow-up|5|||
33453794|NCT00124020|62828374|FG001|Overall Study|Lost to Follow-up|8|||
33453795|NCT00124020|62828373|FG000|Overall Study|Other|1|||
33453796|NCT00124020|62828374|FG001|Overall Study|Other|1|||
33453797|NCT00124020|62828373|FG000|Overall Study|Transfer to another hospital|2|||
33453798|NCT00124020|62828374|FG001|Overall Study|Transfer to another hospital|0|||
33453799|NCT00215540|62828383|FG000|Overall Study|Withdrew from study medication|1|||
33453800|NCT00215540|62828384|FG001|Overall Study|Withdrew from study medication|0|||
33453801|NCT00215540|62828385|FG002|Overall Study|Withdrew from study medication|0|||
33453802|NCT00143390|62828395|FG000|Overall Study|Death|2|||
33453803|NCT00143390|62828396|FG001|Overall Study|Death|0|||
33453804|NCT00143390|62828395|FG000|Overall Study|Not meeting entry criteria|2|||
33453805|NCT00143390|62828396|FG001|Overall Study|Not meeting entry criteria|5|||
33453806|NCT00143390|62828395|FG000|Overall Study|Withdrawal by Subject|4|||
33453807|NCT00143390|62828396|FG001|Overall Study|Withdrawal by Subject|4|||
33453808|NCT00143390|62828395|FG000|Overall Study|Progressive disease|119|||
33453809|NCT00143390|62828396|FG001|Overall Study|Progressive disease|115|||
33453810|NCT00143390|62828395|FG000|Overall Study|Protocol Violation|2|||
33453811|NCT00143390|62828396|FG001|Overall Study|Protocol Violation|0|||
33453812|NCT00143390|62828395|FG000|Overall Study|Study termination|10|||
33453813|NCT00143390|62828396|FG001|Overall Study|Study termination|15|||
33453814|NCT00143390|62828395|FG000|Overall Study|Adverse Event|9|||
33453815|NCT00143390|62828396|FG001|Overall Study|Adverse Event|8|||
33453816|NCT00143390|62828395|FG000|Overall Study|Other|1|||
33453817|NCT00143390|62828396|FG001|Overall Study|Other|2|||
33453818|NCT00141102|62828404|FG000|Overall Study|Adverse Event|233|||
33453819|NCT00141102|62828405|FG001|Overall Study|Adverse Event|305|||
33453820|NCT00141102|62828404|FG000|Overall Study|Laboratory Abnormality|9|||
33453821|NCT00141102|62828405|FG001|Overall Study|Laboratory Abnormality|33|||
33453822|NCT00141102|62828404|FG000|Overall Study|Lack of Efficacy|21|||
33453823|NCT00141102|62828405|FG001|Overall Study|Lack of Efficacy|26|||
33453824|NCT00141102|62828404|FG000|Overall Study|Lost to Follow-up|29|||
33453825|NCT00141102|62828405|FG001|Overall Study|Lost to Follow-up|32|||
33453826|NCT00141102|62828404|FG000|Overall Study|Other|87|||
33453827|NCT00141102|62828405|FG001|Overall Study|Other|76|||
33453828|NCT00141102|62828404|FG000|Overall Study|Withdrawal by Subject|112|||
33453829|NCT00141102|62828405|FG001|Overall Study|Withdrawal by Subject|142|||
33516401|NCT03334175|62901270|FG001|Overall Study|Lost to Follow-up|1|||
33516402|NCT02942771|62901281|FG000|Overall Study|Adverse Event|1|||
33516403|NCT02942771|62901282|FG001|Overall Study|Adverse Event|0|||
33516404|NCT02942771|62901283|FG002|Overall Study|Adverse Event|0|||
33516405|NCT02942771|62901284|FG003|Overall Study|Adverse Event|0|||
33516406|NCT02942771|62901285|FG004|Overall Study|Adverse Event|2|||
33516407|NCT02942771|62901281|FG000|Overall Study|Lost to Follow-up|1|||
33516408|NCT02942771|62901282|FG001|Overall Study|Lost to Follow-up|0|||
33516409|NCT02942771|62901283|FG002|Overall Study|Lost to Follow-up|0|||
33516410|NCT02942771|62901284|FG003|Overall Study|Lost to Follow-up|0|||
33516411|NCT02942771|62901285|FG004|Overall Study|Lost to Follow-up|0|||
33516412|NCT02942771|62901281|FG000|Overall Study|Withdrawal by Subject|1|||
33516413|NCT02942771|62901282|FG001|Overall Study|Withdrawal by Subject|0|||
33516414|NCT02942771|62901283|FG002|Overall Study|Withdrawal by Subject|0|||
33516415|NCT02942771|62901284|FG003|Overall Study|Withdrawal by Subject|0|||
33516416|NCT02942771|62901285|FG004|Overall Study|Withdrawal by Subject|2|||
33516417|NCT03036150|62901299|FG000|Overall Study|Withdrawal by Subject|8|||
33516418|NCT03036150|62901300|FG001|Overall Study|Withdrawal by Subject|3|||
33516419|NCT03036150|62901299|FG000|Overall Study|Lost to Follow-up|2|||
33516420|NCT03036150|62901300|FG001|Overall Study|Lost to Follow-up|2|||
33453830|NCT00141102|62828404|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
33453831|NCT00141102|62828405|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
33453832|NCT00141102|62828404|FG000|Overall Study|Death|2|||
33453833|NCT00141102|62828405|FG001|Overall Study|Death|2|||
33453834|NCT00255008|62828416|FG000|Overall Study|Adverse Event|1|||
33453835|NCT00255008|62828417|FG001|Overall Study|Adverse Event|1|||
33453836|NCT00255008|62828418|FG002|Overall Study|Adverse Event|2|||
33453837|NCT00255008|62828419|FG003|Overall Study|Adverse Event|0|||
33453838|NCT00255008|62828416|FG000|Overall Study|Lost to Follow-up|1|||
33453839|NCT00255008|62828417|FG001|Overall Study|Lost to Follow-up|0|||
33453840|NCT00255008|62828418|FG002|Overall Study|Lost to Follow-up|1|||
33453841|NCT00255008|62828419|FG003|Overall Study|Lost to Follow-up|2|||
33453842|NCT00255008|62828416|FG000|Overall Study|Did not meet viral reduction criteria|4|||
33453843|NCT00255008|62828417|FG001|Overall Study|Did not meet viral reduction criteria|5|||
33453844|NCT00255008|62828418|FG002|Overall Study|Did not meet viral reduction criteria|0|||
33453845|NCT00255008|62828419|FG003|Overall Study|Did not meet viral reduction criteria|1|||
33453846|NCT00255008|62828416|FG000|Overall Study|Withdrew consent|0|||
33453847|NCT00255008|62828417|FG001|Overall Study|Withdrew consent|0|||
33453848|NCT00255008|62828418|FG002|Overall Study|Withdrew consent|2|||
33453849|NCT00255008|62828419|FG003|Overall Study|Withdrew consent|0|||
33324678|NCT01119066|62701245|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
33324679|NCT01119066|62701246|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
33324680|NCT01119066|62701247|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
33324681|NCT01119066|62701248|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
33324682|NCT01119066|62701245|FG000|Overall Study|Relapse identified before transplant|0|||
33324683|NCT01119066|62701246|FG001|Overall Study|Relapse identified before transplant|4|||
33453850|NCT00255008|62828416|FG000|Overall Study|Sponsor request|18|||
33516421|NCT03332771|62901310|FG000|Overall Study|Adverse Event|6|||
33516422|NCT03332771|62901311|FG001|Overall Study|Adverse Event|4|||
33516423|NCT03332771|62901312|FG002|Overall Study|Adverse Event|1|||
33516424|NCT03332771|62901313|FG003|Overall Study|Adverse Event|3|||
33516425|NCT03332771|62901310|FG000|Overall Study|Poor Compliance to Protocol|0|||
33516426|NCT03332771|62901311|FG001|Overall Study|Poor Compliance to Protocol|1|||
33516427|NCT03332771|62901312|FG002|Overall Study|Poor Compliance to Protocol|0|||
33516428|NCT03332771|62901313|FG003|Overall Study|Poor Compliance to Protocol|1|||
33516429|NCT03332771|62901310|FG000|Overall Study|Lost to Follow-up|2|||
33516430|NCT03332771|62901311|FG001|Overall Study|Lost to Follow-up|2|||
33516431|NCT03332771|62901312|FG002|Overall Study|Lost to Follow-up|1|||
33516432|NCT03332771|62901313|FG003|Overall Study|Lost to Follow-up|2|||
33516433|NCT03332771|62901310|FG000|Overall Study|At the Participant's own request|20|||
33516434|NCT03332771|62901311|FG001|Overall Study|At the Participant's own request|26|||
33453851|NCT00255008|62828417|FG001|Overall Study|Sponsor request|3|||
33453852|NCT00255008|62828418|FG002|Overall Study|Sponsor request|8|||
33453853|NCT00255008|62828419|FG003|Overall Study|Sponsor request|17|||
33516435|NCT03332771|62901312|FG002|Overall Study|At the Participant's own request|14|||
33516436|NCT03332771|62901313|FG003|Overall Study|At the Participant's own request|23|||
33516437|NCT03332771|62901310|FG000|Overall Study|Reason Not Specified|6|||
33516438|NCT03332771|62901311|FG001|Overall Study|Reason Not Specified|18|||
33516439|NCT03332771|62901312|FG002|Overall Study|Reason Not Specified|16|||
33516440|NCT03332771|62901313|FG003|Overall Study|Reason Not Specified|19|||
33516441|NCT03310775|62901325|FG000|Overall Study|Lost to Follow-up|2|||
33516442|NCT03310775|62901326|FG001|Overall Study|Lost to Follow-up|3|||
33516443|NCT03310775|62901325|FG000|Overall Study|aggravation of depression|0|||
33516444|NCT03310775|62901326|FG001|Overall Study|aggravation of depression|1|||
33516445|NCT03330119|62901338|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
33516446|NCT03330119|62901339|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
33516447|NCT03040986|62901347|FG000|Overall Study|Hospice|1|||
33516448|NCT03040986|62901348|FG001|Overall Study|Hospice|0|||
33516449|NCT03040986|62901347|FG000|Overall Study|Adverse Event|2|||
33516450|NCT03040986|62901348|FG001|Overall Study|Adverse Event|1|||
33516451|NCT03040986|62901347|FG000|Overall Study|Disease progression on study|3|||
33516452|NCT03040986|62901348|FG001|Overall Study|Disease progression on study|1|||
33516453|NCT03039192|62901358|FG000|Overall Study|Lost to Follow-up|4|||
33516454|NCT03039192|62901359|FG001|Overall Study|Lost to Follow-up|4|||
33516455|NCT03039192|62901358|FG000|Overall Study|Adverse event, serious fatal|0|||
33516456|NCT03039192|62901359|FG001|Overall Study|Adverse event, serious fatal|1|||
33516457|NCT03039192|62901358|FG000|Overall Study|Adverse event, non-fatal|0|||
33516458|NCT03039192|62901359|FG001|Overall Study|Adverse event, non-fatal|2|||
33516459|NCT03039192|62901358|FG000|Overall Study|Withdrawal by Subject|6|||
33516460|NCT03039192|62901359|FG001|Overall Study|Withdrawal by Subject|9|||
33516461|NCT03039192|62901358|FG000|Overall Study|Discontinued from treatment phase|19|||
33516462|NCT03039192|62901359|FG001|Overall Study|Discontinued from treatment phase|12|||
33516463|NCT03039192|62901358|FG000|Overall Study|Other|3|||
33516464|NCT03039192|62901359|FG001|Overall Study|Other|2|||
33516465|NCT03698279|62901371|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33516466|NCT03698279|62901372|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33516467|NCT03698279|62901373|FG002|Overall Study|Withdrawal by parent/guardian|1|||
33516468|NCT03698279|62901374|FG003|Overall Study|Withdrawal by parent/guardian|1|||
33516469|NCT03698279|62901375|FG004|Overall Study|Withdrawal by parent/guardian|0|||
33516470|NCT03698279|62901376|FG005|Overall Study|Withdrawal by parent/guardian|0|||
33516471|NCT03698279|62901371|FG000|Overall Study|Protocol deviation|1|||
33516472|NCT03698279|62901372|FG001|Overall Study|Protocol deviation|0|||
33516473|NCT03698279|62901373|FG002|Overall Study|Protocol deviation|1|||
33516474|NCT03698279|62901374|FG003|Overall Study|Protocol deviation|0|||
33516475|NCT03698279|62901375|FG004|Overall Study|Protocol deviation|0|||
33516476|NCT03698279|62901376|FG005|Overall Study|Protocol deviation|0|||
33516477|NCT03698279|62901371|FG000|Overall Study|Withdrawal by Subject|0|||
33516478|NCT03698279|62901372|FG001|Overall Study|Withdrawal by Subject|0|||
33516479|NCT03698279|62901373|FG002|Overall Study|Withdrawal by Subject|1|||
33516480|NCT03698279|62901374|FG003|Overall Study|Withdrawal by Subject|0|||
33516481|NCT03698279|62901375|FG004|Overall Study|Withdrawal by Subject|0|||
33516482|NCT03698279|62901376|FG005|Overall Study|Withdrawal by Subject|0|||
33516483|NCT03698279|62901371|FG000|Overall Study|Lost to Follow-up|3|||
33516484|NCT03698279|62901372|FG001|Overall Study|Lost to Follow-up|1|||
33516485|NCT03698279|62901373|FG002|Overall Study|Lost to Follow-up|4|||
33516486|NCT03698279|62901374|FG003|Overall Study|Lost to Follow-up|5|||
33516487|NCT03698279|62901375|FG004|Overall Study|Lost to Follow-up|0|||
33516488|NCT03698279|62901376|FG005|Overall Study|Lost to Follow-up|0|||
33516489|NCT01529034|62901395|FG000|Overall Study|Discontinued prior to study treatment|14|||
33516490|NCT01529034|62901395|FG000|Overall Study|Site closure|62|||
33516491|NCT01529034|62901395|FG000|Overall Study|Study termination|29|||
33516492|NCT01529034|62901395|FG000|Overall Study|Withdrawal by Subject|25|||
33516493|NCT01529034|62901395|FG000|Overall Study|No treated SCs within protocol window|13|||
33516494|NCT01529034|62901395|FG000|Overall Study|Noncompliance|8|||
33516495|NCT01529034|62901395|FG000|Overall Study|Caregiver no longer available|7|||
33516496|NCT01529034|62901395|FG000|Overall Study|Adverse Event|4|||
33516497|NCT01529034|62901395|FG000|Overall Study|Protocol Violation|4|||
33516498|NCT01529034|62901395|FG000|Overall Study|Lack of Efficacy|4|||
33516499|NCT01529034|62901395|FG000|Overall Study|Investigator no longer available|2|||
33516500|NCT01529034|62901395|FG000|Overall Study|Study drug not available|2|||
33516501|NCT03036072|62901402|FG000|Overall Study|Death|0|||
33516502|NCT03036072|62901403|FG001|Overall Study|Death|1|||
33516503|NCT03036072|62901402|FG000|Overall Study|Withdrawal by Subject|0|||
33516504|NCT03036072|62901403|FG001|Overall Study|Withdrawal by Subject|1|||
33516505|NCT03036072|62901402|FG000|Overall Study|Physician Decision|0|||
33516506|NCT03036072|62901403|FG001|Overall Study|Physician Decision|1|||
33516507|NCT03038880|62901412|FG000|Overall Study|Death|1|||
33516508|NCT03038880|62901413|FG001|Overall Study|Death|2|||
33516509|NCT03038880|62901414|FG002|Overall Study|Death|0|||
33516510|NCT03038880|62901412|FG000|Overall Study|Physician Decision|2|||
33516511|NCT03038880|62901413|FG001|Overall Study|Physician Decision|1|||
33516512|NCT03038880|62901414|FG002|Overall Study|Physician Decision|0|||
33516513|NCT03035916|62901425|FG000|Overall Study|Puncture failed|0|||
33516514|NCT03035916|62901426|FG001|Overall Study|Puncture failed|2|||
33516515|NCT03035916|62901427|FG002|Overall Study|Puncture failed|0|||
33516516|NCT01702571|62901437|FG000|Overall Study|Death|1067|||
33516517|NCT01702571|62901438|FG001|Overall Study|Death|76|||
33516518|NCT01702571|62901437|FG000|Overall Study|Lost to Follow-up|144|||
33516519|NCT01702571|62901438|FG001|Overall Study|Lost to Follow-up|10|||
33516520|NCT01702571|62901437|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
33516521|NCT01702571|62901438|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
33516522|NCT01702571|62901437|FG000|Overall Study|Investigator Decision|5|||
33516523|NCT01702571|62901438|FG001|Overall Study|Investigator Decision|0|||
33516524|NCT01702571|62901437|FG000|Overall Study|Not Classifiable|1|||
33516525|NCT01702571|62901438|FG001|Overall Study|Not Classifiable|0|||
33516526|NCT01702571|62901437|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
33516527|NCT01702571|62901438|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
33516528|NCT01702571|62901437|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
33516529|NCT01702571|62901438|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
33516530|NCT01702571|62901437|FG000|Overall Study|Progressive Disease|3|||
33516531|NCT01702571|62901438|FG001|Overall Study|Progressive Disease|0|||
33516532|NCT01702571|62901437|FG000|Overall Study|Protocol Violation|2|||
33516533|NCT01702571|62901438|FG001|Overall Study|Protocol Violation|0|||
33516534|NCT01702571|62901437|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
33516535|NCT01702571|62901438|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
33516536|NCT01702571|62901437|FG000|Overall Study|Termination By Sponsor|4|||
33516537|NCT01702571|62901438|FG001|Overall Study|Termination By Sponsor|0|||
33516538|NCT01702571|62901437|FG000|Overall Study|Withdrawal by Subject|177|||
33516539|NCT01702571|62901438|FG001|Overall Study|Withdrawal by Subject|29|||
33516540|NCT03231943|62901461|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33516541|NCT03231943|62901462|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
33516542|NCT03231943|62901463|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
33516543|NCT03231943|62901464|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33516544|NCT03231943|62901465|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33516545|NCT03231943|62901466|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33516546|NCT03231943|62901467|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33516547|NCT03231943|62901468|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33516548|NCT03231943|62901469|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33516549|NCT03231943|62901470|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33516550|NCT03231943|62901471|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33516551|NCT03231943|62901472|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33516552|NCT03231943|62901473|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33516553|NCT03231943|62901461|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33516554|NCT03231943|62901462|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
33516555|NCT03231943|62901463|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33516556|NCT03231943|62901464|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33516557|NCT03231943|62901465|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33516558|NCT03231943|62901466|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33516559|NCT03231943|62901467|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33516560|NCT03231943|62901468|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33516561|NCT03231943|62901469|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33516562|NCT03231943|62901470|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33516563|NCT03231943|62901471|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33516564|NCT03231943|62901472|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33516565|NCT03231943|62901473|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33516566|NCT03231943|62901461|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
33516567|NCT03231943|62901462|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33516568|NCT03231943|62901463|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33516569|NCT03231943|62901464|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33516570|NCT03231943|62901465|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33615573|NCT02161718|63016587|FG002|Post- Randomization Period|Protocol Violation|3|||
33615574|NCT02161718|63016585|FG000|Post- Randomization Period|Lack of Efficacy|0|||
33615575|NCT02161718|63016586|FG001|Post- Randomization Period|Lack of Efficacy|0|||
33516571|NCT03231943|62901466|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33516572|NCT03231943|62901467|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33516573|NCT03231943|62901468|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33516574|NCT03231943|62901469|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33516575|NCT03231943|62901470|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33516576|NCT03231943|62901471|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33516577|NCT03231943|62901472|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33516578|NCT03231943|62901473|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33516579|NCT03231943|62901461|FG000|Part 2|Adverse Event|0|||
33516580|NCT03231943|62901462|FG001|Part 2|Adverse Event|0|||
33516581|NCT03231943|62901463|FG002|Part 2|Adverse Event|0|||
33516582|NCT03231943|62901464|FG003|Part 2|Adverse Event|0|||
33516583|NCT03231943|62901465|FG004|Part 2|Adverse Event|0|||
33615576|NCT02161718|63016587|FG002|Post- Randomization Period|Lack of Efficacy|1|||
33615577|NCT02161718|63016585|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
33615578|NCT02161718|63016586|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
33615579|NCT02161718|63016587|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
33615580|NCT02161718|63016585|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
33615581|NCT02161718|63016586|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
33615582|NCT02161718|63016587|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
33615583|NCT02161718|63016585|FG000|Post- Randomization Period|Relocation|0|||
33615584|NCT02161718|63016586|FG001|Post- Randomization Period|Relocation|3|||
33615585|NCT02161718|63016587|FG002|Post- Randomization Period|Relocation|0|||
33615586|NCT02219048|63016596|FG000|Overall Study|Adverse Event|2|||
33453854|NCT00255008|62828416|FG000|Overall Study|Adverse lab experience|1|||
33453855|NCT00255008|62828417|FG001|Overall Study|Adverse lab experience|0|||
33453856|NCT00255008|62828418|FG002|Overall Study|Adverse lab experience|0|||
33453857|NCT00255008|62828419|FG003|Overall Study|Adverse lab experience|0|||
33453858|NCT00255008|62828416|FG000|Overall Study|Other|7|||
33453859|NCT00255008|62828417|FG001|Overall Study|Other|0|||
33453860|NCT00255008|62828418|FG002|Overall Study|Other|3|||
33453861|NCT00255008|62828419|FG003|Overall Study|Other|2|||
33453862|NCT03714022|62828431|FG000|Overall Study|Adverse Event|1|||
33453863|NCT03714022|62828432|FG001|Overall Study|Adverse Event|0|||
33453864|NCT03714022|62828431|FG000|Overall Study|Consent withdrawal|0|||
33453865|NCT03714022|62828432|FG001|Overall Study|Consent withdrawal|1|||
33516584|NCT03231943|62901466|FG005|Part 2|Adverse Event|0|||
33453866|NCT03714022|62828431|FG000|Overall Study|Lost to Follow-up|3|||
33516585|NCT03231943|62901467|FG006|Part 2|Adverse Event|0|||
33516586|NCT03231943|62901468|FG007|Part 2|Adverse Event|0|||
33516587|NCT03231943|62901469|FG008|Part 2|Adverse Event|0|||
33453867|NCT03714022|62828432|FG001|Overall Study|Lost to Follow-up|2|||
33453868|NCT00143312|62828438|FG000|Overall Study|Death|11|||
33453869|NCT00143312|62828438|FG000|Overall Study|Adverse Event|2|||
33453870|NCT00143312|62828438|FG000|Overall Study|Lost to Follow-up|1|||
33453871|NCT00143312|62828438|FG000|Overall Study|Other|1|||
33453872|NCT00143312|62828438|FG000|Overall Study|Withdrawal by Subject|1|||
33453873|NCT00254540|62828444|FG000|Overall Study|Adverse Event|6|||
33453874|NCT00254540|62828445|FG001|Overall Study|Adverse Event|7|||
33453875|NCT00254540|62828444|FG000|Overall Study|Lack of Efficacy|13|||
33453876|NCT00254540|62828445|FG001|Overall Study|Lack of Efficacy|13|||
33453877|NCT00254540|62828444|FG000|Overall Study|Death|0|||
33453878|NCT00254540|62828445|FG001|Overall Study|Death|1|||
33453879|NCT00254540|62828444|FG000|Overall Study|Laboratory Test Abnormality|0|||
33453880|NCT00254540|62828445|FG001|Overall Study|Laboratory Test Abnormality|1|||
33453881|NCT00139776|62828454|FG000|Period I|Did not enter Period II|575|||
33453882|NCT00139776|62828455|FG001|Period I|Did not enter Period II|0|||
33453883|NCT00139776|62828456|FG002|Period I|Did not enter Period II|0|||
33453884|NCT00139776|62828457|FG003|Period I|Did not enter Period II|0|||
33453885|NCT00139776|62828454|FG000|Period II|Not Randomized into Period III|0|||
33453886|NCT00139776|62828455|FG001|Period II|Not Randomized into Period III|322|||
33453887|NCT00139776|62828456|FG002|Period II|Not Randomized into Period III|0|||
33453888|NCT00139776|62828457|FG003|Period II|Not Randomized into Period III|0|||
33453889|NCT00139776|62828454|FG000|Period III|Adverse Event|0|||
33453890|NCT00139776|62828455|FG001|Period III|Adverse Event|0|||
33516588|NCT03231943|62901470|FG009|Part 2|Adverse Event|0|||
33516589|NCT03231943|62901471|FG010|Part 2|Adverse Event|1|||
33516590|NCT03231943|62901472|FG011|Part 2|Adverse Event|0|||
33516591|NCT03231943|62901473|FG012|Part 2|Adverse Event|0|||
33516592|NCT03231943|62901461|FG000|Part 2|Withdrawal by Subject|0|||
33516593|NCT03231943|62901462|FG001|Part 2|Withdrawal by Subject|0|||
33516594|NCT03231943|62901463|FG002|Part 2|Withdrawal by Subject|0|||
33516595|NCT03231943|62901464|FG003|Part 2|Withdrawal by Subject|0|||
33516596|NCT03231943|62901465|FG004|Part 2|Withdrawal by Subject|0|||
33516597|NCT03231943|62901466|FG005|Part 2|Withdrawal by Subject|0|||
33516598|NCT03231943|62901467|FG006|Part 2|Withdrawal by Subject|0|||
33516599|NCT03231943|62901468|FG007|Part 2|Withdrawal by Subject|0|||
33516600|NCT03231943|62901469|FG008|Part 2|Withdrawal by Subject|0|||
33516601|NCT03231943|62901470|FG009|Part 2|Withdrawal by Subject|0|||
33516602|NCT03231943|62901471|FG010|Part 2|Withdrawal by Subject|0|||
33516603|NCT03231943|62901472|FG011|Part 2|Withdrawal by Subject|1|||
33453891|NCT00139776|62828456|FG002|Period III|Adverse Event|22|||
33516604|NCT03231943|62901473|FG012|Part 2|Withdrawal by Subject|0|||
33516605|NCT01578239|62901505|FG000|Treatment Period|Progressive Disease|19|||
33516606|NCT01578239|62901506|FG001|Treatment Period|Progressive Disease|64|||
33516607|NCT01578239|62901505|FG000|Treatment Period|Physician Decision|17|||
33516608|NCT01578239|62901506|FG001|Treatment Period|Physician Decision|17|||
33453892|NCT00139776|62828457|FG003|Period III|Adverse Event|23|||
33516609|NCT01578239|62901505|FG000|Treatment Period|Adverse Event|13|||
33516610|NCT01578239|62901506|FG001|Treatment Period|Adverse Event|10|||
33516611|NCT01578239|62901505|FG000|Treatment Period|Non-compliance|2|||
33516612|NCT01578239|62901506|FG001|Treatment Period|Non-compliance|0|||
33516613|NCT01578239|62901505|FG000|Treatment Period|Withdrawal by Subject|10|||
33516614|NCT01578239|62901506|FG001|Treatment Period|Withdrawal by Subject|9|||
33516615|NCT01578239|62901505|FG000|Treatment Period|Other|6|||
33516616|NCT01578239|62901506|FG001|Treatment Period|Other|1|||
33516617|NCT01578239|62901505|FG000|Long-term Follow-Up Period|Death|69|||
33516618|NCT01578239|62901506|FG001|Long-term Follow-Up Period|Death|64|||
33516619|NCT01578239|62901505|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
33516620|NCT01578239|62901506|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
33516621|NCT01578239|62901505|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
33516622|NCT01578239|62901506|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
33516623|NCT01578239|62901505|FG000|Long-term Follow-Up Period|Other|2|||
33516624|NCT01578239|62901506|FG001|Long-term Follow-Up Period|Other|2|||
33516625|NCT03231709|62901514|FG000|Treatment Period 1|Reason not Specified|0|||
33516626|NCT03231709|62901515|FG001|Treatment Period 1|Reason not Specified|1|||
33516627|NCT03231709|62901514|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
33516628|NCT03231709|62901515|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
33516629|NCT03241927|62901525|FG000|Overall Study|study terminated|1|||
33516630|NCT03241927|62901526|FG001|Overall Study|study terminated|0|||
33516631|NCT03329885|62901538|FG000|Overall Study|Sponsor discontinued the study early|0|||
33516632|NCT03329885|62901539|FG001|Overall Study|Sponsor discontinued the study early|0|||
33516633|NCT03329885|62901540|FG002|Overall Study|Sponsor discontinued the study early|0|||
33516634|NCT03329885|62901541|FG003|Overall Study|Sponsor discontinued the study early|0|||
33516635|NCT03329885|62901542|FG004|Overall Study|Sponsor discontinued the study early|0|||
33516636|NCT03329885|62901543|FG005|Overall Study|Sponsor discontinued the study early|0|||
33516637|NCT03329885|62901544|FG006|Overall Study|Sponsor discontinued the study early|1|||
33516638|NCT03329885|62901545|FG007|Overall Study|Sponsor discontinued the study early|1|||
33516639|NCT03329885|62901546|FG008|Overall Study|Sponsor discontinued the study early|0|||
33516640|NCT02941523|62901568|FG000|Monotherapy|Withdrawal by Subject|0|||
33516641|NCT02941523|62901569|FG001|Monotherapy|Withdrawal by Subject|1|||
33516642|NCT02941523|62901568|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
33516643|NCT02941523|62901569|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
33516644|NCT02941523|62901568|FG000|Carboplatin Combination Therapy|Death|1|||
33516645|NCT02941523|62901569|FG001|Carboplatin Combination Therapy|Death|2|||
33516646|NCT02941523|62901568|FG000|Carboplatin Combination Therapy|Disease progression|2|||
33516647|NCT02941523|62901569|FG001|Carboplatin Combination Therapy|Disease progression|0|||
33516648|NCT02941523|62901568|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
33516649|NCT02941523|62901569|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
33516650|NCT02938585|62901587|FG000|Overall Study|Withdrawal by parent or guardian|0|||
33453893|NCT00139776|62828454|FG000|Period III|Other|0|||
33453894|NCT00139776|62828455|FG001|Period III|Other|0|||
33453895|NCT00139776|62828456|FG002|Period III|Other|23|||
33453896|NCT00139776|62828457|FG003|Period III|Other|34|||
33453897|NCT00139776|62828454|FG000|Period III|Lack of Efficacy|0|||
33453898|NCT00139776|62828455|FG001|Period III|Lack of Efficacy|0|||
33453899|NCT00139776|62828456|FG002|Period III|Lack of Efficacy|10|||
33453900|NCT00139776|62828457|FG003|Period III|Lack of Efficacy|24|||
33453901|NCT00139776|62828454|FG000|Period III|Lost to Follow-up|0|||
33453902|NCT00139776|62828455|FG001|Period III|Lost to Follow-up|0|||
33453903|NCT00139776|62828456|FG002|Period III|Lost to Follow-up|5|||
33453904|NCT00139776|62828457|FG003|Period III|Lost to Follow-up|4|||
33453905|NCT00139776|62828454|FG000|Period III|Withdrawal by Subject|0|||
33453906|NCT00139776|62828455|FG001|Period III|Withdrawal by Subject|0|||
33453907|NCT00139776|62828456|FG002|Period III|Withdrawal by Subject|16|||
33453908|NCT00139776|62828457|FG003|Period III|Withdrawal by Subject|21|||
33453909|NCT00413699|62828466|FG000|Initial Period|Death|25|||
33453910|NCT00413699|62828467|FG001|Initial Period|Death|30|||
33453911|NCT00413699|62828468|FG002|Initial Period|Death|0|||
33453912|NCT00413699|62828466|FG000|Initial Period|Lack of Efficacy|59|||
33453913|NCT00413699|62828467|FG001|Initial Period|Lack of Efficacy|115|||
33453914|NCT00413699|62828468|FG002|Initial Period|Lack of Efficacy|0|||
33453915|NCT00413699|62828466|FG000|Initial Period|Lost to Follow-up|31|||
33453916|NCT00413699|62828467|FG001|Initial Period|Lost to Follow-up|101|||
33453917|NCT00413699|62828468|FG002|Initial Period|Lost to Follow-up|0|||
33453918|NCT00413699|62828466|FG000|Initial Period|Protocol Violation|38|||
33453919|NCT00413699|62828467|FG001|Initial Period|Protocol Violation|89|||
33453920|NCT00413699|62828468|FG002|Initial Period|Protocol Violation|0|||
33453921|NCT00413699|62828466|FG000|Initial Period|Pregnancy|10|||
33453922|NCT00413699|62828467|FG001|Initial Period|Pregnancy|8|||
33516651|NCT02938585|62901588|FG001|Overall Study|Withdrawal by parent or guardian|1|||
33516652|NCT02938585|62901589|FG002|Overall Study|Withdrawal by parent or guardian|0|||
33516653|NCT02938585|62901590|FG003|Overall Study|Withdrawal by parent or guardian|0|||
33516654|NCT02938585|62901587|FG000|Overall Study|Withdrawal by Subject|0|||
33516655|NCT02938585|62901588|FG001|Overall Study|Withdrawal by Subject|0|||
33516656|NCT02938585|62901589|FG002|Overall Study|Withdrawal by Subject|0|||
33516657|NCT02938585|62901590|FG003|Overall Study|Withdrawal by Subject|5|||
33516658|NCT03229759|62901614|FG000|Overall Study|Screen Failure|30|||
33516659|NCT03228433|62901626|FG000|Overall Study|Lost to Follow-up|1|||
33516660|NCT03228433|62901627|FG001|Overall Study|Lost to Follow-up|0|||
33516661|NCT03228433|62901628|FG002|Overall Study|Lost to Follow-up|0|||
33516662|NCT03228433|62901629|FG003|Overall Study|Lost to Follow-up|0|||
33516663|NCT03228433|62901630|FG004|Overall Study|Lost to Follow-up|0|||
33516664|NCT03228433|62901631|FG005|Overall Study|Lost to Follow-up|0|||
33516665|NCT03228433|62901626|FG000|Overall Study|Positive alcohol test|0|||
33516666|NCT03228433|62901627|FG001|Overall Study|Positive alcohol test|0|||
33516667|NCT03228433|62901628|FG002|Overall Study|Positive alcohol test|0|||
33516668|NCT03228433|62901629|FG003|Overall Study|Positive alcohol test|1|||
33516669|NCT03228433|62901630|FG004|Overall Study|Positive alcohol test|0|||
33516670|NCT03228433|62901631|FG005|Overall Study|Positive alcohol test|0|||
33516671|NCT01496118|62901661|FG000|Overall Study|Disease progression|3|||
33516672|NCT01496118|62901662|FG001|Overall Study|Disease progression|2|||
33516673|NCT01496118|62901663|FG002|Overall Study|Disease progression|3|||
33516674|NCT01496118|62901664|FG003|Overall Study|Disease progression|1|||
33516675|NCT01496118|62901665|FG004|Overall Study|Disease progression|2|||
33516676|NCT01496118|62901666|FG005|Overall Study|Disease progression|2|||
33516677|NCT01496118|62901667|FG006|Overall Study|Disease progression|14|||
33516678|NCT01496118|62901668|FG007|Overall Study|Disease progression|10|||
33516679|NCT01496118|62901661|FG000|Overall Study|Physician Decision|0|||
33516680|NCT01496118|62901662|FG001|Overall Study|Physician Decision|0|||
33516681|NCT01496118|62901663|FG002|Overall Study|Physician Decision|0|||
33516682|NCT01496118|62901664|FG003|Overall Study|Physician Decision|0|||
33516683|NCT01496118|62901665|FG004|Overall Study|Physician Decision|1|||
33516684|NCT01496118|62901666|FG005|Overall Study|Physician Decision|0|||
33516685|NCT01496118|62901667|FG006|Overall Study|Physician Decision|3|||
33516686|NCT01496118|62901668|FG007|Overall Study|Physician Decision|6|||
33516687|NCT01496118|62901661|FG000|Overall Study|Adverse Event|1|||
33516688|NCT01496118|62901662|FG001|Overall Study|Adverse Event|1|||
33516689|NCT01496118|62901663|FG002|Overall Study|Adverse Event|0|||
33516690|NCT01496118|62901664|FG003|Overall Study|Adverse Event|0|||
33516691|NCT01496118|62901665|FG004|Overall Study|Adverse Event|0|||
33516692|NCT01496118|62901666|FG005|Overall Study|Adverse Event|0|||
33516693|NCT01496118|62901667|FG006|Overall Study|Adverse Event|6|||
33516694|NCT01496118|62901668|FG007|Overall Study|Adverse Event|10|||
33516695|NCT01496118|62901661|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
33516696|NCT01496118|62901662|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
33516697|NCT01496118|62901663|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
33516698|NCT01496118|62901664|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
33615587|NCT02219048|63016597|FG001|Overall Study|Adverse Event|5|||
33453923|NCT00413699|62828468|FG002|Initial Period|Pregnancy|0|||
33453924|NCT00413699|62828466|FG000|Initial Period|Did not meet entrance criteria|2|||
33453925|NCT00413699|62828467|FG001|Initial Period|Did not meet entrance criteria|2|||
33453926|NCT00413699|62828468|FG002|Initial Period|Did not meet entrance criteria|0|||
33453927|NCT00413699|62828466|FG000|Initial Period|Medication error without adverse event|0|||
33453928|NCT00413699|62828467|FG001|Initial Period|Medication error without adverse event|1|||
33453929|NCT00413699|62828468|FG002|Initial Period|Medication error without adverse event|0|||
33453930|NCT00413699|62828466|FG000|Initial Period|Study terminated by Sponsor|0|||
33453931|NCT00413699|62828467|FG001|Initial Period|Study terminated by Sponsor|1|||
33453932|NCT00413699|62828468|FG002|Initial Period|Study terminated by Sponsor|0|||
33453933|NCT00413699|62828466|FG000|Initial Period|Other|67|||
33453934|NCT00413699|62828467|FG001|Initial Period|Other|211|||
33453935|NCT00413699|62828468|FG002|Initial Period|Other|0|||
33453936|NCT00413699|62828466|FG000|Initial Period|Adverse event related to study drug|178|||
33453937|NCT00413699|62828467|FG001|Initial Period|Adverse event related to study drug|527|||
33453938|NCT00413699|62828468|FG002|Initial Period|Adverse event related to study drug|0|||
33453939|NCT00413699|62828466|FG000|Initial Period|Adverse event not related to study drug|113|||
33453940|NCT00413699|62828467|FG001|Initial Period|Adverse event not related to study drug|248|||
33516699|NCT01496118|62901665|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
33516700|NCT01496118|62901666|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
33516701|NCT01496118|62901667|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
33516702|NCT01496118|62901668|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
33516703|NCT01496118|62901661|FG000|Overall Study|Death|0|||
33516704|NCT01496118|62901662|FG001|Overall Study|Death|0|||
33516705|NCT01496118|62901663|FG002|Overall Study|Death|0|||
33516706|NCT01496118|62901664|FG003|Overall Study|Death|0|||
33516707|NCT01496118|62901665|FG004|Overall Study|Death|0|||
33516708|NCT01496118|62901666|FG005|Overall Study|Death|0|||
33516709|NCT01496118|62901667|FG006|Overall Study|Death|1|||
33516710|NCT01496118|62901668|FG007|Overall Study|Death|1|||
33516711|NCT01496118|62901661|FG000|Overall Study|Withdrawal by Subject|0|||
33516712|NCT01496118|62901662|FG001|Overall Study|Withdrawal by Subject|0|||
33516713|NCT01496118|62901663|FG002|Overall Study|Withdrawal by Subject|0|||
33516714|NCT01496118|62901664|FG003|Overall Study|Withdrawal by Subject|2|||
33516715|NCT01496118|62901665|FG004|Overall Study|Withdrawal by Subject|0|||
33516716|NCT01496118|62901666|FG005|Overall Study|Withdrawal by Subject|1|||
33516717|NCT01496118|62901667|FG006|Overall Study|Withdrawal by Subject|6|||
33516718|NCT01496118|62901668|FG007|Overall Study|Withdrawal by Subject|3|||
33516719|NCT02936869|62901688|FG000|Overall Study|Lost to Follow-up|1|||
33516720|NCT02936869|62901689|FG001|Overall Study|Lost to Follow-up|3|||
33516721|NCT02936869|62901688|FG000|Overall Study|Death|0|||
33516722|NCT02936869|62901689|FG001|Overall Study|Death|1|||
33516723|NCT02936869|62901688|FG000|Overall Study|Legal Case|0|||
33516724|NCT02936869|62901689|FG001|Overall Study|Legal Case|1|||
33516725|NCT02936869|62901688|FG000|Overall Study|Protocol Violation|1|||
33516726|NCT02936869|62901689|FG001|Overall Study|Protocol Violation|0|||
33615588|NCT02219048|63016596|FG000|Overall Study|No longer meets eligibility criteria|1|||
33516727|NCT03309605|62901704|FG000|Overall Study|Adverse Event|0|||
33516728|NCT03309605|62901705|FG001|Overall Study|Adverse Event|0|||
33516729|NCT03309605|62901706|FG002|Overall Study|Adverse Event|0|||
33516730|NCT03309605|62901707|FG003|Overall Study|Adverse Event|1|||
33615589|NCT02219048|63016597|FG001|Overall Study|No longer meets eligibility criteria|0|||
33615590|NCT02219048|63016596|FG000|Overall Study|Study terminated by sponsor|16|||
33615591|NCT02219048|63016597|FG001|Overall Study|Study terminated by sponsor|15|||
33615592|NCT02219048|63016596|FG000|Overall Study|Withdrawal by Subject|2|||
33615593|NCT02219048|63016597|FG001|Overall Study|Withdrawal by Subject|0|||
33615594|NCT02219048|63016596|FG000|Overall Study|Other|0|||
33615595|NCT02219048|63016597|FG001|Overall Study|Other|1|||
33615596|NCT02218736|63016605|FG000|Overall Study|Withdrawal by Subject|10|||
33615597|NCT02218736|63016606|FG001|Overall Study|Withdrawal by Subject|9|||
33615598|NCT02218736|63016605|FG000|Overall Study|Protocol Violation|2|||
33615599|NCT02218736|63016606|FG001|Overall Study|Protocol Violation|0|||
33615600|NCT01540474|63016616|FG000|Vaccination Period|Lost to Follow-up|0|||
33615601|NCT01540474|63016617|FG001|Vaccination Period|Lost to Follow-up|1|||
33615602|NCT01540474|63016618|FG002|Vaccination Period|Lost to Follow-up|0|||
33615603|NCT01540474|63016619|FG003|Vaccination Period|Lost to Follow-up|0|||
33516731|NCT03309605|62901708|FG004|Overall Study|Adverse Event|0|||
33516732|NCT03309605|62901709|FG005|Overall Study|Adverse Event|0|||
33516733|NCT03309605|62901710|FG006|Overall Study|Adverse Event|2|||
33516734|NCT03309605|62901711|FG007|Overall Study|Adverse Event|1|||
33516735|NCT03309605|62901704|FG000|Overall Study|Withdrawal by Subject|0|||
33516736|NCT03309605|62901705|FG001|Overall Study|Withdrawal by Subject|0|||
33516737|NCT03309605|62901706|FG002|Overall Study|Withdrawal by Subject|0|||
33516738|NCT03309605|62901707|FG003|Overall Study|Withdrawal by Subject|0|||
33516739|NCT03309605|62901708|FG004|Overall Study|Withdrawal by Subject|1|||
33516740|NCT03309605|62901709|FG005|Overall Study|Withdrawal by Subject|0|||
33516741|NCT03309605|62901710|FG006|Overall Study|Withdrawal by Subject|1|||
33516742|NCT03309605|62901711|FG007|Overall Study|Withdrawal by Subject|1|||
33516743|NCT02936635|62901727|FG000|Overall Study|Adverse Event|43|||
33516744|NCT02936635|62901728|FG001|Overall Study|Adverse Event|25|||
33516745|NCT02936635|62901727|FG000|Overall Study|Progressive Disease|10|||
33516746|NCT02936635|62901728|FG001|Overall Study|Progressive Disease|18|||
33516747|NCT02936635|62901727|FG000|Overall Study|Sponsor Discretion|10|||
33516748|NCT02936635|62901728|FG001|Overall Study|Sponsor Discretion|16|||
33516749|NCT02936635|62901727|FG000|Overall Study|Death|9|||
33516750|NCT02936635|62901728|FG001|Overall Study|Death|15|||
33615604|NCT01580488|63016630|FG000|Overall Study|Withdrawal by Subject|1|||
33615605|NCT01580020|63016646|FG000|Overall Study|Lack of Efficacy|0|||
33516751|NCT02936635|62901727|FG000|Overall Study|Withdrawal by Subject|8|||
33516752|NCT02936635|62901728|FG001|Overall Study|Withdrawal by Subject|15|||
33516753|NCT02936635|62901727|FG000|Overall Study|Physician Decision|2|||
33516754|NCT02936635|62901728|FG001|Overall Study|Physician Decision|9|||
33516755|NCT02936635|62901727|FG000|Overall Study|Lost to Follow-up|1|||
33516756|NCT02936635|62901728|FG001|Overall Study|Lost to Follow-up|2|||
33516757|NCT02936635|62901727|FG000|Overall Study|Protocol Violation|1|||
33516758|NCT02936635|62901728|FG001|Overall Study|Protocol Violation|0|||
33516759|NCT02936635|62901727|FG000|Overall Study|Lack of effect/Entry into other study|31|||
33516760|NCT02936635|62901728|FG001|Overall Study|Lack of effect/Entry into other study|65|||
33615606|NCT01580020|63016647|FG001|Overall Study|Lack of Efficacy|5|||
33516761|NCT03227029|62901737|FG000|Overall Study|Child Wheezed (no treatment)|0|||
33516762|NCT03227029|62901738|FG001|Overall Study|Child Wheezed (no treatment)|1|||
33615607|NCT01580020|63016648|FG002|Overall Study|Lack of Efficacy|0|||
33516763|NCT03227029|62901739|FG002|Overall Study|Child Wheezed (no treatment)|0|||
33516764|NCT03227029|62901737|FG000|Overall Study|No post RSV season visit due to COVID|3|||
33516765|NCT03227029|62901738|FG001|Overall Study|No post RSV season visit due to COVID|3|||
33516766|NCT03227029|62901739|FG002|Overall Study|No post RSV season visit due to COVID|2|||
33516767|NCT03227029|62901737|FG000|Overall Study|Not able to get to clinic|0|||
33516768|NCT03227029|62901738|FG001|Overall Study|Not able to get to clinic|0|||
33516769|NCT03227029|62901739|FG002|Overall Study|Not able to get to clinic|1|||
33516770|NCT03227029|62901737|FG000|Overall Study|Withdrawal by Subject|1|||
33516771|NCT03227029|62901738|FG001|Overall Study|Withdrawal by Subject|0|||
33516772|NCT03227029|62901739|FG002|Overall Study|Withdrawal by Subject|0|||
33516773|NCT03227029|62901737|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
33516774|NCT03227029|62901738|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
33516775|NCT03227029|62901739|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
33516776|NCT03329573|62901751|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
33516777|NCT03329573|62901752|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
33516778|NCT03329573|62901753|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
33516779|NCT03329573|62901754|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
33516780|NCT03329573|62901751|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
33516781|NCT03329573|62901752|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
33516782|NCT03329573|62901753|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33516783|NCT03329573|62901754|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33516784|NCT03329573|62901751|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
33516785|NCT03329573|62901752|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
33516786|NCT03329573|62901753|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
33516787|NCT03329573|62901754|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
33516788|NCT03329573|62901751|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
33516789|NCT03329573|62901752|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
33516790|NCT03329573|62901753|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
33516791|NCT03329573|62901754|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
33516792|NCT03308825|62901785|FG000|Overall Study|Lost to Follow-up|2|||
33516793|NCT03308825|62901786|FG001|Overall Study|Lost to Follow-up|2|||
33516794|NCT03308825|62901787|FG002|Overall Study|Lost to Follow-up|1|||
33516795|NCT03308825|62901788|FG003|Overall Study|Lost to Follow-up|0|||
33516796|NCT03308825|62901785|FG000|Overall Study|Protocol Violation|0|||
33516797|NCT03308825|62901786|FG001|Overall Study|Protocol Violation|2|||
33516798|NCT03308825|62901787|FG002|Overall Study|Protocol Violation|0|||
33516799|NCT03308825|62901788|FG003|Overall Study|Protocol Violation|0|||
33516800|NCT03328325|62901802|FG000|Overall Study|Lost to Follow-up|4|||
33516801|NCT03328325|62901802|FG000|Overall Study|Physician Decision|1|||
33516802|NCT03328325|62901802|FG000|Overall Study|Withdrawal by Subject|3|||
33516803|NCT03328325|62901802|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
33516804|NCT03305081|62901812|FG000|Overall Study|Lost to Follow-up|10|||
33516805|NCT03305081|62901813|FG001|Overall Study|Lost to Follow-up|15|||
33516806|NCT03325673|62901831|FG000|Overall Study|Adverse Event|4|||
33516807|NCT03325673|62901832|FG001|Overall Study|Adverse Event|0|||
33516808|NCT03223909|62901841|FG000|Overall Study|Protocol Violation|48|||
33516809|NCT03223909|62901842|FG001|Overall Study|Protocol Violation|45|||
33516810|NCT03223909|62901843|FG002|Overall Study|Protocol Violation|16|||
33516811|NCT03733925|62901851|FG000|Overall Study|Lost to Follow-up|1|||
33516812|NCT03733925|62901851|FG000|Overall Study|Withdrawal by Subject|2|||
33516813|NCT03733925|62901851|FG000|Overall Study|Adverse Event|2|||
33516814|NCT03733925|62901851|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33516815|NCT03649711|62901858|FG000|Overall Study|Adverse Event|0|||
33516816|NCT03649711|62901859|FG001|Overall Study|Adverse Event|1|||
33516817|NCT03649711|62901860|FG002|Overall Study|Adverse Event|0|||
33516818|NCT03649711|62901858|FG000|Overall Study|Kidney Transplant|1|||
33516819|NCT03649711|62901859|FG001|Overall Study|Kidney Transplant|0|||
33516820|NCT03649711|62901860|FG002|Overall Study|Kidney Transplant|0|||
33516821|NCT03303521|62901870|FG000|Overall Study|Withdrawal by Subject|2|||
33516822|NCT03303521|62901871|FG001|Overall Study|Withdrawal by Subject|0|||
33516823|NCT03303521|62901870|FG000|Overall Study|Death|1|||
33516824|NCT03303521|62901871|FG001|Overall Study|Death|0|||
33516825|NCT03303521|62901870|FG000|Overall Study|Kidney transplantation|0|||
33516826|NCT03303521|62901871|FG001|Overall Study|Kidney transplantation|1|||
33516827|NCT03303521|62901870|FG000|Overall Study|Investigational product discontinuation|0|||
33516828|NCT03303521|62901871|FG001|Overall Study|Investigational product discontinuation|1|||
33516829|NCT03303521|62901870|FG000|Overall Study|Transferred to non-study dialysis center|1|||
33516830|NCT03303521|62901871|FG001|Overall Study|Transferred to non-study dialysis center|0|||
33516831|NCT03303521|62901870|FG000|Overall Study|Non-comliance to study protocol|0|||
33516832|NCT03303521|62901871|FG001|Overall Study|Non-comliance to study protocol|1|||
33516833|NCT03303521|62901870|FG000|Overall Study|Adverse Event|1|||
33516834|NCT03303521|62901871|FG001|Overall Study|Adverse Event|0|||
33516835|NCT03214081|62901877|FG000|Overall Study|Case Report Forms Uncollected|9|||
33516836|NCT03214081|62901877|FG000|Overall Study|Protocol Deviation|54|||
33516837|NCT02888171|62901883|FG000|Overall Study|Lost to Follow-up|2|||
33516838|NCT02888171|62901884|FG001|Overall Study|Lost to Follow-up|1|||
33516839|NCT02888171|62901883|FG000|Overall Study|Withdrawal by Subject|3|||
33516840|NCT02888171|62901884|FG001|Overall Study|Withdrawal by Subject|2|||
33516841|NCT02888171|62901883|FG000|Overall Study|Adverse Event|0|||
33516842|NCT02888171|62901884|FG001|Overall Study|Adverse Event|1|||
33516843|NCT02932891|62901890|FG000|Overall Study|Lost to Follow-up|2|||
33516844|NCT02932891|62901890|FG000|Overall Study|HPA Suppress|2|||
33516845|NCT03302975|62901894|FG000|Overall Study|Lost to Follow-up|4|||
33516846|NCT03212521|62901898|FG000|Overall Study|Adverse Event|1|||
33516847|NCT03212521|62901898|FG000|Overall Study|Lost to Follow-up|4|||
33516848|NCT03212521|62901898|FG000|Overall Study|Withdrawal by Subject|1|||
33516849|NCT03212521|62901898|FG000|Overall Study|Other|1|||
33516850|NCT03212365|62901904|FG000|Overall Study|Discharged prior to Xa level|12|||
33516851|NCT03212365|62901905|FG001|Overall Study|Discharged prior to Xa level|8|||
33516852|NCT03212365|62901904|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
33516853|NCT03212365|62901905|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
33516854|NCT03212365|62901904|FG000|Overall Study|Refused study medication|3|||
33516855|NCT03212365|62901905|FG001|Overall Study|Refused study medication|0|||
33516856|NCT03212365|62901904|FG000|Overall Study|Initiated heparin infusion on floor|1|||
33516857|NCT03212365|62901905|FG001|Overall Study|Initiated heparin infusion on floor|1|||
33516858|NCT03212365|62901904|FG000|Overall Study|Unexpected return to OR|1|||
33516859|NCT03212365|62901905|FG001|Overall Study|Unexpected return to OR|1|||
33516860|NCT03212365|62901904|FG000|Overall Study|Medication distribution error|1|||
33516861|NCT03212365|62901905|FG001|Overall Study|Medication distribution error|0|||
33516862|NCT03212365|62901904|FG000|Overall Study|Required epidural placement|1|||
33516863|NCT03212365|62901905|FG001|Overall Study|Required epidural placement|0|||
33516864|NCT03212365|62901904|FG000|Overall Study|Withdrawal by Subject|0|||
33516865|NCT03212365|62901905|FG001|Overall Study|Withdrawal by Subject|1|||
33516866|NCT03212365|62901904|FG000|Overall Study|developed acute renal failure|0|||
33516867|NCT03212365|62901905|FG001|Overall Study|developed acute renal failure|1|||
33516868|NCT03273257|62901913|FG000|Overall Study|Death|0|||
33516869|NCT03273257|62901914|FG001|Overall Study|Death|1|||
33516870|NCT03273257|62901913|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
33516871|NCT03273257|62901914|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
33516872|NCT03273257|62901913|FG000|Overall Study|Study terminated|3|||
33516873|NCT03273257|62901914|FG001|Overall Study|Study terminated|2|||
33516874|NCT04316741|62901922|FG000|Baseline Enrollment|Lost to Follow-up|1|||
33516875|NCT04316741|62901923|FG001|Baseline Enrollment|Lost to Follow-up|1|||
33516876|NCT04316741|62901922|FG000|Immediate Post-Test|Lost to Follow-up|5|||
33516877|NCT04316741|62901923|FG001|Immediate Post-Test|Lost to Follow-up|1|||
33516878|NCT04316741|62901922|FG000|1-month Post-test|Lost to Follow-up|7|||
33516879|NCT04316741|62901923|FG001|1-month Post-test|Lost to Follow-up|2|||
33516880|NCT04316741|62901922|FG000|3-month Follow-up|Lost to Follow-up|10|||
33516881|NCT04316741|62901923|FG001|3-month Follow-up|Lost to Follow-up|2|||
33516882|NCT03271307|62901933|FG000|Overall Study|Lost to Follow-up|0|||
33516883|NCT03271307|62901934|FG001|Overall Study|Lost to Follow-up|0|||
33516884|NCT03271307|62901935|FG002|Overall Study|Lost to Follow-up|0|||
33516885|NCT03271307|62901936|FG003|Overall Study|Lost to Follow-up|28|||
33516886|NCT03271307|62901937|FG004|Overall Study|Lost to Follow-up|91|||
33516887|NCT03271151|62901954|FG000|Overall Study|Lost to Follow-up|1|||
33516888|NCT03271151|62901955|FG001|Overall Study|Lost to Follow-up|3|||
33516889|NCT03271151|62901954|FG000|Overall Study|Withdrawal by Subject|1|||
33516890|NCT03271151|62901955|FG001|Overall Study|Withdrawal by Subject|0|||
33516891|NCT03245723|62901963|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
33516892|NCT03245723|62901964|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
33516893|NCT03245723|62901963|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
33516894|NCT03245723|62901964|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
33516895|NCT03245723|62901963|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
33516896|NCT03245723|62901964|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
33516897|NCT03245723|62901963|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
33516898|NCT03245723|62901964|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
33516899|NCT03301649|62901973|FG000|Overall Study|Need alternate therapy due to live lice|17|||
33516900|NCT03301649|62901974|FG001|Overall Study|Need alternate therapy due to live lice|25|||
33516901|NCT03301649|62901975|FG002|Overall Study|Need alternate therapy due to live lice|81|||
33516902|NCT03301649|62901973|FG000|Overall Study|Lost to Follow-up|11|||
33516903|NCT03301649|62901974|FG001|Overall Study|Lost to Follow-up|11|||
33516904|NCT03301649|62901975|FG002|Overall Study|Lost to Follow-up|3|||
33516905|NCT03301649|62901973|FG000|Overall Study|Protocol Violation|0|||
33516906|NCT03301649|62901974|FG001|Overall Study|Protocol Violation|1|||
33516907|NCT03301649|62901975|FG002|Overall Study|Protocol Violation|1|||
33615608|NCT01580020|63016649|FG003|Overall Study|Lack of Efficacy|1|||
33516908|NCT03301649|62901973|FG000|Overall Study|Withdrawal by Subject|10|||
33516909|NCT03301649|62901974|FG001|Overall Study|Withdrawal by Subject|4|||
33516910|NCT03301649|62901975|FG002|Overall Study|Withdrawal by Subject|0|||
33516911|NCT03301649|62901973|FG000|Overall Study|Other than specified|5|||
33516912|NCT03301649|62901974|FG001|Overall Study|Other than specified|3|||
33516913|NCT03301649|62901975|FG002|Overall Study|Other than specified|0|||
33516914|NCT03222973|62901985|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
33516915|NCT03222973|62901986|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
33516916|NCT03222973|62901987|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
33516917|NCT03222973|62901988|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
33516918|NCT03222973|62901985|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
33516919|NCT03222973|62901986|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
33516920|NCT03222973|62901987|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
33516921|NCT03222973|62901988|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
33516922|NCT03222973|62901985|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
33516923|NCT03222973|62901986|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
33516924|NCT03222973|62901987|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
33516925|NCT03222973|62901988|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
33516926|NCT03222973|62901985|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
33516927|NCT03222973|62901986|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
33516928|NCT03222973|62901987|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
33516929|NCT03222973|62901988|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
33516930|NCT03222973|62901985|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
33516931|NCT03222973|62901986|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
33516932|NCT03222973|62901987|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
33516933|NCT03222973|62901988|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
33516934|NCT03222973|62901985|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
33516935|NCT03222973|62901986|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
33516936|NCT03222973|62901987|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
33516937|NCT03222973|62901988|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
33516938|NCT03222973|62901985|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
33516939|NCT03222973|62901986|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
33516940|NCT03222973|62901987|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
33516941|NCT03222973|62901988|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
33516942|NCT03222973|62901985|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
33516943|NCT03222973|62901986|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
33516944|NCT03222973|62901987|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
33516945|NCT03222973|62901988|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
33516946|NCT03222973|62901985|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
33516947|NCT03222973|62901986|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
33516948|NCT03222973|62901987|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
33516949|NCT03222973|62901988|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
33516950|NCT03222973|62901985|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
33516951|NCT03222973|62901986|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
33516952|NCT03222973|62901987|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
33516953|NCT03222973|62901988|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
33516954|NCT03222973|62901985|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
33516955|NCT03222973|62901986|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
33516956|NCT03222973|62901987|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
33516957|NCT03222973|62901988|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
33516958|NCT03222973|62901985|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
33516959|NCT03222973|62901986|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
33516960|NCT03222973|62901987|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
33516961|NCT03222973|62901988|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
33516962|NCT01144416|62902000|FG000|Intervention Period|Adverse Event|5|||
33516963|NCT01144416|62902001|FG001|Intervention Period|Adverse Event|6|||
33516964|NCT01144416|62902000|FG000|Intervention Period|Insufficient ovarian response|11|||
33516965|NCT01144416|62902001|FG001|Intervention Period|Insufficient ovarian response|17|||
33516966|NCT01144416|62902000|FG000|Intervention Period|Risk of OHSS|0|||
33516967|NCT01144416|62902001|FG001|Intervention Period|Risk of OHSS|1|||
33516968|NCT01144416|62902000|FG000|Intervention Period|Too high ovarian response|4|||
33516969|NCT01144416|62902001|FG001|Intervention Period|Too high ovarian response|2|||
33516970|NCT01144416|62902000|FG000|Intervention Period|No/too few/bad oocytes|7|||
33516971|NCT01144416|62902001|FG001|Intervention Period|No/too few/bad oocytes|5|||
33516972|NCT01144416|62902000|FG000|Intervention Period|No or abnormal fertilization|25|||
33516973|NCT01144416|62902001|FG001|Intervention Period|No or abnormal fertilization|10|||
33516974|NCT01144416|62902000|FG000|Intervention Period|No/too few/bad quality embryos|3|||
33516975|NCT01144416|62902001|FG001|Intervention Period|No/too few/bad quality embryos|3|||
33516976|NCT01144416|62902000|FG000|Intervention Period|Other|7|||
33516977|NCT01144416|62902001|FG001|Intervention Period|Other|5|||
33516978|NCT00335777|62902011|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
33516979|NCT00335777|62902011|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
33516980|NCT00335777|62902011|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
33516981|NCT00335777|62902011|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
33516982|NCT00335777|62902011|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
33516983|NCT01140048|62902016|FG000|Overall Study|Physician Decision|1|||
33516984|NCT01140048|62902016|FG000|Overall Study|Withdrawal by Subject|13|||
33516985|NCT01140048|62902016|FG000|Overall Study|Lost to Follow-up|31|||
33516986|NCT02889809|62902022|FG000|Overall Study|Withdrawal by Subject|30|||
33516987|NCT02889809|62902023|FG001|Overall Study|Withdrawal by Subject|21|||
33516988|NCT02889809|62902022|FG000|Overall Study|Lost to Follow-up|1|||
33516989|NCT02889809|62902023|FG001|Overall Study|Lost to Follow-up|1|||
33516990|NCT02889809|62902022|FG000|Overall Study|Site Closed|12|||
33516991|NCT02889809|62902023|FG001|Overall Study|Site Closed|11|||
33516992|NCT00972738|62902036|FG000|Overall Study|Adverse Event|7|||
33516993|NCT00972738|62902037|FG001|Overall Study|Adverse Event|1|||
33516994|NCT00972738|62902038|FG002|Overall Study|Adverse Event|8|||
33516995|NCT00972738|62902036|FG000|Overall Study|Protocol Violation|2|||
33516996|NCT00972738|62902037|FG001|Overall Study|Protocol Violation|1|||
33516997|NCT00972738|62902038|FG002|Overall Study|Protocol Violation|3|||
33516998|NCT00972738|62902036|FG000|Overall Study|Lost to Follow-up|1|||
33516999|NCT00972738|62902037|FG001|Overall Study|Lost to Follow-up|0|||
33517000|NCT00972738|62902038|FG002|Overall Study|Lost to Follow-up|1|||
33517001|NCT00972738|62902036|FG000|Overall Study|Lack of Efficacy|5|||
33517002|NCT00972738|62902037|FG001|Overall Study|Lack of Efficacy|1|||
33517003|NCT00972738|62902038|FG002|Overall Study|Lack of Efficacy|11|||
33517004|NCT00972738|62902036|FG000|Overall Study|Withdrawal by Subject|5|||
33517005|NCT00972738|62902037|FG001|Overall Study|Withdrawal by Subject|1|||
33517006|NCT00972738|62902038|FG002|Overall Study|Withdrawal by Subject|4|||
33517007|NCT00972738|62902036|FG000|Overall Study|Moved|0|||
33517008|NCT00972738|62902037|FG001|Overall Study|Moved|0|||
33517009|NCT00972738|62902038|FG002|Overall Study|Moved|1|||
33517010|NCT00972738|62902036|FG000|Overall Study|Other|1|||
33517011|NCT00972738|62902037|FG001|Overall Study|Other|2|||
33517012|NCT00972738|62902038|FG002|Overall Study|Other|1|||
33517013|NCT03243305|62902046|FG000|Overall Study|Lost to Follow-up|250|||
33517014|NCT03243305|62902046|FG000|Overall Study|Withdrawal by Subject|170|||
33517015|NCT03243305|62902046|FG000|Overall Study|Pregnancy|104|||
33517016|NCT03243305|62902046|FG000|Overall Study|Non-Compliance with Study Drug|38|||
33517017|NCT03243305|62902046|FG000|Overall Study|Adverse Event|23|||
33517018|NCT03243305|62902046|FG000|Overall Study|No sexually active|26|||
33517019|NCT03243305|62902046|FG000|Overall Study|Physician Decision|22|||
33517020|NCT03243305|62902046|FG000|Overall Study|Protocol Violation|22|||
33517021|NCT03243305|62902046|FG000|Overall Study|Study method no longer primary method|12|||
33517022|NCT03243305|62902046|FG000|Overall Study|Study Terminated by Sponsor|1|||
33517023|NCT03243305|62902046|FG000|Overall Study|Early terminations|267|||
33517024|NCT03222583|62902052|FG000|Overall Study|Withdrawal by Subject|3|||
33517025|NCT03222583|62902053|FG001|Overall Study|Withdrawal by Subject|3|||
33517026|NCT03222583|62902052|FG000|Overall Study|Lost to Follow-up|1|||
33517027|NCT03222583|62902053|FG001|Overall Study|Lost to Follow-up|0|||
33517028|NCT03222583|62902052|FG000|Overall Study|Other|1|||
33517029|NCT03222583|62902053|FG001|Overall Study|Other|3|||
33517030|NCT03295721|62902062|FG000|Overall Study|Adverse Event|1|||
33517031|NCT03295721|62902063|FG001|Overall Study|Adverse Event|0|||
33517032|NCT03295721|62902064|FG002|Overall Study|Adverse Event|0|||
33517033|NCT03295721|62902062|FG000|Overall Study|Lost to Follow-up|1|||
33453941|NCT00413699|62828468|FG002|Initial Period|Adverse event not related to study drug|0|||
33453942|NCT00413699|62828466|FG000|Initial Period|Missing end of study page|0|||
33453943|NCT00413699|62828467|FG001|Initial Period|Missing end of study page|4|||
33453944|NCT00413699|62828468|FG002|Initial Period|Missing end of study page|0|||
33453945|NCT00413699|62828466|FG000|Initial Period|No longer willing to participate|116|||
33453946|NCT00413699|62828467|FG001|Initial Period|No longer willing to participate|368|||
33453947|NCT00413699|62828468|FG002|Initial Period|No longer willing to participate|0|||
33615609|NCT01580020|63016646|FG000|Overall Study|Withdrawal by Subject|0|||
33453948|NCT00413699|62828466|FG000|Extension Period|No Longer Willing to Participate|0|||
33453949|NCT00413699|62828467|FG001|Extension Period|No Longer Willing to Participate|0|||
33517034|NCT03295721|62902063|FG001|Overall Study|Lost to Follow-up|1|||
33517035|NCT03295721|62902064|FG002|Overall Study|Lost to Follow-up|1|||
33517036|NCT03295721|62902062|FG000|Overall Study|Withdrawal by Subject|1|||
33517037|NCT03295721|62902063|FG001|Overall Study|Withdrawal by Subject|0|||
33517038|NCT03295721|62902064|FG002|Overall Study|Withdrawal by Subject|1|||
33517039|NCT03295721|62902062|FG000|Overall Study|Death|0|||
33517040|NCT03295721|62902063|FG001|Overall Study|Death|0|||
33517041|NCT03295721|62902064|FG002|Overall Study|Death|1|||
33517042|NCT00803790|62902075|FG000|Period 1|Adverse Event|0|||
33324684|NCT01119066|62701247|FG002|Overall Study|Relapse identified before transplant|0|||
33324685|NCT01119066|62701248|FG003|Overall Study|Relapse identified before transplant|0|||
33324686|NCT00910624|62701262|FG000|Treatment Phase|Adverse Event|2|||
33453950|NCT00413699|62828468|FG002|Extension Period|No Longer Willing to Participate|2|||
33453951|NCT00413699|62828466|FG000|Extension Period|Protocol Violation|0|||
33453952|NCT00413699|62828467|FG001|Extension Period|Protocol Violation|0|||
33453953|NCT00413699|62828468|FG002|Extension Period|Protocol Violation|1|||
33453954|NCT00413699|62828466|FG000|Extension Period|Adverse Event|0|||
33453955|NCT00413699|62828467|FG001|Extension Period|Adverse Event|0|||
33453956|NCT00413699|62828468|FG002|Extension Period|Adverse Event|2|||
33453957|NCT03713320|62828496|FG000|Randomized Period|Adverse Event|1|||
33453958|NCT03713320|62828497|FG001|Randomized Period|Adverse Event|5|||
33453959|NCT03713320|62828498|FG002|Randomized Period|Adverse Event|0|||
33453960|NCT03713320|62828496|FG000|Randomized Period|Physician Decision|1|||
33453961|NCT03713320|62828497|FG001|Randomized Period|Physician Decision|1|||
33453962|NCT03713320|62828498|FG002|Randomized Period|Physician Decision|0|||
33453963|NCT03713320|62828496|FG000|Randomized Period|Withdrawal by Subject|4|||
33453964|NCT03713320|62828497|FG001|Randomized Period|Withdrawal by Subject|0|||
33453965|NCT03713320|62828498|FG002|Randomized Period|Withdrawal by Subject|0|||
33453966|NCT03713320|62828496|FG000|Randomized Period|Participant decision|3|||
33453967|NCT03713320|62828497|FG001|Randomized Period|Participant decision|1|||
33453968|NCT03713320|62828498|FG002|Randomized Period|Participant decision|0|||
33453969|NCT03713320|62828496|FG000|Randomized Period|Study terminated by sponsor|6|||
33453970|NCT03713320|62828497|FG001|Randomized Period|Study terminated by sponsor|3|||
33453971|NCT03713320|62828498|FG002|Randomized Period|Study terminated by sponsor|0|||
33453972|NCT03713320|62828496|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
33453973|NCT03713320|62828497|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
33453974|NCT03713320|62828498|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
33453975|NCT03713320|62828496|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
33453976|NCT03713320|62828497|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
33453977|NCT03713320|62828498|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
33453978|NCT03712930|62828505|FG000|Overall Study|Death|7|||
33453979|NCT03712930|62828505|FG000|Overall Study|Physician Decision|1|||
33453980|NCT03712930|62828505|FG000|Overall Study|Study Terminated by Sponsor|3|||
33517043|NCT00803790|62902076|FG001|Period 1|Adverse Event|1|||
33517044|NCT00803790|62902077|FG002|Period 1|Adverse Event|0|||
33517045|NCT00803790|62902078|FG003|Period 1|Adverse Event|0|||
33517046|NCT00803790|62902075|FG000|Period 1|Lost to Follow-up|1|||
33517047|NCT00803790|62902076|FG001|Period 1|Lost to Follow-up|2|||
33517048|NCT00803790|62902077|FG002|Period 1|Lost to Follow-up|0|||
33517049|NCT00803790|62902078|FG003|Period 1|Lost to Follow-up|0|||
33517050|NCT00803790|62902075|FG000|Period 1|Withdrawal by Subject|8|||
33517051|NCT00803790|62902076|FG001|Period 1|Withdrawal by Subject|6|||
33517052|NCT00803790|62902077|FG002|Period 1|Withdrawal by Subject|0|||
33517053|NCT00803790|62902078|FG003|Period 1|Withdrawal by Subject|0|||
33517054|NCT00803790|62902075|FG000|Period 1|positive drug screen or personal reasons|0|||
33517055|NCT00803790|62902076|FG001|Period 1|positive drug screen or personal reasons|3|||
33517056|NCT00803790|62902077|FG002|Period 1|positive drug screen or personal reasons|0|||
33517057|NCT00803790|62902078|FG003|Period 1|positive drug screen or personal reasons|4|||
33517058|NCT00803790|62902075|FG000|Period 1|Protocol Violation|0|||
33517059|NCT00803790|62902076|FG001|Period 1|Protocol Violation|0|||
33517060|NCT00803790|62902077|FG002|Period 1|Protocol Violation|1|||
33517061|NCT00803790|62902078|FG003|Period 1|Protocol Violation|0|||
33517062|NCT00803790|62902075|FG000|Period 2|Adverse Event|0|||
33517063|NCT00803790|62902076|FG001|Period 2|Adverse Event|0|||
33517064|NCT00803790|62902077|FG002|Period 2|Adverse Event|1|||
33517065|NCT00803790|62902078|FG003|Period 2|Adverse Event|1|||
33517066|NCT00803790|62902075|FG000|Period 2|Withdrawal by Subject|1|||
33517067|NCT00803790|62902076|FG001|Period 2|Withdrawal by Subject|0|||
33517068|NCT00803790|62902077|FG002|Period 2|Withdrawal by Subject|0|||
33517069|NCT00803790|62902078|FG003|Period 2|Withdrawal by Subject|0|||
33517070|NCT00803790|62902075|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
33517071|NCT00803790|62902076|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
33517072|NCT00803790|62902077|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
33517073|NCT00803790|62902078|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
33517074|NCT00250458|62902126|FG000|Overall Study|Lost to Follow-up|4|||
33517075|NCT00250458|62902127|FG001|Overall Study|Lost to Follow-up|2|||
33517076|NCT00250458|62902126|FG000|Overall Study|Protocol Violation|0|||
33517077|NCT00250458|62902127|FG001|Overall Study|Protocol Violation|1|||
33517078|NCT00250458|62902126|FG000|Overall Study|Withdrawal by Subject|4|||
33517079|NCT00250458|62902127|FG001|Overall Study|Withdrawal by Subject|2|||
33517080|NCT00250458|62902126|FG000|Overall Study|Lack of Migraine Attack|20|||
33517081|NCT00250458|62902127|FG001|Overall Study|Lack of Migraine Attack|9|||
33517082|NCT00250458|62902126|FG000|Overall Study|Qualifying migraine but did not treat|3|||
33517083|NCT00250458|62902127|FG001|Overall Study|Qualifying migraine but did not treat|3|||
33517084|NCT00250458|62902126|FG000|Overall Study|Other|1|||
33517085|NCT00250458|62902127|FG001|Overall Study|Other|0|||
33517086|NCT01667133|62902145|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
33517087|NCT01667133|62902146|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
33517088|NCT01667133|62902147|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
33517089|NCT01667133|62902148|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
33517090|NCT01667133|62902149|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
33517091|NCT01667133|62902150|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
33517092|NCT01667133|62902151|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
33453981|NCT03712930|62828505|FG000|Overall Study|Progressive Disease|2|||
33453982|NCT00420407|62828511|FG000|Overall Study|Lost to Follow-up|0|||
33517093|NCT01667133|62902152|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
33517094|NCT01667133|62902153|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
33517095|NCT01667133|62902154|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
33517096|NCT01667133|62902155|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
33517097|NCT01667133|62902156|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
33517098|NCT01667133|62902145|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33517099|NCT01667133|62902146|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33453983|NCT00420407|62828512|FG001|Overall Study|Lost to Follow-up|3|||
33453984|NCT00420407|62828511|FG000|Overall Study|Physician Decision|2|||
33453985|NCT00420407|62828512|FG001|Overall Study|Physician Decision|1|||
33453986|NCT00420407|62828511|FG000|Overall Study|subject identified as detainee|1|||
33453987|NCT00420407|62828512|FG001|Overall Study|subject identified as detainee|0|||
33453988|NCT00420407|62828511|FG000|Overall Study|subject identified as Jehovah's witness|1|||
33453989|NCT00420407|62828512|FG001|Overall Study|subject identified as Jehovah's witness|0|||
33453990|NCT00420407|62828511|FG000|Overall Study|Withdrawal by Subject|0|||
33517100|NCT01667133|62902147|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
33517101|NCT01667133|62902148|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33517102|NCT01667133|62902149|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33517103|NCT01667133|62902150|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33517104|NCT01667133|62902151|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33517105|NCT01667133|62902152|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33517106|NCT01667133|62902153|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33517107|NCT01667133|62902154|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33517108|NCT01667133|62902155|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33517109|NCT01667133|62902156|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33453991|NCT00420407|62828512|FG001|Overall Study|Withdrawal by Subject|2|||
33517110|NCT01667133|62902145|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
33517111|NCT01667133|62902146|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
33517112|NCT01667133|62902147|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
33517113|NCT01667133|62902148|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
33517114|NCT01667133|62902149|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
33517115|NCT01667133|62902150|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
33517116|NCT01667133|62902151|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
33517117|NCT01667133|62902152|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
33517118|NCT01667133|62902153|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
33517119|NCT01667133|62902154|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
33517120|NCT01667133|62902155|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
33517121|NCT01667133|62902156|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
33517122|NCT01667133|62902145|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33517123|NCT01667133|62902146|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33517124|NCT01667133|62902147|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33615610|NCT01580020|63016647|FG001|Overall Study|Withdrawal by Subject|1|||
33615611|NCT01580020|63016648|FG002|Overall Study|Withdrawal by Subject|1|||
33615612|NCT01580020|63016649|FG003|Overall Study|Withdrawal by Subject|0|||
33615613|NCT01580020|63016646|FG000|Overall Study|Adverse Event|1|||
33615614|NCT01580020|63016647|FG001|Overall Study|Adverse Event|1|||
33615615|NCT01580020|63016648|FG002|Overall Study|Adverse Event|1|||
33453992|NCT00420095|62828521|FG000|Overall Study|Adverse Event|1|||
33517125|NCT01667133|62902148|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
33517126|NCT01667133|62902149|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33517127|NCT01667133|62902150|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33517128|NCT01667133|62902151|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33517129|NCT01667133|62902152|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33517130|NCT01667133|62902153|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33517131|NCT01667133|62902154|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33517132|NCT01667133|62902155|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33517133|NCT01667133|62902156|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33517134|NCT01667133|62902145|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
33517135|NCT01667133|62902146|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
33517136|NCT01667133|62902147|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
33517137|NCT01667133|62902148|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
33517138|NCT01667133|62902149|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
33517139|NCT01667133|62902150|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
33517140|NCT01667133|62902151|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
33517141|NCT01667133|62902152|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
33517142|NCT01667133|62902153|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
33517143|NCT01667133|62902154|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
33517144|NCT01667133|62902155|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
33615616|NCT01580020|63016649|FG003|Overall Study|Adverse Event|1|||
33615617|NCT01580020|63016646|FG000|Overall Study|Administrative Problems|0|||
33453993|NCT00420095|62828522|FG001|Overall Study|Adverse Event|0|||
33453994|NCT00420095|62828521|FG000|Overall Study|Protocol Violation|1|||
33453995|NCT00420095|62828522|FG001|Overall Study|Protocol Violation|1|||
33453996|NCT00420095|62828521|FG000|Overall Study|Lost to Follow-up|1|||
33453997|NCT00420095|62828522|FG001|Overall Study|Lost to Follow-up|0|||
33453998|NCT00419393|62828528|FG000|Overall Study|Adverse Event|5|||
33453999|NCT00419393|62828528|FG000|Overall Study|Protocol Violation|5|||
33454000|NCT00419393|62828528|FG000|Overall Study|Withdrawal by Subject|7|||
33454001|NCT00419393|62828528|FG000|Overall Study|Other: Sponsor request|3|||
33454002|NCT00419393|62828528|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
33454003|NCT00419393|62828528|FG000|Overall Study|Other: Site closure|1|||
33454004|NCT00419393|62828528|FG000|Overall Study|Other: Other health problems|1|||
33454005|NCT00419393|62828528|FG000|Overall Study|Other: Investigator decision|1|||
33454006|NCT00419159|62828534|FG000|Overall Study|Adverse Event|7|||
33454007|NCT00419159|62828535|FG001|Overall Study|Adverse Event|15|||
33454008|NCT00419159|62828534|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33454009|NCT00419159|62828535|FG001|Overall Study|Abnormal laboratory value(s)|2|||
33454010|NCT00419159|62828534|FG000|Overall Study|Subject's no longer requires study drug|0|||
33454011|NCT00419159|62828535|FG001|Overall Study|Subject's no longer requires study drug|1|||
33454012|NCT00419159|62828534|FG000|Overall Study|Protocol Violation|1|||
33454013|NCT00419159|62828535|FG001|Overall Study|Protocol Violation|0|||
33454014|NCT00419159|62828534|FG000|Overall Study|Withdrawal by Subject|10|||
33454015|NCT00419159|62828535|FG001|Overall Study|Withdrawal by Subject|3|||
33454016|NCT00419159|62828534|FG000|Overall Study|Lost to Follow-up|0|||
33454017|NCT00419159|62828535|FG001|Overall Study|Lost to Follow-up|1|||
33454018|NCT00419159|62828534|FG000|Overall Study|Death|2|||
33615618|NCT01580020|63016647|FG001|Overall Study|Administrative Problems|0|||
33517145|NCT01667133|62902156|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
33454019|NCT00419159|62828535|FG001|Overall Study|Death|2|||
33454020|NCT00419159|62828534|FG000|Overall Study|Disease progression|79|||
33517146|NCT01667133|62902145|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33517147|NCT01667133|62902146|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33517148|NCT01667133|62902147|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33517149|NCT01667133|62902148|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33517150|NCT01667133|62902149|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33517151|NCT01667133|62902150|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33615619|NCT01580020|63016648|FG002|Overall Study|Administrative Problems|1|||
33615620|NCT01580020|63016649|FG003|Overall Study|Administrative Problems|0|||
33615621|NCT01580020|63016646|FG000|Overall Study|Lost to Follow-up|0|||
33615622|NCT01580020|63016647|FG001|Overall Study|Lost to Follow-up|0|||
33615623|NCT01580020|63016648|FG002|Overall Study|Lost to Follow-up|1|||
33615624|NCT01580020|63016649|FG003|Overall Study|Lost to Follow-up|0|||
33615625|NCT01579474|63016665|FG000|Overall Study|Adverse Event|1|||
33615626|NCT01579474|63016666|FG001|Overall Study|Adverse Event|13|||
33615627|NCT01579474|63016667|FG002|Overall Study|Adverse Event|2|||
33615628|NCT01579474|63016668|FG003|Overall Study|Adverse Event|0|||
33615629|NCT01579474|63016669|FG004|Overall Study|Adverse Event|0|||
33615630|NCT01579474|63016670|FG005|Overall Study|Adverse Event|1|||
33615631|NCT01579474|63016665|FG000|Overall Study|Lack of Efficacy|1|||
33615632|NCT01579474|63016666|FG001|Overall Study|Lack of Efficacy|0|||
33615633|NCT01579474|63016667|FG002|Overall Study|Lack of Efficacy|0|||
33615634|NCT01579474|63016668|FG003|Overall Study|Lack of Efficacy|0|||
33615635|NCT01579474|63016669|FG004|Overall Study|Lack of Efficacy|1|||
33615636|NCT01579474|63016670|FG005|Overall Study|Lack of Efficacy|0|||
33615637|NCT01579474|63016665|FG000|Overall Study|Withdrawal by Subject|1|||
33615638|NCT01579474|63016666|FG001|Overall Study|Withdrawal by Subject|0|||
33615639|NCT01579474|63016667|FG002|Overall Study|Withdrawal by Subject|0|||
33615640|NCT01579474|63016668|FG003|Overall Study|Withdrawal by Subject|0|||
33615641|NCT01579474|63016669|FG004|Overall Study|Withdrawal by Subject|0|||
33615642|NCT01579474|63016670|FG005|Overall Study|Withdrawal by Subject|0|||
33615643|NCT01579318|63016683|FG000|Overall Study|Disease Progression|1|||
33615644|NCT01562782|63016689|FG000|Overall Study|Withdrawal by Subject|3|||
33615645|NCT01562782|63016690|FG001|Overall Study|Withdrawal by Subject|3|||
33615646|NCT01562782|63016689|FG000|Overall Study|screen failure|1|||
33615647|NCT01562782|63016690|FG001|Overall Study|screen failure|2|||
33615648|NCT01579006|63016696|FG000|Overall Study|Lack of Efficacy|10|||
33615649|NCT01579006|63016696|FG000|Overall Study|Adverse Event|13|||
33454021|NCT00419159|62828535|FG001|Overall Study|Disease progression|76|||
33454022|NCT03717064|62828549|FG000|Period 2|Adverse Event|1|||
33454023|NCT03716050|62828561|FG000|Overall Study|Lost to Follow-up|0|||
33454024|NCT03716050|62828562|FG001|Overall Study|Lost to Follow-up|0|||
33454025|NCT03716050|62828563|FG002|Overall Study|Lost to Follow-up|1|||
33454026|NCT03716050|62828564|FG003|Overall Study|Lost to Follow-up|0|||
33454027|NCT03716050|62828565|FG004|Overall Study|Lost to Follow-up|0|||
33454028|NCT03716050|62828566|FG005|Overall Study|Lost to Follow-up|0|||
33454029|NCT03716050|62828567|FG006|Overall Study|Lost to Follow-up|0|||
33454030|NCT03716050|62828568|FG007|Overall Study|Lost to Follow-up|0|||
33454031|NCT03716050|62828561|FG000|Overall Study|Physician Decision|0|||
33454032|NCT03716050|62828562|FG001|Overall Study|Physician Decision|0|||
33454033|NCT03716050|62828563|FG002|Overall Study|Physician Decision|0|||
33454034|NCT03716050|62828564|FG003|Overall Study|Physician Decision|1|||
33454035|NCT03716050|62828565|FG004|Overall Study|Physician Decision|0|||
33454036|NCT03716050|62828566|FG005|Overall Study|Physician Decision|0|||
33454037|NCT03716050|62828567|FG006|Overall Study|Physician Decision|0|||
33454038|NCT03716050|62828568|FG007|Overall Study|Physician Decision|0|||
33454039|NCT03716050|62828561|FG000|Overall Study|Protocol Violation|0|||
33454040|NCT03716050|62828562|FG001|Overall Study|Protocol Violation|0|||
33454041|NCT03716050|62828563|FG002|Overall Study|Protocol Violation|0|||
33454042|NCT03716050|62828564|FG003|Overall Study|Protocol Violation|1|||
33454043|NCT03716050|62828565|FG004|Overall Study|Protocol Violation|0|||
33454044|NCT03716050|62828566|FG005|Overall Study|Protocol Violation|0|||
33454045|NCT03716050|62828567|FG006|Overall Study|Protocol Violation|0|||
33454046|NCT03716050|62828568|FG007|Overall Study|Protocol Violation|2|||
33454047|NCT00413231|62828585|FG000|0 to 30-day Post Treatment|Death|5|||
33454048|NCT00413231|62828585|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
33454049|NCT00413231|62828585|FG000|30-day to 365-day Post Treatment|Death|13|||
33454050|NCT00413231|62828585|FG000|365-day to 60-month Post Treatment|Death|36|||
33454051|NCT00413231|62828585|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
33454052|NCT00413231|62828585|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
33454053|NCT00413231|62828585|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
33454054|NCT00413153|62828605|FG000|Overall Study|Withdrawal by Subject|1|||
33454055|NCT00413153|62828606|FG001|Overall Study|Withdrawal by Subject|1|||
33454056|NCT00413153|62828605|FG000|Overall Study|Adverse Event|1|||
33454057|NCT00413153|62828606|FG001|Overall Study|Adverse Event|0|||
33454058|NCT00412607|62828612|FG000|Overall Study|Withdrawal by Subject|9|||
33454059|NCT00412607|62828612|FG000|Overall Study|Lost to Follow-up|19|||
33454060|NCT00412607|62828612|FG000|Overall Study|Death|61|||
33517152|NCT01667133|62902151|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33454061|NCT00412607|62828612|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
33454062|NCT00419003|62828621|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
33454063|NCT00419003|62828622|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
33454064|NCT00419003|62828621|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
33454065|NCT00419003|62828622|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
33517153|NCT01667133|62902152|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33517154|NCT01667133|62902153|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33517155|NCT01667133|62902154|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
33517156|NCT01667133|62902155|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33517157|NCT01667133|62902156|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33517158|NCT01667133|62902145|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
33517159|NCT01667133|62902146|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
33517160|NCT01667133|62902147|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
33517161|NCT01667133|62902148|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
33517162|NCT01667133|62902149|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
33517163|NCT01667133|62902150|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
33517164|NCT01667133|62902151|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
33517165|NCT01667133|62902152|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
33517166|NCT01667133|62902153|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
33517167|NCT01667133|62902154|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
33517168|NCT01667133|62902155|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
33517169|NCT01667133|62902156|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
33517170|NCT01667133|62902145|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33517171|NCT01667133|62902146|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33517172|NCT01667133|62902147|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33517173|NCT01667133|62902148|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33517174|NCT01667133|62902149|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33517175|NCT01667133|62902150|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33517176|NCT01667133|62902151|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33517177|NCT01667133|62902152|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33517178|NCT01667133|62902153|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33517179|NCT01667133|62902154|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
33517180|NCT01667133|62902155|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33517181|NCT01667133|62902156|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33517182|NCT01667133|62902145|FG000|Phase 2: Dose-expansion|Death|0|||
33517183|NCT01667133|62902146|FG001|Phase 2: Dose-expansion|Death|0|||
33517184|NCT01667133|62902147|FG002|Phase 2: Dose-expansion|Death|0|||
33517185|NCT01667133|62902148|FG003|Phase 2: Dose-expansion|Death|0|||
33454066|NCT00418691|62828634|FG000|Overall Study|Lost to Follow-up|1|||
33454067|NCT00418691|62828635|FG001|Overall Study|Lost to Follow-up|2|||
33454068|NCT00418691|62828636|FG002|Overall Study|Lost to Follow-up|3|||
33454069|NCT00418691|62828634|FG000|Overall Study|Started new medication voiding entry|0|||
33454070|NCT00418691|62828635|FG001|Overall Study|Started new medication voiding entry|0|||
33454071|NCT00418691|62828636|FG002|Overall Study|Started new medication voiding entry|1|||
33454072|NCT00418691|62828634|FG000|Overall Study|Progressive Disease|1|||
33454073|NCT00418691|62828635|FG001|Overall Study|Progressive Disease|0|||
33454074|NCT00418691|62828636|FG002|Overall Study|Progressive Disease|1|||
33454075|NCT00412373|62828646|FG000|Overall Study|Adverse Event|8|||
33454076|NCT00412373|62828647|FG001|Overall Study|Adverse Event|13|||
33454077|NCT00412373|62828646|FG000|Overall Study|Lack of Efficacy|16|||
33454078|NCT00412373|62828647|FG001|Overall Study|Lack of Efficacy|22|||
33454079|NCT00412373|62828646|FG000|Overall Study|Lost to Follow-up|7|||
33454080|NCT00412373|62828647|FG001|Overall Study|Lost to Follow-up|13|||
33454081|NCT00412373|62828646|FG000|Overall Study|Withdrawal by Subject|8|||
33454082|NCT00412373|62828647|FG001|Overall Study|Withdrawal by Subject|27|||
33517186|NCT01667133|62902149|FG004|Phase 2: Dose-expansion|Death|0|||
33517187|NCT01667133|62902150|FG005|Phase 2: Dose-expansion|Death|0|||
33454083|NCT00412373|62828646|FG000|Overall Study|Other|2|||
33454084|NCT00412373|62828647|FG001|Overall Study|Other|2|||
33517188|NCT01667133|62902151|FG006|Phase 2: Dose-expansion|Death|0|||
33454085|NCT00418379|62828656|FG000|Year 1|Adverse Event|9|||
33517189|NCT01667133|62902152|FG007|Phase 2: Dose-expansion|Death|0|||
33517190|NCT01667133|62902153|FG008|Phase 2: Dose-expansion|Death|0|||
33517191|NCT01667133|62902154|FG009|Phase 2: Dose-expansion|Death|1|||
33517192|NCT01667133|62902155|FG010|Phase 2: Dose-expansion|Death|0|||
33517193|NCT01667133|62902156|FG011|Phase 2: Dose-expansion|Death|0|||
33517194|NCT01667133|62902145|FG000|Phase 2: Dose-expansion|Other|0|||
33517195|NCT01667133|62902146|FG001|Phase 2: Dose-expansion|Other|0|||
33517196|NCT01667133|62902147|FG002|Phase 2: Dose-expansion|Other|0|||
33517197|NCT01667133|62902148|FG003|Phase 2: Dose-expansion|Other|0|||
33517198|NCT01667133|62902149|FG004|Phase 2: Dose-expansion|Other|0|||
33517199|NCT01667133|62902150|FG005|Phase 2: Dose-expansion|Other|0|||
33324687|NCT00910624|62701263|FG001|Treatment Phase|Adverse Event|6|||
33324688|NCT00910624|62701264|FG002|Treatment Phase|Adverse Event|6|||
33324689|NCT00910624|62701265|FG003|Treatment Phase|Adverse Event|0|||
33454086|NCT00418379|62828657|FG001|Year 1|Adverse Event|15|||
33454087|NCT00418379|62828658|FG002|Year 1|Adverse Event|3|||
33454088|NCT00418379|62828656|FG000|Year 1|Withdrawal by Subject|7|||
33454089|NCT00418379|62828657|FG001|Year 1|Withdrawal by Subject|8|||
33454090|NCT00418379|62828658|FG002|Year 1|Withdrawal by Subject|5|||
33454091|NCT00418379|62828656|FG000|Year 1|Any other reason not above-mentioned|2|||
33454092|NCT00418379|62828657|FG001|Year 1|Any other reason not above-mentioned|5|||
33454093|NCT00418379|62828658|FG002|Year 1|Any other reason not above-mentioned|7|||
33454094|NCT00418379|62828656|FG000|Year 2|Adverse Event|5|||
33454095|NCT00418379|62828657|FG001|Year 2|Adverse Event|2|||
33454096|NCT00418379|62828658|FG002|Year 2|Adverse Event|1|||
33454097|NCT00418379|62828656|FG000|Year 2|Withdrawal by Subject|1|||
33454098|NCT00418379|62828657|FG001|Year 2|Withdrawal by Subject|1|||
33454099|NCT00418379|62828658|FG002|Year 2|Withdrawal by Subject|3|||
33454100|NCT00418379|62828656|FG000|Year 2|Any other reason not above-mentioned|2|||
33454101|NCT00418379|62828657|FG001|Year 2|Any other reason not above-mentioned|1|||
33454102|NCT00418379|62828658|FG002|Year 2|Any other reason not above-mentioned|6|||
33454103|NCT00418379|62828656|FG000|Year 3|Withdrawal by Subject|1|||
33454104|NCT00418379|62828657|FG001|Year 3|Withdrawal by Subject|1|||
33454105|NCT00418379|62828658|FG002|Year 3|Withdrawal by Subject|2|||
33454106|NCT00418379|62828656|FG000|Year 3|Any other reason not above-mentioned|2|||
33454107|NCT00418379|62828657|FG001|Year 3|Any other reason not above-mentioned|1|||
33454108|NCT00418379|62828658|FG002|Year 3|Any other reason not above-mentioned|1|||
33454109|NCT00418379|62828656|FG000|Year 4|Adverse Event|0|||
33454110|NCT00418379|62828657|FG001|Year 4|Adverse Event|1|||
33454111|NCT00418379|62828658|FG002|Year 4|Adverse Event|0|||
33454112|NCT00418379|62828656|FG000|Year 4|Withdrawal by Subject|2|||
33454113|NCT00418379|62828657|FG001|Year 4|Withdrawal by Subject|3|||
33454114|NCT00418379|62828658|FG002|Year 4|Withdrawal by Subject|2|||
33454115|NCT00418379|62828656|FG000|Year 4|Any other reason not above-mentioned|1|||
33454116|NCT00418379|62828657|FG001|Year 4|Any other reason not above-mentioned|1|||
33454117|NCT00418379|62828658|FG002|Year 4|Any other reason not above-mentioned|0|||
33454118|NCT00418379|62828656|FG000|Year 5|Adverse Event|0|||
33454119|NCT00418379|62828657|FG001|Year 5|Adverse Event|1|||
33517200|NCT01667133|62902151|FG006|Phase 2: Dose-expansion|Other|0|||
33454120|NCT00418379|62828658|FG002|Year 5|Adverse Event|0|||
33454121|NCT00418379|62828656|FG000|Year 5|Any other reason not above-mentioned|2|||
33517201|NCT01667133|62902152|FG007|Phase 2: Dose-expansion|Other|0|||
33517202|NCT01667133|62902153|FG008|Phase 2: Dose-expansion|Other|0|||
33517203|NCT01667133|62902154|FG009|Phase 2: Dose-expansion|Other|0|||
33517204|NCT01667133|62902155|FG010|Phase 2: Dose-expansion|Other|0|||
33454122|NCT00418379|62828657|FG001|Year 5|Any other reason not above-mentioned|4|||
33454123|NCT00418379|62828658|FG002|Year 5|Any other reason not above-mentioned|3|||
33517205|NCT01667133|62902156|FG011|Phase 2: Dose-expansion|Other|1|||
33517206|NCT01181778|62902217|FG000|Overall Study|Physician Decision|48|||
33517207|NCT00092118|62902225|FG000|Overall Study|Adverse Event|35|||
33517208|NCT00092118|62902226|FG001|Overall Study|Adverse Event|32|||
33517209|NCT00092118|62902225|FG000|Overall Study|Lack of Efficacy|12|||
33615650|NCT01579006|63016696|FG000|Overall Study|Withdrawal by Subject|5|||
33615651|NCT01579006|63016696|FG000|Overall Study|Non-compliance|3|||
33615652|NCT01579006|63016696|FG000|Overall Study|Due to participant's health fund|1|||
33615653|NCT01579006|63016696|FG000|Overall Study|Scheduled surgery|1|||
33615654|NCT01578850|63016702|FG000|Period 1|Insufficient Clinical Response|1|||
33615655|NCT01578850|63016703|FG001|Period 1|Insufficient Clinical Response|0|||
33615656|NCT01578850|63016704|FG002|Period 1|Insufficient Clinical Response|0|||
33615657|NCT01578850|63016702|FG000|Period 1|Adverse Event|11|||
33615658|NCT01578850|63016703|FG001|Period 1|Adverse Event|0|||
33615659|NCT01578850|63016704|FG002|Period 1|Adverse Event|0|||
33615660|NCT01578850|63016702|FG000|Period 1|Death|1|||
33615661|NCT01578850|63016703|FG001|Period 1|Death|0|||
33324690|NCT00910624|62701262|FG000|Treatment Phase|Treatment Failure|23|||
33324691|NCT00910624|62701263|FG001|Treatment Phase|Treatment Failure|10|||
33517210|NCT00092118|62902226|FG001|Overall Study|Lack of Efficacy|14|||
33517211|NCT00092118|62902225|FG000|Overall Study|Lost to Follow-up|4|||
33517212|NCT00092118|62902226|FG001|Overall Study|Lost to Follow-up|3|||
33517213|NCT00092118|62902225|FG000|Overall Study|Protocol Violation|23|||
33517214|NCT00092118|62902226|FG001|Overall Study|Protocol Violation|25|||
33517215|NCT00092118|62902225|FG000|Overall Study|Withdrawal by Subject|4|||
33517216|NCT00092118|62902226|FG001|Overall Study|Withdrawal by Subject|10|||
33517217|NCT00092118|62902225|FG000|Overall Study|Other|6|||
33517218|NCT00092118|62902226|FG001|Overall Study|Other|5|||
33517219|NCT03261947|62902237|FG000|Overall Study|Death|10|||
33517220|NCT03261947|62902238|FG001|Overall Study|Death|13|||
33517221|NCT03261947|62902239|FG002|Overall Study|Death|17|||
33517222|NCT03261947|62902240|FG003|Overall Study|Death|12|||
33517223|NCT03261947|62902241|FG004|Overall Study|Death|8|||
33517224|NCT03261947|62902237|FG000|Overall Study|Lost to Follow-up|0|||
33517225|NCT03261947|62902238|FG001|Overall Study|Lost to Follow-up|0|||
33517226|NCT03261947|62902239|FG002|Overall Study|Lost to Follow-up|2|||
33517227|NCT03261947|62902240|FG003|Overall Study|Lost to Follow-up|1|||
33517228|NCT03261947|62902241|FG004|Overall Study|Lost to Follow-up|0|||
33517229|NCT03261947|62902237|FG000|Overall Study|Withdrawal by Subject|0|||
33517230|NCT03261947|62902238|FG001|Overall Study|Withdrawal by Subject|0|||
33517231|NCT03261947|62902239|FG002|Overall Study|Withdrawal by Subject|3|||
33517232|NCT03261947|62902240|FG003|Overall Study|Withdrawal by Subject|0|||
33517233|NCT03261947|62902241|FG004|Overall Study|Withdrawal by Subject|1|||
33517234|NCT03261947|62902237|FG000|Overall Study|Site Terminated by Sponsor|0|||
33517235|NCT03261947|62902238|FG001|Overall Study|Site Terminated by Sponsor|0|||
33517236|NCT03261947|62902239|FG002|Overall Study|Site Terminated by Sponsor|4|||
33517237|NCT03261947|62902240|FG003|Overall Study|Site Terminated by Sponsor|7|||
33517238|NCT03261947|62902241|FG004|Overall Study|Site Terminated by Sponsor|5|||
33517239|NCT03261947|62902237|FG000|Overall Study|Reason not Specified|2|||
33517240|NCT03261947|62902238|FG001|Overall Study|Reason not Specified|0|||
33517241|NCT03261947|62902239|FG002|Overall Study|Reason not Specified|4|||
33517242|NCT03261947|62902240|FG003|Overall Study|Reason not Specified|1|||
33517243|NCT03261947|62902241|FG004|Overall Study|Reason not Specified|3|||
33517244|NCT03034044|62902257|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
33517245|NCT03098979|62902276|FG000|Overall Study|Adverse Event|1|||
33517246|NCT03098979|62902277|FG001|Overall Study|Adverse Event|0|||
33517247|NCT03098979|62902278|FG002|Overall Study|Adverse Event|1|||
33517248|NCT03098979|62902279|FG003|Overall Study|Adverse Event|4|||
33517249|NCT03098979|62902280|FG004|Overall Study|Adverse Event|6|||
33517250|NCT03098979|62902281|FG005|Overall Study|Adverse Event|1|||
33517251|NCT03098979|62902276|FG000|Overall Study|Withdrawal by Subject|2|||
33517252|NCT03098979|62902277|FG001|Overall Study|Withdrawal by Subject|1|||
33517253|NCT03098979|62902278|FG002|Overall Study|Withdrawal by Subject|1|||
33517254|NCT03098979|62902279|FG003|Overall Study|Withdrawal by Subject|1|||
33517255|NCT03098979|62902280|FG004|Overall Study|Withdrawal by Subject|2|||
33517256|NCT03098979|62902281|FG005|Overall Study|Withdrawal by Subject|1|||
33517257|NCT03098979|62902276|FG000|Overall Study|Death|1|||
33324692|NCT00910624|62701264|FG002|Treatment Phase|Treatment Failure|0|||
33324693|NCT00910624|62701265|FG003|Treatment Phase|Treatment Failure|0|||
33517258|NCT03098979|62902277|FG001|Overall Study|Death|0|||
33517259|NCT03098979|62902278|FG002|Overall Study|Death|2|||
33324694|NCT00910624|62701262|FG000|Treatment Phase|Lost to Follow-up|0|||
33517260|NCT03098979|62902279|FG003|Overall Study|Death|0|||
33615662|NCT01578850|63016704|FG002|Period 1|Death|0|||
33615663|NCT01578850|63016702|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
33324695|NCT00910624|62701263|FG001|Treatment Phase|Lost to Follow-up|0|||
33517261|NCT03098979|62902280|FG004|Overall Study|Death|1|||
33517262|NCT03098979|62902281|FG005|Overall Study|Death|0|||
33517263|NCT03098979|62902276|FG000|Overall Study|Physician Decision|2|||
33615664|NCT01578850|63016703|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
33615665|NCT01578850|63016704|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
33517264|NCT03098979|62902277|FG001|Overall Study|Physician Decision|1|||
33517265|NCT03098979|62902278|FG002|Overall Study|Physician Decision|0|||
33517266|NCT03098979|62902279|FG003|Overall Study|Physician Decision|0|||
33517267|NCT03098979|62902280|FG004|Overall Study|Physician Decision|0|||
33517268|NCT03098979|62902281|FG005|Overall Study|Physician Decision|0|||
33517269|NCT03098979|62902276|FG000|Overall Study|Non-compliance|0|||
33517270|NCT03098979|62902277|FG001|Overall Study|Non-compliance|0|||
33517271|NCT03098979|62902278|FG002|Overall Study|Non-compliance|0|||
33517272|NCT03098979|62902279|FG003|Overall Study|Non-compliance|0|||
33517273|NCT03098979|62902280|FG004|Overall Study|Non-compliance|0|||
33517274|NCT03098979|62902281|FG005|Overall Study|Non-compliance|1|||
33517275|NCT03098979|62902276|FG000|Overall Study|Protocol Violation|0|||
33324696|NCT00910624|62701264|FG002|Treatment Phase|Lost to Follow-up|1|||
33324697|NCT00910624|62701265|FG003|Treatment Phase|Lost to Follow-up|0|||
33517276|NCT03098979|62902277|FG001|Overall Study|Protocol Violation|0|||
33517277|NCT03098979|62902278|FG002|Overall Study|Protocol Violation|0|||
33517278|NCT03098979|62902279|FG003|Overall Study|Protocol Violation|0|||
33517279|NCT03098979|62902280|FG004|Overall Study|Protocol Violation|0|||
33517280|NCT03098979|62902281|FG005|Overall Study|Protocol Violation|1|||
33517281|NCT03261167|62902297|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
33517282|NCT03261167|62902298|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
33517283|NCT03261167|62902297|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
33517284|NCT03261167|62902298|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
33615666|NCT01578850|63016702|FG000|Period 1|Withdrawal by Subject|9|||
33324698|NCT00910624|62701262|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
33324699|NCT00910624|62701263|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
33324700|NCT00910624|62701264|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
33324701|NCT00910624|62701265|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
33324702|NCT00910624|62701262|FG000|Treatment Phase|Withdrawal by Subject|2|||
33324703|NCT00910624|62701263|FG001|Treatment Phase|Withdrawal by Subject|1|||
33324704|NCT00910624|62701264|FG002|Treatment Phase|Withdrawal by Subject|0|||
33324705|NCT00910624|62701265|FG003|Treatment Phase|Withdrawal by Subject|0|||
33324706|NCT00910624|62701262|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
33324707|NCT00910624|62701263|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
33324708|NCT00910624|62701264|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
33324709|NCT00910624|62701265|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
33324710|NCT00910624|62701262|FG000|Follow-Up Phase|Adverse Event|0|||
33324711|NCT00910624|62701263|FG001|Follow-Up Phase|Adverse Event|0|||
33324712|NCT00910624|62701264|FG002|Follow-Up Phase|Adverse Event|1|||
33324713|NCT00910624|62701265|FG003|Follow-Up Phase|Adverse Event|0|||
33324714|NCT00910624|62701262|FG000|Follow-Up Phase|Lost to Follow-up|3|||
33324715|NCT00910624|62701263|FG001|Follow-Up Phase|Lost to Follow-up|1|||
33324716|NCT00910624|62701264|FG002|Follow-Up Phase|Lost to Follow-up|2|||
33324717|NCT00910624|62701265|FG003|Follow-Up Phase|Lost to Follow-up|0|||
33324718|NCT00910624|62701262|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
33324719|NCT00910624|62701263|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
33324720|NCT00910624|62701264|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
33324721|NCT00910624|62701265|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
33324722|NCT00910624|62701262|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
33454124|NCT00418145|62828666|FG000|Overall Study|study terminated|6|||
33454125|NCT00417989|62828674|FG000|Overall Study|Withdrawal by Subject|13|||
33454126|NCT00417989|62828675|FG001|Overall Study|Withdrawal by Subject|13|||
33454127|NCT00417989|62828674|FG000|Overall Study|Lost to Follow-up|1|||
33454128|NCT00417989|62828675|FG001|Overall Study|Lost to Follow-up|6|||
33454129|NCT00417989|62828674|FG000|Overall Study|Protocol Violation|1|||
33454130|NCT00417989|62828675|FG001|Overall Study|Protocol Violation|0|||
33454131|NCT00417989|62828674|FG000|Overall Study|Death|0|||
33454132|NCT00417989|62828675|FG001|Overall Study|Death|1|||
33454133|NCT00417989|62828674|FG000|Overall Study|Physician Decision|5|||
33454134|NCT00417989|62828675|FG001|Overall Study|Physician Decision|2|||
33454135|NCT00412217|62828685|FG000|Overall Study|Insufficient Data Available|8|||
33454136|NCT00412217|62828686|FG001|Overall Study|Insufficient Data Available|3|||
33454137|NCT00412217|62828685|FG000|Overall Study|Death|5|||
33454138|NCT00412217|62828686|FG001|Overall Study|Death|4|||
33454139|NCT00412217|62828685|FG000|Overall Study|Disease Progression|2|||
33454140|NCT00412217|62828686|FG001|Overall Study|Disease Progression|3|||
33454141|NCT00412217|62828685|FG000|Overall Study|Investigator Decision|1|||
33454142|NCT00412217|62828686|FG001|Overall Study|Investigator Decision|0|||
33454143|NCT00412217|62828685|FG000|Overall Study|Withdrawal by Subject|2|||
33454144|NCT00412217|62828686|FG001|Overall Study|Withdrawal by Subject|0|||
33517285|NCT03261167|62902297|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
33517286|NCT03261167|62902298|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
33517287|NCT03261167|62902297|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
33454145|NCT00412217|62828685|FG000|Overall Study|Lost to Follow-up|1|||
33517288|NCT03261167|62902298|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
33615667|NCT01578850|63016703|FG001|Period 1|Withdrawal by Subject|0|||
33615668|NCT01578850|63016704|FG002|Period 1|Withdrawal by Subject|0|||
33615669|NCT01578850|63016702|FG000|Period 1|Study Terminated by Sponsor|3|||
33615670|NCT01578850|63016703|FG001|Period 1|Study Terminated by Sponsor|0|||
33615671|NCT01578850|63016704|FG002|Period 1|Study Terminated by Sponsor|0|||
33615672|NCT01578850|63016702|FG000|Period 2|Insufficient Clinical Response|0|||
33615673|NCT01578850|63016703|FG001|Period 2|Insufficient Clinical Response|1|||
33615674|NCT01578850|63016704|FG002|Period 2|Insufficient Clinical Response|0|||
33615675|NCT01578850|63016702|FG000|Period 2|Adverse Event|0|||
33615676|NCT01578850|63016703|FG001|Period 2|Adverse Event|3|||
33615677|NCT01578850|63016704|FG002|Period 2|Adverse Event|6|||
33615678|NCT01578850|63016702|FG000|Period 2|Lost to Follow-up|0|||
33324723|NCT00910624|62701263|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
33324724|NCT00910624|62701264|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
33454146|NCT00412217|62828686|FG001|Overall Study|Lost to Follow-up|4|||
33454147|NCT00412217|62828685|FG000|Overall Study|Study Terminated by Sponsor|26|||
33454148|NCT00412217|62828686|FG001|Overall Study|Study Terminated by Sponsor|33|||
33454149|NCT00412217|62828685|FG000|Overall Study|Other|1|||
33454150|NCT00412217|62828686|FG001|Overall Study|Other|1|||
33454151|NCT05000164|62828692|FG000|Overall Study|Adverse Event|1|||
33454152|NCT05000164|62828692|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
33454153|NCT05000164|62828692|FG000|Overall Study|Lens Discomfort|3|||
33517289|NCT03261167|62902297|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
33517290|NCT03261167|62902298|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
33615679|NCT01578850|63016703|FG001|Period 2|Lost to Follow-up|1|||
33615680|NCT01578850|63016704|FG002|Period 2|Lost to Follow-up|2|||
33615681|NCT01578850|63016702|FG000|Period 2|Withdrawal by Subject|0|||
33615682|NCT01578850|63016703|FG001|Period 2|Withdrawal by Subject|2|||
33615683|NCT01578850|63016704|FG002|Period 2|Withdrawal by Subject|2|||
33615684|NCT01578850|63016702|FG000|Period 2|Study Terminated by Sponsor|0|||
33615685|NCT01578850|63016703|FG001|Period 2|Study Terminated by Sponsor|5|||
33615686|NCT01578850|63016704|FG002|Period 2|Study Terminated by Sponsor|4|||
33615687|NCT01578850|63016702|FG000|Period 2|Unspecified Reasons|0|||
33615688|NCT01578850|63016703|FG001|Period 2|Unspecified Reasons|1|||
33615689|NCT01578850|63016704|FG002|Period 2|Unspecified Reasons|0|||
33615690|NCT01539538|63016714|FG000|Overall Study|Adverse Event|13|||
33615691|NCT01539538|63016715|FG001|Overall Study|Adverse Event|18|||
33517291|NCT03294941|62902312|FG000|Overall Study|Withdrawal by Subject|0|||
33615692|NCT01539538|63016714|FG000|Overall Study|Lack of Efficacy|13|||
33615693|NCT01539538|63016715|FG001|Overall Study|Lack of Efficacy|16|||
33615694|NCT01539538|63016714|FG000|Overall Study|Withdrawal by Subject|2|||
33615695|NCT01539538|63016715|FG001|Overall Study|Withdrawal by Subject|3|||
33615696|NCT01539538|63016714|FG000|Overall Study|PCA no longer required or PCA problem|3|||
33615697|NCT01539538|63016715|FG001|Overall Study|PCA no longer required or PCA problem|7|||
33615698|NCT01562548|63016725|FG000|Overall Study|Lost to Follow-up|0|||
33615699|NCT01562548|63016726|FG001|Overall Study|Lost to Follow-up|0|||
33615700|NCT01562548|63016727|FG002|Overall Study|Lost to Follow-up|1|||
33615701|NCT01562548|63016728|FG003|Overall Study|Lost to Follow-up|0|||
33615702|NCT01562314|63016742|FG000|Overall Study|Adverse Event|10|||
33615703|NCT01562314|63016743|FG001|Overall Study|Adverse Event|5|||
33517292|NCT03294941|62902313|FG001|Overall Study|Withdrawal by Subject|2|||
33615704|NCT01562314|63016742|FG000|Overall Study|Met Withdrawal Criteria|3|||
33615705|NCT01562314|63016743|FG001|Overall Study|Met Withdrawal Criteria|2|||
33517293|NCT03098433|62902320|FG000|Overall Study|Withdrawal by Subject|10|||
33517294|NCT03294317|62902325|FG000|Overall Study|Physician Decision|1|||
33517295|NCT03294317|62902325|FG000|Overall Study|Withdrawal by Subject|6|||
33517296|NCT03294317|62902325|FG000|Overall Study|Lost to Follow-up|1|||
33517297|NCT03294317|62902325|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
33517298|NCT03294317|62902325|FG000|Overall Study|Failed HB lead implant|8|||
33517299|NCT03294317|62902325|FG000|Overall Study|Received CRT instead|1|||
33615706|NCT01562314|63016742|FG000|Overall Study|Withdrawal by Subject|0|||
33615707|NCT01562314|63016743|FG001|Overall Study|Withdrawal by Subject|1|||
33324725|NCT00910624|62701265|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
33324726|NCT00910624|62701262|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
33517300|NCT03294317|62902325|FG000|Overall Study|Exited after lead revision|2|||
33517301|NCT03292913|62902331|FG000|Overall Study|Death|9|||
33517302|NCT03292913|62902332|FG001|Overall Study|Death|3|||
33615708|NCT01539226|63016751|FG000|Overall Study|Withdrawal by Subject|24|||
33615709|NCT01539226|63016752|FG001|Overall Study|Withdrawal by Subject|54|||
33615710|NCT01539226|63016751|FG000|Overall Study|Lost to Follow-up|20|||
33615711|NCT01539226|63016752|FG001|Overall Study|Lost to Follow-up|54|||
33517303|NCT03292913|62902331|FG000|Overall Study|Lost to Follow-up|49|||
33615712|NCT01539226|63016751|FG000|Overall Study|Death|1|||
33615713|NCT01539226|63016752|FG001|Overall Study|Death|2|||
33615714|NCT01539226|63016751|FG000|Overall Study|Adverse Event|2|||
33615715|NCT01539226|63016752|FG001|Overall Study|Adverse Event|0|||
33454154|NCT05000164|62828692|FG000|Overall Study|Withdrew Consent during Study|2|||
33615716|NCT01539226|63016751|FG000|Overall Study|Pregnancy|13|||
33517304|NCT03292913|62902332|FG001|Overall Study|Lost to Follow-up|49|||
33517305|NCT03292913|62902331|FG000|Overall Study|Withdrawal by Subject|2|||
33517306|NCT03292913|62902332|FG001|Overall Study|Withdrawal by Subject|0|||
33517307|NCT03292913|62902331|FG000|Overall Study|Clinic closed due to COVID|22|||
33517308|NCT03292913|62902332|FG001|Overall Study|Clinic closed due to COVID|36|||
33615717|NCT01539226|63016752|FG001|Overall Study|Pregnancy|29|||
33454155|NCT05000164|62828692|FG000|Overall Study|Subject Withdrawn by PI|2|||
33454156|NCT05000164|62828692|FG000|Overall Study|Other Fractured Test Article|1|||
33454157|NCT00123474|62828700|FG000|Randomized to Treatment|Randomized, never treated|1|||
33454158|NCT00123474|62828701|FG001|Randomized to Treatment|Randomized, never treated|4|||
33454159|NCT00123474|62828702|FG002|Randomized to Treatment|Randomized, never treated|2|||
33454160|NCT00123474|62828703|FG003|Randomized to Treatment|Randomized, never treated|1|||
33454161|NCT00123474|62828700|FG000|As Treated at Study Closure|not reported when site closed|1|||
33454162|NCT00123474|62828701|FG001|As Treated at Study Closure|not reported when site closed|0|||
33454163|NCT00123474|62828702|FG002|As Treated at Study Closure|not reported when site closed|1|||
33454164|NCT00123474|62828703|FG003|As Treated at Study Closure|not reported when site closed|0|||
33454165|NCT00123474|62828700|FG000|As Treated at Study Closure|Adverse Event|10|||
33454166|NCT00123474|62828701|FG001|As Treated at Study Closure|Adverse Event|4|||
33454167|NCT00123474|62828702|FG002|As Treated at Study Closure|Adverse Event|10|||
33454168|NCT00123474|62828703|FG003|As Treated at Study Closure|Adverse Event|8|||
33454169|NCT00123474|62828700|FG000|As Treated at Study Closure|Disease Progression|35|||
33454170|NCT00123474|62828701|FG001|As Treated at Study Closure|Disease Progression|42|||
33454171|NCT00123474|62828702|FG002|As Treated at Study Closure|Disease Progression|29|||
33454172|NCT00123474|62828703|FG003|As Treated at Study Closure|Disease Progression|27|||
33454173|NCT00123474|62828700|FG000|As Treated at Study Closure|Investigator Request|12|||
33454174|NCT00123474|62828701|FG001|As Treated at Study Closure|Investigator Request|6|||
33454175|NCT00123474|62828702|FG002|As Treated at Study Closure|Investigator Request|7|||
33454176|NCT00123474|62828703|FG003|As Treated at Study Closure|Investigator Request|5|||
33454177|NCT00123474|62828700|FG000|As Treated at Study Closure|non-specified|54|||
33454178|NCT00123474|62828701|FG001|As Treated at Study Closure|non-specified|47|||
33454179|NCT00123474|62828702|FG002|As Treated at Study Closure|non-specified|57|||
33454180|NCT00123474|62828703|FG003|As Treated at Study Closure|non-specified|60|||
33454181|NCT00123474|62828700|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
33454182|NCT00123474|62828701|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
33454183|NCT00123474|62828702|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
33454184|NCT00123474|62828703|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
33454185|NCT00123474|62828700|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
33454186|NCT00123474|62828701|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
33454187|NCT00123474|62828702|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
33454188|NCT00123474|62828703|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
33454189|NCT00142298|62828744|FG000|Overall Study|Adverse Event|10|||
33454190|NCT00142298|62828745|FG001|Overall Study|Adverse Event|10|||
33454191|NCT00142298|62828746|FG002|Overall Study|Adverse Event|1|||
33454192|NCT00142298|62828747|FG003|Overall Study|Adverse Event|5|||
33454193|NCT00142298|62828748|FG004|Overall Study|Adverse Event|2|||
33454194|NCT00142298|62828749|FG005|Overall Study|Adverse Event|2|||
33454195|NCT00142298|62828750|FG006|Overall Study|Adverse Event|0|||
33454196|NCT00142298|62828751|FG007|Overall Study|Adverse Event|0|||
33454197|NCT00142298|62828752|FG008|Overall Study|Adverse Event|0|||
33454198|NCT00142298|62828753|FG009|Overall Study|Adverse Event|0|||
33454199|NCT00142298|62828744|FG000|Overall Study|Clinical disease progression|1|||
33454200|NCT00142298|62828745|FG001|Overall Study|Clinical disease progression|0|||
33454201|NCT00142298|62828746|FG002|Overall Study|Clinical disease progression|0|||
33454202|NCT00142298|62828747|FG003|Overall Study|Clinical disease progression|0|||
33615718|NCT01539226|63016751|FG000|Overall Study|inappropriate enrollment|0|||
33454203|NCT00142298|62828748|FG004|Overall Study|Clinical disease progression|0|||
33454204|NCT00142298|62828749|FG005|Overall Study|Clinical disease progression|0|||
33454205|NCT00142298|62828750|FG006|Overall Study|Clinical disease progression|0|||
33454206|NCT00142298|62828751|FG007|Overall Study|Clinical disease progression|0|||
33454207|NCT00142298|62828752|FG008|Overall Study|Clinical disease progression|0|||
33324727|NCT00910624|62701263|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
33324728|NCT00910624|62701264|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
33454208|NCT00142298|62828753|FG009|Overall Study|Clinical disease progression|0|||
33454209|NCT00142298|62828744|FG000|Overall Study|Death|1|||
33454210|NCT00142298|62828745|FG001|Overall Study|Death|1|||
33615719|NCT01539226|63016752|FG001|Overall Study|inappropriate enrollment|1|||
33454211|NCT00142298|62828746|FG002|Overall Study|Death|1|||
33454212|NCT00142298|62828747|FG003|Overall Study|Death|0|||
33454213|NCT00142298|62828748|FG004|Overall Study|Death|0|||
33454214|NCT00142298|62828749|FG005|Overall Study|Death|6|||
33454215|NCT00142298|62828750|FG006|Overall Study|Death|0|||
33454216|NCT00142298|62828751|FG007|Overall Study|Death|0|||
33454217|NCT00142298|62828752|FG008|Overall Study|Death|0|||
33454218|NCT00142298|62828753|FG009|Overall Study|Death|0|||
33454219|NCT00142298|62828744|FG000|Overall Study|Lack of Efficacy|44|||
33324729|NCT00910624|62701265|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
33454220|NCT00142298|62828745|FG001|Overall Study|Lack of Efficacy|62|||
33454221|NCT00142298|62828746|FG002|Overall Study|Lack of Efficacy|9|||
33454222|NCT00142298|62828747|FG003|Overall Study|Lack of Efficacy|12|||
33454223|NCT00142298|62828748|FG004|Overall Study|Lack of Efficacy|1|||
33454224|NCT00142298|62828749|FG005|Overall Study|Lack of Efficacy|0|||
33454225|NCT00142298|62828750|FG006|Overall Study|Lack of Efficacy|0|||
33454226|NCT00142298|62828751|FG007|Overall Study|Lack of Efficacy|1|||
33454227|NCT00142298|62828752|FG008|Overall Study|Lack of Efficacy|0|||
33454228|NCT00142298|62828753|FG009|Overall Study|Lack of Efficacy|0|||
33454229|NCT00142298|62828744|FG000|Overall Study|Non-compliance|15|||
33454230|NCT00142298|62828745|FG001|Overall Study|Non-compliance|13|||
33454231|NCT00142298|62828746|FG002|Overall Study|Non-compliance|0|||
33454232|NCT00142298|62828747|FG003|Overall Study|Non-compliance|6|||
33454233|NCT00142298|62828748|FG004|Overall Study|Non-compliance|1|||
33454234|NCT00142298|62828749|FG005|Overall Study|Non-compliance|0|||
33454235|NCT00142298|62828750|FG006|Overall Study|Non-compliance|0|||
33454236|NCT00142298|62828751|FG007|Overall Study|Non-compliance|3|||
33454237|NCT00142298|62828752|FG008|Overall Study|Non-compliance|3|||
33454238|NCT00142298|62828753|FG009|Overall Study|Non-compliance|0|||
33454239|NCT00142298|62828744|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
33454240|NCT00142298|62828745|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
33454241|NCT00142298|62828746|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
33454242|NCT00142298|62828747|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
33454243|NCT00142298|62828748|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
33454244|NCT00142298|62828749|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
33454245|NCT00142298|62828750|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
33454246|NCT00142298|62828751|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
33454247|NCT00142298|62828752|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
33454248|NCT00142298|62828753|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
33454249|NCT00142298|62828744|FG000|Overall Study|Pregnancy|4|||
33454250|NCT00142298|62828745|FG001|Overall Study|Pregnancy|4|||
33454251|NCT00142298|62828746|FG002|Overall Study|Pregnancy|2|||
33454252|NCT00142298|62828747|FG003|Overall Study|Pregnancy|3|||
33454253|NCT00142298|62828748|FG004|Overall Study|Pregnancy|0|||
33454254|NCT00142298|62828749|FG005|Overall Study|Pregnancy|0|||
33454255|NCT00142298|62828750|FG006|Overall Study|Pregnancy|0|||
33454256|NCT00142298|62828751|FG007|Overall Study|Pregnancy|0|||
33454257|NCT00142298|62828752|FG008|Overall Study|Pregnancy|1|||
33454258|NCT00142298|62828753|FG009|Overall Study|Pregnancy|0|||
33454259|NCT00142298|62828744|FG000|Overall Study|Virologic breakthrough|19|||
33454260|NCT00142298|62828745|FG001|Overall Study|Virologic breakthrough|23|||
33454261|NCT00142298|62828746|FG002|Overall Study|Virologic breakthrough|9|||
33454262|NCT00142298|62828747|FG003|Overall Study|Virologic breakthrough|7|||
33454263|NCT00142298|62828748|FG004|Overall Study|Virologic breakthrough|2|||
33454264|NCT00142298|62828749|FG005|Overall Study|Virologic breakthrough|3|||
33454265|NCT00142298|62828750|FG006|Overall Study|Virologic breakthrough|3|||
33454266|NCT00142298|62828751|FG007|Overall Study|Virologic breakthrough|0|||
33454267|NCT00142298|62828752|FG008|Overall Study|Virologic breakthrough|0|||
33454268|NCT00142298|62828753|FG009|Overall Study|Virologic breakthrough|0|||
33454269|NCT00142298|62828744|FG000|Overall Study|Other- not specified|0|||
33454270|NCT00142298|62828745|FG001|Overall Study|Other- not specified|3|||
33454271|NCT00142298|62828746|FG002|Overall Study|Other- not specified|0|||
33454272|NCT00142298|62828747|FG003|Overall Study|Other- not specified|1|||
33454273|NCT00142298|62828748|FG004|Overall Study|Other- not specified|0|||
33454274|NCT00142298|62828749|FG005|Overall Study|Other- not specified|0|||
33454275|NCT00142298|62828750|FG006|Overall Study|Other- not specified|0|||
33454276|NCT00142298|62828751|FG007|Overall Study|Other- not specified|0|||
33454277|NCT00142298|62828752|FG008|Overall Study|Other- not specified|0|||
33454278|NCT00142298|62828753|FG009|Overall Study|Other- not specified|0|||
33454279|NCT00142298|62828744|FG000|Overall Study|Lost to Follow-up|0|||
33454280|NCT00142298|62828745|FG001|Overall Study|Lost to Follow-up|0|||
33454281|NCT00142298|62828746|FG002|Overall Study|Lost to Follow-up|0|||
33454282|NCT00142298|62828747|FG003|Overall Study|Lost to Follow-up|0|||
33454283|NCT00142298|62828748|FG004|Overall Study|Lost to Follow-up|0|||
33454284|NCT00142298|62828749|FG005|Overall Study|Lost to Follow-up|0|||
33615720|NCT01539226|63016751|FG000|Overall Study|Multiple Reasons|3|||
33615721|NCT01539226|63016752|FG001|Overall Study|Multiple Reasons|1|||
33615722|NCT01539226|63016751|FG000|Overall Study|not HIV seroconversion-related|93|||
33615723|NCT01539226|63016752|FG001|Overall Study|not HIV seroconversion-related|176|||
33454285|NCT00142298|62828750|FG006|Overall Study|Lost to Follow-up|2|||
33454286|NCT00142298|62828751|FG007|Overall Study|Lost to Follow-up|0|||
33454287|NCT00142298|62828752|FG008|Overall Study|Lost to Follow-up|0|||
33454288|NCT00142298|62828753|FG009|Overall Study|Lost to Follow-up|0|||
33454289|NCT00142298|62828744|FG000|Overall Study|Treatment Failure|0|||
33454290|NCT00142298|62828745|FG001|Overall Study|Treatment Failure|0|||
33454291|NCT00142298|62828746|FG002|Overall Study|Treatment Failure|0|||
33454292|NCT00142298|62828747|FG003|Overall Study|Treatment Failure|0|||
33454293|NCT00142298|62828748|FG004|Overall Study|Treatment Failure|0|||
33454294|NCT00142298|62828749|FG005|Overall Study|Treatment Failure|2|||
33454295|NCT00142298|62828750|FG006|Overall Study|Treatment Failure|2|||
33454296|NCT00142298|62828751|FG007|Overall Study|Treatment Failure|0|||
33454297|NCT00142298|62828752|FG008|Overall Study|Treatment Failure|0|||
33454298|NCT00142298|62828753|FG009|Overall Study|Treatment Failure|0|||
33454299|NCT03709654|62828777|FG000|Overall Study|Lost to Follow-up|1|||
33454300|NCT03709654|62828778|FG001|Overall Study|Lost to Follow-up|1|||
33517344|NCT03291587|62902369|FG000|Overall Study|Lost to Follow-up|62|||
33517345|NCT03291587|62902370|FG001|Overall Study|Lost to Follow-up|43|||
33517346|NCT03291587|62902369|FG000|Overall Study|Refused to Answer|5|||
33517347|NCT03291587|62902370|FG001|Overall Study|Refused to Answer|2|||
33517348|NCT03291587|62902369|FG000|Overall Study|Death|2|||
33517349|NCT03291587|62902370|FG001|Overall Study|Death|4|||
33517350|NCT03291587|62902369|FG000|Overall Study|Not interested in participating|8|||
33517351|NCT03291587|62902370|FG001|Overall Study|Not interested in participating|6|||
33517352|NCT03291587|62902369|FG000|Overall Study|Too busy to participate|4|||
33517353|NCT03291587|62902370|FG001|Overall Study|Too busy to participate|2|||
33517354|NCT03210961|62902401|FG000|Overall Study|Adverse Event|0|||
33517355|NCT03210961|62902402|FG001|Overall Study|Adverse Event|0|||
33517356|NCT03210961|62902403|FG002|Overall Study|Adverse Event|0|||
33517357|NCT03210961|62902404|FG003|Overall Study|Adverse Event|0|||
33517358|NCT03210961|62902405|FG004|Overall Study|Adverse Event|0|||
33615724|NCT01539226|63016751|FG000|Overall Study|HIV seroconversion-related|55|||
33615725|NCT01539226|63016752|FG001|Overall Study|HIV seroconversion-related|80|||
33615726|NCT01539226|63016751|FG000|Overall Study|Non-compliance|6|||
33615727|NCT01539226|63016752|FG001|Overall Study|Non-compliance|8|||
33615728|NCT01577758|63016758|FG000|Dose Escalation Phase|Adverse Event|0|||
33615729|NCT01577758|63016759|FG001|Dose Escalation Phase|Adverse Event|0|||
33615730|NCT01577758|63016760|FG002|Dose Escalation Phase|Adverse Event|0|||
33615731|NCT01577758|63016761|FG003|Dose Escalation Phase|Adverse Event|0|||
33615732|NCT01577758|63016762|FG004|Dose Escalation Phase|Adverse Event|0|||
33615733|NCT01577758|63016763|FG005|Dose Escalation Phase|Adverse Event|2|||
33615734|NCT01577758|63016764|FG006|Dose Escalation Phase|Adverse Event|1|||
33615735|NCT01577758|63016765|FG007|Dose Escalation Phase|Adverse Event|0|||
33615736|NCT01577758|63016758|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
33615737|NCT01577758|63016759|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
33615738|NCT01577758|63016760|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
33615739|NCT01577758|63016761|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
33615740|NCT01577758|63016762|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
33615741|NCT01577758|63016763|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
33615742|NCT01577758|63016764|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
33615743|NCT01577758|63016765|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
33615744|NCT01577758|63016758|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
33615745|NCT01577758|63016759|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
33615746|NCT01577758|63016760|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
33615747|NCT01577758|63016761|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
33615748|NCT01577758|63016762|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
33615749|NCT01577758|63016763|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
33615750|NCT01577758|63016764|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
33615751|NCT01577758|63016765|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
33615752|NCT01577758|63016758|FG000|Dose Escalation Phase|Progression Disease|2|||
33615753|NCT01577758|63016759|FG001|Dose Escalation Phase|Progression Disease|2|||
33615754|NCT01577758|63016760|FG002|Dose Escalation Phase|Progression Disease|1|||
33615755|NCT01577758|63016761|FG003|Dose Escalation Phase|Progression Disease|2|||
33615756|NCT01577758|63016762|FG004|Dose Escalation Phase|Progression Disease|5|||
33615757|NCT01577758|63016763|FG005|Dose Escalation Phase|Progression Disease|0|||
33615758|NCT01577758|63016764|FG006|Dose Escalation Phase|Progression Disease|0|||
33615759|NCT01577758|63016765|FG007|Dose Escalation Phase|Progression Disease|0|||
33615760|NCT01577758|63016758|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
33615761|NCT01577758|63016759|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
33615762|NCT01577758|63016760|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
33615763|NCT01577758|63016761|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
33615764|NCT01577758|63016762|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
33615765|NCT01577758|63016763|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
33615766|NCT01577758|63016764|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
33615767|NCT01577758|63016765|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
33615768|NCT01577758|63016758|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
33615769|NCT01577758|63016759|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
33615770|NCT01577758|63016760|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
33615771|NCT01577758|63016761|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
33615772|NCT01577758|63016762|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
33615773|NCT01577758|63016763|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
33615774|NCT01577758|63016764|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
33615775|NCT01577758|63016765|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
33615776|NCT01577758|63016758|FG000|mCRC Expansion Phase|Progression Disease|0|||
33615777|NCT01577758|63016759|FG001|mCRC Expansion Phase|Progression Disease|0|||
33615778|NCT01577758|63016760|FG002|mCRC Expansion Phase|Progression Disease|0|||
33615779|NCT01577758|63016761|FG003|mCRC Expansion Phase|Progression Disease|0|||
33615780|NCT01577758|63016762|FG004|mCRC Expansion Phase|Progression Disease|0|||
33615781|NCT01577758|63016763|FG005|mCRC Expansion Phase|Progression Disease|0|||
33615782|NCT01577758|63016764|FG006|mCRC Expansion Phase|Progression Disease|0|||
33615783|NCT01577758|63016765|FG007|mCRC Expansion Phase|Progression Disease|19|||
33615784|NCT01537432|63016787|FG000|Overall Study|Lost to Follow-up|3|||
33615785|NCT01537432|63016788|FG001|Overall Study|Lost to Follow-up|1|||
33615786|NCT01537432|63016787|FG000|Overall Study|Withdrawal by Subject|0|||
33615787|NCT01537432|63016788|FG001|Overall Study|Withdrawal by Subject|1|||
33615788|NCT01537432|63016787|FG000|Overall Study|Administrative problems|1|||
33615789|NCT01537432|63016788|FG001|Overall Study|Administrative problems|0|||
33615790|NCT01537432|63016787|FG000|Overall Study|Adverse Event|1|||
33615791|NCT01537432|63016788|FG001|Overall Study|Adverse Event|0|||
33615792|NCT01537432|63016787|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33615793|NCT01537432|63016788|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33615794|NCT01537198|63016794|FG000|Overall Study|RSV infection|2|||
33615795|NCT01537198|63016794|FG000|Overall Study|Adverse Event|4|||
33615796|NCT01537198|63016794|FG000|Overall Study|No Further Visits to the Clinic|37|||
33615797|NCT01537198|63016794|FG000|Overall Study|Other|111|||
33615798|NCT01537120|63016798|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
33615799|NCT01537120|63016798|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
33615800|NCT01537042|63016806|FG000|Overall Study|Adverse Event|0|||
33615801|NCT01537042|63016807|FG001|Overall Study|Adverse Event|2|||
33615802|NCT01537042|63016806|FG000|Overall Study|Lack of Efficacy|0|||
33615803|NCT01537042|63016807|FG001|Overall Study|Lack of Efficacy|1|||
33615804|NCT01537042|63016806|FG000|Overall Study|Protocol Violation|0|||
33615805|NCT01537042|63016807|FG001|Overall Study|Protocol Violation|1|||
33615806|NCT01537042|63016806|FG000|Overall Study|Other|0|||
33615807|NCT01537042|63016807|FG001|Overall Study|Other|1|||
33615808|NCT01536574|63016828|FG000|Overall Study|Adverse Event|4|||
33615809|NCT01536574|63016829|FG001|Overall Study|Adverse Event|5|||
33615810|NCT01536574|63016828|FG000|Overall Study|Withdrawal by Subject|1|||
33615811|NCT01536574|63016829|FG001|Overall Study|Withdrawal by Subject|2|||
33615812|NCT01536574|63016828|FG000|Overall Study|Lack of Efficacy|1|||
33615813|NCT01536574|63016829|FG001|Overall Study|Lack of Efficacy|0|||
33615814|NCT01536418|63016837|FG000|Overall Study|Protocol Violation|2|||
33615815|NCT01536418|63016838|FG001|Overall Study|Protocol Violation|3|||
33615816|NCT01536418|63016837|FG000|Overall Study|Physician Decision|1|||
33615817|NCT01536418|63016838|FG001|Overall Study|Physician Decision|3|||
33615818|NCT01536418|63016837|FG000|Overall Study|Study closed/terminated|41|||
33615819|NCT01536418|63016838|FG001|Overall Study|Study closed/terminated|37|||
33615820|NCT01536418|63016837|FG000|Overall Study|Lack of Efficacy|10|||
33615821|NCT01536418|63016838|FG001|Overall Study|Lack of Efficacy|16|||
33615822|NCT01536418|63016837|FG000|Overall Study|Adverse Event|9|||
33615823|NCT01536418|63016838|FG001|Overall Study|Adverse Event|4|||
33615824|NCT01536418|63016837|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
33615825|NCT01536418|63016838|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
33615826|NCT01536418|63016837|FG000|Overall Study|Withdrawal by Subject|5|||
33615827|NCT01536418|63016838|FG001|Overall Study|Withdrawal by Subject|3|||
33615828|NCT01576042|63016847|FG000|Overall Study|Physician Decision|2|||
33615829|NCT01576042|63016848|FG001|Overall Study|Physician Decision|0|||
33615830|NCT01561300|63016854|FG000|Run in on Placebo|Adverse Event|1|||
33615831|NCT01561300|63016855|FG001|Run in on Placebo|Adverse Event|0|||
33615832|NCT01536262|63016865|FG000|Overall Study|Adverse Event|6|||
33615833|NCT01536262|63016866|FG001|Overall Study|Adverse Event|1|||
33615834|NCT01536262|63016867|FG002|Overall Study|Adverse Event|2|||
33615835|NCT01536262|63016865|FG000|Overall Study|Withdrawal by Subject|1|||
33615836|NCT01536262|63016866|FG001|Overall Study|Withdrawal by Subject|1|||
33615837|NCT01536262|63016867|FG002|Overall Study|Withdrawal by Subject|0|||
33615838|NCT01536262|63016865|FG000|Overall Study|Other than stated above|1|||
33615839|NCT01536262|63016866|FG001|Overall Study|Other than stated above|0|||
33615840|NCT01536262|63016867|FG002|Overall Study|Other than stated above|0|||
33615841|NCT01560988|63016876|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
33324730|NCT00910624|62701262|FG000|Follow-Up Phase|Administrative|0|||
33615842|NCT01560988|63016877|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
33615843|NCT01560988|63016876|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
33615844|NCT01560988|63016877|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
33615845|NCT01560988|63016876|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
33615846|NCT01560988|63016877|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
33615847|NCT01535638|63016888|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
33615848|NCT01535638|63016889|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
33615849|NCT01535638|63016890|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
33615850|NCT01535638|63016891|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
33615851|NCT01535638|63016892|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
33615852|NCT01535638|63016893|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
33615853|NCT01535638|63016888|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
33615854|NCT01535638|63016889|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
33615855|NCT01535638|63016890|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
33615856|NCT01535638|63016891|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
33615857|NCT01535638|63016892|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
33615858|NCT01535638|63016893|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
33454301|NCT03709654|62828777|FG000|Overall Study|Withdrawal by Subject|1|||
33454302|NCT03709654|62828778|FG001|Overall Study|Withdrawal by Subject|1|||
33454303|NCT03709654|62828777|FG000|Overall Study|Adverse Event|1|||
33454304|NCT03709654|62828778|FG001|Overall Study|Adverse Event|0|||
33454305|NCT00412061|62828786|FG000|Double Blind Phase|Disease Progression|101|||
33454306|NCT00412061|62828787|FG001|Double Blind Phase|Disease Progression|154|||
33454307|NCT00412061|62828786|FG000|Double Blind Phase|Adverse Event|61|||
33454308|NCT00412061|62828787|FG001|Double Blind Phase|Adverse Event|16|||
33615859|NCT01535560|63016904|FG000|Overall Study|Adverse Event|12|||
33324731|NCT00910624|62701263|FG001|Follow-Up Phase|Administrative|1|||
33454309|NCT00412061|62828786|FG000|Double Blind Phase|Final Primary Analysis|26|||
33615860|NCT01535560|63016905|FG001|Overall Study|Adverse Event|7|||
33615861|NCT01535560|63016904|FG000|Overall Study|Lost to Follow-up|1|||
33615862|NCT01535560|63016905|FG001|Overall Study|Lost to Follow-up|3|||
33615863|NCT01535560|63016904|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
33615864|NCT01535560|63016905|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
33615865|NCT01535560|63016904|FG000|Overall Study|Treatment Failure|21|||
33517359|NCT03210961|62902406|FG005|Overall Study|Adverse Event|0|||
33517360|NCT03210961|62902407|FG006|Overall Study|Adverse Event|0|||
33517361|NCT03210961|62902408|FG007|Overall Study|Adverse Event|0|||
33517362|NCT03210961|62902409|FG008|Overall Study|Adverse Event|0|||
33517363|NCT03210961|62902410|FG009|Overall Study|Adverse Event|0|||
33517364|NCT03210961|62902411|FG010|Overall Study|Adverse Event|0|||
33517365|NCT03210961|62902412|FG011|Overall Study|Adverse Event|0|||
33517366|NCT03210961|62902413|FG012|Overall Study|Adverse Event|0|||
33517367|NCT03210961|62902414|FG013|Overall Study|Adverse Event|1|||
33517368|NCT03210961|62902415|FG014|Overall Study|Adverse Event|0|||
33517369|NCT03210961|62902401|FG000|Overall Study|Lost to Follow-up|0|||
33517370|NCT03210961|62902402|FG001|Overall Study|Lost to Follow-up|0|||
33517371|NCT03210961|62902403|FG002|Overall Study|Lost to Follow-up|0|||
33517372|NCT03210961|62902404|FG003|Overall Study|Lost to Follow-up|0|||
33517373|NCT03210961|62902405|FG004|Overall Study|Lost to Follow-up|0|||
33517374|NCT03210961|62902406|FG005|Overall Study|Lost to Follow-up|0|||
33615866|NCT01535560|63016905|FG001|Overall Study|Treatment Failure|83|||
33517375|NCT03210961|62902407|FG006|Overall Study|Lost to Follow-up|0|||
33517376|NCT03210961|62902408|FG007|Overall Study|Lost to Follow-up|0|||
33517377|NCT03210961|62902409|FG008|Overall Study|Lost to Follow-up|0|||
33517378|NCT03210961|62902410|FG009|Overall Study|Lost to Follow-up|0|||
33517379|NCT03210961|62902411|FG010|Overall Study|Lost to Follow-up|0|||
33517380|NCT03210961|62902412|FG011|Overall Study|Lost to Follow-up|0|||
33517381|NCT03210961|62902413|FG012|Overall Study|Lost to Follow-up|0|||
33517382|NCT03210961|62902414|FG013|Overall Study|Lost to Follow-up|0|||
33517383|NCT03210961|62902415|FG014|Overall Study|Lost to Follow-up|1|||
33517384|NCT03210961|62902401|FG000|Overall Study|Withdrawal by Subject|0|||
33517385|NCT03210961|62902402|FG001|Overall Study|Withdrawal by Subject|0|||
33517386|NCT03210961|62902403|FG002|Overall Study|Withdrawal by Subject|0|||
33517387|NCT03210961|62902404|FG003|Overall Study|Withdrawal by Subject|0|||
33517388|NCT03210961|62902405|FG004|Overall Study|Withdrawal by Subject|0|||
33517389|NCT03210961|62902406|FG005|Overall Study|Withdrawal by Subject|0|||
33517390|NCT03210961|62902407|FG006|Overall Study|Withdrawal by Subject|0|||
33517391|NCT03210961|62902408|FG007|Overall Study|Withdrawal by Subject|0|||
33517392|NCT03210961|62902409|FG008|Overall Study|Withdrawal by Subject|0|||
33517393|NCT03210961|62902410|FG009|Overall Study|Withdrawal by Subject|0|||
33517394|NCT03210961|62902411|FG010|Overall Study|Withdrawal by Subject|0|||
33517395|NCT03210961|62902412|FG011|Overall Study|Withdrawal by Subject|0|||
33517396|NCT03210961|62902413|FG012|Overall Study|Withdrawal by Subject|0|||
33517397|NCT03210961|62902414|FG013|Overall Study|Withdrawal by Subject|0|||
33517398|NCT03210961|62902415|FG014|Overall Study|Withdrawal by Subject|1|||
33517399|NCT03210961|62902401|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33517400|NCT03210961|62902402|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33517401|NCT03210961|62902403|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
33517402|NCT03210961|62902404|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
33517403|NCT03210961|62902405|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
33517404|NCT03210961|62902406|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
33517405|NCT03210961|62902407|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
33517406|NCT03210961|62902408|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
33517407|NCT03210961|62902409|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
33517408|NCT03210961|62902410|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
33517409|NCT03210961|62902411|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
33517410|NCT03210961|62902412|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
33615867|NCT01535560|63016904|FG000|Overall Study|Other|0|||
33615868|NCT01535560|63016905|FG001|Overall Study|Other|1|||
33615869|NCT01535560|63016904|FG000|Overall Study|Randomized in Error|0|||
33615870|NCT01535560|63016905|FG001|Overall Study|Randomized in Error|1|||
33517411|NCT03210961|62902413|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
33517412|NCT03210961|62902414|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
33517413|NCT03210961|62902415|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
33517414|NCT03210961|62902401|FG000|Overall Study|Other|0|||
33517415|NCT03210961|62902402|FG001|Overall Study|Other|0|||
33517416|NCT03210961|62902403|FG002|Overall Study|Other|0|||
33517417|NCT03210961|62902404|FG003|Overall Study|Other|1|||
33517418|NCT03210961|62902405|FG004|Overall Study|Other|0|||
33517419|NCT03210961|62902406|FG005|Overall Study|Other|0|||
33517420|NCT03210961|62902407|FG006|Overall Study|Other|1|||
33517421|NCT03210961|62902408|FG007|Overall Study|Other|0|||
33517422|NCT03210961|62902409|FG008|Overall Study|Other|0|||
33517423|NCT03210961|62902410|FG009|Overall Study|Other|0|||
33615871|NCT01575028|63016913|FG000|Overall Study|Physician Decision|0|||
33615872|NCT01575028|63016914|FG001|Overall Study|Physician Decision|1|||
33615873|NCT01574716|63016930|FG000|Part 1|Death|3|||
33615874|NCT01574716|63016931|FG001|Part 1|Death|1|||
33615875|NCT01574716|63016932|FG002|Part 1|Death|8|||
33615876|NCT01574716|63016933|FG003|Part 1|Death|0|||
33615877|NCT01574716|63016934|FG004|Part 1|Death|0|||
33615878|NCT01574716|63016930|FG000|Part 1|Discontinuation of study by sponsor|0|||
33615879|NCT01574716|63016931|FG001|Part 1|Discontinuation of study by sponsor|0|||
33615880|NCT01574716|63016932|FG002|Part 1|Discontinuation of study by sponsor|1|||
33454310|NCT00412061|62828787|FG001|Double Blind Phase|Final Primary Analysis|14|||
33454311|NCT00412061|62828786|FG000|Double Blind Phase|Withdrawal by Subject|18|||
33454312|NCT00412061|62828787|FG001|Double Blind Phase|Withdrawal by Subject|20|||
33454313|NCT00412061|62828786|FG000|Double Blind Phase|Death|6|||
33454314|NCT00412061|62828787|FG001|Double Blind Phase|Death|3|||
33454315|NCT00412061|62828786|FG000|Double Blind Phase|Protocol Violation|3|||
33454316|NCT00412061|62828787|FG001|Double Blind Phase|Protocol Violation|4|||
33324732|NCT00910624|62701264|FG002|Follow-Up Phase|Administrative|1|||
33454317|NCT00412061|62828786|FG000|Double Blind Phase|New Cander Therapy|1|||
33454318|NCT00412061|62828787|FG001|Double Blind Phase|New Cander Therapy|1|||
33454319|NCT00412061|62828786|FG000|Double Blind Phase|Lost to Follow-up|0|||
33454320|NCT00412061|62828787|FG001|Double Blind Phase|Lost to Follow-up|1|||
33454321|NCT00412061|62828786|FG000|Open Label Phase|Disease Progression|0|||
33454322|NCT00412061|62828787|FG001|Open Label Phase|Disease Progression|86|||
33454323|NCT00412061|62828786|FG000|Open Label Phase|Adverse Event|0|||
33454324|NCT00412061|62828787|FG001|Open Label Phase|Adverse Event|46|||
33454325|NCT00412061|62828786|FG000|Open Label Phase|Withdrawal by Subject|0|||
33454326|NCT00412061|62828787|FG001|Open Label Phase|Withdrawal by Subject|15|||
33454327|NCT00412061|62828786|FG000|Open Label Phase|Administrative Problems|0|||
33454328|NCT00412061|62828787|FG001|Open Label Phase|Administrative Problems|13|||
33454329|NCT00412061|62828786|FG000|Open Label Phase|Death|0|||
33454330|NCT00412061|62828787|FG001|Open Label Phase|Death|7|||
33454331|NCT00412061|62828786|FG000|Open Label Phase|Lost to Follow-up|0|||
33454332|NCT00412061|62828787|FG001|Open Label Phase|Lost to Follow-up|2|||
33454333|NCT00412061|62828786|FG000|Open Label Phase|New Cancer Therapy|0|||
33454334|NCT00412061|62828787|FG001|Open Label Phase|New Cancer Therapy|1|||
33454335|NCT00411671|62828805|FG000|Overall Study|Adverse Event|15|||
33454336|NCT00411671|62828805|FG000|Overall Study|Death|2|||
33454337|NCT00411671|62828805|FG000|Overall Study|Lost to Follow-up|3|||
33454338|NCT03835481|62828814|FG000|Double-blind Period|Other not stated below|0|||
33454339|NCT03835481|62828815|FG001|Double-blind Period|Other not stated below|0|||
33454340|NCT03835481|62828816|FG002|Double-blind Period|Other not stated below|0|||
33454341|NCT03835481|62828817|FG003|Double-blind Period|Other not stated below|1|||
33454342|NCT03835481|62828818|FG004|Double-blind Period|Other not stated below|1|||
33454343|NCT03835481|62828814|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
33454344|NCT03835481|62828815|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
33454345|NCT03835481|62828816|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
33454346|NCT03835481|62828817|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
33454347|NCT03835481|62828818|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
33454348|NCT03835481|62828814|FG000|Double-blind Period|Withdrawal by Subject|0|||
33454349|NCT03835481|62828815|FG001|Double-blind Period|Withdrawal by Subject|0|||
33454350|NCT03835481|62828816|FG002|Double-blind Period|Withdrawal by Subject|1|||
33454351|NCT03835481|62828817|FG003|Double-blind Period|Withdrawal by Subject|0|||
33454352|NCT03835481|62828818|FG004|Double-blind Period|Withdrawal by Subject|5|||
33615881|NCT01574716|63016933|FG003|Part 1|Discontinuation of study by sponsor|0|||
33517424|NCT03210961|62902411|FG010|Overall Study|Other|1|||
33517425|NCT03210961|62902412|FG011|Overall Study|Other|0|||
33517426|NCT03210961|62902413|FG012|Overall Study|Other|2|||
33517427|NCT03210961|62902414|FG013|Overall Study|Other|2|||
33517428|NCT03210961|62902415|FG014|Overall Study|Other|0|||
33517429|NCT03242759|62902468|FG000|Overall Study|Adverse Event|5|||
33517430|NCT03242759|62902469|FG001|Overall Study|Adverse Event|1|||
33517431|NCT03242759|62902468|FG000|Overall Study|Withdrawal by Subject|4|||
33517432|NCT03242759|62902469|FG001|Overall Study|Withdrawal by Subject|3|||
33517433|NCT03242759|62902468|FG000|Overall Study|Lost to Follow-up|3|||
33517434|NCT03242759|62902469|FG001|Overall Study|Lost to Follow-up|1|||
33517435|NCT03242759|62902468|FG000|Overall Study|Administrative problems|1|||
33517436|NCT03242759|62902469|FG001|Overall Study|Administrative problems|1|||
33517437|NCT03242759|62902468|FG000|Overall Study|Death|22|||
33517438|NCT03242759|62902469|FG001|Overall Study|Death|0|||
33517439|NCT03242759|62902468|FG000|Overall Study|Change visit schedule|0|||
33517440|NCT03242759|62902469|FG001|Overall Study|Change visit schedule|1|||
33517441|NCT03097029|62902475|FG000|Overall Study|Withdrawal by Subject|1|||
33615882|NCT01574716|63016934|FG004|Part 1|Discontinuation of study by sponsor|0|||
33454353|NCT03835481|62828814|FG000|Double-blind Period|Lost to Follow-up|0|||
33454354|NCT03835481|62828815|FG001|Double-blind Period|Lost to Follow-up|0|||
33454355|NCT03835481|62828816|FG002|Double-blind Period|Lost to Follow-up|0|||
33454356|NCT03835481|62828817|FG003|Double-blind Period|Lost to Follow-up|1|||
33454357|NCT03835481|62828818|FG004|Double-blind Period|Lost to Follow-up|0|||
33454358|NCT03835481|62828814|FG000|Double-blind Period|Protocol Violation|0|||
33454359|NCT03835481|62828815|FG001|Double-blind Period|Protocol Violation|2|||
33454360|NCT03835481|62828816|FG002|Double-blind Period|Protocol Violation|0|||
33454361|NCT03835481|62828817|FG003|Double-blind Period|Protocol Violation|1|||
33454362|NCT03835481|62828818|FG004|Double-blind Period|Protocol Violation|0|||
33454363|NCT03835481|62828814|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
33454364|NCT03835481|62828815|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
33454365|NCT03835481|62828816|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
33454366|NCT03835481|62828817|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
33454367|NCT03835481|62828818|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
33454368|NCT03835481|62828814|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
33454369|NCT03835481|62828815|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
33454370|NCT03835481|62828816|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
33454371|NCT03835481|62828817|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
33454372|NCT03835481|62828818|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
33454373|NCT03835481|62828814|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
33454374|NCT03835481|62828815|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
33454375|NCT03835481|62828816|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
33454376|NCT03835481|62828817|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
33454377|NCT03835481|62828818|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
33454378|NCT03835481|62828814|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
33454379|NCT03835481|62828815|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
33454380|NCT03835481|62828816|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
33517442|NCT03257813|62902481|FG000|Overall Study|Protocol Violation|6|||
33517443|NCT03257813|62902482|FG001|Overall Study|Protocol Violation|3|||
33517444|NCT03210259|62902493|FG000|12-Week Run-in Period|Adverse Event|1|||
33517445|NCT03210259|62902494|FG001|12-Week Run-in Period|Adverse Event|0|||
33517446|NCT03210259|62902495|FG002|12-Week Run-in Period|Adverse Event|0|||
33517447|NCT03210259|62902493|FG000|12-Week Run-in Period|Death|1|||
33517448|NCT03210259|62902494|FG001|12-Week Run-in Period|Death|0|||
33517449|NCT03210259|62902495|FG002|12-Week Run-in Period|Death|0|||
33517450|NCT03210259|62902493|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
33517451|NCT03210259|62902494|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
33517452|NCT03210259|62902495|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
33517453|NCT03210259|62902493|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
33517454|NCT03210259|62902494|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
33517455|NCT03210259|62902495|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
33517456|NCT03210259|62902493|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
33517457|NCT03210259|62902494|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
33517458|NCT03210259|62902495|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
33517459|NCT03210259|62902493|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
33517460|NCT03210259|62902494|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
33517461|NCT03210259|62902495|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
33517462|NCT03210259|62902493|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
33517463|NCT03210259|62902494|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
33517464|NCT03210259|62902495|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
33517465|NCT03210259|62902493|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
33517466|NCT03210259|62902494|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
33517467|NCT03210259|62902495|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
33517468|NCT03210259|62902493|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
33517469|NCT03210259|62902494|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
33517470|NCT03210259|62902495|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
33615883|NCT01574716|63016930|FG000|Part 1|Withdrawal by Subject|0|||
33615884|NCT01574716|63016931|FG001|Part 1|Withdrawal by Subject|2|||
33615885|NCT01574716|63016932|FG002|Part 1|Withdrawal by Subject|0|||
33615886|NCT01574716|63016933|FG003|Part 1|Withdrawal by Subject|0|||
33615887|NCT01574716|63016934|FG004|Part 1|Withdrawal by Subject|0|||
33615888|NCT01574716|63016930|FG000|Part 1|Lost to Follow-up|0|||
33615889|NCT01574716|63016931|FG001|Part 1|Lost to Follow-up|1|||
33615890|NCT01574716|63016932|FG002|Part 1|Lost to Follow-up|0|||
33615891|NCT01574716|63016933|FG003|Part 1|Lost to Follow-up|0|||
33615892|NCT01574716|63016934|FG004|Part 1|Lost to Follow-up|0|||
33615893|NCT01574716|63016930|FG000|Part 2|Progressive disease|0|||
33517471|NCT03210259|62902493|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
33517472|NCT03210259|62902494|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
33517473|NCT03210259|62902495|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
33517474|NCT03210259|62902493|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
33517475|NCT03210259|62902494|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
33517476|NCT03210259|62902495|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
33517477|NCT03257657|62902504|FG000|Overall Study|Lost to Follow-up|0|||
33517478|NCT03257657|62902505|FG001|Overall Study|Lost to Follow-up|3|||
33517479|NCT03257657|62902504|FG000|Overall Study|Withdrawn|0|||
33517480|NCT03257657|62902505|FG001|Overall Study|Withdrawn|1|||
33517481|NCT03257657|62902504|FG000|Overall Study|Noted not eligible right after enrolled|0|||
33517482|NCT03257657|62902505|FG001|Overall Study|Noted not eligible right after enrolled|1|||
33517483|NCT02496611|62902514|FG000|Overall Study|Lost to Follow-up|2|||
33517484|NCT02496611|62902515|FG001|Overall Study|Lost to Follow-up|1|||
33517485|NCT02496611|62902514|FG000|Overall Study|Withdrawal by Subject|5|||
33517486|NCT02496611|62902515|FG001|Overall Study|Withdrawal by Subject|2|||
33517487|NCT03237481|62902525|FG000|Overall Study|Lost to Follow-up|1|||
33517488|NCT03237481|62902526|FG001|Overall Study|Lost to Follow-up|0|||
33517489|NCT03237481|62902527|FG002|Overall Study|Lost to Follow-up|0|||
33517490|NCT03237481|62902525|FG000|Overall Study|Protocol Violation|1|||
33517491|NCT03237481|62902526|FG001|Overall Study|Protocol Violation|0|||
33517492|NCT03237481|62902527|FG002|Overall Study|Protocol Violation|0|||
33517493|NCT03237481|62902525|FG000|Overall Study|Withdrawal by Subject|3|||
33517494|NCT03237481|62902526|FG001|Overall Study|Withdrawal by Subject|2|||
33517495|NCT03237481|62902527|FG002|Overall Study|Withdrawal by Subject|1|||
33517496|NCT03222349|62902535|FG000|Overall Study|Treatment B not done|5|||
33517497|NCT03222349|62902536|FG001|Overall Study|Treatment B not done|0|||
33517498|NCT03222349|62902535|FG000|Overall Study|Lost to Follow-up|1|||
33615894|NCT01574716|63016931|FG001|Part 2|Progressive disease|0|||
33615895|NCT01574716|63016932|FG002|Part 2|Progressive disease|0|||
33615896|NCT01574716|63016933|FG003|Part 2|Progressive disease|1|||
33615897|NCT01574716|63016934|FG004|Part 2|Progressive disease|0|||
33615898|NCT01574716|63016930|FG000|Part 2|Death|0|||
33615899|NCT01574716|63016931|FG001|Part 2|Death|0|||
33517499|NCT03222349|62902536|FG001|Overall Study|Lost to Follow-up|2|||
33517500|NCT03222349|62902535|FG000|Overall Study|Withdrawal by Subject|1|||
33517501|NCT03222349|62902536|FG001|Overall Study|Withdrawal by Subject|0|||
33517502|NCT03222349|62902535|FG000|Overall Study|Treatment A not done|0|||
33517503|NCT03222349|62902536|FG001|Overall Study|Treatment A not done|5|||
33615900|NCT01574716|63016932|FG002|Part 2|Death|0|||
33615901|NCT01574716|63016933|FG003|Part 2|Death|76|||
33615902|NCT01574716|63016934|FG004|Part 2|Death|35|||
33517504|NCT03222349|62902535|FG000|Overall Study|Study terminated by sponsor|1|||
33517505|NCT03222349|62902536|FG001|Overall Study|Study terminated by sponsor|0|||
33517506|NCT02927925|62902549|FG000|Overall Study|Death|16|||
33517507|NCT02927925|62902549|FG000|Overall Study|Physician Decision|1|||
33517508|NCT02927925|62902549|FG000|Overall Study|Withdrawal by Subject|11|||
33517509|NCT02927925|62902549|FG000|Overall Study|Other|3|||
33517510|NCT02927925|62902549|FG000|Overall Study|Disease progression at clinical cutoff|1|||
33454381|NCT03835481|62828817|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
33517511|NCT03208933|62902553|FG000|Overall Study|Death|3|||
33517512|NCT03208933|62902553|FG000|Overall Study|Withdrawal by Subject|3|||
33517513|NCT03208933|62902553|FG000|Overall Study|Adverse Event|1|||
33517514|NCT03208933|62902553|FG000|Overall Study|Lost to Follow-up|2|||
33517515|NCT03208933|62902553|FG000|Overall Study|Physician Decision|3|||
33517516|NCT03208933|62902553|FG000|Overall Study|Protocol Violation|1|||
33517517|NCT03207763|62902559|FG000|Overall Study|Lost to Follow-up|1|||
33517518|NCT03207763|62902560|FG001|Overall Study|Lost to Follow-up|0|||
33517519|NCT04766034|62902579|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
33517520|NCT04766034|62902580|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
33517521|NCT04766034|62902581|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
33517522|NCT04766034|62902582|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
33517523|NCT04766034|62902583|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
33517524|NCT04766034|62902579|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
33517525|NCT04766034|62902580|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
33517526|NCT04766034|62902581|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
33324733|NCT00910624|62701265|FG003|Follow-Up Phase|Administrative|0|||
33454382|NCT03835481|62828818|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
33454383|NCT03835481|62828814|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
33454384|NCT03835481|62828815|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
33454385|NCT03835481|62828816|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
33454386|NCT03835481|62828817|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
33454387|NCT03835481|62828818|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
33454388|NCT03835481|62828814|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
33454389|NCT03835481|62828815|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
33454390|NCT03835481|62828816|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
33454391|NCT03835481|62828817|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
33454392|NCT03835481|62828818|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
33454393|NCT03709576|62828865|FG000|Overall Study|progression prior to enrollment|1|||
33454394|NCT00122460|62828872|FG000|Overall Study|investigational study phase ongoing|7|||
33454395|NCT00122460|62828873|FG001|Overall Study|investigational study phase ongoing|1|||
33454396|NCT00137436|62828879|FG000|Overall Study|Adverse Event|13|||
33454397|NCT00137436|62828879|FG000|Overall Study|Death|2|||
33454398|NCT00137436|62828879|FG000|Overall Study|Lack of Efficacy|17|||
33454399|NCT00137436|62828879|FG000|Overall Study|Withdrawal by Subject|6|||
33454400|NCT00137436|62828879|FG000|Overall Study|Other|5|||
33454401|NCT03834623|62828885|FG000|Overall Study|Progression|0|||
33454402|NCT03834623|62828886|FG001|Overall Study|Progression|1|||
33454403|NCT00410813|62828894|FG000|Overall Study|Adverse Event|6|||
33454404|NCT00410813|62828895|FG001|Overall Study|Adverse Event|11|||
33454405|NCT00410813|62828894|FG000|Overall Study|Progression|32|||
33454406|NCT00410813|62828895|FG001|Overall Study|Progression|21|||
33454407|NCT00410813|62828894|FG000|Overall Study|Not protocol specified|3|||
33454408|NCT00410813|62828895|FG001|Overall Study|Not protocol specified|4|||
33454409|NCT00410813|62828894|FG000|Overall Study|Ineligible|2|||
33454410|NCT00410813|62828895|FG001|Overall Study|Ineligible|4|||
33454411|NCT00410813|62828894|FG000|Overall Study|Death|0|||
33454412|NCT00410813|62828895|FG001|Overall Study|Death|2|||
33454413|NCT00405821|62828926|FG000|Overall Study|Death|5|||
33454414|NCT00405821|62828927|FG001|Overall Study|Death|7|||
33454415|NCT00405821|62828926|FG000|Overall Study|Lost to Follow-up|7|||
33454416|NCT00405821|62828927|FG001|Overall Study|Lost to Follow-up|7|||
33454417|NCT00405821|62828926|FG000|Overall Study|Protocol Violation|1|||
33454418|NCT00405821|62828927|FG001|Overall Study|Protocol Violation|0|||
33454419|NCT00405821|62828926|FG000|Overall Study|initiated ART|9|||
33324734|NCT01123980|62701279|FG000|Overall Study|Adverse Event|1|||
33324735|NCT01123980|62701280|FG001|Overall Study|Adverse Event|1|||
33324736|NCT01123980|62701279|FG000|Overall Study|Lack of Efficacy|1|||
33324737|NCT01123980|62701280|FG001|Overall Study|Lack of Efficacy|0|||
33324738|NCT01123980|62701279|FG000|Overall Study|Physician Decision|0|||
33324739|NCT01123980|62701280|FG001|Overall Study|Physician Decision|1|||
33324740|NCT01123980|62701279|FG000|Overall Study|Lost to Follow-up|0|||
33517527|NCT04766034|62902582|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
33517528|NCT04766034|62902583|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
33517529|NCT04766034|62902579|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
33615903|NCT01574716|63016930|FG000|Part 2|Discontinuation of study by sponsor|0|||
33615904|NCT01574716|63016931|FG001|Part 2|Discontinuation of study by sponsor|0|||
33615905|NCT01574716|63016932|FG002|Part 2|Discontinuation of study by sponsor|0|||
33615906|NCT01574716|63016933|FG003|Part 2|Discontinuation of study by sponsor|51|||
33615907|NCT01574716|63016934|FG004|Part 2|Discontinuation of study by sponsor|31|||
33615908|NCT01574716|63016930|FG000|Part 2|Withdrawal by Subject|0|||
33615909|NCT01574716|63016931|FG001|Part 2|Withdrawal by Subject|0|||
33615910|NCT01574716|63016932|FG002|Part 2|Withdrawal by Subject|0|||
33615911|NCT01574716|63016933|FG003|Part 2|Withdrawal by Subject|5|||
33615912|NCT01574716|63016934|FG004|Part 2|Withdrawal by Subject|4|||
33517530|NCT04766034|62902580|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
33517531|NCT04766034|62902581|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
33517532|NCT04766034|62902582|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
33517533|NCT04766034|62902583|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
33517534|NCT04766034|62902579|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
33517535|NCT04766034|62902580|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
33517536|NCT04766034|62902581|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
33517537|NCT04766034|62902582|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
33517538|NCT04766034|62902583|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
33517539|NCT03237013|62902598|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
33517540|NCT03237013|62902599|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
33517541|NCT03237013|62902600|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
33517542|NCT03236779|62902610|FG000|Overall Study|Lost to Follow-up|13|||
33517543|NCT03236779|62902611|FG001|Overall Study|Lost to Follow-up|21|||
33517544|NCT03096483|62902619|FG000|Overall Study|Withdrawal by site|1|||
33615913|NCT01574716|63016930|FG000|Part 2|Brain metastases|0|||
33454420|NCT00405821|62828927|FG001|Overall Study|initiated ART|8|||
33454421|NCT01446016|62828933|FG000|Overall Study|Lost to Follow-up|3|||
33454422|NCT01446016|62828933|FG000|Overall Study|Withdrawal by Subject|1|||
33454423|NCT01446016|62828933|FG000|Overall Study|Toxicity|3|||
33615914|NCT01574716|63016931|FG001|Part 2|Brain metastases|0|||
33615915|NCT01574716|63016932|FG002|Part 2|Brain metastases|0|||
33454424|NCT00137046|62828939|FG000|Overall Study|Death|2|||
33454425|NCT00137046|62828940|FG001|Overall Study|Death|1|||
33454426|NCT00137046|62828939|FG000|Overall Study|Adverse Event|16|||
33454427|NCT00137046|62828940|FG001|Overall Study|Adverse Event|5|||
33454428|NCT00137046|62828939|FG000|Overall Study|Laboratory Abnormality|2|||
33454429|NCT00137046|62828940|FG001|Overall Study|Laboratory Abnormality|0|||
33454430|NCT00137046|62828939|FG000|Overall Study|Lack of Efficacy|13|||
33454431|NCT00137046|62828940|FG001|Overall Study|Lack of Efficacy|1|||
33454432|NCT00137046|62828939|FG000|Overall Study|Lost to Follow-up|8|||
33454433|NCT00137046|62828940|FG001|Overall Study|Lost to Follow-up|24|||
33454434|NCT00137046|62828939|FG000|Overall Study|Other|23|||
33454435|NCT00137046|62828940|FG001|Overall Study|Other|19|||
33454436|NCT00137046|62828939|FG000|Overall Study|Withdrawal by Subject|33|||
33454437|NCT00137046|62828940|FG001|Overall Study|Withdrawal by Subject|42|||
33454438|NCT00137046|62828939|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
33454439|NCT00137046|62828940|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
33454440|NCT00137046|62828939|FG000|Overall Study|Withdrew prior to study treatment|1|||
33454441|NCT00137046|62828940|FG001|Overall Study|Withdrew prior to study treatment|1|||
33454442|NCT00122382|62828952|FG000|Double-Blind Study|Adverse Event|9|||
33454443|NCT00122382|62828953|FG001|Double-Blind Study|Adverse Event|11|||
33454444|NCT00122382|62828954|FG002|Double-Blind Study|Adverse Event|0|||
33454445|NCT00122382|62828952|FG000|Double-Blind Study|Death|2|||
33454446|NCT00122382|62828953|FG001|Double-Blind Study|Death|2|||
33454447|NCT00122382|62828954|FG002|Double-Blind Study|Death|0|||
33454448|NCT00122382|62828952|FG000|Double-Blind Study|Lack of Efficacy|0|||
33454449|NCT00122382|62828953|FG001|Double-Blind Study|Lack of Efficacy|8|||
33454450|NCT00122382|62828954|FG002|Double-Blind Study|Lack of Efficacy|0|||
33454451|NCT00122382|62828952|FG000|Double-Blind Study|Lost to Follow-up|2|||
33454452|NCT00122382|62828953|FG001|Double-Blind Study|Lost to Follow-up|1|||
33454453|NCT00122382|62828954|FG002|Double-Blind Study|Lost to Follow-up|0|||
33454454|NCT00122382|62828952|FG000|Double-Blind Study|Pregnancy|2|||
33454455|NCT00122382|62828953|FG001|Double-Blind Study|Pregnancy|0|||
33454456|NCT00122382|62828954|FG002|Double-Blind Study|Pregnancy|0|||
33454457|NCT00122382|62828952|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
33454458|NCT00122382|62828953|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
33454459|NCT00122382|62828954|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
33454460|NCT00122382|62828952|FG000|Double-Blind Study|Withdrawal of Consent|7|||
33454461|NCT00122382|62828953|FG001|Double-Blind Study|Withdrawal of Consent|3|||
33454462|NCT00122382|62828954|FG002|Double-Blind Study|Withdrawal of Consent|0|||
33454463|NCT00122382|62828952|FG000|Double-Blind Study|Protocol Violation|1|||
33454464|NCT00122382|62828953|FG001|Double-Blind Study|Protocol Violation|0|||
33454465|NCT00122382|62828954|FG002|Double-Blind Study|Protocol Violation|0|||
33454466|NCT00122382|62828952|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
33454467|NCT00122382|62828953|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
33454468|NCT00122382|62828954|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
33454469|NCT00122382|62828952|FG000|Double-Blind Study|Randomized but not treated|0|||
33454470|NCT00122382|62828953|FG001|Double-Blind Study|Randomized but not treated|2|||
33454471|NCT00122382|62828954|FG002|Double-Blind Study|Randomized but not treated|0|||
33454472|NCT00122382|62828952|FG000|Open-Label Study|Adverse Event|0|||
33454473|NCT00122382|62828953|FG001|Open-Label Study|Adverse Event|0|||
33454474|NCT00122382|62828954|FG002|Open-Label Study|Adverse Event|11|||
33454475|NCT00122382|62828952|FG000|Open-Label Study|Death|0|||
33454476|NCT00122382|62828953|FG001|Open-Label Study|Death|0|||
33454477|NCT00122382|62828954|FG002|Open-Label Study|Death|2|||
33454478|NCT00122382|62828952|FG000|Open-Label Study|Lack of Efficacy|0|||
33454479|NCT00122382|62828953|FG001|Open-Label Study|Lack of Efficacy|0|||
33517545|NCT02932579|62902625|FG000|Overall Study|Withdrawal by Subject|4|||
33517546|NCT02932579|62902626|FG001|Overall Study|Withdrawal by Subject|1|||
33454480|NCT00122382|62828954|FG002|Open-Label Study|Lack of Efficacy|3|||
33454481|NCT00122382|62828952|FG000|Open-Label Study|Lost to Follow-up|0|||
33454482|NCT00122382|62828953|FG001|Open-Label Study|Lost to Follow-up|0|||
33454483|NCT00122382|62828954|FG002|Open-Label Study|Lost to Follow-up|3|||
33454484|NCT00122382|62828952|FG000|Open-Label Study|Pregnancy|0|||
33454485|NCT00122382|62828953|FG001|Open-Label Study|Pregnancy|0|||
33517547|NCT03207451|62902636|FG000|Overall Study|scheduling conflict|1|||
33324741|NCT01123980|62701280|FG001|Overall Study|Lost to Follow-up|6|||
33517548|NCT03207451|62902637|FG001|Overall Study|scheduling conflict|0|||
33517549|NCT03207451|62902638|FG002|Overall Study|scheduling conflict|2|||
33517550|NCT03207451|62902639|FG003|Overall Study|scheduling conflict|2|||
33517551|NCT03207451|62902636|FG000|Overall Study|Adverse Event|0|||
33517552|NCT03207451|62902637|FG001|Overall Study|Adverse Event|0|||
33517553|NCT03207451|62902638|FG002|Overall Study|Adverse Event|0|||
33517554|NCT03207451|62902639|FG003|Overall Study|Adverse Event|1|||
33517555|NCT03350503|62902666|FG000|Overall Study|Adverse Event|5|||
33517556|NCT03350503|62902666|FG000|Overall Study|Withdrawal by Subject|5|||
33517557|NCT03350503|62902666|FG000|Overall Study|Continuation impossible due to move|4|||
33517558|NCT03350503|62902666|FG000|Overall Study|Physician Decision|3|||
33517559|NCT03288779|62902689|FG000|Overall Study|Withdrawal by Subject|3|||
33517560|NCT03206749|62902696|FG000|Overall Study|Withdrawal of consent|5|||
33517561|NCT03206749|62902697|FG001|Overall Study|Withdrawal of consent|3|||
33615916|NCT01574716|63016933|FG003|Part 2|Brain metastases|1|||
33615917|NCT01574716|63016934|FG004|Part 2|Brain metastases|0|||
33615918|NCT01574716|63016930|FG000|Part 2|Lost to Follow-up|0|||
33324742|NCT01123980|62701279|FG000|Overall Study|Protocol Violation|6|||
33324743|NCT01123980|62701280|FG001|Overall Study|Protocol Violation|6|||
33324744|NCT01123980|62701279|FG000|Overall Study|Withdrawal by Subject|5|||
33324745|NCT01123980|62701280|FG001|Overall Study|Withdrawal by Subject|3|||
33324746|NCT01123980|62701279|FG000|Overall Study|Unclassified|6|||
33324747|NCT01123980|62701280|FG001|Overall Study|Unclassified|7|||
33324748|NCT01118520|62701289|FG000|Overall Study|AAA repair|9|||
33324749|NCT01118520|62701290|FG001|Overall Study|AAA repair|7|||
33324750|NCT01118520|62701291|FG002|Overall Study|AAA repair|9|||
33324751|NCT01118520|62701289|FG000|Overall Study|Adverse Event|3|||
33324752|NCT01118520|62701290|FG001|Overall Study|Adverse Event|3|||
33615919|NCT01574716|63016931|FG001|Part 2|Lost to Follow-up|0|||
33615920|NCT01574716|63016932|FG002|Part 2|Lost to Follow-up|0|||
33517562|NCT03206749|62902698|FG002|Overall Study|Withdrawal of consent|6|||
33517563|NCT03206749|62902696|FG000|Overall Study|Lost to Follow-up|0|||
33615921|NCT01574716|63016933|FG003|Part 2|Lost to Follow-up|3|||
33324753|NCT01118520|62701291|FG002|Overall Study|Adverse Event|3|||
33324754|NCT01118520|62701289|FG000|Overall Study|Withdrawal by Subject|8|||
33324755|NCT01118520|62701290|FG001|Overall Study|Withdrawal by Subject|13|||
33324756|NCT01118520|62701291|FG002|Overall Study|Withdrawal by Subject|8|||
33517564|NCT03206749|62902697|FG001|Overall Study|Lost to Follow-up|0|||
33517565|NCT03206749|62902698|FG002|Overall Study|Lost to Follow-up|1|||
33517566|NCT03255941|62902718|FG000|Overall Study|Not eligible or refused injection|37|||
33615922|NCT01574716|63016934|FG004|Part 2|Lost to Follow-up|0|||
33324757|NCT01135992|62701299|FG000|Overall Study|Adverse Event|1|||
33324758|NCT01135992|62701299|FG000|Overall Study|Lack of Efficacy|1|||
33324759|NCT01135992|62701299|FG000|Overall Study|Protocol Violation|2|||
33324760|NCT01135992|62701299|FG000|Overall Study|Withdrawal criteria|10|||
33324761|NCT01135992|62701299|FG000|Overall Study|Unclassified|7|||
33324762|NCT00959049|62701309|FG000|Overall Study|Adverse Event|1|||
33324763|NCT00959049|62701310|FG001|Overall Study|Adverse Event|0|||
33324764|NCT00959049|62701311|FG002|Overall Study|Adverse Event|0|||
33517567|NCT03255941|62902719|FG001|Overall Study|Not eligible or refused injection|44|||
33517568|NCT03255941|62902720|FG002|Overall Study|Not eligible or refused injection|5|||
33517569|NCT03255941|62902721|FG003|Overall Study|Not eligible or refused injection|6|||
33517570|NCT03255941|62902718|FG000|Overall Study|Did not complete exit interview|1|||
33517571|NCT03255941|62902719|FG001|Overall Study|Did not complete exit interview|2|||
33517572|NCT03255941|62902720|FG002|Overall Study|Did not complete exit interview|0|||
33517573|NCT03255941|62902721|FG003|Overall Study|Did not complete exit interview|0|||
33615923|NCT02161562|63016945|FG000|Overall Study|Withdrawal by Subject|5|||
33517574|NCT03255629|62902743|FG000|Overall Study|Adverse Event|1|||
33517575|NCT03255629|62902744|FG001|Overall Study|Adverse Event|0|||
33517576|NCT03255629|62902743|FG000|Overall Study|did not experience hypoglycemia|2|||
33517577|NCT03255629|62902744|FG001|Overall Study|did not experience hypoglycemia|1|||
33517578|NCT03031938|62902753|FG000|Overall Study|Death|1|||
33517579|NCT03031938|62902754|FG001|Overall Study|Death|0|||
33517580|NCT01137773|62902762|FG000|Overall Study|Death|3|||
33517581|NCT01137773|62902763|FG001|Overall Study|Death|3|||
33517582|NCT01137773|62902762|FG000|Overall Study|Lost to Follow-up|6|||
33517583|NCT01137773|62902763|FG001|Overall Study|Lost to Follow-up|0|||
33517584|NCT03094611|62902771|FG000|Overall Study|Lack of Efficacy|1|||
33517585|NCT03094611|62902771|FG000|Overall Study|Stem Cell Transplant|1|||
33517586|NCT04105725|62902795|FG000|Primary Intervention|Lost to Follow-up|0|||
33517587|NCT04105725|62902796|FG001|Primary Intervention|Lost to Follow-up|2|||
33517588|NCT04105725|62902795|FG000|Primary Intervention|Withdrawal by Subject|0|||
33517589|NCT04105725|62902796|FG001|Primary Intervention|Withdrawal by Subject|1|||
33517590|NCT04066023|62902805|FG000|Overall Study|Adverse Event|0|||
33517591|NCT04066023|62902806|FG001|Overall Study|Adverse Event|0|||
33517592|NCT04066023|62902807|FG002|Overall Study|Adverse Event|1|||
33517593|NCT04066023|62902805|FG000|Overall Study|Sponsor decision|3|||
33517594|NCT04066023|62902806|FG001|Overall Study|Sponsor decision|6|||
33517595|NCT04066023|62902807|FG002|Overall Study|Sponsor decision|2|||
33517596|NCT04066023|62902805|FG000|Overall Study|Physician Decision|0|||
33517597|NCT04066023|62902806|FG001|Overall Study|Physician Decision|0|||
33517598|NCT04066023|62902807|FG002|Overall Study|Physician Decision|1|||
33517599|NCT04066023|62902805|FG000|Overall Study|Lost to Follow-up|0|||
33517600|NCT04066023|62902806|FG001|Overall Study|Lost to Follow-up|1|||
33517601|NCT04066023|62902807|FG002|Overall Study|Lost to Follow-up|1|||
33517602|NCT04066023|62902805|FG000|Overall Study|Noncompliance|0|||
33517603|NCT04066023|62902806|FG001|Overall Study|Noncompliance|1|||
33517604|NCT04066023|62902807|FG002|Overall Study|Noncompliance|1|||
33517605|NCT03106987|62902819|FG000|Overall Study|Death|37|||
33615924|NCT02161562|63016946|FG001|Overall Study|Withdrawal by Subject|8|||
33615925|NCT02161562|63016945|FG000|Overall Study|Protocol Violation|9|||
33615926|NCT02161562|63016946|FG001|Overall Study|Protocol Violation|4|||
33615927|NCT02161562|63016945|FG000|Overall Study|Pregnancy|1|||
33324765|NCT00959049|62701312|FG003|Overall Study|Adverse Event|0|||
33324766|NCT00959049|62701313|FG004|Overall Study|Adverse Event|0|||
33615928|NCT02161562|63016946|FG001|Overall Study|Pregnancy|2|||
33324767|NCT00959049|62701314|FG005|Overall Study|Adverse Event|0|||
33517606|NCT03106987|62902820|FG001|Overall Study|Death|22|||
33517607|NCT03106987|62902821|FG002|Overall Study|Death|12|||
33517608|NCT03106987|62902822|FG003|Overall Study|Death|8|||
33517609|NCT03106987|62902819|FG000|Overall Study|Lost to Follow-up|2|||
33615929|NCT02161562|63016945|FG000|Overall Study|Lost to Follow-up|3|||
33615930|NCT02161562|63016946|FG001|Overall Study|Lost to Follow-up|1|||
33324768|NCT00959049|62701309|FG000|Overall Study|Lost to Follow-up|17|||
33324769|NCT00959049|62701310|FG001|Overall Study|Lost to Follow-up|5|||
33517610|NCT03106987|62902820|FG001|Overall Study|Lost to Follow-up|0|||
33517611|NCT03106987|62902821|FG002|Overall Study|Lost to Follow-up|2|||
33517612|NCT03106987|62902822|FG003|Overall Study|Lost to Follow-up|2|||
33517613|NCT03106987|62902819|FG000|Overall Study|Withdrawal by Subject|5|||
33517614|NCT03106987|62902820|FG001|Overall Study|Withdrawal by Subject|1|||
33517615|NCT03106987|62902821|FG002|Overall Study|Withdrawal by Subject|4|||
33517616|NCT03106987|62902822|FG003|Overall Study|Withdrawal by Subject|1|||
33615931|NCT02161562|63016945|FG000|Overall Study|Lack of Efficacy|4|||
33517617|NCT02932267|62902832|FG000|Overall Study|Withdrawal by Subject|3|||
33517618|NCT02932267|62902832|FG000|Overall Study|Lost to Follow-up|4|||
33615932|NCT02161562|63016946|FG001|Overall Study|Lack of Efficacy|1|||
33615933|NCT02161562|63016945|FG000|Overall Study|Adverse Event|1|||
33615934|NCT02161562|63016946|FG001|Overall Study|Adverse Event|1|||
33615935|NCT02161562|63016945|FG000|Overall Study|Participant moved back to home country|1|||
33615936|NCT02161562|63016946|FG001|Overall Study|Participant moved back to home country|0|||
33615937|NCT02161562|63016945|FG000|Overall Study|Withdrew due to being out of the country|1|||
33615938|NCT02161562|63016946|FG001|Overall Study|Withdrew due to being out of the country|0|||
33615939|NCT02161562|63016945|FG000|Overall Study|Participant moved out of province|1|||
33615940|NCT02161562|63016946|FG001|Overall Study|Participant moved out of province|0|||
33615941|NCT01559116|63016965|FG000|Overall Study|Adverse Event|10|||
33615942|NCT01559116|63016965|FG000|Overall Study|Lack of Efficacy|1|||
33517619|NCT02932267|62902832|FG000|Overall Study|Pregnancy|1|||
33517620|NCT03217591|62902839|FG000|Overall Study|Adverse Event|1|||
33517621|NCT03217591|62902840|FG001|Overall Study|Adverse Event|2|||
33517622|NCT03217591|62902841|FG002|Overall Study|Adverse Event|6|||
33517623|NCT03217591|62902839|FG000|Overall Study|Withdrawal by Subject|0|||
33517624|NCT03217591|62902840|FG001|Overall Study|Withdrawal by Subject|1|||
33517625|NCT03217591|62902841|FG002|Overall Study|Withdrawal by Subject|3|||
33517626|NCT03217591|62902839|FG000|Overall Study|Lost to Follow-up|1|||
33517627|NCT03217591|62902840|FG001|Overall Study|Lost to Follow-up|0|||
33517628|NCT03217591|62902841|FG002|Overall Study|Lost to Follow-up|0|||
33517629|NCT03217591|62902839|FG000|Overall Study|Protocol Violation|1|||
33517630|NCT03217591|62902840|FG001|Overall Study|Protocol Violation|0|||
33517631|NCT03217591|62902841|FG002|Overall Study|Protocol Violation|1|||
33517632|NCT03031782|62902850|FG000|Treatment Period 1|Lack of Efficacy|3|||
33517633|NCT03031782|62902851|FG001|Treatment Period 1|Lack of Efficacy|0|||
33517634|NCT03031782|62902852|FG002|Treatment Period 1|Lack of Efficacy|0|||
33615943|NCT01559116|63016965|FG000|Overall Study|Lost to Follow-up|1|||
33615944|NCT01559116|63016965|FG000|Overall Study|Protocol Violation|1|||
33517635|NCT03031782|62902853|FG003|Treatment Period 1|Lack of Efficacy|0|||
33517636|NCT03031782|62902854|FG004|Treatment Period 1|Lack of Efficacy|0|||
33517637|NCT03031782|62902850|FG000|Treatment Period 2|Physician Decision|0|||
33517638|NCT03031782|62902851|FG001|Treatment Period 2|Physician Decision|1|||
33517639|NCT03031782|62902852|FG002|Treatment Period 2|Physician Decision|0|||
33517640|NCT03031782|62902853|FG003|Treatment Period 2|Physician Decision|0|||
33517641|NCT03031782|62902854|FG004|Treatment Period 2|Physician Decision|3|||
33615945|NCT01559116|63016965|FG000|Overall Study|Withdrawal by Subject|4|||
33615946|NCT01559116|63016965|FG000|Overall Study|other than stated above|9|||
33615947|NCT01574326|63016984|FG000|Overall Study|Randomized but not treated|0|||
33615948|NCT01574326|63016985|FG001|Overall Study|Randomized but not treated|1|||
33454486|NCT00122382|62828954|FG002|Open-Label Study|Pregnancy|2|||
33454487|NCT00122382|62828952|FG000|Open-Label Study|Poor/Non-Compliance|0|||
33454488|NCT00122382|62828953|FG001|Open-Label Study|Poor/Non-Compliance|0|||
33454489|NCT00122382|62828954|FG002|Open-Label Study|Poor/Non-Compliance|1|||
33454490|NCT00122382|62828952|FG000|Open-Label Study|Withdrawal of Consent|0|||
33454491|NCT00122382|62828953|FG001|Open-Label Study|Withdrawal of Consent|0|||
33454492|NCT00122382|62828954|FG002|Open-Label Study|Withdrawal of Consent|4|||
33454493|NCT01028716|62828972|FG000|Overall Study|Physician Decision|1|||
33454494|NCT00106704|62828979|FG000|Overall Study|Adverse Event|10|||
33454495|NCT00106704|62828980|FG001|Overall Study|Adverse Event|7|||
33454496|NCT00106704|62828979|FG000|Overall Study|Death|2|||
33454497|NCT00106704|62828980|FG001|Overall Study|Death|1|||
33454498|NCT00106704|62828979|FG000|Overall Study|Lack of Efficacy|67|||
33454499|NCT00106704|62828980|FG001|Overall Study|Lack of Efficacy|69|||
33454500|NCT00106704|62828979|FG000|Overall Study|Lost to Follow-up|7|||
33454501|NCT00106704|62828980|FG001|Overall Study|Lost to Follow-up|3|||
33454502|NCT00106704|62828979|FG000|Overall Study|Pregnancy|1|||
33454503|NCT00106704|62828980|FG001|Overall Study|Pregnancy|0|||
33454504|NCT00106704|62828979|FG000|Overall Study|Protocol Violation|4|||
33454505|NCT00106704|62828980|FG001|Overall Study|Protocol Violation|7|||
33454506|NCT00106704|62828979|FG000|Overall Study|Withdrawal by Subject|14|||
33454507|NCT00106704|62828980|FG001|Overall Study|Withdrawal by Subject|21|||
33517642|NCT03031782|62902850|FG000|Treatment Period 2|Lack of Efficacy|0|||
33517643|NCT03031782|62902851|FG001|Treatment Period 2|Lack of Efficacy|1|||
33517644|NCT03031782|62902852|FG002|Treatment Period 2|Lack of Efficacy|0|||
33517645|NCT03031782|62902853|FG003|Treatment Period 2|Lack of Efficacy|0|||
33517646|NCT03031782|62902854|FG004|Treatment Period 2|Lack of Efficacy|1|||
33517647|NCT03031782|62902850|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33517648|NCT03031782|62902851|FG001|Treatment Period 2|Withdrawal by Subject|3|||
33517649|NCT03031782|62902852|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33517650|NCT03031782|62902853|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33517651|NCT03031782|62902854|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33517652|NCT03031782|62902850|FG000|Treatment Period 2|Adverse Event|0|||
33517653|NCT03031782|62902851|FG001|Treatment Period 2|Adverse Event|1|||
33517654|NCT03031782|62902852|FG002|Treatment Period 2|Adverse Event|2|||
33517655|NCT03031782|62902853|FG003|Treatment Period 2|Adverse Event|0|||
33517656|NCT03031782|62902854|FG004|Treatment Period 2|Adverse Event|0|||
33517657|NCT03031782|62902850|FG000|Treatment Period 3|Withdrawal by Subject|0|||
33517658|NCT03031782|62902851|FG001|Treatment Period 3|Withdrawal by Subject|0|||
33517659|NCT03031782|62902852|FG002|Treatment Period 3|Withdrawal by Subject|0|||
33517660|NCT03031782|62902853|FG003|Treatment Period 3|Withdrawal by Subject|1|||
33517661|NCT03031782|62902854|FG004|Treatment Period 3|Withdrawal by Subject|0|||
33517662|NCT03216265|62902871|FG000|Overall Study|Adverse Event|2|||
33517663|NCT03216265|62902872|FG001|Overall Study|Adverse Event|0|||
33517664|NCT03216265|62902873|FG002|Overall Study|Adverse Event|2|||
33517665|NCT03216265|62902871|FG000|Overall Study|Lost to Follow-up|0|||
33517666|NCT03216265|62902872|FG001|Overall Study|Lost to Follow-up|1|||
33517667|NCT03216265|62902873|FG002|Overall Study|Lost to Follow-up|0|||
33517668|NCT03216265|62902871|FG000|Overall Study|Withdrawal by Subject|0|||
33517669|NCT03216265|62902872|FG001|Overall Study|Withdrawal by Subject|0|||
33517670|NCT03216265|62902873|FG002|Overall Study|Withdrawal by Subject|1|||
33517671|NCT04486950|62902895|FG000|Overall Study|Lost to Follow-up|0|||
33517672|NCT04486950|62902896|FG001|Overall Study|Lost to Follow-up|0|||
33517673|NCT04486950|62902897|FG002|Overall Study|Lost to Follow-up|0|||
33517674|NCT04486950|62902898|FG003|Overall Study|Lost to Follow-up|0|||
33517675|NCT04486950|62902899|FG004|Overall Study|Lost to Follow-up|0|||
33517676|NCT04486950|62902900|FG005|Overall Study|Lost to Follow-up|1|||
33517677|NCT04486950|62902901|FG006|Overall Study|Lost to Follow-up|0|||
33517678|NCT04693416|62902923|FG000|Overall Study|Lost to Follow-up|13|||
33517679|NCT04693416|62902924|FG001|Overall Study|Lost to Follow-up|0|||
33517680|NCT00265941|62902932|FG000|Overall Study|Protocol Violation|22|||
33517681|NCT00265941|62902933|FG001|Overall Study|Protocol Violation|25|||
33517682|NCT00265941|62902932|FG000|Overall Study|Lost to Follow-up|1|||
33517683|NCT00265941|62902933|FG001|Overall Study|Lost to Follow-up|1|||
33517684|NCT03882957|62902947|FG000|Overall Study|Did not complete all three arms|1|||
33517685|NCT03201211|62902959|FG000|Overall Study|Adverse Event|1|||
33517686|NCT03201211|62902960|FG001|Overall Study|Adverse Event|0|||
33517687|NCT03201211|62902961|FG002|Overall Study|Adverse Event|0|||
33517688|NCT03201211|62902959|FG000|Overall Study|Protocol Violation|1|||
33517689|NCT03201211|62902960|FG001|Overall Study|Protocol Violation|0|||
33517690|NCT03201211|62902961|FG002|Overall Study|Protocol Violation|0|||
33517691|NCT03201211|62902959|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33615949|NCT01574326|63016984|FG000|Overall Study|Withdrawal by Participant|2|||
33517692|NCT03201211|62902960|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33517693|NCT03201211|62902961|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
33454508|NCT00106704|62828979|FG000|Overall Study|Patient moved|1|||
33454509|NCT00106704|62828980|FG001|Overall Study|Patient moved|0|||
33454510|NCT00106704|62828979|FG000|Overall Study|Site terminated|0|||
33454511|NCT00106704|62828980|FG001|Overall Study|Site terminated|1|||
33454512|NCT00106704|62828979|FG000|Overall Study|Planned major surgery|1|||
33454513|NCT00106704|62828980|FG001|Overall Study|Planned major surgery|0|||
33454514|NCT00106704|62828979|FG000|Overall Study|Patient Received Glycemic Medication|22|||
33454515|NCT00106704|62828980|FG001|Overall Study|Patient Received Glycemic Medication|41|||
33454516|NCT00106704|62828979|FG000|Overall Study|Unable to re-enter US|1|||
33454517|NCT00106704|62828980|FG001|Overall Study|Unable to re-enter US|0|||
33454518|NCT00106704|62828979|FG000|Overall Study|Laboratory test|1|||
33454519|NCT00106704|62828980|FG001|Overall Study|Laboratory test|1|||
33454520|NCT00105066|62828988|FG000|Overall Study|Adverse Event|2|||
33454521|NCT00105066|62828989|FG001|Overall Study|Adverse Event|5|||
33454522|NCT00104520|62828997|FG000|Overall Study|Unrelated adverse event|34|||
33454523|NCT00104520|62828998|FG001|Overall Study|Unrelated adverse event|47|||
33454524|NCT00104520|62828997|FG000|Overall Study|Study drug intolerance|0|||
33454525|NCT00104520|62828998|FG001|Overall Study|Study drug intolerance|1|||
33454526|NCT00104520|62828997|FG000|Overall Study|Related adverse event|13|||
33454527|NCT00104520|62828998|FG001|Overall Study|Related adverse event|15|||
33454528|NCT00104520|62828997|FG000|Overall Study|Lost to Follow-up|1|||
33454529|NCT00104520|62828998|FG001|Overall Study|Lost to Follow-up|0|||
33454530|NCT00104520|62828997|FG000|Overall Study|Noncompliance|0|||
33454531|NCT00104520|62828998|FG001|Overall Study|Noncompliance|2|||
33454532|NCT00104520|62828997|FG000|Overall Study|Personal/administrative|1|||
33454533|NCT00104520|62828998|FG001|Overall Study|Personal/administrative|1|||
33454534|NCT00104520|62828997|FG000|Overall Study|Other|1|||
33454535|NCT00104520|62828998|FG001|Overall Study|Other|5|||
33454536|NCT00135330|62829007|FG000|Overall Study|Adverse Event|2|||
33454537|NCT00135330|62829008|FG001|Overall Study|Adverse Event|5|||
33454538|NCT00135330|62829009|FG002|Overall Study|Adverse Event|1|||
33454539|NCT00135330|62829007|FG000|Overall Study|Lost to Follow-up|0|||
33454540|NCT00135330|62829008|FG001|Overall Study|Lost to Follow-up|2|||
33454541|NCT00135330|62829009|FG002|Overall Study|Lost to Follow-up|3|||
33454542|NCT00135330|62829007|FG000|Overall Study|Physician Decision|1|||
33454543|NCT00135330|62829008|FG001|Overall Study|Physician Decision|1|||
33454544|NCT00135330|62829009|FG002|Overall Study|Physician Decision|0|||
33454545|NCT00135330|62829007|FG000|Overall Study|Protocol Violation|4|||
33454546|NCT00135330|62829008|FG001|Overall Study|Protocol Violation|3|||
33454547|NCT00135330|62829009|FG002|Overall Study|Protocol Violation|3|||
33454548|NCT00135330|62829007|FG000|Overall Study|Patient Decision|5|||
33454549|NCT00135330|62829008|FG001|Overall Study|Patient Decision|1|||
33454550|NCT00135330|62829009|FG002|Overall Study|Patient Decision|4|||
33454551|NCT00135330|62829007|FG000|Overall Study|Sponsor Decision|0|||
33454552|NCT00135330|62829008|FG001|Overall Study|Sponsor Decision|1|||
33454553|NCT00135330|62829009|FG002|Overall Study|Sponsor Decision|0|||
33454554|NCT00134784|62829021|FG000|Overall Study|Withdrawal by Subject|2|||
33454555|NCT00134784|62829022|FG001|Overall Study|Withdrawal by Subject|2|||
33454556|NCT00134784|62829023|FG002|Overall Study|Withdrawal by Subject|2|||
33454557|NCT00134784|62829024|FG003|Overall Study|Withdrawal by Subject|1|||
33454558|NCT00134082|62829031|FG000|Overall Study|Adverse Event|2|||
33454559|NCT00134082|62829031|FG000|Overall Study|Death|1|||
33454560|NCT03703336|62829037|FG000|Overall Study|Parent withdrew consent|29|||
33454561|NCT03703336|62829038|FG001|Overall Study|Parent withdrew consent|8|||
33454562|NCT03703336|62829037|FG000|Overall Study|Migration|3|||
33454563|NCT03703336|62829038|FG001|Overall Study|Migration|3|||
33454564|NCT03703336|62829037|FG000|Overall Study|Protocol Violation|3|||
33454565|NCT03703336|62829038|FG001|Overall Study|Protocol Violation|1|||
33517694|NCT03201211|62902959|FG000|Overall Study|OTHER unknown reasons|0|||
33517695|NCT03201211|62902960|FG001|Overall Study|OTHER unknown reasons|1|||
33517696|NCT03201211|62902961|FG002|Overall Study|OTHER unknown reasons|0|||
33517697|NCT04633837|62902971|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
33517698|NCT04633837|62902972|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
33517699|NCT03029832|62902980|FG000|Overall Study|Safety Follow-Up Completed|2|||
33517700|NCT03029832|62902981|FG001|Overall Study|Safety Follow-Up Completed|0|||
33517701|NCT03029832|62902980|FG000|Overall Study|Death due to Disease Progression|1|||
33517702|NCT03029832|62902981|FG001|Overall Study|Death due to Disease Progression|0|||
33454566|NCT03703336|62829037|FG000|Overall Study|Physician Decision|2|||
33454567|NCT03703336|62829038|FG001|Overall Study|Physician Decision|0|||
33454568|NCT03703336|62829037|FG000|Overall Study|Adverse Event|0|||
33454569|NCT03703336|62829038|FG001|Overall Study|Adverse Event|2|||
33517703|NCT03029832|62902980|FG000|Overall Study|Study Terminated By Sponsor|1|||
33517704|NCT03029832|62902981|FG001|Overall Study|Study Terminated By Sponsor|1|||
33454570|NCT03703336|62829037|FG000|Overall Study|Lost to Follow-up|1|||
33454571|NCT03703336|62829038|FG001|Overall Study|Lost to Follow-up|0|||
33454572|NCT03702166|62829044|FG000|Overall Study|Lost to Follow-up|1|||
33454573|NCT03702166|62829044|FG000|Overall Study|Withdrawal by Subject|1|||
33454574|NCT00132678|62829051|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
33454575|NCT00132678|62829052|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
33454576|NCT00132678|62829053|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
33517705|NCT03089697|62902989|FG000|Overall Study|Adverse Event|1|||
33517706|NCT03089697|62902990|FG001|Overall Study|Adverse Event|2|||
33517707|NCT03089697|62902989|FG000|Overall Study|Withdrawal by Subject|1|||
33517708|NCT03089697|62902990|FG001|Overall Study|Withdrawal by Subject|0|||
33517709|NCT03199963|62902998|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
33517710|NCT03199963|62902999|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
33517711|NCT03199963|62902998|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
33517712|NCT03199963|62902999|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
33517713|NCT03199963|62902998|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
33517714|NCT03199963|62902999|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
33517715|NCT03199963|62902998|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
33517716|NCT03199963|62902999|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
33517717|NCT03199963|62902998|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
33517718|NCT03199963|62902999|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
33517719|NCT03199963|62902998|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
33517720|NCT03199963|62902999|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
33517721|NCT03257631|62903015|FG000|Overall Study|Death|8|||
33517722|NCT03257631|62903016|FG001|Overall Study|Death|5|||
33517723|NCT03257631|62903017|FG002|Overall Study|Death|13|||
33517724|NCT03257631|62903018|FG003|Overall Study|Death|5|||
33517725|NCT03257631|62903015|FG000|Overall Study|Progressive Disease|0|||
33517726|NCT03257631|62903016|FG001|Overall Study|Progressive Disease|0|||
33517727|NCT03257631|62903017|FG002|Overall Study|Progressive Disease|1|||
33517728|NCT03257631|62903018|FG003|Overall Study|Progressive Disease|0|||
33517729|NCT03257631|62903015|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33517730|NCT03257631|62903016|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
33517731|NCT03257631|62903017|FG002|Overall Study|Withdrawal by Parent/Guardian|4|||
33517732|NCT03257631|62903018|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
33517733|NCT03257631|62903015|FG000|Overall Study|Lost to Follow-up|0|||
33517734|NCT03257631|62903016|FG001|Overall Study|Lost to Follow-up|0|||
33517735|NCT03257631|62903017|FG002|Overall Study|Lost to Follow-up|1|||
33517736|NCT03257631|62903018|FG003|Overall Study|Lost to Follow-up|0|||
33517737|NCT03257631|62903015|FG000|Overall Study|Still on Study|3|||
33517738|NCT03257631|62903016|FG001|Overall Study|Still on Study|2|||
33517739|NCT03257631|62903017|FG002|Overall Study|Still on Study|4|||
33517740|NCT03257631|62903018|FG003|Overall Study|Still on Study|4|||
33517741|NCT03883581|62903028|FG000|Overall Study|Withdrawal by Subject|4|||
33517742|NCT03029208|62903034|FG000|Overall Study|Withdrawal by Subject|2|||
33517743|NCT03029208|62903035|FG001|Overall Study|Withdrawal by Subject|3|||
33517744|NCT03029208|62903034|FG000|Overall Study|Lost to Follow-up|0|||
33517745|NCT03029208|62903035|FG001|Overall Study|Lost to Follow-up|1|||
33517746|NCT03198715|62903055|FG000|Overall Study|Death|0|||
33517747|NCT03198715|62903056|FG001|Overall Study|Death|0|||
33517748|NCT03198715|62903057|FG002|Overall Study|Death|1|||
33517749|NCT03198715|62903058|FG003|Overall Study|Death|0|||
33517750|NCT03198715|62903059|FG004|Overall Study|Death|2|||
33517751|NCT03198715|62903055|FG000|Overall Study|Other|0|||
33517752|NCT03198715|62903056|FG001|Overall Study|Other|1|||
33517753|NCT03198715|62903057|FG002|Overall Study|Other|1|||
33517754|NCT03198715|62903058|FG003|Overall Study|Other|0|||
33517755|NCT03198715|62903059|FG004|Overall Study|Other|0|||
33517756|NCT03197935|62903082|FG000|Overall Study|Death due to any cause|9|||
33517757|NCT03197935|62903083|FG001|Overall Study|Death due to any cause|7|||
33517758|NCT03197935|62903082|FG000|Overall Study|Lost to Follow-up|0|||
33517759|NCT03197935|62903083|FG001|Overall Study|Lost to Follow-up|3|||
33517760|NCT03197935|62903082|FG000|Overall Study|Physician Decision|0|||
33517761|NCT03197935|62903083|FG001|Overall Study|Physician Decision|1|||
33517762|NCT03197935|62903082|FG000|Overall Study|Withdrawal by Subject|11|||
33615950|NCT01574326|63016985|FG001|Overall Study|Withdrawal by Participant|4|||
33615951|NCT01574326|63016984|FG000|Overall Study|Physician Decision|5|||
33615952|NCT01574326|63016985|FG001|Overall Study|Physician Decision|3|||
33615953|NCT01574326|63016984|FG000|Overall Study|Adverse Event|1|||
33615954|NCT01574326|63016985|FG001|Overall Study|Adverse Event|3|||
33615955|NCT01574326|63016984|FG000|Overall Study|Other: Mainly kidney transplant|8|||
33615956|NCT01574326|63016985|FG001|Overall Study|Other: Mainly kidney transplant|8|||
33324770|NCT00959049|62701311|FG002|Overall Study|Lost to Follow-up|1|||
33324771|NCT00959049|62701312|FG003|Overall Study|Lost to Follow-up|10|||
33324772|NCT00959049|62701313|FG004|Overall Study|Lost to Follow-up|9|||
33324773|NCT00959049|62701314|FG005|Overall Study|Lost to Follow-up|1|||
33324774|NCT00959049|62701309|FG000|Overall Study|Contraindicated medication|0|||
33324775|NCT00959049|62701310|FG001|Overall Study|Contraindicated medication|0|||
33324776|NCT00959049|62701311|FG002|Overall Study|Contraindicated medication|0|||
33454577|NCT00132678|62829051|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
33454578|NCT00132678|62829052|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
33454579|NCT00132678|62829053|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
33454580|NCT00132678|62829051|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
33454581|NCT00132678|62829052|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
33454582|NCT00132678|62829053|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
33454583|NCT00132678|62829051|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
33454584|NCT00132678|62829052|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
33454585|NCT00132678|62829053|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
33517763|NCT03197935|62903083|FG001|Overall Study|Withdrawal by Subject|7|||
33517764|NCT03197935|62903082|FG000|Overall Study|On-Going in Study|147|||
33517765|NCT03197935|62903083|FG001|Overall Study|On-Going in Study|146|||
33517766|NCT03197935|62903082|FG000|Overall Study|Did not receive any study treatment|1|||
33517767|NCT03197935|62903083|FG001|Overall Study|Did not receive any study treatment|1|||
33454586|NCT00132678|62829051|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
33454587|NCT00132678|62829052|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
33517768|NCT03088917|62903090|FG000|Overall Study|In care/cured elsewhere|15|||
33615957|NCT01574248|63016998|FG000|Overall Study|Withdrawal by Subject|2|||
33615958|NCT01574248|63016999|FG001|Overall Study|Withdrawal by Subject|0|||
33615959|NCT01574248|63016998|FG000|Overall Study|Missing primary endpoint data|1|||
33615960|NCT01574248|63016999|FG001|Overall Study|Missing primary endpoint data|0|||
33615961|NCT01573624|63017005|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
33615962|NCT01573624|63017006|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
33615963|NCT01573624|63017007|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
33615964|NCT01573624|63017008|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
33615965|NCT01573624|63017009|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
33615966|NCT01573624|63017010|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
33615967|NCT01573624|63017011|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
33615968|NCT01573624|63017005|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
33615969|NCT01573624|63017006|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
33615970|NCT01573624|63017007|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
33615971|NCT01573624|63017008|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
33615972|NCT01573624|63017009|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
33615973|NCT01573624|63017010|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
33615974|NCT01573624|63017011|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
33615975|NCT01573624|63017005|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
33615976|NCT01573624|63017006|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
33615977|NCT01573624|63017007|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
33615978|NCT01573624|63017008|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
33615979|NCT01573624|63017009|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
33615980|NCT01573624|63017010|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
33615981|NCT01573624|63017011|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
33615982|NCT01573624|63017005|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33615983|NCT01573624|63017006|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33615984|NCT01573624|63017007|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33615985|NCT01573624|63017008|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33615986|NCT01573624|63017009|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33615987|NCT01573624|63017010|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
33615988|NCT01573624|63017011|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33615989|NCT01573624|63017005|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
33615990|NCT01573624|63017006|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
33615991|NCT01573624|63017007|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
33615992|NCT01573624|63017008|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
33615993|NCT01573624|63017009|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
33615994|NCT01573624|63017010|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
33615995|NCT01573624|63017011|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
33615996|NCT01573624|63017005|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
33615997|NCT01573624|63017006|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
33615998|NCT01573624|63017007|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
33615999|NCT01573624|63017008|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
33616000|NCT01573624|63017009|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
33616001|NCT01573624|63017010|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
33616002|NCT01573624|63017011|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
33616003|NCT01573624|63017005|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
33616004|NCT01573624|63017006|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
33616005|NCT01573624|63017007|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
33616006|NCT01573624|63017008|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
33616007|NCT01573624|63017009|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
33616008|NCT01573624|63017010|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
33616009|NCT01573624|63017011|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
33616010|NCT01573624|63017005|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
33517769|NCT03088917|62903090|FG000|Overall Study|Refuse re-evaluation|13|||
33517770|NCT03088917|62903090|FG000|Overall Study|Contact not established|13|||
33517771|NCT03088917|62903090|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
33517772|NCT03088917|62903090|FG000|Overall Study|Moved outside study region|50|||
33517773|NCT03087513|62903096|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
33517774|NCT02917629|62903111|FG000|Overall Study|Withdrawal by Subject|0|||
33517775|NCT02917629|62903112|FG001|Overall Study|Withdrawal by Subject|1|||
33517776|NCT02927847|62903121|FG000|Overall Study|Lost to Follow-up|1|||
33517777|NCT02927847|62903122|FG001|Overall Study|Lost to Follow-up|0|||
33517778|NCT02927847|62903121|FG000|Overall Study|Withdrawal by Subject|4|||
33517779|NCT02927847|62903122|FG001|Overall Study|Withdrawal by Subject|2|||
33616011|NCT01573624|63017006|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33616012|NCT01573624|63017007|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
33616013|NCT01573624|63017008|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
33616014|NCT01573624|63017009|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33616015|NCT01573624|63017010|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33616016|NCT01573624|63017011|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33616017|NCT01573624|63017005|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
33616018|NCT01573624|63017006|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
33616019|NCT01573624|63017007|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
33616020|NCT01573624|63017008|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
33616021|NCT01573624|63017009|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
33616022|NCT01573624|63017010|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
33616023|NCT01573624|63017011|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
33616024|NCT01573624|63017005|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33616025|NCT01573624|63017006|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33616026|NCT01573624|63017007|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33616027|NCT01573624|63017008|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
33616028|NCT01573624|63017009|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33616029|NCT01573624|63017010|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33616030|NCT01573624|63017011|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
33616031|NCT01573624|63017005|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
33616032|NCT01573624|63017006|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
33616033|NCT01573624|63017007|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
33616034|NCT01573624|63017008|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
33616035|NCT01573624|63017009|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
33616036|NCT01573624|63017010|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
33616037|NCT01573624|63017011|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
33616038|NCT01573624|63017005|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
33616039|NCT01573624|63017006|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
33616040|NCT01573624|63017007|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
33454588|NCT00132678|62829053|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
33454589|NCT00132678|62829051|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
33454590|NCT00132678|62829052|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
33454591|NCT00132678|62829053|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
33454592|NCT00132678|62829051|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
33454593|NCT00132678|62829052|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
33454594|NCT00132678|62829053|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
33454595|NCT00132678|62829051|FG000|Period III (Open-Label Stabilization)|Death|2|||
33454596|NCT00132678|62829052|FG001|Period III (Open-Label Stabilization)|Death|0|||
33454597|NCT00132678|62829053|FG002|Period III (Open-Label Stabilization)|Death|0|||
33454598|NCT00132678|62829051|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
33454599|NCT00132678|62829052|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
33454600|NCT00132678|62829053|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
33454601|NCT00132678|62829051|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
33454602|NCT00132678|62829052|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
33454603|NCT00132678|62829053|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
33454604|NCT00132678|62829051|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
33454605|NCT00132678|62829052|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
33454606|NCT00132678|62829053|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
33454607|NCT00132678|62829051|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
33454608|NCT00132678|62829052|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
33454609|NCT00132678|62829053|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
33454610|NCT00132678|62829051|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
33454611|NCT00132678|62829052|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
33454612|NCT00132678|62829053|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
33454613|NCT00132678|62829051|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
33454614|NCT00132678|62829052|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
33324777|NCT00959049|62701312|FG003|Overall Study|Contraindicated medication|1|||
33454615|NCT00132678|62829053|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
33324778|NCT00959049|62701313|FG004|Overall Study|Contraindicated medication|0|||
33324779|NCT00959049|62701314|FG005|Overall Study|Contraindicated medication|0|||
33324780|NCT00959049|62701309|FG000|Overall Study|Withdrawal by Subject|0|||
33324781|NCT00959049|62701310|FG001|Overall Study|Withdrawal by Subject|2|||
33324782|NCT00959049|62701311|FG002|Overall Study|Withdrawal by Subject|0|||
33324783|NCT00959049|62701312|FG003|Overall Study|Withdrawal by Subject|0|||
33324784|NCT00959049|62701313|FG004|Overall Study|Withdrawal by Subject|0|||
33324785|NCT00959049|62701314|FG005|Overall Study|Withdrawal by Subject|0|||
33324786|NCT00956943|62701341|FG000|Overall Study|Lost to Follow-up|9|||
33324787|NCT00956943|62701342|FG001|Overall Study|Lost to Follow-up|10|||
33324788|NCT00958893|62701348|FG000|Overall Study|Study prematurely terminated|4|||
33324789|NCT01135914|62701355|FG000|Overall Study|Withdrawal by Subject|1|||
33324790|NCT01135914|62701356|FG001|Overall Study|Withdrawal by Subject|3|||
33324791|NCT01135914|62701357|FG002|Overall Study|Withdrawal by Subject|6|||
33324792|NCT01135914|62701355|FG000|Overall Study|Lost to Follow-up|1|||
33324793|NCT01135914|62701356|FG001|Overall Study|Lost to Follow-up|0|||
33324794|NCT01135914|62701357|FG002|Overall Study|Lost to Follow-up|1|||
33324795|NCT01135914|62701355|FG000|Overall Study|Protocol Violation|0|||
33324796|NCT01135914|62701356|FG001|Overall Study|Protocol Violation|0|||
33324797|NCT01135914|62701357|FG002|Overall Study|Protocol Violation|3|||
33324798|NCT01135914|62701355|FG000|Overall Study|Lack of Efficacy|2|||
33324799|NCT01135914|62701356|FG001|Overall Study|Lack of Efficacy|1|||
33324800|NCT01135914|62701357|FG002|Overall Study|Lack of Efficacy|10|||
33324801|NCT01135914|62701355|FG000|Overall Study|Adverse Event|0|||
33324802|NCT01135914|62701356|FG001|Overall Study|Adverse Event|1|||
33324803|NCT01135914|62701357|FG002|Overall Study|Adverse Event|2|||
33324804|NCT00907738|62701370|FG000|Overall Study|Adverse Event|2|||
33324805|NCT00907738|62701371|FG001|Overall Study|Adverse Event|0|||
33324806|NCT00907738|62701372|FG002|Overall Study|Adverse Event|1|||
33324807|NCT00907738|62701373|FG003|Overall Study|Adverse Event|0|||
33517780|NCT02927847|62903121|FG000|Overall Study|PI withdrawn due to missed visits|1|||
33517781|NCT02927847|62903122|FG001|Overall Study|PI withdrawn due to missed visits|1|||
33517782|NCT02960438|62903132|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
33517783|NCT02960438|62903133|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
33517784|NCT02960438|62903134|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
33517785|NCT02960438|62903135|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
33616041|NCT01573624|63017008|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
33616042|NCT01573624|63017009|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
33616043|NCT01573624|63017010|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
33616044|NCT01573624|63017011|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
33616045|NCT01573624|63017005|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
33517786|NCT02960438|62903132|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
33517787|NCT02960438|62903133|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
33517788|NCT02960438|62903134|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
33517789|NCT02960438|62903135|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
33517790|NCT02960438|62903132|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
33517791|NCT02960438|62903133|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
33517792|NCT02960438|62903134|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
33517793|NCT02960438|62903135|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
33517794|NCT02960438|62903132|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
33517795|NCT02960438|62903133|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
33517796|NCT02960438|62903134|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
33517797|NCT02960438|62903135|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
33517798|NCT02960438|62903132|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
33517799|NCT02960438|62903133|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
33517800|NCT02960438|62903134|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
33517801|NCT02960438|62903135|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
33517802|NCT02960438|62903132|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
33517803|NCT02960438|62903133|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
33517804|NCT02960438|62903134|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
33517805|NCT02960438|62903135|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
33517806|NCT02960438|62903132|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
33517807|NCT02960438|62903133|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
33616046|NCT01573624|63017006|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
33616047|NCT01573624|63017007|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
33616048|NCT01573624|63017008|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
33324808|NCT00907738|62701374|FG004|Overall Study|Adverse Event|0|||
33324809|NCT00907738|62701370|FG000|Overall Study|not specified or withdrew consent|3|||
33324810|NCT00907738|62701371|FG001|Overall Study|not specified or withdrew consent|0|||
33324811|NCT00907738|62701372|FG002|Overall Study|not specified or withdrew consent|0|||
33517808|NCT02960438|62903134|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
33517809|NCT02960438|62903135|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
33517810|NCT02960438|62903132|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
33517811|NCT02960438|62903133|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
33517812|NCT02960438|62903134|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
33517813|NCT02960438|62903135|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
33517814|NCT02960438|62903132|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
33517815|NCT02960438|62903133|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
33517816|NCT02960438|62903134|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
33517817|NCT02960438|62903135|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
33517818|NCT02960438|62903132|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
33517819|NCT02960438|62903133|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
33517820|NCT02960438|62903134|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
33517821|NCT02960438|62903135|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
33517822|NCT02960438|62903132|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
33517823|NCT02960438|62903133|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
33517824|NCT02960438|62903134|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
33517825|NCT02960438|62903135|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
33517826|NCT02960438|62903132|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
33517827|NCT02960438|62903133|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
33517828|NCT02960438|62903134|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
33517829|NCT02960438|62903135|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
33517830|NCT02957942|62903155|FG000|Overall Study|Withdrawal by Subject|0|||
33517831|NCT02957942|62903156|FG001|Overall Study|Withdrawal by Subject|1|||
33517832|NCT02957942|62903155|FG000|Overall Study|Practicing experiment protocol|0|||
33616049|NCT01573624|63017009|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
33616050|NCT01573624|63017010|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
33616051|NCT01573624|63017011|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
33616052|NCT01573624|63017005|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
33616053|NCT01573624|63017006|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
33616054|NCT01573624|63017007|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
33616055|NCT01573624|63017008|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
33616056|NCT01573624|63017009|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
33616057|NCT01573624|63017010|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
33616058|NCT01573624|63017011|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
33616059|NCT01573624|63017005|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33616060|NCT01573624|63017006|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
33616061|NCT01573624|63017007|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
33616062|NCT01573624|63017008|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33616063|NCT01573624|63017009|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33517833|NCT02957942|62903156|FG001|Overall Study|Practicing experiment protocol|6|||
33517834|NCT02959970|62903164|FG000|Overall Study|Adverse Event|1|||
33517835|NCT02959970|62903165|FG001|Overall Study|Adverse Event|0|||
33517836|NCT02959970|62903164|FG000|Overall Study|Withdrawal by Subject|0|||
33517837|NCT02959970|62903165|FG001|Overall Study|Withdrawal by Subject|2|||
33517838|NCT02959970|62903164|FG000|Overall Study|Lost to Follow-up|1|||
33517839|NCT02959970|62903165|FG001|Overall Study|Lost to Follow-up|5|||
33517840|NCT05300763|62903198|FG000|Overall Study|Adverse Event|0|||
33517841|NCT05300763|62903199|FG001|Overall Study|Adverse Event|1|||
33517842|NCT05300763|62903198|FG000|Overall Study|Major Protocol Deviation|1|||
33517843|NCT05300763|62903199|FG001|Overall Study|Major Protocol Deviation|0|||
33517844|NCT05300763|62903198|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
33517845|NCT05300763|62903199|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
33517846|NCT02925312|62903207|FG000|Overall Study|Lost to Follow-up|25|||
33616064|NCT01573624|63017010|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
33616065|NCT01573624|63017011|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33517847|NCT02925312|62903208|FG001|Overall Study|Lost to Follow-up|0|||
33517848|NCT02925312|62903207|FG000|Overall Study|Adverse Event|2|||
33517849|NCT02925312|62903208|FG001|Overall Study|Adverse Event|0|||
33517850|NCT03196297|62903223|FG000|Main Period|Withdrawal by Subject|4|||
33517851|NCT03196297|62903223|FG000|Extension Period|Withdrawal by Subject|1|||
33517852|NCT03196297|62903223|FG000|Extension Period|Lack of Efficacy|2|||
33517853|NCT03192475|62903248|FG000|Overall Study|Death|0|||
33517854|NCT03192475|62903249|FG001|Overall Study|Death|1|||
33517855|NCT03192475|62903248|FG000|Overall Study|Lost to Follow-up|13|||
33517856|NCT03192475|62903249|FG001|Overall Study|Lost to Follow-up|8|||
33517857|NCT03189745|62903258|FG000|Overall Study|Conflict in work schedule of participant|1|||
33517858|NCT03189745|62903259|FG001|Overall Study|Conflict in work schedule of participant|1|||
33517859|NCT03188263|62903267|FG000|Overall Study|Withdrawal by Subject|3|||
33517860|NCT03188263|62903268|FG001|Overall Study|Withdrawal by Subject|0|||
33517861|NCT03188263|62903267|FG000|Overall Study|Physician Decision|1|||
33517862|NCT03188263|62903268|FG001|Overall Study|Physician Decision|0|||
33517863|NCT03188185|62903276|FG000|Stage 1|Adverse Event|4|||
33517864|NCT03188185|62903277|FG001|Stage 1|Adverse Event|12|||
33517865|NCT03188185|62903278|FG002|Stage 1|Adverse Event|0|||
33517866|NCT03188185|62903279|FG003|Stage 1|Adverse Event|0|||
33517867|NCT03188185|62903276|FG000|Stage 1|Lack of Efficacy|0|||
33517868|NCT03188185|62903277|FG001|Stage 1|Lack of Efficacy|2|||
33517869|NCT03188185|62903278|FG002|Stage 1|Lack of Efficacy|0|||
33517870|NCT03188185|62903279|FG003|Stage 1|Lack of Efficacy|0|||
33517871|NCT03188185|62903276|FG000|Stage 1|Lost to Follow-up|6|||
33517872|NCT03188185|62903277|FG001|Stage 1|Lost to Follow-up|1|||
33517873|NCT03188185|62903278|FG002|Stage 1|Lost to Follow-up|0|||
33517874|NCT03188185|62903279|FG003|Stage 1|Lost to Follow-up|0|||
33517875|NCT03188185|62903276|FG000|Stage 1|Withdrawal by Subject|9|||
33454616|NCT00132678|62829051|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
33454617|NCT00132678|62829052|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
33454618|NCT00132678|62829053|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
33454619|NCT00132678|62829051|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
33454620|NCT00132678|62829052|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
33454621|NCT00132678|62829053|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
33454622|NCT00132678|62829051|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
33517876|NCT03188185|62903277|FG001|Stage 1|Withdrawal by Subject|0|||
33517877|NCT03188185|62903278|FG002|Stage 1|Withdrawal by Subject|0|||
33517878|NCT03188185|62903279|FG003|Stage 1|Withdrawal by Subject|0|||
33517879|NCT03188185|62903276|FG000|Stage 1|Identified as a professional patient|0|||
33517880|NCT03188185|62903277|FG001|Stage 1|Identified as a professional patient|1|||
33517881|NCT03188185|62903278|FG002|Stage 1|Identified as a professional patient|0|||
33517882|NCT03188185|62903279|FG003|Stage 1|Identified as a professional patient|0|||
33517883|NCT03188185|62903276|FG000|Stage 2|Adverse Event|0|||
33517884|NCT03188185|62903277|FG001|Stage 2|Adverse Event|0|||
33517885|NCT03188185|62903278|FG002|Stage 2|Adverse Event|2|||
33517886|NCT03188185|62903279|FG003|Stage 2|Adverse Event|4|||
33517887|NCT03188185|62903276|FG000|Stage 2|Lack of Efficacy|0|||
33517888|NCT03188185|62903277|FG001|Stage 2|Lack of Efficacy|0|||
33517889|NCT03188185|62903278|FG002|Stage 2|Lack of Efficacy|3|||
33517890|NCT03188185|62903279|FG003|Stage 2|Lack of Efficacy|0|||
33517891|NCT03188185|62903276|FG000|Stage 2|Lost to Follow-up|0|||
33517892|NCT03188185|62903277|FG001|Stage 2|Lost to Follow-up|0|||
33517893|NCT03188185|62903278|FG002|Stage 2|Lost to Follow-up|1|||
33324812|NCT00907738|62701373|FG003|Overall Study|not specified or withdrew consent|0|||
33324813|NCT00907738|62701374|FG004|Overall Study|not specified or withdrew consent|0|||
33324814|NCT00907738|62701370|FG000|Overall Study|Disease progression|8|||
33454623|NCT00132678|62829052|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
33454624|NCT00132678|62829053|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
33454625|NCT00132678|62829051|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
33454626|NCT00132678|62829052|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
33454627|NCT00132678|62829053|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
33454628|NCT00132678|62829051|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
33517894|NCT03188185|62903279|FG003|Stage 2|Lost to Follow-up|0|||
33517895|NCT03188185|62903276|FG000|Stage 2|Physician Decision|0|||
33517896|NCT03188185|62903277|FG001|Stage 2|Physician Decision|0|||
33517897|NCT03188185|62903278|FG002|Stage 2|Physician Decision|0|||
33324815|NCT00907738|62701371|FG001|Overall Study|Disease progression|1|||
33454629|NCT00132678|62829052|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
33454630|NCT00132678|62829053|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
33454631|NCT00132678|62829051|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
33517898|NCT03188185|62903279|FG003|Stage 2|Physician Decision|1|||
33517899|NCT03188185|62903276|FG000|Stage 2|Withdrawal by Subject|0|||
33517900|NCT03188185|62903277|FG001|Stage 2|Withdrawal by Subject|0|||
33517901|NCT03188185|62903278|FG002|Stage 2|Withdrawal by Subject|3|||
33517902|NCT03188185|62903279|FG003|Stage 2|Withdrawal by Subject|1|||
33517903|NCT03186781|62903295|FG000|Overall Study|Lost to Follow-up|0|||
33517904|NCT03186781|62903296|FG001|Overall Study|Lost to Follow-up|0|||
33517905|NCT03186781|62903297|FG002|Overall Study|Lost to Follow-up|1|||
33517906|NCT03186781|62903298|FG003|Overall Study|Lost to Follow-up|0|||
33517907|NCT03186781|62903299|FG004|Overall Study|Lost to Follow-up|1|||
33517908|NCT03186781|62903300|FG005|Overall Study|Lost to Follow-up|0|||
33517909|NCT03186781|62903295|FG000|Overall Study|Moved from Area|0|||
33517910|NCT03186781|62903296|FG001|Overall Study|Moved from Area|0|||
33517911|NCT03186781|62903297|FG002|Overall Study|Moved from Area|0|||
33517912|NCT03186781|62903298|FG003|Overall Study|Moved from Area|0|||
33517913|NCT03186781|62903299|FG004|Overall Study|Moved from Area|1|||
33517914|NCT03186781|62903300|FG005|Overall Study|Moved from Area|0|||
33517915|NCT03186781|62903295|FG000|Overall Study|Withdrawal by Subject|0|||
33517916|NCT03186781|62903296|FG001|Overall Study|Withdrawal by Subject|0|||
33517917|NCT03186781|62903297|FG002|Overall Study|Withdrawal by Subject|0|||
33517918|NCT03186781|62903298|FG003|Overall Study|Withdrawal by Subject|0|||
33517919|NCT03186781|62903299|FG004|Overall Study|Withdrawal by Subject|1|||
33517920|NCT03186781|62903300|FG005|Overall Study|Withdrawal by Subject|0|||
33517921|NCT03184987|62903327|FG000|Overall Study|Withdrawal by Subject|0|||
33517922|NCT03184987|62903328|FG001|Overall Study|Withdrawal by Subject|1|||
33517923|NCT03184987|62903329|FG002|Overall Study|Withdrawal by Subject|2|||
33517924|NCT03184987|62903327|FG000|Overall Study|Physician Decision|0|||
33517925|NCT03184987|62903328|FG001|Overall Study|Physician Decision|0|||
33517926|NCT03184987|62903329|FG002|Overall Study|Physician Decision|1|||
33517927|NCT03184987|62903327|FG000|Overall Study|Adverse Event|1|||
33517928|NCT03184987|62903328|FG001|Overall Study|Adverse Event|0|||
33517929|NCT03184987|62903329|FG002|Overall Study|Adverse Event|1|||
33517930|NCT03184519|62903337|FG000|Overall Study|Lost to Follow-up|6|||
33517931|NCT03184519|62903337|FG000|Overall Study|Physician Decision|21|||
33517932|NCT03184441|62903341|FG000|Overall Study|Withdrawal by Subject|1|||
33517933|NCT03026166|62903350|FG000|Overall Study|Death|22|||
33517934|NCT03026166|62903351|FG001|Overall Study|Death|7|||
33517935|NCT03026166|62903350|FG000|Overall Study|Physician Decision|2|||
33517936|NCT03026166|62903351|FG001|Overall Study|Physician Decision|0|||
33517937|NCT03026166|62903350|FG000|Overall Study|Withdrawal by Subject|1|||
33517938|NCT03026166|62903351|FG001|Overall Study|Withdrawal by Subject|2|||
33517939|NCT03026166|62903350|FG000|Overall Study|Lost to Follow-up|1|||
33517940|NCT03026166|62903351|FG001|Overall Study|Lost to Follow-up|0|||
33517941|NCT03026166|62903350|FG000|Overall Study|Study Terminated by Sponsor|3|||
33517942|NCT03026166|62903351|FG001|Overall Study|Study Terminated by Sponsor|3|||
33517943|NCT03026166|62903350|FG000|Overall Study|Other|1|||
33517944|NCT03026166|62903351|FG001|Overall Study|Other|0|||
33517945|NCT03026088|62903357|FG000|Overall Study|Study termination|20|||
33616066|NCT01573624|63017005|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
33616067|NCT01573624|63017006|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
33616068|NCT01573624|63017007|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
33616069|NCT01573624|63017008|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
33616070|NCT01573624|63017009|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
33616071|NCT01573624|63017010|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
33616072|NCT01573624|63017011|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
33616073|NCT01573624|63017005|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
33324816|NCT00907738|62701372|FG002|Overall Study|Disease progression|6|||
33324817|NCT00907738|62701373|FG003|Overall Study|Disease progression|4|||
33454632|NCT00132678|62829052|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
33454633|NCT00132678|62829053|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
33454634|NCT00132678|62829051|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
33454635|NCT00132678|62829052|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
33454636|NCT00132678|62829053|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
33454637|NCT00132678|62829051|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
33454638|NCT00132678|62829052|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
33454639|NCT00132678|62829053|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
33517946|NCT03181789|62903365|FG000|Overall Study|Withdrawal by Subject|0|||
33517947|NCT03181789|62903366|FG001|Overall Study|Withdrawal by Subject|1|||
33517948|NCT03181789|62903367|FG002|Overall Study|Withdrawal by Subject|1|||
33517949|NCT03181789|62903368|FG003|Overall Study|Withdrawal by Subject|0|||
33517950|NCT03181789|62903365|FG000|Overall Study|Lost to Follow-up|7|||
33517951|NCT03181789|62903366|FG001|Overall Study|Lost to Follow-up|1|||
33324818|NCT00907738|62701374|FG004|Overall Study|Disease progression|2|||
33454640|NCT00132678|62829051|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
33517952|NCT03181789|62903367|FG002|Overall Study|Lost to Follow-up|0|||
33517953|NCT03181789|62903368|FG003|Overall Study|Lost to Follow-up|0|||
33517954|NCT03181789|62903365|FG000|Overall Study|Participant unable to adhere to visit|0|||
33517955|NCT03181789|62903366|FG001|Overall Study|Participant unable to adhere to visit|1|||
33517956|NCT03181789|62903367|FG002|Overall Study|Participant unable to adhere to visit|0|||
33517957|NCT03181789|62903368|FG003|Overall Study|Participant unable to adhere to visit|0|||
33517958|NCT03024606|62903380|FG000|Overall Study|Withdrawal by Subject|9|||
33517959|NCT03024606|62903381|FG001|Overall Study|Withdrawal by Subject|10|||
33517960|NCT03180619|62903390|FG000|Overall Study|Withdrew Consent|5|||
33517961|NCT03180619|62903391|FG001|Overall Study|Withdrew Consent|0|||
33517962|NCT03180619|62903392|FG002|Overall Study|Withdrew Consent|2|||
33517963|NCT03180619|62903390|FG000|Overall Study|Death|2|||
33517964|NCT03180619|62903391|FG001|Overall Study|Death|1|||
33517965|NCT03180619|62903392|FG002|Overall Study|Death|2|||
33517966|NCT03180619|62903390|FG000|Overall Study|Adverse Event|2|||
33517967|NCT03180619|62903391|FG001|Overall Study|Adverse Event|0|||
33517968|NCT03180619|62903392|FG002|Overall Study|Adverse Event|1|||
33517969|NCT03180619|62903390|FG000|Overall Study|Investigator's discretion|2|||
33517970|NCT03180619|62903391|FG001|Overall Study|Investigator's discretion|0|||
33616074|NCT01573624|63017006|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
33616075|NCT01573624|63017007|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
33616076|NCT01573624|63017008|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
33616077|NCT01573624|63017009|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
33616078|NCT01573624|63017010|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
33616079|NCT01573624|63017011|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
33616080|NCT01573624|63017005|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
33616081|NCT01573624|63017006|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
33616082|NCT01573624|63017007|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
33616083|NCT01573624|63017008|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
33616084|NCT01573624|63017009|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
33616085|NCT01573624|63017010|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
33616086|NCT01573624|63017011|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
33616087|NCT01573624|63017005|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
33616088|NCT01573624|63017006|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
33616089|NCT01573624|63017007|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
33616090|NCT01573624|63017008|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
33616091|NCT01573624|63017009|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
33616092|NCT01573624|63017010|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
33454641|NCT00132678|62829052|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
33454642|NCT00132678|62829053|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
33454643|NCT00101868|62829063|FG000|Overall Study|Death|10|||
33454644|NCT00101868|62829064|FG001|Overall Study|Death|10|||
33454645|NCT00101868|62829063|FG000|Overall Study|Withdrawal by Subject|8|||
33454646|NCT00101868|62829064|FG001|Overall Study|Withdrawal by Subject|9|||
33454647|NCT00101868|62829063|FG000|Overall Study|Protocol Violation|3|||
33454648|NCT00101868|62829064|FG001|Overall Study|Protocol Violation|0|||
33454649|NCT00101868|62829063|FG000|Overall Study|Lost to Follow-up|8|||
33454650|NCT00101868|62829064|FG001|Overall Study|Lost to Follow-up|13|||
33454651|NCT00101400|62829072|FG000|Survival Follow-Up|Alive|7|||
33454652|NCT03821064|62829076|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
33454653|NCT00141518|62829083|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
33454654|NCT00141518|62829084|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
33454655|NCT00141518|62829085|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
33454656|NCT00141518|62829083|FG000|Overall Study|Adverse Event|7|||
33454657|NCT00141518|62829084|FG001|Overall Study|Adverse Event|5|||
33454658|NCT00141518|62829085|FG002|Overall Study|Adverse Event|2|||
33454659|NCT00141518|62829083|FG000|Overall Study|Withdrawal by Subject|2|||
33454660|NCT00141518|62829084|FG001|Overall Study|Withdrawal by Subject|0|||
33454661|NCT00141518|62829085|FG002|Overall Study|Withdrawal by Subject|2|||
33454662|NCT00141518|62829083|FG000|Overall Study|Protocol Violation|1|||
33517971|NCT03180619|62903392|FG002|Overall Study|Investigator's discretion|1|||
33517972|NCT02915874|62903409|FG000|Overall Study|Lost to Follow-up|5|||
33517973|NCT02915874|62903410|FG001|Overall Study|Lost to Follow-up|4|||
33616093|NCT01573624|63017011|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
33616094|NCT01573624|63017005|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
33616095|NCT01573624|63017006|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
33616096|NCT01573624|63017007|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
33616097|NCT01573624|63017008|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
33616098|NCT01573624|63017009|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
33616099|NCT01573624|63017010|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
33616100|NCT01573624|63017011|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
33616101|NCT01573624|63017005|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33616102|NCT01573624|63017006|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33616103|NCT01573624|63017007|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33616104|NCT01573624|63017008|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33616105|NCT01573624|63017009|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33616106|NCT01573624|63017010|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
33517974|NCT02915874|62903409|FG000|Overall Study|Withdrawal by Subject|1|||
33517975|NCT02915874|62903410|FG001|Overall Study|Withdrawal by Subject|1|||
33517976|NCT02915874|62903409|FG000|Overall Study|Started New Anxiety Medication|0|||
33517977|NCT02915874|62903410|FG001|Overall Study|Started New Anxiety Medication|1|||
33517978|NCT03022578|62903416|FG000|Overall Study|Adverse Event|1|||
33517979|NCT03022578|62903416|FG000|Overall Study|Lack of Efficacy|2|||
33517980|NCT03022578|62903416|FG000|Overall Study|Withdrawal by Subject|1|||
33517981|NCT03022422|62903426|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
33517982|NCT03022422|62903427|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
33517983|NCT03022422|62903428|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
33517984|NCT03022422|62903429|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
33517985|NCT03022422|62903430|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
33517986|NCT03022422|62903431|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
33517987|NCT03023826|62903447|FG000|Period 1|Withdrawal by Subject|0|||
33517988|NCT03023826|62903448|FG001|Period 1|Withdrawal by Subject|0|||
33616107|NCT01573624|63017011|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
33616108|NCT01573624|63017005|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
33616109|NCT01573624|63017006|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
33616110|NCT01573624|63017007|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
33616111|NCT01573624|63017008|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
33616112|NCT01573624|63017009|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
33616113|NCT01573624|63017010|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
33616114|NCT01573624|63017011|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
33616115|NCT01573624|63017005|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
33616116|NCT01573624|63017006|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33616117|NCT01573624|63017007|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33616118|NCT01573624|63017008|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33517989|NCT03023826|62903449|FG002|Period 1|Withdrawal by Subject|0|||
33454663|NCT00141518|62829084|FG001|Overall Study|Protocol Violation|1|||
33454664|NCT00141518|62829085|FG002|Overall Study|Protocol Violation|2|||
33454665|NCT00141518|62829083|FG000|Overall Study|Lack of Efficacy|5|||
33454666|NCT00141518|62829084|FG001|Overall Study|Lack of Efficacy|0|||
33454667|NCT00141518|62829085|FG002|Overall Study|Lack of Efficacy|0|||
33454668|NCT00253448|62829095|FG000|Overall Study|Withdrawal by Subject|1|||
33454669|NCT00098748|62829102|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
33454670|NCT00098748|62829103|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
33454671|NCT00098748|62829104|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
33454672|NCT00098748|62829102|FG000|Received Study Treatment|Death|2|||
33454673|NCT00098748|62829103|FG001|Received Study Treatment|Death|1|||
33517990|NCT03023826|62903450|FG003|Period 1|Withdrawal by Subject|0|||
33454674|NCT00098748|62829104|FG002|Received Study Treatment|Death|2|||
33454675|NCT00098748|62829102|FG000|Received Study Treatment|Adverse Event|1|||
33517991|NCT03023826|62903451|FG004|Period 1|Withdrawal by Subject|1|||
33517992|NCT03023826|62903452|FG005|Period 1|Withdrawal by Subject|0|||
33517993|NCT03166735|62903465|FG000|Overall Study|Not Treated|1|||
33517994|NCT03166735|62903466|FG001|Overall Study|Not Treated|0|||
33517995|NCT03166735|62903467|FG002|Overall Study|Not Treated|0|||
33517996|NCT03166735|62903468|FG003|Overall Study|Not Treated|0|||
33517997|NCT03166735|62903469|FG004|Overall Study|Not Treated|0|||
33517998|NCT03166735|62903465|FG000|Overall Study|follow-up not completed as planned|0|||
33454676|NCT00098748|62829103|FG001|Received Study Treatment|Adverse Event|2|||
33454677|NCT00098748|62829104|FG002|Received Study Treatment|Adverse Event|5|||
33454678|NCT00098748|62829102|FG000|Received Study Treatment|Lack of Efficacy|40|||
33454679|NCT00098748|62829103|FG001|Received Study Treatment|Lack of Efficacy|27|||
33454680|NCT00098748|62829104|FG002|Received Study Treatment|Lack of Efficacy|27|||
33454681|NCT00098748|62829102|FG000|Received Study Treatment|Other|2|||
33454682|NCT00098748|62829103|FG001|Received Study Treatment|Other|2|||
33454683|NCT00098748|62829104|FG002|Received Study Treatment|Other|6|||
33454684|NCT00098748|62829102|FG000|Received Study Treatment|Subject defaulted|3|||
33454685|NCT00098748|62829103|FG001|Received Study Treatment|Subject defaulted|4|||
33454686|NCT00098748|62829104|FG002|Received Study Treatment|Subject defaulted|4|||
33454687|NCT00098748|62829102|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
33454688|NCT00098748|62829103|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
33454689|NCT00098748|62829104|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
33454690|NCT00098748|62829102|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
33454691|NCT00098748|62829103|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
33454692|NCT00098748|62829104|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
33454693|NCT00098748|62829102|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
33454694|NCT00098748|62829103|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
33454695|NCT00098748|62829104|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
33454696|NCT00098748|62829102|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
33454697|NCT00098748|62829103|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
33517999|NCT03166735|62903466|FG001|Overall Study|follow-up not completed as planned|1|||
33518000|NCT03166735|62903467|FG002|Overall Study|follow-up not completed as planned|1|||
33518001|NCT03166735|62903468|FG003|Overall Study|follow-up not completed as planned|0|||
33518002|NCT03166735|62903469|FG004|Overall Study|follow-up not completed as planned|1|||
33518003|NCT03166735|62903465|FG000|Overall Study|Withdrawal by Subject|0|||
33518004|NCT03166735|62903466|FG001|Overall Study|Withdrawal by Subject|0|||
33518005|NCT03166735|62903467|FG002|Overall Study|Withdrawal by Subject|1|||
33454698|NCT00098748|62829104|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
33454699|NCT00098748|62829102|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
33454700|NCT00098748|62829103|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
33454701|NCT00098748|62829104|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
33454702|NCT00130520|62829112|FG000|Overall Study|Adverse Event|11|||
33454703|NCT00130520|62829112|FG000|Overall Study|Death|1|||
33454704|NCT00130520|62829112|FG000|Overall Study|Physician Decision|1|||
33454705|NCT00130520|62829112|FG000|Overall Study|Withdrawal by Subject|1|||
33454706|NCT00130520|62829112|FG000|Overall Study|Disease Progression|23|||
33454707|NCT00130520|62829112|FG000|Overall Study|Protocol non-compliance|1|||
33454708|NCT00130520|62829112|FG000|Overall Study|Did not meet re-treatment criteria|1|||
33454709|NCT00132132|62829118|FG000|Overall Study|Lost to Follow-up|7|||
33454710|NCT00132132|62829119|FG001|Overall Study|Lost to Follow-up|2|||
33454711|NCT00130442|62829127|FG000|Overall Study|Withdrawal by Subject|0|||
33454712|NCT00130442|62829128|FG001|Overall Study|Withdrawal by Subject|1|||
33454713|NCT00130442|62829127|FG000|Overall Study|did not meet criteria|1|||
33454714|NCT00130442|62829128|FG001|Overall Study|did not meet criteria|1|||
33518006|NCT03166735|62903468|FG003|Overall Study|Withdrawal by Subject|1|||
33518007|NCT03166735|62903469|FG004|Overall Study|Withdrawal by Subject|2|||
33518008|NCT03166735|62903465|FG000|Overall Study|Lost to Follow-up|0|||
33518009|NCT03166735|62903466|FG001|Overall Study|Lost to Follow-up|2|||
33518010|NCT03166735|62903467|FG002|Overall Study|Lost to Follow-up|1|||
33518011|NCT03166735|62903468|FG003|Overall Study|Lost to Follow-up|0|||
33518012|NCT03166735|62903469|FG004|Overall Study|Lost to Follow-up|1|||
33518013|NCT03165955|62903482|FG000|Treatment|Withdrawal by Subject|3|||
33518014|NCT03165955|62903482|FG000|Treatment|Death|1|||
33518015|NCT03165955|62903482|FG000|Treatment|Adverse Event|1|||
33518016|NCT03165955|62903482|FG000|Treatment|Progressive disease|3|||
33518017|NCT03055494|62903488|FG000|Overall Study|Lost to Follow-up|6|||
33518018|NCT03055494|62903489|FG001|Overall Study|Lost to Follow-up|0|||
33518019|NCT03055494|62903488|FG000|Overall Study|Physician Decision|2|||
33518020|NCT03055494|62903489|FG001|Overall Study|Physician Decision|0|||
33518021|NCT03055494|62903488|FG000|Overall Study|Withdrawal by Subject|1|||
33518022|NCT03055494|62903489|FG001|Overall Study|Withdrawal by Subject|0|||
33518023|NCT03055494|62903488|FG000|Overall Study|Adverse Event|0|||
33518024|NCT03055494|62903489|FG001|Overall Study|Adverse Event|1|||
33518025|NCT03055494|62903488|FG000|Overall Study|Non-compliance with study treatment|1|||
33518026|NCT03055494|62903489|FG001|Overall Study|Non-compliance with study treatment|0|||
33518027|NCT02914548|62903499|FG000|Overall Study|Adverse Event|15|||
33518028|NCT02914548|62903500|FG001|Overall Study|Adverse Event|7|||
33518029|NCT02914548|62903501|FG002|Overall Study|Adverse Event|15|||
33518030|NCT02914548|62903499|FG000|Overall Study|Physician Decision|2|||
33616119|NCT01573624|63017009|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
33324819|NCT01123356|62701390|FG000|Overall Study|Adverse Event|2|||
33454715|NCT00130208|62829138|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
33454716|NCT00130208|62829139|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
33518031|NCT02914548|62903500|FG001|Overall Study|Physician Decision|2|||
33518032|NCT02914548|62903501|FG002|Overall Study|Physician Decision|0|||
33518033|NCT02914548|62903499|FG000|Overall Study|Protocol Violation|1|||
33518034|NCT02914548|62903500|FG001|Overall Study|Protocol Violation|0|||
33518035|NCT02914548|62903501|FG002|Overall Study|Protocol Violation|0|||
33518036|NCT02914548|62903499|FG000|Overall Study|Withdrawal by Subject|3|||
33324820|NCT01123356|62701390|FG000|Overall Study|Lack of Efficacy|4|||
33518037|NCT02914548|62903500|FG001|Overall Study|Withdrawal by Subject|4|||
33518038|NCT02914548|62903501|FG002|Overall Study|Withdrawal by Subject|4|||
33518039|NCT02914548|62903499|FG000|Overall Study|>40% of body surface area|0|||
33518040|NCT02914548|62903500|FG001|Overall Study|>40% of body surface area|1|||
33518041|NCT02914548|62903501|FG002|Overall Study|>40% of body surface area|1|||
33518042|NCT03165721|62903517|FG000|Overall Study|Refused further treatment|3|||
33518043|NCT03165721|62903518|FG001|Overall Study|Refused further treatment|0|||
33616120|NCT01573624|63017010|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
33616121|NCT01573624|63017011|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
33616122|NCT01573624|63017005|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
33616123|NCT01573624|63017006|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
33616124|NCT01573624|63017007|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
33616125|NCT01573624|63017008|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
33616126|NCT01573624|63017009|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
33616127|NCT01573624|63017010|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
33616128|NCT01573624|63017011|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
33616129|NCT01573624|63017005|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
33616130|NCT01573624|63017006|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
33616131|NCT01573624|63017007|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
33518044|NCT03165721|62903519|FG002|Overall Study|Refused further treatment|0|||
33518045|NCT03165721|62903517|FG000|Overall Study|Physician Decision|1|||
33518046|NCT03165721|62903518|FG001|Overall Study|Physician Decision|0|||
33518047|NCT03165721|62903519|FG002|Overall Study|Physician Decision|0|||
33518048|NCT02187198|62903535|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
33518049|NCT02187198|62903536|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
33518050|NCT02187198|62903535|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
33518051|NCT02187198|62903536|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
33616132|NCT01573624|63017008|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
33616133|NCT01573624|63017009|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
33616134|NCT01573624|63017010|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
33616135|NCT01573624|63017011|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
33616136|NCT01573624|63017005|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
33616137|NCT01573624|63017006|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
33616138|NCT01573624|63017007|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
33616139|NCT01573624|63017008|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
33616140|NCT01573624|63017009|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
33616141|NCT01573624|63017010|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
33616142|NCT01573624|63017011|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
33616143|NCT01573624|63017005|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
33616144|NCT01573624|63017006|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
33518052|NCT02642029|62903542|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
33518053|NCT02642029|62903543|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
33518054|NCT02642029|62903544|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
33518055|NCT02642029|62903545|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
33518056|NCT02642029|62903546|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
33518057|NCT02642029|62903547|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
33518058|NCT02642029|62903542|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
33518059|NCT02642029|62903543|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
33518060|NCT02642029|62903544|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
33518061|NCT02642029|62903545|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
33518062|NCT02642029|62903546|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
33518063|NCT02642029|62903547|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
33518064|NCT02642029|62903542|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
33518065|NCT02642029|62903543|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
33518066|NCT02642029|62903544|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
33518067|NCT02642029|62903545|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
33518068|NCT02642029|62903546|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
33518069|NCT02642029|62903547|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
33518070|NCT02642029|62903542|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
33518071|NCT02642029|62903543|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
33518072|NCT02642029|62903544|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
33518073|NCT02642029|62903545|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
33518074|NCT02642029|62903546|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
33518075|NCT02642029|62903547|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
33616145|NCT01573624|63017007|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
33616146|NCT01573624|63017008|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
33518076|NCT02642029|62903542|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
33518077|NCT02642029|62903543|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
33518078|NCT02642029|62903544|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
33518079|NCT02642029|62903545|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
33518080|NCT02642029|62903546|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
33616147|NCT01573624|63017009|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
33616148|NCT01573624|63017010|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
33616149|NCT01573624|63017011|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
33616150|NCT01557946|63017035|FG000|Overall Study|Adverse Event|3|||
33518081|NCT02642029|62903547|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
33518082|NCT02642029|62903542|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
33518083|NCT02642029|62903543|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
33518084|NCT02642029|62903544|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
33518085|NCT02642029|62903545|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
33518086|NCT02642029|62903546|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
33518087|NCT02642029|62903547|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
33518088|NCT03178669|62903560|FG000|Overall Study|Adverse Event|4|||
33518089|NCT03178669|62903561|FG001|Overall Study|Adverse Event|1|||
33518090|NCT03178669|62903562|FG002|Overall Study|Adverse Event|4|||
33518091|NCT03178669|62903563|FG003|Overall Study|Adverse Event|2|||
33518092|NCT03178669|62903564|FG004|Overall Study|Adverse Event|2|||
33518093|NCT03178669|62903560|FG000|Overall Study|Lack of Efficacy|0|||
33518094|NCT03178669|62903561|FG001|Overall Study|Lack of Efficacy|0|||
33518095|NCT03178669|62903562|FG002|Overall Study|Lack of Efficacy|2|||
33518096|NCT03178669|62903563|FG003|Overall Study|Lack of Efficacy|0|||
33518097|NCT03178669|62903564|FG004|Overall Study|Lack of Efficacy|1|||
33518098|NCT03178669|62903560|FG000|Overall Study|Physician Decision|0|||
33518099|NCT03178669|62903561|FG001|Overall Study|Physician Decision|0|||
33518100|NCT03178669|62903562|FG002|Overall Study|Physician Decision|0|||
33518101|NCT03178669|62903563|FG003|Overall Study|Physician Decision|0|||
33518102|NCT03178669|62903564|FG004|Overall Study|Physician Decision|1|||
33518103|NCT03178669|62903560|FG000|Overall Study|Withdrawal by Subject|1|||
33518104|NCT03178669|62903561|FG001|Overall Study|Withdrawal by Subject|0|||
33518105|NCT03178669|62903562|FG002|Overall Study|Withdrawal by Subject|1|||
33518106|NCT03178669|62903563|FG003|Overall Study|Withdrawal by Subject|1|||
33518107|NCT03178669|62903564|FG004|Overall Study|Withdrawal by Subject|0|||
33518108|NCT03178669|62903560|FG000|Overall Study|Lost to Follow-up|0|||
33518109|NCT03178669|62903561|FG001|Overall Study|Lost to Follow-up|0|||
33518110|NCT03178669|62903562|FG002|Overall Study|Lost to Follow-up|0|||
33518111|NCT03178669|62903563|FG003|Overall Study|Lost to Follow-up|1|||
33518112|NCT03178669|62903564|FG004|Overall Study|Lost to Follow-up|0|||
33518113|NCT03178201|62903576|FG000|Overall Study|Off study|5|||
33518114|NCT03021642|62903580|FG000|Washout Period (21 Days)|Adverse Event|1|||
33518115|NCT03021642|62903581|FG001|Washout Period (21 Days)|Adverse Event|1|||
33518116|NCT03021564|62903589|FG000|Overall Study|Death|84|||
33518117|NCT03021564|62903590|FG001|Overall Study|Death|466|||
33518118|NCT03021564|62903589|FG000|Overall Study|Lost to Follow-up|0|||
33518119|NCT03021564|62903590|FG001|Overall Study|Lost to Follow-up|2|||
33518120|NCT03023046|62903600|FG000|Overall Study|Withdrawal by Subject|1|||
33518121|NCT03019458|62903608|FG000|Overall Study|Death|0|||
33616151|NCT01557946|63017036|FG001|Overall Study|Adverse Event|0|||
33616152|NCT01534078|63017041|FG000|Overall Study|Death|1|||
33454717|NCT00130208|62829138|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
33454718|NCT00130208|62829139|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
33454719|NCT00130208|62829138|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
33454720|NCT00130208|62829139|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
33454721|NCT00130208|62829138|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
33454722|NCT00130208|62829139|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
33454723|NCT00130208|62829138|FG000|Maintenance Period (26 Weeks)|Other|1|||
33454724|NCT00130208|62829139|FG001|Maintenance Period (26 Weeks)|Other|1|||
33454725|NCT00130208|62829138|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
33454726|NCT00130208|62829139|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
33454727|NCT00130208|62829138|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
33454728|NCT00130208|62829139|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
33454729|NCT00130208|62829138|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
33518122|NCT03019458|62903609|FG001|Overall Study|Death|1|||
33518123|NCT02923830|62903619|FG000|Overall Study|Physician Decision|13|||
33518124|NCT02923830|62903620|FG001|Overall Study|Physician Decision|15|||
33616153|NCT01534078|63017041|FG000|Overall Study|Withdrawal by Subject|1|||
33454730|NCT00130208|62829139|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
33454731|NCT00130208|62829138|FG000|Washout Period (8 Weeks)|Other|1|||
33518125|NCT03021018|62903629|FG000|Overall Study|Adverse Event|1|||
33518126|NCT03021018|62903630|FG001|Overall Study|Adverse Event|0|||
33518127|NCT03021018|62903631|FG002|Overall Study|Adverse Event|0|||
33454732|NCT00130208|62829139|FG001|Washout Period (8 Weeks)|Other|1|||
33616154|NCT02185040|63017050|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
33616155|NCT02185040|63017051|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
33616156|NCT02185040|63017052|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
33616157|NCT02185040|63017053|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
33616158|NCT02185040|63017054|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
33616159|NCT02185040|63017055|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
33616160|NCT02185040|63017056|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
33616161|NCT02185040|63017050|FG000|Part 1 Treatment Phase|Adverse Event|1|||
33616162|NCT02185040|63017051|FG001|Part 1 Treatment Phase|Adverse Event|0|||
33616163|NCT02185040|63017052|FG002|Part 1 Treatment Phase|Adverse Event|0|||
33616164|NCT02185040|63017053|FG003|Part 1 Treatment Phase|Adverse Event|2|||
33616165|NCT02185040|63017054|FG004|Part 1 Treatment Phase|Adverse Event|3|||
33616166|NCT02185040|63017055|FG005|Part 1 Treatment Phase|Adverse Event|0|||
33616167|NCT02185040|63017056|FG006|Part 1 Treatment Phase|Adverse Event|0|||
33616168|NCT02185040|63017050|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
33616169|NCT02185040|63017051|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
33616170|NCT02185040|63017052|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
33616171|NCT02185040|63017053|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
33616172|NCT02185040|63017054|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
33616173|NCT02185040|63017055|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
33518128|NCT03021018|62903629|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
33616174|NCT02185040|63017056|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
33616175|NCT02185040|63017050|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
33616176|NCT02185040|63017051|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
33616177|NCT02185040|63017052|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
33616178|NCT02185040|63017053|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
33616179|NCT02185040|63017054|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
33616180|NCT02185040|63017055|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
33616181|NCT02185040|63017056|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
33616182|NCT02185040|63017050|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
33616183|NCT02185040|63017051|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
33616184|NCT02185040|63017052|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
33616185|NCT02185040|63017053|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
33616186|NCT02185040|63017054|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
33616187|NCT02185040|63017055|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
33616188|NCT02185040|63017056|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
33616189|NCT02185040|63017050|FG000|Active Treatment Extension Phase|Adverse Event|0|||
33616190|NCT02185040|63017051|FG001|Active Treatment Extension Phase|Adverse Event|0|||
33616191|NCT02185040|63017052|FG002|Active Treatment Extension Phase|Adverse Event|0|||
33616192|NCT02185040|63017053|FG003|Active Treatment Extension Phase|Adverse Event|0|||
33616193|NCT02185040|63017054|FG004|Active Treatment Extension Phase|Adverse Event|0|||
33616194|NCT02185040|63017055|FG005|Active Treatment Extension Phase|Adverse Event|1|||
33616195|NCT02185040|63017056|FG006|Active Treatment Extension Phase|Adverse Event|4|||
33616196|NCT02185040|63017050|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
33616197|NCT02185040|63017051|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
33454733|NCT00253370|62829145|FG000|Overall Study|Adverse Event|18|||
33454734|NCT00253370|62829145|FG000|Overall Study|Disease progression|13|||
33454735|NCT00253370|62829145|FG000|Overall Study|Death|2|||
33454736|NCT00253370|62829145|FG000|Overall Study|Withdrawal by Subject|6|||
33454737|NCT00253370|62829145|FG000|Overall Study|Non-protocol therapy|1|||
33454738|NCT00253370|62829145|FG000|Overall Study|Physician Decision|1|||
33454739|NCT00253370|62829145|FG000|Overall Study|Protocol Violation|1|||
33454740|NCT00253370|62829145|FG000|Overall Study|Abdominal pain due to disease|1|||
33454741|NCT00140426|62829152|FG000|Overall Study|Withdrawal by Subject|0|||
33454742|NCT00140426|62829153|FG001|Overall Study|Withdrawal by Subject|3|||
33454743|NCT00121134|62829168|FG000|Overall Study|Progression of Disease|5|||
33454744|NCT00121134|62829169|FG001|Overall Study|Progression of Disease|3|||
33518129|NCT03021018|62903630|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
33518130|NCT03021018|62903631|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
33518131|NCT02509507|62903648|FG000|Overall Study|Death|21|||
33616198|NCT02185040|63017052|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
33616199|NCT02185040|63017053|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
33616200|NCT02185040|63017054|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
33616201|NCT02185040|63017055|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
33616202|NCT02185040|63017056|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
33616203|NCT02185040|63017050|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
33616204|NCT02185040|63017051|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
33616205|NCT02185040|63017052|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
33616206|NCT02185040|63017053|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
33616207|NCT02185040|63017054|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
33616208|NCT02185040|63017055|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
33616209|NCT02185040|63017056|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
33616210|NCT02161406|63017078|FG000|Overall Study|Death|2|||
33616211|NCT02161406|63017079|FG001|Overall Study|Death|1|||
33616212|NCT02161406|63017078|FG000|Overall Study|Lost to Follow-up|2|||
33616213|NCT02161406|63017079|FG001|Overall Study|Lost to Follow-up|1|||
33616214|NCT02161406|63017078|FG000|Overall Study|Withdrawal by Subject|2|||
33616215|NCT02161406|63017079|FG001|Overall Study|Withdrawal by Subject|4|||
33616216|NCT02161406|63017078|FG000|Overall Study|investigator withdrew subject|3|||
33616217|NCT02161406|63017079|FG001|Overall Study|investigator withdrew subject|1|||
33616218|NCT02161406|63017078|FG000|Overall Study|Lack of Efficacy|1|||
33616219|NCT02161406|63017079|FG001|Overall Study|Lack of Efficacy|1|||
33616220|NCT02161406|63017078|FG000|Overall Study|relocation|0|||
33616221|NCT02161406|63017079|FG001|Overall Study|relocation|1|||
33616222|NCT02161016|63017085|FG000|Overall Study|withdrawn by IRB|1|||
33616223|NCT01573000|63017091|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
33616224|NCT01573000|63017092|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
33616225|NCT01573000|63017091|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
33616226|NCT01573000|63017092|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
33616227|NCT01573000|63017091|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
33616228|NCT01573000|63017092|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
33616229|NCT01573000|63017091|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
33616230|NCT01573000|63017092|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
33616231|NCT01573000|63017091|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
33616232|NCT01573000|63017092|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
33616233|NCT01573000|63017091|FG000|Crossover Phase|Lack of Efficacy|0|||
33616234|NCT01573000|63017092|FG001|Crossover Phase|Lack of Efficacy|13|||
33616235|NCT01573000|63017091|FG000|Crossover Phase|Lost to Follow-up|0|||
33616236|NCT01573000|63017092|FG001|Crossover Phase|Lost to Follow-up|2|||
33616237|NCT01573000|63017091|FG000|Crossover Phase|Death|0|||
33616238|NCT01573000|63017092|FG001|Crossover Phase|Death|3|||
33616239|NCT01573000|63017091|FG000|Long-Term Follow-Up|Death|3|||
33616240|NCT01573000|63017092|FG001|Long-Term Follow-Up|Death|0|||
33616241|NCT01573000|63017091|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
33616242|NCT01573000|63017092|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
33616243|NCT01572922|63017102|FG000|Overall Study|Adverse Event|1|||
33616244|NCT01572922|63017102|FG000|Overall Study|Protocol Violation|1|||
33616245|NCT01572922|63017102|FG000|Overall Study|Death|1|||
33616246|NCT01572844|63017111|FG000|Overall Study|Physician Decision|1|||
33616247|NCT01572844|63017112|FG001|Overall Study|Physician Decision|1|||
33616248|NCT01557400|63017121|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
33616249|NCT01557400|63017121|FG000|Overall Study|Adverse Event|3|||
33616250|NCT01557400|63017121|FG000|Overall Study|Lost to Follow-up|5|||
33616251|NCT01557400|63017121|FG000|Overall Study|Withdrawal by Subject|9|||
33616252|NCT01533922|63017125|FG000|Overall Study|Adverse Event|5|||
33616253|NCT01533922|63017126|FG001|Overall Study|Adverse Event|8|||
33616254|NCT01533922|63017127|FG002|Overall Study|Adverse Event|6|||
33518132|NCT02509507|62903649|FG001|Overall Study|Death|3|||
33518133|NCT02509507|62903650|FG002|Overall Study|Death|22|||
33518134|NCT02509507|62903651|FG003|Overall Study|Death|13|||
33518135|NCT02509507|62903652|FG004|Overall Study|Death|6|||
33518136|NCT02509507|62903653|FG005|Overall Study|Death|9|||
33518137|NCT02509507|62903654|FG006|Overall Study|Death|4|||
33518138|NCT02509507|62903655|FG007|Overall Study|Death|3|||
33518139|NCT02509507|62903656|FG008|Overall Study|Death|7|||
33518140|NCT02509507|62903648|FG000|Overall Study|Lost to Follow-up|0|||
33518141|NCT02509507|62903649|FG001|Overall Study|Lost to Follow-up|1|||
33518142|NCT02509507|62903650|FG002|Overall Study|Lost to Follow-up|0|||
33518143|NCT02509507|62903651|FG003|Overall Study|Lost to Follow-up|0|||
33518144|NCT02509507|62903652|FG004|Overall Study|Lost to Follow-up|0|||
33518145|NCT02509507|62903653|FG005|Overall Study|Lost to Follow-up|1|||
33518146|NCT02509507|62903654|FG006|Overall Study|Lost to Follow-up|0|||
33518147|NCT02509507|62903655|FG007|Overall Study|Lost to Follow-up|0|||
33518148|NCT02509507|62903656|FG008|Overall Study|Lost to Follow-up|0|||
33518149|NCT02509507|62903648|FG000|Overall Study|Withdrawal by Subject|2|||
33518150|NCT02509507|62903649|FG001|Overall Study|Withdrawal by Subject|0|||
33518151|NCT02509507|62903650|FG002|Overall Study|Withdrawal by Subject|1|||
33518152|NCT02509507|62903651|FG003|Overall Study|Withdrawal by Subject|4|||
33518153|NCT02509507|62903652|FG004|Overall Study|Withdrawal by Subject|0|||
33518154|NCT02509507|62903653|FG005|Overall Study|Withdrawal by Subject|3|||
33518155|NCT02509507|62903654|FG006|Overall Study|Withdrawal by Subject|3|||
33518156|NCT02509507|62903655|FG007|Overall Study|Withdrawal by Subject|0|||
33518157|NCT02509507|62903656|FG008|Overall Study|Withdrawal by Subject|0|||
33518158|NCT02509507|62903648|FG000|Overall Study|Continuing Study|0|||
33518159|NCT02509507|62903649|FG001|Overall Study|Continuing Study|1|||
33518160|NCT02509507|62903650|FG002|Overall Study|Continuing Study|1|||
33518161|NCT02509507|62903651|FG003|Overall Study|Continuing Study|5|||
33518162|NCT02509507|62903652|FG004|Overall Study|Continuing Study|4|||
33518163|NCT02509507|62903653|FG005|Overall Study|Continuing Study|5|||
33518164|NCT02509507|62903654|FG006|Overall Study|Continuing Study|3|||
33518165|NCT02509507|62903655|FG007|Overall Study|Continuing Study|2|||
33518166|NCT02509507|62903656|FG008|Overall Study|Continuing Study|3|||
33454745|NCT00121134|62829170|FG002|Overall Study|Progression of Disease|4|||
33454746|NCT00121134|62829171|FG003|Overall Study|Progression of Disease|2|||
33454747|NCT00121134|62829168|FG000|Overall Study|Toxicity|4|||
33454748|NCT00121134|62829169|FG001|Overall Study|Toxicity|7|||
33454749|NCT00121134|62829170|FG002|Overall Study|Toxicity|13|||
33454750|NCT00121134|62829171|FG003|Overall Study|Toxicity|5|||
33454751|NCT00121134|62829168|FG000|Overall Study|Physician Decision|6|||
33454752|NCT00121134|62829169|FG001|Overall Study|Physician Decision|4|||
33454753|NCT00121134|62829170|FG002|Overall Study|Physician Decision|4|||
33454754|NCT00121134|62829171|FG003|Overall Study|Physician Decision|1|||
33454755|NCT00121134|62829168|FG000|Overall Study|Treatment Delay|1|||
33454756|NCT00121134|62829169|FG001|Overall Study|Treatment Delay|0|||
33454757|NCT00121134|62829170|FG002|Overall Study|Treatment Delay|0|||
33454758|NCT00121134|62829171|FG003|Overall Study|Treatment Delay|0|||
33454759|NCT00121134|62829168|FG000|Overall Study|Intercurrent Illness|0|||
33454760|NCT00121134|62829169|FG001|Overall Study|Intercurrent Illness|0|||
33454761|NCT00121134|62829170|FG002|Overall Study|Intercurrent Illness|0|||
33454762|NCT00121134|62829171|FG003|Overall Study|Intercurrent Illness|1|||
33454763|NCT00121134|62829168|FG000|Overall Study|Patient Personal Reasons|0|||
33454764|NCT00121134|62829169|FG001|Overall Study|Patient Personal Reasons|1|||
33454765|NCT00121134|62829170|FG002|Overall Study|Patient Personal Reasons|0|||
33454766|NCT00121134|62829171|FG003|Overall Study|Patient Personal Reasons|0|||
33454767|NCT02657434|62829183|FG000|Overall Study|On-Going in Study|77|||
33454768|NCT02657434|62829184|FG001|Overall Study|On-Going in Study|91|||
33454769|NCT02657434|62829183|FG000|Overall Study|Death|177|||
33454770|NCT02657434|62829184|FG001|Overall Study|Death|183|||
33454771|NCT02657434|62829183|FG000|Overall Study|Lost to Follow-up|2|||
33454772|NCT02657434|62829184|FG001|Overall Study|Lost to Follow-up|2|||
33454773|NCT02657434|62829183|FG000|Overall Study|Randomization by Error|2|||
33454774|NCT02657434|62829184|FG001|Overall Study|Randomization by Error|0|||
33454775|NCT02657434|62829183|FG000|Overall Study|Withdrawal by Subject|27|||
33454776|NCT02657434|62829184|FG001|Overall Study|Withdrawal by Subject|16|||
33454777|NCT02657434|62829183|FG000|Overall Study|Protocol Violation|1|||
33454778|NCT02657434|62829184|FG001|Overall Study|Protocol Violation|0|||
33454779|NCT00119262|62829193|FG000|Overall Study|Lack of Efficacy|0|||
33454780|NCT00119262|62829194|FG001|Overall Study|Lack of Efficacy|3|||
33454781|NCT00119262|62829193|FG000|Overall Study|Withdrawal by Subject|12|||
33454782|NCT00119262|62829194|FG001|Overall Study|Withdrawal by Subject|11|||
33454783|NCT00119262|62829193|FG000|Overall Study|Adverse Event|33|||
33454784|NCT00119262|62829194|FG001|Overall Study|Adverse Event|35|||
33454785|NCT00119262|62829193|FG000|Overall Study|other disease|0|||
33454786|NCT00119262|62829194|FG001|Overall Study|other disease|2|||
33454787|NCT00119262|62829193|FG000|Overall Study|ineligble|1|||
33454788|NCT00119262|62829194|FG001|Overall Study|ineligble|2|||
33454789|NCT00119262|62829193|FG000|Overall Study|others|0|||
33454790|NCT00119262|62829194|FG001|Overall Study|others|5|||
33454791|NCT03703882|62829202|FG000|Overall Study|Adverse Event|1|||
33454792|NCT03703882|62829203|FG001|Overall Study|Adverse Event|0|||
33454793|NCT03703882|62829202|FG000|Overall Study|Lost to Follow-up|0|||
33454794|NCT03703882|62829203|FG001|Overall Study|Lost to Follow-up|2|||
33454795|NCT03703882|62829202|FG000|Overall Study|Non-compliance with study drug|0|||
33454796|NCT03703882|62829203|FG001|Overall Study|Non-compliance with study drug|1|||
33454797|NCT03703882|62829202|FG000|Overall Study|Physician Decision|0|||
33454798|NCT03703882|62829203|FG001|Overall Study|Physician Decision|1|||
33454799|NCT03703882|62829202|FG000|Overall Study|Progressive disease|1|||
33454800|NCT03703882|62829203|FG001|Overall Study|Progressive disease|0|||
33454801|NCT03703882|62829202|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33454802|NCT03703882|62829203|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33454803|NCT03703882|62829202|FG000|Overall Study|Starting another treatment|0|||
33518167|NCT03176407|62903681|FG000|Overall Study|Protocol Violation|1|||
33518168|NCT03176407|62903681|FG000|Overall Study|human failure|1|||
33518169|NCT03176407|62903681|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
33518170|NCT03175549|62903689|FG000|Overall Study|Lost to Follow-up|2|||
33518171|NCT03175549|62903690|FG001|Overall Study|Lost to Follow-up|2|||
33518172|NCT03175549|62903689|FG000|Overall Study|Medication non-compliance|2|||
33454804|NCT03703882|62829203|FG001|Overall Study|Starting another treatment|1|||
33454805|NCT03703882|62829202|FG000|Overall Study|noncompliance with study procedures|0|||
33454806|NCT03703882|62829203|FG001|Overall Study|noncompliance with study procedures|1|||
33454807|NCT00131664|62829212|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
33454808|NCT00131664|62829213|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
33454809|NCT00131664|62829214|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
33518173|NCT03175549|62903690|FG001|Overall Study|Medication non-compliance|2|||
33518174|NCT03174925|62903698|FG000|Overall Study|Elastographic images not retrievable|2|||
33518175|NCT03174925|62903698|FG000|Overall Study|Elastography image not interpretable|1|||
33518176|NCT02924688|62903708|FG000|Overall Study|Adverse Event|9|||
33518177|NCT02924688|62903709|FG001|Overall Study|Adverse Event|3|||
33518178|NCT02924688|62903710|FG002|Overall Study|Adverse Event|2|||
33518179|NCT02924688|62903711|FG003|Overall Study|Adverse Event|2|||
33518180|NCT02924688|62903712|FG004|Overall Study|Adverse Event|3|||
33454810|NCT00131664|62829215|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
33454811|NCT00131664|62829216|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
33454812|NCT00131664|62829217|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
33454813|NCT00131664|62829212|FG000|First Period (First 6 Months)|Death|0|||
33454814|NCT00131664|62829213|FG001|First Period (First 6 Months)|Death|1|||
33454815|NCT00131664|62829214|FG002|First Period (First 6 Months)|Death|0|||
33518181|NCT02924688|62903713|FG005|Overall Study|Adverse Event|2|||
33518182|NCT02924688|62903708|FG000|Overall Study|Lack of Efficacy|2|||
33518183|NCT02924688|62903709|FG001|Overall Study|Lack of Efficacy|3|||
33518184|NCT02924688|62903710|FG002|Overall Study|Lack of Efficacy|4|||
33518185|NCT02924688|62903711|FG003|Overall Study|Lack of Efficacy|2|||
33518186|NCT02924688|62903712|FG004|Overall Study|Lack of Efficacy|1|||
33616255|NCT01533922|63017128|FG003|Overall Study|Adverse Event|3|||
33616256|NCT01533922|63017129|FG004|Overall Study|Adverse Event|4|||
33616257|NCT01533922|63017125|FG000|Overall Study|Lack of Efficacy|0|||
33616258|NCT01533922|63017126|FG001|Overall Study|Lack of Efficacy|0|||
33616259|NCT01533922|63017127|FG002|Overall Study|Lack of Efficacy|1|||
33616260|NCT01533922|63017128|FG003|Overall Study|Lack of Efficacy|0|||
33616261|NCT01533922|63017129|FG004|Overall Study|Lack of Efficacy|0|||
33616262|NCT01533922|63017125|FG000|Overall Study|Protocol Violation|0|||
33616263|NCT01533922|63017126|FG001|Overall Study|Protocol Violation|3|||
33616264|NCT01533922|63017127|FG002|Overall Study|Protocol Violation|0|||
33616265|NCT01533922|63017128|FG003|Overall Study|Protocol Violation|0|||
33616266|NCT01533922|63017129|FG004|Overall Study|Protocol Violation|1|||
33616267|NCT01533922|63017125|FG000|Overall Study|Withdrawal by Subject|3|||
33616268|NCT01533922|63017126|FG001|Overall Study|Withdrawal by Subject|1|||
33616269|NCT01533922|63017127|FG002|Overall Study|Withdrawal by Subject|2|||
33616270|NCT01533922|63017128|FG003|Overall Study|Withdrawal by Subject|2|||
33616271|NCT01533922|63017129|FG004|Overall Study|Withdrawal by Subject|1|||
33616272|NCT01533922|63017125|FG000|Overall Study|Other reason not defined above|2|||
33616273|NCT01533922|63017126|FG001|Overall Study|Other reason not defined above|0|||
33518187|NCT02924688|62903713|FG005|Overall Study|Lack of Efficacy|1|||
33518188|NCT02924688|62903708|FG000|Overall Study|Protocol Violation|3|||
33518189|NCT02924688|62903709|FG001|Overall Study|Protocol Violation|7|||
33518190|NCT02924688|62903710|FG002|Overall Study|Protocol Violation|5|||
33518191|NCT02924688|62903711|FG003|Overall Study|Protocol Violation|6|||
33518192|NCT02924688|62903712|FG004|Overall Study|Protocol Violation|2|||
33518193|NCT02924688|62903713|FG005|Overall Study|Protocol Violation|2|||
33518194|NCT02924688|62903708|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
33518195|NCT02924688|62903709|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
33518196|NCT02924688|62903710|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
33518197|NCT02924688|62903711|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
33518198|NCT02924688|62903712|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
33518199|NCT02924688|62903713|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
33518200|NCT02924688|62903708|FG000|Overall Study|Lost to Follow-up|2|||
33518201|NCT02924688|62903709|FG001|Overall Study|Lost to Follow-up|4|||
33518202|NCT02924688|62903710|FG002|Overall Study|Lost to Follow-up|2|||
33518203|NCT02924688|62903711|FG003|Overall Study|Lost to Follow-up|4|||
33518204|NCT02924688|62903712|FG004|Overall Study|Lost to Follow-up|2|||
33518205|NCT02924688|62903713|FG005|Overall Study|Lost to Follow-up|4|||
33518206|NCT02924688|62903708|FG000|Overall Study|Physician Decision|2|||
33518207|NCT02924688|62903709|FG001|Overall Study|Physician Decision|1|||
33518208|NCT02924688|62903710|FG002|Overall Study|Physician Decision|0|||
33518209|NCT02924688|62903711|FG003|Overall Study|Physician Decision|1|||
33518210|NCT02924688|62903712|FG004|Overall Study|Physician Decision|1|||
33518211|NCT02924688|62903713|FG005|Overall Study|Physician Decision|1|||
33518212|NCT02924688|62903708|FG000|Overall Study|Withdrawal by Subject|14|||
33518213|NCT02924688|62903709|FG001|Overall Study|Withdrawal by Subject|13|||
33518214|NCT02924688|62903710|FG002|Overall Study|Withdrawal by Subject|9|||
33518215|NCT02924688|62903711|FG003|Overall Study|Withdrawal by Subject|12|||
33518216|NCT02924688|62903712|FG004|Overall Study|Withdrawal by Subject|13|||
33518217|NCT02924688|62903713|FG005|Overall Study|Withdrawal by Subject|14|||
33616274|NCT01533922|63017127|FG002|Overall Study|Other reason not defined above|1|||
33616275|NCT01533922|63017128|FG003|Overall Study|Other reason not defined above|0|||
33616276|NCT01533922|63017129|FG004|Overall Study|Other reason not defined above|0|||
33616277|NCT01533688|63017144|FG000|Overall Study|Withdrawal by Subject|5|||
33324821|NCT01123356|62701390|FG000|Overall Study|Withdrawal by Subject|1|||
33616278|NCT01533688|63017145|FG001|Overall Study|Withdrawal by Subject|4|||
33616279|NCT01533688|63017146|FG002|Overall Study|Withdrawal by Subject|3|||
33454816|NCT00131664|62829215|FG003|First Period (First 6 Months)|Death|0|||
33454817|NCT00131664|62829216|FG004|First Period (First 6 Months)|Death|0|||
33454818|NCT00131664|62829217|FG005|First Period (First 6 Months)|Death|0|||
33454819|NCT00131664|62829212|FG000|First Period (First 6 Months)|Protocol Violation|2|||
33454820|NCT00131664|62829213|FG001|First Period (First 6 Months)|Protocol Violation|2|||
33454821|NCT00131664|62829214|FG002|First Period (First 6 Months)|Protocol Violation|1|||
33454822|NCT00131664|62829215|FG003|First Period (First 6 Months)|Protocol Violation|0|||
33454823|NCT00131664|62829216|FG004|First Period (First 6 Months)|Protocol Violation|0|||
33454824|NCT00131664|62829217|FG005|First Period (First 6 Months)|Protocol Violation|0|||
33454825|NCT00131664|62829212|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
33518218|NCT03011892|62903736|FG000|Double Blind (DB) Period|Adverse Event|0|||
33518219|NCT03011892|62903737|FG001|Double Blind (DB) Period|Adverse Event|1|||
33616280|NCT01533688|63017144|FG000|Overall Study|Medically unstable|1|||
33616281|NCT01533688|63017145|FG001|Overall Study|Medically unstable|3|||
33616282|NCT01533688|63017146|FG002|Overall Study|Medically unstable|3|||
33616283|NCT01533688|63017144|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
33616284|NCT01533688|63017145|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
33518220|NCT03011892|62903738|FG002|Double Blind (DB) Period|Adverse Event|1|||
33518221|NCT03011892|62903739|FG003|Double Blind (DB) Period|Adverse Event|0|||
33518222|NCT03011892|62903740|FG004|Double Blind (DB) Period|Adverse Event|0|||
33518223|NCT03011892|62903741|FG005|Double Blind (DB) Period|Adverse Event|0|||
33518224|NCT03011892|62903742|FG006|Double Blind (DB) Period|Adverse Event|0|||
33518225|NCT03011892|62903743|FG007|Double Blind (DB) Period|Adverse Event|0|||
33518226|NCT03011892|62903744|FG008|Double Blind (DB) Period|Adverse Event|0|||
33518227|NCT03011892|62903745|FG009|Double Blind (DB) Period|Adverse Event|0|||
33518228|NCT03011892|62903746|FG010|Double Blind (DB) Period|Adverse Event|0|||
33518229|NCT03011892|62903747|FG011|Double Blind (DB) Period|Adverse Event|0|||
33616285|NCT01533688|63017146|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
33616286|NCT01532986|63017158|FG000|Overall Study|Death|9|||
33616287|NCT01532986|63017159|FG001|Overall Study|Death|9|||
33616288|NCT01532986|63017158|FG000|Overall Study|Withdrawal by Subject|7|||
33616289|NCT01532986|63017159|FG001|Overall Study|Withdrawal by Subject|10|||
33616290|NCT01532986|63017158|FG000|Overall Study|Physician Decision|7|||
33616291|NCT01532986|63017159|FG001|Overall Study|Physician Decision|5|||
33616292|NCT01532908|63017168|FG000|Overall Study|Not Transplanted|1|||
33616293|NCT01532908|63017169|FG001|Overall Study|Not Transplanted|0|||
33616294|NCT02160782|63017175|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
33616295|NCT02160782|63017176|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
33616296|NCT02160782|63017177|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
33616297|NCT02160782|63017178|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
33616298|NCT02160782|63017179|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
33454826|NCT00131664|62829213|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
33454827|NCT00131664|62829214|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
33454828|NCT00131664|62829215|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
33454829|NCT00131664|62829216|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
33454830|NCT00131664|62829217|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
33454831|NCT00131664|62829212|FG000|First Period (First 6 Months)|Adverse Event|9|||
33454832|NCT00131664|62829213|FG001|First Period (First 6 Months)|Adverse Event|4|||
33454833|NCT00131664|62829214|FG002|First Period (First 6 Months)|Adverse Event|5|||
33454834|NCT00131664|62829215|FG003|First Period (First 6 Months)|Adverse Event|0|||
33454835|NCT00131664|62829216|FG004|First Period (First 6 Months)|Adverse Event|0|||
33454836|NCT00131664|62829217|FG005|First Period (First 6 Months)|Adverse Event|0|||
33454837|NCT00131664|62829212|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
33454838|NCT00131664|62829213|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
33454839|NCT00131664|62829214|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
33454840|NCT00131664|62829215|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
33454841|NCT00131664|62829216|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
33454842|NCT00131664|62829217|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
33454843|NCT00131664|62829212|FG000|First Period (First 6 Months)|Administrative reasons|2|||
33454844|NCT00131664|62829213|FG001|First Period (First 6 Months)|Administrative reasons|0|||
33454845|NCT00131664|62829214|FG002|First Period (First 6 Months)|Administrative reasons|5|||
33454846|NCT00131664|62829215|FG003|First Period (First 6 Months)|Administrative reasons|0|||
33454847|NCT00131664|62829216|FG004|First Period (First 6 Months)|Administrative reasons|0|||
33454848|NCT00131664|62829217|FG005|First Period (First 6 Months)|Administrative reasons|0|||
33616299|NCT02160782|63017175|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
33616300|NCT02160782|63017176|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
33616301|NCT02160782|63017177|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
33616302|NCT02160782|63017178|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
33616303|NCT02160782|63017179|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
33518230|NCT03011892|62903736|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
33518231|NCT03011892|62903737|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
33518232|NCT03011892|62903738|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
33518233|NCT03011892|62903739|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
33518234|NCT03011892|62903740|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
33518235|NCT03011892|62903741|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
33518236|NCT03011892|62903742|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
33518237|NCT03011892|62903743|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
33518238|NCT03011892|62903744|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
33518239|NCT03011892|62903745|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
33518240|NCT03011892|62903746|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
33518241|NCT03011892|62903747|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
33518242|NCT03011892|62903736|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
33518243|NCT03011892|62903737|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
33518244|NCT03011892|62903738|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
33518245|NCT03011892|62903739|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
33518246|NCT03011892|62903740|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
33518247|NCT03011892|62903741|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
33518248|NCT03011892|62903742|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
33518249|NCT03011892|62903743|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
33518250|NCT03011892|62903744|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
33518251|NCT03011892|62903745|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
33518252|NCT03011892|62903746|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
33518253|NCT03011892|62903747|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
33518254|NCT03011892|62903736|FG000|Double Blind (DB) Period|Other|1|||
33518255|NCT03011892|62903737|FG001|Double Blind (DB) Period|Other|1|||
33518256|NCT03011892|62903738|FG002|Double Blind (DB) Period|Other|1|||
33518257|NCT03011892|62903739|FG003|Double Blind (DB) Period|Other|0|||
33518258|NCT03011892|62903740|FG004|Double Blind (DB) Period|Other|1|||
33518259|NCT03011892|62903741|FG005|Double Blind (DB) Period|Other|0|||
33616304|NCT02160782|63017175|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
33454849|NCT00131664|62829212|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
33454850|NCT00131664|62829213|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
33454851|NCT00131664|62829214|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
33454852|NCT00131664|62829215|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
33454853|NCT00131664|62829216|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
33454854|NCT00131664|62829217|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
33454855|NCT00131664|62829212|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
33454856|NCT00131664|62829213|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
33454857|NCT00131664|62829214|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
33518260|NCT03011892|62903742|FG006|Double Blind (DB) Period|Other|0|||
33518261|NCT03011892|62903743|FG007|Double Blind (DB) Period|Other|0|||
33518262|NCT03011892|62903744|FG008|Double Blind (DB) Period|Other|0|||
33518263|NCT03011892|62903745|FG009|Double Blind (DB) Period|Other|0|||
33518264|NCT03011892|62903746|FG010|Double Blind (DB) Period|Other|0|||
33518265|NCT03011892|62903747|FG011|Double Blind (DB) Period|Other|0|||
33518266|NCT03011892|62903736|FG000|Double Blind (DB) Period|Physician Decision|1|||
33518267|NCT03011892|62903737|FG001|Double Blind (DB) Period|Physician Decision|0|||
33518268|NCT03011892|62903738|FG002|Double Blind (DB) Period|Physician Decision|1|||
33518269|NCT03011892|62903739|FG003|Double Blind (DB) Period|Physician Decision|0|||
33518270|NCT03011892|62903740|FG004|Double Blind (DB) Period|Physician Decision|0|||
33518271|NCT03011892|62903741|FG005|Double Blind (DB) Period|Physician Decision|0|||
33518272|NCT03011892|62903742|FG006|Double Blind (DB) Period|Physician Decision|0|||
33651425|NCT01746901|63062908|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33454858|NCT00131664|62829215|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
33454859|NCT00131664|62829216|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
33454860|NCT00131664|62829217|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
33454861|NCT00131664|62829212|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
33454862|NCT00131664|62829213|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
33454863|NCT00131664|62829214|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
33454864|NCT00131664|62829215|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
33454865|NCT00131664|62829216|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
33454866|NCT00131664|62829217|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
33454867|NCT00131664|62829212|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
33454868|NCT00131664|62829213|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
33454869|NCT00131664|62829214|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
33454870|NCT00131664|62829215|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
33454871|NCT00131664|62829216|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
33454872|NCT00131664|62829217|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
33454873|NCT00131664|62829212|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
33454874|NCT00131664|62829213|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
33454875|NCT00131664|62829214|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
33454876|NCT00131664|62829215|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
33454877|NCT00131664|62829216|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
33454878|NCT00131664|62829217|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
33454879|NCT00131664|62829212|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
33454880|NCT00131664|62829213|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
33454881|NCT00131664|62829214|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
33454882|NCT00131664|62829215|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
33454883|NCT00131664|62829216|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
33454884|NCT00131664|62829217|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
33454885|NCT00131508|62829230|FG000|Overall Study|Disease progression|0|||
33454886|NCT00131508|62829231|FG001|Overall Study|Disease progression|2|||
33454887|NCT00131508|62829230|FG000|Overall Study|Non-Compliance|2|||
33454888|NCT00131508|62829231|FG001|Overall Study|Non-Compliance|4|||
33454889|NCT00131508|62829230|FG000|Overall Study|Withdrawal by Subject|1|||
33454890|NCT00131508|62829231|FG001|Overall Study|Withdrawal by Subject|2|||
33454891|NCT05050318|62829240|FG000|Overall Study|Protocol Deviation|1|||
33454892|NCT05050318|62829241|FG001|Overall Study|Protocol Deviation|0|||
33454893|NCT05050318|62829242|FG002|Overall Study|Protocol Deviation|0|||
33454894|NCT03699124|62829253|FG000|Overall Study|Adverse Event|6|||
33454895|NCT03699124|62829254|FG001|Overall Study|Adverse Event|5|||
33454896|NCT03699124|62829255|FG002|Overall Study|Adverse Event|2|||
33454897|NCT03699124|62829253|FG000|Overall Study|Death|0|||
33454898|NCT03699124|62829254|FG001|Overall Study|Death|2|||
33454899|NCT03699124|62829255|FG002|Overall Study|Death|0|||
33454900|NCT03699124|62829253|FG000|Overall Study|Lost to Follow-up|20|||
33454901|NCT03699124|62829254|FG001|Overall Study|Lost to Follow-up|16|||
33454902|NCT03699124|62829255|FG002|Overall Study|Lost to Follow-up|15|||
33454903|NCT03699124|62829253|FG000|Overall Study|Protocol Violation|1|||
33454904|NCT03699124|62829254|FG001|Overall Study|Protocol Violation|0|||
33454905|NCT03699124|62829255|FG002|Overall Study|Protocol Violation|0|||
33454906|NCT03699124|62829253|FG000|Overall Study|Withdrawal by Subject|13|||
33454907|NCT03699124|62829254|FG001|Overall Study|Withdrawal by Subject|14|||
33454908|NCT03699124|62829255|FG002|Overall Study|Withdrawal by Subject|13|||
33454909|NCT03699124|62829253|FG000|Overall Study|Other reasons|5|||
33454910|NCT03699124|62829254|FG001|Overall Study|Other reasons|3|||
33518273|NCT03011892|62903743|FG007|Double Blind (DB) Period|Physician Decision|0|||
33454911|NCT03699124|62829255|FG002|Overall Study|Other reasons|10|||
33454912|NCT05002972|62829263|FG000|Overall Study|Withdrawal by Subject|2|||
33454913|NCT04651114|62829267|FG000|Overall Study|Withdrawal by Subject|8|||
33454914|NCT04980040|62829271|FG000|Overall Study|Violated the Inclusion Criteria|260|||
33454915|NCT04980040|62829271|FG000|Overall Study|Violated the Administration & Dosage|225|||
33454916|NCT04980040|62829271|FG000|Overall Study|Lost to Safety-Follow-up|4|||
33518274|NCT03011892|62903744|FG008|Double Blind (DB) Period|Physician Decision|0|||
33518275|NCT03011892|62903745|FG009|Double Blind (DB) Period|Physician Decision|0|||
33518276|NCT03011892|62903746|FG010|Double Blind (DB) Period|Physician Decision|0|||
33518277|NCT03011892|62903747|FG011|Double Blind (DB) Period|Physician Decision|0|||
33518278|NCT03011892|62903736|FG000|Double Blind (DB) Period|Pregnancy|0|||
33518279|NCT03011892|62903737|FG001|Double Blind (DB) Period|Pregnancy|0|||
33518280|NCT03011892|62903738|FG002|Double Blind (DB) Period|Pregnancy|0|||
33518281|NCT03011892|62903739|FG003|Double Blind (DB) Period|Pregnancy|0|||
33518282|NCT03011892|62903740|FG004|Double Blind (DB) Period|Pregnancy|1|||
33518283|NCT03011892|62903741|FG005|Double Blind (DB) Period|Pregnancy|0|||
33518284|NCT03011892|62903742|FG006|Double Blind (DB) Period|Pregnancy|0|||
33518285|NCT03011892|62903743|FG007|Double Blind (DB) Period|Pregnancy|0|||
33518286|NCT03011892|62903744|FG008|Double Blind (DB) Period|Pregnancy|0|||
33616305|NCT02160782|63017176|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
33616306|NCT02160782|63017177|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
33616307|NCT02160782|63017178|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
33616308|NCT02160782|63017179|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
33616309|NCT02160782|63017175|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
33616310|NCT02160782|63017176|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
33616311|NCT02160782|63017177|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
33616312|NCT02160782|63017178|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
33616313|NCT02160782|63017179|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
33518287|NCT03011892|62903745|FG009|Double Blind (DB) Period|Pregnancy|0|||
33518288|NCT03011892|62903746|FG010|Double Blind (DB) Period|Pregnancy|0|||
33518289|NCT03011892|62903747|FG011|Double Blind (DB) Period|Pregnancy|0|||
33518290|NCT03011892|62903736|FG000|Double Blind (DB) Period|Protocol Violation|1|||
33518291|NCT03011892|62903737|FG001|Double Blind (DB) Period|Protocol Violation|0|||
33518292|NCT03011892|62903738|FG002|Double Blind (DB) Period|Protocol Violation|0|||
33518293|NCT03011892|62903739|FG003|Double Blind (DB) Period|Protocol Violation|0|||
33518294|NCT03011892|62903740|FG004|Double Blind (DB) Period|Protocol Violation|0|||
33518295|NCT03011892|62903741|FG005|Double Blind (DB) Period|Protocol Violation|0|||
33518296|NCT03011892|62903742|FG006|Double Blind (DB) Period|Protocol Violation|0|||
33518297|NCT03011892|62903743|FG007|Double Blind (DB) Period|Protocol Violation|0|||
33518298|NCT03011892|62903744|FG008|Double Blind (DB) Period|Protocol Violation|0|||
33518299|NCT03011892|62903745|FG009|Double Blind (DB) Period|Protocol Violation|0|||
33518300|NCT03011892|62903746|FG010|Double Blind (DB) Period|Protocol Violation|0|||
33518301|NCT03011892|62903747|FG011|Double Blind (DB) Period|Protocol Violation|0|||
33518302|NCT03011892|62903736|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
33518303|NCT03011892|62903737|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
33518304|NCT03011892|62903738|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
33518305|NCT03011892|62903739|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
33518306|NCT03011892|62903740|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
33518307|NCT03011892|62903741|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
33518308|NCT03011892|62903742|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
33518309|NCT03011892|62903743|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
33616314|NCT02160782|63017175|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
33616315|NCT02160782|63017176|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
33616316|NCT02160782|63017177|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
33616317|NCT02160782|63017178|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
33616318|NCT02160782|63017179|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
33616319|NCT02160782|63017175|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
33616320|NCT02160782|63017176|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
33616321|NCT02160782|63017177|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
33616322|NCT02160782|63017178|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
33616323|NCT02160782|63017179|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
33616324|NCT02160782|63017175|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
33616325|NCT02160782|63017176|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
33616326|NCT02160782|63017177|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
33616327|NCT02160782|63017178|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
33616328|NCT02160782|63017179|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
33616329|NCT02160626|63017206|FG000|Overall Study|Adverse Event|1|||
33616330|NCT02160626|63017207|FG001|Overall Study|Adverse Event|0|||
33616331|NCT02160626|63017208|FG002|Overall Study|Adverse Event|0|||
33616332|NCT02160626|63017206|FG000|Overall Study|Schedule not conducive to study visits|0|||
33616333|NCT02160626|63017207|FG001|Overall Study|Schedule not conducive to study visits|0|||
33616334|NCT02160626|63017208|FG002|Overall Study|Schedule not conducive to study visits|1|||
33616335|NCT02160626|63017206|FG000|Overall Study|Withdrawal by Subject|0|||
33616336|NCT02160626|63017207|FG001|Overall Study|Withdrawal by Subject|1|||
33616337|NCT02160626|63017208|FG002|Overall Study|Withdrawal by Subject|0|||
33616338|NCT02160314|63017220|FG000|Overall Study|Adverse Event|0|||
33616339|NCT02160314|63017221|FG001|Overall Study|Adverse Event|6|||
33616340|NCT02160314|63017220|FG000|Overall Study|Protocol Violation|0|||
33616341|NCT02160314|63017221|FG001|Overall Study|Protocol Violation|4|||
33616342|NCT02160314|63017220|FG000|Overall Study|Withdrawal by Subject|1|||
33616343|NCT02160314|63017221|FG001|Overall Study|Withdrawal by Subject|2|||
33616344|NCT02160314|63017220|FG000|Overall Study|Lost to Follow-up|0|||
33616345|NCT02160314|63017221|FG001|Overall Study|Lost to Follow-up|1|||
33616346|NCT02160002|63017229|FG000|Overall Study|Withdrawal by Subject|2|||
33616347|NCT02160002|63017230|FG001|Overall Study|Withdrawal by Subject|1|||
33616348|NCT02218268|63017236|FG000|24 Hour Washout|Physician Decision|11|||
33616349|NCT02218268|63017237|FG001|24 Hour Washout|Physician Decision|9|||
33616350|NCT02217878|63017245|FG000|Overall Study|required morphine due to chest pain|1|||
33616351|NCT02217878|63017246|FG001|Overall Study|required morphine due to chest pain|2|||
33616352|NCT02217878|63017245|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
33616353|NCT02217878|63017246|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
33616354|NCT02217566|63017252|FG000|Overall Study|Lost to Follow-up|2|||
33616355|NCT02217566|63017252|FG000|Overall Study|Death|3|||
33616356|NCT02217566|63017252|FG000|Overall Study|Early study termination|6|||
33616357|NCT02217410|63017259|FG000|Overall Study|Graft Loss|0|||
33616358|NCT02217410|63017260|FG001|Overall Study|Graft Loss|0|||
33616359|NCT02217410|63017261|FG002|Overall Study|Graft Loss|2|||
33616360|NCT02217410|63017259|FG000|Overall Study|Withdrawal by Subject|0|||
33616361|NCT02217410|63017260|FG001|Overall Study|Withdrawal by Subject|0|||
33616362|NCT02217410|63017261|FG002|Overall Study|Withdrawal by Subject|2|||
33616363|NCT02217410|63017259|FG000|Overall Study|Lost to Follow-up|0|||
33616364|NCT02217410|63017260|FG001|Overall Study|Lost to Follow-up|0|||
33616365|NCT02217410|63017261|FG002|Overall Study|Lost to Follow-up|1|||
33616366|NCT02217410|63017259|FG000|Overall Study|Lack of Efficacy|0|||
33616367|NCT02217410|63017260|FG001|Overall Study|Lack of Efficacy|1|||
33616368|NCT02217410|63017261|FG002|Overall Study|Lack of Efficacy|0|||
33616369|NCT02217410|63017259|FG000|Overall Study|Physician Decision|1|||
33616370|NCT02217410|63017260|FG001|Overall Study|Physician Decision|3|||
33616371|NCT02217410|63017261|FG002|Overall Study|Physician Decision|0|||
33616372|NCT02217332|63017274|FG000|Overall Study|Adverse Event|3|||
33616373|NCT02217332|63017274|FG000|Overall Study|Dose interruption >1 month|1|||
33616374|NCT02217332|63017274|FG000|Overall Study|Protocol Violation (eligibility)|1|||
33616375|NCT02217332|63017274|FG000|Overall Study|Withdrawal by Subject|1|||
33518310|NCT03011892|62903744|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
33518311|NCT03011892|62903745|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
33518312|NCT03011892|62903746|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
33518313|NCT03011892|62903747|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
33518314|NCT03011892|62903736|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
33518315|NCT03011892|62903737|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
33518316|NCT03011892|62903738|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
33518317|NCT03011892|62903739|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
33518318|NCT03011892|62903740|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
33518319|NCT03011892|62903741|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
33518320|NCT03011892|62903742|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
33518321|NCT03011892|62903743|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
33518322|NCT03011892|62903744|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
33518323|NCT03011892|62903745|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
33518324|NCT03011892|62903746|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
33518325|NCT03011892|62903747|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
33518326|NCT03011892|62903736|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
33518327|NCT03011892|62903737|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
33518328|NCT03011892|62903738|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
33518329|NCT03011892|62903739|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
33518330|NCT03011892|62903740|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
33518331|NCT03011892|62903741|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
33518332|NCT03011892|62903742|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
33518333|NCT03011892|62903743|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
33518334|NCT03011892|62903744|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
33518335|NCT03011892|62903745|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
33518336|NCT03011892|62903746|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
33518337|NCT03011892|62903747|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
33518338|NCT03011892|62903736|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
33518339|NCT03011892|62903737|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
33518340|NCT03011892|62903738|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
33518341|NCT03011892|62903739|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
33518342|NCT03011892|62903740|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
33616376|NCT02217332|63017274|FG000|Overall Study|Lost to Follow-up|1|||
33616377|NCT02184572|63017280|FG000|Overall Study|Lost to Follow-up|29|||
33616378|NCT02184572|63017281|FG001|Overall Study|Lost to Follow-up|21|||
33518343|NCT03011892|62903741|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
33518344|NCT03011892|62903742|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
33518345|NCT03011892|62903743|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
33518346|NCT03011892|62903744|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
33518347|NCT03011892|62903745|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
33518348|NCT03011892|62903746|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
33518349|NCT03011892|62903747|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
33518350|NCT03011892|62903736|FG000|Open Label (OL) Period|Reason not specified|0|||
33518351|NCT03011892|62903737|FG001|Open Label (OL) Period|Reason not specified|0|||
33518352|NCT03011892|62903738|FG002|Open Label (OL) Period|Reason not specified|0|||
33518353|NCT03011892|62903739|FG003|Open Label (OL) Period|Reason not specified|0|||
33518354|NCT03011892|62903740|FG004|Open Label (OL) Period|Reason not specified|0|||
33518355|NCT03011892|62903741|FG005|Open Label (OL) Period|Reason not specified|0|||
33518356|NCT03011892|62903742|FG006|Open Label (OL) Period|Reason not specified|0|||
33518357|NCT03011892|62903743|FG007|Open Label (OL) Period|Reason not specified|1|||
33518358|NCT03011892|62903744|FG008|Open Label (OL) Period|Reason not specified|0|||
33518359|NCT03011892|62903745|FG009|Open Label (OL) Period|Reason not specified|0|||
33518360|NCT03011892|62903746|FG010|Open Label (OL) Period|Reason not specified|0|||
33518361|NCT03011892|62903747|FG011|Open Label (OL) Period|Reason not specified|0|||
33518362|NCT03017742|62903774|FG000|Overall Study|Protocol Violation|36|||
33518363|NCT03017742|62903774|FG000|Overall Study|Withdrawal by Subject|37|||
33518364|NCT03012828|62903784|FG000|Overall Study|Lost to Follow-up|1|||
33518365|NCT03012828|62903785|FG001|Overall Study|Lost to Follow-up|0|||
33518366|NCT03012828|62903786|FG002|Overall Study|Lost to Follow-up|1|||
33518367|NCT03012828|62903787|FG003|Overall Study|Lost to Follow-up|0|||
33518368|NCT03012828|62903788|FG004|Overall Study|Lost to Follow-up|1|||
33518369|NCT03012828|62903789|FG005|Overall Study|Lost to Follow-up|0|||
33518370|NCT03012828|62903784|FG000|Overall Study|Withdrawal by Subject|0|||
33518371|NCT03012828|62903785|FG001|Overall Study|Withdrawal by Subject|0|||
33518372|NCT03012828|62903786|FG002|Overall Study|Withdrawal by Subject|1|||
33518373|NCT03012828|62903787|FG003|Overall Study|Withdrawal by Subject|0|||
33518374|NCT03012828|62903788|FG004|Overall Study|Withdrawal by Subject|0|||
33518375|NCT03012828|62903789|FG005|Overall Study|Withdrawal by Subject|1|||
33518376|NCT03012828|62903784|FG000|Overall Study|Non-compliance with protocol|0|||
33518377|NCT03012828|62903785|FG001|Overall Study|Non-compliance with protocol|0|||
33518378|NCT03012828|62903786|FG002|Overall Study|Non-compliance with protocol|0|||
33518379|NCT03012828|62903787|FG003|Overall Study|Non-compliance with protocol|0|||
33518380|NCT03012828|62903788|FG004|Overall Study|Non-compliance with protocol|1|||
33518381|NCT03012828|62903789|FG005|Overall Study|Non-compliance with protocol|0|||
33518382|NCT03012828|62903784|FG000|Overall Study|Delay to last visit would delay DBL|0|||
33518383|NCT03012828|62903785|FG001|Overall Study|Delay to last visit would delay DBL|0|||
33518384|NCT03012828|62903786|FG002|Overall Study|Delay to last visit would delay DBL|0|||
33518385|NCT03012828|62903787|FG003|Overall Study|Delay to last visit would delay DBL|0|||
33518386|NCT03012828|62903788|FG004|Overall Study|Delay to last visit would delay DBL|0|||
33518387|NCT03012828|62903789|FG005|Overall Study|Delay to last visit would delay DBL|1|||
33518388|NCT03010254|62903807|FG000|Overall Study|Adverse Event|0|||
33518389|NCT03010254|62903808|FG001|Overall Study|Adverse Event|1|||
33518390|NCT03010254|62903807|FG000|Overall Study|Lost to Follow-up|4|||
33518391|NCT03010254|62903808|FG001|Overall Study|Lost to Follow-up|0|||
33518392|NCT03010254|62903807|FG000|Overall Study|Withdrawal by Subject|1|||
33518393|NCT03010254|62903808|FG001|Overall Study|Withdrawal by Subject|1|||
33518394|NCT03010254|62903807|FG000|Overall Study|Other|2|||
33518395|NCT03010254|62903808|FG001|Overall Study|Other|3|||
33518396|NCT03008460|62903823|FG000|Overall Study|Protocol deviation|0|||
33518397|NCT03008460|62903824|FG001|Overall Study|Protocol deviation|2|||
33518398|NCT03008460|62903823|FG000|Overall Study|Study drug not dispensed|0|||
33616379|NCT02184572|63017280|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
33518399|NCT03008460|62903824|FG001|Overall Study|Study drug not dispensed|1|||
33518400|NCT03008460|62903823|FG000|Overall Study|Adverse Event|0|||
33518401|NCT03008460|62903824|FG001|Overall Study|Adverse Event|1|||
33616380|NCT02184572|63017281|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
33616381|NCT02184572|63017280|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
33616382|NCT02184572|63017281|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
33616383|NCT02184572|63017280|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
33616384|NCT02184572|63017281|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
33616385|NCT02184572|63017280|FG000|Overall Study|Traveling Outside The Country|1|||
33616386|NCT02184572|63017281|FG001|Overall Study|Traveling Outside The Country|0|||
33616387|NCT02184572|63017280|FG000|Overall Study|Withdrawal by Subject|14|||
33616388|NCT02184572|63017281|FG001|Overall Study|Withdrawal by Subject|9|||
33616389|NCT02181842|63017289|FG000|Overall Study|Case Report Forms Uncollected|2|||
33616390|NCT01632020|63017295|FG000|Overall Study|Withdrawal by Subject|1|||
33454917|NCT04980040|62829271|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
33454918|NCT00131352|62829277|FG000|Initial Treatment Period|Adverse Event|1|||
33454919|NCT00131352|62829278|FG001|Initial Treatment Period|Adverse Event|3|||
33454920|NCT00131352|62829277|FG000|Initial Treatment Period|Non-compliant|1|||
33454921|NCT00131352|62829278|FG001|Initial Treatment Period|Non-compliant|2|||
33454922|NCT00131352|62829277|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
33454923|NCT00131352|62829278|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
33454924|NCT00131352|62829277|FG000|Initial Treatment Period|Lack of Efficacy|6|||
33454925|NCT00131352|62829278|FG001|Initial Treatment Period|Lack of Efficacy|4|||
33454926|NCT00131352|62829277|FG000|Initial Treatment Period|Other|0|||
33454927|NCT00131352|62829278|FG001|Initial Treatment Period|Other|2|||
33454928|NCT00131352|62829277|FG000|Repeat Treatment Period|Adverse Event|1|||
33518402|NCT03008460|62903823|FG000|Overall Study|Withdrawal by Subject|5|||
33518403|NCT03008460|62903824|FG001|Overall Study|Withdrawal by Subject|6|||
33518404|NCT03008460|62903823|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
33518405|NCT03008460|62903824|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
33518406|NCT03008460|62903823|FG000|Overall Study|End of study visit outside permitted time window|0|||
33518407|NCT03008460|62903824|FG001|Overall Study|End of study visit outside permitted time window|1|||
33518408|NCT03008460|62903823|FG000|Overall Study|Lost to Follow-up|1|||
33518409|NCT03008460|62903824|FG001|Overall Study|Lost to Follow-up|3|||
33616391|NCT01632020|63017296|FG001|Overall Study|Withdrawal by Subject|0|||
33616392|NCT01632020|63017295|FG000|Overall Study|Adverse Event|1|||
33616393|NCT01632020|63017296|FG001|Overall Study|Adverse Event|0|||
33616394|NCT02181296|63017304|FG000|Overall Study|Lost to Follow-up|7|||
33616395|NCT02181296|63017305|FG001|Overall Study|Lost to Follow-up|6|||
33616396|NCT02215616|63017315|FG000|Overall Study|Sponsor requested to stop study drug|0|||
33616397|NCT02215616|63017316|FG001|Overall Study|Sponsor requested to stop study drug|0|||
33616398|NCT02215616|63017317|FG002|Overall Study|Sponsor requested to stop study drug|1|||
33616399|NCT02215616|63017318|FG003|Overall Study|Sponsor requested to stop study drug|4|||
33616400|NCT02215616|63017315|FG000|Overall Study|Death|1|||
33616401|NCT02215616|63017316|FG001|Overall Study|Death|0|||
33616402|NCT02215616|63017317|FG002|Overall Study|Death|0|||
33616403|NCT02215616|63017318|FG003|Overall Study|Death|0|||
33616404|NCT02215616|63017315|FG000|Overall Study|Adverse Event|7|||
33616405|NCT02215616|63017316|FG001|Overall Study|Adverse Event|4|||
33616406|NCT02215616|63017317|FG002|Overall Study|Adverse Event|9|||
33616407|NCT02215616|63017318|FG003|Overall Study|Adverse Event|2|||
33616408|NCT02215616|63017315|FG000|Overall Study|Withdrawal by Subject|1|||
33616409|NCT02215616|63017316|FG001|Overall Study|Withdrawal by Subject|8|||
33616410|NCT02215616|63017317|FG002|Overall Study|Withdrawal by Subject|2|||
33518410|NCT02914236|62903830|FG000|Overall Study|Lost to Follow-up|1|||
33518411|NCT03003390|62903836|FG000|Overall Study|Physician Decision|2|||
33518412|NCT03003390|62903837|FG001|Overall Study|Physician Decision|0|||
33518413|NCT03003390|62903836|FG000|Overall Study|Parent refused intervention|2|||
33518414|NCT03003390|62903837|FG001|Overall Study|Parent refused intervention|0|||
33324822|NCT00908596|62701399|FG000|Overall Study|Other reasons|46|||
33324823|NCT00908596|62701400|FG001|Overall Study|Other reasons|6|||
33324824|NCT00908596|62701401|FG002|Overall Study|Other reasons|2|||
33324825|NCT00908596|62701402|FG003|Overall Study|Other reasons|0|||
33324826|NCT00908596|62701399|FG000|Overall Study|Lost to Follow-up|0|||
33324827|NCT00908596|62701400|FG001|Overall Study|Lost to Follow-up|1|||
33324828|NCT00908596|62701401|FG002|Overall Study|Lost to Follow-up|12|||
33324829|NCT00908596|62701402|FG003|Overall Study|Lost to Follow-up|4|||
33454929|NCT00131352|62829278|FG001|Repeat Treatment Period|Adverse Event|0|||
33454930|NCT00131352|62829277|FG000|Repeat Treatment Period|Other|1|||
33454931|NCT00131352|62829278|FG001|Repeat Treatment Period|Other|0|||
33454932|NCT04633642|62829288|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
33454933|NCT04633642|62829289|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
33454934|NCT00136916|62829297|FG000|Overall Study|Never received study treatment|3|||
33454935|NCT00136916|62829298|FG001|Overall Study|Never received study treatment|5|||
33454936|NCT00136916|62829297|FG000|Overall Study|Death|1|||
33454937|NCT00136916|62829298|FG001|Overall Study|Death|3|||
33454938|NCT00136916|62829297|FG000|Overall Study|Adverse Event|27|||
33454939|NCT00136916|62829298|FG001|Overall Study|Adverse Event|8|||
33454940|NCT00136916|62829297|FG000|Overall Study|Laboratory abnormality|0|||
33454941|NCT00136916|62829298|FG001|Overall Study|Laboratory abnormality|1|||
33518415|NCT03003000|62903851|FG000|Overall Study|Adverse Event|1|||
33454942|NCT00136916|62829297|FG000|Overall Study|Lack of Efficacy|13|||
33518416|NCT03003000|62903852|FG001|Overall Study|Adverse Event|2|||
33616411|NCT02215616|63017318|FG003|Overall Study|Withdrawal by Subject|5|||
33616412|NCT02215616|63017315|FG000|Overall Study|Non-compliance|0|||
33616413|NCT02215616|63017316|FG001|Overall Study|Non-compliance|2|||
33616414|NCT02215616|63017317|FG002|Overall Study|Non-compliance|1|||
33616415|NCT02215616|63017318|FG003|Overall Study|Non-compliance|0|||
33324830|NCT00908596|62701399|FG000|Overall Study|Death|0|||
33324831|NCT00908596|62701400|FG001|Overall Study|Death|5|||
33324832|NCT00908596|62701401|FG002|Overall Study|Death|57|||
33324833|NCT00908596|62701402|FG003|Overall Study|Death|32|||
33324834|NCT00908596|62701399|FG000|Overall Study|Protocol Violation|1|||
33324835|NCT00908596|62701400|FG001|Overall Study|Protocol Violation|0|||
33324836|NCT00908596|62701401|FG002|Overall Study|Protocol Violation|0|||
33324837|NCT00908596|62701402|FG003|Overall Study|Protocol Violation|0|||
33324838|NCT00908596|62701399|FG000|Overall Study|Withdrawal by Subject|0|||
33324839|NCT00908596|62701400|FG001|Overall Study|Withdrawal by Subject|1|||
33324840|NCT00908596|62701401|FG002|Overall Study|Withdrawal by Subject|3|||
33324841|NCT00908596|62701402|FG003|Overall Study|Withdrawal by Subject|1|||
33324842|NCT01118052|62701412|FG000|Overall Study|Never treated|2|||
33324843|NCT01123200|62701422|FG000|Overall Study|Withdrawal by Subject|1|||
33324844|NCT00955617|62701426|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
33324845|NCT00955617|62701427|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
33324846|NCT00955617|62701426|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
33324847|NCT00955617|62701427|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
33324848|NCT00955617|62701426|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
33324849|NCT00955617|62701427|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
33454943|NCT00136916|62829298|FG001|Overall Study|Lack of Efficacy|3|||
33454944|NCT00136916|62829297|FG000|Overall Study|Lost to Follow-up|12|||
33454945|NCT00136916|62829298|FG001|Overall Study|Lost to Follow-up|14|||
33454946|NCT00136916|62829297|FG000|Overall Study|Withdrawal by Subject|44|||
33454947|NCT00136916|62829298|FG001|Overall Study|Withdrawal by Subject|46|||
33454948|NCT00136916|62829297|FG000|Overall Study|Other|22|||
33454949|NCT00136916|62829298|FG001|Overall Study|Other|24|||
33454950|NCT00136916|62829297|FG000|Overall Study|Discontinued in follow up period|3|||
33454951|NCT00136916|62829298|FG001|Overall Study|Discontinued in follow up period|0|||
33454952|NCT04633564|62829308|FG000|Period 1|Adverse Event|28|||
33454953|NCT04633564|62829309|FG001|Period 1|Adverse Event|19|||
33454954|NCT04633564|62829308|FG000|Period 1|Death|8|||
33454955|NCT04633564|62829309|FG001|Period 1|Death|7|||
33454956|NCT04633564|62829308|FG000|Period 1|Lost to Follow-up|3|||
33454957|NCT04633564|62829309|FG001|Period 1|Lost to Follow-up|5|||
33454958|NCT04633564|62829308|FG000|Period 1|Physician Decision|4|||
33454959|NCT04633564|62829309|FG001|Period 1|Physician Decision|12|||
33454960|NCT04633564|62829308|FG000|Period 1|Protocol Violation|0|||
33454961|NCT04633564|62829309|FG001|Period 1|Protocol Violation|1|||
33454962|NCT04633564|62829308|FG000|Period 1|Withdrawal by Subject|10|||
33454963|NCT04633564|62829309|FG001|Period 1|Withdrawal by Subject|8|||
33454964|NCT04633564|62829308|FG000|Period 1|Progressive disease|47|||
33454965|NCT04633564|62829309|FG001|Period 1|Progressive disease|51|||
33454966|NCT04633564|62829308|FG000|Period 1|Terminated by Sponsor|8|||
33454967|NCT04633564|62829309|FG001|Period 1|Terminated by Sponsor|6|||
33454968|NCT04633564|62829308|FG000|Period 2|Adverse Event|3|||
33616416|NCT02215616|63017315|FG000|Overall Study|Protocol Violation|0|||
33616417|NCT02215616|63017316|FG001|Overall Study|Protocol Violation|2|||
33616418|NCT02215616|63017317|FG002|Overall Study|Protocol Violation|0|||
33616419|NCT02215616|63017318|FG003|Overall Study|Protocol Violation|0|||
33616420|NCT02215616|63017315|FG000|Overall Study|Lost to Follow-up|1|||
33616421|NCT02215616|63017316|FG001|Overall Study|Lost to Follow-up|1|||
33616422|NCT02215616|63017317|FG002|Overall Study|Lost to Follow-up|0|||
33616423|NCT02215616|63017318|FG003|Overall Study|Lost to Follow-up|1|||
33616424|NCT02215616|63017315|FG000|Overall Study|Other than specified|1|||
33616425|NCT02215616|63017316|FG001|Overall Study|Other than specified|0|||
33616426|NCT02215616|63017317|FG002|Overall Study|Other than specified|1|||
33616427|NCT02215616|63017318|FG003|Overall Study|Other than specified|1|||
33616428|NCT02213666|63017328|FG000|Overall Study|Withdrawal by Subject|1|||
33616429|NCT02213510|63017334|FG000|Overall Study|Death|0|||
33616430|NCT02213510|63017335|FG001|Overall Study|Death|1|||
33616431|NCT02213510|63017334|FG000|Overall Study|Lost to Follow-up|1|||
33616432|NCT02213510|63017335|FG001|Overall Study|Lost to Follow-up|0|||
33616433|NCT02158442|63017343|FG000|Overall Study|Withdrawal by Subject|1|||
33616434|NCT02158442|63017344|FG001|Overall Study|Withdrawal by Subject|0|||
33324850|NCT00955617|62701426|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
33324851|NCT00955617|62701427|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
33324852|NCT00958347|62701433|FG000|Overall Study|Death|43|||
33324853|NCT00958347|62701433|FG000|Overall Study|Withdrawal by Subject|23|||
33454969|NCT04633564|62829309|FG001|Period 2|Adverse Event|4|||
33454970|NCT04633564|62829308|FG000|Period 2|Death|0|||
33454971|NCT04633564|62829309|FG001|Period 2|Death|2|||
33454972|NCT04633564|62829308|FG000|Period 2|Lost to Follow-up|0|||
33454973|NCT04633564|62829309|FG001|Period 2|Lost to Follow-up|1|||
33616435|NCT02158442|63017343|FG000|Overall Study|Perfusion staff not available|1|||
33616436|NCT02158442|63017344|FG001|Overall Study|Perfusion staff not available|0|||
33616437|NCT02158364|63017350|FG000|Overall Study|Case report forms uncollected|10|||
33616438|NCT02158364|63017350|FG000|Overall Study|Protocol Deviation|50|||
33616439|NCT02180672|63017356|FG000|Overall Study|Lost to Follow-up|5|||
33616440|NCT02180672|63017357|FG001|Overall Study|Lost to Follow-up|7|||
33616441|NCT02213198|63017365|FG000|Baseline|No show for intake|7|||
33616442|NCT02213198|63017366|FG001|Baseline|No show for intake|9|||
33616443|NCT02213198|63017365|FG000|Baseline|Withdrawal by Subject|34|||
33616444|NCT02213198|63017366|FG001|Baseline|Withdrawal by Subject|11|||
33616445|NCT02213198|63017365|FG000|Baseline|transferred out of clinic|7|||
33616446|NCT02213198|63017366|FG001|Baseline|transferred out of clinic|9|||
33616447|NCT02213198|63017365|FG000|Baseline|Lost to Follow-up|40|||
33616448|NCT02213198|63017366|FG001|Baseline|Lost to Follow-up|21|||
33616449|NCT02213198|63017365|FG000|Baseline|incarcerated,violent|0|||
33616450|NCT02213198|63017366|FG001|Baseline|incarcerated,violent|1|||
33616451|NCT02213198|63017365|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
33616452|NCT02213198|63017366|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
33616453|NCT02213198|63017365|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
33616454|NCT02213198|63017366|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
33616455|NCT02213198|63017365|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
33616456|NCT02213198|63017366|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
33616457|NCT02213198|63017365|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
33616458|NCT02213198|63017366|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
33616459|NCT02213198|63017365|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
33616460|NCT02213198|63017366|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
33616461|NCT02213198|63017365|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
33616462|NCT02213198|63017366|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
33616463|NCT02157506|63017377|FG000|Overall Study|Adverse Event|0|||
33616464|NCT02157506|63017378|FG001|Overall Study|Adverse Event|1|||
33616465|NCT02157506|63017379|FG002|Overall Study|Adverse Event|0|||
33616466|NCT02157506|63017380|FG003|Overall Study|Adverse Event|0|||
33454974|NCT04633564|62829308|FG000|Period 2|Physician Decision|2|||
33454975|NCT04633564|62829309|FG001|Period 2|Physician Decision|4|||
33518417|NCT03003000|62903853|FG002|Overall Study|Adverse Event|3|||
33518418|NCT03003000|62903851|FG000|Overall Study|Lack of Efficacy|1|||
33518419|NCT03003000|62903852|FG001|Overall Study|Lack of Efficacy|0|||
33518420|NCT03003000|62903853|FG002|Overall Study|Lack of Efficacy|0|||
33518421|NCT03003000|62903851|FG000|Overall Study|Non-compliant with protocol|0|||
33518422|NCT03003000|62903852|FG001|Overall Study|Non-compliant with protocol|1|||
33518423|NCT03003000|62903853|FG002|Overall Study|Non-compliant with protocol|1|||
33518424|NCT03003000|62903851|FG000|Overall Study|Refused to continue medication|2|||
33518425|NCT03003000|62903852|FG001|Overall Study|Refused to continue medication|0|||
33518426|NCT03003000|62903853|FG002|Overall Study|Refused to continue medication|0|||
33518427|NCT03003000|62903851|FG000|Overall Study|Other than listed|1|||
33518428|NCT03003000|62903852|FG001|Overall Study|Other than listed|1|||
33518429|NCT03003000|62903853|FG002|Overall Study|Other than listed|1|||
33518430|NCT03002610|62903864|FG000|Overall Study|Withdrawal by Subject|6|||
33454976|NCT04633564|62829308|FG000|Period 2|Withdrawal by Subject|5|||
33454977|NCT04633564|62829309|FG001|Period 2|Withdrawal by Subject|1|||
33454978|NCT04633564|62829308|FG000|Period 2|Progressive Disease|74|||
33454979|NCT04633564|62829309|FG001|Period 2|Progressive Disease|82|||
33454980|NCT04633564|62829308|FG000|Period 2|Terminated by Sponsor|9|||
33454981|NCT04633564|62829309|FG001|Period 2|Terminated by Sponsor|3|||
33454982|NCT04960228|62829317|FG000|Overall Study|Withdrawal by Subject|216|||
33454983|NCT04960228|62829318|FG001|Overall Study|Withdrawal by Subject|35|||
33454984|NCT04960228|62829317|FG000|Overall Study|Failed attention check|69|||
33454985|NCT04960228|62829318|FG001|Overall Study|Failed attention check|148|||
33454986|NCT04960228|62829317|FG000|Overall Study|Flagged for response quality by Dynata|3|||
33454987|NCT04960228|62829318|FG001|Overall Study|Flagged for response quality by Dynata|3|||
33454988|NCT04619992|62829326|FG000|Overall Study|Withdrawal by Subject|1|||
33518431|NCT03002610|62903865|FG001|Overall Study|Withdrawal by Subject|25|||
33518432|NCT03002610|62903866|FG002|Overall Study|Withdrawal by Subject|13|||
33518433|NCT03005106|62903874|FG000|Overall Study|Lost to Follow-up|16|||
33518434|NCT03005106|62903874|FG000|Overall Study|Adverse Event|1|||
33454989|NCT04619992|62829327|FG001|Overall Study|Withdrawal by Subject|0|||
33518435|NCT03005106|62903874|FG000|Overall Study|Physician Decision|1|||
33518436|NCT03005106|62903874|FG000|Overall Study|Death|2|||
33518437|NCT01004861|62903891|FG000|Overall Study|Disease progression|3|||
33616467|NCT02157506|63017381|FG004|Overall Study|Adverse Event|0|||
33616468|NCT02157506|63017377|FG000|Overall Study|Lost to Follow-up|0|||
33518438|NCT01004861|62903892|FG001|Overall Study|Disease progression|4|||
33518439|NCT01004861|62903893|FG002|Overall Study|Disease progression|5|||
33518440|NCT01004861|62903894|FG003|Overall Study|Disease progression|4|||
33518441|NCT01004861|62903895|FG004|Overall Study|Disease progression|4|||
33518442|NCT01004861|62903896|FG005|Overall Study|Disease progression|4|||
33518443|NCT01004861|62903897|FG006|Overall Study|Disease progression|5|||
33518444|NCT01004861|62903898|FG007|Overall Study|Disease progression|1|||
33518445|NCT01004861|62903899|FG008|Overall Study|Disease progression|4|||
33518446|NCT01004861|62903900|FG009|Overall Study|Disease progression|7|||
33518447|NCT01004861|62903901|FG010|Overall Study|Disease progression|6|||
33518448|NCT01004861|62903902|FG011|Overall Study|Disease progression|3|||
33518449|NCT01004861|62903903|FG012|Overall Study|Disease progression|8|||
33518450|NCT01004861|62903891|FG000|Overall Study|Physician Decision|0|||
33518451|NCT01004861|62903892|FG001|Overall Study|Physician Decision|2|||
33518452|NCT01004861|62903893|FG002|Overall Study|Physician Decision|1|||
33518453|NCT01004861|62903894|FG003|Overall Study|Physician Decision|1|||
33518454|NCT01004861|62903895|FG004|Overall Study|Physician Decision|1|||
33518455|NCT01004861|62903896|FG005|Overall Study|Physician Decision|0|||
33518456|NCT01004861|62903897|FG006|Overall Study|Physician Decision|0|||
33518457|NCT01004861|62903898|FG007|Overall Study|Physician Decision|1|||
33518458|NCT01004861|62903899|FG008|Overall Study|Physician Decision|0|||
33518459|NCT01004861|62903900|FG009|Overall Study|Physician Decision|0|||
33518460|NCT01004861|62903901|FG010|Overall Study|Physician Decision|0|||
33518461|NCT01004861|62903902|FG011|Overall Study|Physician Decision|0|||
33518462|NCT01004861|62903903|FG012|Overall Study|Physician Decision|3|||
33616469|NCT02157506|63017378|FG001|Overall Study|Lost to Follow-up|0|||
33616470|NCT02157506|63017379|FG002|Overall Study|Lost to Follow-up|1|||
33616471|NCT02157506|63017380|FG003|Overall Study|Lost to Follow-up|0|||
33616472|NCT02157506|63017381|FG004|Overall Study|Lost to Follow-up|0|||
33616473|NCT01920711|63017395|FG000|Overall Study|Death|347|||
33616474|NCT01920711|63017396|FG001|Overall Study|Death|356|||
33616475|NCT01920711|63017395|FG000|Overall Study|Lost to Follow-up|13|||
33616476|NCT01920711|63017396|FG001|Overall Study|Lost to Follow-up|14|||
33324854|NCT00958347|62701433|FG000|Overall Study|Lost to Follow-up|15|||
33324855|NCT00958347|62701433|FG000|Overall Study|revision/removal|10|||
33324856|NCT00958347|62701433|FG000|Overall Study|study termination|135|||
33454990|NCT00136604|62829338|FG000|Overall Study|Lost to Follow-up|1|||
33454991|NCT00136604|62829339|FG001|Overall Study|Lost to Follow-up|0|||
33454992|NCT00136604|62829340|FG002|Overall Study|Lost to Follow-up|0|||
33454993|NCT00136604|62829341|FG003|Overall Study|Lost to Follow-up|0|||
33454994|NCT00136604|62829342|FG004|Overall Study|Lost to Follow-up|1|||
33454995|NCT00136604|62829338|FG000|Overall Study|Migrated/moved from study area|0|||
33454996|NCT00136604|62829339|FG001|Overall Study|Migrated/moved from study area|1|||
33454997|NCT00136604|62829340|FG002|Overall Study|Migrated/moved from study area|0|||
33454998|NCT00136604|62829341|FG003|Overall Study|Migrated/moved from study area|0|||
33454999|NCT00136604|62829342|FG004|Overall Study|Migrated/moved from study area|0|||
33455000|NCT00135512|62829358|FG000|Overall Study|Adverse Event|56|||
33455001|NCT00135512|62829358|FG000|Overall Study|Lack of Efficacy|25|||
33455002|NCT00135512|62829358|FG000|Overall Study|Other|42|||
33455003|NCT00130728|62829364|FG000|Overall Study|Death|258|||
33455004|NCT00130728|62829365|FG001|Overall Study|Death|258|||
33455005|NCT00130728|62829364|FG000|Overall Study|Lost to Follow-up|4|||
33455006|NCT00130728|62829365|FG001|Overall Study|Lost to Follow-up|0|||
33455007|NCT00130728|62829364|FG000|Overall Study|Withdrawal by Subject|0|||
33455008|NCT00130728|62829365|FG001|Overall Study|Withdrawal by Subject|2|||
33455009|NCT00129974|62829371|FG000|Overall Study|Other|1|||
33455010|NCT04947436|62829378|FG000|Overall Study|Lost to Follow-up|3|||
33455011|NCT04947436|62829379|FG001|Overall Study|Lost to Follow-up|7|||
33518463|NCT01004861|62903891|FG000|Overall Study|Adverse Event|0|||
33518464|NCT01004861|62903892|FG001|Overall Study|Adverse Event|0|||
33518465|NCT01004861|62903893|FG002|Overall Study|Adverse Event|0|||
33616477|NCT01920711|63017395|FG000|Overall Study|Withdrawal by Subject|4|||
33324857|NCT00958191|62701437|FG000|Overall Study|Death|4|||
33455012|NCT04947436|62829380|FG002|Overall Study|Lost to Follow-up|5|||
33455013|NCT04947436|62829378|FG000|Overall Study|Death|1|||
33455014|NCT04947436|62829379|FG001|Overall Study|Death|1|||
33455015|NCT04947436|62829380|FG002|Overall Study|Death|1|||
33455016|NCT00119106|62829390|FG000|Overall Study|HIV infected at baseline|179|||
33455017|NCT00119106|62829391|FG001|Overall Study|HIV infected at baseline|178|||
33455018|NCT00135356|62829407|FG000|Overall Study|Adverse Event|6|||
33455019|NCT00135356|62829408|FG001|Overall Study|Adverse Event|2|||
33518466|NCT01004861|62903894|FG003|Overall Study|Adverse Event|1|||
33518467|NCT01004861|62903895|FG004|Overall Study|Adverse Event|0|||
33518468|NCT01004861|62903896|FG005|Overall Study|Adverse Event|2|||
33518469|NCT01004861|62903897|FG006|Overall Study|Adverse Event|1|||
33518470|NCT01004861|62903898|FG007|Overall Study|Adverse Event|1|||
33518471|NCT01004861|62903899|FG008|Overall Study|Adverse Event|13|||
33324858|NCT00958191|62701437|FG000|Overall Study|Lost to Follow-up|5|||
33455020|NCT00135356|62829407|FG000|Overall Study|Lack of Efficacy|2|||
33518472|NCT01004861|62903900|FG009|Overall Study|Adverse Event|1|||
33518473|NCT01004861|62903901|FG010|Overall Study|Adverse Event|1|||
33324859|NCT00958191|62701437|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
33324860|NCT00958191|62701437|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
33324861|NCT00958191|62701437|FG000|Overall Study|Revision of study device|4|||
33324862|NCT00958191|62701437|FG000|Overall Study|Site termination|11|||
33324863|NCT00958191|62701437|FG000|Overall Study|No 5 yr x-rays|56|||
33324864|NCT00960843|62701445|FG000|Overall Study|Lost to Follow-up|2|||
33324865|NCT00960843|62701446|FG001|Overall Study|Lost to Follow-up|0|||
33324866|NCT00960843|62701445|FG000|Overall Study|Protocol Violation|0|||
33324867|NCT00960843|62701446|FG001|Overall Study|Protocol Violation|4|||
33324868|NCT00960843|62701445|FG000|Overall Study|Repeated needle dislodgment|0|||
33324869|NCT00960843|62701446|FG001|Overall Study|Repeated needle dislodgment|1|||
33324870|NCT02396199|62701452|FG000|Overall Study|Lost to Follow-up|1|||
33324871|NCT02396199|62701452|FG000|Overall Study|Death|4|||
33324872|NCT01605253|62701458|FG000|Overall Study|Physician Decision|3|||
33324873|NCT01605253|62701459|FG001|Overall Study|Physician Decision|2|||
33324874|NCT01605253|62701458|FG000|Overall Study|Lost to Follow-up|3|||
33324875|NCT01605253|62701459|FG001|Overall Study|Lost to Follow-up|1|||
33324876|NCT00955305|62701469|FG000|Overall Study|Disease progression|39|||
33324877|NCT00955305|62701470|FG001|Overall Study|Disease progression|41|||
33324878|NCT00955305|62701469|FG000|Overall Study|Adverse Event|22|||
33324879|NCT00955305|62701470|FG001|Overall Study|Adverse Event|22|||
33324880|NCT00955305|62701469|FG000|Overall Study|Death|2|||
33324881|NCT00955305|62701470|FG001|Overall Study|Death|1|||
33518474|NCT01004861|62903902|FG011|Overall Study|Adverse Event|0|||
33324882|NCT00955305|62701469|FG000|Overall Study|Withdrawal by Subject|5|||
33324883|NCT00955305|62701470|FG001|Overall Study|Withdrawal by Subject|4|||
33324884|NCT00955305|62701469|FG000|Overall Study|Alternative therapy|4|||
33324885|NCT00955305|62701470|FG001|Overall Study|Alternative therapy|0|||
33324886|NCT00955305|62701469|FG000|Overall Study|Other complicating disease|2|||
33324887|NCT00955305|62701470|FG001|Overall Study|Other complicating disease|4|||
33324888|NCT00955305|62701469|FG000|Overall Study|Physician Decision|1|||
33324889|NCT00955305|62701470|FG001|Overall Study|Physician Decision|0|||
33324890|NCT00955305|62701469|FG000|Overall Study|Continued presence of residual disease|0|||
33324891|NCT00955305|62701470|FG001|Overall Study|Continued presence of residual disease|1|||
33324892|NCT00955305|62701469|FG000|Overall Study|Functional decline|2|||
33324893|NCT00955305|62701470|FG001|Overall Study|Functional decline|0|||
33324894|NCT00955305|62701469|FG000|Overall Study|Maximum response achieved|0|||
33324895|NCT00955305|62701470|FG001|Overall Study|Maximum response achieved|1|||
33324896|NCT00955305|62701469|FG000|Overall Study|Lost to Follow-up|0|||
33324897|NCT00955305|62701470|FG001|Overall Study|Lost to Follow-up|1|||
33324898|NCT00955305|62701469|FG000|Overall Study|No off-treatment reason submitted|1|||
33324899|NCT00955305|62701470|FG001|Overall Study|No off-treatment reason submitted|0|||
33324900|NCT00955305|62701469|FG000|Overall Study|Never started protocol treatment|5|||
33324901|NCT00955305|62701470|FG001|Overall Study|Never started protocol treatment|5|||
33324902|NCT00955305|62701469|FG000|Overall Study|Ineligible|5|||
33324903|NCT00955305|62701470|FG001|Overall Study|Ineligible|7|||
33324904|NCT00598585|62701478|FG000|Overall Study|Lost to Follow-up|1|||
33324905|NCT00598585|62701479|FG001|Overall Study|Lost to Follow-up|0|||
33324906|NCT00953667|62701485|FG000|Overall Study|Lost to Follow-up|11|||
33324907|NCT00953667|62701485|FG000|Overall Study|Physician Decision|35|||
33324908|NCT00953667|62701485|FG000|Overall Study|Withdrawal by Subject|63|||
33518475|NCT01004861|62903903|FG012|Overall Study|Adverse Event|2|||
33518476|NCT01004861|62903891|FG000|Overall Study|Protocol Violation|0|||
33324909|NCT00953667|62701485|FG000|Overall Study|Adverse Event|10|||
33324910|NCT00953667|62701485|FG000|Overall Study|poor venous access,unable to draw blood|4|||
33324911|NCT00883129|62701491|FG000|Overall Study|Adverse Event|7|||
33324912|NCT00883129|62701492|FG001|Overall Study|Adverse Event|15|||
33324913|NCT00883129|62701491|FG000|Overall Study|Withdrawal by Subject|8|||
33324914|NCT00883129|62701492|FG001|Overall Study|Withdrawal by Subject|9|||
33324915|NCT00883129|62701491|FG000|Overall Study|Non-compliance|3|||
33518477|NCT01004861|62903892|FG001|Overall Study|Protocol Violation|0|||
33324916|NCT00883129|62701492|FG001|Overall Study|Non-compliance|6|||
33518478|NCT01004861|62903893|FG002|Overall Study|Protocol Violation|0|||
33518479|NCT01004861|62903894|FG003|Overall Study|Protocol Violation|0|||
33518480|NCT01004861|62903895|FG004|Overall Study|Protocol Violation|1|||
33518481|NCT01004861|62903896|FG005|Overall Study|Protocol Violation|0|||
33518482|NCT01004861|62903897|FG006|Overall Study|Protocol Violation|0|||
33518483|NCT01004861|62903898|FG007|Overall Study|Protocol Violation|0|||
33518484|NCT01004861|62903899|FG008|Overall Study|Protocol Violation|0|||
33518485|NCT01004861|62903900|FG009|Overall Study|Protocol Violation|0|||
33518486|NCT01004861|62903901|FG010|Overall Study|Protocol Violation|0|||
33518487|NCT01004861|62903902|FG011|Overall Study|Protocol Violation|0|||
33518488|NCT01004861|62903903|FG012|Overall Study|Protocol Violation|0|||
33518489|NCT01004861|62903891|FG000|Overall Study|Lost to Follow-up|0|||
33518490|NCT01004861|62903892|FG001|Overall Study|Lost to Follow-up|0|||
33324917|NCT00883129|62701491|FG000|Overall Study|Lost to Follow-up|1|||
33324918|NCT00883129|62701492|FG001|Overall Study|Lost to Follow-up|2|||
33324919|NCT00883129|62701491|FG000|Overall Study|Death|1|||
33324920|NCT00883129|62701492|FG001|Overall Study|Death|2|||
33616478|NCT01920711|63017396|FG001|Overall Study|Withdrawal by Subject|3|||
33616479|NCT02180438|63017403|FG000|Overall Study|Lost to Follow-up|1|||
33616480|NCT02179190|63017407|FG000|Enrollment|Exit Prior to Device Attempt|11|||
33616481|NCT02179190|63017407|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
33616482|NCT02179190|63017407|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
33324921|NCT00883129|62701491|FG000|Overall Study|Defined Treatment Failure|0|||
33324922|NCT00883129|62701492|FG001|Overall Study|Defined Treatment Failure|2|||
33324923|NCT00905632|62701523|FG000|Overall Study|Adverse Event|0|||
33324924|NCT00905632|62701524|FG001|Overall Study|Adverse Event|0|||
33616483|NCT02179190|63017407|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
33616484|NCT02179190|63017407|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
33616485|NCT02179190|63017407|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
33616486|NCT02157116|63017411|FG000|Overall Study|Withdrawal by Subject|4|||
33616487|NCT02157116|63017411|FG000|Overall Study|Physician Decision|3|||
33616488|NCT02157116|63017411|FG000|Overall Study|Failed Screening|2|||
33616489|NCT01920555|63017420|FG000|Overall Study|Physician Decision|1|||
33455021|NCT00135356|62829408|FG001|Overall Study|Lack of Efficacy|0|||
33455022|NCT00135356|62829407|FG000|Overall Study|Lost to Follow-up|3|||
33518491|NCT01004861|62903893|FG002|Overall Study|Lost to Follow-up|0|||
33518492|NCT01004861|62903894|FG003|Overall Study|Lost to Follow-up|0|||
33455023|NCT00135356|62829408|FG001|Overall Study|Lost to Follow-up|1|||
33455024|NCT00135356|62829407|FG000|Overall Study|Surgery for abdominal fat|1|||
33455025|NCT00135356|62829408|FG001|Overall Study|Surgery for abdominal fat|0|||
33455026|NCT00135356|62829407|FG000|Overall Study|Change in antiviral regimen|0|||
33455027|NCT00135356|62829408|FG001|Overall Study|Change in antiviral regimen|1|||
33455028|NCT00135356|62829407|FG000|Overall Study|Poor/noncompliance|1|||
33455029|NCT00135356|62829408|FG001|Overall Study|Poor/noncompliance|1|||
33455030|NCT00135356|62829407|FG000|Overall Study|No longer meets study criteria|2|||
33455031|NCT00135356|62829408|FG001|Overall Study|No longer meets study criteria|0|||
33455032|NCT00135356|62829407|FG000|Overall Study|Withdrawal by Subject|2|||
33455033|NCT00135356|62829408|FG001|Overall Study|Withdrawal by Subject|4|||
33455034|NCT00118716|62829416|FG000|Overall Study|Adverse Event|2|||
33455035|NCT00118716|62829417|FG001|Overall Study|Adverse Event|7|||
33455036|NCT00118716|62829416|FG000|Overall Study|Protocol Violation|5|||
33455037|NCT00118716|62829417|FG001|Overall Study|Protocol Violation|4|||
33455038|NCT00118716|62829416|FG000|Overall Study|Withdrawal by Subject|0|||
33455039|NCT00118716|62829417|FG001|Overall Study|Withdrawal by Subject|1|||
33455040|NCT00118716|62829416|FG000|Overall Study|Exacerbation|2|||
33455041|NCT00118716|62829417|FG001|Overall Study|Exacerbation|2|||
33455042|NCT00118716|62829416|FG000|Overall Study|Discontinued by sponsor|1|||
33455043|NCT00118716|62829417|FG001|Overall Study|Discontinued by sponsor|1|||
33455044|NCT00118716|62829416|FG000|Overall Study|Non-compliance|1|||
33455045|NCT00118716|62829417|FG001|Overall Study|Non-compliance|3|||
33518493|NCT01004861|62903895|FG004|Overall Study|Lost to Follow-up|0|||
33518494|NCT01004861|62903896|FG005|Overall Study|Lost to Follow-up|0|||
33616490|NCT01920555|63017421|FG001|Overall Study|Physician Decision|2|||
33455046|NCT00118716|62829416|FG000|Overall Study|misrandomized|1|||
33455047|NCT00118716|62829417|FG001|Overall Study|misrandomized|1|||
33455048|NCT00118716|62829416|FG000|Overall Study|Expired drug use|1|||
33455049|NCT00118716|62829417|FG001|Overall Study|Expired drug use|2|||
33455050|NCT00118716|62829416|FG000|Overall Study|Investigator discretion|0|||
33455051|NCT00118716|62829417|FG001|Overall Study|Investigator discretion|1|||
33455052|NCT04584346|62829425|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
33616491|NCT01920555|63017422|FG002|Overall Study|Physician Decision|1|||
33324925|NCT00905632|62701525|FG002|Overall Study|Adverse Event|0|||
33518495|NCT01004861|62903897|FG006|Overall Study|Lost to Follow-up|0|||
33518496|NCT01004861|62903898|FG007|Overall Study|Lost to Follow-up|1|||
33518497|NCT01004861|62903899|FG008|Overall Study|Lost to Follow-up|3|||
33518498|NCT01004861|62903900|FG009|Overall Study|Lost to Follow-up|0|||
33616492|NCT01920555|63017423|FG003|Overall Study|Physician Decision|2|||
33324926|NCT00905632|62701526|FG003|Overall Study|Adverse Event|0|||
33518499|NCT01004861|62903901|FG010|Overall Study|Lost to Follow-up|0|||
33518500|NCT01004861|62903902|FG011|Overall Study|Lost to Follow-up|1|||
33518501|NCT01004861|62903903|FG012|Overall Study|Lost to Follow-up|0|||
33518502|NCT01004861|62903891|FG000|Overall Study|Non-compliance|0|||
33518503|NCT01004861|62903892|FG001|Overall Study|Non-compliance|0|||
33518504|NCT01004861|62903893|FG002|Overall Study|Non-compliance|0|||
33616493|NCT01920555|63017424|FG004|Overall Study|Physician Decision|0|||
33616494|NCT01920555|63017420|FG000|Overall Study|Lack of Efficacy|2|||
33616495|NCT01920555|63017421|FG001|Overall Study|Lack of Efficacy|0|||
33616496|NCT01920555|63017422|FG002|Overall Study|Lack of Efficacy|0|||
33616497|NCT01920555|63017423|FG003|Overall Study|Lack of Efficacy|0|||
33616498|NCT01920555|63017424|FG004|Overall Study|Lack of Efficacy|0|||
33616499|NCT01920555|63017420|FG000|Overall Study|Travel Difficulties|1|||
33616500|NCT01920555|63017421|FG001|Overall Study|Travel Difficulties|1|||
33616501|NCT01920555|63017422|FG002|Overall Study|Travel Difficulties|0|||
33616502|NCT01920555|63017423|FG003|Overall Study|Travel Difficulties|0|||
33616503|NCT01920555|63017424|FG004|Overall Study|Travel Difficulties|1|||
33616504|NCT01920555|63017420|FG000|Overall Study|Lost to Follow-up|0|||
33616505|NCT01920555|63017421|FG001|Overall Study|Lost to Follow-up|1|||
33616506|NCT01920555|63017422|FG002|Overall Study|Lost to Follow-up|0|||
33616507|NCT01920555|63017423|FG003|Overall Study|Lost to Follow-up|1|||
33616508|NCT01920555|63017424|FG004|Overall Study|Lost to Follow-up|0|||
33616509|NCT02156804|63017436|FG000|Overall Study|Withdrawal by Subject|1|||
33616510|NCT02156492|63017443|FG000|Period 1|No Reason Given|0|||
33616511|NCT02156492|63017444|FG001|Period 1|No Reason Given|1|||
33616512|NCT02156492|63017445|FG002|Period 1|No Reason Given|0|||
33616513|NCT02156492|63017443|FG000|Period 3|Adverse Event|0|||
33616514|NCT02156492|63017444|FG001|Period 3|Adverse Event|1|||
33616515|NCT02156492|63017445|FG002|Period 3|Adverse Event|0|||
33616516|NCT01920477|63017465|FG000|Overall Study|Adverse Event|0|||
33616517|NCT01920477|63017466|FG001|Overall Study|Adverse Event|1|||
33616518|NCT01920477|63017465|FG000|Overall Study|Lack of Efficacy|1|||
33616519|NCT01920477|63017466|FG001|Overall Study|Lack of Efficacy|0|||
33324927|NCT00905632|62701527|FG004|Overall Study|Adverse Event|0|||
33324928|NCT00905632|62701528|FG005|Overall Study|Adverse Event|1|||
33324929|NCT00905632|62701529|FG006|Overall Study|Adverse Event|4|||
33324930|NCT00954447|62701554|FG000|Overall Study|Adverse Event|33|||
33324931|NCT00954447|62701555|FG001|Overall Study|Adverse Event|25|||
33324932|NCT00954447|62701554|FG000|Overall Study|Lack of Efficacy|17|||
33518505|NCT01004861|62903894|FG003|Overall Study|Non-compliance|0|||
33518506|NCT01004861|62903895|FG004|Overall Study|Non-compliance|0|||
33518507|NCT01004861|62903896|FG005|Overall Study|Non-compliance|0|||
33324933|NCT00954447|62701555|FG001|Overall Study|Lack of Efficacy|3|||
33324934|NCT00954447|62701554|FG000|Overall Study|Protocol Violation|5|||
33324935|NCT00954447|62701555|FG001|Overall Study|Protocol Violation|7|||
33324936|NCT00954447|62701554|FG000|Overall Study|Lost to Follow-up|8|||
33324937|NCT00954447|62701555|FG001|Overall Study|Lost to Follow-up|14|||
33324938|NCT00954447|62701554|FG000|Overall Study|Withdrawal by Subject|26|||
33324939|NCT00954447|62701555|FG001|Overall Study|Withdrawal by Subject|21|||
33455053|NCT04584346|62829426|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
33455054|NCT00118482|62829436|FG000|Overall Study|Lost to Follow-up|7|||
33455055|NCT00118482|62829437|FG001|Overall Study|Lost to Follow-up|7|||
33455056|NCT00118482|62829436|FG000|Overall Study|Withdrawal by Subject|23|||
33455057|NCT00118482|62829437|FG001|Overall Study|Withdrawal by Subject|22|||
33455058|NCT00129272|62829445|FG000|Overall Study|Lost to Follow-up|12|||
33455059|NCT00129272|62829446|FG001|Overall Study|Lost to Follow-up|11|||
33455060|NCT00129272|62829445|FG000|Overall Study|Withdrawal by Subject|5|||
33455061|NCT00129272|62829446|FG001|Overall Study|Withdrawal by Subject|11|||
33455062|NCT04899232|62829455|FG000|Screening Period|Physician Decision|1|||
33455063|NCT04899232|62829456|FG001|Screening Period|Physician Decision|0|||
33455064|NCT04899232|62829457|FG002|Screening Period|Physician Decision|0|||
33455065|NCT04899232|62829455|FG000|Screening Period|Withdrawal by Subject|1|||
33455066|NCT04899232|62829456|FG001|Screening Period|Withdrawal by Subject|0|||
33455067|NCT04899232|62829457|FG002|Screening Period|Withdrawal by Subject|0|||
33455068|NCT04899232|62829455|FG000|Screening Period|Participant discharged before receiving intervention|3|||
33455069|NCT04899232|62829456|FG001|Screening Period|Participant discharged before receiving intervention|0|||
33455070|NCT04899232|62829457|FG002|Screening Period|Participant discharged before receiving intervention|0|||
33455071|NCT04559698|62829476|FG000|Overall Study|Lost to Follow-up|14|||
33518508|NCT01004861|62903897|FG006|Overall Study|Non-compliance|0|||
33616520|NCT01920477|63017465|FG000|Overall Study|Study closed/terminated|14|||
33616521|NCT01920477|63017466|FG001|Overall Study|Study closed/terminated|15|||
33616522|NCT01920477|63017465|FG000|Overall Study|Withdrawal by Subject|0|||
33616523|NCT01920477|63017466|FG001|Overall Study|Withdrawal by Subject|1|||
33616524|NCT02213042|63017475|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
33616525|NCT02213042|63017476|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
33616526|NCT02213042|63017477|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
33324940|NCT00954447|62701554|FG000|Overall Study|Other|21|||
33616527|NCT02213042|63017475|FG000|Overall Study|Adverse Event|2|||
33518509|NCT01004861|62903898|FG007|Overall Study|Non-compliance|0|||
33518510|NCT01004861|62903899|FG008|Overall Study|Non-compliance|5|||
33518511|NCT01004861|62903900|FG009|Overall Study|Non-compliance|0|||
33518512|NCT01004861|62903901|FG010|Overall Study|Non-compliance|0|||
33518513|NCT01004861|62903902|FG011|Overall Study|Non-compliance|0|||
33518514|NCT01004861|62903903|FG012|Overall Study|Non-compliance|1|||
33518515|NCT01004861|62903891|FG000|Overall Study|Other|0|||
33518516|NCT01004861|62903892|FG001|Overall Study|Other|0|||
33518517|NCT01004861|62903893|FG002|Overall Study|Other|0|||
33518518|NCT01004861|62903894|FG003|Overall Study|Other|0|||
33518519|NCT01004861|62903895|FG004|Overall Study|Other|0|||
33518520|NCT01004861|62903896|FG005|Overall Study|Other|0|||
33518521|NCT01004861|62903897|FG006|Overall Study|Other|0|||
33518522|NCT01004861|62903898|FG007|Overall Study|Other|0|||
33518523|NCT01004861|62903899|FG008|Overall Study|Other|0|||
33518524|NCT01004861|62903900|FG009|Overall Study|Other|2|||
33518525|NCT01004861|62903901|FG010|Overall Study|Other|1|||
33518526|NCT01004861|62903902|FG011|Overall Study|Other|2|||
33518527|NCT01004861|62903903|FG012|Overall Study|Other|3|||
33518528|NCT01004861|62903891|FG000|Overall Study|Patient decision|0|||
33518529|NCT01004861|62903892|FG001|Overall Study|Patient decision|0|||
33518530|NCT01004861|62903893|FG002|Overall Study|Patient decision|0|||
33518531|NCT01004861|62903894|FG003|Overall Study|Patient decision|0|||
33518532|NCT01004861|62903895|FG004|Overall Study|Patient decision|1|||
33518533|NCT01004861|62903896|FG005|Overall Study|Patient decision|0|||
33518534|NCT01004861|62903897|FG006|Overall Study|Patient decision|1|||
33518535|NCT01004861|62903898|FG007|Overall Study|Patient decision|0|||
33518536|NCT01004861|62903899|FG008|Overall Study|Patient decision|7|||
33518537|NCT01004861|62903900|FG009|Overall Study|Patient decision|1|||
33518538|NCT01004861|62903901|FG010|Overall Study|Patient decision|1|||
33518539|NCT01004861|62903902|FG011|Overall Study|Patient decision|2|||
33518540|NCT01004861|62903903|FG012|Overall Study|Patient decision|3|||
33518541|NCT01004861|62903891|FG000|Overall Study|Transitioned to Phase 4 study|0|||
33518542|NCT01004861|62903892|FG001|Overall Study|Transitioned to Phase 4 study|0|||
33518543|NCT01004861|62903893|FG002|Overall Study|Transitioned to Phase 4 study|0|||
33518544|NCT01004861|62903894|FG003|Overall Study|Transitioned to Phase 4 study|0|||
33518545|NCT01004861|62903895|FG004|Overall Study|Transitioned to Phase 4 study|0|||
33518546|NCT01004861|62903896|FG005|Overall Study|Transitioned to Phase 4 study|0|||
33518547|NCT01004861|62903897|FG006|Overall Study|Transitioned to Phase 4 study|0|||
33518548|NCT01004861|62903898|FG007|Overall Study|Transitioned to Phase 4 study|0|||
33518549|NCT01004861|62903899|FG008|Overall Study|Transitioned to Phase 4 study|2|||
33518550|NCT01004861|62903900|FG009|Overall Study|Transitioned to Phase 4 study|0|||
33518551|NCT01004861|62903901|FG010|Overall Study|Transitioned to Phase 4 study|0|||
33518552|NCT01004861|62903902|FG011|Overall Study|Transitioned to Phase 4 study|0|||
33518553|NCT01004861|62903903|FG012|Overall Study|Transitioned to Phase 4 study|0|||
33518554|NCT01004861|62903891|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33518555|NCT01004861|62903892|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33518556|NCT01004861|62903893|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33518557|NCT01004861|62903894|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33518558|NCT01004861|62903895|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33518559|NCT01004861|62903896|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33518560|NCT01004861|62903897|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33518561|NCT01004861|62903898|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33518562|NCT01004861|62903899|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
33518563|NCT01004861|62903900|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33518564|NCT01004861|62903901|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33518565|NCT01004861|62903902|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33518566|NCT01004861|62903903|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33518567|NCT01004861|62903891|FG000|Overall Study|Patient withdrew|0|||
33518568|NCT01004861|62903892|FG001|Overall Study|Patient withdrew|0|||
33518569|NCT01004861|62903893|FG002|Overall Study|Patient withdrew|0|||
33518570|NCT01004861|62903894|FG003|Overall Study|Patient withdrew|0|||
33518571|NCT01004861|62903895|FG004|Overall Study|Patient withdrew|0|||
33518572|NCT01004861|62903896|FG005|Overall Study|Patient withdrew|0|||
33518573|NCT01004861|62903897|FG006|Overall Study|Patient withdrew|0|||
33518574|NCT01004861|62903898|FG007|Overall Study|Patient withdrew|0|||
33518575|NCT01004861|62903899|FG008|Overall Study|Patient withdrew|1|||
33518576|NCT01004861|62903900|FG009|Overall Study|Patient withdrew|0|||
33518577|NCT01004861|62903901|FG010|Overall Study|Patient withdrew|0|||
33518578|NCT01004861|62903902|FG011|Overall Study|Patient withdrew|0|||
33518579|NCT01004861|62903903|FG012|Overall Study|Patient withdrew|0|||
33518580|NCT01004861|62903891|FG000|Overall Study|Surgical resection|0|||
33518581|NCT01004861|62903892|FG001|Overall Study|Surgical resection|0|||
33518582|NCT01004861|62903893|FG002|Overall Study|Surgical resection|0|||
33518583|NCT01004861|62903894|FG003|Overall Study|Surgical resection|0|||
33518584|NCT01004861|62903895|FG004|Overall Study|Surgical resection|0|||
33518585|NCT01004861|62903896|FG005|Overall Study|Surgical resection|0|||
33518586|NCT01004861|62903897|FG006|Overall Study|Surgical resection|0|||
33518587|NCT01004861|62903898|FG007|Overall Study|Surgical resection|0|||
33518588|NCT01004861|62903899|FG008|Overall Study|Surgical resection|1|||
33518589|NCT01004861|62903900|FG009|Overall Study|Surgical resection|0|||
33518590|NCT01004861|62903901|FG010|Overall Study|Surgical resection|0|||
33518591|NCT01004861|62903902|FG011|Overall Study|Surgical resection|0|||
33518592|NCT01004861|62903903|FG012|Overall Study|Surgical resection|0|||
33518593|NCT01004861|62903891|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33518594|NCT01004861|62903892|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33518595|NCT01004861|62903893|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33518596|NCT01004861|62903894|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33518597|NCT01004861|62903895|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33518598|NCT01004861|62903896|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33518599|NCT01004861|62903897|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33518600|NCT01004861|62903898|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33518601|NCT01004861|62903899|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
33518602|NCT01004861|62903900|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33518603|NCT01004861|62903901|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33616528|NCT02213042|63017476|FG001|Overall Study|Adverse Event|1|||
33616529|NCT02213042|63017477|FG002|Overall Study|Adverse Event|0|||
33518604|NCT01004861|62903902|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33518605|NCT01004861|62903903|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33518606|NCT01004861|62903891|FG000|Overall Study|Study termination by Sponsor|0|||
33518607|NCT01004861|62903892|FG001|Overall Study|Study termination by Sponsor|0|||
33518608|NCT01004861|62903893|FG002|Overall Study|Study termination by Sponsor|0|||
33518609|NCT01004861|62903894|FG003|Overall Study|Study termination by Sponsor|0|||
33518610|NCT01004861|62903895|FG004|Overall Study|Study termination by Sponsor|0|||
33518611|NCT01004861|62903896|FG005|Overall Study|Study termination by Sponsor|0|||
33518612|NCT01004861|62903897|FG006|Overall Study|Study termination by Sponsor|0|||
33518613|NCT01004861|62903898|FG007|Overall Study|Study termination by Sponsor|0|||
33518614|NCT01004861|62903899|FG008|Overall Study|Study termination by Sponsor|1|||
33518615|NCT01004861|62903900|FG009|Overall Study|Study termination by Sponsor|0|||
33518616|NCT01004861|62903901|FG010|Overall Study|Study termination by Sponsor|0|||
33518617|NCT01004861|62903902|FG011|Overall Study|Study termination by Sponsor|0|||
33518618|NCT01004861|62903903|FG012|Overall Study|Study termination by Sponsor|0|||
33518619|NCT03254459|62903950|FG000|Overall Study|Adverse Event|7|||
33518620|NCT03254459|62903951|FG001|Overall Study|Adverse Event|20|||
33518621|NCT03254459|62903950|FG000|Overall Study|Withdrawal by Subject Consent|3|||
33518622|NCT03254459|62903951|FG001|Overall Study|Withdrawal by Subject Consent|1|||
33518623|NCT03254459|62903950|FG000|Overall Study|Lost to Follow-up|0|||
33518624|NCT03254459|62903951|FG001|Overall Study|Lost to Follow-up|1|||
33518625|NCT03254459|62903950|FG000|Overall Study|Miscellaneous|0|||
33518626|NCT03254459|62903951|FG001|Overall Study|Miscellaneous|1|||
33518627|NCT02736617|62903957|FG000|Treatment|Adverse Event|1|||
33518628|NCT02736617|62903957|FG000|Treatment|Lack of Efficacy|1|||
33518629|NCT02736617|62903957|FG000|Treatment|Withdrawal by Subject|1|||
33518630|NCT02736617|62903957|FG000|Maintenance|Lack of Efficacy|4|||
33518631|NCT02736617|62903957|FG000|Maintenance|Physician Decision|1|||
33518632|NCT03251963|62903964|FG000|Overall Study|inappropriate Xa level timing|6|||
33518633|NCT03251963|62903965|FG001|Overall Study|inappropriate Xa level timing|3|||
33518634|NCT03251963|62903964|FG000|Overall Study|no peak Xa level drawn|2|||
33518635|NCT03251963|62903965|FG001|Overall Study|no peak Xa level drawn|0|||
33518636|NCT03251963|62903964|FG000|Overall Study|bled prior to Xa level|1|||
33518637|NCT03251963|62903965|FG001|Overall Study|bled prior to Xa level|2|||
33616530|NCT02213042|63017475|FG000|Overall Study|Withdrawal by Subject|0|||
33616531|NCT02213042|63017476|FG001|Overall Study|Withdrawal by Subject|1|||
33616532|NCT02213042|63017477|FG002|Overall Study|Withdrawal by Subject|1|||
33616533|NCT02213042|63017475|FG000|Overall Study|Protocol Violation|1|||
33616534|NCT02213042|63017476|FG001|Overall Study|Protocol Violation|0|||
33616535|NCT02213042|63017477|FG002|Overall Study|Protocol Violation|0|||
33616536|NCT02213042|63017475|FG000|Overall Study|Investigator discretion|0|||
33616537|NCT02213042|63017476|FG001|Overall Study|Investigator discretion|0|||
33616538|NCT02213042|63017477|FG002|Overall Study|Investigator discretion|1|||
33616539|NCT02212730|63017489|FG000|Overall Study|Tumor not of the required cell histology|1|||
33616540|NCT02212730|63017490|FG001|Overall Study|Tumor not of the required cell histology|0|||
33616541|NCT02212730|63017489|FG000|Overall Study|Withdrawal by Subject|1|||
33616542|NCT02212730|63017490|FG001|Overall Study|Withdrawal by Subject|0|||
33616543|NCT02212730|63017489|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
33616544|NCT02212730|63017490|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
33616545|NCT02178956|63017500|FG000|Overall Study|Lost to Follow-up|4|||
33324941|NCT00954447|62701555|FG001|Overall Study|Other|18|||
33324942|NCT00904150|62701563|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
33324943|NCT00904150|62701564|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
33324944|NCT00904150|62701563|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
33324945|NCT00904150|62701564|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
33324946|NCT00903760|62701572|FG000|Overall Study|Disease Progression/Death|8|||
33455072|NCT04559698|62829477|FG001|Overall Study|Lost to Follow-up|15|||
33455073|NCT04559698|62829476|FG000|Overall Study|Withdrawal by Subject|0|||
33455074|NCT04559698|62829477|FG001|Overall Study|Withdrawal by Subject|1|||
33455075|NCT00133952|62829485|FG000|Overall Study|Adverse Event|1|||
33455076|NCT00133952|62829486|FG001|Overall Study|Adverse Event|2|||
33455077|NCT00133952|62829485|FG000|Overall Study|Death|3|||
33455078|NCT00133952|62829486|FG001|Overall Study|Death|2|||
33455079|NCT00133952|62829485|FG000|Overall Study|Lost to Follow-up|9|||
33455080|NCT00133952|62829486|FG001|Overall Study|Lost to Follow-up|14|||
33455081|NCT00133952|62829485|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
33455082|NCT00133952|62829486|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
33518638|NCT03287219|62903973|FG000|Overall Study|Protocol Violation|0|||
33518639|NCT03287219|62903974|FG001|Overall Study|Protocol Violation|2|||
33518640|NCT03286751|62904013|FG000|Washout Period 1|Withdrawal by Subject|0|||
33518641|NCT03286751|62904014|FG001|Washout Period 1|Withdrawal by Subject|0|||
33518642|NCT03286751|62904015|FG002|Washout Period 1|Withdrawal by Subject|0|||
33518643|NCT03286751|62904016|FG003|Washout Period 1|Withdrawal by Subject|0|||
33616546|NCT02178956|63017501|FG001|Overall Study|Lost to Follow-up|4|||
33616547|NCT02178956|63017500|FG000|Overall Study|Sponsor terminated study|49|||
33518644|NCT03286751|62904017|FG004|Washout Period 1|Withdrawal by Subject|1|||
33616548|NCT02178956|63017501|FG001|Overall Study|Sponsor terminated study|58|||
33324947|NCT00903760|62701573|FG001|Overall Study|Disease Progression/Death|6|||
33324948|NCT00903760|62701572|FG000|Overall Study|Stem Cell Transplant|8|||
33324949|NCT00903760|62701573|FG001|Overall Study|Stem Cell Transplant|4|||
33324950|NCT00903760|62701572|FG000|Overall Study|Physician Decision|1|||
33324951|NCT00903760|62701573|FG001|Overall Study|Physician Decision|2|||
33324952|NCT00903760|62701572|FG000|Overall Study|Death|0|||
33324953|NCT00903760|62701573|FG001|Overall Study|Death|1|||
33324954|NCT00903760|62701572|FG000|Overall Study|Lost to Follow-up|1|||
33324955|NCT00903760|62701573|FG001|Overall Study|Lost to Follow-up|0|||
33324956|NCT00903760|62701572|FG000|Overall Study|Withdrawal by Subject|1|||
33324957|NCT00903760|62701573|FG001|Overall Study|Withdrawal by Subject|2|||
33324958|NCT00903760|62701572|FG000|Overall Study|Off treatment for long period|0|||
33324959|NCT00903760|62701573|FG001|Overall Study|Off treatment for long period|1|||
33324960|NCT00883051|62701584|FG000|Overall Study|Lost to Follow-up|0|||
33324961|NCT00883051|62701585|FG001|Overall Study|Lost to Follow-up|0|||
33324962|NCT00883051|62701586|FG002|Overall Study|Lost to Follow-up|0|||
33324963|NCT00883051|62701587|FG003|Overall Study|Lost to Follow-up|0|||
33455083|NCT00133952|62829485|FG000|Overall Study|Protocol Violation|1|||
33455084|NCT00133952|62829486|FG001|Overall Study|Protocol Violation|1|||
33455085|NCT00133952|62829485|FG000|Overall Study|Withdrawal by Subject|20|||
33455086|NCT00133952|62829486|FG001|Overall Study|Withdrawal by Subject|4|||
33518645|NCT03286751|62904018|FG005|Washout Period 1|Withdrawal by Subject|0|||
33518646|NCT03286751|62904013|FG000|Washout Period 2|Personal Reasons|0|||
33518647|NCT03286751|62904014|FG001|Washout Period 2|Personal Reasons|1|||
33518648|NCT03286751|62904015|FG002|Washout Period 2|Personal Reasons|0|||
33518649|NCT03286751|62904016|FG003|Washout Period 2|Personal Reasons|0|||
33518650|NCT03286751|62904017|FG004|Washout Period 2|Personal Reasons|0|||
33518651|NCT03286751|62904018|FG005|Washout Period 2|Personal Reasons|0|||
33518652|NCT03286751|62904013|FG000|Washout Period 5|Adverse Event|0|||
33518653|NCT03286751|62904014|FG001|Washout Period 5|Adverse Event|0|||
33518654|NCT03286751|62904015|FG002|Washout Period 5|Adverse Event|0|||
33518655|NCT03286751|62904016|FG003|Washout Period 5|Adverse Event|0|||
33518656|NCT03286751|62904017|FG004|Washout Period 5|Adverse Event|1|||
33518657|NCT03286751|62904018|FG005|Washout Period 5|Adverse Event|0|||
33518658|NCT03249935|62904032|FG000|Overall Study|Discharged from facility early|36|||
33518659|NCT03249935|62904032|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
33518660|NCT03249935|62904032|FG000|Overall Study|Protocol Violation|5|||
33455087|NCT00133952|62829485|FG000|Overall Study|Physician Decision|4|||
33455088|NCT00133952|62829486|FG001|Overall Study|Physician Decision|3|||
33455089|NCT00133952|62829485|FG000|Overall Study|Sponsor Decision|0|||
33455090|NCT00133952|62829486|FG001|Overall Study|Sponsor Decision|1|||
33455091|NCT00118092|62829492|FG000|Overall Study|Withdrawal by Subject|1|||
33455092|NCT00118092|62829492|FG000|Overall Study|Protocol Violation|1|||
33455093|NCT04555096|62829499|FG000|Overall Study|Death|4|||
33455094|NCT04555096|62829500|FG001|Overall Study|Death|4|||
33455095|NCT04555096|62829499|FG000|Overall Study|Withdrawal by Subject|1|||
33455096|NCT04555096|62829500|FG001|Overall Study|Withdrawal by Subject|0|||
33455097|NCT04555096|62829499|FG000|Overall Study|Other|0|||
33455098|NCT04555096|62829500|FG001|Overall Study|Other|1|||
33455099|NCT00097500|62829508|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
33455100|NCT00097500|62829509|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
33455101|NCT00097500|62829508|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
33455102|NCT00097500|62829509|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
33455103|NCT00097500|62829508|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
33455104|NCT00097500|62829509|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
33455105|NCT00097500|62829508|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
33455106|NCT00097500|62829509|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
33455107|NCT00097500|62829508|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
33455108|NCT00097500|62829509|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
33455109|NCT00097500|62829508|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
33455110|NCT00097500|62829509|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
33455111|NCT00097500|62829508|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
33518661|NCT03285113|62904038|FG000|Overall Study|Unable to implant leads|2|||
33616549|NCT02178956|63017500|FG000|Overall Study|Withdrawal by Subject|15|||
33455112|NCT00097500|62829509|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
33455113|NCT04551898|62829519|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
33455114|NCT04551898|62829520|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
33455115|NCT04551898|62829521|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
33455116|NCT04551898|62829522|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
33455117|NCT04551898|62829519|FG000|Overall Study|Withdrawal by Subject|5|||
33616550|NCT02178956|63017501|FG001|Overall Study|Withdrawal by Subject|11|||
33616551|NCT02178956|63017500|FG000|Overall Study|Various Reasons|3|||
33324964|NCT00883051|62701588|FG004|Overall Study|Lost to Follow-up|1|||
33324965|NCT00883051|62701584|FG000|Overall Study|Did not use study medication|24|||
33324966|NCT00883051|62701585|FG001|Overall Study|Did not use study medication|22|||
33518662|NCT03000348|62904048|FG000|Overall Study|Adverse Event|1|||
33518663|NCT03000348|62904049|FG001|Overall Study|Adverse Event|1|||
33518664|NCT03000348|62904050|FG002|Overall Study|Adverse Event|1|||
33518665|NCT03000348|62904051|FG003|Overall Study|Adverse Event|1|||
33518666|NCT03000348|62904052|FG004|Overall Study|Adverse Event|1|||
33518667|NCT03000348|62904053|FG005|Overall Study|Adverse Event|1|||
33518668|NCT03000348|62904048|FG000|Overall Study|Lost to Follow-up|0|||
33518669|NCT03000348|62904049|FG001|Overall Study|Lost to Follow-up|0|||
33518670|NCT03000348|62904050|FG002|Overall Study|Lost to Follow-up|1|||
33518671|NCT03000348|62904051|FG003|Overall Study|Lost to Follow-up|0|||
33518672|NCT03000348|62904052|FG004|Overall Study|Lost to Follow-up|0|||
33518673|NCT03000348|62904053|FG005|Overall Study|Lost to Follow-up|0|||
33518674|NCT03000348|62904048|FG000|Overall Study|Withdrawal by Subject|0|||
33518675|NCT03000348|62904049|FG001|Overall Study|Withdrawal by Subject|1|||
33518676|NCT03000348|62904050|FG002|Overall Study|Withdrawal by Subject|0|||
33518677|NCT03000348|62904051|FG003|Overall Study|Withdrawal by Subject|0|||
33518678|NCT03000348|62904052|FG004|Overall Study|Withdrawal by Subject|0|||
33518679|NCT03000348|62904053|FG005|Overall Study|Withdrawal by Subject|0|||
33518680|NCT03000348|62904048|FG000|Overall Study|Consent|0|||
33518681|NCT03000348|62904049|FG001|Overall Study|Consent|0|||
33518682|NCT03000348|62904050|FG002|Overall Study|Consent|0|||
33518683|NCT03000348|62904051|FG003|Overall Study|Consent|0|||
33616552|NCT02178956|63017501|FG001|Overall Study|Various Reasons|5|||
33518684|NCT03000348|62904052|FG004|Overall Study|Consent|1|||
33518685|NCT03000348|62904053|FG005|Overall Study|Consent|0|||
33518686|NCT03000348|62904048|FG000|Overall Study|Failure to expectorate sputum|1|||
33518687|NCT03000348|62904049|FG001|Overall Study|Failure to expectorate sputum|0|||
33518688|NCT03000348|62904050|FG002|Overall Study|Failure to expectorate sputum|1|||
33518689|NCT03000348|62904051|FG003|Overall Study|Failure to expectorate sputum|0|||
33518690|NCT03000348|62904052|FG004|Overall Study|Failure to expectorate sputum|1|||
33518691|NCT03000348|62904053|FG005|Overall Study|Failure to expectorate sputum|0|||
33518692|NCT03000348|62904048|FG000|Overall Study|No gram negative|1|||
33518693|NCT03000348|62904049|FG001|Overall Study|No gram negative|2|||
33518694|NCT03000348|62904050|FG002|Overall Study|No gram negative|1|||
33518695|NCT03000348|62904051|FG003|Overall Study|No gram negative|1|||
33518696|NCT03000348|62904052|FG004|Overall Study|No gram negative|1|||
33518697|NCT03000348|62904053|FG005|Overall Study|No gram negative|1|||
33518698|NCT03000348|62904048|FG000|Overall Study|Patient had no transport|0|||
33518699|NCT03000348|62904049|FG001|Overall Study|Patient had no transport|0|||
33518700|NCT03000348|62904050|FG002|Overall Study|Patient had no transport|0|||
33616553|NCT02211638|63017511|FG000|Overall Study|Case Report Forms Uncollected|291|||
33616554|NCT02211638|63017511|FG000|Overall Study|Protocol Violation|692|||
33616555|NCT02178566|63017517|FG000|Overall Study|patient did not complete due to noncompliance|0|||
33616556|NCT02178566|63017518|FG001|Overall Study|patient did not complete due to noncompliance|1|||
33616557|NCT02211014|63017526|FG000|Overall Study|Adverse Event|0|||
33616558|NCT02211014|63017527|FG001|Overall Study|Adverse Event|2|||
33616559|NCT02211014|63017526|FG000|Overall Study|Physician Decision|1|||
33616560|NCT02211014|63017527|FG001|Overall Study|Physician Decision|2|||
33616561|NCT02211014|63017526|FG000|Overall Study|Started another cancer therapy|1|||
33616562|NCT02211014|63017527|FG001|Overall Study|Started another cancer therapy|0|||
33616563|NCT02211014|63017526|FG000|Overall Study|Withdrawal by Subject|0|||
33616564|NCT02211014|63017527|FG001|Overall Study|Withdrawal by Subject|1|||
33616565|NCT02211014|63017526|FG000|Overall Study|In agreement with patient, no benefit|0|||
33616566|NCT02211014|63017527|FG001|Overall Study|In agreement with patient, no benefit|1|||
33616567|NCT01631864|63017551|FG000|Overall Study|Withdrawal by Subject|0|||
33616568|NCT01631864|63017552|FG001|Overall Study|Withdrawal by Subject|1|||
33616569|NCT01631864|63017551|FG000|Overall Study|Adverse Event|2|||
33455118|NCT04551898|62829520|FG001|Overall Study|Withdrawal by Subject|1|||
33455119|NCT04551898|62829521|FG002|Overall Study|Withdrawal by Subject|2|||
33455120|NCT04551898|62829522|FG003|Overall Study|Withdrawal by Subject|2|||
33455121|NCT04551898|62829519|FG000|Overall Study|Lost to Follow-up|2|||
33455122|NCT04551898|62829520|FG001|Overall Study|Lost to Follow-up|1|||
33455123|NCT04551898|62829521|FG002|Overall Study|Lost to Follow-up|2|||
33455124|NCT04551898|62829522|FG003|Overall Study|Lost to Follow-up|2|||
33455125|NCT04551898|62829519|FG000|Overall Study|Death|1|||
33455126|NCT04551898|62829520|FG001|Overall Study|Death|0|||
33455127|NCT04551898|62829521|FG002|Overall Study|Death|0|||
33455128|NCT04551898|62829522|FG003|Overall Study|Death|0|||
33455129|NCT04551898|62829519|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
33455130|NCT04551898|62829520|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
33455131|NCT04551898|62829521|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
33518701|NCT03000348|62904051|FG003|Overall Study|Patient had no transport|1|||
33518702|NCT03000348|62904052|FG004|Overall Study|Patient had no transport|0|||
33518703|NCT03000348|62904053|FG005|Overall Study|Patient had no transport|0|||
33518704|NCT03000348|62904048|FG000|Overall Study|Dosing|0|||
33518705|NCT03000348|62904049|FG001|Overall Study|Dosing|0|||
33518706|NCT03000348|62904050|FG002|Overall Study|Dosing|0|||
33518707|NCT03000348|62904051|FG003|Overall Study|Dosing|0|||
33518708|NCT03000348|62904052|FG004|Overall Study|Dosing|1|||
33518709|NCT03000348|62904053|FG005|Overall Study|Dosing|0|||
33518710|NCT03283709|62904072|FG000|Overall Study|trial terminated|0|||
33518711|NCT03283709|62904073|FG001|Overall Study|trial terminated|1|||
33518712|NCT03247673|62904082|FG000|Overall Study|Withdrawal by Subject|1|||
33518713|NCT03247673|62904083|FG001|Overall Study|Withdrawal by Subject|0|||
33518714|NCT03247673|62904084|FG002|Overall Study|Withdrawal by Subject|3|||
33518715|NCT03247673|62904082|FG000|Overall Study|Lost to Follow-up|0|||
33518716|NCT03247673|62904083|FG001|Overall Study|Lost to Follow-up|0|||
33518717|NCT03247673|62904084|FG002|Overall Study|Lost to Follow-up|1|||
33518718|NCT03247517|62904095|FG000|Overall Study|Adverse Event|0|||
33324967|NCT00883051|62701586|FG002|Overall Study|Did not use study medication|29|||
33324968|NCT00883051|62701587|FG003|Overall Study|Did not use study medication|29|||
33324969|NCT00883051|62701588|FG004|Overall Study|Did not use study medication|17|||
33324970|NCT00903682|62701602|FG000|Overall Study|Adverse Event|6|||
33324971|NCT00903682|62701603|FG001|Overall Study|Adverse Event|13|||
33324972|NCT00903682|62701602|FG000|Overall Study|Lost to Follow-up|1|||
33324973|NCT00903682|62701603|FG001|Overall Study|Lost to Follow-up|0|||
33324974|NCT00903682|62701602|FG000|Overall Study|Withdrawal by Subject|5|||
33324975|NCT00903682|62701603|FG001|Overall Study|Withdrawal by Subject|0|||
33324976|NCT00903682|62701602|FG000|Overall Study|Pregnancy|0|||
33324977|NCT00903682|62701603|FG001|Overall Study|Pregnancy|1|||
33324978|NCT00903682|62701602|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
33324979|NCT00903682|62701603|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
33324980|NCT00903682|62701602|FG000|Overall Study|Subject Non-Compliant|1|||
33324981|NCT00903682|62701603|FG001|Overall Study|Subject Non-Compliant|0|||
33324982|NCT00903682|62701602|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
33324983|NCT00903682|62701603|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
33324984|NCT00903682|62701602|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
33324985|NCT00903682|62701603|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
33324986|NCT01117428|62701615|FG000|Overall Study|Lack of Efficacy|1|||
33324987|NCT01117428|62701616|FG001|Overall Study|Lack of Efficacy|0|||
33324988|NCT01117428|62701617|FG002|Overall Study|Lack of Efficacy|0|||
33518719|NCT03247517|62904096|FG001|Overall Study|Adverse Event|4|||
33518720|NCT03247517|62904097|FG002|Overall Study|Adverse Event|2|||
33518721|NCT03247517|62904095|FG000|Overall Study|Lost to Follow-up|2|||
33518722|NCT03247517|62904096|FG001|Overall Study|Lost to Follow-up|6|||
33324989|NCT01117428|62701618|FG003|Overall Study|Lack of Efficacy|0|||
33324990|NCT01117428|62701619|FG004|Overall Study|Lack of Efficacy|0|||
33324991|NCT01117428|62701620|FG005|Overall Study|Lack of Efficacy|0|||
33324992|NCT01117428|62701615|FG000|Overall Study|Adverse Event|4|||
33324993|NCT01117428|62701616|FG001|Overall Study|Adverse Event|0|||
33324994|NCT01117428|62701617|FG002|Overall Study|Adverse Event|0|||
33324995|NCT01117428|62701618|FG003|Overall Study|Adverse Event|0|||
33324996|NCT01117428|62701619|FG004|Overall Study|Adverse Event|1|||
33324997|NCT01117428|62701620|FG005|Overall Study|Adverse Event|2|||
33324998|NCT01117428|62701615|FG000|Overall Study|Death|0|||
33324999|NCT01117428|62701616|FG001|Overall Study|Death|1|||
33455132|NCT04551898|62829522|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
33455133|NCT04849780|62829540|FG000|Period 1|Covid-19 Related|1|||
33455134|NCT04849780|62829541|FG001|Period 1|Covid-19 Related|0|||
33455135|NCT04849780|62829540|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
33455136|NCT04849780|62829541|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
33455137|NCT04849780|62829540|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
33455138|NCT04849780|62829541|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
33455139|NCT04823494|62829555|FG000|Overall Study|Programming software malfunction.|1|||
33455140|NCT04823494|62829556|FG001|Overall Study|Programming software malfunction.|0|||
33518723|NCT03247517|62904097|FG002|Overall Study|Lost to Follow-up|4|||
33616570|NCT01631864|63017552|FG001|Overall Study|Adverse Event|3|||
33325000|NCT01117428|62701617|FG002|Overall Study|Death|2|||
33455141|NCT04823494|62829555|FG000|Overall Study|Withdrawal by Subject|1|||
33455142|NCT04823494|62829556|FG001|Overall Study|Withdrawal by Subject|0|||
33455143|NCT04823494|62829555|FG000|Overall Study|Devices lost|0|||
33518724|NCT03247517|62904095|FG000|Overall Study|Consent withdrawn by caregiver|1|||
33455144|NCT04823494|62829556|FG001|Overall Study|Devices lost|1|||
33518725|NCT03247517|62904096|FG001|Overall Study|Consent withdrawn by caregiver|4|||
33518726|NCT03247517|62904097|FG002|Overall Study|Consent withdrawn by caregiver|7|||
33518727|NCT03247517|62904095|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
33518728|NCT03247517|62904096|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
33325001|NCT01117428|62701618|FG003|Overall Study|Death|0|||
33325002|NCT01117428|62701619|FG004|Overall Study|Death|0|||
33325003|NCT01117428|62701620|FG005|Overall Study|Death|1|||
33325004|NCT01117428|62701615|FG000|Overall Study|Physician Decision|0|||
33325005|NCT01117428|62701616|FG001|Overall Study|Physician Decision|1|||
33325006|NCT01117428|62701617|FG002|Overall Study|Physician Decision|0|||
33325007|NCT01117428|62701618|FG003|Overall Study|Physician Decision|0|||
33518729|NCT03247517|62904097|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
33518730|NCT03247517|62904095|FG000|Overall Study|Protocol Violation|0|||
33518731|NCT03247517|62904096|FG001|Overall Study|Protocol Violation|2|||
33518732|NCT03247517|62904097|FG002|Overall Study|Protocol Violation|0|||
33518733|NCT03247517|62904095|FG000|Overall Study|Multiple reasons|3|||
33518734|NCT03247517|62904096|FG001|Overall Study|Multiple reasons|1|||
33518735|NCT03247517|62904097|FG002|Overall Study|Multiple reasons|0|||
33518736|NCT03283553|62904107|FG000|Patient Participant Flow|Death|5|||
33518737|NCT03283553|62904108|FG001|Patient Participant Flow|Death|10|||
33518738|NCT03283553|62904107|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
33518739|NCT03283553|62904108|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
33518740|NCT03283553|62904107|FG000|Patient Participant Flow|Lost to Follow-up|1|||
33518741|NCT03283553|62904108|FG001|Patient Participant Flow|Lost to Follow-up|1|||
33518742|NCT03283553|62904107|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
33325008|NCT01117428|62701619|FG004|Overall Study|Physician Decision|0|||
33455145|NCT04542694|62829566|FG000|Overall Study|The need for prohibited therapy|2|||
33518743|NCT03283553|62904108|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
33518744|NCT03283553|62904107|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
33518745|NCT03283553|62904108|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
33518746|NCT03283553|62904107|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
33518747|NCT03283553|62904108|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
33518748|NCT03283319|62904122|FG000|Overall Study|Lost to Follow-up|5|||
33518749|NCT03283319|62904123|FG001|Overall Study|Lost to Follow-up|4|||
33518750|NCT03283319|62904124|FG002|Overall Study|Lost to Follow-up|5|||
33518751|NCT03283319|62904125|FG003|Overall Study|Lost to Follow-up|5|||
33518752|NCT03283319|62904126|FG004|Overall Study|Lost to Follow-up|4|||
33518753|NCT03283319|62904127|FG005|Overall Study|Lost to Follow-up|3|||
33518754|NCT03283319|62904122|FG000|Overall Study|Withdrawal by Subject|2|||
33518755|NCT03283319|62904123|FG001|Overall Study|Withdrawal by Subject|2|||
33518756|NCT03283319|62904124|FG002|Overall Study|Withdrawal by Subject|2|||
33455146|NCT04542694|62829567|FG001|Overall Study|The need for prohibited therapy|0|||
33455147|NCT04542694|62829566|FG000|Overall Study|Adverse Event|1|||
33455148|NCT04542694|62829567|FG001|Overall Study|Adverse Event|0|||
33455149|NCT04542694|62829566|FG000|Overall Study|Protocol Violation|1|||
33455150|NCT04542694|62829567|FG001|Overall Study|Protocol Violation|0|||
33455151|NCT00117312|62829577|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
33455152|NCT00117312|62829578|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
33455153|NCT00117312|62829579|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
33325009|NCT01117428|62701620|FG005|Overall Study|Physician Decision|0|||
33455154|NCT00117312|62829580|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
33455155|NCT00117312|62829577|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
33455156|NCT00117312|62829578|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
33455157|NCT00117312|62829579|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
33455158|NCT00117312|62829580|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
33455159|NCT00117312|62829577|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
33455160|NCT00117312|62829578|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
33455161|NCT00117312|62829579|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
33455162|NCT00117312|62829580|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
33518757|NCT03283319|62904125|FG003|Overall Study|Withdrawal by Subject|1|||
33616571|NCT02210780|63017560|FG000|Overall Study|Adverse Event|0|||
33616572|NCT02210780|63017561|FG001|Overall Study|Adverse Event|5|||
33325010|NCT01117428|62701615|FG000|Overall Study|Withdrawal by Subject|0|||
33325011|NCT01117428|62701616|FG001|Overall Study|Withdrawal by Subject|0|||
33455163|NCT00117312|62829577|FG000|Overall Study|Other|0|||
33455164|NCT00117312|62829578|FG001|Overall Study|Other|1|||
33455165|NCT00117312|62829579|FG002|Overall Study|Other|3|||
33455166|NCT00117312|62829580|FG003|Overall Study|Other|1|||
33455167|NCT00117312|62829577|FG000|Overall Study|Patient choice|0|||
33518758|NCT03283319|62904126|FG004|Overall Study|Withdrawal by Subject|0|||
33518759|NCT03283319|62904127|FG005|Overall Study|Withdrawal by Subject|1|||
33518760|NCT03283319|62904122|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
33455168|NCT00117312|62829578|FG001|Overall Study|Patient choice|0|||
33518761|NCT03283319|62904123|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
33518762|NCT03283319|62904124|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
33518763|NCT03283319|62904125|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
33518764|NCT03283319|62904126|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
33518765|NCT03283319|62904127|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
33518766|NCT03282227|62904141|FG000|Overall Study|Exposure Goals Achieved|60|||
33518767|NCT03282227|62904141|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
33518768|NCT03282227|62904141|FG000|Overall Study|Adverse Event|15|||
33518769|NCT03282227|62904141|FG000|Overall Study|Lost to Follow-up|21|||
33518770|NCT03282227|62904141|FG000|Overall Study|Withdrawal by Subject|20|||
33518771|NCT03282227|62904141|FG000|Overall Study|Lack of Efficacy|12|||
33518772|NCT03282227|62904141|FG000|Overall Study|Sponsor decision|3|||
33518773|NCT03282227|62904141|FG000|Overall Study|Physician Decision|2|||
33518774|NCT03282227|62904141|FG000|Overall Study|Pregnancy|2|||
33518775|NCT03282227|62904141|FG000|Overall Study|Other|1|||
33518776|NCT03240575|62904149|FG000|Overall Study|Adverse Event|0|||
33518777|NCT03240575|62904150|FG001|Overall Study|Adverse Event|2|||
33518778|NCT03240575|62904151|FG002|Overall Study|Adverse Event|0|||
33518779|NCT03240575|62904152|FG003|Overall Study|Adverse Event|1|||
33518780|NCT03240575|62904149|FG000|Overall Study|Withdrawal by Subject|2|||
33518781|NCT03240575|62904150|FG001|Overall Study|Withdrawal by Subject|11|||
33518782|NCT03240575|62904151|FG002|Overall Study|Withdrawal by Subject|0|||
33518783|NCT03240575|62904152|FG003|Overall Study|Withdrawal by Subject|1|||
33518784|NCT03240575|62904149|FG000|Overall Study|Other|0|||
33518785|NCT03240575|62904150|FG001|Overall Study|Other|1|||
33518786|NCT03240575|62904151|FG002|Overall Study|Other|0|||
33518787|NCT03240575|62904152|FG003|Overall Study|Other|0|||
33518788|NCT03385265|62904164|FG000|Overall Study|Withdrawal by Subject|5|||
33518789|NCT03385265|62904165|FG001|Overall Study|Withdrawal by Subject|2|||
33518790|NCT03385265|62904166|FG002|Overall Study|Withdrawal by Subject|5|||
33518791|NCT03385265|62904167|FG003|Overall Study|Withdrawal by Subject|2|||
33518792|NCT03280121|62904179|FG000|Overall Study|Physician Decision|1|||
33518793|NCT03280121|62904179|FG000|Overall Study|Lost to Follow-up|1|||
33518794|NCT03280121|62904179|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
33518795|NCT03233009|62904183|FG000|Overall Study|Lost to Follow-up|1|||
33518796|NCT04034225|62904198|FG000|Overall Study|Death|3|||
33518797|NCT04034225|62904198|FG000|Overall Study|Withdrawal by Subject|2|||
33518798|NCT04034225|62904198|FG000|Overall Study|Study termination by Sponsor|18|||
33518799|NCT04034225|62904198|FG000|Overall Study|Physician Decision|1|||
33518800|NCT04034225|62904198|FG000|Overall Study|Lack of Efficacy|1|||
33518801|NCT02999178|62904206|FG000|Overall Study|Adverse Event|85|||
33518802|NCT02999178|62904207|FG001|Overall Study|Adverse Event|62|||
33518803|NCT02999178|62904206|FG000|Overall Study|Protocol Violation|1|||
33518804|NCT02999178|62904207|FG001|Overall Study|Protocol Violation|2|||
33518805|NCT02999178|62904206|FG000|Overall Study|Lost to Follow-up|0|||
33518806|NCT02999178|62904207|FG001|Overall Study|Lost to Follow-up|2|||
33518807|NCT02999178|62904206|FG000|Overall Study|Withdrawal by Subject|21|||
33518808|NCT02999178|62904207|FG001|Overall Study|Withdrawal by Subject|21|||
33518809|NCT02999178|62904206|FG000|Overall Study|Other reason not defined above|7|||
33518810|NCT02999178|62904207|FG001|Overall Study|Other reason not defined above|13|||
33518811|NCT02959190|62904219|FG000|Open Label|Adverse Event|5|||
33518812|NCT02959190|62904220|FG001|Open Label|Adverse Event|7|||
33518813|NCT02959190|62904221|FG002|Open Label|Adverse Event|3|||
33616573|NCT02210780|63017560|FG000|Overall Study|Lost to Follow-up|2|||
33616574|NCT02210780|63017561|FG001|Overall Study|Lost to Follow-up|1|||
33616575|NCT02210780|63017560|FG000|Overall Study|Withdrawal by Subject|1|||
33616576|NCT02210780|63017561|FG001|Overall Study|Withdrawal by Subject|1|||
33616577|NCT02210780|63017560|FG000|Overall Study|Physician Decision|1|||
33616578|NCT02210780|63017561|FG001|Overall Study|Physician Decision|0|||
33518814|NCT02959190|62904222|FG003|Open Label|Adverse Event|4|||
33518815|NCT02959190|62904219|FG000|Open Label|Pregnancy|0|||
33518816|NCT02959190|62904220|FG001|Open Label|Pregnancy|1|||
33518817|NCT02959190|62904221|FG002|Open Label|Pregnancy|0|||
33518818|NCT02959190|62904222|FG003|Open Label|Pregnancy|0|||
33518819|NCT02959190|62904219|FG000|Open Label|Withdrawal by Subject|2|||
33518820|NCT02959190|62904220|FG001|Open Label|Withdrawal by Subject|8|||
33518821|NCT02959190|62904221|FG002|Open Label|Withdrawal by Subject|0|||
33518822|NCT02959190|62904222|FG003|Open Label|Withdrawal by Subject|0|||
33518823|NCT02959190|62904219|FG000|Open Label|Physician Decision|0|||
33518824|NCT02959190|62904220|FG001|Open Label|Physician Decision|0|||
33616579|NCT02210780|63017560|FG000|Overall Study|Protocol Violation|1|||
33616580|NCT02210780|63017561|FG001|Overall Study|Protocol Violation|0|||
33518825|NCT02959190|62904221|FG002|Open Label|Physician Decision|1|||
33518826|NCT02959190|62904222|FG003|Open Label|Physician Decision|0|||
33518827|NCT02959190|62904219|FG000|Open Label|Protocol Violation|0|||
33518828|NCT02959190|62904220|FG001|Open Label|Protocol Violation|0|||
33518829|NCT02959190|62904221|FG002|Open Label|Protocol Violation|0|||
33518830|NCT02959190|62904222|FG003|Open Label|Protocol Violation|2|||
33518831|NCT02959190|62904219|FG000|Post Treatment Follow Up|Adverse Event|1|||
33518832|NCT02959190|62904220|FG001|Post Treatment Follow Up|Adverse Event|1|||
33518833|NCT02959190|62904221|FG002|Post Treatment Follow Up|Adverse Event|0|||
33518834|NCT02959190|62904222|FG003|Post Treatment Follow Up|Adverse Event|0|||
33616581|NCT02210780|63017560|FG000|Overall Study|Other than specified above|0|||
33616582|NCT02210780|63017561|FG001|Overall Study|Other than specified above|1|||
33616583|NCT01557244|63017572|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
33616584|NCT01557244|63017573|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
33616585|NCT01557244|63017574|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
33616586|NCT01557244|63017575|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
33616587|NCT01557244|63017576|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
33616588|NCT01557244|63017577|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
33616589|NCT01557244|63017578|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
33616590|NCT01557244|63017572|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
33616591|NCT01557244|63017573|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
33616592|NCT01557244|63017574|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
33616593|NCT01557244|63017575|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
33518835|NCT02959190|62904219|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
33518836|NCT02959190|62904220|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
33518837|NCT02959190|62904221|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
33518838|NCT02959190|62904222|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
33518839|NCT01344356|62904243|FG000|Overall Study|Physician Decision|0|||
33518840|NCT01344356|62904244|FG001|Overall Study|Physician Decision|3|||
33518841|NCT01344356|62904243|FG000|Overall Study|Lost to Follow-up|0|||
33518842|NCT01344356|62904244|FG001|Overall Study|Lost to Follow-up|6|||
33518843|NCT02956460|62904270|FG000|Lens 1|Lost to Follow-up|1|||
33518844|NCT02956460|62904271|FG001|Lens 1|Lost to Follow-up|0|||
33518845|NCT02999100|62904283|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
33518846|NCT02999100|62904284|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
33518847|NCT02999100|62904285|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
33518848|NCT02999100|62904286|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
33518849|NCT02999100|62904287|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
33518850|NCT02999100|62904288|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
33518851|NCT02999100|62904283|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
33518852|NCT02999100|62904284|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
33518853|NCT02999100|62904285|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
33518854|NCT02999100|62904286|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
33518855|NCT02999100|62904287|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
33518856|NCT02999100|62904288|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
33518857|NCT02999100|62904283|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
33518858|NCT02999100|62904284|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
33518859|NCT02999100|62904285|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
33518860|NCT02999100|62904286|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
33616594|NCT01557244|63017576|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
33616595|NCT01557244|63017577|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
33455169|NCT00117312|62829579|FG002|Overall Study|Patient choice|2|||
33455170|NCT00117312|62829580|FG003|Overall Study|Patient choice|1|||
33455171|NCT00117312|62829577|FG000|Overall Study|Adverse Event|0|||
33455172|NCT00117312|62829578|FG001|Overall Study|Adverse Event|2|||
33455173|NCT00117312|62829579|FG002|Overall Study|Adverse Event|0|||
33455174|NCT00117312|62829580|FG003|Overall Study|Adverse Event|0|||
33455175|NCT00117312|62829577|FG000|Overall Study|Protocol Violation|0|||
33455176|NCT00117312|62829578|FG001|Overall Study|Protocol Violation|1|||
33455177|NCT00117312|62829579|FG002|Overall Study|Protocol Violation|3|||
33455178|NCT00117312|62829580|FG003|Overall Study|Protocol Violation|0|||
33455179|NCT00117312|62829577|FG000|Overall Study|PSA decrease <=50%|0|||
33455180|NCT00117312|62829578|FG001|Overall Study|PSA decrease <=50%|2|||
33455181|NCT00117312|62829579|FG002|Overall Study|PSA decrease <=50%|2|||
33455182|NCT00117312|62829580|FG003|Overall Study|PSA decrease <=50%|4|||
33455183|NCT00117312|62829577|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
33455184|NCT00117312|62829578|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
33455185|NCT00117312|62829579|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
33455186|NCT00117312|62829580|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
33455187|NCT00117312|62829577|FG000|Overall Study|Hepatic abnormality|0|||
33455188|NCT00117312|62829578|FG001|Overall Study|Hepatic abnormality|1|||
33518861|NCT02999100|62904287|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
33518862|NCT02999100|62904288|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
33518863|NCT02749370|62904310|FG000|Overall Study|Withdrawal by Subject|11|||
33455189|NCT00117312|62829579|FG002|Overall Study|Hepatic abnormality|0|||
33455190|NCT00117312|62829580|FG003|Overall Study|Hepatic abnormality|1|||
33455191|NCT00117312|62829577|FG000|Overall Study|Withdrawal by Subject|0|||
33518864|NCT02749370|62904310|FG000|Overall Study|Lost to Follow-up|3|||
33518865|NCT03607994|62904316|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
33518866|NCT03607994|62904317|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
33616596|NCT01557244|63017578|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
33616597|NCT01557244|63017572|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
33616598|NCT01557244|63017573|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
33616599|NCT01557244|63017574|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
33616600|NCT01557244|63017575|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
33616601|NCT01557244|63017576|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
33616602|NCT01557244|63017577|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
33616603|NCT01557244|63017578|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
33616604|NCT01557244|63017572|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
33616605|NCT01557244|63017573|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
33616606|NCT01557244|63017574|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
33616607|NCT01557244|63017575|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
33616608|NCT01557244|63017576|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
33616609|NCT01557244|63017577|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
33616610|NCT01557244|63017578|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
33616611|NCT01557244|63017572|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
33616612|NCT01557244|63017573|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
33616613|NCT01557244|63017574|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
33616614|NCT01557244|63017575|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
33616615|NCT01557244|63017576|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
33616616|NCT01557244|63017577|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
33616617|NCT01557244|63017578|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
33616618|NCT01557244|63017572|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
33616619|NCT01557244|63017573|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
33616620|NCT01557244|63017574|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
33616621|NCT01557244|63017575|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
33616622|NCT01557244|63017576|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
33616623|NCT01557244|63017577|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
33616624|NCT01557244|63017578|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
33616625|NCT01557244|63017572|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
33616626|NCT01557244|63017573|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
33616627|NCT01557244|63017574|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
33616628|NCT01557244|63017575|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
33616629|NCT01557244|63017576|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
33616630|NCT01557244|63017577|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
33616631|NCT01557244|63017578|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
33616632|NCT01557244|63017572|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
33616633|NCT01557244|63017573|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
33616634|NCT01557244|63017574|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
33616635|NCT01557244|63017575|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
33616636|NCT01557244|63017576|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
33616637|NCT01557244|63017577|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
33616638|NCT01557244|63017578|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
33616639|NCT01557244|63017572|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
33616640|NCT01557244|63017573|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
33616641|NCT01557244|63017574|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
33616642|NCT01557244|63017575|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
33616643|NCT01557244|63017576|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
33616644|NCT01557244|63017577|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
33616645|NCT01557244|63017578|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
33518867|NCT02996682|62904325|FG000|Overall Study|Death|0|||
33518868|NCT02996682|62904326|FG001|Overall Study|Death|3|||
33518869|NCT02873702|62904334|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
33518870|NCT02873702|62904335|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
33518871|NCT02873702|62904336|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
33518872|NCT02873702|62904337|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
33518873|NCT02873702|62904334|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
33518874|NCT02873702|62904335|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
33518875|NCT02873702|62904336|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
33518876|NCT02873702|62904337|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
33518877|NCT02873702|62904334|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
33518878|NCT02873702|62904335|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
33518879|NCT02873702|62904336|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
33518880|NCT02873702|62904337|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
33518881|NCT02873702|62904334|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
33518882|NCT02873702|62904335|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
33518883|NCT02873702|62904336|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
33518884|NCT02873702|62904337|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
33518885|NCT02873702|62904334|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
33518886|NCT02873702|62904335|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
33518887|NCT02873702|62904336|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
33518888|NCT02873702|62904337|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
33518889|NCT02911116|62904349|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33518890|NCT02911116|62904350|FG001|Overall Study|Insufficient Therapeutic Response|0|||
33518891|NCT02911116|62904349|FG000|Overall Study|Lost to Follow-up|0|||
33518892|NCT02911116|62904350|FG001|Overall Study|Lost to Follow-up|1|||
33518893|NCT02998554|62904358|FG000|Overall Study|Adverse Event|8|||
33518894|NCT02998554|62904359|FG001|Overall Study|Adverse Event|3|||
33518895|NCT02998554|62904358|FG000|Overall Study|Protocol deviation|1|||
33518896|NCT02998554|62904359|FG001|Overall Study|Protocol deviation|0|||
33518897|NCT02998554|62904358|FG000|Overall Study|Withdrawal by Subject|2|||
33518898|NCT02998554|62904359|FG001|Overall Study|Withdrawal by Subject|6|||
33518899|NCT02998554|62904358|FG000|Overall Study|Lost to Follow-up|0|||
33518900|NCT02998554|62904359|FG001|Overall Study|Lost to Follow-up|1|||
33518901|NCT02998554|62904358|FG000|Overall Study|Lack of Efficacy|0|||
33518902|NCT02998554|62904359|FG001|Overall Study|Lack of Efficacy|1|||
33518903|NCT02996448|62904367|FG000|Overall Study|Study terminated due to adverse effects|3|||
33518904|NCT02995980|62904372|FG000|Overall Study|Lost to Follow-up|14|||
33518905|NCT02872142|62904377|FG000|Overall Study|Adverse Event|2|||
33518906|NCT02872142|62904377|FG000|Overall Study|Death|1|||
33518907|NCT02872142|62904377|FG000|Overall Study|Participant Decision|3|||
33518908|NCT02994654|62904381|FG000|Overall Study|Lost to Follow-up|1|||
33518909|NCT02870972|62904391|FG000|Overall Study|Adverse Event|1|||
33518910|NCT02870972|62904392|FG001|Overall Study|Adverse Event|0|||
33518911|NCT02870972|62904393|FG002|Overall Study|Adverse Event|0|||
33518912|NCT02870972|62904394|FG003|Overall Study|Adverse Event|0|||
33518913|NCT02870972|62904395|FG004|Overall Study|Adverse Event|0|||
33518914|NCT03214367|62904415|FG000|Lead-in Period|Withdrawal by Subject|50|||
33518915|NCT03214367|62904416|FG001|Lead-in Period|Withdrawal by Subject|0|||
33518916|NCT03214367|62904417|FG002|Lead-in Period|Withdrawal by Subject|0|||
33518917|NCT03214367|62904418|FG003|Lead-in Period|Withdrawal by Subject|0|||
33518918|NCT03214367|62904419|FG004|Lead-in Period|Withdrawal by Subject|2|||
33518919|NCT03214367|62904420|FG005|Lead-in Period|Withdrawal by Subject|0|||
33518920|NCT03214367|62904421|FG006|Lead-in Period|Withdrawal by Subject|0|||
33518921|NCT03214367|62904422|FG007|Lead-in Period|Withdrawal by Subject|0|||
33518922|NCT03214367|62904415|FG000|Lead-in Period|Adverse Event|3|||
33518923|NCT03214367|62904416|FG001|Lead-in Period|Adverse Event|0|||
33518924|NCT03214367|62904417|FG002|Lead-in Period|Adverse Event|0|||
33518925|NCT03214367|62904418|FG003|Lead-in Period|Adverse Event|0|||
33518926|NCT03214367|62904419|FG004|Lead-in Period|Adverse Event|0|||
33518927|NCT03214367|62904420|FG005|Lead-in Period|Adverse Event|0|||
33518928|NCT03214367|62904421|FG006|Lead-in Period|Adverse Event|0|||
33518929|NCT03214367|62904422|FG007|Lead-in Period|Adverse Event|0|||
33518930|NCT03214367|62904415|FG000|Lead-in Period|Lost to Follow-up|12|||
33518931|NCT03214367|62904416|FG001|Lead-in Period|Lost to Follow-up|0|||
33518932|NCT03214367|62904417|FG002|Lead-in Period|Lost to Follow-up|0|||
33518933|NCT03214367|62904418|FG003|Lead-in Period|Lost to Follow-up|0|||
33518934|NCT03214367|62904419|FG004|Lead-in Period|Lost to Follow-up|0|||
33518935|NCT03214367|62904420|FG005|Lead-in Period|Lost to Follow-up|0|||
33325012|NCT01117428|62701617|FG002|Overall Study|Withdrawal by Subject|1|||
33518936|NCT03214367|62904421|FG006|Lead-in Period|Lost to Follow-up|0|||
33518937|NCT03214367|62904422|FG007|Lead-in Period|Lost to Follow-up|0|||
33325013|NCT01117428|62701618|FG003|Overall Study|Withdrawal by Subject|0|||
33518938|NCT03214367|62904415|FG000|Lead-in Period|Sponsor Decision|11|||
33518939|NCT03214367|62904416|FG001|Lead-in Period|Sponsor Decision|0|||
33518940|NCT03214367|62904417|FG002|Lead-in Period|Sponsor Decision|0|||
33518941|NCT03214367|62904418|FG003|Lead-in Period|Sponsor Decision|0|||
33518942|NCT03214367|62904419|FG004|Lead-in Period|Sponsor Decision|0|||
33518943|NCT03214367|62904420|FG005|Lead-in Period|Sponsor Decision|0|||
33518944|NCT03214367|62904421|FG006|Lead-in Period|Sponsor Decision|0|||
33325014|NCT01117428|62701619|FG004|Overall Study|Withdrawal by Subject|0|||
33616646|NCT01557244|63017572|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
33518945|NCT03214367|62904422|FG007|Lead-in Period|Sponsor Decision|0|||
33518946|NCT03214367|62904415|FG000|Lead-in Period|Physician Decision|12|||
33518947|NCT03214367|62904416|FG001|Lead-in Period|Physician Decision|0|||
33325015|NCT01117428|62701620|FG005|Overall Study|Withdrawal by Subject|0|||
33325016|NCT01117428|62701615|FG000|Overall Study|Progressive disease|15|||
33325017|NCT01117428|62701616|FG001|Overall Study|Progressive disease|27|||
33325018|NCT01117428|62701617|FG002|Overall Study|Progressive disease|10|||
33325019|NCT01117428|62701618|FG003|Overall Study|Progressive disease|12|||
33325020|NCT01117428|62701619|FG004|Overall Study|Progressive disease|16|||
33325021|NCT01117428|62701620|FG005|Overall Study|Progressive disease|17|||
33325022|NCT00655681|62701638|FG000|Overall Study|Lost to Follow-up|1|||
33325023|NCT00655681|62701639|FG001|Overall Study|Lost to Follow-up|1|||
33325024|NCT01135524|62701658|FG000|Overall Study|Withdrawal by Subject|14|||
33325025|NCT01135524|62701658|FG000|Overall Study|Adverse Event|20|||
33325026|NCT01135524|62701658|FG000|Overall Study|Lost to Follow-up|3|||
33325027|NCT01135524|62701658|FG000|Overall Study|Administrative|151|||
33325028|NCT01135524|62701658|FG000|Overall Study|Lack of Efficacy|8|||
33325029|NCT00948675|62701664|FG000|Overall Study|Lost to Follow-up|1|||
33325030|NCT00948675|62701665|FG001|Overall Study|Lost to Follow-up|0|||
33325031|NCT00903370|62701673|FG000|Overall Study|Death|13|||
33325032|NCT00903370|62701674|FG001|Overall Study|Death|10|||
33325033|NCT00903370|62701673|FG000|Overall Study|Withdrawal by Subject|9|||
33325034|NCT00903370|62701674|FG001|Overall Study|Withdrawal by Subject|6|||
33518948|NCT03214367|62904417|FG002|Lead-in Period|Physician Decision|0|||
33518949|NCT03214367|62904418|FG003|Lead-in Period|Physician Decision|0|||
33518950|NCT03214367|62904419|FG004|Lead-in Period|Physician Decision|0|||
33518951|NCT03214367|62904420|FG005|Lead-in Period|Physician Decision|0|||
33518952|NCT03214367|62904421|FG006|Lead-in Period|Physician Decision|0|||
33518953|NCT03214367|62904422|FG007|Lead-in Period|Physician Decision|0|||
33518954|NCT03214367|62904415|FG000|Lead-in Period|Protocol Violation|5|||
33518955|NCT03214367|62904416|FG001|Lead-in Period|Protocol Violation|0|||
33518956|NCT03214367|62904417|FG002|Lead-in Period|Protocol Violation|0|||
33518957|NCT03214367|62904418|FG003|Lead-in Period|Protocol Violation|0|||
33518958|NCT03214367|62904419|FG004|Lead-in Period|Protocol Violation|0|||
33518959|NCT03214367|62904420|FG005|Lead-in Period|Protocol Violation|0|||
33518960|NCT03214367|62904421|FG006|Lead-in Period|Protocol Violation|0|||
33518961|NCT03214367|62904422|FG007|Lead-in Period|Protocol Violation|0|||
33518962|NCT03214367|62904415|FG000|Lead-in Period|Treatment Interruption|1|||
33518963|NCT03214367|62904416|FG001|Lead-in Period|Treatment Interruption|0|||
33518964|NCT03214367|62904417|FG002|Lead-in Period|Treatment Interruption|0|||
33518965|NCT03214367|62904418|FG003|Lead-in Period|Treatment Interruption|0|||
33518966|NCT03214367|62904419|FG004|Lead-in Period|Treatment Interruption|0|||
33518967|NCT03214367|62904420|FG005|Lead-in Period|Treatment Interruption|0|||
33518968|NCT03214367|62904421|FG006|Lead-in Period|Treatment Interruption|0|||
33518969|NCT03214367|62904422|FG007|Lead-in Period|Treatment Interruption|0|||
33518970|NCT03214367|62904415|FG000|Treatment Period|Adverse Event|0|||
33518971|NCT03214367|62904416|FG001|Treatment Period|Adverse Event|1|||
33518972|NCT03214367|62904417|FG002|Treatment Period|Adverse Event|4|||
33518973|NCT03214367|62904418|FG003|Treatment Period|Adverse Event|2|||
33518974|NCT03214367|62904419|FG004|Treatment Period|Adverse Event|0|||
33518975|NCT03214367|62904420|FG005|Treatment Period|Adverse Event|0|||
33518976|NCT03214367|62904421|FG006|Treatment Period|Adverse Event|0|||
33518977|NCT03214367|62904422|FG007|Treatment Period|Adverse Event|0|||
33518978|NCT03214367|62904415|FG000|Treatment Period|Death|0|||
33518979|NCT03214367|62904416|FG001|Treatment Period|Death|1|||
33518980|NCT03214367|62904417|FG002|Treatment Period|Death|1|||
33518981|NCT03214367|62904418|FG003|Treatment Period|Death|1|||
33518982|NCT03214367|62904419|FG004|Treatment Period|Death|0|||
33518983|NCT03214367|62904420|FG005|Treatment Period|Death|0|||
33518984|NCT03214367|62904421|FG006|Treatment Period|Death|0|||
33518985|NCT03214367|62904422|FG007|Treatment Period|Death|0|||
33518986|NCT03214367|62904415|FG000|Treatment Period|Lost to Follow-up|0|||
33518987|NCT03214367|62904416|FG001|Treatment Period|Lost to Follow-up|5|||
33518988|NCT03214367|62904417|FG002|Treatment Period|Lost to Follow-up|3|||
33518989|NCT03214367|62904418|FG003|Treatment Period|Lost to Follow-up|2|||
33518990|NCT03214367|62904419|FG004|Treatment Period|Lost to Follow-up|0|||
33325035|NCT00903370|62701673|FG000|Overall Study|Lost to Follow-up|6|||
33325036|NCT00903370|62701674|FG001|Overall Study|Lost to Follow-up|8|||
33518991|NCT03214367|62904420|FG005|Treatment Period|Lost to Follow-up|2|||
33518992|NCT03214367|62904421|FG006|Treatment Period|Lost to Follow-up|1|||
33616647|NCT01557244|63017573|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
33325037|NCT01110408|62701682|FG000|Overall Study|Protocol Violation|1|||
33325038|NCT01110408|62701683|FG001|Overall Study|Protocol Violation|0|||
33518993|NCT03214367|62904422|FG007|Treatment Period|Lost to Follow-up|0|||
33518994|NCT03214367|62904415|FG000|Treatment Period|Sponsor Decision|0|||
33518995|NCT03214367|62904416|FG001|Treatment Period|Sponsor Decision|3|||
33325039|NCT00953043|62701691|FG000|Overall Study|Withdrawal by Subject|4|||
33325040|NCT00953043|62701692|FG001|Overall Study|Withdrawal by Subject|0|||
33325041|NCT00953043|62701691|FG000|Overall Study|Physician Decision|0|||
33518996|NCT03214367|62904417|FG002|Treatment Period|Sponsor Decision|0|||
33518997|NCT03214367|62904418|FG003|Treatment Period|Sponsor Decision|0|||
33518998|NCT03214367|62904419|FG004|Treatment Period|Sponsor Decision|0|||
33518999|NCT03214367|62904420|FG005|Treatment Period|Sponsor Decision|0|||
33519000|NCT03214367|62904421|FG006|Treatment Period|Sponsor Decision|0|||
33616648|NCT01557244|63017574|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
33616649|NCT01557244|63017575|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
33616650|NCT01557244|63017576|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
33616651|NCT01557244|63017577|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
33616652|NCT01557244|63017578|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
33616653|NCT01557244|63017572|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
33616654|NCT01557244|63017573|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
33616655|NCT01557244|63017574|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
33616656|NCT01557244|63017575|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
33616657|NCT01557244|63017576|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
33616658|NCT01557244|63017577|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
33616659|NCT01557244|63017578|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
33616660|NCT01557244|63017572|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
33616661|NCT01557244|63017573|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
33616662|NCT01557244|63017574|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
33616663|NCT01557244|63017575|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
33325042|NCT00953043|62701692|FG001|Overall Study|Physician Decision|2|||
33325043|NCT01135134|62701700|FG000|Overall Study|Adverse Event|1|||
33325044|NCT01135134|62701701|FG001|Overall Study|Adverse Event|1|||
33325045|NCT01135134|62701700|FG000|Overall Study|Did not meet protocol eligibility|1|||
33325046|NCT01135134|62701701|FG001|Overall Study|Did not meet protocol eligibility|0|||
33325047|NCT00948441|62701709|FG000|Overall Study|no longer meet inclusion criteria|1|||
33325048|NCT00948441|62701710|FG001|Overall Study|no longer meet inclusion criteria|4|||
33325049|NCT01117350|62701720|FG000|Comparative Period|Not Treated|5|||
33325050|NCT01117350|62701721|FG001|Comparative Period|Not Treated|8|||
33325051|NCT01117350|62701720|FG000|Comparative Period|Adverse Event|6|||
33325052|NCT01117350|62701721|FG001|Comparative Period|Adverse Event|33|||
33325053|NCT01117350|62701720|FG000|Comparative Period|Lost to Follow-up|11|||
33325054|NCT01117350|62701721|FG001|Comparative Period|Lost to Follow-up|7|||
33325055|NCT01117350|62701720|FG000|Comparative Period|Withdrawal by Subject|9|||
33325056|NCT01117350|62701721|FG001|Comparative Period|Withdrawal by Subject|13|||
33325057|NCT01117350|62701720|FG000|Comparative Period|Protocol Violation|8|||
33325058|NCT01117350|62701721|FG001|Comparative Period|Protocol Violation|12|||
33325059|NCT01117350|62701720|FG000|Comparative Period|Lack of Efficacy|1|||
33325060|NCT01117350|62701721|FG001|Comparative Period|Lack of Efficacy|0|||
33325061|NCT01117350|62701720|FG000|Comparative Period|Physician Decision|0|||
33325062|NCT01117350|62701721|FG001|Comparative Period|Physician Decision|1|||
33325063|NCT01117350|62701720|FG000|Comparative Period|Move to another city/country|2|||
33325064|NCT01117350|62701721|FG001|Comparative Period|Move to another city/country|1|||
33325065|NCT01117350|62701720|FG000|Extension Period|Not included in extension, not treated|0|||
33455192|NCT00117312|62829578|FG001|Overall Study|Withdrawal by Subject|2|||
33455193|NCT00117312|62829579|FG002|Overall Study|Withdrawal by Subject|0|||
33455194|NCT00117312|62829580|FG003|Overall Study|Withdrawal by Subject|0|||
33455195|NCT00129116|62829595|FG000|Primary Phase|Lost to Follow-up|1|||
33455196|NCT00129116|62829596|FG001|Primary Phase|Lost to Follow-up|1|||
33455197|NCT00129116|62829597|FG002|Primary Phase|Lost to Follow-up|0|||
33455198|NCT00129116|62829598|FG003|Primary Phase|Lost to Follow-up|1|||
33455199|NCT00129116|62829599|FG004|Primary Phase|Lost to Follow-up|1|||
33455200|NCT00129116|62829595|FG000|Primary Phase|Protocol Violation|0|||
33455201|NCT00129116|62829596|FG001|Primary Phase|Protocol Violation|1|||
33455202|NCT00129116|62829597|FG002|Primary Phase|Protocol Violation|0|||
33455203|NCT00129116|62829598|FG003|Primary Phase|Protocol Violation|0|||
33455204|NCT00129116|62829599|FG004|Primary Phase|Protocol Violation|0|||
33455205|NCT00129116|62829595|FG000|Primary Phase|Adverse Event|1|||
33455206|NCT00129116|62829596|FG001|Primary Phase|Adverse Event|1|||
33455207|NCT00129116|62829597|FG002|Primary Phase|Adverse Event|0|||
33455208|NCT00129116|62829598|FG003|Primary Phase|Adverse Event|0|||
33455209|NCT00129116|62829599|FG004|Primary Phase|Adverse Event|0|||
33455210|NCT00129116|62829595|FG000|Primary Phase|Withdrawal by Subject|0|||
33455211|NCT00129116|62829596|FG001|Primary Phase|Withdrawal by Subject|1|||
33455212|NCT00129116|62829597|FG002|Primary Phase|Withdrawal by Subject|0|||
33455213|NCT00129116|62829598|FG003|Primary Phase|Withdrawal by Subject|0|||
33455214|NCT00129116|62829599|FG004|Primary Phase|Withdrawal by Subject|0|||
33455215|NCT00129116|62829595|FG000|Primary Phase|Other|0|||
33455216|NCT00129116|62829596|FG001|Primary Phase|Other|0|||
33455217|NCT00129116|62829597|FG002|Primary Phase|Other|1|||
33519001|NCT03214367|62904422|FG007|Treatment Period|Sponsor Decision|0|||
33519002|NCT03214367|62904415|FG000|Treatment Period|Physician Decision|0|||
33325066|NCT01117350|62701721|FG001|Extension Period|Not included in extension, not treated|50|||
33325067|NCT01117350|62701720|FG000|Extension Period|Adverse Event|0|||
33325068|NCT01117350|62701721|FG001|Extension Period|Adverse Event|2|||
33325069|NCT01117350|62701720|FG000|Extension Period|Protocol Violation|0|||
33325070|NCT01117350|62701721|FG001|Extension Period|Protocol Violation|2|||
33325071|NCT01117350|62701720|FG000|Extension Period|Lost to Follow-up|0|||
33325072|NCT01117350|62701721|FG001|Extension Period|Lost to Follow-up|2|||
33325073|NCT01117350|62701720|FG000|Extension Period|Withdrawal by Subject|0|||
33325074|NCT01117350|62701721|FG001|Extension Period|Withdrawal by Subject|3|||
33325075|NCT01117350|62701720|FG000|Extension Period|Lack of Efficacy|0|||
33455218|NCT00129116|62829598|FG003|Primary Phase|Other|0|||
33455219|NCT00129116|62829599|FG004|Primary Phase|Other|0|||
33455220|NCT00129116|62829595|FG000|Booster Phase|Lost to Follow-up|2|||
33455221|NCT00129116|62829596|FG001|Booster Phase|Lost to Follow-up|0|||
33519003|NCT03214367|62904416|FG001|Treatment Period|Physician Decision|1|||
33519004|NCT03214367|62904417|FG002|Treatment Period|Physician Decision|2|||
33519005|NCT03214367|62904418|FG003|Treatment Period|Physician Decision|0|||
33616664|NCT01557244|63017576|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
33455222|NCT00129116|62829597|FG002|Booster Phase|Lost to Follow-up|0|||
33616665|NCT01557244|63017577|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
33455223|NCT00129116|62829598|FG003|Booster Phase|Lost to Follow-up|0|||
33455224|NCT00129116|62829599|FG004|Booster Phase|Lost to Follow-up|1|||
33455225|NCT00117156|62829611|FG000|Overall Study|Adverse Event|9|||
33616666|NCT01557244|63017578|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
33616667|NCT02155712|63017608|FG000|Primary Objective|Death|3|||
33616668|NCT02155712|63017609|FG001|Primary Objective|Death|0|||
33616669|NCT02155712|63017608|FG000|Primary Objective|Lost to Follow-up|22|||
33616670|NCT02155712|63017609|FG001|Primary Objective|Lost to Follow-up|0|||
33455226|NCT00117156|62829611|FG000|Overall Study|Physician Decision|1|||
33455227|NCT00117156|62829611|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
33455228|NCT00096954|62829617|FG000|Overall Study|Adverse Event|3|||
33455229|NCT00096954|62829618|FG001|Overall Study|Adverse Event|1|||
33455230|NCT00096954|62829617|FG000|Overall Study|Withdrawal by Subject|9|||
33455231|NCT00096954|62829618|FG001|Overall Study|Withdrawal by Subject|8|||
33455232|NCT00096954|62829617|FG000|Overall Study|Physician Decision|1|||
33455233|NCT00096954|62829618|FG001|Overall Study|Physician Decision|1|||
33455234|NCT00096954|62829617|FG000|Overall Study|Sponsors Decision|1|||
33455235|NCT00096954|62829618|FG001|Overall Study|Sponsors Decision|1|||
33455236|NCT00096954|62829617|FG000|Overall Study|Pregnancy|1|||
33455237|NCT00096954|62829618|FG001|Overall Study|Pregnancy|1|||
33455238|NCT00096954|62829617|FG000|Overall Study|Initiation of immunotherapy|1|||
33455239|NCT00096954|62829618|FG001|Overall Study|Initiation of immunotherapy|0|||
33455240|NCT00096954|62829617|FG000|Overall Study|Non-compliance|0|||
33455241|NCT00096954|62829618|FG001|Overall Study|Non-compliance|3|||
33455242|NCT00096954|62829617|FG000|Overall Study|Lost to Follow-up|8|||
33455243|NCT00096954|62829618|FG001|Overall Study|Lost to Follow-up|5|||
33455244|NCT00096486|62829628|FG000|Overall Study|Withdrawal by Subject|0|||
33455245|NCT00096486|62829629|FG001|Overall Study|Withdrawal by Subject|0|||
33455246|NCT00096486|62829630|FG002|Overall Study|Withdrawal by Subject|1|||
33455247|NCT00096486|62829631|FG003|Overall Study|Withdrawal by Subject|1|||
33455248|NCT00096486|62829628|FG000|Overall Study|Not Treated|0|||
33455249|NCT00096486|62829629|FG001|Overall Study|Not Treated|0|||
33455250|NCT00096486|62829630|FG002|Overall Study|Not Treated|1|||
33455251|NCT00096486|62829631|FG003|Overall Study|Not Treated|1|||
33455252|NCT00116844|62829643|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
33455253|NCT00116844|62829644|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
33455254|NCT00116844|62829643|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
33455255|NCT00116844|62829644|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
33455256|NCT00116844|62829643|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
33455257|NCT00116844|62829644|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
33455258|NCT00116844|62829643|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
33455259|NCT00116844|62829644|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
33455260|NCT00116844|62829643|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
33455261|NCT00116844|62829644|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
33325076|NCT01117350|62701721|FG001|Extension Period|Lack of Efficacy|2|||
33455262|NCT00116844|62829643|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
33455263|NCT00116844|62829644|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
33455264|NCT00116844|62829643|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
33455265|NCT00116844|62829644|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
33455266|NCT00116844|62829643|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
33455267|NCT00116844|62829644|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
33455268|NCT00116844|62829643|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
33325077|NCT01117350|62701720|FG000|Extension Period|Inclusion criteria not respected|0|||
33616671|NCT02155712|63017608|FG000|Primary Objective|No 2-Year Forms but not Terminated|13|||
33519006|NCT03214367|62904419|FG004|Treatment Period|Physician Decision|0|||
33519007|NCT03214367|62904420|FG005|Treatment Period|Physician Decision|0|||
33519008|NCT03214367|62904421|FG006|Treatment Period|Physician Decision|0|||
33519009|NCT03214367|62904422|FG007|Treatment Period|Physician Decision|0|||
33519010|NCT03214367|62904415|FG000|Treatment Period|Protocol Violation|0|||
33519011|NCT03214367|62904416|FG001|Treatment Period|Protocol Violation|3|||
33519012|NCT03214367|62904417|FG002|Treatment Period|Protocol Violation|0|||
33519013|NCT03214367|62904418|FG003|Treatment Period|Protocol Violation|0|||
33519014|NCT03214367|62904419|FG004|Treatment Period|Protocol Violation|0|||
33519015|NCT03214367|62904420|FG005|Treatment Period|Protocol Violation|0|||
33519016|NCT03214367|62904421|FG006|Treatment Period|Protocol Violation|0|||
33519017|NCT03214367|62904422|FG007|Treatment Period|Protocol Violation|0|||
33519018|NCT03214367|62904415|FG000|Treatment Period|Withdrawal by Subject|0|||
33519019|NCT03214367|62904416|FG001|Treatment Period|Withdrawal by Subject|20|||
33519020|NCT03214367|62904417|FG002|Treatment Period|Withdrawal by Subject|23|||
33519021|NCT03214367|62904418|FG003|Treatment Period|Withdrawal by Subject|14|||
33519022|NCT03214367|62904419|FG004|Treatment Period|Withdrawal by Subject|0|||
33519023|NCT03214367|62904420|FG005|Treatment Period|Withdrawal by Subject|1|||
33519024|NCT03214367|62904421|FG006|Treatment Period|Withdrawal by Subject|1|||
33519025|NCT03214367|62904422|FG007|Treatment Period|Withdrawal by Subject|1|||
33519026|NCT02994108|62904438|FG000|Intervention Messages|Withdrawal by Subject|2|||
33519027|NCT02994108|62904439|FG001|Intervention Messages|Withdrawal by Subject|0|||
33519028|NCT02994108|62904438|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
33519029|NCT02994108|62904439|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
33519030|NCT02994108|62904438|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
33519031|NCT02994108|62904439|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
33519032|NCT02994108|62904438|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
33519033|NCT02994108|62904439|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
33519034|NCT03231371|62904446|FG000|Overall Study|Withdrawal by Subject|1|||
33519035|NCT03231371|62904446|FG000|Overall Study|chose or were ineligible to have MRI|12|||
33519036|NCT02870348|62904450|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
33519037|NCT03239873|62904456|FG000|Overall Study|Lost to Follow-up|15|||
33519038|NCT03239873|62904457|FG001|Overall Study|Lost to Follow-up|16|||
33519039|NCT03239873|62904456|FG000|Overall Study|Physician Decision|1|||
33519040|NCT03239873|62904457|FG001|Overall Study|Physician Decision|0|||
33519041|NCT03239873|62904456|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
33519042|NCT03239873|62904457|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
33519043|NCT03239873|62904456|FG000|Overall Study|Withdrawal by Subject|2|||
33519044|NCT03239873|62904457|FG001|Overall Study|Withdrawal by Subject|0|||
33519045|NCT03239873|62904456|FG000|Overall Study|Contraindication to study medication|1|||
33519046|NCT03239873|62904457|FG001|Overall Study|Contraindication to study medication|0|||
33519047|NCT03239873|62904456|FG000|Overall Study|Protocol Violation|1|||
33519048|NCT03239873|62904457|FG001|Overall Study|Protocol Violation|0|||
33519049|NCT03213509|62904465|FG000|Overall Study|Did not consent for verbal autopsy|4|||
33519050|NCT03213509|62904466|FG001|Overall Study|Did not consent for verbal autopsy|5|||
33519051|NCT03239483|62904475|FG000|Overall Study|Lost to Follow-up|1|||
33519052|NCT03239483|62904476|FG001|Overall Study|Lost to Follow-up|0|||
33519053|NCT03239483|62904475|FG000|Overall Study|Withdrawal by Subject|1|||
33519054|NCT03239483|62904476|FG001|Overall Study|Withdrawal by Subject|0|||
33455269|NCT00116844|62829644|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
33455270|NCT00128492|62829652|FG000|Overall Study|AE unrelated to study|2|||
33519055|NCT02868554|62904485|FG000|Overall Study|Lost to Follow-up|3|||
33519056|NCT02868554|62904486|FG001|Overall Study|Lost to Follow-up|0|||
33519057|NCT02868554|62904487|FG002|Overall Study|Lost to Follow-up|1|||
33519058|NCT01068912|62904498|FG000|Overall Study|Adverse Event|2|||
33519059|NCT01068912|62904499|FG001|Overall Study|Adverse Event|3|||
33519060|NCT01068912|62904500|FG002|Overall Study|Adverse Event|2|||
33519061|NCT01068912|62904498|FG000|Overall Study|Withdrawal by Subject|5|||
33519062|NCT01068912|62904499|FG001|Overall Study|Withdrawal by Subject|6|||
33519063|NCT01068912|62904500|FG002|Overall Study|Withdrawal by Subject|6|||
33519064|NCT01068912|62904498|FG000|Overall Study|Lost to Follow-up|3|||
33519065|NCT01068912|62904499|FG001|Overall Study|Lost to Follow-up|7|||
33519066|NCT01068912|62904500|FG002|Overall Study|Lost to Follow-up|3|||
33519067|NCT01068912|62904498|FG000|Overall Study|Protocol Violation|0|||
33519068|NCT01068912|62904499|FG001|Overall Study|Protocol Violation|2|||
33455271|NCT00128492|62829653|FG001|Overall Study|AE unrelated to study|9|||
33455272|NCT00128492|62829652|FG000|Overall Study|Study drug intolerance (AE)|2|||
33455273|NCT00128492|62829653|FG001|Overall Study|Study drug intolerance (AE)|8|||
33455274|NCT00128492|62829652|FG000|Overall Study|AE related to study|1|||
33455275|NCT00128492|62829653|FG001|Overall Study|AE related to study|4|||
33455276|NCT00128492|62829652|FG000|Overall Study|Death|1|||
33455277|NCT00128492|62829653|FG001|Overall Study|Death|0|||
33455278|NCT00128492|62829652|FG000|Overall Study|Lost to Follow-up|1|||
33455279|NCT00128492|62829653|FG001|Overall Study|Lost to Follow-up|5|||
33455280|NCT00128492|62829652|FG000|Overall Study|Noncompliance|0|||
33519069|NCT01068912|62904500|FG002|Overall Study|Protocol Violation|0|||
33519070|NCT01068912|62904498|FG000|Overall Study|aggravation influenza|1|||
33519071|NCT01068912|62904499|FG001|Overall Study|aggravation influenza|1|||
33519072|NCT01068912|62904500|FG002|Overall Study|aggravation influenza|1|||
33519073|NCT01068912|62904498|FG000|Overall Study|other underlying illness|0|||
33519074|NCT01068912|62904499|FG001|Overall Study|other underlying illness|3|||
33519075|NCT01068912|62904500|FG002|Overall Study|other underlying illness|3|||
33519076|NCT03229109|62904512|FG000|Overall Study|Withdrawal by Subject|0|||
33519077|NCT03229109|62904513|FG001|Overall Study|Withdrawal by Subject|0|||
33616672|NCT02155712|63017609|FG001|Primary Objective|No 2-Year Forms but not Terminated|0|||
33616673|NCT02155712|63017608|FG000|Primary Objective|Revision/Removal of Tibial Baseplate|1|||
33519078|NCT03229109|62904514|FG002|Overall Study|Withdrawal by Subject|0|||
33519079|NCT03229109|62904515|FG003|Overall Study|Withdrawal by Subject|1|||
33519080|NCT03212261|62904525|FG000|Overall Study|Became ineligible d/t tech|2|||
33519081|NCT03212261|62904525|FG000|Overall Study|Tech Trouble- No first study visit|1|||
33616674|NCT02155712|63017609|FG001|Primary Objective|Revision/Removal of Tibial Baseplate|0|||
33616675|NCT02155712|63017608|FG000|Primary Objective|Withdrawal by Subject|21|||
33616676|NCT02155712|63017609|FG001|Primary Objective|Withdrawal by Subject|0|||
33325078|NCT01117350|62701721|FG001|Extension Period|Inclusion criteria not respected|1|||
33455281|NCT00128492|62829653|FG001|Overall Study|Noncompliance|5|||
33455282|NCT00128492|62829652|FG000|Overall Study|Personal or administrative|10|||
33455283|NCT00128492|62829653|FG001|Overall Study|Personal or administrative|22|||
33455284|NCT00128492|62829652|FG000|Overall Study|Withdrawal by Subject|3|||
33455285|NCT00128492|62829653|FG001|Overall Study|Withdrawal by Subject|5|||
33455286|NCT00128492|62829652|FG000|Overall Study|Pregnancy|0|||
33455287|NCT00128492|62829653|FG001|Overall Study|Pregnancy|1|||
33455288|NCT00132314|62829661|FG000|Overall Study|Lost to Follow-up|70|||
33455289|NCT00132314|62829662|FG001|Overall Study|Lost to Follow-up|62|||
33455290|NCT00132314|62829661|FG000|Overall Study|Lacked SSN|1|||
33455291|NCT00132314|62829662|FG001|Overall Study|Lacked SSN|3|||
33455292|NCT00132314|62829661|FG000|Overall Study|Refused intervention at baseline|2|||
33455293|NCT00132314|62829662|FG001|Overall Study|Refused intervention at baseline|7|||
33455294|NCT04539262|62829676|FG000|Overall Study|Adverse Event|0|||
33455295|NCT04539262|62829677|FG001|Overall Study|Adverse Event|0|||
33455296|NCT04539262|62829678|FG002|Overall Study|Adverse Event|1|||
33455297|NCT04539262|62829679|FG003|Overall Study|Adverse Event|0|||
33455298|NCT04539262|62829680|FG004|Overall Study|Adverse Event|0|||
33455299|NCT04539262|62829681|FG005|Overall Study|Adverse Event|0|||
33455300|NCT04539262|62829682|FG006|Overall Study|Adverse Event|0|||
33455301|NCT04539262|62829683|FG007|Overall Study|Adverse Event|0|||
33455302|NCT04539262|62829676|FG000|Overall Study|Withdrew Consent|0|||
33455303|NCT04539262|62829677|FG001|Overall Study|Withdrew Consent|0|||
33455304|NCT04539262|62829678|FG002|Overall Study|Withdrew Consent|0|||
33455305|NCT04539262|62829679|FG003|Overall Study|Withdrew Consent|1|||
33455306|NCT04539262|62829680|FG004|Overall Study|Withdrew Consent|0|||
33455307|NCT04539262|62829681|FG005|Overall Study|Withdrew Consent|0|||
33455308|NCT04539262|62829682|FG006|Overall Study|Withdrew Consent|0|||
33455309|NCT04539262|62829683|FG007|Overall Study|Withdrew Consent|0|||
33455310|NCT04539262|62829676|FG000|Overall Study|Randomized, Not treated|0|||
33455311|NCT04539262|62829677|FG001|Overall Study|Randomized, Not treated|1|||
33455312|NCT04539262|62829678|FG002|Overall Study|Randomized, Not treated|0|||
33455313|NCT04539262|62829679|FG003|Overall Study|Randomized, Not treated|0|||
33455314|NCT04539262|62829680|FG004|Overall Study|Randomized, Not treated|0|||
33455315|NCT04539262|62829681|FG005|Overall Study|Randomized, Not treated|0|||
33455316|NCT04539262|62829682|FG006|Overall Study|Randomized, Not treated|1|||
33455317|NCT04539262|62829683|FG007|Overall Study|Randomized, Not treated|0|||
33455318|NCT03702010|62829706|FG000|Follow-up (30days)|Lack of Efficacy|2|||
33455319|NCT03702010|62829707|FG001|Follow-up (30days)|Lack of Efficacy|2|||
33455320|NCT04538170|62829721|FG000|Overall Study|Withdrawal by Subject|104|||
33455321|NCT04538170|62829722|FG001|Overall Study|Withdrawal by Subject|210|||
33455322|NCT04537234|62829734|FG000|Overall Study|Withdrawal by Subject|2|||
33455323|NCT04537234|62829735|FG001|Overall Study|Withdrawal by Subject|0|||
33455324|NCT04537078|62829743|FG000|Overall Study|Protocol Violation|3|||
33455325|NCT04537078|62829744|FG001|Overall Study|Protocol Violation|2|||
33616677|NCT02177942|63017617|FG000|Overall Study|Adverse Event|1|||
33325079|NCT01117350|62701720|FG000|Extension Period|Prohibited medication|0|||
33455326|NCT04537078|62829743|FG000|Overall Study|Lost to Follow-up|1|||
33455327|NCT04537078|62829744|FG001|Overall Study|Lost to Follow-up|0|||
33455328|NCT04537078|62829743|FG000|Overall Study|Withdrawal by Subject|0|||
33455329|NCT04537078|62829744|FG001|Overall Study|Withdrawal by Subject|1|||
33455330|NCT04532164|62829757|FG000|Overall Study|Adverse Event|1|||
33455331|NCT04532164|62829757|FG000|Overall Study|Protocol Violation|5|||
33455332|NCT04532164|62829757|FG000|Overall Study|Lost to Follow-up|1|||
33519082|NCT03212261|62904525|FG000|Overall Study|Lost to Follow-up|7|||
33455333|NCT04532164|62829757|FG000|Overall Study|Found to be Ineligible|3|||
33455334|NCT04532164|62829757|FG000|Overall Study|Withdrawal by Subject|14|||
33519083|NCT03212261|62904525|FG000|Overall Study|Family Emergency|1|||
33325080|NCT01117350|62701721|FG001|Extension Period|Prohibited medication|1|||
33325081|NCT00952731|62701732|FG000|Overall Study|Drug supply expired|1|||
33325082|NCT00952731|62701733|FG001|Overall Study|Drug supply expired|0|||
33325083|NCT00947427|62701741|FG000|Overall Study|Withdrawal by Subject|1|||
33325084|NCT00947427|62701742|FG001|Overall Study|Withdrawal by Subject|3|||
33325085|NCT00947427|62701741|FG000|Overall Study|Protocol Violation|0|||
33325086|NCT00947427|62701742|FG001|Overall Study|Protocol Violation|1|||
33325087|NCT01116882|62701750|FG000|30-day|Lost to Follow-up|50|||
33325088|NCT01116882|62701751|FG001|30-day|Lost to Follow-up|21|||
33325089|NCT01116882|62701750|FG000|30-day|Withdrawal by Subject|2|||
33325090|NCT01116882|62701751|FG001|30-day|Withdrawal by Subject|4|||
33325091|NCT01116882|62701750|FG000|30-day|Other Reasons|16|||
33325092|NCT01116882|62701751|FG001|30-day|Other Reasons|6|||
33325093|NCT01116882|62701750|FG000|12-month|Lost to Follow-up|111|||
33325094|NCT01116882|62701751|FG001|12-month|Lost to Follow-up|42|||
33325095|NCT01116882|62701750|FG000|12-month|Other Reasons|151|||
33325096|NCT01116882|62701751|FG001|12-month|Other Reasons|49|||
33325097|NCT01116882|62701750|FG000|12-month|Withdrawal by Subject|5|||
33325098|NCT01116882|62701751|FG001|12-month|Withdrawal by Subject|8|||
33325099|NCT00953745|62701762|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
33325100|NCT00953745|62701763|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
33325101|NCT00953745|62701762|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
33325102|NCT00953745|62701763|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
33325103|NCT00953745|62701762|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
33325104|NCT00953745|62701763|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
33325105|NCT00953745|62701762|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
33325106|NCT00953745|62701763|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
33325107|NCT00953745|62701762|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
33325108|NCT00953745|62701763|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
33325109|NCT00953745|62701762|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
33325110|NCT00953745|62701763|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
33325111|NCT00902746|62701780|FG000|Overall Study|Protocol Violation|7|||
33325112|NCT00902746|62701780|FG000|Overall Study|Withdrawal by Subject|16|||
33325113|NCT00902746|62701780|FG000|Overall Study|Adverse Event|8|||
33325114|NCT00902746|62701780|FG000|Overall Study|Lost to Follow-up|3|||
33325115|NCT00902746|62701780|FG000|Overall Study|Physician Decision|2|||
33325116|NCT00902668|62701793|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
33325117|NCT00947349|62701801|FG000|Triple Treatment Combination Period|Adverse Event|0|||
33325118|NCT00947349|62701802|FG001|Triple Treatment Combination Period|Adverse Event|1|||
33325119|NCT00947349|62701803|FG002|Triple Treatment Combination Period|Adverse Event|0|||
33325120|NCT00947349|62701804|FG003|Triple Treatment Combination Period|Adverse Event|0|||
33325121|NCT00947349|62701801|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
33325122|NCT00947349|62701802|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
33325123|NCT00947349|62701803|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
33325124|NCT00947349|62701804|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
33325125|NCT00947349|62701801|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
33455335|NCT00116688|62829764|FG000|Overall Study|Protocol deviation|1|||
33455336|NCT00116688|62829765|FG001|Overall Study|Protocol deviation|0|||
33455337|NCT00116688|62829764|FG000|Overall Study|Noncompliance|3|||
33455338|NCT00116688|62829765|FG001|Overall Study|Noncompliance|1|||
33455339|NCT00116688|62829764|FG000|Overall Study|Adverse Event|11|||
33455340|NCT00116688|62829765|FG001|Overall Study|Adverse Event|0|||
33455341|NCT00116688|62829764|FG000|Overall Study|Withdrawal by Subject|26|||
33455342|NCT00116688|62829765|FG001|Overall Study|Withdrawal by Subject|2|||
33455343|NCT00116688|62829764|FG000|Overall Study|Requirement for alternative therapy|11|||
33455344|NCT00116688|62829765|FG001|Overall Study|Requirement for alternative therapy|1|||
33455345|NCT00116688|62829764|FG000|Overall Study|Physician Decision|7|||
33455346|NCT00116688|62829765|FG001|Overall Study|Physician Decision|0|||
33455347|NCT00116688|62829764|FG000|Overall Study|Lost to Follow-up|3|||
33455348|NCT00116688|62829765|FG001|Overall Study|Lost to Follow-up|0|||
33455349|NCT00116688|62829764|FG000|Overall Study|Death|15|||
33455350|NCT00116688|62829765|FG001|Overall Study|Death|0|||
33455351|NCT00116688|62829764|FG000|Overall Study|Protocol-specified criteria|3|||
33455352|NCT00116688|62829765|FG001|Overall Study|Protocol-specified criteria|0|||
33455353|NCT00116688|62829764|FG000|Overall Study|Pregnancy|1|||
33455354|NCT00116688|62829765|FG001|Overall Study|Pregnancy|0|||
33325126|NCT00947349|62701802|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
33325127|NCT00947349|62701803|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
33325128|NCT00947349|62701804|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
33455355|NCT00116688|62829764|FG000|Overall Study|Other|11|||
33455356|NCT00116688|62829765|FG001|Overall Study|Other|0|||
33455357|NCT04531540|62829771|FG000|Overall Study|Adverse Event|1|||
33455358|NCT04531540|62829771|FG000|Overall Study|Protocol Violation|3|||
33455359|NCT04531540|62829771|FG000|Overall Study|Withdrawal by Subject|4|||
33455360|NCT04531540|62829771|FG000|Overall Study|Found to be Ineligible|1|||
33455361|NCT04799782|62829775|FG000|Washout|Physician Decision|2|||
33325129|NCT00947349|62701801|FG000|Overall Study Standard of Care|Other|0|||
33325130|NCT00947349|62701802|FG001|Overall Study Standard of Care|Other|0|||
33325131|NCT00947349|62701803|FG002|Overall Study Standard of Care|Other|0|||
33325132|NCT00947349|62701804|FG003|Overall Study Standard of Care|Other|1|||
33325133|NCT00947193|62701832|FG000|Overall Study|Lost to Follow-up|1|||
33325134|NCT00947193|62701833|FG001|Overall Study|Lost to Follow-up|0|||
33325135|NCT00947193|62701832|FG000|Overall Study|Withdrawal by Subject|1|||
33325136|NCT00947193|62701833|FG001|Overall Study|Withdrawal by Subject|0|||
33325137|NCT00947193|62701832|FG000|Overall Study|Factor VIII >1%|1|||
33325138|NCT00947193|62701833|FG001|Overall Study|Factor VIII >1%|0|||
33325139|NCT00947115|62701841|FG000|Overall Study|Missed reporting interval|3|||
33325140|NCT00947115|62701842|FG001|Overall Study|Missed reporting interval|4|||
33325141|NCT00947115|62701843|FG002|Overall Study|Missed reporting interval|2|||
33519084|NCT03212261|62904525|FG000|Overall Study|Too busy/ No time|5|||
33519085|NCT02993250|62904532|FG000|Overall Study|Lost to Follow-up|0|||
33519086|NCT02993250|62904533|FG001|Overall Study|Lost to Follow-up|1|||
33519087|NCT02989194|62904542|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
33519088|NCT02989194|62904543|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
33616678|NCT02177942|63017618|FG001|Overall Study|Adverse Event|0|||
33616679|NCT02177942|63017617|FG000|Overall Study|Lost to Follow-up|1|||
33616680|NCT02177942|63017618|FG001|Overall Study|Lost to Follow-up|1|||
33616681|NCT02177942|63017617|FG000|Overall Study|Protocol Violation|4|||
33616682|NCT02177942|63017618|FG001|Overall Study|Protocol Violation|6|||
33519089|NCT02989194|62904544|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
33519090|NCT02989194|62904542|FG000|Overall Study|Lost to Follow-up|0|||
33519091|NCT02989194|62904543|FG001|Overall Study|Lost to Follow-up|1|||
33519092|NCT02989194|62904544|FG002|Overall Study|Lost to Follow-up|0|||
33519093|NCT02989194|62904542|FG000|Overall Study|Withdrawal by Subject|0|||
33519094|NCT02989194|62904543|FG001|Overall Study|Withdrawal by Subject|1|||
33519095|NCT02989194|62904544|FG002|Overall Study|Withdrawal by Subject|0|||
33519096|NCT02990910|62904565|FG000|Overall Study|Lack of Efficacy|6|||
33519097|NCT02990910|62904566|FG001|Overall Study|Lack of Efficacy|10|||
33519098|NCT03227861|62904572|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
33519099|NCT03227861|62904572|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
33616683|NCT02177942|63017617|FG000|Overall Study|Withdrawal by Subject|71|||
33325142|NCT00947115|62701841|FG000|Overall Study|Physician Decision|0|||
33325143|NCT00947115|62701842|FG001|Overall Study|Physician Decision|2|||
33455362|NCT04799782|62829776|FG001|Washout|Physician Decision|0|||
33455363|NCT04799782|62829775|FG000|Washout|Withdrawal by Subject|0|||
33455364|NCT04799782|62829776|FG001|Washout|Withdrawal by Subject|2|||
33455365|NCT04799782|62829775|FG000|Washout|Lost to Follow-up|0|||
33455366|NCT04799782|62829776|FG001|Washout|Lost to Follow-up|1|||
33455367|NCT03697252|62829784|FG000|Overall Study|Adverse Event|3|||
33455368|NCT03697252|62829785|FG001|Overall Study|Adverse Event|2|||
33455369|NCT03697252|62829784|FG000|Overall Study|Withdrawal by Subject|14|||
33455370|NCT03697252|62829785|FG001|Overall Study|Withdrawal by Subject|14|||
33455371|NCT03697252|62829784|FG000|Overall Study|Lost to Follow-up|0|||
33455372|NCT03697252|62829785|FG001|Overall Study|Lost to Follow-up|1|||
33455373|NCT03697252|62829784|FG000|Overall Study|Physician Decision|1|||
33455374|NCT03697252|62829785|FG001|Overall Study|Physician Decision|1|||
33455375|NCT03697252|62829784|FG000|Overall Study|Other|0|||
33455376|NCT03697252|62829785|FG001|Overall Study|Other|1|||
33455377|NCT03701074|62829793|FG000|Overall Study|Physician Decision|1|||
33455378|NCT03701074|62829794|FG001|Overall Study|Physician Decision|0|||
33455379|NCT04728802|62829802|FG000|Overall Study|Withdrawal by Subject|4|||
33455380|NCT04728802|62829803|FG001|Overall Study|Withdrawal by Subject|20|||
33455381|NCT04728802|62829802|FG000|Overall Study|Physician Decision|7|||
33455382|NCT04728802|62829803|FG001|Overall Study|Physician Decision|7|||
33455383|NCT04728802|62829802|FG000|Overall Study|Protocol Violation|10|||
33455384|NCT04728802|62829803|FG001|Overall Study|Protocol Violation|4|||
33455385|NCT04728802|62829802|FG000|Overall Study|Transfer|1|||
33519100|NCT03227861|62904572|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
33519101|NCT03227861|62904572|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
33519102|NCT03227861|62904572|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
33519103|NCT03227861|62904572|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
33519104|NCT03227861|62904572|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
33519105|NCT03227861|62904572|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
33519106|NCT03227861|62904572|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
33519107|NCT03227861|62904572|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
33519108|NCT01336712|62904578|FG000|Overall Study|Death|2|||
33519109|NCT01336712|62904578|FG000|Overall Study|Lack of Efficacy|1|||
33519110|NCT03208127|62904582|FG000|Overall Study|Death|1|||
33519111|NCT02865122|62904589|FG000|Overall Study|Adverse Event|1|||
33519112|NCT02865122|62904590|FG001|Overall Study|Adverse Event|0|||
33519113|NCT02865122|62904591|FG002|Overall Study|Adverse Event|0|||
33519114|NCT02864498|62904602|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
33519115|NCT02864498|62904603|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
33519116|NCT02864498|62904604|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
33519117|NCT02864498|62904602|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
33519118|NCT02864498|62904603|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
33519119|NCT02864498|62904604|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
33519120|NCT02864498|62904602|FG000|Overall Study|Investigator Discretion|0|||
33616684|NCT02177942|63017618|FG001|Overall Study|Withdrawal by Subject|81|||
33616685|NCT02155322|63017628|FG000|Overall Study|Adverse Event|1|||
33616686|NCT02155322|63017628|FG000|Overall Study|Physician Decision|1|||
33616687|NCT02155322|63017628|FG000|Overall Study|Relapse/Recurrence|8|||
33519121|NCT02864498|62904603|FG001|Overall Study|Investigator Discretion|2|||
33519122|NCT02864498|62904604|FG002|Overall Study|Investigator Discretion|1|||
33519123|NCT02864498|62904602|FG000|Overall Study|Lost to Follow-up|8|||
33519124|NCT02864498|62904603|FG001|Overall Study|Lost to Follow-up|6|||
33519125|NCT02864498|62904604|FG002|Overall Study|Lost to Follow-up|3|||
33519126|NCT02864498|62904602|FG000|Overall Study|Lack of Efficacy|5|||
33519127|NCT02864498|62904603|FG001|Overall Study|Lack of Efficacy|3|||
33519128|NCT02864498|62904604|FG002|Overall Study|Lack of Efficacy|3|||
33519129|NCT02864498|62904602|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
33519130|NCT02864498|62904603|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
33519131|NCT02864498|62904604|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
33519132|NCT02864498|62904602|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
33519133|NCT02864498|62904603|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
33519134|NCT02864498|62904604|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
33519135|NCT02864498|62904602|FG000|Overall Study|Subject moved out of the country.|0|||
33519136|NCT02864498|62904603|FG001|Overall Study|Subject moved out of the country.|0|||
33519137|NCT02864498|62904604|FG002|Overall Study|Subject moved out of the country.|1|||
33519138|NCT03238781|62904615|FG000|Overall Study|Adverse Event|1|||
33519139|NCT03238781|62904616|FG001|Overall Study|Adverse Event|1|||
33519140|NCT03238781|62904617|FG002|Overall Study|Adverse Event|2|||
33519141|NCT03238781|62904615|FG000|Overall Study|Lost to Follow-up|2|||
33519142|NCT03238781|62904616|FG001|Overall Study|Lost to Follow-up|1|||
33519143|NCT03238781|62904617|FG002|Overall Study|Lost to Follow-up|2|||
33519144|NCT03238781|62904615|FG000|Overall Study|Withdrawal by Subject|23|||
33519145|NCT03238781|62904616|FG001|Overall Study|Withdrawal by Subject|14|||
33519146|NCT03238781|62904617|FG002|Overall Study|Withdrawal by Subject|16|||
33519147|NCT03238781|62904615|FG000|Overall Study|Decision by sponsor|0|||
33519148|NCT03238781|62904616|FG001|Overall Study|Decision by sponsor|1|||
33519149|NCT03238781|62904617|FG002|Overall Study|Decision by sponsor|0|||
33519150|NCT02097121|62904628|FG000|Overall Study|Other, not specified|4|||
33519151|NCT02097121|62904629|FG001|Overall Study|Other, not specified|2|||
33519152|NCT02097121|62904630|FG002|Overall Study|Other, not specified|3|||
33519153|NCT02097121|62904628|FG000|Overall Study|Lack of Efficacy|2|||
33616688|NCT02155322|63017628|FG000|Overall Study|Withdrawal by Subject|4|||
33616689|NCT02210000|63017634|FG000|Overall Study|Study Terminated|11|||
33519154|NCT02097121|62904629|FG001|Overall Study|Lack of Efficacy|1|||
33519155|NCT02097121|62904630|FG002|Overall Study|Lack of Efficacy|3|||
33519156|NCT02097121|62904628|FG000|Overall Study|Withdrawal by Subject|0|||
33519157|NCT02097121|62904629|FG001|Overall Study|Withdrawal by Subject|1|||
33616690|NCT02210000|63017635|FG001|Overall Study|Study Terminated|12|||
33519158|NCT02097121|62904630|FG002|Overall Study|Withdrawal by Subject|2|||
33519159|NCT02097121|62904628|FG000|Overall Study|Adverse Event|0|||
33519160|NCT02097121|62904629|FG001|Overall Study|Adverse Event|1|||
33519161|NCT02097121|62904630|FG002|Overall Study|Adverse Event|0|||
33519162|NCT02097121|62904628|FG000|Overall Study|Lost to Follow-up|1|||
33519163|NCT02097121|62904629|FG001|Overall Study|Lost to Follow-up|1|||
33519164|NCT02097121|62904630|FG002|Overall Study|Lost to Follow-up|2|||
33519165|NCT02747420|62904659|FG000|Overall Study|Lost to Follow-up|4|||
33519166|NCT02747420|62904660|FG001|Overall Study|Lost to Follow-up|2|||
33519167|NCT02747420|62904659|FG000|Overall Study|Withdrawal by Subject|3|||
33519168|NCT02747420|62904660|FG001|Overall Study|Withdrawal by Subject|2|||
33519169|NCT03238001|62904666|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
33519170|NCT03238001|62904666|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
33519171|NCT03238001|62904666|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
33519172|NCT03238001|62904666|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
33519173|NCT03238001|62904666|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
33519174|NCT03238001|62904666|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
33519175|NCT03238001|62904666|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
33519176|NCT03238001|62904666|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
33519177|NCT02747108|62904680|FG000|Overall Study|Death|2|||
33519178|NCT02747108|62904681|FG001|Overall Study|Death|2|||
33519179|NCT02747108|62904680|FG000|Overall Study|Withdrawal by Subject|1|||
33519180|NCT02747108|62904681|FG001|Overall Study|Withdrawal by Subject|0|||
33519181|NCT02747108|62904680|FG000|Overall Study|Protocol Violation|2|||
33519182|NCT02747108|62904681|FG001|Overall Study|Protocol Violation|0|||
33519183|NCT03226769|62904709|FG000|Overall Study|Withdrawal by Subject|0|||
33519184|NCT03226769|62904710|FG001|Overall Study|Withdrawal by Subject|1|||
33519185|NCT02864342|62904718|FG000|Overall Study|Eligibility Criteria Deviation|2|||
33519186|NCT02864342|62904719|FG001|Overall Study|Eligibility Criteria Deviation|3|||
33519187|NCT02864342|62904718|FG000|Overall Study|Withdrawal by Subject|4|||
33519188|NCT02864342|62904719|FG001|Overall Study|Withdrawal by Subject|2|||
33519189|NCT02864342|62904718|FG000|Overall Study|Device Technology Issue|6|||
33519190|NCT02864342|62904719|FG001|Overall Study|Device Technology Issue|7|||
33519191|NCT02864342|62904718|FG000|Overall Study|Death|0|||
33519192|NCT02864342|62904719|FG001|Overall Study|Death|1|||
33519193|NCT02864342|62904718|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
33519194|NCT02864342|62904719|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
33519195|NCT02864342|62904718|FG000|Overall Study|Lost to Follow-up|1|||
33519196|NCT02864342|62904719|FG001|Overall Study|Lost to Follow-up|5|||
33519197|NCT02864342|62904718|FG000|Overall Study|Lost Device|1|||
33519198|NCT02864342|62904719|FG001|Overall Study|Lost Device|0|||
33519199|NCT02864342|62904718|FG000|Overall Study|Adverse Event|1|||
33519200|NCT02864342|62904719|FG001|Overall Study|Adverse Event|0|||
33519201|NCT03237065|62904728|FG000|Overall Study|Adverse Event|0|||
33519202|NCT03237065|62904729|FG001|Overall Study|Adverse Event|2|||
33519203|NCT03237065|62904728|FG000|Overall Study|Protocol Violation|0|||
33616691|NCT02210000|63017634|FG000|Overall Study|Withdrawal by Subject|7|||
33616692|NCT02210000|63017635|FG001|Overall Study|Withdrawal by Subject|1|||
33616693|NCT02210000|63017634|FG000|Overall Study|Adverse Event|1|||
33616694|NCT02210000|63017635|FG001|Overall Study|Adverse Event|5|||
33616695|NCT02210000|63017634|FG000|Overall Study|Lost to Follow-up|0|||
33616696|NCT02210000|63017635|FG001|Overall Study|Lost to Follow-up|2|||
33616697|NCT02210000|63017634|FG000|Overall Study|Physician Decision|0|||
33616698|NCT02210000|63017635|FG001|Overall Study|Physician Decision|1|||
33616699|NCT01531894|63017641|FG000|Overall Study|Physician Decision|8|||
33616700|NCT01531894|63017641|FG000|Overall Study|Death|1|||
33519204|NCT03237065|62904729|FG001|Overall Study|Protocol Violation|1|||
33519205|NCT03237065|62904728|FG000|Overall Study|Withdrawal by Subject|3|||
33519206|NCT03237065|62904729|FG001|Overall Study|Withdrawal by Subject|0|||
33519207|NCT03237065|62904728|FG000|Overall Study|Lost to Follow-up|1|||
33519208|NCT03237065|62904729|FG001|Overall Study|Lost to Follow-up|0|||
33519209|NCT03237065|62904728|FG000|Overall Study|Unable to obtain venous access|0|||
33519210|NCT03237065|62904729|FG001|Overall Study|Unable to obtain venous access|1|||
33519211|NCT03171415|62904740|FG000|Overall Study|Lost to Follow-up|0|||
33519212|NCT03171415|62904741|FG001|Overall Study|Lost to Follow-up|0|||
33519213|NCT03171415|62904742|FG002|Overall Study|Lost to Follow-up|0|||
33519214|NCT03171415|62904743|FG003|Overall Study|Lost to Follow-up|0|||
33616701|NCT02209766|63017649|FG000|Overall Study|Withdrawal by Subject|0|||
33616702|NCT02209766|63017650|FG001|Overall Study|Withdrawal by Subject|0|||
33616703|NCT02209766|63017651|FG002|Overall Study|Withdrawal by Subject|0|||
33519215|NCT03171415|62904744|FG004|Overall Study|Lost to Follow-up|2|||
33519216|NCT03829241|62904769|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
33519217|NCT03829241|62904770|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
33519218|NCT03829241|62904769|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
33519219|NCT03829241|62904770|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
33519220|NCT03829241|62904769|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
33519221|NCT03829241|62904770|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
33616704|NCT02209766|63017652|FG003|Overall Study|Withdrawal by Subject|1|||
33616705|NCT02209766|63017653|FG004|Overall Study|Withdrawal by Subject|0|||
33519222|NCT03829241|62904769|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
33519223|NCT03829241|62904770|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
33519224|NCT03829241|62904769|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
33519225|NCT03829241|62904770|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
33519226|NCT03829241|62904769|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
33519227|NCT03829241|62904770|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
33519228|NCT03829241|62904769|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
33519229|NCT03829241|62904770|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
33519230|NCT03829241|62904769|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
33519231|NCT03829241|62904770|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
33519232|NCT03829241|62904769|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
33519233|NCT03829241|62904770|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
33519234|NCT03829241|62904769|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
33519235|NCT03829241|62904770|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
33519236|NCT03829241|62904769|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
33519237|NCT03829241|62904770|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
33519238|NCT03829241|62904769|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
33519239|NCT03829241|62904770|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
33519240|NCT03829241|62904769|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
33519241|NCT03829241|62904770|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
33519242|NCT03829241|62904769|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
33519243|NCT03829241|62904770|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
33519244|NCT03164551|62904782|FG000|Overall Study|Imaging discontinued prior completion|8|||
33519245|NCT03164551|62904783|FG001|Overall Study|Imaging discontinued prior completion|0|||
33519246|NCT03164551|62904782|FG000|Overall Study|Participant was non-compliant|1|||
33519247|NCT03164551|62904783|FG001|Overall Study|Participant was non-compliant|0|||
33519248|NCT03164551|62904782|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
33519249|NCT03164551|62904783|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
33519250|NCT03164551|62904782|FG000|Overall Study|Other|8|||
33519251|NCT03164551|62904783|FG001|Overall Study|Other|2|||
33519252|NCT02863328|62904791|FG000|Overall Study|Lost to Follow-up|4|||
33519253|NCT02863328|62904792|FG001|Overall Study|Lost to Follow-up|10|||
33519254|NCT02863328|62904791|FG000|Overall Study|Withdrawal by Subject|7|||
33519255|NCT02863328|62904792|FG001|Overall Study|Withdrawal by Subject|12|||
33519256|NCT02863328|62904791|FG000|Overall Study|Died|0|||
33519257|NCT02863328|62904792|FG001|Overall Study|Died|1|||
33519258|NCT03040141|62904801|FG000|Overall Study|Death|1|||
33519259|NCT03040141|62904802|FG001|Overall Study|Death|2|||
33519260|NCT03040141|62904803|FG002|Overall Study|Death|3|||
33519261|NCT03040141|62904801|FG000|Overall Study|Withdrawal by Subject|3|||
33519262|NCT03040141|62904802|FG001|Overall Study|Withdrawal by Subject|1|||
33519263|NCT03040141|62904803|FG002|Overall Study|Withdrawal by Subject|1|||
33519264|NCT03040141|62904801|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
33519265|NCT03040141|62904802|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
33519266|NCT03040141|62904803|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
33519267|NCT03040141|62904801|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
33519268|NCT03040141|62904802|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
33519269|NCT03040141|62904803|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
33616706|NCT02209454|63017663|FG000|Second Period|Adverse Event|1|||
33616707|NCT02209454|63017664|FG001|Second Period|Adverse Event|0|||
33519270|NCT02937701|62904817|FG000|Day 1 to Week 22|Adverse Event|11|||
33519271|NCT02937701|62904818|FG001|Day 1 to Week 22|Adverse Event|14|||
33519272|NCT02937701|62904819|FG002|Day 1 to Week 22|Adverse Event|0|||
33519273|NCT02937701|62904820|FG003|Day 1 to Week 22|Adverse Event|0|||
33519274|NCT02937701|62904821|FG004|Day 1 to Week 22|Adverse Event|0|||
33519275|NCT02937701|62904817|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
33519276|NCT02937701|62904818|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
33519277|NCT02937701|62904819|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
33519278|NCT02937701|62904820|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
33519279|NCT02937701|62904821|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
33616708|NCT01571596|63017673|FG000|Overall Study|Adverse Event|2|||
33519280|NCT02937701|62904817|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
33519281|NCT02937701|62904818|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
33519282|NCT02937701|62904819|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
33519283|NCT02937701|62904820|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
33519284|NCT02937701|62904821|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
33519285|NCT02937701|62904817|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
33616709|NCT01571596|63017674|FG001|Overall Study|Adverse Event|0|||
33616710|NCT01571596|63017675|FG002|Overall Study|Adverse Event|0|||
33519286|NCT02937701|62904818|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
33519287|NCT02937701|62904819|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
33519288|NCT02937701|62904820|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
33519289|NCT02937701|62904821|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
33519290|NCT02937701|62904817|FG000|Day 1 to Week 22|Death|1|||
33519291|NCT02937701|62904818|FG001|Day 1 to Week 22|Death|1|||
33519292|NCT02937701|62904819|FG002|Day 1 to Week 22|Death|0|||
33519293|NCT02937701|62904820|FG003|Day 1 to Week 22|Death|0|||
33519294|NCT02937701|62904821|FG004|Day 1 to Week 22|Death|0|||
33519295|NCT02937701|62904817|FG000|Day 1 to Week 22|Protocol Violation|1|||
33519296|NCT02937701|62904818|FG001|Day 1 to Week 22|Protocol Violation|1|||
33519297|NCT02937701|62904819|FG002|Day 1 to Week 22|Protocol Violation|0|||
33519298|NCT02937701|62904820|FG003|Day 1 to Week 22|Protocol Violation|0|||
33519299|NCT02937701|62904821|FG004|Day 1 to Week 22|Protocol Violation|0|||
33519300|NCT02937701|62904817|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
33519301|NCT02937701|62904818|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
33519302|NCT02937701|62904819|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
33519303|NCT02937701|62904820|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
33519304|NCT02937701|62904821|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
33519305|NCT02937701|62904817|FG000|Day 1 to Week 22|Physician Decision|2|||
33519306|NCT02937701|62904818|FG001|Day 1 to Week 22|Physician Decision|0|||
33519307|NCT02937701|62904819|FG002|Day 1 to Week 22|Physician Decision|0|||
33519308|NCT02937701|62904820|FG003|Day 1 to Week 22|Physician Decision|0|||
33519309|NCT02937701|62904821|FG004|Day 1 to Week 22|Physician Decision|0|||
33519310|NCT02937701|62904817|FG000|Day 1 to Week 22|Other|1|||
33519311|NCT02937701|62904818|FG001|Day 1 to Week 22|Other|0|||
33519312|NCT02937701|62904819|FG002|Day 1 to Week 22|Other|0|||
33519313|NCT02937701|62904820|FG003|Day 1 to Week 22|Other|0|||
33519314|NCT02937701|62904821|FG004|Day 1 to Week 22|Other|0|||
33519315|NCT02937701|62904817|FG000|Week 22 to Week 50|Adverse Event|0|||
33519316|NCT02937701|62904818|FG001|Week 22 to Week 50|Adverse Event|0|||
33519317|NCT02937701|62904819|FG002|Week 22 to Week 50|Adverse Event|10|||
33519318|NCT02937701|62904820|FG003|Week 22 to Week 50|Adverse Event|3|||
33519319|NCT02937701|62904821|FG004|Week 22 to Week 50|Adverse Event|3|||
33519320|NCT02937701|62904817|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
33519321|NCT02937701|62904818|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
33519322|NCT02937701|62904819|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
33519323|NCT02937701|62904820|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
33519324|NCT02937701|62904821|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
33519325|NCT02937701|62904817|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
33519326|NCT02937701|62904818|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
33519327|NCT02937701|62904819|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
33519328|NCT02937701|62904820|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
33519329|NCT02937701|62904821|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
33519330|NCT02937701|62904817|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
33519331|NCT02937701|62904818|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
33519332|NCT02937701|62904819|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
33519333|NCT02937701|62904820|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
33519334|NCT02937701|62904821|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
33519335|NCT02937701|62904817|FG000|Week 22 to Week 50|Physician Decision|0|||
33519336|NCT02937701|62904818|FG001|Week 22 to Week 50|Physician Decision|0|||
33519337|NCT02937701|62904819|FG002|Week 22 to Week 50|Physician Decision|2|||
33519338|NCT02937701|62904820|FG003|Week 22 to Week 50|Physician Decision|0|||
33519339|NCT02937701|62904821|FG004|Week 22 to Week 50|Physician Decision|1|||
33519340|NCT02937701|62904817|FG000|Week 22 to Week 50|Other|0|||
33519341|NCT02937701|62904818|FG001|Week 22 to Week 50|Other|0|||
33519342|NCT02937701|62904819|FG002|Week 22 to Week 50|Other|0|||
33519343|NCT02937701|62904820|FG003|Week 22 to Week 50|Other|0|||
33519344|NCT02937701|62904821|FG004|Week 22 to Week 50|Other|1|||
33519345|NCT03169153|62904833|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
33519346|NCT03169153|62904834|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
33519347|NCT03169153|62904833|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
33519348|NCT03169153|62904834|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
33519349|NCT03169153|62904833|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
33519350|NCT03169153|62904834|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
33519351|NCT03169153|62904833|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
33519352|NCT03169153|62904834|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
33519353|NCT03168919|62904840|FG000|Overall Study|Withdrawal by Subject|2|||
33519354|NCT03205163|62904850|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
33519355|NCT03205163|62904851|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
33519356|NCT01759537|62904866|FG000|Overall Study|Death|1|||
33519357|NCT01759537|62904867|FG001|Overall Study|Death|1|||
33519358|NCT01759537|62904866|FG000|Overall Study|Pregnancy|1|||
33519359|NCT01759537|62904867|FG001|Overall Study|Pregnancy|1|||
33519360|NCT01759537|62904866|FG000|Overall Study|Lost to Follow-up|9|||
33519361|NCT01759537|62904867|FG001|Overall Study|Lost to Follow-up|9|||
33519362|NCT01759537|62904866|FG000|Overall Study|Accident involving jaw fracture|1|||
33519363|NCT01759537|62904867|FG001|Overall Study|Accident involving jaw fracture|1|||
33519364|NCT01759537|62904866|FG000|Overall Study|Subcrestal implant too coronal|1|||
33519365|NCT01759537|62904867|FG001|Overall Study|Subcrestal implant too coronal|1|||
33519366|NCT03204539|62904875|FG000|Overall Study|Loss of funding|0|||
33519367|NCT03204539|62904876|FG001|Overall Study|Loss of funding|1|||
33519368|NCT03502681|62904893|FG000|Overall Study|Adverse Event|1|||
33519369|NCT03502681|62904894|FG001|Overall Study|Adverse Event|1|||
33519370|NCT03502681|62904893|FG000|Overall Study|Disease Progression|2|||
33519371|NCT03502681|62904894|FG001|Overall Study|Disease Progression|1|||
33519372|NCT02860130|62904901|FG000|Overall Study|Adverse Event|2|||
33519373|NCT02860130|62904902|FG001|Overall Study|Adverse Event|3|||
33519374|NCT02860130|62904901|FG000|Overall Study|Protocol Violation|1|||
33519375|NCT02860130|62904902|FG001|Overall Study|Protocol Violation|1|||
33519376|NCT02860130|62904901|FG000|Overall Study|Withdrawal by Subject|0|||
33519377|NCT02860130|62904902|FG001|Overall Study|Withdrawal by Subject|2|||
33519378|NCT02860130|62904901|FG000|Overall Study|Physician Decision|2|||
33519379|NCT02860130|62904902|FG001|Overall Study|Physician Decision|2|||
33519380|NCT02860130|62904901|FG000|Overall Study|Other|2|||
33519381|NCT02860130|62904902|FG001|Overall Study|Other|1|||
33519382|NCT02986854|62904911|FG000|Overall Study|Withdrawal by Subject|0|||
33519383|NCT02986854|62904912|FG001|Overall Study|Withdrawal by Subject|1|||
33519384|NCT02986854|62904913|FG002|Overall Study|Withdrawal by Subject|1|||
33519385|NCT02986854|62904911|FG000|Overall Study|Lost to Follow-up|3|||
33519386|NCT02986854|62904912|FG001|Overall Study|Lost to Follow-up|11|||
33519387|NCT02986854|62904913|FG002|Overall Study|Lost to Follow-up|2|||
33519388|NCT02887183|62904923|FG000|Overall Study|Adverse Event|44|||
33519389|NCT02887183|62904923|FG000|Overall Study|Death|30|||
33519390|NCT02887183|62904923|FG000|Overall Study|Pregnancy|1|||
33519391|NCT02887183|62904923|FG000|Overall Study|Protocol Violation|6|||
33519392|NCT02887183|62904923|FG000|Overall Study|Technical Problems|2|||
33519393|NCT02887183|62904923|FG000|Overall Study|Lost to Follow-up|13|||
33519394|NCT02887183|62904923|FG000|Overall Study|Physician Decision|10|||
33519395|NCT02887183|62904923|FG000|Overall Study|Withdrawal by Subject|35|||
33519396|NCT03167359|62904927|FG000|Overall Study|Physician Decision|1|||
33519397|NCT03167359|62904927|FG000|Overall Study|Lost to Follow-up|1|||
33519398|NCT01068600|62904933|FG000|Overall Study|Withdrawal by Subject|5|||
33519399|NCT01068600|62904934|FG001|Overall Study|Withdrawal by Subject|6|||
33519400|NCT01068600|62904933|FG000|Overall Study|Adverse Event|3|||
33519401|NCT01068600|62904934|FG001|Overall Study|Adverse Event|3|||
33519402|NCT01068600|62904933|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33519403|NCT01068600|62904934|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33519404|NCT01068600|62904933|FG000|Overall Study|Lost to Follow-up|1|||
33519405|NCT01068600|62904934|FG001|Overall Study|Lost to Follow-up|2|||
33519406|NCT01068600|62904933|FG000|Overall Study|Protocol deviation|1|||
33519407|NCT01068600|62904934|FG001|Overall Study|Protocol deviation|1|||
33519408|NCT01068600|62904933|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33519409|NCT01068600|62904934|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
33519410|NCT01068600|62904933|FG000|Overall Study|Administrative problems|0|||
33519411|NCT01068600|62904934|FG001|Overall Study|Administrative problems|1|||
33519412|NCT01067976|62904940|FG000|Overall Study|Study drug never administered|20|||
33519413|NCT01067976|62904940|FG000|Overall Study|Study prematurely discontinued|2|||
33519414|NCT02858492|62904962|FG000|Overall Study|Withdrawal by Subject|0|||
33455386|NCT04728802|62829803|FG001|Overall Study|Transfer|0|||
33455387|NCT04728802|62829802|FG000|Overall Study|Death|4|||
33519415|NCT02858492|62904963|FG001|Overall Study|Withdrawal by Subject|1|||
33519416|NCT02858492|62904964|FG002|Overall Study|Withdrawal by Subject|0|||
33519417|NCT02858492|62904965|FG003|Overall Study|Withdrawal by Subject|1|||
33519418|NCT02858492|62904962|FG000|Overall Study|Adverse Event|0|||
33519419|NCT02858492|62904963|FG001|Overall Study|Adverse Event|0|||
33519420|NCT02858492|62904964|FG002|Overall Study|Adverse Event|0|||
33519421|NCT02858492|62904965|FG003|Overall Study|Adverse Event|3|||
33519422|NCT02858492|62904962|FG000|Overall Study|Lack of Efficacy|0|||
33519423|NCT02858492|62904963|FG001|Overall Study|Lack of Efficacy|0|||
33519424|NCT02858492|62904964|FG002|Overall Study|Lack of Efficacy|0|||
33519425|NCT02858492|62904965|FG003|Overall Study|Lack of Efficacy|1|||
33519426|NCT02858492|62904962|FG000|Overall Study|Protocol defined stopping criteria|0|||
33519427|NCT02858492|62904963|FG001|Overall Study|Protocol defined stopping criteria|0|||
33519428|NCT02858492|62904964|FG002|Overall Study|Protocol defined stopping criteria|0|||
33519429|NCT02858492|62904965|FG003|Overall Study|Protocol defined stopping criteria|1|||
33519430|NCT01067508|62904979|FG000|Overall Study|Physician Decision|0|||
33519431|NCT01067508|62904980|FG001|Overall Study|Physician Decision|1|||
33519432|NCT01067508|62904979|FG000|Overall Study|Withdrawal by Subject|0|||
33519433|NCT01067508|62904980|FG001|Overall Study|Withdrawal by Subject|1|||
33519434|NCT01067352|62904989|FG000|Overall Study|Withdrawal by Subject|1|||
33616711|NCT01571596|63017673|FG000|Overall Study|Study Terminated by the Sponsor|0|||
33616712|NCT01571596|63017674|FG001|Overall Study|Study Terminated by the Sponsor|1|||
33616713|NCT01571596|63017675|FG002|Overall Study|Study Terminated by the Sponsor|1|||
33616714|NCT01557166|63017687|FG000|Overall Study|Adverse Event|20|||
33616715|NCT01557166|63017688|FG001|Overall Study|Adverse Event|6|||
33616716|NCT01557166|63017687|FG000|Overall Study|Lack of Efficacy|2|||
33519435|NCT01067352|62904990|FG001|Overall Study|Withdrawal by Subject|2|||
33519436|NCT01067352|62904991|FG002|Overall Study|Withdrawal by Subject|1|||
33519437|NCT01067352|62904989|FG000|Overall Study|Physician Decision|0|||
33519438|NCT01067352|62904990|FG001|Overall Study|Physician Decision|1|||
33519439|NCT01067352|62904991|FG002|Overall Study|Physician Decision|0|||
33519440|NCT02986074|62904999|FG000|First Trial Period|Adverse Event|1|||
33519441|NCT02986074|62905000|FG001|First Trial Period|Adverse Event|0|||
33519442|NCT02986074|62905001|FG002|First Trial Period|Adverse Event|0|||
33519443|NCT02986074|62905002|FG003|First Trial Period|Adverse Event|0|||
33519444|NCT02986074|62904999|FG000|Follow up Period|system explant|0|||
33519445|NCT02986074|62905000|FG001|Follow up Period|system explant|0|||
33519446|NCT02986074|62905001|FG002|Follow up Period|system explant|1|||
33519447|NCT02986074|62905002|FG003|Follow up Period|system explant|2|||
33455388|NCT04728802|62829803|FG001|Overall Study|Death|5|||
33519448|NCT02986074|62904999|FG000|Follow up Period|Physician Decision|0|||
33519449|NCT02986074|62905000|FG001|Follow up Period|Physician Decision|0|||
33616717|NCT01557166|63017688|FG001|Overall Study|Lack of Efficacy|1|||
33616718|NCT01557166|63017687|FG000|Overall Study|Protocol Violation|8|||
33455389|NCT04728802|62829802|FG000|Overall Study|Other|3|||
33455390|NCT04728802|62829803|FG001|Overall Study|Other|0|||
33455391|NCT04715932|62829811|FG000|Overall Study|Lost to Follow-up|1|||
33455392|NCT04715932|62829812|FG001|Overall Study|Lost to Follow-up|0|||
33455393|NCT00130832|62829820|FG000|Overall Study|Adverse Event|1|||
33455394|NCT00130832|62829821|FG001|Overall Study|Adverse Event|1|||
33455395|NCT00130832|62829820|FG000|Overall Study|Lost to Follow-up|1|||
33455396|NCT00130832|62829821|FG001|Overall Study|Lost to Follow-up|2|||
33519450|NCT02986074|62905001|FG002|Follow up Period|Physician Decision|0|||
33519451|NCT02986074|62905002|FG003|Follow up Period|Physician Decision|1|||
33519452|NCT02920242|62905010|FG000|Overall Study|Withdrawal by Subject|1|||
33519453|NCT02920242|62905011|FG001|Overall Study|Withdrawal by Subject|0|||
33519454|NCT02920242|62905012|FG002|Overall Study|Withdrawal by Subject|1|||
33519455|NCT02920242|62905010|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
33519456|NCT02920242|62905011|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
33616719|NCT01557166|63017688|FG001|Overall Study|Protocol Violation|5|||
33616720|NCT01557166|63017687|FG000|Overall Study|Withdrawn consent|12|||
33455397|NCT00130832|62829820|FG000|Overall Study|Protocol Violation|6|||
33519457|NCT02920242|62905012|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
33519458|NCT02985996|62905025|FG000|Overall Study|Withdrawal by Subject|0|||
33519459|NCT02985996|62905026|FG001|Overall Study|Withdrawal by Subject|0|||
33519460|NCT02985996|62905027|FG002|Overall Study|Withdrawal by Subject|1|||
33519461|NCT02985996|62905028|FG003|Overall Study|Withdrawal by Subject|0|||
33519462|NCT02985996|62905029|FG004|Overall Study|Withdrawal by Subject|0|||
33519463|NCT02985996|62905025|FG000|Overall Study|Protocol Violation|0|||
33519464|NCT02985996|62905026|FG001|Overall Study|Protocol Violation|1|||
33519465|NCT02985996|62905027|FG002|Overall Study|Protocol Violation|0|||
33519466|NCT02985996|62905028|FG003|Overall Study|Protocol Violation|0|||
33519467|NCT02985996|62905029|FG004|Overall Study|Protocol Violation|0|||
33519468|NCT03225833|62905051|FG000|Overall Study|Adverse Event|0|||
33519469|NCT03225833|62905052|FG001|Overall Study|Adverse Event|1|||
33519470|NCT03225833|62905053|FG002|Overall Study|Adverse Event|2|||
33519471|NCT03225833|62905054|FG003|Overall Study|Adverse Event|0|||
33519472|NCT03225833|62905055|FG004|Overall Study|Adverse Event|0|||
33616721|NCT01557166|63017688|FG001|Overall Study|Withdrawn consent|20|||
33519473|NCT03225833|62905056|FG005|Overall Study|Adverse Event|2|||
33616722|NCT01557166|63017687|FG000|Overall Study|Target dose not tolerated|1|||
33519474|NCT03225833|62905051|FG000|Overall Study|Withdrawal by Subject|1|||
33519475|NCT03225833|62905052|FG001|Overall Study|Withdrawal by Subject|0|||
33519476|NCT03225833|62905053|FG002|Overall Study|Withdrawal by Subject|0|||
33519477|NCT03225833|62905054|FG003|Overall Study|Withdrawal by Subject|0|||
33519478|NCT03225833|62905055|FG004|Overall Study|Withdrawal by Subject|1|||
33519479|NCT03225833|62905056|FG005|Overall Study|Withdrawal by Subject|0|||
33519480|NCT03225833|62905051|FG000|Overall Study|Termination of Study by Sponsor|4|||
33519481|NCT03225833|62905052|FG001|Overall Study|Termination of Study by Sponsor|0|||
33519482|NCT03225833|62905053|FG002|Overall Study|Termination of Study by Sponsor|0|||
33519483|NCT03225833|62905054|FG003|Overall Study|Termination of Study by Sponsor|0|||
33519484|NCT03225833|62905055|FG004|Overall Study|Termination of Study by Sponsor|0|||
33519485|NCT03225833|62905056|FG005|Overall Study|Termination of Study by Sponsor|7|||
33519486|NCT03225833|62905051|FG000|Overall Study|Sponsor Decision|0|||
33519487|NCT03225833|62905052|FG001|Overall Study|Sponsor Decision|0|||
33519488|NCT03225833|62905053|FG002|Overall Study|Sponsor Decision|0|||
33519489|NCT03225833|62905054|FG003|Overall Study|Sponsor Decision|0|||
33519490|NCT03225833|62905055|FG004|Overall Study|Sponsor Decision|0|||
33519491|NCT03225833|62905056|FG005|Overall Study|Sponsor Decision|1|||
33519492|NCT03203447|62905077|FG000|Overall Study|Withdrawal by Subject|2|||
33519493|NCT03203447|62905078|FG001|Overall Study|Withdrawal by Subject|1|||
33519494|NCT03203447|62905077|FG000|Overall Study|Lost to Follow-up|1|||
33519495|NCT03203447|62905078|FG001|Overall Study|Lost to Follow-up|10|||
33519496|NCT03203447|62905077|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
33519497|NCT03203447|62905078|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
33519498|NCT02858726|62905088|FG000|Overall Study|Adverse Event|4|||
33519499|NCT02858726|62905089|FG001|Overall Study|Adverse Event|4|||
33519500|NCT02858726|62905090|FG002|Overall Study|Adverse Event|9|||
33519501|NCT02858726|62905091|FG003|Overall Study|Adverse Event|1|||
33519502|NCT02858726|62905088|FG000|Overall Study|Physician Decision|0|||
33455398|NCT00130832|62829821|FG001|Overall Study|Protocol Violation|8|||
33519503|NCT02858726|62905089|FG001|Overall Study|Physician Decision|0|||
33519504|NCT02858726|62905090|FG002|Overall Study|Physician Decision|1|||
33519505|NCT02858726|62905091|FG003|Overall Study|Physician Decision|0|||
33519506|NCT02858726|62905088|FG000|Overall Study|Protocol Violation|0|||
33519507|NCT02858726|62905089|FG001|Overall Study|Protocol Violation|0|||
33519508|NCT02858726|62905090|FG002|Overall Study|Protocol Violation|0|||
33519509|NCT02858726|62905091|FG003|Overall Study|Protocol Violation|1|||
33519510|NCT02858726|62905088|FG000|Overall Study|Study Terminated by Sponsor|0|||
33519511|NCT02858726|62905089|FG001|Overall Study|Study Terminated by Sponsor|0|||
33519512|NCT02858726|62905090|FG002|Overall Study|Study Terminated by Sponsor|0|||
33519513|NCT02858726|62905091|FG003|Overall Study|Study Terminated by Sponsor|1|||
33455399|NCT00130832|62829820|FG000|Overall Study|Withdrawal by Subject|6|||
33455400|NCT00130832|62829821|FG001|Overall Study|Withdrawal by Subject|1|||
33455401|NCT00130832|62829820|FG000|Overall Study|Moved|2|||
33455402|NCT00130832|62829821|FG001|Overall Study|Moved|2|||
33455403|NCT00130832|62829820|FG000|Overall Study|Other|0|||
33455404|NCT00130832|62829821|FG001|Overall Study|Other|3|||
33455405|NCT00096018|62829829|FG000|Overall Study|Became Ineligible (not treated)|0|||
33455406|NCT00096018|62829830|FG001|Overall Study|Became Ineligible (not treated)|3|||
33455407|NCT00096018|62829829|FG000|Overall Study|Miscellaneous (not treated)|0|||
33455408|NCT00096018|62829830|FG001|Overall Study|Miscellaneous (not treated)|2|||
33455409|NCT00096018|62829829|FG000|Overall Study|Adverse Event|0|||
33455410|NCT00096018|62829830|FG001|Overall Study|Adverse Event|5|||
33455411|NCT00096018|62829829|FG000|Overall Study|Death|0|||
33455412|NCT00096018|62829830|FG001|Overall Study|Death|1|||
33455413|NCT00096018|62829829|FG000|Overall Study|Withdrawal by Subject|0|||
33455414|NCT00096018|62829830|FG001|Overall Study|Withdrawal by Subject|2|||
33455415|NCT00096018|62829829|FG000|Overall Study|Miscellaneous|2|||
33455416|NCT00096018|62829830|FG001|Overall Study|Miscellaneous|1|||
33455417|NCT04713748|62829836|FG000|Overall Study|Not enough kits allocated|35|||
33455418|NCT04702984|62829840|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
33455419|NCT04701658|62829846|FG000|Overall Study|Lost to Follow-up|6|||
33455420|NCT00128102|62829852|FG000|Overall Study|Site Discontinued|3|||
33455421|NCT00128102|62829853|FG001|Overall Study|Site Discontinued|6|||
33455422|NCT00128102|62829852|FG000|Overall Study|Other|0|||
33455423|NCT00128102|62829853|FG001|Overall Study|Other|1|||
33455424|NCT00128102|62829852|FG000|Overall Study|Progressive Disease|255|||
33455425|NCT00128102|62829853|FG001|Overall Study|Progressive Disease|285|||
33455426|NCT00128102|62829852|FG000|Overall Study|Adverse Event|34|||
33455427|NCT00128102|62829853|FG001|Overall Study|Adverse Event|11|||
33455428|NCT00128102|62829852|FG000|Overall Study|Death|12|||
33455429|NCT00128102|62829853|FG001|Overall Study|Death|13|||
33455430|NCT00128102|62829852|FG000|Overall Study|Physician Decision|3|||
33455431|NCT00128102|62829853|FG001|Overall Study|Physician Decision|3|||
33455432|NCT00128102|62829852|FG000|Overall Study|Withdrawal by Subject|19|||
33455433|NCT00128102|62829853|FG001|Overall Study|Withdrawal by Subject|11|||
33455434|NCT00128102|62829852|FG000|Overall Study|Protocol Violation|2|||
33519514|NCT02858726|62905088|FG000|Overall Study|Withdrawal by Subject|1|||
33519515|NCT02858726|62905089|FG001|Overall Study|Withdrawal by Subject|2|||
33519516|NCT02858726|62905090|FG002|Overall Study|Withdrawal by Subject|1|||
33519517|NCT02858726|62905091|FG003|Overall Study|Withdrawal by Subject|0|||
33455435|NCT00128102|62829853|FG001|Overall Study|Protocol Violation|2|||
33455436|NCT04668274|62829859|FG000|Part 1 Study Period 1|Adverse Event|3|||
33455437|NCT04668274|62829860|FG001|Part 1 Study Period 1|Adverse Event|0|||
33616723|NCT01557166|63017688|FG001|Overall Study|Target dose not tolerated|0|||
33616724|NCT01557166|63017687|FG000|Overall Study|Psychiatric disorder|1|||
33519518|NCT02858726|62905088|FG000|Overall Study|Noncompliance|0|||
33519519|NCT02858726|62905089|FG001|Overall Study|Noncompliance|1|||
33519520|NCT02858726|62905090|FG002|Overall Study|Noncompliance|0|||
33519521|NCT02858726|62905091|FG003|Overall Study|Noncompliance|0|||
33519522|NCT03203291|62905105|FG000|Overall Study|Withdrawal by Subject|1|||
33519523|NCT01068678|62905111|FG000|Overall Study|Lack of Efficacy|3|||
33519524|NCT01068678|62905112|FG001|Overall Study|Lack of Efficacy|2|||
33519525|NCT01068678|62905111|FG000|Overall Study|Protocol Violation|5|||
33519526|NCT01068678|62905112|FG001|Overall Study|Protocol Violation|1|||
33519527|NCT01068678|62905111|FG000|Overall Study|Withdrawal criteria|12|||
33616725|NCT01557166|63017688|FG001|Overall Study|Psychiatric disorder|0|||
33519528|NCT01068678|62905112|FG001|Overall Study|Withdrawal criteria|6|||
33519529|NCT01068678|62905111|FG000|Overall Study|Unclassified|18|||
33519530|NCT01068678|62905112|FG001|Overall Study|Unclassified|15|||
33519531|NCT03202511|62905118|FG000|Overall Study|Withdrawal by Subject|1|||
33519532|NCT03202511|62905119|FG001|Overall Study|Withdrawal by Subject|0|||
33519533|NCT02919696|62905140|FG000|Overall Study|Adverse Event|1|||
33519534|NCT02919696|62905141|FG001|Overall Study|Adverse Event|2|||
33519535|NCT02919696|62905140|FG000|Overall Study|Withdrawal by Subject|2|||
33519536|NCT02919696|62905141|FG001|Overall Study|Withdrawal by Subject|1|||
33519537|NCT02919696|62905140|FG000|Overall Study|Sponsor Decision|1|||
33519538|NCT02919696|62905141|FG001|Overall Study|Sponsor Decision|1|||
33519539|NCT02919696|62905140|FG000|Overall Study|Never Treated|0|||
33616726|NCT01557166|63017687|FG000|Overall Study|Unclassified|2|||
33325144|NCT00947115|62701843|FG002|Overall Study|Physician Decision|0|||
33325145|NCT00947115|62701841|FG000|Overall Study|Death|0|||
33325146|NCT00947115|62701842|FG001|Overall Study|Death|1|||
33455438|NCT04668274|62829861|FG002|Part 1 Study Period 1|Adverse Event|0|||
33519540|NCT02919696|62905141|FG001|Overall Study|Never Treated|1|||
33519541|NCT02935673|62905156|FG000|Overall Study|Adverse Event|0|||
33519542|NCT02935673|62905157|FG001|Overall Study|Adverse Event|1|||
33519543|NCT02935673|62905158|FG002|Overall Study|Adverse Event|0|||
33519544|NCT02935673|62905156|FG000|Overall Study|Withdrawal by Subject|1|||
33519545|NCT02935673|62905157|FG001|Overall Study|Withdrawal by Subject|2|||
33616727|NCT01557166|63017688|FG001|Overall Study|Unclassified|5|||
33616728|NCT01556932|63017694|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
33455439|NCT04668274|62829862|FG003|Part 1 Study Period 1|Adverse Event|0|||
33455440|NCT04668274|62829859|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
33455441|NCT04668274|62829860|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
33455442|NCT04668274|62829861|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
33455443|NCT04668274|62829862|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
33455444|NCT04668274|62829859|FG000|Part 1 Study Period 2|Other|0|||
33455445|NCT04668274|62829860|FG001|Part 1 Study Period 2|Other|1|||
33455446|NCT04668274|62829861|FG002|Part 1 Study Period 2|Other|0|||
33455447|NCT04668274|62829862|FG003|Part 1 Study Period 2|Other|0|||
33455448|NCT04668274|62829859|FG000|Part 1 Study Period 3|Adverse Event|0|||
33455449|NCT04668274|62829860|FG001|Part 1 Study Period 3|Adverse Event|0|||
33455450|NCT04668274|62829861|FG002|Part 1 Study Period 3|Adverse Event|1|||
33455451|NCT04668274|62829862|FG003|Part 1 Study Period 3|Adverse Event|0|||
33455452|NCT04668274|62829859|FG000|Part 1 Study Period 3|Other|0|||
33455453|NCT04668274|62829860|FG001|Part 1 Study Period 3|Other|0|||
33455454|NCT04668274|62829861|FG002|Part 1 Study Period 3|Other|2|||
33455455|NCT04668274|62829862|FG003|Part 1 Study Period 3|Other|0|||
33455456|NCT04668274|62829859|FG000|Part 2 Study Period 4|Other|0|||
33455457|NCT04668274|62829860|FG001|Part 2 Study Period 4|Other|0|||
33455458|NCT04668274|62829861|FG002|Part 2 Study Period 4|Other|0|||
33455459|NCT04668274|62829862|FG003|Part 2 Study Period 4|Other|1|||
33455460|NCT04406194|62829877|FG000|Period 1|Withdrawal by Subject|0|||
33455461|NCT04406194|62829878|FG001|Period 1|Withdrawal by Subject|1|||
33455462|NCT03822884|62829893|FG000|Overall Study|Withdrawal by Subject|0|||
33455463|NCT03822884|62829894|FG001|Overall Study|Withdrawal by Subject|0|||
33616729|NCT01556932|63017695|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
33616730|NCT02177786|63017704|FG000|Overall Study|Withdrew Consent|2|||
33616731|NCT02177786|63017705|FG001|Overall Study|Withdrew Consent|6|||
33455464|NCT03822884|62829895|FG002|Overall Study|Withdrawal by Subject|0|||
33519546|NCT02935673|62905158|FG002|Overall Study|Withdrawal by Subject|0|||
33519547|NCT03201809|62905170|FG000|Overall Study|Lost to Follow-up|2|||
33519548|NCT03201809|62905171|FG001|Overall Study|Lost to Follow-up|0|||
33519549|NCT02985450|62905182|FG000|Overall Study|Lost to Follow-up|7|||
33519550|NCT02908464|62905191|FG000|Overall Study|Withdrawal by Subject|2|||
33616732|NCT02177786|63017706|FG002|Overall Study|Withdrew Consent|9|||
33455465|NCT03822884|62829896|FG003|Overall Study|Withdrawal by Subject|0|||
33455466|NCT03822884|62829897|FG004|Overall Study|Withdrawal by Subject|1|||
33455467|NCT03822884|62829898|FG005|Overall Study|Withdrawal by Subject|0|||
33455468|NCT03822416|62829908|FG000|Overall Study|Lost to Follow-up|1|||
33455469|NCT03822416|62829909|FG001|Overall Study|Lost to Follow-up|0|||
33519551|NCT02908464|62905192|FG001|Overall Study|Withdrawal by Subject|1|||
33519552|NCT02908464|62905191|FG000|Overall Study|Found ineligible after randomization|0|||
33519553|NCT02908464|62905192|FG001|Overall Study|Found ineligible after randomization|2|||
33519554|NCT02907216|62905201|FG000|Overall Study|No benefit to be obtained by continuing|0|||
33519555|NCT02907216|62905202|FG001|Overall Study|No benefit to be obtained by continuing|1|||
33519556|NCT02907216|62905201|FG000|Overall Study|Withdrawal by Subject|1|||
33519557|NCT02907216|62905202|FG001|Overall Study|Withdrawal by Subject|0|||
33616733|NCT02177786|63017707|FG003|Overall Study|Withdrew Consent|5|||
33616734|NCT02177786|63017704|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
33616735|NCT02177786|63017705|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
33616736|NCT02177786|63017706|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
33616737|NCT02177786|63017707|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
33616738|NCT02177786|63017704|FG000|Overall Study|Adverse Event|1|||
33616739|NCT02177786|63017705|FG001|Overall Study|Adverse Event|1|||
33616740|NCT02177786|63017706|FG002|Overall Study|Adverse Event|2|||
33616741|NCT02177786|63017707|FG003|Overall Study|Adverse Event|3|||
33616742|NCT02177786|63017704|FG000|Overall Study|Death|1|||
33616743|NCT02177786|63017705|FG001|Overall Study|Death|1|||
33616744|NCT02177786|63017706|FG002|Overall Study|Death|1|||
33616745|NCT02177786|63017707|FG003|Overall Study|Death|1|||
33616746|NCT02177786|63017704|FG000|Overall Study|Lost to Follow-up|0|||
33616747|NCT02177786|63017705|FG001|Overall Study|Lost to Follow-up|0|||
33616748|NCT02177786|63017706|FG002|Overall Study|Lost to Follow-up|2|||
33616749|NCT02177786|63017707|FG003|Overall Study|Lost to Follow-up|2|||
33616750|NCT02177786|63017704|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33616751|NCT02177786|63017705|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33616752|NCT02177786|63017706|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33616753|NCT02177786|63017707|FG003|Overall Study|Non-Compliance with Study Drug|1|||
33616754|NCT02177786|63017704|FG000|Overall Study|Protocol Violation|0|||
33616755|NCT02177786|63017705|FG001|Overall Study|Protocol Violation|0|||
33616756|NCT02177786|63017706|FG002|Overall Study|Protocol Violation|2|||
33616757|NCT02177786|63017707|FG003|Overall Study|Protocol Violation|0|||
33616758|NCT02177786|63017704|FG000|Overall Study|Progressive Disease|0|||
33616759|NCT02177786|63017705|FG001|Overall Study|Progressive Disease|1|||
33616760|NCT02177786|63017706|FG002|Overall Study|Progressive Disease|0|||
33616761|NCT02177786|63017707|FG003|Overall Study|Progressive Disease|0|||
33616762|NCT02177786|63017704|FG000|Overall Study|Missing study completion status|0|||
33616763|NCT02177786|63017705|FG001|Overall Study|Missing study completion status|1|||
33616764|NCT02177786|63017706|FG002|Overall Study|Missing study completion status|0|||
33616765|NCT02177786|63017707|FG003|Overall Study|Missing study completion status|0|||
33616766|NCT01555762|63017717|FG000|Overall Study|No information on Bevacizumab intake|11|||
33616767|NCT01555762|63017717|FG000|Overall Study|Missing start date of infusion|8|||
33616768|NCT01555762|63017717|FG000|Overall Study|75 years old or more ticked No|1|||
33616769|NCT01555762|63017717|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
33616770|NCT01555762|63017717|FG000|Overall Study|Death linked to progression of disease|165|||
33616771|NCT01555762|63017717|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
33616772|NCT01555762|63017717|FG000|Overall Study|Investigator's decision|10|||
33616773|NCT01555762|63017717|FG000|Overall Study|Participant not wishing to continue|5|||
33616774|NCT01555762|63017717|FG000|Overall Study|Missing data|1|||
33616775|NCT01555762|63017717|FG000|Overall Study|Death linked to an adverse event|14|||
33616776|NCT02153918|63017721|FG000|Overall Study|Refused further treatment|1|||
33455470|NCT03822416|62829908|FG000|Overall Study|Withdrawal by Subject|0|||
33455471|NCT03822416|62829909|FG001|Overall Study|Withdrawal by Subject|1|||
33455472|NCT04405570|62829919|FG000|Overall Study|Adverse Event|0|||
33455473|NCT04405570|62829920|FG001|Overall Study|Adverse Event|1|||
33455474|NCT04405570|62829921|FG002|Overall Study|Adverse Event|1|||
33455475|NCT04405570|62829922|FG003|Overall Study|Adverse Event|1|||
33455476|NCT04405570|62829919|FG000|Overall Study|Lost to Follow-up|0|||
33519558|NCT02984982|62905210|FG000|Overall Study|Adverse Event|2|||
33325147|NCT00947115|62701843|FG002|Overall Study|Death|1|||
33455477|NCT04405570|62829920|FG001|Overall Study|Lost to Follow-up|1|||
33455478|NCT04405570|62829921|FG002|Overall Study|Lost to Follow-up|0|||
33519559|NCT02984982|62905211|FG001|Overall Study|Adverse Event|5|||
33519560|NCT02984982|62905210|FG000|Overall Study|Poor Compliance to Protocol|4|||
33519561|NCT02984982|62905211|FG001|Overall Study|Poor Compliance to Protocol|4|||
33616777|NCT02176928|63017727|FG000|Overall Study|Lost to Follow-up|2|||
33616778|NCT02176928|63017728|FG001|Overall Study|Lost to Follow-up|4|||
33616779|NCT01628510|63017736|FG000|Overall Study|Withdrawal by Subject|0|||
33616780|NCT01628510|63017737|FG001|Overall Study|Withdrawal by Subject|4|||
33616781|NCT01628510|63017736|FG000|Overall Study|Death|3|||
33616782|NCT01628510|63017737|FG001|Overall Study|Death|1|||
33616783|NCT01571362|63017745|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
33616784|NCT01571362|63017746|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
33455479|NCT04405570|62829922|FG003|Overall Study|Lost to Follow-up|0|||
33455480|NCT04405570|62829919|FG000|Overall Study|Physician Decision|0|||
33519562|NCT02984982|62905210|FG000|Overall Study|Withdrawal by Subject|2|||
33519563|NCT02984982|62905211|FG001|Overall Study|Withdrawal by Subject|0|||
33519564|NCT02984982|62905210|FG000|Overall Study|Randomized but not treated|0|||
33519565|NCT02984982|62905211|FG001|Overall Study|Randomized but not treated|1|||
33519566|NCT02981472|62905220|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
33519567|NCT02981472|62905221|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
33519568|NCT02981472|62905220|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
33519569|NCT02981472|62905221|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33519570|NCT02981472|62905220|FG000|Treatment Period|Adverse Event|6|||
33519571|NCT02981472|62905221|FG001|Treatment Period|Adverse Event|1|||
33519572|NCT02981472|62905220|FG000|Treatment Period|Participant withdrew consent|1|||
33519573|NCT02981472|62905221|FG001|Treatment Period|Participant withdrew consent|0|||
33519574|NCT02981472|62905220|FG000|Treatment Period|Lost to Follow-up|0|||
33519575|NCT02981472|62905221|FG001|Treatment Period|Lost to Follow-up|1|||
33455481|NCT04405570|62829920|FG001|Overall Study|Physician Decision|0|||
33455482|NCT04405570|62829921|FG002|Overall Study|Physician Decision|1|||
33455483|NCT04405570|62829922|FG003|Overall Study|Physician Decision|0|||
33455484|NCT04405570|62829919|FG000|Overall Study|Withdrawal by Subject|0|||
33455485|NCT04405570|62829920|FG001|Overall Study|Withdrawal by Subject|1|||
33455486|NCT04405570|62829921|FG002|Overall Study|Withdrawal by Subject|1|||
33455487|NCT04405570|62829922|FG003|Overall Study|Withdrawal by Subject|0|||
33455488|NCT04405570|62829919|FG000|Overall Study|Randomized not dosed|0|||
33455489|NCT04405570|62829920|FG001|Overall Study|Randomized not dosed|2|||
33455490|NCT04405570|62829921|FG002|Overall Study|Randomized not dosed|0|||
33455491|NCT04405570|62829922|FG003|Overall Study|Randomized not dosed|0|||
33455492|NCT00127712|62829937|FG000|Overall Study|Adverse Event|3|||
33455493|NCT00127712|62829938|FG001|Overall Study|Adverse Event|0|||
33455494|NCT00127712|62829937|FG000|Overall Study|Lack of GI access to continue|2|||
33455495|NCT00127712|62829938|FG001|Overall Study|Lack of GI access to continue|0|||
33455496|NCT04404010|62829946|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
33455497|NCT04404010|62829947|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
33455498|NCT04401202|62829957|FG000|Overall Study|Lost to Follow-up|2|||
33455499|NCT04401202|62829958|FG001|Overall Study|Lost to Follow-up|2|||
33455500|NCT04401202|62829957|FG000|Overall Study|Adverse Event|0|||
33519576|NCT02982720|62905233|FG000|Overall Study|Adverse Event|3|||
33519577|NCT02982720|62905233|FG000|Overall Study|Death|1|||
33519578|NCT00849667|62905240|FG000|Overall Study|Withdrawal by Subject|16|||
33519579|NCT00849667|62905241|FG001|Overall Study|Withdrawal by Subject|33|||
33519580|NCT00849667|62905242|FG002|Overall Study|Withdrawal by Subject|35|||
33519581|NCT00849667|62905240|FG000|Overall Study|Lost to Follow-up|8|||
33519582|NCT00849667|62905241|FG001|Overall Study|Lost to Follow-up|8|||
33519583|NCT00849667|62905242|FG002|Overall Study|Lost to Follow-up|8|||
33519584|NCT00849667|62905240|FG000|Overall Study|Adverse Event|1|||
33519585|NCT00849667|62905241|FG001|Overall Study|Adverse Event|2|||
33519586|NCT00849667|62905242|FG002|Overall Study|Adverse Event|0|||
33519587|NCT00849667|62905240|FG000|Overall Study|Other|18|||
33519588|NCT00849667|62905241|FG001|Overall Study|Other|19|||
33519589|NCT00849667|62905242|FG002|Overall Study|Other|18|||
33519590|NCT00849667|62905240|FG000|Overall Study|Progressive disease|119|||
33519591|NCT00849667|62905241|FG001|Overall Study|Progressive disease|100|||
33455501|NCT04401202|62829958|FG001|Overall Study|Adverse Event|1|||
33519592|NCT00849667|62905242|FG002|Overall Study|Progressive disease|112|||
33519593|NCT00849667|62905240|FG000|Overall Study|Sponsor decision|208|||
33519594|NCT00849667|62905241|FG001|Overall Study|Sponsor decision|204|||
33519595|NCT00849667|62905242|FG002|Overall Study|Sponsor decision|190|||
33519596|NCT00849667|62905240|FG000|Overall Study|Investigator discretion|0|||
33519597|NCT00849667|62905241|FG001|Overall Study|Investigator discretion|0|||
33519598|NCT00849667|62905242|FG002|Overall Study|Investigator discretion|1|||
33519599|NCT03201419|62905261|FG000|Overall Study|Adverse Event|3|||
33519600|NCT03201419|62905262|FG001|Overall Study|Adverse Event|1|||
33519601|NCT03201419|62905263|FG002|Overall Study|Adverse Event|0|||
33519602|NCT03201419|62905264|FG003|Overall Study|Adverse Event|0|||
33519603|NCT03201419|62905265|FG004|Overall Study|Adverse Event|1|||
33519604|NCT03201419|62905266|FG005|Overall Study|Adverse Event|1|||
33519605|NCT03201419|62905267|FG006|Overall Study|Adverse Event|5|||
33519606|NCT03201419|62905268|FG007|Overall Study|Adverse Event|0|||
33519607|NCT03201419|62905269|FG008|Overall Study|Adverse Event|0|||
33519608|NCT03201419|62905261|FG000|Overall Study|Lost to Follow-up|1|||
33519609|NCT03201419|62905262|FG001|Overall Study|Lost to Follow-up|0|||
33519610|NCT03201419|62905263|FG002|Overall Study|Lost to Follow-up|0|||
33519611|NCT03201419|62905264|FG003|Overall Study|Lost to Follow-up|0|||
33519612|NCT03201419|62905265|FG004|Overall Study|Lost to Follow-up|0|||
33519613|NCT03201419|62905266|FG005|Overall Study|Lost to Follow-up|0|||
33519614|NCT03201419|62905267|FG006|Overall Study|Lost to Follow-up|0|||
33519615|NCT03201419|62905268|FG007|Overall Study|Lost to Follow-up|0|||
33519616|NCT03201419|62905269|FG008|Overall Study|Lost to Follow-up|0|||
33519617|NCT03201419|62905261|FG000|Overall Study|Protocol Deviation|0|||
33519618|NCT03201419|62905262|FG001|Overall Study|Protocol Deviation|0|||
33519619|NCT03201419|62905263|FG002|Overall Study|Protocol Deviation|0|||
33519620|NCT03201419|62905264|FG003|Overall Study|Protocol Deviation|0|||
33325148|NCT00947115|62701841|FG000|Overall Study|Migrated from study area|2|||
33325149|NCT00947115|62701842|FG001|Overall Study|Migrated from study area|0|||
33325150|NCT00947115|62701843|FG002|Overall Study|Migrated from study area|0|||
33325151|NCT00947115|62701841|FG000|Overall Study|Withdrawal by Subject|1|||
33325152|NCT00947115|62701842|FG001|Overall Study|Withdrawal by Subject|3|||
33325153|NCT00947115|62701843|FG002|Overall Study|Withdrawal by Subject|4|||
33519621|NCT03201419|62905265|FG004|Overall Study|Protocol Deviation|0|||
33519622|NCT03201419|62905266|FG005|Overall Study|Protocol Deviation|0|||
33519623|NCT03201419|62905267|FG006|Overall Study|Protocol Deviation|1|||
33519624|NCT03201419|62905268|FG007|Overall Study|Protocol Deviation|0|||
33519625|NCT03201419|62905269|FG008|Overall Study|Protocol Deviation|0|||
33519626|NCT03201419|62905261|FG000|Overall Study|Withdrawal by Subject|4|||
33519627|NCT03201419|62905262|FG001|Overall Study|Withdrawal by Subject|2|||
33455502|NCT04401202|62829957|FG000|Overall Study|Hospitalized|4|||
33519628|NCT03201419|62905263|FG002|Overall Study|Withdrawal by Subject|1|||
33519629|NCT03201419|62905264|FG003|Overall Study|Withdrawal by Subject|0|||
33519630|NCT03201419|62905265|FG004|Overall Study|Withdrawal by Subject|0|||
33519631|NCT03201419|62905266|FG005|Overall Study|Withdrawal by Subject|0|||
33519632|NCT03201419|62905267|FG006|Overall Study|Withdrawal by Subject|0|||
33519633|NCT03201419|62905268|FG007|Overall Study|Withdrawal by Subject|1|||
33519634|NCT03201419|62905269|FG008|Overall Study|Withdrawal by Subject|2|||
33519635|NCT03201419|62905261|FG000|Overall Study|Other|0|||
33519636|NCT03201419|62905262|FG001|Overall Study|Other|0|||
33519637|NCT03201419|62905263|FG002|Overall Study|Other|1|||
33519638|NCT03201419|62905264|FG003|Overall Study|Other|0|||
33455503|NCT04401202|62829958|FG001|Overall Study|Hospitalized|1|||
33519639|NCT03201419|62905265|FG004|Overall Study|Other|0|||
33519640|NCT03201419|62905266|FG005|Overall Study|Other|0|||
33519641|NCT03201419|62905267|FG006|Overall Study|Other|0|||
33519642|NCT03201419|62905268|FG007|Overall Study|Other|0|||
33519643|NCT03201419|62905269|FG008|Overall Study|Other|0|||
33519644|NCT01764633|62905305|FG000|Overall Study|Withdrawal by Subject|105|||
33519645|NCT01764633|62905306|FG001|Overall Study|Withdrawal by Subject|88|||
33519646|NCT01764633|62905305|FG000|Overall Study|Lost to Follow-up|13|||
33519647|NCT01764633|62905306|FG001|Overall Study|Lost to Follow-up|5|||
33519648|NCT02924389|62905314|FG000|Overall Study|Lost to Follow-up|1|||
33519649|NCT02924389|62905315|FG001|Overall Study|Lost to Follow-up|0|||
33519650|NCT02924389|62905314|FG000|Overall Study|Physician Decision|2|||
33519651|NCT02924389|62905315|FG001|Overall Study|Physician Decision|0|||
33519652|NCT02924389|62905314|FG000|Overall Study|Withdrawal by Subject|3|||
33519653|NCT02924389|62905315|FG001|Overall Study|Withdrawal by Subject|0|||
33519654|NCT02924389|62905314|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
33519655|NCT02924389|62905315|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
33519656|NCT03235349|62905322|FG000|Overall Study|Adverse Event|1|||
33519657|NCT03235349|62905322|FG000|Overall Study|Other|1|||
33519658|NCT03235115|62905326|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
33519659|NCT03235115|62905327|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
33519660|NCT03235115|62905328|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
33519661|NCT03235115|62905329|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
33519662|NCT03235115|62905330|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
33455504|NCT00096356|62829967|FG000|Overall Study|Adverse Event|11|||
33455505|NCT00096356|62829968|FG001|Overall Study|Adverse Event|9|||
33455506|NCT00096356|62829967|FG000|Overall Study|Physician Decision|5|||
33455507|NCT00096356|62829968|FG001|Overall Study|Physician Decision|3|||
33455508|NCT00096356|62829967|FG000|Overall Study|Withdrawal by Subject|17|||
33455509|NCT00096356|62829968|FG001|Overall Study|Withdrawal by Subject|23|||
33455510|NCT00096356|62829967|FG000|Overall Study|Lack of Efficacy|1|||
33455511|NCT00096356|62829968|FG001|Overall Study|Lack of Efficacy|0|||
33455512|NCT00096356|62829967|FG000|Overall Study|multiple reasons|10|||
33455513|NCT00096356|62829968|FG001|Overall Study|multiple reasons|18|||
33455514|NCT04358068|62829977|FG000|Overall Study|Did not initiate study treatment|2|||
33455515|NCT04358068|62829978|FG001|Overall Study|Did not initiate study treatment|2|||
33455516|NCT03694210|62829984|FG000|Overall Study|Death|1|||
33519663|NCT03235115|62905331|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
33519664|NCT02923531|62905339|FG000|Overall Study|Adverse Event|4|||
33519665|NCT02923531|62905339|FG000|Overall Study|Clinical Deterioration|1|||
33455517|NCT03694210|62829984|FG000|Overall Study|Screen Failure|7|||
33455518|NCT04339972|62829992|FG000|Overall Study|Scheduling Issues|3|||
33455519|NCT04339972|62829993|FG001|Overall Study|Scheduling Issues|3|||
33519666|NCT02923531|62905339|FG000|Overall Study|Disease Progression|3|||
33519667|NCT02923531|62905339|FG000|Overall Study|Study Termination|1|||
33519668|NCT02934503|62905344|FG000|Overall Study|progression of disease|3|||
33519669|NCT02934503|62905344|FG000|Overall Study|Withdrawal by Subject|1|||
33519670|NCT02937545|62905350|FG000|Overall Study|Withdrawal by Subject|1|||
33455520|NCT04339972|62829992|FG000|Overall Study|dropout|1|||
33519671|NCT02937545|62905351|FG001|Overall Study|Withdrawal by Subject|2|||
33519672|NCT02937545|62905352|FG002|Overall Study|Withdrawal by Subject|6|||
33519673|NCT02937545|62905353|FG003|Overall Study|Withdrawal by Subject|7|||
33519674|NCT02937545|62905350|FG000|Overall Study|Lost to Follow-up|1|||
33455521|NCT04339972|62829993|FG001|Overall Study|dropout|1|||
33455522|NCT04339972|62829992|FG000|Overall Study|Technical issues|1|||
33519675|NCT02937545|62905351|FG001|Overall Study|Lost to Follow-up|0|||
33519676|NCT02937545|62905352|FG002|Overall Study|Lost to Follow-up|0|||
33519677|NCT02937545|62905353|FG003|Overall Study|Lost to Follow-up|0|||
33519678|NCT03199391|62905364|FG000|Overall Study|Death|1|||
33519679|NCT03199391|62905364|FG000|Overall Study|Lost to Follow-up|3|||
33519680|NCT03199391|62905364|FG000|Overall Study|Adverse Event|2|||
33519681|NCT03199391|62905364|FG000|Overall Study|Withdrawal by Subject|10|||
33616785|NCT01571362|63017747|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
33616786|NCT01571362|63017745|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
33616787|NCT01571362|63017746|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
33616788|NCT01571362|63017747|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
33616789|NCT01571362|63017745|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
33616790|NCT01571362|63017746|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
33616791|NCT01571362|63017747|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
33616792|NCT01571362|63017745|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
33616793|NCT01571362|63017746|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
33616794|NCT01571362|63017747|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
33616795|NCT01571362|63017745|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
33616796|NCT01571362|63017746|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
33616797|NCT01571362|63017747|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
33616798|NCT01571362|63017745|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
33616799|NCT01571362|63017746|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
33616800|NCT01571362|63017747|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
33616801|NCT01571362|63017745|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33616802|NCT01571362|63017746|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
33616803|NCT01571362|63017747|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
33519682|NCT03198767|62905375|FG000|Overall Study|Protocol Violation|0|||
33519683|NCT03198767|62905376|FG001|Overall Study|Protocol Violation|0|||
33519684|NCT03198767|62905377|FG002|Overall Study|Protocol Violation|0|||
33616804|NCT01571362|63017745|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
33455523|NCT04339972|62829993|FG001|Overall Study|Technical issues|0|||
33455524|NCT04339972|62829992|FG000|Overall Study|Claustraphobia|0|||
33455525|NCT04339972|62829993|FG001|Overall Study|Claustraphobia|1|||
33455526|NCT00096278|62830001|FG000|Overall Study|No follow-up data|15|||
33455527|NCT00096278|62830002|FG001|Overall Study|No follow-up data|18|||
33455528|NCT00096278|62830001|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
33455529|NCT00096278|62830002|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
33455530|NCT00095940|62830017|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
33455531|NCT00095940|62830018|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
33455532|NCT00095940|62830019|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
33455533|NCT00095940|62830020|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
33455534|NCT00095940|62830021|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
33455535|NCT00095940|62830022|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
33455536|NCT00095940|62830023|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
33455537|NCT00095940|62830024|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
33455538|NCT00095940|62830025|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
33455539|NCT00095940|62830017|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
33455540|NCT00095940|62830018|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
33455541|NCT00095940|62830019|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
33455542|NCT00095940|62830020|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
33519685|NCT03198767|62905378|FG003|Overall Study|Protocol Violation|6|||
33519686|NCT03198767|62905379|FG004|Overall Study|Protocol Violation|0|||
33519687|NCT03198767|62905380|FG005|Overall Study|Protocol Violation|0|||
33519688|NCT03198767|62905381|FG006|Overall Study|Protocol Violation|0|||
33519689|NCT03162055|62905398|FG000|Overall Study|Adverse Event|6|||
33519690|NCT03162055|62905399|FG001|Overall Study|Adverse Event|5|||
33519691|NCT03162055|62905398|FG000|Overall Study|Death|3|||
33519692|NCT03162055|62905399|FG001|Overall Study|Death|3|||
33519693|NCT03162055|62905398|FG000|Overall Study|Lost to Follow-up|0|||
33519694|NCT03162055|62905399|FG001|Overall Study|Lost to Follow-up|1|||
33519695|NCT03162055|62905398|FG000|Overall Study|Study-specific withdrawal criteria|22|||
33519696|NCT03162055|62905399|FG001|Overall Study|Study-specific withdrawal criteria|14|||
33519697|NCT03162055|62905398|FG000|Overall Study|Withdrawal by Subject|17|||
33519698|NCT03162055|62905399|FG001|Overall Study|Withdrawal by Subject|2|||
33519699|NCT03162055|62905398|FG000|Overall Study|Did not receive treatment|2|||
33519700|NCT03162055|62905399|FG001|Overall Study|Did not receive treatment|0|||
33616805|NCT01571362|63017746|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
33616806|NCT01571362|63017747|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
33616807|NCT01571362|63017745|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33616808|NCT01571362|63017746|FG001|Double-Blind Treatment Period|Adverse Event|9|||
33455543|NCT00095940|62830021|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
33455544|NCT00095940|62830022|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
33455545|NCT00095940|62830023|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
33455546|NCT00095940|62830024|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
33455547|NCT00095940|62830025|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
33455548|NCT00095940|62830017|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
33455549|NCT00095940|62830018|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
33455550|NCT00095940|62830019|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
33455551|NCT00095940|62830020|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
33455552|NCT00095940|62830021|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
33455553|NCT00095940|62830022|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
33455554|NCT00095940|62830023|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
33455555|NCT00095940|62830024|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
33455556|NCT00095940|62830025|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
33455557|NCT00114218|62830043|FG000|Overall Study|Wrong Cell Type|2|||
33455558|NCT00114218|62830043|FG000|Overall Study|Wrong Primary|1|||
33455559|NCT00114218|62830043|FG000|Overall Study|Never Treated|1|||
33455560|NCT00095628|62830047|FG000|Overall Study|Disease progression prior to treatment|1|||
33455561|NCT04380142|62830053|FG000|LD/CD Stabilization Period|Adverse Event|3|||
33455562|NCT04380142|62830054|FG001|LD/CD Stabilization Period|Adverse Event|0|||
33455563|NCT04380142|62830055|FG002|LD/CD Stabilization Period|Adverse Event|0|||
33455564|NCT04380142|62830053|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
33455565|NCT04380142|62830054|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
33455566|NCT04380142|62830055|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
33455567|NCT04380142|62830053|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
33455568|NCT04380142|62830054|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
33455569|NCT04380142|62830055|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
33455570|NCT04380142|62830053|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
33455571|NCT04380142|62830054|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
33455572|NCT04380142|62830055|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
33455573|NCT04380142|62830053|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
33455574|NCT04380142|62830054|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
33455575|NCT04380142|62830055|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
33455576|NCT04380142|62830053|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
33455577|NCT04380142|62830054|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
33455578|NCT04380142|62830055|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
33455579|NCT04380142|62830053|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33455580|NCT04380142|62830054|FG001|Double-Blind Treatment Period|Adverse Event|1|||
33455581|NCT04380142|62830055|FG002|Double-Blind Treatment Period|Adverse Event|14|||
33519701|NCT03162055|62905398|FG000|Overall Study|Incorrect randomization|4|||
33519702|NCT03162055|62905399|FG001|Overall Study|Incorrect randomization|3|||
33519703|NCT03162055|62905398|FG000|Overall Study|Other|8|||
33519704|NCT03162055|62905399|FG001|Overall Study|Other|15|||
33519705|NCT02927145|62905412|FG000|Initial Recruitment|Withdrawal by Subject|0|||
33519706|NCT02927145|62905413|FG001|Initial Recruitment|Withdrawal by Subject|1|||
33519707|NCT02927145|62905414|FG002|Initial Recruitment|Withdrawal by Subject|1|||
33519708|NCT02927145|62905415|FG003|Initial Recruitment|Withdrawal by Subject|4|||
33519709|NCT02927145|62905416|FG004|Initial Recruitment|Withdrawal by Subject|1|||
33616809|NCT01571362|63017747|FG002|Double-Blind Treatment Period|Adverse Event|14|||
33616810|NCT01571362|63017745|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33616811|NCT01571362|63017746|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
33616812|NCT01571362|63017747|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
33616813|NCT01571362|63017745|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
33616814|NCT01571362|63017746|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
33616815|NCT01571362|63017747|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
33616816|NCT01571362|63017745|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
33616817|NCT01571362|63017746|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
33616818|NCT01571362|63017747|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
33616819|NCT01571284|63017755|FG000|Overall Study|Participant's decision|84|||
33616820|NCT01571284|63017755|FG000|Overall Study|Lost to Follow-up|3|||
33616821|NCT01571284|63017755|FG000|Overall Study|Enrolled but not treated|2|||
33616822|NCT01571284|63017755|FG000|Overall Study|Other than specified above|80|||
33519710|NCT02927145|62905417|FG005|Initial Recruitment|Withdrawal by Subject|1|||
33519711|NCT02927145|62905418|FG006|Initial Recruitment|Withdrawal by Subject|0|||
33519712|NCT02927145|62905419|FG007|Initial Recruitment|Withdrawal by Subject|0|||
33519713|NCT02927145|62905420|FG008|Initial Recruitment|Withdrawal by Subject|2|||
33519714|NCT02927145|62905412|FG000|Initial Recruitment|Adverse Event|0|||
33519715|NCT02927145|62905413|FG001|Initial Recruitment|Adverse Event|0|||
33519716|NCT02927145|62905414|FG002|Initial Recruitment|Adverse Event|0|||
33519717|NCT02927145|62905415|FG003|Initial Recruitment|Adverse Event|0|||
33519718|NCT02927145|62905416|FG004|Initial Recruitment|Adverse Event|2|||
33616823|NCT02137772|63017761|FG000|Overall Study|Adverse Event|6|||
33616824|NCT02137772|63017762|FG001|Overall Study|Adverse Event|3|||
33616825|NCT02137772|63017761|FG000|Overall Study|Death|71|||
33455582|NCT04380142|62830053|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
33455583|NCT04380142|62830054|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
33455584|NCT04380142|62830055|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
33455585|NCT04380142|62830053|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
33455586|NCT04380142|62830054|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
33455587|NCT04380142|62830055|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
33455588|NCT04380142|62830053|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
33455589|NCT04380142|62830054|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
33455590|NCT04380142|62830055|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
33455591|NCT04380142|62830053|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
33455592|NCT04380142|62830054|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
33455593|NCT04380142|62830055|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
33455594|NCT04380142|62830053|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
33455595|NCT04380142|62830054|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
33455596|NCT04380142|62830055|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
33455597|NCT04335136|62830065|FG000|Overall Study|Death|8|||
33455598|NCT04335136|62830066|FG001|Overall Study|Death|4|||
33455599|NCT04335136|62830065|FG000|Overall Study|Lost to Follow-up|2|||
33455600|NCT04335136|62830066|FG001|Overall Study|Lost to Follow-up|0|||
33455601|NCT04335136|62830065|FG000|Overall Study|Protocol Violation|1|||
33455602|NCT04335136|62830066|FG001|Overall Study|Protocol Violation|0|||
33455603|NCT04335136|62830065|FG000|Overall Study|Withdrawal by Subject|1|||
33455604|NCT04335136|62830066|FG001|Overall Study|Withdrawal by Subject|1|||
33455605|NCT04335136|62830065|FG000|Overall Study|Health-threatening condition|0|||
33455606|NCT04335136|62830066|FG001|Overall Study|Health-threatening condition|1|||
33455607|NCT04335136|62830065|FG000|Overall Study|Adverse Event|0|||
33455608|NCT04335136|62830066|FG001|Overall Study|Adverse Event|1|||
33455609|NCT04335136|62830065|FG000|Overall Study|Erroneously randomized|2|||
33455610|NCT04335136|62830066|FG001|Overall Study|Erroneously randomized|0|||
33455611|NCT04171414|62830072|FG000|Overall Study|Death|1|||
33455612|NCT04171414|62830072|FG000|Overall Study|Withdrawal by Subject|1|||
33455613|NCT04167670|62830079|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
33455614|NCT04167670|62830080|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
33455615|NCT04167670|62830081|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
33519719|NCT02927145|62905417|FG005|Initial Recruitment|Adverse Event|0|||
33519720|NCT02927145|62905418|FG006|Initial Recruitment|Adverse Event|0|||
33519721|NCT02927145|62905419|FG007|Initial Recruitment|Adverse Event|0|||
33519722|NCT02927145|62905420|FG008|Initial Recruitment|Adverse Event|0|||
33519723|NCT02927145|62905412|FG000|Invitation for Additional Challenge|Pregnancy|0|||
33519724|NCT02927145|62905413|FG001|Invitation for Additional Challenge|Pregnancy|0|||
33519725|NCT02927145|62905414|FG002|Invitation for Additional Challenge|Pregnancy|0|||
33519726|NCT02927145|62905415|FG003|Invitation for Additional Challenge|Pregnancy|0|||
33519727|NCT02927145|62905416|FG004|Invitation for Additional Challenge|Pregnancy|0|||
33519728|NCT02927145|62905417|FG005|Invitation for Additional Challenge|Pregnancy|0|||
33519729|NCT02927145|62905418|FG006|Invitation for Additional Challenge|Pregnancy|1|||
33519730|NCT02927145|62905419|FG007|Invitation for Additional Challenge|Pregnancy|0|||
33519731|NCT02927145|62905420|FG008|Invitation for Additional Challenge|Pregnancy|0|||
33519732|NCT03688919|62905443|FG000|Overall Study|Lost to Follow-up|2|||
33519733|NCT03688919|62905444|FG001|Overall Study|Lost to Follow-up|1|||
33519734|NCT03688919|62905443|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
33519735|NCT03688919|62905444|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
33519736|NCT02888119|62905467|FG000|Overall Study|Lost to Follow-up|5|||
33519737|NCT02888119|62905468|FG001|Overall Study|Lost to Follow-up|4|||
33519738|NCT02888119|62905469|FG002|Overall Study|Lost to Follow-up|0|||
33519739|NCT03197129|62905478|FG000|Overall Study|did not answer the VPT: shyness|4|||
33519740|NCT03197129|62905479|FG001|Overall Study|did not answer the VPT: shyness|5|||
33519741|NCT03196973|62905488|FG000|Overall Study|Adverse Event|1|||
33519742|NCT03196973|62905489|FG001|Overall Study|Adverse Event|1|||
33519743|NCT03196973|62905490|FG002|Overall Study|Adverse Event|2|||
33519744|NCT03196973|62905488|FG000|Overall Study|Lack of Efficacy|2|||
33519745|NCT03196973|62905489|FG001|Overall Study|Lack of Efficacy|6|||
33519746|NCT03196973|62905490|FG002|Overall Study|Lack of Efficacy|1|||
33519747|NCT03196973|62905488|FG000|Overall Study|Lost to Follow-up|4|||
33519748|NCT03196973|62905489|FG001|Overall Study|Lost to Follow-up|3|||
33519749|NCT03196973|62905490|FG002|Overall Study|Lost to Follow-up|2|||
33519750|NCT03196973|62905488|FG000|Overall Study|Consent withdrawn|2|||
33519751|NCT03196973|62905489|FG001|Overall Study|Consent withdrawn|1|||
33519752|NCT03196973|62905490|FG002|Overall Study|Consent withdrawn|0|||
33519753|NCT03196973|62905488|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
33519754|NCT03196973|62905489|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
33519755|NCT03196973|62905490|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
33519756|NCT03196505|62905500|FG000|Overall Study|Physician Decision|26|||
33519757|NCT03196505|62905501|FG001|Overall Study|Physician Decision|26|||
33519758|NCT03196349|62905510|FG000|Overall Study|Did not receive study drug|0|||
33519759|NCT03196349|62905511|FG001|Overall Study|Did not receive study drug|1|||
33519760|NCT03196349|62905512|FG002|Overall Study|Did not receive study drug|2|||
33519761|NCT03196349|62905510|FG000|Overall Study|No data entered|2|||
33519762|NCT03196349|62905511|FG001|Overall Study|No data entered|4|||
33519763|NCT03196349|62905512|FG002|Overall Study|No data entered|0|||
33519764|NCT03196349|62905510|FG000|Overall Study|Study Terminated early|15|||
33519765|NCT03196349|62905511|FG001|Overall Study|Study Terminated early|9|||
33616826|NCT02137772|63017762|FG001|Overall Study|Death|44|||
33616827|NCT02137772|63017761|FG000|Overall Study|Lost to Follow-up|8|||
33616828|NCT02137772|63017762|FG001|Overall Study|Lost to Follow-up|4|||
33616829|NCT02137772|63017761|FG000|Overall Study|Physician Decision|15|||
33616830|NCT02137772|63017762|FG001|Overall Study|Physician Decision|5|||
33616831|NCT02137772|63017761|FG000|Overall Study|Withdrawal by Subject|28|||
33616832|NCT02137772|63017762|FG001|Overall Study|Withdrawal by Subject|17|||
33616833|NCT02137772|63017761|FG000|Overall Study|Non-compliance with study drug|1|||
33616834|NCT02137772|63017762|FG001|Overall Study|Non-compliance with study drug|0|||
33616835|NCT02137772|63017761|FG000|Overall Study|Not treated|3|||
33616836|NCT02137772|63017762|FG001|Overall Study|Not treated|2|||
33616837|NCT01555138|63017770|FG000|Overall Study|Death|0|||
33616838|NCT01555138|63017771|FG001|Overall Study|Death|1|||
33616839|NCT01555138|63017770|FG000|Overall Study|Lost to Follow-up|1|||
33616840|NCT01555138|63017771|FG001|Overall Study|Lost to Follow-up|0|||
33616841|NCT01555138|63017770|FG000|Overall Study|Abnormal Lab reults|1|||
33616842|NCT01555138|63017771|FG001|Overall Study|Abnormal Lab reults|3|||
33616843|NCT01555138|63017770|FG000|Overall Study|Lack of Efficacy|2|||
33616844|NCT01555138|63017771|FG001|Overall Study|Lack of Efficacy|2|||
33616845|NCT01555138|63017770|FG000|Overall Study|Protocol Violation|5|||
33616846|NCT01555138|63017771|FG001|Overall Study|Protocol Violation|3|||
33616847|NCT01555138|63017770|FG000|Overall Study|Administrative problems|8|||
33616848|NCT01555138|63017771|FG001|Overall Study|Administrative problems|0|||
33616849|NCT01555138|63017770|FG000|Overall Study|Withdrawal by Subject|16|||
33616850|NCT01555138|63017771|FG001|Overall Study|Withdrawal by Subject|15|||
33616851|NCT01555138|63017770|FG000|Overall Study|Adverse Event|14|||
33616852|NCT01555138|63017771|FG001|Overall Study|Adverse Event|14|||
33616853|NCT02137226|63017779|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
33616854|NCT02137226|63017780|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
33616855|NCT02137226|63017781|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
33616856|NCT02137226|63017782|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
33616857|NCT02137226|63017783|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
33616858|NCT02137226|63017779|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
33616859|NCT02137226|63017780|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
33616860|NCT02137226|63017781|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
33616861|NCT02137226|63017782|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
33616862|NCT02137226|63017783|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
33616863|NCT02137226|63017779|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
33616864|NCT02137226|63017780|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
33616865|NCT02137226|63017781|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
33616866|NCT02137226|63017782|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
33616867|NCT02137226|63017783|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
33616868|NCT02137226|63017779|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
33616869|NCT02137226|63017780|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
33616870|NCT02137226|63017781|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
33616871|NCT02137226|63017782|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
33616872|NCT02137226|63017783|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
33616873|NCT02137226|63017779|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
33616874|NCT02137226|63017780|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
33455616|NCT04167670|62830079|FG000|Overall Study|Significant protocol deviation|3|||
33455617|NCT04167670|62830080|FG001|Overall Study|Significant protocol deviation|1|||
33455618|NCT04167670|62830081|FG002|Overall Study|Significant protocol deviation|0|||
33455619|NCT04167670|62830079|FG000|Overall Study|Lost to Follow-up|0|||
33455620|NCT04167670|62830080|FG001|Overall Study|Lost to Follow-up|3|||
33455621|NCT04167670|62830081|FG002|Overall Study|Lost to Follow-up|3|||
33455622|NCT04167670|62830079|FG000|Overall Study|Voluntary Withdrawal|0|||
33455623|NCT04167670|62830080|FG001|Overall Study|Voluntary Withdrawal|1|||
33455624|NCT04167670|62830081|FG002|Overall Study|Voluntary Withdrawal|1|||
33455625|NCT04167670|62830079|FG000|Overall Study|Withdrawal of Consent|4|||
33455626|NCT04167670|62830080|FG001|Overall Study|Withdrawal of Consent|1|||
33616875|NCT02137226|63017781|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
33616876|NCT02137226|63017782|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
33616877|NCT02137226|63017783|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
33616878|NCT02137226|63017779|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
33616879|NCT02137226|63017780|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
33616880|NCT02137226|63017781|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
33455627|NCT04167670|62830081|FG002|Overall Study|Withdrawal of Consent|3|||
33455628|NCT04167670|62830079|FG000|Overall Study|Miscellaneous|7|||
33616881|NCT02137226|63017782|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
33616882|NCT02137226|63017783|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
33616883|NCT02137226|63017779|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
33616884|NCT02137226|63017780|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
33616885|NCT02137226|63017781|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
33616886|NCT02137226|63017782|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
33616887|NCT02137226|63017783|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
33616888|NCT02137226|63017779|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
33616889|NCT02137226|63017780|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
33616890|NCT02137226|63017781|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
33616891|NCT02137226|63017782|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
33616892|NCT02137226|63017783|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
33616893|NCT02137226|63017779|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
33616894|NCT02137226|63017780|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
33616895|NCT02137226|63017781|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
33616896|NCT02137226|63017782|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
33616897|NCT02137226|63017783|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
33616898|NCT02137226|63017779|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
33616899|NCT02137226|63017780|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
33616900|NCT02137226|63017781|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
33616901|NCT02137226|63017782|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
33519766|NCT03196349|62905512|FG002|Overall Study|Study Terminated early|11|||
33519767|NCT02886715|62905523|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33519768|NCT02886715|62905524|FG001|Overall Study|Non-Compliance With Study Drug|2|||
33519769|NCT02886715|62905525|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33519770|NCT02886715|62905523|FG000|Overall Study|Adverse Event|4|||
33519771|NCT02886715|62905524|FG001|Overall Study|Adverse Event|2|||
33616902|NCT02137226|63017783|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
33616903|NCT02137226|63017779|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
33616904|NCT02137226|63017780|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
33616905|NCT02137226|63017781|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
33616906|NCT02137226|63017782|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
33616907|NCT02137226|63017783|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
33616908|NCT02137226|63017779|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
33616909|NCT02137226|63017780|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
33616910|NCT02137226|63017781|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
33616911|NCT02137226|63017782|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
33616912|NCT02137226|63017783|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
33616913|NCT01530334|63017791|FG000|Overall Study|Adverse Event|3|||
33616914|NCT01530334|63017791|FG000|Overall Study|unknown reason|1|||
33616915|NCT01530334|63017791|FG000|Overall Study|Progressive disease|47|||
33455629|NCT04167670|62830080|FG001|Overall Study|Miscellaneous|5|||
33455630|NCT04167670|62830081|FG002|Overall Study|Miscellaneous|3|||
33455631|NCT00113516|62830089|FG000|Part 1|Adverse Event|6|||
33455632|NCT00113516|62830090|FG001|Part 1|Adverse Event|0|||
33455633|NCT00113516|62830089|FG000|Part 1|Death|3|||
33455634|NCT00113516|62830090|FG001|Part 1|Death|0|||
33455635|NCT00113516|62830089|FG000|Part 1|Other|3|||
33616916|NCT01570192|63017797|FG000|Overall Study|no qualifying organism|6|||
33455636|NCT00113516|62830090|FG001|Part 1|Other|0|||
33519772|NCT02886715|62905525|FG002|Overall Study|Adverse Event|0|||
33455637|NCT00113516|62830089|FG000|Part 1|Withdrawal by Subject|2|||
33616917|NCT01570192|63017798|FG001|Overall Study|no qualifying organism|12|||
33616918|NCT01570192|63017797|FG000|Overall Study|changed to palliative care|1|||
33616919|NCT01570192|63017798|FG001|Overall Study|changed to palliative care|0|||
33616920|NCT01570192|63017797|FG000|Overall Study|Physician Decision|0|||
33616921|NCT01570192|63017798|FG001|Overall Study|Physician Decision|1|||
33616922|NCT02136914|63017811|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
33616923|NCT02136914|63017812|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
33616924|NCT02136914|63017811|FG000|Overall Study|Withdrawal by Subject|3|||
33519773|NCT02886715|62905523|FG000|Overall Study|Lack of Efficacy|0|||
33519774|NCT02886715|62905524|FG001|Overall Study|Lack of Efficacy|2|||
33519775|NCT02886715|62905525|FG002|Overall Study|Lack of Efficacy|1|||
33519776|NCT02886715|62905523|FG000|Overall Study|Lost to Follow-up|29|||
33519777|NCT02886715|62905524|FG001|Overall Study|Lost to Follow-up|26|||
33519778|NCT02886715|62905525|FG002|Overall Study|Lost to Follow-up|10|||
33519779|NCT02886715|62905523|FG000|Overall Study|Pregnancy|1|||
33519780|NCT02886715|62905524|FG001|Overall Study|Pregnancy|1|||
33519781|NCT02886715|62905525|FG002|Overall Study|Pregnancy|1|||
33519782|NCT02886715|62905523|FG000|Overall Study|Protocol Violation|3|||
33519783|NCT02886715|62905524|FG001|Overall Study|Protocol Violation|2|||
33519784|NCT02886715|62905525|FG002|Overall Study|Protocol Violation|1|||
33519785|NCT02886715|62905523|FG000|Overall Study|Withdrawal by Subject|20|||
33519786|NCT02886715|62905524|FG001|Overall Study|Withdrawal by Subject|18|||
33519787|NCT02886715|62905525|FG002|Overall Study|Withdrawal by Subject|5|||
33519788|NCT02886715|62905523|FG000|Overall Study|missing|7|||
33519789|NCT02886715|62905524|FG001|Overall Study|missing|2|||
33519790|NCT02886715|62905525|FG002|Overall Study|missing|2|||
33519791|NCT03085797|62905535|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
33519792|NCT03085797|62905536|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
33519793|NCT03085797|62905535|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
33519794|NCT03085797|62905536|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
33519795|NCT03085797|62905535|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
33519796|NCT03085797|62905536|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
33519797|NCT03157531|62905544|FG000|Overall Study|Death|2|||
33519798|NCT03157531|62905544|FG000|Overall Study|Lost to Follow-up|4|||
33519799|NCT03159091|62905550|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
33519800|NCT03159091|62905551|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
33519801|NCT03159091|62905550|FG000|Overall Study|Patient has taken no dose of study drug|0|||
33519802|NCT03159091|62905551|FG001|Overall Study|Patient has taken no dose of study drug|1|||
33519803|NCT03196193|62905559|FG000|Overall Study|Adverse Event|1|||
33519804|NCT03196193|62905560|FG001|Overall Study|Adverse Event|0|||
33519805|NCT03196193|62905559|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
33519806|NCT03196193|62905560|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
33519807|NCT03621761|62905569|FG000|Overall Study|Lost to Follow-up|1|||
33519808|NCT03621761|62905570|FG001|Overall Study|Lost to Follow-up|1|||
33519809|NCT03621761|62905571|FG002|Overall Study|Lost to Follow-up|2|||
33455638|NCT00113516|62830090|FG001|Part 1|Withdrawal by Subject|0|||
33455639|NCT00113516|62830089|FG000|Part 1|Lack of Efficacy|2|||
33455640|NCT00113516|62830090|FG001|Part 1|Lack of Efficacy|0|||
33455641|NCT00113516|62830089|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
33455642|NCT00113516|62830090|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
33455643|NCT00113516|62830089|FG000|Part 1|Laboratory Abnormality|1|||
33455644|NCT00113516|62830090|FG001|Part 1|Laboratory Abnormality|0|||
33455645|NCT00113516|62830089|FG000|Part 1|Ongoing|1|||
33455646|NCT00113516|62830090|FG001|Part 1|Ongoing|0|||
33455647|NCT00113516|62830089|FG000|Part 1|Missing|65|||
33455648|NCT00113516|62830090|FG001|Part 1|Missing|0|||
33455649|NCT00113516|62830089|FG000|Part 2|Adverse Event|0|||
33455650|NCT00113516|62830090|FG001|Part 2|Adverse Event|16|||
33455651|NCT00113516|62830089|FG000|Part 2|Death|0|||
33455652|NCT00113516|62830090|FG001|Part 2|Death|5|||
33455653|NCT00113516|62830089|FG000|Part 2|Lack of Efficacy|0|||
33616925|NCT02136914|63017812|FG001|Overall Study|Withdrawal by Subject|10|||
33616926|NCT02136914|63017811|FG000|Overall Study|Subject Unwilling to Proceed|7|||
33616927|NCT02136914|63017812|FG001|Overall Study|Subject Unwilling to Proceed|2|||
33455654|NCT00113516|62830090|FG001|Part 2|Lack of Efficacy|37|||
33455655|NCT00113516|62830089|FG000|Part 2|Withdrawal by Subject|0|||
33455656|NCT00113516|62830090|FG001|Part 2|Withdrawal by Subject|3|||
33455657|NCT00113516|62830089|FG000|Part 2|Other|0|||
33455658|NCT00113516|62830090|FG001|Part 2|Other|3|||
33455659|NCT00113516|62830089|FG000|Part 2|Laboratory Abnormality|0|||
33455660|NCT00113516|62830090|FG001|Part 2|Laboratory Abnormality|1|||
33519810|NCT03621761|62905569|FG000|Overall Study|Withdrawal by Subject|2|||
33519811|NCT03621761|62905570|FG001|Overall Study|Withdrawal by Subject|1|||
33519812|NCT03621761|62905571|FG002|Overall Study|Withdrawal by Subject|1|||
33519813|NCT03621761|62905569|FG000|Overall Study|Became Ineligible|0|||
33519814|NCT03621761|62905570|FG001|Overall Study|Became Ineligible|2|||
33519815|NCT03621761|62905571|FG002|Overall Study|Became Ineligible|0|||
33519816|NCT03221387|62905579|FG000|Overall Study|Lost to Follow-up|1|||
33519817|NCT03221387|62905579|FG000|Overall Study|Lung transplant|1|||
33519818|NCT03318861|62905588|FG000|Overall Study|Death|1|||
33519819|NCT03318861|62905589|FG001|Overall Study|Death|2|||
33616928|NCT02136914|63017811|FG000|Overall Study|Lost to Follow-up|1|||
33616929|NCT02136914|63017812|FG001|Overall Study|Lost to Follow-up|1|||
33616930|NCT02136914|63017811|FG000|Overall Study|Did Not Receive Study Drug|2|||
33616931|NCT02136914|63017812|FG001|Overall Study|Did Not Receive Study Drug|0|||
33616932|NCT02136914|63017811|FG000|Overall Study|Lack of Efficacy|1|||
33616933|NCT02136914|63017812|FG001|Overall Study|Lack of Efficacy|0|||
33616934|NCT02136914|63017811|FG000|Overall Study|Death|0|||
33616935|NCT02136914|63017812|FG001|Overall Study|Death|1|||
33616936|NCT01530256|63017818|FG000|Overall Study|Death|2|||
33616937|NCT01554904|63017822|FG000|Overall Study|Withdrawal by Subject|3|||
33616938|NCT01554904|63017822|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
33616939|NCT01529632|63017828|FG000|Overall Study|Administrative problem|2|||
33325154|NCT00947115|62701841|FG000|Overall Study|Lost to Follow-up|11|||
33325155|NCT00947115|62701842|FG001|Overall Study|Lost to Follow-up|12|||
33325156|NCT00947115|62701843|FG002|Overall Study|Lost to Follow-up|8|||
33325157|NCT00952419|62701854|FG000|Overall Study|Adverse Event|2|||
33325158|NCT00952419|62701855|FG001|Overall Study|Adverse Event|0|||
33325159|NCT00952419|62701856|FG002|Overall Study|Adverse Event|0|||
33325160|NCT00952419|62701854|FG000|Overall Study|Protocol Violation|3|||
33325161|NCT00952419|62701855|FG001|Overall Study|Protocol Violation|7|||
33325162|NCT00952419|62701856|FG002|Overall Study|Protocol Violation|0|||
33325163|NCT00952419|62701854|FG000|Overall Study|Withdrawal by Subject|1|||
33325164|NCT00952419|62701855|FG001|Overall Study|Withdrawal by Subject|3|||
33325165|NCT00952419|62701856|FG002|Overall Study|Withdrawal by Subject|0|||
33325166|NCT00902278|62701869|FG000|Overall Study|Physician Decision|1|||
33455661|NCT00113516|62830089|FG000|Part 2|Ongoing|0|||
33455662|NCT00113516|62830090|FG001|Part 2|Ongoing|1|||
33455663|NCT04142242|62830102|FG000|Overall Study|Non-compliance with the protocol|1|||
33616940|NCT01529632|63017829|FG001|Overall Study|Administrative problem|1|||
33616941|NCT01529632|63017828|FG000|Overall Study|Protocol Violation|0|||
33616942|NCT01529632|63017829|FG001|Overall Study|Protocol Violation|1|||
33616943|NCT01529632|63017828|FG000|Overall Study|Adverse Event|1|||
33616944|NCT01529632|63017829|FG001|Overall Study|Adverse Event|1|||
33616945|NCT01554514|63017835|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
33616946|NCT01554514|63017835|FG000|Overall Study|Physician Decision|1|||
33616947|NCT01553188|63017843|FG000|Overall Study|Patient choice|1|||
33616948|NCT01553188|63017844|FG001|Overall Study|Patient choice|0|||
33616949|NCT01553188|63017845|FG002|Overall Study|Patient choice|0|||
33616950|NCT01553188|63017846|FG003|Overall Study|Patient choice|0|||
33616951|NCT01553188|63017843|FG000|Overall Study|Intercurrent illness and adverse event|0|||
33616952|NCT01553188|63017844|FG001|Overall Study|Intercurrent illness and adverse event|1|||
33616953|NCT01553188|63017845|FG002|Overall Study|Intercurrent illness and adverse event|2|||
33616954|NCT01553188|63017846|FG003|Overall Study|Intercurrent illness and adverse event|0|||
33616955|NCT02175758|63017865|FG000|Treatment Phase|Lost to Follow-up|0|||
33616956|NCT02175758|63017866|FG001|Treatment Phase|Lost to Follow-up|1|||
33616957|NCT02175758|63017867|FG002|Treatment Phase|Lost to Follow-up|0|||
33616958|NCT02175758|63017868|FG003|Treatment Phase|Lost to Follow-up|0|||
33616959|NCT02175758|63017869|FG004|Treatment Phase|Lost to Follow-up|0|||
33616960|NCT02175758|63017870|FG005|Treatment Phase|Lost to Follow-up|0|||
33325167|NCT00902278|62701870|FG001|Overall Study|Physician Decision|0|||
33325168|NCT00902278|62701871|FG002|Overall Study|Physician Decision|2|||
33455664|NCT04142242|62830103|FG001|Overall Study|Non-compliance with the protocol|0|||
33455665|NCT04142242|62830104|FG002|Overall Study|Non-compliance with the protocol|0|||
33455666|NCT04142242|62830105|FG003|Overall Study|Non-compliance with the protocol|0|||
33519820|NCT03318861|62905590|FG002|Overall Study|Death|2|||
33616961|NCT02175758|63017865|FG000|Treatment Phase|Adverse Event|0|||
33616962|NCT02175758|63017866|FG001|Treatment Phase|Adverse Event|0|||
33616963|NCT02175758|63017867|FG002|Treatment Phase|Adverse Event|0|||
33616964|NCT02175758|63017868|FG003|Treatment Phase|Adverse Event|0|||
33455667|NCT04142242|62830106|FG004|Overall Study|Non-compliance with the protocol|0|||
33616965|NCT02175758|63017869|FG004|Treatment Phase|Adverse Event|1|||
33616966|NCT02175758|63017870|FG005|Treatment Phase|Adverse Event|0|||
33455668|NCT04142242|62830107|FG005|Overall Study|Non-compliance with the protocol|1|||
33616967|NCT01529008|63017912|FG000|Bone Marrow Harvesting|Physician Decision|1|||
33616968|NCT01529008|63017913|FG001|Bone Marrow Harvesting|Physician Decision|1|||
33616969|NCT01529008|63017912|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
33616970|NCT01529008|63017913|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
33616971|NCT01529008|63017912|FG000|Treatment|Adverse Event|6|||
33616972|NCT01529008|63017913|FG001|Treatment|Adverse Event|0|||
33616973|NCT01529008|63017912|FG000|Treatment|Other|3|||
33616974|NCT01529008|63017913|FG001|Treatment|Other|1|||
33616975|NCT01529008|63017912|FG000|Efficacy Analysis|Protocol Violation|2|||
33519821|NCT03318861|62905591|FG003|Overall Study|Death|1|||
33519822|NCT03318861|62905592|FG004|Overall Study|Death|1|||
33519823|NCT03318861|62905588|FG000|Overall Study|Still on Study|2|||
33519824|NCT03318861|62905589|FG001|Overall Study|Still on Study|1|||
33519825|NCT03318861|62905590|FG002|Overall Study|Still on Study|1|||
33519826|NCT03318861|62905591|FG003|Overall Study|Still on Study|2|||
33519827|NCT03318861|62905592|FG004|Overall Study|Still on Study|1|||
33519828|NCT03318861|62905588|FG000|Overall Study|Enrolled But Did Not Initiate KITE-585|0|||
33519829|NCT03318861|62905589|FG001|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
33519830|NCT03318861|62905590|FG002|Overall Study|Enrolled But Did Not Initiate KITE-585|0|||
33519831|NCT03318861|62905591|FG003|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
33519832|NCT03318861|62905592|FG004|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
33519833|NCT03084315|62905606|FG000|Overall Study|Lost to Follow-up|8|||
33519834|NCT03084315|62905607|FG001|Overall Study|Lost to Follow-up|7|||
33519835|NCT03084315|62905606|FG000|Overall Study|Withdrawal by Subject|2|||
33519836|NCT03084315|62905607|FG001|Overall Study|Withdrawal by Subject|2|||
33519837|NCT03187301|62905613|FG000|Titration Period|Adverse Event|0|||
33519838|NCT03187301|62905614|FG001|Titration Period|Adverse Event|0|||
33519839|NCT03187301|62905615|FG002|Titration Period|Adverse Event|0|||
33519840|NCT03187301|62905616|FG003|Titration Period|Adverse Event|0|||
33519841|NCT03187301|62905617|FG004|Titration Period|Adverse Event|0|||
33519842|NCT03187301|62905618|FG005|Titration Period|Adverse Event|0|||
33616976|NCT01529008|63017913|FG001|Efficacy Analysis|Protocol Violation|0|||
33616977|NCT01529008|63017912|FG000|Efficacy Analysis|Physician Decision|0|||
33616978|NCT01529008|63017913|FG001|Efficacy Analysis|Physician Decision|1|||
33616979|NCT01529008|63017912|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
33616980|NCT01529008|63017913|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
33616981|NCT01599104|63017922|FG000|Overall Study|Withdrawal by Subject|1|||
33616982|NCT01599104|63017923|FG001|Overall Study|Withdrawal by Subject|1|||
33616983|NCT01599104|63017924|FG002|Overall Study|Withdrawal by Subject|2|||
33616984|NCT01599104|63017922|FG000|Overall Study|Technical Problems|1|||
33616985|NCT01599104|63017923|FG001|Overall Study|Technical Problems|0|||
33616986|NCT01599104|63017924|FG002|Overall Study|Technical Problems|0|||
33616987|NCT01599104|63017922|FG000|Overall Study|Physician Decision|3|||
33616988|NCT01599104|63017923|FG001|Overall Study|Physician Decision|2|||
33519843|NCT03187301|62905619|FG006|Titration Period|Adverse Event|5|||
33616989|NCT01599104|63017924|FG002|Overall Study|Physician Decision|2|||
33519844|NCT03187301|62905613|FG000|Titration Period|Withdrawal by Subject|0|||
33616990|NCT01599104|63017922|FG000|Overall Study|Non-compliance with study treatment|0|||
33616991|NCT01599104|63017923|FG001|Overall Study|Non-compliance with study treatment|1|||
33616992|NCT01599104|63017924|FG002|Overall Study|Non-compliance with study treatment|0|||
33616993|NCT01599104|63017922|FG000|Overall Study|Lack of Efficacy|4|||
33616994|NCT01599104|63017923|FG001|Overall Study|Lack of Efficacy|4|||
33616995|NCT01599104|63017924|FG002|Overall Study|Lack of Efficacy|10|||
33616996|NCT01599104|63017922|FG000|Overall Study|Adverse Event|7|||
33616997|NCT01599104|63017923|FG001|Overall Study|Adverse Event|6|||
33519845|NCT03187301|62905614|FG001|Titration Period|Withdrawal by Subject|0|||
33519846|NCT03187301|62905615|FG002|Titration Period|Withdrawal by Subject|0|||
33519847|NCT03187301|62905616|FG003|Titration Period|Withdrawal by Subject|0|||
33519848|NCT03187301|62905617|FG004|Titration Period|Withdrawal by Subject|0|||
33519849|NCT03187301|62905618|FG005|Titration Period|Withdrawal by Subject|0|||
33519850|NCT03187301|62905619|FG006|Titration Period|Withdrawal by Subject|1|||
33519851|NCT03187301|62905613|FG000|Titration Period|Exclusion Criteria Met|0|||
33519852|NCT03187301|62905614|FG001|Titration Period|Exclusion Criteria Met|0|||
33519853|NCT03187301|62905615|FG002|Titration Period|Exclusion Criteria Met|0|||
33519854|NCT03187301|62905616|FG003|Titration Period|Exclusion Criteria Met|0|||
33519855|NCT03187301|62905617|FG004|Titration Period|Exclusion Criteria Met|0|||
33519856|NCT03187301|62905618|FG005|Titration Period|Exclusion Criteria Met|0|||
33519857|NCT03187301|62905619|FG006|Titration Period|Exclusion Criteria Met|1|||
33519858|NCT03187301|62905613|FG000|Pre-Intervention|Withdrawal by Subject|1|||
33519859|NCT03187301|62905614|FG001|Pre-Intervention|Withdrawal by Subject|0|||
33519860|NCT03187301|62905615|FG002|Pre-Intervention|Withdrawal by Subject|0|||
33616998|NCT01599104|63017924|FG002|Overall Study|Adverse Event|12|||
33616999|NCT01569568|63017934|FG000|Overall Study|Physician Decision|0|||
33519861|NCT03187301|62905616|FG003|Pre-Intervention|Withdrawal by Subject|0|||
33519862|NCT03187301|62905617|FG004|Pre-Intervention|Withdrawal by Subject|0|||
33519863|NCT03187301|62905618|FG005|Pre-Intervention|Withdrawal by Subject|0|||
33519864|NCT03187301|62905619|FG006|Pre-Intervention|Withdrawal by Subject|0|||
33519865|NCT02946047|62905644|FG000|Overall Study|Adverse Event|1|||
33519866|NCT02946047|62905645|FG001|Overall Study|Adverse Event|0|||
33617000|NCT01569568|63017935|FG001|Overall Study|Physician Decision|2|||
33617001|NCT02136680|63017943|FG000|Overall Study|No Longer Interested|1|||
33617002|NCT02136680|63017944|FG001|Overall Study|No Longer Interested|1|||
33455669|NCT04142242|62830102|FG000|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
33455670|NCT04142242|62830103|FG001|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|1|||
33455671|NCT04142242|62830104|FG002|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
33455672|NCT04142242|62830105|FG003|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
33455673|NCT04142242|62830106|FG004|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
33455674|NCT04142242|62830107|FG005|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
33455675|NCT04142242|62830102|FG000|Overall Study|Ongoing|0|||
33455676|NCT04142242|62830103|FG001|Overall Study|Ongoing|0|||
33455677|NCT04142242|62830104|FG002|Overall Study|Ongoing|31|||
33519867|NCT02946047|62905646|FG002|Overall Study|Adverse Event|0|||
33519868|NCT02946047|62905647|FG003|Overall Study|Adverse Event|0|||
33519869|NCT03077919|62905659|FG000|Overall Study|Lost to Follow-up|4|||
33519870|NCT03077919|62905660|FG001|Overall Study|Lost to Follow-up|1|||
33519871|NCT03220217|62905669|FG000|Overall Study|Withdrawal by Subject|0|||
33519872|NCT03220217|62905670|FG001|Overall Study|Withdrawal by Subject|1|||
33617003|NCT02136680|63017943|FG000|Overall Study|No longer receiving care at clinic|3|||
33455678|NCT04142242|62830105|FG003|Overall Study|Ongoing|39|||
33455679|NCT04142242|62830106|FG004|Overall Study|Ongoing|0|||
33455680|NCT04142242|62830107|FG005|Overall Study|Ongoing|0|||
33455681|NCT04140292|62830135|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
33455682|NCT04140292|62830136|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
33455683|NCT04138810|62830145|FG000|Overall Study|Withdrawal by Subject|0|||
33455684|NCT04138810|62830146|FG001|Overall Study|Withdrawal by Subject|1|||
33455685|NCT04138810|62830145|FG000|Overall Study|Subject cancelled surgery|1|||
33455686|NCT04138810|62830146|FG001|Overall Study|Subject cancelled surgery|0|||
33617004|NCT02136680|63017944|FG001|Overall Study|No longer receiving care at clinic|5|||
33617005|NCT02136680|63017943|FG000|Overall Study|Moved away|5|||
33617006|NCT02136680|63017944|FG001|Overall Study|Moved away|4|||
33455687|NCT00127166|62830154|FG000|Period I|Protocol Violation|0|||
33455688|NCT00127166|62830155|FG001|Period I|Protocol Violation|2|||
33455689|NCT00127166|62830154|FG000|Period I|Withdrawal by Subject|2|||
33455690|NCT00127166|62830155|FG001|Period I|Withdrawal by Subject|0|||
33519873|NCT03220217|62905671|FG002|Overall Study|Withdrawal by Subject|0|||
33519874|NCT03220217|62905669|FG000|Overall Study|Subject Missed Procedure|0|||
33519875|NCT03220217|62905670|FG001|Overall Study|Subject Missed Procedure|0|||
33519876|NCT03220217|62905671|FG002|Overall Study|Subject Missed Procedure|1|||
33519877|NCT03192137|62905702|FG000|Overall Study|Adverse Event|10|||
33519878|NCT03192137|62905703|FG001|Overall Study|Adverse Event|11|||
33519879|NCT03192137|62905702|FG000|Overall Study|Physician Decision|1|||
33519880|NCT03192137|62905703|FG001|Overall Study|Physician Decision|0|||
33519881|NCT03192137|62905702|FG000|Overall Study|Lack of Efficacy|20|||
33519882|NCT03192137|62905703|FG001|Overall Study|Lack of Efficacy|37|||
33617007|NCT02136680|63017943|FG000|Overall Study|Unable to schedule|17|||
33617008|NCT02136680|63017944|FG001|Overall Study|Unable to schedule|16|||
33519883|NCT03192137|62905702|FG000|Overall Study|Withdrawal by Subject|3|||
33519884|NCT03192137|62905703|FG001|Overall Study|Withdrawal by Subject|3|||
33617009|NCT02136680|63017943|FG000|Overall Study|Study ended before interview due|6|||
33617010|NCT02136680|63017944|FG001|Overall Study|Study ended before interview due|3|||
33617011|NCT01552954|63017952|FG000|Overall Study|Adverse Event|1|||
33617012|NCT01552954|63017953|FG001|Overall Study|Adverse Event|2|||
33519885|NCT03192137|62905702|FG000|Overall Study|Protocol Violation|4|||
33519886|NCT03192137|62905703|FG001|Overall Study|Protocol Violation|3|||
33519887|NCT03192137|62905702|FG000|Overall Study|Surgery Cancelled|4|||
33519888|NCT03192137|62905703|FG001|Overall Study|Surgery Cancelled|1|||
33519889|NCT03192137|62905702|FG000|Overall Study|Other - Various Administrative Reasons|8|||
33519890|NCT03192137|62905703|FG001|Overall Study|Other - Various Administrative Reasons|3|||
33617013|NCT01552954|63017952|FG000|Overall Study|Lost to Follow-up|1|||
33617014|NCT01552954|63017953|FG001|Overall Study|Lost to Follow-up|1|||
33617015|NCT01552954|63017952|FG000|Overall Study|Withdrawal by Subject|1|||
33617016|NCT01552954|63017953|FG001|Overall Study|Withdrawal by Subject|1|||
33617017|NCT01552954|63017952|FG000|Overall Study|Protocol Violation|1|||
33617018|NCT01552954|63017953|FG001|Overall Study|Protocol Violation|2|||
33617019|NCT01552954|63017952|FG000|Overall Study|diagnosed DM|1|||
33617020|NCT01552954|63017953|FG001|Overall Study|diagnosed DM|0|||
33617021|NCT02175368|63017959|FG000|Overall Study|Lost to Follow-up|1|||
33617022|NCT01518244|63017963|FG000|Overall Study|Adverse Event|3|||
33617023|NCT01552408|63017969|FG000|Overall Study|Lost to Follow-up|2|||
33617024|NCT01552408|63017970|FG001|Overall Study|Lost to Follow-up|0|||
33617025|NCT01552408|63017969|FG000|Overall Study|Relocation|0|||
33617026|NCT01552408|63017970|FG001|Overall Study|Relocation|1|||
33617027|NCT01552408|63017969|FG000|Overall Study|Withdrawal by Subject|2|||
33617028|NCT01552408|63017970|FG001|Overall Study|Withdrawal by Subject|1|||
33617029|NCT01528696|63017979|FG000|Overall Study|See detailed description|18|||
33519891|NCT03881059|62905723|FG000|Treatment Period - Part A|Adverse Event|1|||
33519892|NCT03881059|62905724|FG001|Treatment Period - Part A|Adverse Event|3|||
33617030|NCT01528696|63017980|FG001|Overall Study|See detailed description|19|||
33617031|NCT02174276|63017990|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
33519893|NCT03881059|62905725|FG002|Treatment Period - Part A|Adverse Event|4|||
33617032|NCT02174276|63017991|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
33617033|NCT02174276|63017992|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
33519894|NCT03881059|62905723|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
33617034|NCT02174276|63017993|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
33617035|NCT02174276|63017990|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
33617036|NCT02174276|63017991|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
33617037|NCT02174276|63017992|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
33617038|NCT02174276|63017993|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
33617039|NCT02174276|63017990|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
33617040|NCT02174276|63017991|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
33617041|NCT02174276|63017992|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
33617042|NCT02174276|63017993|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
33617043|NCT02174276|63017990|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
33617044|NCT02174276|63017991|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
33617045|NCT02174276|63017992|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
33617046|NCT02174276|63017993|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
33617047|NCT02174276|63017990|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
33617048|NCT02174276|63017991|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
33617049|NCT02174276|63017992|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
33617050|NCT02174276|63017993|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
33617051|NCT02174276|63017990|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
33617052|NCT02174276|63017991|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
33617053|NCT02174276|63017992|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
33617054|NCT02174276|63017993|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
33617055|NCT01528072|63018003|FG000|Overall Study|Withdrawal by Subject|5|||
33617056|NCT01528072|63018003|FG000|Overall Study|Physician Decision|1|||
33617057|NCT01528072|63018003|FG000|Overall Study|Determined not eligible by AEAC|1|||
33617058|NCT01528072|63018003|FG000|Overall Study|Missed Visit|2|||
33617059|NCT01528072|63018003|FG000|Overall Study|Lost to Follow-up|5|||
33617060|NCT01528072|63018003|FG000|Overall Study|Explanted|2|||
33617061|NCT01528072|63018003|FG000|Overall Study|Site Closure|4|||
33617062|NCT01528072|63018003|FG000|Overall Study|Death|2|||
33617063|NCT01528072|63018003|FG000|Overall Study|Early Termination of Study|52|||
33617064|NCT01527682|63018007|FG000|Overall Study|Protocol Violation|8|||
33617065|NCT01527370|63018011|FG000|Overall Study|Withdrawal by Subject|4|||
33617066|NCT01527370|63018011|FG000|Overall Study|Physician Decision|1|||
33617067|NCT01527370|63018011|FG000|Overall Study|Death|1|||
33617068|NCT01527292|63018017|FG000|Overall Study|Physician Decision|0|||
33617069|NCT01527292|63018018|FG001|Overall Study|Physician Decision|3|||
33617070|NCT01516216|63018026|FG000|Overall Study|Adverse Event|2|||
33617071|NCT01516216|63018027|FG001|Overall Study|Adverse Event|4|||
33617072|NCT01516216|63018026|FG000|Overall Study|Disease Progression|38|||
33617073|NCT01516216|63018027|FG001|Overall Study|Disease Progression|34|||
33617074|NCT01516216|63018026|FG000|Overall Study|Withdrawal by Subject|9|||
33617075|NCT01516216|63018027|FG001|Overall Study|Withdrawal by Subject|11|||
33617076|NCT01516216|63018026|FG000|Overall Study|Potentially Curative Resection|6|||
33617077|NCT01516216|63018027|FG001|Overall Study|Potentially Curative Resection|12|||
33617078|NCT01516216|63018026|FG000|Overall Study|Nonadherence|2|||
33617079|NCT01516216|63018027|FG001|Overall Study|Nonadherence|3|||
33617080|NCT01516216|63018026|FG000|Overall Study|Physician Decision|6|||
33617081|NCT01516216|63018027|FG001|Overall Study|Physician Decision|3|||
33617082|NCT01516216|63018026|FG000|Overall Study|Prolonged Treatment Delay|5|||
33617083|NCT01516216|63018027|FG001|Overall Study|Prolonged Treatment Delay|1|||
33519895|NCT03881059|62905724|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
33519896|NCT03881059|62905725|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
33519897|NCT03881059|62905723|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
33519898|NCT03881059|62905724|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
33519899|NCT03881059|62905725|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
33519900|NCT03881059|62905723|FG000|Treatment Period - Part A|Other reasons|2|||
33519901|NCT03881059|62905724|FG001|Treatment Period - Part A|Other reasons|1|||
33519902|NCT03881059|62905725|FG002|Treatment Period - Part A|Other reasons|0|||
33519903|NCT03881059|62905723|FG000|Treatment Period - Part B|Adverse Event|0|||
33519904|NCT03881059|62905724|FG001|Treatment Period - Part B|Adverse Event|0|||
33519905|NCT03881059|62905725|FG002|Treatment Period - Part B|Adverse Event|3|||
33519906|NCT03881059|62905723|FG000|Treatment Period - Part B|Death|0|||
33617084|NCT01516216|63018026|FG000|Overall Study|Intercurrent Illness|1|||
33617085|NCT01516216|63018027|FG001|Overall Study|Intercurrent Illness|0|||
33617086|NCT01516216|63018026|FG000|Overall Study|Death|1|||
33617087|NCT01516216|63018027|FG001|Overall Study|Death|1|||
33617088|NCT01950819|63018037|FG000|Overall Study|Graft Loss|35|||
33617089|NCT01950819|63018038|FG001|Overall Study|Graft Loss|30|||
33617090|NCT01950819|63018037|FG000|Overall Study|Death|29|||
33617091|NCT01950819|63018038|FG001|Overall Study|Death|34|||
33617092|NCT01950819|63018037|FG000|Overall Study|Subject / Gardian decision|54|||
33617093|NCT01950819|63018038|FG001|Overall Study|Subject / Gardian decision|51|||
33617094|NCT01950819|63018037|FG000|Overall Study|technical problems|2|||
33617095|NCT01950819|63018038|FG001|Overall Study|technical problems|0|||
33617096|NCT01950819|63018037|FG000|Overall Study|Pregnancy|0|||
33617097|NCT01950819|63018038|FG001|Overall Study|Pregnancy|2|||
33617098|NCT01950819|63018037|FG000|Overall Study|Lost to Follow-up|9|||
33617099|NCT01950819|63018038|FG001|Overall Study|Lost to Follow-up|17|||
33617100|NCT01514422|63018044|FG000|Overall Study|Lost to Follow-up|1|||
33617101|NCT01513330|63018048|FG000|SenSura Mio First,|Adverse Event|2|||
33617102|NCT01513330|63018049|FG001|SenSura Mio First,|Adverse Event|0|||
33617103|NCT01513330|63018048|FG000|SenSura Mio First,|Lack of Efficacy|0|||
33617104|NCT01513330|63018049|FG001|SenSura Mio First,|Lack of Efficacy|1|||
33617105|NCT01513330|63018048|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
33617106|NCT01513330|63018049|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
33617107|NCT01513330|63018048|FG000|SenSura Mio First,|Other|1|||
33617108|NCT01513330|63018049|FG001|SenSura Mio First,|Other|0|||
33617109|NCT01513330|63018048|FG000|Standard Care First,|Lack of Efficacy|2|||
33617110|NCT01513330|63018049|FG001|Standard Care First,|Lack of Efficacy|2|||
33617111|NCT01513330|63018048|FG000|Standard Care First,|Withdrawal by Subject|1|||
33617112|NCT01513330|63018049|FG001|Standard Care First,|Withdrawal by Subject|2|||
33617113|NCT01513330|63018048|FG000|Standard Care First,|Other|1|||
33617114|NCT01513330|63018049|FG001|Standard Care First,|Other|0|||
33617115|NCT01524796|63018055|FG000|Overall Study|Adverse Event|13|||
33617116|NCT01524796|63018055|FG000|Overall Study|Lack of Efficacy|3|||
33617117|NCT01524796|63018055|FG000|Overall Study|Lost to Follow-up|1|||
33617118|NCT01524796|63018055|FG000|Overall Study|The price|1|||
33617119|NCT01524796|63018055|FG000|Overall Study|Withdrawal by Subject|4|||
33617120|NCT01524796|63018055|FG000|Overall Study|Move|1|||
33617121|NCT01524796|63018055|FG000|Overall Study|Deterioration of pains|1|||
33617122|NCT01524796|63018055|FG000|Overall Study|Gall stone surgery|1|||
33617123|NCT01524796|63018055|FG000|Overall Study|Nervous about confidentiality|1|||
33617124|NCT01524796|63018055|FG000|Overall Study|Switch to carbamazapine|1|||
33617125|NCT01524796|63018055|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
33617126|NCT01547728|63018059|FG000|Overall Study|Change in procedure and equipment|1|||
33617127|NCT01547728|63018059|FG000|Overall Study|Drug not ready for subject|1|||
33617128|NCT01547728|63018059|FG000|Overall Study|Screen failure|39|||
33617129|NCT01523392|63018065|FG000|Treatment Period 1|Withdrawal by Subject|2|||
33455691|NCT00127166|62830154|FG000|Period I|Patient did not meet inclusion criteria|1|||
33617130|NCT01523392|63018066|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33455692|NCT00127166|62830155|FG001|Period I|Patient did not meet inclusion criteria|0|||
33455693|NCT00127166|62830154|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
33455694|NCT00127166|62830155|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
33455695|NCT00127166|62830154|FG000|Period II|Withdrawal by Subject|2|||
33455696|NCT00127166|62830155|FG001|Period II|Withdrawal by Subject|0|||
33455697|NCT00127166|62830154|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
33455698|NCT00127166|62830155|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
33455699|NCT00125138|62830165|FG000|Overall Study|Adverse Event|1|||
33455700|NCT00125138|62830166|FG001|Overall Study|Adverse Event|0|||
33455701|NCT00125138|62830167|FG002|Overall Study|Adverse Event|3|||
33455702|NCT00125138|62830168|FG003|Overall Study|Adverse Event|2|||
33455703|NCT00125138|62830165|FG000|Overall Study|Withdrawal by Subject|2|||
33455704|NCT00125138|62830166|FG001|Overall Study|Withdrawal by Subject|3|||
33455705|NCT00125138|62830167|FG002|Overall Study|Withdrawal by Subject|1|||
33455706|NCT00125138|62830168|FG003|Overall Study|Withdrawal by Subject|1|||
33455707|NCT00125138|62830165|FG000|Overall Study|Lack of Efficacy|0|||
33455708|NCT00125138|62830166|FG001|Overall Study|Lack of Efficacy|0|||
33455709|NCT00125138|62830167|FG002|Overall Study|Lack of Efficacy|0|||
33455710|NCT00125138|62830168|FG003|Overall Study|Lack of Efficacy|1|||
33455711|NCT00125138|62830165|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
33455712|NCT00125138|62830166|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
33455713|NCT00125138|62830167|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
33455714|NCT00125138|62830168|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
33455715|NCT04132336|62830185|FG000|Overall Study|Investigator Decision|0|||
33455716|NCT04132336|62830186|FG001|Overall Study|Investigator Decision|1|||
33455717|NCT04132336|62830187|FG002|Overall Study|Investigator Decision|0|||
33455718|NCT04132336|62830188|FG003|Overall Study|Investigator Decision|0|||
33455719|NCT04132336|62830189|FG004|Overall Study|Investigator Decision|0|||
33455720|NCT04132336|62830190|FG005|Overall Study|Investigator Decision|0|||
33455721|NCT04132336|62830191|FG006|Overall Study|Investigator Decision|0|||
33617131|NCT01523392|63018065|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
33617132|NCT01523392|63018066|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
33617133|NCT01523392|63018065|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
33617134|NCT01523392|63018066|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
33617135|NCT01512160|63018078|FG000|Overall Study|Lost to Follow-up|1|||
33617136|NCT01512160|63018079|FG001|Overall Study|Lost to Follow-up|0|||
33617137|NCT01512160|63018080|FG002|Overall Study|Lost to Follow-up|0|||
33617138|NCT01512160|63018081|FG003|Overall Study|Lost to Follow-up|0|||
33519907|NCT03881059|62905724|FG001|Treatment Period - Part B|Death|1|||
33519908|NCT03881059|62905725|FG002|Treatment Period - Part B|Death|1|||
33519909|NCT03881059|62905723|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
33519910|NCT03881059|62905724|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
33519911|NCT03881059|62905725|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
33519912|NCT03881059|62905723|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
33519913|NCT03881059|62905724|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
33519914|NCT03881059|62905725|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
33519915|NCT03881059|62905723|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
33519916|NCT03881059|62905724|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
33519917|NCT03881059|62905725|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
33519918|NCT03881059|62905723|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
33519919|NCT03881059|62905724|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
33519920|NCT03881059|62905725|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
33519921|NCT03881059|62905723|FG000|Treatment Period - Part B|Other reasons|4|||
33519922|NCT03881059|62905724|FG001|Treatment Period - Part B|Other reasons|3|||
33519923|NCT03881059|62905725|FG002|Treatment Period - Part B|Other reasons|3|||
33519924|NCT02861534|62905740|FG000|Overall Study|Death|541|||
33519925|NCT02861534|62905741|FG001|Overall Study|Death|552|||
33519926|NCT02861534|62905740|FG000|Overall Study|Lost to Follow-up|14|||
33519927|NCT02861534|62905741|FG001|Overall Study|Lost to Follow-up|14|||
33519928|NCT02861534|62905740|FG000|Overall Study|Site Terminated by Sponsor|4|||
33519929|NCT02861534|62905741|FG001|Overall Study|Site Terminated by Sponsor|3|||
33519930|NCT02861534|62905740|FG000|Overall Study|Withdrawal by Subject|15|||
33519931|NCT02861534|62905741|FG001|Overall Study|Withdrawal by Subject|18|||
33519932|NCT03083847|62905782|FG000|Main|Physician Decision|0|||
33519933|NCT03083847|62905783|FG001|Main|Physician Decision|0|||
33519934|NCT03083847|62905784|FG002|Main|Physician Decision|0|||
33519935|NCT03083847|62905785|FG003|Main|Physician Decision|0|||
33519936|NCT03083847|62905786|FG004|Main|Physician Decision|0|||
33519937|NCT03083847|62905787|FG005|Main|Physician Decision|1|||
33519938|NCT03083847|62905788|FG006|Main|Physician Decision|0|||
33519939|NCT03083847|62905789|FG007|Main|Physician Decision|0|||
33519940|NCT03083847|62905790|FG008|Main|Physician Decision|0|||
33519941|NCT03083847|62905791|FG009|Main|Physician Decision|0|||
33519942|NCT03083847|62905782|FG000|Main|Pregnancy|0|||
33519943|NCT03083847|62905783|FG001|Main|Pregnancy|0|||
33519944|NCT03083847|62905784|FG002|Main|Pregnancy|0|||
33519945|NCT03083847|62905785|FG003|Main|Pregnancy|0|||
33519946|NCT03083847|62905786|FG004|Main|Pregnancy|0|||
33519947|NCT03083847|62905787|FG005|Main|Pregnancy|0|||
33519948|NCT03083847|62905788|FG006|Main|Pregnancy|0|||
33519949|NCT03083847|62905789|FG007|Main|Pregnancy|1|||
33519950|NCT03083847|62905790|FG008|Main|Pregnancy|0|||
33519951|NCT03083847|62905791|FG009|Main|Pregnancy|0|||
33519952|NCT03083847|62905782|FG000|Main|Adverse Event|0|||
33519953|NCT03083847|62905783|FG001|Main|Adverse Event|0|||
33519954|NCT03083847|62905784|FG002|Main|Adverse Event|0|||
33519955|NCT03083847|62905785|FG003|Main|Adverse Event|0|||
33519956|NCT03083847|62905786|FG004|Main|Adverse Event|0|||
33519957|NCT03083847|62905787|FG005|Main|Adverse Event|0|||
33519958|NCT03083847|62905788|FG006|Main|Adverse Event|0|||
33617139|NCT01512160|63018078|FG000|Overall Study|Withdrawal by Subject|1|||
33617140|NCT01512160|63018079|FG001|Overall Study|Withdrawal by Subject|0|||
33617141|NCT01512160|63018080|FG002|Overall Study|Withdrawal by Subject|0|||
33617142|NCT01512160|63018081|FG003|Overall Study|Withdrawal by Subject|1|||
33617143|NCT01546168|63018094|FG000|Overall Study|Lost to Follow-up|1|||
33617144|NCT01546168|63018095|FG001|Overall Study|Lost to Follow-up|0|||
33617145|NCT01546168|63018094|FG000|Overall Study|Withdrawal by Subject|1|||
33617146|NCT01546168|63018095|FG001|Overall Study|Withdrawal by Subject|0|||
33617147|NCT01546168|63018094|FG000|Overall Study|ineligible after signing consent|2|||
33617148|NCT01546168|63018095|FG001|Overall Study|ineligible after signing consent|0|||
33617149|NCT01901289|63018101|FG000|Overall Study|Death|32|||
33617150|NCT01901289|63018101|FG000|Overall Study|Lost to Follow-up|16|||
33617151|NCT01901289|63018101|FG000|Overall Study|Withdrawal by Subject|35|||
33617152|NCT01901289|63018101|FG000|Overall Study|Other type of endpoint met|2|||
33617153|NCT01950741|63018105|FG000|Overall Study|Lost to Follow-up|1|||
33617154|NCT01950741|63018105|FG000|Overall Study|Death|1|||
33617155|NCT01950741|63018105|FG000|Overall Study|Withdrawal by Subject|1|||
33617156|NCT01950273|63018111|FG000|Overall Study|Protocol Violation|1|||
33617157|NCT01950273|63018112|FG001|Overall Study|Protocol Violation|0|||
33519959|NCT03083847|62905789|FG007|Main|Adverse Event|2|||
33519960|NCT03083847|62905790|FG008|Main|Adverse Event|0|||
33519961|NCT03083847|62905791|FG009|Main|Adverse Event|0|||
33519962|NCT03083847|62905782|FG000|Main|Withdrawal by Subject|0|||
33519963|NCT03083847|62905783|FG001|Main|Withdrawal by Subject|0|||
33519964|NCT03083847|62905784|FG002|Main|Withdrawal by Subject|0|||
33519965|NCT03083847|62905785|FG003|Main|Withdrawal by Subject|0|||
33519966|NCT03083847|62905786|FG004|Main|Withdrawal by Subject|0|||
33617158|NCT01950273|63018111|FG000|Overall Study|Withdrawal by Subject|2|||
33617159|NCT01950273|63018112|FG001|Overall Study|Withdrawal by Subject|0|||
33617160|NCT01950273|63018111|FG000|Overall Study|Other not defined above|1|||
33617161|NCT01950273|63018112|FG001|Overall Study|Other not defined above|0|||
33617162|NCT01919307|63018118|FG000|Overall Study|Withdrawal by Subject|9|||
33617163|NCT01919229|63018125|FG000|Overall Study|Subject/guardian decision|0|||
33617164|NCT01919229|63018126|FG001|Overall Study|Subject/guardian decision|0|||
33617165|NCT01919229|63018127|FG002|Overall Study|Subject/guardian decision|1|||
33519967|NCT03083847|62905787|FG005|Main|Withdrawal by Subject|0|||
33519968|NCT03083847|62905788|FG006|Main|Withdrawal by Subject|1|||
33519969|NCT03083847|62905789|FG007|Main|Withdrawal by Subject|1|||
33519970|NCT03083847|62905790|FG008|Main|Withdrawal by Subject|0|||
33519971|NCT03083847|62905791|FG009|Main|Withdrawal by Subject|0|||
33519972|NCT03082677|62905819|FG000|Overall Study|Not Treated|2|||
33519973|NCT02858180|62905834|FG000|Overall Study|Lost to Follow-up|0|||
33519974|NCT02858180|62905835|FG001|Overall Study|Lost to Follow-up|2|||
33519975|NCT03082599|62905843|FG000|Overall Study|Lost to Follow-up|1|||
33519976|NCT03082599|62905844|FG001|Overall Study|Lost to Follow-up|0|||
33617166|NCT01901055|63018137|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
33617167|NCT01901055|63018138|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
33617168|NCT01901055|63018137|FG000|Randomization But Not Titrated|Physician Decision|0|||
33617169|NCT01901055|63018138|FG001|Randomization But Not Titrated|Physician Decision|1|||
33617170|NCT01901055|63018137|FG000|Started Protocol to Week 6|Physician Decision|2|||
33617171|NCT01901055|63018138|FG001|Started Protocol to Week 6|Physician Decision|1|||
33617172|NCT01901055|63018137|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
33617173|NCT01901055|63018138|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
33617174|NCT01901055|63018137|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
33617175|NCT01901055|63018138|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
33617176|NCT01901055|63018137|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
33617177|NCT01901055|63018138|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
33617178|NCT01901055|63018137|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
33617179|NCT01901055|63018138|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
33519977|NCT01346501|62905852|FG000|Overall Study|Initiated Other Biological Agents|3|||
33519978|NCT01346501|62905853|FG001|Overall Study|Initiated Other Biological Agents|1|||
33519979|NCT01346501|62905852|FG000|Overall Study|Other|8|||
33519980|NCT01346501|62905853|FG001|Overall Study|Other|12|||
33519981|NCT03160885|62905863|FG000|Initial Treatment Period|Not dosed|2|||
33519982|NCT03160885|62905864|FG001|Initial Treatment Period|Not dosed|0|||
33519983|NCT03160885|62905865|FG002|Initial Treatment Period|Not dosed|0|||
33519984|NCT03160885|62905866|FG003|Initial Treatment Period|Not dosed|0|||
33519985|NCT03160885|62905867|FG004|Initial Treatment Period|Not dosed|0|||
33519986|NCT03160885|62905868|FG005|Initial Treatment Period|Not dosed|0|||
33519987|NCT03160885|62905869|FG006|Initial Treatment Period|Not dosed|0|||
33519988|NCT03160885|62905863|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
33519989|NCT03160885|62905864|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
33519990|NCT03160885|62905865|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33519991|NCT03160885|62905866|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33519992|NCT03160885|62905867|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33617180|NCT01901055|63018137|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
33617181|NCT01901055|63018138|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
33519993|NCT03160885|62905868|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33519994|NCT03160885|62905869|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33519995|NCT03160885|62905863|FG000|Open-label Treatment|Not dosed|0|||
33617182|NCT01901055|63018137|FG000|Week 24|Withdrawal by Subject|13|||
33617183|NCT01901055|63018138|FG001|Week 24|Withdrawal by Subject|19|||
33617184|NCT01901055|63018137|FG000|Week 24|Physician Decision|1|||
33617185|NCT01901055|63018138|FG001|Week 24|Physician Decision|0|||
33617186|NCT01901055|63018137|FG000|Week 36|Withdrawal by Subject|0|||
33455722|NCT04131556|62830207|FG000|Overall Study|Adverse Event|1|||
33455723|NCT04131556|62830207|FG000|Overall Study|Withdrawal by Subject|1|||
33455724|NCT04295356|62830216|FG000|Overall Study|Physician Decision|1|||
33455725|NCT04295356|62830217|FG001|Overall Study|Physician Decision|0|||
33455726|NCT04295356|62830216|FG000|Overall Study|Lost to Follow-up|0|||
33455727|NCT04295356|62830217|FG001|Overall Study|Lost to Follow-up|3|||
33455728|NCT04295356|62830216|FG000|Overall Study|Protocol Violation|0|||
33455729|NCT04295356|62830217|FG001|Overall Study|Protocol Violation|1|||
33455730|NCT03691948|62830225|FG000|Overall Study|Lost to Follow-up|1|||
33455731|NCT03691948|62830226|FG001|Overall Study|Lost to Follow-up|3|||
33455732|NCT04126174|62830233|FG000|Overall Study|Lost to Follow-up|3|||
33519996|NCT03160885|62905864|FG001|Open-label Treatment|Not dosed|0|||
33519997|NCT03160885|62905865|FG002|Open-label Treatment|Not dosed|0|||
33519998|NCT03160885|62905866|FG003|Open-label Treatment|Not dosed|0|||
33519999|NCT03160885|62905867|FG004|Open-label Treatment|Not dosed|0|||
33520000|NCT03160885|62905868|FG005|Open-label Treatment|Not dosed|0|||
33520001|NCT03160885|62905869|FG006|Open-label Treatment|Not dosed|2|||
33520002|NCT03160885|62905863|FG000|Open-label Treatment|Discontinued IMP|0|||
33520003|NCT03160885|62905864|FG001|Open-label Treatment|Discontinued IMP|0|||
33520004|NCT03160885|62905865|FG002|Open-label Treatment|Discontinued IMP|0|||
33520005|NCT03160885|62905866|FG003|Open-label Treatment|Discontinued IMP|0|||
33520006|NCT03160885|62905867|FG004|Open-label Treatment|Discontinued IMP|0|||
33520007|NCT03160885|62905868|FG005|Open-label Treatment|Discontinued IMP|0|||
33520008|NCT03160885|62905869|FG006|Open-label Treatment|Discontinued IMP|131|||
33520009|NCT03160885|62905863|FG000|Open-label Treatment|Completed Week 50|0|||
33520010|NCT03160885|62905864|FG001|Open-label Treatment|Completed Week 50|0|||
33520011|NCT03160885|62905865|FG002|Open-label Treatment|Completed Week 50|0|||
33520012|NCT03160885|62905866|FG003|Open-label Treatment|Completed Week 50|0|||
33520013|NCT03160885|62905867|FG004|Open-label Treatment|Completed Week 50|0|||
33520014|NCT03160885|62905868|FG005|Open-label Treatment|Completed Week 50|0|||
33520015|NCT03160885|62905869|FG006|Open-label Treatment|Completed Week 50|4|||
33520016|NCT03160885|62905863|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
33520017|NCT03160885|62905864|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
33520018|NCT03160885|62905865|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
33520019|NCT03160885|62905866|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
33520020|NCT03160885|62905867|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
33520021|NCT03160885|62905868|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
33520022|NCT03160885|62905869|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
33617187|NCT01901055|63018138|FG001|Week 36|Withdrawal by Subject|5|||
33617188|NCT01511536|63018150|FG000|Phase 1|Other|0|||
33617189|NCT01511536|63018151|FG001|Phase 1|Other|1|||
33617190|NCT01511536|63018152|FG002|Phase 1|Other|0|||
33617191|NCT01511536|63018150|FG000|Phase 2|Other|0|||
33617192|NCT01511536|63018151|FG001|Phase 2|Other|0|||
33617193|NCT01511536|63018152|FG002|Phase 2|Other|9|||
33617194|NCT01890759|63018162|FG000|Overall Study|Protocol Violation|0|||
33617195|NCT01890759|63018163|FG001|Overall Study|Protocol Violation|2|||
33455733|NCT04126174|62830234|FG001|Overall Study|Lost to Follow-up|3|||
33455734|NCT04124926|62830242|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
33520023|NCT03160885|62905863|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
33520024|NCT03160885|62905864|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
33520025|NCT03160885|62905865|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
33520026|NCT03160885|62905866|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
33520027|NCT03160885|62905867|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
33520028|NCT03160885|62905868|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
33520029|NCT03160885|62905869|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
33520030|NCT03160885|62905863|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
33520031|NCT03160885|62905864|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
33520032|NCT03160885|62905865|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
33520033|NCT03160885|62905866|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
33520034|NCT03160885|62905867|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
33520035|NCT03160885|62905868|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
33520036|NCT03160885|62905869|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
33520037|NCT03160885|62905863|FG000|Maintenance Treatment Period|Completed Week 50|0|||
33520038|NCT03160885|62905864|FG001|Maintenance Treatment Period|Completed Week 50|0|||
33520039|NCT03160885|62905865|FG002|Maintenance Treatment Period|Completed Week 50|1|||
33520040|NCT03160885|62905866|FG003|Maintenance Treatment Period|Completed Week 50|0|||
33520041|NCT03160885|62905867|FG004|Maintenance Treatment Period|Completed Week 50|0|||
33520042|NCT03160885|62905868|FG005|Maintenance Treatment Period|Completed Week 50|0|||
33520043|NCT03160885|62905869|FG006|Maintenance Treatment Period|Completed Week 50|0|||
33617196|NCT01890759|63018162|FG000|Overall Study|Lost to Follow-up|0|||
33617197|NCT01890759|63018163|FG001|Overall Study|Lost to Follow-up|2|||
33617198|NCT01890759|63018162|FG000|Overall Study|Withdrawal by Subject|2|||
33617199|NCT01890759|63018163|FG001|Overall Study|Withdrawal by Subject|8|||
33455735|NCT04124926|62830243|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
33455736|NCT04124926|62830244|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
33455737|NCT04124926|62830245|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
33455738|NCT04124926|62830246|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
33455739|NCT04124926|62830242|FG000|Healing Phase|Protocol Violation|0|||
33455740|NCT04124926|62830243|FG001|Healing Phase|Protocol Violation|1|||
33520044|NCT03181451|62905889|FG000|Overall Study|Adverse Event|0|||
33520045|NCT03181451|62905890|FG001|Overall Study|Adverse Event|1|||
33617200|NCT01900899|63018171|FG000|Overall Study|Withdrawal by Subject|7|||
33617201|NCT01900899|63018172|FG001|Overall Study|Withdrawal by Subject|1|||
33455741|NCT04124926|62830244|FG002|Healing Phase|Protocol Violation|0|||
33455742|NCT04124926|62830245|FG003|Healing Phase|Protocol Violation|0|||
33617202|NCT01900899|63018171|FG000|Overall Study|Migrated from study area|2|||
33520046|NCT03181451|62905891|FG002|Overall Study|Adverse Event|0|||
33520047|NCT03181451|62905889|FG000|Overall Study|Withdrawal by Subject|0|||
33520048|NCT03181451|62905890|FG001|Overall Study|Withdrawal by Subject|1|||
33520049|NCT03181451|62905891|FG002|Overall Study|Withdrawal by Subject|0|||
33520050|NCT00406783|62905903|FG000|Overall Study|Adverse Event|4|||
33520051|NCT00406783|62905904|FG001|Overall Study|Adverse Event|4|||
33520052|NCT00406783|62905903|FG000|Overall Study|Treatment Failure|2|||
33520053|NCT00406783|62905904|FG001|Overall Study|Treatment Failure|3|||
33520054|NCT00406783|62905903|FG000|Overall Study|Lost to Follow-up|3|||
33520055|NCT00406783|62905904|FG001|Overall Study|Lost to Follow-up|0|||
33520056|NCT00406783|62905903|FG000|Overall Study|Withdrawal by Subject|1|||
33520057|NCT00406783|62905904|FG001|Overall Study|Withdrawal by Subject|4|||
33520058|NCT00406783|62905903|FG000|Overall Study|Protocol Violation|4|||
33520059|NCT00406783|62905904|FG001|Overall Study|Protocol Violation|4|||
33520060|NCT03179891|62905910|FG000|First Intervention|Withdrawal by Subject|1|||
33520061|NCT03179891|62905911|FG001|First Intervention|Withdrawal by Subject|1|||
33520062|NCT03179891|62905910|FG000|First Intervention|Unspecified reason|1|||
33520063|NCT03179891|62905911|FG001|First Intervention|Unspecified reason|0|||
33520064|NCT03179891|62905910|FG000|First Intervention|Protocol Violation|0|||
33520065|NCT03179891|62905911|FG001|First Intervention|Protocol Violation|1|||
33520066|NCT02973815|62905922|FG000|Post Intervention|Death|1|||
33520067|NCT02973815|62905923|FG001|Post Intervention|Death|0|||
33520068|NCT02973815|62905922|FG000|Post Intervention|Lost to Follow-up|7|||
33520069|NCT02973815|62905923|FG001|Post Intervention|Lost to Follow-up|24|||
33520070|NCT02973815|62905922|FG000|Follow-up|Lost to Follow-up|2|||
33520071|NCT02973815|62905923|FG001|Follow-up|Lost to Follow-up|0|||
33520072|NCT03160573|62905933|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
33520073|NCT03160573|62905934|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
33520074|NCT03160573|62905935|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
33520075|NCT03160573|62905936|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
33520076|NCT02736227|62905949|FG000|Overall Study|Withdrawal by Subject|0|||
33520077|NCT02736227|62905950|FG001|Overall Study|Withdrawal by Subject|0|||
33520078|NCT02736227|62905951|FG002|Overall Study|Withdrawal by Subject|1|||
33520079|NCT02736227|62905949|FG000|Overall Study|Physician Decision|0|||
33520080|NCT02736227|62905950|FG001|Overall Study|Physician Decision|0|||
33520081|NCT02736227|62905951|FG002|Overall Study|Physician Decision|5|||
33520082|NCT02736227|62905949|FG000|Overall Study|Non Compliant|0|||
33520083|NCT02736227|62905950|FG001|Overall Study|Non Compliant|0|||
33520084|NCT02736227|62905951|FG002|Overall Study|Non Compliant|2|||
33520085|NCT03176459|62905960|FG000|Overall Study|Lost to Follow-up|5|||
33520086|NCT03176459|62905961|FG001|Overall Study|Lost to Follow-up|7|||
33520087|NCT03155269|62905969|FG000|Overall Study|Withdrawal by Subject|4|||
33520088|NCT03155269|62905970|FG001|Overall Study|Withdrawal by Subject|5|||
33520089|NCT03155269|62905969|FG000|Overall Study|Lost to Follow-up|1|||
33520090|NCT03155269|62905970|FG001|Overall Study|Lost to Follow-up|2|||
33520091|NCT02906670|62905986|FG000|Cohort 1, QW|Radiological Progression|1|||
33520092|NCT02906670|62905987|FG001|Cohort 1, QW|Radiological Progression|0|||
33520093|NCT02906670|62905988|FG002|Cohort 1, QW|Radiological Progression|0|||
33520094|NCT02906670|62905989|FG003|Cohort 1, QW|Radiological Progression|0|||
33520095|NCT02906670|62905990|FG004|Cohort 1, QW|Radiological Progression|0|||
33520096|NCT02906670|62905991|FG005|Cohort 1, QW|Radiological Progression|0|||
33520097|NCT02906670|62905992|FG006|Cohort 1, QW|Radiological Progression|0|||
33520098|NCT02906670|62905993|FG007|Cohort 1, QW|Radiological Progression|0|||
33520099|NCT02906670|62905994|FG008|Cohort 1, QW|Radiological Progression|0|||
33520100|NCT02906670|62905995|FG009|Cohort 1, QW|Radiological Progression|0|||
33520101|NCT02906670|62905986|FG000|Cohort 2, QW|Radiological Progression|0|||
33520102|NCT02906670|62905987|FG001|Cohort 2, QW|Radiological Progression|1|||
33520103|NCT02906670|62905988|FG002|Cohort 2, QW|Radiological Progression|0|||
33520104|NCT02906670|62905989|FG003|Cohort 2, QW|Radiological Progression|0|||
33520105|NCT02906670|62905990|FG004|Cohort 2, QW|Radiological Progression|0|||
33520106|NCT02906670|62905991|FG005|Cohort 2, QW|Radiological Progression|0|||
33520107|NCT02906670|62905992|FG006|Cohort 2, QW|Radiological Progression|0|||
33520108|NCT02906670|62905993|FG007|Cohort 2, QW|Radiological Progression|0|||
33520109|NCT02906670|62905994|FG008|Cohort 2, QW|Radiological Progression|0|||
33520110|NCT02906670|62905995|FG009|Cohort 2, QW|Radiological Progression|0|||
33520111|NCT02906670|62905986|FG000|Cohort 3, QW|Radiological Progression|0|||
33520112|NCT02906670|62905987|FG001|Cohort 3, QW|Radiological Progression|0|||
33520113|NCT02906670|62905988|FG002|Cohort 3, QW|Radiological Progression|2|||
33520114|NCT02906670|62905989|FG003|Cohort 3, QW|Radiological Progression|0|||
33520115|NCT02906670|62905990|FG004|Cohort 3, QW|Radiological Progression|0|||
33520116|NCT02906670|62905991|FG005|Cohort 3, QW|Radiological Progression|0|||
33520117|NCT02906670|62905992|FG006|Cohort 3, QW|Radiological Progression|0|||
33520118|NCT02906670|62905993|FG007|Cohort 3, QW|Radiological Progression|0|||
33520119|NCT02906670|62905994|FG008|Cohort 3, QW|Radiological Progression|0|||
33520120|NCT02906670|62905995|FG009|Cohort 3, QW|Radiological Progression|0|||
33520121|NCT02906670|62905986|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
33520122|NCT02906670|62905987|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
33520123|NCT02906670|62905988|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
33520124|NCT02906670|62905989|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
33520125|NCT02906670|62905990|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
33520126|NCT02906670|62905991|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
33520127|NCT02906670|62905992|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
33520128|NCT02906670|62905993|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
33520129|NCT02906670|62905994|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
33520130|NCT02906670|62905995|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
33520131|NCT02906670|62905986|FG000|Cohort 4, Q2W|Radiological Progression|0|||
33520132|NCT02906670|62905987|FG001|Cohort 4, Q2W|Radiological Progression|0|||
33520133|NCT02906670|62905988|FG002|Cohort 4, Q2W|Radiological Progression|0|||
33520134|NCT02906670|62905989|FG003|Cohort 4, Q2W|Radiological Progression|0|||
33520135|NCT02906670|62905990|FG004|Cohort 4, Q2W|Radiological Progression|0|||
33520136|NCT02906670|62905991|FG005|Cohort 4, Q2W|Radiological Progression|1|||
33520137|NCT02906670|62905992|FG006|Cohort 4, Q2W|Radiological Progression|0|||
33520138|NCT02906670|62905993|FG007|Cohort 4, Q2W|Radiological Progression|0|||
33520139|NCT02906670|62905994|FG008|Cohort 4, Q2W|Radiological Progression|0|||
33520140|NCT02906670|62905995|FG009|Cohort 4, Q2W|Radiological Progression|0|||
33520141|NCT02906670|62905986|FG000|Cohort 4, Q2W|Clinical Progression|0|||
33520142|NCT02906670|62905987|FG001|Cohort 4, Q2W|Clinical Progression|0|||
33520143|NCT02906670|62905988|FG002|Cohort 4, Q2W|Clinical Progression|0|||
33520144|NCT02906670|62905989|FG003|Cohort 4, Q2W|Clinical Progression|0|||
33520145|NCT02906670|62905990|FG004|Cohort 4, Q2W|Clinical Progression|0|||
33520146|NCT02906670|62905991|FG005|Cohort 4, Q2W|Clinical Progression|2|||
33520147|NCT02906670|62905992|FG006|Cohort 4, Q2W|Clinical Progression|0|||
33520148|NCT02906670|62905993|FG007|Cohort 4, Q2W|Clinical Progression|0|||
33520149|NCT02906670|62905994|FG008|Cohort 4, Q2W|Clinical Progression|0|||
33520150|NCT02906670|62905995|FG009|Cohort 4, Q2W|Clinical Progression|0|||
33520151|NCT02906670|62905986|FG000|Cohort 5, Q2W|Radiological Progression|0|||
33520152|NCT02906670|62905987|FG001|Cohort 5, Q2W|Radiological Progression|0|||
33520153|NCT02906670|62905988|FG002|Cohort 5, Q2W|Radiological Progression|0|||
33520154|NCT02906670|62905989|FG003|Cohort 5, Q2W|Radiological Progression|0|||
33520155|NCT02906670|62905990|FG004|Cohort 5, Q2W|Radiological Progression|0|||
33520156|NCT02906670|62905991|FG005|Cohort 5, Q2W|Radiological Progression|0|||
33520157|NCT02906670|62905992|FG006|Cohort 5, Q2W|Radiological Progression|4|||
33520158|NCT02906670|62905993|FG007|Cohort 5, Q2W|Radiological Progression|0|||
33520159|NCT02906670|62905994|FG008|Cohort 5, Q2W|Radiological Progression|0|||
33520160|NCT02906670|62905995|FG009|Cohort 5, Q2W|Radiological Progression|0|||
33520161|NCT02906670|62905986|FG000|Cohort 5, Q2W|Clinical Progression|0|||
33520162|NCT02906670|62905987|FG001|Cohort 5, Q2W|Clinical Progression|0|||
33520163|NCT02906670|62905988|FG002|Cohort 5, Q2W|Clinical Progression|0|||
33520164|NCT02906670|62905989|FG003|Cohort 5, Q2W|Clinical Progression|0|||
33520165|NCT02906670|62905990|FG004|Cohort 5, Q2W|Clinical Progression|0|||
33520166|NCT02906670|62905991|FG005|Cohort 5, Q2W|Clinical Progression|0|||
33520167|NCT02906670|62905992|FG006|Cohort 5, Q2W|Clinical Progression|1|||
33520168|NCT02906670|62905993|FG007|Cohort 5, Q2W|Clinical Progression|0|||
33520169|NCT02906670|62905994|FG008|Cohort 5, Q2W|Clinical Progression|0|||
33520170|NCT02906670|62905995|FG009|Cohort 5, Q2W|Clinical Progression|0|||
33520171|NCT02906670|62905986|FG000|Cohort 5, Q2W|Adverse Event|0|||
33617203|NCT01900899|63018172|FG001|Overall Study|Migrated from study area|0|||
33520172|NCT02906670|62905987|FG001|Cohort 5, Q2W|Adverse Event|0|||
33520173|NCT02906670|62905988|FG002|Cohort 5, Q2W|Adverse Event|0|||
33520174|NCT02906670|62905989|FG003|Cohort 5, Q2W|Adverse Event|0|||
33520175|NCT02906670|62905990|FG004|Cohort 5, Q2W|Adverse Event|0|||
33520176|NCT02906670|62905991|FG005|Cohort 5, Q2W|Adverse Event|0|||
33520177|NCT02906670|62905992|FG006|Cohort 5, Q2W|Adverse Event|1|||
33520178|NCT02906670|62905993|FG007|Cohort 5, Q2W|Adverse Event|0|||
33520179|NCT02906670|62905994|FG008|Cohort 5, Q2W|Adverse Event|0|||
33520180|NCT02906670|62905995|FG009|Cohort 5, Q2W|Adverse Event|0|||
33520181|NCT02906670|62905986|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33520182|NCT02906670|62905987|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33520183|NCT02906670|62905988|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33520184|NCT02906670|62905989|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33520185|NCT02906670|62905990|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33520186|NCT02906670|62905991|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33520187|NCT02906670|62905992|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
33520188|NCT02906670|62905993|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33520189|NCT02906670|62905994|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33520190|NCT02906670|62905995|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33520191|NCT02906670|62905986|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
33520192|NCT02906670|62905987|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
33520193|NCT02906670|62905988|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
33520194|NCT02906670|62905989|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
33520195|NCT02906670|62905990|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
33520196|NCT02906670|62905991|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
33520197|NCT02906670|62905992|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
33520198|NCT02906670|62905993|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
33520199|NCT02906670|62905994|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
33520200|NCT02906670|62905995|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
33520201|NCT02906670|62905986|FG000|Cohort 5P, Q2W|Adverse Event|0|||
33520202|NCT02906670|62905987|FG001|Cohort 5P, Q2W|Adverse Event|0|||
33520203|NCT02906670|62905988|FG002|Cohort 5P, Q2W|Adverse Event|0|||
33520204|NCT02906670|62905989|FG003|Cohort 5P, Q2W|Adverse Event|0|||
33520205|NCT02906670|62905990|FG004|Cohort 5P, Q2W|Adverse Event|0|||
33520206|NCT02906670|62905991|FG005|Cohort 5P, Q2W|Adverse Event|0|||
33520207|NCT02906670|62905992|FG006|Cohort 5P, Q2W|Adverse Event|0|||
33520208|NCT02906670|62905993|FG007|Cohort 5P, Q2W|Adverse Event|1|||
33520209|NCT02906670|62905994|FG008|Cohort 5P, Q2W|Adverse Event|0|||
33520210|NCT02906670|62905995|FG009|Cohort 5P, Q2W|Adverse Event|0|||
33520211|NCT02906670|62905986|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
33520212|NCT02906670|62905987|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
33520213|NCT02906670|62905988|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
33520214|NCT02906670|62905989|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
33520215|NCT02906670|62905990|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
33520216|NCT02906670|62905991|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
33520217|NCT02906670|62905992|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
33520218|NCT02906670|62905993|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
33520219|NCT02906670|62905994|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
33520220|NCT02906670|62905995|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
33520221|NCT02906670|62905986|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
33520222|NCT02906670|62905987|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
33520223|NCT02906670|62905988|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
33520224|NCT02906670|62905989|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
33520225|NCT02906670|62905990|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
33520226|NCT02906670|62905991|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
33520227|NCT02906670|62905992|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
33520228|NCT02906670|62905993|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
33520229|NCT02906670|62905994|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
33520230|NCT02906670|62905995|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
33520231|NCT02906670|62905986|FG000|Cohort 4P, QW|Radiological Progression|0|||
33520232|NCT02906670|62905987|FG001|Cohort 4P, QW|Radiological Progression|0|||
33520233|NCT02906670|62905988|FG002|Cohort 4P, QW|Radiological Progression|0|||
33617204|NCT01510912|63018178|FG000|Overall Study|Adverse Event|99|||
33617205|NCT01510912|63018178|FG000|Overall Study|Lack of Efficacy|12|||
33617206|NCT01510912|63018178|FG000|Overall Study|Non-compliance with trial drug|23|||
33617207|NCT01510912|63018178|FG000|Overall Study|Withdrawal by Subject|49|||
33617208|NCT01510912|63018178|FG000|Overall Study|Physician Decision|1|||
33617209|NCT01510912|63018178|FG000|Overall Study|Protocol Violation|27|||
33617210|NCT01510912|63018178|FG000|Overall Study|Lost to Follow-up|26|||
33520234|NCT02906670|62905989|FG003|Cohort 4P, QW|Radiological Progression|3|||
33520235|NCT02906670|62905990|FG004|Cohort 4P, QW|Radiological Progression|0|||
33520236|NCT02906670|62905991|FG005|Cohort 4P, QW|Radiological Progression|0|||
33520237|NCT02906670|62905992|FG006|Cohort 4P, QW|Radiological Progression|0|||
33520238|NCT02906670|62905993|FG007|Cohort 4P, QW|Radiological Progression|0|||
33617211|NCT01510912|63018178|FG000|Overall Study|Other, including joint replacement|5|||
33520239|NCT02906670|62905994|FG008|Cohort 4P, QW|Radiological Progression|0|||
33520240|NCT02906670|62905995|FG009|Cohort 4P, QW|Radiological Progression|0|||
33520241|NCT02906670|62905986|FG000|Cohort 7P, Q2W|Adverse Event|0|||
33520242|NCT02906670|62905987|FG001|Cohort 7P, Q2W|Adverse Event|0|||
33520243|NCT02906670|62905988|FG002|Cohort 7P, Q2W|Adverse Event|0|||
33520244|NCT02906670|62905989|FG003|Cohort 7P, Q2W|Adverse Event|0|||
33520245|NCT02906670|62905990|FG004|Cohort 7P, Q2W|Adverse Event|0|||
33617212|NCT01510756|63018182|FG000|Overall Study|Death|1|||
33520246|NCT02906670|62905991|FG005|Cohort 7P, Q2W|Adverse Event|0|||
33520247|NCT02906670|62905992|FG006|Cohort 7P, Q2W|Adverse Event|0|||
33520248|NCT02906670|62905993|FG007|Cohort 7P, Q2W|Adverse Event|0|||
33520249|NCT02906670|62905994|FG008|Cohort 7P, Q2W|Adverse Event|0|||
33520250|NCT02906670|62905995|FG009|Cohort 7P, Q2W|Adverse Event|1|||
33520251|NCT02906670|62905986|FG000|Cohort 7P, Q2W|Physician Decision|0|||
33520252|NCT02906670|62905987|FG001|Cohort 7P, Q2W|Physician Decision|0|||
33520253|NCT02906670|62905988|FG002|Cohort 7P, Q2W|Physician Decision|0|||
33520254|NCT02906670|62905989|FG003|Cohort 7P, Q2W|Physician Decision|0|||
33520255|NCT02906670|62905990|FG004|Cohort 7P, Q2W|Physician Decision|0|||
33520256|NCT02906670|62905991|FG005|Cohort 7P, Q2W|Physician Decision|0|||
33520257|NCT02906670|62905992|FG006|Cohort 7P, Q2W|Physician Decision|0|||
33520258|NCT02906670|62905993|FG007|Cohort 7P, Q2W|Physician Decision|0|||
33520259|NCT02906670|62905994|FG008|Cohort 7P, Q2W|Physician Decision|0|||
33520260|NCT02906670|62905995|FG009|Cohort 7P, Q2W|Physician Decision|1|||
33520261|NCT02906670|62905986|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33520262|NCT02906670|62905987|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33520263|NCT02906670|62905988|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33520264|NCT02906670|62905989|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33617213|NCT01510756|63018182|FG000|Overall Study|Lack of Efficacy|2|||
33617214|NCT01510756|63018182|FG000|Overall Study|Physician Decision|1|||
33520265|NCT02906670|62905990|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33520266|NCT02906670|62905991|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33520267|NCT02906670|62905992|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33520268|NCT02906670|62905993|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33520269|NCT02906670|62905994|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33520270|NCT02906670|62905995|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
33617215|NCT01522456|63018186|FG000|Overall Study|Adverse Event|2|||
33520271|NCT02906670|62905986|FG000|Cohort 5P, QW|Radiological Progression|0|||
33617216|NCT01522456|63018186|FG000|Overall Study|Lost to Follow-up|2|||
33520272|NCT02906670|62905987|FG001|Cohort 5P, QW|Radiological Progression|0|||
33520273|NCT02906670|62905988|FG002|Cohort 5P, QW|Radiological Progression|0|||
33617217|NCT01522456|63018186|FG000|Overall Study|Withdrawal by Subject|2|||
33520274|NCT02906670|62905989|FG003|Cohort 5P, QW|Radiological Progression|0|||
33520275|NCT02906670|62905990|FG004|Cohort 5P, QW|Radiological Progression|3|||
33520276|NCT02906670|62905991|FG005|Cohort 5P, QW|Radiological Progression|0|||
33520277|NCT02906670|62905992|FG006|Cohort 5P, QW|Radiological Progression|0|||
33520278|NCT02906670|62905993|FG007|Cohort 5P, QW|Radiological Progression|0|||
33520279|NCT02906670|62905994|FG008|Cohort 5P, QW|Radiological Progression|0|||
33617218|NCT01522456|63018186|FG000|Overall Study|Pregnancy|1|||
33617219|NCT01522456|63018186|FG000|Overall Study|Tolerability Assessment|1|||
33617220|NCT01545934|63018199|FG000|Overall Study|Withdrawal by Subject|4|||
33617221|NCT01545934|63018200|FG001|Overall Study|Withdrawal by Subject|3|||
33617222|NCT01545934|63018199|FG000|Overall Study|Lost to Follow-up|1|||
33617223|NCT01545934|63018200|FG001|Overall Study|Lost to Follow-up|0|||
33617224|NCT01521364|63018207|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
33617225|NCT01521364|63018207|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
33617226|NCT01545388|63018221|FG000|Overall Study|Adverse Event|2|||
33617227|NCT01545388|63018222|FG001|Overall Study|Adverse Event|4|||
33617228|NCT01545388|63018223|FG002|Overall Study|Adverse Event|1|||
33617229|NCT01545388|63018221|FG000|Overall Study|Lack of Efficacy|3|||
33617230|NCT01545388|63018222|FG001|Overall Study|Lack of Efficacy|2|||
33617231|NCT01545388|63018223|FG002|Overall Study|Lack of Efficacy|5|||
33617232|NCT01545388|63018221|FG000|Overall Study|Participant moved or relocated|1|||
33617233|NCT01545388|63018222|FG001|Overall Study|Participant moved or relocated|0|||
33617234|NCT01545388|63018223|FG002|Overall Study|Participant moved or relocated|0|||
33617235|NCT01545388|63018221|FG000|Overall Study|Withdrawal by Subject|1|||
33617236|NCT01545388|63018222|FG001|Overall Study|Withdrawal by Subject|4|||
33617237|NCT01545388|63018223|FG002|Overall Study|Withdrawal by Subject|2|||
33617238|NCT01545388|63018221|FG000|Overall Study|Other|1|||
33617239|NCT01545388|63018222|FG001|Overall Study|Other|1|||
33617240|NCT01545388|63018223|FG002|Overall Study|Other|0|||
33617241|NCT01545076|63018231|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
33617242|NCT01545076|63018232|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
33617243|NCT01545076|63018233|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
33617244|NCT01545076|63018234|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
33617245|NCT01545076|63018235|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
33617246|NCT01545076|63018231|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
33617247|NCT01545076|63018232|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
33617248|NCT01545076|63018233|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
33617249|NCT01545076|63018234|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
33617250|NCT01545076|63018235|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
33617251|NCT01545076|63018231|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
33617252|NCT01545076|63018232|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
33617253|NCT01545076|63018233|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
33617254|NCT01545076|63018234|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
33455743|NCT04124926|62830246|FG004|Healing Phase|Protocol Violation|0|||
33455744|NCT04124926|62830242|FG000|Healing Phase|Lost to Follow-up|5|||
33455745|NCT04124926|62830243|FG001|Healing Phase|Lost to Follow-up|4|||
33455746|NCT04124926|62830244|FG002|Healing Phase|Lost to Follow-up|0|||
33455747|NCT04124926|62830245|FG003|Healing Phase|Lost to Follow-up|0|||
33455748|NCT04124926|62830246|FG004|Healing Phase|Lost to Follow-up|0|||
33455749|NCT04124926|62830242|FG000|Healing Phase|Voluntary Withdrawal|10|||
33455750|NCT04124926|62830243|FG001|Healing Phase|Voluntary Withdrawal|7|||
33455751|NCT04124926|62830244|FG002|Healing Phase|Voluntary Withdrawal|0|||
33455752|NCT04124926|62830245|FG003|Healing Phase|Voluntary Withdrawal|0|||
33455753|NCT04124926|62830246|FG004|Healing Phase|Voluntary Withdrawal|0|||
33617255|NCT01545076|63018235|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
33617256|NCT01545076|63018231|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
33617257|NCT01545076|63018232|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
33617258|NCT01545076|63018233|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
33617259|NCT01545076|63018234|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
33617260|NCT01545076|63018235|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
33455754|NCT04124926|62830242|FG000|Healing Phase|Withdrawal of Consent|5|||
33455755|NCT04124926|62830243|FG001|Healing Phase|Withdrawal of Consent|3|||
33520280|NCT02906670|62905995|FG009|Cohort 5P, QW|Radiological Progression|0|||
33520281|NCT02906358|62906047|FG000|Overall Study|Withdrawal by Subject|10|||
33617261|NCT01545076|63018231|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
33617262|NCT01545076|63018232|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
33520282|NCT02906358|62906048|FG001|Overall Study|Withdrawal by Subject|7|||
33520283|NCT02906358|62906047|FG000|Overall Study|Lost to Follow-up|12|||
33520284|NCT02906358|62906048|FG001|Overall Study|Lost to Follow-up|15|||
33520285|NCT02186834|62906054|FG000|Dose Escalation|Death|0|||
33520286|NCT02186834|62906055|FG001|Dose Escalation|Death|0|||
33520287|NCT02186834|62906056|FG002|Dose Escalation|Death|0|||
33520288|NCT02186834|62906057|FG003|Dose Escalation|Death|1|||
33520289|NCT02186834|62906058|FG004|Dose Escalation|Death|0|||
33520290|NCT02186834|62906059|FG005|Dose Escalation|Death|0|||
33520291|NCT02186834|62906054|FG000|Treatment at RP2D|Died prior to treatment|0|||
33520292|NCT02186834|62906055|FG001|Treatment at RP2D|Died prior to treatment|0|||
33520293|NCT02186834|62906056|FG002|Treatment at RP2D|Died prior to treatment|0|||
33520294|NCT02186834|62906057|FG003|Treatment at RP2D|Died prior to treatment|0|||
33520295|NCT02186834|62906058|FG004|Treatment at RP2D|Died prior to treatment|0|||
33520296|NCT02186834|62906059|FG005|Treatment at RP2D|Died prior to treatment|1|||
33520297|NCT03144687|62906070|FG000|Overall Study|Death|0|||
33520298|NCT03144687|62906071|FG001|Overall Study|Death|2|||
33520299|NCT03144687|62906070|FG000|Overall Study|Lost to Follow-up|0|||
33520300|NCT03144687|62906071|FG001|Overall Study|Lost to Follow-up|1|||
33520301|NCT03144687|62906070|FG000|Overall Study|Physician Decision|0|||
33520302|NCT03144687|62906071|FG001|Overall Study|Physician Decision|1|||
33617263|NCT01545076|63018233|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
33617264|NCT01545076|63018234|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
33617265|NCT01545076|63018235|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
33617266|NCT01545076|63018231|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
33617267|NCT01545076|63018232|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
33617268|NCT01545076|63018233|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
33617269|NCT01545076|63018234|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
33617270|NCT01545076|63018235|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
33617271|NCT01545076|63018231|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
33617272|NCT01545076|63018232|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
33617273|NCT01545076|63018233|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
33617274|NCT01545076|63018234|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
33617275|NCT01545076|63018235|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
33617276|NCT01545076|63018231|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
33617277|NCT01545076|63018232|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
33617278|NCT01545076|63018233|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
33617279|NCT01545076|63018234|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
33617280|NCT01545076|63018235|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
33617281|NCT01545076|63018231|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
33520303|NCT03144687|62906070|FG000|Overall Study|Withdrawal by Subject|1|||
33520304|NCT03144687|62906071|FG001|Overall Study|Withdrawal by Subject|3|||
33520305|NCT03144687|62906070|FG000|Overall Study|Not Reported|2|||
33520306|NCT03144687|62906071|FG001|Overall Study|Not Reported|0|||
33520307|NCT03080961|62906081|FG000|Overall Study|Withdrawal by Subject|3|||
33520308|NCT02905266|62906105|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
33520309|NCT02905266|62906106|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
33520310|NCT02905266|62906105|FG000|Treatment Phase Part 1|Disease Progression|6|||
33520311|NCT02905266|62906106|FG001|Treatment Phase Part 1|Disease Progression|7|||
33520312|NCT02905266|62906105|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
33520313|NCT02905266|62906106|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
33520314|NCT02905266|62906105|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
33520315|NCT02905266|62906106|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
33520316|NCT02905266|62906105|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
33520317|NCT02905266|62906106|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
33520318|NCT02905266|62906105|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
33520319|NCT02905266|62906106|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
33520320|NCT02905266|62906105|FG000|Transition From Part 1 to Part 2|Death|0|||
33520321|NCT02905266|62906106|FG001|Transition From Part 1 to Part 2|Death|1|||
33520322|NCT02905266|62906105|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
33520323|NCT02905266|62906106|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
33520324|NCT02905266|62906105|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
33520325|NCT02905266|62906106|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
33520326|NCT02905266|62906105|FG000|Maintenance Phase Part 2|Disease Progression|9|||
33520327|NCT02905266|62906106|FG001|Maintenance Phase Part 2|Disease Progression|2|||
33520328|NCT02905266|62906105|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
33520329|NCT02905266|62906106|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
33520330|NCT02905266|62906105|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
33520331|NCT02905266|62906106|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
33520332|NCT02982018|62906114|FG000|Overall Study|Incorrect Lens Dispensed|1|||
33520333|NCT02982018|62906115|FG001|Overall Study|Incorrect Lens Dispensed|0|||
33520334|NCT02982018|62906114|FG000|Overall Study|Protocol Violation|1|||
33520335|NCT02982018|62906115|FG001|Overall Study|Protocol Violation|1|||
33520336|NCT02982018|62906114|FG000|Overall Study|Adverse Event|1|||
33520337|NCT02982018|62906115|FG001|Overall Study|Adverse Event|1|||
33520338|NCT02982018|62906114|FG000|Overall Study|Lens Discomfort|2|||
33520339|NCT02982018|62906115|FG001|Overall Study|Lens Discomfort|0|||
33520340|NCT02982018|62906114|FG000|Overall Study|Withdrawal by Subject|0|||
33520341|NCT02982018|62906115|FG001|Overall Study|Withdrawal by Subject|1|||
33520342|NCT03080493|62906123|FG000|Overall Study|Did not provide NRS pain results|1|||
33520343|NCT03080493|62906124|FG001|Overall Study|Did not provide NRS pain results|0|||
33520344|NCT03080493|62906123|FG000|Overall Study|Adverse Event|0|||
33520345|NCT03080493|62906124|FG001|Overall Study|Adverse Event|1|||
33520346|NCT03080493|62906123|FG000|Overall Study|Randomization error (parity group)|0|||
33520347|NCT03080493|62906124|FG001|Overall Study|Randomization error (parity group)|1|||
33520348|NCT01339910|62906132|FG000|Overall Study|Withdrawal by Subject|1|||
33520349|NCT01339910|62906133|FG001|Overall Study|Withdrawal by Subject|0|||
33520350|NCT01339910|62906132|FG000|Overall Study|Physician Decision|1|||
33520351|NCT01339910|62906133|FG001|Overall Study|Physician Decision|0|||
33520352|NCT01339910|62906132|FG000|Overall Study|Disease relapse|1|||
33520353|NCT01339910|62906133|FG001|Overall Study|Disease relapse|4|||
33520354|NCT02981082|62906141|FG000|Overall Study|Withdrawal by Subject|2|||
33520355|NCT02981082|62906142|FG001|Overall Study|Withdrawal by Subject|0|||
33520356|NCT02981082|62906141|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
33520357|NCT02981082|62906142|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
33520358|NCT02981082|62906141|FG000|Overall Study|Adverse Event|0|||
33520359|NCT02981082|62906142|FG001|Overall Study|Adverse Event|1|||
33520360|NCT01066104|62906150|FG000|Overall Study|Adverse Event|1|||
33520361|NCT01066104|62906151|FG001|Overall Study|Adverse Event|1|||
33520362|NCT01066104|62906150|FG000|Overall Study|Protocol Violation|1|||
33520363|NCT01066104|62906151|FG001|Overall Study|Protocol Violation|0|||
33520364|NCT02736968|62906162|FG000|Overall Study|Lost to Follow-up|0|||
33520365|NCT02736968|62906163|FG001|Overall Study|Lost to Follow-up|0|||
33520366|NCT02736968|62906164|FG002|Overall Study|Lost to Follow-up|0|||
33520367|NCT02736968|62906165|FG003|Overall Study|Lost to Follow-up|0|||
33520368|NCT02736968|62906166|FG004|Overall Study|Lost to Follow-up|0|||
33520369|NCT02736968|62906167|FG005|Overall Study|Lost to Follow-up|0|||
33520370|NCT02736968|62906168|FG006|Overall Study|Lost to Follow-up|5|||
33520371|NCT02736968|62906169|FG007|Overall Study|Lost to Follow-up|2|||
33520372|NCT02736968|62906162|FG000|Overall Study|COVID-19 Pandemic|0|||
33520373|NCT02736968|62906163|FG001|Overall Study|COVID-19 Pandemic|0|||
33520374|NCT02736968|62906164|FG002|Overall Study|COVID-19 Pandemic|0|||
33520375|NCT02736968|62906165|FG003|Overall Study|COVID-19 Pandemic|0|||
33520376|NCT02736968|62906166|FG004|Overall Study|COVID-19 Pandemic|0|||
33520377|NCT02736968|62906167|FG005|Overall Study|COVID-19 Pandemic|0|||
33520378|NCT02736968|62906168|FG006|Overall Study|COVID-19 Pandemic|2|||
33520379|NCT02736968|62906169|FG007|Overall Study|COVID-19 Pandemic|0|||
33520380|NCT02736968|62906162|FG000|Overall Study|Withdrawal by Subject|0|||
33520381|NCT02736968|62906163|FG001|Overall Study|Withdrawal by Subject|0|||
33520382|NCT02736968|62906164|FG002|Overall Study|Withdrawal by Subject|0|||
33520383|NCT02736968|62906165|FG003|Overall Study|Withdrawal by Subject|0|||
33520384|NCT02736968|62906166|FG004|Overall Study|Withdrawal by Subject|0|||
33520385|NCT02736968|62906167|FG005|Overall Study|Withdrawal by Subject|0|||
33520386|NCT02736968|62906168|FG006|Overall Study|Withdrawal by Subject|1|||
33617282|NCT01545076|63018232|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
33617283|NCT01545076|63018233|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
33617284|NCT01545076|63018234|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
33617285|NCT01545076|63018235|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
33520387|NCT02736968|62906169|FG007|Overall Study|Withdrawal by Subject|0|||
33520388|NCT02980224|62906182|FG000|Overall Study|Adverse Event|4|||
33520389|NCT02980224|62906183|FG001|Overall Study|Adverse Event|1|||
33520390|NCT02980224|62906182|FG000|Overall Study|Withdrawal by Subject|0|||
33520391|NCT02980224|62906183|FG001|Overall Study|Withdrawal by Subject|2|||
33520392|NCT02591615|62906193|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
33520393|NCT02591615|62906194|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
33520394|NCT02591615|62906195|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
33520395|NCT02591615|62906196|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
33520396|NCT02591615|62906193|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
33520397|NCT02591615|62906194|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
33520398|NCT02591615|62906195|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
33520399|NCT02591615|62906196|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
33520400|NCT02591615|62906193|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
33520401|NCT02591615|62906194|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
33520402|NCT02591615|62906195|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
33520403|NCT02591615|62906196|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
33520404|NCT02591615|62906193|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
33520405|NCT02591615|62906194|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
33520406|NCT02591615|62906195|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
33520407|NCT02591615|62906196|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
33520408|NCT02591615|62906193|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
33520409|NCT02591615|62906194|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
33520410|NCT02591615|62906195|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
33520411|NCT02591615|62906196|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
33520412|NCT02591615|62906193|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
33520413|NCT02591615|62906194|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
33520414|NCT02591615|62906195|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
33520415|NCT02591615|62906196|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
33520416|NCT02591615|62906193|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
33520417|NCT02591615|62906194|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
33520418|NCT02591615|62906195|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
33520419|NCT02591615|62906196|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
33520420|NCT02591615|62906193|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
33520421|NCT02591615|62906194|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
33520422|NCT02591615|62906195|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
33520423|NCT02591615|62906196|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
33520424|NCT02591615|62906193|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
33520425|NCT02591615|62906194|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
33520426|NCT02591615|62906195|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
33520427|NCT02591615|62906196|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
33520428|NCT02591615|62906193|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
33520429|NCT02591615|62906194|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
33520430|NCT02591615|62906195|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
33520431|NCT02591615|62906196|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
33520432|NCT02591615|62906193|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
33520433|NCT02591615|62906194|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
33520434|NCT02591615|62906195|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
33520435|NCT02591615|62906196|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
33520436|NCT02591615|62906193|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
33520437|NCT02591615|62906194|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
33520438|NCT02591615|62906195|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
33520439|NCT02591615|62906196|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
33520440|NCT02591615|62906193|FG000|Maintenance MK-3475|Adverse Event|0|||
33520441|NCT02591615|62906194|FG001|Maintenance MK-3475|Adverse Event|3|||
33520442|NCT02591615|62906195|FG002|Maintenance MK-3475|Adverse Event|1|||
33520443|NCT02591615|62906196|FG003|Maintenance MK-3475|Adverse Event|2|||
33520444|NCT02591615|62906193|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
33520445|NCT02591615|62906194|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
33520446|NCT02591615|62906195|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
33520447|NCT02591615|62906196|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
33520448|NCT02591615|62906193|FG000|Maintenance MK-3475|Death|0|||
33520449|NCT02591615|62906194|FG001|Maintenance MK-3475|Death|1|||
33520450|NCT02591615|62906195|FG002|Maintenance MK-3475|Death|1|||
33520451|NCT02591615|62906196|FG003|Maintenance MK-3475|Death|0|||
33520452|NCT02591615|62906193|FG000|Maintenance MK-3475|Physician discretion|0|||
33520453|NCT02591615|62906194|FG001|Maintenance MK-3475|Physician discretion|0|||
33520454|NCT02591615|62906195|FG002|Maintenance MK-3475|Physician discretion|1|||
33520455|NCT02591615|62906196|FG003|Maintenance MK-3475|Physician discretion|0|||
33520456|NCT02591615|62906193|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
33520457|NCT02591615|62906194|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
33520458|NCT02591615|62906195|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
33520459|NCT02591615|62906196|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
33617286|NCT01544920|63018250|FG000|Overall Study|Adverse Event|0|||
33520460|NCT02591615|62906193|FG000|Maintenance MK-3475|In active treatment|2|||
33520461|NCT02591615|62906194|FG001|Maintenance MK-3475|In active treatment|0|||
33520462|NCT02591615|62906195|FG002|Maintenance MK-3475|In active treatment|0|||
33520463|NCT02591615|62906196|FG003|Maintenance MK-3475|In active treatment|1|||
33520464|NCT03077607|62906211|FG000|Period 1 (15 Days)|Adverse Event|1|||
33520465|NCT03077607|62906212|FG001|Period 1 (15 Days)|Adverse Event|0|||
33325169|NCT00902278|62701872|FG003|Overall Study|Physician Decision|0|||
33325170|NCT00902278|62701873|FG004|Overall Study|Physician Decision|1|||
33325171|NCT00902278|62701869|FG000|Overall Study|Lost to Follow-up|3|||
33325172|NCT00902278|62701870|FG001|Overall Study|Lost to Follow-up|2|||
33325173|NCT00902278|62701871|FG002|Overall Study|Lost to Follow-up|3|||
33325174|NCT00902278|62701872|FG003|Overall Study|Lost to Follow-up|0|||
33325175|NCT00902278|62701873|FG004|Overall Study|Lost to Follow-up|1|||
33455756|NCT04124926|62830244|FG002|Healing Phase|Withdrawal of Consent|0|||
33455757|NCT04124926|62830245|FG003|Healing Phase|Withdrawal of Consent|0|||
33455758|NCT04124926|62830246|FG004|Healing Phase|Withdrawal of Consent|0|||
33455759|NCT04124926|62830242|FG000|Healing Phase|Miscellaneous|8|||
33455760|NCT04124926|62830243|FG001|Healing Phase|Miscellaneous|7|||
33455761|NCT04124926|62830244|FG002|Healing Phase|Miscellaneous|0|||
33455762|NCT04124926|62830245|FG003|Healing Phase|Miscellaneous|0|||
33455763|NCT04124926|62830246|FG004|Healing Phase|Miscellaneous|0|||
33455764|NCT04124926|62830242|FG000|Healing Phase|Randomized but not Treated|0|||
33455765|NCT04124926|62830243|FG001|Healing Phase|Randomized but not Treated|3|||
33455766|NCT04124926|62830244|FG002|Healing Phase|Randomized but not Treated|0|||
33455767|NCT04124926|62830245|FG003|Healing Phase|Randomized but not Treated|0|||
33455768|NCT04124926|62830246|FG004|Healing Phase|Randomized but not Treated|0|||
33455769|NCT04124926|62830242|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
33455770|NCT04124926|62830243|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
33455771|NCT04124926|62830244|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
33455772|NCT04124926|62830245|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
33455773|NCT04124926|62830246|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
33455774|NCT04124926|62830242|FG000|Maintenance Phase|Protocol Violation|0|||
33455775|NCT04124926|62830243|FG001|Maintenance Phase|Protocol Violation|0|||
33455776|NCT04124926|62830244|FG002|Maintenance Phase|Protocol Violation|3|||
33455777|NCT04124926|62830245|FG003|Maintenance Phase|Protocol Violation|0|||
33455778|NCT04124926|62830246|FG004|Maintenance Phase|Protocol Violation|0|||
33455779|NCT04124926|62830242|FG000|Maintenance Phase|Lost to Follow-up|0|||
33455780|NCT04124926|62830243|FG001|Maintenance Phase|Lost to Follow-up|0|||
33455781|NCT04124926|62830244|FG002|Maintenance Phase|Lost to Follow-up|7|||
33455782|NCT04124926|62830245|FG003|Maintenance Phase|Lost to Follow-up|8|||
33455783|NCT04124926|62830246|FG004|Maintenance Phase|Lost to Follow-up|9|||
33455784|NCT04124926|62830242|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
33455785|NCT04124926|62830243|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
33455786|NCT04124926|62830244|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
33455787|NCT04124926|62830245|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
33455788|NCT04124926|62830246|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
33455789|NCT04124926|62830242|FG000|Maintenance Phase|Pregnancy|0|||
33455790|NCT04124926|62830243|FG001|Maintenance Phase|Pregnancy|0|||
33455791|NCT04124926|62830244|FG002|Maintenance Phase|Pregnancy|0|||
33455792|NCT04124926|62830245|FG003|Maintenance Phase|Pregnancy|1|||
33455793|NCT04124926|62830246|FG004|Maintenance Phase|Pregnancy|0|||
33455794|NCT04124926|62830242|FG000|Maintenance Phase|Lack of Efficacy|0|||
33455795|NCT04124926|62830243|FG001|Maintenance Phase|Lack of Efficacy|0|||
33455796|NCT04124926|62830244|FG002|Maintenance Phase|Lack of Efficacy|0|||
33455797|NCT04124926|62830245|FG003|Maintenance Phase|Lack of Efficacy|0|||
33455798|NCT04124926|62830246|FG004|Maintenance Phase|Lack of Efficacy|1|||
33455799|NCT04124926|62830242|FG000|Maintenance Phase|Withdrawal of Consent|0|||
33455800|NCT04124926|62830243|FG001|Maintenance Phase|Withdrawal of Consent|0|||
33455801|NCT04124926|62830244|FG002|Maintenance Phase|Withdrawal of Consent|5|||
33455802|NCT04124926|62830245|FG003|Maintenance Phase|Withdrawal of Consent|5|||
33520466|NCT03077607|62906211|FG000|Period 1 (15 Days)|Death|1|||
33520467|NCT03077607|62906212|FG001|Period 1 (15 Days)|Death|0|||
33520468|NCT03077607|62906211|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
33325176|NCT01998633|62701887|FG000|Overall Study|Death|1|||
33455803|NCT04124926|62830246|FG004|Maintenance Phase|Withdrawal of Consent|5|||
33455804|NCT04124926|62830242|FG000|Maintenance Phase|Miscellaneous|0|||
33617287|NCT01544920|63018251|FG001|Overall Study|Adverse Event|3|||
33617288|NCT01544920|63018250|FG000|Overall Study|Death|0|||
33617289|NCT01544920|63018251|FG001|Overall Study|Death|1|||
33617290|NCT01544920|63018250|FG000|Overall Study|Lost to Follow-up|11|||
33617291|NCT01544920|63018251|FG001|Overall Study|Lost to Follow-up|12|||
33617292|NCT01544920|63018250|FG000|Overall Study|Protocol Violation|0|||
33617293|NCT01544920|63018251|FG001|Overall Study|Protocol Violation|2|||
33617294|NCT01544920|63018250|FG000|Overall Study|Physician Decision|4|||
33617295|NCT01544920|63018251|FG001|Overall Study|Physician Decision|1|||
33617296|NCT01544920|63018250|FG000|Overall Study|Withdrawal by Subject|4|||
33617297|NCT01544920|63018251|FG001|Overall Study|Withdrawal by Subject|4|||
33520469|NCT03077607|62906212|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
33520470|NCT03077607|62906211|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
33520471|NCT03077607|62906212|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
33520472|NCT02977572|62906231|FG000|Overall Study|Exclusion criterion|2|||
33520473|NCT02977572|62906232|FG001|Overall Study|Exclusion criterion|2|||
33520474|NCT02746874|62906244|FG000|Overall Study|Withdrawal by Subject|0|||
33520475|NCT02746874|62906245|FG001|Overall Study|Withdrawal by Subject|1|||
33520476|NCT02746874|62906244|FG000|Overall Study|Surgery Date Changed|0|||
33520477|NCT02746874|62906245|FG001|Overall Study|Surgery Date Changed|2|||
33520478|NCT03217175|62906251|FG000|Overall Study|Physician Decision|4|||
33520479|NCT03217175|62906252|FG001|Overall Study|Physician Decision|1|||
33520480|NCT01062126|62906258|FG000|Overall Study|Death|209|||
33520481|NCT01062126|62906258|FG000|Overall Study|All Withdrawals|324|||
33520482|NCT02522429|62906262|FG000|Overall Study|Lost to Follow-up|8|||
33520483|NCT02522429|62906262|FG000|Overall Study|Adverse Event|2|||
33520484|NCT02522429|62906262|FG000|Overall Study|Death|1|||
33520485|NCT02522429|62906262|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
33520486|NCT02974140|62906266|FG000|Overall Study|Adverse Event|2|||
33520487|NCT02974140|62906266|FG000|Overall Study|Lost to Follow-up|1|||
33520488|NCT02974140|62906266|FG000|Overall Study|Study Terminated by Sponsor|36|||
33520489|NCT02974842|62906273|FG000|Overall Study|Withdrawal by Subject|4|||
33520490|NCT02974842|62906273|FG000|Overall Study|Screen failures|4|||
33520491|NCT03172481|62906279|FG000|Double-blind|Withdrawal by Subject|1|||
33520492|NCT03172481|62906280|FG001|Double-blind|Withdrawal by Subject|0|||
33520493|NCT02855450|62906288|FG000|Overall Study|Adverse Event|1|||
33520494|NCT02855450|62906289|FG001|Overall Study|Adverse Event|0|||
33520495|NCT02855450|62906288|FG000|Overall Study|Lost to Follow-up|4|||
33520496|NCT02855450|62906289|FG001|Overall Study|Lost to Follow-up|0|||
33520497|NCT03172325|62906297|FG000|Overall Study|Adverse Event|2|||
33520498|NCT03172325|62906298|FG001|Overall Study|Adverse Event|3|||
33520499|NCT03172325|62906297|FG000|Overall Study|Positive PPD|1|||
33520500|NCT03172325|62906298|FG001|Overall Study|Positive PPD|0|||
33520501|NCT03172325|62906297|FG000|Overall Study|Poor Compliance|1|||
33520502|NCT03172325|62906298|FG001|Overall Study|Poor Compliance|1|||
33520503|NCT03085017|62906306|FG000|Overall Study|Death|0|||
33520504|NCT03085017|62906307|FG001|Overall Study|Death|3|||
33520505|NCT03215771|62906313|FG000|Overall Study|Withdrawal by Subject|2|||
33520506|NCT03215771|62906313|FG000|Overall Study|Physician Decision|1|||
33520507|NCT02745392|62906322|FG000|Overall Study|Lost to Follow-up|0|||
33520508|NCT02745392|62906323|FG001|Overall Study|Lost to Follow-up|1|||
33520509|NCT02745392|62906324|FG002|Overall Study|Lost to Follow-up|0|||
33520510|NCT02745392|62906325|FG003|Overall Study|Lost to Follow-up|0|||
33520511|NCT03076515|62906337|FG000|Overall Study|DMC decision based on interim analysis|25|||
33520512|NCT03076515|62906338|FG001|Overall Study|DMC decision based on interim analysis|29|||
33520513|NCT03170609|62906351|FG000|Overall Study|Death|0|||
33520514|NCT03170609|62906352|FG001|Overall Study|Death|0|||
33520515|NCT03170609|62906353|FG002|Overall Study|Death|1|||
33520516|NCT03170609|62906354|FG003|Overall Study|Death|0|||
33520517|NCT03170609|62906355|FG004|Overall Study|Death|0|||
33520518|NCT03170609|62906356|FG005|Overall Study|Death|0|||
33520519|NCT03170609|62906357|FG006|Overall Study|Death|0|||
33520520|NCT03170609|62906351|FG000|Overall Study|Withdrawal by Subject|1|||
33520521|NCT03170609|62906352|FG001|Overall Study|Withdrawal by Subject|2|||
33617298|NCT01509664|63018261|FG000|Overall Study|Lost to Follow-up|15|||
33617299|NCT01509664|63018262|FG001|Overall Study|Lost to Follow-up|21|||
33617300|NCT01543828|63018270|FG000|Treatment 2|Lost to Follow-up|1|||
33617301|NCT01543828|63018271|FG001|Treatment 2|Lost to Follow-up|0|||
33617302|NCT01520506|63018279|FG000|Overall Study|Missed Visit|4|||
33520522|NCT03170609|62906353|FG002|Overall Study|Withdrawal by Subject|0|||
33520523|NCT03170609|62906354|FG003|Overall Study|Withdrawal by Subject|0|||
33520524|NCT03170609|62906355|FG004|Overall Study|Withdrawal by Subject|0|||
33520525|NCT03170609|62906356|FG005|Overall Study|Withdrawal by Subject|0|||
33520526|NCT03170609|62906357|FG006|Overall Study|Withdrawal by Subject|1|||
33520527|NCT03170609|62906351|FG000|Overall Study|Lost to Follow-up|1|||
33520528|NCT03170609|62906352|FG001|Overall Study|Lost to Follow-up|0|||
33520529|NCT03170609|62906353|FG002|Overall Study|Lost to Follow-up|5|||
33617303|NCT01520506|63018279|FG000|Overall Study|Lost to Follow-up|1|||
33617304|NCT01520506|63018279|FG000|Overall Study|Withdrawal by Subject|1|||
33520530|NCT03170609|62906354|FG003|Overall Study|Lost to Follow-up|2|||
33520531|NCT03170609|62906355|FG004|Overall Study|Lost to Follow-up|1|||
33520532|NCT03170609|62906356|FG005|Overall Study|Lost to Follow-up|1|||
33520533|NCT03170609|62906357|FG006|Overall Study|Lost to Follow-up|0|||
33520534|NCT03170609|62906351|FG000|Overall Study|Other|1|||
33520535|NCT03170609|62906352|FG001|Overall Study|Other|0|||
33520536|NCT03170609|62906353|FG002|Overall Study|Other|0|||
33520537|NCT03170609|62906354|FG003|Overall Study|Other|0|||
33520538|NCT03170609|62906355|FG004|Overall Study|Other|0|||
33520539|NCT03170609|62906356|FG005|Overall Study|Other|1|||
33520540|NCT03170609|62906357|FG006|Overall Study|Other|0|||
33520541|NCT01141712|62906373|FG000|Overall Study|Disease progression|3|||
33520542|NCT03219333|62906383|FG000|Overall Study|Withdrawal by Subject|8|||
33520543|NCT03219333|62906384|FG001|Overall Study|Withdrawal by Subject|3|||
33520544|NCT03219333|62906383|FG000|Overall Study|Lost to Follow-up|1|||
33520545|NCT03219333|62906384|FG001|Overall Study|Lost to Follow-up|0|||
33520546|NCT03219333|62906383|FG000|Overall Study|Death|94|||
33520547|NCT03219333|62906384|FG001|Overall Study|Death|44|||
33520548|NCT03219333|62906383|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
33520549|NCT03219333|62906384|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
33520550|NCT03168867|62906392|FG000|Overall Study|Withdrawal by Subject|1|||
33520551|NCT03168867|62906393|FG001|Overall Study|Withdrawal by Subject|5|||
33520552|NCT01064622|62906402|FG000|Randomized Phase II|Withdrawal by Subject|2|||
33520553|NCT01064622|62906403|FG001|Randomized Phase II|Withdrawal by Subject|2|||
33520554|NCT01064622|62906402|FG000|Randomized Phase II|Protocol Violation|0|||
33520555|NCT01064622|62906403|FG001|Randomized Phase II|Protocol Violation|1|||
33520556|NCT04163718|62906412|FG000|Overall Study|Study terminated|12|||
33520557|NCT01063764|62906416|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
33520558|NCT01063764|62906416|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
33520559|NCT01063764|62906416|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
33520560|NCT01063764|62906416|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
33520561|NCT01063764|62906416|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
33520562|NCT01063764|62906416|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
33520563|NCT01063764|62906416|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
33520564|NCT03075891|62906426|FG000|Overall Study|Withdrawal by Subject|3|||
33520565|NCT03075891|62906427|FG001|Overall Study|Withdrawal by Subject|6|||
33520566|NCT03075891|62906426|FG000|Overall Study|Lost to Follow-up|1|||
33520567|NCT03075891|62906427|FG001|Overall Study|Lost to Follow-up|0|||
33520568|NCT03075891|62906426|FG000|Overall Study|Pregnancy|3|||
33520569|NCT03075891|62906427|FG001|Overall Study|Pregnancy|1|||
33520570|NCT03075891|62906426|FG000|Overall Study|visits not performed (no time)|1|||
33520571|NCT03075891|62906427|FG001|Overall Study|visits not performed (no time)|0|||
33520572|NCT03075891|62906426|FG000|Overall Study|Drug abuse relapse issue|0|||
33520573|NCT03075891|62906427|FG001|Overall Study|Drug abuse relapse issue|1|||
33520574|NCT03075891|62906426|FG000|Overall Study|Participant requiring study withdrawal|0|||
33520575|NCT03075891|62906427|FG001|Overall Study|Participant requiring study withdrawal|1|||
33520576|NCT03075891|62906426|FG000|Overall Study|Adverse event, non-fatal|1|||
33520577|NCT03075891|62906427|FG001|Overall Study|Adverse event, non-fatal|4|||
33520578|NCT02013167|62906437|FG000|Overall Study|Withdrawal by Subject|15|||
33520579|NCT02013167|62906438|FG001|Overall Study|Withdrawal by Subject|14|||
33520580|NCT02013167|62906437|FG000|Overall Study|Sponsor Decision|1|||
33520581|NCT02013167|62906438|FG001|Overall Study|Sponsor Decision|3|||
33520582|NCT02013167|62906437|FG000|Overall Study|Lost to Follow-up|0|||
33520583|NCT02013167|62906438|FG001|Overall Study|Lost to Follow-up|1|||
33520584|NCT02013167|62906437|FG000|Overall Study|Death|85|||
33520585|NCT02013167|62906438|FG001|Overall Study|Death|160|||
33520586|NCT01063062|62906447|FG000|Overall Study|Patient withdrew consent|0|||
33520587|NCT01063062|62906448|FG001|Overall Study|Patient withdrew consent|1|||
33520588|NCT01063062|62906447|FG000|Overall Study|Adverse Event|2|||
33520589|NCT01063062|62906448|FG001|Overall Study|Adverse Event|4|||
33617305|NCT01519960|63018286|FG000|Overall Study|Withdrawal from the study|26|||
33520590|NCT01063062|62906447|FG000|Overall Study|Protocol Violation|5|||
33520591|NCT01063062|62906448|FG001|Overall Study|Protocol Violation|4|||
33520592|NCT01063062|62906447|FG000|Overall Study|Investigator's request|1|||
33520593|NCT01063062|62906448|FG001|Overall Study|Investigator's request|0|||
33520594|NCT01063062|62906447|FG000|Overall Study|Lost to Follow-up|0|||
33520595|NCT01063062|62906448|FG001|Overall Study|Lost to Follow-up|2|||
33520596|NCT01063062|62906447|FG000|Overall Study|Miscellaneous reason|0|||
33520597|NCT01063062|62906448|FG001|Overall Study|Miscellaneous reason|1|||
33520598|NCT02973048|62906457|FG000|Overall Study|Epidural catheter insertion failure|1|||
33520599|NCT02973048|62906458|FG001|Overall Study|Epidural catheter insertion failure|0|||
33520600|NCT02973048|62906457|FG000|Overall Study|Withdrawal by Subject|0|||
33520601|NCT02973048|62906458|FG001|Overall Study|Withdrawal by Subject|3|||
33520602|NCT02932943|62906466|FG000|Overall Study|Lost to Follow-up|0|||
33520603|NCT02932943|62906467|FG001|Overall Study|Lost to Follow-up|2|||
33520604|NCT02932943|62906466|FG000|Overall Study|Adverse Event|2|||
33520605|NCT02932943|62906467|FG001|Overall Study|Adverse Event|2|||
33520606|NCT02932943|62906466|FG000|Overall Study|Withdrawal by Subject|3|||
33520607|NCT02932943|62906467|FG001|Overall Study|Withdrawal by Subject|3|||
33520608|NCT02972658|62906492|FG000|Overall Study|Adverse Event|0|||
33520609|NCT02972658|62906493|FG001|Overall Study|Adverse Event|3|||
33520610|NCT02972658|62906494|FG002|Overall Study|Adverse Event|0|||
33520611|NCT02972658|62906495|FG003|Overall Study|Adverse Event|2|||
33520612|NCT02972658|62906492|FG000|Overall Study|Other-determined by Investigator|1|||
33520613|NCT02972658|62906493|FG001|Overall Study|Other-determined by Investigator|1|||
33520614|NCT02972658|62906494|FG002|Overall Study|Other-determined by Investigator|0|||
33520615|NCT02972658|62906495|FG003|Overall Study|Other-determined by Investigator|0|||
33520616|NCT02972658|62906492|FG000|Overall Study|Death|0|||
33520617|NCT02972658|62906493|FG001|Overall Study|Death|0|||
33520618|NCT02972658|62906494|FG002|Overall Study|Death|0|||
33520619|NCT02972658|62906495|FG003|Overall Study|Death|1|||
33520620|NCT02972658|62906492|FG000|Overall Study|Lost to Follow-up|0|||
33520621|NCT02972658|62906493|FG001|Overall Study|Lost to Follow-up|1|||
33520622|NCT02972658|62906494|FG002|Overall Study|Lost to Follow-up|1|||
33520623|NCT02972658|62906495|FG003|Overall Study|Lost to Follow-up|2|||
33520624|NCT02972658|62906492|FG000|Overall Study|Progressive Disease|0|||
33520625|NCT02972658|62906493|FG001|Overall Study|Progressive Disease|1|||
33520626|NCT02972658|62906494|FG002|Overall Study|Progressive Disease|0|||
33520627|NCT02972658|62906495|FG003|Overall Study|Progressive Disease|1|||
33520628|NCT02972658|62906492|FG000|Overall Study|Withdrawal by Subject|4|||
33520629|NCT02972658|62906493|FG001|Overall Study|Withdrawal by Subject|4|||
33520630|NCT02972658|62906494|FG002|Overall Study|Withdrawal by Subject|1|||
33520631|NCT02972658|62906495|FG003|Overall Study|Withdrawal by Subject|6|||
33520632|NCT02972658|62906492|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
33520633|NCT02972658|62906493|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
33520634|NCT02972658|62906494|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
33520635|NCT02972658|62906495|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
33520636|NCT02972658|62906492|FG000|Overall Study|Sponsor Decision|70|||
33520637|NCT02972658|62906493|FG001|Overall Study|Sponsor Decision|127|||
33520638|NCT02972658|62906494|FG002|Overall Study|Sponsor Decision|72|||
33520639|NCT02972658|62906495|FG003|Overall Study|Sponsor Decision|119|||
33520640|NCT02853032|62906507|FG000|Overall Study|Adverse Event|4|||
33520641|NCT02853032|62906508|FG001|Overall Study|Adverse Event|0|||
33520642|NCT02853032|62906507|FG000|Overall Study|Withdrawal by Subject|3|||
33520643|NCT02853032|62906508|FG001|Overall Study|Withdrawal by Subject|1|||
33520644|NCT02853032|62906507|FG000|Overall Study|Requested to withdraw from all treatment|2|||
33520645|NCT02853032|62906508|FG001|Overall Study|Requested to withdraw from all treatment|2|||
33520646|NCT02232087|62906516|FG000|Overall Study|Withdrawal by Subject|2|||
33520647|NCT02232087|62906517|FG001|Overall Study|Withdrawal by Subject|0|||
33520648|NCT02232087|62906518|FG002|Overall Study|Withdrawal by Subject|0|||
33520649|NCT02232087|62906519|FG003|Overall Study|Withdrawal by Subject|0|||
33520650|NCT02232087|62906520|FG004|Overall Study|Withdrawal by Subject|0|||
33520651|NCT02232087|62906521|FG005|Overall Study|Withdrawal by Subject|1|||
33520652|NCT02232087|62906516|FG000|Overall Study|poor inhalation technique|0|||
33520653|NCT02232087|62906517|FG001|Overall Study|poor inhalation technique|1|||
33617306|NCT01519960|63018287|FG001|Overall Study|Withdrawal from the study|22|||
33617307|NCT01519960|63018288|FG002|Overall Study|Withdrawal from the study|5|||
33617308|NCT01543204|63018304|FG000|Overall Study|Non-compliance|1|||
33617309|NCT01543204|63018304|FG000|Overall Study|Adverse Event|1|||
33617310|NCT01543204|63018304|FG000|Overall Study|Withdrawal by Subject|4|||
33617311|NCT01543204|63018304|FG000|Overall Study|Requirement for Alternative Therapy|1|||
33617312|NCT01543204|63018304|FG000|Overall Study|Lost to Follow-up|1|||
33455805|NCT04124926|62830243|FG001|Maintenance Phase|Miscellaneous|0|||
33455806|NCT04124926|62830244|FG002|Maintenance Phase|Miscellaneous|1|||
33455807|NCT04124926|62830245|FG003|Maintenance Phase|Miscellaneous|2|||
33455808|NCT04124926|62830246|FG004|Maintenance Phase|Miscellaneous|4|||
33455809|NCT04124926|62830242|FG000|Maintenance Phase|Randomized but not Treated|0|||
33455810|NCT04124926|62830243|FG001|Maintenance Phase|Randomized but not Treated|0|||
33455811|NCT04124926|62830244|FG002|Maintenance Phase|Randomized but not Treated|2|||
33455812|NCT04124926|62830245|FG003|Maintenance Phase|Randomized but not Treated|2|||
33520654|NCT02232087|62906518|FG002|Overall Study|poor inhalation technique|0|||
33455813|NCT04124926|62830246|FG004|Maintenance Phase|Randomized but not Treated|0|||
33455814|NCT04274686|62830258|FG000|Overall Study|Physician Decision|1|||
33520655|NCT02232087|62906519|FG003|Overall Study|poor inhalation technique|0|||
33520656|NCT02232087|62906520|FG004|Overall Study|poor inhalation technique|0|||
33520657|NCT02232087|62906521|FG005|Overall Study|poor inhalation technique|2|||
33520658|NCT02232087|62906516|FG000|Overall Study|protocol stop criteria|0|||
33520659|NCT02232087|62906517|FG001|Overall Study|protocol stop criteria|1|||
33520660|NCT02232087|62906518|FG002|Overall Study|protocol stop criteria|0|||
33520661|NCT02232087|62906519|FG003|Overall Study|protocol stop criteria|1|||
33617313|NCT01488994|63018314|FG000|Overall Study|Withdrawal by Subject|0|||
33520662|NCT02232087|62906520|FG004|Overall Study|protocol stop criteria|0|||
33520663|NCT02232087|62906521|FG005|Overall Study|protocol stop criteria|0|||
33520664|NCT02232087|62906516|FG000|Overall Study|Adverse Event|0|||
33520665|NCT02232087|62906517|FG001|Overall Study|Adverse Event|0|||
33520666|NCT02232087|62906518|FG002|Overall Study|Adverse Event|0|||
33520667|NCT02232087|62906519|FG003|Overall Study|Adverse Event|0|||
33520668|NCT02232087|62906520|FG004|Overall Study|Adverse Event|1|||
33520669|NCT02232087|62906521|FG005|Overall Study|Adverse Event|0|||
33520670|NCT03168425|62906542|FG000|Overall Study|Lost to Follow-up|5|||
33520671|NCT03168425|62906543|FG001|Overall Study|Lost to Follow-up|8|||
33520672|NCT03168425|62906542|FG000|Overall Study|unable to confirm post op opioids|2|||
33520673|NCT03168425|62906543|FG001|Overall Study|unable to confirm post op opioids|3|||
33520674|NCT00004445|62906550|FG000|Overall Study|Physician Decision|2|||
33520675|NCT00004445|62906550|FG000|Overall Study|Withdrawal by Subject|1|||
33520676|NCT02972502|62906560|FG000|Overall Study|Lost to Follow-up|3|||
33520677|NCT02972502|62906561|FG001|Overall Study|Lost to Follow-up|1|||
33520678|NCT02972502|62906560|FG000|Overall Study|Withdrawal by Subject|1|||
33520679|NCT02972502|62906561|FG001|Overall Study|Withdrawal by Subject|1|||
33520680|NCT02971800|62906567|FG000|Overall Study|Protocol Violation|1|||
33520681|NCT02971800|62906567|FG000|Overall Study|Withdrawal by Subject|1|||
33520682|NCT02971800|62906567|FG000|Overall Study|Exclusion criteria prior intervention|1|||
33520683|NCT02971800|62906567|FG000|Overall Study|Number evaluable participant already reached|4|||
33520684|NCT03163667|62906573|FG000|Overall Study|Death|15|||
33520685|NCT03163667|62906574|FG001|Overall Study|Death|27|||
33520686|NCT03163667|62906573|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
33520687|NCT03163667|62906574|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
33520688|NCT03167411|62906582|FG000|Overall Study|Adverse Event|0|||
33520689|NCT03167411|62906583|FG001|Overall Study|Adverse Event|1|||
33520690|NCT01952847|62906593|FG000|Overall Study|Ineligible|1|||
33520691|NCT01952847|62906594|FG001|Overall Study|Ineligible|0|||
33520692|NCT01952847|62906595|FG002|Overall Study|Ineligible|0|||
33520693|NCT01952847|62906596|FG003|Overall Study|Ineligible|0|||
33520694|NCT01952847|62906593|FG000|Overall Study|Lack of Insurance Coverage|0|||
33520695|NCT01952847|62906594|FG001|Overall Study|Lack of Insurance Coverage|1|||
33520696|NCT01952847|62906595|FG002|Overall Study|Lack of Insurance Coverage|0|||
33520697|NCT01952847|62906596|FG003|Overall Study|Lack of Insurance Coverage|0|||
33520698|NCT01952847|62906593|FG000|Overall Study|Withdrawal by Subject|1|||
33520699|NCT01952847|62906594|FG001|Overall Study|Withdrawal by Subject|1|||
33617314|NCT01488994|63018315|FG001|Overall Study|Withdrawal by Subject|1|||
33617315|NCT01508650|63018328|FG000|Overall Study|Lost to Follow-up|0|||
33617316|NCT01508650|63018329|FG001|Overall Study|Lost to Follow-up|3|||
33520700|NCT01952847|62906595|FG002|Overall Study|Withdrawal by Subject|0|||
33520701|NCT01952847|62906596|FG003|Overall Study|Withdrawal by Subject|1|||
33520702|NCT01560585|62906608|FG000|Overall Study|Physician Decision|3|||
33520703|NCT03075501|62906615|FG000|Overall Study|Scheduling difficulties|15|||
33520704|NCT03075501|62906616|FG001|Overall Study|Scheduling difficulties|9|||
33520705|NCT02317991|62906623|FG000|Overall Study|Adverse Event|12|||
33520706|NCT02317991|62906623|FG000|Overall Study|Death|4|||
33520707|NCT02317991|62906623|FG000|Overall Study|Withdrawal by Subject|8|||
33617317|NCT01488448|63018337|FG000|Overall Study|Withdrawal by Subject|3|||
33617318|NCT01488448|63018338|FG001|Overall Study|Withdrawal by Subject|1|||
33617319|NCT01488448|63018337|FG000|Overall Study|Adverse Event|9|||
33617320|NCT01488448|63018338|FG001|Overall Study|Adverse Event|4|||
33617321|NCT01488448|63018337|FG000|Overall Study|Physician Decision|4|||
33617322|NCT01488448|63018338|FG001|Overall Study|Physician Decision|9|||
33520708|NCT02317991|62906623|FG000|Overall Study|Progressive Disease|41|||
33520709|NCT03075267|62906630|FG000|Overall Study|Protocol Violation|1|||
33520710|NCT03075267|62906631|FG001|Overall Study|Protocol Violation|0|||
33520711|NCT03075267|62906632|FG002|Overall Study|Protocol Violation|0|||
33520712|NCT03074331|62906640|FG000|Overall Study|Enrolled but Not Treated|1|||
33520713|NCT03074331|62906640|FG000|Overall Study|Lost to Follow-up|5|||
33520714|NCT03074331|62906640|FG000|Overall Study|Withdrew Consent|1|||
33520715|NCT02260193|62906647|FG000|Overall Study|Lack of Efficacy|0|||
33520716|NCT02260193|62906648|FG001|Overall Study|Lack of Efficacy|1|||
33520717|NCT02260193|62906649|FG002|Overall Study|Lack of Efficacy|6|||
33325177|NCT00952341|62701897|FG000|Cycle 1|Adverse Event|4|||
33520718|NCT02260193|62906647|FG000|Overall Study|Adverse Event|3|||
33520719|NCT02260193|62906648|FG001|Overall Study|Adverse Event|4|||
33520720|NCT02260193|62906649|FG002|Overall Study|Adverse Event|1|||
33520721|NCT02260193|62906647|FG000|Overall Study|Protocol Violation|0|||
33520722|NCT02260193|62906648|FG001|Overall Study|Protocol Violation|4|||
33520723|NCT02260193|62906649|FG002|Overall Study|Protocol Violation|0|||
33520724|NCT02260193|62906647|FG000|Overall Study|Withdrawal by Subject|3|||
33520725|NCT02260193|62906648|FG001|Overall Study|Withdrawal by Subject|0|||
33520726|NCT02260193|62906649|FG002|Overall Study|Withdrawal by Subject|2|||
33617323|NCT01488448|63018337|FG000|Overall Study|Protocol Violation|4|||
33617324|NCT01488448|63018338|FG001|Overall Study|Protocol Violation|3|||
33617325|NCT01518946|63018348|FG000|Open-label Phase|Other|4|||
33520727|NCT02260193|62906647|FG000|Overall Study|Kidney Transplantation|0|||
33520728|NCT02260193|62906648|FG001|Overall Study|Kidney Transplantation|0|||
33520729|NCT02260193|62906649|FG002|Overall Study|Kidney Transplantation|1|||
33520730|NCT02849678|62906659|FG000|Overall Study|Protocol Violation|3|||
33520731|NCT02849678|62906660|FG001|Overall Study|Protocol Violation|6|||
33520732|NCT01596257|62906668|FG000|Overall Study|Inadequate Collection|23|||
33520733|NCT01596257|62906669|FG001|Overall Study|Inadequate Collection|19|||
33520734|NCT04577781|62906679|FG000|Overall Study|Adverse Event|2|||
33520735|NCT04577781|62906680|FG001|Overall Study|Adverse Event|2|||
33520736|NCT04577781|62906679|FG000|Overall Study|Physician Decision|1|||
33520737|NCT04577781|62906680|FG001|Overall Study|Physician Decision|0|||
33520738|NCT02737826|62906687|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
33520739|NCT02737826|62906688|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
33520740|NCT02737826|62906689|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
33520741|NCT03070431|62906716|FG000|Overall Study|Withdrawal by Subject|2|||
33520742|NCT03070431|62906716|FG000|Overall Study|Lost to Follow-up|2|||
33520743|NCT01071395|62906727|FG000|Overall Study|Withdrawal by Subject|2|||
33520744|NCT01071395|62906728|FG001|Overall Study|Withdrawal by Subject|1|||
33520745|NCT01071395|62906727|FG000|Overall Study|Adverse Event|3|||
33520746|NCT01071395|62906728|FG001|Overall Study|Adverse Event|1|||
33520747|NCT02970942|62906738|FG000|Overall Study|Death|0|||
33520748|NCT02970942|62906739|FG001|Overall Study|Death|1|||
33520749|NCT02970942|62906740|FG002|Overall Study|Death|0|||
33520750|NCT02970942|62906741|FG003|Overall Study|Death|0|||
33520751|NCT02970942|62906738|FG000|Overall Study|Lost to Follow-up|1|||
33520752|NCT02970942|62906739|FG001|Overall Study|Lost to Follow-up|0|||
33520753|NCT02970942|62906740|FG002|Overall Study|Lost to Follow-up|2|||
33520754|NCT02970942|62906741|FG003|Overall Study|Lost to Follow-up|1|||
33520755|NCT02970942|62906738|FG000|Overall Study|Withdrawal by Subject|3|||
33520756|NCT02970942|62906739|FG001|Overall Study|Withdrawal by Subject|5|||
33520757|NCT02970942|62906740|FG002|Overall Study|Withdrawal by Subject|3|||
33520758|NCT02970942|62906741|FG003|Overall Study|Withdrawal by Subject|2|||
33520759|NCT03073005|62906755|FG000|Overall Study|Death|6|||
33520760|NCT03073005|62906756|FG001|Overall Study|Death|0|||
33520761|NCT03073005|62906757|FG002|Overall Study|Death|7|||
33520762|NCT03073005|62906758|FG003|Overall Study|Death|0|||
33520763|NCT03073005|62906755|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
33520764|NCT03073005|62906756|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
33617326|NCT01518946|63018349|FG001|Open-label Phase|Other|0|||
33617327|NCT01518946|63018350|FG002|Open-label Phase|Other|0|||
33617328|NCT01518946|63018348|FG000|Randomized Phase (First Intervention)|Other|0|||
33520765|NCT03073005|62906757|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
33520766|NCT03073005|62906758|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
33520767|NCT03073005|62906755|FG000|Overall Study|Lost to Follow-up|2|||
33520768|NCT03073005|62906756|FG001|Overall Study|Lost to Follow-up|2|||
33520769|NCT03073005|62906757|FG002|Overall Study|Lost to Follow-up|1|||
33520770|NCT03073005|62906758|FG003|Overall Study|Lost to Follow-up|2|||
33520771|NCT03073005|62906755|FG000|Overall Study|Withdrawal by Subject|0|||
33520772|NCT03073005|62906756|FG001|Overall Study|Withdrawal by Subject|4|||
33520773|NCT03073005|62906757|FG002|Overall Study|Withdrawal by Subject|4|||
33520774|NCT03073005|62906758|FG003|Overall Study|Withdrawal by Subject|4|||
33520775|NCT02849171|62906771|FG000|Overall Study|Withdrawal by Subject|1|||
33520776|NCT02849171|62906771|FG000|Overall Study|Not treated|1|||
33520777|NCT02848664|62906784|FG000|Overall Study|Withdrawal by Subject|2|||
33520778|NCT02848664|62906784|FG000|Overall Study|Adverse Event|1|||
33520779|NCT02848664|62906784|FG000|Overall Study|no assistance for device training|1|||
33520780|NCT02969382|62906794|FG000|Overall Study|Adverse Event|8|||
33520781|NCT02969382|62906795|FG001|Overall Study|Adverse Event|10|||
33520782|NCT02969382|62906794|FG000|Overall Study|Lack of Efficacy|4|||
33520783|NCT02969382|62906795|FG001|Overall Study|Lack of Efficacy|5|||
33520784|NCT02969382|62906794|FG000|Overall Study|Death|0|||
33520785|NCT02969382|62906795|FG001|Overall Study|Death|1|||
33617329|NCT01518946|63018349|FG001|Randomized Phase (First Intervention)|Other|1|||
33617330|NCT01518946|63018350|FG002|Randomized Phase (First Intervention)|Other|0|||
33617331|NCT01488370|63018360|FG000|Overall Study|Protocol Violation|0|||
33617332|NCT01488370|63018361|FG001|Overall Study|Protocol Violation|1|||
33520786|NCT02969382|62906794|FG000|Overall Study|PROTOCOL DEVIATION|0|||
33520787|NCT02969382|62906795|FG001|Overall Study|PROTOCOL DEVIATION|1|||
33617333|NCT01488370|63018362|FG002|Overall Study|Protocol Violation|1|||
33520788|NCT02969382|62906794|FG000|Overall Study|Withdrawal by Subject|14|||
33520789|NCT02969382|62906795|FG001|Overall Study|Withdrawal by Subject|9|||
33520790|NCT01989104|62906806|FG000|Overall Study|Withdrawal by Subject|3|||
33520791|NCT01989104|62906807|FG001|Overall Study|Withdrawal by Subject|0|||
33520792|NCT01989104|62906808|FG002|Overall Study|Withdrawal by Subject|0|||
33617334|NCT01518322|63018370|FG000|Overall Study|FeNO measurement was missing|13|||
33520793|NCT01989104|62906809|FG003|Overall Study|Withdrawal by Subject|0|||
33520794|NCT01989104|62906810|FG004|Overall Study|Withdrawal by Subject|0|||
33520795|NCT02903238|62906822|FG000|Overall Study|Lost to Follow-up|4|||
33520796|NCT02847260|62906827|FG000|Overall Study|Adverse Event|3|||
33520797|NCT02847260|62906827|FG000|Overall Study|Withdrawal by Subject|2|||
33520798|NCT02847260|62906827|FG000|Overall Study|Clinical Deterioration|1|||
33520799|NCT02847260|62906827|FG000|Overall Study|Physician Decision|1|||
33520800|NCT02968563|62906833|FG000|Overall Study|Adverse Event|0|||
33520801|NCT02968563|62906834|FG001|Overall Study|Adverse Event|6|||
33520802|NCT02968563|62906833|FG000|Overall Study|Death|1|||
33520803|NCT02968563|62906834|FG001|Overall Study|Death|1|||
33520804|NCT02968563|62906833|FG000|Overall Study|Lost to Follow-up|0|||
33520805|NCT02968563|62906834|FG001|Overall Study|Lost to Follow-up|1|||
33520806|NCT02904096|62906842|FG000|Overall Study|Adverse Event|1|||
33520807|NCT02904096|62906843|FG001|Overall Study|Adverse Event|0|||
33520808|NCT02904096|62906842|FG000|Overall Study|Withdrawal by Subject|4|||
33520809|NCT02904096|62906843|FG001|Overall Study|Withdrawal by Subject|3|||
33520810|NCT02904096|62906842|FG000|Overall Study|Lost to Follow-up|10|||
33520811|NCT02904096|62906843|FG001|Overall Study|Lost to Follow-up|17|||
33520812|NCT02904096|62906842|FG000|Overall Study|Non-compliant|3|||
33520813|NCT02904096|62906843|FG001|Overall Study|Non-compliant|1|||
33520814|NCT02904096|62906842|FG000|Overall Study|Sponsor instructed|1|||
33520815|NCT02904096|62906843|FG001|Overall Study|Sponsor instructed|0|||
33520816|NCT03161405|62906853|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
33520817|NCT01813929|62906862|FG000|Overall Study|Withdrawal by Subject|0|||
33520818|NCT01813929|62906863|FG001|Overall Study|Withdrawal by Subject|1|||
33520819|NCT02901054|62906873|FG000|Overall Study|Physician Decision|1|||
33520820|NCT02901054|62906873|FG000|Overall Study|Withdrawal by Subject|3|||
33520821|NCT03068715|62906879|FG000|Overall Study|No longer met inclusion criteria|1|||
33520822|NCT03068715|62906880|FG001|Overall Study|No longer met inclusion criteria|0|||
33520823|NCT02966340|62906888|FG000|Overall Study|Adverse Event|0|||
33520824|NCT02966340|62906889|FG001|Overall Study|Adverse Event|1|||
33520825|NCT02966340|62906888|FG000|Overall Study|Lost to Follow-up|0|||
33520826|NCT02966340|62906889|FG001|Overall Study|Lost to Follow-up|1|||
33520827|NCT02966340|62906888|FG000|Overall Study|Withdrawal by Subject|1|||
33520828|NCT02966340|62906889|FG001|Overall Study|Withdrawal by Subject|0|||
33520829|NCT02966340|62906888|FG000|Overall Study|data acquisition error|1|||
33520830|NCT02966340|62906889|FG001|Overall Study|data acquisition error|0|||
33520831|NCT02966340|62906888|FG000|Overall Study|startle non-responder|1|||
33520832|NCT02966340|62906889|FG001|Overall Study|startle non-responder|1|||
33520833|NCT03067311|62906897|FG000|Overall Study|Lost to Follow-up|1|||
33520834|NCT03067311|62906898|FG001|Overall Study|Lost to Follow-up|1|||
33520835|NCT03067311|62906897|FG000|Overall Study|Moved away|1|||
33520836|NCT03067311|62906898|FG001|Overall Study|Moved away|1|||
33520837|NCT04380519|62906907|FG000|Overall Study|Withdrawal by Subject|4|||
33520838|NCT04380519|62906908|FG001|Overall Study|Withdrawal by Subject|0|||
33520839|NCT04380519|62906909|FG002|Overall Study|Withdrawal by Subject|1|||
33520840|NCT04380519|62906907|FG000|Overall Study|Death|14|||
33520841|NCT04380519|62906908|FG001|Overall Study|Death|9|||
33520842|NCT04380519|62906909|FG002|Overall Study|Death|6|||
33520843|NCT04380519|62906907|FG000|Overall Study|Adverse Event|0|||
33520844|NCT04380519|62906908|FG001|Overall Study|Adverse Event|1|||
33520845|NCT04380519|62906909|FG002|Overall Study|Adverse Event|0|||
33520846|NCT04380519|62906907|FG000|Overall Study|relatives' decision|0|||
33520847|NCT04380519|62906908|FG001|Overall Study|relatives' decision|1|||
33520848|NCT04380519|62906909|FG002|Overall Study|relatives' decision|0|||
33520849|NCT02847182|62906919|FG000|Overall Study|Withdrawal by Subject|0|||
33520850|NCT02847182|62906920|FG001|Overall Study|Withdrawal by Subject|1|||
33520851|NCT02846558|62906936|FG000|Overall Study|Adverse Event|1|||
33520852|NCT02846558|62906937|FG001|Overall Study|Adverse Event|0|||
33520853|NCT02846558|62906938|FG002|Overall Study|Adverse Event|0|||
33520854|NCT02846558|62906939|FG003|Overall Study|Adverse Event|0|||
33520855|NCT02846558|62906936|FG000|Overall Study|Withdrawal by Subject|5|||
33520856|NCT02846558|62906937|FG001|Overall Study|Withdrawal by Subject|4|||
33520857|NCT02846558|62906938|FG002|Overall Study|Withdrawal by Subject|2|||
33617335|NCT01507246|63018381|FG000|Overall Study|Required different surgical procedures|2|||
33617336|NCT01507246|63018382|FG001|Overall Study|Required different surgical procedures|1|||
33617337|NCT01507090|63018391|FG000|Overall Study|incomplete dataset|18|||
33617338|NCT01464346|63018405|FG000|Overall Study|Withdrawal by Subject|0|||
33617339|NCT01464346|63018406|FG001|Overall Study|Withdrawal by Subject|0|||
33617340|NCT01464346|63018407|FG002|Overall Study|Withdrawal by Subject|1|||
33520858|NCT02846558|62906939|FG003|Overall Study|Withdrawal by Subject|2|||
33520859|NCT02846558|62906936|FG000|Overall Study|Lost to Follow-up|2|||
33520860|NCT02846558|62906937|FG001|Overall Study|Lost to Follow-up|0|||
33520861|NCT02846558|62906938|FG002|Overall Study|Lost to Follow-up|0|||
33617341|NCT01487200|63018434|FG000|Overall Study|Withdrawal by Subject|0|||
33520862|NCT02846558|62906939|FG003|Overall Study|Lost to Follow-up|0|||
33520863|NCT04362813|62906958|FG000|Overall Study|Death|12|||
33520864|NCT04362813|62906959|FG001|Overall Study|Death|16|||
33617342|NCT01487200|63018435|FG001|Overall Study|Withdrawal by Subject|1|||
33520865|NCT04362813|62906958|FG000|Overall Study|Withdrawal by Subject|3|||
33520866|NCT04362813|62906959|FG001|Overall Study|Withdrawal by Subject|1|||
33520867|NCT04362813|62906958|FG000|Overall Study|Protocol Violation|0|||
33520868|NCT04362813|62906959|FG001|Overall Study|Protocol Violation|3|||
33520869|NCT04362813|62906958|FG000|Overall Study|Lost to Follow-up|1|||
33520870|NCT04362813|62906959|FG001|Overall Study|Lost to Follow-up|1|||
33520871|NCT04362813|62906958|FG000|Overall Study|Enrolled but did not receive treatment|2|||
33520872|NCT04362813|62906959|FG001|Overall Study|Enrolled but did not receive treatment|4|||
33520873|NCT02966028|62906968|FG000|Overall Study|Adverse Event|7|||
33520874|NCT02966028|62906969|FG001|Overall Study|Adverse Event|13|||
33520875|NCT02966028|62906970|FG002|Overall Study|Adverse Event|10|||
33520876|NCT02966028|62906968|FG000|Overall Study|Physician Decision|1|||
33520877|NCT02966028|62906969|FG001|Overall Study|Physician Decision|0|||
33520878|NCT02966028|62906970|FG002|Overall Study|Physician Decision|2|||
33520879|NCT02966028|62906968|FG000|Overall Study|Withdrawal by Subject|7|||
33520880|NCT02966028|62906969|FG001|Overall Study|Withdrawal by Subject|5|||
33520881|NCT02966028|62906970|FG002|Overall Study|Withdrawal by Subject|5|||
33520882|NCT02966028|62906968|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
33520883|NCT02966028|62906969|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
33520884|NCT02966028|62906970|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
33520885|NCT02925741|62906984|FG000|Overall Study|Withdrawal by Subject|11|||
33520886|NCT02925741|62906985|FG001|Overall Study|Withdrawal by Subject|0|||
33520887|NCT02964312|62906994|FG000|Overall Study|Lost to Follow-up|28|||
33520888|NCT02964312|62906994|FG000|Overall Study|Withdrawal by Subject|11|||
33520889|NCT02964312|62906994|FG000|Overall Study|Lack of Efficacy|10|||
33520890|NCT02964312|62906994|FG000|Overall Study|Did not consent to long-term FU|14|||
33520891|NCT02964312|62906994|FG000|Overall Study|Death|1|||
33520892|NCT02899962|62907018|FG000|Open-label Phase|Adverse Event|2|||
33520893|NCT02899962|62907019|FG001|Open-label Phase|Adverse Event|0|||
33520894|NCT02899962|62907020|FG002|Open-label Phase|Adverse Event|0|||
33520895|NCT02899962|62907018|FG000|Open-label Phase|Lost to Follow-up|9|||
33520896|NCT02899962|62907019|FG001|Open-label Phase|Lost to Follow-up|0|||
33520897|NCT02899962|62907020|FG002|Open-label Phase|Lost to Follow-up|0|||
33520898|NCT02899962|62907018|FG000|Open-label Phase|Other reasons|9|||
33520899|NCT02899962|62907019|FG001|Open-label Phase|Other reasons|0|||
33520900|NCT02899962|62907020|FG002|Open-label Phase|Other reasons|0|||
33520901|NCT02899962|62907018|FG000|Open-label Phase|Withdrawal by Subject|7|||
33520902|NCT02899962|62907019|FG001|Open-label Phase|Withdrawal by Subject|0|||
33520903|NCT02899962|62907020|FG002|Open-label Phase|Withdrawal by Subject|0|||
33520904|NCT02899962|62907018|FG000|Maintenance Phase|Adverse Event|0|||
33520905|NCT02899962|62907019|FG001|Maintenance Phase|Adverse Event|2|||
33520906|NCT02899962|62907020|FG002|Maintenance Phase|Adverse Event|1|||
33520907|NCT02899962|62907018|FG000|Maintenance Phase|Death|0|||
33520908|NCT02899962|62907019|FG001|Maintenance Phase|Death|0|||
33520909|NCT02899962|62907020|FG002|Maintenance Phase|Death|1|||
33520910|NCT02899962|62907018|FG000|Maintenance Phase|Lack of Efficacy|0|||
33520911|NCT02899962|62907019|FG001|Maintenance Phase|Lack of Efficacy|20|||
33520912|NCT02899962|62907020|FG002|Maintenance Phase|Lack of Efficacy|16|||
33520913|NCT02899962|62907018|FG000|Maintenance Phase|Lost to Follow-up|0|||
33520914|NCT02899962|62907019|FG001|Maintenance Phase|Lost to Follow-up|12|||
33520915|NCT02899962|62907020|FG002|Maintenance Phase|Lost to Follow-up|14|||
33520916|NCT02899962|62907018|FG000|Maintenance Phase|Other reasons|0|||
33520917|NCT02899962|62907019|FG001|Maintenance Phase|Other reasons|9|||
33520918|NCT02899962|62907020|FG002|Maintenance Phase|Other reasons|13|||
33520919|NCT02899962|62907018|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
33520920|NCT02899962|62907019|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
33520921|NCT02899962|62907020|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
33520922|NCT02899962|62907018|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
33520923|NCT02899962|62907019|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
33520924|NCT02899962|62907020|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
33520925|NCT02899962|62907018|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33520926|NCT02899962|62907019|FG001|Maintenance Phase|Withdrawal by Subject|30|||
33520927|NCT02899962|62907020|FG002|Maintenance Phase|Withdrawal by Subject|36|||
33520928|NCT02899728|62907029|FG000|Overall Study|Withdrawal by Subject|1|||
33520929|NCT02899728|62907030|FG001|Overall Study|Withdrawal by Subject|1|||
33520930|NCT02899338|62907038|FG000|Overall Study|Adverse Event|1|||
33520931|NCT02899338|62907039|FG001|Overall Study|Adverse Event|2|||
33520932|NCT02899338|62907038|FG000|Overall Study|Withdrawal by Subject|2|||
33520933|NCT02899338|62907039|FG001|Overall Study|Withdrawal by Subject|0|||
33520934|NCT03066609|62907048|FG000|INDUCTION|Pregnancy|0|||
33520935|NCT03066609|62907049|FG001|INDUCTION|Pregnancy|0|||
33520936|NCT03066609|62907050|FG002|INDUCTION|Pregnancy|1|||
33520937|NCT03066609|62907051|FG003|INDUCTION|Pregnancy|0|||
33520938|NCT03066609|62907048|FG000|INDUCTION|Lack of Efficacy|0|||
33520939|NCT03066609|62907049|FG001|INDUCTION|Lack of Efficacy|0|||
33520940|NCT03066609|62907050|FG002|INDUCTION|Lack of Efficacy|1|||
33520941|NCT03066609|62907051|FG003|INDUCTION|Lack of Efficacy|0|||
33520942|NCT03066609|62907048|FG000|INDUCTION|Adverse Event|2|||
33520943|NCT03066609|62907049|FG001|INDUCTION|Adverse Event|2|||
33520944|NCT03066609|62907050|FG002|INDUCTION|Adverse Event|0|||
33520945|NCT03066609|62907051|FG003|INDUCTION|Adverse Event|0|||
33520946|NCT03066609|62907048|FG000|MAINTENANCE|Adverse Event|0|||
33520947|NCT03066609|62907049|FG001|MAINTENANCE|Adverse Event|0|||
33520948|NCT03066609|62907050|FG002|MAINTENANCE|Adverse Event|0|||
33520949|NCT03066609|62907051|FG003|MAINTENANCE|Adverse Event|1|||
33520950|NCT03066609|62907048|FG000|MAINTENANCE|Withdrawal by Subject|4|||
33520951|NCT03066609|62907049|FG001|MAINTENANCE|Withdrawal by Subject|2|||
33520952|NCT03066609|62907050|FG002|MAINTENANCE|Withdrawal by Subject|1|||
33520953|NCT03066609|62907051|FG003|MAINTENANCE|Withdrawal by Subject|1|||
33520954|NCT03066609|62907048|FG000|MAINTENANCE|Lost to Follow-up|0|||
33520955|NCT03066609|62907049|FG001|MAINTENANCE|Lost to Follow-up|1|||
33520956|NCT03066609|62907050|FG002|MAINTENANCE|Lost to Follow-up|1|||
33520957|NCT03066609|62907051|FG003|MAINTENANCE|Lost to Follow-up|0|||
33520958|NCT03066609|62907048|FG000|MAINTENANCE|Pregnancy|1|||
33520959|NCT03066609|62907049|FG001|MAINTENANCE|Pregnancy|0|||
33520960|NCT03066609|62907050|FG002|MAINTENANCE|Pregnancy|0|||
33520961|NCT03066609|62907051|FG003|MAINTENANCE|Pregnancy|0|||
33520962|NCT03066609|62907048|FG000|MAINTENANCE|Lack of Efficacy|2|||
33520963|NCT03066609|62907049|FG001|MAINTENANCE|Lack of Efficacy|1|||
33520964|NCT03066609|62907050|FG002|MAINTENANCE|Lack of Efficacy|0|||
33520965|NCT03066609|62907051|FG003|MAINTENANCE|Lack of Efficacy|1|||
33520966|NCT03066609|62907048|FG000|OVERALL STUDY|Adverse Event|2|||
33520967|NCT03066609|62907049|FG001|OVERALL STUDY|Adverse Event|2|||
33520968|NCT03066609|62907050|FG002|OVERALL STUDY|Adverse Event|0|||
33520969|NCT03066609|62907051|FG003|OVERALL STUDY|Adverse Event|1|||
33455815|NCT04274686|62830259|FG001|Overall Study|Physician Decision|0|||
33455816|NCT04113694|62830267|FG000|Overall Study|Adverse Event|2|||
33455817|NCT04113694|62830267|FG000|Overall Study|Lost to Follow-up|2|||
33520970|NCT03066609|62907048|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
33520971|NCT03066609|62907049|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
33520972|NCT03066609|62907050|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
33520973|NCT03066609|62907051|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
33520974|NCT03066609|62907048|FG000|OVERALL STUDY|Lost to Follow-up|1|||
33520975|NCT03066609|62907049|FG001|OVERALL STUDY|Lost to Follow-up|1|||
33520976|NCT03066609|62907050|FG002|OVERALL STUDY|Lost to Follow-up|1|||
33520977|NCT03066609|62907051|FG003|OVERALL STUDY|Lost to Follow-up|1|||
33520978|NCT03066609|62907048|FG000|OVERALL STUDY|Pregnancy|1|||
33520979|NCT03066609|62907049|FG001|OVERALL STUDY|Pregnancy|0|||
33520980|NCT03066609|62907050|FG002|OVERALL STUDY|Pregnancy|1|||
33520981|NCT03066609|62907051|FG003|OVERALL STUDY|Pregnancy|0|||
33520982|NCT03066609|62907048|FG000|OVERALL STUDY|Lack of Efficacy|2|||
33520983|NCT03066609|62907049|FG001|OVERALL STUDY|Lack of Efficacy|1|||
33520984|NCT03066609|62907050|FG002|OVERALL STUDY|Lack of Efficacy|1|||
33455818|NCT04113694|62830267|FG000|Overall Study|Withdrawal by Subject|6|||
33455819|NCT04113694|62830267|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
33455820|NCT04105972|62830276|FG000|Overall Study|Adverse Event|2|||
33455821|NCT04105972|62830277|FG001|Overall Study|Adverse Event|1|||
33455822|NCT04102540|62830283|FG000|Overall Study|Withdrawn by PI|2|||
33455823|NCT04102540|62830283|FG000|Overall Study|Lost to Follow-up|6|||
33455824|NCT00124982|62830289|FG000|Short-term Period|Death|1|||
33455825|NCT00124982|62830290|FG001|Short-term Period|Death|1|||
33520985|NCT03066609|62907051|FG003|OVERALL STUDY|Lack of Efficacy|1|||
33520986|NCT03066609|62907048|FG000|OVERALL STUDY|discontinued follow up|0|||
33520987|NCT03066609|62907049|FG001|OVERALL STUDY|discontinued follow up|2|||
33520988|NCT03066609|62907050|FG002|OVERALL STUDY|discontinued follow up|0|||
33520989|NCT03066609|62907051|FG003|OVERALL STUDY|discontinued follow up|0|||
33520990|NCT02964234|62907068|FG000|Overall Study|Lost to Follow-up|22|||
33520991|NCT02964234|62907069|FG001|Overall Study|Lost to Follow-up|13|||
33520992|NCT01345188|62907075|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
33520993|NCT01345188|62907075|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
33520994|NCT03852459|62907084|FG000|Overall Study|Adverse Event|2|||
33520995|NCT03852459|62907085|FG001|Overall Study|Adverse Event|2|||
33520996|NCT03852459|62907084|FG000|Overall Study|Withdrawal by Subject|1|||
33520997|NCT03852459|62907085|FG001|Overall Study|Withdrawal by Subject|1|||
33520998|NCT02896296|62907091|FG000|Overall Study|Adverse Event|1|||
33520999|NCT02896296|62907091|FG000|Overall Study|Lost to Follow-up|19|||
33521000|NCT02896296|62907091|FG000|Overall Study|Pregnancy|1|||
33521001|NCT02896296|62907091|FG000|Overall Study|Physician Decision|2|||
33521002|NCT02896296|62907091|FG000|Overall Study|Withdrawal by Subject|10|||
33521003|NCT02896296|62907091|FG000|Overall Study|Site closing|7|||
33521004|NCT02896296|62907091|FG000|Overall Study|Incarceration|1|||
33521005|NCT02896296|62907091|FG000|Overall Study|Relocation|1|||
33521006|NCT03740919|62907098|FG000|Lead-in Period|Lost to Follow-up|1|||
33521007|NCT03740919|62907099|FG001|Lead-in Period|Lost to Follow-up|0|||
33521008|NCT03740919|62907100|FG002|Lead-in Period|Lost to Follow-up|0|||
33521009|NCT03740919|62907101|FG003|Lead-in Period|Lost to Follow-up|0|||
33521010|NCT03740919|62907098|FG000|Lead-in Period|Physician Decision|2|||
33521011|NCT03740919|62907099|FG001|Lead-in Period|Physician Decision|0|||
33521012|NCT03740919|62907100|FG002|Lead-in Period|Physician Decision|0|||
33521013|NCT03740919|62907101|FG003|Lead-in Period|Physician Decision|0|||
33521014|NCT03740919|62907098|FG000|Lead-in Period|Protocol Violation|1|||
33521015|NCT03740919|62907099|FG001|Lead-in Period|Protocol Violation|0|||
33521016|NCT03740919|62907100|FG002|Lead-in Period|Protocol Violation|0|||
33521017|NCT03740919|62907101|FG003|Lead-in Period|Protocol Violation|0|||
33521018|NCT03740919|62907098|FG000|Lead-in Period|Withdrawal by Subject|10|||
33521019|NCT03740919|62907099|FG001|Lead-in Period|Withdrawal by Subject|0|||
33521020|NCT03740919|62907100|FG002|Lead-in Period|Withdrawal by Subject|0|||
33521021|NCT03740919|62907101|FG003|Lead-in Period|Withdrawal by Subject|0|||
33521022|NCT03740919|62907098|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
33521023|NCT03740919|62907099|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
33521024|NCT03740919|62907100|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
33521025|NCT03740919|62907101|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
33521026|NCT03740919|62907098|FG000|Lead-in Period|Study Task Too Burdensome|1|||
33521027|NCT03740919|62907099|FG001|Lead-in Period|Study Task Too Burdensome|0|||
33521028|NCT03740919|62907100|FG002|Lead-in Period|Study Task Too Burdensome|0|||
33521029|NCT03740919|62907101|FG003|Lead-in Period|Study Task Too Burdensome|0|||
33521030|NCT03740919|62907098|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
33521031|NCT03740919|62907099|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
33521032|NCT03740919|62907100|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
33521033|NCT03740919|62907101|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
33521034|NCT03740919|62907098|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
33521035|NCT03740919|62907099|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
33521036|NCT03740919|62907100|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
33521037|NCT03740919|62907101|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
33521038|NCT03740919|62907098|FG000|Treatment Period|Adverse Event|0|||
33521039|NCT03740919|62907099|FG001|Treatment Period|Adverse Event|0|||
33521040|NCT03740919|62907100|FG002|Treatment Period|Adverse Event|2|||
33521041|NCT03740919|62907101|FG003|Treatment Period|Adverse Event|0|||
33521042|NCT03740919|62907098|FG000|Treatment Period|Protocol Violation|0|||
33521043|NCT03740919|62907099|FG001|Treatment Period|Protocol Violation|1|||
33521044|NCT03740919|62907100|FG002|Treatment Period|Protocol Violation|0|||
33521045|NCT03740919|62907101|FG003|Treatment Period|Protocol Violation|0|||
33521046|NCT03740919|62907098|FG000|Treatment Period|Withdrawal by Subject|0|||
33521047|NCT03740919|62907099|FG001|Treatment Period|Withdrawal by Subject|7|||
33521048|NCT03740919|62907100|FG002|Treatment Period|Withdrawal by Subject|6|||
33521049|NCT03740919|62907101|FG003|Treatment Period|Withdrawal by Subject|2|||
33521050|NCT03740919|62907098|FG000|Treatment Period|Terminated by Sponsor|0|||
33521051|NCT03740919|62907099|FG001|Treatment Period|Terminated by Sponsor|1|||
33521052|NCT03740919|62907100|FG002|Treatment Period|Terminated by Sponsor|0|||
33521053|NCT03740919|62907101|FG003|Treatment Period|Terminated by Sponsor|0|||
33521054|NCT03740919|62907098|FG000|Treatment Period|Issue with Insulin Pump|0|||
33521055|NCT03740919|62907099|FG001|Treatment Period|Issue with Insulin Pump|1|||
33521056|NCT03740919|62907100|FG002|Treatment Period|Issue with Insulin Pump|0|||
33521057|NCT03740919|62907101|FG003|Treatment Period|Issue with Insulin Pump|0|||
33521058|NCT03740919|62907098|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
33521059|NCT03740919|62907099|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
33521060|NCT03740919|62907100|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
33521061|NCT03740919|62907101|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
33521062|NCT03740919|62907098|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
33521063|NCT03740919|62907099|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
33521064|NCT03740919|62907100|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
33521065|NCT03740919|62907101|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
33521066|NCT03740919|62907098|FG000|Treatment Period|Not Completing Diary|0|||
33521067|NCT03740919|62907099|FG001|Treatment Period|Not Completing Diary|0|||
33521068|NCT03740919|62907100|FG002|Treatment Period|Not Completing Diary|1|||
33521069|NCT03740919|62907101|FG003|Treatment Period|Not Completing Diary|0|||
33521070|NCT03740919|62907098|FG000|Treatment Period|Insulin Painful to Participant|0|||
33521071|NCT03740919|62907099|FG001|Treatment Period|Insulin Painful to Participant|0|||
33521072|NCT03740919|62907100|FG002|Treatment Period|Insulin Painful to Participant|1|||
33521073|NCT03740919|62907101|FG003|Treatment Period|Insulin Painful to Participant|0|||
33521074|NCT01335685|62907116|FG000|Overall Study|Study Terminated by Sponsor|2|||
33521075|NCT01335685|62907117|FG001|Overall Study|Study Terminated by Sponsor|1|||
33521076|NCT01335685|62907118|FG002|Overall Study|Study Terminated by Sponsor|1|||
33521077|NCT01335685|62907119|FG003|Overall Study|Study Terminated by Sponsor|10|||
33521078|NCT01335685|62907120|FG004|Overall Study|Study Terminated by Sponsor|0|||
33521079|NCT01335685|62907121|FG005|Overall Study|Study Terminated by Sponsor|4|||
33521080|NCT01335685|62907122|FG006|Overall Study|Study Terminated by Sponsor|2|||
33521081|NCT01335685|62907123|FG007|Overall Study|Study Terminated by Sponsor|3|||
33521082|NCT01335685|62907116|FG000|Overall Study|Withdrawal by Subject|1|||
33521083|NCT01335685|62907117|FG001|Overall Study|Withdrawal by Subject|0|||
33521084|NCT01335685|62907118|FG002|Overall Study|Withdrawal by Subject|0|||
33521085|NCT01335685|62907119|FG003|Overall Study|Withdrawal by Subject|1|||
33521086|NCT01335685|62907120|FG004|Overall Study|Withdrawal by Subject|0|||
33521087|NCT01335685|62907121|FG005|Overall Study|Withdrawal by Subject|0|||
33521088|NCT01335685|62907122|FG006|Overall Study|Withdrawal by Subject|0|||
33521089|NCT01335685|62907123|FG007|Overall Study|Withdrawal by Subject|0|||
33521090|NCT01335685|62907116|FG000|Overall Study|Reason not Specified|0|||
33521091|NCT01335685|62907117|FG001|Overall Study|Reason not Specified|0|||
33521092|NCT01335685|62907118|FG002|Overall Study|Reason not Specified|1|||
33521093|NCT01335685|62907119|FG003|Overall Study|Reason not Specified|0|||
33521094|NCT01335685|62907120|FG004|Overall Study|Reason not Specified|0|||
33521095|NCT01335685|62907121|FG005|Overall Study|Reason not Specified|1|||
33521096|NCT01335685|62907122|FG006|Overall Study|Reason not Specified|0|||
33521097|NCT01335685|62907123|FG007|Overall Study|Reason not Specified|0|||
33521098|NCT02926209|62907146|FG000|Study Cohort|Poor Bowel Preparation|1|||
33521099|NCT02926209|62907147|FG001|Study Cohort|Poor Bowel Preparation|0|||
33521100|NCT03066999|62907156|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
33521101|NCT03066999|62907157|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
33521102|NCT02963922|62907171|FG000|Overall Study|Adverse Event|15|||
33521103|NCT02963922|62907172|FG001|Overall Study|Adverse Event|6|||
33521104|NCT02963922|62907171|FG000|Overall Study|Protocol deviation|6|||
33521105|NCT02963922|62907172|FG001|Overall Study|Protocol deviation|6|||
33521106|NCT02963922|62907171|FG000|Overall Study|Lack of Efficacy|1|||
33521107|NCT02963922|62907172|FG001|Overall Study|Lack of Efficacy|1|||
33521108|NCT02963922|62907171|FG000|Overall Study|Lost to Follow-up|2|||
33521109|NCT02963922|62907172|FG001|Overall Study|Lost to Follow-up|3|||
33521110|NCT02963922|62907171|FG000|Overall Study|Other|8|||
33521111|NCT02963922|62907172|FG001|Overall Study|Other|14|||
33521112|NCT02881567|62907178|FG000|Overall Study|Adverse Event|1|||
33521113|NCT02881567|62907178|FG000|Overall Study|Lost to Follow-up|3|||
33521114|NCT02881567|62907178|FG000|Overall Study|Consent withdrawn|1|||
33617343|NCT01487200|63018436|FG002|Overall Study|Withdrawal by Subject|0|||
33521115|NCT02881567|62907178|FG000|Overall Study|Investigator decision|1|||
33521116|NCT02881567|62907178|FG000|Overall Study|Study terminated by sponsor|9|||
33521117|NCT02881567|62907178|FG000|Overall Study|Reason not Specified|3|||
33521118|NCT02962674|62907182|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
33521119|NCT02962908|62907192|FG000|Overall Study|Lost to Follow-up|0|||
33521120|NCT02962908|62907193|FG001|Overall Study|Lost to Follow-up|3|||
33521121|NCT02962908|62907194|FG002|Overall Study|Lost to Follow-up|0|||
33521122|NCT02962908|62907195|FG003|Overall Study|Lost to Follow-up|1|||
33521123|NCT02962908|62907192|FG000|Overall Study|Withdrawal by Subject|0|||
33521124|NCT02962908|62907193|FG001|Overall Study|Withdrawal by Subject|3|||
33521125|NCT02962908|62907194|FG002|Overall Study|Withdrawal by Subject|0|||
33521126|NCT02962908|62907195|FG003|Overall Study|Withdrawal by Subject|2|||
33521127|NCT02962908|62907192|FG000|Overall Study|Protocol Violation|0|||
33617344|NCT01487200|63018437|FG003|Overall Study|Withdrawal by Subject|0|||
33521128|NCT02962908|62907193|FG001|Overall Study|Protocol Violation|1|||
33521129|NCT02962908|62907194|FG002|Overall Study|Protocol Violation|0|||
33521130|NCT02962908|62907195|FG003|Overall Study|Protocol Violation|0|||
33521131|NCT02962908|62907192|FG000|Overall Study|Physician Decision|0|||
33521132|NCT02962908|62907193|FG001|Overall Study|Physician Decision|1|||
33521133|NCT02962908|62907194|FG002|Overall Study|Physician Decision|0|||
33521134|NCT02962908|62907195|FG003|Overall Study|Physician Decision|0|||
33521135|NCT02962284|62907213|FG000|Overall Study|Death|2|||
33521136|NCT02962284|62907214|FG001|Overall Study|Death|0|||
33521137|NCT02962284|62907213|FG000|Overall Study|Progressive disease|2|||
33521138|NCT02962284|62907214|FG001|Overall Study|Progressive disease|3|||
33521139|NCT02962284|62907213|FG000|Overall Study|Withdrawal by Subject|1|||
33521140|NCT02962284|62907214|FG001|Overall Study|Withdrawal by Subject|0|||
33521141|NCT01344876|62907222|FG000|Overall Study|Adverse Event|0|||
33521142|NCT01344876|62907223|FG001|Overall Study|Adverse Event|0|||
33521143|NCT01344876|62907224|FG002|Overall Study|Adverse Event|0|||
33521144|NCT01344876|62907225|FG003|Overall Study|Adverse Event|0|||
33521145|NCT01344876|62907226|FG004|Overall Study|Adverse Event|1|||
33521146|NCT01344876|62907222|FG000|Overall Study|Withdrawal by Subject|0|||
33521147|NCT01344876|62907223|FG001|Overall Study|Withdrawal by Subject|0|||
33521148|NCT01344876|62907224|FG002|Overall Study|Withdrawal by Subject|1|||
33521149|NCT01344876|62907225|FG003|Overall Study|Withdrawal by Subject|0|||
33521150|NCT01344876|62907226|FG004|Overall Study|Withdrawal by Subject|0|||
33521151|NCT01344876|62907222|FG000|Overall Study|Definite progression of primary disease|1|||
33521152|NCT01344876|62907223|FG001|Overall Study|Definite progression of primary disease|0|||
33521153|NCT01344876|62907224|FG002|Overall Study|Definite progression of primary disease|0|||
33521154|NCT01344876|62907225|FG003|Overall Study|Definite progression of primary disease|3|||
33521155|NCT01344876|62907226|FG004|Overall Study|Definite progression of primary disease|0|||
33521156|NCT02846324|62907243|FG000|Overall Study|Other|1|||
33521157|NCT02846324|62907244|FG001|Overall Study|Other|0|||
33521158|NCT02846324|62907245|FG002|Overall Study|Other|0|||
33521159|NCT02846324|62907246|FG003|Overall Study|Other|0|||
33521160|NCT02846324|62907243|FG000|Overall Study|Withdrawal by Subject|1|||
33521161|NCT02846324|62907244|FG001|Overall Study|Withdrawal by Subject|0|||
33521162|NCT02846324|62907245|FG002|Overall Study|Withdrawal by Subject|4|||
33521163|NCT02846324|62907246|FG003|Overall Study|Withdrawal by Subject|0|||
33521164|NCT03161093|62907271|FG000|Overall Study|Protocol Violation|11|||
33521165|NCT03161093|62907272|FG001|Overall Study|Protocol Violation|14|||
33521166|NCT03161093|62907273|FG002|Overall Study|Protocol Violation|6|||
33521167|NCT03161093|62907274|FG003|Overall Study|Protocol Violation|13|||
33521168|NCT03161093|62907275|FG004|Overall Study|Protocol Violation|1|||
33521169|NCT03161093|62907276|FG005|Overall Study|Protocol Violation|0|||
33521170|NCT03161093|62907271|FG000|Overall Study|Adverse Event|5|||
33521171|NCT03161093|62907272|FG001|Overall Study|Adverse Event|21|||
33521172|NCT03161093|62907273|FG002|Overall Study|Adverse Event|16|||
33521173|NCT03161093|62907274|FG003|Overall Study|Adverse Event|35|||
33521174|NCT03161093|62907275|FG004|Overall Study|Adverse Event|2|||
33521175|NCT03161093|62907276|FG005|Overall Study|Adverse Event|1|||
33521176|NCT03161093|62907271|FG000|Overall Study|Lack of Efficacy|9|||
33521177|NCT03161093|62907272|FG001|Overall Study|Lack of Efficacy|13|||
33521178|NCT03161093|62907273|FG002|Overall Study|Lack of Efficacy|9|||
33521179|NCT03161093|62907274|FG003|Overall Study|Lack of Efficacy|24|||
33521180|NCT03161093|62907275|FG004|Overall Study|Lack of Efficacy|4|||
33521181|NCT03161093|62907276|FG005|Overall Study|Lack of Efficacy|1|||
33521182|NCT03161093|62907271|FG000|Overall Study|Physician Decision|0|||
33521183|NCT03161093|62907272|FG001|Overall Study|Physician Decision|1|||
33521184|NCT03161093|62907273|FG002|Overall Study|Physician Decision|0|||
33521185|NCT03161093|62907274|FG003|Overall Study|Physician Decision|2|||
33521186|NCT03161093|62907275|FG004|Overall Study|Physician Decision|17|||
33521187|NCT03161093|62907276|FG005|Overall Study|Physician Decision|15|||
33521188|NCT03161093|62907271|FG000|Overall Study|Withdrawal by Subject|24|||
33521189|NCT03161093|62907272|FG001|Overall Study|Withdrawal by Subject|73|||
33521190|NCT03161093|62907273|FG002|Overall Study|Withdrawal by Subject|44|||
33521191|NCT03161093|62907274|FG003|Overall Study|Withdrawal by Subject|97|||
33521192|NCT03161093|62907275|FG004|Overall Study|Withdrawal by Subject|11|||
33521193|NCT03161093|62907276|FG005|Overall Study|Withdrawal by Subject|10|||
33521194|NCT03161093|62907271|FG000|Overall Study|Lost to Follow-up|3|||
33521195|NCT03161093|62907272|FG001|Overall Study|Lost to Follow-up|12|||
33521196|NCT03161093|62907273|FG002|Overall Study|Lost to Follow-up|4|||
33521197|NCT03161093|62907274|FG003|Overall Study|Lost to Follow-up|7|||
33521198|NCT03161093|62907275|FG004|Overall Study|Lost to Follow-up|8|||
33521199|NCT03161093|62907276|FG005|Overall Study|Lost to Follow-up|13|||
33521200|NCT03161093|62907271|FG000|Overall Study|Death|3|||
33521201|NCT03161093|62907272|FG001|Overall Study|Death|9|||
33521202|NCT03161093|62907273|FG002|Overall Study|Death|7|||
33521203|NCT03161093|62907274|FG003|Overall Study|Death|9|||
33521204|NCT03161093|62907275|FG004|Overall Study|Death|0|||
33521205|NCT03161093|62907276|FG005|Overall Study|Death|0|||
33521206|NCT03161093|62907271|FG000|Overall Study|Unknown - Not reported|0|||
33521207|NCT03161093|62907272|FG001|Overall Study|Unknown - Not reported|1|||
33521208|NCT03161093|62907273|FG002|Overall Study|Unknown - Not reported|0|||
33521209|NCT03161093|62907274|FG003|Overall Study|Unknown - Not reported|0|||
33521210|NCT03161093|62907275|FG004|Overall Study|Unknown - Not reported|0|||
33521211|NCT03161093|62907276|FG005|Overall Study|Unknown - Not reported|1|||
33521212|NCT02847650|62907297|FG000|Overall Study|Adverse Event|2|||
33521213|NCT02847650|62907298|FG001|Overall Study|Adverse Event|4|||
33521214|NCT02847650|62907297|FG000|Overall Study|Lost to Follow-up|1|||
33521215|NCT02847650|62907298|FG001|Overall Study|Lost to Follow-up|0|||
33521216|NCT02847650|62907297|FG000|Overall Study|Protocol Violation|0|||
33521217|NCT02847650|62907298|FG001|Overall Study|Protocol Violation|1|||
33521218|NCT02847650|62907297|FG000|Overall Study|Withdrawal by Subject|1|||
33521219|NCT02847650|62907298|FG001|Overall Study|Withdrawal by Subject|1|||
33521220|NCT02847494|62907306|FG000|Overall Study|Lost to Follow-up|8|||
33521221|NCT02847494|62907307|FG001|Overall Study|Lost to Follow-up|5|||
33521222|NCT02554253|62907315|FG000|Overall Study|ineligible after enrollment|1|||
33521223|NCT02554253|62907316|FG001|Overall Study|ineligible after enrollment|0|||
33521224|NCT02554253|62907315|FG000|Overall Study|converted to transcatheter procedure|0|||
33521225|NCT02554253|62907316|FG001|Overall Study|converted to transcatheter procedure|1|||
33521226|NCT02554253|62907315|FG000|Overall Study|received both drugs|0|||
33521227|NCT02554253|62907316|FG001|Overall Study|received both drugs|1|||
33521228|NCT03157583|62907323|FG000|Overall Study|Other (did not meet study criteria)|1|||
33521229|NCT02842736|62907341|FG000|Overall Study|Lost to Follow-up|13|||
33521230|NCT02842736|62907341|FG000|Overall Study|Intervention for menstrual bleeding|17|||
33521231|NCT02842736|62907341|FG000|Overall Study|Withdrawal by Subject|4|||
33521232|NCT02842736|62907341|FG000|Overall Study|Pregnancy|3|||
33521233|NCT02842736|62907341|FG000|Overall Study|Hysterectomy for fibroids|2|||
33521234|NCT02842736|62907341|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
33521235|NCT02842736|62907341|FG000|Overall Study|IUD: Mirena|1|||
33521236|NCT01307033|62907347|FG000|8-week Double-blind Period|Adverse Event|2|||
33521237|NCT01307033|62907348|FG001|8-week Double-blind Period|Adverse Event|0|||
33521238|NCT01307033|62907349|FG002|8-week Double-blind Period|Adverse Event|0|||
33521239|NCT01307033|62907350|FG003|8-week Double-blind Period|Adverse Event|0|||
33521240|NCT01307033|62907347|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
33521241|NCT01307033|62907348|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
33521242|NCT01307033|62907349|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
33521243|NCT01307033|62907350|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
33521244|NCT01307033|62907347|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
33521245|NCT01307033|62907348|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
33521246|NCT01307033|62907349|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
33521247|NCT01307033|62907350|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
33521248|NCT01307033|62907347|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
33521249|NCT01307033|62907348|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
33521250|NCT01307033|62907349|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
33521251|NCT01307033|62907350|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
33521252|NCT01307033|62907347|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
33521253|NCT01307033|62907348|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
33521254|NCT01307033|62907349|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
33521255|NCT01307033|62907350|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
33521256|NCT01307033|62907347|FG000|44-week Open-label Extension|Adverse Event|0|||
33521257|NCT01307033|62907348|FG001|44-week Open-label Extension|Adverse Event|0|||
33521258|NCT01307033|62907349|FG002|44-week Open-label Extension|Adverse Event|2|||
33521259|NCT01307033|62907350|FG003|44-week Open-label Extension|Adverse Event|1|||
33521260|NCT01307033|62907347|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
33521261|NCT01307033|62907348|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
33521262|NCT01307033|62907349|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
33521263|NCT01307033|62907350|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
33521264|NCT01307033|62907347|FG000|44-week Open-label Extension|Physician Decision|0|||
33521265|NCT01307033|62907348|FG001|44-week Open-label Extension|Physician Decision|0|||
33521266|NCT01307033|62907349|FG002|44-week Open-label Extension|Physician Decision|1|||
33617345|NCT01463878|63018450|FG000|Overall Study|no longer met criteria for tube feed|2|||
33521267|NCT01307033|62907350|FG003|44-week Open-label Extension|Physician Decision|0|||
33521268|NCT01307033|62907347|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
33521269|NCT01307033|62907348|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
33521270|NCT01307033|62907349|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
33617346|NCT01463878|63018451|FG001|Overall Study|no longer met criteria for tube feed|2|||
33521271|NCT01307033|62907350|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
33521272|NCT01307033|62907347|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
33617347|NCT01486966|63018459|FG000|Overall Study|Adverse Event|0|||
33455826|NCT00124982|62830291|FG002|Short-term Period|Death|0|||
33455827|NCT00124982|62830289|FG000|Short-term Period|Adverse Event|17|||
33455828|NCT00124982|62830290|FG001|Short-term Period|Adverse Event|22|||
33455829|NCT00124982|62830291|FG002|Short-term Period|Adverse Event|0|||
33521273|NCT01307033|62907348|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
33521274|NCT01307033|62907349|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
33617348|NCT01486966|63018460|FG001|Overall Study|Adverse Event|1|||
33617349|NCT01486966|63018459|FG000|Overall Study|Withdrawal by Subject|0|||
33617350|NCT01486966|63018460|FG001|Overall Study|Withdrawal by Subject|1|||
33617351|NCT01900665|63018468|FG000|Placebo Controlled Period|Death|9|||
33617352|NCT01900665|63018469|FG001|Placebo Controlled Period|Death|16|||
33617353|NCT01900665|63018468|FG000|Placebo Controlled Period|Adverse Event|48|||
33521275|NCT01307033|62907350|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
33521276|NCT01307033|62907347|FG000|44-week Open-label Extension|Death|0|||
33521277|NCT01307033|62907348|FG001|44-week Open-label Extension|Death|0|||
33521278|NCT01307033|62907349|FG002|44-week Open-label Extension|Death|0|||
33521279|NCT01307033|62907350|FG003|44-week Open-label Extension|Death|1|||
33521280|NCT02844920|62907362|FG000|Overall Study|Lost to Follow-up|2|||
33521281|NCT03158311|62907369|FG000|Overall Study|Subject/Guardian Decision|10|||
33521282|NCT03158311|62907370|FG001|Overall Study|Subject/Guardian Decision|6|||
33521283|NCT03158311|62907371|FG002|Overall Study|Subject/Guardian Decision|11|||
33521284|NCT03158311|62907369|FG000|Overall Study|Adverse Event|5|||
33521285|NCT03158311|62907370|FG001|Overall Study|Adverse Event|3|||
33521286|NCT03158311|62907371|FG002|Overall Study|Adverse Event|3|||
33521287|NCT03158311|62907369|FG000|Overall Study|Techinical Problems|3|||
33521288|NCT03158311|62907370|FG001|Overall Study|Techinical Problems|1|||
33617354|NCT01900665|63018469|FG001|Placebo Controlled Period|Adverse Event|39|||
33455830|NCT00124982|62830289|FG000|Short-term Period|Lack of Efficacy|32|||
33455831|NCT00124982|62830290|FG001|Short-term Period|Lack of Efficacy|73|||
33455832|NCT00124982|62830291|FG002|Short-term Period|Lack of Efficacy|0|||
33455833|NCT00124982|62830289|FG000|Short-term Period|Lost to Follow-up|8|||
33455834|NCT00124982|62830290|FG001|Short-term Period|Lost to Follow-up|5|||
33455835|NCT00124982|62830291|FG002|Short-term Period|Lost to Follow-up|0|||
33455836|NCT00124982|62830289|FG000|Short-term Period|Withdrawal of Consent|7|||
33455837|NCT00124982|62830290|FG001|Short-term Period|Withdrawal of Consent|9|||
33455838|NCT00124982|62830291|FG002|Short-term Period|Withdrawal of Consent|0|||
33455839|NCT00124982|62830289|FG000|Short-term Period|Poor/Non-compliance|3|||
33455840|NCT00124982|62830290|FG001|Short-term Period|Poor/Non-compliance|1|||
33455841|NCT00124982|62830291|FG002|Short-term Period|Poor/Non-compliance|0|||
33455842|NCT00124982|62830289|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
33455843|NCT00124982|62830290|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
33455844|NCT00124982|62830291|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
33455845|NCT00124982|62830289|FG000|Short-term Period|Participant Decision|1|||
33455846|NCT00124982|62830290|FG001|Short-term Period|Participant Decision|0|||
33455847|NCT00124982|62830291|FG002|Short-term Period|Participant Decision|0|||
33617355|NCT01900665|63018468|FG000|Placebo Controlled Period|Protocol Violation|1|||
33617356|NCT01900665|63018469|FG001|Placebo Controlled Period|Protocol Violation|7|||
33617357|NCT01900665|63018468|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
33521289|NCT03158311|62907371|FG002|Overall Study|Techinical Problems|5|||
33521290|NCT03158311|62907369|FG000|Overall Study|Physician Decision|2|||
33521291|NCT03158311|62907370|FG001|Overall Study|Physician Decision|3|||
33521292|NCT03158311|62907371|FG002|Overall Study|Physician Decision|7|||
33521293|NCT03158311|62907369|FG000|Overall Study|Lost to Follow-up|1|||
33521294|NCT03158311|62907370|FG001|Overall Study|Lost to Follow-up|1|||
33521295|NCT03158311|62907371|FG002|Overall Study|Lost to Follow-up|1|||
33521296|NCT03158311|62907369|FG000|Overall Study|Sponsor decision|1|||
33521297|NCT03158311|62907370|FG001|Overall Study|Sponsor decision|0|||
33521298|NCT03158311|62907371|FG002|Overall Study|Sponsor decision|0|||
33521299|NCT03158311|62907369|FG000|Overall Study|Pregnancy|0|||
33521300|NCT03158311|62907370|FG001|Overall Study|Pregnancy|2|||
33521301|NCT03158311|62907371|FG002|Overall Study|Pregnancy|0|||
33521302|NCT03158311|62907369|FG000|Overall Study|Randomized in error|0|||
33521303|NCT03158311|62907370|FG001|Overall Study|Randomized in error|0|||
33521304|NCT03158311|62907371|FG002|Overall Study|Randomized in error|1|||
33521305|NCT01336621|62907383|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
33521306|NCT01336621|62907383|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
33521307|NCT01336621|62907383|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
33521308|NCT01336621|62907383|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
33521309|NCT01336621|62907383|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
33521310|NCT01336621|62907383|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
33521311|NCT01336621|62907383|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
33521312|NCT01336621|62907383|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
33521313|NCT01336621|62907383|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
33521314|NCT01336621|62907383|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
33521315|NCT01336621|62907383|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
33521316|NCT01336621|62907383|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
33521317|NCT01336621|62907383|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
33521318|NCT01336621|62907383|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
33521319|NCT00383435|62907395|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
33521320|NCT00383435|62907396|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
33521321|NCT00383435|62907397|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
33521322|NCT00383435|62907398|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
33521323|NCT00383435|62907399|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
33521324|NCT00383435|62907395|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
33521325|NCT00383435|62907396|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
33521326|NCT00383435|62907397|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
33521327|NCT00383435|62907398|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
33521328|NCT00383435|62907399|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
33521329|NCT00383435|62907395|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
33521330|NCT00383435|62907396|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
33521331|NCT00383435|62907397|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
33521332|NCT00383435|62907398|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
33521333|NCT00383435|62907399|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
33521334|NCT00383435|62907395|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
33455848|NCT00124982|62830289|FG000|Short-term Period|Participant Chose Own Doctor|0|||
33455849|NCT00124982|62830290|FG001|Short-term Period|Participant Chose Own Doctor|1|||
33455850|NCT00124982|62830291|FG002|Short-term Period|Participant Chose Own Doctor|0|||
33455851|NCT00124982|62830289|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
33455852|NCT00124982|62830290|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
33455853|NCT00124982|62830291|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
33455854|NCT00124982|62830289|FG000|Short-term Period|Participant Had Lymphopenia|1|||
33455855|NCT00124982|62830290|FG001|Short-term Period|Participant Had Lymphopenia|0|||
33521335|NCT00383435|62907396|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
33521336|NCT00383435|62907397|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
33521337|NCT00383435|62907398|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
33521338|NCT00383435|62907399|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
33521339|NCT00383435|62907395|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
33521340|NCT00383435|62907396|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
33521341|NCT00383435|62907397|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
33521342|NCT00383435|62907398|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
33521343|NCT00383435|62907399|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
33521344|NCT00383435|62907395|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
33521345|NCT00383435|62907396|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
33521346|NCT00383435|62907397|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
33521347|NCT00383435|62907398|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
33521348|NCT00383435|62907399|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
33521349|NCT00383435|62907395|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
33521350|NCT00383435|62907396|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
33521351|NCT00383435|62907397|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
33521352|NCT00383435|62907398|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
33521353|NCT00383435|62907399|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
33521354|NCT00383435|62907395|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
33521355|NCT00383435|62907396|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
33521356|NCT00383435|62907397|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
33521357|NCT00383435|62907398|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
33521358|NCT00383435|62907399|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
33521359|NCT00383435|62907395|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
33521360|NCT00383435|62907396|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
33521361|NCT00383435|62907397|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
33521362|NCT00383435|62907398|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
33521363|NCT00383435|62907399|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
33521364|NCT00383435|62907395|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
33521365|NCT00383435|62907396|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
33521366|NCT00383435|62907397|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
33521367|NCT00383435|62907398|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
33521368|NCT00383435|62907399|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
33521369|NCT00383435|62907395|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
33521370|NCT00383435|62907396|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
33521371|NCT00383435|62907397|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
33521372|NCT00383435|62907398|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
33521373|NCT00383435|62907399|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
33521374|NCT00383435|62907395|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
33544109|NCT01661140|62934937|FG001|Double-Blind Period|Refused Treatment|0|||
33544110|NCT01661140|62934938|FG002|Double-Blind Period|Refused Treatment|1|||
33544111|NCT01661140|62934936|FG000|Double-Blind Period|Adverse Event|0|||
33521375|NCT00383435|62907396|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
33521376|NCT00383435|62907397|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
33521377|NCT00383435|62907398|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
33521378|NCT00383435|62907399|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
33521379|NCT00383435|62907395|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
33544112|NCT01661140|62934937|FG001|Double-Blind Period|Adverse Event|16|||
33544113|NCT01661140|62934938|FG002|Double-Blind Period|Adverse Event|18|||
33544114|NCT01661140|62934936|FG000|Double-Blind Period|Protocol Violation|0|||
33455856|NCT00124982|62830291|FG002|Short-term Period|Participant Had Lymphopenia|0|||
33455857|NCT00124982|62830289|FG000|Long-term Period|Death|0|||
33521380|NCT00383435|62907396|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
33521381|NCT00383435|62907397|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
33521382|NCT00383435|62907398|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
33521383|NCT00383435|62907399|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
33521384|NCT00383435|62907395|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
33521385|NCT00383435|62907396|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
33455858|NCT00124982|62830290|FG001|Long-term Period|Death|0|||
33455859|NCT00124982|62830291|FG002|Long-term Period|Death|1|||
33455860|NCT00124982|62830289|FG000|Long-term Period|Adverse Event|0|||
33455861|NCT00124982|62830290|FG001|Long-term Period|Adverse Event|0|||
33455862|NCT00124982|62830291|FG002|Long-term Period|Adverse Event|17|||
33455863|NCT00124982|62830289|FG000|Long-term Period|Lack of Efficacy|0|||
33455864|NCT00124982|62830290|FG001|Long-term Period|Lack of Efficacy|0|||
33455865|NCT00124982|62830291|FG002|Long-term Period|Lack of Efficacy|46|||
33455866|NCT00124982|62830289|FG000|Long-term Period|Lost to Follow-up|0|||
33455867|NCT00124982|62830290|FG001|Long-term Period|Lost to Follow-up|0|||
33455868|NCT00124982|62830291|FG002|Long-term Period|Lost to Follow-up|4|||
33455869|NCT00124982|62830289|FG000|Long-term Period|Withdrawal by Subject|0|||
33455870|NCT00124982|62830290|FG001|Long-term Period|Withdrawal by Subject|0|||
33455871|NCT00124982|62830291|FG002|Long-term Period|Withdrawal by Subject|16|||
33455872|NCT00124982|62830289|FG000|Long-term Period|Pregnancy|0|||
33455873|NCT00124982|62830290|FG001|Long-term Period|Pregnancy|0|||
33455874|NCT00124982|62830291|FG002|Long-term Period|Pregnancy|1|||
33521386|NCT00383435|62907397|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
33521387|NCT00383435|62907398|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
33521388|NCT00383435|62907399|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
33617358|NCT01900665|63018469|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
33617359|NCT01900665|63018468|FG000|Placebo Controlled Period|Physician Decision|11|||
33617360|NCT01900665|63018469|FG001|Placebo Controlled Period|Physician Decision|7|||
33617361|NCT01900665|63018468|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
33617362|NCT01900665|63018469|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
33521389|NCT00383435|62907395|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
33521390|NCT00383435|62907396|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
33521391|NCT00383435|62907397|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
33521392|NCT00383435|62907398|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
33617363|NCT01900665|63018468|FG000|Placebo Controlled Period|Caregiver Decision|33|||
33521393|NCT00383435|62907399|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
33521394|NCT00383435|62907395|FG000|26-Week Treatment Safety Extension|Administrative|1|||
33521395|NCT00383435|62907396|FG001|26-Week Treatment Safety Extension|Administrative|1|||
33521396|NCT00383435|62907397|FG002|26-Week Treatment Safety Extension|Administrative|0|||
33521397|NCT00383435|62907398|FG003|26-Week Treatment Safety Extension|Administrative|1|||
33521398|NCT00383435|62907399|FG004|26-Week Treatment Safety Extension|Administrative|0|||
33521399|NCT03157037|62907411|FG000|Overall Study|Death|1|||
33617364|NCT01900665|63018469|FG001|Placebo Controlled Period|Caregiver Decision|41|||
33617365|NCT01900665|63018468|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
33617366|NCT01900665|63018469|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
33617367|NCT01900665|63018468|FG000|Open Label Period|Adverse Event|16|||
33617368|NCT01900665|63018469|FG001|Open Label Period|Adverse Event|20|||
33617369|NCT01900665|63018468|FG000|Open Label Period|Death|5|||
33617370|NCT01900665|63018469|FG001|Open Label Period|Death|6|||
33617371|NCT01900665|63018468|FG000|Open Label Period|Lost to Follow-up|1|||
33617372|NCT01900665|63018469|FG001|Open Label Period|Lost to Follow-up|1|||
33617373|NCT01900665|63018468|FG000|Open Label Period|Parent/Caregiver Decision|33|||
33617374|NCT01900665|63018469|FG001|Open Label Period|Parent/Caregiver Decision|34|||
33521400|NCT00381485|62907433|FG000|Open-Label Run-In Period|Adverse Event|9|||
33521401|NCT00381485|62907434|FG001|Open-Label Run-In Period|Adverse Event|0|||
33521402|NCT00381485|62907435|FG002|Open-Label Run-In Period|Adverse Event|0|||
33521403|NCT00381485|62907436|FG003|Open-Label Run-In Period|Adverse Event|0|||
33617375|NCT01900665|63018468|FG000|Open Label Period|Physician Decision|4|||
33617376|NCT01900665|63018469|FG001|Open Label Period|Physician Decision|4|||
33617377|NCT01900665|63018468|FG000|Open Label Period|Protocol Violation|0|||
33617378|NCT01900665|63018469|FG001|Open Label Period|Protocol Violation|1|||
33617379|NCT01900665|63018468|FG000|Open Label Period|Sponsor Decision|802|||
33617380|NCT01900665|63018469|FG001|Open Label Period|Sponsor Decision|765|||
33455875|NCT00124982|62830289|FG000|Long-term Period|Poor/Non-compliance|0|||
33455876|NCT00124982|62830290|FG001|Long-term Period|Poor/Non-compliance|0|||
33455877|NCT00124982|62830291|FG002|Long-term Period|Poor/Non-compliance|2|||
33455878|NCT00124982|62830289|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
33617381|NCT01900665|63018468|FG000|Open Label Period|Withdrawal by Subject|20|||
33521404|NCT00381485|62907433|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
33521405|NCT00381485|62907434|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
33521406|NCT00381485|62907435|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
33521407|NCT00381485|62907436|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
33521408|NCT00381485|62907433|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
33521409|NCT00381485|62907434|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
33521410|NCT00381485|62907435|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
33521411|NCT00381485|62907436|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
33521412|NCT00381485|62907433|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
33521413|NCT00381485|62907434|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
33521414|NCT00381485|62907435|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
33521415|NCT00381485|62907436|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
33521416|NCT00381485|62907433|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
33521417|NCT00381485|62907434|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
33521418|NCT00381485|62907435|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
33521419|NCT00381485|62907436|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
33521420|NCT00381485|62907433|FG000|Open-Label Run-In Period|Treatment failure|1|||
33521421|NCT00381485|62907434|FG001|Open-Label Run-In Period|Treatment failure|0|||
33521422|NCT00381485|62907435|FG002|Open-Label Run-In Period|Treatment failure|0|||
33521423|NCT00381485|62907436|FG003|Open-Label Run-In Period|Treatment failure|0|||
33521424|NCT00381485|62907433|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33521425|NCT00381485|62907434|FG001|Double-Blind Treatment Period|Adverse Event|2|||
33521426|NCT00381485|62907435|FG002|Double-Blind Treatment Period|Adverse Event|2|||
33521427|NCT00381485|62907436|FG003|Double-Blind Treatment Period|Adverse Event|5|||
33521428|NCT00381485|62907433|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
33521429|NCT00381485|62907434|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
33521430|NCT00381485|62907435|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
33521431|NCT00381485|62907436|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
33521432|NCT00381485|62907433|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33455879|NCT00124982|62830290|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
33455880|NCT00124982|62830291|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
33455881|NCT00124982|62830289|FG000|Long-term Period|Neurologist Recommendation|0|||
33455882|NCT00124982|62830290|FG001|Long-term Period|Neurologist Recommendation|0|||
33455883|NCT00124982|62830291|FG002|Long-term Period|Neurologist Recommendation|1|||
33455884|NCT04263142|62830305|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
33455885|NCT04263142|62830306|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
33455886|NCT04263142|62830307|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
33455887|NCT04263142|62830308|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
33455888|NCT04263142|62830309|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
33455889|NCT04263142|62830305|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
33455890|NCT04263142|62830306|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
33455891|NCT04263142|62830307|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
33455892|NCT04263142|62830308|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
33455893|NCT04263142|62830309|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
33455894|NCT04095286|62830322|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33455895|NCT04095286|62830323|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
33521433|NCT00381485|62907434|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
33521434|NCT00381485|62907435|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
33521435|NCT00381485|62907436|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
33521436|NCT00381485|62907433|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
33521437|NCT00381485|62907434|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
33521438|NCT00381485|62907435|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
33521439|NCT00381485|62907436|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
33455896|NCT04095286|62830324|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33455897|NCT04095286|62830325|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33455898|NCT04095286|62830326|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33455899|NCT04095286|62830327|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33455900|NCT04095286|62830322|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
33455901|NCT04095286|62830323|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
33455902|NCT04095286|62830324|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
33521440|NCT00381485|62907433|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
33521441|NCT00381485|62907434|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
33521442|NCT00381485|62907435|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
33521443|NCT00381485|62907436|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
33521444|NCT00381485|62907433|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
33521445|NCT00381485|62907434|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
33521446|NCT00381485|62907435|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
33521447|NCT00381485|62907436|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
33521448|NCT00381485|62907433|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
33521449|NCT00381485|62907434|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
33521450|NCT00381485|62907435|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
33521451|NCT00381485|62907436|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
33521452|NCT00381485|62907433|FG000|Double-Blind Treatment Period|Administrative|0|||
33521453|NCT00381485|62907434|FG001|Double-Blind Treatment Period|Administrative|1|||
33521454|NCT00381485|62907435|FG002|Double-Blind Treatment Period|Administrative|0|||
33521455|NCT00381485|62907436|FG003|Double-Blind Treatment Period|Administrative|1|||
33521456|NCT02840474|62907447|FG000|Overall Study|Lost to Follow-up|1|||
33521457|NCT02840474|62907448|FG001|Overall Study|Lost to Follow-up|0|||
33521458|NCT03155945|62907456|FG000|Overall Study|Lost to Follow-up|0|||
33521459|NCT03155945|62907457|FG001|Overall Study|Lost to Follow-up|1|||
33521460|NCT03155945|62907456|FG000|Overall Study|Withdrawal by Subject|0|||
33521461|NCT03155945|62907457|FG001|Overall Study|Withdrawal by Subject|1|||
33521462|NCT03155945|62907456|FG000|Overall Study|Other Reason|0|||
33455903|NCT04095286|62830325|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
33455904|NCT04095286|62830326|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
33455905|NCT04095286|62830327|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
33521463|NCT03155945|62907457|FG001|Overall Study|Other Reason|1|||
33617382|NCT01900665|63018469|FG001|Open Label Period|Withdrawal by Subject|28|||
33617383|NCT01900431|63018480|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
33617384|NCT01900431|63018481|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
33617385|NCT01900431|63018482|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
33617386|NCT01900431|63018480|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
33617387|NCT01900431|63018481|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
33617388|NCT01900431|63018482|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
33617389|NCT01900431|63018480|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
33617390|NCT01900431|63018481|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
33617391|NCT01900431|63018482|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
33617392|NCT01900431|63018480|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
33617393|NCT01900431|63018481|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
33617394|NCT01900431|63018482|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
33617395|NCT01900431|63018480|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
33617396|NCT01900431|63018481|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
33617397|NCT01900431|63018482|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
33617398|NCT01900431|63018480|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
33617399|NCT01900431|63018481|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
33617400|NCT01900431|63018482|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
33617401|NCT01900431|63018480|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
33617402|NCT01900431|63018481|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
33617403|NCT01900431|63018482|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
33617404|NCT01900431|63018480|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
33617405|NCT01900431|63018481|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
33617406|NCT01900431|63018482|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
33617407|NCT01900431|63018480|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
33617408|NCT01900431|63018481|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
33617409|NCT01900431|63018482|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
33617410|NCT01948791|63018490|FG000|Overall Study|Adverse Event|12|||
33617411|NCT01948791|63018490|FG000|Overall Study|Lack of Efficacy|3|||
33617412|NCT01948791|63018490|FG000|Overall Study|Protocol Violation|2|||
33617413|NCT01948791|63018490|FG000|Overall Study|Withdrawal by Subject|5|||
33617414|NCT01948791|63018490|FG000|Overall Study|Lost to Follow-up|6|||
33617415|NCT01948791|63018490|FG000|Overall Study|Management issues|1|||
33617416|NCT01948791|63018490|FG000|Overall Study|Others|7|||
33617417|NCT01948791|63018490|FG000|Overall Study|Screening failure|35|||
33617418|NCT01899729|63018499|FG000|Overall Study|Adverse Event|1|||
33617419|NCT01899729|63018500|FG001|Overall Study|Adverse Event|0|||
33617420|NCT01899729|63018501|FG002|Overall Study|Adverse Event|0|||
33617421|NCT01899729|63018502|FG003|Overall Study|Adverse Event|0|||
33455906|NCT04095286|62830322|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
33455907|NCT04095286|62830323|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
33455908|NCT04095286|62830324|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
33455909|NCT04095286|62830325|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
33455910|NCT04095286|62830326|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
33455911|NCT04095286|62830327|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
33455912|NCT04095286|62830322|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33455913|NCT04095286|62830323|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33521464|NCT03160703|62907467|FG000|Overall Study|Withdrawal by Subject|0|||
33521465|NCT03160703|62907468|FG001|Overall Study|Withdrawal by Subject|0|||
33521466|NCT03160703|62907469|FG002|Overall Study|Withdrawal by Subject|0|||
33521467|NCT03160703|62907470|FG003|Overall Study|Withdrawal by Subject|1|||
33521468|NCT03159611|62907482|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
33521469|NCT03159611|62907483|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
33617422|NCT01899729|63018503|FG004|Overall Study|Adverse Event|1|||
33617423|NCT01899729|63018499|FG000|Overall Study|Withdrawal by Subject|1|||
33617424|NCT01899729|63018500|FG001|Overall Study|Withdrawal by Subject|2|||
33617425|NCT01899729|63018501|FG002|Overall Study|Withdrawal by Subject|0|||
33617426|NCT01899729|63018502|FG003|Overall Study|Withdrawal by Subject|0|||
33617427|NCT01899729|63018503|FG004|Overall Study|Withdrawal by Subject|0|||
33617428|NCT01899729|63018499|FG000|Overall Study|Lack of Efficacy|0|||
33617429|NCT01899729|63018500|FG001|Overall Study|Lack of Efficacy|0|||
33617430|NCT01899729|63018501|FG002|Overall Study|Lack of Efficacy|2|||
33521470|NCT03159611|62907482|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
33521471|NCT03159611|62907483|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
33521472|NCT03159611|62907482|FG000|Overall Study|Protocol Violation|7|||
33521473|NCT03159611|62907483|FG001|Overall Study|Protocol Violation|4|||
33521474|NCT03159611|62907482|FG000|Overall Study|Adverse Event|1|||
33521475|NCT03159611|62907483|FG001|Overall Study|Adverse Event|0|||
33521476|NCT03159611|62907482|FG000|Overall Study|Withdrawal by Subject|1|||
33521477|NCT03159611|62907483|FG001|Overall Study|Withdrawal by Subject|1|||
33521478|NCT03159611|62907482|FG000|Overall Study|Non-compliance with protocol requirement|3|||
33521479|NCT03159611|62907483|FG001|Overall Study|Non-compliance with protocol requirement|2|||
33617431|NCT01899729|63018502|FG003|Overall Study|Lack of Efficacy|0|||
33521480|NCT03159611|62907482|FG000|Overall Study|Inability to perform procedures|1|||
33521481|NCT03159611|62907483|FG001|Overall Study|Inability to perform procedures|0|||
33617432|NCT01899729|63018503|FG004|Overall Study|Lack of Efficacy|1|||
33617433|NCT01898091|63018517|FG000|Overall Study|Lost to Follow-up|1|||
33521482|NCT03159455|62907495|FG000|Overall Study|Adverse Event|0|||
33521483|NCT03159455|62907496|FG001|Overall Study|Adverse Event|0|||
33521484|NCT03159455|62907497|FG002|Overall Study|Adverse Event|0|||
33521485|NCT03159455|62907498|FG003|Overall Study|Adverse Event|0|||
33521486|NCT03159455|62907499|FG004|Overall Study|Adverse Event|0|||
33521487|NCT03159455|62907500|FG005|Overall Study|Adverse Event|1|||
33521488|NCT02838134|62907520|FG000|Overall Study|Lost to Follow-up|1|||
33521489|NCT02838134|62907521|FG001|Overall Study|Lost to Follow-up|2|||
33521490|NCT02838134|62907520|FG000|Overall Study|logistic problems|1|||
33521491|NCT02838134|62907521|FG001|Overall Study|logistic problems|1|||
33521492|NCT03150589|62907529|FG000|Overall Study|Withdrawal by Subject|16|||
33521493|NCT03150589|62907530|FG001|Overall Study|Withdrawal by Subject|9|||
33521494|NCT03150589|62907529|FG000|Overall Study|Adverse Event|7|||
33521495|NCT03150589|62907530|FG001|Overall Study|Adverse Event|6|||
33521496|NCT03150589|62907529|FG000|Overall Study|Protocol Violation|4|||
33521497|NCT03150589|62907530|FG001|Overall Study|Protocol Violation|3|||
33521498|NCT03150589|62907529|FG000|Overall Study|Lost to Follow-up|3|||
33521499|NCT03150589|62907530|FG001|Overall Study|Lost to Follow-up|3|||
33521500|NCT03150589|62907529|FG000|Overall Study|Death|2|||
33521501|NCT03150589|62907530|FG001|Overall Study|Death|3|||
33521502|NCT03150589|62907529|FG000|Overall Study|IP non-compliance and other reasons|12|||
33521503|NCT03150589|62907530|FG001|Overall Study|IP non-compliance and other reasons|3|||
33521504|NCT02835092|62907539|FG000|Overall Study|Withdrawal by Subject|3|||
33521505|NCT02835092|62907540|FG001|Overall Study|Withdrawal by Subject|6|||
33521506|NCT02835092|62907541|FG002|Overall Study|Withdrawal by Subject|3|||
33521507|NCT02835092|62907539|FG000|Overall Study|Lost to Follow-up|0|||
33521508|NCT02835092|62907540|FG001|Overall Study|Lost to Follow-up|2|||
33521509|NCT02835092|62907541|FG002|Overall Study|Lost to Follow-up|0|||
33521510|NCT03145207|62907549|FG000|Overall Study|volunteer started taking allergy shots|1|||
33521511|NCT03145207|62907549|FG000|Overall Study|baseline blood pressure high|1|||
33521512|NCT02836652|62907566|FG000|Overall Study|Death|3|||
33521513|NCT02836652|62907567|FG001|Overall Study|Death|3|||
33521514|NCT02836652|62907566|FG000|Overall Study|Transplant/Explant|3|||
33521515|NCT02836652|62907567|FG001|Overall Study|Transplant/Explant|4|||
33521516|NCT02836652|62907566|FG000|Overall Study|Withdrawn|9|||
33521517|NCT02836652|62907567|FG001|Overall Study|Withdrawn|9|||
33521518|NCT02836652|62907566|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
33521519|NCT02836652|62907567|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
33617434|NCT01898091|63018518|FG001|Overall Study|Lost to Follow-up|1|||
33521520|NCT02836496|62907575|FG000|Overall Study|Adverse Event|2|||
33521521|NCT02836496|62907576|FG001|Overall Study|Adverse Event|1|||
33521522|NCT02836496|62907575|FG000|Overall Study|Withdrawal by Subject|0|||
33521523|NCT02836496|62907576|FG001|Overall Study|Withdrawal by Subject|1|||
33521524|NCT04213807|62907585|FG000|Overall Study|Physician Decision|0|||
33617435|NCT01898091|63018517|FG000|Overall Study|Withdrawal by Subject|1|||
33521525|NCT04213807|62907586|FG001|Overall Study|Physician Decision|0|||
33521526|NCT04213807|62907587|FG002|Overall Study|Physician Decision|1|||
33521527|NCT00577577|62907606|FG000|Overall Study|Adverse Event|3|||
33521528|NCT00577577|62907607|FG001|Overall Study|Adverse Event|2|||
33521529|NCT00577577|62907606|FG000|Overall Study|Lost to Follow-up|1|||
33521530|NCT00577577|62907607|FG001|Overall Study|Lost to Follow-up|0|||
33521531|NCT00577577|62907606|FG000|Overall Study|Protocol Violation|0|||
33521532|NCT00577577|62907607|FG001|Overall Study|Protocol Violation|3|||
33521533|NCT00577577|62907606|FG000|Overall Study|Transportation|1|||
33521534|NCT00577577|62907607|FG001|Overall Study|Transportation|0|||
33521535|NCT02833844|62907615|FG000|Double-Blind Period|Withdrawal by Subject|2|||
33521536|NCT02833844|62907616|FG001|Double-Blind Period|Withdrawal by Subject|3|||
33521537|NCT02833844|62907615|FG000|Double-Blind Period|Protocol Violation|0|||
33521538|NCT02833844|62907616|FG001|Double-Blind Period|Protocol Violation|4|||
33521539|NCT02833844|62907615|FG000|Open-Label Period|Death|0|||
33521540|NCT02833844|62907616|FG001|Open-Label Period|Death|2|||
33521541|NCT02833844|62907615|FG000|Open-Label Period|Lost to Follow-up|1|||
33521542|NCT02833844|62907616|FG001|Open-Label Period|Lost to Follow-up|0|||
33521543|NCT02833844|62907615|FG000|Open-Label Period|Withdrawal by Subject|1|||
33521544|NCT02833844|62907616|FG001|Open-Label Period|Withdrawal by Subject|0|||
33521545|NCT01341782|62907626|FG000|Overall Study|Adverse Event|1|||
33521546|NCT01341782|62907627|FG001|Overall Study|Adverse Event|1|||
33521547|NCT01341782|62907626|FG000|Overall Study|Withdrawal by Subject|6|||
33521548|NCT01341782|62907627|FG001|Overall Study|Withdrawal by Subject|5|||
33521549|NCT01341782|62907626|FG000|Overall Study|Missed 3 consecutive doses|0|||
33521550|NCT01341782|62907627|FG001|Overall Study|Missed 3 consecutive doses|4|||
33521551|NCT01341782|62907626|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
33521552|NCT01341782|62907627|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
33521553|NCT01341782|62907626|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
33521554|NCT01341782|62907627|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
33521555|NCT01341782|62907626|FG000|Overall Study|Other|5|||
33521556|NCT01341782|62907627|FG001|Overall Study|Other|0|||
33521557|NCT01341470|62907639|FG000|Overall Study|Sponsor decision|0|||
33521558|NCT01341470|62907640|FG001|Overall Study|Sponsor decision|0|||
33521559|NCT01341470|62907641|FG002|Overall Study|Sponsor decision|1|||
33521560|NCT01341470|62907642|FG003|Overall Study|Sponsor decision|1|||
33521561|NCT01341470|62907643|FG004|Overall Study|Sponsor decision|0|||
33521562|NCT01341470|62907644|FG005|Overall Study|Sponsor decision|1|||
33521563|NCT03143101|62907663|FG000|Overall Study|Withdrawal by Subject|0|||
33521564|NCT03143101|62907664|FG001|Overall Study|Withdrawal by Subject|1|||
33521565|NCT03143101|62907665|FG002|Overall Study|Withdrawal by Subject|0|||
33521566|NCT03143101|62907663|FG000|Overall Study|Lost to Follow-up|2|||
33521567|NCT03143101|62907664|FG001|Overall Study|Lost to Follow-up|2|||
33521568|NCT03143101|62907665|FG002|Overall Study|Lost to Follow-up|0|||
33521569|NCT00871351|62907676|FG000|Overall Study|Withdrawal by Subject|1|||
33521570|NCT00871351|62907677|FG001|Overall Study|Withdrawal by Subject|0|||
33521571|NCT00871351|62907678|FG002|Overall Study|Withdrawal by Subject|0|||
33521572|NCT00871351|62907676|FG000|Overall Study|Adverse Event|3|||
33455914|NCT04095286|62830324|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
33455915|NCT04095286|62830325|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33521573|NCT00871351|62907677|FG001|Overall Study|Adverse Event|1|||
33455916|NCT04095286|62830326|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33455917|NCT04095286|62830327|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33455918|NCT04095286|62830322|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
33455919|NCT04095286|62830323|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
33455920|NCT04095286|62830324|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
33455921|NCT04095286|62830325|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
33455922|NCT04095286|62830326|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
33455923|NCT04095286|62830327|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
33455924|NCT04093414|62830337|FG000|3 Month Follow up|Physician Decision|0|||
33455925|NCT04093414|62830338|FG001|3 Month Follow up|Physician Decision|1|||
33455926|NCT04093414|62830337|FG000|6month Follow up|Physician Decision|1|||
33455927|NCT04093414|62830338|FG001|6month Follow up|Physician Decision|3|||
33455928|NCT04093258|62830344|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
33455929|NCT04093258|62830345|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
33455930|NCT04253236|62830353|FG000|Overall Study|Adverse Event|1|||
33455931|NCT04253236|62830354|FG001|Overall Study|Adverse Event|0|||
33455932|NCT04253236|62830353|FG000|Overall Study|Safety Concerns|1|||
33455933|NCT04253236|62830354|FG001|Overall Study|Safety Concerns|0|||
33455934|NCT04253236|62830353|FG000|Overall Study|Study Terminated by Sponsor|1|||
33455935|NCT04253236|62830354|FG001|Overall Study|Study Terminated by Sponsor|0|||
33455936|NCT04087720|62830360|FG000|Overall Study|Withdrawal by Subject|2|||
33455937|NCT04087720|62830360|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
33455938|NCT04086472|62830369|FG000|Overall Study|Lost to Follow-up|1|||
33455939|NCT04086472|62830370|FG001|Overall Study|Lost to Follow-up|0|||
33455940|NCT04086472|62830371|FG002|Overall Study|Lost to Follow-up|0|||
33455941|NCT04086472|62830372|FG003|Overall Study|Lost to Follow-up|0|||
33455942|NCT04086472|62830373|FG004|Overall Study|Lost to Follow-up|1|||
33455943|NCT04086472|62830369|FG000|Overall Study|Physician Decision|0|||
33455944|NCT04086472|62830370|FG001|Overall Study|Physician Decision|1|||
33455945|NCT04086472|62830371|FG002|Overall Study|Physician Decision|1|||
33455946|NCT04086472|62830372|FG003|Overall Study|Physician Decision|0|||
33455947|NCT04086472|62830373|FG004|Overall Study|Physician Decision|0|||
33455948|NCT04086472|62830369|FG000|Overall Study|Withdrawal by Subject|1|||
33455949|NCT04086472|62830370|FG001|Overall Study|Withdrawal by Subject|1|||
33455950|NCT04086472|62830371|FG002|Overall Study|Withdrawal by Subject|1|||
33455951|NCT04086472|62830372|FG003|Overall Study|Withdrawal by Subject|0|||
33455952|NCT04086472|62830373|FG004|Overall Study|Withdrawal by Subject|0|||
33455953|NCT04086472|62830369|FG000|Overall Study|Various reasons|2|||
33455954|NCT04086472|62830370|FG001|Overall Study|Various reasons|0|||
33455955|NCT04086472|62830371|FG002|Overall Study|Various reasons|0|||
33455956|NCT04086472|62830372|FG003|Overall Study|Various reasons|3|||
33455957|NCT04086472|62830373|FG004|Overall Study|Various reasons|1|||
33455958|NCT04249336|62830389|FG000|Overall Study|Lost to Follow-up|3|||
33455959|NCT04249336|62830390|FG001|Overall Study|Lost to Follow-up|3|||
33455960|NCT04249336|62830391|FG002|Overall Study|Lost to Follow-up|3|||
33455961|NCT04249336|62830392|FG003|Overall Study|Lost to Follow-up|3|||
33455962|NCT04245202|62830404|FG000|Overall Study|Lack of Efficacy|10|||
33455963|NCT04245202|62830405|FG001|Overall Study|Lack of Efficacy|1|||
33521574|NCT00871351|62907678|FG002|Overall Study|Adverse Event|0|||
33521575|NCT02745080|62907688|FG000|Overall Study|Adverse Event|13|||
33521576|NCT02745080|62907689|FG001|Overall Study|Adverse Event|21|||
33521577|NCT02745080|62907688|FG000|Overall Study|Lack of Efficacy|11|||
33521578|NCT02745080|62907689|FG001|Overall Study|Lack of Efficacy|23|||
33521579|NCT02745080|62907688|FG000|Overall Study|Lost to Follow-up|3|||
33455964|NCT04079842|62830412|FG000|Overall Study|Request of subject|2|||
33455965|NCT04079842|62830412|FG000|Overall Study|Unable to draw Arterial samples|1|||
33455966|NCT04078126|62830416|FG000|Washout|Study put on hold due to COVID-19|0|||
33455967|NCT04078126|62830417|FG001|Washout|Study put on hold due to COVID-19|2|||
33455968|NCT04078126|62830416|FG000|Period 2|Study put on hold due to COVID-19|1|||
33455969|NCT04078126|62830417|FG001|Period 2|Study put on hold due to COVID-19|1|||
33455970|NCT04073368|62830427|FG000|Overall Study|Adverse Event|2|||
33455971|NCT04073368|62830428|FG001|Overall Study|Adverse Event|0|||
33455972|NCT04073368|62830429|FG002|Overall Study|Adverse Event|1|||
33455973|NCT04073368|62830430|FG003|Overall Study|Adverse Event|1|||
33521580|NCT02745080|62907689|FG001|Overall Study|Lost to Follow-up|3|||
33521581|NCT02745080|62907688|FG000|Overall Study|Physician Decision|3|||
33521582|NCT02745080|62907689|FG001|Overall Study|Physician Decision|0|||
33521583|NCT02745080|62907688|FG000|Overall Study|Protocol Violation|3|||
33521584|NCT02745080|62907689|FG001|Overall Study|Protocol Violation|1|||
33521585|NCT02745080|62907688|FG000|Overall Study|Withdrawal by Subject|22|||
33521586|NCT02745080|62907689|FG001|Overall Study|Withdrawal by Subject|41|||
33521587|NCT00521599|62907699|FG000|Overall Study|Adverse Event|5|||
33521588|NCT00521599|62907700|FG001|Overall Study|Adverse Event|7|||
33521589|NCT00521599|62907701|FG002|Overall Study|Adverse Event|6|||
33521590|NCT00521599|62907699|FG000|Overall Study|Treatment Failure|8|||
33521591|NCT00521599|62907700|FG001|Overall Study|Treatment Failure|9|||
33521592|NCT00521599|62907701|FG002|Overall Study|Treatment Failure|22|||
33521593|NCT00521599|62907699|FG000|Overall Study|Lost to Follow-up|2|||
33521594|NCT00521599|62907700|FG001|Overall Study|Lost to Follow-up|1|||
33521595|NCT00521599|62907701|FG002|Overall Study|Lost to Follow-up|2|||
33521596|NCT00521599|62907699|FG000|Overall Study|Withdrawal by Subject|3|||
33521597|NCT00521599|62907700|FG001|Overall Study|Withdrawal by Subject|5|||
33521598|NCT00521599|62907701|FG002|Overall Study|Withdrawal by Subject|1|||
33521599|NCT00521599|62907699|FG000|Overall Study|Withdrawal by subject treatment related|3|||
33521600|NCT00521599|62907700|FG001|Overall Study|Withdrawal by subject treatment related|1|||
33521601|NCT00521599|62907701|FG002|Overall Study|Withdrawal by subject treatment related|2|||
33521602|NCT00521599|62907699|FG000|Overall Study|Protocol Violation|2|||
33521603|NCT00521599|62907700|FG001|Overall Study|Protocol Violation|4|||
33521604|NCT00521599|62907701|FG002|Overall Study|Protocol Violation|2|||
33521605|NCT00521599|62907699|FG000|Overall Study|Did not meet protocol eligibility|2|||
33521606|NCT00521599|62907700|FG001|Overall Study|Did not meet protocol eligibility|2|||
33521607|NCT00521599|62907701|FG002|Overall Study|Did not meet protocol eligibility|1|||
33521608|NCT00442897|62907712|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
33521609|NCT00442897|62907713|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
33521610|NCT00442897|62907712|FG000|Base Study (12 Week Follow-up)|Death|0|||
33521611|NCT00442897|62907713|FG001|Base Study (12 Week Follow-up)|Death|1|||
33521612|NCT00442897|62907712|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
33521613|NCT00442897|62907713|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
33521614|NCT00442897|62907712|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
33521615|NCT00442897|62907713|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
33521616|NCT00442897|62907712|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
33521617|NCT00442897|62907713|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
33521618|NCT00442897|62907712|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
33521619|NCT00442897|62907713|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
33521620|NCT00442897|62907712|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
33521621|NCT00442897|62907713|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
33521622|NCT00442897|62907712|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
33521623|NCT00442897|62907713|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
33521624|NCT02834390|62907721|FG000|Induction Phase|Progressive disease|0|||
33521625|NCT02834390|62907722|FG001|Induction Phase|Progressive disease|1|||
33521626|NCT02834390|62907721|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
33521627|NCT02834390|62907722|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
33521628|NCT02834390|62907721|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
33521629|NCT02834390|62907722|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
33521630|NCT02834390|62907721|FG000|Consolidation Phase|Physician Decision|1|||
33521631|NCT02834390|62907722|FG001|Consolidation Phase|Physician Decision|1|||
33521632|NCT03141151|62907730|FG000|Overall Study|Lost to Follow-up|3|||
33521633|NCT03141151|62907731|FG001|Overall Study|Lost to Follow-up|2|||
33521634|NCT03141151|62907730|FG000|Overall Study|Withdrawal by Subject|3|||
33521635|NCT03141151|62907731|FG001|Overall Study|Withdrawal by Subject|2|||
33521636|NCT01358708|62907739|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
33521637|NCT01358708|62907740|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33521638|NCT01358708|62907739|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
33521639|NCT01358708|62907740|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
33521640|NCT01356602|62907753|FG000|Overall Study|Protocol Deviation|0|||
33521641|NCT01356602|62907754|FG001|Overall Study|Protocol Deviation|1|||
33521642|NCT01356602|62907755|FG002|Overall Study|Protocol Deviation|1|||
33521643|NCT01356602|62907753|FG000|Overall Study|Administrative Problems|1|||
33521644|NCT01356602|62907754|FG001|Overall Study|Administrative Problems|4|||
33521645|NCT01356602|62907755|FG002|Overall Study|Administrative Problems|5|||
33521646|NCT01356602|62907753|FG000|Overall Study|Lost to Follow-up|4|||
33521647|NCT01356602|62907754|FG001|Overall Study|Lost to Follow-up|5|||
33521648|NCT01356602|62907755|FG002|Overall Study|Lost to Follow-up|6|||
33521649|NCT01356602|62907753|FG000|Overall Study|Withdrawal by Subject|4|||
33521650|NCT01356602|62907754|FG001|Overall Study|Withdrawal by Subject|3|||
33521651|NCT01356602|62907755|FG002|Overall Study|Withdrawal by Subject|7|||
33521652|NCT01356602|62907753|FG000|Overall Study|Lack of Efficacy|0|||
33521653|NCT01356602|62907754|FG001|Overall Study|Lack of Efficacy|1|||
33521654|NCT01356602|62907755|FG002|Overall Study|Lack of Efficacy|4|||
33521655|NCT01356602|62907753|FG000|Overall Study|Adverse Event|0|||
33521656|NCT01356602|62907754|FG001|Overall Study|Adverse Event|1|||
33455974|NCT04073368|62830427|FG000|Overall Study|Withdrawal by Subject|2|||
33455975|NCT04073368|62830428|FG001|Overall Study|Withdrawal by Subject|2|||
33455976|NCT04073368|62830429|FG002|Overall Study|Withdrawal by Subject|1|||
33455977|NCT04073368|62830430|FG003|Overall Study|Withdrawal by Subject|1|||
33455978|NCT04073368|62830427|FG000|Overall Study|Lost to Follow-up|1|||
33455979|NCT04073368|62830428|FG001|Overall Study|Lost to Follow-up|1|||
33455980|NCT04073368|62830429|FG002|Overall Study|Lost to Follow-up|1|||
33455981|NCT04073368|62830430|FG003|Overall Study|Lost to Follow-up|0|||
33455982|NCT04073368|62830427|FG000|Overall Study|Protocol Violation|0|||
33455983|NCT04073368|62830428|FG001|Overall Study|Protocol Violation|1|||
33455984|NCT04073368|62830429|FG002|Overall Study|Protocol Violation|0|||
33455985|NCT04073368|62830430|FG003|Overall Study|Protocol Violation|0|||
33521657|NCT01356602|62907755|FG002|Overall Study|Adverse Event|1|||
33521658|NCT02830880|62907763|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
33521659|NCT02830880|62907763|FG000|Overall Study|Death|1|||
33455986|NCT04073368|62830427|FG000|Overall Study|Subject noncompliance|7|||
33455987|NCT04073368|62830428|FG001|Overall Study|Subject noncompliance|4|||
33455988|NCT04073368|62830429|FG002|Overall Study|Subject noncompliance|0|||
33521660|NCT02830880|62907763|FG000|Overall Study|Physician Decision|1|||
33455989|NCT04073368|62830430|FG003|Overall Study|Subject noncompliance|0|||
33455990|NCT04380688|62830442|FG000|Overall Study|Death|2|||
33455991|NCT04380688|62830443|FG001|Overall Study|Death|2|||
33455992|NCT04380688|62830442|FG000|Overall Study|Lost to Follow-up|2|||
33521661|NCT03141307|62907769|FG000|In-Hospital|Withdrawal by Subject|0|||
33521662|NCT03141307|62907770|FG001|In-Hospital|Withdrawal by Subject|2|||
33617436|NCT01898091|63018518|FG001|Overall Study|Withdrawal by Subject|5|||
33617437|NCT01947855|63018527|FG000|Overall Study|Withdrawal by Subject|1|||
33617438|NCT01947855|63018528|FG001|Overall Study|Withdrawal by Subject|0|||
33617439|NCT01947855|63018529|FG002|Overall Study|Withdrawal by Subject|0|||
33617440|NCT01888965|63018537|FG000|Overall Study|Adverse Event|5|||
33617441|NCT01888965|63018537|FG000|Overall Study|Lack of Efficacy|4|||
33617442|NCT01888497|63018541|FG000|Washout Period 1|Withdrawal by Subject|0|||
33617443|NCT01888497|63018542|FG001|Washout Period 1|Withdrawal by Subject|0|||
33617444|NCT01888497|63018543|FG002|Washout Period 1|Withdrawal by Subject|1|||
33617445|NCT01888497|63018544|FG003|Washout Period 1|Withdrawal by Subject|1|||
33617446|NCT01888497|63018541|FG000|Washout Period 2|Adverse Event|0|||
33617447|NCT01888497|63018542|FG001|Washout Period 2|Adverse Event|0|||
33617448|NCT01888497|63018543|FG002|Washout Period 2|Adverse Event|0|||
33617449|NCT01888497|63018544|FG003|Washout Period 2|Adverse Event|1|||
33617450|NCT01888497|63018541|FG000|Washout Period 2|Withdrawal by Subject|0|||
33617451|NCT01888497|63018542|FG001|Washout Period 2|Withdrawal by Subject|0|||
33617452|NCT01888497|63018543|FG002|Washout Period 2|Withdrawal by Subject|0|||
33617453|NCT01888497|63018544|FG003|Washout Period 2|Withdrawal by Subject|1|||
33617454|NCT01505530|63018557|FG000|Overall Study|Progressive Disease|19|||
33617455|NCT01505530|63018558|FG001|Overall Study|Progressive Disease|17|||
33617456|NCT01505530|63018559|FG002|Overall Study|Progressive Disease|18|||
33617457|NCT01505530|63018557|FG000|Overall Study|Adverse Event|1|||
33617458|NCT01505530|63018558|FG001|Overall Study|Adverse Event|1|||
33617459|NCT01505530|63018559|FG002|Overall Study|Adverse Event|0|||
33617460|NCT01505530|63018557|FG000|Overall Study|Withdrawal by Subject|7|||
33617461|NCT01505530|63018558|FG001|Overall Study|Withdrawal by Subject|8|||
33455993|NCT04380688|62830443|FG001|Overall Study|Lost to Follow-up|4|||
33455994|NCT04380688|62830442|FG000|Overall Study|Withdrawal by Subject|3|||
33455995|NCT04380688|62830443|FG001|Overall Study|Withdrawal by Subject|3|||
33455996|NCT00124748|62830451|FG000|Overall Study|Adverse Event|8|||
33455997|NCT00124748|62830452|FG001|Overall Study|Adverse Event|39|||
33455998|NCT00124748|62830451|FG000|Overall Study|Abnormal laboratory Value|2|||
33455999|NCT00124748|62830452|FG001|Overall Study|Abnormal laboratory Value|2|||
33456000|NCT00124748|62830451|FG000|Overall Study|Abnormal Procedure|0|||
33456001|NCT00124748|62830452|FG001|Overall Study|Abnormal Procedure|1|||
33456002|NCT00124748|62830451|FG000|Overall Study|Lack of Efficacy|20|||
33456003|NCT00124748|62830452|FG001|Overall Study|Lack of Efficacy|41|||
33456004|NCT00124748|62830451|FG000|Overall Study|No longer requires study drug|1|||
33456005|NCT00124748|62830452|FG001|Overall Study|No longer requires study drug|1|||
33456006|NCT00124748|62830451|FG000|Overall Study|Protocol Violation|3|||
33456007|NCT00124748|62830452|FG001|Overall Study|Protocol Violation|1|||
33456008|NCT00124748|62830451|FG000|Overall Study|Withdrawal by Subject|5|||
33456009|NCT00124748|62830452|FG001|Overall Study|Withdrawal by Subject|15|||
33456010|NCT00124748|62830451|FG000|Overall Study|Lost to Follow-up|2|||
33456011|NCT00124748|62830452|FG001|Overall Study|Lost to Follow-up|7|||
33456012|NCT00124748|62830451|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
33456013|NCT00124748|62830452|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
33456014|NCT00124748|62830451|FG000|Overall Study|Death|1|||
33456015|NCT00124748|62830452|FG001|Overall Study|Death|3|||
33456016|NCT04070326|62830460|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
33456017|NCT04070326|62830461|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
33456018|NCT03689452|62830471|FG000|Overall Study|Lost to Follow-up|1|||
33456019|NCT03689452|62830472|FG001|Overall Study|Lost to Follow-up|1|||
33456020|NCT04067050|62830480|FG000|One Month|Lost to Follow-up|4|||
33456021|NCT04067050|62830481|FG001|One Month|Lost to Follow-up|0|||
33456022|NCT04067050|62830480|FG000|Two Month|Lost to Follow-up|1|||
33456023|NCT04067050|62830481|FG001|Two Month|Lost to Follow-up|0|||
33456024|NCT04067050|62830480|FG000|Two Month|Adverse Event|1|||
33456025|NCT04067050|62830481|FG001|Two Month|Adverse Event|0|||
33456026|NCT04060654|62830487|FG000|Overall Study|Withdrawal by Subject|1|||
33456027|NCT04060654|62830487|FG000|Overall Study|Lost to Follow-up|5|||
33456028|NCT00096200|62830494|FG000|Overall Study|Adverse Event|0|||
33617462|NCT01505530|63018559|FG002|Overall Study|Withdrawal by Subject|6|||
33617463|NCT01505530|63018557|FG000|Overall Study|Physician Decision|6|||
33617464|NCT01505530|63018558|FG001|Overall Study|Physician Decision|2|||
33617465|NCT01505530|63018559|FG002|Overall Study|Physician Decision|5|||
33617466|NCT01505530|63018557|FG000|Overall Study|Sponsor Decision|1|||
33617467|NCT01505530|63018558|FG001|Overall Study|Sponsor Decision|8|||
33617468|NCT01505530|63018559|FG002|Overall Study|Sponsor Decision|7|||
33617469|NCT01505530|63018557|FG000|Overall Study|Death|7|||
33521663|NCT03141307|62907769|FG000|In-Hospital|Protocol Violation|4|||
33521664|NCT03141307|62907770|FG001|In-Hospital|Protocol Violation|0|||
33521665|NCT03141307|62907769|FG000|Follow-Up|Lost to Follow-up|97|||
33521666|NCT03141307|62907770|FG001|Follow-Up|Lost to Follow-up|54|||
33521667|NCT02825420|62907778|FG000|Overall Study|Death|30|||
33521668|NCT02825420|62907779|FG001|Overall Study|Death|12|||
33521669|NCT02825420|62907778|FG000|Overall Study|Progressive disease|6|||
33521670|NCT02825420|62907779|FG001|Overall Study|Progressive disease|1|||
33521671|NCT02825420|62907778|FG000|Overall Study|Lost to Follow-up|2|||
33521672|NCT02825420|62907779|FG001|Overall Study|Lost to Follow-up|2|||
33521673|NCT02825420|62907778|FG000|Overall Study|Withdrawal by Subject|1|||
33521674|NCT02825420|62907779|FG001|Overall Study|Withdrawal by Subject|1|||
33521675|NCT02825420|62907778|FG000|Overall Study|Protocol amendment not signed|1|||
33521676|NCT02825420|62907779|FG001|Overall Study|Protocol amendment not signed|1|||
33617470|NCT01505530|63018558|FG001|Overall Study|Death|6|||
33617471|NCT01505530|63018559|FG002|Overall Study|Death|5|||
33617472|NCT01505530|63018557|FG000|Overall Study|entry criteria not met|0|||
33617473|NCT01505530|63018558|FG001|Overall Study|entry criteria not met|1|||
33617474|NCT01505530|63018559|FG002|Overall Study|entry criteria not met|0|||
33617475|NCT01485796|63018567|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
33617476|NCT01485796|63018567|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
33617477|NCT01485796|63018567|FG000|Period 2: Epoch 2|Adverse Event|3|||
33617478|NCT01485796|63018567|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
33617479|NCT01485796|63018567|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
33617480|NCT01485796|63018567|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
33521677|NCT02825420|62907778|FG000|Overall Study|Physician Decision|1|||
33521678|NCT02825420|62907779|FG001|Overall Study|Physician Decision|0|||
33521679|NCT02825420|62907778|FG000|Overall Study|Did not receive PLD|2|||
33521680|NCT02825420|62907779|FG001|Overall Study|Did not receive PLD|0|||
33521681|NCT02829944|62907792|FG000|Overall Study|Physician Decision|0|||
33521682|NCT02829944|62907793|FG001|Overall Study|Physician Decision|1|||
33521683|NCT02829944|62907792|FG000|Overall Study|Screen Failure|2|||
33521684|NCT02829944|62907793|FG001|Overall Study|Screen Failure|2|||
33521685|NCT02829944|62907792|FG000|Overall Study|Inadequate Neuraxial Block|1|||
33521686|NCT02829944|62907793|FG001|Overall Study|Inadequate Neuraxial Block|1|||
33521687|NCT02829944|62907792|FG000|Overall Study|Withdrawal by Subject|2|||
33521688|NCT02829944|62907793|FG001|Overall Study|Withdrawal by Subject|1|||
33521689|NCT02829944|62907792|FG000|Overall Study|Catheter Displacement|1|||
33521690|NCT02829944|62907793|FG001|Overall Study|Catheter Displacement|0|||
33521691|NCT02829944|62907792|FG000|Overall Study|Catheter broke|0|||
33521692|NCT02829944|62907793|FG001|Overall Study|Catheter broke|1|||
33521693|NCT02829944|62907792|FG000|Overall Study|Staff unavailable|0|||
33521694|NCT02829944|62907793|FG001|Overall Study|Staff unavailable|1|||
33617481|NCT01485796|63018567|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
33617482|NCT01485796|63018567|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
33521695|NCT02824562|62907801|FG000|Overall Study|Lost to Follow-up|3|||
33521696|NCT02824562|62907802|FG001|Overall Study|Lost to Follow-up|4|||
33521697|NCT02824562|62907801|FG000|Overall Study|Death|0|||
33521698|NCT02824562|62907802|FG001|Overall Study|Death|1|||
33521699|NCT02744066|62907810|FG000|Overall Study|Withdrawal by parent|0|||
33617483|NCT01505374|63018575|FG000|Overall Study|Lost to Follow-up|1|||
33521700|NCT02744066|62907811|FG001|Overall Study|Withdrawal by parent|1|||
33521701|NCT02744066|62907810|FG000|Overall Study|Discharged from NICU prior to completion|0|||
33521702|NCT02744066|62907811|FG001|Overall Study|Discharged from NICU prior to completion|4|||
33521703|NCT01338818|62907819|FG000|Overall Study|Adverse Event|8|||
33521704|NCT01338818|62907819|FG000|Overall Study|Lack of Efficacy|5|||
33521705|NCT01338818|62907819|FG000|Overall Study|no longer require study drug|1|||
33521706|NCT01338818|62907819|FG000|Overall Study|Withdrawal by Subject|11|||
33521707|NCT01338818|62907819|FG000|Overall Study|Lost to Follow-up|4|||
33521708|NCT01338818|62907819|FG000|Overall Study|Administrative problems|3|||
33617484|NCT01505374|63018576|FG001|Overall Study|Lost to Follow-up|0|||
33617485|NCT01897233|63018583|FG000|Part B (24 Weeks)|Adverse Event|1|||
33617486|NCT01897233|63018583|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
33617487|NCT01897233|63018583|FG000|Part B (24 Weeks)|Physician Decision|1|||
33617488|NCT01887717|63018593|FG000|Overall Study|Withdrawal by Subject|1|||
33617489|NCT01887717|63018594|FG001|Overall Study|Withdrawal by Subject|7|||
33617490|NCT01887717|63018593|FG000|Overall Study|Physician Decision|0|||
33456029|NCT00096200|62830495|FG001|Overall Study|Adverse Event|4|||
33456030|NCT00096200|62830496|FG002|Overall Study|Adverse Event|0|||
33456031|NCT00096200|62830494|FG000|Overall Study|Withdrawal by Subject|1|||
33456032|NCT00096200|62830495|FG001|Overall Study|Withdrawal by Subject|2|||
33456033|NCT00096200|62830496|FG002|Overall Study|Withdrawal by Subject|0|||
33456034|NCT00096200|62830494|FG000|Overall Study|Ineligible pathology|0|||
33456035|NCT00096200|62830495|FG001|Overall Study|Ineligible pathology|1|||
33456036|NCT00096200|62830496|FG002|Overall Study|Ineligible pathology|0|||
33456037|NCT04059094|62830509|FG000|Overall Study|Adverse Event|0|||
33456038|NCT04059094|62830510|FG001|Overall Study|Adverse Event|0|||
33456039|NCT04059094|62830511|FG002|Overall Study|Adverse Event|0|||
33456040|NCT04059094|62830512|FG003|Overall Study|Adverse Event|0|||
33456041|NCT04059094|62830513|FG004|Overall Study|Adverse Event|1|||
33456042|NCT04059094|62830509|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
33456043|NCT04059094|62830510|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
33456044|NCT04059094|62830511|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
33456045|NCT04059094|62830512|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
33456046|NCT04059094|62830513|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
33456047|NCT00096044|62830529|FG000|Overall Study|Withdrawal by Subject|9|||
33456048|NCT00096044|62830529|FG000|Overall Study|Adverse Event|21|||
33456049|NCT00096044|62830529|FG000|Overall Study|Disease Progression|4|||
33456050|NCT03689374|62830535|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
33521709|NCT01338818|62907819|FG000|Overall Study|Protocol Deviation|4|||
33617491|NCT01887717|63018594|FG001|Overall Study|Physician Decision|2|||
33456051|NCT03689374|62830536|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
33617492|NCT01887717|63018593|FG000|Overall Study|Administrative reasons|5|||
33456052|NCT03689374|62830537|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
33456053|NCT03689374|62830535|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
33521710|NCT02823470|62907825|FG000|Overall Study|Adverse Event|1|||
33521711|NCT02823470|62907826|FG001|Overall Study|Adverse Event|0|||
33521712|NCT02823470|62907825|FG000|Overall Study|Study terminated by sponsor|8|||
33521713|NCT02823470|62907826|FG001|Overall Study|Study terminated by sponsor|15|||
33521714|NCT01371656|62907837|FG000|Overall Study|Death|7|||
33521715|NCT01371656|62907838|FG001|Overall Study|Death|4|||
33521716|NCT01371656|62907837|FG000|Overall Study|Physician Decision|46|||
33521717|NCT01371656|62907838|FG001|Overall Study|Physician Decision|7|||
33521718|NCT01371656|62907837|FG000|Overall Study|Withdrawal by Subject|7|||
33521719|NCT01371656|62907838|FG001|Overall Study|Withdrawal by Subject|0|||
33521720|NCT01371656|62907837|FG000|Overall Study|Ineligible|4|||
33617493|NCT01887717|63018594|FG001|Overall Study|Administrative reasons|2|||
33617494|NCT01886781|63018602|FG000|Overall Study|Protocol Violation|5|||
33617495|NCT01886781|63018603|FG001|Overall Study|Protocol Violation|0|||
33521721|NCT01371656|62907838|FG001|Overall Study|Ineligible|3|||
33521722|NCT01354106|62907844|FG000|Overall Study|Withdrawal by Subject|2|||
33521723|NCT01354028|62907850|FG000|Overall Study|Physician Decision|0|||
33521724|NCT01354028|62907851|FG001|Overall Study|Physician Decision|2|||
33521725|NCT01354028|62907850|FG000|Overall Study|Discharged before study start|2|||
33521726|NCT01354028|62907851|FG001|Overall Study|Discharged before study start|2|||
33521727|NCT01354028|62907850|FG000|Overall Study|No quiet alert state|0|||
33521728|NCT01354028|62907851|FG001|Overall Study|No quiet alert state|1|||
33521729|NCT01354964|62907865|FG000|Overall Study|Lost to Follow-up|2|||
33521730|NCT01354964|62907866|FG001|Overall Study|Lost to Follow-up|0|||
33521731|NCT01354964|62907865|FG000|Overall Study|IV access issues|1|||
33521732|NCT01354964|62907866|FG001|Overall Study|IV access issues|1|||
33521733|NCT01354964|62907865|FG000|Overall Study|Physician Decision|1|||
33521734|NCT01354964|62907866|FG001|Overall Study|Physician Decision|0|||
33521735|NCT01354496|62907876|FG000|Period 1|Adverse Event|0|||
33521736|NCT01354496|62907877|FG001|Period 1|Adverse Event|0|||
33617496|NCT01886781|63018602|FG000|Overall Study|Adverse Event|1|||
33521737|NCT01354496|62907878|FG002|Period 1|Adverse Event|1|||
33521738|NCT01354496|62907879|FG003|Period 1|Adverse Event|0|||
33521739|NCT01354496|62907880|FG004|Period 1|Adverse Event|0|||
33521740|NCT01354496|62907881|FG005|Period 1|Adverse Event|0|||
33521741|NCT01354496|62907876|FG000|Period 1|Physician Decision|0|||
33617497|NCT01886781|63018603|FG001|Overall Study|Adverse Event|0|||
33521742|NCT01354496|62907877|FG001|Period 1|Physician Decision|0|||
33521743|NCT01354496|62907878|FG002|Period 1|Physician Decision|1|||
33521744|NCT01354496|62907879|FG003|Period 1|Physician Decision|0|||
33521745|NCT01354496|62907880|FG004|Period 1|Physician Decision|0|||
33521746|NCT01354496|62907881|FG005|Period 1|Physician Decision|0|||
33521747|NCT01354496|62907876|FG000|Period 2|Adverse Event|0|||
33521748|NCT01354496|62907877|FG001|Period 2|Adverse Event|0|||
33521749|NCT01354496|62907878|FG002|Period 2|Adverse Event|0|||
33521750|NCT01354496|62907879|FG003|Period 2|Adverse Event|1|||
33521751|NCT01354496|62907880|FG004|Period 2|Adverse Event|0|||
33521752|NCT01354496|62907881|FG005|Period 2|Adverse Event|0|||
33521753|NCT01354496|62907876|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
33521754|NCT01354496|62907877|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
33521755|NCT01354496|62907878|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
33521756|NCT01354496|62907879|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
33521757|NCT01354496|62907880|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
33521758|NCT01354496|62907881|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
33617498|NCT01886781|63018602|FG000|Overall Study|Lost to Follow-up|5|||
33617499|NCT01886781|63018603|FG001|Overall Study|Lost to Follow-up|0|||
33617500|NCT01886781|63018602|FG000|Overall Study|Withdrawal by Subject|2|||
33617501|NCT01886781|63018603|FG001|Overall Study|Withdrawal by Subject|1|||
33617502|NCT01886781|63018602|FG000|Overall Study|Worsening of symptoms|1|||
33617503|NCT01886781|63018603|FG001|Overall Study|Worsening of symptoms|1|||
33617504|NCT01463098|63018623|FG000|Part A (11 Days)|Participant Choice|2|||
33617505|NCT01463098|63018624|FG001|Part A (11 Days)|Participant Choice|0|||
33617506|NCT01463098|63018625|FG002|Part A (11 Days)|Participant Choice|0|||
33617507|NCT01463098|63018626|FG003|Part A (11 Days)|Participant Choice|0|||
33617508|NCT01463098|63018627|FG004|Part A (11 Days)|Participant Choice|0|||
33617509|NCT01463098|63018628|FG005|Part A (11 Days)|Participant Choice|0|||
33617510|NCT01463098|63018629|FG006|Part A (11 Days)|Participant Choice|0|||
33617511|NCT01463098|63018630|FG007|Part A (11 Days)|Participant Choice|0|||
33617512|NCT01463098|63018631|FG008|Part A (11 Days)|Participant Choice|1|||
33456054|NCT03689374|62830536|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
33456055|NCT03689374|62830537|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
33456056|NCT03689374|62830535|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
33456057|NCT03689374|62830536|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
33456058|NCT03689374|62830537|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
33456059|NCT03689374|62830535|FG000|Treatment Period (Week 0 to 52)|Death|0|||
33456060|NCT03689374|62830536|FG001|Treatment Period (Week 0 to 52)|Death|11|||
33456061|NCT03689374|62830537|FG002|Treatment Period (Week 0 to 52)|Death|1|||
33456062|NCT00113360|62830543|FG000|Overall Study|Adverse Event|3|||
33456063|NCT00113360|62830543|FG000|Overall Study|Subject required surgery|1|||
33456064|NCT00113360|62830543|FG000|Overall Study|Did not meet eligibility criteria|3|||
33456065|NCT00123734|62830547|FG000|Overall Study|Death|3|||
33456066|NCT00123734|62830547|FG000|Overall Study|Lost to Follow-up|3|||
33456067|NCT00123734|62830547|FG000|Overall Study|Dropout|1|||
33521759|NCT02822222|62907904|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
33521760|NCT02822222|62907905|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
33617513|NCT01463098|63018632|FG009|Part A (11 Days)|Participant Choice|0|||
33456068|NCT00123734|62830547|FG000|Overall Study|Withdrawal by Subject|1|||
33521761|NCT02821910|62907917|FG000|Overall Study|Withdrawal by Subject|0|||
33617514|NCT01463098|63018633|FG010|Part A (11 Days)|Participant Choice|0|||
33617515|NCT01463098|63018634|FG011|Part A (11 Days)|Participant Choice|0|||
33617516|NCT01463098|63018635|FG012|Part A (11 Days)|Participant Choice|0|||
33456069|NCT00112736|62830557|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
33617517|NCT01463098|63018636|FG013|Part A (11 Days)|Participant Choice|0|||
33617518|NCT01463098|63018623|FG000|Part A (11 Days)|Lost to Follow-up|0|||
33456070|NCT00112736|62830558|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
33456071|NCT00123422|62830573|FG000|Overall Study|Physician Decision|2|||
33456072|NCT00123422|62830574|FG001|Overall Study|Physician Decision|2|||
33456073|NCT00123422|62830575|FG002|Overall Study|Physician Decision|6|||
33456074|NCT00123422|62830573|FG000|Overall Study|Withdrawal by Subject|1|||
33456075|NCT00123422|62830574|FG001|Overall Study|Withdrawal by Subject|2|||
33456076|NCT00123422|62830575|FG002|Overall Study|Withdrawal by Subject|2|||
33456077|NCT00123422|62830573|FG000|Overall Study|Lost to Follow-up|1|||
33456078|NCT00123422|62830574|FG001|Overall Study|Lost to Follow-up|2|||
33456079|NCT00123422|62830575|FG002|Overall Study|Lost to Follow-up|2|||
33456080|NCT04052620|62830585|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
33456081|NCT04052620|62830586|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
33456082|NCT04052620|62830585|FG000|Overall Study|Withdrawal by Subject|1|||
33456083|NCT04052620|62830586|FG001|Overall Study|Withdrawal by Subject|0|||
33456084|NCT04052620|62830585|FG000|Overall Study|Lost to Follow-up|1|||
33617519|NCT01463098|63018624|FG001|Part A (11 Days)|Lost to Follow-up|0|||
33617520|NCT01463098|63018625|FG002|Part A (11 Days)|Lost to Follow-up|0|||
33456085|NCT04052620|62830586|FG001|Overall Study|Lost to Follow-up|1|||
33456086|NCT04052620|62830585|FG000|Overall Study|Adverse Event|1|||
33456087|NCT04052620|62830586|FG001|Overall Study|Adverse Event|0|||
33456088|NCT04052620|62830585|FG000|Overall Study|Subject did not meet study Criteria|0|||
33456089|NCT04052620|62830586|FG001|Overall Study|Subject did not meet study Criteria|1|||
33456090|NCT04052620|62830585|FG000|Overall Study|Screened failure, randomized by mistake|0|||
33456091|NCT04052620|62830586|FG001|Overall Study|Screened failure, randomized by mistake|1|||
33456092|NCT04052620|62830585|FG000|Overall Study|Personal reasons|2|||
33521762|NCT02821910|62907918|FG001|Overall Study|Withdrawal by Subject|0|||
33521763|NCT02821910|62907919|FG002|Overall Study|Withdrawal by Subject|1|||
33617521|NCT01463098|63018626|FG003|Part A (11 Days)|Lost to Follow-up|0|||
33617522|NCT01463098|63018627|FG004|Part A (11 Days)|Lost to Follow-up|1|||
33617523|NCT01463098|63018628|FG005|Part A (11 Days)|Lost to Follow-up|0|||
33456093|NCT04052620|62830586|FG001|Overall Study|Personal reasons|4|||
33456094|NCT04052620|62830585|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
33325178|NCT00952341|62701898|FG001|Cycle 1|Adverse Event|1|||
33325179|NCT00952341|62701897|FG000|Cycle 1|Withdrawal by Subject|3|||
33325180|NCT00952341|62701898|FG001|Cycle 1|Withdrawal by Subject|8|||
33325181|NCT00952341|62701897|FG000|Cycle 1|Protocol Violation|2|||
33325182|NCT00952341|62701898|FG001|Cycle 1|Protocol Violation|1|||
33325183|NCT00952341|62701897|FG000|Cycle 1|Lost to Follow-up|11|||
33456095|NCT04052620|62830586|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
33456096|NCT00112580|62830594|FG000|Overall Study|Adverse Event|1|||
33456097|NCT00112580|62830595|FG001|Overall Study|Adverse Event|2|||
33456098|NCT00112580|62830594|FG000|Overall Study|Disease progression|5|||
33456099|NCT00112580|62830595|FG001|Overall Study|Disease progression|16|||
33456100|NCT00112580|62830594|FG000|Overall Study|Participant withdrew consent|2|||
33456101|NCT00112580|62830595|FG001|Overall Study|Participant withdrew consent|1|||
33456102|NCT04238650|62830602|FG000|Overall Study|Withdrawal by Subject|0|||
33456103|NCT04238650|62830603|FG001|Overall Study|Withdrawal by Subject|1|||
33456104|NCT00095576|62830611|FG000|Overall Study|Adverse Event|5|||
33521764|NCT02821910|62907920|FG003|Overall Study|Withdrawal by Subject|0|||
33521765|NCT02821910|62907921|FG004|Overall Study|Withdrawal by Subject|0|||
33521766|NCT02821910|62907922|FG005|Overall Study|Withdrawal by Subject|1|||
33521767|NCT02821910|62907917|FG000|Overall Study|Other than specified|1|||
33521768|NCT02821910|62907918|FG001|Overall Study|Other than specified|0|||
33521769|NCT02821910|62907919|FG002|Overall Study|Other than specified|1|||
33521770|NCT02821910|62907920|FG003|Overall Study|Other than specified|0|||
33456105|NCT00095576|62830612|FG001|Overall Study|Adverse Event|3|||
33521771|NCT02821910|62907921|FG004|Overall Study|Other than specified|0|||
33521772|NCT02821910|62907922|FG005|Overall Study|Other than specified|0|||
33521773|NCT02817776|62907936|FG000|Overall Study|Excluded|33|||
33456106|NCT00095576|62830611|FG000|Overall Study|Lost to Follow-up|233|||
33456107|NCT00095576|62830612|FG001|Overall Study|Lost to Follow-up|229|||
33456108|NCT00095576|62830611|FG000|Overall Study|Protocol Violation|1|||
33456109|NCT00095576|62830612|FG001|Overall Study|Protocol Violation|0|||
33456110|NCT00095576|62830611|FG000|Overall Study|Withdrawal by Subject|34|||
33521774|NCT02817776|62907936|FG000|Overall Study|Lost to Follow-up|20|||
33521775|NCT02817776|62907936|FG000|Overall Study|Withdrawal by Subject|33|||
33456111|NCT00095576|62830612|FG001|Overall Study|Withdrawal by Subject|47|||
33521776|NCT02817776|62907936|FG000|Overall Study|Death|2|||
33521777|NCT03138655|62907948|FG000|Overall Study|Adverse Event|2|||
33456112|NCT00095576|62830611|FG000|Overall Study|Option to switch to a rollover study|1097|||
33521778|NCT03138655|62907949|FG001|Overall Study|Adverse Event|1|||
33521779|NCT03138655|62907950|FG002|Overall Study|Adverse Event|2|||
33521780|NCT03138655|62907951|FG003|Overall Study|Adverse Event|1|||
33521781|NCT03138655|62907952|FG004|Overall Study|Adverse Event|1|||
33521782|NCT03138655|62907953|FG005|Overall Study|Adverse Event|4|||
33521783|NCT03138655|62907954|FG006|Overall Study|Adverse Event|2|||
33521784|NCT03138655|62907955|FG007|Overall Study|Adverse Event|2|||
33521785|NCT03138655|62907948|FG000|Overall Study|Withdrawal by Subject|0|||
33456113|NCT00095576|62830612|FG001|Overall Study|Option to switch to a rollover study|1099|||
33456114|NCT00095576|62830611|FG000|Overall Study|Site terminated|75|||
33456115|NCT00095576|62830612|FG001|Overall Study|Site terminated|67|||
33521786|NCT03138655|62907949|FG001|Overall Study|Withdrawal by Subject|1|||
33521787|NCT03138655|62907950|FG002|Overall Study|Withdrawal by Subject|0|||
33456116|NCT00095576|62830611|FG000|Overall Study|Subject moved|30|||
33456117|NCT00095576|62830612|FG001|Overall Study|Subject moved|36|||
33456118|NCT04049578|62830618|FG000|Overall Study|Physician Decision|1|||
33456119|NCT04044352|62830622|FG000|Overall Study|Lost to Follow-up|9|||
33456120|NCT04044352|62830622|FG000|Overall Study|Withdrawal by Subject|2|||
33456121|NCT04043962|62830627|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
33521788|NCT03138655|62907951|FG003|Overall Study|Withdrawal by Subject|0|||
33521789|NCT03138655|62907952|FG004|Overall Study|Withdrawal by Subject|0|||
33521790|NCT03138655|62907953|FG005|Overall Study|Withdrawal by Subject|0|||
33521791|NCT03138655|62907954|FG006|Overall Study|Withdrawal by Subject|1|||
33456122|NCT04043962|62830627|FG000|Post-Treatment|Withdrawal by Subject|5|||
33456123|NCT04043962|62830627|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
33456124|NCT04043728|62830634|FG000|Overall Study|Lost to Follow-up|1|||
33521792|NCT03138655|62907955|FG007|Overall Study|Withdrawal by Subject|0|||
33456125|NCT04043728|62830635|FG001|Overall Study|Lost to Follow-up|2|||
33617524|NCT01463098|63018629|FG006|Part A (11 Days)|Lost to Follow-up|0|||
33617525|NCT01463098|63018630|FG007|Part A (11 Days)|Lost to Follow-up|0|||
33617526|NCT01463098|63018631|FG008|Part A (11 Days)|Lost to Follow-up|0|||
33617527|NCT01463098|63018632|FG009|Part A (11 Days)|Lost to Follow-up|0|||
33617528|NCT01463098|63018633|FG010|Part A (11 Days)|Lost to Follow-up|0|||
33617529|NCT01463098|63018634|FG011|Part A (11 Days)|Lost to Follow-up|0|||
33617530|NCT01463098|63018635|FG012|Part A (11 Days)|Lost to Follow-up|0|||
33617531|NCT01463098|63018636|FG013|Part A (11 Days)|Lost to Follow-up|0|||
33617532|NCT01463098|63018623|FG000|Part B (11 Days)|Participant Choice|0|||
33617533|NCT01463098|63018624|FG001|Part B (11 Days)|Participant Choice|0|||
33617534|NCT01463098|63018625|FG002|Part B (11 Days)|Participant Choice|0|||
33617535|NCT01463098|63018626|FG003|Part B (11 Days)|Participant Choice|0|||
33617536|NCT01463098|63018627|FG004|Part B (11 Days)|Participant Choice|0|||
33617537|NCT01463098|63018628|FG005|Part B (11 Days)|Participant Choice|0|||
33617538|NCT01463098|63018629|FG006|Part B (11 Days)|Participant Choice|0|||
33617539|NCT01463098|63018630|FG007|Part B (11 Days)|Participant Choice|0|||
33617540|NCT01463098|63018631|FG008|Part B (11 Days)|Participant Choice|0|||
33617541|NCT01463098|63018632|FG009|Part B (11 Days)|Participant Choice|0|||
33617542|NCT01463098|63018633|FG010|Part B (11 Days)|Participant Choice|0|||
33617543|NCT01463098|63018634|FG011|Part B (11 Days)|Participant Choice|1|||
33617544|NCT01463098|63018635|FG012|Part B (11 Days)|Participant Choice|0|||
33617545|NCT01463098|63018636|FG013|Part B (11 Days)|Participant Choice|0|||
33617546|NCT01626079|63018688|FG000|Overall Study|Death|117|||
33617547|NCT01626079|63018689|FG001|Overall Study|Death|153|||
33521793|NCT03138655|62907948|FG000|Overall Study|Reason not Specified|1|||
33521794|NCT03138655|62907949|FG001|Overall Study|Reason not Specified|0|||
33521795|NCT03138655|62907950|FG002|Overall Study|Reason not Specified|0|||
33521796|NCT03138655|62907951|FG003|Overall Study|Reason not Specified|2|||
33521797|NCT03138655|62907952|FG004|Overall Study|Reason not Specified|1|||
33521798|NCT03138655|62907953|FG005|Overall Study|Reason not Specified|1|||
33521799|NCT03138655|62907954|FG006|Overall Study|Reason not Specified|0|||
33521800|NCT03138655|62907955|FG007|Overall Study|Reason not Specified|0|||
33521801|NCT02820038|62907981|FG000|Overall Study|Lost to Follow-up|7|||
33521802|NCT02820038|62907982|FG001|Overall Study|Lost to Follow-up|11|||
33521803|NCT02820038|62907983|FG002|Overall Study|Lost to Follow-up|2|||
33521804|NCT02820038|62907984|FG003|Overall Study|Lost to Follow-up|9|||
33521805|NCT02820038|62907981|FG000|Overall Study|Withdrawal by Subject|3|||
33521806|NCT02820038|62907982|FG001|Overall Study|Withdrawal by Subject|14|||
33521807|NCT02820038|62907983|FG002|Overall Study|Withdrawal by Subject|3|||
33521808|NCT02820038|62907984|FG003|Overall Study|Withdrawal by Subject|13|||
33521809|NCT02819804|62907995|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
33521810|NCT02819726|62908002|FG000|Part A (All Participants)|Lost to Follow-up|0|||
33521811|NCT02819726|62908003|FG001|Part A (All Participants)|Lost to Follow-up|1|||
33521812|NCT02819726|62908004|FG002|Part A (All Participants)|Lost to Follow-up|0|||
33521813|NCT02819726|62908005|FG003|Part A (All Participants)|Lost to Follow-up|0|||
33521814|NCT02819726|62908002|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
33521815|NCT02819726|62908003|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
33521816|NCT02819726|62908004|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
33521817|NCT02819726|62908005|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
33521818|NCT02819726|62908002|FG000|Part A (All Participants)|Protocol non-compliance|3|||
33617548|NCT01626079|63018690|FG002|Overall Study|Death|39|||
33617549|NCT01626079|63018688|FG000|Overall Study|Withdrawal by Subject|15|||
33617550|NCT01626079|63018689|FG001|Overall Study|Withdrawal by Subject|39|||
33521819|NCT02819726|62908003|FG001|Part A (All Participants)|Protocol non-compliance|4|||
33521820|NCT02819726|62908004|FG002|Part A (All Participants)|Protocol non-compliance|5|||
33521821|NCT02819726|62908005|FG003|Part A (All Participants)|Protocol non-compliance|0|||
33521822|NCT02819726|62908002|FG000|Part B (All Participants)|Lost to Follow-up|1|||
33617551|NCT01626079|63018690|FG002|Overall Study|Withdrawal by Subject|5|||
33617552|NCT01626079|63018688|FG000|Overall Study|Lost to Follow-up|5|||
33617553|NCT01626079|63018689|FG001|Overall Study|Lost to Follow-up|4|||
33456126|NCT04043728|62830636|FG002|Overall Study|Lost to Follow-up|0|||
33456127|NCT04043416|62830646|FG000|Washout|Change in health condition|0|||
33456128|NCT04043416|62830647|FG001|Washout|Change in health condition|1|||
33456129|NCT00095498|62830659|FG000|Overall Study|Physician Decision|9|||
33456130|NCT00095498|62830660|FG001|Overall Study|Physician Decision|10|||
33456131|NCT00095498|62830661|FG002|Overall Study|Physician Decision|8|||
33617554|NCT01626079|63018690|FG002|Overall Study|Lost to Follow-up|2|||
33617555|NCT01626079|63018688|FG000|Overall Study|Missed Visits|13|||
33617556|NCT01626079|63018689|FG001|Overall Study|Missed Visits|5|||
33617557|NCT01626079|63018690|FG002|Overall Study|Missed Visits|6|||
33617558|NCT01462942|63018706|FG000|Overall Study|Adverse Event|7|||
33617559|NCT01462942|63018707|FG001|Overall Study|Adverse Event|12|||
33617560|NCT01462942|63018708|FG002|Overall Study|Adverse Event|10|||
33617561|NCT01462942|63018709|FG003|Overall Study|Adverse Event|11|||
33617562|NCT01462942|63018710|FG004|Overall Study|Adverse Event|11|||
33617563|NCT01462942|63018706|FG000|Overall Study|Other, including COPD exacerbation|3|||
33617564|NCT01462942|63018707|FG001|Overall Study|Other, including COPD exacerbation|5|||
33617565|NCT01462942|63018708|FG002|Overall Study|Other, including COPD exacerbation|2|||
33617566|NCT01462942|63018709|FG003|Overall Study|Other, including COPD exacerbation|8|||
33617567|NCT01462942|63018710|FG004|Overall Study|Other, including COPD exacerbation|5|||
33617568|NCT01462942|63018706|FG000|Overall Study|Withdrawal by Subject|14|||
33617569|NCT01462942|63018707|FG001|Overall Study|Withdrawal by Subject|10|||
33617570|NCT01462942|63018708|FG002|Overall Study|Withdrawal by Subject|14|||
33617571|NCT01462942|63018709|FG003|Overall Study|Withdrawal by Subject|16|||
33617572|NCT01462942|63018710|FG004|Overall Study|Withdrawal by Subject|19|||
33617573|NCT01462942|63018706|FG000|Overall Study|Lack of Efficacy|6|||
33617574|NCT01462942|63018707|FG001|Overall Study|Lack of Efficacy|0|||
33617575|NCT01462942|63018708|FG002|Overall Study|Lack of Efficacy|4|||
33617576|NCT01462942|63018709|FG003|Overall Study|Lack of Efficacy|5|||
33617577|NCT01462942|63018710|FG004|Overall Study|Lack of Efficacy|3|||
33617578|NCT01462942|63018706|FG000|Overall Study|Lost to Follow-up|0|||
33617579|NCT01462942|63018707|FG001|Overall Study|Lost to Follow-up|1|||
33617580|NCT01462942|63018708|FG002|Overall Study|Lost to Follow-up|1|||
33617581|NCT01462942|63018709|FG003|Overall Study|Lost to Follow-up|1|||
33617582|NCT01462942|63018710|FG004|Overall Study|Lost to Follow-up|1|||
33617583|NCT01462942|63018706|FG000|Overall Study|Protocol Violation|4|||
33617584|NCT01462942|63018707|FG001|Overall Study|Protocol Violation|6|||
33617585|NCT01462942|63018708|FG002|Overall Study|Protocol Violation|9|||
33617586|NCT01462942|63018709|FG003|Overall Study|Protocol Violation|9|||
33617587|NCT01462942|63018710|FG004|Overall Study|Protocol Violation|6|||
33456132|NCT00095498|62830659|FG000|Overall Study|Adverse Event|1|||
33521823|NCT02819726|62908003|FG001|Part B (All Participants)|Lost to Follow-up|1|||
33521824|NCT02819726|62908004|FG002|Part B (All Participants)|Lost to Follow-up|2|||
33521825|NCT02819726|62908005|FG003|Part B (All Participants)|Lost to Follow-up|2|||
33521826|NCT02819726|62908002|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
33521827|NCT02819726|62908003|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
33521828|NCT02819726|62908004|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
33521829|NCT02819726|62908005|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
33521830|NCT02819726|62908002|FG000|Part B (All Participants)|Protocol non-compliance|0|||
33521831|NCT02819726|62908003|FG001|Part B (All Participants)|Protocol non-compliance|0|||
33521832|NCT02819726|62908004|FG002|Part B (All Participants)|Protocol non-compliance|1|||
33521833|NCT02819726|62908005|FG003|Part B (All Participants)|Protocol non-compliance|0|||
33456133|NCT00095498|62830660|FG001|Overall Study|Adverse Event|0|||
33456134|NCT00095498|62830661|FG002|Overall Study|Adverse Event|1|||
33521834|NCT02816138|62908013|FG000|Overall Study|Adverse Event|1|||
33521835|NCT02815670|62908017|FG000|Overall Study|Prematurely discontinued of the trial|1|||
33617588|NCT01462630|63018722|FG000|Overall Study|Did not initiate therapy|3|||
33617589|NCT01462630|63018722|FG000|Overall Study|Death|1|||
33617590|NCT01462630|63018722|FG000|Overall Study|Protocol Violation|2|||
33617591|NCT01462630|63018722|FG000|Overall Study|Adverse Event|1|||
33617592|NCT01504204|63018728|FG000|Overall Study|Lost to Follow-up|1|||
33617593|NCT01504204|63018729|FG001|Overall Study|Lost to Follow-up|1|||
33617594|NCT01485640|63018735|FG000|Overall Study|Adverse Event|10|||
33617595|NCT01485640|63018735|FG000|Overall Study|Lack of Efficacy|2|||
33521836|NCT02809976|62908021|FG000|Overall Study|Lost to Follow-up|1|||
33521837|NCT02809976|62908021|FG000|Overall Study|Withdrawal by Subject|1|||
33521838|NCT02880865|62908027|FG000|Overall Study|Adverse Event|1|||
33521839|NCT02880865|62908028|FG001|Overall Study|Adverse Event|0|||
33521840|NCT02880865|62908027|FG000|Overall Study|Withdrawal by Subject|0|||
33521841|NCT02880865|62908028|FG001|Overall Study|Withdrawal by Subject|2|||
33521842|NCT02880865|62908027|FG000|Overall Study|Physician Decision|0|||
33521843|NCT02880865|62908028|FG001|Overall Study|Physician Decision|1|||
33521844|NCT01854385|62908055|FG000|Pre-Treatment|Withdrawal by Subject|4|||
33521845|NCT01854385|62908055|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
33521846|NCT01854385|62908055|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
33521847|NCT01854385|62908055|FG000|Pre-Treatment|Unable to come for study visits|1|||
33521848|NCT01854385|62908055|FG000|Treatment|Lost to Follow-up|1|||
33521849|NCT02809118|62908062|FG000|Overall Study|Withdrawal by Subject|0|||
33521850|NCT02809118|62908063|FG001|Overall Study|Withdrawal by Subject|1|||
33521851|NCT02809118|62908064|FG002|Overall Study|Withdrawal by Subject|1|||
33521852|NCT03604159|62908074|FG000|Overall Study|Lost to Follow-up|6|||
33521853|NCT03604159|62908075|FG001|Overall Study|Lost to Follow-up|7|||
33617596|NCT01485640|63018735|FG000|Overall Study|Protocol Violation|1|||
33617597|NCT01485640|63018735|FG000|Overall Study|Withdrawal by Subject|14|||
33617598|NCT01485640|63018735|FG000|Overall Study|Terminated by Sponsor|95|||
33617599|NCT02118961|63018741|FG000|Overall Study|Withdrawal by Subject|1|||
33617600|NCT02118961|63018742|FG001|Overall Study|Withdrawal by Subject|0|||
33617601|NCT02140645|63018754|FG000|Overall Study|Not linked|5489|||
33617602|NCT02140645|63018755|FG001|Overall Study|Not linked|61654|||
33617603|NCT02140645|63018756|FG002|Overall Study|Not linked|4236|||
33456135|NCT00095498|62830659|FG000|Overall Study|Withdrawal by Subject|15|||
33456136|NCT00095498|62830660|FG001|Overall Study|Withdrawal by Subject|16|||
33456137|NCT00095498|62830661|FG002|Overall Study|Withdrawal by Subject|15|||
33456138|NCT00095498|62830659|FG000|Overall Study|Disease progression|0|||
33456139|NCT00095498|62830660|FG001|Overall Study|Disease progression|1|||
33456140|NCT00095498|62830661|FG002|Overall Study|Disease progression|1|||
33456141|NCT00095498|62830659|FG000|Overall Study|Ineligibility determined|3|||
33456142|NCT00095498|62830660|FG001|Overall Study|Ineligibility determined|0|||
33456143|NCT00095498|62830661|FG002|Overall Study|Ineligibility determined|2|||
33456144|NCT00095498|62830659|FG000|Overall Study|Lost to Follow-up|1|||
33456145|NCT00095498|62830660|FG001|Overall Study|Lost to Follow-up|1|||
33521854|NCT02808338|62908081|FG000|Screening|Screen Failure|10|||
33521855|NCT02808338|62908081|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
33521856|NCT02808338|62908081|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
33521857|NCT02807948|62908092|FG000|Overall Study|Physician Decision|1|||
33521858|NCT02807948|62908093|FG001|Overall Study|Physician Decision|0|||
33521859|NCT02879383|62908102|FG000|First 24 Weeks|Physician Decision|0|||
33521860|NCT02879383|62908103|FG001|First 24 Weeks|Physician Decision|1|||
33617604|NCT02140645|63018757|FG003|Overall Study|Not linked|13833|||
33617605|NCT02140645|63018758|FG004|Overall Study|Not linked|3286|||
33456146|NCT00095498|62830661|FG002|Overall Study|Lost to Follow-up|2|||
33456147|NCT00095498|62830659|FG000|Overall Study|Noncompliance|1|||
33456148|NCT00095498|62830660|FG001|Overall Study|Noncompliance|0|||
33617606|NCT02140645|63018759|FG005|Overall Study|Not linked|70896|||
33617607|NCT02140567|63018768|FG000|Overall Study|Problems with recording equipment|6|||
33521861|NCT02879383|62908104|FG002|First 24 Weeks|Physician Decision|0|||
33521862|NCT02879383|62908105|FG003|First 24 Weeks|Physician Decision|0|||
33521863|NCT02049710|62908119|FG000|Overall Study|Lost to Follow-up|319|||
33521864|NCT02049710|62908120|FG001|Overall Study|Lost to Follow-up|324|||
33521865|NCT02806232|62908148|FG000|Overall Study|Lost to Follow-up|1|||
33521866|NCT02806232|62908149|FG001|Overall Study|Lost to Follow-up|2|||
33521867|NCT02806232|62908150|FG002|Overall Study|Lost to Follow-up|1|||
33521868|NCT02806232|62908151|FG003|Overall Study|Lost to Follow-up|0|||
33521869|NCT02806232|62908152|FG004|Overall Study|Lost to Follow-up|0|||
33521870|NCT02806232|62908153|FG005|Overall Study|Lost to Follow-up|1|||
33521871|NCT02806232|62908154|FG006|Overall Study|Lost to Follow-up|0|||
33521872|NCT02806232|62908155|FG007|Overall Study|Lost to Follow-up|0|||
33521873|NCT02806232|62908156|FG008|Overall Study|Lost to Follow-up|0|||
33521874|NCT02806232|62908148|FG000|Overall Study|Withdrawal by Subject|0|||
33521875|NCT02806232|62908149|FG001|Overall Study|Withdrawal by Subject|2|||
33617608|NCT02140411|63018773|FG000|Overall Study|Adverse Event|1|||
33617609|NCT02139943|63018780|FG000|Overall Study|Adverse Event|0|||
33521876|NCT02806232|62908150|FG002|Overall Study|Withdrawal by Subject|0|||
33521877|NCT02806232|62908151|FG003|Overall Study|Withdrawal by Subject|0|||
33521878|NCT02806232|62908152|FG004|Overall Study|Withdrawal by Subject|2|||
33521879|NCT02806232|62908153|FG005|Overall Study|Withdrawal by Subject|1|||
33521880|NCT02806232|62908154|FG006|Overall Study|Withdrawal by Subject|0|||
33521881|NCT02806232|62908155|FG007|Overall Study|Withdrawal by Subject|0|||
33521882|NCT02806232|62908156|FG008|Overall Study|Withdrawal by Subject|0|||
33521883|NCT02807402|62908176|FG000|Overall Study|Failure to Return|1|||
33521884|NCT02807402|62908176|FG000|Overall Study|Death|3|||
33521885|NCT02807402|62908176|FG000|Overall Study|Other|2|||
33521886|NCT00392327|62908196|FG000|Overall Study|Death|1|||
33521887|NCT00392327|62908197|FG001|Overall Study|Death|0|||
33521888|NCT00392327|62908198|FG002|Overall Study|Death|1|||
33521889|NCT00392327|62908199|FG003|Overall Study|Death|0|||
33521890|NCT00392327|62908200|FG004|Overall Study|Death|0|||
33521891|NCT00392327|62908201|FG005|Overall Study|Death|0|||
33521892|NCT00392327|62908202|FG006|Overall Study|Death|0|||
33521893|NCT00392327|62908203|FG007|Overall Study|Death|0|||
33521894|NCT00392327|62908196|FG000|Overall Study|Lack of Efficacy|8|||
33521895|NCT00392327|62908197|FG001|Overall Study|Lack of Efficacy|8|||
33617610|NCT02139943|63018781|FG001|Overall Study|Adverse Event|1|||
33617611|NCT02139943|63018782|FG002|Overall Study|Adverse Event|2|||
33456149|NCT00095498|62830661|FG002|Overall Study|Noncompliance|1|||
33456150|NCT00095498|62830659|FG000|Overall Study|Other|6|||
33617612|NCT02139943|63018780|FG000|Overall Study|Lost to Follow-up|3|||
33617613|NCT02139943|63018781|FG001|Overall Study|Lost to Follow-up|2|||
33617614|NCT02139943|63018782|FG002|Overall Study|Lost to Follow-up|2|||
33617615|NCT02139943|63018780|FG000|Overall Study|Withdrawal by Subject|4|||
33617616|NCT02139943|63018781|FG001|Overall Study|Withdrawal by Subject|3|||
33617617|NCT02139943|63018782|FG002|Overall Study|Withdrawal by Subject|0|||
33456151|NCT00095498|62830660|FG001|Overall Study|Other|7|||
33456152|NCT00095498|62830661|FG002|Overall Study|Other|6|||
33456153|NCT00095498|62830659|FG000|Overall Study|Protocol Violation|0|||
33456154|NCT00095498|62830660|FG001|Overall Study|Protocol Violation|0|||
33456155|NCT00095498|62830661|FG002|Overall Study|Protocol Violation|1|||
33456156|NCT00095498|62830659|FG000|Overall Study|Requirement for alternative therapy|1|||
33456157|NCT00095498|62830660|FG001|Overall Study|Requirement for alternative therapy|0|||
33456158|NCT00095498|62830661|FG002|Overall Study|Requirement for alternative therapy|2|||
33456159|NCT04237792|62830675|FG000|Treatment (Day 1)|Adverse Event|1|||
33521896|NCT00392327|62908198|FG002|Overall Study|Lack of Efficacy|9|||
33617618|NCT02139943|63018780|FG000|Overall Study|Other|0|||
33521897|NCT00392327|62908199|FG003|Overall Study|Lack of Efficacy|6|||
33521898|NCT00392327|62908200|FG004|Overall Study|Lack of Efficacy|3|||
33521899|NCT00392327|62908201|FG005|Overall Study|Lack of Efficacy|3|||
33617619|NCT02139943|63018781|FG001|Overall Study|Other|0|||
33617620|NCT02139943|63018782|FG002|Overall Study|Other|1|||
33521900|NCT00392327|62908202|FG006|Overall Study|Lack of Efficacy|3|||
33617621|NCT02139943|63018780|FG000|Overall Study|Participant wishes to discontinue|2|||
33617622|NCT02139943|63018781|FG001|Overall Study|Participant wishes to discontinue|0|||
33456160|NCT04237792|62830676|FG001|Treatment (Day 1)|Adverse Event|0|||
33456161|NCT04237792|62830677|FG002|Treatment (Day 1)|Adverse Event|0|||
33456162|NCT04237792|62830678|FG003|Treatment (Day 1)|Adverse Event|0|||
33456163|NCT04237792|62830679|FG004|Treatment (Day 1)|Adverse Event|1|||
33521901|NCT00392327|62908203|FG007|Overall Study|Lack of Efficacy|3|||
33521902|NCT00392327|62908196|FG000|Overall Study|Physician Decision|3|||
33521903|NCT00392327|62908197|FG001|Overall Study|Physician Decision|5|||
33617623|NCT02139943|63018782|FG002|Overall Study|Participant wishes to discontinue|0|||
33617624|NCT02139943|63018780|FG000|Overall Study|Participant in Poor Compliance|1|||
33617625|NCT02139943|63018781|FG001|Overall Study|Participant in Poor Compliance|0|||
33617626|NCT02139943|63018782|FG002|Overall Study|Participant in Poor Compliance|1|||
33617627|NCT02139943|63018780|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
33617628|NCT02139943|63018781|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
33617629|NCT02139943|63018782|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
33617630|NCT01485172|63018796|FG000|Overall Study|Adverse Event|2|||
33617631|NCT01485172|63018797|FG001|Overall Study|Adverse Event|1|||
33617632|NCT01485172|63018798|FG002|Overall Study|Adverse Event|2|||
33617633|NCT01485172|63018799|FG003|Overall Study|Adverse Event|2|||
33456164|NCT04237792|62830680|FG005|Treatment (Day 1)|Adverse Event|1|||
33456165|NCT04237792|62830675|FG000|Treatment (Day 1)|Other|0|||
33456166|NCT04237792|62830676|FG001|Treatment (Day 1)|Other|0|||
33456167|NCT04237792|62830677|FG002|Treatment (Day 1)|Other|1|||
33456168|NCT04237792|62830678|FG003|Treatment (Day 1)|Other|0|||
33521904|NCT00392327|62908198|FG002|Overall Study|Physician Decision|2|||
33521905|NCT00392327|62908199|FG003|Overall Study|Physician Decision|2|||
33456169|NCT04237792|62830679|FG004|Treatment (Day 1)|Other|0|||
33456170|NCT04237792|62830680|FG005|Treatment (Day 1)|Other|1|||
33456171|NCT04237792|62830675|FG000|Treatment (Day 1)|Not treated|1|||
33456172|NCT04237792|62830676|FG001|Treatment (Day 1)|Not treated|1|||
33456173|NCT04237792|62830677|FG002|Treatment (Day 1)|Not treated|2|||
33456174|NCT04237792|62830678|FG003|Treatment (Day 1)|Not treated|1|||
33456175|NCT04237792|62830679|FG004|Treatment (Day 1)|Not treated|0|||
33521906|NCT00392327|62908200|FG004|Overall Study|Physician Decision|0|||
33521907|NCT00392327|62908201|FG005|Overall Study|Physician Decision|1|||
33521908|NCT00392327|62908202|FG006|Overall Study|Physician Decision|5|||
33521909|NCT00392327|62908203|FG007|Overall Study|Physician Decision|3|||
33521910|NCT00392327|62908196|FG000|Overall Study|Protocol Violation|0|||
33521911|NCT00392327|62908197|FG001|Overall Study|Protocol Violation|0|||
33521912|NCT00392327|62908198|FG002|Overall Study|Protocol Violation|1|||
33521913|NCT00392327|62908199|FG003|Overall Study|Protocol Violation|0|||
33521914|NCT00392327|62908200|FG004|Overall Study|Protocol Violation|0|||
33521915|NCT00392327|62908201|FG005|Overall Study|Protocol Violation|0|||
33521916|NCT00392327|62908202|FG006|Overall Study|Protocol Violation|0|||
33521917|NCT00392327|62908203|FG007|Overall Study|Protocol Violation|0|||
33521918|NCT00392327|62908196|FG000|Overall Study|Withdrawal by Subject|3|||
33521919|NCT00392327|62908197|FG001|Overall Study|Withdrawal by Subject|2|||
33521920|NCT00392327|62908198|FG002|Overall Study|Withdrawal by Subject|4|||
33521921|NCT00392327|62908199|FG003|Overall Study|Withdrawal by Subject|6|||
33521922|NCT00392327|62908200|FG004|Overall Study|Withdrawal by Subject|0|||
33521923|NCT00392327|62908201|FG005|Overall Study|Withdrawal by Subject|1|||
33521924|NCT00392327|62908202|FG006|Overall Study|Withdrawal by Subject|1|||
33521925|NCT00392327|62908203|FG007|Overall Study|Withdrawal by Subject|5|||
33521926|NCT00392327|62908196|FG000|Overall Study|Ineligible|0|||
33521927|NCT00392327|62908197|FG001|Overall Study|Ineligible|4|||
33521928|NCT00392327|62908198|FG002|Overall Study|Ineligible|3|||
33521929|NCT00392327|62908199|FG003|Overall Study|Ineligible|2|||
33521930|NCT00392327|62908200|FG004|Overall Study|Ineligible|0|||
33521931|NCT00392327|62908201|FG005|Overall Study|Ineligible|0|||
33521932|NCT00392327|62908202|FG006|Overall Study|Ineligible|0|||
33521933|NCT00392327|62908203|FG007|Overall Study|Ineligible|0|||
33521934|NCT02960490|62908223|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
33521935|NCT02960490|62908224|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
33521936|NCT02960490|62908225|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33521937|NCT02960490|62908226|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33521938|NCT02960490|62908227|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33521939|NCT02960490|62908228|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33521940|NCT02960490|62908229|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33521941|NCT02960490|62908230|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33521942|NCT02960490|62908231|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33521943|NCT02960490|62908232|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33617634|NCT01485172|63018800|FG004|Overall Study|Adverse Event|1|||
33617635|NCT01485172|63018801|FG005|Overall Study|Adverse Event|2|||
33617636|NCT01485172|63018796|FG000|Overall Study|Lack of Efficacy|2|||
33521944|NCT02960490|62908223|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33521945|NCT02960490|62908224|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
33521946|NCT02960490|62908225|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33521947|NCT02960490|62908226|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33617637|NCT01485172|63018797|FG001|Overall Study|Lack of Efficacy|0|||
33617638|NCT01485172|63018798|FG002|Overall Study|Lack of Efficacy|0|||
33456176|NCT04237792|62830680|FG005|Treatment (Day 1)|Not treated|1|||
33456177|NCT00122954|62830711|FG000|Overall Study|Withdrawal by Subject|2|||
33456178|NCT00122954|62830712|FG001|Overall Study|Withdrawal by Subject|2|||
33456179|NCT00122954|62830711|FG000|Overall Study|Protocol Violation|0|||
33456180|NCT00122954|62830712|FG001|Overall Study|Protocol Violation|1|||
33456181|NCT04491994|62830720|FG000|Overall Study|Withdrawal by Subject|10|||
33617639|NCT01485172|63018799|FG003|Overall Study|Lack of Efficacy|0|||
33521948|NCT02960490|62908227|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33521949|NCT02960490|62908228|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33521950|NCT02960490|62908229|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33521951|NCT02960490|62908230|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33521952|NCT02960490|62908231|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33521953|NCT02960490|62908232|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33521954|NCT02960490|62908223|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
33617640|NCT01485172|63018800|FG004|Overall Study|Lack of Efficacy|0|||
33617641|NCT01485172|63018801|FG005|Overall Study|Lack of Efficacy|0|||
33617642|NCT01485172|63018796|FG000|Overall Study|Protocol Violation|0|||
33617643|NCT01485172|63018797|FG001|Overall Study|Protocol Violation|0|||
33521955|NCT02960490|62908224|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
33521956|NCT02960490|62908225|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33521957|NCT02960490|62908226|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33521958|NCT02960490|62908227|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33521959|NCT02960490|62908228|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33521960|NCT02960490|62908229|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33521961|NCT02960490|62908230|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33521962|NCT02960490|62908231|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33521963|NCT02960490|62908232|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33521964|NCT02960490|62908223|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
33521965|NCT02960490|62908224|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
33521966|NCT02960490|62908225|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33521967|NCT02960490|62908226|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33521968|NCT02960490|62908227|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33521969|NCT02960490|62908228|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33521970|NCT02960490|62908229|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33521971|NCT02960490|62908230|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33521972|NCT02960490|62908231|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33521973|NCT02960490|62908232|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33521974|NCT02960490|62908223|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
33521975|NCT02960490|62908224|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
33521976|NCT02960490|62908225|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
33521977|NCT02960490|62908226|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
33521978|NCT02960490|62908227|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
33521979|NCT02960490|62908228|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
33521980|NCT02960490|62908229|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
33521981|NCT02960490|62908230|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
33521982|NCT02960490|62908231|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
33521983|NCT02960490|62908232|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
33521984|NCT02960490|62908223|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33521985|NCT02960490|62908224|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33521986|NCT02960490|62908225|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
33521987|NCT02960490|62908226|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33521988|NCT02960490|62908227|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
33617644|NCT01485172|63018798|FG002|Overall Study|Protocol Violation|4|||
33617645|NCT01485172|63018799|FG003|Overall Study|Protocol Violation|5|||
33521989|NCT02960490|62908228|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33521990|NCT02960490|62908229|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33521991|NCT02960490|62908230|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33521992|NCT02960490|62908231|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33521993|NCT02960490|62908232|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33521994|NCT02960490|62908223|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
33617646|NCT01485172|63018800|FG004|Overall Study|Protocol Violation|1|||
33617647|NCT01485172|63018801|FG005|Overall Study|Protocol Violation|0|||
33617648|NCT01485172|63018796|FG000|Overall Study|Protocol defined stopping criteria|1|||
33617649|NCT01485172|63018797|FG001|Overall Study|Protocol defined stopping criteria|0|||
33617650|NCT01485172|63018798|FG002|Overall Study|Protocol defined stopping criteria|0|||
33617651|NCT01485172|63018799|FG003|Overall Study|Protocol defined stopping criteria|0|||
33521995|NCT02960490|62908224|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
33521996|NCT02960490|62908225|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
33521997|NCT02960490|62908226|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
33521998|NCT02960490|62908227|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
33521999|NCT02960490|62908228|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
33522000|NCT02960490|62908229|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
33522001|NCT02960490|62908230|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
33522002|NCT02960490|62908231|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
33522003|NCT02960490|62908232|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
33522004|NCT02960490|62908223|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
33522005|NCT02960490|62908224|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
33522006|NCT02960490|62908225|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
33522007|NCT02960490|62908226|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
33522008|NCT02960490|62908227|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
33522009|NCT02960490|62908228|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
33522010|NCT02960490|62908229|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
33522011|NCT02960490|62908230|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
33617652|NCT01485172|63018800|FG004|Overall Study|Protocol defined stopping criteria|1|||
33617653|NCT01485172|63018801|FG005|Overall Study|Protocol defined stopping criteria|0|||
33617654|NCT01485172|63018796|FG000|Overall Study|Lost to Follow-up|0|||
33617655|NCT01485172|63018797|FG001|Overall Study|Lost to Follow-up|0|||
33617656|NCT01485172|63018798|FG002|Overall Study|Lost to Follow-up|1|||
33617657|NCT01485172|63018799|FG003|Overall Study|Lost to Follow-up|0|||
33617658|NCT01485172|63018800|FG004|Overall Study|Lost to Follow-up|0|||
33617659|NCT01485172|63018801|FG005|Overall Study|Lost to Follow-up|1|||
33522012|NCT02960490|62908231|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
33522013|NCT02960490|62908232|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
33522014|NCT02960490|62908223|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33522015|NCT02960490|62908224|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33522016|NCT02960490|62908225|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33522017|NCT02960490|62908226|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33522018|NCT02960490|62908227|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33522019|NCT02960490|62908228|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33522020|NCT02960490|62908229|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33522021|NCT02960490|62908230|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
33522022|NCT02960490|62908231|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33522023|NCT02960490|62908232|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33522024|NCT02960490|62908223|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
33522025|NCT02960490|62908224|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
33522026|NCT02960490|62908225|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
33522027|NCT02960490|62908226|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
33522028|NCT02960490|62908227|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
33522029|NCT02960490|62908228|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
33522030|NCT02960490|62908229|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
33522031|NCT02960490|62908230|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
33522032|NCT02960490|62908231|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
33522033|NCT02960490|62908232|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
33522034|NCT02960490|62908223|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33522035|NCT02960490|62908224|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33522036|NCT02960490|62908225|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33522037|NCT02960490|62908226|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33522038|NCT02960490|62908227|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33522039|NCT02960490|62908228|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33522040|NCT02960490|62908229|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
33522041|NCT02960490|62908230|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33522042|NCT02960490|62908231|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33522043|NCT02960490|62908232|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33522044|NCT02960490|62908223|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
33522045|NCT02960490|62908224|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
33522046|NCT02960490|62908225|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
33617660|NCT01485172|63018796|FG000|Overall Study|Physician Decision|0|||
33617661|NCT01485172|63018797|FG001|Overall Study|Physician Decision|0|||
33617662|NCT01485172|63018798|FG002|Overall Study|Physician Decision|0|||
33617663|NCT01485172|63018799|FG003|Overall Study|Physician Decision|0|||
33617664|NCT01485172|63018800|FG004|Overall Study|Physician Decision|1|||
33617665|NCT01485172|63018801|FG005|Overall Study|Physician Decision|0|||
33522047|NCT02960490|62908226|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
33522048|NCT02960490|62908227|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
33522049|NCT02960490|62908228|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
33522050|NCT02960490|62908229|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
33522051|NCT02960490|62908230|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
33522052|NCT02960490|62908231|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
33522053|NCT02960490|62908232|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
33522054|NCT02804750|62908256|FG000|Period 1|Adverse Event|0|||
33522055|NCT02804750|62908257|FG001|Period 1|Adverse Event|2|||
33522056|NCT02804750|62908256|FG000|Period 1|Withdrawal by Subject|0|||
33522057|NCT02804750|62908257|FG001|Period 1|Withdrawal by Subject|1|||
33522058|NCT02804750|62908256|FG000|Period 2|Adverse Event|1|||
33522059|NCT02804750|62908257|FG001|Period 2|Adverse Event|0|||
33522060|NCT02804750|62908256|FG000|Period 3|Adverse Event|0|||
33522061|NCT02804750|62908257|FG001|Period 3|Adverse Event|2|||
33522062|NCT02804750|62908256|FG000|Period 4|Adverse Event|0|||
33522063|NCT02804750|62908257|FG001|Period 4|Adverse Event|5|||
33522064|NCT02959866|62908265|FG000|Overall Study|Withdrawal by Subject|1|||
33522065|NCT02748512|62908272|FG000|Overall Study|Lost to Follow-up|1|||
33522066|NCT02748512|62908273|FG001|Overall Study|Lost to Follow-up|1|||
33522067|NCT02748356|62908279|FG000|Overall Study|Withdrawal by Subject|1|||
33522068|NCT03439657|62908285|FG000|Overall Study|Adverse Event|2|||
33522069|NCT03439657|62908286|FG001|Overall Study|Adverse Event|3|||
33522070|NCT03439657|62908285|FG000|Overall Study|Lost to Follow-up|1|||
33522071|NCT03439657|62908286|FG001|Overall Study|Lost to Follow-up|0|||
33522072|NCT03439657|62908285|FG000|Overall Study|Protocol Violation|1|||
33522073|NCT03439657|62908286|FG001|Overall Study|Protocol Violation|1|||
33522074|NCT03439657|62908285|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
33522075|NCT03439657|62908286|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
33522076|NCT02803580|62908294|FG000|Overall Study|Death|13|||
33522077|NCT02803580|62908294|FG000|Overall Study|Lost to Follow-up|19|||
33522078|NCT02803580|62908294|FG000|Overall Study|Withdrawal by Subject|3|||
33522079|NCT02803580|62908294|FG000|Overall Study|Inclusion in clinical trial|1|||
33617666|NCT01485172|63018796|FG000|Overall Study|Withdrawal by Subject|2|||
33617667|NCT01485172|63018797|FG001|Overall Study|Withdrawal by Subject|0|||
33617668|NCT01485172|63018798|FG002|Overall Study|Withdrawal by Subject|0|||
33522080|NCT02878213|62908298|FG000|Overall Study|Withdrawal by Subject|2|||
33522081|NCT02878213|62908298|FG000|Overall Study|Adverse Event|1|||
33522082|NCT02802878|62908305|FG000|Overall Study|Withdrawal by Subject|3|||
33522083|NCT02802878|62908306|FG001|Overall Study|Withdrawal by Subject|3|||
33522084|NCT02802878|62908305|FG000|Overall Study|Protocol Violation|1|||
33522085|NCT02802878|62908306|FG001|Overall Study|Protocol Violation|0|||
33522086|NCT02801396|62908312|FG000|Period 1|Withdrawal by Subject|0|||
33522087|NCT02801396|62908313|FG001|Period 1|Withdrawal by Subject|0|||
33522088|NCT02801396|62908314|FG002|Period 1|Withdrawal by Subject|0|||
33522089|NCT02801396|62908315|FG003|Period 1|Withdrawal by Subject|0|||
33456182|NCT04491994|62830721|FG001|Overall Study|Withdrawal by Subject|5|||
33456183|NCT04491994|62830720|FG000|Overall Study|developed fever > 3 days|4|||
33456184|NCT04491994|62830721|FG001|Overall Study|developed fever > 3 days|1|||
33456185|NCT04491994|62830720|FG000|Overall Study|Protocol Violation|11|||
33456186|NCT04491994|62830721|FG001|Overall Study|Protocol Violation|2|||
33456187|NCT04491994|62830720|FG000|Overall Study|Lost to Follow-up|4|||
33456188|NCT04491994|62830721|FG001|Overall Study|Lost to Follow-up|3|||
33456189|NCT04041700|62830727|FG000|Overall Study|Pregnancy|1|||
33456190|NCT04041700|62830727|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
33522090|NCT02801396|62908316|FG004|Period 1|Withdrawal by Subject|1|||
33522091|NCT02801396|62908317|FG005|Period 1|Withdrawal by Subject|0|||
33522092|NCT02800928|62908325|FG000|Overall Study|Withdrawal by Subject|1|||
33522093|NCT02800928|62908326|FG001|Overall Study|Withdrawal by Subject|1|||
33522094|NCT02800928|62908325|FG000|Overall Study|Protocol Violation|1|||
33522095|NCT02800928|62908326|FG001|Overall Study|Protocol Violation|1|||
33522096|NCT03148691|62908335|FG000|Overall Study|Protocol Violation|1|||
33522097|NCT03148691|62908336|FG001|Overall Study|Protocol Violation|2|||
33522098|NCT03148691|62908337|FG002|Overall Study|Protocol Violation|7|||
33522099|NCT03148691|62908335|FG000|Overall Study|Lost to Follow-up|0|||
33617669|NCT01485172|63018799|FG003|Overall Study|Withdrawal by Subject|1|||
33456191|NCT04227340|62830733|FG000|Overall Study|Withdrawal by Subject|3|||
33456192|NCT04033432|62830740|FG000|Overall Study|Progressive Disease|8|||
33456193|NCT04033432|62830740|FG000|Overall Study|Adverse Event|4|||
33456194|NCT04033432|62830740|FG000|Overall Study|Death|1|||
33522100|NCT03148691|62908336|FG001|Overall Study|Lost to Follow-up|0|||
33522101|NCT03148691|62908337|FG002|Overall Study|Lost to Follow-up|1|||
33522102|NCT03148691|62908335|FG000|Overall Study|Other|1|||
33522103|NCT03148691|62908336|FG001|Overall Study|Other|0|||
33522104|NCT03148691|62908337|FG002|Overall Study|Other|0|||
33522105|NCT03148691|62908335|FG000|Overall Study|Withdrawal by Subject|1|||
33522106|NCT03148691|62908336|FG001|Overall Study|Withdrawal by Subject|0|||
33522107|NCT03148691|62908337|FG002|Overall Study|Withdrawal by Subject|0|||
33522108|NCT03148067|62908345|FG000|Overall Study|Lost to Follow-up|3|||
33522109|NCT03148067|62908345|FG000|Overall Study|Death|1|||
33522110|NCT03146741|62908359|FG000|Overall Study|Txp with non-HCV+ heart|4|||
33522111|NCT03146741|62908359|FG000|Overall Study|Listeted for MOT|2|||
33522112|NCT03146741|62908359|FG000|Overall Study|Physician Decision|2|||
33522113|NCT03146741|62908359|FG000|Overall Study|Awaiting txp|2|||
33522114|NCT03150719|62908365|FG000|Overall Study|Adverse Event|0|||
33522115|NCT03150719|62908366|FG001|Overall Study|Adverse Event|1|||
33522116|NCT03150719|62908365|FG000|Overall Study|Death|0|||
33522117|NCT03150719|62908366|FG001|Overall Study|Death|1|||
33522118|NCT03150719|62908365|FG000|Overall Study|Other|1|||
33522119|NCT03150719|62908366|FG001|Overall Study|Other|0|||
33522120|NCT04039217|62908372|FG000|Overall Study|Lost to Follow-up|1|||
33522121|NCT00982111|62908382|FG000|Overall Study|Adverse Event|1|||
33522122|NCT00982111|62908383|FG001|Overall Study|Adverse Event|1|||
33522123|NCT00982111|62908382|FG000|Overall Study|Progressive Disease|46|||
33522124|NCT00982111|62908383|FG001|Overall Study|Progressive Disease|39|||
33522125|NCT00982111|62908382|FG000|Overall Study|Lost to Follow-up|9|||
33522126|NCT00982111|62908383|FG001|Overall Study|Lost to Follow-up|6|||
33522127|NCT00982111|62908382|FG000|Overall Study|New Anti-Cancer Therapy|5|||
33522128|NCT00982111|62908383|FG001|Overall Study|New Anti-Cancer Therapy|5|||
33522129|NCT00982111|62908382|FG000|Overall Study|Medical Decision|1|||
33522130|NCT00982111|62908383|FG001|Overall Study|Medical Decision|0|||
33522131|NCT00982111|62908382|FG000|Overall Study|Withdrawal by Subject|17|||
33522132|NCT00982111|62908383|FG001|Overall Study|Withdrawal by Subject|19|||
33522133|NCT00982111|62908382|FG000|Overall Study|Global Study End|0|||
33522134|NCT00982111|62908383|FG001|Overall Study|Global Study End|1|||
33522135|NCT00982111|62908382|FG000|Overall Study|Sponsor's Decision|0|||
33456195|NCT04223830|62830745|FG000|Overall Study|Lost to Follow-up|9|||
33456196|NCT04223830|62830745|FG000|Overall Study|Adverse Event|1|||
33456197|NCT04032652|62830752|FG000|Overall Study|The study was terminated and the PI has|1|||
33456198|NCT04032652|62830753|FG001|Overall Study|The study was terminated and the PI has|1|||
33456199|NCT04031404|62830759|FG000|Baseline|Lost to Follow-up|0|||
33456200|NCT04031404|62830760|FG001|Baseline|Lost to Follow-up|1|||
33456201|NCT04031404|62830759|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
33456202|NCT04031404|62830760|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
33456203|NCT04031404|62830759|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
33456204|NCT04031404|62830760|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
33456205|NCT04031404|62830759|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
33456206|NCT04031404|62830760|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
33456207|NCT04031404|62830759|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
33456208|NCT04031404|62830760|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
33456209|NCT04476784|62830776|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
33456210|NCT04476784|62830777|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
33456211|NCT04026568|62830788|FG000|Overall Study|study terminated|0|||
33456212|NCT04026568|62830789|FG001|Overall Study|study terminated|1|||
33456213|NCT04025632|62830797|FG000|Overall Study|Adverse Event|1|||
33456214|NCT04025632|62830798|FG001|Overall Study|Adverse Event|1|||
33456215|NCT04025632|62830797|FG000|Overall Study|Withdrawal by Subject|1|||
33456216|NCT04025632|62830798|FG001|Overall Study|Withdrawal by Subject|1|||
33456217|NCT04025632|62830797|FG000|Overall Study|Study Terminated by Sponsor|10|||
33456218|NCT04025632|62830798|FG001|Overall Study|Study Terminated by Sponsor|9|||
33456219|NCT04025632|62830797|FG000|Overall Study|Physician Decision|3|||
33522136|NCT00982111|62908383|FG001|Overall Study|Sponsor's Decision|1|||
33522137|NCT02957682|62908392|FG000|Overall Study|Adverse Event|64|||
33522138|NCT02957682|62908393|FG001|Overall Study|Adverse Event|67|||
33456220|NCT04025632|62830798|FG001|Overall Study|Physician Decision|1|||
33456221|NCT04024228|62830809|FG000|Overall Study|Adverse Event|1|||
33456222|NCT04024228|62830810|FG001|Overall Study|Adverse Event|0|||
33456223|NCT04024228|62830809|FG000|Overall Study|Protocol Deviation|0|||
33522139|NCT02957682|62908392|FG000|Overall Study|Poor Compliance to Protocol|30|||
33522140|NCT02957682|62908393|FG001|Overall Study|Poor Compliance to Protocol|26|||
33522141|NCT02957682|62908392|FG000|Overall Study|Physician Decision|4|||
33522142|NCT02957682|62908393|FG001|Overall Study|Physician Decision|4|||
33522143|NCT02957682|62908392|FG000|Overall Study|Study Terminated by Sponsor|4|||
33522144|NCT02957682|62908393|FG001|Overall Study|Study Terminated by Sponsor|3|||
33522145|NCT02957682|62908392|FG000|Overall Study|Subject Moved|10|||
33522146|NCT02957682|62908393|FG001|Overall Study|Subject Moved|16|||
33522147|NCT02957682|62908392|FG000|Overall Study|Withdrawal by Subject|64|||
33522148|NCT02957682|62908393|FG001|Overall Study|Withdrawal by Subject|33|||
33522149|NCT02957682|62908392|FG000|Overall Study|Related to IMP Administration|3|||
33617670|NCT01485172|63018800|FG004|Overall Study|Withdrawal by Subject|1|||
33617671|NCT01485172|63018801|FG005|Overall Study|Withdrawal by Subject|1|||
33617672|NCT02105701|63018819|FG000|Overall Study|Lost to Follow-up|1|||
33617673|NCT02105701|63018820|FG001|Overall Study|Lost to Follow-up|0|||
33617674|NCT02105701|63018821|FG002|Overall Study|Lost to Follow-up|2|||
33617675|NCT02105701|63018822|FG003|Overall Study|Lost to Follow-up|1|||
33617676|NCT02105701|63018819|FG000|Overall Study|Protocol Violation|0|||
33617677|NCT02105701|63018820|FG001|Overall Study|Protocol Violation|0|||
33522150|NCT02957682|62908393|FG001|Overall Study|Related to IMP Administration|6|||
33522151|NCT02957682|62908392|FG000|Overall Study|Non-disclosed|16|||
33522152|NCT02957682|62908393|FG001|Overall Study|Non-disclosed|12|||
33522153|NCT02957682|62908392|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
33522154|NCT02957682|62908393|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
33522155|NCT03057951|62908401|FG000|Overall Study|Adverse Event|553|||
33522156|NCT03057951|62908402|FG001|Overall Study|Adverse Event|575|||
33325184|NCT00952341|62701898|FG001|Cycle 1|Lost to Follow-up|2|||
33522157|NCT03057951|62908401|FG000|Overall Study|Protocol Violation|30|||
33522158|NCT03057951|62908402|FG001|Overall Study|Protocol Violation|24|||
33522159|NCT03057951|62908401|FG000|Overall Study|Lost to Follow-up|6|||
33522160|NCT03057951|62908402|FG001|Overall Study|Lost to Follow-up|16|||
33522161|NCT03057951|62908401|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
33617678|NCT02105701|63018821|FG002|Overall Study|Protocol Violation|1|||
33617679|NCT02105701|63018822|FG003|Overall Study|Protocol Violation|0|||
33522162|NCT03057951|62908402|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
33522163|NCT03057951|62908401|FG000|Overall Study|Study drug stopped, reason missing|6|||
33522164|NCT03057951|62908402|FG001|Overall Study|Study drug stopped, reason missing|1|||
33522165|NCT03057951|62908401|FG000|Overall Study|Medical advice|6|||
33522166|NCT03057951|62908402|FG001|Overall Study|Medical advice|2|||
33617680|NCT02105701|63018819|FG000|Overall Study|Withdrawal by Subject|2|||
33617681|NCT02105701|63018820|FG001|Overall Study|Withdrawal by Subject|1|||
33617682|NCT02105701|63018821|FG002|Overall Study|Withdrawal by Subject|0|||
33617683|NCT02105701|63018822|FG003|Overall Study|Withdrawal by Subject|1|||
33617684|NCT02105701|63018819|FG000|Overall Study|Death|1|||
33617685|NCT02105701|63018820|FG001|Overall Study|Death|0|||
33617686|NCT02105701|63018821|FG002|Overall Study|Death|0|||
33325185|NCT00952341|62701897|FG000|Cycle 1|Physician Decision|0|||
33522167|NCT03057951|62908401|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
33522168|NCT03057951|62908402|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
33522169|NCT03057951|62908401|FG000|Overall Study|Investigator decision|2|||
33522170|NCT03057951|62908402|FG001|Overall Study|Investigator decision|0|||
33522171|NCT03057951|62908401|FG000|Overall Study|Patient decision|5|||
33522172|NCT03057951|62908402|FG001|Overall Study|Patient decision|2|||
33522173|NCT03057951|62908401|FG000|Overall Study|Not attending study visits|3|||
33522174|NCT03057951|62908402|FG001|Overall Study|Not attending study visits|0|||
33522175|NCT03057951|62908401|FG000|Overall Study|Patient moved away|3|||
33522176|NCT03057951|62908402|FG001|Overall Study|Patient moved away|4|||
33522177|NCT03057951|62908401|FG000|Overall Study|Other reason than stated above|23|||
33522178|NCT03057951|62908402|FG001|Overall Study|Other reason than stated above|29|||
33522179|NCT03057951|62908401|FG000|Overall Study|Not treated|2|||
33522180|NCT03057951|62908402|FG001|Overall Study|Not treated|1|||
33522181|NCT03146663|62908410|FG000|Overall Study|Did not receive study treatment|1|||
33522182|NCT03146663|62908411|FG001|Overall Study|Did not receive study treatment|1|||
33522183|NCT02956278|62908421|FG000|Overall Study|Withdrawal by Subject|6|||
33617687|NCT02105701|63018822|FG003|Overall Study|Death|0|||
33617688|NCT01502956|63018834|FG000|Overall Study|Death|0|||
33617689|NCT01502956|63018835|FG001|Overall Study|Death|2|||
33617690|NCT01502956|63018834|FG000|Overall Study|Lost to Follow-up|14|||
33522184|NCT02956278|62908422|FG001|Overall Study|Withdrawal by Subject|2|||
33522185|NCT02956278|62908423|FG002|Overall Study|Withdrawal by Subject|0|||
33522186|NCT02957136|62908433|FG000|Overall Study|Withdrawal by Subject|2|||
33522187|NCT02957136|62908434|FG001|Overall Study|Withdrawal by Subject|1|||
33522188|NCT03150485|62908440|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
33522189|NCT03150485|62908441|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
33522190|NCT03150485|62908442|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
33522191|NCT03150485|62908443|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
33522192|NCT03150485|62908444|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
33522193|NCT03150485|62908445|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
33522194|NCT03134911|62908452|FG000|Overall Study|Screen failure|31|||
33522195|NCT03134911|62908452|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
33522196|NCT03134599|62908471|FG000|Week 1|Lost to Follow-up|0|||
33522197|NCT03134599|62908472|FG001|Week 1|Lost to Follow-up|0|||
33522198|NCT03134599|62908473|FG002|Week 1|Lost to Follow-up|0|||
33522199|NCT03134599|62908474|FG003|Week 1|Lost to Follow-up|0|||
33522200|NCT03134599|62908475|FG004|Week 1|Lost to Follow-up|1|||
33522201|NCT03134599|62908476|FG005|Week 1|Lost to Follow-up|0|||
33522202|NCT03134599|62908471|FG000|Week 2|Lost to Follow-up|1|||
33522203|NCT03134599|62908472|FG001|Week 2|Lost to Follow-up|0|||
33522204|NCT03134599|62908473|FG002|Week 2|Lost to Follow-up|0|||
33522205|NCT03134599|62908474|FG003|Week 2|Lost to Follow-up|1|||
33522206|NCT03134599|62908475|FG004|Week 2|Lost to Follow-up|1|||
33522207|NCT03134599|62908476|FG005|Week 2|Lost to Follow-up|0|||
33522208|NCT03134599|62908471|FG000|Week 3|Lost to Follow-up|0|||
33522209|NCT03134599|62908472|FG001|Week 3|Lost to Follow-up|0|||
33522210|NCT03134599|62908473|FG002|Week 3|Lost to Follow-up|0|||
33522211|NCT03134599|62908474|FG003|Week 3|Lost to Follow-up|1|||
33522212|NCT03134599|62908475|FG004|Week 3|Lost to Follow-up|0|||
33522213|NCT03134599|62908476|FG005|Week 3|Lost to Follow-up|1|||
33522214|NCT03153137|62908486|FG000|Overall Study|Lost to Follow-up|1|||
33522215|NCT03153137|62908487|FG001|Overall Study|Lost to Follow-up|0|||
33325186|NCT00952341|62701898|FG001|Cycle 1|Physician Decision|1|||
33325187|NCT00952341|62701897|FG000|Cycle 2|Withdrawal by Subject|1|||
33325188|NCT00952341|62701898|FG001|Cycle 2|Withdrawal by Subject|1|||
33522216|NCT03153137|62908486|FG000|Overall Study|Withdrawal by Subject|2|||
33522217|NCT03153137|62908487|FG001|Overall Study|Withdrawal by Subject|1|||
33522218|NCT03153137|62908486|FG000|Overall Study|Physician Decision|0|||
33522219|NCT03153137|62908487|FG001|Overall Study|Physician Decision|3|||
33522220|NCT03136861|62908500|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
33522221|NCT03136861|62908501|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
33522222|NCT03136861|62908502|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
33522223|NCT03136861|62908503|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
33522224|NCT03136861|62908504|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
33522225|NCT03136861|62908505|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
33522226|NCT03136861|62908506|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
33522227|NCT03136861|62908500|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
33522228|NCT03136861|62908501|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
33522229|NCT03136861|62908502|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
33522230|NCT03136861|62908503|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
33522231|NCT03136861|62908504|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
33522232|NCT03136861|62908505|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
33522233|NCT03136861|62908506|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
33522234|NCT03136861|62908500|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
33522235|NCT03136861|62908501|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
33522236|NCT03136861|62908502|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
33522237|NCT03136861|62908503|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
33522238|NCT03136861|62908504|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
33522239|NCT03136861|62908505|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
33522240|NCT03136861|62908506|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
33325189|NCT00952341|62701897|FG000|Cycle 2|Protocol Violation|1|||
33325190|NCT00952341|62701898|FG001|Cycle 2|Protocol Violation|0|||
33325191|NCT00952341|62701897|FG000|Cycle 2|Lost to Follow-up|6|||
33325192|NCT00952341|62701898|FG001|Cycle 2|Lost to Follow-up|9|||
33522241|NCT03136861|62908500|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
33522242|NCT03136861|62908501|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
33617691|NCT01502956|63018835|FG001|Overall Study|Lost to Follow-up|11|||
33522243|NCT03136861|62908502|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
33522244|NCT03136861|62908503|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
33522245|NCT03136861|62908504|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
33522246|NCT03136861|62908505|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
33522247|NCT03136861|62908506|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
33522248|NCT03136861|62908500|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
33522249|NCT03136861|62908501|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
33522250|NCT03136861|62908502|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
33522251|NCT03136861|62908503|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
33522252|NCT03136861|62908504|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
33522253|NCT03136861|62908505|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
33522254|NCT03136861|62908506|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
33522255|NCT03136861|62908500|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
33522256|NCT03136861|62908501|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
33522257|NCT03136861|62908502|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
33522258|NCT03136861|62908503|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
33522259|NCT03136861|62908504|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
33522260|NCT03136861|62908505|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
33522261|NCT03136861|62908506|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
33522262|NCT03136861|62908500|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
33522263|NCT03136861|62908501|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
33522264|NCT03136861|62908502|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
33522265|NCT03136861|62908503|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
33522266|NCT03136861|62908504|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
33522267|NCT03136861|62908505|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
33522268|NCT03136861|62908506|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
33522269|NCT03136861|62908500|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
33522270|NCT03136861|62908501|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
33617692|NCT01502956|63018834|FG000|Overall Study|Physician Decision|2|||
33617693|NCT01502956|63018835|FG001|Overall Study|Physician Decision|3|||
33617694|NCT01502956|63018834|FG000|Overall Study|Withdrawal by Subject|8|||
33617695|NCT01502956|63018835|FG001|Overall Study|Withdrawal by Subject|10|||
33617696|NCT01502644|63018844|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
33617697|NCT01502644|63018845|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
33617698|NCT01502644|63018846|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
33617699|NCT01502644|63018847|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
33617700|NCT01502644|63018844|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
33456224|NCT04024228|62830810|FG001|Overall Study|Protocol Deviation|2|||
33456225|NCT04024228|62830809|FG000|Overall Study|Withdrawal by Subject|3|||
33456226|NCT04024228|62830810|FG001|Overall Study|Withdrawal by Subject|4|||
33456227|NCT04023994|62830824|FG000|Overall Study|Lost to Follow-up|0|||
33456228|NCT04023994|62830825|FG001|Overall Study|Lost to Follow-up|1|||
33456229|NCT04023994|62830826|FG002|Overall Study|Lost to Follow-up|2|||
33456230|NCT04023994|62830827|FG003|Overall Study|Lost to Follow-up|0|||
33456231|NCT04023994|62830828|FG004|Overall Study|Lost to Follow-up|0|||
33456232|NCT04023994|62830829|FG005|Overall Study|Lost to Follow-up|0|||
33456233|NCT04023994|62830824|FG000|Overall Study|Withdrawal by Subject|0|||
33456234|NCT04023994|62830825|FG001|Overall Study|Withdrawal by Subject|0|||
33456235|NCT04023994|62830826|FG002|Overall Study|Withdrawal by Subject|0|||
33456236|NCT04023994|62830827|FG003|Overall Study|Withdrawal by Subject|1|||
33456237|NCT04023994|62830828|FG004|Overall Study|Withdrawal by Subject|0|||
33456238|NCT04023994|62830829|FG005|Overall Study|Withdrawal by Subject|0|||
33456239|NCT04023682|62830848|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
33456240|NCT04018612|62830859|FG000|Overall Study|Withdrawal by Subject|1|||
33456241|NCT04018612|62830860|FG001|Overall Study|Withdrawal by Subject|0|||
33456242|NCT04018612|62830861|FG002|Overall Study|Withdrawal by Subject|1|||
33456243|NCT04018066|62830869|FG000|Overall Study|participants started taking medications during the study period|3|||
33456244|NCT04018066|62830869|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
33456245|NCT04209400|62830876|FG000|Overall Study|Withdrawal by Subject|0|||
33456246|NCT04209400|62830877|FG001|Overall Study|Withdrawal by Subject|1|||
33456247|NCT04207840|62830883|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
33456248|NCT04207840|62830884|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
33456249|NCT04207840|62830885|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
33456250|NCT04207840|62830883|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
33456251|NCT04207840|62830884|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
33456252|NCT04207840|62830885|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
33617701|NCT01502644|63018845|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
33617702|NCT01502644|63018846|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
33617703|NCT01502644|63018847|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
33617704|NCT01502644|63018844|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
33617705|NCT01502644|63018845|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
33617706|NCT01502644|63018846|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
33617707|NCT01502644|63018847|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
33617708|NCT01502644|63018844|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
33617709|NCT01502644|63018845|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
33617710|NCT01502644|63018846|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
33617711|NCT01502644|63018847|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
33617712|NCT01502644|63018844|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
33617713|NCT01502644|63018845|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
33617714|NCT01502644|63018846|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
33617715|NCT01502644|63018847|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
33617716|NCT01462318|63018857|FG000|Main Study / TP-DI Study|Other|2|||
33617717|NCT01462318|63018858|FG001|Main Study / TP-DI Study|Other|0|||
33617718|NCT01462318|63018859|FG002|Main Study / TP-DI Study|Other|0|||
33617719|NCT01462318|63018857|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
33617720|NCT01462318|63018858|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
33617721|NCT01462318|63018859|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
33617722|NCT01462318|63018857|FG000|Main Study / TP-DI Study|Adverse Event|4|||
33617723|NCT01462318|63018858|FG001|Main Study / TP-DI Study|Adverse Event|0|||
33617724|NCT01462318|63018859|FG002|Main Study / TP-DI Study|Adverse Event|0|||
33617725|NCT01462318|63018857|FG000|Extension Phase|Lost to Follow-up|0|||
33617726|NCT01462318|63018858|FG001|Extension Phase|Lost to Follow-up|0|||
33617727|NCT01462318|63018859|FG002|Extension Phase|Lost to Follow-up|1|||
33617728|NCT01462318|63018857|FG000|Extension Phase|Other|0|||
33617729|NCT01462318|63018858|FG001|Extension Phase|Other|0|||
33617730|NCT01462318|63018859|FG002|Extension Phase|Other|1|||
33617731|NCT01462318|63018857|FG000|Extension Phase|Disease Progression|0|||
33617732|NCT01462318|63018858|FG001|Extension Phase|Disease Progression|0|||
33617733|NCT01462318|63018859|FG002|Extension Phase|Disease Progression|1|||
33617734|NCT01462318|63018857|FG000|Extension Phase|Withdrawal by Subject|0|||
33617735|NCT01462318|63018858|FG001|Extension Phase|Withdrawal by Subject|0|||
33617736|NCT01462318|63018859|FG002|Extension Phase|Withdrawal by Subject|15|||
33617737|NCT01462318|63018857|FG000|Extension Phase|Investigator Decision|0|||
33617738|NCT01462318|63018858|FG001|Extension Phase|Investigator Decision|0|||
33617739|NCT01462318|63018859|FG002|Extension Phase|Investigator Decision|5|||
33617740|NCT01462318|63018857|FG000|Extension Phase|Adverse Event|0|||
33617741|NCT01462318|63018858|FG001|Extension Phase|Adverse Event|0|||
33617742|NCT01462318|63018859|FG002|Extension Phase|Adverse Event|22|||
33617743|NCT01485094|63018867|FG000|Overall Study|Adverse Event|1|||
33617744|NCT01485094|63018868|FG001|Overall Study|Adverse Event|1|||
33617745|NCT01485094|63018869|FG002|Overall Study|Adverse Event|1|||
33617746|NCT01485094|63018867|FG000|Overall Study|Lost to Follow-up|1|||
33617747|NCT01485094|63018868|FG001|Overall Study|Lost to Follow-up|0|||
33617748|NCT01485094|63018869|FG002|Overall Study|Lost to Follow-up|0|||
33617749|NCT01485094|63018867|FG000|Overall Study|Withdrawal by Subject|1|||
33617750|NCT01485094|63018868|FG001|Overall Study|Withdrawal by Subject|1|||
33617751|NCT01485094|63018869|FG002|Overall Study|Withdrawal by Subject|0|||
33617752|NCT01484938|63018877|FG000|Overall Study|Adverse Event|2|||
33617753|NCT01484938|63018877|FG000|Overall Study|Lost to Follow-up|1|||
33617754|NCT01484938|63018877|FG000|Overall Study|Noncompliance|1|||
33617755|NCT01502410|63018885|FG000|Overall Study|Adverse Event|1|||
33617756|NCT01502410|63018886|FG001|Overall Study|Adverse Event|2|||
33617757|NCT01502410|63018887|FG002|Overall Study|Adverse Event|0|||
33617758|NCT01502410|63018888|FG003|Overall Study|Adverse Event|0|||
33456253|NCT04006366|62830893|FG000|Overall Study|Withdrawal by Subject|1|||
33456254|NCT04191148|62830899|FG000|Overall Study|Withdrawal by Subject|1|||
33617759|NCT01502410|63018885|FG000|Overall Study|Lack of Efficacy|7|||
33617760|NCT01502410|63018886|FG001|Overall Study|Lack of Efficacy|7|||
33617761|NCT01502410|63018887|FG002|Overall Study|Lack of Efficacy|0|||
33617762|NCT01502410|63018888|FG003|Overall Study|Lack of Efficacy|0|||
33617763|NCT01502410|63018885|FG000|Overall Study|Physician Decision|0|||
33617764|NCT01502410|63018886|FG001|Overall Study|Physician Decision|1|||
33617765|NCT01502410|63018887|FG002|Overall Study|Physician Decision|0|||
33617766|NCT01502410|63018888|FG003|Overall Study|Physician Decision|0|||
33617767|NCT01502410|63018885|FG000|Overall Study|Withdrawal by Subject|2|||
33617768|NCT01502410|63018886|FG001|Overall Study|Withdrawal by Subject|0|||
33617769|NCT01502410|63018887|FG002|Overall Study|Withdrawal by Subject|0|||
33522271|NCT03136861|62908502|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
33522272|NCT03136861|62908503|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
33522273|NCT03136861|62908504|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
33522274|NCT03136861|62908505|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
33522275|NCT03136861|62908506|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
33522276|NCT03316950|62908534|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
33522277|NCT03316950|62908535|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
33522278|NCT03316950|62908536|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
33522279|NCT03316950|62908537|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
33522280|NCT03316950|62908534|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
33522281|NCT03316950|62908535|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
33522282|NCT03316950|62908536|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
33522283|NCT03316950|62908537|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
33522284|NCT03316950|62908534|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
33522285|NCT03316950|62908535|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
33522286|NCT03316950|62908536|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
33522287|NCT03316950|62908537|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
33522288|NCT03139279|62908551|FG000|Overall Study|Physician Decision|2|||
33522289|NCT03139279|62908552|FG001|Overall Study|Physician Decision|0|||
33522290|NCT03139279|62908551|FG000|Overall Study|Protocol Violation|5|||
33522291|NCT03139279|62908552|FG001|Overall Study|Protocol Violation|4|||
33522292|NCT03139279|62908551|FG000|Overall Study|Withdrawal by Subject|0|||
33522293|NCT03139279|62908552|FG001|Overall Study|Withdrawal by Subject|2|||
33522294|NCT01370642|62908561|FG000|Overall Study|Adverse Event|2|||
33522295|NCT01370642|62908562|FG001|Overall Study|Adverse Event|1|||
33522296|NCT01370642|62908563|FG002|Overall Study|Adverse Event|1|||
33522297|NCT01370642|62908561|FG000|Overall Study|Detectable HCV RNA|0|||
33522298|NCT01370642|62908562|FG001|Overall Study|Detectable HCV RNA|0|||
33522299|NCT01370642|62908563|FG002|Overall Study|Detectable HCV RNA|22|||
33522300|NCT01370642|62908561|FG000|Overall Study|Lost to Follow-up|0|||
33522301|NCT01370642|62908562|FG001|Overall Study|Lost to Follow-up|0|||
33456255|NCT04191148|62830900|FG001|Overall Study|Withdrawal by Subject|0|||
33456256|NCT04191148|62830899|FG000|Overall Study|Adverse Event|1|||
33456257|NCT04191148|62830900|FG001|Overall Study|Adverse Event|0|||
33456258|NCT04004260|62830910|FG000|Overall Study|Withdrawal by Subject|7|||
33456259|NCT04004260|62830911|FG001|Overall Study|Withdrawal by Subject|3|||
33456260|NCT04004260|62830910|FG000|Overall Study|Lost to Follow-up|22|||
33456261|NCT04004260|62830911|FG001|Overall Study|Lost to Follow-up|12|||
33456262|NCT04004260|62830910|FG000|Overall Study|Did not engage in intervention|13|||
33456263|NCT04004260|62830911|FG001|Overall Study|Did not engage in intervention|17|||
33456264|NCT04470622|62830919|FG000|Overall Study|Withdrawal by Subject|0|||
33456265|NCT04470622|62830920|FG001|Overall Study|Withdrawal by Subject|1|||
33456266|NCT04470622|62830919|FG000|Overall Study|Screen Failure|0|||
33456267|NCT04470622|62830920|FG001|Overall Study|Screen Failure|1|||
33456268|NCT04470622|62830919|FG000|Overall Study|Death|0|||
33456269|NCT04470622|62830920|FG001|Overall Study|Death|1|||
33456270|NCT04465630|62830926|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
33456271|NCT04465630|62830926|FG000|Overall Study|Screen failure|8|||
33522302|NCT01370642|62908563|FG002|Overall Study|Lost to Follow-up|1|||
33522303|NCT01370642|62908561|FG000|Overall Study|Physician Decision|4|||
33522304|NCT01370642|62908562|FG001|Overall Study|Physician Decision|1|||
33617770|NCT01502410|63018888|FG003|Overall Study|Withdrawal by Subject|0|||
33456272|NCT04465630|62830926|FG000|Overall Study|Baseline failure|16|||
33522305|NCT01370642|62908563|FG002|Overall Study|Physician Decision|2|||
33522306|NCT01370642|62908561|FG000|Overall Study|Withdrawal by Subject|2|||
33522307|NCT01370642|62908562|FG001|Overall Study|Withdrawal by Subject|4|||
33522308|NCT01370642|62908563|FG002|Overall Study|Withdrawal by Subject|3|||
33522309|NCT02873208|62908571|FG000|Overall Study|Withdrawal by Subject|36|||
33522310|NCT02873208|62908571|FG000|Overall Study|Lost to Follow-up|22|||
33522311|NCT02873208|62908571|FG000|Overall Study|Adverse Event|15|||
33522312|NCT02873208|62908571|FG000|Overall Study|Non-compliance with study drug|12|||
33522313|NCT02873208|62908571|FG000|Overall Study|Protocol Violation|8|||
33522314|NCT02873208|62908571|FG000|Overall Study|Pregnancy|2|||
33522315|NCT02873208|62908571|FG000|Overall Study|Incarceration|1|||
33522316|NCT02873208|62908571|FG000|Overall Study|Lack of Efficacy|1|||
33522317|NCT02873208|62908571|FG000|Overall Study|Physician Decision|1|||
33522318|NCT03138967|62908577|FG000|Overall Study|Death|0|||
33522319|NCT03138967|62908578|FG001|Overall Study|Death|1|||
33522320|NCT03138967|62908577|FG000|Overall Study|Physician Decision|1|||
33522321|NCT03138967|62908578|FG001|Overall Study|Physician Decision|3|||
33522322|NCT01547117|62908588|FG000|Overall Study|Physician Decision|0|||
33522323|NCT01547117|62908589|FG001|Overall Study|Physician Decision|1|||
33617771|NCT01462162|63018897|FG000|Overall Study|Adverse Event|5|||
33617772|NCT01462162|63018897|FG000|Overall Study|Lack of Efficacy|4|||
33325193|NCT00952341|62701897|FG000|Cycle 2|Physician Decision|1|||
33456273|NCT04182880|62830933|FG000|Overall Study|Pregnancy|1|||
33456274|NCT04182880|62830934|FG001|Overall Study|Pregnancy|0|||
33456275|NCT04465396|62830944|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
33456276|NCT04465396|62830945|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
33456277|NCT04465396|62830946|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
33456278|NCT04465396|62830947|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
33456279|NCT03999892|62830972|FG000|Overall Study|Lost to Follow-up|1|||
33456280|NCT03996694|62830976|FG000|First Washout (7 Days)|positive urine drug screen|0|||
33456281|NCT03996694|62830977|FG001|First Washout (7 Days)|positive urine drug screen|0|||
33456282|NCT03996694|62830978|FG002|First Washout (7 Days)|positive urine drug screen|1|||
33456283|NCT03996694|62830979|FG003|First Washout (7 Days)|positive urine drug screen|0|||
33456284|NCT03996694|62830980|FG004|First Washout (7 Days)|positive urine drug screen|0|||
33456285|NCT03996694|62830981|FG005|First Washout (7 Days)|positive urine drug screen|0|||
33456286|NCT03996694|62830976|FG000|First Washout (7 Days)|Adverse Event|0|||
33456287|NCT03996694|62830977|FG001|First Washout (7 Days)|Adverse Event|1|||
33456288|NCT03996694|62830978|FG002|First Washout (7 Days)|Adverse Event|0|||
33456289|NCT03996694|62830979|FG003|First Washout (7 Days)|Adverse Event|0|||
33456290|NCT03996694|62830980|FG004|First Washout (7 Days)|Adverse Event|0|||
33456291|NCT03996694|62830981|FG005|First Washout (7 Days)|Adverse Event|0|||
33456292|NCT03996694|62830976|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
33456293|NCT03996694|62830977|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
33456294|NCT03996694|62830978|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
33456295|NCT03996694|62830979|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
33456296|NCT03996694|62830980|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
33456297|NCT03996694|62830981|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
33456298|NCT03996694|62830976|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
33456299|NCT03996694|62830977|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
33456300|NCT03996694|62830978|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
33456301|NCT03996694|62830979|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
33456302|NCT03996694|62830980|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
33456303|NCT03996694|62830981|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
33456304|NCT04179838|62830997|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
33456305|NCT04179838|62830998|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
33456306|NCT04179838|62830997|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
33456307|NCT04179838|62830998|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
33456308|NCT03994120|62831006|FG000|Overall Study|Lost to Follow-up|3|||
33456309|NCT03994120|62831007|FG001|Overall Study|Lost to Follow-up|1|||
33456310|NCT04178590|62831013|FG000|Overall Study|Pregnancy|1|||
33456311|NCT04178590|62831013|FG000|Overall Study|Lost to Follow-up|1|||
33456312|NCT04175392|62831041|FG000|Overall Study|Withdrawal by Subject|3|||
33456313|NCT04175392|62831042|FG001|Overall Study|Withdrawal by Subject|2|||
33456314|NCT03986866|62831050|FG000|Overall Study|Withdrawal by Subject|0|||
33522324|NCT01547117|62908590|FG002|Overall Study|Physician Decision|1|||
33456315|NCT03986866|62831051|FG001|Overall Study|Withdrawal by Subject|3|||
33456316|NCT03986866|62831050|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
33456317|NCT03986866|62831051|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
33522325|NCT01547117|62908591|FG003|Overall Study|Physician Decision|3|||
33617773|NCT01462162|63018897|FG000|Overall Study|Abnormal laboratory parameters|1|||
33617774|NCT01462162|63018897|FG000|Overall Study|Other|2|||
33617775|NCT01483924|63018907|FG000|Overall Study|Withdrawal by Subject|2|||
33617776|NCT01483924|63018908|FG001|Overall Study|Withdrawal by Subject|0|||
33617777|NCT01483924|63018909|FG002|Overall Study|Withdrawal by Subject|0|||
33617778|NCT01483924|63018910|FG003|Overall Study|Withdrawal by Subject|1|||
33617779|NCT01483924|63018911|FG004|Overall Study|Withdrawal by Subject|1|||
33617780|NCT01483924|63018907|FG000|Overall Study|Adverse Event|0|||
33617781|NCT01483924|63018908|FG001|Overall Study|Adverse Event|0|||
33617782|NCT01483924|63018909|FG002|Overall Study|Adverse Event|1|||
33617783|NCT01483924|63018910|FG003|Overall Study|Adverse Event|1|||
33617784|NCT01483924|63018911|FG004|Overall Study|Adverse Event|0|||
33617785|NCT01483924|63018907|FG000|Overall Study|Non-compliance|0|||
33522326|NCT01547117|62908588|FG000|Overall Study|Withdrawal by Subject|1|||
33522327|NCT01547117|62908589|FG001|Overall Study|Withdrawal by Subject|2|||
33522328|NCT01547117|62908590|FG002|Overall Study|Withdrawal by Subject|1|||
33522329|NCT01547117|62908591|FG003|Overall Study|Withdrawal by Subject|2|||
33522330|NCT03136159|62908619|FG000|Overall Study|chorioamnionitis|2|||
33522331|NCT03136159|62908620|FG001|Overall Study|chorioamnionitis|0|||
33522332|NCT03136159|62908619|FG000|Overall Study|vertical skin incision|1|||
33522333|NCT03136159|62908620|FG001|Overall Study|vertical skin incision|0|||
33522334|NCT03136159|62908619|FG000|Overall Study|additional dressing|1|||
33522335|NCT03136159|62908620|FG001|Overall Study|additional dressing|0|||
33522336|NCT03136159|62908619|FG000|Overall Study|never got dressing placed|1|||
33522337|NCT03136159|62908620|FG001|Overall Study|never got dressing placed|0|||
33522338|NCT01986933|62908631|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
33522339|NCT01986933|62908632|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
33522340|NCT01986933|62908633|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
33522341|NCT01986933|62908634|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
33522342|NCT01986933|62908635|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
33522343|NCT01986933|62908631|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
33522344|NCT01986933|62908632|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
33522345|NCT01986933|62908633|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
33522346|NCT01986933|62908634|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
33522347|NCT01986933|62908635|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
33522348|NCT01986933|62908631|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
33522349|NCT01986933|62908632|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
33522350|NCT01986933|62908633|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
33522351|NCT01986933|62908634|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
33522352|NCT01986933|62908635|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
33522353|NCT01986933|62908631|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
33522354|NCT01986933|62908632|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
33522355|NCT01986933|62908633|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
33522356|NCT01986933|62908634|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
33522357|NCT01986933|62908635|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
33522358|NCT01986933|62908631|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
33522359|NCT01986933|62908632|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
33617786|NCT01483924|63018908|FG001|Overall Study|Non-compliance|0|||
33522360|NCT01986933|62908633|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
33522361|NCT01986933|62908634|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
33522362|NCT01986933|62908635|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
33522363|NCT01986933|62908631|FG000|Active-to-active (Part B)|Adverse Event|0|||
33522364|NCT01986933|62908632|FG001|Active-to-active (Part B)|Adverse Event|2|||
33617787|NCT01483924|63018909|FG002|Overall Study|Non-compliance|0|||
33617788|NCT01483924|63018910|FG003|Overall Study|Non-compliance|1|||
33617789|NCT01483924|63018911|FG004|Overall Study|Non-compliance|1|||
33522365|NCT01986933|62908633|FG002|Active-to-active (Part B)|Adverse Event|0|||
33522366|NCT01986933|62908634|FG003|Active-to-active (Part B)|Adverse Event|1|||
33522367|NCT01986933|62908635|FG004|Active-to-active (Part B)|Adverse Event|3|||
33522368|NCT01986933|62908631|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
33522369|NCT01986933|62908632|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
33522370|NCT01986933|62908633|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
33522371|NCT01986933|62908634|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
33522372|NCT01986933|62908635|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
33522373|NCT01986933|62908631|FG000|Active-to-active (Part B)|Pregnancy|0|||
33522374|NCT01986933|62908632|FG001|Active-to-active (Part B)|Pregnancy|0|||
33522375|NCT01986933|62908633|FG002|Active-to-active (Part B)|Pregnancy|0|||
33522376|NCT01986933|62908634|FG003|Active-to-active (Part B)|Pregnancy|0|||
33522377|NCT01986933|62908635|FG004|Active-to-active (Part B)|Pregnancy|1|||
33522378|NCT01986933|62908631|FG000|Active-to-active (Part B)|Physician Decision|0|||
33522379|NCT01986933|62908632|FG001|Active-to-active (Part B)|Physician Decision|0|||
33522380|NCT01986933|62908633|FG002|Active-to-active (Part B)|Physician Decision|1|||
33522381|NCT01986933|62908634|FG003|Active-to-active (Part B)|Physician Decision|1|||
33522382|NCT01986933|62908635|FG004|Active-to-active (Part B)|Physician Decision|0|||
33617790|NCT01483924|63018907|FG000|Overall Study|Sponsor concern over ECG result|0|||
33617791|NCT01483924|63018908|FG001|Overall Study|Sponsor concern over ECG result|0|||
33617792|NCT01483924|63018909|FG002|Overall Study|Sponsor concern over ECG result|0|||
33617793|NCT01483924|63018910|FG003|Overall Study|Sponsor concern over ECG result|1|||
33617794|NCT01483924|63018911|FG004|Overall Study|Sponsor concern over ECG result|0|||
33617795|NCT01462084|63018932|FG000|Overall Study|Withdrawal by Subject|1|||
33617796|NCT01462084|63018933|FG001|Overall Study|Withdrawal by Subject|0|||
33617797|NCT01462084|63018932|FG000|Overall Study|Protocol Violation|1|||
33617798|NCT01462084|63018933|FG001|Overall Study|Protocol Violation|1|||
33617799|NCT02134028|63018948|FG000|Overall Study|Lack of Efficacy|1|||
33617800|NCT02134028|63018949|FG001|Overall Study|Lack of Efficacy|0|||
33617801|NCT02134028|63018950|FG002|Overall Study|Lack of Efficacy|3|||
33617802|NCT02134028|63018951|FG003|Overall Study|Lack of Efficacy|2|||
33617803|NCT02134028|63018952|FG004|Overall Study|Lack of Efficacy|1|||
33617804|NCT02134028|63018953|FG005|Overall Study|Lack of Efficacy|2|||
33617805|NCT02134028|63018954|FG006|Overall Study|Lack of Efficacy|1|||
33617806|NCT02134028|63018955|FG007|Overall Study|Lack of Efficacy|0|||
33617807|NCT02134028|63018948|FG000|Overall Study|Poor compliance to protocol|1|||
33456318|NCT03980938|62831059|FG000|Treatment Period 1|Study Terminated|1|||
33456319|NCT03980938|62831060|FG001|Treatment Period 1|Study Terminated|1|||
33456320|NCT03980938|62831059|FG000|Treatment Period 2|Study Terminated|2|||
33456321|NCT03980938|62831060|FG001|Treatment Period 2|Study Terminated|2|||
33456322|NCT03656692|62831066|FG000|Overall Study|Worsening of disease activity|2|||
33456323|NCT03656692|62831066|FG000|Overall Study|Physician Decision|1|||
33456324|NCT04439266|62831070|FG000|Overall Study|Ineligible|1|||
33456325|NCT04439266|62831070|FG000|Overall Study|Adverse Event|1|||
33456326|NCT04439266|62831070|FG000|Overall Study|Death|1|||
33522383|NCT01986933|62908631|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
33522384|NCT01986933|62908632|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
33617808|NCT02134028|63018949|FG001|Overall Study|Poor compliance to protocol|1|||
33456327|NCT04439266|62831070|FG000|Overall Study|Disease progression|1|||
33617809|NCT02134028|63018950|FG002|Overall Study|Poor compliance to protocol|3|||
33617810|NCT02134028|63018951|FG003|Overall Study|Poor compliance to protocol|7|||
33617811|NCT02134028|63018952|FG004|Overall Study|Poor compliance to protocol|1|||
33617812|NCT02134028|63018953|FG005|Overall Study|Poor compliance to protocol|1|||
33617813|NCT02134028|63018954|FG006|Overall Study|Poor compliance to protocol|0|||
33617814|NCT02134028|63018955|FG007|Overall Study|Poor compliance to protocol|0|||
33617815|NCT02134028|63018948|FG000|Overall Study|Other unspecified|4|||
33617816|NCT02134028|63018949|FG001|Overall Study|Other unspecified|22|||
33617817|NCT02134028|63018950|FG002|Overall Study|Other unspecified|33|||
33617818|NCT02134028|63018951|FG003|Overall Study|Other unspecified|64|||
33617819|NCT02134028|63018952|FG004|Overall Study|Other unspecified|8|||
33617820|NCT02134028|63018953|FG005|Overall Study|Other unspecified|6|||
33617821|NCT02134028|63018954|FG006|Overall Study|Other unspecified|2|||
33617822|NCT02134028|63018955|FG007|Overall Study|Other unspecified|1|||
33617823|NCT02134028|63018948|FG000|Overall Study|Adverse Event|3|||
33617824|NCT02134028|63018949|FG001|Overall Study|Adverse Event|19|||
33617825|NCT02134028|63018950|FG002|Overall Study|Adverse Event|13|||
33617826|NCT02134028|63018951|FG003|Overall Study|Adverse Event|32|||
33617827|NCT02134028|63018952|FG004|Overall Study|Adverse Event|4|||
33617828|NCT02134028|63018953|FG005|Overall Study|Adverse Event|5|||
33617829|NCT02134028|63018954|FG006|Overall Study|Adverse Event|1|||
33617830|NCT02134028|63018955|FG007|Overall Study|Adverse Event|2|||
33617831|NCT02172950|63018977|FG000|Overall Study|Physician Decision|3|||
33617832|NCT02172950|63018978|FG001|Overall Study|Physician Decision|3|||
33617833|NCT02172950|63018977|FG000|Overall Study|Lack of Efficacy|1|||
33617834|NCT02172950|63018978|FG001|Overall Study|Lack of Efficacy|0|||
33617835|NCT02172950|63018977|FG000|Overall Study|Adverse Event|4|||
33617836|NCT02172950|63018978|FG001|Overall Study|Adverse Event|1|||
33617837|NCT02172950|63018977|FG000|Overall Study|Withdrawal by Subject|10|||
33617838|NCT02172950|63018978|FG001|Overall Study|Withdrawal by Subject|0|||
33617839|NCT02172950|63018977|FG000|Overall Study|Protocol Violation|1|||
33325194|NCT00952341|62701898|FG001|Cycle 2|Physician Decision|1|||
33522385|NCT01986933|62908633|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
33522386|NCT01986933|62908634|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
33522387|NCT01986933|62908635|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
33522388|NCT01986933|62908631|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
33522389|NCT01986933|62908632|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
33522390|NCT01986933|62908633|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
33522391|NCT01986933|62908634|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
33522392|NCT01986933|62908635|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
33522393|NCT01986933|62908631|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
33522394|NCT01986933|62908632|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
33522395|NCT01986933|62908633|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
33522396|NCT01986933|62908634|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
33522397|NCT01986933|62908635|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
33522398|NCT01986933|62908631|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
33522399|NCT01986933|62908632|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
33522400|NCT01986933|62908633|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
33522401|NCT01986933|62908634|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
33617840|NCT02172950|63018978|FG001|Overall Study|Protocol Violation|0|||
33617841|NCT02172950|63018977|FG000|Overall Study|Lost to Follow-up|1|||
33325195|NCT00952341|62701897|FG000|Cycle 2|Progressive Disease|0|||
33456328|NCT04439266|62831070|FG000|Overall Study|Still on treatment|1|||
33456329|NCT03682120|62831078|FG000|Overall Study|Lost to Follow-up|11|||
33456330|NCT03682120|62831079|FG001|Overall Study|Lost to Follow-up|4|||
33456331|NCT03682120|62831080|FG002|Overall Study|Lost to Follow-up|5|||
33456332|NCT03682120|62831081|FG003|Overall Study|Lost to Follow-up|2|||
33456333|NCT03682120|62831078|FG000|Overall Study|Physician Decision|1|||
33456334|NCT03682120|62831079|FG001|Overall Study|Physician Decision|0|||
33456335|NCT03682120|62831080|FG002|Overall Study|Physician Decision|0|||
33456336|NCT03682120|62831081|FG003|Overall Study|Physician Decision|0|||
33456337|NCT03682120|62831078|FG000|Overall Study|Withdrawal by Subject|1|||
33456338|NCT03682120|62831079|FG001|Overall Study|Withdrawal by Subject|2|||
33456339|NCT03682120|62831080|FG002|Overall Study|Withdrawal by Subject|3|||
33456340|NCT03682120|62831081|FG003|Overall Study|Withdrawal by Subject|0|||
33456341|NCT03682120|62831078|FG000|Overall Study|Death|0|||
33456342|NCT03682120|62831079|FG001|Overall Study|Death|1|||
33456343|NCT03682120|62831080|FG002|Overall Study|Death|0|||
33456344|NCT03682120|62831081|FG003|Overall Study|Death|0|||
33456345|NCT03682120|62831078|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
33522402|NCT01986933|62908635|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
33522403|NCT01986933|62908631|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
33522404|NCT01986933|62908632|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
33617842|NCT02172950|63018978|FG001|Overall Study|Lost to Follow-up|0|||
33617843|NCT02172950|63018977|FG000|Overall Study|Death|1|||
33617844|NCT02172950|63018978|FG001|Overall Study|Death|0|||
33617845|NCT02172950|63018977|FG000|Overall Study|Patient traveling|1|||
33617846|NCT02172950|63018978|FG001|Overall Study|Patient traveling|0|||
33617847|NCT02172950|63018977|FG000|Overall Study|Patient went to other country|1|||
33522405|NCT01986933|62908633|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
33522406|NCT01986933|62908634|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
33522407|NCT01986933|62908635|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
33522408|NCT01986933|62908631|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
33522409|NCT01986933|62908632|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
33522410|NCT01986933|62908633|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
33522411|NCT01986933|62908634|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
33522412|NCT01986933|62908635|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
33522413|NCT01986933|62908631|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
33522414|NCT01986933|62908632|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
33522415|NCT01986933|62908633|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
33522416|NCT01986933|62908634|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
33522417|NCT01986933|62908635|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
33522418|NCT01986933|62908631|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
33522419|NCT01986933|62908632|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
33522420|NCT01986933|62908633|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
33522421|NCT01986933|62908634|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
33522422|NCT01986933|62908635|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
33522423|NCT00394355|62908679|FG000|Overall Study|Adverse Event|10|||
33522424|NCT00394355|62908680|FG001|Overall Study|Adverse Event|6|||
33522425|NCT00394355|62908681|FG002|Overall Study|Adverse Event|7|||
33522426|NCT00394355|62908682|FG003|Overall Study|Adverse Event|8|||
33617848|NCT02172950|63018978|FG001|Overall Study|Patient went to other country|0|||
33617849|NCT02172950|63018977|FG000|Overall Study|Patient relocated overseas|1|||
33617850|NCT02172950|63018978|FG001|Overall Study|Patient relocated overseas|1|||
33522427|NCT00394355|62908679|FG000|Overall Study|Did not meet protocol eligibility|1|||
33522428|NCT00394355|62908680|FG001|Overall Study|Did not meet protocol eligibility|5|||
33522429|NCT00394355|62908681|FG002|Overall Study|Did not meet protocol eligibility|4|||
33522430|NCT00394355|62908682|FG003|Overall Study|Did not meet protocol eligibility|2|||
33522431|NCT00394355|62908679|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
33522432|NCT00394355|62908680|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
33456346|NCT03682120|62831079|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
33456347|NCT03682120|62831080|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
33456348|NCT03682120|62831081|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
33456349|NCT04428502|62831093|FG000|Overall Study|Did not meet entrance criteria|14|||
33456350|NCT04428424|62831098|FG000|Overall Study|Does not meet entrance criteria|132|||
33456351|NCT04428424|62831098|FG000|Overall Study|Lost to Follow-up|115|||
33456352|NCT03655756|62831102|FG000|Overall Study|Death|1|||
33456353|NCT00095238|62831108|FG000|Overall Study|Lack of Efficacy|9|||
33456354|NCT00095238|62831109|FG001|Overall Study|Lack of Efficacy|9|||
33456355|NCT00095238|62831108|FG000|Overall Study|Adverse Event|331|||
33456356|NCT00095238|62831109|FG001|Overall Study|Adverse Event|287|||
33456357|NCT00095238|62831108|FG000|Overall Study|Subject Withdrew Consent|208|||
33456358|NCT00095238|62831109|FG001|Overall Study|Subject Withdrew Consent|223|||
33456359|NCT00095238|62831108|FG000|Overall Study|Death|154|||
33522433|NCT00394355|62908681|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
33522434|NCT00394355|62908682|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
33522435|NCT00394355|62908679|FG000|Overall Study|Subject withdrawal - related to drug|1|||
33522436|NCT00394355|62908680|FG001|Overall Study|Subject withdrawal - related to drug|0|||
33522437|NCT00394355|62908681|FG002|Overall Study|Subject withdrawal - related to drug|0|||
33522438|NCT00394355|62908682|FG003|Overall Study|Subject withdrawal - related to drug|0|||
33617851|NCT02172950|63018977|FG000|Overall Study|Patient moving|1|||
33617852|NCT02172950|63018978|FG001|Overall Study|Patient moving|0|||
33617853|NCT02151266|63018988|FG000|Overall Study|Lost to Follow-up|1|||
33617854|NCT02151266|63018989|FG001|Overall Study|Lost to Follow-up|4|||
33617855|NCT02151266|63018990|FG002|Overall Study|Lost to Follow-up|1|||
33617856|NCT02151266|63018988|FG000|Overall Study|Did NOT receive intervention|3|||
33617857|NCT02151266|63018989|FG001|Overall Study|Did NOT receive intervention|6|||
33617858|NCT02151266|63018990|FG002|Overall Study|Did NOT receive intervention|2|||
33617859|NCT02151266|63018988|FG000|Overall Study|Not able to exercise|4|||
33617860|NCT02151266|63018989|FG001|Overall Study|Not able to exercise|5|||
33522439|NCT00394355|62908679|FG000|Overall Study|Lost to Follow-up|7|||
33522440|NCT00394355|62908680|FG001|Overall Study|Lost to Follow-up|5|||
33522441|NCT00394355|62908681|FG002|Overall Study|Lost to Follow-up|4|||
33522442|NCT00394355|62908682|FG003|Overall Study|Lost to Follow-up|3|||
33522443|NCT00394355|62908679|FG000|Overall Study|Noncompliance with protocol|4|||
33522444|NCT00394355|62908680|FG001|Overall Study|Noncompliance with protocol|3|||
33522445|NCT00394355|62908681|FG002|Overall Study|Noncompliance with protocol|10|||
33522446|NCT00394355|62908682|FG003|Overall Study|Noncompliance with protocol|8|||
33522447|NCT00394355|62908679|FG000|Overall Study|Administrative|0|||
33522448|NCT00394355|62908680|FG001|Overall Study|Administrative|1|||
33522449|NCT00394355|62908681|FG002|Overall Study|Administrative|1|||
33522450|NCT00394355|62908682|FG003|Overall Study|Administrative|1|||
33522451|NCT00394355|62908679|FG000|Overall Study|Lack of Efficacy|0|||
33522452|NCT00394355|62908680|FG001|Overall Study|Lack of Efficacy|0|||
33522453|NCT00394355|62908681|FG002|Overall Study|Lack of Efficacy|2|||
33522454|NCT00394355|62908682|FG003|Overall Study|Lack of Efficacy|3|||
33522455|NCT02797808|62908694|FG000|Overall Study|Withdrawal by Subject|1|||
33617861|NCT02151266|63018990|FG002|Overall Study|Not able to exercise|4|||
33522456|NCT02797808|62908695|FG001|Overall Study|Withdrawal by Subject|1|||
33522457|NCT02797808|62908694|FG000|Overall Study|Physician Decision|6|||
33617862|NCT02151110|63019006|FG000|Overall Study|Withdrawal by Subject|0|||
33617863|NCT02151110|63019007|FG001|Overall Study|Withdrawal by Subject|0|||
33325196|NCT00952341|62701898|FG001|Cycle 2|Progressive Disease|1|||
33522458|NCT02797808|62908695|FG001|Overall Study|Physician Decision|2|||
33617864|NCT02151110|63019008|FG002|Overall Study|Withdrawal by Subject|0|||
33617865|NCT02151110|63019009|FG003|Overall Study|Withdrawal by Subject|0|||
33617866|NCT02151110|63019010|FG004|Overall Study|Withdrawal by Subject|0|||
33617867|NCT02151110|63019011|FG005|Overall Study|Withdrawal by Subject|0|||
33617868|NCT02151110|63019012|FG006|Overall Study|Withdrawal by Subject|0|||
33617869|NCT02151110|63019013|FG007|Overall Study|Withdrawal by Subject|1|||
33617870|NCT02151110|63019006|FG000|Overall Study|Lost to Follow-up|0|||
33617871|NCT02151110|63019007|FG001|Overall Study|Lost to Follow-up|0|||
33617872|NCT02151110|63019008|FG002|Overall Study|Lost to Follow-up|0|||
33617873|NCT02151110|63019009|FG003|Overall Study|Lost to Follow-up|0|||
33617874|NCT02151110|63019010|FG004|Overall Study|Lost to Follow-up|0|||
33617875|NCT02151110|63019011|FG005|Overall Study|Lost to Follow-up|0|||
33617876|NCT02151110|63019012|FG006|Overall Study|Lost to Follow-up|0|||
33617877|NCT02151110|63019013|FG007|Overall Study|Lost to Follow-up|2|||
33617878|NCT02132312|63019040|FG000|Overall Study|Adverse Event|2|||
33617879|NCT02132312|63019041|FG001|Overall Study|Adverse Event|0|||
33617880|NCT02132312|63019040|FG000|Overall Study|Physician Decision|1|||
33617881|NCT02132312|63019041|FG001|Overall Study|Physician Decision|1|||
33617882|NCT02132312|63019040|FG000|Overall Study|Protocol Violation|0|||
33617883|NCT02132312|63019041|FG001|Overall Study|Protocol Violation|1|||
33617884|NCT02132312|63019040|FG000|Overall Study|Withdrawal by Subject|1|||
33617885|NCT02132312|63019041|FG001|Overall Study|Withdrawal by Subject|0|||
33617886|NCT02132312|63019040|FG000|Overall Study|Lost to Follow-up|2|||
33617887|NCT02132312|63019041|FG001|Overall Study|Lost to Follow-up|1|||
33617888|NCT02131766|63019047|FG000|Overall Study|Withdrawal by Subject|4|||
33617889|NCT02150954|63019056|FG000|Overall Study|Protocol Violation|1|||
33617890|NCT02150954|63019057|FG001|Overall Study|Protocol Violation|0|||
33617891|NCT02131532|63019063|FG000|Overall Study|Withdrawal by Subject|1|||
33617892|NCT02131532|63019063|FG000|Overall Study|Physician Decision|1|||
33617893|NCT02131532|63019063|FG000|Overall Study|Other health conditions|2|||
33617894|NCT02170688|63019077|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
33617895|NCT02170688|63019078|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
33617896|NCT02170688|63019079|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
33617897|NCT02170688|63019080|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
33617898|NCT02170688|63019081|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
33617899|NCT02170688|63019077|FG000|Overall Study|Full dose not received|0|||
33617900|NCT02170688|63019078|FG001|Overall Study|Full dose not received|1|||
33617901|NCT02170688|63019079|FG002|Overall Study|Full dose not received|0|||
33617902|NCT02170688|63019080|FG003|Overall Study|Full dose not received|0|||
33617903|NCT02170688|63019081|FG004|Overall Study|Full dose not received|0|||
33617904|NCT02170688|63019077|FG000|Overall Study|Physician Decision|0|||
33617905|NCT02170688|63019078|FG001|Overall Study|Physician Decision|0|||
33617906|NCT02170688|63019079|FG002|Overall Study|Physician Decision|1|||
33617907|NCT02170688|63019080|FG003|Overall Study|Physician Decision|0|||
33617908|NCT02170688|63019081|FG004|Overall Study|Physician Decision|0|||
33617909|NCT02170298|63019095|FG000|Overall Study|Withdrawal by Subject|0|||
33617910|NCT02170298|63019096|FG001|Overall Study|Withdrawal by Subject|1|||
33617911|NCT02170298|63019095|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
33617912|NCT02170298|63019096|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
33617913|NCT02131064|63019104|FG000|Overall Study|Death|5|||
33617914|NCT02131064|63019105|FG001|Overall Study|Death|6|||
33617915|NCT02131064|63019104|FG000|Overall Study|Lost to Follow-up|4|||
33617916|NCT02131064|63019105|FG001|Overall Study|Lost to Follow-up|8|||
33617917|NCT02131064|63019104|FG000|Overall Study|Withdrawal by Subject|14|||
33617918|NCT02131064|63019105|FG001|Overall Study|Withdrawal by Subject|18|||
33617919|NCT02131064|63019104|FG000|Overall Study|Other|2|||
33617920|NCT02131064|63019105|FG001|Overall Study|Other|2|||
33617921|NCT02130986|63019114|FG000|Overall Study|Withdrawal by Subject|4|||
33617922|NCT02130986|63019115|FG001|Overall Study|Withdrawal by Subject|4|||
33617923|NCT02130986|63019114|FG000|Overall Study|Lost to Follow-up|151|||
33617924|NCT02130986|63019115|FG001|Overall Study|Lost to Follow-up|160|||
33617925|NCT02130284|63019123|FG000|Overall Study|Withdrawal by Subject|3|||
33617926|NCT02130284|63019123|FG000|Overall Study|Subject Withdrew Consent|1|||
33617927|NCT02130284|63019123|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
33617928|NCT02130284|63019123|FG000|Overall Study|Subject was screened as backup for study|3|||
33617929|NCT02130284|63019123|FG000|Overall Study|Screen Failure|1|||
33617930|NCT02147288|63019129|FG000|Overall Study|post-operative hematoma|1|||
33617931|NCT02147288|63019130|FG001|Overall Study|post-operative hematoma|1|||
33617932|NCT02147288|63019131|FG002|Overall Study|post-operative hematoma|0|||
33617933|NCT02147288|63019132|FG003|Overall Study|post-operative hematoma|0|||
33617934|NCT02147288|63019133|FG004|Overall Study|post-operative hematoma|0|||
33617935|NCT02147288|63019134|FG005|Overall Study|post-operative hematoma|0|||
33617936|NCT02147288|63019135|FG006|Overall Study|post-operative hematoma|0|||
33617937|NCT02147288|63019136|FG007|Overall Study|post-operative hematoma|0|||
33617938|NCT02147288|63019137|FG008|Overall Study|post-operative hematoma|0|||
33617939|NCT02147288|63019138|FG009|Overall Study|post-operative hematoma|0|||
33617940|NCT02147288|63019129|FG000|Overall Study|complications from concurrent hernia rep|0|||
33617941|NCT02147288|63019130|FG001|Overall Study|complications from concurrent hernia rep|1|||
33522459|NCT02796560|62908703|FG000|Overall Study|Adverse Event|2|||
33617942|NCT02147288|63019131|FG002|Overall Study|complications from concurrent hernia rep|0|||
33617943|NCT02147288|63019132|FG003|Overall Study|complications from concurrent hernia rep|0|||
33617944|NCT02147288|63019133|FG004|Overall Study|complications from concurrent hernia rep|0|||
33617945|NCT02147288|63019134|FG005|Overall Study|complications from concurrent hernia rep|0|||
33617946|NCT02147288|63019135|FG006|Overall Study|complications from concurrent hernia rep|0|||
33617947|NCT02147288|63019136|FG007|Overall Study|complications from concurrent hernia rep|0|||
33617948|NCT02147288|63019137|FG008|Overall Study|complications from concurrent hernia rep|0|||
33617949|NCT02147288|63019138|FG009|Overall Study|complications from concurrent hernia rep|0|||
33522460|NCT02796560|62908704|FG001|Overall Study|Adverse Event|0|||
33522461|NCT02796560|62908703|FG000|Overall Study|Withdrawal by Subject|2|||
33522462|NCT02796560|62908704|FG001|Overall Study|Withdrawal by Subject|2|||
33522463|NCT00344487|62908710|FG000|Overall Study|immunologic failure|1|||
33522464|NCT02871492|62908719|FG000|Overall Study|Lost to Follow-up|6|||
33522465|NCT02871492|62908720|FG001|Overall Study|Lost to Follow-up|3|||
33522466|NCT02871492|62908721|FG002|Overall Study|Lost to Follow-up|5|||
33522467|NCT02871492|62908719|FG000|Overall Study|Withdrawal by Subject|0|||
33522468|NCT02871492|62908720|FG001|Overall Study|Withdrawal by Subject|0|||
33522469|NCT02871492|62908721|FG002|Overall Study|Withdrawal by Subject|1|||
33522470|NCT03143855|62908731|FG000|Overall Study|Withdrawal by Subject|4|||
33522471|NCT03143855|62908732|FG001|Overall Study|Withdrawal by Subject|3|||
33522472|NCT03143855|62908731|FG000|Overall Study|Protocol Violation|1|||
33522473|NCT03143855|62908732|FG001|Overall Study|Protocol Violation|0|||
33522474|NCT03143855|62908731|FG000|Overall Study|Participant experienced withdrawal|0|||
33522475|NCT03143855|62908732|FG001|Overall Study|Participant experienced withdrawal|1|||
33522476|NCT02878603|62908740|FG000|Overall Study|Lost to Follow-up|4|||
33522477|NCT02878603|62908741|FG001|Overall Study|Lost to Follow-up|1|||
33522478|NCT02878603|62908740|FG000|Overall Study|Withdrawal by Subject|1|||
33522479|NCT02878603|62908741|FG001|Overall Study|Withdrawal by Subject|1|||
33522480|NCT02878603|62908740|FG000|Overall Study|Death|1|||
33522481|NCT02878603|62908741|FG001|Overall Study|Death|0|||
33522482|NCT02878603|62908740|FG000|Overall Study|Physician Decision|0|||
33522483|NCT02878603|62908741|FG001|Overall Study|Physician Decision|3|||
33522484|NCT01370408|62908747|FG000|Overall Study|treatment failure|9|||
33522485|NCT03294109|62908753|FG000|Overall Study|Withdrawal by Subject|6|||
33522486|NCT03294109|62908754|FG001|Overall Study|Withdrawal by Subject|5|||
33522487|NCT03132805|62908773|FG000|Overall Study|Lost to Follow-up|142|||
33522488|NCT03132805|62908774|FG001|Overall Study|Lost to Follow-up|141|||
33522489|NCT03132805|62908775|FG002|Overall Study|Lost to Follow-up|113|||
33522490|NCT02793128|62908783|FG000|Overall Study|Death|4|||
33522491|NCT02793128|62908783|FG000|Overall Study|Withdrawal by Subject|2|||
33522492|NCT02793128|62908783|FG000|Overall Study|Physician Decision|1|||
33522493|NCT02793128|62908783|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
33522494|NCT02793128|62908783|FG000|Overall Study|Patient elected nephroureterectomy|1|||
33522495|NCT03142451|62908797|FG000|Overall Study|Adverse Event|5|||
33617950|NCT02147132|63019144|FG000|Overall Study|Lost to Follow-up|1|||
33617951|NCT02147132|63019145|FG001|Overall Study|Lost to Follow-up|0|||
33617952|NCT02147132|63019146|FG002|Overall Study|Lost to Follow-up|0|||
33522496|NCT03142451|62908798|FG001|Overall Study|Adverse Event|2|||
33522497|NCT03142451|62908797|FG000|Overall Study|Lost to Follow-up|25|||
33617953|NCT02147132|63019147|FG003|Overall Study|Lost to Follow-up|0|||
33617954|NCT02146430|63019161|FG000|Overall Study|Protocol Violation|5|||
33522498|NCT03142451|62908798|FG001|Overall Study|Lost to Follow-up|8|||
33522499|NCT03142451|62908797|FG000|Overall Study|Participant request|24|||
33522500|NCT03142451|62908798|FG001|Overall Study|Participant request|12|||
33522501|NCT03142451|62908797|FG000|Overall Study|Protocol Violation|3|||
33522502|NCT03142451|62908798|FG001|Overall Study|Protocol Violation|1|||
33522503|NCT03142451|62908797|FG000|Overall Study|Other|1|||
33522504|NCT03142451|62908798|FG001|Overall Study|Other|1|||
33522505|NCT03141905|62908806|FG000|Overall Study|Death|3|||
33522506|NCT03141905|62908807|FG001|Overall Study|Death|2|||
33522507|NCT03141905|62908806|FG000|Overall Study|Withdrawal by Subject|1|||
33522508|NCT03141905|62908807|FG001|Overall Study|Withdrawal by Subject|0|||
33522509|NCT03141905|62908806|FG000|Overall Study|Lost to Follow-up|3|||
33522510|NCT03141905|62908807|FG001|Overall Study|Lost to Follow-up|7|||
33522511|NCT03141905|62908806|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
33522512|NCT03141905|62908807|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
33522513|NCT01370018|62908814|FG000|Overall Study|Did not meet criteria for analysis|1|||
33522514|NCT04034355|62908820|FG000|Overall Study|Study terminated by Sponsor|10|||
33522515|NCT04034355|62908821|FG001|Overall Study|Study terminated by Sponsor|17|||
33522516|NCT04034355|62908820|FG000|Overall Study|Withdrawal by Subject|12|||
33617955|NCT02146430|63019162|FG001|Overall Study|Protocol Violation|4|||
33617956|NCT02146430|63019163|FG002|Overall Study|Protocol Violation|8|||
33617957|NCT02146430|63019164|FG003|Overall Study|Protocol Violation|6|||
33617958|NCT02146430|63019161|FG000|Overall Study|Lack of Efficacy|13|||
33617959|NCT02146430|63019162|FG001|Overall Study|Lack of Efficacy|11|||
33617960|NCT02146430|63019163|FG002|Overall Study|Lack of Efficacy|8|||
33617961|NCT02146430|63019164|FG003|Overall Study|Lack of Efficacy|5|||
33617962|NCT02146430|63019161|FG000|Overall Study|Adverse Event|20|||
33456360|NCT00095238|62831109|FG001|Overall Study|Death|170|||
33456361|NCT00095238|62831108|FG000|Overall Study|Lost to Follow-up|19|||
33456362|NCT00095238|62831109|FG001|Overall Study|Lost to Follow-up|24|||
33456363|NCT00095238|62831108|FG000|Overall Study|Noncompliance|44|||
33456364|NCT00095238|62831109|FG001|Overall Study|Noncompliance|45|||
33456365|NCT00095238|62831108|FG000|Overall Study|No longer met study criteria|4|||
33456366|NCT00095238|62831109|FG001|Overall Study|No longer met study criteria|5|||
33456367|NCT00095238|62831108|FG000|Overall Study|Study terminated by sponsor|0|||
33456368|NCT00095238|62831109|FG001|Overall Study|Study terminated by sponsor|1|||
33456369|NCT00095238|62831108|FG000|Overall Study|Missing|1|||
33456370|NCT00095238|62831109|FG001|Overall Study|Missing|0|||
33522517|NCT04034355|62908821|FG001|Overall Study|Withdrawal by Subject|11|||
33522518|NCT04034355|62908820|FG000|Overall Study|Site terminated by Sponsor|4|||
33522519|NCT04034355|62908821|FG001|Overall Study|Site terminated by Sponsor|5|||
33522520|NCT04034355|62908820|FG000|Overall Study|Adverse Event|2|||
33522521|NCT04034355|62908821|FG001|Overall Study|Adverse Event|0|||
33522522|NCT04034355|62908820|FG000|Overall Study|Death|1|||
33522523|NCT04034355|62908821|FG001|Overall Study|Death|1|||
33522524|NCT04034355|62908820|FG000|Overall Study|Not reported|2|||
33522525|NCT04034355|62908821|FG001|Overall Study|Not reported|0|||
33522526|NCT04034355|62908820|FG000|Overall Study|Lost to Follow-up|1|||
33617963|NCT02146430|63019162|FG001|Overall Study|Adverse Event|40|||
33456371|NCT00095238|62831108|FG000|Overall Study|Other Reasons|87|||
33456372|NCT00095238|62831109|FG001|Overall Study|Other Reasons|88|||
33522527|NCT04034355|62908821|FG001|Overall Study|Lost to Follow-up|0|||
33522528|NCT04034355|62908820|FG000|Overall Study|Physician Decision|1|||
33522529|NCT04034355|62908821|FG001|Overall Study|Physician Decision|0|||
33522530|NCT04034355|62908820|FG000|Overall Study|Protocol Violation|0|||
33617964|NCT02146430|63019163|FG002|Overall Study|Adverse Event|32|||
33617965|NCT02146430|63019164|FG003|Overall Study|Adverse Event|49|||
33617966|NCT02146430|63019161|FG000|Overall Study|Reason missing or not reported|2|||
33617967|NCT02146430|63019162|FG001|Overall Study|Reason missing or not reported|3|||
33617968|NCT02146430|63019163|FG002|Overall Study|Reason missing or not reported|4|||
33617969|NCT02146430|63019164|FG003|Overall Study|Reason missing or not reported|5|||
33522531|NCT04034355|62908821|FG001|Overall Study|Protocol Violation|1|||
33522532|NCT04034355|62908820|FG000|Overall Study|Progressive disease|1|||
33522533|NCT04034355|62908821|FG001|Overall Study|Progressive disease|0|||
33522534|NCT01336764|62908838|FG000|Overall Study|Withdrawal by Subject|5|||
33522535|NCT01336764|62908839|FG001|Overall Study|Withdrawal by Subject|5|||
33522536|NCT01336608|62908848|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
33522537|NCT01336608|62908849|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33522538|NCT01336608|62908850|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33617970|NCT02146430|63019161|FG000|Overall Study|Withdrawal by Subject|27|||
33617971|NCT02146430|63019162|FG001|Overall Study|Withdrawal by Subject|29|||
33617972|NCT02146430|63019163|FG002|Overall Study|Withdrawal by Subject|30|||
33522539|NCT01336608|62908851|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33522540|NCT01336608|62908848|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
33522541|NCT01336608|62908849|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33522542|NCT01336608|62908850|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33522543|NCT01336608|62908851|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33522544|NCT01336608|62908848|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
33522545|NCT01336608|62908849|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
33522546|NCT01336608|62908850|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
33522547|NCT01336608|62908851|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
33522548|NCT01336608|62908848|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
33617973|NCT02146430|63019164|FG003|Overall Study|Withdrawal by Subject|34|||
33617974|NCT02129192|63019180|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
33617975|NCT02129192|63019181|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
33522549|NCT01336608|62908849|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
33522550|NCT01336608|62908850|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
33522551|NCT01336608|62908851|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
33522552|NCT01336608|62908848|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
33522553|NCT01336608|62908849|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33522554|NCT01336608|62908850|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33522555|NCT01336608|62908851|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33522556|NCT01336608|62908848|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
33522557|NCT01336608|62908849|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
33522558|NCT01336608|62908850|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
33522559|NCT01336608|62908851|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
33522560|NCT01336608|62908848|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33522561|NCT01336608|62908849|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
33522562|NCT01336608|62908850|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33522563|NCT01336608|62908851|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33617976|NCT02105948|63019194|FG000|Overall Study|Adverse Event|10|||
33522564|NCT01336608|62908848|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
33522565|NCT01336608|62908849|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
33522566|NCT01336608|62908850|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
33522567|NCT01336608|62908851|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
33617977|NCT02105948|63019195|FG001|Overall Study|Adverse Event|7|||
33617978|NCT02105948|63019196|FG002|Overall Study|Adverse Event|11|||
33617979|NCT02105948|63019197|FG003|Overall Study|Adverse Event|11|||
33617980|NCT02105948|63019194|FG000|Overall Study|Lack of Efficacy|0|||
33617981|NCT02105948|63019195|FG001|Overall Study|Lack of Efficacy|1|||
33617982|NCT02105948|63019196|FG002|Overall Study|Lack of Efficacy|3|||
33617983|NCT02105948|63019197|FG003|Overall Study|Lack of Efficacy|2|||
33617984|NCT02105948|63019194|FG000|Overall Study|Lost to Follow-up|0|||
33617985|NCT02105948|63019195|FG001|Overall Study|Lost to Follow-up|0|||
33617986|NCT02105948|63019196|FG002|Overall Study|Lost to Follow-up|2|||
33617987|NCT02105948|63019197|FG003|Overall Study|Lost to Follow-up|1|||
33617988|NCT02105948|63019194|FG000|Overall Study|Physician Decision|2|||
33522568|NCT01336608|62908848|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
33617989|NCT02105948|63019195|FG001|Overall Study|Physician Decision|2|||
33617990|NCT02105948|63019196|FG002|Overall Study|Physician Decision|2|||
33617991|NCT02105948|63019197|FG003|Overall Study|Physician Decision|2|||
33617992|NCT02105948|63019194|FG000|Overall Study|Withdrawal by Subject|15|||
33522569|NCT01336608|62908849|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
33522570|NCT01336608|62908850|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
33522571|NCT01336608|62908851|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
33522572|NCT01336608|62908848|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
33522573|NCT01336608|62908849|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
33522574|NCT01336608|62908850|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
33522575|NCT01336608|62908851|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
33522576|NCT01336608|62908848|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33522577|NCT01336608|62908849|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
33522578|NCT01336608|62908850|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33522579|NCT01336608|62908851|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33522580|NCT01336608|62908848|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
33522581|NCT01336608|62908849|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
33522582|NCT01336608|62908850|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
33522583|NCT01336608|62908851|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
33522584|NCT01336608|62908848|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
33522585|NCT01336608|62908849|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
33522586|NCT01336608|62908850|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
33522587|NCT01336608|62908851|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
33522588|NCT01346371|62908870|FG000|Overall Study|Lost to Follow-up|2|||
33522589|NCT01346371|62908871|FG001|Overall Study|Lost to Follow-up|0|||
33522590|NCT03644849|62908889|FG000|Overall Study|Lost to Follow-up|1|||
33522591|NCT03644849|62908890|FG001|Overall Study|Lost to Follow-up|3|||
33522592|NCT03131479|62908901|FG000|Overall Study|Adverse Event|0|||
33522593|NCT03131479|62908902|FG001|Overall Study|Adverse Event|0|||
33522594|NCT03131479|62908903|FG002|Overall Study|Adverse Event|1|||
33522595|NCT03131479|62908904|FG003|Overall Study|Adverse Event|1|||
33522596|NCT03131479|62908905|FG004|Overall Study|Adverse Event|0|||
33522597|NCT03131479|62908901|FG000|Overall Study|Subject/Guardian Decision|0|||
33522598|NCT03131479|62908902|FG001|Overall Study|Subject/Guardian Decision|0|||
33522599|NCT03131479|62908903|FG002|Overall Study|Subject/Guardian Decision|0|||
33522600|NCT03131479|62908904|FG003|Overall Study|Subject/Guardian Decision|1|||
33522601|NCT03131479|62908905|FG004|Overall Study|Subject/Guardian Decision|0|||
33522602|NCT03602885|62908919|FG000|Overall Study|Lost to Follow-up|3|||
33617993|NCT02105948|63019195|FG001|Overall Study|Withdrawal by Subject|10|||
33617994|NCT02105948|63019196|FG002|Overall Study|Withdrawal by Subject|10|||
33617995|NCT02105948|63019197|FG003|Overall Study|Withdrawal by Subject|11|||
33617996|NCT02128724|63019212|FG000|Overall Study|Death|1|||
33617997|NCT02128724|63019213|FG001|Overall Study|Death|0|||
33617998|NCT02128724|63019214|FG002|Overall Study|Death|0|||
33617999|NCT02128724|63019215|FG003|Overall Study|Death|0|||
33522603|NCT03602885|62908920|FG001|Overall Study|Lost to Follow-up|0|||
33522604|NCT02880761|62908928|FG000|Overall Study|Death|6|||
33522605|NCT02880761|62908929|FG001|Overall Study|Death|8|||
33522606|NCT02880761|62908928|FG000|Overall Study|Withdrawal by Subject|3|||
33522607|NCT02880761|62908929|FG001|Overall Study|Withdrawal by Subject|6|||
33522608|NCT02880761|62908928|FG000|Overall Study|Protocol Violation|4|||
33522609|NCT02880761|62908929|FG001|Overall Study|Protocol Violation|3|||
33522610|NCT02880761|62908928|FG000|Overall Study|Lost to Follow-up|3|||
33522611|NCT02880761|62908929|FG001|Overall Study|Lost to Follow-up|4|||
33522612|NCT02930941|62908937|FG000|Overall Study|Lost to Follow-up|1|||
33522613|NCT02930941|62908938|FG001|Overall Study|Lost to Follow-up|2|||
33522614|NCT03137537|62908950|FG000|Overall Study|Adverse Event|0|||
33522615|NCT03137537|62908951|FG001|Overall Study|Adverse Event|1|||
33522616|NCT03137459|62908959|FG000|2-month Assessment|Withdrawal by Subject|13|||
33522617|NCT03137459|62908960|FG001|2-month Assessment|Withdrawal by Subject|3|||
33522618|NCT03137459|62908959|FG000|2-month Assessment|Unable to reach|42|||
33522619|NCT03137459|62908960|FG001|2-month Assessment|Unable to reach|32|||
33522620|NCT03137459|62908959|FG000|2-month Assessment|Refused assessment|7|||
33522621|NCT03137459|62908960|FG001|2-month Assessment|Refused assessment|5|||
33522622|NCT03137459|62908959|FG000|2-month Assessment|Acutely ill|6|||
33522623|NCT03137459|62908960|FG001|2-month Assessment|Acutely ill|2|||
33522624|NCT03137459|62908959|FG000|4-month Assessment|Death|4|||
33522625|NCT03137459|62908960|FG001|4-month Assessment|Death|2|||
33522626|NCT03137459|62908959|FG000|4-month Assessment|Withdrawal by Subject|4|||
33522627|NCT03137459|62908960|FG001|4-month Assessment|Withdrawal by Subject|2|||
33522628|NCT03137459|62908959|FG000|4-month Assessment|Unable to reach|44|||
33522629|NCT03137459|62908960|FG001|4-month Assessment|Unable to reach|29|||
33522630|NCT03137459|62908959|FG000|4-month Assessment|Refused assessment|24|||
33456373|NCT00082368|62831147|FG000|Overall Study|Not treated-pt had poor IV access|1|||
33456374|NCT00094770|62831153|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
33456375|NCT00094770|62831154|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
33456376|NCT00094770|62831153|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
33456377|NCT00094770|62831154|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
33456378|NCT00094770|62831153|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
33456379|NCT00094770|62831154|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
33456380|NCT00094770|62831153|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
33456381|NCT00094770|62831154|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
33456382|NCT00094770|62831153|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
33456383|NCT00094770|62831154|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
33456384|NCT00094770|62831153|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
33456385|NCT00094770|62831154|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
33456386|NCT00094770|62831153|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
33456387|NCT00094770|62831154|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
33456388|NCT00094770|62831153|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
33456389|NCT00094770|62831154|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
33456390|NCT00094770|62831153|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
33456391|NCT00094770|62831154|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
33456392|NCT00094770|62831153|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
33456393|NCT00094770|62831154|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
33456394|NCT00094770|62831153|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
33456395|NCT00094770|62831154|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
33456396|NCT00094770|62831153|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
33456397|NCT00094770|62831154|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
33456398|NCT00094770|62831153|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
33456399|NCT00094770|62831154|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
33456400|NCT00094770|62831153|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
33456401|NCT00094770|62831154|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
33456402|NCT00094770|62831153|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
33456403|NCT00094770|62831154|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
33456404|NCT00094770|62831153|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
33456405|NCT00094770|62831154|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
33456406|NCT00094770|62831153|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
33456407|NCT00094770|62831154|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
33456408|NCT00094770|62831153|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
33456409|NCT00094770|62831154|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
33456410|NCT00069576|62831162|FG000|Original Trial|Lost to Follow-up|25|||
33456411|NCT00069576|62831163|FG001|Original Trial|Lost to Follow-up|33|||
33522631|NCT03137459|62908960|FG001|4-month Assessment|Refused assessment|10|||
33522632|NCT03137459|62908959|FG000|4-month Assessment|Acutely ill|2|||
33522633|NCT03137459|62908960|FG001|4-month Assessment|Acutely ill|3|||
33456412|NCT00069576|62831162|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
33456413|NCT00069576|62831163|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
33522634|NCT03137459|62908959|FG000|6-months|Lost to Follow-up|14|||
33522635|NCT03137459|62908960|FG001|6-months|Lost to Follow-up|11|||
33522636|NCT03137459|62908959|FG000|6-months|Death|0|||
33522637|NCT03137459|62908960|FG001|6-months|Death|2|||
33522638|NCT03137459|62908959|FG000|6-months|Refused assessment|6|||
33522639|NCT03137459|62908960|FG001|6-months|Refused assessment|3|||
33522640|NCT03137459|62908959|FG000|6-months|Acutely ill|1|||
33522641|NCT03137459|62908960|FG001|6-months|Acutely ill|1|||
33522642|NCT03131713|62908969|FG000|Overall Study|Lost to Follow-up|5|||
33522643|NCT03131713|62908970|FG001|Overall Study|Lost to Follow-up|0|||
33522644|NCT02930005|62908978|FG000|Overall Study|Lost to Follow-up|1|||
33522645|NCT02930005|62908979|FG001|Overall Study|Lost to Follow-up|5|||
33522646|NCT03637491|62908989|FG000|Overall Study|Death|9|||
33522647|NCT03637491|62908990|FG001|Overall Study|Death|9|||
33522648|NCT03637491|62908991|FG002|Overall Study|Death|5|||
33522649|NCT03637491|62908992|FG003|Overall Study|Death|3|||
33522650|NCT03637491|62908989|FG000|Overall Study|Lost to Follow-up|0|||
33522651|NCT03637491|62908990|FG001|Overall Study|Lost to Follow-up|1|||
33522652|NCT03637491|62908991|FG002|Overall Study|Lost to Follow-up|0|||
33522653|NCT03637491|62908992|FG003|Overall Study|Lost to Follow-up|1|||
33522654|NCT03637491|62908989|FG000|Overall Study|Study Terminated By Sponsor|0|||
33522655|NCT03637491|62908990|FG001|Overall Study|Study Terminated By Sponsor|2|||
33522656|NCT03637491|62908991|FG002|Overall Study|Study Terminated By Sponsor|1|||
33522657|NCT03637491|62908992|FG003|Overall Study|Study Terminated By Sponsor|0|||
33522658|NCT03637491|62908989|FG000|Overall Study|Withdrawal by Subject|1|||
33522659|NCT03637491|62908990|FG001|Overall Study|Withdrawal by Subject|0|||
33522660|NCT03637491|62908991|FG002|Overall Study|Withdrawal by Subject|1|||
33522661|NCT03637491|62908992|FG003|Overall Study|Withdrawal by Subject|2|||
33522662|NCT03334539|62909026|FG000|Overall Study|Adverse Event|3|||
33522663|NCT03334539|62909027|FG001|Overall Study|Adverse Event|5|||
33522664|NCT03334539|62909028|FG002|Overall Study|Adverse Event|0|||
33522665|NCT03334539|62909026|FG000|Overall Study|Withdrawal by Subject|0|||
33522666|NCT03334539|62909027|FG001|Overall Study|Withdrawal by Subject|1|||
33522667|NCT03334539|62909028|FG002|Overall Study|Withdrawal by Subject|1|||
33522668|NCT03334539|62909026|FG000|Overall Study|Administrative Reasons|1|||
33522669|NCT03334539|62909027|FG001|Overall Study|Administrative Reasons|0|||
33522670|NCT03334539|62909028|FG002|Overall Study|Administrative Reasons|0|||
33522671|NCT03334539|62909026|FG000|Overall Study|Hypertension Not Controlled|0|||
33522672|NCT03334539|62909027|FG001|Overall Study|Hypertension Not Controlled|1|||
33522673|NCT03334539|62909028|FG002|Overall Study|Hypertension Not Controlled|0|||
33522674|NCT03137303|62909043|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
33522675|NCT03137303|62909044|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
33522676|NCT03137303|62909043|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
33522677|NCT03137303|62909044|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
33522678|NCT03137303|62909043|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
33522679|NCT03137303|62909044|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
33522680|NCT03137303|62909043|FG000|T3: 9-month Follow-up|Death|1|||
33522681|NCT03137303|62909044|FG001|T3: 9-month Follow-up|Death|0|||
33522682|NCT03137303|62909043|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
33522683|NCT03137303|62909044|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
33522684|NCT03137303|62909043|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
33522685|NCT03137303|62909044|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
33522686|NCT03137303|62909043|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
33522687|NCT03137303|62909044|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
33522688|NCT03296553|62909052|FG000|Overall Study|Withdrawal by Subject|1|||
33522689|NCT03296553|62909053|FG001|Overall Study|Withdrawal by Subject|1|||
33522690|NCT03296553|62909052|FG000|Overall Study|Death|1|||
33522691|NCT03296553|62909053|FG001|Overall Study|Death|0|||
33522692|NCT03131167|62909072|FG000|Overall Study|Other (Unspecified)|0|||
33522693|NCT03131167|62909073|FG001|Overall Study|Other (Unspecified)|0|||
33522694|NCT03131167|62909074|FG002|Overall Study|Other (Unspecified)|0|||
33522695|NCT03131167|62909075|FG003|Overall Study|Other (Unspecified)|0|||
33522696|NCT03131167|62909076|FG004|Overall Study|Other (Unspecified)|0|||
33522697|NCT03131167|62909077|FG005|Overall Study|Other (Unspecified)|1|||
33522698|NCT03131167|62909078|FG006|Overall Study|Other (Unspecified)|0|||
33522699|NCT03131167|62909079|FG007|Overall Study|Other (Unspecified)|0|||
33522700|NCT03131167|62909080|FG008|Overall Study|Other (Unspecified)|0|||
33522701|NCT03131167|62909081|FG009|Overall Study|Other (Unspecified)|0|||
33522702|NCT03131167|62909082|FG010|Overall Study|Other (Unspecified)|0|||
33522703|NCT03131167|62909083|FG011|Overall Study|Other (Unspecified)|0|||
33522704|NCT03131167|62909084|FG012|Overall Study|Other (Unspecified)|0|||
33522705|NCT03060447|62909115|FG000|Overall Study|Withdrawal by Subject|2|||
33522706|NCT03060447|62909116|FG001|Overall Study|Withdrawal by Subject|0|||
33522707|NCT01712789|62909128|FG000|Overall Study|Lack of Efficacy|2|||
33522708|NCT01712789|62909128|FG000|Overall Study|Lost to Follow-up|1|||
33522709|NCT01712789|62909128|FG000|Overall Study|Progressive Disease|504|||
33522710|NCT01712789|62909128|FG000|Overall Study|Death|57|||
33522711|NCT01712789|62909128|FG000|Overall Study|Adverse Event|52|||
33522712|NCT01712789|62909128|FG000|Overall Study|Miscellaneous|31|||
33522713|NCT01712789|62909128|FG000|Overall Study|Withdrawal by Subject|21|||
33522714|NCT01712789|62909128|FG000|Overall Study|Transition to Commercial Treatment|8|||
33522715|NCT01712789|62909128|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
33522716|NCT02978781|62909135|FG000|Part A|Adverse Event|1|||
33522717|NCT02978781|62909136|FG001|Part A|Adverse Event|1|||
33522718|NCT02978781|62909137|FG002|Part A|Adverse Event|0|||
33522719|NCT02978781|62909138|FG003|Part A|Adverse Event|0|||
33522720|NCT02978781|62909139|FG004|Part A|Adverse Event|0|||
33522721|NCT02978781|62909135|FG000|Part A|Withdrawal by Subject|0|||
33522722|NCT02978781|62909136|FG001|Part A|Withdrawal by Subject|1|||
33522723|NCT02978781|62909137|FG002|Part A|Withdrawal by Subject|0|||
33522724|NCT02978781|62909138|FG003|Part A|Withdrawal by Subject|0|||
33522725|NCT02978781|62909139|FG004|Part A|Withdrawal by Subject|0|||
33522726|NCT02978781|62909135|FG000|Part B|Withdrawal by Subject|0|||
33522727|NCT02978781|62909136|FG001|Part B|Withdrawal by Subject|0|||
33522728|NCT02978781|62909137|FG002|Part B|Withdrawal by Subject|0|||
33522729|NCT02978781|62909138|FG003|Part B|Withdrawal by Subject|1|||
33522730|NCT02978781|62909139|FG004|Part B|Withdrawal by Subject|0|||
33522731|NCT02978781|62909135|FG000|Part C|Adverse Event|0|||
33522732|NCT02978781|62909136|FG001|Part C|Adverse Event|0|||
33522733|NCT02978781|62909137|FG002|Part C|Adverse Event|0|||
33522734|NCT02978781|62909138|FG003|Part C|Adverse Event|0|||
33522735|NCT02978781|62909139|FG004|Part C|Adverse Event|2|||
33522736|NCT02978781|62909135|FG000|Part C|Withdrawal by Subject|0|||
33522737|NCT02978781|62909136|FG001|Part C|Withdrawal by Subject|0|||
33618000|NCT02128724|63019212|FG000|Overall Study|Adverse Event|0|||
33618001|NCT02128724|63019213|FG001|Overall Study|Adverse Event|1|||
33618002|NCT02128724|63019214|FG002|Overall Study|Adverse Event|0|||
33522738|NCT02978781|62909137|FG002|Part C|Withdrawal by Subject|0|||
33522739|NCT02978781|62909138|FG003|Part C|Withdrawal by Subject|0|||
33522740|NCT02978781|62909139|FG004|Part C|Withdrawal by Subject|1|||
33522741|NCT02978781|62909135|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
33522742|NCT02978781|62909136|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
33522743|NCT02978781|62909137|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
33522744|NCT02978781|62909138|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
33522745|NCT02978781|62909139|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
33522746|NCT03074318|62909169|FG000|Overall Study|Adverse Event|0|||
33522747|NCT03074318|62909170|FG001|Overall Study|Adverse Event|1|||
33522748|NCT03074318|62909171|FG002|Overall Study|Adverse Event|1|||
33522749|NCT03074318|62909172|FG003|Overall Study|Adverse Event|1|||
33522750|NCT03074318|62909169|FG000|Overall Study|Death|1|||
33522751|NCT03074318|62909170|FG001|Overall Study|Death|0|||
33522752|NCT03074318|62909171|FG002|Overall Study|Death|0|||
33522753|NCT03074318|62909172|FG003|Overall Study|Death|0|||
33522754|NCT03074318|62909169|FG000|Overall Study|Withdrawal by Subject|1|||
33522755|NCT03074318|62909170|FG001|Overall Study|Withdrawal by Subject|2|||
33522756|NCT03074318|62909171|FG002|Overall Study|Withdrawal by Subject|2|||
33522757|NCT03074318|62909172|FG003|Overall Study|Withdrawal by Subject|4|||
33522758|NCT03074318|62909169|FG000|Overall Study|Trial Closure|2|||
33522759|NCT03074318|62909170|FG001|Overall Study|Trial Closure|2|||
33522760|NCT03074318|62909171|FG002|Overall Study|Trial Closure|3|||
33522761|NCT03074318|62909172|FG003|Overall Study|Trial Closure|11|||
33522762|NCT03135119|62909193|FG000|Overall Study|Lost to Follow-up|2|||
33522763|NCT03135119|62909194|FG001|Overall Study|Lost to Follow-up|0|||
33522764|NCT03135119|62909193|FG000|Overall Study|Physician Decision|1|||
33522765|NCT03135119|62909194|FG001|Overall Study|Physician Decision|1|||
33522766|NCT03135119|62909193|FG000|Overall Study|COVID-19 Shutdown|2|||
33522767|NCT03135119|62909194|FG001|Overall Study|COVID-19 Shutdown|2|||
33522768|NCT01369784|62909200|FG000|Overall Study|Protocol Violation|12|||
33522769|NCT03353675|62909204|FG000|Overall Study|Adverse Event|4|||
33522770|NCT03137069|62909214|FG000|Overall Study|Withdrawal by Subject|1|||
33522771|NCT03137069|62909215|FG001|Overall Study|Withdrawal by Subject|2|||
33522772|NCT03137069|62909216|FG002|Overall Study|Withdrawal by Subject|2|||
33522773|NCT03137069|62909217|FG003|Overall Study|Withdrawal by Subject|2|||
33522774|NCT03137069|62909218|FG004|Overall Study|Withdrawal by Subject|0|||
33522775|NCT03137069|62909219|FG005|Overall Study|Withdrawal by Subject|0|||
33522776|NCT03137069|62909214|FG000|Overall Study|Adverse Event|0|||
33522777|NCT03137069|62909215|FG001|Overall Study|Adverse Event|3|||
33522778|NCT03137069|62909216|FG002|Overall Study|Adverse Event|1|||
33522779|NCT03137069|62909217|FG003|Overall Study|Adverse Event|1|||
33522780|NCT03137069|62909218|FG004|Overall Study|Adverse Event|0|||
33522781|NCT03137069|62909219|FG005|Overall Study|Adverse Event|1|||
33522782|NCT03137069|62909214|FG000|Overall Study|Protocol Violation|0|||
33522783|NCT03137069|62909215|FG001|Overall Study|Protocol Violation|1|||
33522784|NCT03137069|62909216|FG002|Overall Study|Protocol Violation|0|||
33522785|NCT03137069|62909217|FG003|Overall Study|Protocol Violation|1|||
33522786|NCT03137069|62909218|FG004|Overall Study|Protocol Violation|1|||
33618003|NCT02128724|63019215|FG003|Overall Study|Adverse Event|0|||
33522787|NCT03137069|62909219|FG005|Overall Study|Protocol Violation|1|||
33522788|NCT03137069|62909214|FG000|Overall Study|Physician Decision|0|||
33522789|NCT03137069|62909215|FG001|Overall Study|Physician Decision|0|||
33522790|NCT03137069|62909216|FG002|Overall Study|Physician Decision|0|||
33522791|NCT03137069|62909217|FG003|Overall Study|Physician Decision|1|||
33522792|NCT03137069|62909218|FG004|Overall Study|Physician Decision|0|||
33522793|NCT03137069|62909219|FG005|Overall Study|Physician Decision|0|||
33522794|NCT03137069|62909214|FG000|Overall Study|Study Terminated by Sponsor|0|||
33522795|NCT03137069|62909215|FG001|Overall Study|Study Terminated by Sponsor|0|||
33522796|NCT03137069|62909216|FG002|Overall Study|Study Terminated by Sponsor|0|||
33522797|NCT03137069|62909217|FG003|Overall Study|Study Terminated by Sponsor|0|||
33522798|NCT03137069|62909218|FG004|Overall Study|Study Terminated by Sponsor|1|||
33522799|NCT03137069|62909219|FG005|Overall Study|Study Terminated by Sponsor|0|||
33522800|NCT03137069|62909214|FG000|Overall Study|Data Entry Error|0|||
33522801|NCT03137069|62909215|FG001|Overall Study|Data Entry Error|0|||
33325197|NCT00946881|62701904|FG000|First Treatment|Withdrawal by Subject|1|||
33325198|NCT00946881|62701904|FG000|First Treatment|Patient relocated to another state|1|||
33325199|NCT00946881|62701904|FG000|Retreatment|Withdrawal by Subject|1|||
33325200|NCT01214642|62701941|FG000|Overall Study|Progressive Disease|3|||
33325201|NCT01214642|62701942|FG001|Overall Study|Progressive Disease|2|||
33325202|NCT01214642|62701943|FG002|Overall Study|Progressive Disease|3|||
33325203|NCT01214642|62701944|FG003|Overall Study|Progressive Disease|5|||
33325204|NCT01214642|62701945|FG004|Overall Study|Progressive Disease|5|||
33325205|NCT01214642|62701946|FG005|Overall Study|Progressive Disease|3|||
33325206|NCT01214642|62701947|FG006|Overall Study|Progressive Disease|5|||
33325207|NCT01214642|62701948|FG007|Overall Study|Progressive Disease|3|||
33325208|NCT01214642|62701949|FG008|Overall Study|Progressive Disease|10|||
33325209|NCT01214642|62701950|FG009|Overall Study|Progressive Disease|2|||
33325210|NCT01214642|62701951|FG010|Overall Study|Progressive Disease|1|||
33325211|NCT01214642|62701952|FG011|Overall Study|Progressive Disease|4|||
33325212|NCT01214642|62701941|FG000|Overall Study|Adverse Event|0|||
33325213|NCT01214642|62701942|FG001|Overall Study|Adverse Event|1|||
33325214|NCT01214642|62701943|FG002|Overall Study|Adverse Event|0|||
33325215|NCT01214642|62701944|FG003|Overall Study|Adverse Event|0|||
33325216|NCT01214642|62701945|FG004|Overall Study|Adverse Event|0|||
33325217|NCT01214642|62701946|FG005|Overall Study|Adverse Event|0|||
33325218|NCT01214642|62701947|FG006|Overall Study|Adverse Event|1|||
33325219|NCT01214642|62701948|FG007|Overall Study|Adverse Event|0|||
33325220|NCT01214642|62701949|FG008|Overall Study|Adverse Event|0|||
33325221|NCT01214642|62701950|FG009|Overall Study|Adverse Event|1|||
33325222|NCT01214642|62701951|FG010|Overall Study|Adverse Event|1|||
33325223|NCT01214642|62701952|FG011|Overall Study|Adverse Event|0|||
33522802|NCT03137069|62909216|FG002|Overall Study|Data Entry Error|0|||
33522803|NCT03137069|62909217|FG003|Overall Study|Data Entry Error|1|||
33325224|NCT01214642|62701941|FG000|Overall Study|Death|0|||
33325225|NCT01214642|62701942|FG001|Overall Study|Death|0|||
33325226|NCT01214642|62701943|FG002|Overall Study|Death|1|||
33325227|NCT01214642|62701944|FG003|Overall Study|Death|0|||
33325228|NCT01214642|62701945|FG004|Overall Study|Death|0|||
33325229|NCT01214642|62701946|FG005|Overall Study|Death|0|||
33325230|NCT01214642|62701947|FG006|Overall Study|Death|0|||
33325231|NCT01214642|62701948|FG007|Overall Study|Death|0|||
33618004|NCT02128724|63019212|FG000|Overall Study|Physician Decision|0|||
33618005|NCT02128724|63019213|FG001|Overall Study|Physician Decision|0|||
33618006|NCT02128724|63019214|FG002|Overall Study|Physician Decision|0|||
33618007|NCT02128724|63019215|FG003|Overall Study|Physician Decision|2|||
33618008|NCT02128724|63019212|FG000|Overall Study|Withdrawal by Subject|0|||
33618009|NCT02128724|63019213|FG001|Overall Study|Withdrawal by Subject|0|||
33618010|NCT02128724|63019214|FG002|Overall Study|Withdrawal by Subject|0|||
33618011|NCT02128724|63019215|FG003|Overall Study|Withdrawal by Subject|1|||
33618012|NCT02128490|63019229|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
33456414|NCT00069264|62831169|FG000|Overall Study|Adverse Event|3|||
33522804|NCT03137069|62909218|FG004|Overall Study|Data Entry Error|0|||
33522805|NCT03137069|62909219|FG005|Overall Study|Data Entry Error|0|||
33522806|NCT02792504|62909237|FG000|Overall Study|Lost to Follow-up|24|||
33522807|NCT02792504|62909237|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
33618013|NCT02128490|63019230|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
33618014|NCT02128490|63019231|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
33618015|NCT02128490|63019232|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
33618016|NCT02128490|63019233|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
33618017|NCT02128490|63019229|FG000|Overall Study|Major Protocol Deviation|1|||
33618018|NCT02128490|63019230|FG001|Overall Study|Major Protocol Deviation|2|||
33618019|NCT02128490|63019231|FG002|Overall Study|Major Protocol Deviation|0|||
33618020|NCT02128490|63019232|FG003|Overall Study|Major Protocol Deviation|2|||
33618021|NCT02128490|63019233|FG004|Overall Study|Major Protocol Deviation|2|||
33618022|NCT02128490|63019229|FG000|Overall Study|Lost to Follow-up|0|||
33522808|NCT03124459|62909247|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
33522809|NCT03124459|62909248|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
33325232|NCT01214642|62701949|FG008|Overall Study|Death|0|||
33456415|NCT00069264|62831169|FG000|Overall Study|Progressive Disease|23|||
33456416|NCT00069264|62831169|FG000|Overall Study|Withdrawal by Subject|3|||
33456417|NCT00069264|62831169|FG000|Overall Study|Discon Therapy|3|||
33456418|NCT00069108|62831175|FG000|Overall Study|Withdrawal by Subject|5|||
33456419|NCT00069108|62831176|FG001|Overall Study|Withdrawal by Subject|9|||
33456420|NCT00069108|62831175|FG000|Overall Study|Adverse Event|64|||
33456421|NCT00069108|62831176|FG001|Overall Study|Adverse Event|42|||
33456422|NCT00069108|62831175|FG000|Overall Study|Death|6|||
33456423|NCT00069108|62831176|FG001|Overall Study|Death|6|||
33456424|NCT00069108|62831175|FG000|Overall Study|Administration|15|||
33456425|NCT00069108|62831176|FG001|Overall Study|Administration|4|||
33456426|NCT00069108|62831175|FG000|Overall Study|Insufficient therapy|117|||
33456427|NCT00069108|62831176|FG001|Overall Study|Insufficient therapy|144|||
33456428|NCT00069108|62831175|FG000|Overall Study|Violation criteria|1|||
33456429|NCT00069108|62831176|FG001|Overall Study|Violation criteria|4|||
33456430|NCT00069108|62831175|FG000|Overall Study|Refused treatment|5|||
33618023|NCT02128490|63019230|FG001|Overall Study|Lost to Follow-up|0|||
33325233|NCT01214642|62701950|FG009|Overall Study|Death|0|||
33325234|NCT01214642|62701951|FG010|Overall Study|Death|1|||
33456431|NCT00069108|62831176|FG001|Overall Study|Refused treatment|10|||
33456432|NCT00094536|62831183|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
33618024|NCT02128490|63019231|FG002|Overall Study|Lost to Follow-up|1|||
33618025|NCT02128490|63019232|FG003|Overall Study|Lost to Follow-up|1|||
33522810|NCT03124459|62909249|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
33522811|NCT03124459|62909250|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
33522812|NCT03124459|62909251|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
33522813|NCT03124459|62909252|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
33522814|NCT03124459|62909247|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
33522815|NCT03124459|62909248|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
33522816|NCT03124459|62909249|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
33522817|NCT03124459|62909250|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
33522818|NCT03124459|62909251|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
33522819|NCT03124459|62909252|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
33522820|NCT03124459|62909247|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
33522821|NCT03124459|62909248|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
33522822|NCT03124459|62909249|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
33522823|NCT03124459|62909250|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
33522824|NCT03124459|62909251|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
33522825|NCT03124459|62909252|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
33522826|NCT03124459|62909247|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
33522827|NCT03124459|62909248|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
33522828|NCT03124459|62909249|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
33522829|NCT03124459|62909250|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
33522830|NCT03124459|62909251|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
33522831|NCT03124459|62909252|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
33522832|NCT03124459|62909247|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
33522833|NCT03124459|62909248|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
33522834|NCT03124459|62909249|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
33522835|NCT03124459|62909250|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
33522836|NCT03124459|62909251|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
33522837|NCT03124459|62909252|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
33522838|NCT03124459|62909247|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
33522839|NCT03124459|62909248|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
33522840|NCT03124459|62909249|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
33522841|NCT03124459|62909250|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
33522842|NCT03124459|62909251|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
33522843|NCT03124459|62909252|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
33522844|NCT03134183|62909267|FG000|Overall Study|Withdrawal by Subject|1|||
33522845|NCT03134183|62909268|FG001|Overall Study|Withdrawal by Subject|1|||
33522846|NCT03136367|62909277|FG000|T1 Consultation|discontinued mistakenly included|2|||
33522847|NCT03136367|62909278|FG001|T1 Consultation|discontinued mistakenly included|6|||
33522848|NCT03136367|62909279|FG002|T1 Consultation|discontinued mistakenly included|1|||
33522849|NCT03136367|62909277|FG000|T1 Consultation|Discontinued other|0|||
33522850|NCT03136367|62909278|FG001|T1 Consultation|Discontinued other|1|||
33522851|NCT03136367|62909279|FG002|T1 Consultation|Discontinued other|0|||
33522852|NCT03136367|62909277|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
33522853|NCT03136367|62909278|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
33522854|NCT03136367|62909279|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
33522855|NCT03136367|62909277|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
33522856|NCT03136367|62909278|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
33522857|NCT03136367|62909279|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
33522858|NCT03136367|62909277|FG000|T2 Post-consultation|Discontinued other|0|||
33522859|NCT03136367|62909278|FG001|T2 Post-consultation|Discontinued other|2|||
33456433|NCT00094536|62831183|FG000|Treatment and Follow-up|Adverse Event|4|||
33456434|NCT00094536|62831183|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
33456435|NCT00094536|62831183|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
33456436|NCT00094536|62831183|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
33456437|NCT00094536|62831183|FG000|Treatment and Follow-up|Subject non-compliance|9|||
33456438|NCT00094536|62831183|FG000|Treatment and Follow-up|Unable to attend visits|1|||
33456439|NCT00405587|62831191|FG000|Overall Study|Death|0|||
33456440|NCT00405587|62831192|FG001|Overall Study|Death|0|||
33456441|NCT00405587|62831193|FG002|Overall Study|Death|0|||
33456442|NCT00405587|62831194|FG003|Overall Study|Death|1|||
33456443|NCT00405587|62831191|FG000|Overall Study|Disease Progression|22|||
33456444|NCT00405587|62831192|FG001|Overall Study|Disease Progression|23|||
33522860|NCT03136367|62909279|FG002|T2 Post-consultation|Discontinued other|6|||
33618026|NCT02128490|63019233|FG004|Overall Study|Lost to Follow-up|1|||
33456445|NCT00405587|62831193|FG002|Overall Study|Disease Progression|21|||
33456446|NCT00405587|62831194|FG003|Overall Study|Disease Progression|17|||
33456447|NCT00405587|62831191|FG000|Overall Study|Physician Decision|3|||
33456448|NCT00405587|62831192|FG001|Overall Study|Physician Decision|2|||
33456449|NCT00405587|62831193|FG002|Overall Study|Physician Decision|0|||
33522861|NCT03136367|62909277|FG000|T2 Post-consultation|Discontinued transferred care|0|||
33522862|NCT03136367|62909278|FG001|T2 Post-consultation|Discontinued transferred care|0|||
33522863|NCT03136367|62909279|FG002|T2 Post-consultation|Discontinued transferred care|3|||
33522864|NCT03136367|62909277|FG000|T2 Post-consultation|Discontinued lost contact|0|||
33522865|NCT03136367|62909278|FG001|T2 Post-consultation|Discontinued lost contact|1|||
33522866|NCT03136367|62909279|FG002|T2 Post-consultation|Discontinued lost contact|0|||
33522867|NCT03136367|62909277|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
33522868|NCT03136367|62909278|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
33522869|NCT03136367|62909279|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
33522870|NCT03136367|62909277|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
33522871|NCT03136367|62909278|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
33522872|NCT03136367|62909279|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
33522873|NCT03136367|62909277|FG000|T3 1 Week After Surgery|other discontinued|2|||
33522874|NCT03136367|62909278|FG001|T3 1 Week After Surgery|other discontinued|4|||
33522875|NCT03136367|62909279|FG002|T3 1 Week After Surgery|other discontinued|3|||
33522876|NCT03136367|62909277|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
33522877|NCT03136367|62909278|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
33522878|NCT03136367|62909279|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
33522879|NCT03136367|62909277|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
33522880|NCT03136367|62909278|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
33522881|NCT03136367|62909279|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
33522882|NCT03136367|62909277|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
33522883|NCT03136367|62909278|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
33618027|NCT02128490|63019229|FG000|Overall Study|Voluntary Withdrawal|3|||
33618028|NCT02128490|63019230|FG001|Overall Study|Voluntary Withdrawal|3|||
33618029|NCT02128490|63019231|FG002|Overall Study|Voluntary Withdrawal|1|||
33618030|NCT02128490|63019232|FG003|Overall Study|Voluntary Withdrawal|1|||
33456450|NCT00405587|62831194|FG003|Overall Study|Physician Decision|0|||
33456451|NCT00405587|62831191|FG000|Overall Study|Adverse Event|1|||
33456452|NCT00405587|62831192|FG001|Overall Study|Adverse Event|0|||
33456453|NCT00405587|62831193|FG002|Overall Study|Adverse Event|0|||
33456454|NCT00405587|62831194|FG003|Overall Study|Adverse Event|0|||
33456455|NCT00405587|62831191|FG000|Overall Study|Lost to Follow-up|0|||
33456456|NCT00405587|62831192|FG001|Overall Study|Lost to Follow-up|1|||
33456457|NCT00405587|62831193|FG002|Overall Study|Lost to Follow-up|1|||
33456458|NCT00405587|62831194|FG003|Overall Study|Lost to Follow-up|0|||
33456459|NCT00405587|62831191|FG000|Overall Study|Radiation induced necrosis|0|||
33456460|NCT00405587|62831192|FG001|Overall Study|Radiation induced necrosis|1|||
33456461|NCT00405587|62831193|FG002|Overall Study|Radiation induced necrosis|0|||
33456462|NCT00405587|62831194|FG003|Overall Study|Radiation induced necrosis|0|||
33456463|NCT00405587|62831191|FG000|Overall Study|Withdrawal by Subject|0|||
33456464|NCT00405587|62831192|FG001|Overall Study|Withdrawal by Subject|0|||
33456465|NCT00405587|62831193|FG002|Overall Study|Withdrawal by Subject|0|||
33456466|NCT00405587|62831194|FG003|Overall Study|Withdrawal by Subject|2|||
33456467|NCT00405587|62831191|FG000|Overall Study|Participant not dosed|0|||
33456468|NCT00405587|62831192|FG001|Overall Study|Participant not dosed|1|||
33456469|NCT00405587|62831193|FG002|Overall Study|Participant not dosed|0|||
33456470|NCT00405587|62831194|FG003|Overall Study|Participant not dosed|0|||
33456471|NCT00405275|62831232|FG000|Overall Study|Death|1|||
33522884|NCT03136367|62909279|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
33522885|NCT03136367|62909277|FG000|T4 12 Weeks After Surgery|Death|0|||
33522886|NCT03136367|62909278|FG001|T4 12 Weeks After Surgery|Death|1|||
33522887|NCT03136367|62909279|FG002|T4 12 Weeks After Surgery|Death|3|||
33522888|NCT03136367|62909277|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
33522889|NCT03136367|62909278|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
33522890|NCT03136367|62909279|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
33522891|NCT03136367|62909277|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
33522892|NCT03136367|62909278|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
33522893|NCT03136367|62909279|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
33522894|NCT03136367|62909277|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
33522895|NCT03136367|62909278|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
33522896|NCT03136367|62909279|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
33522897|NCT03136367|62909277|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
33522898|NCT03136367|62909278|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
33522899|NCT03136367|62909279|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
33522900|NCT03136367|62909277|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
33522901|NCT03136367|62909278|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
33522902|NCT03136367|62909279|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
33522903|NCT03136367|62909277|FG000|T5 1 Year After Surgery|Death|0|||
33522904|NCT03136367|62909278|FG001|T5 1 Year After Surgery|Death|0|||
33522905|NCT03136367|62909279|FG002|T5 1 Year After Surgery|Death|1|||
33522906|NCT03136367|62909277|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
33522907|NCT03136367|62909278|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
33522908|NCT03136367|62909279|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
33522909|NCT03136367|62909277|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
33522910|NCT03136367|62909278|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
33522911|NCT03136367|62909279|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
33522912|NCT03136367|62909277|FG000|T5 1 Year After Surgery|study ended before due|31|||
33522913|NCT03136367|62909278|FG001|T5 1 Year After Surgery|study ended before due|103|||
33522914|NCT03136367|62909279|FG002|T5 1 Year After Surgery|study ended before due|110|||
33522915|NCT03136367|62909277|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
33522916|NCT03136367|62909278|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
33522917|NCT03136367|62909279|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
33522918|NCT03124381|62909292|FG000|Overall Study|Lost to Follow-up|1|||
33522919|NCT03124381|62909293|FG001|Overall Study|Lost to Follow-up|1|||
33522920|NCT03124381|62909292|FG000|Overall Study|Withdrawal by Subject|6|||
33522921|NCT03124381|62909293|FG001|Overall Study|Withdrawal by Subject|3|||
33456472|NCT00405275|62831233|FG001|Overall Study|Death|0|||
33456473|NCT00405275|62831232|FG000|Overall Study|Lost to Follow-up|5|||
33456474|NCT00405275|62831233|FG001|Overall Study|Lost to Follow-up|1|||
33456475|NCT00405275|62831232|FG000|Overall Study|Withdrawal by Subject|7|||
33522922|NCT03124381|62909292|FG000|Overall Study|Protocol Violation|0|||
33522923|NCT03124381|62909293|FG001|Overall Study|Protocol Violation|1|||
33522924|NCT03124381|62909292|FG000|Overall Study|Adverse Event|1|||
33522925|NCT03124381|62909293|FG001|Overall Study|Adverse Event|1|||
33522926|NCT03124381|62909292|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
33522927|NCT03124381|62909293|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
33522928|NCT03133793|62909303|FG000|Overall Study|Withdrawal by Subject|0|||
33522929|NCT03133793|62909304|FG001|Overall Study|Withdrawal by Subject|4|||
33522930|NCT03133793|62909305|FG002|Overall Study|Withdrawal by Subject|2|||
33522931|NCT03133793|62909306|FG003|Overall Study|Withdrawal by Subject|4|||
33522932|NCT03133793|62909303|FG000|Overall Study|Lost to Follow-up|1|||
33522933|NCT03133793|62909304|FG001|Overall Study|Lost to Follow-up|0|||
33522934|NCT03133793|62909305|FG002|Overall Study|Lost to Follow-up|2|||
33522935|NCT03133793|62909306|FG003|Overall Study|Lost to Follow-up|0|||
33522936|NCT03133793|62909303|FG000|Overall Study|Death|0|||
33522937|NCT03133793|62909304|FG001|Overall Study|Death|0|||
33522938|NCT03133793|62909305|FG002|Overall Study|Death|0|||
33522939|NCT03133793|62909306|FG003|Overall Study|Death|1|||
33456476|NCT00405275|62831233|FG001|Overall Study|Withdrawal by Subject|9|||
33456477|NCT00405275|62831232|FG000|Overall Study|Unwilling to continue|10|||
33456478|NCT00405275|62831233|FG001|Overall Study|Unwilling to continue|9|||
33456479|NCT00404651|62831243|FG000|Overall Study|Serious Adverse Event|0|||
33456480|NCT00404651|62831244|FG001|Overall Study|Serious Adverse Event|0|||
33456481|NCT00404651|62831245|FG002|Overall Study|Serious Adverse Event|2|||
33522940|NCT02747238|62909322|FG000|Overall Study|Lack of Efficacy|0|||
33522941|NCT02747238|62909323|FG001|Overall Study|Lack of Efficacy|1|||
33522942|NCT02747238|62909322|FG000|Overall Study|Data lost|3|||
33456482|NCT00404651|62831246|FG003|Overall Study|Serious Adverse Event|0|||
33456483|NCT00404651|62831243|FG000|Overall Study|Protocol Violation|10|||
33456484|NCT00404651|62831244|FG001|Overall Study|Protocol Violation|5|||
33522943|NCT02747238|62909323|FG001|Overall Study|Data lost|5|||
33522944|NCT03133481|62909331|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
33522945|NCT03133481|62909332|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
33522946|NCT02864316|62909340|FG000|Overall Study|Progressive Disease|2|||
33522947|NCT02864316|62909341|FG001|Overall Study|Progressive Disease|1|||
33618031|NCT02128490|63019233|FG004|Overall Study|Voluntary Withdrawal|2|||
33618032|NCT02128490|63019229|FG000|Overall Study|Lack of Efficacy|0|||
33618033|NCT02128490|63019230|FG001|Overall Study|Lack of Efficacy|1|||
33618034|NCT02128490|63019231|FG002|Overall Study|Lack of Efficacy|0|||
33618035|NCT02128490|63019232|FG003|Overall Study|Lack of Efficacy|0|||
33618036|NCT02128490|63019233|FG004|Overall Study|Lack of Efficacy|0|||
33618037|NCT02128490|63019229|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
33618038|NCT02128490|63019230|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
33618039|NCT02128490|63019231|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
33456485|NCT00404651|62831245|FG002|Overall Study|Protocol Violation|14|||
33522948|NCT02864316|62909340|FG000|Overall Study|Adverse Event|0|||
33522949|NCT02864316|62909341|FG001|Overall Study|Adverse Event|1|||
33522950|NCT02862600|62909347|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
33522951|NCT02862600|62909347|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
33522952|NCT02862600|62909347|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
33522953|NCT02862600|62909347|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
33522954|NCT02864082|62909355|FG000|Overall Study|Adverse Event|1|||
33522955|NCT02864082|62909356|FG001|Overall Study|Adverse Event|1|||
33522956|NCT02864082|62909355|FG000|Overall Study|Lost to Follow-up|0|||
33522957|NCT02864082|62909356|FG001|Overall Study|Lost to Follow-up|1|||
33522958|NCT02864082|62909355|FG000|Overall Study|Withdrawal by Subject|2|||
33522959|NCT02864082|62909356|FG001|Overall Study|Withdrawal by Subject|2|||
33522960|NCT02792192|62909380|FG000|Overall Study|Death|1|||
33522961|NCT02792192|62909381|FG001|Overall Study|Death|0|||
33522962|NCT02792192|62909382|FG002|Overall Study|Death|0|||
33522963|NCT02792192|62909383|FG003|Overall Study|Death|0|||
33522964|NCT02792192|62909380|FG000|Overall Study|Informed Consent Withdrawn|4|||
33522965|NCT02792192|62909381|FG001|Overall Study|Informed Consent Withdrawn|0|||
33522966|NCT02792192|62909382|FG002|Overall Study|Informed Consent Withdrawn|0|||
33522967|NCT02792192|62909383|FG003|Overall Study|Informed Consent Withdrawn|0|||
33522968|NCT02792192|62909380|FG000|Overall Study|Physician Decision|1|||
33522969|NCT02792192|62909381|FG001|Overall Study|Physician Decision|0|||
33522970|NCT02792192|62909382|FG002|Overall Study|Physician Decision|0|||
33522971|NCT02792192|62909383|FG003|Overall Study|Physician Decision|0|||
33522972|NCT02792192|62909380|FG000|Overall Study|Progressive Disease|0|||
33522973|NCT02792192|62909381|FG001|Overall Study|Progressive Disease|1|||
33522974|NCT02792192|62909382|FG002|Overall Study|Progressive Disease|0|||
33522975|NCT02792192|62909383|FG003|Overall Study|Progressive Disease|0|||
33522976|NCT02792192|62909380|FG000|Overall Study|Study Terminated By Sponsor|6|||
33522977|NCT02792192|62909381|FG001|Overall Study|Study Terminated By Sponsor|10|||
33522978|NCT02792192|62909382|FG002|Overall Study|Study Terminated By Sponsor|0|||
33522979|NCT02792192|62909383|FG003|Overall Study|Study Terminated By Sponsor|0|||
33522980|NCT02964507|62909402|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
33618040|NCT02128490|63019232|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
33618041|NCT02128490|63019233|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
33456486|NCT00404651|62831246|FG003|Overall Study|Protocol Violation|5|||
33456487|NCT00404651|62831243|FG000|Overall Study|Lost to Follow-up|15|||
33456488|NCT00404651|62831244|FG001|Overall Study|Lost to Follow-up|11|||
33456489|NCT00404651|62831245|FG002|Overall Study|Lost to Follow-up|13|||
33456490|NCT00404651|62831246|FG003|Overall Study|Lost to Follow-up|10|||
33456491|NCT00404651|62831243|FG000|Overall Study|Withdrawal by Subject|14|||
33456492|NCT00404651|62831244|FG001|Overall Study|Withdrawal by Subject|12|||
33456493|NCT00404651|62831245|FG002|Overall Study|Withdrawal by Subject|16|||
33456494|NCT00404651|62831246|FG003|Overall Study|Withdrawal by Subject|6|||
33456495|NCT00404495|62831258|FG000|Overall Study|Death|37|||
33456496|NCT00404495|62831259|FG001|Overall Study|Death|11|||
33456497|NCT00404495|62831258|FG000|Overall Study|Lost to Follow-up|5|||
33456498|NCT00404495|62831259|FG001|Overall Study|Lost to Follow-up|0|||
33456499|NCT00404495|62831258|FG000|Overall Study|Other|1|||
33522981|NCT02964507|62909403|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
33522982|NCT02964507|62909404|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
33522983|NCT02964507|62909405|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
33522984|NCT02964507|62909406|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
33618042|NCT02128490|63019229|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33618043|NCT02128490|63019230|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33325235|NCT01214642|62701952|FG011|Overall Study|Death|0|||
33325236|NCT01214642|62701941|FG000|Overall Study|Withdrawal by Subject|0|||
33456500|NCT00404495|62831259|FG001|Overall Study|Other|0|||
33522985|NCT02964507|62909407|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
33522986|NCT02964507|62909408|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
33522987|NCT02964507|62909409|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
33522988|NCT02964507|62909402|FG000|Overall Study|Study terminated by Sponsor|9|||
33522989|NCT02964507|62909403|FG001|Overall Study|Study terminated by Sponsor|1|||
33522990|NCT02964507|62909404|FG002|Overall Study|Study terminated by Sponsor|9|||
33522991|NCT02964507|62909405|FG003|Overall Study|Study terminated by Sponsor|3|||
33522992|NCT02964507|62909406|FG004|Overall Study|Study terminated by Sponsor|3|||
33522993|NCT02964507|62909407|FG005|Overall Study|Study terminated by Sponsor|2|||
33522994|NCT02964507|62909408|FG006|Overall Study|Study terminated by Sponsor|0|||
33522995|NCT02964507|62909409|FG007|Overall Study|Study terminated by Sponsor|0|||
33522996|NCT02964507|62909402|FG000|Overall Study|Other|3|||
33522997|NCT02964507|62909403|FG001|Overall Study|Other|0|||
33522998|NCT02964507|62909404|FG002|Overall Study|Other|0|||
33522999|NCT02964507|62909405|FG003|Overall Study|Other|0|||
33523000|NCT02964507|62909406|FG004|Overall Study|Other|1|||
33523001|NCT02964507|62909407|FG005|Overall Study|Other|0|||
33523002|NCT02964507|62909408|FG006|Overall Study|Other|0|||
33523003|NCT02964507|62909409|FG007|Overall Study|Other|0|||
33523004|NCT02964507|62909402|FG000|Overall Study|Death|11|||
33523005|NCT02964507|62909403|FG001|Overall Study|Death|9|||
33523006|NCT02964507|62909404|FG002|Overall Study|Death|12|||
33523007|NCT02964507|62909405|FG003|Overall Study|Death|2|||
33523008|NCT02964507|62909406|FG004|Overall Study|Death|10|||
33523009|NCT02964507|62909407|FG005|Overall Study|Death|5|||
33523010|NCT02964507|62909408|FG006|Overall Study|Death|0|||
33523011|NCT02964507|62909409|FG007|Overall Study|Death|0|||
33523012|NCT02964507|62909402|FG000|Overall Study|Withdrawal by Subject|1|||
33523013|NCT02964507|62909403|FG001|Overall Study|Withdrawal by Subject|0|||
33523014|NCT02964507|62909404|FG002|Overall Study|Withdrawal by Subject|1|||
33523015|NCT02964507|62909405|FG003|Overall Study|Withdrawal by Subject|1|||
33523016|NCT02964507|62909406|FG004|Overall Study|Withdrawal by Subject|0|||
33523017|NCT02964507|62909407|FG005|Overall Study|Withdrawal by Subject|1|||
33523018|NCT02964507|62909408|FG006|Overall Study|Withdrawal by Subject|0|||
33523019|NCT02964507|62909409|FG007|Overall Study|Withdrawal by Subject|0|||
33523020|NCT02964507|62909402|FG000|Overall Study|Physician Decision|2|||
33523021|NCT02964507|62909403|FG001|Overall Study|Physician Decision|0|||
33523022|NCT02964507|62909404|FG002|Overall Study|Physician Decision|3|||
33523023|NCT02964507|62909405|FG003|Overall Study|Physician Decision|0|||
33523024|NCT02964507|62909406|FG004|Overall Study|Physician Decision|1|||
33523025|NCT02964507|62909407|FG005|Overall Study|Physician Decision|0|||
33523026|NCT02964507|62909408|FG006|Overall Study|Physician Decision|0|||
33523027|NCT02964507|62909409|FG007|Overall Study|Physician Decision|0|||
33523028|NCT03170869|62909428|FG000|Overall Study|Protocol Violation|5|||
33523029|NCT03170869|62909428|FG000|Overall Study|Early study termination|3|||
33523030|NCT02440464|62909435|FG000|Overall Study|Withdrawal by Subject|3|||
33523031|NCT02440464|62909436|FG001|Overall Study|Withdrawal by Subject|2|||
33523032|NCT03103321|62909447|FG000|Overall Study|Protocol Violation|1|||
33523033|NCT03103321|62909448|FG001|Overall Study|Protocol Violation|1|||
33523034|NCT03103321|62909449|FG002|Overall Study|Protocol Violation|1|||
33523035|NCT03103321|62909450|FG003|Overall Study|Protocol Violation|0|||
33523036|NCT03131453|62909463|FG000|Overall Study|Study terminated by Sponsor|424|||
33523037|NCT03131453|62909464|FG001|Overall Study|Study terminated by Sponsor|222|||
33523038|NCT03131453|62909465|FG002|Overall Study|Study terminated by Sponsor|438|||
33523039|NCT03131453|62909463|FG000|Overall Study|Withdrawal by Subject|18|||
33523040|NCT03131453|62909464|FG001|Overall Study|Withdrawal by Subject|7|||
33523041|NCT03131453|62909465|FG002|Overall Study|Withdrawal by Subject|13|||
33523042|NCT03131453|62909463|FG000|Overall Study|Adverse Event|10|||
33456501|NCT00404495|62831258|FG000|Overall Study|Withdrawal by Subject|1|||
33456502|NCT00404495|62831259|FG001|Overall Study|Withdrawal by Subject|0|||
33456503|NCT00409409|62831267|FG000|Overall Study|Adverse Event|7|||
33456504|NCT00409409|62831268|FG001|Overall Study|Adverse Event|2|||
33456505|NCT00409409|62831267|FG000|Overall Study|Withdrawal by Subject|1|||
33456506|NCT00409409|62831268|FG001|Overall Study|Withdrawal by Subject|1|||
33456507|NCT00409409|62831267|FG000|Overall Study|Any other reason not above-mentioned|0|||
33456508|NCT00409409|62831268|FG001|Overall Study|Any other reason not above-mentioned|1|||
33456509|NCT00409331|62831274|FG000|Overall Study|Physician Decision|1|||
33456510|NCT00409175|62831280|FG000|Overall Study|Adverse Event|4|||
33456511|NCT00409175|62831281|FG001|Overall Study|Adverse Event|3|||
33456512|NCT00409175|62831280|FG000|Overall Study|Withdrawal by Subject|1|||
33456513|NCT00409175|62831281|FG001|Overall Study|Withdrawal by Subject|2|||
33456514|NCT00409175|62831280|FG000|Overall Study|Negative genotype|0|||
33456515|NCT00409175|62831281|FG001|Overall Study|Negative genotype|1|||
33456516|NCT00409175|62831280|FG000|Overall Study|Liver transplantation|13|||
33456517|NCT00409175|62831281|FG001|Overall Study|Liver transplantation|13|||
33456518|NCT00408629|62831289|FG000|Overall Study|Adverse Event|13|||
33523043|NCT03131453|62909464|FG001|Overall Study|Adverse Event|3|||
33456519|NCT00408629|62831290|FG001|Overall Study|Adverse Event|27|||
33456520|NCT00408629|62831289|FG000|Overall Study|Withdrawal by Subject|8|||
33456521|NCT00408629|62831290|FG001|Overall Study|Withdrawal by Subject|4|||
33456522|NCT00408629|62831289|FG000|Overall Study|Lost to Follow-up|1|||
33523044|NCT03131453|62909465|FG002|Overall Study|Adverse Event|3|||
33523045|NCT03131453|62909463|FG000|Overall Study|Lost to Follow-up|1|||
33523046|NCT03131453|62909464|FG001|Overall Study|Lost to Follow-up|0|||
33523047|NCT03131453|62909465|FG002|Overall Study|Lost to Follow-up|1|||
33523048|NCT03131453|62909463|FG000|Overall Study|Physician Decision|1|||
33523049|NCT03131453|62909464|FG001|Overall Study|Physician Decision|0|||
33523050|NCT03131453|62909465|FG002|Overall Study|Physician Decision|1|||
33523051|NCT03131453|62909463|FG000|Overall Study|Non-compliance with study treatment|1|||
33523052|NCT03131453|62909464|FG001|Overall Study|Non-compliance with study treatment|0|||
33523053|NCT03131453|62909465|FG002|Overall Study|Non-compliance with study treatment|0|||
33523054|NCT03131453|62909463|FG000|Overall Study|Technical problems|1|||
33523055|NCT03131453|62909464|FG001|Overall Study|Technical problems|0|||
33523056|NCT03131453|62909465|FG002|Overall Study|Technical problems|0|||
33523057|NCT03131453|62909463|FG000|Overall Study|Protocol deviation|0|||
33523058|NCT03131453|62909464|FG001|Overall Study|Protocol deviation|1|||
33523059|NCT03131453|62909465|FG002|Overall Study|Protocol deviation|0|||
33523060|NCT02942277|62909493|FG000|Year 1|Withdrawal by Subject|0|||
33523061|NCT02942277|62909494|FG001|Year 1|Withdrawal by Subject|0|||
33523062|NCT02942277|62909495|FG002|Year 1|Withdrawal by Subject|0|||
33523063|NCT02942277|62909496|FG003|Year 1|Withdrawal by Subject|0|||
33456523|NCT00408629|62831290|FG001|Overall Study|Lost to Follow-up|1|||
33456524|NCT00408629|62831289|FG000|Overall Study|Lack of Efficacy|63|||
33456525|NCT00408629|62831290|FG001|Overall Study|Lack of Efficacy|73|||
33456526|NCT00408629|62831289|FG000|Overall Study|Protocol Violation|1|||
33456527|NCT00408629|62831290|FG001|Overall Study|Protocol Violation|5|||
33456528|NCT00408629|62831289|FG000|Overall Study|Miscellaneous|11|||
33456529|NCT00408629|62831290|FG001|Overall Study|Miscellaneous|15|||
33456530|NCT00408317|62831297|FG000|First Intervention Period|Adverse Event|0|||
33456531|NCT00408317|62831298|FG001|First Intervention Period|Adverse Event|1|||
33456532|NCT00408317|62831297|FG000|Second Intervention Period|Adverse Event|2|||
33456533|NCT00408317|62831298|FG001|Second Intervention Period|Adverse Event|0|||
33456534|NCT00408317|62831297|FG000|Second Intervention Period|Protocol Violation|0|||
33523064|NCT02942277|62909497|FG004|Year 1|Withdrawal by Subject|1|||
33523065|NCT02942277|62909498|FG005|Year 1|Withdrawal by Subject|3|||
33523066|NCT02942277|62909499|FG006|Year 1|Withdrawal by Subject|0|||
33523067|NCT02942277|62909500|FG007|Year 1|Withdrawal by Subject|1|||
33523068|NCT02942277|62909501|FG008|Year 1|Withdrawal by Subject|0|||
33523069|NCT02942277|62909502|FG009|Year 1|Withdrawal by Subject|0|||
33456535|NCT00408317|62831298|FG001|Second Intervention Period|Protocol Violation|1|||
33456536|NCT00408317|62831297|FG000|Second Intervention Period|Withdrawal of consent|0|||
33456537|NCT00408317|62831298|FG001|Second Intervention Period|Withdrawal of consent|1|||
33456538|NCT00112502|62831312|FG000|Overall Study|Withdrawal by Subject|0|||
33523070|NCT02942277|62909503|FG010|Year 1|Withdrawal by Subject|3|||
33523071|NCT02942277|62909493|FG000|Year 1|Travel|0|||
33523072|NCT02942277|62909494|FG001|Year 1|Travel|1|||
33523073|NCT02942277|62909495|FG002|Year 1|Travel|0|||
33523074|NCT02942277|62909496|FG003|Year 1|Travel|0|||
33523075|NCT02942277|62909497|FG004|Year 1|Travel|4|||
33523076|NCT02942277|62909498|FG005|Year 1|Travel|5|||
33523077|NCT02942277|62909499|FG006|Year 1|Travel|0|||
33456539|NCT00112502|62831313|FG001|Overall Study|Withdrawal by Subject|1|||
33456540|NCT00112502|62831314|FG002|Overall Study|Withdrawal by Subject|1|||
33523078|NCT02942277|62909500|FG007|Year 1|Travel|0|||
33456541|NCT00112502|62831315|FG003|Overall Study|Withdrawal by Subject|4|||
33456542|NCT00112502|62831316|FG004|Overall Study|Withdrawal by Subject|2|||
33456543|NCT00112502|62831317|FG005|Overall Study|Withdrawal by Subject|5|||
33456544|NCT00112502|62831318|FG006|Overall Study|Withdrawal by Subject|3|||
33456545|NCT00112502|62831319|FG007|Overall Study|Withdrawal by Subject|7|||
33456546|NCT03822182|62831350|FG000|Overall Study|Protocol Violation|0|||
33523079|NCT02942277|62909501|FG008|Year 1|Travel|0|||
33456547|NCT03822182|62831351|FG001|Overall Study|Protocol Violation|1|||
33456548|NCT03822182|62831352|FG002|Overall Study|Protocol Violation|1|||
33456549|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
33456550|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
33456551|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
33456552|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
33456553|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
33456554|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
33523080|NCT02942277|62909502|FG009|Year 1|Travel|0|||
33523081|NCT02942277|62909503|FG010|Year 1|Travel|8|||
33523082|NCT02942277|62909493|FG000|Year 1|Joined Army|0|||
33523083|NCT02942277|62909494|FG001|Year 1|Joined Army|1|||
33523084|NCT02942277|62909495|FG002|Year 1|Joined Army|0|||
33523085|NCT02942277|62909496|FG003|Year 1|Joined Army|0|||
33523086|NCT02942277|62909497|FG004|Year 1|Joined Army|0|||
33523087|NCT02942277|62909498|FG005|Year 1|Joined Army|0|||
33523088|NCT02942277|62909499|FG006|Year 1|Joined Army|0|||
33523089|NCT02942277|62909500|FG007|Year 1|Joined Army|0|||
33523090|NCT02942277|62909501|FG008|Year 1|Joined Army|0|||
33523091|NCT02942277|62909502|FG009|Year 1|Joined Army|0|||
33523092|NCT02942277|62909503|FG010|Year 1|Joined Army|0|||
33523093|NCT02942277|62909493|FG000|Year 1|Subject met withdrawal criteria|0|||
33523094|NCT02942277|62909494|FG001|Year 1|Subject met withdrawal criteria|0|||
33523095|NCT02942277|62909495|FG002|Year 1|Subject met withdrawal criteria|0|||
33523096|NCT02942277|62909496|FG003|Year 1|Subject met withdrawal criteria|1|||
33523097|NCT02942277|62909497|FG004|Year 1|Subject met withdrawal criteria|0|||
33523098|NCT02942277|62909498|FG005|Year 1|Subject met withdrawal criteria|0|||
33523099|NCT02942277|62909499|FG006|Year 1|Subject met withdrawal criteria|0|||
33456555|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
33456556|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
33523100|NCT02942277|62909500|FG007|Year 1|Subject met withdrawal criteria|0|||
33523101|NCT02942277|62909501|FG008|Year 1|Subject met withdrawal criteria|0|||
33523102|NCT02942277|62909502|FG009|Year 1|Subject met withdrawal criteria|0|||
33523103|NCT02942277|62909503|FG010|Year 1|Subject met withdrawal criteria|0|||
33523104|NCT02942277|62909493|FG000|Year 1|Lost to Follow-up|0|||
33523105|NCT02942277|62909494|FG001|Year 1|Lost to Follow-up|0|||
33523106|NCT02942277|62909495|FG002|Year 1|Lost to Follow-up|0|||
33523107|NCT02942277|62909496|FG003|Year 1|Lost to Follow-up|0|||
33523108|NCT02942277|62909497|FG004|Year 1|Lost to Follow-up|1|||
33523109|NCT02942277|62909498|FG005|Year 1|Lost to Follow-up|0|||
33523110|NCT02942277|62909499|FG006|Year 1|Lost to Follow-up|0|||
33523111|NCT02942277|62909500|FG007|Year 1|Lost to Follow-up|0|||
33523112|NCT02942277|62909501|FG008|Year 1|Lost to Follow-up|0|||
33523113|NCT02942277|62909502|FG009|Year 1|Lost to Follow-up|0|||
33523114|NCT02942277|62909503|FG010|Year 1|Lost to Follow-up|2|||
33523115|NCT02942277|62909493|FG000|Year 1|Protocol Violation|0|||
33523116|NCT02942277|62909494|FG001|Year 1|Protocol Violation|0|||
33523117|NCT02942277|62909495|FG002|Year 1|Protocol Violation|0|||
33523118|NCT02942277|62909496|FG003|Year 1|Protocol Violation|0|||
33523119|NCT02942277|62909497|FG004|Year 1|Protocol Violation|1|||
33523120|NCT02942277|62909498|FG005|Year 1|Protocol Violation|1|||
33523121|NCT02942277|62909499|FG006|Year 1|Protocol Violation|0|||
33523122|NCT02942277|62909500|FG007|Year 1|Protocol Violation|0|||
33523123|NCT02942277|62909501|FG008|Year 1|Protocol Violation|0|||
33523124|NCT02942277|62909502|FG009|Year 1|Protocol Violation|0|||
33523125|NCT02942277|62909503|FG010|Year 1|Protocol Violation|2|||
33456557|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
33456558|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
33456559|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
33456560|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
33456561|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
33456562|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
33456563|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
33456564|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
33456565|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
33523126|NCT02942277|62909493|FG000|Year 1|Pregnancy|0|||
33523127|NCT02942277|62909494|FG001|Year 1|Pregnancy|0|||
33523128|NCT02942277|62909495|FG002|Year 1|Pregnancy|0|||
33456566|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
33456567|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
33456568|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
33456569|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
33456570|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
33456571|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
33456572|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
33456573|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
33456574|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
33523129|NCT02942277|62909496|FG003|Year 1|Pregnancy|0|||
33523130|NCT02942277|62909497|FG004|Year 1|Pregnancy|0|||
33523131|NCT02942277|62909498|FG005|Year 1|Pregnancy|1|||
33523132|NCT02942277|62909499|FG006|Year 1|Pregnancy|0|||
33523133|NCT02942277|62909500|FG007|Year 1|Pregnancy|0|||
33523134|NCT02942277|62909501|FG008|Year 1|Pregnancy|0|||
33523135|NCT02942277|62909502|FG009|Year 1|Pregnancy|0|||
33523136|NCT02942277|62909503|FG010|Year 1|Pregnancy|0|||
33523137|NCT02942277|62909493|FG000|Year 2|Lost to Follow-up|0|||
33523138|NCT02942277|62909494|FG001|Year 2|Lost to Follow-up|0|||
33523139|NCT02942277|62909495|FG002|Year 2|Lost to Follow-up|0|||
33523140|NCT02942277|62909496|FG003|Year 2|Lost to Follow-up|0|||
33523141|NCT02942277|62909497|FG004|Year 2|Lost to Follow-up|2|||
33523142|NCT02942277|62909498|FG005|Year 2|Lost to Follow-up|1|||
33523143|NCT02942277|62909499|FG006|Year 2|Lost to Follow-up|0|||
33523144|NCT02942277|62909500|FG007|Year 2|Lost to Follow-up|0|||
33523145|NCT02942277|62909501|FG008|Year 2|Lost to Follow-up|0|||
33523146|NCT02942277|62909502|FG009|Year 2|Lost to Follow-up|0|||
33523147|NCT02942277|62909503|FG010|Year 2|Lost to Follow-up|0|||
33523148|NCT02942277|62909493|FG000|Year 2|Did not rescreen|0|||
33523149|NCT02942277|62909494|FG001|Year 2|Did not rescreen|0|||
33523150|NCT02942277|62909495|FG002|Year 2|Did not rescreen|1|||
33523151|NCT02942277|62909496|FG003|Year 2|Did not rescreen|1|||
33523152|NCT02942277|62909497|FG004|Year 2|Did not rescreen|9|||
33523153|NCT02942277|62909498|FG005|Year 2|Did not rescreen|6|||
33523154|NCT02942277|62909499|FG006|Year 2|Did not rescreen|0|||
33523155|NCT02942277|62909500|FG007|Year 2|Did not rescreen|1|||
33523156|NCT02942277|62909501|FG008|Year 2|Did not rescreen|0|||
33523157|NCT02942277|62909502|FG009|Year 2|Did not rescreen|0|||
33523158|NCT02942277|62909503|FG010|Year 2|Did not rescreen|21|||
33523159|NCT02942277|62909493|FG000|Year 2|Met withdrawal criteria|0|||
33523160|NCT02942277|62909494|FG001|Year 2|Met withdrawal criteria|0|||
33523161|NCT02942277|62909495|FG002|Year 2|Met withdrawal criteria|0|||
33523162|NCT02942277|62909496|FG003|Year 2|Met withdrawal criteria|0|||
33523163|NCT02942277|62909497|FG004|Year 2|Met withdrawal criteria|1|||
33523164|NCT02942277|62909498|FG005|Year 2|Met withdrawal criteria|2|||
33523165|NCT02942277|62909499|FG006|Year 2|Met withdrawal criteria|0|||
33523166|NCT02942277|62909500|FG007|Year 2|Met withdrawal criteria|0|||
33523167|NCT02942277|62909501|FG008|Year 2|Met withdrawal criteria|0|||
33523168|NCT02942277|62909502|FG009|Year 2|Met withdrawal criteria|0|||
33456575|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
33456576|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
33456577|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
33456578|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
33456579|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
33456580|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
33523169|NCT02942277|62909503|FG010|Year 2|Met withdrawal criteria|1|||
33456581|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
33456582|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
33456583|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
33456584|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
33456585|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
33456586|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
33456587|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
33456588|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
33456589|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
33523170|NCT02942277|62909493|FG000|Year 2|Travel|0|||
33523171|NCT02942277|62909494|FG001|Year 2|Travel|1|||
33523172|NCT02942277|62909495|FG002|Year 2|Travel|0|||
33523173|NCT02942277|62909496|FG003|Year 2|Travel|0|||
33523174|NCT02942277|62909497|FG004|Year 2|Travel|0|||
33523175|NCT02942277|62909498|FG005|Year 2|Travel|1|||
33618044|NCT02128490|63019231|FG002|Overall Study|Other Miscellaneous Reasons|2|||
33618045|NCT02128490|63019232|FG003|Overall Study|Other Miscellaneous Reasons|1|||
33618046|NCT02128490|63019233|FG004|Overall Study|Other Miscellaneous Reasons|1|||
33523176|NCT02942277|62909499|FG006|Year 2|Travel|0|||
33523177|NCT02942277|62909500|FG007|Year 2|Travel|0|||
33523178|NCT02942277|62909501|FG008|Year 2|Travel|0|||
33523179|NCT02942277|62909502|FG009|Year 2|Travel|1|||
33523180|NCT02942277|62909503|FG010|Year 2|Travel|3|||
33523181|NCT02942277|62909493|FG000|Year 2|Non-compliant|0|||
33523182|NCT02942277|62909494|FG001|Year 2|Non-compliant|0|||
33523183|NCT02942277|62909495|FG002|Year 2|Non-compliant|0|||
33523184|NCT02942277|62909496|FG003|Year 2|Non-compliant|0|||
33618047|NCT02146352|63019245|FG000|Overall Study|Death|1|||
33523185|NCT02942277|62909497|FG004|Year 2|Non-compliant|1|||
33523186|NCT02942277|62909498|FG005|Year 2|Non-compliant|1|||
33523187|NCT02942277|62909499|FG006|Year 2|Non-compliant|0|||
33523188|NCT02942277|62909500|FG007|Year 2|Non-compliant|0|||
33523189|NCT02942277|62909501|FG008|Year 2|Non-compliant|0|||
33523190|NCT02942277|62909502|FG009|Year 2|Non-compliant|0|||
33523191|NCT02942277|62909503|FG010|Year 2|Non-compliant|0|||
33523192|NCT02942277|62909493|FG000|Year 2|Withdrawal by Subject|0|||
33523193|NCT02942277|62909494|FG001|Year 2|Withdrawal by Subject|0|||
33523194|NCT02942277|62909495|FG002|Year 2|Withdrawal by Subject|0|||
33523195|NCT02942277|62909496|FG003|Year 2|Withdrawal by Subject|0|||
33523196|NCT02942277|62909497|FG004|Year 2|Withdrawal by Subject|0|||
33523197|NCT02942277|62909498|FG005|Year 2|Withdrawal by Subject|0|||
33523198|NCT02942277|62909499|FG006|Year 2|Withdrawal by Subject|1|||
33523199|NCT02942277|62909500|FG007|Year 2|Withdrawal by Subject|0|||
33523200|NCT02942277|62909501|FG008|Year 2|Withdrawal by Subject|0|||
33523201|NCT02942277|62909502|FG009|Year 2|Withdrawal by Subject|0|||
33523202|NCT02942277|62909503|FG010|Year 2|Withdrawal by Subject|0|||
33523203|NCT02859324|62909554|FG000|Overall Study|Death|4|||
33523204|NCT02859324|62909555|FG001|Overall Study|Death|6|||
33523205|NCT02859324|62909556|FG002|Overall Study|Death|5|||
33523206|NCT02859324|62909554|FG000|Overall Study|Other reasons|3|||
33523207|NCT02859324|62909555|FG001|Overall Study|Other reasons|3|||
33523208|NCT02859324|62909556|FG002|Overall Study|Other reasons|0|||
33523209|NCT02143063|62909567|FG000|Overall Study|Lost to Follow-up|16|||
33523210|NCT02143063|62909568|FG001|Overall Study|Lost to Follow-up|28|||
33523211|NCT02143063|62909569|FG002|Overall Study|Lost to Follow-up|29|||
33523212|NCT02143063|62909567|FG000|Overall Study|Withdrawal by Subject|0|||
33523213|NCT02143063|62909568|FG001|Overall Study|Withdrawal by Subject|1|||
33523214|NCT02143063|62909569|FG002|Overall Study|Withdrawal by Subject|0|||
33523215|NCT02143063|62909567|FG000|Overall Study|Death|0|||
33523216|NCT02143063|62909568|FG001|Overall Study|Death|1|||
33523217|NCT02143063|62909569|FG002|Overall Study|Death|1|||
33523218|NCT02859246|62909577|FG000|Overall Study|Screen fails|3|||
33523219|NCT02859246|62909577|FG000|Overall Study|Adverse Event|1|||
33523220|NCT02859246|62909577|FG000|Overall Study|Withdrawal by Subject|1|||
33523221|NCT01083433|62909600|FG000|Overall Study|Lost to Follow-up|2|||
33523222|NCT01083433|62909601|FG001|Overall Study|Lost to Follow-up|1|||
33523223|NCT01083433|62909602|FG002|Overall Study|Lost to Follow-up|1|||
33523224|NCT01083433|62909600|FG000|Overall Study|Withdrawal by Subject|0|||
33523225|NCT01083433|62909601|FG001|Overall Study|Withdrawal by Subject|5|||
33523226|NCT01083433|62909602|FG002|Overall Study|Withdrawal by Subject|3|||
33523227|NCT01083433|62909600|FG000|Overall Study|Pregnancy|0|||
33523228|NCT01083433|62909601|FG001|Overall Study|Pregnancy|0|||
33523229|NCT01083433|62909602|FG002|Overall Study|Pregnancy|1|||
33523230|NCT02791490|62909616|FG000|Overall Study|Lost to Follow-up|1|||
33523231|NCT02791490|62909617|FG001|Overall Study|Lost to Follow-up|2|||
33523232|NCT02791490|62909616|FG000|Overall Study|Withdrawal by Subject|2|||
33618048|NCT02146352|63019245|FG000|Overall Study|Patient entered hospice care|1|||
33618049|NCT02146274|63019249|FG000|Overall Study|Protocol Violation|73|||
33618050|NCT02105636|63019258|FG000|Pre-Treatment|Disease Progression|1|||
33523233|NCT02791490|62909617|FG001|Overall Study|Withdrawal by Subject|6|||
33523234|NCT02507973|62909632|FG000|Overall Study|Adverse Event|1|||
33618051|NCT02105636|63019259|FG001|Pre-Treatment|Disease Progression|0|||
33523235|NCT02425644|62909640|FG000|Overall Study|Lost to Follow-up|2|||
33523236|NCT02425644|62909641|FG001|Overall Study|Lost to Follow-up|3|||
33523237|NCT02425644|62909640|FG000|Overall Study|Withdrawal by Subject|41|||
33523238|NCT02425644|62909641|FG001|Overall Study|Withdrawal by Subject|36|||
33523239|NCT02425644|62909640|FG000|Overall Study|Lack of Efficacy|3|||
33523240|NCT02425644|62909641|FG001|Overall Study|Lack of Efficacy|10|||
33523241|NCT02425644|62909640|FG000|Overall Study|Adverse Event|13|||
33523242|NCT02425644|62909641|FG001|Overall Study|Adverse Event|3|||
33523243|NCT02425644|62909640|FG000|Overall Study|Death|0|||
33523244|NCT02425644|62909641|FG001|Overall Study|Death|2|||
33523245|NCT02425644|62909640|FG000|Overall Study|Other|18|||
33523246|NCT02425644|62909641|FG001|Overall Study|Other|17|||
33523247|NCT02861664|62909653|FG000|Overall Study|Withdrawal of Consent|0|||
33456590|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
33523248|NCT02861664|62909654|FG001|Overall Study|Withdrawal of Consent|1|||
33523249|NCT01307787|62909662|FG000|Overall Study|Withdrawal by Subject|2|||
33618052|NCT02105636|63019258|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
33456591|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
33523250|NCT01307787|62909663|FG001|Overall Study|Withdrawal by Subject|0|||
33523251|NCT03284853|62909676|FG000|Overall Study|Adverse Event|40|||
33523252|NCT03284853|62909677|FG001|Overall Study|Adverse Event|4|||
33523253|NCT03284853|62909676|FG000|Overall Study|Withdrawal by Subject|5|||
33523254|NCT03284853|62909677|FG001|Overall Study|Withdrawal by Subject|1|||
33523255|NCT03284853|62909676|FG000|Overall Study|Lost to Follow-up|1|||
33523256|NCT03284853|62909677|FG001|Overall Study|Lost to Follow-up|0|||
33523257|NCT03284853|62909676|FG000|Overall Study|Lack of Efficacy|1|||
33523258|NCT03284853|62909677|FG001|Overall Study|Lack of Efficacy|0|||
33523259|NCT03284853|62909676|FG000|Overall Study|Disallowed Concurrent Medication|1|||
33523260|NCT03284853|62909677|FG001|Overall Study|Disallowed Concurrent Medication|1|||
33523261|NCT03284853|62909676|FG000|Overall Study|Protocol Violation|3|||
33523262|NCT03284853|62909677|FG001|Overall Study|Protocol Violation|3|||
33523263|NCT03284853|62909676|FG000|Overall Study|Death|0|||
33523264|NCT03284853|62909677|FG001|Overall Study|Death|1|||
33523265|NCT03284853|62909676|FG000|Overall Study|Other - Reason not reported in CSR|4|||
33523266|NCT03284853|62909677|FG001|Overall Study|Other - Reason not reported in CSR|3|||
33618053|NCT02105636|63019259|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
33618054|NCT02105636|63019258|FG000|Pre-Treatment|Participant withdrew consent|0|||
33618055|NCT02105636|63019259|FG001|Pre-Treatment|Participant withdrew consent|6|||
33456592|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
33456593|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
33456594|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
33456595|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
33456596|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
33456597|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
33456598|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
33456599|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
33456600|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
33456601|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
33456602|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
33456603|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
33456604|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
33456605|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
33456606|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
33456607|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
33456608|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
33456609|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
33456610|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
33456611|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
33456612|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
33456613|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
33456614|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
33456615|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
33456616|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
33456617|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
33523267|NCT03055221|62909683|FG000|Overall Study|Adverse Event|2|||
33523268|NCT03055221|62909683|FG000|Overall Study|Withdrawal by Subject|4|||
33523269|NCT03055221|62909683|FG000|Overall Study|Death|6|||
33523270|NCT03055221|62909683|FG000|Overall Study|Physician Decision|1|||
33523271|NCT03055221|62909683|FG000|Overall Study|Study terminated by Sponsor|3|||
33523272|NCT04497415|62909709|FG000|Overall Study|Lost to Follow-up|43|||
33523273|NCT04497415|62909710|FG001|Overall Study|Lost to Follow-up|27|||
33523274|NCT03125941|62909718|FG000|Overall Study|did not receive intervention|1|||
33523275|NCT03125941|62909719|FG001|Overall Study|did not receive intervention|2|||
33523276|NCT02774889|62909727|FG000|Overall Study|Lost to Follow-up|2|||
33523277|NCT02774889|62909728|FG001|Overall Study|Lost to Follow-up|1|||
33523278|NCT03125629|62909736|FG000|Overall Study|Withdrawal by Subject|2|||
33523279|NCT03125629|62909736|FG000|Overall Study|Equipment malfunction|1|||
33523280|NCT03125395|62909748|FG000|Overall Study|Adverse Event|2|||
33523281|NCT03125395|62909748|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
33523282|NCT03125395|62909748|FG000|Overall Study|Physician Decision|2|||
33523283|NCT03125395|62909748|FG000|Overall Study|Commercial drug is available|5|||
33523284|NCT00261807|62909762|FG000|Overall Study|Lost to Follow-up|2|||
33523285|NCT00261807|62909762|FG000|Overall Study|Adverse Event|2|||
33523286|NCT00261807|62909762|FG000|Overall Study|Death|1|||
33523287|NCT00261807|62909762|FG000|Overall Study|Protocol Violation|2|||
33523288|NCT02820753|62909769|FG000|2 Month|Withdrawal by Subject|3|||
33523289|NCT02820753|62909770|FG001|2 Month|Withdrawal by Subject|3|||
33523290|NCT02820753|62909769|FG000|2 Month|Lost to Follow-up|24|||
33523291|NCT02820753|62909770|FG001|2 Month|Lost to Follow-up|26|||
33523292|NCT02820753|62909769|FG000|2 Month|Stopped per NIH Hold|51|||
33523293|NCT02820753|62909770|FG001|2 Month|Stopped per NIH Hold|13|||
33523294|NCT02820753|62909769|FG000|6 Month|Withdrawal by Subject|2|||
33523295|NCT02820753|62909770|FG001|6 Month|Withdrawal by Subject|2|||
33523296|NCT02820753|62909769|FG000|6 Month|Lost to Follow-up|20|||
33523297|NCT02820753|62909770|FG001|6 Month|Lost to Follow-up|27|||
33523298|NCT02820753|62909769|FG000|6 Month|Stopped per NIH Hold|81|||
33523299|NCT02820753|62909770|FG001|6 Month|Stopped per NIH Hold|81|||
33523300|NCT02820753|62909769|FG000|6 Month|Death|0|||
33523301|NCT02820753|62909770|FG001|6 Month|Death|1|||
33523302|NCT02861586|62909784|FG000|Overall Study|Withdrawal by Subject|1|||
33523303|NCT02861586|62909785|FG001|Overall Study|Withdrawal by Subject|2|||
33523304|NCT02861586|62909786|FG002|Overall Study|Withdrawal by Subject|0|||
33523305|NCT02861586|62909787|FG003|Overall Study|Withdrawal by Subject|0|||
33523306|NCT02861586|62909788|FG004|Overall Study|Withdrawal by Subject|0|||
33523307|NCT02861586|62909789|FG005|Overall Study|Withdrawal by Subject|1|||
33523308|NCT02861586|62909790|FG006|Overall Study|Withdrawal by Subject|1|||
33523309|NCT02861586|62909791|FG007|Overall Study|Withdrawal by Subject|0|||
33523310|NCT02861586|62909784|FG000|Overall Study|Lost to Follow-up|3|||
33523311|NCT02861586|62909785|FG001|Overall Study|Lost to Follow-up|1|||
33523312|NCT02861586|62909786|FG002|Overall Study|Lost to Follow-up|1|||
33523313|NCT02861586|62909787|FG003|Overall Study|Lost to Follow-up|0|||
33523314|NCT02861586|62909788|FG004|Overall Study|Lost to Follow-up|0|||
33523315|NCT02861586|62909789|FG005|Overall Study|Lost to Follow-up|3|||
33523316|NCT02861586|62909790|FG006|Overall Study|Lost to Follow-up|0|||
33523317|NCT02861586|62909791|FG007|Overall Study|Lost to Follow-up|0|||
33523318|NCT02861586|62909784|FG000|Overall Study|Adverse Event|0|||
33523319|NCT02861586|62909785|FG001|Overall Study|Adverse Event|0|||
33618056|NCT02105636|63019258|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
33618057|NCT02105636|63019259|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
33618058|NCT02105636|63019258|FG000|Treatment|Study Drug Toxicity|14|||
33523320|NCT02861586|62909786|FG002|Overall Study|Adverse Event|0|||
33523321|NCT02861586|62909787|FG003|Overall Study|Adverse Event|0|||
33523322|NCT02861586|62909788|FG004|Overall Study|Adverse Event|0|||
33523323|NCT02861586|62909789|FG005|Overall Study|Adverse Event|1|||
33523324|NCT02861586|62909790|FG006|Overall Study|Adverse Event|0|||
33523325|NCT02861586|62909791|FG007|Overall Study|Adverse Event|0|||
33523326|NCT03120949|62909827|FG000|Overall Study|randomized in error|1|||
33523327|NCT03120949|62909828|FG001|Overall Study|randomized in error|0|||
33523328|NCT03120949|62909827|FG000|Overall Study|Death|13|||
33523329|NCT03120949|62909828|FG001|Overall Study|Death|13|||
33523330|NCT03120949|62909827|FG000|Overall Study|Lost to Follow-up|23|||
33618059|NCT02105636|63019259|FG001|Treatment|Study Drug Toxicity|10|||
33618060|NCT02105636|63019258|FG000|Treatment|Adverse event unrelated to study drug|19|||
33523331|NCT03120949|62909828|FG001|Overall Study|Lost to Follow-up|13|||
33523332|NCT03120949|62909827|FG000|Overall Study|Withdrawal by Subject|139|||
33523333|NCT03120949|62909828|FG001|Overall Study|Withdrawal by Subject|124|||
33523334|NCT03120949|62909827|FG000|Overall Study|Covid-19|43|||
33523335|NCT03120949|62909828|FG001|Overall Study|Covid-19|34|||
33523336|NCT03120949|62909827|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
33523337|NCT03120949|62909828|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
33523338|NCT03120949|62909827|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
33523339|NCT03120949|62909828|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
33523340|NCT03120949|62909827|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
33523341|NCT03120949|62909828|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
33523342|NCT03120949|62909827|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
33523343|NCT03120949|62909828|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
33523344|NCT03120949|62909827|FG000|Overall Study|Site was closed|2|||
33523345|NCT03120949|62909828|FG001|Overall Study|Site was closed|3|||
33523346|NCT03120949|62909827|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
33523347|NCT03120949|62909828|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
33523348|NCT03120949|62909827|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
33523349|NCT03120949|62909828|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
33523350|NCT03120949|62909827|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
33523351|NCT03120949|62909828|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
33523352|NCT03120949|62909827|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
33523353|NCT03120949|62909828|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
33523354|NCT03120949|62909827|FG000|Overall Study|Other: Adverse Event|0|||
33523355|NCT03120949|62909828|FG001|Overall Study|Other: Adverse Event|1|||
33523356|NCT03120949|62909827|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
33523357|NCT03120949|62909828|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
33523358|NCT03120949|62909827|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
33523359|NCT03120949|62909828|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
33523360|NCT03120949|62909827|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
33523361|NCT03120949|62909828|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
33523362|NCT03120949|62909827|FG000|Overall Study|Personal Reasons|0|||
33523363|NCT03120949|62909828|FG001|Overall Study|Personal Reasons|1|||
33523364|NCT03120949|62909827|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
33523365|NCT03120949|62909828|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
33523366|NCT03120949|62909827|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
33523367|NCT03120949|62909828|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
33523368|NCT03120949|62909827|FG000|Overall Study|Compliance With Medication|0|||
33523369|NCT03120949|62909828|FG001|Overall Study|Compliance With Medication|1|||
33523370|NCT03120949|62909827|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
33523371|NCT03120949|62909828|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
33523372|NCT03120949|62909827|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
33523373|NCT03120949|62909828|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
33523374|NCT03120949|62909827|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
33523375|NCT03120949|62909828|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
33523376|NCT03124537|62909847|FG000|Overall Study|Lost to Follow-up|3|||
33523377|NCT03124537|62909848|FG001|Overall Study|Lost to Follow-up|5|||
33523378|NCT03124537|62909847|FG000|Overall Study|App Crash, Incomplete Data|7|||
33523379|NCT03124537|62909848|FG001|Overall Study|App Crash, Incomplete Data|8|||
33523380|NCT03118297|62909856|FG000|Overall Study|Lost to Follow-up|0|||
33523381|NCT03118297|62909857|FG001|Overall Study|Lost to Follow-up|2|||
33523382|NCT03117361|62909863|FG000|Overall Study|Progressive disease|5|||
33523383|NCT03117361|62909863|FG000|Overall Study|Death|1|||
33523384|NCT03117361|62909863|FG000|Overall Study|Physician Decision|2|||
33523385|NCT03117361|62909863|FG000|Overall Study|On study treatment at the end of study|1|||
33523386|NCT03117361|62909863|FG000|Overall Study|Treatment-related adverse event|1|||
33523387|NCT01368614|62909867|FG000|Screening Period|Screen Failure|58|||
33523388|NCT01368614|62909868|FG001|Screening Period|Screen Failure|0|||
33523389|NCT01368614|62909869|FG002|Screening Period|Screen Failure|0|||
33523390|NCT01368614|62909870|FG003|Screening Period|Screen Failure|0|||
33523391|NCT01368614|62909867|FG000|Study Period|Withdrawal by Subject|0|||
33523392|NCT01368614|62909868|FG001|Study Period|Withdrawal by Subject|1|||
33523393|NCT01368614|62909869|FG002|Study Period|Withdrawal by Subject|1|||
33523394|NCT01368614|62909870|FG003|Study Period|Withdrawal by Subject|3|||
33523395|NCT01368614|62909867|FG000|Study Period|Lost to Follow-up|0|||
33523396|NCT01368614|62909868|FG001|Study Period|Lost to Follow-up|0|||
33523397|NCT01368614|62909869|FG002|Study Period|Lost to Follow-up|1|||
33523398|NCT01368614|62909870|FG003|Study Period|Lost to Follow-up|0|||
33523399|NCT03053427|62909880|FG000|Overall Study|Adverse Event|4|||
33523400|NCT03053427|62909881|FG001|Overall Study|Adverse Event|4|||
33523401|NCT03053427|62909880|FG000|Overall Study|Lack of Efficacy|1|||
33523402|NCT03053427|62909881|FG001|Overall Study|Lack of Efficacy|3|||
33523403|NCT03053427|62909880|FG000|Overall Study|Lost to Follow-up|2|||
33523404|NCT03053427|62909881|FG001|Overall Study|Lost to Follow-up|2|||
33523405|NCT03053427|62909880|FG000|Overall Study|Worsening of the target disease|0|||
33523406|NCT03053427|62909881|FG001|Overall Study|Worsening of the target disease|1|||
33523407|NCT03053427|62909880|FG000|Overall Study|Protocol Deviation|3|||
33523408|NCT03053427|62909881|FG001|Overall Study|Protocol Deviation|3|||
33523409|NCT03053427|62909880|FG000|Overall Study|Withdrawal by Subject|3|||
33523410|NCT03053427|62909881|FG001|Overall Study|Withdrawal by Subject|2|||
33523411|NCT03053427|62909880|FG000|Overall Study|Miscellaneous|0|||
33523412|NCT03053427|62909881|FG001|Overall Study|Miscellaneous|1|||
33523413|NCT03052959|62909898|FG000|Overall Study|Lost to Follow-up|4|||
33523414|NCT03052959|62909899|FG001|Overall Study|Lost to Follow-up|5|||
33618061|NCT02105636|63019259|FG001|Treatment|Adverse event unrelated to study drug|3|||
33618062|NCT02105636|63019258|FG000|Treatment|Participant request to discontinue study treatment|8|||
33618063|NCT02105636|63019259|FG001|Treatment|Participant request to discontinue study treatment|6|||
33618064|NCT02105636|63019258|FG000|Treatment|Participant withdrew consent|5|||
33618065|NCT02105636|63019259|FG001|Treatment|Participant withdrew consent|1|||
33618066|NCT02105636|63019258|FG000|Treatment|Lost to Follow-up|1|||
33618067|NCT02105636|63019259|FG001|Treatment|Lost to Follow-up|0|||
33618068|NCT02105636|63019258|FG000|Treatment|Maximum Clinical Benefit|1|||
33618069|NCT02105636|63019259|FG001|Treatment|Maximum Clinical Benefit|3|||
33618070|NCT02105636|63019258|FG000|Treatment|Poor/Non-compliance|0|||
33618071|NCT02105636|63019259|FG001|Treatment|Poor/Non-compliance|1|||
33618072|NCT02105636|63019258|FG000|Treatment|Participant no longer meets study criteria|1|||
33618073|NCT02105636|63019259|FG001|Treatment|Participant no longer meets study criteria|0|||
33618074|NCT02105636|63019258|FG000|Treatment|Other reasons|1|||
33618075|NCT02105636|63019259|FG001|Treatment|Other reasons|0|||
33618076|NCT02105636|63019258|FG000|Treatment|Disease Progression|185|||
33618077|NCT02105636|63019259|FG001|Treatment|Disease Progression|87|||
33618078|NCT01626872|63019268|FG000|Overall Study|Physician Decision|13|||
33618079|NCT01626872|63019269|FG001|Overall Study|Physician Decision|9|||
33618080|NCT01626872|63019270|FG002|Overall Study|Physician Decision|6|||
33618081|NCT01626872|63019268|FG000|Overall Study|Withdrawal by Subject|19|||
33618082|NCT01626872|63019269|FG001|Overall Study|Withdrawal by Subject|27|||
33618083|NCT01626872|63019270|FG002|Overall Study|Withdrawal by Subject|8|||
33618084|NCT01626872|63019268|FG000|Overall Study|Adverse Event (including Death)|20|||
33325237|NCT01214642|62701942|FG001|Overall Study|Withdrawal by Subject|0|||
33456618|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
33456619|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
33456620|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
33456621|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
33456622|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
33456623|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
33456624|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
33456625|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
33456626|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
33456627|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
33456628|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
33456629|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
33456630|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
33456631|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
33523415|NCT03120013|62909906|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33523416|NCT03120013|62909907|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
33523417|NCT01845649|62909915|FG000|Overall Study|Adverse Event|7|||
33523418|NCT01845649|62909916|FG001|Overall Study|Adverse Event|10|||
33523419|NCT01845649|62909915|FG000|Overall Study|Lack of Efficacy|1|||
33523420|NCT01845649|62909916|FG001|Overall Study|Lack of Efficacy|1|||
33523421|NCT01845649|62909915|FG000|Overall Study|Lost to Follow-up|2|||
33618085|NCT01626872|63019269|FG001|Overall Study|Adverse Event (including Death)|28|||
33618086|NCT01626872|63019270|FG002|Overall Study|Adverse Event (including Death)|8|||
33618087|NCT01626872|63019268|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
33618088|NCT01626872|63019269|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
33523422|NCT01845649|62909916|FG001|Overall Study|Lost to Follow-up|2|||
33523423|NCT01845649|62909915|FG000|Overall Study|Withdrew Consent|12|||
33523424|NCT01845649|62909916|FG001|Overall Study|Withdrew Consent|4|||
33523425|NCT01845649|62909915|FG000|Overall Study|Protocol Deviation|7|||
33523426|NCT01845649|62909916|FG001|Overall Study|Protocol Deviation|4|||
33523427|NCT01845649|62909915|FG000|Overall Study|Reason not Specified|2|||
33523428|NCT01845649|62909916|FG001|Overall Study|Reason not Specified|1|||
33523429|NCT01345929|62909924|FG000|Overall Study|Withdrawal by Subject|9|||
33523430|NCT01345929|62909925|FG001|Overall Study|Withdrawal by Subject|8|||
33523431|NCT01345929|62909924|FG000|Overall Study|Lost to Follow-up|9|||
33523432|NCT01345929|62909925|FG001|Overall Study|Lost to Follow-up|9|||
33523433|NCT01345929|62909924|FG000|Overall Study|Adverse Event|0|||
33523434|NCT01345929|62909925|FG001|Overall Study|Adverse Event|1|||
33523435|NCT01345929|62909924|FG000|Overall Study|Didn't meet eligibility criteria|2|||
33523436|NCT01345929|62909925|FG001|Overall Study|Didn't meet eligibility criteria|0|||
33523437|NCT01345929|62909924|FG000|Overall Study|40,000 CFU/ML|1|||
33523438|NCT01345929|62909925|FG001|Overall Study|40,000 CFU/ML|0|||
33523439|NCT01345929|62909924|FG000|Overall Study|Patient withdrawal|0|||
33523440|NCT01345929|62909925|FG001|Overall Study|Patient withdrawal|1|||
33523441|NCT01343901|62909931|FG000|Overall Study|Death|85|||
33523442|NCT01343901|62909931|FG000|Overall Study|Physician Decision|4|||
33523443|NCT01343901|62909931|FG000|Overall Study|Lost to Follow-up|12|||
33523444|NCT01343901|62909931|FG000|Overall Study|Management by another medical team|11|||
33523445|NCT01343901|62909931|FG000|Overall Study|Participant decision|1|||
33523446|NCT03053271|62909935|FG000|Overall Study|Did not meet randomization criteria|3|||
33523447|NCT03053271|62909935|FG000|Overall Study|Withdrawal by Subject|1|||
33523448|NCT01343823|62909943|FG000|Overall Study|Study Terminated|1|||
33523449|NCT01343823|62909944|FG001|Overall Study|Study Terminated|0|||
33523450|NCT01343823|62909945|FG002|Overall Study|Study Terminated|0|||
33523451|NCT01343823|62909946|FG003|Overall Study|Study Terminated|1|||
33523452|NCT01343823|62909943|FG000|Overall Study|Withdrawal by Subject|1|||
33523453|NCT01343823|62909944|FG001|Overall Study|Withdrawal by Subject|0|||
33523454|NCT01343823|62909945|FG002|Overall Study|Withdrawal by Subject|0|||
33523455|NCT01343823|62909946|FG003|Overall Study|Withdrawal by Subject|0|||
33523456|NCT01318083|62909959|FG000|Overall Study|Adverse Event|4|||
33523457|NCT01318083|62909960|FG001|Overall Study|Adverse Event|1|||
33523458|NCT01318083|62909961|FG002|Overall Study|Adverse Event|2|||
33523459|NCT01318083|62909959|FG000|Overall Study|Withdrawal by Subject|1|||
33523460|NCT01318083|62909960|FG001|Overall Study|Withdrawal by Subject|0|||
33523461|NCT01318083|62909961|FG002|Overall Study|Withdrawal by Subject|2|||
33523462|NCT01318083|62909959|FG000|Overall Study|Lack of Efficacy|0|||
33523463|NCT01318083|62909960|FG001|Overall Study|Lack of Efficacy|0|||
33523464|NCT01318083|62909961|FG002|Overall Study|Lack of Efficacy|1|||
33523465|NCT01318083|62909959|FG000|Overall Study|Treatment Complications|1|||
33523466|NCT01318083|62909960|FG001|Overall Study|Treatment Complications|0|||
33523467|NCT01318083|62909961|FG002|Overall Study|Treatment Complications|0|||
33523468|NCT01318083|62909959|FG000|Overall Study|Lack of Study Medication Compliance|0|||
33523469|NCT01318083|62909960|FG001|Overall Study|Lack of Study Medication Compliance|1|||
33523470|NCT01318083|62909961|FG002|Overall Study|Lack of Study Medication Compliance|0|||
33523471|NCT01376323|62909974|FG000|Overall Study|Adverse Event|1|||
33523472|NCT01376323|62909975|FG001|Overall Study|Adverse Event|0|||
33523473|NCT01376323|62909976|FG002|Overall Study|Adverse Event|0|||
33523474|NCT01376323|62909977|FG003|Overall Study|Adverse Event|2|||
33523475|NCT01376323|62909978|FG004|Overall Study|Adverse Event|0|||
33523476|NCT01376323|62909974|FG000|Overall Study|Lost to Follow-up|0|||
33523477|NCT01376323|62909975|FG001|Overall Study|Lost to Follow-up|0|||
33523478|NCT01376323|62909976|FG002|Overall Study|Lost to Follow-up|0|||
33523479|NCT01376323|62909977|FG003|Overall Study|Lost to Follow-up|2|||
33523480|NCT01376323|62909978|FG004|Overall Study|Lost to Follow-up|0|||
33523481|NCT01376323|62909974|FG000|Overall Study|Physician Decision|1|||
33523482|NCT01376323|62909975|FG001|Overall Study|Physician Decision|0|||
33523483|NCT01376323|62909976|FG002|Overall Study|Physician Decision|2|||
33523484|NCT01376323|62909977|FG003|Overall Study|Physician Decision|1|||
33523485|NCT01376323|62909978|FG004|Overall Study|Physician Decision|1|||
33523486|NCT01376323|62909974|FG000|Overall Study|Withdrawal by Subject|0|||
33523487|NCT01376323|62909975|FG001|Overall Study|Withdrawal by Subject|1|||
33523488|NCT01376323|62909976|FG002|Overall Study|Withdrawal by Subject|1|||
33523489|NCT01376323|62909977|FG003|Overall Study|Withdrawal by Subject|0|||
33523490|NCT01376323|62909978|FG004|Overall Study|Withdrawal by Subject|0|||
33523491|NCT03725293|62910015|FG000|Overall Study|Physician Decision|9|||
33523492|NCT03725293|62910016|FG001|Overall Study|Physician Decision|6|||
33523493|NCT03725293|62910015|FG000|Overall Study|alternative vascular access needs|1|||
33523494|NCT03725293|62910016|FG001|Overall Study|alternative vascular access needs|2|||
33523495|NCT03725293|62910015|FG000|Overall Study|venous anatomy screen failures|2|||
33523496|NCT03725293|62910016|FG001|Overall Study|venous anatomy screen failures|1|||
33523497|NCT01368536|62910025|FG000|Overall Study|Adverse Event|5|||
33523498|NCT01368536|62910026|FG001|Overall Study|Adverse Event|6|||
33523499|NCT01368536|62910027|FG002|Overall Study|Adverse Event|8|||
33523500|NCT01368536|62910025|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33523501|NCT01368536|62910026|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33523502|NCT01368536|62910027|FG002|Overall Study|Abnormal laboratory value(s)|2|||
33523503|NCT01368536|62910025|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33523504|NCT01368536|62910026|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33523505|NCT01368536|62910027|FG002|Overall Study|Abnormal test procedure result(s)|1|||
33523506|NCT01368536|62910025|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
33523507|NCT01368536|62910026|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33523508|NCT01368536|62910027|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
33523509|NCT01368536|62910025|FG000|Overall Study|No longer required study medication|0|||
33523510|NCT01368536|62910026|FG001|Overall Study|No longer required study medication|0|||
33523511|NCT01368536|62910027|FG002|Overall Study|No longer required study medication|1|||
33523512|NCT01368536|62910025|FG000|Overall Study|Withdrawal by Subject|2|||
33523513|NCT01368536|62910026|FG001|Overall Study|Withdrawal by Subject|5|||
33523514|NCT01368536|62910027|FG002|Overall Study|Withdrawal by Subject|4|||
33523515|NCT01368536|62910025|FG000|Overall Study|Lost to Follow-up|3|||
33523516|NCT01368536|62910026|FG001|Overall Study|Lost to Follow-up|3|||
33523517|NCT01368536|62910027|FG002|Overall Study|Lost to Follow-up|5|||
33523518|NCT01368536|62910025|FG000|Overall Study|Administrative problems|34|||
33523519|NCT01368536|62910026|FG001|Overall Study|Administrative problems|39|||
33523520|NCT01368536|62910027|FG002|Overall Study|Administrative problems|35|||
33523521|NCT01368536|62910025|FG000|Overall Study|Protocol deviation|0|||
33523522|NCT01368536|62910026|FG001|Overall Study|Protocol deviation|3|||
33523523|NCT01368536|62910027|FG002|Overall Study|Protocol deviation|1|||
33523524|NCT03051165|62910036|FG000|Overall Study|Withdrawal by Subject|1|||
33523525|NCT03051165|62910036|FG000|Overall Study|Early termination of study|12|||
33523526|NCT01319929|62910042|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
33523527|NCT01319929|62910043|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
33325238|NCT01214642|62701943|FG002|Overall Study|Withdrawal by Subject|1|||
33325239|NCT01214642|62701944|FG003|Overall Study|Withdrawal by Subject|0|||
33325240|NCT01214642|62701945|FG004|Overall Study|Withdrawal by Subject|0|||
33456632|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
33456633|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
33456634|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
33456635|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
33456636|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
33456637|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
33456638|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
33456639|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
33456640|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
33456641|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
33456642|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
33456643|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
33456644|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
33456645|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
33523528|NCT01319929|62910042|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
33523529|NCT01319929|62910043|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
33523530|NCT01319929|62910042|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
33523531|NCT01319929|62910043|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
33618089|NCT01626872|63019270|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
33523532|NCT01319929|62910042|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
33523533|NCT01319929|62910043|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
33523534|NCT01319929|62910042|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
33523535|NCT01319929|62910043|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
33523536|NCT03110185|62910052|FG000|Overall Study|Death|0|||
33523537|NCT03110185|62910053|FG001|Overall Study|Death|1|||
33523538|NCT03110185|62910052|FG000|Overall Study|Withdrawal by Subject|2|||
33523539|NCT03110185|62910053|FG001|Overall Study|Withdrawal by Subject|7|||
33523540|NCT03110185|62910052|FG000|Overall Study|Time Constraints|0|||
33456646|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
33523541|NCT03110185|62910053|FG001|Overall Study|Time Constraints|6|||
33523542|NCT03110185|62910052|FG000|Overall Study|Conflict with care|5|||
33523543|NCT03110185|62910053|FG001|Overall Study|Conflict with care|12|||
33523544|NCT03110185|62910052|FG000|Overall Study|Protocol Violation|1|||
33523545|NCT03110185|62910053|FG001|Overall Study|Protocol Violation|4|||
33523546|NCT03110185|62910052|FG000|Overall Study|MRI Incompatible|2|||
33523547|NCT03110185|62910053|FG001|Overall Study|MRI Incompatible|0|||
33523548|NCT03110185|62910052|FG000|Overall Study|Patient Refusal|0|||
33523549|NCT03110185|62910053|FG001|Overall Study|Patient Refusal|1|||
33523550|NCT02858076|62910064|FG000|Overall Study|Death|6|||
33523551|NCT02858076|62910065|FG001|Overall Study|Death|3|||
33523552|NCT02858076|62910064|FG000|Overall Study|Withdrawal by Subject|1|||
33523553|NCT02858076|62910065|FG001|Overall Study|Withdrawal by Subject|5|||
33523554|NCT02858076|62910064|FG000|Overall Study|Lost to Follow-up|2|||
33523555|NCT02858076|62910065|FG001|Overall Study|Lost to Follow-up|7|||
33523556|NCT02858076|62910064|FG000|Overall Study|Completed Out of Window|1|||
33456647|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
33523557|NCT02858076|62910065|FG001|Overall Study|Completed Out of Window|3|||
33523558|NCT04594759|62910073|FG000|Overall Study|Lost to Follow-up|3|||
33523559|NCT02856282|62910077|FG000|Overall Study|Withdrawal by Subject|1|||
33523560|NCT03833817|62910083|FG000|Overall Study|Withdrawal by Subject|3|||
33523561|NCT03833817|62910084|FG001|Overall Study|Withdrawal by Subject|3|||
33523562|NCT03833817|62910083|FG000|Overall Study|Lost to Follow-up|3|||
33523563|NCT03833817|62910084|FG001|Overall Study|Lost to Follow-up|3|||
33523564|NCT03119701|62910092|FG000|6-day Dosing|Death|4|||
33523565|NCT03119701|62910093|FG001|6-day Dosing|Death|1|||
33523566|NCT03119701|62910092|FG000|6-day Dosing|Adverse Event|3|||
33523567|NCT03119701|62910093|FG001|6-day Dosing|Adverse Event|0|||
33523568|NCT03119701|62910092|FG000|6-day Dosing|Physician Decision|0|||
33523569|NCT03119701|62910093|FG001|6-day Dosing|Physician Decision|1|||
33523570|NCT03119701|62910092|FG000|6-day Dosing|Withdrawal by Subject|0|||
33523571|NCT03119701|62910093|FG001|6-day Dosing|Withdrawal by Subject|1|||
33523572|NCT03119701|62910092|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
33523573|NCT03119701|62910093|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
33523574|NCT02679781|62910107|FG000|Overall Study|Lost to Follow-up|1|||
33523575|NCT02679781|62910108|FG001|Overall Study|Lost to Follow-up|2|||
33523576|NCT02679781|62910107|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
33523577|NCT02679781|62910108|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
33456648|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
33456649|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
33456650|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
33456651|NCT00111800|62831367|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
33456652|NCT00111800|62831368|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
33456653|NCT00111800|62831369|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
33456654|NCT00111800|62831370|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
33456655|NCT00111800|62831371|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
33456656|NCT00111800|62831372|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
33456657|NCT00111800|62831367|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
33456658|NCT00111800|62831368|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
33456659|NCT00111800|62831369|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
33456660|NCT00111800|62831370|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
33456661|NCT00111800|62831371|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
33456662|NCT00111800|62831372|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
33523578|NCT02624869|62910117|FG000|Overall Study|Lost to Follow-up|0|||
33523579|NCT02624869|62910118|FG001|Overall Study|Lost to Follow-up|0|||
33523580|NCT02624869|62910119|FG002|Overall Study|Lost to Follow-up|1|||
33523581|NCT02624869|62910117|FG000|Overall Study|Withdrawal by Subject|1|||
33523582|NCT02624869|62910118|FG001|Overall Study|Withdrawal by Subject|3|||
33523583|NCT02624869|62910119|FG002|Overall Study|Withdrawal by Subject|1|||
33523584|NCT03110029|62910139|FG000|Overall Study|Withdrawal by Subject|1|||
33523585|NCT03110029|62910140|FG001|Overall Study|Withdrawal by Subject|1|||
33523586|NCT04207749|62910148|FG000|Overall Study|Lost to Follow-up|0|||
33523587|NCT04207749|62910149|FG001|Overall Study|Lost to Follow-up|2|||
33523588|NCT04207749|62910148|FG000|Overall Study|Protocol Violation|0|||
33523589|NCT04207749|62910149|FG001|Overall Study|Protocol Violation|1|||
33523590|NCT04207749|62910148|FG000|Overall Study|Withdrawal by Subject|3|||
33523591|NCT04207749|62910149|FG001|Overall Study|Withdrawal by Subject|0|||
33523592|NCT04207749|62910148|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
33523593|NCT04207749|62910149|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
33523594|NCT03043365|62910160|FG000|Weeks 0 to Week 8|Adverse Event|1|||
33523595|NCT03043365|62910161|FG001|Weeks 0 to Week 8|Adverse Event|3|||
33523596|NCT03043365|62910160|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
33523597|NCT03043365|62910161|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
33523598|NCT03043365|62910160|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
33523599|NCT03043365|62910161|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
33523600|NCT03108157|62910171|FG000|Overall Study|Protocol Violation|15|||
33523601|NCT03108157|62910172|FG001|Overall Study|Protocol Violation|4|||
33523602|NCT04421131|62910179|FG000|Overall Study|Lost to Follow-up|1|||
33523603|NCT04421131|62910179|FG000|Overall Study|Protocol Violation|2|||
33523604|NCT04421131|62910179|FG000|Overall Study|App crashed|5|||
33523605|NCT04167345|62910188|FG000|Overall Study|Other|1|||
33523606|NCT04167345|62910189|FG001|Overall Study|Other|1|||
33523607|NCT04167345|62910190|FG002|Overall Study|Other|0|||
33618090|NCT01598090|63019281|FG000|Treatment Period|Poor/non-compliance|0|||
33618091|NCT01598090|63019282|FG001|Treatment Period|Poor/non-compliance|2|||
33618092|NCT01598090|63019283|FG002|Treatment Period|Poor/non-compliance|0|||
33618093|NCT01598090|63019281|FG000|Treatment Period|No longer meet study criteria|0|||
33618094|NCT01598090|63019282|FG001|Treatment Period|No longer meet study criteria|1|||
33618095|NCT01598090|63019283|FG002|Treatment Period|No longer meet study criteria|0|||
33618096|NCT01598090|63019281|FG000|Treatment Period|Lack of Efficacy|5|||
33618097|NCT01598090|63019282|FG001|Treatment Period|Lack of Efficacy|14|||
33618098|NCT01598090|63019283|FG002|Treatment Period|Lack of Efficacy|6|||
33618099|NCT01598090|63019281|FG000|Treatment Period|Adverse Event|2|||
33618100|NCT01598090|63019282|FG001|Treatment Period|Adverse Event|33|||
33618101|NCT01598090|63019283|FG002|Treatment Period|Adverse Event|17|||
33618102|NCT01598090|63019281|FG000|Treatment Period|Other reasons|0|||
33618103|NCT01598090|63019282|FG001|Treatment Period|Other reasons|4|||
33618104|NCT01598090|63019283|FG002|Treatment Period|Other reasons|1|||
33618105|NCT01598090|63019281|FG000|Treatment Period|Withdrawal by Subject|3|||
33618106|NCT01598090|63019282|FG001|Treatment Period|Withdrawal by Subject|13|||
33523608|NCT04167345|62910191|FG003|Overall Study|Other|0|||
33523609|NCT04167345|62910192|FG004|Overall Study|Other|0|||
33618107|NCT01598090|63019283|FG002|Treatment Period|Withdrawal by Subject|10|||
33618108|NCT01598090|63019281|FG000|Treatment Period|Lost to Follow-up|1|||
33618109|NCT01598090|63019282|FG001|Treatment Period|Lost to Follow-up|5|||
33618110|NCT01598090|63019283|FG002|Treatment Period|Lost to Follow-up|1|||
33618111|NCT01598090|63019281|FG000|Follow-up Period|Death|0|||
33618112|NCT01598090|63019282|FG001|Follow-up Period|Death|1|||
33618113|NCT01598090|63019283|FG002|Follow-up Period|Death|0|||
33618114|NCT01598090|63019281|FG000|Follow-up Period|No longer required per protocol|1|||
33618115|NCT01598090|63019282|FG001|Follow-up Period|No longer required per protocol|3|||
33618116|NCT01598090|63019283|FG002|Follow-up Period|No longer required per protocol|2|||
33618117|NCT01598090|63019281|FG000|Follow-up Period|Not reported|0|||
33618118|NCT01598090|63019282|FG001|Follow-up Period|Not reported|10|||
33618119|NCT01598090|63019283|FG002|Follow-up Period|Not reported|4|||
33618120|NCT01598090|63019281|FG000|Follow-up Period|Withdrawal by Subject|0|||
33618121|NCT01598090|63019282|FG001|Follow-up Period|Withdrawal by Subject|3|||
33618122|NCT01598090|63019283|FG002|Follow-up Period|Withdrawal by Subject|2|||
33618123|NCT01598090|63019281|FG000|Follow-up Period|Other reasons|2|||
33618124|NCT01598090|63019282|FG001|Follow-up Period|Other reasons|8|||
33523610|NCT02854800|62910211|FG000|Overall Study|Protocol Violation|16|||
33618125|NCT01598090|63019283|FG002|Follow-up Period|Other reasons|8|||
33618126|NCT01598090|63019281|FG000|Follow-up Period|Lost to Follow-up|2|||
33618127|NCT01598090|63019282|FG001|Follow-up Period|Lost to Follow-up|10|||
33618128|NCT01598090|63019283|FG002|Follow-up Period|Lost to Follow-up|12|||
33523611|NCT02854800|62910212|FG001|Overall Study|Protocol Violation|11|||
33523612|NCT02854800|62910213|FG002|Overall Study|Protocol Violation|3|||
33523613|NCT02854800|62910211|FG000|Overall Study|Withdrawal by Subject|4|||
33523614|NCT02854800|62910212|FG001|Overall Study|Withdrawal by Subject|2|||
33523615|NCT02854800|62910213|FG002|Overall Study|Withdrawal by Subject|3|||
33618129|NCT02105012|63019294|FG000|Overall Study|Withdrawal by Subject|11|||
33618130|NCT02105012|63019294|FG000|Overall Study|Protocol Specified Criteria|9|||
33618131|NCT02105012|63019294|FG000|Overall Study|Lost to Follow-up|4|||
33618132|NCT02105012|63019294|FG000|Overall Study|Protocol Violation|4|||
33618133|NCT02105012|63019294|FG000|Overall Study|Physician Decision|3|||
33618134|NCT02105012|63019294|FG000|Overall Study|Adverse Event|1|||
33523616|NCT02931539|62910226|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
33523617|NCT02931539|62910227|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
33523618|NCT02931539|62910228|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
33523619|NCT02931539|62910226|FG000|Period 1: Treatment Phase|Adverse Event|5|||
33523620|NCT02931539|62910227|FG001|Period 1: Treatment Phase|Adverse Event|1|||
33523621|NCT02931539|62910228|FG002|Period 1: Treatment Phase|Adverse Event|0|||
33523622|NCT02931539|62910226|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
33523623|NCT02931539|62910227|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
33523624|NCT02931539|62910228|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
33523625|NCT02931539|62910226|FG000|Period 1: Treatment Phase|Death|8|||
33456663|NCT00111800|62831367|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
33456664|NCT00111800|62831368|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
33456665|NCT00111800|62831369|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
33456666|NCT00111800|62831370|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
33456667|NCT00111800|62831371|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
33456668|NCT00111800|62831372|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
33456669|NCT00111800|62831367|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
33456670|NCT00111800|62831368|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
33456671|NCT00111800|62831369|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
33523626|NCT02931539|62910227|FG001|Period 1: Treatment Phase|Death|24|||
33456672|NCT00111800|62831370|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
33523627|NCT02931539|62910228|FG002|Period 1: Treatment Phase|Death|0|||
33523628|NCT02931539|62910226|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
33618135|NCT02105012|63019294|FG000|Overall Study|Lack of Efficacy|1|||
33618136|NCT02145182|63019308|FG000|Overall Study|Adverse Event|4|||
33523629|NCT02931539|62910227|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
33523630|NCT02931539|62910228|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
33523631|NCT02931539|62910226|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
33523632|NCT02931539|62910227|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
33523633|NCT02931539|62910228|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
33523634|NCT02931539|62910226|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
33523635|NCT02931539|62910227|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
33523636|NCT02931539|62910228|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
33523637|NCT02931539|62910226|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
33523638|NCT02931539|62910227|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
33523639|NCT02931539|62910228|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
33523640|NCT04042077|62910245|FG000|Overall Study|Adverse Event|0|||
33523641|NCT04042077|62910246|FG001|Overall Study|Adverse Event|1|||
33523642|NCT04042077|62910245|FG000|Overall Study|Death|2|||
33523643|NCT04042077|62910246|FG001|Overall Study|Death|1|||
33523644|NCT04042077|62910245|FG000|Overall Study|Physician Decision|2|||
33523645|NCT04042077|62910246|FG001|Overall Study|Physician Decision|0|||
33523646|NCT04042077|62910245|FG000|Overall Study|Withdrawal by Subject|3|||
33523647|NCT04042077|62910246|FG001|Overall Study|Withdrawal by Subject|2|||
33523648|NCT04042077|62910245|FG000|Overall Study|Lack of Efficacy|0|||
33523649|NCT04042077|62910246|FG001|Overall Study|Lack of Efficacy|1|||
33523650|NCT02853318|62910267|FG000|Overall Study|Withdrawal by Subject|1|||
33523651|NCT03113071|62910277|FG000|Overall Study|Withdrawal by Subject|1|||
33523652|NCT03113071|62910278|FG001|Overall Study|Withdrawal by Subject|0|||
33523653|NCT03050307|62910286|FG000|Overall Study|Adverse Event|4|||
33523654|NCT03050307|62910287|FG001|Overall Study|Adverse Event|2|||
33523655|NCT03050307|62910286|FG000|Overall Study|Significant Protocol Deviation|0|||
33523656|NCT03050307|62910287|FG001|Overall Study|Significant Protocol Deviation|1|||
33523657|NCT03050307|62910286|FG000|Overall Study|Lost to Follow-up|0|||
33523658|NCT03050307|62910287|FG001|Overall Study|Lost to Follow-up|1|||
33523659|NCT03050307|62910286|FG000|Overall Study|Voluntary Withdrawal|3|||
33325241|NCT01214642|62701946|FG005|Overall Study|Withdrawal by Subject|0|||
33456673|NCT00111800|62831371|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
33523660|NCT03050307|62910287|FG001|Overall Study|Voluntary Withdrawal|4|||
33523661|NCT03050307|62910286|FG000|Overall Study|Reason not Specified|1|||
33456674|NCT00111800|62831372|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
33456675|NCT00111800|62831367|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
33456676|NCT00111800|62831368|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
33456677|NCT00111800|62831369|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
33456678|NCT00111800|62831370|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
33456679|NCT00111800|62831371|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
33456680|NCT00111800|62831372|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
33456681|NCT00111800|62831367|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
33456682|NCT00111800|62831368|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
33456683|NCT00111800|62831369|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
33456684|NCT00111800|62831370|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
33456685|NCT00111800|62831371|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
33456686|NCT00111800|62831372|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
33456687|NCT00111800|62831367|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
33456688|NCT00111800|62831368|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
33456689|NCT00111800|62831369|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
33523662|NCT03050307|62910287|FG001|Overall Study|Reason not Specified|1|||
33523663|NCT03118765|62910313|FG000|Overall Study|Withdrawal by Subject|0|||
33523664|NCT03118765|62910314|FG001|Overall Study|Withdrawal by Subject|0|||
33523665|NCT03118765|62910315|FG002|Overall Study|Withdrawal by Subject|1|||
33523666|NCT03118765|62910316|FG003|Overall Study|Withdrawal by Subject|0|||
33523667|NCT03118765|62910317|FG004|Overall Study|Withdrawal by Subject|0|||
33523668|NCT03118765|62910313|FG000|Overall Study|Adverse Event|1|||
33523669|NCT03118765|62910314|FG001|Overall Study|Adverse Event|1|||
33523670|NCT03118765|62910315|FG002|Overall Study|Adverse Event|1|||
33523671|NCT03118765|62910316|FG003|Overall Study|Adverse Event|1|||
33523672|NCT03118765|62910317|FG004|Overall Study|Adverse Event|1|||
33523673|NCT03118765|62910313|FG000|Overall Study|Non compliance with Study Procedures|0|||
33523674|NCT03118765|62910314|FG001|Overall Study|Non compliance with Study Procedures|0|||
33523675|NCT03118765|62910315|FG002|Overall Study|Non compliance with Study Procedures|0|||
33523676|NCT03118765|62910316|FG003|Overall Study|Non compliance with Study Procedures|1|||
33618137|NCT02145182|63019309|FG001|Overall Study|Adverse Event|1|||
33618138|NCT02145182|63019308|FG000|Overall Study|Death|7|||
33523677|NCT03118765|62910317|FG004|Overall Study|Non compliance with Study Procedures|0|||
33523678|NCT03118765|62910313|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
33523679|NCT03118765|62910314|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
33523680|NCT03118765|62910315|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
33523681|NCT03118765|62910316|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
33523682|NCT03118765|62910317|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
33523683|NCT03118765|62910313|FG000|Overall Study|COPD Exacerbation|1|||
33523684|NCT03118765|62910314|FG001|Overall Study|COPD Exacerbation|0|||
33523685|NCT03118765|62910315|FG002|Overall Study|COPD Exacerbation|0|||
33523686|NCT03118765|62910316|FG003|Overall Study|COPD Exacerbation|1|||
33523687|NCT03118765|62910317|FG004|Overall Study|COPD Exacerbation|0|||
33523688|NCT03118765|62910313|FG000|Overall Study|Lost to Follow-up|1|||
33523689|NCT03118765|62910314|FG001|Overall Study|Lost to Follow-up|0|||
33523690|NCT03118765|62910315|FG002|Overall Study|Lost to Follow-up|1|||
33523691|NCT03118765|62910316|FG003|Overall Study|Lost to Follow-up|0|||
33523692|NCT03118765|62910317|FG004|Overall Study|Lost to Follow-up|0|||
33523693|NCT03118765|62910313|FG000|Overall Study|Sponsor Decision|1|||
33523694|NCT03118765|62910314|FG001|Overall Study|Sponsor Decision|0|||
33523695|NCT03118765|62910315|FG002|Overall Study|Sponsor Decision|1|||
33618139|NCT02145182|63019309|FG001|Overall Study|Death|7|||
33618140|NCT02145182|63019308|FG000|Overall Study|Lost to Follow-up|2|||
33618141|NCT02145182|63019309|FG001|Overall Study|Lost to Follow-up|2|||
33618142|NCT02145182|63019308|FG000|Overall Study|Pre-transplant Withdrawal|0|||
33325242|NCT01214642|62701947|FG006|Overall Study|Withdrawal by Subject|0|||
33456690|NCT00111800|62831370|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
33456691|NCT00111800|62831371|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
33456692|NCT00111800|62831372|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
33456693|NCT00111800|62831367|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
33456694|NCT00111800|62831368|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
33456695|NCT00111800|62831369|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
33456696|NCT00111800|62831370|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
33456697|NCT00111800|62831371|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
33456698|NCT00111800|62831372|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
33456699|NCT00111800|62831367|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
33456700|NCT00111800|62831368|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
33456701|NCT00111800|62831369|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
33523696|NCT03118765|62910316|FG003|Overall Study|Sponsor Decision|0|||
33523697|NCT03118765|62910317|FG004|Overall Study|Sponsor Decision|1|||
33523698|NCT05222880|62910332|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
33523699|NCT05222880|62910332|FG000|Overall Study|Withdrew Consent during Study|1|||
33523700|NCT05222880|62910332|FG000|Overall Study|COVID-19 Related|1|||
33618143|NCT02145182|63019309|FG001|Overall Study|Pre-transplant Withdrawal|2|||
33523701|NCT04810962|62910349|FG000|Overall Study|Adverse Event|0|||
33523702|NCT04810962|62910350|FG001|Overall Study|Adverse Event|1|||
33523703|NCT04810962|62910349|FG000|Overall Study|Lost to Follow-up|2|||
33523704|NCT04810962|62910350|FG001|Overall Study|Lost to Follow-up|1|||
33523705|NCT04810962|62910349|FG000|Overall Study|Physician Decision|1|||
33523706|NCT04810962|62910350|FG001|Overall Study|Physician Decision|0|||
33523707|NCT04810962|62910349|FG000|Overall Study|Withdrawal by Subject|1|||
33523708|NCT04810962|62910350|FG001|Overall Study|Withdrawal by Subject|3|||
33523709|NCT04810962|62910349|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
33523710|NCT04810962|62910350|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
33523711|NCT04606134|62910383|FG000|Overall Study|Adverse Event|0|||
33523712|NCT04606134|62910384|FG001|Overall Study|Adverse Event|1|||
33523713|NCT04426825|62910390|FG000|Overall Study|Continuing on study|6|||
33523714|NCT04426825|62910390|FG000|Overall Study|Death|17|||
33523715|NCT04399538|62910399|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
33523716|NCT04399538|62910400|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
33523717|NCT04399538|62910401|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
33523718|NCT04399538|62910402|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
33523719|NCT04399538|62910403|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
33523720|NCT04399538|62910399|FG000|Double-Blind Treatment|Adverse Event|0|||
33523721|NCT04399538|62910400|FG001|Double-Blind Treatment|Adverse Event|0|||
33523722|NCT04399538|62910401|FG002|Double-Blind Treatment|Adverse Event|0|||
33523723|NCT04399538|62910402|FG003|Double-Blind Treatment|Adverse Event|0|||
33523724|NCT04399538|62910403|FG004|Double-Blind Treatment|Adverse Event|1|||
33523725|NCT04399538|62910399|FG000|Follow-Up|Adverse Event|0|||
33523726|NCT04399538|62910400|FG001|Follow-Up|Adverse Event|0|||
33523727|NCT04399538|62910401|FG002|Follow-Up|Adverse Event|0|||
33523728|NCT04399538|62910402|FG003|Follow-Up|Adverse Event|0|||
33523729|NCT04399538|62910403|FG004|Follow-Up|Adverse Event|1|||
33523730|NCT04399538|62910399|FG000|Follow-Up|Withdrawal by Subject|0|||
33523731|NCT04399538|62910400|FG001|Follow-Up|Withdrawal by Subject|0|||
33523732|NCT04399538|62910401|FG002|Follow-Up|Withdrawal by Subject|0|||
33523733|NCT04399538|62910402|FG003|Follow-Up|Withdrawal by Subject|2|||
33523734|NCT04399538|62910403|FG004|Follow-Up|Withdrawal by Subject|0|||
33523735|NCT03094832|62910462|FG000|Overall Study|Lost to Follow-up|0|||
33523736|NCT03094832|62910463|FG001|Overall Study|Lost to Follow-up|0|||
33523737|NCT03094832|62910464|FG002|Overall Study|Lost to Follow-up|0|||
33523738|NCT03094832|62910465|FG003|Overall Study|Lost to Follow-up|1|||
33523739|NCT03094832|62910466|FG004|Overall Study|Lost to Follow-up|1|||
33523740|NCT03094832|62910462|FG000|Overall Study|Death|1|||
33523741|NCT03094832|62910463|FG001|Overall Study|Death|0|||
33523742|NCT03094832|62910464|FG002|Overall Study|Death|0|||
33523743|NCT03094832|62910465|FG003|Overall Study|Death|0|||
33523744|NCT03094832|62910466|FG004|Overall Study|Death|0|||
33523745|NCT03094832|62910462|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
33523746|NCT03094832|62910463|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33523747|NCT03094832|62910464|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
33523748|NCT03094832|62910465|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
33523749|NCT03094832|62910466|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
33523750|NCT03094832|62910462|FG000|Overall Study|Other|13|||
33523751|NCT03094832|62910463|FG001|Overall Study|Other|20|||
33523752|NCT03094832|62910464|FG002|Overall Study|Other|1|||
33523753|NCT03094832|62910465|FG003|Overall Study|Other|7|||
33523754|NCT03094832|62910466|FG004|Overall Study|Other|1|||
33523755|NCT03036579|62910480|FG000|2 Years|Lost to Follow-up|1|||
33523756|NCT03036579|62910481|FG001|2 Years|Lost to Follow-up|0|||
33523757|NCT03036579|62910480|FG000|3 Years|Lost to Follow-up|0|||
33523758|NCT03036579|62910481|FG001|3 Years|Lost to Follow-up|1|||
33618144|NCT02145182|63019308|FG000|Overall Study|Withdrawal by Subject|5|||
33618145|NCT02145182|63019309|FG001|Overall Study|Withdrawal by Subject|4|||
33523759|NCT02867761|62910489|FG000|Overall Study|Participant withdrawn by investigator|0|||
33523760|NCT02867761|62910490|FG001|Overall Study|Participant withdrawn by investigator|1|||
33523761|NCT02867761|62910489|FG000|Overall Study|Lost to Follow-up|25|||
33523762|NCT02867761|62910490|FG001|Overall Study|Lost to Follow-up|18|||
33523763|NCT02867761|62910489|FG000|Overall Study|Unable to complete protocol|3|||
33523764|NCT02867761|62910490|FG001|Overall Study|Unable to complete protocol|7|||
33523765|NCT02719990|62910505|FG000|Overall Study|Physician Decision|2|||
33523766|NCT02719990|62910505|FG000|Overall Study|Withdrawal by Subject|2|||
33523767|NCT02719990|62910505|FG000|Overall Study|Study Terminated By Sponsor|32|||
33523768|NCT02494583|62910512|FG000|Overall Study|Death|224|||
33523769|NCT02494583|62910513|FG001|Overall Study|Death|214|||
33523770|NCT02494583|62910514|FG002|Overall Study|Death|225|||
33523771|NCT02494583|62910512|FG000|Overall Study|Lost to Follow-up|1|||
33523772|NCT02494583|62910513|FG001|Overall Study|Lost to Follow-up|0|||
33523773|NCT02494583|62910514|FG002|Overall Study|Lost to Follow-up|0|||
33523774|NCT02494583|62910512|FG000|Overall Study|Protocol Violation|1|||
33523775|NCT02494583|62910513|FG001|Overall Study|Protocol Violation|2|||
33523776|NCT02494583|62910514|FG002|Overall Study|Protocol Violation|0|||
33523777|NCT02494583|62910512|FG000|Overall Study|Screen Failure|0|||
33523778|NCT02494583|62910513|FG001|Overall Study|Screen Failure|1|||
33523779|NCT02494583|62910514|FG002|Overall Study|Screen Failure|0|||
33523780|NCT02494583|62910512|FG000|Overall Study|Transferred to Extension Study|15|||
33523781|NCT02494583|62910513|FG001|Overall Study|Transferred to Extension Study|15|||
33523782|NCT02494583|62910514|FG002|Overall Study|Transferred to Extension Study|6|||
33523783|NCT02494583|62910512|FG000|Overall Study|Did Not Continue on Extension Study|8|||
33523784|NCT02494583|62910513|FG001|Overall Study|Did Not Continue on Extension Study|10|||
33523785|NCT02494583|62910514|FG002|Overall Study|Did Not Continue on Extension Study|4|||
33523786|NCT02494583|62910512|FG000|Overall Study|Withdrawal by Subject|7|||
33523787|NCT02494583|62910513|FG001|Overall Study|Withdrawal by Subject|15|||
33618146|NCT02145026|63019315|FG000|Overall Study|Adverse Event|2|||
33618147|NCT02145026|63019315|FG000|Overall Study|Death|4|||
33618148|NCT02145026|63019315|FG000|Overall Study|Withdrawal by Subject|2|||
33618149|NCT02145026|63019315|FG000|Overall Study|Physician Decision|4|||
33618150|NCT02144012|63019321|FG000|Overall Study|Adverse Event|1|||
33618151|NCT02144012|63019322|FG001|Overall Study|Adverse Event|0|||
33618152|NCT02144012|63019321|FG000|Overall Study|Death|1|||
33618153|NCT02144012|63019322|FG001|Overall Study|Death|0|||
33618154|NCT02144012|63019321|FG000|Overall Study|Withdrawal by Subject|11|||
33618155|NCT02144012|63019322|FG001|Overall Study|Withdrawal by Subject|3|||
33618156|NCT02144012|63019321|FG000|Overall Study|Study Terminated by Sponsor|18|||
33618157|NCT02144012|63019322|FG001|Overall Study|Study Terminated by Sponsor|12|||
33618158|NCT02144012|63019321|FG000|Overall Study|Other|3|||
33618159|NCT02144012|63019322|FG001|Overall Study|Other|0|||
33618160|NCT02103062|63019330|FG000|Overall Study|Adverse Event|1|||
33618161|NCT02103062|63019331|FG001|Overall Study|Adverse Event|2|||
33618162|NCT02103062|63019330|FG000|Overall Study|Progressive Disease|17|||
33618163|NCT02103062|63019331|FG001|Overall Study|Progressive Disease|20|||
33618164|NCT02103062|63019330|FG000|Overall Study|Death|0|||
33618165|NCT02103062|63019331|FG001|Overall Study|Death|1|||
33618166|NCT02141984|63019339|FG000|Overall Study|Lack of Efficacy|2|||
33523788|NCT02494583|62910514|FG002|Overall Study|Withdrawal by Subject|15|||
33523789|NCT02322814|62910529|FG000|Overall Study|Death|7|||
33523790|NCT02322814|62910530|FG001|Overall Study|Death|29|||
33523791|NCT02322814|62910531|FG002|Overall Study|Death|32|||
33523792|NCT02322814|62910532|FG003|Overall Study|Death|23|||
33523793|NCT02322814|62910533|FG004|Overall Study|Death|14|||
33523794|NCT02322814|62910529|FG000|Overall Study|Lost to Follow-up|1|||
33523795|NCT02322814|62910530|FG001|Overall Study|Lost to Follow-up|3|||
33523796|NCT02322814|62910531|FG002|Overall Study|Lost to Follow-up|3|||
33523797|NCT02322814|62910532|FG003|Overall Study|Lost to Follow-up|1|||
33523798|NCT02322814|62910533|FG004|Overall Study|Lost to Follow-up|0|||
33523799|NCT02322814|62910529|FG000|Overall Study|Various Reasons|2|||
33523800|NCT02322814|62910530|FG001|Overall Study|Various Reasons|0|||
33523801|NCT02322814|62910531|FG002|Overall Study|Various Reasons|1|||
33523802|NCT02322814|62910532|FG003|Overall Study|Various Reasons|1|||
33618167|NCT02141672|63019346|FG000|Overall Study|Adverse Event|0|||
33618168|NCT02141672|63019347|FG001|Overall Study|Adverse Event|1|||
33618169|NCT02141672|63019348|FG002|Overall Study|Adverse Event|0|||
33618170|NCT02141672|63019346|FG000|Overall Study|Death|10|||
33523803|NCT02322814|62910533|FG004|Overall Study|Various Reasons|0|||
33523804|NCT02322814|62910529|FG000|Overall Study|Progressive Disease|0|||
33523805|NCT02322814|62910530|FG001|Overall Study|Progressive Disease|0|||
33523806|NCT02322814|62910531|FG002|Overall Study|Progressive Disease|0|||
33523807|NCT02322814|62910532|FG003|Overall Study|Progressive Disease|1|||
33523808|NCT02322814|62910533|FG004|Overall Study|Progressive Disease|1|||
33523809|NCT02322814|62910529|FG000|Overall Study|Protocol Violation|1|||
33523810|NCT02322814|62910530|FG001|Overall Study|Protocol Violation|0|||
33523811|NCT02322814|62910531|FG002|Overall Study|Protocol Violation|0|||
33523812|NCT02322814|62910532|FG003|Overall Study|Protocol Violation|0|||
33618171|NCT02141672|63019347|FG001|Overall Study|Death|2|||
33618172|NCT02141672|63019348|FG002|Overall Study|Death|1|||
33618173|NCT02141672|63019346|FG000|Overall Study|Lack of Efficacy|0|||
33618174|NCT02141672|63019347|FG001|Overall Study|Lack of Efficacy|0|||
33618175|NCT02141672|63019348|FG002|Overall Study|Lack of Efficacy|2|||
33618176|NCT02141672|63019346|FG000|Overall Study|Lost to Follow-up|1|||
33456702|NCT00111800|62831370|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
33456703|NCT00111800|62831371|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
33456704|NCT00111800|62831372|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
33456705|NCT00094328|62831395|FG000|Overall Study|Lost to Follow-up|1|||
33618177|NCT02141672|63019347|FG001|Overall Study|Lost to Follow-up|1|||
33618178|NCT02141672|63019348|FG002|Overall Study|Lost to Follow-up|3|||
33618179|NCT02141672|63019346|FG000|Overall Study|Physician Decision|1|||
33618180|NCT02141672|63019347|FG001|Overall Study|Physician Decision|2|||
33618181|NCT02141672|63019348|FG002|Overall Study|Physician Decision|5|||
33618182|NCT02141672|63019346|FG000|Overall Study|Protocol Violation|0|||
33618183|NCT02141672|63019347|FG001|Overall Study|Protocol Violation|0|||
33618184|NCT02141672|63019348|FG002|Overall Study|Protocol Violation|1|||
33618185|NCT02141672|63019346|FG000|Overall Study|Withdrawal by Subject|3|||
33618186|NCT02141672|63019347|FG001|Overall Study|Withdrawal by Subject|2|||
33618187|NCT02141672|63019348|FG002|Overall Study|Withdrawal by Subject|5|||
33618188|NCT02141672|63019346|FG000|Overall Study|refused to follow-up|1|||
33618189|NCT02141672|63019347|FG001|Overall Study|refused to follow-up|0|||
33456706|NCT00094172|62831401|FG000|Overall Study|Adverse Event|0|||
33456707|NCT00094172|62831402|FG001|Overall Study|Adverse Event|1|||
33456708|NCT00094172|62831401|FG000|Overall Study|Lost to Follow-up|2|||
33456709|NCT00094172|62831402|FG001|Overall Study|Lost to Follow-up|0|||
33456710|NCT00094172|62831401|FG000|Overall Study|Protocol Violation|0|||
33523813|NCT02322814|62910533|FG004|Overall Study|Protocol Violation|0|||
33523814|NCT02322814|62910529|FG000|Overall Study|Study Terminated by Sponsor|0|||
33523815|NCT02322814|62910530|FG001|Overall Study|Study Terminated by Sponsor|7|||
33523816|NCT02322814|62910531|FG002|Overall Study|Study Terminated by Sponsor|9|||
33523817|NCT02322814|62910532|FG003|Overall Study|Study Terminated by Sponsor|5|||
33523818|NCT02322814|62910533|FG004|Overall Study|Study Terminated by Sponsor|13|||
33456711|NCT00094172|62831402|FG001|Overall Study|Protocol Violation|1|||
33456712|NCT00094172|62831401|FG000|Overall Study|Withdrawal by Subject|10|||
33456713|NCT00094172|62831402|FG001|Overall Study|Withdrawal by Subject|5|||
33456714|NCT00094172|62831401|FG000|Overall Study|Primary endpoint met.|1|||
33456715|NCT00094172|62831402|FG001|Overall Study|Primary endpoint met.|0|||
33456716|NCT00094172|62831401|FG000|Overall Study|Started other MS therapy due to disease|1|||
33456717|NCT00094172|62831402|FG001|Overall Study|Started other MS therapy due to disease|0|||
33456718|NCT00094094|62831408|FG000|Overall Study|Death|2|||
33456719|NCT00094094|62831408|FG000|Overall Study|Lack of Efficacy|23|||
33456720|NCT00094094|62831408|FG000|Overall Study|Adverse Event|7|||
33456721|NCT00110396|62831412|FG000|Overall Study|Adverse Event|15|||
33456722|NCT00110396|62831412|FG000|Overall Study|Lost to Follow-up|1|||
33456723|NCT00110396|62831412|FG000|Overall Study|Administration of plasmapheresis|1|||
33456724|NCT00110396|62831412|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
33456725|NCT00110396|62831412|FG000|Overall Study|Lack of Efficacy|1|||
33523819|NCT02322814|62910529|FG000|Overall Study|Withdrawal by Subject|5|||
33523820|NCT02322814|62910530|FG001|Overall Study|Withdrawal by Subject|4|||
33523821|NCT02322814|62910531|FG002|Overall Study|Withdrawal by Subject|2|||
33523822|NCT02322814|62910532|FG003|Overall Study|Withdrawal by Subject|1|||
33618190|NCT02141672|63019348|FG002|Overall Study|refused to follow-up|1|||
33456726|NCT00110396|62831412|FG000|Overall Study|Decided not to continue treatment|1|||
33456727|NCT00110396|62831412|FG000|Overall Study|Patient non-compliance|1|||
33456728|NCT00110396|62831412|FG000|Overall Study|Patient refused to continue|1|||
33456729|NCT00110396|62831412|FG000|Overall Study|Patient refused to participate|1|||
33523823|NCT02322814|62910533|FG004|Overall Study|Withdrawal by Subject|3|||
33618191|NCT02141516|63019359|FG000|Overall Study|Adverse Event|0|||
33618192|NCT02141516|63019360|FG001|Overall Study|Adverse Event|1|||
33523824|NCT01333033|62910555|FG000|Overall Study|Ineligible|0|||
33618193|NCT02141516|63019361|FG002|Overall Study|Adverse Event|0|||
33523825|NCT01333033|62910556|FG001|Overall Study|Ineligible|0|||
33523826|NCT01333033|62910557|FG002|Overall Study|Ineligible|0|||
33523827|NCT01333033|62910558|FG003|Overall Study|Ineligible|0|||
33523828|NCT01333033|62910559|FG004|Overall Study|Ineligible|6|||
33523829|NCT01333033|62910560|FG005|Overall Study|Ineligible|8|||
33523830|NCT01333033|62910555|FG000|Overall Study|Withdrawal by Subject|0|||
33523831|NCT01333033|62910556|FG001|Overall Study|Withdrawal by Subject|0|||
33523832|NCT01333033|62910557|FG002|Overall Study|Withdrawal by Subject|0|||
33523833|NCT01333033|62910558|FG003|Overall Study|Withdrawal by Subject|0|||
33523834|NCT01333033|62910559|FG004|Overall Study|Withdrawal by Subject|4|||
33523835|NCT01333033|62910560|FG005|Overall Study|Withdrawal by Subject|2|||
33523836|NCT01333033|62910555|FG000|Overall Study|PET inevaluable|0|||
33523837|NCT01333033|62910556|FG001|Overall Study|PET inevaluable|0|||
33523838|NCT01333033|62910557|FG002|Overall Study|PET inevaluable|0|||
33523839|NCT01333033|62910558|FG003|Overall Study|PET inevaluable|0|||
33523840|NCT01333033|62910559|FG004|Overall Study|PET inevaluable|2|||
33523841|NCT01333033|62910560|FG005|Overall Study|PET inevaluable|4|||
33523842|NCT01333033|62910555|FG000|Overall Study|Adverse Event|0|||
33523843|NCT01333033|62910556|FG001|Overall Study|Adverse Event|0|||
33523844|NCT01333033|62910557|FG002|Overall Study|Adverse Event|0|||
33523845|NCT01333033|62910558|FG003|Overall Study|Adverse Event|0|||
33523846|NCT01333033|62910559|FG004|Overall Study|Adverse Event|2|||
33618194|NCT02141516|63019359|FG000|Overall Study|Lost to Follow-up|0|||
33618195|NCT02141516|63019360|FG001|Overall Study|Lost to Follow-up|1|||
33618196|NCT02141516|63019361|FG002|Overall Study|Lost to Follow-up|0|||
33618197|NCT02141516|63019359|FG000|Overall Study|Other|0|||
33523847|NCT01333033|62910560|FG005|Overall Study|Adverse Event|1|||
33523848|NCT01333033|62910555|FG000|Overall Study|Progression|0|||
33618198|NCT02141516|63019360|FG001|Overall Study|Other|3|||
33618199|NCT02141516|63019361|FG002|Overall Study|Other|0|||
33618200|NCT02141360|63019375|FG000|Overall Study|Withdrawal by Subject|6|||
33618201|NCT02141360|63019376|FG001|Overall Study|Withdrawal by Subject|0|||
33618202|NCT02141360|63019377|FG002|Overall Study|Withdrawal by Subject|0|||
33618203|NCT02141360|63019375|FG000|Overall Study|Study Terminated before Visit|1|||
33618204|NCT02141360|63019376|FG001|Overall Study|Study Terminated before Visit|0|||
33618205|NCT02141360|63019377|FG002|Overall Study|Study Terminated before Visit|0|||
33618206|NCT01628198|63019385|FG000|Overall Study|Lost to Follow-up|7|||
33618207|NCT01628198|63019385|FG000|Overall Study|Withdrawal by Subject|10|||
33618208|NCT01628198|63019385|FG000|Overall Study|Screen failure|1|||
33618209|NCT01628120|63019389|FG000|Overall Study|Withdrawal by Subject|7|||
33618210|NCT01628120|63019389|FG000|Overall Study|Adverse Event|12|||
33618211|NCT01628120|63019389|FG000|Overall Study|Lost to Follow-up|1|||
33618212|NCT01628120|63019389|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
33618213|NCT01628120|63019389|FG000|Overall Study|Non-compliant with Study Procedures|1|||
33618214|NCT01628120|63019389|FG000|Overall Study|Not Treated|3|||
33618215|NCT01628120|63019389|FG000|Overall Study|Sponsor Decision|5|||
33618216|NCT01628120|63019389|FG000|Overall Study|Switched Dialysis Method|2|||
33618217|NCT01628120|63019389|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
33618218|NCT01628120|63019389|FG000|Overall Study|Moved or Relocated|5|||
33618219|NCT01628120|63019389|FG000|Overall Study|Kidney Transplant|2|||
33618220|NCT01628120|63019389|FG000|Overall Study|Use of Standard of Care|1|||
33618221|NCT01627340|63019395|FG000|Overall Study|Adverse Event|1|||
33523849|NCT01333033|62910556|FG001|Overall Study|Progression|0|||
33523850|NCT01333033|62910557|FG002|Overall Study|Progression|0|||
33523851|NCT01333033|62910558|FG003|Overall Study|Progression|0|||
33523852|NCT01333033|62910559|FG004|Overall Study|Progression|0|||
33523853|NCT01333033|62910560|FG005|Overall Study|Progression|1|||
33523854|NCT01333033|62910555|FG000|Overall Study|MD Decision|0|||
33618222|NCT01627340|63019396|FG001|Overall Study|Adverse Event|0|||
33618223|NCT01627340|63019395|FG000|Overall Study|Lost to Follow-up|8|||
33618224|NCT01627340|63019396|FG001|Overall Study|Lost to Follow-up|4|||
33618225|NCT01627340|63019395|FG000|Overall Study|Pregnancy|1|||
33523855|NCT01333033|62910556|FG001|Overall Study|MD Decision|0|||
33618226|NCT01627340|63019396|FG001|Overall Study|Pregnancy|0|||
33618227|NCT01627340|63019395|FG000|Overall Study|Withdrawal by Subject|2|||
33618228|NCT01627340|63019396|FG001|Overall Study|Withdrawal by Subject|0|||
33618229|NCT02125838|63019406|FG000|Overall Study|Lost to Follow-up|4|||
33618230|NCT02125838|63019407|FG001|Overall Study|Lost to Follow-up|4|||
33523856|NCT01333033|62910557|FG002|Overall Study|MD Decision|0|||
33618231|NCT02125604|63019413|FG000|Overall Study|Other|4|||
33618232|NCT02125604|63019413|FG000|Overall Study|Investigator Decision|1|||
33618233|NCT02125604|63019413|FG000|Overall Study|Lost to Follow-up|2|||
33523857|NCT01333033|62910558|FG003|Overall Study|MD Decision|0|||
33523858|NCT01333033|62910559|FG004|Overall Study|MD Decision|0|||
33523859|NCT01333033|62910560|FG005|Overall Study|MD Decision|2|||
33523860|NCT01192776|62910582|FG000|Overall Study|Death|8|||
33523861|NCT01192776|62910583|FG001|Overall Study|Death|15|||
33523862|NCT01192776|62910584|FG002|Overall Study|Death|18|||
33523863|NCT01192776|62910585|FG003|Overall Study|Death|15|||
33523864|NCT01192776|62910582|FG000|Overall Study|Lost to Follow-up|3|||
33523865|NCT01192776|62910583|FG001|Overall Study|Lost to Follow-up|6|||
33523866|NCT01192776|62910584|FG002|Overall Study|Lost to Follow-up|3|||
33523867|NCT01192776|62910585|FG003|Overall Study|Lost to Follow-up|5|||
33523868|NCT01367834|62910618|FG000|Overall Study|Withdrawal by Subject|2|||
33523869|NCT01367834|62910619|FG001|Overall Study|Withdrawal by Subject|2|||
33523870|NCT01367834|62910618|FG000|Overall Study|Study was ended.|0|||
33523871|NCT01367834|62910619|FG001|Overall Study|Study was ended.|1|||
33523872|NCT03106753|62910627|FG000|Overall Study|Withdrawal by Subject|0|||
33523873|NCT03106753|62910628|FG001|Overall Study|Withdrawal by Subject|1|||
33523874|NCT03045081|62910638|FG000|Overall Study|Withdrawal by Subject|6|||
33523875|NCT03045081|62910639|FG001|Overall Study|Withdrawal by Subject|11|||
33523876|NCT03107377|62910647|FG000|Overall Study|Adverse Event|3|||
33523877|NCT03107377|62910648|FG001|Overall Study|Adverse Event|3|||
33523878|NCT03107377|62910647|FG000|Overall Study|Protocol Violation|9|||
33523879|NCT03107377|62910648|FG001|Overall Study|Protocol Violation|12|||
33523880|NCT03107377|62910647|FG000|Overall Study|Physician Decision|3|||
33523881|NCT03107377|62910648|FG001|Overall Study|Physician Decision|6|||
33523882|NCT03107377|62910647|FG000|Overall Study|Pregnancy|7|||
33523883|NCT03107377|62910648|FG001|Overall Study|Pregnancy|7|||
33523884|NCT03107377|62910647|FG000|Overall Study|Withdrawal by Subject|16|||
33523885|NCT03107377|62910648|FG001|Overall Study|Withdrawal by Subject|22|||
33523886|NCT03107377|62910647|FG000|Overall Study|Lost to Follow-up|37|||
33523887|NCT03107377|62910648|FG001|Overall Study|Lost to Follow-up|34|||
33523888|NCT03107377|62910647|FG000|Overall Study|Other reason not specified|16|||
33523889|NCT03107377|62910648|FG001|Overall Study|Other reason not specified|15|||
33523890|NCT02545283|62910656|FG000|Overall Study|Lost to Follow-up|2|||
33523891|NCT02545283|62910657|FG001|Overall Study|Lost to Follow-up|4|||
33523892|NCT02545283|62910656|FG000|Overall Study|Withdrawal by Subject|5|||
33523893|NCT02545283|62910657|FG001|Overall Study|Withdrawal by Subject|9|||
33523894|NCT02545283|62910656|FG000|Overall Study|Death|109|||
33523895|NCT02545283|62910657|FG001|Overall Study|Death|211|||
33523896|NCT02545283|62910656|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
33523897|NCT02545283|62910657|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
33523898|NCT02545283|62910656|FG000|Overall Study|Study Terminated By Sponsor|33|||
33523899|NCT02545283|62910657|FG001|Overall Study|Study Terminated By Sponsor|71|||
33523900|NCT03282565|62910668|FG000|Overall Study|COVID-19 Research Shutdown|0|||
33523901|NCT03282565|62910669|FG001|Overall Study|COVID-19 Research Shutdown|2|||
33523902|NCT03282565|62910670|FG002|Overall Study|COVID-19 Research Shutdown|2|||
33523903|NCT02875613|62910678|FG000|Overall Study|Withdrawal by Subject|1|||
33523904|NCT02815267|62910688|FG000|Double-Blind Phase|Adverse Event|0|||
33523905|NCT02815267|62910689|FG001|Double-Blind Phase|Adverse Event|3|||
33523906|NCT02815267|62910688|FG000|Double-Blind Phase|Lost to Follow-up|17|||
33523907|NCT02815267|62910689|FG001|Double-Blind Phase|Lost to Follow-up|9|||
33523908|NCT02815267|62910688|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
33523909|NCT02815267|62910689|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
33523910|NCT02815267|62910688|FG000|Double-Blind Phase|Protocol Violation|3|||
33523911|NCT02815267|62910689|FG001|Double-Blind Phase|Protocol Violation|2|||
33523912|NCT02815267|62910688|FG000|Double-Blind Phase|Site withdrawal|1|||
33523913|NCT02815267|62910689|FG001|Double-Blind Phase|Site withdrawal|6|||
33523914|NCT02815267|62910688|FG000|Double-Blind Phase|Received a disallowed medication|1|||
33523915|NCT02815267|62910689|FG001|Double-Blind Phase|Received a disallowed medication|1|||
33523916|NCT02815267|62910688|FG000|Open-Label Phase|Adverse Event|1|||
33523917|NCT02815267|62910689|FG001|Open-Label Phase|Adverse Event|1|||
33618234|NCT02125604|63019413|FG000|Overall Study|Consent Withdrawn|4|||
33523918|NCT02815267|62910688|FG000|Open-Label Phase|Lost to Follow-up|23|||
33523919|NCT02815267|62910689|FG001|Open-Label Phase|Lost to Follow-up|9|||
33523920|NCT02815267|62910688|FG000|Open-Label Phase|Withdrawal by Subject|24|||
33523921|NCT02815267|62910689|FG001|Open-Label Phase|Withdrawal by Subject|13|||
33523922|NCT02815267|62910688|FG000|Open-Label Phase|Protocol Violation|0|||
33618235|NCT02125604|63019413|FG000|Overall Study|Adverse Event|20|||
33618236|NCT02124746|63019420|FG000|Overall Study|Adverse Event|2|||
33523923|NCT02815267|62910689|FG001|Open-Label Phase|Protocol Violation|1|||
33523924|NCT02815267|62910688|FG000|Open-Label Phase|Administrative|21|||
33523925|NCT02815267|62910689|FG001|Open-Label Phase|Administrative|12|||
33523926|NCT02815267|62910688|FG000|Open-Label Phase|Other|2|||
33523927|NCT02815267|62910689|FG001|Open-Label Phase|Other|5|||
33523928|NCT02930837|62910699|FG000|Overall Study|Adverse Event|6|||
33618237|NCT02124746|63019421|FG001|Overall Study|Adverse Event|1|||
33618238|NCT02124746|63019422|FG002|Overall Study|Adverse Event|2|||
33618239|NCT02124746|63019420|FG000|Overall Study|Death|2|||
33618240|NCT02124746|63019421|FG001|Overall Study|Death|1|||
33618241|NCT02124746|63019422|FG002|Overall Study|Death|3|||
33618242|NCT02124746|63019420|FG000|Overall Study|Lack of Efficacy|3|||
33618243|NCT02124746|63019421|FG001|Overall Study|Lack of Efficacy|2|||
33618244|NCT02124746|63019422|FG002|Overall Study|Lack of Efficacy|2|||
33618245|NCT02124746|63019420|FG000|Overall Study|Physician Decision|6|||
33618246|NCT02124746|63019421|FG001|Overall Study|Physician Decision|4|||
33618247|NCT02124746|63019422|FG002|Overall Study|Physician Decision|5|||
33618248|NCT02124746|63019420|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33618249|NCT02124746|63019421|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33618250|NCT02124746|63019422|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33618251|NCT02124746|63019420|FG000|Overall Study|Withdrawal by Subject|3|||
33618252|NCT02124746|63019421|FG001|Overall Study|Withdrawal by Subject|3|||
33618253|NCT02124746|63019422|FG002|Overall Study|Withdrawal by Subject|0|||
33618254|NCT02124746|63019420|FG000|Overall Study|Study Terminated by Sponsor|0|||
33618255|NCT02124746|63019421|FG001|Overall Study|Study Terminated by Sponsor|0|||
33523929|NCT02930837|62910699|FG000|Overall Study|Lost to Follow-up|5|||
33523930|NCT02930837|62910699|FG000|Overall Study|Withdrawal by Subject|1|||
33523931|NCT01343277|62910705|FG000|Overall Study|Other|3|||
33523932|NCT01343277|62910706|FG001|Overall Study|Other|3|||
33523933|NCT01343277|62910705|FG000|Overall Study|Withdrawal by Subject|18|||
33523934|NCT01343277|62910706|FG001|Overall Study|Withdrawal by Subject|13|||
33523935|NCT01343277|62910705|FG000|Overall Study|Physician Decision|1|||
33523936|NCT01343277|62910706|FG001|Overall Study|Physician Decision|2|||
33523937|NCT01343277|62910705|FG000|Overall Study|Death|10|||
33523938|NCT01343277|62910706|FG001|Overall Study|Death|1|||
33523939|NCT01343277|62910705|FG000|Overall Study|Adverse Event|67|||
33523940|NCT01343277|62910706|FG001|Overall Study|Adverse Event|13|||
33523941|NCT01343277|62910705|FG000|Overall Study|Disease progression|270|||
33523942|NCT01343277|62910706|FG001|Overall Study|Disease progression|138|||
33523943|NCT01343277|62910705|FG000|Overall Study|Randomized not treated|6|||
33523944|NCT01343277|62910706|FG001|Overall Study|Randomized not treated|21|||
33523945|NCT01343277|62910705|FG000|Overall Study|Treatment ongoing|8|||
33523946|NCT01343277|62910706|FG001|Overall Study|Treatment ongoing|2|||
33523947|NCT01343277|62910705|FG000|Overall Study|Subsequent anticancer therapy|1|||
33523948|NCT01343277|62910706|FG001|Overall Study|Subsequent anticancer therapy|0|||
33523949|NCT03135899|62910720|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
33523950|NCT03135899|62910721|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
33523951|NCT03135899|62910722|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
33523952|NCT03135899|62910723|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
33523953|NCT03135899|62910724|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
33523954|NCT03135899|62910725|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
33523955|NCT03135899|62910726|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
33523956|NCT03135899|62910727|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
33523957|NCT03135899|62910720|FG000|Overall Study|Withdrawal by Subject|0|||
33523958|NCT03135899|62910721|FG001|Overall Study|Withdrawal by Subject|0|||
33523959|NCT03135899|62910722|FG002|Overall Study|Withdrawal by Subject|0|||
33523960|NCT03135899|62910723|FG003|Overall Study|Withdrawal by Subject|0|||
33523961|NCT03135899|62910724|FG004|Overall Study|Withdrawal by Subject|0|||
33523962|NCT03135899|62910725|FG005|Overall Study|Withdrawal by Subject|2|||
33523963|NCT03135899|62910726|FG006|Overall Study|Withdrawal by Subject|0|||
33523964|NCT03135899|62910727|FG007|Overall Study|Withdrawal by Subject|0|||
33523965|NCT02487979|62910741|FG000|Overall Study|Physician Decision|2|||
33523966|NCT02487979|62910741|FG000|Overall Study|Withdrawal by Subject|2|||
33523967|NCT02487979|62910741|FG000|Overall Study|Progressive Disease|17|||
33523968|NCT03103087|62910752|FG000|Overall Study|Did not receive any study drug|1|||
33523969|NCT03103087|62910753|FG001|Overall Study|Did not receive any study drug|0|||
33523970|NCT03103087|62910754|FG002|Overall Study|Did not receive any study drug|0|||
33523971|NCT03103087|62910752|FG000|Overall Study|Protocol Violation|1|||
33523972|NCT03103087|62910753|FG001|Overall Study|Protocol Violation|2|||
33523973|NCT03103087|62910754|FG002|Overall Study|Protocol Violation|1|||
33618256|NCT02124746|63019422|FG002|Overall Study|Study Terminated by Sponsor|6|||
33618257|NCT02124746|63019420|FG000|Overall Study|Disease Progression|3|||
33523974|NCT03103087|62910752|FG000|Overall Study|Lack of Efficacy|2|||
33523975|NCT03103087|62910753|FG001|Overall Study|Lack of Efficacy|1|||
33523976|NCT03103087|62910754|FG002|Overall Study|Lack of Efficacy|1|||
33523977|NCT03103087|62910752|FG000|Overall Study|Pregnancy|0|||
33523978|NCT03103087|62910753|FG001|Overall Study|Pregnancy|0|||
33523979|NCT03103087|62910754|FG002|Overall Study|Pregnancy|1|||
33618258|NCT02124746|63019421|FG001|Overall Study|Disease Progression|6|||
33618259|NCT02124746|63019422|FG002|Overall Study|Disease Progression|4|||
33523980|NCT03103087|62910752|FG000|Overall Study|Adverse Event|2|||
33523981|NCT03103087|62910753|FG001|Overall Study|Adverse Event|15|||
33523982|NCT03103087|62910754|FG002|Overall Study|Adverse Event|6|||
33523983|NCT03103087|62910752|FG000|Overall Study|Withdrawal by Subject|13|||
33523984|NCT03103087|62910753|FG001|Overall Study|Withdrawal by Subject|6|||
33523985|NCT03103087|62910754|FG002|Overall Study|Withdrawal by Subject|6|||
33523986|NCT03103087|62910752|FG000|Overall Study|Lost to Follow-up|4|||
33523987|NCT03103087|62910753|FG001|Overall Study|Lost to Follow-up|2|||
33523988|NCT03103087|62910754|FG002|Overall Study|Lost to Follow-up|7|||
33523989|NCT03103087|62910752|FG000|Overall Study|Other reason not reported|1|||
33523990|NCT03103087|62910753|FG001|Overall Study|Other reason not reported|3|||
33523991|NCT03103087|62910754|FG002|Overall Study|Other reason not reported|5|||
33523992|NCT03131999|62910766|FG000|Overall Study|Withdrawal by Subject|0|||
33523993|NCT03131999|62910767|FG001|Overall Study|Withdrawal by Subject|1|||
33523994|NCT02263885|62910782|FG000|Overall Study|Withdrawal by Subject|7|||
33523995|NCT02263885|62910782|FG000|Overall Study|Alternative Treatment|3|||
33523996|NCT02000219|62910787|FG000|14-Week Study Period|Physician Decision|1|||
33523997|NCT02000219|62910787|FG000|14-Week Study Period|Adverse Event|1|||
33523998|NCT02000219|62910787|FG000|14-Week Study Period|Underwent transplantation|1|||
33523999|NCT02000219|62910787|FG000|Continuation Period|Withdrawal by Subject|1|||
33524000|NCT02000219|62910787|FG000|Continuation Period|Had liver transplant|2|||
33524001|NCT02000219|62910787|FG000|Continuation Period|Non-compliance with study drug|2|||
33524002|NCT03101371|62910793|FG000|Overall Study|Physician Decision|0|||
33524003|NCT03101371|62910794|FG001|Overall Study|Physician Decision|1|||
33524004|NCT03101371|62910793|FG000|Overall Study|Lost to Follow-up|1|||
33524005|NCT03101371|62910794|FG001|Overall Study|Lost to Follow-up|4|||
33524006|NCT03101371|62910793|FG000|Overall Study|Did not meet eligibility criteria|2|||
33524007|NCT03101371|62910794|FG001|Overall Study|Did not meet eligibility criteria|1|||
33524008|NCT02850276|62910800|FG000|Overall Study|screen failure|43|||
33524009|NCT02850276|62910800|FG000|Overall Study|Withdrawal by Subject|14|||
33524010|NCT02850276|62910800|FG000|Overall Study|Physician Decision|2|||
33524011|NCT02850276|62910800|FG000|Overall Study|Lost to Follow-up|2|||
33524012|NCT02783768|62910805|FG000|Overall Study|Lost to Follow-up|1|||
33524013|NCT02783768|62910806|FG001|Overall Study|Lost to Follow-up|0|||
33524014|NCT03131687|62910818|FG000|Overall Study|Adverse Event|0|||
33524015|NCT03131687|62910819|FG001|Overall Study|Adverse Event|1|||
33524016|NCT03131687|62910820|FG002|Overall Study|Adverse Event|0|||
33524017|NCT03131687|62910821|FG003|Overall Study|Adverse Event|1|||
33524018|NCT03131687|62910822|FG004|Overall Study|Adverse Event|2|||
33524019|NCT03131687|62910823|FG005|Overall Study|Adverse Event|2|||
33524020|NCT03131687|62910818|FG000|Overall Study|Death|1|||
33524021|NCT03131687|62910819|FG001|Overall Study|Death|0|||
33524022|NCT03131687|62910820|FG002|Overall Study|Death|0|||
33524023|NCT03131687|62910821|FG003|Overall Study|Death|0|||
33524024|NCT03131687|62910822|FG004|Overall Study|Death|0|||
33524025|NCT03131687|62910823|FG005|Overall Study|Death|0|||
33524026|NCT03131687|62910818|FG000|Overall Study|Withdrawal by Subject|3|||
33524027|NCT03131687|62910819|FG001|Overall Study|Withdrawal by Subject|3|||
33524028|NCT03131687|62910820|FG002|Overall Study|Withdrawal by Subject|3|||
33524029|NCT03131687|62910821|FG003|Overall Study|Withdrawal by Subject|1|||
33524030|NCT03131687|62910822|FG004|Overall Study|Withdrawal by Subject|2|||
33524031|NCT03131687|62910823|FG005|Overall Study|Withdrawal by Subject|1|||
33524032|NCT03131687|62910818|FG000|Overall Study|Lost to Follow-up|1|||
33524033|NCT03131687|62910819|FG001|Overall Study|Lost to Follow-up|4|||
33524034|NCT03131687|62910820|FG002|Overall Study|Lost to Follow-up|0|||
33524035|NCT03131687|62910821|FG003|Overall Study|Lost to Follow-up|1|||
33524036|NCT03131687|62910822|FG004|Overall Study|Lost to Follow-up|4|||
33524037|NCT03131687|62910823|FG005|Overall Study|Lost to Follow-up|2|||
33524038|NCT03131687|62910818|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
33524039|NCT03131687|62910819|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
33524040|NCT03131687|62910820|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
33524041|NCT03131687|62910821|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
33524042|NCT03131687|62910822|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
33524043|NCT03131687|62910823|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
33524044|NCT03131687|62910818|FG000|Overall Study|Principle Investigator Decision|0|||
33524045|NCT03131687|62910819|FG001|Overall Study|Principle Investigator Decision|1|||
33524046|NCT03131687|62910820|FG002|Overall Study|Principle Investigator Decision|0|||
33524047|NCT03131687|62910821|FG003|Overall Study|Principle Investigator Decision|0|||
33524048|NCT03131687|62910822|FG004|Overall Study|Principle Investigator Decision|0|||
33524049|NCT03131687|62910823|FG005|Overall Study|Principle Investigator Decision|0|||
33524050|NCT03131687|62910818|FG000|Overall Study|Inadvertent Enrollment|0|||
33524051|NCT03131687|62910819|FG001|Overall Study|Inadvertent Enrollment|0|||
33524052|NCT03131687|62910820|FG002|Overall Study|Inadvertent Enrollment|0|||
33524053|NCT03131687|62910821|FG003|Overall Study|Inadvertent Enrollment|1|||
33524054|NCT03131687|62910822|FG004|Overall Study|Inadvertent Enrollment|0|||
33524055|NCT03131687|62910823|FG005|Overall Study|Inadvertent Enrollment|0|||
33524056|NCT03101293|62910852|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
33524057|NCT03101293|62910853|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
33524058|NCT02850978|62910859|FG000|Overall Study|Uncollectable CRF|27|||
33524059|NCT02850978|62910859|FG000|Overall Study|No visit since the first visit|35|||
33524060|NCT02850978|62910859|FG000|Overall Study|Adverse Event|81|||
33524061|NCT02850978|62910859|FG000|Overall Study|Lack of Efficacy|40|||
33524062|NCT02850978|62910859|FG000|Overall Study|Improvement in condition|34|||
33524063|NCT02850978|62910859|FG000|Overall Study|Lost to Follow-up|121|||
33524064|NCT02850978|62910859|FG000|Overall Study|Reason not listed|88|||
33524065|NCT03135431|62910865|FG000|Overall Study|Study Surgeon not available|2|||
33524066|NCT03135431|62910866|FG001|Overall Study|Study Surgeon not available|0|||
33524067|NCT04534517|62910888|FG000|Overall Study|Adverse Event|1|||
33524068|NCT04534517|62910888|FG000|Overall Study|Withdrawal by Subject|1|||
33524069|NCT04534517|62910888|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
33524070|NCT04534517|62910888|FG000|Overall Study|COVID-19 Related|1|||
33524071|NCT02831257|62910892|FG000|Overall Study|Lack of Efficacy|3|||
33524072|NCT02831257|62910892|FG000|Overall Study|Adverse Event|2|||
33524073|NCT02831257|62910892|FG000|Overall Study|Physician Decision|1|||
33524074|NCT02831257|62910892|FG000|Overall Study|Withdrawal by Subject|6|||
33524075|NCT03100825|62910896|FG000|Overall Study|Participant/Guardian Decision|7|||
33524076|NCT03100825|62910896|FG000|Overall Study|Physician Decision|1|||
33524077|NCT02250534|62910903|FG000|Overall Study|Lost to Follow-up|18|||
33524078|NCT02250534|62910904|FG001|Overall Study|Lost to Follow-up|28|||
33524079|NCT02250534|62910905|FG002|Overall Study|Lost to Follow-up|33|||
33524080|NCT02250534|62910903|FG000|Overall Study|Personal reasons|7|||
33524081|NCT02250534|62910904|FG001|Overall Study|Personal reasons|8|||
33524082|NCT02250534|62910905|FG002|Overall Study|Personal reasons|14|||
33524083|NCT02250534|62910903|FG000|Overall Study|Adverse Event|6|||
33524084|NCT02250534|62910904|FG001|Overall Study|Adverse Event|3|||
33524085|NCT02250534|62910905|FG002|Overall Study|Adverse Event|8|||
33524086|NCT02250534|62910903|FG000|Overall Study|incarcerated|2|||
33524087|NCT02250534|62910904|FG001|Overall Study|incarcerated|1|||
33524088|NCT02250534|62910905|FG002|Overall Study|incarcerated|2|||
33524089|NCT02250534|62910903|FG000|Overall Study|Withdrawal by Subject|0|||
33524090|NCT02250534|62910904|FG001|Overall Study|Withdrawal by Subject|1|||
33524091|NCT02250534|62910905|FG002|Overall Study|Withdrawal by Subject|2|||
33524092|NCT02250534|62910903|FG000|Overall Study|Death|0|||
33524093|NCT02250534|62910904|FG001|Overall Study|Death|1|||
33524094|NCT02250534|62910905|FG002|Overall Study|Death|1|||
33524095|NCT02250534|62910903|FG000|Overall Study|Physician Decision|1|||
33524096|NCT02250534|62910904|FG001|Overall Study|Physician Decision|3|||
33524097|NCT02250534|62910905|FG002|Overall Study|Physician Decision|1|||
33524098|NCT02250534|62910903|FG000|Overall Study|Protocol Violation|1|||
33524099|NCT02250534|62910904|FG001|Overall Study|Protocol Violation|0|||
33524100|NCT02250534|62910905|FG002|Overall Study|Protocol Violation|1|||
33524101|NCT02250534|62910903|FG000|Overall Study|Reason unknown|1|||
33524102|NCT02250534|62910904|FG001|Overall Study|Reason unknown|0|||
33524103|NCT02250534|62910905|FG002|Overall Study|Reason unknown|0|||
33524104|NCT02848326|62910919|FG000|Treatment Period|Adverse Event|5|||
33524105|NCT02848326|62910920|FG001|Treatment Period|Adverse Event|4|||
33524106|NCT02848326|62910921|FG002|Treatment Period|Adverse Event|11|||
33524107|NCT02848326|62910922|FG003|Treatment Period|Adverse Event|6|||
33524108|NCT02848326|62910923|FG004|Treatment Period|Adverse Event|5|||
33524109|NCT02848326|62910924|FG005|Treatment Period|Adverse Event|7|||
33524110|NCT02848326|62910919|FG000|Treatment Period|Withdrawal of Consent|20|||
33524111|NCT02848326|62910920|FG001|Treatment Period|Withdrawal of Consent|6|||
33524112|NCT02848326|62910921|FG002|Treatment Period|Withdrawal of Consent|9|||
33524113|NCT02848326|62910922|FG003|Treatment Period|Withdrawal of Consent|6|||
33524114|NCT02848326|62910923|FG004|Treatment Period|Withdrawal of Consent|9|||
33524115|NCT02848326|62910924|FG005|Treatment Period|Withdrawal of Consent|6|||
33524116|NCT02848326|62910919|FG000|Treatment Period|Lost to Follow-up|5|||
33524117|NCT02848326|62910920|FG001|Treatment Period|Lost to Follow-up|1|||
33524118|NCT02848326|62910921|FG002|Treatment Period|Lost to Follow-up|11|||
33524119|NCT02848326|62910922|FG003|Treatment Period|Lost to Follow-up|7|||
33524120|NCT02848326|62910923|FG004|Treatment Period|Lost to Follow-up|2|||
33524121|NCT02848326|62910924|FG005|Treatment Period|Lost to Follow-up|3|||
33524122|NCT02848326|62910919|FG000|Treatment Period|Pregnancy|0|||
33524123|NCT02848326|62910920|FG001|Treatment Period|Pregnancy|0|||
33524124|NCT02848326|62910921|FG002|Treatment Period|Pregnancy|1|||
33524125|NCT02848326|62910922|FG003|Treatment Period|Pregnancy|1|||
33524126|NCT02848326|62910923|FG004|Treatment Period|Pregnancy|0|||
33524127|NCT02848326|62910924|FG005|Treatment Period|Pregnancy|1|||
33524128|NCT02848326|62910919|FG000|Treatment Period|Protocol Violation|4|||
33524129|NCT02848326|62910920|FG001|Treatment Period|Protocol Violation|3|||
33524130|NCT02848326|62910921|FG002|Treatment Period|Protocol Violation|4|||
33524131|NCT02848326|62910922|FG003|Treatment Period|Protocol Violation|2|||
33524132|NCT02848326|62910923|FG004|Treatment Period|Protocol Violation|3|||
33524133|NCT02848326|62910924|FG005|Treatment Period|Protocol Violation|3|||
33524134|NCT02848326|62910919|FG000|Treatment Period|Non-compliance with Study Drug|4|||
33524135|NCT02848326|62910920|FG001|Treatment Period|Non-compliance with Study Drug|0|||
33524136|NCT02848326|62910921|FG002|Treatment Period|Non-compliance with Study Drug|0|||
33524137|NCT02848326|62910922|FG003|Treatment Period|Non-compliance with Study Drug|1|||
33524138|NCT02848326|62910923|FG004|Treatment Period|Non-compliance with Study Drug|0|||
33524139|NCT02848326|62910924|FG005|Treatment Period|Non-compliance with Study Drug|0|||
33524140|NCT02848326|62910919|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
33524141|NCT02848326|62910920|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
33524142|NCT02848326|62910921|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
33524143|NCT02848326|62910922|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
33524144|NCT02848326|62910923|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
33524145|NCT02848326|62910924|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
33524146|NCT02848326|62910919|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
33524147|NCT02848326|62910920|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
33524148|NCT02848326|62910921|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
33524149|NCT02848326|62910922|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
33524150|NCT02848326|62910923|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
33524151|NCT02848326|62910924|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
33524152|NCT03128723|62910938|FG000|Overall Study|Withdrawal by Subject|2|||
33524153|NCT03128411|62910942|FG000|Treatment Phase|Adverse Event|21|||
33524154|NCT03128411|62910942|FG000|Treatment Phase|Physician Decision|1|||
33524155|NCT03128411|62910942|FG000|Treatment Phase|Other|2|||
33524156|NCT03128411|62910942|FG000|Long Term Follow-up Phase|Death|2|||
33524157|NCT02847858|62910948|FG000|Overall Study|Lost to Follow-up|401|||
33524158|NCT02847858|62910949|FG001|Overall Study|Lost to Follow-up|269|||
33524159|NCT03124199|62910960|FG000|Overall Study|Lost to Follow-up|4|||
33524160|NCT04465916|62910966|FG000|Overall Study|Withdrawal by Subject|0|||
33524161|NCT04465916|62910967|FG001|Overall Study|Withdrawal by Subject|1|||
33524162|NCT05090852|62910973|FG000|Overall Study|Physician Decision|5|||
33524163|NCT00075816|62910988|FG000|Overall Study|Did not undergo transplantation|14|||
33524164|NCT00075816|62910989|FG001|Overall Study|Did not undergo transplantation|11|||
33524165|NCT00109772|62911003|FG000|Double-blind Treatment|Adverse Event|14|||
33524166|NCT00109772|62911004|FG001|Double-blind Treatment|Adverse Event|5|||
33524167|NCT00109772|62911003|FG000|Double-blind Treatment|Lack of Efficacy|1|||
33618260|NCT02123966|63019430|FG000|Overall Study|Intercurrent Illness|1|||
33618261|NCT02123576|63019436|FG000|Overall Study|Adverse Event|1|||
33524168|NCT00109772|62911004|FG001|Double-blind Treatment|Lack of Efficacy|0|||
33524169|NCT00109772|62911003|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
33524170|NCT00109772|62911004|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
33524171|NCT00109772|62911003|FG000|Double-blind Treatment|Lost to Follow-up|2|||
33524172|NCT00109772|62911004|FG001|Double-blind Treatment|Lost to Follow-up|3|||
33524173|NCT00109772|62911003|FG000|Double-blind Treatment|Protocol Violation|0|||
33524174|NCT00109772|62911004|FG001|Double-blind Treatment|Protocol Violation|1|||
33524175|NCT00109772|62911003|FG000|Double-blind Treatment|Other|0|||
33524176|NCT00109772|62911004|FG001|Double-blind Treatment|Other|4|||
33524177|NCT00109772|62911003|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
33524178|NCT00109772|62911004|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
33524179|NCT00109772|62911003|FG000|Open-label Extension|Adverse Event|10|||
33524180|NCT00109772|62911004|FG001|Open-label Extension|Adverse Event|19|||
33524181|NCT00109772|62911003|FG000|Open-label Extension|Lack of Efficacy|19|||
33618262|NCT02123576|63019437|FG001|Overall Study|Adverse Event|0|||
33618263|NCT01177397|63019455|FG000|Overall Study|Protocol Violation|0|||
33618264|NCT01177397|63019456|FG001|Overall Study|Protocol Violation|0|||
33618265|NCT01177397|63019457|FG002|Overall Study|Protocol Violation|0|||
33456730|NCT00110396|62831412|FG000|Overall Study|Patient will|1|||
33456731|NCT00110396|62831412|FG000|Overall Study|Patient's decision|1|||
33456732|NCT00110396|62831412|FG000|Overall Study|Participation in MS vaccine study|1|||
33456733|NCT00110396|62831412|FG000|Overall Study|Pregnancy|1|||
33456734|NCT00110396|62831412|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
33456735|NCT00110396|62831412|FG000|Overall Study|Protocol Violation|2|||
33456736|NCT00110396|62831412|FG000|Overall Study|Patient refused to come back|1|||
33456737|NCT00110396|62831412|FG000|Overall Study|The patient has refused|2|||
33456738|NCT00110396|62831412|FG000|Overall Study|The patient has refused to visit site|1|||
33456739|NCT00110396|62831412|FG000|Overall Study|Patient is to be administered copaxone|1|||
33456740|NCT03819218|62831416|FG000|Overall Study|Protocol Violation|1|||
33456741|NCT00093470|62831422|FG000|Overall Study|Disease progression|39|||
33456742|NCT00093470|62831423|FG001|Overall Study|Disease progression|0|||
33524182|NCT00109772|62911004|FG001|Open-label Extension|Lack of Efficacy|11|||
33524183|NCT00109772|62911003|FG000|Open-label Extension|Withdrawal by Subject|9|||
33524184|NCT00109772|62911004|FG001|Open-label Extension|Withdrawal by Subject|6|||
33524185|NCT00109772|62911003|FG000|Open-label Extension|Lost to Follow-up|1|||
33524186|NCT00109772|62911004|FG001|Open-label Extension|Lost to Follow-up|0|||
33618266|NCT01177397|63019458|FG003|Overall Study|Protocol Violation|0|||
33456743|NCT00093470|62831422|FG000|Overall Study|Adverse Event|15|||
33618267|NCT01177397|63019459|FG004|Overall Study|Protocol Violation|0|||
33456744|NCT00093470|62831423|FG001|Overall Study|Adverse Event|0|||
33524187|NCT00109772|62911003|FG000|Open-label Extension|Death|0|||
33524188|NCT00109772|62911004|FG001|Open-label Extension|Death|1|||
33524189|NCT00109772|62911003|FG000|Open-label Extension|Protocol Violation|2|||
33524190|NCT00109772|62911004|FG001|Open-label Extension|Protocol Violation|2|||
33524191|NCT00109772|62911003|FG000|Open-label Extension|Other|4|||
33524192|NCT00109772|62911004|FG001|Open-label Extension|Other|10|||
33524193|NCT02783066|62911010|FG000|Overall Study|Withdrawal by Subject|13|||
33524194|NCT01371305|62911021|FG000|Overall Study|Adverse Event|0|||
33524195|NCT01371305|62911022|FG001|Overall Study|Adverse Event|0|||
33524196|NCT01371305|62911023|FG002|Overall Study|Adverse Event|0|||
33524197|NCT01371305|62911024|FG003|Overall Study|Adverse Event|2|||
33524198|NCT01371305|62911025|FG004|Overall Study|Adverse Event|1|||
33524199|NCT01371305|62911026|FG005|Overall Study|Adverse Event|0|||
33524200|NCT01371305|62911021|FG000|Overall Study|Study terminated by sponsor|0|||
33524201|NCT01371305|62911022|FG001|Overall Study|Study terminated by sponsor|0|||
33524202|NCT01371305|62911023|FG002|Overall Study|Study terminated by sponsor|0|||
33524203|NCT01371305|62911024|FG003|Overall Study|Study terminated by sponsor|0|||
33524204|NCT01371305|62911025|FG004|Overall Study|Study terminated by sponsor|3|||
33524205|NCT01371305|62911026|FG005|Overall Study|Study terminated by sponsor|1|||
33524206|NCT01371305|62911021|FG000|Overall Study|Subject request|0|||
33524207|NCT01371305|62911022|FG001|Overall Study|Subject request|0|||
33524208|NCT01371305|62911023|FG002|Overall Study|Subject request|0|||
33524209|NCT01371305|62911024|FG003|Overall Study|Subject request|0|||
33524210|NCT01371305|62911025|FG004|Overall Study|Subject request|0|||
33524211|NCT01371305|62911026|FG005|Overall Study|Subject request|1|||
33524212|NCT00109928|62911041|FG000|Overall Study|Adverse Event|2|||
33524213|NCT00109928|62911041|FG000|Overall Study|Progression|6|||
33524214|NCT00109928|62911041|FG000|Overall Study|Death|2|||
33524215|NCT00109928|62911041|FG000|Overall Study|not protocol specified|2|||
33524216|NCT00109928|62911041|FG000|Overall Study|not eligible|1|||
33524217|NCT00109850|62911046|FG000|Overall Study|Adverse Event|1|||
33524218|NCT00109850|62911046|FG000|Overall Study|Death|2|||
33524219|NCT00109850|62911046|FG000|Overall Study|Ineligible|1|||
33524220|NCT01342926|62911054|FG000|Overall Study|Adverse Event|5|||
33524221|NCT01342926|62911055|FG001|Overall Study|Adverse Event|8|||
33524222|NCT01342926|62911056|FG002|Overall Study|Adverse Event|10|||
33524223|NCT01342926|62911057|FG003|Overall Study|Adverse Event|7|||
33524224|NCT01342926|62911054|FG000|Overall Study|Lost to Follow-up|0|||
33524225|NCT01342926|62911055|FG001|Overall Study|Lost to Follow-up|1|||
33524226|NCT01342926|62911056|FG002|Overall Study|Lost to Follow-up|1|||
33524227|NCT01342926|62911057|FG003|Overall Study|Lost to Follow-up|0|||
33524228|NCT01342926|62911054|FG000|Overall Study|Investigator Discretion|2|||
33524229|NCT01342926|62911055|FG001|Overall Study|Investigator Discretion|2|||
33524230|NCT01342926|62911056|FG002|Overall Study|Investigator Discretion|0|||
33524231|NCT01342926|62911057|FG003|Overall Study|Investigator Discretion|0|||
33524232|NCT01342926|62911054|FG000|Overall Study|Withdrawal by Subject|2|||
33524233|NCT01342926|62911055|FG001|Overall Study|Withdrawal by Subject|4|||
33524234|NCT01342926|62911056|FG002|Overall Study|Withdrawal by Subject|3|||
33524235|NCT01342926|62911057|FG003|Overall Study|Withdrawal by Subject|5|||
33524236|NCT01810016|62911070|FG000|Overall Study|Progressive disease|1|||
33524237|NCT01810016|62911071|FG001|Overall Study|Progressive disease|1|||
33524238|NCT01810016|62911072|FG002|Overall Study|Progressive disease|0|||
33524239|NCT01810016|62911070|FG000|Overall Study|Death|0|||
33524240|NCT01810016|62911071|FG001|Overall Study|Death|0|||
33618268|NCT01177397|63019460|FG005|Overall Study|Protocol Violation|1|||
33456745|NCT00093470|62831422|FG000|Overall Study|Death|2|||
33456746|NCT00093470|62831423|FG001|Overall Study|Death|0|||
33456747|NCT00093470|62831422|FG000|Overall Study|Withdrawal by Subject|8|||
33456748|NCT00093470|62831423|FG001|Overall Study|Withdrawal by Subject|0|||
33456749|NCT00093470|62831422|FG000|Overall Study|Alternative therapy|2|||
33456750|NCT00093470|62831423|FG001|Overall Study|Alternative therapy|0|||
33456751|NCT00093470|62831422|FG000|Overall Study|Other complicating disease|3|||
33524241|NCT01810016|62911072|FG002|Overall Study|Death|1|||
33524242|NCT02843178|62911084|FG000|Overall Study|Lost to Follow-up|8|||
33524243|NCT02843178|62911085|FG001|Overall Study|Lost to Follow-up|8|||
33524244|NCT02843178|62911086|FG002|Overall Study|Lost to Follow-up|6|||
33524245|NCT02843178|62911087|FG003|Overall Study|Lost to Follow-up|3|||
33524246|NCT02843178|62911084|FG000|Overall Study|Withdrawal by Subject|0|||
33524247|NCT02843178|62911085|FG001|Overall Study|Withdrawal by Subject|0|||
33524248|NCT02843178|62911086|FG002|Overall Study|Withdrawal by Subject|1|||
33524249|NCT02843178|62911087|FG003|Overall Study|Withdrawal by Subject|1|||
33524250|NCT01722266|62911101|FG000|Overall Study|Withdrawal by Subject|1|||
33524251|NCT01722266|62911102|FG001|Overall Study|Withdrawal by Subject|2|||
33524252|NCT01722266|62911103|FG002|Overall Study|Withdrawal by Subject|0|||
33524253|NCT01722266|62911104|FG003|Overall Study|Withdrawal by Subject|0|||
33456752|NCT00093470|62831423|FG001|Overall Study|Other complicating disease|0|||
33456753|NCT00093470|62831422|FG000|Overall Study|Physician Decision|2|||
33524254|NCT01722266|62911101|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
33524255|NCT01722266|62911102|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
33524256|NCT01722266|62911103|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
33524257|NCT01722266|62911104|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
33524258|NCT01722266|62911101|FG000|Overall Study|Dropped out due to Nausea|0|||
33524259|NCT01722266|62911102|FG001|Overall Study|Dropped out due to Nausea|0|||
33524260|NCT01722266|62911103|FG002|Overall Study|Dropped out due to Nausea|2|||
33524261|NCT01722266|62911104|FG003|Overall Study|Dropped out due to Nausea|0|||
33524262|NCT03123185|62911128|FG000|Overall Study|Withdrawal by Subject|0|||
33524263|NCT03123185|62911129|FG001|Overall Study|Withdrawal by Subject|0|||
33524264|NCT03123185|62911130|FG002|Overall Study|Withdrawal by Subject|0|||
33524265|NCT03123185|62911131|FG003|Overall Study|Withdrawal by Subject|0|||
33524266|NCT03123185|62911132|FG004|Overall Study|Withdrawal by Subject|0|||
33524267|NCT03123185|62911133|FG005|Overall Study|Withdrawal by Subject|0|||
33524268|NCT03123185|62911134|FG006|Overall Study|Withdrawal by Subject|0|||
33524269|NCT03123185|62911135|FG007|Overall Study|Withdrawal by Subject|0|||
33524270|NCT03123185|62911136|FG008|Overall Study|Withdrawal by Subject|0|||
33524271|NCT03123185|62911137|FG009|Overall Study|Withdrawal by Subject|0|||
33524272|NCT03123185|62911138|FG010|Overall Study|Withdrawal by Subject|0|||
33524273|NCT03123185|62911139|FG011|Overall Study|Withdrawal by Subject|0|||
33524274|NCT03123185|62911140|FG012|Overall Study|Withdrawal by Subject|1|||
33524275|NCT03123185|62911141|FG013|Overall Study|Withdrawal by Subject|0|||
33524276|NCT02842866|62911200|FG000|Overall Study|Serious Adverse Event|0|||
33524277|NCT02842866|62911201|FG001|Overall Study|Serious Adverse Event|1|||
33524278|NCT02842866|62911200|FG000|Overall Study|Protocol Violation|4|||
33524279|NCT02842866|62911201|FG001|Overall Study|Protocol Violation|2|||
33524280|NCT02842866|62911200|FG000|Overall Study|Lost to Follow-up|2|||
33524281|NCT02842866|62911201|FG001|Overall Study|Lost to Follow-up|0|||
33524282|NCT02842866|62911200|FG000|Overall Study|Withdrawal by Subject|1|||
33524283|NCT02842866|62911201|FG001|Overall Study|Withdrawal by Subject|0|||
33524284|NCT01316913|62911211|FG000|Overall Study|Adverse Event|17|||
33524285|NCT01316913|62911212|FG001|Overall Study|Adverse Event|20|||
33524286|NCT01316913|62911213|FG002|Overall Study|Adverse Event|15|||
33524287|NCT01316913|62911214|FG003|Overall Study|Adverse Event|11|||
33524288|NCT01316913|62911211|FG000|Overall Study|Lack of Efficacy|22|||
33524289|NCT01316913|62911212|FG001|Overall Study|Lack of Efficacy|12|||
33524290|NCT01316913|62911213|FG002|Overall Study|Lack of Efficacy|9|||
33524291|NCT01316913|62911214|FG003|Overall Study|Lack of Efficacy|13|||
33524292|NCT01316913|62911211|FG000|Overall Study|Protocol Violation|1|||
33524293|NCT01316913|62911212|FG001|Overall Study|Protocol Violation|4|||
33524294|NCT01316913|62911213|FG002|Overall Study|Protocol Violation|4|||
33524295|NCT01316913|62911214|FG003|Overall Study|Protocol Violation|1|||
33524296|NCT01316913|62911211|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
33524297|NCT01316913|62911212|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
33524298|NCT01316913|62911213|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
33524299|NCT01316913|62911214|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
33524300|NCT01316913|62911211|FG000|Overall Study|Lost to Follow-up|0|||
33524301|NCT01316913|62911212|FG001|Overall Study|Lost to Follow-up|1|||
33524302|NCT01316913|62911213|FG002|Overall Study|Lost to Follow-up|0|||
33524303|NCT01316913|62911214|FG003|Overall Study|Lost to Follow-up|2|||
33618269|NCT01177397|63019461|FG006|Overall Study|Protocol Violation|0|||
33618270|NCT01177397|63019462|FG007|Overall Study|Protocol Violation|0|||
33456754|NCT00093470|62831423|FG001|Overall Study|Physician Decision|0|||
33456755|NCT00093470|62831422|FG000|Overall Study|Never started treatment|1|||
33456756|NCT00093470|62831423|FG001|Overall Study|Never started treatment|0|||
33456757|NCT00093470|62831422|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
33456758|NCT00093470|62831423|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
33456759|NCT00407537|62831431|FG000|Overall Study|Death|5|||
33456760|NCT00407537|62831432|FG001|Overall Study|Death|2|||
33456761|NCT00407537|62831431|FG000|Overall Study|Adverse Event|36|||
33456762|NCT00407537|62831432|FG001|Overall Study|Adverse Event|0|||
33456763|NCT00407537|62831431|FG000|Overall Study|Lost to Follow-up|12|||
33456764|NCT00407537|62831432|FG001|Overall Study|Lost to Follow-up|19|||
33456765|NCT00407537|62831431|FG000|Overall Study|Other|6|||
33456766|NCT00407537|62831432|FG001|Overall Study|Other|7|||
33456767|NCT00407537|62831431|FG000|Overall Study|Withdrawal by Subject|34|||
33456768|NCT00407537|62831432|FG001|Overall Study|Withdrawal by Subject|16|||
33456769|NCT00094458|62831441|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
33456770|NCT00094458|62831442|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
33524304|NCT01316913|62911211|FG000|Overall Study|Withdrawal by Subject|10|||
33524305|NCT01316913|62911212|FG001|Overall Study|Withdrawal by Subject|9|||
33524306|NCT01316913|62911213|FG002|Overall Study|Withdrawal by Subject|10|||
33524307|NCT01316913|62911214|FG003|Overall Study|Withdrawal by Subject|6|||
33524308|NCT02875067|62911225|FG000|Overall Study|Withdrawal by Subject|1|||
33524309|NCT02875067|62911225|FG000|Overall Study|Withdrawal by Termination of Study|5|||
33618271|NCT01177397|63019463|FG008|Overall Study|Protocol Violation|0|||
33456771|NCT00094458|62831443|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
33618272|NCT01177397|63019464|FG009|Overall Study|Protocol Violation|0|||
33456772|NCT00094458|62831444|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
33456773|NCT00094458|62831445|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
33456774|NCT00094458|62831446|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
33456775|NCT00094458|62831441|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
33456776|NCT00094458|62831442|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
33456777|NCT00094458|62831443|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
33524310|NCT02781506|62911229|FG000|Overall Study|Adverse Event|5|||
33524311|NCT03132753|62911235|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
33524312|NCT03132753|62911236|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
33524313|NCT03132753|62911235|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
33524314|NCT03132753|62911236|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
33524315|NCT01468454|62911242|FG000|Overall Study|Did not have surgery after PET|9|||
33524316|NCT03067077|62911247|FG000|Overall Study|Did not receive surgery|4|||
33524317|NCT03067077|62911248|FG001|Overall Study|Did not receive surgery|5|||
33524318|NCT03067077|62911247|FG000|Overall Study|Lost to Follow-up|3|||
33618273|NCT01177397|63019465|FG010|Overall Study|Protocol Violation|0|||
33618274|NCT01177397|63019466|FG011|Overall Study|Protocol Violation|0|||
33524319|NCT03067077|62911248|FG001|Overall Study|Lost to Follow-up|2|||
33524320|NCT03096847|62911257|FG000|Overall Study|Other|2|||
33524321|NCT03096847|62911258|FG001|Overall Study|Other|1|||
33524322|NCT03096847|62911259|FG002|Overall Study|Other|2|||
33524323|NCT03096847|62911257|FG000|Overall Study|Lost to Follow-up|1|||
33524324|NCT03096847|62911258|FG001|Overall Study|Lost to Follow-up|0|||
33524325|NCT03096847|62911259|FG002|Overall Study|Lost to Follow-up|1|||
33524326|NCT03096847|62911257|FG000|Overall Study|Death|6|||
33524327|NCT03096847|62911258|FG001|Overall Study|Death|0|||
33618275|NCT01177397|63019455|FG000|Overall Study|Lost to Follow-up|0|||
33618276|NCT01177397|63019456|FG001|Overall Study|Lost to Follow-up|0|||
33618277|NCT01177397|63019457|FG002|Overall Study|Lost to Follow-up|0|||
33618278|NCT01177397|63019458|FG003|Overall Study|Lost to Follow-up|0|||
33618279|NCT01177397|63019459|FG004|Overall Study|Lost to Follow-up|1|||
33618280|NCT01177397|63019460|FG005|Overall Study|Lost to Follow-up|0|||
33618281|NCT01177397|63019461|FG006|Overall Study|Lost to Follow-up|0|||
33618282|NCT01177397|63019462|FG007|Overall Study|Lost to Follow-up|2|||
33618283|NCT01177397|63019463|FG008|Overall Study|Lost to Follow-up|0|||
33618284|NCT01177397|63019464|FG009|Overall Study|Lost to Follow-up|0|||
33618285|NCT01177397|63019465|FG010|Overall Study|Lost to Follow-up|0|||
33618286|NCT01177397|63019466|FG011|Overall Study|Lost to Follow-up|0|||
33618287|NCT01177397|63019455|FG000|Overall Study|Death|0|||
33618288|NCT01177397|63019456|FG001|Overall Study|Death|0|||
33618289|NCT01177397|63019457|FG002|Overall Study|Death|1|||
33618290|NCT01177397|63019458|FG003|Overall Study|Death|1|||
33618291|NCT01177397|63019459|FG004|Overall Study|Death|0|||
33618292|NCT01177397|63019460|FG005|Overall Study|Death|0|||
33618293|NCT01177397|63019461|FG006|Overall Study|Death|0|||
33618294|NCT01177397|63019462|FG007|Overall Study|Death|5|||
33618295|NCT01177397|63019463|FG008|Overall Study|Death|2|||
33618296|NCT01177397|63019464|FG009|Overall Study|Death|1|||
33618297|NCT01177397|63019465|FG010|Overall Study|Death|0|||
33618298|NCT01177397|63019466|FG011|Overall Study|Death|0|||
33618299|NCT01177397|63019455|FG000|Overall Study|Withdrawal by Subject|0|||
33618300|NCT01177397|63019456|FG001|Overall Study|Withdrawal by Subject|0|||
33618301|NCT01177397|63019457|FG002|Overall Study|Withdrawal by Subject|1|||
33618302|NCT01177397|63019458|FG003|Overall Study|Withdrawal by Subject|1|||
33618303|NCT01177397|63019459|FG004|Overall Study|Withdrawal by Subject|1|||
33618304|NCT01177397|63019460|FG005|Overall Study|Withdrawal by Subject|2|||
33618305|NCT01177397|63019461|FG006|Overall Study|Withdrawal by Subject|0|||
33618306|NCT01177397|63019462|FG007|Overall Study|Withdrawal by Subject|5|||
33456778|NCT00094458|62831444|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
33456779|NCT00094458|62831445|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
33456780|NCT00094458|62831446|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
33456781|NCT00094458|62831441|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
33456782|NCT00094458|62831442|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
33456783|NCT00094458|62831443|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
33456784|NCT00094458|62831444|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
33456785|NCT00094458|62831445|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
33618307|NCT01177397|63019463|FG008|Overall Study|Withdrawal by Subject|9|||
33618308|NCT01177397|63019464|FG009|Overall Study|Withdrawal by Subject|1|||
33524328|NCT03096847|62911259|FG002|Overall Study|Death|2|||
33618309|NCT01177397|63019465|FG010|Overall Study|Withdrawal by Subject|1|||
33456786|NCT00094458|62831446|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
33524329|NCT03096847|62911257|FG000|Overall Study|Protocol Violation|3|||
33524330|NCT03096847|62911258|FG001|Overall Study|Protocol Violation|0|||
33524331|NCT03096847|62911259|FG002|Overall Study|Protocol Violation|6|||
33618310|NCT01177397|63019466|FG011|Overall Study|Withdrawal by Subject|0|||
33618311|NCT01177397|63019455|FG000|Overall Study|Adverse Event|0|||
33618312|NCT01177397|63019456|FG001|Overall Study|Adverse Event|0|||
33618313|NCT01177397|63019457|FG002|Overall Study|Adverse Event|1|||
33618314|NCT01177397|63019458|FG003|Overall Study|Adverse Event|2|||
33618315|NCT01177397|63019459|FG004|Overall Study|Adverse Event|0|||
33618316|NCT01177397|63019460|FG005|Overall Study|Adverse Event|12|||
33618317|NCT01177397|63019461|FG006|Overall Study|Adverse Event|1|||
33618318|NCT01177397|63019462|FG007|Overall Study|Adverse Event|14|||
33618319|NCT01177397|63019463|FG008|Overall Study|Adverse Event|8|||
33618320|NCT01177397|63019464|FG009|Overall Study|Adverse Event|6|||
33618321|NCT01177397|63019465|FG010|Overall Study|Adverse Event|3|||
33618322|NCT01177397|63019466|FG011|Overall Study|Adverse Event|7|||
33618323|NCT01177397|63019455|FG000|Overall Study|Disease progression|1|||
33618324|NCT01177397|63019456|FG001|Overall Study|Disease progression|2|||
33618325|NCT01177397|63019457|FG002|Overall Study|Disease progression|5|||
33618326|NCT01177397|63019458|FG003|Overall Study|Disease progression|5|||
33618327|NCT01177397|63019459|FG004|Overall Study|Disease progression|4|||
33618328|NCT01177397|63019460|FG005|Overall Study|Disease progression|10|||
33618329|NCT01177397|63019461|FG006|Overall Study|Disease progression|10|||
33618330|NCT01177397|63019462|FG007|Overall Study|Disease progression|21|||
33524332|NCT03096847|62911257|FG000|Overall Study|Physician Decision|12|||
33524333|NCT03096847|62911258|FG001|Overall Study|Physician Decision|2|||
33524334|NCT03096847|62911259|FG002|Overall Study|Physician Decision|8|||
33524335|NCT03096847|62911257|FG000|Overall Study|Withdrawal by Subject|24|||
33524336|NCT03096847|62911258|FG001|Overall Study|Withdrawal by Subject|1|||
33524337|NCT03096847|62911259|FG002|Overall Study|Withdrawal by Subject|12|||
33524338|NCT03096847|62911257|FG000|Overall Study|Adverse Event|72|||
33524339|NCT03096847|62911258|FG001|Overall Study|Adverse Event|6|||
33524340|NCT03096847|62911259|FG002|Overall Study|Adverse Event|28|||
33524341|NCT03096847|62911257|FG000|Overall Study|Progressive disease|97|||
33524342|NCT03096847|62911258|FG001|Overall Study|Progressive disease|10|||
33524343|NCT03096847|62911259|FG002|Overall Study|Progressive disease|78|||
33524344|NCT03096847|62911257|FG000|Overall Study|Non-compliance with study medication|1|||
33524345|NCT03096847|62911258|FG001|Overall Study|Non-compliance with study medication|0|||
33524346|NCT03096847|62911259|FG002|Overall Study|Non-compliance with study medication|0|||
33524347|NCT03096847|62911257|FG000|Overall Study|New therapy for study indication|1|||
33524348|NCT03096847|62911258|FG001|Overall Study|New therapy for study indication|0|||
33524349|NCT03096847|62911259|FG002|Overall Study|New therapy for study indication|1|||
33524350|NCT01365182|62911278|FG000|Overall Study|Withdrawal by Subject|10|||
33524351|NCT01365182|62911279|FG001|Overall Study|Withdrawal by Subject|13|||
33524352|NCT01365182|62911280|FG002|Overall Study|Withdrawal by Subject|12|||
33524353|NCT03128099|62911298|FG000|Overall Study|High dose task was too long|0|||
33524354|NCT03128099|62911299|FG001|Overall Study|High dose task was too long|4|||
33524355|NCT03128099|62911300|FG002|Overall Study|High dose task was too long|0|||
33524356|NCT03128099|62911298|FG000|Overall Study|Participant got a full time job.|1|||
33524357|NCT03128099|62911299|FG001|Overall Study|Participant got a full time job.|0|||
33524358|NCT03128099|62911300|FG002|Overall Study|Participant got a full time job.|0|||
33618331|NCT01177397|63019463|FG008|Overall Study|Disease progression|18|||
33618332|NCT01177397|63019464|FG009|Overall Study|Disease progression|12|||
33618333|NCT01177397|63019465|FG010|Overall Study|Disease progression|10|||
33456787|NCT00094458|62831441|FG000|Main Study: Through Week 30|Adverse Event|38|||
33456788|NCT00094458|62831442|FG001|Main Study: Through Week 30|Adverse Event|20|||
33456789|NCT00094458|62831443|FG002|Main Study: Through Week 30|Adverse Event|28|||
33456790|NCT00094458|62831444|FG003|Main Study: Through Week 30|Adverse Event|0|||
33456791|NCT00094458|62831445|FG004|Main Study: Through Week 30|Adverse Event|0|||
33456792|NCT00094458|62831446|FG005|Main Study: Through Week 30|Adverse Event|0|||
33456793|NCT00094458|62831441|FG000|Main Study: Through Week 30|Death|1|||
33456794|NCT00094458|62831442|FG001|Main Study: Through Week 30|Death|0|||
33456795|NCT00094458|62831443|FG002|Main Study: Through Week 30|Death|0|||
33456796|NCT00094458|62831444|FG003|Main Study: Through Week 30|Death|0|||
33456797|NCT00094458|62831445|FG004|Main Study: Through Week 30|Death|0|||
33456798|NCT00094458|62831446|FG005|Main Study: Through Week 30|Death|0|||
33456799|NCT00094458|62831441|FG000|Main Study: Through Week 30|Other|19|||
33456800|NCT00094458|62831442|FG001|Main Study: Through Week 30|Other|16|||
33456801|NCT00094458|62831443|FG002|Main Study: Through Week 30|Other|9|||
33456802|NCT00094458|62831444|FG003|Main Study: Through Week 30|Other|0|||
33456803|NCT00094458|62831445|FG004|Main Study: Through Week 30|Other|0|||
33456804|NCT00094458|62831446|FG005|Main Study: Through Week 30|Other|0|||
33456805|NCT00094458|62831441|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
33524359|NCT03128099|62911298|FG000|Overall Study|Became homeless and lost contact|1|||
33618334|NCT01177397|63019466|FG011|Overall Study|Disease progression|8|||
33618335|NCT01177397|63019455|FG000|Overall Study|Other reasons|0|||
33618336|NCT01177397|63019456|FG001|Overall Study|Other reasons|0|||
33524360|NCT03128099|62911299|FG001|Overall Study|Became homeless and lost contact|0|||
33325243|NCT01214642|62701948|FG007|Overall Study|Withdrawal by Subject|0|||
33524361|NCT03128099|62911300|FG002|Overall Study|Became homeless and lost contact|0|||
33524362|NCT03128099|62911298|FG000|Overall Study|Did not complete all the assessments|0|||
33524363|NCT03128099|62911299|FG001|Overall Study|Did not complete all the assessments|0|||
33618337|NCT01177397|63019457|FG002|Overall Study|Other reasons|1|||
33456806|NCT00094458|62831442|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
33618338|NCT01177397|63019458|FG003|Overall Study|Other reasons|0|||
33618339|NCT01177397|63019459|FG004|Overall Study|Other reasons|1|||
33618340|NCT01177397|63019460|FG005|Overall Study|Other reasons|1|||
33618341|NCT01177397|63019461|FG006|Overall Study|Other reasons|2|||
33618342|NCT01177397|63019462|FG007|Overall Study|Other reasons|6|||
33618343|NCT01177397|63019463|FG008|Overall Study|Other reasons|10|||
33618344|NCT01177397|63019464|FG009|Overall Study|Other reasons|8|||
33618345|NCT01177397|63019465|FG010|Overall Study|Other reasons|0|||
33618346|NCT01177397|63019466|FG011|Overall Study|Other reasons|2|||
33618347|NCT00864227|63019507|FG000|Overall Study|Withdrawal by Subject|1|||
33618348|NCT00864227|63019507|FG000|Overall Study|Disease Relapse/Progression|3|||
33618349|NCT02102204|63019511|FG000|Overall Study|Withdrawal by Subject|137|||
33618350|NCT02102204|63019511|FG000|Overall Study|Death|92|||
33618351|NCT02102204|63019511|FG000|Overall Study|Lost to Follow-up|65|||
33618352|NCT02102204|63019511|FG000|Overall Study|Sponsor Decision|5|||
33618353|NCT02102204|63019511|FG000|Overall Study|Ongoing|5|||
33618354|NCT02141204|63019517|FG000|Overall Study|Lost to Follow-up|2|||
33618355|NCT02141204|63019518|FG001|Overall Study|Lost to Follow-up|1|||
33618356|NCT02141204|63019517|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
33618357|NCT02141204|63019518|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
33618358|NCT02141204|63019517|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
33618359|NCT02141204|63019518|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
33618360|NCT02141204|63019517|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
33618361|NCT02141204|63019518|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
33618362|NCT02140970|63019526|FG000|Overall Study|Lost to Follow-up|1|||
33618363|NCT02140970|63019527|FG001|Overall Study|Lost to Follow-up|2|||
33618364|NCT02140970|63019526|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
33618365|NCT02140970|63019527|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
33618366|NCT02140970|63019526|FG000|Overall Study|Did not meet inclusion criteria|0|||
33524364|NCT03128099|62911300|FG002|Overall Study|Did not complete all the assessments|1|||
33524365|NCT02886494|62911308|FG000|Overall Study|Adverse Event|1|||
33524366|NCT02886494|62911309|FG001|Overall Study|Adverse Event|0|||
33524367|NCT02886494|62911308|FG000|Overall Study|Withdrawal by Subject|12|||
33618367|NCT02140970|63019527|FG001|Overall Study|Did not meet inclusion criteria|1|||
33618368|NCT02101112|63019533|FG000|Overall Study|Adverse Event|0|||
33618369|NCT02101112|63019534|FG001|Overall Study|Adverse Event|0|||
33618370|NCT02101112|63019535|FG002|Overall Study|Adverse Event|1|||
33618371|NCT02101112|63019536|FG003|Overall Study|Adverse Event|0|||
33618372|NCT02101112|63019537|FG004|Overall Study|Adverse Event|0|||
33618373|NCT02101112|63019538|FG005|Overall Study|Adverse Event|0|||
33618374|NCT02101112|63019533|FG000|Overall Study|Withdrawal by Subject|0|||
33618375|NCT02101112|63019534|FG001|Overall Study|Withdrawal by Subject|0|||
33618376|NCT02101112|63019535|FG002|Overall Study|Withdrawal by Subject|0|||
33618377|NCT02101112|63019536|FG003|Overall Study|Withdrawal by Subject|0|||
33618378|NCT02101112|63019537|FG004|Overall Study|Withdrawal by Subject|1|||
33618379|NCT02101112|63019538|FG005|Overall Study|Withdrawal by Subject|0|||
33618380|NCT02139644|63019553|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
33618381|NCT02139644|63019554|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33618382|NCT02139644|63019555|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33618383|NCT02139644|63019556|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33618384|NCT02139644|63019557|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33618385|NCT02139644|63019558|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33618386|NCT02139644|63019553|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
33618387|NCT02139644|63019554|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33618388|NCT02139644|63019555|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33618389|NCT02139644|63019556|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33524368|NCT02886494|62911309|FG001|Overall Study|Withdrawal by Subject|3|||
33524369|NCT02886494|62911308|FG000|Overall Study|Protocol Violation|4|||
33524370|NCT02886494|62911309|FG001|Overall Study|Protocol Violation|1|||
33524371|NCT02846532|62911321|FG000|Overall Study|Lost to Follow-up|0|||
33618390|NCT02139644|63019557|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33618391|NCT02139644|63019558|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33618392|NCT02139644|63019553|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
33618393|NCT02139644|63019554|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33618394|NCT02139644|63019555|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33618395|NCT02139644|63019556|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33618396|NCT02139644|63019557|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33618397|NCT02139644|63019558|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33618398|NCT02139644|63019553|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
33618399|NCT02139644|63019554|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33618400|NCT02139644|63019555|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33524372|NCT02846532|62911322|FG001|Overall Study|Lost to Follow-up|1|||
33524373|NCT02846532|62911323|FG002|Overall Study|Lost to Follow-up|1|||
33524374|NCT02846532|62911321|FG000|Overall Study|Withdrawal by Subject|1|||
33524375|NCT02846532|62911322|FG001|Overall Study|Withdrawal by Subject|2|||
33524376|NCT02846532|62911323|FG002|Overall Study|Withdrawal by Subject|0|||
33524377|NCT00842348|62911342|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
33524378|NCT00842348|62911343|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
33524379|NCT00842348|62911342|FG000|Study 729|Disease progression/death|19|||
33524380|NCT00842348|62911343|FG001|Study 729|Disease progression/death|30|||
33524381|NCT00842348|62911342|FG000|Study 729|Adverse Event|1|||
33524382|NCT00842348|62911343|FG001|Study 729|Adverse Event|1|||
33524383|NCT00842348|62911342|FG000|Study 729|Protocol Violation|1|||
33524384|NCT00842348|62911343|FG001|Study 729|Protocol Violation|1|||
33524385|NCT00842348|62911342|FG000|Study 729|Withdrawal by Subject|2|||
33524386|NCT00842348|62911343|FG001|Study 729|Withdrawal by Subject|4|||
33524387|NCT00842348|62911342|FG000|Study 729|Due to Sponsor stopping the study|1|||
33524388|NCT00842348|62911343|FG001|Study 729|Due to Sponsor stopping the study|1|||
33524389|NCT00842348|62911342|FG000|Study 729|Due to non-availability of IP|0|||
33524390|NCT00842348|62911343|FG001|Study 729|Due to non-availability of IP|1|||
33524391|NCT00842348|62911342|FG000|Study 729|Sponsor's decision|1|||
33524392|NCT00842348|62911343|FG001|Study 729|Sponsor's decision|0|||
33524393|NCT00842348|62911342|FG000|Study 729|Surgical resection|1|||
33524394|NCT00842348|62911343|FG001|Study 729|Surgical resection|0|||
33524395|NCT03095599|62911355|FG000|Overall Study|Withdrawal by Subject|1|||
33524396|NCT03095599|62911356|FG001|Overall Study|Withdrawal by Subject|0|||
33524397|NCT03095599|62911355|FG000|Overall Study|Lost to Follow-up|1|||
33524398|NCT03095599|62911356|FG001|Overall Study|Lost to Follow-up|0|||
33524399|NCT03095599|62911355|FG000|Overall Study|Withdrawal prior to vaccination|1|||
33524400|NCT03095599|62911356|FG001|Overall Study|Withdrawal prior to vaccination|0|||
33618401|NCT02139644|63019556|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33618402|NCT02139644|63019557|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33618403|NCT02139644|63019558|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33618404|NCT02139644|63019553|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
33618405|NCT02139644|63019554|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33618406|NCT02139644|63019555|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33524401|NCT03095521|62911366|FG000|Overall Study|Withdrawal by Subject|0|||
33524402|NCT03095521|62911367|FG001|Overall Study|Withdrawal by Subject|1|||
33618407|NCT02139644|63019556|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33618408|NCT02139644|63019557|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33618409|NCT02139644|63019558|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33618410|NCT02139644|63019553|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
33618411|NCT02139644|63019554|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
33618412|NCT02139644|63019555|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
33618413|NCT02139644|63019556|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
33524403|NCT03095521|62911366|FG000|Overall Study|Lost to Follow-up|0|||
33524404|NCT03095521|62911367|FG001|Overall Study|Lost to Follow-up|1|||
33524405|NCT03033875|62911376|FG000|Overall Study|Withdrawal by Subject|5|||
33524406|NCT03033875|62911377|FG001|Overall Study|Withdrawal by Subject|9|||
33524407|NCT03033875|62911378|FG002|Overall Study|Withdrawal by Subject|4|||
33524408|NCT03033875|62911376|FG000|Overall Study|Other|14|||
33524409|NCT03033875|62911377|FG001|Overall Study|Other|15|||
33524410|NCT03033875|62911378|FG002|Overall Study|Other|8|||
33524411|NCT01968785|62911392|FG000|Overall Study|Withdrawal by Subject|1|||
33524412|NCT01968785|62911393|FG001|Overall Study|Withdrawal by Subject|0|||
33524413|NCT03095287|62911399|FG000|Overall Study|Treatment Failure|1|||
33524414|NCT03095287|62911399|FG000|Overall Study|Adverse Event|1|||
33524415|NCT02839746|62911417|FG000|Overall Study|Not met selection criteria|12|||
33524416|NCT00033293|62911423|FG000|Overall Study|Death|0|||
33524417|NCT00033293|62911424|FG001|Overall Study|Death|1|||
33524418|NCT00033293|62911423|FG000|Overall Study|Lack of Efficacy|5|||
33618414|NCT02139644|63019557|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
33618415|NCT02139644|63019558|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
33618416|NCT02139644|63019553|FG000|Run-In Period (Pre-assignment)|Other|6|||
33618417|NCT02139644|63019554|FG001|Run-In Period (Pre-assignment)|Other|0|||
33524419|NCT00033293|62911424|FG001|Overall Study|Lack of Efficacy|8|||
33524420|NCT00033293|62911423|FG000|Overall Study|Lost to Follow-up|0|||
33618418|NCT02139644|63019555|FG002|Run-In Period (Pre-assignment)|Other|0|||
33618419|NCT02139644|63019556|FG003|Run-In Period (Pre-assignment)|Other|0|||
33618420|NCT02139644|63019557|FG004|Run-In Period (Pre-assignment)|Other|0|||
33524421|NCT00033293|62911424|FG001|Overall Study|Lost to Follow-up|1|||
33524422|NCT00033293|62911423|FG000|Overall Study|Physician Decision|3|||
33524423|NCT00033293|62911424|FG001|Overall Study|Physician Decision|1|||
33524424|NCT00033293|62911423|FG000|Overall Study|Withdrawal by Subject|1|||
33524425|NCT00033293|62911424|FG001|Overall Study|Withdrawal by Subject|0|||
33524426|NCT00033293|62911423|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
33524427|NCT00033293|62911424|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
33524428|NCT00033293|62911423|FG000|Overall Study|Treatment refused|0|||
33524429|NCT00033293|62911424|FG001|Overall Study|Treatment refused|6|||
33524430|NCT02039674|62911446|FG000|Overall Study|Adverse Event|0|||
33524431|NCT02039674|62911447|FG001|Overall Study|Adverse Event|0|||
33524432|NCT02039674|62911448|FG002|Overall Study|Adverse Event|0|||
33524433|NCT02039674|62911449|FG003|Overall Study|Adverse Event|1|||
33524434|NCT02039674|62911450|FG004|Overall Study|Adverse Event|0|||
33524435|NCT02039674|62911451|FG005|Overall Study|Adverse Event|0|||
33524436|NCT02039674|62911452|FG006|Overall Study|Adverse Event|0|||
33524437|NCT02039674|62911453|FG007|Overall Study|Adverse Event|0|||
33524438|NCT02039674|62911454|FG008|Overall Study|Adverse Event|2|||
33524439|NCT02039674|62911455|FG009|Overall Study|Adverse Event|1|||
33524440|NCT02039674|62911456|FG010|Overall Study|Adverse Event|0|||
33524441|NCT02039674|62911457|FG011|Overall Study|Adverse Event|2|||
33524442|NCT02039674|62911458|FG012|Overall Study|Adverse Event|3|||
33524443|NCT02039674|62911459|FG013|Overall Study|Adverse Event|1|||
33524444|NCT02039674|62911446|FG000|Overall Study|Death|2|||
33524445|NCT02039674|62911447|FG001|Overall Study|Death|0|||
33524446|NCT02039674|62911448|FG002|Overall Study|Death|2|||
33524447|NCT02039674|62911449|FG003|Overall Study|Death|3|||
33524448|NCT02039674|62911450|FG004|Overall Study|Death|0|||
33524449|NCT02039674|62911451|FG005|Overall Study|Death|0|||
33524450|NCT02039674|62911452|FG006|Overall Study|Death|1|||
33524451|NCT02039674|62911453|FG007|Overall Study|Death|0|||
33524452|NCT02039674|62911454|FG008|Overall Study|Death|2|||
33524453|NCT02039674|62911455|FG009|Overall Study|Death|0|||
33524454|NCT02039674|62911456|FG010|Overall Study|Death|1|||
33524455|NCT02039674|62911457|FG011|Overall Study|Death|3|||
33524456|NCT02039674|62911458|FG012|Overall Study|Death|2|||
33524457|NCT02039674|62911459|FG013|Overall Study|Death|8|||
33524458|NCT02039674|62911446|FG000|Overall Study|Excluded Medication|1|||
33524459|NCT02039674|62911447|FG001|Overall Study|Excluded Medication|1|||
33524460|NCT02039674|62911448|FG002|Overall Study|Excluded Medication|0|||
33524461|NCT02039674|62911449|FG003|Overall Study|Excluded Medication|1|||
33524462|NCT02039674|62911450|FG004|Overall Study|Excluded Medication|0|||
33524463|NCT02039674|62911451|FG005|Overall Study|Excluded Medication|1|||
33524464|NCT02039674|62911452|FG006|Overall Study|Excluded Medication|0|||
33524465|NCT02039674|62911453|FG007|Overall Study|Excluded Medication|0|||
33524466|NCT02039674|62911454|FG008|Overall Study|Excluded Medication|2|||
33524467|NCT02039674|62911455|FG009|Overall Study|Excluded Medication|3|||
33524468|NCT02039674|62911456|FG010|Overall Study|Excluded Medication|5|||
33524469|NCT02039674|62911457|FG011|Overall Study|Excluded Medication|6|||
33524470|NCT02039674|62911458|FG012|Overall Study|Excluded Medication|8|||
33524471|NCT02039674|62911459|FG013|Overall Study|Excluded Medication|3|||
33524472|NCT02039674|62911446|FG000|Overall Study|Lost to Follow-up|0|||
33524473|NCT02039674|62911447|FG001|Overall Study|Lost to Follow-up|0|||
33524474|NCT02039674|62911448|FG002|Overall Study|Lost to Follow-up|0|||
33524475|NCT02039674|62911449|FG003|Overall Study|Lost to Follow-up|0|||
33524476|NCT02039674|62911450|FG004|Overall Study|Lost to Follow-up|1|||
33524477|NCT02039674|62911451|FG005|Overall Study|Lost to Follow-up|1|||
33524478|NCT02039674|62911452|FG006|Overall Study|Lost to Follow-up|0|||
33524479|NCT02039674|62911453|FG007|Overall Study|Lost to Follow-up|0|||
33524480|NCT02039674|62911454|FG008|Overall Study|Lost to Follow-up|0|||
33524481|NCT02039674|62911455|FG009|Overall Study|Lost to Follow-up|0|||
33524482|NCT02039674|62911456|FG010|Overall Study|Lost to Follow-up|0|||
33524483|NCT02039674|62911457|FG011|Overall Study|Lost to Follow-up|2|||
33524484|NCT02039674|62911458|FG012|Overall Study|Lost to Follow-up|2|||
33524485|NCT02039674|62911459|FG013|Overall Study|Lost to Follow-up|1|||
33524486|NCT02039674|62911446|FG000|Overall Study|Physician Decision|0|||
33325244|NCT01214642|62701949|FG008|Overall Study|Withdrawal by Subject|3|||
33325245|NCT01214642|62701950|FG009|Overall Study|Withdrawal by Subject|1|||
33325246|NCT01214642|62701951|FG010|Overall Study|Withdrawal by Subject|1|||
33524487|NCT02039674|62911447|FG001|Overall Study|Physician Decision|0|||
33524488|NCT02039674|62911448|FG002|Overall Study|Physician Decision|0|||
33325247|NCT01214642|62701952|FG011|Overall Study|Withdrawal by Subject|0|||
33524489|NCT02039674|62911449|FG003|Overall Study|Physician Decision|0|||
33524490|NCT02039674|62911450|FG004|Overall Study|Physician Decision|0|||
33524491|NCT02039674|62911451|FG005|Overall Study|Physician Decision|0|||
33524492|NCT02039674|62911452|FG006|Overall Study|Physician Decision|0|||
33524493|NCT02039674|62911453|FG007|Overall Study|Physician Decision|0|||
33524494|NCT02039674|62911454|FG008|Overall Study|Physician Decision|0|||
33524495|NCT02039674|62911455|FG009|Overall Study|Physician Decision|0|||
33524496|NCT02039674|62911456|FG010|Overall Study|Physician Decision|0|||
33524497|NCT02039674|62911457|FG011|Overall Study|Physician Decision|1|||
33524498|NCT02039674|62911458|FG012|Overall Study|Physician Decision|1|||
33524499|NCT02039674|62911459|FG013|Overall Study|Physician Decision|0|||
33524500|NCT02039674|62911446|FG000|Overall Study|Progressive Disease|8|||
33524501|NCT02039674|62911447|FG001|Overall Study|Progressive Disease|8|||
33524502|NCT02039674|62911448|FG002|Overall Study|Progressive Disease|6|||
33524503|NCT02039674|62911449|FG003|Overall Study|Progressive Disease|7|||
33524504|NCT02039674|62911450|FG004|Overall Study|Progressive Disease|9|||
33524505|NCT02039674|62911451|FG005|Overall Study|Progressive Disease|10|||
33524506|NCT02039674|62911452|FG006|Overall Study|Progressive Disease|1|||
33524507|NCT02039674|62911453|FG007|Overall Study|Progressive Disease|3|||
33524508|NCT02039674|62911454|FG008|Overall Study|Progressive Disease|6|||
33524509|NCT02039674|62911455|FG009|Overall Study|Progressive Disease|4|||
33524510|NCT02039674|62911456|FG010|Overall Study|Progressive Disease|0|||
33524511|NCT02039674|62911457|FG011|Overall Study|Progressive Disease|34|||
33524512|NCT02039674|62911458|FG012|Overall Study|Progressive Disease|34|||
33524513|NCT02039674|62911459|FG013|Overall Study|Progressive Disease|18|||
33524514|NCT02039674|62911446|FG000|Overall Study|Withdrawal by Subject|1|||
33524515|NCT02039674|62911447|FG001|Overall Study|Withdrawal by Subject|2|||
33524516|NCT02039674|62911448|FG002|Overall Study|Withdrawal by Subject|3|||
33524517|NCT02039674|62911449|FG003|Overall Study|Withdrawal by Subject|0|||
33524518|NCT02039674|62911450|FG004|Overall Study|Withdrawal by Subject|1|||
33524519|NCT02039674|62911451|FG005|Overall Study|Withdrawal by Subject|0|||
33524520|NCT02039674|62911452|FG006|Overall Study|Withdrawal by Subject|0|||
33524521|NCT02039674|62911453|FG007|Overall Study|Withdrawal by Subject|0|||
33618421|NCT02139644|63019558|FG005|Run-In Period (Pre-assignment)|Other|0|||
33618422|NCT02139644|63019553|FG000|Treatment Period|Adverse Event|0|||
33618423|NCT02139644|63019554|FG001|Treatment Period|Adverse Event|0|||
33618424|NCT02139644|63019555|FG002|Treatment Period|Adverse Event|3|||
33618425|NCT02139644|63019556|FG003|Treatment Period|Adverse Event|2|||
33618426|NCT02139644|63019557|FG004|Treatment Period|Adverse Event|1|||
33618427|NCT02139644|63019558|FG005|Treatment Period|Adverse Event|6|||
33618428|NCT02139644|63019553|FG000|Treatment Period|Withdrawal by Subject|0|||
33618429|NCT02139644|63019554|FG001|Treatment Period|Withdrawal by Subject|0|||
33618430|NCT02139644|63019555|FG002|Treatment Period|Withdrawal by Subject|2|||
33618431|NCT02139644|63019556|FG003|Treatment Period|Withdrawal by Subject|2|||
33618432|NCT02139644|63019557|FG004|Treatment Period|Withdrawal by Subject|3|||
33618433|NCT02139644|63019558|FG005|Treatment Period|Withdrawal by Subject|2|||
33618434|NCT02139644|63019553|FG000|Treatment Period|Non-compliance|0|||
33618435|NCT02139644|63019554|FG001|Treatment Period|Non-compliance|0|||
33618436|NCT02139644|63019555|FG002|Treatment Period|Non-compliance|0|||
33618437|NCT02139644|63019556|FG003|Treatment Period|Non-compliance|1|||
33618438|NCT02139644|63019557|FG004|Treatment Period|Non-compliance|0|||
33618439|NCT02139644|63019558|FG005|Treatment Period|Non-compliance|0|||
33618440|NCT02139644|63019553|FG000|Treatment Period|Protocol Violation|0|||
33618441|NCT02139644|63019554|FG001|Treatment Period|Protocol Violation|0|||
33618442|NCT02139644|63019555|FG002|Treatment Period|Protocol Violation|0|||
33618443|NCT02139644|63019556|FG003|Treatment Period|Protocol Violation|1|||
33618444|NCT02139644|63019557|FG004|Treatment Period|Protocol Violation|1|||
33618445|NCT02139644|63019558|FG005|Treatment Period|Protocol Violation|1|||
33618446|NCT02139644|63019553|FG000|Treatment Period|Disease progression|0|||
33618447|NCT02139644|63019554|FG001|Treatment Period|Disease progression|0|||
33618448|NCT02139644|63019555|FG002|Treatment Period|Disease progression|0|||
33618449|NCT02139644|63019556|FG003|Treatment Period|Disease progression|1|||
33618450|NCT02139644|63019557|FG004|Treatment Period|Disease progression|1|||
33618451|NCT02139644|63019558|FG005|Treatment Period|Disease progression|2|||
33618452|NCT02139644|63019553|FG000|Treatment Period|Lost to Follow-up|0|||
33618453|NCT02139644|63019554|FG001|Treatment Period|Lost to Follow-up|0|||
33618454|NCT02139644|63019555|FG002|Treatment Period|Lost to Follow-up|1|||
33618455|NCT02139644|63019556|FG003|Treatment Period|Lost to Follow-up|1|||
33618456|NCT02139644|63019557|FG004|Treatment Period|Lost to Follow-up|1|||
33618457|NCT02139644|63019558|FG005|Treatment Period|Lost to Follow-up|1|||
33618458|NCT02139644|63019553|FG000|Treatment Period|Lack of Efficacy|0|||
33618459|NCT02139644|63019554|FG001|Treatment Period|Lack of Efficacy|0|||
33618460|NCT02139644|63019555|FG002|Treatment Period|Lack of Efficacy|1|||
33456807|NCT00094458|62831443|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
33456808|NCT00094458|62831444|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
33456809|NCT00094458|62831445|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
33456810|NCT00094458|62831446|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
33456811|NCT00094458|62831441|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
33456812|NCT00094458|62831442|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
33456813|NCT00094458|62831443|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
33456814|NCT00094458|62831444|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
33456815|NCT00094458|62831445|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
33456816|NCT00094458|62831446|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
33456817|NCT00094458|62831441|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
33456818|NCT00094458|62831442|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
33456819|NCT00094458|62831443|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
33524522|NCT02039674|62911454|FG008|Overall Study|Withdrawal by Subject|0|||
33618461|NCT02139644|63019556|FG003|Treatment Period|Lack of Efficacy|0|||
33618462|NCT02139644|63019557|FG004|Treatment Period|Lack of Efficacy|1|||
33618463|NCT02139644|63019558|FG005|Treatment Period|Lack of Efficacy|4|||
33618464|NCT02139644|63019553|FG000|Treatment Period|Other|0|||
33618465|NCT02139644|63019554|FG001|Treatment Period|Other|3|||
33618466|NCT02139644|63019555|FG002|Treatment Period|Other|1|||
33618467|NCT02139644|63019556|FG003|Treatment Period|Other|1|||
33618468|NCT02139644|63019557|FG004|Treatment Period|Other|0|||
33618469|NCT02139644|63019558|FG005|Treatment Period|Other|1|||
33618470|NCT02100644|63019570|FG000|LTG Escalation Phase|Adverse Event|9|||
33618471|NCT02100644|63019571|FG001|LTG Escalation Phase|Adverse Event|0|||
33618472|NCT02100644|63019572|FG002|LTG Escalation Phase|Adverse Event|0|||
33618473|NCT02100644|63019570|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
33618474|NCT02100644|63019571|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
33618475|NCT02100644|63019572|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
33618476|NCT02100644|63019570|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
33618477|NCT02100644|63019571|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
33618478|NCT02100644|63019572|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
33618479|NCT02074982|63019578|FG000|Overall Study|Adverse Event|15|||
33618480|NCT02074982|63019579|FG001|Overall Study|Adverse Event|7|||
33618481|NCT02074982|63019578|FG000|Overall Study|Lack of Efficacy|6|||
33618482|NCT02074982|63019579|FG001|Overall Study|Lack of Efficacy|1|||
33618483|NCT02074982|63019578|FG000|Overall Study|Lost to Follow-up|9|||
33618484|NCT02074982|63019579|FG001|Overall Study|Lost to Follow-up|10|||
33618485|NCT02074982|63019578|FG000|Overall Study|Non-compliance with study treatment|0|||
33618486|NCT02074982|63019579|FG001|Overall Study|Non-compliance with study treatment|2|||
33618487|NCT02074982|63019578|FG000|Overall Study|Physician Decision|1|||
33618488|NCT02074982|63019579|FG001|Overall Study|Physician Decision|1|||
33618489|NCT02074982|63019578|FG000|Overall Study|Pregnancy|1|||
33618490|NCT02074982|63019579|FG001|Overall Study|Pregnancy|2|||
33524523|NCT02039674|62911455|FG009|Overall Study|Withdrawal by Subject|1|||
33524524|NCT02039674|62911456|FG010|Overall Study|Withdrawal by Subject|1|||
33524525|NCT02039674|62911457|FG011|Overall Study|Withdrawal by Subject|4|||
33524526|NCT02039674|62911458|FG012|Overall Study|Withdrawal by Subject|6|||
33524527|NCT02039674|62911459|FG013|Overall Study|Withdrawal by Subject|2|||
33524528|NCT02039674|62911446|FG000|Overall Study|Clinical Progression|0|||
33524529|NCT02039674|62911447|FG001|Overall Study|Clinical Progression|0|||
33524530|NCT02039674|62911448|FG002|Overall Study|Clinical Progression|0|||
33524531|NCT02039674|62911449|FG003|Overall Study|Clinical Progression|0|||
33524532|NCT02039674|62911450|FG004|Overall Study|Clinical Progression|0|||
33524533|NCT02039674|62911451|FG005|Overall Study|Clinical Progression|0|||
33524534|NCT02039674|62911452|FG006|Overall Study|Clinical Progression|1|||
33524535|NCT02039674|62911453|FG007|Overall Study|Clinical Progression|0|||
33524536|NCT02039674|62911454|FG008|Overall Study|Clinical Progression|0|||
33524537|NCT02039674|62911455|FG009|Overall Study|Clinical Progression|0|||
33524538|NCT02039674|62911456|FG010|Overall Study|Clinical Progression|0|||
33524539|NCT02039674|62911457|FG011|Overall Study|Clinical Progression|0|||
33524540|NCT02039674|62911458|FG012|Overall Study|Clinical Progression|1|||
33524541|NCT02039674|62911459|FG013|Overall Study|Clinical Progression|0|||
33524542|NCT02039674|62911446|FG000|Overall Study|Sponsor Decision|1|||
33524543|NCT02039674|62911447|FG001|Overall Study|Sponsor Decision|1|||
33524544|NCT02039674|62911448|FG002|Overall Study|Sponsor Decision|1|||
33524545|NCT02039674|62911449|FG003|Overall Study|Sponsor Decision|1|||
33524546|NCT02039674|62911450|FG004|Overall Study|Sponsor Decision|1|||
33524547|NCT02039674|62911451|FG005|Overall Study|Sponsor Decision|0|||
33524548|NCT02039674|62911452|FG006|Overall Study|Sponsor Decision|0|||
33524549|NCT02039674|62911453|FG007|Overall Study|Sponsor Decision|0|||
33524550|NCT02039674|62911454|FG008|Overall Study|Sponsor Decision|0|||
33524551|NCT02039674|62911455|FG009|Overall Study|Sponsor Decision|3|||
33524552|NCT02039674|62911456|FG010|Overall Study|Sponsor Decision|0|||
33524553|NCT02039674|62911457|FG011|Overall Study|Sponsor Decision|8|||
33524554|NCT02039674|62911458|FG012|Overall Study|Sponsor Decision|5|||
33524555|NCT02039674|62911459|FG013|Overall Study|Sponsor Decision|0|||
33524556|NCT02039674|62911446|FG000|Overall Study|Other|0|||
33524557|NCT02039674|62911447|FG001|Overall Study|Other|0|||
33524558|NCT02039674|62911448|FG002|Overall Study|Other|0|||
33618491|NCT02074982|63019578|FG000|Overall Study|Protocol deviation|4|||
33618492|NCT02074982|63019579|FG001|Overall Study|Protocol deviation|3|||
33618493|NCT02074982|63019578|FG000|Overall Study|Technical problems|0|||
33618494|NCT02074982|63019579|FG001|Overall Study|Technical problems|2|||
33325248|NCT01214642|62701941|FG000|Overall Study|Physician Decision|0|||
33524559|NCT02039674|62911449|FG003|Overall Study|Other|0|||
33524560|NCT02039674|62911450|FG004|Overall Study|Other|0|||
33524561|NCT02039674|62911451|FG005|Overall Study|Other|0|||
33524562|NCT02039674|62911452|FG006|Overall Study|Other|0|||
33524563|NCT02039674|62911453|FG007|Overall Study|Other|0|||
33524564|NCT02039674|62911454|FG008|Overall Study|Other|0|||
33524565|NCT02039674|62911455|FG009|Overall Study|Other|0|||
33524566|NCT02039674|62911456|FG010|Overall Study|Other|0|||
33524567|NCT02039674|62911457|FG011|Overall Study|Other|0|||
33618495|NCT02074982|63019578|FG000|Overall Study|Subject/guardian decision|15|||
33524568|NCT02039674|62911458|FG012|Overall Study|Other|1|||
33524569|NCT02039674|62911459|FG013|Overall Study|Other|0|||
33524570|NCT03126227|62911499|FG000|Overall Study|Adverse Event|43|||
33524571|NCT03126227|62911500|FG001|Overall Study|Adverse Event|4|||
33524572|NCT03126227|62911499|FG000|Overall Study|Death|0|||
33524573|NCT03126227|62911500|FG001|Overall Study|Death|1|||
33524574|NCT03126227|62911499|FG000|Overall Study|Lost to Follow-up|0|||
33524575|NCT03126227|62911500|FG001|Overall Study|Lost to Follow-up|1|||
33524576|NCT03126227|62911499|FG000|Overall Study|Physician Decision|2|||
33524577|NCT03126227|62911500|FG001|Overall Study|Physician Decision|0|||
33524578|NCT03126227|62911499|FG000|Overall Study|Protocol Violation|1|||
33524579|NCT03126227|62911500|FG001|Overall Study|Protocol Violation|0|||
33524580|NCT03126227|62911499|FG000|Overall Study|Withdrawal by Subject|19|||
33524581|NCT03126227|62911500|FG001|Overall Study|Withdrawal by Subject|3|||
33524582|NCT03126227|62911499|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
33524583|NCT03126227|62911500|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
33524584|NCT03126227|62911499|FG000|Overall Study|Lack of dosing compliance|2|||
33524585|NCT03126227|62911500|FG001|Overall Study|Lack of dosing compliance|0|||
33524586|NCT03126227|62911499|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
33524587|NCT03126227|62911500|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
33524588|NCT03126227|62911499|FG000|Overall Study|Scheduling conflict|1|||
33524589|NCT03126227|62911500|FG001|Overall Study|Scheduling conflict|0|||
33524590|NCT03099187|62911508|FG000|Double-blind Treatment|Adverse Event|19|||
33524591|NCT03099187|62911509|FG001|Double-blind Treatment|Adverse Event|1|||
33524592|NCT03099187|62911510|FG002|Double-blind Treatment|Adverse Event|0|||
33524593|NCT03099187|62911511|FG003|Double-blind Treatment|Adverse Event|0|||
33524594|NCT03099187|62911508|FG000|Double-blind Treatment|Death|1|||
33524595|NCT03099187|62911509|FG001|Double-blind Treatment|Death|3|||
33524596|NCT03099187|62911510|FG002|Double-blind Treatment|Death|0|||
33524597|NCT03099187|62911511|FG003|Double-blind Treatment|Death|0|||
33524598|NCT03099187|62911508|FG000|Double-blind Treatment|Lack of Efficacy|1|||
33524599|NCT03099187|62911509|FG001|Double-blind Treatment|Lack of Efficacy|0|||
33524600|NCT03099187|62911510|FG002|Double-blind Treatment|Lack of Efficacy|0|||
33524601|NCT03099187|62911511|FG003|Double-blind Treatment|Lack of Efficacy|0|||
33524602|NCT03099187|62911508|FG000|Double-blind Treatment|Physician Decision|2|||
33524603|NCT03099187|62911509|FG001|Double-blind Treatment|Physician Decision|1|||
33524604|NCT03099187|62911510|FG002|Double-blind Treatment|Physician Decision|0|||
33524605|NCT03099187|62911511|FG003|Double-blind Treatment|Physician Decision|0|||
33524606|NCT03099187|62911508|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
33524607|NCT03099187|62911509|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
33524608|NCT03099187|62911510|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
33524609|NCT03099187|62911511|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
33524610|NCT03099187|62911508|FG000|Double-blind Treatment|Lung transplantation|0|||
33524611|NCT03099187|62911509|FG001|Double-blind Treatment|Lung transplantation|1|||
33524612|NCT03099187|62911510|FG002|Double-blind Treatment|Lung transplantation|0|||
33524613|NCT03099187|62911511|FG003|Double-blind Treatment|Lung transplantation|0|||
33524614|NCT03099187|62911508|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
33524615|NCT03099187|62911509|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
33524616|NCT03099187|62911510|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
33524617|NCT03099187|62911511|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
33524618|NCT03099187|62911508|FG000|Double-blind Treatment|Disease progression|0|||
33524619|NCT03099187|62911509|FG001|Double-blind Treatment|Disease progression|1|||
33524620|NCT03099187|62911510|FG002|Double-blind Treatment|Disease progression|0|||
33524621|NCT03099187|62911511|FG003|Double-blind Treatment|Disease progression|0|||
33524622|NCT03099187|62911508|FG000|Double-blind Treatment|Randomization error|0|||
33524623|NCT03099187|62911509|FG001|Double-blind Treatment|Randomization error|2|||
33524624|NCT03099187|62911510|FG002|Double-blind Treatment|Randomization error|0|||
33524625|NCT03099187|62911511|FG003|Double-blind Treatment|Randomization error|0|||
33524626|NCT03099187|62911508|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
33524627|NCT03099187|62911509|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
33524628|NCT03099187|62911510|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
33524629|NCT03099187|62911511|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
33524630|NCT03099187|62911508|FG000|12-month Safety Follow-up|Adverse Event|0|||
33524631|NCT03099187|62911509|FG001|12-month Safety Follow-up|Adverse Event|0|||
33524632|NCT03099187|62911510|FG002|12-month Safety Follow-up|Adverse Event|5|||
33524633|NCT03099187|62911511|FG003|12-month Safety Follow-up|Adverse Event|12|||
33524634|NCT03099187|62911508|FG000|12-month Safety Follow-up|Death|0|||
33524635|NCT03099187|62911509|FG001|12-month Safety Follow-up|Death|0|||
33524636|NCT03099187|62911510|FG002|12-month Safety Follow-up|Death|7|||
33524637|NCT03099187|62911511|FG003|12-month Safety Follow-up|Death|9|||
33524638|NCT03099187|62911508|FG000|12-month Safety Follow-up|Lung transplantation|0|||
33524639|NCT03099187|62911509|FG001|12-month Safety Follow-up|Lung transplantation|0|||
33524640|NCT03099187|62911510|FG002|12-month Safety Follow-up|Lung transplantation|2|||
33524641|NCT03099187|62911511|FG003|12-month Safety Follow-up|Lung transplantation|1|||
33524642|NCT03099187|62911508|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
33524643|NCT03099187|62911509|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
33524644|NCT03099187|62911510|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
33524645|NCT03099187|62911511|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
33524646|NCT03099187|62911508|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
33524647|NCT03099187|62911509|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
33618496|NCT02074982|63019579|FG001|Overall Study|Subject/guardian decision|24|||
33618497|NCT02074982|63019578|FG000|Overall Study|Death|0|||
33618498|NCT02074982|63019579|FG001|Overall Study|Death|2|||
33524648|NCT03099187|62911510|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
33524649|NCT03099187|62911511|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
33524650|NCT03099187|62911508|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
33524651|NCT03099187|62911509|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
33524652|NCT03099187|62911510|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
33524653|NCT03099187|62911511|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
33524654|NCT03099187|62911508|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
33524655|NCT03099187|62911509|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
33524656|NCT03099187|62911510|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
33524657|NCT03099187|62911511|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
33524658|NCT04535453|62911533|FG000|Overall Study|Death|0|||
33524659|NCT04535453|62911534|FG001|Overall Study|Death|1|||
33524660|NCT04535453|62911535|FG002|Overall Study|Death|0|||
33524661|NCT04535453|62911536|FG003|Overall Study|Death|0|||
33524662|NCT04535453|62911537|FG004|Overall Study|Death|0|||
33524663|NCT04535453|62911538|FG005|Overall Study|Death|0|||
33618499|NCT02074514|63019589|FG000|Overall Study|Lack of Efficacy|3|||
33618500|NCT02074514|63019590|FG001|Overall Study|Lack of Efficacy|2|||
33618501|NCT02074514|63019589|FG000|Overall Study|Lost to Follow-up|0|||
33618502|NCT02074514|63019590|FG001|Overall Study|Lost to Follow-up|1|||
33618503|NCT02074514|63019589|FG000|Overall Study|Withdrew Consent|0|||
33618504|NCT02074514|63019590|FG001|Overall Study|Withdrew Consent|1|||
33618505|NCT02099708|63019600|FG000|Overall Study|Data Not Available|30|||
33618506|NCT02099708|63019600|FG000|Overall Study|Lost to Follow-up|141|||
33618507|NCT02099708|63019600|FG000|Overall Study|Other|29|||
33618508|NCT02073656|63019604|FG000|Primary Study|Lost to Follow-up|6|||
33618509|NCT02073656|63019604|FG000|Primary Study|Death|1|||
33618510|NCT02073656|63019604|FG000|Primary Study|Withdrew Consent|1|||
33618511|NCT02242643|63019612|FG000|Overall Study|Protocol Violation|1|||
33618512|NCT02242643|63019613|FG001|Overall Study|Protocol Violation|2|||
33618513|NCT02242643|63019612|FG000|Overall Study|Withdrawal by Subject|15|||
33618514|NCT02242643|63019613|FG001|Overall Study|Withdrawal by Subject|10|||
33618515|NCT02242643|63019612|FG000|Overall Study|Migrated/moved from study area|1|||
33618516|NCT02242643|63019613|FG001|Overall Study|Migrated/moved from study area|3|||
33325249|NCT01214642|62701942|FG001|Overall Study|Physician Decision|0|||
33456820|NCT00094458|62831444|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
33456821|NCT00094458|62831445|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
33456822|NCT00094458|62831446|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
33456823|NCT00094458|62831441|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
33456824|NCT00094458|62831442|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
33456825|NCT00094458|62831443|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
33456826|NCT00094458|62831444|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
33456827|NCT00094458|62831445|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
33456828|NCT00094458|62831446|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
33456829|NCT00094458|62831441|FG000|OLE: Open-Label Extension|Adverse Event|0|||
33456830|NCT00094458|62831442|FG001|OLE: Open-Label Extension|Adverse Event|0|||
33456831|NCT00094458|62831443|FG002|OLE: Open-Label Extension|Adverse Event|0|||
33456832|NCT00094458|62831444|FG003|OLE: Open-Label Extension|Adverse Event|0|||
33456833|NCT00094458|62831445|FG004|OLE: Open-Label Extension|Adverse Event|3|||
33456834|NCT00094458|62831446|FG005|OLE: Open-Label Extension|Adverse Event|4|||
33456835|NCT00094458|62831441|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
33456836|NCT00094458|62831442|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
33456837|NCT00094458|62831443|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
33524664|NCT04535453|62911539|FG006|Overall Study|Death|0|||
33524665|NCT04535453|62911540|FG007|Overall Study|Death|0|||
33524666|NCT04535453|62911541|FG008|Overall Study|Death|0|||
33524667|NCT04535453|62911542|FG009|Overall Study|Death|0|||
33524668|NCT04535453|62911543|FG010|Overall Study|Death|0|||
33524669|NCT04535453|62911544|FG011|Overall Study|Death|0|||
33524670|NCT04535453|62911533|FG000|Overall Study|Lost to Follow-up|1|||
33618517|NCT02242643|63019612|FG000|Overall Study|Lost to Follow-up|54|||
33618518|NCT02242643|63019613|FG001|Overall Study|Lost to Follow-up|61|||
33618519|NCT02242643|63019612|FG000|Overall Study|Child placed in foster care by family|0|||
33618520|NCT02242643|63019613|FG001|Overall Study|Child placed in foster care by family|1|||
33618521|NCT02242643|63019612|FG000|Overall Study|Non-compliance|1|||
33618522|NCT02242643|63019613|FG001|Overall Study|Non-compliance|0|||
33618523|NCT02242643|63019612|FG000|Overall Study|Consent withdrawal by parent|1|||
33618524|NCT02242643|63019613|FG001|Overall Study|Consent withdrawal by parent|0|||
33618525|NCT02242643|63019612|FG000|Overall Study|Protocol requirements not followed|1|||
33618526|NCT02242643|63019613|FG001|Overall Study|Protocol requirements not followed|0|||
33618527|NCT02242643|63019612|FG000|Overall Study|Language barrier|1|||
33618528|NCT02242643|63019613|FG001|Overall Study|Language barrier|0|||
33618529|NCT02242643|63019612|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
33618530|NCT02242643|63019613|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
33618531|NCT02097290|63019621|FG000|Overall Study|Death|6|||
33618532|NCT02097290|63019621|FG000|Overall Study|Total Withdrawals|3|||
33618533|NCT02097290|63019621|FG000|Overall Study|Attempt|8|||
33618534|NCT02072174|63019627|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
33618535|NCT02072174|63019628|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
33524671|NCT04535453|62911534|FG001|Overall Study|Lost to Follow-up|1|||
33524672|NCT04535453|62911535|FG002|Overall Study|Lost to Follow-up|1|||
33524673|NCT04535453|62911536|FG003|Overall Study|Lost to Follow-up|0|||
33524674|NCT04535453|62911537|FG004|Overall Study|Lost to Follow-up|3|||
33524675|NCT04535453|62911538|FG005|Overall Study|Lost to Follow-up|1|||
33524676|NCT04535453|62911539|FG006|Overall Study|Lost to Follow-up|0|||
33524677|NCT04535453|62911540|FG007|Overall Study|Lost to Follow-up|0|||
33524678|NCT04535453|62911541|FG008|Overall Study|Lost to Follow-up|1|||
33524679|NCT04535453|62911542|FG009|Overall Study|Lost to Follow-up|1|||
33524680|NCT04535453|62911543|FG010|Overall Study|Lost to Follow-up|0|||
33524681|NCT04535453|62911544|FG011|Overall Study|Lost to Follow-up|0|||
33524682|NCT04535453|62911533|FG000|Overall Study|Physician Decision|0|||
33524683|NCT04535453|62911534|FG001|Overall Study|Physician Decision|0|||
33524684|NCT04535453|62911535|FG002|Overall Study|Physician Decision|0|||
33524685|NCT04535453|62911536|FG003|Overall Study|Physician Decision|1|||
33524686|NCT04535453|62911537|FG004|Overall Study|Physician Decision|0|||
33618536|NCT02072174|63019627|FG000|Overall Study|Protocol Violation|16|||
33618537|NCT02072174|63019628|FG001|Overall Study|Protocol Violation|23|||
33618538|NCT02072174|63019627|FG000|Overall Study|Physician Decision|0|||
33618539|NCT02072174|63019628|FG001|Overall Study|Physician Decision|1|||
33618540|NCT02072174|63019627|FG000|Overall Study|Non-compliance with protocol requirement|2|||
33524687|NCT04535453|62911538|FG005|Overall Study|Physician Decision|0|||
33524688|NCT04535453|62911539|FG006|Overall Study|Physician Decision|0|||
33524689|NCT04535453|62911540|FG007|Overall Study|Physician Decision|0|||
33618541|NCT02072174|63019628|FG001|Overall Study|Non-compliance with protocol requirement|0|||
33456838|NCT00094458|62831444|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
33456839|NCT00094458|62831445|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
33456840|NCT00094458|62831446|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
33456841|NCT00094458|62831441|FG000|OLE: Open-Label Extension|Patient decision|0|||
33456842|NCT00094458|62831442|FG001|OLE: Open-Label Extension|Patient decision|0|||
33456843|NCT00094458|62831443|FG002|OLE: Open-Label Extension|Patient decision|0|||
33456844|NCT00094458|62831444|FG003|OLE: Open-Label Extension|Patient decision|0|||
33456845|NCT00094458|62831445|FG004|OLE: Open-Label Extension|Patient decision|1|||
33456846|NCT00094458|62831446|FG005|OLE: Open-Label Extension|Patient decision|0|||
33456847|NCT00406367|62831462|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
33456848|NCT00406367|62831463|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
33456849|NCT00406367|62831462|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
33456850|NCT00406367|62831463|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
33456851|NCT00406367|62831462|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
33456852|NCT00406367|62831463|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
33456853|NCT00406367|62831462|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
33456854|NCT00406367|62831463|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
33456855|NCT00406367|62831462|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
33524690|NCT04535453|62911541|FG008|Overall Study|Physician Decision|0|||
33524691|NCT04535453|62911542|FG009|Overall Study|Physician Decision|0|||
33524692|NCT04535453|62911543|FG010|Overall Study|Physician Decision|0|||
33524693|NCT04535453|62911544|FG011|Overall Study|Physician Decision|0|||
33524694|NCT04535453|62911533|FG000|Overall Study|Withdrawal by Subject|3|||
33524695|NCT04535453|62911534|FG001|Overall Study|Withdrawal by Subject|6|||
33524696|NCT04535453|62911535|FG002|Overall Study|Withdrawal by Subject|3|||
33524697|NCT04535453|62911536|FG003|Overall Study|Withdrawal by Subject|3|||
33524698|NCT04535453|62911537|FG004|Overall Study|Withdrawal by Subject|2|||
33524699|NCT04535453|62911538|FG005|Overall Study|Withdrawal by Subject|1|||
33524700|NCT04535453|62911539|FG006|Overall Study|Withdrawal by Subject|1|||
33618542|NCT02209181|63019640|FG000|Overall Study|Adverse Event|1|||
33618543|NCT02209181|63019641|FG001|Overall Study|Adverse Event|0|||
33618544|NCT02209181|63019642|FG002|Overall Study|Adverse Event|1|||
33618545|NCT02209181|63019643|FG003|Overall Study|Adverse Event|0|||
33618546|NCT02209181|63019640|FG000|Overall Study|Withdrawal by Subject|0|||
33524701|NCT04535453|62911540|FG007|Overall Study|Withdrawal by Subject|1|||
33524702|NCT04535453|62911541|FG008|Overall Study|Withdrawal by Subject|1|||
33524703|NCT04535453|62911542|FG009|Overall Study|Withdrawal by Subject|1|||
33524704|NCT04535453|62911543|FG010|Overall Study|Withdrawal by Subject|0|||
33524705|NCT04535453|62911544|FG011|Overall Study|Withdrawal by Subject|1|||
33524706|NCT04535453|62911533|FG000|Overall Study|Other|0|||
33618547|NCT02209181|63019641|FG001|Overall Study|Withdrawal by Subject|1|||
33618548|NCT02209181|63019642|FG002|Overall Study|Withdrawal by Subject|0|||
33618549|NCT02209181|63019643|FG003|Overall Study|Withdrawal by Subject|0|||
33618550|NCT02208089|63019655|FG000|Overall Study|Withdrawal by Subject|1|||
33618551|NCT02208089|63019656|FG001|Overall Study|Withdrawal by Subject|0|||
33618552|NCT02208089|63019655|FG000|Overall Study|Lost to Follow-up|6|||
33618553|NCT02208089|63019656|FG001|Overall Study|Lost to Follow-up|0|||
33618554|NCT02242487|63019665|FG000|Overall Study|Adverse Event|13|||
33524707|NCT04535453|62911534|FG001|Overall Study|Other|0|||
33524708|NCT04535453|62911535|FG002|Overall Study|Other|1|||
33524709|NCT04535453|62911536|FG003|Overall Study|Other|0|||
33524710|NCT04535453|62911537|FG004|Overall Study|Other|1|||
33524711|NCT04535453|62911538|FG005|Overall Study|Other|0|||
33618555|NCT02242487|63019666|FG001|Overall Study|Adverse Event|15|||
33618556|NCT02242487|63019665|FG000|Overall Study|Lack of Efficacy|4|||
33618557|NCT02242487|63019666|FG001|Overall Study|Lack of Efficacy|6|||
33618558|NCT02242487|63019665|FG000|Overall Study|Protocol Violation|2|||
33456856|NCT00406367|62831463|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
33456857|NCT00406367|62831462|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
33456858|NCT00406367|62831463|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
33456859|NCT00406367|62831462|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
33456860|NCT00406367|62831463|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
33456861|NCT00406367|62831462|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
33456862|NCT00406367|62831463|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
33456863|NCT00406367|62831462|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
33456864|NCT00406367|62831463|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
33456865|NCT00406367|62831462|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
33456866|NCT00406367|62831463|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
33456867|NCT00406367|62831462|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
33456868|NCT00406367|62831463|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
33456869|NCT00406367|62831462|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
33456870|NCT00406367|62831463|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
33456871|NCT00394589|62831472|FG000|Overall Study|Adverse Event|2|||
33456872|NCT00394589|62831473|FG001|Overall Study|Adverse Event|1|||
33456873|NCT00394589|62831474|FG002|Overall Study|Adverse Event|2|||
33456874|NCT00394589|62831472|FG000|Overall Study|Lack of Efficacy|2|||
33456875|NCT00394589|62831473|FG001|Overall Study|Lack of Efficacy|2|||
33456876|NCT00394589|62831474|FG002|Overall Study|Lack of Efficacy|3|||
33456877|NCT00394589|62831472|FG000|Overall Study|Protocol Violation|4|||
33456878|NCT00394589|62831473|FG001|Overall Study|Protocol Violation|0|||
33456879|NCT00394589|62831474|FG002|Overall Study|Protocol Violation|2|||
33456880|NCT00068406|62831482|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
33456881|NCT00068406|62831482|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
33456882|NCT00403559|62831488|FG000|Overall Study|Adverse Event|0|||
33456883|NCT00403559|62831489|FG001|Overall Study|Adverse Event|1|||
33618559|NCT02242487|63019666|FG001|Overall Study|Protocol Violation|0|||
33618560|NCT02242487|63019665|FG000|Overall Study|Lost to Follow-up|2|||
33618561|NCT02242487|63019666|FG001|Overall Study|Lost to Follow-up|1|||
33618562|NCT02242487|63019665|FG000|Overall Study|Other - Miscellaneous|4|||
33325250|NCT01214642|62701943|FG002|Overall Study|Physician Decision|1|||
33524712|NCT04535453|62911539|FG006|Overall Study|Other|1|||
33524713|NCT04535453|62911540|FG007|Overall Study|Other|1|||
33524714|NCT04535453|62911541|FG008|Overall Study|Other|1|||
33524715|NCT04535453|62911542|FG009|Overall Study|Other|0|||
33524716|NCT04535453|62911543|FG010|Overall Study|Other|0|||
33524717|NCT04535453|62911544|FG011|Overall Study|Other|0|||
33524718|NCT04463069|62911587|FG000|Overall Study|Withdrawal by Subject|2|||
33524719|NCT04463069|62911588|FG001|Overall Study|Withdrawal by Subject|10|||
33524720|NCT04463069|62911587|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
33524721|NCT04463069|62911588|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
33524722|NCT03521687|62911594|FG000|Overall Study|Adverse Event|4|||
33524723|NCT03521687|62911594|FG000|Overall Study|Physician Decision|1|||
33524724|NCT03125915|62911602|FG000|1 Month Follow up|Lost to Follow-up|3|||
33524725|NCT03125915|62911603|FG001|1 Month Follow up|Lost to Follow-up|3|||
33524726|NCT03125915|62911604|FG002|1 Month Follow up|Lost to Follow-up|2|||
33524727|NCT03125915|62911605|FG003|1 Month Follow up|Lost to Follow-up|3|||
33524728|NCT03125915|62911602|FG000|3 Month Follow-up|Lost to Follow-up|6|||
33524729|NCT03125915|62911603|FG001|3 Month Follow-up|Lost to Follow-up|4|||
33524730|NCT03125915|62911604|FG002|3 Month Follow-up|Lost to Follow-up|4|||
33524731|NCT03125915|62911605|FG003|3 Month Follow-up|Lost to Follow-up|2|||
33524732|NCT03125915|62911602|FG000|6 Month Follow-up|Lost to Follow-up|7|||
33524733|NCT03125915|62911603|FG001|6 Month Follow-up|Lost to Follow-up|3|||
33524734|NCT03125915|62911604|FG002|6 Month Follow-up|Lost to Follow-up|6|||
33524735|NCT03125915|62911605|FG003|6 Month Follow-up|Lost to Follow-up|3|||
33524736|NCT03122171|62911615|FG000|Overall Study|Withdrawal by Subject|1|||
33524737|NCT01427725|62911619|FG000|Overall Study|Lost to Follow-up|17|||
33524738|NCT01427725|62911619|FG000|Overall Study|Protocol Violation|1|||
33524739|NCT01427725|62911619|FG000|Overall Study|Drug not administered|1|||
33524740|NCT01427725|62911619|FG000|Overall Study|Failure to visit|7|||
33524741|NCT01427725|62911619|FG000|Overall Study|Adverse Event|46|||
33524742|NCT01427725|62911619|FG000|Overall Study|Failure to visit after administration|40|||
33524743|NCT01427725|62911619|FG000|Overall Study|Patient's rejection|27|||
33524744|NCT01427725|62911619|FG000|Overall Study|Transfer to a different hospital|17|||
33524745|NCT01427725|62911619|FG000|Overall Study|Lack of Efficacy|8|||
33524746|NCT01427725|62911619|FG000|Overall Study|Death|7|||
33524747|NCT01427725|62911619|FG000|Overall Study|Symptom improvement|6|||
33524748|NCT01427725|62911619|FG000|Overall Study|AE and Patient's rejection|5|||
33524749|NCT01427725|62911619|FG000|Overall Study|Physician Decision|5|||
33524750|NCT01427725|62911619|FG000|Overall Study|Exacerbation of underlying disease|5|||
33524751|NCT01427725|62911619|FG000|Overall Study|Oral feeding difficulty|5|||
33524752|NCT01427725|62911619|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
33524753|NCT01427725|62911619|FG000|Overall Study|Forgetting prescription|1|||
33524754|NCT01427725|62911619|FG000|Overall Study|Other|2|||
33524755|NCT02839200|62911630|FG000|Overall Study|Withdrawal by Subject|2|||
33524756|NCT02839200|62911631|FG001|Overall Study|Withdrawal by Subject|0|||
33524757|NCT02839200|62911632|FG002|Overall Study|Withdrawal by Subject|1|||
33524758|NCT02839200|62911633|FG003|Overall Study|Withdrawal by Subject|0|||
33524759|NCT02839200|62911634|FG004|Overall Study|Withdrawal by Subject|0|||
33524760|NCT02839200|62911635|FG005|Overall Study|Withdrawal by Subject|1|||
33524761|NCT02839200|62911630|FG000|Overall Study|Lost to Follow-up|2|||
33524762|NCT02839200|62911631|FG001|Overall Study|Lost to Follow-up|0|||
33524763|NCT02839200|62911632|FG002|Overall Study|Lost to Follow-up|0|||
33524764|NCT02839200|62911633|FG003|Overall Study|Lost to Follow-up|0|||
33524765|NCT02839200|62911634|FG004|Overall Study|Lost to Follow-up|1|||
33524766|NCT02839200|62911635|FG005|Overall Study|Lost to Follow-up|0|||
33524767|NCT02839200|62911630|FG000|Overall Study|Adverse Event|0|||
33524768|NCT02839200|62911631|FG001|Overall Study|Adverse Event|0|||
33524769|NCT02839200|62911632|FG002|Overall Study|Adverse Event|0|||
33524770|NCT02839200|62911633|FG003|Overall Study|Adverse Event|0|||
33524771|NCT02839200|62911634|FG004|Overall Study|Adverse Event|1|||
33524772|NCT02839200|62911635|FG005|Overall Study|Adverse Event|0|||
33524773|NCT02839200|62911630|FG000|Overall Study|Randomized in error|0|||
33524774|NCT02839200|62911631|FG001|Overall Study|Randomized in error|1|||
33524775|NCT02839200|62911632|FG002|Overall Study|Randomized in error|0|||
33524776|NCT02839200|62911633|FG003|Overall Study|Randomized in error|0|||
33524777|NCT02839200|62911634|FG004|Overall Study|Randomized in error|0|||
33524778|NCT02839200|62911635|FG005|Overall Study|Randomized in error|0|||
33524779|NCT03118739|62911651|FG000|Overall Study|Physician Decision|0|||
33618563|NCT02242487|63019666|FG001|Overall Study|Other - Miscellaneous|6|||
33524780|NCT03118739|62911652|FG001|Overall Study|Physician Decision|1|||
33524781|NCT03118739|62911651|FG000|Overall Study|Withdrawal by Subject|5|||
33524782|NCT03118739|62911652|FG001|Overall Study|Withdrawal by Subject|3|||
33524783|NCT03118739|62911651|FG000|Overall Study|Lost to Follow-up|2|||
33524784|NCT03118739|62911652|FG001|Overall Study|Lost to Follow-up|0|||
33524785|NCT03094195|62911661|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
33325251|NCT01214642|62701944|FG003|Overall Study|Physician Decision|1|||
33524786|NCT03094195|62911662|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
33524787|NCT03094195|62911663|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
33524788|NCT03094195|62911664|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33524789|NCT03094195|62911665|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33524790|NCT03094195|62911666|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33524791|NCT03094195|62911667|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33524792|NCT03094195|62911668|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33524793|NCT03094195|62911661|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
33618564|NCT02242487|63019665|FG000|Overall Study|Withdrawal by Subject|37|||
33618565|NCT02242487|63019666|FG001|Overall Study|Withdrawal by Subject|19|||
33618566|NCT02241785|63019674|FG000|Overall Study|Sponsor Termination|43|||
33618567|NCT02241785|63019674|FG000|Overall Study|Withdrawal by Subject|1|||
33618568|NCT02241785|63019674|FG000|Overall Study|Lost to Follow-up|2|||
33618569|NCT02241785|63019674|FG000|Overall Study|Adverse Event|1|||
33618570|NCT02241551|63019680|FG000|Overall Study|Adverse Event|1|||
33618571|NCT02241551|63019681|FG001|Overall Study|Adverse Event|0|||
33618572|NCT02207621|63019692|FG000|Overall Study|Adverse Event|71|||
33618573|NCT02207621|63019693|FG001|Overall Study|Adverse Event|15|||
33618574|NCT02207621|63019694|FG002|Overall Study|Adverse Event|132|||
33618575|NCT02207621|63019692|FG000|Overall Study|Withdrawal by Subject|9|||
33618576|NCT02207621|63019693|FG001|Overall Study|Withdrawal by Subject|9|||
33618577|NCT02207621|63019694|FG002|Overall Study|Withdrawal by Subject|13|||
33618578|NCT02207621|63019692|FG000|Overall Study|Non-Compliant|3|||
33618579|NCT02207621|63019693|FG001|Overall Study|Non-Compliant|3|||
33618580|NCT02207621|63019694|FG002|Overall Study|Non-Compliant|1|||
33618581|NCT02207621|63019692|FG000|Overall Study|Lost to Follow-up|1|||
33618582|NCT02207621|63019693|FG001|Overall Study|Lost to Follow-up|0|||
33618583|NCT02207621|63019694|FG002|Overall Study|Lost to Follow-up|3|||
33618584|NCT02207621|63019692|FG000|Overall Study|Lack of Efficacy|10|||
33618585|NCT02207621|63019693|FG001|Overall Study|Lack of Efficacy|2|||
33618586|NCT02207621|63019694|FG002|Overall Study|Lack of Efficacy|4|||
33618587|NCT02207621|63019692|FG000|Overall Study|Disallowed Concurrent Medication|2|||
33618588|NCT02207621|63019693|FG001|Overall Study|Disallowed Concurrent Medication|5|||
33618589|NCT02207621|63019694|FG002|Overall Study|Disallowed Concurrent Medication|2|||
33618590|NCT02207621|63019692|FG000|Overall Study|Physician Decision|1|||
33524794|NCT03094195|62911662|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
33524795|NCT03094195|62911663|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
33524796|NCT03094195|62911664|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33524797|NCT03094195|62911665|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33524798|NCT03094195|62911666|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33524799|NCT03094195|62911667|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33524800|NCT03094195|62911668|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33524801|NCT03094195|62911661|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33524802|NCT03094195|62911662|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33524803|NCT03094195|62911663|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
33524804|NCT03094195|62911664|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33524805|NCT03094195|62911665|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33524806|NCT03094195|62911666|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33524807|NCT03094195|62911667|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33524808|NCT03094195|62911668|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33524809|NCT03094195|62911661|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33524810|NCT03094195|62911662|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
33618591|NCT02207621|63019693|FG001|Overall Study|Physician Decision|2|||
33618592|NCT02207621|63019694|FG002|Overall Study|Physician Decision|2|||
33618593|NCT02207621|63019692|FG000|Overall Study|Protocol Violation|4|||
33618594|NCT02207621|63019693|FG001|Overall Study|Protocol Violation|10|||
33618595|NCT02207621|63019694|FG002|Overall Study|Protocol Violation|6|||
33618596|NCT02207621|63019692|FG000|Overall Study|Death|2|||
33618597|NCT02207621|63019693|FG001|Overall Study|Death|0|||
33618598|NCT02207621|63019694|FG002|Overall Study|Death|0|||
33618599|NCT02207621|63019692|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
33618600|NCT02207621|63019693|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
33618601|NCT02207621|63019694|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
33618602|NCT02240693|63019708|FG000|Overall Study|Adverse Event|0|||
33618603|NCT02240693|63019709|FG001|Overall Study|Adverse Event|0|||
33618604|NCT02240693|63019710|FG002|Overall Study|Adverse Event|0|||
33618605|NCT02240693|63019711|FG003|Overall Study|Adverse Event|0|||
33618606|NCT02240693|63019712|FG004|Overall Study|Adverse Event|1|||
33618607|NCT02240693|63019708|FG000|Overall Study|Withdrawal by Subject|0|||
33618608|NCT02240693|63019709|FG001|Overall Study|Withdrawal by Subject|0|||
33618609|NCT02240693|63019710|FG002|Overall Study|Withdrawal by Subject|2|||
33618610|NCT02240693|63019711|FG003|Overall Study|Withdrawal by Subject|1|||
33618611|NCT02240693|63019712|FG004|Overall Study|Withdrawal by Subject|0|||
33618612|NCT02240693|63019708|FG000|Overall Study|Other than specified|0|||
33618613|NCT02240693|63019709|FG001|Overall Study|Other than specified|0|||
33618614|NCT02240693|63019710|FG002|Overall Study|Other than specified|2|||
33618615|NCT02240693|63019711|FG003|Overall Study|Other than specified|0|||
33618616|NCT02240693|63019712|FG004|Overall Study|Other than specified|0|||
33618617|NCT02239679|63019729|FG000|Overall Study|Lost to Follow-up|1|||
33618618|NCT02239679|63019730|FG001|Overall Study|Lost to Follow-up|0|||
33618619|NCT02239679|63019731|FG002|Overall Study|Lost to Follow-up|0|||
33524811|NCT03094195|62911663|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
33524812|NCT03094195|62911664|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33524813|NCT03094195|62911665|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33524814|NCT03094195|62911666|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33524815|NCT03094195|62911667|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33524816|NCT03094195|62911668|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33524817|NCT02835690|62911689|FG000|Overall Study|Death|12|||
33524818|NCT02835690|62911690|FG001|Overall Study|Death|11|||
33524819|NCT02835690|62911691|FG002|Overall Study|Death|13|||
33524820|NCT02835690|62911689|FG000|Overall Study|Transferred to Extension Study|2|||
33524821|NCT02835690|62911690|FG001|Overall Study|Transferred to Extension Study|2|||
33524822|NCT02835690|62911691|FG002|Overall Study|Transferred to Extension Study|1|||
33524823|NCT02835690|62911689|FG000|Overall Study|Did Not Continue on Extension Study|0|||
33524824|NCT02835690|62911690|FG001|Overall Study|Did Not Continue on Extension Study|0|||
33524825|NCT02835690|62911691|FG002|Overall Study|Did Not Continue on Extension Study|1|||
33524826|NCT02835690|62911689|FG000|Overall Study|Not Treated|0|||
33524827|NCT02835690|62911690|FG001|Overall Study|Not Treated|2|||
33524828|NCT02835690|62911691|FG002|Overall Study|Not Treated|0|||
33524829|NCT02837952|62911702|FG000|Overall Study|Adverse Event|0|||
33524830|NCT02837952|62911703|FG001|Overall Study|Adverse Event|1|||
33524831|NCT02837952|62911702|FG000|Overall Study|Withdrawal by Subject|4|||
33524832|NCT02837952|62911703|FG001|Overall Study|Withdrawal by Subject|5|||
33524833|NCT02837952|62911702|FG000|Overall Study|Medication Error|1|||
33524834|NCT02837952|62911703|FG001|Overall Study|Medication Error|0|||
33524835|NCT02832167|62911709|FG000|Treatment Period 1|Disease progression|90|||
33524836|NCT02832167|62911709|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
33524837|NCT02832167|62911709|FG000|Treatment Period 1|Death|2|||
33524838|NCT02832167|62911709|FG000|Treatment Period 1|Study Drug Toxicity|6|||
33524839|NCT02832167|62911709|FG000|Treatment Period 1|Participant request to discontinue|9|||
33524840|NCT02832167|62911709|FG000|Treatment Period 1|No longer meet study criteria|1|||
33524841|NCT02832167|62911709|FG000|Treatment Period 1|Participant withdrew consent|3|||
33524842|NCT02832167|62911709|FG000|Treatment Period 1|Other reasons|6|||
33524843|NCT02832167|62911709|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
33524844|NCT02832167|62911709|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
33524845|NCT02832167|62911709|FG000|Transition From Period 1 to Period 2|Death|2|||
33524846|NCT02832167|62911709|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
33524847|NCT02832167|62911709|FG000|Treatment Period 2|Disease progression|69|||
33524848|NCT02832167|62911709|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
33524849|NCT02832167|62911709|FG000|Treatment Period 2|Maximum clinical benefit|1|||
33524850|NCT02832167|62911709|FG000|Treatment Period 2|Study Drug Toxicity|5|||
33524851|NCT02832167|62911709|FG000|Treatment Period 2|Participant request to discontinue|2|||
33524852|NCT02832167|62911709|FG000|Treatment Period 2|Participant withdrew consent|3|||
33524853|NCT02832167|62911709|FG000|Treatment Period 2|Other reasons|3|||
33524854|NCT02674529|62911715|FG000|Overall Study|Lost to Follow-up|1|||
33524855|NCT02674529|62911716|FG001|Overall Study|Lost to Follow-up|2|||
33524856|NCT02674529|62911715|FG000|Overall Study|Withdrawal by Subject|2|||
33524857|NCT02674529|62911716|FG001|Overall Study|Withdrawal by Subject|1|||
33524858|NCT02674529|62911715|FG000|Overall Study|Physician Decision|0|||
33524859|NCT02674529|62911716|FG001|Overall Study|Physician Decision|1|||
33524860|NCT02674529|62911715|FG000|Overall Study|Protocol Violation|0|||
33524861|NCT02674529|62911716|FG001|Overall Study|Protocol Violation|1|||
33524862|NCT02626949|62911727|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
33524863|NCT02626949|62911728|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
33524864|NCT02626949|62911727|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
33524865|NCT02626949|62911728|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
33524866|NCT02626949|62911727|FG000|Enrolled|Lost to Follow-up|7|||
33524867|NCT02626949|62911728|FG001|Enrolled|Lost to Follow-up|6|||
33524868|NCT02626949|62911727|FG000|Enrolled|Withdrawal by Subject|3|||
33524869|NCT02626949|62911728|FG001|Enrolled|Withdrawal by Subject|2|||
33618620|NCT02239679|63019729|FG000|Overall Study|Withdrawal by Subject|2|||
33618621|NCT02239679|63019730|FG001|Overall Study|Withdrawal by Subject|3|||
33618622|NCT02239679|63019731|FG002|Overall Study|Withdrawal by Subject|1|||
33524870|NCT03116399|62911736|FG000|Overall Study|Death|8|||
33524871|NCT03116399|62911737|FG001|Overall Study|Death|3|||
33524872|NCT03116399|62911736|FG000|Overall Study|Lost to Follow-up|7|||
33524873|NCT03116399|62911737|FG001|Overall Study|Lost to Follow-up|11|||
33524874|NCT03116399|62911736|FG000|Overall Study|Investigator Decision|1|||
33524875|NCT03116399|62911737|FG001|Overall Study|Investigator Decision|1|||
33524876|NCT03116399|62911736|FG000|Overall Study|Withdrawal by Subject|24|||
33524877|NCT03116399|62911737|FG001|Overall Study|Withdrawal by Subject|9|||
33524878|NCT03097861|62911746|FG000|Overall Study|Adverse Event|3|||
33524879|NCT03097861|62911747|FG001|Overall Study|Adverse Event|8|||
33524880|NCT03097861|62911748|FG002|Overall Study|Adverse Event|4|||
33524881|NCT03097861|62911746|FG000|Overall Study|Investigator Decision|0|||
33524882|NCT03097861|62911747|FG001|Overall Study|Investigator Decision|1|||
33524883|NCT03097861|62911748|FG002|Overall Study|Investigator Decision|0|||
33524884|NCT03097861|62911746|FG000|Overall Study|Lost to Follow-up|0|||
33524885|NCT03097861|62911747|FG001|Overall Study|Lost to Follow-up|7|||
33524886|NCT03097861|62911748|FG002|Overall Study|Lost to Follow-up|1|||
33524887|NCT03097861|62911746|FG000|Overall Study|Withdrawal by Subject|1|||
33524888|NCT03097861|62911747|FG001|Overall Study|Withdrawal by Subject|5|||
33524889|NCT03097861|62911748|FG002|Overall Study|Withdrawal by Subject|3|||
33524890|NCT03097861|62911746|FG000|Overall Study|Reason not provided|3|||
33524891|NCT03097861|62911747|FG001|Overall Study|Reason not provided|1|||
33524892|NCT03097861|62911748|FG002|Overall Study|Reason not provided|1|||
33524893|NCT03910673|62911763|FG000|Overall Study|Adverse Event|0|||
33524894|NCT03910673|62911764|FG001|Overall Study|Adverse Event|0|||
33524895|NCT03910673|62911765|FG002|Overall Study|Adverse Event|0|||
33524896|NCT03910673|62911766|FG003|Overall Study|Adverse Event|2|||
33524897|NCT03910673|62911767|FG004|Overall Study|Adverse Event|0|||
33524898|NCT01816139|62911777|FG000|Overall Study|Adverse Event|6|||
33524899|NCT01816139|62911778|FG001|Overall Study|Adverse Event|8|||
33524900|NCT01816139|62911777|FG000|Overall Study|Lack of Efficacy|1|||
33524901|NCT01816139|62911778|FG001|Overall Study|Lack of Efficacy|2|||
33524902|NCT01816139|62911777|FG000|Overall Study|Lost to Follow-up|5|||
33524903|NCT01816139|62911778|FG001|Overall Study|Lost to Follow-up|3|||
33524904|NCT01816139|62911777|FG000|Overall Study|Withdrew Consent|6|||
33524905|NCT01816139|62911778|FG001|Overall Study|Withdrew Consent|4|||
33524906|NCT01816139|62911777|FG000|Overall Study|Protocol Violation|6|||
33524907|NCT01816139|62911778|FG001|Overall Study|Protocol Violation|3|||
33524908|NCT01816139|62911777|FG000|Overall Study|Reason not Specified|4|||
33524909|NCT01816139|62911778|FG001|Overall Study|Reason not Specified|2|||
33524910|NCT02833350|62911821|FG000|Overall Study|Adverse Event|0|||
33524911|NCT02833350|62911822|FG001|Overall Study|Adverse Event|3|||
33524912|NCT02833350|62911823|FG002|Overall Study|Adverse Event|4|||
33524913|NCT02833350|62911824|FG003|Overall Study|Adverse Event|4|||
33524914|NCT02833350|62911825|FG004|Overall Study|Adverse Event|1|||
33524915|NCT02833350|62911826|FG005|Overall Study|Adverse Event|0|||
33524916|NCT02833350|62911827|FG006|Overall Study|Adverse Event|1|||
33524917|NCT02833350|62911821|FG000|Overall Study|Death|0|||
33524918|NCT02833350|62911822|FG001|Overall Study|Death|0|||
33524919|NCT02833350|62911823|FG002|Overall Study|Death|1|||
33524920|NCT02833350|62911824|FG003|Overall Study|Death|0|||
33524921|NCT02833350|62911825|FG004|Overall Study|Death|0|||
33524922|NCT02833350|62911826|FG005|Overall Study|Death|0|||
33524923|NCT02833350|62911827|FG006|Overall Study|Death|0|||
33524924|NCT02833350|62911821|FG000|Overall Study|Lack of Efficacy|0|||
33524925|NCT02833350|62911822|FG001|Overall Study|Lack of Efficacy|2|||
33524926|NCT02833350|62911823|FG002|Overall Study|Lack of Efficacy|1|||
33524927|NCT02833350|62911824|FG003|Overall Study|Lack of Efficacy|4|||
33524928|NCT02833350|62911825|FG004|Overall Study|Lack of Efficacy|0|||
33524929|NCT02833350|62911826|FG005|Overall Study|Lack of Efficacy|1|||
33524930|NCT02833350|62911827|FG006|Overall Study|Lack of Efficacy|1|||
33524931|NCT02833350|62911821|FG000|Overall Study|Lost to Follow-up|0|||
33524932|NCT02833350|62911822|FG001|Overall Study|Lost to Follow-up|1|||
33524933|NCT02833350|62911823|FG002|Overall Study|Lost to Follow-up|0|||
33524934|NCT02833350|62911824|FG003|Overall Study|Lost to Follow-up|0|||
33524935|NCT02833350|62911825|FG004|Overall Study|Lost to Follow-up|0|||
33524936|NCT02833350|62911826|FG005|Overall Study|Lost to Follow-up|0|||
33524937|NCT02833350|62911827|FG006|Overall Study|Lost to Follow-up|1|||
33524938|NCT02833350|62911821|FG000|Overall Study|Withdrawal by Subject|3|||
33524939|NCT02833350|62911822|FG001|Overall Study|Withdrawal by Subject|3|||
33524940|NCT02833350|62911823|FG002|Overall Study|Withdrawal by Subject|2|||
33524941|NCT02833350|62911824|FG003|Overall Study|Withdrawal by Subject|0|||
33524942|NCT02833350|62911825|FG004|Overall Study|Withdrawal by Subject|2|||
33524943|NCT02833350|62911826|FG005|Overall Study|Withdrawal by Subject|0|||
33524944|NCT02833350|62911827|FG006|Overall Study|Withdrawal by Subject|2|||
33524945|NCT01343043|62911850|FG000|Overall Study|Disease progression before treatment|1|||
33524946|NCT01343043|62911851|FG001|Overall Study|Disease progression before treatment|0|||
33524947|NCT01343043|62911852|FG002|Overall Study|Disease progression before treatment|0|||
33524948|NCT01343043|62911853|FG003|Overall Study|Disease progression before treatment|0|||
33524949|NCT01343043|62911850|FG000|Overall Study|Withdrawal by Subject|1|||
33524950|NCT01343043|62911851|FG001|Overall Study|Withdrawal by Subject|0|||
33524951|NCT01343043|62911852|FG002|Overall Study|Withdrawal by Subject|0|||
33524952|NCT01343043|62911853|FG003|Overall Study|Withdrawal by Subject|0|||
33524953|NCT01343043|62911850|FG000|Overall Study|Death|1|||
33524954|NCT01343043|62911851|FG001|Overall Study|Death|1|||
33524955|NCT01343043|62911852|FG002|Overall Study|Death|0|||
33524956|NCT01343043|62911853|FG003|Overall Study|Death|1|||
33524957|NCT03548987|62911868|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
33524958|NCT03548987|62911869|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
33524959|NCT03548987|62911868|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
33524960|NCT03548987|62911869|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
33524961|NCT03548987|62911868|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
33524962|NCT03548987|62911869|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
33524963|NCT03548987|62911868|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
33524964|NCT03548987|62911869|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
33524965|NCT03548987|62911868|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
33524966|NCT03548987|62911869|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
33524967|NCT03548987|62911868|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
33524968|NCT03548987|62911869|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
33524969|NCT03548987|62911868|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
33524970|NCT03548987|62911869|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
33524971|NCT03548987|62911868|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
33524972|NCT03548987|62911869|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
33524973|NCT03548987|62911868|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
33524974|NCT03548987|62911869|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
33524975|NCT03548987|62911868|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
33524976|NCT03548987|62911869|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
33524977|NCT03548987|62911868|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
33524978|NCT03548987|62911869|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
33524979|NCT03548987|62911868|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
33524980|NCT03548987|62911869|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
33524981|NCT03548987|62911868|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
33524982|NCT03548987|62911869|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
33524983|NCT03548987|62911868|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
33524984|NCT03548987|62911869|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
33524985|NCT01358760|62911879|FG000|Overall Study|Adverse Event|3|||
33524986|NCT01358760|62911880|FG001|Overall Study|Adverse Event|4|||
33524987|NCT01358760|62911881|FG002|Overall Study|Adverse Event|3|||
33524988|NCT01358760|62911879|FG000|Overall Study|Lost to Follow-up|1|||
33524989|NCT01358760|62911880|FG001|Overall Study|Lost to Follow-up|1|||
33524990|NCT01358760|62911881|FG002|Overall Study|Lost to Follow-up|3|||
33524991|NCT01358760|62911879|FG000|Overall Study|Withdrawal by Subject|5|||
33325252|NCT01214642|62701945|FG004|Overall Study|Physician Decision|1|||
33524992|NCT01358760|62911880|FG001|Overall Study|Withdrawal by Subject|3|||
33524993|NCT01358760|62911881|FG002|Overall Study|Withdrawal by Subject|2|||
33524994|NCT01358760|62911879|FG000|Overall Study|Physician Decision|1|||
33524995|NCT01358760|62911880|FG001|Overall Study|Physician Decision|0|||
33524996|NCT01358760|62911881|FG002|Overall Study|Physician Decision|1|||
33524997|NCT01358760|62911879|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
33524998|NCT01358760|62911880|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
33524999|NCT01358760|62911881|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
33525000|NCT01341990|62911891|FG000|Overall Study|Adverse Event|0|||
33525001|NCT01341990|62911892|FG001|Overall Study|Adverse Event|1|||
33525002|NCT01341990|62911891|FG000|Overall Study|Torn Study Lens|1|||
33525003|NCT01341990|62911892|FG001|Overall Study|Torn Study Lens|0|||
33525004|NCT01341990|62911891|FG000|Overall Study|Withdrawal by Subject|2|||
33525005|NCT01341990|62911892|FG001|Overall Study|Withdrawal by Subject|0|||
33525006|NCT03048747|62911898|FG000|Overall Study|Adverse Event|2|||
33525007|NCT03048747|62911898|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
33525008|NCT03048747|62911898|FG000|Overall Study|Physician Decision|1|||
33525009|NCT01991067|62911960|FG000|Overall Study|Lost to Follow-up|6|||
33525010|NCT01991067|62911961|FG001|Overall Study|Lost to Follow-up|5|||
33525011|NCT01709331|62911967|FG000|Overall Study|Adverse Event|1|||
33525012|NCT03255083|62911975|FG000|Overall Study|Clinical progression|1|||
33525013|NCT03255083|62911976|FG001|Overall Study|Clinical progression|0|||
33525014|NCT03255083|62911977|FG002|Overall Study|Clinical progression|0|||
33525015|NCT03255083|62911978|FG003|Overall Study|Clinical progression|0|||
33525016|NCT03255083|62911975|FG000|Overall Study|Adverse Event|0|||
33525017|NCT03255083|62911976|FG001|Overall Study|Adverse Event|1|||
33525018|NCT03255083|62911977|FG002|Overall Study|Adverse Event|0|||
33525019|NCT03255083|62911978|FG003|Overall Study|Adverse Event|0|||
33525020|NCT03255083|62911975|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
33525021|NCT03255083|62911976|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
33525022|NCT03255083|62911977|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
33525023|NCT03255083|62911978|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
33525024|NCT03255083|62911975|FG000|Overall Study|Withdrawal by Subject|1|||
33525025|NCT03255083|62911976|FG001|Overall Study|Withdrawal by Subject|1|||
33525026|NCT03255083|62911977|FG002|Overall Study|Withdrawal by Subject|1|||
33525027|NCT03255083|62911978|FG003|Overall Study|Withdrawal by Subject|0|||
33525028|NCT04552587|62911994|FG000|Overall Study|Lost to Follow-up|4|||
33525029|NCT01316055|62912010|FG000|Overall Study|Lost to Follow-up|1|||
33525030|NCT01316055|62912011|FG001|Overall Study|Lost to Follow-up|0|||
33525031|NCT01316055|62912012|FG002|Overall Study|Lost to Follow-up|0|||
33525032|NCT01340976|62912029|FG000|Overall Study|Physician Decision|2|||
33525033|NCT01340976|62912030|FG001|Overall Study|Physician Decision|0|||
33525034|NCT01340976|62912031|FG002|Overall Study|Physician Decision|1|||
33525035|NCT01340976|62912032|FG003|Overall Study|Physician Decision|1|||
33525036|NCT01340976|62912033|FG004|Overall Study|Physician Decision|1|||
33525037|NCT01340976|62912034|FG005|Overall Study|Physician Decision|0|||
33525038|NCT01340976|62912029|FG000|Overall Study|Death|0|||
33525039|NCT01340976|62912030|FG001|Overall Study|Death|1|||
33525040|NCT01340976|62912031|FG002|Overall Study|Death|0|||
33525041|NCT01340976|62912032|FG003|Overall Study|Death|0|||
33525042|NCT01340976|62912033|FG004|Overall Study|Death|0|||
33525043|NCT01340976|62912034|FG005|Overall Study|Death|0|||
33525044|NCT01340976|62912029|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
33525045|NCT01340976|62912030|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
33525046|NCT01340976|62912031|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
33525047|NCT01340976|62912032|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
33525048|NCT01340976|62912033|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
33525049|NCT01340976|62912034|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
33325253|NCT01214642|62701946|FG005|Overall Study|Physician Decision|0|||
33325254|NCT01214642|62701947|FG006|Overall Study|Physician Decision|0|||
33325255|NCT01214642|62701948|FG007|Overall Study|Physician Decision|0|||
33325256|NCT01214642|62701949|FG008|Overall Study|Physician Decision|0|||
33525050|NCT01340976|62912029|FG000|Overall Study|Withdrawal by Subject|0|||
33525051|NCT01340976|62912030|FG001|Overall Study|Withdrawal by Subject|0|||
33525052|NCT01340976|62912031|FG002|Overall Study|Withdrawal by Subject|0|||
33525053|NCT01340976|62912032|FG003|Overall Study|Withdrawal by Subject|1|||
33525054|NCT01340976|62912033|FG004|Overall Study|Withdrawal by Subject|1|||
33525055|NCT01340976|62912034|FG005|Overall Study|Withdrawal by Subject|0|||
33525056|NCT01340976|62912029|FG000|Overall Study|Other anemia treatment|1|||
33525057|NCT01340976|62912030|FG001|Overall Study|Other anemia treatment|0|||
33525058|NCT01340976|62912031|FG002|Overall Study|Other anemia treatment|2|||
33525059|NCT01340976|62912032|FG003|Overall Study|Other anemia treatment|1|||
33525060|NCT01340976|62912033|FG004|Overall Study|Other anemia treatment|0|||
33525061|NCT01340976|62912034|FG005|Overall Study|Other anemia treatment|1|||
33525062|NCT01340976|62912029|FG000|Overall Study|Adverse Event|0|||
33525063|NCT01340976|62912030|FG001|Overall Study|Adverse Event|1|||
33525064|NCT01340976|62912031|FG002|Overall Study|Adverse Event|0|||
33525065|NCT01340976|62912032|FG003|Overall Study|Adverse Event|0|||
33525066|NCT01340976|62912033|FG004|Overall Study|Adverse Event|0|||
33525067|NCT01340976|62912034|FG005|Overall Study|Adverse Event|0|||
33525068|NCT01680016|62912056|FG000|Overall Study|Adverse Event|0|||
33525069|NCT01680016|62912057|FG001|Overall Study|Adverse Event|0|||
33525070|NCT01680016|62912058|FG002|Overall Study|Adverse Event|1|||
33525071|NCT01680016|62912059|FG003|Overall Study|Adverse Event|4|||
33525072|NCT01680016|62912056|FG000|Overall Study|The Subject went out of The Trial|1|||
33525073|NCT01680016|62912057|FG001|Overall Study|The Subject went out of The Trial|0|||
33525074|NCT01680016|62912058|FG002|Overall Study|The Subject went out of The Trial|3|||
33525075|NCT01680016|62912059|FG003|Overall Study|The Subject went out of The Trial|0|||
33525076|NCT01680016|62912056|FG000|Overall Study|Protocol Violation|0|||
33525077|NCT01680016|62912057|FG001|Overall Study|Protocol Violation|1|||
33525078|NCT01680016|62912058|FG002|Overall Study|Protocol Violation|0|||
33525079|NCT01680016|62912059|FG003|Overall Study|Protocol Violation|0|||
33525080|NCT01680016|62912056|FG000|Overall Study|Withdrawal by Subject|5|||
33525081|NCT01680016|62912057|FG001|Overall Study|Withdrawal by Subject|7|||
33525082|NCT01680016|62912058|FG002|Overall Study|Withdrawal by Subject|1|||
33525083|NCT01680016|62912059|FG003|Overall Study|Withdrawal by Subject|1|||
33525084|NCT01340898|62912084|FG000|Primary Phase|Serious Adverse Events|0|||
33525085|NCT01340898|62912085|FG001|Primary Phase|Serious Adverse Events|0|||
33525086|NCT01340898|62912086|FG002|Primary Phase|Serious Adverse Events|1|||
33525087|NCT01340898|62912084|FG000|Primary Phase|Withdrawal by Subject|8|||
33525088|NCT01340898|62912085|FG001|Primary Phase|Withdrawal by Subject|7|||
33525089|NCT01340898|62912086|FG002|Primary Phase|Withdrawal by Subject|5|||
33525090|NCT01340898|62912084|FG000|Primary Phase|Migrated/moved from study area|4|||
33525091|NCT01340898|62912085|FG001|Primary Phase|Migrated/moved from study area|1|||
33525092|NCT01340898|62912086|FG002|Primary Phase|Migrated/moved from study area|0|||
33525093|NCT01340898|62912084|FG000|Primary Phase|Lost to Follow-up|4|||
33525094|NCT01340898|62912085|FG001|Primary Phase|Lost to Follow-up|1|||
33525095|NCT01340898|62912086|FG002|Primary Phase|Lost to Follow-up|0|||
33525096|NCT01340898|62912084|FG000|Booster Phase|Withdrawal by Subject|3|||
33525097|NCT01340898|62912085|FG001|Booster Phase|Withdrawal by Subject|0|||
33525098|NCT01340898|62912086|FG002|Booster Phase|Withdrawal by Subject|4|||
33525099|NCT01340898|62912084|FG000|Booster Phase|Migrated/moved from study area|3|||
33525100|NCT01340898|62912085|FG001|Booster Phase|Migrated/moved from study area|0|||
33525101|NCT01340898|62912086|FG002|Booster Phase|Migrated/moved from study area|0|||
33525102|NCT01340898|62912084|FG000|Booster Phase|Lost to Follow-up|4|||
33525103|NCT01340898|62912085|FG001|Booster Phase|Lost to Follow-up|2|||
33525104|NCT01340898|62912086|FG002|Booster Phase|Lost to Follow-up|3|||
33525105|NCT03097315|62912107|FG000|Overall Study|Withdrawal by Subject|1|||
33525106|NCT03039699|62912113|FG000|Overall Study|Incorrect inclusion|5|||
33525107|NCT03039699|62912114|FG001|Overall Study|Incorrect inclusion|4|||
33525108|NCT03039699|62912113|FG000|Overall Study|Lack of data to assess study endpoint|5|||
33525109|NCT03039699|62912114|FG001|Overall Study|Lack of data to assess study endpoint|3|||
33525110|NCT03039699|62912113|FG000|Overall Study|Bacterial infection|12|||
33525111|NCT03039699|62912114|FG001|Overall Study|Bacterial infection|28|||
33525112|NCT02833974|62912122|FG000|Overall Study|Lost to Follow-up|1|||
33525113|NCT02833974|62912123|FG001|Overall Study|Lost to Follow-up|0|||
33525114|NCT02833974|62912122|FG000|Overall Study|Adverse Event|0|||
33525115|NCT02833974|62912123|FG001|Overall Study|Adverse Event|3|||
33525116|NCT03093415|62912132|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
33525117|NCT03093415|62912133|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
33525118|NCT03093415|62912134|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
33525119|NCT03093415|62912132|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
33525120|NCT03093415|62912133|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
33525121|NCT03093415|62912134|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
33525122|NCT03093415|62912132|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
33325257|NCT01214642|62701950|FG009|Overall Study|Physician Decision|0|||
33325258|NCT01214642|62701951|FG010|Overall Study|Physician Decision|0|||
33525123|NCT03093415|62912133|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
33525124|NCT03093415|62912134|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
33525125|NCT03093415|62912132|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
33525126|NCT03093415|62912133|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
33525127|NCT03093415|62912134|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
33525128|NCT03093415|62912132|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
33525129|NCT03093415|62912133|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
33525130|NCT03093415|62912134|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
33525131|NCT03093415|62912132|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
33618623|NCT02072096|63019741|FG000|Overall Study|Lack of Efficacy|18|||
33325259|NCT01214642|62701952|FG011|Overall Study|Physician Decision|2|||
33525132|NCT03093415|62912133|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
33525133|NCT03093415|62912134|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
33525134|NCT03093415|62912132|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
33525135|NCT03093415|62912133|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
33525136|NCT03093415|62912134|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
33525137|NCT03093415|62912132|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
33525138|NCT03093415|62912133|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
33525139|NCT03093415|62912134|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
33618624|NCT02072096|63019742|FG001|Overall Study|Lack of Efficacy|29|||
33618625|NCT02072096|63019741|FG000|Overall Study|Protocol Violation|7|||
33618626|NCT02072096|63019742|FG001|Overall Study|Protocol Violation|7|||
33618627|NCT02072096|63019741|FG000|Overall Study|Withdrawal by Subject|5|||
33618628|NCT02072096|63019742|FG001|Overall Study|Withdrawal by Subject|7|||
33618629|NCT02072096|63019741|FG000|Overall Study|Adverse Event|5|||
33618630|NCT02072096|63019742|FG001|Overall Study|Adverse Event|2|||
33618631|NCT02072096|63019741|FG000|Overall Study|No Reason Provided|4|||
33618632|NCT02072096|63019742|FG001|Overall Study|No Reason Provided|2|||
33618633|NCT02072096|63019741|FG000|Overall Study|Death|2|||
33618634|NCT02072096|63019742|FG001|Overall Study|Death|0|||
33618635|NCT02072096|63019741|FG000|Overall Study|Physician Decision|0|||
33618636|NCT02072096|63019742|FG001|Overall Study|Physician Decision|1|||
33618637|NCT02072096|63019741|FG000|Overall Study|Study Terminated by Sponsor|43|||
33618638|NCT02072096|63019742|FG001|Overall Study|Study Terminated by Sponsor|30|||
33618639|NCT02072096|63019741|FG000|Overall Study|Lost to Follow-up|1|||
33618640|NCT02072096|63019742|FG001|Overall Study|Lost to Follow-up|0|||
33618641|NCT02071706|63019749|FG000|Overall Study|Adverse Event|1|||
33618642|NCT02071706|63019749|FG000|Overall Study|Withdrawal by Subject|2|||
33618643|NCT01631825|63019753|FG000|Overall Study|Adverse Event|42|||
33618644|NCT01631825|63019753|FG000|Overall Study|Lack of Efficacy|7|||
33618645|NCT01631825|63019753|FG000|Overall Study|Withdrawal by Subject|9|||
33618646|NCT01631825|63019753|FG000|Overall Study|Protocol Violation|4|||
33618647|NCT01631825|63019753|FG000|Overall Study|Discontinuation criteria|1|||
33618648|NCT01631825|63019753|FG000|Overall Study|Physician Decision|2|||
33618649|NCT02071082|63019759|FG000|Overall Study|Enrolled and Never Treated|1|||
33618650|NCT02071082|63019760|FG001|Overall Study|Enrolled and Never Treated|1|||
33618651|NCT02071082|63019759|FG000|Overall Study|Adverse Event|0|||
33618652|NCT02071082|63019760|FG001|Overall Study|Adverse Event|1|||
33618653|NCT02071082|63019759|FG000|Overall Study|Withdrew Consent|0|||
33618654|NCT02071082|63019760|FG001|Overall Study|Withdrew Consent|4|||
33525140|NCT03093415|62912132|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
33525141|NCT03093415|62912133|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
33525142|NCT03093415|62912134|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
33525143|NCT03093415|62912132|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
33525144|NCT03093415|62912133|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
33525145|NCT03093415|62912134|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
33525146|NCT03093415|62912132|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
33525147|NCT03093415|62912133|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
33525148|NCT03093415|62912134|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
33525149|NCT01358526|62912144|FG000|Open-label Titration Period|Adverse Event|95|||
33525150|NCT01358526|62912145|FG001|Open-label Titration Period|Adverse Event|0|||
33525151|NCT01358526|62912146|FG002|Open-label Titration Period|Adverse Event|0|||
33525152|NCT01358526|62912144|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
33525153|NCT01358526|62912145|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
33618655|NCT02071082|63019759|FG000|Overall Study|Lost to Follow-up|1|||
33618656|NCT02071082|63019760|FG001|Overall Study|Lost to Follow-up|1|||
33618657|NCT02123108|63019768|FG000|Overall Study|Death|2|||
33618658|NCT02123108|63019769|FG001|Overall Study|Death|3|||
33618659|NCT02121392|63019777|FG000|Prior to Intervention|Protocol Violation|40|||
33618660|NCT02121392|63019778|FG001|Prior to Intervention|Protocol Violation|35|||
33618661|NCT02121392|63019777|FG000|Prior to Intervention|Withdrawal by Subject|8|||
33618662|NCT02121392|63019778|FG001|Prior to Intervention|Withdrawal by Subject|6|||
33618663|NCT02121392|63019777|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
33325260|NCT01214252|62701995|FG000|Overall Study|Not eligible per protocol|82|||
33325261|NCT01214174|62702003|FG000|Overall Study|Withdrawal by Subject|0|||
33618664|NCT02121392|63019778|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
33618665|NCT02121392|63019777|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
33618666|NCT02121392|63019778|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
33618667|NCT02097056|63019784|FG000|Overall Study|Protocol Violation|2|||
33618668|NCT02097056|63019784|FG000|Overall Study|Withdrawal by Subject|15|||
33618669|NCT02097056|63019784|FG000|Overall Study|Lost to Follow-up|2|||
33618670|NCT02097056|63019784|FG000|Overall Study|Adverse Event|37|||
33618671|NCT02097056|63019784|FG000|Overall Study|Other|2|||
33525154|NCT01358526|62912146|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
33525155|NCT01358526|62912144|FG000|Open-label Titration Period|Lost to Follow-up|25|||
33525156|NCT01358526|62912145|FG001|Open-label Titration Period|Lost to Follow-up|0|||
33525157|NCT01358526|62912146|FG002|Open-label Titration Period|Lost to Follow-up|0|||
33525158|NCT01358526|62912144|FG000|Open-label Titration Period|Lack of Efficacy|107|||
33525159|NCT01358526|62912145|FG001|Open-label Titration Period|Lack of Efficacy|0|||
33525160|NCT01358526|62912146|FG002|Open-label Titration Period|Lack of Efficacy|0|||
33525161|NCT01358526|62912144|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
33525162|NCT01358526|62912145|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
33525163|NCT01358526|62912146|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
33525164|NCT01358526|62912144|FG000|Open-label Titration Period|Administrative|8|||
33525165|NCT01358526|62912145|FG001|Open-label Titration Period|Administrative|0|||
33525166|NCT01358526|62912146|FG002|Open-label Titration Period|Administrative|0|||
33525167|NCT01358526|62912144|FG000|Open-label Titration Period|Did not qualify|178|||
33618672|NCT02121002|63019791|FG000|Overall Study|Physician Decision|2|||
33618673|NCT02121002|63019792|FG001|Overall Study|Physician Decision|0|||
33618674|NCT02121002|63019793|FG002|Overall Study|Physician Decision|0|||
33618675|NCT02121002|63019791|FG000|Overall Study|Withdrawal by Subject|3|||
33618676|NCT02121002|63019792|FG001|Overall Study|Withdrawal by Subject|1|||
33618677|NCT02121002|63019793|FG002|Overall Study|Withdrawal by Subject|4|||
33618678|NCT02121002|63019791|FG000|Overall Study|Protocol Violation|1|||
33618679|NCT02121002|63019792|FG001|Overall Study|Protocol Violation|2|||
33618680|NCT02121002|63019793|FG002|Overall Study|Protocol Violation|4|||
33618681|NCT02121002|63019791|FG000|Overall Study|Concomitant therapy|0|||
33618682|NCT02121002|63019792|FG001|Overall Study|Concomitant therapy|1|||
33618683|NCT02121002|63019793|FG002|Overall Study|Concomitant therapy|1|||
33618684|NCT02121002|63019791|FG000|Overall Study|Others|1|||
33618685|NCT02121002|63019792|FG001|Overall Study|Others|0|||
33618686|NCT02121002|63019793|FG002|Overall Study|Others|1|||
33618687|NCT02096900|63019803|FG000|Overall Study|Did not receive medication|3|||
33618688|NCT02096900|63019804|FG001|Overall Study|Did not receive medication|1|||
33618689|NCT02096900|63019803|FG000|Overall Study|Surgery cancelled- medication received|1|||
33618690|NCT02096900|63019804|FG001|Overall Study|Surgery cancelled- medication received|1|||
33618691|NCT02120924|63019813|FG000|Overall Study|Lack of Efficacy|1|||
33618692|NCT02120924|63019814|FG001|Overall Study|Lack of Efficacy|2|||
33618693|NCT02120924|63019815|FG002|Overall Study|Lack of Efficacy|3|||
33525168|NCT01358526|62912145|FG001|Open-label Titration Period|Did not qualify|0|||
33525169|NCT01358526|62912146|FG002|Open-label Titration Period|Did not qualify|0|||
33525170|NCT01358526|62912144|FG000|Double-blind Phase|Adverse Event|0|||
33525171|NCT01358526|62912145|FG001|Double-blind Phase|Adverse Event|24|||
33525172|NCT01358526|62912146|FG002|Double-blind Phase|Adverse Event|23|||
33525173|NCT01358526|62912144|FG000|Double-blind Phase|Withdrawal by Subject|0|||
33525174|NCT01358526|62912145|FG001|Double-blind Phase|Withdrawal by Subject|10|||
33525175|NCT01358526|62912146|FG002|Double-blind Phase|Withdrawal by Subject|8|||
33525176|NCT01358526|62912144|FG000|Double-blind Phase|Lost to Follow-up|0|||
33525177|NCT01358526|62912145|FG001|Double-blind Phase|Lost to Follow-up|4|||
33525178|NCT01358526|62912146|FG002|Double-blind Phase|Lost to Follow-up|1|||
33525179|NCT01358526|62912144|FG000|Double-blind Phase|Lack of Efficacy|0|||
33525180|NCT01358526|62912145|FG001|Double-blind Phase|Lack of Efficacy|31|||
33525181|NCT01358526|62912146|FG002|Double-blind Phase|Lack of Efficacy|73|||
33525182|NCT01358526|62912144|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
33525183|NCT01358526|62912145|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
33525184|NCT01358526|62912146|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
33525185|NCT01358526|62912144|FG000|Double-blind Phase|Administrative|0|||
33618694|NCT02120924|63019813|FG000|Overall Study|Adverse Event|0|||
33618695|NCT02120924|63019814|FG001|Overall Study|Adverse Event|1|||
33618696|NCT02120924|63019815|FG002|Overall Study|Adverse Event|3|||
33618697|NCT02120924|63019813|FG000|Overall Study|Withdrawal by Subject|16|||
33618698|NCT02120924|63019814|FG001|Overall Study|Withdrawal by Subject|20|||
33618699|NCT02120924|63019815|FG002|Overall Study|Withdrawal by Subject|8|||
33618700|NCT02120924|63019813|FG000|Overall Study|Lost to Follow-up|14|||
33525186|NCT01358526|62912145|FG001|Double-blind Phase|Administrative|6|||
33525187|NCT01358526|62912146|FG002|Double-blind Phase|Administrative|10|||
33525188|NCT02830776|62912153|FG000|Overall Study|Lost to Follow-up|1|||
33525189|NCT03039621|62912160|FG000|Overall Study|Violation of inclusion criteria|3|||
33618701|NCT02120924|63019814|FG001|Overall Study|Lost to Follow-up|14|||
33618702|NCT02120924|63019815|FG002|Overall Study|Lost to Follow-up|11|||
33618703|NCT02120924|63019813|FG000|Overall Study|Pregnancy|2|||
33618704|NCT02120924|63019814|FG001|Overall Study|Pregnancy|0|||
33618705|NCT02120924|63019815|FG002|Overall Study|Pregnancy|0|||
33618706|NCT02120924|63019813|FG000|Overall Study|Protocol Violation|3|||
33618707|NCT02120924|63019814|FG001|Overall Study|Protocol Violation|7|||
33618708|NCT02120924|63019815|FG002|Overall Study|Protocol Violation|2|||
33618709|NCT02120924|63019813|FG000|Overall Study|Physician Decision|0|||
33618710|NCT02120924|63019814|FG001|Overall Study|Physician Decision|1|||
33618711|NCT02120924|63019815|FG002|Overall Study|Physician Decision|1|||
33618712|NCT02120924|63019813|FG000|Overall Study|Death|1|||
33618713|NCT02120924|63019814|FG001|Overall Study|Death|0|||
33618714|NCT02120924|63019815|FG002|Overall Study|Death|0|||
33618715|NCT02120924|63019813|FG000|Overall Study|Compliance with IP|5|||
33618716|NCT02120924|63019814|FG001|Overall Study|Compliance with IP|1|||
33525190|NCT03039621|62912161|FG001|Overall Study|Violation of inclusion criteria|2|||
33525191|NCT03039621|62912160|FG000|Overall Study|Non-compliance with protocol requirement|4|||
33525192|NCT03039621|62912161|FG001|Overall Study|Non-compliance with protocol requirement|5|||
33525193|NCT03039621|62912160|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
33618717|NCT02120924|63019815|FG002|Overall Study|Compliance with IP|1|||
33618718|NCT02096744|63019824|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
33618719|NCT02096744|63019825|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
33618720|NCT02096744|63019824|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
33618721|NCT02096744|63019825|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
33618722|NCT02096744|63019824|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
33618723|NCT02096744|63019825|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
33618724|NCT02096042|63019833|FG000|Overall Study|Disease Progression|1|||
33618725|NCT02096042|63019834|FG001|Overall Study|Disease Progression|0|||
33618726|NCT02096042|63019835|FG002|Overall Study|Disease Progression|0|||
33618727|NCT02120456|63019851|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33618728|NCT02120456|63019852|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33618729|NCT02120456|63019853|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33618730|NCT02120456|63019854|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33618731|NCT02120456|63019855|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33618732|NCT02120456|63019856|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33618733|NCT02120456|63019857|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
33618734|NCT02120456|63019858|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33618735|NCT02120456|63019859|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33618736|NCT02120456|63019851|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33618737|NCT02120456|63019852|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33525194|NCT03039621|62912161|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
33525195|NCT03039621|62912160|FG000|Overall Study|Violation of non-inclusion criteria|1|||
33525196|NCT03039621|62912161|FG001|Overall Study|Violation of non-inclusion criteria|2|||
33525197|NCT03041181|62912169|FG000|Overall Study|Disease Progression|1|||
33525198|NCT03041181|62912170|FG001|Overall Study|Disease Progression|2|||
33525199|NCT02828436|62912176|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
33525200|NCT02828436|62912177|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
33525201|NCT02828436|62912176|FG000|Period 1|Lost to Follow-up|0|||
33525202|NCT02828436|62912177|FG001|Period 1|Lost to Follow-up|1|||
33525203|NCT02828436|62912176|FG000|Period 2|Withdrawal by Subject|4|||
33525204|NCT02828436|62912177|FG001|Period 2|Withdrawal by Subject|0|||
33525205|NCT02828436|62912176|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
33525206|NCT02828436|62912177|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
33525207|NCT02828436|62912176|FG000|Period 2|Lost to Follow-up|1|||
33525208|NCT02828436|62912177|FG001|Period 2|Lost to Follow-up|0|||
33525209|NCT02828124|62912191|FG000|Overall Study|Disease Progression|1|||
33525210|NCT02828124|62912192|FG001|Overall Study|Disease Progression|2|||
33525211|NCT02828124|62912193|FG002|Overall Study|Disease Progression|1|||
33525212|NCT02828124|62912194|FG003|Overall Study|Disease Progression|4|||
33525213|NCT02828124|62912191|FG000|Overall Study|AE Unrelated to Study Drug|0|||
33618738|NCT02120456|63019853|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33618739|NCT02120456|63019854|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33618740|NCT02120456|63019855|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33525214|NCT02828124|62912192|FG001|Overall Study|AE Unrelated to Study Drug|0|||
33618741|NCT02120456|63019856|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33618742|NCT02120456|63019857|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
33618743|NCT02120456|63019858|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33618744|NCT02120456|63019859|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33618745|NCT02120456|63019851|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33618746|NCT02120456|63019852|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33618747|NCT02120456|63019853|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33618748|NCT02120456|63019854|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33618749|NCT02120456|63019855|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33525215|NCT02828124|62912193|FG002|Overall Study|AE Unrelated to Study Drug|0|||
33618750|NCT02120456|63019856|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33618751|NCT02120456|63019857|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33618752|NCT02120456|63019858|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33525216|NCT02828124|62912194|FG003|Overall Study|AE Unrelated to Study Drug|1|||
33525217|NCT02828124|62912191|FG000|Overall Study|Subject Withdrew Consent|0|||
33525218|NCT02828124|62912192|FG001|Overall Study|Subject Withdrew Consent|0|||
33525219|NCT02828124|62912193|FG002|Overall Study|Subject Withdrew Consent|0|||
33525220|NCT02828124|62912194|FG003|Overall Study|Subject Withdrew Consent|1|||
33525221|NCT02829996|62912209|FG000|Overall Study|Withdrawal by Subject|1|||
33525222|NCT02829996|62912210|FG001|Overall Study|Withdrawal by Subject|0|||
33525223|NCT02829996|62912211|FG002|Overall Study|Withdrawal by Subject|0|||
33525224|NCT02829996|62912212|FG003|Overall Study|Withdrawal by Subject|0|||
33525225|NCT02829996|62912213|FG004|Overall Study|Withdrawal by Subject|0|||
33525226|NCT02827500|62912227|FG000|Overall Study|Death|7|||
33525227|NCT02827500|62912228|FG001|Overall Study|Death|3|||
33525228|NCT02827500|62912227|FG000|Overall Study|Lost to Follow-up|1|||
33525229|NCT02827500|62912228|FG001|Overall Study|Lost to Follow-up|1|||
33525230|NCT02827500|62912227|FG000|Overall Study|Withdrawal by Subject|3|||
33525231|NCT02827500|62912228|FG001|Overall Study|Withdrawal by Subject|1|||
33525232|NCT02827500|62912227|FG000|Overall Study|Missing primary endpoint data|3|||
33525233|NCT02827500|62912228|FG001|Overall Study|Missing primary endpoint data|1|||
33525234|NCT02827500|62912227|FG000|Overall Study|Other|5|||
33525235|NCT02827500|62912228|FG001|Overall Study|Other|1|||
33525236|NCT02826798|62912239|FG000|Overall Study|Withdrawal by Subject|0|||
33525237|NCT02826798|62912240|FG001|Overall Study|Withdrawal by Subject|1|||
33525238|NCT02826798|62912241|FG002|Overall Study|Withdrawal by Subject|0|||
33525239|NCT02826798|62912242|FG003|Overall Study|Withdrawal by Subject|1|||
33525240|NCT02826798|62912243|FG004|Overall Study|Withdrawal by Subject|0|||
33525241|NCT02829138|62912257|FG000|Overall Study|Withdrawal by Subject|1|||
33525242|NCT02829138|62912258|FG001|Overall Study|Withdrawal by Subject|0|||
33525243|NCT02825550|62912264|FG000|Overall Study|Physician Decision|1|||
33525244|NCT02744040|62912273|FG000|Overall Study|Withdrawal by Subject|3|||
33525245|NCT02744040|62912274|FG001|Overall Study|Withdrawal by Subject|2|||
33525246|NCT02744040|62912275|FG002|Overall Study|Withdrawal by Subject|2|||
33525247|NCT02744040|62912273|FG000|Overall Study|Physician Decision|0|||
33525248|NCT02744040|62912274|FG001|Overall Study|Physician Decision|8|||
33525249|NCT02744040|62912275|FG002|Overall Study|Physician Decision|13|||
33525250|NCT02744040|62912273|FG000|Overall Study|Lost to Follow-up|3|||
33525251|NCT02744040|62912274|FG001|Overall Study|Lost to Follow-up|1|||
33525252|NCT02744040|62912275|FG002|Overall Study|Lost to Follow-up|7|||
33525253|NCT02743962|62912285|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
33525254|NCT02743962|62912286|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
33525255|NCT03094416|62912295|FG000|Run-in|Screening failure|8|||
33525256|NCT03094416|62912295|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
33525257|NCT03094416|62912295|FG000|Run-in|Withdrawal by Subject|3|||
33525258|NCT03094416|62912295|FG000|Treatment Period|Withdrawal by Subject|2|||
33525259|NCT03041025|62912303|FG000|Overall Study|Adverse Event|0|||
33525260|NCT03041025|62912304|FG001|Overall Study|Adverse Event|0|||
33525261|NCT03041025|62912305|FG002|Overall Study|Adverse Event|1|||
33525262|NCT03041025|62912303|FG000|Overall Study|Lost to Follow-up|1|||
33618753|NCT02120456|63019859|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
33618754|NCT02120300|63019883|FG000|Overall Study|Enrolled but Never Treated|2|||
33618755|NCT02120300|63019884|FG001|Overall Study|Enrolled but Never Treated|0|||
33618756|NCT02120300|63019885|FG002|Overall Study|Enrolled but Never Treated|0|||
33618757|NCT02120300|63019886|FG003|Overall Study|Enrolled but Never Treated|0|||
33618758|NCT02120300|63019883|FG000|Overall Study|Lack of Efficacy|0|||
33618759|NCT02120300|63019884|FG001|Overall Study|Lack of Efficacy|0|||
33618760|NCT02120300|63019885|FG002|Overall Study|Lack of Efficacy|0|||
33618761|NCT02120300|63019886|FG003|Overall Study|Lack of Efficacy|1|||
33618762|NCT02120300|63019883|FG000|Overall Study|Lost to Follow-up|1|||
33618763|NCT02120300|63019884|FG001|Overall Study|Lost to Follow-up|0|||
33618764|NCT02120300|63019885|FG002|Overall Study|Lost to Follow-up|0|||
33618765|NCT02120300|63019886|FG003|Overall Study|Lost to Follow-up|0|||
33525263|NCT03041025|62912304|FG001|Overall Study|Lost to Follow-up|0|||
33618766|NCT02070380|63019902|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
33525264|NCT03041025|62912305|FG002|Overall Study|Lost to Follow-up|0|||
33525265|NCT03041025|62912303|FG000|Overall Study|Withdrawal by Subject|0|||
33525266|NCT03041025|62912304|FG001|Overall Study|Withdrawal by Subject|0|||
33525267|NCT03041025|62912305|FG002|Overall Study|Withdrawal by Subject|1|||
33525268|NCT01338870|62912322|FG000|Overall Study|Lost to Follow-up|0|||
33525269|NCT01338870|62912323|FG001|Overall Study|Lost to Follow-up|0|||
33525270|NCT01338870|62912324|FG002|Overall Study|Lost to Follow-up|1|||
33525271|NCT01338870|62912325|FG003|Overall Study|Lost to Follow-up|0|||
33525272|NCT01338870|62912326|FG004|Overall Study|Lost to Follow-up|1|||
33525273|NCT01338870|62912327|FG005|Overall Study|Lost to Follow-up|0|||
33525274|NCT01338870|62912322|FG000|Overall Study|Withdrawal by Subject|2|||
33525275|NCT01338870|62912323|FG001|Overall Study|Withdrawal by Subject|3|||
33525276|NCT01338870|62912324|FG002|Overall Study|Withdrawal by Subject|4|||
33525277|NCT01338870|62912325|FG003|Overall Study|Withdrawal by Subject|0|||
33525278|NCT01338870|62912326|FG004|Overall Study|Withdrawal by Subject|0|||
33525279|NCT01338870|62912327|FG005|Overall Study|Withdrawal by Subject|2|||
33525280|NCT01338870|62912322|FG000|Overall Study|Other|3|||
33525281|NCT01338870|62912323|FG001|Overall Study|Other|3|||
33525282|NCT01338870|62912324|FG002|Overall Study|Other|3|||
33525283|NCT01338870|62912325|FG003|Overall Study|Other|2|||
33525284|NCT01338870|62912326|FG004|Overall Study|Other|0|||
33525285|NCT01338870|62912327|FG005|Overall Study|Other|2|||
33525286|NCT01338870|62912322|FG000|Overall Study|Protocol Violation|0|||
33525287|NCT01338870|62912323|FG001|Overall Study|Protocol Violation|2|||
33525288|NCT01338870|62912324|FG002|Overall Study|Protocol Violation|2|||
33525289|NCT01338870|62912325|FG003|Overall Study|Protocol Violation|2|||
33525290|NCT01338870|62912326|FG004|Overall Study|Protocol Violation|1|||
33525291|NCT01338870|62912327|FG005|Overall Study|Protocol Violation|1|||
33525292|NCT01338870|62912322|FG000|Overall Study|Adverse Event|4|||
33525293|NCT01338870|62912323|FG001|Overall Study|Adverse Event|4|||
33525294|NCT01338870|62912324|FG002|Overall Study|Adverse Event|1|||
33525295|NCT01338870|62912325|FG003|Overall Study|Adverse Event|5|||
33525296|NCT01338870|62912326|FG004|Overall Study|Adverse Event|4|||
33525297|NCT01338870|62912327|FG005|Overall Study|Adverse Event|1|||
33525298|NCT02824224|62912343|FG000|Overall Study|Discontinued, IUS expulsion|0|||
33525299|NCT02824224|62912344|FG001|Overall Study|Discontinued, IUS expulsion|1|||
33525300|NCT02824224|62912343|FG000|Overall Study|Did not show up for allocation visit|2|||
33525301|NCT02824224|62912344|FG001|Overall Study|Did not show up for allocation visit|0|||
33525302|NCT01338792|62912350|FG000|Overall Study|Adverse Event|2|||
33525303|NCT01338792|62912350|FG000|Overall Study|Death|1|||
33525304|NCT01338792|62912350|FG000|Overall Study|Withdrawal by Subject|1|||
33525305|NCT01314105|62912356|FG000|Overall Study|Progressive Disease|6|||
33525306|NCT01314105|62912357|FG001|Overall Study|Progressive Disease|10|||
33525307|NCT01314105|62912356|FG000|Overall Study|Refused to continue taking medication|0|||
33525308|NCT01314105|62912357|FG001|Overall Study|Refused to continue taking medication|1|||
33525309|NCT01314105|62912356|FG000|Overall Study|Other Adverse Event|1|||
33525310|NCT01314105|62912357|FG001|Overall Study|Other Adverse Event|1|||
33525311|NCT03040713|62912365|FG000|Overall Study|Positive amyloid scan|3|||
33525312|NCT01966471|62912371|FG000|Overall Study|Death|44|||
33525313|NCT01966471|62912372|FG001|Overall Study|Death|56|||
33525314|NCT01966471|62912371|FG000|Overall Study|Lost to Follow-up|46|||
33525315|NCT01966471|62912372|FG001|Overall Study|Lost to Follow-up|39|||
33525316|NCT01966471|62912371|FG000|Overall Study|Various reasons|4|||
33525317|NCT01966471|62912372|FG001|Overall Study|Various reasons|4|||
33525318|NCT01966471|62912371|FG000|Overall Study|Physician Decision|7|||
33525319|NCT01966471|62912372|FG001|Overall Study|Physician Decision|5|||
33525320|NCT01966471|62912371|FG000|Overall Study|Study Terminated By Sponsor|758|||
33525321|NCT01966471|62912372|FG001|Overall Study|Study Terminated By Sponsor|773|||
33525322|NCT01966471|62912371|FG000|Overall Study|Withdrawal by Subject|59|||
33525323|NCT01966471|62912372|FG001|Overall Study|Withdrawal by Subject|51|||
33525324|NCT03227471|62912401|FG000|Overall Study|Withdrawal by Subject|0|||
33525325|NCT03227471|62912402|FG001|Overall Study|Withdrawal by Subject|0|||
33525326|NCT03227471|62912403|FG002|Overall Study|Withdrawal by Subject|0|||
33525327|NCT03227471|62912404|FG003|Overall Study|Withdrawal by Subject|0|||
33618767|NCT02070380|63019903|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
33618768|NCT02070380|63019904|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
33618769|NCT02070380|63019905|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
33525328|NCT03227471|62912405|FG004|Overall Study|Withdrawal by Subject|1|||
33618770|NCT02070380|63019902|FG000|Second Injection|Image sets missing or technically inadeq|0|||
33618771|NCT02070380|63019903|FG001|Second Injection|Image sets missing or technically inadeq|1|||
33618772|NCT02070380|63019904|FG002|Second Injection|Image sets missing or technically inadeq|0|||
33618773|NCT02070380|63019905|FG003|Second Injection|Image sets missing or technically inadeq|0|||
33525329|NCT03227471|62912406|FG005|Overall Study|Withdrawal by Subject|0|||
33525330|NCT03227471|62912407|FG006|Overall Study|Withdrawal by Subject|0|||
33525331|NCT03227471|62912408|FG007|Overall Study|Withdrawal by Subject|0|||
33525332|NCT03227471|62912409|FG008|Overall Study|Withdrawal by Subject|0|||
33525333|NCT03227471|62912410|FG009|Overall Study|Withdrawal by Subject|0|||
33525334|NCT03227471|62912411|FG010|Overall Study|Withdrawal by Subject|0|||
33525335|NCT03227471|62912412|FG011|Overall Study|Withdrawal by Subject|0|||
33525336|NCT03227471|62912413|FG012|Overall Study|Withdrawal by Subject|1|||
33525337|NCT03227471|62912414|FG013|Overall Study|Withdrawal by Subject|0|||
33525338|NCT03227471|62912415|FG014|Overall Study|Withdrawal by Subject|0|||
33525339|NCT03227471|62912401|FG000|Overall Study|Randomized, Never Dosed|0|||
33525340|NCT03227471|62912402|FG001|Overall Study|Randomized, Never Dosed|0|||
33525341|NCT03227471|62912403|FG002|Overall Study|Randomized, Never Dosed|0|||
33525342|NCT03227471|62912404|FG003|Overall Study|Randomized, Never Dosed|0|||
33525343|NCT03227471|62912405|FG004|Overall Study|Randomized, Never Dosed|0|||
33525344|NCT03227471|62912406|FG005|Overall Study|Randomized, Never Dosed|0|||
33525345|NCT03227471|62912407|FG006|Overall Study|Randomized, Never Dosed|0|||
33525346|NCT03227471|62912408|FG007|Overall Study|Randomized, Never Dosed|0|||
33525347|NCT03227471|62912409|FG008|Overall Study|Randomized, Never Dosed|0|||
33525348|NCT03227471|62912410|FG009|Overall Study|Randomized, Never Dosed|0|||
33525349|NCT03227471|62912411|FG010|Overall Study|Randomized, Never Dosed|0|||
33525350|NCT03227471|62912412|FG011|Overall Study|Randomized, Never Dosed|0|||
33525351|NCT03227471|62912413|FG012|Overall Study|Randomized, Never Dosed|0|||
33525352|NCT03227471|62912414|FG013|Overall Study|Randomized, Never Dosed|0|||
33525353|NCT03227471|62912415|FG014|Overall Study|Randomized, Never Dosed|1|||
33525354|NCT01354314|62912480|FG000|Overall Study|Lost to Follow-up|1|||
33525355|NCT01354314|62912481|FG001|Overall Study|Lost to Follow-up|0|||
33525356|NCT01354314|62912482|FG002|Overall Study|Lost to Follow-up|1|||
33525357|NCT01354314|62912483|FG003|Overall Study|Lost to Follow-up|1|||
33525358|NCT01354314|62912480|FG000|Overall Study|Withdrawal by Subject|0|||
33525359|NCT01354314|62912481|FG001|Overall Study|Withdrawal by Subject|0|||
33525360|NCT01354314|62912482|FG002|Overall Study|Withdrawal by Subject|1|||
33525361|NCT01354314|62912483|FG003|Overall Study|Withdrawal by Subject|0|||
33525362|NCT01354314|62912480|FG000|Overall Study|Adverse Event|0|||
33525363|NCT01354314|62912481|FG001|Overall Study|Adverse Event|0|||
33525364|NCT01354314|62912482|FG002|Overall Study|Adverse Event|0|||
33525365|NCT01354314|62912483|FG003|Overall Study|Adverse Event|1|||
33525366|NCT01354314|62912480|FG000|Overall Study|Protocol Violation|1|||
33525367|NCT01354314|62912481|FG001|Overall Study|Protocol Violation|1|||
33525368|NCT01354314|62912482|FG002|Overall Study|Protocol Violation|0|||
33525369|NCT01354314|62912483|FG003|Overall Study|Protocol Violation|0|||
33525370|NCT01354314|62912480|FG000|Overall Study|Less than 90% Adherence|4|||
33525371|NCT01354314|62912481|FG001|Overall Study|Less than 90% Adherence|2|||
33525372|NCT01354314|62912482|FG002|Overall Study|Less than 90% Adherence|6|||
33525373|NCT01354314|62912483|FG003|Overall Study|Less than 90% Adherence|4|||
33525374|NCT03194321|62912495|FG000|Overall Study|Withdrawal by Subject|1|||
33525375|NCT03194321|62912495|FG000|Overall Study|Lost to Follow-up|1|||
33525376|NCT03194321|62912495|FG000|Overall Study|Travel for Follow-up|1|||
33525377|NCT01354938|62912499|FG000|Overall Study|Lost to Follow-up|1|||
33525378|NCT03092791|62912522|FG000|Overall Study|Lost to Follow-up|0|||
33525379|NCT03092791|62912523|FG001|Overall Study|Lost to Follow-up|0|||
33525380|NCT03092791|62912524|FG002|Overall Study|Lost to Follow-up|0|||
33525381|NCT03092791|62912525|FG003|Overall Study|Lost to Follow-up|0|||
33525382|NCT03092791|62912526|FG004|Overall Study|Lost to Follow-up|0|||
33525383|NCT03092791|62912527|FG005|Overall Study|Lost to Follow-up|0|||
33525384|NCT03092791|62912528|FG006|Overall Study|Lost to Follow-up|1|||
33525385|NCT03092791|62912529|FG007|Overall Study|Lost to Follow-up|0|||
33525386|NCT03092791|62912522|FG000|Overall Study|Withdrawal of Consent|0|||
33525387|NCT03092791|62912523|FG001|Overall Study|Withdrawal of Consent|0|||
33525388|NCT03092791|62912524|FG002|Overall Study|Withdrawal of Consent|0|||
33525389|NCT03092791|62912525|FG003|Overall Study|Withdrawal of Consent|0|||
33525390|NCT03092791|62912526|FG004|Overall Study|Withdrawal of Consent|4|||
33525391|NCT03092791|62912527|FG005|Overall Study|Withdrawal of Consent|12|||
33525392|NCT03092791|62912528|FG006|Overall Study|Withdrawal of Consent|6|||
33525393|NCT03092791|62912529|FG007|Overall Study|Withdrawal of Consent|4|||
33525394|NCT03092791|62912522|FG000|Overall Study|Study Termination|0|||
33525395|NCT03092791|62912523|FG001|Overall Study|Study Termination|0|||
33525396|NCT03092791|62912524|FG002|Overall Study|Study Termination|0|||
33525397|NCT03092791|62912525|FG003|Overall Study|Study Termination|0|||
33525398|NCT03092791|62912526|FG004|Overall Study|Study Termination|55|||
33525399|NCT03092791|62912527|FG005|Overall Study|Study Termination|46|||
33525400|NCT03092791|62912528|FG006|Overall Study|Study Termination|53|||
33525401|NCT03092791|62912529|FG007|Overall Study|Study Termination|55|||
33525402|NCT03092791|62912522|FG000|Overall Study|Death|0|||
33525403|NCT03092791|62912523|FG001|Overall Study|Death|0|||
33525404|NCT03092791|62912524|FG002|Overall Study|Death|0|||
33525405|NCT03092791|62912525|FG003|Overall Study|Death|0|||
33525406|NCT03092791|62912526|FG004|Overall Study|Death|0|||
33525407|NCT03092791|62912527|FG005|Overall Study|Death|1|||
33525408|NCT03092791|62912528|FG006|Overall Study|Death|0|||
33525409|NCT03092791|62912529|FG007|Overall Study|Death|1|||
33525410|NCT03092791|62912522|FG000|Overall Study|Reason Not Specified|0|||
33525411|NCT03092791|62912523|FG001|Overall Study|Reason Not Specified|0|||
33525412|NCT03092791|62912524|FG002|Overall Study|Reason Not Specified|0|||
33525413|NCT03092791|62912525|FG003|Overall Study|Reason Not Specified|0|||
33525414|NCT03092791|62912526|FG004|Overall Study|Reason Not Specified|1|||
33525415|NCT03092791|62912527|FG005|Overall Study|Reason Not Specified|1|||
33525416|NCT03092791|62912528|FG006|Overall Study|Reason Not Specified|0|||
33525417|NCT03092791|62912529|FG007|Overall Study|Reason Not Specified|0|||
33525418|NCT04283461|62912557|FG000|Overall Study|Enrolled in separate trial|0|||
33525419|NCT04283461|62912558|FG001|Overall Study|Enrolled in separate trial|0|||
33525420|NCT04283461|62912559|FG002|Overall Study|Enrolled in separate trial|8|||
33525421|NCT04283461|62912560|FG003|Overall Study|Enrolled in separate trial|13|||
33525422|NCT04283461|62912561|FG004|Overall Study|Enrolled in separate trial|12|||
33525423|NCT04283461|62912562|FG005|Overall Study|Enrolled in separate trial|0|||
33525424|NCT04283461|62912563|FG006|Overall Study|Enrolled in separate trial|0|||
33525425|NCT04283461|62912564|FG007|Overall Study|Enrolled in separate trial|8|||
33525426|NCT04283461|62912565|FG008|Overall Study|Enrolled in separate trial|0|||
33525427|NCT04283461|62912566|FG009|Overall Study|Enrolled in separate trial|0|||
33525428|NCT04283461|62912567|FG010|Overall Study|Enrolled in separate trial|0|||
33525429|NCT04283461|62912568|FG011|Overall Study|Enrolled in separate trial|7|||
33525430|NCT04283461|62912569|FG012|Overall Study|Enrolled in separate trial|0|||
33525431|NCT02505425|62912600|FG000|Overall Study|Lost to Follow-up|41|||
33525432|NCT02505425|62912601|FG001|Overall Study|Lost to Follow-up|61|||
33525433|NCT02505425|62912602|FG002|Overall Study|Lost to Follow-up|31|||
33525434|NCT02505425|62912603|FG003|Overall Study|Lost to Follow-up|19|||
33525435|NCT02505425|62912600|FG000|Overall Study|Withdrawal by Subject|39|||
33525436|NCT02505425|62912601|FG001|Overall Study|Withdrawal by Subject|9|||
33525437|NCT02505425|62912602|FG002|Overall Study|Withdrawal by Subject|19|||
33525438|NCT02505425|62912603|FG003|Overall Study|Withdrawal by Subject|7|||
33525439|NCT02505425|62912600|FG000|Overall Study|Death|8|||
33525440|NCT02505425|62912601|FG001|Overall Study|Death|12|||
33525441|NCT02505425|62912602|FG002|Overall Study|Death|0|||
33525442|NCT02505425|62912603|FG003|Overall Study|Death|0|||
33525443|NCT03089047|62912615|FG000|Overall Study|Lost to Follow-up|1|||
33525444|NCT03089047|62912616|FG001|Overall Study|Lost to Follow-up|0|||
33525445|NCT01371006|62912624|FG000|Overall Study|Adverse Event|1|||
33525446|NCT01371006|62912625|FG001|Overall Study|Adverse Event|0|||
33525447|NCT01371552|62912660|FG000|Part 1, First 3 Days|Inconvenience|0|||
33525448|NCT01371552|62912661|FG001|Part 1, First 3 Days|Inconvenience|0|||
33525449|NCT01371552|62912662|FG002|Part 1, First 3 Days|Inconvenience|1|||
33525450|NCT01371552|62912663|FG003|Part 1, First 3 Days|Inconvenience|0|||
33525451|NCT01371552|62912664|FG004|Part 1, First 3 Days|Inconvenience|0|||
33525452|NCT01371552|62912665|FG005|Part 1, First 3 Days|Inconvenience|0|||
33525453|NCT02819310|62912674|FG000|Overall Study|Withdrawal by Subject|37|||
33525454|NCT02819310|62912674|FG000|Overall Study|Lost to Follow-up|16|||
33525455|NCT02819310|62912674|FG000|Overall Study|Adverse Event|13|||
33618774|NCT02070380|63019902|FG000|Second Injection|Protocol Violation|0|||
33618775|NCT02070380|63019903|FG001|Second Injection|Protocol Violation|1|||
33525456|NCT02819310|62912674|FG000|Overall Study|Lack of Efficacy|5|||
33525457|NCT02819310|62912674|FG000|Overall Study|Physician Decision|8|||
33525458|NCT02819310|62912674|FG000|Overall Study|Protocol Violation|30|||
33525459|NCT03087643|62912680|FG000|Overall Study|Withdrawal by Subject|2|||
33618776|NCT02070380|63019904|FG002|Second Injection|Protocol Violation|1|||
33618777|NCT02070380|63019905|FG003|Second Injection|Protocol Violation|5|||
33618778|NCT02069366|63019923|FG000|Overall Study|Lost to Follow-up|0|||
33618779|NCT02069366|63019924|FG001|Overall Study|Lost to Follow-up|0|||
33618780|NCT02069366|63019925|FG002|Overall Study|Lost to Follow-up|1|||
33618781|NCT02069366|63019926|FG003|Overall Study|Lost to Follow-up|0|||
33618782|NCT02069366|63019927|FG004|Overall Study|Lost to Follow-up|0|||
33618783|NCT02069366|63019928|FG005|Overall Study|Lost to Follow-up|2|||
33618784|NCT02069366|63019923|FG000|Overall Study|Protocol Violation|0|||
33618785|NCT02069366|63019924|FG001|Overall Study|Protocol Violation|0|||
33618786|NCT02069366|63019925|FG002|Overall Study|Protocol Violation|1|||
33618787|NCT02069366|63019926|FG003|Overall Study|Protocol Violation|0|||
33618788|NCT02069366|63019927|FG004|Overall Study|Protocol Violation|0|||
33525460|NCT03087643|62912681|FG001|Overall Study|Withdrawal by Subject|4|||
33618789|NCT02069366|63019928|FG005|Overall Study|Protocol Violation|0|||
33618790|NCT02069366|63019923|FG000|Overall Study|Withdrawal by Subject|1|||
33525461|NCT03087643|62912680|FG000|Overall Study|Death|2|||
33525462|NCT03087643|62912681|FG001|Overall Study|Death|2|||
33525463|NCT02821962|62912689|FG000|Overall Study|Lost to Follow-up|2|||
33525464|NCT02821962|62912690|FG001|Overall Study|Lost to Follow-up|0|||
33525465|NCT03092479|62912698|FG000|Overall Study|Lost to Follow-up|3|||
33525466|NCT03092479|62912699|FG001|Overall Study|Lost to Follow-up|2|||
33525467|NCT03092479|62912698|FG000|Overall Study|Withdrawal by Subject|4|||
33525468|NCT03092479|62912699|FG001|Overall Study|Withdrawal by Subject|0|||
33618791|NCT02069366|63019924|FG001|Overall Study|Withdrawal by Subject|0|||
33618792|NCT02069366|63019925|FG002|Overall Study|Withdrawal by Subject|1|||
33618793|NCT02069366|63019926|FG003|Overall Study|Withdrawal by Subject|2|||
33618794|NCT02069366|63019927|FG004|Overall Study|Withdrawal by Subject|0|||
33618795|NCT02069366|63019928|FG005|Overall Study|Withdrawal by Subject|0|||
33618796|NCT02068508|63019943|FG000|Overall Study|Case report forms uncollected|27|||
33618797|NCT02068508|63019943|FG000|Overall Study|Patient did not visit the study site|1|||
33618798|NCT02068508|63019943|FG000|Overall Study|Protocol Violation|4|||
33618799|NCT02068352|63019950|FG000|Overall Study|Lost to Follow-up|0|||
33618800|NCT02068352|63019951|FG001|Overall Study|Lost to Follow-up|2|||
33618801|NCT02068352|63019952|FG002|Overall Study|Lost to Follow-up|0|||
33618802|NCT02068352|63019950|FG000|Overall Study|Adverse Event|4|||
33618803|NCT02068352|63019951|FG001|Overall Study|Adverse Event|2|||
33618804|NCT02068352|63019952|FG002|Overall Study|Adverse Event|7|||
33618805|NCT02068352|63019950|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
33618806|NCT02068352|63019951|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
33618807|NCT02068352|63019952|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
33618808|NCT02068352|63019950|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
33618809|NCT02068352|63019951|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
33618810|NCT02068352|63019952|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
33618811|NCT02068352|63019950|FG000|Overall Study|Protocol Deviation|0|||
33618812|NCT02068352|63019951|FG001|Overall Study|Protocol Deviation|0|||
33618813|NCT02068352|63019952|FG002|Overall Study|Protocol Deviation|1|||
33618814|NCT02207231|63019963|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
33618815|NCT02207231|63019964|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
33618816|NCT02207231|63019965|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
33618817|NCT02207231|63019966|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
33618818|NCT02207231|63019963|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
33618819|NCT02207231|63019964|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
33618820|NCT02207231|63019965|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
33618821|NCT02207231|63019966|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
33618822|NCT02207231|63019963|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
33618823|NCT02207231|63019964|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
33618824|NCT02207231|63019965|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
33618825|NCT02207231|63019966|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
33618826|NCT02207231|63019963|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
33618827|NCT02207231|63019964|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
33618828|NCT02207231|63019965|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
33618829|NCT02207231|63019966|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
33618830|NCT02207231|63019963|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
33618831|NCT02207231|63019964|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
33525469|NCT03086551|62912707|FG000|First Intervention|Failure to meet inclusion criterion|1|||
33525470|NCT03086551|62912708|FG001|First Intervention|Failure to meet inclusion criterion|0|||
33525471|NCT03086551|62912707|FG000|First Intervention|Lost to Follow-up|0|||
33525472|NCT03086551|62912708|FG001|First Intervention|Lost to Follow-up|1|||
33525473|NCT03086551|62912707|FG000|Washout|Lost to Follow-up|1|||
33525474|NCT03086551|62912708|FG001|Washout|Lost to Follow-up|2|||
33525475|NCT03086551|62912707|FG000|Washout|Withdrawal by Subject|2|||
33525476|NCT03086551|62912708|FG001|Washout|Withdrawal by Subject|1|||
33525477|NCT03265249|62912716|FG000|Overall Study|Withdrawal by Subject|0|||
33525478|NCT03265249|62912717|FG001|Overall Study|Withdrawal by Subject|1|||
33525479|NCT02951767|62912723|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54|||
33525480|NCT02951767|62912723|FG000|Overall Study|Withdrawal by Subject|5|||
33525481|NCT02951767|62912723|FG000|Overall Study|Death|59|||
33525482|NCT02951767|62912723|FG000|Overall Study|Lost to Follow-up|1|||
33525483|NCT03093181|62912730|FG000|Overall Study|Withdrawal by Subject|2|||
33525484|NCT03093181|62912731|FG001|Overall Study|Withdrawal by Subject|1|||
33525485|NCT03093181|62912732|FG002|Overall Study|Withdrawal by Subject|2|||
33525486|NCT03093181|62912730|FG000|Overall Study|Other (Not specified)|1|||
33525487|NCT03093181|62912731|FG001|Overall Study|Other (Not specified)|0|||
33525488|NCT03093181|62912732|FG002|Overall Study|Other (Not specified)|0|||
33525489|NCT03093181|62912730|FG000|Overall Study|Adverse Event|0|||
33525490|NCT03093181|62912731|FG001|Overall Study|Adverse Event|1|||
33525491|NCT03093181|62912732|FG002|Overall Study|Adverse Event|0|||
33525492|NCT03093181|62912730|FG000|Overall Study|Other (Protocol violation)|0|||
33525493|NCT03093181|62912731|FG001|Overall Study|Other (Protocol violation)|0|||
33525494|NCT03093181|62912732|FG002|Overall Study|Other (Protocol violation)|1|||
33525495|NCT03091777|62912743|FG000|Overall Study|Pregnancy|2|||
33525496|NCT03091777|62912744|FG001|Overall Study|Pregnancy|1|||
33525497|NCT03091777|62912745|FG002|Overall Study|Pregnancy|0|||
33525498|NCT03091777|62912743|FG000|Overall Study|Adverse Event|2|||
33525499|NCT03091777|62912744|FG001|Overall Study|Adverse Event|1|||
33618832|NCT02207231|63019965|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
33618833|NCT02207231|63019966|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
33618834|NCT02207231|63019963|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
33618835|NCT02207231|63019964|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
33618836|NCT02207231|63019965|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
33618837|NCT02207231|63019966|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
33618838|NCT02207231|63019963|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
33618839|NCT02207231|63019964|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
33618840|NCT02207231|63019965|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
33618841|NCT02207231|63019966|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
33618842|NCT02207231|63019963|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
33618843|NCT02207231|63019964|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
33618844|NCT02207231|63019965|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
33618845|NCT02207231|63019966|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
33618846|NCT02207231|63019963|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
33618847|NCT02207231|63019964|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
33618848|NCT02207231|63019965|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
33618849|NCT02207231|63019966|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
33618850|NCT02207231|63019963|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
33618851|NCT02207231|63019964|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
33618852|NCT02207231|63019965|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
33618853|NCT02207231|63019966|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
33618854|NCT02207231|63019963|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
33618855|NCT02207231|63019964|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
33618856|NCT02207231|63019965|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
33618857|NCT02207231|63019966|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
33618858|NCT02207231|63019963|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
33618859|NCT02207231|63019964|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
33618860|NCT02207231|63019965|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
33618861|NCT02207231|63019966|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
33618862|NCT02207231|63019963|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
33618863|NCT02207231|63019964|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
33618864|NCT02207231|63019965|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
33618865|NCT02207231|63019966|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
33618866|NCT02207231|63019963|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
33618867|NCT02207231|63019964|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
33618868|NCT02207231|63019965|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
33618869|NCT02207231|63019966|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
33618870|NCT02207231|63019963|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
33618871|NCT02207231|63019964|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
33618872|NCT02207231|63019965|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
33618873|NCT02207231|63019966|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
33618874|NCT02207231|63019963|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
33618875|NCT02207231|63019964|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
33618876|NCT02207231|63019965|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
33618877|NCT02207231|63019966|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
33618878|NCT02207231|63019963|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
33618879|NCT02207231|63019964|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
33618880|NCT02207231|63019965|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
33618881|NCT02207231|63019966|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
33618882|NCT02207231|63019963|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
33618883|NCT02207231|63019964|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
33618884|NCT02207231|63019965|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
33618885|NCT02207231|63019966|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
33618886|NCT02207231|63019963|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
33618887|NCT02207231|63019964|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
33618888|NCT02207231|63019965|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
33618889|NCT02207231|63019966|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
33618890|NCT02207231|63019963|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
33618891|NCT02207231|63019964|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
33618892|NCT02207231|63019965|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
33618893|NCT02207231|63019966|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
33618894|NCT02207231|63019963|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
33618895|NCT02207231|63019964|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
33618896|NCT02207231|63019965|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
33618897|NCT02207231|63019966|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
33618898|NCT02239601|63019986|FG000|Overall Study|Withdrawal by Subject|3|||
33618899|NCT02239601|63019987|FG001|Overall Study|Withdrawal by Subject|4|||
33618900|NCT02239601|63019986|FG000|Overall Study|Protocol Violation|4|||
33618901|NCT02239601|63019987|FG001|Overall Study|Protocol Violation|2|||
33618902|NCT02236559|63020000|FG000|Overall Study|Met Exclusion|3|||
33618903|NCT02236559|63020001|FG001|Overall Study|Met Exclusion|6|||
33618904|NCT02236559|63020000|FG000|Overall Study|Did not Meet Inclusion|3|||
33618905|NCT02236559|63020001|FG001|Overall Study|Did not Meet Inclusion|3|||
33618906|NCT02236559|63020000|FG000|Overall Study|Subject Did Not Consent|4|||
33618907|NCT02236559|63020001|FG001|Overall Study|Subject Did Not Consent|2|||
33618908|NCT02236559|63020000|FG000|Overall Study|Physician Decision|1|||
33618909|NCT02236559|63020001|FG001|Overall Study|Physician Decision|1|||
33618910|NCT02236559|63020000|FG000|Overall Study|Withdrawal by Subject|1|||
33618911|NCT02236559|63020001|FG001|Overall Study|Withdrawal by Subject|0|||
33618912|NCT02206685|63020009|FG000|Overall Study|Surgery cancelled/changed|2|||
33618913|NCT02206685|63020010|FG001|Overall Study|Surgery cancelled/changed|3|||
33618914|NCT02206685|63020009|FG000|Overall Study|Withdrawal by Subject|1|||
33618915|NCT02206685|63020010|FG001|Overall Study|Withdrawal by Subject|2|||
33618916|NCT02206685|63020009|FG000|Overall Study|Protocol Violation|2|||
33618917|NCT02206685|63020010|FG001|Overall Study|Protocol Violation|2|||
33525500|NCT03091777|62912745|FG002|Overall Study|Adverse Event|4|||
33525501|NCT03091777|62912743|FG000|Overall Study|Withdrawal by Subject|4|||
33525502|NCT03091777|62912744|FG001|Overall Study|Withdrawal by Subject|2|||
33525503|NCT03091777|62912745|FG002|Overall Study|Withdrawal by Subject|6|||
33525504|NCT03091777|62912743|FG000|Overall Study|Protocol Violation|2|||
33525505|NCT03091777|62912744|FG001|Overall Study|Protocol Violation|1|||
33525506|NCT03091777|62912745|FG002|Overall Study|Protocol Violation|1|||
33525507|NCT03091777|62912743|FG000|Overall Study|Lost to Follow-up|12|||
33525508|NCT03091777|62912744|FG001|Overall Study|Lost to Follow-up|14|||
33525509|NCT03091777|62912745|FG002|Overall Study|Lost to Follow-up|7|||
33525510|NCT03091777|62912743|FG000|Overall Study|Lack of Efficacy|0|||
33525511|NCT03091777|62912744|FG001|Overall Study|Lack of Efficacy|0|||
33525512|NCT03091777|62912745|FG002|Overall Study|Lack of Efficacy|5|||
33525513|NCT03091777|62912743|FG000|Overall Study|Noncompliance with study drug|2|||
33525514|NCT03091777|62912744|FG001|Overall Study|Noncompliance with study drug|3|||
33525515|NCT03091777|62912745|FG002|Overall Study|Noncompliance with study drug|1|||
33525516|NCT03091777|62912743|FG000|Overall Study|Physician Decision|1|||
33525517|NCT03091777|62912744|FG001|Overall Study|Physician Decision|0|||
33525518|NCT03091777|62912745|FG002|Overall Study|Physician Decision|1|||
33525519|NCT03091777|62912743|FG000|Overall Study|Abnormal Laboratory Value|7|||
33525520|NCT03091777|62912744|FG001|Overall Study|Abnormal Laboratory Value|11|||
33618918|NCT02206607|63020016|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
33618919|NCT02206607|63020017|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
33618920|NCT02206607|63020018|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
33618921|NCT02206607|63020019|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
33525521|NCT03091777|62912745|FG002|Overall Study|Abnormal Laboratory Value|12|||
33525522|NCT02818998|62912756|FG000|Overall Study|Adverse Event|3|||
33525523|NCT02818998|62912757|FG001|Overall Study|Adverse Event|2|||
33525524|NCT02818998|62912758|FG002|Overall Study|Adverse Event|1|||
33525525|NCT02818998|62912756|FG000|Overall Study|Lost to Follow-up|4|||
33525526|NCT02818998|62912757|FG001|Overall Study|Lost to Follow-up|1|||
33525527|NCT02818998|62912758|FG002|Overall Study|Lost to Follow-up|2|||
33525528|NCT02818998|62912756|FG000|Overall Study|Withdrawal by sponsor|0|||
33525529|NCT02818998|62912757|FG001|Overall Study|Withdrawal by sponsor|1|||
33618922|NCT02206607|63020020|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
33525530|NCT02818998|62912758|FG002|Overall Study|Withdrawal by sponsor|1|||
33525531|NCT02818998|62912756|FG000|Overall Study|Death|3|||
33525532|NCT02818998|62912757|FG001|Overall Study|Death|6|||
33525533|NCT02818998|62912758|FG002|Overall Study|Death|8|||
33525534|NCT02818998|62912756|FG000|Overall Study|Withdrawal by Subject|7|||
33525535|NCT02818998|62912757|FG001|Overall Study|Withdrawal by Subject|6|||
33525536|NCT02818998|62912758|FG002|Overall Study|Withdrawal by Subject|6|||
33525537|NCT02818998|62912756|FG000|Overall Study|Physician Decision|1|||
33618923|NCT02206607|63020016|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
33618924|NCT02206607|63020017|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
33525538|NCT02818998|62912757|FG001|Overall Study|Physician Decision|0|||
33618925|NCT02206607|63020018|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
33618926|NCT02206607|63020019|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
33618927|NCT02206607|63020020|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
33525539|NCT02818998|62912758|FG002|Overall Study|Physician Decision|0|||
33456884|NCT00403559|62831488|FG000|Overall Study|Lost to Follow-up|3|||
33456885|NCT00403559|62831489|FG001|Overall Study|Lost to Follow-up|3|||
33456886|NCT00403559|62831488|FG000|Overall Study|Withdrawal by Subject|1|||
33456887|NCT00403559|62831489|FG001|Overall Study|Withdrawal by Subject|0|||
33456888|NCT00403481|62831497|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
33456889|NCT00403481|62831497|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
33456890|NCT00403481|62831497|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
33456891|NCT00403481|62831497|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
33456892|NCT00403481|62831497|FG000|Olm 40 mg|Adverse Event|2|||
33456893|NCT00403481|62831497|FG000|Olm 40 mg|Protocol Violation|1|||
33456894|NCT00403481|62831497|FG000|Olm 40 mg|Withdrawal by Subject|1|||
33456895|NCT00403481|62831497|FG000|Olm 40 mg|Other|1|||
33456896|NCT00403481|62831497|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
33456897|NCT00403481|62831497|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
33456898|NCT00403481|62831497|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
33456899|NCT00403481|62831497|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
33456900|NCT00403481|62831497|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
33456901|NCT00403481|62831497|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
33456902|NCT00402779|62831506|FG000|Overall Study|Screen Failure|77|||
33456903|NCT00402779|62831507|FG001|Overall Study|Screen Failure|76|||
33456904|NCT00394433|62831513|FG000|Overall Study|Adverse Event|2|||
33456905|NCT00394433|62831513|FG000|Overall Study|Alternative Therapy|1|||
33456906|NCT00092534|62831519|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
33456907|NCT00092534|62831520|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
33456908|NCT00092534|62831521|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
33456909|NCT00092534|62831522|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
33456910|NCT00092534|62831523|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
33456911|NCT00092534|62831519|FG000|Base Study Vaccination Period|Adverse Event|3|||
33456912|NCT00092534|62831520|FG001|Base Study Vaccination Period|Adverse Event|1|||
33456913|NCT00092534|62831521|FG002|Base Study Vaccination Period|Adverse Event|0|||
33456914|NCT00092534|62831522|FG003|Base Study Vaccination Period|Adverse Event|0|||
33456915|NCT00092534|62831523|FG004|Base Study Vaccination Period|Adverse Event|0|||
33456916|NCT00092534|62831519|FG000|Base Study Vaccination Period|Death|5|||
33456917|NCT00092534|62831520|FG001|Base Study Vaccination Period|Death|4|||
33456918|NCT00092534|62831521|FG002|Base Study Vaccination Period|Death|0|||
33456919|NCT00092534|62831522|FG003|Base Study Vaccination Period|Death|0|||
33456920|NCT00092534|62831523|FG004|Base Study Vaccination Period|Death|0|||
33456921|NCT00092534|62831519|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
33456922|NCT00092534|62831520|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
33456923|NCT00092534|62831521|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
33456924|NCT00092534|62831522|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
33456925|NCT00092534|62831523|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
33456926|NCT00092534|62831519|FG000|Base Study Vaccination Period|Physician Decision|1|||
33456927|NCT00092534|62831520|FG001|Base Study Vaccination Period|Physician Decision|0|||
33456928|NCT00092534|62831521|FG002|Base Study Vaccination Period|Physician Decision|0|||
33456929|NCT00092534|62831522|FG003|Base Study Vaccination Period|Physician Decision|0|||
33456930|NCT00092534|62831523|FG004|Base Study Vaccination Period|Physician Decision|0|||
33456931|NCT00092534|62831519|FG000|Base Study Vaccination Period|Pregnancy|9|||
33456932|NCT00092534|62831520|FG001|Base Study Vaccination Period|Pregnancy|7|||
33456933|NCT00092534|62831521|FG002|Base Study Vaccination Period|Pregnancy|0|||
33456934|NCT00092534|62831522|FG003|Base Study Vaccination Period|Pregnancy|0|||
33456935|NCT00092534|62831523|FG004|Base Study Vaccination Period|Pregnancy|0|||
33456936|NCT00092534|62831519|FG000|Base Study Vaccination Period|Protocol Violation|2|||
33525540|NCT02821416|62912768|FG000|Overall Study|Adverse Event|0|||
33525541|NCT02821416|62912769|FG001|Overall Study|Adverse Event|1|||
33325262|NCT01214174|62702004|FG001|Overall Study|Withdrawal by Subject|0|||
33325263|NCT01214174|62702005|FG002|Overall Study|Withdrawal by Subject|1|||
33325264|NCT00901342|62702013|FG000|Overall Study|Adverse Event|1|||
33325265|NCT00901342|62702013|FG000|Overall Study|Death|4|||
33325266|NCT00901342|62702013|FG000|Overall Study|Disease progression|1|||
33325267|NCT00901342|62702013|FG000|Overall Study|Withdrawal by Subject|9|||
33325268|NCT00901186|62702019|FG000|Overall Study|Lack of Efficacy|0|||
33456937|NCT00092534|62831520|FG001|Base Study Vaccination Period|Protocol Violation|1|||
33456938|NCT00092534|62831521|FG002|Base Study Vaccination Period|Protocol Violation|0|||
33456939|NCT00092534|62831522|FG003|Base Study Vaccination Period|Protocol Violation|0|||
33456940|NCT00092534|62831523|FG004|Base Study Vaccination Period|Protocol Violation|0|||
33525542|NCT02821416|62912768|FG000|Overall Study|Withdrawal by Subject|2|||
33525543|NCT02821416|62912769|FG001|Overall Study|Withdrawal by Subject|0|||
33525544|NCT02821416|62912768|FG000|Overall Study|Lost to Follow-up|1|||
33525545|NCT02821416|62912769|FG001|Overall Study|Lost to Follow-up|0|||
33525546|NCT03108521|62912778|FG000|Overall Study|Lost to Follow-up|3|||
33525547|NCT03108521|62912779|FG001|Overall Study|Lost to Follow-up|0|||
33525548|NCT03108521|62912778|FG000|Overall Study|Lack of Efficacy|2|||
33525549|NCT03108521|62912779|FG001|Overall Study|Lack of Efficacy|0|||
33525550|NCT03108521|62912778|FG000|Overall Study|Physician Decision|4|||
33525551|NCT03108521|62912779|FG001|Overall Study|Physician Decision|0|||
33525552|NCT03108521|62912778|FG000|Overall Study|Adverse Event|3|||
33525553|NCT03108521|62912779|FG001|Overall Study|Adverse Event|0|||
33525554|NCT02817828|62912802|FG000|Overall Study|Lost to Follow-up|41|||
33525555|NCT02817828|62912802|FG000|Overall Study|Adverse event not related to bleeding|104|||
33525556|NCT02817828|62912802|FG000|Overall Study|Adverse event related to bleeding|53|||
33525557|NCT02817828|62912802|FG000|Overall Study|Protocol Violation|11|||
33525558|NCT02817828|62912802|FG000|Overall Study|Pregnancy|7|||
33525559|NCT02817828|62912802|FG000|Overall Study|Pregnancy wish|15|||
33525560|NCT02817828|62912802|FG000|Overall Study|Withdrawal by Subject|78|||
33525561|NCT02817828|62912802|FG000|Overall Study|Other|26|||
33525562|NCT02817906|62912813|FG000|Overall Study|Adverse Event|3|||
33525563|NCT02817906|62912814|FG001|Overall Study|Adverse Event|0|||
33525564|NCT02817906|62912813|FG000|Overall Study|Lack of Efficacy|1|||
33525565|NCT02817906|62912814|FG001|Overall Study|Lack of Efficacy|0|||
33525566|NCT02817906|62912813|FG000|Overall Study|Protocol Violation|1|||
33525567|NCT02817906|62912814|FG001|Overall Study|Protocol Violation|1|||
33525568|NCT02817906|62912813|FG000|Overall Study|Study Terminated by Sponsor|2|||
33525569|NCT02817906|62912814|FG001|Overall Study|Study Terminated by Sponsor|2|||
33525570|NCT02817906|62912813|FG000|Overall Study|Withdrawal by Subject|7|||
33525571|NCT02817906|62912814|FG001|Overall Study|Withdrawal by Subject|0|||
33525572|NCT02817906|62912813|FG000|Overall Study|Other|2|||
33525573|NCT02817906|62912814|FG001|Overall Study|Other|2|||
33525574|NCT02817594|62912825|FG000|Overall Study|Withdrawal by Subject|1|||
33525575|NCT02817594|62912825|FG000|Overall Study|Other|1|||
33525576|NCT02817594|62912825|FG000|Overall Study|Did Not Receive Treatment|1|||
33525577|NCT02813694|62912835|FG000|Overall Study|Physician Decision|0|||
33525578|NCT02813694|62912836|FG001|Overall Study|Physician Decision|1|||
33525579|NCT02813694|62912835|FG000|Overall Study|Withdrawal by Subject|10|||
33525580|NCT02813694|62912836|FG001|Overall Study|Withdrawal by Subject|9|||
33618928|NCT02119676|63020040|FG000|Overall Study|Adverse Event|9|||
33456941|NCT00092534|62831519|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
33456942|NCT00092534|62831520|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
33456943|NCT00092534|62831521|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
33456944|NCT00092534|62831522|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
33456945|NCT00092534|62831523|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
33525581|NCT02813694|62912835|FG000|Overall Study|Lost to Follow-up|1|||
33525582|NCT02813694|62912836|FG001|Overall Study|Lost to Follow-up|1|||
33525583|NCT02813694|62912835|FG000|Overall Study|Death|3|||
33325269|NCT00901186|62702020|FG001|Overall Study|Lack of Efficacy|1|||
33456946|NCT00092534|62831519|FG000|Base Study Vaccination Period|Moved|14|||
33525584|NCT02813694|62912836|FG001|Overall Study|Death|3|||
33525585|NCT02813694|62912835|FG000|Overall Study|Randomized- did not receive study drug|2|||
33525586|NCT02813694|62912836|FG001|Overall Study|Randomized- did not receive study drug|0|||
33525587|NCT02813694|62912835|FG000|Overall Study|Patient hospitalized|1|||
33525588|NCT02813694|62912836|FG001|Overall Study|Patient hospitalized|0|||
33525589|NCT03103919|62912844|FG000|Overall Study|Adverse Event|2|||
33525590|NCT03103919|62912845|FG001|Overall Study|Adverse Event|2|||
33618929|NCT02119676|63020041|FG001|Overall Study|Adverse Event|17|||
33525591|NCT02810964|62912855|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
33525592|NCT02810964|62912856|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
33325270|NCT00901186|62702019|FG000|Overall Study|Abnormal laboratory values|0|||
33325271|NCT00901186|62702020|FG001|Overall Study|Abnormal laboratory values|1|||
33456947|NCT00092534|62831520|FG001|Base Study Vaccination Period|Moved|12|||
33456948|NCT00092534|62831521|FG002|Base Study Vaccination Period|Moved|0|||
33456949|NCT00092534|62831522|FG003|Base Study Vaccination Period|Moved|0|||
33456950|NCT00092534|62831523|FG004|Base Study Vaccination Period|Moved|0|||
33456951|NCT00092534|62831519|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
33456952|NCT00092534|62831520|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
33456953|NCT00092534|62831521|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
33456954|NCT00092534|62831522|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
33456955|NCT00092534|62831523|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
33525593|NCT02810964|62912855|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
33525594|NCT02810964|62912856|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
33525595|NCT02810964|62912855|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
33525596|NCT02810964|62912856|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
33525597|NCT02810964|62912855|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
33525598|NCT02810964|62912856|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
33525599|NCT03103763|62912865|FG000|Overall Study|Death|15|||
33525600|NCT03103763|62912866|FG001|Overall Study|Death|5|||
33525601|NCT03103763|62912867|FG002|Overall Study|Death|5|||
33525602|NCT03103763|62912865|FG000|Overall Study|Withdrawal by Subject|0|||
33525603|NCT03103763|62912866|FG001|Overall Study|Withdrawal by Subject|3|||
33525604|NCT03103763|62912867|FG002|Overall Study|Withdrawal by Subject|2|||
33525605|NCT03101267|62912891|FG000|Primary Study Period|Withdrawal by Subject|1|||
33525606|NCT03101267|62912892|FG001|Primary Study Period|Withdrawal by Subject|2|||
33525607|NCT03101267|62912893|FG002|Primary Study Period|Withdrawal by Subject|3|||
33525608|NCT03101267|62912891|FG000|Primary Study Period|Miscellaneous|2|||
33525609|NCT03101267|62912892|FG001|Primary Study Period|Miscellaneous|0|||
33525610|NCT03101267|62912893|FG002|Primary Study Period|Miscellaneous|0|||
33525611|NCT02810418|62912908|FG000|Arm A Dose Escalation|Adverse Event|2|||
33525612|NCT02810418|62912909|FG001|Arm A Dose Escalation|Adverse Event|1|||
33525613|NCT02810418|62912910|FG002|Arm A Dose Escalation|Adverse Event|0|||
33525614|NCT02810418|62912911|FG003|Arm A Dose Escalation|Adverse Event|0|||
33525615|NCT02810418|62912912|FG004|Arm A Dose Escalation|Adverse Event|0|||
33525616|NCT02810418|62912913|FG005|Arm A Dose Escalation|Adverse Event|0|||
33525617|NCT02810418|62912914|FG006|Arm A Dose Escalation|Adverse Event|0|||
33525618|NCT02810418|62912908|FG000|Dose Expansion|Adverse Event|0|||
33525619|NCT02810418|62912909|FG001|Dose Expansion|Adverse Event|1|||
33525620|NCT02810418|62912910|FG002|Dose Expansion|Adverse Event|1|||
33525621|NCT02810418|62912911|FG003|Dose Expansion|Adverse Event|0|||
33525622|NCT02810418|62912912|FG004|Dose Expansion|Adverse Event|0|||
33525623|NCT02810418|62912913|FG005|Dose Expansion|Adverse Event|0|||
33525624|NCT02810418|62912914|FG006|Dose Expansion|Adverse Event|0|||
33525625|NCT02810418|62912908|FG000|Dose Expansion|Physician Decision|0|||
33525626|NCT02810418|62912909|FG001|Dose Expansion|Physician Decision|0|||
33525627|NCT02810418|62912910|FG002|Dose Expansion|Physician Decision|2|||
33525628|NCT02810418|62912911|FG003|Dose Expansion|Physician Decision|0|||
33525629|NCT02810418|62912912|FG004|Dose Expansion|Physician Decision|0|||
33525630|NCT02810418|62912913|FG005|Dose Expansion|Physician Decision|0|||
33525631|NCT02810418|62912914|FG006|Dose Expansion|Physician Decision|0|||
33525632|NCT02810418|62912908|FG000|Arm B Dose Escalation|Adverse Event|0|||
33525633|NCT02810418|62912909|FG001|Arm B Dose Escalation|Adverse Event|0|||
33525634|NCT02810418|62912910|FG002|Arm B Dose Escalation|Adverse Event|0|||
33525635|NCT02810418|62912911|FG003|Arm B Dose Escalation|Adverse Event|0|||
33525636|NCT02810418|62912912|FG004|Arm B Dose Escalation|Adverse Event|1|||
33525637|NCT02810418|62912913|FG005|Arm B Dose Escalation|Adverse Event|2|||
33525638|NCT02810418|62912914|FG006|Arm B Dose Escalation|Adverse Event|0|||
33525639|NCT02810340|62912980|FG000|Overall Study|Withdrawal by Subject|1|||
33525640|NCT02810340|62912981|FG001|Overall Study|Withdrawal by Subject|0|||
33525641|NCT02810340|62912982|FG002|Overall Study|Withdrawal by Subject|0|||
33525642|NCT02810340|62912980|FG000|Overall Study|Incarceration|0|||
33525643|NCT02810340|62912981|FG001|Overall Study|Incarceration|1|||
33525644|NCT02810340|62912982|FG002|Overall Study|Incarceration|0|||
33525645|NCT02810340|62912980|FG000|Overall Study|Lost to Follow-up|0|||
33525646|NCT02810340|62912981|FG001|Overall Study|Lost to Follow-up|0|||
33525647|NCT02810340|62912982|FG002|Overall Study|Lost to Follow-up|1|||
33525648|NCT02817516|62912994|FG000|Overall Study|Other|0|||
33525649|NCT02817516|62912995|FG001|Overall Study|Other|0|||
33525650|NCT02817516|62912996|FG002|Overall Study|Other|1|||
33525651|NCT02817516|62912997|FG003|Overall Study|Other|0|||
33525652|NCT02928029|62913012|FG000|Overall Study|Withdrawal by Subject|0|||
33525653|NCT02928029|62913013|FG001|Overall Study|Withdrawal by Subject|1|||
33525654|NCT02928029|62913012|FG000|Overall Study|Radiological progression|1|||
33525655|NCT02928029|62913013|FG001|Overall Study|Radiological progression|0|||
33525656|NCT02928029|62913012|FG000|Overall Study|Clinical progression|1|||
33525657|NCT02928029|62913013|FG001|Overall Study|Clinical progression|2|||
33525658|NCT02928029|62913012|FG000|Overall Study|AE not related to clinical progression|1|||
33525659|NCT02928029|62913013|FG001|Overall Study|AE not related to clinical progression|1|||
33525660|NCT02806986|62913019|FG000|Treatment Stage 1|Adverse Event|1|||
33525661|NCT02806986|62913019|FG000|Treatment Stage 2|Adverse Event|3|||
33525662|NCT02806986|62913019|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
33525663|NCT03095651|62913035|FG000|Overall Study|Lost to Follow-up|1|||
33525664|NCT03095651|62913036|FG001|Overall Study|Lost to Follow-up|1|||
33525665|NCT03095651|62913037|FG002|Overall Study|Lost to Follow-up|0|||
33525666|NCT03095651|62913038|FG003|Overall Study|Lost to Follow-up|1|||
33525667|NCT03095651|62913039|FG004|Overall Study|Lost to Follow-up|0|||
33525668|NCT03095651|62913040|FG005|Overall Study|Lost to Follow-up|0|||
33525669|NCT03095651|62913041|FG006|Overall Study|Lost to Follow-up|0|||
33525670|NCT03095651|62913042|FG007|Overall Study|Lost to Follow-up|0|||
33525671|NCT03095651|62913035|FG000|Overall Study|Withdrawal by Subject|0|||
33525672|NCT03095651|62913036|FG001|Overall Study|Withdrawal by Subject|0|||
33525673|NCT03095651|62913037|FG002|Overall Study|Withdrawal by Subject|0|||
33525674|NCT03095651|62913038|FG003|Overall Study|Withdrawal by Subject|0|||
33525675|NCT03095651|62913039|FG004|Overall Study|Withdrawal by Subject|0|||
33525676|NCT03095651|62913040|FG005|Overall Study|Withdrawal by Subject|1|||
33525677|NCT03095651|62913041|FG006|Overall Study|Withdrawal by Subject|0|||
33525678|NCT03095651|62913042|FG007|Overall Study|Withdrawal by Subject|0|||
33525679|NCT02808312|62913065|FG000|Overall Study|Enrolled but Never Treated|0|||
33525680|NCT02808312|62913066|FG001|Overall Study|Enrolled but Never Treated|0|||
33525681|NCT02808312|62913067|FG002|Overall Study|Enrolled but Never Treated|1|||
33525682|NCT02808312|62913068|FG003|Overall Study|Enrolled but Never Treated|0|||
33525683|NCT02808312|62913069|FG004|Overall Study|Enrolled but Never Treated|0|||
33525684|NCT03099161|62913089|FG000|Overall Study|Adverse Event|0|||
33525685|NCT03099161|62913090|FG001|Overall Study|Adverse Event|0|||
33525686|NCT03099161|62913091|FG002|Overall Study|Adverse Event|2|||
33525687|NCT03099161|62913089|FG000|Overall Study|Physician Decision|2|||
33525688|NCT03099161|62913090|FG001|Overall Study|Physician Decision|0|||
33456956|NCT00092534|62831519|FG000|Base Study Vaccination Period|Travel|1|||
33456957|NCT00092534|62831520|FG001|Base Study Vaccination Period|Travel|0|||
33456958|NCT00092534|62831521|FG002|Base Study Vaccination Period|Travel|0|||
33456959|NCT00092534|62831522|FG003|Base Study Vaccination Period|Travel|0|||
33456960|NCT00092534|62831523|FG004|Base Study Vaccination Period|Travel|0|||
33456961|NCT00092534|62831519|FG000|Base Study Vaccination Period|Site Closed|0|||
33456962|NCT00092534|62831520|FG001|Base Study Vaccination Period|Site Closed|1|||
33456963|NCT00092534|62831521|FG002|Base Study Vaccination Period|Site Closed|0|||
33456964|NCT00092534|62831522|FG003|Base Study Vaccination Period|Site Closed|0|||
33456965|NCT00092534|62831523|FG004|Base Study Vaccination Period|Site Closed|0|||
33456966|NCT00092534|62831519|FG000|Base Study Follow-Up Period|Adverse Event|2|||
33456967|NCT00092534|62831520|FG001|Base Study Follow-Up Period|Adverse Event|4|||
33456968|NCT00092534|62831521|FG002|Base Study Follow-Up Period|Adverse Event|0|||
33456969|NCT00092534|62831522|FG003|Base Study Follow-Up Period|Adverse Event|0|||
33525689|NCT03099161|62913091|FG002|Overall Study|Physician Decision|0|||
33525690|NCT03099161|62913089|FG000|Overall Study|Progressive Disease|1|||
33525691|NCT03099161|62913090|FG001|Overall Study|Progressive Disease|4|||
33525692|NCT03099161|62913091|FG002|Overall Study|Progressive Disease|1|||
33525693|NCT03095027|62913099|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
33525694|NCT03095027|62913100|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
33525695|NCT04227197|62913108|FG000|Randomization|Protocol Violation|1|||
33525696|NCT04227197|62913109|FG001|Randomization|Protocol Violation|0|||
33525697|NCT04227197|62913108|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
33525698|NCT04227197|62913109|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
33525699|NCT04227197|62913108|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
33525700|NCT04227197|62913109|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
33525701|NCT04227197|62913108|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
33456970|NCT00092534|62831523|FG004|Base Study Follow-Up Period|Adverse Event|0|||
33456971|NCT00092534|62831519|FG000|Base Study Follow-Up Period|Death|2|||
33525702|NCT04227197|62913109|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
33525703|NCT04227197|62913108|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
33525704|NCT04227197|62913109|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
33525705|NCT04227197|62913108|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
33525706|NCT04227197|62913109|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
33525707|NCT04227197|62913108|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
33525708|NCT04227197|62913109|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
33525709|NCT03080935|62913120|FG000|Overall Study|Death|34|||
33525710|NCT03080935|62913121|FG001|Overall Study|Death|50|||
33525711|NCT03080935|62913120|FG000|Overall Study|Lost to Follow-up|5|||
33525712|NCT03080935|62913121|FG001|Overall Study|Lost to Follow-up|4|||
33525713|NCT03080935|62913120|FG000|Overall Study|Withdrawal by Subject|11|||
33525714|NCT03080935|62913121|FG001|Overall Study|Withdrawal by Subject|15|||
33525715|NCT02921789|62913133|FG000|Overall Study|Adverse Event|0|||
33525716|NCT02921789|62913134|FG001|Overall Study|Adverse Event|1|||
33525717|NCT02921789|62913133|FG000|Overall Study|Lost to Follow-up|1|||
33525718|NCT02921789|62913134|FG001|Overall Study|Lost to Follow-up|0|||
33525719|NCT02921789|62913133|FG000|Overall Study|Protocol Deviation|2|||
33525720|NCT02921789|62913134|FG001|Overall Study|Protocol Deviation|0|||
33525721|NCT02921789|62913133|FG000|Overall Study|Withdrawal by Subject|2|||
33525722|NCT02921789|62913134|FG001|Overall Study|Withdrawal by Subject|1|||
33525723|NCT02921789|62913133|FG000|Overall Study|Miscellaneous|3|||
33525724|NCT02921789|62913134|FG001|Overall Study|Miscellaneous|2|||
33525725|NCT03364673|62913149|FG000|Overall Study|Withdrawal by Subject|2|||
33525726|NCT03364673|62913149|FG000|Overall Study|Injury unrelated to study|3|||
33525727|NCT03097289|62913153|FG000|Overall Study|Adverse Event|1|||
33525728|NCT03097289|62913153|FG000|Overall Study|Equipment failure|2|||
33525729|NCT03097289|62913153|FG000|Overall Study|Collected platelet product unusable|3|||
33525730|NCT02419742|62913175|FG000|Overall Study|Adverse Event|2|||
33525731|NCT02419742|62913176|FG001|Overall Study|Adverse Event|0|||
33525732|NCT02419742|62913175|FG000|Overall Study|Disease Progression|0|||
33525733|NCT02419742|62913176|FG001|Overall Study|Disease Progression|1|||
33618930|NCT02119676|63020042|FG002|Overall Study|Adverse Event|10|||
33618931|NCT02119676|63020043|FG003|Overall Study|Adverse Event|10|||
33618932|NCT02119676|63020040|FG000|Overall Study|Disease progression|53|||
33618933|NCT02119676|63020041|FG001|Overall Study|Disease progression|55|||
33618934|NCT02119676|63020042|FG002|Overall Study|Disease progression|68|||
33618935|NCT02119676|63020043|FG003|Overall Study|Disease progression|73|||
33618936|NCT02119676|63020040|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
33618937|NCT02119676|63020041|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
33618938|NCT02119676|63020042|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
33325272|NCT00901186|62702019|FG000|Overall Study|Lost to Follow-up|2|||
33325273|NCT00901186|62702020|FG001|Overall Study|Lost to Follow-up|0|||
33325274|NCT00901186|62702019|FG000|Overall Study|Adverse Event|2|||
33325275|NCT00901186|62702020|FG001|Overall Study|Adverse Event|4|||
33325276|NCT00901186|62702019|FG000|Overall Study|Administration problems|0|||
33325277|NCT00901186|62702020|FG001|Overall Study|Administration problems|1|||
33325278|NCT00901186|62702019|FG000|Overall Study|Protocol deviations|5|||
33325279|NCT00901186|62702020|FG001|Overall Study|Protocol deviations|4|||
33325280|NCT01213472|62702026|FG000|Overall Study|Recurrence/Progressive disease|25|||
33325281|NCT01213472|62702026|FG000|Overall Study|Withdrawal by Subject|1|||
33325282|NCT01213472|62702026|FG000|Overall Study|Physician Decision|1|||
33325283|NCT00900796|62702030|FG000|Phase 1|Lacked sufficient information|4|||
33325284|NCT00900796|62702030|FG000|Phase 1|Missing information at Week 16|7|||
33325285|NCT00900796|62702030|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
33456972|NCT00092534|62831520|FG001|Base Study Follow-Up Period|Death|1|||
33456973|NCT00092534|62831521|FG002|Base Study Follow-Up Period|Death|0|||
33456974|NCT00092534|62831522|FG003|Base Study Follow-Up Period|Death|0|||
33456975|NCT00092534|62831523|FG004|Base Study Follow-Up Period|Death|0|||
33525734|NCT02419742|62913175|FG000|Overall Study|Withdrew Consent|2|||
33525735|NCT02419742|62913176|FG001|Overall Study|Withdrew Consent|1|||
33456976|NCT00092534|62831519|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
33456977|NCT00092534|62831520|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
33456978|NCT00092534|62831521|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
33456979|NCT00092534|62831522|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
33456980|NCT00092534|62831523|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
33456981|NCT00092534|62831519|FG000|Base Study Follow-Up Period|Pregnancy|6|||
33456982|NCT00092534|62831520|FG001|Base Study Follow-Up Period|Pregnancy|10|||
33456983|NCT00092534|62831521|FG002|Base Study Follow-Up Period|Pregnancy|0|||
33456984|NCT00092534|62831522|FG003|Base Study Follow-Up Period|Pregnancy|0|||
33456985|NCT00092534|62831523|FG004|Base Study Follow-Up Period|Pregnancy|0|||
33525736|NCT02419742|62913175|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
33525737|NCT02419742|62913176|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
33525738|NCT02409290|62913186|FG000|Overall Study|Protocol Violation|3|||
33525739|NCT02409290|62913187|FG001|Overall Study|Protocol Violation|6|||
33525740|NCT02409290|62913188|FG002|Overall Study|Protocol Violation|9|||
33525741|NCT02409290|62913189|FG003|Overall Study|Protocol Violation|4|||
33525742|NCT02409290|62913186|FG000|Overall Study|No positive culture/no baseline sample|3|||
33525743|NCT02409290|62913187|FG001|Overall Study|No positive culture/no baseline sample|9|||
33456986|NCT00092534|62831519|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
33525744|NCT02409290|62913188|FG002|Overall Study|No positive culture/no baseline sample|6|||
33525745|NCT02409290|62913189|FG003|Overall Study|No positive culture/no baseline sample|5|||
33525746|NCT02409290|62913186|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
33525747|NCT02409290|62913187|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
33525748|NCT02409290|62913188|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
33525749|NCT02409290|62913189|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
33525750|NCT02898077|62913201|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
33525751|NCT02898077|62913202|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
33525752|NCT02898077|62913201|FG000|Overall Study|Lost to Follow-up|4|||
33525753|NCT02898077|62913202|FG001|Overall Study|Lost to Follow-up|3|||
33525754|NCT02898077|62913201|FG000|Overall Study|Physician Decision|0|||
33525755|NCT02898077|62913202|FG001|Overall Study|Physician Decision|2|||
33525756|NCT02898077|62913201|FG000|Overall Study|Sponsor Decision|32|||
33525757|NCT02898077|62913202|FG001|Overall Study|Sponsor Decision|13|||
33618939|NCT02119676|63020043|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
33618940|NCT02119676|63020040|FG000|Overall Study|Physician Decision|4|||
33325286|NCT00900796|62702030|FG000|Phase 2|Lost to Follow-up|5|||
33325287|NCT01213082|62702038|FG000|Overall Study|Lost to Follow-up|6|||
33325288|NCT01213082|62702039|FG001|Overall Study|Lost to Follow-up|7|||
33456987|NCT00092534|62831520|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
33456988|NCT00092534|62831521|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
33525758|NCT02898077|62913201|FG000|Overall Study|Withdrawal by Subject|6|||
33525759|NCT02898077|62913202|FG001|Overall Study|Withdrawal by Subject|3|||
33525760|NCT02898077|62913201|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
33525761|NCT02898077|62913202|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
33525762|NCT02898077|62913201|FG000|Overall Study|Ended extension period|3|||
33525763|NCT02898077|62913202|FG001|Overall Study|Ended extension period|0|||
33525764|NCT03097133|62913210|FG000|Overall Study|Lost to Follow-up|3|||
33525765|NCT03097133|62913211|FG001|Overall Study|Lost to Follow-up|2|||
33525766|NCT03097133|62913210|FG000|Overall Study|Withdrawal by Subject|2|||
33525767|NCT03097133|62913211|FG001|Overall Study|Withdrawal by Subject|5|||
33525768|NCT03097133|62913210|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
33525769|NCT03097133|62913211|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
33525770|NCT03097133|62913210|FG000|Overall Study|Other|3|||
33525771|NCT03097133|62913211|FG001|Overall Study|Other|2|||
33525772|NCT03097133|62913210|FG000|Overall Study|Adverse Event|1|||
33525773|NCT03097133|62913211|FG001|Overall Study|Adverse Event|0|||
33525774|NCT03889639|62913225|FG000|Overall Study|Withdrawal by Subject|0|||
33525775|NCT03889639|62913226|FG001|Overall Study|Withdrawal by Subject|0|||
33525776|NCT03889639|62913227|FG002|Overall Study|Withdrawal by Subject|0|||
33525777|NCT03889639|62913228|FG003|Overall Study|Withdrawal by Subject|0|||
33525778|NCT03889639|62913229|FG004|Overall Study|Withdrawal by Subject|0|||
33525779|NCT03889639|62913230|FG005|Overall Study|Withdrawal by Subject|0|||
33525780|NCT03889639|62913231|FG006|Overall Study|Withdrawal by Subject|0|||
33525781|NCT03889639|62913232|FG007|Overall Study|Withdrawal by Subject|1|||
33525782|NCT03265145|62913255|FG000|Overall Study|Protocol Violation|2|||
33525783|NCT03265145|62913256|FG001|Overall Study|Protocol Violation|0|||
33525784|NCT03265145|62913255|FG000|Overall Study|Adverse Event|1|||
33618941|NCT02119676|63020041|FG001|Overall Study|Physician Decision|2|||
33618942|NCT02119676|63020042|FG002|Overall Study|Physician Decision|3|||
33618943|NCT02119676|63020043|FG003|Overall Study|Physician Decision|2|||
33618944|NCT02119676|63020040|FG000|Overall Study|Death|9|||
33618945|NCT02119676|63020041|FG001|Overall Study|Death|3|||
33618946|NCT02119676|63020042|FG002|Overall Study|Death|2|||
33618947|NCT02119676|63020043|FG003|Overall Study|Death|1|||
33618948|NCT02119676|63020040|FG000|Overall Study|Noncompliance|0|||
33618949|NCT02119676|63020041|FG001|Overall Study|Noncompliance|1|||
33618950|NCT02119676|63020042|FG002|Overall Study|Noncompliance|0|||
33618951|NCT02119676|63020043|FG003|Overall Study|Noncompliance|0|||
33618952|NCT02119676|63020040|FG000|Overall Study|Lost to Follow-up|0|||
33618953|NCT02119676|63020041|FG001|Overall Study|Lost to Follow-up|0|||
33618954|NCT02119676|63020042|FG002|Overall Study|Lost to Follow-up|1|||
33618955|NCT02119676|63020043|FG003|Overall Study|Lost to Follow-up|0|||
33618956|NCT02119676|63020040|FG000|Overall Study|Protocol deviation|0|||
33618957|NCT02119676|63020041|FG001|Overall Study|Protocol deviation|0|||
33618958|NCT02119676|63020042|FG002|Overall Study|Protocol deviation|1|||
33618959|NCT02119676|63020043|FG003|Overall Study|Protocol deviation|0|||
33618960|NCT02119676|63020040|FG000|Overall Study|Other, unspecified|2|||
33618961|NCT02119676|63020041|FG001|Overall Study|Other, unspecified|1|||
33618962|NCT02119676|63020042|FG002|Overall Study|Other, unspecified|3|||
33618963|NCT02119676|63020043|FG003|Overall Study|Other, unspecified|4|||
33618964|NCT02119676|63020040|FG000|Overall Study|Did not receive study med|2|||
33618965|NCT02119676|63020041|FG001|Overall Study|Did not receive study med|2|||
33618966|NCT02119676|63020042|FG002|Overall Study|Did not receive study med|4|||
33618967|NCT02119676|63020043|FG003|Overall Study|Did not receive study med|5|||
33618968|NCT02206061|63020056|FG000|Overall Study|Withdrawal by Subject|4|||
33618969|NCT02206061|63020057|FG001|Overall Study|Withdrawal by Subject|7|||
33618970|NCT02206061|63020058|FG002|Overall Study|Withdrawal by Subject|1|||
33618971|NCT02206061|63020056|FG000|Overall Study|Lost to Follow-up|14|||
33618972|NCT02206061|63020057|FG001|Overall Study|Lost to Follow-up|7|||
33618973|NCT02206061|63020058|FG002|Overall Study|Lost to Follow-up|20|||
33618974|NCT02095106|63020068|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
33618975|NCT02095106|63020069|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
33325289|NCT01213082|62702040|FG002|Overall Study|Lost to Follow-up|4|||
33525785|NCT03265145|62913256|FG001|Overall Study|Adverse Event|0|||
33525786|NCT03265145|62913255|FG000|Overall Study|Withdrawal by Subject|23|||
33525787|NCT03265145|62913256|FG001|Overall Study|Withdrawal by Subject|19|||
33525788|NCT03265145|62913255|FG000|Overall Study|Death|12|||
33525789|NCT03265145|62913256|FG001|Overall Study|Death|12|||
33618976|NCT01631747|63020081|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
33618977|NCT01631747|63020082|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
33618978|NCT01631747|63020081|FG000|Live Birth|Pregnancy Termination|1|||
33618979|NCT01631747|63020082|FG001|Live Birth|Pregnancy Termination|0|||
33618980|NCT01631747|63020081|FG000|Live Birth|MIscarriage|2|||
33618981|NCT01631747|63020082|FG001|Live Birth|MIscarriage|0|||
33618982|NCT01631747|63020081|FG000|Live Birth|Stillbirth|1|||
33618983|NCT01631747|63020082|FG001|Live Birth|Stillbirth|1|||
33618984|NCT01631747|63020081|FG000|One Year Infant Outcomes|Patient Refused|13|||
33618985|NCT01631747|63020082|FG001|One Year Infant Outcomes|Patient Refused|9|||
33525790|NCT03265145|62913255|FG000|Overall Study|Lost to Follow-up|13|||
33525791|NCT03265145|62913256|FG001|Overall Study|Lost to Follow-up|9|||
33525792|NCT03265145|62913255|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
33525793|NCT03265145|62913256|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
33525794|NCT03265145|62913255|FG000|Overall Study|Switched back to previous medication|1|||
33525795|NCT03265145|62913256|FG001|Overall Study|Switched back to previous medication|0|||
33525796|NCT03265145|62913255|FG000|Overall Study|Did not want to take medication|1|||
33525797|NCT03265145|62913256|FG001|Overall Study|Did not want to take medication|0|||
33525798|NCT03265145|62913255|FG000|Overall Study|Subject could not afford medication|0|||
33525799|NCT03265145|62913256|FG001|Overall Study|Subject could not afford medication|1|||
33525800|NCT03265145|62913255|FG000|Overall Study|Site closed|2|||
33525801|NCT03265145|62913256|FG001|Overall Study|Site closed|3|||
33525802|NCT03265145|62913255|FG000|Overall Study|Incorrectly randomized|16|||
33525803|NCT03265145|62913256|FG001|Overall Study|Incorrectly randomized|6|||
33525804|NCT03265145|62913255|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
33525805|NCT03265145|62913256|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
33525806|NCT03265145|62913255|FG000|Overall Study|Physician Decision|0|||
33525807|NCT03265145|62913256|FG001|Overall Study|Physician Decision|3|||
33525808|NCT03265145|62913255|FG000|Overall Study|Subject transferred to another facility|0|||
33618986|NCT02068118|63020091|FG000|18-month Comparative Study Period|Death|90|||
33618987|NCT02068118|63020092|FG001|18-month Comparative Study Period|Death|97|||
33618988|NCT02068118|63020091|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
33618989|NCT02068118|63020092|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
33618990|NCT02068118|63020091|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
33618991|NCT02068118|63020092|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
33618992|NCT02068118|63020091|FG000|18-month Comparative Study Period|Heart transplant|9|||
33618993|NCT02068118|63020092|FG001|18-month Comparative Study Period|Heart transplant|15|||
33618994|NCT02068118|63020091|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
33618995|NCT02068118|63020092|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
33618996|NCT02068118|63020091|FG000|18-month Comparative Study Period|Hemiplegia|0|||
33618997|NCT02068118|63020092|FG001|18-month Comparative Study Period|Hemiplegia|1|||
33618998|NCT02068118|63020091|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
33618999|NCT02068118|63020092|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
33619000|NCT02068118|63020091|FG000|18-month Comparative Study Period|Move|0|||
33619001|NCT02068118|63020092|FG001|18-month Comparative Study Period|Move|1|||
33619002|NCT02068118|63020091|FG000|18-month Comparative Study Period|Hearing loss|0|||
33619003|NCT02068118|63020092|FG001|18-month Comparative Study Period|Hearing loss|1|||
33619004|NCT02068118|63020091|FG000|Extension Period|Death|0|||
33619005|NCT02068118|63020092|FG001|Extension Period|Death|2|||
33619006|NCT02068118|63020091|FG000|Extension Period|Withdrawal by Subject|1|||
33619007|NCT02068118|63020092|FG001|Extension Period|Withdrawal by Subject|0|||
33619008|NCT02068118|63020091|FG000|Extension Period|Heart transplant|1|||
33525809|NCT03265145|62913256|FG001|Overall Study|Subject transferred to another facility|1|||
33525810|NCT05674344|62913267|FG000|Overall Study|Screen Fail|21|||
33525811|NCT05674344|62913267|FG000|Overall Study|Incomplete study procedures|3|||
33525812|NCT04424641|62913333|FG000|Overall Study|Death|1|||
33525813|NCT04424641|62913334|FG001|Overall Study|Death|2|||
33456989|NCT00092534|62831522|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
33456990|NCT00092534|62831523|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
33456991|NCT00092534|62831519|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
33456992|NCT00092534|62831520|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
33456993|NCT00092534|62831521|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
33456994|NCT00092534|62831522|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
33456995|NCT00092534|62831523|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
33456996|NCT00092534|62831519|FG000|Base Study Follow-Up Period|Moved|62|||
33456997|NCT00092534|62831520|FG001|Base Study Follow-Up Period|Moved|58|||
33456998|NCT00092534|62831521|FG002|Base Study Follow-Up Period|Moved|0|||
33456999|NCT00092534|62831522|FG003|Base Study Follow-Up Period|Moved|0|||
33457000|NCT00092534|62831523|FG004|Base Study Follow-Up Period|Moved|0|||
33457001|NCT00092534|62831519|FG000|Base Study Follow-Up Period|Travel|10|||
33457002|NCT00092534|62831520|FG001|Base Study Follow-Up Period|Travel|7|||
33457003|NCT00092534|62831521|FG002|Base Study Follow-Up Period|Travel|0|||
33525814|NCT04424641|62913335|FG002|Overall Study|Death|3|||
33525815|NCT04424641|62913336|FG003|Overall Study|Death|0|||
33525816|NCT04424641|62913337|FG004|Overall Study|Death|3|||
33525817|NCT04424641|62913338|FG005|Overall Study|Death|0|||
33619009|NCT02068118|63020092|FG001|Extension Period|Heart transplant|0|||
33619010|NCT02068118|63020091|FG000|Extension Period|Wrong device use|0|||
33457004|NCT00092534|62831522|FG003|Base Study Follow-Up Period|Travel|0|||
33525818|NCT04424641|62913339|FG006|Overall Study|Death|1|||
33525819|NCT04424641|62913340|FG007|Overall Study|Death|2|||
33525820|NCT04424641|62913333|FG000|Overall Study|Sponsor decision|0|||
33525821|NCT04424641|62913334|FG001|Overall Study|Sponsor decision|2|||
33525822|NCT04424641|62913335|FG002|Overall Study|Sponsor decision|3|||
33619011|NCT02068118|63020092|FG001|Extension Period|Wrong device use|1|||
33619012|NCT01623830|63020102|FG000|Overall Study|Withdrawal by Subject|6|||
33619013|NCT01623830|63020103|FG001|Overall Study|Withdrawal by Subject|7|||
33619014|NCT01623830|63020102|FG000|Overall Study|Exclusion from Study|1|||
33619015|NCT01623830|63020103|FG001|Overall Study|Exclusion from Study|2|||
33619016|NCT01634165|63020109|FG000|Period 2|Adverse Event|0|||
33619017|NCT01634165|63020110|FG001|Period 2|Adverse Event|1|||
33457005|NCT00092534|62831523|FG004|Base Study Follow-Up Period|Travel|0|||
33457006|NCT00092534|62831519|FG000|Base Study Follow-Up Period|Site Closed|0|||
33457007|NCT00092534|62831520|FG001|Base Study Follow-Up Period|Site Closed|2|||
33457008|NCT00092534|62831521|FG002|Base Study Follow-Up Period|Site Closed|0|||
33457009|NCT00092534|62831522|FG003|Base Study Follow-Up Period|Site Closed|0|||
33457010|NCT00092534|62831523|FG004|Base Study Follow-Up Period|Site Closed|0|||
33457011|NCT00092534|62831519|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
33525823|NCT04424641|62913336|FG003|Overall Study|Sponsor decision|7|||
33525824|NCT04424641|62913337|FG004|Overall Study|Sponsor decision|2|||
33525825|NCT04424641|62913338|FG005|Overall Study|Sponsor decision|2|||
33525826|NCT04424641|62913339|FG006|Overall Study|Sponsor decision|3|||
33525827|NCT04424641|62913340|FG007|Overall Study|Sponsor decision|4|||
33525828|NCT04424641|62913333|FG000|Overall Study|Withdrawal by Subject|0|||
33525829|NCT04424641|62913334|FG001|Overall Study|Withdrawal by Subject|0|||
33525830|NCT04424641|62913335|FG002|Overall Study|Withdrawal by Subject|0|||
33525831|NCT04424641|62913336|FG003|Overall Study|Withdrawal by Subject|0|||
33525832|NCT04424641|62913337|FG004|Overall Study|Withdrawal by Subject|1|||
33525833|NCT04424641|62913338|FG005|Overall Study|Withdrawal by Subject|0|||
33525834|NCT04424641|62913339|FG006|Overall Study|Withdrawal by Subject|0|||
33525835|NCT04424641|62913340|FG007|Overall Study|Withdrawal by Subject|0|||
33525836|NCT04424641|62913333|FG000|Overall Study|Other|0|||
33525837|NCT04424641|62913334|FG001|Overall Study|Other|0|||
33525838|NCT04424641|62913335|FG002|Overall Study|Other|1|||
33525839|NCT04424641|62913336|FG003|Overall Study|Other|0|||
33525840|NCT04424641|62913337|FG004|Overall Study|Other|0|||
33525841|NCT04424641|62913338|FG005|Overall Study|Other|0|||
33525842|NCT04424641|62913339|FG006|Overall Study|Other|0|||
33525843|NCT04424641|62913340|FG007|Overall Study|Other|0|||
33525844|NCT04276090|62913369|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
33525845|NCT04276090|62913370|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
33525846|NCT04105842|62913380|FG000|Overall Study|Withdrawal by Subject|2|||
33525847|NCT04088734|62913387|FG000|Overall Study|Other, Not Specified|5|||
33525848|NCT03868787|62913410|FG000|Overall Study|Withdrawal by Subject|2|||
33525849|NCT03868787|62913411|FG001|Overall Study|Withdrawal by Subject|1|||
33525850|NCT03457701|62913442|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
33525851|NCT03457701|62913443|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
33525852|NCT03457701|62913442|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
33525853|NCT03457701|62913443|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
33525854|NCT02694978|62913579|FG000|Overall Study|Adverse Event|10|||
33525855|NCT02694978|62913580|FG001|Overall Study|Adverse Event|9|||
33525856|NCT02694978|62913579|FG000|Overall Study|Withdrawal by Subject|22|||
33525857|NCT02694978|62913580|FG001|Overall Study|Withdrawal by Subject|19|||
33525858|NCT02694978|62913579|FG000|Overall Study|Lost to Follow-up|14|||
33525859|NCT02694978|62913580|FG001|Overall Study|Lost to Follow-up|17|||
33525860|NCT02694978|62913579|FG000|Overall Study|Death|4|||
33525861|NCT02694978|62913580|FG001|Overall Study|Death|1|||
33525862|NCT02694978|62913579|FG000|Overall Study|Other-Decision of Participant|6|||
33619018|NCT01634165|63020111|FG002|Period 2|Adverse Event|0|||
33619019|NCT01634165|63020112|FG003|Period 2|Adverse Event|0|||
33619020|NCT03575897|63020124|FG000|Overall Study|Lost to Follow-up|12|||
33619021|NCT03575897|63020125|FG001|Overall Study|Lost to Follow-up|13|||
33525863|NCT02694978|62913580|FG001|Overall Study|Other-Decision of Participant|1|||
33525864|NCT02694978|62913579|FG000|Overall Study|Other-Investigator's decision|1|||
33525865|NCT02694978|62913580|FG001|Overall Study|Other-Investigator's decision|0|||
33525866|NCT02694978|62913579|FG000|Overall Study|Other-Unable to be reached|0|||
33457012|NCT00092534|62831520|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
33525867|NCT02694978|62913580|FG001|Overall Study|Other-Unable to be reached|1|||
33525868|NCT02694978|62913579|FG000|Overall Study|Other-Protocol noncompliant|2|||
33619022|NCT02235311|63020133|FG000|Overall Study|Lost to Follow-up|0|||
33619023|NCT02235311|63020134|FG001|Overall Study|Lost to Follow-up|1|||
33619024|NCT02235311|63020133|FG000|Overall Study|Protocol Violation|0|||
33525869|NCT02694978|62913580|FG001|Overall Study|Other-Protocol noncompliant|1|||
33525870|NCT02694978|62913579|FG000|Overall Study|Other-Personal reasons|3|||
33525871|NCT02694978|62913580|FG001|Overall Study|Other-Personal reasons|3|||
33525872|NCT02694978|62913579|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
33619025|NCT02235311|63020134|FG001|Overall Study|Protocol Violation|1|||
33619026|NCT02204579|63020140|FG000|Overall Study|Screen failures|2|||
33325290|NCT01213082|62702038|FG000|Overall Study|Physician Decision|0|||
33457013|NCT00092534|62831521|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
33457014|NCT00092534|62831522|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
33457015|NCT00092534|62831523|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
33457016|NCT00092534|62831519|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
33457017|NCT00092534|62831520|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
33457018|NCT00092534|62831521|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
33457019|NCT00092534|62831522|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
33457020|NCT00092534|62831523|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
33457021|NCT00092534|62831519|FG000|Base Study EXT|Lost to Follow-up|0|||
33457022|NCT00092534|62831520|FG001|Base Study EXT|Lost to Follow-up|0|||
33457023|NCT00092534|62831521|FG002|Base Study EXT|Lost to Follow-up|41|||
33457024|NCT00092534|62831522|FG003|Base Study EXT|Lost to Follow-up|0|||
33457025|NCT00092534|62831523|FG004|Base Study EXT|Lost to Follow-up|0|||
33457026|NCT00092534|62831519|FG000|Base Study EXT|Physician Decision|0|||
33457027|NCT00092534|62831520|FG001|Base Study EXT|Physician Decision|0|||
33457028|NCT00092534|62831521|FG002|Base Study EXT|Physician Decision|1|||
33457029|NCT00092534|62831522|FG003|Base Study EXT|Physician Decision|0|||
33457030|NCT00092534|62831523|FG004|Base Study EXT|Physician Decision|0|||
33457031|NCT00092534|62831519|FG000|Base Study EXT|Pregnancy|0|||
33457032|NCT00092534|62831520|FG001|Base Study EXT|Pregnancy|0|||
33457033|NCT00092534|62831521|FG002|Base Study EXT|Pregnancy|12|||
33457034|NCT00092534|62831522|FG003|Base Study EXT|Pregnancy|0|||
33457035|NCT00092534|62831523|FG004|Base Study EXT|Pregnancy|0|||
33457036|NCT00092534|62831519|FG000|Base Study EXT|Withdrawal by Subject|0|||
33457037|NCT00092534|62831520|FG001|Base Study EXT|Withdrawal by Subject|0|||
33457038|NCT00092534|62831521|FG002|Base Study EXT|Withdrawal by Subject|18|||
33457039|NCT00092534|62831522|FG003|Base Study EXT|Withdrawal by Subject|0|||
33457040|NCT00092534|62831523|FG004|Base Study EXT|Withdrawal by Subject|0|||
33525873|NCT02694978|62913580|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
33619027|NCT02235077|63020151|FG000|Overall Study|Death|5|||
33619028|NCT02235077|63020152|FG001|Overall Study|Death|7|||
33619029|NCT02235077|63020151|FG000|Overall Study|Lost to Follow-up|5|||
33619030|NCT02235077|63020152|FG001|Overall Study|Lost to Follow-up|6|||
33619031|NCT02235077|63020151|FG000|Overall Study|Withdrawal by Subject|8|||
33619032|NCT02235077|63020152|FG001|Overall Study|Withdrawal by Subject|5|||
33525874|NCT02563002|62913588|FG000|Overall Study|Death|62|||
33525875|NCT02563002|62913589|FG001|Overall Study|Death|75|||
33525876|NCT02563002|62913588|FG000|Overall Study|Lost to Follow-up|1|||
33525877|NCT02563002|62913589|FG001|Overall Study|Lost to Follow-up|0|||
33525878|NCT02563002|62913588|FG000|Overall Study|Withdrawal by Subject|0|||
33525879|NCT02563002|62913589|FG001|Overall Study|Withdrawal by Subject|9|||
33525880|NCT02563002|62913588|FG000|Overall Study|Ongoing|90|||
33525881|NCT02563002|62913589|FG001|Overall Study|Ongoing|70|||
33525882|NCT02454933|62913600|FG000|Overall Study|Progressive disease|7|||
33525883|NCT02454933|62913601|FG001|Overall Study|Progressive disease|5|||
33525884|NCT02454933|62913600|FG000|Overall Study|Adverse Event|1|||
33525885|NCT02454933|62913601|FG001|Overall Study|Adverse Event|1|||
33525886|NCT02454933|62913600|FG000|Overall Study|Withdrawal by Subject|0|||
33525887|NCT02454933|62913601|FG001|Overall Study|Withdrawal by Subject|2|||
33525888|NCT02430480|62913606|FG000|Overall Study|Death|1|||
33525889|NCT02430480|62913606|FG000|Overall Study|Anesthesia concerns|1|||
33525890|NCT02430480|62913606|FG000|Overall Study|Progressed on treatment|1|||
33525891|NCT01967888|62913620|FG000|Overall Study|Lost to Follow-up|6|||
33525892|NCT01967888|62913621|FG001|Overall Study|Lost to Follow-up|4|||
33525893|NCT01967888|62913620|FG000|Overall Study|Withdrawal by Subject|1|||
33525894|NCT01967888|62913621|FG001|Overall Study|Withdrawal by Subject|1|||
33525895|NCT01967888|62913620|FG000|Overall Study|Did Not Have Transplant|1|||
33525896|NCT01967888|62913621|FG001|Overall Study|Did Not Have Transplant|0|||
33525897|NCT01967888|62913620|FG000|Overall Study|Research visit not done, data recorded|1|||
33525898|NCT01967888|62913621|FG001|Overall Study|Research visit not done, data recorded|0|||
33525899|NCT01967888|62913620|FG000|Overall Study|Subject excluded after randomization|1|||
33525900|NCT01967888|62913621|FG001|Overall Study|Subject excluded after randomization|0|||
33525901|NCT01967888|62913620|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
33525902|NCT01967888|62913621|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
33525903|NCT01967888|62913620|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
33525904|NCT01967888|62913621|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
33525905|NCT01864018|62913629|FG000|Overall Study|Ineligible|3|||
33525906|NCT01864018|62913630|FG001|Overall Study|Ineligible|1|||
33525907|NCT01796197|62913641|FG000|Overall Study|Lost to Follow-up|1|||
33525908|NCT01796197|62913641|FG000|Overall Study|Lack of Efficacy|1|||
33525909|NCT01205048|62913647|FG000|Overall Study|Withdrawal by Subject|14|||
33525910|NCT01205048|62913647|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
33525911|NCT01205048|62913647|FG000|Overall Study|Lost to Follow-up|4|||
33525912|NCT01205048|62913647|FG000|Overall Study|Other|2|||
33525913|NCT01052779|62913655|FG000|Overall Study|Adverse Event|1|||
33525914|NCT01052779|62913656|FG001|Overall Study|Adverse Event|4|||
33525915|NCT01052779|62913655|FG000|Overall Study|Withdrawal by Subject|1|||
33525916|NCT01052779|62913656|FG001|Overall Study|Withdrawal by Subject|2|||
33525917|NCT01052779|62913655|FG000|Overall Study|Other-Protocol Violation|1|||
33525918|NCT01052779|62913656|FG001|Overall Study|Other-Protocol Violation|1|||
33525919|NCT01052779|62913655|FG000|Overall Study|Other-Surgery|0|||
33525920|NCT01052779|62913656|FG001|Overall Study|Other-Surgery|2|||
33525921|NCT01052779|62913655|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
33525922|NCT01052779|62913656|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
33525923|NCT00591370|62913666|FG000|Overall Study|Not Treated|2|||
33525924|NCT00389610|62913672|FG000|Overall Study|Disease Progression|0|||
33525925|NCT00389610|62913673|FG001|Overall Study|Disease Progression|19|||
33525926|NCT00389610|62913672|FG000|Overall Study|Death|0|||
33525927|NCT00389610|62913673|FG001|Overall Study|Death|1|||
33325291|NCT01213082|62702039|FG001|Overall Study|Physician Decision|0|||
33325292|NCT01213082|62702040|FG002|Overall Study|Physician Decision|1|||
33457041|NCT00092534|62831519|FG000|Base Study EXT|Participant moved|0|||
33457042|NCT00092534|62831520|FG001|Base Study EXT|Participant moved|0|||
33457043|NCT00092534|62831521|FG002|Base Study EXT|Participant moved|6|||
33457044|NCT00092534|62831522|FG003|Base Study EXT|Participant moved|0|||
33457045|NCT00092534|62831523|FG004|Base Study EXT|Participant moved|0|||
33457046|NCT00092534|62831519|FG000|Base Study EXT|Travel|0|||
33457047|NCT00092534|62831520|FG001|Base Study EXT|Travel|0|||
33457048|NCT00092534|62831521|FG002|Base Study EXT|Travel|2|||
33457049|NCT00092534|62831522|FG003|Base Study EXT|Travel|0|||
33457050|NCT00092534|62831523|FG004|Base Study EXT|Travel|0|||
33525928|NCT00389610|62913672|FG000|Overall Study|Physician Decision|0|||
33525929|NCT00389610|62913673|FG001|Overall Study|Physician Decision|1|||
33525930|NCT00389610|62913672|FG000|Overall Study|Withdrawal by Subject|0|||
33619033|NCT02235077|63020151|FG000|Overall Study|Physician Decision|0|||
33619034|NCT02235077|63020152|FG001|Overall Study|Physician Decision|1|||
33619035|NCT02234141|63020162|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
33619036|NCT02234141|63020163|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
33619037|NCT02234141|63020164|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
33619038|NCT02234141|63020165|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
33619039|NCT02234141|63020166|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
33619040|NCT02234141|63020167|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
33619041|NCT02234141|63020168|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
33619042|NCT02234141|63020162|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
33619043|NCT02234141|63020163|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
33619044|NCT02234141|63020164|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
33619045|NCT02234141|63020165|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
33619046|NCT02234141|63020166|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
33619047|NCT02234141|63020167|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
33619048|NCT02234141|63020168|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
33619049|NCT02234141|63020162|FG000|Treatment Period (24 Weeks)|Death|1|||
33525931|NCT00389610|62913673|FG001|Overall Study|Withdrawal by Subject|1|||
33525932|NCT03064763|62913679|FG000|Overall Study|Lost to Follow-up|1|||
33525933|NCT03064763|62913679|FG000|Overall Study|Death|8|||
33525934|NCT02782676|62913683|FG000|Overall Study|Lost to Follow-up|0|||
33525935|NCT02782676|62913684|FG001|Overall Study|Lost to Follow-up|1|||
33525936|NCT02471339|62913692|FG000|Overall Study|Did not provide follow-up data|2|||
33525937|NCT02471339|62913693|FG001|Overall Study|Did not provide follow-up data|0|||
33525938|NCT00107978|62913701|FG000|Overall Study|Adverse Event|1|||
33525939|NCT00107978|62913702|FG001|Overall Study|Adverse Event|5|||
33525940|NCT00107978|62913701|FG000|Overall Study|Death|3|||
33525941|NCT00107978|62913702|FG001|Overall Study|Death|3|||
33525942|NCT00107978|62913701|FG000|Overall Study|Lost to Follow-up|20|||
33525943|NCT00107978|62913702|FG001|Overall Study|Lost to Follow-up|28|||
33525944|NCT00107978|62913701|FG000|Overall Study|Withdrawal by Subject|4|||
33525945|NCT00107978|62913702|FG001|Overall Study|Withdrawal by Subject|9|||
33525946|NCT00107978|62913701|FG000|Overall Study|Protocol Violation|0|||
33525947|NCT00107978|62913702|FG001|Overall Study|Protocol Violation|1|||
33525948|NCT00107978|62913701|FG000|Overall Study|Other|5|||
33525949|NCT00107978|62913702|FG001|Overall Study|Other|4|||
33525950|NCT02781818|62913711|FG000|Overall Study|Lost to Follow-up|4|||
33525951|NCT02781818|62913712|FG001|Overall Study|Lost to Follow-up|2|||
33525952|NCT02781818|62913713|FG002|Overall Study|Lost to Follow-up|1|||
33525953|NCT02927873|62913727|FG000|Overall Study|Lost to Follow-up|0|||
33525954|NCT02927873|62913728|FG001|Overall Study|Lost to Follow-up|1|||
33619050|NCT02234141|63020163|FG001|Treatment Period (24 Weeks)|Death|2|||
33619051|NCT02234141|63020164|FG002|Treatment Period (24 Weeks)|Death|0|||
33619052|NCT02234141|63020165|FG003|Treatment Period (24 Weeks)|Death|1|||
33619053|NCT02234141|63020166|FG004|Treatment Period (24 Weeks)|Death|0|||
33619054|NCT02234141|63020167|FG005|Treatment Period (24 Weeks)|Death|0|||
33619055|NCT02234141|63020168|FG006|Treatment Period (24 Weeks)|Death|0|||
33619056|NCT02234141|63020162|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
33619057|NCT02234141|63020163|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
33619058|NCT02234141|63020164|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
33619059|NCT02234141|63020165|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
33619060|NCT02234141|63020166|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
33619061|NCT02234141|63020167|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
33619062|NCT02234141|63020168|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
33619063|NCT02234141|63020162|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
33619064|NCT02234141|63020163|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
33619065|NCT02234141|63020164|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
33619066|NCT02234141|63020165|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
33619067|NCT02234141|63020166|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
33619068|NCT02234141|63020167|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
33619069|NCT02234141|63020168|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
33619070|NCT02234141|63020162|FG000|Long-Term Treatment Period|Death|0|||
33619071|NCT02234141|63020163|FG001|Long-Term Treatment Period|Death|0|||
33325293|NCT00885703|62702055|FG000|Overall Study|Death|9|||
33525955|NCT02927873|62913729|FG002|Overall Study|Lost to Follow-up|0|||
33525956|NCT02927873|62913730|FG003|Overall Study|Lost to Follow-up|0|||
33525957|NCT02927873|62913731|FG004|Overall Study|Lost to Follow-up|0|||
33619072|NCT02234141|63020164|FG002|Long-Term Treatment Period|Death|0|||
33619073|NCT02234141|63020165|FG003|Long-Term Treatment Period|Death|0|||
33619074|NCT02234141|63020166|FG004|Long-Term Treatment Period|Death|0|||
33619075|NCT02234141|63020167|FG005|Long-Term Treatment Period|Death|1|||
33525958|NCT02927873|62913732|FG005|Overall Study|Lost to Follow-up|0|||
33525959|NCT02927873|62913727|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33525960|NCT02927873|62913728|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
33525961|NCT02927873|62913729|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33525962|NCT02927873|62913730|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33525963|NCT02927873|62913731|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33525964|NCT02927873|62913732|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33525965|NCT02927873|62913727|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33619076|NCT02234141|63020168|FG006|Long-Term Treatment Period|Death|0|||
33619077|NCT02234141|63020162|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
33619078|NCT02234141|63020163|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
33619079|NCT02234141|63020164|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
33525966|NCT02927873|62913728|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33525967|NCT02927873|62913729|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33525968|NCT02927873|62913730|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33525969|NCT02927873|62913731|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33525970|NCT02927873|62913732|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33525971|NCT02927873|62913727|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
33525972|NCT02927873|62913728|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
33525973|NCT02927873|62913729|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
33525974|NCT02927873|62913730|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
33525975|NCT02927873|62913731|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
33525976|NCT02927873|62913732|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
33525977|NCT02927873|62913727|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
33525978|NCT02927873|62913728|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
33525979|NCT02927873|62913729|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
33525980|NCT02927873|62913730|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
33525981|NCT02927873|62913731|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
33525982|NCT02927873|62913732|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
33525983|NCT02927873|62913727|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
33619080|NCT02234141|63020165|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
33619081|NCT02234141|63020166|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
33619082|NCT02234141|63020167|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
33619083|NCT02234141|63020168|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
33619084|NCT02234141|63020162|FG000|Long-Term Treatment Period|Adverse Event|4|||
33619085|NCT02234141|63020163|FG001|Long-Term Treatment Period|Adverse Event|0|||
33619086|NCT02234141|63020164|FG002|Long-Term Treatment Period|Adverse Event|5|||
33619087|NCT02234141|63020165|FG003|Long-Term Treatment Period|Adverse Event|0|||
33619088|NCT02234141|63020166|FG004|Long-Term Treatment Period|Adverse Event|1|||
33619089|NCT02234141|63020167|FG005|Long-Term Treatment Period|Adverse Event|1|||
33619090|NCT02234141|63020168|FG006|Long-Term Treatment Period|Adverse Event|1|||
33619091|NCT02234141|63020162|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
33619092|NCT02234141|63020163|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
33619093|NCT02234141|63020164|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
33619094|NCT02234141|63020165|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
33619095|NCT02234141|63020166|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
33619096|NCT02234141|63020167|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
33619097|NCT02234141|63020168|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
33619098|NCT02234141|63020162|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
33619099|NCT02234141|63020163|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
33619100|NCT02234141|63020164|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
33619101|NCT02234141|63020165|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
33619102|NCT02234141|63020166|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
33619103|NCT02234141|63020167|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
33619104|NCT02234141|63020168|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
33619105|NCT02234063|63020181|FG000|Overall Study|Lost to Follow-up|235|||
33619106|NCT02234063|63020182|FG001|Overall Study|Lost to Follow-up|42|||
33619107|NCT02234063|63020181|FG000|Overall Study|Withdrawal by Subject|20|||
33619108|NCT02234063|63020182|FG001|Overall Study|Withdrawal by Subject|1|||
33619109|NCT02232893|63020195|FG000|Overall Study|Withdrawal by Subject|4|||
33619110|NCT02232893|63020196|FG001|Overall Study|Withdrawal by Subject|1|||
33619111|NCT02232893|63020195|FG000|Overall Study|Adverse Event|0|||
33619112|NCT02232893|63020196|FG001|Overall Study|Adverse Event|1|||
33619113|NCT02232893|63020195|FG000|Overall Study|Sponsor request early termination|0|||
33619114|NCT02232893|63020196|FG001|Overall Study|Sponsor request early termination|1|||
33619115|NCT02232893|63020195|FG000|Overall Study|Developed exclusion criteria|0|||
33619116|NCT02232893|63020196|FG001|Overall Study|Developed exclusion criteria|1|||
33619117|NCT02232893|63020195|FG000|Overall Study|Other|0|||
33619118|NCT02232893|63020196|FG001|Overall Study|Other|3|||
33619119|NCT02203721|63020204|FG000|Overall Study|Lost to Follow-up|1|||
33619120|NCT02203721|63020205|FG001|Overall Study|Lost to Follow-up|0|||
33619121|NCT02203721|63020204|FG000|Overall Study|Death|0|||
33619122|NCT02203721|63020205|FG001|Overall Study|Death|2|||
33619123|NCT02203721|63020204|FG000|Overall Study|Illness|0|||
33525984|NCT02927873|62913728|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
33525985|NCT02927873|62913729|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
33525986|NCT02927873|62913730|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
33525987|NCT02927873|62913731|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
33525988|NCT02927873|62913732|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
33525989|NCT01220999|62913751|FG000|Overall Study|Progressive disease|0|||
33525990|NCT01220999|62913752|FG001|Overall Study|Progressive disease|0|||
33525991|NCT01220999|62913753|FG002|Overall Study|Progressive disease|1|||
33525992|NCT01220999|62913754|FG003|Overall Study|Progressive disease|0|||
33525993|NCT01220999|62913755|FG004|Overall Study|Progressive disease|0|||
33525994|NCT00142415|62913773|FG000|Overall Study|Physician Decision|0|||
33525995|NCT00142415|62913774|FG001|Overall Study|Physician Decision|0|||
33525996|NCT00142415|62913775|FG002|Overall Study|Physician Decision|0|||
33525997|NCT00142415|62913776|FG003|Overall Study|Physician Decision|0|||
33525998|NCT00142415|62913777|FG004|Overall Study|Physician Decision|1|||
33525999|NCT00142415|62913778|FG005|Overall Study|Physician Decision|2|||
33526000|NCT02781584|62913820|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
33526001|NCT02781584|62913821|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
33526002|NCT02781584|62913822|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
33526003|NCT02781584|62913823|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
33526004|NCT02781584|62913824|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
33526005|NCT02781584|62913825|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
33619124|NCT02203721|63020205|FG001|Overall Study|Illness|1|||
33619125|NCT01618695|63020215|FG000|Core Phase|Adverse Event|4|||
33619126|NCT01618695|63020216|FG001|Core Phase|Adverse Event|5|||
33619127|NCT01618695|63020217|FG002|Core Phase|Adverse Event|15|||
33619128|NCT01618695|63020218|FG003|Core Phase|Adverse Event|20|||
33619129|NCT01618695|63020215|FG000|Core Phase|Lost to Follow-up|0|||
33619130|NCT01618695|63020216|FG001|Core Phase|Lost to Follow-up|0|||
33619131|NCT01618695|63020217|FG002|Core Phase|Lost to Follow-up|1|||
33619132|NCT01618695|63020218|FG003|Core Phase|Lost to Follow-up|0|||
33619133|NCT01618695|63020215|FG000|Core Phase|Withdrawal by Subject|16|||
33619134|NCT01618695|63020216|FG001|Core Phase|Withdrawal by Subject|11|||
33619135|NCT01618695|63020217|FG002|Core Phase|Withdrawal by Subject|9|||
33619136|NCT01618695|63020218|FG003|Core Phase|Withdrawal by Subject|13|||
33619137|NCT01618695|63020215|FG000|Core Phase|Pregnancy|2|||
33619138|NCT01618695|63020216|FG001|Core Phase|Pregnancy|0|||
33619139|NCT01618695|63020217|FG002|Core Phase|Pregnancy|0|||
33619140|NCT01618695|63020218|FG003|Core Phase|Pregnancy|0|||
33619141|NCT01618695|63020215|FG000|Core Phase|Lack of Efficacy|1|||
33619142|NCT01618695|63020216|FG001|Core Phase|Lack of Efficacy|2|||
33619143|NCT01618695|63020217|FG002|Core Phase|Lack of Efficacy|1|||
33619144|NCT01618695|63020218|FG003|Core Phase|Lack of Efficacy|1|||
33619145|NCT01618695|63020215|FG000|Core Phase|Other than specified|1|||
33619146|NCT01618695|63020216|FG001|Core Phase|Other than specified|2|||
33619147|NCT01618695|63020217|FG002|Core Phase|Other than specified|2|||
33619148|NCT01618695|63020218|FG003|Core Phase|Other than specified|2|||
33619149|NCT01618695|63020215|FG000|Core Phase|Not treated|1|||
33619150|NCT01618695|63020216|FG001|Core Phase|Not treated|0|||
33619151|NCT01618695|63020217|FG002|Core Phase|Not treated|2|||
33619152|NCT01618695|63020218|FG003|Core Phase|Not treated|0|||
33619153|NCT01618695|63020215|FG000|Extension Phase|Lack of Efficacy|17|||
33619154|NCT01618695|63020216|FG001|Extension Phase|Lack of Efficacy|33|||
33619155|NCT01618695|63020217|FG002|Extension Phase|Lack of Efficacy|26|||
33619156|NCT01618695|63020218|FG003|Extension Phase|Lack of Efficacy|24|||
33619157|NCT01618695|63020215|FG000|Extension Phase|Pregnancy|2|||
33619158|NCT01618695|63020216|FG001|Extension Phase|Pregnancy|0|||
33619159|NCT01618695|63020217|FG002|Extension Phase|Pregnancy|1|||
33619160|NCT01618695|63020218|FG003|Extension Phase|Pregnancy|1|||
33619161|NCT01618695|63020215|FG000|Extension Phase|Withdrawal by Subject|43|||
33619162|NCT01618695|63020216|FG001|Extension Phase|Withdrawal by Subject|48|||
33619163|NCT01618695|63020217|FG002|Extension Phase|Withdrawal by Subject|42|||
33619164|NCT01618695|63020218|FG003|Extension Phase|Withdrawal by Subject|33|||
33325294|NCT00885703|62702056|FG001|Overall Study|Death|7|||
33526006|NCT02781584|62913826|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
33526007|NCT02781584|62913827|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
33526008|NCT02781584|62913828|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
33526009|NCT02781584|62913829|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
33619165|NCT01618695|63020215|FG000|Extension Phase|Adverse Event|18|||
33619166|NCT01618695|63020216|FG001|Extension Phase|Adverse Event|16|||
33619167|NCT01618695|63020217|FG002|Extension Phase|Adverse Event|9|||
33619168|NCT01618695|63020218|FG003|Extension Phase|Adverse Event|20|||
33619169|NCT01618695|63020215|FG000|Extension Phase|Lost to Follow-up|2|||
33619170|NCT01618695|63020216|FG001|Extension Phase|Lost to Follow-up|1|||
33457051|NCT00092534|62831519|FG000|Base Study EXT|Site closed|0|||
33457052|NCT00092534|62831520|FG001|Base Study EXT|Site closed|0|||
33457053|NCT00092534|62831521|FG002|Base Study EXT|Site closed|21|||
33457054|NCT00092534|62831522|FG003|Base Study EXT|Site closed|0|||
33457055|NCT00092534|62831523|FG004|Base Study EXT|Site closed|0|||
33457056|NCT00092534|62831519|FG000|Base Study EXT|Study ended|0|||
33457057|NCT00092534|62831520|FG001|Base Study EXT|Study ended|0|||
33457058|NCT00092534|62831521|FG002|Base Study EXT|Study ended|29|||
33457059|NCT00092534|62831522|FG003|Base Study EXT|Study ended|0|||
33457060|NCT00092534|62831523|FG004|Base Study EXT|Study ended|0|||
33457061|NCT00092534|62831519|FG000|Base Study EXT|Protocol Violation|0|||
33457062|NCT00092534|62831520|FG001|Base Study EXT|Protocol Violation|0|||
33457063|NCT00092534|62831521|FG002|Base Study EXT|Protocol Violation|15|||
33457064|NCT00092534|62831522|FG003|Base Study EXT|Protocol Violation|0|||
33457065|NCT00092534|62831523|FG004|Base Study EXT|Protocol Violation|0|||
33457066|NCT00092534|62831519|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
33457067|NCT00092534|62831520|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
33457068|NCT00092534|62831521|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
33457069|NCT00092534|62831522|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
33457070|NCT00092534|62831523|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
33457071|NCT00068250|62831536|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
33457072|NCT00068250|62831537|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
33457073|NCT00068250|62831538|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
33457074|NCT00068250|62831539|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
33457075|NCT00393887|62831549|FG000|Overall Study|Physician Decision|5|||
33457076|NCT00393887|62831550|FG001|Overall Study|Physician Decision|0|||
33457077|NCT00393887|62831549|FG000|Overall Study|Lost to Follow-up|11|||
33457078|NCT00393887|62831550|FG001|Overall Study|Lost to Follow-up|9|||
33457079|NCT00393029|62831558|FG000|Overall Study|Not treated|0|||
33457080|NCT00393029|62831559|FG001|Overall Study|Not treated|1|||
33457081|NCT00402233|62831570|FG000|Overall Study|Adverse Event|1|||
33457082|NCT00402233|62831571|FG001|Overall Study|Adverse Event|7|||
33457083|NCT00402233|62831572|FG002|Overall Study|Adverse Event|9|||
33457084|NCT00402233|62831573|FG003|Overall Study|Adverse Event|9|||
33457085|NCT00402233|62831570|FG000|Overall Study|Protocol Violation|0|||
33457086|NCT00402233|62831571|FG001|Overall Study|Protocol Violation|1|||
33457087|NCT00402233|62831572|FG002|Overall Study|Protocol Violation|0|||
33457088|NCT00402233|62831573|FG003|Overall Study|Protocol Violation|0|||
33457089|NCT00402233|62831570|FG000|Overall Study|Withdrawal by Subject|2|||
33457090|NCT00402233|62831571|FG001|Overall Study|Withdrawal by Subject|1|||
33457091|NCT00402233|62831572|FG002|Overall Study|Withdrawal by Subject|2|||
33457092|NCT00402233|62831573|FG003|Overall Study|Withdrawal by Subject|2|||
33457093|NCT00402233|62831570|FG000|Overall Study|Worsening of disease under study|2|||
33457094|NCT00402233|62831571|FG001|Overall Study|Worsening of disease under study|0|||
33457095|NCT00402233|62831572|FG002|Overall Study|Worsening of disease under study|0|||
33457096|NCT00402233|62831573|FG003|Overall Study|Worsening of disease under study|0|||
33457097|NCT00402233|62831570|FG000|Overall Study|Worsening of other pre-existing disease|0|||
33457098|NCT00402233|62831571|FG001|Overall Study|Worsening of other pre-existing disease|1|||
33457099|NCT00402233|62831572|FG002|Overall Study|Worsening of other pre-existing disease|0|||
33457100|NCT00402233|62831573|FG003|Overall Study|Worsening of other pre-existing disease|0|||
33457101|NCT00092456|62831587|FG000|Overall Study|Adverse Event|0|||
33457102|NCT00092456|62831588|FG001|Overall Study|Adverse Event|0|||
33526010|NCT02781584|62913830|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
33526011|NCT02781584|62913831|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
33526012|NCT02781584|62913832|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
33526013|NCT02781584|62913820|FG000|Pre-treatment Phase|Adverse Event|0|||
33526014|NCT02781584|62913821|FG001|Pre-treatment Phase|Adverse Event|0|||
33526015|NCT02781584|62913822|FG002|Pre-treatment Phase|Adverse Event|0|||
33619171|NCT01618695|63020217|FG002|Extension Phase|Lost to Follow-up|1|||
33457103|NCT00092456|62831589|FG002|Overall Study|Adverse Event|1|||
33457104|NCT00092456|62831590|FG003|Overall Study|Adverse Event|1|||
33457105|NCT00092456|62831587|FG000|Overall Study|Lost to Follow-up|2|||
33457106|NCT00092456|62831588|FG001|Overall Study|Lost to Follow-up|2|||
33457107|NCT00092456|62831589|FG002|Overall Study|Lost to Follow-up|1|||
33457108|NCT00092456|62831590|FG003|Overall Study|Lost to Follow-up|2|||
33457109|NCT00092456|62831587|FG000|Overall Study|Protocol Violation|5|||
33457110|NCT00092456|62831588|FG001|Overall Study|Protocol Violation|7|||
33457111|NCT00092456|62831589|FG002|Overall Study|Protocol Violation|8|||
33457112|NCT00092456|62831590|FG003|Overall Study|Protocol Violation|6|||
33457113|NCT00092456|62831587|FG000|Overall Study|Withdrawal by Subject|13|||
33526016|NCT02781584|62913823|FG003|Pre-treatment Phase|Adverse Event|0|||
33457114|NCT00092456|62831588|FG001|Overall Study|Withdrawal by Subject|5|||
33457115|NCT00092456|62831589|FG002|Overall Study|Withdrawal by Subject|16|||
33457116|NCT00092456|62831590|FG003|Overall Study|Withdrawal by Subject|6|||
33457117|NCT00092456|62831587|FG000|Overall Study|Moved|1|||
33526017|NCT02781584|62913824|FG004|Pre-treatment Phase|Adverse Event|0|||
33526018|NCT02781584|62913825|FG005|Pre-treatment Phase|Adverse Event|0|||
33526019|NCT02781584|62913826|FG006|Pre-treatment Phase|Adverse Event|0|||
33619172|NCT01618695|63020218|FG003|Extension Phase|Lost to Follow-up|1|||
33619173|NCT01618695|63020215|FG000|Extension Phase|Other than specified|13|||
33619174|NCT01618695|63020216|FG001|Extension Phase|Other than specified|18|||
33619175|NCT01618695|63020217|FG002|Extension Phase|Other than specified|13|||
33619176|NCT01618695|63020218|FG003|Extension Phase|Other than specified|18|||
33619177|NCT01896531|63020231|FG000|Overall Study|Death|57|||
33619178|NCT01896531|63020232|FG001|Overall Study|Death|59|||
33619179|NCT01896531|63020231|FG000|Overall Study|Lost to Follow-up|3|||
33619180|NCT01896531|63020232|FG001|Overall Study|Lost to Follow-up|0|||
33619181|NCT01896531|63020231|FG000|Overall Study|Non-compliance|0|||
33619182|NCT01896531|63020232|FG001|Overall Study|Non-compliance|1|||
33619183|NCT01896531|63020231|FG000|Overall Study|Study Ended by Sponsor|7|||
33619184|NCT01896531|63020232|FG001|Overall Study|Study Ended by Sponsor|20|||
33619185|NCT01896531|63020231|FG000|Overall Study|Withdrawal by Subject|3|||
33619186|NCT01896531|63020232|FG001|Overall Study|Withdrawal by Subject|2|||
33619187|NCT01896531|63020231|FG000|Overall Study|Death Prior to Treatment|1|||
33619188|NCT01896531|63020232|FG001|Overall Study|Death Prior to Treatment|0|||
33619189|NCT01618305|63020240|FG000|Overall Study|Death|0|||
33619190|NCT01618305|63020241|FG001|Overall Study|Death|1|||
33619191|NCT01618305|63020240|FG000|Overall Study|Lost to Follow-up|11|||
33619192|NCT01618305|63020241|FG001|Overall Study|Lost to Follow-up|7|||
33619193|NCT01618305|63020240|FG000|Overall Study|Protocol Violation|1|||
33619194|NCT01618305|63020241|FG001|Overall Study|Protocol Violation|0|||
33619195|NCT01618305|63020240|FG000|Overall Study|Withdrawal by Subject|3|||
33619196|NCT01618305|63020241|FG001|Overall Study|Withdrawal by Subject|2|||
33619197|NCT01886313|63020253|FG000|Overall Study|Adverse Event|1|||
33619198|NCT01886313|63020254|FG001|Overall Study|Adverse Event|1|||
33619199|NCT01896297|63020260|FG000|Overall Study|Died in post treatment phase|1|||
33619200|NCT01884675|63020266|FG000|Overall Study|Study closed/terminated|3|||
33619201|NCT01884675|63020267|FG001|Overall Study|Study closed/terminated|2|||
33619202|NCT01884597|63020278|FG000|Overall Study|Adverse Event|0|||
33619203|NCT01884597|63020279|FG001|Overall Study|Adverse Event|0|||
33619204|NCT01884597|63020280|FG002|Overall Study|Adverse Event|1|||
33619205|NCT01884597|63020278|FG000|Overall Study|Lack of Efficacy|1|||
33619206|NCT01884597|63020279|FG001|Overall Study|Lack of Efficacy|0|||
33619207|NCT01884597|63020280|FG002|Overall Study|Lack of Efficacy|0|||
33619208|NCT01884597|63020278|FG000|Overall Study|Death|0|||
33619209|NCT01884597|63020279|FG001|Overall Study|Death|1|||
33619210|NCT01884597|63020280|FG002|Overall Study|Death|0|||
33619211|NCT01895361|63020297|FG000|Overall Study|Adverse Event|1|||
33619212|NCT01895361|63020298|FG001|Overall Study|Adverse Event|1|||
33457118|NCT00092456|62831588|FG001|Overall Study|Moved|1|||
33457119|NCT00092456|62831589|FG002|Overall Study|Moved|0|||
33457120|NCT00092456|62831590|FG003|Overall Study|Moved|1|||
33457121|NCT00092456|62831587|FG000|Overall Study|Other|4|||
33457122|NCT00092456|62831588|FG001|Overall Study|Other|2|||
33457123|NCT00092456|62831589|FG002|Overall Study|Other|3|||
33457124|NCT00092456|62831590|FG003|Overall Study|Other|0|||
33457125|NCT00067470|62831602|FG000|Overall Study|Withdrawal by Subject|0|||
33457126|NCT00067470|62831603|FG001|Overall Study|Withdrawal by Subject|1|||
33526020|NCT02781584|62913827|FG007|Pre-treatment Phase|Adverse Event|0|||
33526021|NCT02781584|62913828|FG008|Pre-treatment Phase|Adverse Event|0|||
33526022|NCT02781584|62913829|FG009|Pre-treatment Phase|Adverse Event|0|||
33526023|NCT02781584|62913830|FG010|Pre-treatment Phase|Adverse Event|0|||
33526024|NCT02781584|62913831|FG011|Pre-treatment Phase|Adverse Event|1|||
33526025|NCT02781584|62913832|FG012|Pre-treatment Phase|Adverse Event|0|||
33526026|NCT02781584|62913820|FG000|Treatment Phase|Withdrew Consent|0|||
33526027|NCT02781584|62913821|FG001|Treatment Phase|Withdrew Consent|0|||
33526028|NCT02781584|62913822|FG002|Treatment Phase|Withdrew Consent|0|||
33526029|NCT02781584|62913823|FG003|Treatment Phase|Withdrew Consent|0|||
33526030|NCT02781584|62913824|FG004|Treatment Phase|Withdrew Consent|0|||
33526031|NCT02781584|62913825|FG005|Treatment Phase|Withdrew Consent|1|||
33526032|NCT02781584|62913826|FG006|Treatment Phase|Withdrew Consent|0|||
33526033|NCT02781584|62913827|FG007|Treatment Phase|Withdrew Consent|0|||
33619213|NCT01895361|63020299|FG002|Overall Study|Adverse Event|3|||
33619214|NCT01895361|63020297|FG000|Overall Study|Death|2|||
33619215|NCT01895361|63020298|FG001|Overall Study|Death|1|||
33619216|NCT01895361|63020299|FG002|Overall Study|Death|2|||
33619217|NCT01895361|63020297|FG000|Overall Study|Lost to Follow-up|4|||
33457127|NCT00401843|62831612|FG000|Overall Study|Achieved Complete Response|1|||
33526034|NCT02781584|62913828|FG008|Treatment Phase|Withdrew Consent|0|||
33526035|NCT02781584|62913829|FG009|Treatment Phase|Withdrew Consent|0|||
33526036|NCT02781584|62913830|FG010|Treatment Phase|Withdrew Consent|1|||
33619218|NCT01895361|63020298|FG001|Overall Study|Lost to Follow-up|4|||
33619219|NCT01895361|63020299|FG002|Overall Study|Lost to Follow-up|6|||
33619220|NCT01895361|63020297|FG000|Overall Study|Non-compliance with study|1|||
33619221|NCT01895361|63020298|FG001|Overall Study|Non-compliance with study|3|||
33619222|NCT01895361|63020299|FG002|Overall Study|Non-compliance with study|1|||
33619223|NCT01895361|63020297|FG000|Overall Study|Physician Decision|2|||
33619224|NCT01895361|63020298|FG001|Overall Study|Physician Decision|2|||
33619225|NCT01895361|63020299|FG002|Overall Study|Physician Decision|2|||
33619226|NCT01895361|63020297|FG000|Overall Study|Withdrawal by Subject|7|||
33619227|NCT01895361|63020298|FG001|Overall Study|Withdrawal by Subject|6|||
33619228|NCT01895361|63020299|FG002|Overall Study|Withdrawal by Subject|6|||
33619229|NCT01895361|63020297|FG000|Overall Study|Lack of Efficacy|0|||
33619230|NCT01895361|63020298|FG001|Overall Study|Lack of Efficacy|1|||
33619231|NCT01895361|63020299|FG002|Overall Study|Lack of Efficacy|0|||
33526037|NCT02781584|62913831|FG011|Treatment Phase|Withdrew Consent|2|||
33526038|NCT02781584|62913832|FG012|Treatment Phase|Withdrew Consent|0|||
33526039|NCT02781584|62913820|FG000|Treatment Phase|Adverse Event|0|||
33526040|NCT02781584|62913821|FG001|Treatment Phase|Adverse Event|0|||
33526041|NCT02781584|62913822|FG002|Treatment Phase|Adverse Event|0|||
33526042|NCT02781584|62913823|FG003|Treatment Phase|Adverse Event|0|||
33619232|NCT01895361|63020297|FG000|Overall Study|Reasons different from categories above|7|||
33619233|NCT01895361|63020298|FG001|Overall Study|Reasons different from categories above|3|||
33619234|NCT01895361|63020299|FG002|Overall Study|Reasons different from categories above|4|||
33619235|NCT01883895|63020307|FG000|Overall Study|Lost to Follow-up|2|||
33619236|NCT01864005|63020313|FG000|Overall Study|Protocol Violation|0|||
33619237|NCT01864005|63020314|FG001|Overall Study|Protocol Violation|1|||
33619238|NCT01864005|63020313|FG000|Overall Study|Withdrawal by Subject|0|||
33619239|NCT01864005|63020314|FG001|Overall Study|Withdrawal by Subject|1|||
33619240|NCT01864005|63020313|FG000|Overall Study|Incorrect enrolment|1|||
33619241|NCT01864005|63020314|FG001|Overall Study|Incorrect enrolment|0|||
33619242|NCT01864005|63020313|FG000|Overall Study|Disease need|1|||
33619243|NCT01864005|63020314|FG001|Overall Study|Disease need|1|||
33619244|NCT01864005|63020313|FG000|Overall Study|Need GP IIb/IIIa|1|||
33619245|NCT01864005|63020314|FG001|Overall Study|Need GP IIb/IIIa|3|||
33619246|NCT01863849|63020322|FG000|Overall Study|Lost to Follow-up|1|||
33619247|NCT01863849|63020323|FG001|Overall Study|Lost to Follow-up|0|||
33619248|NCT01863771|63020330|FG000|Induction Phase|Adverse Event|9|||
33619249|NCT01863771|63020331|FG001|Induction Phase|Adverse Event|0|||
33619250|NCT01863771|63020332|FG002|Induction Phase|Adverse Event|0|||
33619251|NCT01863771|63020333|FG003|Induction Phase|Adverse Event|0|||
33619252|NCT01863771|63020330|FG000|Induction Phase|Lack of Efficacy|10|||
33619253|NCT01863771|63020331|FG001|Induction Phase|Lack of Efficacy|0|||
33619254|NCT01863771|63020332|FG002|Induction Phase|Lack of Efficacy|0|||
33619255|NCT01863771|63020333|FG003|Induction Phase|Lack of Efficacy|0|||
33619256|NCT01863771|63020330|FG000|Induction Phase|Withdrawal by Subject|2|||
33619257|NCT01863771|63020331|FG001|Induction Phase|Withdrawal by Subject|0|||
33619258|NCT01863771|63020332|FG002|Induction Phase|Withdrawal by Subject|0|||
33325295|NCT00885703|62702057|FG002|Overall Study|Death|8|||
33325296|NCT00885703|62702058|FG003|Overall Study|Death|7|||
33325297|NCT00885703|62702059|FG004|Overall Study|Death|7|||
33325298|NCT00885703|62702060|FG005|Overall Study|Death|8|||
33325299|NCT00885703|62702061|FG006|Overall Study|Death|4|||
33325300|NCT00885703|62702055|FG000|Overall Study|Lost to Follow-up|0|||
33325301|NCT00885703|62702056|FG001|Overall Study|Lost to Follow-up|0|||
33325302|NCT00885703|62702057|FG002|Overall Study|Lost to Follow-up|1|||
33325303|NCT00885703|62702058|FG003|Overall Study|Lost to Follow-up|0|||
33325304|NCT00885703|62702059|FG004|Overall Study|Lost to Follow-up|0|||
33325305|NCT00885703|62702060|FG005|Overall Study|Lost to Follow-up|1|||
33325306|NCT00885703|62702061|FG006|Overall Study|Lost to Follow-up|0|||
33325307|NCT00885703|62702055|FG000|Overall Study|Withdrawal by Subject|0|||
33325308|NCT00885703|62702056|FG001|Overall Study|Withdrawal by Subject|0|||
33325309|NCT00885703|62702057|FG002|Overall Study|Withdrawal by Subject|0|||
33325310|NCT00885703|62702058|FG003|Overall Study|Withdrawal by Subject|1|||
33526043|NCT02781584|62913824|FG004|Treatment Phase|Adverse Event|0|||
33526044|NCT02781584|62913825|FG005|Treatment Phase|Adverse Event|0|||
33325311|NCT00885703|62702059|FG004|Overall Study|Withdrawal by Subject|3|||
33325312|NCT00885703|62702060|FG005|Overall Study|Withdrawal by Subject|1|||
33526045|NCT02781584|62913826|FG006|Treatment Phase|Adverse Event|0|||
33526046|NCT02781584|62913827|FG007|Treatment Phase|Adverse Event|1|||
33526047|NCT02781584|62913828|FG008|Treatment Phase|Adverse Event|0|||
33526048|NCT02781584|62913829|FG009|Treatment Phase|Adverse Event|0|||
33526049|NCT02781584|62913830|FG010|Treatment Phase|Adverse Event|0|||
33526050|NCT02781584|62913831|FG011|Treatment Phase|Adverse Event|0|||
33619259|NCT01863771|63020333|FG003|Induction Phase|Withdrawal by Subject|0|||
33325313|NCT00885703|62702061|FG006|Overall Study|Withdrawal by Subject|1|||
33325314|NCT00885703|62702055|FG000|Overall Study|Ineligible (no CM)|1|||
33325315|NCT00885703|62702056|FG001|Overall Study|Ineligible (no CM)|3|||
33325316|NCT00885703|62702057|FG002|Overall Study|Ineligible (no CM)|2|||
33526051|NCT02781584|62913832|FG012|Treatment Phase|Adverse Event|0|||
33526052|NCT02776670|62913862|FG000|Overall Study|Adverse Event|0|||
33526053|NCT02776670|62913863|FG001|Overall Study|Adverse Event|2|||
33619260|NCT01863771|63020330|FG000|Maintenance Phase|Adverse Event|0|||
33619261|NCT01863771|63020331|FG001|Maintenance Phase|Adverse Event|0|||
33619262|NCT01863771|63020332|FG002|Maintenance Phase|Adverse Event|1|||
33325317|NCT00885703|62702058|FG003|Overall Study|Ineligible (no CM)|1|||
33325318|NCT00885703|62702059|FG004|Overall Study|Ineligible (no CM)|2|||
33526054|NCT02776670|62913862|FG000|Overall Study|Protocol Violation|0|||
33526055|NCT02776670|62913863|FG001|Overall Study|Protocol Violation|2|||
33526056|NCT02776670|62913862|FG000|Overall Study|Withdrawal by Subject|0|||
33526057|NCT02776670|62913863|FG001|Overall Study|Withdrawal by Subject|1|||
33526058|NCT02776670|62913862|FG000|Overall Study|Other - Reason not given|0|||
33526059|NCT02776670|62913863|FG001|Overall Study|Other - Reason not given|1|||
33325319|NCT00885703|62702060|FG005|Overall Study|Ineligible (no CM)|3|||
33325320|NCT00885703|62702061|FG006|Overall Study|Ineligible (no CM)|1|||
33325321|NCT00901576|62702087|FG000|Second Intervention|Withdrawal by Subject|0|||
33325322|NCT00901576|62702088|FG001|Second Intervention|Withdrawal by Subject|0|||
33325323|NCT00901576|62702089|FG002|Second Intervention|Withdrawal by Subject|0|||
33325324|NCT00901576|62702090|FG003|Second Intervention|Withdrawal by Subject|1|||
33325325|NCT00901576|62702091|FG004|Second Intervention|Withdrawal by Subject|0|||
33325326|NCT00901576|62702092|FG005|Second Intervention|Withdrawal by Subject|1|||
33325327|NCT00901576|62702087|FG000|Second Intervention|Physician Decision|1|||
33325328|NCT00901576|62702088|FG001|Second Intervention|Physician Decision|0|||
33325329|NCT00901576|62702089|FG002|Second Intervention|Physician Decision|0|||
33325330|NCT00901576|62702090|FG003|Second Intervention|Physician Decision|0|||
33325331|NCT00901576|62702091|FG004|Second Intervention|Physician Decision|0|||
33526060|NCT01307423|62913872|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
33526061|NCT01307423|62913873|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
33457128|NCT00401843|62831613|FG001|Overall Study|Achieved Complete Response|5|||
33526062|NCT01307423|62913874|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
33526063|NCT01307423|62913875|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33619263|NCT01863771|63020333|FG003|Maintenance Phase|Adverse Event|1|||
33619264|NCT01863771|63020330|FG000|Maintenance Phase|Lack of Efficacy|0|||
33457129|NCT00401843|62831614|FG002|Overall Study|Achieved Complete Response|11|||
33457130|NCT00401843|62831612|FG000|Overall Study|Adverse Event|7|||
33457131|NCT00401843|62831613|FG001|Overall Study|Adverse Event|26|||
33619265|NCT01863771|63020331|FG001|Maintenance Phase|Lack of Efficacy|3|||
33619266|NCT01863771|63020332|FG002|Maintenance Phase|Lack of Efficacy|7|||
33619267|NCT01863771|63020333|FG003|Maintenance Phase|Lack of Efficacy|38|||
33619268|NCT01863771|63020330|FG000|Maintenance Phase|Physician Decision|0|||
33619269|NCT01863771|63020331|FG001|Maintenance Phase|Physician Decision|0|||
33619270|NCT01863771|63020332|FG002|Maintenance Phase|Physician Decision|2|||
33619271|NCT01863771|63020333|FG003|Maintenance Phase|Physician Decision|1|||
33619272|NCT01863771|63020330|FG000|Maintenance Phase|Pregnancy|0|||
33619273|NCT01863771|63020331|FG001|Maintenance Phase|Pregnancy|1|||
33619274|NCT01863771|63020332|FG002|Maintenance Phase|Pregnancy|0|||
33619275|NCT01863771|63020333|FG003|Maintenance Phase|Pregnancy|0|||
33619276|NCT01863771|63020330|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33619277|NCT01863771|63020331|FG001|Maintenance Phase|Withdrawal by Subject|1|||
33619278|NCT01863771|63020332|FG002|Maintenance Phase|Withdrawal by Subject|2|||
33619279|NCT01863771|63020333|FG003|Maintenance Phase|Withdrawal by Subject|3|||
33619280|NCT01894581|63020343|FG000|Overall Study|Withdrawal by Subject|2|||
33619281|NCT01894581|63020344|FG001|Overall Study|Withdrawal by Subject|3|||
33619282|NCT01894581|63020343|FG000|Overall Study|Screen Failure|3|||
33619283|NCT01894581|63020344|FG001|Overall Study|Screen Failure|4|||
33619284|NCT02203331|63020356|FG000|Overall Study|Pregnancy|1|||
33619285|NCT02203331|63020357|FG001|Overall Study|Pregnancy|0|||
33619286|NCT02203331|63020358|FG002|Overall Study|Pregnancy|0|||
33457132|NCT00401843|62831614|FG002|Overall Study|Adverse Event|27|||
33457133|NCT00401843|62831612|FG000|Overall Study|Death|0|||
33457134|NCT00401843|62831613|FG001|Overall Study|Death|8|||
33457135|NCT00401843|62831614|FG002|Overall Study|Death|10|||
33457136|NCT00401843|62831612|FG000|Overall Study|Disease progression|10|||
33619287|NCT02203331|63020359|FG003|Overall Study|Pregnancy|0|||
33619288|NCT02203331|63020360|FG004|Overall Study|Pregnancy|2|||
33619289|NCT02203331|63020361|FG005|Overall Study|Pregnancy|0|||
33619290|NCT02203331|63020356|FG000|Overall Study|Withdrawal by Subject|1|||
33619291|NCT02203331|63020357|FG001|Overall Study|Withdrawal by Subject|0|||
33325332|NCT00901576|62702092|FG005|Second Intervention|Physician Decision|0|||
33325333|NCT00882583|62702102|FG000|Overall Study|Physician Decision|1|||
33325334|NCT00882583|62702103|FG001|Overall Study|Physician Decision|0|||
33325335|NCT00882583|62702102|FG000|Overall Study|Adverse Event|0|||
33325336|NCT00882583|62702103|FG001|Overall Study|Adverse Event|1|||
33325337|NCT00900562|62702111|FG000|Overall Study|Progressive disease|9|||
33457137|NCT00401843|62831613|FG001|Overall Study|Disease progression|60|||
33457138|NCT00401843|62831614|FG002|Overall Study|Disease progression|49|||
33457139|NCT00401843|62831612|FG000|Overall Study|End of Study|1|||
33325338|NCT00900562|62702112|FG001|Overall Study|Progressive disease|5|||
33619292|NCT02203331|63020358|FG002|Overall Study|Withdrawal by Subject|1|||
33526064|NCT01307423|62913876|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33619293|NCT02203331|63020359|FG003|Overall Study|Withdrawal by Subject|0|||
33619294|NCT02203331|63020360|FG004|Overall Study|Withdrawal by Subject|0|||
33619295|NCT02203331|63020361|FG005|Overall Study|Withdrawal by Subject|3|||
33619296|NCT02203331|63020356|FG000|Overall Study|Adverse Event|4|||
33619297|NCT02203331|63020357|FG001|Overall Study|Adverse Event|8|||
33619298|NCT02203331|63020358|FG002|Overall Study|Adverse Event|3|||
33619299|NCT02203331|63020359|FG003|Overall Study|Adverse Event|4|||
33619300|NCT02203331|63020360|FG004|Overall Study|Adverse Event|3|||
33619301|NCT02203331|63020361|FG005|Overall Study|Adverse Event|3|||
33619302|NCT02203331|63020356|FG000|Overall Study|Other Reasons|1|||
33619303|NCT02203331|63020357|FG001|Overall Study|Other Reasons|2|||
33619304|NCT02203331|63020358|FG002|Overall Study|Other Reasons|0|||
33619305|NCT02203331|63020359|FG003|Overall Study|Other Reasons|2|||
33619306|NCT02203331|63020360|FG004|Overall Study|Other Reasons|0|||
33619307|NCT02203331|63020361|FG005|Overall Study|Other Reasons|0|||
33619308|NCT02203331|63020356|FG000|Overall Study|Lack of Efficacy|0|||
33619309|NCT02203331|63020357|FG001|Overall Study|Lack of Efficacy|2|||
33619310|NCT02203331|63020358|FG002|Overall Study|Lack of Efficacy|1|||
33619311|NCT02203331|63020359|FG003|Overall Study|Lack of Efficacy|0|||
33619312|NCT02203331|63020360|FG004|Overall Study|Lack of Efficacy|0|||
33619313|NCT02203331|63020361|FG005|Overall Study|Lack of Efficacy|1|||
33619314|NCT02203331|63020356|FG000|Overall Study|Protocol Violation|0|||
33619315|NCT02203331|63020357|FG001|Overall Study|Protocol Violation|2|||
33619316|NCT02203331|63020358|FG002|Overall Study|Protocol Violation|0|||
33619317|NCT02203331|63020359|FG003|Overall Study|Protocol Violation|1|||
33526065|NCT01307423|62913877|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33526066|NCT01307423|62913878|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33526067|NCT01307423|62913879|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33526068|NCT01307423|62913880|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33526069|NCT01307423|62913872|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
33526070|NCT01307423|62913873|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
33526071|NCT01307423|62913874|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
33526072|NCT01307423|62913875|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33526073|NCT01307423|62913876|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33526074|NCT01307423|62913877|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33526075|NCT01307423|62913878|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33526076|NCT01307423|62913879|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33526077|NCT01307423|62913880|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33526078|NCT01307423|62913872|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
33526079|NCT01307423|62913873|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
33526080|NCT01307423|62913874|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
33526081|NCT01307423|62913875|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33526082|NCT01307423|62913876|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33526083|NCT01307423|62913877|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33526084|NCT01307423|62913878|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33526085|NCT01307423|62913879|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33526086|NCT01307423|62913880|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33526087|NCT01307423|62913872|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33526088|NCT01307423|62913873|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33526089|NCT01307423|62913874|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
33526090|NCT01307423|62913875|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33526091|NCT01307423|62913876|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33526092|NCT01307423|62913877|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33526093|NCT01307423|62913878|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33526094|NCT01307423|62913879|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33526095|NCT01307423|62913880|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33526096|NCT01307423|62913872|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
33619318|NCT02203331|63020360|FG004|Overall Study|Protocol Violation|1|||
33619319|NCT02203331|63020361|FG005|Overall Study|Protocol Violation|0|||
33619320|NCT02203331|63020356|FG000|Overall Study|Lost to Follow-up|0|||
33619321|NCT02203331|63020357|FG001|Overall Study|Lost to Follow-up|0|||
33619322|NCT02203331|63020358|FG002|Overall Study|Lost to Follow-up|0|||
33619323|NCT02203331|63020359|FG003|Overall Study|Lost to Follow-up|0|||
33619324|NCT02203331|63020360|FG004|Overall Study|Lost to Follow-up|1|||
33619325|NCT02203331|63020361|FG005|Overall Study|Lost to Follow-up|0|||
33619326|NCT01893411|63020378|FG000|Overall Study|Protocol Violation|1|||
33526097|NCT01307423|62913873|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
33526098|NCT01307423|62913874|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
33526099|NCT01307423|62913875|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33526100|NCT01307423|62913876|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33526101|NCT01307423|62913877|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33526102|NCT01307423|62913878|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33526103|NCT01307423|62913879|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33526104|NCT01307423|62913880|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33526105|NCT01307423|62913872|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
33526106|NCT01307423|62913873|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33526107|NCT01307423|62913874|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33526108|NCT01307423|62913875|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33526109|NCT01307423|62913876|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33526110|NCT01307423|62913877|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33526111|NCT01307423|62913878|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33526112|NCT01307423|62913879|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33526113|NCT01307423|62913880|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33526114|NCT01307423|62913872|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
33526115|NCT01307423|62913873|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
33526116|NCT01307423|62913874|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33526117|NCT01307423|62913875|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33526118|NCT01307423|62913876|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33526119|NCT01307423|62913877|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33526120|NCT01307423|62913878|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33526121|NCT01307423|62913879|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33526122|NCT01307423|62913880|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33526123|NCT01307423|62913872|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
33526124|NCT01307423|62913873|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
33526125|NCT01307423|62913874|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
33526126|NCT01307423|62913875|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
33526127|NCT01307423|62913876|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
33526128|NCT01307423|62913877|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
33526129|NCT01307423|62913878|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
33526130|NCT01307423|62913879|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
33526131|NCT01307423|62913880|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
33526132|NCT01307423|62913872|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
33526133|NCT01307423|62913873|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
33526134|NCT01307423|62913874|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
33526135|NCT01307423|62913875|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
33526136|NCT01307423|62913876|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
33619327|NCT01893411|63020379|FG001|Overall Study|Protocol Violation|0|||
33526137|NCT01307423|62913877|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
33526138|NCT01307423|62913878|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
33619328|NCT01893411|63020380|FG002|Overall Study|Protocol Violation|0|||
33619329|NCT01893411|63020378|FG000|Overall Study|Physician Decision|1|||
33619330|NCT01893411|63020379|FG001|Overall Study|Physician Decision|1|||
33619331|NCT01893411|63020380|FG002|Overall Study|Physician Decision|2|||
33619332|NCT01893411|63020378|FG000|Overall Study|Lack of Efficacy|2|||
33619333|NCT01893411|63020379|FG001|Overall Study|Lack of Efficacy|1|||
33619334|NCT01893411|63020380|FG002|Overall Study|Lack of Efficacy|0|||
33619335|NCT01893411|63020378|FG000|Overall Study|Other|3|||
33619336|NCT01893411|63020379|FG001|Overall Study|Other|1|||
33619337|NCT01893411|63020380|FG002|Overall Study|Other|3|||
33619338|NCT01893411|63020378|FG000|Overall Study|Adverse Event|1|||
33619339|NCT01893411|63020379|FG001|Overall Study|Adverse Event|0|||
33619340|NCT01893411|63020380|FG002|Overall Study|Adverse Event|0|||
33619341|NCT01893411|63020378|FG000|Overall Study|Withdrawal by Subject|7|||
33619342|NCT01893411|63020379|FG001|Overall Study|Withdrawal by Subject|4|||
33619343|NCT01893411|63020380|FG002|Overall Study|Withdrawal by Subject|3|||
33619344|NCT01893411|63020378|FG000|Overall Study|Lost to Follow-up|2|||
33619345|NCT01893411|63020379|FG001|Overall Study|Lost to Follow-up|0|||
33619346|NCT01893411|63020380|FG002|Overall Study|Lost to Follow-up|1|||
33526139|NCT01307423|62913879|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
33526140|NCT01307423|62913880|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
33526141|NCT01307423|62913872|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
33619347|NCT02232425|63020390|FG000|Overall Study|Lost to Follow-up|6|||
33619348|NCT02232425|63020391|FG001|Overall Study|Lost to Follow-up|2|||
33619349|NCT02232425|63020390|FG000|Overall Study|Adverse Event|2|||
33619350|NCT02232425|63020391|FG001|Overall Study|Adverse Event|0|||
33619351|NCT02232425|63020390|FG000|Overall Study|Withdrawal by Subject|5|||
33619352|NCT02232425|63020391|FG001|Overall Study|Withdrawal by Subject|6|||
33619353|NCT02232425|63020390|FG000|Overall Study|Lack of Efficacy|1|||
33619354|NCT02232425|63020391|FG001|Overall Study|Lack of Efficacy|0|||
33619355|NCT01631435|63020397|FG000|Overall Study|Adverse Event|2|||
33619356|NCT01631435|63020397|FG000|Overall Study|Withdrawal by Subject|2|||
33619357|NCT01631435|63020397|FG000|Overall Study|incomplete study procedure|5|||
33619358|NCT02230085|63020402|FG000|Overall Study|Physician Decision|1|||
33619359|NCT02230085|63020402|FG000|Overall Study|Withdrawal by Subject|3|||
33619360|NCT02202785|63020409|FG000|Overall Study|Study Terminated by Sponsor|1|||
33619361|NCT02202785|63020410|FG001|Overall Study|Study Terminated by Sponsor|6|||
33619362|NCT02202785|63020411|FG002|Overall Study|Study Terminated by Sponsor|4|||
33619363|NCT02202785|63020409|FG000|Overall Study|Withdrawal by Subject|0|||
33619364|NCT02202785|63020410|FG001|Overall Study|Withdrawal by Subject|1|||
33619365|NCT02202785|63020411|FG002|Overall Study|Withdrawal by Subject|0|||
33619366|NCT02202785|63020409|FG000|Overall Study|Lost to Follow-up|0|||
33619367|NCT02202785|63020410|FG001|Overall Study|Lost to Follow-up|1|||
33619368|NCT02202785|63020411|FG002|Overall Study|Lost to Follow-up|0|||
33619369|NCT02202785|63020409|FG000|Overall Study|Reason not Specified|10|||
33619370|NCT02202785|63020410|FG001|Overall Study|Reason not Specified|7|||
33619371|NCT02202785|63020411|FG002|Overall Study|Reason not Specified|13|||
33619372|NCT01882647|63020421|FG000|Overall Study|Lost to Follow-up|2|||
33619373|NCT01882647|63020422|FG001|Overall Study|Lost to Follow-up|2|||
33619374|NCT01882647|63020421|FG000|Overall Study|Withdrawal by Subject|0|||
33619375|NCT01882647|63020422|FG001|Overall Study|Withdrawal by Subject|4|||
33619376|NCT01882257|63020431|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
33619377|NCT01882257|63020432|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
33619378|NCT01882257|63020433|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
33619379|NCT01882257|63020431|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
33619380|NCT01882257|63020432|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
33619381|NCT01882257|63020433|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
33619382|NCT01862991|63020443|FG000|Overall Study|Lost to Follow-up|2|||
33619383|NCT01862991|63020444|FG001|Overall Study|Lost to Follow-up|1|||
33619384|NCT01862991|63020445|FG002|Overall Study|Lost to Follow-up|1|||
33619385|NCT01862991|63020443|FG000|Overall Study|Protocol Violation|1|||
33619386|NCT01862991|63020444|FG001|Overall Study|Protocol Violation|0|||
33619387|NCT01862991|63020445|FG002|Overall Study|Protocol Violation|0|||
33619388|NCT02202551|63020457|FG000|Overall Study|Adverse Event|8|||
33619389|NCT02202551|63020458|FG001|Overall Study|Adverse Event|19|||
33619390|NCT02202551|63020459|FG002|Overall Study|Adverse Event|5|||
33619391|NCT02202551|63020460|FG003|Overall Study|Adverse Event|9|||
33619392|NCT02202551|63020457|FG000|Overall Study|Death|3|||
33619393|NCT02202551|63020458|FG001|Overall Study|Death|2|||
33619394|NCT02202551|63020459|FG002|Overall Study|Death|1|||
33526142|NCT01307423|62913873|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
33526143|NCT01307423|62913874|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
33619395|NCT02202551|63020460|FG003|Overall Study|Death|1|||
33619396|NCT02202551|63020457|FG000|Overall Study|Lost to Follow-up|0|||
33619397|NCT02202551|63020458|FG001|Overall Study|Lost to Follow-up|1|||
33619398|NCT02202551|63020459|FG002|Overall Study|Lost to Follow-up|0|||
33619399|NCT02202551|63020460|FG003|Overall Study|Lost to Follow-up|1|||
33619400|NCT02202551|63020457|FG000|Overall Study|Needed to take excluded medication|0|||
33619401|NCT02202551|63020458|FG001|Overall Study|Needed to take excluded medication|2|||
33619402|NCT02202551|63020459|FG002|Overall Study|Needed to take excluded medication|0|||
33619403|NCT02202551|63020460|FG003|Overall Study|Needed to take excluded medication|1|||
33619404|NCT02202551|63020457|FG000|Overall Study|Subject moved away|0|||
33619405|NCT02202551|63020458|FG001|Overall Study|Subject moved away|1|||
33619406|NCT02202551|63020459|FG002|Overall Study|Subject moved away|0|||
33457140|NCT00401843|62831613|FG001|Overall Study|End of Study|1|||
33457141|NCT00401843|62831614|FG002|Overall Study|End of Study|2|||
33457142|NCT00401843|62831612|FG000|Overall Study|Lost to Follow-up|0|||
33457143|NCT00401843|62831613|FG001|Overall Study|Lost to Follow-up|0|||
33457144|NCT00401843|62831614|FG002|Overall Study|Lost to Follow-up|2|||
33457145|NCT00401843|62831612|FG000|Overall Study|Other Unspecified|0|||
33457146|NCT00401843|62831613|FG001|Overall Study|Other Unspecified|3|||
33457147|NCT00401843|62831614|FG002|Overall Study|Other Unspecified|5|||
33457148|NCT00401843|62831612|FG000|Overall Study|Physician Decision|0|||
33457149|NCT00401843|62831613|FG001|Overall Study|Physician Decision|16|||
33457150|NCT00401843|62831614|FG002|Overall Study|Physician Decision|10|||
33457151|NCT00401843|62831612|FG000|Overall Study|Protocol Violation|0|||
33457152|NCT00401843|62831613|FG001|Overall Study|Protocol Violation|0|||
33457153|NCT00401843|62831614|FG002|Overall Study|Protocol Violation|1|||
33457154|NCT00401843|62831612|FG000|Overall Study|Withdrawal by Subject|1|||
33619407|NCT02202551|63020460|FG003|Overall Study|Subject moved away|0|||
33619408|NCT02202551|63020457|FG000|Overall Study|DBS surgery|3|||
33619409|NCT02202551|63020458|FG001|Overall Study|DBS surgery|0|||
33619410|NCT02202551|63020459|FG002|Overall Study|DBS surgery|0|||
33619411|NCT02202551|63020460|FG003|Overall Study|DBS surgery|0|||
33619412|NCT02202551|63020457|FG000|Overall Study|Dyskinesia upon taper|1|||
33619413|NCT02202551|63020458|FG001|Overall Study|Dyskinesia upon taper|0|||
33619414|NCT02202551|63020459|FG002|Overall Study|Dyskinesia upon taper|0|||
33619415|NCT02202551|63020460|FG003|Overall Study|Dyskinesia upon taper|0|||
33619416|NCT02202551|63020457|FG000|Overall Study|Lack of Efficacy|0|||
33619417|NCT02202551|63020458|FG001|Overall Study|Lack of Efficacy|1|||
33619418|NCT02202551|63020459|FG002|Overall Study|Lack of Efficacy|0|||
33619419|NCT02202551|63020460|FG003|Overall Study|Lack of Efficacy|0|||
33619420|NCT02202551|63020457|FG000|Overall Study|Physician Decision|1|||
33619421|NCT02202551|63020458|FG001|Overall Study|Physician Decision|0|||
33619422|NCT02202551|63020459|FG002|Overall Study|Physician Decision|0|||
33619423|NCT02202551|63020460|FG003|Overall Study|Physician Decision|0|||
33619424|NCT02202551|63020457|FG000|Overall Study|Site closure|3|||
33619425|NCT02202551|63020458|FG001|Overall Study|Site closure|0|||
33619426|NCT02202551|63020459|FG002|Overall Study|Site closure|0|||
33619427|NCT02202551|63020460|FG003|Overall Study|Site closure|1|||
33619428|NCT02202551|63020457|FG000|Overall Study|Unable to complete visits per protocol|1|||
33619429|NCT02202551|63020458|FG001|Overall Study|Unable to complete visits per protocol|0|||
33526144|NCT01307423|62913875|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
33526145|NCT01307423|62913876|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
33526146|NCT01307423|62913877|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
33526147|NCT01307423|62913878|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
33526148|NCT01307423|62913879|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
33526149|NCT01307423|62913880|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
33526150|NCT01307423|62913872|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33526151|NCT01307423|62913873|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33526152|NCT01307423|62913874|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33619430|NCT02202551|63020459|FG002|Overall Study|Unable to complete visits per protocol|0|||
33619431|NCT02202551|63020460|FG003|Overall Study|Unable to complete visits per protocol|0|||
33619432|NCT02202551|63020457|FG000|Overall Study|Worsening Dyskinesia|0|||
33619433|NCT02202551|63020458|FG001|Overall Study|Worsening Dyskinesia|0|||
33619434|NCT02202551|63020459|FG002|Overall Study|Worsening Dyskinesia|0|||
33619435|NCT02202551|63020460|FG003|Overall Study|Worsening Dyskinesia|1|||
33619436|NCT02202551|63020457|FG000|Overall Study|Protocol Violation|0|||
33619437|NCT02202551|63020458|FG001|Overall Study|Protocol Violation|1|||
33619438|NCT02202551|63020459|FG002|Overall Study|Protocol Violation|0|||
33619439|NCT02202551|63020460|FG003|Overall Study|Protocol Violation|0|||
33619440|NCT02202551|63020457|FG000|Overall Study|Sponsor's decision|2|||
33619441|NCT02202551|63020458|FG001|Overall Study|Sponsor's decision|0|||
33526153|NCT01307423|62913875|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33526154|NCT01307423|62913876|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33526155|NCT01307423|62913877|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
33526156|NCT01307423|62913878|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33526157|NCT01307423|62913879|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33526158|NCT01307423|62913880|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33619442|NCT02202551|63020459|FG002|Overall Study|Sponsor's decision|0|||
33619443|NCT02202551|63020460|FG003|Overall Study|Sponsor's decision|0|||
33619444|NCT02202551|63020457|FG000|Overall Study|Subject unwilling to proceed|1|||
33619445|NCT02202551|63020458|FG001|Overall Study|Subject unwilling to proceed|5|||
33619446|NCT02202551|63020459|FG002|Overall Study|Subject unwilling to proceed|3|||
33619447|NCT02202551|63020460|FG003|Overall Study|Subject unwilling to proceed|5|||
33619448|NCT02202551|63020457|FG000|Overall Study|Subject consent withdrawn|0|||
33619449|NCT02202551|63020458|FG001|Overall Study|Subject consent withdrawn|3|||
33619450|NCT02202551|63020459|FG002|Overall Study|Subject consent withdrawn|1|||
33619451|NCT02202551|63020460|FG003|Overall Study|Subject consent withdrawn|2|||
33526159|NCT01307423|62913872|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
33526160|NCT01307423|62913873|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
33526161|NCT01307423|62913874|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
33619452|NCT02202551|63020457|FG000|Overall Study|eGFR<50mL/min/m2|2|||
33619453|NCT02202551|63020458|FG001|Overall Study|eGFR<50mL/min/m2|2|||
33619454|NCT02202551|63020459|FG002|Overall Study|eGFR<50mL/min/m2|0|||
33619455|NCT02202551|63020460|FG003|Overall Study|eGFR<50mL/min/m2|1|||
33619456|NCT02202317|63020474|FG000|Overall Study|Lost to Follow-up|1|||
33619457|NCT02118337|63020487|FG000|Overall Study|Other|1|||
33619458|NCT02118337|63020488|FG001|Overall Study|Other|0|||
33619459|NCT02118337|63020489|FG002|Overall Study|Other|0|||
33619460|NCT02118337|63020490|FG003|Overall Study|Other|0|||
33619461|NCT02118337|63020491|FG004|Overall Study|Other|2|||
33619462|NCT02118337|63020492|FG005|Overall Study|Other|3|||
33619463|NCT02118337|63020493|FG006|Overall Study|Other|1|||
33619464|NCT02118337|63020494|FG007|Overall Study|Other|28|||
33619465|NCT02118337|63020495|FG008|Overall Study|Other|15|||
33619466|NCT02118337|63020487|FG000|Overall Study|Lost to Follow-up|0|||
33619467|NCT02118337|63020488|FG001|Overall Study|Lost to Follow-up|0|||
33619468|NCT02118337|63020489|FG002|Overall Study|Lost to Follow-up|0|||
33619469|NCT02118337|63020490|FG003|Overall Study|Lost to Follow-up|0|||
33619470|NCT02118337|63020491|FG004|Overall Study|Lost to Follow-up|0|||
33619471|NCT02118337|63020492|FG005|Overall Study|Lost to Follow-up|0|||
33619472|NCT02118337|63020493|FG006|Overall Study|Lost to Follow-up|0|||
33619473|NCT02118337|63020494|FG007|Overall Study|Lost to Follow-up|1|||
33619474|NCT02118337|63020495|FG008|Overall Study|Lost to Follow-up|0|||
33619475|NCT02118337|63020487|FG000|Overall Study|Withdrawal by Subject|1|||
33619476|NCT02118337|63020488|FG001|Overall Study|Withdrawal by Subject|3|||
33619477|NCT02118337|63020489|FG002|Overall Study|Withdrawal by Subject|2|||
33619478|NCT02118337|63020490|FG003|Overall Study|Withdrawal by Subject|1|||
33619479|NCT02118337|63020491|FG004|Overall Study|Withdrawal by Subject|2|||
33619480|NCT02118337|63020492|FG005|Overall Study|Withdrawal by Subject|2|||
33619481|NCT02118337|63020493|FG006|Overall Study|Withdrawal by Subject|1|||
33619482|NCT02118337|63020494|FG007|Overall Study|Withdrawal by Subject|4|||
33619483|NCT02118337|63020495|FG008|Overall Study|Withdrawal by Subject|2|||
33619484|NCT02118337|63020487|FG000|Overall Study|Death|2|||
33619485|NCT02118337|63020488|FG001|Overall Study|Death|2|||
33619486|NCT02118337|63020489|FG002|Overall Study|Death|1|||
33619487|NCT02118337|63020490|FG003|Overall Study|Death|2|||
33619488|NCT02118337|63020491|FG004|Overall Study|Death|5|||
33619489|NCT02118337|63020492|FG005|Overall Study|Death|1|||
33619490|NCT02118337|63020493|FG006|Overall Study|Death|2|||
33619491|NCT02118337|63020494|FG007|Overall Study|Death|9|||
33619492|NCT02118337|63020495|FG008|Overall Study|Death|4|||
33619493|NCT02117713|63020519|FG000|Week 48|Adverse Event|4|||
33619494|NCT02117713|63020519|FG000|Week 48|Withdrawal by caregiver|2|||
33619495|NCT02117713|63020519|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
33619496|NCT02117713|63020519|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
33619497|NCT02117713|63020519|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
33619498|NCT02117713|63020519|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
33619499|NCT02105467|63020533|FG000|Period 1|Lost to Follow-up|1|||
33619500|NCT02105467|63020534|FG001|Period 1|Lost to Follow-up|0|||
33619501|NCT02105467|63020533|FG000|Period 1|Death|1|||
33619502|NCT02105467|63020534|FG001|Period 1|Death|0|||
33619503|NCT02105467|63020533|FG000|Period 2|Lost to Follow-up|1|||
33619504|NCT02105467|63020534|FG001|Period 2|Lost to Follow-up|0|||
33619505|NCT02105467|63020533|FG000|Period 2|Death|1|||
33619506|NCT02105467|63020534|FG001|Period 2|Death|0|||
33619507|NCT02105467|63020533|FG000|Period 2|Withdrawal by Subject|0|||
33619508|NCT02105467|63020534|FG001|Period 2|Withdrawal by Subject|2|||
33619509|NCT02105467|63020533|FG000|Period 3|Lost to Follow-up|0|||
33619510|NCT02105467|63020534|FG001|Period 3|Lost to Follow-up|1|||
33619511|NCT02202161|63020549|FG000|Overall Study|Adverse Event|1|||
33619512|NCT02202161|63020550|FG001|Overall Study|Adverse Event|1|||
33619513|NCT02202161|63020551|FG002|Overall Study|Adverse Event|0|||
33619514|NCT02202161|63020552|FG003|Overall Study|Adverse Event|0|||
33619515|NCT02202161|63020553|FG004|Overall Study|Adverse Event|0|||
33619516|NCT02202161|63020554|FG005|Overall Study|Adverse Event|1|||
33619517|NCT02202161|63020555|FG006|Overall Study|Adverse Event|0|||
33325339|NCT00900562|62702111|FG000|Overall Study|Toxicity|1|||
33457155|NCT00401843|62831613|FG001|Overall Study|Withdrawal by Subject|5|||
33457156|NCT00401843|62831614|FG002|Overall Study|Withdrawal by Subject|5|||
33457157|NCT00401843|62831612|FG000|Overall Study|Withdrawal of consent to study agent|1|||
33457158|NCT00401843|62831613|FG001|Overall Study|Withdrawal of consent to study agent|15|||
33457159|NCT00401843|62831614|FG002|Overall Study|Withdrawal of consent to study agent|17|||
33457160|NCT00401843|62831612|FG000|Overall Study|Randomized but not Treated|0|||
33457161|NCT00401843|62831613|FG001|Overall Study|Randomized but not Treated|2|||
33457162|NCT00401843|62831614|FG002|Overall Study|Randomized but not Treated|3|||
33457163|NCT00401843|62831612|FG000|Overall Study|Received incorrect treatment|0|||
33457164|NCT00401843|62831613|FG001|Overall Study|Received incorrect treatment|3|||
33457165|NCT00401843|62831614|FG002|Overall Study|Received incorrect treatment|0|||
33457166|NCT00401531|62831626|FG000|Overall Study|Adverse Event|2|||
33457167|NCT00401531|62831627|FG001|Overall Study|Adverse Event|0|||
33619518|NCT02202161|63020556|FG007|Overall Study|Adverse Event|0|||
33619519|NCT02202161|63020549|FG000|Overall Study|Did not meet continuation criteria|0|||
33619520|NCT02202161|63020550|FG001|Overall Study|Did not meet continuation criteria|0|||
33619521|NCT02202161|63020551|FG002|Overall Study|Did not meet continuation criteria|0|||
33619522|NCT02202161|63020552|FG003|Overall Study|Did not meet continuation criteria|0|||
33619523|NCT02202161|63020553|FG004|Overall Study|Did not meet continuation criteria|0|||
33619524|NCT02202161|63020554|FG005|Overall Study|Did not meet continuation criteria|0|||
33619525|NCT02202161|63020555|FG006|Overall Study|Did not meet continuation criteria|0|||
33619526|NCT02202161|63020556|FG007|Overall Study|Did not meet continuation criteria|3|||
33619527|NCT02202161|63020549|FG000|Overall Study|Physician Decision|0|||
33619528|NCT02202161|63020550|FG001|Overall Study|Physician Decision|0|||
33619529|NCT02202161|63020551|FG002|Overall Study|Physician Decision|0|||
33619530|NCT02202161|63020552|FG003|Overall Study|Physician Decision|0|||
33619531|NCT02202161|63020553|FG004|Overall Study|Physician Decision|0|||
33619532|NCT02202161|63020554|FG005|Overall Study|Physician Decision|0|||
33619533|NCT02202161|63020555|FG006|Overall Study|Physician Decision|0|||
33619534|NCT02202161|63020556|FG007|Overall Study|Physician Decision|3|||
33619535|NCT02202161|63020549|FG000|Overall Study|Withdrawal by Subject|0|||
33619536|NCT02202161|63020550|FG001|Overall Study|Withdrawal by Subject|0|||
33619537|NCT02202161|63020551|FG002|Overall Study|Withdrawal by Subject|0|||
33619538|NCT02202161|63020552|FG003|Overall Study|Withdrawal by Subject|0|||
33619539|NCT02202161|63020553|FG004|Overall Study|Withdrawal by Subject|1|||
33619540|NCT02202161|63020554|FG005|Overall Study|Withdrawal by Subject|0|||
33619541|NCT02202161|63020555|FG006|Overall Study|Withdrawal by Subject|0|||
33619542|NCT02202161|63020556|FG007|Overall Study|Withdrawal by Subject|0|||
33619543|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Adverse Event|76|||
33619544|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Adverse Event|0|||
33619545|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Adverse Event|0|||
33619546|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Death|3|||
33619547|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Death|0|||
33619548|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Death|0|||
33619549|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
33619550|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
33619551|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
33619552|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Physician Decision|9|||
33619553|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Physician Decision|0|||
33619554|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Physician Decision|0|||
33619555|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
33619556|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
33619557|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
33619558|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Disease progression|45|||
33619559|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Disease progression|0|||
33619560|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Disease progression|0|||
33619561|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
33619562|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
33619563|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
33619564|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
33619565|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
33619566|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
33619567|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
33619568|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
33619569|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
33619570|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
33619571|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
33619572|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
33619573|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
33619574|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
33619575|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
33619576|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
33619577|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
33619578|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
33619579|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
33619580|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
33619581|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
33619582|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
33619583|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
33619584|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
33619585|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
33619586|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
33619587|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
33619588|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Promotor request|1|||
33619589|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Promotor request|0|||
33619590|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Promotor request|0|||
33325340|NCT00900562|62702112|FG001|Overall Study|Toxicity|0|||
33619591|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
33619592|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
33619593|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
33619594|NCT01461928|63020575|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
33619595|NCT01461928|63020576|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
33619596|NCT01461928|63020577|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
33619597|NCT01461928|63020575|FG000|Maintenance I (24 Months)|Death|3|||
33619598|NCT01461928|63020576|FG001|Maintenance I (24 Months)|Death|0|||
33619599|NCT01461928|63020577|FG002|Maintenance I (24 Months)|Death|0|||
33619600|NCT01461928|63020575|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
33619601|NCT01461928|63020576|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
33619602|NCT01461928|63020577|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
33619603|NCT01461928|63020575|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
33619604|NCT01461928|63020576|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
33619605|NCT01461928|63020577|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
33619606|NCT01461928|63020575|FG000|Maintenance I (24 Months)|Diseases progression|91|||
33619607|NCT01461928|63020576|FG001|Maintenance I (24 Months)|Diseases progression|0|||
33619608|NCT01461928|63020577|FG002|Maintenance I (24 Months)|Diseases progression|0|||
33619609|NCT01461928|63020575|FG000|Maintenance I (24 Months)|Adverse Event|70|||
33619610|NCT01461928|63020576|FG001|Maintenance I (24 Months)|Adverse Event|0|||
33619611|NCT01461928|63020577|FG002|Maintenance I (24 Months)|Adverse Event|0|||
33619612|NCT01461928|63020575|FG000|Maintenance I (24 Months)|Physician Decision|9|||
33619613|NCT01461928|63020576|FG001|Maintenance I (24 Months)|Physician Decision|0|||
33619614|NCT01461928|63020577|FG002|Maintenance I (24 Months)|Physician Decision|0|||
33526162|NCT01307423|62913875|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
33526163|NCT01307423|62913876|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
33526164|NCT01307423|62913877|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
33526165|NCT01307423|62913878|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
33526166|NCT01307423|62913879|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
33526167|NCT01307423|62913880|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
33526168|NCT01307423|62913872|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33526169|NCT01307423|62913873|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33526170|NCT01307423|62913874|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33526171|NCT01307423|62913875|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
33526172|NCT01307423|62913876|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33526173|NCT01307423|62913877|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33526174|NCT01307423|62913878|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33526175|NCT01307423|62913879|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33526176|NCT01307423|62913880|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33526177|NCT01307423|62913872|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
33526178|NCT01307423|62913873|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
33526179|NCT01307423|62913874|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
33526180|NCT01307423|62913875|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
33526181|NCT01307423|62913876|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
33526182|NCT01307423|62913877|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
33526183|NCT01307423|62913878|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
33526184|NCT01307423|62913879|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
33526185|NCT01307423|62913880|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
33526186|NCT01307423|62913872|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33526187|NCT01307423|62913873|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33526188|NCT01307423|62913874|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33526189|NCT01307423|62913875|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33526190|NCT01307423|62913876|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33526191|NCT01307423|62913877|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
33526192|NCT01307423|62913878|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33526193|NCT01307423|62913879|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33526194|NCT01307423|62913880|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33526195|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33526196|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
33526197|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
33526198|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33526199|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33526200|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33526201|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33526202|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
33526203|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
33526204|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33526205|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
33526206|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
33526207|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33526208|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33526209|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33526210|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33526211|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
33526212|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
33526213|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33526214|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33526215|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
33526216|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33526217|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33526218|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33526219|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33619615|NCT01461928|63020575|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
33619616|NCT01461928|63020576|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
33619617|NCT01461928|63020577|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
33619618|NCT01461928|63020575|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
33619619|NCT01461928|63020576|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
33619620|NCT01461928|63020577|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
33619621|NCT01461928|63020575|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
33619622|NCT01461928|63020576|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
33619623|NCT01461928|63020577|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
33619624|NCT01461928|63020575|FG000|Maintenance I (24 Months)|Not compliant|1|||
33619625|NCT01461928|63020576|FG001|Maintenance I (24 Months)|Not compliant|0|||
33619626|NCT01461928|63020577|FG002|Maintenance I (24 Months)|Not compliant|0|||
33619627|NCT01461928|63020575|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
33619628|NCT01461928|63020576|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
33619629|NCT01461928|63020577|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
33619630|NCT01461928|63020575|FG000|Maintenance II (15 Months)|Adverse Event|0|||
33619631|NCT01461928|63020576|FG001|Maintenance II (15 Months)|Adverse Event|2|||
33619632|NCT01461928|63020577|FG002|Maintenance II (15 Months)|Adverse Event|0|||
33619633|NCT01461928|63020575|FG000|Maintenance II (15 Months)|Death|0|||
33619634|NCT01461928|63020576|FG001|Maintenance II (15 Months)|Death|10|||
33619635|NCT01461928|63020577|FG002|Maintenance II (15 Months)|Death|8|||
33619636|NCT01461928|63020575|FG000|Maintenance II (15 Months)|Physician Decision|0|||
33619637|NCT01461928|63020576|FG001|Maintenance II (15 Months)|Physician Decision|0|||
33619638|NCT01461928|63020577|FG002|Maintenance II (15 Months)|Physician Decision|4|||
33619639|NCT01461928|63020575|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
33619640|NCT01461928|63020576|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
33619641|NCT01461928|63020577|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
33619642|NCT01461928|63020575|FG000|Maintenance II (15 Months)|Moved to another town|0|||
33619643|NCT01461928|63020576|FG001|Maintenance II (15 Months)|Moved to another town|1|||
33619644|NCT01461928|63020577|FG002|Maintenance II (15 Months)|Moved to another town|0|||
33619645|NCT01461928|63020575|FG000|Maintenance II (15 Months)|Disease progression|0|||
33457168|NCT00401531|62831626|FG000|Overall Study|Protocol Violation|3|||
33619646|NCT01461928|63020576|FG001|Maintenance II (15 Months)|Disease progression|0|||
33619647|NCT01461928|63020577|FG002|Maintenance II (15 Months)|Disease progression|3|||
33619648|NCT01461928|63020575|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
33619649|NCT01461928|63020576|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
33619650|NCT01461928|63020577|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
33619651|NCT01461928|63020575|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
33457169|NCT00401531|62831627|FG001|Overall Study|Protocol Violation|7|||
33457170|NCT00401531|62831626|FG000|Overall Study|Lost to Follow-up|1|||
33457171|NCT00401531|62831627|FG001|Overall Study|Lost to Follow-up|1|||
33457172|NCT00401531|62831626|FG000|Overall Study|Withdrawal by Subject|3|||
33457173|NCT00401531|62831627|FG001|Overall Study|Withdrawal by Subject|2|||
33457174|NCT00401375|62831636|FG000|Overall Study|Protocol Violation|2|||
33457175|NCT00401375|62831637|FG001|Overall Study|Protocol Violation|2|||
33457176|NCT00401375|62831638|FG002|Overall Study|Protocol Violation|1|||
33526220|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33457177|NCT00401375|62831636|FG000|Overall Study|Adverse Event|6|||
33325341|NCT00900562|62702111|FG000|Overall Study|Death|1|||
33457178|NCT00401375|62831637|FG001|Overall Study|Adverse Event|11|||
33457179|NCT00401375|62831638|FG002|Overall Study|Adverse Event|10|||
33457180|NCT00401375|62831636|FG000|Overall Study|Withdrawal by Subject|9|||
33457181|NCT00401375|62831637|FG001|Overall Study|Withdrawal by Subject|7|||
33457182|NCT00401375|62831638|FG002|Overall Study|Withdrawal by Subject|7|||
33457183|NCT00401375|62831636|FG000|Overall Study|Lost to Follow-up|0|||
33457184|NCT00401375|62831637|FG001|Overall Study|Lost to Follow-up|1|||
33457185|NCT00401375|62831638|FG002|Overall Study|Lost to Follow-up|1|||
33526221|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33526222|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33526223|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
33526224|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
33526225|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33526226|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33526227|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33526228|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33526229|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
33526230|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
33457186|NCT00401375|62831636|FG000|Overall Study|Other than specified|2|||
33457187|NCT00401375|62831637|FG001|Overall Study|Other than specified|1|||
33526231|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33457188|NCT00401375|62831638|FG002|Overall Study|Other than specified|3|||
33457189|NCT00401375|62831636|FG000|Overall Study|Randomized but not treated|3|||
33457190|NCT00401375|62831637|FG001|Overall Study|Randomized but not treated|3|||
33457191|NCT00401375|62831638|FG002|Overall Study|Randomized but not treated|3|||
33457192|NCT00400985|62831646|FG000|Overall Study|Withdrawal by Subject|5|||
33619652|NCT01461928|63020576|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
33619653|NCT01461928|63020577|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
33619654|NCT01461928|63020575|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
33619655|NCT01461928|63020576|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
33619656|NCT01461928|63020577|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
33619657|NCT01461928|63020575|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
33619658|NCT01461928|63020576|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
33619659|NCT01461928|63020577|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
33619660|NCT01461928|63020575|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
33619661|NCT01461928|63020576|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
33619662|NCT01461928|63020577|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
33619663|NCT03097991|63020590|FG000|Overall Study|Didn't meet study criteria|8|||
33619664|NCT03097991|63020591|FG001|Overall Study|Didn't meet study criteria|0|||
33619665|NCT03097991|63020590|FG000|Overall Study|Withdrawal by Subject|12|||
33619666|NCT03097991|63020591|FG001|Overall Study|Withdrawal by Subject|6|||
33619667|NCT03097991|63020590|FG000|Overall Study|Death of Baby|3|||
33619668|NCT03097991|63020591|FG001|Overall Study|Death of Baby|1|||
33619669|NCT03097991|63020590|FG000|Overall Study|Lost to Follow-up|24|||
33619670|NCT03097991|63020591|FG001|Overall Study|Lost to Follow-up|38|||
33619671|NCT03097991|63020590|FG000|Overall Study|Adverse Event|3|||
33619672|NCT03097991|63020591|FG001|Overall Study|Adverse Event|5|||
33619673|NCT02623205|63020603|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
33619674|NCT02623205|63020604|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
33619675|NCT01500694|63020613|FG000|Overall Study|Adverse Event|4|||
33619676|NCT01500694|63020614|FG001|Overall Study|Adverse Event|3|||
33619677|NCT01500694|63020613|FG000|Overall Study|Protocol Violation|0|||
33619678|NCT01500694|63020614|FG001|Overall Study|Protocol Violation|1|||
33619679|NCT01500694|63020613|FG000|Overall Study|Withdrawal by Subject|23|||
33619680|NCT01500694|63020614|FG001|Overall Study|Withdrawal by Subject|14|||
33619681|NCT01500694|63020613|FG000|Overall Study|Lost to Follow-up|2|||
33619682|NCT01500694|63020614|FG001|Overall Study|Lost to Follow-up|3|||
33619683|NCT01500694|63020613|FG000|Overall Study|Lack of Efficacy|14|||
33619684|NCT01500694|63020614|FG001|Overall Study|Lack of Efficacy|5|||
33619685|NCT01500694|63020613|FG000|Overall Study|Other|9|||
33619686|NCT01500694|63020614|FG001|Overall Study|Other|3|||
33619687|NCT01500382|63020624|FG000|Washout Period|Study site went out of business|0|||
33619688|NCT01500382|63020625|FG001|Washout Period|Study site went out of business|0|||
33619689|NCT01500382|63020626|FG002|Washout Period|Study site went out of business|1|||
33619690|NCT01500382|63020627|FG003|Washout Period|Study site went out of business|0|||
33651426|NCT01746901|63062909|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33651427|NCT01746901|63062910|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33651428|NCT01746901|63062911|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33651429|NCT01746901|63062912|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33651430|NCT01746901|63062904|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
33651431|NCT01746901|63062905|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
33651432|NCT01746901|63062906|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
33651433|NCT01746901|63062907|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
33651434|NCT01746901|63062908|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
33651435|NCT01746901|63062909|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
33651436|NCT01746901|63062910|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
33651437|NCT01746901|63062911|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
33651438|NCT01746901|63062912|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
33651439|NCT01746901|63062904|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
33651440|NCT01746901|63062905|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
33651441|NCT01746901|63062906|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
33651442|NCT01746901|63062907|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
33651443|NCT01746901|63062908|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
33651444|NCT01746901|63062909|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
33651445|NCT01746901|63062910|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
33651446|NCT01746901|63062911|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
33457193|NCT00400985|62831646|FG000|Overall Study|system modification|8|||
33651447|NCT01746901|63062912|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
33651448|NCT01746901|63062904|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33651449|NCT01746901|63062905|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
33651450|NCT01746901|63062906|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
33619691|NCT02137837|63020640|FG000|Overall Study|Adverse Event|0|||
33619692|NCT02137837|63020641|FG001|Overall Study|Adverse Event|2|||
33619693|NCT02137837|63020642|FG002|Overall Study|Adverse Event|1|||
33619694|NCT02137837|63020640|FG000|Overall Study|Refusal unrelated to adverse event|2|||
33526232|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
33526233|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33526234|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33526235|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33526236|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33526237|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33526238|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
33526239|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
33526240|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33526241|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
33526242|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
33526243|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33526244|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33526245|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33526246|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33526247|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
33526248|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
33526249|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33526250|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
33526251|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
33526252|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33619695|NCT02137837|63020641|FG001|Overall Study|Refusal unrelated to adverse event|2|||
33619696|NCT02137837|63020642|FG002|Overall Study|Refusal unrelated to adverse event|1|||
33619697|NCT02137837|63020640|FG000|Overall Study|Progression/relapse|9|||
33619698|NCT02137837|63020641|FG001|Overall Study|Progression/relapse|7|||
33619699|NCT02137837|63020642|FG002|Overall Study|Progression/relapse|7|||
33619700|NCT02137837|63020640|FG000|Overall Study|Not protocol specified|2|||
33619701|NCT02137837|63020641|FG001|Overall Study|Not protocol specified|1|||
33619702|NCT02137837|63020642|FG002|Overall Study|Not protocol specified|3|||
33457194|NCT00400985|62831646|FG000|Overall Study|Death|30|||
33457195|NCT00400985|62831646|FG000|Overall Study|Lost to Follow-up|9|||
33457196|NCT00400517|62831650|FG000|Overall Study|Withdrawal by Subject|1|||
33457197|NCT00400517|62831650|FG000|Overall Study|Physician Decision|1|||
33457198|NCT00392171|62831654|FG000|Overall Study|Did not meet inclusion criteria|4|||
33457199|NCT00392171|62831654|FG000|Overall Study|Disease progression|101|||
33457200|NCT00391625|62831658|FG000|Month 14|Withdrawal by Subject|1|||
33457201|NCT00391625|62831658|FG000|Month 50|Physician Decision|1|||
33457202|NCT00091832|62831691|FG000|Overall Study|Physician Decision|1|||
33457203|NCT00091832|62831692|FG001|Overall Study|Physician Decision|0|||
33325342|NCT00900562|62702112|FG001|Overall Study|Death|1|||
33457204|NCT00091832|62831693|FG002|Overall Study|Physician Decision|0|||
33457205|NCT00091832|62831694|FG003|Overall Study|Physician Decision|0|||
33457206|NCT00091832|62831695|FG004|Overall Study|Physician Decision|0|||
33457207|NCT00091832|62831696|FG005|Overall Study|Physician Decision|0|||
33526253|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33619703|NCT01483690|63020657|FG000|Overall Study|Adverse Event|1|||
33526254|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33526255|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33526256|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
33457208|NCT00091832|62831691|FG000|Overall Study|Adverse Event|0|||
33457209|NCT00091832|62831692|FG001|Overall Study|Adverse Event|0|||
33526257|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
33526258|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
33526259|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
33526260|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
33526261|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
33526262|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
33526263|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
33526264|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
33619704|NCT01483690|63020658|FG001|Overall Study|Adverse Event|2|||
33619705|NCT01483690|63020657|FG000|Overall Study|clinical deterioration|1|||
33619706|NCT01483690|63020658|FG001|Overall Study|clinical deterioration|0|||
33526265|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
33526266|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
33619707|NCT01483690|63020657|FG000|Overall Study|Physician Decision|0|||
33619708|NCT01483690|63020658|FG001|Overall Study|Physician Decision|2|||
33619709|NCT01483690|63020657|FG000|Overall Study|exclusionary procedure|0|||
33526267|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33526268|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
33526269|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
33526270|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33526271|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33526272|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33526273|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33526274|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
33526275|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
33526276|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33526277|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
33526278|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
33526279|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33526280|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33526281|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33526282|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33526283|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
33526284|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
33526285|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33526286|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
33526287|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33526288|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33526289|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33526290|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33526291|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33526292|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
33526293|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33526294|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33526295|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
33526296|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33526297|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33526298|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33526299|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33526300|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33526301|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33526302|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33526303|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33526304|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
33526305|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33526306|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33526307|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33526308|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33526309|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33526310|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33526311|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
33619710|NCT01483690|63020658|FG001|Overall Study|exclusionary procedure|1|||
33526312|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33526313|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
33619711|NCT02104765|63020671|FG000|Overall Study|Lost to Follow-up|0|||
33619712|NCT02104765|63020672|FG001|Overall Study|Lost to Follow-up|0|||
33526314|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
33526315|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33526316|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33526317|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33526318|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33526319|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
33526320|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
33526321|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33526322|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33526323|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
33526324|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33526325|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33526326|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33526327|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33526328|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33526329|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33526330|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33526331|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33526332|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33526333|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33526334|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33526335|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33526336|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33526337|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
33619713|NCT02104765|63020673|FG002|Overall Study|Lost to Follow-up|1|||
33619714|NCT02104765|63020674|FG003|Overall Study|Lost to Follow-up|0|||
33619715|NCT02104765|63020675|FG004|Overall Study|Lost to Follow-up|0|||
33619716|NCT02104765|63020676|FG005|Overall Study|Lost to Follow-up|0|||
33619717|NCT02104765|63020677|FG006|Overall Study|Lost to Follow-up|0|||
33619718|NCT02104765|63020671|FG000|Overall Study|Withdrawal by Subject|0|||
33619719|NCT02104765|63020672|FG001|Overall Study|Withdrawal by Subject|0|||
33619720|NCT02104765|63020673|FG002|Overall Study|Withdrawal by Subject|0|||
33619721|NCT02104765|63020674|FG003|Overall Study|Withdrawal by Subject|1|||
33619722|NCT02104765|63020675|FG004|Overall Study|Withdrawal by Subject|1|||
33619723|NCT02104765|63020676|FG005|Overall Study|Withdrawal by Subject|0|||
33619724|NCT02104765|63020677|FG006|Overall Study|Withdrawal by Subject|1|||
33619725|NCT01483144|63020702|FG000|Overall Study|Adverse Event|9|||
33619726|NCT01483144|63020703|FG001|Overall Study|Adverse Event|4|||
33619727|NCT01483144|63020704|FG002|Overall Study|Adverse Event|6|||
33619728|NCT01483144|63020702|FG000|Overall Study|Withdrawal by Subject|0|||
33619729|NCT01483144|63020703|FG001|Overall Study|Withdrawal by Subject|2|||
33619730|NCT01483144|63020704|FG002|Overall Study|Withdrawal by Subject|5|||
33619731|NCT01483144|63020702|FG000|Overall Study|Physician Decision|1|||
33619732|NCT01483144|63020703|FG001|Overall Study|Physician Decision|0|||
33619733|NCT01483144|63020704|FG002|Overall Study|Physician Decision|0|||
33619734|NCT01483144|63020702|FG000|Overall Study|Lost to Follow-up|2|||
33619735|NCT01483144|63020703|FG001|Overall Study|Lost to Follow-up|4|||
33619736|NCT01483144|63020704|FG002|Overall Study|Lost to Follow-up|1|||
33619737|NCT01483144|63020702|FG000|Overall Study|Protocol Violation|3|||
33619738|NCT01483144|63020703|FG001|Overall Study|Protocol Violation|3|||
33619739|NCT01483144|63020704|FG002|Overall Study|Protocol Violation|3|||
33619740|NCT01881789|63020718|FG000|Overall Study|Withdrawal by Subject|0|||
33619741|NCT01881789|63020719|FG001|Overall Study|Withdrawal by Subject|2|||
33619742|NCT01881789|63020720|FG002|Overall Study|Withdrawal by Subject|1|||
33457210|NCT00091832|62831693|FG002|Overall Study|Adverse Event|0|||
33457211|NCT00091832|62831694|FG003|Overall Study|Adverse Event|1|||
33457212|NCT00091832|62831695|FG004|Overall Study|Adverse Event|3|||
33457213|NCT00091832|62831696|FG005|Overall Study|Adverse Event|0|||
33457214|NCT00091832|62831691|FG000|Overall Study|Withdrawal by Subject|4|||
33457215|NCT00091832|62831692|FG001|Overall Study|Withdrawal by Subject|5|||
33457216|NCT00091832|62831693|FG002|Overall Study|Withdrawal by Subject|0|||
33457217|NCT00091832|62831694|FG003|Overall Study|Withdrawal by Subject|1|||
33457218|NCT00091832|62831695|FG004|Overall Study|Withdrawal by Subject|3|||
33457219|NCT00091832|62831696|FG005|Overall Study|Withdrawal by Subject|1|||
33457220|NCT00091832|62831691|FG000|Overall Study|Death|6|||
33457221|NCT00091832|62831692|FG001|Overall Study|Death|4|||
33325343|NCT00900562|62702111|FG000|Overall Study|Withdrawal by Subject|0|||
33619743|NCT01881789|63020721|FG003|Overall Study|Withdrawal by Subject|0|||
33619744|NCT01881789|63020722|FG004|Overall Study|Withdrawal by Subject|1|||
33619745|NCT01881789|63020723|FG005|Overall Study|Withdrawal by Subject|1|||
33619746|NCT01881789|63020718|FG000|Overall Study|Study Terminated by Sponsor|0|||
33619747|NCT01881789|63020719|FG001|Overall Study|Study Terminated by Sponsor|0|||
33619748|NCT01881789|63020720|FG002|Overall Study|Study Terminated by Sponsor|0|||
33619749|NCT01881789|63020721|FG003|Overall Study|Study Terminated by Sponsor|0|||
33619750|NCT01881789|63020722|FG004|Overall Study|Study Terminated by Sponsor|0|||
33619751|NCT01881789|63020723|FG005|Overall Study|Study Terminated by Sponsor|1|||
33619752|NCT01881789|63020718|FG000|Overall Study|Other|3|||
33619753|NCT01881789|63020719|FG001|Overall Study|Other|5|||
33619754|NCT01881789|63020720|FG002|Overall Study|Other|2|||
33619755|NCT01881789|63020721|FG003|Overall Study|Other|3|||
33619756|NCT01881789|63020722|FG004|Overall Study|Other|1|||
33619757|NCT01881789|63020723|FG005|Overall Study|Other|1|||
33619758|NCT02075203|63020741|FG000|Overall Study|Withdrawal by Subject|1|||
33619759|NCT02075203|63020742|FG001|Overall Study|Withdrawal by Subject|0|||
33619760|NCT02075203|63020743|FG002|Overall Study|Withdrawal by Subject|1|||
33619761|NCT02075203|63020741|FG000|Overall Study|Adverse Event|1|||
33619762|NCT02075203|63020742|FG001|Overall Study|Adverse Event|0|||
33619763|NCT02075203|63020743|FG002|Overall Study|Adverse Event|0|||
33619764|NCT02075203|63020741|FG000|Overall Study|participant refused to use contraception|1|||
33619765|NCT02075203|63020742|FG001|Overall Study|participant refused to use contraception|0|||
33619766|NCT02075203|63020743|FG002|Overall Study|participant refused to use contraception|0|||
33619767|NCT01892163|63020753|FG000|Overall Study|Death|1|||
33619768|NCT01892163|63020754|FG001|Overall Study|Death|1|||
33619769|NCT01892163|63020753|FG000|Overall Study|Lost to Follow-up|1|||
33619770|NCT01892163|63020754|FG001|Overall Study|Lost to Follow-up|0|||
33619771|NCT01881009|63020762|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
33619772|NCT01881009|63020763|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
33619773|NCT01500226|63020772|FG000|Overall Study|Adverse Event|31|||
33619774|NCT01500226|63020773|FG001|Overall Study|Adverse Event|38|||
33619775|NCT01500226|63020772|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
33619776|NCT01500226|63020773|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
33325344|NCT00900562|62702112|FG001|Overall Study|Withdrawal by Subject|1|||
33325345|NCT00900562|62702111|FG000|Overall Study|Unrelated adverse event|1|||
33325346|NCT00900562|62702112|FG001|Overall Study|Unrelated adverse event|0|||
33457222|NCT00091832|62831693|FG002|Overall Study|Death|5|||
33457223|NCT00091832|62831694|FG003|Overall Study|Death|8|||
33457224|NCT00091832|62831695|FG004|Overall Study|Death|5|||
33457225|NCT00091832|62831696|FG005|Overall Study|Death|6|||
33457226|NCT00091832|62831691|FG000|Overall Study|Disease Progression|2|||
33457227|NCT00091832|62831692|FG001|Overall Study|Disease Progression|0|||
33457228|NCT00091832|62831693|FG002|Overall Study|Disease Progression|0|||
33457229|NCT00091832|62831694|FG003|Overall Study|Disease Progression|1|||
33526338|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33526339|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33526340|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
33526341|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
33526342|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33526343|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33526344|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33526345|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33526346|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33526347|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
33526348|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33526349|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
33526350|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
33526351|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33526352|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33619777|NCT01500226|63020772|FG000|Overall Study|Withdrawal by Subject|93|||
33619778|NCT01500226|63020773|FG001|Overall Study|Withdrawal by Subject|96|||
33619779|NCT01500226|63020772|FG000|Overall Study|Death|12|||
33619780|NCT01500226|63020773|FG001|Overall Study|Death|4|||
33619781|NCT01500226|63020772|FG000|Overall Study|Disease Progression|16|||
33619782|NCT01500226|63020773|FG001|Overall Study|Disease Progression|14|||
33619783|NCT01500226|63020772|FG000|Overall Study|Protocol Violation|53|||
33619784|NCT01500226|63020773|FG001|Overall Study|Protocol Violation|39|||
33619785|NCT01500226|63020772|FG000|Overall Study|Physician Decision|17|||
33619786|NCT01500226|63020773|FG001|Overall Study|Physician Decision|15|||
33619787|NCT01500226|63020772|FG000|Overall Study|Lack of Efficacy|14|||
33457230|NCT00091832|62831695|FG004|Overall Study|Disease Progression|1|||
33457231|NCT00091832|62831696|FG005|Overall Study|Disease Progression|2|||
33526353|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33619788|NCT01500226|63020773|FG001|Overall Study|Lack of Efficacy|30|||
33619789|NCT01500226|63020772|FG000|Overall Study|Lost to Follow-up|9|||
33619790|NCT01500226|63020773|FG001|Overall Study|Lost to Follow-up|5|||
33619791|NCT01500226|63020772|FG000|Overall Study|Other Reasons|19|||
33619792|NCT01500226|63020773|FG001|Overall Study|Other Reasons|16|||
33619793|NCT02075047|63020781|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
33619794|NCT02075047|63020782|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
33619795|NCT02075047|63020781|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
33619796|NCT02075047|63020782|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
33619797|NCT02075047|63020781|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
33619798|NCT02075047|63020782|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
33619799|NCT02075047|63020781|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
33619800|NCT02075047|63020782|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
33619801|NCT02075047|63020781|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
33619802|NCT02075047|63020782|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
33619803|NCT02075047|63020781|FG000|Treatment Phase (4 Weeks)|Other|1|||
33619804|NCT02075047|63020782|FG001|Treatment Phase (4 Weeks)|Other|1|||
33619805|NCT02075047|63020781|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
33619806|NCT02075047|63020782|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
33619807|NCT02075047|63020781|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
33619808|NCT02075047|63020782|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
33619809|NCT02075047|63020781|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
33619810|NCT02075047|63020782|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
33619811|NCT02075047|63020781|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
33619812|NCT02075047|63020782|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
33619813|NCT02075047|63020781|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
33619814|NCT02075047|63020782|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
33619815|NCT02075047|63020781|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
33619816|NCT02075047|63020782|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
33619817|NCT02075047|63020781|FG000|Follow up Phase (5 Weeks)|Other|1|||
33619818|NCT02075047|63020782|FG001|Follow up Phase (5 Weeks)|Other|2|||
33619819|NCT02075047|63020781|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
33619820|NCT02075047|63020782|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
33619821|NCT01859949|63020790|FG000|Overall Study|Family Matters|0|||
33619822|NCT01859949|63020791|FG001|Overall Study|Family Matters|1|||
33619823|NCT01859949|63020790|FG000|Overall Study|Physician Decision|2|||
33619824|NCT01859949|63020791|FG001|Overall Study|Physician Decision|4|||
33619825|NCT01859949|63020790|FG000|Overall Study|Withdrawal by Subject|11|||
33619826|NCT01859949|63020791|FG001|Overall Study|Withdrawal by Subject|10|||
33619827|NCT01859949|63020790|FG000|Overall Study|Protocol Violation|1|||
33619828|NCT01859949|63020791|FG001|Overall Study|Protocol Violation|1|||
33619829|NCT01859949|63020790|FG000|Overall Study|Adverse Event|0|||
33619830|NCT01859949|63020791|FG001|Overall Study|Adverse Event|1|||
33619831|NCT01859793|63020799|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
33619832|NCT01859793|63020800|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
33619833|NCT01859793|63020799|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
33619834|NCT01859793|63020800|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
33526354|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33526355|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33526356|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33526357|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33526358|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
33526359|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
33526360|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33526361|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33526362|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33526363|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33526364|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33526365|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
33526366|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33619835|NCT01859793|63020799|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
33619836|NCT01859793|63020800|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
33619837|NCT01859793|63020799|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
33619838|NCT01859793|63020800|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
33619839|NCT01859715|63020809|FG000|Overall Study|No 2nd VAS|16|||
33619840|NCT01859715|63020810|FG001|Overall Study|No 2nd VAS|8|||
33619841|NCT01859715|63020811|FG002|Overall Study|No 2nd VAS|23|||
33619842|NCT01890915|63020823|FG000|Overall Study|Adverse Event|1|||
33619843|NCT01890915|63020824|FG001|Overall Study|Adverse Event|0|||
33526367|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
33526368|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33526369|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33526370|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33526371|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33526372|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33619844|NCT01890915|63020823|FG000|Overall Study|Protocol Violation|2|||
33619845|NCT01890915|63020824|FG001|Overall Study|Protocol Violation|0|||
33619846|NCT01890915|63020823|FG000|Overall Study|Equipment Malfunction|0|||
33619847|NCT01890915|63020824|FG001|Overall Study|Equipment Malfunction|1|||
33619848|NCT01615263|63020832|FG000|Overall Study|Post-randomization exclusion|0|||
33619849|NCT01615263|63020833|FG001|Overall Study|Post-randomization exclusion|2|||
33619850|NCT01859403|63020850|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
33619851|NCT01859403|63020851|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
33619852|NCT01859403|63020850|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
33619853|NCT01859403|63020851|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
33619854|NCT01859403|63020850|FG000|Primary Endpoint Measure|Physician Decision|0|||
33619855|NCT01859403|63020851|FG001|Primary Endpoint Measure|Physician Decision|1|||
33619856|NCT01859403|63020850|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
33619857|NCT01859403|63020851|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
33619858|NCT01858701|63020857|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
33619859|NCT01858701|63020858|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
33619860|NCT01858701|63020857|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
33619861|NCT01858701|63020858|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
33619862|NCT01858701|63020857|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
33619863|NCT01858701|63020858|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
33619864|NCT01858701|63020857|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
33619865|NCT01858701|63020858|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
33619866|NCT01461538|63020867|FG000|Overall Study|Death|15|||
33619867|NCT01461538|63020868|FG001|Overall Study|Death|6|||
33619868|NCT01461538|63020869|FG002|Overall Study|Death|2|||
33619869|NCT01461538|63020867|FG000|Overall Study|Study Stopped by Sponsor|2|||
33619870|NCT01461538|63020868|FG001|Overall Study|Study Stopped by Sponsor|1|||
33619871|NCT01461538|63020869|FG002|Overall Study|Study Stopped by Sponsor|0|||
33619872|NCT01461538|63020867|FG000|Overall Study|Withdrawal by Subject|1|||
33619873|NCT01461538|63020868|FG001|Overall Study|Withdrawal by Subject|1|||
33619874|NCT01461538|63020869|FG002|Overall Study|Withdrawal by Subject|0|||
33619875|NCT02117479|63020881|FG000|Overall Study|Death|13|||
33619876|NCT02117479|63020882|FG001|Overall Study|Death|8|||
33619877|NCT02117479|63020881|FG000|Overall Study|Adverse Event|8|||
33619878|NCT02117479|63020882|FG001|Overall Study|Adverse Event|16|||
33619879|NCT02117479|63020881|FG000|Overall Study|Subject decision|8|||
33619880|NCT02117479|63020882|FG001|Overall Study|Subject decision|9|||
33526373|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33526374|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33526375|NCT01307423|62913872|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33526376|NCT01307423|62913873|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33526377|NCT01307423|62913874|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
33526378|NCT01307423|62913875|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33526379|NCT01307423|62913876|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33526380|NCT01307423|62913877|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33526381|NCT01307423|62913878|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33526382|NCT01307423|62913879|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
33526383|NCT01307423|62913880|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
33526384|NCT02778074|62913914|FG000|Overall Study|Lost to Follow-up|7|||
33526385|NCT02778074|62913915|FG001|Overall Study|Lost to Follow-up|10|||
33526386|NCT02775344|62913932|FG000|Overall Study|No ovarian cyst identified|3|||
33619881|NCT02117479|63020881|FG000|Overall Study|Disease progression|104|||
33619882|NCT02117479|63020882|FG001|Overall Study|Disease progression|108|||
33526387|NCT02775344|62913933|FG001|Overall Study|No ovarian cyst identified|2|||
33619883|NCT02117479|63020881|FG000|Overall Study|Noncompliance with study treatment|1|||
33619884|NCT02117479|63020882|FG001|Overall Study|Noncompliance with study treatment|0|||
33619885|NCT02117479|63020881|FG000|Overall Study|Study terminated by the sponsor|4|||
33619886|NCT02117479|63020882|FG001|Overall Study|Study terminated by the sponsor|6|||
33619887|NCT02117479|63020881|FG000|Overall Study|Physician Decision|7|||
33526388|NCT02777918|62913941|FG000|Overall Study|Medical reasons|1|||
33619888|NCT02117479|63020882|FG001|Overall Study|Physician Decision|2|||
33619889|NCT02117479|63020881|FG000|Overall Study|Other unspecified|11|||
33619890|NCT02117479|63020882|FG001|Overall Study|Other unspecified|7|||
33619891|NCT02229851|63020891|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
33526389|NCT02777918|62913942|FG001|Overall Study|Medical reasons|2|||
33526390|NCT02777918|62913941|FG000|Overall Study|Too busy / stressed|1|||
33526391|NCT02777918|62913942|FG001|Overall Study|Too busy / stressed|1|||
33526392|NCT02777918|62913941|FG000|Overall Study|Withdrawal by Subject|1|||
33526393|NCT02777918|62913942|FG001|Overall Study|Withdrawal by Subject|1|||
33526394|NCT02927795|62913948|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
33526395|NCT02927795|62913948|FG000|Overall Study|Not Treated|4|||
33526396|NCT02767856|62913954|FG000|Overall Study|Lost to Follow-up|9|||
33526397|NCT02767856|62913955|FG001|Overall Study|Lost to Follow-up|1|||
33526398|NCT02767856|62913954|FG000|Overall Study|Withdrawal by Subject|2|||
33526399|NCT02767856|62913955|FG001|Overall Study|Withdrawal by Subject|1|||
33526400|NCT03087851|62913964|FG000|Overall Study|Withdraw on medical grounds|0|||
33526401|NCT03087851|62913965|FG001|Overall Study|Withdraw on medical grounds|1|||
33526402|NCT03087851|62913966|FG002|Overall Study|Withdraw on medical grounds|2|||
33526403|NCT03092375|62913978|FG000|Overall Study|Lack of Efficacy|0|||
33526404|NCT03092375|62913979|FG001|Overall Study|Lack of Efficacy|1|||
33526405|NCT03092375|62913980|FG002|Overall Study|Lack of Efficacy|1|||
33526406|NCT03092375|62913981|FG003|Overall Study|Lack of Efficacy|0|||
33526407|NCT01995513|62913998|FG000|Period 1: First Open Label Treatment|Other|34|||
33526408|NCT01995513|62913999|FG001|Period 1: First Open Label Treatment|Other|0|||
33526409|NCT01995513|62914000|FG002|Period 1: First Open Label Treatment|Other|0|||
33526410|NCT01995513|62914001|FG003|Period 1: First Open Label Treatment|Other|0|||
33526411|NCT01995513|62913998|FG000|Period 1: First Open Label Treatment|Death|14|||
33526412|NCT01995513|62913999|FG001|Period 1: First Open Label Treatment|Death|0|||
33526413|NCT01995513|62914000|FG002|Period 1: First Open Label Treatment|Death|0|||
33526414|NCT01995513|62914001|FG003|Period 1: First Open Label Treatment|Death|0|||
33526415|NCT01995513|62913998|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
33526416|NCT01995513|62913999|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
33526417|NCT01995513|62914000|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
33526418|NCT01995513|62914001|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
33526419|NCT01995513|62913998|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
33526420|NCT01995513|62913999|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
33526421|NCT01995513|62914000|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
33526422|NCT01995513|62914001|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
33526423|NCT01995513|62913998|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
33526424|NCT01995513|62913999|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
33526425|NCT01995513|62914000|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
33526426|NCT01995513|62914001|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
33526427|NCT01995513|62913998|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
33526428|NCT01995513|62913999|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
33526429|NCT01995513|62914000|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
33526430|NCT01995513|62914001|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
33526431|NCT01995513|62913998|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
33526432|NCT01995513|62913999|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
33526433|NCT01995513|62914000|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
33526434|NCT01995513|62914001|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
33526435|NCT01995513|62913998|FG000|Period 1: Second Open Label Treatment|Other|0|||
33526436|NCT01995513|62913999|FG001|Period 1: Second Open Label Treatment|Other|2|||
33526437|NCT01995513|62914000|FG002|Period 1: Second Open Label Treatment|Other|0|||
33526438|NCT01995513|62914001|FG003|Period 1: Second Open Label Treatment|Other|0|||
33526439|NCT01995513|62913998|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
33526440|NCT01995513|62913999|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
33526441|NCT01995513|62914000|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
33526442|NCT01995513|62914001|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
33526443|NCT01995513|62913998|FG000|Period 2: Double Blind Treatment|Death|0|||
33526444|NCT01995513|62913999|FG001|Period 2: Double Blind Treatment|Death|0|||
33526445|NCT01995513|62914000|FG002|Period 2: Double Blind Treatment|Death|0|||
33526446|NCT01995513|62914001|FG003|Period 2: Double Blind Treatment|Death|1|||
33526447|NCT01995513|62913998|FG000|Period 2: Double Blind Treatment|Other|0|||
33526448|NCT01995513|62913999|FG001|Period 2: Double Blind Treatment|Other|0|||
33526449|NCT01995513|62914000|FG002|Period 2: Double Blind Treatment|Other|3|||
33526450|NCT01995513|62914001|FG003|Period 2: Double Blind Treatment|Other|3|||
33526451|NCT01995513|62913998|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
33526452|NCT01995513|62913999|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
33619892|NCT02229851|63020892|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
33619893|NCT02229851|63020893|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
33619894|NCT02229851|63020894|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
33619895|NCT02229851|63020895|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
33619896|NCT02229851|63020896|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
33619897|NCT02229851|63020897|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
33619898|NCT02229851|63020891|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
33619899|NCT02229851|63020892|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
33619900|NCT02229851|63020893|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
33619901|NCT02229851|63020894|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
33619902|NCT02229851|63020895|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
33619903|NCT02229851|63020896|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
33619904|NCT02229851|63020897|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
33619905|NCT02229851|63020891|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
33619906|NCT02229851|63020892|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
33619907|NCT02229851|63020893|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
33619908|NCT02229851|63020894|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
33526453|NCT01995513|62914000|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
33526454|NCT01995513|62914001|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
33526455|NCT01995513|62913998|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
33526456|NCT01995513|62913999|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
33526457|NCT01995513|62914000|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
33526458|NCT01995513|62914001|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
33526459|NCT01995513|62913998|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
33526460|NCT01995513|62913999|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
33526461|NCT01995513|62914000|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
33526462|NCT01995513|62914001|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
33526463|NCT01995513|62913998|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
33526464|NCT01995513|62913999|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
33526465|NCT01995513|62914000|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
33526466|NCT01995513|62914001|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
33526467|NCT02927171|62914017|FG000|Overall Study|Lost to Follow-up|0|||
33526468|NCT02927171|62914018|FG001|Overall Study|Lost to Follow-up|1|||
33526469|NCT03087617|62914028|FG000|Overall Study|Lost to Follow-up|32|||
33526470|NCT03087617|62914029|FG001|Overall Study|Lost to Follow-up|30|||
33526471|NCT03087617|62914030|FG002|Overall Study|Lost to Follow-up|30|||
33526472|NCT03087617|62914031|FG003|Overall Study|Lost to Follow-up|39|||
33526473|NCT00103610|62914043|FG000|Overall Study|Entered Rescue Procedure|10|||
33526474|NCT00103610|62914044|FG001|Overall Study|Entered Rescue Procedure|52|||
33526475|NCT00103610|62914043|FG000|Overall Study|Death|16|||
33526476|NCT00103610|62914044|FG001|Overall Study|Death|12|||
33526477|NCT00103610|62914043|FG000|Overall Study|Elective Withdrawal|4|||
33526478|NCT00103610|62914044|FG001|Overall Study|Elective Withdrawal|0|||
33526479|NCT00103610|62914043|FG000|Overall Study|Lost to Follow-up|3|||
33526480|NCT00103610|62914044|FG001|Overall Study|Lost to Follow-up|1|||
33526481|NCT00103610|62914043|FG000|Overall Study|Adverse Event|2|||
33526482|NCT00103610|62914044|FG001|Overall Study|Adverse Event|2|||
33526483|NCT00103610|62914043|FG000|Overall Study|Other|2|||
33526484|NCT00103610|62914044|FG001|Overall Study|Other|7|||
33526485|NCT00103610|62914043|FG000|Overall Study|Failed mobilization|1|||
33526486|NCT00103610|62914044|FG001|Overall Study|Failed mobilization|5|||
33526487|NCT00103610|62914043|FG000|Overall Study|Noncompliance|0|||
33526488|NCT00103610|62914044|FG001|Overall Study|Noncompliance|1|||
33526489|NCT03091439|62914053|FG000|Overall Study|Study Terminated by the Sponsor|1|||
33526490|NCT03091439|62914054|FG001|Overall Study|Study Terminated by the Sponsor|0|||
33526491|NCT03086447|62914062|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33526492|NCT03086447|62914063|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
33526493|NCT03086447|62914062|FG000|Overall Study|Lost Lens|2|||
33526494|NCT03086447|62914063|FG001|Overall Study|Lost Lens|5|||
33526495|NCT03086447|62914062|FG000|Overall Study|Product quality complaint|0|||
33526496|NCT03086447|62914063|FG001|Overall Study|Product quality complaint|1|||
33526497|NCT03086447|62914062|FG000|Overall Study|Lens Damage|1|||
33526498|NCT03086447|62914063|FG001|Overall Study|Lens Damage|6|||
33526499|NCT03086447|62914062|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
33619909|NCT02229851|63020895|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
33526500|NCT03086447|62914063|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
33619910|NCT02229851|63020896|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
33526501|NCT03086447|62914062|FG000|Overall Study|Test Article No Longer Available|1|||
33526502|NCT03086447|62914063|FG001|Overall Study|Test Article No Longer Available|0|||
33526503|NCT03086447|62914062|FG000|Overall Study|Protocol Violation|2|||
33619911|NCT02229851|63020897|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
33619912|NCT02229851|63020891|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
33619913|NCT02229851|63020892|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
33619914|NCT02229851|63020893|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
33619915|NCT02229851|63020894|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
33619916|NCT02229851|63020895|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
33619917|NCT02229851|63020896|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
33619918|NCT02229851|63020897|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
33619919|NCT02229851|63020891|FG000|Main Phase (Double-blind Phase)|Death|1|||
33619920|NCT02229851|63020892|FG001|Main Phase (Double-blind Phase)|Death|1|||
33619921|NCT02229851|63020893|FG002|Main Phase (Double-blind Phase)|Death|0|||
33619922|NCT02229851|63020894|FG003|Main Phase (Double-blind Phase)|Death|0|||
33619923|NCT02229851|63020895|FG004|Main Phase (Double-blind Phase)|Death|0|||
33619924|NCT02229851|63020896|FG005|Main Phase (Double-blind Phase)|Death|0|||
33619925|NCT02229851|63020897|FG006|Main Phase (Double-blind Phase)|Death|0|||
33619926|NCT02229851|63020891|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
33619927|NCT02229851|63020892|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
33619928|NCT02229851|63020893|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
33619929|NCT02229851|63020894|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
33619930|NCT02229851|63020895|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
33619931|NCT02229851|63020896|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
33619932|NCT02229851|63020897|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
33619933|NCT02229851|63020891|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
33619934|NCT02229851|63020892|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
33619935|NCT02229851|63020893|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
33619936|NCT02229851|63020894|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
33619937|NCT02229851|63020895|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
33619938|NCT02229851|63020896|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
33526504|NCT03086447|62914063|FG001|Overall Study|Protocol Violation|4|||
33526505|NCT03086447|62914062|FG000|Overall Study|Lost to Follow-up|0|||
33526506|NCT03086447|62914063|FG001|Overall Study|Lost to Follow-up|1|||
33526507|NCT03086447|62914062|FG000|Overall Study|Adverse Event|3|||
33526508|NCT03086447|62914063|FG001|Overall Study|Adverse Event|0|||
33526509|NCT03086447|62914062|FG000|Overall Study|Lens Discomfort|2|||
33526510|NCT03086447|62914063|FG001|Overall Study|Lens Discomfort|1|||
33526511|NCT03083639|62914094|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
33526512|NCT03083639|62914095|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
33526513|NCT03083639|62914094|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
33526514|NCT03083639|62914095|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
33526515|NCT02927431|62914104|FG000|Overall Study|Withdrawal by Subject|0|||
33526516|NCT02927431|62914105|FG001|Overall Study|Withdrawal by Subject|0|||
33526517|NCT02927431|62914106|FG002|Overall Study|Withdrawal by Subject|1|||
33526518|NCT03083483|62914119|FG000|Overall Study|Adverse Event|1|||
33526519|NCT03083483|62914120|FG001|Overall Study|Adverse Event|1|||
33526520|NCT03083483|62914121|FG002|Overall Study|Adverse Event|1|||
33526521|NCT03083483|62914119|FG000|Overall Study|Lost to Follow-up|2|||
33526522|NCT03083483|62914120|FG001|Overall Study|Lost to Follow-up|1|||
33526523|NCT03083483|62914121|FG002|Overall Study|Lost to Follow-up|1|||
33526524|NCT03083483|62914119|FG000|Overall Study|technological issues|1|||
33526525|NCT03083483|62914120|FG001|Overall Study|technological issues|0|||
33526526|NCT03083483|62914121|FG002|Overall Study|technological issues|1|||
33526527|NCT03085927|62914133|FG000|Overall Study|Withdrawal by Subject|1|||
33526528|NCT03085927|62914134|FG001|Overall Study|Withdrawal by Subject|4|||
33526529|NCT03085927|62914133|FG000|Overall Study|Lost to Follow-up|3|||
33526530|NCT03085927|62914134|FG001|Overall Study|Lost to Follow-up|1|||
33526531|NCT03085927|62914133|FG000|Overall Study|Death|1|||
33526532|NCT03085927|62914134|FG001|Overall Study|Death|0|||
33526533|NCT03085927|62914133|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
33619939|NCT02229851|63020897|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
33619940|NCT02229851|63020891|FG000|Extension Phase (Open-label Phase)|Death|0|||
33619941|NCT02229851|63020892|FG001|Extension Phase (Open-label Phase)|Death|0|||
33619942|NCT02229851|63020893|FG002|Extension Phase (Open-label Phase)|Death|0|||
33619943|NCT02229851|63020894|FG003|Extension Phase (Open-label Phase)|Death|1|||
33619944|NCT02229851|63020895|FG004|Extension Phase (Open-label Phase)|Death|0|||
33619945|NCT02229851|63020896|FG005|Extension Phase (Open-label Phase)|Death|1|||
33619946|NCT02229851|63020897|FG006|Extension Phase (Open-label Phase)|Death|1|||
33619947|NCT01482910|63020914|FG000|Overall Study|Adverse Event|6|||
33619948|NCT01482910|63020915|FG001|Overall Study|Adverse Event|5|||
33619949|NCT01482910|63020914|FG000|Overall Study|Lost to Follow-up|0|||
33619950|NCT01482910|63020915|FG001|Overall Study|Lost to Follow-up|1|||
33619951|NCT01482910|63020914|FG000|Overall Study|Protocol Violation|1|||
33619952|NCT01482910|63020915|FG001|Overall Study|Protocol Violation|1|||
33619953|NCT01482910|63020914|FG000|Overall Study|Withdrawal by Subject|7|||
33619954|NCT01482910|63020915|FG001|Overall Study|Withdrawal by Subject|2|||
33619955|NCT01482910|63020914|FG000|Overall Study|Death|1|||
33619956|NCT01482910|63020915|FG001|Overall Study|Death|0|||
33619957|NCT01626391|63020925|FG000|Overall Study|Physician Decision|1|||
33619958|NCT01626391|63020926|FG001|Overall Study|Physician Decision|0|||
33619959|NCT01626391|63020925|FG000|Overall Study|Withdrawal by Subject|1|||
33619960|NCT01626391|63020926|FG001|Overall Study|Withdrawal by Subject|0|||
33619961|NCT02103439|63020934|FG000|Overall Study|Adverse Event|0|||
33619962|NCT02103439|63020935|FG001|Overall Study|Adverse Event|2|||
33619963|NCT02103439|63020934|FG000|Overall Study|Withdrawal by Subject|3|||
33619964|NCT02103439|63020935|FG001|Overall Study|Withdrawal by Subject|1|||
33619965|NCT02229539|63020948|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
33619966|NCT02229539|63020949|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
33619967|NCT02229539|63020950|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
33619968|NCT02229539|63020948|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
33619969|NCT02229539|63020949|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
33619970|NCT02229539|63020950|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
33619971|NCT02229539|63020948|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
33619972|NCT02229539|63020949|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
33619973|NCT02229539|63020950|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
33619974|NCT02229539|63020948|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
33619975|NCT02229539|63020949|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
33619976|NCT02229539|63020950|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
33619977|NCT02229539|63020948|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
33619978|NCT02229539|63020949|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
33619979|NCT02229539|63020950|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
33619980|NCT02229539|63020948|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
33619981|NCT02229539|63020949|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
33619982|NCT02229539|63020950|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
33619983|NCT02229539|63020948|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
33619984|NCT02229539|63020949|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
33619985|NCT02229539|63020950|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
33619986|NCT02229539|63020948|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
33619987|NCT02229539|63020949|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
33619988|NCT02229539|63020950|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
33619989|NCT02229539|63020948|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
33619990|NCT02229539|63020949|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
33619991|NCT02229539|63020950|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
33619992|NCT01835223|63020960|FG000|Overall Study|Adverse Event|1|||
33619993|NCT01835223|63020961|FG001|Overall Study|Adverse Event|0|||
33619994|NCT01835223|63020960|FG000|Overall Study|Withdrawal by Subject|2|||
33619995|NCT01835223|63020961|FG001|Overall Study|Withdrawal by Subject|0|||
33619996|NCT01835223|63020960|FG000|Overall Study|Disease progression|2|||
33619997|NCT01835223|63020961|FG001|Overall Study|Disease progression|1|||
33619998|NCT01835223|63020960|FG000|Overall Study|Became Inelligible|4|||
33619999|NCT01835223|63020961|FG001|Overall Study|Became Inelligible|0|||
33620000|NCT01482598|63020971|FG000|Overall Study|Death|7|||
33620001|NCT01482598|63020972|FG001|Overall Study|Death|10|||
33620002|NCT01482598|63020971|FG000|Overall Study|Physician Decision|0|||
33620003|NCT01482598|63020972|FG001|Overall Study|Physician Decision|3|||
33620004|NCT01482598|63020971|FG000|Overall Study|Withdrawal by Subject|4|||
33620005|NCT01482598|63020972|FG001|Overall Study|Withdrawal by Subject|5|||
33620006|NCT01482598|63020971|FG000|Overall Study|Lost to Follow-up|5|||
33620007|NCT01482598|63020972|FG001|Overall Study|Lost to Follow-up|4|||
33620008|NCT01460446|63020980|FG000|Overall Study|Non-compliance|2|||
33620009|NCT01460446|63020981|FG001|Overall Study|Non-compliance|9|||
33620010|NCT01460446|63020980|FG000|Overall Study|Consent Withdrawn|0|||
33620011|NCT01460446|63020981|FG001|Overall Study|Consent Withdrawn|4|||
33620012|NCT01460446|63020980|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
33620013|NCT01460446|63020981|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
33620014|NCT01460446|63020980|FG000|Overall Study|Surgery/Illness|1|||
33620015|NCT01460446|63020981|FG001|Overall Study|Surgery/Illness|1|||
33620016|NCT01460446|63020980|FG000|Overall Study|Pregnancy|1|||
33620017|NCT01460446|63020981|FG001|Overall Study|Pregnancy|0|||
33620018|NCT01460446|63020980|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
33620019|NCT01460446|63020981|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
33620020|NCT02229383|63020990|FG000|Overall Study|Adverse Event|7|||
33620021|NCT02229383|63020991|FG001|Overall Study|Adverse Event|4|||
33620022|NCT02229383|63020990|FG000|Overall Study|Death|0|||
33620023|NCT02229383|63020991|FG001|Overall Study|Death|1|||
33620024|NCT02229383|63020990|FG000|Overall Study|Lost to Follow-up|5|||
33620025|NCT02229383|63020991|FG001|Overall Study|Lost to Follow-up|3|||
33620026|NCT02229383|63020990|FG000|Overall Study|Withdrawal by Subject|4|||
33620027|NCT02229383|63020991|FG001|Overall Study|Withdrawal by Subject|6|||
33620028|NCT02229383|63020990|FG000|Overall Study|Did not receive treatment|1|||
33620029|NCT02229383|63020991|FG001|Overall Study|Did not receive treatment|0|||
33620030|NCT02229383|63020990|FG000|Overall Study|Other|3|||
33620031|NCT02229383|63020991|FG001|Overall Study|Other|8|||
33620032|NCT01499368|63021000|FG000|Overall Study|Did not meet I/E criteria|8|||
33620033|NCT01499368|63021001|FG001|Overall Study|Did not meet I/E criteria|4|||
33620034|NCT01499368|63021002|FG002|Overall Study|Did not meet I/E criteria|4|||
33620035|NCT01499368|63021000|FG000|Overall Study|Prohibited Concomitant medication|1|||
33620036|NCT01499368|63021001|FG001|Overall Study|Prohibited Concomitant medication|1|||
33620037|NCT01499368|63021002|FG002|Overall Study|Prohibited Concomitant medication|0|||
33620038|NCT01499368|63021000|FG000|Overall Study|Withdrawal by Subject|11|||
33620039|NCT01499368|63021001|FG001|Overall Study|Withdrawal by Subject|10|||
33620040|NCT01499368|63021002|FG002|Overall Study|Withdrawal by Subject|8|||
33620041|NCT01499368|63021000|FG000|Overall Study|Lost to Follow-up|3|||
33620042|NCT01499368|63021001|FG001|Overall Study|Lost to Follow-up|2|||
33620043|NCT01499368|63021002|FG002|Overall Study|Lost to Follow-up|5|||
33620044|NCT01499368|63021000|FG000|Overall Study|Adverse Event|4|||
33620045|NCT01499368|63021001|FG001|Overall Study|Adverse Event|0|||
33620046|NCT01499368|63021002|FG002|Overall Study|Adverse Event|2|||
33620047|NCT01499368|63021000|FG000|Overall Study|Physician Decision|0|||
33620048|NCT01499368|63021001|FG001|Overall Study|Physician Decision|1|||
33620049|NCT01499368|63021002|FG002|Overall Study|Physician Decision|0|||
33620050|NCT01499368|63021000|FG000|Overall Study|Deviation from visit window|0|||
33620051|NCT01499368|63021001|FG001|Overall Study|Deviation from visit window|0|||
33620052|NCT01499368|63021002|FG002|Overall Study|Deviation from visit window|1|||
33620053|NCT01499368|63021000|FG000|Overall Study|Error of Prescriptions|0|||
33620054|NCT01499368|63021001|FG001|Overall Study|Error of Prescriptions|0|||
33620055|NCT01499368|63021002|FG002|Overall Study|Error of Prescriptions|1|||
33620056|NCT01835145|63021012|FG000|Overall Study|Ineligible prior to treatment|1|||
33620057|NCT01835145|63021013|FG001|Overall Study|Ineligible prior to treatment|0|||
33620058|NCT02229227|63021023|FG000|Overall Study|Adverse Event|14|||
33325347|NCT00599521|62702121|FG000|Overall Study|Lack of Efficacy|4|||
33526534|NCT03085927|62914134|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
33526535|NCT03085927|62914133|FG000|Overall Study|Dyad Became Ineligible|0|||
33526536|NCT03085927|62914134|FG001|Overall Study|Dyad Became Ineligible|1|||
33526537|NCT04392583|62914142|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
33526538|NCT04497987|62914148|FG000|Overall Study|Adverse Event|1|||
33526539|NCT04497987|62914149|FG001|Overall Study|Adverse Event|0|||
33526540|NCT04497987|62914148|FG000|Overall Study|Death|21|||
33526541|NCT04497987|62914149|FG001|Overall Study|Death|13|||
33526542|NCT04497987|62914148|FG000|Overall Study|Lost to Follow-up|19|||
33526543|NCT04497987|62914149|FG001|Overall Study|Lost to Follow-up|17|||
33526544|NCT04497987|62914148|FG000|Overall Study|Other - as reported by the investigator|22|||
33526545|NCT04497987|62914149|FG001|Overall Study|Other - as reported by the investigator|16|||
33526546|NCT04497987|62914148|FG000|Overall Study|Physician Decision|1|||
33526547|NCT04497987|62914149|FG001|Overall Study|Physician Decision|0|||
33526548|NCT04497987|62914148|FG000|Overall Study|Withdrawal by Subject|35|||
33526549|NCT04497987|62914149|FG001|Overall Study|Withdrawal by Subject|21|||
33620059|NCT02229227|63021024|FG001|Overall Study|Adverse Event|9|||
33620060|NCT02229227|63021023|FG000|Overall Study|Lack of Efficacy|3|||
33620061|NCT02229227|63021024|FG001|Overall Study|Lack of Efficacy|3|||
33620062|NCT02229227|63021023|FG000|Overall Study|Protocol Violation|6|||
33325348|NCT00599521|62702122|FG001|Overall Study|Lack of Efficacy|8|||
33620063|NCT02229227|63021024|FG001|Overall Study|Protocol Violation|8|||
33620064|NCT02229227|63021023|FG000|Overall Study|Protocol defined stopping criteria|1|||
33620065|NCT02229227|63021024|FG001|Overall Study|Protocol defined stopping criteria|3|||
33526550|NCT00974571|62914159|FG000|Overall Study|Adverse Event|31|||
33526551|NCT00974571|62914160|FG001|Overall Study|Adverse Event|4|||
33526552|NCT00974571|62914161|FG002|Overall Study|Adverse Event|27|||
33620066|NCT02229227|63021023|FG000|Overall Study|Lost to Follow-up|3|||
33620067|NCT02229227|63021024|FG001|Overall Study|Lost to Follow-up|3|||
33620068|NCT02229227|63021023|FG000|Overall Study|Study terminated by sponsor|11|||
33526553|NCT00974571|62914159|FG000|Overall Study|Lack of Efficacy|3|||
33526554|NCT00974571|62914160|FG001|Overall Study|Lack of Efficacy|2|||
33526555|NCT00974571|62914161|FG002|Overall Study|Lack of Efficacy|9|||
33526556|NCT00974571|62914159|FG000|Overall Study|Lost to Follow-up|2|||
33526557|NCT00974571|62914160|FG001|Overall Study|Lost to Follow-up|1|||
33620069|NCT02229227|63021024|FG001|Overall Study|Study terminated by sponsor|11|||
33620070|NCT02229227|63021023|FG000|Overall Study|Withdrawal by Subject|8|||
33620071|NCT02229227|63021024|FG001|Overall Study|Withdrawal by Subject|12|||
33620072|NCT02229227|63021023|FG000|Overall Study|Other|0|||
33620073|NCT02229227|63021024|FG001|Overall Study|Other|1|||
33620074|NCT02229227|63021023|FG000|Overall Study|Physician Decision|5|||
33620075|NCT02229227|63021024|FG001|Overall Study|Physician Decision|12|||
33620076|NCT01499290|63021032|FG000|Overall Study|Withdrawal by Subject|22|||
33620077|NCT01499290|63021033|FG001|Overall Study|Withdrawal by Subject|15|||
33620078|NCT01499290|63021032|FG000|Overall Study|Not specified in study report|11|||
33620079|NCT01499290|63021033|FG001|Overall Study|Not specified in study report|5|||
33620080|NCT01499290|63021032|FG000|Overall Study|Condition improved/subject recovered|1|||
33620081|NCT01499290|63021033|FG001|Overall Study|Condition improved/subject recovered|0|||
33620082|NCT01499290|63021032|FG000|Overall Study|Lack of Efficacy|7|||
33620083|NCT01499290|63021033|FG001|Overall Study|Lack of Efficacy|8|||
33620084|NCT01499290|63021032|FG000|Overall Study|Adverse Event|14|||
33620085|NCT01499290|63021033|FG001|Overall Study|Adverse Event|7|||
33620086|NCT01833897|63021058|FG000|Overall Study|Lack of Efficacy|1|||
33620087|NCT01481896|63021062|FG000|Overall Study|Lost to Follow-up|12|||
33526558|NCT00974571|62914161|FG002|Overall Study|Lost to Follow-up|2|||
33526559|NCT00974571|62914159|FG000|Overall Study|Protocol Violation|13|||
33526560|NCT00974571|62914160|FG001|Overall Study|Protocol Violation|4|||
33526561|NCT00974571|62914161|FG002|Overall Study|Protocol Violation|18|||
33526562|NCT00974571|62914159|FG000|Overall Study|Withdrawal by Subject|14|||
33526563|NCT00974571|62914160|FG001|Overall Study|Withdrawal by Subject|5|||
33526564|NCT00974571|62914161|FG002|Overall Study|Withdrawal by Subject|16|||
33526565|NCT00974571|62914159|FG000|Overall Study|Patient Moved|1|||
33526566|NCT00974571|62914160|FG001|Overall Study|Patient Moved|0|||
33526567|NCT00974571|62914161|FG002|Overall Study|Patient Moved|1|||
33526568|NCT00974571|62914159|FG000|Overall Study|Other|4|||
33526569|NCT00974571|62914160|FG001|Overall Study|Other|0|||
33526570|NCT00974571|62914161|FG002|Overall Study|Other|10|||
33526571|NCT02766608|62914174|FG000|Overall Study|Adverse Event|27|||
33526572|NCT02766608|62914175|FG001|Overall Study|Adverse Event|22|||
33526573|NCT02766608|62914176|FG002|Overall Study|Adverse Event|17|||
33526574|NCT02766608|62914177|FG003|Overall Study|Adverse Event|13|||
33526575|NCT02766608|62914178|FG004|Overall Study|Adverse Event|12|||
33526576|NCT02766608|62914174|FG000|Overall Study|Withdrawal by Subject|21|||
33526577|NCT02766608|62914175|FG001|Overall Study|Withdrawal by Subject|20|||
33526578|NCT02766608|62914176|FG002|Overall Study|Withdrawal by Subject|24|||
33526579|NCT02766608|62914177|FG003|Overall Study|Withdrawal by Subject|13|||
33526580|NCT02766608|62914178|FG004|Overall Study|Withdrawal by Subject|10|||
33526581|NCT02766608|62914174|FG000|Overall Study|Lack of Efficacy|16|||
33526582|NCT02766608|62914175|FG001|Overall Study|Lack of Efficacy|15|||
33526583|NCT02766608|62914176|FG002|Overall Study|Lack of Efficacy|32|||
33526584|NCT02766608|62914177|FG003|Overall Study|Lack of Efficacy|8|||
33526585|NCT02766608|62914178|FG004|Overall Study|Lack of Efficacy|2|||
33526586|NCT02766608|62914174|FG000|Overall Study|Lost to Follow-up|6|||
33526587|NCT02766608|62914175|FG001|Overall Study|Lost to Follow-up|3|||
33526588|NCT02766608|62914176|FG002|Overall Study|Lost to Follow-up|5|||
33526589|NCT02766608|62914177|FG003|Overall Study|Lost to Follow-up|2|||
33526590|NCT02766608|62914178|FG004|Overall Study|Lost to Follow-up|2|||
33526591|NCT02766608|62914174|FG000|Overall Study|Physician Decision|3|||
33526592|NCT02766608|62914175|FG001|Overall Study|Physician Decision|2|||
33526593|NCT02766608|62914176|FG002|Overall Study|Physician Decision|3|||
33526594|NCT02766608|62914177|FG003|Overall Study|Physician Decision|1|||
33526595|NCT02766608|62914178|FG004|Overall Study|Physician Decision|2|||
33526596|NCT02766608|62914174|FG000|Overall Study|Protocol disc criteria|3|||
33526597|NCT02766608|62914175|FG001|Overall Study|Protocol disc criteria|3|||
33620088|NCT02226653|63021078|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
33620089|NCT02226653|63021079|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
33620090|NCT02226653|63021078|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
33620091|NCT02226653|63021079|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
33620092|NCT02201771|63021095|FG000|Overall Study|Death|3|||
33620093|NCT02201771|63021096|FG001|Overall Study|Death|2|||
33620094|NCT02201771|63021097|FG002|Overall Study|Death|0|||
33620095|NCT02201771|63021095|FG000|Overall Study|Protocol Violation|10|||
33620096|NCT02201771|63021096|FG001|Overall Study|Protocol Violation|8|||
33620097|NCT02201771|63021097|FG002|Overall Study|Protocol Violation|10|||
33620098|NCT01460368|63021107|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
33620099|NCT01460368|63021108|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
33620100|NCT01460368|63021109|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
33620101|NCT01460368|63021110|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
33620102|NCT01460368|63021111|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
33620103|NCT01460368|63021112|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
33620104|NCT01460368|63021113|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
33620105|NCT01460368|63021107|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
33620106|NCT01460368|63021108|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
33620107|NCT01460368|63021109|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
33620108|NCT01460368|63021110|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
33620109|NCT01460368|63021111|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
33620110|NCT01460368|63021112|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
33620111|NCT01460368|63021113|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
33620112|NCT01460368|63021107|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
33620113|NCT01460368|63021108|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
33620114|NCT01460368|63021109|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
33620115|NCT01460368|63021110|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
33620116|NCT01460368|63021111|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
33620117|NCT01460368|63021112|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
33620118|NCT01460368|63021113|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
33620119|NCT01460368|63021107|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
33620120|NCT01460368|63021108|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
33620121|NCT01460368|63021109|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
33620122|NCT01460368|63021110|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
33620123|NCT01460368|63021111|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
33620124|NCT01460368|63021112|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
33620125|NCT01460368|63021113|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
33620126|NCT01460368|63021107|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
33620127|NCT01460368|63021108|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
33620128|NCT01460368|63021109|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
33526598|NCT02766608|62914176|FG002|Overall Study|Protocol disc criteria|4|||
33526599|NCT02766608|62914177|FG003|Overall Study|Protocol disc criteria|0|||
33526600|NCT02766608|62914178|FG004|Overall Study|Protocol disc criteria|0|||
33526601|NCT02766608|62914174|FG000|Overall Study|Protocol Violation|0|||
33526602|NCT02766608|62914175|FG001|Overall Study|Protocol Violation|4|||
33526603|NCT02766608|62914176|FG002|Overall Study|Protocol Violation|4|||
33526604|NCT02766608|62914177|FG003|Overall Study|Protocol Violation|0|||
33526605|NCT02766608|62914178|FG004|Overall Study|Protocol Violation|1|||
33526606|NCT02766608|62914174|FG000|Overall Study|Administrative Reasons|3|||
33526607|NCT02766608|62914175|FG001|Overall Study|Administrative Reasons|1|||
33526608|NCT02766608|62914176|FG002|Overall Study|Administrative Reasons|1|||
33526609|NCT02766608|62914177|FG003|Overall Study|Administrative Reasons|0|||
33526610|NCT02766608|62914178|FG004|Overall Study|Administrative Reasons|0|||
33526611|NCT00960141|62914196|FG000|Overall Study|Adverse Event|4|||
33526612|NCT00960141|62914197|FG001|Overall Study|Adverse Event|8|||
33526613|NCT00960141|62914198|FG002|Overall Study|Adverse Event|2|||
33526614|NCT00960141|62914196|FG000|Overall Study|Lack of Efficacy|3|||
33526615|NCT00960141|62914197|FG001|Overall Study|Lack of Efficacy|4|||
33526616|NCT00960141|62914198|FG002|Overall Study|Lack of Efficacy|2|||
33526617|NCT00960141|62914196|FG000|Overall Study|Lost to Follow-up|1|||
33526618|NCT00960141|62914197|FG001|Overall Study|Lost to Follow-up|0|||
33526619|NCT00960141|62914198|FG002|Overall Study|Lost to Follow-up|0|||
33526620|NCT00960141|62914196|FG000|Overall Study|Protocol Violation|1|||
33526621|NCT00960141|62914197|FG001|Overall Study|Protocol Violation|3|||
33526622|NCT00960141|62914198|FG002|Overall Study|Protocol Violation|2|||
33526623|NCT00960141|62914196|FG000|Overall Study|Withdrawal by Subject|1|||
33526624|NCT00960141|62914197|FG001|Overall Study|Withdrawal by Subject|2|||
33526625|NCT00960141|62914198|FG002|Overall Study|Withdrawal by Subject|1|||
33526626|NCT02771522|62914206|FG000|Overall Study|Lost to Follow-up|3|||
33526627|NCT02771522|62914206|FG000|Overall Study|Withdrawal by Subject|2|||
33620129|NCT01460368|63021110|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
33620130|NCT01460368|63021111|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
33620131|NCT01460368|63021112|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
33620132|NCT01460368|63021113|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
33620133|NCT01460290|63021122|FG000|Overall Study|Adverse Event|3|||
33620134|NCT01460290|63021122|FG000|Overall Study|Elevated liver function|1|||
33620135|NCT02200211|63021131|FG000|Overall Study|Lost to Follow-up|7|||
33620136|NCT02200211|63021132|FG001|Overall Study|Lost to Follow-up|7|||
33526628|NCT02771522|62914206|FG000|Overall Study|No white spot lesions|3|||
33526629|NCT00759655|62914215|FG000|Overall Study|Termination of the study by sponsor|1|||
33526630|NCT02771366|62914221|FG000|Period 1|Withdrawal by Subject|0|||
33620137|NCT02200211|63021133|FG002|Overall Study|Lost to Follow-up|1|||
33620138|NCT02200211|63021134|FG003|Overall Study|Lost to Follow-up|2|||
33620139|NCT02200211|63021131|FG000|Overall Study|Withdrawal by Subject|1|||
33620140|NCT02200211|63021132|FG001|Overall Study|Withdrawal by Subject|0|||
33620141|NCT02200211|63021133|FG002|Overall Study|Withdrawal by Subject|0|||
33620142|NCT02200211|63021134|FG003|Overall Study|Withdrawal by Subject|0|||
33620143|NCT01459666|63021154|FG000|Overall Study|PI left institution|5|||
33620144|NCT01459666|63021155|FG001|Overall Study|PI left institution|4|||
33620145|NCT01858389|63021163|FG000|Overall Study|Death|1|||
33620146|NCT01858389|63021164|FG001|Overall Study|Death|3|||
33620147|NCT01858389|63021163|FG000|Overall Study|Study terminated by sponsor|0|||
33620148|NCT01858389|63021164|FG001|Overall Study|Study terminated by sponsor|2|||
33620149|NCT01858389|63021163|FG000|Overall Study|Withdrawal by Subject|0|||
33620150|NCT01858389|63021164|FG001|Overall Study|Withdrawal by Subject|1|||
33620151|NCT01858389|63021163|FG000|Overall Study|Progressive disease|10|||
33620152|NCT01858389|63021164|FG001|Overall Study|Progressive disease|11|||
33620153|NCT01858389|63021163|FG000|Overall Study|Other|2|||
33620154|NCT01858389|63021164|FG001|Overall Study|Other|4|||
33620155|NCT01858389|63021163|FG000|Overall Study|Adverse Event|3|||
33620156|NCT01858389|63021164|FG001|Overall Study|Adverse Event|1|||
33620157|NCT01858389|63021163|FG000|Overall Study|Did not receive treatment|0|||
33620158|NCT01858389|63021164|FG001|Overall Study|Did not receive treatment|3|||
33620159|NCT02199509|63021172|FG000|Overall Study|Suicidal Ideation|0|||
33620160|NCT02199509|63021173|FG001|Overall Study|Suicidal Ideation|1|||
33620161|NCT02199509|63021172|FG000|Overall Study|Misunderstood titration schedule|1|||
33620162|NCT02199509|63021173|FG001|Overall Study|Misunderstood titration schedule|0|||
33620163|NCT01458574|63021186|FG000|Overall Study|Adverse Event|5|||
33620164|NCT01458574|63021187|FG001|Overall Study|Adverse Event|9|||
33620165|NCT01458574|63021188|FG002|Overall Study|Adverse Event|7|||
33620166|NCT01458574|63021186|FG000|Overall Study|Lack of Efficacy|70|||
33526631|NCT02771366|62914222|FG001|Period 1|Withdrawal by Subject|2|||
33526632|NCT02771366|62914221|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
33620167|NCT01458574|63021187|FG001|Overall Study|Lack of Efficacy|53|||
33620168|NCT01458574|63021188|FG002|Overall Study|Lack of Efficacy|132|||
33620169|NCT01458574|63021186|FG000|Overall Study|Lost to Follow-up|3|||
33620170|NCT01458574|63021187|FG001|Overall Study|Lost to Follow-up|2|||
33620171|NCT01458574|63021188|FG002|Overall Study|Lost to Follow-up|1|||
33620172|NCT01458574|63021186|FG000|Overall Study|Pregnancy|1|||
33620173|NCT01458574|63021187|FG001|Overall Study|Pregnancy|1|||
33620174|NCT01458574|63021188|FG002|Overall Study|Pregnancy|0|||
33620175|NCT01458574|63021186|FG000|Overall Study|Protocol Violation|0|||
33620176|NCT01458574|63021187|FG001|Overall Study|Protocol Violation|1|||
33526633|NCT02771366|62914222|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
33526634|NCT03396471|62914229|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
33526635|NCT03396471|62914229|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
33526636|NCT03396471|62914229|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
33526637|NCT03396471|62914229|FG000|Study Treatment - Up to 22 Months|Death|2|||
33526638|NCT03396471|62914229|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
33526639|NCT03396471|62914229|FG000|Follow up - Up to 2 Years|Death|9|||
33526640|NCT03396471|62914229|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
33526641|NCT03396471|62914229|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
33620177|NCT01458574|63021188|FG002|Overall Study|Protocol Violation|0|||
33620178|NCT01458574|63021186|FG000|Overall Study|Withdrawal by Subject|6|||
33620179|NCT01458574|63021187|FG001|Overall Study|Withdrawal by Subject|3|||
33620180|NCT01458574|63021188|FG002|Overall Study|Withdrawal by Subject|5|||
33620181|NCT01458574|63021186|FG000|Overall Study|Other|2|||
33620182|NCT01458574|63021187|FG001|Overall Study|Other|1|||
33620183|NCT01458574|63021188|FG002|Overall Study|Other|0|||
33620184|NCT01458574|63021186|FG000|Overall Study|Randomized but not treated|0|||
33620185|NCT01458574|63021187|FG001|Overall Study|Randomized but not treated|1|||
33526642|NCT03396471|62914229|FG000|Follow up - Up to 2 Years|study terminated|1|||
33620186|NCT01458574|63021188|FG002|Overall Study|Randomized but not treated|0|||
33620187|NCT02224703|63021199|FG000|Overall Study|Adverse Event|0|||
33620188|NCT02224703|63021200|FG001|Overall Study|Adverse Event|5|||
33620189|NCT02224703|63021201|FG002|Overall Study|Adverse Event|0|||
33526643|NCT03396471|62914229|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
33526644|NCT03396471|62914229|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
33526645|NCT00103142|62914235|FG000|Overall Study|Adverse Event|1|||
33526646|NCT00103142|62914236|FG001|Overall Study|Adverse Event|0|||
33526647|NCT00103142|62914235|FG000|Overall Study|Progression of disease|2|||
33526648|NCT00103142|62914236|FG001|Overall Study|Progression of disease|1|||
33526649|NCT00943683|62914246|FG000|Overall Study|Adverse Event|3|||
33526650|NCT00943683|62914247|FG001|Overall Study|Adverse Event|3|||
33620190|NCT02224703|63021199|FG000|Overall Study|Withdrawn by investigator|1|||
33620191|NCT02224703|63021200|FG001|Overall Study|Withdrawn by investigator|0|||
33620192|NCT02224703|63021201|FG002|Overall Study|Withdrawn by investigator|0|||
33620193|NCT02224703|63021199|FG000|Overall Study|Advised by medical monitor|1|||
33526651|NCT00943683|62914246|FG000|Overall Study|Lost to Follow-up|1|||
33620194|NCT02224703|63021200|FG001|Overall Study|Advised by medical monitor|0|||
33620195|NCT02224703|63021201|FG002|Overall Study|Advised by medical monitor|0|||
33620196|NCT02224703|63021199|FG000|Overall Study|Withdrawn by parent/guardian|0|||
33620197|NCT02224703|63021200|FG001|Overall Study|Withdrawn by parent/guardian|1|||
33620198|NCT02224703|63021201|FG002|Overall Study|Withdrawn by parent/guardian|0|||
33620199|NCT02224703|63021199|FG000|Overall Study|Lack of Efficacy|1|||
33620200|NCT02224703|63021200|FG001|Overall Study|Lack of Efficacy|0|||
33620201|NCT02224703|63021201|FG002|Overall Study|Lack of Efficacy|0|||
33620202|NCT02198963|63021210|FG000|Overall Study|Adverse Event|1|||
33620203|NCT02198963|63021210|FG000|Overall Study|Withdrawal by Subject|6|||
33620204|NCT01458106|63021234|FG000|Overall Study|Withdrawal by Subject|2|||
33620205|NCT01458106|63021235|FG001|Overall Study|Withdrawal by Subject|0|||
33620206|NCT01458106|63021234|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
33620207|NCT01458106|63021235|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
33620208|NCT01458106|63021234|FG000|Overall Study|Withdrawn Per Protocol|0|||
33620209|NCT01458106|63021235|FG001|Overall Study|Withdrawn Per Protocol|1|||
33620210|NCT01457950|63021246|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
33620211|NCT01457950|63021247|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
33620212|NCT01457950|63021248|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
33620213|NCT01457950|63021249|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
33620214|NCT01457950|63021246|FG000|Double-Blind Phase|Protocol Violation|2|||
33620215|NCT01457950|63021247|FG001|Double-Blind Phase|Protocol Violation|1|||
33620216|NCT01457950|63021248|FG002|Double-Blind Phase|Protocol Violation|0|||
33620217|NCT01457950|63021249|FG003|Double-Blind Phase|Protocol Violation|0|||
33620218|NCT01457950|63021246|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
33620219|NCT01457950|63021247|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
33620220|NCT01457950|63021248|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
33620221|NCT01457950|63021249|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
33620222|NCT01457950|63021246|FG000|Open-Label Phase|Adverse Event|0|||
33620223|NCT01457950|63021247|FG001|Open-Label Phase|Adverse Event|0|||
33620224|NCT01457950|63021248|FG002|Open-Label Phase|Adverse Event|0|||
33325349|NCT00599521|62702121|FG000|Overall Study|Adverse Event|4|||
33526652|NCT00943683|62914247|FG001|Overall Study|Lost to Follow-up|1|||
33526653|NCT00943683|62914246|FG000|Overall Study|Protocol Violation|1|||
33526654|NCT00943683|62914247|FG001|Overall Study|Protocol Violation|2|||
33526655|NCT00943683|62914246|FG000|Overall Study|Withdrawal by Subject|1|||
33526656|NCT00943683|62914247|FG001|Overall Study|Withdrawal by Subject|0|||
33526657|NCT00943683|62914246|FG000|Overall Study|Patient Moved|1|||
33526658|NCT00943683|62914247|FG001|Overall Study|Patient Moved|0|||
33526659|NCT00911547|62914257|FG000|Overall Study|Adverse Event|8|||
33526660|NCT00911547|62914258|FG001|Overall Study|Adverse Event|27|||
33526661|NCT00911547|62914259|FG002|Overall Study|Adverse Event|11|||
33526662|NCT00911547|62914260|FG003|Overall Study|Adverse Event|6|||
33526663|NCT00911547|62914257|FG000|Overall Study|Lost to Follow-up|0|||
33526664|NCT00911547|62914258|FG001|Overall Study|Lost to Follow-up|0|||
33526665|NCT00911547|62914259|FG002|Overall Study|Lost to Follow-up|2|||
33526666|NCT00911547|62914260|FG003|Overall Study|Lost to Follow-up|1|||
33620225|NCT01457950|63021249|FG003|Open-Label Phase|Adverse Event|1|||
33620226|NCT01457950|63021246|FG000|Open-Label Phase|Protocol Violation|0|||
33620227|NCT01457950|63021247|FG001|Open-Label Phase|Protocol Violation|0|||
33620228|NCT01457950|63021248|FG002|Open-Label Phase|Protocol Violation|0|||
33620229|NCT01457950|63021249|FG003|Open-Label Phase|Protocol Violation|1|||
33620230|NCT01457950|63021246|FG000|Open-Label Phase|Withdrawal by Subject|0|||
33620231|NCT01457950|63021247|FG001|Open-Label Phase|Withdrawal by Subject|0|||
33620232|NCT01457950|63021248|FG002|Open-Label Phase|Withdrawal by Subject|2|||
33620233|NCT01457950|63021249|FG003|Open-Label Phase|Withdrawal by Subject|0|||
33325350|NCT00599521|62702122|FG001|Overall Study|Adverse Event|1|||
33526667|NCT00911547|62914257|FG000|Overall Study|Protocol Violation|0|||
33526668|NCT00911547|62914258|FG001|Overall Study|Protocol Violation|5|||
33526669|NCT00911547|62914259|FG002|Overall Study|Protocol Violation|5|||
33526670|NCT00911547|62914260|FG003|Overall Study|Protocol Violation|1|||
33526671|NCT00911547|62914257|FG000|Overall Study|Withdrawal by Subject|3|||
33526672|NCT00911547|62914258|FG001|Overall Study|Withdrawal by Subject|10|||
33526673|NCT00911547|62914259|FG002|Overall Study|Withdrawal by Subject|4|||
33526674|NCT00911547|62914260|FG003|Overall Study|Withdrawal by Subject|8|||
33526675|NCT00899379|62914275|FG000|Overall Study|Adverse Event|2|||
33526676|NCT00899379|62914276|FG001|Overall Study|Adverse Event|2|||
33526677|NCT00899379|62914277|FG002|Overall Study|Adverse Event|1|||
33620234|NCT01499134|63021262|FG000|Overall Study|Withdrawal by Subject|0|||
33620235|NCT01499134|63021263|FG001|Overall Study|Withdrawal by Subject|1|||
33620236|NCT02198651|63021269|FG000|Lead-in Period|Withdrew consent|13|||
33620237|NCT02198651|63021270|FG001|Lead-in Period|Withdrew consent|0|||
33620238|NCT02198651|63021271|FG002|Lead-in Period|Withdrew consent|0|||
33620239|NCT02198651|63021272|FG003|Lead-in Period|Withdrew consent|0|||
33620240|NCT02198651|63021273|FG004|Lead-in Period|Withdrew consent|0|||
33620241|NCT02198651|63021269|FG000|Lead-in Period|Adverse Event|2|||
33620242|NCT02198651|63021270|FG001|Lead-in Period|Adverse Event|0|||
33620243|NCT02198651|63021271|FG002|Lead-in Period|Adverse Event|0|||
33620244|NCT02198651|63021272|FG003|Lead-in Period|Adverse Event|0|||
33620245|NCT02198651|63021273|FG004|Lead-in Period|Adverse Event|0|||
33620246|NCT02198651|63021269|FG000|Lead-in Period|Other, not specified|22|||
33620247|NCT02198651|63021270|FG001|Lead-in Period|Other, not specified|0|||
33620248|NCT02198651|63021271|FG002|Lead-in Period|Other, not specified|0|||
33620249|NCT02198651|63021272|FG003|Lead-in Period|Other, not specified|0|||
33620250|NCT02198651|63021273|FG004|Lead-in Period|Other, not specified|0|||
33620251|NCT02198651|63021269|FG000|Double-blind Period|Withdrew consent|0|||
33620252|NCT02198651|63021270|FG001|Double-blind Period|Withdrew consent|4|||
33620253|NCT02198651|63021271|FG002|Double-blind Period|Withdrew consent|0|||
33620254|NCT02198651|63021272|FG003|Double-blind Period|Withdrew consent|0|||
33620255|NCT02198651|63021273|FG004|Double-blind Period|Withdrew consent|0|||
33620256|NCT02198651|63021269|FG000|Double-blind Period|Adverse Event|0|||
33620257|NCT02198651|63021270|FG001|Double-blind Period|Adverse Event|1|||
33620258|NCT02198651|63021271|FG002|Double-blind Period|Adverse Event|0|||
33620259|NCT02198651|63021272|FG003|Double-blind Period|Adverse Event|0|||
33620260|NCT02198651|63021273|FG004|Double-blind Period|Adverse Event|0|||
33620261|NCT02198651|63021269|FG000|Double-blind Period|Other, not specified|0|||
33620262|NCT02198651|63021270|FG001|Double-blind Period|Other, not specified|4|||
33620263|NCT02198651|63021271|FG002|Double-blind Period|Other, not specified|1|||
33620264|NCT02198651|63021272|FG003|Double-blind Period|Other, not specified|0|||
33620265|NCT02198651|63021273|FG004|Double-blind Period|Other, not specified|0|||
33620266|NCT02198651|63021269|FG000|Open-label Rescue Period|Withdrew consent|0|||
33620267|NCT02198651|63021270|FG001|Open-label Rescue Period|Withdrew consent|0|||
33620268|NCT02198651|63021271|FG002|Open-label Rescue Period|Withdrew consent|0|||
33620269|NCT02198651|63021272|FG003|Open-label Rescue Period|Withdrew consent|2|||
33620270|NCT02198651|63021273|FG004|Open-label Rescue Period|Withdrew consent|0|||
33620271|NCT02198651|63021269|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
33620272|NCT02198651|63021270|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
33620273|NCT02198651|63021271|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
33620274|NCT02198651|63021272|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
33620275|NCT02198651|63021273|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
33620276|NCT01498822|63021288|FG000|Overall Study|Protocol Violation|8|||
33526678|NCT00899379|62914278|FG003|Overall Study|Adverse Event|1|||
33526679|NCT00899379|62914279|FG004|Overall Study|Adverse Event|2|||
33526680|NCT00899379|62914275|FG000|Overall Study|Lack of Efficacy|0|||
33526681|NCT00899379|62914276|FG001|Overall Study|Lack of Efficacy|4|||
33526682|NCT00899379|62914277|FG002|Overall Study|Lack of Efficacy|3|||
33526683|NCT00899379|62914278|FG003|Overall Study|Lack of Efficacy|0|||
33526684|NCT00899379|62914279|FG004|Overall Study|Lack of Efficacy|1|||
33526685|NCT00899379|62914275|FG000|Overall Study|Lost to Follow-up|9|||
33526686|NCT00899379|62914276|FG001|Overall Study|Lost to Follow-up|3|||
33526687|NCT00899379|62914277|FG002|Overall Study|Lost to Follow-up|0|||
33526688|NCT00899379|62914278|FG003|Overall Study|Lost to Follow-up|6|||
33526689|NCT00899379|62914279|FG004|Overall Study|Lost to Follow-up|2|||
33526690|NCT00899379|62914275|FG000|Overall Study|Protocol Violation|0|||
33526691|NCT00899379|62914276|FG001|Overall Study|Protocol Violation|0|||
33526692|NCT00899379|62914277|FG002|Overall Study|Protocol Violation|1|||
33526693|NCT00899379|62914278|FG003|Overall Study|Protocol Violation|1|||
33620277|NCT01498822|63021289|FG001|Overall Study|Protocol Violation|4|||
33620278|NCT01498822|63021288|FG000|Overall Study|Other Reason|5|||
33620279|NCT01498822|63021289|FG001|Overall Study|Other Reason|2|||
33620280|NCT01498822|63021288|FG000|Overall Study|Lack of Efficacy|7|||
33620281|NCT01498822|63021289|FG001|Overall Study|Lack of Efficacy|2|||
33620282|NCT01498822|63021288|FG000|Overall Study|AE, non-serious non-fatal|8|||
33620283|NCT01498822|63021289|FG001|Overall Study|AE, non-serious non-fatal|17|||
33620284|NCT01498822|63021288|FG000|Overall Study|SAE, non-fatal|2|||
33526694|NCT00899379|62914279|FG004|Overall Study|Protocol Violation|0|||
33526695|NCT00899379|62914275|FG000|Overall Study|Withdrawal by Subject|2|||
33526696|NCT00899379|62914276|FG001|Overall Study|Withdrawal by Subject|4|||
33526697|NCT00899379|62914277|FG002|Overall Study|Withdrawal by Subject|2|||
33620285|NCT01498822|63021289|FG001|Overall Study|SAE, non-fatal|2|||
33620286|NCT01498822|63021288|FG000|Overall Study|Adverse Event, serious fatal|1|||
33620287|NCT01498822|63021289|FG001|Overall Study|Adverse Event, serious fatal|1|||
33620288|NCT01498822|63021288|FG000|Overall Study|Withdrawal by Subject|15|||
33620289|NCT01498822|63021289|FG001|Overall Study|Withdrawal by Subject|25|||
33620290|NCT01498822|63021288|FG000|Overall Study|Lost to Follow-up|8|||
33620291|NCT01498822|63021289|FG001|Overall Study|Lost to Follow-up|3|||
33620292|NCT01498120|63021297|FG000|Overall Study|Lost to Follow-up|1|||
33620293|NCT01498120|63021297|FG000|Overall Study|Withdrawal by Subject|5|||
33620294|NCT01498120|63021297|FG000|Overall Study|AE, non-serious non-fatal|3|||
33620295|NCT01498120|63021297|FG000|Overall Study|Other|4|||
33620296|NCT01497262|63021301|FG000|Overall Study|Abnormal Lab Values|4|||
33620297|NCT01497262|63021301|FG000|Overall Study|Abnormal Test Procedure Result|1|||
33620298|NCT01497262|63021301|FG000|Overall Study|Physician Decision|1|||
33620299|NCT01497262|63021301|FG000|Overall Study|Withdrawal by Subject|2|||
33620300|NCT01497262|63021301|FG000|Overall Study|Adverse Event|2|||
33620301|NCT01497262|63021301|FG000|Overall Study|Protocol Violation|1|||
33620302|NCT02224625|63021305|FG000|Irritation|Adverse Event|6|||
33620303|NCT02224625|63021305|FG000|Sensitization|Adverse Event|55|||
33620304|NCT02197247|63021317|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
33620305|NCT02197247|63021317|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
33620306|NCT02197247|63021317|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
33620307|NCT02197247|63021317|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
33620308|NCT02197247|63021317|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
33620309|NCT02197247|63021317|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
33620310|NCT02197247|63021317|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
33620311|NCT02197247|63021317|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
33620312|NCT02224157|63021329|FG000|Overall Study|Severe non-compliance to protocol|2|||
33620313|NCT02224157|63021330|FG001|Overall Study|Severe non-compliance to protocol|2|||
33620314|NCT02224157|63021329|FG000|Overall Study|Other|13|||
33620315|NCT02224157|63021330|FG001|Overall Study|Other|10|||
33620316|NCT02224157|63021329|FG000|Overall Study|Subject decision|58|||
33620317|NCT02224157|63021330|FG001|Overall Study|Subject decision|50|||
33620318|NCT02224157|63021329|FG000|Overall Study|Prematurely closed site|4|||
33620319|NCT02224157|63021330|FG001|Overall Study|Prematurely closed site|2|||
33620320|NCT02224157|63021329|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
33620321|NCT02224157|63021330|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
33620322|NCT02224157|63021329|FG000|Overall Study|Lost to Follow-up|27|||
33620323|NCT02224157|63021330|FG001|Overall Study|Lost to Follow-up|35|||
33620324|NCT02224157|63021329|FG000|Overall Study|Death|1|||
33620325|NCT02224157|63021330|FG001|Overall Study|Death|1|||
33620326|NCT02224157|63021329|FG000|Overall Study|Adverse Event|1|||
33620327|NCT02224157|63021330|FG001|Overall Study|Adverse Event|3|||
33620328|NCT02196701|63021338|FG000|Overall Study|Adverse Event|1|||
33526698|NCT00899379|62914278|FG003|Overall Study|Withdrawal by Subject|3|||
33526699|NCT00899379|62914279|FG004|Overall Study|Withdrawal by Subject|6|||
33526700|NCT00899379|62914275|FG000|Overall Study|Pregnancy|0|||
33526701|NCT00899379|62914276|FG001|Overall Study|Pregnancy|0|||
33526702|NCT00899379|62914277|FG002|Overall Study|Pregnancy|1|||
33526703|NCT00899379|62914278|FG003|Overall Study|Pregnancy|0|||
33526704|NCT00899379|62914279|FG004|Overall Study|Pregnancy|1|||
33526705|NCT00899379|62914275|FG000|Overall Study|Patient Uncooperative|0|||
33526706|NCT00899379|62914276|FG001|Overall Study|Patient Uncooperative|1|||
33526707|NCT00899379|62914277|FG002|Overall Study|Patient Uncooperative|0|||
33526708|NCT00899379|62914278|FG003|Overall Study|Patient Uncooperative|1|||
33526709|NCT00899379|62914279|FG004|Overall Study|Patient Uncooperative|2|||
33526710|NCT00899379|62914275|FG000|Overall Study|Abnormal Baseline ECG|0|||
33526711|NCT00899379|62914276|FG001|Overall Study|Abnormal Baseline ECG|0|||
33526712|NCT00899379|62914277|FG002|Overall Study|Abnormal Baseline ECG|0|||
33526713|NCT00899379|62914278|FG003|Overall Study|Abnormal Baseline ECG|1|||
33526714|NCT00899379|62914279|FG004|Overall Study|Abnormal Baseline ECG|0|||
33620329|NCT02196701|63021338|FG000|Overall Study|Lost to Follow-up|1|||
33620330|NCT02196701|63021338|FG000|Overall Study|Non-adherence to Protocol|1|||
33620331|NCT01481116|63021348|FG000|Overall Study|Adverse Event|26|||
33620332|NCT01481116|63021349|FG001|Overall Study|Adverse Event|26|||
33620333|NCT01481116|63021350|FG002|Overall Study|Adverse Event|42|||
33620334|NCT01481116|63021348|FG000|Overall Study|Major Protocol Deviation|3|||
33620335|NCT01481116|63021349|FG001|Overall Study|Major Protocol Deviation|7|||
33526715|NCT00899379|62914275|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
33526716|NCT00899379|62914276|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
33526717|NCT00899379|62914277|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
33526718|NCT00899379|62914278|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33526719|NCT00899379|62914279|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33526720|NCT00899379|62914275|FG000|Overall Study|Not Completed/Entered Extn|5|||
33526721|NCT00899379|62914276|FG001|Overall Study|Not Completed/Entered Extn|1|||
33526722|NCT00899379|62914277|FG002|Overall Study|Not Completed/Entered Extn|6|||
33526723|NCT00899379|62914278|FG003|Overall Study|Not Completed/Entered Extn|4|||
33526724|NCT00899379|62914279|FG004|Overall Study|Not Completed/Entered Extn|3|||
33526725|NCT00899379|62914275|FG000|Overall Study|Study Terminated|3|||
33526726|NCT00899379|62914276|FG001|Overall Study|Study Terminated|0|||
33526727|NCT00899379|62914277|FG002|Overall Study|Study Terminated|3|||
33526728|NCT00899379|62914278|FG003|Overall Study|Study Terminated|3|||
33526729|NCT00899379|62914279|FG004|Overall Study|Study Terminated|1|||
33526730|NCT00899379|62914275|FG000|Overall Study|Lost to Follow-up|3|||
33526731|NCT00899379|62914276|FG001|Overall Study|Lost to Follow-up|1|||
33526732|NCT00899379|62914277|FG002|Overall Study|Lost to Follow-up|0|||
33526733|NCT00899379|62914278|FG003|Overall Study|Lost to Follow-up|2|||
33526734|NCT00899379|62914279|FG004|Overall Study|Lost to Follow-up|5|||
33526735|NCT00899379|62914275|FG000|Overall Study|Withdrawal by Subject|4|||
33526736|NCT00899379|62914276|FG001|Overall Study|Withdrawal by Subject|7|||
33526737|NCT00899379|62914277|FG002|Overall Study|Withdrawal by Subject|4|||
33526738|NCT00899379|62914278|FG003|Overall Study|Withdrawal by Subject|7|||
33526739|NCT00899379|62914279|FG004|Overall Study|Withdrawal by Subject|2|||
33526740|NCT00899379|62914275|FG000|Overall Study|Pregnancy|1|||
33526741|NCT00899379|62914276|FG001|Overall Study|Pregnancy|0|||
33526742|NCT00899379|62914277|FG002|Overall Study|Pregnancy|0|||
33526743|NCT00899379|62914278|FG003|Overall Study|Pregnancy|0|||
33526744|NCT00899379|62914279|FG004|Overall Study|Pregnancy|0|||
33526745|NCT00899379|62914275|FG000|Overall Study|Patient Uncooperative|0|||
33526746|NCT00899379|62914276|FG001|Overall Study|Patient Uncooperative|0|||
33526747|NCT00899379|62914277|FG002|Overall Study|Patient Uncooperative|0|||
33526748|NCT00899379|62914278|FG003|Overall Study|Patient Uncooperative|1|||
33526749|NCT00899379|62914279|FG004|Overall Study|Patient Uncooperative|0|||
33526750|NCT00899379|62914275|FG000|Overall Study|Abnormal Prestudy Labs|0|||
33526751|NCT00899379|62914276|FG001|Overall Study|Abnormal Prestudy Labs|0|||
33526752|NCT00899379|62914277|FG002|Overall Study|Abnormal Prestudy Labs|0|||
33526753|NCT00899379|62914278|FG003|Overall Study|Abnormal Prestudy Labs|0|||
33526754|NCT00899379|62914279|FG004|Overall Study|Abnormal Prestudy Labs|2|||
33526755|NCT00899379|62914275|FG000|Overall Study|Abnormal Baseline ECG|0|||
33526756|NCT00899379|62914276|FG001|Overall Study|Abnormal Baseline ECG|0|||
33526757|NCT00899379|62914277|FG002|Overall Study|Abnormal Baseline ECG|1|||
33526758|NCT00899379|62914278|FG003|Overall Study|Abnormal Baseline ECG|1|||
33526759|NCT00899379|62914279|FG004|Overall Study|Abnormal Baseline ECG|0|||
33526760|NCT00899379|62914275|FG000|Overall Study|No Attack Pretreatment|3|||
33526761|NCT00899379|62914276|FG001|Overall Study|No Attack Pretreatment|5|||
33526762|NCT00899379|62914277|FG002|Overall Study|No Attack Pretreatment|5|||
33526763|NCT00899379|62914278|FG003|Overall Study|No Attack Pretreatment|6|||
33526764|NCT00899379|62914279|FG004|Overall Study|No Attack Pretreatment|4|||
33526765|NCT00899379|62914275|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
33526766|NCT00899379|62914276|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33526767|NCT00899379|62914277|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33526768|NCT00899379|62914278|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33526769|NCT00899379|62914279|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33620336|NCT01481116|63021350|FG002|Overall Study|Major Protocol Deviation|1|||
33620337|NCT01481116|63021348|FG000|Overall Study|Lost to Follow-up|8|||
33620338|NCT01481116|63021349|FG001|Overall Study|Lost to Follow-up|12|||
33620339|NCT01481116|63021350|FG002|Overall Study|Lost to Follow-up|11|||
33526770|NCT00899379|62914275|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
33526771|NCT00899379|62914276|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
33526772|NCT00899379|62914277|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
33526773|NCT00899379|62914278|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
33526774|NCT00899379|62914279|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
33526775|NCT04326439|62914287|FG000|Overall Study|Withdrawal by Subject|1|||
33620340|NCT01481116|63021348|FG000|Overall Study|Withdrawal by Subject|37|||
33526776|NCT04326439|62914288|FG001|Overall Study|Withdrawal by Subject|0|||
33526777|NCT04326439|62914287|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
33526778|NCT04326439|62914288|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
33620341|NCT01481116|63021349|FG001|Overall Study|Withdrawal by Subject|33|||
33620342|NCT01481116|63021350|FG002|Overall Study|Withdrawal by Subject|37|||
33620343|NCT01481116|63021348|FG000|Overall Study|Study Termination|730|||
33620344|NCT01481116|63021349|FG001|Overall Study|Study Termination|729|||
33620345|NCT01481116|63021350|FG002|Overall Study|Study Termination|713|||
33620346|NCT01481116|63021348|FG000|Overall Study|Pregnancy|0|||
33620347|NCT01481116|63021349|FG001|Overall Study|Pregnancy|0|||
33620348|NCT01481116|63021350|FG002|Overall Study|Pregnancy|1|||
33620349|NCT01481116|63021348|FG000|Overall Study|Lack of Efficacy|3|||
33620350|NCT01481116|63021349|FG001|Overall Study|Lack of Efficacy|3|||
33620351|NCT01481116|63021350|FG002|Overall Study|Lack of Efficacy|1|||
33620352|NCT01481116|63021348|FG000|Overall Study|Contraindications|1|||
33620353|NCT01481116|63021349|FG001|Overall Study|Contraindications|1|||
33620354|NCT01481116|63021350|FG002|Overall Study|Contraindications|0|||
33620355|NCT01481116|63021348|FG000|Overall Study|Other|1|||
33620356|NCT01481116|63021349|FG001|Overall Study|Other|1|||
33457232|NCT00091832|62831691|FG000|Overall Study|Ineligibility Determined|0|||
33457233|NCT00091832|62831692|FG001|Overall Study|Ineligibility Determined|0|||
33526779|NCT04326439|62914287|FG000|Overall Study|Relapse after Induction 2|0|||
33526780|NCT04326439|62914288|FG001|Overall Study|Relapse after Induction 2|1|||
33526781|NCT04326439|62914287|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
33526782|NCT04326439|62914288|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
33526783|NCT00145795|62914302|FG000|Overall Study|Adverse Event|1|||
33526784|NCT00145795|62914303|FG001|Overall Study|Adverse Event|0|||
33526785|NCT02771210|62914311|FG000|Period 1|Adverse Event|5|||
33526786|NCT02771210|62914312|FG001|Period 1|Adverse Event|3|||
33526787|NCT02771210|62914311|FG000|Period 1|Lack of Efficacy|3|||
33526788|NCT02771210|62914312|FG001|Period 1|Lack of Efficacy|6|||
33526789|NCT02771210|62914311|FG000|Period 1|Lost to Follow-up|2|||
33526790|NCT02771210|62914312|FG001|Period 1|Lost to Follow-up|0|||
33526791|NCT02771210|62914311|FG000|Period 1|Physician Decision|0|||
33526792|NCT02771210|62914312|FG001|Period 1|Physician Decision|1|||
33526793|NCT02771210|62914311|FG000|Period 1|Withdrawal by Subject|0|||
33526794|NCT02771210|62914312|FG001|Period 1|Withdrawal by Subject|3|||
33526795|NCT02771210|62914311|FG000|Period 1|Withdrawal of informed consent|1|||
33526796|NCT02771210|62914312|FG001|Period 1|Withdrawal of informed consent|5|||
33526797|NCT02771210|62914311|FG000|Period 2|Adverse Event|1|||
33526798|NCT02771210|62914312|FG001|Period 2|Adverse Event|0|||
33526799|NCT02771210|62914311|FG000|Period 2|Lack of Efficacy|0|||
33526800|NCT02771210|62914312|FG001|Period 2|Lack of Efficacy|1|||
33526801|NCT02771210|62914311|FG000|Period 2|Withdrawal by Subject|1|||
33526802|NCT02771210|62914312|FG001|Period 2|Withdrawal by Subject|0|||
33526803|NCT02771210|62914311|FG000|Period 2|Withdrawal of informed consent|0|||
33526804|NCT02771210|62914312|FG001|Period 2|Withdrawal of informed consent|2|||
33526805|NCT00898677|62914322|FG000|Overall Study|Adverse Event|0|||
33526806|NCT00898677|62914323|FG001|Overall Study|Adverse Event|0|||
33526807|NCT00898677|62914324|FG002|Overall Study|Adverse Event|1|||
33526808|NCT00898677|62914325|FG003|Overall Study|Adverse Event|0|||
33526809|NCT00898677|62914322|FG000|Overall Study|Lost to Follow-up|0|||
33526810|NCT00898677|62914323|FG001|Overall Study|Lost to Follow-up|0|||
33526811|NCT00898677|62914324|FG002|Overall Study|Lost to Follow-up|2|||
33526812|NCT00898677|62914325|FG003|Overall Study|Lost to Follow-up|0|||
33526813|NCT00898677|62914322|FG000|Overall Study|Protocol Violation|1|||
33526814|NCT00898677|62914323|FG001|Overall Study|Protocol Violation|1|||
33526815|NCT00898677|62914324|FG002|Overall Study|Protocol Violation|2|||
33457234|NCT00091832|62831693|FG002|Overall Study|Ineligibility Determined|1|||
33457235|NCT00091832|62831694|FG003|Overall Study|Ineligibility Determined|0|||
33457236|NCT00091832|62831695|FG004|Overall Study|Ineligibility Determined|1|||
33457237|NCT00091832|62831696|FG005|Overall Study|Ineligibility Determined|0|||
33457238|NCT00091832|62831691|FG000|Overall Study|Lost to Follow-up|1|||
33457239|NCT00091832|62831692|FG001|Overall Study|Lost to Follow-up|0|||
33457240|NCT00091832|62831693|FG002|Overall Study|Lost to Follow-up|3|||
33457241|NCT00091832|62831694|FG003|Overall Study|Lost to Follow-up|3|||
33526816|NCT00898677|62914325|FG003|Overall Study|Protocol Violation|0|||
33526817|NCT00898677|62914322|FG000|Overall Study|Withdrawal by Subject|0|||
33526818|NCT00898677|62914323|FG001|Overall Study|Withdrawal by Subject|0|||
33620357|NCT01481116|63021350|FG002|Overall Study|Other|0|||
33620358|NCT01481116|63021348|FG000|Overall Study|Participant Started Taking Glipizide|1|||
33620359|NCT01481116|63021349|FG001|Overall Study|Participant Started Taking Glipizide|0|||
33526819|NCT00898677|62914324|FG002|Overall Study|Withdrawal by Subject|0|||
33526820|NCT00898677|62914325|FG003|Overall Study|Withdrawal by Subject|1|||
33526821|NCT00898677|62914322|FG000|Overall Study|Not Treated: Adverse Event|0|||
33526822|NCT00898677|62914323|FG001|Overall Study|Not Treated: Adverse Event|2|||
33526823|NCT00898677|62914324|FG002|Overall Study|Not Treated: Adverse Event|1|||
33620360|NCT01481116|63021350|FG002|Overall Study|Participant Started Taking Glipizide|0|||
33620361|NCT01481116|63021348|FG000|Overall Study|Participant Moved Out of Area|2|||
33457242|NCT00091832|62831695|FG004|Overall Study|Lost to Follow-up|2|||
33457243|NCT00091832|62831696|FG005|Overall Study|Lost to Follow-up|1|||
33620362|NCT01481116|63021349|FG001|Overall Study|Participant Moved Out of Area|0|||
33620363|NCT01481116|63021350|FG002|Overall Study|Participant Moved Out of Area|1|||
33620364|NCT01481116|63021348|FG000|Overall Study|Participant Moved Out of Country|1|||
33620365|NCT01481116|63021349|FG001|Overall Study|Participant Moved Out of Country|0|||
33620366|NCT01481116|63021350|FG002|Overall Study|Participant Moved Out of Country|1|||
33620367|NCT01481116|63021348|FG000|Overall Study|Investigator Decision|3|||
33620368|NCT01481116|63021349|FG001|Overall Study|Investigator Decision|2|||
33620369|NCT01481116|63021350|FG002|Overall Study|Investigator Decision|1|||
33620370|NCT01481116|63021348|FG000|Overall Study|Sponsor Decision|0|||
33620371|NCT01481116|63021349|FG001|Overall Study|Sponsor Decision|1|||
33620372|NCT01481116|63021350|FG002|Overall Study|Sponsor Decision|3|||
33620373|NCT01481116|63021348|FG000|Overall Study|Non-Compliant With Study Drug|0|||
33620374|NCT01481116|63021349|FG001|Overall Study|Non-Compliant With Study Drug|1|||
33620375|NCT01481116|63021350|FG002|Overall Study|Non-Compliant With Study Drug|1|||
33620376|NCT01481116|63021348|FG000|Overall Study|Investigator's Discretion|2|||
33620377|NCT01481116|63021349|FG001|Overall Study|Investigator's Discretion|0|||
33620378|NCT01481116|63021350|FG002|Overall Study|Investigator's Discretion|0|||
33620379|NCT01481116|63021348|FG000|Overall Study|Death|2|||
33620380|NCT01481116|63021349|FG001|Overall Study|Death|1|||
33620381|NCT01481116|63021350|FG002|Overall Study|Death|0|||
33620382|NCT01481116|63021348|FG000|Overall Study|Hypoglycemic Event|4|||
33620383|NCT01481116|63021349|FG001|Overall Study|Hypoglycemic Event|0|||
33620384|NCT01481116|63021350|FG002|Overall Study|Hypoglycemic Event|0|||
33620385|NCT02222207|63021358|FG000|Overall Study|Death|1|||
33620386|NCT02222207|63021358|FG000|Overall Study|Other reasons|2|||
33620387|NCT02222207|63021358|FG000|Overall Study|Adverse Event|1|||
33620388|NCT01457014|63021362|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
33620389|NCT01457014|63021363|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
33620390|NCT01457014|63021364|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
33620391|NCT01457014|63021365|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
33620392|NCT01457014|63021362|FG000|First Night|Withdrawal by Subject|3|||
33620393|NCT01457014|63021363|FG001|First Night|Withdrawal by Subject|0|||
33620394|NCT01457014|63021364|FG002|First Night|Withdrawal by Subject|0|||
33620395|NCT01457014|63021365|FG003|First Night|Withdrawal by Subject|0|||
33620396|NCT02254421|63021375|FG000|Overall Study|Randomized but Not Treated|1|||
33620397|NCT02254421|63021376|FG001|Overall Study|Randomized but Not Treated|0|||
33620398|NCT02254421|63021375|FG000|Overall Study|Death|0|||
33620399|NCT02254421|63021376|FG001|Overall Study|Death|2|||
33620400|NCT02254421|63021375|FG000|Overall Study|Withdrew Consent|1|||
33620401|NCT02254421|63021376|FG001|Overall Study|Withdrew Consent|1|||
33620402|NCT02252939|63021382|FG000|Overall Study|Lost to Follow-up|3|||
33620403|NCT02196077|63021391|FG000|Overall Study|Adverse Event|4|||
33620404|NCT02196077|63021391|FG000|Overall Study|Lack of Efficacy|1|||
33620405|NCT02196077|63021391|FG000|Overall Study|Withdrawal by Subject|14|||
33620406|NCT02196077|63021391|FG000|Overall Study|Physician Decision|1|||
33620407|NCT02196077|63021391|FG000|Overall Study|Lost to Follow-up|3|||
33526824|NCT00898677|62914325|FG003|Overall Study|Not Treated: Adverse Event|0|||
33526825|NCT00898677|62914322|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
33526826|NCT00898677|62914323|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
33526827|NCT00898677|62914324|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
33526828|NCT00898677|62914325|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
33526829|NCT00898677|62914322|FG000|Overall Study|Not Treated: Pregnancy|0|||
33526830|NCT00898677|62914323|FG001|Overall Study|Not Treated: Pregnancy|0|||
33526831|NCT00898677|62914324|FG002|Overall Study|Not Treated: Pregnancy|1|||
33526832|NCT00898677|62914325|FG003|Overall Study|Not Treated: Pregnancy|0|||
33526833|NCT00898677|62914322|FG000|Overall Study|Not Treated: Protocol Violation|2|||
33526834|NCT00898677|62914323|FG001|Overall Study|Not Treated: Protocol Violation|0|||
33526835|NCT00898677|62914324|FG002|Overall Study|Not Treated: Protocol Violation|2|||
33526836|NCT00898677|62914325|FG003|Overall Study|Not Treated: Protocol Violation|0|||
33526837|NCT00898677|62914322|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
33526838|NCT00898677|62914323|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
33526839|NCT00898677|62914324|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
33620408|NCT02196077|63021391|FG000|Overall Study|Protocol Violation|24|||
33620409|NCT02195687|63021405|FG000|Overall Study|Personal Reasons|1|||
33620410|NCT02195687|63021406|FG001|Overall Study|Personal Reasons|1|||
33620411|NCT02195687|63021405|FG000|Overall Study|Lost to Follow-up|4|||
33620412|NCT02195687|63021406|FG001|Overall Study|Lost to Follow-up|1|||
33620413|NCT02195531|63021415|FG000|Overall Study|Withdrawal by Subject|1|||
33526840|NCT00898677|62914325|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
33526841|NCT00898677|62914322|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
33526842|NCT00898677|62914323|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
33620414|NCT02195531|63021416|FG001|Overall Study|Withdrawal by Subject|1|||
33620415|NCT02195531|63021417|FG002|Overall Study|Withdrawal by Subject|1|||
33620416|NCT02252081|63021427|FG000|Overall Study|Withdrawal by Subject|2|||
33620417|NCT02252081|63021428|FG001|Overall Study|Withdrawal by Subject|1|||
33620418|NCT02252081|63021427|FG000|Overall Study|Adverse Event|4|||
33620419|NCT02252081|63021428|FG001|Overall Study|Adverse Event|1|||
33620420|NCT02252081|63021427|FG000|Overall Study|non compliance & others|0|||
33620421|NCT02252081|63021428|FG001|Overall Study|non compliance & others|2|||
33620422|NCT01623752|63021442|FG000|Phase 1 (78 Weeks)|No Data|249|||
33620423|NCT01623752|63021443|FG001|Phase 1 (78 Weeks)|No Data|66|||
33620424|NCT01623752|63021444|FG002|Phase 1 (78 Weeks)|No Data|2|||
33620425|NCT01623752|63021442|FG000|Phase 1 (78 Weeks)|Other|33|||
33620426|NCT01623752|63021443|FG001|Phase 1 (78 Weeks)|Other|20|||
33620427|NCT01623752|63021444|FG002|Phase 1 (78 Weeks)|Other|0|||
33620428|NCT01623752|63021442|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
33620429|NCT01623752|63021443|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
33620430|NCT01623752|63021444|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
33620431|NCT01623752|63021442|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
33620432|NCT01623752|63021443|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
33620433|NCT01623752|63021444|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
33620434|NCT01623752|63021442|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
33620435|NCT01623752|63021443|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
33620436|NCT01623752|63021444|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
33620437|NCT01623752|63021442|FG000|Phase 2 (78 Weeks)|Other|5|||
33620438|NCT01623752|63021443|FG001|Phase 2 (78 Weeks)|Other|1|||
33620439|NCT01623752|63021444|FG002|Phase 2 (78 Weeks)|Other|0|||
33620440|NCT01623752|63021442|FG000|Phase 2 (78 Weeks)|No Data|43|||
33620441|NCT01623752|63021443|FG001|Phase 2 (78 Weeks)|No Data|11|||
33620442|NCT01623752|63021444|FG002|Phase 2 (78 Weeks)|No Data|0|||
33620443|NCT01623752|63021442|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
33620444|NCT01623752|63021443|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
33620445|NCT01623752|63021444|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
33620446|NCT01623596|63021455|FG000|Overall Study|Abnormal laboratory values|2|||
33620447|NCT01623596|63021456|FG001|Overall Study|Abnormal laboratory values|0|||
33620448|NCT01623596|63021455|FG000|Overall Study|Administrative problems|9|||
33620449|NCT01623596|63021456|FG001|Overall Study|Administrative problems|13|||
33620450|NCT01623596|63021455|FG000|Overall Study|Adverse Event|20|||
33620451|NCT01623596|63021456|FG001|Overall Study|Adverse Event|29|||
33620452|NCT01623596|63021455|FG000|Overall Study|Death|0|||
33620453|NCT01623596|63021456|FG001|Overall Study|Death|2|||
33620454|NCT01623596|63021455|FG000|Overall Study|Lost to Follow-up|12|||
33620455|NCT01623596|63021456|FG001|Overall Study|Lost to Follow-up|16|||
33620456|NCT01623596|63021455|FG000|Overall Study|Withdrawal by Subject|13|||
33620457|NCT01623596|63021456|FG001|Overall Study|Withdrawal by Subject|31|||
33620458|NCT01623596|63021455|FG000|Overall Study|Patient no longer requires study drug|1|||
33620459|NCT01623596|63021456|FG001|Overall Study|Patient no longer requires study drug|0|||
33620460|NCT01623596|63021455|FG000|Overall Study|Protocol Violation|0|||
33620461|NCT01623596|63021456|FG001|Overall Study|Protocol Violation|6|||
33620462|NCT01623596|63021455|FG000|Overall Study|Lack of Efficacy|5|||
33620463|NCT01623596|63021456|FG001|Overall Study|Lack of Efficacy|3|||
33620464|NCT02219477|63021467|FG000|Overall Study|Adverse Event|0|||
33620465|NCT02219477|63021468|FG001|Overall Study|Adverse Event|1|||
33620466|NCT02219477|63021469|FG002|Overall Study|Adverse Event|1|||
33620467|NCT02219477|63021467|FG000|Overall Study|Withdrawal by Subject|0|||
33620468|NCT02219477|63021468|FG001|Overall Study|Withdrawal by Subject|1|||
33620469|NCT02219477|63021469|FG002|Overall Study|Withdrawal by Subject|0|||
33620470|NCT02119286|63021481|FG000|Overall Study|Adverse Event|9|||
33620471|NCT02119286|63021482|FG001|Overall Study|Adverse Event|7|||
33620472|NCT02119286|63021483|FG002|Overall Study|Adverse Event|2|||
33620473|NCT02119286|63021481|FG000|Overall Study|Lack of Efficacy|11|||
33620474|NCT02119286|63021482|FG001|Overall Study|Lack of Efficacy|3|||
33620475|NCT02119286|63021483|FG002|Overall Study|Lack of Efficacy|4|||
33620476|NCT02119286|63021481|FG000|Overall Study|Lost to Follow-up|2|||
33620477|NCT02119286|63021482|FG001|Overall Study|Lost to Follow-up|0|||
33620478|NCT02119286|63021483|FG002|Overall Study|Lost to Follow-up|1|||
33620479|NCT02119286|63021481|FG000|Overall Study|Withdrawal by Subject|4|||
33620480|NCT02119286|63021482|FG001|Overall Study|Withdrawal by Subject|1|||
33620481|NCT02119286|63021483|FG002|Overall Study|Withdrawal by Subject|0|||
33620482|NCT02250443|63021491|FG000|Overall Study|Administrative problems|7|||
33620483|NCT02250443|63021491|FG000|Overall Study|Adverse Event|3|||
33620484|NCT02093390|63021497|FG000|Overall Study|Withdrawal by Subject|0|||
33620485|NCT02093390|63021498|FG001|Overall Study|Withdrawal by Subject|1|||
33620486|NCT02194985|63021505|FG000|Overall Study|Adverse Event|1|||
33620487|NCT02194985|63021505|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
33620488|NCT02194985|63021505|FG000|Overall Study|Physician Decision|4|||
33620489|NCT02194985|63021505|FG000|Overall Study|Lost to Follow-up|1|||
33620490|NCT02194985|63021505|FG000|Overall Study|Withdrawal by Subject|2|||
33620491|NCT02219087|63021511|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
33620492|NCT02219087|63021512|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
33620493|NCT02248961|63021520|FG000|Overall Study|Adverse Event|1|||
33620494|NCT02248961|63021521|FG001|Overall Study|Adverse Event|0|||
33620495|NCT02248961|63021520|FG000|Overall Study|Withdrawal by Subject|1|||
33620496|NCT02248961|63021521|FG001|Overall Study|Withdrawal by Subject|2|||
33620497|NCT02248961|63021520|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
33620498|NCT02248961|63021521|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
33620499|NCT02219009|63021529|FG000|Overall Study|Withdrawal by Subject|5|||
33620500|NCT02219009|63021530|FG001|Overall Study|Withdrawal by Subject|1|||
33620501|NCT02219009|63021529|FG000|Overall Study|Adverse Event|2|||
33620502|NCT02219009|63021530|FG001|Overall Study|Adverse Event|4|||
33620503|NCT02219009|63021529|FG000|Overall Study|Lost to Follow-up|2|||
33620504|NCT02219009|63021530|FG001|Overall Study|Lost to Follow-up|2|||
33620505|NCT02219009|63021529|FG000|Overall Study|Protocol deviation|1|||
33620506|NCT02219009|63021530|FG001|Overall Study|Protocol deviation|0|||
33620507|NCT02219009|63021529|FG000|Overall Study|Physician Decision|0|||
33620508|NCT02219009|63021530|FG001|Overall Study|Physician Decision|1|||
33620509|NCT02248649|63021538|FG000|Overall Study|Death|7|||
33620510|NCT02248649|63021539|FG001|Overall Study|Death|11|||
33620511|NCT02248649|63021538|FG000|Overall Study|Lost to Follow-up|14|||
33620512|NCT02248649|63021539|FG001|Overall Study|Lost to Follow-up|10|||
33620513|NCT02218541|63021547|FG000|Overall Study|Lost to Follow-up|2|||
33620514|NCT02218541|63021548|FG001|Overall Study|Lost to Follow-up|1|||
33620515|NCT02218541|63021547|FG000|Overall Study|Implant Failure|4|||
33620516|NCT02218541|63021548|FG001|Overall Study|Implant Failure|1|||
33620517|NCT02217527|63021557|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
33620518|NCT02217527|63021558|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
33620519|NCT02217527|63021557|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
33620520|NCT02217527|63021558|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
33620521|NCT01456936|63021568|FG000|Overall Study|Other reason|41|||
33620522|NCT01456936|63021569|FG001|Overall Study|Other reason|30|||
33620523|NCT01456936|63021570|FG002|Overall Study|Other reason|36|||
33620524|NCT01456936|63021571|FG003|Overall Study|Other reason|33|||
33620525|NCT01456936|63021568|FG000|Overall Study|No longer meets eligibility criteria|4|||
33620526|NCT01456936|63021569|FG001|Overall Study|No longer meets eligibility criteria|8|||
33620527|NCT01456936|63021570|FG002|Overall Study|No longer meets eligibility criteria|6|||
33620528|NCT01456936|63021571|FG003|Overall Study|No longer meets eligibility criteria|5|||
33620529|NCT01456936|63021568|FG000|Overall Study|Protocol Violation|4|||
33620530|NCT01456936|63021569|FG001|Overall Study|Protocol Violation|2|||
33620531|NCT01456936|63021570|FG002|Overall Study|Protocol Violation|5|||
33620532|NCT01456936|63021571|FG003|Overall Study|Protocol Violation|5|||
33620533|NCT01456936|63021568|FG000|Overall Study|Pregnancy|1|||
33620534|NCT01456936|63021569|FG001|Overall Study|Pregnancy|0|||
33620535|NCT01456936|63021570|FG002|Overall Study|Pregnancy|0|||
33620536|NCT01456936|63021571|FG003|Overall Study|Pregnancy|1|||
33620537|NCT01456936|63021568|FG000|Overall Study|Insufficient clinical response|4|||
33620538|NCT01456936|63021569|FG001|Overall Study|Insufficient clinical response|4|||
33620539|NCT01456936|63021570|FG002|Overall Study|Insufficient clinical response|14|||
33620540|NCT01456936|63021571|FG003|Overall Study|Insufficient clinical response|13|||
33620541|NCT01456936|63021568|FG000|Overall Study|No longer willing to participate|195|||
33620542|NCT01456936|63021569|FG001|Overall Study|No longer willing to participate|218|||
33620543|NCT01456936|63021570|FG002|Overall Study|No longer willing to participate|224|||
33620544|NCT01456936|63021571|FG003|Overall Study|No longer willing to participate|248|||
33620545|NCT01456936|63021568|FG000|Overall Study|Lost to Follow-up|135|||
33620546|NCT01456936|63021569|FG001|Overall Study|Lost to Follow-up|126|||
33620547|NCT01456936|63021570|FG002|Overall Study|Lost to Follow-up|144|||
33620548|NCT01456936|63021571|FG003|Overall Study|Lost to Follow-up|127|||
33620549|NCT01456936|63021568|FG000|Overall Study|Medication error|0|||
33620550|NCT01456936|63021569|FG001|Overall Study|Medication error|1|||
33620551|NCT01456936|63021570|FG002|Overall Study|Medication error|0|||
33620552|NCT01456936|63021571|FG003|Overall Study|Medication error|1|||
33620553|NCT01456936|63021568|FG000|Overall Study|Adverse event (study drug)|25|||
33620554|NCT01456936|63021569|FG001|Overall Study|Adverse event (study drug)|21|||
33620555|NCT01456936|63021570|FG002|Overall Study|Adverse event (study drug)|26|||
33620556|NCT01456936|63021571|FG003|Overall Study|Adverse event (study drug)|17|||
33620557|NCT01456936|63021568|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
33620558|NCT01456936|63021569|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
33620559|NCT01456936|63021570|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
33620560|NCT01456936|63021571|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
33620561|NCT01456936|63021568|FG000|Overall Study|Death|0|||
33620562|NCT01456936|63021569|FG001|Overall Study|Death|3|||
33620563|NCT01456936|63021570|FG002|Overall Study|Death|1|||
33620564|NCT01456936|63021571|FG003|Overall Study|Death|3|||
33620565|NCT01456936|63021568|FG000|Overall Study|Randomized but not treated|21|||
33620566|NCT01456936|63021569|FG001|Overall Study|Randomized but not treated|28|||
33620567|NCT01456936|63021570|FG002|Overall Study|Randomized but not treated|16|||
33620568|NCT01456936|63021571|FG003|Overall Study|Randomized but not treated|21|||
33620569|NCT01456780|63021584|FG000|Overall Study|Lost to Follow-up|3|||
33620570|NCT01456780|63021585|FG001|Overall Study|Lost to Follow-up|3|||
33620571|NCT01456780|63021586|FG002|Overall Study|Lost to Follow-up|0|||
33620572|NCT01480258|63021596|FG000|Infant Series|Protocol Violation|2|||
33620573|NCT01480258|63021597|FG001|Infant Series|Protocol Violation|0|||
33620574|NCT01480258|63021596|FG000|Infant Series|Physician Decision|0|||
33620575|NCT01480258|63021597|FG001|Infant Series|Physician Decision|1|||
33620576|NCT01480258|63021596|FG000|Infant Series|Not Vaccinated|3|||
33620577|NCT01480258|63021597|FG001|Infant Series|Not Vaccinated|0|||
33620578|NCT01480258|63021596|FG000|Infant Series|Adverse Event|1|||
33620579|NCT01480258|63021597|FG001|Infant Series|Adverse Event|1|||
33526843|NCT00898677|62914324|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
33526844|NCT00898677|62914325|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
33526845|NCT00898677|62914322|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
33620580|NCT01480258|63021596|FG000|Infant Series|Withdrawal by Subject|1|||
33620581|NCT01480258|63021597|FG001|Infant Series|Withdrawal by Subject|6|||
33620582|NCT01480258|63021596|FG000|Interim Period|Lost to Follow-up|0|||
33620583|NCT01480258|63021597|FG001|Interim Period|Lost to Follow-up|2|||
33620584|NCT01480258|63021596|FG000|Interim Period|Physician Decision|1|||
33620585|NCT01480258|63021597|FG001|Interim Period|Physician Decision|0|||
33620586|NCT01480258|63021596|FG000|Interim Period|Protocol Violation|0|||
33620587|NCT01480258|63021597|FG001|Interim Period|Protocol Violation|1|||
33620588|NCT01480258|63021596|FG000|Interim Period|Withdrawal by Subject|9|||
33620589|NCT01480258|63021597|FG001|Interim Period|Withdrawal by Subject|6|||
33620590|NCT01479868|63021603|FG000|Overall Study|Adverse Event|1|||
33620591|NCT01479868|63021603|FG000|Overall Study|Lost to Follow-up|4|||
33620592|NCT01479868|63021603|FG000|Overall Study|Protocol Violation|1|||
33620593|NCT01479868|63021603|FG000|Overall Study|Withdrawal by Subject|1|||
33457244|NCT00091832|62831691|FG000|Overall Study|Noncompliance|0|||
33457245|NCT00091832|62831692|FG001|Overall Study|Noncompliance|1|||
33457246|NCT00091832|62831693|FG002|Overall Study|Noncompliance|0|||
33457247|NCT00091832|62831694|FG003|Overall Study|Noncompliance|0|||
33457248|NCT00091832|62831695|FG004|Overall Study|Noncompliance|0|||
33457249|NCT00091832|62831696|FG005|Overall Study|Noncompliance|0|||
33457250|NCT00091832|62831691|FG000|Overall Study|Other|0|||
33457251|NCT00091832|62831692|FG001|Overall Study|Other|1|||
33457252|NCT00091832|62831693|FG002|Overall Study|Other|2|||
33457253|NCT00091832|62831694|FG003|Overall Study|Other|0|||
33457254|NCT00091832|62831695|FG004|Overall Study|Other|0|||
33457255|NCT00091832|62831696|FG005|Overall Study|Other|0|||
33457256|NCT00091832|62831691|FG000|Overall Study|Protocol Violation|0|||
33457257|NCT00091832|62831692|FG001|Overall Study|Protocol Violation|0|||
33526846|NCT00898677|62914323|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
33526847|NCT00898677|62914324|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
33526848|NCT00898677|62914325|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
33526849|NCT00898677|62914322|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
33526850|NCT00898677|62914323|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
33526851|NCT00898677|62914324|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
33526852|NCT00898677|62914325|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
33526853|NCT00898677|62914322|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
33526854|NCT00898677|62914323|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
33526855|NCT00898677|62914324|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
33526856|NCT00898677|62914325|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
33526857|NCT00898677|62914322|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
33526858|NCT00898677|62914323|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
33526859|NCT00898677|62914324|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
33526860|NCT00898677|62914325|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
33526861|NCT00898677|62914322|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
33526862|NCT00898677|62914323|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
33526863|NCT00898677|62914324|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
33526864|NCT00898677|62914325|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
33526865|NCT02770820|62914335|FG000|Overall Study|Death|1|||
33526866|NCT02770820|62914335|FG000|Overall Study|Physician Decision|2|||
33526867|NCT03082729|62914339|FG000|Overall Study|Lost to Follow-up|7|||
33526868|NCT03082729|62914339|FG000|Overall Study|Physician Decision|2|||
33526869|NCT03082729|62914339|FG000|Overall Study|Withdrawal by Subject|1|||
33526870|NCT03082729|62914339|FG000|Overall Study|Lack of Efficacy|9|||
33526871|NCT03082729|62914339|FG000|Overall Study|Adverse Event|4|||
33620594|NCT01479868|63021603|FG000|Overall Study|Sponsor's Decision|1|||
33620595|NCT01479868|63021603|FG000|Overall Study|Initiation of new HCV Therapy|1|||
33620596|NCT01478620|63021607|FG000|Overall Study|Lost to Follow-up|6|||
33620597|NCT01455220|63021611|FG000|Overall Study|screen fail|30|||
33457258|NCT00091832|62831693|FG002|Overall Study|Protocol Violation|1|||
33457259|NCT00091832|62831694|FG003|Overall Study|Protocol Violation|0|||
33620598|NCT01454830|63021620|FG000|Overall Study|Withdrawal by Subject|4|||
33620599|NCT01454830|63021621|FG001|Overall Study|Withdrawal by Subject|4|||
33620600|NCT01454830|63021620|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
33620601|NCT01454830|63021621|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
33620602|NCT01454830|63021620|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
33620603|NCT01454830|63021621|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
33620604|NCT01454830|63021620|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
33620605|NCT01454830|63021621|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
33620606|NCT01454830|63021620|FG000|Overall Study|Withdrawal - no polysomnography|3|||
33620607|NCT01454830|63021621|FG001|Overall Study|Withdrawal - no polysomnography|2|||
33620608|NCT01454596|63021639|FG000|Overall Study|Death|0|||
33620609|NCT01454596|63021640|FG001|Overall Study|Death|0|||
33620610|NCT01454596|63021641|FG002|Overall Study|Death|0|||
33620611|NCT01454596|63021642|FG003|Overall Study|Death|0|||
33620612|NCT01454596|63021643|FG004|Overall Study|Death|0|||
33620613|NCT01454596|63021644|FG005|Overall Study|Death|0|||
33620614|NCT01454596|63021645|FG006|Overall Study|Death|0|||
33620615|NCT01454596|63021646|FG007|Overall Study|Death|0|||
33620616|NCT01454596|63021647|FG008|Overall Study|Death|0|||
33620617|NCT01454596|63021648|FG009|Overall Study|Death|1|||
33620618|NCT01454596|63021649|FG010|Overall Study|Death|1|||
33620619|NCT01454596|63021650|FG011|Overall Study|Death|0|||
33526872|NCT03082729|62914339|FG000|Overall Study|Protocol Violation|6|||
33526873|NCT03082729|62914339|FG000|Overall Study|Fear of study procedure|1|||
33620620|NCT02247479|63021679|FG000|Overall Study|Adverse Event|8|||
33620621|NCT02247479|63021680|FG001|Overall Study|Adverse Event|9|||
33620622|NCT02247479|63021681|FG002|Overall Study|Adverse Event|8|||
33620623|NCT02247479|63021679|FG000|Overall Study|Death|5|||
33620624|NCT02247479|63021680|FG001|Overall Study|Death|4|||
33620625|NCT02247479|63021681|FG002|Overall Study|Death|6|||
33620626|NCT02247479|63021679|FG000|Overall Study|Lost to Follow-up|3|||
33526874|NCT03082729|62914339|FG000|Overall Study|Scheduling conflict|1|||
33526875|NCT02764190|62914351|FG000|Overall Study|Lost to Follow-up|17|||
33526876|NCT02764190|62914352|FG001|Overall Study|Lost to Follow-up|13|||
33526877|NCT03077659|62914361|FG000|Overall Study|Withdrawal by Subject|0|||
33620627|NCT02247479|63021680|FG001|Overall Study|Lost to Follow-up|3|||
33620628|NCT02247479|63021681|FG002|Overall Study|Lost to Follow-up|1|||
33620629|NCT02247479|63021679|FG000|Overall Study|Non-compliance|0|||
33620630|NCT02247479|63021680|FG001|Overall Study|Non-compliance|0|||
33620631|NCT02247479|63021681|FG002|Overall Study|Non-compliance|1|||
33620632|NCT02247479|63021679|FG000|Overall Study|Withdrawal by Subject|25|||
33620633|NCT02247479|63021680|FG001|Overall Study|Withdrawal by Subject|29|||
33457260|NCT00091832|62831695|FG004|Overall Study|Protocol Violation|0|||
33457261|NCT00091832|62831696|FG005|Overall Study|Protocol Violation|1|||
33457262|NCT00391391|62831714|FG000|Overall Study|Adverse Event|0|||
33457263|NCT00391391|62831715|FG001|Overall Study|Adverse Event|0|||
33457264|NCT00391391|62831716|FG002|Overall Study|Adverse Event|0|||
33457265|NCT00391391|62831717|FG003|Overall Study|Adverse Event|1|||
33457266|NCT00391391|62831714|FG000|Overall Study|Lost to Follow-up|1|||
33457267|NCT00391391|62831715|FG001|Overall Study|Lost to Follow-up|3|||
33457268|NCT00391391|62831716|FG002|Overall Study|Lost to Follow-up|7|||
33457269|NCT00391391|62831717|FG003|Overall Study|Lost to Follow-up|4|||
33457270|NCT00391391|62831714|FG000|Overall Study|Protocol Violation|2|||
33457271|NCT00391391|62831715|FG001|Overall Study|Protocol Violation|3|||
33457272|NCT00391391|62831716|FG002|Overall Study|Protocol Violation|6|||
33526878|NCT03077659|62914362|FG001|Overall Study|Withdrawal by Subject|0|||
33526879|NCT03077659|62914363|FG002|Overall Study|Withdrawal by Subject|1|||
33526880|NCT02807883|62914374|FG000|Overall Study|Withdrawal by Subject|2|||
33526881|NCT03082261|62914378|FG000|Overall Study|Death|4|||
33526882|NCT03082261|62914378|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
33526883|NCT03082261|62914378|FG000|Overall Study|Insurance denial|1|||
33526884|NCT03082261|62914378|FG000|Overall Study|Peripheral lead added|1|||
33620634|NCT02247479|63021681|FG002|Overall Study|Withdrawal by Subject|24|||
33620635|NCT02247479|63021679|FG000|Overall Study|Study Terminated by Sponsor|98|||
33620636|NCT02247479|63021680|FG001|Overall Study|Study Terminated by Sponsor|88|||
33526885|NCT03082261|62914378|FG000|Overall Study|Withdrawal by Subject|40|||
33526886|NCT03082261|62914378|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
33620637|NCT02247479|63021681|FG002|Overall Study|Study Terminated by Sponsor|94|||
33620638|NCT02247479|63021679|FG000|Overall Study|Physician Decision|1|||
33457273|NCT00391391|62831717|FG003|Overall Study|Protocol Violation|7|||
33526887|NCT03082261|62914378|FG000|Overall Study|Subject implanted with device other than study device|1|||
33526888|NCT03082261|62914378|FG000|Overall Study|Lost to Follow-up|14|||
33620639|NCT02247479|63021680|FG001|Overall Study|Physician Decision|0|||
33620640|NCT02247479|63021681|FG002|Overall Study|Physician Decision|2|||
33620641|NCT02247479|63021679|FG000|Overall Study|Unspecified Reason|2|||
33620642|NCT02247479|63021680|FG001|Overall Study|Unspecified Reason|5|||
33620643|NCT02247479|63021681|FG002|Overall Study|Unspecified Reason|2|||
33620644|NCT01454284|63021691|FG000|Overall Study|Adverse Event|20|||
33620645|NCT01454284|63021692|FG001|Overall Study|Adverse Event|7|||
33620646|NCT01454284|63021691|FG000|Overall Study|Death|0|||
33620647|NCT01454284|63021692|FG001|Overall Study|Death|3|||
33620648|NCT01454284|63021691|FG000|Overall Study|Lost to Follow-up|13|||
33620649|NCT01454284|63021692|FG001|Overall Study|Lost to Follow-up|8|||
33620650|NCT01454284|63021691|FG000|Overall Study|Protocol Violation|9|||
33620651|NCT01454284|63021692|FG001|Overall Study|Protocol Violation|6|||
33620652|NCT01454284|63021691|FG000|Overall Study|Withdrawal by Subject|58|||
33620653|NCT01454284|63021692|FG001|Overall Study|Withdrawal by Subject|36|||
33620654|NCT01454284|63021691|FG000|Overall Study|Physician Decision|16|||
33620655|NCT01454284|63021692|FG001|Overall Study|Physician Decision|11|||
33620656|NCT01454284|63021691|FG000|Overall Study|Sponsor Decision|0|||
33620657|NCT01454284|63021692|FG001|Overall Study|Sponsor Decision|2|||
33620658|NCT02247401|63021701|FG000|Overall Study|Adverse Event|1|||
33620659|NCT02247401|63021702|FG001|Overall Study|Adverse Event|0|||
33620660|NCT02247401|63021703|FG002|Overall Study|Adverse Event|0|||
33620661|NCT02247401|63021701|FG000|Overall Study|Withdrawal by Subject|4|||
33620662|NCT02247401|63021702|FG001|Overall Study|Withdrawal by Subject|1|||
33620663|NCT02247401|63021703|FG002|Overall Study|Withdrawal by Subject|1|||
33620664|NCT02247401|63021701|FG000|Overall Study|Lost to Follow-up|1|||
33620665|NCT02247401|63021702|FG001|Overall Study|Lost to Follow-up|1|||
33620666|NCT02247401|63021703|FG002|Overall Study|Lost to Follow-up|1|||
33620667|NCT02247011|63021714|FG000|Overall Study|Poor quality of radiological results|125|||
33620668|NCT02246777|63021721|FG000|Overall Study|Adverse Event|2|||
33620669|NCT02246777|63021721|FG000|Overall Study|Change of residence|1|||
33620670|NCT01495702|63021732|FG000|Randomized Phase|Randomized But Not Treated|1|||
33620671|NCT01495702|63021733|FG001|Randomized Phase|Randomized But Not Treated|4|||
33620672|NCT01495702|63021732|FG000|Randomized Phase|Adverse Event|2|||
33620673|NCT01495702|63021733|FG001|Randomized Phase|Adverse Event|2|||
33620674|NCT01495702|63021732|FG000|Randomized Phase|Death|1|||
33620675|NCT01495702|63021733|FG001|Randomized Phase|Death|0|||
33620676|NCT01495702|63021732|FG000|Randomized Phase|Lack of Efficacy|2|||
33620677|NCT01495702|63021733|FG001|Randomized Phase|Lack of Efficacy|0|||
33620678|NCT01495702|63021732|FG000|Randomized Phase|Investigators Discretion|2|||
33620679|NCT01495702|63021733|FG001|Randomized Phase|Investigators Discretion|0|||
33620680|NCT01495702|63021732|FG000|Randomized Phase|Withdrew Consent|10|||
33620681|NCT01495702|63021733|FG001|Randomized Phase|Withdrew Consent|18|||
33620682|NCT01495702|63021732|FG000|Randomized Phase|Lost to Follow-up|4|||
33620683|NCT01495702|63021733|FG001|Randomized Phase|Lost to Follow-up|3|||
33620684|NCT01495702|63021732|FG000|Randomized Phase|Participant Noncompliance|1|||
33620685|NCT01495702|63021733|FG001|Randomized Phase|Participant Noncompliance|0|||
33620686|NCT01495702|63021732|FG000|Randomized Phase|Protocol Violation|3|||
33620687|NCT01495702|63021733|FG001|Randomized Phase|Protocol Violation|1|||
33620688|NCT01630889|63021740|FG000|Overall Study|Death|2|||
33620689|NCT01630889|63021740|FG000|Overall Study|Withdrawal by Subject|1|||
33620690|NCT01630889|63021740|FG000|Overall Study|Other than Specified|2|||
33620691|NCT01630889|63021740|FG000|Overall Study|Lost to Follow-up|4|||
33620692|NCT01630889|63021740|FG000|Overall Study|Other|1|||
33620693|NCT01495000|63021746|FG000|Overall Study|Lost to Follow-up|2|||
33620694|NCT01495000|63021747|FG001|Overall Study|Lost to Follow-up|2|||
33620695|NCT01495000|63021746|FG000|Overall Study|Protocol Violation|1|||
33620696|NCT01495000|63021747|FG001|Overall Study|Protocol Violation|0|||
33620697|NCT01495000|63021746|FG000|Overall Study|Withdrawal by Subject|10|||
33620698|NCT01495000|63021747|FG001|Overall Study|Withdrawal by Subject|10|||
33620699|NCT01494922|63021753|FG000|Overall Study|Adverse Event|1|||
33620700|NCT02192099|63021757|FG000|Overall Study|Adverse Event|1|||
33620701|NCT02192099|63021757|FG000|Overall Study|Lost to Follow-up|2|||
33620702|NCT02192099|63021757|FG000|Overall Study|Physician Decision|1|||
33620703|NCT02192099|63021757|FG000|Overall Study|Pregnancy|1|||
33457274|NCT00391391|62831714|FG000|Overall Study|Withdrawal by Subject|6|||
33457275|NCT00391391|62831715|FG001|Overall Study|Withdrawal by Subject|4|||
33457276|NCT00391391|62831716|FG002|Overall Study|Withdrawal by Subject|10|||
33457277|NCT00391391|62831717|FG003|Overall Study|Withdrawal by Subject|7|||
33457278|NCT00091442|62831729|FG000|Overall Study|Progressive Disease|220|||
33457279|NCT00091442|62831730|FG001|Overall Study|Progressive Disease|189|||
33457280|NCT00091442|62831729|FG000|Overall Study|Physician Decision|61|||
33457281|NCT00091442|62831730|FG001|Overall Study|Physician Decision|58|||
33457282|NCT00091442|62831729|FG000|Overall Study|Withdrawal by Subject|38|||
33457283|NCT00091442|62831730|FG001|Overall Study|Withdrawal by Subject|46|||
33457284|NCT00091442|62831729|FG000|Overall Study|Adverse Event|29|||
33457285|NCT00091442|62831730|FG001|Overall Study|Adverse Event|48|||
33457286|NCT00091442|62831729|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
33457287|NCT00091442|62831730|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
33457288|NCT00091442|62831729|FG000|Overall Study|Death|9|||
33620704|NCT02192099|63021757|FG000|Overall Study|Protocol Violation|8|||
33620705|NCT02192099|63021757|FG000|Overall Study|Study Terminated by Sponsor|32|||
33620706|NCT02192099|63021757|FG000|Overall Study|Withdrawal by Subject|11|||
33620707|NCT02192099|63021757|FG000|Overall Study|Miscellaneous Reasons|5|||
33620708|NCT01494610|63021761|FG000|Period 1|Withdrawal by Subject|1|||
33620709|NCT01494610|63021762|FG001|Period 1|Withdrawal by Subject|1|||
33620710|NCT01494610|63021761|FG000|Period 3|Adverse Event|1|||
33620711|NCT01494610|63021762|FG001|Period 3|Adverse Event|0|||
33620712|NCT01494610|63021761|FG000|Period 3|Withdrawal by Subject|1|||
33620713|NCT01494610|63021762|FG001|Period 3|Withdrawal by Subject|0|||
33620714|NCT01494610|63021761|FG000|Period 4|Protocol Violation|1|||
33620715|NCT01494610|63021762|FG001|Period 4|Protocol Violation|0|||
33620716|NCT02116777|63021781|FG000|Overall Study|Adverse Event|0|||
33620717|NCT02116777|63021782|FG001|Overall Study|Adverse Event|0|||
33620718|NCT02116777|63021783|FG002|Overall Study|Adverse Event|0|||
33620719|NCT02116777|63021784|FG003|Overall Study|Adverse Event|0|||
33620720|NCT02116777|63021785|FG004|Overall Study|Adverse Event|2|||
33620721|NCT02116777|63021786|FG005|Overall Study|Adverse Event|2|||
33620722|NCT02116777|63021787|FG006|Overall Study|Adverse Event|0|||
33620723|NCT02116777|63021781|FG000|Overall Study|Death|0|||
33620724|NCT02116777|63021782|FG001|Overall Study|Death|0|||
33620725|NCT02116777|63021783|FG002|Overall Study|Death|0|||
33620726|NCT02116777|63021784|FG003|Overall Study|Death|1|||
33620727|NCT02116777|63021785|FG004|Overall Study|Death|0|||
33620728|NCT02116777|63021786|FG005|Overall Study|Death|0|||
33620729|NCT02116777|63021787|FG006|Overall Study|Death|0|||
33620730|NCT02116777|63021781|FG000|Overall Study|Lack of Efficacy|3|||
33620731|NCT02116777|63021782|FG001|Overall Study|Lack of Efficacy|3|||
33620732|NCT02116777|63021783|FG002|Overall Study|Lack of Efficacy|3|||
33620733|NCT02116777|63021784|FG003|Overall Study|Lack of Efficacy|8|||
33620734|NCT02116777|63021785|FG004|Overall Study|Lack of Efficacy|4|||
33620735|NCT02116777|63021786|FG005|Overall Study|Lack of Efficacy|1|||
33620736|NCT02116777|63021787|FG006|Overall Study|Lack of Efficacy|9|||
33620737|NCT02116777|63021781|FG000|Overall Study|Physician Decision|0|||
33620738|NCT02116777|63021782|FG001|Overall Study|Physician Decision|0|||
33620739|NCT02116777|63021783|FG002|Overall Study|Physician Decision|0|||
33620740|NCT02116777|63021784|FG003|Overall Study|Physician Decision|2|||
33620741|NCT02116777|63021785|FG004|Overall Study|Physician Decision|0|||
33620742|NCT02116777|63021786|FG005|Overall Study|Physician Decision|0|||
33526889|NCT03082261|62914378|FG000|Overall Study|Subject moved to a different state|1|||
33526890|NCT03082261|62914378|FG000|Overall Study|Subject non-compliance|2|||
33526891|NCT03082261|62914378|FG000|Overall Study|Subject participation terminated by investigator|9|||
33526892|NCT03082261|62914378|FG000|Overall Study|Subject participation terminated by sponsor|4|||
33526893|NCT03082261|62914378|FG000|Overall Study|System explant|19|||
33526894|NCT03082261|62914378|FG000|Overall Study|Unable to place lead(s)|2|||
33526895|NCT03082261|62914378|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
33526896|NCT00102440|62914385|FG000|Overall Study|Lost to Follow-up|25|||
33526897|NCT00102440|62914386|FG001|Overall Study|Lost to Follow-up|18|||
33526898|NCT00102440|62914387|FG002|Overall Study|Lost to Follow-up|21|||
33526899|NCT00102440|62914385|FG000|Overall Study|Adverse Event|16|||
33526900|NCT00102440|62914386|FG001|Overall Study|Adverse Event|23|||
33526901|NCT00102440|62914387|FG002|Overall Study|Adverse Event|8|||
33526902|NCT00102440|62914385|FG000|Overall Study|Gout Flare|10|||
33526903|NCT00102440|62914386|FG001|Overall Study|Gout Flare|28|||
33526904|NCT00102440|62914387|FG002|Overall Study|Gout Flare|9|||
33526905|NCT00102440|62914385|FG000|Overall Study|Personal Reason(s)|19|||
33526906|NCT00102440|62914386|FG001|Overall Study|Personal Reason(s)|13|||
33526907|NCT00102440|62914387|FG002|Overall Study|Personal Reason(s)|13|||
33526908|NCT00102440|62914385|FG000|Overall Study|Other|11|||
33526909|NCT00102440|62914386|FG001|Overall Study|Other|14|||
33526910|NCT00102440|62914387|FG002|Overall Study|Other|14|||
33526911|NCT00102440|62914385|FG000|Overall Study|Protocol Violation|7|||
33526912|NCT00102440|62914386|FG001|Overall Study|Protocol Violation|2|||
33526913|NCT00102440|62914387|FG002|Overall Study|Protocol Violation|1|||
33620743|NCT02116777|63021787|FG006|Overall Study|Physician Decision|0|||
33620744|NCT02116777|63021781|FG000|Overall Study|Protocol Violation|0|||
33620745|NCT02116777|63021782|FG001|Overall Study|Protocol Violation|0|||
33620746|NCT02116777|63021783|FG002|Overall Study|Protocol Violation|0|||
33620747|NCT02116777|63021784|FG003|Overall Study|Protocol Violation|1|||
33620748|NCT02116777|63021785|FG004|Overall Study|Protocol Violation|0|||
33620749|NCT02116777|63021786|FG005|Overall Study|Protocol Violation|0|||
33526914|NCT02762084|62914411|FG000|Overall Study|Withdrawal by Subject|1|||
33526915|NCT02762084|62914412|FG001|Overall Study|Withdrawal by Subject|0|||
33526916|NCT02762084|62914413|FG002|Overall Study|Withdrawal by Subject|0|||
33526917|NCT02762084|62914411|FG000|Overall Study|Adverse Event|0|||
33526918|NCT02762084|62914412|FG001|Overall Study|Adverse Event|0|||
33526919|NCT02762084|62914413|FG002|Overall Study|Adverse Event|1|||
33620750|NCT02116777|63021787|FG006|Overall Study|Protocol Violation|0|||
33620751|NCT02116777|63021781|FG000|Overall Study|Withdrawal by Subject|0|||
33620752|NCT02116777|63021782|FG001|Overall Study|Withdrawal by Subject|0|||
33620753|NCT02116777|63021783|FG002|Overall Study|Withdrawal by Subject|0|||
33620754|NCT02116777|63021784|FG003|Overall Study|Withdrawal by Subject|1|||
33620755|NCT02116777|63021785|FG004|Overall Study|Withdrawal by Subject|0|||
33620756|NCT02116777|63021786|FG005|Overall Study|Withdrawal by Subject|0|||
33620757|NCT02116777|63021787|FG006|Overall Study|Withdrawal by Subject|0|||
33620758|NCT01494532|63021812|FG000|Overall Study|Adverse Event|4|||
33620759|NCT01494532|63021813|FG001|Overall Study|Adverse Event|1|||
33620760|NCT01494532|63021814|FG002|Overall Study|Adverse Event|8|||
33620761|NCT01494532|63021815|FG003|Overall Study|Adverse Event|6|||
33620762|NCT01494532|63021816|FG004|Overall Study|Adverse Event|5|||
33620763|NCT01494532|63021817|FG005|Overall Study|Adverse Event|0|||
33620764|NCT01494532|63021812|FG000|Overall Study|Lack of Efficacy|0|||
33620765|NCT01494532|63021813|FG001|Overall Study|Lack of Efficacy|0|||
33620766|NCT01494532|63021814|FG002|Overall Study|Lack of Efficacy|0|||
33620767|NCT01494532|63021815|FG003|Overall Study|Lack of Efficacy|0|||
33620768|NCT01494532|63021816|FG004|Overall Study|Lack of Efficacy|2|||
33620769|NCT01494532|63021817|FG005|Overall Study|Lack of Efficacy|0|||
33620770|NCT01494532|63021812|FG000|Overall Study|Protocol deviation|2|||
33620771|NCT01494532|63021813|FG001|Overall Study|Protocol deviation|1|||
33620772|NCT01494532|63021814|FG002|Overall Study|Protocol deviation|3|||
33526920|NCT02763644|62914425|FG000|Overall Study|Patient/guardian decision|1|||
33526921|NCT02763644|62914426|FG001|Overall Study|Patient/guardian decision|0|||
33526922|NCT02763644|62914425|FG000|Overall Study|Death|1|||
33526923|NCT02763644|62914426|FG001|Overall Study|Death|1|||
33526924|NCT02763644|62914425|FG000|Overall Study|Adverse Event|1|||
33526925|NCT02763644|62914426|FG001|Overall Study|Adverse Event|1|||
33526926|NCT02807844|62914444|FG000|Overall Study|Physician Decision|0|||
33526927|NCT02807844|62914445|FG001|Overall Study|Physician Decision|0|||
33526928|NCT02807844|62914446|FG002|Overall Study|Physician Decision|0|||
33526929|NCT02807844|62914447|FG003|Overall Study|Physician Decision|0|||
33526930|NCT02807844|62914448|FG004|Overall Study|Physician Decision|0|||
33526931|NCT02807844|62914449|FG005|Overall Study|Physician Decision|0|||
33526932|NCT02807844|62914450|FG006|Overall Study|Physician Decision|3|||
33526933|NCT02807844|62914451|FG007|Overall Study|Physician Decision|0|||
33526934|NCT02807844|62914452|FG008|Overall Study|Physician Decision|1|||
33526935|NCT02807844|62914453|FG009|Overall Study|Physician Decision|2|||
33526936|NCT02807844|62914444|FG000|Overall Study|Death|0|||
33526937|NCT02807844|62914445|FG001|Overall Study|Death|0|||
33526938|NCT02807844|62914446|FG002|Overall Study|Death|2|||
33526939|NCT02807844|62914447|FG003|Overall Study|Death|4|||
33526940|NCT02807844|62914448|FG004|Overall Study|Death|1|||
33526941|NCT02807844|62914449|FG005|Overall Study|Death|2|||
33526942|NCT02807844|62914450|FG006|Overall Study|Death|1|||
33526943|NCT02807844|62914451|FG007|Overall Study|Death|2|||
33526944|NCT02807844|62914452|FG008|Overall Study|Death|0|||
33526945|NCT02807844|62914453|FG009|Overall Study|Death|1|||
33526946|NCT02807844|62914444|FG000|Overall Study|Withdrawal by Subject|0|||
33526947|NCT02807844|62914445|FG001|Overall Study|Withdrawal by Subject|0|||
33526948|NCT02807844|62914446|FG002|Overall Study|Withdrawal by Subject|2|||
33620773|NCT01494532|63021815|FG003|Overall Study|Protocol deviation|2|||
33620774|NCT01494532|63021816|FG004|Overall Study|Protocol deviation|3|||
33620775|NCT01494532|63021817|FG005|Overall Study|Protocol deviation|0|||
33620776|NCT01494532|63021812|FG000|Overall Study|Protocol-defined stopping criteria|0|||
33620777|NCT01494532|63021813|FG001|Overall Study|Protocol-defined stopping criteria|0|||
33620778|NCT01494532|63021814|FG002|Overall Study|Protocol-defined stopping criteria|1|||
33457289|NCT00091442|62831730|FG001|Overall Study|Death|7|||
33457290|NCT00091442|62831729|FG000|Overall Study|Lost to Follow-up|1|||
33457291|NCT00091442|62831730|FG001|Overall Study|Lost to Follow-up|3|||
33457292|NCT00091442|62831729|FG000|Overall Study|Other|2|||
33457293|NCT00091442|62831730|FG001|Overall Study|Other|6|||
33457294|NCT00390689|62831739|FG000|Overall Study|Adverse Event|2|||
33457295|NCT00390689|62831740|FG001|Overall Study|Adverse Event|5|||
33457296|NCT00390689|62831741|FG002|Overall Study|Adverse Event|2|||
33457297|NCT00390689|62831739|FG000|Overall Study|Lack of Efficacy|0|||
33457298|NCT00390689|62831740|FG001|Overall Study|Lack of Efficacy|0|||
33457299|NCT00390689|62831741|FG002|Overall Study|Lack of Efficacy|1|||
33620779|NCT01494532|63021815|FG003|Overall Study|Protocol-defined stopping criteria|0|||
33620780|NCT01494532|63021816|FG004|Overall Study|Protocol-defined stopping criteria|0|||
33526949|NCT02807844|62914447|FG003|Overall Study|Withdrawal by Subject|1|||
33526950|NCT02807844|62914448|FG004|Overall Study|Withdrawal by Subject|1|||
33526951|NCT02807844|62914449|FG005|Overall Study|Withdrawal by Subject|0|||
33620781|NCT01494532|63021817|FG005|Overall Study|Protocol-defined stopping criteria|0|||
33457300|NCT00390689|62831739|FG000|Overall Study|Protocol Violation|1|||
33526952|NCT02807844|62914450|FG006|Overall Study|Withdrawal by Subject|1|||
33526953|NCT02807844|62914451|FG007|Overall Study|Withdrawal by Subject|0|||
33526954|NCT02807844|62914452|FG008|Overall Study|Withdrawal by Subject|0|||
33526955|NCT02807844|62914453|FG009|Overall Study|Withdrawal by Subject|0|||
33526956|NCT02807844|62914444|FG000|Overall Study|Progressive disease|5|||
33526957|NCT02807844|62914445|FG001|Overall Study|Progressive disease|12|||
33457301|NCT00390689|62831740|FG001|Overall Study|Protocol Violation|0|||
33457302|NCT00390689|62831741|FG002|Overall Study|Protocol Violation|0|||
33526958|NCT02807844|62914446|FG002|Overall Study|Progressive disease|8|||
33526959|NCT02807844|62914447|FG003|Overall Study|Progressive disease|8|||
33620782|NCT01494532|63021812|FG000|Overall Study|Lost to Follow-up|1|||
33620783|NCT01494532|63021813|FG001|Overall Study|Lost to Follow-up|0|||
33620784|NCT01494532|63021814|FG002|Overall Study|Lost to Follow-up|0|||
33620785|NCT01494532|63021815|FG003|Overall Study|Lost to Follow-up|2|||
33620786|NCT01494532|63021816|FG004|Overall Study|Lost to Follow-up|0|||
33620787|NCT01494532|63021817|FG005|Overall Study|Lost to Follow-up|0|||
33620788|NCT01494532|63021812|FG000|Overall Study|Physician Decision|0|||
33620789|NCT01494532|63021813|FG001|Overall Study|Physician Decision|1|||
33620790|NCT01494532|63021814|FG002|Overall Study|Physician Decision|1|||
33620791|NCT01494532|63021815|FG003|Overall Study|Physician Decision|2|||
33620792|NCT01494532|63021816|FG004|Overall Study|Physician Decision|0|||
33620793|NCT01494532|63021817|FG005|Overall Study|Physician Decision|0|||
33620794|NCT01494532|63021812|FG000|Overall Study|Withdrawal by Subject|3|||
33620795|NCT01494532|63021813|FG001|Overall Study|Withdrawal by Subject|1|||
33620796|NCT01494532|63021814|FG002|Overall Study|Withdrawal by Subject|4|||
33620797|NCT01494532|63021815|FG003|Overall Study|Withdrawal by Subject|3|||
33620798|NCT01494532|63021816|FG004|Overall Study|Withdrawal by Subject|2|||
33620799|NCT01494532|63021817|FG005|Overall Study|Withdrawal by Subject|0|||
33620800|NCT02191397|63021834|FG000|Overall Study|Adverse Event|28|||
33620801|NCT02191397|63021835|FG001|Overall Study|Adverse Event|17|||
33620802|NCT02191397|63021834|FG000|Overall Study|Lack of Efficacy|10|||
33620803|NCT02191397|63021835|FG001|Overall Study|Lack of Efficacy|5|||
33620804|NCT02191397|63021834|FG000|Overall Study|Protocol Violation|0|||
33620805|NCT02191397|63021835|FG001|Overall Study|Protocol Violation|3|||
33620806|NCT02191397|63021834|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
33526960|NCT02807844|62914448|FG004|Overall Study|Progressive disease|3|||
33526961|NCT02807844|62914449|FG005|Overall Study|Progressive disease|8|||
33526962|NCT02807844|62914450|FG006|Overall Study|Progressive disease|14|||
33526963|NCT02807844|62914451|FG007|Overall Study|Progressive disease|17|||
33526964|NCT02807844|62914452|FG008|Overall Study|Progressive disease|19|||
33526965|NCT02807844|62914453|FG009|Overall Study|Progressive disease|15|||
33526966|NCT02807844|62914444|FG000|Overall Study|Adverse Event|1|||
33526967|NCT02807844|62914445|FG001|Overall Study|Adverse Event|0|||
33526968|NCT02807844|62914446|FG002|Overall Study|Adverse Event|0|||
33526969|NCT02807844|62914447|FG003|Overall Study|Adverse Event|0|||
33526970|NCT02807844|62914448|FG004|Overall Study|Adverse Event|1|||
33526971|NCT02807844|62914449|FG005|Overall Study|Adverse Event|1|||
33526972|NCT02807844|62914450|FG006|Overall Study|Adverse Event|1|||
33526973|NCT02807844|62914451|FG007|Overall Study|Adverse Event|1|||
33526974|NCT02807844|62914452|FG008|Overall Study|Adverse Event|1|||
33526975|NCT02807844|62914453|FG009|Overall Study|Adverse Event|2|||
33526976|NCT02763254|62914479|FG000|Overall Study|Adverse Event|1|||
33526977|NCT02805972|62914485|FG000|Washout Period|Lost to Follow-up|3|||
33526978|NCT02805972|62914486|FG001|Washout Period|Lost to Follow-up|0|||
33526979|NCT03032523|62914504|FG000|Overall Study|Withdrawal by Subject|2|||
33526980|NCT03032523|62914505|FG001|Overall Study|Withdrawal by Subject|2|||
33526981|NCT03032523|62914504|FG000|Overall Study|Physician Decision|1|||
33526982|NCT03032523|62914505|FG001|Overall Study|Physician Decision|0|||
33526983|NCT03031899|62914512|FG000|Overall Study|Protocol Violation|1|||
33526984|NCT03031899|62914512|FG000|Overall Study|lesion disappeared after stopping habit|1|||
33526985|NCT03086369|62914525|FG000|Overall Study|Lost to Follow-up|1|||
33526986|NCT03086369|62914526|FG001|Overall Study|Lost to Follow-up|0|||
33526987|NCT03086369|62914527|FG002|Overall Study|Lost to Follow-up|0|||
33526988|NCT03086369|62914528|FG003|Overall Study|Lost to Follow-up|2|||
33526989|NCT03086369|62914529|FG004|Overall Study|Lost to Follow-up|1|||
33526990|NCT03086369|62914525|FG000|Overall Study|Physician Decision|0|||
33526991|NCT03086369|62914526|FG001|Overall Study|Physician Decision|0|||
33526992|NCT03086369|62914527|FG002|Overall Study|Physician Decision|0|||
33526993|NCT03086369|62914528|FG003|Overall Study|Physician Decision|1|||
33526994|NCT03086369|62914529|FG004|Overall Study|Physician Decision|2|||
33526995|NCT03086369|62914525|FG000|Overall Study|Withdrawal by Subject|0|||
33526996|NCT03086369|62914526|FG001|Overall Study|Withdrawal by Subject|0|||
33526997|NCT03086369|62914527|FG002|Overall Study|Withdrawal by Subject|0|||
33526998|NCT03086369|62914528|FG003|Overall Study|Withdrawal by Subject|5|||
33526999|NCT03086369|62914529|FG004|Overall Study|Withdrawal by Subject|3|||
33527000|NCT03086369|62914525|FG000|Overall Study|Progressive Disease|0|||
33527001|NCT03086369|62914526|FG001|Overall Study|Progressive Disease|0|||
33527002|NCT03086369|62914527|FG002|Overall Study|Progressive Disease|0|||
33527003|NCT03086369|62914528|FG003|Overall Study|Progressive Disease|1|||
33527004|NCT03086369|62914529|FG004|Overall Study|Progressive Disease|1|||
33527005|NCT00101582|62914545|FG000|Overall Study|Ineligibility determined|0|||
33527006|NCT00101582|62914546|FG001|Overall Study|Ineligibility determined|1|||
33527007|NCT00101582|62914545|FG000|Overall Study|Adverse Event|1|||
33527008|NCT00101582|62914546|FG001|Overall Study|Adverse Event|4|||
33527009|NCT00101582|62914545|FG000|Overall Study|Withdrawal by Subject|6|||
33527010|NCT00101582|62914546|FG001|Overall Study|Withdrawal by Subject|4|||
33527011|NCT00101582|62914545|FG000|Overall Study|Physician Decision|1|||
33527012|NCT00101582|62914546|FG001|Overall Study|Physician Decision|0|||
33527013|NCT00101582|62914545|FG000|Overall Study|Death|3|||
33527014|NCT00101582|62914546|FG001|Overall Study|Death|5|||
33527015|NCT00101582|62914545|FG000|Overall Study|Other|0|||
33527016|NCT00101582|62914546|FG001|Overall Study|Other|1|||
33620807|NCT02191397|63021835|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
33620808|NCT02191397|63021834|FG000|Overall Study|Lost to Follow-up|10|||
33620809|NCT02191397|63021835|FG001|Overall Study|Lost to Follow-up|11|||
33620810|NCT02191397|63021834|FG000|Overall Study|Physician Decision|8|||
33620811|NCT02191397|63021835|FG001|Overall Study|Physician Decision|3|||
33620812|NCT02191397|63021834|FG000|Overall Study|Withdrawal by Subject|22|||
33620813|NCT02191397|63021835|FG001|Overall Study|Withdrawal by Subject|27|||
33620814|NCT01630811|63021841|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
33620815|NCT01630811|63021842|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
33620816|NCT01494298|63021852|FG000|Overall Study|Protocol Violation|2|||
33527017|NCT03086135|62914577|FG000|Overall Study|Adverse Event|1|||
33527018|NCT03086135|62914577|FG000|Overall Study|Lost to Follow-up|2|||
33527019|NCT02762708|62914594|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
33527020|NCT02762708|62914595|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
33527021|NCT02762708|62914596|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
33527022|NCT02762708|62914597|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
33527023|NCT02760602|62914609|FG000|Overall Study|Withdrawal by Subject|1|||
33527024|NCT02760602|62914610|FG001|Overall Study|Withdrawal by Subject|0|||
33527025|NCT02760602|62914609|FG000|Overall Study|Terminated by sponsor|12|||
33527026|NCT02760602|62914610|FG001|Overall Study|Terminated by sponsor|13|||
33527027|NCT03852719|62914619|FG000|Overall Study|Still on study|50|||
33527028|NCT03852719|62914620|FG001|Overall Study|Still on study|48|||
33527029|NCT03852719|62914621|FG002|Overall Study|Still on study|47|||
33527030|NCT03852719|62914619|FG000|Overall Study|Withdrawal of consent|0|||
33527031|NCT03852719|62914620|FG001|Overall Study|Withdrawal of consent|1|||
33527032|NCT03852719|62914621|FG002|Overall Study|Withdrawal of consent|2|||
33527033|NCT03852719|62914619|FG000|Overall Study|Physician Decision|0|||
33527034|NCT03852719|62914620|FG001|Overall Study|Physician Decision|0|||
33527035|NCT03852719|62914621|FG002|Overall Study|Physician Decision|1|||
33527036|NCT03852719|62914619|FG000|Overall Study|Pregnancy|1|||
33527037|NCT03852719|62914620|FG001|Overall Study|Pregnancy|0|||
33527038|NCT03852719|62914621|FG002|Overall Study|Pregnancy|0|||
33527039|NCT00210249|62914629|FG000|Overall Study|Lost to Follow-up|5|||
33527040|NCT00210249|62914629|FG000|Overall Study|Protocol Violation|11|||
33527041|NCT03086057|62914637|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
33527042|NCT03086057|62914638|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
33620817|NCT01494298|63021853|FG001|Overall Study|Protocol Violation|8|||
33620818|NCT02170025|63021863|FG000|Overall Study|Adverse Event|2|||
33620819|NCT02170025|63021864|FG001|Overall Study|Adverse Event|0|||
33620820|NCT02169791|63021870|FG000|Overall Study|Death|6|||
33620821|NCT02169791|63021870|FG000|Overall Study|patient withdrew consent|1|||
33620822|NCT02216591|63021876|FG000|Overall Study|Lost to Follow-up|0|||
33620823|NCT02216591|63021877|FG001|Overall Study|Lost to Follow-up|1|||
33620824|NCT02216357|63021885|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
33620825|NCT02216357|63021886|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
33620826|NCT01492426|63021894|FG000|Treatment|Death|0|||
33620827|NCT01492426|63021895|FG001|Treatment|Death|1|||
33620828|NCT01492426|63021894|FG000|Treatment|Other|1|||
33620829|NCT01492426|63021895|FG001|Treatment|Other|0|||
33620830|NCT01492426|63021894|FG000|Treatment|Adverse Event|25|||
33620831|NCT01492426|63021895|FG001|Treatment|Adverse Event|25|||
33620832|NCT01492426|63021894|FG000|Treatment|Lack of Efficacy|38|||
33457303|NCT00390689|62831739|FG000|Overall Study|Investigator's judgement|2|||
33457304|NCT00390689|62831740|FG001|Overall Study|Investigator's judgement|0|||
33457305|NCT00390689|62831741|FG002|Overall Study|Investigator's judgement|0|||
33457306|NCT00121238|62831758|FG000|Overall Study|disease progression before intervention|1|||
33457307|NCT00121238|62831758|FG000|Overall Study|Protocol Violation|2|||
33457308|NCT00390455|62831764|FG000|Overall Study|Adverse Event|17|||
33457309|NCT00390455|62831765|FG001|Overall Study|Adverse Event|3|||
33457310|NCT00390455|62831764|FG000|Overall Study|Withdrawal by Subject|8|||
33457311|NCT00390455|62831765|FG001|Overall Study|Withdrawal by Subject|8|||
33457312|NCT00390455|62831764|FG000|Overall Study|Alternate Treatment|0|||
33457313|NCT00390455|62831765|FG001|Overall Study|Alternate Treatment|1|||
33457314|NCT00390455|62831764|FG000|Overall Study|Other Medical Reasons|7|||
33527043|NCT03086057|62914639|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
33527044|NCT03086057|62914640|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
33527045|NCT03086057|62914637|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
33527046|NCT03086057|62914638|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
33620833|NCT01492426|63021895|FG001|Treatment|Lack of Efficacy|5|||
33620834|NCT01492426|63021894|FG000|Treatment|Participant withdrew consent|1|||
33527047|NCT03086057|62914639|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
33527048|NCT03086057|62914640|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
33620835|NCT01492426|63021895|FG001|Treatment|Participant withdrew consent|2|||
33620836|NCT01492426|63021894|FG000|Treatment|Poor compliance/noncompliance|1|||
33620837|NCT01492426|63021895|FG001|Treatment|Poor compliance/noncompliance|0|||
33620838|NCT01492426|63021894|FG000|Treatment|Subject requested discontinue study drug|7|||
33620839|NCT01492426|63021895|FG001|Treatment|Subject requested discontinue study drug|3|||
33620840|NCT01492426|63021894|FG000|Treatment|Lost to Follow-up|9|||
33620841|NCT01492426|63021895|FG001|Treatment|Lost to Follow-up|4|||
33620842|NCT01492426|63021894|FG000|Treatment|Participant does not meet study criteria|1|||
33620843|NCT01492426|63021895|FG001|Treatment|Participant does not meet study criteria|0|||
33620844|NCT01492426|63021894|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
33620845|NCT01492426|63021895|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
33620846|NCT01492426|63021894|FG000|Follow-Up|Death|1|||
33620847|NCT01492426|63021895|FG001|Follow-Up|Death|0|||
33620848|NCT01492426|63021894|FG000|Follow-Up|Other|4|||
33620849|NCT01492426|63021895|FG001|Follow-Up|Other|2|||
33620850|NCT01492426|63021894|FG000|Follow-Up|Participant Withdrew Consent|6|||
33620851|NCT01492426|63021895|FG001|Follow-Up|Participant Withdrew Consent|1|||
33620852|NCT01492426|63021894|FG000|Follow-Up|Lost to Follow-up|12|||
33620853|NCT01492426|63021895|FG001|Follow-Up|Lost to Follow-up|6|||
33620854|NCT01453348|63021908|FG000|Overall Study|Death|0|||
33620855|NCT01453348|63021909|FG001|Overall Study|Death|0|||
33620856|NCT01453348|63021910|FG002|Overall Study|Death|1|||
33620857|NCT01453348|63021908|FG000|Overall Study|Withdrawal by Subject|0|||
33620858|NCT01453348|63021909|FG001|Overall Study|Withdrawal by Subject|1|||
33620859|NCT01453348|63021910|FG002|Overall Study|Withdrawal by Subject|0|||
33620860|NCT01453348|63021908|FG000|Overall Study|Protocol Violation|1|||
33620861|NCT01453348|63021909|FG001|Overall Study|Protocol Violation|0|||
33620862|NCT01453348|63021910|FG002|Overall Study|Protocol Violation|0|||
33620863|NCT01453036|63021924|FG000|Overall Study|Lost to Follow-up|26|||
33620864|NCT01453036|63021925|FG001|Overall Study|Lost to Follow-up|115|||
33620865|NCT01453036|63021926|FG002|Overall Study|Lost to Follow-up|31|||
33620866|NCT01475734|63021936|FG000|Overall Study|Withdrawal by Subject|1|||
33620867|NCT01475734|63021937|FG001|Overall Study|Withdrawal by Subject|0|||
33620868|NCT01475734|63021936|FG000|Overall Study|Protocol Violation|1|||
33620869|NCT01475734|63021937|FG001|Overall Study|Protocol Violation|0|||
33620870|NCT01475734|63021936|FG000|Overall Study|Physician Decision|0|||
33620871|NCT01475734|63021937|FG001|Overall Study|Physician Decision|1|||
33620872|NCT01452412|63021945|FG000|Overall Study|Withdrawal by Subject|15|||
33620873|NCT01452412|63021946|FG001|Overall Study|Withdrawal by Subject|11|||
33620874|NCT01452412|63021945|FG000|Overall Study|Adverse Event|4|||
33620875|NCT01452412|63021946|FG001|Overall Study|Adverse Event|3|||
33620876|NCT01452412|63021945|FG000|Overall Study|Lost to Follow-up|5|||
33620877|NCT01452412|63021946|FG001|Overall Study|Lost to Follow-up|3|||
33620878|NCT01452412|63021945|FG000|Overall Study|Death|1|||
33620879|NCT01452412|63021946|FG001|Overall Study|Death|0|||
33620880|NCT01452412|63021945|FG000|Overall Study|Initiated dialysis|1|||
33620881|NCT01452412|63021946|FG001|Overall Study|Initiated dialysis|0|||
33620882|NCT01452412|63021945|FG000|Overall Study|Other|2|||
33620883|NCT01452412|63021946|FG001|Overall Study|Other|0|||
33620884|NCT01474876|63021955|FG000|Overall Study|Adverse Event|11|||
33620885|NCT01474876|63021956|FG001|Overall Study|Adverse Event|5|||
33620886|NCT01474876|63021957|FG002|Overall Study|Adverse Event|0|||
33620887|NCT01474876|63021955|FG000|Overall Study|Serious Adverse Event|2|||
33620888|NCT01474876|63021956|FG001|Overall Study|Serious Adverse Event|3|||
33457315|NCT00390455|62831765|FG001|Overall Study|Other Medical Reasons|11|||
33457316|NCT03812510|62831771|FG000|Overall Study|Lost to Follow-up|39|||
33457317|NCT03812510|62831771|FG000|Overall Study|Withdrawal by Subject|42|||
33457318|NCT03812510|62831771|FG000|Overall Study|Physician Decision|2|||
33457319|NCT03812510|62831771|FG000|Overall Study|Study Terminated by Sponsor|9|||
33620889|NCT01474876|63021957|FG002|Overall Study|Serious Adverse Event|0|||
33620890|NCT01474876|63021955|FG000|Overall Study|Lost to Follow-up|5|||
33620891|NCT01474876|63021956|FG001|Overall Study|Lost to Follow-up|4|||
33620892|NCT01474876|63021957|FG002|Overall Study|Lost to Follow-up|0|||
33620893|NCT01474876|63021955|FG000|Overall Study|Investigator's decision|28|||
33620894|NCT01474876|63021956|FG001|Overall Study|Investigator's decision|6|||
33457320|NCT03812510|62831771|FG000|Overall Study|Did Not Start Study Medication|55|||
33620895|NCT01474876|63021957|FG002|Overall Study|Investigator's decision|0|||
33620896|NCT01474876|63021955|FG000|Overall Study|Patient's request|19|||
33620897|NCT01474876|63021956|FG001|Overall Study|Patient's request|5|||
33620898|NCT01474876|63021957|FG002|Overall Study|Patient's request|0|||
33457321|NCT03812510|62831771|FG000|Overall Study|Adverse Event|5|||
33620899|NCT01474876|63021955|FG000|Overall Study|Investigator's decision and pt request|1|||
33620900|NCT01474876|63021956|FG001|Overall Study|Investigator's decision and pt request|0|||
33457322|NCT00390299|62831781|FG000|Overall Study|Cancellation|1|||
33457323|NCT00390299|62831782|FG001|Overall Study|Cancellation|0|||
33457324|NCT00390299|62831783|FG002|Overall Study|Cancellation|0|||
33620901|NCT01474876|63021957|FG002|Overall Study|Investigator's decision and pt request|0|||
33620902|NCT01491802|63021963|FG000|Overall Study|Adverse Event|1|||
33620903|NCT01491802|63021964|FG001|Overall Study|Adverse Event|1|||
33620904|NCT01491802|63021963|FG000|Overall Study|Withdrawal by Subject|0|||
33620905|NCT01491802|63021964|FG001|Overall Study|Withdrawal by Subject|1|||
33620906|NCT02168777|63021974|FG000|Overall Study|Withdrawal by Subject|1|||
33620907|NCT02168777|63021975|FG001|Overall Study|Withdrawal by Subject|0|||
33620908|NCT02168777|63021976|FG002|Overall Study|Withdrawal by Subject|2|||
33620909|NCT02168777|63021974|FG000|Overall Study|Adverse Event|1|||
33620910|NCT02168777|63021975|FG001|Overall Study|Adverse Event|0|||
33620911|NCT02168777|63021976|FG002|Overall Study|Adverse Event|1|||
33620912|NCT02168777|63021974|FG000|Overall Study|Disease recurrence|0|||
33620913|NCT02168777|63021975|FG001|Overall Study|Disease recurrence|0|||
33620914|NCT02168777|63021976|FG002|Overall Study|Disease recurrence|1|||
33620915|NCT02168777|63021974|FG000|Overall Study|Radiological disease progression|0|||
33620916|NCT02168777|63021975|FG001|Overall Study|Radiological disease progression|5|||
33620917|NCT02168777|63021976|FG002|Overall Study|Radiological disease progression|5|||
33620918|NCT02168777|63021974|FG000|Overall Study|Clinical disease progression|0|||
33620919|NCT02168777|63021975|FG001|Overall Study|Clinical disease progression|1|||
33620920|NCT02168777|63021976|FG002|Overall Study|Clinical disease progression|2|||
33620921|NCT02168777|63021974|FG000|Overall Study|Other reason|0|||
33620922|NCT02168777|63021975|FG001|Overall Study|Other reason|1|||
33620923|NCT02168777|63021976|FG002|Overall Study|Other reason|0|||
33620924|NCT01491178|63021987|FG000|Overall Study|Adverse Event|1016|||
33620925|NCT01491178|63021987|FG000|Overall Study|Improvement of NVAF|210|||
33620926|NCT01491178|63021987|FG000|Overall Study|To conduct invasive treatment|59|||
33620927|NCT01491178|63021987|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
33620928|NCT01491178|63021987|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
33620929|NCT01491178|63021987|FG000|Overall Study|To take a contraindication|20|||
33620930|NCT01491178|63021987|FG000|Overall Study|Other than specified above|657|||
33620931|NCT02189837|63021995|FG000|Overall Study|Withdrawal by Subject|2|||
33620932|NCT02189837|63021996|FG001|Overall Study|Withdrawal by Subject|1|||
33620933|NCT02189837|63021997|FG002|Overall Study|Withdrawal by Subject|3|||
33620934|NCT02189837|63021998|FG003|Overall Study|Withdrawal by Subject|1|||
33620935|NCT02189837|63021995|FG000|Overall Study|Sponsor Decision|0|||
33620936|NCT02189837|63021996|FG001|Overall Study|Sponsor Decision|0|||
33620937|NCT02189837|63021997|FG002|Overall Study|Sponsor Decision|0|||
33620938|NCT02189837|63021998|FG003|Overall Study|Sponsor Decision|1|||
33620939|NCT02216123|63022010|FG000|Overall Study|Lost to Follow-up|4|||
33620940|NCT02216123|63022011|FG001|Overall Study|Lost to Follow-up|2|||
33620941|NCT02216123|63022010|FG000|Overall Study|Withdrawal by Subject|2|||
33620942|NCT02216123|63022011|FG001|Overall Study|Withdrawal by Subject|0|||
33620943|NCT02189759|63022025|FG000|Overall Study|Lost to Follow-up|0|||
33620944|NCT02189759|63022026|FG001|Overall Study|Lost to Follow-up|0|||
33620945|NCT02189759|63022027|FG002|Overall Study|Lost to Follow-up|2|||
33620946|NCT02189759|63022028|FG003|Overall Study|Lost to Follow-up|5|||
33620947|NCT01490866|63022040|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
33620948|NCT01490866|63022040|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
33620949|NCT01490866|63022040|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
33620950|NCT01490866|63022040|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
33620951|NCT01490866|63022040|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
33620952|NCT01490866|63022040|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
33620953|NCT01490866|63022040|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
33620954|NCT01490866|63022040|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
33620955|NCT01490866|63022040|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
33620956|NCT01490866|63022040|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
33620957|NCT01490866|63022040|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
33620958|NCT02215967|63022051|FG000|Overall Study|Patient became ineligible for treatment|0|||
33620959|NCT02215967|63022052|FG001|Overall Study|Patient became ineligible for treatment|0|||
33620960|NCT02215967|63022053|FG002|Overall Study|Patient became ineligible for treatment|0|||
33620961|NCT02215967|63022054|FG003|Overall Study|Patient became ineligible for treatment|3|||
33620962|NCT02215967|63022051|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
33620963|NCT02215967|63022052|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
33620964|NCT02215967|63022053|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
33620965|NCT02215967|63022054|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
33620966|NCT02168387|63022066|FG000|Overall Study|Planned exubation|6|||
33620967|NCT02168387|63022067|FG001|Overall Study|Planned exubation|3|||
33325351|NCT00599521|62702121|FG000|Overall Study|Withdrawal by Subject|28|||
33325352|NCT00599521|62702122|FG001|Overall Study|Withdrawal by Subject|34|||
33620968|NCT02168387|63022066|FG000|Overall Study|Death|1|||
33620969|NCT02168387|63022067|FG001|Overall Study|Death|0|||
33620970|NCT02188589|63022073|FG000|Overall Study|Withdrawal by Subject|5|||
33620971|NCT02167451|63022078|FG000|Overall Study|Withdrawal by Subject|1|||
33620972|NCT02167139|63022084|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
33620973|NCT02167139|63022085|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
33620974|NCT02167139|63022086|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
33620975|NCT02167139|63022087|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
33620976|NCT02167139|63022084|FG000|Randomised, Double-blind|Adverse Event|2|||
33620977|NCT02167139|63022085|FG001|Randomised, Double-blind|Adverse Event|9|||
33620978|NCT02167139|63022086|FG002|Randomised, Double-blind|Adverse Event|0|||
33620979|NCT02167139|63022087|FG003|Randomised, Double-blind|Adverse Event|0|||
33620980|NCT02167139|63022084|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
33620981|NCT02167139|63022085|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
33620982|NCT02167139|63022086|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
33620983|NCT02167139|63022087|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
33620984|NCT02167139|63022084|FG000|Randomised, Double-blind|Other|3|||
33620985|NCT02167139|63022085|FG001|Randomised, Double-blind|Other|0|||
33620986|NCT02167139|63022086|FG002|Randomised, Double-blind|Other|0|||
33620987|NCT02167139|63022087|FG003|Randomised, Double-blind|Other|0|||
33620988|NCT02167139|63022084|FG000|Transition-extension|Adverse Event|2|||
33620989|NCT02167139|63022085|FG001|Transition-extension|Adverse Event|0|||
33620990|NCT02167139|63022086|FG002|Transition-extension|Adverse Event|2|||
33620991|NCT02167139|63022087|FG003|Transition-extension|Adverse Event|3|||
33620992|NCT02167139|63022084|FG000|Transition-extension|Withdrawal by Subject|2|||
33620993|NCT02167139|63022085|FG001|Transition-extension|Withdrawal by Subject|0|||
33620994|NCT02167139|63022086|FG002|Transition-extension|Withdrawal by Subject|4|||
33620995|NCT02167139|63022087|FG003|Transition-extension|Withdrawal by Subject|1|||
33620996|NCT02167139|63022084|FG000|Transition-extension|Lack of Efficacy|0|||
33620997|NCT02167139|63022085|FG001|Transition-extension|Lack of Efficacy|0|||
33620998|NCT02167139|63022086|FG002|Transition-extension|Lack of Efficacy|1|||
33620999|NCT02167139|63022087|FG003|Transition-extension|Lack of Efficacy|1|||
33621000|NCT02167139|63022084|FG000|Transition-extension|Other|1|||
33621001|NCT02167139|63022085|FG001|Transition-extension|Other|0|||
33621002|NCT02167139|63022086|FG002|Transition-extension|Other|1|||
33621003|NCT02167139|63022087|FG003|Transition-extension|Other|0|||
33621004|NCT02167139|63022084|FG000|Transition-extension|Lost to Follow-up|1|||
33621005|NCT02167139|63022085|FG001|Transition-extension|Lost to Follow-up|0|||
33621006|NCT02167139|63022086|FG002|Transition-extension|Lost to Follow-up|0|||
33621007|NCT02167139|63022087|FG003|Transition-extension|Lost to Follow-up|0|||
33621008|NCT02116621|63022103|FG000|Baseline|Withdrawal by Subject|0|||
33621009|NCT02116621|63022104|FG001|Baseline|Withdrawal by Subject|4|||
33621010|NCT02116621|63022103|FG000|Three Month Follow-up|Death|1|||
33621011|NCT02116621|63022104|FG001|Three Month Follow-up|Death|1|||
33325353|NCT00599521|62702121|FG000|Overall Study|Protocol Violation|1|||
33527049|NCT03086057|62914637|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
33527050|NCT03086057|62914638|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
33527051|NCT03086057|62914639|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
33527052|NCT03086057|62914640|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
33527053|NCT03086057|62914637|FG000|Stage 1: PrEP Uptake|Death|1|||
33527054|NCT03086057|62914638|FG001|Stage 1: PrEP Uptake|Death|0|||
33527055|NCT03086057|62914639|FG002|Stage 1: PrEP Uptake|Death|0|||
33527056|NCT03086057|62914640|FG003|Stage 1: PrEP Uptake|Death|0|||
33621012|NCT02116621|63022103|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
33621013|NCT02116621|63022104|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
33621014|NCT02116621|63022103|FG000|Three Month Follow-up|Lost to Follow-up|0|||
33621015|NCT02116621|63022104|FG001|Three Month Follow-up|Lost to Follow-up|1|||
33621016|NCT02116621|63022103|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
33457325|NCT00390299|62831784|FG003|Overall Study|Cancellation|0|||
33457326|NCT00390299|62831785|FG004|Overall Study|Cancellation|0|||
33457327|NCT00119678|62831801|FG000|Double-blind Treatment Period|Death|1|||
33457328|NCT00119678|62831802|FG001|Double-blind Treatment Period|Death|0|||
33457329|NCT00119678|62831801|FG000|Double-blind Treatment Period|Adverse Event|7|||
33457330|NCT00119678|62831802|FG001|Double-blind Treatment Period|Adverse Event|1|||
33457331|NCT00119678|62831801|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
33457332|NCT00119678|62831802|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
33457333|NCT00119678|62831801|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
33457334|NCT00119678|62831802|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
33457335|NCT00119678|62831801|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
33457336|NCT00119678|62831802|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
33457337|NCT00119678|62831801|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
33527057|NCT03086057|62914637|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
33527058|NCT03086057|62914638|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
33621017|NCT02116621|63022104|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
33621018|NCT02116621|63022103|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
33621019|NCT02116621|63022104|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
33621020|NCT02116621|63022103|FG000|Six Month Follow-up|Lost to Follow-up|2|||
33621021|NCT02116621|63022104|FG001|Six Month Follow-up|Lost to Follow-up|1|||
33621022|NCT02116621|63022103|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
33621023|NCT02116621|63022104|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
33621024|NCT02116621|63022103|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
33621025|NCT02116621|63022104|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
33621026|NCT02116621|63022103|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
33621027|NCT02116621|63022104|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
33621028|NCT02116621|63022103|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
33621029|NCT02116621|63022104|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
33621030|NCT02116621|63022103|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
33621031|NCT02116621|63022104|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
33621032|NCT02116309|63022112|FG000|Overall Study|Lost to Follow-up|0|||
33621033|NCT02116309|63022113|FG001|Overall Study|Lost to Follow-up|1|||
33621034|NCT02115607|63022119|FG000|Overall Study|Withdrawal by Subject|1|||
33621035|NCT01490632|63022128|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
33621036|NCT01490632|63022129|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
33621037|NCT01490632|63022130|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
33621038|NCT01490632|63022131|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
33621039|NCT01490632|63022132|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
33621040|NCT01490632|63022133|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
33621041|NCT01490632|63022134|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
33621042|NCT01490632|63022135|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
33621043|NCT01490632|63022136|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
33621044|NCT01490632|63022137|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
33621045|NCT01490632|63022138|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
33621046|NCT01490632|63022139|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
33621047|NCT01490632|63022140|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
33621048|NCT01490632|63022141|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
33621049|NCT01490632|63022142|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
33621050|NCT01490632|63022143|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
33621051|NCT01490632|63022144|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
33621052|NCT01490632|63022145|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
33621053|NCT01490632|63022146|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
33621054|NCT01490632|63022147|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
33621055|NCT01490632|63022128|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
33621056|NCT01490632|63022129|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
33621057|NCT01490632|63022130|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
33621058|NCT01490632|63022131|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
33457338|NCT00119678|62831802|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
33457339|NCT00119678|62831801|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
33457340|NCT00119678|62831802|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
33457341|NCT00119678|62831801|FG000|Double-blind Treatment Period|Pregnancy|0|||
33457342|NCT00119678|62831802|FG001|Double-blind Treatment Period|Pregnancy|2|||
33457343|NCT00119678|62831801|FG000|Double-blind Treatment Period|Not treated|1|||
33457344|NCT00119678|62831802|FG001|Double-blind Treatment Period|Not treated|2|||
33457345|NCT00119678|62831801|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
33457346|NCT00119678|62831802|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
33457347|NCT00119678|62831801|FG000|Open-label Treatment Period|Death|1|||
33457348|NCT00119678|62831802|FG001|Open-label Treatment Period|Death|0|||
33457349|NCT00119678|62831801|FG000|Open-label Treatment Period|Adverse Event|3|||
33457350|NCT00119678|62831802|FG001|Open-label Treatment Period|Adverse Event|0|||
33457351|NCT00119678|62831801|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
33457352|NCT00119678|62831802|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
33457353|NCT00119678|62831801|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
33457354|NCT00119678|62831802|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
33457355|NCT00119678|62831801|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
33457356|NCT00119678|62831802|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
33457357|NCT00119678|62831801|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
33527059|NCT03086057|62914639|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
33527060|NCT03086057|62914640|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
33527061|NCT03086057|62914637|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
33527062|NCT03086057|62914638|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
33527063|NCT03086057|62914639|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
33527064|NCT03086057|62914640|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
33527065|NCT03086057|62914637|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
33527066|NCT03086057|62914638|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
33527067|NCT03086057|62914639|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
33621059|NCT01490632|63022132|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33621060|NCT01490632|63022133|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33621061|NCT01490632|63022134|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33621062|NCT01490632|63022135|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33621063|NCT01490632|63022136|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33621064|NCT01490632|63022137|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33621065|NCT01490632|63022138|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33621066|NCT01490632|63022139|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33621067|NCT01490632|63022140|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33621068|NCT01490632|63022141|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33621069|NCT01490632|63022142|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33527068|NCT03086057|62914640|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
33527069|NCT02759120|62914652|FG000|Overall Study|Death|34|||
33527070|NCT02759120|62914653|FG001|Overall Study|Death|36|||
33621070|NCT01490632|63022143|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33621071|NCT01490632|63022144|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33621072|NCT01490632|63022145|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33621073|NCT01490632|63022146|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33621074|NCT01490632|63022147|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33621075|NCT01490632|63022128|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621076|NCT01490632|63022129|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621077|NCT01490632|63022130|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
33621078|NCT01490632|63022131|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
33621079|NCT01490632|63022132|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
33621080|NCT01490632|63022133|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621081|NCT01490632|63022134|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621082|NCT01490632|63022135|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621083|NCT01490632|63022136|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621084|NCT01490632|63022137|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621085|NCT01490632|63022138|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621086|NCT01490632|63022139|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621087|NCT01490632|63022140|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621088|NCT01490632|63022141|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621089|NCT01490632|63022142|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621090|NCT01490632|63022143|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621091|NCT01490632|63022144|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621092|NCT01490632|63022145|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621093|NCT01490632|63022146|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621094|NCT01490632|63022147|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33621095|NCT01490632|63022128|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
33621096|NCT01490632|63022129|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
33621097|NCT01490632|63022130|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
33621098|NCT01490632|63022131|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
33621099|NCT01490632|63022132|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
33621100|NCT01490632|63022133|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
33621101|NCT01490632|63022134|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
33621102|NCT01490632|63022135|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
33621103|NCT01490632|63022136|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
33621104|NCT01490632|63022137|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
33621105|NCT01490632|63022138|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
33527071|NCT02759120|62914652|FG000|Overall Study|Lost to Follow-up|4|||
33527072|NCT02759120|62914653|FG001|Overall Study|Lost to Follow-up|7|||
33527073|NCT02759120|62914652|FG000|Overall Study|Physician Decision|3|||
33527074|NCT02759120|62914653|FG001|Overall Study|Physician Decision|0|||
33527075|NCT02759120|62914652|FG000|Overall Study|Withdrawal by Subject|28|||
33527076|NCT02759120|62914653|FG001|Overall Study|Withdrawal by Subject|15|||
33527077|NCT02759120|62914652|FG000|Overall Study|Moved out of area|3|||
33527078|NCT02759120|62914653|FG001|Overall Study|Moved out of area|4|||
33527079|NCT02759120|62914652|FG000|Overall Study|Lung transplant|3|||
33527080|NCT02759120|62914653|FG001|Overall Study|Lung transplant|5|||
33527081|NCT02759120|62914652|FG000|Overall Study|Other reason not completed|10|||
33527082|NCT02759120|62914653|FG001|Overall Study|Other reason not completed|12|||
33527083|NCT00101192|62914659|FG000|Overall Study|Ineligible|6|||
33527084|NCT00101192|62914659|FG000|Overall Study|Inevaluable|1|||
33621106|NCT01490632|63022139|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
33621107|NCT01490632|63022140|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
33527085|NCT03031431|62914663|FG000|Overall Study|Infant removed by maternal request|1|||
33527086|NCT03029247|62914669|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
33527087|NCT03029247|62914670|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
33527088|NCT03029247|62914669|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
33527089|NCT03029247|62914670|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
33527090|NCT03029247|62914669|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
33527091|NCT03029247|62914670|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
33527092|NCT03029247|62914669|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
33527093|NCT03029247|62914670|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
33527094|NCT04313283|62914676|FG000|Overall Study|did not complete intervention|4|||
33527095|NCT02754440|62914684|FG000|Overall Study|Protocol Violation|3|||
33527096|NCT02754440|62914685|FG001|Overall Study|Protocol Violation|2|||
33527097|NCT02754440|62914686|FG002|Overall Study|Protocol Violation|2|||
33527098|NCT02754440|62914687|FG003|Overall Study|Protocol Violation|6|||
33527099|NCT02754440|62914684|FG000|Overall Study|Adverse Event|3|||
33527100|NCT02754440|62914685|FG001|Overall Study|Adverse Event|1|||
33621108|NCT01490632|63022141|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
33621109|NCT01490632|63022142|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
33621110|NCT01490632|63022143|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
33621111|NCT01490632|63022144|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
33621112|NCT01490632|63022145|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
33621113|NCT01490632|63022146|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
33621114|NCT01490632|63022147|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
33621115|NCT01490632|63022128|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
33621116|NCT01490632|63022129|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621117|NCT01490632|63022130|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621118|NCT01490632|63022131|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621119|NCT01490632|63022132|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621120|NCT01490632|63022133|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621121|NCT01490632|63022134|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621122|NCT01490632|63022135|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621123|NCT01490632|63022136|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621124|NCT01490632|63022137|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621125|NCT01490632|63022138|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621126|NCT01490632|63022139|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621127|NCT01490632|63022140|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
33457358|NCT00119678|62831802|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
33621128|NCT01490632|63022141|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621129|NCT01490632|63022142|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621130|NCT01490632|63022143|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621131|NCT01490632|63022144|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621132|NCT01490632|63022145|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621133|NCT01490632|63022146|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
33621134|NCT01490632|63022147|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
33457359|NCT00119678|62831801|FG000|Open-label Treatment Period|Pregnancy|1|||
33457360|NCT00119678|62831802|FG001|Open-label Treatment Period|Pregnancy|0|||
33457361|NCT00119678|62831801|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
33457362|NCT00119678|62831802|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
33457363|NCT00110084|62831810|FG000|Overall Study|Adverse Event|9|||
33457364|NCT00110084|62831810|FG000|Overall Study|Death|1|||
33457365|NCT00110084|62831810|FG000|Overall Study|Patient Refusal|10|||
33457366|NCT00110084|62831810|FG000|Overall Study|Alternate Therapy|5|||
33457367|NCT00110084|62831810|FG000|Overall Study|Intercurrent Illness|1|||
33457368|NCT00110084|62831810|FG000|Overall Study|Other|2|||
33457369|NCT00390221|62831817|FG000|Overall Study|Lost to Follow-up|0|||
33457370|NCT00390221|62831818|FG001|Overall Study|Lost to Follow-up|3|||
33457371|NCT00390221|62831819|FG002|Overall Study|Lost to Follow-up|0|||
33457372|NCT00390221|62831817|FG000|Overall Study|Adverse Event|1|||
33457373|NCT00390221|62831818|FG001|Overall Study|Adverse Event|4|||
33457374|NCT00390221|62831819|FG002|Overall Study|Adverse Event|3|||
33457375|NCT00390221|62831817|FG000|Overall Study|Investigator Decision|0|||
33457376|NCT00390221|62831818|FG001|Overall Study|Investigator Decision|0|||
33457377|NCT00390221|62831819|FG002|Overall Study|Investigator Decision|1|||
33621135|NCT01490632|63022128|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
33457378|NCT00390221|62831817|FG000|Overall Study|Withdrawal by Subject|13|||
33457379|NCT00390221|62831818|FG001|Overall Study|Withdrawal by Subject|9|||
33457380|NCT00390221|62831819|FG002|Overall Study|Withdrawal by Subject|7|||
33527101|NCT02754440|62914686|FG002|Overall Study|Adverse Event|0|||
33527102|NCT02754440|62914687|FG003|Overall Study|Adverse Event|9|||
33621136|NCT01490632|63022129|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
33621137|NCT01490632|63022130|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621138|NCT01490632|63022131|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
33621139|NCT01490632|63022132|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
33621140|NCT01490632|63022133|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621141|NCT01490632|63022134|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621142|NCT01490632|63022135|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621143|NCT01490632|63022136|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621144|NCT01490632|63022137|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621145|NCT01490632|63022138|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621146|NCT01490632|63022139|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621147|NCT01490632|63022140|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621148|NCT01490632|63022141|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621149|NCT01490632|63022142|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621150|NCT01490632|63022143|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621151|NCT01490632|63022144|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621152|NCT01490632|63022145|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621153|NCT01490632|63022146|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621154|NCT01490632|63022147|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33621155|NCT01490632|63022128|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621156|NCT01490632|63022129|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621157|NCT01490632|63022130|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621158|NCT01490632|63022131|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621159|NCT01490632|63022132|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
33621160|NCT01490632|63022133|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621161|NCT01490632|63022134|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621162|NCT01490632|63022135|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621163|NCT01490632|63022136|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621164|NCT01490632|63022137|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621165|NCT01490632|63022138|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621166|NCT01490632|63022139|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33457381|NCT00390221|62831817|FG000|Overall Study|Subject Non-compliance|1|||
33527103|NCT02754440|62914684|FG000|Overall Study|Withdrawal by Subject|0|||
33527104|NCT02754440|62914685|FG001|Overall Study|Withdrawal by Subject|0|||
33527105|NCT02754440|62914686|FG002|Overall Study|Withdrawal by Subject|0|||
33527106|NCT02754440|62914687|FG003|Overall Study|Withdrawal by Subject|1|||
33527107|NCT02754440|62914684|FG000|Overall Study|Equipment failure|0|||
33527108|NCT02754440|62914685|FG001|Overall Study|Equipment failure|5|||
33527109|NCT02754440|62914686|FG002|Overall Study|Equipment failure|5|||
33527110|NCT02754440|62914687|FG003|Overall Study|Equipment failure|7|||
33527111|NCT02754440|62914684|FG000|Overall Study|Subject issues not resulting in AE|0|||
33527112|NCT02754440|62914685|FG001|Overall Study|Subject issues not resulting in AE|0|||
33457382|NCT00390221|62831818|FG001|Overall Study|Subject Non-compliance|0|||
33457383|NCT00390221|62831819|FG002|Overall Study|Subject Non-compliance|2|||
33457384|NCT00390221|62831817|FG000|Overall Study|Other|3|||
33457385|NCT00390221|62831818|FG001|Overall Study|Other|4|||
33457386|NCT00390221|62831819|FG002|Overall Study|Other|2|||
33457387|NCT00389831|62831830|FG000|Overall Study|Lack of Efficacy|0|||
33457388|NCT00389831|62831831|FG001|Overall Study|Lack of Efficacy|2|||
33457389|NCT00389831|62831830|FG000|Overall Study|Did not receive treatment.|0|||
33457390|NCT00389831|62831831|FG001|Overall Study|Did not receive treatment.|2|||
33457391|NCT00389831|62831830|FG000|Overall Study|Other reasons|0|||
33457392|NCT00389831|62831831|FG001|Overall Study|Other reasons|2|||
33457393|NCT00389831|62831830|FG000|Overall Study|Lost to Follow-up|0|||
33457394|NCT00389831|62831831|FG001|Overall Study|Lost to Follow-up|1|||
33457395|NCT00389597|62831853|FG000|Overall Study|Lost to Follow-up|8|||
33457396|NCT00389597|62831854|FG001|Overall Study|Lost to Follow-up|6|||
33621167|NCT01490632|63022140|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621168|NCT01490632|63022141|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621169|NCT01490632|63022142|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621170|NCT01490632|63022143|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621171|NCT01490632|63022144|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621172|NCT01490632|63022145|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621173|NCT01490632|63022146|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621174|NCT01490632|63022147|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33621175|NCT01490632|63022128|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
33621176|NCT01490632|63022129|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
33621177|NCT01490632|63022130|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
33621178|NCT01490632|63022131|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
33621179|NCT01490632|63022132|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
33325354|NCT00599521|62702122|FG001|Overall Study|Protocol Violation|1|||
33325355|NCT00599521|62702121|FG000|Overall Study|Lost to Follow-up|23|||
33325356|NCT00599521|62702122|FG001|Overall Study|Lost to Follow-up|23|||
33621180|NCT01490632|63022133|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
33621181|NCT01490632|63022134|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
33621182|NCT01490632|63022135|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
33621183|NCT01490632|63022136|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
33621184|NCT01490632|63022137|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
33621185|NCT01490632|63022138|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
33621186|NCT01490632|63022139|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
33621187|NCT01490632|63022140|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
33621188|NCT01490632|63022141|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
33621189|NCT01490632|63022142|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
33621190|NCT01490632|63022143|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
33621191|NCT01490632|63022144|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
33621192|NCT01490632|63022145|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
33621193|NCT01490632|63022146|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
33621194|NCT01490632|63022147|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
33621195|NCT01490632|63022128|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621196|NCT01490632|63022129|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621197|NCT01490632|63022130|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621198|NCT01490632|63022131|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621199|NCT01490632|63022132|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621200|NCT01490632|63022133|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621201|NCT01490632|63022134|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
33621202|NCT01490632|63022135|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621203|NCT01490632|63022136|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
33621204|NCT01490632|63022137|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
33621205|NCT01490632|63022138|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
33621206|NCT01490632|63022139|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621207|NCT01490632|63022140|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621208|NCT01490632|63022141|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621209|NCT01490632|63022142|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621210|NCT01490632|63022143|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621211|NCT01490632|63022144|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621212|NCT01490632|63022145|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621213|NCT01490632|63022146|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621214|NCT01490632|63022147|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33621215|NCT01490632|63022128|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621216|NCT01490632|63022129|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621217|NCT01490632|63022130|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621218|NCT01490632|63022131|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621219|NCT01490632|63022132|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621220|NCT01490632|63022133|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621221|NCT01490632|63022134|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
33621222|NCT01490632|63022135|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621223|NCT01490632|63022136|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621224|NCT01490632|63022137|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
33621225|NCT01490632|63022138|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621226|NCT01490632|63022139|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621227|NCT01490632|63022140|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621228|NCT01490632|63022141|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621229|NCT01490632|63022142|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621230|NCT01490632|63022143|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621231|NCT01490632|63022144|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621232|NCT01490632|63022145|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621233|NCT01490632|63022146|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621234|NCT01490632|63022147|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33621235|NCT01490632|63022128|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621236|NCT01490632|63022129|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621237|NCT01490632|63022130|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621238|NCT01490632|63022131|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621239|NCT01490632|63022132|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621240|NCT01490632|63022133|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621241|NCT01490632|63022134|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
33621242|NCT01490632|63022135|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621243|NCT01490632|63022136|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621244|NCT01490632|63022137|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
33527113|NCT02754440|62914686|FG002|Overall Study|Subject issues not resulting in AE|0|||
33527114|NCT02754440|62914687|FG003|Overall Study|Subject issues not resulting in AE|12|||
33527115|NCT02753816|62914699|FG000|Overall Study|Protocol Violation|0|||
33527116|NCT02753816|62914700|FG001|Overall Study|Protocol Violation|1|||
33527117|NCT02753816|62914701|FG002|Overall Study|Protocol Violation|0|||
33527118|NCT02752802|62914709|FG000|Overall Study|Contrast Volume Not Collected|1|||
33621245|NCT01490632|63022138|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621246|NCT01490632|63022139|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621247|NCT01490632|63022140|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621248|NCT01490632|63022141|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621249|NCT01490632|63022142|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621250|NCT01490632|63022143|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621251|NCT01490632|63022144|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621252|NCT01490632|63022145|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621253|NCT01490632|63022146|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621254|NCT01490632|63022147|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
33621255|NCT01490632|63022128|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621256|NCT01490632|63022129|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621257|NCT01490632|63022130|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621258|NCT01490632|63022131|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621259|NCT01490632|63022132|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621260|NCT01490632|63022133|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
33621261|NCT01490632|63022134|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621262|NCT01490632|63022135|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621263|NCT01490632|63022136|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621264|NCT01490632|63022137|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621265|NCT01490632|63022138|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621266|NCT01490632|63022139|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621267|NCT01490632|63022140|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621268|NCT01490632|63022141|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621269|NCT01490632|63022142|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621270|NCT01490632|63022143|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621271|NCT01490632|63022144|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621272|NCT01490632|63022145|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621273|NCT01490632|63022146|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621274|NCT01490632|63022147|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33621275|NCT01490632|63022128|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33621276|NCT01490632|63022129|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33621277|NCT01490632|63022130|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33621278|NCT01490632|63022131|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33621279|NCT01490632|63022132|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33621280|NCT01490632|63022133|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33621281|NCT01490632|63022134|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
33621282|NCT01490632|63022135|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33621283|NCT01490632|63022136|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
33621284|NCT01490632|63022137|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33621285|NCT01490632|63022138|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
33621286|NCT01490632|63022139|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
33621287|NCT01490632|63022140|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33621288|NCT01490632|63022141|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33527119|NCT02752802|62914710|FG001|Overall Study|Contrast Volume Not Collected|0|||
33527120|NCT02756078|62914727|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
33527121|NCT02756078|62914728|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
33527122|NCT02756078|62914727|FG000|Period 1|Lost to Follow-up|0|||
33527123|NCT02756078|62914728|FG001|Period 1|Lost to Follow-up|2|||
33527124|NCT02756078|62914727|FG000|Period 1|Protocol Violation|0|||
33621289|NCT01490632|63022142|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33621290|NCT01490632|63022143|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33527125|NCT02756078|62914728|FG001|Period 1|Protocol Violation|1|||
33527126|NCT02756078|62914727|FG000|Period 1|Adverse Event|1|||
33527127|NCT02756078|62914728|FG001|Period 1|Adverse Event|10|||
33527128|NCT02756078|62914727|FG000|Period 1|Withdrawal by Subject|6|||
33527129|NCT02756078|62914728|FG001|Period 1|Withdrawal by Subject|6|||
33621291|NCT01490632|63022144|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33621292|NCT01490632|63022145|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33621293|NCT01490632|63022146|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33621294|NCT01490632|63022147|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33621295|NCT01490632|63022128|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33621296|NCT01490632|63022129|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33621297|NCT01490632|63022130|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33621298|NCT01490632|63022131|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33621299|NCT01490632|63022132|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33621300|NCT01490632|63022133|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
33621301|NCT01490632|63022134|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
33621302|NCT01490632|63022135|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
33621303|NCT01490632|63022136|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
33621304|NCT01490632|63022137|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
33621305|NCT01490632|63022138|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
33621306|NCT01490632|63022139|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
33621307|NCT01490632|63022140|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33621308|NCT01490632|63022141|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33621309|NCT01490632|63022142|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33621310|NCT01490632|63022143|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33621311|NCT01490632|63022144|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33621312|NCT01490632|63022145|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33621313|NCT01490632|63022146|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33621314|NCT01490632|63022147|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33621315|NCT01490632|63022128|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621316|NCT01490632|63022129|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621317|NCT01490632|63022130|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621318|NCT01490632|63022131|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621319|NCT01490632|63022132|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621320|NCT01490632|63022133|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621321|NCT01490632|63022134|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621322|NCT01490632|63022135|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621323|NCT01490632|63022136|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621324|NCT01490632|63022137|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621325|NCT01490632|63022138|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621326|NCT01490632|63022139|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621327|NCT01490632|63022140|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621328|NCT01490632|63022141|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621329|NCT01490632|63022142|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
33621330|NCT01490632|63022143|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
33621331|NCT01490632|63022144|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621332|NCT01490632|63022145|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621333|NCT01490632|63022146|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621334|NCT01490632|63022147|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
33621335|NCT01490632|63022128|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621336|NCT01490632|63022129|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621337|NCT01490632|63022130|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621338|NCT01490632|63022131|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621339|NCT01490632|63022132|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621340|NCT01490632|63022133|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621341|NCT01490632|63022134|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621342|NCT01490632|63022135|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621343|NCT01490632|63022136|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621344|NCT01490632|63022137|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621345|NCT01490632|63022138|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621346|NCT01490632|63022139|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621347|NCT01490632|63022140|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621348|NCT01490632|63022141|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
33621349|NCT01490632|63022142|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621350|NCT01490632|63022143|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621351|NCT01490632|63022144|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621352|NCT01490632|63022145|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621353|NCT01490632|63022146|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621354|NCT01490632|63022147|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33621355|NCT01490632|63022128|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621356|NCT01490632|63022129|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621357|NCT01490632|63022130|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621358|NCT01490632|63022131|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621359|NCT01490632|63022132|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621360|NCT01490632|63022133|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621361|NCT01490632|63022134|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621362|NCT01490632|63022135|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621363|NCT01490632|63022136|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621364|NCT01490632|63022137|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621365|NCT01490632|63022138|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621366|NCT01490632|63022139|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621367|NCT01490632|63022140|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621368|NCT01490632|63022141|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621369|NCT01490632|63022142|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
33527130|NCT02756078|62914727|FG000|Period 1|Lens Discomfort|2|||
33527131|NCT02756078|62914728|FG001|Period 1|Lens Discomfort|2|||
33527132|NCT02756078|62914727|FG000|Period 2|Adverse Event|3|||
33527133|NCT02756078|62914728|FG001|Period 2|Adverse Event|5|||
33527134|NCT02756078|62914727|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
33527135|NCT02756078|62914728|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
33527136|NCT02756078|62914727|FG000|Period 2|Withdrawal by Subject|3|||
33527137|NCT02756078|62914728|FG001|Period 2|Withdrawal by Subject|1|||
33527138|NCT03813147|62914736|FG000|Overall Study|Lack of Efficacy|4|||
33527139|NCT03813147|62914737|FG001|Overall Study|Lack of Efficacy|4|||
33527140|NCT03813147|62914736|FG000|Overall Study|Physician Decision|2|||
33527141|NCT03813147|62914737|FG001|Overall Study|Physician Decision|1|||
33527142|NCT02752958|62914743|FG000|Overall Study|Adverse Event|3|||
33527143|NCT02752958|62914743|FG000|Overall Study|Lost to Follow-up|1|||
33527144|NCT02752958|62914743|FG000|Overall Study|Protocol Violation|1|||
33527145|NCT02752958|62914743|FG000|Overall Study|Withdrawal by Subject|2|||
33527146|NCT02752958|62914743|FG000|Overall Study|Other (Reason not specified)|2|||
33621370|NCT01490632|63022143|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
33621371|NCT01490632|63022144|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621372|NCT01490632|63022145|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621373|NCT01490632|63022146|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621374|NCT01490632|63022147|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33621375|NCT01490632|63022128|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621376|NCT01490632|63022129|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621377|NCT01490632|63022130|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621378|NCT01490632|63022131|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621379|NCT01490632|63022132|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621380|NCT01490632|63022133|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621381|NCT01490632|63022134|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621382|NCT01490632|63022135|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621383|NCT01490632|63022136|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621384|NCT01490632|63022137|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621385|NCT01490632|63022138|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621386|NCT01490632|63022139|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621387|NCT01490632|63022140|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
33621388|NCT01490632|63022141|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
33621389|NCT01490632|63022142|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
33527147|NCT02805660|62914756|FG000|Overall Study|Death|5|||
33527148|NCT02805660|62914757|FG001|Overall Study|Death|2|||
33527149|NCT02805660|62914758|FG002|Overall Study|Death|9|||
33621390|NCT01490632|63022143|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
33621391|NCT01490632|63022144|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621392|NCT01490632|63022145|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621393|NCT01490632|63022146|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621394|NCT01490632|63022147|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33621395|NCT01490632|63022128|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
33621396|NCT01490632|63022129|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
33621397|NCT01490632|63022130|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
33621398|NCT01490632|63022131|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
33621399|NCT01490632|63022132|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
33621400|NCT01490632|63022133|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
33621401|NCT01490632|63022134|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
33621402|NCT01490632|63022135|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
33621403|NCT01490632|63022136|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
33621404|NCT01490632|63022137|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
33621405|NCT01490632|63022138|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
33621406|NCT01490632|63022139|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
33621407|NCT01490632|63022140|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
33621408|NCT01490632|63022141|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
33621409|NCT01490632|63022142|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
33621410|NCT01490632|63022143|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
33621411|NCT01490632|63022144|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
33621412|NCT01490632|63022145|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
33621413|NCT01490632|63022146|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
33621414|NCT01490632|63022147|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
33621415|NCT01490632|63022128|FG000|Part D: Re-Treatment Period|Death|0|||
33621416|NCT01490632|63022129|FG001|Part D: Re-Treatment Period|Death|0|||
33621417|NCT01490632|63022130|FG002|Part D: Re-Treatment Period|Death|0|||
33621418|NCT01490632|63022131|FG003|Part D: Re-Treatment Period|Death|0|||
33621419|NCT01490632|63022132|FG004|Part D: Re-Treatment Period|Death|0|||
33621420|NCT01490632|63022133|FG005|Part D: Re-Treatment Period|Death|0|||
33621421|NCT01490632|63022134|FG006|Part D: Re-Treatment Period|Death|0|||
33621422|NCT01490632|63022135|FG007|Part D: Re-Treatment Period|Death|0|||
33621423|NCT01490632|63022136|FG008|Part D: Re-Treatment Period|Death|0|||
33621424|NCT01490632|63022137|FG009|Part D: Re-Treatment Period|Death|0|||
33621425|NCT01490632|63022138|FG010|Part D: Re-Treatment Period|Death|0|||
33621426|NCT01490632|63022139|FG011|Part D: Re-Treatment Period|Death|0|||
33621427|NCT01490632|63022140|FG012|Part D: Re-Treatment Period|Death|0|||
33621428|NCT01490632|63022141|FG013|Part D: Re-Treatment Period|Death|0|||
33621429|NCT01490632|63022142|FG014|Part D: Re-Treatment Period|Death|0|||
33621430|NCT01490632|63022143|FG015|Part D: Re-Treatment Period|Death|0|||
33621431|NCT01490632|63022144|FG016|Part D: Re-Treatment Period|Death|0|||
33621432|NCT01490632|63022145|FG017|Part D: Re-Treatment Period|Death|0|||
33621433|NCT01490632|63022146|FG018|Part D: Re-Treatment Period|Death|1|||
33621434|NCT01490632|63022147|FG019|Part D: Re-Treatment Period|Death|0|||
33621435|NCT01490632|63022128|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621436|NCT01490632|63022129|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621437|NCT01490632|63022130|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621438|NCT01490632|63022131|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621439|NCT01490632|63022132|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621440|NCT01490632|63022133|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621441|NCT01490632|63022134|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621442|NCT01490632|63022135|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621443|NCT01490632|63022136|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621444|NCT01490632|63022137|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621445|NCT01490632|63022138|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621446|NCT01490632|63022139|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621447|NCT01490632|63022140|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621448|NCT01490632|63022141|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621449|NCT01490632|63022142|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621450|NCT01490632|63022143|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621451|NCT01490632|63022144|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33621452|NCT01490632|63022145|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
33621453|NCT01490632|63022146|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
33621454|NCT01490632|63022147|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
33621455|NCT01490632|63022128|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33325357|NCT00599521|62702121|FG000|Overall Study|Pregnancy|0|||
33527150|NCT02805660|62914759|FG003|Overall Study|Death|5|||
33621456|NCT01490632|63022129|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621457|NCT01490632|63022130|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621458|NCT01490632|63022131|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621459|NCT01490632|63022132|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621460|NCT01490632|63022133|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621461|NCT01490632|63022134|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621462|NCT01490632|63022135|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621463|NCT01490632|63022136|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621464|NCT01490632|63022137|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621465|NCT01490632|63022138|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621466|NCT01490632|63022139|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621467|NCT01490632|63022140|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621468|NCT01490632|63022141|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621469|NCT01490632|63022142|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621470|NCT01490632|63022143|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621471|NCT01490632|63022144|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621472|NCT01490632|63022145|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621473|NCT01490632|63022146|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
33621474|NCT01490632|63022147|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33621475|NCT01490632|63022128|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
33621476|NCT01490632|63022129|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
33621477|NCT01490632|63022130|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
33621478|NCT01490632|63022131|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
33621479|NCT01490632|63022132|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
33621480|NCT01490632|63022133|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
33621481|NCT01490632|63022134|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
33621482|NCT01490632|63022135|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
33621483|NCT01490632|63022136|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
33621484|NCT01490632|63022137|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
33621485|NCT01490632|63022138|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
33621486|NCT01490632|63022139|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
33621487|NCT01490632|63022140|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
33621488|NCT01490632|63022141|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
33621489|NCT01490632|63022142|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
33621490|NCT01490632|63022143|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
33621491|NCT01490632|63022144|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
33621492|NCT01490632|63022145|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
33621493|NCT01490632|63022146|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
33621494|NCT01490632|63022147|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
33621495|NCT01490632|63022128|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
33621496|NCT01490632|63022129|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
33621497|NCT01490632|63022130|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
33621498|NCT01490632|63022131|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
33621499|NCT01490632|63022132|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
33621500|NCT01490632|63022133|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
33621501|NCT01490632|63022134|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
33621502|NCT01490632|63022135|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
33621503|NCT01490632|63022136|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
33621504|NCT01490632|63022137|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
33621505|NCT01490632|63022138|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
33621506|NCT01490632|63022139|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
33621507|NCT01490632|63022140|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
33621508|NCT01490632|63022141|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
33621509|NCT01490632|63022142|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
33621510|NCT01490632|63022143|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
33621511|NCT01490632|63022144|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
33621512|NCT01490632|63022145|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
33457397|NCT00389597|62831855|FG002|Overall Study|Lost to Follow-up|4|||
33457398|NCT00389597|62831856|FG003|Overall Study|Lost to Follow-up|6|||
33457399|NCT00389519|62831870|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
33457400|NCT00389519|62831871|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
33457401|NCT00389519|62831872|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
33457402|NCT00389519|62831873|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
33457403|NCT00389519|62831870|FG000|Placebo Run-In|Withdrawal by Subject|19|||
33457404|NCT00389519|62831871|FG001|Placebo Run-In|Withdrawal by Subject|0|||
33457405|NCT00389519|62831872|FG002|Placebo Run-In|Withdrawal by Subject|0|||
33457406|NCT00389519|62831873|FG003|Placebo Run-In|Withdrawal by Subject|0|||
33457407|NCT00389519|62831870|FG000|Placebo Run-In|Reason not specified|40|||
33457408|NCT00389519|62831871|FG001|Placebo Run-In|Reason not specified|0|||
33457409|NCT00389519|62831872|FG002|Placebo Run-In|Reason not specified|0|||
33457410|NCT00389519|62831873|FG003|Placebo Run-In|Reason not specified|0|||
33457411|NCT00389519|62831870|FG000|Randomized|Did not receive study drug|2|||
33457412|NCT00389519|62831871|FG001|Randomized|Did not receive study drug|0|||
33457413|NCT00389519|62831872|FG002|Randomized|Did not receive study drug|0|||
33457414|NCT00389519|62831873|FG003|Randomized|Did not receive study drug|0|||
33621513|NCT01490632|63022146|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
33621514|NCT01490632|63022147|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
33621515|NCT01490632|63022128|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621516|NCT01490632|63022129|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621517|NCT01490632|63022130|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621518|NCT01490632|63022131|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621519|NCT01490632|63022132|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621520|NCT01490632|63022133|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621521|NCT01490632|63022134|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621522|NCT01490632|63022135|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621523|NCT01490632|63022136|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621524|NCT01490632|63022137|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621525|NCT01490632|63022138|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621526|NCT01490632|63022139|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621527|NCT01490632|63022140|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621528|NCT01490632|63022141|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621529|NCT01490632|63022142|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621530|NCT01490632|63022143|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621531|NCT01490632|63022144|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33621532|NCT01490632|63022145|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
33621533|NCT01490632|63022146|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
33621534|NCT01490632|63022147|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
33621535|NCT02073643|63022190|FG000|Overall Study|Lost to Follow-up|24|||
33621536|NCT01451554|63022196|FG000|Overall Study|Withdrawal by Subject|14|||
33621537|NCT01451554|63022197|FG001|Overall Study|Withdrawal by Subject|9|||
33621538|NCT01474486|63022203|FG000|Overall Study|Death|2|||
33621539|NCT01474486|63022203|FG000|Overall Study|Withdrawal by Subject|4|||
33621540|NCT01474486|63022203|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
33621541|NCT01451398|63022213|FG000|Overall Study|Adverse Event|7|||
33621542|NCT01451398|63022214|FG001|Overall Study|Adverse Event|9|||
33621543|NCT01451398|63022213|FG000|Overall Study|Protocol Violation|1|||
33621544|NCT01451398|63022214|FG001|Overall Study|Protocol Violation|2|||
33621545|NCT01451398|63022213|FG000|Overall Study|Physician Decision|1|||
33621546|NCT01451398|63022214|FG001|Overall Study|Physician Decision|1|||
33621547|NCT01451398|63022213|FG000|Overall Study|Withdrawal by Subject|10|||
33621548|NCT01451398|63022214|FG001|Overall Study|Withdrawal by Subject|14|||
33621549|NCT01451398|63022213|FG000|Overall Study|Lost to Follow-up|6|||
33621550|NCT01451398|63022214|FG001|Overall Study|Lost to Follow-up|4|||
33621551|NCT01451398|63022213|FG000|Overall Study|Non-compliance with study drug|1|||
33621552|NCT01451398|63022214|FG001|Overall Study|Non-compliance with study drug|3|||
33621553|NCT01451398|63022213|FG000|Overall Study|Non-compliance with protocol|1|||
33527151|NCT02805660|62914760|FG004|Overall Study|Death|0|||
33527152|NCT02805660|62914761|FG005|Overall Study|Death|14|||
33527153|NCT02805660|62914762|FG006|Overall Study|Death|12|||
33527154|NCT02805660|62914756|FG000|Overall Study|Lost to Follow-up|0|||
33527155|NCT02805660|62914757|FG001|Overall Study|Lost to Follow-up|1|||
33527156|NCT02805660|62914758|FG002|Overall Study|Lost to Follow-up|1|||
33527157|NCT02805660|62914759|FG003|Overall Study|Lost to Follow-up|2|||
33527158|NCT02805660|62914760|FG004|Overall Study|Lost to Follow-up|0|||
33527159|NCT02805660|62914761|FG005|Overall Study|Lost to Follow-up|0|||
33527160|NCT02805660|62914762|FG006|Overall Study|Lost to Follow-up|0|||
33527161|NCT02805660|62914756|FG000|Overall Study|Withdrawal by Subject|0|||
33527162|NCT02805660|62914757|FG001|Overall Study|Withdrawal by Subject|0|||
33527163|NCT02805660|62914758|FG002|Overall Study|Withdrawal by Subject|0|||
33527164|NCT02805660|62914759|FG003|Overall Study|Withdrawal by Subject|3|||
33527165|NCT02805660|62914760|FG004|Overall Study|Withdrawal by Subject|1|||
33527166|NCT02805660|62914761|FG005|Overall Study|Withdrawal by Subject|0|||
33527167|NCT02805660|62914762|FG006|Overall Study|Withdrawal by Subject|2|||
33527168|NCT02805660|62914756|FG000|Overall Study|Study terminated by Sponsor|0|||
33527169|NCT02805660|62914757|FG001|Overall Study|Study terminated by Sponsor|0|||
33527170|NCT02805660|62914758|FG002|Overall Study|Study terminated by Sponsor|1|||
33527171|NCT02805660|62914759|FG003|Overall Study|Study terminated by Sponsor|4|||
33621554|NCT01451398|63022214|FG001|Overall Study|Non-compliance with protocol|1|||
33621555|NCT01451398|63022213|FG000|Overall Study|Moved out of country|0|||
33621556|NCT01451398|63022214|FG001|Overall Study|Moved out of country|1|||
33621557|NCT01451398|63022213|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
33527172|NCT02805660|62914760|FG004|Overall Study|Study terminated by Sponsor|2|||
33621558|NCT01451398|63022214|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
33527173|NCT02805660|62914761|FG005|Overall Study|Study terminated by Sponsor|3|||
33527174|NCT02805660|62914762|FG006|Overall Study|Study terminated by Sponsor|1|||
33527175|NCT02805660|62914756|FG000|Overall Study|Miscellaneous|0|||
33527176|NCT02805660|62914757|FG001|Overall Study|Miscellaneous|1|||
33527177|NCT02805660|62914758|FG002|Overall Study|Miscellaneous|0|||
33621559|NCT01451398|63022213|FG000|Overall Study|Lack of Efficacy|0|||
33621560|NCT01451398|63022214|FG001|Overall Study|Lack of Efficacy|1|||
33621561|NCT02073565|63022222|FG000|Cohort A|Withdrawal by Subject|1|||
33621562|NCT02073565|63022223|FG001|Cohort A|Withdrawal by Subject|0|||
33621563|NCT02073565|63022222|FG000|Cohort B|Withdrawal by Subject|1|||
33621564|NCT02073565|63022223|FG001|Cohort B|Withdrawal by Subject|2|||
33621565|NCT02073565|63022222|FG000|Cohort C|Withdrawal by Subject|0|||
33621566|NCT02073565|63022223|FG001|Cohort C|Withdrawal by Subject|2|||
33621567|NCT02073565|63022222|FG000|Cohort C|Lost to Follow-up|0|||
33621568|NCT02073565|63022223|FG001|Cohort C|Lost to Follow-up|2|||
33621569|NCT02072941|63022231|FG000|Overall Study|Withdrawal by Subject|29|||
33621570|NCT02072941|63022232|FG001|Overall Study|Withdrawal by Subject|21|||
33621571|NCT02072941|63022231|FG000|Overall Study|Lost to Follow-up|4|||
33621572|NCT02072941|63022232|FG001|Overall Study|Lost to Follow-up|4|||
33621573|NCT02072941|63022231|FG000|Overall Study|Death|3|||
33621574|NCT02072941|63022232|FG001|Overall Study|Death|2|||
33621575|NCT02072941|63022231|FG000|Overall Study|Removed by Study Staff|2|||
33621576|NCT02072941|63022232|FG001|Overall Study|Removed by Study Staff|2|||
33621577|NCT02100631|63022241|FG000|Overall Study|Withdrawal by Subject|1|||
33621578|NCT02100631|63022242|FG001|Overall Study|Withdrawal by Subject|0|||
33621579|NCT02100631|63022243|FG002|Overall Study|Withdrawal by Subject|0|||
33621580|NCT02100631|63022241|FG000|Overall Study|Lost to Follow-up|3|||
33621581|NCT02100631|63022242|FG001|Overall Study|Lost to Follow-up|4|||
33621582|NCT02100631|63022243|FG002|Overall Study|Lost to Follow-up|0|||
33621583|NCT02100631|63022241|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
33621584|NCT02100631|63022242|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
33621585|NCT02100631|63022243|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
33621586|NCT01451164|63022255|FG000|Overall Study|Adverse Event|19|||
33621587|NCT01451164|63022256|FG001|Overall Study|Adverse Event|12|||
33527178|NCT02805660|62914759|FG003|Overall Study|Miscellaneous|4|||
33527179|NCT02805660|62914760|FG004|Overall Study|Miscellaneous|0|||
33621588|NCT01451164|63022257|FG002|Overall Study|Adverse Event|18|||
33621589|NCT01451164|63022258|FG003|Overall Study|Adverse Event|21|||
33621590|NCT01451164|63022255|FG000|Overall Study|Withdrawal Criteria|1|||
33621591|NCT01451164|63022256|FG001|Overall Study|Withdrawal Criteria|1|||
33621592|NCT01451164|63022257|FG002|Overall Study|Withdrawal Criteria|1|||
33621593|NCT01451164|63022258|FG003|Overall Study|Withdrawal Criteria|1|||
33621594|NCT01451164|63022255|FG000|Overall Study|Physician Decision|2|||
33621595|NCT01451164|63022256|FG001|Overall Study|Physician Decision|0|||
33621596|NCT01451164|63022257|FG002|Overall Study|Physician Decision|1|||
33621597|NCT01451164|63022258|FG003|Overall Study|Physician Decision|0|||
33621598|NCT01451164|63022255|FG000|Overall Study|Withdrawal by Subject|14|||
33621599|NCT01451164|63022256|FG001|Overall Study|Withdrawal by Subject|11|||
33621600|NCT01451164|63022257|FG002|Overall Study|Withdrawal by Subject|16|||
33621601|NCT01451164|63022258|FG003|Overall Study|Withdrawal by Subject|17|||
33621602|NCT01451164|63022255|FG000|Overall Study|Protocol Violation|0|||
33621603|NCT01451164|63022256|FG001|Overall Study|Protocol Violation|1|||
33621604|NCT01451164|63022257|FG002|Overall Study|Protocol Violation|0|||
33621605|NCT01451164|63022258|FG003|Overall Study|Protocol Violation|0|||
33621606|NCT01451164|63022255|FG000|Overall Study|Lack of Efficacy|7|||
33621607|NCT01451164|63022256|FG001|Overall Study|Lack of Efficacy|9|||
33621608|NCT01451164|63022257|FG002|Overall Study|Lack of Efficacy|9|||
33621609|NCT01451164|63022258|FG003|Overall Study|Lack of Efficacy|7|||
33621610|NCT02071849|63022268|FG000|6-month Primary Endpoint|Did not receive device|4|||
33621611|NCT02071849|63022268|FG000|6-month Primary Endpoint|Adverse Event|1|||
33621612|NCT02071849|63022268|FG000|2-year Extended Follow-up|Adverse Event|1|||
33621613|NCT02071771|63022272|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
33527180|NCT02805660|62914761|FG005|Overall Study|Miscellaneous|6|||
33527181|NCT02805660|62914762|FG006|Overall Study|Miscellaneous|4|||
33621614|NCT02071771|63022273|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
33621615|NCT02071771|63022272|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
33621616|NCT02071771|63022273|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
33621617|NCT02071225|63022279|FG000|Overall Study|Withdrawal of Consent|2|||
33621618|NCT02071225|63022279|FG000|Overall Study|Protocol Deviation|1|||
33621619|NCT02071225|63022279|FG000|Overall Study|Lost to Follow-up|2|||
33621620|NCT02071225|63022279|FG000|Overall Study|Death|25|||
33621621|NCT01450696|63022285|FG000|Overall Study|Never Treated|1|||
33621622|NCT01450696|63022286|FG001|Overall Study|Never Treated|1|||
33527182|NCT02807376|62914793|FG000|Overall Study|Intra-operative exclusion criteria|3|||
33621623|NCT01450696|63022285|FG000|Overall Study|Death|77|||
33621624|NCT01450696|63022286|FG001|Overall Study|Death|84|||
33621625|NCT01450696|63022285|FG000|Overall Study|Lost to Follow-up|3|||
33621626|NCT01450696|63022286|FG001|Overall Study|Lost to Follow-up|3|||
33621627|NCT01450696|63022285|FG000|Overall Study|Non-Compliance|1|||
33621628|NCT01450696|63022286|FG001|Overall Study|Non-Compliance|0|||
33621629|NCT01450696|63022285|FG000|Overall Study|Withdrawal by Subject|13|||
33621630|NCT01450696|63022286|FG001|Overall Study|Withdrawal by Subject|2|||
33621631|NCT01450696|63022285|FG000|Overall Study|Study Terminated by Sponsor|53|||
33621632|NCT01450696|63022286|FG001|Overall Study|Study Terminated by Sponsor|58|||
33621633|NCT02070991|63022294|FG000|Overall Study|Death|2|||
33621634|NCT02070991|63022295|FG001|Overall Study|Death|0|||
33621635|NCT02070991|63022294|FG000|Overall Study|Withdrawal by Subject|1|||
33621636|NCT02070991|63022295|FG001|Overall Study|Withdrawal by Subject|0|||
33621637|NCT02114515|63022303|FG000|Overall Study|Lost to Follow-up|52|||
33621638|NCT02114515|63022304|FG001|Overall Study|Lost to Follow-up|55|||
33621639|NCT02114515|63022303|FG000|Overall Study|Death|12|||
33621640|NCT02114515|63022304|FG001|Overall Study|Death|12|||
33621641|NCT02114515|63022303|FG000|Overall Study|Withdrawal by Subject|4|||
33621642|NCT02114515|63022304|FG001|Overall Study|Withdrawal by Subject|22|||
33621643|NCT02114515|63022303|FG000|Overall Study|Other|65|||
33621644|NCT02114515|63022304|FG001|Overall Study|Other|61|||
33621645|NCT01490086|63022315|FG000|Overall Study|Consent withdrawn|4|||
33621646|NCT01490086|63022316|FG001|Overall Study|Consent withdrawn|4|||
33621647|NCT01490086|63022317|FG002|Overall Study|Consent withdrawn|3|||
33621648|NCT01490086|63022318|FG003|Overall Study|Consent withdrawn|0|||
33621649|NCT01490086|63022319|FG004|Overall Study|Consent withdrawn|1|||
33621650|NCT01490086|63022315|FG000|Overall Study|Non-compliance|0|||
33621651|NCT01490086|63022316|FG001|Overall Study|Non-compliance|1|||
33527183|NCT02807376|62914794|FG001|Overall Study|Intra-operative exclusion criteria|0|||
33527184|NCT02807376|62914793|FG000|Overall Study|Lost to Follow-up|0|||
33527185|NCT02807376|62914794|FG001|Overall Study|Lost to Follow-up|1|||
33527186|NCT02804178|62914813|FG000|Overall Study|Adverse Event|1|||
33527187|NCT02917941|62914817|FG000|Treatment Period|Adverse Event|11|||
33527188|NCT02917941|62914817|FG000|Treatment Period|Progressive Disease|11|||
33527189|NCT02917941|62914817|FG000|Treatment Period|Reason not Specified|2|||
33527190|NCT02917941|62914817|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
33527191|NCT02917941|62914817|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
33527192|NCT01333956|62914825|FG000|Overall Study|Lost to Follow-up|1|||
33527193|NCT01333956|62914826|FG001|Overall Study|Lost to Follow-up|2|||
33527194|NCT01333956|62914827|FG002|Overall Study|Lost to Follow-up|0|||
33527195|NCT01333956|62914828|FG003|Overall Study|Lost to Follow-up|1|||
33527196|NCT01333956|62914825|FG000|Overall Study|Unable to complete study procedure|1|||
33527197|NCT01333956|62914826|FG001|Overall Study|Unable to complete study procedure|0|||
33527198|NCT01333956|62914827|FG002|Overall Study|Unable to complete study procedure|0|||
33527199|NCT01333956|62914828|FG003|Overall Study|Unable to complete study procedure|1|||
33527200|NCT01333956|62914825|FG000|Overall Study|Withdrawal by Subject|0|||
33621652|NCT01490086|63022317|FG002|Overall Study|Non-compliance|0|||
33621653|NCT01490086|63022318|FG003|Overall Study|Non-compliance|0|||
33621654|NCT01490086|63022319|FG004|Overall Study|Non-compliance|0|||
33621655|NCT01490086|63022315|FG000|Overall Study|Abnormal laboratory findings|1|||
33621656|NCT01490086|63022316|FG001|Overall Study|Abnormal laboratory findings|0|||
33621657|NCT01490086|63022317|FG002|Overall Study|Abnormal laboratory findings|0|||
33621658|NCT01490086|63022318|FG003|Overall Study|Abnormal laboratory findings|0|||
33621659|NCT01490086|63022319|FG004|Overall Study|Abnormal laboratory findings|0|||
33621660|NCT01490086|63022315|FG000|Overall Study|Lost to Follow-up|0|||
33621661|NCT01490086|63022316|FG001|Overall Study|Lost to Follow-up|0|||
33621662|NCT01490086|63022317|FG002|Overall Study|Lost to Follow-up|0|||
33621663|NCT01490086|63022318|FG003|Overall Study|Lost to Follow-up|0|||
33621664|NCT01490086|63022319|FG004|Overall Study|Lost to Follow-up|1|||
33621665|NCT01490086|63022315|FG000|Overall Study|Physician Decision|3|||
33621666|NCT01490086|63022316|FG001|Overall Study|Physician Decision|4|||
33621667|NCT01490086|63022317|FG002|Overall Study|Physician Decision|2|||
33621668|NCT01490086|63022318|FG003|Overall Study|Physician Decision|3|||
33527201|NCT01333956|62914826|FG001|Overall Study|Withdrawal by Subject|2|||
33527202|NCT01333956|62914827|FG002|Overall Study|Withdrawal by Subject|1|||
33527203|NCT01333956|62914828|FG003|Overall Study|Withdrawal by Subject|0|||
33527204|NCT01333722|62914841|FG000|Overall Study|Lack of Efficacy|0|||
33621669|NCT01490086|63022319|FG004|Overall Study|Physician Decision|1|||
33527205|NCT01333722|62914842|FG001|Overall Study|Lack of Efficacy|2|||
33527206|NCT01333722|62914841|FG000|Overall Study|Withdrawal by Subject|0|||
33621670|NCT01490086|63022315|FG000|Overall Study|Adverse Event|0|||
33621671|NCT01490086|63022316|FG001|Overall Study|Adverse Event|0|||
33621672|NCT01490086|63022317|FG002|Overall Study|Adverse Event|1|||
33621673|NCT01490086|63022318|FG003|Overall Study|Adverse Event|2|||
33621674|NCT01490086|63022319|FG004|Overall Study|Adverse Event|0|||
33621675|NCT01490086|63022315|FG000|Overall Study|Lack of Efficacy|0|||
33621676|NCT01490086|63022316|FG001|Overall Study|Lack of Efficacy|3|||
33621677|NCT01490086|63022317|FG002|Overall Study|Lack of Efficacy|1|||
33621678|NCT01490086|63022318|FG003|Overall Study|Lack of Efficacy|0|||
33621679|NCT01490086|63022319|FG004|Overall Study|Lack of Efficacy|8|||
33621680|NCT01490086|63022315|FG000|Overall Study|Worsening of symptoms|0|||
33621681|NCT01490086|63022316|FG001|Overall Study|Worsening of symptoms|1|||
33621682|NCT01490086|63022317|FG002|Overall Study|Worsening of symptoms|0|||
33621683|NCT01490086|63022318|FG003|Overall Study|Worsening of symptoms|1|||
33621684|NCT01490086|63022319|FG004|Overall Study|Worsening of symptoms|0|||
33621685|NCT01490086|63022315|FG000|Overall Study|Subject uncontrollable and abusive|0|||
33621686|NCT01490086|63022316|FG001|Overall Study|Subject uncontrollable and abusive|1|||
33527207|NCT01333722|62914842|FG001|Overall Study|Withdrawal by Subject|1|||
33527208|NCT01370694|62914850|FG000|Overall Study|Switched to rituximab|4|||
33527209|NCT01370694|62914850|FG000|Overall Study|Progressive disease|2|||
33621687|NCT01490086|63022317|FG002|Overall Study|Subject uncontrollable and abusive|0|||
33621688|NCT01490086|63022318|FG003|Overall Study|Subject uncontrollable and abusive|0|||
33621689|NCT01490086|63022319|FG004|Overall Study|Subject uncontrollable and abusive|0|||
33621690|NCT01490086|63022315|FG000|Overall Study|Subject left hospital|0|||
33621691|NCT01490086|63022316|FG001|Overall Study|Subject left hospital|1|||
33621692|NCT01490086|63022317|FG002|Overall Study|Subject left hospital|0|||
33621693|NCT01490086|63022318|FG003|Overall Study|Subject left hospital|1|||
33621694|NCT01490086|63022319|FG004|Overall Study|Subject left hospital|0|||
33621695|NCT02114203|63022334|FG000|Overall Study|Adverse Event|0|||
33621696|NCT02114203|63022335|FG001|Overall Study|Adverse Event|1|||
33621697|NCT02114203|63022336|FG002|Overall Study|Adverse Event|0|||
33621698|NCT02114203|63022334|FG000|Overall Study|Withdrawal by Subject|0|||
33621699|NCT02114203|63022335|FG001|Overall Study|Withdrawal by Subject|1|||
33621700|NCT02114203|63022336|FG002|Overall Study|Withdrawal by Subject|0|||
33621701|NCT02113579|63022346|FG000|Overall Study|Adverse Event|1|||
33621702|NCT02113579|63022347|FG001|Overall Study|Adverse Event|0|||
33621703|NCT02113579|63022346|FG000|Overall Study|Withdrawal by Subject|3|||
33621704|NCT02113579|63022347|FG001|Overall Study|Withdrawal by Subject|2|||
33621705|NCT02113579|63022346|FG000|Overall Study|Lost to Follow-up|6|||
33621706|NCT02113579|63022347|FG001|Overall Study|Lost to Follow-up|2|||
33621707|NCT01474018|63022355|FG000|Overall Study|Lost to Follow-up|0|||
33621708|NCT01474018|63022356|FG001|Overall Study|Lost to Follow-up|1|||
33621709|NCT01474018|63022355|FG000|Overall Study|Withdrawal by Subject|0|||
33621710|NCT01474018|63022356|FG001|Overall Study|Withdrawal by Subject|2|||
33621711|NCT02100475|63022364|FG000|Overall Study|Unclassified|1|||
33621712|NCT02100475|63022365|FG001|Overall Study|Unclassified|2|||
33621713|NCT02100475|63022364|FG000|Overall Study|Withdrawal criteria|1|||
33621714|NCT02100475|63022365|FG001|Overall Study|Withdrawal criteria|0|||
33621715|NCT02113189|63022374|FG000|Overall Study|Lost to follow up|2|||
33457415|NCT00389519|62831870|FG000|Treated|Adverse Event|1|||
33457416|NCT00389519|62831871|FG001|Treated|Adverse Event|0|||
33457417|NCT00389519|62831872|FG002|Treated|Adverse Event|0|||
33457418|NCT00389519|62831873|FG003|Treated|Adverse Event|2|||
33457419|NCT00389519|62831870|FG000|Treated|Reason not specified|1|||
33457420|NCT00389519|62831871|FG001|Treated|Reason not specified|1|||
33457421|NCT00389519|62831872|FG002|Treated|Reason not specified|0|||
33457422|NCT00389519|62831873|FG003|Treated|Reason not specified|2|||
33527210|NCT03315143|62914856|FG000|Overall Study|Death|240|||
33527211|NCT03315143|62914857|FG001|Overall Study|Death|246|||
33527212|NCT03315143|62914856|FG000|Overall Study|Withdrawal by Subject|57|||
33527213|NCT03315143|62914857|FG001|Overall Study|Withdrawal by Subject|68|||
33527214|NCT03315143|62914856|FG000|Overall Study|Site Terminated by Sponsor|256|||
33527215|NCT03315143|62914857|FG001|Overall Study|Site Terminated by Sponsor|282|||
33527216|NCT03315143|62914856|FG000|Overall Study|Study Terminated by Sponsor|4723|||
33527217|NCT03315143|62914857|FG001|Overall Study|Study Terminated by Sponsor|4664|||
33527218|NCT03315143|62914856|FG000|Overall Study|Reason not Specified|16|||
33527219|NCT03315143|62914857|FG001|Overall Study|Reason not Specified|32|||
33527220|NCT02797080|62914863|FG000|Overall Study|Lost to Follow-up|1|||
33527221|NCT02797080|62914863|FG000|Overall Study|Withdrawal by Subject|1|||
33527222|NCT02915835|62914869|FG000|Overall Study|Physician Decision|1|||
33527223|NCT02915835|62914870|FG001|Overall Study|Physician Decision|0|||
33527224|NCT02915835|62914869|FG000|Overall Study|Withdrawal by Subject|0|||
33457423|NCT00389441|62831883|FG000|Overall Study|Adverse Event|7|||
33457424|NCT00389441|62831883|FG000|Overall Study|Death|4|||
33527225|NCT02915835|62914870|FG001|Overall Study|Withdrawal by Subject|1|||
33621716|NCT02113189|63022375|FG001|Overall Study|Lost to follow up|1|||
33621717|NCT02113189|63022376|FG002|Overall Study|Lost to follow up|3|||
33621718|NCT01440946|63022389|FG000|Overall Study|Lost to Follow-up|1|||
33621719|NCT01440946|63022390|FG001|Overall Study|Lost to Follow-up|1|||
33621720|NCT01440946|63022389|FG000|Overall Study|Physician Decision|1|||
33457425|NCT00389441|62831883|FG000|Overall Study|Lost to Follow-up|2|||
33457426|NCT00389441|62831883|FG000|Overall Study|Withdrawal by Subject|4|||
33527226|NCT01370616|62914878|FG000|Overall Study|Adverse Event|11|||
33527227|NCT01370616|62914879|FG001|Overall Study|Adverse Event|16|||
33457427|NCT00389441|62831883|FG000|Overall Study|Physician Decision|1|||
33457428|NCT00389441|62831883|FG000|Overall Study|Protocol Violation|1|||
33527228|NCT01370616|62914878|FG000|Overall Study|Death|1|||
33621721|NCT01440946|63022390|FG001|Overall Study|Physician Decision|0|||
33621722|NCT01450540|63022399|FG000|Overall Study|Withdrawal by Subject|19|||
33621723|NCT01450540|63022400|FG001|Overall Study|Withdrawal by Subject|13|||
33621724|NCT01450540|63022399|FG000|Overall Study|protocol deviation|3|||
33621725|NCT01450540|63022400|FG001|Overall Study|protocol deviation|23|||
33621726|NCT02070757|63022410|FG000|Overall Study|Adverse Event|107|||
33621727|NCT02070757|63022411|FG001|Overall Study|Adverse Event|99|||
33621728|NCT02070757|63022410|FG000|Overall Study|Lost to Follow-up|7|||
33621729|NCT02070757|63022411|FG001|Overall Study|Lost to Follow-up|4|||
33621730|NCT02070757|63022410|FG000|Overall Study|Protocol Violation|0|||
33621731|NCT02070757|63022411|FG001|Overall Study|Protocol Violation|4|||
33621732|NCT02070757|63022410|FG000|Overall Study|Withdrawal by Subject|1|||
33621733|NCT02070757|63022411|FG001|Overall Study|Withdrawal by Subject|3|||
33621734|NCT02070757|63022410|FG000|Overall Study|Investigator Decision|0|||
33621735|NCT02070757|63022411|FG001|Overall Study|Investigator Decision|2|||
33621736|NCT02070757|63022410|FG000|Overall Study|Discharged from Study Hospital|2|||
33621737|NCT02070757|63022411|FG001|Overall Study|Discharged from Study Hospital|2|||
33621738|NCT02100319|63022417|FG000|Overall Study|Case Report Forms Uncollected|11|||
33621739|NCT02100319|63022417|FG000|Overall Study|Protocol Deviation|5|||
33621740|NCT01625845|63022423|FG000|Overall Study|Adverse Event|1|||
33621741|NCT01625845|63022424|FG001|Overall Study|Adverse Event|2|||
33621742|NCT01625845|63022423|FG000|Overall Study|Lost to Follow-up|2|||
33621743|NCT01625845|63022424|FG001|Overall Study|Lost to Follow-up|1|||
33621744|NCT01625845|63022423|FG000|Overall Study|Withdrawal by Subject|2|||
33621745|NCT01625845|63022424|FG001|Overall Study|Withdrawal by Subject|0|||
33621746|NCT01473940|63022434|FG000|Induction Therapy|Death|0|||
33621747|NCT01473940|63022435|FG001|Induction Therapy|Death|0|||
33621748|NCT01473940|63022436|FG002|Induction Therapy|Death|1|||
33527229|NCT01370616|62914879|FG001|Overall Study|Death|0|||
33527230|NCT01370616|62914878|FG000|Overall Study|Lack of Efficacy|6|||
33527231|NCT01370616|62914879|FG001|Overall Study|Lack of Efficacy|2|||
33527232|NCT01370616|62914878|FG000|Overall Study|Lost to Follow-up|0|||
33527233|NCT01370616|62914879|FG001|Overall Study|Lost to Follow-up|3|||
33527234|NCT01370616|62914878|FG000|Overall Study|Physician Decision|6|||
33527235|NCT01370616|62914879|FG001|Overall Study|Physician Decision|6|||
33527236|NCT01370616|62914878|FG000|Overall Study|Progressive Disease|0|||
33527237|NCT01370616|62914879|FG001|Overall Study|Progressive Disease|1|||
33527238|NCT01370616|62914878|FG000|Overall Study|Recovery|1|||
33527239|NCT01370616|62914879|FG001|Overall Study|Recovery|0|||
33527240|NCT01370616|62914878|FG000|Overall Study|Technical Problems|3|||
33527241|NCT01370616|62914879|FG001|Overall Study|Technical Problems|5|||
33527242|NCT01370616|62914878|FG000|Overall Study|Withdrawal by Subject|34|||
33527243|NCT01370616|62914879|FG001|Overall Study|Withdrawal by Subject|34|||
33527244|NCT02916927|62914892|FG000|Overall Study|Discharged prior to study drug receipt|0|||
33527245|NCT02916927|62914893|FG001|Overall Study|Discharged prior to study drug receipt|2|||
33527246|NCT02916927|62914892|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
33527247|NCT02916927|62914893|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
33527248|NCT02916927|62914892|FG000|Overall Study|Withdrawal before first time point|1|||
33527249|NCT02916927|62914893|FG001|Overall Study|Withdrawal before first time point|0|||
33527250|NCT02916693|62914899|FG000|Overall Study|Lost to Follow-up|7|||
33527251|NCT02574455|62914909|FG000|Overall Study|Death|197|||
33527252|NCT02574455|62914910|FG001|Overall Study|Death|210|||
33527253|NCT02574455|62914909|FG000|Overall Study|Withdrawal of Consent|11|||
33527254|NCT02574455|62914910|FG001|Overall Study|Withdrawal of Consent|28|||
33527255|NCT02574455|62914909|FG000|Overall Study|Lost to Follow-up|4|||
33527256|NCT02574455|62914910|FG001|Overall Study|Lost to Follow-up|4|||
33527257|NCT02574455|62914909|FG000|Overall Study|Sponsor's Decision|55|||
33527258|NCT02574455|62914910|FG001|Overall Study|Sponsor's Decision|20|||
33527259|NCT02795832|62914922|FG000|Overall Study|Adverse Event|0|||
33527260|NCT02795832|62914923|FG001|Overall Study|Adverse Event|0|||
33527261|NCT02795832|62914924|FG002|Overall Study|Adverse Event|0|||
33527262|NCT02795832|62914925|FG003|Overall Study|Adverse Event|0|||
33527263|NCT02795832|62914926|FG004|Overall Study|Adverse Event|0|||
33527264|NCT02795832|62914927|FG005|Overall Study|Adverse Event|3|||
33527265|NCT02794974|62914951|FG000|Overall Study|Physician Decision|0|||
33527266|NCT02794974|62914952|FG001|Overall Study|Physician Decision|1|||
33621749|NCT01473940|63022437|FG003|Induction Therapy|Death|1|||
33621750|NCT01473940|63022434|FG000|Induction Therapy|Progressive Disease|0|||
33621751|NCT01473940|63022435|FG001|Induction Therapy|Progressive Disease|1|||
33621752|NCT01473940|63022436|FG002|Induction Therapy|Progressive Disease|1|||
33621753|NCT01473940|63022437|FG003|Induction Therapy|Progressive Disease|0|||
33621754|NCT01473940|63022434|FG000|Maintenance Therapy|Progressive Disease|1|||
33621755|NCT01473940|63022435|FG001|Maintenance Therapy|Progressive Disease|2|||
33527267|NCT02419417|62914969|FG000|Overall Study|Disease progression|5|||
33527268|NCT02419417|62914970|FG001|Overall Study|Disease progression|4|||
33527269|NCT02419417|62914971|FG002|Overall Study|Disease progression|13|||
33527270|NCT02419417|62914972|FG003|Overall Study|Disease progression|10|||
33527271|NCT02419417|62914973|FG004|Overall Study|Disease progression|10|||
33621756|NCT01473940|63022436|FG002|Maintenance Therapy|Progressive Disease|1|||
33621757|NCT01473940|63022437|FG003|Maintenance Therapy|Progressive Disease|4|||
33621758|NCT01832727|63022459|FG000|Overall Study|Adverse Event|4|||
33621759|NCT01832727|63022460|FG001|Overall Study|Adverse Event|6|||
33621760|NCT01832727|63022461|FG002|Overall Study|Adverse Event|1|||
33621761|NCT01832727|63022462|FG003|Overall Study|Adverse Event|0|||
33621762|NCT01832727|63022463|FG004|Overall Study|Adverse Event|1|||
33621763|NCT01832727|63022464|FG005|Overall Study|Adverse Event|1|||
33621764|NCT01832727|63022465|FG006|Overall Study|Adverse Event|2|||
33621765|NCT01832727|63022466|FG007|Overall Study|Adverse Event|1|||
33621766|NCT01832727|63022467|FG008|Overall Study|Adverse Event|9|||
33621767|NCT01832727|63022459|FG000|Overall Study|Disease progression|3|||
33621768|NCT01832727|63022460|FG001|Overall Study|Disease progression|0|||
33621769|NCT01832727|63022461|FG002|Overall Study|Disease progression|2|||
33621770|NCT01832727|63022462|FG003|Overall Study|Disease progression|1|||
33621771|NCT01832727|63022463|FG004|Overall Study|Disease progression|3|||
33621772|NCT01832727|63022464|FG005|Overall Study|Disease progression|3|||
33621773|NCT01832727|63022465|FG006|Overall Study|Disease progression|6|||
33621774|NCT01832727|63022466|FG007|Overall Study|Disease progression|2|||
33621775|NCT01832727|63022467|FG008|Overall Study|Disease progression|7|||
33621776|NCT01832727|63022459|FG000|Overall Study|Lost to Follow-up|0|||
33621777|NCT01832727|63022460|FG001|Overall Study|Lost to Follow-up|0|||
33621778|NCT01832727|63022461|FG002|Overall Study|Lost to Follow-up|0|||
33621779|NCT01832727|63022462|FG003|Overall Study|Lost to Follow-up|1|||
33621780|NCT01832727|63022463|FG004|Overall Study|Lost to Follow-up|0|||
33621781|NCT01832727|63022464|FG005|Overall Study|Lost to Follow-up|0|||
33621782|NCT01832727|63022465|FG006|Overall Study|Lost to Follow-up|0|||
33621783|NCT01832727|63022466|FG007|Overall Study|Lost to Follow-up|0|||
33621784|NCT01832727|63022467|FG008|Overall Study|Lost to Follow-up|0|||
33621785|NCT01832727|63022459|FG000|Overall Study|Physician Decision|1|||
33621786|NCT01832727|63022460|FG001|Overall Study|Physician Decision|0|||
33621787|NCT01832727|63022461|FG002|Overall Study|Physician Decision|0|||
33621788|NCT01832727|63022462|FG003|Overall Study|Physician Decision|1|||
33621789|NCT01832727|63022463|FG004|Overall Study|Physician Decision|0|||
33621790|NCT01832727|63022464|FG005|Overall Study|Physician Decision|1|||
33621791|NCT01832727|63022465|FG006|Overall Study|Physician Decision|0|||
33621792|NCT01832727|63022466|FG007|Overall Study|Physician Decision|0|||
33621793|NCT01832727|63022467|FG008|Overall Study|Physician Decision|0|||
33621794|NCT01832727|63022459|FG000|Overall Study|Withdrawal by Subject|1|||
33621795|NCT01832727|63022460|FG001|Overall Study|Withdrawal by Subject|1|||
33621796|NCT01832727|63022461|FG002|Overall Study|Withdrawal by Subject|0|||
33621797|NCT01832727|63022462|FG003|Overall Study|Withdrawal by Subject|1|||
33621798|NCT01832727|63022463|FG004|Overall Study|Withdrawal by Subject|0|||
33621799|NCT01832727|63022464|FG005|Overall Study|Withdrawal by Subject|1|||
33457429|NCT00389441|62831883|FG000|Overall Study|Global deterioration of health status|4|||
33457430|NCT00389441|62831883|FG000|Overall Study|Objective progression or relapse|26|||
33457431|NCT00389441|62831883|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
33457432|NCT00389441|62831883|FG000|Overall Study|Clinical progression|1|||
33457433|NCT00118898|62831891|FG000|Overall Study|Death|6|||
33527272|NCT02419417|62914974|FG005|Overall Study|Disease progression|3|||
33527273|NCT02419417|62914975|FG006|Overall Study|Disease progression|4|||
33527274|NCT02419417|62914976|FG007|Overall Study|Disease progression|5|||
33527275|NCT02419417|62914977|FG008|Overall Study|Disease progression|13|||
33527276|NCT02419417|62914978|FG009|Overall Study|Disease progression|9|||
33527277|NCT02419417|62914979|FG010|Overall Study|Disease progression|0|||
33527278|NCT02419417|62914969|FG000|Overall Study|Study drug toxicity|0|||
33527279|NCT02419417|62914970|FG001|Overall Study|Study drug toxicity|0|||
33457434|NCT00118898|62831892|FG001|Overall Study|Death|11|||
33457435|NCT00118898|62831893|FG002|Overall Study|Death|6|||
33457436|NCT00118898|62831894|FG003|Overall Study|Death|8|||
33457437|NCT00118898|62831891|FG000|Overall Study|Lost to Follow-up|26|||
33457438|NCT00118898|62831892|FG001|Overall Study|Lost to Follow-up|34|||
33527280|NCT02419417|62914971|FG002|Overall Study|Study drug toxicity|0|||
33527281|NCT02419417|62914972|FG003|Overall Study|Study drug toxicity|0|||
33527282|NCT02419417|62914973|FG004|Overall Study|Study drug toxicity|1|||
33527283|NCT02419417|62914974|FG005|Overall Study|Study drug toxicity|0|||
33621800|NCT01832727|63022465|FG006|Overall Study|Withdrawal by Subject|0|||
33621801|NCT01832727|63022466|FG007|Overall Study|Withdrawal by Subject|2|||
33621802|NCT01832727|63022467|FG008|Overall Study|Withdrawal by Subject|1|||
33621803|NCT01832727|63022459|FG000|Overall Study|Study terminated by sponsor|0|||
33621804|NCT01832727|63022460|FG001|Overall Study|Study terminated by sponsor|0|||
33621805|NCT01832727|63022461|FG002|Overall Study|Study terminated by sponsor|0|||
33621806|NCT01832727|63022462|FG003|Overall Study|Study terminated by sponsor|0|||
33621807|NCT01832727|63022463|FG004|Overall Study|Study terminated by sponsor|0|||
33621808|NCT01832727|63022464|FG005|Overall Study|Study terminated by sponsor|0|||
33621809|NCT01832727|63022465|FG006|Overall Study|Study terminated by sponsor|0|||
33621810|NCT01832727|63022466|FG007|Overall Study|Study terminated by sponsor|1|||
33621811|NCT01832727|63022467|FG008|Overall Study|Study terminated by sponsor|1|||
33621812|NCT01473394|63022498|FG000|Overall Study|Adverse Event|13|||
33527284|NCT02419417|62914975|FG006|Overall Study|Study drug toxicity|0|||
33527285|NCT02419417|62914976|FG007|Overall Study|Study drug toxicity|0|||
33527286|NCT02419417|62914977|FG008|Overall Study|Study drug toxicity|0|||
33527287|NCT02419417|62914978|FG009|Overall Study|Study drug toxicity|0|||
33527288|NCT02419417|62914979|FG010|Overall Study|Study drug toxicity|0|||
33527289|NCT02419417|62914969|FG000|Overall Study|Adverse event unrelated to study drug|0|||
33527290|NCT02419417|62914970|FG001|Overall Study|Adverse event unrelated to study drug|0|||
33527291|NCT02419417|62914971|FG002|Overall Study|Adverse event unrelated to study drug|0|||
33527292|NCT02419417|62914972|FG003|Overall Study|Adverse event unrelated to study drug|0|||
33527293|NCT02419417|62914973|FG004|Overall Study|Adverse event unrelated to study drug|2|||
33527294|NCT02419417|62914974|FG005|Overall Study|Adverse event unrelated to study drug|1|||
33527295|NCT02419417|62914975|FG006|Overall Study|Adverse event unrelated to study drug|0|||
33527296|NCT02419417|62914976|FG007|Overall Study|Adverse event unrelated to study drug|1|||
33527297|NCT02419417|62914977|FG008|Overall Study|Adverse event unrelated to study drug|0|||
33527298|NCT02419417|62914978|FG009|Overall Study|Adverse event unrelated to study drug|0|||
33527299|NCT02419417|62914979|FG010|Overall Study|Adverse event unrelated to study drug|0|||
33527300|NCT02419417|62914969|FG000|Overall Study|Participant request to discontinue|0|||
33527301|NCT02419417|62914970|FG001|Overall Study|Participant request to discontinue|0|||
33527302|NCT02419417|62914971|FG002|Overall Study|Participant request to discontinue|0|||
33527303|NCT02419417|62914972|FG003|Overall Study|Participant request to discontinue|0|||
33527304|NCT02419417|62914973|FG004|Overall Study|Participant request to discontinue|0|||
33527305|NCT02419417|62914974|FG005|Overall Study|Participant request to discontinue|0|||
33527306|NCT02419417|62914975|FG006|Overall Study|Participant request to discontinue|0|||
33527307|NCT02419417|62914976|FG007|Overall Study|Participant request to discontinue|0|||
33527308|NCT02419417|62914977|FG008|Overall Study|Participant request to discontinue|0|||
33527309|NCT02419417|62914978|FG009|Overall Study|Participant request to discontinue|1|||
33527310|NCT02419417|62914979|FG010|Overall Study|Participant request to discontinue|0|||
33527311|NCT02419417|62914969|FG000|Overall Study|Withdrawal by Subject|0|||
33527312|NCT02419417|62914970|FG001|Overall Study|Withdrawal by Subject|0|||
33527313|NCT02419417|62914971|FG002|Overall Study|Withdrawal by Subject|0|||
33527314|NCT02419417|62914972|FG003|Overall Study|Withdrawal by Subject|0|||
33527315|NCT02419417|62914973|FG004|Overall Study|Withdrawal by Subject|0|||
33527316|NCT02419417|62914974|FG005|Overall Study|Withdrawal by Subject|0|||
33527317|NCT02419417|62914975|FG006|Overall Study|Withdrawal by Subject|0|||
33621813|NCT01473394|63022499|FG001|Overall Study|Adverse Event|16|||
33621814|NCT01473394|63022498|FG000|Overall Study|Insufficient Therapeutic Response|4|||
33621815|NCT01473394|63022499|FG001|Overall Study|Insufficient Therapeutic Response|1|||
33621816|NCT01473394|63022498|FG000|Overall Study|Protocol Violation|7|||
33621817|NCT01473394|63022499|FG001|Overall Study|Protocol Violation|5|||
33621818|NCT01473394|63022498|FG000|Overall Study|Withdrew Consent|12|||
33621819|NCT01473394|63022499|FG001|Overall Study|Withdrew Consent|10|||
33621820|NCT01473394|63022498|FG000|Overall Study|Lost to Follow-up|9|||
33621821|NCT01473394|63022499|FG001|Overall Study|Lost to Follow-up|11|||
33621822|NCT01449682|63022507|FG000|Overall Study|Death|0|||
33621823|NCT01449682|63022508|FG001|Overall Study|Death|1|||
33621824|NCT01449682|63022507|FG000|Overall Study|Adverse Event|1|||
33621825|NCT01449682|63022508|FG001|Overall Study|Adverse Event|0|||
33621826|NCT01449526|63022516|FG000|Overall Study|Lost to Follow-up|1|||
33621827|NCT01449526|63022517|FG001|Overall Study|Lost to Follow-up|2|||
33621828|NCT01449526|63022516|FG000|Overall Study|Withdrawal by Subject|1|||
33457439|NCT00118898|62831893|FG002|Overall Study|Lost to Follow-up|33|||
33457440|NCT00118898|62831894|FG003|Overall Study|Lost to Follow-up|33|||
33457441|NCT00118898|62831891|FG000|Overall Study|Withdrawal by Subject|10|||
33457442|NCT00118898|62831892|FG001|Overall Study|Withdrawal by Subject|5|||
33457443|NCT00118898|62831893|FG002|Overall Study|Withdrawal by Subject|8|||
33457444|NCT00118898|62831894|FG003|Overall Study|Withdrawal by Subject|8|||
33457445|NCT00118898|62831891|FG000|Overall Study|Site Closure|33|||
33457446|NCT00118898|62831892|FG001|Overall Study|Site Closure|31|||
33457447|NCT00118898|62831893|FG002|Overall Study|Site Closure|28|||
33457448|NCT00118898|62831894|FG003|Overall Study|Site Closure|37|||
33457449|NCT00118898|62831891|FG000|Overall Study|Severe debilitation|1|||
33457450|NCT00118898|62831892|FG001|Overall Study|Severe debilitation|4|||
33527318|NCT02419417|62914976|FG007|Overall Study|Withdrawal by Subject|0|||
33527319|NCT02419417|62914977|FG008|Overall Study|Withdrawal by Subject|0|||
33527320|NCT02419417|62914978|FG009|Overall Study|Withdrawal by Subject|0|||
33527321|NCT02419417|62914979|FG010|Overall Study|Withdrawal by Subject|1|||
33325358|NCT00599521|62702122|FG001|Overall Study|Pregnancy|2|||
33457451|NCT00118898|62831893|FG002|Overall Study|Severe debilitation|6|||
33457452|NCT00118898|62831894|FG003|Overall Study|Severe debilitation|4|||
33527322|NCT00777491|62915020|FG000|Overall Study|Protocol Violation|0|||
33527323|NCT00777491|62915021|FG001|Overall Study|Protocol Violation|2|||
33621829|NCT01449526|63022517|FG001|Overall Study|Withdrawal by Subject|1|||
33621830|NCT01449526|63022516|FG000|Overall Study|Symptoms/complaints|0|||
33621831|NCT01449526|63022517|FG001|Overall Study|Symptoms/complaints|1|||
33457453|NCT00118898|62831891|FG000|Overall Study|Not compliant with requirements|11|||
33621832|NCT01449526|63022516|FG000|Overall Study|Lack of Motivation|0|||
33621833|NCT01449526|63022517|FG001|Overall Study|Lack of Motivation|1|||
33621834|NCT01449526|63022516|FG000|Overall Study|Cannot maintain visits|0|||
33621835|NCT01449526|63022517|FG001|Overall Study|Cannot maintain visits|1|||
33621836|NCT01440322|63022525|FG000|Overall Study|Discomfort|2|||
33621837|NCT01440322|63022526|FG001|Overall Study|Discomfort|0|||
33621838|NCT01440322|63022525|FG000|Overall Study|Biomicroscopy|1|||
33457454|NCT00118898|62831892|FG001|Overall Study|Not compliant with requirements|13|||
33457455|NCT00118898|62831893|FG002|Overall Study|Not compliant with requirements|11|||
33457456|NCT00118898|62831894|FG003|Overall Study|Not compliant with requirements|11|||
33457457|NCT00118898|62831891|FG000|Overall Study|Not able to get to clinic|34|||
33457458|NCT00118898|62831892|FG001|Overall Study|Not able to get to clinic|43|||
33457459|NCT00118898|62831893|FG002|Overall Study|Not able to get to clinic|31|||
33457460|NCT00118898|62831894|FG003|Overall Study|Not able to get to clinic|40|||
33457461|NCT00118430|62831907|FG000|Overall Study|Withdrawal by Subject|6|||
33457462|NCT00118430|62831908|FG001|Overall Study|Withdrawal by Subject|2|||
33457463|NCT00118430|62831909|FG002|Overall Study|Withdrawal by Subject|0|||
33527324|NCT00777491|62915020|FG000|Overall Study|Did not receive any protocol treatment|2|||
33527325|NCT00777491|62915021|FG001|Overall Study|Did not receive any protocol treatment|0|||
33527326|NCT02066532|62915031|FG000|Phase II|Withdrawal by Subject|1|||
33527327|NCT02066532|62915032|FG001|Phase II|Withdrawal by Subject|0|||
33527328|NCT02066532|62915033|FG002|Phase II|Withdrawal by Subject|0|||
33527329|NCT02066532|62915034|FG003|Phase II|Withdrawal by Subject|0|||
33527330|NCT03077711|62915041|FG000|Overall Study|Lost to Follow-up|2|||
33527331|NCT03077711|62915042|FG001|Overall Study|Lost to Follow-up|2|||
33527332|NCT03077711|62915041|FG000|Overall Study|noncompliant taking medication|2|||
33527333|NCT03077711|62915042|FG001|Overall Study|noncompliant taking medication|0|||
33527334|NCT04311463|62915069|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
33527335|NCT04311463|62915070|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
33527336|NCT04311463|62915069|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
33527337|NCT04311463|62915070|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
33527338|NCT04311463|62915069|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
33527339|NCT04311463|62915070|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
33527340|NCT01370538|62915083|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
33527341|NCT01370538|62915084|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
33527342|NCT01370538|62915083|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33527343|NCT01370538|62915084|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33527344|NCT01370538|62915083|FG000|Overall Study|Adverse Event|1|||
33527345|NCT01370538|62915084|FG001|Overall Study|Adverse Event|0|||
33527346|NCT01370538|62915083|FG000|Overall Study|Protocol Violation|8|||
33527347|NCT01370538|62915084|FG001|Overall Study|Protocol Violation|5|||
33527348|NCT01370538|62915083|FG000|Overall Study|Development of study specific withdrawal|1|||
33527349|NCT01370538|62915084|FG001|Overall Study|Development of study specific withdrawal|1|||
33527350|NCT01370538|62915083|FG000|Overall Study|Lost to follow up|6|||
33527351|NCT01370538|62915084|FG001|Overall Study|Lost to follow up|10|||
33527352|NCT03402841|62915103|FG000|Overall Study|Withdrawal by Subject|3|||
33527353|NCT03402841|62915103|FG000|Overall Study|Lost to Follow-up|2|||
33527354|NCT03402841|62915103|FG000|Overall Study|Death|146|||
33527355|NCT02881957|62915118|FG000|Overall Study|Comfort care|0|||
33527356|NCT02881957|62915119|FG001|Overall Study|Comfort care|1|||
33527357|NCT02881957|62915118|FG000|Overall Study|Concurrent trial enrollment|0|||
33527358|NCT02881957|62915119|FG001|Overall Study|Concurrent trial enrollment|1|||
33527359|NCT02881957|62915118|FG000|Overall Study|Discharged within 48 hours|0|||
33527360|NCT02881957|62915119|FG001|Overall Study|Discharged within 48 hours|1|||
33527361|NCT02881957|62915118|FG000|Overall Study|Withdrawal by Subject|2|||
33527362|NCT02881957|62915119|FG001|Overall Study|Withdrawal by Subject|1|||
33527363|NCT02881957|62915118|FG000|Overall Study|Protocol Violation|1|||
33527364|NCT02881957|62915119|FG001|Overall Study|Protocol Violation|0|||
33527365|NCT03022461|62915125|FG000|Overall Study|Death|3|||
33527366|NCT02750930|62915130|FG000|Overall Study|Study closed/terminated|8|||
33527367|NCT03078907|62915136|FG000|Overall Study|Adverse Event|2|||
33527368|NCT03078907|62915137|FG001|Overall Study|Adverse Event|0|||
33527369|NCT03078907|62915136|FG000|Overall Study|Other|1|||
33527370|NCT03078907|62915137|FG001|Overall Study|Other|0|||
33527371|NCT03078907|62915136|FG000|Overall Study|Protocol Violation|0|||
33527372|NCT03078907|62915137|FG001|Overall Study|Protocol Violation|1|||
33527373|NCT03249714|62915145|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
33527374|NCT03249714|62915146|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
33527375|NCT03249714|62915145|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
33527376|NCT03249714|62915146|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
33527377|NCT03249714|62915145|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
33527378|NCT03249714|62915146|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
33621839|NCT01440322|63022526|FG001|Overall Study|Biomicroscopy|0|||
33621840|NCT01440322|63022525|FG000|Overall Study|Symptoms and Problems|1|||
33621841|NCT01440322|63022526|FG001|Overall Study|Symptoms and Problems|0|||
33621842|NCT01440322|63022525|FG000|Overall Study|Unacceptable Subjective Vision|1|||
33621843|NCT01440322|63022526|FG001|Overall Study|Unacceptable Subjective Vision|0|||
33621844|NCT01440322|63022525|FG000|Overall Study|Other Product Related|1|||
33621845|NCT01440322|63022526|FG001|Overall Study|Other Product Related|0|||
33621846|NCT01440322|63022525|FG000|Overall Study|Unrelated Medical Problem|0|||
33621847|NCT01440322|63022526|FG001|Overall Study|Unrelated Medical Problem|1|||
33621848|NCT01440322|63022525|FG000|Overall Study|Other Non-Product Related|1|||
33621849|NCT01440322|63022526|FG001|Overall Study|Other Non-Product Related|0|||
33621850|NCT01832493|63022532|FG000|Overall Study|Physician Decision|2|||
33621851|NCT01832493|63022532|FG000|Overall Study|Protocol Violation|4|||
33621852|NCT01832493|63022532|FG000|Overall Study|Unable to place LV lead|2|||
33621853|NCT01831791|63022536|FG000|Overall Study|Withdrawal by Subject|10|||
33621854|NCT01857531|63022540|FG000|Overall Study|Withdrawal by Subject|4|||
33621855|NCT02166047|63022556|FG000|Overall Study|Withdrawal by Participant|0|||
33621856|NCT02166047|63022557|FG001|Overall Study|Withdrawal by Participant|1|||
33621857|NCT02166047|63022558|FG002|Overall Study|Withdrawal by Participant|2|||
33621858|NCT02166047|63022559|FG003|Overall Study|Withdrawal by Participant|0|||
33621859|NCT02166047|63022560|FG004|Overall Study|Withdrawal by Participant|0|||
33621860|NCT02166047|63022561|FG005|Overall Study|Withdrawal by Participant|0|||
33621861|NCT02166047|63022562|FG006|Overall Study|Withdrawal by Participant|1|||
33621862|NCT02166047|63022563|FG007|Overall Study|Withdrawal by Participant|0|||
33621863|NCT02166047|63022564|FG008|Overall Study|Withdrawal by Participant|0|||
33621864|NCT02166047|63022565|FG009|Overall Study|Withdrawal by Participant|0|||
33621865|NCT02166047|63022566|FG010|Overall Study|Withdrawal by Participant|0|||
33621866|NCT02166047|63022567|FG011|Overall Study|Withdrawal by Participant|0|||
33621867|NCT02166047|63022556|FG000|Overall Study|Adverse Event|0|||
33621868|NCT02166047|63022557|FG001|Overall Study|Adverse Event|0|||
33621869|NCT02166047|63022558|FG002|Overall Study|Adverse Event|0|||
33621870|NCT02166047|63022559|FG003|Overall Study|Adverse Event|0|||
33621871|NCT02166047|63022560|FG004|Overall Study|Adverse Event|1|||
33621872|NCT02166047|63022561|FG005|Overall Study|Adverse Event|0|||
33621873|NCT02166047|63022562|FG006|Overall Study|Adverse Event|1|||
33621874|NCT02166047|63022563|FG007|Overall Study|Adverse Event|0|||
33621875|NCT02166047|63022564|FG008|Overall Study|Adverse Event|0|||
33621876|NCT02166047|63022565|FG009|Overall Study|Adverse Event|0|||
33621877|NCT02166047|63022566|FG010|Overall Study|Adverse Event|2|||
33621878|NCT02166047|63022567|FG011|Overall Study|Adverse Event|0|||
33621879|NCT01493284|63022593|FG000|Overall Study|Death|29|||
33621880|NCT01493284|63022593|FG000|Overall Study|Withdrawal by Subject|32|||
33621881|NCT02165735|63022599|FG000|Overall Study|Lost to Follow-up|12|||
33621882|NCT02165735|63022600|FG001|Overall Study|Lost to Follow-up|10|||
33621883|NCT02165735|63022599|FG000|Overall Study|Withdrawal by Subject|3|||
33621884|NCT02165735|63022600|FG001|Overall Study|Withdrawal by Subject|0|||
33621885|NCT02165735|63022599|FG000|Overall Study|Participant indicated lack of time|1|||
33621886|NCT02165735|63022600|FG001|Overall Study|Participant indicated lack of time|3|||
33621887|NCT02165735|63022599|FG000|Overall Study|Protocol Violation|0|||
33621888|NCT02165735|63022600|FG001|Overall Study|Protocol Violation|1|||
33621889|NCT02069899|63022609|FG000|Overall Study|Adverse Event|6|||
33621890|NCT02069899|63022610|FG001|Overall Study|Adverse Event|0|||
33621891|NCT02069899|63022611|FG002|Overall Study|Adverse Event|1|||
33621892|NCT02069899|63022609|FG000|Overall Study|Withdrawal by Participant|2|||
33621893|NCT02069899|63022610|FG001|Overall Study|Withdrawal by Participant|0|||
33621894|NCT02069899|63022611|FG002|Overall Study|Withdrawal by Participant|0|||
33621895|NCT02069899|63022609|FG000|Overall Study|Lost to Follow-up|1|||
33621896|NCT02069899|63022610|FG001|Overall Study|Lost to Follow-up|0|||
33621897|NCT02069899|63022611|FG002|Overall Study|Lost to Follow-up|1|||
33621898|NCT02069899|63022609|FG000|Overall Study|Other|4|||
33621899|NCT02069899|63022610|FG001|Overall Study|Other|0|||
33621900|NCT02069899|63022611|FG002|Overall Study|Other|0|||
33621901|NCT02069899|63022609|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
33621902|NCT02069899|63022610|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
33621903|NCT02069899|63022611|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
33325359|NCT00882115|62702128|FG000|Overall Study|Withdrawal by Subject|3|||
33527379|NCT03249714|62915145|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
33621904|NCT02069899|63022609|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
33621905|NCT02069899|63022610|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
33621906|NCT02069899|63022611|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
33621907|NCT01831089|63022626|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
33621908|NCT01831089|63022627|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
33621909|NCT01831089|63022628|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
33621910|NCT01831089|63022629|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
33621911|NCT01831089|63022630|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
33621912|NCT01831089|63022631|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
33527380|NCT03249714|62915146|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
33527381|NCT02925117|62915172|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
33527382|NCT02925117|62915173|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
33527383|NCT02925117|62915174|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
33527384|NCT02925117|62915175|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
33527385|NCT02925117|62915176|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33527386|NCT02925117|62915177|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33527387|NCT02925117|62915178|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33527388|NCT02925117|62915179|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33527389|NCT02925117|62915180|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33527390|NCT02925117|62915181|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33527391|NCT02925117|62915182|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33527392|NCT02925117|62915183|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33527393|NCT02925117|62915172|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
33527394|NCT02925117|62915173|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
33527395|NCT02925117|62915174|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
33527396|NCT02925117|62915175|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33621913|NCT01831089|63022626|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
33621914|NCT01831089|63022627|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
33621915|NCT01831089|63022628|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
33621916|NCT01831089|63022629|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
33621917|NCT01831089|63022630|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
33621918|NCT01831089|63022631|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
33621919|NCT01831089|63022626|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
33621920|NCT01831089|63022627|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
33621921|NCT01831089|63022628|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
33621922|NCT01831089|63022629|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
33621923|NCT01831089|63022630|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
33621924|NCT01831089|63022631|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
33621925|NCT01831089|63022626|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
33621926|NCT01831089|63022627|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
33621927|NCT01831089|63022628|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
33621928|NCT01831089|63022629|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
33621929|NCT01831089|63022630|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
33621930|NCT01831089|63022631|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
33621931|NCT01831089|63022626|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
33621932|NCT01831089|63022627|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
33325360|NCT00882115|62702128|FG000|Overall Study|did not respond to DEP challe|6|||
33325361|NCT00881959|62702134|FG000|Overall Study|Lost to Follow-up|2|||
33325362|NCT00881959|62702135|FG001|Overall Study|Lost to Follow-up|4|||
33325363|NCT00884377|62702143|FG000|Overall Study|Withdrawal by Subject|1|||
33621933|NCT01831089|63022628|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
33621934|NCT01831089|63022629|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
33621935|NCT01831089|63022630|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
33621936|NCT01831089|63022631|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
33621937|NCT01831089|63022626|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
33621938|NCT01831089|63022627|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
33621939|NCT01831089|63022628|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
33621940|NCT01831089|63022629|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
33621941|NCT01831089|63022630|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
33621942|NCT01831089|63022631|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
33621943|NCT01831089|63022626|FG000|Cohort III: Dose Level 3|Global end of study|0|||
33621944|NCT01831089|63022627|FG001|Cohort III: Dose Level 3|Global end of study|0|||
33621945|NCT01831089|63022628|FG002|Cohort III: Dose Level 3|Global end of study|1|||
33621946|NCT01831089|63022629|FG003|Cohort III: Dose Level 3|Global end of study|0|||
33621947|NCT01831089|63022630|FG004|Cohort III: Dose Level 3|Global end of study|0|||
33457464|NCT00118430|62831907|FG000|Overall Study|Lost to Follow-up|15|||
33457465|NCT00118430|62831908|FG001|Overall Study|Lost to Follow-up|22|||
33457466|NCT00118430|62831909|FG002|Overall Study|Lost to Follow-up|28|||
33457467|NCT00090584|62831918|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
33457468|NCT00090584|62831919|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
33457469|NCT00090584|62831918|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
33457470|NCT00090584|62831919|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
33457471|NCT03670810|62831939|FG000|Main Study|Adverse Event|37|||
33527397|NCT02925117|62915176|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33621948|NCT01831089|63022631|FG005|Cohort III: Dose Level 3|Global end of study|0|||
33325364|NCT00884377|62702144|FG001|Overall Study|Withdrawal by Subject|0|||
33527398|NCT02925117|62915177|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33457472|NCT03670810|62831940|FG001|Main Study|Adverse Event|38|||
33527399|NCT02925117|62915178|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33527400|NCT02925117|62915179|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33527401|NCT02925117|62915180|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33527402|NCT02925117|62915181|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33527403|NCT02925117|62915182|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33527404|NCT02925117|62915183|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33527405|NCT02925117|62915172|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
33527406|NCT02925117|62915173|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
33527407|NCT02925117|62915174|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33527408|NCT02925117|62915175|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33527409|NCT02925117|62915176|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33527410|NCT02925117|62915177|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33527411|NCT02925117|62915178|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33527412|NCT02925117|62915179|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33527413|NCT02925117|62915180|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33527414|NCT02925117|62915181|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33527415|NCT02925117|62915182|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33527416|NCT02925117|62915183|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33527417|NCT02925117|62915172|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
33527418|NCT02925117|62915173|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
33527419|NCT02925117|62915174|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
33527420|NCT02925117|62915175|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
33527421|NCT02925117|62915176|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
33325365|NCT00884377|62702143|FG000|Overall Study|Could not confirm diagnosis|1|||
33325366|NCT00884377|62702144|FG001|Overall Study|Could not confirm diagnosis|0|||
33457473|NCT03670810|62831941|FG002|Main Study|Adverse Event|3|||
33527422|NCT02925117|62915177|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
33527423|NCT02925117|62915178|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
33527424|NCT02925117|62915179|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
33527425|NCT02925117|62915180|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
33527426|NCT02925117|62915181|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
33527427|NCT02925117|62915182|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
33527428|NCT02925117|62915183|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
33527429|NCT02925117|62915172|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33325367|NCT00884377|62702143|FG000|Overall Study|Physician Decision|0|||
33457474|NCT03670810|62831942|FG003|Main Study|Adverse Event|4|||
33457475|NCT03670810|62831943|FG004|Main Study|Adverse Event|4|||
33457476|NCT03670810|62831944|FG005|Main Study|Adverse Event|5|||
33457477|NCT03670810|62831945|FG006|Main Study|Adverse Event|0|||
33457478|NCT03670810|62831946|FG007|Main Study|Adverse Event|0|||
33457479|NCT03670810|62831947|FG008|Main Study|Adverse Event|0|||
33457480|NCT03670810|62831939|FG000|Main Study|Lack of Efficacy|8|||
33457481|NCT03670810|62831940|FG001|Main Study|Lack of Efficacy|9|||
33457482|NCT03670810|62831941|FG002|Main Study|Lack of Efficacy|3|||
33457483|NCT03670810|62831942|FG003|Main Study|Lack of Efficacy|4|||
33457484|NCT03670810|62831943|FG004|Main Study|Lack of Efficacy|0|||
33457485|NCT03670810|62831944|FG005|Main Study|Lack of Efficacy|0|||
33457486|NCT03670810|62831945|FG006|Main Study|Lack of Efficacy|0|||
33457487|NCT03670810|62831946|FG007|Main Study|Lack of Efficacy|0|||
33457488|NCT03670810|62831947|FG008|Main Study|Lack of Efficacy|0|||
33457489|NCT03670810|62831939|FG000|Main Study|Lost to Follow-up|9|||
33457490|NCT03670810|62831940|FG001|Main Study|Lost to Follow-up|7|||
33457491|NCT03670810|62831941|FG002|Main Study|Lost to Follow-up|4|||
33457492|NCT03670810|62831942|FG003|Main Study|Lost to Follow-up|6|||
33457493|NCT03670810|62831943|FG004|Main Study|Lost to Follow-up|1|||
33457494|NCT03670810|62831944|FG005|Main Study|Lost to Follow-up|0|||
33457495|NCT03670810|62831945|FG006|Main Study|Lost to Follow-up|0|||
33457496|NCT03670810|62831946|FG007|Main Study|Lost to Follow-up|0|||
33527430|NCT02925117|62915173|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33527431|NCT02925117|62915174|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33457497|NCT03670810|62831947|FG008|Main Study|Lost to Follow-up|0|||
33325368|NCT00884377|62702144|FG001|Overall Study|Physician Decision|1|||
33457498|NCT03670810|62831939|FG000|Main Study|Non-compliance with Study Drug|0|||
33457499|NCT03670810|62831940|FG001|Main Study|Non-compliance with Study Drug|2|||
33527432|NCT02925117|62915175|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33527433|NCT02925117|62915176|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33527434|NCT02925117|62915177|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
33527435|NCT02925117|62915178|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33457500|NCT03670810|62831941|FG002|Main Study|Non-compliance with Study Drug|3|||
33457501|NCT03670810|62831942|FG003|Main Study|Non-compliance with Study Drug|0|||
33527436|NCT02925117|62915179|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33527437|NCT02925117|62915180|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33527438|NCT02925117|62915181|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33527439|NCT02925117|62915182|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
33527440|NCT02925117|62915183|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
33527441|NCT02925117|62915172|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
33527442|NCT02925117|62915173|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
33527443|NCT02925117|62915174|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
33527444|NCT02925117|62915175|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
33527445|NCT02925117|62915176|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
33527446|NCT02925117|62915177|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
33527447|NCT02925117|62915178|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
33527448|NCT02925117|62915179|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
33527449|NCT02925117|62915180|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
33527450|NCT02925117|62915181|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
33527451|NCT02925117|62915182|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
33621949|NCT01831089|63022626|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
33621950|NCT01831089|63022627|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
33621951|NCT01831089|63022628|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
33621952|NCT01831089|63022629|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
33621953|NCT01831089|63022630|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
33621954|NCT01831089|63022631|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
33621955|NCT01831089|63022626|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
33621956|NCT01831089|63022627|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
33621957|NCT01831089|63022628|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
33621958|NCT01831089|63022629|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
33621959|NCT01831089|63022630|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
33621960|NCT01831089|63022631|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
33621961|NCT01831089|63022626|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
33621962|NCT01831089|63022627|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
33621963|NCT01831089|63022628|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
33621964|NCT01831089|63022629|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
33621965|NCT01831089|63022630|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
33621966|NCT01831089|63022631|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
33621967|NCT01831089|63022626|FG000|Cohort V: Dose Level 5|Death|0|||
33621968|NCT01831089|63022627|FG001|Cohort V: Dose Level 5|Death|0|||
33621969|NCT01831089|63022628|FG002|Cohort V: Dose Level 5|Death|0|||
33621970|NCT01831089|63022629|FG003|Cohort V: Dose Level 5|Death|0|||
33621971|NCT01831089|63022630|FG004|Cohort V: Dose Level 5|Death|1|||
33621972|NCT01831089|63022631|FG005|Cohort V: Dose Level 5|Death|0|||
33621973|NCT01831089|63022626|FG000|Cohort V: Dose Level 5|Global end of study|0|||
33621974|NCT01831089|63022627|FG001|Cohort V: Dose Level 5|Global end of study|0|||
33621975|NCT01831089|63022628|FG002|Cohort V: Dose Level 5|Global end of study|0|||
33621976|NCT01831089|63022629|FG003|Cohort V: Dose Level 5|Global end of study|0|||
33621977|NCT01831089|63022630|FG004|Cohort V: Dose Level 5|Global end of study|2|||
33621978|NCT01831089|63022631|FG005|Cohort V: Dose Level 5|Global end of study|0|||
33621979|NCT01831089|63022626|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
33621980|NCT01831089|63022627|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
33621981|NCT01831089|63022628|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
33621982|NCT01831089|63022629|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
33621983|NCT01831089|63022630|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
33621984|NCT01831089|63022631|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
33621985|NCT01831089|63022626|FG000|Cohort B: Arm B|Progressive disease|0|||
33621986|NCT01831089|63022627|FG001|Cohort B: Arm B|Progressive disease|0|||
33621987|NCT01831089|63022628|FG002|Cohort B: Arm B|Progressive disease|0|||
33621988|NCT01831089|63022629|FG003|Cohort B: Arm B|Progressive disease|0|||
33457502|NCT03670810|62831943|FG004|Main Study|Non-compliance with Study Drug|0|||
33457503|NCT03670810|62831944|FG005|Main Study|Non-compliance with Study Drug|0|||
33457504|NCT03670810|62831945|FG006|Main Study|Non-compliance with Study Drug|0|||
33457505|NCT03670810|62831946|FG007|Main Study|Non-compliance with Study Drug|1|||
33457506|NCT03670810|62831947|FG008|Main Study|Non-compliance with Study Drug|0|||
33457507|NCT03670810|62831939|FG000|Main Study|Physician Decision|3|||
33457508|NCT03670810|62831940|FG001|Main Study|Physician Decision|0|||
33457509|NCT03670810|62831941|FG002|Main Study|Physician Decision|1|||
33457510|NCT03670810|62831942|FG003|Main Study|Physician Decision|0|||
33457511|NCT03670810|62831943|FG004|Main Study|Physician Decision|0|||
33621989|NCT01831089|63022630|FG004|Cohort B: Arm B|Progressive disease|0|||
33457512|NCT03670810|62831944|FG005|Main Study|Physician Decision|0|||
33457513|NCT03670810|62831945|FG006|Main Study|Physician Decision|1|||
33621990|NCT01831089|63022631|FG005|Cohort B: Arm B|Progressive disease|8|||
33621991|NCT01831089|63022626|FG000|Cohort B: Arm B|Physician Decision|0|||
33621992|NCT01831089|63022627|FG001|Cohort B: Arm B|Physician Decision|0|||
33527452|NCT02925117|62915183|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
33621993|NCT01831089|63022628|FG002|Cohort B: Arm B|Physician Decision|0|||
33527453|NCT02925117|62915172|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
33527454|NCT02925117|62915173|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
33527455|NCT02925117|62915174|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
33527456|NCT02925117|62915175|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
33527457|NCT02925117|62915176|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
33527458|NCT02925117|62915177|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
33527459|NCT02925117|62915178|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
33527460|NCT02925117|62915179|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
33621994|NCT01831089|63022629|FG003|Cohort B: Arm B|Physician Decision|0|||
33621995|NCT01831089|63022630|FG004|Cohort B: Arm B|Physician Decision|0|||
33621996|NCT01831089|63022631|FG005|Cohort B: Arm B|Physician Decision|2|||
33527461|NCT02925117|62915180|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
33527462|NCT02925117|62915181|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
33527463|NCT02925117|62915182|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
33527464|NCT02925117|62915183|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
33527465|NCT02925117|62915172|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
33527466|NCT02925117|62915173|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
33527467|NCT02925117|62915174|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
33527468|NCT02925117|62915175|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
33527469|NCT02925117|62915176|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
33527470|NCT02925117|62915177|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
33527471|NCT02925117|62915178|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
33527472|NCT02925117|62915179|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
33527473|NCT02925117|62915180|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
33527474|NCT02925117|62915181|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
33527475|NCT02925117|62915182|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
33527476|NCT02925117|62915183|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
33527477|NCT03075163|62915207|FG000|Overall Study|not eligible for treatment limb|138|||
33527478|NCT03075163|62915208|FG001|Overall Study|not eligible for treatment limb|138|||
33527479|NCT03078751|62915216|FG000|Overall Study|Adverse Event|4|||
33527480|NCT03078751|62915217|FG001|Overall Study|Adverse Event|0|||
33527481|NCT03078751|62915216|FG000|Overall Study|Physician Decision|1|||
33527482|NCT03078751|62915217|FG001|Overall Study|Physician Decision|0|||
33527483|NCT03078751|62915216|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
33527484|NCT03078751|62915217|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
33527485|NCT03078751|62915216|FG000|Overall Study|Subject/guardian decision|8|||
33527486|NCT03078751|62915217|FG001|Overall Study|Subject/guardian decision|1|||
33527487|NCT03078751|62915216|FG000|Overall Study|Untreated|0|||
33527488|NCT03078751|62915217|FG001|Overall Study|Untreated|4|||
33527489|NCT02924883|62915225|FG000|Overall Study|Death|39|||
33527490|NCT02924883|62915226|FG001|Overall Study|Death|20|||
33527491|NCT02924883|62915225|FG000|Overall Study|Lost to Follow-up|1|||
33527492|NCT02924883|62915226|FG001|Overall Study|Lost to Follow-up|0|||
33527493|NCT02924883|62915225|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
33527494|NCT02924883|62915226|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
33527495|NCT02924883|62915225|FG000|Overall Study|Protocol Violation|1|||
33527496|NCT02924883|62915226|FG001|Overall Study|Protocol Violation|0|||
33527497|NCT02924883|62915225|FG000|Overall Study|Withdrawal by Subject|22|||
33527498|NCT02924883|62915226|FG001|Overall Study|Withdrawal by Subject|16|||
33527499|NCT02924883|62915225|FG000|Overall Study|Progressive Disease|1|||
33527500|NCT02924883|62915226|FG001|Overall Study|Progressive Disease|0|||
33527501|NCT02924883|62915225|FG000|Overall Study|Study Terminated by Sponsor|69|||
33527502|NCT02924883|62915226|FG001|Overall Study|Study Terminated by Sponsor|32|||
33527503|NCT01369680|62915249|FG000|Overall Study|Lost to Follow-up|0|||
33527504|NCT01369680|62915250|FG001|Overall Study|Lost to Follow-up|0|||
33527505|NCT01369680|62915251|FG002|Overall Study|Lost to Follow-up|1|||
33527506|NCT01369680|62915252|FG003|Overall Study|Lost to Follow-up|2|||
33527507|NCT03074149|62915284|FG000|Overall Study|Reason unknown|22|||
33527508|NCT03074149|62915285|FG001|Overall Study|Reason unknown|35|||
33527509|NCT03074149|62915284|FG000|Overall Study|Death|10|||
33527510|NCT03074149|62915285|FG001|Overall Study|Death|45|||
33527511|NCT02751320|62915293|FG000|Overall Study|Adverse Event|2|||
33527512|NCT02751320|62915293|FG000|Overall Study|Withdrawal by Subject|1|||
33527513|NCT02206035|62915321|FG000|Overall Study|Physician Decision|10|||
33527514|NCT02206035|62915322|FG001|Overall Study|Physician Decision|0|||
33527515|NCT02206035|62915323|FG002|Overall Study|Physician Decision|175|||
33621997|NCT01831089|63022626|FG000|Cohort B: Arm B|Never treated|0|||
33621998|NCT01831089|63022627|FG001|Cohort B: Arm B|Never treated|0|||
33527516|NCT02746471|62915330|FG000|Overall Study|Death|43|||
33527517|NCT02746471|62915330|FG000|Overall Study|Exited before 36 months|1119|||
33527518|NCT02591953|62915337|FG000|Overall Study|Lost to Follow-up|6|||
33527519|NCT02591953|62915338|FG001|Overall Study|Lost to Follow-up|6|||
33527520|NCT03073213|62915346|FG000|Multiple Dose Period|Protocol Violation|0|||
33527521|NCT03073213|62915347|FG001|Multiple Dose Period|Protocol Violation|0|||
33527522|NCT03073213|62915348|FG002|Multiple Dose Period|Protocol Violation|1|||
33527523|NCT03070483|62915357|FG000|Overall Study|Lost to Follow-up|2|||
33621999|NCT01831089|63022628|FG002|Cohort B: Arm B|Never treated|0|||
33622000|NCT01831089|63022629|FG003|Cohort B: Arm B|Never treated|0|||
33622001|NCT01831089|63022630|FG004|Cohort B: Arm B|Never treated|0|||
33622002|NCT01831089|63022631|FG005|Cohort B: Arm B|Never treated|2|||
33622003|NCT01831089|63022626|FG000|Cohort B: Arm B|Adverse Event|0|||
33622004|NCT01831089|63022627|FG001|Cohort B: Arm B|Adverse Event|0|||
33622005|NCT01831089|63022628|FG002|Cohort B: Arm B|Adverse Event|0|||
33622006|NCT01831089|63022629|FG003|Cohort B: Arm B|Adverse Event|0|||
33622007|NCT01831089|63022630|FG004|Cohort B: Arm B|Adverse Event|0|||
33622008|NCT01831089|63022631|FG005|Cohort B: Arm B|Adverse Event|1|||
33622009|NCT01831089|63022626|FG000|Cohort B: Arm B|Global end of study|0|||
33622010|NCT01831089|63022627|FG001|Cohort B: Arm B|Global end of study|0|||
33622011|NCT01831089|63022628|FG002|Cohort B: Arm B|Global end of study|0|||
33622012|NCT01831089|63022629|FG003|Cohort B: Arm B|Global end of study|0|||
33622013|NCT01831089|63022630|FG004|Cohort B: Arm B|Global end of study|0|||
33622014|NCT01831089|63022631|FG005|Cohort B: Arm B|Global end of study|1|||
33622015|NCT02112877|63022648|FG000|Overall Study|Withdrawal by Subject|1|||
33622016|NCT02112877|63022649|FG001|Overall Study|Withdrawal by Subject|7|||
33622017|NCT02112877|63022648|FG000|Overall Study|Visit Missed|1|||
33622018|NCT02112877|63022649|FG001|Overall Study|Visit Missed|6|||
33622019|NCT02098369|63022660|FG000|Overall Study|Withdrawal by Subject|1|||
33622020|NCT02098369|63022661|FG001|Overall Study|Withdrawal by Subject|5|||
33622021|NCT02098369|63022662|FG002|Overall Study|Withdrawal by Subject|0|||
33527524|NCT02231762|62915362|FG000|Combination Phase|Adverse Event|10|||
33527525|NCT02231762|62915363|FG001|Combination Phase|Adverse Event|0|||
33527526|NCT02231762|62915364|FG002|Combination Phase|Adverse Event|0|||
33527527|NCT02231762|62915365|FG003|Combination Phase|Adverse Event|0|||
33527528|NCT02231762|62915362|FG000|Combination Phase|Withdrawal by Subject|2|||
33527529|NCT02231762|62915363|FG001|Combination Phase|Withdrawal by Subject|0|||
33527530|NCT02231762|62915364|FG002|Combination Phase|Withdrawal by Subject|0|||
33527531|NCT02231762|62915365|FG003|Combination Phase|Withdrawal by Subject|0|||
33527532|NCT02231762|62915362|FG000|Combination Phase|Disease Progression|6|||
33527533|NCT02231762|62915363|FG001|Combination Phase|Disease Progression|0|||
33527534|NCT02231762|62915364|FG002|Combination Phase|Disease Progression|0|||
33527535|NCT02231762|62915365|FG003|Combination Phase|Disease Progression|0|||
33527536|NCT02231762|62915362|FG000|Combination Phase|Did not meet inclusion criteria|1|||
33527537|NCT02231762|62915363|FG001|Combination Phase|Did not meet inclusion criteria|0|||
33527538|NCT02231762|62915364|FG002|Combination Phase|Did not meet inclusion criteria|0|||
33527539|NCT02231762|62915365|FG003|Combination Phase|Did not meet inclusion criteria|0|||
33527540|NCT02231762|62915362|FG000|Combination Phase|Protocol Violation|1|||
33527541|NCT02231762|62915363|FG001|Combination Phase|Protocol Violation|0|||
33527542|NCT02231762|62915364|FG002|Combination Phase|Protocol Violation|0|||
33527543|NCT02231762|62915365|FG003|Combination Phase|Protocol Violation|0|||
33527544|NCT02231762|62915362|FG000|Maintenance Phase|Disease progression|0|||
33527545|NCT02231762|62915363|FG001|Maintenance Phase|Disease progression|3|||
33527546|NCT02231762|62915364|FG002|Maintenance Phase|Disease progression|4|||
33527547|NCT02231762|62915365|FG003|Maintenance Phase|Disease progression|3|||
33527548|NCT02231762|62915362|FG000|Maintenance Phase|Adverse Event|0|||
33527549|NCT02231762|62915363|FG001|Maintenance Phase|Adverse Event|0|||
33527550|NCT02231762|62915364|FG002|Maintenance Phase|Adverse Event|1|||
33527551|NCT02231762|62915365|FG003|Maintenance Phase|Adverse Event|2|||
33527552|NCT03023397|62915382|FG000|Run-In|Failed screening allergen challenge|1|||
33527553|NCT03023397|62915383|FG001|Run-In|Failed screening allergen challenge|0|||
33622022|NCT02098369|63022660|FG000|Overall Study|Lost to Follow-up|5|||
33622023|NCT02098369|63022661|FG001|Overall Study|Lost to Follow-up|1|||
33622024|NCT02098369|63022662|FG002|Overall Study|Lost to Follow-up|3|||
33622025|NCT02098369|63022660|FG000|Overall Study|Death|1|||
33622026|NCT02098369|63022661|FG001|Overall Study|Death|1|||
33622027|NCT02098369|63022662|FG002|Overall Study|Death|1|||
33622028|NCT02098369|63022660|FG000|Overall Study|Other|0|||
33622029|NCT02098369|63022661|FG001|Overall Study|Other|2|||
33622030|NCT02098369|63022662|FG002|Overall Study|Other|1|||
33527554|NCT03023397|62915384|FG002|Run-In|Failed screening allergen challenge|0|||
33527555|NCT03023397|62915382|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
33527556|NCT03023397|62915383|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
33622031|NCT02111785|63022674|FG000|Overall Study|Death|0|||
33527557|NCT03023397|62915384|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
33527558|NCT04325906|62915395|FG000|Overall Study|Withdrawal by Subject|2|||
33527559|NCT04325906|62915396|FG001|Overall Study|Withdrawal by Subject|0|||
33622032|NCT02111785|63022675|FG001|Overall Study|Death|1|||
33622033|NCT02111785|63022676|FG002|Overall Study|Death|0|||
33622034|NCT02111785|63022677|FG003|Overall Study|Death|0|||
33622035|NCT02068885|63022694|FG000|Overall Study|Withdrew|3|||
33622036|NCT02068885|63022695|FG001|Overall Study|Withdrew|5|||
33622037|NCT02068885|63022696|FG002|Overall Study|Withdrew|8|||
33622038|NCT02068495|63022705|FG000|Overall Study|Case Report Forms Uncollected|60|||
33622039|NCT02068495|63022705|FG000|Overall Study|Protocol Deviation|49|||
33622040|NCT02097823|63022711|FG000|Overall Study|Withdrawal by Subject|1|||
33622041|NCT02097823|63022712|FG001|Overall Study|Withdrawal by Subject|1|||
33622042|NCT01830855|63022723|FG000|Overall Study|Other|7|||
33622043|NCT01830855|63022724|FG001|Overall Study|Other|1|||
33622044|NCT01830855|63022725|FG002|Overall Study|Other|4|||
33622045|NCT01830855|63022726|FG003|Overall Study|Other|4|||
33622046|NCT01830855|63022723|FG000|Overall Study|Medication error without associated AE|1|||
33622047|NCT01830855|63022724|FG001|Overall Study|Medication error without associated AE|0|||
33622048|NCT01830855|63022725|FG002|Overall Study|Medication error without associated AE|0|||
33622049|NCT01830855|63022726|FG003|Overall Study|Medication error without associated AE|1|||
33622050|NCT01830855|63022723|FG000|Overall Study|Pregnancy|3|||
33622051|NCT01830855|63022724|FG001|Overall Study|Pregnancy|1|||
33622052|NCT01830855|63022725|FG002|Overall Study|Pregnancy|2|||
33622053|NCT01830855|63022726|FG003|Overall Study|Pregnancy|1|||
33622054|NCT01830855|63022723|FG000|Overall Study|No longer meets eligibility criteria|11|||
33622055|NCT01830855|63022724|FG001|Overall Study|No longer meets eligibility criteria|2|||
33527560|NCT03068455|62915404|FG000|Pre-treatment Period|Disease progression|0|||
33527561|NCT03068455|62915405|FG001|Pre-treatment Period|Disease progression|1|||
33527562|NCT03068455|62915404|FG000|Pre-treatment Period|Participant withdrew consent|1|||
33527563|NCT03068455|62915405|FG001|Pre-treatment Period|Participant withdrew consent|1|||
33527564|NCT03068455|62915404|FG000|Pre-treatment Period|Poor/non-compliance|0|||
33527565|NCT03068455|62915405|FG001|Pre-treatment Period|Poor/non-compliance|1|||
33527566|NCT03068455|62915404|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
33527567|NCT03068455|62915405|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
33527568|NCT03068455|62915404|FG000|Pre-treatment Period|Not reported|2|||
33527569|NCT03068455|62915405|FG001|Pre-treatment Period|Not reported|1|||
33527570|NCT03068455|62915404|FG000|Treatment Period|Disease progression|166|||
33527571|NCT03068455|62915405|FG001|Treatment Period|Disease progression|208|||
33527572|NCT03068455|62915404|FG000|Treatment Period|Study drug toxicity|317|||
33527573|NCT03068455|62915405|FG001|Treatment Period|Study drug toxicity|104|||
33527574|NCT03068455|62915404|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
33527575|NCT03068455|62915405|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
33527576|NCT03068455|62915404|FG000|Treatment Period|Participant request to stop therapy|33|||
33527577|NCT03068455|62915405|FG001|Treatment Period|Participant request to stop therapy|20|||
33527578|NCT03068455|62915404|FG000|Treatment Period|Participant withdrew consent|5|||
33527579|NCT03068455|62915405|FG001|Treatment Period|Participant withdrew consent|10|||
33622056|NCT01830855|63022725|FG002|Overall Study|No longer meets eligibility criteria|3|||
33622057|NCT01830855|63022726|FG003|Overall Study|No longer meets eligibility criteria|5|||
33622058|NCT01830855|63022723|FG000|Overall Study|Adverse Event|11|||
33622059|NCT01830855|63022724|FG001|Overall Study|Adverse Event|5|||
33622060|NCT01830855|63022725|FG002|Overall Study|Adverse Event|6|||
33622061|NCT01830855|63022726|FG003|Overall Study|Adverse Event|3|||
33622062|NCT01830855|63022723|FG000|Overall Study|Protocol deviation|10|||
33622063|NCT01830855|63022724|FG001|Overall Study|Protocol deviation|5|||
33622064|NCT01830855|63022725|FG002|Overall Study|Protocol deviation|6|||
33622065|NCT01830855|63022726|FG003|Overall Study|Protocol deviation|6|||
33622066|NCT01830855|63022723|FG000|Overall Study|Withdrawal by Subject|33|||
33622067|NCT01830855|63022724|FG001|Overall Study|Withdrawal by Subject|14|||
33622068|NCT01830855|63022725|FG002|Overall Study|Withdrawal by Subject|10|||
33622069|NCT01830855|63022726|FG003|Overall Study|Withdrawal by Subject|12|||
33622070|NCT01830855|63022723|FG000|Overall Study|No longer willing to participate|32|||
33622071|NCT01830855|63022724|FG001|Overall Study|No longer willing to participate|13|||
33622072|NCT01830855|63022725|FG002|Overall Study|No longer willing to participate|12|||
33622073|NCT01830855|63022726|FG003|Overall Study|No longer willing to participate|17|||
33622074|NCT01830855|63022723|FG000|Overall Study|Lost to Follow-up|47|||
33622075|NCT01830855|63022724|FG001|Overall Study|Lost to Follow-up|20|||
33622076|NCT01830855|63022725|FG002|Overall Study|Lost to Follow-up|23|||
33622077|NCT01830855|63022726|FG003|Overall Study|Lost to Follow-up|33|||
33622078|NCT01857063|63022743|FG000|Period 1 (7 Days)|Adverse Event|0|||
33622079|NCT01857063|63022744|FG001|Period 1 (7 Days)|Adverse Event|1|||
33622080|NCT01857063|63022743|FG000|Period 1 (7 Days)|Physician Decision|1|||
33622081|NCT01857063|63022744|FG001|Period 1 (7 Days)|Physician Decision|0|||
33527580|NCT03068455|62915404|FG000|Treatment Period|Poor/non-compliance|3|||
33622082|NCT01857063|63022743|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
33622083|NCT01857063|63022744|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
33622084|NCT01857063|63022743|FG000|Period 2 (7 Days)|Adverse Event|2|||
33622085|NCT01857063|63022744|FG001|Period 2 (7 Days)|Adverse Event|1|||
33622086|NCT01857063|63022743|FG000|Period 2 (7 Days)|Physician Decision|1|||
33622087|NCT01857063|63022744|FG001|Period 2 (7 Days)|Physician Decision|1|||
33622088|NCT01857063|63022743|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
33622089|NCT01857063|63022744|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
33622090|NCT01856907|63022753|FG000|Overall Study|Pregnancy|0|||
33622091|NCT01856907|63022754|FG001|Overall Study|Pregnancy|1|||
33622092|NCT01856907|63022755|FG002|Overall Study|Pregnancy|0|||
33622093|NCT01856907|63022753|FG000|Overall Study|Pregnancy|0|||
33622094|NCT01856907|63022754|FG001|Overall Study|Pregnancy|1|||
33622095|NCT01856907|63022755|FG002|Overall Study|Pregnancy|0|||
33622096|NCT01856907|63022753|FG000|Overall Study|Withdrawal by Subject|0|||
33622097|NCT01856907|63022754|FG001|Overall Study|Withdrawal by Subject|1|||
33622098|NCT01856907|63022755|FG002|Overall Study|Withdrawal by Subject|0|||
33622099|NCT02212457|63022772|FG000|Overall Study|Adverse Event|1|||
33622100|NCT02212457|63022773|FG001|Overall Study|Adverse Event|2|||
33622101|NCT02212457|63022774|FG002|Overall Study|Adverse Event|2|||
33622102|NCT02212457|63022775|FG003|Overall Study|Adverse Event|2|||
33622103|NCT02212457|63022776|FG004|Overall Study|Adverse Event|0|||
33622104|NCT02212457|63022777|FG005|Overall Study|Adverse Event|1|||
33622105|NCT02212457|63022772|FG000|Overall Study|Withdrawal by Subject|8|||
33622106|NCT02212457|63022773|FG001|Overall Study|Withdrawal by Subject|10|||
33622107|NCT02212457|63022774|FG002|Overall Study|Withdrawal by Subject|8|||
33622108|NCT02212457|63022775|FG003|Overall Study|Withdrawal by Subject|6|||
33622109|NCT02212457|63022776|FG004|Overall Study|Withdrawal by Subject|5|||
33622110|NCT02212457|63022777|FG005|Overall Study|Withdrawal by Subject|4|||
33622111|NCT02212457|63022772|FG000|Overall Study|Lost to Follow-up|6|||
33622112|NCT02212457|63022773|FG001|Overall Study|Lost to Follow-up|7|||
33622113|NCT02212457|63022774|FG002|Overall Study|Lost to Follow-up|4|||
33622114|NCT02212457|63022775|FG003|Overall Study|Lost to Follow-up|1|||
33622115|NCT02212457|63022776|FG004|Overall Study|Lost to Follow-up|8|||
33622116|NCT02212457|63022777|FG005|Overall Study|Lost to Follow-up|4|||
33622117|NCT02212457|63022772|FG000|Overall Study|Protocol Violation|2|||
33622118|NCT02212457|63022773|FG001|Overall Study|Protocol Violation|1|||
33622119|NCT02212457|63022774|FG002|Overall Study|Protocol Violation|0|||
33622120|NCT02212457|63022775|FG003|Overall Study|Protocol Violation|1|||
33622121|NCT02212457|63022776|FG004|Overall Study|Protocol Violation|2|||
33622122|NCT02212457|63022777|FG005|Overall Study|Protocol Violation|3|||
33622123|NCT02212457|63022772|FG000|Overall Study|Other|2|||
33622124|NCT02212457|63022773|FG001|Overall Study|Other|1|||
33622125|NCT02212457|63022774|FG002|Overall Study|Other|2|||
33622126|NCT02212457|63022775|FG003|Overall Study|Other|1|||
33622127|NCT02212457|63022776|FG004|Overall Study|Other|0|||
33622128|NCT02212457|63022777|FG005|Overall Study|Other|1|||
33622129|NCT02097745|63022798|FG000|Overall Study|Adverse Event|25|||
33622130|NCT02097745|63022798|FG000|Overall Study|Death|16|||
33622131|NCT02097745|63022798|FG000|Overall Study|Failure to Return|14|||
33622132|NCT02097745|63022798|FG000|Overall Study|Administrative/Other|27|||
33622133|NCT02097745|63022798|FG000|Overall Study|Reason Not Specified|96|||
33622134|NCT02111083|63022807|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
33622135|NCT02111083|63022808|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
33622136|NCT01629563|63022816|FG000|Overall Study|Adverse Event|16|||
33622137|NCT01629563|63022817|FG001|Overall Study|Adverse Event|16|||
33622138|NCT01629563|63022816|FG000|Overall Study|Death|2|||
33622139|NCT01629563|63022817|FG001|Overall Study|Death|0|||
33622140|NCT01629563|63022816|FG000|Overall Study|Lack of Efficacy|2|||
33622141|NCT01629563|63022817|FG001|Overall Study|Lack of Efficacy|3|||
33622142|NCT01629563|63022816|FG000|Overall Study|Lost to Follow-up|1|||
33622143|NCT01629563|63022817|FG001|Overall Study|Lost to Follow-up|0|||
33622144|NCT01629563|63022816|FG000|Overall Study|Pregnancy|1|||
33622145|NCT01629563|63022817|FG001|Overall Study|Pregnancy|2|||
33622146|NCT01629563|63022816|FG000|Overall Study|Protocol Violation|0|||
33622147|NCT01629563|63022817|FG001|Overall Study|Protocol Violation|1|||
33622148|NCT01629563|63022816|FG000|Overall Study|Withdrawal by Subject|27|||
33622149|NCT01629563|63022817|FG001|Overall Study|Withdrawal by Subject|20|||
33622150|NCT01629563|63022816|FG000|Overall Study|surgery|0|||
33622151|NCT01629563|63022817|FG001|Overall Study|surgery|3|||
33622152|NCT01629563|63022816|FG000|Overall Study|Lack of return of menses|12|||
33622153|NCT01629563|63022817|FG001|Overall Study|Lack of return of menses|7|||
33622154|NCT01629563|63022816|FG000|Overall Study|Protocol Violation|0|||
33622155|NCT01629563|63022817|FG001|Overall Study|Protocol Violation|1|||
33622156|NCT02097277|63022828|FG000|Overall Study|Subject no longer meets study criteria|0|||
33622157|NCT02097277|63022829|FG001|Overall Study|Subject no longer meets study criteria|1|||
33622158|NCT02097277|63022830|FG002|Overall Study|Subject no longer meets study criteria|0|||
33622159|NCT02097277|63022831|FG003|Overall Study|Subject no longer meets study criteria|1|||
33622160|NCT02097277|63022832|FG004|Overall Study|Subject no longer meets study criteria|0|||
33622161|NCT02097277|63022828|FG000|Overall Study|Subject request to discontinue treatment|0|||
33622162|NCT02097277|63022829|FG001|Overall Study|Subject request to discontinue treatment|0|||
33622163|NCT02097277|63022830|FG002|Overall Study|Subject request to discontinue treatment|0|||
33622164|NCT02097277|63022831|FG003|Overall Study|Subject request to discontinue treatment|0|||
33622165|NCT02097277|63022832|FG004|Overall Study|Subject request to discontinue treatment|1|||
33622166|NCT02097277|63022828|FG000|Overall Study|Lost to Follow-up|0|||
33622167|NCT02097277|63022829|FG001|Overall Study|Lost to Follow-up|1|||
33622168|NCT02097277|63022830|FG002|Overall Study|Lost to Follow-up|1|||
33622169|NCT02097277|63022831|FG003|Overall Study|Lost to Follow-up|0|||
33622170|NCT02097277|63022832|FG004|Overall Study|Lost to Follow-up|0|||
33622171|NCT02097277|63022828|FG000|Overall Study|Withdrawal by Subject|2|||
33622172|NCT02097277|63022829|FG001|Overall Study|Withdrawal by Subject|1|||
33622173|NCT02097277|63022830|FG002|Overall Study|Withdrawal by Subject|0|||
33622174|NCT02097277|63022831|FG003|Overall Study|Withdrawal by Subject|1|||
33622175|NCT02097277|63022832|FG004|Overall Study|Withdrawal by Subject|0|||
33622176|NCT02097277|63022828|FG000|Overall Study|Adverse Event|0|||
33622177|NCT02097277|63022829|FG001|Overall Study|Adverse Event|0|||
33622178|NCT02097277|63022830|FG002|Overall Study|Adverse Event|1|||
33622179|NCT02097277|63022831|FG003|Overall Study|Adverse Event|2|||
33622180|NCT02097277|63022832|FG004|Overall Study|Adverse Event|0|||
33622181|NCT02212379|63022848|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
33622182|NCT02212379|63022848|FG000|From Baseline to Week 48|Adverse Event|7|||
33622183|NCT02212379|63022848|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
33622184|NCT02212379|63022848|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
33622185|NCT02212379|63022848|FG000|From Week 48 to Week 96|Adverse Event|1|||
33622186|NCT02212379|63022848|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
33622187|NCT02110693|63022855|FG000|Overall Study|Withdrawal by Subject|6|||
33622188|NCT02110693|63022856|FG001|Overall Study|Withdrawal by Subject|7|||
33622189|NCT02110693|63022855|FG000|Overall Study|skipped assessment|15|||
33622190|NCT02110693|63022856|FG001|Overall Study|skipped assessment|18|||
33622191|NCT02110693|63022855|FG000|Overall Study|technical difficulties|6|||
33622192|NCT02110693|63022856|FG001|Overall Study|technical difficulties|4|||
33622193|NCT02110693|63022855|FG000|Overall Study|Other|1|||
33622194|NCT02110693|63022856|FG001|Overall Study|Other|0|||
33622195|NCT02212301|63022876|FG000|Period 1|Lost to Follow-up|0|||
33622196|NCT02212301|63022877|FG001|Period 1|Lost to Follow-up|1|||
33622197|NCT02211209|63022886|FG000|Overall Study|Investigator judgment|0|||
33622198|NCT02211209|63022887|FG001|Overall Study|Investigator judgment|1|||
33622199|NCT02211209|63022886|FG000|Overall Study|Voluntary withdrawal|1|||
33622200|NCT02211209|63022887|FG001|Overall Study|Voluntary withdrawal|4|||
33622201|NCT02211209|63022886|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
33622202|NCT02211209|63022887|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
33622203|NCT02211209|63022886|FG000|Overall Study|Reason Not Specified|1|||
33622204|NCT02211209|63022887|FG001|Overall Study|Reason Not Specified|0|||
33622205|NCT02187809|63022893|FG000|Overall Study|The study was terminated|3|||
33622206|NCT02110225|63022900|FG000|Overall Study|Lost to Follow-up|0|||
33622207|NCT02110225|63022901|FG001|Overall Study|Lost to Follow-up|1|||
33622208|NCT02110225|63022902|FG002|Overall Study|Lost to Follow-up|0|||
33622209|NCT02187029|63022915|FG000|Overall Study|Adverse Event|0|||
33622210|NCT02187029|63022916|FG001|Overall Study|Adverse Event|1|||
33622211|NCT02187029|63022917|FG002|Overall Study|Adverse Event|1|||
33622212|NCT02187029|63022918|FG003|Overall Study|Adverse Event|0|||
33622213|NCT02187029|63022915|FG000|Overall Study|Study Terminated by Sponsor|0|||
33622214|NCT02187029|63022916|FG001|Overall Study|Study Terminated by Sponsor|0|||
33622215|NCT02187029|63022917|FG002|Overall Study|Study Terminated by Sponsor|10|||
33622216|NCT02187029|63022918|FG003|Overall Study|Study Terminated by Sponsor|3|||
33622217|NCT02187029|63022915|FG000|Overall Study|Withdrawal by Subject|1|||
33622218|NCT02187029|63022916|FG001|Overall Study|Withdrawal by Subject|0|||
33622219|NCT02187029|63022917|FG002|Overall Study|Withdrawal by Subject|0|||
33622220|NCT02187029|63022918|FG003|Overall Study|Withdrawal by Subject|0|||
33622221|NCT02163395|63022928|FG000|Overall Study|Withdrawal by Subject|1|||
33622222|NCT02163395|63022928|FG000|Overall Study|Lost to Follow-up|3|||
33622223|NCT02163395|63022928|FG000|Overall Study|Adverse Event|1|||
33622224|NCT02162771|63022934|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
33622225|NCT02162771|63022935|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
33622226|NCT02162771|63022934|FG000|Core Study Period (Part 2)|Adverse Event|4|||
33622227|NCT02162771|63022935|FG001|Core Study Period (Part 2)|Adverse Event|1|||
33622228|NCT02162771|63022934|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
33622229|NCT02162771|63022935|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
33622230|NCT02162771|63022934|FG000|Core Study Period (Part 2)|Physician Decision|0|||
33622231|NCT02162771|63022935|FG001|Core Study Period (Part 2)|Physician Decision|2|||
33622232|NCT02162771|63022934|FG000|Core Study Period (Part 2)|Death|1|||
33325369|NCT00884221|62702158|FG000|Overall Study|Withdrawal by Subject|0|||
33622233|NCT02162771|63022935|FG001|Core Study Period (Part 2)|Death|0|||
33622234|NCT02162771|63022934|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
33622235|NCT02162771|63022935|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
33622236|NCT02162771|63022934|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
33622237|NCT02162771|63022935|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
33622238|NCT02162771|63022934|FG000|Maintenance Study Period (Part 2)|Death|2|||
33622239|NCT02162771|63022935|FG001|Maintenance Study Period (Part 2)|Death|1|||
33622240|NCT02162771|63022934|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
33622241|NCT02162771|63022935|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
33622242|NCT02162771|63022934|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
33622243|NCT02162771|63022935|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
33622244|NCT02162771|63022934|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
33622245|NCT02162771|63022935|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
33622246|NCT02161757|63022944|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
33622247|NCT02161757|63022945|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
33622248|NCT02161757|63022946|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
33622249|NCT02161757|63022944|FG000|Treatment Through Study Completion|Adverse Event|1|||
33622250|NCT02161757|63022945|FG001|Treatment Through Study Completion|Adverse Event|1|||
33622251|NCT02161757|63022946|FG002|Treatment Through Study Completion|Adverse Event|0|||
33622252|NCT02161757|63022944|FG000|Treatment Through Study Completion|Protocol Violation|0|||
33622253|NCT02161757|63022945|FG001|Treatment Through Study Completion|Protocol Violation|1|||
33622254|NCT02161757|63022946|FG002|Treatment Through Study Completion|Protocol Violation|2|||
33622255|NCT02161757|63022944|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
33622256|NCT02161757|63022945|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
33622257|NCT02161757|63022946|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
33622258|NCT02161757|63022944|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
33622259|NCT02161757|63022945|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
33622260|NCT02161757|63022946|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
33622261|NCT02161757|63022944|FG000|Treatment Through Study Completion|Other|20|||
33622262|NCT02161757|63022945|FG001|Treatment Through Study Completion|Other|19|||
33622263|NCT02161757|63022946|FG002|Treatment Through Study Completion|Other|12|||
33622264|NCT02161757|63022944|FG000|Treatment Through Study Completion|Death|2|||
33622265|NCT02161757|63022945|FG001|Treatment Through Study Completion|Death|1|||
33622266|NCT02161757|63022946|FG002|Treatment Through Study Completion|Death|1|||
33622267|NCT02160977|63022956|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
33622268|NCT02160977|63022957|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
33527581|NCT03068455|62915405|FG001|Treatment Period|Poor/non-compliance|0|||
33527582|NCT03068455|62915404|FG000|Treatment Period|Participant no longer meets study criteria|1|||
33527583|NCT03068455|62915405|FG001|Treatment Period|Participant no longer meets study criteria|3|||
33527584|NCT03068455|62915404|FG000|Treatment Period|Other reasons|12|||
33527585|NCT03068455|62915405|FG001|Treatment Period|Other reasons|4|||
33527586|NCT03067987|62915413|FG000|Overall Study|Lost to Follow-up|7|||
33527587|NCT03067987|62915414|FG001|Overall Study|Lost to Follow-up|10|||
33527588|NCT03067987|62915413|FG000|Overall Study|Protocol Violation|1|||
33527589|NCT03067987|62915414|FG001|Overall Study|Protocol Violation|2|||
33527590|NCT03067987|62915413|FG000|Overall Study|Withdrawal by Subject|2|||
33527591|NCT03067987|62915414|FG001|Overall Study|Withdrawal by Subject|1|||
33527592|NCT04035200|62915423|FG000|Overall Study|Lost to Follow-up|0|||
33527593|NCT04035200|62915424|FG001|Overall Study|Lost to Follow-up|1|||
33527594|NCT04035200|62915425|FG002|Overall Study|Lost to Follow-up|0|||
33527595|NCT04035200|62915423|FG000|Overall Study|Withdrawal by Subject|1|||
33527596|NCT04035200|62915424|FG001|Overall Study|Withdrawal by Subject|4|||
33527597|NCT04035200|62915425|FG002|Overall Study|Withdrawal by Subject|4|||
33527598|NCT04035200|62915423|FG000|Overall Study|COVID-19|1|||
33622269|NCT02160977|63022956|FG000|Three Months After Surgery|Lost to Follow-up|0|||
33457514|NCT03670810|62831946|FG007|Main Study|Physician Decision|1|||
33457515|NCT03670810|62831947|FG008|Main Study|Physician Decision|0|||
33457516|NCT03670810|62831939|FG000|Main Study|Pregnancy|1|||
33457517|NCT03670810|62831940|FG001|Main Study|Pregnancy|2|||
33457518|NCT03670810|62831941|FG002|Main Study|Pregnancy|0|||
33457519|NCT03670810|62831942|FG003|Main Study|Pregnancy|0|||
33457520|NCT03670810|62831943|FG004|Main Study|Pregnancy|0|||
33457521|NCT03670810|62831944|FG005|Main Study|Pregnancy|0|||
33457522|NCT03670810|62831945|FG006|Main Study|Pregnancy|0|||
33457523|NCT03670810|62831946|FG007|Main Study|Pregnancy|0|||
33457524|NCT03670810|62831947|FG008|Main Study|Pregnancy|0|||
33457525|NCT03670810|62831939|FG000|Main Study|Protocol Deviation|2|||
33457526|NCT03670810|62831940|FG001|Main Study|Protocol Deviation|12|||
33457527|NCT03670810|62831941|FG002|Main Study|Protocol Deviation|8|||
33457528|NCT03670810|62831942|FG003|Main Study|Protocol Deviation|4|||
33457529|NCT03670810|62831943|FG004|Main Study|Protocol Deviation|0|||
33457530|NCT03670810|62831944|FG005|Main Study|Protocol Deviation|0|||
33457531|NCT03670810|62831945|FG006|Main Study|Protocol Deviation|0|||
33457532|NCT03670810|62831946|FG007|Main Study|Protocol Deviation|0|||
33457533|NCT03670810|62831947|FG008|Main Study|Protocol Deviation|0|||
33457534|NCT03670810|62831939|FG000|Main Study|Withdrawal by Subject|21|||
33457535|NCT03670810|62831940|FG001|Main Study|Withdrawal by Subject|21|||
33527599|NCT04035200|62915424|FG001|Overall Study|COVID-19|0|||
33527600|NCT04035200|62915425|FG002|Overall Study|COVID-19|0|||
33527601|NCT04035200|62915423|FG000|Overall Study|Early Termination|0|||
33622270|NCT02160977|63022957|FG001|Three Months After Surgery|Lost to Follow-up|2|||
33622271|NCT02160977|63022956|FG000|Six Months After Surgery|Lost to Follow-up|2|||
33622272|NCT02160977|63022957|FG001|Six Months After Surgery|Lost to Follow-up|1|||
33622273|NCT02160899|63022969|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
33622274|NCT02160899|63022970|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
33622275|NCT02160899|63022971|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
33622276|NCT02160899|63022972|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
33622277|NCT02160899|63022973|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
33622278|NCT02160899|63022974|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
33622279|NCT02160041|63022988|FG000|Overall Study|Adverse Event|11|||
33622280|NCT02160041|63022988|FG000|Overall Study|Death|2|||
33622281|NCT02160041|63022988|FG000|Overall Study|disease progression|57|||
33622282|NCT02160041|63022988|FG000|Overall Study|Protocol Violation|1|||
33622283|NCT02160041|63022988|FG000|Overall Study|non-compliance with study|1|||
33622284|NCT02160041|63022988|FG000|Overall Study|Physician Decision|3|||
33622285|NCT02160041|63022988|FG000|Overall Study|Withdrawal by Subject|8|||
33622286|NCT02160041|63022988|FG000|Overall Study|study terminated by by sponsor|1|||
33622287|NCT02186873|63022994|FG000|Overall Study|Adverse Event|1|||
33622288|NCT02186873|63022995|FG001|Overall Study|Adverse Event|3|||
33622289|NCT02186873|63022994|FG000|Overall Study|Lack of Efficacy|0|||
33622290|NCT02186873|63022995|FG001|Overall Study|Lack of Efficacy|1|||
33622291|NCT02186873|63022994|FG000|Overall Study|Lost to Follow-up|1|||
33622292|NCT02186873|63022995|FG001|Overall Study|Lost to Follow-up|2|||
33622293|NCT02186873|63022994|FG000|Overall Study|Withdrawal by Subject|7|||
33622294|NCT02186873|63022995|FG001|Overall Study|Withdrawal by Subject|2|||
33622295|NCT02096263|63023005|FG000|Overall Study|Adverse Event|1|||
33622296|NCT02096263|63023006|FG001|Overall Study|Adverse Event|0|||
33622297|NCT02096263|63023007|FG002|Overall Study|Adverse Event|1|||
33325370|NCT00884221|62702159|FG001|Overall Study|Withdrawal by Subject|3|||
33527602|NCT04035200|62915424|FG001|Overall Study|Early Termination|1|||
33527603|NCT04035200|62915425|FG002|Overall Study|Early Termination|0|||
33527604|NCT04035200|62915423|FG000|Overall Study|Non-compliance|0|||
33527605|NCT04035200|62915424|FG001|Overall Study|Non-compliance|1|||
33527606|NCT04035200|62915425|FG002|Overall Study|Non-compliance|0|||
33527607|NCT03197870|62915436|FG000|Overall Study|Adverse Event|9|||
33527608|NCT03197870|62915437|FG001|Overall Study|Adverse Event|4|||
33527609|NCT03197870|62915438|FG002|Overall Study|Adverse Event|6|||
33527610|NCT03197870|62915436|FG000|Overall Study|Withdrawal by Subject|2|||
33527611|NCT03197870|62915437|FG001|Overall Study|Withdrawal by Subject|3|||
33527612|NCT03197870|62915438|FG002|Overall Study|Withdrawal by Subject|0|||
33622298|NCT02096263|63023005|FG000|Overall Study|Lost to Follow-up|14|||
33325371|NCT00884221|62702158|FG000|Overall Study|Adverse Event|6|||
33325372|NCT00884221|62702159|FG001|Overall Study|Adverse Event|3|||
33457536|NCT03670810|62831941|FG002|Main Study|Withdrawal by Subject|8|||
33457537|NCT03670810|62831942|FG003|Main Study|Withdrawal by Subject|9|||
33457538|NCT03670810|62831943|FG004|Main Study|Withdrawal by Subject|5|||
33457539|NCT03670810|62831944|FG005|Main Study|Withdrawal by Subject|2|||
33457540|NCT03670810|62831945|FG006|Main Study|Withdrawal by Subject|1|||
33457541|NCT03670810|62831946|FG007|Main Study|Withdrawal by Subject|1|||
33457542|NCT03670810|62831947|FG008|Main Study|Withdrawal by Subject|0|||
33457543|NCT03670810|62831939|FG000|Main Study|Participant did not want to take the three other treatments|1|||
33457544|NCT03670810|62831940|FG001|Main Study|Participant did not want to take the three other treatments|0|||
33457545|NCT03670810|62831941|FG002|Main Study|Participant did not want to take the three other treatments|0|||
33457546|NCT03670810|62831942|FG003|Main Study|Participant did not want to take the three other treatments|0|||
33457547|NCT03670810|62831943|FG004|Main Study|Participant did not want to take the three other treatments|0|||
33457548|NCT03670810|62831944|FG005|Main Study|Participant did not want to take the three other treatments|0|||
33457549|NCT03670810|62831945|FG006|Main Study|Participant did not want to take the three other treatments|0|||
33457550|NCT03670810|62831946|FG007|Main Study|Participant did not want to take the three other treatments|0|||
33457551|NCT03670810|62831947|FG008|Main Study|Participant did not want to take the three other treatments|0|||
33457552|NCT03670810|62831939|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33457553|NCT03670810|62831940|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
33457554|NCT03670810|62831941|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33457555|NCT03670810|62831942|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33457556|NCT03670810|62831943|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33457557|NCT03670810|62831944|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33457558|NCT03670810|62831945|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33527613|NCT03197870|62915436|FG000|Overall Study|Lost to Follow-up|2|||
33527614|NCT03197870|62915437|FG001|Overall Study|Lost to Follow-up|2|||
33527615|NCT03197870|62915438|FG002|Overall Study|Lost to Follow-up|0|||
33622299|NCT02096263|63023006|FG001|Overall Study|Lost to Follow-up|18|||
33622300|NCT02096263|63023007|FG002|Overall Study|Lost to Follow-up|15|||
33622301|NCT02096263|63023005|FG000|Overall Study|Other|7|||
33622302|NCT02096263|63023006|FG001|Overall Study|Other|9|||
33622303|NCT02096263|63023007|FG002|Overall Study|Other|6|||
33622304|NCT02096263|63023005|FG000|Overall Study|Sponsor study termination|0|||
33622305|NCT02096263|63023006|FG001|Overall Study|Sponsor study termination|0|||
33622306|NCT02096263|63023007|FG002|Overall Study|Sponsor study termination|1|||
33622307|NCT02096263|63023005|FG000|Overall Study|Protocol Violation|7|||
33622308|NCT02096263|63023006|FG001|Overall Study|Protocol Violation|2|||
33622309|NCT02096263|63023007|FG002|Overall Study|Protocol Violation|8|||
33622310|NCT02096263|63023005|FG000|Overall Study|Withdrawal by Subject|5|||
33622311|NCT02096263|63023006|FG001|Overall Study|Withdrawal by Subject|7|||
33622312|NCT02096263|63023007|FG002|Overall Study|Withdrawal by Subject|8|||
33622313|NCT01830543|63023018|FG000|Overall Study|Subject Decision|19|||
33622314|NCT01830543|63023019|FG001|Overall Study|Subject Decision|21|||
33622315|NCT01830543|63023020|FG002|Overall Study|Subject Decision|57|||
33622316|NCT01830543|63023018|FG000|Overall Study|Adverse Event|91|||
33622317|NCT01830543|63023019|FG001|Overall Study|Adverse Event|77|||
33622318|NCT01830543|63023020|FG002|Overall Study|Adverse Event|76|||
33622319|NCT01830543|63023018|FG000|Overall Study|Death|20|||
33622320|NCT01830543|63023019|FG001|Overall Study|Death|22|||
33622321|NCT01830543|63023020|FG002|Overall Study|Death|22|||
33622322|NCT01830543|63023018|FG000|Overall Study|Protocol Violation|3|||
33622323|NCT01830543|63023019|FG001|Overall Study|Protocol Violation|7|||
33622324|NCT01830543|63023020|FG002|Overall Study|Protocol Violation|7|||
33622325|NCT01830543|63023018|FG000|Overall Study|Physician Decision|11|||
33622326|NCT01830543|63023019|FG001|Overall Study|Physician Decision|5|||
33622327|NCT01830543|63023020|FG002|Overall Study|Physician Decision|12|||
33622328|NCT01830543|63023018|FG000|Overall Study|Withdrawal by consent|3|||
33622329|NCT01830543|63023019|FG001|Overall Study|Withdrawal by consent|3|||
33622330|NCT01830543|63023020|FG002|Overall Study|Withdrawal by consent|3|||
33622331|NCT01830543|63023018|FG000|Overall Study|Other|12|||
33622332|NCT01830543|63023019|FG001|Overall Study|Other|17|||
33622333|NCT01830543|63023020|FG002|Overall Study|Other|37|||
33622334|NCT02109445|63023028|FG000|Overall Study|Symptomatic deterioration|2|||
33622335|NCT02109445|63023028|FG000|Overall Study|Adverse Event|1|||
33622336|NCT02109133|63023034|FG000|Overall Study|Lost to Follow-up|1|||
33622337|NCT02109133|63023035|FG001|Overall Study|Lost to Follow-up|0|||
33622338|NCT01623271|63023043|FG000|Overall Study|Withdrawal by Subject|2|||
33622339|NCT01856673|63023050|FG000|Overall Study|Withdrawal by Subject|44|||
33622340|NCT01856673|63023051|FG001|Overall Study|Withdrawal by Subject|50|||
33622341|NCT01856673|63023052|FG002|Overall Study|Withdrawal by Subject|33|||
33622342|NCT01856673|63023050|FG000|Overall Study|Lost to Follow-up|31|||
33622343|NCT01856673|63023051|FG001|Overall Study|Lost to Follow-up|34|||
33622344|NCT01856673|63023052|FG002|Overall Study|Lost to Follow-up|0|||
33622345|NCT01856673|63023050|FG000|Overall Study|Unknown reasons|9|||
33622346|NCT01856673|63023051|FG001|Overall Study|Unknown reasons|0|||
33622347|NCT01856673|63023052|FG002|Overall Study|Unknown reasons|0|||
33622348|NCT01856673|63023050|FG000|Overall Study|Psychologist decision|1|||
33622349|NCT01856673|63023051|FG001|Overall Study|Psychologist decision|0|||
33622350|NCT01856673|63023052|FG002|Overall Study|Psychologist decision|0|||
33622351|NCT01856673|63023050|FG000|Overall Study|Paperwork errors|8|||
33622352|NCT01856673|63023051|FG001|Overall Study|Paperwork errors|0|||
33622353|NCT01856673|63023052|FG002|Overall Study|Paperwork errors|0|||
33622354|NCT01856673|63023050|FG000|Overall Study|Death|1|||
33527616|NCT03197870|62915436|FG000|Overall Study|data not available|1|||
33527617|NCT03197870|62915437|FG001|Overall Study|data not available|1|||
33527618|NCT03197870|62915438|FG002|Overall Study|data not available|0|||
33527619|NCT04889222|62915449|FG000|Overall Study|Did not meet eligibility criteria|8|||
33527620|NCT04889222|62915449|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
33527621|NCT04889222|62915449|FG000|Overall Study|Did not proceed due to time constraints|5|||
33527622|NCT03067441|62915481|FG000|Overall Study|Withdrawal by Subject|16|||
33527623|NCT03067441|62915482|FG001|Overall Study|Withdrawal by Subject|34|||
33527624|NCT03067441|62915481|FG000|Overall Study|Lost to Follow-up|7|||
33527625|NCT03067441|62915482|FG001|Overall Study|Lost to Follow-up|5|||
33527626|NCT03067441|62915481|FG000|Overall Study|Adverse Event|7|||
33527627|NCT03067441|62915482|FG001|Overall Study|Adverse Event|14|||
33622355|NCT01856673|63023051|FG001|Overall Study|Death|1|||
33622356|NCT01856673|63023052|FG002|Overall Study|Death|0|||
33622357|NCT01856673|63023050|FG000|Overall Study|Protocol Violation|1|||
33622358|NCT01856673|63023051|FG001|Overall Study|Protocol Violation|0|||
33622359|NCT01856673|63023052|FG002|Overall Study|Protocol Violation|1|||
33622360|NCT02095951|63023062|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
33622361|NCT02095951|63023063|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
33622362|NCT02095873|63023075|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
33622363|NCT02095873|63023076|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
33622364|NCT02095873|63023075|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
33622365|NCT02095873|63023076|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
33622366|NCT02095873|63023075|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
33622367|NCT02095873|63023076|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
33622368|NCT02094937|63023084|FG000|8 Weeks in Period 1|Adverse Event|9|||
33622369|NCT02094937|63023085|FG001|8 Weeks in Period 1|Adverse Event|0|||
33622370|NCT02094937|63023086|FG002|8 Weeks in Period 1|Adverse Event|0|||
33622371|NCT02094937|63023087|FG003|8 Weeks in Period 1|Adverse Event|0|||
33622372|NCT02094937|63023084|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
33622373|NCT02094937|63023085|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
33622374|NCT02094937|63023086|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
33622375|NCT02094937|63023087|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
33622376|NCT02094937|63023084|FG000|8 Weeks in Period 1|Protocol Violation|2|||
33622377|NCT02094937|63023085|FG001|8 Weeks in Period 1|Protocol Violation|0|||
33622378|NCT02094937|63023086|FG002|8 Weeks in Period 1|Protocol Violation|0|||
33622379|NCT02094937|63023087|FG003|8 Weeks in Period 1|Protocol Violation|0|||
33622380|NCT02094937|63023084|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
33622381|NCT02094937|63023085|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
33622382|NCT02094937|63023086|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
33622383|NCT02094937|63023087|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
33622384|NCT02094937|63023084|FG000|8 Weeks in Period 1|Physician Decision|1|||
33622385|NCT02094937|63023085|FG001|8 Weeks in Period 1|Physician Decision|0|||
33622386|NCT02094937|63023086|FG002|8 Weeks in Period 1|Physician Decision|0|||
33622387|NCT02094937|63023087|FG003|8 Weeks in Period 1|Physician Decision|0|||
33622388|NCT02094937|63023084|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
33622389|NCT02094937|63023085|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
33622390|NCT02094937|63023086|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
33622391|NCT02094937|63023087|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
33622392|NCT02094937|63023084|FG000|12 Weeks in Period 2|Adverse Event|0|||
33622393|NCT02094937|63023085|FG001|12 Weeks in Period 2|Adverse Event|2|||
33622394|NCT02094937|63023086|FG002|12 Weeks in Period 2|Adverse Event|4|||
33622395|NCT02094937|63023087|FG003|12 Weeks in Period 2|Adverse Event|1|||
33622396|NCT02094937|63023084|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
33622397|NCT02094937|63023085|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
33622398|NCT02094937|63023086|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
33622399|NCT02094937|63023087|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
33622400|NCT02094937|63023084|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
33622401|NCT02094937|63023085|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
33622402|NCT02094937|63023086|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
33622403|NCT02094937|63023087|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
33622404|NCT02094937|63023084|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
33622405|NCT02094937|63023085|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
33622406|NCT02094937|63023086|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
33622407|NCT02094937|63023087|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
33622408|NCT02094937|63023084|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
33622409|NCT02094937|63023085|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
33622410|NCT02094937|63023086|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
33622411|NCT02094937|63023087|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
33622412|NCT02093923|63023101|FG000|Overall Study|Lost to Follow-up|0|||
33622413|NCT02093923|63023102|FG001|Overall Study|Lost to Follow-up|0|||
33325373|NCT00884221|62702158|FG000|Overall Study|Protocol Violation|16|||
33325374|NCT00884221|62702159|FG001|Overall Study|Protocol Violation|13|||
33527628|NCT03067441|62915481|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
33527629|NCT03067441|62915482|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
33527630|NCT03067441|62915481|FG000|Overall Study|Physician Decision|1|||
33527631|NCT03067441|62915482|FG001|Overall Study|Physician Decision|3|||
33527632|NCT03067441|62915481|FG000|Overall Study|Other|1|||
33527633|NCT03067441|62915482|FG001|Overall Study|Other|1|||
33527634|NCT02600923|62915491|FG000|Overall Study|Death|10|||
33527635|NCT02600923|62915491|FG000|Overall Study|Adverse Event|3|||
33527636|NCT02600923|62915491|FG000|Overall Study|Global deterioration of health status|2|||
33527637|NCT02600923|62915491|FG000|Overall Study|Insufficient clinical response|6|||
33527638|NCT02600923|62915491|FG000|Overall Study|Lost to Follow-up|1|||
33527639|NCT02600923|62915491|FG000|Overall Study|Withdrawal by Subject|5|||
33527640|NCT02600923|62915491|FG000|Overall Study|Objective progression or relapse|50|||
33527641|NCT02600923|62915491|FG000|Overall Study|Study terminated by Sponsor|53|||
33527642|NCT02600923|62915491|FG000|Overall Study|Not treated|1|||
33527643|NCT03070171|62915497|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
33527644|NCT03070171|62915498|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
33527645|NCT03070171|62915497|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
33622414|NCT02093923|63023103|FG002|Overall Study|Lost to Follow-up|0|||
33622415|NCT02093923|63023104|FG003|Overall Study|Lost to Follow-up|1|||
33622416|NCT02093923|63023105|FG004|Overall Study|Lost to Follow-up|0|||
33622417|NCT02093923|63023101|FG000|Overall Study|Screen failure after randomization|0|||
33622418|NCT02093923|63023102|FG001|Overall Study|Screen failure after randomization|0|||
33622419|NCT02093923|63023103|FG002|Overall Study|Screen failure after randomization|0|||
33527646|NCT03070171|62915498|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
33527647|NCT03644017|62915504|FG000|Overall Study|Access Abandonment|5|||
33527648|NCT03644017|62915504|FG000|Overall Study|Kidney Transplant|2|||
33527649|NCT00158054|62915510|FG000|Overall Study|Refused to continue|3|||
33527650|NCT00158054|62915511|FG001|Overall Study|Refused to continue|0|||
33527651|NCT00158054|62915510|FG000|Overall Study|Unavailable for follow up|7|||
33527652|NCT00158054|62915511|FG001|Overall Study|Unavailable for follow up|3|||
33527653|NCT01337960|62915520|FG000|Overall Study|Lost to Follow-up|1|||
33527654|NCT01337960|62915521|FG001|Overall Study|Lost to Follow-up|0|||
33527655|NCT01337960|62915522|FG002|Overall Study|Lost to Follow-up|0|||
33527656|NCT01337960|62915520|FG000|Overall Study|Withdrawal by Subject|1|||
33527657|NCT01337960|62915521|FG001|Overall Study|Withdrawal by Subject|0|||
33527658|NCT01337960|62915522|FG002|Overall Study|Withdrawal by Subject|0|||
33527659|NCT02750306|62915541|FG000|Overall Study|Withdrawal by Subject|5|||
33527660|NCT02750306|62915542|FG001|Overall Study|Withdrawal by Subject|2|||
33527661|NCT02750306|62915541|FG000|Overall Study|Protocol Violation|1|||
33527662|NCT02750306|62915542|FG001|Overall Study|Protocol Violation|0|||
33527663|NCT01816165|62915550|FG000|Overall Study|Adverse Event|1|||
33527664|NCT01816165|62915551|FG001|Overall Study|Adverse Event|0|||
33527665|NCT01816165|62915552|FG002|Overall Study|Adverse Event|0|||
33527666|NCT01816165|62915553|FG003|Overall Study|Adverse Event|0|||
33527667|NCT01677988|62915582|FG000|Overall Study|Lack of Efficacy|2|||
33527668|NCT02926573|62915589|FG000|Overall Study|Nausea|1|||
33622420|NCT02093923|63023104|FG003|Overall Study|Screen failure after randomization|1|||
33622421|NCT02093923|63023105|FG004|Overall Study|Screen failure after randomization|0|||
33622422|NCT02186561|63023121|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
33622423|NCT02186561|63023121|FG000|Enrollment|Enrollment Cap Reached|5|||
33622424|NCT02186561|63023121|FG000|Enrollment|Insurance Denial|2|||
33622425|NCT02186561|63023121|FG000|Enrollment|Withdrawal by Subject|2|||
33622426|NCT02186561|63023121|FG000|Enrollment|Investigator Withdrew Consent|1|||
33622427|NCT02186561|63023121|FG000|30-Day Post Index Procedure Visit|Death|1|||
33622428|NCT02186561|63023121|FG000|1- Year Post Index Procedure Visit|Death|1|||
33622429|NCT02186561|63023121|FG000|1- Year Post Index Procedure Visit|Missed|1|||
33622430|NCT02066467|63023127|FG000|Overall Study|Did not undergo implant procedure|24|||
33622431|NCT02066467|63023127|FG000|Overall Study|Attempted to implant withoput success|43|||
33622432|NCT02066467|63023127|FG000|Overall Study|Consent ineligible|1|||
33622433|NCT02066467|63023127|FG000|Overall Study|Death|54|||
33622434|NCT02066467|63023127|FG000|Overall Study|Lost to Follow-up|51|||
33622435|NCT02066467|63023127|FG000|Overall Study|Adverse Event|20|||
33622436|NCT02066467|63023127|FG000|Overall Study|Withdrawal by Subject|16|||
33622437|NCT02066467|63023127|FG000|Overall Study|Physician Decision|2|||
33622438|NCT02066467|63023127|FG000|Overall Study|Not defined|4|||
33622439|NCT02186171|63023133|FG000|Overall Study|Withdrawal by Subject|1|||
33622440|NCT02186171|63023134|FG001|Overall Study|Withdrawal by Subject|9|||
33622441|NCT02186171|63023133|FG000|Overall Study|Lost to Follow-up|2|||
33622442|NCT02186171|63023134|FG001|Overall Study|Lost to Follow-up|2|||
33622443|NCT02186171|63023133|FG000|Overall Study|Death|1|||
33622444|NCT02186171|63023134|FG001|Overall Study|Death|2|||
33622445|NCT02186171|63023133|FG000|Overall Study|Protocol-specified Criteria|0|||
33622446|NCT02186171|63023134|FG001|Overall Study|Protocol-specified Criteria|2|||
33622447|NCT02186015|63023142|FG000|Overall Study|Physician Decision|1|||
33622448|NCT02186015|63023143|FG001|Overall Study|Physician Decision|0|||
33622449|NCT02066389|63023156|FG000|Overall Study|Adverse Event|1|||
33622450|NCT02066389|63023157|FG001|Overall Study|Adverse Event|1|||
33622451|NCT02066389|63023158|FG002|Overall Study|Adverse Event|1|||
33622452|NCT02066389|63023159|FG003|Overall Study|Adverse Event|1|||
33622453|NCT02066389|63023160|FG004|Overall Study|Adverse Event|5|||
33622454|NCT02066389|63023161|FG005|Overall Study|Adverse Event|1|||
33622455|NCT02066389|63023156|FG000|Overall Study|Withdrawal by Subject|4|||
33622456|NCT02066389|63023157|FG001|Overall Study|Withdrawal by Subject|0|||
33622457|NCT02066389|63023158|FG002|Overall Study|Withdrawal by Subject|5|||
33622458|NCT02066389|63023159|FG003|Overall Study|Withdrawal by Subject|1|||
33622459|NCT02066389|63023160|FG004|Overall Study|Withdrawal by Subject|1|||
33622460|NCT02066389|63023161|FG005|Overall Study|Withdrawal by Subject|2|||
33622461|NCT02066389|63023156|FG000|Overall Study|Lost to Follow-up|0|||
33527669|NCT02926573|62915590|FG001|Overall Study|Nausea|0|||
33527670|NCT02926573|62915589|FG000|Overall Study|Remain intubated|2|||
33527671|NCT02926573|62915590|FG001|Overall Study|Remain intubated|2|||
33527672|NCT02926573|62915589|FG000|Overall Study|Change in surgery plan|3|||
33527673|NCT02926573|62915590|FG001|Overall Study|Change in surgery plan|1|||
33622462|NCT02066389|63023157|FG001|Overall Study|Lost to Follow-up|0|||
33622463|NCT02066389|63023158|FG002|Overall Study|Lost to Follow-up|0|||
33622464|NCT02066389|63023159|FG003|Overall Study|Lost to Follow-up|1|||
33622465|NCT02066389|63023160|FG004|Overall Study|Lost to Follow-up|1|||
33622466|NCT02066389|63023161|FG005|Overall Study|Lost to Follow-up|1|||
33622467|NCT02066389|63023156|FG000|Overall Study|Randomized in Error|0|||
33622468|NCT02066389|63023157|FG001|Overall Study|Randomized in Error|0|||
33622469|NCT02066389|63023158|FG002|Overall Study|Randomized in Error|0|||
33622470|NCT02066389|63023159|FG003|Overall Study|Randomized in Error|0|||
33622471|NCT02066389|63023160|FG004|Overall Study|Randomized in Error|0|||
33622472|NCT02066389|63023161|FG005|Overall Study|Randomized in Error|1|||
33622473|NCT02106403|63023175|FG000|Follow-Up Visit 3|Other Reason|0|||
33622474|NCT02106403|63023176|FG001|Follow-Up Visit 3|Other Reason|0|||
33622475|NCT02106403|63023177|FG002|Follow-Up Visit 3|Other Reason|0|||
33622476|NCT02106403|63023178|FG003|Follow-Up Visit 3|Other Reason|0|||
33622477|NCT02106403|63023179|FG004|Follow-Up Visit 3|Other Reason|0|||
33622478|NCT02106403|63023180|FG005|Follow-Up Visit 3|Other Reason|1|||
33622479|NCT02133131|63023197|FG000|Overall Study|Adverse Event|0|||
33622480|NCT02133131|63023198|FG001|Overall Study|Adverse Event|0|||
33622481|NCT02133131|63023199|FG002|Overall Study|Adverse Event|0|||
33622482|NCT02133131|63023200|FG003|Overall Study|Adverse Event|1|||
33622483|NCT02133131|63023201|FG004|Overall Study|Adverse Event|0|||
33325375|NCT00884221|62702158|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
33325376|NCT00884221|62702159|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
33325377|NCT00899548|62702180|FG000|Overall Study|Physician Decision|3|||
33325378|NCT00899392|62702190|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
33325379|NCT00899392|62702191|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
33325380|NCT00690898|62702197|FG000|SCREENING|Screen failure|18|||
33325381|NCT00690898|62702197|FG000|TREATMENT|Adverse Event|3|||
33325382|NCT00690898|62702197|FG000|TREATMENT|Lack of Efficacy|18|||
33325383|NCT00690898|62702197|FG000|TREATMENT|Withdrawal by Subject|4|||
33325384|NCT00690898|62702197|FG000|TREATMENT|Other (not otherwise specified)|1|||
33325385|NCT00895414|62702201|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
33325386|NCT00895414|62702202|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
33325387|NCT00895414|62702201|FG000|First Intervention (14 Days)|Physician Decision|0|||
33325388|NCT00895414|62702202|FG001|First Intervention (14 Days)|Physician Decision|1|||
33325389|NCT01212770|62702211|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
33325390|NCT01212770|62702212|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
33325391|NCT01212770|62702213|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
33325392|NCT01212770|62702214|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33325393|NCT01212770|62702215|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33325394|NCT01212770|62702216|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33325395|NCT01212770|62702217|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33325396|NCT01212770|62702218|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33325397|NCT01212770|62702219|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33325398|NCT01212770|62702211|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
33325399|NCT01212770|62702212|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
33325400|NCT01212770|62702213|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
33325401|NCT01212770|62702214|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33325402|NCT01212770|62702215|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33325403|NCT01212770|62702216|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33527674|NCT02926573|62915589|FG000|Overall Study|Change to outpatient status|5|||
33527675|NCT02926573|62915590|FG001|Overall Study|Change to outpatient status|1|||
33527676|NCT02926573|62915589|FG000|Overall Study|Withdrawal by Subject|0|||
33527677|NCT02926573|62915590|FG001|Overall Study|Withdrawal by Subject|2|||
33527678|NCT02926573|62915589|FG000|Overall Study|Return to operating room|0|||
33527679|NCT02926573|62915590|FG001|Overall Study|Return to operating room|2|||
33527680|NCT02926573|62915589|FG000|Overall Study|Delirium|0|||
33527681|NCT02926573|62915590|FG001|Overall Study|Delirium|1|||
33527682|NCT00158860|62915598|FG000|Overall Study|Adverse Event|3|||
33527683|NCT00158860|62915599|FG001|Overall Study|Adverse Event|6|||
33325404|NCT01212770|62702217|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33325405|NCT01212770|62702218|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33325406|NCT01212770|62702219|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33527684|NCT00158860|62915598|FG000|Overall Study|Lost to Follow-up|11|||
33527685|NCT00158860|62915599|FG001|Overall Study|Lost to Follow-up|17|||
33527686|NCT00158860|62915598|FG000|Overall Study|Protocol Violation|8|||
33622484|NCT02133131|63023202|FG005|Overall Study|Adverse Event|0|||
33622485|NCT02133131|63023203|FG006|Overall Study|Adverse Event|0|||
33622486|NCT02133131|63023197|FG000|Overall Study|Lost to Follow-up|1|||
33622487|NCT02133131|63023198|FG001|Overall Study|Lost to Follow-up|0|||
33622488|NCT02133131|63023199|FG002|Overall Study|Lost to Follow-up|0|||
33622489|NCT02133131|63023200|FG003|Overall Study|Lost to Follow-up|1|||
33622490|NCT02133131|63023201|FG004|Overall Study|Lost to Follow-up|0|||
33325407|NCT01212770|62702211|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
33325408|NCT01212770|62702212|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
33325409|NCT01212770|62702213|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
33325410|NCT01212770|62702214|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33325411|NCT01212770|62702215|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33325412|NCT01212770|62702216|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33325413|NCT01212770|62702217|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33325414|NCT01212770|62702218|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33325415|NCT01212770|62702219|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33325416|NCT01212770|62702211|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
33325417|NCT01212770|62702212|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33325418|NCT01212770|62702213|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
33622491|NCT02133131|63023202|FG005|Overall Study|Lost to Follow-up|0|||
33622492|NCT02133131|63023203|FG006|Overall Study|Lost to Follow-up|0|||
33622493|NCT02133131|63023197|FG000|Overall Study|Status not recorded|4|||
33622494|NCT02133131|63023198|FG001|Overall Study|Status not recorded|5|||
33622495|NCT02133131|63023199|FG002|Overall Study|Status not recorded|1|||
33622496|NCT02133131|63023200|FG003|Overall Study|Status not recorded|4|||
33622497|NCT02133131|63023201|FG004|Overall Study|Status not recorded|0|||
33622498|NCT02133131|63023202|FG005|Overall Study|Status not recorded|0|||
33622499|NCT02133131|63023203|FG006|Overall Study|Status not recorded|0|||
33622500|NCT02133131|63023197|FG000|Overall Study|Ongoing in study|0|||
33622501|NCT02133131|63023198|FG001|Overall Study|Ongoing in study|0|||
33325419|NCT01212770|62702214|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33325420|NCT01212770|62702215|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33622502|NCT02133131|63023199|FG002|Overall Study|Ongoing in study|0|||
33622503|NCT02133131|63023200|FG003|Overall Study|Ongoing in study|0|||
33622504|NCT02133131|63023201|FG004|Overall Study|Ongoing in study|15|||
33622505|NCT02133131|63023202|FG005|Overall Study|Ongoing in study|14|||
33622506|NCT02133131|63023203|FG006|Overall Study|Ongoing in study|11|||
33622507|NCT02133131|63023197|FG000|Overall Study|Protocol Violation|0|||
33622508|NCT02133131|63023198|FG001|Overall Study|Protocol Violation|0|||
33622509|NCT02133131|63023199|FG002|Overall Study|Protocol Violation|0|||
33622510|NCT02133131|63023200|FG003|Overall Study|Protocol Violation|0|||
33622511|NCT02133131|63023201|FG004|Overall Study|Protocol Violation|0|||
33622512|NCT02133131|63023202|FG005|Overall Study|Protocol Violation|0|||
33622513|NCT02133131|63023203|FG006|Overall Study|Protocol Violation|1|||
33622514|NCT02106325|63023221|FG000|Phase 1|Lost to Follow-up|2|||
33622515|NCT02106325|63023222|FG001|Phase 1|Lost to Follow-up|2|||
33622516|NCT02106325|63023221|FG000|Phase 2|Lost to Follow-up|2|||
33622517|NCT02106325|63023222|FG001|Phase 2|Lost to Follow-up|3|||
33622518|NCT02106325|63023221|FG000|Phase 3|Lost to Follow-up|2|||
33325421|NCT01212770|62702216|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33325422|NCT01212770|62702217|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33457559|NCT03670810|62831946|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33457560|NCT03670810|62831947|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33457561|NCT03670810|62831939|FG000|Main Study|Travel and Coronavirus issues|0|||
33457562|NCT03670810|62831940|FG001|Main Study|Travel and Coronavirus issues|0|||
33457563|NCT03670810|62831941|FG002|Main Study|Travel and Coronavirus issues|0|||
33457564|NCT03670810|62831942|FG003|Main Study|Travel and Coronavirus issues|1|||
33457565|NCT03670810|62831943|FG004|Main Study|Travel and Coronavirus issues|0|||
33457566|NCT03670810|62831944|FG005|Main Study|Travel and Coronavirus issues|0|||
33457567|NCT03670810|62831945|FG006|Main Study|Travel and Coronavirus issues|0|||
33457568|NCT03670810|62831946|FG007|Main Study|Travel and Coronavirus issues|0|||
33457569|NCT03670810|62831947|FG008|Main Study|Travel and Coronavirus issues|0|||
33457570|NCT03670810|62831939|FG000|Open Label Extension|Protocol Deviation|0|||
33457571|NCT03670810|62831940|FG001|Open Label Extension|Protocol Deviation|0|||
33457572|NCT03670810|62831941|FG002|Open Label Extension|Protocol Deviation|0|||
33457573|NCT03670810|62831942|FG003|Open Label Extension|Protocol Deviation|0|||
33457574|NCT03670810|62831943|FG004|Open Label Extension|Protocol Deviation|0|||
33457575|NCT03670810|62831944|FG005|Open Label Extension|Protocol Deviation|0|||
33622519|NCT02106325|63023222|FG001|Phase 3|Lost to Follow-up|1|||
33622520|NCT01625689|63023230|FG000|Overall Study|Migration|2|||
33622521|NCT01625689|63023231|FG001|Overall Study|Migration|1|||
33622522|NCT02184611|63023239|FG000|Overall Study|Lack of Efficacy|11|||
33622523|NCT02184611|63023240|FG001|Overall Study|Lack of Efficacy|15|||
33622524|NCT02184611|63023239|FG000|Overall Study|Withdrawal by Subject|5|||
33622525|NCT02184611|63023240|FG001|Overall Study|Withdrawal by Subject|6|||
33622526|NCT02184611|63023239|FG000|Overall Study|Adverse Event|4|||
33622527|NCT02184611|63023240|FG001|Overall Study|Adverse Event|5|||
33622528|NCT02184611|63023239|FG000|Overall Study|Protocol Violation|1|||
33622529|NCT02184611|63023240|FG001|Overall Study|Protocol Violation|1|||
33622530|NCT02184611|63023239|FG000|Overall Study|Protocol defined stopping criteria|0|||
33622531|NCT02184611|63023240|FG001|Overall Study|Protocol defined stopping criteria|1|||
33622532|NCT02066311|63023246|FG000|Overall Study|Adverse Event|4|||
33622533|NCT02066311|63023246|FG000|Overall Study|Withdrawal by Subject|1|||
33622534|NCT02184455|63023250|FG000|Overall Study|Lost to Follow-up|1|||
33622535|NCT02184143|63023256|FG000|Overall Study|Withdrawal by Subject|4|||
33622536|NCT02184143|63023257|FG001|Overall Study|Withdrawal by Subject|4|||
33622537|NCT02184143|63023256|FG000|Overall Study|Lost to Follow-up|5|||
33622538|NCT02184143|63023257|FG001|Overall Study|Lost to Follow-up|3|||
33622539|NCT02184143|63023256|FG000|Overall Study|Death|1|||
33622540|NCT02184143|63023257|FG001|Overall Study|Death|0|||
33622541|NCT01625611|63023267|FG000|Overall Study|No adlib drinks Lab 1|3|||
33622542|NCT01625611|63023268|FG001|Overall Study|No adlib drinks Lab 1|0|||
33622543|NCT01625611|63023267|FG000|Overall Study|Technical issues with PET|1|||
33622544|NCT01625611|63023268|FG001|Overall Study|Technical issues with PET|0|||
33622545|NCT01625611|63023267|FG000|Overall Study|Unable to complete study procedures|1|||
33622546|NCT01625611|63023268|FG001|Overall Study|Unable to complete study procedures|0|||
33622547|NCT01625611|63023267|FG000|Overall Study|Withdrawal by Subject|3|||
33622548|NCT01625611|63023268|FG001|Overall Study|Withdrawal by Subject|0|||
33622549|NCT02159807|63023278|FG000|Overall Study|Adverse Event|0|||
33622550|NCT02159807|63023279|FG001|Overall Study|Adverse Event|0|||
33622551|NCT02159807|63023280|FG002|Overall Study|Adverse Event|1|||
33622552|NCT02159807|63023278|FG000|Overall Study|No CSF|1|||
33622553|NCT02159807|63023279|FG001|Overall Study|No CSF|1|||
33622554|NCT02159807|63023280|FG002|Overall Study|No CSF|1|||
33622555|NCT02159807|63023278|FG000|Overall Study|elevated blood pressure|0|||
33622556|NCT02159807|63023279|FG001|Overall Study|elevated blood pressure|0|||
33622557|NCT02159807|63023280|FG002|Overall Study|elevated blood pressure|1|||
33622558|NCT02066233|63023290|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
33622559|NCT02066233|63023291|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
33622560|NCT02159729|63023299|FG000|Overall Study|Adverse Event|0|||
33622561|NCT02159729|63023300|FG001|Overall Study|Adverse Event|1|||
33622562|NCT02159729|63023299|FG000|Overall Study|Subject's Request|13|||
33622563|NCT02159729|63023300|FG001|Overall Study|Subject's Request|10|||
33622564|NCT02159729|63023299|FG000|Overall Study|Lost to Follow-up|24|||
33622565|NCT02159729|63023300|FG001|Overall Study|Lost to Follow-up|9|||
33527687|NCT00158860|62915599|FG001|Overall Study|Protocol Violation|23|||
33527688|NCT00158860|62915598|FG000|Overall Study|Withdrawal by Subject|7|||
33527689|NCT00158860|62915599|FG001|Overall Study|Withdrawal by Subject|17|||
33622566|NCT02159729|63023299|FG000|Overall Study|Non compliance|2|||
33622567|NCT02159729|63023300|FG001|Overall Study|Non compliance|0|||
33622568|NCT02159729|63023299|FG000|Overall Study|Other Unspecified|3|||
33622569|NCT02159729|63023300|FG001|Overall Study|Other Unspecified|1|||
33622570|NCT02159183|63023308|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
33622571|NCT02159183|63023309|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
33622572|NCT02159183|63023308|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
33622573|NCT02159183|63023309|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
33622574|NCT02159183|63023308|FG000|Analysis After the 36 Months Follow-up|Death|0|||
33622575|NCT02159183|63023309|FG001|Analysis After the 36 Months Follow-up|Death|1|||
33622576|NCT02159183|63023308|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
33622577|NCT02159183|63023309|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
33622578|NCT02159183|63023308|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
33622579|NCT02159183|63023309|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
33622580|NCT02183675|63023321|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
33622581|NCT02183675|63023322|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
33527690|NCT00158860|62915598|FG000|Overall Study|MOVING OUT OF STATE|1|||
33527691|NCT00158860|62915599|FG001|Overall Study|MOVING OUT OF STATE|0|||
33527692|NCT00158860|62915598|FG000|Overall Study|Pregnancy|3|||
33527693|NCT00158860|62915599|FG001|Overall Study|Pregnancy|3|||
33527694|NCT00158860|62915598|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
33527695|NCT00158860|62915599|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
33622582|NCT02183675|63023323|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
33622583|NCT02183675|63023324|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
33527696|NCT00158860|62915598|FG000|Overall Study|SPONSOR REQUEST|0|||
33622584|NCT02183675|63023325|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
33622585|NCT02183675|63023326|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
33527697|NCT00158860|62915599|FG001|Overall Study|SPONSOR REQUEST|1|||
33622586|NCT02183519|63023338|FG000|Overall Study|computer error|3|||
33622587|NCT02183519|63023339|FG001|Overall Study|computer error|0|||
33622588|NCT02183519|63023338|FG000|Overall Study|Did not respond to cough inducter|0|||
33622589|NCT02183519|63023339|FG001|Overall Study|Did not respond to cough inducter|3|||
33622590|NCT02132195|63023348|FG000|Initial Assignment|Relapsed|14|||
33622591|NCT02132195|63023349|FG001|Initial Assignment|Relapsed|0|||
33622592|NCT02132195|63023350|FG002|Initial Assignment|Relapsed|0|||
33622593|NCT02132195|63023348|FG000|Rescue Therapy|Relapsed|0|||
33622594|NCT02132195|63023349|FG001|Rescue Therapy|Relapsed|0|||
33622595|NCT02132195|63023350|FG002|Rescue Therapy|Relapsed|7|||
33622596|NCT02132195|63023348|FG000|Rescue Therapy|Physician Decision|0|||
33622597|NCT02132195|63023349|FG001|Rescue Therapy|Physician Decision|0|||
33622598|NCT02132195|63023350|FG002|Rescue Therapy|Physician Decision|1|||
33622599|NCT02132195|63023348|FG000|Rescue Therapy|Withdrawal by Subject|0|||
33622600|NCT02132195|63023349|FG001|Rescue Therapy|Withdrawal by Subject|0|||
33527698|NCT00158860|62915598|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
33527699|NCT00158860|62915599|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
33527700|NCT00158860|62915598|FG000|Overall Study|Closed per sponsor|0|||
33527701|NCT00158860|62915599|FG001|Overall Study|Closed per sponsor|1|||
33527702|NCT03067129|62915610|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
33527703|NCT03067129|62915611|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
33527704|NCT03067129|62915612|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
33527705|NCT03067129|62915613|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
33622601|NCT02132195|63023350|FG002|Rescue Therapy|Withdrawal by Subject|1|||
33622602|NCT02132195|63023348|FG000|Rescue Therapy|Adverse Event|0|||
33622603|NCT02132195|63023349|FG001|Rescue Therapy|Adverse Event|0|||
33622604|NCT02132195|63023350|FG002|Rescue Therapy|Adverse Event|2|||
33622605|NCT02182973|63023360|FG000|Overall Study|Withdrawal by Subject|3|||
33622606|NCT02182973|63023361|FG001|Overall Study|Withdrawal by Subject|0|||
33622607|NCT02182895|63023370|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
33622608|NCT02182895|63023371|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
33622609|NCT01625377|63023379|FG000|Overall Study|Death|1|||
33622610|NCT01625377|63023380|FG001|Overall Study|Death|1|||
33622611|NCT01625377|63023379|FG000|Overall Study|Administrative Problem|1|||
33622612|NCT01625377|63023380|FG001|Overall Study|Administrative Problem|1|||
33622613|NCT01625377|63023379|FG000|Overall Study|Protocol Violation|0|||
33622614|NCT01625377|63023380|FG001|Overall Study|Protocol Violation|3|||
33622615|NCT01625377|63023379|FG000|Overall Study|Adverse Event|3|||
33622616|NCT01625377|63023380|FG001|Overall Study|Adverse Event|16|||
33622617|NCT01625377|63023379|FG000|Overall Study|Graft loss|1|||
33622618|NCT01625377|63023380|FG001|Overall Study|Graft loss|0|||
33622619|NCT01625377|63023379|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33622620|NCT01625377|63023380|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33622621|NCT01625377|63023379|FG000|Overall Study|Abnormal laboratory values|1|||
33622622|NCT01625377|63023380|FG001|Overall Study|Abnormal laboratory values|0|||
33622623|NCT02158949|63023388|FG000|Overall Study|Withdrawal by Subject|1|||
33622624|NCT02158949|63023389|FG001|Overall Study|Withdrawal by Subject|0|||
33622625|NCT02158949|63023388|FG000|Overall Study|Lost to Follow-up|5|||
33622626|NCT02158949|63023389|FG001|Overall Study|Lost to Follow-up|11|||
33622627|NCT02132117|63023397|FG000|Overall Study|Adverse Event|6|||
33622628|NCT02132117|63023398|FG001|Overall Study|Adverse Event|1|||
33622629|NCT02132117|63023397|FG000|Overall Study|Lost to Follow-up|2|||
33622630|NCT02132117|63023398|FG001|Overall Study|Lost to Follow-up|2|||
33622631|NCT02132117|63023397|FG000|Overall Study|Personal Reasons|1|||
33622632|NCT02132117|63023398|FG001|Overall Study|Personal Reasons|2|||
33622633|NCT02132117|63023397|FG000|Overall Study|Other Miscellaneous Reasons|2|||
33622634|NCT02132117|63023398|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33622635|NCT02093689|63023407|FG000|Overall Study|Physician Decision|4|||
33622636|NCT02093689|63023408|FG001|Overall Study|Physician Decision|0|||
33622637|NCT02093689|63023409|FG002|Overall Study|Physician Decision|0|||
33622638|NCT02047045|63023417|FG000|Baseline|Withdrawal by Subject|3|||
33622639|NCT02047045|63023418|FG001|Baseline|Withdrawal by Subject|2|||
33622640|NCT02047045|63023417|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
33622641|NCT02047045|63023418|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
33325423|NCT01212770|62702218|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33527706|NCT03067129|62915610|FG000|Overall Study|Withdrawal by Subject|0|||
33527707|NCT03067129|62915611|FG001|Overall Study|Withdrawal by Subject|0|||
33527708|NCT03067129|62915612|FG002|Overall Study|Withdrawal by Subject|1|||
33325424|NCT01212770|62702219|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33622642|NCT02047045|63023417|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
33622643|NCT02047045|63023418|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
33622644|NCT02047045|63023417|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
33622645|NCT02047045|63023418|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
33622646|NCT02047045|63023417|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
33622647|NCT02047045|63023418|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
33622648|NCT02047045|63023417|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
33622649|NCT02047045|63023418|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
33622650|NCT02047045|63023417|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
33622651|NCT02047045|63023418|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
33622652|NCT02047045|63023417|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
33622653|NCT02047045|63023418|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
33622654|NCT02047045|63023417|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
33622655|NCT02047045|63023418|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
33622656|NCT02131259|63023424|FG000|Overall Study|Progressive disease|751|||
33622657|NCT02131259|63023424|FG000|Overall Study|Adverse Event|341|||
33622658|NCT02131259|63023424|FG000|Overall Study|Lost to Follow-up|7|||
33622659|NCT02131259|63023424|FG000|Overall Study|Relocation|32|||
33622660|NCT02131259|63023424|FG000|Overall Study|Other|63|||
33622661|NCT02131259|63023424|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
33622662|NCT02131259|63023424|FG000|Overall Study|Progressive disease/relocation|1|||
33622663|NCT02131259|63023424|FG000|Overall Study|Progressive disease/other|2|||
33622664|NCT02131259|63023424|FG000|Overall Study|AE/lost to follow-up|1|||
33622665|NCT02131259|63023424|FG000|Overall Study|AE/other|1|||
33622666|NCT02131259|63023424|FG000|Overall Study|Progressive disease/AE/other|1|||
33622667|NCT02131259|63023424|FG000|Overall Study|Missing|3|||
33622668|NCT01856595|63023437|FG000|Overall Study|Withdrawal by Subject|0|||
33622669|NCT01856595|63023438|FG001|Overall Study|Withdrawal by Subject|1|||
33527709|NCT03067129|62915613|FG003|Overall Study|Withdrawal by Subject|2|||
33527710|NCT03067129|62915610|FG000|Overall Study|Lost to Follow-up|5|||
33527711|NCT03067129|62915611|FG001|Overall Study|Lost to Follow-up|5|||
33527712|NCT03067129|62915612|FG002|Overall Study|Lost to Follow-up|4|||
33527713|NCT03067129|62915613|FG003|Overall Study|Lost to Follow-up|3|||
33527714|NCT01679236|62915635|FG000|Overall Study|Lost to Follow-up|15|||
33527715|NCT01679236|62915636|FG001|Overall Study|Lost to Follow-up|15|||
33527716|NCT01679002|62915645|FG000|Overall Study|Adverse Event|1|||
33527717|NCT01679002|62915646|FG001|Overall Study|Adverse Event|1|||
33527718|NCT01679002|62915647|FG002|Overall Study|Adverse Event|0|||
33527719|NCT04409509|62915657|FG000|Overall Study|Failure to meet randomization requirement|1|||
33527720|NCT04409509|62915658|FG001|Overall Study|Failure to meet randomization requirement|0|||
33527721|NCT04409509|62915657|FG000|Overall Study|Adverse Event|0|||
33527722|NCT04409509|62915658|FG001|Overall Study|Adverse Event|1|||
33527723|NCT04409509|62915657|FG000|Overall Study|Death|11|||
33527724|NCT04409509|62915658|FG001|Overall Study|Death|10|||
33527725|NCT04409509|62915657|FG000|Overall Study|Non-compliance with study drug|0|||
33527726|NCT04409509|62915658|FG001|Overall Study|Non-compliance with study drug|1|||
33622670|NCT01856595|63023439|FG002|Overall Study|Withdrawal by Subject|0|||
33622671|NCT01856595|63023440|FG003|Overall Study|Withdrawal by Subject|0|||
33622672|NCT01856595|63023441|FG004|Overall Study|Withdrawal by Subject|0|||
33622673|NCT01856595|63023442|FG005|Overall Study|Withdrawal by Subject|0|||
33622674|NCT01856595|63023443|FG006|Overall Study|Withdrawal by Subject|1|||
33622675|NCT01856595|63023444|FG007|Overall Study|Withdrawal by Subject|0|||
33622676|NCT01856595|63023445|FG008|Overall Study|Withdrawal by Subject|0|||
33527727|NCT04409509|62915657|FG000|Overall Study|Lost to Follow-up|0|||
33527728|NCT04409509|62915658|FG001|Overall Study|Lost to Follow-up|3|||
33527729|NCT04409509|62915657|FG000|Overall Study|Withdrawal by Subject|0|||
33527730|NCT04409509|62915658|FG001|Overall Study|Withdrawal by Subject|3|||
33527731|NCT04409509|62915657|FG000|Overall Study|Randomized by mistake|0|||
33527732|NCT04409509|62915658|FG001|Overall Study|Randomized by mistake|1|||
33527733|NCT04409509|62915657|FG000|Overall Study|Other|1|||
33527734|NCT04409509|62915658|FG001|Overall Study|Other|1|||
33527735|NCT01678924|62915669|FG000|Overall Study|Adverse Event|1|||
33527736|NCT01678924|62915670|FG001|Overall Study|Adverse Event|1|||
33527737|NCT01678924|62915671|FG002|Overall Study|Adverse Event|0|||
33527738|NCT01678924|62915672|FG003|Overall Study|Adverse Event|1|||
33527739|NCT01678924|62915669|FG000|Overall Study|Lack of Efficacy|7|||
33527740|NCT01678924|62915670|FG001|Overall Study|Lack of Efficacy|2|||
33527741|NCT01678924|62915671|FG002|Overall Study|Lack of Efficacy|0|||
33527742|NCT01678924|62915672|FG003|Overall Study|Lack of Efficacy|5|||
33527743|NCT01678924|62915669|FG000|Overall Study|Lost to Follow-up|0|||
33527744|NCT01678924|62915670|FG001|Overall Study|Lost to Follow-up|4|||
33527745|NCT01678924|62915671|FG002|Overall Study|Lost to Follow-up|0|||
33527746|NCT01678924|62915672|FG003|Overall Study|Lost to Follow-up|2|||
33527747|NCT01678924|62915669|FG000|Overall Study|Personal Reasons|2|||
33622677|NCT02158247|63023482|FG000|Overall Study|Invisible vocal cords|5|||
33622678|NCT01829295|63023504|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
33527748|NCT01678924|62915670|FG001|Overall Study|Personal Reasons|2|||
33527749|NCT01678924|62915671|FG002|Overall Study|Personal Reasons|2|||
33622679|NCT01829295|63023505|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
33622680|NCT01829295|63023506|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
33622681|NCT01829295|63023507|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
33622682|NCT01829295|63023504|FG000|6-12 Months|Adverse Event|0|||
33527750|NCT01678924|62915672|FG003|Overall Study|Personal Reasons|7|||
33527751|NCT01678924|62915669|FG000|Overall Study|Withdrawal by Subject|0|||
33527752|NCT01678924|62915670|FG001|Overall Study|Withdrawal by Subject|3|||
33527753|NCT01678924|62915671|FG002|Overall Study|Withdrawal by Subject|0|||
33622683|NCT01829295|63023505|FG001|6-12 Months|Adverse Event|0|||
33622684|NCT01829295|63023506|FG002|6-12 Months|Adverse Event|3|||
33527754|NCT01678924|62915672|FG003|Overall Study|Withdrawal by Subject|2|||
33527755|NCT01678924|62915669|FG000|Overall Study|Unable to attend scheduled visits|0|||
33527756|NCT01678924|62915670|FG001|Overall Study|Unable to attend scheduled visits|0|||
33527757|NCT01678924|62915671|FG002|Overall Study|Unable to attend scheduled visits|0|||
33527758|NCT01678924|62915672|FG003|Overall Study|Unable to attend scheduled visits|1|||
33527759|NCT02925793|62915686|FG000|Overall Study|Adverse Event|3|||
33527760|NCT02925793|62915687|FG001|Overall Study|Adverse Event|3|||
33622685|NCT01829295|63023507|FG003|6-12 Months|Adverse Event|2|||
33622686|NCT01829295|63023504|FG000|6-12 Months|Lost to Follow-up|2|||
33622687|NCT01829295|63023505|FG001|6-12 Months|Lost to Follow-up|0|||
33622688|NCT01829295|63023506|FG002|6-12 Months|Lost to Follow-up|0|||
33622689|NCT01829295|63023507|FG003|6-12 Months|Lost to Follow-up|0|||
33622690|NCT01829295|63023504|FG000|6-12 Months|Withdrawal by Subject|2|||
33622691|NCT01829295|63023505|FG001|6-12 Months|Withdrawal by Subject|2|||
33622692|NCT01829295|63023506|FG002|6-12 Months|Withdrawal by Subject|0|||
33622693|NCT01829295|63023507|FG003|6-12 Months|Withdrawal by Subject|0|||
33622694|NCT02157935|63023519|FG000|Overall Study|Withdrawal by Subject|25|||
33622695|NCT02157935|63023520|FG001|Overall Study|Withdrawal by Subject|39|||
33622696|NCT02157935|63023519|FG000|Overall Study|Screen failure|1|||
33622697|NCT02157935|63023520|FG001|Overall Study|Screen failure|2|||
33622698|NCT02157935|63023519|FG000|Overall Study|Protocol Violation|1|||
33622699|NCT02157935|63023520|FG001|Overall Study|Protocol Violation|0|||
33622700|NCT02157935|63023519|FG000|Overall Study|Progressive disease|0|||
33622701|NCT02157935|63023520|FG001|Overall Study|Progressive disease|2|||
33622702|NCT02157935|63023519|FG000|Overall Study|Other|5|||
33622703|NCT02157935|63023520|FG001|Overall Study|Other|12|||
33622704|NCT02157935|63023519|FG000|Overall Study|Lack of Efficacy|0|||
33622705|NCT02157935|63023520|FG001|Overall Study|Lack of Efficacy|1|||
33622706|NCT02157935|63023519|FG000|Overall Study|Death|4|||
33622707|NCT02157935|63023520|FG001|Overall Study|Death|4|||
33622708|NCT02157935|63023519|FG000|Overall Study|Adverse Event|3|||
33622709|NCT02157935|63023520|FG001|Overall Study|Adverse Event|5|||
33622710|NCT02157779|63023528|FG000|Overall Study|Logistical|9|||
33622711|NCT02157779|63023529|FG001|Overall Study|Logistical|3|||
33622712|NCT02157779|63023528|FG000|Overall Study|Stopped attending, reason unknown|11|||
33622713|NCT02157779|63023529|FG001|Overall Study|Stopped attending, reason unknown|7|||
33622714|NCT02157779|63023528|FG000|Overall Study|No response to outreach after Baseline|1|||
33457576|NCT03670810|62831945|FG006|Open Label Extension|Protocol Deviation|0|||
33457577|NCT03670810|62831946|FG007|Open Label Extension|Protocol Deviation|0|||
33527761|NCT02925793|62915688|FG002|Overall Study|Adverse Event|6|||
33527762|NCT02925793|62915686|FG000|Overall Study|Withdrawal by Subject|16|||
33527763|NCT02925793|62915687|FG001|Overall Study|Withdrawal by Subject|15|||
33527764|NCT02925793|62915688|FG002|Overall Study|Withdrawal by Subject|13|||
33527765|NCT02925793|62915686|FG000|Overall Study|Investigator Discretion|0|||
33527766|NCT02925793|62915687|FG001|Overall Study|Investigator Discretion|1|||
33527767|NCT02925793|62915688|FG002|Overall Study|Investigator Discretion|1|||
33527768|NCT02925793|62915686|FG000|Overall Study|Lost to Follow-up|2|||
33527769|NCT02925793|62915687|FG001|Overall Study|Lost to Follow-up|3|||
33527770|NCT02925793|62915688|FG002|Overall Study|Lost to Follow-up|1|||
33527771|NCT02925793|62915686|FG000|Overall Study|Lack of Efficacy|2|||
33527772|NCT02925793|62915687|FG001|Overall Study|Lack of Efficacy|6|||
33527773|NCT02925793|62915688|FG002|Overall Study|Lack of Efficacy|4|||
33527774|NCT02925793|62915686|FG000|Overall Study|Other:|2|||
33527775|NCT02925793|62915687|FG001|Overall Study|Other:|1|||
33457578|NCT03670810|62831947|FG008|Open Label Extension|Protocol Deviation|5|||
33457579|NCT03670810|62831939|FG000|Open Label Extension|Death|0|||
33457580|NCT03670810|62831940|FG001|Open Label Extension|Death|0|||
33457581|NCT03670810|62831941|FG002|Open Label Extension|Death|0|||
33457582|NCT03670810|62831942|FG003|Open Label Extension|Death|0|||
33457583|NCT03670810|62831943|FG004|Open Label Extension|Death|0|||
33457584|NCT03670810|62831944|FG005|Open Label Extension|Death|0|||
33457585|NCT03670810|62831945|FG006|Open Label Extension|Death|0|||
33457586|NCT03670810|62831946|FG007|Open Label Extension|Death|0|||
33527776|NCT02925793|62915688|FG002|Overall Study|Other:|3|||
33527777|NCT03071263|62915698|FG000|Overall Study|Adverse Event|1|||
33527778|NCT03071263|62915699|FG001|Overall Study|Adverse Event|3|||
33527779|NCT03071263|62915698|FG000|Overall Study|Withdrawal by Subject|1|||
33622715|NCT02157779|63023529|FG001|Overall Study|No response to outreach after Baseline|1|||
33622716|NCT02157779|63023528|FG000|Overall Study|Moved|1|||
33622717|NCT02157779|63023529|FG001|Overall Study|Moved|0|||
33622718|NCT02157779|63023528|FG000|Overall Study|Medical|1|||
33622719|NCT02157779|63023529|FG001|Overall Study|Medical|0|||
33622720|NCT02157779|63023528|FG000|Overall Study|Legal issue|1|||
33457587|NCT03670810|62831947|FG008|Open Label Extension|Death|1|||
33527780|NCT03071263|62915699|FG001|Overall Study|Withdrawal by Subject|3|||
33527781|NCT03071263|62915698|FG000|Overall Study|Physician Decision|1|||
33527782|NCT03071263|62915699|FG001|Overall Study|Physician Decision|0|||
33622721|NCT02157779|63023529|FG001|Overall Study|Legal issue|0|||
33622722|NCT02093221|63023543|FG000|Overall Study|Adverse Event|1|||
33622723|NCT02093221|63023544|FG001|Overall Study|Adverse Event|0|||
33622724|NCT02093221|63023545|FG002|Overall Study|Adverse Event|0|||
33622725|NCT02093221|63023546|FG003|Overall Study|Adverse Event|0|||
33622726|NCT02093221|63023547|FG004|Overall Study|Adverse Event|0|||
33622727|NCT02093221|63023543|FG000|Overall Study|Withdrawal by Subject|1|||
33622728|NCT02093221|63023544|FG001|Overall Study|Withdrawal by Subject|1|||
33622729|NCT02093221|63023545|FG002|Overall Study|Withdrawal by Subject|4|||
33622730|NCT02093221|63023546|FG003|Overall Study|Withdrawal by Subject|1|||
33622731|NCT02093221|63023547|FG004|Overall Study|Withdrawal by Subject|1|||
33622732|NCT02093221|63023543|FG000|Overall Study|Lost to Follow-up|2|||
33622733|NCT02093221|63023544|FG001|Overall Study|Lost to Follow-up|0|||
33622734|NCT02093221|63023545|FG002|Overall Study|Lost to Follow-up|1|||
33622735|NCT02093221|63023546|FG003|Overall Study|Lost to Follow-up|1|||
33622736|NCT02093221|63023547|FG004|Overall Study|Lost to Follow-up|0|||
33622737|NCT02093221|63023543|FG000|Overall Study|Death|0|||
33622738|NCT02093221|63023544|FG001|Overall Study|Death|1|||
33622739|NCT02093221|63023545|FG002|Overall Study|Death|0|||
33622740|NCT02093221|63023546|FG003|Overall Study|Death|0|||
33622741|NCT02093221|63023547|FG004|Overall Study|Death|0|||
33622742|NCT02093221|63023543|FG000|Overall Study|Protocol Violation|0|||
33622743|NCT02093221|63023544|FG001|Overall Study|Protocol Violation|1|||
33622744|NCT02093221|63023545|FG002|Overall Study|Protocol Violation|0|||
33622745|NCT02093221|63023546|FG003|Overall Study|Protocol Violation|0|||
33622746|NCT02093221|63023547|FG004|Overall Study|Protocol Violation|0|||
33622747|NCT02093221|63023543|FG000|Overall Study|Study termination|6|||
33622748|NCT02093221|63023544|FG001|Overall Study|Study termination|5|||
33622749|NCT02093221|63023545|FG002|Overall Study|Study termination|4|||
33527783|NCT03071263|62915698|FG000|Overall Study|Participant moved to another city|0|||
33527784|NCT03071263|62915699|FG001|Overall Study|Participant moved to another city|1|||
33527785|NCT00157196|62915711|FG000|Overall Study|Ongoing at data cut-off|9|||
33527786|NCT03066193|62915715|FG000|Overall Study|Withdrawal by Subject|1|||
33527787|NCT03922321|62915719|FG000|Overall Study|Participant Moved|1|||
33527788|NCT03922321|62915719|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
33527789|NCT01677910|62915726|FG000|Double-Blind Treatment Period|Adverse Event|6|||
33622750|NCT02093221|63023546|FG003|Overall Study|Study termination|6|||
33622751|NCT02093221|63023547|FG004|Overall Study|Study termination|7|||
33622752|NCT02092909|63023563|FG000|Overall Study|Adverse Event|0|||
33622753|NCT02092909|63023564|FG001|Overall Study|Adverse Event|0|||
33622754|NCT02092909|63023565|FG002|Overall Study|Adverse Event|4|||
33622755|NCT02092909|63023566|FG003|Overall Study|Adverse Event|2|||
33622756|NCT02092909|63023563|FG000|Overall Study|Lack of Efficacy|0|||
33622757|NCT02092909|63023564|FG001|Overall Study|Lack of Efficacy|2|||
33622758|NCT02092909|63023565|FG002|Overall Study|Lack of Efficacy|1|||
33622759|NCT02092909|63023566|FG003|Overall Study|Lack of Efficacy|0|||
33622760|NCT02092909|63023563|FG000|Overall Study|Withdrawal by Subject|0|||
33622761|NCT02092909|63023564|FG001|Overall Study|Withdrawal by Subject|0|||
33622762|NCT02092909|63023565|FG002|Overall Study|Withdrawal by Subject|2|||
33622763|NCT02092909|63023566|FG003|Overall Study|Withdrawal by Subject|1|||
33622764|NCT02092909|63023563|FG000|Overall Study|Study terminated by Sponsor|0|||
33622765|NCT02092909|63023564|FG001|Overall Study|Study terminated by Sponsor|0|||
33622766|NCT02092909|63023565|FG002|Overall Study|Study terminated by Sponsor|0|||
33622767|NCT02092909|63023566|FG003|Overall Study|Study terminated by Sponsor|2|||
33622768|NCT02092909|63023563|FG000|Overall Study|Miscellaneous|1|||
33622769|NCT02092909|63023564|FG001|Overall Study|Miscellaneous|1|||
33622770|NCT02092909|63023565|FG002|Overall Study|Miscellaneous|2|||
33622771|NCT02092909|63023566|FG003|Overall Study|Miscellaneous|1|||
33622772|NCT01623115|63023578|FG000|Overall Study|Randomized but not treated|0|||
33622773|NCT01623115|63023579|FG001|Overall Study|Randomized but not treated|1|||
33622774|NCT01623115|63023578|FG000|Overall Study|Physician Decision|1|||
33622775|NCT01623115|63023579|FG001|Overall Study|Physician Decision|0|||
33622776|NCT01623115|63023578|FG000|Overall Study|Participants moved|1|||
33622777|NCT01623115|63023579|FG001|Overall Study|Participants moved|5|||
33622778|NCT01623115|63023578|FG000|Overall Study|Adverse Event|10|||
33622779|NCT01623115|63023579|FG001|Overall Study|Adverse Event|13|||
33622780|NCT01623115|63023578|FG000|Overall Study|Poor compliance to protocol|4|||
33622781|NCT01623115|63023579|FG001|Overall Study|Poor compliance to protocol|10|||
33622782|NCT01623115|63023578|FG000|Overall Study|Consent withdrawn by participant|2|||
33622783|NCT01623115|63023579|FG001|Overall Study|Consent withdrawn by participant|6|||
33622784|NCT01623115|63023578|FG000|Overall Study|Related to study drug administration|0|||
33622785|NCT01623115|63023579|FG001|Overall Study|Related to study drug administration|2|||
33622786|NCT01623115|63023578|FG000|Overall Study|Last visit outside protocol visit window|14|||
33622787|NCT01623115|63023579|FG001|Overall Study|Last visit outside protocol visit window|26|||
33622788|NCT01623115|63023578|FG000|Overall Study|Site closure|1|||
33622789|NCT01623115|63023579|FG001|Overall Study|Site closure|7|||
33622790|NCT01623115|63023578|FG000|Overall Study|Death|0|||
33622791|NCT01623115|63023579|FG001|Overall Study|Death|4|||
33527790|NCT01677910|62915727|FG001|Double-Blind Treatment Period|Adverse Event|2|||
33622792|NCT01623115|63023578|FG000|Overall Study|Other than specified above|0|||
33622793|NCT01623115|63023579|FG001|Overall Study|Other than specified above|3|||
33622794|NCT02092285|63023585|FG000|Induction Phase|Adverse Event|7|||
33622795|NCT02092285|63023585|FG000|Induction Phase|Physician Decision|4|||
33622796|NCT02092285|63023585|FG000|Induction Phase|Pregnancy|1|||
33622797|NCT02092285|63023585|FG000|Induction Phase|Relapse/Recurrence|7|||
33622798|NCT02092285|63023585|FG000|Induction Phase|Withdrawal by Subject|2|||
33622799|NCT02092285|63023585|FG000|Induction Phase|Lack of Efficacy|14|||
33622800|NCT02092285|63023585|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
33622801|NCT02092285|63023585|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
33622802|NCT02092285|63023585|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
33622803|NCT02092285|63023585|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
33622804|NCT02092285|63023585|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
33622805|NCT02092285|63023585|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
33622806|NCT02092285|63023585|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
33622807|NCT02092285|63023585|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
33622808|NCT02092285|63023585|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
33622809|NCT02091739|63023592|FG000|MP: 16 Weeks|Adverse Event|1|||
33622810|NCT02091739|63023593|FG001|MP: 16 Weeks|Adverse Event|1|||
33622811|NCT02091739|63023594|FG002|MP: 16 Weeks|Adverse Event|1|||
33622812|NCT02091739|63023595|FG003|MP: 16 Weeks|Adverse Event|0|||
33622813|NCT02091739|63023596|FG004|MP: 16 Weeks|Adverse Event|0|||
33622814|NCT02091739|63023592|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
33622815|NCT02091739|63023593|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
33622816|NCT02091739|63023594|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
33622817|NCT02091739|63023595|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
33622818|NCT02091739|63023596|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
33622819|NCT02091739|63023592|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
33622820|NCT02091739|63023593|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
33622821|NCT02091739|63023594|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
33622822|NCT02091739|63023595|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
33622823|NCT02091739|63023596|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
33622824|NCT02091739|63023592|FG000|EP: 48 Weeks|Other|0|||
33622825|NCT02091739|63023593|FG001|EP: 48 Weeks|Other|0|||
33622826|NCT02091739|63023594|FG002|EP: 48 Weeks|Other|0|||
33622827|NCT02091739|63023595|FG003|EP: 48 Weeks|Other|1|||
33622828|NCT02091739|63023596|FG004|EP: 48 Weeks|Other|0|||
33622829|NCT02091739|63023592|FG000|EP: 48 Weeks|Death|0|||
33622830|NCT02091739|63023593|FG001|EP: 48 Weeks|Death|0|||
33622831|NCT02091739|63023594|FG002|EP: 48 Weeks|Death|0|||
33622832|NCT02091739|63023595|FG003|EP: 48 Weeks|Death|3|||
33622833|NCT02091739|63023596|FG004|EP: 48 Weeks|Death|2|||
33622834|NCT02091739|63023592|FG000|EP: 48 Weeks|Adverse Event|0|||
33622835|NCT02091739|63023593|FG001|EP: 48 Weeks|Adverse Event|0|||
33622836|NCT02091739|63023594|FG002|EP: 48 Weeks|Adverse Event|0|||
33622837|NCT02091739|63023595|FG003|EP: 48 Weeks|Adverse Event|2|||
33622838|NCT02091739|63023596|FG004|EP: 48 Weeks|Adverse Event|6|||
33622839|NCT02091739|63023592|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
33622840|NCT02091739|63023593|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
33622841|NCT02091739|63023594|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
33622842|NCT02091739|63023595|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
33622843|NCT02091739|63023596|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
33622844|NCT02045875|63023608|FG000|Overall Study|Lost to Follow-up|3|||
33622845|NCT02045875|63023609|FG001|Overall Study|Lost to Follow-up|0|||
33622846|NCT02045875|63023608|FG000|Overall Study|Withdrawal by Subject|4|||
33622847|NCT02045875|63023609|FG001|Overall Study|Withdrawal by Subject|3|||
33622848|NCT01597635|63023618|FG000|Part A|Adverse Event|3|||
33622849|NCT01597635|63023619|FG001|Part A|Adverse Event|0|||
33622850|NCT01597635|63023620|FG002|Part A|Adverse Event|0|||
33622851|NCT01597635|63023618|FG000|Part B|Adverse Event|0|||
33622852|NCT01597635|63023619|FG001|Part B|Adverse Event|0|||
33622853|NCT01597635|63023620|FG002|Part B|Adverse Event|1|||
33622854|NCT01597635|63023618|FG000|Part B|Protocol Violation|0|||
33622855|NCT01597635|63023619|FG001|Part B|Protocol Violation|1|||
33622856|NCT01597635|63023620|FG002|Part B|Protocol Violation|0|||
33622857|NCT01597635|63023618|FG000|Part B|Protocol-defined stopping criteria|0|||
33622858|NCT01597635|63023619|FG001|Part B|Protocol-defined stopping criteria|4|||
33622859|NCT01597635|63023620|FG002|Part B|Protocol-defined stopping criteria|3|||
33622860|NCT01597635|63023618|FG000|Part B|Withdrawal by Subject|0|||
33622861|NCT01597635|63023619|FG001|Part B|Withdrawal by Subject|1|||
33622862|NCT01597635|63023620|FG002|Part B|Withdrawal by Subject|0|||
33622863|NCT01828281|63023631|FG000|Overall Study|Withdrawal by Subject|1|||
33622864|NCT01828281|63023632|FG001|Overall Study|Withdrawal by Subject|0|||
33622865|NCT01827267|63023641|FG000|Overall Study|Did not receive study drug|1|||
33622866|NCT01827267|63023642|FG001|Overall Study|Did not receive study drug|1|||
33622867|NCT01827267|63023641|FG000|Overall Study|Physician Decision|1|||
33622868|NCT01827267|63023642|FG001|Overall Study|Physician Decision|0|||
33457588|NCT03670810|62831939|FG000|Open Label Extension|COVID-19|0|||
33622869|NCT01827267|63023641|FG000|Overall Study|Disease Progression|1|||
33622870|NCT01827267|63023642|FG001|Overall Study|Disease Progression|1|||
33457589|NCT03670810|62831940|FG001|Open Label Extension|COVID-19|0|||
33622871|NCT01827267|63023641|FG000|Overall Study|Sponsor Discontinued Study|2|||
33622872|NCT01827267|63023642|FG001|Overall Study|Sponsor Discontinued Study|8|||
33622873|NCT01827267|63023641|FG000|Overall Study|Still on study|0|||
33622874|NCT01827267|63023642|FG001|Overall Study|Still on study|2|||
33622875|NCT01855425|63023649|FG000|Overall Study|Physician Decision|20|||
33622876|NCT01854879|63023653|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
33622877|NCT01854879|63023653|FG000|Overall Study|screen fail|3|||
33622878|NCT01854879|63023653|FG000|Overall Study|incomplete data set|1|||
33622879|NCT01827111|63023657|FG000|Overall Study|Disease Progression|1|||
33622880|NCT02045095|63023661|FG000|Overall Study|Other|0|||
33622881|NCT02045095|63023662|FG001|Overall Study|Other|0|||
33622882|NCT02045095|63023663|FG002|Overall Study|Other|1|||
33622883|NCT02045095|63023664|FG003|Overall Study|Other|0|||
33622884|NCT02045095|63023665|FG004|Overall Study|Other|0|||
33622885|NCT02045095|63023666|FG005|Overall Study|Other|2|||
33622886|NCT02045095|63023667|FG006|Overall Study|Other|0|||
33622887|NCT02045095|63023661|FG000|Overall Study|Progressive Disease|3|||
33622888|NCT02045095|63023662|FG001|Overall Study|Progressive Disease|3|||
33622889|NCT02045095|63023663|FG002|Overall Study|Progressive Disease|2|||
33622890|NCT02045095|63023664|FG003|Overall Study|Progressive Disease|4|||
33622891|NCT02045095|63023665|FG004|Overall Study|Progressive Disease|2|||
33622892|NCT02045095|63023666|FG005|Overall Study|Progressive Disease|4|||
33527791|NCT01677910|62915728|FG002|Double-Blind Treatment Period|Adverse Event|3|||
33527792|NCT01677910|62915729|FG003|Double-Blind Treatment Period|Adverse Event|0|||
33527793|NCT01677910|62915726|FG000|Double-Blind Treatment Period|Physician Decision|0|||
33527794|NCT01677910|62915727|FG001|Double-Blind Treatment Period|Physician Decision|0|||
33527795|NCT01677910|62915728|FG002|Double-Blind Treatment Period|Physician Decision|1|||
33527796|NCT01677910|62915729|FG003|Double-Blind Treatment Period|Physician Decision|0|||
33527797|NCT01677910|62915726|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
33527798|NCT01677910|62915727|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
33527799|NCT01677910|62915728|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
33527800|NCT01677910|62915729|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
33527801|NCT01677910|62915726|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
33527802|NCT01677910|62915727|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
33527803|NCT01677910|62915728|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
33527804|NCT01677910|62915729|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
33527805|NCT01677910|62915726|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
33457590|NCT03670810|62831941|FG002|Open Label Extension|COVID-19|0|||
33457591|NCT03670810|62831942|FG003|Open Label Extension|COVID-19|0|||
33457592|NCT03670810|62831943|FG004|Open Label Extension|COVID-19|0|||
33457593|NCT03670810|62831944|FG005|Open Label Extension|COVID-19|0|||
33457594|NCT03670810|62831945|FG006|Open Label Extension|COVID-19|0|||
33457595|NCT03670810|62831946|FG007|Open Label Extension|COVID-19|0|||
33457596|NCT03670810|62831947|FG008|Open Label Extension|COVID-19|1|||
33457597|NCT03670810|62831939|FG000|Open Label Extension|Lack of Efficacy|0|||
33457598|NCT03670810|62831940|FG001|Open Label Extension|Lack of Efficacy|0|||
33457599|NCT03670810|62831941|FG002|Open Label Extension|Lack of Efficacy|0|||
33457600|NCT03670810|62831942|FG003|Open Label Extension|Lack of Efficacy|0|||
33527806|NCT01677910|62915727|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
33622893|NCT02045095|63023667|FG006|Overall Study|Progressive Disease|1|||
33622894|NCT02045095|63023661|FG000|Overall Study|Withdrawal by Subject|0|||
33622895|NCT02045095|63023662|FG001|Overall Study|Withdrawal by Subject|0|||
33622896|NCT02045095|63023663|FG002|Overall Study|Withdrawal by Subject|0|||
33622897|NCT02045095|63023664|FG003|Overall Study|Withdrawal by Subject|0|||
33622898|NCT02045095|63023665|FG004|Overall Study|Withdrawal by Subject|3|||
33457601|NCT03670810|62831943|FG004|Open Label Extension|Lack of Efficacy|0|||
33622899|NCT02045095|63023666|FG005|Overall Study|Withdrawal by Subject|0|||
33622900|NCT02045095|63023667|FG006|Overall Study|Withdrawal by Subject|0|||
33622901|NCT02045095|63023661|FG000|Overall Study|Adverse Event|0|||
33622902|NCT02045095|63023662|FG001|Overall Study|Adverse Event|1|||
33622903|NCT02045095|63023663|FG002|Overall Study|Adverse Event|1|||
33622904|NCT02045095|63023664|FG003|Overall Study|Adverse Event|0|||
33622905|NCT02045095|63023665|FG004|Overall Study|Adverse Event|0|||
33622906|NCT02045095|63023666|FG005|Overall Study|Adverse Event|2|||
33527807|NCT01677910|62915728|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
33622907|NCT02045095|63023667|FG006|Overall Study|Adverse Event|0|||
33622908|NCT02181803|63023692|FG000|Overall Study|Withdrawal by Subject|0|||
33622909|NCT02181803|63023693|FG001|Overall Study|Withdrawal by Subject|2|||
33622910|NCT02181803|63023694|FG002|Overall Study|Withdrawal by Subject|0|||
33622911|NCT02181803|63023695|FG003|Overall Study|Withdrawal by Subject|0|||
33622912|NCT02181803|63023696|FG004|Overall Study|Withdrawal by Subject|0|||
33622913|NCT02181803|63023697|FG005|Overall Study|Withdrawal by Subject|0|||
33622914|NCT02181803|63023698|FG006|Overall Study|Withdrawal by Subject|0|||
33622915|NCT02181803|63023699|FG007|Overall Study|Withdrawal by Subject|0|||
33622916|NCT02181803|63023700|FG008|Overall Study|Withdrawal by Subject|0|||
33622917|NCT02181803|63023692|FG000|Overall Study|Physician Decision|0|||
33622918|NCT02181803|63023693|FG001|Overall Study|Physician Decision|0|||
33622919|NCT02181803|63023694|FG002|Overall Study|Physician Decision|0|||
33527808|NCT01677910|62915729|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
33527809|NCT01677910|62915726|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
33527810|NCT01677910|62915727|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
33527811|NCT01677910|62915728|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
33527812|NCT01677910|62915729|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
33527813|NCT01677910|62915726|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
33527814|NCT01677910|62915727|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
33527815|NCT01677910|62915728|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
33527816|NCT01677910|62915729|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
33527817|NCT01677910|62915726|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
33527818|NCT01677910|62915727|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
33527819|NCT01677910|62915728|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
33527820|NCT01677910|62915729|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
33527821|NCT01677910|62915726|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
33527822|NCT01677910|62915727|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
33527823|NCT01677910|62915728|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
33527824|NCT01677910|62915729|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
33527825|NCT01677910|62915726|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
33527826|NCT01677910|62915727|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
33527827|NCT01677910|62915728|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
33527828|NCT01677910|62915729|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
33527829|NCT03911713|62915744|FG000|Overall Study|Lost to Follow-up|0|||
33527830|NCT03911713|62915745|FG001|Overall Study|Lost to Follow-up|2|||
33527831|NCT03911713|62915746|FG002|Overall Study|Lost to Follow-up|0|||
33527832|NCT03911713|62915747|FG003|Overall Study|Lost to Follow-up|0|||
33622920|NCT02181803|63023695|FG003|Overall Study|Physician Decision|1|||
33622921|NCT02181803|63023696|FG004|Overall Study|Physician Decision|0|||
33622922|NCT02181803|63023697|FG005|Overall Study|Physician Decision|0|||
33622923|NCT02181803|63023698|FG006|Overall Study|Physician Decision|0|||
33527833|NCT03911713|62915748|FG004|Overall Study|Lost to Follow-up|0|||
33527834|NCT03911713|62915744|FG000|Overall Study|Other|0|||
33527835|NCT03911713|62915745|FG001|Overall Study|Other|0|||
33527836|NCT03911713|62915746|FG002|Overall Study|Other|0|||
33527837|NCT03911713|62915747|FG003|Overall Study|Other|1|||
33527838|NCT03911713|62915748|FG004|Overall Study|Other|0|||
33527839|NCT03911713|62915744|FG000|Overall Study|Randomized, Never Dosed|1|||
33527840|NCT03911713|62915745|FG001|Overall Study|Randomized, Never Dosed|0|||
33527841|NCT03911713|62915746|FG002|Overall Study|Randomized, Never Dosed|0|||
33527842|NCT03911713|62915747|FG003|Overall Study|Randomized, Never Dosed|1|||
33527843|NCT03911713|62915748|FG004|Overall Study|Randomized, Never Dosed|0|||
33325425|NCT01212770|62702211|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33527844|NCT03065023|62915766|FG000|Overall Study|Progressive Disease|0|||
33527845|NCT03065023|62915767|FG001|Overall Study|Progressive Disease|1|||
33527846|NCT03065023|62915768|FG002|Overall Study|Progressive Disease|0|||
33527847|NCT03065023|62915769|FG003|Overall Study|Progressive Disease|0|||
33527848|NCT03065023|62915770|FG004|Overall Study|Progressive Disease|0|||
33527849|NCT03065023|62915766|FG000|Overall Study|Death|2|||
33527850|NCT03065023|62915767|FG001|Overall Study|Death|0|||
33527851|NCT03065023|62915768|FG002|Overall Study|Death|1|||
33527852|NCT03065023|62915769|FG003|Overall Study|Death|1|||
33622924|NCT02181803|63023699|FG007|Overall Study|Physician Decision|1|||
33622925|NCT02181803|63023700|FG008|Overall Study|Physician Decision|0|||
33622926|NCT02181803|63023692|FG000|Overall Study|Adverse Event|0|||
33622927|NCT02181803|63023693|FG001|Overall Study|Adverse Event|2|||
33622928|NCT02181803|63023694|FG002|Overall Study|Adverse Event|0|||
33622929|NCT02181803|63023695|FG003|Overall Study|Adverse Event|1|||
33622930|NCT02181803|63023696|FG004|Overall Study|Adverse Event|0|||
33622931|NCT02181803|63023697|FG005|Overall Study|Adverse Event|0|||
33622932|NCT02181803|63023698|FG006|Overall Study|Adverse Event|1|||
33622933|NCT02181803|63023699|FG007|Overall Study|Adverse Event|0|||
33622934|NCT02181803|63023700|FG008|Overall Study|Adverse Event|0|||
33622935|NCT01826487|63023747|FG000|Overall Study|Adverse Event|1|||
33622936|NCT01826487|63023748|FG001|Overall Study|Adverse Event|1|||
33622937|NCT01826487|63023747|FG000|Overall Study|Lost to Follow-up|1|||
33622938|NCT01826487|63023748|FG001|Overall Study|Lost to Follow-up|0|||
33622939|NCT01826487|63023747|FG000|Overall Study|Withdrawal by Subject|1|||
33622940|NCT01826487|63023748|FG001|Overall Study|Withdrawal by Subject|3|||
33622941|NCT01826487|63023747|FG000|Overall Study|Protocol Violation|1|||
33622942|NCT01826487|63023748|FG001|Overall Study|Protocol Violation|1|||
33622943|NCT02064439|63023758|FG000|Overall Study|Adverse Event|51|||
33622944|NCT02064439|63023759|FG001|Overall Study|Adverse Event|47|||
33622945|NCT02064439|63023760|FG002|Overall Study|Adverse Event|46|||
33622946|NCT02064439|63023758|FG000|Overall Study|Death|0|||
33622947|NCT02064439|63023759|FG001|Overall Study|Death|2|||
33622948|NCT02064439|63023760|FG002|Overall Study|Death|3|||
33622949|NCT02064439|63023758|FG000|Overall Study|Withdrawal by Subject|29|||
33622950|NCT02064439|63023759|FG001|Overall Study|Withdrawal by Subject|18|||
33622951|NCT02064439|63023760|FG002|Overall Study|Withdrawal by Subject|26|||
33622952|NCT02064439|63023758|FG000|Overall Study|Protocol Violation|3|||
33622953|NCT02064439|63023759|FG001|Overall Study|Protocol Violation|5|||
33622954|NCT02064439|63023760|FG002|Overall Study|Protocol Violation|3|||
33622955|NCT02064439|63023758|FG000|Overall Study|Lost to Follow-up|1|||
33622956|NCT02064439|63023759|FG001|Overall Study|Lost to Follow-up|3|||
33622957|NCT02064439|63023760|FG002|Overall Study|Lost to Follow-up|4|||
33622958|NCT02064439|63023758|FG000|Overall Study|Non-compliance with study medication|21|||
33622959|NCT02064439|63023759|FG001|Overall Study|Non-compliance with study medication|19|||
33622960|NCT02064439|63023760|FG002|Overall Study|Non-compliance with study medication|23|||
33622961|NCT02064439|63023758|FG000|Overall Study|Physician Decision|0|||
33622962|NCT02064439|63023759|FG001|Overall Study|Physician Decision|1|||
33622963|NCT02064439|63023760|FG002|Overall Study|Physician Decision|1|||
33622964|NCT02064439|63023758|FG000|Overall Study|Logistical difficulties|6|||
33622965|NCT02064439|63023759|FG001|Overall Study|Logistical difficulties|5|||
33622966|NCT02064439|63023760|FG002|Overall Study|Logistical difficulties|2|||
33622967|NCT02064439|63023758|FG000|Overall Study|Efficacy outcome reached|18|||
33622968|NCT02064439|63023759|FG001|Overall Study|Efficacy outcome reached|16|||
33622969|NCT02064439|63023760|FG002|Overall Study|Efficacy outcome reached|57|||
33527853|NCT03065023|62915770|FG004|Overall Study|Death|0|||
33527854|NCT03065023|62915766|FG000|Overall Study|Lost to Follow-up|0|||
33527855|NCT03065023|62915767|FG001|Overall Study|Lost to Follow-up|1|||
33527856|NCT03065023|62915768|FG002|Overall Study|Lost to Follow-up|0|||
33527857|NCT03065023|62915769|FG003|Overall Study|Lost to Follow-up|0|||
33527858|NCT03065023|62915770|FG004|Overall Study|Lost to Follow-up|0|||
33527859|NCT03065023|62915766|FG000|Overall Study|Participant Decision|0|||
33527860|NCT03065023|62915767|FG001|Overall Study|Participant Decision|0|||
33527861|NCT03065023|62915768|FG002|Overall Study|Participant Decision|0|||
33527862|NCT03065023|62915769|FG003|Overall Study|Participant Decision|1|||
33527863|NCT03065023|62915770|FG004|Overall Study|Participant Decision|0|||
33527864|NCT03065023|62915766|FG000|Overall Study|Withdrawal by Subject|0|||
33527865|NCT03065023|62915767|FG001|Overall Study|Withdrawal by Subject|0|||
33527866|NCT03065023|62915768|FG002|Overall Study|Withdrawal by Subject|0|||
33527867|NCT03065023|62915769|FG003|Overall Study|Withdrawal by Subject|1|||
33527868|NCT03065023|62915770|FG004|Overall Study|Withdrawal by Subject|0|||
33527869|NCT03614923|62915783|FG000|Overall Study|Withdrawal by Subject|2|||
33527870|NCT03614923|62915784|FG001|Overall Study|Withdrawal by Subject|1|||
33527871|NCT03614923|62915785|FG002|Overall Study|Withdrawal by Subject|1|||
33527872|NCT03614923|62915783|FG000|Overall Study|Adverse Event|0|||
33527873|NCT03614923|62915784|FG001|Overall Study|Adverse Event|2|||
33527874|NCT03614923|62915785|FG002|Overall Study|Adverse Event|1|||
33527875|NCT03614923|62915783|FG000|Overall Study|Lost to Follow-up|1|||
33622970|NCT02064439|63023758|FG000|Overall Study|Safety outcome reached|12|||
33527876|NCT03614923|62915784|FG001|Overall Study|Lost to Follow-up|0|||
33527877|NCT03614923|62915785|FG002|Overall Study|Lost to Follow-up|1|||
33527878|NCT03614923|62915783|FG000|Overall Study|Lack of Efficacy|2|||
33527879|NCT03614923|62915784|FG001|Overall Study|Lack of Efficacy|0|||
33622971|NCT02064439|63023759|FG001|Overall Study|Safety outcome reached|20|||
33622972|NCT02064439|63023760|FG002|Overall Study|Safety outcome reached|10|||
33622973|NCT02064439|63023758|FG000|Overall Study|Other|2|||
33622974|NCT02064439|63023759|FG001|Overall Study|Other|2|||
33622975|NCT02064439|63023760|FG002|Overall Study|Other|7|||
33622976|NCT02130557|63023770|FG000|Overall Study|Withdrawal by Subject|12|||
33622977|NCT02130557|63023771|FG001|Overall Study|Withdrawal by Subject|12|||
33622978|NCT02130557|63023770|FG000|Overall Study|Investigator Request|0|||
33622979|NCT02130557|63023771|FG001|Overall Study|Investigator Request|2|||
33622980|NCT02130557|63023770|FG000|Overall Study|Deceased|14|||
33622981|NCT02130557|63023771|FG001|Overall Study|Deceased|14|||
33622982|NCT02130557|63023770|FG000|Overall Study|Lost to Follow-up|6|||
33622983|NCT02130557|63023771|FG001|Overall Study|Lost to Follow-up|7|||
33622984|NCT02130557|63023770|FG000|Overall Study|Other|2|||
33622985|NCT02130557|63023771|FG001|Overall Study|Other|1|||
33622986|NCT02130557|63023770|FG000|Overall Study|Missing|2|||
33622987|NCT02130557|63023771|FG001|Overall Study|Missing|1|||
33622988|NCT01854645|63023782|FG000|Overall Study|Protocol-Specified Criteria|13|||
33622989|NCT01854645|63023783|FG001|Overall Study|Protocol-Specified Criteria|10|||
33622990|NCT01854645|63023784|FG002|Overall Study|Protocol-Specified Criteria|8|||
33622991|NCT01854645|63023785|FG003|Overall Study|Protocol-Specified Criteria|5|||
33622992|NCT01854645|63023786|FG004|Overall Study|Protocol-Specified Criteria|7|||
33622993|NCT01854645|63023782|FG000|Overall Study|Administrative Reasons / Missing|0|||
33622994|NCT01854645|63023783|FG001|Overall Study|Administrative Reasons / Missing|0|||
33622995|NCT01854645|63023784|FG002|Overall Study|Administrative Reasons / Missing|0|||
33622996|NCT01854645|63023785|FG003|Overall Study|Administrative Reasons / Missing|1|||
33622997|NCT01854645|63023786|FG004|Overall Study|Administrative Reasons / Missing|1|||
33622998|NCT01854645|63023782|FG000|Overall Study|Protocol Violation|3|||
33622999|NCT01854645|63023783|FG001|Overall Study|Protocol Violation|0|||
33623000|NCT01854645|63023784|FG002|Overall Study|Protocol Violation|5|||
33623001|NCT01854645|63023785|FG003|Overall Study|Protocol Violation|4|||
33623002|NCT01854645|63023786|FG004|Overall Study|Protocol Violation|1|||
33623003|NCT01854645|63023782|FG000|Overall Study|Lost to Follow-up|10|||
33623004|NCT01854645|63023783|FG001|Overall Study|Lost to Follow-up|7|||
33623005|NCT01854645|63023784|FG002|Overall Study|Lost to Follow-up|8|||
33623006|NCT01854645|63023785|FG003|Overall Study|Lost to Follow-up|5|||
33623007|NCT01854645|63023786|FG004|Overall Study|Lost to Follow-up|0|||
33623008|NCT01854645|63023782|FG000|Overall Study|Physician Decision|1|||
33623009|NCT01854645|63023783|FG001|Overall Study|Physician Decision|5|||
33623010|NCT01854645|63023784|FG002|Overall Study|Physician Decision|3|||
33623011|NCT01854645|63023785|FG003|Overall Study|Physician Decision|3|||
33623012|NCT01854645|63023786|FG004|Overall Study|Physician Decision|7|||
33623013|NCT01854645|63023782|FG000|Overall Study|Withdrawal by Subject|31|||
33623014|NCT01854645|63023783|FG001|Overall Study|Withdrawal by Subject|41|||
33623015|NCT01854645|63023784|FG002|Overall Study|Withdrawal by Subject|30|||
33623016|NCT01854645|63023785|FG003|Overall Study|Withdrawal by Subject|21|||
33623017|NCT01854645|63023786|FG004|Overall Study|Withdrawal by Subject|24|||
33623018|NCT01854645|63023782|FG000|Overall Study|Lack of Efficacy|7|||
33623019|NCT01854645|63023783|FG001|Overall Study|Lack of Efficacy|12|||
33623020|NCT01854645|63023784|FG002|Overall Study|Lack of Efficacy|9|||
33623021|NCT01854645|63023785|FG003|Overall Study|Lack of Efficacy|3|||
33623022|NCT01854645|63023786|FG004|Overall Study|Lack of Efficacy|9|||
33623023|NCT01854645|63023782|FG000|Overall Study|Adverse Event|33|||
33623024|NCT01854645|63023783|FG001|Overall Study|Adverse Event|31|||
33623025|NCT01854645|63023784|FG002|Overall Study|Adverse Event|19|||
33623026|NCT01854645|63023785|FG003|Overall Study|Adverse Event|20|||
33623027|NCT01854645|63023786|FG004|Overall Study|Adverse Event|11|||
33623028|NCT01825941|63023800|FG000|Overall Study|Lost to Follow-up|4|||
33623029|NCT01825941|63023801|FG001|Overall Study|Lost to Follow-up|1|||
33623030|NCT02064205|63023807|FG000|Overall Study|Withdrawal by Subject|1|||
33623031|NCT02090959|63023823|FG000|Overall Study|Withdrawal by Subject|10|||
33623032|NCT02090959|63023823|FG000|Overall Study|Adverse Event|1|||
33623033|NCT02090959|63023823|FG000|Overall Study|Investigator decision|2|||
33623034|NCT02090959|63023823|FG000|Overall Study|Study termination|6|||
33623035|NCT02090959|63023823|FG000|Overall Study|Enrolled but not treated|1|||
33623036|NCT02090959|63023823|FG000|Overall Study|Transfer for compassionate use medicine|4|||
33623037|NCT02090959|63023823|FG000|Overall Study|Move to medical need program|3|||
33623038|NCT02090959|63023823|FG000|Overall Study|Entered in to other study|34|||
33623039|NCT02090959|63023823|FG000|Overall Study|Switched to commercial supply|88|||
33623040|NCT02090959|63023823|FG000|Overall Study|Other than specified|2|||
33623041|NCT02044159|63023829|FG000|Overall Study|Consent declined (deferred consent)|2|||
33623042|NCT02044159|63023830|FG001|Overall Study|Consent declined (deferred consent)|4|||
33623043|NCT02044159|63023829|FG000|Overall Study|No longer eligible, drug not given|1|||
33623044|NCT02044159|63023830|FG001|Overall Study|No longer eligible, drug not given|0|||
33623045|NCT02044159|63023829|FG000|Overall Study|Nurse declined to give study drug|1|||
33623046|NCT02044159|63023830|FG001|Overall Study|Nurse declined to give study drug|0|||
33623047|NCT02090725|63023839|FG000|Overall Study|Withdrawal by Subject|1|||
33623048|NCT02090725|63023839|FG000|Overall Study|participants moved from area|3|||
33623049|NCT02180165|63023847|FG000|Overall Study|Not Treated|0|||
33623050|NCT02180165|63023848|FG001|Overall Study|Not Treated|0|||
33623051|NCT02180165|63023849|FG002|Overall Study|Not Treated|1|||
33623052|NCT02180165|63023850|FG003|Overall Study|Not Treated|0|||
33623053|NCT02180165|63023847|FG000|Overall Study|Adverse Event|7|||
33623054|NCT02180165|63023848|FG001|Overall Study|Adverse Event|0|||
33623055|NCT02180165|63023849|FG002|Overall Study|Adverse Event|18|||
33623056|NCT02180165|63023850|FG003|Overall Study|Adverse Event|3|||
33623057|NCT02180165|63023847|FG000|Overall Study|Lack of Efficacy|0|||
33623058|NCT02180165|63023848|FG001|Overall Study|Lack of Efficacy|1|||
33623059|NCT02180165|63023849|FG002|Overall Study|Lack of Efficacy|3|||
33623060|NCT02180165|63023850|FG003|Overall Study|Lack of Efficacy|2|||
33623061|NCT02180165|63023847|FG000|Overall Study|Physician Decision|1|||
33623062|NCT02180165|63023848|FG001|Overall Study|Physician Decision|0|||
33623063|NCT02180165|63023849|FG002|Overall Study|Physician Decision|5|||
33623064|NCT02180165|63023850|FG003|Overall Study|Physician Decision|0|||
33623065|NCT02180165|63023847|FG000|Overall Study|Withdrawal by Subject|3|||
33623066|NCT02180165|63023848|FG001|Overall Study|Withdrawal by Subject|0|||
33623067|NCT02180165|63023849|FG002|Overall Study|Withdrawal by Subject|2|||
33623068|NCT02180165|63023850|FG003|Overall Study|Withdrawal by Subject|1|||
33325426|NCT01212770|62702212|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33325427|NCT01212770|62702213|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
33325428|NCT01212770|62702214|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33325429|NCT01212770|62702215|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33325430|NCT01212770|62702216|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33325431|NCT01212770|62702217|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33623069|NCT02155985|63023865|FG000|Overall Study|Withdrawal by Subject|0|||
33623070|NCT02155985|63023866|FG001|Overall Study|Withdrawal by Subject|0|||
33623071|NCT02155985|63023867|FG002|Overall Study|Withdrawal by Subject|1|||
33623072|NCT02155985|63023865|FG000|Overall Study|Lost to Follow-up|1|||
33623073|NCT02155985|63023866|FG001|Overall Study|Lost to Follow-up|0|||
33623074|NCT02155985|63023867|FG002|Overall Study|Lost to Follow-up|0|||
33623075|NCT02155829|63023877|FG000|Overall Study|Adverse Event|1|||
33623076|NCT02155829|63023878|FG001|Overall Study|Adverse Event|0|||
33623077|NCT02155829|63023877|FG000|Overall Study|Withdrawal by Subject|3|||
33623078|NCT02155829|63023878|FG001|Overall Study|Withdrawal by Subject|3|||
33623079|NCT02155829|63023877|FG000|Overall Study|Protocol Violation|2|||
33623080|NCT02155829|63023878|FG001|Overall Study|Protocol Violation|0|||
33623081|NCT02129777|63023890|FG000|Double-Blind Period|Adverse Event|0|||
33623082|NCT02129777|63023891|FG001|Double-Blind Period|Adverse Event|0|||
33623083|NCT02129777|63023892|FG002|Double-Blind Period|Adverse Event|0|||
33623084|NCT02129777|63023893|FG003|Double-Blind Period|Adverse Event|0|||
33623085|NCT02129777|63023894|FG004|Double-Blind Period|Adverse Event|1|||
33623086|NCT02129777|63023895|FG005|Double-Blind Period|Adverse Event|0|||
33623087|NCT02129777|63023896|FG006|Double-Blind Period|Adverse Event|0|||
33623088|NCT02129777|63023890|FG000|Double-Blind Period|Lost to Follow-up|1|||
33623089|NCT02129777|63023891|FG001|Double-Blind Period|Lost to Follow-up|1|||
33623090|NCT02129777|63023892|FG002|Double-Blind Period|Lost to Follow-up|1|||
33623091|NCT02129777|63023893|FG003|Double-Blind Period|Lost to Follow-up|2|||
33623092|NCT02129777|63023894|FG004|Double-Blind Period|Lost to Follow-up|0|||
33623093|NCT02129777|63023895|FG005|Double-Blind Period|Lost to Follow-up|0|||
33623094|NCT02129777|63023896|FG006|Double-Blind Period|Lost to Follow-up|0|||
33623095|NCT02129777|63023890|FG000|Double-Blind Period|Withdrawal by Subject|2|||
33623096|NCT02129777|63023891|FG001|Double-Blind Period|Withdrawal by Subject|4|||
33623097|NCT02129777|63023892|FG002|Double-Blind Period|Withdrawal by Subject|3|||
33623098|NCT02129777|63023893|FG003|Double-Blind Period|Withdrawal by Subject|2|||
33623099|NCT02129777|63023894|FG004|Double-Blind Period|Withdrawal by Subject|3|||
33623100|NCT02129777|63023895|FG005|Double-Blind Period|Withdrawal by Subject|0|||
33623101|NCT02129777|63023896|FG006|Double-Blind Period|Withdrawal by Subject|0|||
33623102|NCT02129777|63023890|FG000|Double-Blind Period|Pregnancy|0|||
33623103|NCT02129777|63023891|FG001|Double-Blind Period|Pregnancy|0|||
33623104|NCT02129777|63023892|FG002|Double-Blind Period|Pregnancy|0|||
33623105|NCT02129777|63023893|FG003|Double-Blind Period|Pregnancy|0|||
33623106|NCT02129777|63023894|FG004|Double-Blind Period|Pregnancy|1|||
33623107|NCT02129777|63023895|FG005|Double-Blind Period|Pregnancy|0|||
33623108|NCT02129777|63023896|FG006|Double-Blind Period|Pregnancy|0|||
33325432|NCT01212770|62702218|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33325433|NCT01212770|62702219|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33623109|NCT02129777|63023890|FG000|Double-Blind Period|Lack of Efficacy|3|||
33623110|NCT02129777|63023891|FG001|Double-Blind Period|Lack of Efficacy|1|||
33623111|NCT02129777|63023892|FG002|Double-Blind Period|Lack of Efficacy|0|||
33623112|NCT02129777|63023893|FG003|Double-Blind Period|Lack of Efficacy|3|||
33623113|NCT02129777|63023894|FG004|Double-Blind Period|Lack of Efficacy|2|||
33623114|NCT02129777|63023895|FG005|Double-Blind Period|Lack of Efficacy|0|||
33623115|NCT02129777|63023896|FG006|Double-Blind Period|Lack of Efficacy|0|||
33623116|NCT02129777|63023890|FG000|Double-Blind Period|Other|1|||
33623117|NCT02129777|63023891|FG001|Double-Blind Period|Other|2|||
33623118|NCT02129777|63023892|FG002|Double-Blind Period|Other|0|||
33623119|NCT02129777|63023893|FG003|Double-Blind Period|Other|0|||
33623120|NCT02129777|63023894|FG004|Double-Blind Period|Other|0|||
33623121|NCT02129777|63023895|FG005|Double-Blind Period|Other|0|||
33623122|NCT02129777|63023896|FG006|Double-Blind Period|Other|0|||
33623123|NCT02129777|63023890|FG000|Open-Label Period|Lack of Efficacy|0|||
33623124|NCT02129777|63023891|FG001|Open-Label Period|Lack of Efficacy|0|||
33623125|NCT02129777|63023892|FG002|Open-Label Period|Lack of Efficacy|0|||
33623126|NCT02129777|63023893|FG003|Open-Label Period|Lack of Efficacy|0|||
33623127|NCT02129777|63023894|FG004|Open-Label Period|Lack of Efficacy|0|||
33623128|NCT02129777|63023895|FG005|Open-Label Period|Lack of Efficacy|0|||
33623129|NCT02129777|63023896|FG006|Open-Label Period|Lack of Efficacy|5|||
33527880|NCT03614923|62915785|FG002|Overall Study|Lack of Efficacy|1|||
33527881|NCT03614923|62915783|FG000|Overall Study|Non-compliance|0|||
33527882|NCT03614923|62915784|FG001|Overall Study|Non-compliance|1|||
33527883|NCT03614923|62915785|FG002|Overall Study|Non-compliance|0|||
33527884|NCT03614923|62915783|FG000|Overall Study|Other|0|||
33527885|NCT03614923|62915784|FG001|Overall Study|Other|1|||
33527886|NCT03614923|62915785|FG002|Overall Study|Other|1|||
33527887|NCT02915016|62915801|FG000|Overall Study|Lost to Follow-up|4|||
33527888|NCT02915016|62915802|FG001|Overall Study|Lost to Follow-up|2|||
33527889|NCT02915016|62915803|FG002|Overall Study|Lost to Follow-up|5|||
33527890|NCT02915016|62915804|FG003|Overall Study|Lost to Follow-up|3|||
33527891|NCT02915016|62915805|FG004|Overall Study|Lost to Follow-up|5|||
33527892|NCT02915016|62915806|FG005|Overall Study|Lost to Follow-up|2|||
33527893|NCT02915016|62915807|FG006|Overall Study|Lost to Follow-up|8|||
33527894|NCT02915016|62915808|FG007|Overall Study|Lost to Follow-up|2|||
33623130|NCT02129777|63023890|FG000|Open-Label Period|Lost to Follow-up|0|||
33623131|NCT02129777|63023891|FG001|Open-Label Period|Lost to Follow-up|0|||
33623132|NCT02129777|63023892|FG002|Open-Label Period|Lost to Follow-up|0|||
33623133|NCT02129777|63023893|FG003|Open-Label Period|Lost to Follow-up|0|||
33623134|NCT02129777|63023894|FG004|Open-Label Period|Lost to Follow-up|0|||
33623135|NCT02129777|63023895|FG005|Open-Label Period|Lost to Follow-up|1|||
33623136|NCT02129777|63023896|FG006|Open-Label Period|Lost to Follow-up|1|||
33623137|NCT02129777|63023890|FG000|Open-Label Period|Withdrawal by Subject|0|||
33623138|NCT02129777|63023891|FG001|Open-Label Period|Withdrawal by Subject|0|||
33623139|NCT02129777|63023892|FG002|Open-Label Period|Withdrawal by Subject|0|||
33623140|NCT02129777|63023893|FG003|Open-Label Period|Withdrawal by Subject|0|||
33623141|NCT02129777|63023894|FG004|Open-Label Period|Withdrawal by Subject|0|||
33623142|NCT02129777|63023895|FG005|Open-Label Period|Withdrawal by Subject|1|||
33623143|NCT02129777|63023896|FG006|Open-Label Period|Withdrawal by Subject|3|||
33623144|NCT02129777|63023890|FG000|Open-Label Period|Study Termination|0|||
33623145|NCT02129777|63023891|FG001|Open-Label Period|Study Termination|0|||
33623146|NCT02129777|63023892|FG002|Open-Label Period|Study Termination|0|||
33623147|NCT02129777|63023893|FG003|Open-Label Period|Study Termination|0|||
33623148|NCT02129777|63023894|FG004|Open-Label Period|Study Termination|0|||
33623149|NCT02129777|63023895|FG005|Open-Label Period|Study Termination|10|||
33623150|NCT02129777|63023896|FG006|Open-Label Period|Study Termination|39|||
33623151|NCT02178995|63023917|FG000|Double Blind|Adverse Event|0|||
33623152|NCT02178995|63023918|FG001|Double Blind|Adverse Event|0|||
33623153|NCT02178995|63023919|FG002|Double Blind|Adverse Event|0|||
33623154|NCT02178995|63023920|FG003|Double Blind|Adverse Event|0|||
33623155|NCT02178995|63023921|FG004|Double Blind|Adverse Event|0|||
33623156|NCT02178995|63023922|FG005|Double Blind|Adverse Event|1|||
33623157|NCT02178995|63023923|FG006|Double Blind|Adverse Event|0|||
33623158|NCT02178995|63023924|FG007|Double Blind|Adverse Event|1|||
33623159|NCT02178995|63023925|FG008|Double Blind|Adverse Event|1|||
33623160|NCT02178995|63023917|FG000|Double Blind|Lost to Follow-up|0|||
33623161|NCT02178995|63023918|FG001|Double Blind|Lost to Follow-up|1|||
33623162|NCT02178995|63023919|FG002|Double Blind|Lost to Follow-up|0|||
33623163|NCT02178995|63023920|FG003|Double Blind|Lost to Follow-up|0|||
33623164|NCT02178995|63023921|FG004|Double Blind|Lost to Follow-up|0|||
33623165|NCT02178995|63023922|FG005|Double Blind|Lost to Follow-up|0|||
33623166|NCT02178995|63023923|FG006|Double Blind|Lost to Follow-up|0|||
33623167|NCT02178995|63023924|FG007|Double Blind|Lost to Follow-up|1|||
33623168|NCT02178995|63023925|FG008|Double Blind|Lost to Follow-up|0|||
33623169|NCT02178995|63023917|FG000|Open Label|Adverse Event|2|||
33623170|NCT02178995|63023918|FG001|Open Label|Adverse Event|0|||
33623171|NCT02178995|63023919|FG002|Open Label|Adverse Event|0|||
33623172|NCT02178995|63023920|FG003|Open Label|Adverse Event|0|||
33623173|NCT02178995|63023921|FG004|Open Label|Adverse Event|0|||
33527895|NCT02915016|62915801|FG000|Overall Study|Physician Decision|0|||
33623174|NCT02178995|63023922|FG005|Open Label|Adverse Event|0|||
33623175|NCT02178995|63023923|FG006|Open Label|Adverse Event|0|||
33527896|NCT02915016|62915802|FG001|Overall Study|Physician Decision|0|||
33527897|NCT02915016|62915803|FG002|Overall Study|Physician Decision|1|||
33623176|NCT02178995|63023924|FG007|Open Label|Adverse Event|0|||
33527898|NCT02915016|62915804|FG003|Overall Study|Physician Decision|0|||
33623177|NCT02178995|63023925|FG008|Open Label|Adverse Event|0|||
33623178|NCT02128997|63023951|FG000|Overall Study|Lost to Follow-up|6|||
33623179|NCT02128997|63023952|FG001|Overall Study|Lost to Follow-up|11|||
33623180|NCT02155283|63023958|FG000|Overall Study|Lost to Follow-up|3|||
33623181|NCT02155283|63023958|FG000|Overall Study|Withdrawal by Subject|1|||
33623182|NCT02155283|63023958|FG000|Overall Study|Protocol Violation|3|||
33623183|NCT02154581|63023964|FG000|Overall Study|Lost to Follow-up|7|||
33623184|NCT02154581|63023965|FG001|Overall Study|Lost to Follow-up|8|||
33623185|NCT02154425|63023973|FG000|Screening Period|Adverse Event|1|||
33623186|NCT02154347|63023983|FG000|Double-blind Period|Adverse Event|1|||
33623187|NCT02154347|63023984|FG001|Double-blind Period|Adverse Event|2|||
33623188|NCT02154347|63023983|FG000|Double-blind Period|Lack of Efficacy|1|||
33623189|NCT02154347|63023984|FG001|Double-blind Period|Lack of Efficacy|0|||
33623190|NCT02154347|63023983|FG000|Double-blind Period|Physician Decision|0|||
33623191|NCT02154347|63023984|FG001|Double-blind Period|Physician Decision|1|||
33623192|NCT02154347|63023983|FG000|Double-blind Period|Withdrawal by Subject|1|||
33623193|NCT02154347|63023984|FG001|Double-blind Period|Withdrawal by Subject|1|||
33623194|NCT02154347|63023983|FG000|Open-label Period|Adverse Event|3|||
33623195|NCT02154347|63023984|FG001|Open-label Period|Adverse Event|4|||
33623196|NCT02154347|63023983|FG000|Open-label Period|Lack of Efficacy|4|||
33527899|NCT02915016|62915805|FG004|Overall Study|Physician Decision|0|||
33527900|NCT02915016|62915806|FG005|Overall Study|Physician Decision|1|||
33527901|NCT02915016|62915807|FG006|Overall Study|Physician Decision|2|||
33527902|NCT02915016|62915808|FG007|Overall Study|Physician Decision|0|||
33527903|NCT02915016|62915801|FG000|Overall Study|Withdrawal by Subject|2|||
33623197|NCT02154347|63023984|FG001|Open-label Period|Lack of Efficacy|19|||
33623198|NCT02154347|63023983|FG000|Open-label Period|Protocol Violation|0|||
33623199|NCT02154347|63023984|FG001|Open-label Period|Protocol Violation|1|||
33623200|NCT02154347|63023983|FG000|Open-label Period|Withdrawal by Subject|0|||
33623201|NCT02154347|63023984|FG001|Open-label Period|Withdrawal by Subject|1|||
33623202|NCT01627067|63023991|FG000|Overall Study|Screen Failure|1|||
33623203|NCT02178059|63023997|FG000|Washout|Physician Decision|1|||
33623204|NCT02178059|63023998|FG001|Washout|Physician Decision|0|||
33623205|NCT01626989|63024004|FG000|Screening Period|Screen Failure|15|||
33623206|NCT01626989|63024005|FG001|Screening Period|Screen Failure|0|||
33623207|NCT01626989|63024006|FG002|Screening Period|Screen Failure|0|||
33623208|NCT01626989|63024004|FG000|Screening Period|Withdrawal by Subject|2|||
33623209|NCT01626989|63024005|FG001|Screening Period|Withdrawal by Subject|0|||
33623210|NCT01626989|63024006|FG002|Screening Period|Withdrawal by Subject|0|||
33623211|NCT02128217|63024017|FG000|Overall Study|Lost to Follow-up|0|||
33623212|NCT02128217|63024018|FG001|Overall Study|Lost to Follow-up|1|||
33623213|NCT01629953|63024031|FG000|Overall Study|Death|3|||
33623214|NCT01629953|63024032|FG001|Overall Study|Death|1|||
33623215|NCT01629953|63024031|FG000|Overall Study|Lost to Follow-up|10|||
33623216|NCT01629953|63024032|FG001|Overall Study|Lost to Follow-up|14|||
33623217|NCT02127281|63024040|FG000|Overall Study|Lost to Follow-up|1|||
33623218|NCT02127281|63024041|FG001|Overall Study|Lost to Follow-up|0|||
33623219|NCT01628549|63024051|FG000|Overall Study|Adverse Event|1|||
33623220|NCT01628549|63024052|FG001|Overall Study|Adverse Event|1|||
33623221|NCT01628549|63024053|FG002|Overall Study|Adverse Event|0|||
33623222|NCT01628549|63024054|FG003|Overall Study|Adverse Event|4|||
33623223|NCT01628549|63024051|FG000|Overall Study|Lost to Follow-up|3|||
33623224|NCT01628549|63024052|FG001|Overall Study|Lost to Follow-up|4|||
33623225|NCT01628549|63024053|FG002|Overall Study|Lost to Follow-up|3|||
33623226|NCT01628549|63024054|FG003|Overall Study|Lost to Follow-up|3|||
33623227|NCT01628549|63024051|FG000|Overall Study|Withdrawal by Subject|3|||
33623228|NCT01628549|63024052|FG001|Overall Study|Withdrawal by Subject|4|||
33623229|NCT01628549|63024053|FG002|Overall Study|Withdrawal by Subject|4|||
33623230|NCT01628549|63024054|FG003|Overall Study|Withdrawal by Subject|1|||
33623231|NCT01628549|63024051|FG000|Overall Study|Protocol Violation|2|||
33623232|NCT01628549|63024052|FG001|Overall Study|Protocol Violation|1|||
33623233|NCT01628549|63024053|FG002|Overall Study|Protocol Violation|1|||
33527904|NCT02915016|62915802|FG001|Overall Study|Withdrawal by Subject|0|||
33623234|NCT01628549|63024054|FG003|Overall Study|Protocol Violation|0|||
33623235|NCT01628549|63024051|FG000|Overall Study|withdrawn for noncompliance|0|||
33623236|NCT01628549|63024052|FG001|Overall Study|withdrawn for noncompliance|2|||
33623237|NCT01628549|63024053|FG002|Overall Study|withdrawn for noncompliance|1|||
33623238|NCT01628549|63024054|FG003|Overall Study|withdrawn for noncompliance|0|||
33623239|NCT01628549|63024051|FG000|Overall Study|abnormal laboratory test results|0|||
33623240|NCT01628549|63024052|FG001|Overall Study|abnormal laboratory test results|0|||
33623241|NCT01628549|63024053|FG002|Overall Study|abnormal laboratory test results|1|||
33623242|NCT01628549|63024054|FG003|Overall Study|abnormal laboratory test results|0|||
33623243|NCT01628549|63024051|FG000|Overall Study|positive pregnancy test|0|||
33623244|NCT01628549|63024052|FG001|Overall Study|positive pregnancy test|0|||
33623245|NCT01628549|63024053|FG002|Overall Study|positive pregnancy test|0|||
33623246|NCT01628549|63024054|FG003|Overall Study|positive pregnancy test|1|||
33623247|NCT02127125|63024073|FG000|Overall Study|Lost to Follow-up|0|||
33623248|NCT02127125|63024074|FG001|Overall Study|Lost to Follow-up|0|||
33623249|NCT02127125|63024075|FG002|Overall Study|Lost to Follow-up|0|||
33623250|NCT02127125|63024076|FG003|Overall Study|Lost to Follow-up|0|||
33623251|NCT02127125|63024077|FG004|Overall Study|Lost to Follow-up|2|||
33623252|NCT02127125|63024078|FG005|Overall Study|Lost to Follow-up|1|||
33623253|NCT02127125|63024079|FG006|Overall Study|Lost to Follow-up|0|||
33623254|NCT02127125|63024080|FG007|Overall Study|Lost to Follow-up|0|||
33623255|NCT02127125|63024081|FG008|Overall Study|Lost to Follow-up|0|||
33623256|NCT02127125|63024073|FG000|Overall Study|Withdrawal by Subject|0|||
33623257|NCT02127125|63024074|FG001|Overall Study|Withdrawal by Subject|0|||
33623258|NCT02127125|63024075|FG002|Overall Study|Withdrawal by Subject|0|||
33623259|NCT02127125|63024076|FG003|Overall Study|Withdrawal by Subject|1|||
33623260|NCT02127125|63024077|FG004|Overall Study|Withdrawal by Subject|0|||
33623261|NCT02127125|63024078|FG005|Overall Study|Withdrawal by Subject|0|||
33623262|NCT02127125|63024079|FG006|Overall Study|Withdrawal by Subject|0|||
33623263|NCT02127125|63024080|FG007|Overall Study|Withdrawal by Subject|0|||
33623264|NCT02127125|63024081|FG008|Overall Study|Withdrawal by Subject|0|||
33623265|NCT02127125|63024073|FG000|Overall Study|Physician Decision|0|||
33623266|NCT02127125|63024074|FG001|Overall Study|Physician Decision|0|||
33623267|NCT02127125|63024075|FG002|Overall Study|Physician Decision|1|||
33623268|NCT02127125|63024076|FG003|Overall Study|Physician Decision|0|||
33623269|NCT02127125|63024077|FG004|Overall Study|Physician Decision|1|||
33623270|NCT02127125|63024078|FG005|Overall Study|Physician Decision|2|||
33623271|NCT02127125|63024079|FG006|Overall Study|Physician Decision|0|||
33623272|NCT02127125|63024080|FG007|Overall Study|Physician Decision|0|||
33623273|NCT02127125|63024081|FG008|Overall Study|Physician Decision|0|||
33623274|NCT02090413|63024104|FG000|Overall Study|Adverse Event|11|||
33623275|NCT02090413|63024105|FG001|Overall Study|Adverse Event|15|||
33623276|NCT02090413|63024106|FG002|Overall Study|Adverse Event|20|||
33623277|NCT02090413|63024104|FG000|Overall Study|Flushing event|2|||
33623278|NCT02090413|63024105|FG001|Overall Study|Flushing event|0|||
33623279|NCT02090413|63024106|FG002|Overall Study|Flushing event|1|||
33623280|NCT02090413|63024104|FG000|Overall Study|Withdrawal by Subject|2|||
33623281|NCT02090413|63024105|FG001|Overall Study|Withdrawal by Subject|2|||
33623282|NCT02090413|63024106|FG002|Overall Study|Withdrawal by Subject|2|||
33527905|NCT02915016|62915803|FG002|Overall Study|Withdrawal by Subject|1|||
33527906|NCT02915016|62915804|FG003|Overall Study|Withdrawal by Subject|0|||
33527907|NCT02915016|62915805|FG004|Overall Study|Withdrawal by Subject|1|||
33527908|NCT02915016|62915806|FG005|Overall Study|Withdrawal by Subject|3|||
33527909|NCT02915016|62915807|FG006|Overall Study|Withdrawal by Subject|1|||
33527910|NCT02915016|62915808|FG007|Overall Study|Withdrawal by Subject|1|||
33527911|NCT02915016|62915801|FG000|Overall Study|Elected not to continue|0|||
33527912|NCT02915016|62915802|FG001|Overall Study|Elected not to continue|0|||
33527913|NCT02915016|62915803|FG002|Overall Study|Elected not to continue|0|||
33527914|NCT02915016|62915804|FG003|Overall Study|Elected not to continue|1|||
33527915|NCT02915016|62915805|FG004|Overall Study|Elected not to continue|0|||
33527916|NCT02915016|62915806|FG005|Overall Study|Elected not to continue|0|||
33527917|NCT02915016|62915807|FG006|Overall Study|Elected not to continue|1|||
33527918|NCT02915016|62915808|FG007|Overall Study|Elected not to continue|0|||
33527919|NCT02915016|62915801|FG000|Overall Study|HIV infection|1|||
33527920|NCT02915016|62915802|FG001|Overall Study|HIV infection|1|||
33527921|NCT02915016|62915803|FG002|Overall Study|HIV infection|1|||
33527922|NCT02915016|62915804|FG003|Overall Study|HIV infection|0|||
33527923|NCT02915016|62915805|FG004|Overall Study|HIV infection|1|||
33527924|NCT02915016|62915806|FG005|Overall Study|HIV infection|0|||
33527925|NCT02915016|62915807|FG006|Overall Study|HIV infection|0|||
33527926|NCT02915016|62915808|FG007|Overall Study|HIV infection|0|||
33527927|NCT02915016|62915801|FG000|Overall Study|Participant unable to adhere|0|||
33623283|NCT02090413|63024104|FG000|Overall Study|Investigator Decision|1|||
33623284|NCT02090413|63024105|FG001|Overall Study|Investigator Decision|1|||
33527928|NCT02915016|62915802|FG001|Overall Study|Participant unable to adhere|0|||
33527929|NCT02915016|62915803|FG002|Overall Study|Participant unable to adhere|0|||
33527930|NCT02915016|62915804|FG003|Overall Study|Participant unable to adhere|0|||
33623285|NCT02090413|63024106|FG002|Overall Study|Investigator Decision|0|||
33623286|NCT02090413|63024104|FG000|Overall Study|Other|2|||
33623287|NCT02090413|63024105|FG001|Overall Study|Other|1|||
33623288|NCT02090413|63024106|FG002|Overall Study|Other|0|||
33623289|NCT02090413|63024104|FG000|Overall Study|Lost to Follow-up|1|||
33623290|NCT02090413|63024105|FG001|Overall Study|Lost to Follow-up|1|||
33623291|NCT02090413|63024106|FG002|Overall Study|Lost to Follow-up|0|||
33623292|NCT02063737|63024117|FG000|Overall Study|Lost to Follow-up|11|||
33623293|NCT02063737|63024118|FG001|Overall Study|Lost to Follow-up|4|||
33623294|NCT02125877|63024126|FG000|Overall Study|Physician Decision|1|||
33623295|NCT02125877|63024127|FG001|Overall Study|Physician Decision|0|||
33623296|NCT02125877|63024126|FG000|Overall Study|Death|0|||
33623297|NCT02125877|63024127|FG001|Overall Study|Death|1|||
33623298|NCT02125877|63024126|FG000|Overall Study|Administrative problems|0|||
33623299|NCT02125877|63024127|FG001|Overall Study|Administrative problems|1|||
33623300|NCT02125877|63024126|FG000|Overall Study|Participant/guardian decision|0|||
33623301|NCT02125877|63024127|FG001|Overall Study|Participant/guardian decision|2|||
33623302|NCT02125877|63024126|FG000|Overall Study|Withdrawal by Subject|2|||
33623303|NCT02125877|63024127|FG001|Overall Study|Withdrawal by Subject|1|||
33623304|NCT02125877|63024126|FG000|Overall Study|Protocol deviation|4|||
33623305|NCT02125877|63024127|FG001|Overall Study|Protocol deviation|1|||
33623306|NCT02125877|63024126|FG000|Overall Study|Adverse Event|6|||
33623307|NCT02125877|63024127|FG001|Overall Study|Adverse Event|4|||
33623308|NCT01598987|63024133|FG000|Baseline to Month 12|Administrative problems|2|||
33623309|NCT01598987|63024133|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
33623310|NCT01598987|63024133|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
33623311|NCT01598987|63024133|FG000|Baseline to 24 Month|Administrative problems|2|||
33623312|NCT01598987|63024133|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
33623313|NCT02063659|63024147|FG000|Double-Blind Treatment Period|Adverse Event|1|||
33623314|NCT02063659|63024148|FG001|Double-Blind Treatment Period|Adverse Event|2|||
33623315|NCT02063659|63024149|FG002|Double-Blind Treatment Period|Adverse Event|0|||
33623316|NCT02063659|63024150|FG003|Double-Blind Treatment Period|Adverse Event|0|||
33623317|NCT02063659|63024147|FG000|Double-Blind Treatment Period|Physician Decision|1|||
33623318|NCT02063659|63024148|FG001|Double-Blind Treatment Period|Physician Decision|0|||
33623319|NCT02063659|63024149|FG002|Double-Blind Treatment Period|Physician Decision|0|||
33623320|NCT02063659|63024150|FG003|Double-Blind Treatment Period|Physician Decision|0|||
33623321|NCT02063659|63024147|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
33623322|NCT02063659|63024148|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
33623323|NCT02063659|63024149|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
33623324|NCT02063659|63024150|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
33623325|NCT02063659|63024147|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
33623326|NCT02063659|63024148|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
33623327|NCT02063659|63024149|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
33623328|NCT02063659|63024150|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
33623329|NCT02063659|63024147|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
33623330|NCT02063659|63024148|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
33623331|NCT02063659|63024149|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
33623332|NCT02063659|63024150|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
33623333|NCT02063659|63024147|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
33623334|NCT02063659|63024148|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
33623335|NCT02063659|63024149|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
33623336|NCT02063659|63024150|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
33623337|NCT02063659|63024147|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
33623338|NCT02063659|63024148|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
33623339|NCT02063659|63024149|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
33623340|NCT02063659|63024150|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
33623341|NCT02063659|63024147|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
33623342|NCT02063659|63024148|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
33527931|NCT02915016|62915805|FG004|Overall Study|Participant unable to adhere|0|||
33527932|NCT02915016|62915806|FG005|Overall Study|Participant unable to adhere|0|||
33527933|NCT02915016|62915807|FG006|Overall Study|Participant unable to adhere|0|||
33527934|NCT02915016|62915808|FG007|Overall Study|Participant unable to adhere|1|||
33527935|NCT03323749|62915828|FG000|Double-blind Period|Lost to Follow-up|4|||
33527936|NCT03323749|62915829|FG001|Double-blind Period|Lost to Follow-up|5|||
33527937|NCT03323749|62915828|FG000|Double-blind Period|Adverse Event|3|||
33527938|NCT03323749|62915829|FG001|Double-blind Period|Adverse Event|1|||
33527939|NCT03323749|62915828|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
33527940|NCT03323749|62915829|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
33527941|NCT03323749|62915828|FG000|Open-Label Period|Adverse Event|3|||
33527942|NCT03323749|62915829|FG001|Open-Label Period|Adverse Event|10|||
33527943|NCT03323749|62915828|FG000|Open-Label Period|Withdrawal by Subject|7|||
33527944|NCT03323749|62915829|FG001|Open-Label Period|Withdrawal by Subject|5|||
33623343|NCT02063659|63024149|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
33623344|NCT02063659|63024150|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
33623345|NCT02062879|63024166|FG000|Overall Study|Withdrawal by Subject|4|||
33623346|NCT02062879|63024167|FG001|Overall Study|Withdrawal by Subject|1|||
33623347|NCT02062645|63024173|FG000|Overall Study|Adverse Event|2|||
33527945|NCT02208024|62915848|FG000|Overall Study|Withdrawal by Subject|1|||
33623348|NCT02062645|63024173|FG000|Overall Study|Protocol Violation|8|||
33623349|NCT02062645|63024173|FG000|Overall Study|Lost to Follow-up|5|||
33623350|NCT02088697|63024179|FG000|Period I|Physician Decision|1|||
33623351|NCT02088697|63024180|FG001|Period I|Physician Decision|4|||
33623352|NCT02088697|63024179|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
33623353|NCT02088697|63024180|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
33623354|NCT01825785|63024193|FG000|Overall Study|Adverse Event|0|||
33623355|NCT01825785|63024194|FG001|Overall Study|Adverse Event|0|||
33623356|NCT01825785|63024195|FG002|Overall Study|Adverse Event|0|||
33623357|NCT01825785|63024196|FG003|Overall Study|Adverse Event|0|||
33623358|NCT01825785|63024197|FG004|Overall Study|Adverse Event|1|||
33623359|NCT01825785|63024198|FG005|Overall Study|Adverse Event|0|||
33623360|NCT01825785|63024199|FG006|Overall Study|Adverse Event|0|||
33623361|NCT01825785|63024193|FG000|Overall Study|Withdrawal by Subject|0|||
33623362|NCT01825785|63024194|FG001|Overall Study|Withdrawal by Subject|0|||
33623363|NCT01825785|63024195|FG002|Overall Study|Withdrawal by Subject|0|||
33623364|NCT01825785|63024196|FG003|Overall Study|Withdrawal by Subject|0|||
33623365|NCT01825785|63024197|FG004|Overall Study|Withdrawal by Subject|1|||
33623366|NCT01825785|63024198|FG005|Overall Study|Withdrawal by Subject|1|||
33623367|NCT01825785|63024199|FG006|Overall Study|Withdrawal by Subject|0|||
33623368|NCT02043301|63024224|FG000|Overall Study|Discontinued|0|||
33623369|NCT02043301|63024225|FG001|Overall Study|Discontinued|1|||
33623370|NCT02043301|63024226|FG002|Overall Study|Discontinued|0|||
33623371|NCT01598753|63024238|FG000|Overall Study|Adverse Event|1|||
33623372|NCT01598753|63024239|FG001|Overall Study|Adverse Event|9|||
33623373|NCT01598753|63024240|FG002|Overall Study|Adverse Event|1|||
33623374|NCT01598753|63024241|FG003|Overall Study|Adverse Event|7|||
33623375|NCT01598753|63024238|FG000|Overall Study|Lost to Follow-up|4|||
33623376|NCT01598753|63024239|FG001|Overall Study|Lost to Follow-up|3|||
33623377|NCT01598753|63024240|FG002|Overall Study|Lost to Follow-up|7|||
33623378|NCT01598753|63024241|FG003|Overall Study|Lost to Follow-up|5|||
33623379|NCT01598753|63024238|FG000|Overall Study|Physician Decision|0|||
33623380|NCT01598753|63024239|FG001|Overall Study|Physician Decision|1|||
33623381|NCT01598753|63024240|FG002|Overall Study|Physician Decision|0|||
33623382|NCT01598753|63024241|FG003|Overall Study|Physician Decision|2|||
33623383|NCT01598753|63024238|FG000|Overall Study|Withdrawal by Subject|7|||
33623384|NCT01598753|63024239|FG001|Overall Study|Withdrawal by Subject|2|||
33623385|NCT01598753|63024240|FG002|Overall Study|Withdrawal by Subject|0|||
33623386|NCT01598753|63024241|FG003|Overall Study|Withdrawal by Subject|1|||
33623387|NCT02177123|63024251|FG000|Overall Study|Lost to Follow-up|6|||
33623388|NCT02177123|63024251|FG000|Overall Study|Withdrawal by Subject|4|||
33623389|NCT02177123|63024251|FG000|Overall Study|Adverse Event|4|||
33623390|NCT02177123|63024251|FG000|Overall Study|Physician Decision|3|||
33623391|NCT02177123|63024251|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
33623392|NCT02177123|63024251|FG000|Overall Study|Excluded for medical reasons|2|||
33623393|NCT02177123|63024251|FG000|Overall Study|Death|1|||
33623394|NCT02177123|63024251|FG000|Overall Study|Other|1|||
33623395|NCT02177123|63024251|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
33527946|NCT02660086|62915854|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
33527947|NCT02660086|62915855|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
33527948|NCT02660086|62915854|FG000|Overall Study- 12-month|Left full-time employment|12|||
33527949|NCT02660086|62915855|FG001|Overall Study- 12-month|Left full-time employment|20|||
33527950|NCT02660086|62915854|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
33527951|NCT02660086|62915855|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
33527952|NCT02660086|62915854|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
33527953|NCT02660086|62915855|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
33527954|NCT02660086|62915854|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
33527955|NCT02660086|62915855|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
33527956|NCT02660086|62915854|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
33527957|NCT02660086|62915855|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
33623396|NCT01824693|63024261|FG000|Overall Study|Death|0|||
33623397|NCT01824693|63024262|FG001|Overall Study|Death|1|||
33623398|NCT01824693|63024263|FG002|Overall Study|Death|0|||
33623399|NCT01824693|63024261|FG000|Overall Study|Physician Decision|1|||
33623400|NCT01824693|63024262|FG001|Overall Study|Physician Decision|1|||
33623401|NCT01824693|63024263|FG002|Overall Study|Physician Decision|1|||
33623402|NCT01824693|63024261|FG000|Overall Study|Withdrawal by Subject|0|||
33623403|NCT01824693|63024262|FG001|Overall Study|Withdrawal by Subject|0|||
33623404|NCT01824693|63024263|FG002|Overall Study|Withdrawal by Subject|1|||
33623405|NCT01824693|63024261|FG000|Overall Study|Progressive Disease|0|||
33623406|NCT01824693|63024262|FG001|Overall Study|Progressive Disease|5|||
33623407|NCT01824693|63024263|FG002|Overall Study|Progressive Disease|0|||
33623408|NCT01824693|63024261|FG000|Overall Study|Ineligible|0|||
33623409|NCT01824693|63024262|FG001|Overall Study|Ineligible|0|||
33623410|NCT01824693|63024263|FG002|Overall Study|Ineligible|3|||
33623411|NCT01824693|63024261|FG000|Overall Study|No Transplant Planned|0|||
33623412|NCT01824693|63024262|FG001|Overall Study|No Transplant Planned|0|||
33623413|NCT01824693|63024263|FG002|Overall Study|No Transplant Planned|10|||
33623414|NCT02176655|63024270|FG000|Overall Study|Subjects did not treat|6|||
33623415|NCT02125331|63024277|FG000|Overall Study|Protocol Violation|1|||
33623416|NCT02125331|63024278|FG001|Overall Study|Protocol Violation|0|||
33623417|NCT02125331|63024277|FG000|Overall Study|technical problem|2|||
33623418|NCT02125331|63024278|FG001|Overall Study|technical problem|0|||
33623419|NCT02125331|63024277|FG000|Overall Study|screen failure|2|||
33623420|NCT02125331|63024278|FG001|Overall Study|screen failure|0|||
33623421|NCT01622569|63024288|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
33457602|NCT03670810|62831944|FG005|Open Label Extension|Lack of Efficacy|0|||
33457603|NCT03670810|62831945|FG006|Open Label Extension|Lack of Efficacy|0|||
33457604|NCT03670810|62831946|FG007|Open Label Extension|Lack of Efficacy|0|||
33457605|NCT03670810|62831947|FG008|Open Label Extension|Lack of Efficacy|39|||
33457606|NCT03670810|62831939|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
33457607|NCT03670810|62831940|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
33457608|NCT03670810|62831941|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
33457609|NCT03670810|62831942|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
33457610|NCT03670810|62831943|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
33457611|NCT03670810|62831944|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
33457612|NCT03670810|62831945|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
33457613|NCT03670810|62831946|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
33457614|NCT03670810|62831947|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
33527958|NCT01678144|62915861|FG000|Stage 1: MAR Classic|Adverse Event|1|||
33527959|NCT00153920|62915865|FG000|Overall Study|Adverse Event|9|||
33527960|NCT00153920|62915865|FG000|Overall Study|Progressive Disease|9|||
33527961|NCT00153920|62915865|FG000|Overall Study|Physician Decision|3|||
33527962|NCT00153920|62915865|FG000|Overall Study|Lack of Response|3|||
33527963|NCT00153920|62915865|FG000|Overall Study|Death|2|||
33527964|NCT00153920|62915865|FG000|Overall Study|Withdrawal by Subject|1|||
33527965|NCT00153920|62915865|FG000|Overall Study|Non-Protocol Therapy|1|||
33527966|NCT00153920|62915865|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
33527967|NCT00153920|62915865|FG000|Overall Study|Progressive Disease before Trt|1|||
33527968|NCT02660242|62915869|FG000|Glucose Tabs|Lost to Follow-up|1|||
33527969|NCT02660242|62915869|FG000|Glucagon Injection|Lost to Follow-up|1|||
33527970|NCT03072043|62915885|FG000|Overall Study|Death|0|||
33527971|NCT03072043|62915886|FG001|Overall Study|Death|0|||
33527972|NCT03072043|62915887|FG002|Overall Study|Death|3|||
33527973|NCT03072043|62915885|FG000|Overall Study|Adverse Event|0|||
33527974|NCT03072043|62915886|FG001|Overall Study|Adverse Event|0|||
33527975|NCT03072043|62915887|FG002|Overall Study|Adverse Event|2|||
33527976|NCT03072043|62915885|FG000|Overall Study|Withdrawal by Subject|0|||
33527977|NCT03072043|62915886|FG001|Overall Study|Withdrawal by Subject|0|||
33527978|NCT03072043|62915887|FG002|Overall Study|Withdrawal by Subject|4|||
33527979|NCT03069313|62915899|FG000|Overall Study|Adverse Event|5|||
33527980|NCT03068767|62915905|FG000|Overall Study|Lost to Follow-up|7|||
33527981|NCT03068767|62915906|FG001|Overall Study|Lost to Follow-up|3|||
33527982|NCT03068767|62915905|FG000|Overall Study|Protocol Violation|3|||
33527983|NCT03068767|62915906|FG001|Overall Study|Protocol Violation|0|||
33527984|NCT03020745|62915920|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
33527985|NCT03020745|62915921|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
33527986|NCT03020745|62915922|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
33527987|NCT03020745|62915923|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
33527988|NCT03020745|62915924|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
33527989|NCT03020745|62915925|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
33527990|NCT03020745|62915926|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
33527991|NCT03020745|62915927|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
33527992|NCT03020745|62915928|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
33527993|NCT03020745|62915929|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
33527994|NCT03020745|62915920|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33527995|NCT03020745|62915921|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33527996|NCT03020745|62915922|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33527997|NCT03020745|62915923|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33623422|NCT01622569|63024289|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
33623423|NCT01622569|63024290|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
33527998|NCT03020745|62915924|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33527999|NCT03020745|62915925|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33528000|NCT03020745|62915926|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33528001|NCT03020745|62915927|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
33528002|NCT03020745|62915928|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33623424|NCT01622569|63024291|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
33457615|NCT03670810|62831939|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33623425|NCT01622569|63024288|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
33623426|NCT01622569|63024289|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
33623427|NCT01622569|63024290|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
33623428|NCT01622569|63024291|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
33623429|NCT01622569|63024288|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
33623430|NCT01622569|63024289|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
33623431|NCT01622569|63024290|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
33623432|NCT01622569|63024291|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
33623433|NCT01622569|63024288|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
33623434|NCT01622569|63024289|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
33623435|NCT01622569|63024290|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
33623436|NCT01622569|63024291|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
33623437|NCT01622569|63024288|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
33623438|NCT01622569|63024289|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
33623439|NCT01622569|63024290|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
33623440|NCT01622569|63024291|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
33623441|NCT01622569|63024288|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
33623442|NCT01622569|63024289|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
33623443|NCT01622569|63024290|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
33623444|NCT01622569|63024291|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
33623445|NCT01622569|63024288|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
33623446|NCT01622569|63024289|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
33623447|NCT01622569|63024290|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
33623448|NCT01622569|63024291|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
33623449|NCT01622569|63024288|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
33528003|NCT03020745|62915929|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33528004|NCT03020745|62915920|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33528005|NCT03020745|62915921|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33623450|NCT01622569|63024289|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
33623451|NCT01622569|63024290|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
33623452|NCT01622569|63024291|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
33623453|NCT01824303|63024313|FG000|Randomized Study|Withdrawal by Subject|1|||
33623454|NCT01824303|63024314|FG001|Randomized Study|Withdrawal by Subject|1|||
33623455|NCT01824303|63024313|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
33623456|NCT01824303|63024314|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
33623457|NCT01853397|63024326|FG000|Overall Study|Withdrawal by Subject|0|||
33623458|NCT01853397|63024327|FG001|Overall Study|Withdrawal by Subject|0|||
33623459|NCT01853397|63024328|FG002|Overall Study|Withdrawal by Subject|0|||
33623460|NCT01853397|63024329|FG003|Overall Study|Withdrawal by Subject|1|||
33623461|NCT01853397|63024326|FG000|Overall Study|Subject Noncompliance|0|||
33623462|NCT01853397|63024327|FG001|Overall Study|Subject Noncompliance|0|||
33623463|NCT01853397|63024328|FG002|Overall Study|Subject Noncompliance|0|||
33623464|NCT01853397|63024329|FG003|Overall Study|Subject Noncompliance|1|||
33623465|NCT02088073|63024344|FG000|Acute Phase|Withdrawal by Subject|5|||
33623466|NCT02088073|63024345|FG001|Acute Phase|Withdrawal by Subject|0|||
33623467|NCT02088073|63024346|FG002|Acute Phase|Withdrawal by Subject|0|||
33623468|NCT02088073|63024347|FG003|Acute Phase|Withdrawal by Subject|0|||
33623469|NCT02088073|63024348|FG004|Acute Phase|Withdrawal by Subject|0|||
33623470|NCT02088073|63024344|FG000|Acute Phase|Hyperkalemia|2|||
33623471|NCT02088073|63024345|FG001|Acute Phase|Hyperkalemia|0|||
33623472|NCT02088073|63024346|FG002|Acute Phase|Hyperkalemia|0|||
33623473|NCT02088073|63024347|FG003|Acute Phase|Hyperkalemia|0|||
33623474|NCT02088073|63024348|FG004|Acute Phase|Hyperkalemia|0|||
33623475|NCT02088073|63024344|FG000|Maintanance Phase|Withdrawal by Subject|0|||
33623476|NCT02088073|63024345|FG001|Maintanance Phase|Withdrawal by Subject|2|||
33623477|NCT02088073|63024346|FG002|Maintanance Phase|Withdrawal by Subject|0|||
33528006|NCT03020745|62915922|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33528007|NCT03020745|62915923|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33528008|NCT03020745|62915924|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33528009|NCT03020745|62915925|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
33528010|NCT03020745|62915926|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33528011|NCT03020745|62915927|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33528012|NCT03020745|62915928|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
33528013|NCT03020745|62915929|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33623478|NCT02088073|63024347|FG003|Maintanance Phase|Withdrawal by Subject|0|||
33623479|NCT02088073|63024348|FG004|Maintanance Phase|Withdrawal by Subject|0|||
33623480|NCT02088073|63024344|FG000|Maintanance Phase|Adverse Event|0|||
33623481|NCT02088073|63024345|FG001|Maintanance Phase|Adverse Event|0|||
33623482|NCT02088073|63024346|FG002|Maintanance Phase|Adverse Event|3|||
33528014|NCT03020745|62915920|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33457616|NCT03670810|62831940|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33457617|NCT03670810|62831941|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33457618|NCT03670810|62831942|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33457619|NCT03670810|62831943|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33457620|NCT03670810|62831944|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33457621|NCT03670810|62831945|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33457622|NCT03670810|62831946|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33457623|NCT03670810|62831947|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
33457624|NCT03670810|62831939|FG000|Open Label Extension|Withdrawal by Subject|0|||
33457625|NCT03670810|62831940|FG001|Open Label Extension|Withdrawal by Subject|0|||
33457626|NCT03670810|62831941|FG002|Open Label Extension|Withdrawal by Subject|0|||
33457627|NCT03670810|62831942|FG003|Open Label Extension|Withdrawal by Subject|0|||
33457628|NCT03670810|62831943|FG004|Open Label Extension|Withdrawal by Subject|0|||
33457629|NCT03670810|62831944|FG005|Open Label Extension|Withdrawal by Subject|0|||
33457630|NCT03670810|62831945|FG006|Open Label Extension|Withdrawal by Subject|0|||
33457631|NCT03670810|62831946|FG007|Open Label Extension|Withdrawal by Subject|0|||
33457632|NCT03670810|62831947|FG008|Open Label Extension|Withdrawal by Subject|46|||
33457633|NCT03670810|62831939|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33457634|NCT03670810|62831940|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33457635|NCT03670810|62831941|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33457636|NCT03670810|62831942|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33457637|NCT03670810|62831943|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33457638|NCT03670810|62831944|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33457639|NCT03670810|62831945|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33457640|NCT03670810|62831946|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33457641|NCT03670810|62831947|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
33457642|NCT03670810|62831939|FG000|Open Label Extension|Physician Decision|0|||
33457643|NCT03670810|62831940|FG001|Open Label Extension|Physician Decision|0|||
33457644|NCT03670810|62831941|FG002|Open Label Extension|Physician Decision|0|||
33528015|NCT03020745|62915921|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33528016|NCT03020745|62915922|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33528017|NCT03020745|62915923|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33528018|NCT03020745|62915924|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33528019|NCT03020745|62915925|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33528020|NCT03020745|62915926|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33528021|NCT03020745|62915927|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33528022|NCT03020745|62915928|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
33528023|NCT03020745|62915929|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33528024|NCT03019965|62915964|FG000|Overall Study|Withdrawal by Subject|1|||
33528025|NCT03019965|62915965|FG001|Overall Study|Withdrawal by Subject|0|||
33528026|NCT03019965|62915964|FG000|Overall Study|Protocol Violation|1|||
33528027|NCT03019965|62915965|FG001|Overall Study|Protocol Violation|3|||
33528028|NCT03019965|62915964|FG000|Overall Study|viral or fungal infection|3|||
33528029|NCT03019965|62915965|FG001|Overall Study|viral or fungal infection|4|||
33528030|NCT03019965|62915964|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
33528031|NCT03019965|62915965|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
33528032|NCT03019965|62915964|FG000|Overall Study|Physician Decision|1|||
33528033|NCT03019965|62915965|FG001|Overall Study|Physician Decision|1|||
33528034|NCT01675882|62915984|FG000|Overall Study|Adverse Event|0|||
33528035|NCT01675882|62915985|FG001|Overall Study|Adverse Event|2|||
33528036|NCT01675882|62915986|FG002|Overall Study|Adverse Event|1|||
33528037|NCT01675882|62915987|FG003|Overall Study|Adverse Event|0|||
33528038|NCT01675882|62915984|FG000|Overall Study|Participant unwilling to continue|2|||
33528039|NCT01675882|62915985|FG001|Overall Study|Participant unwilling to continue|4|||
33528040|NCT01675882|62915986|FG002|Overall Study|Participant unwilling to continue|2|||
33528041|NCT01675882|62915987|FG003|Overall Study|Participant unwilling to continue|1|||
33528042|NCT01675882|62915984|FG000|Overall Study|Lost to Follow-up|0|||
33528043|NCT01675882|62915985|FG001|Overall Study|Lost to Follow-up|1|||
33528044|NCT01675882|62915986|FG002|Overall Study|Lost to Follow-up|0|||
33528045|NCT01675882|62915987|FG003|Overall Study|Lost to Follow-up|0|||
33528046|NCT01675882|62915984|FG000|Overall Study|Non-compliance|0|||
33528047|NCT01675882|62915985|FG001|Overall Study|Non-compliance|0|||
33528048|NCT01675882|62915986|FG002|Overall Study|Non-compliance|0|||
33528049|NCT01675882|62915987|FG003|Overall Study|Non-compliance|1|||
33528050|NCT03018249|62915999|FG000|Overall Study|Withdrawal by Subject|2|||
33528051|NCT03018249|62916000|FG001|Overall Study|Withdrawal by Subject|2|||
33528052|NCT02923245|62916018|FG000|Overall Study|ultrasound order was cancelled|2|||
33528053|NCT02923245|62916019|FG001|Overall Study|ultrasound order was cancelled|1|||
33528054|NCT00905606|62916035|FG000|Period 1|Adverse Event|0|||
33623483|NCT02088073|63024347|FG003|Maintanance Phase|Adverse Event|0|||
33623484|NCT02088073|63024348|FG004|Maintanance Phase|Adverse Event|1|||
33623485|NCT02088073|63024344|FG000|Maintanance Phase|Physician Decision|0|||
33623486|NCT02088073|63024345|FG001|Maintanance Phase|Physician Decision|0|||
33623487|NCT02088073|63024346|FG002|Maintanance Phase|Physician Decision|0|||
33623488|NCT02088073|63024347|FG003|Maintanance Phase|Physician Decision|0|||
33623489|NCT02088073|63024348|FG004|Maintanance Phase|Physician Decision|1|||
33623490|NCT02088073|63024344|FG000|Maintanance Phase|Sponsor's decision|0|||
33623491|NCT02088073|63024345|FG001|Maintanance Phase|Sponsor's decision|2|||
33623492|NCT02088073|63024346|FG002|Maintanance Phase|Sponsor's decision|0|||
33623493|NCT02088073|63024347|FG003|Maintanance Phase|Sponsor's decision|2|||
33623494|NCT02088073|63024348|FG004|Maintanance Phase|Sponsor's decision|1|||
33623495|NCT02088073|63024344|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
33623496|NCT02088073|63024345|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
33623497|NCT02088073|63024346|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
33623498|NCT02088073|63024347|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
33623499|NCT02088073|63024348|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
33623500|NCT02088073|63024344|FG000|Maintanance Phase|Miscellaneous|0|||
33623501|NCT02088073|63024345|FG001|Maintanance Phase|Miscellaneous|2|||
33623502|NCT02088073|63024346|FG002|Maintanance Phase|Miscellaneous|1|||
33623503|NCT02088073|63024347|FG003|Maintanance Phase|Miscellaneous|2|||
33623504|NCT02088073|63024348|FG004|Maintanance Phase|Miscellaneous|1|||
33623505|NCT02088073|63024344|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
33623506|NCT02088073|63024345|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
33623507|NCT02088073|63024346|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
33623508|NCT02088073|63024347|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
33623509|NCT02088073|63024348|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
33623510|NCT02088073|63024344|FG000|Maintanance Phase|Subject compliance|0|||
33623511|NCT02088073|63024345|FG001|Maintanance Phase|Subject compliance|1|||
33623512|NCT02088073|63024346|FG002|Maintanance Phase|Subject compliance|0|||
33623513|NCT02088073|63024347|FG003|Maintanance Phase|Subject compliance|0|||
33623514|NCT02088073|63024348|FG004|Maintanance Phase|Subject compliance|0|||
33623515|NCT01823991|63024363|FG000|Overall Study|Withdrawal by Subject|8|||
33623516|NCT01823991|63024364|FG001|Overall Study|Withdrawal by Subject|5|||
33623517|NCT02087059|63024374|FG000|Overall Study|Disease Progression|1|||
33623518|NCT02087059|63024374|FG000|Overall Study|Adverse Event|5|||
33623519|NCT02087059|63024374|FG000|Overall Study|Lost to Follow-up|1|||
33623520|NCT02152163|63024380|FG000|Overall Study|Physician Decision|12|||
33623521|NCT02152163|63024381|FG001|Overall Study|Physician Decision|13|||
33623522|NCT02152007|63024387|FG000|Overall Study|Withdrawal by Subject|1|||
33623523|NCT02151851|63024394|FG000|Overall Study|Lack of Efficacy|67|||
33623524|NCT02151851|63024395|FG001|Overall Study|Lack of Efficacy|94|||
33623525|NCT02151851|63024394|FG000|Overall Study|Protocol Violation|0|||
33623526|NCT02151851|63024395|FG001|Overall Study|Protocol Violation|1|||
33623527|NCT02151851|63024394|FG000|Overall Study|Withdrawal by Subject|2|||
33623528|NCT02151851|63024395|FG001|Overall Study|Withdrawal by Subject|5|||
33623529|NCT02151851|63024394|FG000|Overall Study|Medical impairment|1|||
33623530|NCT02151851|63024395|FG001|Overall Study|Medical impairment|0|||
33623531|NCT02151851|63024394|FG000|Overall Study|Low compliance to study visits|0|||
33325434|NCT01212770|62702211|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
33325435|NCT01212770|62702212|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
33325436|NCT01212770|62702213|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
33325437|NCT01212770|62702214|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
33325438|NCT01212770|62702215|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
33325439|NCT01212770|62702216|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
33325440|NCT01212770|62702217|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
33457645|NCT03670810|62831942|FG003|Open Label Extension|Physician Decision|0|||
33457646|NCT03670810|62831943|FG004|Open Label Extension|Physician Decision|0|||
33457647|NCT03670810|62831944|FG005|Open Label Extension|Physician Decision|0|||
33457648|NCT03670810|62831945|FG006|Open Label Extension|Physician Decision|0|||
33457649|NCT03670810|62831946|FG007|Open Label Extension|Physician Decision|0|||
33457650|NCT03670810|62831947|FG008|Open Label Extension|Physician Decision|2|||
33457651|NCT03670810|62831939|FG000|Open Label Extension|Non-compliance with study drug|0|||
33457652|NCT03670810|62831940|FG001|Open Label Extension|Non-compliance with study drug|0|||
33528055|NCT00905606|62916036|FG001|Period 1|Adverse Event|1|||
33623532|NCT02151851|63024395|FG001|Overall Study|Low compliance to study visits|1|||
33623533|NCT02151851|63024394|FG000|Overall Study|Subject entered into study in error|0|||
33623534|NCT02151851|63024395|FG001|Overall Study|Subject entered into study in error|1|||
33623535|NCT02151851|63024394|FG000|Overall Study|Adverse Event|6|||
33623536|NCT02151851|63024395|FG001|Overall Study|Adverse Event|28|||
33623537|NCT02176421|63024401|FG000|Overall Study|Lost to Follow-up|4|||
33623538|NCT02176421|63024401|FG000|Overall Study|Adverse Event|1|||
33623539|NCT02042443|63024407|FG000|Overall Study|Adverse Event|2|||
33623540|NCT02042443|63024408|FG001|Overall Study|Adverse Event|1|||
33623541|NCT02042443|63024407|FG000|Overall Study|Withdrawal by Subject|0|||
33623542|NCT02042443|63024408|FG001|Overall Study|Withdrawal by Subject|1|||
33623543|NCT02042443|63024407|FG000|Overall Study|Progression|21|||
33623544|NCT02042443|63024408|FG001|Overall Study|Progression|17|||
33623545|NCT02042443|63024407|FG000|Overall Study|not protocol specified|1|||
33623546|NCT02042443|63024408|FG001|Overall Study|not protocol specified|1|||
33623547|NCT02042443|63024407|FG000|Overall Study|Not eligible/not analyzable|3|||
33623548|NCT02042443|63024408|FG001|Overall Study|Not eligible/not analyzable|6|||
33623549|NCT02118896|63024425|FG000|Overall Study|Death|4|||
33623550|NCT02118896|63024426|FG001|Overall Study|Death|0|||
33623551|NCT02118896|63024427|FG002|Overall Study|Death|4|||
33623552|NCT02118896|63024428|FG003|Overall Study|Death|6|||
33623553|NCT02118896|63024429|FG004|Overall Study|Death|3|||
33623554|NCT02118896|63024430|FG005|Overall Study|Death|1|||
33623555|NCT02118896|63024431|FG006|Overall Study|Death|0|||
33623556|NCT02118896|63024432|FG007|Overall Study|Death|0|||
33623557|NCT02118896|63024433|FG008|Overall Study|Death|0|||
33623558|NCT02118896|63024434|FG009|Overall Study|Death|0|||
33623559|NCT02118896|63024425|FG000|Overall Study|Adverse Event|5|||
33623560|NCT02118896|63024426|FG001|Overall Study|Adverse Event|4|||
33623561|NCT02118896|63024427|FG002|Overall Study|Adverse Event|4|||
33623562|NCT02118896|63024428|FG003|Overall Study|Adverse Event|5|||
33623563|NCT02118896|63024429|FG004|Overall Study|Adverse Event|5|||
33623564|NCT02118896|63024430|FG005|Overall Study|Adverse Event|9|||
33623565|NCT02118896|63024431|FG006|Overall Study|Adverse Event|1|||
33623566|NCT02118896|63024432|FG007|Overall Study|Adverse Event|1|||
33623567|NCT02118896|63024433|FG008|Overall Study|Adverse Event|4|||
33623568|NCT02118896|63024434|FG009|Overall Study|Adverse Event|0|||
33528056|NCT00905606|62916035|FG000|Washout|Withdrawal by Subject|1|||
33528057|NCT00905606|62916036|FG001|Washout|Withdrawal by Subject|0|||
33623569|NCT02118896|63024425|FG000|Overall Study|Consent withdrawn|2|||
33623570|NCT02118896|63024426|FG001|Overall Study|Consent withdrawn|0|||
33623571|NCT02118896|63024427|FG002|Overall Study|Consent withdrawn|3|||
33528058|NCT01676896|62916043|FG000|Overall Study|Withdrawal by Subject|12|||
33528059|NCT01676896|62916044|FG001|Overall Study|Withdrawal by Subject|7|||
33528060|NCT01676896|62916045|FG002|Overall Study|Withdrawal by Subject|19|||
33528061|NCT03017235|62916055|FG000|Overall Study|Withdrawal by Subject|4|||
33623572|NCT02118896|63024428|FG003|Overall Study|Consent withdrawn|4|||
33623573|NCT02118896|63024429|FG004|Overall Study|Consent withdrawn|1|||
33528062|NCT03017235|62916056|FG001|Overall Study|Withdrawal by Subject|3|||
33528063|NCT03017235|62916055|FG000|Overall Study|Lost to Follow-up|2|||
33528064|NCT03017235|62916056|FG001|Overall Study|Lost to Follow-up|7|||
33528065|NCT03017235|62916055|FG000|Overall Study|Adverse Event|0|||
33528066|NCT03017235|62916056|FG001|Overall Study|Adverse Event|1|||
33528067|NCT03017235|62916055|FG000|Overall Study|Protocol Violation|2|||
33528068|NCT03017235|62916056|FG001|Overall Study|Protocol Violation|1|||
33528069|NCT03017235|62916055|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
33528070|NCT03017235|62916056|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
33528071|NCT03017079|62916064|FG000|Overall Study|Physician Decision|1|||
33528072|NCT03017079|62916065|FG001|Overall Study|Physician Decision|1|||
33528073|NCT03017079|62916064|FG000|Overall Study|Death|3|||
33528074|NCT03017079|62916065|FG001|Overall Study|Death|2|||
33528075|NCT03017079|62916064|FG000|Overall Study|Lack of Efficacy|2|||
33528076|NCT03017079|62916065|FG001|Overall Study|Lack of Efficacy|2|||
33528077|NCT03017079|62916064|FG000|Overall Study|Protocol Violation|0|||
33528078|NCT03017079|62916065|FG001|Overall Study|Protocol Violation|1|||
33528079|NCT03015363|62916078|FG000|Overall Study|Physician Decision|14|||
33528080|NCT03015363|62916078|FG000|Overall Study|Withdrawal by Subject|3|||
33528081|NCT02880371|62916090|FG000|Phase 1b|Lost to Follow-up|1|||
33528082|NCT02880371|62916091|FG001|Phase 1b|Lost to Follow-up|0|||
33528083|NCT02880371|62916092|FG002|Phase 1b|Lost to Follow-up|0|||
33528084|NCT02880371|62916093|FG003|Phase 1b|Lost to Follow-up|0|||
33528085|NCT02880371|62916094|FG004|Phase 1b|Lost to Follow-up|0|||
33623574|NCT02118896|63024430|FG005|Overall Study|Consent withdrawn|4|||
33623575|NCT02118896|63024431|FG006|Overall Study|Consent withdrawn|0|||
33528086|NCT02880371|62916095|FG005|Phase 1b|Lost to Follow-up|0|||
33528087|NCT02880371|62916096|FG006|Phase 1b|Lost to Follow-up|0|||
33528088|NCT02880371|62916097|FG007|Phase 1b|Lost to Follow-up|0|||
33528089|NCT02880371|62916090|FG000|Phase 1b|Participants terminated by Sponsor|1|||
33528090|NCT02880371|62916091|FG001|Phase 1b|Participants terminated by Sponsor|0|||
33528091|NCT02880371|62916092|FG002|Phase 1b|Participants terminated by Sponsor|0|||
33623576|NCT02118896|63024432|FG007|Overall Study|Consent withdrawn|0|||
33623577|NCT02118896|63024433|FG008|Overall Study|Consent withdrawn|0|||
33623578|NCT02118896|63024434|FG009|Overall Study|Consent withdrawn|0|||
33623579|NCT02118896|63024425|FG000|Overall Study|Non-compliance|2|||
33623580|NCT02118896|63024426|FG001|Overall Study|Non-compliance|1|||
33623581|NCT02118896|63024427|FG002|Overall Study|Non-compliance|1|||
33623582|NCT02118896|63024428|FG003|Overall Study|Non-compliance|5|||
33623583|NCT02118896|63024429|FG004|Overall Study|Non-compliance|0|||
33623584|NCT02118896|63024430|FG005|Overall Study|Non-compliance|1|||
33623585|NCT02118896|63024431|FG006|Overall Study|Non-compliance|0|||
33623586|NCT02118896|63024432|FG007|Overall Study|Non-compliance|1|||
33623587|NCT02118896|63024433|FG008|Overall Study|Non-compliance|0|||
33623588|NCT02118896|63024434|FG009|Overall Study|Non-compliance|0|||
33623589|NCT02118896|63024425|FG000|Overall Study|Pregnancy|1|||
33623590|NCT02118896|63024426|FG001|Overall Study|Pregnancy|1|||
33623591|NCT02118896|63024427|FG002|Overall Study|Pregnancy|0|||
33623592|NCT02118896|63024428|FG003|Overall Study|Pregnancy|0|||
33623593|NCT02118896|63024429|FG004|Overall Study|Pregnancy|1|||
33623594|NCT02118896|63024430|FG005|Overall Study|Pregnancy|3|||
33623595|NCT02118896|63024431|FG006|Overall Study|Pregnancy|1|||
33623596|NCT02118896|63024432|FG007|Overall Study|Pregnancy|0|||
33623597|NCT02118896|63024433|FG008|Overall Study|Pregnancy|0|||
33623598|NCT02118896|63024434|FG009|Overall Study|Pregnancy|0|||
33623599|NCT02118896|63024425|FG000|Overall Study|Lost to Follow-up|1|||
33623600|NCT02118896|63024426|FG001|Overall Study|Lost to Follow-up|2|||
33623601|NCT02118896|63024427|FG002|Overall Study|Lost to Follow-up|1|||
33623602|NCT02118896|63024428|FG003|Overall Study|Lost to Follow-up|0|||
33623603|NCT02118896|63024429|FG004|Overall Study|Lost to Follow-up|2|||
33623604|NCT02118896|63024430|FG005|Overall Study|Lost to Follow-up|1|||
33623605|NCT02118896|63024431|FG006|Overall Study|Lost to Follow-up|0|||
33623606|NCT02118896|63024432|FG007|Overall Study|Lost to Follow-up|0|||
33623607|NCT02118896|63024433|FG008|Overall Study|Lost to Follow-up|0|||
33623608|NCT02118896|63024434|FG009|Overall Study|Lost to Follow-up|0|||
33623609|NCT02118896|63024425|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
33623610|NCT02118896|63024426|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
33623611|NCT02118896|63024427|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
33623612|NCT02118896|63024428|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
33623613|NCT02118896|63024429|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
33623614|NCT02118896|63024430|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
33623615|NCT02118896|63024431|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
33623616|NCT02118896|63024432|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
33623617|NCT02118896|63024433|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
33623618|NCT02118896|63024434|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
33623619|NCT02118896|63024425|FG000|Overall Study|Prohibited medication|0|||
33623620|NCT02118896|63024426|FG001|Overall Study|Prohibited medication|0|||
33623621|NCT02118896|63024427|FG002|Overall Study|Prohibited medication|0|||
33623622|NCT02118896|63024428|FG003|Overall Study|Prohibited medication|0|||
33623623|NCT02118896|63024429|FG004|Overall Study|Prohibited medication|1|||
33623624|NCT02118896|63024430|FG005|Overall Study|Prohibited medication|3|||
33623625|NCT02118896|63024431|FG006|Overall Study|Prohibited medication|0|||
33623626|NCT02118896|63024432|FG007|Overall Study|Prohibited medication|0|||
33623627|NCT02118896|63024433|FG008|Overall Study|Prohibited medication|0|||
33623628|NCT02118896|63024434|FG009|Overall Study|Prohibited medication|0|||
33623629|NCT02118896|63024425|FG000|Overall Study|Miscellaneous|1|||
33623630|NCT02118896|63024426|FG001|Overall Study|Miscellaneous|2|||
33623631|NCT02118896|63024427|FG002|Overall Study|Miscellaneous|0|||
33623632|NCT02118896|63024428|FG003|Overall Study|Miscellaneous|2|||
33623633|NCT02118896|63024429|FG004|Overall Study|Miscellaneous|0|||
33623634|NCT02118896|63024430|FG005|Overall Study|Miscellaneous|4|||
33623635|NCT02118896|63024431|FG006|Overall Study|Miscellaneous|0|||
33623636|NCT02118896|63024432|FG007|Overall Study|Miscellaneous|0|||
33623637|NCT02118896|63024433|FG008|Overall Study|Miscellaneous|0|||
33623638|NCT02118896|63024434|FG009|Overall Study|Miscellaneous|0|||
33623639|NCT02124707|63024457|FG000|Overall Study|Adverse Event|5|||
33623640|NCT02124707|63024457|FG000|Overall Study|Physician Decision|1|||
33623641|NCT02124707|63024457|FG000|Overall Study|Death|1|||
33623642|NCT02067728|63024464|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
33623643|NCT02067728|63024465|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
33623644|NCT02067728|63024464|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
33623645|NCT02067728|63024465|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
33623646|NCT02067728|63024464|FG000|6 Month Measurements|Unable to attend|114|||
33623647|NCT02067728|63024465|FG001|6 Month Measurements|Unable to attend|97|||
33623648|NCT02118428|63024473|FG000|Overall Study|Physician Decision|0|||
33623649|NCT02118428|63024474|FG001|Overall Study|Physician Decision|1|||
33623650|NCT02118428|63024475|FG002|Overall Study|Physician Decision|0|||
33623651|NCT02118428|63024473|FG000|Overall Study|Withdrawal by Subject|2|||
33623652|NCT02118428|63024474|FG001|Overall Study|Withdrawal by Subject|2|||
33623653|NCT02118428|63024475|FG002|Overall Study|Withdrawal by Subject|0|||
33623654|NCT02118428|63024473|FG000|Overall Study|Death|7|||
33623655|NCT02118428|63024474|FG001|Overall Study|Death|5|||
33623656|NCT02118428|63024475|FG002|Overall Study|Death|0|||
33623657|NCT02118428|63024473|FG000|Overall Study|Lost to Follow-up|3|||
33623658|NCT02118428|63024474|FG001|Overall Study|Lost to Follow-up|1|||
33623659|NCT02118428|63024475|FG002|Overall Study|Lost to Follow-up|0|||
33623660|NCT02118428|63024473|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
33623661|NCT02118428|63024474|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
33623662|NCT02118428|63024475|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
33623663|NCT02067104|63024483|FG000|Overall Study|Study termination due to low accrual|4|||
33623664|NCT02067104|63024484|FG001|Overall Study|Study termination due to low accrual|5|||
33623665|NCT02092220|63024490|FG000|Period 1|Unrelated Illness|0|||
33623666|NCT02092220|63024491|FG001|Period 1|Unrelated Illness|2|||
33623667|NCT02092220|63024490|FG000|Period 2|Severe Hypoglycaemia|1|||
33623668|NCT02092220|63024491|FG001|Period 2|Severe Hypoglycaemia|0|||
33623669|NCT02092220|63024490|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
33623670|NCT02092220|63024491|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
33623671|NCT02066402|63024501|FG000|Overall Study|Adverse Event|1|||
33623672|NCT02066402|63024502|FG001|Overall Study|Adverse Event|2|||
33623673|NCT02066402|63024501|FG000|Overall Study|Lost to Follow-up|11|||
33623674|NCT02066402|63024502|FG001|Overall Study|Lost to Follow-up|8|||
33623675|NCT02066402|63024501|FG000|Overall Study|Withdrawal by Subject|14|||
33623676|NCT02066402|63024502|FG001|Overall Study|Withdrawal by Subject|11|||
33623677|NCT02066402|63024501|FG000|Overall Study|Progressive disease-clinical progression|0|||
33623678|NCT02066402|63024502|FG001|Overall Study|Progressive disease-clinical progression|1|||
33623679|NCT02066402|63024501|FG000|Overall Study|Protocol driven decision point|0|||
33623680|NCT02066402|63024502|FG001|Overall Study|Protocol driven decision point|1|||
33623681|NCT02060383|63024513|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
33623682|NCT02060383|63024514|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
33623683|NCT02060383|63024515|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
33623684|NCT02060383|63024516|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
33623685|NCT02060383|63024517|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
33623686|NCT02060383|63024513|FG000|Core Phase|Adverse Event|2|||
33623687|NCT02060383|63024514|FG001|Core Phase|Adverse Event|0|||
33623688|NCT02060383|63024515|FG002|Core Phase|Adverse Event|0|||
33623689|NCT02060383|63024516|FG003|Core Phase|Adverse Event|2|||
33623690|NCT02060383|63024517|FG004|Core Phase|Adverse Event|6|||
33623691|NCT02060383|63024513|FG000|Core Phase|Administrative problems|0|||
33623692|NCT02060383|63024514|FG001|Core Phase|Administrative problems|1|||
33623693|NCT02060383|63024515|FG002|Core Phase|Administrative problems|0|||
33623694|NCT02060383|63024516|FG003|Core Phase|Administrative problems|0|||
33623695|NCT02060383|63024517|FG004|Core Phase|Administrative problems|0|||
33623696|NCT02060383|63024513|FG000|Core Phase|Protocol Violation|0|||
33623697|NCT02060383|63024514|FG001|Core Phase|Protocol Violation|0|||
33623698|NCT02060383|63024515|FG002|Core Phase|Protocol Violation|0|||
33623699|NCT02060383|63024516|FG003|Core Phase|Protocol Violation|1|||
33623700|NCT02060383|63024517|FG004|Core Phase|Protocol Violation|0|||
33623701|NCT02060383|63024513|FG000|Core Phase|Withdrawal by Subject|0|||
33623702|NCT02060383|63024514|FG001|Core Phase|Withdrawal by Subject|0|||
33623703|NCT02060383|63024515|FG002|Core Phase|Withdrawal by Subject|0|||
33623704|NCT02060383|63024516|FG003|Core Phase|Withdrawal by Subject|4|||
33623705|NCT02060383|63024517|FG004|Core Phase|Withdrawal by Subject|2|||
33623706|NCT02060383|63024513|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
33623707|NCT02060383|63024514|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
33623708|NCT02060383|63024515|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
33623709|NCT02060383|63024516|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
33623710|NCT02060383|63024517|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
33623711|NCT02060383|63024513|FG000|Extension Phase|Adverse Event|1|||
33623712|NCT02060383|63024514|FG001|Extension Phase|Adverse Event|1|||
33623713|NCT02060383|63024515|FG002|Extension Phase|Adverse Event|2|||
33623714|NCT02060383|63024516|FG003|Extension Phase|Adverse Event|0|||
33623715|NCT02060383|63024517|FG004|Extension Phase|Adverse Event|1|||
33623716|NCT02060383|63024513|FG000|Extension Phase|Withdrawal by Subject|0|||
33623717|NCT02060383|63024514|FG001|Extension Phase|Withdrawal by Subject|1|||
33623718|NCT02060383|63024515|FG002|Extension Phase|Withdrawal by Subject|0|||
33623719|NCT02060383|63024516|FG003|Extension Phase|Withdrawal by Subject|0|||
33623720|NCT02060383|63024517|FG004|Extension Phase|Withdrawal by Subject|2|||
33623721|NCT02060383|63024513|FG000|Extension Phase|Administrative problems|1|||
33623722|NCT02060383|63024514|FG001|Extension Phase|Administrative problems|0|||
33623723|NCT02060383|63024515|FG002|Extension Phase|Administrative problems|0|||
33623724|NCT02060383|63024516|FG003|Extension Phase|Administrative problems|0|||
33623725|NCT02060383|63024517|FG004|Extension Phase|Administrative problems|0|||
33623726|NCT02060383|63024513|FG000|Extension Phase|Death|0|||
33623727|NCT02060383|63024514|FG001|Extension Phase|Death|0|||
33623728|NCT02060383|63024515|FG002|Extension Phase|Death|1|||
33623729|NCT02060383|63024516|FG003|Extension Phase|Death|0|||
33623730|NCT02060383|63024517|FG004|Extension Phase|Death|1|||
33623731|NCT02060383|63024513|FG000|Extension Phase|Protocol Violation|0|||
33623732|NCT02060383|63024514|FG001|Extension Phase|Protocol Violation|0|||
33623733|NCT02060383|63024515|FG002|Extension Phase|Protocol Violation|0|||
33623734|NCT02060383|63024516|FG003|Extension Phase|Protocol Violation|0|||
33623735|NCT02060383|63024517|FG004|Extension Phase|Protocol Violation|1|||
33623736|NCT02086591|63024529|FG000|Overall Study|Adverse Event|1|||
33623737|NCT02086591|63024529|FG000|Overall Study|Withdrawal by Subject|1|||
33623738|NCT02086591|63024529|FG000|Overall Study|protocol terminated|3|||
33623739|NCT02065622|63024535|FG000|Induction Study|Adverse Event|13|||
33623740|NCT02065622|63024536|FG001|Induction Study|Adverse Event|19|||
33623741|NCT02065622|63024537|FG002|Induction Study|Adverse Event|0|||
33623742|NCT02065622|63024538|FG003|Induction Study|Adverse Event|0|||
33623743|NCT02065622|63024539|FG004|Induction Study|Adverse Event|0|||
33623744|NCT02065622|63024535|FG000|Induction Study|Withdrawal by Subject|3|||
33623745|NCT02065622|63024536|FG001|Induction Study|Withdrawal by Subject|5|||
33623746|NCT02065622|63024537|FG002|Induction Study|Withdrawal by Subject|0|||
33623747|NCT02065622|63024538|FG003|Induction Study|Withdrawal by Subject|0|||
33623748|NCT02065622|63024539|FG004|Induction Study|Withdrawal by Subject|0|||
33623749|NCT02065622|63024535|FG000|Induction Study|Lost to Follow-up|1|||
33623750|NCT02065622|63024536|FG001|Induction Study|Lost to Follow-up|0|||
33623751|NCT02065622|63024537|FG002|Induction Study|Lost to Follow-up|0|||
33623752|NCT02065622|63024538|FG003|Induction Study|Lost to Follow-up|0|||
33623753|NCT02065622|63024539|FG004|Induction Study|Lost to Follow-up|0|||
33623754|NCT02065622|63024535|FG000|Induction Study|Lack of Efficacy|22|||
33623755|NCT02065622|63024536|FG001|Induction Study|Lack of Efficacy|27|||
33623756|NCT02065622|63024537|FG002|Induction Study|Lack of Efficacy|0|||
33623757|NCT02065622|63024538|FG003|Induction Study|Lack of Efficacy|0|||
33623758|NCT02065622|63024539|FG004|Induction Study|Lack of Efficacy|0|||
33623759|NCT02065622|63024535|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
33623760|NCT02065622|63024536|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
33623761|NCT02065622|63024537|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
33623762|NCT02065622|63024538|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
33623763|NCT02065622|63024539|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
33623764|NCT02065622|63024535|FG000|Induction Study|Subject Noncompliance|1|||
33623765|NCT02065622|63024536|FG001|Induction Study|Subject Noncompliance|1|||
33623766|NCT02065622|63024537|FG002|Induction Study|Subject Noncompliance|0|||
33623767|NCT02065622|63024538|FG003|Induction Study|Subject Noncompliance|0|||
33623768|NCT02065622|63024539|FG004|Induction Study|Subject Noncompliance|0|||
33623769|NCT02065622|63024535|FG000|Induction Study|Other, Not Specified|3|||
33623770|NCT02065622|63024536|FG001|Induction Study|Other, Not Specified|2|||
33623771|NCT02065622|63024537|FG002|Induction Study|Other, Not Specified|0|||
33623772|NCT02065622|63024538|FG003|Induction Study|Other, Not Specified|0|||
33623773|NCT02065622|63024539|FG004|Induction Study|Other, Not Specified|0|||
33623774|NCT02065622|63024535|FG000|Maintenance Study|Adverse Event|0|||
33623775|NCT02065622|63024536|FG001|Maintenance Study|Adverse Event|0|||
33623776|NCT02065622|63024537|FG002|Maintenance Study|Adverse Event|25|||
33623777|NCT02065622|63024538|FG003|Maintenance Study|Adverse Event|22|||
33623778|NCT02065622|63024539|FG004|Maintenance Study|Adverse Event|11|||
33623779|NCT02065622|63024535|FG000|Maintenance Study|Withdrawal by Subject|0|||
33623780|NCT02065622|63024536|FG001|Maintenance Study|Withdrawal by Subject|0|||
33623781|NCT02065622|63024537|FG002|Maintenance Study|Withdrawal by Subject|11|||
33623782|NCT02065622|63024538|FG003|Maintenance Study|Withdrawal by Subject|5|||
33623783|NCT02065622|63024539|FG004|Maintenance Study|Withdrawal by Subject|7|||
33623784|NCT02065622|63024535|FG000|Maintenance Study|Lost to Follow-up|0|||
33623785|NCT02065622|63024536|FG001|Maintenance Study|Lost to Follow-up|0|||
33623786|NCT02065622|63024537|FG002|Maintenance Study|Lost to Follow-up|4|||
33623787|NCT02065622|63024538|FG003|Maintenance Study|Lost to Follow-up|1|||
33623788|NCT02065622|63024539|FG004|Maintenance Study|Lost to Follow-up|1|||
33623789|NCT02065622|63024535|FG000|Maintenance Study|Lack of Efficacy|0|||
33623790|NCT02065622|63024536|FG001|Maintenance Study|Lack of Efficacy|0|||
33623791|NCT02065622|63024537|FG002|Maintenance Study|Lack of Efficacy|70|||
33623792|NCT02065622|63024538|FG003|Maintenance Study|Lack of Efficacy|55|||
33325441|NCT01212770|62702218|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
33623793|NCT02065622|63024539|FG004|Maintenance Study|Lack of Efficacy|19|||
33623794|NCT02065622|63024535|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
33623795|NCT02065622|63024536|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
33623796|NCT02065622|63024537|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
33623797|NCT02065622|63024538|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
33623798|NCT02065622|63024539|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
33623799|NCT02065622|63024535|FG000|Maintenance Study|Subject Non-Compliance|0|||
33623800|NCT02065622|63024536|FG001|Maintenance Study|Subject Non-Compliance|0|||
33623801|NCT02065622|63024537|FG002|Maintenance Study|Subject Non-Compliance|1|||
33623802|NCT02065622|63024538|FG003|Maintenance Study|Subject Non-Compliance|3|||
33623803|NCT02065622|63024539|FG004|Maintenance Study|Subject Non-Compliance|2|||
33623804|NCT02065622|63024535|FG000|Maintenance Study|Other, Not Specified|0|||
33623805|NCT02065622|63024536|FG001|Maintenance Study|Other, Not Specified|0|||
33623806|NCT02065622|63024537|FG002|Maintenance Study|Other, Not Specified|6|||
33623807|NCT02065622|63024538|FG003|Maintenance Study|Other, Not Specified|14|||
33623808|NCT02065622|63024539|FG004|Maintenance Study|Other, Not Specified|2|||
33623809|NCT02065622|63024535|FG000|Maintenance Study|Unknown Reason|0|||
33623810|NCT02065622|63024536|FG001|Maintenance Study|Unknown Reason|0|||
33623811|NCT02065622|63024537|FG002|Maintenance Study|Unknown Reason|0|||
33623812|NCT02065622|63024538|FG003|Maintenance Study|Unknown Reason|1|||
33623813|NCT02065622|63024539|FG004|Maintenance Study|Unknown Reason|0|||
33623814|NCT02117648|63024554|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
33623815|NCT02117648|63024554|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
33623816|NCT02117648|63024554|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
33623817|NCT02117648|63024554|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
33623818|NCT02117648|63024554|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
33623819|NCT02117648|63024554|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
33623820|NCT02117648|63024554|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
33623821|NCT02117648|63024554|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
33623822|NCT02117648|63024554|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
33623823|NCT02117648|63024554|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
33623824|NCT02117648|63024554|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
33623825|NCT02124161|63024564|FG000|Overall Study|Other unspecified|0|||
33623826|NCT02124161|63024565|FG001|Overall Study|Other unspecified|1|||
33623827|NCT02124161|63024564|FG000|Overall Study|Death|1|||
33623828|NCT02124161|63024565|FG001|Overall Study|Death|0|||
33623829|NCT02124161|63024564|FG000|Overall Study|Protocol Violation|2|||
33623830|NCT02124161|63024565|FG001|Overall Study|Protocol Violation|1|||
33623831|NCT02124161|63024564|FG000|Overall Study|Withdrawal by Subject|1|||
33623832|NCT02124161|63024565|FG001|Overall Study|Withdrawal by Subject|2|||
33623833|NCT02124161|63024564|FG000|Overall Study|Adverse Event|2|||
33623834|NCT02124161|63024565|FG001|Overall Study|Adverse Event|0|||
33623835|NCT02124161|63024564|FG000|Overall Study|Does not meet entrance criteria|2|||
33623836|NCT02124161|63024565|FG001|Overall Study|Does not meet entrance criteria|3|||
33623837|NCT02124161|63024564|FG000|Overall Study|No longer meets eligibility criteria|5|||
33623838|NCT02124161|63024565|FG001|Overall Study|No longer meets eligibility criteria|4|||
33623839|NCT02124161|63024564|FG000|Overall Study|Lost to Follow-up|3|||
33623840|NCT02124161|63024565|FG001|Overall Study|Lost to Follow-up|4|||
33623841|NCT02175641|63024580|FG000|Overall Study|Death|3|||
33623842|NCT02175641|63024581|FG001|Overall Study|Death|4|||
33623843|NCT02175641|63024580|FG000|Overall Study|Lost to Follow-up|4|||
33623844|NCT02175641|63024581|FG001|Overall Study|Lost to Follow-up|4|||
33623845|NCT02175641|63024580|FG000|Overall Study|Withdrawal by Subject|7|||
33623846|NCT02175641|63024581|FG001|Overall Study|Withdrawal by Subject|4|||
33623847|NCT02175641|63024580|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
33623848|NCT02175641|63024581|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
33623849|NCT02175641|63024580|FG000|Overall Study|Developed Contraindicated Condition|8|||
33623850|NCT02175641|63024581|FG001|Overall Study|Developed Contraindicated Condition|0|||
33623851|NCT02117570|63024590|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
33623852|NCT02117570|63024591|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
33623853|NCT02117570|63024592|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
33623854|NCT02117570|63024590|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
33623855|NCT02117570|63024591|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
33623856|NCT02117570|63024592|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
33623857|NCT02117570|63024590|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
33623858|NCT02117570|63024591|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
33623859|NCT02117570|63024592|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
33623860|NCT02117570|63024590|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
33623861|NCT02117570|63024591|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
33623862|NCT02117570|63024592|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
33623863|NCT02117570|63024590|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
33325442|NCT01212770|62702219|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
33623864|NCT02117570|63024591|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
33623865|NCT02117570|63024592|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
33528092|NCT02880371|62916093|FG003|Phase 1b|Participants terminated by Sponsor|0|||
33528093|NCT02880371|62916094|FG004|Phase 1b|Participants terminated by Sponsor|0|||
33528094|NCT02880371|62916095|FG005|Phase 1b|Participants terminated by Sponsor|0|||
33528095|NCT02880371|62916096|FG006|Phase 1b|Participants terminated by Sponsor|0|||
33528096|NCT02880371|62916097|FG007|Phase 1b|Participants terminated by Sponsor|0|||
33528097|NCT02880371|62916090|FG000|Phase 1b|Withdrawal by Subject|0|||
33623866|NCT02117570|63024590|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
33623867|NCT02117570|63024591|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
33623868|NCT02117570|63024592|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
33623869|NCT02117570|63024590|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
33623870|NCT02117570|63024591|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
33623871|NCT02117570|63024592|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
33623872|NCT02123459|63024603|FG000|Washout Period (1 Day)|Adverse Event|1|||
33623873|NCT02123459|63024604|FG001|Washout Period (1 Day)|Adverse Event|0|||
33623874|NCT01853475|63024613|FG000|Overall Study|Withdrawal by Subject|0|||
33623875|NCT01853475|63024614|FG001|Overall Study|Withdrawal by Subject|1|||
33623876|NCT01853475|63024615|FG002|Overall Study|Withdrawal by Subject|0|||
33623877|NCT02151773|63024623|FG000|Overall Study|Protocol Deviation|64|||
33623878|NCT02151461|63024631|FG000|Overall Study|Adverse Event|5|||
33623879|NCT02151461|63024632|FG001|Overall Study|Adverse Event|1|||
33623880|NCT02151461|63024633|FG002|Overall Study|Adverse Event|0|||
33623881|NCT02151461|63024634|FG003|Overall Study|Adverse Event|2|||
33623882|NCT02151461|63024631|FG000|Overall Study|Lost to Follow-up|0|||
33623883|NCT02151461|63024632|FG001|Overall Study|Lost to Follow-up|0|||
33623884|NCT02151461|63024633|FG002|Overall Study|Lost to Follow-up|1|||
33623885|NCT02151461|63024634|FG003|Overall Study|Lost to Follow-up|1|||
33623886|NCT02151461|63024631|FG000|Overall Study|Withdrawal by Subject|1|||
33623887|NCT02151461|63024632|FG001|Overall Study|Withdrawal by Subject|0|||
33623888|NCT02151461|63024633|FG002|Overall Study|Withdrawal by Subject|1|||
33623889|NCT02151461|63024634|FG003|Overall Study|Withdrawal by Subject|1|||
33623890|NCT02151461|63024631|FG000|Overall Study|Treatment discontinuation|0|||
33623891|NCT02151461|63024632|FG001|Overall Study|Treatment discontinuation|0|||
33623892|NCT02151461|63024633|FG002|Overall Study|Treatment discontinuation|1|||
33623893|NCT02151461|63024634|FG003|Overall Study|Treatment discontinuation|0|||
33623894|NCT02117414|63024646|FG000|Overall Study|Death|5|||
33623895|NCT02117414|63024647|FG001|Overall Study|Death|2|||
33623896|NCT02117414|63024646|FG000|Overall Study|Withdrawal by Subject|10|||
33623897|NCT02117414|63024647|FG001|Overall Study|Withdrawal by Subject|4|||
33623898|NCT02091986|63024658|FG000|Overall Study|7 rand in error 1 patient decision|2|||
33623899|NCT02091986|63024659|FG001|Overall Study|7 rand in error 1 patient decision|3|||
33623900|NCT02091986|63024660|FG002|Overall Study|7 rand in error 1 patient decision|3|||
33623901|NCT02091986|63024658|FG000|Overall Study|Lost to Follow-up|1|||
33623902|NCT02091986|63024659|FG001|Overall Study|Lost to Follow-up|0|||
33623903|NCT02091986|63024660|FG002|Overall Study|Lost to Follow-up|0|||
33623904|NCT02091986|63024658|FG000|Overall Study|Withdrawal by Subject|4|||
33623905|NCT02091986|63024659|FG001|Overall Study|Withdrawal by Subject|8|||
33528098|NCT02880371|62916091|FG001|Phase 1b|Withdrawal by Subject|0|||
33623906|NCT02091986|63024660|FG002|Overall Study|Withdrawal by Subject|3|||
33623907|NCT02091986|63024658|FG000|Overall Study|Adverse Event|0|||
33623908|NCT02091986|63024659|FG001|Overall Study|Adverse Event|0|||
33623909|NCT02091986|63024660|FG002|Overall Study|Adverse Event|2|||
33623910|NCT02091752|63024668|FG000|Overall Study|Study terminated by Sponsor|2|||
33623911|NCT02091752|63024668|FG000|Overall Study|Adverse Event|1|||
33457653|NCT03670810|62831941|FG002|Open Label Extension|Non-compliance with study drug|0|||
33457654|NCT03670810|62831942|FG003|Open Label Extension|Non-compliance with study drug|0|||
33457655|NCT03670810|62831943|FG004|Open Label Extension|Non-compliance with study drug|0|||
33457656|NCT03670810|62831944|FG005|Open Label Extension|Non-compliance with study drug|0|||
33457657|NCT03670810|62831945|FG006|Open Label Extension|Non-compliance with study drug|0|||
33457658|NCT03670810|62831946|FG007|Open Label Extension|Non-compliance with study drug|0|||
33457659|NCT03670810|62831947|FG008|Open Label Extension|Non-compliance with study drug|5|||
33457660|NCT03670810|62831939|FG000|Open Label Extension|Pregnancy|0|||
33457661|NCT03670810|62831940|FG001|Open Label Extension|Pregnancy|0|||
33528099|NCT02880371|62916092|FG002|Phase 1b|Withdrawal by Subject|1|||
33528100|NCT02880371|62916093|FG003|Phase 1b|Withdrawal by Subject|0|||
33623912|NCT02117024|63024674|FG000|Overall Study|Progressive Disease|26|||
33457662|NCT03670810|62831941|FG002|Open Label Extension|Pregnancy|0|||
33457663|NCT03670810|62831942|FG003|Open Label Extension|Pregnancy|0|||
33623913|NCT02117024|63024675|FG001|Overall Study|Progressive Disease|9|||
33623914|NCT02117024|63024674|FG000|Overall Study|Significant Clinical Progression|7|||
33623915|NCT02117024|63024675|FG001|Overall Study|Significant Clinical Progression|4|||
33623916|NCT02117024|63024674|FG000|Overall Study|Death|5|||
33528101|NCT02880371|62916094|FG004|Phase 1b|Withdrawal by Subject|0|||
33623917|NCT02117024|63024675|FG001|Overall Study|Death|0|||
33623918|NCT02117024|63024674|FG000|Overall Study|Withdrawal by Subject|3|||
33623919|NCT02117024|63024675|FG001|Overall Study|Withdrawal by Subject|1|||
33623920|NCT02117024|63024674|FG000|Overall Study|Protocol Violation|1|||
33623921|NCT02117024|63024675|FG001|Overall Study|Protocol Violation|0|||
33623922|NCT02117024|63024674|FG000|Overall Study|Adverse Event|1|||
33623923|NCT02117024|63024675|FG001|Overall Study|Adverse Event|2|||
33623924|NCT02117024|63024674|FG000|Overall Study|Randomized in Error|1|||
33623925|NCT02117024|63024675|FG001|Overall Study|Randomized in Error|0|||
33623926|NCT02117024|63024674|FG000|Overall Study|Patient returned to primary oncologist|0|||
33623927|NCT02117024|63024675|FG001|Overall Study|Patient returned to primary oncologist|1|||
33623928|NCT02117024|63024674|FG000|Overall Study|Patient took treatment break|0|||
33623929|NCT02117024|63024675|FG001|Overall Study|Patient took treatment break|1|||
33623930|NCT02117024|63024674|FG000|Overall Study|Physician Decision|0|||
33623931|NCT02117024|63024675|FG001|Overall Study|Physician Decision|2|||
33623932|NCT02091440|63024681|FG000|Overall Study|Death|2|||
33623933|NCT02064920|63024687|FG000|Overall Study|Adverse Event|0|||
33623934|NCT02064920|63024688|FG001|Overall Study|Adverse Event|4|||
33623935|NCT02064920|63024687|FG000|Overall Study|Physician Decision|0|||
33623936|NCT02064920|63024688|FG001|Overall Study|Physician Decision|1|||
33623937|NCT02064920|63024687|FG000|Overall Study|Technical Problems|0|||
33623938|NCT02064920|63024688|FG001|Overall Study|Technical Problems|1|||
33623939|NCT02064920|63024687|FG000|Overall Study|Withdrawal by Subject|1|||
33623940|NCT02064920|63024688|FG001|Overall Study|Withdrawal by Subject|3|||
33623941|NCT02151149|63024696|FG000|Treatment Period|Death|2|||
33623942|NCT02151149|63024697|FG001|Treatment Period|Death|3|||
33623943|NCT02151149|63024696|FG000|Treatment Period|Adverse Event|17|||
33623944|NCT02151149|63024697|FG001|Treatment Period|Adverse Event|14|||
33623945|NCT02151149|63024696|FG000|Treatment Period|Progressive Disease|25|||
33623946|NCT02151149|63024697|FG001|Treatment Period|Progressive Disease|24|||
33623947|NCT02151149|63024696|FG000|Treatment Period|Symptomatic Deterioration|2|||
33623948|NCT02151149|63024697|FG001|Treatment Period|Symptomatic Deterioration|10|||
33623949|NCT02151149|63024696|FG000|Treatment Period|Withdrawal by Subject|13|||
33623950|NCT02151149|63024697|FG001|Treatment Period|Withdrawal by Subject|11|||
33623951|NCT02151149|63024696|FG000|Treatment Period|Miscellaneous|8|||
33623952|NCT02151149|63024697|FG001|Treatment Period|Miscellaneous|7|||
33623953|NCT02151149|63024696|FG000|Treatment Period|Participants randomized but not treated|3|||
33623954|NCT02151149|63024697|FG001|Treatment Period|Participants randomized but not treated|2|||
33623955|NCT02151149|63024696|FG000|Follow-Up Period|Lost to Follow-up|2|||
33623956|NCT02151149|63024697|FG001|Follow-Up Period|Lost to Follow-up|3|||
33623957|NCT02151149|63024696|FG000|Follow-Up Period|Death|37|||
33623958|NCT02151149|63024697|FG001|Follow-Up Period|Death|34|||
33623959|NCT02150213|63024703|FG000|Overall Study|Lost to Follow-up|1|||
33623960|NCT02150213|63024703|FG000|Overall Study|Withdrawal by Subject|1|||
33623961|NCT02091362|63024709|FG000|Period 1|Protocol Violation|1|||
33623962|NCT02091362|63024710|FG001|Period 1|Protocol Violation|0|||
33623963|NCT02091362|63024709|FG000|Period 1|Withdrawal by Subject|2|||
33623964|NCT02091362|63024710|FG001|Period 1|Withdrawal by Subject|3|||
33623965|NCT02091362|63024709|FG000|Period 1|Lost to Follow-up|0|||
33623966|NCT02091362|63024710|FG001|Period 1|Lost to Follow-up|1|||
33623967|NCT02091362|63024709|FG000|Period 1|Adverse Event|2|||
33623968|NCT02091362|63024710|FG001|Period 1|Adverse Event|0|||
33623969|NCT02091362|63024709|FG000|Wash-out|Lost to Follow-up|1|||
33623970|NCT02091362|63024710|FG001|Wash-out|Lost to Follow-up|1|||
33623971|NCT02091362|63024709|FG000|Wash-out|Withdrawal by Subject|0|||
33623972|NCT02091362|63024710|FG001|Wash-out|Withdrawal by Subject|2|||
33623973|NCT02091362|63024709|FG000|Period 2|Adverse Event|1|||
33623974|NCT02091362|63024710|FG001|Period 2|Adverse Event|0|||
33623975|NCT02091362|63024709|FG000|Period 2|Lost to Follow-up|0|||
33623976|NCT02091362|63024710|FG001|Period 2|Lost to Follow-up|1|||
33623977|NCT02091362|63024709|FG000|Period 2|Withdrawal by Subject|1|||
33623978|NCT02091362|63024710|FG001|Period 2|Withdrawal by Subject|1|||
33623979|NCT02150057|63024722|FG000|Overall Study|Lost to Follow-up|6|||
33623980|NCT02150057|63024723|FG001|Overall Study|Lost to Follow-up|4|||
33623981|NCT02064296|63024732|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
33623982|NCT02064296|63024733|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
33623983|NCT02064296|63024734|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
33623984|NCT02064296|63024732|FG000|Intervention|Withdrawal by Subject|0|||
33623985|NCT02064296|63024733|FG001|Intervention|Withdrawal by Subject|1|||
33457664|NCT03670810|62831943|FG004|Open Label Extension|Pregnancy|0|||
33457665|NCT03670810|62831944|FG005|Open Label Extension|Pregnancy|0|||
33457666|NCT03670810|62831945|FG006|Open Label Extension|Pregnancy|0|||
33457667|NCT03670810|62831946|FG007|Open Label Extension|Pregnancy|0|||
33457668|NCT03670810|62831947|FG008|Open Label Extension|Pregnancy|3|||
33457669|NCT03670810|62831939|FG000|Open Label Extension|Adverse Event|0|||
33457670|NCT03670810|62831940|FG001|Open Label Extension|Adverse Event|0|||
33457671|NCT03670810|62831941|FG002|Open Label Extension|Adverse Event|0|||
33528102|NCT02880371|62916095|FG005|Phase 1b|Withdrawal by Subject|0|||
33528103|NCT02880371|62916096|FG006|Phase 1b|Withdrawal by Subject|0|||
33528104|NCT02880371|62916097|FG007|Phase 1b|Withdrawal by Subject|0|||
33528105|NCT02880371|62916090|FG000|Phase 1b|Death|4|||
33528106|NCT02880371|62916091|FG001|Phase 1b|Death|6|||
33528107|NCT02880371|62916092|FG002|Phase 1b|Death|5|||
33528108|NCT02880371|62916093|FG003|Phase 1b|Death|1|||
33528109|NCT02880371|62916094|FG004|Phase 1b|Death|0|||
33623986|NCT02064296|63024734|FG002|Intervention|Withdrawal by Subject|2|||
33623987|NCT02063984|63024746|FG000|Overall Study|Lost to Follow-up|6|||
33623988|NCT02063984|63024747|FG001|Overall Study|Lost to Follow-up|5|||
33623989|NCT02091284|63024759|FG000|Overall Study|Withdrawal by Subject|2|||
33623990|NCT02091284|63024760|FG001|Overall Study|Withdrawal by Subject|1|||
33623991|NCT02091284|63024759|FG000|Overall Study|unreliable data|1|||
33623992|NCT02091284|63024760|FG001|Overall Study|unreliable data|0|||
33623993|NCT02115386|63024768|FG000|Overall Study|Protocol Violation|1|||
33623994|NCT02115386|63024768|FG000|Overall Study|Administrative - trial was terminated|6|||
33623995|NCT02091206|63024776|FG000|Treatment Period|Adverse Event|0|||
33623996|NCT02091206|63024777|FG001|Treatment Period|Adverse Event|1|||
33623997|NCT02091206|63024778|FG002|Treatment Period|Adverse Event|0|||
33623998|NCT02091206|63024779|FG003|Treatment Period|Adverse Event|0|||
33623999|NCT02091206|63024776|FG000|Treatment Period|Met withdrawal criteria|0|||
33624000|NCT02091206|63024777|FG001|Treatment Period|Met withdrawal criteria|0|||
33624001|NCT02091206|63024778|FG002|Treatment Period|Met withdrawal criteria|1|||
33624002|NCT02091206|63024779|FG003|Treatment Period|Met withdrawal criteria|0|||
33624003|NCT02091206|63024776|FG000|Taper Period|Participant refused study drug|1|||
33624004|NCT02091206|63024777|FG001|Taper Period|Participant refused study drug|0|||
33624005|NCT02091206|63024778|FG002|Taper Period|Participant refused study drug|0|||
33624006|NCT02091206|63024779|FG003|Taper Period|Participant refused study drug|1|||
33624007|NCT02091206|63024776|FG000|Taper Period|Lost to Follow-up|0|||
33624008|NCT02091206|63024777|FG001|Taper Period|Lost to Follow-up|0|||
33624009|NCT02091206|63024778|FG002|Taper Period|Lost to Follow-up|0|||
33624010|NCT02091206|63024779|FG003|Taper Period|Lost to Follow-up|1|||
33624011|NCT02090426|63024791|FG000|Overall Study|Lost to Follow-up|12|||
33624012|NCT02090426|63024792|FG001|Overall Study|Lost to Follow-up|6|||
33624013|NCT02063828|63024801|FG000|Overall Study|Withdrawal by Subject|4|||
33624014|NCT02063828|63024802|FG001|Overall Study|Withdrawal by Subject|6|||
33624015|NCT02063828|63024803|FG002|Overall Study|Withdrawal by Subject|3|||
33457672|NCT03670810|62831942|FG003|Open Label Extension|Adverse Event|0|||
33457673|NCT03670810|62831943|FG004|Open Label Extension|Adverse Event|0|||
33528110|NCT02880371|62916095|FG005|Phase 1b|Death|0|||
33528111|NCT02880371|62916096|FG006|Phase 1b|Death|0|||
33528112|NCT02880371|62916097|FG007|Phase 1b|Death|0|||
33528113|NCT02880371|62916090|FG000|Phase 1b|Enrolled but not Treated|0|||
33624016|NCT02063828|63024801|FG000|Overall Study|Death|0|||
33624017|NCT02063828|63024802|FG001|Overall Study|Death|0|||
33624018|NCT02063828|63024803|FG002|Overall Study|Death|1|||
33624019|NCT02063672|63024813|FG000|Overall Study|Ongoing Follow-up|27|||
33624020|NCT02063672|63024814|FG001|Overall Study|Ongoing Follow-up|14|||
33624021|NCT02063672|63024813|FG000|Overall Study|Death|5|||
33624022|NCT02063672|63024814|FG001|Overall Study|Death|3|||
33624023|NCT02063672|63024813|FG000|Overall Study|Lost to Follow-up|1|||
33624024|NCT02063672|63024814|FG001|Overall Study|Lost to Follow-up|3|||
33624025|NCT02063672|63024813|FG000|Overall Study|Withdrawal by Subject|2|||
33624026|NCT02063672|63024814|FG001|Overall Study|Withdrawal by Subject|2|||
33624027|NCT02062658|63024820|FG000|Overall Study|Withdrawal by Subject|1|||
33624028|NCT02062658|63024820|FG000|Overall Study|Lack of Efficacy|1|||
33624029|NCT02115308|63024826|FG000|Overall Study|Safety Screening|2|||
33624030|NCT02115308|63024827|FG001|Overall Study|Safety Screening|2|||
33624031|NCT02114684|63024839|FG000|Overall Study|Death|6|||
33624032|NCT02114684|63024840|FG001|Overall Study|Death|4|||
33624033|NCT02114684|63024839|FG000|Overall Study|Lost to Follow-up|1|||
33624034|NCT02114684|63024840|FG001|Overall Study|Lost to Follow-up|2|||
33624035|NCT02114684|63024839|FG000|Overall Study|Withdrawal by Subject|1|||
33624036|NCT02114684|63024840|FG001|Overall Study|Withdrawal by Subject|2|||
33624037|NCT02114684|63024839|FG000|Overall Study|Relocation|3|||
33624038|NCT02114684|63024840|FG001|Overall Study|Relocation|1|||
33624039|NCT02114684|63024839|FG000|Overall Study|Rifampicin resistant on culture|0|||
33624040|NCT02114684|63024840|FG001|Overall Study|Rifampicin resistant on culture|1|||
33624041|NCT02114684|63024839|FG000|Overall Study|Patient Incarcerated|1|||
33624042|NCT02114684|63024840|FG001|Overall Study|Patient Incarcerated|0|||
33624043|NCT02090114|63024854|FG000|Overall Study|Withdrawal by Subject|3|||
33624044|NCT02090114|63024855|FG001|Overall Study|Withdrawal by Subject|6|||
33624045|NCT02090114|63024856|FG002|Overall Study|Withdrawal by Subject|2|||
33624046|NCT02090114|63024857|FG003|Overall Study|Withdrawal by Subject|1|||
33624047|NCT02090114|63024854|FG000|Overall Study|Physician Decision|5|||
33624048|NCT02090114|63024855|FG001|Overall Study|Physician Decision|0|||
33624049|NCT02090114|63024856|FG002|Overall Study|Physician Decision|1|||
33624050|NCT02090114|63024857|FG003|Overall Study|Physician Decision|1|||
33624051|NCT02090114|63024854|FG000|Overall Study|Adverse Event|1|||
33624052|NCT02090114|63024855|FG001|Overall Study|Adverse Event|2|||
33624053|NCT02090114|63024856|FG002|Overall Study|Adverse Event|2|||
33624054|NCT02090114|63024857|FG003|Overall Study|Adverse Event|0|||
33624055|NCT02090114|63024854|FG000|Overall Study|Progressive Disease|20|||
33624056|NCT02090114|63024855|FG001|Overall Study|Progressive Disease|21|||
33624057|NCT02090114|63024856|FG002|Overall Study|Progressive Disease|23|||
33624058|NCT02090114|63024857|FG003|Overall Study|Progressive Disease|6|||
33624059|NCT02090114|63024854|FG000|Overall Study|Death|1|||
33624060|NCT02090114|63024855|FG001|Overall Study|Death|0|||
33624061|NCT02090114|63024856|FG002|Overall Study|Death|1|||
33624062|NCT02090114|63024857|FG003|Overall Study|Death|0|||
33624063|NCT01623050|63024867|FG000|Overall Study|Lost to Follow-up|9|||
33624064|NCT02089334|63024875|FG000|Overall Study|Withdrawal by Subject|0|||
33624065|NCT02089334|63024876|FG001|Overall Study|Withdrawal by Subject|0|||
33624066|NCT02089334|63024877|FG002|Overall Study|Withdrawal by Subject|0|||
33624067|NCT02089334|63024878|FG003|Overall Study|Withdrawal by Subject|2|||
33624068|NCT02089334|63024875|FG000|Overall Study|Adverse Event|0|||
33624069|NCT02089334|63024876|FG001|Overall Study|Adverse Event|0|||
33624070|NCT02089334|63024877|FG002|Overall Study|Adverse Event|0|||
33624071|NCT02089334|63024878|FG003|Overall Study|Adverse Event|2|||
33624072|NCT02089334|63024875|FG000|Overall Study|Progressive disease|0|||
33624073|NCT02089334|63024876|FG001|Overall Study|Progressive disease|0|||
33624074|NCT02089334|63024877|FG002|Overall Study|Progressive disease|0|||
33624075|NCT02089334|63024878|FG003|Overall Study|Progressive disease|2|||
33624076|NCT02089334|63024875|FG000|Overall Study|Physician Decision|0|||
33624077|NCT02089334|63024876|FG001|Overall Study|Physician Decision|0|||
33624078|NCT02089334|63024877|FG002|Overall Study|Physician Decision|1|||
33624079|NCT02089334|63024878|FG003|Overall Study|Physician Decision|1|||
33624080|NCT02114606|63024891|FG000|Overall Study|Unable to swallow Cytosponge|6|||
33624081|NCT02113436|63024897|FG000|Period 1: 8 Weeks|Adverse Event|1|||
33624082|NCT02113436|63024898|FG001|Period 1: 8 Weeks|Adverse Event|0|||
33624083|NCT02113436|63024899|FG002|Period 1: 8 Weeks|Adverse Event|0|||
33624084|NCT02113436|63024900|FG003|Period 1: 8 Weeks|Adverse Event|0|||
33624085|NCT02113436|63024897|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
33624086|NCT02113436|63024898|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
33624087|NCT02113436|63024899|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
33624088|NCT02113436|63024900|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
33624089|NCT02113436|63024897|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
33624090|NCT02113436|63024898|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
33624091|NCT02113436|63024899|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
33624092|NCT02113436|63024900|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
33624093|NCT02113436|63024897|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
33624094|NCT02113436|63024898|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
33624095|NCT02113436|63024899|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
33624096|NCT02113436|63024900|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
33624097|NCT02113436|63024897|FG000|Period 2: 16 Weeks|Adverse Event|0|||
33624098|NCT02113436|63024898|FG001|Period 2: 16 Weeks|Adverse Event|0|||
33624099|NCT02113436|63024899|FG002|Period 2: 16 Weeks|Adverse Event|4|||
33624100|NCT02113436|63024900|FG003|Period 2: 16 Weeks|Adverse Event|5|||
33624101|NCT02113436|63024897|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
33624102|NCT02113436|63024898|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
33624103|NCT02113436|63024899|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
33624104|NCT02113436|63024900|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
33624105|NCT02113436|63024897|FG000|Period 2: 16 Weeks|Physician Decision|0|||
33624106|NCT02113436|63024898|FG001|Period 2: 16 Weeks|Physician Decision|0|||
33624107|NCT02113436|63024899|FG002|Period 2: 16 Weeks|Physician Decision|2|||
33624108|NCT02113436|63024900|FG003|Period 2: 16 Weeks|Physician Decision|0|||
33624109|NCT02113436|63024897|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
33624110|NCT02113436|63024898|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
33624111|NCT02113436|63024899|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
33624112|NCT02113436|63024900|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
33624113|NCT02113124|63024911|FG000|Overall Study|Unable to retrieve blood sample|1|||
33624114|NCT02113124|63024912|FG001|Overall Study|Unable to retrieve blood sample|1|||
33624115|NCT02087774|63024920|FG000|Overall Study|Were absent day of data collection|8|||
33624116|NCT02087774|63024921|FG001|Overall Study|Were absent day of data collection|20|||
33624117|NCT02111564|63024929|FG000|Overall Study|Death|109|||
33624118|NCT02111564|63024930|FG001|Overall Study|Death|120|||
33624119|NCT02111564|63024929|FG000|Overall Study|Lost to Follow-up|2|||
33624120|NCT02111564|63024930|FG001|Overall Study|Lost to Follow-up|3|||
33624121|NCT02111564|63024929|FG000|Overall Study|Withdrawal by Subject|20|||
33624122|NCT02111564|63024930|FG001|Overall Study|Withdrawal by Subject|20|||
33624123|NCT02087150|63024939|FG000|Overall Study|Death|0|||
33624124|NCT02087150|63024940|FG001|Overall Study|Death|1|||
33624125|NCT02087150|63024941|FG002|Overall Study|Death|0|||
33624126|NCT02087150|63024939|FG000|Overall Study|Lost to Follow-up|6|||
33624127|NCT02087150|63024940|FG001|Overall Study|Lost to Follow-up|13|||
33624128|NCT02087150|63024941|FG002|Overall Study|Lost to Follow-up|7|||
33624129|NCT02087150|63024939|FG000|Overall Study|Withdrawal by Subject|2|||
33624130|NCT02087150|63024940|FG001|Overall Study|Withdrawal by Subject|5|||
33624131|NCT02087150|63024941|FG002|Overall Study|Withdrawal by Subject|3|||
33624132|NCT02087150|63024939|FG000|Overall Study|Physician Decision|0|||
33624133|NCT02087150|63024940|FG001|Overall Study|Physician Decision|1|||
33624134|NCT02087150|63024941|FG002|Overall Study|Physician Decision|0|||
33624135|NCT02087150|63024939|FG000|Overall Study|Procedure not done|1|||
33624136|NCT02087150|63024940|FG001|Overall Study|Procedure not done|13|||
33624137|NCT02087150|63024941|FG002|Overall Study|Procedure not done|0|||
33624138|NCT02087150|63024939|FG000|Overall Study|F/U not completed w/in study window|0|||
33624139|NCT02087150|63024940|FG001|Overall Study|F/U not completed w/in study window|0|||
33624140|NCT02087150|63024941|FG002|Overall Study|F/U not completed w/in study window|1|||
33624141|NCT02087150|63024939|FG000|Overall Study|Other|1|||
33624142|NCT02087150|63024940|FG001|Overall Study|Other|0|||
33624143|NCT02087150|63024941|FG002|Overall Study|Other|0|||
33624144|NCT02087150|63024939|FG000|Overall Study|Pt moved out of town|0|||
33624145|NCT02087150|63024940|FG001|Overall Study|Pt moved out of town|1|||
33624146|NCT02087150|63024941|FG002|Overall Study|Pt moved out of town|0|||
33624147|NCT02111174|63024952|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
33624148|NCT02111174|63024953|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
33624149|NCT02111174|63024952|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
33624150|NCT02111174|63024953|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
33624151|NCT02111174|63024952|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
33624152|NCT02111174|63024953|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
33624153|NCT02111174|63024952|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
33624154|NCT02111174|63024953|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
33624155|NCT02111096|63024962|FG000|Overall Study|Adverse Event|4|||
33624156|NCT02111096|63024963|FG001|Overall Study|Adverse Event|1|||
33624157|NCT02111096|63024964|FG002|Overall Study|Adverse Event|2|||
33624158|NCT02111096|63024962|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33624159|NCT02111096|63024963|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33624160|NCT02111096|63024964|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33624161|NCT02111096|63024962|FG000|Overall Study|Lost to Follow Up|1|||
33624162|NCT02111096|63024963|FG001|Overall Study|Lost to Follow Up|1|||
33528114|NCT02880371|62916091|FG001|Phase 1b|Enrolled but not Treated|1|||
33528115|NCT02880371|62916092|FG002|Phase 1b|Enrolled but not Treated|0|||
33624163|NCT02111096|63024964|FG002|Overall Study|Lost to Follow Up|1|||
33624164|NCT02111096|63024962|FG000|Overall Study|Physician Decision|0|||
33624165|NCT02111096|63024963|FG001|Overall Study|Physician Decision|1|||
33624166|NCT02111096|63024964|FG002|Overall Study|Physician Decision|0|||
33624167|NCT02111096|63024962|FG000|Overall Study|Protocol Violation|1|||
33624168|NCT02111096|63024963|FG001|Overall Study|Protocol Violation|0|||
33624169|NCT02111096|63024964|FG002|Overall Study|Protocol Violation|1|||
33624170|NCT02111096|63024962|FG000|Overall Study|Terminated by Sponsor|53|||
33624171|NCT02111096|63024963|FG001|Overall Study|Terminated by Sponsor|35|||
33528116|NCT02880371|62916093|FG003|Phase 1b|Enrolled but not Treated|0|||
33624172|NCT02111096|63024964|FG002|Overall Study|Terminated by Sponsor|54|||
33624173|NCT02111096|63024962|FG000|Overall Study|Withdrawal by Subject|4|||
33624174|NCT02111096|63024963|FG001|Overall Study|Withdrawal by Subject|2|||
33624175|NCT02111096|63024964|FG002|Overall Study|Withdrawal by Subject|8|||
33624176|NCT02110706|63024977|FG000|Overall Study|Adverse Event|2|||
33624177|NCT02110706|63024978|FG001|Overall Study|Adverse Event|3|||
33624178|NCT02110706|63024977|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
33624179|NCT02110706|63024978|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
33624180|NCT02110238|63024988|FG000|12 Week Pivotal Phase|Adverse Event|3|||
33624181|NCT02110238|63024989|FG001|12 Week Pivotal Phase|Adverse Event|0|||
33624182|NCT02110238|63024988|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
33624183|NCT02110238|63024989|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
33624184|NCT02110238|63024988|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
33624185|NCT02110238|63024989|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
33624186|NCT02110238|63024988|FG000|12 Week Pivotal Phase|Physician Decision|0|||
33624187|NCT02110238|63024989|FG001|12 Week Pivotal Phase|Physician Decision|2|||
33624188|NCT02110238|63024988|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
33624189|NCT02110238|63024989|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
33624190|NCT02110238|63024988|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
33624191|NCT02110238|63024989|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
33624192|NCT02110238|63024988|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
33624193|NCT02110238|63024989|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
33624194|NCT02110238|63024988|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
33624195|NCT02110238|63024989|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
33624196|NCT02110238|63024988|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
33624197|NCT02110238|63024989|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
33624198|NCT02110238|63024988|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
33624199|NCT02110238|63024989|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
33624200|NCT02110238|63024988|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
33624201|NCT02110238|63024989|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
33624202|NCT02108912|63024997|FG000|Overall Study|Lost to Follow-up|1|||
33624203|NCT02108912|63024998|FG001|Overall Study|Lost to Follow-up|1|||
33624204|NCT02108912|63024997|FG000|Overall Study|lack of transportation|1|||
33624205|NCT02108912|63024998|FG001|Overall Study|lack of transportation|0|||
33624206|NCT02108912|63024997|FG000|Overall Study|high blood pressure|1|||
33624207|NCT02108912|63024998|FG001|Overall Study|high blood pressure|0|||
33624208|NCT02108600|63025006|FG000|Overall Study|Withdrawal by Subject|2|||
33624209|NCT02108600|63025007|FG001|Overall Study|Withdrawal by Subject|0|||
33624210|NCT02108600|63025006|FG000|Overall Study|Lost to Follow-up|1|||
33624211|NCT02108600|63025007|FG001|Overall Study|Lost to Follow-up|1|||
33624212|NCT02107898|63025015|FG000|Overall Study|Adverse Event|4|||
33624213|NCT02107898|63025016|FG001|Overall Study|Adverse Event|7|||
33624214|NCT02107898|63025015|FG000|Overall Study|Poor compliance to protocol|0|||
33624215|NCT02107898|63025016|FG001|Overall Study|Poor compliance to protocol|1|||
33624216|NCT02107898|63025015|FG000|Overall Study|Participant moved|0|||
33624217|NCT02107898|63025016|FG001|Overall Study|Participant moved|2|||
33624218|NCT02107898|63025015|FG000|Overall Study|Consent withdrawn by participant|2|||
33624219|NCT02107898|63025016|FG001|Overall Study|Consent withdrawn by participant|1|||
33624220|NCT02107898|63025015|FG000|Overall Study|Randomized but not treated|0|||
33624221|NCT02107898|63025016|FG001|Overall Study|Randomized but not treated|1|||
33624222|NCT02059148|63025022|FG000|Treatment 1|Protocol Violation|0|||
33624223|NCT02059148|63025023|FG001|Treatment 1|Protocol Violation|0|||
33624224|NCT02059148|63025024|FG002|Treatment 1|Protocol Violation|0|||
33624225|NCT02059148|63025025|FG003|Treatment 1|Protocol Violation|0|||
33624226|NCT02059148|63025026|FG004|Treatment 1|Protocol Violation|0|||
33624227|NCT02059148|63025027|FG005|Treatment 1|Protocol Violation|1|||
33624228|NCT02058992|63025038|FG000|Overall Study|Lost to Follow-up|4|||
33624229|NCT02058992|63025038|FG000|Overall Study|Protocol Violation|92|||
33624230|NCT02058992|63025038|FG000|Overall Study|CRF Uncollected|20|||
33624231|NCT02058836|63025044|FG000|Overall Study|Withdrawal by Subject|1|||
33624232|NCT02058836|63025045|FG001|Overall Study|Withdrawal by Subject|1|||
33624233|NCT02107274|63025053|FG000|Treatment vs. Placebo|Adverse Event|3|||
33457674|NCT03670810|62831944|FG005|Open Label Extension|Adverse Event|0|||
33457675|NCT03670810|62831945|FG006|Open Label Extension|Adverse Event|0|||
33624234|NCT02107274|63025054|FG001|Treatment vs. Placebo|Adverse Event|0|||
33624235|NCT02107274|63025053|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
33624236|NCT02107274|63025054|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
33457676|NCT03670810|62831946|FG007|Open Label Extension|Adverse Event|0|||
33457677|NCT03670810|62831947|FG008|Open Label Extension|Adverse Event|24|||
33624237|NCT02107274|63025053|FG000|Control Phase|Lost to Follow-up|1|||
33624238|NCT02107274|63025054|FG001|Control Phase|Lost to Follow-up|1|||
33624239|NCT02107274|63025053|FG000|Control Phase|Death|2|||
33624240|NCT02107274|63025054|FG001|Control Phase|Death|0|||
33624241|NCT02107274|63025053|FG000|Control Phase|Adverse Event|0|||
33624242|NCT02107274|63025054|FG001|Control Phase|Adverse Event|1|||
33624243|NCT02174627|63025062|FG000|Overall Study|Missing|0|||
33624244|NCT02174627|63025063|FG001|Overall Study|Missing|1|||
33624245|NCT02174627|63025062|FG000|Overall Study|Incorrect enrolment before randomization|0|||
33624246|NCT02174627|63025063|FG001|Overall Study|Incorrect enrolment before randomization|1|||
33624247|NCT02174627|63025062|FG000|Overall Study|Participant decision|84|||
33624248|NCT02174627|63025063|FG001|Overall Study|Participant decision|128|||
33624249|NCT02173769|63025069|FG000|Overall Study|Protocol Violation|4|||
33624250|NCT02121509|63025076|FG000|Washout Period (35 Days)|Adverse Event|1|||
33624251|NCT02121509|63025077|FG001|Washout Period (35 Days)|Adverse Event|1|||
33624252|NCT02121509|63025078|FG002|Washout Period (35 Days)|Adverse Event|0|||
33624253|NCT02121509|63025079|FG003|Washout Period (35 Days)|Adverse Event|0|||
33624254|NCT02121509|63025076|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
33624255|NCT02121509|63025077|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
33624256|NCT02121509|63025078|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
33624257|NCT02121509|63025079|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
33624258|NCT02121509|63025076|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
33624259|NCT02121509|63025077|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
33624260|NCT02121509|63025078|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
33624261|NCT02121509|63025079|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
33624262|NCT02149199|63025092|FG000|Overall Study|Study specific withdrawal criteria|4|||
33624263|NCT02149199|63025093|FG001|Overall Study|Study specific withdrawal criteria|21|||
33624264|NCT02149199|63025094|FG002|Overall Study|Study specific withdrawal criteria|6|||
33624265|NCT02149199|63025092|FG000|Overall Study|Other|20|||
33624266|NCT02149199|63025093|FG001|Overall Study|Other|25|||
33624267|NCT02149199|63025094|FG002|Overall Study|Other|20|||
33624268|NCT02149199|63025092|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
33624269|NCT02149199|63025093|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
33624270|NCT02149199|63025094|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
33624271|NCT02149199|63025092|FG000|Overall Study|Withdrawal by Subject|75|||
33624272|NCT02149199|63025093|FG001|Overall Study|Withdrawal by Subject|93|||
33624273|NCT02149199|63025094|FG002|Overall Study|Withdrawal by Subject|77|||
33528117|NCT02880371|62916094|FG004|Phase 1b|Enrolled but not Treated|0|||
33528118|NCT02880371|62916095|FG005|Phase 1b|Enrolled but not Treated|0|||
33528119|NCT02880371|62916096|FG006|Phase 1b|Enrolled but not Treated|0|||
33528120|NCT02880371|62916097|FG007|Phase 1b|Enrolled but not Treated|0|||
33528121|NCT02880371|62916090|FG000|Phase 2|Enrolled but not Treated|0|||
33528122|NCT02880371|62916091|FG001|Phase 2|Enrolled but not Treated|0|||
33528123|NCT02880371|62916092|FG002|Phase 2|Enrolled but not Treated|0|||
33528124|NCT02880371|62916093|FG003|Phase 2|Enrolled but not Treated|0|||
33528125|NCT02880371|62916094|FG004|Phase 2|Enrolled but not Treated|0|||
33528126|NCT02880371|62916095|FG005|Phase 2|Enrolled but not Treated|1|||
33528127|NCT02880371|62916096|FG006|Phase 2|Enrolled but not Treated|1|||
33528128|NCT02880371|62916097|FG007|Phase 2|Enrolled but not Treated|0|||
33528129|NCT02880371|62916090|FG000|Phase 2|Other|0|||
33528130|NCT02880371|62916091|FG001|Phase 2|Other|0|||
33528131|NCT02880371|62916092|FG002|Phase 2|Other|0|||
33528132|NCT02880371|62916093|FG003|Phase 2|Other|0|||
33528133|NCT02880371|62916094|FG004|Phase 2|Other|0|||
33528134|NCT02880371|62916095|FG005|Phase 2|Other|1|||
33528135|NCT02880371|62916096|FG006|Phase 2|Other|2|||
33528136|NCT02880371|62916097|FG007|Phase 2|Other|1|||
33528137|NCT02880371|62916090|FG000|Phase 2|Participants terminated by Sponsor|0|||
33528138|NCT02880371|62916091|FG001|Phase 2|Participants terminated by Sponsor|0|||
33528139|NCT02880371|62916092|FG002|Phase 2|Participants terminated by Sponsor|0|||
33528140|NCT02880371|62916093|FG003|Phase 2|Participants terminated by Sponsor|0|||
33528141|NCT02880371|62916094|FG004|Phase 2|Participants terminated by Sponsor|1|||
33528142|NCT02880371|62916095|FG005|Phase 2|Participants terminated by Sponsor|6|||
33528143|NCT02880371|62916096|FG006|Phase 2|Participants terminated by Sponsor|1|||
33528144|NCT02880371|62916097|FG007|Phase 2|Participants terminated by Sponsor|5|||
33528145|NCT02880371|62916090|FG000|Phase 2|Death|0|||
33528146|NCT02880371|62916091|FG001|Phase 2|Death|0|||
33528147|NCT02880371|62916092|FG002|Phase 2|Death|0|||
33528148|NCT02880371|62916093|FG003|Phase 2|Death|0|||
33528149|NCT02880371|62916094|FG004|Phase 2|Death|1|||
33528150|NCT02880371|62916095|FG005|Phase 2|Death|10|||
33528151|NCT02880371|62916096|FG006|Phase 2|Death|20|||
33528152|NCT02880371|62916097|FG007|Phase 2|Death|5|||
33528153|NCT02880371|62916090|FG000|Phase 2|Lost to Follow-up|0|||
33528154|NCT02880371|62916091|FG001|Phase 2|Lost to Follow-up|0|||
33528155|NCT02880371|62916092|FG002|Phase 2|Lost to Follow-up|0|||
33528156|NCT02880371|62916093|FG003|Phase 2|Lost to Follow-up|0|||
33528157|NCT02880371|62916094|FG004|Phase 2|Lost to Follow-up|0|||
33624274|NCT02149199|63025092|FG000|Overall Study|Protocol Violation|16|||
33528158|NCT02880371|62916095|FG005|Phase 2|Lost to Follow-up|0|||
33528159|NCT02880371|62916096|FG006|Phase 2|Lost to Follow-up|3|||
33528160|NCT02880371|62916097|FG007|Phase 2|Lost to Follow-up|0|||
33528161|NCT02880371|62916090|FG000|Phase 2|Withdrawal by Subject|0|||
33624275|NCT02149199|63025093|FG001|Overall Study|Protocol Violation|13|||
33624276|NCT02149199|63025094|FG002|Overall Study|Protocol Violation|15|||
33624277|NCT02149199|63025092|FG000|Overall Study|Lost to Follow-up|3|||
33624278|NCT02149199|63025093|FG001|Overall Study|Lost to Follow-up|12|||
33624279|NCT02149199|63025094|FG002|Overall Study|Lost to Follow-up|11|||
33624280|NCT02149199|63025092|FG000|Overall Study|Death|0|||
33624281|NCT02149199|63025093|FG001|Overall Study|Death|0|||
33624282|NCT02149199|63025094|FG002|Overall Study|Death|1|||
33624283|NCT02149199|63025092|FG000|Overall Study|Adverse Event|6|||
33624284|NCT02149199|63025093|FG001|Overall Study|Adverse Event|15|||
33624285|NCT02149199|63025094|FG002|Overall Study|Adverse Event|9|||
33624286|NCT02120417|63025104|FG000|Overall Study|Death|5|||
33624287|NCT02120417|63025105|FG001|Overall Study|Death|1|||
33624288|NCT02120417|63025104|FG000|Overall Study|Adverse Event|3|||
33624289|NCT02120417|63025105|FG001|Overall Study|Adverse Event|9|||
33624290|NCT02120417|63025104|FG000|Overall Study|Participant decision|4|||
33624291|NCT02120417|63025105|FG001|Overall Study|Participant decision|4|||
33624292|NCT02120417|63025104|FG000|Overall Study|Disease progression|41|||
33624293|NCT02120417|63025105|FG001|Overall Study|Disease progression|45|||
33624294|NCT02120417|63025104|FG000|Overall Study|Noncompliance with study treatment|0|||
33624295|NCT02120417|63025105|FG001|Overall Study|Noncompliance with study treatment|2|||
33624296|NCT02120417|63025104|FG000|Overall Study|Physician Decision|2|||
33624297|NCT02120417|63025105|FG001|Overall Study|Physician Decision|3|||
33624298|NCT02120417|63025104|FG000|Overall Study|Other unspecified|5|||
33624299|NCT02120417|63025105|FG001|Overall Study|Other unspecified|4|||
33624300|NCT02148263|63025113|FG000|Overall Study|Withdrawal by Subject|3|||
33624301|NCT02148263|63025114|FG001|Overall Study|Withdrawal by Subject|2|||
33624302|NCT02147561|63025120|FG000|Overall Study|Lost to Follow-up|3|||
33624303|NCT02147561|63025120|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
33624304|NCT02058368|63025126|FG000|Overall Study|Adverse Event|15|||
33624305|NCT02058368|63025127|FG001|Overall Study|Adverse Event|20|||
33624306|NCT02058368|63025126|FG000|Overall Study|Lack of Efficacy|0|||
33624307|NCT02058368|63025127|FG001|Overall Study|Lack of Efficacy|1|||
33624308|NCT02058368|63025126|FG000|Overall Study|Protocol Violation|0|||
33624309|NCT02058368|63025127|FG001|Overall Study|Protocol Violation|4|||
33624310|NCT02058368|63025126|FG000|Overall Study|Lost to Follow-up|2|||
33624311|NCT02058368|63025127|FG001|Overall Study|Lost to Follow-up|0|||
33624312|NCT02058368|63025126|FG000|Overall Study|Physician Decision|2|||
33624313|NCT02058368|63025127|FG001|Overall Study|Physician Decision|3|||
33624314|NCT02058368|63025126|FG000|Overall Study|Withdrawal by Subject|22|||
33624315|NCT02058368|63025127|FG001|Overall Study|Withdrawal by Subject|26|||
33624316|NCT02107196|63025135|FG000|12-week Treatment Period|Adverse Event|6|||
33624317|NCT02107196|63025136|FG001|12-week Treatment Period|Adverse Event|3|||
33624318|NCT02107196|63025135|FG000|12-week Treatment Period|Lack of Efficacy|2|||
33624319|NCT02107196|63025136|FG001|12-week Treatment Period|Lack of Efficacy|1|||
33624320|NCT02107196|63025135|FG000|12-week Treatment Period|Lost to Follow-up|3|||
33624321|NCT02107196|63025136|FG001|12-week Treatment Period|Lost to Follow-up|6|||
33624322|NCT02107196|63025135|FG000|12-week Treatment Period|Physician Decision|0|||
33624323|NCT02107196|63025136|FG001|12-week Treatment Period|Physician Decision|1|||
33624324|NCT02107196|63025135|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
33624325|NCT02107196|63025136|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
33624326|NCT02107196|63025135|FG000|12-week Treatment Period|Protocol Violation|7|||
33624327|NCT02107196|63025136|FG001|12-week Treatment Period|Protocol Violation|8|||
33624328|NCT02107196|63025135|FG000|12-week Treatment Period|Reason Missing|11|||
33624329|NCT02107196|63025136|FG001|12-week Treatment Period|Reason Missing|8|||
33624330|NCT02107196|63025135|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
33624331|NCT02107196|63025136|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
33624332|NCT02107196|63025135|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
33624333|NCT02107196|63025136|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
33624334|NCT02107196|63025135|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
33624335|NCT02107196|63025136|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
33624336|NCT02107196|63025135|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
33624337|NCT02107196|63025136|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
33624338|NCT02058290|63025144|FG000|Overall Study|Protocol Violation|2|||
33624339|NCT02058290|63025145|FG001|Overall Study|Protocol Violation|1|||
33624340|NCT02058290|63025144|FG000|Overall Study|Physician Decision|1|||
33624341|NCT02058290|63025145|FG001|Overall Study|Physician Decision|0|||
33624342|NCT02058290|63025144|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
33624343|NCT02058290|63025145|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
33624344|NCT02058290|63025144|FG000|Overall Study|Withdrawal by Subject|0|||
33624345|NCT02058290|63025145|FG001|Overall Study|Withdrawal by Subject|1|||
33624346|NCT02082158|63025157|FG000|Overall Study|Withdrawal by Subject|0|||
33624347|NCT02082158|63025158|FG001|Overall Study|Withdrawal by Subject|0|||
33624348|NCT02082158|63025159|FG002|Overall Study|Withdrawal by Subject|0|||
33624349|NCT02082158|63025160|FG003|Overall Study|Withdrawal by Subject|0|||
33624350|NCT02082158|63025161|FG004|Overall Study|Withdrawal by Subject|1|||
33624351|NCT02082158|63025162|FG005|Overall Study|Withdrawal by Subject|0|||
33624352|NCT02082158|63025157|FG000|Overall Study|Failed Fit-testing|8|||
33624353|NCT02082158|63025158|FG001|Overall Study|Failed Fit-testing|8|||
33624354|NCT02082158|63025159|FG002|Overall Study|Failed Fit-testing|14|||
33624355|NCT02082158|63025160|FG003|Overall Study|Failed Fit-testing|4|||
33624356|NCT02082158|63025161|FG004|Overall Study|Failed Fit-testing|3|||
33624357|NCT02082158|63025162|FG005|Overall Study|Failed Fit-testing|7|||
33624358|NCT02106884|63025184|FG000|Overall Study|Change of diagnosis/exclusion|0|||
33624359|NCT02106884|63025185|FG001|Overall Study|Change of diagnosis/exclusion|1|||
33624360|NCT02081846|63025196|FG000|Overall Study|Withdrawal by Subject|1|||
33624361|NCT02081846|63025197|FG001|Overall Study|Withdrawal by Subject|0|||
33624362|NCT02081846|63025196|FG000|Overall Study|invalid consent|1|||
33624363|NCT02081846|63025197|FG001|Overall Study|invalid consent|0|||
33624364|NCT02081690|63025203|FG000|Overall Study|Death|3|||
33624365|NCT02081690|63025203|FG000|Overall Study|Physician Decision|3|||
33624366|NCT02081690|63025203|FG000|Overall Study|Withdrawal by Subject|1|||
33624367|NCT02057666|63025209|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
33624368|NCT02057666|63025210|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
33624369|NCT02057666|63025209|FG000|Double Blind Treatment Period|Poor tolerability|7|||
33624370|NCT02057666|63025210|FG001|Double Blind Treatment Period|Poor tolerability|2|||
33624371|NCT02057666|63025209|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
33624372|NCT02057666|63025210|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
33624373|NCT02057666|63025209|FG000|Double Blind Treatment Period|Physician Decision|1|||
33624374|NCT02057666|63025210|FG001|Double Blind Treatment Period|Physician Decision|0|||
33624375|NCT02057666|63025209|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
33624376|NCT02057666|63025210|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
33624377|NCT02057666|63025209|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
33624378|NCT02057666|63025210|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
33624379|NCT02057666|63025209|FG000|Double Blind Treatment Period|Sponsor's request|70|||
33624380|NCT02057666|63025210|FG001|Double Blind Treatment Period|Sponsor's request|34|||
33624381|NCT02057666|63025209|FG000|Open-Label Treatment Period|Poor tolerability|0|||
33624382|NCT02057666|63025210|FG001|Open-Label Treatment Period|Poor tolerability|1|||
33624383|NCT02057666|63025209|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
33624384|NCT02057666|63025210|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
33624385|NCT02057666|63025209|FG000|Open-Label Treatment Period|Sponsor's request|0|||
33624386|NCT02057666|63025210|FG001|Open-Label Treatment Period|Sponsor's request|4|||
33624387|NCT01625000|63025221|FG000|Overall Study|Physician Decision|15|||
33624388|NCT01625000|63025222|FG001|Overall Study|Physician Decision|7|||
33624389|NCT01625000|63025223|FG002|Overall Study|Physician Decision|7|||
33624390|NCT01625000|63025224|FG003|Overall Study|Physician Decision|2|||
33624391|NCT01625000|63025225|FG004|Overall Study|Physician Decision|15|||
33624392|NCT01625000|63025221|FG000|Overall Study|Protocol Violation|3|||
33624393|NCT01625000|63025222|FG001|Overall Study|Protocol Violation|10|||
33624394|NCT01625000|63025223|FG002|Overall Study|Protocol Violation|4|||
33624395|NCT01625000|63025224|FG003|Overall Study|Protocol Violation|1|||
33624396|NCT01625000|63025225|FG004|Overall Study|Protocol Violation|2|||
33624397|NCT01625000|63025221|FG000|Overall Study|Withdrawal by Subject|19|||
33624398|NCT01625000|63025222|FG001|Overall Study|Withdrawal by Subject|16|||
33624399|NCT01625000|63025223|FG002|Overall Study|Withdrawal by Subject|11|||
33624400|NCT01625000|63025224|FG003|Overall Study|Withdrawal by Subject|9|||
33624401|NCT01625000|63025225|FG004|Overall Study|Withdrawal by Subject|17|||
33624402|NCT01625000|63025221|FG000|Overall Study|Adverse Event (including Death)|15|||
33624403|NCT01625000|63025222|FG001|Overall Study|Adverse Event (including Death)|19|||
33624404|NCT01625000|63025223|FG002|Overall Study|Adverse Event (including Death)|11|||
33624405|NCT01625000|63025224|FG003|Overall Study|Adverse Event (including Death)|7|||
33624406|NCT01625000|63025225|FG004|Overall Study|Adverse Event (including Death)|21|||
33624407|NCT02081534|63025244|FG000|Overall Study|Adverse Event|5|||
33624408|NCT02081534|63025245|FG001|Overall Study|Adverse Event|4|||
33624409|NCT02081534|63025246|FG002|Overall Study|Adverse Event|3|||
33624410|NCT02081534|63025247|FG003|Overall Study|Adverse Event|10|||
33624411|NCT02081534|63025248|FG004|Overall Study|Adverse Event|2|||
33624412|NCT02081534|63025249|FG005|Overall Study|Adverse Event|8|||
33624413|NCT02081534|63025250|FG006|Overall Study|Adverse Event|2|||
33624414|NCT02081534|63025244|FG000|Overall Study|Withdrawal by Subject|0|||
33624415|NCT02081534|63025245|FG001|Overall Study|Withdrawal by Subject|1|||
33624416|NCT02081534|63025246|FG002|Overall Study|Withdrawal by Subject|1|||
33624417|NCT02081534|63025247|FG003|Overall Study|Withdrawal by Subject|1|||
33624418|NCT02081534|63025248|FG004|Overall Study|Withdrawal by Subject|1|||
33624419|NCT02081534|63025249|FG005|Overall Study|Withdrawal by Subject|0|||
33624420|NCT02081534|63025250|FG006|Overall Study|Withdrawal by Subject|1|||
33624421|NCT02081534|63025244|FG000|Overall Study|Protocol Violation|0|||
33624422|NCT02081534|63025245|FG001|Overall Study|Protocol Violation|3|||
33624423|NCT02081534|63025246|FG002|Overall Study|Protocol Violation|0|||
33624424|NCT02081534|63025247|FG003|Overall Study|Protocol Violation|0|||
33624425|NCT02081534|63025248|FG004|Overall Study|Protocol Violation|0|||
33624426|NCT02081534|63025249|FG005|Overall Study|Protocol Violation|0|||
33624427|NCT02081534|63025250|FG006|Overall Study|Protocol Violation|1|||
33624428|NCT02081534|63025244|FG000|Overall Study|Lost to Follow-up|0|||
33624429|NCT02081534|63025245|FG001|Overall Study|Lost to Follow-up|0|||
33624430|NCT02081534|63025246|FG002|Overall Study|Lost to Follow-up|0|||
33624431|NCT02081534|63025247|FG003|Overall Study|Lost to Follow-up|2|||
33624432|NCT02081534|63025248|FG004|Overall Study|Lost to Follow-up|1|||
33624433|NCT02081534|63025249|FG005|Overall Study|Lost to Follow-up|1|||
33624434|NCT02081534|63025250|FG006|Overall Study|Lost to Follow-up|0|||
33624435|NCT02057198|63025269|FG000|Overall Study|Death|0|||
33624436|NCT02057198|63025270|FG001|Overall Study|Death|0|||
33624437|NCT02057198|63025271|FG002|Overall Study|Death|1|||
33624438|NCT02057198|63025269|FG000|Overall Study|Discharged early; lost to followup|0|||
33624439|NCT02057198|63025270|FG001|Overall Study|Discharged early; lost to followup|1|||
33624440|NCT02057198|63025271|FG002|Overall Study|Discharged early; lost to followup|0|||
33624441|NCT02056652|63025281|FG000|Overall Study|Withdrawal by Subject|1|||
33624442|NCT02056652|63025282|FG001|Overall Study|Withdrawal by Subject|0|||
33624443|NCT02056652|63025281|FG000|Overall Study|Lost to Follow-up|0|||
33624444|NCT02056652|63025282|FG001|Overall Study|Lost to Follow-up|3|||
33624445|NCT02056340|63025290|FG000|Overall Study|Lost to Follow-up|5|||
33624446|NCT02056340|63025291|FG001|Overall Study|Lost to Follow-up|5|||
33624447|NCT02056340|63025290|FG000|Overall Study|Withdrawal by Subject|2|||
33624448|NCT02056340|63025291|FG001|Overall Study|Withdrawal by Subject|6|||
33624449|NCT02046122|63025297|FG000|Overall Study|Physician Decision|8|||
33624450|NCT02046122|63025297|FG000|Overall Study|Withdrawal by Subject|1|||
33624451|NCT02080832|63025304|FG000|Overall Study|Excluded from analysis by MRI|9|||
33624452|NCT02080832|63025305|FG001|Overall Study|Excluded from analysis by MRI|10|||
33624453|NCT02080832|63025306|FG002|Overall Study|Excluded from analysis by MRI|14|||
33624454|NCT02080832|63025304|FG000|Overall Study|Lost to Follow-up|0|||
33624455|NCT02080832|63025305|FG001|Overall Study|Lost to Follow-up|2|||
33624456|NCT02080832|63025306|FG002|Overall Study|Lost to Follow-up|2|||
33624457|NCT02080364|63025320|FG000|Baseline Period|Protocol Violation|2|||
33624458|NCT02080364|63025321|FG001|Baseline Period|Protocol Violation|1|||
33624459|NCT02080364|63025322|FG002|Baseline Period|Protocol Violation|0|||
33624460|NCT02080364|63025323|FG003|Baseline Period|Protocol Violation|0|||
33624461|NCT02080364|63025320|FG000|Baseline Period|Other|0|||
33624462|NCT02080364|63025321|FG001|Baseline Period|Other|1|||
33624463|NCT02080364|63025322|FG002|Baseline Period|Other|1|||
33624464|NCT02080364|63025323|FG003|Baseline Period|Other|0|||
33624465|NCT02080364|63025320|FG000|Treatment Period|Adverse Event|10|||
33624466|NCT02080364|63025321|FG001|Treatment Period|Adverse Event|15|||
33624467|NCT02080364|63025322|FG002|Treatment Period|Adverse Event|11|||
33624468|NCT02080364|63025323|FG003|Treatment Period|Adverse Event|14|||
33624469|NCT02080364|63025320|FG000|Treatment Period|Lost to Follow-up|2|||
33624470|NCT02080364|63025321|FG001|Treatment Period|Lost to Follow-up|3|||
33624471|NCT02080364|63025322|FG002|Treatment Period|Lost to Follow-up|5|||
33624472|NCT02080364|63025323|FG003|Treatment Period|Lost to Follow-up|0|||
33624473|NCT02080364|63025320|FG000|Treatment Period|Protocol Violation|5|||
33624474|NCT02080364|63025321|FG001|Treatment Period|Protocol Violation|3|||
33624475|NCT02080364|63025322|FG002|Treatment Period|Protocol Violation|5|||
33624476|NCT02080364|63025323|FG003|Treatment Period|Protocol Violation|1|||
33624477|NCT02080364|63025320|FG000|Treatment Period|Withdrawal by Subject|16|||
33624478|NCT02080364|63025321|FG001|Treatment Period|Withdrawal by Subject|16|||
33624479|NCT02080364|63025322|FG002|Treatment Period|Withdrawal by Subject|15|||
33624480|NCT02080364|63025323|FG003|Treatment Period|Withdrawal by Subject|10|||
33624481|NCT02080364|63025320|FG000|Treatment Period|Study Terminated by Sponsor|0|||
33624482|NCT02080364|63025321|FG001|Treatment Period|Study Terminated by Sponsor|0|||
33624483|NCT02080364|63025322|FG002|Treatment Period|Study Terminated by Sponsor|180|||
33624484|NCT02080364|63025323|FG003|Treatment Period|Study Terminated by Sponsor|183|||
33624485|NCT02080364|63025320|FG000|Treatment Period|Other|14|||
33624486|NCT02080364|63025321|FG001|Treatment Period|Other|12|||
33624487|NCT02080364|63025322|FG002|Treatment Period|Other|21|||
33624488|NCT02080364|63025323|FG003|Treatment Period|Other|16|||
33624489|NCT02079038|63025335|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
33624490|NCT02079038|63025336|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
33624491|NCT02079038|63025335|FG000|Modified Intent to Treat Population|Death|1|||
33624492|NCT02079038|63025336|FG001|Modified Intent to Treat Population|Death|0|||
33624493|NCT02079038|63025335|FG000|Completed 6 Months|Lost to Follow-up|2|||
33325443|NCT01212770|62702211|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
33457678|NCT03670810|62831939|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
33624494|NCT02079038|63025336|FG001|Completed 6 Months|Lost to Follow-up|1|||
33624495|NCT02045732|63025344|FG000|Overall Study|At the discretion of the investigator|1|||
33624496|NCT02045732|63025345|FG001|Overall Study|At the discretion of the investigator|1|||
33624497|NCT02044874|63025354|FG000|Overall Study|Adverse Event|5|||
33457679|NCT03670810|62831940|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
33457680|NCT03670810|62831941|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
33457681|NCT03670810|62831942|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
33457682|NCT03670810|62831943|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
33624498|NCT02044874|63025355|FG001|Overall Study|Adverse Event|6|||
33624499|NCT02044874|63025356|FG002|Overall Study|Adverse Event|6|||
33624500|NCT02044874|63025354|FG000|Overall Study|Withdrawal by Subject|8|||
33624501|NCT02044874|63025355|FG001|Overall Study|Withdrawal by Subject|16|||
33624502|NCT02044874|63025356|FG002|Overall Study|Withdrawal by Subject|23|||
33624503|NCT02044874|63025354|FG000|Overall Study|Physician Decision|0|||
33624504|NCT02044874|63025355|FG001|Overall Study|Physician Decision|2|||
33624505|NCT02044874|63025356|FG002|Overall Study|Physician Decision|1|||
33624506|NCT02044874|63025354|FG000|Overall Study|Lost to Follow-up|10|||
33624507|NCT02044874|63025355|FG001|Overall Study|Lost to Follow-up|27|||
33624508|NCT02044874|63025356|FG002|Overall Study|Lost to Follow-up|21|||
33624509|NCT02044874|63025354|FG000|Overall Study|Sponsor Decision|0|||
33624510|NCT02044874|63025355|FG001|Overall Study|Sponsor Decision|1|||
33624511|NCT02044874|63025356|FG002|Overall Study|Sponsor Decision|1|||
33624512|NCT02044874|63025354|FG000|Overall Study|Other|7|||
33624513|NCT02044874|63025355|FG001|Overall Study|Other|3|||
33624514|NCT02044874|63025356|FG002|Overall Study|Other|8|||
33624515|NCT02078960|63025369|FG000|Treatment Period|Other|0|||
33624516|NCT02078960|63025370|FG001|Treatment Period|Other|0|||
33624517|NCT02078960|63025371|FG002|Treatment Period|Other|1|||
33624518|NCT02078960|63025369|FG000|Treatment Period|Lack of Efficacy|0|||
33624519|NCT02078960|63025370|FG001|Treatment Period|Lack of Efficacy|1|||
33624520|NCT02078960|63025371|FG002|Treatment Period|Lack of Efficacy|0|||
33624521|NCT02078960|63025369|FG000|Treatment Period|Disease progression - accelerated phase|0|||
33624522|NCT02078960|63025370|FG001|Treatment Period|Disease progression - accelerated phase|1|||
33624523|NCT02078960|63025371|FG002|Treatment Period|Disease progression - accelerated phase|0|||
33624524|NCT02078960|63025369|FG000|Treatment Period|Disease progression - blast phase|1|||
33624525|NCT02078960|63025370|FG001|Treatment Period|Disease progression - blast phase|0|||
33624526|NCT02078960|63025371|FG002|Treatment Period|Disease progression - blast phase|0|||
33624527|NCT02078960|63025369|FG000|Treatment Period|Withdrawal by Subject|0|||
33624528|NCT02078960|63025370|FG001|Treatment Period|Withdrawal by Subject|1|||
33624529|NCT02078960|63025371|FG002|Treatment Period|Withdrawal by Subject|1|||
33624530|NCT02078960|63025369|FG000|Treatment Period|Adverse Event|1|||
33624531|NCT02078960|63025370|FG001|Treatment Period|Adverse Event|0|||
33624532|NCT02078960|63025371|FG002|Treatment Period|Adverse Event|0|||
33624533|NCT02078960|63025369|FG000|Treatment Period|Death|0|||
33624534|NCT02078960|63025370|FG001|Treatment Period|Death|0|||
33624535|NCT02078960|63025371|FG002|Treatment Period|Death|1|||
33624536|NCT02078960|63025369|FG000|Follow-up Period|Death|2|||
33624537|NCT02078960|63025370|FG001|Follow-up Period|Death|0|||
33624538|NCT02078960|63025371|FG002|Follow-up Period|Death|0|||
33624539|NCT02078960|63025369|FG000|Follow-up Period|Lost to Follow-up|0|||
33624540|NCT02078960|63025370|FG001|Follow-up Period|Lost to Follow-up|1|||
33624541|NCT02078960|63025371|FG002|Follow-up Period|Lost to Follow-up|0|||
33624542|NCT02078102|63025383|FG000|Overall Study|Adverse Event|1|||
33624543|NCT02078102|63025384|FG001|Overall Study|Adverse Event|0|||
33624544|NCT02078102|63025383|FG000|Overall Study|Withdrawal by Subject|1|||
33624545|NCT02078102|63025384|FG001|Overall Study|Withdrawal by Subject|0|||
33624546|NCT02078102|63025383|FG000|Overall Study|Physician Decision|0|||
33624547|NCT02078102|63025384|FG001|Overall Study|Physician Decision|1|||
33624548|NCT02054702|63025393|FG000|Overall Study|Lost to Follow-up|3|||
33624549|NCT02054702|63025394|FG001|Overall Study|Lost to Follow-up|5|||
33624550|NCT02054702|63025393|FG000|Overall Study|Adverse Event|3|||
33624551|NCT02054702|63025394|FG001|Overall Study|Adverse Event|1|||
33624552|NCT02054702|63025393|FG000|Overall Study|Met Withdrawal Criteria|4|||
33624553|NCT02054702|63025394|FG001|Overall Study|Met Withdrawal Criteria|1|||
33624554|NCT02054702|63025393|FG000|Overall Study|Physician Decision|0|||
33624555|NCT02054702|63025394|FG001|Overall Study|Physician Decision|1|||
33624556|NCT02054702|63025393|FG000|Overall Study|Withdrawal by Subject|14|||
33624557|NCT02054702|63025394|FG001|Overall Study|Withdrawal by Subject|4|||
33325444|NCT01212770|62702212|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
33325445|NCT01212770|62702213|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
33624558|NCT02044094|63025400|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
33624559|NCT02044094|63025400|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
33624560|NCT02044094|63025400|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
33624561|NCT02044094|63025400|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
33624562|NCT02044094|63025400|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
33624563|NCT02044094|63025400|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
33624564|NCT02044094|63025400|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
33624565|NCT02044094|63025400|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
33325446|NCT01212770|62702214|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
33325447|NCT01212770|62702215|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
33325448|NCT01212770|62702216|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
33624566|NCT02043938|63025415|FG000|Overall Study|Withdrawal by Subject|7|||
33624567|NCT02043938|63025415|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
33624568|NCT02043938|63025415|FG000|Overall Study|No show by subject|1|||
33624569|NCT02043938|63025415|FG000|Overall Study|Investigator decision|1|||
33624570|NCT02053610|63025424|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
33624571|NCT02053610|63025425|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
33624572|NCT02053610|63025424|FG000|Overall Study|Withdrew Consent|2|||
33624573|NCT02053610|63025425|FG001|Overall Study|Withdrew Consent|9|||
33624574|NCT02053610|63025424|FG000|Overall Study|Death|5|||
33624575|NCT02053610|63025425|FG001|Overall Study|Death|5|||
33624576|NCT02053610|63025424|FG000|Overall Study|Administrative/Other|1|||
33624577|NCT02053610|63025425|FG001|Overall Study|Administrative/Other|1|||
33624578|NCT02053610|63025424|FG000|Overall Study|Disease Progression|2|||
33624579|NCT02053610|63025425|FG001|Overall Study|Disease Progression|3|||
33624580|NCT02053610|63025424|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
33624581|NCT02053610|63025425|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
33624582|NCT02053610|63025424|FG000|Overall Study|Did not Receive Treatment|4|||
33624583|NCT02053610|63025425|FG001|Overall Study|Did not Receive Treatment|2|||
33624584|NCT02053610|63025424|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33624585|NCT02053610|63025425|FG001|Overall Study|Insufficient Therapeutic Response|1|||
33624586|NCT02053610|63025424|FG000|Overall Study|Violation of Selection Criteria|1|||
33624587|NCT02053610|63025425|FG001|Overall Study|Violation of Selection Criteria|0|||
33624588|NCT02075606|63025431|FG000|Overall Study|Adverse Event|5|||
33624589|NCT02075606|63025431|FG000|Overall Study|Withdrawal by Subject|1|||
33624590|NCT02075606|63025431|FG000|Overall Study|Death|1|||
33624591|NCT02075606|63025431|FG000|Overall Study|Investigator's decision|1|||
33624592|NCT02075606|63025431|FG000|Overall Study|Symptom management|1|||
33624593|NCT02075606|63025431|FG000|Overall Study|Increasing Symptoms|1|||
33624594|NCT02043782|63025440|FG000|Period 1|Adverse Event|0|||
33624595|NCT02043782|63025441|FG001|Period 1|Adverse Event|0|||
33624596|NCT02043782|63025442|FG002|Period 1|Adverse Event|1|||
33624597|NCT02043782|63025443|FG003|Period 1|Adverse Event|0|||
33624598|NCT02043782|63025444|FG004|Period 1|Adverse Event|0|||
33624599|NCT02043782|63025445|FG005|Period 1|Adverse Event|0|||
33624600|NCT02052596|63025455|FG000|Active Phase|Adverse Event|3|||
33624601|NCT02052596|63025456|FG001|Active Phase|Adverse Event|2|||
33624602|NCT02052596|63025455|FG000|Active Phase|Lost to Follow-up|8|||
33624603|NCT02052596|63025456|FG001|Active Phase|Lost to Follow-up|11|||
33624604|NCT02052596|63025455|FG000|Active Phase|Protocol Violation|1|||
33624605|NCT02052596|63025456|FG001|Active Phase|Protocol Violation|2|||
33624606|NCT02052596|63025455|FG000|Active Phase|Withdrawal by Subject|3|||
33624607|NCT02052596|63025456|FG001|Active Phase|Withdrawal by Subject|4|||
33624608|NCT02052596|63025455|FG000|Active Phase|Enrolled in error|1|||
33624609|NCT02052596|63025456|FG001|Active Phase|Enrolled in error|0|||
33624610|NCT02052596|63025455|FG000|Active Phase|Lost due to Crohn's disease|0|||
33624611|NCT02052596|63025456|FG001|Active Phase|Lost due to Crohn's disease|1|||
33624612|NCT02052596|63025455|FG000|Safety Phase|Adverse Event|6|||
33624613|NCT02052596|63025456|FG001|Safety Phase|Adverse Event|3|||
33624614|NCT02052596|63025455|FG000|Safety Phase|Lost to Follow-up|11|||
33624615|NCT02052596|63025456|FG001|Safety Phase|Lost to Follow-up|18|||
33624616|NCT02052596|63025455|FG000|Safety Phase|Protocol Violation|1|||
33624617|NCT02052596|63025456|FG001|Safety Phase|Protocol Violation|2|||
33624618|NCT02052596|63025455|FG000|Safety Phase|Withdrawal by Subject|8|||
33624619|NCT02052596|63025456|FG001|Safety Phase|Withdrawal by Subject|11|||
33624620|NCT02052596|63025455|FG000|Safety Phase|Enrolled in error|1|||
33624621|NCT02052596|63025456|FG001|Safety Phase|Enrolled in error|0|||
33624622|NCT02052596|63025455|FG000|Safety Phase|Lost due to Crohn's disease|0|||
33624623|NCT02052596|63025456|FG001|Safety Phase|Lost due to Crohn's disease|1|||
33624624|NCT02052440|63025464|FG000|Overall Study|Withdrawal by Subject|0|||
33624625|NCT02052440|63025465|FG001|Overall Study|Withdrawal by Subject|1|||
33624626|NCT02049944|63025471|FG000|Overall Study|Protocol Violation|2|||
33624627|NCT02043548|63025477|FG000|Overall Study|Lack of Efficacy|1|||
33624628|NCT02043548|63025478|FG001|Overall Study|Lack of Efficacy|0|||
33624629|NCT02043548|63025477|FG000|Overall Study|Adverse Event|0|||
33624630|NCT02043548|63025478|FG001|Overall Study|Adverse Event|1|||
33624631|NCT01622348|63025487|FG000|Overall Study|Withdrawal by Subject|1|||
33624632|NCT01622348|63025488|FG001|Overall Study|Withdrawal by Subject|0|||
33624633|NCT01622348|63025489|FG002|Overall Study|Withdrawal by Subject|1|||
33624634|NCT01621880|63025499|FG000|Overall Study|Adverse Event|5|||
33624635|NCT01621880|63025500|FG001|Overall Study|Adverse Event|1|||
33528162|NCT02880371|62916091|FG001|Phase 2|Withdrawal by Subject|0|||
33624636|NCT01621880|63025499|FG000|Overall Study|Withdrawal by Subject|5|||
33624637|NCT01621880|63025500|FG001|Overall Study|Withdrawal by Subject|4|||
33624638|NCT01621802|63025513|FG000|Overall Study|Protocol Violation|0|||
33624639|NCT01621802|63025514|FG001|Overall Study|Protocol Violation|0|||
33624640|NCT01621802|63025515|FG002|Overall Study|Protocol Violation|0|||
33624641|NCT01621802|63025516|FG003|Overall Study|Protocol Violation|0|||
33624642|NCT01621802|63025517|FG004|Overall Study|Protocol Violation|0|||
33624643|NCT01621802|63025518|FG005|Overall Study|Protocol Violation|1|||
33624644|NCT01621802|63025513|FG000|Overall Study|Withdrawal by Subject|8|||
33624645|NCT01621802|63025514|FG001|Overall Study|Withdrawal by Subject|4|||
33624646|NCT01621802|63025515|FG002|Overall Study|Withdrawal by Subject|4|||
33624647|NCT01621802|63025516|FG003|Overall Study|Withdrawal by Subject|2|||
33624648|NCT01621802|63025517|FG004|Overall Study|Withdrawal by Subject|2|||
33624649|NCT01621802|63025518|FG005|Overall Study|Withdrawal by Subject|0|||
33624650|NCT01621802|63025513|FG000|Overall Study|Migrated/moved from study area|0|||
33624651|NCT01621802|63025514|FG001|Overall Study|Migrated/moved from study area|0|||
33624652|NCT01621802|63025515|FG002|Overall Study|Migrated/moved from study area|2|||
33624653|NCT01621802|63025516|FG003|Overall Study|Migrated/moved from study area|0|||
33624654|NCT01621802|63025517|FG004|Overall Study|Migrated/moved from study area|1|||
33624655|NCT01621802|63025518|FG005|Overall Study|Migrated/moved from study area|0|||
33624656|NCT01621802|63025513|FG000|Overall Study|Others|3|||
33624657|NCT01621802|63025514|FG001|Overall Study|Others|3|||
33624658|NCT01621802|63025515|FG002|Overall Study|Others|3|||
33624659|NCT01621802|63025516|FG003|Overall Study|Others|2|||
33624660|NCT01621802|63025517|FG004|Overall Study|Others|1|||
33624661|NCT01621802|63025518|FG005|Overall Study|Others|0|||
33624662|NCT01621802|63025513|FG000|Overall Study|Lost to Follow-up|36|||
33624663|NCT01621802|63025514|FG001|Overall Study|Lost to Follow-up|16|||
33624664|NCT01621802|63025515|FG002|Overall Study|Lost to Follow-up|24|||
33624665|NCT01621802|63025516|FG003|Overall Study|Lost to Follow-up|7|||
33624666|NCT01621802|63025517|FG004|Overall Study|Lost to Follow-up|31|||
33624667|NCT01621802|63025518|FG005|Overall Study|Lost to Follow-up|11|||
33624668|NCT02059291|63025544|FG000|Epoch 2|Lack of Efficacy|0|||
33624669|NCT02059291|63025545|FG001|Epoch 2|Lack of Efficacy|0|||
33624670|NCT02059291|63025546|FG002|Epoch 2|Lack of Efficacy|0|||
33624671|NCT02059291|63025547|FG003|Epoch 2|Lack of Efficacy|1|||
33624672|NCT02059291|63025548|FG004|Epoch 2|Lack of Efficacy|0|||
33624673|NCT02059291|63025549|FG005|Epoch 2|Lack of Efficacy|1|||
33624674|NCT02059291|63025550|FG006|Epoch 2|Lack of Efficacy|0|||
33624675|NCT02059291|63025551|FG007|Epoch 2|Lack of Efficacy|0|||
33624676|NCT02059291|63025552|FG008|Epoch 2|Lack of Efficacy|0|||
33624677|NCT02059291|63025553|FG009|Epoch 2|Lack of Efficacy|0|||
33624678|NCT02059291|63025554|FG010|Epoch 2|Lack of Efficacy|0|||
33624679|NCT02059291|63025555|FG011|Epoch 2|Lack of Efficacy|0|||
33624680|NCT02059291|63025556|FG012|Epoch 2|Lack of Efficacy|0|||
33624681|NCT02059291|63025557|FG013|Epoch 2|Lack of Efficacy|0|||
33624682|NCT02059291|63025558|FG014|Epoch 2|Lack of Efficacy|0|||
33624683|NCT02059291|63025559|FG015|Epoch 2|Lack of Efficacy|0|||
33624684|NCT02059291|63025560|FG016|Epoch 2|Lack of Efficacy|0|||
33624685|NCT02059291|63025561|FG017|Epoch 2|Lack of Efficacy|0|||
33624686|NCT02059291|63025562|FG018|Epoch 2|Lack of Efficacy|0|||
33624687|NCT02059291|63025563|FG019|Epoch 2|Lack of Efficacy|0|||
33624688|NCT02059291|63025564|FG020|Epoch 2|Lack of Efficacy|0|||
33624689|NCT02059291|63025565|FG021|Epoch 2|Lack of Efficacy|0|||
33624690|NCT02059291|63025566|FG022|Epoch 2|Lack of Efficacy|0|||
33624691|NCT02059291|63025567|FG023|Epoch 2|Lack of Efficacy|0|||
33624692|NCT02059291|63025568|FG024|Epoch 2|Lack of Efficacy|0|||
33624693|NCT02059291|63025544|FG000|Epoch 2|Adverse Event|0|||
33624694|NCT02059291|63025545|FG001|Epoch 2|Adverse Event|0|||
33624695|NCT02059291|63025546|FG002|Epoch 2|Adverse Event|1|||
33624696|NCT02059291|63025547|FG003|Epoch 2|Adverse Event|1|||
33528163|NCT02880371|62916092|FG002|Phase 2|Withdrawal by Subject|0|||
33528164|NCT02880371|62916093|FG003|Phase 2|Withdrawal by Subject|0|||
33528165|NCT02880371|62916094|FG004|Phase 2|Withdrawal by Subject|0|||
33528166|NCT02880371|62916095|FG005|Phase 2|Withdrawal by Subject|1|||
33528167|NCT02880371|62916096|FG006|Phase 2|Withdrawal by Subject|1|||
33528168|NCT02880371|62916097|FG007|Phase 2|Withdrawal by Subject|0|||
33528169|NCT02880371|62916090|FG000|Phase 2|End of Study page not completed by error|0|||
33528170|NCT02880371|62916091|FG001|Phase 2|End of Study page not completed by error|0|||
33528171|NCT02880371|62916092|FG002|Phase 2|End of Study page not completed by error|0|||
33624697|NCT02059291|63025548|FG004|Epoch 2|Adverse Event|0|||
33624698|NCT02059291|63025549|FG005|Epoch 2|Adverse Event|0|||
33624699|NCT02059291|63025550|FG006|Epoch 2|Adverse Event|0|||
33624700|NCT02059291|63025551|FG007|Epoch 2|Adverse Event|1|||
33624701|NCT02059291|63025552|FG008|Epoch 2|Adverse Event|1|||
33528172|NCT02880371|62916093|FG003|Phase 2|End of Study page not completed by error|0|||
33528173|NCT02880371|62916094|FG004|Phase 2|End of Study page not completed by error|0|||
33528174|NCT02880371|62916095|FG005|Phase 2|End of Study page not completed by error|1|||
33624702|NCT02059291|63025553|FG009|Epoch 2|Adverse Event|0|||
33624703|NCT02059291|63025554|FG010|Epoch 2|Adverse Event|0|||
33624704|NCT02059291|63025555|FG011|Epoch 2|Adverse Event|0|||
33624705|NCT02059291|63025556|FG012|Epoch 2|Adverse Event|0|||
33624706|NCT02059291|63025557|FG013|Epoch 2|Adverse Event|0|||
33624707|NCT02059291|63025558|FG014|Epoch 2|Adverse Event|0|||
33624708|NCT02059291|63025559|FG015|Epoch 2|Adverse Event|0|||
33624709|NCT02059291|63025560|FG016|Epoch 2|Adverse Event|0|||
33624710|NCT02059291|63025561|FG017|Epoch 2|Adverse Event|0|||
33624711|NCT02059291|63025562|FG018|Epoch 2|Adverse Event|0|||
33624712|NCT02059291|63025563|FG019|Epoch 2|Adverse Event|0|||
33624713|NCT02059291|63025564|FG020|Epoch 2|Adverse Event|0|||
33624714|NCT02059291|63025565|FG021|Epoch 2|Adverse Event|0|||
33624715|NCT02059291|63025566|FG022|Epoch 2|Adverse Event|0|||
33624716|NCT02059291|63025567|FG023|Epoch 2|Adverse Event|0|||
33624717|NCT02059291|63025568|FG024|Epoch 2|Adverse Event|0|||
33624718|NCT02059291|63025544|FG000|Epoch 2|Withdrawal by Subject|0|||
33624719|NCT02059291|63025545|FG001|Epoch 2|Withdrawal by Subject|1|||
33624720|NCT02059291|63025546|FG002|Epoch 2|Withdrawal by Subject|0|||
33624721|NCT02059291|63025547|FG003|Epoch 2|Withdrawal by Subject|0|||
33624722|NCT02059291|63025548|FG004|Epoch 2|Withdrawal by Subject|0|||
33624723|NCT02059291|63025549|FG005|Epoch 2|Withdrawal by Subject|1|||
33624724|NCT02059291|63025550|FG006|Epoch 2|Withdrawal by Subject|0|||
33624725|NCT02059291|63025551|FG007|Epoch 2|Withdrawal by Subject|0|||
33624726|NCT02059291|63025552|FG008|Epoch 2|Withdrawal by Subject|1|||
33624727|NCT02059291|63025553|FG009|Epoch 2|Withdrawal by Subject|0|||
33624728|NCT02059291|63025554|FG010|Epoch 2|Withdrawal by Subject|0|||
33624729|NCT02059291|63025555|FG011|Epoch 2|Withdrawal by Subject|0|||
33624730|NCT02059291|63025556|FG012|Epoch 2|Withdrawal by Subject|0|||
33624731|NCT02059291|63025557|FG013|Epoch 2|Withdrawal by Subject|0|||
33624732|NCT02059291|63025558|FG014|Epoch 2|Withdrawal by Subject|0|||
33624733|NCT02059291|63025559|FG015|Epoch 2|Withdrawal by Subject|0|||
33624734|NCT02059291|63025560|FG016|Epoch 2|Withdrawal by Subject|0|||
33624735|NCT02059291|63025561|FG017|Epoch 2|Withdrawal by Subject|0|||
33624736|NCT02059291|63025562|FG018|Epoch 2|Withdrawal by Subject|0|||
33624737|NCT02059291|63025563|FG019|Epoch 2|Withdrawal by Subject|0|||
33624738|NCT02059291|63025564|FG020|Epoch 2|Withdrawal by Subject|0|||
33624739|NCT02059291|63025565|FG021|Epoch 2|Withdrawal by Subject|0|||
33624740|NCT02059291|63025566|FG022|Epoch 2|Withdrawal by Subject|0|||
33624741|NCT02059291|63025567|FG023|Epoch 2|Withdrawal by Subject|0|||
33624742|NCT02059291|63025568|FG024|Epoch 2|Withdrawal by Subject|0|||
33624743|NCT02059291|63025544|FG000|Epoch 3|Physician Decision|0|||
33624744|NCT02059291|63025545|FG001|Epoch 3|Physician Decision|0|||
33624745|NCT02059291|63025546|FG002|Epoch 3|Physician Decision|0|||
33624746|NCT02059291|63025547|FG003|Epoch 3|Physician Decision|0|||
33624747|NCT02059291|63025548|FG004|Epoch 3|Physician Decision|0|||
33624748|NCT02059291|63025549|FG005|Epoch 3|Physician Decision|0|||
33624749|NCT02059291|63025550|FG006|Epoch 3|Physician Decision|0|||
33624750|NCT02059291|63025551|FG007|Epoch 3|Physician Decision|0|||
33624751|NCT02059291|63025552|FG008|Epoch 3|Physician Decision|0|||
33624752|NCT02059291|63025553|FG009|Epoch 3|Physician Decision|0|||
33624753|NCT02059291|63025554|FG010|Epoch 3|Physician Decision|0|||
33624754|NCT02059291|63025555|FG011|Epoch 3|Physician Decision|0|||
33624755|NCT02059291|63025556|FG012|Epoch 3|Physician Decision|0|||
33624756|NCT02059291|63025557|FG013|Epoch 3|Physician Decision|1|||
33624757|NCT02059291|63025558|FG014|Epoch 3|Physician Decision|0|||
33624758|NCT02059291|63025559|FG015|Epoch 3|Physician Decision|1|||
33624759|NCT02059291|63025560|FG016|Epoch 3|Physician Decision|0|||
33528175|NCT02880371|62916096|FG006|Phase 2|End of Study page not completed by error|0|||
33528176|NCT02880371|62916097|FG007|Phase 2|End of Study page not completed by error|0|||
33528177|NCT02837029|62916120|FG000|Screening|Failed to meet screening requirements.|7|||
33528178|NCT02837029|62916121|FG001|Screening|Failed to meet screening requirements.|3|||
33528179|NCT02837029|62916122|FG002|Screening|Failed to meet screening requirements.|0|||
33528180|NCT02837029|62916120|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
33528181|NCT02837029|62916121|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
33528182|NCT02837029|62916122|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
33528183|NCT02837029|62916120|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
33528184|NCT02837029|62916121|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
33528185|NCT02837029|62916122|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
33528186|NCT02837029|62916120|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
33528187|NCT02837029|62916121|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
33528188|NCT02837029|62916122|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
33528189|NCT02837029|62916120|FG000|Cycle 2 and Beyond|Adverse Event|1|||
33528190|NCT02837029|62916121|FG001|Cycle 2 and Beyond|Adverse Event|0|||
33528191|NCT02837029|62916122|FG002|Cycle 2 and Beyond|Adverse Event|0|||
33528192|NCT02837029|62916120|FG000|2 Year Follow-up|Death|6|||
33528193|NCT02837029|62916121|FG001|2 Year Follow-up|Death|7|||
33528194|NCT02837029|62916122|FG002|2 Year Follow-up|Death|0|||
33528195|NCT03010527|62916134|FG000|Overall Study|Death|0|||
33624760|NCT02059291|63025561|FG017|Epoch 3|Physician Decision|0|||
33624761|NCT02059291|63025562|FG018|Epoch 3|Physician Decision|0|||
33624762|NCT02059291|63025563|FG019|Epoch 3|Physician Decision|0|||
33624763|NCT02059291|63025564|FG020|Epoch 3|Physician Decision|0|||
33624764|NCT02059291|63025565|FG021|Epoch 3|Physician Decision|0|||
33624765|NCT02059291|63025566|FG022|Epoch 3|Physician Decision|0|||
33624766|NCT02059291|63025567|FG023|Epoch 3|Physician Decision|0|||
33624767|NCT02059291|63025568|FG024|Epoch 3|Physician Decision|0|||
33624768|NCT02059291|63025544|FG000|Epoch 3|Adverse Event|0|||
33624769|NCT02059291|63025545|FG001|Epoch 3|Adverse Event|0|||
33624770|NCT02059291|63025546|FG002|Epoch 3|Adverse Event|0|||
33624771|NCT02059291|63025547|FG003|Epoch 3|Adverse Event|0|||
33624772|NCT02059291|63025548|FG004|Epoch 3|Adverse Event|0|||
33624773|NCT02059291|63025549|FG005|Epoch 3|Adverse Event|0|||
33624774|NCT02059291|63025550|FG006|Epoch 3|Adverse Event|0|||
33624775|NCT02059291|63025551|FG007|Epoch 3|Adverse Event|0|||
33624776|NCT02059291|63025552|FG008|Epoch 3|Adverse Event|0|||
33624777|NCT02059291|63025553|FG009|Epoch 3|Adverse Event|0|||
33624778|NCT02059291|63025554|FG010|Epoch 3|Adverse Event|0|||
33624779|NCT02059291|63025555|FG011|Epoch 3|Adverse Event|0|||
33624780|NCT02059291|63025556|FG012|Epoch 3|Adverse Event|0|||
33624781|NCT02059291|63025557|FG013|Epoch 3|Adverse Event|0|||
33624782|NCT02059291|63025558|FG014|Epoch 3|Adverse Event|0|||
33624783|NCT02059291|63025559|FG015|Epoch 3|Adverse Event|1|||
33624784|NCT02059291|63025560|FG016|Epoch 3|Adverse Event|0|||
33624785|NCT02059291|63025561|FG017|Epoch 3|Adverse Event|0|||
33624786|NCT02059291|63025562|FG018|Epoch 3|Adverse Event|0|||
33624787|NCT02059291|63025563|FG019|Epoch 3|Adverse Event|0|||
33624788|NCT02059291|63025564|FG020|Epoch 3|Adverse Event|0|||
33624789|NCT02059291|63025565|FG021|Epoch 3|Adverse Event|0|||
33624790|NCT02059291|63025566|FG022|Epoch 3|Adverse Event|0|||
33624791|NCT02059291|63025567|FG023|Epoch 3|Adverse Event|0|||
33624792|NCT02059291|63025568|FG024|Epoch 3|Adverse Event|0|||
33624793|NCT02059291|63025544|FG000|Epoch 3|Lack of Efficacy|0|||
33624794|NCT02059291|63025545|FG001|Epoch 3|Lack of Efficacy|0|||
33624795|NCT02059291|63025546|FG002|Epoch 3|Lack of Efficacy|0|||
33624796|NCT02059291|63025547|FG003|Epoch 3|Lack of Efficacy|0|||
33624797|NCT02059291|63025548|FG004|Epoch 3|Lack of Efficacy|0|||
33624798|NCT02059291|63025549|FG005|Epoch 3|Lack of Efficacy|0|||
33624799|NCT02059291|63025550|FG006|Epoch 3|Lack of Efficacy|0|||
33624800|NCT02059291|63025551|FG007|Epoch 3|Lack of Efficacy|0|||
33624801|NCT02059291|63025552|FG008|Epoch 3|Lack of Efficacy|0|||
33624802|NCT02059291|63025553|FG009|Epoch 3|Lack of Efficacy|0|||
33624803|NCT02059291|63025554|FG010|Epoch 3|Lack of Efficacy|0|||
33624804|NCT02059291|63025555|FG011|Epoch 3|Lack of Efficacy|0|||
33624805|NCT02059291|63025556|FG012|Epoch 3|Lack of Efficacy|0|||
33624806|NCT02059291|63025557|FG013|Epoch 3|Lack of Efficacy|0|||
33624807|NCT02059291|63025558|FG014|Epoch 3|Lack of Efficacy|0|||
33624808|NCT02059291|63025559|FG015|Epoch 3|Lack of Efficacy|3|||
33624809|NCT02059291|63025560|FG016|Epoch 3|Lack of Efficacy|0|||
33624810|NCT02059291|63025561|FG017|Epoch 3|Lack of Efficacy|0|||
33624811|NCT02059291|63025562|FG018|Epoch 3|Lack of Efficacy|0|||
33624812|NCT02059291|63025563|FG019|Epoch 3|Lack of Efficacy|0|||
33624813|NCT02059291|63025564|FG020|Epoch 3|Lack of Efficacy|0|||
33624814|NCT02059291|63025565|FG021|Epoch 3|Lack of Efficacy|0|||
33624815|NCT02059291|63025566|FG022|Epoch 3|Lack of Efficacy|0|||
33624816|NCT02059291|63025567|FG023|Epoch 3|Lack of Efficacy|0|||
33624817|NCT02059291|63025568|FG024|Epoch 3|Lack of Efficacy|0|||
33624818|NCT02059291|63025544|FG000|Epoch 3|Withdrawal by Subject|0|||
33624819|NCT02059291|63025545|FG001|Epoch 3|Withdrawal by Subject|0|||
33624820|NCT02059291|63025546|FG002|Epoch 3|Withdrawal by Subject|0|||
33624821|NCT02059291|63025547|FG003|Epoch 3|Withdrawal by Subject|0|||
33624822|NCT02059291|63025548|FG004|Epoch 3|Withdrawal by Subject|0|||
33624823|NCT02059291|63025549|FG005|Epoch 3|Withdrawal by Subject|0|||
33624824|NCT02059291|63025550|FG006|Epoch 3|Withdrawal by Subject|0|||
33528196|NCT03010527|62916135|FG001|Overall Study|Death|0|||
33528197|NCT03010527|62916136|FG002|Overall Study|Death|1|||
33528198|NCT03010527|62916134|FG000|Overall Study|Adverse Event|0|||
33528199|NCT03010527|62916135|FG001|Overall Study|Adverse Event|4|||
33528200|NCT03010527|62916136|FG002|Overall Study|Adverse Event|2|||
33528201|NCT03010527|62916134|FG000|Overall Study|Protocol Violation|0|||
33624825|NCT02059291|63025551|FG007|Epoch 3|Withdrawal by Subject|0|||
33624826|NCT02059291|63025552|FG008|Epoch 3|Withdrawal by Subject|0|||
33624827|NCT02059291|63025553|FG009|Epoch 3|Withdrawal by Subject|0|||
33624828|NCT02059291|63025554|FG010|Epoch 3|Withdrawal by Subject|0|||
33624829|NCT02059291|63025555|FG011|Epoch 3|Withdrawal by Subject|0|||
33624830|NCT02059291|63025556|FG012|Epoch 3|Withdrawal by Subject|0|||
33624831|NCT02059291|63025557|FG013|Epoch 3|Withdrawal by Subject|0|||
33624832|NCT02059291|63025558|FG014|Epoch 3|Withdrawal by Subject|0|||
33624833|NCT02059291|63025559|FG015|Epoch 3|Withdrawal by Subject|1|||
33624834|NCT02059291|63025560|FG016|Epoch 3|Withdrawal by Subject|0|||
33624835|NCT02059291|63025561|FG017|Epoch 3|Withdrawal by Subject|0|||
33624836|NCT02059291|63025562|FG018|Epoch 3|Withdrawal by Subject|0|||
33624837|NCT02059291|63025563|FG019|Epoch 3|Withdrawal by Subject|0|||
33624838|NCT02059291|63025564|FG020|Epoch 3|Withdrawal by Subject|0|||
33624839|NCT02059291|63025565|FG021|Epoch 3|Withdrawal by Subject|0|||
33624840|NCT02059291|63025566|FG022|Epoch 3|Withdrawal by Subject|0|||
33528202|NCT03010527|62916135|FG001|Overall Study|Protocol Violation|1|||
33624841|NCT02059291|63025567|FG023|Epoch 3|Withdrawal by Subject|0|||
33624842|NCT02059291|63025568|FG024|Epoch 3|Withdrawal by Subject|0|||
33624843|NCT02059291|63025544|FG000|Epoch 4|Adverse Event|0|||
33624844|NCT02059291|63025545|FG001|Epoch 4|Adverse Event|0|||
33624845|NCT02059291|63025546|FG002|Epoch 4|Adverse Event|0|||
33624846|NCT02059291|63025547|FG003|Epoch 4|Adverse Event|0|||
33624847|NCT02059291|63025548|FG004|Epoch 4|Adverse Event|0|||
33624848|NCT02059291|63025549|FG005|Epoch 4|Adverse Event|0|||
33624849|NCT02059291|63025550|FG006|Epoch 4|Adverse Event|0|||
33528203|NCT03010527|62916136|FG002|Overall Study|Protocol Violation|0|||
33528204|NCT03010527|62916134|FG000|Overall Study|Lost to Follow-up|0|||
33528205|NCT03010527|62916135|FG001|Overall Study|Lost to Follow-up|2|||
33528206|NCT03010527|62916136|FG002|Overall Study|Lost to Follow-up|1|||
33528207|NCT03010527|62916134|FG000|Overall Study|Withdrawal by Subject|0|||
33528208|NCT03010527|62916135|FG001|Overall Study|Withdrawal by Subject|3|||
33528209|NCT03010527|62916136|FG002|Overall Study|Withdrawal by Subject|4|||
33528210|NCT03010527|62916134|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
33528211|NCT03010527|62916135|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
33528212|NCT03010527|62916136|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
33528213|NCT03010527|62916134|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
33624850|NCT02059291|63025551|FG007|Epoch 4|Adverse Event|0|||
33624851|NCT02059291|63025552|FG008|Epoch 4|Adverse Event|0|||
33624852|NCT02059291|63025553|FG009|Epoch 4|Adverse Event|0|||
33624853|NCT02059291|63025554|FG010|Epoch 4|Adverse Event|0|||
33624854|NCT02059291|63025555|FG011|Epoch 4|Adverse Event|0|||
33624855|NCT02059291|63025556|FG012|Epoch 4|Adverse Event|0|||
33624856|NCT02059291|63025557|FG013|Epoch 4|Adverse Event|0|||
33624857|NCT02059291|63025558|FG014|Epoch 4|Adverse Event|0|||
33624858|NCT02059291|63025559|FG015|Epoch 4|Adverse Event|0|||
33624859|NCT02059291|63025560|FG016|Epoch 4|Adverse Event|1|||
33624860|NCT02059291|63025561|FG017|Epoch 4|Adverse Event|0|||
33624861|NCT02059291|63025562|FG018|Epoch 4|Adverse Event|0|||
33624862|NCT02059291|63025563|FG019|Epoch 4|Adverse Event|0|||
33624863|NCT02059291|63025564|FG020|Epoch 4|Adverse Event|0|||
33624864|NCT02059291|63025565|FG021|Epoch 4|Adverse Event|0|||
33624865|NCT02059291|63025566|FG022|Epoch 4|Adverse Event|1|||
33624866|NCT02059291|63025567|FG023|Epoch 4|Adverse Event|0|||
33624867|NCT02059291|63025568|FG024|Epoch 4|Adverse Event|0|||
33624868|NCT02059291|63025544|FG000|Epoch 4|Pregnancy|0|||
33624869|NCT02059291|63025545|FG001|Epoch 4|Pregnancy|0|||
33624870|NCT02059291|63025546|FG002|Epoch 4|Pregnancy|0|||
33624871|NCT02059291|63025547|FG003|Epoch 4|Pregnancy|0|||
33624872|NCT02059291|63025548|FG004|Epoch 4|Pregnancy|0|||
33624873|NCT02059291|63025549|FG005|Epoch 4|Pregnancy|0|||
33624874|NCT02059291|63025550|FG006|Epoch 4|Pregnancy|0|||
33624875|NCT02059291|63025551|FG007|Epoch 4|Pregnancy|0|||
33624876|NCT02059291|63025552|FG008|Epoch 4|Pregnancy|0|||
33624877|NCT02059291|63025553|FG009|Epoch 4|Pregnancy|0|||
33624878|NCT02059291|63025554|FG010|Epoch 4|Pregnancy|0|||
33624879|NCT02059291|63025555|FG011|Epoch 4|Pregnancy|0|||
33624880|NCT02059291|63025556|FG012|Epoch 4|Pregnancy|0|||
33624881|NCT02059291|63025557|FG013|Epoch 4|Pregnancy|0|||
33528214|NCT03010527|62916135|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
33528215|NCT03010527|62916136|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
33528216|NCT03010527|62916134|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
33528217|NCT03010527|62916135|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
33528218|NCT03010527|62916136|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
33528219|NCT00794924|62916169|FG000|Overall Study|Lost to Follow-up|6|||
33528220|NCT00794924|62916170|FG001|Overall Study|Lost to Follow-up|8|||
33528221|NCT00794924|62916169|FG000|Overall Study|Withdrawal by Subject|48|||
33528222|NCT00794924|62916170|FG001|Overall Study|Withdrawal by Subject|60|||
33528223|NCT00794924|62916169|FG000|Overall Study|Adverse Event|6|||
33528224|NCT00794924|62916170|FG001|Overall Study|Adverse Event|2|||
33528225|NCT02914275|62916176|FG000|Overall Study|Lost to Follow-up|84|||
33528226|NCT02914275|62916177|FG001|Overall Study|Lost to Follow-up|29|||
33528227|NCT02914275|62916176|FG000|Overall Study|Withdrawal by Subject|26|||
33528228|NCT02914275|62916177|FG001|Overall Study|Withdrawal by Subject|10|||
33528229|NCT02914275|62916176|FG000|Overall Study|Protocol Violation|1|||
33528230|NCT02914275|62916177|FG001|Overall Study|Protocol Violation|1|||
33528231|NCT02914275|62916176|FG000|Overall Study|Physician Decision|3|||
33528232|NCT02914275|62916177|FG001|Overall Study|Physician Decision|1|||
33528233|NCT02914275|62916176|FG000|Overall Study|Other|4|||
33528234|NCT02914275|62916177|FG001|Overall Study|Other|1|||
33528235|NCT02914275|62916176|FG000|Overall Study|Excluded due to invalid informed consent|3|||
33528236|NCT02914275|62916177|FG001|Overall Study|Excluded due to invalid informed consent|0|||
33624882|NCT02059291|63025558|FG014|Epoch 4|Pregnancy|0|||
33624883|NCT02059291|63025559|FG015|Epoch 4|Pregnancy|0|||
33624884|NCT02059291|63025560|FG016|Epoch 4|Pregnancy|1|||
33624885|NCT02059291|63025561|FG017|Epoch 4|Pregnancy|0|||
33624886|NCT02059291|63025562|FG018|Epoch 4|Pregnancy|0|||
33528237|NCT00792116|62916189|FG000|Overall Study|Lost to Follow-up|0|||
33528238|NCT00792116|62916190|FG001|Overall Study|Lost to Follow-up|1|||
33528239|NCT00792116|62916189|FG000|Overall Study|Discontnued intervention|1|||
33624887|NCT02059291|63025563|FG019|Epoch 4|Pregnancy|0|||
33624888|NCT02059291|63025564|FG020|Epoch 4|Pregnancy|0|||
33624889|NCT02059291|63025565|FG021|Epoch 4|Pregnancy|0|||
33624890|NCT02059291|63025566|FG022|Epoch 4|Pregnancy|0|||
33624891|NCT02059291|63025567|FG023|Epoch 4|Pregnancy|0|||
33624892|NCT02059291|63025568|FG024|Epoch 4|Pregnancy|0|||
33624893|NCT02059291|63025544|FG000|Epoch 4|Withdrawal by Subject|0|||
33624894|NCT02059291|63025545|FG001|Epoch 4|Withdrawal by Subject|0|||
33624895|NCT02059291|63025546|FG002|Epoch 4|Withdrawal by Subject|0|||
33624896|NCT02059291|63025547|FG003|Epoch 4|Withdrawal by Subject|0|||
33624897|NCT02059291|63025548|FG004|Epoch 4|Withdrawal by Subject|0|||
33624898|NCT02059291|63025549|FG005|Epoch 4|Withdrawal by Subject|0|||
33624899|NCT02059291|63025550|FG006|Epoch 4|Withdrawal by Subject|0|||
33624900|NCT02059291|63025551|FG007|Epoch 4|Withdrawal by Subject|0|||
33624901|NCT02059291|63025552|FG008|Epoch 4|Withdrawal by Subject|0|||
33624902|NCT02059291|63025553|FG009|Epoch 4|Withdrawal by Subject|0|||
33624903|NCT02059291|63025554|FG010|Epoch 4|Withdrawal by Subject|0|||
33528240|NCT00792116|62916190|FG001|Overall Study|Discontnued intervention|0|||
33528241|NCT00489827|62916205|FG000|Overall Study|Intraoperative exclusion criteria|1|||
33528242|NCT00489827|62916206|FG001|Overall Study|Intraoperative exclusion criteria|1|||
33528243|NCT00489827|62916205|FG000|Overall Study|Intraoperative exclusion criteria|1|||
33624904|NCT02059291|63025555|FG011|Epoch 4|Withdrawal by Subject|0|||
33624905|NCT02059291|63025556|FG012|Epoch 4|Withdrawal by Subject|0|||
33624906|NCT02059291|63025557|FG013|Epoch 4|Withdrawal by Subject|0|||
33624907|NCT02059291|63025558|FG014|Epoch 4|Withdrawal by Subject|0|||
33624908|NCT02059291|63025559|FG015|Epoch 4|Withdrawal by Subject|0|||
33624909|NCT02059291|63025560|FG016|Epoch 4|Withdrawal by Subject|0|||
33624910|NCT02059291|63025561|FG017|Epoch 4|Withdrawal by Subject|0|||
33624911|NCT02059291|63025562|FG018|Epoch 4|Withdrawal by Subject|0|||
33624912|NCT02059291|63025563|FG019|Epoch 4|Withdrawal by Subject|0|||
33624913|NCT02059291|63025564|FG020|Epoch 4|Withdrawal by Subject|1|||
33528244|NCT00489827|62916206|FG001|Overall Study|Intraoperative exclusion criteria|1|||
33528245|NCT02604433|62916214|FG000|Overall Study|Withdrawal by Subject|37|||
33528246|NCT02604433|62916215|FG001|Overall Study|Withdrawal by Subject|16|||
33528247|NCT02604433|62916214|FG000|Overall Study|Adverse Event|4|||
33528248|NCT02604433|62916215|FG001|Overall Study|Adverse Event|0|||
33528249|NCT02604433|62916214|FG000|Overall Study|Other reasons|3|||
33528250|NCT02604433|62916215|FG001|Overall Study|Other reasons|5|||
33528251|NCT02604433|62916214|FG000|Overall Study|Death|4|||
33528252|NCT02604433|62916215|FG001|Overall Study|Death|1|||
33528253|NCT02604433|62916214|FG000|Overall Study|Transition to Rollover Protocol|169|||
33528254|NCT02604433|62916215|FG001|Overall Study|Transition to Rollover Protocol|82|||
33528255|NCT02604433|62916214|FG000|Overall Study|Physician Decision|1|||
33528256|NCT02604433|62916215|FG001|Overall Study|Physician Decision|1|||
33528257|NCT02604433|62916214|FG000|Overall Study|Lack of Efficacy|0|||
33624914|NCT02059291|63025565|FG021|Epoch 4|Withdrawal by Subject|0|||
33624915|NCT02059291|63025566|FG022|Epoch 4|Withdrawal by Subject|0|||
33624916|NCT02059291|63025567|FG023|Epoch 4|Withdrawal by Subject|0|||
33624917|NCT02059291|63025568|FG024|Epoch 4|Withdrawal by Subject|0|||
33624918|NCT02059291|63025544|FG000|Epoch 4|Lack of Efficacy|0|||
33624919|NCT02059291|63025545|FG001|Epoch 4|Lack of Efficacy|0|||
33624920|NCT02059291|63025546|FG002|Epoch 4|Lack of Efficacy|0|||
33624921|NCT02059291|63025547|FG003|Epoch 4|Lack of Efficacy|0|||
33624922|NCT02059291|63025548|FG004|Epoch 4|Lack of Efficacy|0|||
33624923|NCT02059291|63025549|FG005|Epoch 4|Lack of Efficacy|0|||
33624924|NCT02059291|63025550|FG006|Epoch 4|Lack of Efficacy|0|||
33624925|NCT02059291|63025551|FG007|Epoch 4|Lack of Efficacy|0|||
33624926|NCT02059291|63025552|FG008|Epoch 4|Lack of Efficacy|0|||
33624927|NCT02059291|63025553|FG009|Epoch 4|Lack of Efficacy|0|||
33528258|NCT02604433|62916215|FG001|Overall Study|Lack of Efficacy|1|||
33528259|NCT02659150|62916221|FG000|Subject Enrollment|Physician Decision|3|||
33528260|NCT02659150|62916221|FG000|Subject Enrollment|Withdrawal by Subject|2|||
33528261|NCT02659150|62916221|FG000|Baseline Imaging|Withdrawal by Subject|1|||
33528262|NCT02659150|62916221|FG000|Baseline Imaging|Physician Decision|1|||
33528263|NCT02659150|62916221|FG000|Study Drug Dosing|Adverse Event|1|||
33528264|NCT03006393|62916228|FG000|Overall Study|Withdrawal by Subject|1|||
33528265|NCT03006393|62916229|FG001|Overall Study|Withdrawal by Subject|1|||
33528266|NCT03006393|62916228|FG000|Overall Study|Pregnancy|0|||
33528267|NCT03006393|62916229|FG001|Overall Study|Pregnancy|1|||
33528268|NCT03006393|62916228|FG000|Overall Study|Lost to Follow-up|0|||
33528269|NCT03006393|62916229|FG001|Overall Study|Lost to Follow-up|1|||
33528270|NCT00882440|62916246|FG000|Overall Study|Adverse Event|2|||
33624928|NCT02059291|63025554|FG010|Epoch 4|Lack of Efficacy|0|||
33624929|NCT02059291|63025555|FG011|Epoch 4|Lack of Efficacy|0|||
33624930|NCT02059291|63025556|FG012|Epoch 4|Lack of Efficacy|0|||
33528271|NCT00882440|62916247|FG001|Overall Study|Adverse Event|2|||
33528272|NCT00882440|62916248|FG002|Overall Study|Adverse Event|2|||
33528273|NCT00882440|62916249|FG003|Overall Study|Adverse Event|1|||
33528274|NCT00882440|62916250|FG004|Overall Study|Adverse Event|1|||
33528275|NCT00882440|62916251|FG005|Overall Study|Adverse Event|4|||
33528276|NCT00882440|62916252|FG006|Overall Study|Adverse Event|2|||
33528277|NCT00882440|62916246|FG000|Overall Study|Lack of Efficacy|3|||
33528278|NCT00882440|62916247|FG001|Overall Study|Lack of Efficacy|5|||
33528279|NCT00882440|62916248|FG002|Overall Study|Lack of Efficacy|2|||
33528280|NCT00882440|62916249|FG003|Overall Study|Lack of Efficacy|0|||
33528281|NCT00882440|62916250|FG004|Overall Study|Lack of Efficacy|0|||
33528282|NCT00882440|62916251|FG005|Overall Study|Lack of Efficacy|3|||
33624931|NCT02059291|63025557|FG013|Epoch 4|Lack of Efficacy|0|||
33624932|NCT02059291|63025558|FG014|Epoch 4|Lack of Efficacy|0|||
33624933|NCT02059291|63025559|FG015|Epoch 4|Lack of Efficacy|0|||
33624934|NCT02059291|63025560|FG016|Epoch 4|Lack of Efficacy|0|||
33624935|NCT02059291|63025561|FG017|Epoch 4|Lack of Efficacy|0|||
33624936|NCT02059291|63025562|FG018|Epoch 4|Lack of Efficacy|0|||
33624937|NCT02059291|63025563|FG019|Epoch 4|Lack of Efficacy|0|||
33624938|NCT02059291|63025564|FG020|Epoch 4|Lack of Efficacy|0|||
33624939|NCT02059291|63025565|FG021|Epoch 4|Lack of Efficacy|0|||
33325449|NCT01212770|62702217|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
33325450|NCT01212770|62702218|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
33325451|NCT01212770|62702219|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
33325452|NCT01212770|62702211|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
33325453|NCT01212770|62702212|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
33325454|NCT01212770|62702213|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
33325455|NCT01212770|62702214|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
33325456|NCT01212770|62702215|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
33325457|NCT01212770|62702216|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
33325458|NCT01212770|62702217|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
33325459|NCT01212770|62702218|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
33325460|NCT01212770|62702219|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
33325461|NCT01212770|62702211|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
33325462|NCT01212770|62702212|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
33325463|NCT01212770|62702213|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
33325464|NCT01212770|62702214|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
33325465|NCT01212770|62702215|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
33624940|NCT02059291|63025566|FG022|Epoch 4|Lack of Efficacy|0|||
33624941|NCT02059291|63025567|FG023|Epoch 4|Lack of Efficacy|1|||
33624942|NCT02059291|63025568|FG024|Epoch 4|Lack of Efficacy|0|||
33624943|NCT02042924|63025596|FG000|Overall Study|Early Death|1|||
33624944|NCT02041520|63025602|FG000|Overall Study|Adverse Event|2|||
33325466|NCT01212770|62702216|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
33325467|NCT01212770|62702217|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
33325468|NCT01212770|62702218|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
33325469|NCT01212770|62702219|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
33325470|NCT01212770|62702211|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33325471|NCT01212770|62702212|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33325472|NCT01212770|62702213|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
33325473|NCT01212770|62702214|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33325474|NCT01212770|62702215|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33325475|NCT01212770|62702216|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33325476|NCT01212770|62702217|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33325477|NCT01212770|62702218|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33325478|NCT01212770|62702219|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33325479|NCT01212770|62702211|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33325480|NCT01212770|62702212|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33325481|NCT01212770|62702213|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33325482|NCT01212770|62702214|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
33325483|NCT01212770|62702215|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33325484|NCT01212770|62702216|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33325485|NCT01212770|62702217|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33325486|NCT01212770|62702218|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33325487|NCT01212770|62702219|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33325488|NCT01212770|62702211|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
33325489|NCT01212770|62702212|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
33325490|NCT01212770|62702213|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
33325491|NCT01212770|62702214|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
33325492|NCT01212770|62702215|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
33325493|NCT01212770|62702216|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
33325494|NCT01212770|62702217|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
33325495|NCT01212770|62702218|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
33325496|NCT01212770|62702219|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
33325497|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33325498|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
33325499|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
33325500|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33325501|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33325502|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33624945|NCT02041520|63025603|FG001|Overall Study|Adverse Event|1|||
33624946|NCT02041520|63025602|FG000|Overall Study|Withdrawal by Subject|3|||
33624947|NCT02041520|63025603|FG001|Overall Study|Withdrawal by Subject|4|||
33624948|NCT02041520|63025602|FG000|Overall Study|Protocol Violation|1|||
33624949|NCT02041520|63025603|FG001|Overall Study|Protocol Violation|0|||
33624950|NCT02041520|63025602|FG000|Overall Study|Lost to Follow-up|0|||
33624951|NCT02041520|63025603|FG001|Overall Study|Lost to Follow-up|1|||
33624952|NCT02041520|63025602|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
33624953|NCT02041520|63025603|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
33624954|NCT02041429|63025615|FG000|Overall Study|Progressive Disease|2|||
33624955|NCT02041429|63025616|FG001|Overall Study|Progressive Disease|2|||
33624956|NCT02041429|63025617|FG002|Overall Study|Progressive Disease|3|||
33624957|NCT02041429|63025618|FG003|Overall Study|Progressive Disease|2|||
33624958|NCT02041429|63025615|FG000|Overall Study|Toxicity|0|||
33624959|NCT02041429|63025616|FG001|Overall Study|Toxicity|1|||
33624960|NCT02041429|63025617|FG002|Overall Study|Toxicity|4|||
33624961|NCT02041429|63025618|FG003|Overall Study|Toxicity|2|||
33624962|NCT02041429|63025615|FG000|Overall Study|Withdrawal by Subject|0|||
33624963|NCT02041429|63025616|FG001|Overall Study|Withdrawal by Subject|1|||
33624964|NCT02041429|63025617|FG002|Overall Study|Withdrawal by Subject|0|||
33624965|NCT02041429|63025618|FG003|Overall Study|Withdrawal by Subject|0|||
33624966|NCT02041429|63025615|FG000|Overall Study|On Maintenance Therapy|1|||
33624967|NCT02041429|63025616|FG001|Overall Study|On Maintenance Therapy|0|||
33624968|NCT02041429|63025617|FG002|Overall Study|On Maintenance Therapy|0|||
33624969|NCT02041429|63025618|FG003|Overall Study|On Maintenance Therapy|2|||
33624970|NCT02083783|63025635|FG000|Overall Study|Withdrawal by Subject|1|||
33624971|NCT02083783|63025636|FG001|Overall Study|Withdrawal by Subject|0|||
33624972|NCT02083081|63025646|FG000|Overall Study|Lost to Follow-up|31|||
33624973|NCT02083081|63025647|FG001|Overall Study|Lost to Follow-up|9|||
33624974|NCT02040805|63025655|FG000|Overall Study|Lost to Follow-up|14|||
33624975|NCT02040805|63025656|FG001|Overall Study|Lost to Follow-up|9|||
33624976|NCT02040805|63025655|FG000|Overall Study|Withdrawal by Subject|28|||
33624977|NCT02040805|63025656|FG001|Overall Study|Withdrawal by Subject|41|||
33624978|NCT02040259|63025662|FG000|Overall Study|Death|280|||
33624979|NCT02040259|63025662|FG000|Overall Study|Lost to Follow-up|76|||
33624980|NCT02040259|63025662|FG000|Overall Study|Assessment not completed|3|||
33624981|NCT02040259|63025662|FG000|Overall Study|Withdrawal by Subject|4|||
33624982|NCT02059135|63025670|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
33528283|NCT00882440|62916252|FG006|Overall Study|Lack of Efficacy|0|||
33528284|NCT00882440|62916246|FG000|Overall Study|Lost to Follow-up|2|||
33528285|NCT00882440|62916247|FG001|Overall Study|Lost to Follow-up|0|||
33528286|NCT00882440|62916248|FG002|Overall Study|Lost to Follow-up|1|||
33528287|NCT00882440|62916249|FG003|Overall Study|Lost to Follow-up|1|||
33528288|NCT00882440|62916250|FG004|Overall Study|Lost to Follow-up|1|||
33528289|NCT00882440|62916251|FG005|Overall Study|Lost to Follow-up|0|||
33528290|NCT00882440|62916252|FG006|Overall Study|Lost to Follow-up|1|||
33624983|NCT02059135|63025671|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
33624984|NCT02059135|63025670|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
33624985|NCT02059135|63025671|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
33624986|NCT02059135|63025670|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
33624987|NCT02059135|63025671|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
33624988|NCT02059135|63025670|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
33624989|NCT02059135|63025671|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
33528291|NCT00882440|62916246|FG000|Overall Study|Protocol Violation|0|||
33528292|NCT00882440|62916247|FG001|Overall Study|Protocol Violation|0|||
33528293|NCT00882440|62916248|FG002|Overall Study|Protocol Violation|1|||
33528294|NCT00882440|62916249|FG003|Overall Study|Protocol Violation|1|||
33528295|NCT00882440|62916250|FG004|Overall Study|Protocol Violation|1|||
33528296|NCT00882440|62916251|FG005|Overall Study|Protocol Violation|0|||
33528297|NCT00882440|62916252|FG006|Overall Study|Protocol Violation|0|||
33528298|NCT00882440|62916246|FG000|Overall Study|Withdrawal by Subject|2|||
33528299|NCT00882440|62916247|FG001|Overall Study|Withdrawal by Subject|1|||
33528300|NCT00882440|62916248|FG002|Overall Study|Withdrawal by Subject|1|||
33528301|NCT00882440|62916249|FG003|Overall Study|Withdrawal by Subject|0|||
33528302|NCT00882440|62916250|FG004|Overall Study|Withdrawal by Subject|6|||
33528303|NCT00882440|62916251|FG005|Overall Study|Withdrawal by Subject|0|||
33528304|NCT00882440|62916252|FG006|Overall Study|Withdrawal by Subject|1|||
33528305|NCT00882440|62916246|FG000|Overall Study|Patient Uncooperative|2|||
33528306|NCT00882440|62916247|FG001|Overall Study|Patient Uncooperative|0|||
33528307|NCT00882440|62916248|FG002|Overall Study|Patient Uncooperative|0|||
33528308|NCT00882440|62916249|FG003|Overall Study|Patient Uncooperative|0|||
33528309|NCT00882440|62916250|FG004|Overall Study|Patient Uncooperative|1|||
33624990|NCT02059135|63025670|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
33528310|NCT00882440|62916251|FG005|Overall Study|Patient Uncooperative|0|||
33528311|NCT00882440|62916252|FG006|Overall Study|Patient Uncooperative|0|||
33528312|NCT03005067|62916263|FG000|Overall Study|Withdrawal by Subject|3|||
33528313|NCT03005067|62916264|FG001|Overall Study|Withdrawal by Subject|2|||
33528314|NCT03005067|62916263|FG000|Overall Study|Adverse Event|4|||
33528315|NCT03005067|62916264|FG001|Overall Study|Adverse Event|3|||
33624991|NCT02059135|63025671|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
33624992|NCT02059135|63025670|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
33624993|NCT02059135|63025671|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
33624994|NCT02059135|63025670|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
33624995|NCT02059135|63025671|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
33624996|NCT02059135|63025670|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
33624997|NCT02059135|63025671|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
33624998|NCT02081677|63025683|FG000|Overall Study|Adverse Event|0|||
33624999|NCT02081677|63025684|FG001|Overall Study|Adverse Event|0|||
33625000|NCT02081677|63025685|FG002|Overall Study|Adverse Event|1|||
33625001|NCT02081677|63025686|FG003|Overall Study|Adverse Event|0|||
33625002|NCT02081677|63025683|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33625003|NCT02081677|63025684|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33625004|NCT02081677|63025685|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
33625005|NCT02081677|63025686|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
33625006|NCT02081677|63025683|FG000|Overall Study|Not comfortable with lens care system|1|||
33625007|NCT02081677|63025684|FG001|Overall Study|Not comfortable with lens care system|0|||
33625008|NCT02081677|63025685|FG002|Overall Study|Not comfortable with lens care system|0|||
33625009|NCT02081677|63025686|FG003|Overall Study|Not comfortable with lens care system|0|||
33625010|NCT02081677|63025683|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
33625011|NCT02081677|63025684|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
33625012|NCT02081677|63025685|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
33625013|NCT02081677|63025686|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
33625014|NCT02038933|63025698|FG000|Overall Study|Disease progression|104|||
33625015|NCT02038933|63025698|FG000|Overall Study|Study drug toxicity|6|||
33625016|NCT02038933|63025698|FG000|Overall Study|Adverse event unrelated to study drug|6|||
33625017|NCT02038933|63025698|FG000|Overall Study|Participant request to discontinue treatment|2|||
33625018|NCT02038933|63025698|FG000|Overall Study|Lost to Follow-up|1|||
33625019|NCT02038933|63025698|FG000|Overall Study|Other reasons|2|||
33625020|NCT02081599|63025705|FG000|Period 1：Double-blind Period|Adverse Event|3|||
33625021|NCT02081599|63025706|FG001|Period 1：Double-blind Period|Adverse Event|0|||
33625022|NCT02081599|63025705|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
33625023|NCT02081599|63025706|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
33625024|NCT02081599|63025705|FG000|Period 1：Double-blind Period|Physician Decision|1|||
33625025|NCT02081599|63025706|FG001|Period 1：Double-blind Period|Physician Decision|0|||
33625026|NCT02081599|63025705|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
33625027|NCT02081599|63025706|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
33625028|NCT02081599|63025705|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
33625029|NCT02081599|63025706|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
33528316|NCT03005067|62916263|FG000|Overall Study|Other (reason not specified)|3|||
33528317|NCT03005067|62916264|FG001|Overall Study|Other (reason not specified)|1|||
33528318|NCT03005067|62916263|FG000|Overall Study|Protocol Violation|0|||
33528319|NCT03005067|62916264|FG001|Overall Study|Protocol Violation|1|||
33528320|NCT02658448|62916270|FG000|Overall Study|Lost to Follow-up|1|||
33528321|NCT00870818|62916279|FG000|Overall Study|Lost to Follow-up|3|||
33528322|NCT00870818|62916280|FG001|Overall Study|Lost to Follow-up|2|||
33528323|NCT00870818|62916281|FG002|Overall Study|Lost to Follow-up|1|||
33528324|NCT00870818|62916282|FG003|Overall Study|Lost to Follow-up|0|||
33528325|NCT00870818|62916283|FG004|Overall Study|Lost to Follow-up|0|||
33528326|NCT00870818|62916279|FG000|Overall Study|Withdrawal by Subject|0|||
33528327|NCT00870818|62916280|FG001|Overall Study|Withdrawal by Subject|0|||
33528328|NCT00870818|62916281|FG002|Overall Study|Withdrawal by Subject|1|||
33528329|NCT00870818|62916282|FG003|Overall Study|Withdrawal by Subject|2|||
33528330|NCT00870818|62916283|FG004|Overall Study|Withdrawal by Subject|0|||
33528331|NCT00870818|62916279|FG000|Overall Study|Terminated by sponsor|29|||
33625030|NCT02081599|63025705|FG000|Period 1：Double-blind Period|stopping criteria|1|||
33625031|NCT02081599|63025706|FG001|Period 1：Double-blind Period|stopping criteria|0|||
33625032|NCT02081599|63025705|FG000|Period 2：Open-label Period|Adverse Event|1|||
33625033|NCT02081599|63025706|FG001|Period 2：Open-label Period|Adverse Event|0|||
33625034|NCT02081599|63025705|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
33625035|NCT02081599|63025706|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
33625036|NCT02081599|63025705|FG000|Period 2：Open-label Period|Physician Decision|1|||
33625037|NCT02081599|63025706|FG001|Period 2：Open-label Period|Physician Decision|0|||
33625038|NCT02081599|63025705|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
33625039|NCT02081599|63025706|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
33528332|NCT00870818|62916280|FG001|Overall Study|Terminated by sponsor|70|||
33625040|NCT02038543|63025718|FG000|Overall Study|Screen Failure|0|||
33625041|NCT02038543|63025719|FG001|Overall Study|Screen Failure|0|||
33625042|NCT02038543|63025720|FG002|Overall Study|Screen Failure|0|||
33625043|NCT02038543|63025721|FG003|Overall Study|Screen Failure|1|||
33528333|NCT00870818|62916281|FG002|Overall Study|Terminated by sponsor|36|||
33528334|NCT00870818|62916282|FG003|Overall Study|Terminated by sponsor|36|||
33528335|NCT00870818|62916283|FG004|Overall Study|Terminated by sponsor|38|||
33625044|NCT02038543|63025718|FG000|Overall Study|Withdrawal by Subject|0|||
33625045|NCT02038543|63025719|FG001|Overall Study|Withdrawal by Subject|0|||
33625046|NCT02038543|63025720|FG002|Overall Study|Withdrawal by Subject|0|||
33625047|NCT02038543|63025721|FG003|Overall Study|Withdrawal by Subject|1|||
33625048|NCT02038153|63025731|FG000|Overall Study|Withdrawal by Subject|1|||
33625049|NCT02038075|63025737|FG000|Overall Study|Withdrawal by Subject|3|||
33625050|NCT02038075|63025738|FG001|Overall Study|Withdrawal by Subject|0|||
33625051|NCT02058589|63025746|FG000|Overall Study|Serious Adverse Event|1|||
33625052|NCT02058589|63025747|FG001|Overall Study|Serious Adverse Event|1|||
33625053|NCT02058589|63025746|FG000|Overall Study|Non-Serious Adverse Event|1|||
33625054|NCT02058589|63025747|FG001|Overall Study|Non-Serious Adverse Event|0|||
33625055|NCT02058589|63025746|FG000|Overall Study|Withdrawal by Subject|0|||
33625056|NCT02058589|63025747|FG001|Overall Study|Withdrawal by Subject|1|||
33625057|NCT02079805|63025757|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33528336|NCT00870818|62916279|FG000|Overall Study|Other|0|||
33528337|NCT00870818|62916280|FG001|Overall Study|Other|1|||
33528338|NCT00870818|62916281|FG002|Overall Study|Other|0|||
33528339|NCT00870818|62916282|FG003|Overall Study|Other|0|||
33625058|NCT02079805|63025758|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
33625059|NCT02079805|63025757|FG000|Overall Study|Voluntary Withdrawal|0|||
33625060|NCT02079805|63025758|FG001|Overall Study|Voluntary Withdrawal|1|||
33625061|NCT02037295|63025768|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
33625062|NCT02037295|63025769|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
33625063|NCT02037295|63025770|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
33625064|NCT02037295|63025771|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
33625065|NCT02079649|63025787|FG000|Overall Study|Lost to Follow-up|0|||
33625066|NCT02079649|63025788|FG001|Overall Study|Lost to Follow-up|0|||
33625067|NCT02079649|63025789|FG002|Overall Study|Lost to Follow-up|0|||
33625068|NCT02079649|63025790|FG003|Overall Study|Lost to Follow-up|1|||
33625069|NCT02079649|63025787|FG000|Overall Study|Withdrawal by Subject|0|||
33625070|NCT02079649|63025788|FG001|Overall Study|Withdrawal by Subject|0|||
33625071|NCT02079649|63025789|FG002|Overall Study|Withdrawal by Subject|0|||
33625072|NCT02079649|63025790|FG003|Overall Study|Withdrawal by Subject|1|||
33625073|NCT02079649|63025787|FG000|Overall Study|Randomization error (prior to treatment)|1|||
33625074|NCT02079649|63025788|FG001|Overall Study|Randomization error (prior to treatment)|0|||
33625075|NCT02079649|63025789|FG002|Overall Study|Randomization error (prior to treatment)|1|||
33625076|NCT02079649|63025790|FG003|Overall Study|Randomization error (prior to treatment)|0|||
33625077|NCT02036515|63025804|FG000|Overall Study|Adverse Event|1|||
33625078|NCT02036515|63025805|FG001|Overall Study|Adverse Event|1|||
33528340|NCT00870818|62916283|FG004|Overall Study|Other|0|||
33528341|NCT03075761|62916297|FG000|Overall Study|Lost to Follow-up|1|||
33528342|NCT03075761|62916298|FG001|Overall Study|Lost to Follow-up|6|||
33528343|NCT03000075|62916312|FG000|Part A|Adverse Event|4|||
33528344|NCT03000075|62916313|FG001|Part A|Adverse Event|0|||
33528345|NCT03000075|62916314|FG002|Part A|Adverse Event|0|||
33528346|NCT03000075|62916315|FG003|Part A|Adverse Event|0|||
33528347|NCT03000075|62916316|FG004|Part A|Adverse Event|0|||
33528348|NCT03000075|62916317|FG005|Part A|Adverse Event|0|||
33528349|NCT03000075|62916318|FG006|Part A|Adverse Event|0|||
33625079|NCT02036515|63025806|FG002|Overall Study|Adverse Event|2|||
33625080|NCT02036515|63025804|FG000|Overall Study|Lost to Follow-up|0|||
33625081|NCT02036515|63025805|FG001|Overall Study|Lost to Follow-up|2|||
33625082|NCT02036515|63025806|FG002|Overall Study|Lost to Follow-up|0|||
33625083|NCT02036515|63025804|FG000|Overall Study|Non-compliance with study drug|0|||
33325503|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33325504|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33325505|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
33325506|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33325507|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
33625084|NCT02036515|63025805|FG001|Overall Study|Non-compliance with study drug|0|||
33457683|NCT03670810|62831944|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
33457684|NCT03670810|62831945|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
33457685|NCT03670810|62831946|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
33457686|NCT03670810|62831947|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
33457687|NCT03670810|62831939|FG000|Open Label Extension|Lost to Follow-up|0|||
33457688|NCT03670810|62831940|FG001|Open Label Extension|Lost to Follow-up|0|||
33457689|NCT03670810|62831941|FG002|Open Label Extension|Lost to Follow-up|0|||
33457690|NCT03670810|62831942|FG003|Open Label Extension|Lost to Follow-up|0|||
33457691|NCT03670810|62831943|FG004|Open Label Extension|Lost to Follow-up|0|||
33457692|NCT03670810|62831944|FG005|Open Label Extension|Lost to Follow-up|0|||
33528350|NCT03000075|62916312|FG000|Part B|Not dosed due to AE|0|||
33528351|NCT03000075|62916313|FG001|Part B|Not dosed due to AE|0|||
33528352|NCT03000075|62916314|FG002|Part B|Not dosed due to AE|0|||
33528353|NCT03000075|62916315|FG003|Part B|Not dosed due to AE|0|||
33625085|NCT02036515|63025806|FG002|Overall Study|Non-compliance with study drug|2|||
33625086|NCT02036515|63025804|FG000|Overall Study|Screen failure|0|||
33625087|NCT02036515|63025805|FG001|Overall Study|Screen failure|2|||
33625088|NCT02036515|63025806|FG002|Overall Study|Screen failure|0|||
33625089|NCT02036515|63025804|FG000|Overall Study|Withdrawal by Subject|4|||
33625090|NCT02036515|63025805|FG001|Overall Study|Withdrawal by Subject|7|||
33625091|NCT02036515|63025806|FG002|Overall Study|Withdrawal by Subject|9|||
33625092|NCT02036515|63025804|FG000|Overall Study|Hyperglycemia|0|||
33625093|NCT02036515|63025805|FG001|Overall Study|Hyperglycemia|0|||
33625094|NCT02036515|63025806|FG002|Overall Study|Hyperglycemia|1|||
33625095|NCT02078713|63025818|FG000|Overall Study|Lost to Follow-up|49|||
33625096|NCT02078713|63025819|FG001|Overall Study|Lost to Follow-up|55|||
33625097|NCT02078713|63025820|FG002|Overall Study|Lost to Follow-up|0|||
33625098|NCT02078713|63025821|FG003|Overall Study|Lost to Follow-up|0|||
33325508|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
33325509|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33325510|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33325511|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33325512|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33457693|NCT03670810|62831945|FG006|Open Label Extension|Lost to Follow-up|0|||
33457694|NCT03670810|62831946|FG007|Open Label Extension|Lost to Follow-up|0|||
33457695|NCT03670810|62831947|FG008|Open Label Extension|Lost to Follow-up|23|||
33457696|NCT00089648|62831961|FG000|Overall Study|Adverse Event|7|||
33457697|NCT00089648|62831961|FG000|Overall Study|Withdrawal by Subject|1|||
33457698|NCT00089648|62831961|FG000|Overall Study|Lack of Efficacy|33|||
33457699|NCT00118040|62831968|FG000|Overall Study|Adverse Event|0|||
33457700|NCT00118040|62831969|FG001|Overall Study|Adverse Event|1|||
33457701|NCT00118040|62831970|FG002|Overall Study|Adverse Event|0|||
33528354|NCT03000075|62916316|FG004|Part B|Not dosed due to AE|0|||
33528355|NCT03000075|62916317|FG005|Part B|Not dosed due to AE|2|||
33528356|NCT03000075|62916318|FG006|Part B|Not dosed due to AE|1|||
33528357|NCT03000075|62916312|FG000|Part B|Adverse Event|0|||
33528358|NCT03000075|62916313|FG001|Part B|Adverse Event|0|||
33528359|NCT03000075|62916314|FG002|Part B|Adverse Event|0|||
33528360|NCT03000075|62916315|FG003|Part B|Adverse Event|0|||
33528361|NCT03000075|62916316|FG004|Part B|Adverse Event|1|||
33528362|NCT03000075|62916317|FG005|Part B|Adverse Event|0|||
33528363|NCT03000075|62916318|FG006|Part B|Adverse Event|0|||
33528364|NCT03073109|62916336|FG000|Overall Study|Adverse Event|0|||
33528365|NCT03073109|62916337|FG001|Overall Study|Adverse Event|1|||
33528366|NCT03073109|62916336|FG000|Overall Study|Other|2|||
33528367|NCT03073109|62916337|FG001|Overall Study|Other|0|||
33528368|NCT03073109|62916336|FG000|Overall Study|Lost to Follow-up|8|||
33625099|NCT02078713|63025818|FG000|Overall Study|Pregnant at baseline|3|||
33457702|NCT00118040|62831968|FG000|Overall Study|Withdrawal by Subject|0|||
33457703|NCT00118040|62831969|FG001|Overall Study|Withdrawal by Subject|0|||
33625100|NCT02078713|63025819|FG001|Overall Study|Pregnant at baseline|5|||
33625101|NCT02078713|63025820|FG002|Overall Study|Pregnant at baseline|0|||
33528369|NCT03073109|62916337|FG001|Overall Study|Lost to Follow-up|1|||
33528370|NCT02371889|62916359|FG000|Overall Study|Adverse medication effect|11|||
33528371|NCT02371889|62916360|FG001|Overall Study|Adverse medication effect|2|||
33625102|NCT02078713|63025821|FG003|Overall Study|Pregnant at baseline|0|||
33625103|NCT02078713|63025818|FG000|Overall Study|Enrolled twice|0|||
33625104|NCT02078713|63025819|FG001|Overall Study|Enrolled twice|1|||
33625105|NCT02078713|63025820|FG002|Overall Study|Enrolled twice|0|||
33625106|NCT02078713|63025821|FG003|Overall Study|Enrolled twice|0|||
33625107|NCT02035267|63025837|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
33625108|NCT02035267|63025838|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
33625109|NCT02035267|63025839|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
33625110|NCT02035267|63025840|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
33625111|NCT02035267|63025837|FG000|Overall Study|Adverse Event|0|||
33625112|NCT02035267|63025838|FG001|Overall Study|Adverse Event|0|||
33625113|NCT02035267|63025839|FG002|Overall Study|Adverse Event|1|||
33625114|NCT02035267|63025840|FG003|Overall Study|Adverse Event|0|||
33625115|NCT02035267|63025837|FG000|Overall Study|Lost to Follow-up|0|||
33625116|NCT02035267|63025838|FG001|Overall Study|Lost to Follow-up|0|||
33625117|NCT02035267|63025839|FG002|Overall Study|Lost to Follow-up|0|||
33625118|NCT02035267|63025840|FG003|Overall Study|Lost to Follow-up|1|||
33625119|NCT02035267|63025837|FG000|Overall Study|Other unspecified|0|||
33625120|NCT02035267|63025838|FG001|Overall Study|Other unspecified|1|||
33625121|NCT02035267|63025839|FG002|Overall Study|Other unspecified|0|||
33625122|NCT02035267|63025840|FG003|Overall Study|Other unspecified|0|||
33625123|NCT04373460|63025874|FG000|Overall Study|Did not receive tranfusion|18|||
33625124|NCT04373460|63025875|FG001|Overall Study|Did not receive tranfusion|26|||
33625125|NCT04280081|63025885|FG000|Overall Study|Adverse Event|4|||
33625126|NCT04280081|63025885|FG000|Overall Study|Death|2|||
33625127|NCT04280081|63025885|FG000|Overall Study|Progressive Disease|6|||
33625128|NCT04159805|63025901|FG000|Overall Study|Withdrawal by Subject|0|||
33625129|NCT04159805|63025902|FG001|Overall Study|Withdrawal by Subject|2|||
33625130|NCT04159805|63025903|FG002|Overall Study|Withdrawal by Subject|2|||
33625131|NCT03901456|63025914|FG000|Overall Study|Withdrawal by Subject|0|||
33625132|NCT03901456|63025915|FG001|Overall Study|Withdrawal by Subject|0|||
33625133|NCT03901456|63025916|FG002|Overall Study|Withdrawal by Subject|1|||
33625134|NCT03901456|63025914|FG000|Overall Study|Lost to Follow-up|0|||
33625135|NCT03901456|63025915|FG001|Overall Study|Lost to Follow-up|1|||
33625136|NCT03901456|63025916|FG002|Overall Study|Lost to Follow-up|0|||
33625137|NCT03286504|63025969|FG000|Overall Study|Lost to Follow-up|19|||
33625138|NCT03286504|63025970|FG001|Overall Study|Lost to Follow-up|16|||
33625139|NCT03226249|63025976|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
33625140|NCT03226249|63025976|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
33625141|NCT03226249|63025976|FG000|Survival Follow-up|Patients still in follow-up.|30|||
33625142|NCT02941926|63025980|FG000|Overall Study|Progressive disease|1109|||
33625143|NCT02941926|63025980|FG000|Overall Study|Adverse Event|504|||
33625144|NCT02941926|63025980|FG000|Overall Study|Subject/guardian decision|127|||
33625145|NCT02941926|63025980|FG000|Overall Study|Physician Decision|112|||
33625146|NCT02941926|63025980|FG000|Overall Study|Death|46|||
33625147|NCT02941926|63025980|FG000|Overall Study|Protocol deviation|34|||
33625148|NCT02941926|63025980|FG000|Overall Study|Lost to Follow-up|8|||
33625149|NCT02941926|63025980|FG000|Overall Study|Technical problems|5|||
33528372|NCT02371889|62916359|FG000|Overall Study|Lost to Follow-up|6|||
33528373|NCT02371889|62916360|FG001|Overall Study|Lost to Follow-up|5|||
33528374|NCT02371889|62916359|FG000|Overall Study|Personal time constraints|2|||
33528375|NCT02371889|62916360|FG001|Overall Study|Personal time constraints|4|||
33528376|NCT02371889|62916359|FG000|Overall Study|Lack of Efficacy|0|||
33528377|NCT02371889|62916360|FG001|Overall Study|Lack of Efficacy|2|||
33528378|NCT02371889|62916359|FG000|Overall Study|Relapse|0|||
33528379|NCT02371889|62916360|FG001|Overall Study|Relapse|1|||
33625150|NCT02849548|63025988|FG000|Overall Study|Lost to Follow-up|1|||
33625151|NCT02849548|63025989|FG001|Overall Study|Lost to Follow-up|2|||
33625152|NCT02849548|63025988|FG000|Overall Study|Protocol Violation|1|||
33625153|NCT02849548|63025989|FG001|Overall Study|Protocol Violation|0|||
33625154|NCT02411448|63026007|FG000|Overall Study|Withdrawal by Subject|1|||
33625155|NCT02411448|63026008|FG001|Overall Study|Withdrawal by Subject|14|||
33625156|NCT02411448|63026009|FG002|Overall Study|Withdrawal by Subject|9|||
33528380|NCT03072875|62916370|FG000|Overall Study|Lost to Follow-up|1|||
33625157|NCT02411448|63026007|FG000|Overall Study|Other|0|||
33625158|NCT02411448|63026008|FG001|Overall Study|Other|2|||
33625159|NCT02411448|63026009|FG002|Overall Study|Other|0|||
33625160|NCT02411448|63026007|FG000|Overall Study|Did not receive study treatment|0|||
33625161|NCT02411448|63026008|FG001|Overall Study|Did not receive study treatment|3|||
33625162|NCT02411448|63026009|FG002|Overall Study|Did not receive study treatment|0|||
33625163|NCT02411448|63026007|FG000|Overall Study|Alive on study treatment|3|||
33625164|NCT02411448|63026008|FG001|Overall Study|Alive on study treatment|64|||
33625165|NCT02411448|63026009|FG002|Overall Study|Alive on study treatment|43|||
33325513|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
33325514|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
33325515|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33325516|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
33457704|NCT00118040|62831970|FG002|Overall Study|Withdrawal by Subject|2|||
33457705|NCT00118040|62831968|FG000|Overall Study|Medical Contraindication|0|||
33457706|NCT00118040|62831969|FG001|Overall Study|Medical Contraindication|0|||
33457707|NCT00118040|62831970|FG002|Overall Study|Medical Contraindication|1|||
33457708|NCT00118040|62831968|FG000|Overall Study|Non-Compliant Participant|1|||
33457709|NCT00118040|62831969|FG001|Overall Study|Non-Compliant Participant|1|||
33457710|NCT00118040|62831970|FG002|Overall Study|Non-Compliant Participant|2|||
33457711|NCT00118040|62831968|FG000|Overall Study|Other|0|||
33457712|NCT00118040|62831969|FG001|Overall Study|Other|0|||
33457713|NCT00118040|62831970|FG002|Overall Study|Other|1|||
33528381|NCT04250077|62916378|FG000|Overall Study|Withdrawal by Subject|0|||
33528382|NCT04250077|62916379|FG001|Overall Study|Withdrawal by Subject|1|||
33528383|NCT04250077|62916380|FG002|Overall Study|Withdrawal by Subject|0|||
33528384|NCT04250077|62916378|FG000|Overall Study|Lost to Follow-up|2|||
33528385|NCT04250077|62916379|FG001|Overall Study|Lost to Follow-up|3|||
33528386|NCT04250077|62916380|FG002|Overall Study|Lost to Follow-up|0|||
33528387|NCT00859430|62916392|FG000|First Intervention|Withdrawal by Subject|0|||
33528388|NCT00859430|62916393|FG001|First Intervention|Withdrawal by Subject|1|||
33528389|NCT02913105|62916410|FG000|Overall Study|Adverse Event|11|||
33625166|NCT02321514|63026021|FG000|Overall Study|Death|15|||
33457714|NCT00389207|62831986|FG000|Overall Study|Adverse Event|26|||
33457715|NCT00389207|62831987|FG001|Overall Study|Adverse Event|32|||
33457716|NCT00389207|62831988|FG002|Overall Study|Adverse Event|10|||
33457717|NCT00389207|62831986|FG000|Overall Study|Protocol Violation|3|||
33457718|NCT00389207|62831987|FG001|Overall Study|Protocol Violation|1|||
33457719|NCT00389207|62831988|FG002|Overall Study|Protocol Violation|4|||
33457720|NCT00389207|62831986|FG000|Overall Study|Lost to Follow-up|12|||
33457721|NCT00389207|62831987|FG001|Overall Study|Lost to Follow-up|9|||
33457722|NCT00389207|62831988|FG002|Overall Study|Lost to Follow-up|7|||
33457723|NCT00389207|62831986|FG000|Overall Study|Withdrawal by Subject|5|||
33457724|NCT00389207|62831987|FG001|Overall Study|Withdrawal by Subject|7|||
33457725|NCT00389207|62831988|FG002|Overall Study|Withdrawal by Subject|11|||
33457726|NCT00389207|62831986|FG000|Overall Study|Other|17|||
33457727|NCT00389207|62831987|FG001|Overall Study|Other|23|||
33457728|NCT00389207|62831988|FG002|Overall Study|Other|9|||
33457729|NCT00388973|62832003|FG000|Overall Study|Adverse Event|16|||
33457730|NCT00388973|62832004|FG001|Overall Study|Adverse Event|6|||
33457731|NCT00388973|62832003|FG000|Overall Study|Lack of Efficacy|1|||
33325517|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33457732|NCT00388973|62832004|FG001|Overall Study|Lack of Efficacy|12|||
33457733|NCT00388973|62832003|FG000|Overall Study|Protocol Violation|3|||
33457734|NCT00388973|62832004|FG001|Overall Study|Protocol Violation|0|||
33457735|NCT00388973|62832003|FG000|Overall Study|Withdrawal by Subject|14|||
33457736|NCT00388973|62832004|FG001|Overall Study|Withdrawal by Subject|17|||
33457737|NCT00388973|62832003|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
33457738|NCT00388973|62832004|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
33625167|NCT02321514|63026021|FG000|Overall Study|Missed Visit|7|||
33325518|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33457739|NCT00388973|62832003|FG000|Overall Study|Did not complete 61 days of treatment|5|||
33457740|NCT00388973|62832004|FG001|Overall Study|Did not complete 61 days of treatment|4|||
33457741|NCT00388973|62832003|FG000|Overall Study|Left region|0|||
33457742|NCT00388973|62832004|FG001|Overall Study|Left region|1|||
33528390|NCT02913105|62916411|FG001|Overall Study|Adverse Event|0|||
33457743|NCT00388973|62832003|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
33457744|NCT00388973|62832004|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
33457745|NCT00388583|62832012|FG000|Overall Study|Protocol Violation|1|||
33457746|NCT00388583|62832013|FG001|Overall Study|Protocol Violation|0|||
33625168|NCT02321514|63026021|FG000|Overall Study|Study Exit|3|||
33625169|NCT02266134|63026029|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
33625170|NCT02266134|63026030|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
33625171|NCT02266134|63026031|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
33625172|NCT02266134|63026032|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
33625173|NCT02266134|63026029|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
33625174|NCT02266134|63026030|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
33625175|NCT02266134|63026031|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
33625176|NCT02266134|63026032|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
33625177|NCT02266134|63026029|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
33625178|NCT02266134|63026030|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
33625179|NCT02266134|63026031|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
33625180|NCT02266134|63026032|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
33625181|NCT02266134|63026029|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
33625182|NCT02266134|63026030|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
33625183|NCT02266134|63026031|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
33625184|NCT02266134|63026032|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
33625185|NCT02266134|63026029|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
33625186|NCT02266134|63026030|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
33625187|NCT02266134|63026031|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
33625188|NCT02266134|63026032|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
33625189|NCT02266134|63026029|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
33625190|NCT02266134|63026030|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
33625191|NCT02266134|63026031|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
33625192|NCT02266134|63026032|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
33625193|NCT01847274|63026060|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
33625194|NCT01847274|63026061|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
33625195|NCT01847274|63026062|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
33625196|NCT01847274|63026063|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
33625197|NCT01847274|63026064|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
33625198|NCT01847274|63026065|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
33625199|NCT01847274|63026066|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
33625200|NCT01847274|63026067|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
33625201|NCT01847274|63026068|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
33625202|NCT01847274|63026069|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
33625203|NCT01847274|63026070|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
33625204|NCT01847274|63026060|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
33625205|NCT01847274|63026061|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
33625206|NCT01847274|63026062|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
33625207|NCT01847274|63026063|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
33625208|NCT01847274|63026064|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
33625209|NCT01847274|63026065|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
33625210|NCT01847274|63026066|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
33625211|NCT01847274|63026067|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
33625212|NCT01847274|63026068|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
33457747|NCT00388583|62832012|FG000|Overall Study|Withdrawal by Subject|3|||
33457748|NCT00388583|62832013|FG001|Overall Study|Withdrawal by Subject|3|||
33457749|NCT00388583|62832012|FG000|Overall Study|Serious Adverse Event|2|||
33457750|NCT00388583|62832013|FG001|Overall Study|Serious Adverse Event|0|||
33457751|NCT00388583|62832012|FG000|Overall Study|Did not receive vaccine|0|||
33457752|NCT00388583|62832013|FG001|Overall Study|Did not receive vaccine|1|||
33457753|NCT00117572|62832021|FG000|Overall Study|Site withdrew before starting treatment|2|||
33528391|NCT02913105|62916412|FG002|Overall Study|Adverse Event|4|||
33528392|NCT02913105|62916410|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33528393|NCT02913105|62916411|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33528394|NCT02913105|62916412|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33528395|NCT02913105|62916410|FG000|Overall Study|Reason Not Specified|3|||
33528396|NCT02913105|62916411|FG001|Overall Study|Reason Not Specified|1|||
33528397|NCT02913105|62916412|FG002|Overall Study|Reason Not Specified|1|||
33528398|NCT02913105|62916410|FG000|Overall Study|Physician Decision|1|||
33528399|NCT02913105|62916411|FG001|Overall Study|Physician Decision|1|||
33528400|NCT02913105|62916412|FG002|Overall Study|Physician Decision|0|||
33528401|NCT02913105|62916410|FG000|Overall Study|Withdrawal by Subject|0|||
33528402|NCT02913105|62916411|FG001|Overall Study|Withdrawal by Subject|3|||
33528403|NCT02913105|62916412|FG002|Overall Study|Withdrawal by Subject|1|||
33528404|NCT00840632|62916430|FG000|First Intervention|Withdrawal by Subject|0|||
33528405|NCT00840632|62916431|FG001|First Intervention|Withdrawal by Subject|1|||
33528406|NCT00840632|62916430|FG000|Washout|Withdrawal by Subject|1|||
33528407|NCT00840632|62916431|FG001|Washout|Withdrawal by Subject|1|||
33528408|NCT01602562|62916448|FG000|Overall Study|Adverse Event|3|||
33528409|NCT01602562|62916449|FG001|Overall Study|Adverse Event|1|||
33528410|NCT01602562|62916448|FG000|Overall Study|Physician Decision|1|||
33528411|NCT01602562|62916449|FG001|Overall Study|Physician Decision|1|||
33528412|NCT01602562|62916448|FG000|Overall Study|Withdrawal by Subject|1|||
33528413|NCT01602562|62916449|FG001|Overall Study|Withdrawal by Subject|1|||
33528414|NCT01945775|62916458|FG000|Overall Study|Death|214|||
33528415|NCT01945775|62916459|FG001|Overall Study|Death|98|||
33528416|NCT01945775|62916458|FG000|Overall Study|Lost to Follow-up|12|||
33528417|NCT01945775|62916459|FG001|Overall Study|Lost to Follow-up|7|||
33528418|NCT01945775|62916458|FG000|Overall Study|Withdrawal by Subject|11|||
33528419|NCT01945775|62916459|FG001|Overall Study|Withdrawal by Subject|21|||
33528420|NCT01945775|62916458|FG000|Overall Study|Other|50|||
33528421|NCT01945775|62916459|FG001|Overall Study|Other|18|||
33528422|NCT03072719|62916487|FG000|Overall Study|Adverse Event|1|||
33528423|NCT03072719|62916488|FG001|Overall Study|Adverse Event|1|||
33528424|NCT00835796|62916496|FG000|First Intervention|Withdrawal by Subject|0|||
33528425|NCT00835796|62916497|FG001|First Intervention|Withdrawal by Subject|1|||
33528426|NCT00835640|62916503|FG000|Second Intervention|Protocol Violation|1|||
33528427|NCT00835640|62916504|FG001|Second Intervention|Protocol Violation|0|||
33528428|NCT02942017|62916510|FG000|Overall Study|Adverse Event|0|||
33528429|NCT02942017|62916511|FG001|Overall Study|Adverse Event|1|||
33528430|NCT02942017|62916510|FG000|Overall Study|Withdrawal by Subject|0|||
33528431|NCT02942017|62916511|FG001|Overall Study|Withdrawal by Subject|1|||
33528432|NCT02942017|62916510|FG000|Overall Study|Lost to Follow-up|1|||
33528433|NCT02942017|62916511|FG001|Overall Study|Lost to Follow-up|1|||
33528434|NCT02942017|62916510|FG000|Overall Study|Randomized but not dosed|1|||
33528435|NCT02942017|62916511|FG001|Overall Study|Randomized but not dosed|3|||
33528436|NCT00835406|62916526|FG000|Period: First Intervention|Adverse Event|0|||
33528437|NCT00835406|62916527|FG001|Period: First Intervention|Adverse Event|1|||
33528438|NCT00835406|62916526|FG000|Period: First Intervention|Withdrawal by Subject|2|||
33528439|NCT00835406|62916527|FG001|Period: First Intervention|Withdrawal by Subject|0|||
33528440|NCT00835406|62916526|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
33528441|NCT00835406|62916527|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
33528442|NCT00835172|62916533|FG000|Washout|Protocol Violation|0|||
33528443|NCT00835172|62916534|FG001|Washout|Protocol Violation|1|||
33528444|NCT01676116|62916540|FG000|Overall Study|Withdrawal criteria|2|||
33528445|NCT01676116|62916541|FG001|Overall Study|Withdrawal criteria|14|||
33528446|NCT01676116|62916540|FG000|Overall Study|Adverse Event|1|||
33528447|NCT01676116|62916541|FG001|Overall Study|Adverse Event|2|||
33528448|NCT01676116|62916540|FG000|Overall Study|Unclassified|4|||
33528449|NCT01676116|62916541|FG001|Overall Study|Unclassified|10|||
33528450|NCT01676116|62916540|FG000|Overall Study|Protocol Violation|9|||
33528451|NCT01676116|62916541|FG001|Overall Study|Protocol Violation|3|||
33528452|NCT00740480|62916547|FG000|Overall Study|Adverse Event|1|||
33528453|NCT00740480|62916547|FG000|Overall Study|Physician Decision|1|||
33528454|NCT02743520|62916550|FG000|Overall Study|Withdrawal by Subject|1|||
33528455|NCT03001557|62916569|FG000|Core Phase|Randomized but not treated|0|||
33528456|NCT03001557|62916570|FG001|Core Phase|Randomized but not treated|0|||
33528457|NCT03001557|62916571|FG002|Core Phase|Randomized but not treated|1|||
33528458|NCT03001557|62916572|FG003|Core Phase|Randomized but not treated|0|||
33528459|NCT03001557|62916573|FG004|Core Phase|Randomized but not treated|0|||
33528460|NCT03001557|62916574|FG005|Core Phase|Randomized but not treated|0|||
33528461|NCT03001557|62916575|FG006|Core Phase|Randomized but not treated|0|||
33528462|NCT03001557|62916576|FG007|Core Phase|Randomized but not treated|0|||
33528463|NCT03001557|62916569|FG000|Extension Phase|Adverse Event|0|||
33528464|NCT03001557|62916570|FG001|Extension Phase|Adverse Event|0|||
33528465|NCT03001557|62916571|FG002|Extension Phase|Adverse Event|0|||
33528466|NCT03001557|62916572|FG003|Extension Phase|Adverse Event|0|||
33528467|NCT03001557|62916573|FG004|Extension Phase|Adverse Event|0|||
33528468|NCT03001557|62916574|FG005|Extension Phase|Adverse Event|2|||
33528469|NCT03001557|62916575|FG006|Extension Phase|Adverse Event|0|||
33528470|NCT03001557|62916576|FG007|Extension Phase|Adverse Event|0|||
33528471|NCT03001557|62916569|FG000|Extension Phase|Withdrawal by Subject|0|||
33528472|NCT03001557|62916570|FG001|Extension Phase|Withdrawal by Subject|0|||
33528473|NCT03001557|62916571|FG002|Extension Phase|Withdrawal by Subject|0|||
33528474|NCT03001557|62916572|FG003|Extension Phase|Withdrawal by Subject|0|||
33528475|NCT03001557|62916573|FG004|Extension Phase|Withdrawal by Subject|0|||
33457754|NCT00117572|62832022|FG001|Overall Study|Site withdrew before starting treatment|3|||
33457755|NCT00117572|62832021|FG000|Overall Study|Withdrawal by Subject|3|||
33457756|NCT00117572|62832022|FG001|Overall Study|Withdrawal by Subject|3|||
33457757|NCT00117572|62832021|FG000|Overall Study|Protocol Violation|1|||
33457758|NCT00117572|62832022|FG001|Overall Study|Protocol Violation|0|||
33457759|NCT00388505|62832030|FG000|Overall Study|Adverse Event or Death|43|||
33528476|NCT03001557|62916574|FG005|Extension Phase|Withdrawal by Subject|1|||
33528477|NCT03001557|62916575|FG006|Extension Phase|Withdrawal by Subject|5|||
33528478|NCT03001557|62916576|FG007|Extension Phase|Withdrawal by Subject|2|||
33528479|NCT03001557|62916569|FG000|Extension Phase|Lost to Follow-up|0|||
33528480|NCT03001557|62916570|FG001|Extension Phase|Lost to Follow-up|0|||
33528481|NCT03001557|62916571|FG002|Extension Phase|Lost to Follow-up|0|||
33528482|NCT03001557|62916572|FG003|Extension Phase|Lost to Follow-up|0|||
33528483|NCT03001557|62916573|FG004|Extension Phase|Lost to Follow-up|0|||
33528484|NCT03001557|62916574|FG005|Extension Phase|Lost to Follow-up|0|||
33528485|NCT03001557|62916575|FG006|Extension Phase|Lost to Follow-up|2|||
33528486|NCT03001557|62916576|FG007|Extension Phase|Lost to Follow-up|1|||
33528487|NCT03001557|62916569|FG000|Extension Phase|Administrative Reason|0|||
33528488|NCT03001557|62916570|FG001|Extension Phase|Administrative Reason|0|||
33528489|NCT03001557|62916571|FG002|Extension Phase|Administrative Reason|0|||
33528490|NCT03001557|62916572|FG003|Extension Phase|Administrative Reason|0|||
33528491|NCT03001557|62916573|FG004|Extension Phase|Administrative Reason|0|||
33528492|NCT03001557|62916574|FG005|Extension Phase|Administrative Reason|1|||
33528493|NCT03001557|62916575|FG006|Extension Phase|Administrative Reason|3|||
33528494|NCT03001557|62916576|FG007|Extension Phase|Administrative Reason|3|||
33457760|NCT00388505|62832031|FG001|Overall Study|Adverse Event or Death|17|||
33457761|NCT00388505|62832030|FG000|Overall Study|Withdrawal by Subject|24|||
33457762|NCT00388505|62832031|FG001|Overall Study|Withdrawal by Subject|9|||
33457763|NCT00388505|62832030|FG000|Overall Study|Lost to Follow-up|5|||
33457764|NCT00388505|62832031|FG001|Overall Study|Lost to Follow-up|3|||
33457765|NCT00388505|62832030|FG000|Overall Study|Inappropriate Enrollment|0|||
33457766|NCT00388505|62832031|FG001|Overall Study|Inappropriate Enrollment|1|||
33457767|NCT00388505|62832030|FG000|Overall Study|Administrative Reason|1|||
33457768|NCT00388505|62832031|FG001|Overall Study|Administrative Reason|0|||
33457769|NCT00388505|62832030|FG000|Overall Study|Protocol Violation|6|||
33457770|NCT00388505|62832031|FG001|Overall Study|Protocol Violation|5|||
33457771|NCT00388505|62832030|FG000|Overall Study|Unable to classify|4|||
33457772|NCT00388505|62832031|FG001|Overall Study|Unable to classify|3|||
33457773|NCT00388349|62832037|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
33457774|NCT00388349|62832038|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
33457775|NCT00117338|62832048|FG000|Overall Study|Adverse Event|0|||
33457776|NCT00117338|62832049|FG001|Overall Study|Adverse Event|1|||
33457777|NCT00117338|62832048|FG000|Overall Study|Protocol Violation|3|||
33528495|NCT03001557|62916569|FG000|Extension Phase|Loss of caregiver|0|||
33528496|NCT03001557|62916570|FG001|Extension Phase|Loss of caregiver|0|||
33528497|NCT03001557|62916571|FG002|Extension Phase|Loss of caregiver|0|||
33457778|NCT00117338|62832049|FG001|Overall Study|Protocol Violation|2|||
33457779|NCT00117338|62832048|FG000|Overall Study|Withdrawal by Subject|1|||
33457780|NCT00117338|62832049|FG001|Overall Study|Withdrawal by Subject|0|||
33457781|NCT00117338|62832048|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
33457782|NCT00117338|62832049|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
33457783|NCT00117338|62832048|FG000|Overall Study|Lack of Efficacy|0|||
33457784|NCT00117338|62832049|FG001|Overall Study|Lack of Efficacy|1|||
33457785|NCT00388037|62832055|FG000|Overall Study|Protocol Violation|1|||
33457786|NCT00387881|62832061|FG000|Overall Study|Lost to Follow-up|23|||
33457787|NCT00387881|62832062|FG001|Overall Study|Lost to Follow-up|23|||
33457788|NCT00387881|62832061|FG000|Overall Study|Protocol Violation|2|||
33457789|NCT00387881|62832062|FG001|Overall Study|Protocol Violation|12|||
33457790|NCT00387881|62832061|FG000|Overall Study|Withdrawal by Subject|15|||
33457791|NCT00387881|62832062|FG001|Overall Study|Withdrawal by Subject|18|||
33457792|NCT00387881|62832061|FG000|Overall Study|Sponsor terminated Study|0|||
33457793|NCT00387881|62832062|FG001|Overall Study|Sponsor terminated Study|1|||
33457794|NCT00387881|62832061|FG000|Overall Study|Not eligible|6|||
33457795|NCT00387881|62832062|FG001|Overall Study|Not eligible|7|||
33457796|NCT00387881|62832061|FG000|Overall Study|No opportunity to treat headache|32|||
33457797|NCT00387881|62832062|FG001|Overall Study|No opportunity to treat headache|34|||
33457798|NCT00387881|62832061|FG000|Overall Study|Not otherwise specified|11|||
33457799|NCT00387881|62832062|FG001|Overall Study|Not otherwise specified|7|||
33457800|NCT00084656|62832071|FG000|Overall Study|Other reasons|0|||
33457801|NCT00084656|62832072|FG001|Overall Study|Other reasons|12|||
33457802|NCT00084656|62832073|FG002|Overall Study|Other reasons|11|||
33457803|NCT00084656|62832071|FG000|Overall Study|Withdrawal by Subject|15|||
33457804|NCT00084656|62832072|FG001|Overall Study|Withdrawal by Subject|4|||
33457805|NCT00084656|62832073|FG002|Overall Study|Withdrawal by Subject|4|||
33457806|NCT00084656|62832071|FG000|Overall Study|Disease relapse|0|||
33457807|NCT00084656|62832072|FG001|Overall Study|Disease relapse|9|||
33457808|NCT00084656|62832073|FG002|Overall Study|Disease relapse|10|||
33457809|NCT00084656|62832071|FG000|Overall Study|Disease progression|9|||
33457810|NCT00084656|62832072|FG001|Overall Study|Disease progression|0|||
33457811|NCT00084656|62832073|FG002|Overall Study|Disease progression|0|||
33457812|NCT00084656|62832071|FG000|Overall Study|Lost to Follow-up|1|||
33457813|NCT00084656|62832072|FG001|Overall Study|Lost to Follow-up|0|||
33528498|NCT03001557|62916572|FG003|Extension Phase|Loss of caregiver|0|||
33528499|NCT03001557|62916573|FG004|Extension Phase|Loss of caregiver|0|||
33528500|NCT03001557|62916574|FG005|Extension Phase|Loss of caregiver|0|||
33528501|NCT03001557|62916575|FG006|Extension Phase|Loss of caregiver|1|||
33528502|NCT03001557|62916576|FG007|Extension Phase|Loss of caregiver|0|||
33528503|NCT03001557|62916569|FG000|Extension Phase|Others|0|||
33528504|NCT03001557|62916570|FG001|Extension Phase|Others|0|||
33528505|NCT03001557|62916571|FG002|Extension Phase|Others|0|||
33528506|NCT03001557|62916572|FG003|Extension Phase|Others|0|||
33528507|NCT03001557|62916573|FG004|Extension Phase|Others|0|||
33528508|NCT03001557|62916574|FG005|Extension Phase|Others|1|||
33528509|NCT03001557|62916575|FG006|Extension Phase|Others|3|||
33457814|NCT00084656|62832073|FG002|Overall Study|Lost to Follow-up|1|||
33457815|NCT00387725|62832087|FG000|Overall Study|Adverse Event|0|||
33457816|NCT00387725|62832088|FG001|Overall Study|Adverse Event|0|||
33457817|NCT00387725|62832089|FG002|Overall Study|Adverse Event|0|||
33457818|NCT00387725|62832090|FG003|Overall Study|Adverse Event|1|||
33457819|NCT00387725|62832087|FG000|Overall Study|Protocol Violation|0|||
33528510|NCT03001557|62916576|FG007|Extension Phase|Others|0|||
33528511|NCT00830336|62916613|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
33528512|NCT00830336|62916614|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
33528513|NCT00830258|62916620|FG000|First Intervention|Adverse Event|1|||
33528514|NCT00830258|62916621|FG001|First Intervention|Adverse Event|0|||
33528515|NCT00830258|62916620|FG000|Washout: 7 Days|Protocol Violation|1|||
33528516|NCT00830258|62916621|FG001|Washout: 7 Days|Protocol Violation|0|||
33528517|NCT03349775|62916627|FG000|Overall Study|Side Effects|1|||
33528518|NCT03349775|62916628|FG001|Overall Study|Side Effects|2|||
33528519|NCT03349775|62916627|FG000|Overall Study|Withdrawal by Subject|1|||
33528520|NCT03349775|62916628|FG001|Overall Study|Withdrawal by Subject|1|||
33528521|NCT03349775|62916627|FG000|Overall Study|No primary outcome measurements|0|||
33528522|NCT03349775|62916628|FG001|Overall Study|No primary outcome measurements|1|||
33528523|NCT00830024|62916636|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
33528524|NCT00830024|62916637|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
33528525|NCT00829868|62916643|FG000|Washout|Physician Decision|1|||
33528526|NCT00829868|62916644|FG001|Washout|Physician Decision|0|||
33528527|NCT00829790|62916650|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
33528528|NCT00829790|62916651|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
33528529|NCT03207815|62916657|FG000|Overall Study|Protocol Violation|3|||
33528530|NCT03207815|62916658|FG001|Overall Study|Protocol Violation|1|||
33528531|NCT03207815|62916657|FG000|Overall Study|Adverse Event|1|||
33528532|NCT03207815|62916658|FG001|Overall Study|Adverse Event|2|||
33528533|NCT03207815|62916657|FG000|Overall Study|Lost to Follow-up|1|||
33528534|NCT03207815|62916658|FG001|Overall Study|Lost to Follow-up|2|||
33528535|NCT03207815|62916657|FG000|Overall Study|Investigator's Discretion|1|||
33528536|NCT03207815|62916658|FG001|Overall Study|Investigator's Discretion|1|||
33528537|NCT03207815|62916657|FG000|Overall Study|Lack of Efficacy|0|||
33528538|NCT03207815|62916658|FG001|Overall Study|Lack of Efficacy|1|||
33528539|NCT03207815|62916657|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
33528540|NCT03207815|62916658|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
33528541|NCT03207815|62916657|FG000|Overall Study|Withdrew Consent|1|||
33528542|NCT03207815|62916658|FG001|Overall Study|Withdrew Consent|0|||
33528543|NCT02911935|62916666|FG000|Overall Study|Lost to Follow-up|5|||
33528544|NCT02911935|62916667|FG001|Overall Study|Lost to Follow-up|7|||
33528545|NCT00829712|62916675|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
33528546|NCT00829712|62916676|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
33528547|NCT03069989|62916691|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
33528548|NCT03069989|62916692|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
33528549|NCT02698163|62916719|FG000|Overall Study|Lost to Follow-up|0|||
33528550|NCT02698163|62916720|FG001|Overall Study|Lost to Follow-up|1|||
33528551|NCT03817190|62916728|FG000|Overall Study|Early Termination|13|||
33528552|NCT03817190|62916729|FG001|Overall Study|Early Termination|20|||
33528553|NCT03817190|62916728|FG000|Overall Study|Adverse Event|10|||
33528554|NCT03817190|62916729|FG001|Overall Study|Adverse Event|17|||
33528555|NCT03817190|62916728|FG000|Overall Study|Withdrawal by Subject|12|||
33528556|NCT03817190|62916729|FG001|Overall Study|Withdrawal by Subject|8|||
33528557|NCT03817190|62916728|FG000|Overall Study|Lost to Follow-up|11|||
33528558|NCT03817190|62916729|FG001|Overall Study|Lost to Follow-up|7|||
33528559|NCT03817190|62916728|FG000|Overall Study|Lack of Efficacy|7|||
33528560|NCT03817190|62916729|FG001|Overall Study|Lack of Efficacy|5|||
33528561|NCT03817190|62916728|FG000|Overall Study|Investigator Decision|5|||
33528562|NCT03817190|62916729|FG001|Overall Study|Investigator Decision|1|||
33528563|NCT03817190|62916728|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
33528564|NCT03817190|62916729|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
33528565|NCT03817190|62916728|FG000|Overall Study|Lack of Contact|1|||
33528566|NCT03817190|62916729|FG001|Overall Study|Lack of Contact|0|||
33528567|NCT03817190|62916728|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
33528568|NCT03817190|62916729|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
33528569|NCT03797222|62916748|FG000|Overall Study|Withdrawal by Subject|1|||
33528570|NCT02742818|62916758|FG000|Overall Study|Adverse Event|0|||
33528571|NCT02742818|62916759|FG001|Overall Study|Adverse Event|1|||
33528572|NCT02742818|62916758|FG000|Overall Study|Protocol Violation|0|||
33528573|NCT02742818|62916759|FG001|Overall Study|Protocol Violation|1|||
33528574|NCT03069365|62916767|FG000|Overall Study|Adverse Event|1|||
33528575|NCT03065933|62916771|FG000|Overall Study|study terminated|5|||
33528576|NCT04256629|62916781|FG000|Overall Study|Adverse Event|0|||
33528577|NCT04256629|62916782|FG001|Overall Study|Adverse Event|0|||
33528578|NCT04256629|62916783|FG002|Overall Study|Adverse Event|0|||
33528579|NCT04256629|62916784|FG003|Overall Study|Adverse Event|0|||
33528580|NCT04256629|62916785|FG004|Overall Study|Adverse Event|0|||
33528581|NCT04256629|62916786|FG005|Overall Study|Adverse Event|1|||
33528582|NCT04256629|62916781|FG000|Overall Study|Protocol Violation|0|||
33528583|NCT04256629|62916782|FG001|Overall Study|Protocol Violation|1|||
33528584|NCT04256629|62916783|FG002|Overall Study|Protocol Violation|0|||
33528585|NCT04256629|62916784|FG003|Overall Study|Protocol Violation|0|||
33528586|NCT04256629|62916785|FG004|Overall Study|Protocol Violation|0|||
33528587|NCT04256629|62916786|FG005|Overall Study|Protocol Violation|0|||
33528588|NCT01346293|62916796|FG000|Overall Study|Protocol Violation|30|||
33528589|NCT01346293|62916797|FG001|Overall Study|Protocol Violation|9|||
33528590|NCT01346293|62916796|FG000|Overall Study|Lost to Follow-up|21|||
33528591|NCT01346293|62916797|FG001|Overall Study|Lost to Follow-up|8|||
33528592|NCT01346293|62916796|FG000|Overall Study|Withdrawal by Subject|15|||
33528593|NCT01346293|62916797|FG001|Overall Study|Withdrawal by Subject|4|||
33528594|NCT01346293|62916796|FG000|Overall Study|Other|1|||
33528595|NCT01346293|62916797|FG001|Overall Study|Other|0|||
33528596|NCT03502187|62916808|FG000|Overall Study|Withdrawal by Subject|4|||
33528597|NCT03502187|62916809|FG001|Overall Study|Withdrawal by Subject|3|||
33528598|NCT03502187|62916810|FG002|Overall Study|Withdrawal by Subject|3|||
33528599|NCT03502187|62916808|FG000|Overall Study|Lost to Follow-up|5|||
33528600|NCT03502187|62916809|FG001|Overall Study|Lost to Follow-up|4|||
33528601|NCT03502187|62916810|FG002|Overall Study|Lost to Follow-up|5|||
33528602|NCT03058705|62916818|FG000|Overall Study|Withdrawal by Subject|2|||
33528603|NCT03058705|62916818|FG000|Overall Study|Physician Decision|2|||
33528604|NCT02998671|62916827|FG000|Period 1|Study Terminated By Sponsor|2|||
33528605|NCT02998671|62916828|FG001|Period 1|Study Terminated By Sponsor|1|||
33528606|NCT02998671|62916829|FG002|Period 1|Study Terminated By Sponsor|0|||
33528607|NCT02998671|62916830|FG003|Period 1|Study Terminated By Sponsor|0|||
33528608|NCT02998671|62916831|FG004|Period 1|Study Terminated By Sponsor|1|||
33528609|NCT02998671|62916827|FG000|Period 1|Withdrawal by Subject|1|||
33528610|NCT02998671|62916828|FG001|Period 1|Withdrawal by Subject|2|||
33325519|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33528611|NCT02998671|62916829|FG002|Period 1|Withdrawal by Subject|0|||
33528612|NCT02998671|62916830|FG003|Period 1|Withdrawal by Subject|0|||
33528613|NCT02998671|62916831|FG004|Period 1|Withdrawal by Subject|2|||
33528614|NCT02998671|62916827|FG000|Period 1|Pregnancy|1|||
33528615|NCT02998671|62916828|FG001|Period 1|Pregnancy|0|||
33528616|NCT02998671|62916829|FG002|Period 1|Pregnancy|0|||
33528617|NCT02998671|62916830|FG003|Period 1|Pregnancy|0|||
33528618|NCT02998671|62916831|FG004|Period 1|Pregnancy|0|||
33528619|NCT02998671|62916827|FG000|Period 1|Adverse Event|0|||
33528620|NCT02998671|62916828|FG001|Period 1|Adverse Event|0|||
33528621|NCT02998671|62916829|FG002|Period 1|Adverse Event|0|||
33528622|NCT02998671|62916830|FG003|Period 1|Adverse Event|0|||
33528623|NCT02998671|62916831|FG004|Period 1|Adverse Event|1|||
33528624|NCT02998671|62916827|FG000|Period 2|Adverse Event|0|||
33528625|NCT02998671|62916828|FG001|Period 2|Adverse Event|1|||
33528626|NCT02998671|62916829|FG002|Period 2|Adverse Event|0|||
33528627|NCT02998671|62916830|FG003|Period 2|Adverse Event|0|||
33528628|NCT02998671|62916831|FG004|Period 2|Adverse Event|0|||
33528629|NCT02998671|62916827|FG000|Period 2|Study Terminated By Sponsor|3|||
33528630|NCT02998671|62916828|FG001|Period 2|Study Terminated By Sponsor|5|||
33528631|NCT02998671|62916829|FG002|Period 2|Study Terminated By Sponsor|1|||
33528632|NCT02998671|62916830|FG003|Period 2|Study Terminated By Sponsor|3|||
33528633|NCT02998671|62916831|FG004|Period 2|Study Terminated By Sponsor|0|||
33528634|NCT02998671|62916827|FG000|Period 2|Withdrawal by Subject|0|||
33528635|NCT02998671|62916828|FG001|Period 2|Withdrawal by Subject|1|||
33528636|NCT02998671|62916829|FG002|Period 2|Withdrawal by Subject|0|||
33528637|NCT02998671|62916830|FG003|Period 2|Withdrawal by Subject|0|||
33528638|NCT02998671|62916831|FG004|Period 2|Withdrawal by Subject|0|||
33528639|NCT02998671|62916827|FG000|Period 2|Lost to Follow-up|0|||
33528640|NCT02998671|62916828|FG001|Period 2|Lost to Follow-up|0|||
33528641|NCT02998671|62916829|FG002|Period 2|Lost to Follow-up|0|||
33528642|NCT02998671|62916830|FG003|Period 2|Lost to Follow-up|1|||
33528643|NCT02998671|62916831|FG004|Period 2|Lost to Follow-up|0|||
33528644|NCT02660827|62916851|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
33528645|NCT02660827|62916851|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
33528646|NCT02660827|62916851|FG000|From Study to End of Continued Access|Adverse Event|3|||
33528647|NCT02660827|62916851|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
33528648|NCT02660827|62916851|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
33528649|NCT02660827|62916851|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
33528650|NCT02660827|62916851|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
33528651|NCT02660827|62916851|FG000|Period 2: Continued Access Period|Adverse Event|3|||
33528652|NCT01069419|62916872|FG000|Overall Study|Adverse Event|233|||
33528653|NCT01069419|62916872|FG000|Overall Study|Lack of Efficacy|332|||
33528654|NCT01069419|62916872|FG000|Overall Study|Lost to Follow-up|49|||
33457820|NCT00387725|62832088|FG001|Overall Study|Protocol Violation|1|||
33457821|NCT00387725|62832089|FG002|Overall Study|Protocol Violation|0|||
33457822|NCT00387725|62832090|FG003|Overall Study|Protocol Violation|0|||
33457823|NCT00387725|62832087|FG000|Overall Study|Withdrawal by Subject|1|||
33457824|NCT00387725|62832088|FG001|Overall Study|Withdrawal by Subject|0|||
33457825|NCT00387725|62832089|FG002|Overall Study|Withdrawal by Subject|1|||
33457826|NCT00387725|62832090|FG003|Overall Study|Withdrawal by Subject|0|||
33457827|NCT00387725|62832087|FG000|Overall Study|Parent/legal guardian request|0|||
33457828|NCT00387725|62832088|FG001|Overall Study|Parent/legal guardian request|0|||
33457829|NCT00387725|62832089|FG002|Overall Study|Parent/legal guardian request|1|||
33457830|NCT00387725|62832090|FG003|Overall Study|Parent/legal guardian request|1|||
33457831|NCT00102596|62832100|FG000|Part A|Screen failures|6|||
33457832|NCT00102596|62832101|FG001|Part A|Screen failures|0|||
33457833|NCT00102596|62832100|FG000|Part A|Adverse Event|1|||
33457834|NCT00102596|62832101|FG001|Part A|Adverse Event|0|||
33457835|NCT00387647|62832108|FG000|Overall Study|Death|18|||
33528655|NCT01069419|62916872|FG000|Overall Study|Remission of disease|11|||
33528656|NCT01069419|62916872|FG000|Overall Study|Withdrawal by Subject|34|||
33528657|NCT01069419|62916872|FG000|Overall Study|Other Reason|43|||
33528658|NCT01069419|62916872|FG000|Overall Study|Missing termination information|13|||
33528659|NCT01069341|62916876|FG000|Overall Study|Lost to Follow-up|1|||
33528660|NCT02996097|62916880|FG000|Overall Study|Lost to Follow-up|11|||
33528661|NCT02996097|62916881|FG001|Overall Study|Lost to Follow-up|11|||
33528662|NCT02992899|62916888|FG000|Overall Study|Withdrawal by Subject|1|||
33528663|NCT02992899|62916889|FG001|Overall Study|Withdrawal by Subject|0|||
33457836|NCT00386009|62832114|FG000|Overall Study|Adverse Event|0|||
33457837|NCT00386009|62832115|FG001|Overall Study|Adverse Event|2|||
33457838|NCT00386009|62832114|FG000|Overall Study|Death|1|||
33457839|NCT00386009|62832115|FG001|Overall Study|Death|0|||
33457840|NCT00386009|62832114|FG000|Overall Study|Entry Criteria Not Met|0|||
33457841|NCT00386009|62832115|FG001|Overall Study|Entry Criteria Not Met|2|||
33457842|NCT00386009|62832114|FG000|Overall Study|Lost to Follow-up|1|||
33457843|NCT00386009|62832115|FG001|Overall Study|Lost to Follow-up|1|||
33457844|NCT00386009|62832114|FG000|Overall Study|Protocol Violation|1|||
33457845|NCT00386009|62832115|FG001|Overall Study|Protocol Violation|0|||
33457846|NCT00386009|62832114|FG000|Overall Study|Sponsor Decision|1|||
33457847|NCT00386009|62832115|FG001|Overall Study|Sponsor Decision|1|||
33528664|NCT02992899|62916888|FG000|Overall Study|Lost to Follow-up|1|||
33528665|NCT02992899|62916889|FG001|Overall Study|Lost to Follow-up|3|||
33457848|NCT00386009|62832114|FG000|Overall Study|Withdrawal by Subject|5|||
33457849|NCT00386009|62832115|FG001|Overall Study|Withdrawal by Subject|4|||
33457850|NCT00373685|62832123|FG000|Overall Study|Death|2|||
33528670|NCT01602484|62916906|FG000|Overall Study|Airway issues unrelated to study|0|||
33528671|NCT01602484|62916907|FG001|Overall Study|Airway issues unrelated to study|1|||
33528672|NCT02989389|62916927|FG000|Period 1|Lost to Follow-up|0|||
33528673|NCT02989389|62916928|FG001|Period 1|Lost to Follow-up|1|||
33528674|NCT02989389|62916929|FG002|Period 1|Lost to Follow-up|0|||
33528675|NCT02989389|62916930|FG003|Period 1|Lost to Follow-up|0|||
33528676|NCT02989389|62916931|FG004|Period 1|Lost to Follow-up|0|||
33457851|NCT00373685|62832124|FG001|Overall Study|Death|1|||
33457852|NCT00373685|62832123|FG000|Overall Study|Adverse Event|278|||
33457853|NCT00373685|62832124|FG001|Overall Study|Adverse Event|253|||
33457854|NCT00373685|62832123|FG000|Overall Study|Insufficient clinical response|169|||
33457855|NCT00373685|62832124|FG001|Overall Study|Insufficient clinical response|119|||
33457856|NCT00373685|62832123|FG000|Overall Study|Did not meet entrance criteria|167|||
33457857|NCT00373685|62832124|FG001|Overall Study|Did not meet entrance criteria|184|||
33457858|NCT00373685|62832123|FG000|Overall Study|Lost to follow up|83|||
33457859|NCT00373685|62832124|FG001|Overall Study|Lost to follow up|103|||
33457860|NCT00373685|62832123|FG000|Overall Study|No longer willing to participate|337|||
33457861|NCT00373685|62832124|FG001|Overall Study|No longer willing to participate|352|||
33457862|NCT00373685|62832123|FG000|Overall Study|Other|149|||
33457863|NCT00373685|62832124|FG001|Overall Study|Other|146|||
33457864|NCT00373685|62832123|FG000|Overall Study|Protocol Violation|191|||
33528677|NCT02989389|62916932|FG005|Period 1|Lost to Follow-up|0|||
33528678|NCT02989389|62916933|FG006|Period 1|Lost to Follow-up|0|||
33528679|NCT02989389|62916934|FG007|Period 1|Lost to Follow-up|0|||
33528680|NCT02989389|62916935|FG008|Period 1|Lost to Follow-up|0|||
33528681|NCT02989389|62916936|FG009|Period 1|Lost to Follow-up|0|||
33528682|NCT02989389|62916927|FG000|Period 1|Physician Decision|0|||
33528683|NCT02989389|62916928|FG001|Period 1|Physician Decision|0|||
33528684|NCT02989389|62916929|FG002|Period 1|Physician Decision|0|||
33528685|NCT02989389|62916930|FG003|Period 1|Physician Decision|0|||
33528686|NCT02989389|62916931|FG004|Period 1|Physician Decision|0|||
33528687|NCT02989389|62916932|FG005|Period 1|Physician Decision|0|||
33528688|NCT02989389|62916933|FG006|Period 1|Physician Decision|0|||
33528689|NCT02989389|62916934|FG007|Period 1|Physician Decision|0|||
33528690|NCT02989389|62916935|FG008|Period 1|Physician Decision|1|||
33528691|NCT02989389|62916936|FG009|Period 1|Physician Decision|0|||
33528692|NCT02653300|62916976|FG000|Overall Study|Withdrawal by Subject|2|||
33528693|NCT01757665|62916982|FG000|Overall Study|Still on Study - Visit Completed|240|||
33528694|NCT01757665|62916983|FG001|Overall Study|Still on Study - Visit Completed|30|||
33528695|NCT01757665|62916982|FG000|Overall Study|Still on Study - Visit Pending|398|||
33528696|NCT01757665|62916983|FG001|Overall Study|Still on Study - Visit Pending|40|||
33528697|NCT01757665|62916982|FG000|Overall Study|Still on Study - Missed Visit|14|||
33528698|NCT01757665|62916983|FG001|Overall Study|Still on Study - Missed Visit|1|||
33528699|NCT01757665|62916982|FG000|Overall Study|Death|25|||
33528700|NCT01757665|62916983|FG001|Overall Study|Death|8|||
33528701|NCT01757665|62916982|FG000|Overall Study|Explant|1|||
33528702|NCT01757665|62916983|FG001|Overall Study|Explant|2|||
33528703|NCT01757665|62916982|FG000|Overall Study|Withdrawal by Subject|10|||
33528704|NCT01757665|62916983|FG001|Overall Study|Withdrawal by Subject|0|||
33528705|NCT01757665|62916982|FG000|Overall Study|Lost to Follow-up|1|||
33528706|NCT01757665|62916983|FG001|Overall Study|Lost to Follow-up|1|||
33528707|NCT01757665|62916982|FG000|Overall Study|Not Implanted with Device|5|||
33528708|NCT01757665|62916983|FG001|Overall Study|Not Implanted with Device|1|||
33457865|NCT00373685|62832124|FG001|Overall Study|Protocol Violation|182|||
33457866|NCT00373685|62832123|FG000|Overall Study|Final Status Unknown|12|||
33457867|NCT00373685|62832124|FG001|Overall Study|Final Status Unknown|4|||
33457868|NCT00373685|62832123|FG000|Overall Study|Randomized, not treated|51|||
33528709|NCT00430508|62917008|FG000|Overall Study|Adverse Event|2|||
33528710|NCT00430508|62917009|FG001|Overall Study|Adverse Event|3|||
33528711|NCT00430508|62917010|FG002|Overall Study|Adverse Event|5|||
33528712|NCT00430508|62917011|FG003|Overall Study|Adverse Event|3|||
33528713|NCT00430508|62917008|FG000|Overall Study|Withdrawal by Subject|0|||
33528714|NCT00430508|62917009|FG001|Overall Study|Withdrawal by Subject|1|||
33528715|NCT00430508|62917010|FG002|Overall Study|Withdrawal by Subject|1|||
33528716|NCT00430508|62917011|FG003|Overall Study|Withdrawal by Subject|1|||
33457869|NCT00373685|62832124|FG001|Overall Study|Randomized, not treated|77|||
33457870|NCT00373529|62832130|FG000|Overall Study|Physician Decision|19|||
33528717|NCT00430508|62917008|FG000|Overall Study|responder at visit 4|0|||
33528718|NCT00430508|62917009|FG001|Overall Study|responder at visit 4|0|||
33528719|NCT00430508|62917010|FG002|Overall Study|responder at visit 4|2|||
33528720|NCT00430508|62917011|FG003|Overall Study|responder at visit 4|0|||
33528721|NCT00430508|62917008|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
33528722|NCT00430508|62917009|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
33528723|NCT00430508|62917010|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
33528724|NCT00430508|62917011|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
33528725|NCT00430508|62917008|FG000|Overall Study|Other|1|||
33528726|NCT00430508|62917009|FG001|Overall Study|Other|1|||
33528727|NCT00430508|62917010|FG002|Overall Study|Other|3|||
33528728|NCT00430508|62917011|FG003|Overall Study|Other|0|||
33528729|NCT02988219|62917019|FG000|Overall Study|Lack of Efficacy|1|||
33528730|NCT02988219|62917020|FG001|Overall Study|Lack of Efficacy|1|||
33528731|NCT02988219|62917019|FG000|Overall Study|Withdrawal by Subject|0|||
33528732|NCT02988219|62917020|FG001|Overall Study|Withdrawal by Subject|2|||
33528733|NCT01346059|62917028|FG000|Overall Study|Withdrawal by Subject|1|||
33457871|NCT00373529|62832130|FG000|Overall Study|Withdrawal by Subject|7|||
33528734|NCT01346059|62917029|FG001|Overall Study|Withdrawal by Subject|0|||
33528735|NCT01318915|62917035|FG000|Overall Study|Lost to Follow-up|1|||
33528736|NCT02987205|62917041|FG000|Overall Study|Adverse Event|1|||
33457872|NCT00373529|62832130|FG000|Overall Study|Adverse Event|7|||
33457873|NCT00373529|62832130|FG000|Overall Study|Treatment failure|36|||
33457874|NCT00373529|62832130|FG000|Overall Study|Disease recurrence|10|||
33457875|NCT00373529|62832130|FG000|Overall Study|Death|16|||
33457876|NCT00373529|62832130|FG000|Overall Study|Need for treatment prohibited by study|1|||
33457877|NCT00373529|62832130|FG000|Overall Study|Other|8|||
33457878|NCT00373529|62832130|FG000|Overall Study|Failed independent confirmation of AML|3|||
33457879|NCT00373529|62832130|FG000|Overall Study|Consent violation|1|||
33457880|NCT00373295|62832134|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
33457881|NCT00373295|62832135|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
33457882|NCT00373295|62832136|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
33457883|NCT00373295|62832137|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
33457884|NCT00373295|62832138|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
33457885|NCT00373295|62832139|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
33457886|NCT00385541|62832149|FG000|Overall Study|severe pain, clinician requested unblind|0|||
33457887|NCT00385541|62832150|FG001|Overall Study|severe pain, clinician requested unblind|1|||
33457888|NCT00392015|62832162|FG000|Overall Study|Lost to Follow-up|2|||
33457889|NCT00392015|62832163|FG001|Overall Study|Lost to Follow-up|0|||
33457890|NCT00392015|62832164|FG002|Overall Study|Lost to Follow-up|2|||
33457891|NCT00392015|62832165|FG003|Overall Study|Lost to Follow-up|1|||
33457892|NCT00392015|62832166|FG004|Overall Study|Lost to Follow-up|1|||
33457893|NCT00392015|62832167|FG005|Overall Study|Lost to Follow-up|0|||
33457894|NCT00392015|62832162|FG000|Overall Study|Withdrawal by Subject|0|||
33457895|NCT00392015|62832163|FG001|Overall Study|Withdrawal by Subject|0|||
33457896|NCT00392015|62832164|FG002|Overall Study|Withdrawal by Subject|2|||
33457897|NCT00392015|62832165|FG003|Overall Study|Withdrawal by Subject|0|||
33457898|NCT00392015|62832166|FG004|Overall Study|Withdrawal by Subject|0|||
33457899|NCT00392015|62832167|FG005|Overall Study|Withdrawal by Subject|0|||
33457900|NCT00392015|62832162|FG000|Overall Study|Adverse Event|0|||
33457901|NCT00392015|62832163|FG001|Overall Study|Adverse Event|0|||
33457902|NCT00392015|62832164|FG002|Overall Study|Adverse Event|0|||
33457903|NCT00392015|62832165|FG003|Overall Study|Adverse Event|0|||
33457904|NCT00392015|62832166|FG004|Overall Study|Adverse Event|1|||
33457905|NCT00392015|62832167|FG005|Overall Study|Adverse Event|0|||
33457906|NCT00392015|62832162|FG000|Overall Study|Previous trial recipient|0|||
33457907|NCT00392015|62832163|FG001|Overall Study|Previous trial recipient|0|||
33457908|NCT00392015|62832164|FG002|Overall Study|Previous trial recipient|0|||
33528737|NCT02987205|62917041|FG000|Overall Study|Withdrawal by Subject|3|||
33528738|NCT02926937|62917063|FG000|Overall Study|Adverse Event|0|||
33528739|NCT02926937|62917064|FG001|Overall Study|Adverse Event|1|||
33528740|NCT02926937|62917065|FG002|Overall Study|Adverse Event|1|||
33457909|NCT00392015|62832165|FG003|Overall Study|Previous trial recipient|0|||
33457910|NCT00392015|62832166|FG004|Overall Study|Previous trial recipient|1|||
33457911|NCT00392015|62832167|FG005|Overall Study|Previous trial recipient|0|||
33457912|NCT00094302|62832188|FG000|Overall Study|Lost to Follow-up|43|||
33457913|NCT00094302|62832189|FG001|Overall Study|Lost to Follow-up|41|||
33457914|NCT00094302|62832188|FG000|Overall Study|Physician Decision|5|||
33457915|NCT00094302|62832189|FG001|Overall Study|Physician Decision|8|||
33325520|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33325521|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33325522|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33325523|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33457916|NCT00094302|62832188|FG000|Overall Study|Withdrawal by Subject|103|||
33457917|NCT00094302|62832189|FG001|Overall Study|Withdrawal by Subject|111|||
33457918|NCT00094302|62832188|FG000|Overall Study|Death|266|||
33457919|NCT00094302|62832189|FG001|Overall Study|Death|246|||
33457920|NCT00372905|62832195|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
33457921|NCT00372905|62832196|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
33457922|NCT00372905|62832197|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
33457923|NCT00372905|62832198|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
33457924|NCT00372905|62832195|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
33457925|NCT00372905|62832196|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
33457926|NCT00372905|62832197|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
33457927|NCT00372905|62832198|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
33457928|NCT00372905|62832195|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
33457929|NCT00372905|62832196|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
33457930|NCT00372905|62832197|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
33528741|NCT02926937|62917063|FG000|Overall Study|Poor Compliance to Protocol|1|||
33528742|NCT02926937|62917064|FG001|Overall Study|Poor Compliance to Protocol|0|||
33528743|NCT02926937|62917065|FG002|Overall Study|Poor Compliance to Protocol|0|||
33528744|NCT02926937|62917063|FG000|Overall Study|Lost to Follow-up|4|||
33528745|NCT02926937|62917064|FG001|Overall Study|Lost to Follow-up|5|||
33528746|NCT02926937|62917065|FG002|Overall Study|Lost to Follow-up|0|||
33528747|NCT02926937|62917063|FG000|Overall Study|At the Participant's own Request|11|||
33528748|NCT02926937|62917064|FG001|Overall Study|At the Participant's own Request|5|||
33528749|NCT02926937|62917065|FG002|Overall Study|At the Participant's own Request|8|||
33528750|NCT02926937|62917063|FG000|Overall Study|Reason not Specified|3|||
33457931|NCT00372905|62832198|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
33457932|NCT00372905|62832195|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
33457933|NCT00372905|62832196|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
33457934|NCT00372905|62832197|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
33457935|NCT00372905|62832198|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
33457936|NCT00372905|62832195|FG000|Follow up Until Relapse or Progression|Study closed|0|||
33457937|NCT00372905|62832196|FG001|Follow up Until Relapse or Progression|Study closed|0|||
33528751|NCT02926937|62917064|FG001|Overall Study|Reason not Specified|4|||
33528752|NCT02926937|62917065|FG002|Overall Study|Reason not Specified|2|||
33528753|NCT04189588|62917076|FG000|Overall Study|Death|0|||
33528754|NCT04189588|62917077|FG001|Overall Study|Death|1|||
33528755|NCT04189588|62917076|FG000|Overall Study|Lost to Follow-up|0|||
33528756|NCT04189588|62917077|FG001|Overall Study|Lost to Follow-up|1|||
33528757|NCT00151892|62917085|FG000|Overall Study|Lack of Efficacy|50|||
33528758|NCT00151892|62917086|FG001|Overall Study|Lack of Efficacy|57|||
33528759|NCT00151892|62917085|FG000|Overall Study|Patient request|10|||
33528760|NCT00151892|62917086|FG001|Overall Study|Patient request|7|||
33528761|NCT00151892|62917085|FG000|Overall Study|Lost to Follow-up|5|||
33528762|NCT00151892|62917086|FG001|Overall Study|Lost to Follow-up|10|||
33528763|NCT00151892|62917085|FG000|Overall Study|Adverse Event|6|||
33528764|NCT00151892|62917086|FG001|Overall Study|Adverse Event|3|||
33528765|NCT00151892|62917085|FG000|Overall Study|Protocol Violation|3|||
33325524|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33325525|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
33457938|NCT00372905|62832197|FG002|Follow up Until Relapse or Progression|Study closed|0|||
33457939|NCT00372905|62832198|FG003|Follow up Until Relapse or Progression|Study closed|3|||
33457940|NCT00372905|62832195|FG000|Follow up Until Relapse or Progression|Other|0|||
33457941|NCT00372905|62832196|FG001|Follow up Until Relapse or Progression|Other|1|||
33528766|NCT00151892|62917086|FG001|Overall Study|Protocol Violation|3|||
33528767|NCT00151892|62917085|FG000|Overall Study|Non-compliance|0|||
33528768|NCT00151892|62917086|FG001|Overall Study|Non-compliance|1|||
33528769|NCT00151892|62917085|FG000|Overall Study|Pregnancy|0|||
33528770|NCT00151892|62917086|FG001|Overall Study|Pregnancy|1|||
33528771|NCT00151892|62917085|FG000|Overall Study|Did not return for a visit|1|||
33528772|NCT00151892|62917086|FG001|Overall Study|Did not return for a visit|0|||
33528773|NCT00151892|62917085|FG000|Overall Study|Used prohibited corticosteroids|1|||
33528774|NCT00151892|62917086|FG001|Overall Study|Used prohibited corticosteroids|0|||
33528775|NCT00151892|62917085|FG000|Overall Study|Lack of study medication at center|0|||
33528776|NCT00151892|62917086|FG001|Overall Study|Lack of study medication at center|1|||
33528777|NCT03055195|62917110|FG000|Overall Study|Lack of Efficacy|1|||
33528778|NCT03055195|62917111|FG001|Overall Study|Lack of Efficacy|0|||
33528779|NCT03055195|62917110|FG000|Overall Study|Withdrawal by Subject|6|||
33528780|NCT03055195|62917111|FG001|Overall Study|Withdrawal by Subject|7|||
33528781|NCT03055195|62917110|FG000|Overall Study|Study Terminated by Sponsor|2|||
33528782|NCT03055195|62917111|FG001|Overall Study|Study Terminated by Sponsor|6|||
33528783|NCT03055195|62917110|FG000|Overall Study|Protocol Violation|2|||
33528784|NCT03055195|62917111|FG001|Overall Study|Protocol Violation|1|||
33528785|NCT03055195|62917110|FG000|Overall Study|Physician Decision|1|||
33528786|NCT03055195|62917111|FG001|Overall Study|Physician Decision|0|||
33528787|NCT02921919|62917119|FG000|Overall Study|Other|5|||
33528788|NCT02921919|62917120|FG001|Overall Study|Other|6|||
33528789|NCT02921919|62917119|FG000|Overall Study|Lost to Follow-up|0|||
33528790|NCT02921919|62917120|FG001|Overall Study|Lost to Follow-up|1|||
33528791|NCT02921919|62917119|FG000|Overall Study|Withdrawal by Subject|5|||
33528792|NCT02921919|62917120|FG001|Overall Study|Withdrawal by Subject|1|||
33528793|NCT02921919|62917119|FG000|Overall Study|Disease Progression|47|||
33528794|NCT02921919|62917120|FG001|Overall Study|Disease Progression|38|||
33528795|NCT02921919|62917119|FG000|Overall Study|Physician Decision|3|||
33528796|NCT02921919|62917120|FG001|Overall Study|Physician Decision|2|||
33528797|NCT02921919|62917119|FG000|Overall Study|Adverse Event|6|||
33528798|NCT02921919|62917120|FG001|Overall Study|Adverse Event|4|||
33528799|NCT02910219|62917142|FG000|Overall Study|Withdrawal by Subject|1|||
33528800|NCT02910219|62917143|FG001|Overall Study|Withdrawal by Subject|1|||
33528801|NCT01068717|62917149|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
33528802|NCT01068717|62917150|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
33528803|NCT01068717|62917151|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
33528804|NCT01068717|62917152|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
33528805|NCT02921763|62917166|FG000|Overall Study|Adverse Event|4|||
33528806|NCT02921763|62917166|FG000|Overall Study|Lost to Follow-up|4|||
33528807|NCT02921763|62917166|FG000|Overall Study|Lack of Efficacy|3|||
33528808|NCT02921763|62917166|FG000|Overall Study|Protocol Violation|2|||
33528809|NCT02921763|62917166|FG000|Overall Study|Withdrawal by Subject|2|||
33528810|NCT02921763|62917166|FG000|Overall Study|Physician Decision|1|||
33528811|NCT02921763|62917166|FG000|Overall Study|No data obtained|2|||
33528812|NCT01318135|62917188|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
33528813|NCT01318135|62917189|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33528814|NCT01318135|62917190|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33528815|NCT01318135|62917191|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33528816|NCT01318135|62917192|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33528817|NCT01318135|62917193|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33528818|NCT01318135|62917194|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33528819|NCT01318135|62917195|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33528820|NCT01318135|62917188|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
33528821|NCT01318135|62917189|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
33528822|NCT01318135|62917190|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
33528823|NCT01318135|62917191|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
33528824|NCT01318135|62917192|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
33528825|NCT01318135|62917193|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
33528826|NCT01318135|62917194|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
33528827|NCT01318135|62917195|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
33528828|NCT01318135|62917188|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
33528829|NCT01318135|62917189|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
33528830|NCT01318135|62917190|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
33528831|NCT01318135|62917191|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
33528832|NCT01318135|62917192|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
33528833|NCT01318135|62917193|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
33528834|NCT01318135|62917194|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
33457942|NCT00372905|62832197|FG002|Follow up Until Relapse or Progression|Other|0|||
33457943|NCT00372905|62832198|FG003|Follow up Until Relapse or Progression|Other|0|||
33457944|NCT00384839|62832208|FG000|Overall Study|Adverse Event|4|||
33528835|NCT01318135|62917195|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
33528836|NCT01318135|62917188|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
33528837|NCT01318135|62917189|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
33528838|NCT01318135|62917190|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
33528839|NCT01318135|62917191|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
33528840|NCT01318135|62917192|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
33528841|NCT01318135|62917193|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
33528842|NCT01318135|62917194|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
33528843|NCT01318135|62917195|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
33457945|NCT00384839|62832208|FG000|Overall Study|Investigator Request|1|||
33625213|NCT01847274|63026069|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
33625214|NCT01847274|63026070|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
33625215|NCT01847274|63026060|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
33625216|NCT01847274|63026061|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
33625217|NCT01847274|63026062|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
33625218|NCT01847274|63026063|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
33625219|NCT01847274|63026064|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
33625220|NCT01847274|63026065|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
33625221|NCT01847274|63026066|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
33625222|NCT01847274|63026067|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
33625223|NCT01847274|63026068|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
33457946|NCT00384839|62832208|FG000|Overall Study|Patient Request|1|||
33457947|NCT00384839|62832208|FG000|Overall Study|Ineligible|2|||
33457948|NCT00384293|62832214|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
33457949|NCT00384293|62832215|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
33457950|NCT00384293|62832216|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
33457951|NCT00384293|62832214|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
33457952|NCT00384293|62832215|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
33457953|NCT00384293|62832216|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
33457954|NCT00384293|62832214|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
33457955|NCT00384293|62832215|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
33457956|NCT00384293|62832216|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
33457957|NCT00384293|62832214|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
33457958|NCT00384293|62832215|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
33528844|NCT01318135|62917188|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33528845|NCT01318135|62917189|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33457959|NCT00384293|62832216|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
33457960|NCT00384293|62832214|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
33457961|NCT00384293|62832215|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
33457962|NCT00384293|62832216|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
33528846|NCT01318135|62917190|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33528847|NCT01318135|62917191|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33528848|NCT01318135|62917192|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33528849|NCT01318135|62917193|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
33528850|NCT01318135|62917194|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
33528851|NCT01318135|62917195|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33528852|NCT01318135|62917188|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
33528853|NCT01318135|62917189|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
33625224|NCT01847274|63026069|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
33625225|NCT01847274|63026070|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
33625226|NCT01847274|63026060|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33625227|NCT01847274|63026061|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33625228|NCT01847274|63026062|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33528854|NCT01318135|62917190|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
33528855|NCT01318135|62917191|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
33528856|NCT01318135|62917192|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
33528857|NCT01318135|62917193|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
33528858|NCT01318135|62917194|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
33528859|NCT01318135|62917195|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
33528860|NCT01318135|62917188|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
33528861|NCT01318135|62917189|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
33528862|NCT01318135|62917190|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
33528863|NCT01318135|62917191|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
33528864|NCT01318135|62917192|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
33528865|NCT01318135|62917193|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
33528866|NCT01318135|62917194|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
33528867|NCT01318135|62917195|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
33528868|NCT02922153|62917207|FG000|Overall Study|Death|8|||
33528869|NCT02922153|62917208|FG001|Overall Study|Death|1|||
33528870|NCT02922153|62917207|FG000|Overall Study|Lost to Follow-up|1|||
33528871|NCT02922153|62917208|FG001|Overall Study|Lost to Follow-up|0|||
33528872|NCT02922153|62917207|FG000|Overall Study|Physician Decision|1|||
33528873|NCT02922153|62917208|FG001|Overall Study|Physician Decision|1|||
33528874|NCT02920983|62917214|FG000|Dispense 1|Unacceptable Lens Fit|0|||
33528875|NCT02920983|62917215|FG001|Dispense 1|Unacceptable Lens Fit|0|||
33625229|NCT01847274|63026063|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
33528876|NCT02920983|62917216|FG002|Dispense 1|Unacceptable Lens Fit|0|||
33528877|NCT02920983|62917217|FG003|Dispense 1|Unacceptable Lens Fit|0|||
33528878|NCT02920983|62917218|FG004|Dispense 1|Unacceptable Lens Fit|1|||
33528879|NCT02920983|62917219|FG005|Dispense 1|Unacceptable Lens Fit|0|||
33528880|NCT02920983|62917214|FG000|Dispense 2|Unscceptable lens fit|1|||
33457963|NCT00384293|62832214|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
33528881|NCT02920983|62917215|FG001|Dispense 2|Unscceptable lens fit|0|||
33625230|NCT01847274|63026064|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33457964|NCT00384293|62832215|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
33457965|NCT00384293|62832216|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
33457966|NCT00384293|62832214|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
33457967|NCT00384293|62832215|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
33457968|NCT00384293|62832216|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
33457969|NCT00384293|62832214|FG000|Post-randomization Period|Adverse Event|0|||
33457970|NCT00384293|62832215|FG001|Post-randomization Period|Adverse Event|23|||
33528882|NCT02920983|62917216|FG002|Dispense 2|Unscceptable lens fit|0|||
33528883|NCT02920983|62917217|FG003|Dispense 2|Unscceptable lens fit|0|||
33528884|NCT02920983|62917218|FG004|Dispense 2|Unscceptable lens fit|1|||
33528885|NCT02920983|62917219|FG005|Dispense 2|Unscceptable lens fit|0|||
33528886|NCT02920983|62917214|FG000|Dispense 3|Unacceptable Lens Fit|1|||
33528887|NCT02920983|62917215|FG001|Dispense 3|Unacceptable Lens Fit|1|||
33528888|NCT02920983|62917216|FG002|Dispense 3|Unacceptable Lens Fit|0|||
33625231|NCT01847274|63026065|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33625232|NCT01847274|63026066|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33625233|NCT01847274|63026067|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33625234|NCT01847274|63026068|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33625235|NCT01847274|63026069|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33625236|NCT01847274|63026070|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33625237|NCT01847274|63026060|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
33625238|NCT01847274|63026061|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
33625239|NCT01847274|63026062|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
33457971|NCT00384293|62832216|FG002|Post-randomization Period|Adverse Event|7|||
33457972|NCT00384293|62832214|FG000|Post-randomization Period|Lost to Follow-up|0|||
33457973|NCT00384293|62832215|FG001|Post-randomization Period|Lost to Follow-up|2|||
33457974|NCT00384293|62832216|FG002|Post-randomization Period|Lost to Follow-up|1|||
33457975|NCT00384293|62832214|FG000|Post-randomization Period|Protocol Violation|0|||
33457976|NCT00384293|62832215|FG001|Post-randomization Period|Protocol Violation|1|||
33457977|NCT00384293|62832216|FG002|Post-randomization Period|Protocol Violation|0|||
33457978|NCT00384293|62832214|FG000|Post-randomization Period|Withdrawal by Subject|0|||
33457979|NCT00384293|62832215|FG001|Post-randomization Period|Withdrawal by Subject|8|||
33457980|NCT00384293|62832216|FG002|Post-randomization Period|Withdrawal by Subject|6|||
33457981|NCT00384293|62832214|FG000|Post-randomization Period|Trial Termination|0|||
33457982|NCT00384293|62832215|FG001|Post-randomization Period|Trial Termination|180|||
33457983|NCT00384293|62832216|FG002|Post-randomization Period|Trial Termination|204|||
33457984|NCT00384293|62832214|FG000|Post-randomization Period|Patient Randomized in Error|0|||
33457985|NCT00384293|62832215|FG001|Post-randomization Period|Patient Randomized in Error|0|||
33457986|NCT00384293|62832216|FG002|Post-randomization Period|Patient Randomized in Error|1|||
33457987|NCT00067002|62832226|FG000|Overall Study|Early Death|1|||
33457988|NCT00067002|62832227|FG001|Overall Study|Early Death|2|||
33457989|NCT00067002|62832226|FG000|Overall Study|Delayed|1|||
33457990|NCT00067002|62832227|FG001|Overall Study|Delayed|1|||
33457991|NCT00067002|62832226|FG000|Overall Study|Graft Failure|5|||
33457992|NCT00067002|62832227|FG001|Overall Study|Graft Failure|6|||
33457993|NCT00091572|62832235|FG000|Overall Study|Lost to Follow-up|1|||
33457994|NCT00091572|62832236|FG001|Overall Study|Lost to Follow-up|1|||
33457995|NCT00091572|62832235|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
33457996|NCT00091572|62832236|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
33457997|NCT00091572|62832235|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
33528889|NCT02920983|62917217|FG003|Dispense 3|Unacceptable Lens Fit|0|||
33528890|NCT02920983|62917218|FG004|Dispense 3|Unacceptable Lens Fit|1|||
33325526|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
33528891|NCT02920983|62917219|FG005|Dispense 3|Unacceptable Lens Fit|0|||
33528892|NCT02654002|62917236|FG000|Overall Study|Adverse Event|0|||
33625240|NCT01847274|63026063|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
33625241|NCT01847274|63026064|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
33325527|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33325528|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33325529|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33528893|NCT02654002|62917237|FG001|Overall Study|Adverse Event|0|||
33325530|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33325531|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
33325532|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
33325533|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
33325534|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
33325535|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
33325536|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
33325537|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
33325538|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
33325539|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
33325540|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
33325541|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
33325542|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33325543|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
33325544|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
33325545|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33325546|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33325547|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33325548|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33325549|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33325550|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
33457998|NCT00091572|62832236|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
33457999|NCT00091572|62832235|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
33458000|NCT00091572|62832236|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
33458001|NCT00091572|62832235|FG000|Overall Study|Other Reason|6|||
33458002|NCT00091572|62832236|FG001|Overall Study|Other Reason|13|||
33458003|NCT00091572|62832235|FG000|Overall Study|Ongoing (still on treatment)|8|||
33458004|NCT00091572|62832236|FG001|Overall Study|Ongoing (still on treatment)|12|||
33458005|NCT00091572|62832235|FG000|Overall Study|Major Protocol Violation|2|||
33458006|NCT00091572|62832236|FG001|Overall Study|Major Protocol Violation|0|||
33458007|NCT00091572|62832235|FG000|Overall Study|Toxicity (Related AE)|53|||
33458008|NCT00091572|62832236|FG001|Overall Study|Toxicity (Related AE)|9|||
33458009|NCT00084266|62832244|FG000|Overall Study|Death|42|||
33458010|NCT00084266|62832245|FG001|Overall Study|Death|39|||
33458011|NCT00084266|62832244|FG000|Overall Study|Adverse Event|8|||
33458012|NCT00084266|62832245|FG001|Overall Study|Adverse Event|5|||
33458013|NCT00084266|62832244|FG000|Overall Study|Lack of Efficacy|2|||
33458014|NCT00084266|62832245|FG001|Overall Study|Lack of Efficacy|4|||
33458015|NCT00084266|62832244|FG000|Overall Study|Lost to Follow-up|5|||
33458016|NCT00084266|62832245|FG001|Overall Study|Lost to Follow-up|3|||
33458017|NCT00084266|62832244|FG000|Overall Study|Participant not willing to participate|3|||
33458018|NCT00084266|62832245|FG001|Overall Study|Participant not willing to participate|8|||
33458019|NCT00084266|62832244|FG000|Overall Study|Other|360|||
33458020|NCT00084266|62832245|FG001|Overall Study|Other|344|||
33458021|NCT00084266|62832244|FG000|Overall Study|Randomized not treated|21|||
33458022|NCT00084266|62832245|FG001|Overall Study|Randomized not treated|20|||
33458023|NCT00091026|62832253|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
33528894|NCT02654002|62917238|FG002|Overall Study|Adverse Event|0|||
33528895|NCT02654002|62917239|FG003|Overall Study|Adverse Event|0|||
33528896|NCT02654002|62917240|FG004|Overall Study|Adverse Event|0|||
33528897|NCT02654002|62917241|FG005|Overall Study|Adverse Event|0|||
33528898|NCT02654002|62917242|FG006|Overall Study|Adverse Event|1|||
33528899|NCT02654002|62917243|FG007|Overall Study|Adverse Event|0|||
33528900|NCT02654002|62917244|FG008|Overall Study|Adverse Event|0|||
33528901|NCT02654002|62917236|FG000|Overall Study|Withdrew Consent|0|||
33528902|NCT02654002|62917237|FG001|Overall Study|Withdrew Consent|0|||
33528903|NCT02654002|62917238|FG002|Overall Study|Withdrew Consent|0|||
33528904|NCT02654002|62917239|FG003|Overall Study|Withdrew Consent|0|||
33528905|NCT02654002|62917240|FG004|Overall Study|Withdrew Consent|0|||
33528906|NCT02654002|62917241|FG005|Overall Study|Withdrew Consent|1|||
33528907|NCT02654002|62917242|FG006|Overall Study|Withdrew Consent|0|||
33528908|NCT02654002|62917243|FG007|Overall Study|Withdrew Consent|1|||
33528909|NCT02654002|62917244|FG008|Overall Study|Withdrew Consent|0|||
33528910|NCT01675492|62917279|FG000|Overall Study|study completed early - product approval|42|||
33528911|NCT03924622|62917290|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
33528912|NCT03924622|62917291|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
33528913|NCT03924622|62917292|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
33528914|NCT03924622|62917293|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
33528915|NCT03924622|62917294|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
33528916|NCT03924622|62917295|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
33528917|NCT04044664|62917312|FG000|Stage 1|Adverse Event|3|||
33528918|NCT04044664|62917313|FG001|Stage 1|Adverse Event|3|||
33528919|NCT04044664|62917314|FG002|Stage 1|Adverse Event|1|||
33528920|NCT04044664|62917312|FG000|Stage 1|Lost to Follow-up|3|||
33528921|NCT04044664|62917313|FG001|Stage 1|Lost to Follow-up|2|||
33528922|NCT04044664|62917314|FG002|Stage 1|Lost to Follow-up|2|||
33528923|NCT04044664|62917312|FG000|Stage 1|Withdrawal by Subject|9|||
33528924|NCT04044664|62917313|FG001|Stage 1|Withdrawal by Subject|1|||
33528925|NCT04044664|62917314|FG002|Stage 1|Withdrawal by Subject|0|||
33528926|NCT04044664|62917312|FG000|Stage 1|noncompliance, personal reason|2|||
33528927|NCT04044664|62917313|FG001|Stage 1|noncompliance, personal reason|0|||
33458024|NCT00091026|62832254|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
33458025|NCT00091026|62832253|FG000|Overall Study|Patient withdrew and never received trea|0|||
33458026|NCT00091026|62832254|FG001|Overall Study|Patient withdrew and never received trea|2|||
33458027|NCT00091026|62832253|FG000|Overall Study|Unknown-never received treatment|0|||
33458028|NCT00091026|62832254|FG001|Overall Study|Unknown-never received treatment|1|||
33458029|NCT00116558|62832263|FG000|Overall Study|Death|11|||
33458030|NCT00116558|62832264|FG001|Overall Study|Death|5|||
33458031|NCT00116558|62832265|FG002|Overall Study|Death|3|||
33458032|NCT00116558|62832263|FG000|Overall Study|Withdrawal by Subject|17|||
33458033|NCT00116558|62832264|FG001|Overall Study|Withdrawal by Subject|3|||
33458034|NCT00116558|62832265|FG002|Overall Study|Withdrawal by Subject|12|||
33458035|NCT00116558|62832263|FG000|Overall Study|disease progression|3|||
33458036|NCT00116558|62832264|FG001|Overall Study|disease progression|7|||
33458037|NCT00116558|62832265|FG002|Overall Study|disease progression|18|||
33458038|NCT00116168|62832276|FG000|Overall Study|Lost to Follow-up|6|||
33458039|NCT00116168|62832277|FG001|Overall Study|Lost to Follow-up|5|||
33458040|NCT00116168|62832278|FG002|Overall Study|Lost to Follow-up|0|||
33458041|NCT00116168|62832279|FG003|Overall Study|Lost to Follow-up|0|||
33458042|NCT00115934|62832291|FG000|Overall Study|Lost to Follow-up|1|||
33458043|NCT00115934|62832292|FG001|Overall Study|Lost to Follow-up|0|||
33458044|NCT00115934|62832291|FG000|Overall Study|Did not receive intervention|3|||
33458045|NCT00115934|62832292|FG001|Overall Study|Did not receive intervention|2|||
33458046|NCT00115778|62832298|FG000|Overall Study|Withdrawal by Subject|0|||
33528928|NCT04044664|62917314|FG002|Stage 1|noncompliance, personal reason|0|||
33458047|NCT00115778|62832299|FG001|Overall Study|Withdrawal by Subject|1|||
33458048|NCT00100178|62832308|FG000|Overall Study|Lost to Follow-up|0|||
33528929|NCT04044664|62917312|FG000|Stage 1|randomization error|0|||
33528930|NCT04044664|62917313|FG001|Stage 1|randomization error|1|||
33528931|NCT04044664|62917314|FG002|Stage 1|randomization error|0|||
33528932|NCT04044664|62917312|FG000|Stage 2|Adverse Event|2|||
33458049|NCT00100178|62832309|FG001|Overall Study|Lost to Follow-up|6|||
33458050|NCT00100178|62832310|FG002|Overall Study|Lost to Follow-up|5|||
33458051|NCT00100178|62832308|FG000|Overall Study|Adverse Event|2|||
33528933|NCT04044664|62917313|FG001|Stage 2|Adverse Event|0|||
33528934|NCT04044664|62917314|FG002|Stage 2|Adverse Event|0|||
33528935|NCT04044664|62917312|FG000|Stage 2|Lost to Follow-up|3|||
33458052|NCT00100178|62832309|FG001|Overall Study|Adverse Event|2|||
33458053|NCT00100178|62832310|FG002|Overall Study|Adverse Event|1|||
33458054|NCT00100178|62832308|FG000|Overall Study|Withdrawal by Subject|1|||
33458055|NCT00100178|62832309|FG001|Overall Study|Withdrawal by Subject|1|||
33528936|NCT04044664|62917313|FG001|Stage 2|Lost to Follow-up|2|||
33458056|NCT00100178|62832310|FG002|Overall Study|Withdrawal by Subject|1|||
33458057|NCT00100178|62832308|FG000|Overall Study|Physician Decision|6|||
33458058|NCT00100178|62832309|FG001|Overall Study|Physician Decision|1|||
33458059|NCT00100178|62832310|FG002|Overall Study|Physician Decision|3|||
33458060|NCT00099632|62832324|FG000|Overall Study|Lost to Follow-up|1|||
33458061|NCT00099632|62832325|FG001|Overall Study|Lost to Follow-up|0|||
33458062|NCT00099632|62832326|FG002|Overall Study|Lost to Follow-up|3|||
33458063|NCT00099632|62832327|FG003|Overall Study|Lost to Follow-up|1|||
33458064|NCT00099632|62832328|FG004|Overall Study|Lost to Follow-up|1|||
33458065|NCT00099632|62832329|FG005|Overall Study|Lost to Follow-up|0|||
33458066|NCT00099632|62832324|FG000|Overall Study|Withdrawal by Subject|0|||
33458067|NCT00099632|62832325|FG001|Overall Study|Withdrawal by Subject|1|||
33458068|NCT00099632|62832326|FG002|Overall Study|Withdrawal by Subject|0|||
33458069|NCT00099632|62832327|FG003|Overall Study|Withdrawal by Subject|0|||
33528937|NCT04044664|62917314|FG002|Stage 2|Lost to Follow-up|1|||
33528938|NCT04044664|62917312|FG000|Stage 2|Withdrawal by Subject|3|||
33528939|NCT04044664|62917313|FG001|Stage 2|Withdrawal by Subject|0|||
33528940|NCT04044664|62917314|FG002|Stage 2|Withdrawal by Subject|0|||
33458070|NCT00099632|62832328|FG004|Overall Study|Withdrawal by Subject|0|||
33458071|NCT00099632|62832329|FG005|Overall Study|Withdrawal by Subject|1|||
33458072|NCT00099632|62832324|FG000|Overall Study|Protocol Violation|0|||
33458073|NCT00099632|62832325|FG001|Overall Study|Protocol Violation|0|||
33458074|NCT00099632|62832326|FG002|Overall Study|Protocol Violation|0|||
33458075|NCT00099632|62832327|FG003|Overall Study|Protocol Violation|0|||
33458076|NCT00099632|62832328|FG004|Overall Study|Protocol Violation|0|||
33458077|NCT00099632|62832329|FG005|Overall Study|Protocol Violation|1|||
33458078|NCT00098774|62832343|FG000|Overall Study|Adverse Event|2|||
33458079|NCT00098774|62832343|FG000|Overall Study|Disease Progression|9|||
33458080|NCT00098774|62832343|FG000|Overall Study|Withdrawal by Subject|1|||
33458081|NCT00098774|62832343|FG000|Overall Study|Failed (to respond) during induction|4|||
33528941|NCT04044664|62917312|FG000|Stage 2|protocol deviation|1|||
33528942|NCT04044664|62917313|FG001|Stage 2|protocol deviation|0|||
33625242|NCT01847274|63026065|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
33625243|NCT01847274|63026066|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
33625244|NCT01847274|63026067|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
33625245|NCT01847274|63026068|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
33625246|NCT01847274|63026069|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
33625247|NCT01847274|63026070|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
33625248|NCT01847274|63026060|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
33625249|NCT01847274|63026061|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
33625250|NCT01847274|63026062|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
33625251|NCT01847274|63026063|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
33625252|NCT01847274|63026064|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
33625253|NCT01847274|63026065|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
33625254|NCT01847274|63026066|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
33625255|NCT01847274|63026067|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
33528943|NCT04044664|62917314|FG002|Stage 2|protocol deviation|0|||
33528944|NCT00150176|62917324|FG000|Overall Study|Adverse Event|16|||
33528945|NCT00150176|62917325|FG001|Overall Study|Adverse Event|53|||
33528946|NCT00150176|62917324|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
33528947|NCT00150176|62917325|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
33528948|NCT00150176|62917324|FG000|Overall Study|Withdrawal by Subject|19|||
33528949|NCT00150176|62917325|FG001|Overall Study|Withdrawal by Subject|12|||
33528950|NCT00150176|62917324|FG000|Overall Study|Lost to Follow-up|3|||
33528951|NCT00150176|62917325|FG001|Overall Study|Lost to Follow-up|3|||
33528952|NCT00150176|62917324|FG000|Overall Study|OTHER|11|||
33528953|NCT00150176|62917325|FG001|Overall Study|OTHER|13|||
33528954|NCT02985879|62917335|FG000|Overall Study|Adverse Event|7|||
33528955|NCT02985879|62917336|FG001|Overall Study|Adverse Event|9|||
33528956|NCT02985879|62917337|FG002|Overall Study|Adverse Event|7|||
33528957|NCT02985879|62917335|FG000|Overall Study|Withdrew consent|6|||
33458082|NCT00098774|62832343|FG000|Overall Study|Physician Decision|2|||
33458083|NCT00384059|62832349|FG000|Infant Series|Not consented|2|||
33458084|NCT00384059|62832350|FG001|Infant Series|Not consented|6|||
33458085|NCT00384059|62832349|FG000|Infant Series|Withdrawal by Subject|2|||
33528958|NCT02985879|62917336|FG001|Overall Study|Withdrew consent|8|||
33528959|NCT02985879|62917337|FG002|Overall Study|Withdrew consent|10|||
33458086|NCT00384059|62832350|FG001|Infant Series|Withdrawal by Subject|2|||
33458087|NCT00384059|62832349|FG000|Infant Series|Adverse Event|1|||
33458088|NCT00384059|62832350|FG001|Infant Series|Adverse Event|2|||
33458089|NCT00384059|62832349|FG000|Infant Series|Protocol Violation|1|||
33458090|NCT00384059|62832350|FG001|Infant Series|Protocol Violation|2|||
33458091|NCT00384059|62832349|FG000|Infant Series|Lost to Follow-up|0|||
33458092|NCT00384059|62832350|FG001|Infant Series|Lost to Follow-up|1|||
33528960|NCT02985879|62917335|FG000|Overall Study|Lost to Follow-up|1|||
33528961|NCT02985879|62917336|FG001|Overall Study|Lost to Follow-up|0|||
33528962|NCT02985879|62917337|FG002|Overall Study|Lost to Follow-up|2|||
33528963|NCT02985879|62917335|FG000|Overall Study|Other, not specified|62|||
33528964|NCT02985879|62917336|FG001|Overall Study|Other, not specified|58|||
33528965|NCT02985879|62917337|FG002|Overall Study|Other, not specified|58|||
33528966|NCT01067469|62917353|FG000|Overall Study|Withdrawal by Subject|0|||
33528967|NCT01067469|62917354|FG001|Overall Study|Withdrawal by Subject|1|||
33325551|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33325552|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
33325553|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
33325554|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33325555|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33325556|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33528968|NCT01067469|62917353|FG000|Overall Study|Disease Progression|0|||
33528969|NCT01067469|62917354|FG001|Overall Study|Disease Progression|1|||
33528970|NCT02985021|62917360|FG000|Overall Study|Inability to comply with study procedures|1|||
33528971|NCT01066923|62917368|FG000|Overall Study|Withdrawal by Subject|3|||
33528972|NCT01066923|62917369|FG001|Overall Study|Withdrawal by Subject|3|||
33528973|NCT01066923|62917370|FG002|Overall Study|Withdrawal by Subject|8|||
33528974|NCT01066923|62917371|FG003|Overall Study|Withdrawal by Subject|8|||
33528975|NCT02919267|62917396|FG000|Overall Study|Protocol Violation|0|||
33528976|NCT02919267|62917397|FG001|Overall Study|Protocol Violation|3|||
33528977|NCT02919267|62917398|FG002|Overall Study|Protocol Violation|3|||
33528978|NCT02919267|62917399|FG003|Overall Study|Protocol Violation|4|||
33528979|NCT01368900|62917409|FG000|Overall Study|Lost to Follow-up|7|||
33528980|NCT02910063|62917415|FG000|Phase 2|Withdrawal by Subject|3|||
33528981|NCT02910063|62917416|FG001|Phase 2|Withdrawal by Subject|0|||
33528982|NCT02910063|62917417|FG002|Phase 2|Withdrawal by Subject|0|||
33528983|NCT02910063|62917415|FG000|Phase 2|Lost to Follow-up|1|||
33528984|NCT02910063|62917416|FG001|Phase 2|Lost to Follow-up|0|||
33528985|NCT02910063|62917417|FG002|Phase 2|Lost to Follow-up|0|||
33528986|NCT02910063|62917415|FG000|Phase 2|Death|24|||
33528987|NCT02910063|62917416|FG001|Phase 2|Death|0|||
33528988|NCT02910063|62917417|FG002|Phase 2|Death|0|||
33528989|NCT02909907|62917428|FG000|Overall Study|Withdrawal by Subject|0|||
33528990|NCT02909907|62917429|FG001|Overall Study|Withdrawal by Subject|1|||
33528991|NCT02651194|62917435|FG000|Overall Study|Lost to Follow-up|3|||
33528992|NCT02651194|62917435|FG000|Overall Study|Other|2|||
33528993|NCT02907177|62917441|FG000|Overall Study|Death|0|||
33528994|NCT02907177|62917442|FG001|Overall Study|Death|1|||
33528995|NCT02907177|62917441|FG000|Overall Study|Physician Decision|3|||
33528996|NCT02907177|62917442|FG001|Overall Study|Physician Decision|3|||
33528997|NCT02907177|62917441|FG000|Overall Study|Withdrawal by Subject|15|||
33528998|NCT02907177|62917442|FG001|Overall Study|Withdrawal by Subject|7|||
33528999|NCT02907177|62917441|FG000|Overall Study|Sponsor's Decision|50|||
33529000|NCT02907177|62917442|FG001|Overall Study|Sponsor's Decision|57|||
33529001|NCT02652442|62917448|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
33529002|NCT02906709|62917462|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
33529003|NCT02906709|62917463|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
33529004|NCT02906709|62917462|FG000|Phase A (Week 0 to Week 16)|Death|0|||
33529005|NCT02906709|62917463|FG001|Phase A (Week 0 to Week 16)|Death|1|||
33529006|NCT02906709|62917462|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
33529007|NCT02906709|62917463|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
33529008|NCT02906709|62917462|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
33325557|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33325558|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
33529009|NCT02906709|62917463|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
33544115|NCT01661140|62934937|FG001|Double-Blind Period|Protocol Violation|2|||
33544116|NCT01661140|62934938|FG002|Double-Blind Period|Protocol Violation|3|||
33544117|NCT01661140|62934936|FG000|Double-Blind Period|Withdrawal by Subject|0|||
33544118|NCT01661140|62934937|FG001|Double-Blind Period|Withdrawal by Subject|1|||
33544119|NCT01661140|62934938|FG002|Double-Blind Period|Withdrawal by Subject|3|||
33544120|NCT01661140|62934936|FG000|Double-Blind Period|Investigator's Decision|0|||
33544121|NCT01661140|62934937|FG001|Double-Blind Period|Investigator's Decision|1|||
33544122|NCT01661140|62934938|FG002|Double-Blind Period|Investigator's Decision|2|||
33544123|NCT01661140|62934936|FG000|Double-Blind Period|Sponsor Termination|0|||
33544124|NCT01661140|62934937|FG001|Double-Blind Period|Sponsor Termination|14|||
33544125|NCT01661140|62934938|FG002|Double-Blind Period|Sponsor Termination|17|||
33544126|NCT01661140|62934936|FG000|Double-Blind Period|Administrative/Other|0|||
33544127|NCT01661140|62934937|FG001|Double-Blind Period|Administrative/Other|7|||
33544128|NCT01661140|62934938|FG002|Double-Blind Period|Administrative/Other|6|||
33544129|NCT03019549|62934946|FG000|Washout|DId not meet genotype criteria|11|||
33544130|NCT03019549|62934946|FG000|Period 2|Adverse Event|2|||
33544131|NCT03019549|62934946|FG000|Period 2|Physician Decision|2|||
33544132|NCT03019549|62934946|FG000|Period 2|Withdrawal by Subject|1|||
33544133|NCT01661062|62934955|FG000|Overall Study|Completed Treatment Off Study|3|||
33544134|NCT01661062|62934955|FG000|Overall Study|Withdrawal by Subject|2|||
33529010|NCT00318656|62917477|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
33529011|NCT00318656|62917478|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
33529012|NCT00318656|62917477|FG000|Overall Study|Did not receive any treatment|0|||
33529013|NCT00318656|62917478|FG001|Overall Study|Did not receive any treatment|1|||
33529014|NCT02908347|62917484|FG000|Overall Study|Adverse Event|0|||
33529015|NCT02908347|62917485|FG001|Overall Study|Adverse Event|1|||
33325559|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
33325560|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33325561|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
33325562|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
33458093|NCT00384059|62832349|FG000|After Infant Series|Protocol Violation|2|||
33458094|NCT00384059|62832350|FG001|After Infant Series|Protocol Violation|3|||
33625256|NCT01847274|63026068|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
33625257|NCT01847274|63026069|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
33625258|NCT01847274|63026070|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
33625259|NCT01847274|63026060|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
33625260|NCT01847274|63026061|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
33625261|NCT01847274|63026062|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
33625262|NCT01847274|63026063|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
33625263|NCT01847274|63026064|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
33625264|NCT01847274|63026065|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
33625265|NCT01847274|63026066|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
33625266|NCT01847274|63026067|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
33625267|NCT01847274|63026068|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
33625268|NCT01847274|63026069|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
33625269|NCT01847274|63026070|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
33625270|NCT01847274|63026060|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33625271|NCT01847274|63026061|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33625272|NCT01847274|63026062|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33625273|NCT01847274|63026063|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33625274|NCT01847274|63026064|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33625275|NCT01847274|63026065|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
33625276|NCT01847274|63026066|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33625277|NCT01847274|63026067|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33625278|NCT01847274|63026068|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33625279|NCT01847274|63026069|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33625280|NCT01847274|63026070|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33625281|NCT01847274|63026060|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33625282|NCT01847274|63026061|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33625283|NCT01847274|63026062|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33625284|NCT01847274|63026063|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33625285|NCT01847274|63026064|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
33625286|NCT01847274|63026065|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33625287|NCT01847274|63026066|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33625288|NCT01847274|63026067|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33625289|NCT01847274|63026068|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33458095|NCT00384059|62832349|FG000|After Infant Series|Withdrawal by Subject|2|||
33458096|NCT00384059|62832350|FG001|After Infant Series|Withdrawal by Subject|2|||
33458097|NCT00384059|62832349|FG000|After Infant Series|Failed to Return|0|||
33458098|NCT00384059|62832350|FG001|After Infant Series|Failed to Return|2|||
33458099|NCT00384059|62832349|FG000|After Infant Series|Adverse Event|0|||
33458100|NCT00384059|62832350|FG001|After Infant Series|Adverse Event|1|||
33458101|NCT00384059|62832349|FG000|After Infant Series|Physician Decision|0|||
33458102|NCT00384059|62832350|FG001|After Infant Series|Physician Decision|1|||
33458103|NCT00384059|62832349|FG000|After Infant Series|Lost to Follow-up|0|||
33458104|NCT00384059|62832350|FG001|After Infant Series|Lost to Follow-up|1|||
33458105|NCT00384059|62832349|FG000|Toddler Dose|Lost to Follow-up|1|||
33458106|NCT00384059|62832350|FG001|Toddler Dose|Lost to Follow-up|1|||
33458107|NCT00384059|62832349|FG000|Toddler Dose|Failed to return|0|||
33458108|NCT00384059|62832350|FG001|Toddler Dose|Failed to return|1|||
33458109|NCT00383123|62832379|FG000|Overall Study|Adverse Event|1|||
33529016|NCT02908347|62917484|FG000|Overall Study|Lost to Follow-up|1|||
33529017|NCT02908347|62917485|FG001|Overall Study|Lost to Follow-up|0|||
33529018|NCT02983305|62917507|FG000|Overall Study|incomplete data|2|||
33529019|NCT02983305|62917508|FG001|Overall Study|incomplete data|0|||
33458110|NCT00383123|62832380|FG001|Overall Study|Adverse Event|0|||
33458111|NCT00383123|62832379|FG000|Overall Study|Lost to Follow-up|68|||
33458112|NCT00383123|62832380|FG001|Overall Study|Lost to Follow-up|61|||
33458113|NCT00383123|62832379|FG000|Overall Study|Protocol Violation|5|||
33529020|NCT03663166|62917514|FG000|Overall Study|Withdrawal by Subject|1|||
33529021|NCT02983227|62917521|FG000|Overall Study|Adverse Event|21|||
33529022|NCT02983227|62917522|FG001|Overall Study|Adverse Event|3|||
33529023|NCT02983227|62917521|FG000|Overall Study|Death|3|||
33529024|NCT02983227|62917522|FG001|Overall Study|Death|0|||
33625290|NCT01847274|63026069|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33625291|NCT01847274|63026070|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33625292|NCT01847274|63026060|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33625293|NCT01847274|63026061|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33529025|NCT02983227|62917521|FG000|Overall Study|Lack of Efficacy|8|||
33529026|NCT02983227|62917522|FG001|Overall Study|Lack of Efficacy|1|||
33529027|NCT02983227|62917521|FG000|Overall Study|Lost to Follow-up|3|||
33458114|NCT00383123|62832380|FG001|Overall Study|Protocol Violation|1|||
33458115|NCT00383123|62832379|FG000|Overall Study|Withdrawal by Subject|27|||
33458116|NCT00383123|62832380|FG001|Overall Study|Withdrawal by Subject|18|||
33458117|NCT00383123|62832379|FG000|Overall Study|Other reason|10|||
33458118|NCT00383123|62832380|FG001|Overall Study|Other reason|6|||
33458119|NCT00382967|62832388|FG000|Overall Study|Protocol Violation|1|||
33458120|NCT00382967|62832389|FG001|Overall Study|Protocol Violation|1|||
33458121|NCT00858364|62832397|FG000|Overall Study|Administrative Decision|3|||
33458122|NCT00858364|62832398|FG001|Overall Study|Administrative Decision|2|||
33458123|NCT00858364|62832397|FG000|Overall Study|Adverse Event|5|||
33458124|NCT00858364|62832398|FG001|Overall Study|Adverse Event|2|||
33458125|NCT00858364|62832397|FG000|Overall Study|Withdrawal by Subject|44|||
33458126|NCT00858364|62832398|FG001|Overall Study|Withdrawal by Subject|118|||
33458127|NCT00858364|62832397|FG000|Overall Study|Ineligibility Determined|1|||
33458128|NCT00858364|62832398|FG001|Overall Study|Ineligibility Determined|10|||
33529028|NCT02983227|62917522|FG001|Overall Study|Lost to Follow-up|0|||
33529029|NCT02983227|62917521|FG000|Overall Study|Multiple Reasons|2|||
33529030|NCT02983227|62917522|FG001|Overall Study|Multiple Reasons|1|||
33529031|NCT02983227|62917521|FG000|Overall Study|Physician Decision|3|||
33529032|NCT02983227|62917522|FG001|Overall Study|Physician Decision|1|||
33529033|NCT02983227|62917521|FG000|Overall Study|Withdrawal by Subject|19|||
33529034|NCT02983227|62917522|FG001|Overall Study|Withdrawal by Subject|8|||
33529035|NCT00301262|62917530|FG000|Double Blind Phase (DB)|Adverse Event|1|||
33529036|NCT00301262|62917531|FG001|Double Blind Phase (DB)|Adverse Event|0|||
33529037|NCT00301262|62917530|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
33529038|NCT00301262|62917531|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
33529039|NCT00301262|62917530|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
33529040|NCT00301262|62917531|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
33529041|NCT00301262|62917530|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
33529042|NCT00301262|62917531|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
33529043|NCT00301262|62917530|FG000|Double Blind Phase (DB)|Other|1|||
33529044|NCT00301262|62917531|FG001|Double Blind Phase (DB)|Other|4|||
33529045|NCT00301262|62917530|FG000|Open Label Phase (OL)|Adverse Event|1|||
33529046|NCT00301262|62917531|FG001|Open Label Phase (OL)|Adverse Event|0|||
33529047|NCT00301262|62917530|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
33529048|NCT00301262|62917531|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
33529049|NCT00301262|62917530|FG000|Open Label Phase (OL)|Other|2|||
33529050|NCT00301262|62917531|FG001|Open Label Phase (OL)|Other|0|||
33529051|NCT02905149|62917558|FG000|Overall Study|Lost to Follow-up|2|||
33529052|NCT02905149|62917559|FG001|Overall Study|Lost to Follow-up|0|||
33529053|NCT02790606|62917565|FG000|Overall Study|Death|27|||
33529054|NCT02790606|62917565|FG000|Overall Study|Lost to Follow-up|4|||
33529055|NCT02790606|62917565|FG000|Overall Study|Physician Decision|3|||
33529056|NCT02790606|62917565|FG000|Overall Study|Withdrawal by Subject|1|||
33529057|NCT03077620|62917573|FG000|Overall Study|Unable to place lumbar catheter|1|||
33529058|NCT03077620|62917574|FG001|Overall Study|Unable to place lumbar catheter|0|||
33529059|NCT03077620|62917575|FG002|Overall Study|Unable to place lumbar catheter|1|||
33529060|NCT03077620|62917576|FG003|Overall Study|Unable to place lumbar catheter|0|||
33529061|NCT03077620|62917573|FG000|Overall Study|Withdrawal by Subject|0|||
33529062|NCT03077620|62917574|FG001|Overall Study|Withdrawal by Subject|1|||
33529063|NCT03077620|62917575|FG002|Overall Study|Withdrawal by Subject|0|||
33529064|NCT03077620|62917576|FG003|Overall Study|Withdrawal by Subject|0|||
33458129|NCT00858364|62832397|FG000|Overall Study|Lost to Follow-up|24|||
33458130|NCT00858364|62832398|FG001|Overall Study|Lost to Follow-up|54|||
33529065|NCT03077620|62917573|FG000|Overall Study|Physician Decision|0|||
33458131|NCT00858364|62832397|FG000|Overall Study|Noncompliance|3|||
33529066|NCT03077620|62917574|FG001|Overall Study|Physician Decision|0|||
33529067|NCT03077620|62917575|FG002|Overall Study|Physician Decision|1|||
33529068|NCT03077620|62917576|FG003|Overall Study|Physician Decision|0|||
33529069|NCT02982213|62917597|FG000|Overall Study|Did not complete follow up questionnaire|5|||
33529070|NCT02982213|62917598|FG001|Overall Study|Did not complete follow up questionnaire|1|||
33529071|NCT02649634|62917606|FG000|Overall Study|Withdrawal by Subject|3|||
33529072|NCT02649634|62917607|FG001|Overall Study|Withdrawal by Subject|5|||
33529073|NCT02649634|62917606|FG000|Overall Study|Lost to Follow-up|0|||
33529074|NCT02649634|62917607|FG001|Overall Study|Lost to Follow-up|1|||
33529075|NCT01066143|62917613|FG000|Overall Study|ineligible for the study|8|||
33529076|NCT02980107|62917619|FG000|Overall Study|Withdrawal by Subject|51|||
33529077|NCT02980107|62917620|FG001|Overall Study|Withdrawal by Subject|62|||
33529078|NCT02652130|62917626|FG000|Overall Study|Death|1|||
33529079|NCT02979639|62917630|FG000|Overall Study|Withdrawal based on medical judgement|1|||
33529080|NCT02979639|62917630|FG000|Overall Study|Lost to Follow-up|8|||
33529081|NCT02979639|62917630|FG000|Overall Study|Withdrawal by Subject|3|||
33529082|NCT02979639|62917630|FG000|Overall Study|Adverse Event|2|||
33529083|NCT01674634|62917634|FG000|Overall Study|Withdrawal by Subject|3|||
33529084|NCT01674634|62917634|FG000|Overall Study|Lost to Follow-up|3|||
33529085|NCT02979249|62917642|FG000|Overall Study|Lost to Follow-up|2|||
33529086|NCT02979249|62917642|FG000|Overall Study|Withdrawal by Subject|4|||
33529087|NCT02112552|62917646|FG000|Overall Study|Withdrawal by Subject|1|||
33529088|NCT02112552|62917646|FG000|Overall Study|Adverse Event|1|||
33529089|NCT02976519|62917657|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
33529090|NCT02976519|62917658|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
33529091|NCT02976519|62917659|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
33529092|NCT02976519|62917660|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
33529093|NCT02976519|62917661|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
33529094|NCT02976519|62917662|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
33529095|NCT02976519|62917663|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
33529096|NCT02976519|62917657|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
33529097|NCT02976519|62917658|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
33529098|NCT02976519|62917659|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
33529099|NCT02976519|62917660|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
33529100|NCT02976519|62917661|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
33529101|NCT02976519|62917662|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
33529102|NCT02976519|62917663|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
33529103|NCT02976519|62917657|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
33529104|NCT02976519|62917658|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
33529105|NCT02976519|62917659|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
33529106|NCT02976519|62917660|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
33529107|NCT02976519|62917661|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
33529108|NCT02976519|62917662|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
33529109|NCT02976519|62917663|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
33529110|NCT02976519|62917657|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
33529111|NCT02976519|62917658|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
33529112|NCT02976519|62917659|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
33529113|NCT02976519|62917660|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
33529114|NCT02976519|62917661|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
33529115|NCT02976519|62917662|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
33529116|NCT02976519|62917663|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
33529117|NCT02976519|62917657|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
33529118|NCT02976519|62917658|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
33529119|NCT02976519|62917659|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
33529120|NCT02976519|62917660|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
33529121|NCT02976519|62917661|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
33529122|NCT02976519|62917662|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
33529123|NCT02976519|62917663|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
33529124|NCT02975973|62917768|FG000|Overall Study|Adverse Event|1|||
33529125|NCT02975973|62917769|FG001|Overall Study|Adverse Event|1|||
33529126|NCT02975973|62917770|FG002|Overall Study|Adverse Event|1|||
33529127|NCT02975973|62917771|FG003|Overall Study|Adverse Event|0|||
33529128|NCT01362322|62917783|FG000|Overall Study|Withdrawal by Subject|3|||
33529129|NCT01362322|62917784|FG001|Overall Study|Withdrawal by Subject|1|||
33529130|NCT01362322|62917783|FG000|Overall Study|Lost to Follow-up|2|||
33625294|NCT01847274|63026062|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33625295|NCT01847274|63026063|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33625296|NCT01847274|63026064|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33625297|NCT01847274|63026065|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33529131|NCT01362322|62917784|FG001|Overall Study|Lost to Follow-up|6|||
33529132|NCT02918877|62917792|FG000|Overall Study|Withdrawal by Subject|2|||
33529133|NCT02918877|62917793|FG001|Overall Study|Withdrawal by Subject|2|||
33529134|NCT02918877|62917792|FG000|Overall Study|Surgery cancelled|1|||
33529135|NCT02918877|62917793|FG001|Overall Study|Surgery cancelled|0|||
33529136|NCT02918877|62917792|FG000|Overall Study|Physician Decision|1|||
33625298|NCT01847274|63026066|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
33529137|NCT02918877|62917793|FG001|Overall Study|Physician Decision|0|||
33529138|NCT02918877|62917792|FG000|Overall Study|Received intraoperative steroids|1|||
33529139|NCT02918877|62917793|FG001|Overall Study|Received intraoperative steroids|0|||
33529140|NCT02918877|62917792|FG000|Overall Study|Unable to obtain lab samples|1|||
33529141|NCT02918877|62917793|FG001|Overall Study|Unable to obtain lab samples|0|||
33458132|NCT00858364|62832398|FG001|Overall Study|Noncompliance|4|||
33458133|NCT00858364|62832397|FG000|Overall Study|Protocol Deviation|0|||
33529142|NCT02918877|62917792|FG000|Overall Study|Unsafe to perform BAL|0|||
33529143|NCT02918877|62917793|FG001|Overall Study|Unsafe to perform BAL|1|||
33529144|NCT01674712|62917804|FG000|Overall Study|Adverse Event|5|||
33529145|NCT01674712|62917805|FG001|Overall Study|Adverse Event|6|||
33529146|NCT01674712|62917806|FG002|Overall Study|Adverse Event|3|||
33529147|NCT01674712|62917807|FG003|Overall Study|Adverse Event|4|||
33529148|NCT01674712|62917808|FG004|Overall Study|Adverse Event|6|||
33529149|NCT01674712|62917804|FG000|Overall Study|Lost to Follow-up|1|||
33529150|NCT01674712|62917805|FG001|Overall Study|Lost to Follow-up|0|||
33529151|NCT01674712|62917806|FG002|Overall Study|Lost to Follow-up|0|||
33529152|NCT01674712|62917807|FG003|Overall Study|Lost to Follow-up|0|||
33529153|NCT01674712|62917808|FG004|Overall Study|Lost to Follow-up|0|||
33529154|NCT01674712|62917804|FG000|Overall Study|Protocol Violation|2|||
33529155|NCT01674712|62917805|FG001|Overall Study|Protocol Violation|0|||
33529156|NCT01674712|62917806|FG002|Overall Study|Protocol Violation|0|||
33529157|NCT01674712|62917807|FG003|Overall Study|Protocol Violation|0|||
33529158|NCT01674712|62917808|FG004|Overall Study|Protocol Violation|0|||
33529159|NCT01674712|62917804|FG000|Overall Study|Withdrawal by Subject|2|||
33529160|NCT01674712|62917805|FG001|Overall Study|Withdrawal by Subject|2|||
33529161|NCT01674712|62917806|FG002|Overall Study|Withdrawal by Subject|5|||
33529162|NCT01674712|62917807|FG003|Overall Study|Withdrawal by Subject|4|||
33529163|NCT01674712|62917808|FG004|Overall Study|Withdrawal by Subject|3|||
33529164|NCT01674712|62917804|FG000|Overall Study|Administrative|0|||
33529165|NCT01674712|62917805|FG001|Overall Study|Administrative|1|||
33529166|NCT01674712|62917806|FG002|Overall Study|Administrative|0|||
33458134|NCT00858364|62832398|FG001|Overall Study|Protocol Deviation|2|||
33458135|NCT00858364|62832397|FG000|Overall Study|Other|9|||
33458136|NCT00858364|62832398|FG001|Overall Study|Other|17|||
33458137|NCT00858364|62832397|FG000|Overall Study|Missing|1|||
33458138|NCT00858364|62832398|FG001|Overall Study|Missing|1|||
33458139|NCT00858364|62832397|FG000|Overall Study|Still on-study|114|||
33458140|NCT00858364|62832398|FG001|Overall Study|Still on-study|247|||
33458141|NCT00382733|62832404|FG000|Overall Study|Withdrawal by Subject|0|||
33458142|NCT00382733|62832405|FG001|Overall Study|Withdrawal by Subject|1|||
33458143|NCT00382733|62832406|FG002|Overall Study|Withdrawal by Subject|0|||
33529167|NCT01674712|62917807|FG003|Overall Study|Administrative|0|||
33529168|NCT01674712|62917808|FG004|Overall Study|Administrative|1|||
33529169|NCT01674712|62917804|FG000|Overall Study|Lack of Efficacy|0|||
33625299|NCT01847274|63026067|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33625300|NCT01847274|63026068|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33458144|NCT00382733|62832407|FG003|Overall Study|Withdrawal by Subject|0|||
33458145|NCT00382733|62832408|FG004|Overall Study|Withdrawal by Subject|0|||
33529170|NCT01674712|62917805|FG001|Overall Study|Lack of Efficacy|0|||
33458146|NCT03631732|62832423|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
33458147|NCT03631732|62832424|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
33458148|NCT03631732|62832423|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
33458149|NCT03631732|62832424|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
33458150|NCT03631732|62832423|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
33458151|NCT03631732|62832424|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
33458152|NCT03631732|62832423|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
33458153|NCT03631732|62832424|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
33458154|NCT03631732|62832423|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
33529171|NCT01674712|62917806|FG002|Overall Study|Lack of Efficacy|1|||
33529172|NCT01674712|62917807|FG003|Overall Study|Lack of Efficacy|0|||
33625301|NCT01847274|63026069|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33458155|NCT03631732|62832424|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
33458156|NCT03631732|62832423|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
33458157|NCT03631732|62832424|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
33529173|NCT01674712|62917808|FG004|Overall Study|Lack of Efficacy|1|||
33529174|NCT01368432|62917822|FG000|Overall Study|Lost to Follow-up|0|||
33529175|NCT01368432|62917823|FG001|Overall Study|Lost to Follow-up|1|||
33529176|NCT01063881|62917846|FG000|Overall Study|Adverse Event|12|||
33529177|NCT01063881|62917847|FG001|Overall Study|Adverse Event|2|||
33529178|NCT01063881|62917848|FG002|Overall Study|Adverse Event|0|||
33529179|NCT01063881|62917846|FG000|Overall Study|Lost to Follow-up|13|||
33529180|NCT01063881|62917847|FG001|Overall Study|Lost to Follow-up|7|||
33529181|NCT01063881|62917848|FG002|Overall Study|Lost to Follow-up|1|||
33529182|NCT01063881|62917846|FG000|Overall Study|Withdrawal by Subject|25|||
33529183|NCT01063881|62917847|FG001|Overall Study|Withdrawal by Subject|1|||
33529184|NCT01063881|62917848|FG002|Overall Study|Withdrawal by Subject|0|||
33529185|NCT01063881|62917846|FG000|Overall Study|Reason for not completed not specified|5|||
33529186|NCT01063881|62917847|FG001|Overall Study|Reason for not completed not specified|1|||
33529187|NCT01063881|62917848|FG002|Overall Study|Reason for not completed not specified|0|||
33529188|NCT01062555|62917865|FG000|Phase 1|Death|10|||
33529189|NCT01062555|62917866|FG001|Phase 1|Death|17|||
33529190|NCT01062555|62917867|FG002|Phase 1|Death|0|||
33529191|NCT01062555|62917868|FG003|Phase 1|Death|0|||
33529192|NCT01062555|62917865|FG000|Phase 1|Graft Failure|12|||
33529193|NCT01062555|62917866|FG001|Phase 1|Graft Failure|8|||
33529194|NCT01062555|62917867|FG002|Phase 1|Graft Failure|0|||
33529195|NCT01062555|62917868|FG003|Phase 1|Graft Failure|0|||
33529196|NCT01062555|62917865|FG000|Phase 1|Withdrawal by Subject|1|||
33529197|NCT01062555|62917866|FG001|Phase 1|Withdrawal by Subject|1|||
33529198|NCT01062555|62917867|FG002|Phase 1|Withdrawal by Subject|0|||
33529199|NCT01062555|62917868|FG003|Phase 1|Withdrawal by Subject|0|||
33529200|NCT01062555|62917865|FG000|Phase 2|Death|0|||
33529201|NCT01062555|62917866|FG001|Phase 2|Death|0|||
33529202|NCT01062555|62917867|FG002|Phase 2|Death|8|||
33529203|NCT01062555|62917868|FG003|Phase 2|Death|3|||
33529204|NCT01062555|62917865|FG000|Phase 2|Graft failure|0|||
33529205|NCT01062555|62917866|FG001|Phase 2|Graft failure|0|||
33529206|NCT01062555|62917867|FG002|Phase 2|Graft failure|7|||
33529207|NCT01062555|62917868|FG003|Phase 2|Graft failure|4|||
33529208|NCT01062555|62917865|FG000|Phase 2|Withdrawal by Subject|0|||
33529209|NCT01062555|62917866|FG001|Phase 2|Withdrawal by Subject|0|||
33529210|NCT01062555|62917867|FG002|Phase 2|Withdrawal by Subject|0|||
33529211|NCT01062555|62917868|FG003|Phase 2|Withdrawal by Subject|7|||
33458158|NCT03631732|62832423|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
33458159|NCT03631732|62832424|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
33458160|NCT03631732|62832423|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
33458161|NCT03631732|62832424|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
33458162|NCT03631732|62832423|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
33458163|NCT03631732|62832424|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
33458164|NCT03631732|62832423|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
33458165|NCT03631732|62832424|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
33458166|NCT03630016|62832434|FG000|Overall Study|Poor Sensor Placement|1|||
33458167|NCT03628924|62832441|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
33458168|NCT03628924|62832442|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
33458169|NCT03628924|62832443|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
33458170|NCT03628924|62832444|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
33529212|NCT01062555|62917865|FG000|Phase 2|Protocol Violation|0|||
33529213|NCT01062555|62917866|FG001|Phase 2|Protocol Violation|0|||
33529214|NCT01062555|62917867|FG002|Phase 2|Protocol Violation|0|||
33529215|NCT01062555|62917868|FG003|Phase 2|Protocol Violation|3|||
33529216|NCT01062555|62917865|FG000|Phase 2|Physician Decision|0|||
33529217|NCT01062555|62917866|FG001|Phase 2|Physician Decision|0|||
33529218|NCT01062555|62917867|FG002|Phase 2|Physician Decision|0|||
33529219|NCT01062555|62917868|FG003|Phase 2|Physician Decision|17|||
33529220|NCT01064817|62917880|FG000|Study Completion|Physician Decision|1|||
33529221|NCT01064817|62917881|FG001|Study Completion|Physician Decision|0|||
33529222|NCT01064817|62917880|FG000|Study Completion|Withdrawal by Subject|1|||
33529223|NCT01064817|62917881|FG001|Study Completion|Withdrawal by Subject|0|||
33529224|NCT01368276|62917889|FG000|Overall Study|Death|1|||
33529225|NCT01368276|62917890|FG001|Overall Study|Death|10|||
33529226|NCT01064739|62917896|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
33529227|NCT01061775|62917906|FG000|Overall Study|Physician Decision|2|||
33529228|NCT01061775|62917906|FG000|Overall Study|Lost to Follow-up|1|||
33529229|NCT02651116|62917913|FG000|Overall Study|Adverse Event|0|||
33529230|NCT02651116|62917914|FG001|Overall Study|Adverse Event|1|||
33529231|NCT02651116|62917913|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
33529232|NCT02651116|62917914|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
33529233|NCT01061385|62917922|FG000|Overall Study|Lost to Follow-up|1|||
33529234|NCT01061385|62917923|FG001|Overall Study|Lost to Follow-up|0|||
33529235|NCT01061385|62917922|FG000|Overall Study|subject decision not related to AE|0|||
33529236|NCT01061385|62917923|FG001|Overall Study|subject decision not related to AE|1|||
33529237|NCT02973477|62917932|FG000|First Intervention|Lost to Follow-up|0|||
33529238|NCT02973477|62917933|FG001|First Intervention|Lost to Follow-up|2|||
33529239|NCT02973477|62917932|FG000|Washout|Withdrawal by Subject|1|||
33529240|NCT02973477|62917933|FG001|Washout|Withdrawal by Subject|0|||
33529241|NCT02973477|62917932|FG000|Second Intervention|Lost to Follow-up|1|||
33529242|NCT02973477|62917933|FG001|Second Intervention|Lost to Follow-up|0|||
33529243|NCT02788656|62917947|FG000|Overall Study|Withdrawal by Subject|1|||
33529244|NCT02788656|62917948|FG001|Overall Study|Withdrawal by Subject|0|||
33529245|NCT00283868|62917956|FG000|Overall Study|Lost to Follow-up|7|||
33529246|NCT00283868|62917957|FG001|Overall Study|Lost to Follow-up|8|||
33529247|NCT02973087|62917963|FG000|Overall Study|Withdrawal by Subject|2|||
33529248|NCT02973087|62917964|FG001|Overall Study|Withdrawal by Subject|1|||
33529249|NCT02973087|62917963|FG000|Overall Study|Adverse Event|1|||
33529250|NCT02973087|62917964|FG001|Overall Study|Adverse Event|0|||
33529251|NCT02973087|62917963|FG000|Overall Study|other|1|||
33529252|NCT02973087|62917964|FG001|Overall Study|other|1|||
33529253|NCT00271544|62917984|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
33529254|NCT00271544|62917984|FG000|Overall Study|Model 4196 lead not attempted|9|||
33529255|NCT00271544|62917984|FG000|Overall Study|Implant not attempted|4|||
33529256|NCT05342532|62918002|FG000|Overall Study|Adverse Event|5|||
33529257|NCT05342532|62918003|FG001|Overall Study|Adverse Event|20|||
33529258|NCT05342532|62918002|FG000|Overall Study|Lost to Follow-up|10|||
33529259|NCT05342532|62918003|FG001|Overall Study|Lost to Follow-up|15|||
33529260|NCT02984943|62918009|FG000|Overall Study|Withdrawal by Subject|3|||
33529261|NCT02984943|62918009|FG000|Overall Study|Physician Decision|1|||
33529262|NCT02787408|62918013|FG000|Overall Study|Death|16|||
33529263|NCT02787408|62918013|FG000|Overall Study|Withdrawal by Subject|1|||
33529264|NCT02787408|62918013|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
33529265|NCT02971605|62918017|FG000|Overall Study|Withdrawal by Subject|1|||
33529266|NCT03054337|62918029|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
33529267|NCT03054337|62918030|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
33458171|NCT03628924|62832445|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
33458172|NCT03628924|62832446|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
33458173|NCT03628924|62832447|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
33458174|NCT03628924|62832441|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33458175|NCT03628924|62832442|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33458176|NCT03628924|62832443|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
33458177|NCT03628924|62832444|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33458178|NCT03628924|62832445|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33458179|NCT03628924|62832446|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33458180|NCT03628924|62832447|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33458181|NCT03628924|62832441|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
33458182|NCT03628924|62832442|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
33458183|NCT03628924|62832443|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
33458184|NCT03628924|62832444|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
33529268|NCT03054337|62918031|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
33529269|NCT03054337|62918032|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
33529270|NCT03054337|62918033|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
33529271|NCT03054337|62918034|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
33529272|NCT01060059|62918067|FG000|Overall Study|Adverse Event|1|||
33529273|NCT01060059|62918068|FG001|Overall Study|Adverse Event|1|||
33529274|NCT01060059|62918067|FG000|Overall Study|Death|2|||
33529275|NCT01060059|62918068|FG001|Overall Study|Death|3|||
33529276|NCT01060059|62918067|FG000|Overall Study|Lost to Follow-up|18|||
33529277|NCT01060059|62918068|FG001|Overall Study|Lost to Follow-up|34|||
33529278|NCT01060059|62918067|FG000|Overall Study|entry criteria not met|4|||
33529279|NCT01060059|62918068|FG001|Overall Study|entry criteria not met|3|||
33529280|NCT01060059|62918067|FG000|Overall Study|Withdrawal by Subject|35|||
33529281|NCT01060059|62918068|FG001|Overall Study|Withdrawal by Subject|23|||
33458185|NCT03628924|62832445|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
33458186|NCT03628924|62832446|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
33458187|NCT03628924|62832447|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
33458188|NCT03628924|62832441|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33458189|NCT03628924|62832442|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
33458190|NCT03628924|62832443|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33458191|NCT03628924|62832444|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33458192|NCT03628924|62832445|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33458193|NCT03628924|62832446|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33529282|NCT01060059|62918067|FG000|Overall Study|lack of glycemic control|2|||
33529283|NCT01060059|62918068|FG001|Overall Study|lack of glycemic control|1|||
33529284|NCT01060059|62918067|FG000|Overall Study|lack of compliance|5|||
33529285|NCT01060059|62918068|FG001|Overall Study|lack of compliance|2|||
33529286|NCT02648932|62918082|FG000|Overall Study|No transplant|3|||
33529287|NCT02648932|62918083|FG001|Overall Study|No transplant|1|||
33529288|NCT02122458|62918096|FG000|Overall Study|Withdrawal by Subject|0|||
33529289|NCT02122458|62918097|FG001|Overall Study|Withdrawal by Subject|0|||
33529290|NCT02122458|62918098|FG002|Overall Study|Withdrawal by Subject|0|||
33529291|NCT02122458|62918099|FG003|Overall Study|Withdrawal by Subject|4|||
33529292|NCT02122458|62918100|FG004|Overall Study|Withdrawal by Subject|4|||
33529293|NCT02122458|62918101|FG005|Overall Study|Withdrawal by Subject|4|||
33529294|NCT02122458|62918102|FG006|Overall Study|Withdrawal by Subject|0|||
33529295|NCT02122458|62918096|FG000|Overall Study|Lost to Follow-up|1|||
33529296|NCT02122458|62918097|FG001|Overall Study|Lost to Follow-up|3|||
33529297|NCT02122458|62918098|FG002|Overall Study|Lost to Follow-up|0|||
33529298|NCT02122458|62918099|FG003|Overall Study|Lost to Follow-up|7|||
33529299|NCT02122458|62918100|FG004|Overall Study|Lost to Follow-up|5|||
33529300|NCT02122458|62918101|FG005|Overall Study|Lost to Follow-up|15|||
33529301|NCT02122458|62918102|FG006|Overall Study|Lost to Follow-up|1|||
33529302|NCT02122458|62918096|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
33529303|NCT02122458|62918097|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
33529304|NCT02122458|62918098|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
33529305|NCT02122458|62918099|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
33529306|NCT02122458|62918100|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
33529307|NCT02122458|62918101|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
33458194|NCT03628924|62832447|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33529308|NCT02122458|62918102|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
33529309|NCT02122458|62918096|FG000|Overall Study|Adverse Event|1|||
33529310|NCT02122458|62918097|FG001|Overall Study|Adverse Event|0|||
33529311|NCT02122458|62918098|FG002|Overall Study|Adverse Event|0|||
33529312|NCT02122458|62918099|FG003|Overall Study|Adverse Event|0|||
33529313|NCT02122458|62918100|FG004|Overall Study|Adverse Event|0|||
33529314|NCT02122458|62918101|FG005|Overall Study|Adverse Event|0|||
33529315|NCT02122458|62918102|FG006|Overall Study|Adverse Event|0|||
33529316|NCT02122458|62918096|FG000|Overall Study|Experimental Error|0|||
33529317|NCT02122458|62918097|FG001|Overall Study|Experimental Error|0|||
33529318|NCT02122458|62918098|FG002|Overall Study|Experimental Error|0|||
33529319|NCT02122458|62918099|FG003|Overall Study|Experimental Error|0|||
33529320|NCT02122458|62918100|FG004|Overall Study|Experimental Error|3|||
33529321|NCT02122458|62918101|FG005|Overall Study|Experimental Error|0|||
33529322|NCT02122458|62918102|FG006|Overall Study|Experimental Error|0|||
33529323|NCT02122458|62918096|FG000|Overall Study|Deployed or Moved|0|||
33529324|NCT02122458|62918097|FG001|Overall Study|Deployed or Moved|0|||
33529325|NCT02122458|62918098|FG002|Overall Study|Deployed or Moved|0|||
33529326|NCT02122458|62918099|FG003|Overall Study|Deployed or Moved|0|||
33529327|NCT02122458|62918100|FG004|Overall Study|Deployed or Moved|1|||
33458195|NCT03628924|62832441|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
33458196|NCT03628924|62832442|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
33529328|NCT02122458|62918101|FG005|Overall Study|Deployed or Moved|0|||
33529329|NCT02122458|62918102|FG006|Overall Study|Deployed or Moved|0|||
33529330|NCT02122458|62918096|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
33529331|NCT02122458|62918097|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
33544135|NCT02536378|62934961|FG000|Overall Study|Physician Decision|0|||
33544136|NCT02536378|62934962|FG001|Overall Study|Physician Decision|2|||
33544137|NCT02536378|62934961|FG000|Overall Study|Withdrawal by Subject|0|||
33544138|NCT02536378|62934962|FG001|Overall Study|Withdrawal by Subject|1|||
33544139|NCT02536378|62934961|FG000|Overall Study|Death|1|||
33544140|NCT02536378|62934962|FG001|Overall Study|Death|2|||
33458197|NCT03628924|62832443|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
33458198|NCT03628924|62832444|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
33458199|NCT03628924|62832445|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
33458200|NCT03628924|62832446|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
33458201|NCT03628924|62832447|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
33458202|NCT03628924|62832441|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
33458203|NCT03628924|62832442|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
33458204|NCT03628924|62832443|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
33458205|NCT03628924|62832444|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
33458206|NCT03628924|62832445|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
33458207|NCT03628924|62832446|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
33458208|NCT03628924|62832447|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
33458209|NCT03628924|62832441|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
33458210|NCT03628924|62832442|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
33529332|NCT02122458|62918098|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
33529333|NCT02122458|62918099|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
33529334|NCT02122458|62918100|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
33529335|NCT02122458|62918101|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
33529336|NCT02122458|62918102|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
33529337|NCT02122458|62918096|FG000|Overall Study|Noncompliance|0|||
33529338|NCT02122458|62918097|FG001|Overall Study|Noncompliance|1|||
33529339|NCT02122458|62918098|FG002|Overall Study|Noncompliance|0|||
33529340|NCT02122458|62918099|FG003|Overall Study|Noncompliance|0|||
33529341|NCT02122458|62918100|FG004|Overall Study|Noncompliance|0|||
33529342|NCT02122458|62918101|FG005|Overall Study|Noncompliance|0|||
33529343|NCT02122458|62918102|FG006|Overall Study|Noncompliance|0|||
33529344|NCT02903511|62918118|FG000|Overall Study|Withdrawal by Subject|1|||
33529345|NCT02903511|62918119|FG001|Overall Study|Withdrawal by Subject|0|||
33529346|NCT02903511|62918118|FG000|Overall Study|Lost to Follow-up|3|||
33529347|NCT02903511|62918119|FG001|Overall Study|Lost to Follow-up|2|||
33529348|NCT01368042|62918136|FG000|Overall Study|Death|14|||
33529349|NCT01368042|62918136|FG000|Overall Study|Protocol Violation|11|||
33529350|NCT01368042|62918136|FG000|Overall Study|Lost to Follow-up|4|||
33529351|NCT01368042|62918136|FG000|Overall Study|Transplanted|1|||
33529352|NCT00126776|62918142|FG000|Overall Study|follow up complete on all patients|0|||
33529353|NCT00126776|62918143|FG001|Overall Study|follow up complete on all patients|0|||
33529354|NCT01674010|62918147|FG000|Open Treatment Phase 1|Adverse Event|10|||
33529355|NCT01674010|62918148|FG001|Open Treatment Phase 1|Adverse Event|0|||
33529356|NCT01674010|62918149|FG002|Open Treatment Phase 1|Adverse Event|0|||
33529357|NCT01674010|62918147|FG000|Open Treatment Phase 1|Death|1|||
33529358|NCT01674010|62918148|FG001|Open Treatment Phase 1|Death|0|||
33529359|NCT01674010|62918149|FG002|Open Treatment Phase 1|Death|0|||
33529360|NCT01674010|62918147|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
33529361|NCT01674010|62918148|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
33529362|NCT01674010|62918149|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
33529363|NCT01674010|62918147|FG000|Open Treatment Phase 1|Physician Decision|9|||
33529364|NCT01674010|62918148|FG001|Open Treatment Phase 1|Physician Decision|0|||
33529365|NCT01674010|62918149|FG002|Open Treatment Phase 1|Physician Decision|0|||
33529366|NCT01674010|62918147|FG000|Open Treatment Phase 1|Protocol Violation|7|||
33625302|NCT01847274|63026070|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33625303|NCT01847274|63026060|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33529367|NCT01674010|62918148|FG001|Open Treatment Phase 1|Protocol Violation|0|||
33529368|NCT01674010|62918149|FG002|Open Treatment Phase 1|Protocol Violation|0|||
33529369|NCT01674010|62918147|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
33529370|NCT01674010|62918148|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
33625304|NCT01847274|63026061|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33625305|NCT01847274|63026062|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33625306|NCT01847274|63026063|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33529371|NCT01674010|62918149|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
33529372|NCT01674010|62918147|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
33529373|NCT01674010|62918148|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
33529374|NCT01674010|62918149|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
33529375|NCT01674010|62918147|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
33529376|NCT01674010|62918148|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
33529377|NCT01674010|62918149|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
33529378|NCT01674010|62918147|FG000|Randomization Phase 2|Adverse Event|0|||
33529379|NCT01674010|62918148|FG001|Randomization Phase 2|Adverse Event|1|||
33529380|NCT01674010|62918149|FG002|Randomization Phase 2|Adverse Event|1|||
33529381|NCT01674010|62918147|FG000|Randomization Phase 2|Lost to Follow-up|0|||
33529382|NCT01674010|62918148|FG001|Randomization Phase 2|Lost to Follow-up|1|||
33529383|NCT01674010|62918149|FG002|Randomization Phase 2|Lost to Follow-up|2|||
33529384|NCT01674010|62918147|FG000|Randomization Phase 2|Mood episode recurrence|0|||
33529385|NCT01674010|62918148|FG001|Randomization Phase 2|Mood episode recurrence|8|||
33529386|NCT01674010|62918149|FG002|Randomization Phase 2|Mood episode recurrence|2|||
33529387|NCT01674010|62918147|FG000|Randomization Phase 2|Physician Decision|0|||
33529388|NCT01674010|62918148|FG001|Randomization Phase 2|Physician Decision|0|||
33529389|NCT01674010|62918149|FG002|Randomization Phase 2|Physician Decision|2|||
33529390|NCT01674010|62918147|FG000|Randomization Phase 2|Pregnancy|0|||
33529391|NCT01674010|62918148|FG001|Randomization Phase 2|Pregnancy|1|||
33529392|NCT01674010|62918149|FG002|Randomization Phase 2|Pregnancy|1|||
33529393|NCT01674010|62918147|FG000|Randomization Phase 2|Protocol Violation|0|||
33529394|NCT01674010|62918148|FG001|Randomization Phase 2|Protocol Violation|1|||
33529395|NCT01674010|62918149|FG002|Randomization Phase 2|Protocol Violation|1|||
33529396|NCT01674010|62918147|FG000|Randomization Phase 2|Sponsor Decision|0|||
33529397|NCT01674010|62918148|FG001|Randomization Phase 2|Sponsor Decision|42|||
33529398|NCT01674010|62918149|FG002|Randomization Phase 2|Sponsor Decision|45|||
33529399|NCT01674010|62918147|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
33529400|NCT01674010|62918148|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
33529401|NCT01674010|62918149|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
33529402|NCT01345669|62918159|FG000|Overall Study|Primary tumour recurrence|53|||
33529403|NCT01345669|62918160|FG001|Overall Study|Primary tumour recurrence|32|||
33529404|NCT01345669|62918159|FG000|Overall Study|Second primary tumour|4|||
33529405|NCT01345669|62918160|FG001|Overall Study|Second primary tumour|3|||
33529406|NCT01345669|62918159|FG000|Overall Study|Adverse Event|63|||
33529407|NCT01345669|62918160|FG001|Overall Study|Adverse Event|9|||
33529408|NCT01345669|62918159|FG000|Overall Study|Protocol Violation|3|||
33529409|NCT01345669|62918160|FG001|Overall Study|Protocol Violation|1|||
33529410|NCT01345669|62918159|FG000|Overall Study|Lost to Follow-up|1|||
33529411|NCT01345669|62918160|FG001|Overall Study|Lost to Follow-up|1|||
33529412|NCT01345669|62918159|FG000|Overall Study|Withdrawal by Subject|52|||
33529413|NCT01345669|62918160|FG001|Overall Study|Withdrawal by Subject|13|||
33529414|NCT01345669|62918159|FG000|Overall Study|Other Reasons|111|||
33529415|NCT01345669|62918160|FG001|Overall Study|Other Reasons|60|||
33529416|NCT05334212|62918166|FG000|Overall Study|Study terminated prematurely|7|||
33529417|NCT01673854|62918170|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
33529418|NCT01673854|62918170|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
33529419|NCT01673854|62918170|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
33529420|NCT01673854|62918170|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
33529421|NCT01673854|62918170|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
33529422|NCT01673854|62918170|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
33529423|NCT01673854|62918170|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
33529424|NCT01673854|62918170|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
33529425|NCT01673854|62918170|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
33625307|NCT01847274|63026064|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33625308|NCT01847274|63026065|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33625309|NCT01847274|63026066|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
33625310|NCT01847274|63026067|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33529426|NCT01673854|62918170|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
33529427|NCT01673854|62918170|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
33529428|NCT01673854|62918170|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
33625311|NCT01847274|63026068|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33625312|NCT01847274|63026069|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33625313|NCT01847274|63026070|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33625314|NCT01847274|63026060|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33625315|NCT01847274|63026061|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33625316|NCT01847274|63026062|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33529429|NCT01343407|62918174|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
33529430|NCT01343407|62918175|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
33529431|NCT01343407|62918176|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
33325563|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33529432|NCT01343407|62918177|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
33529433|NCT01343407|62918178|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
33529434|NCT01343407|62918179|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
33529435|NCT01343407|62918174|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
33529436|NCT01343407|62918175|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
33529437|NCT01343407|62918176|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
33529438|NCT01343407|62918177|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
33529439|NCT01343407|62918178|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
33529440|NCT01343407|62918179|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
33529441|NCT01367886|62918187|FG000|Overall Study|Lost to Follow-up|4|||
33529442|NCT01367886|62918187|FG000|Overall Study|Lack of Efficacy|2|||
33529443|NCT01367886|62918187|FG000|Overall Study|Death|1|||
33529444|NCT01673698|62918194|FG000|Overall Study|Lost to Follow-up|51|||
33529445|NCT01673698|62918195|FG001|Overall Study|Lost to Follow-up|13|||
33529446|NCT02786004|62918204|FG000|Overall Study|Withdrawal by Subject|0|||
33529447|NCT02786004|62918205|FG001|Overall Study|Withdrawal by Subject|1|||
33529448|NCT03051607|62918213|FG000|Overall Study|Adverse Event|66|||
33529449|NCT01062399|62918222|FG000|Overall Study|Protocol Violation|0|||
33529450|NCT01062399|62918223|FG001|Overall Study|Protocol Violation|1|||
33529451|NCT01062399|62918224|FG002|Overall Study|Protocol Violation|0|||
33529452|NCT01062399|62918225|FG003|Overall Study|Protocol Violation|6|||
33529453|NCT01062399|62918226|FG004|Overall Study|Protocol Violation|4|||
33529454|NCT01317277|62918240|FG000|Overall Study|Lost to Follow-up|3|||
33529455|NCT01317277|62918241|FG001|Overall Study|Lost to Follow-up|1|||
33529456|NCT01317277|62918240|FG000|Overall Study|Lost MEMS|1|||
33529457|NCT01317277|62918241|FG001|Overall Study|Lost MEMS|1|||
33529458|NCT01317277|62918240|FG000|Overall Study|Unable to comply with intervention|1|||
33529459|NCT01317277|62918241|FG001|Overall Study|Unable to comply with intervention|0|||
33529460|NCT01317277|62918240|FG000|Overall Study|Withdrawal by Subject|1|||
33529461|NCT01317277|62918241|FG001|Overall Study|Withdrawal by Subject|0|||
33529462|NCT01317277|62918240|FG000|Overall Study|Adverse Event|1|||
33529463|NCT01317277|62918241|FG001|Overall Study|Adverse Event|0|||
33458211|NCT03628924|62832443|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
33458212|NCT03628924|62832444|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
33458213|NCT03628924|62832445|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
33458214|NCT03628924|62832446|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
33529464|NCT02740478|62918247|FG000|Overall Study|Withdrawal by Subject|1|||
33529465|NCT02969655|62918253|FG000|Overall Study|Withdrawal by Subject|3|||
33529466|NCT02969655|62918254|FG001|Overall Study|Withdrawal by Subject|2|||
33529467|NCT02969655|62918253|FG000|Overall Study|Physician Decision|4|||
33529468|NCT02969655|62918254|FG001|Overall Study|Physician Decision|3|||
33529469|NCT02969655|62918253|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
33529470|NCT02969655|62918254|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
33529471|NCT02969655|62918253|FG000|Overall Study|Adverse Event|10|||
33529472|NCT02969655|62918254|FG001|Overall Study|Adverse Event|8|||
33529473|NCT01317199|62918265|FG000|Dose-escalation Phase 1|Physician Decision|5|||
33529474|NCT01317199|62918266|FG001|Dose-escalation Phase 1|Physician Decision|0|||
33529475|NCT01317199|62918267|FG002|Dose-escalation Phase 1|Physician Decision|0|||
33529476|NCT01317199|62918268|FG003|Dose-escalation Phase 1|Physician Decision|0|||
33529477|NCT01317199|62918265|FG000|Dose-escalation Phase 1|Disease progression|1|||
33529478|NCT01317199|62918266|FG001|Dose-escalation Phase 1|Disease progression|0|||
33458215|NCT03628924|62832447|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
33458216|NCT03628924|62832441|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
33458217|NCT03628924|62832442|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
33458218|NCT03628924|62832443|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
33458219|NCT03628924|62832444|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
33458220|NCT03628924|62832445|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
33458221|NCT03628924|62832446|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
33458222|NCT03628924|62832447|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
33458223|NCT03628924|62832441|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
33529479|NCT01317199|62918267|FG002|Dose-escalation Phase 1|Disease progression|0|||
33529480|NCT01317199|62918268|FG003|Dose-escalation Phase 1|Disease progression|0|||
33529481|NCT01317199|62918265|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
33529482|NCT01317199|62918266|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
33529483|NCT01317199|62918267|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
33529484|NCT01317199|62918268|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
33529485|NCT01317199|62918265|FG000|Randomized Phase 2|Disease progression|0|||
33529486|NCT01317199|62918266|FG001|Randomized Phase 2|Disease progression|3|||
33529487|NCT01317199|62918267|FG002|Randomized Phase 2|Disease progression|7|||
33529488|NCT01317199|62918268|FG003|Randomized Phase 2|Disease progression|5|||
33529489|NCT01317199|62918265|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
33529490|NCT01317199|62918266|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
33529491|NCT01317199|62918267|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
33529492|NCT01317199|62918268|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
33529493|NCT01317199|62918265|FG000|Randomized Phase 2|Adverse Event|0|||
33529494|NCT01317199|62918266|FG001|Randomized Phase 2|Adverse Event|0|||
33529495|NCT01317199|62918267|FG002|Randomized Phase 2|Adverse Event|0|||
33529496|NCT01317199|62918268|FG003|Randomized Phase 2|Adverse Event|1|||
33529497|NCT01317199|62918265|FG000|Randomized Phase 2|Comorbidities|0|||
33529498|NCT01317199|62918266|FG001|Randomized Phase 2|Comorbidities|2|||
33458224|NCT03628924|62832442|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
33458225|NCT03628924|62832443|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
33625317|NCT01847274|63026063|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33625318|NCT01847274|63026064|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33625319|NCT01847274|63026065|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33625320|NCT01847274|63026066|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
33625321|NCT01847274|63026067|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33625322|NCT01847274|63026068|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33625323|NCT01847274|63026069|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33625324|NCT01847274|63026070|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33625325|NCT01847274|63026060|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
33625326|NCT01847274|63026061|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
33625327|NCT01847274|63026062|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
33625328|NCT01847274|63026063|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
33625329|NCT01847274|63026064|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
33625330|NCT01847274|63026065|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
33625331|NCT01847274|63026066|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
33625332|NCT01847274|63026067|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
33625333|NCT01847274|63026068|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
33625334|NCT01847274|63026069|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
33458226|NCT03628924|62832444|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
33458227|NCT03628924|62832445|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
33458228|NCT03628924|62832446|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
33458229|NCT03628924|62832447|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
33458230|NCT03628924|62832441|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
33458231|NCT03628924|62832442|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
33529499|NCT01317199|62918267|FG002|Randomized Phase 2|Comorbidities|2|||
33529500|NCT01317199|62918268|FG003|Randomized Phase 2|Comorbidities|2|||
33529501|NCT01317199|62918265|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
33529502|NCT01317199|62918266|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
33529503|NCT01317199|62918267|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
33458232|NCT03628924|62832443|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
33458233|NCT03628924|62832444|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
33625335|NCT01847274|63026070|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
33458234|NCT03628924|62832445|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
33529504|NCT01317199|62918268|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
33529505|NCT01317199|62918265|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
33529506|NCT01317199|62918266|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
33625336|NCT01847274|63026060|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33625337|NCT01847274|63026061|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33625338|NCT01847274|63026062|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33625339|NCT01847274|63026063|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33625340|NCT01847274|63026064|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33625341|NCT01847274|63026065|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33625342|NCT01847274|63026066|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33625343|NCT01847274|63026067|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
33625344|NCT01847274|63026068|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33625345|NCT01847274|63026069|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
33625346|NCT01847274|63026070|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33625347|NCT01847274|63026060|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33625348|NCT01847274|63026061|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33625349|NCT01847274|63026062|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33529507|NCT01317199|62918267|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
33529508|NCT01317199|62918268|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
33529509|NCT01317199|62918265|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
33529510|NCT01317199|62918266|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
33529511|NCT01317199|62918267|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
33529512|NCT01317199|62918268|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
33529513|NCT01317199|62918265|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
33529514|NCT01317199|62918266|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
33529515|NCT01317199|62918267|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
33529516|NCT01317199|62918268|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
33529517|NCT02648698|62918287|FG000|Overall Study|Protocol Violation|1|||
33529518|NCT02648698|62918288|FG001|Overall Study|Protocol Violation|5|||
33529519|NCT02970669|62918296|FG000|Double-blind Period|Adverse Event|4|||
33529520|NCT02970669|62918297|FG001|Double-blind Period|Adverse Event|0|||
33529521|NCT02970669|62918296|FG000|Double-blind Period|Death|1|||
33529522|NCT02970669|62918297|FG001|Double-blind Period|Death|0|||
33529523|NCT02970669|62918296|FG000|Double-blind Period|Study terminated by sponsor|1|||
33529524|NCT02970669|62918297|FG001|Double-blind Period|Study terminated by sponsor|2|||
33529525|NCT02970669|62918296|FG000|Double-blind Period|Physician Decision|0|||
33529526|NCT02970669|62918297|FG001|Double-blind Period|Physician Decision|2|||
33529527|NCT02970669|62918296|FG000|Double-blind Period|Withdrawal by Subject|2|||
33529528|NCT02970669|62918297|FG001|Double-blind Period|Withdrawal by Subject|2|||
33529529|NCT02970669|62918296|FG000|Open-label Period|Withdrawal by Subject|2|||
33529530|NCT02970669|62918297|FG001|Open-label Period|Withdrawal by Subject|2|||
33529531|NCT02970669|62918296|FG000|Open-label Period|Adverse Event|1|||
33529532|NCT02970669|62918297|FG001|Open-label Period|Adverse Event|0|||
33529533|NCT02970669|62918296|FG000|Open-label Period|Physician Decision|1|||
33529534|NCT02970669|62918297|FG001|Open-label Period|Physician Decision|0|||
33529535|NCT02902965|62918305|FG000|Overall Study|Withdrawal by Subject|10|||
33529536|NCT02902809|62918310|FG000|Overall Study|Discontinuation of asthma program|28|||
33529537|NCT01362244|62918316|FG000|Overall Study|Adverse Event|3|||
33529538|NCT01362244|62918317|FG001|Overall Study|Adverse Event|5|||
33529539|NCT01362244|62918316|FG000|Overall Study|Lack of Efficacy|5|||
33529540|NCT01362244|62918317|FG001|Overall Study|Lack of Efficacy|11|||
33529541|NCT01362244|62918316|FG000|Overall Study|Lost to Follow-up|0|||
33529542|NCT01362244|62918317|FG001|Overall Study|Lost to Follow-up|2|||
33529543|NCT01362244|62918316|FG000|Overall Study|Protocol Violation|5|||
33529544|NCT01362244|62918317|FG001|Overall Study|Protocol Violation|1|||
33529545|NCT01362244|62918316|FG000|Overall Study|Withdrawal by Subject|2|||
33529546|NCT01362244|62918317|FG001|Overall Study|Withdrawal by Subject|1|||
33529547|NCT01362244|62918316|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
33529548|NCT01362244|62918317|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
33529549|NCT01362244|62918316|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
33529550|NCT01362244|62918317|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
33529551|NCT02969187|62918325|FG000|Overall Study|Physician Decision|12|||
33625350|NCT01847274|63026063|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33625351|NCT01847274|63026064|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33458235|NCT03628924|62832446|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
33458236|NCT03628924|62832447|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
33458237|NCT03627832|62832461|FG000|Overall Study|Withdrawal by Subject|10|||
33458238|NCT03627832|62832462|FG001|Overall Study|Withdrawal by Subject|1|||
33458239|NCT00112437|62832473|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
33458240|NCT00112437|62832474|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
33458241|NCT00112437|62832475|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
33458242|NCT00112437|62832476|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
33458243|NCT00112437|62832477|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
33458244|NCT00112437|62832478|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458245|NCT00112437|62832479|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
33529552|NCT02969187|62918326|FG001|Overall Study|Physician Decision|13|||
33529553|NCT03050359|62918336|FG000|Overall Study|Randomized But Not Treated|2|||
33529554|NCT03050359|62918337|FG001|Overall Study|Randomized But Not Treated|0|||
33529555|NCT03050359|62918336|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
33529556|NCT03050359|62918337|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
33529557|NCT03050359|62918336|FG000|Overall Study|Significant Protocol Deviation|2|||
33529558|NCT03050359|62918337|FG001|Overall Study|Significant Protocol Deviation|3|||
33529559|NCT03050359|62918336|FG000|Overall Study|Lost to Follow-up|2|||
33529560|NCT03050359|62918337|FG001|Overall Study|Lost to Follow-up|1|||
33529561|NCT03050359|62918336|FG000|Overall Study|Voluntary Withdrawal|4|||
33529562|NCT03050359|62918337|FG001|Overall Study|Voluntary Withdrawal|6|||
33529563|NCT03050359|62918336|FG000|Overall Study|Pregnancy|1|||
33529564|NCT03050359|62918337|FG001|Overall Study|Pregnancy|0|||
33529565|NCT03050359|62918336|FG000|Overall Study|Reason Not Specified|1|||
33529566|NCT03050359|62918337|FG001|Overall Study|Reason Not Specified|0|||
33625352|NCT01847274|63026065|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33625353|NCT01847274|63026066|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33625354|NCT01847274|63026067|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
33625355|NCT01847274|63026068|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33625356|NCT01847274|63026069|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
33625357|NCT01847274|63026070|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
33529567|NCT02785770|62918345|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
33529568|NCT02785770|62918346|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
33529569|NCT02785770|62918347|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
33529570|NCT02785770|62918348|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
33529571|NCT02785770|62918345|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
33529572|NCT02785770|62918346|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
33529573|NCT02785770|62918347|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
33529574|NCT02785770|62918348|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
33529575|NCT02785770|62918345|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
33529576|NCT02785770|62918346|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
33529577|NCT02785770|62918347|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
33529578|NCT02785770|62918348|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
33529579|NCT02965833|62918361|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
33529580|NCT02965833|62918362|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
33529581|NCT02965833|62918361|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
33529582|NCT02965833|62918362|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
33625358|NCT01847274|63026060|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33529583|NCT02965833|62918361|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
33529584|NCT02965833|62918362|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
33529585|NCT02965833|62918361|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
33529586|NCT02965833|62918362|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
33529587|NCT02965833|62918361|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
33529588|NCT02965833|62918362|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
33529589|NCT02968173|62918368|FG000|Overall Study|Withdrawal by Subject|1|||
33529590|NCT02785458|62918375|FG000|1 Month|Withdrawal by Subject|2|||
33625359|NCT01847274|63026061|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33625360|NCT01847274|63026062|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33625361|NCT01847274|63026063|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33625362|NCT01847274|63026064|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33625363|NCT01847274|63026065|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33625364|NCT01847274|63026066|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33625365|NCT01847274|63026067|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33458246|NCT00112437|62832480|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458247|NCT00112437|62832481|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458248|NCT00112437|62832482|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458249|NCT00112437|62832483|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458250|NCT00112437|62832484|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
33529591|NCT02785458|62918376|FG001|1 Month|Withdrawal by Subject|1|||
33529592|NCT02785458|62918375|FG000|1 Month|Lost to Follow-up|38|||
33529593|NCT02785458|62918376|FG001|1 Month|Lost to Follow-up|31|||
33529594|NCT02785458|62918375|FG000|1 Month|Deemed Ineligible|1|||
33529595|NCT02785458|62918376|FG001|1 Month|Deemed Ineligible|0|||
33529596|NCT02785458|62918375|FG000|1 Month|Completed Evaluation by Baseline|42|||
33458251|NCT00112437|62832485|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458252|NCT00112437|62832486|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458253|NCT00112437|62832487|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458254|NCT00112437|62832488|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458255|NCT00112437|62832489|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458256|NCT00112437|62832490|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
33529597|NCT02785458|62918376|FG001|1 Month|Completed Evaluation by Baseline|39|||
33529598|NCT02785458|62918375|FG000|1 Month|Partial Interview|0|||
33529599|NCT02785458|62918376|FG001|1 Month|Partial Interview|4|||
33529600|NCT02785458|62918375|FG000|3 Months|Withdrawal by Subject|3|||
33529601|NCT02785458|62918376|FG001|3 Months|Withdrawal by Subject|1|||
33529602|NCT02785458|62918375|FG000|3 Months|Lost to Follow-up|25|||
33529603|NCT02785458|62918376|FG001|3 Months|Lost to Follow-up|21|||
33529604|NCT02785458|62918375|FG000|3 Months|Completed Evaluation at 1 Month|100|||
33529605|NCT02785458|62918376|FG001|3 Months|Completed Evaluation at 1 Month|89|||
33529606|NCT02784834|62918382|FG000|Overall Study|Lack of Efficacy|1|||
33529607|NCT02966223|62918386|FG000|Overall Study|Physician Decision|3|||
33529608|NCT02966223|62918386|FG000|Overall Study|Withdrawal by Subject|11|||
33529609|NCT02966223|62918386|FG000|Overall Study|Lost to Follow-up|1|||
33529610|NCT03049735|62918393|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
33529611|NCT03049735|62918394|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
33529612|NCT03049735|62918395|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
33529613|NCT03049735|62918393|FG000|Overall Study|Other|5|||
33529614|NCT03049735|62918394|FG001|Overall Study|Other|3|||
33529615|NCT03049735|62918395|FG002|Overall Study|Other|1|||
33529616|NCT03049735|62918393|FG000|Overall Study|Lack of Efficacy|4|||
33529617|NCT03049735|62918394|FG001|Overall Study|Lack of Efficacy|0|||
33529618|NCT03049735|62918395|FG002|Overall Study|Lack of Efficacy|3|||
33529619|NCT03049735|62918393|FG000|Overall Study|Protocol deviation|1|||
33529620|NCT03049735|62918394|FG001|Overall Study|Protocol deviation|0|||
33529621|NCT03049735|62918395|FG002|Overall Study|Protocol deviation|0|||
33529622|NCT03049735|62918393|FG000|Overall Study|Pregnancy|0|||
33625366|NCT01847274|63026068|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33625367|NCT01847274|63026069|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
33625368|NCT01847274|63026070|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33458257|NCT00112437|62832491|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458258|NCT00112437|62832492|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458259|NCT00112437|62832493|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458260|NCT00112437|62832494|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458261|NCT00112437|62832495|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458262|NCT00112437|62832496|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458263|NCT00112437|62832497|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458264|NCT00112437|62832498|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
33458265|NCT00112437|62832473|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458266|NCT00112437|62832474|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
33458267|NCT00112437|62832475|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458268|NCT00112437|62832476|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458269|NCT00112437|62832477|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458270|NCT00112437|62832478|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458271|NCT00112437|62832479|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458272|NCT00112437|62832480|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458273|NCT00112437|62832481|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458274|NCT00112437|62832482|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458275|NCT00112437|62832483|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458276|NCT00112437|62832484|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33529623|NCT03049735|62918394|FG001|Overall Study|Pregnancy|0|||
33529624|NCT03049735|62918395|FG002|Overall Study|Pregnancy|1|||
33529625|NCT03049735|62918393|FG000|Overall Study|Adverse Event|7|||
33529626|NCT03049735|62918394|FG001|Overall Study|Adverse Event|18|||
33529627|NCT03049735|62918395|FG002|Overall Study|Adverse Event|5|||
33529628|NCT03049735|62918393|FG000|Overall Study|Withdrawal by Subject|10|||
33529629|NCT03049735|62918394|FG001|Overall Study|Withdrawal by Subject|3|||
33529630|NCT03049735|62918395|FG002|Overall Study|Withdrawal by Subject|7|||
33529631|NCT03049735|62918393|FG000|Overall Study|Lost to Follow-up|1|||
33529632|NCT03049735|62918394|FG001|Overall Study|Lost to Follow-up|5|||
33529633|NCT03049735|62918395|FG002|Overall Study|Lost to Follow-up|5|||
33529634|NCT01295944|62918403|FG000|Overall Study|Switched to alternative treatment|1|||
33529635|NCT01295944|62918403|FG000|Overall Study|Ineligible|9|||
33529636|NCT01295944|62918403|FG000|Overall Study|Withdrawal by Subject|4|||
33529637|NCT01295944|62918403|FG000|Overall Study|Participant chose to be treated in Peru|1|||
33529638|NCT01295944|62918403|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
33529639|NCT01295944|62918403|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
33529640|NCT01295944|62918403|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
33529641|NCT02965599|62918409|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
33529642|NCT02965599|62918410|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
33529643|NCT02898597|62918419|FG000|Overall Study|Protocol Violation|4|||
33529644|NCT02898597|62918420|FG001|Overall Study|Protocol Violation|2|||
33529645|NCT02898597|62918419|FG000|Overall Study|Lost to Follow-up|0|||
33458277|NCT00112437|62832485|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458278|NCT00112437|62832486|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458279|NCT00112437|62832487|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458280|NCT00112437|62832488|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33625369|NCT01566695|63026109|FG000|Overall Study|Lack of Efficacy|18|||
33625370|NCT01566695|63026110|FG001|Overall Study|Lack of Efficacy|45|||
33529646|NCT02898597|62918420|FG001|Overall Study|Lost to Follow-up|9|||
33529647|NCT02898597|62918419|FG000|Overall Study|Death|0|||
33529648|NCT02898597|62918420|FG001|Overall Study|Death|1|||
33529649|NCT02899377|62918428|FG000|Overall Study|Adverse Event|1|||
33625371|NCT01566695|63026109|FG000|Overall Study|Adverse Event|28|||
33625372|NCT01566695|63026110|FG001|Overall Study|Adverse Event|27|||
33625373|NCT01566695|63026109|FG000|Overall Study|Death|20|||
33625374|NCT01566695|63026110|FG001|Overall Study|Death|8|||
33625375|NCT01566695|63026109|FG000|Overall Study|Withdrawal by Subject|14|||
33625376|NCT01566695|63026110|FG001|Overall Study|Withdrawal by Subject|7|||
33625377|NCT01566695|63026109|FG000|Overall Study|Progressive Disease|11|||
33625378|NCT01566695|63026110|FG001|Overall Study|Progressive Disease|6|||
33625379|NCT01566695|63026109|FG000|Overall Study|Miscellaneous|4|||
33625380|NCT01566695|63026110|FG001|Overall Study|Miscellaneous|6|||
33625381|NCT01560819|63026118|FG000|Overall Study|Physician Decision|1|||
33625382|NCT01560819|63026119|FG001|Overall Study|Physician Decision|0|||
33625383|NCT01425528|63026125|FG000|Overall Study|Withdrawal by Subject|1|||
33625384|NCT01425528|63026126|FG001|Overall Study|Withdrawal by Subject|1|||
33625385|NCT00442104|63026132|FG000|Overall Study|Adverse Event|5|||
33625386|NCT00442104|63026132|FG000|Overall Study|Death|2|||
33625387|NCT00442104|63026132|FG000|Overall Study|Lost to Follow-up|3|||
33625388|NCT00442104|63026132|FG000|Overall Study|Withdrawal by Subject|5|||
33625389|NCT00442104|63026132|FG000|Overall Study|Insufficient Clinical Response|10|||
33625390|NCT00442104|63026132|FG000|Overall Study|Other|21|||
33625391|NCT00442104|63026132|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
33625392|NCT00441896|63026146|FG000|Overall Study|Withdrawal by Subject|0|||
33625393|NCT00441896|63026147|FG001|Overall Study|Withdrawal by Subject|0|||
33625394|NCT00441896|63026148|FG002|Overall Study|Withdrawal by Subject|0|||
33625395|NCT00441896|63026149|FG003|Overall Study|Withdrawal by Subject|1|||
33625396|NCT00441896|63026150|FG004|Overall Study|Withdrawal by Subject|0|||
33625397|NCT00441896|63026151|FG005|Overall Study|Withdrawal by Subject|0|||
33625398|NCT00441896|63026152|FG006|Overall Study|Withdrawal by Subject|0|||
33625399|NCT00441896|63026153|FG007|Overall Study|Withdrawal by Subject|0|||
33625400|NCT00441896|63026154|FG008|Overall Study|Withdrawal by Subject|0|||
33625401|NCT00441896|63026155|FG009|Overall Study|Withdrawal by Subject|0|||
33625402|NCT00441896|63026146|FG000|Overall Study|Other|0|||
33625403|NCT00441896|63026147|FG001|Overall Study|Other|0|||
33625404|NCT00441896|63026148|FG002|Overall Study|Other|0|||
33625405|NCT00441896|63026149|FG003|Overall Study|Other|0|||
33625406|NCT00441896|63026150|FG004|Overall Study|Other|1|||
33625407|NCT00441896|63026151|FG005|Overall Study|Other|0|||
33625408|NCT00441896|63026152|FG006|Overall Study|Other|0|||
33625409|NCT00441896|63026153|FG007|Overall Study|Other|0|||
33625410|NCT00441896|63026154|FG008|Overall Study|Other|0|||
33625411|NCT00441896|63026155|FG009|Overall Study|Other|0|||
33625412|NCT02034877|63026183|FG000|Overall Study|Lost to Follow-up|0|||
33625413|NCT02034877|63026184|FG001|Overall Study|Lost to Follow-up|3|||
33625414|NCT02034877|63026183|FG000|Overall Study|No Longer Willing to Participate|0|||
33625415|NCT02034877|63026184|FG001|Overall Study|No Longer Willing to Participate|3|||
33625416|NCT02034799|63026192|FG000|Overall Study|Withdrawal by Subject|0|||
33625417|NCT02034799|63026193|FG001|Overall Study|Withdrawal by Subject|2|||
33625418|NCT02034799|63026192|FG000|Overall Study|Lost to Follow-up|0|||
33625419|NCT02034799|63026193|FG001|Overall Study|Lost to Follow-up|1|||
33625420|NCT02034799|63026192|FG000|Overall Study|Death|2|||
33458281|NCT00112437|62832489|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458282|NCT00112437|62832490|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458283|NCT00112437|62832491|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458284|NCT00112437|62832492|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458285|NCT00112437|62832493|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458286|NCT00112437|62832494|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458287|NCT00112437|62832495|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458288|NCT00112437|62832496|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458289|NCT00112437|62832497|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458290|NCT00112437|62832498|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33458291|NCT00112437|62832473|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458292|NCT00112437|62832474|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
33458293|NCT00112437|62832475|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458294|NCT00112437|62832476|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458295|NCT00112437|62832477|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458296|NCT00112437|62832478|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33529650|NCT02899377|62918429|FG001|Overall Study|Adverse Event|0|||
33529651|NCT01316887|62918440|FG000|Overall Study|Adverse Event|13|||
33529652|NCT01316887|62918441|FG001|Overall Study|Adverse Event|21|||
33625421|NCT02034799|63026193|FG001|Overall Study|Death|1|||
33625422|NCT02057575|63026203|FG000|Overall Study|Adverse Event|0|||
33625423|NCT02057575|63026204|FG001|Overall Study|Adverse Event|2|||
33625424|NCT02057575|63026205|FG002|Overall Study|Adverse Event|0|||
33625425|NCT02057575|63026206|FG003|Overall Study|Adverse Event|1|||
33625426|NCT02057575|63026203|FG000|Overall Study|Withdrawal by Subject|1|||
33625427|NCT02057575|63026204|FG001|Overall Study|Withdrawal by Subject|0|||
33625428|NCT02057575|63026205|FG002|Overall Study|Withdrawal by Subject|0|||
33625429|NCT02057575|63026206|FG003|Overall Study|Withdrawal by Subject|0|||
33529653|NCT01316887|62918442|FG002|Overall Study|Adverse Event|17|||
33529654|NCT01316887|62918440|FG000|Overall Study|Lack of Efficacy|9|||
33529655|NCT01316887|62918441|FG001|Overall Study|Lack of Efficacy|3|||
33529656|NCT01316887|62918442|FG002|Overall Study|Lack of Efficacy|1|||
33529657|NCT01316887|62918440|FG000|Overall Study|Protocol Violation|2|||
33529658|NCT01316887|62918441|FG001|Overall Study|Protocol Violation|6|||
33529659|NCT01316887|62918442|FG002|Overall Study|Protocol Violation|6|||
33529660|NCT01316887|62918440|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
33529661|NCT01316887|62918441|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
33529662|NCT01316887|62918442|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
33529663|NCT01316887|62918440|FG000|Overall Study|Study Closed/Terminated|2|||
33529664|NCT01316887|62918441|FG001|Overall Study|Study Closed/Terminated|4|||
33625430|NCT02057575|63026203|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
33625431|NCT02057575|63026204|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
33458297|NCT00112437|62832479|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458298|NCT00112437|62832480|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458299|NCT00112437|62832481|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458300|NCT00112437|62832482|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458301|NCT00112437|62832483|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458302|NCT00112437|62832484|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458303|NCT00112437|62832485|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458304|NCT00112437|62832486|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458305|NCT00112437|62832487|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458306|NCT00112437|62832488|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458307|NCT00112437|62832489|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458308|NCT00112437|62832490|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458309|NCT00112437|62832491|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458310|NCT00112437|62832492|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458311|NCT00112437|62832493|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458312|NCT00112437|62832494|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458313|NCT00112437|62832495|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458314|NCT00112437|62832496|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458315|NCT00112437|62832497|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458316|NCT00112437|62832498|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33458317|NCT00112437|62832473|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
33458318|NCT00112437|62832474|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458319|NCT00112437|62832475|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
33458320|NCT00112437|62832476|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
33458321|NCT00112437|62832477|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
33458322|NCT00112437|62832478|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458323|NCT00112437|62832479|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458324|NCT00112437|62832480|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458325|NCT00112437|62832481|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458326|NCT00112437|62832482|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458327|NCT00112437|62832483|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458328|NCT00112437|62832484|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458329|NCT00112437|62832485|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458330|NCT00112437|62832486|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458331|NCT00112437|62832487|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458332|NCT00112437|62832488|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458333|NCT00112437|62832489|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458334|NCT00112437|62832490|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458335|NCT00112437|62832491|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458336|NCT00112437|62832492|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458337|NCT00112437|62832493|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458338|NCT00112437|62832494|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458339|NCT00112437|62832495|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458340|NCT00112437|62832496|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458341|NCT00112437|62832497|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458342|NCT00112437|62832498|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33458343|NCT00112437|62832473|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
33625432|NCT02057575|63026205|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
33625433|NCT02057575|63026206|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
33458344|NCT00112437|62832474|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
33458345|NCT00112437|62832475|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
33458346|NCT00112437|62832476|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
33458347|NCT00112437|62832477|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
33458348|NCT00112437|62832478|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33529665|NCT01316887|62918442|FG002|Overall Study|Study Closed/Terminated|3|||
33529666|NCT01316887|62918440|FG000|Overall Study|Lost to Follow-up|1|||
33529667|NCT01316887|62918441|FG001|Overall Study|Lost to Follow-up|7|||
33458349|NCT00112437|62832479|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458350|NCT00112437|62832480|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458351|NCT00112437|62832481|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458352|NCT00112437|62832482|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458353|NCT00112437|62832483|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458354|NCT00112437|62832484|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458355|NCT00112437|62832485|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458356|NCT00112437|62832486|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458357|NCT00112437|62832487|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458358|NCT00112437|62832488|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458359|NCT00112437|62832489|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458360|NCT00112437|62832490|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458361|NCT00112437|62832491|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458362|NCT00112437|62832492|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458363|NCT00112437|62832493|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458364|NCT00112437|62832494|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458365|NCT00112437|62832495|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458366|NCT00112437|62832496|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458367|NCT00112437|62832497|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458368|NCT00112437|62832498|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33458369|NCT00112437|62832473|FG000|Year 1 (12-Month Base Study)|moved|0|||
33458370|NCT00112437|62832474|FG001|Year 1 (12-Month Base Study)|moved|1|||
33458371|NCT00112437|62832475|FG002|Year 1 (12-Month Base Study)|moved|1|||
33458372|NCT00112437|62832476|FG003|Year 1 (12-Month Base Study)|moved|0|||
33458373|NCT00112437|62832477|FG004|Year 1 (12-Month Base Study)|moved|0|||
33458374|NCT00112437|62832478|FG005|Year 1 (12-Month Base Study)|moved|0|||
33458375|NCT00112437|62832479|FG006|Year 1 (12-Month Base Study)|moved|0|||
33458376|NCT00112437|62832480|FG007|Year 1 (12-Month Base Study)|moved|0|||
33458377|NCT00112437|62832481|FG008|Year 1 (12-Month Base Study)|moved|0|||
33458378|NCT00112437|62832482|FG009|Year 1 (12-Month Base Study)|moved|0|||
33458379|NCT00112437|62832483|FG010|Year 1 (12-Month Base Study)|moved|0|||
33458380|NCT00112437|62832484|FG011|Year 1 (12-Month Base Study)|moved|0|||
33529668|NCT01316887|62918442|FG002|Overall Study|Lost to Follow-up|5|||
33529669|NCT01316887|62918440|FG000|Overall Study|Withdrawal by Subject|8|||
33529670|NCT01316887|62918441|FG001|Overall Study|Withdrawal by Subject|16|||
33625434|NCT02057575|63026203|FG000|Overall Study|Protocol Violation|0|||
33625435|NCT02057575|63026204|FG001|Overall Study|Protocol Violation|1|||
33529671|NCT01316887|62918442|FG002|Overall Study|Withdrawal by Subject|15|||
33529672|NCT02897349|62918453|FG000|Overall Study|Lost to Follow-up|2|||
33529673|NCT02897349|62918454|FG001|Overall Study|Lost to Follow-up|2|||
33529674|NCT02897349|62918453|FG000|Overall Study|Adverse Event|3|||
33529675|NCT02897349|62918454|FG001|Overall Study|Adverse Event|3|||
33529676|NCT02897349|62918453|FG000|Overall Study|Other than listed above|0|||
33529677|NCT02897349|62918454|FG001|Overall Study|Other than listed above|1|||
33529678|NCT03047551|62918471|FG000|Overall Study|Did not receive TAS|1|||
33529679|NCT03047551|62918472|FG001|Overall Study|Did not receive TAS|0|||
33529680|NCT03047551|62918471|FG000|Overall Study|Physician Decision|1|||
33529681|NCT03047551|62918472|FG001|Overall Study|Physician Decision|0|||
33529682|NCT03047551|62918471|FG000|Overall Study|Withdrawal by Subject|0|||
33529683|NCT03047551|62918472|FG001|Overall Study|Withdrawal by Subject|1|||
33529684|NCT03047551|62918471|FG000|Overall Study|Probe malfunction|0|||
33529685|NCT03047551|62918472|FG001|Overall Study|Probe malfunction|1|||
33529686|NCT03047551|62918471|FG000|Overall Study|Ineligible|0|||
33529687|NCT03047551|62918472|FG001|Overall Study|Ineligible|1|||
33529688|NCT02964741|62918481|FG000|Overall Study|Protocol Violation|1|||
33529689|NCT02964741|62918482|FG001|Overall Study|Protocol Violation|0|||
33529690|NCT02964741|62918483|FG002|Overall Study|Protocol Violation|0|||
33625436|NCT02057575|63026205|FG002|Overall Study|Protocol Violation|0|||
33625437|NCT02057575|63026206|FG003|Overall Study|Protocol Violation|0|||
33625438|NCT02077465|63026218|FG000|Overall Study|Withdrew Consent|0|||
33458381|NCT00112437|62832485|FG012|Year 1 (12-Month Base Study)|moved|0|||
33458382|NCT00112437|62832486|FG013|Year 1 (12-Month Base Study)|moved|0|||
33458383|NCT00112437|62832487|FG014|Year 1 (12-Month Base Study)|moved|0|||
33458384|NCT00112437|62832488|FG015|Year 1 (12-Month Base Study)|moved|0|||
33458385|NCT00112437|62832489|FG016|Year 1 (12-Month Base Study)|moved|0|||
33529691|NCT02964741|62918481|FG000|Overall Study|Withdrawal by Subject|0|||
33529692|NCT02964741|62918482|FG001|Overall Study|Withdrawal by Subject|1|||
33529693|NCT02964741|62918483|FG002|Overall Study|Withdrawal by Subject|0|||
33529694|NCT02964741|62918481|FG000|Overall Study|claustrophobia|1|||
33529695|NCT02964741|62918482|FG001|Overall Study|claustrophobia|0|||
33625439|NCT02077465|63026219|FG001|Overall Study|Withdrew Consent|1|||
33458386|NCT00112437|62832490|FG017|Year 1 (12-Month Base Study)|moved|0|||
33529696|NCT02964741|62918483|FG002|Overall Study|claustrophobia|0|||
33529697|NCT01316419|62918489|FG000|Overall Study|Not treated|103|||
33529698|NCT01316419|62918489|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
33529699|NCT01316419|62918489|FG000|Overall Study|Lost to Follow-up|19|||
33529700|NCT02964039|62918496|FG000|Overall Study|Medical reason unrelated to study participation|1|||
33529701|NCT02964039|62918497|FG001|Overall Study|Medical reason unrelated to study participation|0|||
33529702|NCT02964039|62918498|FG002|Overall Study|Medical reason unrelated to study participation|3|||
33529703|NCT02964039|62918496|FG000|Overall Study|Research shutdown due to pandemic|2|||
33325564|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33325565|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33325566|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33325567|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
33458387|NCT00112437|62832491|FG018|Year 1 (12-Month Base Study)|moved|0|||
33458388|NCT00112437|62832492|FG019|Year 1 (12-Month Base Study)|moved|0|||
33458389|NCT00112437|62832493|FG020|Year 1 (12-Month Base Study)|moved|0|||
33458390|NCT00112437|62832494|FG021|Year 1 (12-Month Base Study)|moved|0|||
33458391|NCT00112437|62832495|FG022|Year 1 (12-Month Base Study)|moved|0|||
33458392|NCT00112437|62832496|FG023|Year 1 (12-Month Base Study)|moved|0|||
33458393|NCT00112437|62832497|FG024|Year 1 (12-Month Base Study)|moved|0|||
33458394|NCT00112437|62832498|FG025|Year 1 (12-Month Base Study)|moved|0|||
33458395|NCT00112437|62832473|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458396|NCT00112437|62832474|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458397|NCT00112437|62832475|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458398|NCT00112437|62832476|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
33458399|NCT00112437|62832477|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458400|NCT00112437|62832478|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458401|NCT00112437|62832479|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458402|NCT00112437|62832480|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458403|NCT00112437|62832481|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458404|NCT00112437|62832482|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458405|NCT00112437|62832483|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458406|NCT00112437|62832484|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458407|NCT00112437|62832485|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458408|NCT00112437|62832486|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458409|NCT00112437|62832487|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458410|NCT00112437|62832488|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458411|NCT00112437|62832489|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458412|NCT00112437|62832490|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458413|NCT00112437|62832491|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458414|NCT00112437|62832492|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458415|NCT00112437|62832493|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458416|NCT00112437|62832494|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458417|NCT00112437|62832495|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458418|NCT00112437|62832496|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458419|NCT00112437|62832497|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458420|NCT00112437|62832498|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33458421|NCT00112437|62832473|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458422|NCT00112437|62832474|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458423|NCT00112437|62832475|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458424|NCT00112437|62832476|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458425|NCT00112437|62832477|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
33458426|NCT00112437|62832478|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33529704|NCT02964039|62918497|FG001|Overall Study|Research shutdown due to pandemic|0|||
33529705|NCT02964039|62918498|FG002|Overall Study|Research shutdown due to pandemic|1|||
33625440|NCT02077465|63026218|FG000|Overall Study|Lost to Follow-up|1|||
33325568|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
33325569|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33325570|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
33325571|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
33325572|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33325573|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33325574|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33325575|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33325576|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
33325577|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
33325578|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33325579|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
33325580|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33325581|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33325582|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33325583|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33325584|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33325585|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33325586|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33325587|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33325588|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33325589|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33325590|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33325591|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33325592|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33325593|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33325594|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
33325595|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33325596|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33325597|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
33325598|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
33325599|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33325600|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33529706|NCT02964039|62918496|FG000|Overall Study|Withdrawal by Subject|0|||
33529707|NCT02964039|62918497|FG001|Overall Study|Withdrawal by Subject|1|||
33529708|NCT02964039|62918498|FG002|Overall Study|Withdrawal by Subject|0|||
33529709|NCT02964039|62918496|FG000|Overall Study|Lost to Follow-up|1|||
33529710|NCT02964039|62918497|FG001|Overall Study|Lost to Follow-up|0|||
33529711|NCT02964039|62918498|FG002|Overall Study|Lost to Follow-up|1|||
33529712|NCT02897115|62918508|FG000|Overall Study|Early termination of study by sponsor|11|||
33529713|NCT02897115|62918509|FG001|Overall Study|Early termination of study by sponsor|8|||
33529714|NCT02896569|62918517|FG000|Overall Study|Lost to Follow-up|2|||
33529715|NCT02896569|62918518|FG001|Overall Study|Lost to Follow-up|1|||
33529716|NCT02896569|62918517|FG000|Overall Study|Physician Decision|1|||
33529717|NCT02896569|62918518|FG001|Overall Study|Physician Decision|3|||
33625441|NCT02077465|63026219|FG001|Overall Study|Lost to Follow-up|0|||
33625442|NCT02034565|63026225|FG000|Overall Study|Adverse Event|1|||
33625443|NCT02034565|63026226|FG001|Overall Study|Adverse Event|0|||
33625444|NCT02075515|63026237|FG000|Overall Study|Serious Adverse Event|1|||
33625445|NCT02075515|63026238|FG001|Overall Study|Serious Adverse Event|1|||
33625446|NCT02075515|63026239|FG002|Overall Study|Serious Adverse Event|1|||
33625447|NCT02075515|63026237|FG000|Overall Study|Non-Serious Adverse Event|0|||
33625448|NCT02075515|63026238|FG001|Overall Study|Non-Serious Adverse Event|1|||
33625449|NCT02075515|63026239|FG002|Overall Study|Non-Serious Adverse Event|0|||
33625450|NCT02075515|63026237|FG000|Overall Study|Withdrawal by Subject|2|||
33625451|NCT02075515|63026238|FG001|Overall Study|Withdrawal by Subject|0|||
33325601|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33325602|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33325603|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
33325604|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
33625452|NCT02075515|63026239|FG002|Overall Study|Withdrawal by Subject|1|||
33625453|NCT02075515|63026237|FG000|Overall Study|Lost to Follow-up|1|||
33529718|NCT02896569|62918517|FG000|Overall Study|Adverse Event|0|||
33529719|NCT02896569|62918518|FG001|Overall Study|Adverse Event|1|||
33625454|NCT02075515|63026238|FG001|Overall Study|Lost to Follow-up|3|||
33458427|NCT00112437|62832479|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458428|NCT00112437|62832480|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458429|NCT00112437|62832481|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458430|NCT00112437|62832482|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458431|NCT00112437|62832483|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458432|NCT00112437|62832484|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458433|NCT00112437|62832485|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458434|NCT00112437|62832486|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458435|NCT00112437|62832487|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458436|NCT00112437|62832488|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458437|NCT00112437|62832489|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458438|NCT00112437|62832490|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458439|NCT00112437|62832491|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458440|NCT00112437|62832492|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458441|NCT00112437|62832493|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458442|NCT00112437|62832494|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458443|NCT00112437|62832495|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458444|NCT00112437|62832496|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458445|NCT00112437|62832497|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458446|NCT00112437|62832498|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33458447|NCT00112437|62832473|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
33458448|NCT00112437|62832474|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
33458449|NCT00112437|62832475|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
33625455|NCT02075515|63026239|FG002|Overall Study|Lost to Follow-up|6|||
33529720|NCT02896569|62918517|FG000|Overall Study|Withdrawal by Subject|1|||
33529721|NCT02896569|62918518|FG001|Overall Study|Withdrawal by Subject|0|||
33529722|NCT04030195|62918527|FG000|Overall Study|Withdrawal by Subject|2|||
33529723|NCT04030195|62918528|FG001|Overall Study|Withdrawal by Subject|0|||
33529724|NCT04030195|62918529|FG002|Overall Study|Withdrawal by Subject|0|||
33529725|NCT01673620|62918540|FG000|Overall Study|Adverse Event|1|||
33529726|NCT01673620|62918541|FG001|Overall Study|Adverse Event|0|||
33529727|NCT03044197|62918555|FG000|Overall Study|Withdrawal by Subject|3|||
33529728|NCT03044197|62918556|FG001|Overall Study|Withdrawal by Subject|1|||
33529729|NCT03575325|62918575|FG000|Overall Study|Death|1|||
33529730|NCT03043651|62918590|FG000|Overall Study|Death|1|||
33529731|NCT03043651|62918590|FG000|Overall Study|Progressive Disease|2|||
33529732|NCT03043651|62918590|FG000|Overall Study|Adverse Event|2|||
33529733|NCT03043651|62918590|FG000|Overall Study|Withdrawal by Subject|4|||
33529734|NCT03043651|62918590|FG000|Overall Study|Study Terminated by Sponsor|39|||
33529735|NCT03536143|62918594|FG000|Overall Study|Early termination, Sponsor decision|1|||
33529736|NCT01344759|62918604|FG000|Overall Study|Patients failed to reach sedation level|0|||
33529737|NCT01344759|62918605|FG001|Overall Study|Patients failed to reach sedation level|2|||
33529738|NCT05027451|62918628|FG000|Overall Study|Lost to Follow-up|1|||
33529739|NCT05027451|62918629|FG001|Overall Study|Lost to Follow-up|1|||
33529740|NCT04757649|62918661|FG000|Overall Study|Withdrawal by Subject|1|||
33529741|NCT04757649|62918661|FG000|Overall Study|Adverse Event|1|||
33529742|NCT04621786|62918665|FG000|Overall Study|Lost to Follow-up|9|||
33529743|NCT04621786|62918665|FG000|Overall Study|Protocol Violation|3|||
33529744|NCT04549454|62918671|FG000|T1 to T2|Lost to Follow-up|22|||
33529745|NCT04549454|62918672|FG001|T1 to T2|Lost to Follow-up|26|||
33529746|NCT04549454|62918671|FG000|T1 to T3|Lost to Follow-up|31|||
33458450|NCT00112437|62832476|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
33458451|NCT00112437|62832477|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
33458452|NCT00112437|62832478|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
33458453|NCT00112437|62832479|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
33458454|NCT00112437|62832480|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
33458455|NCT00112437|62832481|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
33458456|NCT00112437|62832482|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
33458457|NCT00112437|62832483|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
33458458|NCT00112437|62832484|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
33458459|NCT00112437|62832485|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
33458460|NCT00112437|62832486|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
33458461|NCT00112437|62832487|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
33458462|NCT00112437|62832488|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
33458463|NCT00112437|62832489|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
33458464|NCT00112437|62832490|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
33458465|NCT00112437|62832491|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
33458466|NCT00112437|62832492|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
33458467|NCT00112437|62832493|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
33458468|NCT00112437|62832494|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
33458469|NCT00112437|62832495|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
33458470|NCT00112437|62832496|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
33458471|NCT00112437|62832497|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
33458472|NCT00112437|62832498|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
33458473|NCT00112437|62832473|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458474|NCT00112437|62832474|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458475|NCT00112437|62832475|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458476|NCT00112437|62832476|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458477|NCT00112437|62832477|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458478|NCT00112437|62832478|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
33458479|NCT00112437|62832479|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
33458480|NCT00112437|62832480|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458481|NCT00112437|62832481|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458482|NCT00112437|62832482|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
33458483|NCT00112437|62832483|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458484|NCT00112437|62832484|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458485|NCT00112437|62832485|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458486|NCT00112437|62832486|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458487|NCT00112437|62832487|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458488|NCT00112437|62832488|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458489|NCT00112437|62832489|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33529747|NCT04549454|62918672|FG001|T1 to T3|Lost to Follow-up|36|||
33529748|NCT03519256|62918719|FG000|Overall Study|Disease recurrence|4|||
33529749|NCT03519256|62918720|FG001|Overall Study|Disease recurrence|4|||
33529750|NCT03519256|62918721|FG002|Overall Study|Disease recurrence|5|||
33529751|NCT03519256|62918722|FG003|Overall Study|Disease recurrence|2|||
33529752|NCT03519256|62918719|FG000|Overall Study|Study drug toxicity|0|||
33529753|NCT03519256|62918720|FG001|Overall Study|Study drug toxicity|2|||
33529754|NCT03519256|62918721|FG002|Overall Study|Study drug toxicity|5|||
33529755|NCT03519256|62918722|FG003|Overall Study|Study drug toxicity|2|||
33529756|NCT03519256|62918719|FG000|Overall Study|Adverse event unrelated to study drug|0|||
33529757|NCT03519256|62918720|FG001|Overall Study|Adverse event unrelated to study drug|1|||
33458490|NCT00112437|62832490|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458491|NCT00112437|62832491|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458492|NCT00112437|62832492|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33529758|NCT03519256|62918721|FG002|Overall Study|Adverse event unrelated to study drug|1|||
33529759|NCT03519256|62918722|FG003|Overall Study|Adverse event unrelated to study drug|0|||
33529760|NCT03519256|62918719|FG000|Overall Study|Participant request to discontinue study treatment|0|||
33529761|NCT03519256|62918720|FG001|Overall Study|Participant request to discontinue study treatment|0|||
33529762|NCT03519256|62918721|FG002|Overall Study|Participant request to discontinue study treatment|0|||
33529763|NCT03519256|62918722|FG003|Overall Study|Participant request to discontinue study treatment|2|||
33529764|NCT03519256|62918719|FG000|Overall Study|Other reasons|0|||
33529765|NCT03519256|62918720|FG001|Overall Study|Other reasons|0|||
33529766|NCT03519256|62918721|FG002|Overall Study|Other reasons|2|||
33529767|NCT03519256|62918722|FG003|Overall Study|Other reasons|0|||
33529768|NCT03519256|62918719|FG000|Overall Study|Disease progression|6|||
33529769|NCT03519256|62918720|FG001|Overall Study|Disease progression|3|||
33529770|NCT03519256|62918721|FG002|Overall Study|Disease progression|2|||
33529771|NCT03519256|62918722|FG003|Overall Study|Disease progression|1|||
33458493|NCT00112437|62832493|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458494|NCT00112437|62832494|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458495|NCT00112437|62832495|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458496|NCT00112437|62832496|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458497|NCT00112437|62832497|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33458498|NCT00112437|62832498|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33529772|NCT03519256|62918719|FG000|Overall Study|Lost to Follow-up|0|||
33458499|NCT00112437|62832473|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458500|NCT00112437|62832474|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33529773|NCT03519256|62918720|FG001|Overall Study|Lost to Follow-up|1|||
33529774|NCT03519256|62918721|FG002|Overall Study|Lost to Follow-up|0|||
33529775|NCT03519256|62918722|FG003|Overall Study|Lost to Follow-up|0|||
33529776|NCT02799602|62918758|FG000|Overall Study|Protocol Violation|1|||
33529777|NCT02799602|62918759|FG001|Overall Study|Protocol Violation|0|||
33529778|NCT02799602|62918758|FG000|Overall Study|Physician Decision|3|||
33529779|NCT02799602|62918759|FG001|Overall Study|Physician Decision|7|||
33529780|NCT02799602|62918758|FG000|Overall Study|COVID-19 pandemic related other reason|0|||
33529781|NCT02799602|62918759|FG001|Overall Study|COVID-19 pandemic related other reason|1|||
33529782|NCT02799602|62918758|FG000|Overall Study|Lost to Follow-up|4|||
33529783|NCT02799602|62918759|FG001|Overall Study|Lost to Follow-up|1|||
33529784|NCT02799602|62918758|FG000|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|11|||
33529785|NCT02799602|62918759|FG001|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|6|||
33529786|NCT02799602|62918758|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|14|||
33529787|NCT02799602|62918759|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|12|||
33529788|NCT02799602|62918758|FG000|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|24|||
33529789|NCT02799602|62918759|FG001|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|26|||
33529790|NCT02799602|62918758|FG000|Overall Study|Withdrawal by Subject|25|||
33529791|NCT02799602|62918759|FG001|Overall Study|Withdrawal by Subject|37|||
33529792|NCT02799602|62918758|FG000|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|48|||
33529793|NCT02799602|62918759|FG001|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|27|||
33529794|NCT02799602|62918758|FG000|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|84|||
33529795|NCT02799602|62918759|FG001|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|132|||
33529796|NCT02799602|62918758|FG000|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|127|||
33529797|NCT02799602|62918759|FG001|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|272|||
33529798|NCT02799602|62918758|FG000|Overall Study|Death|8|||
33529799|NCT02799602|62918759|FG001|Overall Study|Death|5|||
33529800|NCT02799602|62918758|FG000|Overall Study|Other|3|||
33529801|NCT02799602|62918759|FG001|Overall Study|Other|3|||
33529802|NCT02799602|62918758|FG000|Overall Study|GCP violation|1|||
33529803|NCT02799602|62918759|FG001|Overall Study|GCP violation|0|||
33529804|NCT02243709|62918776|FG000|Phase 1|Lost to Follow-up|0|||
33529805|NCT02243709|62918777|FG001|Phase 1|Lost to Follow-up|1|||
33529806|NCT02243709|62918776|FG000|Phase 1|Withdrawal by Subject|1|||
33529807|NCT02243709|62918777|FG001|Phase 1|Withdrawal by Subject|0|||
33529808|NCT02243709|62918776|FG000|Phase 1|Protocol Violation|0|||
33529809|NCT02243709|62918777|FG001|Phase 1|Protocol Violation|1|||
33529810|NCT02243709|62918776|FG000|Phase 1|Adverse Event|0|||
33529811|NCT02243709|62918777|FG001|Phase 1|Adverse Event|1|||
33529812|NCT01891396|62918789|FG000|Overall Study|Withdrawal by Subject|4|||
33529813|NCT01891396|62918790|FG001|Overall Study|Withdrawal by Subject|4|||
33529814|NCT01891396|62918791|FG002|Overall Study|Withdrawal by Subject|3|||
33529815|NCT01891396|62918789|FG000|Overall Study|Lost to Follow-up|0|||
33529816|NCT01891396|62918790|FG001|Overall Study|Lost to Follow-up|1|||
33529817|NCT01891396|62918791|FG002|Overall Study|Lost to Follow-up|0|||
33529818|NCT01746225|62918806|FG000|Overall Study|Death|1|||
33529819|NCT01746225|62918807|FG001|Overall Study|Death|0|||
33529820|NCT01746225|62918808|FG002|Overall Study|Death|1|||
33529821|NCT01746225|62918806|FG000|Overall Study|Withdrawal by Subject|5|||
33529822|NCT01746225|62918807|FG001|Overall Study|Withdrawal by Subject|15|||
33529823|NCT01746225|62918808|FG002|Overall Study|Withdrawal by Subject|19|||
33529824|NCT01746225|62918806|FG000|Overall Study|Physician Decision|14|||
33529825|NCT01746225|62918807|FG001|Overall Study|Physician Decision|11|||
33529826|NCT01746225|62918808|FG002|Overall Study|Physician Decision|3|||
33529827|NCT01746225|62918806|FG000|Overall Study|Adverse Event|15|||
33529828|NCT01746225|62918807|FG001|Overall Study|Adverse Event|12|||
33529829|NCT01746225|62918808|FG002|Overall Study|Adverse Event|17|||
33529830|NCT01746225|62918806|FG000|Overall Study|Continuing Treatment|5|||
33529831|NCT01746225|62918807|FG001|Overall Study|Continuing Treatment|8|||
33529832|NCT01746225|62918808|FG002|Overall Study|Continuing Treatment|3|||
33529833|NCT01471522|62918829|FG000|Overall Study|Withdrawal by Subject|28|||
33529834|NCT01471522|62918830|FG001|Overall Study|Withdrawal by Subject|22|||
33529835|NCT01471522|62918829|FG000|Overall Study|Lost to Follow-up|36|||
33529836|NCT01471522|62918830|FG001|Overall Study|Lost to Follow-up|26|||
33529837|NCT01191008|62918837|FG000|Overall Study|Protocol Violation|7|||
33529838|NCT01191008|62918837|FG000|Overall Study|Lost to Follow-up|8|||
33529839|NCT00821587|62918843|FG000|Overall Study|Physician Decision|0|||
33529840|NCT00821587|62918844|FG001|Overall Study|Physician Decision|1|||
33529841|NCT00645801|62918852|FG000|Overall Study|unclear if patient took all the medication.|1|||
33529842|NCT00645801|62918853|FG001|Overall Study|unclear if patient took all the medication.|0|||
33529843|NCT00645801|62918852|FG000|Overall Study|Lost to Follow-up|19|||
33529844|NCT00645801|62918853|FG001|Overall Study|Lost to Follow-up|15|||
33529845|NCT00424099|62918867|FG000|Overall Study|Adverse Event|0|||
33529846|NCT00424099|62918868|FG001|Overall Study|Adverse Event|1|||
33529847|NCT00424099|62918869|FG002|Overall Study|Adverse Event|1|||
33529848|NCT00424099|62918870|FG003|Overall Study|Adverse Event|0|||
33529849|NCT00424099|62918867|FG000|Overall Study|Death|0|||
33529850|NCT00424099|62918868|FG001|Overall Study|Death|1|||
33529851|NCT00424099|62918869|FG002|Overall Study|Death|0|||
33529852|NCT00424099|62918870|FG003|Overall Study|Death|0|||
33325605|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33325606|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
33325607|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
33325608|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33325609|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33325610|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33325611|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33325612|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33325613|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
33625456|NCT02034409|63026250|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
33625457|NCT02034409|63026251|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
33625458|NCT02034409|63026250|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
33625459|NCT02034409|63026251|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
33625460|NCT02034409|63026250|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
33325614|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33458501|NCT00112437|62832475|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458502|NCT00112437|62832476|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458503|NCT00112437|62832477|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458504|NCT00112437|62832478|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458505|NCT00112437|62832479|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458506|NCT00112437|62832480|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33325615|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
33529853|NCT00424099|62918867|FG000|Overall Study|Illness|2|||
33529854|NCT00424099|62918868|FG001|Overall Study|Illness|0|||
33529855|NCT00424099|62918869|FG002|Overall Study|Illness|1|||
33529856|NCT00424099|62918870|FG003|Overall Study|Illness|4|||
33529857|NCT00424099|62918867|FG000|Overall Study|Lost to Follow-up|0|||
33529858|NCT00424099|62918868|FG001|Overall Study|Lost to Follow-up|0|||
33529859|NCT00424099|62918869|FG002|Overall Study|Lost to Follow-up|3|||
33529860|NCT00424099|62918870|FG003|Overall Study|Lost to Follow-up|0|||
33529861|NCT00424099|62918867|FG000|Overall Study|Hospitalized|1|||
33529862|NCT00424099|62918868|FG001|Overall Study|Hospitalized|2|||
33529863|NCT00424099|62918869|FG002|Overall Study|Hospitalized|1|||
33529864|NCT00424099|62918870|FG003|Overall Study|Hospitalized|3|||
33529865|NCT00424099|62918867|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
33529866|NCT00424099|62918868|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
33529867|NCT00424099|62918869|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
33529868|NCT00424099|62918870|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
33529869|NCT00424099|62918867|FG000|Overall Study|Withdrawal by Subject|1|||
33529870|NCT00424099|62918868|FG001|Overall Study|Withdrawal by Subject|9|||
33529871|NCT00424099|62918869|FG002|Overall Study|Withdrawal by Subject|4|||
33529872|NCT00424099|62918870|FG003|Overall Study|Withdrawal by Subject|6|||
33529873|NCT00424099|62918867|FG000|Overall Study|Physician Decision|0|||
33529874|NCT00424099|62918868|FG001|Overall Study|Physician Decision|0|||
33529875|NCT00424099|62918869|FG002|Overall Study|Physician Decision|1|||
33529876|NCT00424099|62918870|FG003|Overall Study|Physician Decision|0|||
33529877|NCT00424099|62918867|FG000|Overall Study|Missing|0|||
33529878|NCT00424099|62918868|FG001|Overall Study|Missing|0|||
33529879|NCT00424099|62918869|FG002|Overall Study|Missing|1|||
33529880|NCT00424099|62918870|FG003|Overall Study|Missing|0|||
33529881|NCT02988661|62918893|FG000|Overall Study|Death|2|||
33529882|NCT02988661|62918894|FG001|Overall Study|Death|18|||
33529883|NCT02988661|62918893|FG000|Overall Study|Lost to Follow-up|0|||
33529884|NCT02988661|62918894|FG001|Overall Study|Lost to Follow-up|33|||
33529885|NCT02988661|62918893|FG000|Overall Study|Withdrawal by Subject|0|||
33529886|NCT02988661|62918894|FG001|Overall Study|Withdrawal by Subject|6|||
33529887|NCT02988661|62918893|FG000|Overall Study|Unable to complete the 18-month survey|1|||
33458507|NCT00112437|62832481|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
33458508|NCT00112437|62832482|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33529888|NCT02988661|62918894|FG001|Overall Study|Unable to complete the 18-month survey|27|||
33529889|NCT03738397|62918902|FG000|Overall Study|Adverse Event|3|||
33325616|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
33529890|NCT03738397|62918903|FG001|Overall Study|Adverse Event|7|||
33529891|NCT03738397|62918902|FG000|Overall Study|Withdrawal by Subject|8|||
33529892|NCT03738397|62918903|FG001|Overall Study|Withdrawal by Subject|11|||
33529893|NCT03738397|62918902|FG000|Overall Study|Lost to Follow-up|8|||
33529894|NCT03738397|62918903|FG001|Overall Study|Lost to Follow-up|5|||
33529895|NCT03738397|62918902|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
33529896|NCT03738397|62918903|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
33625461|NCT02034409|63026251|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
33625462|NCT02034409|63026250|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
33625463|NCT02034409|63026251|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
33625464|NCT02034409|63026250|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
33529897|NCT03738397|62918902|FG000|Overall Study|Other|4|||
33529898|NCT03738397|62918903|FG001|Overall Study|Other|6|||
33529899|NCT02960217|62918911|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
33529900|NCT02960217|62918912|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
33529901|NCT02960217|62918911|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
33529902|NCT02960217|62918912|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
33529903|NCT02960217|62918911|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
33529904|NCT02960217|62918912|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
33529905|NCT02960217|62918911|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
33529906|NCT02960217|62918912|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
33529907|NCT02960217|62918911|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
33529908|NCT02960217|62918912|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
33529909|NCT02960217|62918911|FG000|Open-Label Extension Phase|Adverse Event|1|||
33529910|NCT02960217|62918912|FG001|Open-Label Extension Phase|Adverse Event|0|||
33529911|NCT02960217|62918911|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
33529912|NCT02960217|62918912|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
33529913|NCT02960217|62918911|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
33529914|NCT02960217|62918912|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
33529915|NCT02960217|62918911|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
33529916|NCT02960217|62918912|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
33529917|NCT02959983|62918924|FG000|Overall Study|Protocol Violation|0|||
33529918|NCT02959983|62918925|FG001|Overall Study|Protocol Violation|1|||
33529919|NCT02959983|62918924|FG000|Overall Study|Lack of Efficacy|0|||
33529920|NCT02959983|62918925|FG001|Overall Study|Lack of Efficacy|1|||
33529921|NCT02959983|62918924|FG000|Overall Study|Lost to Follow-up|12|||
33529922|NCT02959983|62918925|FG001|Overall Study|Lost to Follow-up|9|||
33529923|NCT02959983|62918924|FG000|Overall Study|Other|1|||
33529924|NCT02959983|62918925|FG001|Overall Study|Other|1|||
33625465|NCT02034409|63026251|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
33625466|NCT02034409|63026250|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
33625467|NCT02034409|63026251|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
33625468|NCT02021318|63026259|FG000|Overall Study|Adverse Event|2|||
33625469|NCT02021318|63026260|FG001|Overall Study|Adverse Event|1|||
33625470|NCT02021318|63026259|FG000|Overall Study|Death|33|||
33625471|NCT02021318|63026260|FG001|Overall Study|Death|34|||
33625472|NCT02021318|63026259|FG000|Overall Study|Lost to Follow-up|3|||
33458509|NCT00112437|62832483|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458510|NCT00112437|62832484|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458511|NCT00112437|62832485|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458512|NCT00112437|62832486|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458513|NCT00112437|62832487|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458514|NCT00112437|62832488|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458515|NCT00112437|62832489|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458516|NCT00112437|62832490|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458517|NCT00112437|62832491|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458518|NCT00112437|62832492|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458519|NCT00112437|62832493|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458520|NCT00112437|62832494|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458521|NCT00112437|62832495|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458522|NCT00112437|62832496|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458523|NCT00112437|62832497|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458524|NCT00112437|62832498|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33458525|NCT00112437|62832473|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458526|NCT00112437|62832474|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458527|NCT00112437|62832475|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458528|NCT00112437|62832476|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458529|NCT00112437|62832477|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458530|NCT00112437|62832478|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458531|NCT00112437|62832479|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458532|NCT00112437|62832480|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
33529925|NCT02959983|62918924|FG000|Overall Study|Physician Decision|1|||
33529926|NCT02959983|62918925|FG001|Overall Study|Physician Decision|0|||
33458533|NCT00112437|62832481|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
33458534|NCT00112437|62832482|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458535|NCT00112437|62832483|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458536|NCT00112437|62832484|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458537|NCT00112437|62832485|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458538|NCT00112437|62832486|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458539|NCT00112437|62832487|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458540|NCT00112437|62832488|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458541|NCT00112437|62832489|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458542|NCT00112437|62832490|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458543|NCT00112437|62832491|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458544|NCT00112437|62832492|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
33529927|NCT02959983|62918924|FG000|Overall Study|Adverse Event|5|||
33529928|NCT02959983|62918925|FG001|Overall Study|Adverse Event|1|||
33529929|NCT02959983|62918924|FG000|Overall Study|Withdrawal by Subject|7|||
33625473|NCT02021318|63026260|FG001|Overall Study|Lost to Follow-up|3|||
33625474|NCT02021318|63026259|FG000|Overall Study|Progressive Disease|0|||
33529930|NCT02959983|62918925|FG001|Overall Study|Withdrawal by Subject|12|||
33529931|NCT01344447|62918931|FG000|Overall Study|Adverse Event|1|||
33529932|NCT01344447|62918931|FG000|Overall Study|Protocol Violation|1|||
33529933|NCT01344447|62918931|FG000|Overall Study|Withdrawal by Subject|1|||
33529934|NCT01344447|62918931|FG000|Overall Study|The contrast was not seen|1|||
33529935|NCT01344447|62918931|FG000|Overall Study|Physician Decision|1|||
33529936|NCT01344447|62918931|FG000|Overall Study|MRA unsuccessful|1|||
33529937|NCT01344447|62918931|FG000|Overall Study|Bolus tracking failed|1|||
33529938|NCT01344447|62918931|FG000|Overall Study|Error of power injector|1|||
33529939|NCT03513068|62918941|FG000|Overall Study|Death|1|||
33529940|NCT03513068|62918942|FG001|Overall Study|Death|0|||
33529941|NCT03513068|62918941|FG000|Overall Study|Withdrawal by Subject|4|||
33529942|NCT03513068|62918942|FG001|Overall Study|Withdrawal by Subject|6|||
33529943|NCT01348425|62918950|FG000|Overall Study|Imaging was not taken.|1|||
33529944|NCT01348425|62918951|FG001|Overall Study|Imaging was not taken.|1|||
33529945|NCT03041701|62918959|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
33529946|NCT03041701|62918960|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
33529947|NCT03041701|62918961|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
33529948|NCT03041701|62918959|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
33529949|NCT03041701|62918960|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
33529950|NCT03041701|62918961|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
33529951|NCT02956629|62918978|FG000|Overall Study|Adverse Event|0|||
33529952|NCT02956629|62918979|FG001|Overall Study|Adverse Event|0|||
33529953|NCT02956629|62918980|FG002|Overall Study|Adverse Event|1|||
33529954|NCT02956629|62918981|FG003|Overall Study|Adverse Event|0|||
33529955|NCT02956629|62918982|FG004|Overall Study|Adverse Event|0|||
33529956|NCT02956629|62918983|FG005|Overall Study|Adverse Event|0|||
33529957|NCT02956629|62918978|FG000|Overall Study|Lost to Follow-up|2|||
33625475|NCT02021318|63026260|FG001|Overall Study|Progressive Disease|1|||
33625476|NCT02021318|63026259|FG000|Overall Study|Withdrawal by Subject|30|||
33625477|NCT02021318|63026260|FG001|Overall Study|Withdrawal by Subject|18|||
33625478|NCT02021318|63026259|FG000|Overall Study|Physician Decision|3|||
33625479|NCT02021318|63026260|FG001|Overall Study|Physician Decision|3|||
33625480|NCT02021318|63026259|FG000|Overall Study|Miscellaneous|2|||
33625481|NCT02021318|63026260|FG001|Overall Study|Miscellaneous|3|||
33625482|NCT02041286|63026267|FG000|Overall Study|Adverse Event|1|||
33625483|NCT02020616|63026280|FG000|Overall Study|Adverse Event|0|||
33625484|NCT02020616|63026281|FG001|Overall Study|Adverse Event|0|||
33625485|NCT02020616|63026282|FG002|Overall Study|Adverse Event|0|||
33625486|NCT02020616|63026283|FG003|Overall Study|Adverse Event|0|||
33625487|NCT02020616|63026284|FG004|Overall Study|Adverse Event|0|||
33625488|NCT02020616|63026285|FG005|Overall Study|Adverse Event|1|||
33625489|NCT02020616|63026286|FG006|Overall Study|Adverse Event|1|||
33529958|NCT02956629|62918979|FG001|Overall Study|Lost to Follow-up|5|||
33529959|NCT02956629|62918980|FG002|Overall Study|Lost to Follow-up|3|||
33529960|NCT02956629|62918981|FG003|Overall Study|Lost to Follow-up|1|||
33625490|NCT02020616|63026280|FG000|Overall Study|Physician Decision|0|||
33529961|NCT02956629|62918982|FG004|Overall Study|Lost to Follow-up|0|||
33529962|NCT02956629|62918983|FG005|Overall Study|Lost to Follow-up|1|||
33529963|NCT02956629|62918978|FG000|Overall Study|Withdrawal by Subject|3|||
33529964|NCT02956629|62918979|FG001|Overall Study|Withdrawal by Subject|1|||
33625491|NCT02020616|63026281|FG001|Overall Study|Physician Decision|0|||
33625492|NCT02020616|63026282|FG002|Overall Study|Physician Decision|0|||
33625493|NCT02020616|63026283|FG003|Overall Study|Physician Decision|0|||
33625494|NCT02020616|63026284|FG004|Overall Study|Physician Decision|0|||
33625495|NCT02020616|63026285|FG005|Overall Study|Physician Decision|1|||
33625496|NCT02020616|63026286|FG006|Overall Study|Physician Decision|2|||
33625497|NCT02020616|63026280|FG000|Overall Study|Withdrawal by Subject|0|||
33625498|NCT02020616|63026281|FG001|Overall Study|Withdrawal by Subject|0|||
33625499|NCT02020616|63026282|FG002|Overall Study|Withdrawal by Subject|1|||
33625500|NCT02020616|63026283|FG003|Overall Study|Withdrawal by Subject|0|||
33625501|NCT02020616|63026284|FG004|Overall Study|Withdrawal by Subject|0|||
33625502|NCT02020616|63026285|FG005|Overall Study|Withdrawal by Subject|1|||
33625503|NCT02020616|63026286|FG006|Overall Study|Withdrawal by Subject|1|||
33529965|NCT02956629|62918980|FG002|Overall Study|Withdrawal by Subject|0|||
33529966|NCT02956629|62918981|FG003|Overall Study|Withdrawal by Subject|0|||
33529967|NCT02956629|62918982|FG004|Overall Study|Withdrawal by Subject|0|||
33529968|NCT02956629|62918983|FG005|Overall Study|Withdrawal by Subject|0|||
33529969|NCT01348347|62919000|FG000|Overall Study|Withdrawal by Subject|1|||
33529970|NCT01348347|62919001|FG001|Overall Study|Withdrawal by Subject|1|||
33529971|NCT01348347|62919002|FG002|Overall Study|Withdrawal by Subject|1|||
33529972|NCT01348347|62919000|FG000|Overall Study|Progressive disease|2|||
33529973|NCT01348347|62919001|FG001|Overall Study|Progressive disease|5|||
33529974|NCT01348347|62919002|FG002|Overall Study|Progressive disease|5|||
33529975|NCT02959671|62919011|FG000|Overall Study|Adverse Event|2|||
33529976|NCT02959671|62919011|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
33529977|NCT01597258|62919015|FG000|Overall Study|No Drug Administration|1|||
33529978|NCT02958267|62919021|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
33529979|NCT02958267|62919022|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
33529980|NCT02958267|62919021|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
33529981|NCT02958267|62919022|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
33529982|NCT02958267|62919021|FG000|Follow-up Visits|Additional treatment pursued|2|||
33529983|NCT02958267|62919022|FG001|Follow-up Visits|Additional treatment pursued|1|||
33529984|NCT01952574|62919032|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
33529985|NCT01952574|62919033|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
33529986|NCT01952574|62919034|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
33529987|NCT01952574|62919035|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
33529988|NCT01952574|62919036|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33529989|NCT01952574|62919037|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33529990|NCT01952574|62919038|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33529991|NCT01952574|62919032|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
33529992|NCT01952574|62919033|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
33529993|NCT01952574|62919034|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
33529994|NCT01952574|62919035|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
33529995|NCT01952574|62919036|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
33529996|NCT01952574|62919037|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
33529997|NCT01952574|62919038|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
33529998|NCT01952574|62919032|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
33529999|NCT01952574|62919033|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
33530000|NCT01952574|62919034|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
33530001|NCT01952574|62919035|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
33530002|NCT01952574|62919036|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
33530003|NCT01952574|62919037|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
33530004|NCT01952574|62919038|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
33530005|NCT01952574|62919032|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
33530006|NCT01952574|62919033|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
33530007|NCT01952574|62919034|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
33530008|NCT01952574|62919035|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
33530009|NCT01952574|62919036|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
33530010|NCT01952574|62919037|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
33530011|NCT01952574|62919038|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
33530012|NCT01952574|62919032|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
33530013|NCT01952574|62919033|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
33530014|NCT01952574|62919034|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
33530015|NCT01952574|62919035|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
33625504|NCT02020616|63026280|FG000|Overall Study|Lost to Follow-up|0|||
33625505|NCT02020616|63026281|FG001|Overall Study|Lost to Follow-up|1|||
33530016|NCT01952574|62919036|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
33530017|NCT01952574|62919037|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
33530018|NCT01952574|62919038|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
33530019|NCT01952574|62919032|FG000|Open-label Treatment Phase|Missing|0|||
33530020|NCT01952574|62919033|FG001|Open-label Treatment Phase|Missing|0|||
33530021|NCT01952574|62919034|FG002|Open-label Treatment Phase|Missing|0|||
33530022|NCT01952574|62919035|FG003|Open-label Treatment Phase|Missing|0|||
33530023|NCT01952574|62919036|FG004|Open-label Treatment Phase|Missing|4|||
33530024|NCT01952574|62919037|FG005|Open-label Treatment Phase|Missing|0|||
33530025|NCT01952574|62919038|FG006|Open-label Treatment Phase|Missing|0|||
33530026|NCT01952574|62919032|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
33530027|NCT01952574|62919033|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
33530028|NCT01952574|62919034|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
33530029|NCT01952574|62919035|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
33530030|NCT01952574|62919036|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
33530031|NCT01952574|62919037|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
33530032|NCT01952574|62919038|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
33530033|NCT01952574|62919032|FG000|Open-label Treatment Phase|Death|0|||
33530034|NCT01952574|62919033|FG001|Open-label Treatment Phase|Death|0|||
33530035|NCT01952574|62919034|FG002|Open-label Treatment Phase|Death|0|||
33530036|NCT01952574|62919035|FG003|Open-label Treatment Phase|Death|0|||
33325617|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33325618|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33325619|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33458545|NCT00112437|62832493|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
33325620|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33325621|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
33325622|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33325623|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
33325624|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
33325625|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
33325626|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
33325627|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
33325628|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
33325629|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
33458546|NCT00112437|62832494|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
33530037|NCT01952574|62919036|FG004|Open-label Treatment Phase|Death|1|||
33530038|NCT01952574|62919037|FG005|Open-label Treatment Phase|Death|0|||
33530039|NCT01952574|62919038|FG006|Open-label Treatment Phase|Death|0|||
33530040|NCT01952574|62919032|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
33530041|NCT01952574|62919033|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
33530042|NCT01952574|62919034|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
33530043|NCT01952574|62919035|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
33530044|NCT01952574|62919036|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
33530045|NCT01952574|62919037|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
33530046|NCT01952574|62919038|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
33530047|NCT01952574|62919032|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
33530048|NCT01952574|62919033|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
33530049|NCT01952574|62919034|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
33530050|NCT01952574|62919035|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
33530051|NCT01952574|62919036|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
33530052|NCT01952574|62919037|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
33530053|NCT01952574|62919038|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
33530054|NCT02959437|62919067|FG000|Overall Study|Death|33|||
33530055|NCT02959437|62919068|FG001|Overall Study|Death|3|||
33530056|NCT02959437|62919069|FG002|Overall Study|Death|0|||
33530057|NCT02959437|62919070|FG003|Overall Study|Death|0|||
33458547|NCT00112437|62832495|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458548|NCT00112437|62832496|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458549|NCT00112437|62832497|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458550|NCT00112437|62832498|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
33458551|NCT00112437|62832473|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458552|NCT00112437|62832474|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33530058|NCT02959437|62919067|FG000|Overall Study|Lost to Follow-up|3|||
33530059|NCT02959437|62919068|FG001|Overall Study|Lost to Follow-up|1|||
33530060|NCT02959437|62919069|FG002|Overall Study|Lost to Follow-up|0|||
33530061|NCT02959437|62919070|FG003|Overall Study|Lost to Follow-up|0|||
33530062|NCT02959437|62919067|FG000|Overall Study|Withdrawal by Subject|11|||
33530063|NCT02959437|62919068|FG001|Overall Study|Withdrawal by Subject|3|||
33530064|NCT02959437|62919069|FG002|Overall Study|Withdrawal by Subject|0|||
33458553|NCT00112437|62832475|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33530065|NCT02959437|62919070|FG003|Overall Study|Withdrawal by Subject|0|||
33530066|NCT02959437|62919067|FG000|Overall Study|Progressive Disease|9|||
33458554|NCT00112437|62832476|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33530067|NCT02959437|62919068|FG001|Overall Study|Progressive Disease|1|||
33530068|NCT02959437|62919069|FG002|Overall Study|Progressive Disease|0|||
33530069|NCT02959437|62919070|FG003|Overall Study|Progressive Disease|0|||
33530070|NCT02959437|62919067|FG000|Overall Study|Study Terminated by Sponsor|4|||
33530071|NCT02959437|62919068|FG001|Overall Study|Study Terminated by Sponsor|0|||
33530072|NCT02959437|62919069|FG002|Overall Study|Study Terminated by Sponsor|0|||
33530073|NCT02959437|62919070|FG003|Overall Study|Study Terminated by Sponsor|0|||
33530074|NCT02959437|62919067|FG000|Overall Study|Other Unspecified|2|||
33530075|NCT02959437|62919068|FG001|Overall Study|Other Unspecified|0|||
33530076|NCT02959437|62919069|FG002|Overall Study|Other Unspecified|0|||
33530077|NCT02959437|62919070|FG003|Overall Study|Other Unspecified|0|||
33530078|NCT02957331|62919083|FG000|Overall Study|Protocol Violation|1|||
33530079|NCT02957331|62919084|FG001|Overall Study|Protocol Violation|0|||
33530080|NCT05212883|62919090|FG000|Overall Study|Invalid test result|125|||
33530081|NCT04995055|62919098|FG000|Period 1|COVID-19 Related|1|||
33530082|NCT04995055|62919099|FG001|Period 1|COVID-19 Related|0|||
33530083|NCT04995055|62919098|FG000|Period 1|Withdrawal by Subject|0|||
33530084|NCT04995055|62919099|FG001|Period 1|Withdrawal by Subject|1|||
33530085|NCT04995055|62919098|FG000|Period 1|Subject discontinued due to timing|4|||
33530086|NCT04995055|62919099|FG001|Period 1|Subject discontinued due to timing|4|||
33530087|NCT04785144|62919115|FG000|Overall Study|Withdrawal by Subject|4|||
33530088|NCT04785144|62919116|FG001|Overall Study|Withdrawal by Subject|1|||
33530089|NCT04785144|62919117|FG002|Overall Study|Withdrawal by Subject|0|||
33530090|NCT04785144|62919118|FG003|Overall Study|Withdrawal by Subject|0|||
33530091|NCT04785144|62919119|FG004|Overall Study|Withdrawal by Subject|0|||
33530092|NCT04785144|62919120|FG005|Overall Study|Withdrawal by Subject|2|||
33530093|NCT04785144|62919121|FG006|Overall Study|Withdrawal by Subject|2|||
33530094|NCT04785144|62919122|FG007|Overall Study|Withdrawal by Subject|0|||
33530095|NCT04785144|62919123|FG008|Overall Study|Withdrawal by Subject|1|||
33530096|NCT04785144|62919124|FG009|Overall Study|Withdrawal by Subject|0|||
33530097|NCT04785144|62919115|FG000|Overall Study|Lost to Follow-up|1|||
33530098|NCT04785144|62919116|FG001|Overall Study|Lost to Follow-up|0|||
33530099|NCT04785144|62919117|FG002|Overall Study|Lost to Follow-up|0|||
33530100|NCT04785144|62919118|FG003|Overall Study|Lost to Follow-up|0|||
33530101|NCT04785144|62919119|FG004|Overall Study|Lost to Follow-up|1|||
33530102|NCT04785144|62919120|FG005|Overall Study|Lost to Follow-up|2|||
33530103|NCT04785144|62919121|FG006|Overall Study|Lost to Follow-up|1|||
33530104|NCT04785144|62919122|FG007|Overall Study|Lost to Follow-up|2|||
33530105|NCT04785144|62919123|FG008|Overall Study|Lost to Follow-up|4|||
33530106|NCT04785144|62919124|FG009|Overall Study|Lost to Follow-up|1|||
33530107|NCT04785144|62919115|FG000|Overall Study|Protocol Violation|0|||
33530108|NCT04785144|62919116|FG001|Overall Study|Protocol Violation|0|||
33530109|NCT04785144|62919117|FG002|Overall Study|Protocol Violation|0|||
33530110|NCT04785144|62919118|FG003|Overall Study|Protocol Violation|0|||
33530111|NCT04785144|62919119|FG004|Overall Study|Protocol Violation|0|||
33625506|NCT02020616|63026282|FG002|Overall Study|Lost to Follow-up|0|||
33625507|NCT02020616|63026283|FG003|Overall Study|Lost to Follow-up|1|||
33625508|NCT02020616|63026284|FG004|Overall Study|Lost to Follow-up|1|||
33625509|NCT02020616|63026285|FG005|Overall Study|Lost to Follow-up|1|||
33625510|NCT02020616|63026286|FG006|Overall Study|Lost to Follow-up|0|||
33625511|NCT02020616|63026280|FG000|Overall Study|Early Termination Criteria Met|0|||
33625512|NCT02020616|63026281|FG001|Overall Study|Early Termination Criteria Met|0|||
33625513|NCT02020616|63026282|FG002|Overall Study|Early Termination Criteria Met|1|||
33625514|NCT02020616|63026283|FG003|Overall Study|Early Termination Criteria Met|0|||
33625515|NCT02020616|63026284|FG004|Overall Study|Early Termination Criteria Met|0|||
33625516|NCT02020616|63026285|FG005|Overall Study|Early Termination Criteria Met|1|||
33625517|NCT02020616|63026286|FG006|Overall Study|Early Termination Criteria Met|0|||
33530112|NCT04785144|62919120|FG005|Overall Study|Protocol Violation|0|||
33530113|NCT04785144|62919121|FG006|Overall Study|Protocol Violation|1|||
33530114|NCT04785144|62919122|FG007|Overall Study|Protocol Violation|0|||
33530115|NCT04785144|62919123|FG008|Overall Study|Protocol Violation|0|||
33530116|NCT04785144|62919124|FG009|Overall Study|Protocol Violation|0|||
33625518|NCT02020616|63026280|FG000|Overall Study|Randomized in Error|0|||
33530117|NCT04785144|62919115|FG000|Overall Study|Physician Decision|0|||
33625519|NCT02020616|63026281|FG001|Overall Study|Randomized in Error|0|||
33530118|NCT04785144|62919116|FG001|Overall Study|Physician Decision|0|||
33530119|NCT04785144|62919117|FG002|Overall Study|Physician Decision|0|||
33530120|NCT04785144|62919118|FG003|Overall Study|Physician Decision|0|||
33530121|NCT04785144|62919119|FG004|Overall Study|Physician Decision|0|||
33530122|NCT04785144|62919120|FG005|Overall Study|Physician Decision|0|||
33530123|NCT04785144|62919121|FG006|Overall Study|Physician Decision|0|||
33530124|NCT04785144|62919122|FG007|Overall Study|Physician Decision|0|||
33530125|NCT04785144|62919123|FG008|Overall Study|Physician Decision|0|||
33530126|NCT04785144|62919124|FG009|Overall Study|Physician Decision|1|||
33625520|NCT02020616|63026282|FG002|Overall Study|Randomized in Error|0|||
33625521|NCT02020616|63026283|FG003|Overall Study|Randomized in Error|1|||
33625522|NCT02020616|63026284|FG004|Overall Study|Randomized in Error|0|||
33625523|NCT02020616|63026285|FG005|Overall Study|Randomized in Error|0|||
33625524|NCT02020616|63026286|FG006|Overall Study|Randomized in Error|0|||
33625525|NCT02020616|63026280|FG000|Overall Study|Lack of Efficacy|0|||
33625526|NCT02020616|63026281|FG001|Overall Study|Lack of Efficacy|0|||
33625527|NCT02020616|63026282|FG002|Overall Study|Lack of Efficacy|0|||
33625528|NCT02020616|63026283|FG003|Overall Study|Lack of Efficacy|0|||
33625529|NCT02020616|63026284|FG004|Overall Study|Lack of Efficacy|1|||
33625530|NCT02020616|63026285|FG005|Overall Study|Lack of Efficacy|0|||
33625531|NCT02020616|63026286|FG006|Overall Study|Lack of Efficacy|0|||
33625532|NCT02048072|63026316|FG000|Overall Study|Adverse Event|3|||
33625533|NCT02048072|63026316|FG000|Overall Study|Lost to Follow-up|1|||
33625534|NCT02047604|63026326|FG000|Overall Study|Withdrawal by Subject|0|||
33625535|NCT02047604|63026327|FG001|Overall Study|Withdrawal by Subject|0|||
33625536|NCT02047604|63026328|FG002|Overall Study|Withdrawal by Subject|0|||
33625537|NCT02047604|63026329|FG003|Overall Study|Withdrawal by Subject|0|||
33530127|NCT04785144|62919115|FG000|Overall Study|Unable to continue due to work schedule|0|||
33530128|NCT04785144|62919116|FG001|Overall Study|Unable to continue due to work schedule|0|||
33530129|NCT04785144|62919117|FG002|Overall Study|Unable to continue due to work schedule|0|||
33530130|NCT04785144|62919118|FG003|Overall Study|Unable to continue due to work schedule|0|||
33530131|NCT04785144|62919119|FG004|Overall Study|Unable to continue due to work schedule|0|||
33530132|NCT04785144|62919120|FG005|Overall Study|Unable to continue due to work schedule|0|||
33530133|NCT04785144|62919121|FG006|Overall Study|Unable to continue due to work schedule|0|||
33530134|NCT04785144|62919122|FG007|Overall Study|Unable to continue due to work schedule|0|||
33530135|NCT04785144|62919123|FG008|Overall Study|Unable to continue due to work schedule|0|||
33530136|NCT04785144|62919124|FG009|Overall Study|Unable to continue due to work schedule|1|||
33530137|NCT04778592|62919167|FG000|Overall Study|Adverse Event|1|||
33530138|NCT04778592|62919168|FG001|Overall Study|Adverse Event|2|||
33530139|NCT04778592|62919167|FG000|Overall Study|Withdrawal by Subject|1|||
33530140|NCT04778592|62919168|FG001|Overall Study|Withdrawal by Subject|2|||
33530141|NCT04743635|62919176|FG000|Overall Study|Lost to Follow-up|2|||
33530142|NCT04743635|62919177|FG001|Overall Study|Lost to Follow-up|0|||
33530143|NCT04712110|62919184|FG000|Overall Study|Lost to Follow-up|0|||
33530144|NCT04712110|62919185|FG001|Overall Study|Lost to Follow-up|1|||
33530145|NCT04712110|62919184|FG000|Overall Study|Withdrawal by Subject|0|||
33530146|NCT04712110|62919185|FG001|Overall Study|Withdrawal by Subject|4|||
33530147|NCT04712110|62919184|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
33530148|NCT04712110|62919185|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
33530149|NCT04143594|62919199|FG000|Overall Study|Still on study|48|||
33530150|NCT04143594|62919200|FG001|Overall Study|Still on study|42|||
33530151|NCT04143594|62919201|FG002|Overall Study|Still on study|48|||
33530152|NCT04143594|62919202|FG003|Overall Study|Still on study|18|||
33530153|NCT04143594|62919199|FG000|Overall Study|Withdrew consent|0|||
33530154|NCT04143594|62919200|FG001|Overall Study|Withdrew consent|6|||
33530155|NCT04143594|62919201|FG002|Overall Study|Withdrew consent|1|||
33530156|NCT04143594|62919202|FG003|Overall Study|Withdrew consent|1|||
33530157|NCT04143594|62919199|FG000|Overall Study|Lost to Follow-up|2|||
33530158|NCT04143594|62919200|FG001|Overall Study|Lost to Follow-up|2|||
33530159|NCT04143594|62919201|FG002|Overall Study|Lost to Follow-up|3|||
33530160|NCT04143594|62919202|FG003|Overall Study|Lost to Follow-up|0|||
33530161|NCT04143594|62919199|FG000|Overall Study|Investigator's discretion|1|||
33530162|NCT04143594|62919200|FG001|Overall Study|Investigator's discretion|2|||
33530163|NCT04143594|62919201|FG002|Overall Study|Investigator's discretion|0|||
33530164|NCT04143594|62919202|FG003|Overall Study|Investigator's discretion|0|||
33530165|NCT04143594|62919199|FG000|Overall Study|Lack of Efficacy|0|||
33530166|NCT04143594|62919200|FG001|Overall Study|Lack of Efficacy|1|||
33530167|NCT04143594|62919201|FG002|Overall Study|Lack of Efficacy|0|||
33530168|NCT04143594|62919202|FG003|Overall Study|Lack of Efficacy|0|||
33530169|NCT04143594|62919199|FG000|Overall Study|Protocol Violation|0|||
33530170|NCT04143594|62919200|FG001|Overall Study|Protocol Violation|0|||
33530171|NCT04143594|62919201|FG002|Overall Study|Protocol Violation|0|||
33530172|NCT04143594|62919202|FG003|Overall Study|Protocol Violation|1|||
33625538|NCT02047604|63026330|FG004|Overall Study|Withdrawal by Subject|1|||
33530173|NCT03877510|62919215|FG000|Overall Study|Death|6|||
33530174|NCT03877510|62919215|FG000|Overall Study|Lost to Follow-up|2|||
33530175|NCT03877510|62919215|FG000|Overall Study|Non-compliance with study drug|2|||
33530176|NCT03877510|62919215|FG000|Overall Study|Lack of Efficacy|14|||
33530177|NCT03877510|62919215|FG000|Overall Study|Adverse Event|20|||
33530178|NCT03877510|62919215|FG000|Overall Study|Withdrawal by Subject|22|||
33530179|NCT03877510|62919215|FG000|Overall Study|Miscellaneous|1|||
33530180|NCT03846427|62919219|FG000|Overall Study|Death|13|||
33625539|NCT02047604|63026331|FG005|Overall Study|Withdrawal by Subject|1|||
33625540|NCT01622660|63026345|FG000|Overall Study|Adverse Event|1|||
33625541|NCT02019602|63026351|FG000|Screening Period|Ineligibility|4|||
33625542|NCT02019602|63026352|FG001|Screening Period|Ineligibility|0|||
33625543|NCT02019602|63026351|FG000|Screening Period|Adverse Event|1|||
33530181|NCT03846427|62919219|FG000|Overall Study|Withdrawal by Subject|3|||
33530182|NCT03846427|62919219|FG000|Overall Study|Physician Decision|1|||
33530183|NCT03706079|62919248|FG000|Predecessor Study|Death|0|||
33530184|NCT03706079|62919249|FG001|Predecessor Study|Death|2|||
33530185|NCT03706079|62919250|FG002|Predecessor Study|Death|0|||
33530186|NCT03706079|62919251|FG003|Predecessor Study|Death|1|||
33530187|NCT03706079|62919252|FG004|Predecessor Study|Death|0|||
33530188|NCT03706079|62919253|FG005|Predecessor Study|Death|0|||
33530189|NCT03706079|62919248|FG000|Predecessor Study|Lost to Follow-up|5|||
33530190|NCT03706079|62919249|FG001|Predecessor Study|Lost to Follow-up|2|||
33530191|NCT03706079|62919250|FG002|Predecessor Study|Lost to Follow-up|0|||
33530192|NCT03706079|62919251|FG003|Predecessor Study|Lost to Follow-up|0|||
33530193|NCT03706079|62919252|FG004|Predecessor Study|Lost to Follow-up|1|||
33530194|NCT03706079|62919253|FG005|Predecessor Study|Lost to Follow-up|0|||
33530195|NCT03706079|62919248|FG000|Predecessor Study|Withdrawal by Subject|8|||
33530196|NCT03706079|62919249|FG001|Predecessor Study|Withdrawal by Subject|15|||
33530197|NCT03706079|62919250|FG002|Predecessor Study|Withdrawal by Subject|0|||
33530198|NCT03706079|62919251|FG003|Predecessor Study|Withdrawal by Subject|5|||
33530199|NCT03706079|62919252|FG004|Predecessor Study|Withdrawal by Subject|2|||
33530200|NCT03706079|62919253|FG005|Predecessor Study|Withdrawal by Subject|0|||
33530201|NCT03706079|62919248|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
33530202|NCT03706079|62919249|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
33530203|NCT03706079|62919250|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
33530204|NCT03706079|62919251|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
33530205|NCT03706079|62919252|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
33530206|NCT03706079|62919253|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
33530207|NCT03706079|62919248|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
33530208|NCT03706079|62919249|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
33530209|NCT03706079|62919250|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
33530210|NCT03706079|62919251|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
33530211|NCT03706079|62919252|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
33530212|NCT03706079|62919253|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
33530213|NCT03706079|62919248|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
33625544|NCT02019602|63026352|FG001|Screening Period|Adverse Event|0|||
33625545|NCT01994876|63026359|FG000|Test Period 1|Withdrawal by Subject|0|||
33530214|NCT03706079|62919249|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
33530215|NCT03706079|62919250|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
33530216|NCT03706079|62919251|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
33530217|NCT03706079|62919252|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
33530218|NCT03706079|62919253|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
33530219|NCT03706079|62919248|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
33530220|NCT03706079|62919249|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
33530221|NCT03706079|62919250|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
33530222|NCT03706079|62919251|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
33530223|NCT03706079|62919252|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
33530224|NCT03706079|62919253|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
33530225|NCT03706079|62919248|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
33530226|NCT03706079|62919249|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
33530227|NCT03706079|62919250|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
33530228|NCT03706079|62919251|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
33530229|NCT03706079|62919252|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
33530230|NCT03706079|62919253|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
33530231|NCT03706079|62919248|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
33530232|NCT03706079|62919249|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
33530233|NCT03706079|62919250|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
33530234|NCT03706079|62919251|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
33530235|NCT03706079|62919252|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
33530236|NCT03706079|62919253|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
33530237|NCT03706079|62919248|FG000|Long Term Extension (DESTINATION)|Death|8|||
33530238|NCT03706079|62919249|FG001|Long Term Extension (DESTINATION)|Death|2|||
33625546|NCT01994876|63026360|FG001|Test Period 1|Withdrawal by Subject|1|||
33625547|NCT01994876|63026359|FG000|Test Period 1|Adverse Event|0|||
33625548|NCT01994876|63026360|FG001|Test Period 1|Adverse Event|1|||
33625549|NCT01994876|63026359|FG000|Test Period 2|Adverse Event|1|||
33325630|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
33530239|NCT03706079|62919250|FG002|Long Term Extension (DESTINATION)|Death|2|||
33530240|NCT03706079|62919251|FG003|Long Term Extension (DESTINATION)|Death|1|||
33530241|NCT03706079|62919252|FG004|Long Term Extension (DESTINATION)|Death|0|||
33530242|NCT03706079|62919253|FG005|Long Term Extension (DESTINATION)|Death|0|||
33530243|NCT03657160|62919267|FG000|Overall Study|Adverse Event|5|||
33530244|NCT03657160|62919268|FG001|Overall Study|Adverse Event|6|||
33530245|NCT03657160|62919267|FG000|Overall Study|Protocol Deviation|3|||
33530246|NCT03657160|62919268|FG001|Overall Study|Protocol Deviation|0|||
33530247|NCT03657160|62919267|FG000|Overall Study|Withdrawal by Subject|18|||
33530248|NCT03657160|62919268|FG001|Overall Study|Withdrawal by Subject|16|||
33530249|NCT03657160|62919267|FG000|Overall Study|Site Termination|1|||
33530250|NCT03657160|62919268|FG001|Overall Study|Site Termination|0|||
33530251|NCT03657160|62919267|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
33530252|NCT03657160|62919268|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
33530253|NCT03657160|62919267|FG000|Overall Study|Death|33|||
33530254|NCT03657160|62919268|FG001|Overall Study|Death|26|||
33530255|NCT03657160|62919267|FG000|Overall Study|Death (COVID-19-Related)|1|||
33530256|NCT03657160|62919268|FG001|Overall Study|Death (COVID-19-Related)|0|||
33530257|NCT03657160|62919267|FG000|Overall Study|Reason Not Specified|5|||
33530258|NCT03657160|62919268|FG001|Overall Study|Reason Not Specified|5|||
33530259|NCT03657160|62919267|FG000|Overall Study|Other (COVID-19-Related)|0|||
33530260|NCT03657160|62919268|FG001|Overall Study|Other (COVID-19-Related)|1|||
33530261|NCT03635320|62919278|FG000|Overall Study|not implanted the device|1|||
33530262|NCT03635320|62919279|FG001|Overall Study|not implanted the device|2|||
33530263|NCT03635320|62919278|FG000|Overall Study|Withdrawal by Subject|11|||
33530264|NCT03635320|62919279|FG001|Overall Study|Withdrawal by Subject|6|||
33530265|NCT03508726|62919296|FG000|Overall Study|Withdrawal by Subject|0|||
33530266|NCT03508726|62919297|FG001|Overall Study|Withdrawal by Subject|1|||
33530267|NCT03499964|62919306|FG000|Overall Study|Lack of Efficacy|6|||
33530268|NCT03499964|62919307|FG001|Overall Study|Lack of Efficacy|26|||
33530269|NCT03499964|62919306|FG000|Overall Study|Adverse Event|1|||
33530270|NCT03499964|62919307|FG001|Overall Study|Adverse Event|0|||
33530271|NCT03499964|62919306|FG000|Overall Study|Death|1|||
33530272|NCT03499964|62919307|FG001|Overall Study|Death|0|||
33530273|NCT03499964|62919306|FG000|Overall Study|Withdrawal by Subject|2|||
33530274|NCT03499964|62919307|FG001|Overall Study|Withdrawal by Subject|1|||
33530275|NCT03499964|62919306|FG000|Overall Study|Lost to Follow-up|1|||
33530276|NCT03499964|62919307|FG001|Overall Study|Lost to Follow-up|0|||
33530277|NCT03279692|62919313|FG000|Overall Study|Withdrawal by Subject|1|||
33530278|NCT03001882|62919330|FG000|Overall Study|Death|1|||
33530279|NCT03001882|62919331|FG001|Overall Study|Death|0|||
33530280|NCT03001882|62919332|FG002|Overall Study|Death|0|||
33530281|NCT03001882|62919333|FG003|Overall Study|Death|3|||
33530282|NCT03001882|62919330|FG000|Overall Study|Participant withdrew consent|0|||
33530283|NCT03001882|62919331|FG001|Overall Study|Participant withdrew consent|1|||
33530284|NCT03001882|62919332|FG002|Overall Study|Participant withdrew consent|0|||
33530285|NCT03001882|62919333|FG003|Overall Study|Participant withdrew consent|5|||
33530286|NCT03001882|62919330|FG000|Overall Study|Other reasons|1|||
33530287|NCT03001882|62919331|FG001|Overall Study|Other reasons|2|||
33458555|NCT00112437|62832477|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458556|NCT00112437|62832478|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
33458557|NCT00112437|62832479|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
33458558|NCT00112437|62832480|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
33458559|NCT00112437|62832481|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
33458560|NCT00112437|62832482|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
33458561|NCT00112437|62832483|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458562|NCT00112437|62832484|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458563|NCT00112437|62832485|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458564|NCT00112437|62832486|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458565|NCT00112437|62832487|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33530288|NCT03001882|62919332|FG002|Overall Study|Other reasons|0|||
33530289|NCT03001882|62919333|FG003|Overall Study|Other reasons|5|||
33530290|NCT03001882|62919330|FG000|Overall Study|Administrative reason by sponsor|0|||
33530291|NCT03001882|62919331|FG001|Overall Study|Administrative reason by sponsor|0|||
33530292|NCT03001882|62919332|FG002|Overall Study|Administrative reason by sponsor|0|||
33530293|NCT03001882|62919333|FG003|Overall Study|Administrative reason by sponsor|1|||
33530294|NCT03001882|62919330|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
33530295|NCT03001882|62919331|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
33544141|NCT02536378|62934961|FG000|Overall Study|Patient refused further follow up|6|||
33544142|NCT02536378|62934962|FG001|Overall Study|Patient refused further follow up|2|||
33544143|NCT01373151|62934977|FG000|Period 1|Lack of Efficacy|3|||
33544144|NCT01373151|62934978|FG001|Period 1|Lack of Efficacy|0|||
33530296|NCT03001882|62919332|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
33530297|NCT03001882|62919333|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
33530298|NCT03001882|62919330|FG000|Overall Study|Not reported|0|||
33530299|NCT03001882|62919331|FG001|Overall Study|Not reported|0|||
33530300|NCT03001882|62919332|FG002|Overall Study|Not reported|0|||
33458566|NCT00112437|62832488|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458567|NCT00112437|62832489|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458568|NCT00112437|62832490|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458569|NCT00112437|62832491|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458570|NCT00112437|62832492|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458571|NCT00112437|62832493|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458572|NCT00112437|62832494|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33625550|NCT01994876|63026360|FG001|Test Period 2|Adverse Event|0|||
33458573|NCT00112437|62832495|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458574|NCT00112437|62832496|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458575|NCT00112437|62832497|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458576|NCT00112437|62832498|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33458577|NCT00112437|62832473|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458578|NCT00112437|62832474|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458579|NCT00112437|62832475|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458580|NCT00112437|62832476|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458581|NCT00112437|62832477|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458582|NCT00112437|62832478|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458583|NCT00112437|62832479|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458584|NCT00112437|62832480|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458585|NCT00112437|62832481|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458586|NCT00112437|62832482|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
33458587|NCT00112437|62832483|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458588|NCT00112437|62832484|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458589|NCT00112437|62832485|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33625551|NCT01994876|63026359|FG000|Test Period 2|Protocol Violation|0|||
33625552|NCT01994876|63026360|FG001|Test Period 2|Protocol Violation|1|||
33625553|NCT02040428|63026370|FG000|Overall Study|Death|4|||
33625554|NCT02040428|63026371|FG001|Overall Study|Death|3|||
33625555|NCT02040428|63026370|FG000|Overall Study|Withdrawal by Subject|1|||
33625556|NCT02040428|63026371|FG001|Overall Study|Withdrawal by Subject|1|||
33625557|NCT02018822|63026379|FG000|Overall Study|filling replaced by crown|0|||
33458590|NCT00112437|62832486|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458591|NCT00112437|62832487|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458592|NCT00112437|62832488|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458593|NCT00112437|62832489|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458594|NCT00112437|62832490|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458595|NCT00112437|62832491|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458596|NCT00112437|62832492|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458597|NCT00112437|62832493|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458598|NCT00112437|62832494|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458599|NCT00112437|62832495|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33530301|NCT03001882|62919333|FG003|Overall Study|Not reported|6|||
33544145|NCT01373151|62934979|FG002|Period 1|Lack of Efficacy|0|||
33544146|NCT01373151|62934980|FG003|Period 1|Lack of Efficacy|0|||
33544147|NCT01373151|62934981|FG004|Period 1|Lack of Efficacy|1|||
33544148|NCT01373151|62934982|FG005|Period 1|Lack of Efficacy|0|||
33544149|NCT01373151|62934983|FG006|Period 1|Lack of Efficacy|0|||
33544150|NCT01373151|62934977|FG000|Period 1|Adverse Event|0|||
33544151|NCT01373151|62934978|FG001|Period 1|Adverse Event|0|||
33544152|NCT01373151|62934979|FG002|Period 1|Adverse Event|1|||
33544153|NCT01373151|62934980|FG003|Period 1|Adverse Event|0|||
33544154|NCT01373151|62934981|FG004|Period 1|Adverse Event|4|||
33544155|NCT01373151|62934982|FG005|Period 1|Adverse Event|3|||
33544156|NCT01373151|62934983|FG006|Period 1|Adverse Event|0|||
33544157|NCT01373151|62934977|FG000|Period 1|Withdrawal by Subject|2|||
33544158|NCT01373151|62934978|FG001|Period 1|Withdrawal by Subject|0|||
33544159|NCT01373151|62934979|FG002|Period 1|Withdrawal by Subject|3|||
33544160|NCT01373151|62934980|FG003|Period 1|Withdrawal by Subject|1|||
33544161|NCT01373151|62934981|FG004|Period 1|Withdrawal by Subject|0|||
33544162|NCT01373151|62934982|FG005|Period 1|Withdrawal by Subject|1|||
33544163|NCT01373151|62934983|FG006|Period 1|Withdrawal by Subject|0|||
33544164|NCT01373151|62934977|FG000|Period 2|Lack of Efficacy|9|||
33544165|NCT01373151|62934978|FG001|Period 2|Lack of Efficacy|0|||
33625558|NCT02018822|63026380|FG001|Overall Study|filling replaced by crown|1|||
33625559|NCT02018822|63026381|FG002|Overall Study|filling replaced by crown|0|||
33625560|NCT02018822|63026379|FG000|Overall Study|Physician Decision|0|||
33625561|NCT02018822|63026380|FG001|Overall Study|Physician Decision|1|||
33458600|NCT00112437|62832496|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458601|NCT00112437|62832497|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458602|NCT00112437|62832498|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33458603|NCT00112437|62832473|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458604|NCT00112437|62832474|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458605|NCT00112437|62832475|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458606|NCT00112437|62832476|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458607|NCT00112437|62832477|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458608|NCT00112437|62832478|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458609|NCT00112437|62832479|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458610|NCT00112437|62832480|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458611|NCT00112437|62832481|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458612|NCT00112437|62832482|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
33458613|NCT00112437|62832483|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458614|NCT00112437|62832484|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
33530302|NCT03001882|62919330|FG000|Overall Study|Maximum clinical benefit|1|||
33530303|NCT03001882|62919331|FG001|Overall Study|Maximum clinical benefit|2|||
33530304|NCT03001882|62919332|FG002|Overall Study|Maximum clinical benefit|0|||
33530305|NCT03001882|62919333|FG003|Overall Study|Maximum clinical benefit|10|||
33625562|NCT02018822|63026381|FG002|Overall Study|Physician Decision|1|||
33625563|NCT02018822|63026379|FG000|Overall Study|Lost to Follow-up|6|||
33625564|NCT02018822|63026380|FG001|Overall Study|Lost to Follow-up|6|||
33625565|NCT02018822|63026381|FG002|Overall Study|Lost to Follow-up|5|||
33625566|NCT02055157|63026396|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
33625567|NCT02055157|63026397|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
33625568|NCT02055157|63026398|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
33530306|NCT03001882|62919330|FG000|Overall Study|AE unrelated to study drug|3|||
33530307|NCT03001882|62919331|FG001|Overall Study|AE unrelated to study drug|3|||
33530308|NCT03001882|62919332|FG002|Overall Study|AE unrelated to study drug|0|||
33530309|NCT03001882|62919333|FG003|Overall Study|AE unrelated to study drug|11|||
33530310|NCT03001882|62919330|FG000|Overall Study|Study Drug Toxicity|8|||
33530311|NCT03001882|62919331|FG001|Overall Study|Study Drug Toxicity|5|||
33530312|NCT03001882|62919332|FG002|Overall Study|Study Drug Toxicity|0|||
33530313|NCT03001882|62919333|FG003|Overall Study|Study Drug Toxicity|37|||
33530314|NCT03001882|62919330|FG000|Overall Study|Disease progression|15|||
33625569|NCT02055157|63026399|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
33625570|NCT02055157|63026396|FG000|Initial 6 Months|Adverse Event|0|||
33625571|NCT02055157|63026397|FG001|Initial 6 Months|Adverse Event|0|||
33625572|NCT02055157|63026398|FG002|Initial 6 Months|Adverse Event|0|||
33625573|NCT02055157|63026399|FG003|Initial 6 Months|Adverse Event|1|||
33625574|NCT02055157|63026396|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
33530315|NCT03001882|62919331|FG001|Overall Study|Disease progression|14|||
33530316|NCT03001882|62919332|FG002|Overall Study|Disease progression|2|||
33530317|NCT03001882|62919333|FG003|Overall Study|Disease progression|90|||
33530318|NCT02985151|62919350|FG000|Original Randomization|Withdrawal by Subject|0|||
33530319|NCT02985151|62919351|FG001|Original Randomization|Withdrawal by Subject|1|||
33530320|NCT02603432|62919423|FG000|Overall Study|Ongoing|184|||
33530321|NCT02603432|62919424|FG001|Overall Study|Ongoing|144|||
33530322|NCT02603432|62919423|FG000|Overall Study|Adverse Event|1|||
33530323|NCT02603432|62919424|FG001|Overall Study|Adverse Event|0|||
33530324|NCT02603432|62919423|FG000|Overall Study|Death|144|||
33530325|NCT02603432|62919424|FG001|Overall Study|Death|177|||
33530326|NCT02603432|62919423|FG000|Overall Study|Lost to Follow-up|4|||
33530327|NCT02603432|62919424|FG001|Overall Study|Lost to Follow-up|6|||
33458615|NCT00112437|62832485|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458616|NCT00112437|62832486|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
33530328|NCT02603432|62919423|FG000|Overall Study|Progressive Disease|5|||
33530329|NCT02603432|62919424|FG001|Overall Study|Progressive Disease|5|||
33530330|NCT02603432|62919423|FG000|Overall Study|Withdrawal by Subject|9|||
33530331|NCT02603432|62919424|FG001|Overall Study|Withdrawal by Subject|17|||
33544166|NCT01373151|62934979|FG002|Period 2|Lack of Efficacy|0|||
33544167|NCT01373151|62934980|FG003|Period 2|Lack of Efficacy|1|||
33544168|NCT01373151|62934981|FG004|Period 2|Lack of Efficacy|2|||
33544169|NCT01373151|62934982|FG005|Period 2|Lack of Efficacy|0|||
33544170|NCT01373151|62934983|FG006|Period 2|Lack of Efficacy|3|||
33544171|NCT01373151|62934977|FG000|Period 2|Adverse Event|0|||
33544172|NCT01373151|62934978|FG001|Period 2|Adverse Event|0|||
33544173|NCT01373151|62934979|FG002|Period 2|Adverse Event|3|||
33544174|NCT01373151|62934980|FG003|Period 2|Adverse Event|3|||
33544175|NCT01373151|62934981|FG004|Period 2|Adverse Event|0|||
33544176|NCT01373151|62934982|FG005|Period 2|Adverse Event|0|||
33530332|NCT02603432|62919423|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
33530333|NCT02603432|62919424|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33530334|NCT02603432|62919423|FG000|Overall Study|Other|0|||
33530335|NCT02603432|62919424|FG001|Overall Study|Other|1|||
33530336|NCT02582866|62919430|FG000|Overall Study|Death|1|||
33530337|NCT02582866|62919430|FG000|Overall Study|Lack of Efficacy|2|||
33530338|NCT02582866|62919430|FG000|Overall Study|Lost to Follow-up|2|||
33530339|NCT02582866|62919430|FG000|Overall Study|Withdrawal by Subject|7|||
33530340|NCT02582866|62919430|FG000|Overall Study|Investigator decision|5|||
33530341|NCT02582866|62919430|FG000|Overall Study|Participant wants to get pregnant|1|||
33530342|NCT02582866|62919430|FG000|Overall Study|Pregnancy|2|||
33530343|NCT02582866|62919430|FG000|Overall Study|Sponsor decision|1|||
33530344|NCT02582866|62919430|FG000|Overall Study|Withdrawal due to personal reasons|1|||
33530345|NCT02395666|62919436|FG000|Overall Study|Physician Decision|3|||
33530346|NCT02395666|62919437|FG001|Overall Study|Physician Decision|0|||
33530347|NCT02395666|62919436|FG000|Overall Study|Lost to Follow-up|1|||
33530348|NCT02395666|62919437|FG001|Overall Study|Lost to Follow-up|0|||
33530349|NCT02395666|62919436|FG000|Overall Study|Withdrawal by Subject|2|||
33530350|NCT02395666|62919437|FG001|Overall Study|Withdrawal by Subject|1|||
33530351|NCT01734928|62919453|FG000|Randomization|Physician Decision|0|||
33530352|NCT01734928|62919454|FG001|Randomization|Physician Decision|1|||
33530353|NCT01734928|62919453|FG000|Randomization|clinical progression|0|||
33530354|NCT01734928|62919454|FG001|Randomization|clinical progression|1|||
33530355|NCT01734928|62919453|FG000|Randomization|progressive disease|0|||
33530356|NCT01734928|62919454|FG001|Randomization|progressive disease|2|||
33530357|NCT01734928|62919453|FG000|Randomization|Withdrew informed consent|0|||
33530358|NCT01734928|62919454|FG001|Randomization|Withdrew informed consent|4|||
33530359|NCT01734928|62919453|FG000|Randomization|Death|1|||
33530360|NCT01734928|62919454|FG001|Randomization|Death|0|||
33530361|NCT01734928|62919453|FG000|Randomization|Randomization error|1|||
33530362|NCT01734928|62919454|FG001|Randomization|Randomization error|0|||
33530363|NCT01734928|62919453|FG000|Randomization|Lost to Follow-up|1|||
33530364|NCT01734928|62919454|FG001|Randomization|Lost to Follow-up|0|||
33530365|NCT01734928|62919453|FG000|Treatment Period|Lost to Follow-up|0|||
33530366|NCT01734928|62919454|FG001|Treatment Period|Lost to Follow-up|2|||
33530367|NCT01734928|62919453|FG000|Treatment Period|Progressive Disease|167|||
33530368|NCT01734928|62919454|FG001|Treatment Period|Progressive Disease|165|||
33530369|NCT01734928|62919453|FG000|Treatment Period|Adverse Event|39|||
33530370|NCT01734928|62919454|FG001|Treatment Period|Adverse Event|52|||
33530371|NCT01734928|62919453|FG000|Treatment Period|Withdrawal of Consent|25|||
33530372|NCT01734928|62919454|FG001|Treatment Period|Withdrawal of Consent|22|||
33530373|NCT01734928|62919453|FG000|Treatment Period|Death|20|||
33530374|NCT01734928|62919454|FG001|Treatment Period|Death|9|||
33530375|NCT01734928|62919453|FG000|Treatment Period|Other Reasons|27|||
33530376|NCT01734928|62919454|FG001|Treatment Period|Other Reasons|19|||
33530377|NCT01734928|62919453|FG000|Treatment Period|Pregnancy|0|||
33530378|NCT01734928|62919454|FG001|Treatment Period|Pregnancy|1|||
33530379|NCT00667459|62919471|FG000|Overall Study|Death|0|||
33530380|NCT00667459|62919472|FG001|Overall Study|Death|2|||
33530381|NCT00667459|62919471|FG000|Overall Study|Lost to Follow-up|8|||
33530382|NCT00667459|62919472|FG001|Overall Study|Lost to Follow-up|43|||
33530383|NCT00453544|62919486|FG000|Overall Study|Withdrawal by Subject|1|||
33530384|NCT00453544|62919487|FG001|Overall Study|Withdrawal by Subject|0|||
33530385|NCT00453544|62919488|FG002|Overall Study|Withdrawal by Subject|0|||
33530386|NCT00453544|62919489|FG003|Overall Study|Withdrawal by Subject|0|||
33530387|NCT00453544|62919486|FG000|Overall Study|Primary outcome measure not completed|1|||
33530388|NCT00453544|62919487|FG001|Overall Study|Primary outcome measure not completed|1|||
33530389|NCT00453544|62919488|FG002|Overall Study|Primary outcome measure not completed|0|||
33530390|NCT00453544|62919489|FG003|Overall Study|Primary outcome measure not completed|1|||
33530391|NCT02646124|62919513|FG000|Overall Study|Lost to Follow-up|0|||
33530392|NCT02646124|62919514|FG001|Overall Study|Lost to Follow-up|2|||
33530393|NCT01597492|62919522|FG000|Overall Study|Withdrawal by Subject|1|||
33530394|NCT01597492|62919523|FG001|Overall Study|Withdrawal by Subject|2|||
33530395|NCT01597492|62919522|FG000|Overall Study|Adverse Event|3|||
33530396|NCT01597492|62919523|FG001|Overall Study|Adverse Event|0|||
33530397|NCT01597492|62919522|FG000|Overall Study|Lost to Follow-up|0|||
33530398|NCT01597492|62919523|FG001|Overall Study|Lost to Follow-up|2|||
33530399|NCT01597492|62919522|FG000|Overall Study|Other Reason|2|||
33530400|NCT01597492|62919523|FG001|Overall Study|Other Reason|0|||
33530401|NCT03423602|62919529|FG000|Overall Study|Death|1|||
33530402|NCT03423602|62919529|FG000|Overall Study|Lost to Follow-up|6|||
33530403|NCT03423602|62919529|FG000|Overall Study|Protocol Violation|1|||
33530404|NCT03423602|62919529|FG000|Overall Study|Withdrawal by Subject|4|||
33530405|NCT00109590|62919536|FG000|Overall Study|Lost to Follow-up|1|||
33530406|NCT00109590|62919537|FG001|Overall Study|Lost to Follow-up|0|||
33530407|NCT00109590|62919538|FG002|Overall Study|Lost to Follow-up|1|||
33530408|NCT00109590|62919536|FG000|Overall Study|Never Started Treatment|1|||
33530409|NCT00109590|62919537|FG001|Overall Study|Never Started Treatment|2|||
33530410|NCT00109590|62919538|FG002|Overall Study|Never Started Treatment|3|||
33530411|NCT02781558|62919562|FG000|Overall Study|Lost to Follow-up|2|||
33530412|NCT02781558|62919563|FG001|Overall Study|Lost to Follow-up|2|||
33530413|NCT02781558|62919562|FG000|Overall Study|Adverse Event|1|||
33530414|NCT02781558|62919563|FG001|Overall Study|Adverse Event|0|||
33530415|NCT03041311|62919572|FG000|Overall Study|Death|39|||
33530416|NCT03041311|62919573|FG001|Overall Study|Death|42|||
33530417|NCT03041311|62919572|FG000|Overall Study|Lost to Follow-up|0|||
33530418|NCT03041311|62919573|FG001|Overall Study|Lost to Follow-up|1|||
33530419|NCT03041311|62919572|FG000|Overall Study|Withdrawal by Subject|8|||
33530420|NCT03041311|62919573|FG001|Overall Study|Withdrawal by Subject|5|||
33530421|NCT03041311|62919572|FG000|Overall Study|Sponsor Terminated Study|2|||
33530422|NCT03041311|62919573|FG001|Overall Study|Sponsor Terminated Study|4|||
33530423|NCT03041311|62919572|FG000|Overall Study|Disease Progression|3|||
33530424|NCT03041311|62919573|FG001|Overall Study|Disease Progression|1|||
33530425|NCT03041311|62919572|FG000|Overall Study|Randomized in error, did not receive drug|2|||
33530426|NCT03041311|62919573|FG001|Overall Study|Randomized in error, did not receive drug|0|||
33530427|NCT02644096|62919589|FG000|Overall Study|Withdrawal by Subject|28|||
33530428|NCT02644096|62919590|FG001|Overall Study|Withdrawal by Subject|25|||
33530429|NCT02643628|62919598|FG000|Overall Study|Lost to Follow-up|1|||
33530430|NCT02643628|62919599|FG001|Overall Study|Lost to Follow-up|4|||
33530431|NCT02643628|62919598|FG000|Overall Study|Withdrawal by Subject|0|||
33530432|NCT02643628|62919599|FG001|Overall Study|Withdrawal by Subject|1|||
33530433|NCT02643628|62919598|FG000|Overall Study|Relocated out of state|0|||
33530434|NCT02643628|62919599|FG001|Overall Study|Relocated out of state|1|||
33530435|NCT02643472|62919609|FG000|Overall Study|Death|2|||
33530436|NCT02643472|62919610|FG001|Overall Study|Death|5|||
33530437|NCT02643472|62919609|FG000|Overall Study|Withdrawal by Subject|3|||
33530438|NCT02643472|62919610|FG001|Overall Study|Withdrawal by Subject|2|||
33530439|NCT02643472|62919609|FG000|Overall Study|Protocol Violation|0|||
33530440|NCT02643472|62919610|FG001|Overall Study|Protocol Violation|1|||
33530441|NCT02643472|62919609|FG000|Overall Study|Lost to Follow-up|22|||
33530442|NCT02643472|62919610|FG001|Overall Study|Lost to Follow-up|26|||
33530443|NCT02738840|62919618|FG000|Overall Study|MRI Scan not Performed|5|||
33530444|NCT02738840|62919618|FG000|Overall Study|Lost to Follow-up|1|||
33530445|NCT02738840|62919618|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
33530446|NCT02738840|62919618|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
33530447|NCT02643394|62919624|FG000|Overall Study|Protocol Violation|4|||
33530448|NCT02643394|62919625|FG001|Overall Study|Protocol Violation|5|||
33530449|NCT03538158|62919633|FG000|Overall Study|Lost to Follow-up|13|||
33530450|NCT03538158|62919634|FG001|Overall Study|Lost to Follow-up|7|||
33530451|NCT03538158|62919633|FG000|Overall Study|Withdrawal by Subject|2|||
33530452|NCT03538158|62919634|FG001|Overall Study|Withdrawal by Subject|1|||
33530453|NCT02643082|62919640|FG000|Period 1|Adverse Event|1|||
33530454|NCT02643082|62919641|FG001|Period 1|Adverse Event|0|||
33530455|NCT00353496|62919650|FG000|Overall Study|Adverse Event|1|||
33530456|NCT00353496|62919651|FG001|Overall Study|Adverse Event|0|||
33530457|NCT00353496|62919650|FG000|Overall Study|Protocol Violation|2|||
33530458|NCT00353496|62919651|FG001|Overall Study|Protocol Violation|2|||
33530459|NCT00353496|62919650|FG000|Overall Study|Withdrawal by Subject|3|||
33530460|NCT00353496|62919651|FG001|Overall Study|Withdrawal by Subject|4|||
33530461|NCT00353496|62919650|FG000|Overall Study|Physician Decision|6|||
33530462|NCT00353496|62919651|FG001|Overall Study|Physician Decision|9|||
33530463|NCT00353496|62919650|FG000|Overall Study|Not otherwise specified|4|||
33530464|NCT00353496|62919651|FG001|Overall Study|Not otherwise specified|2|||
33530465|NCT01361464|62919667|FG000|Overall Study|Death|1|||
33530466|NCT01361464|62919667|FG000|Overall Study|Withdrawal by Subject|2|||
33530467|NCT03486912|62919675|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
33530468|NCT03486912|62919676|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
33530469|NCT03486912|62919677|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
33530470|NCT03486912|62919678|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
33530471|NCT03486912|62919675|FG000|Treatment Period|Withdrawal by Subject|3|||
33530472|NCT03486912|62919676|FG001|Treatment Period|Withdrawal by Subject|3|||
33530473|NCT03486912|62919677|FG002|Treatment Period|Withdrawal by Subject|3|||
33530474|NCT03486912|62919678|FG003|Treatment Period|Withdrawal by Subject|2|||
33530475|NCT03486912|62919675|FG000|Treatment Period|Other Reasons|0|||
33530476|NCT03486912|62919676|FG001|Treatment Period|Other Reasons|2|||
33530477|NCT03486912|62919677|FG002|Treatment Period|Other Reasons|1|||
33530478|NCT03486912|62919678|FG003|Treatment Period|Other Reasons|1|||
33530479|NCT03486912|62919675|FG000|Treatment Period|Adverse Event|0|||
33530480|NCT03486912|62919676|FG001|Treatment Period|Adverse Event|1|||
33530481|NCT03486912|62919677|FG002|Treatment Period|Adverse Event|1|||
33530482|NCT03486912|62919678|FG003|Treatment Period|Adverse Event|0|||
33530483|NCT03486912|62919675|FG000|Treatment Period|Lost to Follow-up|1|||
33530484|NCT03486912|62919676|FG001|Treatment Period|Lost to Follow-up|0|||
33530485|NCT03486912|62919677|FG002|Treatment Period|Lost to Follow-up|0|||
33530486|NCT03486912|62919678|FG003|Treatment Period|Lost to Follow-up|2|||
33530487|NCT02642614|62919692|FG000|Overall Study|Adverse Event|1|||
33530488|NCT02642614|62919693|FG001|Overall Study|Adverse Event|1|||
33530489|NCT02642614|62919694|FG002|Overall Study|Adverse Event|2|||
33530490|NCT02642614|62919695|FG003|Overall Study|Adverse Event|2|||
33530491|NCT02642614|62919692|FG000|Overall Study|Lost to Follow-up|1|||
33530492|NCT02642614|62919693|FG001|Overall Study|Lost to Follow-up|0|||
33530493|NCT02642614|62919694|FG002|Overall Study|Lost to Follow-up|0|||
33530494|NCT02642614|62919695|FG003|Overall Study|Lost to Follow-up|0|||
33530495|NCT02642614|62919692|FG000|Overall Study|Withdrawal by Subject|1|||
33530496|NCT02642614|62919693|FG001|Overall Study|Withdrawal by Subject|1|||
33530497|NCT02642614|62919694|FG002|Overall Study|Withdrawal by Subject|0|||
33625575|NCT02055157|63026397|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
33625576|NCT02055157|63026398|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
33625577|NCT02055157|63026399|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
33625578|NCT02055157|63026396|FG000|18-month Extension|Investigator decision|0|||
33625579|NCT02055157|63026397|FG001|18-month Extension|Investigator decision|1|||
33625580|NCT02055157|63026398|FG002|18-month Extension|Investigator decision|0|||
33625581|NCT02055157|63026399|FG003|18-month Extension|Investigator decision|0|||
33625582|NCT02055157|63026396|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
33625583|NCT02055157|63026397|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
33625584|NCT02055157|63026398|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
33625585|NCT02055157|63026399|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
33625586|NCT02022007|63026423|FG000|Overall Study|Withdrawal by Subject|1|||
33625587|NCT02022007|63026424|FG001|Overall Study|Withdrawal by Subject|1|||
33625588|NCT02022007|63026425|FG002|Overall Study|Withdrawal by Subject|1|||
33625589|NCT02022007|63026423|FG000|Overall Study|Noncompliant|0|||
33625590|NCT02022007|63026424|FG001|Overall Study|Noncompliant|0|||
33625591|NCT02022007|63026425|FG002|Overall Study|Noncompliant|1|||
33625592|NCT02031679|63026435|FG000|Overall Study|Protocol Violation|0|||
33625593|NCT02031679|63026436|FG001|Overall Study|Protocol Violation|1|||
33625594|NCT02031679|63026435|FG000|Overall Study|Lack of Efficacy|0|||
33625595|NCT02031679|63026436|FG001|Overall Study|Lack of Efficacy|1|||
33625596|NCT02053753|63026444|FG000|Overall Study|Withdrawal by Subject|2|||
33625597|NCT02053753|63026445|FG001|Overall Study|Withdrawal by Subject|4|||
33625598|NCT02053753|63026444|FG000|Overall Study|Decision by Sponsor|1|||
33625599|NCT02053753|63026445|FG001|Overall Study|Decision by Sponsor|1|||
33625600|NCT02053753|63026444|FG000|Overall Study|Lost to Follow-up|4|||
33625601|NCT02053753|63026445|FG001|Overall Study|Lost to Follow-up|3|||
33625602|NCT02019979|63026451|FG000|Overall Study|study terminated|14|||
33625603|NCT02019667|63026455|FG000|First Intervention (6 Months)|Adverse Event|0|||
33625604|NCT02019667|63026456|FG001|First Intervention (6 Months)|Adverse Event|1|||
33625605|NCT02019667|63026455|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
33625606|NCT02019667|63026456|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
33625607|NCT02019667|63026455|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
33625608|NCT02019667|63026456|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
33625609|NCT02030821|63026468|FG000|Overall Study|Physician Decision|2|||
33625610|NCT02030821|63026469|FG001|Overall Study|Physician Decision|2|||
33625611|NCT02030821|63026470|FG002|Overall Study|Physician Decision|5|||
33625612|NCT02030821|63026471|FG003|Overall Study|Physician Decision|2|||
33625613|NCT02052739|63026483|FG000|Overall Study|Withdrew due to Adverse Event|3|||
33625614|NCT02052739|63026484|FG001|Overall Study|Withdrew due to Adverse Event|0|||
33458617|NCT00112437|62832487|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458618|NCT00112437|62832488|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458619|NCT00112437|62832489|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458620|NCT00112437|62832490|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458621|NCT00112437|62832491|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458622|NCT00112437|62832492|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458623|NCT00112437|62832493|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458624|NCT00112437|62832494|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
33530498|NCT02642614|62919695|FG003|Overall Study|Withdrawal by Subject|0|||
33530499|NCT02781324|62919710|FG000|Overall Study|Withdrawal by Subject|1|||
33625615|NCT02052739|63026483|FG000|Overall Study|Participant Died|2|||
33625616|NCT02052739|63026484|FG001|Overall Study|Participant Died|1|||
33458625|NCT00112437|62832495|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458626|NCT00112437|62832496|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
33530500|NCT02781324|62919711|FG001|Overall Study|Withdrawal by Subject|0|||
33625617|NCT02019277|63026492|FG000|Overall Study|Withdrawal by Subject|3|||
33625618|NCT02019277|63026492|FG000|Overall Study|Death|7|||
33625619|NCT02019277|63026492|FG000|Overall Study|Did no Cooperate|1|||
33625620|NCT02019277|63026492|FG000|Overall Study|Adverse Event|1|||
33625621|NCT02030119|63026500|FG000|Overall Study|Withdrawal by Subject|3|||
33625622|NCT02030119|63026501|FG001|Overall Study|Withdrawal by Subject|1|||
33625623|NCT02030119|63026502|FG002|Overall Study|Withdrawal by Subject|5|||
33625624|NCT02030119|63026503|FG003|Overall Study|Withdrawal by Subject|3|||
33625625|NCT02030119|63026500|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
33625626|NCT02030119|63026501|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
33625627|NCT02030119|63026502|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
33625628|NCT02030119|63026503|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
33625629|NCT01823835|63026528|FG000|Overall Study|Adverse Event|0|||
33625630|NCT01823835|63026529|FG001|Overall Study|Adverse Event|0|||
33625631|NCT01823835|63026530|FG002|Overall Study|Adverse Event|0|||
33625632|NCT01823835|63026531|FG003|Overall Study|Adverse Event|0|||
33625633|NCT01823835|63026532|FG004|Overall Study|Adverse Event|1|||
33625634|NCT01823835|63026533|FG005|Overall Study|Adverse Event|0|||
33625635|NCT01823835|63026534|FG006|Overall Study|Adverse Event|1|||
33625636|NCT01823835|63026535|FG007|Overall Study|Adverse Event|0|||
33625637|NCT01823835|63026536|FG008|Overall Study|Adverse Event|0|||
33625638|NCT01823835|63026537|FG009|Overall Study|Adverse Event|0|||
33625639|NCT01823835|63026538|FG010|Overall Study|Adverse Event|1|||
33625640|NCT01823835|63026539|FG011|Overall Study|Adverse Event|2|||
33530501|NCT02781324|62919710|FG000|Overall Study|Physician Decision|1|||
33530502|NCT02781324|62919711|FG001|Overall Study|Physician Decision|2|||
33530503|NCT03292146|62919721|FG000|Baseline to 12 Months|Relocation|1|||
33530504|NCT03292146|62919722|FG001|Baseline to 12 Months|Relocation|0|||
33530505|NCT03292146|62919721|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
33530506|NCT03292146|62919722|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
33530507|NCT03292146|62919721|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
33530508|NCT03292146|62919722|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
33530509|NCT03292146|62919721|FG000|12 Months to 24 Months|Planning pregnancy|2|||
33530510|NCT03292146|62919722|FG001|12 Months to 24 Months|Planning pregnancy|2|||
33530511|NCT03292146|62919721|FG000|12 Months to 24 Months|Personal reasons|1|||
33530512|NCT03292146|62919722|FG001|12 Months to 24 Months|Personal reasons|0|||
33530513|NCT03292146|62919721|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
33530514|NCT03292146|62919722|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
33530515|NCT01360996|62919731|FG000|Overall Study|Withdrawal by Subject|4|||
33530516|NCT01360996|62919732|FG001|Overall Study|Withdrawal by Subject|3|||
33530517|NCT01360996|62919733|FG002|Overall Study|Withdrawal by Subject|2|||
33530518|NCT01360996|62919731|FG000|Overall Study|Noncompliant|2|||
33530519|NCT01360996|62919732|FG001|Overall Study|Noncompliant|0|||
33530520|NCT01360996|62919733|FG002|Overall Study|Noncompliant|0|||
33530521|NCT02639338|62919742|FG000|Overall Study|Lost to Follow-up|2|||
33530522|NCT02639338|62919743|FG001|Overall Study|Lost to Follow-up|2|||
33530523|NCT02639338|62919742|FG000|Overall Study|Withdrew Consent|1|||
33530524|NCT02639338|62919743|FG001|Overall Study|Withdrew Consent|2|||
33530525|NCT02639338|62919742|FG000|Overall Study|Death|1|||
33530526|NCT02639338|62919743|FG001|Overall Study|Death|0|||
33530527|NCT02639338|62919742|FG000|Overall Study|Randomized but Not Treated|0|||
33530528|NCT02639338|62919743|FG001|Overall Study|Randomized but Not Treated|1|||
33530529|NCT01754857|62919749|FG000|Overall Study|Adverse Event|7|||
33625641|NCT01823835|63026540|FG012|Overall Study|Adverse Event|0|||
33625642|NCT01823835|63026541|FG013|Overall Study|Adverse Event|0|||
33625643|NCT01823835|63026542|FG014|Overall Study|Adverse Event|0|||
33625644|NCT01823835|63026528|FG000|Overall Study|Physician Decision|0|||
33625645|NCT01823835|63026529|FG001|Overall Study|Physician Decision|0|||
33625646|NCT01823835|63026530|FG002|Overall Study|Physician Decision|0|||
33625647|NCT01823835|63026531|FG003|Overall Study|Physician Decision|0|||
33625648|NCT01823835|63026532|FG004|Overall Study|Physician Decision|0|||
33625649|NCT01823835|63026533|FG005|Overall Study|Physician Decision|0|||
33625650|NCT01823835|63026534|FG006|Overall Study|Physician Decision|0|||
33625651|NCT01823835|63026535|FG007|Overall Study|Physician Decision|0|||
33625652|NCT01823835|63026536|FG008|Overall Study|Physician Decision|0|||
33625653|NCT01823835|63026537|FG009|Overall Study|Physician Decision|0|||
33458627|NCT00112437|62832497|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458628|NCT00112437|62832498|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
33458629|NCT00112437|62832473|FG000|Year 2 (12-Month Extension)|Moved|0|||
33458630|NCT00112437|62832474|FG001|Year 2 (12-Month Extension)|Moved|0|||
33458631|NCT00112437|62832475|FG002|Year 2 (12-Month Extension)|Moved|0|||
33458632|NCT00112437|62832476|FG003|Year 2 (12-Month Extension)|Moved|0|||
33458633|NCT00112437|62832477|FG004|Year 2 (12-Month Extension)|Moved|0|||
33458634|NCT00112437|62832478|FG005|Year 2 (12-Month Extension)|Moved|0|||
33458635|NCT00112437|62832479|FG006|Year 2 (12-Month Extension)|Moved|0|||
33458636|NCT00112437|62832480|FG007|Year 2 (12-Month Extension)|Moved|0|||
33458637|NCT00112437|62832481|FG008|Year 2 (12-Month Extension)|Moved|0|||
33458638|NCT00112437|62832482|FG009|Year 2 (12-Month Extension)|Moved|1|||
33458639|NCT00112437|62832483|FG010|Year 2 (12-Month Extension)|Moved|0|||
33458640|NCT00112437|62832484|FG011|Year 2 (12-Month Extension)|Moved|0|||
33530530|NCT01754857|62919749|FG000|Overall Study|Disease progression|3|||
33530531|NCT01754857|62919749|FG000|Overall Study|Physician Decision|2|||
33530532|NCT01754857|62919749|FG000|Overall Study|Withdrawal by Subject|3|||
33530533|NCT01754857|62919749|FG000|Overall Study|other complicating disease|1|||
33530534|NCT01754857|62919749|FG000|Overall Study|ineligible to continue onto maintenance|1|||
33530535|NCT01754857|62919749|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
33530536|NCT01754857|62919749|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
33530537|NCT02900352|62919755|FG000|Overall Study|Lost to Follow-up|28|||
33530538|NCT02900352|62919756|FG001|Overall Study|Lost to Follow-up|17|||
33530539|NCT03040687|62919765|FG000|Overall Study|Withdrawal by Subject|1|||
33530540|NCT03040687|62919766|FG001|Overall Study|Withdrawal by Subject|0|||
33530541|NCT03040687|62919767|FG002|Overall Study|Withdrawal by Subject|0|||
33530542|NCT03042559|62919777|FG000|Overall Study|drop out|1|||
33530543|NCT03042559|62919778|FG001|Overall Study|drop out|1|||
33530544|NCT02780856|62919784|FG000|Overall Study|Lost to Follow-up|1|||
33530545|NCT00108732|62919813|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
33530546|NCT00108732|62919813|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
33530547|NCT00108732|62919813|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
33530548|NCT00108732|62919813|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
33530549|NCT00108732|62919813|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
33530550|NCT00108732|62919813|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
33530551|NCT00108732|62919813|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
33530552|NCT00107952|62919819|FG000|Overall Study|Death|75|||
33530553|NCT00107952|62919820|FG001|Overall Study|Death|61|||
33530554|NCT00107952|62919819|FG000|Overall Study|Lost to Follow-up|0|||
33530555|NCT00107952|62919820|FG001|Overall Study|Lost to Follow-up|3|||
33530556|NCT00107952|62919819|FG000|Overall Study|Withdrawal by Subject|9|||
33530557|NCT00107952|62919820|FG001|Overall Study|Withdrawal by Subject|6|||
33530558|NCT00107952|62919819|FG000|Overall Study|Other|2|||
33530559|NCT00107952|62919820|FG001|Overall Study|Other|5|||
33530560|NCT00107952|62919819|FG000|Overall Study|Never received study treatment|9|||
33530561|NCT00107952|62919820|FG001|Overall Study|Never received study treatment|6|||
33530562|NCT01366638|62919838|FG000|Overall Study|Withdrawal by Subject|0|||
33530563|NCT01366638|62919839|FG001|Overall Study|Withdrawal by Subject|0|||
33530564|NCT01366638|62919840|FG002|Overall Study|Withdrawal by Subject|6|||
33530565|NCT01366638|62919838|FG000|Overall Study|Other|1|||
33530566|NCT01366638|62919839|FG001|Overall Study|Other|0|||
33530567|NCT01366638|62919840|FG002|Overall Study|Other|0|||
33530568|NCT02780700|62919848|FG000|Overall Study|Progressive disease|1|||
33530569|NCT04230122|62919886|FG000|Overall Study|Lost to Follow-up|1|||
33530570|NCT04230122|62919887|FG001|Overall Study|Lost to Follow-up|0|||
33530571|NCT02780388|62919898|FG000|Overall Study|Lost to Follow-up|0|||
33530572|NCT02780388|62919899|FG001|Overall Study|Lost to Follow-up|1|||
33530573|NCT02780388|62919900|FG002|Overall Study|Lost to Follow-up|0|||
33530574|NCT02780388|62919901|FG003|Overall Study|Lost to Follow-up|0|||
33530575|NCT02780388|62919902|FG004|Overall Study|Lost to Follow-up|0|||
33530576|NCT02780388|62919898|FG000|Overall Study|Withdrawal by Subject|1|||
33530577|NCT02780388|62919899|FG001|Overall Study|Withdrawal by Subject|1|||
33530578|NCT02780388|62919900|FG002|Overall Study|Withdrawal by Subject|0|||
33530579|NCT02780388|62919901|FG003|Overall Study|Withdrawal by Subject|0|||
33530580|NCT02780388|62919902|FG004|Overall Study|Withdrawal by Subject|0|||
33530581|NCT03491462|62919920|FG000|Overall Study|Lost to Follow-up|2|||
33530582|NCT03491462|62919921|FG001|Overall Study|Lost to Follow-up|0|||
33530583|NCT03491462|62919920|FG000|Overall Study|Adverse Event|11|||
33530584|NCT03491462|62919921|FG001|Overall Study|Adverse Event|1|||
33530585|NCT03491462|62919920|FG000|Overall Study|Physician Decision|3|||
33530586|NCT03491462|62919921|FG001|Overall Study|Physician Decision|0|||
33530587|NCT03491462|62919920|FG000|Overall Study|Withdrawal by Subject|22|||
33530588|NCT03491462|62919921|FG001|Overall Study|Withdrawal by Subject|15|||
33530589|NCT02224573|62919929|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
33530590|NCT02224573|62919930|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
33530591|NCT02224573|62919929|FG000|Treatment Phase|Started on Other IMP|1|||
33530592|NCT02224573|62919930|FG001|Treatment Phase|Started on Other IMP|0|||
33530593|NCT02224573|62919929|FG000|Treatment Phase|Participant Discontinued IMP|0|||
33530594|NCT02224573|62919930|FG001|Treatment Phase|Participant Discontinued IMP|1|||
33530595|NCT02224573|62919929|FG000|Treatment Phase|Lack of Efficacy|15|||
33530596|NCT02224573|62919930|FG001|Treatment Phase|Lack of Efficacy|8|||
33530597|NCT02224573|62919929|FG000|Treatment Phase|Began Commercial Product|1|||
33530598|NCT02224573|62919930|FG001|Treatment Phase|Began Commercial Product|0|||
33544177|NCT01373151|62934983|FG006|Period 2|Adverse Event|1|||
33544178|NCT01373151|62934977|FG000|Period 2|subject request to discontinue|0|||
33544179|NCT01373151|62934978|FG001|Period 2|subject request to discontinue|1|||
33544180|NCT01373151|62934979|FG002|Period 2|subject request to discontinue|0|||
33544181|NCT01373151|62934980|FG003|Period 2|subject request to discontinue|0|||
33544182|NCT01373151|62934981|FG004|Period 2|subject request to discontinue|0|||
33544183|NCT01373151|62934982|FG005|Period 2|subject request to discontinue|0|||
33544184|NCT01373151|62934983|FG006|Period 2|subject request to discontinue|0|||
33530599|NCT02224573|62919929|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
33530600|NCT02224573|62919930|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
33530601|NCT02224573|62919929|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
33530602|NCT02224573|62919930|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
33530603|NCT02224573|62919929|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
33530604|NCT02224573|62919930|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
33530605|NCT02224573|62919929|FG000|Treatment Phase|Continued Compassionate Use|1|||
33530606|NCT02224573|62919930|FG001|Treatment Phase|Continued Compassionate Use|0|||
33530607|NCT02224573|62919929|FG000|Treatment Phase|Lack of Efficiency|2|||
33530608|NCT02224573|62919930|FG001|Treatment Phase|Lack of Efficiency|1|||
33530609|NCT02224573|62919929|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
33544185|NCT01373151|62934977|FG000|Period 2|Withdrawal by Subject|0|||
33625654|NCT01823835|63026538|FG010|Overall Study|Physician Decision|0|||
33625655|NCT01823835|63026539|FG011|Overall Study|Physician Decision|2|||
33625656|NCT01823835|63026540|FG012|Overall Study|Physician Decision|0|||
33625657|NCT01823835|63026541|FG013|Overall Study|Physician Decision|0|||
33625658|NCT01823835|63026542|FG014|Overall Study|Physician Decision|0|||
33625659|NCT01823835|63026528|FG000|Overall Study|Progressive Disease|3|||
33625660|NCT01823835|63026529|FG001|Overall Study|Progressive Disease|4|||
33625661|NCT01823835|63026530|FG002|Overall Study|Progressive Disease|3|||
33625662|NCT01823835|63026531|FG003|Overall Study|Progressive Disease|6|||
33625663|NCT01823835|63026532|FG004|Overall Study|Progressive Disease|4|||
33625664|NCT01823835|63026533|FG005|Overall Study|Progressive Disease|6|||
33625665|NCT01823835|63026534|FG006|Overall Study|Progressive Disease|5|||
33544186|NCT01373151|62934978|FG001|Period 2|Withdrawal by Subject|0|||
33544187|NCT01373151|62934979|FG002|Period 2|Withdrawal by Subject|0|||
33544188|NCT01373151|62934980|FG003|Period 2|Withdrawal by Subject|1|||
33544189|NCT01373151|62934981|FG004|Period 2|Withdrawal by Subject|0|||
33544190|NCT01373151|62934982|FG005|Period 2|Withdrawal by Subject|0|||
33544191|NCT01373151|62934983|FG006|Period 2|Withdrawal by Subject|0|||
33544192|NCT01373151|62934977|FG000|Period 2|Other|0|||
33544193|NCT01373151|62934978|FG001|Period 2|Other|0|||
33544194|NCT01373151|62934979|FG002|Period 2|Other|1|||
33544195|NCT01373151|62934980|FG003|Period 2|Other|0|||
33544196|NCT01373151|62934981|FG004|Period 2|Other|0|||
33544197|NCT01373151|62934982|FG005|Period 2|Other|0|||
33544198|NCT01373151|62934983|FG006|Period 2|Other|1|||
33544199|NCT01660906|62934999|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
33544200|NCT03015181|62935019|FG000|Overall Study|Enrolled, but product never administered|1|||
33544201|NCT03015181|62935020|FG001|Overall Study|Enrolled, but product never administered|0|||
33544202|NCT03015181|62935021|FG002|Overall Study|Enrolled, but product never administered|0|||
33544203|NCT03015181|62935022|FG003|Overall Study|Enrolled, but product never administered|0|||
33544204|NCT03015181|62935023|FG004|Overall Study|Enrolled, but product never administered|0|||
33544205|NCT03015181|62935024|FG005|Overall Study|Enrolled, but product never administered|0|||
33544206|NCT03015181|62935025|FG006|Overall Study|Enrolled, but product never administered|0|||
33544207|NCT03015181|62935019|FG000|Overall Study|Withdrawal by Subject|0|||
33544208|NCT03015181|62935020|FG001|Overall Study|Withdrawal by Subject|0|||
33544209|NCT03015181|62935021|FG002|Overall Study|Withdrawal by Subject|0|||
33544210|NCT03015181|62935022|FG003|Overall Study|Withdrawal by Subject|0|||
33544211|NCT03015181|62935023|FG004|Overall Study|Withdrawal by Subject|0|||
33544212|NCT03015181|62935024|FG005|Overall Study|Withdrawal by Subject|1|||
33544213|NCT03015181|62935025|FG006|Overall Study|Withdrawal by Subject|0|||
33544214|NCT03015181|62935019|FG000|Overall Study|Physician Decision|0|||
33544215|NCT03015181|62935020|FG001|Overall Study|Physician Decision|0|||
33544216|NCT03015181|62935021|FG002|Overall Study|Physician Decision|0|||
33544217|NCT03015181|62935022|FG003|Overall Study|Physician Decision|0|||
33544218|NCT03015181|62935023|FG004|Overall Study|Physician Decision|0|||
33544219|NCT03015181|62935024|FG005|Overall Study|Physician Decision|0|||
33544220|NCT03015181|62935025|FG006|Overall Study|Physician Decision|1|||
33544221|NCT00960297|62935074|FG000|Overall Study|Physician Decision|1|||
33544222|NCT00960297|62935074|FG000|Overall Study|Venous port infection|1|||
33544223|NCT00960297|62935074|FG000|Overall Study|Disease progression|1|||
33544224|NCT03018691|62935081|FG000|Overall Study|Adverse Event|1|||
33544225|NCT03018691|62935082|FG001|Overall Study|Adverse Event|1|||
33544226|NCT03018691|62935083|FG002|Overall Study|Adverse Event|4|||
33544227|NCT03018691|62935081|FG000|Overall Study|Lack of Efficacy|0|||
33544228|NCT03018691|62935082|FG001|Overall Study|Lack of Efficacy|0|||
33544229|NCT03018691|62935083|FG002|Overall Study|Lack of Efficacy|1|||
33544230|NCT03018691|62935081|FG000|Overall Study|Withdrawal by Subject|0|||
33544231|NCT03018691|62935082|FG001|Overall Study|Withdrawal by Subject|0|||
33544232|NCT03018691|62935083|FG002|Overall Study|Withdrawal by Subject|1|||
33544233|NCT03018691|62935081|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33544234|NCT03018691|62935082|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33544235|NCT03018691|62935083|FG002|Overall Study|Withdrawal by parent/guardian|1|||
33625666|NCT01823835|63026535|FG007|Overall Study|Progressive Disease|3|||
33625667|NCT01823835|63026536|FG008|Overall Study|Progressive Disease|3|||
33625668|NCT01823835|63026537|FG009|Overall Study|Progressive Disease|18|||
33625669|NCT01823835|63026538|FG010|Overall Study|Progressive Disease|8|||
33625670|NCT01823835|63026539|FG011|Overall Study|Progressive Disease|46|||
33625671|NCT01823835|63026540|FG012|Overall Study|Progressive Disease|18|||
33625672|NCT01823835|63026541|FG013|Overall Study|Progressive Disease|4|||
33625673|NCT01823835|63026542|FG014|Overall Study|Progressive Disease|6|||
33625674|NCT01823835|63026528|FG000|Overall Study|Study Termination|0|||
33625675|NCT01823835|63026529|FG001|Overall Study|Study Termination|0|||
33625676|NCT01823835|63026530|FG002|Overall Study|Study Termination|0|||
33625677|NCT01823835|63026531|FG003|Overall Study|Study Termination|0|||
33625678|NCT01823835|63026532|FG004|Overall Study|Study Termination|1|||
33625679|NCT01823835|63026533|FG005|Overall Study|Study Termination|0|||
33625680|NCT01823835|63026534|FG006|Overall Study|Study Termination|0|||
33625681|NCT01823835|63026535|FG007|Overall Study|Study Termination|0|||
33625682|NCT01823835|63026536|FG008|Overall Study|Study Termination|0|||
33625683|NCT01823835|63026537|FG009|Overall Study|Study Termination|0|||
33625684|NCT01823835|63026538|FG010|Overall Study|Study Termination|0|||
33625685|NCT01823835|63026539|FG011|Overall Study|Study Termination|1|||
33625686|NCT01823835|63026540|FG012|Overall Study|Study Termination|0|||
33625687|NCT01823835|63026541|FG013|Overall Study|Study Termination|0|||
33625688|NCT01823835|63026542|FG014|Overall Study|Study Termination|0|||
33625689|NCT01823835|63026528|FG000|Overall Study|Withdrawal by Subject|0|||
33625690|NCT01823835|63026529|FG001|Overall Study|Withdrawal by Subject|0|||
33625691|NCT01823835|63026530|FG002|Overall Study|Withdrawal by Subject|1|||
33625692|NCT01823835|63026531|FG003|Overall Study|Withdrawal by Subject|0|||
33625693|NCT01823835|63026532|FG004|Overall Study|Withdrawal by Subject|0|||
33625694|NCT01823835|63026533|FG005|Overall Study|Withdrawal by Subject|0|||
33625695|NCT01823835|63026534|FG006|Overall Study|Withdrawal by Subject|0|||
33625696|NCT01823835|63026535|FG007|Overall Study|Withdrawal by Subject|0|||
33625697|NCT01823835|63026536|FG008|Overall Study|Withdrawal by Subject|0|||
33625698|NCT01823835|63026537|FG009|Overall Study|Withdrawal by Subject|1|||
33625699|NCT01823835|63026538|FG010|Overall Study|Withdrawal by Subject|1|||
33625700|NCT01823835|63026539|FG011|Overall Study|Withdrawal by Subject|2|||
33625701|NCT01823835|63026540|FG012|Overall Study|Withdrawal by Subject|1|||
33625702|NCT01823835|63026541|FG013|Overall Study|Withdrawal by Subject|0|||
33625703|NCT01823835|63026542|FG014|Overall Study|Withdrawal by Subject|0|||
33625704|NCT02173379|63026584|FG000|Overall Study|Lost to Follow-up|48|||
33625705|NCT02173379|63026585|FG001|Overall Study|Lost to Follow-up|34|||
33625706|NCT02173379|63026584|FG000|Overall Study|Withdrawal by Subject|14|||
33325631|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
33325632|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33325633|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
33325634|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
33325635|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33325636|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33325637|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33325638|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33325639|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33325640|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33325641|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33325642|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33325643|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
33325644|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33625707|NCT02173379|63026585|FG001|Overall Study|Withdrawal by Subject|17|||
33625708|NCT02173379|63026584|FG000|Overall Study|Physician Decision|7|||
33625709|NCT02173379|63026585|FG001|Overall Study|Physician Decision|4|||
33625710|NCT02173379|63026584|FG000|Overall Study|Death|22|||
33625711|NCT02173379|63026585|FG001|Overall Study|Death|22|||
33625712|NCT01823679|63026592|FG000|Overall Study|Death|1|||
33625713|NCT01823289|63026597|FG000|Overall Study|Lost to Follow-up|5|||
33625714|NCT01823289|63026597|FG000|Overall Study|Adverse Event|5|||
33458641|NCT00112437|62832485|FG012|Year 2 (12-Month Extension)|Moved|0|||
33625715|NCT01823289|63026597|FG000|Overall Study|Lack of Efficacy|1|||
33625716|NCT01823289|63026597|FG000|Overall Study|Physician Decision|9|||
33625717|NCT01823289|63026597|FG000|Overall Study|Administered contraindicated medicine|1|||
33325645|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33325646|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33325647|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33530610|NCT02224573|62919930|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
33530611|NCT02224573|62919929|FG000|Treatment Phase|Participant Moved|2|||
33530612|NCT02224573|62919930|FG001|Treatment Phase|Participant Moved|0|||
33530613|NCT02224573|62919929|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
33530614|NCT02224573|62919930|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
33530615|NCT02224573|62919929|FG000|Treatment Phase|Refused Medication|1|||
33530616|NCT02224573|62919930|FG001|Treatment Phase|Refused Medication|1|||
33530617|NCT02224573|62919929|FG000|Treatment Phase|Adverse Event|26|||
33530618|NCT02224573|62919930|FG001|Treatment Phase|Adverse Event|38|||
33530619|NCT02224573|62919929|FG000|Treatment Phase|Placed in Group Home|0|||
33530620|NCT02224573|62919930|FG001|Treatment Phase|Placed in Group Home|1|||
33530621|NCT02224573|62919929|FG000|Treatment Phase|Pursued Other Trials|1|||
33530622|NCT02224573|62919930|FG001|Treatment Phase|Pursued Other Trials|0|||
33530623|NCT02224573|62919929|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
33530624|NCT02224573|62919930|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
33530625|NCT02224573|62919929|FG000|Treatment Phase|Lost to Follow-up|2|||
33530626|NCT02224573|62919930|FG001|Treatment Phase|Lost to Follow-up|1|||
33530627|NCT02224573|62919929|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
33530628|NCT02224573|62919930|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
33530629|NCT02224573|62919929|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
33530630|NCT02224573|62919930|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
33530631|NCT02224573|62919929|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
33530632|NCT02224573|62919930|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
33530633|NCT02224573|62919929|FG000|Taper Phase|Adverse Event|1|||
33530634|NCT02224573|62919930|FG001|Taper Phase|Adverse Event|1|||
33530635|NCT01360840|62919940|FG000|Overall Study|Ongoing at data cut-off|10|||
33530636|NCT01360840|62919941|FG001|Overall Study|Ongoing at data cut-off|10|||
33530637|NCT01360840|62919942|FG002|Overall Study|Ongoing at data cut-off|9|||
33530638|NCT03350984|62919954|FG000|Overall Study|Death|1|||
33530639|NCT03350984|62919955|FG001|Overall Study|Death|0|||
33530640|NCT03350984|62919954|FG000|Overall Study|Lost to Follow-up|5|||
33530641|NCT03350984|62919955|FG001|Overall Study|Lost to Follow-up|6|||
33530642|NCT03350984|62919954|FG000|Overall Study|Protocol Violation|1|||
33530643|NCT03350984|62919955|FG001|Overall Study|Protocol Violation|2|||
33530644|NCT03350984|62919954|FG000|Overall Study|Physician Decision|1|||
33530645|NCT03350984|62919955|FG001|Overall Study|Physician Decision|0|||
33325648|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33325649|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33325650|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33325651|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
33325652|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33325653|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33325654|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33325655|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33530646|NCT05176717|62919973|FG000|Overall Study|Sponsor Decision|1|||
33530647|NCT05176717|62919974|FG001|Overall Study|Sponsor Decision|2|||
33530648|NCT05176717|62919975|FG002|Overall Study|Sponsor Decision|2|||
33530649|NCT02770248|62919985|FG000|Overall Study|Adverse Event|0|||
33530650|NCT02770248|62919986|FG001|Overall Study|Adverse Event|1|||
33530651|NCT02770248|62919985|FG000|Overall Study|Randomized in error, prior to treatment|0|||
33530652|NCT02770248|62919986|FG001|Overall Study|Randomized in error, prior to treatment|1|||
33530653|NCT01344369|62919994|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
33530654|NCT01344369|62919995|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
33530655|NCT01344369|62919994|FG000|Washout of 28 Days|Physician Decision|0|||
33530656|NCT01344369|62919995|FG001|Washout of 28 Days|Physician Decision|1|||
33530657|NCT01344369|62919994|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
33530658|NCT01344369|62919995|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
33530659|NCT03179462|62920004|FG000|Overall Study|screening failure|1|||
33530660|NCT03179462|62920005|FG001|Overall Study|screening failure|2|||
33530661|NCT03179462|62920006|FG002|Overall Study|screening failure|0|||
33530662|NCT01314703|62920014|FG000|Overall Study|screen failure and closed enrollment|8|||
33530663|NCT01360762|62920019|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
33530664|NCT01360762|62920019|FG000|Main Study Period (12-month Treatment)|Death|5|||
33530665|NCT01360762|62920019|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
33325656|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33325657|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33530666|NCT01360762|62920019|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
33530667|NCT01360762|62920019|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
33625718|NCT01823289|63026597|FG000|Overall Study|Transaminase increased more than 3 times|1|||
33530668|NCT01360762|62920019|FG000|Whole Study Period|Lost to Follow-up|10|||
33530669|NCT01360762|62920019|FG000|Whole Study Period|Death|7|||
33530670|NCT01360762|62920019|FG000|Whole Study Period|Patient relapsed|18|||
33530671|NCT01360762|62920019|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
33530672|NCT04382924|62920026|FG000|Overall Study|Death|2|||
33530673|NCT04382924|62920027|FG001|Overall Study|Death|5|||
33530674|NCT04382924|62920028|FG002|Overall Study|Death|4|||
33530675|NCT04382924|62920026|FG000|Overall Study|Protocol Violation|0|||
33530676|NCT04382924|62920027|FG001|Overall Study|Protocol Violation|1|||
33530677|NCT04382924|62920028|FG002|Overall Study|Protocol Violation|1|||
33530678|NCT04382924|62920026|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
33530679|NCT04382924|62920027|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
33530680|NCT04382924|62920028|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
33530681|NCT04382924|62920026|FG000|Overall Study|Withdrawal by Subject|6|||
33530682|NCT04382924|62920027|FG001|Overall Study|Withdrawal by Subject|3|||
33530683|NCT04382924|62920028|FG002|Overall Study|Withdrawal by Subject|6|||
33530684|NCT03044431|62920042|FG000|Overall Study|Lost to Follow-up|59|||
33530685|NCT02770170|62920050|FG000|Overall Study|Withdrawal by Subject|0|||
33530686|NCT02770170|62920051|FG001|Overall Study|Withdrawal by Subject|0|||
33325658|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
33325659|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
33325660|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
33325661|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
33325662|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
33325663|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
33325664|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
33325665|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
33325666|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
33325667|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
33325668|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33325669|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33325670|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
33530687|NCT02770170|62920052|FG002|Overall Study|Withdrawal by Subject|0|||
33530688|NCT02770170|62920053|FG003|Overall Study|Withdrawal by Subject|2|||
33530689|NCT02770170|62920050|FG000|Overall Study|due to pregnancy|1|||
33530690|NCT02770170|62920051|FG001|Overall Study|due to pregnancy|0|||
33530691|NCT02770170|62920052|FG002|Overall Study|due to pregnancy|0|||
33530692|NCT02770170|62920053|FG003|Overall Study|due to pregnancy|0|||
33530693|NCT02770170|62920050|FG000|Overall Study|Lack of Efficacy|2|||
33530694|NCT02770170|62920051|FG001|Overall Study|Lack of Efficacy|0|||
33530695|NCT02770170|62920052|FG002|Overall Study|Lack of Efficacy|0|||
33530696|NCT02770170|62920053|FG003|Overall Study|Lack of Efficacy|1|||
33530697|NCT02770170|62920050|FG000|Overall Study|Adverse Event|4|||
33530698|NCT02770170|62920051|FG001|Overall Study|Adverse Event|3|||
33530699|NCT02770170|62920052|FG002|Overall Study|Adverse Event|5|||
33530700|NCT02770170|62920053|FG003|Overall Study|Adverse Event|3|||
33530701|NCT02770170|62920050|FG000|Overall Study|due to disease worsening|0|||
33530702|NCT02770170|62920051|FG001|Overall Study|due to disease worsening|0|||
33530703|NCT02770170|62920052|FG002|Overall Study|due to disease worsening|0|||
33530704|NCT02770170|62920053|FG003|Overall Study|due to disease worsening|1|||
33530705|NCT02769858|62920063|FG000|Overall Study|Withdrawal by Subject|2|||
33530706|NCT02769624|62920067|FG000|Overall Study|Lost to Follow-up|0|||
33530707|NCT02769624|62920068|FG001|Overall Study|Lost to Follow-up|1|||
33530708|NCT03446768|62920076|FG000|Overall Study|Withdrawal by Subject|0|||
33530709|NCT03446768|62920077|FG001|Overall Study|Withdrawal by Subject|1|||
33530710|NCT02676284|62920083|FG000|Overall Study|Withdrawal by Subject|1|||
33530711|NCT02769312|62920089|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
33530712|NCT02769312|62920090|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
33530713|NCT02769312|62920089|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
33530714|NCT02769312|62920090|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
33530715|NCT02769312|62920089|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
33530716|NCT02769312|62920090|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
33530717|NCT02769312|62920089|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
33530718|NCT02769312|62920090|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
33530719|NCT02769312|62920089|FG000|Follow-up|Lost to Follow-up|1|||
33530720|NCT02769312|62920090|FG001|Follow-up|Lost to Follow-up|1|||
33530721|NCT01673386|62920097|FG000|Overall Study|Study terminated by sponsor|16|||
33530722|NCT01673386|62920098|FG001|Overall Study|Study terminated by sponsor|22|||
33530723|NCT01673386|62920097|FG000|Overall Study|Adverse Event|5|||
33530724|NCT01673386|62920098|FG001|Overall Study|Adverse Event|2|||
33530725|NCT01673386|62920097|FG000|Overall Study|Progressive disease|4|||
33530726|NCT01673386|62920098|FG001|Overall Study|Progressive disease|1|||
33530727|NCT01673386|62920097|FG000|Overall Study|Withdrawal by Subject|0|||
33530728|NCT01673386|62920098|FG001|Overall Study|Withdrawal by Subject|2|||
33530729|NCT00103740|62920106|FG000|Period 1 - Core|Adverse Event|1|||
33530730|NCT00103740|62920107|FG001|Period 1 - Core|Adverse Event|0|||
33530731|NCT00103740|62920106|FG000|Period 1 - Core|Protocol Violation|3|||
33530732|NCT00103740|62920107|FG001|Period 1 - Core|Protocol Violation|2|||
33530733|NCT00103740|62920106|FG000|Period 1 - Core|Patient withdrew consent|3|||
33530734|NCT00103740|62920107|FG001|Period 1 - Core|Patient withdrew consent|2|||
33530735|NCT00103740|62920106|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
33530736|NCT00103740|62920107|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
33530737|NCT00103740|62920106|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
33530738|NCT00103740|62920107|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
33530739|NCT00103740|62920106|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
33530740|NCT00103740|62920107|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
33530741|NCT00103740|62920106|FG000|Period 2 - Extended Observation Period|Death|6|||
33530742|NCT00103740|62920107|FG001|Period 2 - Extended Observation Period|Death|2|||
33530743|NCT00103740|62920106|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
33530744|NCT00103740|62920107|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
33530745|NCT01281644|62920113|FG000|Overall Study|Lost to Follow-up|3|||
33530746|NCT01281644|62920113|FG000|Overall Study|Withdrawal by Subject|2|||
33530747|NCT02869893|62920119|FG000|Overall Study|participant aversion to IV|5|||
33530748|NCT02869893|62920119|FG000|Overall Study|participant fear of MRI scanner|2|||
33530749|NCT02872311|62920152|FG000|Overall Study|Death|2|||
33530750|NCT02872311|62920153|FG001|Overall Study|Death|0|||
33530751|NCT02872311|62920154|FG002|Overall Study|Death|0|||
33530752|NCT02872311|62920155|FG003|Overall Study|Death|0|||
33530753|NCT02872311|62920156|FG004|Overall Study|Death|0|||
33530754|NCT02872311|62920152|FG000|Overall Study|Lost to Follow-up|2|||
33530755|NCT02872311|62920153|FG001|Overall Study|Lost to Follow-up|0|||
33530756|NCT02872311|62920154|FG002|Overall Study|Lost to Follow-up|0|||
33530757|NCT02872311|62920155|FG003|Overall Study|Lost to Follow-up|0|||
33530758|NCT02872311|62920156|FG004|Overall Study|Lost to Follow-up|0|||
33530759|NCT02872311|62920152|FG000|Overall Study|Protocol Violation|0|||
33530760|NCT02872311|62920153|FG001|Overall Study|Protocol Violation|2|||
33530761|NCT02872311|62920154|FG002|Overall Study|Protocol Violation|1|||
33530762|NCT02872311|62920155|FG003|Overall Study|Protocol Violation|0|||
33530763|NCT02872311|62920156|FG004|Overall Study|Protocol Violation|0|||
33530764|NCT02871375|62920184|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
33530765|NCT02871375|62920185|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
33530766|NCT02867709|62920196|FG000|Treatment Period|Adverse Event|1|||
33530767|NCT02867709|62920197|FG001|Treatment Period|Adverse Event|1|||
33530768|NCT02867709|62920198|FG002|Treatment Period|Adverse Event|2|||
33530769|NCT02867709|62920196|FG000|Treatment Period|Withdrawal of Consent|7|||
33530770|NCT02867709|62920197|FG001|Treatment Period|Withdrawal of Consent|9|||
33530771|NCT02867709|62920198|FG002|Treatment Period|Withdrawal of Consent|8|||
33530772|NCT02867709|62920196|FG000|Treatment Period|Lost to Follow-up|17|||
33530773|NCT02867709|62920197|FG001|Treatment Period|Lost to Follow-up|20|||
33530774|NCT02867709|62920198|FG002|Treatment Period|Lost to Follow-up|20|||
33530775|NCT02867709|62920196|FG000|Treatment Period|Lack of Qualifying Event|42|||
33530776|NCT02867709|62920197|FG001|Treatment Period|Lack of Qualifying Event|55|||
33530777|NCT02867709|62920198|FG002|Treatment Period|Lack of Qualifying Event|42|||
33530778|NCT02867709|62920196|FG000|Treatment Period|Protocol Violation|3|||
33530779|NCT02867709|62920197|FG001|Treatment Period|Protocol Violation|2|||
33530780|NCT02867709|62920198|FG002|Treatment Period|Protocol Violation|3|||
33530781|NCT02867709|62920196|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
33530782|NCT02867709|62920197|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
33530783|NCT02867709|62920198|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
33530784|NCT02867709|62920196|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
33530785|NCT02867709|62920197|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
33530786|NCT02867709|62920198|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
33530787|NCT02867709|62920196|FG000|Safety Follow-up Period|Pregnancy|0|||
33625719|NCT01823289|63026597|FG000|Overall Study|Drug affected efficacy and safety|1|||
33625720|NCT01823289|63026597|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
33625721|NCT01822899|63026603|FG000|Overall Study|Adverse Event|6|||
33625722|NCT01822899|63026604|FG001|Overall Study|Adverse Event|5|||
33325671|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33325672|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33325673|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33325674|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33530788|NCT02867709|62920197|FG001|Safety Follow-up Period|Pregnancy|1|||
33530789|NCT02867709|62920198|FG002|Safety Follow-up Period|Pregnancy|0|||
33530790|NCT02867709|62920196|FG000|Safety Follow-up Period|Protocol Violation|0|||
33530791|NCT02867709|62920197|FG001|Safety Follow-up Period|Protocol Violation|1|||
33530792|NCT02867709|62920198|FG002|Safety Follow-up Period|Protocol Violation|1|||
33530793|NCT03044353|62920209|FG000|Overall Study|Adverse Event|0|||
33530794|NCT03044353|62920210|FG001|Overall Study|Adverse Event|1|||
33530795|NCT03044353|62920211|FG002|Overall Study|Adverse Event|0|||
33625723|NCT01822899|63026603|FG000|Overall Study|Lack of Efficacy|6|||
33530796|NCT01361308|62920220|FG000|Overall Study|Withdrawal by Subject|9|||
33530797|NCT01361308|62920221|FG001|Overall Study|Withdrawal by Subject|13|||
33530798|NCT01361308|62920220|FG000|Overall Study|Physician Decision|3|||
33530799|NCT01361308|62920221|FG001|Overall Study|Physician Decision|3|||
33530800|NCT01361308|62920220|FG000|Overall Study|Lack of Efficacy|2|||
33530801|NCT01361308|62920221|FG001|Overall Study|Lack of Efficacy|0|||
33530802|NCT01361308|62920220|FG000|Overall Study|Protocol Violation|1|||
33530803|NCT01361308|62920221|FG001|Overall Study|Protocol Violation|0|||
33530804|NCT01361308|62920220|FG000|Overall Study|Lost to Follow-up|5|||
33530805|NCT01361308|62920221|FG001|Overall Study|Lost to Follow-up|4|||
33530806|NCT01361308|62920220|FG000|Overall Study|Adverse Event|8|||
33530807|NCT01361308|62920221|FG001|Overall Study|Adverse Event|4|||
33530808|NCT01361308|62920220|FG000|Overall Study|Eligibility Criteria Not Met|2|||
33530809|NCT01361308|62920221|FG001|Overall Study|Eligibility Criteria Not Met|3|||
33530810|NCT01361308|62920220|FG000|Overall Study|Failed C-SSRS|5|||
33530811|NCT01361308|62920221|FG001|Overall Study|Failed C-SSRS|2|||
33530812|NCT01361308|62920220|FG000|Overall Study|Other|0|||
33530813|NCT01361308|62920221|FG001|Overall Study|Other|1|||
33530814|NCT02872935|62920233|FG000|Overall Study|Other|0|||
33530815|NCT02872935|62920234|FG001|Overall Study|Other|1|||
33530816|NCT00103662|62920242|FG000|Overall Study|Entered Rescue Procedure|0|||
33325675|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33325676|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33325677|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33325678|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33325679|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
33325680|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33325681|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33325682|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33325683|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33325684|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33325685|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
33325686|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33325687|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33325688|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
33458642|NCT00112437|62832486|FG013|Year 2 (12-Month Extension)|Moved|0|||
33458643|NCT00112437|62832487|FG014|Year 2 (12-Month Extension)|Moved|0|||
33458644|NCT00112437|62832488|FG015|Year 2 (12-Month Extension)|Moved|0|||
33458645|NCT00112437|62832489|FG016|Year 2 (12-Month Extension)|Moved|0|||
33458646|NCT00112437|62832490|FG017|Year 2 (12-Month Extension)|Moved|0|||
33458647|NCT00112437|62832491|FG018|Year 2 (12-Month Extension)|Moved|0|||
33458648|NCT00112437|62832492|FG019|Year 2 (12-Month Extension)|Moved|0|||
33458649|NCT00112437|62832493|FG020|Year 2 (12-Month Extension)|Moved|0|||
33458650|NCT00112437|62832494|FG021|Year 2 (12-Month Extension)|Moved|0|||
33458651|NCT00112437|62832495|FG022|Year 2 (12-Month Extension)|Moved|0|||
33458652|NCT00112437|62832496|FG023|Year 2 (12-Month Extension)|Moved|0|||
33458653|NCT00112437|62832497|FG024|Year 2 (12-Month Extension)|Moved|0|||
33458654|NCT00112437|62832498|FG025|Year 2 (12-Month Extension)|Moved|0|||
33458655|NCT00112437|62832473|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
33458656|NCT00112437|62832474|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
33458657|NCT00112437|62832475|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
33458658|NCT00112437|62832476|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
33458659|NCT00112437|62832477|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
33458660|NCT00112437|62832478|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
33458661|NCT00112437|62832479|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
33458662|NCT00112437|62832480|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
33458663|NCT00112437|62832481|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
33458664|NCT00112437|62832482|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
33458665|NCT00112437|62832483|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
33458666|NCT00112437|62832484|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
33458667|NCT00112437|62832485|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
33458668|NCT00112437|62832486|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
33530817|NCT00103662|62920243|FG001|Overall Study|Entered Rescue Procedure|7|||
33530818|NCT00103662|62920242|FG000|Overall Study|Death|7|||
33530819|NCT00103662|62920243|FG001|Overall Study|Death|7|||
33530820|NCT00103662|62920242|FG000|Overall Study|Elective Withdrawal|5|||
33530821|NCT00103662|62920243|FG001|Overall Study|Elective Withdrawal|5|||
33530822|NCT00103662|62920242|FG000|Overall Study|Lost to Follow-up|0|||
33530823|NCT00103662|62920243|FG001|Overall Study|Lost to Follow-up|1|||
33530824|NCT00103662|62920242|FG000|Overall Study|Other|6|||
33325689|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33325690|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33325691|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33325692|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33325693|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33325694|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33325695|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33530825|NCT00103662|62920243|FG001|Overall Study|Other|9|||
33530826|NCT00103662|62920242|FG000|Overall Study|Failed mobilization|0|||
33530827|NCT00103662|62920243|FG001|Overall Study|Failed mobilization|4|||
33530828|NCT00103662|62920242|FG000|Overall Study|Intercurrent illness|1|||
33530829|NCT00103662|62920243|FG001|Overall Study|Intercurrent illness|0|||
33530830|NCT02865915|62920251|FG000|Overall Study|Pregnancy|1|||
33530831|NCT02865915|62920252|FG001|Overall Study|Pregnancy|0|||
33530832|NCT02865915|62920251|FG000|Overall Study|Withdrawal by Subject|1|||
33530833|NCT02865915|62920252|FG001|Overall Study|Withdrawal by Subject|1|||
33530834|NCT02865915|62920251|FG000|Overall Study|Adverse Event|0|||
33530835|NCT02865915|62920252|FG001|Overall Study|Adverse Event|4|||
33530836|NCT02865915|62920251|FG000|Overall Study|Lost to Follow-up|0|||
33530837|NCT02865915|62920252|FG001|Overall Study|Lost to Follow-up|1|||
33530838|NCT02865915|62920251|FG000|Overall Study|Protocol Violation|0|||
33530839|NCT02865915|62920252|FG001|Overall Study|Protocol Violation|1|||
33530840|NCT02865915|62920251|FG000|Overall Study|Study terminated by sponsor|23|||
33530841|NCT02865915|62920252|FG001|Overall Study|Study terminated by sponsor|18|||
33530842|NCT02865915|62920251|FG000|Overall Study|Dosing group discontinued|0|||
33530843|NCT02865915|62920252|FG001|Overall Study|Dosing group discontinued|5|||
33530844|NCT00104676|62920260|FG000|Overall Study|Death|3|||
33530845|NCT00104676|62920261|FG001|Overall Study|Death|2|||
33530846|NCT00104676|62920260|FG000|Overall Study|Withdrawal by Subject|0|||
33530847|NCT00104676|62920261|FG001|Overall Study|Withdrawal by Subject|2|||
33530848|NCT00104676|62920260|FG000|Overall Study|treatment interruption|4|||
33530849|NCT00104676|62920261|FG001|Overall Study|treatment interruption|10|||
33530850|NCT00354835|62920269|FG000|Overall Study|Death|1|||
33530851|NCT00354835|62920270|FG001|Overall Study|Death|1|||
33530852|NCT00354835|62920269|FG000|Overall Study|Physician Decision|8|||
33530853|NCT00354835|62920270|FG001|Overall Study|Physician Decision|13|||
33530854|NCT00354835|62920269|FG000|Overall Study|Withdrawal by Subject|2|||
33530855|NCT00354835|62920270|FG001|Overall Study|Withdrawal by Subject|1|||
33530856|NCT00354835|62920269|FG000|Overall Study|Ineligible|17|||
33530857|NCT00354835|62920270|FG001|Overall Study|Ineligible|16|||
33530858|NCT00354835|62920269|FG000|Overall Study|Disease progression or relapse|15|||
33530859|NCT00354835|62920270|FG001|Overall Study|Disease progression or relapse|22|||
33530860|NCT00354835|62920269|FG000|Overall Study|Adverse Event|6|||
33530861|NCT00354835|62920270|FG001|Overall Study|Adverse Event|0|||
33530862|NCT00354835|62920269|FG000|Overall Study|Refusal of further therapy|3|||
33530863|NCT00354835|62920270|FG001|Overall Study|Refusal of further therapy|8|||
33530864|NCT02768298|62920293|FG000|Overall Study|Adverse Event|1|||
33530865|NCT02768298|62920294|FG001|Overall Study|Adverse Event|4|||
33530866|NCT02768298|62920293|FG000|Overall Study|Death|2|||
33530867|NCT02768298|62920294|FG001|Overall Study|Death|1|||
33530868|NCT02768298|62920293|FG000|Overall Study|Non-compliance with study treatment|0|||
33530869|NCT02768298|62920294|FG001|Overall Study|Non-compliance with study treatment|1|||
33530870|NCT02768298|62920293|FG000|Overall Study|Subject/guardian decision|1|||
33530871|NCT02768298|62920294|FG001|Overall Study|Subject/guardian decision|0|||
33530872|NCT02768298|62920293|FG000|Overall Study|Withdrawal of informed consent|0|||
33530873|NCT02768298|62920294|FG001|Overall Study|Withdrawal of informed consent|1|||
33530874|NCT02775864|62920304|FG000|Overall Study|Data ended end of 2010|1764|||
33530875|NCT02775864|62920305|FG001|Overall Study|Data ended end of 2010|2880|||
33530876|NCT02775864|62920306|FG002|Overall Study|Data ended end of 2010|1140|||
33530877|NCT02775864|62920307|FG003|Overall Study|Data ended end of 2010|1194|||
33530878|NCT02775864|62920304|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
33530879|NCT02775864|62920305|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
33530880|NCT02775864|62920306|FG002|Overall Study|Medicaid eligibility discontinued|720|||
33530881|NCT02775864|62920307|FG003|Overall Study|Medicaid eligibility discontinued|890|||
33325696|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
33325697|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
33530882|NCT02964273|62920320|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
33530883|NCT02964273|62920321|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
33530884|NCT02964273|62920322|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
33530885|NCT02964273|62920323|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
33530886|NCT02964273|62920320|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
33530887|NCT02964273|62920321|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
33530888|NCT02964273|62920322|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
33530889|NCT02964273|62920323|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
33625724|NCT01822899|63026604|FG001|Overall Study|Lack of Efficacy|3|||
33530890|NCT02964273|62920320|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
33530891|NCT02964273|62920321|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
33530892|NCT02964273|62920322|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
33530893|NCT02964273|62920323|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
33530894|NCT02964273|62920320|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
33530895|NCT02964273|62920321|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
33530896|NCT02964273|62920322|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
33530897|NCT02964273|62920323|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
33530898|NCT02964273|62920320|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
33530899|NCT02964273|62920321|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
33530900|NCT02964273|62920322|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
33530901|NCT02964273|62920323|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
33530902|NCT02964273|62920320|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
33530903|NCT02964273|62920321|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
33530904|NCT02964273|62920322|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
33530905|NCT02964273|62920323|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
33530906|NCT02773446|62920342|FG000|First Admission|Withdrawal by Subject|0|||
33530907|NCT02773446|62920343|FG001|First Admission|Withdrawal by Subject|0|||
33530908|NCT02773446|62920344|FG002|First Admission|Withdrawal by Subject|0|||
33530909|NCT02773446|62920345|FG003|First Admission|Withdrawal by Subject|1|||
33530910|NCT02773446|62920346|FG004|First Admission|Withdrawal by Subject|0|||
33530911|NCT02773446|62920347|FG005|First Admission|Withdrawal by Subject|0|||
33530912|NCT02773446|62920342|FG000|First Admission|Lost to Follow-up|1|||
33530913|NCT02773446|62920343|FG001|First Admission|Lost to Follow-up|0|||
33530914|NCT02773446|62920344|FG002|First Admission|Lost to Follow-up|0|||
33530915|NCT02773446|62920345|FG003|First Admission|Lost to Follow-up|0|||
33530916|NCT02773446|62920346|FG004|First Admission|Lost to Follow-up|0|||
33530917|NCT02773446|62920347|FG005|First Admission|Lost to Follow-up|0|||
33530918|NCT02773368|62920366|FG000|Overall Study|Lost to Follow-up|4|||
33530919|NCT02773368|62920367|FG001|Overall Study|Lost to Follow-up|1|||
33530920|NCT02773368|62920366|FG000|Overall Study|Withdrawal by Subject|5|||
33530921|NCT02773368|62920367|FG001|Overall Study|Withdrawal by Subject|1|||
33530922|NCT02773368|62920366|FG000|Overall Study|Unclassified|1|||
33530923|NCT02773368|62920367|FG001|Overall Study|Unclassified|1|||
33530924|NCT02773368|62920366|FG000|Overall Study|Missing|0|||
33530925|NCT02773368|62920367|FG001|Overall Study|Missing|1|||
33530926|NCT01336647|62920376|FG000|Overall Study|Lost to Follow-up|4|||
33530927|NCT01336647|62920377|FG001|Overall Study|Lost to Follow-up|1|||
33530928|NCT01336647|62920378|FG002|Overall Study|Lost to Follow-up|3|||
33530929|NCT01336569|62920388|FG000|Overall Study|Lost to Follow-up|4|||
33530930|NCT02772978|62920392|FG000|Overall Study|Withdrawal by Subject|1|||
33530931|NCT02772978|62920393|FG001|Overall Study|Withdrawal by Subject|1|||
33530932|NCT00104052|62920398|FG000|Overall Study|Adverse Event|1|||
33530933|NCT00104052|62920398|FG000|Overall Study|Lack of Efficacy|26|||
33530934|NCT00104052|62920398|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
33530935|NCT02777970|62920405|FG000|Overall Study|Lost to Follow-up|0|||
33530936|NCT02777970|62920406|FG001|Overall Study|Lost to Follow-up|1|||
33530937|NCT02777970|62920407|FG002|Overall Study|Lost to Follow-up|0|||
33530938|NCT02777970|62920405|FG000|Overall Study|Protocol Violation|1|||
33530939|NCT02777970|62920406|FG001|Overall Study|Protocol Violation|0|||
33530940|NCT02777970|62920407|FG002|Overall Study|Protocol Violation|0|||
33530941|NCT03037489|62920419|FG000|Overall Study|Adverse Event|4|||
33530942|NCT03037489|62920420|FG001|Overall Study|Adverse Event|0|||
33530943|NCT03037489|62920419|FG000|Overall Study|Withdrawal by Subject|3|||
33530944|NCT03037489|62920420|FG001|Overall Study|Withdrawal by Subject|0|||
33530945|NCT01336023|62920429|FG000|Week 0 to Week 26|Adverse Event|8|||
33530946|NCT01336023|62920430|FG001|Week 0 to Week 26|Adverse Event|10|||
33530947|NCT01336023|62920431|FG002|Week 0 to Week 26|Adverse Event|24|||
33530948|NCT01336023|62920429|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
33530949|NCT01336023|62920430|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
33530950|NCT01336023|62920431|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
33530951|NCT01336023|62920429|FG000|Week 0 to Week 26|Protocol Violation|1|||
33530952|NCT01336023|62920430|FG001|Week 0 to Week 26|Protocol Violation|2|||
33530953|NCT01336023|62920431|FG002|Week 0 to Week 26|Protocol Violation|0|||
33530954|NCT01336023|62920429|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
33530955|NCT01336023|62920430|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
33530956|NCT01336023|62920431|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
33530957|NCT01336023|62920429|FG000|Week 0 to Week 26|Unclassified|5|||
33530958|NCT01336023|62920430|FG001|Week 0 to Week 26|Unclassified|16|||
33530959|NCT01336023|62920431|FG002|Week 0 to Week 26|Unclassified|9|||
33530960|NCT01336023|62920429|FG000|Week 27 to 52|Adverse Event|1|||
33530961|NCT01336023|62920430|FG001|Week 27 to 52|Adverse Event|5|||
33530962|NCT01336023|62920431|FG002|Week 27 to 52|Adverse Event|2|||
33530963|NCT01336023|62920429|FG000|Week 27 to 52|Protocol Violation|0|||
33530964|NCT01336023|62920430|FG001|Week 27 to 52|Protocol Violation|2|||
33530965|NCT01336023|62920431|FG002|Week 27 to 52|Protocol Violation|1|||
33530966|NCT01336023|62920429|FG000|Week 27 to 52|Withdrawal Criteria|14|||
33530967|NCT01336023|62920430|FG001|Week 27 to 52|Withdrawal Criteria|19|||
33530968|NCT01336023|62920431|FG002|Week 27 to 52|Withdrawal Criteria|16|||
33530969|NCT01336023|62920429|FG000|Week 27 to 52|Unclassified|13|||
33530970|NCT01336023|62920430|FG001|Week 27 to 52|Unclassified|18|||
33530971|NCT01336023|62920431|FG002|Week 27 to 52|Unclassified|9|||
33530972|NCT03039283|62920439|FG000|Overall Study|Protocol Violation|2|||
33530973|NCT02863575|62920461|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
33530974|NCT02863575|62920462|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
33530975|NCT02863575|62920463|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
33530976|NCT02863575|62920461|FG000|Overall Study|Withdrawal by Subject|0|||
33530977|NCT02863575|62920462|FG001|Overall Study|Withdrawal by Subject|1|||
33530978|NCT02863575|62920463|FG002|Overall Study|Withdrawal by Subject|1|||
33530979|NCT02863575|62920461|FG000|Overall Study|Adverse Event|0|||
33530980|NCT02863575|62920462|FG001|Overall Study|Adverse Event|1|||
33530981|NCT02863575|62920463|FG002|Overall Study|Adverse Event|0|||
33530982|NCT01227187|62920475|FG000|Overall Study|Physician Decision|0|||
33530983|NCT01227187|62920476|FG001|Overall Study|Physician Decision|0|||
33530984|NCT01227187|62920477|FG002|Overall Study|Physician Decision|0|||
33530985|NCT01227187|62920478|FG003|Overall Study|Physician Decision|1|||
33530986|NCT02638012|62920499|FG000|Overall Study|Lost to Follow-up|1|||
33530987|NCT00103506|62920505|FG000|Overall Study|Study closed by sponsor|34|||
33530988|NCT00103506|62920506|FG001|Overall Study|Study closed by sponsor|37|||
33530989|NCT00103506|62920505|FG000|Overall Study|Death|257|||
33530990|NCT00103506|62920506|FG001|Overall Study|Death|253|||
33530991|NCT00103506|62920505|FG000|Overall Study|Lost to Follow-up|13|||
33530992|NCT00103506|62920506|FG001|Overall Study|Lost to Follow-up|13|||
33530993|NCT00103506|62920505|FG000|Overall Study|Withdrawal by Subject|18|||
33530994|NCT00103506|62920506|FG001|Overall Study|Withdrawal by Subject|21|||
33530995|NCT02765490|62920514|FG000|Overall Study|Lost to Follow-up|1|||
33530996|NCT02765490|62920515|FG001|Overall Study|Lost to Follow-up|1|||
33530997|NCT02765490|62920514|FG000|Overall Study|Other|0|||
33530998|NCT02765490|62920515|FG001|Overall Study|Other|1|||
33530999|NCT02765490|62920514|FG000|Overall Study|Death|0|||
33531000|NCT02765490|62920515|FG001|Overall Study|Death|1|||
33531001|NCT02762370|62920523|FG000|Overall Study|Protocol Violation|1|||
33531002|NCT02762370|62920524|FG001|Overall Study|Protocol Violation|0|||
33531003|NCT02639182|62920534|FG000|Overall Study|Disease Progression|50|||
33531004|NCT02639182|62920535|FG001|Overall Study|Disease Progression|49|||
33531005|NCT02639182|62920534|FG000|Overall Study|Adverse Event|7|||
33531006|NCT02639182|62920535|FG001|Overall Study|Adverse Event|5|||
33531007|NCT02639182|62920534|FG000|Overall Study|Physician Decision|3|||
33531008|NCT02639182|62920535|FG001|Overall Study|Physician Decision|3|||
33531009|NCT02639182|62920534|FG000|Overall Study|Withdrew Consent|5|||
33531010|NCT02639182|62920535|FG001|Overall Study|Withdrew Consent|4|||
33531011|NCT02639182|62920534|FG000|Overall Study|Lost to Follow-up|0|||
33531012|NCT02639182|62920535|FG001|Overall Study|Lost to Follow-up|1|||
33531013|NCT02639182|62920534|FG000|Overall Study|Study Closure|1|||
33531014|NCT02639182|62920535|FG001|Overall Study|Study Closure|2|||
33531015|NCT02639182|62920534|FG000|Overall Study|Sponsor Ended Study|0|||
33531016|NCT02639182|62920535|FG001|Overall Study|Sponsor Ended Study|1|||
33531017|NCT02639182|62920534|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
33531018|NCT02639182|62920535|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
33531019|NCT02863419|62920544|FG000|Overall Study|Lost to Follow-up|0|||
33531020|NCT02863419|62920545|FG001|Overall Study|Lost to Follow-up|1|||
33531021|NCT02863419|62920546|FG002|Overall Study|Lost to Follow-up|4|||
33531022|NCT02863419|62920544|FG000|Overall Study|Withdrawal by Subject|5|||
33531023|NCT02863419|62920545|FG001|Overall Study|Withdrawal by Subject|5|||
33531024|NCT02863419|62920546|FG002|Overall Study|Withdrawal by Subject|3|||
33531025|NCT02863419|62920544|FG000|Overall Study|Died|3|||
33531026|NCT02863419|62920545|FG001|Overall Study|Died|4|||
33531027|NCT02863419|62920546|FG002|Overall Study|Died|1|||
33531028|NCT02765100|62920556|FG000|Overall Study|subject found ineligible after baseline|1|||
33531029|NCT02765100|62920557|FG001|Overall Study|subject found ineligible after baseline|1|||
33531030|NCT02765100|62920556|FG000|Overall Study|Lost to Follow-up|0|||
33531031|NCT02765100|62920557|FG001|Overall Study|Lost to Follow-up|1|||
33531032|NCT02761980|62920567|FG000|Overall Study|Adverse Event|4|||
33531033|NCT02761980|62920568|FG001|Overall Study|Adverse Event|6|||
33531034|NCT02761980|62920569|FG002|Overall Study|Adverse Event|5|||
33531035|NCT02761980|62920570|FG003|Overall Study|Adverse Event|6|||
33531036|NCT02761980|62920567|FG000|Overall Study|Withdrawal by Subject|0|||
33625725|NCT01822899|63026603|FG000|Overall Study|Protocol Violation|6|||
33531037|NCT02761980|62920568|FG001|Overall Study|Withdrawal by Subject|1|||
33531038|NCT02761980|62920569|FG002|Overall Study|Withdrawal by Subject|0|||
33531039|NCT02761980|62920570|FG003|Overall Study|Withdrawal by Subject|0|||
33625726|NCT01822899|63026604|FG001|Overall Study|Protocol Violation|3|||
33531040|NCT02761980|62920567|FG000|Overall Study|Other|0|||
33531041|NCT02761980|62920568|FG001|Overall Study|Other|0|||
33531042|NCT02761980|62920569|FG002|Overall Study|Other|1|||
33531043|NCT02761980|62920570|FG003|Overall Study|Other|0|||
33531044|NCT02862171|62920589|FG000|Overall Study|Death|1|||
33531045|NCT02862171|62920589|FG000|Overall Study|Lost to Follow-up|13|||
33625727|NCT01822899|63026603|FG000|Overall Study|Lost to Follow-up|1|||
33325698|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33531046|NCT02862171|62920589|FG000|Overall Study|Withdrawal by Subject|57|||
33531047|NCT02862171|62920589|FG000|Overall Study|Non-compliance|4|||
33531048|NCT02862171|62920589|FG000|Overall Study|HIV-1 seroconversion|18|||
33531049|NCT02638948|62920597|FG000|Overall Study|Withdrawal by Subject|4|||
33531050|NCT02638948|62920598|FG001|Overall Study|Withdrawal by Subject|5|||
33531051|NCT02638948|62920599|FG002|Overall Study|Withdrawal by Subject|3|||
33531052|NCT02638948|62920600|FG003|Overall Study|Withdrawal by Subject|1|||
33531053|NCT02638948|62920597|FG000|Overall Study|Administrative Reason by Sponsor|0|||
33531054|NCT02638948|62920598|FG001|Overall Study|Administrative Reason by Sponsor|1|||
33531055|NCT02638948|62920599|FG002|Overall Study|Administrative Reason by Sponsor|0|||
33531056|NCT02638948|62920600|FG003|Overall Study|Administrative Reason by Sponsor|4|||
33531057|NCT02638948|62920597|FG000|Overall Study|Adverse Event|0|||
33531058|NCT02638948|62920598|FG001|Overall Study|Adverse Event|0|||
33531059|NCT02638948|62920599|FG002|Overall Study|Adverse Event|1|||
33531060|NCT02638948|62920600|FG003|Overall Study|Adverse Event|1|||
33531061|NCT02638948|62920597|FG000|Overall Study|Lack of Efficacy|1|||
33531062|NCT02638948|62920598|FG001|Overall Study|Lack of Efficacy|1|||
33531063|NCT02638948|62920599|FG002|Overall Study|Lack of Efficacy|0|||
33531064|NCT02638948|62920600|FG003|Overall Study|Lack of Efficacy|0|||
33531065|NCT02638948|62920597|FG000|Overall Study|Lost to Follow-up|0|||
33531066|NCT02638948|62920598|FG001|Overall Study|Lost to Follow-up|0|||
33531067|NCT02638948|62920599|FG002|Overall Study|Lost to Follow-up|1|||
33531068|NCT02638948|62920600|FG003|Overall Study|Lost to Follow-up|1|||
33531069|NCT02638948|62920597|FG000|Overall Study|Poor/Non-Compliance|0|||
33531070|NCT02638948|62920598|FG001|Overall Study|Poor/Non-Compliance|2|||
33531071|NCT02638948|62920599|FG002|Overall Study|Poor/Non-Compliance|1|||
33531072|NCT02638948|62920600|FG003|Overall Study|Poor/Non-Compliance|0|||
33531073|NCT02638948|62920597|FG000|Overall Study|Participant no longer met study criteria|0|||
33531074|NCT02638948|62920598|FG001|Overall Study|Participant no longer met study criteria|1|||
33531075|NCT02638948|62920599|FG002|Overall Study|Participant no longer met study criteria|0|||
33531076|NCT02638948|62920600|FG003|Overall Study|Participant no longer met study criteria|0|||
33531077|NCT02638948|62920597|FG000|Overall Study|Other than specified above|4|||
33531078|NCT02638948|62920598|FG001|Overall Study|Other than specified above|1|||
33531079|NCT02638948|62920599|FG002|Overall Study|Other than specified above|1|||
33531080|NCT02638948|62920600|FG003|Overall Study|Other than specified above|1|||
33531081|NCT00102960|62920616|FG000|Overall Study|Death|23|||
33531082|NCT00102960|62920617|FG001|Overall Study|Death|11|||
33531083|NCT00102960|62920618|FG002|Overall Study|Death|11|||
33531084|NCT00102960|62920616|FG000|Overall Study|Lost to Follow-up|6|||
33531085|NCT00102960|62920617|FG001|Overall Study|Lost to Follow-up|12|||
33531086|NCT00102960|62920618|FG002|Overall Study|Lost to Follow-up|16|||
33531087|NCT00102960|62920616|FG000|Overall Study|Withdrawal by Subject|1|||
33531088|NCT00102960|62920617|FG001|Overall Study|Withdrawal by Subject|0|||
33531089|NCT00102960|62920618|FG002|Overall Study|Withdrawal by Subject|1|||
33531090|NCT02858895|62920630|FG000|Overall Study|Disease progression|31|||
33531091|NCT02858895|62920630|FG000|Overall Study|Death|2|||
33531092|NCT02858895|62920630|FG000|Overall Study|Adverse Event|1|||
33531093|NCT02858895|62920630|FG000|Overall Study|Withdrawal by Subject|3|||
33531094|NCT02858895|62920630|FG000|Overall Study|hospice,|1|||
33531095|NCT02858895|62920630|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
33531096|NCT02637856|62920641|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
33531097|NCT02637856|62920642|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
33531098|NCT02637856|62920641|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
33531099|NCT02637856|62920642|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
33531100|NCT02637856|62920641|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
33531101|NCT02637856|62920642|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
33325699|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33325700|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33531102|NCT02637856|62920641|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
33531103|NCT02637856|62920642|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
33531104|NCT02637856|62920641|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
33531105|NCT02637856|62920642|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
33531106|NCT02637856|62920641|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
33531107|NCT02637856|62920642|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
33531108|NCT02637856|62920641|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
33531109|NCT02637856|62920642|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
33531110|NCT02637856|62920641|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
33531111|NCT02637856|62920642|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
33531112|NCT02637856|62920641|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
33531113|NCT02637856|62920642|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
33531114|NCT02637856|62920641|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
33531115|NCT02637856|62920642|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
33531116|NCT02637856|62920641|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
33531117|NCT02637856|62920642|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
33531118|NCT02637856|62920641|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
33531119|NCT02637856|62920642|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
33531120|NCT02637856|62920641|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
33531121|NCT02637856|62920642|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
33531122|NCT02858037|62920648|FG000|Overall Study|Death|1|||
33531123|NCT02858037|62920648|FG000|Overall Study|Withdrawal by Subject|18|||
33531124|NCT02858037|62920648|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
33531125|NCT02858037|62920648|FG000|Overall Study|Lost to Follow-up|3|||
33531126|NCT02858037|62920648|FG000|Overall Study|Other|4|||
33531127|NCT02856555|62920655|FG000|Overall Study|Adverse Event|1|||
33531128|NCT02856555|62920656|FG001|Overall Study|Adverse Event|0|||
33531129|NCT02856555|62920657|FG002|Overall Study|Adverse Event|0|||
33531130|NCT02856555|62920655|FG000|Overall Study|Lost to Follow-up|1|||
33531131|NCT02856555|62920656|FG001|Overall Study|Lost to Follow-up|3|||
33531132|NCT02856555|62920657|FG002|Overall Study|Lost to Follow-up|0|||
33531133|NCT02856555|62920655|FG000|Overall Study|Withdrawal by Subject|3|||
33531134|NCT02856555|62920656|FG001|Overall Study|Withdrawal by Subject|0|||
33531135|NCT02856555|62920657|FG002|Overall Study|Withdrawal by Subject|0|||
33531136|NCT02856555|62920655|FG000|Overall Study|Randomized but Never Treated|0|||
33531137|NCT02856555|62920656|FG001|Overall Study|Randomized but Never Treated|1|||
33531138|NCT02856555|62920657|FG002|Overall Study|Randomized but Never Treated|0|||
33531139|NCT02637232|62920695|FG000|Overall Study|Lost to Follow-up|42|||
33531140|NCT02637232|62920695|FG000|Overall Study|Adverse Event|11|||
33531141|NCT02637232|62920695|FG000|Overall Study|patient 's decision|2|||
33531142|NCT02855541|62920699|FG000|Overall Study|Change in health status|2|||
33625728|NCT01822899|63026604|FG001|Overall Study|Lost to Follow-up|0|||
33625729|NCT01822899|63026603|FG000|Overall Study|Withdrawal by Subject|5|||
33625730|NCT01822899|63026604|FG001|Overall Study|Withdrawal by Subject|7|||
33625731|NCT01822821|63026612|FG000|Overall Study|Eligible surgery cancelled|1|||
33625732|NCT01822821|63026613|FG001|Overall Study|Eligible surgery cancelled|1|||
33625733|NCT01822821|63026612|FG000|Overall Study|Other reasons|1|||
33625734|NCT01822821|63026613|FG001|Overall Study|Other reasons|0|||
33625735|NCT01822665|63026619|FG000|Overall Study|Adverse Event|3|||
33625736|NCT01822665|63026619|FG000|Overall Study|Other Reason|5|||
33531143|NCT02855541|62920699|FG000|Overall Study|Withdrawal by Subject|2|||
33531144|NCT02635984|62920705|FG000|Overall Study|Lost to Follow-up|2|||
33531145|NCT02635984|62920706|FG001|Overall Study|Lost to Follow-up|4|||
33531146|NCT02635984|62920705|FG000|Overall Study|Study Arm Closed|1|||
33531147|NCT02635984|62920706|FG001|Overall Study|Study Arm Closed|0|||
33531148|NCT01147653|62920714|FG000|Year 2|Withdrawal by Subject|2|||
33531149|NCT01147653|62920715|FG001|Year 2|Withdrawal by Subject|3|||
33531150|NCT02747043|62920736|FG000|Overall Study|Other|1|||
33531151|NCT02747043|62920737|FG001|Overall Study|Other|1|||
33531152|NCT02747043|62920736|FG000|Overall Study|Adverse Event|3|||
33531153|NCT02747043|62920737|FG001|Overall Study|Adverse Event|1|||
33531154|NCT02747043|62920736|FG000|Overall Study|Withdrawal by Subject|1|||
33531155|NCT02747043|62920737|FG001|Overall Study|Withdrawal by Subject|1|||
33531156|NCT02747043|62920736|FG000|Overall Study|Physician Decision|1|||
33531157|NCT02747043|62920737|FG001|Overall Study|Physician Decision|1|||
33531158|NCT02747043|62920736|FG000|Overall Study|Protocol Violation|0|||
33531159|NCT02747043|62920737|FG001|Overall Study|Protocol Violation|1|||
33531160|NCT02747043|62920736|FG000|Overall Study|Disease progression|4|||
33531161|NCT02747043|62920737|FG001|Overall Study|Disease progression|0|||
33531162|NCT02637076|62920745|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
33531163|NCT02637076|62920746|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
33625737|NCT02173301|63026641|FG000|Overall Study|Adverse Event|7|||
33625738|NCT02173301|63026642|FG001|Overall Study|Adverse Event|8|||
33625739|NCT02173301|63026643|FG002|Overall Study|Adverse Event|13|||
33531164|NCT02637076|62920745|FG000|Overall Study|Withdrawal by Subject|0|||
33625740|NCT02173301|63026644|FG003|Overall Study|Adverse Event|5|||
33531165|NCT02637076|62920746|FG001|Overall Study|Withdrawal by Subject|4|||
33531166|NCT02854605|62920755|FG000|Overall Study|Adverse Event|1|||
33531167|NCT02854605|62920756|FG001|Overall Study|Adverse Event|5|||
33531168|NCT02854605|62920757|FG002|Overall Study|Adverse Event|2|||
33531169|NCT02854605|62920755|FG000|Overall Study|Lost to Follow-up|0|||
33531170|NCT02854605|62920756|FG001|Overall Study|Lost to Follow-up|2|||
33531171|NCT02854605|62920757|FG002|Overall Study|Lost to Follow-up|0|||
33531172|NCT02854605|62920755|FG000|Overall Study|Withdrew Consent|1|||
33458669|NCT00112437|62832487|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
33458670|NCT00112437|62832488|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
33458671|NCT00112437|62832489|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
33458672|NCT00112437|62832490|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
33458673|NCT00112437|62832491|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
33458674|NCT00112437|62832492|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
33458675|NCT00112437|62832493|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
33458676|NCT00112437|62832494|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
33458677|NCT00112437|62832495|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
33458678|NCT00112437|62832496|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
33458679|NCT00112437|62832497|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
33458680|NCT00112437|62832498|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
33625741|NCT02173301|63026641|FG000|Overall Study|Withdrawal by Subject|8|||
33625742|NCT02173301|63026642|FG001|Overall Study|Withdrawal by Subject|10|||
33625743|NCT02173301|63026643|FG002|Overall Study|Withdrawal by Subject|4|||
33625744|NCT02173301|63026644|FG003|Overall Study|Withdrawal by Subject|8|||
33625745|NCT02173301|63026641|FG000|Overall Study|Lost to Follow-up|4|||
33625746|NCT02173301|63026642|FG001|Overall Study|Lost to Follow-up|4|||
33625747|NCT02173301|63026643|FG002|Overall Study|Lost to Follow-up|2|||
33625748|NCT02173301|63026644|FG003|Overall Study|Lost to Follow-up|2|||
33625749|NCT02173301|63026641|FG000|Overall Study|Protocol Violation|0|||
33625750|NCT02173301|63026642|FG001|Overall Study|Protocol Violation|1|||
33625751|NCT02173301|63026643|FG002|Overall Study|Protocol Violation|0|||
33625752|NCT02173301|63026644|FG003|Overall Study|Protocol Violation|0|||
33625753|NCT02173301|63026641|FG000|Overall Study|Physician Decision|0|||
33625754|NCT02173301|63026642|FG001|Overall Study|Physician Decision|0|||
33625755|NCT02173301|63026643|FG002|Overall Study|Physician Decision|1|||
33625756|NCT02173301|63026644|FG003|Overall Study|Physician Decision|0|||
33625757|NCT02173301|63026641|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
33625758|NCT02173301|63026642|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
33625759|NCT02173301|63026643|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
33625760|NCT02173301|63026644|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
33625761|NCT01822587|63026657|FG000|Overall Study|Lost to Follow-up|7|||
33625762|NCT01822587|63026658|FG001|Overall Study|Lost to Follow-up|9|||
33625763|NCT01822587|63026659|FG002|Overall Study|Lost to Follow-up|12|||
33625764|NCT01822587|63026657|FG000|Overall Study|Physician Decision|9|||
33625765|NCT01822587|63026658|FG001|Overall Study|Physician Decision|6|||
33625766|NCT01822587|63026659|FG002|Overall Study|Physician Decision|6|||
33625767|NCT01822353|63026670|FG000|Overall Study|Adverse Event|1|||
33625768|NCT01822353|63026671|FG001|Overall Study|Adverse Event|3|||
33625769|NCT01822353|63026672|FG002|Overall Study|Adverse Event|1|||
33625770|NCT01822353|63026670|FG000|Overall Study|Pregnancy|0|||
33625771|NCT01822353|63026671|FG001|Overall Study|Pregnancy|1|||
33625772|NCT01822353|63026672|FG002|Overall Study|Pregnancy|0|||
33625773|NCT01822353|63026670|FG000|Overall Study|Withdrawal by Subject|3|||
33625774|NCT01822353|63026671|FG001|Overall Study|Withdrawal by Subject|1|||
33625775|NCT01822353|63026672|FG002|Overall Study|Withdrawal by Subject|0|||
33625776|NCT01821963|63026683|FG000|Overall Study|Adverse Event|1|||
33625777|NCT01821807|63026689|FG000|Overall Study|Lost to Follow-up|3|||
33625778|NCT01821807|63026690|FG001|Overall Study|Lost to Follow-up|1|||
33625779|NCT01821729|63026696|FG000|Overall Study|Withdrawal by Subject|1|||
33625780|NCT01820637|63026700|FG000|Overall Study|Death|2|||
33625781|NCT01820637|63026700|FG000|Overall Study|Withdrawal by Subject|1|||
33625782|NCT02172911|63026706|FG000|Overall Study|Serious Adverse Event|0|||
33625783|NCT02172911|63026707|FG001|Overall Study|Serious Adverse Event|1|||
33625784|NCT02172911|63026706|FG000|Overall Study|Progression of Disease|0|||
33625785|NCT02172911|63026707|FG001|Overall Study|Progression of Disease|1|||
33625786|NCT02172911|63026706|FG000|Overall Study|Loss of insurance coverage|1|||
33625787|NCT02172911|63026707|FG001|Overall Study|Loss of insurance coverage|0|||
33625788|NCT02120027|63026715|FG000|Overall Study|Adverse Event|4|||
33458681|NCT00112437|62832473|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458682|NCT00112437|62832474|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458683|NCT00112437|62832475|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33625789|NCT02120027|63026716|FG001|Overall Study|Adverse Event|5|||
33458684|NCT00112437|62832476|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458685|NCT00112437|62832477|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458686|NCT00112437|62832478|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458687|NCT00112437|62832479|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458688|NCT00112437|62832480|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458689|NCT00112437|62832481|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33625790|NCT02120027|63026715|FG000|Overall Study|Lack of Efficacy|3|||
33625791|NCT02120027|63026716|FG001|Overall Study|Lack of Efficacy|5|||
33625792|NCT02120027|63026715|FG000|Overall Study|Lost to Follow-up|5|||
33625793|NCT02120027|63026716|FG001|Overall Study|Lost to Follow-up|13|||
33625794|NCT02120027|63026715|FG000|Overall Study|Other|4|||
33625795|NCT02120027|63026716|FG001|Overall Study|Other|0|||
33625796|NCT02120027|63026715|FG000|Overall Study|Physician Decision|4|||
33458690|NCT00112437|62832482|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458691|NCT00112437|62832483|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33625797|NCT02120027|63026716|FG001|Overall Study|Physician Decision|3|||
33625798|NCT02120027|63026715|FG000|Overall Study|Protocol Violation|18|||
33625799|NCT02120027|63026716|FG001|Overall Study|Protocol Violation|21|||
33625800|NCT02120027|63026715|FG000|Overall Study|Study terminated by Sponsor|45|||
33625801|NCT02120027|63026716|FG001|Overall Study|Study terminated by Sponsor|47|||
33325701|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33325702|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
33458692|NCT00112437|62832484|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
33458693|NCT00112437|62832485|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458694|NCT00112437|62832486|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
33458695|NCT00112437|62832487|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458696|NCT00112437|62832488|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
33458697|NCT00112437|62832489|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458698|NCT00112437|62832490|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458699|NCT00112437|62832491|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
33458700|NCT00112437|62832492|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458701|NCT00112437|62832493|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458702|NCT00112437|62832494|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458703|NCT00112437|62832495|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458704|NCT00112437|62832496|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458705|NCT00112437|62832497|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458706|NCT00112437|62832498|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33458707|NCT00112437|62832473|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458708|NCT00112437|62832474|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458709|NCT00112437|62832475|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458710|NCT00112437|62832476|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458711|NCT00112437|62832477|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458712|NCT00112437|62832478|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458713|NCT00112437|62832479|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458714|NCT00112437|62832480|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458715|NCT00112437|62832481|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458716|NCT00112437|62832482|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458717|NCT00112437|62832483|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458718|NCT00112437|62832484|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458719|NCT00112437|62832485|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458720|NCT00112437|62832486|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458721|NCT00112437|62832487|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458722|NCT00112437|62832488|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
33458723|NCT00112437|62832489|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458724|NCT00112437|62832490|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458725|NCT00112437|62832491|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458726|NCT00112437|62832492|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458727|NCT00112437|62832493|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458728|NCT00112437|62832494|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458729|NCT00112437|62832495|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458730|NCT00112437|62832496|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458731|NCT00112437|62832497|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33458732|NCT00112437|62832498|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33625802|NCT02120027|63026715|FG000|Overall Study|Withdrawal by Subject|33|||
33625803|NCT02120027|63026716|FG001|Overall Study|Withdrawal by Subject|25|||
33625804|NCT01850823|63026725|FG000|Overall Study|Early Visit Window|0|||
33625805|NCT01850823|63026726|FG001|Overall Study|Early Visit Window|1|||
33625806|NCT01850823|63026727|FG002|Overall Study|Early Visit Window|4|||
33625807|NCT01850823|63026725|FG000|Overall Study|Enrolled in Error|0|||
33625808|NCT01850823|63026726|FG001|Overall Study|Enrolled in Error|1|||
33625809|NCT01850823|63026727|FG002|Overall Study|Enrolled in Error|2|||
33625810|NCT01850823|63026725|FG000|Overall Study|Lack of Efficacy|1|||
33625811|NCT01850823|63026726|FG001|Overall Study|Lack of Efficacy|0|||
33625812|NCT01850823|63026727|FG002|Overall Study|Lack of Efficacy|0|||
33625813|NCT01850823|63026725|FG000|Overall Study|Lost to Follow-up|0|||
33625814|NCT01850823|63026726|FG001|Overall Study|Lost to Follow-up|0|||
33625815|NCT01850823|63026727|FG002|Overall Study|Lost to Follow-up|1|||
33325703|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33325704|NCT01212770|62702211|FG000|Long-term Safety Phase (Year 5)|Death|0|||
33458733|NCT00112437|62832473|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458734|NCT00112437|62832474|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
33625816|NCT01850823|63026725|FG000|Overall Study|Restricted Medication|0|||
33625817|NCT01850823|63026726|FG001|Overall Study|Restricted Medication|0|||
33458735|NCT00112437|62832475|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458736|NCT00112437|62832476|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458737|NCT00112437|62832477|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458738|NCT00112437|62832478|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458739|NCT00112437|62832479|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458740|NCT00112437|62832480|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458741|NCT00112437|62832481|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458742|NCT00112437|62832482|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458743|NCT00112437|62832483|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458744|NCT00112437|62832484|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458745|NCT00112437|62832485|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458746|NCT00112437|62832486|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458747|NCT00112437|62832487|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458748|NCT00112437|62832488|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
33458749|NCT00112437|62832489|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458750|NCT00112437|62832490|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458751|NCT00112437|62832491|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458752|NCT00112437|62832492|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458753|NCT00112437|62832493|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458754|NCT00112437|62832494|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458755|NCT00112437|62832495|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458756|NCT00112437|62832496|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458757|NCT00112437|62832497|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458758|NCT00112437|62832498|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
33458759|NCT00112437|62832473|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458760|NCT00112437|62832474|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458761|NCT00112437|62832475|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458762|NCT00112437|62832476|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458763|NCT00112437|62832477|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458764|NCT00112437|62832478|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458765|NCT00112437|62832479|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458766|NCT00112437|62832480|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458767|NCT00112437|62832481|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458768|NCT00112437|62832482|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458769|NCT00112437|62832483|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458770|NCT00112437|62832484|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
33458771|NCT00112437|62832485|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458772|NCT00112437|62832486|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458773|NCT00112437|62832487|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
33458774|NCT00112437|62832488|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458775|NCT00112437|62832489|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458776|NCT00112437|62832490|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458777|NCT00112437|62832491|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458778|NCT00112437|62832492|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458779|NCT00112437|62832493|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458780|NCT00112437|62832494|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33625818|NCT01850823|63026727|FG002|Overall Study|Restricted Medication|2|||
33625819|NCT01850823|63026725|FG000|Overall Study|Significant worstening of SAR|0|||
33458781|NCT00112437|62832495|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458782|NCT00112437|62832496|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458783|NCT00112437|62832497|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458784|NCT00112437|62832498|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33458785|NCT00112437|62832473|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458786|NCT00112437|62832474|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458787|NCT00112437|62832475|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458788|NCT00112437|62832476|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458789|NCT00112437|62832477|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458790|NCT00112437|62832478|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458791|NCT00112437|62832479|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458792|NCT00112437|62832480|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458793|NCT00112437|62832481|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458794|NCT00112437|62832482|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458795|NCT00112437|62832483|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
33458796|NCT00112437|62832484|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
33458797|NCT00112437|62832485|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458798|NCT00112437|62832486|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458799|NCT00112437|62832487|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458800|NCT00112437|62832488|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458801|NCT00112437|62832489|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458802|NCT00112437|62832490|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458803|NCT00112437|62832491|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458804|NCT00112437|62832492|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458805|NCT00112437|62832493|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458806|NCT00112437|62832494|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458807|NCT00112437|62832495|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458808|NCT00112437|62832496|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458809|NCT00112437|62832497|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458810|NCT00112437|62832498|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33458811|NCT00112437|62832473|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458812|NCT00112437|62832474|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458813|NCT00112437|62832475|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458814|NCT00112437|62832476|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458815|NCT00112437|62832477|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458816|NCT00112437|62832478|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458817|NCT00112437|62832479|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458818|NCT00112437|62832480|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458819|NCT00112437|62832481|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458820|NCT00112437|62832482|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33531173|NCT02854605|62920756|FG001|Overall Study|Withdrew Consent|0|||
33531174|NCT02854605|62920757|FG002|Overall Study|Withdrew Consent|1|||
33531175|NCT02854605|62920755|FG000|Overall Study|Investigator's Discretion|1|||
33531176|NCT02854605|62920756|FG001|Overall Study|Investigator's Discretion|0|||
33531177|NCT02854605|62920757|FG002|Overall Study|Investigator's Discretion|0|||
33531178|NCT02854605|62920755|FG000|Overall Study|Protocol Violation|0|||
33531179|NCT02854605|62920756|FG001|Overall Study|Protocol Violation|0|||
33531180|NCT02854605|62920757|FG002|Overall Study|Protocol Violation|1|||
33531181|NCT02854527|62920775|FG000|Overall Study|Adverse Event|0|||
33531182|NCT02854527|62920776|FG001|Overall Study|Adverse Event|0|||
33531183|NCT02854527|62920777|FG002|Overall Study|Adverse Event|0|||
33531184|NCT02854527|62920778|FG003|Overall Study|Adverse Event|0|||
33531185|NCT02854527|62920779|FG004|Overall Study|Adverse Event|1|||
33531186|NCT02854527|62920780|FG005|Overall Study|Adverse Event|0|||
33531187|NCT02854527|62920781|FG006|Overall Study|Adverse Event|0|||
33531188|NCT02854527|62920782|FG007|Overall Study|Adverse Event|0|||
33531189|NCT02854527|62920783|FG008|Overall Study|Adverse Event|0|||
33531190|NCT02854527|62920784|FG009|Overall Study|Adverse Event|0|||
33531191|NCT02854527|62920775|FG000|Overall Study|Lost to Follow-up|0|||
33531192|NCT02854527|62920776|FG001|Overall Study|Lost to Follow-up|0|||
33531193|NCT02854527|62920777|FG002|Overall Study|Lost to Follow-up|0|||
33531194|NCT02854527|62920778|FG003|Overall Study|Lost to Follow-up|1|||
33531195|NCT02854527|62920779|FG004|Overall Study|Lost to Follow-up|0|||
33531196|NCT02854527|62920780|FG005|Overall Study|Lost to Follow-up|0|||
33531197|NCT02854527|62920781|FG006|Overall Study|Lost to Follow-up|0|||
33531198|NCT02854527|62920782|FG007|Overall Study|Lost to Follow-up|0|||
33531199|NCT02854527|62920783|FG008|Overall Study|Lost to Follow-up|0|||
33458821|NCT00112437|62832483|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458822|NCT00112437|62832484|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458823|NCT00112437|62832485|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458824|NCT00112437|62832486|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458825|NCT00112437|62832487|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458826|NCT00112437|62832488|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458827|NCT00112437|62832489|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458828|NCT00112437|62832490|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33531200|NCT02854527|62920784|FG009|Overall Study|Lost to Follow-up|0|||
33531201|NCT02853435|62920811|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
33531202|NCT02853435|62920812|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
33531203|NCT02853435|62920813|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
33531204|NCT02853435|62920814|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
33531205|NCT02853435|62920815|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
33531206|NCT02853435|62920816|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
33531207|NCT02635204|62920848|FG000|Overall Study|Adverse Event|1|||
33625820|NCT01850823|63026726|FG001|Overall Study|Significant worstening of SAR|1|||
33625821|NCT01850823|63026727|FG002|Overall Study|Significant worstening of SAR|0|||
33625822|NCT01850823|63026725|FG000|Overall Study|Withdrawal by Subject|2|||
33625823|NCT01850823|63026726|FG001|Overall Study|Withdrawal by Subject|0|||
33625824|NCT01850823|63026727|FG002|Overall Study|Withdrawal by Subject|1|||
33625825|NCT01820559|63026740|FG000|Overall Study|Adverse Event|4|||
33625826|NCT01820559|63026741|FG001|Overall Study|Adverse Event|6|||
33625827|NCT01820559|63026742|FG002|Overall Study|Adverse Event|13|||
33625828|NCT01820559|63026740|FG000|Overall Study|Withdrawal by Subject|1|||
33625829|NCT01820559|63026741|FG001|Overall Study|Withdrawal by Subject|2|||
33625830|NCT01820559|63026742|FG002|Overall Study|Withdrawal by Subject|5|||
33625831|NCT01820559|63026740|FG000|Overall Study|Protocol Violation|2|||
33625832|NCT01820559|63026741|FG001|Overall Study|Protocol Violation|1|||
33625833|NCT01820559|63026742|FG002|Overall Study|Protocol Violation|3|||
33625834|NCT01820559|63026740|FG000|Overall Study|Subject's non-compliance|1|||
33625835|NCT01820559|63026741|FG001|Overall Study|Subject's non-compliance|0|||
33625836|NCT01820559|63026742|FG002|Overall Study|Subject's non-compliance|2|||
33625837|NCT01820559|63026740|FG000|Overall Study|Lost to Follow-up|3|||
33625838|NCT01820559|63026741|FG001|Overall Study|Lost to Follow-up|2|||
33625839|NCT01820559|63026742|FG002|Overall Study|Lost to Follow-up|2|||
33625840|NCT01820559|63026740|FG000|Overall Study|At sponsor request|0|||
33625841|NCT01820559|63026741|FG001|Overall Study|At sponsor request|0|||
33625842|NCT01820559|63026742|FG002|Overall Study|At sponsor request|1|||
33625843|NCT01820559|63026740|FG000|Overall Study|Lack of Efficacy|3|||
33625844|NCT01820559|63026741|FG001|Overall Study|Lack of Efficacy|2|||
33625845|NCT01820559|63026742|FG002|Overall Study|Lack of Efficacy|3|||
33625846|NCT01818765|63026750|FG000|Overall Study|Death|2|||
33531208|NCT02635204|62920849|FG001|Overall Study|Adverse Event|0|||
33531209|NCT02635204|62920848|FG000|Overall Study|Lost to Follow-up|1|||
33531210|NCT02635204|62920849|FG001|Overall Study|Lost to Follow-up|1|||
33531211|NCT00102804|62920857|FG000|Overall Study|Progressive Disease (PD)|307|||
33531212|NCT00102804|62920858|FG001|Overall Study|Progressive Disease (PD)|196|||
33531213|NCT00102804|62920857|FG000|Overall Study|Withdrawal by Subject|46|||
33531214|NCT00102804|62920858|FG001|Overall Study|Withdrawal by Subject|7|||
33531215|NCT00102804|62920857|FG000|Overall Study|Adverse Event|37|||
33531216|NCT00102804|62920858|FG001|Overall Study|Adverse Event|3|||
33531217|NCT00102804|62920857|FG000|Overall Study|Physician Decision|24|||
33531218|NCT00102804|62920858|FG001|Overall Study|Physician Decision|6|||
33531219|NCT00102804|62920857|FG000|Overall Study|Death|5|||
33531220|NCT00102804|62920858|FG001|Overall Study|Death|6|||
33531221|NCT00102804|62920857|FG000|Overall Study|Enrollment Criteria Not Met|6|||
33531222|NCT00102804|62920858|FG001|Overall Study|Enrollment Criteria Not Met|0|||
33531223|NCT00102804|62920857|FG000|Overall Study|Lost to Follow-up|4|||
33531224|NCT00102804|62920858|FG001|Overall Study|Lost to Follow-up|1|||
33531225|NCT00102804|62920857|FG000|Overall Study|Protocol Violation|2|||
33531226|NCT00102804|62920858|FG001|Overall Study|Protocol Violation|1|||
33531227|NCT00102804|62920857|FG000|Overall Study|Satisfactory Response|2|||
33531228|NCT00102804|62920858|FG001|Overall Study|Satisfactory Response|0|||
33531229|NCT00102804|62920857|FG000|Overall Study|Sponsor Decision|1|||
33531230|NCT00102804|62920858|FG001|Overall Study|Sponsor Decision|0|||
33531231|NCT00102804|62920857|FG000|Overall Study|Alive, Receiving Treatment|7|||
33531232|NCT00102804|62920858|FG001|Overall Study|Alive, Receiving Treatment|2|||
33531233|NCT01814072|62920896|FG000|Overall Study|Lost to Follow-up|2|||
33531234|NCT01814072|62920897|FG001|Overall Study|Lost to Follow-up|2|||
33531235|NCT01814072|62920898|FG002|Overall Study|Lost to Follow-up|2|||
33531236|NCT01814072|62920899|FG003|Overall Study|Lost to Follow-up|0|||
33531237|NCT01814072|62920900|FG004|Overall Study|Lost to Follow-up|2|||
33531238|NCT01814072|62920901|FG005|Overall Study|Lost to Follow-up|3|||
33531239|NCT01814072|62920902|FG006|Overall Study|Lost to Follow-up|3|||
33531240|NCT01814072|62920903|FG007|Overall Study|Lost to Follow-up|1|||
33531241|NCT01814072|62920904|FG008|Overall Study|Lost to Follow-up|2|||
33625847|NCT01850589|63026757|FG000|Overall Study|Withdrawal by Subject|8|||
33625848|NCT01850589|63026758|FG001|Overall Study|Withdrawal by Subject|0|||
33625849|NCT01818531|63026766|FG000|Overall Study|Withdrawn for case delay after block|1|||
33625850|NCT01818531|63026767|FG001|Overall Study|Withdrawn for case delay after block|0|||
33625851|NCT01818531|63026766|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
33625852|NCT01818531|63026767|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
33625853|NCT01818531|63026766|FG000|Overall Study|Withdrawn for failure to place block|0|||
33531242|NCT01814072|62920905|FG009|Overall Study|Lost to Follow-up|3|||
33531243|NCT01814072|62920906|FG010|Overall Study|Lost to Follow-up|1|||
33531244|NCT01814072|62920907|FG011|Overall Study|Lost to Follow-up|2|||
33531245|NCT01814072|62920908|FG012|Overall Study|Lost to Follow-up|2|||
33531246|NCT01814072|62920909|FG013|Overall Study|Lost to Follow-up|1|||
33531247|NCT01814072|62920910|FG014|Overall Study|Lost to Follow-up|2|||
33531248|NCT01814072|62920911|FG015|Overall Study|Lost to Follow-up|1|||
33531249|NCT01814072|62920912|FG016|Overall Study|Lost to Follow-up|3|||
33531250|NCT01814072|62920913|FG017|Overall Study|Lost to Follow-up|1|||
33531251|NCT01814072|62920914|FG018|Overall Study|Lost to Follow-up|3|||
33531252|NCT01814072|62920915|FG019|Overall Study|Lost to Follow-up|3|||
33531253|NCT01814072|62920916|FG020|Overall Study|Lost to Follow-up|2|||
33531254|NCT01814072|62920917|FG021|Overall Study|Lost to Follow-up|1|||
33531255|NCT01814072|62920918|FG022|Overall Study|Lost to Follow-up|3|||
33531256|NCT01814072|62920919|FG023|Overall Study|Lost to Follow-up|1|||
33531257|NCT01814072|62920920|FG024|Overall Study|Lost to Follow-up|4|||
33531258|NCT01814072|62920921|FG025|Overall Study|Lost to Follow-up|1|||
33531259|NCT01814072|62920922|FG026|Overall Study|Lost to Follow-up|1|||
33531260|NCT01814072|62920923|FG027|Overall Study|Lost to Follow-up|2|||
33531261|NCT01814072|62920924|FG028|Overall Study|Lost to Follow-up|3|||
33531262|NCT01814072|62920925|FG029|Overall Study|Lost to Follow-up|3|||
33531263|NCT01814072|62920926|FG030|Overall Study|Lost to Follow-up|2|||
33531264|NCT01814072|62920927|FG031|Overall Study|Lost to Follow-up|0|||
33531265|NCT01814072|62920896|FG000|Overall Study|Withdrawal by Subject|2|||
33531266|NCT01814072|62920897|FG001|Overall Study|Withdrawal by Subject|0|||
33531267|NCT01814072|62920898|FG002|Overall Study|Withdrawal by Subject|1|||
33531268|NCT01814072|62920899|FG003|Overall Study|Withdrawal by Subject|0|||
33531269|NCT01814072|62920900|FG004|Overall Study|Withdrawal by Subject|2|||
33531270|NCT01814072|62920901|FG005|Overall Study|Withdrawal by Subject|3|||
33531271|NCT01814072|62920902|FG006|Overall Study|Withdrawal by Subject|1|||
33531272|NCT01814072|62920903|FG007|Overall Study|Withdrawal by Subject|0|||
33531273|NCT01814072|62920904|FG008|Overall Study|Withdrawal by Subject|1|||
33531274|NCT01814072|62920905|FG009|Overall Study|Withdrawal by Subject|2|||
33531275|NCT01814072|62920906|FG010|Overall Study|Withdrawal by Subject|0|||
33531276|NCT01814072|62920907|FG011|Overall Study|Withdrawal by Subject|0|||
33531277|NCT01814072|62920908|FG012|Overall Study|Withdrawal by Subject|1|||
33531278|NCT01814072|62920909|FG013|Overall Study|Withdrawal by Subject|1|||
33531279|NCT01814072|62920910|FG014|Overall Study|Withdrawal by Subject|1|||
33531280|NCT01814072|62920911|FG015|Overall Study|Withdrawal by Subject|1|||
33531281|NCT01814072|62920912|FG016|Overall Study|Withdrawal by Subject|0|||
33531282|NCT01814072|62920913|FG017|Overall Study|Withdrawal by Subject|0|||
33531283|NCT01814072|62920914|FG018|Overall Study|Withdrawal by Subject|0|||
33531284|NCT01814072|62920915|FG019|Overall Study|Withdrawal by Subject|2|||
33531285|NCT01814072|62920916|FG020|Overall Study|Withdrawal by Subject|0|||
33531286|NCT01814072|62920917|FG021|Overall Study|Withdrawal by Subject|0|||
33531287|NCT01814072|62920918|FG022|Overall Study|Withdrawal by Subject|1|||
33531288|NCT01814072|62920919|FG023|Overall Study|Withdrawal by Subject|0|||
33531289|NCT01814072|62920920|FG024|Overall Study|Withdrawal by Subject|2|||
33531290|NCT01814072|62920921|FG025|Overall Study|Withdrawal by Subject|1|||
33531291|NCT01814072|62920922|FG026|Overall Study|Withdrawal by Subject|1|||
33531292|NCT01814072|62920923|FG027|Overall Study|Withdrawal by Subject|2|||
33531293|NCT01814072|62920924|FG028|Overall Study|Withdrawal by Subject|1|||
33531294|NCT01814072|62920925|FG029|Overall Study|Withdrawal by Subject|0|||
33531295|NCT01814072|62920926|FG030|Overall Study|Withdrawal by Subject|0|||
33531296|NCT01814072|62920927|FG031|Overall Study|Withdrawal by Subject|0|||
33531297|NCT03038113|62920982|FG000|Overall Study|Withdrawal by Subject|0|||
33531298|NCT03038113|62920983|FG001|Overall Study|Withdrawal by Subject|0|||
33531299|NCT03038113|62920984|FG002|Overall Study|Withdrawal by Subject|1|||
33531300|NCT03038113|62920985|FG003|Overall Study|Withdrawal by Subject|0|||
33531301|NCT03038113|62920986|FG004|Overall Study|Withdrawal by Subject|0|||
33531302|NCT03038113|62920987|FG005|Overall Study|Withdrawal by Subject|0|||
33458829|NCT00112437|62832491|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458830|NCT00112437|62832492|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458831|NCT00112437|62832493|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
33458832|NCT00112437|62832494|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
33458833|NCT00112437|62832495|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458834|NCT00112437|62832496|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458835|NCT00112437|62832497|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458836|NCT00112437|62832498|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33458837|NCT00112437|62832473|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458838|NCT00112437|62832474|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458839|NCT00112437|62832475|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458840|NCT00112437|62832476|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458841|NCT00112437|62832477|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458842|NCT00112437|62832478|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458843|NCT00112437|62832479|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458844|NCT00112437|62832480|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33531303|NCT03038113|62920988|FG006|Overall Study|Withdrawal by Subject|0|||
33531304|NCT03038113|62920989|FG007|Overall Study|Withdrawal by Subject|0|||
33531305|NCT03038113|62920990|FG008|Overall Study|Withdrawal by Subject|0|||
33531306|NCT03038113|62920991|FG009|Overall Study|Withdrawal by Subject|0|||
33531307|NCT03038113|62920992|FG010|Overall Study|Withdrawal by Subject|0|||
33531308|NCT03038113|62920993|FG011|Overall Study|Withdrawal by Subject|0|||
33531309|NCT03038113|62920994|FG012|Overall Study|Withdrawal by Subject|0|||
33531310|NCT03038113|62920995|FG013|Overall Study|Withdrawal by Subject|1|||
33531311|NCT03038113|62920982|FG000|Overall Study|Lost to Follow-up|0|||
33531312|NCT03038113|62920983|FG001|Overall Study|Lost to Follow-up|0|||
33531313|NCT03038113|62920984|FG002|Overall Study|Lost to Follow-up|0|||
33531314|NCT03038113|62920985|FG003|Overall Study|Lost to Follow-up|0|||
33531315|NCT03038113|62920986|FG004|Overall Study|Lost to Follow-up|0|||
33531316|NCT03038113|62920987|FG005|Overall Study|Lost to Follow-up|0|||
33531317|NCT03038113|62920988|FG006|Overall Study|Lost to Follow-up|1|||
33531318|NCT03038113|62920989|FG007|Overall Study|Lost to Follow-up|0|||
33531319|NCT03038113|62920990|FG008|Overall Study|Lost to Follow-up|0|||
33531320|NCT03038113|62920991|FG009|Overall Study|Lost to Follow-up|0|||
33531321|NCT03038113|62920992|FG010|Overall Study|Lost to Follow-up|0|||
33531322|NCT03038113|62920993|FG011|Overall Study|Lost to Follow-up|0|||
33531323|NCT03038113|62920994|FG012|Overall Study|Lost to Follow-up|0|||
33531324|NCT03038113|62920995|FG013|Overall Study|Lost to Follow-up|0|||
33531325|NCT00968149|62921044|FG000|Overall Study|Adverse Event|5|||
33531326|NCT00968149|62921045|FG001|Overall Study|Adverse Event|1|||
33531327|NCT00968149|62921044|FG000|Overall Study|Lack of Efficacy|0|||
33531328|NCT00968149|62921045|FG001|Overall Study|Lack of Efficacy|4|||
33531329|NCT00968149|62921044|FG000|Overall Study|Lost to Follow-up|0|||
33531330|NCT00968149|62921045|FG001|Overall Study|Lost to Follow-up|1|||
33531331|NCT00968149|62921044|FG000|Overall Study|Protocol Violation|4|||
33531332|NCT00968149|62921045|FG001|Overall Study|Protocol Violation|0|||
33531333|NCT00968149|62921044|FG000|Overall Study|Withdrawal by Subject|2|||
33531334|NCT00968149|62921045|FG001|Overall Study|Withdrawal by Subject|0|||
33531335|NCT00963469|62921054|FG000|Overall Study|Adverse Event|15|||
33531336|NCT00963469|62921055|FG001|Overall Study|Adverse Event|11|||
33531337|NCT00963469|62921056|FG002|Overall Study|Adverse Event|1|||
33531338|NCT00963469|62921054|FG000|Overall Study|Lack of Efficacy|10|||
33531339|NCT00963469|62921055|FG001|Overall Study|Lack of Efficacy|7|||
33531340|NCT00963469|62921056|FG002|Overall Study|Lack of Efficacy|2|||
33531341|NCT00963469|62921054|FG000|Overall Study|Lost to Follow-up|1|||
33531342|NCT00963469|62921055|FG001|Overall Study|Lost to Follow-up|1|||
33531343|NCT00963469|62921056|FG002|Overall Study|Lost to Follow-up|0|||
33531344|NCT00963469|62921054|FG000|Overall Study|Protocol Violation|5|||
33531345|NCT00963469|62921055|FG001|Overall Study|Protocol Violation|5|||
33531346|NCT00963469|62921056|FG002|Overall Study|Protocol Violation|3|||
33531347|NCT00963469|62921054|FG000|Overall Study|Withdrawal by Subject|4|||
33531348|NCT00963469|62921055|FG001|Overall Study|Withdrawal by Subject|1|||
33531349|NCT00963469|62921056|FG002|Overall Study|Withdrawal by Subject|1|||
33531350|NCT00963469|62921054|FG000|Overall Study|Pre-randomization Adverse Event|1|||
33531351|NCT00963469|62921055|FG001|Overall Study|Pre-randomization Adverse Event|2|||
33531352|NCT00963469|62921056|FG002|Overall Study|Pre-randomization Adverse Event|0|||
33531353|NCT00963469|62921054|FG000|Overall Study|Moved|1|||
33531354|NCT00963469|62921055|FG001|Overall Study|Moved|0|||
33531355|NCT00963469|62921056|FG002|Overall Study|Moved|0|||
33531356|NCT00963469|62921054|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
33531357|NCT00963469|62921055|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
33531358|NCT00963469|62921056|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
33531359|NCT00897949|62921067|FG000|Overall Study|Adverse Event|1|||
33531360|NCT00897949|62921068|FG001|Overall Study|Adverse Event|1|||
33531361|NCT00897949|62921069|FG002|Overall Study|Adverse Event|0|||
33531362|NCT00897949|62921067|FG000|Overall Study|Lost to Follow-up|0|||
33531363|NCT00897949|62921068|FG001|Overall Study|Lost to Follow-up|2|||
33531364|NCT00897949|62921069|FG002|Overall Study|Lost to Follow-up|1|||
33531365|NCT00897949|62921067|FG000|Overall Study|Protocol Violation|6|||
33531366|NCT00897949|62921068|FG001|Overall Study|Protocol Violation|3|||
33531367|NCT00897949|62921069|FG002|Overall Study|Protocol Violation|1|||
33531368|NCT00897949|62921067|FG000|Overall Study|Withdrawal by Subject|1|||
33531369|NCT00897949|62921068|FG001|Overall Study|Withdrawal by Subject|2|||
33531370|NCT00897949|62921069|FG002|Overall Study|Withdrawal by Subject|0|||
33531371|NCT00897949|62921067|FG000|Overall Study|Patient Uncoorperative|0|||
33531372|NCT00897949|62921068|FG001|Overall Study|Patient Uncoorperative|2|||
33531373|NCT00897949|62921069|FG002|Overall Study|Patient Uncoorperative|1|||
33531374|NCT00897949|62921067|FG000|Overall Study|Lost to Follow-up|30|||
33625854|NCT01818531|63026767|FG001|Overall Study|Withdrawn for failure to place block|1|||
33625855|NCT02171429|63026776|FG000|Overall Study|Other|0|||
33531375|NCT00897949|62921068|FG001|Overall Study|Lost to Follow-up|23|||
33531376|NCT00897949|62921069|FG002|Overall Study|Lost to Follow-up|17|||
33531377|NCT00897949|62921067|FG000|Overall Study|Withdrawal by Subject|24|||
33531378|NCT00897949|62921068|FG001|Overall Study|Withdrawal by Subject|31|||
33531379|NCT00897949|62921069|FG002|Overall Study|Withdrawal by Subject|17|||
33531380|NCT00897949|62921067|FG000|Overall Study|Abnormal Prestudy Labs|2|||
33531381|NCT00897949|62921068|FG001|Overall Study|Abnormal Prestudy Labs|3|||
33531382|NCT00897949|62921069|FG002|Overall Study|Abnormal Prestudy Labs|4|||
33531383|NCT00897949|62921067|FG000|Overall Study|Abnormal Baseline ECG|2|||
33531384|NCT00897949|62921068|FG001|Overall Study|Abnormal Baseline ECG|2|||
33531385|NCT00897949|62921069|FG002|Overall Study|Abnormal Baseline ECG|4|||
33531386|NCT00897949|62921067|FG000|Overall Study|Need for Concom. Med.|0|||
33531387|NCT00897949|62921068|FG001|Overall Study|Need for Concom. Med.|1|||
33325705|NCT01212770|62702212|FG001|Long-term Safety Phase (Year 5)|Death|0|||
33325706|NCT01212770|62702213|FG002|Long-term Safety Phase (Year 5)|Death|0|||
33325707|NCT01212770|62702214|FG003|Long-term Safety Phase (Year 5)|Death|0|||
33458845|NCT00112437|62832481|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458846|NCT00112437|62832482|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458847|NCT00112437|62832483|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458848|NCT00112437|62832484|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458849|NCT00112437|62832485|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458850|NCT00112437|62832486|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458851|NCT00112437|62832487|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458852|NCT00112437|62832488|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458853|NCT00112437|62832489|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458854|NCT00112437|62832490|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458855|NCT00112437|62832491|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458856|NCT00112437|62832492|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458857|NCT00112437|62832493|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
33458858|NCT00112437|62832494|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458859|NCT00112437|62832495|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458860|NCT00112437|62832496|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458861|NCT00112437|62832497|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458862|NCT00112437|62832498|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33458863|NCT00112437|62832473|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458864|NCT00112437|62832474|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458865|NCT00112437|62832475|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458866|NCT00112437|62832476|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458867|NCT00112437|62832477|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458868|NCT00112437|62832478|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458869|NCT00112437|62832479|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458870|NCT00112437|62832480|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458871|NCT00112437|62832481|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458872|NCT00112437|62832482|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458873|NCT00112437|62832483|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458874|NCT00112437|62832484|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458875|NCT00112437|62832485|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458876|NCT00112437|62832486|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458877|NCT00112437|62832487|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458878|NCT00112437|62832488|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458879|NCT00112437|62832489|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458880|NCT00112437|62832490|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458881|NCT00112437|62832491|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458882|NCT00112437|62832492|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458883|NCT00112437|62832493|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458884|NCT00112437|62832494|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
33458885|NCT00112437|62832495|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458886|NCT00112437|62832496|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458887|NCT00112437|62832497|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458888|NCT00112437|62832498|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33458889|NCT00112437|62832473|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458890|NCT00112437|62832474|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458891|NCT00112437|62832475|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458892|NCT00112437|62832476|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458893|NCT00112437|62832477|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458894|NCT00112437|62832478|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
33531388|NCT00897949|62921069|FG002|Overall Study|Need for Concom. Med.|1|||
33531389|NCT00897949|62921067|FG000|Overall Study|Lack of Migraine Attack|29|||
33531390|NCT00897949|62921068|FG001|Overall Study|Lack of Migraine Attack|30|||
33531391|NCT00897949|62921069|FG002|Overall Study|Lack of Migraine Attack|19|||
33531392|NCT00897949|62921067|FG000|Overall Study|Did not take study drug|9|||
33325708|NCT01212770|62702215|FG004|Long-term Safety Phase (Year 5)|Death|0|||
33531393|NCT00897949|62921068|FG001|Overall Study|Did not take study drug|3|||
33531394|NCT00897949|62921069|FG002|Overall Study|Did not take study drug|4|||
33531395|NCT02760810|62921083|FG000|Overall Study|Protocol Violation|1|||
33531396|NCT02760654|62921089|FG000|Overall Study|Lost to Follow-up|3|||
33531397|NCT02760654|62921090|FG001|Overall Study|Lost to Follow-up|3|||
33531398|NCT02760654|62921089|FG000|Overall Study|Withdrawal by Subject|4|||
33531399|NCT02760654|62921090|FG001|Overall Study|Withdrawal by Subject|3|||
33531400|NCT00725491|62921098|FG000|Overall Study|Adverse Event|3|||
33531401|NCT00725491|62921099|FG001|Overall Study|Adverse Event|2|||
33531402|NCT00725491|62921098|FG000|Overall Study|Pregnancy|0|||
33531403|NCT00725491|62921099|FG001|Overall Study|Pregnancy|3|||
33531404|NCT00725491|62921098|FG000|Overall Study|Risk for hyperstimulation|2|||
33531405|NCT00725491|62921099|FG001|Overall Study|Risk for hyperstimulation|9|||
33531406|NCT00725491|62921098|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
33531407|NCT00725491|62921099|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
33531408|NCT00725491|62921098|FG000|Overall Study|Fertilization failure|0|||
33531409|NCT00725491|62921099|FG001|Overall Study|Fertilization failure|1|||
33531410|NCT00725491|62921098|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
33531411|NCT00725491|62921099|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
33531412|NCT02634580|62921109|FG000|Double-blind Treatment Period|Subject Request|1|||
33531413|NCT02634580|62921110|FG001|Double-blind Treatment Period|Subject Request|0|||
33531414|NCT02634580|62921111|FG002|Double-blind Treatment Period|Subject Request|1|||
33531415|NCT02634580|62921112|FG003|Double-blind Treatment Period|Subject Request|1|||
33531416|NCT02634580|62921109|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
33531417|NCT02634580|62921110|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
33531418|NCT02634580|62921111|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
33531419|NCT02634580|62921112|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
33531420|NCT02225366|62921123|FG000|Overall Study|Lack of Efficacy|1|||
33531421|NCT02225366|62921124|FG001|Overall Study|Lack of Efficacy|0|||
33531422|NCT00697255|62921132|FG000|Stage 1a|Insufficient ovarian response|1|||
33531423|NCT00697255|62921133|FG001|Stage 1a|Insufficient ovarian response|0|||
33531424|NCT00697255|62921132|FG000|Stage 1a|Multifollicular growth|1|||
33531425|NCT00697255|62921133|FG001|Stage 1a|Multifollicular growth|0|||
33531426|NCT00697255|62921132|FG000|Stage 1a|Not growing of dominant follicle|1|||
33531427|NCT00697255|62921133|FG001|Stage 1a|Not growing of dominant follicle|0|||
33531428|NCT00697255|62921132|FG000|Stage 1b|Not growing of dominant follicle|0|||
33531429|NCT00697255|62921133|FG001|Stage 1b|Not growing of dominant follicle|1|||
33531430|NCT00697255|62921132|FG000|Stage 1b|Insufficient ovarian response|0|||
33531431|NCT00697255|62921133|FG001|Stage 1b|Insufficient ovarian response|1|||
33531432|NCT02764320|62921141|FG000|Overall Study|Withdrawal by Subject|35|||
33531433|NCT02764320|62921142|FG001|Overall Study|Withdrawal by Subject|38|||
33531434|NCT02764320|62921141|FG000|Overall Study|Protocol Violation|11|||
33531435|NCT02764320|62921142|FG001|Overall Study|Protocol Violation|6|||
33531436|NCT02764320|62921141|FG000|Overall Study|Adverse Event|2|||
33531437|NCT02764320|62921142|FG001|Overall Study|Adverse Event|0|||
33531438|NCT02764320|62921141|FG000|Overall Study|Health Issues unable to continue|2|||
33531439|NCT02764320|62921142|FG001|Overall Study|Health Issues unable to continue|0|||
33625856|NCT02171429|63026777|FG001|Overall Study|Other|1|||
33625857|NCT02171429|63026778|FG002|Overall Study|Other|1|||
33625858|NCT02171429|63026776|FG000|Overall Study|Non-Compliance|0|||
33625859|NCT02171429|63026777|FG001|Overall Study|Non-Compliance|0|||
33625860|NCT02171429|63026778|FG002|Overall Study|Non-Compliance|1|||
33625861|NCT02171429|63026776|FG000|Overall Study|Physician Decision|0|||
33625862|NCT02171429|63026777|FG001|Overall Study|Physician Decision|0|||
33625863|NCT02171429|63026778|FG002|Overall Study|Physician Decision|1|||
33625864|NCT02171429|63026776|FG000|Overall Study|Withdrawal by Subject|1|||
33625865|NCT02171429|63026777|FG001|Overall Study|Withdrawal by Subject|1|||
33625866|NCT02171429|63026778|FG002|Overall Study|Withdrawal by Subject|1|||
33625867|NCT02171429|63026776|FG000|Overall Study|Lost to Follow-up|0|||
33625868|NCT02171429|63026777|FG001|Overall Study|Lost to Follow-up|1|||
33625869|NCT02171429|63026778|FG002|Overall Study|Lost to Follow-up|0|||
33625870|NCT02171429|63026776|FG000|Overall Study|Death|0|||
33625871|NCT02171429|63026777|FG001|Overall Study|Death|0|||
33625872|NCT02171429|63026778|FG002|Overall Study|Death|1|||
33625873|NCT01818297|63026791|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
33625874|NCT01818297|63026792|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
33531440|NCT02764320|62921141|FG000|Overall Study|Did not meet inclusion criteria|1|||
33531441|NCT02764320|62921142|FG001|Overall Study|Did not meet inclusion criteria|0|||
33531442|NCT02764320|62921141|FG000|Overall Study|Subject moved|0|||
33531443|NCT02764320|62921142|FG001|Overall Study|Subject moved|2|||
33531444|NCT02764320|62921141|FG000|Overall Study|Overused medication unavailable|0|||
33531445|NCT02764320|62921142|FG001|Overall Study|Overused medication unavailable|1|||
33531446|NCT02764320|62921141|FG000|Overall Study|Seeking care outside site|0|||
33531447|NCT02764320|62921142|FG001|Overall Study|Seeking care outside site|1|||
33531448|NCT02764320|62921141|FG000|Overall Study|Technology barriers|0|||
33531449|NCT02764320|62921142|FG001|Overall Study|Technology barriers|1|||
33531450|NCT02851407|62921150|FG000|Overall Study|Withdrawal by parent/guardian|2|||
33531451|NCT02851407|62921151|FG001|Overall Study|Withdrawal by parent/guardian|7|||
33531452|NCT02851407|62921150|FG000|Overall Study|Protocol deviation|0|||
33531453|NCT02851407|62921151|FG001|Overall Study|Protocol deviation|1|||
33531454|NCT02851407|62921150|FG000|Overall Study|Transferred to another hospital to continue|1|||
33531455|NCT02851407|62921151|FG001|Overall Study|Transferred to another hospital to continue|0|||
33531456|NCT02851407|62921150|FG000|Overall Study|Other Death|30|||
33531457|NCT02851407|62921151|FG001|Overall Study|Other Death|20|||
33531458|NCT02851407|62921150|FG000|Overall Study|Adverse event, serious fatal|6|||
33531459|NCT02851407|62921151|FG001|Overall Study|Adverse event, serious fatal|8|||
33531460|NCT02851407|62921150|FG000|Overall Study|Consent withdrawn by participant|5|||
33531461|NCT02851407|62921151|FG001|Overall Study|Consent withdrawn by participant|3|||
33531462|NCT02851407|62921150|FG000|Overall Study|Screen failure|2|||
33531463|NCT02851407|62921151|FG001|Overall Study|Screen failure|1|||
33531464|NCT02851407|62921150|FG000|Overall Study|Disease relapse|9|||
33531465|NCT02851407|62921151|FG001|Overall Study|Disease relapse|6|||
33531466|NCT02851407|62921150|FG000|Overall Study|Physician Decision|7|||
33531467|NCT02851407|62921151|FG001|Overall Study|Physician Decision|6|||
33531468|NCT02851407|62921150|FG000|Overall Study|Transferred to hospital closer to home|0|||
33531469|NCT02851407|62921151|FG001|Overall Study|Transferred to hospital closer to home|1|||
33531470|NCT02851407|62921150|FG000|Overall Study|Enrolled in an investigational study|0|||
33531471|NCT02851407|62921151|FG001|Overall Study|Enrolled in an investigational study|1|||
33531472|NCT02851407|62921150|FG000|Overall Study|Early recovery|1|||
33531473|NCT02851407|62921151|FG001|Overall Study|Early recovery|0|||
33531474|NCT02851407|62921150|FG000|Overall Study|Adverse event, non-fatal|7|||
33531475|NCT02851407|62921151|FG001|Overall Study|Adverse event, non-fatal|5|||
33531476|NCT02851407|62921150|FG000|Overall Study|Lost to Follow-up|0|||
33531477|NCT02851407|62921151|FG001|Overall Study|Lost to Follow-up|2|||
33531478|NCT02636608|62921157|FG000|Overall Study|Failure to Return|4|||
33531479|NCT02636608|62921157|FG000|Overall Study|Insufficient Virological Response|1|||
33531480|NCT02636608|62921157|FG000|Overall Study|Death|3|||
33531481|NCT02636608|62921157|FG000|Overall Study|Other|2|||
33531482|NCT02636608|62921157|FG000|Overall Study|Did Not Receive Treatment|1|||
33531483|NCT02759562|62921166|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
33531484|NCT02759562|62921167|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
33531485|NCT02759562|62921166|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
33531486|NCT02759562|62921167|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
33531487|NCT02746575|62921174|FG000|Overall Study|Surgery cancelled or time chaned|13|||
33531488|NCT02746575|62921174|FG000|Overall Study|Received epidural|10|||
33531489|NCT02746575|62921174|FG000|Overall Study|Withdrawal by Subject|3|||
33531490|NCT02746575|62921174|FG000|Overall Study|Bradycardia/hypotension|9|||
33531491|NCT02746575|62921174|FG000|Overall Study|Study paused|8|||
33531492|NCT02746575|62921174|FG000|Overall Study|put on beta-blocker|3|||
33531493|NCT02746575|62921174|FG000|Overall Study|type of surgery|1|||
33531494|NCT02746575|62921174|FG000|Overall Study|typ of surgery|1|||
33531495|NCT02746575|62921174|FG000|Overall Study|PI unavailable|1|||
33531496|NCT02746575|62921174|FG000|Overall Study|Unknown history of CVA|1|||
33531497|NCT03625466|62921180|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
33531498|NCT03625466|62921181|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
33531499|NCT03625466|62921182|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
33531500|NCT03625466|62921180|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
33531501|NCT03625466|62921181|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
33531502|NCT03625466|62921182|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
33531503|NCT03625466|62921180|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
33531504|NCT03625466|62921181|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
33531505|NCT03625466|62921182|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
33531506|NCT02853123|62921189|FG000|Treatment Period 1|Adverse Event|0|||
33531507|NCT02853123|62921190|FG001|Treatment Period 1|Adverse Event|3|||
33531508|NCT02853123|62921189|FG000|Washout Period|Worsening of COPD|0|||
33531509|NCT02853123|62921190|FG001|Washout Period|Worsening of COPD|3|||
33531510|NCT02853123|62921189|FG000|Washout Period|Adverse Event|1|||
33531511|NCT02853123|62921190|FG001|Washout Period|Adverse Event|0|||
33531512|NCT02634346|62921200|FG000|Overall Study|Withdrawal by Subject|8|||
33531513|NCT02634346|62921201|FG001|Overall Study|Withdrawal by Subject|9|||
33325709|NCT01212770|62702216|FG005|Long-term Safety Phase (Year 5)|Death|0|||
33531514|NCT02634346|62921202|FG002|Overall Study|Withdrawal by Subject|8|||
33531515|NCT02634346|62921200|FG000|Overall Study|Adverse Event|2|||
33531516|NCT02634346|62921201|FG001|Overall Study|Adverse Event|2|||
33531517|NCT02634346|62921202|FG002|Overall Study|Adverse Event|7|||
33531518|NCT02634346|62921200|FG000|Overall Study|Lack of Efficacy|1|||
33531519|NCT02634346|62921201|FG001|Overall Study|Lack of Efficacy|2|||
33531520|NCT02634346|62921202|FG002|Overall Study|Lack of Efficacy|8|||
33531521|NCT02634346|62921200|FG000|Overall Study|Lost to Follow-up|1|||
33325710|NCT01212770|62702217|FG006|Long-term Safety Phase (Year 5)|Death|0|||
33531522|NCT02634346|62921201|FG001|Overall Study|Lost to Follow-up|0|||
33531523|NCT02634346|62921202|FG002|Overall Study|Lost to Follow-up|0|||
33531524|NCT02634346|62921200|FG000|Overall Study|Protocol Violation|0|||
33531525|NCT02634346|62921201|FG001|Overall Study|Protocol Violation|1|||
33531526|NCT02634346|62921202|FG002|Overall Study|Protocol Violation|0|||
33531527|NCT00849147|62921210|FG000|Overall Study|Withdrawal by Subject|1|||
33531528|NCT00849147|62921210|FG000|Overall Study|Protocol Violation|2|||
33531529|NCT00849147|62921210|FG000|Overall Study|Disease Relapse/Progression|2|||
33531530|NCT00101166|62921214|FG000|Overall Study|progressive disease|10|||
33531531|NCT02759016|62921220|FG000|Overall Study|Not treated with BI 836826|1|||
33531532|NCT02759016|62921221|FG001|Overall Study|Not treated with BI 836826|0|||
33531533|NCT02759016|62921220|FG000|Overall Study|Progressive disease|1|||
33531534|NCT02759016|62921221|FG001|Overall Study|Progressive disease|0|||
33531535|NCT02759016|62921220|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
33531536|NCT02759016|62921221|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
33531537|NCT02759016|62921220|FG000|Overall Study|Other not defined above|2|||
33531538|NCT02759016|62921221|FG001|Overall Study|Other not defined above|1|||
33531539|NCT02852967|62921233|FG000|Overall Study|Adverse Event|3|||
33531540|NCT02852967|62921234|FG001|Overall Study|Adverse Event|1|||
33531541|NCT02852967|62921235|FG002|Overall Study|Adverse Event|0|||
33531542|NCT02852967|62921236|FG003|Overall Study|Adverse Event|1|||
33531543|NCT02852967|62921237|FG004|Overall Study|Adverse Event|0|||
33531544|NCT02852967|62921233|FG000|Overall Study|Death|1|||
33531545|NCT02852967|62921234|FG001|Overall Study|Death|0|||
33531546|NCT02852967|62921235|FG002|Overall Study|Death|0|||
33531547|NCT02852967|62921236|FG003|Overall Study|Death|0|||
33531548|NCT02852967|62921237|FG004|Overall Study|Death|0|||
33531549|NCT02852967|62921233|FG000|Overall Study|Lost to Follow-up|1|||
33531550|NCT02852967|62921234|FG001|Overall Study|Lost to Follow-up|2|||
33531551|NCT02852967|62921235|FG002|Overall Study|Lost to Follow-up|3|||
33531552|NCT02852967|62921236|FG003|Overall Study|Lost to Follow-up|4|||
33531553|NCT02852967|62921237|FG004|Overall Study|Lost to Follow-up|4|||
33531554|NCT02852967|62921233|FG000|Overall Study|Withdrawal by Subject|6|||
33531555|NCT02852967|62921234|FG001|Overall Study|Withdrawal by Subject|12|||
33531556|NCT02852967|62921235|FG002|Overall Study|Withdrawal by Subject|7|||
33531557|NCT02852967|62921236|FG003|Overall Study|Withdrawal by Subject|10|||
33531558|NCT02852967|62921237|FG004|Overall Study|Withdrawal by Subject|10|||
33531559|NCT02852967|62921233|FG000|Overall Study|SAE|0|||
33531560|NCT02852967|62921234|FG001|Overall Study|SAE|0|||
33531561|NCT02852967|62921235|FG002|Overall Study|SAE|0|||
33531562|NCT02852967|62921236|FG003|Overall Study|SAE|3|||
33531563|NCT02852967|62921237|FG004|Overall Study|SAE|0|||
33531564|NCT02852967|62921233|FG000|Overall Study|Elevated Liver Enzymes|2|||
33625875|NCT01818297|63026791|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
33625876|NCT01818297|63026792|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
33625877|NCT01818297|63026791|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
33458895|NCT00112437|62832479|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
33531565|NCT02852967|62921234|FG001|Overall Study|Elevated Liver Enzymes|0|||
33531566|NCT02852967|62921235|FG002|Overall Study|Elevated Liver Enzymes|0|||
33531567|NCT02852967|62921236|FG003|Overall Study|Elevated Liver Enzymes|2|||
33531568|NCT02852967|62921237|FG004|Overall Study|Elevated Liver Enzymes|2|||
33625878|NCT01818297|63026792|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
33625879|NCT01818141|63026800|FG000|Overall Study|Withdrawal by Subject|2|||
33458896|NCT00112437|62832480|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458897|NCT00112437|62832481|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458898|NCT00112437|62832482|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458899|NCT00112437|62832483|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458900|NCT00112437|62832484|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458901|NCT00112437|62832485|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458902|NCT00112437|62832486|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458903|NCT00112437|62832487|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458904|NCT00112437|62832488|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458905|NCT00112437|62832489|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458906|NCT00112437|62832490|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
33531569|NCT02852967|62921233|FG000|Overall Study|Physician Decision|0|||
33531570|NCT02852967|62921234|FG001|Overall Study|Physician Decision|0|||
33531571|NCT02852967|62921235|FG002|Overall Study|Physician Decision|0|||
33531572|NCT02852967|62921236|FG003|Overall Study|Physician Decision|1|||
33531573|NCT02852967|62921237|FG004|Overall Study|Physician Decision|0|||
33531574|NCT02852967|62921233|FG000|Overall Study|Lack of Efficacy|0|||
33531575|NCT02852967|62921234|FG001|Overall Study|Lack of Efficacy|1|||
33625880|NCT01818141|63026801|FG001|Overall Study|Withdrawal by Subject|0|||
33531576|NCT02852967|62921235|FG002|Overall Study|Lack of Efficacy|0|||
33531577|NCT02852967|62921236|FG003|Overall Study|Lack of Efficacy|0|||
33458907|NCT00112437|62832491|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
33531578|NCT02852967|62921237|FG004|Overall Study|Lack of Efficacy|0|||
33531579|NCT02852967|62921233|FG000|Overall Study|Non-compliance|0|||
33531580|NCT02852967|62921234|FG001|Overall Study|Non-compliance|0|||
33531581|NCT02852967|62921235|FG002|Overall Study|Non-compliance|1|||
33531582|NCT02852967|62921236|FG003|Overall Study|Non-compliance|1|||
33531583|NCT02852967|62921237|FG004|Overall Study|Non-compliance|0|||
33531584|NCT02852967|62921233|FG000|Overall Study|Dispensing Drug Violation|0|||
33531585|NCT02852967|62921234|FG001|Overall Study|Dispensing Drug Violation|0|||
33531586|NCT02852967|62921235|FG002|Overall Study|Dispensing Drug Violation|1|||
33531587|NCT02852967|62921236|FG003|Overall Study|Dispensing Drug Violation|0|||
33531588|NCT02852967|62921237|FG004|Overall Study|Dispensing Drug Violation|0|||
33531589|NCT02852967|62921233|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
33531590|NCT02852967|62921234|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
33531591|NCT02852967|62921235|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
33531592|NCT02852967|62921236|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
33531593|NCT02852967|62921237|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
33531594|NCT02762994|62921265|FG000|Overall Study|Withdrawal by Subject|0|||
33531595|NCT02762994|62921266|FG001|Overall Study|Withdrawal by Subject|1|||
33531596|NCT02762994|62921267|FG002|Overall Study|Withdrawal by Subject|2|||
33531597|NCT02762994|62921268|FG003|Overall Study|Withdrawal by Subject|0|||
33531598|NCT02762994|62921265|FG000|Overall Study|Protocol Violation|1|||
33531599|NCT02762994|62921266|FG001|Overall Study|Protocol Violation|0|||
33531600|NCT02762994|62921267|FG002|Overall Study|Protocol Violation|0|||
33531601|NCT02762994|62921268|FG003|Overall Study|Protocol Violation|2|||
33531602|NCT02852265|62921284|FG000|3-month Follow-up|Lost to Follow-up|1|||
33531603|NCT02852265|62921285|FG001|3-month Follow-up|Lost to Follow-up|1|||
33531604|NCT02633800|62921297|FG000|Overall Study|Death|3|||
33531605|NCT02633800|62921298|FG001|Overall Study|Death|3|||
33531606|NCT02633800|62921297|FG000|Overall Study|Reason not provided|1|||
33531607|NCT02633800|62921298|FG001|Overall Study|Reason not provided|0|||
33531608|NCT02633800|62921297|FG000|Overall Study|Radiologic(al) progression|23|||
33531609|NCT02633800|62921298|FG001|Overall Study|Radiologic(al) progression|23|||
33531610|NCT02633800|62921297|FG000|Overall Study|Clinical progression|3|||
33531611|NCT02633800|62921298|FG001|Overall Study|Clinical progression|6|||
33531612|NCT02633800|62921297|FG000|Overall Study|Study terminated by sponsor|6|||
33531613|NCT02633800|62921298|FG001|Overall Study|Study terminated by sponsor|5|||
33531614|NCT02633800|62921297|FG000|Overall Study|Adverse event, non-fatal|7|||
33531615|NCT02633800|62921298|FG001|Overall Study|Adverse event, non-fatal|2|||
33531616|NCT02633800|62921297|FG000|Overall Study|Withdrawal by Subject|0|||
33531617|NCT02633800|62921298|FG001|Overall Study|Withdrawal by Subject|3|||
33531618|NCT02633800|62921297|FG000|Overall Study|Patient Request|1|||
33531619|NCT02633800|62921298|FG001|Overall Study|Patient Request|1|||
33531620|NCT03829657|62921307|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
33531621|NCT03829657|62921308|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
33531622|NCT03829657|62921309|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
33531623|NCT03829657|62921310|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
33531624|NCT03829657|62921311|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
33625881|NCT01818141|63026800|FG000|Overall Study|No baseline C.diff colonies|1|||
33625882|NCT01818141|63026801|FG001|Overall Study|No baseline C.diff colonies|1|||
33625883|NCT01818141|63026800|FG000|Overall Study|Lost to Follow-up|0|||
33625884|NCT01818141|63026801|FG001|Overall Study|Lost to Follow-up|2|||
33625885|NCT01849497|63026809|FG000|Overall Study|Withdrawal by Subject|1|||
33625886|NCT01849497|63026810|FG001|Overall Study|Withdrawal by Subject|2|||
33625887|NCT01849497|63026809|FG000|Overall Study|Sponsor Decision|0|||
33625888|NCT01849497|63026810|FG001|Overall Study|Sponsor Decision|1|||
33625889|NCT01849497|63026809|FG000|Overall Study|Lost to Follow-up|0|||
33625890|NCT01849497|63026810|FG001|Overall Study|Lost to Follow-up|1|||
33625891|NCT02147093|63026818|FG000|Period 1|Lost to Follow-up|0|||
33625892|NCT02147093|63026819|FG001|Period 1|Lost to Follow-up|1|||
33625893|NCT02147093|63026818|FG000|Period 2|Protocol Violation|2|||
33531625|NCT03829657|62921307|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
33531626|NCT03829657|62921308|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
33531627|NCT03829657|62921309|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
33531628|NCT03829657|62921310|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
33531629|NCT03829657|62921311|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
33531630|NCT03829657|62921307|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
33531631|NCT03829657|62921308|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
33531632|NCT03829657|62921309|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
33625894|NCT02147093|63026819|FG001|Period 2|Protocol Violation|0|||
33531633|NCT03829657|62921310|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
33625895|NCT02119325|63026825|FG000|Washout Period 1|Adverse Event|0|||
33625896|NCT02119325|63026826|FG001|Washout Period 1|Adverse Event|1|||
33625897|NCT01816893|63026836|FG000|Washout Period|Withdrawal by Subject|2|||
33625898|NCT01816893|63026837|FG001|Washout Period|Withdrawal by Subject|0|||
33625899|NCT01848483|63026845|FG000|Overall Study|Death|2|||
33531634|NCT03829657|62921311|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
33531635|NCT03829657|62921307|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
33531636|NCT03829657|62921308|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
33531637|NCT03829657|62921309|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
33531638|NCT03829657|62921310|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
33531639|NCT03829657|62921311|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
33531640|NCT03829657|62921307|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
33531641|NCT03829657|62921308|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
33625900|NCT01848483|63026846|FG001|Overall Study|Death|1|||
33625901|NCT01848483|63026845|FG000|Overall Study|Lost to Follow-up|6|||
33625902|NCT01848483|63026846|FG001|Overall Study|Lost to Follow-up|8|||
33625903|NCT01848483|63026845|FG000|Overall Study|Withdrawal by Subject|1|||
33625904|NCT01848483|63026846|FG001|Overall Study|Withdrawal by Subject|0|||
33625905|NCT01848483|63026845|FG000|Overall Study|Incarceration|2|||
33625906|NCT01848483|63026846|FG001|Overall Study|Incarceration|2|||
33625907|NCT01610271|63026855|FG000|Overall Study|Surgery not complete|0|||
33625908|NCT01610271|63026856|FG001|Overall Study|Surgery not complete|1|||
33625909|NCT01610271|63026855|FG000|Overall Study|Prosthesis not implanted|2|||
33625910|NCT01610271|63026856|FG001|Overall Study|Prosthesis not implanted|3|||
33625911|NCT02170727|63026866|FG000|Overall Study|Lost to Follow-up|1|||
33458908|NCT00112437|62832492|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458909|NCT00112437|62832493|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458910|NCT00112437|62832494|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
33531642|NCT03829657|62921309|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
33531643|NCT03829657|62921310|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
33531644|NCT03829657|62921311|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
33531645|NCT03829657|62921307|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
33531646|NCT03829657|62921308|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
33531647|NCT03829657|62921309|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
33531648|NCT03829657|62921310|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
33531649|NCT03829657|62921311|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
33531650|NCT03829657|62921307|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
33531651|NCT03829657|62921308|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
33531652|NCT03829657|62921309|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
33531653|NCT03829657|62921310|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
33531654|NCT03829657|62921311|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
33531655|NCT03829657|62921307|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
33531656|NCT03829657|62921308|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
33531657|NCT03829657|62921309|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
33531658|NCT03829657|62921310|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
33531659|NCT03829657|62921311|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
33531660|NCT03829657|62921307|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
33531661|NCT03829657|62921308|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
33625912|NCT02170727|63026867|FG001|Overall Study|Lost to Follow-up|0|||
33625913|NCT02170727|63026866|FG000|Overall Study|Withdrawal by Subject|2|||
33458911|NCT00112437|62832495|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458912|NCT00112437|62832496|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458913|NCT00112437|62832497|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458914|NCT00112437|62832498|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
33458915|NCT00112437|62832473|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458916|NCT00112437|62832474|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458917|NCT00112437|62832475|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458918|NCT00112437|62832476|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458919|NCT00112437|62832477|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458920|NCT00112437|62832478|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458921|NCT00112437|62832479|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458922|NCT00112437|62832480|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458923|NCT00112437|62832481|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458924|NCT00112437|62832482|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458925|NCT00112437|62832483|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458926|NCT00112437|62832484|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458927|NCT00112437|62832485|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33625914|NCT02170727|63026867|FG001|Overall Study|Withdrawal by Subject|0|||
33625915|NCT01847313|63026878|FG000|Overall Study|Death|0|||
33625916|NCT01847313|63026879|FG001|Overall Study|Death|1|||
33625917|NCT01847313|63026878|FG000|Overall Study|Withdrawal by Subject|0|||
33531662|NCT03829657|62921309|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
33531663|NCT03829657|62921310|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
33531664|NCT03829657|62921311|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
33531665|NCT03829657|62921307|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
33531666|NCT03829657|62921308|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
33531667|NCT03829657|62921309|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
33531668|NCT03829657|62921310|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
33531669|NCT03829657|62921311|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
33625918|NCT01847313|63026879|FG001|Overall Study|Withdrawal by Subject|1|||
33625919|NCT02144285|63026895|FG000|Overall Study|Withdrawal by Subject|0|||
33625920|NCT02144285|63026896|FG001|Overall Study|Withdrawal by Subject|0|||
33625921|NCT02144285|63026897|FG002|Overall Study|Withdrawal by Subject|0|||
33625922|NCT02144285|63026898|FG003|Overall Study|Withdrawal by Subject|0|||
33625923|NCT02144285|63026899|FG004|Overall Study|Withdrawal by Subject|1|||
33625924|NCT02144285|63026900|FG005|Overall Study|Withdrawal by Subject|0|||
33625925|NCT02144285|63026901|FG006|Overall Study|Withdrawal by Subject|0|||
33531670|NCT03035227|62921322|FG000|Overall Study|study stopped due to PI leaving institut|1|||
33531671|NCT03035227|62921323|FG001|Overall Study|study stopped due to PI leaving institut|1|||
33531672|NCT00100932|62921333|FG000|Overall Study|Adverse Event|11|||
33531673|NCT00100932|62921334|FG001|Overall Study|Adverse Event|2|||
33531674|NCT00100932|62921333|FG000|Overall Study|Withdrawal by Subject|6|||
33531675|NCT00100932|62921334|FG001|Overall Study|Withdrawal by Subject|0|||
33531676|NCT00100932|62921333|FG000|Overall Study|Progressive Disease|44|||
33531677|NCT00100932|62921334|FG001|Overall Study|Progressive Disease|18|||
33531678|NCT00100932|62921333|FG000|Overall Study|Physician Decision|7|||
33531679|NCT00100932|62921334|FG001|Overall Study|Physician Decision|5|||
33531680|NCT00100932|62921333|FG000|Overall Study|Other|5|||
33531681|NCT00100932|62921334|FG001|Overall Study|Other|2|||
33531682|NCT03180307|62921342|FG000|Overall Study|Lost to Follow-up|2|||
33531683|NCT03180307|62921343|FG001|Overall Study|Lost to Follow-up|0|||
33531684|NCT03180307|62921342|FG000|Overall Study|Death|1|||
33531685|NCT03180307|62921343|FG001|Overall Study|Death|0|||
33531686|NCT03180307|62921342|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
33531687|NCT03180307|62921343|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
33531688|NCT02848833|62921347|FG000|Overall Study|subject who are duplicated|1|||
33531689|NCT02848833|62921347|FG000|Overall Study|have not taken the study drug|11|||
33531690|NCT02848833|62921347|FG000|Overall Study|follow-up failure|6|||
33531691|NCT02848833|62921347|FG000|Overall Study|Protocol Violation|119|||
33531692|NCT03361189|62921353|FG000|Overall Study|Received heart transplant|1|||
33531693|NCT03361189|62921354|FG001|Overall Study|Received heart transplant|0|||
33531694|NCT03361189|62921353|FG000|Overall Study|Pacemake replacement|0|||
33531695|NCT03361189|62921354|FG001|Overall Study|Pacemake replacement|1|||
33531696|NCT00092131|62921362|FG000|Treatment Period I|Adverse Event|1|||
33531697|NCT00092131|62921363|FG001|Treatment Period I|Adverse Event|0|||
33531698|NCT00092131|62921362|FG000|Treatment Period II|Adverse Event|0|||
33531699|NCT00092131|62921363|FG001|Treatment Period II|Adverse Event|1|||
33531700|NCT02668783|62921371|FG000|Overall Study|Pregnancy|0|||
33531701|NCT02668783|62921372|FG001|Overall Study|Pregnancy|1|||
33531702|NCT02668783|62921371|FG000|Overall Study|Protocol Violation|2|||
33531703|NCT02668783|62921372|FG001|Overall Study|Protocol Violation|1|||
33531704|NCT02668783|62921371|FG000|Overall Study|Study terminated by sponsor|9|||
33531705|NCT02668783|62921372|FG001|Overall Study|Study terminated by sponsor|10|||
33531706|NCT02668783|62921371|FG000|Overall Study|Subject moved|1|||
33531707|NCT02668783|62921372|FG001|Overall Study|Subject moved|0|||
33531708|NCT02668783|62921371|FG000|Overall Study|Withdrawal by Subject|1|||
33531709|NCT02668783|62921372|FG001|Overall Study|Withdrawal by Subject|0|||
33531710|NCT00101010|62921378|FG000|Overall Study|Physician Decision|1|||
33531711|NCT02848599|62921384|FG000|Overall Study|Protocol Violation|7|||
33531712|NCT02848599|62921385|FG001|Overall Study|Protocol Violation|9|||
33531713|NCT00778999|62921416|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
33531714|NCT00778999|62921417|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
33531715|NCT00778999|62921416|FG000|Overall Study|Did not receive recFSH|14|||
33625926|NCT02144285|63026902|FG007|Overall Study|Withdrawal by Subject|0|||
33625927|NCT02144285|63026903|FG008|Overall Study|Withdrawal by Subject|0|||
33625928|NCT02144285|63026904|FG009|Overall Study|Withdrawal by Subject|0|||
33625929|NCT02117687|63026942|FG000|Overall Study|Lost to Follow-up|0|||
33625930|NCT02117687|63026943|FG001|Overall Study|Lost to Follow-up|1|||
33531716|NCT00778999|62921417|FG001|Overall Study|Did not receive recFSH|20|||
33531717|NCT02631850|62921427|FG000|Treatment Period|Lost to Follow-up|0|||
33531718|NCT02631850|62921428|FG001|Treatment Period|Lost to Follow-up|1|||
33531719|NCT02631850|62921429|FG002|Treatment Period|Lost to Follow-up|0|||
33531720|NCT02631850|62921430|FG003|Treatment Period|Lost to Follow-up|0|||
33625931|NCT02117687|63026942|FG000|Overall Study|Adverse Event|0|||
33625932|NCT02117687|63026943|FG001|Overall Study|Adverse Event|2|||
33625933|NCT02117687|63026942|FG000|Overall Study|Other Reasons|1|||
33531721|NCT02631850|62921427|FG000|Treatment Period|Protocol Violation|1|||
33531722|NCT02631850|62921428|FG001|Treatment Period|Protocol Violation|0|||
33531723|NCT02631850|62921429|FG002|Treatment Period|Protocol Violation|0|||
33531724|NCT02631850|62921430|FG003|Treatment Period|Protocol Violation|0|||
33531725|NCT02631850|62921427|FG000|Treatment Period|Withdrawal by Subject|0|||
33531726|NCT02631850|62921428|FG001|Treatment Period|Withdrawal by Subject|5|||
33531727|NCT02631850|62921429|FG002|Treatment Period|Withdrawal by Subject|2|||
33531728|NCT02631850|62921430|FG003|Treatment Period|Withdrawal by Subject|2|||
33531729|NCT02631850|62921427|FG000|Treatment Period|Adverse Event|1|||
33531730|NCT02631850|62921428|FG001|Treatment Period|Adverse Event|0|||
33531731|NCT02631850|62921429|FG002|Treatment Period|Adverse Event|2|||
33531732|NCT02631850|62921430|FG003|Treatment Period|Adverse Event|3|||
33531733|NCT02631850|62921427|FG000|Treatment Period|Family medical issue|1|||
33531734|NCT02631850|62921428|FG001|Treatment Period|Family medical issue|0|||
33531735|NCT02631850|62921429|FG002|Treatment Period|Family medical issue|0|||
33531736|NCT02631850|62921430|FG003|Treatment Period|Family medical issue|0|||
33531737|NCT02631850|62921427|FG000|6 Month Follow up|Lost to Follow-up|5|||
33531738|NCT02631850|62921428|FG001|6 Month Follow up|Lost to Follow-up|8|||
33531739|NCT02631850|62921429|FG002|6 Month Follow up|Lost to Follow-up|3|||
33531740|NCT02631850|62921430|FG003|6 Month Follow up|Lost to Follow-up|5|||
33531741|NCT02631850|62921427|FG000|6 Month Follow up|Withdrawal by Subject|1|||
33531742|NCT02631850|62921428|FG001|6 Month Follow up|Withdrawal by Subject|0|||
33531743|NCT02631850|62921429|FG002|6 Month Follow up|Withdrawal by Subject|0|||
33531744|NCT02631850|62921430|FG003|6 Month Follow up|Withdrawal by Subject|2|||
33531745|NCT02631850|62921427|FG000|6 Month Follow up|Adverse Event|1|||
33531746|NCT02631850|62921428|FG001|6 Month Follow up|Adverse Event|4|||
33531747|NCT02631850|62921429|FG002|6 Month Follow up|Adverse Event|1|||
33531748|NCT02631850|62921430|FG003|6 Month Follow up|Adverse Event|3|||
33531749|NCT02631850|62921427|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
33531750|NCT02631850|62921428|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
33531751|NCT02631850|62921429|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
33531752|NCT02631850|62921430|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
33531753|NCT00103038|62921441|FG000|Overall Study|Withdrawal by Subject|8|||
33531754|NCT00103038|62921441|FG000|Overall Study|Screen failure|3|||
33531755|NCT00103038|62921441|FG000|Overall Study|Death|1|||
33531756|NCT00103038|62921441|FG000|Overall Study|Physician Decision|1|||
33531757|NCT00620035|62921448|FG000|Overall Study|Adverse Event|106|||
33531758|NCT00620035|62921448|FG000|Overall Study|Withdrawal of Informed Consent|1|||
33531759|NCT00620035|62921448|FG000|Overall Study|Other Reason|38|||
33531760|NCT03034057|62921452|FG000|Overall Study|Withdrawal by Subject|10|||
33531761|NCT03034057|62921452|FG000|Overall Study|Protocol Violation|1|||
33531762|NCT03034057|62921452|FG000|Overall Study|Not defined|2|||
33531763|NCT03034057|62921452|FG000|Overall Study|Lost to Follow-up|19|||
33531764|NCT03034057|62921452|FG000|Overall Study|Adverse Event|22|||
33531765|NCT03034057|62921452|FG000|Overall Study|Medication error without associated AE|1|||
33531766|NCT02757768|62921458|FG000|Overall Study|Randomized Never Received Study Drug|3|||
33531767|NCT02757768|62921459|FG001|Overall Study|Randomized Never Received Study Drug|4|||
33531768|NCT02757768|62921458|FG000|Overall Study|Adverse Event|5|||
33531769|NCT02757768|62921459|FG001|Overall Study|Adverse Event|3|||
33531770|NCT02757768|62921458|FG000|Overall Study|Lack of Efficacy|2|||
33531771|NCT02757768|62921459|FG001|Overall Study|Lack of Efficacy|1|||
33531772|NCT02757768|62921458|FG000|Overall Study|Lost to Follow-up|1|||
33531773|NCT02757768|62921459|FG001|Overall Study|Lost to Follow-up|0|||
33531774|NCT02757768|62921458|FG000|Overall Study|Protocol Deviation|2|||
33531775|NCT02757768|62921459|FG001|Overall Study|Protocol Deviation|9|||
33531776|NCT02757768|62921458|FG000|Overall Study|Withdrawal by Subject|16|||
33531777|NCT02757768|62921459|FG001|Overall Study|Withdrawal by Subject|9|||
33531778|NCT02757768|62921458|FG000|Overall Study|Miscellaneous|4|||
33531779|NCT02757768|62921459|FG001|Overall Study|Miscellaneous|2|||
33531780|NCT05225389|62921467|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
33531781|NCT02753946|62921473|FG000|Overall Study|Adverse Event|7|||
33531782|NCT02753946|62921474|FG001|Overall Study|Adverse Event|6|||
33531783|NCT02753946|62921473|FG000|Overall Study|Withdrawal by Subject|6|||
33531784|NCT02753946|62921474|FG001|Overall Study|Withdrawal by Subject|1|||
33531785|NCT02753946|62921473|FG000|Overall Study|Lack of Efficacy|1|||
33531786|NCT02753946|62921474|FG001|Overall Study|Lack of Efficacy|0|||
33531787|NCT02753946|62921473|FG000|Overall Study|Physician Decision|0|||
33531788|NCT02753946|62921474|FG001|Overall Study|Physician Decision|2|||
33531789|NCT02756832|62921480|FG000|Overall Study|Lost for Observation after Baseline|6|||
33531790|NCT02756832|62921480|FG000|Overall Study|Lost for Observation|13|||
33531791|NCT02756832|62921480|FG000|Overall Study|Patient's Unwillingness|12|||
33625934|NCT02117687|63026943|FG001|Overall Study|Other Reasons|1|||
33531792|NCT02756832|62921480|FG000|Overall Study|Insufficient Efficacy|2|||
33531793|NCT02756832|62921480|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
33531794|NCT02756832|62921480|FG000|Overall Study|Reason not Specified|9|||
33531795|NCT02756832|62921480|FG000|Overall Study|Protocol Deviation|10|||
33531796|NCT00106080|62921486|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
33531797|NCT00106080|62921487|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
33458928|NCT00112437|62832486|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33531798|NCT02633020|62921495|FG000|Overall Study|Adverse Event|1|||
33531799|NCT02633020|62921496|FG001|Overall Study|Adverse Event|0|||
33531800|NCT00106626|62921506|FG000|Overall Study|Adverse Event|5|||
33531801|NCT00106626|62921507|FG001|Overall Study|Adverse Event|4|||
33531802|NCT00106626|62921508|FG002|Overall Study|Adverse Event|3|||
33531803|NCT00106626|62921509|FG003|Overall Study|Adverse Event|3|||
33531804|NCT00106626|62921506|FG000|Overall Study|Progressive Disease|4|||
33531805|NCT00106626|62921507|FG001|Overall Study|Progressive Disease|1|||
33531806|NCT00106626|62921508|FG002|Overall Study|Progressive Disease|9|||
33531807|NCT00106626|62921509|FG003|Overall Study|Progressive Disease|10|||
33531808|NCT00106626|62921506|FG000|Overall Study|Received radiation on new therapy|1|||
33531809|NCT00106626|62921507|FG001|Overall Study|Received radiation on new therapy|0|||
33531810|NCT00106626|62921508|FG002|Overall Study|Received radiation on new therapy|0|||
33531811|NCT00106626|62921509|FG003|Overall Study|Received radiation on new therapy|0|||
33531812|NCT00106626|62921506|FG000|Overall Study|> 14 day delay in therapy start|0|||
33531813|NCT00106626|62921507|FG001|Overall Study|> 14 day delay in therapy start|1|||
33531814|NCT00106626|62921508|FG002|Overall Study|> 14 day delay in therapy start|0|||
33531815|NCT00106626|62921509|FG003|Overall Study|> 14 day delay in therapy start|0|||
33531816|NCT02632786|62921526|FG000|Overall Study|Adverse Event|2|||
33531817|NCT02632786|62921527|FG001|Overall Study|Adverse Event|1|||
33531818|NCT02632786|62921526|FG000|Overall Study|Death|3|||
33531819|NCT02632786|62921527|FG001|Overall Study|Death|2|||
33531820|NCT02632786|62921526|FG000|Overall Study|Physician Decision|5|||
33531821|NCT02632786|62921527|FG001|Overall Study|Physician Decision|4|||
33531822|NCT02632786|62921526|FG000|Overall Study|Withdrawal by Subject|1|||
33531823|NCT02632786|62921527|FG001|Overall Study|Withdrawal by Subject|0|||
33531824|NCT02755818|62921538|FG000|Overall Study|Withdrawal by Subject|0|||
33531825|NCT02755818|62921539|FG001|Overall Study|Withdrawal by Subject|0|||
33531826|NCT02755818|62921540|FG002|Overall Study|Withdrawal by Subject|0|||
33531827|NCT02755818|62921541|FG003|Overall Study|Withdrawal by Subject|2|||
33531828|NCT02755818|62921538|FG000|Overall Study|withdrawal by PI|0|||
33531829|NCT02755818|62921539|FG001|Overall Study|withdrawal by PI|0|||
33458929|NCT00112437|62832487|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458930|NCT00112437|62832488|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458931|NCT00112437|62832489|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458932|NCT00112437|62832490|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458933|NCT00112437|62832491|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458934|NCT00112437|62832492|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458935|NCT00112437|62832493|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
33458936|NCT00112437|62832494|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
33458937|NCT00112437|62832495|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458938|NCT00112437|62832496|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458939|NCT00112437|62832497|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458940|NCT00112437|62832498|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33458941|NCT00112437|62832473|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458942|NCT00112437|62832474|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458943|NCT00112437|62832475|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458944|NCT00112437|62832476|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458945|NCT00112437|62832477|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33531830|NCT02755818|62921540|FG002|Overall Study|withdrawal by PI|1|||
33531831|NCT02755818|62921541|FG003|Overall Study|withdrawal by PI|1|||
33458946|NCT00112437|62832478|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33531832|NCT03033745|62921556|FG000|Overall Study|Protocol Violation|0|||
33531833|NCT03033745|62921557|FG001|Overall Study|Protocol Violation|0|||
33531834|NCT03033745|62921558|FG002|Overall Study|Protocol Violation|1|||
33625935|NCT02143583|63026952|FG000|Overall Study|Withdrawal by Subject|1|||
33531835|NCT03033745|62921556|FG000|Overall Study|Adverse Event|1|||
33531836|NCT03033745|62921557|FG001|Overall Study|Adverse Event|0|||
33531837|NCT03033745|62921558|FG002|Overall Study|Adverse Event|1|||
33531838|NCT03033745|62921556|FG000|Overall Study|Withdrawal by Subject|0|||
33531839|NCT03033745|62921557|FG001|Overall Study|Withdrawal by Subject|1|||
33531840|NCT03033745|62921558|FG002|Overall Study|Withdrawal by Subject|0|||
33531841|NCT01672294|62921577|FG000|Overall Study|Withdrawal by Subject|4|||
33531842|NCT01672294|62921578|FG001|Overall Study|Withdrawal by Subject|4|||
33531843|NCT01672294|62921579|FG002|Overall Study|Withdrawal by Subject|4|||
33531844|NCT01672294|62921580|FG003|Overall Study|Withdrawal by Subject|4|||
33531845|NCT01672294|62921577|FG000|Overall Study|Excluded by study|1|||
33531846|NCT01672294|62921578|FG001|Overall Study|Excluded by study|1|||
33531847|NCT01672294|62921579|FG002|Overall Study|Excluded by study|0|||
33531848|NCT01672294|62921580|FG003|Overall Study|Excluded by study|0|||
33531849|NCT01672294|62921577|FG000|Overall Study|Lost to Follow-up|1|||
33531850|NCT01672294|62921578|FG001|Overall Study|Lost to Follow-up|16|||
33531851|NCT01672294|62921579|FG002|Overall Study|Lost to Follow-up|7|||
33531852|NCT01672294|62921580|FG003|Overall Study|Lost to Follow-up|9|||
33531853|NCT02755116|62921592|FG000|Overall Study|surgery converted to open, pt admitted|3|||
33531854|NCT02755116|62921593|FG001|Overall Study|surgery converted to open, pt admitted|1|||
33531855|NCT02754492|62921603|FG000|Overall Study|Protocol Violation|2|||
33531856|NCT02754492|62921604|FG001|Overall Study|Protocol Violation|2|||
33531857|NCT02754492|62921605|FG002|Overall Study|Protocol Violation|0|||
33531858|NCT02754492|62921606|FG003|Overall Study|Protocol Violation|1|||
33531859|NCT02754492|62921603|FG000|Overall Study|Withdrawal by Subject|2|||
33531860|NCT02754492|62921604|FG001|Overall Study|Withdrawal by Subject|0|||
33531861|NCT02754492|62921605|FG002|Overall Study|Withdrawal by Subject|0|||
33531862|NCT02754492|62921606|FG003|Overall Study|Withdrawal by Subject|0|||
33531863|NCT02754492|62921603|FG000|Overall Study|Equipment malfuntion|0|||
33531864|NCT02754492|62921604|FG001|Overall Study|Equipment malfuntion|0|||
33531865|NCT02754492|62921605|FG002|Overall Study|Equipment malfuntion|2|||
33531866|NCT02754492|62921606|FG003|Overall Study|Equipment malfuntion|5|||
33531867|NCT02754492|62921603|FG000|Overall Study|Adverse Event|0|||
33531868|NCT02754492|62921604|FG001|Overall Study|Adverse Event|0|||
33531869|NCT02754492|62921605|FG002|Overall Study|Adverse Event|0|||
33531870|NCT02754492|62921606|FG003|Overall Study|Adverse Event|13|||
33531871|NCT02754492|62921603|FG000|Overall Study|Venous access issues not resulting in AE|0|||
33531872|NCT02754492|62921604|FG001|Overall Study|Venous access issues not resulting in AE|0|||
33531873|NCT02754492|62921605|FG002|Overall Study|Venous access issues not resulting in AE|0|||
33531874|NCT02754492|62921606|FG003|Overall Study|Venous access issues not resulting in AE|4|||
33531875|NCT04068688|62921625|FG000|Overall Study|Lost to Follow-up|1|||
33531876|NCT04068688|62921626|FG001|Overall Study|Lost to Follow-up|1|||
33531877|NCT04068688|62921627|FG002|Overall Study|Lost to Follow-up|0|||
33531878|NCT04068688|62921628|FG003|Overall Study|Lost to Follow-up|0|||
33531879|NCT04068688|62921629|FG004|Overall Study|Lost to Follow-up|5|||
33531880|NCT04068688|62921630|FG005|Overall Study|Lost to Follow-up|5|||
33531881|NCT04068688|62921631|FG006|Overall Study|Lost to Follow-up|0|||
33531882|NCT04068688|62921632|FG007|Overall Study|Lost to Follow-up|0|||
33531883|NCT04068688|62921633|FG008|Overall Study|Lost to Follow-up|1|||
33531884|NCT04068688|62921634|FG009|Overall Study|Lost to Follow-up|0|||
33531885|NCT04068688|62921625|FG000|Overall Study|Withdrawal by Subject|1|||
33531886|NCT04068688|62921626|FG001|Overall Study|Withdrawal by Subject|1|||
33531887|NCT04068688|62921627|FG002|Overall Study|Withdrawal by Subject|0|||
33531888|NCT04068688|62921628|FG003|Overall Study|Withdrawal by Subject|0|||
33531889|NCT04068688|62921629|FG004|Overall Study|Withdrawal by Subject|0|||
33531890|NCT04068688|62921630|FG005|Overall Study|Withdrawal by Subject|0|||
33531891|NCT04068688|62921631|FG006|Overall Study|Withdrawal by Subject|0|||
33531892|NCT04068688|62921632|FG007|Overall Study|Withdrawal by Subject|0|||
33531893|NCT04068688|62921633|FG008|Overall Study|Withdrawal by Subject|0|||
33531894|NCT04068688|62921634|FG009|Overall Study|Withdrawal by Subject|0|||
33531895|NCT04068688|62921625|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
33531896|NCT04068688|62921626|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
33531897|NCT04068688|62921627|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33531898|NCT04068688|62921628|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33531899|NCT04068688|62921629|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33531900|NCT04068688|62921630|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33531901|NCT04068688|62921631|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33531902|NCT04068688|62921632|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33531903|NCT04068688|62921633|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33531904|NCT04068688|62921634|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33531905|NCT01671748|62921662|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
33531906|NCT01671748|62921663|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
33531907|NCT01671748|62921662|FG000|4 Week run-in Phase|Adverse Event|1|||
33531908|NCT01671748|62921663|FG001|4 Week run-in Phase|Adverse Event|0|||
33531909|NCT01671748|62921662|FG000|4 Week run-in Phase|Not eligible|9|||
33531910|NCT01671748|62921663|FG001|4 Week run-in Phase|Not eligible|0|||
33531911|NCT02657889|62921673|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
33531912|NCT02657889|62921674|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
33531913|NCT02657889|62921675|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
33531914|NCT02657889|62921676|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
33531915|NCT02657889|62921673|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
33625936|NCT02143583|63026953|FG001|Overall Study|Withdrawal by Subject|0|||
33625937|NCT02143583|63026954|FG002|Overall Study|Withdrawal by Subject|1|||
33625938|NCT02143583|63026952|FG000|Overall Study|husband illness|0|||
33625939|NCT02143583|63026953|FG001|Overall Study|husband illness|0|||
33625940|NCT02143583|63026954|FG002|Overall Study|husband illness|1|||
33625941|NCT02105987|63026964|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
33625942|NCT02105987|63026965|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
33625943|NCT02105987|63026966|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
33625944|NCT02105987|63026967|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
33625945|NCT02105987|63026968|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
33625946|NCT02105987|63026969|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
33625947|NCT02105987|63026964|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
33625948|NCT02105987|63026965|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
33625949|NCT02105987|63026966|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
33625950|NCT02105987|63026967|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
33625951|NCT02105987|63026968|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
33458947|NCT00112437|62832479|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458948|NCT00112437|62832480|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458949|NCT00112437|62832481|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458950|NCT00112437|62832482|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458951|NCT00112437|62832483|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458952|NCT00112437|62832484|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458953|NCT00112437|62832485|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458954|NCT00112437|62832486|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458955|NCT00112437|62832487|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458956|NCT00112437|62832488|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458957|NCT00112437|62832489|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458958|NCT00112437|62832490|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458959|NCT00112437|62832491|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458960|NCT00112437|62832492|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458961|NCT00112437|62832493|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458962|NCT00112437|62832494|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458963|NCT00112437|62832495|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
33458964|NCT00112437|62832496|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
33458965|NCT00112437|62832497|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33458966|NCT00112437|62832498|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
33458967|NCT00112437|62832473|FG000|Years 6-10 (60-Month Extension)|Death|0|||
33458968|NCT00112437|62832474|FG001|Years 6-10 (60-Month Extension)|Death|0|||
33458969|NCT00112437|62832475|FG002|Years 6-10 (60-Month Extension)|Death|0|||
33458970|NCT00112437|62832476|FG003|Years 6-10 (60-Month Extension)|Death|0|||
33458971|NCT00112437|62832477|FG004|Years 6-10 (60-Month Extension)|Death|0|||
33458972|NCT00112437|62832478|FG005|Years 6-10 (60-Month Extension)|Death|0|||
33458973|NCT00112437|62832479|FG006|Years 6-10 (60-Month Extension)|Death|0|||
33458974|NCT00112437|62832480|FG007|Years 6-10 (60-Month Extension)|Death|0|||
33458975|NCT00112437|62832481|FG008|Years 6-10 (60-Month Extension)|Death|0|||
33458976|NCT00112437|62832482|FG009|Years 6-10 (60-Month Extension)|Death|0|||
33458977|NCT00112437|62832483|FG010|Years 6-10 (60-Month Extension)|Death|0|||
33458978|NCT00112437|62832484|FG011|Years 6-10 (60-Month Extension)|Death|0|||
33458979|NCT00112437|62832485|FG012|Years 6-10 (60-Month Extension)|Death|0|||
33458980|NCT00112437|62832486|FG013|Years 6-10 (60-Month Extension)|Death|0|||
33458981|NCT00112437|62832487|FG014|Years 6-10 (60-Month Extension)|Death|0|||
33458982|NCT00112437|62832488|FG015|Years 6-10 (60-Month Extension)|Death|0|||
33458983|NCT00112437|62832489|FG016|Years 6-10 (60-Month Extension)|Death|0|||
33458984|NCT00112437|62832490|FG017|Years 6-10 (60-Month Extension)|Death|0|||
33458985|NCT00112437|62832491|FG018|Years 6-10 (60-Month Extension)|Death|0|||
33458986|NCT00112437|62832492|FG019|Years 6-10 (60-Month Extension)|Death|0|||
33458987|NCT00112437|62832493|FG020|Years 6-10 (60-Month Extension)|Death|0|||
33458988|NCT00112437|62832494|FG021|Years 6-10 (60-Month Extension)|Death|0|||
33458989|NCT00112437|62832495|FG022|Years 6-10 (60-Month Extension)|Death|0|||
33458990|NCT00112437|62832496|FG023|Years 6-10 (60-Month Extension)|Death|2|||
33458991|NCT00112437|62832497|FG024|Years 6-10 (60-Month Extension)|Death|0|||
33458992|NCT00112437|62832498|FG025|Years 6-10 (60-Month Extension)|Death|0|||
33458993|NCT00112437|62832473|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33458994|NCT00112437|62832474|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33458995|NCT00112437|62832475|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33531916|NCT02657889|62921674|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
33531917|NCT02657889|62921675|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
33531918|NCT02657889|62921676|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
33531919|NCT02657889|62921673|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
33531920|NCT02657889|62921674|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
33531921|NCT02657889|62921675|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
33531922|NCT02657889|62921676|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
33531923|NCT02657889|62921673|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
33531924|NCT02657889|62921674|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
33531925|NCT02657889|62921675|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
33531926|NCT02657889|62921676|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
33625952|NCT02105987|63026969|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
33625953|NCT02105987|63026964|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
33625954|NCT02105987|63026965|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
33625955|NCT02105987|63026966|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33625956|NCT02105987|63026967|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33625957|NCT02105987|63026968|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33625958|NCT02105987|63026969|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33625959|NCT02105987|63026964|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
33625960|NCT02105987|63026965|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
33458996|NCT00112437|62832476|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33458997|NCT00112437|62832477|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33458998|NCT00112437|62832478|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33458999|NCT00112437|62832479|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459000|NCT00112437|62832480|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459001|NCT00112437|62832481|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459002|NCT00112437|62832482|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459003|NCT00112437|62832483|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459004|NCT00112437|62832484|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459005|NCT00112437|62832485|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459006|NCT00112437|62832486|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459007|NCT00112437|62832487|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459008|NCT00112437|62832488|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459009|NCT00112437|62832489|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459010|NCT00112437|62832490|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459011|NCT00112437|62832491|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459012|NCT00112437|62832492|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459013|NCT00112437|62832493|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459014|NCT00112437|62832494|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459015|NCT00112437|62832495|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459016|NCT00112437|62832496|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459017|NCT00112437|62832497|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33459018|NCT00112437|62832498|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
33459019|NCT00112437|62832473|FG000|Years 6-10 (60-Month Extension)|Other|0|||
33459020|NCT00112437|62832474|FG001|Years 6-10 (60-Month Extension)|Other|0|||
33459021|NCT00112437|62832475|FG002|Years 6-10 (60-Month Extension)|Other|0|||
33459022|NCT00112437|62832476|FG003|Years 6-10 (60-Month Extension)|Other|0|||
33459023|NCT00112437|62832477|FG004|Years 6-10 (60-Month Extension)|Other|0|||
33459024|NCT00112437|62832478|FG005|Years 6-10 (60-Month Extension)|Other|0|||
33459025|NCT00112437|62832479|FG006|Years 6-10 (60-Month Extension)|Other|0|||
33459026|NCT00112437|62832480|FG007|Years 6-10 (60-Month Extension)|Other|0|||
33459027|NCT00112437|62832481|FG008|Years 6-10 (60-Month Extension)|Other|0|||
33459028|NCT00112437|62832482|FG009|Years 6-10 (60-Month Extension)|Other|0|||
33459029|NCT00112437|62832483|FG010|Years 6-10 (60-Month Extension)|Other|0|||
33459030|NCT00112437|62832484|FG011|Years 6-10 (60-Month Extension)|Other|0|||
33459031|NCT00112437|62832485|FG012|Years 6-10 (60-Month Extension)|Other|0|||
33459032|NCT00112437|62832486|FG013|Years 6-10 (60-Month Extension)|Other|0|||
33459033|NCT00112437|62832487|FG014|Years 6-10 (60-Month Extension)|Other|0|||
33459034|NCT00112437|62832488|FG015|Years 6-10 (60-Month Extension)|Other|0|||
33459035|NCT00112437|62832489|FG016|Years 6-10 (60-Month Extension)|Other|0|||
33459036|NCT00112437|62832490|FG017|Years 6-10 (60-Month Extension)|Other|0|||
33459037|NCT00112437|62832491|FG018|Years 6-10 (60-Month Extension)|Other|0|||
33459038|NCT00112437|62832492|FG019|Years 6-10 (60-Month Extension)|Other|0|||
33531927|NCT02657889|62921673|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
33531928|NCT02657889|62921674|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
33459039|NCT00112437|62832493|FG020|Years 6-10 (60-Month Extension)|Other|0|||
33459040|NCT00112437|62832494|FG021|Years 6-10 (60-Month Extension)|Other|0|||
33459041|NCT00112437|62832495|FG022|Years 6-10 (60-Month Extension)|Other|0|||
33625961|NCT02105987|63026966|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33625962|NCT02105987|63026967|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33625963|NCT02105987|63026968|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33625964|NCT02105987|63026969|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33625965|NCT02105987|63026964|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
33625966|NCT02105987|63026965|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
33625967|NCT02105987|63026966|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
33625968|NCT02105987|63026967|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
33625969|NCT02105987|63026968|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
33625970|NCT02105987|63026969|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
33625971|NCT02105987|63026964|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
33625972|NCT02105987|63026965|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
33625973|NCT02105987|63026966|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
33625974|NCT02105987|63026967|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
33625975|NCT02105987|63026968|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
33625976|NCT02105987|63026969|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
33625977|NCT02105987|63026964|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
33625978|NCT02105987|63026965|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
33625979|NCT02105987|63026966|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
33625980|NCT02105987|63026967|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
33625981|NCT02105987|63026968|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
33625982|NCT02105987|63026969|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
33625983|NCT02105987|63026964|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
33625984|NCT02105987|63026965|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
33625985|NCT02105987|63026966|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
33625986|NCT02105987|63026967|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
33625987|NCT02105987|63026968|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
33625988|NCT02105987|63026969|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
33625989|NCT02105987|63026964|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33625990|NCT02105987|63026965|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33625991|NCT02105987|63026966|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
33625992|NCT02105987|63026967|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
33625993|NCT02105987|63026968|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33625994|NCT02105987|63026969|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33625995|NCT02105987|63026964|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33625996|NCT02105987|63026965|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33625997|NCT02105987|63026966|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
33625998|NCT02105987|63026967|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
33625999|NCT02105987|63026968|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33626000|NCT02105987|63026969|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33626001|NCT02105987|63026964|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
33626002|NCT02105987|63026965|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
33626003|NCT02105987|63026966|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
33626004|NCT02105987|63026967|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
33626005|NCT02105987|63026968|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
33626006|NCT02105987|63026969|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
33626007|NCT02105987|63026964|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
33626008|NCT02105987|63026965|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
33626009|NCT02105987|63026966|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
33626010|NCT02105987|63026967|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
33626011|NCT02105987|63026968|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
33626012|NCT02105987|63026969|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
33626013|NCT02105987|63026964|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
33626014|NCT02105987|63026965|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
33626015|NCT02105987|63026966|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
33626016|NCT02105987|63026967|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
33626017|NCT02105987|63026968|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
33459042|NCT00112437|62832496|FG023|Years 6-10 (60-Month Extension)|Other|0|||
33459043|NCT00112437|62832497|FG024|Years 6-10 (60-Month Extension)|Other|1|||
33459044|NCT00112437|62832498|FG025|Years 6-10 (60-Month Extension)|Other|0|||
33459045|NCT00112437|62832473|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459046|NCT00112437|62832474|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33626018|NCT02105987|63026969|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
33626019|NCT02105987|63026964|FG000|Continuation Phase|Protocol Violation|0|||
33459047|NCT00112437|62832475|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459048|NCT00112437|62832476|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459049|NCT00112437|62832477|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459050|NCT00112437|62832478|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33626020|NCT02105987|63026965|FG001|Continuation Phase|Protocol Violation|0|||
33626021|NCT02105987|63026966|FG002|Continuation Phase|Protocol Violation|0|||
33626022|NCT02105987|63026967|FG003|Continuation Phase|Protocol Violation|0|||
33626023|NCT02105987|63026968|FG004|Continuation Phase|Protocol Violation|1|||
33626024|NCT02105987|63026969|FG005|Continuation Phase|Protocol Violation|0|||
33626025|NCT02141633|63026977|FG000|Overall Study|Physician Decision|1|||
33626026|NCT02141633|63026978|FG001|Overall Study|Physician Decision|0|||
33626027|NCT01846611|63026986|FG000|Overall Study|Lost to Follow-up|4|||
33626028|NCT01846611|63026987|FG001|Overall Study|Lost to Follow-up|6|||
33626029|NCT01846611|63026986|FG000|Overall Study|Withdrawal by Subject|15|||
33626030|NCT01846611|63026987|FG001|Overall Study|Withdrawal by Subject|19|||
33626031|NCT01846611|63026986|FG000|Overall Study|Other|19|||
33626032|NCT01846611|63026987|FG001|Overall Study|Other|18|||
33531929|NCT02657889|62921675|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
33531930|NCT02657889|62921676|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
33531931|NCT02657889|62921673|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
33531932|NCT02657889|62921674|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
33531933|NCT02657889|62921675|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
33531934|NCT02657889|62921676|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
33531935|NCT02657889|62921673|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
33531936|NCT02657889|62921674|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
33626033|NCT02141399|63026993|FG000|Overall Study|Adverse Event|158|||
33626034|NCT02141399|63026993|FG000|Overall Study|Lack of Efficacy|62|||
33626035|NCT02141399|63026993|FG000|Overall Study|Lost to Follow-up|151|||
33626036|NCT02141399|63026993|FG000|Overall Study|Non-compliance with study drug|18|||
33626037|NCT02141399|63026993|FG000|Overall Study|Other|45|||
33626038|NCT02141399|63026993|FG000|Overall Study|Physician Decision|17|||
33626039|NCT02141399|63026993|FG000|Overall Study|Pregnancy|3|||
33626040|NCT02141399|63026993|FG000|Overall Study|Protocol Violation|38|||
33626041|NCT02141399|63026993|FG000|Overall Study|Withdrawal by Subject|238|||
33626042|NCT02141399|63026993|FG000|Overall Study|Failure to meet eligibility criteria|14|||
33626043|NCT01846299|63026999|FG000|Overall Study|Physician Decision|4|||
33626044|NCT01846299|63027000|FG001|Overall Study|Physician Decision|2|||
33626045|NCT01846299|63026999|FG000|Overall Study|Protocol deviation|1|||
33626046|NCT01846299|63027000|FG001|Overall Study|Protocol deviation|0|||
33626047|NCT01846299|63026999|FG000|Overall Study|Death|1|||
33626048|NCT01846299|63027000|FG001|Overall Study|Death|2|||
33626049|NCT01846299|63026999|FG000|Overall Study|Lost to Follow-up|3|||
33626050|NCT01846299|63027000|FG001|Overall Study|Lost to Follow-up|0|||
33626051|NCT01846299|63026999|FG000|Overall Study|Withdrawal by Subject|1|||
33626052|NCT01846299|63027000|FG001|Overall Study|Withdrawal by Subject|6|||
33626053|NCT01846299|63026999|FG000|Overall Study|Adverse Event|2|||
33626054|NCT01846299|63027000|FG001|Overall Study|Adverse Event|0|||
33626055|NCT01628393|63027011|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
33626056|NCT01628393|63027012|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
33626057|NCT01628393|63027013|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
33626058|NCT01628393|63027014|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
33626059|NCT01628393|63027015|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
33626060|NCT01628393|63027011|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
33626061|NCT01628393|63027012|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
33626062|NCT01628393|63027013|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
33626063|NCT01628393|63027014|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
33626064|NCT01628393|63027015|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
33626065|NCT01628393|63027011|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
33626066|NCT01628393|63027012|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
33626067|NCT01628393|63027013|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
33626068|NCT01628393|63027014|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
33626069|NCT01628393|63027015|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
33626070|NCT01628393|63027011|FG000|Blinded Active Extension Period|Adverse Event|0|||
33626071|NCT01628393|63027012|FG001|Blinded Active Extension Period|Adverse Event|1|||
33626072|NCT01628393|63027013|FG002|Blinded Active Extension Period|Adverse Event|0|||
33626073|NCT01628393|63027014|FG003|Blinded Active Extension Period|Adverse Event|2|||
33626074|NCT01628393|63027015|FG004|Blinded Active Extension Period|Adverse Event|2|||
33626075|NCT01628393|63027011|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
33626076|NCT01628393|63027012|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
33626077|NCT01628393|63027013|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
33626078|NCT01628393|63027014|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
33626079|NCT01628393|63027015|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
33626080|NCT01628393|63027011|FG000|Blinded Active Extension Period|Physician Decision|0|||
33626081|NCT01628393|63027012|FG001|Blinded Active Extension Period|Physician Decision|3|||
33626082|NCT01628393|63027013|FG002|Blinded Active Extension Period|Physician Decision|0|||
33626083|NCT01628393|63027014|FG003|Blinded Active Extension Period|Physician Decision|1|||
33626084|NCT01628393|63027015|FG004|Blinded Active Extension Period|Physician Decision|0|||
33626085|NCT01628393|63027011|FG000|Blinded Active Extension Period|Protocol Violation|0|||
33626086|NCT01628393|63027012|FG001|Blinded Active Extension Period|Protocol Violation|0|||
33531937|NCT02657889|62921675|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
33531938|NCT02657889|62921676|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
33531939|NCT02657889|62921673|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
33531940|NCT02657889|62921674|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
33531941|NCT02657889|62921675|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
33531942|NCT02657889|62921676|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
33531943|NCT02657889|62921673|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
33531944|NCT02657889|62921674|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
33531945|NCT02657889|62921675|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
33531946|NCT02657889|62921676|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
33531947|NCT02657889|62921673|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
33531948|NCT02657889|62921674|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
33531949|NCT02657889|62921675|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
33531950|NCT02657889|62921676|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
33531951|NCT02657889|62921673|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
33531952|NCT02657889|62921674|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
33531953|NCT02657889|62921675|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
33531954|NCT02657889|62921676|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
33531955|NCT02657889|62921673|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
33531956|NCT02657889|62921674|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
33531957|NCT02657889|62921675|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
33531958|NCT02657889|62921676|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
33325711|NCT01212770|62702218|FG007|Long-term Safety Phase (Year 5)|Death|1|||
33531959|NCT03034915|62921691|FG000|Overall Study|Adverse Event|29|||
33531960|NCT03034915|62921692|FG001|Overall Study|Adverse Event|32|||
33626087|NCT01628393|63027013|FG002|Blinded Active Extension Period|Protocol Violation|2|||
33626088|NCT01628393|63027014|FG003|Blinded Active Extension Period|Protocol Violation|1|||
33626089|NCT01628393|63027015|FG004|Blinded Active Extension Period|Protocol Violation|0|||
33626090|NCT01628393|63027011|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
33626091|NCT01628393|63027012|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
33531961|NCT03034915|62921693|FG002|Overall Study|Adverse Event|22|||
33531962|NCT03034915|62921691|FG000|Overall Study|Lost to Follow-up|5|||
33531963|NCT03034915|62921692|FG001|Overall Study|Lost to Follow-up|13|||
33531964|NCT03034915|62921693|FG002|Overall Study|Lost to Follow-up|3|||
33531965|NCT03034915|62921691|FG000|Overall Study|Withdrawal by Subject|29|||
33531966|NCT03034915|62921692|FG001|Overall Study|Withdrawal by Subject|46|||
33531967|NCT03034915|62921693|FG002|Overall Study|Withdrawal by Subject|41|||
33531968|NCT03034915|62921691|FG000|Overall Study|Protocol Deviation|2|||
33531969|NCT03034915|62921692|FG001|Overall Study|Protocol Deviation|14|||
33626092|NCT01628393|63027013|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
33626093|NCT01628393|63027014|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
33626094|NCT01628393|63027015|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
33626095|NCT01846221|63027031|FG000|Overall Study|Catheter Failure|2|||
33626096|NCT01846221|63027032|FG001|Overall Study|Catheter Failure|0|||
33626097|NCT01846221|63027031|FG000|Overall Study|Age Exclusion|1|||
33626098|NCT01846221|63027032|FG001|Overall Study|Age Exclusion|0|||
33626099|NCT01815099|63027038|FG000|Overall Study|Lack of Efficacy|1|||
33626100|NCT01815099|63027038|FG000|Overall Study|unable to attend study visits|1|||
33531970|NCT03034915|62921693|FG002|Overall Study|Protocol Deviation|7|||
33531971|NCT03034915|62921691|FG000|Overall Study|Lack of Efficacy|8|||
33531972|NCT03034915|62921692|FG001|Overall Study|Lack of Efficacy|16|||
33626101|NCT01845831|63027045|FG000|Inpatient Phase|Withdrawal by Subject|1|||
33626102|NCT01845831|63027046|FG001|Inpatient Phase|Withdrawal by Subject|1|||
33626103|NCT01845831|63027047|FG002|Inpatient Phase|Withdrawal by Subject|0|||
33626104|NCT01845831|63027048|FG003|Inpatient Phase|Withdrawal by Subject|0|||
33626105|NCT01845831|63027049|FG004|Inpatient Phase|Withdrawal by Subject|0|||
33626106|NCT01627691|63027060|FG000|Overall Study|Death|11|||
33531973|NCT03034915|62921693|FG002|Overall Study|Lack of Efficacy|18|||
33531974|NCT03034915|62921691|FG000|Overall Study|Site closed|2|||
33626107|NCT01627691|63027060|FG000|Overall Study|Lost to Follow-up|3|||
33626108|NCT01627691|63027060|FG000|Overall Study|Withdrawal by Subject|1|||
33626109|NCT01627691|63027060|FG000|Overall Study|Missed the visit|3|||
33626110|NCT01844895|63027064|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
33626111|NCT01844895|63027064|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
33531975|NCT03034915|62921692|FG001|Overall Study|Site closed|2|||
33531976|NCT03034915|62921693|FG002|Overall Study|Site closed|4|||
33531977|NCT03034915|62921691|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
33531978|NCT03034915|62921692|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
33531979|NCT03034915|62921693|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
33531980|NCT03034915|62921691|FG000|Overall Study|Physician Decision|1|||
33531981|NCT03034915|62921692|FG001|Overall Study|Physician Decision|5|||
33531982|NCT03034915|62921693|FG002|Overall Study|Physician Decision|2|||
33531983|NCT02631538|62921705|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
33531984|NCT02631538|62921706|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
33531985|NCT02631538|62921707|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
33531986|NCT02631538|62921708|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
33531987|NCT02631538|62921705|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
33531988|NCT02631538|62921706|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
33531989|NCT02631538|62921707|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
33531990|NCT02631538|62921708|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
33531991|NCT02631538|62921705|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
33531992|NCT02631538|62921706|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
33531993|NCT02631538|62921707|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
33531994|NCT02631538|62921708|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
33531995|NCT02631538|62921705|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
33531996|NCT02631538|62921706|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
33531997|NCT02631538|62921707|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
33531998|NCT02631538|62921708|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
33531999|NCT02631538|62921705|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
33532000|NCT02631538|62921706|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
33532001|NCT02631538|62921707|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
33532002|NCT02631538|62921708|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
33532003|NCT02631538|62921705|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
33532004|NCT02631538|62921706|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
33532005|NCT02631538|62921707|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
33532006|NCT02631538|62921708|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
33532007|NCT02631148|62921731|FG000|Overall Study|8 were ineligible|8|||
33532008|NCT02631148|62921732|FG001|Overall Study|8 were ineligible|0|||
33532009|NCT02631148|62921731|FG000|Overall Study|Withdrawal by Subject|1|||
33532010|NCT02631148|62921732|FG001|Overall Study|Withdrawal by Subject|0|||
33532011|NCT02631148|62921731|FG000|Overall Study|PAH not available to study participant|1|||
33532012|NCT02631148|62921732|FG001|Overall Study|PAH not available to study participant|0|||
33532013|NCT02753400|62921740|FG000|Overall Study|Adverse Event|3|||
33532014|NCT02753400|62921741|FG001|Overall Study|Adverse Event|0|||
33532015|NCT02753400|62921740|FG000|Overall Study|Withdrawal by Subject|2|||
33532016|NCT02753400|62921741|FG001|Overall Study|Withdrawal by Subject|1|||
33532017|NCT03943147|62921758|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
33532018|NCT03943147|62921759|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
33532019|NCT03943147|62921758|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
33532020|NCT03943147|62921759|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
33532021|NCT03943147|62921758|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
33532022|NCT03943147|62921759|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
33532023|NCT03943147|62921758|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
33532024|NCT03943147|62921759|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
33532025|NCT03943147|62921758|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
33325712|NCT01212770|62702219|FG008|Long-term Safety Phase (Year 5)|Death|0|||
33459051|NCT00112437|62832479|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459052|NCT00112437|62832480|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459053|NCT00112437|62832481|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459054|NCT00112437|62832482|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459055|NCT00112437|62832483|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459056|NCT00112437|62832484|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459057|NCT00112437|62832485|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459058|NCT00112437|62832486|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459059|NCT00112437|62832487|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459060|NCT00112437|62832488|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459061|NCT00112437|62832489|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459062|NCT00112437|62832490|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33532026|NCT03943147|62921759|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
33532027|NCT03943147|62921758|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
33532028|NCT03943147|62921759|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
33459063|NCT00112437|62832491|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33532029|NCT03730987|62921777|FG000|Overall Study|Lost to Follow-up|2|||
33626112|NCT01844895|63027064|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
33626113|NCT01844895|63027064|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
33626114|NCT01844895|63027064|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
33626115|NCT01844895|63027064|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
33626116|NCT01844895|63027064|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
33626117|NCT02116361|63027081|FG000|Overall Study|Pregnancy|0|||
33626118|NCT02116361|63027082|FG001|Overall Study|Pregnancy|0|||
33626119|NCT02116361|63027083|FG002|Overall Study|Pregnancy|0|||
33626120|NCT02116361|63027084|FG003|Overall Study|Pregnancy|1|||
33626121|NCT02116361|63027081|FG000|Overall Study|Protocol Violation|1|||
33532030|NCT03730987|62921778|FG001|Overall Study|Lost to Follow-up|0|||
33532031|NCT03730987|62921779|FG002|Overall Study|Lost to Follow-up|2|||
33532032|NCT03730987|62921780|FG003|Overall Study|Lost to Follow-up|0|||
33532033|NCT03556891|62921791|FG000|Overall Study|Adverse Event|4|||
33532034|NCT03556891|62921791|FG000|Overall Study|MRI Need|3|||
33532035|NCT03556891|62921791|FG000|Overall Study|Device Failure|1|||
33532036|NCT03556891|62921791|FG000|Overall Study|Death|1|||
33626122|NCT02116361|63027082|FG001|Overall Study|Protocol Violation|0|||
33459064|NCT00112437|62832492|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459065|NCT00112437|62832493|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459066|NCT00112437|62832494|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459067|NCT00112437|62832495|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459068|NCT00112437|62832496|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
33459069|NCT00112437|62832497|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459070|NCT00112437|62832498|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33459071|NCT00112437|62832473|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459072|NCT00112437|62832474|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459073|NCT00112437|62832475|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459074|NCT00112437|62832476|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459075|NCT00112437|62832477|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459076|NCT00112437|62832478|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459077|NCT00112437|62832479|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459078|NCT00112437|62832480|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459079|NCT00112437|62832481|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459080|NCT00112437|62832482|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459081|NCT00112437|62832483|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459082|NCT00112437|62832484|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459083|NCT00112437|62832485|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459084|NCT00112437|62832486|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459085|NCT00112437|62832487|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459086|NCT00112437|62832488|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459087|NCT00112437|62832489|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459088|NCT00112437|62832490|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459089|NCT00112437|62832491|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33532037|NCT03556891|62921791|FG000|Overall Study|Lost to Follow-up|1|||
33532038|NCT03556891|62921791|FG000|Overall Study|Missing at random|1|||
33532039|NCT03556891|62921791|FG000|Overall Study|Missing due to COVID|1|||
33532040|NCT03556891|62921791|FG000|Overall Study|Protocol Violation|1|||
33532041|NCT02844543|62921795|FG000|Overall Study|Withdrawal by Subject|4|||
33532042|NCT02844543|62921795|FG000|Overall Study|Did not meet eligibility criteria|1|||
33532043|NCT03034135|62921799|FG000|Overall Study|Withdrawal by Subject|2|||
33626123|NCT02116361|63027083|FG002|Overall Study|Protocol Violation|0|||
33626124|NCT02116361|63027084|FG003|Overall Study|Protocol Violation|2|||
33626125|NCT02116361|63027081|FG000|Overall Study|Physician Decision|2|||
33626126|NCT02116361|63027082|FG001|Overall Study|Physician Decision|3|||
33626127|NCT02116361|63027083|FG002|Overall Study|Physician Decision|0|||
33459090|NCT00112437|62832492|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459091|NCT00112437|62832493|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33532044|NCT01671280|62921803|FG000|Overall Study|Withdrawal by Subject|2|||
33626128|NCT02116361|63027084|FG003|Overall Study|Physician Decision|0|||
33626129|NCT02116361|63027081|FG000|Overall Study|Adverse Event|1|||
33626130|NCT02116361|63027082|FG001|Overall Study|Adverse Event|0|||
33532045|NCT01405963|62921809|FG000|Overall Study|Moved Away|2|||
33532046|NCT01405963|62921810|FG001|Overall Study|Moved Away|0|||
33532047|NCT01405963|62921809|FG000|Overall Study|Adverse Event|0|||
33532048|NCT01405963|62921810|FG001|Overall Study|Adverse Event|1|||
33532049|NCT01405963|62921809|FG000|Overall Study|Lost to Follow-up|0|||
33532050|NCT01405963|62921810|FG001|Overall Study|Lost to Follow-up|1|||
33532051|NCT02846415|62921819|FG000|Overall Study|Lost to Follow-up|2|||
33532052|NCT02846415|62921820|FG001|Overall Study|Lost to Follow-up|0|||
33532053|NCT02846415|62921819|FG000|Overall Study|Withdrawal by Subject|1|||
33532054|NCT02846415|62921820|FG001|Overall Study|Withdrawal by Subject|1|||
33532055|NCT02628418|62921839|FG000|Overall Study|Lost to Follow-up|1|||
33532056|NCT02628418|62921840|FG001|Overall Study|Lost to Follow-up|2|||
33532057|NCT02752776|62921868|FG000|Overall Study|Adverse Event|15|||
33532058|NCT02752776|62921869|FG001|Overall Study|Adverse Event|23|||
33532059|NCT02752776|62921870|FG002|Overall Study|Adverse Event|11|||
33532060|NCT02752776|62921868|FG000|Overall Study|Lack of Efficacy|2|||
33532061|NCT02752776|62921869|FG001|Overall Study|Lack of Efficacy|6|||
33532062|NCT02752776|62921870|FG002|Overall Study|Lack of Efficacy|14|||
33532063|NCT02752776|62921868|FG000|Overall Study|Lost to Follow-up|11|||
33532064|NCT02752776|62921869|FG001|Overall Study|Lost to Follow-up|12|||
33532065|NCT02752776|62921870|FG002|Overall Study|Lost to Follow-up|4|||
33532066|NCT02752776|62921868|FG000|Overall Study|Non-compliance with study treatment|0|||
33532067|NCT02752776|62921869|FG001|Overall Study|Non-compliance with study treatment|0|||
33532068|NCT02752776|62921870|FG002|Overall Study|Non-compliance with study treatment|1|||
33532069|NCT02752776|62921868|FG000|Overall Study|Physician Decision|2|||
33532070|NCT02752776|62921869|FG001|Overall Study|Physician Decision|6|||
33532071|NCT02752776|62921870|FG002|Overall Study|Physician Decision|2|||
33532072|NCT02752776|62921868|FG000|Overall Study|Pregnancy|1|||
33532073|NCT02752776|62921869|FG001|Overall Study|Pregnancy|6|||
33532074|NCT02752776|62921870|FG002|Overall Study|Pregnancy|3|||
33532075|NCT02752776|62921868|FG000|Overall Study|Protocol Violation|10|||
33532076|NCT02752776|62921869|FG001|Overall Study|Protocol Violation|13|||
33532077|NCT02752776|62921870|FG002|Overall Study|Protocol Violation|6|||
33532078|NCT02752776|62921868|FG000|Overall Study|Subject/guardian decision|8|||
33532079|NCT02752776|62921869|FG001|Overall Study|Subject/guardian decision|6|||
33532080|NCT02752776|62921870|FG002|Overall Study|Subject/guardian decision|4|||
33532081|NCT02752776|62921868|FG000|Overall Study|Death|0|||
33532082|NCT02752776|62921869|FG001|Overall Study|Death|0|||
33532083|NCT02752776|62921870|FG002|Overall Study|Death|1|||
33532084|NCT02752776|62921868|FG000|Overall Study|Withdrawal by Subject|3|||
33532085|NCT02752776|62921869|FG001|Overall Study|Withdrawal by Subject|4|||
33532086|NCT02752776|62921870|FG002|Overall Study|Withdrawal by Subject|2|||
33532087|NCT01342965|62921882|FG000|Overall Study|Death|58|||
33532088|NCT01342965|62921883|FG001|Overall Study|Death|57|||
33532089|NCT01342965|62921882|FG000|Overall Study|Lost to Follow-up|5|||
33532090|NCT01342965|62921883|FG001|Overall Study|Lost to Follow-up|3|||
33532091|NCT01342965|62921882|FG000|Overall Study|Other Reasons- Unspecified|44|||
33532092|NCT01342965|62921883|FG001|Overall Study|Other Reasons- Unspecified|38|||
33532093|NCT01342965|62921882|FG000|Overall Study|Withdrawal by Subject|2|||
33532094|NCT01342965|62921883|FG001|Overall Study|Withdrawal by Subject|9|||
33532095|NCT02629822|62921889|FG000|Base Study|Lost to Follow-up|2|||
33532096|NCT02629822|62921889|FG000|Base Study|Non-Compliance With Study Drug|1|||
33532097|NCT02629822|62921889|FG000|Extension Study|Adverse Event|1|||
33532098|NCT02629822|62921889|FG000|Extension Study|Lost to Follow-up|1|||
33532099|NCT03462706|62921898|FG000|Overall Study|Polyp was pedunculated|1|||
33532100|NCT03462706|62921899|FG001|Overall Study|Polyp was pedunculated|0|||
33532101|NCT03462706|62921900|FG002|Overall Study|Polyp was pedunculated|1|||
33532102|NCT03462706|62921901|FG003|Overall Study|Polyp was pedunculated|0|||
33532103|NCT03462706|62921898|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
33532104|NCT03462706|62921899|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
33532105|NCT03462706|62921900|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
33532106|NCT03462706|62921901|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
33532107|NCT02840253|62921911|FG000|Overall Study|Unsuccessful block|4|||
33532108|NCT02752074|62921917|FG000|Overall Study|Lost to Follow-up|1|||
33532109|NCT02752074|62921918|FG001|Overall Study|Lost to Follow-up|4|||
33532110|NCT02752074|62921917|FG000|Overall Study|Death|146|||
33532111|NCT02752074|62921918|FG001|Overall Study|Death|129|||
33532112|NCT02752074|62921917|FG000|Overall Study|Withdrawal by Subject|9|||
33532113|NCT02752074|62921918|FG001|Overall Study|Withdrawal by Subject|10|||
33532114|NCT02835495|62921926|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
33532115|NCT02835495|62921927|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
33532116|NCT02835495|62921926|FG000|Overall Study|Declined in-person follow-up visit|4|||
33532117|NCT02835495|62921927|FG001|Overall Study|Declined in-person follow-up visit|2|||
33532118|NCT02835339|62921937|FG000|Overall Study|Did not receive allocated intervention|13|||
33532119|NCT02835339|62921938|FG001|Overall Study|Did not receive allocated intervention|16|||
33532120|NCT02832063|62921946|FG000|Overall Study|Adverse Event|2|||
33532121|NCT02832063|62921947|FG001|Overall Study|Adverse Event|1|||
33532122|NCT02832063|62921946|FG000|Overall Study|Physician Decision|5|||
33532123|NCT02832063|62921947|FG001|Overall Study|Physician Decision|7|||
33532124|NCT02832063|62921946|FG000|Overall Study|Lost to Follow-up|15|||
33532125|NCT02832063|62921947|FG001|Overall Study|Lost to Follow-up|8|||
33532126|NCT02832063|62921946|FG000|Overall Study|Withdrawal by Subject|10|||
33532127|NCT02832063|62921947|FG001|Overall Study|Withdrawal by Subject|21|||
33532128|NCT02832063|62921946|FG000|Overall Study|Other|2|||
33532129|NCT02832063|62921947|FG001|Overall Study|Other|1|||
33532130|NCT03125902|62921966|FG000|Overall Study|Death|52|||
33532131|NCT03125902|62921967|FG001|Overall Study|Death|123|||
33532132|NCT03125902|62921966|FG000|Overall Study|Lost to Follow-up|1|||
33532133|NCT03125902|62921967|FG001|Overall Study|Lost to Follow-up|0|||
33532134|NCT03125902|62921966|FG000|Overall Study|Mastectomy|0|||
33532135|NCT03125902|62921967|FG001|Overall Study|Mastectomy|1|||
33532136|NCT03125902|62921966|FG000|Overall Study|Physician Decision|1|||
33532137|NCT03125902|62921967|FG001|Overall Study|Physician Decision|0|||
33532138|NCT03125902|62921966|FG000|Overall Study|Withdrawal by Subject|13|||
33532139|NCT03125902|62921967|FG001|Overall Study|Withdrawal by Subject|25|||
33532140|NCT03125902|62921966|FG000|Overall Study|Study is ongoing|153|||
33532141|NCT03125902|62921967|FG001|Overall Study|Study is ongoing|282|||
33532142|NCT04412707|62921976|FG000|Cycle 1|Death|0|||
33532143|NCT04412707|62921977|FG001|Cycle 1|Death|3|||
33532144|NCT04412707|62921976|FG000|Cycle 1|Disease progression|1|||
33532145|NCT04412707|62921977|FG001|Cycle 1|Disease progression|2|||
33532146|NCT04412707|62921976|FG000|Cycle 2|Death|0|||
33532147|NCT04412707|62921977|FG001|Cycle 2|Death|1|||
33532148|NCT04412707|62921976|FG000|Cycle 2|Disease progression|3|||
33532149|NCT04412707|62921977|FG001|Cycle 2|Disease progression|0|||
33532150|NCT04412707|62921976|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
33532151|NCT04412707|62921977|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
33532152|NCT04412707|62921976|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
33532153|NCT04412707|62921977|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
33532154|NCT04412707|62921976|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
33532155|NCT04412707|62921977|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
33532156|NCT04412707|62921976|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
33532157|NCT04412707|62921977|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
33532158|NCT01358721|62921996|FG000|Overall Study|Withdrawal by Subject|0|||
33532159|NCT01358721|62921997|FG001|Overall Study|Withdrawal by Subject|0|||
33532160|NCT01358721|62921998|FG002|Overall Study|Withdrawal by Subject|0|||
33532161|NCT01358721|62921999|FG003|Overall Study|Withdrawal by Subject|1|||
33532162|NCT01358721|62921996|FG000|Overall Study|Death|0|||
33532163|NCT01358721|62921997|FG001|Overall Study|Death|2|||
33532164|NCT01358721|62921998|FG002|Overall Study|Death|0|||
33532165|NCT01358721|62921999|FG003|Overall Study|Death|0|||
33459092|NCT00112437|62832494|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459093|NCT00112437|62832495|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
33459094|NCT00112437|62832496|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
33459095|NCT00112437|62832497|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33459096|NCT00112437|62832498|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
33459097|NCT03653416|62832554|FG000|Overall Study|Protocol Violation|6|||
33459098|NCT03653416|62832555|FG001|Overall Study|Protocol Violation|1|||
33459099|NCT00112359|62832563|FG000|Overall Study|Unrelated adverse event|16|||
33459100|NCT00112359|62832564|FG001|Overall Study|Unrelated adverse event|8|||
33459101|NCT00112359|62832563|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
33459102|NCT00112359|62832564|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
33532166|NCT01358721|62921996|FG000|Overall Study|Study Drug Toxicity|1|||
33532167|NCT01358721|62921997|FG001|Overall Study|Study Drug Toxicity|3|||
33532168|NCT01358721|62921998|FG002|Overall Study|Study Drug Toxicity|4|||
33532169|NCT01358721|62921999|FG003|Overall Study|Study Drug Toxicity|5|||
33532170|NCT01358721|62921996|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
33532171|NCT01358721|62921997|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
33532172|NCT01358721|62921998|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
33532173|NCT01358721|62921999|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
33532174|NCT01358721|62921996|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
33532175|NCT01358721|62921997|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
33532176|NCT01358721|62921998|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
33532177|NCT01358721|62921999|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
33532178|NCT01358721|62921996|FG000|Overall Study|Adverse Event related to study drug|1|||
33532179|NCT01358721|62921997|FG001|Overall Study|Adverse Event related to study drug|0|||
33532180|NCT01358721|62921998|FG002|Overall Study|Adverse Event related to study drug|0|||
33532181|NCT01358721|62921999|FG003|Overall Study|Adverse Event related to study drug|1|||
33532182|NCT01358721|62921996|FG000|Overall Study|Disease Progression|19|||
33532183|NCT01358721|62921997|FG001|Overall Study|Disease Progression|15|||
33532184|NCT01358721|62921998|FG002|Overall Study|Disease Progression|17|||
33532185|NCT01358721|62921999|FG003|Overall Study|Disease Progression|15|||
33532186|NCT01358721|62921996|FG000|Overall Study|Out of State/Unmet Criteria|0|||
33532187|NCT01358721|62921997|FG001|Overall Study|Out of State/Unmet Criteria|0|||
33532188|NCT01358721|62921998|FG002|Overall Study|Out of State/Unmet Criteria|1|||
33532189|NCT01358721|62921999|FG003|Overall Study|Out of State/Unmet Criteria|0|||
33626131|NCT02116361|63027083|FG002|Overall Study|Adverse Event|0|||
33626132|NCT02116361|63027084|FG003|Overall Study|Adverse Event|3|||
33626133|NCT02116361|63027081|FG000|Overall Study|Other Reasons|3|||
33626134|NCT02116361|63027082|FG001|Overall Study|Other Reasons|3|||
33626135|NCT02116361|63027083|FG002|Overall Study|Other Reasons|3|||
33532190|NCT01341639|62922011|FG000|Infant Series|Protocol Violation|1|||
33532191|NCT01341639|62922012|FG001|Infant Series|Protocol Violation|0|||
33532192|NCT01341639|62922011|FG000|Infant Series|Not Vaccinated|0|||
33532193|NCT01341639|62922012|FG001|Infant Series|Not Vaccinated|1|||
33532194|NCT01341639|62922011|FG000|Infant Series|Adverse Event|0|||
33532195|NCT01341639|62922012|FG001|Infant Series|Adverse Event|5|||
33532196|NCT01341639|62922011|FG000|Infant Series|Withdrawal by Subject|11|||
33532197|NCT01341639|62922012|FG001|Infant Series|Withdrawal by Subject|8|||
33532198|NCT01341639|62922011|FG000|Infant Series|Lost to Follow-up|0|||
33532199|NCT01341639|62922012|FG001|Infant Series|Lost to Follow-up|2|||
33532200|NCT01341639|62922011|FG000|Infant Series|Site 0048 Participants|17|||
33532201|NCT01341639|62922012|FG001|Infant Series|Site 0048 Participants|16|||
33532202|NCT01341639|62922011|FG000|Interim Period|Withdrawal by Subject|6|||
33532203|NCT01341639|62922012|FG001|Interim Period|Withdrawal by Subject|7|||
33532204|NCT01341639|62922011|FG000|Interim Period|Lost to Follow-up|2|||
33532205|NCT01341639|62922012|FG001|Interim Period|Lost to Follow-up|0|||
33532206|NCT01341639|62922011|FG000|Interim Period|Physician Decision|0|||
33532207|NCT01341639|62922012|FG001|Interim Period|Physician Decision|1|||
33532208|NCT01341639|62922011|FG000|Interim Period|Protocol Violation|0|||
33532209|NCT01341639|62922012|FG001|Interim Period|Protocol Violation|1|||
33532210|NCT01341639|62922011|FG000|Post-Treatment|Withdrawal by Subject|0|||
33532211|NCT01341639|62922012|FG001|Post-Treatment|Withdrawal by Subject|1|||
33532212|NCT01341639|62922011|FG000|Post-Treatment|Adverse Event|0|||
33532213|NCT01341639|62922012|FG001|Post-Treatment|Adverse Event|2|||
33532214|NCT02628028|62922026|FG000|Dosing Period|Withdrawal by Subject|0|||
33532215|NCT02628028|62922027|FG001|Dosing Period|Withdrawal by Subject|0|||
33532216|NCT02628028|62922028|FG002|Dosing Period|Withdrawal by Subject|1|||
33532217|NCT02628028|62922029|FG003|Dosing Period|Withdrawal by Subject|0|||
33532218|NCT02628028|62922030|FG004|Dosing Period|Withdrawal by Subject|2|||
33532219|NCT02628028|62922031|FG005|Dosing Period|Withdrawal by Subject|4|||
33532220|NCT02628028|62922032|FG006|Dosing Period|Withdrawal by Subject|1|||
33532221|NCT02628028|62922033|FG007|Dosing Period|Withdrawal by Subject|1|||
33532222|NCT02628028|62922026|FG000|Dosing Period|Adverse Event|0|||
33532223|NCT02628028|62922027|FG001|Dosing Period|Adverse Event|0|||
33532224|NCT02628028|62922028|FG002|Dosing Period|Adverse Event|0|||
33626136|NCT02116361|63027084|FG003|Overall Study|Other Reasons|3|||
33626137|NCT02116361|63027081|FG000|Overall Study|Lack of Efficacy|5|||
33626138|NCT02116361|63027082|FG001|Overall Study|Lack of Efficacy|7|||
33532225|NCT02628028|62922029|FG003|Dosing Period|Adverse Event|0|||
33626139|NCT02116361|63027083|FG002|Overall Study|Lack of Efficacy|4|||
33532226|NCT02628028|62922030|FG004|Dosing Period|Adverse Event|2|||
33626140|NCT02116361|63027084|FG003|Overall Study|Lack of Efficacy|3|||
33532227|NCT02628028|62922031|FG005|Dosing Period|Adverse Event|1|||
33532228|NCT02628028|62922032|FG006|Dosing Period|Adverse Event|3|||
33626141|NCT02116361|63027081|FG000|Overall Study|Lost to Follow-up|4|||
33626142|NCT02116361|63027082|FG001|Overall Study|Lost to Follow-up|5|||
33532229|NCT02628028|62922033|FG007|Dosing Period|Adverse Event|2|||
33532230|NCT02628028|62922026|FG000|Dosing Period|Death|0|||
33532231|NCT02628028|62922027|FG001|Dosing Period|Death|0|||
33532232|NCT02628028|62922028|FG002|Dosing Period|Death|0|||
33532233|NCT02628028|62922029|FG003|Dosing Period|Death|0|||
33532234|NCT02628028|62922030|FG004|Dosing Period|Death|0|||
33532235|NCT02628028|62922031|FG005|Dosing Period|Death|0|||
33532236|NCT02628028|62922032|FG006|Dosing Period|Death|0|||
33626143|NCT02116361|63027083|FG002|Overall Study|Lost to Follow-up|7|||
33532237|NCT02628028|62922033|FG007|Dosing Period|Death|1|||
33532238|NCT02628028|62922026|FG000|Dosing Period|Lack of Efficacy|0|||
33532239|NCT02628028|62922027|FG001|Dosing Period|Lack of Efficacy|0|||
33532240|NCT02628028|62922028|FG002|Dosing Period|Lack of Efficacy|0|||
33532241|NCT02628028|62922029|FG003|Dosing Period|Lack of Efficacy|0|||
33532242|NCT02628028|62922030|FG004|Dosing Period|Lack of Efficacy|3|||
33532243|NCT02628028|62922031|FG005|Dosing Period|Lack of Efficacy|0|||
33532244|NCT02628028|62922032|FG006|Dosing Period|Lack of Efficacy|1|||
33532245|NCT02628028|62922033|FG007|Dosing Period|Lack of Efficacy|0|||
33532246|NCT02628028|62922026|FG000|Dosing Period|Study Terminated by Sponsor|0|||
33532247|NCT02628028|62922027|FG001|Dosing Period|Study Terminated by Sponsor|0|||
33532248|NCT02628028|62922028|FG002|Dosing Period|Study Terminated by Sponsor|0|||
33532249|NCT02628028|62922029|FG003|Dosing Period|Study Terminated by Sponsor|0|||
33532250|NCT02628028|62922030|FG004|Dosing Period|Study Terminated by Sponsor|7|||
33532251|NCT02628028|62922031|FG005|Dosing Period|Study Terminated by Sponsor|6|||
33532252|NCT02628028|62922032|FG006|Dosing Period|Study Terminated by Sponsor|7|||
33626144|NCT02116361|63027084|FG003|Overall Study|Lost to Follow-up|5|||
33626145|NCT02116361|63027081|FG000|Overall Study|Personal Reasons|6|||
33626146|NCT02116361|63027082|FG001|Overall Study|Personal Reasons|6|||
33626147|NCT02116361|63027083|FG002|Overall Study|Personal Reasons|4|||
33626148|NCT02116361|63027084|FG003|Overall Study|Personal Reasons|9|||
33626149|NCT02116361|63027081|FG000|Overall Study|Investigator Decision - Relapse|9|||
33626150|NCT02116361|63027082|FG001|Overall Study|Investigator Decision - Relapse|7|||
33532253|NCT02628028|62922033|FG007|Dosing Period|Study Terminated by Sponsor|7|||
33532254|NCT02628028|62922026|FG000|Dosing Period|Physician Decision|0|||
33532255|NCT02628028|62922027|FG001|Dosing Period|Physician Decision|0|||
33532256|NCT02628028|62922028|FG002|Dosing Period|Physician Decision|0|||
33532257|NCT02628028|62922029|FG003|Dosing Period|Physician Decision|0|||
33532258|NCT02628028|62922030|FG004|Dosing Period|Physician Decision|0|||
33532259|NCT02628028|62922031|FG005|Dosing Period|Physician Decision|1|||
33532260|NCT02628028|62922032|FG006|Dosing Period|Physician Decision|0|||
33532261|NCT02628028|62922033|FG007|Dosing Period|Physician Decision|0|||
33532262|NCT02628028|62922026|FG000|Dosing Period|Site Terminated by Sponsor|0|||
33532263|NCT02628028|62922027|FG001|Dosing Period|Site Terminated by Sponsor|0|||
33532264|NCT02628028|62922028|FG002|Dosing Period|Site Terminated by Sponsor|0|||
33532265|NCT02628028|62922029|FG003|Dosing Period|Site Terminated by Sponsor|0|||
33532266|NCT02628028|62922030|FG004|Dosing Period|Site Terminated by Sponsor|0|||
33532267|NCT02628028|62922031|FG005|Dosing Period|Site Terminated by Sponsor|1|||
33532268|NCT02628028|62922032|FG006|Dosing Period|Site Terminated by Sponsor|1|||
33626151|NCT02116361|63027083|FG002|Overall Study|Investigator Decision - Relapse|8|||
33626152|NCT02116361|63027084|FG003|Overall Study|Investigator Decision - Relapse|5|||
33626153|NCT02140775|63027096|FG000|Overall Study|Withdrawal by Subject|30|||
33626154|NCT02140775|63027097|FG001|Overall Study|Withdrawal by Subject|7|||
33532269|NCT02628028|62922033|FG007|Dosing Period|Site Terminated by Sponsor|0|||
33532270|NCT02628028|62922026|FG000|Dosing Period|Lost to Follow-up|0|||
33532271|NCT02628028|62922027|FG001|Dosing Period|Lost to Follow-up|0|||
33626155|NCT01844817|63027107|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
33626156|NCT01844817|63027108|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
33626157|NCT01844817|63027107|FG000|Treatment|Progressive Disease|27|||
33626158|NCT01844817|63027108|FG001|Treatment|Progressive Disease|36|||
33626159|NCT01844817|63027107|FG000|Treatment|Adverse Event|17|||
33626160|NCT01844817|63027108|FG001|Treatment|Adverse Event|9|||
33626161|NCT01844817|63027107|FG000|Treatment|Withdrawal by Subject|10|||
33626162|NCT01844817|63027108|FG001|Treatment|Withdrawal by Subject|6|||
33626163|NCT01844817|63027107|FG000|Treatment|Death|10|||
33626164|NCT01844817|63027108|FG001|Treatment|Death|8|||
33626165|NCT01844817|63027107|FG000|Treatment|Lost to Follow-up|0|||
33626166|NCT01844817|63027108|FG001|Treatment|Lost to Follow-up|1|||
33626167|NCT01844817|63027107|FG000|Treatment|Other|0|||
33626168|NCT01844817|63027108|FG001|Treatment|Other|3|||
33626169|NCT01814553|63027117|FG000|Overall Study|PD per clinical progression|6|||
33532272|NCT02628028|62922028|FG002|Dosing Period|Lost to Follow-up|0|||
33532273|NCT02628028|62922029|FG003|Dosing Period|Lost to Follow-up|0|||
33626170|NCT01814553|63027118|FG001|Overall Study|PD per clinical progression|8|||
33626171|NCT01814553|63027117|FG000|Overall Study|Other Adverse Event|4|||
33626172|NCT01814553|63027118|FG001|Overall Study|Other Adverse Event|5|||
33626173|NCT01814553|63027117|FG000|Overall Study|Withdrawal by Subject|1|||
33626174|NCT01814553|63027118|FG001|Overall Study|Withdrawal by Subject|1|||
33532274|NCT02628028|62922030|FG004|Dosing Period|Lost to Follow-up|0|||
33532275|NCT02628028|62922031|FG005|Dosing Period|Lost to Follow-up|0|||
33532276|NCT02628028|62922032|FG006|Dosing Period|Lost to Follow-up|1|||
33532277|NCT02628028|62922033|FG007|Dosing Period|Lost to Follow-up|0|||
33532278|NCT02628028|62922026|FG000|Dosing Period|Other|0|||
33532279|NCT02628028|62922027|FG001|Dosing Period|Other|0|||
33532280|NCT02628028|62922028|FG002|Dosing Period|Other|0|||
33626175|NCT01814553|63027117|FG000|Overall Study|Other than stated|7|||
33626176|NCT01814553|63027118|FG001|Overall Study|Other than stated|8|||
33626177|NCT02116205|63027128|FG000|Overall Study|Withdrawal by Subject|2|||
33626178|NCT02116205|63027129|FG001|Overall Study|Withdrawal by Subject|4|||
33532281|NCT02628028|62922029|FG003|Dosing Period|Other|0|||
33532282|NCT02628028|62922030|FG004|Dosing Period|Other|2|||
33532283|NCT02628028|62922031|FG005|Dosing Period|Other|1|||
33532284|NCT02628028|62922032|FG006|Dosing Period|Other|2|||
33532285|NCT02628028|62922033|FG007|Dosing Period|Other|4|||
33532286|NCT02628028|62922026|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
33626179|NCT02116205|63027130|FG002|Overall Study|Withdrawal by Subject|1|||
33626180|NCT02116205|63027131|FG003|Overall Study|Withdrawal by Subject|3|||
33532287|NCT02628028|62922027|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
33532288|NCT02628028|62922028|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
33532289|NCT02628028|62922029|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
33532290|NCT02628028|62922030|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
33626181|NCT02116205|63027128|FG000|Overall Study|Lost to Follow-up|0|||
33626182|NCT02116205|63027129|FG001|Overall Study|Lost to Follow-up|2|||
33626183|NCT02116205|63027130|FG002|Overall Study|Lost to Follow-up|1|||
33626184|NCT02116205|63027131|FG003|Overall Study|Lost to Follow-up|2|||
33532291|NCT02628028|62922031|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
33532292|NCT02628028|62922032|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
33532293|NCT02628028|62922033|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
33532294|NCT02628028|62922026|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
33532295|NCT02628028|62922027|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
33532296|NCT02628028|62922028|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
33532297|NCT02628028|62922029|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
33532298|NCT02628028|62922030|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
33532299|NCT02628028|62922031|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
33532300|NCT02628028|62922032|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
33532301|NCT02628028|62922033|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
33532302|NCT02628028|62922026|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
33532303|NCT02628028|62922027|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
33532304|NCT02628028|62922028|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
33532305|NCT02628028|62922029|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
33532306|NCT02628028|62922030|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
33532307|NCT02628028|62922031|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
33532308|NCT02628028|62922032|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
33532309|NCT02628028|62922033|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
33532310|NCT02628028|62922026|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
33532311|NCT02628028|62922027|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
33532312|NCT02628028|62922028|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
33626185|NCT02116205|63027128|FG000|Overall Study|Physician Decision|0|||
33532313|NCT02628028|62922029|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
33532314|NCT02628028|62922030|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
33626186|NCT02116205|63027129|FG001|Overall Study|Physician Decision|1|||
33626187|NCT02116205|63027130|FG002|Overall Study|Physician Decision|1|||
33626188|NCT02116205|63027131|FG003|Overall Study|Physician Decision|1|||
33626189|NCT02116205|63027128|FG000|Overall Study|Exclusion criteria|0|||
33626190|NCT02116205|63027129|FG001|Overall Study|Exclusion criteria|0|||
33626191|NCT02116205|63027130|FG002|Overall Study|Exclusion criteria|1|||
33626192|NCT02116205|63027131|FG003|Overall Study|Exclusion criteria|0|||
33626193|NCT01844583|63027143|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
33626194|NCT01844583|63027144|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
33626195|NCT02115815|63027162|FG000|Overall Study|Withdrawal by Subject|2|||
33626196|NCT02115815|63027163|FG001|Overall Study|Withdrawal by Subject|0|||
33626197|NCT02115815|63027164|FG002|Overall Study|Withdrawal by Subject|0|||
33626198|NCT02115815|63027165|FG003|Overall Study|Withdrawal by Subject|0|||
33626199|NCT02115815|63027166|FG004|Overall Study|Withdrawal by Subject|0|||
33626200|NCT02115815|63027167|FG005|Overall Study|Withdrawal by Subject|0|||
33626201|NCT02115815|63027168|FG006|Overall Study|Withdrawal by Subject|0|||
33626202|NCT02115815|63027162|FG000|Overall Study|Not enough drug to dose participant|0|||
33626203|NCT02115815|63027163|FG001|Overall Study|Not enough drug to dose participant|0|||
33626204|NCT02115815|63027164|FG002|Overall Study|Not enough drug to dose participant|0|||
33626205|NCT02115815|63027165|FG003|Overall Study|Not enough drug to dose participant|0|||
33626206|NCT02115815|63027166|FG004|Overall Study|Not enough drug to dose participant|0|||
33626207|NCT02115815|63027167|FG005|Overall Study|Not enough drug to dose participant|1|||
33325713|NCT00598273|62702244|FG000|Overall Study|Adverse Event|4|||
33325714|NCT00598273|62702245|FG001|Overall Study|Adverse Event|5|||
33532315|NCT02628028|62922031|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
33532316|NCT02628028|62922032|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
33532317|NCT02628028|62922033|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
33325715|NCT00598273|62702246|FG002|Overall Study|Adverse Event|2|||
33532318|NCT02628028|62922026|FG000|Long-term Extension (LTE) Period|Other|0|||
33626208|NCT02115815|63027168|FG006|Overall Study|Not enough drug to dose participant|0|||
33626209|NCT02115815|63027162|FG000|Overall Study|Missed appointment, randomized in error|0|||
33532319|NCT02628028|62922027|FG001|Long-term Extension (LTE) Period|Other|0|||
33532320|NCT02628028|62922028|FG002|Long-term Extension (LTE) Period|Other|0|||
33532321|NCT02628028|62922029|FG003|Long-term Extension (LTE) Period|Other|0|||
33532322|NCT02628028|62922030|FG004|Long-term Extension (LTE) Period|Other|0|||
33532323|NCT02628028|62922031|FG005|Long-term Extension (LTE) Period|Other|3|||
33532324|NCT02628028|62922032|FG006|Long-term Extension (LTE) Period|Other|4|||
33532325|NCT02628028|62922033|FG007|Long-term Extension (LTE) Period|Other|3|||
33532326|NCT03977701|62922065|FG000|Overall Study|COVID-19 pandemic|0|||
33532327|NCT03977701|62922066|FG001|Overall Study|COVID-19 pandemic|0|||
33532328|NCT03977701|62922067|FG002|Overall Study|COVID-19 pandemic|0|||
33532329|NCT03977701|62922068|FG003|Overall Study|COVID-19 pandemic|0|||
33532330|NCT03977701|62922069|FG004|Overall Study|COVID-19 pandemic|0|||
33532331|NCT03977701|62922070|FG005|Overall Study|COVID-19 pandemic|1|||
33532332|NCT03977701|62922071|FG006|Overall Study|COVID-19 pandemic|0|||
33532333|NCT03977701|62922072|FG007|Overall Study|COVID-19 pandemic|1|||
33532334|NCT03977701|62922073|FG008|Overall Study|COVID-19 pandemic|0|||
33532335|NCT03977701|62922074|FG009|Overall Study|COVID-19 pandemic|0|||
33532336|NCT02814526|62922113|FG000|Overall Study|Adverse Event|4|||
33532337|NCT02814526|62922114|FG001|Overall Study|Adverse Event|3|||
33532338|NCT02814526|62922113|FG000|Overall Study|Death|1|||
33532339|NCT02814526|62922114|FG001|Overall Study|Death|1|||
33532340|NCT02814526|62922113|FG000|Overall Study|Lost to Follow-up|3|||
33532341|NCT02814526|62922114|FG001|Overall Study|Lost to Follow-up|4|||
33532342|NCT02814526|62922113|FG000|Overall Study|non site physician decision|1|||
33532343|NCT02814526|62922114|FG001|Overall Study|non site physician decision|0|||
33532344|NCT02814526|62922113|FG000|Overall Study|participant noncompliance|1|||
33532345|NCT02814526|62922114|FG001|Overall Study|participant noncompliance|1|||
33532346|NCT02814526|62922113|FG000|Overall Study|Withdrawal by Subject|20|||
33626210|NCT02115815|63027163|FG001|Overall Study|Missed appointment, randomized in error|0|||
33626211|NCT02115815|63027164|FG002|Overall Study|Missed appointment, randomized in error|0|||
33626212|NCT02115815|63027165|FG003|Overall Study|Missed appointment, randomized in error|0|||
33626213|NCT02115815|63027166|FG004|Overall Study|Missed appointment, randomized in error|0|||
33626214|NCT02115815|63027167|FG005|Overall Study|Missed appointment, randomized in error|1|||
33626215|NCT02115815|63027168|FG006|Overall Study|Missed appointment, randomized in error|0|||
33626216|NCT02115269|63027184|FG000|Overall Study|Lost to Follow-up|43|||
33626217|NCT02115269|63027184|FG000|Overall Study|Did not complete patient diary|3|||
33626218|NCT02115269|63027184|FG000|Overall Study|Moved to another city|7|||
33626219|NCT02115269|63027184|FG000|Overall Study|Withdrawal by Subject|2|||
33626220|NCT02115269|63027184|FG000|Overall Study|Didn't take study drug|2|||
33626221|NCT02115113|63027199|FG000|Participants in Run-in Period|Death|0|||
33532347|NCT02814526|62922114|FG001|Overall Study|Withdrawal by Subject|14|||
33532348|NCT02814526|62922113|FG000|Overall Study|safety risk|2|||
33532349|NCT02814526|62922114|FG001|Overall Study|safety risk|1|||
33532350|NCT02814526|62922113|FG000|Overall Study|early termination-study terminated|1|||
33532351|NCT02814526|62922114|FG001|Overall Study|early termination-study terminated|2|||
33532352|NCT02814526|62922113|FG000|Overall Study|Other|0|||
33532353|NCT02814526|62922114|FG001|Overall Study|Other|4|||
33532354|NCT02329834|62922122|FG000|Overall Study|Physician Decision|1|||
33626222|NCT02115113|63027200|FG001|Participants in Run-in Period|Death|0|||
33626223|NCT02115113|63027201|FG002|Participants in Run-in Period|Death|1|||
33626224|NCT02115113|63027199|FG000|Participants in Run-in Period|Administrative problems|0|||
33626225|NCT02115113|63027200|FG001|Participants in Run-in Period|Administrative problems|0|||
33626226|NCT02115113|63027201|FG002|Participants in Run-in Period|Administrative problems|1|||
33532355|NCT02329834|62922123|FG001|Overall Study|Physician Decision|0|||
33532356|NCT01340937|62922134|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
33532357|NCT01340937|62922135|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
33532358|NCT01340937|62922136|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
33532359|NCT01340937|62922137|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
33532360|NCT01340937|62922134|FG000|Period 1: Infant Series|Adverse Event|0|||
33532361|NCT01340937|62922135|FG001|Period 1: Infant Series|Adverse Event|1|||
33532362|NCT01340937|62922136|FG002|Period 1: Infant Series|Adverse Event|4|||
33532363|NCT01340937|62922137|FG003|Period 1: Infant Series|Adverse Event|0|||
33532364|NCT01340937|62922134|FG000|Period 1: Infant Series|Death|2|||
33532365|NCT01340937|62922135|FG001|Period 1: Infant Series|Death|0|||
33532366|NCT01340937|62922136|FG002|Period 1: Infant Series|Death|2|||
33532367|NCT01340937|62922137|FG003|Period 1: Infant Series|Death|0|||
33532368|NCT01340937|62922134|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
33532369|NCT01340937|62922135|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
33532370|NCT01340937|62922136|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
33532371|NCT01340937|62922137|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
33532372|NCT01340937|62922134|FG000|Period 1: Infant Series|Physician Decision|2|||
33532373|NCT01340937|62922135|FG001|Period 1: Infant Series|Physician Decision|3|||
33532374|NCT01340937|62922136|FG002|Period 1: Infant Series|Physician Decision|1|||
33532375|NCT01340937|62922137|FG003|Period 1: Infant Series|Physician Decision|0|||
33532376|NCT01340937|62922134|FG000|Period 1: Infant Series|Protocol Violation|1|||
33532377|NCT01340937|62922135|FG001|Period 1: Infant Series|Protocol Violation|4|||
33532378|NCT01340937|62922136|FG002|Period 1: Infant Series|Protocol Violation|4|||
33532379|NCT01340937|62922137|FG003|Period 1: Infant Series|Protocol Violation|3|||
33532380|NCT01340937|62922134|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
33532381|NCT01340937|62922135|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
33325716|NCT00598273|62702244|FG000|Overall Study|Death|6|||
33325717|NCT00598273|62702245|FG001|Overall Study|Death|12|||
33325718|NCT00598273|62702246|FG002|Overall Study|Death|8|||
33325719|NCT00598273|62702244|FG000|Overall Study|Lost to Follow-up|8|||
33325720|NCT00598273|62702245|FG001|Overall Study|Lost to Follow-up|3|||
33325721|NCT00598273|62702246|FG002|Overall Study|Lost to Follow-up|5|||
33532382|NCT01340937|62922136|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
33532383|NCT01340937|62922137|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
33532384|NCT01340937|62922134|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
33532385|NCT01340937|62922135|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
33532386|NCT01340937|62922136|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
33532387|NCT01340937|62922137|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
33532388|NCT01340937|62922134|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
33532389|NCT01340937|62922135|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
33532390|NCT01340937|62922136|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
33532391|NCT01340937|62922137|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
33532392|NCT01340937|62922134|FG000|Period 2: Interim Period|Adverse Event|1|||
33532393|NCT01340937|62922135|FG001|Period 2: Interim Period|Adverse Event|0|||
33532394|NCT01340937|62922136|FG002|Period 2: Interim Period|Adverse Event|1|||
33532395|NCT01340937|62922137|FG003|Period 2: Interim Period|Adverse Event|0|||
33532396|NCT01340937|62922134|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
33532397|NCT01340937|62922135|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
33532398|NCT01340937|62922136|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
33532399|NCT01340937|62922137|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
33532400|NCT01340937|62922134|FG000|Period 2: Interim Period|Physician Decision|0|||
33532401|NCT01340937|62922135|FG001|Period 2: Interim Period|Physician Decision|1|||
33532402|NCT01340937|62922136|FG002|Period 2: Interim Period|Physician Decision|1|||
33532403|NCT01340937|62922137|FG003|Period 2: Interim Period|Physician Decision|0|||
33532404|NCT01340937|62922134|FG000|Period 2: Interim Period|Protocol Violation|5|||
33532405|NCT01340937|62922135|FG001|Period 2: Interim Period|Protocol Violation|3|||
33532406|NCT01340937|62922136|FG002|Period 2: Interim Period|Protocol Violation|6|||
33532407|NCT01340937|62922137|FG003|Period 2: Interim Period|Protocol Violation|3|||
33532408|NCT01340937|62922134|FG000|Period 2: Interim Period|Technical problems|4|||
33532409|NCT01340937|62922135|FG001|Period 2: Interim Period|Technical problems|4|||
33532410|NCT01340937|62922136|FG002|Period 2: Interim Period|Technical problems|6|||
33532411|NCT01340937|62922137|FG003|Period 2: Interim Period|Technical problems|3|||
33532412|NCT01340937|62922134|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
33532413|NCT01340937|62922135|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
33532414|NCT01340937|62922136|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
33325722|NCT00598273|62702244|FG000|Overall Study|Physician Decision|0|||
33325723|NCT00598273|62702245|FG001|Overall Study|Physician Decision|0|||
33532415|NCT01340937|62922137|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
33532416|NCT01340937|62922134|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
33532417|NCT01340937|62922135|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
33532418|NCT01340937|62922136|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
33532419|NCT01340937|62922137|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
33626227|NCT02115113|63027199|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
33532420|NCT01340937|62922134|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
33532421|NCT01340937|62922135|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
33626228|NCT02115113|63027200|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
33532422|NCT01340937|62922136|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
33626229|NCT02115113|63027201|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
33325724|NCT00598273|62702246|FG002|Overall Study|Physician Decision|1|||
33325725|NCT00598273|62702244|FG000|Overall Study|Withdrawal by Subject|12|||
33325726|NCT00598273|62702245|FG001|Overall Study|Withdrawal by Subject|10|||
33325727|NCT00598273|62702246|FG002|Overall Study|Withdrawal by Subject|10|||
33325728|NCT00598273|62702244|FG000|Overall Study|Noncompliance|3|||
33325729|NCT00598273|62702245|FG001|Overall Study|Noncompliance|2|||
33325730|NCT00598273|62702246|FG002|Overall Study|Noncompliance|3|||
33325731|NCT00598273|62702244|FG000|Overall Study|Relocation|0|||
33325732|NCT00598273|62702245|FG001|Overall Study|Relocation|2|||
33325733|NCT00598273|62702246|FG002|Overall Study|Relocation|4|||
33325734|NCT00598273|62702244|FG000|Overall Study|Renal transplant|1|||
33325735|NCT00598273|62702245|FG001|Overall Study|Renal transplant|0|||
33325736|NCT00598273|62702246|FG002|Overall Study|Renal transplant|1|||
33325737|NCT00598273|62702244|FG000|Overall Study|Site elected to close|1|||
33325738|NCT00598273|62702245|FG001|Overall Study|Site elected to close|0|||
33325739|NCT00598273|62702246|FG002|Overall Study|Site elected to close|0|||
33325740|NCT00598273|62702244|FG000|Overall Study|Started dialysis|6|||
33325741|NCT00598273|62702245|FG001|Overall Study|Started dialysis|4|||
33325742|NCT00598273|62702246|FG002|Overall Study|Started dialysis|5|||
33325743|NCT01211522|62702257|FG000|Overall Study|Withdrawal by Subject|3|||
33325744|NCT01211522|62702258|FG001|Overall Study|Withdrawal by Subject|7|||
33325745|NCT01211522|62702259|FG002|Overall Study|Withdrawal by Subject|5|||
33325746|NCT01211288|62702269|FG000|Overall Study|Lost to Follow-up|1|||
33325747|NCT01211288|62702270|FG001|Overall Study|Lost to Follow-up|1|||
33328301|NCT01134263|62704712|FG000|Overall Study|Serious adverse event|2|||
33328302|NCT01134263|62704713|FG001|Overall Study|Serious adverse event|1|||
33328303|NCT01134263|62704714|FG002|Overall Study|Serious adverse event|1|||
33328304|NCT01134263|62704715|FG003|Overall Study|Serious adverse event|1|||
33328305|NCT01134263|62704716|FG004|Overall Study|Serious adverse event|1|||
33328306|NCT01134263|62704712|FG000|Overall Study|Other adverse event|1|||
33328307|NCT01134263|62704713|FG001|Overall Study|Other adverse event|2|||
33328308|NCT01134263|62704714|FG002|Overall Study|Other adverse event|5|||
33328309|NCT01134263|62704715|FG003|Overall Study|Other adverse event|3|||
33328310|NCT01134263|62704716|FG004|Overall Study|Other adverse event|0|||
33328311|NCT01134263|62704712|FG000|Overall Study|Protocol Violation|8|||
33459103|NCT00112359|62832563|FG000|Overall Study|Related adverse event|5|||
33459104|NCT00112359|62832564|FG001|Overall Study|Related adverse event|3|||
33459105|NCT00112359|62832563|FG000|Overall Study|Lost to Follow-up|0|||
33459106|NCT00112359|62832564|FG001|Overall Study|Lost to Follow-up|1|||
33459107|NCT00112359|62832563|FG000|Overall Study|Personal/administrative|1|||
33459108|NCT00112359|62832564|FG001|Overall Study|Personal/administrative|1|||
33459109|NCT00112359|62832563|FG000|Overall Study|Other|3|||
33459110|NCT00112359|62832564|FG001|Overall Study|Other|0|||
33459111|NCT00119379|62832572|FG000|Overall Study|Adverse Event|4|||
33459112|NCT00119379|62832573|FG001|Overall Study|Adverse Event|1|||
33532423|NCT01340937|62922137|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
33328312|NCT01134263|62704713|FG001|Overall Study|Protocol Violation|7|||
33328313|NCT01134263|62704714|FG002|Overall Study|Protocol Violation|2|||
33626230|NCT02115113|63027199|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
33328314|NCT01134263|62704715|FG003|Overall Study|Protocol Violation|4|||
33459113|NCT00118911|62832581|FG000|Overall Study|Withdrawal by Subject|2|||
33459114|NCT00118911|62832582|FG001|Overall Study|Withdrawal by Subject|5|||
33459115|NCT00131937|62832588|FG000|Overall Study|Adverse Event|3|||
33325748|NCT00883753|62702278|FG000|Overall Study|Adverse Event|37|||
33325749|NCT00883753|62702278|FG000|Overall Study|Death|2|||
33325750|NCT00883753|62702278|FG000|Overall Study|Insufficient therapeutic response|16|||
33325751|NCT00883753|62702278|FG000|Overall Study|Lost to Follow-up|4|||
33325752|NCT00883753|62702278|FG000|Overall Study|Violation of selection criteria at entry|7|||
33325753|NCT00883753|62702278|FG000|Overall Study|Protocol Violation|2|||
33325754|NCT00883753|62702278|FG000|Overall Study|Refused treatment|4|||
33325755|NCT00883753|62702278|FG000|Overall Study|Withdrew consent|10|||
33325756|NCT00883753|62702278|FG000|Overall Study|Investigator's decision|17|||
33325757|NCT00883753|62702278|FG000|Overall Study|Administrative/Other|8|||
33325758|NCT01210664|62702285|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
33325759|NCT01210664|62702286|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
33325760|NCT01210664|62702287|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
33325761|NCT01210664|62702288|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
33325762|NCT01210664|62702285|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
33325763|NCT01210664|62702286|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
33325764|NCT01210664|62702287|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
33325765|NCT01210664|62702288|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
33325766|NCT01210664|62702285|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
33325767|NCT01210664|62702286|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
33325768|NCT01210664|62702287|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
33325769|NCT01210664|62702288|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
33325770|NCT00881569|62702300|FG000|Overall Study|Disease progression|1|||
33325771|NCT00881569|62702301|FG001|Overall Study|Disease progression|1|||
33325772|NCT00881335|62702309|FG000|Overall Study|Lost to Follow-up|3|||
33325773|NCT00881335|62702310|FG001|Overall Study|Lost to Follow-up|2|||
33325774|NCT00879775|62702327|FG000|Overall Study|Lost to Follow-up|2|||
33325775|NCT00879775|62702328|FG001|Overall Study|Lost to Follow-up|1|||
33325776|NCT00894790|62702336|FG000|Overall Study|Protocol Violation|0|||
33325777|NCT00894790|62702337|FG001|Overall Study|Protocol Violation|1|||
33325778|NCT00894790|62702336|FG000|Overall Study|Lost to Follow-up|0|||
33325779|NCT00894790|62702337|FG001|Overall Study|Lost to Follow-up|1|||
33325780|NCT00894790|62702336|FG000|Overall Study|Did not meet entrance criteria|1|||
33325781|NCT00894790|62702337|FG001|Overall Study|Did not meet entrance criteria|0|||
33325782|NCT00879229|62702345|FG000|Overall Study|Study terminated by Sponsor|13|||
33325783|NCT00879229|62702346|FG001|Overall Study|Study terminated by Sponsor|12|||
33325784|NCT00879229|62702345|FG000|Overall Study|Death|4|||
33325785|NCT00879229|62702346|FG001|Overall Study|Death|2|||
33325786|NCT00879229|62702345|FG000|Overall Study|Adverse Event|2|||
33325787|NCT00879229|62702346|FG001|Overall Study|Adverse Event|0|||
33325788|NCT00879229|62702345|FG000|Overall Study|Withdrawal by Subject|1|||
33325789|NCT00879229|62702346|FG001|Overall Study|Withdrawal by Subject|0|||
33325790|NCT00879229|62702345|FG000|Overall Study|Clinical status did not improve|1|||
33459116|NCT00131937|62832588|FG000|Overall Study|Withdrawal by Subject|2|||
33459117|NCT00131937|62832588|FG000|Overall Study|Physician Decision|1|||
33532424|NCT01340937|62922134|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
33325791|NCT00879229|62702346|FG001|Overall Study|Clinical status did not improve|0|||
33325792|NCT00879229|62702345|FG000|Overall Study|Other|1|||
33325793|NCT00879229|62702346|FG001|Overall Study|Other|0|||
33459118|NCT00131937|62832588|FG000|Overall Study|Disease Progression|7|||
33459119|NCT00131937|62832588|FG000|Overall Study|Alternative therapy|1|||
33459120|NCT00131469|62832594|FG000|Overall Study|Withdrawal by Subject|3|||
33459121|NCT00131469|62832595|FG001|Overall Study|Withdrawal by Subject|4|||
33459122|NCT00131469|62832594|FG000|Overall Study|Protocol Violation|3|||
33459123|NCT00131469|62832595|FG001|Overall Study|Protocol Violation|1|||
33459124|NCT00131469|62832594|FG000|Overall Study|Death|0|||
33459125|NCT00131469|62832595|FG001|Overall Study|Death|1|||
33459126|NCT00131469|62832594|FG000|Overall Study|Lost to Follow-up|0|||
33459127|NCT00131469|62832595|FG001|Overall Study|Lost to Follow-up|1|||
33459128|NCT00131469|62832594|FG000|Overall Study|scan not analyzable|3|||
33459129|NCT00131469|62832595|FG001|Overall Study|scan not analyzable|6|||
33459130|NCT00372593|62832604|FG000|Overall Study|Adverse Event|43|||
33459131|NCT00372593|62832605|FG001|Overall Study|Adverse Event|45|||
33459132|NCT00372593|62832606|FG002|Overall Study|Adverse Event|0|||
33459133|NCT00372593|62832604|FG000|Overall Study|Death|16|||
33459134|NCT00372593|62832605|FG001|Overall Study|Death|20|||
33325794|NCT00878995|62702354|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
33325795|NCT00878995|62702355|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
33325796|NCT00879697|62702363|FG000|Overall Study|Physician Decision|2|||
33325797|NCT00879697|62702364|FG001|Overall Study|Physician Decision|2|||
33459135|NCT00372593|62832606|FG002|Overall Study|Death|1|||
33459136|NCT00372593|62832604|FG000|Overall Study|Lack of Efficacy|82|||
33459137|NCT00372593|62832605|FG001|Overall Study|Lack of Efficacy|71|||
33459138|NCT00372593|62832606|FG002|Overall Study|Lack of Efficacy|2|||
33459139|NCT00372593|62832604|FG000|Overall Study|Lost to Follow-up|1|||
33459140|NCT00372593|62832605|FG001|Overall Study|Lost to Follow-up|0|||
33325798|NCT00894556|62702373|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
33325799|NCT00894556|62702374|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
33325800|NCT00894556|62702375|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
33325801|NCT00894556|62702376|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
33325802|NCT00894556|62702373|FG000|Treatment Phase|Lost to Follow-up|2|||
33325803|NCT00894556|62702374|FG001|Treatment Phase|Lost to Follow-up|3|||
33325804|NCT00894556|62702375|FG002|Treatment Phase|Lost to Follow-up|1|||
33325805|NCT00894556|62702376|FG003|Treatment Phase|Lost to Follow-up|0|||
33325806|NCT00894556|62702373|FG000|Treatment Phase|Lack of Qualifying Event|2|||
33325807|NCT00894556|62702374|FG001|Treatment Phase|Lack of Qualifying Event|1|||
33325808|NCT00894556|62702375|FG002|Treatment Phase|Lack of Qualifying Event|0|||
33325809|NCT00894556|62702376|FG003|Treatment Phase|Lack of Qualifying Event|0|||
33325810|NCT01210352|62702392|FG000|Overall Study|Adverse Event|0|||
33325811|NCT01210352|62702393|FG001|Overall Study|Adverse Event|0|||
33325812|NCT01210352|62702394|FG002|Overall Study|Adverse Event|0|||
33325813|NCT01210352|62702395|FG003|Overall Study|Adverse Event|0|||
33325814|NCT01210352|62702396|FG004|Overall Study|Adverse Event|0|||
33325815|NCT01210352|62702397|FG005|Overall Study|Adverse Event|0|||
33325816|NCT01210352|62702398|FG006|Overall Study|Adverse Event|0|||
33325817|NCT01210352|62702399|FG007|Overall Study|Adverse Event|2|||
33325818|NCT01210352|62702400|FG008|Overall Study|Adverse Event|1|||
33325819|NCT01210352|62702392|FG000|Overall Study|Lack of Efficacy|0|||
33325820|NCT01210352|62702393|FG001|Overall Study|Lack of Efficacy|0|||
33325821|NCT01210352|62702394|FG002|Overall Study|Lack of Efficacy|0|||
33325822|NCT01210352|62702395|FG003|Overall Study|Lack of Efficacy|0|||
33325823|NCT01210352|62702396|FG004|Overall Study|Lack of Efficacy|0|||
33325824|NCT01210352|62702397|FG005|Overall Study|Lack of Efficacy|0|||
33325825|NCT01210352|62702398|FG006|Overall Study|Lack of Efficacy|1|||
33325826|NCT01210352|62702399|FG007|Overall Study|Lack of Efficacy|0|||
33325827|NCT01210352|62702400|FG008|Overall Study|Lack of Efficacy|0|||
33325828|NCT01210352|62702392|FG000|Overall Study|Physician Decision|0|||
33325829|NCT01210352|62702393|FG001|Overall Study|Physician Decision|0|||
33325830|NCT01210352|62702394|FG002|Overall Study|Physician Decision|0|||
33325831|NCT01210352|62702395|FG003|Overall Study|Physician Decision|0|||
33325832|NCT01210352|62702396|FG004|Overall Study|Physician Decision|0|||
33325833|NCT01210352|62702397|FG005|Overall Study|Physician Decision|0|||
33325834|NCT01210352|62702398|FG006|Overall Study|Physician Decision|0|||
33325835|NCT01210352|62702399|FG007|Overall Study|Physician Decision|1|||
33325836|NCT01210352|62702400|FG008|Overall Study|Physician Decision|2|||
33325837|NCT01210352|62702392|FG000|Overall Study|Withdrawal by Subject|0|||
33325838|NCT01210352|62702393|FG001|Overall Study|Withdrawal by Subject|0|||
33325839|NCT01210352|62702394|FG002|Overall Study|Withdrawal by Subject|1|||
33325840|NCT01210352|62702395|FG003|Overall Study|Withdrawal by Subject|0|||
33325841|NCT01210352|62702396|FG004|Overall Study|Withdrawal by Subject|0|||
33325842|NCT01210352|62702397|FG005|Overall Study|Withdrawal by Subject|0|||
33325843|NCT01210352|62702398|FG006|Overall Study|Withdrawal by Subject|1|||
33325844|NCT01210352|62702399|FG007|Overall Study|Withdrawal by Subject|0|||
33325845|NCT01210352|62702400|FG008|Overall Study|Withdrawal by Subject|1|||
33325846|NCT01210352|62702392|FG000|Overall Study|Patient Discharged Early|0|||
33325847|NCT01210352|62702393|FG001|Overall Study|Patient Discharged Early|0|||
33325848|NCT01210352|62702394|FG002|Overall Study|Patient Discharged Early|1|||
33325849|NCT01210352|62702395|FG003|Overall Study|Patient Discharged Early|0|||
33325850|NCT01210352|62702396|FG004|Overall Study|Patient Discharged Early|0|||
33325851|NCT01210352|62702397|FG005|Overall Study|Patient Discharged Early|0|||
33325852|NCT01210352|62702398|FG006|Overall Study|Patient Discharged Early|0|||
33325853|NCT01210352|62702399|FG007|Overall Study|Patient Discharged Early|0|||
33325854|NCT01210352|62702400|FG008|Overall Study|Patient Discharged Early|0|||
33325855|NCT01210118|62702507|FG000|Overall Study|Lost to Follow-up|1|||
33325856|NCT01210118|62702508|FG001|Overall Study|Lost to Follow-up|1|||
33325857|NCT01210118|62702507|FG000|Overall Study|Protocol Violation|1|||
33325858|NCT01210118|62702508|FG001|Overall Study|Protocol Violation|1|||
33325859|NCT01210118|62702507|FG000|Overall Study|Spontaneous abortion|1|||
33325860|NCT01210118|62702508|FG001|Overall Study|Spontaneous abortion|3|||
33325861|NCT01208870|62702519|FG000|Overall Study|Lost to Follow-up|2|||
33325862|NCT01208870|62702520|FG001|Overall Study|Lost to Follow-up|8|||
33325863|NCT00880555|62702531|FG000|Overall Study|Physician Decision|0|||
33325864|NCT00880555|62702532|FG001|Overall Study|Physician Decision|8|||
33325865|NCT00880555|62702533|FG002|Overall Study|Physician Decision|0|||
33325866|NCT00880555|62702534|FG003|Overall Study|Physician Decision|2|||
33325867|NCT00880555|62702535|FG004|Overall Study|Physician Decision|1|||
33325868|NCT00880555|62702536|FG005|Overall Study|Physician Decision|0|||
33325869|NCT00880555|62702531|FG000|Overall Study|Withdrawal by Subject|1|||
33325870|NCT00880555|62702532|FG001|Overall Study|Withdrawal by Subject|1|||
33325871|NCT00880555|62702533|FG002|Overall Study|Withdrawal by Subject|0|||
33325872|NCT00880555|62702534|FG003|Overall Study|Withdrawal by Subject|0|||
33325873|NCT00880555|62702535|FG004|Overall Study|Withdrawal by Subject|0|||
33325874|NCT00880555|62702536|FG005|Overall Study|Withdrawal by Subject|0|||
33325875|NCT00880555|62702531|FG000|Overall Study|Lack of resources (hired rater)|9|||
33325876|NCT00880555|62702532|FG001|Overall Study|Lack of resources (hired rater)|7|||
33325877|NCT00880555|62702533|FG002|Overall Study|Lack of resources (hired rater)|5|||
33325878|NCT00880555|62702534|FG003|Overall Study|Lack of resources (hired rater)|0|||
33325879|NCT00880555|62702535|FG004|Overall Study|Lack of resources (hired rater)|0|||
33325880|NCT00880555|62702536|FG005|Overall Study|Lack of resources (hired rater)|0|||
33325881|NCT00880555|62702531|FG000|Overall Study|Death|0|||
33325882|NCT00880555|62702532|FG001|Overall Study|Death|0|||
33325883|NCT00880555|62702533|FG002|Overall Study|Death|0|||
33325884|NCT00880555|62702534|FG003|Overall Study|Death|0|||
33325885|NCT00880555|62702535|FG004|Overall Study|Death|0|||
33325886|NCT00880555|62702536|FG005|Overall Study|Death|1|||
33325887|NCT00880555|62702531|FG000|Overall Study|Lost to Follow-up|0|||
33325888|NCT00880555|62702532|FG001|Overall Study|Lost to Follow-up|1|||
33325889|NCT00880555|62702533|FG002|Overall Study|Lost to Follow-up|0|||
33325890|NCT00880555|62702534|FG003|Overall Study|Lost to Follow-up|0|||
33325891|NCT00880555|62702535|FG004|Overall Study|Lost to Follow-up|0|||
33325892|NCT00880555|62702536|FG005|Overall Study|Lost to Follow-up|0|||
33325893|NCT01208402|62702549|FG000|Overall Study|Withdrawal by Subject|1|||
33325894|NCT01208402|62702550|FG001|Overall Study|Withdrawal by Subject|0|||
33325895|NCT01208324|62702560|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
33325896|NCT01208324|62702561|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
33325897|NCT01208324|62702562|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
33325898|NCT01208324|62702563|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
33325899|NCT00880399|62702576|FG000|Overall Study|Adverse Event|4|||
33325900|NCT00880399|62702577|FG001|Overall Study|Adverse Event|6|||
33325901|NCT00880399|62702578|FG002|Overall Study|Adverse Event|5|||
33325902|NCT00880399|62702576|FG000|Overall Study|Lack of Efficacy|1|||
33325903|NCT00880399|62702577|FG001|Overall Study|Lack of Efficacy|4|||
33325904|NCT00880399|62702578|FG002|Overall Study|Lack of Efficacy|2|||
33325905|NCT00880399|62702576|FG000|Overall Study|Protocol Violation|4|||
33325906|NCT00880399|62702577|FG001|Overall Study|Protocol Violation|4|||
33325907|NCT00880399|62702578|FG002|Overall Study|Protocol Violation|6|||
33325908|NCT00880399|62702576|FG000|Overall Study|Study closed/terminated|3|||
33325909|NCT00880399|62702577|FG001|Overall Study|Study closed/terminated|7|||
33325910|NCT00880399|62702578|FG002|Overall Study|Study closed/terminated|4|||
33325911|NCT00880399|62702576|FG000|Overall Study|Lost to Follow-up|8|||
33325912|NCT00880399|62702577|FG001|Overall Study|Lost to Follow-up|5|||
33325913|NCT00880399|62702578|FG002|Overall Study|Lost to Follow-up|3|||
33325914|NCT00880399|62702576|FG000|Overall Study|Physician Decision|5|||
33325915|NCT00880399|62702577|FG001|Overall Study|Physician Decision|0|||
33325916|NCT00880399|62702578|FG002|Overall Study|Physician Decision|3|||
33325917|NCT00880399|62702576|FG000|Overall Study|Withdrawal by Subject|6|||
33325918|NCT00880399|62702577|FG001|Overall Study|Withdrawal by Subject|3|||
33325919|NCT00880399|62702578|FG002|Overall Study|Withdrawal by Subject|3|||
33325920|NCT01207388|62702586|FG000|Overall Study|Death|67|||
33325921|NCT01207388|62702586|FG000|Overall Study|Withdrawal by Subject|1|||
33325922|NCT01206764|62702598|FG000|Overall Study|Adverse Event|20|||
33325923|NCT01206764|62702598|FG000|Overall Study|Abnormal laboratory value|2|||
33325924|NCT01206764|62702598|FG000|Overall Study|Abnormal test procedure result|1|||
33325925|NCT01206764|62702598|FG000|Overall Study|Patient withdrew consent|5|||
33325926|NCT01206764|62702598|FG000|Overall Study|Lost to Follow-up|6|||
33325927|NCT01206764|62702598|FG000|Overall Study|Death|11|||
33325928|NCT01206764|62702598|FG000|Overall Study|New cancer therapy|2|||
33325929|NCT01206764|62702598|FG000|Overall Study|Disease progression|88|||
33325930|NCT01206764|62702598|FG000|Overall Study|Protocol deviation|3|||
33325931|NCT00894322|62702605|FG000|Overall Study|Withdrawal by Subject|1|||
33325932|NCT00894322|62702606|FG001|Overall Study|Withdrawal by Subject|0|||
33325933|NCT00894322|62702607|FG002|Overall Study|Withdrawal by Subject|0|||
33325934|NCT00596635|62702620|FG000|Overall Study|Lost to Follow-up|0|||
33325935|NCT00596635|62702621|FG001|Overall Study|Lost to Follow-up|2|||
33325936|NCT00596635|62702622|FG002|Overall Study|Lost to Follow-up|0|||
33325937|NCT00596635|62702620|FG000|Overall Study|Treatment for symptomatic UTI|4|||
33325938|NCT00596635|62702621|FG001|Overall Study|Treatment for symptomatic UTI|6|||
33325939|NCT00596635|62702622|FG002|Overall Study|Treatment for symptomatic UTI|3|||
33325940|NCT00596635|62702620|FG000|Overall Study|Hip fracture|2|||
33325941|NCT00596635|62702621|FG001|Overall Study|Hip fracture|3|||
33325942|NCT00596635|62702622|FG002|Overall Study|Hip fracture|3|||
33325943|NCT00596635|62702620|FG000|Overall Study|Could not provide urine specimen|1|||
33325944|NCT00596635|62702621|FG001|Overall Study|Could not provide urine specimen|2|||
33325945|NCT00596635|62702622|FG002|Overall Study|Could not provide urine specimen|2|||
33325946|NCT00894166|62702638|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
33325947|NCT00894166|62702639|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
33459141|NCT00372593|62832606|FG002|Overall Study|Lost to Follow-up|0|||
33459142|NCT00372593|62832604|FG000|Overall Study|Physician Decision|42|||
33459143|NCT00372593|62832605|FG001|Overall Study|Physician Decision|41|||
33459144|NCT00372593|62832606|FG002|Overall Study|Physician Decision|0|||
33325948|NCT00894166|62702640|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
33459145|NCT00372593|62832604|FG000|Overall Study|Ineligible|20|||
33325949|NCT00894166|62702641|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
33325950|NCT00894166|62702642|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
33325951|NCT00894166|62702643|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
33325952|NCT00894166|62702644|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
33325953|NCT00894166|62702645|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
33325954|NCT00894166|62702638|FG000|Overall Study|Death|0|||
33325955|NCT00894166|62702639|FG001|Overall Study|Death|0|||
33325956|NCT00894166|62702640|FG002|Overall Study|Death|0|||
33325957|NCT00894166|62702641|FG003|Overall Study|Death|1|||
33325958|NCT00894166|62702642|FG004|Overall Study|Death|0|||
33325959|NCT00894166|62702643|FG005|Overall Study|Death|0|||
33325960|NCT00894166|62702644|FG006|Overall Study|Death|0|||
33325961|NCT00894166|62702645|FG007|Overall Study|Death|0|||
33325962|NCT00880165|62702670|FG000|Overall Study|Withdrawal by Subject|27|||
33325963|NCT00880165|62702671|FG001|Overall Study|Withdrawal by Subject|23|||
33325964|NCT00880165|62702670|FG000|Overall Study|Not diagnosed with OSA|14|||
33325965|NCT00880165|62702671|FG001|Overall Study|Not diagnosed with OSA|8|||
33325966|NCT00880165|62702670|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
33325967|NCT00880165|62702671|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
33325968|NCT00880165|62702670|FG000|Overall Study|Lost to follow|9|||
33325969|NCT00880165|62702671|FG001|Overall Study|Lost to follow|15|||
33325970|NCT01165229|62702679|FG000|Overall Study|Serious Adverse Event|456|||
33325971|NCT01165229|62702680|FG001|Overall Study|Serious Adverse Event|487|||
33325972|NCT01165229|62702679|FG000|Overall Study|Non-Serious Adverse Event|47|||
33325973|NCT01165229|62702680|FG001|Overall Study|Non-Serious Adverse Event|15|||
33325974|NCT01165229|62702679|FG000|Overall Study|Protocol Violation|6|||
33325975|NCT01165229|62702680|FG001|Overall Study|Protocol Violation|8|||
33325976|NCT01165229|62702679|FG000|Overall Study|Withdrawal by Subject|387|||
33325977|NCT01165229|62702680|FG001|Overall Study|Withdrawal by Subject|396|||
33325978|NCT01165229|62702679|FG000|Overall Study|Migrated/moved from study area|51|||
33325979|NCT01165229|62702680|FG001|Overall Study|Migrated/moved from study area|46|||
33325980|NCT01165229|62702679|FG000|Overall Study|Lost to Follow-up|123|||
33325981|NCT01165229|62702680|FG001|Overall Study|Lost to Follow-up|133|||
33325982|NCT01165229|62702679|FG000|Overall Study|Suspected HZ Episode|2|||
33325983|NCT01165229|62702680|FG001|Overall Study|Suspected HZ Episode|2|||
33325984|NCT01165229|62702679|FG000|Overall Study|No reason from the subject|108|||
33325985|NCT01165229|62702680|FG001|Overall Study|No reason from the subject|102|||
33325986|NCT01165229|62702679|FG000|Overall Study|Unknown completion status|0|||
33325987|NCT01165229|62702680|FG001|Overall Study|Unknown completion status|1|||
33325988|NCT00596011|62702718|FG000|Overall Study|Withdrawal by Subject|2|||
33325989|NCT00596011|62702719|FG001|Overall Study|Withdrawal by Subject|3|||
33325990|NCT00596011|62702718|FG000|Overall Study|Adverse Event|11|||
33325991|NCT00596011|62702719|FG001|Overall Study|Adverse Event|7|||
33325992|NCT01163747|62702727|FG000|Overall Study|Adverse Event|0|||
33325993|NCT01163747|62702728|FG001|Overall Study|Adverse Event|5|||
33325994|NCT01163747|62702727|FG000|Overall Study|Insufficient Therapeutic Response|0|||
33325995|NCT01163747|62702728|FG001|Overall Study|Insufficient Therapeutic Response|1|||
33325996|NCT01163747|62702727|FG000|Overall Study|Protocol Violation|0|||
33325997|NCT01163747|62702728|FG001|Overall Study|Protocol Violation|1|||
33325998|NCT01163747|62702727|FG000|Overall Study|Refused Treatment|6|||
33325999|NCT01163747|62702728|FG001|Overall Study|Refused Treatment|4|||
33326000|NCT01163279|62702736|FG000|Overall Study|Withdrawal by Subject|2|||
33326001|NCT01163279|62702737|FG001|Overall Study|Withdrawal by Subject|0|||
33459146|NCT00372593|62832605|FG001|Overall Study|Ineligible|21|||
33459147|NCT00372593|62832606|FG002|Overall Study|Ineligible|1|||
33459148|NCT03666988|62832621|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
33459149|NCT03666988|62832622|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
33459150|NCT03666988|62832623|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
33459151|NCT03666988|62832624|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
33326002|NCT01162499|62702744|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
33326003|NCT01162499|62702745|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
33326004|NCT01206140|62702755|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
33326005|NCT01206140|62702756|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
33459152|NCT03666988|62832625|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
33459153|NCT03666988|62832626|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
33459154|NCT03666988|62832621|FG000|Part 1 (Up to 28 Months)|Other|0|||
33326006|NCT01162421|62702764|FG000|Overall Study|Did not receive study drug|2|||
33459155|NCT03666988|62832622|FG001|Part 1 (Up to 28 Months)|Other|1|||
33326007|NCT01162421|62702765|FG001|Overall Study|Did not receive study drug|1|||
33326008|NCT01162421|62702764|FG000|Overall Study|Adverse Event|2|||
33326009|NCT01162421|62702765|FG001|Overall Study|Adverse Event|5|||
33326010|NCT01162421|62702764|FG000|Overall Study|Lost to Follow-up|0|||
33326011|NCT01162421|62702765|FG001|Overall Study|Lost to Follow-up|2|||
33326012|NCT01162421|62702764|FG000|Overall Study|Lack of Efficacy|2|||
33326013|NCT01162421|62702765|FG001|Overall Study|Lack of Efficacy|2|||
33326014|NCT01162421|62702764|FG000|Overall Study|Other|2|||
33326015|NCT01162421|62702765|FG001|Overall Study|Other|3|||
33326016|NCT01162343|62702771|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
33326017|NCT01162343|62702771|FG000|Overall Study|Refused psychiatrist assessment|12|||
33459156|NCT03666988|62832623|FG002|Part 1 (Up to 28 Months)|Other|1|||
33459157|NCT03666988|62832624|FG003|Part 1 (Up to 28 Months)|Other|0|||
33459158|NCT03666988|62832625|FG004|Part 1 (Up to 28 Months)|Other|0|||
33459159|NCT03666988|62832626|FG005|Part 1 (Up to 28 Months)|Other|0|||
33532425|NCT01340937|62922135|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
33532426|NCT01340937|62922136|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
33532427|NCT01340937|62922137|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
33532428|NCT03028129|62922155|FG000|Overall Study|Adverse Event|13|||
33532429|NCT03028129|62922156|FG001|Overall Study|Adverse Event|2|||
33532430|NCT03028129|62922155|FG000|Overall Study|Lost to Follow-up|50|||
33532431|NCT03028129|62922156|FG001|Overall Study|Lost to Follow-up|38|||
33532432|NCT03028129|62922155|FG000|Overall Study|Physician Decision|0|||
33532433|NCT03028129|62922156|FG001|Overall Study|Physician Decision|1|||
33532434|NCT03028129|62922155|FG000|Overall Study|Protocol Violation|1|||
33626231|NCT02115113|63027200|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
33626232|NCT02115113|63027201|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
33626233|NCT02115113|63027199|FG000|Participants Randomized|Lost to Follow-up|1|||
33626234|NCT02115113|63027200|FG001|Participants Randomized|Lost to Follow-up|0|||
33626235|NCT02115113|63027201|FG002|Participants Randomized|Lost to Follow-up|0|||
33626236|NCT02115113|63027199|FG000|Participants Randomized|Death|1|||
33626237|NCT02115113|63027200|FG001|Participants Randomized|Death|0|||
33459160|NCT03666988|62832621|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
33626238|NCT02115113|63027201|FG002|Participants Randomized|Death|0|||
33626239|NCT02114879|63027212|FG000|Overall Study|Withdrawal by Subject|9|||
33626240|NCT02114879|63027213|FG001|Overall Study|Withdrawal by Subject|5|||
33626241|NCT02114879|63027212|FG000|Overall Study|Death|6|||
33626242|NCT02114879|63027213|FG001|Overall Study|Death|11|||
33626243|NCT02114879|63027212|FG000|Overall Study|Lost to Follow-up|4|||
33626244|NCT02114879|63027213|FG001|Overall Study|Lost to Follow-up|6|||
33626245|NCT02114879|63027212|FG000|Overall Study|Physician Decision|0|||
33626246|NCT02114879|63027213|FG001|Overall Study|Physician Decision|2|||
33626247|NCT02114177|63027221|FG000|Overall Study|Lost to Follow-up|1|||
33626248|NCT02114177|63027222|FG001|Overall Study|Lost to Follow-up|2|||
33626249|NCT02114177|63027221|FG000|Overall Study|Withdrawal by Subject|6|||
33626250|NCT02114177|63027222|FG001|Overall Study|Withdrawal by Subject|1|||
33459161|NCT03666988|62832622|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
33459162|NCT03666988|62832623|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
33459163|NCT03666988|62832624|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
33459164|NCT03666988|62832625|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
33459165|NCT03666988|62832626|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
33532435|NCT03028129|62922156|FG001|Overall Study|Protocol Violation|1|||
33532436|NCT03028129|62922155|FG000|Overall Study|Withdrawal by Subject|62|||
33532437|NCT03028129|62922156|FG001|Overall Study|Withdrawal by Subject|45|||
33532438|NCT01309672|62922162|FG000|Overall Study|Lack of Efficacy|20|||
33532439|NCT01309672|62922162|FG000|Overall Study|Other|9|||
33532440|NCT01309672|62922162|FG000|Overall Study|Adverse Event|5|||
33626251|NCT02114177|63027221|FG000|Overall Study|Other|2|||
33626252|NCT02114177|63027222|FG001|Overall Study|Other|1|||
33626253|NCT02138825|63027230|FG000|Main Study Treatment|Adverse Event|11|||
33626254|NCT02138825|63027231|FG001|Main Study Treatment|Adverse Event|3|||
33326018|NCT01188551|62702779|FG000|Overall Study|Pharmacy issues|1|||
33326019|NCT01188551|62702780|FG001|Overall Study|Pharmacy issues|0|||
33326020|NCT01188551|62702781|FG002|Overall Study|Pharmacy issues|0|||
33459166|NCT03666988|62832621|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
33532441|NCT01309672|62922162|FG000|Overall Study|Withdrawal by Subject|3|||
33626255|NCT02138825|63027230|FG000|Main Study Treatment|Death|1|||
33626256|NCT02138825|63027231|FG001|Main Study Treatment|Death|2|||
33626257|NCT02138825|63027230|FG000|Main Study Treatment|Protocol Violation|2|||
33532442|NCT03026257|62922173|FG000|Overall Study|Adverse Event|3|||
33532443|NCT03026257|62922174|FG001|Overall Study|Adverse Event|0|||
33532444|NCT03026257|62922175|FG002|Overall Study|Adverse Event|0|||
33532445|NCT03026257|62922176|FG003|Overall Study|Adverse Event|0|||
33532446|NCT03026257|62922177|FG004|Overall Study|Adverse Event|0|||
33532447|NCT03026257|62922178|FG005|Overall Study|Adverse Event|0|||
33532448|NCT03026257|62922173|FG000|Overall Study|Lost to Follow-up|1|||
33532449|NCT03026257|62922174|FG001|Overall Study|Lost to Follow-up|0|||
33532450|NCT03026257|62922175|FG002|Overall Study|Lost to Follow-up|0|||
33532451|NCT03026257|62922176|FG003|Overall Study|Lost to Follow-up|0|||
33532452|NCT03026257|62922177|FG004|Overall Study|Lost to Follow-up|0|||
33532453|NCT03026257|62922178|FG005|Overall Study|Lost to Follow-up|0|||
33532454|NCT03026257|62922173|FG000|Overall Study|Protocol Violation|1|||
33532455|NCT03026257|62922174|FG001|Overall Study|Protocol Violation|0|||
33532456|NCT03026257|62922175|FG002|Overall Study|Protocol Violation|0|||
33532457|NCT03026257|62922176|FG003|Overall Study|Protocol Violation|1|||
33532458|NCT03026257|62922177|FG004|Overall Study|Protocol Violation|1|||
33532459|NCT03026257|62922178|FG005|Overall Study|Protocol Violation|0|||
33532460|NCT03026257|62922173|FG000|Overall Study|Withdrawal by Subject|1|||
33532461|NCT03026257|62922174|FG001|Overall Study|Withdrawal by Subject|1|||
33532462|NCT03026257|62922175|FG002|Overall Study|Withdrawal by Subject|0|||
33532463|NCT03026257|62922176|FG003|Overall Study|Withdrawal by Subject|0|||
33532464|NCT03026257|62922177|FG004|Overall Study|Withdrawal by Subject|0|||
33532465|NCT03026257|62922178|FG005|Overall Study|Withdrawal by Subject|0|||
33532466|NCT01670188|62922194|FG000|Overall Study|Death|0|||
33626258|NCT02138825|63027231|FG001|Main Study Treatment|Protocol Violation|2|||
33626259|NCT02138825|63027230|FG000|Main Study Treatment|Sponsor decision|12|||
33626260|NCT02138825|63027231|FG001|Main Study Treatment|Sponsor decision|18|||
33626261|NCT02138825|63027230|FG000|Main Study Treatment|Study terminated by sponsor|10|||
33626262|NCT02138825|63027231|FG001|Main Study Treatment|Study terminated by sponsor|9|||
33626263|NCT02138825|63027230|FG000|Main Study Treatment|Withdrawal by Subject|3|||
33626264|NCT02138825|63027231|FG001|Main Study Treatment|Withdrawal by Subject|1|||
33626265|NCT02138825|63027230|FG000|Main Study Treatment|Medical decision|1|||
33626266|NCT02138825|63027231|FG001|Main Study Treatment|Medical decision|0|||
33626267|NCT02138825|63027230|FG000|Long-term Extension|Study termination by sponsor|32|||
33626268|NCT02138825|63027231|FG001|Long-term Extension|Study termination by sponsor|38|||
33626269|NCT02138825|63027230|FG000|Safety Follow-up|Adverse Event|4|||
33626270|NCT02138825|63027231|FG001|Safety Follow-up|Adverse Event|3|||
33626271|NCT02138825|63027230|FG000|Safety Follow-up|Death|11|||
33626272|NCT02138825|63027231|FG001|Safety Follow-up|Death|5|||
33626273|NCT02138825|63027230|FG000|Safety Follow-up|Withdrawal by Subject|5|||
33626274|NCT02138825|63027231|FG001|Safety Follow-up|Withdrawal by Subject|3|||
33626275|NCT02138825|63027230|FG000|Safety Follow-up|clinic worsening|1|||
33626276|NCT02138825|63027231|FG001|Safety Follow-up|clinic worsening|0|||
33626277|NCT02138825|63027230|FG000|Safety Follow-up|withdrawal by PI|1|||
33626278|NCT02138825|63027231|FG001|Safety Follow-up|withdrawal by PI|0|||
33626279|NCT02138825|63027230|FG000|Safety Follow-up|logistical difficulties|0|||
33626280|NCT02138825|63027231|FG001|Safety Follow-up|logistical difficulties|1|||
33626281|NCT02138825|63027230|FG000|Safety Follow-up|progressive disease|0|||
33459167|NCT03666988|62832622|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
33459168|NCT03666988|62832623|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
33459169|NCT03666988|62832624|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
33459170|NCT03666988|62832625|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
33459171|NCT03666988|62832626|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
33459172|NCT03666988|62832621|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
33459173|NCT03666988|62832622|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
33459174|NCT03666988|62832623|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
33459175|NCT03666988|62832624|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
33532467|NCT01670188|62922195|FG001|Overall Study|Death|1|||
33532468|NCT01933048|62922203|FG000|Overall Study|Lost to Follow-up|15|||
33532469|NCT01933048|62922204|FG001|Overall Study|Lost to Follow-up|18|||
33532470|NCT01933048|62922203|FG000|Overall Study|personal reasons|1|||
33626282|NCT02138825|63027231|FG001|Safety Follow-up|progressive disease|2|||
33626283|NCT02138825|63027230|FG000|Safety Follow-up|too unwell to attend the visit|0|||
33626284|NCT02138825|63027231|FG001|Safety Follow-up|too unwell to attend the visit|1|||
33626285|NCT02138825|63027230|FG000|Safety Follow-up|treatment unblinded|0|||
33626286|NCT02138825|63027231|FG001|Safety Follow-up|treatment unblinded|1|||
33626287|NCT02138825|63027230|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
33459176|NCT03666988|62832625|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
33532471|NCT01933048|62922204|FG001|Overall Study|personal reasons|1|||
33532472|NCT01933048|62922203|FG000|Overall Study|Protocol Violation|7|||
33532473|NCT01933048|62922204|FG001|Overall Study|Protocol Violation|8|||
33532474|NCT01933048|62922203|FG000|Overall Study|Physician Decision|1|||
33532475|NCT01933048|62922204|FG001|Overall Study|Physician Decision|0|||
33532476|NCT01933048|62922203|FG000|Overall Study|unknown reasons|1|||
33532477|NCT01933048|62922204|FG001|Overall Study|unknown reasons|1|||
33532478|NCT02751450|62922215|FG000|Overall Study|Adverse Event|1|||
33532479|NCT02751450|62922216|FG001|Overall Study|Adverse Event|0|||
33532480|NCT01515748|62922226|FG000|Overall Study|Withdrawal by Subject|32|||
33532481|NCT01515748|62922227|FG001|Overall Study|Withdrawal by Subject|41|||
33532482|NCT01515748|62922226|FG000|Overall Study|Lost to Follow-up|2|||
33532483|NCT01515748|62922227|FG001|Overall Study|Lost to Follow-up|4|||
33532484|NCT01515748|62922226|FG000|Overall Study|Ongoing|86|||
33532485|NCT01515748|62922227|FG001|Overall Study|Ongoing|90|||
33532486|NCT01358175|62922237|FG000|Overall Study|Death|1|||
33532487|NCT01358175|62922238|FG001|Overall Study|Death|0|||
33532488|NCT01358175|62922239|FG002|Overall Study|Death|1|||
33532489|NCT01358175|62922237|FG000|Overall Study|Withdrawal by Subject|9|||
33532490|NCT01358175|62922238|FG001|Overall Study|Withdrawal by Subject|5|||
33532491|NCT01358175|62922239|FG002|Overall Study|Withdrawal by Subject|10|||
33532492|NCT01358175|62922237|FG000|Overall Study|Technical issues|0|||
33532493|NCT01358175|62922238|FG001|Overall Study|Technical issues|1|||
33532494|NCT01358175|62922239|FG002|Overall Study|Technical issues|0|||
33532495|NCT01358175|62922237|FG000|Overall Study|Pregnancy|0|||
33532496|NCT01358175|62922238|FG001|Overall Study|Pregnancy|1|||
33532497|NCT01358175|62922239|FG002|Overall Study|Pregnancy|0|||
33626288|NCT02138825|63027231|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
33626289|NCT02138747|63027246|FG000|Treatment Period 1|Adverse Event|10|||
33626290|NCT02138747|63027247|FG001|Treatment Period 1|Adverse Event|14|||
33626291|NCT02138747|63027248|FG002|Treatment Period 1|Adverse Event|2|||
33626292|NCT02138747|63027249|FG003|Treatment Period 1|Adverse Event|1|||
33626293|NCT02138747|63027246|FG000|Treatment Period 1|Lost to Follow-up|0|||
33626294|NCT02138747|63027247|FG001|Treatment Period 1|Lost to Follow-up|1|||
33459177|NCT03666988|62832626|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
33459178|NCT00382109|62832646|FG000|Overall Study|Adverse Event|3|||
33459179|NCT00382109|62832647|FG001|Overall Study|Adverse Event|0|||
33459180|NCT00382109|62832646|FG000|Overall Study|Physician Decision|6|||
33459181|NCT00382109|62832647|FG001|Overall Study|Physician Decision|1|||
33459182|NCT00382109|62832646|FG000|Overall Study|Withdrawal by Subject|1|||
33459183|NCT00382109|62832647|FG001|Overall Study|Withdrawal by Subject|0|||
33459184|NCT00382109|62832646|FG000|Overall Study|ineligible|2|||
33459185|NCT00382109|62832647|FG001|Overall Study|ineligible|0|||
33459186|NCT00382109|62832646|FG000|Overall Study|Other|0|||
33459187|NCT00382109|62832647|FG001|Overall Study|Other|2|||
33459188|NCT00382109|62832646|FG000|Overall Study|consent withdrawal|0|||
33459189|NCT00382109|62832647|FG001|Overall Study|consent withdrawal|1|||
33459190|NCT03651622|62832659|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
33459191|NCT03651622|62832660|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
33459192|NCT03651622|62832661|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
33459193|NCT03651622|62832659|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
33459194|NCT03651622|62832660|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
33459195|NCT03651622|62832661|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
33459196|NCT03651622|62832659|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
33459197|NCT03651622|62832660|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
33459198|NCT03651622|62832661|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
33459199|NCT03651622|62832659|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
33459200|NCT03651622|62832660|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
33459201|NCT03651622|62832661|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
33459202|NCT03651622|62832659|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
33459203|NCT03651622|62832660|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
33459204|NCT03651622|62832661|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
33459205|NCT00381797|62832674|FG000|Overall Study|Withdrawal by Subject|1|||
33459206|NCT00381797|62832675|FG001|Overall Study|Withdrawal by Subject|1|||
33459207|NCT00381797|62832676|FG002|Overall Study|Withdrawal by Subject|0|||
33459208|NCT00381797|62832677|FG003|Overall Study|Withdrawal by Subject|0|||
33459209|NCT00381797|62832678|FG004|Overall Study|Withdrawal by Subject|2|||
33459210|NCT00381797|62832674|FG000|Overall Study|Ineligible|0|||
33532498|NCT01358175|62922237|FG000|Overall Study|Physician Decision|1|||
33532499|NCT01358175|62922238|FG001|Overall Study|Physician Decision|0|||
33532500|NCT01358175|62922239|FG002|Overall Study|Physician Decision|0|||
33532501|NCT01358175|62922237|FG000|Overall Study|Non Compliance with Study Treatment|0|||
33532502|NCT01358175|62922238|FG001|Overall Study|Non Compliance with Study Treatment|1|||
33532503|NCT01358175|62922239|FG002|Overall Study|Non Compliance with Study Treatment|1|||
33532504|NCT01358175|62922237|FG000|Overall Study|Lost to Follow-up|1|||
33459211|NCT00381797|62832675|FG001|Overall Study|Ineligible|0|||
33459212|NCT00381797|62832676|FG002|Overall Study|Ineligible|0|||
33459213|NCT00381797|62832677|FG003|Overall Study|Ineligible|1|||
33459214|NCT00381797|62832678|FG004|Overall Study|Ineligible|0|||
33626295|NCT02138747|63027248|FG002|Treatment Period 1|Lost to Follow-up|1|||
33626296|NCT02138747|63027249|FG003|Treatment Period 1|Lost to Follow-up|0|||
33626297|NCT02138747|63027246|FG000|Treatment Period 1|Protocol Violation|0|||
33626298|NCT02138747|63027247|FG001|Treatment Period 1|Protocol Violation|2|||
33626299|NCT02138747|63027248|FG002|Treatment Period 1|Protocol Violation|0|||
33626300|NCT02138747|63027249|FG003|Treatment Period 1|Protocol Violation|0|||
33626301|NCT02138747|63027246|FG000|Treatment Period 1|Withdrawal by Subject|8|||
33626302|NCT02138747|63027247|FG001|Treatment Period 1|Withdrawal by Subject|4|||
33626303|NCT02138747|63027248|FG002|Treatment Period 1|Withdrawal by Subject|1|||
33626304|NCT02138747|63027249|FG003|Treatment Period 1|Withdrawal by Subject|3|||
33626305|NCT02138747|63027246|FG000|Treatment Period 1|Other - Miscellaneous|2|||
33532505|NCT01358175|62922238|FG001|Overall Study|Lost to Follow-up|1|||
33532506|NCT01358175|62922239|FG002|Overall Study|Lost to Follow-up|3|||
33532507|NCT01358175|62922237|FG000|Overall Study|Lack of Efficacy|3|||
33532508|NCT01358175|62922238|FG001|Overall Study|Lack of Efficacy|8|||
33532509|NCT01358175|62922239|FG002|Overall Study|Lack of Efficacy|6|||
33532510|NCT01358175|62922237|FG000|Overall Study|Adverse Event|6|||
33532511|NCT01358175|62922238|FG001|Overall Study|Adverse Event|11|||
33532512|NCT01358175|62922239|FG002|Overall Study|Adverse Event|11|||
33532513|NCT04116229|62922253|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
33532514|NCT04116229|62922254|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
33532515|NCT04116229|62922253|FG000|Overall Study|Scheduling not possible.|0|||
33532516|NCT04116229|62922254|FG001|Overall Study|Scheduling not possible.|1|||
33532517|NCT02210832|62922263|FG000|Overall Study|Pregnancy termination .|3|||
33532518|NCT02210832|62922264|FG001|Overall Study|Pregnancy termination .|4|||
33532519|NCT02210832|62922265|FG002|Overall Study|Pregnancy termination .|1|||
33532520|NCT02210832|62922263|FG000|Overall Study|Lost to Follow-up|26|||
33532521|NCT02210832|62922264|FG001|Overall Study|Lost to Follow-up|32|||
33532522|NCT02210832|62922265|FG002|Overall Study|Lost to Follow-up|17|||
33532523|NCT02833077|62922278|FG000|Overall Study|Adverse Event|1|||
33532524|NCT02833077|62922279|FG001|Overall Study|Adverse Event|2|||
33532525|NCT02833077|62922278|FG000|Overall Study|Lost to Follow-up|10|||
33532526|NCT02833077|62922279|FG001|Overall Study|Lost to Follow-up|1|||
33532527|NCT02833077|62922278|FG000|Overall Study|Personal Reasons|6|||
33532528|NCT02833077|62922279|FG001|Overall Study|Personal Reasons|4|||
33532529|NCT02833077|62922278|FG000|Overall Study|Protocol Deviation|0|||
33532530|NCT02833077|62922279|FG001|Overall Study|Protocol Deviation|1|||
33532531|NCT01355679|62922286|FG000|Overall Study|benign tumor types found at biopsy|2|||
33532532|NCT02832375|62922293|FG000|Overall Study|Lost to Follow-up|1|||
33532533|NCT02832375|62922294|FG001|Overall Study|Lost to Follow-up|0|||
33532534|NCT02832375|62922293|FG000|Overall Study|Withdrawal of Consent|1|||
33532535|NCT02832375|62922294|FG001|Overall Study|Withdrawal of Consent|0|||
33532536|NCT02925403|62922303|FG000|Overall Study|Lost to Follow-up|0|||
33626306|NCT02138747|63027247|FG001|Treatment Period 1|Other - Miscellaneous|4|||
33626307|NCT02138747|63027248|FG002|Treatment Period 1|Other - Miscellaneous|0|||
33626308|NCT02138747|63027249|FG003|Treatment Period 1|Other - Miscellaneous|0|||
33626309|NCT02138747|63027246|FG000|Treatment Period 2|Adverse Event|6|||
33626310|NCT02138747|63027247|FG001|Treatment Period 2|Adverse Event|3|||
33626311|NCT02138747|63027248|FG002|Treatment Period 2|Adverse Event|1|||
33626312|NCT02138747|63027249|FG003|Treatment Period 2|Adverse Event|1|||
33626313|NCT02138747|63027246|FG000|Treatment Period 2|Lost to Follow-up|2|||
33626314|NCT02138747|63027247|FG001|Treatment Period 2|Lost to Follow-up|0|||
33626315|NCT02138747|63027248|FG002|Treatment Period 2|Lost to Follow-up|0|||
33626316|NCT02138747|63027249|FG003|Treatment Period 2|Lost to Follow-up|0|||
33626317|NCT02138747|63027246|FG000|Treatment Period 2|Protocol Violation|1|||
33626318|NCT02138747|63027247|FG001|Treatment Period 2|Protocol Violation|0|||
33626319|NCT02138747|63027248|FG002|Treatment Period 2|Protocol Violation|0|||
33626320|NCT02138747|63027249|FG003|Treatment Period 2|Protocol Violation|0|||
33626321|NCT02138747|63027246|FG000|Treatment Period 2|Withdrawal by Subject|5|||
33626322|NCT02138747|63027247|FG001|Treatment Period 2|Withdrawal by Subject|4|||
33626323|NCT02138747|63027248|FG002|Treatment Period 2|Withdrawal by Subject|1|||
33626324|NCT02138747|63027249|FG003|Treatment Period 2|Withdrawal by Subject|2|||
33532537|NCT02925403|62922304|FG001|Overall Study|Lost to Follow-up|1|||
33532538|NCT02626780|62922310|FG000|Overall Study|Withdrawal by Subject|3|||
33532539|NCT02831673|62922325|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
33532540|NCT02831673|62922326|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
33626325|NCT02138747|63027246|FG000|Treatment Period 2|Other - Miscellaneous|3|||
33626326|NCT02138747|63027247|FG001|Treatment Period 2|Other - Miscellaneous|0|||
33532541|NCT02831673|62922327|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
33532542|NCT02831673|62922328|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
33532543|NCT02831673|62922329|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
33626327|NCT02138747|63027248|FG002|Treatment Period 2|Other - Miscellaneous|0|||
33626328|NCT02138747|63027249|FG003|Treatment Period 2|Other - Miscellaneous|0|||
33626329|NCT02105285|63027262|FG000|Overall Study|Adverse Event|1|||
33626330|NCT02105285|63027263|FG001|Overall Study|Adverse Event|1|||
33626331|NCT02105285|63027264|FG002|Overall Study|Adverse Event|0|||
33626332|NCT02105285|63027262|FG000|Overall Study|Protocol Violation|0|||
33626333|NCT02105285|63027263|FG001|Overall Study|Protocol Violation|1|||
33626334|NCT02105285|63027264|FG002|Overall Study|Protocol Violation|0|||
33626335|NCT02105285|63027262|FG000|Overall Study|Withdrawal by Subject|1|||
33626336|NCT02105285|63027263|FG001|Overall Study|Withdrawal by Subject|0|||
33626337|NCT02105285|63027264|FG002|Overall Study|Withdrawal by Subject|0|||
33626338|NCT02104895|63027273|FG000|Overall Study|Withdrawal by Subject|0|||
33626339|NCT02104895|63027274|FG001|Overall Study|Withdrawal by Subject|14|||
33626340|NCT01621490|63027289|FG000|Overall Study|Participant completed treatment|4|||
33626341|NCT01621490|63027290|FG001|Overall Study|Participant completed treatment|4|||
33626342|NCT01621490|63027291|FG002|Overall Study|Participant completed treatment|1|||
33532544|NCT02831673|62922325|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
33532545|NCT02831673|62922326|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
33532546|NCT02831673|62922327|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
33532547|NCT02831673|62922328|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
33532548|NCT02831673|62922329|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
33532549|NCT02831673|62922325|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
33532550|NCT02831673|62922326|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
33532551|NCT02831673|62922327|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
33532552|NCT02831673|62922328|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
33532553|NCT02831673|62922329|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
33532554|NCT02831673|62922325|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
33532555|NCT02831673|62922326|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
33532556|NCT02831673|62922327|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
33459215|NCT03665038|62832714|FG000|Overall Study|Lost to Follow-up|0|||
33626343|NCT01621490|63027292|FG003|Overall Study|Participant completed treatment|0|||
33626344|NCT01621490|63027293|FG004|Overall Study|Participant completed treatment|0|||
33626345|NCT01621490|63027294|FG005|Overall Study|Participant completed treatment|0|||
33626346|NCT01621490|63027295|FG006|Overall Study|Participant completed treatment|0|||
33626347|NCT01621490|63027296|FG007|Overall Study|Participant completed treatment|1|||
33626348|NCT01621490|63027297|FG008|Overall Study|Participant completed treatment|0|||
33626349|NCT01621490|63027289|FG000|Overall Study|Patient could not travel|1|||
33626350|NCT01621490|63027290|FG001|Overall Study|Patient could not travel|0|||
33626351|NCT01621490|63027291|FG002|Overall Study|Patient could not travel|0|||
33626352|NCT01621490|63027292|FG003|Overall Study|Patient could not travel|0|||
33626353|NCT01621490|63027293|FG004|Overall Study|Patient could not travel|0|||
33626354|NCT01621490|63027294|FG005|Overall Study|Patient could not travel|0|||
33532557|NCT02831673|62922328|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
33532558|NCT02831673|62922329|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
33532559|NCT02831673|62922325|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
33532560|NCT02831673|62922326|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
33532561|NCT02831673|62922327|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
33532562|NCT02831673|62922328|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
33532563|NCT02831673|62922329|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
33626355|NCT01621490|63027295|FG006|Overall Study|Patient could not travel|0|||
33626356|NCT01621490|63027296|FG007|Overall Study|Patient could not travel|0|||
33459216|NCT03665038|62832715|FG001|Overall Study|Lost to Follow-up|0|||
33459217|NCT03665038|62832716|FG002|Overall Study|Lost to Follow-up|1|||
33459218|NCT03664024|62832726|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
33459219|NCT03664024|62832726|FG000|Overall Study|Lost to Follow-up|2|||
33459220|NCT03664024|62832726|FG000|Overall Study|Withdrawal by Subject|2|||
33459221|NCT03664024|62832726|FG000|Overall Study|Death|80|||
33459222|NCT00381563|62832735|FG000|Overall Study|Withdrawal by Subject|5|||
33459223|NCT00381563|62832736|FG001|Overall Study|Withdrawal by Subject|5|||
33459224|NCT00381563|62832735|FG000|Overall Study|Lost to Follow-up|2|||
33459225|NCT00381563|62832736|FG001|Overall Study|Lost to Follow-up|0|||
33532564|NCT02831673|62922325|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
33626357|NCT01621490|63027297|FG008|Overall Study|Patient could not travel|0|||
33626358|NCT01621490|63027289|FG000|Overall Study|Subject no longer meets study criteria|0|||
33626359|NCT01621490|63027290|FG001|Overall Study|Subject no longer meets study criteria|0|||
33459226|NCT00381563|62832735|FG000|Overall Study|Protocol Violation|0|||
33459227|NCT00381563|62832736|FG001|Overall Study|Protocol Violation|1|||
33459228|NCT03624946|62832743|FG000|Overall Study|Lost to Follow-up|0|||
33532565|NCT02831673|62922326|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
33532566|NCT02831673|62922327|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
33532567|NCT02831673|62922328|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
33532568|NCT02831673|62922329|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
33532569|NCT02831673|62922325|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
33532570|NCT02831673|62922326|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
33532571|NCT02831673|62922327|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
33532572|NCT02831673|62922328|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
33532573|NCT02831673|62922329|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
33532574|NCT02831673|62922325|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
33532575|NCT02831673|62922326|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
33532576|NCT02831673|62922327|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
33532577|NCT02831673|62922328|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
33532578|NCT02831673|62922329|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
33532579|NCT02831673|62922325|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
33532580|NCT02831673|62922326|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
33532581|NCT02831673|62922327|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
33532582|NCT02831673|62922328|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
33532583|NCT02831673|62922329|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
33532584|NCT02831673|62922325|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
33532585|NCT02831673|62922326|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
33532586|NCT02831673|62922327|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
33532587|NCT02831673|62922328|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
33532588|NCT02831673|62922329|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
33532589|NCT02831673|62922325|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
33532590|NCT02831673|62922326|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
33532591|NCT02831673|62922327|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
33532592|NCT02831673|62922328|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
33532593|NCT02831673|62922329|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
33532594|NCT02831673|62922325|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
33532595|NCT02831673|62922326|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
33532596|NCT02831673|62922327|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
33532597|NCT02831673|62922328|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
33532598|NCT02831673|62922329|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
33532599|NCT02831673|62922325|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
33532600|NCT02831673|62922326|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
33532601|NCT02831673|62922327|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
33532602|NCT02831673|62922328|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
33532603|NCT02831673|62922329|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
33532604|NCT02831673|62922325|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
33532605|NCT02831673|62922326|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
33532606|NCT02831673|62922327|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
33532607|NCT02831673|62922328|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
33532608|NCT02831673|62922329|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
33532609|NCT02831673|62922325|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
33532610|NCT02831673|62922326|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
33532611|NCT02831673|62922327|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
33532612|NCT02831673|62922328|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
33532613|NCT02831673|62922329|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
33532614|NCT02831673|62922325|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
33532615|NCT02831673|62922326|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
33532616|NCT02831673|62922327|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
33532617|NCT02831673|62922328|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
33532618|NCT02831673|62922329|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
33532619|NCT02831673|62922325|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33532620|NCT02831673|62922326|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33532621|NCT02831673|62922327|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33532622|NCT02831673|62922328|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33532623|NCT02831673|62922329|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
33532624|NCT02831673|62922325|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33532625|NCT02831673|62922326|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33532626|NCT02831673|62922327|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33532627|NCT02831673|62922328|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33532628|NCT02831673|62922329|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
33532629|NCT02831673|62922325|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33532630|NCT02831673|62922326|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33532631|NCT02831673|62922327|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33532632|NCT02831673|62922328|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33532633|NCT02831673|62922329|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
33532634|NCT02831673|62922325|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33532635|NCT02831673|62922326|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33532636|NCT02831673|62922327|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33532637|NCT02831673|62922328|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33532638|NCT02831673|62922329|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
33532639|NCT02830893|62922347|FG000|Overall Study|Relocation to out of the country|1|||
33532640|NCT02830893|62922348|FG001|Overall Study|Relocation to out of the country|0|||
33532641|NCT02830893|62922347|FG000|Overall Study|Lost to Follow-up|0|||
33532642|NCT02830893|62922348|FG001|Overall Study|Lost to Follow-up|2|||
33532643|NCT02830893|62922347|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
33532644|NCT02830893|62922348|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
33532645|NCT02625922|62922356|FG000|Overall Study|Non-availability of IMP|1|||
33532646|NCT02625922|62922357|FG001|Overall Study|Non-availability of IMP|1|||
33532647|NCT02625922|62922356|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
33532648|NCT02625922|62922357|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
33532649|NCT03350035|62922369|FG000|Overall Study|Lack of Efficacy|2|||
33532650|NCT03350035|62922370|FG001|Overall Study|Lack of Efficacy|0|||
33532651|NCT03350035|62922371|FG002|Overall Study|Lack of Efficacy|0|||
33532652|NCT03350035|62922369|FG000|Overall Study|Subject discharged to hospice|0|||
33532653|NCT03350035|62922370|FG001|Overall Study|Subject discharged to hospice|0|||
33532654|NCT03350035|62922371|FG002|Overall Study|Subject discharged to hospice|1|||
33532655|NCT01358331|62922405|FG000|Overall Study|Lost to Follow-up|0|||
33532656|NCT01358331|62922406|FG001|Overall Study|Lost to Follow-up|0|||
33532657|NCT01358331|62922407|FG002|Overall Study|Lost to Follow-up|0|||
33532658|NCT01358331|62922408|FG003|Overall Study|Lost to Follow-up|1|||
33532659|NCT01358331|62922409|FG004|Overall Study|Lost to Follow-up|0|||
33532660|NCT01358331|62922410|FG005|Overall Study|Lost to Follow-up|0|||
33532661|NCT01358331|62922405|FG000|Overall Study|Withdrawal by Subject|0|||
33532662|NCT01358331|62922406|FG001|Overall Study|Withdrawal by Subject|0|||
33532663|NCT01358331|62922407|FG002|Overall Study|Withdrawal by Subject|0|||
33532664|NCT01358331|62922408|FG003|Overall Study|Withdrawal by Subject|1|||
33532665|NCT01358331|62922409|FG004|Overall Study|Withdrawal by Subject|1|||
33532666|NCT01358331|62922410|FG005|Overall Study|Withdrawal by Subject|1|||
33532667|NCT01358331|62922405|FG000|Overall Study|Adverse Events|1|||
33532668|NCT01358331|62922406|FG001|Overall Study|Adverse Events|1|||
33532669|NCT01358331|62922407|FG002|Overall Study|Adverse Events|1|||
33532670|NCT01358331|62922408|FG003|Overall Study|Adverse Events|0|||
33532671|NCT01358331|62922409|FG004|Overall Study|Adverse Events|1|||
33532672|NCT01358331|62922410|FG005|Overall Study|Adverse Events|5|||
33532673|NCT01358331|62922405|FG000|Overall Study|Symptomatic Deterioration|0|||
33532674|NCT01358331|62922406|FG001|Overall Study|Symptomatic Deterioration|0|||
33532675|NCT01358331|62922407|FG002|Overall Study|Symptomatic Deterioration|0|||
33532676|NCT01358331|62922408|FG003|Overall Study|Symptomatic Deterioration|0|||
33532677|NCT01358331|62922409|FG004|Overall Study|Symptomatic Deterioration|1|||
33532678|NCT01358331|62922410|FG005|Overall Study|Symptomatic Deterioration|0|||
33532679|NCT01358331|62922405|FG000|Overall Study|Participants did not wish to continue|0|||
33532680|NCT01358331|62922406|FG001|Overall Study|Participants did not wish to continue|0|||
33532681|NCT01358331|62922407|FG002|Overall Study|Participants did not wish to continue|0|||
33532682|NCT01358331|62922408|FG003|Overall Study|Participants did not wish to continue|0|||
33532683|NCT01358331|62922409|FG004|Overall Study|Participants did not wish to continue|1|||
33532684|NCT01358331|62922410|FG005|Overall Study|Participants did not wish to continue|0|||
33532685|NCT01358331|62922405|FG000|Overall Study|Progress of disease under investigation|1|||
33532686|NCT01358331|62922406|FG001|Overall Study|Progress of disease under investigation|2|||
33532687|NCT01358331|62922407|FG002|Overall Study|Progress of disease under investigation|3|||
33532688|NCT01358331|62922408|FG003|Overall Study|Progress of disease under investigation|1|||
33532689|NCT01358331|62922409|FG004|Overall Study|Progress of disease under investigation|3|||
33532690|NCT01358331|62922410|FG005|Overall Study|Progress of disease under investigation|0|||
33532691|NCT02828241|62922426|FG000|Overall Study|Adverse Event|7|||
33532692|NCT02828241|62922427|FG001|Overall Study|Adverse Event|2|||
33532693|NCT02828241|62922426|FG000|Overall Study|Protocol Violation|1|||
33532694|NCT02828241|62922427|FG001|Overall Study|Protocol Violation|0|||
33532695|NCT01355523|62922436|FG000|Overall Study|Withdrawal by Subject|1|||
33532696|NCT01355523|62922437|FG001|Overall Study|Withdrawal by Subject|4|||
33532697|NCT01355523|62922436|FG000|Overall Study|Lost to Follow-up|0|||
33532698|NCT01355523|62922437|FG001|Overall Study|Lost to Follow-up|2|||
33532699|NCT01355523|62922436|FG000|Overall Study|Protocol Violation|0|||
33532700|NCT01355523|62922437|FG001|Overall Study|Protocol Violation|2|||
33532701|NCT01355523|62922436|FG000|Overall Study|Adverse Event|0|||
33532702|NCT01355523|62922437|FG001|Overall Study|Adverse Event|2|||
33532703|NCT02625220|62922443|FG000|Overall Study|Adverse Event|2|||
33626360|NCT01621490|63027291|FG002|Overall Study|Subject no longer meets study criteria|0|||
33532704|NCT02625220|62922443|FG000|Overall Study|Lost to Follow-up|2|||
33532705|NCT02625220|62922443|FG000|Overall Study|Protocol Violation|1|||
33532706|NCT02625220|62922443|FG000|Overall Study|Study discontinued at site|2|||
33532707|NCT02826603|62922449|FG000|Overall Study|Adverse Event|17|||
33532708|NCT02826603|62922450|FG001|Overall Study|Adverse Event|9|||
33532709|NCT02826603|62922449|FG000|Overall Study|Lack of Efficacy|4|||
33532710|NCT02826603|62922450|FG001|Overall Study|Lack of Efficacy|9|||
33532711|NCT02826603|62922449|FG000|Overall Study|Lost to Follow-up|13|||
33532712|NCT02826603|62922450|FG001|Overall Study|Lost to Follow-up|12|||
33532713|NCT02826603|62922449|FG000|Overall Study|Noncompliance with treatment|0|||
33532714|NCT02826603|62922450|FG001|Overall Study|Noncompliance with treatment|2|||
33532715|NCT02826603|62922449|FG000|Overall Study|Physician Decision|1|||
33532716|NCT02826603|62922450|FG001|Overall Study|Physician Decision|7|||
33532717|NCT02826603|62922449|FG000|Overall Study|Pregnancy|1|||
33532718|NCT02826603|62922450|FG001|Overall Study|Pregnancy|2|||
33532719|NCT02826603|62922449|FG000|Overall Study|Protocol Violation|3|||
33532720|NCT02826603|62922450|FG001|Overall Study|Protocol Violation|3|||
33532721|NCT02826603|62922449|FG000|Overall Study|Withdrawal by Subject|20|||
33532722|NCT02826603|62922450|FG001|Overall Study|Withdrawal by Subject|19|||
33532723|NCT02826603|62922449|FG000|Overall Study|Death|2|||
33532724|NCT02826603|62922450|FG001|Overall Study|Death|0|||
33626361|NCT01621490|63027292|FG003|Overall Study|Subject no longer meets study criteria|0|||
33626362|NCT01621490|63027293|FG004|Overall Study|Subject no longer meets study criteria|1|||
33532725|NCT02826603|62922449|FG000|Overall Study|New therapy for study indication|0|||
33532726|NCT02826603|62922450|FG001|Overall Study|New therapy for study indication|1|||
33532727|NCT05270460|62922466|FG000|Overall Study|Adverse Event|0|||
33532728|NCT05270460|62922467|FG001|Overall Study|Adverse Event|1|||
33626363|NCT01621490|63027294|FG005|Overall Study|Subject no longer meets study criteria|0|||
33626364|NCT01621490|63027295|FG006|Overall Study|Subject no longer meets study criteria|0|||
33626365|NCT01621490|63027296|FG007|Overall Study|Subject no longer meets study criteria|0|||
33626366|NCT01621490|63027297|FG008|Overall Study|Subject no longer meets study criteria|0|||
33626367|NCT01621490|63027289|FG000|Overall Study|Maximum clinical benefit|3|||
33626368|NCT01621490|63027290|FG001|Overall Study|Maximum clinical benefit|2|||
33532729|NCT05270460|62922468|FG002|Overall Study|Adverse Event|0|||
33532730|NCT05270460|62922466|FG000|Overall Study|Early Termination|0|||
33626369|NCT01621490|63027291|FG002|Overall Study|Maximum clinical benefit|0|||
33626370|NCT01621490|63027292|FG003|Overall Study|Maximum clinical benefit|0|||
33626371|NCT01621490|63027293|FG004|Overall Study|Maximum clinical benefit|0|||
33626372|NCT01621490|63027294|FG005|Overall Study|Maximum clinical benefit|0|||
33626373|NCT01621490|63027295|FG006|Overall Study|Maximum clinical benefit|1|||
33626374|NCT01621490|63027296|FG007|Overall Study|Maximum clinical benefit|2|||
33626375|NCT01621490|63027297|FG008|Overall Study|Maximum clinical benefit|0|||
33626376|NCT01621490|63027289|FG000|Overall Study|Withdrawal by Subject|1|||
33626377|NCT01621490|63027290|FG001|Overall Study|Withdrawal by Subject|0|||
33626378|NCT01621490|63027291|FG002|Overall Study|Withdrawal by Subject|0|||
33626379|NCT01621490|63027292|FG003|Overall Study|Withdrawal by Subject|0|||
33626380|NCT01621490|63027293|FG004|Overall Study|Withdrawal by Subject|0|||
33626381|NCT01621490|63027294|FG005|Overall Study|Withdrawal by Subject|3|||
33626382|NCT01621490|63027295|FG006|Overall Study|Withdrawal by Subject|0|||
33626383|NCT01621490|63027296|FG007|Overall Study|Withdrawal by Subject|0|||
33626384|NCT01621490|63027297|FG008|Overall Study|Withdrawal by Subject|0|||
33626385|NCT01621490|63027289|FG000|Overall Study|Subject request to discontinue study|1|||
33626386|NCT01621490|63027290|FG001|Overall Study|Subject request to discontinue study|3|||
33626387|NCT01621490|63027291|FG002|Overall Study|Subject request to discontinue study|1|||
33626388|NCT01621490|63027292|FG003|Overall Study|Subject request to discontinue study|1|||
33626389|NCT01621490|63027293|FG004|Overall Study|Subject request to discontinue study|0|||
33532731|NCT05270460|62922467|FG001|Overall Study|Early Termination|1|||
33532732|NCT05270460|62922468|FG002|Overall Study|Early Termination|0|||
33532733|NCT04622592|62922484|FG000|Overall Study|Death|0|||
33532734|NCT04622592|62922485|FG001|Overall Study|Death|0|||
33532735|NCT04622592|62922486|FG002|Overall Study|Death|1|||
33532736|NCT04622592|62922487|FG003|Overall Study|Death|0|||
33532737|NCT04622592|62922488|FG004|Overall Study|Death|0|||
33532738|NCT04622592|62922489|FG005|Overall Study|Death|0|||
33532739|NCT04622592|62922490|FG006|Overall Study|Death|0|||
33532740|NCT04622592|62922491|FG007|Overall Study|Death|1|||
33532741|NCT04622592|62922484|FG000|Overall Study|Lost to Follow-up|0|||
33532742|NCT04622592|62922485|FG001|Overall Study|Lost to Follow-up|0|||
33532743|NCT04622592|62922486|FG002|Overall Study|Lost to Follow-up|0|||
33532744|NCT04622592|62922487|FG003|Overall Study|Lost to Follow-up|3|||
33532745|NCT04622592|62922488|FG004|Overall Study|Lost to Follow-up|1|||
33532746|NCT04622592|62922489|FG005|Overall Study|Lost to Follow-up|0|||
33532747|NCT04622592|62922490|FG006|Overall Study|Lost to Follow-up|2|||
33532748|NCT04622592|62922491|FG007|Overall Study|Lost to Follow-up|2|||
33532749|NCT04622592|62922484|FG000|Overall Study|Physician Decision|0|||
33532750|NCT04622592|62922485|FG001|Overall Study|Physician Decision|0|||
33532751|NCT04622592|62922486|FG002|Overall Study|Physician Decision|0|||
33626390|NCT01621490|63027294|FG005|Overall Study|Subject request to discontinue study|2|||
33626391|NCT01621490|63027295|FG006|Overall Study|Subject request to discontinue study|1|||
33626392|NCT01621490|63027296|FG007|Overall Study|Subject request to discontinue study|0|||
33626393|NCT01621490|63027297|FG008|Overall Study|Subject request to discontinue study|1|||
33626394|NCT01621490|63027289|FG000|Overall Study|Adverse event unrelated to study drug|2|||
33626395|NCT01621490|63027290|FG001|Overall Study|Adverse event unrelated to study drug|1|||
33626396|NCT01621490|63027291|FG002|Overall Study|Adverse event unrelated to study drug|0|||
33532752|NCT04622592|62922487|FG003|Overall Study|Physician Decision|0|||
33532753|NCT04622592|62922488|FG004|Overall Study|Physician Decision|1|||
33626397|NCT01621490|63027292|FG003|Overall Study|Adverse event unrelated to study drug|0|||
33326021|NCT01188551|62702782|FG003|Overall Study|Pharmacy issues|0|||
33326022|NCT01161407|62702794|FG000|Overall Study|Protocol Violation|3|||
33532754|NCT04622592|62922489|FG005|Overall Study|Physician Decision|0|||
33532755|NCT04622592|62922490|FG006|Overall Study|Physician Decision|0|||
33532756|NCT04622592|62922491|FG007|Overall Study|Physician Decision|0|||
33532757|NCT04622592|62922484|FG000|Overall Study|Withdrawal by Subject|1|||
33532758|NCT04622592|62922485|FG001|Overall Study|Withdrawal by Subject|0|||
33532759|NCT04622592|62922486|FG002|Overall Study|Withdrawal by Subject|2|||
33532760|NCT04622592|62922487|FG003|Overall Study|Withdrawal by Subject|0|||
33626398|NCT01621490|63027293|FG004|Overall Study|Adverse event unrelated to study drug|0|||
33626399|NCT01621490|63027294|FG005|Overall Study|Adverse event unrelated to study drug|0|||
33626400|NCT01621490|63027295|FG006|Overall Study|Adverse event unrelated to study drug|0|||
33626401|NCT01621490|63027296|FG007|Overall Study|Adverse event unrelated to study drug|2|||
33626402|NCT01621490|63027297|FG008|Overall Study|Adverse event unrelated to study drug|1|||
33532761|NCT04622592|62922488|FG004|Overall Study|Withdrawal by Subject|0|||
33532762|NCT04622592|62922489|FG005|Overall Study|Withdrawal by Subject|0|||
33532763|NCT04622592|62922490|FG006|Overall Study|Withdrawal by Subject|1|||
33532764|NCT04622592|62922491|FG007|Overall Study|Withdrawal by Subject|4|||
33532765|NCT04622592|62922484|FG000|Overall Study|Other than specified above|0|||
33532766|NCT04622592|62922485|FG001|Overall Study|Other than specified above|0|||
33532767|NCT04622592|62922486|FG002|Overall Study|Other than specified above|1|||
33532768|NCT04622592|62922487|FG003|Overall Study|Other than specified above|0|||
33532769|NCT04622592|62922488|FG004|Overall Study|Other than specified above|0|||
33532770|NCT04622592|62922489|FG005|Overall Study|Other than specified above|0|||
33532771|NCT04622592|62922490|FG006|Overall Study|Other than specified above|0|||
33532772|NCT04622592|62922491|FG007|Overall Study|Other than specified above|0|||
33626403|NCT01621490|63027289|FG000|Overall Study|Disease progression|27|||
33626404|NCT01621490|63027290|FG001|Overall Study|Disease progression|28|||
33626405|NCT01621490|63027291|FG002|Overall Study|Disease progression|1|||
33626406|NCT01621490|63027292|FG003|Overall Study|Disease progression|5|||
33626407|NCT01621490|63027293|FG004|Overall Study|Disease progression|3|||
33626408|NCT01621490|63027294|FG005|Overall Study|Disease progression|8|||
33626409|NCT01621490|63027295|FG006|Overall Study|Disease progression|7|||
33626410|NCT01621490|63027296|FG007|Overall Study|Disease progression|0|||
33626411|NCT01621490|63027297|FG008|Overall Study|Disease progression|4|||
33626412|NCT01621490|63027289|FG000|Overall Study|Study drug toxicity|1|||
33626413|NCT01621490|63027290|FG001|Overall Study|Study drug toxicity|4|||
33626414|NCT01621490|63027291|FG002|Overall Study|Study drug toxicity|5|||
33626415|NCT01621490|63027292|FG003|Overall Study|Study drug toxicity|3|||
33626416|NCT01621490|63027293|FG004|Overall Study|Study drug toxicity|1|||
33626417|NCT01621490|63027294|FG005|Overall Study|Study drug toxicity|10|||
33532773|NCT04523220|62922512|FG000|Main Treatment Period|Physician Decision|1|||
33532774|NCT04523220|62922513|FG001|Main Treatment Period|Physician Decision|1|||
33532775|NCT04523220|62922514|FG002|Main Treatment Period|Physician Decision|0|||
33532776|NCT04523220|62922512|FG000|Main Treatment Period|Other|5|||
33532777|NCT04523220|62922513|FG001|Main Treatment Period|Other|2|||
33532778|NCT04523220|62922514|FG002|Main Treatment Period|Other|4|||
33532779|NCT04523220|62922512|FG000|Main Treatment Period|Subject Decision|5|||
33532780|NCT04523220|62922513|FG001|Main Treatment Period|Subject Decision|7|||
33532781|NCT04523220|62922514|FG002|Main Treatment Period|Subject Decision|3|||
33532782|NCT04523220|62922512|FG000|Main Treatment Period|Death|5|||
33532783|NCT04523220|62922513|FG001|Main Treatment Period|Death|11|||
33532784|NCT04523220|62922514|FG002|Main Treatment Period|Death|4|||
33532785|NCT04523220|62922512|FG000|Main Treatment Period|Adverse Event|11|||
33532786|NCT04523220|62922513|FG001|Main Treatment Period|Adverse Event|9|||
33532787|NCT04523220|62922514|FG002|Main Treatment Period|Adverse Event|9|||
33532788|NCT04523220|62922512|FG000|Main Treatment Period|Withdrawal by Subject|3|||
33532789|NCT04523220|62922513|FG001|Main Treatment Period|Withdrawal by Subject|3|||
33532790|NCT04523220|62922514|FG002|Main Treatment Period|Withdrawal by Subject|4|||
33532791|NCT04523220|62922512|FG000|Main Treatment Period|Study drug never adminstered|10|||
33532792|NCT04523220|62922513|FG001|Main Treatment Period|Study drug never adminstered|3|||
33532793|NCT04523220|62922514|FG002|Main Treatment Period|Study drug never adminstered|5|||
33532794|NCT04523220|62922512|FG000|Extension Treatment Period|Physician Decision|1|||
33532795|NCT04523220|62922513|FG001|Extension Treatment Period|Physician Decision|0|||
33532796|NCT04523220|62922514|FG002|Extension Treatment Period|Physician Decision|3|||
33626418|NCT01621490|63027295|FG006|Overall Study|Study drug toxicity|1|||
33626419|NCT01621490|63027296|FG007|Overall Study|Study drug toxicity|4|||
33626420|NCT01621490|63027297|FG008|Overall Study|Study drug toxicity|1|||
33626421|NCT01621490|63027289|FG000|Overall Study|Death|0|||
33626422|NCT01621490|63027290|FG001|Overall Study|Death|0|||
33626423|NCT01621490|63027291|FG002|Overall Study|Death|0|||
33532797|NCT04523220|62922512|FG000|Extension Treatment Period|Other|2|||
33532798|NCT04523220|62922513|FG001|Extension Treatment Period|Other|6|||
33532799|NCT04523220|62922514|FG002|Extension Treatment Period|Other|6|||
33532800|NCT04523220|62922512|FG000|Extension Treatment Period|Subject Decision|5|||
33532801|NCT04523220|62922513|FG001|Extension Treatment Period|Subject Decision|2|||
33532802|NCT04523220|62922514|FG002|Extension Treatment Period|Subject Decision|4|||
33532803|NCT04523220|62922512|FG000|Extension Treatment Period|Death|6|||
33532804|NCT04523220|62922513|FG001|Extension Treatment Period|Death|4|||
33532805|NCT04523220|62922514|FG002|Extension Treatment Period|Death|7|||
33532806|NCT04523220|62922512|FG000|Extension Treatment Period|Adverse Event|6|||
33532807|NCT04523220|62922513|FG001|Extension Treatment Period|Adverse Event|7|||
33626424|NCT01621490|63027292|FG003|Overall Study|Death|0|||
33626425|NCT01621490|63027293|FG004|Overall Study|Death|0|||
33532808|NCT04523220|62922514|FG002|Extension Treatment Period|Adverse Event|9|||
33532809|NCT04523220|62922512|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
33532810|NCT04523220|62922513|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
33532811|NCT04523220|62922514|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
33532812|NCT04523220|62922512|FG000|Extension Treatment Period|Study drug never administered|0|||
33532813|NCT04523220|62922513|FG001|Extension Treatment Period|Study drug never administered|1|||
33532814|NCT04523220|62922514|FG002|Extension Treatment Period|Study drug never administered|0|||
33532815|NCT04222088|62922545|FG000|Overall Study|Lost to Follow-up|5|||
33532816|NCT04222088|62922546|FG001|Overall Study|Lost to Follow-up|1|||
33532817|NCT04222088|62922545|FG000|Overall Study|Withdrawal by Subject|4|||
33532818|NCT04222088|62922546|FG001|Overall Study|Withdrawal by Subject|0|||
33532819|NCT03981614|62922555|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
33532820|NCT03981614|62922556|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
33532821|NCT03981614|62922557|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
33532822|NCT03978520|62922573|FG000|Overall Study|Adverse Event|2|||
33532823|NCT03978520|62922574|FG001|Overall Study|Adverse Event|5|||
33532824|NCT03978520|62922575|FG002|Overall Study|Adverse Event|3|||
33532825|NCT03978520|62922576|FG003|Overall Study|Adverse Event|5|||
33532826|NCT03978520|62922577|FG004|Overall Study|Adverse Event|6|||
33532827|NCT03978520|62922573|FG000|Overall Study|Withdrawal by Subject|10|||
33532828|NCT03978520|62922574|FG001|Overall Study|Withdrawal by Subject|4|||
33532829|NCT03978520|62922575|FG002|Overall Study|Withdrawal by Subject|5|||
33532830|NCT03978520|62922576|FG003|Overall Study|Withdrawal by Subject|6|||
33532831|NCT03978520|62922577|FG004|Overall Study|Withdrawal by Subject|5|||
33532832|NCT03978520|62922573|FG000|Overall Study|Lost to Follow-up|2|||
33532833|NCT03978520|62922574|FG001|Overall Study|Lost to Follow-up|2|||
33532834|NCT03978520|62922575|FG002|Overall Study|Lost to Follow-up|2|||
33532835|NCT03978520|62922576|FG003|Overall Study|Lost to Follow-up|0|||
33532836|NCT03978520|62922577|FG004|Overall Study|Lost to Follow-up|1|||
33532837|NCT03978520|62922573|FG000|Overall Study|COVID-19 infection|0|||
33626426|NCT01621490|63027294|FG005|Overall Study|Death|0|||
33626427|NCT01621490|63027295|FG006|Overall Study|Death|0|||
33626428|NCT01621490|63027296|FG007|Overall Study|Death|1|||
33626429|NCT01621490|63027297|FG008|Overall Study|Death|0|||
33626430|NCT01621490|63027289|FG000|Overall Study|Grade 4 Lipase elevation|1|||
33626431|NCT01621490|63027290|FG001|Overall Study|Grade 4 Lipase elevation|0|||
33626432|NCT01621490|63027291|FG002|Overall Study|Grade 4 Lipase elevation|0|||
33626433|NCT01621490|63027292|FG003|Overall Study|Grade 4 Lipase elevation|0|||
33626434|NCT01621490|63027293|FG004|Overall Study|Grade 4 Lipase elevation|0|||
33626435|NCT01621490|63027294|FG005|Overall Study|Grade 4 Lipase elevation|0|||
33626436|NCT01621490|63027295|FG006|Overall Study|Grade 4 Lipase elevation|0|||
33626437|NCT01621490|63027296|FG007|Overall Study|Grade 4 Lipase elevation|0|||
33626438|NCT01621490|63027297|FG008|Overall Study|Grade 4 Lipase elevation|0|||
33626439|NCT01621490|63027289|FG000|Overall Study|BMS informed of patient status|0|||
33626440|NCT01621490|63027290|FG001|Overall Study|BMS informed of patient status|0|||
33626441|NCT01621490|63027291|FG002|Overall Study|BMS informed of patient status|1|||
33626442|NCT01621490|63027292|FG003|Overall Study|BMS informed of patient status|0|||
33626443|NCT01621490|63027293|FG004|Overall Study|BMS informed of patient status|0|||
33626444|NCT01621490|63027294|FG005|Overall Study|BMS informed of patient status|0|||
33626445|NCT01621490|63027295|FG006|Overall Study|BMS informed of patient status|0|||
33626446|NCT01621490|63027296|FG007|Overall Study|BMS informed of patient status|0|||
33626447|NCT01621490|63027297|FG008|Overall Study|BMS informed of patient status|0|||
33626448|NCT01621490|63027289|FG000|Overall Study|Investigator decision|0|||
33626449|NCT01621490|63027290|FG001|Overall Study|Investigator decision|0|||
33626450|NCT01621490|63027291|FG002|Overall Study|Investigator decision|1|||
33626451|NCT01621490|63027292|FG003|Overall Study|Investigator decision|0|||
33626452|NCT01621490|63027293|FG004|Overall Study|Investigator decision|1|||
33626453|NCT01621490|63027294|FG005|Overall Study|Investigator decision|0|||
33626454|NCT01621490|63027295|FG006|Overall Study|Investigator decision|1|||
33626455|NCT01621490|63027296|FG007|Overall Study|Investigator decision|0|||
33626456|NCT01621490|63027297|FG008|Overall Study|Investigator decision|0|||
33532838|NCT03978520|62922574|FG001|Overall Study|COVID-19 infection|1|||
33532839|NCT03978520|62922575|FG002|Overall Study|COVID-19 infection|0|||
33532840|NCT03978520|62922576|FG003|Overall Study|COVID-19 infection|0|||
33532841|NCT03978520|62922577|FG004|Overall Study|COVID-19 infection|0|||
33532842|NCT03978520|62922573|FG000|Overall Study|Other, not specified|9|||
33532843|NCT03978520|62922574|FG001|Overall Study|Other, not specified|4|||
33532844|NCT03978520|62922575|FG002|Overall Study|Other, not specified|1|||
33532845|NCT03978520|62922576|FG003|Overall Study|Other, not specified|1|||
33532846|NCT03978520|62922577|FG004|Overall Study|Other, not specified|2|||
33532847|NCT03978520|62922573|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
33626457|NCT01621490|63027289|FG000|Overall Study|Documented disease progression|0|||
33532848|NCT03978520|62922574|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
33532849|NCT03978520|62922575|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
33532850|NCT03978520|62922576|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
33532851|NCT03978520|62922577|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
33532852|NCT03929393|62922589|FG000|Overall Study|Death|1|||
33532853|NCT03929393|62922590|FG001|Overall Study|Death|0|||
33532854|NCT03929393|62922589|FG000|Overall Study|Time Commitment|2|||
33532855|NCT03929393|62922590|FG001|Overall Study|Time Commitment|5|||
33532856|NCT03929393|62922589|FG000|Overall Study|Motor Vehicle Accident|0|||
33532857|NCT03929393|62922590|FG001|Overall Study|Motor Vehicle Accident|1|||
33532858|NCT03929393|62922589|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
33532859|NCT03929393|62922590|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
33326023|NCT01161407|62702795|FG001|Overall Study|Protocol Violation|1|||
33459229|NCT03624946|62832744|FG001|Overall Study|Lost to Follow-up|1|||
33459230|NCT00381095|62832756|FG000|Overall Study|Death|3|||
33459231|NCT00381095|62832757|FG001|Overall Study|Death|4|||
33459232|NCT00381095|62832756|FG000|Overall Study|Lack of Efficacy|2|||
33459233|NCT00381095|62832757|FG001|Overall Study|Lack of Efficacy|4|||
33459234|NCT00381095|62832756|FG000|Overall Study|Other|2|||
33459235|NCT00381095|62832757|FG001|Overall Study|Other|2|||
33459236|NCT00381095|62832756|FG000|Overall Study|Protocol Violation|1|||
33459237|NCT00381095|62832757|FG001|Overall Study|Protocol Violation|1|||
33459238|NCT00381095|62832756|FG000|Overall Study|Withdrawal by Subject|3|||
33459239|NCT00381095|62832757|FG001|Overall Study|Withdrawal by Subject|3|||
33532860|NCT03929393|62922589|FG000|Overall Study|Other|1|||
33532861|NCT03929393|62922590|FG001|Overall Study|Other|3|||
33532862|NCT03874715|62922598|FG000|Overall Study|Adverse Event|2|||
33532863|NCT03874715|62922599|FG001|Overall Study|Adverse Event|0|||
33532864|NCT03874715|62922598|FG000|Overall Study|Poor compliance to protocol|5|||
33532865|NCT03874715|62922599|FG001|Overall Study|Poor compliance to protocol|1|||
33532866|NCT03874715|62922598|FG000|Overall Study|Withdrawal by Subject|1|||
33532867|NCT03874715|62922599|FG001|Overall Study|Withdrawal by Subject|0|||
33532868|NCT03874715|62922598|FG000|Overall Study|Other-unspecified|1|||
33532869|NCT03874715|62922599|FG001|Overall Study|Other-unspecified|0|||
33532870|NCT03502200|62922611|FG000|Overall Study|Adverse Event|1|||
33532871|NCT03502200|62922612|FG001|Overall Study|Adverse Event|0|||
33532872|NCT03502200|62922611|FG000|Overall Study|Lost to Follow-up|36|||
33532873|NCT03502200|62922612|FG001|Overall Study|Lost to Follow-up|38|||
33532874|NCT03502200|62922611|FG000|Overall Study|Study Team Decision|1|||
33532875|NCT03502200|62922612|FG001|Overall Study|Study Team Decision|1|||
33532876|NCT03502200|62922611|FG000|Overall Study|Withdrawal by Subject|5|||
33532877|NCT03502200|62922612|FG001|Overall Study|Withdrawal by Subject|7|||
33532878|NCT03502200|62922611|FG000|Overall Study|Death|0|||
33532879|NCT03502200|62922612|FG001|Overall Study|Death|2|||
33532880|NCT03361306|62922618|FG000|Overall Study|Death|5|||
33532881|NCT03361306|62922618|FG000|Overall Study|Still On Study (on study treatment)|3|||
33532882|NCT03361306|62922618|FG000|Overall Study|Still On Study (in follow up)|7|||
33532883|NCT03336242|62922624|FG000|Overall Study|Adverse Event|0|||
33532884|NCT03336242|62922625|FG001|Overall Study|Adverse Event|1|||
33532885|NCT03334435|62922636|FG000|Overall Study|Ongoing as of Week 52|70|||
33532886|NCT03334435|62922637|FG001|Overall Study|Ongoing as of Week 52|32|||
33532887|NCT03334435|62922638|FG002|Overall Study|Ongoing as of Week 52|379|||
33532888|NCT03334435|62922639|FG003|Overall Study|Ongoing as of Week 52|519|||
33532889|NCT03334435|62922640|FG004|Overall Study|Ongoing as of Week 52|146|||
33532890|NCT03334435|62922636|FG000|Overall Study|Lack of Efficacy|3|||
33532891|NCT03334435|62922637|FG001|Overall Study|Lack of Efficacy|5|||
33532892|NCT03334435|62922638|FG002|Overall Study|Lack of Efficacy|76|||
33532893|NCT03334435|62922639|FG003|Overall Study|Lack of Efficacy|140|||
33532894|NCT03334435|62922640|FG004|Overall Study|Lack of Efficacy|61|||
33459240|NCT00381095|62832756|FG000|Overall Study|Adverse Event|2|||
33459241|NCT00381095|62832757|FG001|Overall Study|Adverse Event|7|||
33459242|NCT03619174|62832765|FG000|Overall Study|Lost to Follow-up|3|||
33532895|NCT03334435|62922636|FG000|Overall Study|Adverse Event|2|||
33532896|NCT03334435|62922637|FG001|Overall Study|Adverse Event|1|||
33532897|NCT03334435|62922638|FG002|Overall Study|Adverse Event|9|||
33532898|NCT03334435|62922639|FG003|Overall Study|Adverse Event|23|||
33532899|NCT03334435|62922640|FG004|Overall Study|Adverse Event|13|||
33532900|NCT03334435|62922636|FG000|Overall Study|Withdrawal by Subject|11|||
33532901|NCT03334435|62922637|FG001|Overall Study|Withdrawal by Subject|4|||
33532902|NCT03334435|62922638|FG002|Overall Study|Withdrawal by Subject|38|||
33532903|NCT03334435|62922639|FG003|Overall Study|Withdrawal by Subject|42|||
33532904|NCT03334435|62922640|FG004|Overall Study|Withdrawal by Subject|20|||
33532905|NCT03334435|62922636|FG000|Overall Study|Lost to Follow-up|3|||
33532906|NCT03334435|62922637|FG001|Overall Study|Lost to Follow-up|0|||
33532907|NCT03334435|62922638|FG002|Overall Study|Lost to Follow-up|2|||
33532908|NCT03334435|62922639|FG003|Overall Study|Lost to Follow-up|1|||
33459243|NCT03619174|62832766|FG001|Overall Study|Lost to Follow-up|0|||
33459244|NCT03619174|62832765|FG000|Overall Study|Withdrawal by Subject|4|||
33459245|NCT03619174|62832766|FG001|Overall Study|Withdrawal by Subject|3|||
33459246|NCT03619174|62832765|FG000|Overall Study|Pregnancy|1|||
33459247|NCT03619174|62832766|FG001|Overall Study|Pregnancy|1|||
33459248|NCT03619174|62832765|FG000|Overall Study|Discomfort during treatment|1|||
33532909|NCT03334435|62922640|FG004|Overall Study|Lost to Follow-up|1|||
33532910|NCT03334435|62922636|FG000|Overall Study|Death|0|||
33532911|NCT03334435|62922637|FG001|Overall Study|Death|0|||
33459249|NCT03619174|62832766|FG001|Overall Study|Discomfort during treatment|0|||
33459250|NCT00112047|62832774|FG000|Randomized Phase|Lost to Follow-up|26|||
33459251|NCT00112047|62832775|FG001|Randomized Phase|Lost to Follow-up|33|||
33459252|NCT00112047|62832774|FG000|Randomized Phase|Adverse Event|10|||
33459253|NCT00112047|62832775|FG001|Randomized Phase|Adverse Event|10|||
33459254|NCT00112047|62832774|FG000|Randomized Phase|Withrawal of consent|10|||
33459255|NCT00112047|62832775|FG001|Randomized Phase|Withrawal of consent|18|||
33459256|NCT00112047|62832774|FG000|Randomized Phase|Sub-optimal virological response|3|||
33459257|NCT00112047|62832775|FG001|Randomized Phase|Sub-optimal virological response|13|||
33459258|NCT00112047|62832774|FG000|Randomized Phase|Noncompliance|8|||
33459259|NCT00112047|62832775|FG001|Randomized Phase|Noncompliance|4|||
33459260|NCT00112047|62832774|FG000|Randomized Phase|Protocol Violation|2|||
33459261|NCT00112047|62832775|FG001|Randomized Phase|Protocol Violation|0|||
33459262|NCT00112047|62832774|FG000|Randomized Phase|Pregnancy|3|||
33459263|NCT00112047|62832775|FG001|Randomized Phase|Pregnancy|1|||
33532912|NCT03334435|62922638|FG002|Overall Study|Death|0|||
33532913|NCT03334435|62922639|FG003|Overall Study|Death|1|||
33532914|NCT03334435|62922640|FG004|Overall Study|Death|0|||
33532915|NCT03334435|62922636|FG000|Overall Study|Other|0|||
33459264|NCT00112047|62832774|FG000|Randomized Phase|Death|1|||
33459265|NCT00112047|62832775|FG001|Randomized Phase|Death|3|||
33459266|NCT00112047|62832774|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
33532916|NCT03334435|62922637|FG001|Overall Study|Other|1|||
33532917|NCT03334435|62922638|FG002|Overall Study|Other|3|||
33532918|NCT03334435|62922639|FG003|Overall Study|Other|2|||
33532919|NCT03334435|62922640|FG004|Overall Study|Other|1|||
33532920|NCT02919449|62922713|FG000|Overall Study|Withdrawal by Subject|1|||
33532921|NCT02919449|62922713|FG000|Overall Study|Investigator decision|1|||
33532922|NCT02913482|62922720|FG000|Overall Study|Death|0|||
33532923|NCT02913482|62922721|FG001|Overall Study|Death|2|||
33532924|NCT02913482|62922722|FG002|Overall Study|Death|2|||
33532925|NCT02913482|62922720|FG000|Overall Study|Progressive Disease|1|||
33532926|NCT02913482|62922721|FG001|Overall Study|Progressive Disease|1|||
33532927|NCT02913482|62922722|FG002|Overall Study|Progressive Disease|1|||
33532928|NCT02769832|62922732|FG000|Overall Study|Death|30|||
33532929|NCT02530970|62922741|FG000|Overall Study|Adverse Event|8|||
33532930|NCT02530970|62922741|FG000|Overall Study|Lost to Follow-up|88|||
33532931|NCT02530970|62922741|FG000|Overall Study|Physician Decision|5|||
33532932|NCT02530970|62922741|FG000|Overall Study|Withdrawal by Subject|14|||
33532933|NCT02530970|62922741|FG000|Overall Study|Death|6|||
33626458|NCT01621490|63027290|FG001|Overall Study|Documented disease progression|0|||
33626459|NCT01621490|63027291|FG002|Overall Study|Documented disease progression|1|||
33626460|NCT01621490|63027292|FG003|Overall Study|Documented disease progression|0|||
33532934|NCT02530970|62922741|FG000|Overall Study|Hospitalization|1|||
33459267|NCT00112047|62832775|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
33532935|NCT02530970|62922741|FG000|Overall Study|Insurance|2|||
33459268|NCT00112047|62832774|FG000|Randomized Phase|Inability to swallow pills|0|||
33459269|NCT00112047|62832775|FG001|Randomized Phase|Inability to swallow pills|1|||
33459270|NCT00112047|62832774|FG000|Randomized Phase|Incarceration|3|||
33459271|NCT00112047|62832775|FG001|Randomized Phase|Incarceration|2|||
33459272|NCT00112047|62832774|FG000|Randomized Phase|Moved out of State|0|||
33459273|NCT00112047|62832775|FG001|Randomized Phase|Moved out of State|1|||
33532936|NCT02530970|62922741|FG000|Overall Study|Explant|2|||
33532937|NCT02530970|62922741|FG000|Overall Study|Change in Provider|5|||
33626461|NCT01621490|63027293|FG004|Overall Study|Documented disease progression|0|||
33532938|NCT02530970|62922741|FG000|Overall Study|Relocation|3|||
33532939|NCT02418156|62922745|FG000|Overall Study|Lost to Follow-up|12|||
33532940|NCT02418156|62922745|FG000|Overall Study|Death|2|||
33532941|NCT02418156|62922745|FG000|Overall Study|Physician Decision|1|||
33532942|NCT02418156|62922745|FG000|Overall Study|Withdrawal by Subject|1|||
33532943|NCT02418156|62922745|FG000|Overall Study|Subject refused to return|1|||
33532944|NCT02029443|62922788|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
33532945|NCT02029443|62922789|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
33532946|NCT02029443|62922790|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
33532947|NCT02029443|62922791|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
33532948|NCT02029443|62922792|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
33532949|NCT02029443|62922788|FG000|Overall Study|Death|13|||
33532950|NCT02029443|62922789|FG001|Overall Study|Death|2|||
33532951|NCT02029443|62922790|FG002|Overall Study|Death|2|||
33459274|NCT00112047|62832774|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
33459275|NCT00112047|62832775|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
33459276|NCT00112047|62832774|FG000|Randomized Phase|High Hepatitis B DNA|0|||
33459277|NCT00112047|62832775|FG001|Randomized Phase|High Hepatitis B DNA|1|||
33459278|NCT00112047|62832774|FG000|Atripla Phase|Adverse Event|2|||
33459279|NCT00112047|62832775|FG001|Atripla Phase|Adverse Event|1|||
33459280|NCT00112047|62832774|FG000|Atripla Phase|Lost to Follow-up|5|||
33459281|NCT00112047|62832775|FG001|Atripla Phase|Lost to Follow-up|7|||
33459282|NCT00112047|62832774|FG000|Atripla Phase|Pregnancy|0|||
33459283|NCT00112047|62832775|FG001|Atripla Phase|Pregnancy|1|||
33459284|NCT00112047|62832774|FG000|Atripla Phase|Death|0|||
33459285|NCT00112047|62832775|FG001|Atripla Phase|Death|2|||
33459286|NCT00112047|62832774|FG000|Atripla Phase|Withdrew consent|7|||
33459287|NCT00112047|62832775|FG001|Atripla Phase|Withdrew consent|7|||
33459288|NCT00112047|62832774|FG000|Atripla Phase|Sub-optimal virological response|0|||
33459289|NCT00112047|62832775|FG001|Atripla Phase|Sub-optimal virological response|1|||
33459290|NCT00112047|62832774|FG000|Atripla Phase|Non-compliance|1|||
33459291|NCT00112047|62832775|FG001|Atripla Phase|Non-compliance|0|||
33459292|NCT00112047|62832774|FG000|Atripla Phase|Other|3|||
33459293|NCT00112047|62832775|FG001|Atripla Phase|Other|1|||
33459294|NCT03658876|62832788|FG000|Overall Study|Protocol Violation|3|||
33459295|NCT03658876|62832789|FG001|Overall Study|Protocol Violation|2|||
33459296|NCT03658876|62832788|FG000|Overall Study|Withdrawal by Subject|2|||
33459297|NCT03658876|62832789|FG001|Overall Study|Withdrawal by Subject|0|||
33459298|NCT03658876|62832788|FG000|Overall Study|Death|0|||
33626462|NCT01621490|63027294|FG005|Overall Study|Documented disease progression|0|||
33626463|NCT01621490|63027295|FG006|Overall Study|Documented disease progression|0|||
33626464|NCT01621490|63027296|FG007|Overall Study|Documented disease progression|0|||
33626465|NCT01621490|63027297|FG008|Overall Study|Documented disease progression|0|||
33626466|NCT01621490|63027289|FG000|Overall Study|Patient reached treatment 2 yr limit|0|||
33626467|NCT01621490|63027290|FG001|Overall Study|Patient reached treatment 2 yr limit|1|||
33626468|NCT01621490|63027291|FG002|Overall Study|Patient reached treatment 2 yr limit|0|||
33626469|NCT01621490|63027292|FG003|Overall Study|Patient reached treatment 2 yr limit|0|||
33626470|NCT01621490|63027293|FG004|Overall Study|Patient reached treatment 2 yr limit|0|||
33626471|NCT01621490|63027294|FG005|Overall Study|Patient reached treatment 2 yr limit|0|||
33626472|NCT01621490|63027295|FG006|Overall Study|Patient reached treatment 2 yr limit|0|||
33532952|NCT02029443|62922791|FG003|Overall Study|Death|11|||
33532953|NCT02029443|62922792|FG004|Overall Study|Death|2|||
33532954|NCT02029443|62922788|FG000|Overall Study|Lost to Follow-up|1|||
33532955|NCT02029443|62922789|FG001|Overall Study|Lost to Follow-up|0|||
33532956|NCT02029443|62922790|FG002|Overall Study|Lost to Follow-up|1|||
33532957|NCT02029443|62922791|FG003|Overall Study|Lost to Follow-up|1|||
33626473|NCT01621490|63027296|FG007|Overall Study|Patient reached treatment 2 yr limit|0|||
33626474|NCT01621490|63027297|FG008|Overall Study|Patient reached treatment 2 yr limit|0|||
33626475|NCT01621490|63027289|FG000|Overall Study|Clinical deterioration|0|||
33626476|NCT01621490|63027290|FG001|Overall Study|Clinical deterioration|1|||
33626477|NCT01621490|63027291|FG002|Overall Study|Clinical deterioration|0|||
33626478|NCT01621490|63027292|FG003|Overall Study|Clinical deterioration|0|||
33326024|NCT01161173|62702801|FG000|Overall Study|Protocol Violation|13|||
33459299|NCT03658876|62832789|FG001|Overall Study|Death|1|||
33459300|NCT03658876|62832788|FG000|Overall Study|Intercurrent illness|6|||
33459301|NCT03658876|62832789|FG001|Overall Study|Intercurrent illness|4|||
33532958|NCT02029443|62922792|FG004|Overall Study|Lost to Follow-up|0|||
33532959|NCT02029443|62922788|FG000|Overall Study|Started other anti-cancer therapy|17|||
33532960|NCT02029443|62922789|FG001|Overall Study|Started other anti-cancer therapy|4|||
33459302|NCT03658876|62832788|FG000|Overall Study|Transplantation/other operation|1|||
33459303|NCT03658876|62832789|FG001|Overall Study|Transplantation/other operation|5|||
33459304|NCT03618628|62832795|FG000|Overall Study|Death|1|||
33459305|NCT03618628|62832795|FG000|Overall Study|Lost to Follow-up|1|||
33459306|NCT03617770|62832801|FG000|Overall Study|Lost to Follow-up|1|||
33532961|NCT02029443|62922790|FG002|Overall Study|Started other anti-cancer therapy|7|||
33532962|NCT02029443|62922791|FG003|Overall Study|Started other anti-cancer therapy|9|||
33532963|NCT02029443|62922792|FG004|Overall Study|Started other anti-cancer therapy|3|||
33459307|NCT03617770|62832802|FG001|Overall Study|Lost to Follow-up|0|||
33459308|NCT03616600|62832810|FG000|Overall Study|Withdrawal by Subject|1|||
33459309|NCT03616600|62832811|FG001|Overall Study|Withdrawal by Subject|0|||
33532964|NCT02029443|62922788|FG000|Overall Study|Withdrawal by Subject|3|||
33532965|NCT02029443|62922789|FG001|Overall Study|Withdrawal by Subject|1|||
33532966|NCT02029443|62922790|FG002|Overall Study|Withdrawal by Subject|1|||
33532967|NCT02029443|62922791|FG003|Overall Study|Withdrawal by Subject|1|||
33532968|NCT02029443|62922792|FG004|Overall Study|Withdrawal by Subject|0|||
33532969|NCT02029443|62922788|FG000|Overall Study|Other|6|||
33532970|NCT02029443|62922789|FG001|Overall Study|Other|6|||
33532971|NCT02029443|62922790|FG002|Overall Study|Other|4|||
33532972|NCT02029443|62922791|FG003|Overall Study|Other|2|||
33532973|NCT02029443|62922792|FG004|Overall Study|Other|0|||
33532974|NCT01850524|62922828|FG000|Overall Study|Lost to Follow-up|5|||
33532975|NCT01850524|62922829|FG001|Overall Study|Lost to Follow-up|10|||
33532976|NCT01850524|62922828|FG000|Overall Study|Withdrawal by Subject|24|||
33532977|NCT01850524|62922829|FG001|Overall Study|Withdrawal by Subject|22|||
33532978|NCT01850524|62922828|FG000|Overall Study|Reason not Specified|142|||
33532979|NCT01850524|62922829|FG001|Overall Study|Reason not Specified|141|||
33532980|NCT01609842|62922846|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
33532981|NCT01609842|62922847|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
33532982|NCT01569594|62922857|FG000|Overall Study|Physician Decision|4|||
33532983|NCT01569594|62922857|FG000|Overall Study|Death|13|||
33532984|NCT01569594|62922857|FG000|Overall Study|Lost to Follow-up|22|||
33532985|NCT01569594|62922857|FG000|Overall Study|Adverse Event|2|||
33532986|NCT01569594|62922857|FG000|Overall Study|Withdrawal by Subject|13|||
33532987|NCT01569594|62922857|FG000|Overall Study|Other|4|||
33532988|NCT01569594|62922857|FG000|Overall Study|No ECM used|9|||
33532989|NCT01207492|62922861|FG000|Overall Study|Still on study|1|||
33532990|NCT01207492|62922861|FG000|Overall Study|Withdrawal by Subject|9|||
33532991|NCT01207492|62922861|FG000|Overall Study|Physician Decision|1|||
33532992|NCT01207492|62922861|FG000|Overall Study|Progressive disease|3|||
33532993|NCT01207492|62922861|FG000|Overall Study|Toxicity|1|||
33532994|NCT00593840|62922865|FG000|Overall Study|Withdrawal by Subject|1|||
33532995|NCT01329900|62922898|FG000|Overall Study|Elevated creatinine/renal function|1|||
33532996|NCT02825043|62922902|FG000|Overall Study|Lost to Follow-up|4|||
33532997|NCT02750592|62922917|FG000|Overall Study|Adverse Event|3|||
33532998|NCT02750592|62922917|FG000|Overall Study|Lack of Efficacy|2|||
33532999|NCT02624986|62922929|FG000|Overall Study|Death|0|||
33533000|NCT02624986|62922930|FG001|Overall Study|Death|1|||
33626479|NCT01621490|63027293|FG004|Overall Study|Clinical deterioration|0|||
33626480|NCT01621490|63027294|FG005|Overall Study|Clinical deterioration|0|||
33626481|NCT01621490|63027295|FG006|Overall Study|Clinical deterioration|0|||
33626482|NCT01621490|63027296|FG007|Overall Study|Clinical deterioration|0|||
33626483|NCT01621490|63027297|FG008|Overall Study|Clinical deterioration|0|||
33626484|NCT01621490|63027289|FG000|Overall Study|Complete response|0|||
33626485|NCT01621490|63027290|FG001|Overall Study|Complete response|0|||
33459310|NCT00380393|62832820|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
33459311|NCT00380393|62832821|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
33533001|NCT02624986|62922931|FG002|Overall Study|Death|2|||
33533002|NCT02624986|62922932|FG003|Overall Study|Death|2|||
33533003|NCT02624986|62922933|FG004|Overall Study|Death|2|||
33533004|NCT02624986|62922934|FG005|Overall Study|Death|0|||
33533005|NCT02624986|62922935|FG006|Overall Study|Death|0|||
33533006|NCT02624986|62922936|FG007|Overall Study|Death|1|||
33533007|NCT02624986|62922929|FG000|Overall Study|Study Terminated by Sponsor|1|||
33533008|NCT02624986|62922930|FG001|Overall Study|Study Terminated by Sponsor|1|||
33533009|NCT02624986|62922931|FG002|Overall Study|Study Terminated by Sponsor|0|||
33626486|NCT01621490|63027291|FG002|Overall Study|Complete response|0|||
33626487|NCT01621490|63027292|FG003|Overall Study|Complete response|0|||
33459312|NCT00380393|62832820|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
33459313|NCT00380393|62832821|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
33459314|NCT00380393|62832820|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
33459315|NCT00380393|62832821|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
33459316|NCT00380393|62832820|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
33459317|NCT00380393|62832821|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
33459318|NCT00380393|62832820|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
33459319|NCT00380393|62832821|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
33533010|NCT02624986|62922932|FG003|Overall Study|Study Terminated by Sponsor|1|||
33533011|NCT02624986|62922933|FG004|Overall Study|Study Terminated by Sponsor|2|||
33533012|NCT02624986|62922934|FG005|Overall Study|Study Terminated by Sponsor|2|||
33626488|NCT01621490|63027293|FG004|Overall Study|Complete response|0|||
33533013|NCT02624986|62922935|FG006|Overall Study|Study Terminated by Sponsor|4|||
33533014|NCT02624986|62922936|FG007|Overall Study|Study Terminated by Sponsor|3|||
33533015|NCT02624986|62922929|FG000|Overall Study|Progressive Disease|0|||
33626489|NCT01621490|63027294|FG005|Overall Study|Complete response|0|||
33626490|NCT01621490|63027295|FG006|Overall Study|Complete response|0|||
33533016|NCT02624986|62922930|FG001|Overall Study|Progressive Disease|1|||
33533017|NCT02624986|62922931|FG002|Overall Study|Progressive Disease|0|||
33533018|NCT02624986|62922932|FG003|Overall Study|Progressive Disease|0|||
33626491|NCT01621490|63027296|FG007|Overall Study|Complete response|0|||
33533019|NCT02624986|62922933|FG004|Overall Study|Progressive Disease|0|||
33533020|NCT02624986|62922934|FG005|Overall Study|Progressive Disease|0|||
33533021|NCT02624986|62922935|FG006|Overall Study|Progressive Disease|0|||
33533022|NCT02624986|62922936|FG007|Overall Study|Progressive Disease|0|||
33533023|NCT02624986|62922929|FG000|Overall Study|Protocol Violation|1|||
33533024|NCT02624986|62922930|FG001|Overall Study|Protocol Violation|0|||
33533025|NCT02624986|62922931|FG002|Overall Study|Protocol Violation|0|||
33533026|NCT02624986|62922932|FG003|Overall Study|Protocol Violation|0|||
33533027|NCT02624986|62922933|FG004|Overall Study|Protocol Violation|0|||
33533028|NCT02624986|62922934|FG005|Overall Study|Protocol Violation|0|||
33533029|NCT02624986|62922935|FG006|Overall Study|Protocol Violation|0|||
33533030|NCT02624986|62922936|FG007|Overall Study|Protocol Violation|0|||
33533031|NCT02624986|62922929|FG000|Overall Study|Withdrawal by Subject|0|||
33533032|NCT02624986|62922930|FG001|Overall Study|Withdrawal by Subject|0|||
33533033|NCT02624986|62922931|FG002|Overall Study|Withdrawal by Subject|0|||
33533034|NCT02624986|62922932|FG003|Overall Study|Withdrawal by Subject|0|||
33533035|NCT02624986|62922933|FG004|Overall Study|Withdrawal by Subject|0|||
33533036|NCT02624986|62922934|FG005|Overall Study|Withdrawal by Subject|0|||
33533037|NCT02624986|62922935|FG006|Overall Study|Withdrawal by Subject|0|||
33533038|NCT02624986|62922936|FG007|Overall Study|Withdrawal by Subject|1|||
33533039|NCT02587598|62922969|FG000|Overall Study|Death|4|||
33533040|NCT02587598|62922970|FG001|Overall Study|Death|8|||
33533041|NCT02587598|62922971|FG002|Overall Study|Death|4|||
33533042|NCT02587598|62922972|FG003|Overall Study|Death|16|||
33533043|NCT02587598|62922973|FG004|Overall Study|Death|9|||
33533044|NCT02587598|62922974|FG005|Overall Study|Death|4|||
33533045|NCT02587598|62922975|FG006|Overall Study|Death|6|||
33533046|NCT02587598|62922976|FG007|Overall Study|Death|7|||
33533047|NCT02587598|62922977|FG008|Overall Study|Death|9|||
33533048|NCT02587598|62922978|FG009|Overall Study|Death|1|||
33533049|NCT02587598|62922979|FG010|Overall Study|Death|3|||
33533050|NCT02587598|62922969|FG000|Overall Study|Study Terminated by the Sponsor|0|||
33533051|NCT02587598|62922970|FG001|Overall Study|Study Terminated by the Sponsor|1|||
33626492|NCT01621490|63027297|FG008|Overall Study|Complete response|1|||
33533052|NCT02587598|62922971|FG002|Overall Study|Study Terminated by the Sponsor|0|||
33533053|NCT02587598|62922972|FG003|Overall Study|Study Terminated by the Sponsor|3|||
33533054|NCT02587598|62922973|FG004|Overall Study|Study Terminated by the Sponsor|0|||
33533055|NCT02587598|62922974|FG005|Overall Study|Study Terminated by the Sponsor|1|||
33533056|NCT02587598|62922975|FG006|Overall Study|Study Terminated by the Sponsor|0|||
33533057|NCT02587598|62922976|FG007|Overall Study|Study Terminated by the Sponsor|0|||
33533058|NCT02587598|62922977|FG008|Overall Study|Study Terminated by the Sponsor|0|||
33533059|NCT02587598|62922978|FG009|Overall Study|Study Terminated by the Sponsor|1|||
33533060|NCT02587598|62922979|FG010|Overall Study|Study Terminated by the Sponsor|6|||
33626493|NCT01621490|63027289|FG000|Overall Study|Patient delayed due to toxicity|0|||
33533061|NCT02587598|62922969|FG000|Overall Study|Reason for study withdrawal not specified|0|||
33533062|NCT02587598|62922970|FG001|Overall Study|Reason for study withdrawal not specified|1|||
33533063|NCT02587598|62922971|FG002|Overall Study|Reason for study withdrawal not specified|0|||
33533064|NCT02587598|62922972|FG003|Overall Study|Reason for study withdrawal not specified|0|||
33533065|NCT02587598|62922973|FG004|Overall Study|Reason for study withdrawal not specified|0|||
33533066|NCT02587598|62922974|FG005|Overall Study|Reason for study withdrawal not specified|0|||
33533067|NCT02587598|62922975|FG006|Overall Study|Reason for study withdrawal not specified|0|||
33533068|NCT02587598|62922976|FG007|Overall Study|Reason for study withdrawal not specified|0|||
33533069|NCT02587598|62922977|FG008|Overall Study|Reason for study withdrawal not specified|0|||
33533070|NCT02587598|62922978|FG009|Overall Study|Reason for study withdrawal not specified|0|||
33533071|NCT02587598|62922979|FG010|Overall Study|Reason for study withdrawal not specified|0|||
33533072|NCT02587598|62922969|FG000|Overall Study|Withdrawal by Subject|0|||
33533073|NCT02587598|62922970|FG001|Overall Study|Withdrawal by Subject|1|||
33326025|NCT01161173|62702801|FG000|Overall Study|Lost to Follow-up|7|||
33459320|NCT00380393|62832820|FG000|Month 14|Withdrawal by Subject|9|||
33459321|NCT00380393|62832821|FG001|Month 14|Withdrawal by Subject|7|||
33459322|NCT00380393|62832820|FG000|Month 14|Death|1|||
33459323|NCT00380393|62832821|FG001|Month 14|Death|0|||
33459324|NCT00380393|62832820|FG000|Month 14|Lost to Follow-up|0|||
33459325|NCT00380393|62832821|FG001|Month 14|Lost to Follow-up|1|||
33459326|NCT00380393|62832820|FG000|Month 14|Migrated/moved from study area|39|||
33459327|NCT00380393|62832821|FG001|Month 14|Migrated/moved from study area|42|||
33459328|NCT00380393|62832820|FG000|Month 14|Protocol Violation|2|||
33459329|NCT00380393|62832821|FG001|Month 14|Protocol Violation|0|||
33459330|NCT00380393|62832820|FG000|Month 14|Others|6|||
33459331|NCT00380393|62832821|FG001|Month 14|Others|6|||
33533074|NCT02587598|62922971|FG002|Overall Study|Withdrawal by Subject|0|||
33533075|NCT02587598|62922972|FG003|Overall Study|Withdrawal by Subject|2|||
33533076|NCT02587598|62922973|FG004|Overall Study|Withdrawal by Subject|3|||
33533077|NCT02587598|62922974|FG005|Overall Study|Withdrawal by Subject|1|||
33533078|NCT02587598|62922975|FG006|Overall Study|Withdrawal by Subject|0|||
33533079|NCT02587598|62922976|FG007|Overall Study|Withdrawal by Subject|0|||
33626494|NCT01621490|63027290|FG001|Overall Study|Patient delayed due to toxicity|0|||
33533080|NCT02587598|62922977|FG008|Overall Study|Withdrawal by Subject|0|||
33533081|NCT02587598|62922978|FG009|Overall Study|Withdrawal by Subject|1|||
33533082|NCT02587598|62922979|FG010|Overall Study|Withdrawal by Subject|2|||
33533083|NCT02587598|62922969|FG000|Overall Study|Physician Decision|0|||
33533084|NCT02587598|62922970|FG001|Overall Study|Physician Decision|0|||
33533085|NCT02587598|62922971|FG002|Overall Study|Physician Decision|0|||
33533086|NCT02587598|62922972|FG003|Overall Study|Physician Decision|0|||
33533087|NCT02587598|62922973|FG004|Overall Study|Physician Decision|0|||
33533088|NCT02587598|62922974|FG005|Overall Study|Physician Decision|0|||
33533089|NCT02587598|62922975|FG006|Overall Study|Physician Decision|0|||
33533090|NCT02587598|62922976|FG007|Overall Study|Physician Decision|0|||
33533091|NCT02587598|62922977|FG008|Overall Study|Physician Decision|0|||
33533092|NCT02587598|62922978|FG009|Overall Study|Physician Decision|0|||
33533093|NCT02587598|62922979|FG010|Overall Study|Physician Decision|3|||
33533094|NCT02485574|62923015|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
33533095|NCT02624284|62923027|FG000|Overall Study|Withdrawal by Subject|3|||
33533096|NCT02624284|62923028|FG001|Overall Study|Withdrawal by Subject|6|||
33533097|NCT02624284|62923029|FG002|Overall Study|Withdrawal by Subject|3|||
33533098|NCT02624284|62923027|FG000|Overall Study|Protocol Violation|9|||
33533099|NCT02624284|62923028|FG001|Overall Study|Protocol Violation|10|||
33626495|NCT01621490|63027291|FG002|Overall Study|Patient delayed due to toxicity|0|||
33626496|NCT01621490|63027292|FG003|Overall Study|Patient delayed due to toxicity|0|||
33533100|NCT02624284|62923029|FG002|Overall Study|Protocol Violation|7|||
33533101|NCT02624284|62923027|FG000|Overall Study|Revealed exclusionary condition|2|||
33533102|NCT02624284|62923028|FG001|Overall Study|Revealed exclusionary condition|2|||
33533103|NCT02624284|62923029|FG002|Overall Study|Revealed exclusionary condition|0|||
33533104|NCT02624284|62923027|FG000|Overall Study|Adverse Event|0|||
33533105|NCT02624284|62923028|FG001|Overall Study|Adverse Event|0|||
33533106|NCT02624284|62923029|FG002|Overall Study|Adverse Event|1|||
33533107|NCT02738450|62923041|FG000|Overall Study|Withdrawal by Subject|0|||
33626497|NCT01621490|63027293|FG004|Overall Study|Patient delayed due to toxicity|0|||
33626498|NCT01621490|63027294|FG005|Overall Study|Patient delayed due to toxicity|1|||
33626499|NCT01621490|63027295|FG006|Overall Study|Patient delayed due to toxicity|0|||
33626500|NCT01621490|63027296|FG007|Overall Study|Patient delayed due to toxicity|0|||
33626501|NCT01621490|63027297|FG008|Overall Study|Patient delayed due to toxicity|0|||
33626502|NCT02018887|63027418|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
33626503|NCT02018887|63027419|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33626504|NCT02018887|63027420|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33626505|NCT02018887|63027421|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33626506|NCT02018887|63027422|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33626507|NCT02018887|63027423|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33626508|NCT02018887|63027424|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33626509|NCT02018887|63027425|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33626510|NCT02018887|63027426|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33626511|NCT02018887|63027427|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33626512|NCT02018887|63027428|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33533108|NCT02738450|62923042|FG001|Overall Study|Withdrawal by Subject|2|||
33533109|NCT02738450|62923043|FG002|Overall Study|Withdrawal by Subject|0|||
33533110|NCT02624050|62923054|FG000|Overall Study|Physician Decision|4|||
33533111|NCT02624050|62923055|FG001|Overall Study|Physician Decision|0|||
33533112|NCT02624050|62923054|FG000|Overall Study|Protocol Violation|2|||
33626513|NCT02018887|63027418|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33533113|NCT02624050|62923055|FG001|Overall Study|Protocol Violation|0|||
33533114|NCT01338987|62923071|FG000|Overall Study|enrolled on new protocol|0|||
33533115|NCT01338987|62923072|FG001|Overall Study|enrolled on new protocol|0|||
33533116|NCT01338987|62923073|FG002|Overall Study|enrolled on new protocol|1|||
33533117|NCT01338987|62923074|FG003|Overall Study|enrolled on new protocol|0|||
33533118|NCT01338987|62923075|FG004|Overall Study|enrolled on new protocol|0|||
33533119|NCT01338987|62923071|FG000|Overall Study|Disease progression on study|2|||
33533120|NCT01338987|62923072|FG001|Overall Study|Disease progression on study|1|||
33626514|NCT02018887|63027419|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33626515|NCT02018887|63027420|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33626516|NCT02018887|63027421|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33533121|NCT01338987|62923073|FG002|Overall Study|Disease progression on study|1|||
33533122|NCT01338987|62923074|FG003|Overall Study|Disease progression on study|0|||
33626517|NCT02018887|63027422|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
33533123|NCT01338987|62923075|FG004|Overall Study|Disease progression on study|0|||
33533124|NCT03706430|62923089|FG000|Overall Study|No A-Line placed|5|||
33533125|NCT03706430|62923089|FG000|Overall Study|Subject had gel nail polish|1|||
33533126|NCT03706430|62923089|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
33533127|NCT03706430|62923089|FG000|Overall Study|Cancelled Case|6|||
33626518|NCT02018887|63027423|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33626519|NCT02018887|63027424|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
33626520|NCT02018887|63027425|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
33533128|NCT03706430|62923089|FG000|Overall Study|Physician Decision|2|||
33533129|NCT02738138|62923111|FG000|Overall Study|Adverse Event|0|||
33533130|NCT02738138|62923112|FG001|Overall Study|Adverse Event|1|||
33533131|NCT02738138|62923111|FG000|Overall Study|Lost to Follow-up|2|||
33533132|NCT02738138|62923112|FG001|Overall Study|Lost to Follow-up|0|||
33533133|NCT02738138|62923111|FG000|Overall Study|Other - not further specified|1|||
33533134|NCT02738138|62923112|FG001|Overall Study|Other - not further specified|0|||
33533135|NCT01355289|62923121|FG000|Core Study|Adverse Event, Non-Fatal|1|||
33533136|NCT01355289|62923122|FG001|Core Study|Adverse Event, Non-Fatal|0|||
33533137|NCT01355289|62923123|FG002|Core Study|Adverse Event, Non-Fatal|0|||
33533138|NCT01355289|62923124|FG003|Core Study|Adverse Event, Non-Fatal|0|||
33533139|NCT01355289|62923125|FG004|Core Study|Adverse Event, Non-Fatal|0|||
33533140|NCT01355289|62923121|FG000|Core Study|Inadequate Therapeutic Effect|0|||
33459332|NCT00380081|62832833|FG000|Overall Study|Withdrawal by Subject|0|||
33533141|NCT01355289|62923122|FG001|Core Study|Inadequate Therapeutic Effect|0|||
33533142|NCT01355289|62923123|FG002|Core Study|Inadequate Therapeutic Effect|0|||
33533143|NCT01355289|62923124|FG003|Core Study|Inadequate Therapeutic Effect|1|||
33533144|NCT01355289|62923125|FG004|Core Study|Inadequate Therapeutic Effect|0|||
33533145|NCT01355289|62923121|FG000|Core Study|Other|0|||
33533146|NCT01355289|62923122|FG001|Core Study|Other|0|||
33533147|NCT01355289|62923123|FG002|Core Study|Other|0|||
33533148|NCT01355289|62923124|FG003|Core Study|Other|1|||
33533149|NCT01355289|62923125|FG004|Core Study|Other|0|||
33533150|NCT01355289|62923121|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
33533151|NCT01355289|62923122|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
33533152|NCT01355289|62923123|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
33533153|NCT01355289|62923124|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
33533154|NCT01355289|62923125|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
33533155|NCT01355289|62923121|FG000|Open Label Extension|Lost to Follow-up|0|||
33533156|NCT01355289|62923122|FG001|Open Label Extension|Lost to Follow-up|0|||
33533157|NCT01355289|62923123|FG002|Open Label Extension|Lost to Follow-up|0|||
33533158|NCT01355289|62923124|FG003|Open Label Extension|Lost to Follow-up|0|||
33533159|NCT01355289|62923125|FG004|Open Label Extension|Lost to Follow-up|1|||
33533160|NCT01355289|62923121|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
33533161|NCT01355289|62923122|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
33533162|NCT01355289|62923123|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
33533163|NCT01355289|62923124|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
33533164|NCT01355289|62923125|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
33533165|NCT01355289|62923121|FG000|Open Label Extension|Other|0|||
33533166|NCT01355289|62923122|FG001|Open Label Extension|Other|0|||
33533167|NCT01355289|62923123|FG002|Open Label Extension|Other|0|||
33533168|NCT01355289|62923124|FG003|Open Label Extension|Other|0|||
33533169|NCT01355289|62923125|FG004|Open Label Extension|Other|3|||
33533170|NCT02737592|62923138|FG000|Overall Study|Withdrawal by Subject|1|||
33626521|NCT02018887|63027426|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33626522|NCT02018887|63027427|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33533171|NCT02737358|62923165|FG000|Overall Study|Withdrawal by Subject|7|||
33533172|NCT02737358|62923166|FG001|Overall Study|Withdrawal by Subject|12|||
33533173|NCT02737358|62923165|FG000|Overall Study|Lost to Follow-up|2|||
33533174|NCT02737358|62923166|FG001|Overall Study|Lost to Follow-up|3|||
33533175|NCT01354431|62923175|FG000|Pre-Treatment Period|Not reported|1|||
33533176|NCT01354431|62923176|FG001|Pre-Treatment Period|Not reported|0|||
33533177|NCT01354431|62923177|FG002|Pre-Treatment Period|Not reported|0|||
33626523|NCT02018887|63027428|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33459333|NCT00380081|62832834|FG001|Overall Study|Withdrawal by Subject|0|||
33459334|NCT00380081|62832835|FG002|Overall Study|Withdrawal by Subject|0|||
33459335|NCT00380081|62832836|FG003|Overall Study|Withdrawal by Subject|0|||
33459336|NCT00380081|62832837|FG004|Overall Study|Withdrawal by Subject|1|||
33459337|NCT00380081|62832838|FG005|Overall Study|Withdrawal by Subject|0|||
33459338|NCT00380081|62832833|FG000|Overall Study|Family Emergency|0|||
33459339|NCT00380081|62832834|FG001|Overall Study|Family Emergency|0|||
33459340|NCT00380081|62832835|FG002|Overall Study|Family Emergency|0|||
33459341|NCT00380081|62832836|FG003|Overall Study|Family Emergency|0|||
33459342|NCT00380081|62832837|FG004|Overall Study|Family Emergency|0|||
33459343|NCT00380081|62832838|FG005|Overall Study|Family Emergency|1|||
33459344|NCT03579940|62832857|FG000|Period 2|Withdrawal by Subject|0|||
33459345|NCT03579940|62832858|FG001|Period 2|Withdrawal by Subject|0|||
33459346|NCT03579940|62832859|FG002|Period 2|Withdrawal by Subject|1|||
33459347|NCT03579940|62832860|FG003|Period 2|Withdrawal by Subject|0|||
33533178|NCT01354431|62923175|FG000|Treatment Period|Disease Progression|50|||
33533179|NCT01354431|62923176|FG001|Treatment Period|Disease Progression|40|||
33533180|NCT01354431|62923177|FG002|Treatment Period|Disease Progression|44|||
33533181|NCT01354431|62923175|FG000|Treatment Period|Study Drug Toxicity|5|||
33533182|NCT01354431|62923176|FG001|Treatment Period|Study Drug Toxicity|8|||
33533183|NCT01354431|62923177|FG002|Treatment Period|Study Drug Toxicity|4|||
33626524|NCT02018887|63027418|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
33533184|NCT01354431|62923175|FG000|Treatment Period|Death|0|||
33533185|NCT01354431|62923176|FG001|Treatment Period|Death|1|||
33533186|NCT01354431|62923177|FG002|Treatment Period|Death|0|||
33533187|NCT01354431|62923175|FG000|Treatment Period|AE unrelated to study drug|1|||
33533188|NCT01354431|62923176|FG001|Treatment Period|AE unrelated to study drug|2|||
33533189|NCT01354431|62923177|FG002|Treatment Period|AE unrelated to study drug|5|||
33533190|NCT01354431|62923175|FG000|Treatment Period|Participant request to discontinue|2|||
33533191|NCT01354431|62923176|FG001|Treatment Period|Participant request to discontinue|2|||
33533192|NCT01354431|62923177|FG002|Treatment Period|Participant request to discontinue|1|||
33533193|NCT01354431|62923175|FG000|Treatment Period|Participant withdrew consent|0|||
33533194|NCT01354431|62923176|FG001|Treatment Period|Participant withdrew consent|1|||
33533195|NCT01354431|62923177|FG002|Treatment Period|Participant withdrew consent|0|||
33533196|NCT01354431|62923175|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
33533197|NCT01354431|62923176|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
33533198|NCT01354431|62923177|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
33533199|NCT02736578|62923187|FG000|Overall Study|Adverse Event|1|||
33533200|NCT02736578|62923188|FG001|Overall Study|Adverse Event|0|||
33533201|NCT02622724|62923200|FG000|Overall Study|Death|51|||
33533202|NCT02622724|62923201|FG001|Overall Study|Death|53|||
33533203|NCT02622724|62923200|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
33533204|NCT02622724|62923201|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
33533205|NCT02622724|62923200|FG000|Overall Study|Early termination of study|38|||
33533206|NCT02622724|62923201|FG001|Overall Study|Early termination of study|43|||
33533207|NCT01354353|62923219|FG000|Overall Study|Adverse Event|1|||
33533208|NCT01354353|62923220|FG001|Overall Study|Adverse Event|0|||
33533209|NCT01354353|62923221|FG002|Overall Study|Adverse Event|0|||
33533210|NCT01354353|62923222|FG003|Overall Study|Adverse Event|4|||
33533211|NCT01354353|62923223|FG004|Overall Study|Adverse Event|0|||
33533212|NCT01354353|62923224|FG005|Overall Study|Adverse Event|5|||
33533213|NCT01354353|62923219|FG000|Overall Study|Entry Criteria Not Met|0|||
33533214|NCT01354353|62923220|FG001|Overall Study|Entry Criteria Not Met|0|||
33533215|NCT01354353|62923221|FG002|Overall Study|Entry Criteria Not Met|0|||
33533216|NCT01354353|62923222|FG003|Overall Study|Entry Criteria Not Met|1|||
33626525|NCT02018887|63027419|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
33626526|NCT02018887|63027420|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
33626527|NCT02018887|63027421|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
33626528|NCT02018887|63027422|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
33626529|NCT02018887|63027423|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
33533217|NCT01354353|62923223|FG004|Overall Study|Entry Criteria Not Met|1|||
33533218|NCT01354353|62923224|FG005|Overall Study|Entry Criteria Not Met|0|||
33533219|NCT01354353|62923219|FG000|Overall Study|Physician Decision|0|||
33533220|NCT01354353|62923220|FG001|Overall Study|Physician Decision|1|||
33533221|NCT01354353|62923221|FG002|Overall Study|Physician Decision|1|||
33533222|NCT01354353|62923222|FG003|Overall Study|Physician Decision|0|||
33533223|NCT01354353|62923223|FG004|Overall Study|Physician Decision|0|||
33533224|NCT01354353|62923224|FG005|Overall Study|Physician Decision|0|||
33533225|NCT01354353|62923219|FG000|Overall Study|Withdrawal by Subject|2|||
33533226|NCT01354353|62923220|FG001|Overall Study|Withdrawal by Subject|0|||
33533227|NCT01354353|62923221|FG002|Overall Study|Withdrawal by Subject|1|||
33533228|NCT01354353|62923222|FG003|Overall Study|Withdrawal by Subject|0|||
33533229|NCT01354353|62923223|FG004|Overall Study|Withdrawal by Subject|0|||
33533230|NCT01354353|62923224|FG005|Overall Study|Withdrawal by Subject|1|||
33533231|NCT02622568|62923247|FG000|Overall Study|Lost to Follow-up|5|||
33533232|NCT02622568|62923248|FG001|Overall Study|Lost to Follow-up|5|||
33533233|NCT01354899|62923254|FG000|Overall Study|discharge from the hospital|2|||
33533234|NCT01354899|62923254|FG000|Overall Study|Protocol Violation|1|||
33533235|NCT01353963|62923258|FG000|Overall Study|Adverse Event|2|||
33533236|NCT02820597|62923267|FG000|Overall Study|Lost to Follow-up|12|||
33533237|NCT02822235|62923273|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
33533238|NCT02822235|62923274|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
33533239|NCT02822235|62923273|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
33533240|NCT02822235|62923274|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
33626530|NCT02018887|63027424|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
33626531|NCT02018887|63027425|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
33626532|NCT02018887|63027426|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
33626533|NCT02018887|63027427|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
33533241|NCT02822235|62923273|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
33533242|NCT02822235|62923274|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
33533243|NCT02822235|62923273|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
33533244|NCT02822235|62923274|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
33533245|NCT02822235|62923273|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
33533246|NCT02822235|62923274|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
33626534|NCT02018887|63027428|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
33533247|NCT02822235|62923273|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
33533248|NCT02822235|62923274|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
33533249|NCT02817555|62923289|FG000|Overall Study|Death|1|||
33533250|NCT02817555|62923290|FG001|Overall Study|Death|3|||
33533251|NCT02817555|62923289|FG000|Overall Study|moved away|1|||
33626535|NCT02018887|63027418|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
33626536|NCT02018887|63027419|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
33626537|NCT02018887|63027420|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
33626538|NCT02018887|63027421|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
33626539|NCT02018887|63027422|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
33626540|NCT02018887|63027423|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
33626541|NCT02018887|63027424|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
33626542|NCT02018887|63027425|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
33626543|NCT02018887|63027426|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
33626544|NCT02018887|63027427|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
33626545|NCT02018887|63027428|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
33626546|NCT02030041|63027497|FG000|Overall Study|Withdrawal by Subject|2|||
33626547|NCT02030041|63027498|FG001|Overall Study|Withdrawal by Subject|2|||
33626548|NCT02030041|63027499|FG002|Overall Study|Withdrawal by Subject|1|||
33626549|NCT01994720|63027509|FG000|Overall Study|Withdrawal by Subject|46|||
33626550|NCT01994720|63027510|FG001|Overall Study|Withdrawal by Subject|56|||
33626551|NCT01814397|63027516|FG000|Overall Study|Adverse Event|7|||
33626552|NCT01814397|63027516|FG000|Overall Study|Withdrawal by Subject|7|||
33626553|NCT01814007|63027520|FG000|Overall Study|Withdrawal by Subject|1|||
33626554|NCT01844115|63027527|FG000|Overall Study|Adverse Event|4|||
33626555|NCT01844115|63027528|FG001|Overall Study|Adverse Event|22|||
33626556|NCT01844115|63027527|FG000|Overall Study|Lack of Efficacy|1|||
33626557|NCT01844115|63027528|FG001|Overall Study|Lack of Efficacy|4|||
33626558|NCT01844115|63027527|FG000|Overall Study|Protocol Violation|12|||
33626559|NCT01844115|63027528|FG001|Overall Study|Protocol Violation|10|||
33626560|NCT01844115|63027527|FG000|Overall Study|Withdrawal by Subject|11|||
33626561|NCT01844115|63027528|FG001|Overall Study|Withdrawal by Subject|11|||
33626562|NCT01844115|63027527|FG000|Overall Study|Lost to Follow-up|11|||
33626563|NCT01844115|63027528|FG001|Overall Study|Lost to Follow-up|10|||
33626564|NCT01844115|63027527|FG000|Overall Study|Pregnancy|0|||
33626565|NCT01844115|63027528|FG001|Overall Study|Pregnancy|1|||
33459348|NCT03579940|62832861|FG004|Period 2|Withdrawal by Subject|0|||
33459349|NCT03579940|62832862|FG005|Period 2|Withdrawal by Subject|0|||
33459350|NCT03579940|62832863|FG006|Period 2|Withdrawal by Subject|0|||
33459351|NCT03579940|62832864|FG007|Period 2|Withdrawal by Subject|0|||
33533252|NCT02817555|62923290|FG001|Overall Study|moved away|0|||
33533253|NCT02817555|62923289|FG000|Overall Study|transplant|1|||
33459352|NCT03579940|62832865|FG008|Period 2|Withdrawal by Subject|0|||
33459353|NCT03579940|62832866|FG009|Period 2|Withdrawal by Subject|0|||
33459354|NCT03579940|62832867|FG010|Period 2|Withdrawal by Subject|0|||
33459355|NCT00098306|62832902|FG000|Double Blind|Randomized, not treated|9|||
33459356|NCT00098306|62832903|FG001|Double Blind|Randomized, not treated|5|||
33459357|NCT00098306|62832904|FG002|Double Blind|Randomized, not treated|2|||
33459358|NCT00098306|62832905|FG003|Double Blind|Randomized, not treated|0|||
33459359|NCT00098306|62832906|FG004|Double Blind|Randomized, not treated|0|||
33459360|NCT00098306|62832907|FG005|Double Blind|Randomized, not treated|0|||
33459361|NCT00098306|62832908|FG006|Double Blind|Randomized, not treated|0|||
33459362|NCT00098306|62832902|FG000|Double Blind|Ongoing at cut-off date|151|||
33459363|NCT00098306|62832903|FG001|Double Blind|Ongoing at cut-off date|166|||
33459364|NCT00098306|62832904|FG002|Double Blind|Ongoing at cut-off date|72|||
33459365|NCT00098306|62832905|FG003|Double Blind|Ongoing at cut-off date|0|||
33459366|NCT00098306|62832906|FG004|Double Blind|Ongoing at cut-off date|0|||
33459367|NCT00098306|62832907|FG005|Double Blind|Ongoing at cut-off date|0|||
33626566|NCT02018042|63027534|FG000|Overall Study|Withdrawal by Subject|1|||
33626567|NCT01813305|63027540|FG000|Overall Study|Withdrawal by Subject|12|||
33626568|NCT01813305|63027541|FG001|Overall Study|Withdrawal by Subject|5|||
33626569|NCT01813305|63027540|FG000|Overall Study|Safety Concern|4|||
33626570|NCT01813305|63027541|FG001|Overall Study|Safety Concern|0|||
33626571|NCT01813305|63027540|FG000|Overall Study|Ulcer became worse|4|||
33626572|NCT01813305|63027541|FG001|Overall Study|Ulcer became worse|0|||
33459368|NCT00098306|62832908|FG006|Double Blind|Ongoing at cut-off date|0|||
33459369|NCT00098306|62832902|FG000|Double Blind|Adverse Event|11|||
33459370|NCT00098306|62832903|FG001|Double Blind|Adverse Event|10|||
33459371|NCT00098306|62832904|FG002|Double Blind|Adverse Event|6|||
33459372|NCT00098306|62832905|FG003|Double Blind|Adverse Event|0|||
33459373|NCT00098306|62832906|FG004|Double Blind|Adverse Event|0|||
33459374|NCT00098306|62832907|FG005|Double Blind|Adverse Event|0|||
33459375|NCT00098306|62832908|FG006|Double Blind|Adverse Event|0|||
33459376|NCT00098306|62832902|FG000|Double Blind|Lack of Efficacy|43|||
33533254|NCT02817555|62923290|FG001|Overall Study|transplant|1|||
33626573|NCT01813305|63027540|FG000|Overall Study|Physician Decision|4|||
33626574|NCT01813305|63027541|FG001|Overall Study|Physician Decision|0|||
33533255|NCT02817555|62923289|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
33533256|NCT02817555|62923290|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
33533257|NCT02817087|62923298|FG000|Overall Study|Withdrawal by Subject|2|||
33533258|NCT02817087|62923299|FG001|Overall Study|Withdrawal by Subject|0|||
33533259|NCT02813577|62923305|FG000|Overall Study|Study terminated|4|||
33533260|NCT02815293|62923312|FG000|Overall Study|Study termination by sponsor|10|||
33533261|NCT02815293|62923313|FG001|Overall Study|Study termination by sponsor|7|||
33533262|NCT02815293|62923314|FG002|Overall Study|Study termination by sponsor|0|||
33533263|NCT02815293|62923312|FG000|Overall Study|Participants not randomized|0|||
33533264|NCT02815293|62923313|FG001|Overall Study|Participants not randomized|0|||
33533265|NCT02815293|62923314|FG002|Overall Study|Participants not randomized|18|||
33533266|NCT02815293|62923312|FG000|Overall Study|Adverse Event|0|||
33533267|NCT02815293|62923313|FG001|Overall Study|Adverse Event|1|||
33533268|NCT02815293|62923314|FG002|Overall Study|Adverse Event|0|||
33533269|NCT02813421|62923322|FG000|Overall Study|Withdrawal by Subject|1|||
33533270|NCT02813421|62923323|FG001|Overall Study|Withdrawal by Subject|2|||
33533271|NCT02813421|62923322|FG000|Overall Study|Lost to Follow-up|1|||
33533272|NCT02813421|62923323|FG001|Overall Study|Lost to Follow-up|1|||
33533273|NCT03672188|62923344|FG000|Overall Study|Withdrawal by Subject|0|||
33533274|NCT03672188|62923345|FG001|Overall Study|Withdrawal by Subject|0|||
33533275|NCT03672188|62923346|FG002|Overall Study|Withdrawal by Subject|0|||
33533276|NCT03672188|62923347|FG003|Overall Study|Withdrawal by Subject|3|||
33533277|NCT03672188|62923348|FG004|Overall Study|Withdrawal by Subject|0|||
33533278|NCT03672188|62923349|FG005|Overall Study|Withdrawal by Subject|0|||
33533279|NCT03672188|62923350|FG006|Overall Study|Withdrawal by Subject|0|||
33533280|NCT03672188|62923351|FG007|Overall Study|Withdrawal by Subject|0|||
33533281|NCT03672188|62923352|FG008|Overall Study|Withdrawal by Subject|0|||
33533282|NCT03672188|62923353|FG009|Overall Study|Withdrawal by Subject|0|||
33533283|NCT03672188|62923354|FG010|Overall Study|Withdrawal by Subject|0|||
33533284|NCT03672188|62923355|FG011|Overall Study|Withdrawal by Subject|0|||
33533285|NCT03672188|62923356|FG012|Overall Study|Withdrawal by Subject|0|||
33533286|NCT03672188|62923357|FG013|Overall Study|Withdrawal by Subject|0|||
33533287|NCT03672188|62923358|FG014|Overall Study|Withdrawal by Subject|0|||
33533288|NCT03672188|62923344|FG000|Overall Study|Death|0|||
33533289|NCT03672188|62923345|FG001|Overall Study|Death|0|||
33533290|NCT03672188|62923346|FG002|Overall Study|Death|0|||
33533291|NCT03672188|62923347|FG003|Overall Study|Death|0|||
33533292|NCT03672188|62923348|FG004|Overall Study|Death|0|||
33533293|NCT03672188|62923349|FG005|Overall Study|Death|0|||
33533294|NCT03672188|62923350|FG006|Overall Study|Death|0|||
33533295|NCT03672188|62923351|FG007|Overall Study|Death|0|||
33533296|NCT03672188|62923352|FG008|Overall Study|Death|0|||
33326026|NCT01161173|62702801|FG000|Overall Study|Progressive Disease|82|||
33326027|NCT01161173|62702801|FG000|Overall Study|Withdrawal of Consent|5|||
33459377|NCT00098306|62832903|FG001|Double Blind|Lack of Efficacy|34|||
33459378|NCT00098306|62832904|FG002|Double Blind|Lack of Efficacy|17|||
33459379|NCT00098306|62832905|FG003|Double Blind|Lack of Efficacy|0|||
33459380|NCT00098306|62832906|FG004|Double Blind|Lack of Efficacy|0|||
33459381|NCT00098306|62832907|FG005|Double Blind|Lack of Efficacy|0|||
33459382|NCT00098306|62832908|FG006|Double Blind|Lack of Efficacy|0|||
33459383|NCT00098306|62832902|FG000|Double Blind|Death|1|||
33459384|NCT00098306|62832903|FG001|Double Blind|Death|4|||
33459385|NCT00098306|62832904|FG002|Double Blind|Death|1|||
33459386|NCT00098306|62832905|FG003|Double Blind|Death|0|||
33459387|NCT00098306|62832906|FG004|Double Blind|Death|0|||
33459388|NCT00098306|62832907|FG005|Double Blind|Death|0|||
33459389|NCT00098306|62832908|FG006|Double Blind|Death|0|||
33459390|NCT00098306|62832902|FG000|Double Blind|Participant defaulted|19|||
33459391|NCT00098306|62832903|FG001|Double Blind|Participant defaulted|18|||
33459392|NCT00098306|62832904|FG002|Double Blind|Participant defaulted|11|||
33459393|NCT00098306|62832905|FG003|Double Blind|Participant defaulted|0|||
33459394|NCT00098306|62832906|FG004|Double Blind|Participant defaulted|0|||
33459395|NCT00098306|62832907|FG005|Double Blind|Participant defaulted|0|||
33459396|NCT00098306|62832908|FG006|Double Blind|Participant defaulted|0|||
33459397|NCT00098306|62832902|FG000|Double Blind|Un-specified|7|||
33459398|NCT00098306|62832903|FG001|Double Blind|Un-specified|3|||
33459399|NCT00098306|62832904|FG002|Double Blind|Un-specified|11|||
33459400|NCT00098306|62832905|FG003|Double Blind|Un-specified|0|||
33459401|NCT00098306|62832906|FG004|Double Blind|Un-specified|0|||
33459402|NCT00098306|62832907|FG005|Double Blind|Un-specified|0|||
33459403|NCT00098306|62832908|FG006|Double Blind|Un-specified|0|||
33459404|NCT00098306|62832902|FG000|Open Label|Lack of Efficacy|0|||
33459405|NCT00098306|62832903|FG001|Open Label|Lack of Efficacy|0|||
33459406|NCT00098306|62832904|FG002|Open Label|Lack of Efficacy|0|||
33459407|NCT00098306|62832905|FG003|Open Label|Lack of Efficacy|13|||
33459408|NCT00098306|62832906|FG004|Open Label|Lack of Efficacy|0|||
33459409|NCT00098306|62832907|FG005|Open Label|Lack of Efficacy|0|||
33459410|NCT00098306|62832908|FG006|Open Label|Lack of Efficacy|0|||
33459411|NCT00098306|62832902|FG000|Open Label|Adverse Event|0|||
33626575|NCT01813305|63027540|FG000|Overall Study|Lost to Follow-up|3|||
33626576|NCT01813305|63027541|FG001|Overall Study|Lost to Follow-up|1|||
33626577|NCT01813305|63027540|FG000|Overall Study|Protocol Violation|1|||
33626578|NCT01813305|63027541|FG001|Overall Study|Protocol Violation|0|||
33626579|NCT01813305|63027540|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
33626580|NCT01813305|63027541|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
33533297|NCT03672188|62923353|FG009|Overall Study|Death|0|||
33533298|NCT03672188|62923354|FG010|Overall Study|Death|0|||
33533299|NCT03672188|62923355|FG011|Overall Study|Death|0|||
33533300|NCT03672188|62923356|FG012|Overall Study|Death|1|||
33533301|NCT03672188|62923357|FG013|Overall Study|Death|0|||
33533302|NCT03672188|62923358|FG014|Overall Study|Death|0|||
33533303|NCT03672188|62923344|FG000|Overall Study|Lost to Follow-up|0|||
33533304|NCT03672188|62923345|FG001|Overall Study|Lost to Follow-up|0|||
33533305|NCT03672188|62923346|FG002|Overall Study|Lost to Follow-up|1|||
33533306|NCT03672188|62923347|FG003|Overall Study|Lost to Follow-up|0|||
33533307|NCT03672188|62923348|FG004|Overall Study|Lost to Follow-up|0|||
33533308|NCT03672188|62923349|FG005|Overall Study|Lost to Follow-up|0|||
33533309|NCT03672188|62923350|FG006|Overall Study|Lost to Follow-up|0|||
33533310|NCT03672188|62923351|FG007|Overall Study|Lost to Follow-up|0|||
33533311|NCT03672188|62923352|FG008|Overall Study|Lost to Follow-up|0|||
33533312|NCT03672188|62923353|FG009|Overall Study|Lost to Follow-up|0|||
33533313|NCT03672188|62923354|FG010|Overall Study|Lost to Follow-up|0|||
33533314|NCT03672188|62923355|FG011|Overall Study|Lost to Follow-up|0|||
33533315|NCT03672188|62923356|FG012|Overall Study|Lost to Follow-up|0|||
33533316|NCT03672188|62923357|FG013|Overall Study|Lost to Follow-up|0|||
33533317|NCT03672188|62923358|FG014|Overall Study|Lost to Follow-up|0|||
33533318|NCT02620384|62923426|FG000|Overall Study|Adverse Event|2|||
33533319|NCT02620384|62923427|FG001|Overall Study|Adverse Event|1|||
33626581|NCT01993940|63027551|FG000|Overall Study|Adverse Event|16|||
33626582|NCT01993940|63027552|FG001|Overall Study|Adverse Event|11|||
33626583|NCT01993940|63027551|FG000|Overall Study|Withdrawal by Subject|15|||
33626584|NCT01993940|63027552|FG001|Overall Study|Withdrawal by Subject|19|||
33626585|NCT01993940|63027551|FG000|Overall Study|Lost to Follow-up|2|||
33626586|NCT01993940|63027552|FG001|Overall Study|Lost to Follow-up|5|||
33626587|NCT01993940|63027551|FG000|Overall Study|Protocol Violation|5|||
33626588|NCT01993940|63027552|FG001|Overall Study|Protocol Violation|8|||
33626589|NCT01993940|63027551|FG000|Overall Study|Death|1|||
33626590|NCT01993940|63027552|FG001|Overall Study|Death|0|||
33626591|NCT01993940|63027551|FG000|Overall Study|Other - Miscellaneous|1|||
33626592|NCT01993940|63027552|FG001|Overall Study|Other - Miscellaneous|1|||
33626593|NCT01843803|63027560|FG000|Overall Study|not a Veteran, did not see provider|1|||
33626594|NCT01843803|63027561|FG001|Overall Study|not a Veteran, did not see provider|3|||
33626595|NCT02017171|63027569|FG000|Overall Study|Death|10|||
33459412|NCT00098306|62832903|FG001|Open Label|Adverse Event|0|||
33533320|NCT02620384|62923426|FG000|Overall Study|Discharged prior to 2nd dose|2|||
33533321|NCT02620384|62923427|FG001|Overall Study|Discharged prior to 2nd dose|5|||
33533322|NCT02620384|62923426|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
33533323|NCT02620384|62923427|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
33533324|NCT03915860|62923433|FG000|Overall Study|Adverse Event|3|||
33533325|NCT03915860|62923433|FG000|Overall Study|Withdrawal by Subject|6|||
33533326|NCT03915860|62923433|FG000|Overall Study|Lost to Follow-up|2|||
33533327|NCT03915860|62923433|FG000|Overall Study|Other than specified|3|||
33533328|NCT05047211|62923448|FG000|Overall Study|Lost to Follow-up|8|||
33533329|NCT05047211|62923449|FG001|Overall Study|Lost to Follow-up|5|||
33533330|NCT04958642|62923458|FG000|Overall Study|Transferred to OLEX program|3|||
33533331|NCT04958642|62923459|FG001|Overall Study|Transferred to OLEX program|0|||
33533332|NCT04958642|62923460|FG002|Overall Study|Transferred to OLEX program|5|||
33533333|NCT04958642|62923458|FG000|Overall Study|Death|0|||
33533334|NCT04958642|62923459|FG001|Overall Study|Death|0|||
33328315|NCT01134263|62704716|FG004|Overall Study|Protocol Violation|2|||
33459413|NCT00098306|62832904|FG002|Open Label|Adverse Event|0|||
33459414|NCT00098306|62832905|FG003|Open Label|Adverse Event|2|||
33459415|NCT00098306|62832906|FG004|Open Label|Adverse Event|0|||
33459416|NCT00098306|62832907|FG005|Open Label|Adverse Event|0|||
33459417|NCT00098306|62832908|FG006|Open Label|Adverse Event|0|||
33459418|NCT00098306|62832902|FG000|Open Label|Death|0|||
33459419|NCT00098306|62832903|FG001|Open Label|Death|0|||
33459420|NCT00098306|62832904|FG002|Open Label|Death|0|||
33459421|NCT00098306|62832905|FG003|Open Label|Death|4|||
33459422|NCT00098306|62832906|FG004|Open Label|Death|0|||
33459423|NCT00098306|62832907|FG005|Open Label|Death|0|||
33459424|NCT00098306|62832908|FG006|Open Label|Death|0|||
33459425|NCT00098306|62832902|FG000|Open Label|Participant defaulted|0|||
33533335|NCT04958642|62923460|FG002|Overall Study|Death|1|||
33533336|NCT04958642|62923458|FG000|Overall Study|Withdrawal by Subject|4|||
33533337|NCT04958642|62923459|FG001|Overall Study|Withdrawal by Subject|9|||
33533338|NCT04958642|62923460|FG002|Overall Study|Withdrawal by Subject|13|||
33626596|NCT02017171|63027570|FG001|Overall Study|Death|4|||
33533339|NCT04958642|62923458|FG000|Overall Study|Investigator's Decision|0|||
33533340|NCT04958642|62923459|FG001|Overall Study|Investigator's Decision|0|||
33533341|NCT04958642|62923460|FG002|Overall Study|Investigator's Decision|1|||
33533342|NCT04958642|62923458|FG000|Overall Study|Adverse Event|1|||
33533343|NCT04958642|62923459|FG001|Overall Study|Adverse Event|0|||
33533344|NCT04958642|62923460|FG002|Overall Study|Adverse Event|1|||
33533345|NCT04958642|62923458|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
33533346|NCT04958642|62923459|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
33533347|NCT04958642|62923460|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
33533348|NCT04958642|62923458|FG000|Overall Study|Lost to Follow-up|1|||
33533349|NCT04958642|62923459|FG001|Overall Study|Lost to Follow-up|0|||
33533350|NCT04958642|62923460|FG002|Overall Study|Lost to Follow-up|0|||
33533351|NCT04958642|62923458|FG000|Overall Study|Transferred to EAP following study termination|0|||
33533352|NCT04958642|62923459|FG001|Overall Study|Transferred to EAP following study termination|0|||
33533353|NCT04958642|62923460|FG002|Overall Study|Transferred to EAP following study termination|1|||
33533354|NCT04958642|62923458|FG000|Overall Study|Transferred to Expanded Access Program|1|||
33533355|NCT04958642|62923459|FG001|Overall Study|Transferred to Expanded Access Program|0|||
33533356|NCT04958642|62923460|FG002|Overall Study|Transferred to Expanded Access Program|0|||
33533357|NCT04439357|62923468|FG000|Overall Study|Disease Progression|4|||
33533358|NCT04321343|62923476|FG000|Overall Study|Adverse Event|0|||
33533359|NCT04321343|62923477|FG001|Overall Study|Adverse Event|0|||
33533360|NCT04321343|62923478|FG002|Overall Study|Adverse Event|1|||
33533361|NCT04321343|62923479|FG003|Overall Study|Adverse Event|0|||
33533362|NCT04321343|62923476|FG000|Overall Study|Death|0|||
33533363|NCT04321343|62923477|FG001|Overall Study|Death|0|||
33533364|NCT04321343|62923478|FG002|Overall Study|Death|0|||
33533365|NCT04321343|62923479|FG003|Overall Study|Death|1|||
33533366|NCT04321343|62923476|FG000|Overall Study|Pregnancy|1|||
33533367|NCT04321343|62923477|FG001|Overall Study|Pregnancy|0|||
33533368|NCT04321343|62923478|FG002|Overall Study|Pregnancy|0|||
33533369|NCT04321343|62923479|FG003|Overall Study|Pregnancy|0|||
33533370|NCT04321343|62923476|FG000|Overall Study|Protocol Violation|1|||
33533371|NCT04321343|62923477|FG001|Overall Study|Protocol Violation|1|||
33533372|NCT04321343|62923478|FG002|Overall Study|Protocol Violation|1|||
33533373|NCT04321343|62923479|FG003|Overall Study|Protocol Violation|1|||
33533374|NCT04321343|62923476|FG000|Overall Study|Withdrawal by Subject|0|||
33533375|NCT04321343|62923477|FG001|Overall Study|Withdrawal by Subject|6|||
33533376|NCT04321343|62923478|FG002|Overall Study|Withdrawal by Subject|0|||
33533377|NCT04321343|62923479|FG003|Overall Study|Withdrawal by Subject|2|||
33533378|NCT04321343|62923476|FG000|Overall Study|Lost to Follow-up|2|||
33533379|NCT04321343|62923477|FG001|Overall Study|Lost to Follow-up|2|||
33533380|NCT04321343|62923478|FG002|Overall Study|Lost to Follow-up|1|||
33533381|NCT04321343|62923479|FG003|Overall Study|Lost to Follow-up|3|||
33533382|NCT04238754|62923493|FG000|Washout - 1 Week|Lost to Follow-up|1|||
33533383|NCT04238754|62923494|FG001|Washout - 1 Week|Lost to Follow-up|0|||
33533384|NCT04150068|62923516|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
33533385|NCT04150068|62923517|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
33533386|NCT04150068|62923518|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
33533387|NCT04150068|62923516|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
33533388|NCT04150068|62923517|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
33533389|NCT04150068|62923518|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
33533390|NCT03920293|62923527|FG000|Overall Study|Withdrawal by Subject|2|||
33533391|NCT03920293|62923528|FG001|Overall Study|Withdrawal by Subject|1|||
33533392|NCT03920293|62923527|FG000|Overall Study|Physician Decision|1|||
33533393|NCT03920293|62923528|FG001|Overall Study|Physician Decision|2|||
33533394|NCT03920293|62923527|FG000|Overall Study|Adverse Event|0|||
33533395|NCT03920293|62923528|FG001|Overall Study|Adverse Event|2|||
33533396|NCT03920293|62923527|FG000|Overall Study|Sponsor Decision|0|||
33533397|NCT03920293|62923528|FG001|Overall Study|Sponsor Decision|1|||
33533398|NCT03920293|62923527|FG000|Overall Study|Death|2|||
33533399|NCT03920293|62923528|FG001|Overall Study|Death|0|||
33533400|NCT03920293|62923527|FG000|Overall Study|Protocol Violation|1|||
33533401|NCT03920293|62923528|FG001|Overall Study|Protocol Violation|0|||
33533402|NCT03920293|62923527|FG000|Overall Study|Noncompliance|1|||
33533403|NCT03920293|62923528|FG001|Overall Study|Noncompliance|0|||
33533404|NCT03602586|62923543|FG000|Overall Study|Withdrawal by Subject|3|||
33533405|NCT03478956|62923549|FG000|Overall Study|Adverse Event|1|||
33533406|NCT03478956|62923550|FG001|Overall Study|Adverse Event|0|||
33533407|NCT03478956|62923549|FG000|Overall Study|Withdrawal by Subject|0|||
33533408|NCT03478956|62923550|FG001|Overall Study|Withdrawal by Subject|1|||
33533409|NCT03478956|62923549|FG000|Overall Study|Ongoing in the Study|11|||
33533410|NCT03478956|62923550|FG001|Overall Study|Ongoing in the Study|11|||
33533411|NCT03317496|62923564|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
33533412|NCT03317496|62923565|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
33533413|NCT03317496|62923566|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
33533414|NCT03317496|62923567|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
33626597|NCT02017171|63027569|FG000|Overall Study|Withdrawal by Subject|23|||
33626598|NCT02017171|63027570|FG001|Overall Study|Withdrawal by Subject|17|||
33626599|NCT02017171|63027569|FG000|Overall Study|Lost to Follow-up|21|||
33626600|NCT02017171|63027570|FG001|Overall Study|Lost to Follow-up|20|||
33626601|NCT02017171|63027569|FG000|Overall Study|ESKD|6|||
33626602|NCT02017171|63027570|FG001|Overall Study|ESKD|2|||
33626603|NCT02017171|63027569|FG000|Overall Study|Miscellaneous|2|||
33626604|NCT02017171|63027570|FG001|Overall Study|Miscellaneous|3|||
33626605|NCT02029417|63027577|FG000|Overall Study|Death|1|||
33626606|NCT02029417|63027577|FG000|Overall Study|Adverse Event|1|||
33626607|NCT02016716|63027584|FG000|Overall Study|Withdrawal by Subject|5|||
33626608|NCT02016716|63027585|FG001|Overall Study|Withdrawal by Subject|5|||
33626609|NCT02016716|63027586|FG002|Overall Study|Withdrawal by Subject|5|||
33626610|NCT02016716|63027584|FG000|Overall Study|Protocol-specified Criteria|0|||
33626611|NCT02016716|63027585|FG001|Overall Study|Protocol-specified Criteria|1|||
33626612|NCT02016716|63027586|FG002|Overall Study|Protocol-specified Criteria|0|||
33626613|NCT02016716|63027584|FG000|Overall Study|Lost to Follow-up|1|||
33626614|NCT02016716|63027585|FG001|Overall Study|Lost to Follow-up|2|||
33626615|NCT02016716|63027586|FG002|Overall Study|Lost to Follow-up|1|||
33626616|NCT02050321|63027595|FG000|Overall Study|Withdrawal by Subject|1|||
33626617|NCT02050321|63027595|FG000|Overall Study|Adverse Event|1|||
33626618|NCT02039414|63027601|FG000|Overall Study|Delivered|1|||
33626619|NCT02039414|63027602|FG001|Overall Study|Delivered|1|||
33626620|NCT02039414|63027601|FG000|Overall Study|Lost to Follow-up|2|||
33626621|NCT02039414|63027602|FG001|Overall Study|Lost to Follow-up|0|||
33626622|NCT02039414|63027601|FG000|Overall Study|Protocol Violation|3|||
33626623|NCT02039414|63027602|FG001|Overall Study|Protocol Violation|1|||
33626624|NCT02017015|63027608|FG000|Overall Study|Adverse Event|9|||
33626625|NCT02017015|63027608|FG000|Overall Study|Withdrawal by Subject|21|||
33626626|NCT02017015|63027608|FG000|Overall Study|Death|4|||
33626627|NCT02017015|63027608|FG000|Overall Study|Progressive Disease|31|||
33626628|NCT02017015|63027608|FG000|Overall Study|Non-compliance with study drug|2|||
33626629|NCT02017015|63027608|FG000|Overall Study|Physician Decision|2|||
33626630|NCT02016625|63027615|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
33626631|NCT02016625|63027616|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
33626632|NCT02016625|63027615|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
33626633|NCT02016625|63027616|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
33626634|NCT02016625|63027615|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
33626635|NCT02016625|63027616|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
33626636|NCT02016482|63027634|FG000|Period A|Adverse Event|3|||
33626637|NCT02016482|63027635|FG001|Period A|Adverse Event|5|||
33626638|NCT02016482|63027634|FG000|Period A|Withdrawal by Subject|3|||
33626639|NCT02016482|63027635|FG001|Period A|Withdrawal by Subject|4|||
33626640|NCT02016482|63027634|FG000|Period A|Lost to Follow-up|3|||
33626641|NCT02016482|63027635|FG001|Period A|Lost to Follow-up|3|||
33626642|NCT02016482|63027634|FG000|Period A|Lack of Efficacy|2|||
33626643|NCT02016482|63027635|FG001|Period A|Lack of Efficacy|1|||
33626644|NCT02016482|63027634|FG000|Period A|Other|3|||
33626645|NCT02016482|63027635|FG001|Period A|Other|0|||
33626646|NCT02016482|63027634|FG000|Period A|Protocol Violation|0|||
33626647|NCT02016482|63027635|FG001|Period A|Protocol Violation|1|||
33626648|NCT02016482|63027634|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
33626649|NCT02016482|63027635|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
33626650|NCT02016482|63027634|FG000|Period B|Withdrawal by Subject|1|||
33626651|NCT02016482|63027635|FG001|Period B|Withdrawal by Subject|1|||
33626652|NCT02016482|63027634|FG000|Period B|Lost to Follow-up|2|||
33626653|NCT02016482|63027635|FG001|Period B|Lost to Follow-up|0|||
33626654|NCT02016482|63027634|FG000|Period B|Lack of Efficacy|6|||
33626655|NCT02016482|63027635|FG001|Period B|Lack of Efficacy|4|||
33626656|NCT02016482|63027634|FG000|Period B|Other|4|||
33626657|NCT02016482|63027635|FG001|Period B|Other|0|||
33626658|NCT02016482|63027634|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
33626659|NCT02016482|63027635|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
33626660|NCT02028871|63027645|FG000|Overall Study|Positive urine drug screen|1|||
33626661|NCT02028871|63027646|FG001|Overall Study|Positive urine drug screen|1|||
33626662|NCT02028871|63027645|FG000|Overall Study|Withdrawal by Subject|1|||
33459426|NCT00098306|62832903|FG001|Open Label|Participant defaulted|0|||
33459427|NCT00098306|62832904|FG002|Open Label|Participant defaulted|0|||
33459428|NCT00098306|62832905|FG003|Open Label|Participant defaulted|24|||
33459429|NCT00098306|62832906|FG004|Open Label|Participant defaulted|0|||
33459430|NCT00098306|62832907|FG005|Open Label|Participant defaulted|0|||
33459431|NCT00098306|62832908|FG006|Open Label|Participant defaulted|0|||
33459432|NCT00098306|62832902|FG000|Open Label|Un-specified|0|||
33459433|NCT00098306|62832903|FG001|Open Label|Un-specified|0|||
33459434|NCT00098306|62832904|FG002|Open Label|Un-specified|0|||
33459435|NCT00098306|62832905|FG003|Open Label|Un-specified|15|||
33459436|NCT00098306|62832906|FG004|Open Label|Un-specified|0|||
33626663|NCT02028871|63027646|FG001|Overall Study|Withdrawal by Subject|2|||
33328316|NCT01134263|62704712|FG000|Overall Study|Lost to Follow-up|4|||
33626664|NCT02028871|63027645|FG000|Overall Study|IV placement difficulty|1|||
33626665|NCT02028871|63027646|FG001|Overall Study|IV placement difficulty|0|||
33626666|NCT02028871|63027645|FG000|Overall Study|Current Illness|1|||
33626667|NCT02028871|63027646|FG001|Overall Study|Current Illness|0|||
33626668|NCT02028715|63027657|FG000|Overall Study|Adverse Event|2|||
33626669|NCT02028715|63027658|FG001|Overall Study|Adverse Event|2|||
33626670|NCT02028715|63027657|FG000|Overall Study|Physician Decision|1|||
33626671|NCT02028715|63027658|FG001|Overall Study|Physician Decision|0|||
33626672|NCT02028715|63027657|FG000|Overall Study|Did not complete satisfaction surveys|2|||
33626673|NCT02028715|63027658|FG001|Overall Study|Did not complete satisfaction surveys|2|||
33626674|NCT02016170|63027667|FG000|Overall Study|Adverse Event|1|||
33533415|NCT03317496|62923568|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
33533416|NCT03317496|62923564|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
33533417|NCT03317496|62923565|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
33533418|NCT03317496|62923566|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
33533419|NCT03317496|62923567|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
33533420|NCT03317496|62923568|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
33533421|NCT03317496|62923564|FG000|Phase 1b Lead-in: Treatment|Death|0|||
33533422|NCT03317496|62923565|FG001|Phase 1b Lead-in: Treatment|Death|0|||
33533423|NCT03317496|62923566|FG002|Phase 1b Lead-in: Treatment|Death|1|||
33533424|NCT03317496|62923567|FG003|Phase 1b Lead-in: Treatment|Death|0|||
33533425|NCT03317496|62923568|FG004|Phase 1b Lead-in: Treatment|Death|0|||
33533426|NCT03317496|62923564|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
33533427|NCT03317496|62923565|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
33533428|NCT03317496|62923566|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
33533429|NCT03317496|62923567|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
33533430|NCT03317496|62923568|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
33533431|NCT03317496|62923564|FG000|Phase 1b Lead-in: Treatment|Other|2|||
33533432|NCT03317496|62923565|FG001|Phase 1b Lead-in: Treatment|Other|1|||
33533433|NCT03317496|62923566|FG002|Phase 1b Lead-in: Treatment|Other|0|||
33626675|NCT02016170|63027668|FG001|Overall Study|Adverse Event|1|||
33626676|NCT02016170|63027669|FG002|Overall Study|Adverse Event|0|||
33626677|NCT02016170|63027667|FG000|Overall Study|Protocol Violation|1|||
33626678|NCT02016170|63027668|FG001|Overall Study|Protocol Violation|0|||
33626679|NCT02016170|63027669|FG002|Overall Study|Protocol Violation|0|||
33626680|NCT02028169|63027676|FG000|Overall Study|Lost to Follow-up|21|||
33626681|NCT02028169|63027676|FG000|Overall Study|Lack of Efficacy|2|||
33626682|NCT02028169|63027676|FG000|Overall Study|Withdrawal by Subject|2|||
33626683|NCT02028169|63027676|FG000|Overall Study|Adverse Event|1|||
33459437|NCT00098306|62832907|FG005|Open Label|Un-specified|0|||
33459438|NCT00098306|62832908|FG006|Open Label|Un-specified|0|||
33459439|NCT00098306|62832902|FG000|Open Label|Ongoing at cut-off date|0|||
33459440|NCT00098306|62832903|FG001|Open Label|Ongoing at cut-off date|0|||
33459441|NCT00098306|62832904|FG002|Open Label|Ongoing at cut-off date|0|||
33459442|NCT00098306|62832905|FG003|Open Label|Ongoing at cut-off date|269|||
33459443|NCT00098306|62832906|FG004|Open Label|Ongoing at cut-off date|62|||
33459444|NCT00098306|62832907|FG005|Open Label|Ongoing at cut-off date|0|||
33459445|NCT00098306|62832908|FG006|Open Label|Ongoing at cut-off date|0|||
33459446|NCT00098306|62832902|FG000|Observational Phase|Death|0|||
33459447|NCT00098306|62832903|FG001|Observational Phase|Death|0|||
33459448|NCT00098306|62832904|FG002|Observational Phase|Death|0|||
33459449|NCT00098306|62832905|FG003|Observational Phase|Death|0|||
33459450|NCT00098306|62832906|FG004|Observational Phase|Death|0|||
33459451|NCT00098306|62832907|FG005|Observational Phase|Death|5|||
33459452|NCT00098306|62832908|FG006|Observational Phase|Death|4|||
33459453|NCT00098306|62832902|FG000|Observational Phase|Participant defaulted|0|||
33459454|NCT00098306|62832903|FG001|Observational Phase|Participant defaulted|0|||
33459455|NCT00098306|62832904|FG002|Observational Phase|Participant defaulted|0|||
33459456|NCT00098306|62832905|FG003|Observational Phase|Participant defaulted|0|||
33533434|NCT03317496|62923567|FG003|Phase 1b Lead-in: Treatment|Other|0|||
33533435|NCT03317496|62923568|FG004|Phase 1b Lead-in: Treatment|Other|0|||
33626684|NCT02028169|63027676|FG000|Overall Study|Cessation of Drug|1|||
33626685|NCT02028169|63027676|FG000|Overall Study|Concomitant Medication Usage|1|||
33626686|NCT02015546|63027683|FG000|Overall Study|Withdrawal by Subject|1|||
33626687|NCT02015546|63027684|FG001|Overall Study|Withdrawal by Subject|1|||
33459457|NCT00098306|62832906|FG004|Observational Phase|Participant defaulted|0|||
33459458|NCT00098306|62832907|FG005|Observational Phase|Participant defaulted|34|||
33459459|NCT00098306|62832908|FG006|Observational Phase|Participant defaulted|18|||
33459460|NCT00098306|62832902|FG000|Observational Phase|Un-specified|0|||
33533436|NCT03317496|62923564|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
33533437|NCT03317496|62923565|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
33459461|NCT00098306|62832903|FG001|Observational Phase|Un-specified|0|||
33459462|NCT00098306|62832904|FG002|Observational Phase|Un-specified|0|||
33626688|NCT02015546|63027685|FG002|Overall Study|Withdrawal by Subject|1|||
33626689|NCT02015546|63027683|FG000|Overall Study|Screem Failure|2|||
33626690|NCT02015546|63027684|FG001|Overall Study|Screem Failure|1|||
33626691|NCT02015546|63027685|FG002|Overall Study|Screem Failure|3|||
33626692|NCT02027701|63027693|FG000|Overall Study|Adverse Event|3|||
33533438|NCT03317496|62923566|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
33533439|NCT03317496|62923567|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
33533440|NCT03317496|62923568|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
33533441|NCT03317496|62923564|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
33533442|NCT03317496|62923565|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
33533443|NCT03317496|62923566|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
33533444|NCT03317496|62923567|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
33533445|NCT03317496|62923568|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
33533446|NCT03317496|62923564|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
33533447|NCT03317496|62923565|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
33626693|NCT02027701|63027693|FG000|Overall Study|Lack of Efficacy|8|||
33626694|NCT02027701|63027693|FG000|Overall Study|Physician Decision|2|||
33626695|NCT02027701|63027693|FG000|Overall Study|Withdrawal by Subject|3|||
33626696|NCT02038790|63027699|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
33626697|NCT02038790|63027700|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
33626698|NCT02027623|63027709|FG000|Overall Study|Lost to Follow-up|3|||
33533448|NCT03317496|62923566|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
33533449|NCT03317496|62923567|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
33533450|NCT03317496|62923568|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
33533451|NCT03317496|62923564|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
33533452|NCT03317496|62923565|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
33533453|NCT03317496|62923566|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
33533454|NCT03317496|62923567|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
33533455|NCT03317496|62923568|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
33533456|NCT03317496|62923564|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
33533457|NCT03317496|62923565|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
33533458|NCT03317496|62923566|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
33533459|NCT03317496|62923567|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
33533460|NCT03317496|62923568|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
33533461|NCT03317496|62923564|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
33533462|NCT03317496|62923565|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
33533463|NCT03317496|62923566|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
33533464|NCT03317496|62923567|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
33533465|NCT03317496|62923568|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
33533466|NCT03317496|62923564|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
33459463|NCT00098306|62832905|FG003|Observational Phase|Un-specified|0|||
33459464|NCT00098306|62832906|FG004|Observational Phase|Un-specified|0|||
33533467|NCT03317496|62923565|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
33626699|NCT02027623|63027710|FG001|Overall Study|Lost to Follow-up|3|||
33626700|NCT02027623|63027709|FG000|Overall Study|Withdrawal by Subject|6|||
33626701|NCT02027623|63027710|FG001|Overall Study|Withdrawal by Subject|9|||
33626702|NCT02015221|63027719|FG000|Overall Study|Withdrawal by Subject|8|||
33626703|NCT02015221|63027720|FG001|Overall Study|Withdrawal by Subject|6|||
33626704|NCT02015221|63027719|FG000|Overall Study|Lost to Follow-up|1|||
33626705|NCT02015221|63027720|FG001|Overall Study|Lost to Follow-up|0|||
33626706|NCT02027311|63027728|FG000|Overall Study|Protocol Violation|3|||
33626707|NCT02027311|63027729|FG001|Overall Study|Protocol Violation|2|||
33626708|NCT02047903|63027737|FG000|Overall Study|Adverse Event|14|||
33626709|NCT02047903|63027737|FG000|Overall Study|Serious adverse event|10|||
33626710|NCT02047903|63027737|FG000|Overall Study|Withdrawal by Subject|16|||
33626711|NCT02047903|63027737|FG000|Overall Study|Lost to Follow-up|4|||
33626712|NCT02047903|63027737|FG000|Overall Study|Reason not listed|6|||
33626713|NCT02047903|63027737|FG000|Overall Study|Not Treated|9|||
33626714|NCT02015065|63027744|FG000|Overall Study|Death on study|1|||
33626715|NCT02015065|63027745|FG001|Overall Study|Death on study|2|||
33533468|NCT03317496|62923566|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
33533469|NCT03317496|62923567|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
33626716|NCT02015065|63027746|FG002|Overall Study|Death on study|1|||
33626717|NCT02026141|63027756|FG000|Overall Study|Protocol Violation|0|||
33626718|NCT02026141|63027757|FG001|Overall Study|Protocol Violation|1|||
33626719|NCT02026063|63027765|FG000|Overall Study|Physician Decision|0|||
33626720|NCT02026063|63027766|FG001|Overall Study|Physician Decision|10|||
33626721|NCT02026063|63027765|FG000|Overall Study|Noncompliance with Study Drug|1|||
33459465|NCT00098306|62832907|FG005|Observational Phase|Un-specified|7|||
33459466|NCT00098306|62832908|FG006|Observational Phase|Un-specified|4|||
33459467|NCT03615040|62832923|FG000|Overall Study|Withdrawal by Subject|2|||
33459468|NCT03615040|62832924|FG001|Overall Study|Withdrawal by Subject|1|||
33459469|NCT03615040|62832923|FG000|Overall Study|Physician Decision|2|||
33459470|NCT03615040|62832924|FG001|Overall Study|Physician Decision|2|||
33459471|NCT03615040|62832923|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
33459472|NCT03615040|62832924|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
33626722|NCT02026063|63027766|FG001|Overall Study|Noncompliance with Study Drug|1|||
33626723|NCT02026063|63027765|FG000|Overall Study|Withdrawal of Consent|1|||
33626724|NCT02026063|63027766|FG001|Overall Study|Withdrawal of Consent|6|||
33626725|NCT02026063|63027765|FG000|Overall Study|Adverse Event|5|||
33533470|NCT03317496|62923568|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
33533471|NCT03317496|62923564|FG000|Phase 2: Treatment|Adverse Event|0|||
33533472|NCT03317496|62923565|FG001|Phase 2: Treatment|Adverse Event|0|||
33533473|NCT03317496|62923566|FG002|Phase 2: Treatment|Adverse Event|0|||
33533474|NCT03317496|62923567|FG003|Phase 2: Treatment|Adverse Event|0|||
33533475|NCT03317496|62923568|FG004|Phase 2: Treatment|Adverse Event|6|||
33533476|NCT03317496|62923564|FG000|Phase 2: Treatment|Progressive disease|0|||
33533477|NCT03317496|62923565|FG001|Phase 2: Treatment|Progressive disease|0|||
33533478|NCT03317496|62923566|FG002|Phase 2: Treatment|Progressive disease|0|||
33533479|NCT03317496|62923567|FG003|Phase 2: Treatment|Progressive disease|0|||
33533480|NCT03317496|62923568|FG004|Phase 2: Treatment|Progressive disease|22|||
33533481|NCT03317496|62923564|FG000|Phase 2: Treatment|Other|0|||
33533482|NCT03317496|62923565|FG001|Phase 2: Treatment|Other|0|||
33533483|NCT03317496|62923566|FG002|Phase 2: Treatment|Other|0|||
33533484|NCT03317496|62923567|FG003|Phase 2: Treatment|Other|0|||
33533485|NCT03317496|62923568|FG004|Phase 2: Treatment|Other|4|||
33533486|NCT03317496|62923564|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
33533487|NCT03317496|62923565|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
33533488|NCT03317496|62923566|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
33533489|NCT03317496|62923567|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
33533490|NCT03317496|62923568|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
33533491|NCT03317496|62923564|FG000|Phase 2: Treatment|Physician Decision|0|||
33533492|NCT03317496|62923565|FG001|Phase 2: Treatment|Physician Decision|0|||
33533493|NCT03317496|62923566|FG002|Phase 2: Treatment|Physician Decision|0|||
33533494|NCT03317496|62923567|FG003|Phase 2: Treatment|Physician Decision|0|||
33533495|NCT03317496|62923568|FG004|Phase 2: Treatment|Physician Decision|1|||
33533496|NCT03317496|62923564|FG000|Phase 2: Treatment|Death|0|||
33533497|NCT03317496|62923565|FG001|Phase 2: Treatment|Death|0|||
33533498|NCT03317496|62923566|FG002|Phase 2: Treatment|Death|0|||
33533499|NCT03317496|62923567|FG003|Phase 2: Treatment|Death|0|||
33533500|NCT03317496|62923568|FG004|Phase 2: Treatment|Death|1|||
33533501|NCT03317496|62923564|FG000|Phase 2: Follow-up|Death|0|||
33533502|NCT03317496|62923565|FG001|Phase 2: Follow-up|Death|0|||
33533503|NCT03317496|62923566|FG002|Phase 2: Follow-up|Death|0|||
33533504|NCT03317496|62923567|FG003|Phase 2: Follow-up|Death|0|||
33533505|NCT03317496|62923568|FG004|Phase 2: Follow-up|Death|24|||
33533506|NCT03317496|62923564|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
33533507|NCT03317496|62923565|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
33533508|NCT03317496|62923566|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
33533509|NCT03317496|62923567|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
33533510|NCT03317496|62923568|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
33533511|NCT03317496|62923564|FG000|Phase 2: Follow-up|Other|0|||
33533512|NCT03317496|62923565|FG001|Phase 2: Follow-up|Other|0|||
33533513|NCT03317496|62923566|FG002|Phase 2: Follow-up|Other|0|||
33533514|NCT03317496|62923567|FG003|Phase 2: Follow-up|Other|0|||
33533515|NCT03317496|62923568|FG004|Phase 2: Follow-up|Other|1|||
33533516|NCT03317496|62923564|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
33533517|NCT03317496|62923565|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
33533518|NCT03317496|62923566|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
33533519|NCT03317496|62923567|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
33533520|NCT03317496|62923568|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
33533521|NCT03096782|62923579|FG000|Overall Study|Death|1|||
33533522|NCT03096782|62923579|FG000|Overall Study|Participant Relapsed|1|||
33533523|NCT02836249|62923594|FG000|Overall Study|Randomized but Never Treated|0|||
33533524|NCT02836249|62923595|FG001|Overall Study|Randomized but Never Treated|1|||
33533525|NCT02836249|62923594|FG000|Overall Study|Pregnancy|2|||
33533526|NCT02836249|62923595|FG001|Overall Study|Pregnancy|0|||
33533527|NCT02836249|62923594|FG000|Overall Study|Withdrew Consent|0|||
33533528|NCT02836249|62923595|FG001|Overall Study|Withdrew Consent|1|||
33533529|NCT02836249|62923594|FG000|Overall Study|Lost to Follow-up|0|||
33626726|NCT02026063|63027766|FG001|Overall Study|Adverse Event|20|||
33626727|NCT02026063|63027765|FG000|Overall Study|Lack of Efficacy|0|||
33626728|NCT02026063|63027766|FG001|Overall Study|Lack of Efficacy|4|||
33626729|NCT02026063|63027765|FG000|Overall Study|Lost to Follow-up|0|||
33626730|NCT02026063|63027766|FG001|Overall Study|Lost to Follow-up|1|||
33626731|NCT02026063|63027765|FG000|Overall Study|Reason not Specified|2|||
33626732|NCT02026063|63027766|FG001|Overall Study|Reason not Specified|7|||
33533530|NCT02836249|62923595|FG001|Overall Study|Lost to Follow-up|1|||
33533531|NCT02836249|62923594|FG000|Overall Study|Still on Study|121|||
33533532|NCT02836249|62923595|FG001|Overall Study|Still on Study|55|||
33533533|NCT02143414|62923607|FG000|Induction|Adverse Event|1|||
33533534|NCT02143414|62923608|FG001|Induction|Adverse Event|2|||
33533535|NCT02143414|62923607|FG000|Induction|Death|1|||
33533536|NCT02143414|62923608|FG001|Induction|Death|2|||
33533537|NCT02143414|62923607|FG000|Induction|Patient refusal|1|||
33533538|NCT02143414|62923608|FG001|Induction|Patient refusal|1|||
33533539|NCT02143414|62923607|FG000|Induction|Refractory|1|||
33533540|NCT02143414|62923608|FG001|Induction|Refractory|0|||
33626733|NCT02025907|63027775|FG000|Overall Study|Lack of Efficacy|1|||
33626734|NCT02025907|63027776|FG001|Overall Study|Lack of Efficacy|0|||
33459473|NCT03615040|62832923|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
33533541|NCT02143414|62923607|FG000|Induction|Began alternative treatment|1|||
33533542|NCT02143414|62923608|FG001|Induction|Began alternative treatment|0|||
33533543|NCT02143414|62923607|FG000|Induction|Ineligible for postremission|5|||
33533544|NCT02143414|62923608|FG001|Induction|Ineligible for postremission|1|||
33533545|NCT02143414|62923607|FG000|Post-remission|Adverse Event|0|||
33533546|NCT02143414|62923608|FG001|Post-remission|Adverse Event|2|||
33533547|NCT02143414|62923607|FG000|Post-remission|Disease progression/relapse|5|||
33533548|NCT02143414|62923608|FG001|Post-remission|Disease progression/relapse|0|||
33533549|NCT02143414|62923607|FG000|Maintenance|Adverse Event|4|||
33533550|NCT02143414|62923608|FG001|Maintenance|Adverse Event|6|||
33533551|NCT02143414|62923607|FG000|Maintenance|Disease progression/relapse|3|||
33533552|NCT02143414|62923608|FG001|Maintenance|Disease progression/relapse|2|||
33533553|NCT02143414|62923607|FG000|Maintenance|Patient refusal|2|||
33533554|NCT02143414|62923608|FG001|Maintenance|Patient refusal|1|||
33533555|NCT02143414|62923607|FG000|Maintenance|Physician Decision|1|||
33533556|NCT02143414|62923608|FG001|Maintenance|Physician Decision|0|||
33533557|NCT02143414|62923607|FG000|Maintenance|Death|0|||
33533558|NCT02143414|62923608|FG001|Maintenance|Death|1|||
33459474|NCT03615040|62832924|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
33459475|NCT03615040|62832923|FG000|Overall Study|Death|0|||
33533559|NCT02143414|62923607|FG000|Maintenance|On protocol treatment|0|||
33533560|NCT02143414|62923608|FG001|Maintenance|On protocol treatment|6|||
33533561|NCT02112916|62923629|FG000|Overall Study|Adverse Event|6|||
33533562|NCT02112916|62923630|FG001|Overall Study|Adverse Event|9|||
33533563|NCT02112916|62923631|FG002|Overall Study|Adverse Event|3|||
33533564|NCT02112916|62923632|FG003|Overall Study|Adverse Event|2|||
33533565|NCT02112916|62923629|FG000|Overall Study|Death|9|||
33533566|NCT02112916|62923630|FG001|Overall Study|Death|9|||
33533567|NCT02112916|62923631|FG002|Overall Study|Death|3|||
33533568|NCT02112916|62923632|FG003|Overall Study|Death|4|||
33533569|NCT02112916|62923629|FG000|Overall Study|Lost to Follow-up|1|||
33533570|NCT02112916|62923630|FG001|Overall Study|Lost to Follow-up|0|||
33533571|NCT02112916|62923631|FG002|Overall Study|Lost to Follow-up|0|||
33533572|NCT02112916|62923632|FG003|Overall Study|Lost to Follow-up|0|||
33533573|NCT02112916|62923629|FG000|Overall Study|Physician Decision|94|||
33533574|NCT02112916|62923630|FG001|Overall Study|Physician Decision|72|||
33533575|NCT02112916|62923631|FG002|Overall Study|Physician Decision|24|||
33533576|NCT02112916|62923632|FG003|Overall Study|Physician Decision|15|||
33533577|NCT02112916|62923629|FG000|Overall Study|Withdrawal by Subject|5|||
33533578|NCT02112916|62923630|FG001|Overall Study|Withdrawal by Subject|3|||
33533579|NCT02112916|62923631|FG002|Overall Study|Withdrawal by Subject|1|||
33533580|NCT02112916|62923632|FG003|Overall Study|Withdrawal by Subject|1|||
33533581|NCT02112916|62923629|FG000|Overall Study|Ineligible|4|||
33533582|NCT02112916|62923630|FG001|Overall Study|Ineligible|8|||
33533583|NCT02112916|62923631|FG002|Overall Study|Ineligible|3|||
33533584|NCT02112916|62923632|FG003|Overall Study|Ineligible|8|||
33533585|NCT02112916|62923629|FG000|Overall Study|Inevaluable|6|||
33328317|NCT01134263|62704713|FG001|Overall Study|Lost to Follow-up|3|||
33459476|NCT03615040|62832924|FG001|Overall Study|Death|2|||
33459477|NCT00068822|62832932|FG000|First Randomized Intervention|Lost to Follow-up|1|||
33459478|NCT00068822|62832933|FG001|First Randomized Intervention|Lost to Follow-up|2|||
33459479|NCT00068588|62832942|FG000|Overall Study|Adverse Event|0|||
33459480|NCT00068588|62832943|FG001|Overall Study|Adverse Event|0|||
33459481|NCT00068588|62832944|FG002|Overall Study|Adverse Event|2|||
33459482|NCT00068588|62832942|FG000|Overall Study|Withdrawal by Subject|0|||
33459483|NCT00068588|62832943|FG001|Overall Study|Withdrawal by Subject|0|||
33459484|NCT00068588|62832944|FG002|Overall Study|Withdrawal by Subject|1|||
33459485|NCT00068588|62832942|FG000|Overall Study|Poor KPS|0|||
33459486|NCT00068588|62832943|FG001|Overall Study|Poor KPS|0|||
33459487|NCT00068588|62832944|FG002|Overall Study|Poor KPS|1|||
33459488|NCT03650452|62832953|FG000|Overall Study|Physician Decision|1|||
33459489|NCT03650452|62832954|FG001|Overall Study|Physician Decision|0|||
33459490|NCT03650452|62832953|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
33459491|NCT03650452|62832954|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33459492|NCT03650452|62832953|FG000|Overall Study|Adverse Event|3|||
33533586|NCT02112916|62923630|FG001|Overall Study|Inevaluable|4|||
33533587|NCT02112916|62923631|FG002|Overall Study|Inevaluable|5|||
33533588|NCT02112916|62923632|FG003|Overall Study|Inevaluable|5|||
33533589|NCT02112916|62923629|FG000|Overall Study|Refusal of further protocol therapy|19|||
33533590|NCT02112916|62923630|FG001|Overall Study|Refusal of further protocol therapy|16|||
33533591|NCT02112916|62923631|FG002|Overall Study|Refusal of further protocol therapy|1|||
33533592|NCT02112916|62923632|FG003|Overall Study|Refusal of further protocol therapy|7|||
33533593|NCT02112916|62923629|FG000|Overall Study|Development of SMN|1|||
33533594|NCT02112916|62923630|FG001|Overall Study|Development of SMN|0|||
33533595|NCT02112916|62923631|FG002|Overall Study|Development of SMN|0|||
33533596|NCT02112916|62923632|FG003|Overall Study|Development of SMN|1|||
33533597|NCT02112916|62923629|FG000|Overall Study|Relapse/Progression|10|||
33533598|NCT02112916|62923630|FG001|Overall Study|Relapse/Progression|18|||
33533599|NCT02112916|62923631|FG002|Overall Study|Relapse/Progression|15|||
33459493|NCT03650452|62832954|FG001|Overall Study|Adverse Event|4|||
33459494|NCT03650452|62832953|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
33533600|NCT02112916|62923632|FG003|Overall Study|Relapse/Progression|2|||
33533601|NCT02112916|62923629|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
33533602|NCT02112916|62923630|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
33626735|NCT02025907|63027775|FG000|Overall Study|Withdrawal by Subject|15|||
33626736|NCT02025907|63027776|FG001|Overall Study|Withdrawal by Subject|8|||
33626737|NCT02025907|63027775|FG000|Overall Study|Protocol Violation|2|||
33626738|NCT02025907|63027776|FG001|Overall Study|Protocol Violation|0|||
33626739|NCT02025907|63027775|FG000|Overall Study|Physician Decision|2|||
33626740|NCT02025907|63027776|FG001|Overall Study|Physician Decision|0|||
33626741|NCT02025907|63027775|FG000|Overall Study|Lost to Follow-up|2|||
33626742|NCT02025907|63027776|FG001|Overall Study|Lost to Follow-up|2|||
33626743|NCT02025907|63027775|FG000|Overall Study|Adverse Event|3|||
33626744|NCT02025907|63027776|FG001|Overall Study|Adverse Event|1|||
33626745|NCT02025907|63027775|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
33626746|NCT02025907|63027776|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
33626747|NCT01813071|63027791|FG000|Overall Study|Protocol Violation|0|||
33626748|NCT01813071|63027792|FG001|Overall Study|Protocol Violation|0|||
33626749|NCT01813071|63027793|FG002|Overall Study|Protocol Violation|0|||
33626750|NCT01813071|63027794|FG003|Overall Study|Protocol Violation|0|||
33626751|NCT01813071|63027795|FG004|Overall Study|Protocol Violation|1|||
33626752|NCT01813071|63027796|FG005|Overall Study|Protocol Violation|4|||
33626753|NCT01813071|63027797|FG006|Overall Study|Protocol Violation|2|||
33626754|NCT01813071|63027798|FG007|Overall Study|Protocol Violation|4|||
33626755|NCT01813071|63027799|FG008|Overall Study|Protocol Violation|2|||
33626756|NCT01813071|63027791|FG000|Overall Study|Withdrawal by Subject|0|||
33626757|NCT01813071|63027792|FG001|Overall Study|Withdrawal by Subject|0|||
33626758|NCT01813071|63027793|FG002|Overall Study|Withdrawal by Subject|0|||
33626759|NCT01813071|63027794|FG003|Overall Study|Withdrawal by Subject|0|||
33626760|NCT01813071|63027795|FG004|Overall Study|Withdrawal by Subject|0|||
33459495|NCT03650452|62832954|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
33533603|NCT02112916|62923631|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
33533604|NCT02112916|62923632|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
33533605|NCT02112916|62923629|FG000|Overall Study|Still on Therapy|44|||
33533606|NCT02112916|62923630|FG001|Overall Study|Still on Therapy|47|||
33533607|NCT02112916|62923631|FG002|Overall Study|Still on Therapy|3|||
33533608|NCT02112916|62923632|FG003|Overall Study|Still on Therapy|2|||
33533609|NCT02112916|62923629|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
33533610|NCT02112916|62923630|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
33533611|NCT02112916|62923631|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
33533612|NCT02112916|62923632|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
33533613|NCT02112916|62923629|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
33533614|NCT02112916|62923630|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
33533615|NCT02112916|62923631|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
33533616|NCT02112916|62923632|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
33533617|NCT01849562|62923650|FG000|Overall Study|Lost to Follow-up|1|||
33533618|NCT01849562|62923651|FG001|Overall Study|Lost to Follow-up|0|||
33533619|NCT01849562|62923652|FG002|Overall Study|Lost to Follow-up|0|||
33533620|NCT01849562|62923650|FG000|Overall Study|Non-compliance with Study Drug|1|||
33533621|NCT01849562|62923651|FG001|Overall Study|Non-compliance with Study Drug|0|||
33626761|NCT01813071|63027796|FG005|Overall Study|Withdrawal by Subject|1|||
33626762|NCT01813071|63027797|FG006|Overall Study|Withdrawal by Subject|0|||
33626763|NCT01813071|63027798|FG007|Overall Study|Withdrawal by Subject|0|||
33626764|NCT01813071|63027799|FG008|Overall Study|Withdrawal by Subject|0|||
33626765|NCT01813071|63027791|FG000|Overall Study|Adverse Event|0|||
33626766|NCT01813071|63027792|FG001|Overall Study|Adverse Event|0|||
33459496|NCT03575806|62832962|FG000|Overall Study|Withdrawal by Subject|0|||
33459497|NCT03575806|62832963|FG001|Overall Study|Withdrawal by Subject|2|||
33459498|NCT03575806|62832962|FG000|Overall Study|Protocol Violation|0|||
33459499|NCT03575806|62832963|FG001|Overall Study|Protocol Violation|2|||
33459500|NCT03610048|62832969|FG000|Overall Study|Study terminated by sponsor|84|||
33459501|NCT03610048|62832969|FG000|Overall Study|Adverse Event|32|||
33459502|NCT03610048|62832969|FG000|Overall Study|Withdrawal by Subject|31|||
33459503|NCT03610048|62832969|FG000|Overall Study|Lost to Follow-up|8|||
33626767|NCT01813071|63027793|FG002|Overall Study|Adverse Event|0|||
33459504|NCT03610048|62832969|FG000|Overall Study|Other|4|||
33459505|NCT03610048|62832969|FG000|Overall Study|Physician Decision|1|||
33459506|NCT03610048|62832969|FG000|Overall Study|Pregnancy|1|||
33464876|NCT00040664|62838368|FG000|Overall Study|Withdrawal by Subject|7|||
33626768|NCT01813071|63027794|FG003|Overall Study|Adverse Event|0|||
33626769|NCT01813071|63027795|FG004|Overall Study|Adverse Event|0|||
33626770|NCT01813071|63027796|FG005|Overall Study|Adverse Event|1|||
33533622|NCT01849562|62923652|FG002|Overall Study|Non-compliance with Study Drug|0|||
33533623|NCT01700179|62923661|FG000|Overall Study|Physician Decision|2|||
33533624|NCT00665223|62923677|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
33533625|NCT00665223|62923678|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
33533626|NCT00665223|62923679|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
33533627|NCT00665223|62923677|FG000|Randomized Phase (26 Weeks)|Death|0|||
33533628|NCT00665223|62923678|FG001|Randomized Phase (26 Weeks)|Death|0|||
33533629|NCT00665223|62923679|FG002|Randomized Phase (26 Weeks)|Death|1|||
33533630|NCT00665223|62923677|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
33533631|NCT00665223|62923678|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
33533632|NCT00665223|62923679|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
33533633|NCT00665223|62923677|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
33626771|NCT01813071|63027797|FG006|Overall Study|Adverse Event|0|||
33626772|NCT01813071|63027798|FG007|Overall Study|Adverse Event|0|||
33626773|NCT01813071|63027799|FG008|Overall Study|Adverse Event|0|||
33626774|NCT01813071|63027791|FG000|Overall Study|Physician Decision|0|||
33626775|NCT01813071|63027792|FG001|Overall Study|Physician Decision|0|||
33626776|NCT01813071|63027793|FG002|Overall Study|Physician Decision|0|||
33626777|NCT01813071|63027794|FG003|Overall Study|Physician Decision|0|||
33626778|NCT01813071|63027795|FG004|Overall Study|Physician Decision|0|||
33626779|NCT01813071|63027796|FG005|Overall Study|Physician Decision|0|||
33626780|NCT01813071|63027797|FG006|Overall Study|Physician Decision|1|||
33626781|NCT01813071|63027798|FG007|Overall Study|Physician Decision|0|||
33626782|NCT01813071|63027799|FG008|Overall Study|Physician Decision|0|||
33626783|NCT01813071|63027791|FG000|Overall Study|Met inc/exc criteria|0|||
33626784|NCT01813071|63027792|FG001|Overall Study|Met inc/exc criteria|0|||
33626785|NCT01813071|63027793|FG002|Overall Study|Met inc/exc criteria|0|||
33626786|NCT01813071|63027794|FG003|Overall Study|Met inc/exc criteria|0|||
33626787|NCT01813071|63027795|FG004|Overall Study|Met inc/exc criteria|0|||
33626788|NCT01813071|63027796|FG005|Overall Study|Met inc/exc criteria|1|||
33626789|NCT01813071|63027797|FG006|Overall Study|Met inc/exc criteria|0|||
33626790|NCT01813071|63027798|FG007|Overall Study|Met inc/exc criteria|1|||
33626791|NCT01813071|63027799|FG008|Overall Study|Met inc/exc criteria|1|||
33626792|NCT02025751|63027835|FG000|Overall Study|Lost to Follow-up|1|||
33626793|NCT02025751|63027836|FG001|Overall Study|Lost to Follow-up|0|||
33626794|NCT02025751|63027835|FG000|Overall Study|Adverse Event|0|||
33626795|NCT02025751|63027836|FG001|Overall Study|Adverse Event|1|||
33626796|NCT02025751|63027835|FG000|Overall Study|Physician Decision|0|||
33626797|NCT02025751|63027836|FG001|Overall Study|Physician Decision|1|||
33533634|NCT00665223|62923678|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
33533635|NCT00665223|62923679|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
33533636|NCT00665223|62923677|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
33533637|NCT00665223|62923678|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
33533638|NCT00665223|62923679|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
33533639|NCT00665223|62923677|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
33533640|NCT00665223|62923678|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
33533641|NCT00665223|62923679|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
33533642|NCT00665223|62923677|FG000|Open-Label Period (26 Weeks)|Death|0|||
33533643|NCT00665223|62923678|FG001|Open-Label Period (26 Weeks)|Death|1|||
33533644|NCT00665223|62923679|FG002|Open-Label Period (26 Weeks)|Death|0|||
33533645|NCT00665223|62923677|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
33533646|NCT00665223|62923678|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
33533647|NCT00665223|62923679|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
33533648|NCT00665223|62923677|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
33533649|NCT00665223|62923678|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
33533650|NCT00665223|62923679|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
33533651|NCT00665223|62923677|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
33533652|NCT00665223|62923678|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
33533653|NCT00665223|62923679|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
33626798|NCT02025751|63027835|FG000|Overall Study|Withdrawal by Subject|0|||
33626799|NCT02025751|63027836|FG001|Overall Study|Withdrawal by Subject|1|||
33626800|NCT02025205|63027844|FG000|Overall Study|Withdrawal by Subject|1|||
33626801|NCT02025205|63027845|FG001|Overall Study|Withdrawal by Subject|1|||
33533654|NCT00665223|62923677|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
33533655|NCT00665223|62923678|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
33533656|NCT00665223|62923679|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
33533657|NCT03786380|62923700|FG000|Overall Study|Adverse Event|1|||
33533658|NCT03786380|62923701|FG001|Overall Study|Adverse Event|0|||
33626802|NCT02025205|63027844|FG000|Overall Study|Protocol Violation|2|||
33626803|NCT02025205|63027845|FG001|Overall Study|Protocol Violation|1|||
33626804|NCT02025205|63027844|FG000|Overall Study|Death|0|||
33626805|NCT02025205|63027845|FG001|Overall Study|Death|1|||
33626806|NCT01812837|63027854|FG000|Overall Study|Lost to Follow-up|1|||
33626807|NCT01812837|63027855|FG001|Overall Study|Lost to Follow-up|1|||
33626808|NCT01812837|63027856|FG002|Overall Study|Lost to Follow-up|0|||
33626809|NCT01812837|63027854|FG000|Overall Study|Protocol Violation|1|||
33626810|NCT01812837|63027855|FG001|Overall Study|Protocol Violation|0|||
33626811|NCT01812837|63027856|FG002|Overall Study|Protocol Violation|0|||
33626812|NCT02024971|63027864|FG000|Overall Study|Data Not Available|30|||
33626813|NCT02024971|63027864|FG000|Overall Study|Lost to Follow-up|6|||
33626814|NCT01843023|63027870|FG000|Overall Study|Death|1|||
33626815|NCT01843023|63027871|FG001|Overall Study|Death|0|||
33626816|NCT01843023|63027870|FG000|Overall Study|Lost to Follow-up|24|||
33626817|NCT01843023|63027871|FG001|Overall Study|Lost to Follow-up|29|||
33626818|NCT01843023|63027870|FG000|Overall Study|Withdrawal by Subject|8|||
33626819|NCT01843023|63027871|FG001|Overall Study|Withdrawal by Subject|6|||
33626820|NCT01812759|63027880|FG000|Overall Study|Physician Decision|0|||
33626821|NCT01812759|63027881|FG001|Overall Study|Physician Decision|0|||
33626822|NCT01812759|63027882|FG002|Overall Study|Physician Decision|1|||
33626823|NCT01812057|63027892|FG000|Overall Study|Protocol Violation|1|||
33626824|NCT01812057|63027893|FG001|Overall Study|Protocol Violation|0|||
33626825|NCT01812057|63027892|FG000|Overall Study|Physician Decision|1|||
33626826|NCT01812057|63027893|FG001|Overall Study|Physician Decision|0|||
33533659|NCT03786380|62923702|FG002|Overall Study|Adverse Event|0|||
33533660|NCT03786380|62923703|FG003|Overall Study|Adverse Event|3|||
33533661|NCT03786380|62923704|FG004|Overall Study|Adverse Event|1|||
33533662|NCT03786380|62923700|FG000|Overall Study|Lack of Efficacy|0|||
33533663|NCT03786380|62923701|FG001|Overall Study|Lack of Efficacy|0|||
33533664|NCT03786380|62923702|FG002|Overall Study|Lack of Efficacy|0|||
33533665|NCT03786380|62923703|FG003|Overall Study|Lack of Efficacy|0|||
33533666|NCT03786380|62923704|FG004|Overall Study|Lack of Efficacy|1|||
33533667|NCT03786380|62923700|FG000|Overall Study|Withdrawal by Subject|1|||
33626827|NCT01842633|63027906|FG000|Overall Study|Screen Failure|1|||
33626828|NCT01842633|63027907|FG001|Overall Study|Screen Failure|0|||
33626829|NCT01842633|63027908|FG002|Overall Study|Screen Failure|0|||
33626830|NCT01842633|63027906|FG000|Overall Study|Adverse Event|1|||
33626831|NCT01842633|63027907|FG001|Overall Study|Adverse Event|1|||
33626832|NCT01842633|63027908|FG002|Overall Study|Adverse Event|0|||
33626833|NCT01842633|63027906|FG000|Overall Study|Withdrawal by Subject|0|||
33626834|NCT01842633|63027907|FG001|Overall Study|Withdrawal by Subject|1|||
33626835|NCT01842633|63027908|FG002|Overall Study|Withdrawal by Subject|0|||
33626836|NCT01842633|63027906|FG000|Overall Study|Technical issues|1|||
33626837|NCT01842633|63027907|FG001|Overall Study|Technical issues|0|||
33626838|NCT01842633|63027908|FG002|Overall Study|Technical issues|0|||
33626839|NCT01810263|63027920|FG000|Overall Study|Lost to Follow-up|8|||
33626840|NCT01810263|63027921|FG001|Overall Study|Lost to Follow-up|7|||
33626841|NCT01841697|63027929|FG000|Overall Study|Death|0|||
33626842|NCT01841697|63027930|FG001|Overall Study|Death|1|||
33626843|NCT01841697|63027929|FG000|Overall Study|Lost to Follow-up|4|||
33626844|NCT01841697|63027930|FG001|Overall Study|Lost to Follow-up|1|||
33459507|NCT03608254|62832973|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
33459508|NCT03608254|62832973|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
33459509|NCT03606460|62832979|FG000|Overall Study|Lost to Follow-up|1|||
33459510|NCT03606460|62832980|FG001|Overall Study|Lost to Follow-up|8|||
33459511|NCT03605836|62832991|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
33459512|NCT03605836|62832992|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
33459513|NCT03605836|62832993|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
33459514|NCT03605836|62832994|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
33459515|NCT03605836|62832991|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
33459516|NCT03605836|62832992|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
33459517|NCT03605836|62832993|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
33459518|NCT03605836|62832994|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
33533668|NCT03786380|62923701|FG001|Overall Study|Withdrawal by Subject|2|||
33533669|NCT03786380|62923702|FG002|Overall Study|Withdrawal by Subject|2|||
33626845|NCT01841697|63027929|FG000|Overall Study|Withdrawal by Subject|16|||
33626846|NCT01841697|63027930|FG001|Overall Study|Withdrawal by Subject|16|||
33626847|NCT01841073|63027938|FG000|Overall Study|Adverse Event|1|||
33626848|NCT01841073|63027939|FG001|Overall Study|Adverse Event|1|||
33626849|NCT01841073|63027938|FG000|Overall Study|Physician Decision|1|||
33626850|NCT01841073|63027939|FG001|Overall Study|Physician Decision|0|||
33626851|NCT01841073|63027938|FG000|Overall Study|Lost to Follow-up|0|||
33626852|NCT01841073|63027939|FG001|Overall Study|Lost to Follow-up|2|||
33533670|NCT03786380|62923703|FG003|Overall Study|Withdrawal by Subject|1|||
33533671|NCT03786380|62923704|FG004|Overall Study|Withdrawal by Subject|2|||
33533672|NCT03786380|62923700|FG000|Overall Study|Lost to Follow-up|3|||
33533673|NCT03786380|62923701|FG001|Overall Study|Lost to Follow-up|0|||
33533674|NCT03786380|62923702|FG002|Overall Study|Lost to Follow-up|1|||
33533675|NCT03786380|62923703|FG003|Overall Study|Lost to Follow-up|2|||
33533676|NCT03786380|62923704|FG004|Overall Study|Lost to Follow-up|0|||
33626853|NCT01809327|63027952|FG000|Overall Study|Lost to Follow-up|5|||
33626854|NCT01809327|63027953|FG001|Overall Study|Lost to Follow-up|2|||
33533677|NCT03786380|62923700|FG000|Overall Study|Physician Decision|0|||
33533678|NCT03786380|62923701|FG001|Overall Study|Physician Decision|0|||
33533679|NCT03786380|62923702|FG002|Overall Study|Physician Decision|1|||
33533680|NCT03786380|62923703|FG003|Overall Study|Physician Decision|0|||
33533681|NCT03786380|62923704|FG004|Overall Study|Physician Decision|0|||
33533682|NCT03786380|62923700|FG000|Overall Study|Study Terminated by the Sponsor|30|||
33533683|NCT03786380|62923701|FG001|Overall Study|Study Terminated by the Sponsor|20|||
33533684|NCT03786380|62923702|FG002|Overall Study|Study Terminated by the Sponsor|50|||
33533685|NCT03786380|62923703|FG003|Overall Study|Study Terminated by the Sponsor|57|||
33533686|NCT03786380|62923704|FG004|Overall Study|Study Terminated by the Sponsor|23|||
33533687|NCT03786380|62923700|FG000|Overall Study|Reason Not Specified|0|||
33533688|NCT03786380|62923701|FG001|Overall Study|Reason Not Specified|0|||
33533689|NCT03786380|62923702|FG002|Overall Study|Reason Not Specified|0|||
33533690|NCT03786380|62923703|FG003|Overall Study|Reason Not Specified|0|||
33533691|NCT03786380|62923704|FG004|Overall Study|Reason Not Specified|1|||
33533692|NCT02626000|62923716|FG000|Overall Study|Decision by Sponsor|1|||
33533693|NCT02626000|62923716|FG000|Overall Study|Death|29|||
33533694|NCT02736890|62923732|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
33533695|NCT02736890|62923733|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
33533696|NCT02736890|62923732|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
33533697|NCT02736890|62923733|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
33533698|NCT02779556|62923741|FG000|Baseline|Partial baseline interview completed|1|||
33533699|NCT02779556|62923742|FG001|Baseline|Partial baseline interview completed|0|||
33533700|NCT02779556|62923741|FG000|3 Months|Lost to Follow-up|40|||
33533701|NCT02779556|62923742|FG001|3 Months|Lost to Follow-up|29|||
33533702|NCT02779556|62923741|FG000|3 Months|Missed 3 month clinic visit|27|||
33533703|NCT02779556|62923742|FG001|3 Months|Missed 3 month clinic visit|19|||
33533704|NCT02779556|62923741|FG000|6 Month|Lost to Follow-up|33|||
33533705|NCT02779556|62923742|FG001|6 Month|Lost to Follow-up|39|||
33533706|NCT02779556|62923741|FG000|6 Month HbA1c|No value collected during window|69|||
33533707|NCT02779556|62923742|FG001|6 Month HbA1c|No value collected during window|50|||
33533708|NCT02779556|62923741|FG000|12 Month HbA1c|No value collected during window|138|||
33533709|NCT02779556|62923742|FG001|12 Month HbA1c|No value collected during window|102|||
33533710|NCT01669798|62923748|FG000|Overall Study|Physician Decision|5|||
33533711|NCT02334722|62923754|FG000|Overall Study|Lost to Follow-up|4|||
33533712|NCT02334722|62923755|FG001|Overall Study|Lost to Follow-up|0|||
33533713|NCT02334722|62923754|FG000|Overall Study|6 week questionnaire not completed|2|||
33533714|NCT02334722|62923755|FG001|Overall Study|6 week questionnaire not completed|0|||
33533715|NCT02334722|62923754|FG000|Overall Study|Unable to obtain medication|1|||
33533716|NCT02334722|62923755|FG001|Overall Study|Unable to obtain medication|1|||
33533717|NCT02334722|62923754|FG000|Overall Study|Withdrawal by Subject|0|||
33533718|NCT02334722|62923755|FG001|Overall Study|Withdrawal by Subject|3|||
33533719|NCT02334722|62923754|FG000|Overall Study|Adverse Event|0|||
33533720|NCT02334722|62923755|FG001|Overall Study|Adverse Event|2|||
33533721|NCT02334722|62923754|FG000|Overall Study|Physician Decision|0|||
33533722|NCT02334722|62923755|FG001|Overall Study|Physician Decision|1|||
33533723|NCT00812708|62923770|FG000|Overall Study|Device could not be implanted|2|||
33533724|NCT00812708|62923770|FG000|Overall Study|Lack of medical insurance|1|||
33533725|NCT00812708|62923770|FG000|Overall Study|Switched to another study|1|||
33533726|NCT00812708|62923770|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
33533727|NCT00812708|62923770|FG000|Overall Study|Signed consent but later withdrew|3|||
33533728|NCT03761810|62923786|FG000|Overall Study|Adverse Event|12|||
33533729|NCT03761810|62923787|FG001|Overall Study|Adverse Event|0|||
33533730|NCT03761810|62923786|FG000|Overall Study|Lost to Follow-up|15|||
33533731|NCT03761810|62923787|FG001|Overall Study|Lost to Follow-up|7|||
33533732|NCT03761810|62923786|FG000|Overall Study|Pregnancy|1|||
33533733|NCT03761810|62923787|FG001|Overall Study|Pregnancy|0|||
33533734|NCT03761810|62923786|FG000|Overall Study|Withdrawal by Subject|14|||
33533735|NCT03761810|62923787|FG001|Overall Study|Withdrawal by Subject|5|||
33533736|NCT03761810|62923786|FG000|Overall Study|Physician Decision|1|||
33533737|NCT03761810|62923787|FG001|Overall Study|Physician Decision|0|||
33533738|NCT03761810|62923786|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
33533739|NCT03761810|62923787|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33533740|NCT03761810|62923786|FG000|Overall Study|Other Than Specified|1|||
33533741|NCT03761810|62923787|FG001|Overall Study|Other Than Specified|0|||
33533742|NCT02811159|62923798|FG000|Treatment Course 1|Lost to Follow-up|1|||
33533743|NCT01889186|62923804|FG000|Overall Study|Adverse event- not related to progression|18|||
33533744|NCT01889186|62923805|FG001|Overall Study|Adverse event- not related to progression|5|||
33533745|NCT01889186|62923804|FG000|Overall Study|Adverse event- related to progression|7|||
33533746|NCT01889186|62923805|FG001|Overall Study|Adverse event- related to progression|2|||
33533747|NCT01889186|62923804|FG000|Overall Study|COVID-19 logistical restrictions|1|||
33533748|NCT01889186|62923805|FG001|Overall Study|COVID-19 logistical restrictions|0|||
33533749|NCT01889186|62923804|FG000|Overall Study|Investigator request|1|||
33533750|NCT01889186|62923805|FG001|Overall Study|Investigator request|1|||
33533751|NCT01889186|62923804|FG000|Overall Study|Progressive disease- Richter's|12|||
33533752|NCT01889186|62923805|FG001|Overall Study|Progressive disease- Richter's|7|||
33533753|NCT01889186|62923804|FG000|Overall Study|Progressive disease per protocol|46|||
33533754|NCT01889186|62923805|FG001|Overall Study|Progressive disease per protocol|17|||
33533755|NCT01889186|62923804|FG000|Overall Study|Stem cell transplant|2|||
33533756|NCT01889186|62923805|FG001|Overall Study|Stem cell transplant|1|||
33533757|NCT01889186|62923804|FG000|Overall Study|Withdrew consent|2|||
33533758|NCT01889186|62923805|FG001|Overall Study|Withdrew consent|3|||
33533759|NCT01889186|62923804|FG000|Overall Study|Other, not specified|18|||
33533760|NCT01889186|62923805|FG001|Overall Study|Other, not specified|15|||
33533761|NCT01510184|62923815|FG000|Overall Study|Sponsor discretion|28|||
33533762|NCT01510184|62923816|FG001|Overall Study|Sponsor discretion|28|||
33533763|NCT01510184|62923815|FG000|Overall Study|Death|1|||
33533764|NCT01510184|62923816|FG001|Overall Study|Death|2|||
33533765|NCT01510184|62923815|FG000|Overall Study|Withdrawal by Subject|1|||
33533766|NCT01510184|62923816|FG001|Overall Study|Withdrawal by Subject|4|||
33533767|NCT01510184|62923815|FG000|Overall Study|Other|0|||
33533768|NCT01510184|62923816|FG001|Overall Study|Other|1|||
33533769|NCT02809833|62923841|FG000|Overall Study|Death|3|||
33533770|NCT02809833|62923841|FG000|Overall Study|Intolerance|54|||
33533771|NCT02809833|62923841|FG000|Overall Study|Lack of Efficacy|89|||
33533772|NCT02809833|62923841|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
33533773|NCT02809833|62923841|FG000|Overall Study|Noncompliance|1|||
33533774|NCT02809833|62923841|FG000|Overall Study|Withdrawal by Subject|34|||
33533775|NCT02809833|62923841|FG000|Overall Study|Lost to Follow-up|35|||
33533776|NCT02809833|62923841|FG000|Overall Study|Adverse Event (AE)|24|||
33533777|NCT02809833|62923841|FG000|Overall Study|Other|5|||
33533778|NCT02809833|62923841|FG000|Overall Study|Missing Information|52|||
33533779|NCT02797262|62923847|FG000|Overall Study|Withdrawal by Subject|5|||
33533780|NCT02797262|62923848|FG001|Overall Study|Withdrawal by Subject|1|||
33533781|NCT02797262|62923847|FG000|Overall Study|Lost to Follow-up|10|||
33533782|NCT02797262|62923848|FG001|Overall Study|Lost to Follow-up|7|||
33533783|NCT02797262|62923847|FG000|Overall Study|Death|1|||
33533784|NCT02797262|62923848|FG001|Overall Study|Death|2|||
33533785|NCT02797262|62923847|FG000|Overall Study|Adverse Event|1|||
33533786|NCT02797262|62923848|FG001|Overall Study|Adverse Event|0|||
33533787|NCT02797262|62923847|FG000|Overall Study|COVID-19|2|||
33533788|NCT02797262|62923848|FG001|Overall Study|COVID-19|1|||
33533789|NCT02797262|62923847|FG000|Overall Study|Out-of-country|1|||
33533790|NCT02797262|62923848|FG001|Overall Study|Out-of-country|0|||
33533791|NCT02809053|62923856|FG000|Overall Study|Death|0|||
33533792|NCT02809053|62923857|FG001|Overall Study|Death|1|||
33533793|NCT02809053|62923856|FG000|Overall Study|Lost to Follow-up|3|||
33533794|NCT02809053|62923857|FG001|Overall Study|Lost to Follow-up|1|||
33626855|NCT01809327|63027954|FG002|Overall Study|Lost to Follow-up|4|||
33626856|NCT01809327|63027955|FG003|Overall Study|Lost to Follow-up|2|||
33626857|NCT01809327|63027956|FG004|Overall Study|Lost to Follow-up|3|||
33626858|NCT01809327|63027952|FG000|Overall Study|Withdrawal by Subject|6|||
33626859|NCT01809327|63027953|FG001|Overall Study|Withdrawal by Subject|4|||
33626860|NCT01809327|63027954|FG002|Overall Study|Withdrawal by Subject|4|||
33626861|NCT01809327|63027955|FG003|Overall Study|Withdrawal by Subject|2|||
33626862|NCT01809327|63027956|FG004|Overall Study|Withdrawal by Subject|5|||
33626863|NCT01809327|63027952|FG000|Overall Study|Adverse Event|4|||
33533795|NCT02809053|62923856|FG000|Overall Study|Withdrawal by Subject|2|||
33533796|NCT02809053|62923857|FG001|Overall Study|Withdrawal by Subject|3|||
33533797|NCT02809053|62923856|FG000|Overall Study|Disease Progression|2|||
33626864|NCT01809327|63027953|FG001|Overall Study|Adverse Event|3|||
33626865|NCT01809327|63027954|FG002|Overall Study|Adverse Event|7|||
33626866|NCT01809327|63027955|FG003|Overall Study|Adverse Event|4|||
33626867|NCT01809327|63027956|FG004|Overall Study|Adverse Event|8|||
33626868|NCT01809327|63027952|FG000|Overall Study|Death|1|||
33626869|NCT01809327|63027953|FG001|Overall Study|Death|0|||
33626870|NCT01809327|63027954|FG002|Overall Study|Death|0|||
33626871|NCT01809327|63027955|FG003|Overall Study|Death|0|||
33626872|NCT01809327|63027956|FG004|Overall Study|Death|0|||
33626873|NCT01809327|63027952|FG000|Overall Study|Protocol Violation|0|||
33626874|NCT01809327|63027953|FG001|Overall Study|Protocol Violation|1|||
33533798|NCT02809053|62923857|FG001|Overall Study|Disease Progression|1|||
33533799|NCT02808975|62923865|FG000|Overall Study|Adverse Event|3|||
33533800|NCT02808975|62923866|FG001|Overall Study|Adverse Event|4|||
33533801|NCT02808975|62923865|FG000|Overall Study|Withdrew consent|9|||
33533802|NCT02808975|62923866|FG001|Overall Study|Withdrew consent|8|||
33533803|NCT02808975|62923865|FG000|Overall Study|Lost to Follow-up|4|||
33533804|NCT02808975|62923866|FG001|Overall Study|Lost to Follow-up|6|||
33533805|NCT02808975|62923865|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
33533806|NCT02808975|62923866|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
33533807|NCT02808975|62923865|FG000|Overall Study|Other, not specified|5|||
33533808|NCT02808975|62923866|FG001|Overall Study|Other, not specified|1|||
33533809|NCT02976038|62923872|FG000|Overall Study|Physician Decision|22|||
33533810|NCT02976038|62923872|FG000|Overall Study|Withdrawal by Subject|3|||
33533811|NCT02976038|62923872|FG000|Overall Study|Lost to Follow-up|2|||
33533812|NCT02976038|62923872|FG000|Overall Study|Adverse Event|1|||
33626875|NCT01809327|63027954|FG002|Overall Study|Protocol Violation|0|||
33626876|NCT01809327|63027955|FG003|Overall Study|Protocol Violation|0|||
33626877|NCT01809327|63027956|FG004|Overall Study|Protocol Violation|0|||
33626878|NCT01809327|63027952|FG000|Overall Study|Physician Decision|1|||
33626879|NCT01809327|63027953|FG001|Overall Study|Physician Decision|1|||
33626880|NCT01809327|63027954|FG002|Overall Study|Physician Decision|0|||
33626881|NCT01809327|63027955|FG003|Overall Study|Physician Decision|0|||
33626882|NCT01809327|63027956|FG004|Overall Study|Physician Decision|0|||
33626883|NCT01809327|63027952|FG000|Overall Study|Pregnancy|1|||
33626884|NCT01809327|63027953|FG001|Overall Study|Pregnancy|0|||
33626885|NCT01809327|63027954|FG002|Overall Study|Pregnancy|0|||
33626886|NCT01809327|63027955|FG003|Overall Study|Pregnancy|0|||
33626887|NCT01809327|63027956|FG004|Overall Study|Pregnancy|0|||
33626888|NCT01809327|63027952|FG000|Overall Study|Other|14|||
33626889|NCT01809327|63027953|FG001|Overall Study|Other|15|||
33626890|NCT01809327|63027954|FG002|Overall Study|Other|7|||
33626891|NCT01809327|63027955|FG003|Overall Study|Other|4|||
33626892|NCT01809327|63027956|FG004|Overall Study|Other|9|||
33626893|NCT01808313|63027977|FG000|Overall Study|Adverse Event|5|||
33626894|NCT01808313|63027977|FG000|Overall Study|Protocol Violation|2|||
33626895|NCT01808313|63027977|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33626896|NCT01808313|63027977|FG000|Overall Study|Lost to Follow-up|1|||
33626897|NCT01808313|63027977|FG000|Overall Study|Physician Decision|1|||
33626898|NCT01840605|63027983|FG000|Overall Study|Adverse Event|0|||
33626899|NCT01840605|63027984|FG001|Overall Study|Adverse Event|1|||
33626900|NCT01840605|63027983|FG000|Overall Study|Physician Decision|2|||
33626901|NCT01840605|63027984|FG001|Overall Study|Physician Decision|1|||
33626902|NCT02023879|63027993|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
33626903|NCT02023879|63027994|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
33533813|NCT02808819|62923897|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
33533814|NCT02808819|62923898|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
33533815|NCT02808819|62923897|FG000|Overall Study|Withdrawal by Subject|10|||
33626904|NCT02023879|63027995|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
33626905|NCT02023879|63027993|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
33626906|NCT02023879|63027994|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
33626907|NCT02023879|63027995|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
33626908|NCT02023879|63027993|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
33626909|NCT02023879|63027994|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
33626910|NCT02023879|63027995|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
33626911|NCT02023879|63027993|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
33626912|NCT02023879|63027994|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
33626913|NCT02023879|63027995|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
33626914|NCT02023879|63027993|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
33626915|NCT02023879|63027994|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
33626916|NCT02023879|63027995|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
33626917|NCT02023879|63027993|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
33626918|NCT02023879|63027994|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
33626919|NCT02023879|63027995|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
33626920|NCT02023879|63027993|FG000|Extension Open Label Treatment|Adverse Event|1|||
33533816|NCT02808819|62923898|FG001|Overall Study|Withdrawal by Subject|13|||
33533817|NCT02808819|62923897|FG000|Overall Study|Site terminated by sponsor|2|||
33533818|NCT02808819|62923898|FG001|Overall Study|Site terminated by sponsor|0|||
33533819|NCT02808819|62923897|FG000|Overall Study|Pregnancy|1|||
33533820|NCT02808819|62923898|FG001|Overall Study|Pregnancy|0|||
33533821|NCT02808819|62923897|FG000|Overall Study|Lost to Follow-up|1|||
33533822|NCT02808819|62923898|FG001|Overall Study|Lost to Follow-up|6|||
33533823|NCT02808819|62923897|FG000|Overall Study|Protocol Violation|0|||
33533824|NCT02808819|62923898|FG001|Overall Study|Protocol Violation|1|||
33533825|NCT02808819|62923897|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
33626921|NCT02023879|63027994|FG001|Extension Open Label Treatment|Adverse Event|7|||
33626922|NCT02023879|63027995|FG002|Extension Open Label Treatment|Adverse Event|3|||
33626923|NCT02023879|63027993|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
33626924|NCT02023879|63027994|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
33626925|NCT02023879|63027995|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
33626926|NCT02023879|63027993|FG000|Extension Open Label Treatment|Participant moved|1|||
33533826|NCT02808819|62923898|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
33626927|NCT02023879|63027994|FG001|Extension Open Label Treatment|Participant moved|2|||
33626928|NCT02023879|63027995|FG002|Extension Open Label Treatment|Participant moved|0|||
33533827|NCT02808819|62923897|FG000|Overall Study|Death|1|||
33533828|NCT02808819|62923898|FG001|Overall Study|Death|0|||
33533829|NCT02808819|62923897|FG000|Overall Study|Adverse Event|3|||
33533830|NCT02808819|62923898|FG001|Overall Study|Adverse Event|4|||
33533831|NCT02808429|62923908|FG000|Overall Study|Lost to Follow-up|1|||
33626929|NCT02023879|63027993|FG000|Extension Open Label Treatment|Other than specified above|2|||
33626930|NCT02023879|63027994|FG001|Extension Open Label Treatment|Other than specified above|7|||
33626931|NCT02023879|63027995|FG002|Extension Open Label Treatment|Other than specified above|2|||
33626932|NCT02014441|63028010|FG000|Overall Study|Withdrawal by Subject|12|||
33626933|NCT02013817|63028016|FG000|Overall Study|Adverse Event|12|||
33626934|NCT02013817|63028016|FG000|Overall Study|Withdrawal by Subject|4|||
33626935|NCT02013817|63028016|FG000|Overall Study|Death|2|||
33626936|NCT02013817|63028016|FG000|Overall Study|Other|9|||
33626937|NCT01994863|63028020|FG000|Period 1|Adverse Event|4|||
33626938|NCT01994863|63028021|FG001|Period 1|Adverse Event|0|||
33626939|NCT01994863|63028020|FG000|Period 1|Withdrawal by Subject|1|||
33626940|NCT01994863|63028021|FG001|Period 1|Withdrawal by Subject|0|||
33626941|NCT01994863|63028020|FG000|Period 1|Trial stopped by sponsor|1|||
33626942|NCT01994863|63028021|FG001|Period 1|Trial stopped by sponsor|3|||
33626943|NCT01994863|63028020|FG000|Period 1|Lack of Efficacy|1|||
33626944|NCT01994863|63028021|FG001|Period 1|Lack of Efficacy|0|||
33626945|NCT01994863|63028020|FG000|Period 2|Adverse Event|0|||
33626946|NCT01994863|63028021|FG001|Period 2|Adverse Event|1|||
33626947|NCT01994863|63028020|FG000|Period 2|Lack of Efficacy|0|||
33626948|NCT01994863|63028021|FG001|Period 2|Lack of Efficacy|2|||
33626949|NCT01994863|63028020|FG000|Period 2|Withdrawal by Subject|1|||
33626950|NCT01994863|63028021|FG001|Period 2|Withdrawal by Subject|1|||
33626951|NCT02023099|63028030|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
33626952|NCT02023099|63028031|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
33626953|NCT02023099|63028032|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
33626954|NCT02023099|63028030|FG000|Overall Study|Withdrawn Consent|3|||
33626955|NCT02023099|63028031|FG001|Overall Study|Withdrawn Consent|0|||
33326028|NCT01161173|62702801|FG000|Overall Study|Unacceptable Toxicity|21|||
33533832|NCT02808429|62923909|FG001|Overall Study|Lost to Follow-up|0|||
33533833|NCT02808429|62923910|FG002|Overall Study|Lost to Follow-up|0|||
33533834|NCT02808429|62923908|FG000|Overall Study|Protocol Violation|0|||
33533835|NCT02808429|62923909|FG001|Overall Study|Protocol Violation|1|||
33533836|NCT02808429|62923910|FG002|Overall Study|Protocol Violation|0|||
33533837|NCT02808429|62923908|FG000|Overall Study|Premature study termination by sponsor|2|||
33533838|NCT02808429|62923909|FG001|Overall Study|Premature study termination by sponsor|0|||
33533839|NCT02808429|62923910|FG002|Overall Study|Premature study termination by sponsor|1|||
33533840|NCT02808429|62923908|FG000|Overall Study|Relocation|0|||
33533841|NCT02808429|62923909|FG001|Overall Study|Relocation|0|||
33533842|NCT02808429|62923910|FG002|Overall Study|Relocation|1|||
33533843|NCT01594762|62923920|FG000|Overall Study|Withdrawal by Subject|1|||
33533844|NCT01594762|62923921|FG001|Overall Study|Withdrawal by Subject|0|||
33533845|NCT01594762|62923920|FG000|Overall Study|Lost to Follow-up|10|||
33533846|NCT01594762|62923921|FG001|Overall Study|Lost to Follow-up|10|||
33533847|NCT02615470|62923929|FG000|Overall Study|Lost to Follow-up|21|||
33533848|NCT02615470|62923930|FG001|Overall Study|Lost to Follow-up|32|||
33533849|NCT02806947|62923938|FG000|Overall Study|Withdrawal by Subject|5|||
33533850|NCT02806947|62923939|FG001|Overall Study|Withdrawal by Subject|1|||
33533851|NCT02806713|62923947|FG000|Overall Study|Urethral injury during procedure|1|||
33533852|NCT02806713|62923948|FG001|Overall Study|Urethral injury during procedure|0|||
33533853|NCT02806713|62923947|FG000|Overall Study|cancelled surgery|1|||
33533854|NCT02806713|62923948|FG001|Overall Study|cancelled surgery|2|||
33533855|NCT02807493|62923956|FG000|Overall Study|Adverse Event|5|||
33533856|NCT02807493|62923957|FG001|Overall Study|Adverse Event|2|||
33533857|NCT02807493|62923956|FG000|Overall Study|Lost to Follow-up|6|||
33533858|NCT02807493|62923957|FG001|Overall Study|Lost to Follow-up|0|||
33533859|NCT02807493|62923956|FG000|Overall Study|Physician Decision|4|||
33626956|NCT02023099|63028032|FG002|Overall Study|Withdrawn Consent|1|||
33626957|NCT02023099|63028030|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
33626958|NCT02023099|63028031|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
33626959|NCT02023099|63028032|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
33626960|NCT02013037|63028040|FG000|Overall Study|Death|6|||
33626961|NCT02013037|63028040|FG000|Overall Study|Withdrawal by Subject|1|||
33626962|NCT02013037|63028040|FG000|Overall Study|Awaiting Transplantation|7|||
33626963|NCT02013037|63028040|FG000|Overall Study|Transplanted without DSA|2|||
33626964|NCT01967719|63028047|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
33533860|NCT02807493|62923957|FG001|Overall Study|Physician Decision|1|||
33533861|NCT02807493|62923956|FG000|Overall Study|Protocol Violation|7|||
33533862|NCT02807493|62923957|FG001|Overall Study|Protocol Violation|0|||
33533863|NCT02807493|62923956|FG000|Overall Study|Withdrawal by Subject|17|||
33533864|NCT02807493|62923957|FG001|Overall Study|Withdrawal by Subject|10|||
33533865|NCT02807493|62923956|FG000|Overall Study|Other withdrawal|17|||
33533866|NCT02807493|62923957|FG001|Overall Study|Other withdrawal|0|||
33533867|NCT02807493|62923956|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
33533868|NCT02807493|62923957|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
33626965|NCT01967719|63028048|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
33626966|NCT01967719|63028049|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
33626967|NCT01967719|63028050|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
33626968|NCT01967719|63028047|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
33626969|NCT01967719|63028048|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
33626970|NCT01967719|63028049|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
33626971|NCT01967719|63028050|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
33626972|NCT01967173|63028068|FG000|Overall Study|Lost to Follow-up|5|||
33626973|NCT01967173|63028069|FG001|Overall Study|Lost to Follow-up|3|||
33626974|NCT01967173|63028070|FG002|Overall Study|Lost to Follow-up|2|||
33626975|NCT01967173|63028071|FG003|Overall Study|Lost to Follow-up|4|||
33626976|NCT01967173|63028072|FG004|Overall Study|Lost to Follow-up|8|||
33626977|NCT01967173|63028073|FG005|Overall Study|Lost to Follow-up|12|||
33626978|NCT01967173|63028074|FG006|Overall Study|Lost to Follow-up|6|||
33626979|NCT01967173|63028075|FG007|Overall Study|Lost to Follow-up|8|||
33626980|NCT01967173|63028068|FG000|Overall Study|Physician Decision|2|||
33626981|NCT01967173|63028069|FG001|Overall Study|Physician Decision|0|||
33626982|NCT01967173|63028070|FG002|Overall Study|Physician Decision|2|||
33626983|NCT01967173|63028071|FG003|Overall Study|Physician Decision|1|||
33626984|NCT01967173|63028072|FG004|Overall Study|Physician Decision|1|||
33626985|NCT01967173|63028073|FG005|Overall Study|Physician Decision|1|||
33626986|NCT01967173|63028074|FG006|Overall Study|Physician Decision|1|||
33626987|NCT01967173|63028075|FG007|Overall Study|Physician Decision|0|||
33626988|NCT01967173|63028068|FG000|Overall Study|Lack of Efficacy|2|||
33626989|NCT01967173|63028069|FG001|Overall Study|Lack of Efficacy|0|||
33626990|NCT01967173|63028070|FG002|Overall Study|Lack of Efficacy|2|||
33626991|NCT01967173|63028071|FG003|Overall Study|Lack of Efficacy|2|||
33626992|NCT01967173|63028072|FG004|Overall Study|Lack of Efficacy|0|||
33626993|NCT01967173|63028073|FG005|Overall Study|Lack of Efficacy|1|||
33626994|NCT01967173|63028074|FG006|Overall Study|Lack of Efficacy|0|||
33626995|NCT01967173|63028075|FG007|Overall Study|Lack of Efficacy|2|||
33626996|NCT01967173|63028068|FG000|Overall Study|Pregnancy|0|||
33626997|NCT01967173|63028069|FG001|Overall Study|Pregnancy|0|||
33626998|NCT01967173|63028070|FG002|Overall Study|Pregnancy|0|||
33626999|NCT01967173|63028071|FG003|Overall Study|Pregnancy|0|||
33627000|NCT01967173|63028072|FG004|Overall Study|Pregnancy|0|||
33627001|NCT01967173|63028073|FG005|Overall Study|Pregnancy|0|||
33627002|NCT01967173|63028074|FG006|Overall Study|Pregnancy|1|||
33627003|NCT01967173|63028075|FG007|Overall Study|Pregnancy|1|||
33627004|NCT01967173|63028068|FG000|Overall Study|Adverse Event|0|||
33627005|NCT01967173|63028069|FG001|Overall Study|Adverse Event|0|||
33533869|NCT02807259|62923965|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
33533870|NCT02807259|62923966|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
33533871|NCT02807259|62923965|FG000|Midline (3 Months)|migration, refusal, not available|30|||
33533872|NCT02807259|62923966|FG001|Midline (3 Months)|migration, refusal, not available|34|||
33533873|NCT02807259|62923965|FG000|Endline (3 Months)|migration, refusal, not available|35|||
33533874|NCT02807259|62923966|FG001|Endline (3 Months)|migration, refusal, not available|87|||
33533875|NCT02802345|62923976|FG000|Overall Study|Not Treated|0|||
33533876|NCT02802345|62923977|FG001|Overall Study|Not Treated|1|||
33533877|NCT02802345|62923976|FG000|Overall Study|Adverse Event|28|||
33533878|NCT02802345|62923977|FG001|Overall Study|Adverse Event|20|||
33533879|NCT02802345|62923976|FG000|Overall Study|Withdrawal by Subject|3|||
33533880|NCT02802345|62923977|FG001|Overall Study|Withdrawal by Subject|3|||
33533881|NCT02802345|62923976|FG000|Overall Study|Protocol Violation|0|||
33533882|NCT02802345|62923977|FG001|Overall Study|Protocol Violation|1|||
33533883|NCT02802345|62923976|FG000|Overall Study|Other than listed|1|||
33533884|NCT02802345|62923977|FG001|Overall Study|Other than listed|5|||
33533885|NCT02801877|62923987|FG000|Overall Study|Lost to Follow-up|1|||
33533886|NCT02801877|62923988|FG001|Overall Study|Lost to Follow-up|1|||
33533887|NCT02801877|62923989|FG002|Overall Study|Lost to Follow-up|2|||
33533888|NCT02801877|62923990|FG003|Overall Study|Lost to Follow-up|0|||
33533889|NCT02801877|62923987|FG000|Overall Study|Never Started Treatment|2|||
33533890|NCT02801877|62923988|FG001|Overall Study|Never Started Treatment|0|||
33627006|NCT01967173|63028070|FG002|Overall Study|Adverse Event|0|||
33627007|NCT01967173|63028071|FG003|Overall Study|Adverse Event|0|||
33533891|NCT02801877|62923989|FG002|Overall Study|Never Started Treatment|4|||
33627008|NCT01967173|63028072|FG004|Overall Study|Adverse Event|0|||
33533892|NCT02801877|62923990|FG003|Overall Study|Never Started Treatment|0|||
33533893|NCT02805309|62924003|FG000|Overall Study|Lost to Follow-up|2|||
33627009|NCT01967173|63028073|FG005|Overall Study|Adverse Event|0|||
33627010|NCT01967173|63028074|FG006|Overall Study|Adverse Event|0|||
33627011|NCT01967173|63028075|FG007|Overall Study|Adverse Event|1|||
33627012|NCT01967173|63028068|FG000|Overall Study|Withdrawal by Subject|15|||
33627013|NCT01967173|63028069|FG001|Overall Study|Withdrawal by Subject|14|||
33627014|NCT01967173|63028070|FG002|Overall Study|Withdrawal by Subject|10|||
33627015|NCT01967173|63028071|FG003|Overall Study|Withdrawal by Subject|7|||
33627016|NCT01967173|63028072|FG004|Overall Study|Withdrawal by Subject|8|||
33627017|NCT01967173|63028073|FG005|Overall Study|Withdrawal by Subject|9|||
33533894|NCT02805309|62924004|FG001|Overall Study|Lost to Follow-up|2|||
33533895|NCT02805309|62924005|FG002|Overall Study|Lost to Follow-up|2|||
33533896|NCT02805309|62924003|FG000|Overall Study|Post-Randomization Exclusion|0|||
33533897|NCT02805309|62924004|FG001|Overall Study|Post-Randomization Exclusion|2|||
33533898|NCT02805309|62924005|FG002|Overall Study|Post-Randomization Exclusion|1|||
33533899|NCT02804763|62924017|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
33533900|NCT02804763|62924018|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
33533901|NCT02804763|62924019|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
33533902|NCT02804763|62924020|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
33533903|NCT02804763|62924017|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
33533904|NCT02804763|62924018|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
33533905|NCT02804763|62924019|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
33533906|NCT02804763|62924020|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
33533907|NCT02804763|62924017|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
33533908|NCT02804763|62924018|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
33533909|NCT02804763|62924019|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
33627018|NCT01967173|63028074|FG006|Overall Study|Withdrawal by Subject|10|||
33627019|NCT01967173|63028075|FG007|Overall Study|Withdrawal by Subject|12|||
33627020|NCT01994629|63028089|FG000|Overall Study|Withdrawal by Subject|1|||
33627021|NCT01994629|63028090|FG001|Overall Study|Withdrawal by Subject|0|||
33627022|NCT01994629|63028089|FG000|Overall Study|Lost to Follow-up|0|||
33627023|NCT01994629|63028090|FG001|Overall Study|Lost to Follow-up|3|||
33627024|NCT01994395|63028098|FG000|Overall Study|Withdrawal by Subject|1|||
33627025|NCT01994395|63028099|FG001|Overall Study|Withdrawal by Subject|2|||
33627026|NCT01992536|63028115|FG000|Overall Study|Administrative Reason|0|||
33533910|NCT02804763|62924020|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
33533911|NCT02804763|62924017|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
33533912|NCT02804763|62924018|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
33533913|NCT02804763|62924019|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
33533914|NCT02804763|62924020|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
33533915|NCT02804763|62924017|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
33533916|NCT02804763|62924018|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
33533917|NCT02804763|62924019|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
33533918|NCT02804763|62924020|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
33533919|NCT02804763|62924017|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
33533920|NCT02804763|62924018|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
33533921|NCT02804763|62924019|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
33533922|NCT02804763|62924020|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
33533923|NCT02748057|62924036|FG000|Overall Study|Adverse Event|1|||
33533924|NCT02748057|62924037|FG001|Overall Study|Adverse Event|0|||
33533925|NCT02748057|62924036|FG000|Overall Study|Physician Decision|0|||
33533926|NCT02748057|62924037|FG001|Overall Study|Physician Decision|1|||
33533927|NCT02748057|62924036|FG000|Overall Study|Protocol Violation|2|||
33533928|NCT02748057|62924037|FG001|Overall Study|Protocol Violation|1|||
33533929|NCT02748057|62924036|FG000|Overall Study|Participant Moved|1|||
33533930|NCT02748057|62924037|FG001|Overall Study|Participant Moved|0|||
33533931|NCT02748057|62924036|FG000|Overall Study|Withdrawal by Subject|1|||
33533932|NCT02748057|62924037|FG001|Overall Study|Withdrawal by Subject|0|||
33533933|NCT02748213|62924045|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
33533934|NCT02748213|62924046|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
33533935|NCT02748213|62924045|FG000|Overall Study|Abnormal Laboratory Test|1|||
33533936|NCT02748213|62924046|FG001|Overall Study|Abnormal Laboratory Test|0|||
33627027|NCT01992536|63028116|FG001|Overall Study|Administrative Reason|0|||
33627028|NCT01992536|63028117|FG002|Overall Study|Administrative Reason|0|||
33459519|NCT03605836|62832991|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
33459520|NCT03605836|62832992|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
33459521|NCT03605836|62832993|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
33459522|NCT03605836|62832994|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
33459523|NCT03605836|62832991|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
33459524|NCT03605836|62832992|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
33533937|NCT02748213|62924045|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
33533938|NCT02748213|62924046|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
33533939|NCT02748213|62924045|FG000|Overall Study|Death|5|||
33533940|NCT02748213|62924046|FG001|Overall Study|Death|3|||
33627029|NCT01992536|63028118|FG003|Overall Study|Administrative Reason|0|||
33627030|NCT01992536|63028119|FG004|Overall Study|Administrative Reason|0|||
33627031|NCT01992536|63028120|FG005|Overall Study|Administrative Reason|0|||
33533941|NCT02748213|62924045|FG000|Overall Study|Insufficient Therapeutic Response|56|||
33627032|NCT01992536|63028121|FG006|Overall Study|Administrative Reason|7|||
33627033|NCT01992536|63028122|FG007|Overall Study|Administrative Reason|0|||
33627034|NCT01992536|63028123|FG008|Overall Study|Administrative Reason|0|||
33627035|NCT01992536|63028124|FG009|Overall Study|Administrative Reason|0|||
33627036|NCT01992536|63028115|FG000|Overall Study|Lost to Follow-up|4|||
33627037|NCT01992536|63028116|FG001|Overall Study|Lost to Follow-up|2|||
33627038|NCT01992536|63028117|FG002|Overall Study|Lost to Follow-up|1|||
33627039|NCT01992536|63028118|FG003|Overall Study|Lost to Follow-up|0|||
33627040|NCT01992536|63028119|FG004|Overall Study|Lost to Follow-up|0|||
33627041|NCT01992536|63028120|FG005|Overall Study|Lost to Follow-up|1|||
33627042|NCT01992536|63028121|FG006|Overall Study|Lost to Follow-up|0|||
33627043|NCT01992536|63028122|FG007|Overall Study|Lost to Follow-up|0|||
33627044|NCT01992536|63028123|FG008|Overall Study|Lost to Follow-up|1|||
33627045|NCT01992536|63028124|FG009|Overall Study|Lost to Follow-up|1|||
33627046|NCT01992536|63028115|FG000|Overall Study|Withdrawal by Subject|0|||
33627047|NCT01992536|63028116|FG001|Overall Study|Withdrawal by Subject|1|||
33627048|NCT01992536|63028117|FG002|Overall Study|Withdrawal by Subject|0|||
33627049|NCT01992536|63028118|FG003|Overall Study|Withdrawal by Subject|2|||
33627050|NCT01992536|63028119|FG004|Overall Study|Withdrawal by Subject|0|||
33627051|NCT01992536|63028120|FG005|Overall Study|Withdrawal by Subject|0|||
33627052|NCT01992536|63028121|FG006|Overall Study|Withdrawal by Subject|0|||
33627053|NCT01992536|63028122|FG007|Overall Study|Withdrawal by Subject|0|||
33627054|NCT01992536|63028123|FG008|Overall Study|Withdrawal by Subject|0|||
33627055|NCT01992536|63028124|FG009|Overall Study|Withdrawal by Subject|0|||
33627056|NCT01993927|63028166|FG000|Overall Study|Case Report Forms Uncollected|18|||
33627057|NCT01993927|63028166|FG000|Overall Study|Protocol Violation|11|||
33627058|NCT02015390|63028172|FG000|Overall Study|Lost to Follow-up|1|||
33627059|NCT02015390|63028173|FG001|Overall Study|Lost to Follow-up|0|||
33627060|NCT02015390|63028172|FG000|Overall Study|Adverse Event|0|||
33627061|NCT02015390|63028173|FG001|Overall Study|Adverse Event|3|||
33627062|NCT02015390|63028172|FG000|Overall Study|Physician Decision|0|||
33627063|NCT02015390|63028173|FG001|Overall Study|Physician Decision|1|||
33627064|NCT02012959|63028180|FG000|Treatment Phase A|Adverse Event|2|||
33627065|NCT02012959|63028181|FG001|Treatment Phase A|Adverse Event|0|||
33627066|NCT02012959|63028182|FG002|Treatment Phase A|Adverse Event|0|||
33627067|NCT02012959|63028183|FG003|Treatment Phase A|Adverse Event|0|||
33627068|NCT02012959|63028184|FG004|Treatment Phase A|Adverse Event|0|||
33627069|NCT01990742|63028196|FG000|Overall Study|Withdrawal by facility|407|||
33627070|NCT01990742|63028197|FG001|Overall Study|Withdrawal by facility|1083|||
33627071|NCT01990742|63028196|FG000|Overall Study|Facility closed|0|||
33627072|NCT01990742|63028197|FG001|Overall Study|Facility closed|270|||
33627073|NCT02012491|63028205|FG000|Overall Study|Lost to Follow-up|1|||
33627074|NCT02012491|63028206|FG001|Overall Study|Lost to Follow-up|0|||
33627075|NCT02012491|63028205|FG000|Overall Study|Protocol Violation|0|||
33627076|NCT02012491|63028206|FG001|Overall Study|Protocol Violation|1|||
33627077|NCT02012491|63028205|FG000|Overall Study|Withdrawal by Subject|1|||
33627078|NCT02012491|63028206|FG001|Overall Study|Withdrawal by Subject|0|||
33627079|NCT01990664|63028214|FG000|Overall Study|Lost to Follow-up|2|||
33627080|NCT01990664|63028215|FG001|Overall Study|Lost to Follow-up|6|||
33627081|NCT01990664|63028214|FG000|Overall Study|Withdrawal by Subject|2|||
33627082|NCT01990664|63028215|FG001|Overall Study|Withdrawal by Subject|3|||
33627083|NCT01990664|63028214|FG000|Overall Study|Protocol Violation|1|||
33459525|NCT03605836|62832993|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
33459526|NCT03605836|62832994|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
33459527|NCT03605836|62832991|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
33459528|NCT03605836|62832992|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
33459529|NCT03605836|62832993|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
33459530|NCT03605836|62832994|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
33459531|NCT03605836|62832991|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
33459532|NCT03605836|62832992|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
33459533|NCT03605836|62832993|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
33459534|NCT03605836|62832994|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
33459535|NCT03605836|62832991|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
33459536|NCT03605836|62832992|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
33627084|NCT01990664|63028215|FG001|Overall Study|Protocol Violation|0|||
33627085|NCT01990664|63028214|FG000|Overall Study|Lens Discomfort|1|||
33627086|NCT01990664|63028215|FG001|Overall Study|Lens Discomfort|1|||
33627087|NCT01990664|63028214|FG000|Overall Study|Lens Handling Difficulties|1|||
33627088|NCT01990664|63028215|FG001|Overall Study|Lens Handling Difficulties|0|||
33627089|NCT01990664|63028214|FG000|Overall Study|Unsatisfactory Visual Response|0|||
33627090|NCT01990664|63028215|FG001|Overall Study|Unsatisfactory Visual Response|1|||
33627091|NCT02038010|63028221|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
33627092|NCT02038010|63028222|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
33627093|NCT02038010|63028223|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
33627094|NCT02038010|63028224|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
33627095|NCT02038010|63028221|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
33627096|NCT02038010|63028222|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
33627097|NCT02038010|63028223|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
33627098|NCT02038010|63028224|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
33627099|NCT02038010|63028221|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
33627100|NCT02038010|63028222|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
33627101|NCT02038010|63028223|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
33627102|NCT02038010|63028224|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
33627103|NCT02038010|63028221|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
33627104|NCT02038010|63028222|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
33627105|NCT02038010|63028223|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
33627106|NCT02038010|63028224|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
33627107|NCT02038010|63028221|FG000|Follow Up|Death|4|||
33627108|NCT02038010|63028222|FG001|Follow Up|Death|3|||
33627109|NCT02038010|63028223|FG002|Follow Up|Death|0|||
33627110|NCT02038010|63028224|FG003|Follow Up|Death|0|||
33627111|NCT02038010|63028221|FG000|Follow Up|Other|3|||
33627112|NCT02038010|63028222|FG001|Follow Up|Other|0|||
33627113|NCT02038010|63028223|FG002|Follow Up|Other|0|||
33627114|NCT02038010|63028224|FG003|Follow Up|Other|0|||
33627115|NCT01989572|63028238|FG000|Overall Study|Lack of Efficacy|35|||
33627116|NCT01989572|63028239|FG001|Overall Study|Lack of Efficacy|48|||
33627117|NCT01989572|63028240|FG002|Overall Study|Lack of Efficacy|48|||
33627118|NCT01989572|63028241|FG003|Overall Study|Lack of Efficacy|43|||
33627119|NCT01989572|63028242|FG004|Overall Study|Lack of Efficacy|71|||
33627120|NCT01989572|63028243|FG005|Overall Study|Lack of Efficacy|79|||
33627121|NCT01989572|63028238|FG000|Overall Study|Adverse Event|2|||
33627122|NCT01989572|63028239|FG001|Overall Study|Adverse Event|1|||
33627123|NCT01989572|63028240|FG002|Overall Study|Adverse Event|3|||
33627124|NCT01989572|63028241|FG003|Overall Study|Adverse Event|0|||
33627125|NCT01989572|63028242|FG004|Overall Study|Adverse Event|3|||
33627126|NCT01989572|63028243|FG005|Overall Study|Adverse Event|0|||
33459537|NCT03605836|62832993|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
33459538|NCT03605836|62832994|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
33459539|NCT03605836|62832991|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
33459540|NCT03605836|62832992|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
33459541|NCT03605836|62832993|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
33459542|NCT03605836|62832994|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
33459543|NCT03605836|62832991|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
33533942|NCT02748213|62924046|FG001|Overall Study|Insufficient Therapeutic Response|57|||
33533943|NCT02748213|62924045|FG000|Overall Study|Violation of Selection Criteria|2|||
33533944|NCT02748213|62924046|FG001|Overall Study|Violation of Selection Criteria|0|||
33533945|NCT02748213|62924045|FG000|Overall Study|Protocol Violation|6|||
33533946|NCT02748213|62924046|FG001|Overall Study|Protocol Violation|4|||
33533947|NCT02748213|62924045|FG000|Overall Study|Refused Treatment*|6|||
33533948|NCT02748213|62924046|FG001|Overall Study|Refused Treatment*|6|||
33533949|NCT02748213|62924045|FG000|Overall Study|Failure to Return|1|||
33533950|NCT02748213|62924046|FG001|Overall Study|Failure to Return|0|||
33533951|NCT02748213|62924045|FG000|Overall Study|Other|30|||
33533952|NCT02748213|62924046|FG001|Overall Study|Other|29|||
33533953|NCT02613910|62924052|FG000|Overall Study|Termination of study|1|||
33533954|NCT02802735|62924059|FG000|Overall Study|Withdrawal by Subject|0|||
33533955|NCT02802735|62924060|FG001|Overall Study|Withdrawal by Subject|1|||
33533956|NCT02802735|62924061|FG002|Overall Study|Withdrawal by Subject|0|||
33533957|NCT02802735|62924062|FG003|Overall Study|Withdrawal by Subject|0|||
33533958|NCT02802735|62924063|FG004|Overall Study|Withdrawal by Subject|0|||
33533959|NCT02799381|62924093|FG000|Overall Study|Withdrew consent|3|||
33533960|NCT02799381|62924094|FG001|Overall Study|Withdrew consent|2|||
33533961|NCT02799381|62924093|FG000|Overall Study|Adverse Event|0|||
33533962|NCT02799381|62924094|FG001|Overall Study|Adverse Event|1|||
33533963|NCT02799381|62924093|FG000|Overall Study|Participant did not take any study drug|1|||
33533964|NCT02799381|62924094|FG001|Overall Study|Participant did not take any study drug|0|||
33533965|NCT01333059|62924102|FG000|Overall Study|Physician Decision|3|||
33533966|NCT01333059|62924103|FG001|Overall Study|Physician Decision|3|||
33533967|NCT01333059|62924102|FG000|Overall Study|Protocol Violation|3|||
33533968|NCT01333059|62924103|FG001|Overall Study|Protocol Violation|0|||
33627127|NCT01989572|63028238|FG000|Overall Study|Death|0|||
33627128|NCT01989572|63028239|FG001|Overall Study|Death|0|||
33627129|NCT01989572|63028240|FG002|Overall Study|Death|0|||
33627130|NCT01989572|63028241|FG003|Overall Study|Death|0|||
33627131|NCT01989572|63028242|FG004|Overall Study|Death|1|||
33627132|NCT01989572|63028243|FG005|Overall Study|Death|0|||
33627133|NCT01989572|63028238|FG000|Overall Study|Withdrawal by Subject|4|||
33627134|NCT01989572|63028239|FG001|Overall Study|Withdrawal by Subject|1|||
33533969|NCT01370733|62924113|FG000|Overall Study|Withdrawal by Subject|8|||
33627135|NCT01989572|63028240|FG002|Overall Study|Withdrawal by Subject|5|||
33627136|NCT01989572|63028241|FG003|Overall Study|Withdrawal by Subject|1|||
33627137|NCT01989572|63028242|FG004|Overall Study|Withdrawal by Subject|12|||
33627138|NCT01989572|63028243|FG005|Overall Study|Withdrawal by Subject|4|||
33627139|NCT01989572|63028238|FG000|Overall Study|complicating disease|1|||
33627140|NCT01989572|63028239|FG001|Overall Study|complicating disease|1|||
33627141|NCT01989572|63028240|FG002|Overall Study|complicating disease|2|||
33627142|NCT01989572|63028241|FG003|Overall Study|complicating disease|0|||
33627143|NCT01989572|63028242|FG004|Overall Study|complicating disease|1|||
33627144|NCT01989572|63028243|FG005|Overall Study|complicating disease|0|||
33627145|NCT01989572|63028238|FG000|Overall Study|error|2|||
33627146|NCT01989572|63028239|FG001|Overall Study|error|1|||
33627147|NCT01989572|63028240|FG002|Overall Study|error|1|||
33627148|NCT01989572|63028241|FG003|Overall Study|error|1|||
33627149|NCT01989572|63028242|FG004|Overall Study|error|1|||
33627150|NCT01989572|63028243|FG005|Overall Study|error|1|||
33627151|NCT01989572|63028238|FG000|Overall Study|maximum dose reached|0|||
33627152|NCT01989572|63028239|FG001|Overall Study|maximum dose reached|1|||
33627153|NCT01989572|63028240|FG002|Overall Study|maximum dose reached|0|||
33627154|NCT01989572|63028241|FG003|Overall Study|maximum dose reached|0|||
33627155|NCT01989572|63028242|FG004|Overall Study|maximum dose reached|1|||
33627156|NCT01989572|63028243|FG005|Overall Study|maximum dose reached|0|||
33627157|NCT01989572|63028238|FG000|Overall Study|unknown/not specify|3|||
33627158|NCT01989572|63028239|FG001|Overall Study|unknown/not specify|4|||
33627159|NCT01989572|63028240|FG002|Overall Study|unknown/not specify|1|||
33627160|NCT01989572|63028241|FG003|Overall Study|unknown/not specify|3|||
33627161|NCT01989572|63028242|FG004|Overall Study|unknown/not specify|3|||
33627162|NCT01989572|63028243|FG005|Overall Study|unknown/not specify|5|||
33627163|NCT01989572|63028238|FG000|Overall Study|not start protocol therapy|5|||
33627164|NCT01989572|63028239|FG001|Overall Study|not start protocol therapy|1|||
33627165|NCT01989572|63028240|FG002|Overall Study|not start protocol therapy|2|||
33627166|NCT01989572|63028241|FG003|Overall Study|not start protocol therapy|3|||
33627167|NCT01989572|63028242|FG004|Overall Study|not start protocol therapy|4|||
33627168|NCT01989572|63028243|FG005|Overall Study|not start protocol therapy|18|||
33627169|NCT01989572|63028238|FG000|Overall Study|alternative therapy|3|||
33627170|NCT01989572|63028239|FG001|Overall Study|alternative therapy|0|||
33627171|NCT01989572|63028240|FG002|Overall Study|alternative therapy|0|||
33627172|NCT01989572|63028241|FG003|Overall Study|alternative therapy|0|||
33627173|NCT01989572|63028242|FG004|Overall Study|alternative therapy|1|||
33627174|NCT01989572|63028243|FG005|Overall Study|alternative therapy|3|||
33627175|NCT02036294|63028263|FG000|Overall Study|Death|7|||
33627176|NCT02036294|63028264|FG001|Overall Study|Death|8|||
33627177|NCT02036294|63028263|FG000|Overall Study|Withdrawal by Subject|2|||
33627178|NCT02036294|63028264|FG001|Overall Study|Withdrawal by Subject|3|||
33627179|NCT02035748|63028270|FG000|Overall Study|Adverse Event|5|||
33627180|NCT02035748|63028270|FG000|Overall Study|Death|3|||
33627181|NCT02035748|63028270|FG000|Overall Study|Lost to Follow-up|2|||
33627182|NCT02035748|63028270|FG000|Overall Study|Physician Decision|3|||
33627183|NCT02035748|63028270|FG000|Overall Study|Withdrawal by Subject|6|||
33627184|NCT02035748|63028270|FG000|Overall Study|Progressive Disease|1|||
33627185|NCT02014376|63028278|FG000|Overall Study|Adverse Event|1|||
33627186|NCT02014376|63028279|FG001|Overall Study|Adverse Event|1|||
33627187|NCT02014376|63028280|FG002|Overall Study|Adverse Event|0|||
33627188|NCT02014376|63028278|FG000|Overall Study|Lost to Follow-up|2|||
33627189|NCT02014376|63028279|FG001|Overall Study|Lost to Follow-up|0|||
33627190|NCT02014376|63028280|FG002|Overall Study|Lost to Follow-up|0|||
33627191|NCT02035202|63028291|FG000|Overall Study|Lost to Follow-up|8|||
33627192|NCT02035202|63028292|FG001|Overall Study|Lost to Follow-up|16|||
33627193|NCT02035202|63028293|FG002|Overall Study|Lost to Follow-up|2|||
33627194|NCT01988402|63028303|FG000|Overall Study|Adverse Event|1|||
33627195|NCT01988402|63028304|FG001|Overall Study|Adverse Event|2|||
33627196|NCT01988402|63028303|FG000|Overall Study|Withdrawal by Subject|1|||
33627197|NCT01988402|63028304|FG001|Overall Study|Withdrawal by Subject|0|||
33627198|NCT01988090|63028312|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
33627199|NCT01988090|63028313|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
33627200|NCT01988090|63028312|FG000|Start Treament After Randomization|Protocol Violation|0|||
33627201|NCT01988090|63028313|FG001|Start Treament After Randomization|Protocol Violation|1|||
33627202|NCT01988090|63028312|FG000|Complete Study After Start|Withdrawal by Subject|2|||
33627203|NCT01988090|63028313|FG001|Complete Study After Start|Withdrawal by Subject|0|||
33627204|NCT01988090|63028312|FG000|Complete Study After Start|Protocol Violation|1|||
33627205|NCT01988090|63028313|FG001|Complete Study After Start|Protocol Violation|1|||
33627206|NCT01988012|63028319|FG000|Overall Study|Adverse Event|5|||
33627207|NCT01988012|63028319|FG000|Overall Study|Insufficient Therapeutic Response|3|||
33627208|NCT01988012|63028319|FG000|Overall Study|Patient Withdrawal of Consent|4|||
33627209|NCT01988012|63028319|FG000|Overall Study|Lost to Follow-up|1|||
33627210|NCT01988012|63028319|FG000|Overall Study|Physician Decision|1|||
33627211|NCT01988012|63028319|FG000|Overall Study|Protocol Violation|1|||
33627212|NCT02011945|63028326|FG000|Overall Study|Participant requested to Discontinue|0|||
33627213|NCT02011945|63028327|FG001|Overall Study|Participant requested to Discontinue|1|||
33627214|NCT02011945|63028328|FG002|Overall Study|Participant requested to Discontinue|1|||
33627215|NCT02011945|63028326|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
33627216|NCT02011945|63028327|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
33627217|NCT02011945|63028328|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
33627218|NCT02011945|63028326|FG000|Overall Study|Study Drug Toxicity|0|||
33627219|NCT02011945|63028327|FG001|Overall Study|Study Drug Toxicity|0|||
33627220|NCT02011945|63028328|FG002|Overall Study|Study Drug Toxicity|1|||
33459544|NCT03605836|62832992|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
33459545|NCT03605836|62832993|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
33459546|NCT03605836|62832994|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
33459547|NCT03605836|62832991|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
33459548|NCT03605836|62832992|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
33459549|NCT03605836|62832993|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
33459550|NCT03605836|62832994|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
33459551|NCT03605836|62832991|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
33459552|NCT03605836|62832992|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
33459553|NCT03605836|62832993|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
33459554|NCT03605836|62832994|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
33459555|NCT03605836|62832991|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
33459556|NCT03605836|62832992|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
33459557|NCT03605836|62832993|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
33459558|NCT03605836|62832994|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
33459559|NCT03605836|62832991|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
33459560|NCT03605836|62832992|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
33459561|NCT03605836|62832993|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
33533970|NCT01370733|62924114|FG001|Overall Study|Withdrawal by Subject|8|||
33533971|NCT01370733|62924113|FG000|Overall Study|Lost to Follow-up|3|||
33533972|NCT01370733|62924114|FG001|Overall Study|Lost to Follow-up|0|||
33533973|NCT01370733|62924113|FG000|Overall Study|Adverse Event|2|||
33533974|NCT01370733|62924114|FG001|Overall Study|Adverse Event|4|||
33533975|NCT01370733|62924113|FG000|Overall Study|Lack of Efficacy|3|||
33533976|NCT01370733|62924114|FG001|Overall Study|Lack of Efficacy|5|||
33533977|NCT01370733|62924113|FG000|Overall Study|Physician Decision|0|||
33533978|NCT01370733|62924114|FG001|Overall Study|Physician Decision|2|||
33533979|NCT01370733|62924113|FG000|Overall Study|Protocol Violation|1|||
33533980|NCT01370733|62924114|FG001|Overall Study|Protocol Violation|3|||
33533981|NCT02613364|62924123|FG000|Overall Study|Other|19|||
33533982|NCT02613364|62924124|FG001|Overall Study|Other|29|||
33533983|NCT02613364|62924125|FG002|Overall Study|Other|17|||
33533984|NCT02613364|62924123|FG000|Overall Study|Too time consuming|21|||
33533985|NCT02613364|62924124|FG001|Overall Study|Too time consuming|26|||
33533986|NCT02613364|62924125|FG002|Overall Study|Too time consuming|26|||
33533987|NCT02613364|62924123|FG000|Overall Study|Withdrawal by Subject|13|||
33533988|NCT02613364|62924124|FG001|Overall Study|Withdrawal by Subject|18|||
33533989|NCT02613364|62924125|FG002|Overall Study|Withdrawal by Subject|17|||
33533990|NCT02613364|62924123|FG000|Overall Study|Medical|12|||
33533991|NCT02613364|62924124|FG001|Overall Study|Medical|13|||
33533992|NCT02613364|62924125|FG002|Overall Study|Medical|9|||
33533993|NCT02613364|62924123|FG000|Overall Study|Disliked Study Procedure|1|||
33533994|NCT02613364|62924124|FG001|Overall Study|Disliked Study Procedure|1|||
33533995|NCT02613364|62924125|FG002|Overall Study|Disliked Study Procedure|4|||
33533996|NCT02613364|62924123|FG000|Overall Study|Disliked Intervention|0|||
33533997|NCT02613364|62924124|FG001|Overall Study|Disliked Intervention|3|||
33533998|NCT02613364|62924125|FG002|Overall Study|Disliked Intervention|3|||
33533999|NCT01370655|62924145|FG000|Period 1|Adverse Event|2|||
33534000|NCT01370655|62924146|FG001|Period 1|Adverse Event|0|||
33534001|NCT01370655|62924147|FG002|Period 1|Adverse Event|0|||
33534002|NCT01370655|62924148|FG003|Period 1|Adverse Event|0|||
33534003|NCT01370655|62924149|FG004|Period 1|Adverse Event|0|||
33534004|NCT01370655|62924150|FG005|Period 1|Adverse Event|0|||
33534005|NCT01370655|62924151|FG006|Period 1|Adverse Event|1|||
33534006|NCT01370655|62924152|FG007|Period 1|Adverse Event|0|||
33534007|NCT01370655|62924153|FG008|Period 1|Adverse Event|0|||
33534008|NCT01370655|62924154|FG009|Period 1|Adverse Event|0|||
33534009|NCT01370655|62924155|FG010|Period 1|Adverse Event|0|||
33534010|NCT01370655|62924156|FG011|Period 1|Adverse Event|0|||
33534011|NCT01370655|62924145|FG000|Period 2|Adverse Event|0|||
33534012|NCT01370655|62924146|FG001|Period 2|Adverse Event|0|||
33534013|NCT01370655|62924147|FG002|Period 2|Adverse Event|1|||
33534014|NCT01370655|62924148|FG003|Period 2|Adverse Event|0|||
33534015|NCT01370655|62924149|FG004|Period 2|Adverse Event|1|||
33534016|NCT01370655|62924150|FG005|Period 2|Adverse Event|0|||
33534017|NCT01370655|62924151|FG006|Period 2|Adverse Event|0|||
33627221|NCT02011945|63028326|FG000|Overall Study|Treatment Failure|0|||
33627222|NCT02011945|63028327|FG001|Overall Study|Treatment Failure|7|||
33627223|NCT02011945|63028328|FG002|Overall Study|Treatment Failure|6|||
33627224|NCT02011945|63028326|FG000|Overall Study|No Longer Meets Study Criteria|1|||
33627225|NCT02011945|63028327|FG001|Overall Study|No Longer Meets Study Criteria|0|||
33627226|NCT02011945|63028328|FG002|Overall Study|No Longer Meets Study Criteria|0|||
33627227|NCT02011945|63028326|FG000|Overall Study|Proceeded to stem cell transplant|0|||
33534018|NCT01370655|62924152|FG007|Period 2|Adverse Event|1|||
33534019|NCT01370655|62924153|FG008|Period 2|Adverse Event|0|||
33534020|NCT01370655|62924154|FG009|Period 2|Adverse Event|0|||
33534021|NCT01370655|62924155|FG010|Period 2|Adverse Event|0|||
33534022|NCT01370655|62924156|FG011|Period 2|Adverse Event|0|||
33534023|NCT01370655|62924145|FG000|Period 2|met protocol specified stopping criteria|0|||
33627228|NCT02011945|63028327|FG001|Overall Study|Proceeded to stem cell transplant|0|||
33627229|NCT02011945|63028328|FG002|Overall Study|Proceeded to stem cell transplant|1|||
33627230|NCT02011945|63028326|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
33627231|NCT02011945|63028327|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
33627232|NCT02011945|63028328|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
33627233|NCT02013830|63028336|FG000|Overall Study|Adverse Event|3|||
33627234|NCT02013830|63028336|FG000|Overall Study|Death|1|||
33627235|NCT02013830|63028336|FG000|Overall Study|Insufficient therapeutic response|25|||
33627236|NCT02013830|63028336|FG000|Overall Study|Refused treatment|1|||
33627237|NCT02010775|63028345|FG000|Overall Study|Adverse Event|0|||
33459562|NCT03605836|62832994|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
33459563|NCT03605836|62832991|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
33459564|NCT03605836|62832992|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
33459565|NCT03605836|62832993|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
33459566|NCT03605836|62832994|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
33459567|NCT03605836|62832991|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
33459568|NCT03605836|62832992|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
33459569|NCT03605836|62832993|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
33534024|NCT01370655|62924146|FG001|Period 2|met protocol specified stopping criteria|0|||
33459570|NCT03605836|62832994|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
33459571|NCT03605836|62832991|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
33459572|NCT03605836|62832992|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
33459573|NCT03605836|62832993|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
33459574|NCT03605836|62832994|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
33459575|NCT03605836|62832991|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
33459576|NCT03605836|62832992|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
33459577|NCT03605836|62832993|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
33459578|NCT03605836|62832994|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
33459579|NCT03605836|62832991|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
33459580|NCT03605836|62832992|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
33459581|NCT03605836|62832993|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
33459582|NCT03605836|62832994|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
33459583|NCT03605836|62832991|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
33534025|NCT01370655|62924147|FG002|Period 2|met protocol specified stopping criteria|1|||
33534026|NCT01370655|62924148|FG003|Period 2|met protocol specified stopping criteria|0|||
33534027|NCT01370655|62924149|FG004|Period 2|met protocol specified stopping criteria|0|||
33534028|NCT01370655|62924150|FG005|Period 2|met protocol specified stopping criteria|0|||
33534029|NCT01370655|62924151|FG006|Period 2|met protocol specified stopping criteria|1|||
33534030|NCT01370655|62924152|FG007|Period 2|met protocol specified stopping criteria|0|||
33534031|NCT01370655|62924153|FG008|Period 2|met protocol specified stopping criteria|1|||
33534032|NCT01370655|62924154|FG009|Period 2|met protocol specified stopping criteria|0|||
33534033|NCT01370655|62924155|FG010|Period 2|met protocol specified stopping criteria|1|||
33534034|NCT01370655|62924156|FG011|Period 2|met protocol specified stopping criteria|0|||
33534035|NCT01370655|62924145|FG000|Period 2|Withdrawal by Subject|0|||
33534036|NCT01370655|62924146|FG001|Period 2|Withdrawal by Subject|0|||
33534037|NCT01370655|62924147|FG002|Period 2|Withdrawal by Subject|0|||
33534038|NCT01370655|62924148|FG003|Period 2|Withdrawal by Subject|0|||
33534039|NCT01370655|62924149|FG004|Period 2|Withdrawal by Subject|0|||
33534040|NCT01370655|62924150|FG005|Period 2|Withdrawal by Subject|0|||
33534041|NCT01370655|62924151|FG006|Period 2|Withdrawal by Subject|0|||
33534042|NCT01370655|62924152|FG007|Period 2|Withdrawal by Subject|0|||
33534043|NCT01370655|62924153|FG008|Period 2|Withdrawal by Subject|1|||
33534044|NCT01370655|62924154|FG009|Period 2|Withdrawal by Subject|0|||
33534045|NCT01370655|62924155|FG010|Period 2|Withdrawal by Subject|0|||
33534046|NCT01370655|62924156|FG011|Period 2|Withdrawal by Subject|0|||
33534047|NCT02612194|62924169|FG000|Overall Study|Death|5|||
33534048|NCT02612194|62924170|FG001|Overall Study|Death|0|||
33534049|NCT02612194|62924171|FG002|Overall Study|Death|2|||
33534050|NCT02612194|62924169|FG000|Overall Study|Early Study Termination|1|||
33534051|NCT02612194|62924170|FG001|Overall Study|Early Study Termination|0|||
33627238|NCT02010775|63028346|FG001|Overall Study|Adverse Event|0|||
33627239|NCT02010775|63028347|FG002|Overall Study|Adverse Event|0|||
33627240|NCT02010775|63028348|FG003|Overall Study|Adverse Event|0|||
33627241|NCT02010775|63028349|FG004|Overall Study|Adverse Event|1|||
33627242|NCT02010775|63028345|FG000|Overall Study|Pregnancy|0|||
33627243|NCT02010775|63028346|FG001|Overall Study|Pregnancy|0|||
33627244|NCT02010775|63028347|FG002|Overall Study|Pregnancy|2|||
33627245|NCT02010775|63028348|FG003|Overall Study|Pregnancy|0|||
33627246|NCT02010775|63028349|FG004|Overall Study|Pregnancy|0|||
33627247|NCT02010775|63028345|FG000|Overall Study|Lost to Follow-up|2|||
33534052|NCT02612194|62924171|FG002|Overall Study|Early Study Termination|0|||
33534053|NCT02798211|62924181|FG000|Period 1|Adverse Event|1|||
33534054|NCT02798211|62924182|FG001|Period 1|Adverse Event|1|||
33534055|NCT02798211|62924183|FG002|Period 1|Adverse Event|0|||
33534056|NCT02798211|62924184|FG003|Period 1|Adverse Event|0|||
33534057|NCT02798211|62924185|FG004|Period 1|Adverse Event|0|||
33534058|NCT02798211|62924186|FG005|Period 1|Adverse Event|0|||
33534059|NCT02798211|62924181|FG000|Period 1|Lost to Follow-up|2|||
33534060|NCT02798211|62924182|FG001|Period 1|Lost to Follow-up|1|||
33534061|NCT02798211|62924183|FG002|Period 1|Lost to Follow-up|0|||
33534062|NCT02798211|62924184|FG003|Period 1|Lost to Follow-up|0|||
33627248|NCT02010775|63028346|FG001|Overall Study|Lost to Follow-up|0|||
33534063|NCT02798211|62924185|FG004|Period 1|Lost to Follow-up|0|||
33627249|NCT02010775|63028347|FG002|Overall Study|Lost to Follow-up|0|||
33627250|NCT02010775|63028348|FG003|Overall Study|Lost to Follow-up|1|||
33627251|NCT02010775|63028349|FG004|Overall Study|Lost to Follow-up|1|||
33627252|NCT02010775|63028345|FG000|Overall Study|Personal Reasons|3|||
33627253|NCT02010775|63028346|FG001|Overall Study|Personal Reasons|3|||
33534064|NCT02798211|62924186|FG005|Period 1|Lost to Follow-up|0|||
33534065|NCT02798211|62924181|FG000|Period 1|Protocol Violation|0|||
33534066|NCT02798211|62924182|FG001|Period 1|Protocol Violation|0|||
33534067|NCT02798211|62924183|FG002|Period 1|Protocol Violation|2|||
33534068|NCT02798211|62924184|FG003|Period 1|Protocol Violation|0|||
33534069|NCT02798211|62924185|FG004|Period 1|Protocol Violation|0|||
33534070|NCT02798211|62924186|FG005|Period 1|Protocol Violation|0|||
33534071|NCT02798211|62924181|FG000|Period 1|Withdrawal by Subject|1|||
33534072|NCT02798211|62924182|FG001|Period 1|Withdrawal by Subject|1|||
33534073|NCT02798211|62924183|FG002|Period 1|Withdrawal by Subject|0|||
33534074|NCT02798211|62924184|FG003|Period 1|Withdrawal by Subject|0|||
33534075|NCT02798211|62924185|FG004|Period 1|Withdrawal by Subject|0|||
33534076|NCT02798211|62924186|FG005|Period 1|Withdrawal by Subject|0|||
33534077|NCT02798211|62924181|FG000|Period 1|Death|0|||
33534078|NCT02798211|62924182|FG001|Period 1|Death|0|||
33534079|NCT02798211|62924183|FG002|Period 1|Death|1|||
33534080|NCT02798211|62924184|FG003|Period 1|Death|0|||
33534081|NCT02798211|62924185|FG004|Period 1|Death|0|||
33534082|NCT02798211|62924186|FG005|Period 1|Death|0|||
33534083|NCT02798211|62924181|FG000|Period 1|Withdrawal of Informed Consent|2|||
33534084|NCT02798211|62924182|FG001|Period 1|Withdrawal of Informed Consent|7|||
33534085|NCT02798211|62924183|FG002|Period 1|Withdrawal of Informed Consent|3|||
33534086|NCT02798211|62924184|FG003|Period 1|Withdrawal of Informed Consent|0|||
33534087|NCT02798211|62924185|FG004|Period 1|Withdrawal of Informed Consent|0|||
33534088|NCT02798211|62924186|FG005|Period 1|Withdrawal of Informed Consent|0|||
33534089|NCT02798211|62924181|FG000|Period 2|Withdrawal by Subject|2|||
33534090|NCT02798211|62924182|FG001|Period 2|Withdrawal by Subject|0|||
33534091|NCT02798211|62924183|FG002|Period 2|Withdrawal by Subject|0|||
33534092|NCT02798211|62924184|FG003|Period 2|Withdrawal by Subject|0|||
33534093|NCT02798211|62924185|FG004|Period 2|Withdrawal by Subject|2|||
33534094|NCT02798211|62924186|FG005|Period 2|Withdrawal by Subject|2|||
33534095|NCT02798211|62924181|FG000|Period 2|Adverse Event|5|||
33627254|NCT02010775|63028347|FG002|Overall Study|Personal Reasons|1|||
33627255|NCT02010775|63028348|FG003|Overall Study|Personal Reasons|2|||
33627256|NCT02010775|63028349|FG004|Overall Study|Personal Reasons|4|||
33627257|NCT01993615|63028363|FG000|Overall Study|Death|1|||
33326029|NCT01161173|62702801|FG000|Overall Study|Death|194|||
33534096|NCT02798211|62924182|FG001|Period 2|Adverse Event|0|||
33534097|NCT02798211|62924183|FG002|Period 2|Adverse Event|0|||
33534098|NCT02798211|62924184|FG003|Period 2|Adverse Event|0|||
33534099|NCT02798211|62924185|FG004|Period 2|Adverse Event|1|||
33534100|NCT02798211|62924186|FG005|Period 2|Adverse Event|0|||
33534101|NCT02798211|62924181|FG000|Period 2|Lack of Efficacy|1|||
33534102|NCT02798211|62924182|FG001|Period 2|Lack of Efficacy|0|||
33534103|NCT02798211|62924183|FG002|Period 2|Lack of Efficacy|0|||
33534104|NCT02798211|62924184|FG003|Period 2|Lack of Efficacy|1|||
33534105|NCT02798211|62924185|FG004|Period 2|Lack of Efficacy|0|||
33534106|NCT02798211|62924186|FG005|Period 2|Lack of Efficacy|1|||
33534107|NCT02798211|62924181|FG000|Period 2|Lost to Follow-up|3|||
33534108|NCT02798211|62924182|FG001|Period 2|Lost to Follow-up|0|||
33534109|NCT02798211|62924183|FG002|Period 2|Lost to Follow-up|0|||
33534110|NCT02798211|62924184|FG003|Period 2|Lost to Follow-up|0|||
33627258|NCT01993615|63028364|FG001|Overall Study|Death|0|||
33627259|NCT01619059|63028372|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
33534111|NCT02798211|62924185|FG004|Period 2|Lost to Follow-up|2|||
33534112|NCT02798211|62924186|FG005|Period 2|Lost to Follow-up|0|||
33534113|NCT02798211|62924181|FG000|Period 2|Physician Decision|1|||
33534114|NCT02798211|62924182|FG001|Period 2|Physician Decision|0|||
33534115|NCT02798211|62924183|FG002|Period 2|Physician Decision|0|||
33534116|NCT02798211|62924184|FG003|Period 2|Physician Decision|1|||
33534117|NCT02798211|62924185|FG004|Period 2|Physician Decision|1|||
33534118|NCT02798211|62924186|FG005|Period 2|Physician Decision|0|||
33534119|NCT02798211|62924181|FG000|Period 2|Pregnancy|0|||
33534120|NCT02798211|62924182|FG001|Period 2|Pregnancy|0|||
33534121|NCT02798211|62924183|FG002|Period 2|Pregnancy|0|||
33534122|NCT02798211|62924184|FG003|Period 2|Pregnancy|2|||
33534123|NCT02798211|62924185|FG004|Period 2|Pregnancy|0|||
33534124|NCT02798211|62924186|FG005|Period 2|Pregnancy|0|||
33534125|NCT02798211|62924181|FG000|Period 2|Technical problems|1|||
33534126|NCT02798211|62924182|FG001|Period 2|Technical problems|0|||
33534127|NCT02798211|62924183|FG002|Period 2|Technical problems|0|||
33534128|NCT02798211|62924184|FG003|Period 2|Technical problems|1|||
33534129|NCT02798211|62924185|FG004|Period 2|Technical problems|0|||
33534130|NCT02798211|62924186|FG005|Period 2|Technical problems|0|||
33534131|NCT02798211|62924181|FG000|Period 2|Withdrawal of Informed Consent|1|||
33534132|NCT02798211|62924182|FG001|Period 2|Withdrawal of Informed Consent|0|||
33534133|NCT02798211|62924183|FG002|Period 2|Withdrawal of Informed Consent|0|||
33534134|NCT02798211|62924184|FG003|Period 2|Withdrawal of Informed Consent|2|||
33534135|NCT02798211|62924185|FG004|Period 2|Withdrawal of Informed Consent|2|||
33534136|NCT02798211|62924186|FG005|Period 2|Withdrawal of Informed Consent|3|||
33534137|NCT02799069|62924201|FG000|Overall Study|Adverse Event|0|||
33534138|NCT02799069|62924202|FG001|Overall Study|Adverse Event|2|||
33534139|NCT02799069|62924203|FG002|Overall Study|Adverse Event|2|||
33534140|NCT02799069|62924201|FG000|Overall Study|Lack of Efficacy|2|||
33534141|NCT02799069|62924202|FG001|Overall Study|Lack of Efficacy|0|||
33534142|NCT02799069|62924203|FG002|Overall Study|Lack of Efficacy|0|||
33627260|NCT01619059|63028373|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
33627261|NCT01619059|63028372|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
33627262|NCT01619059|63028373|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
33627263|NCT01619059|63028372|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
33627264|NCT01619059|63028373|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
33627265|NCT01619059|63028372|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
33459584|NCT03605836|62832992|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
33459585|NCT03605836|62832993|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
33459586|NCT03605836|62832994|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
33459587|NCT03605836|62832991|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
33459588|NCT03605836|62832992|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
33459589|NCT03605836|62832993|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
33459590|NCT03605836|62832994|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
33459591|NCT03605836|62832991|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
33459592|NCT03605836|62832992|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
33459593|NCT03605836|62832993|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
33459594|NCT03605836|62832994|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
33459595|NCT03605836|62832991|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
33459596|NCT03605836|62832992|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
33459597|NCT03605836|62832993|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
33459598|NCT03605836|62832994|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
33459599|NCT03605680|62833007|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
33459600|NCT03605680|62833008|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
33459601|NCT03605680|62833009|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
33459602|NCT03605680|62833010|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
33459603|NCT03605680|62833007|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
33459604|NCT03605680|62833008|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
33459605|NCT03605680|62833009|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
33459606|NCT03605680|62833010|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
33459607|NCT03605680|62833007|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
33459608|NCT03605680|62833008|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
33534143|NCT02799069|62924201|FG000|Overall Study|Lost to Follow-up|1|||
33534144|NCT02799069|62924202|FG001|Overall Study|Lost to Follow-up|1|||
33534145|NCT02799069|62924203|FG002|Overall Study|Lost to Follow-up|0|||
33534146|NCT02799069|62924201|FG000|Overall Study|Withdrawal by Subject|4|||
33534147|NCT02799069|62924202|FG001|Overall Study|Withdrawal by Subject|4|||
33534148|NCT02799069|62924203|FG002|Overall Study|Withdrawal by Subject|3|||
33534149|NCT02799069|62924201|FG000|Overall Study|Protocol Violation|1|||
33534150|NCT02799069|62924202|FG001|Overall Study|Protocol Violation|0|||
33534151|NCT02799069|62924203|FG002|Overall Study|Protocol Violation|2|||
33534152|NCT01669174|62924213|FG000|Overall Study|Subject withdrew consent|2|||
33627266|NCT01619059|63028373|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
33627267|NCT01619059|63028372|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
33627268|NCT01619059|63028373|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
33627269|NCT01619059|63028372|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
33627270|NCT01619059|63028373|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
33627271|NCT01619059|63028372|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
33627272|NCT01619059|63028373|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
33627273|NCT01619059|63028372|FG000|Long-Term (LT) Treatment Period|Death|1|||
33627274|NCT01619059|63028373|FG001|Long-Term (LT) Treatment Period|Death|0|||
33627275|NCT01619059|63028372|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
33627276|NCT01619059|63028373|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
33627277|NCT01619059|63028372|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
33627278|NCT01619059|63028373|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
33627279|NCT02013206|63028381|FG000|Overall Study|Progressive disease (PD)|14|||
33627280|NCT02013206|63028382|FG001|Overall Study|Progressive disease (PD)|17|||
33627281|NCT02013206|63028381|FG000|Overall Study|Symptomatic deterioration|3|||
33627282|NCT02013206|63028382|FG001|Overall Study|Symptomatic deterioration|1|||
33627283|NCT02013206|63028381|FG000|Overall Study|Adverse Event|1|||
33627284|NCT02013206|63028382|FG001|Overall Study|Adverse Event|0|||
33627285|NCT02013206|63028381|FG000|Overall Study|Patient refusal|2|||
33627286|NCT02013206|63028382|FG001|Overall Study|Patient refusal|0|||
33627287|NCT02013206|63028381|FG000|Overall Study|Patient non-compliance|1|||
33627288|NCT02013206|63028382|FG001|Overall Study|Patient non-compliance|0|||
33627289|NCT02013206|63028381|FG000|Overall Study|Death|1|||
33627290|NCT02013206|63028382|FG001|Overall Study|Death|2|||
33627291|NCT02013206|63028381|FG000|Overall Study|Other reasons off treatment|5|||
33627292|NCT02013206|63028382|FG001|Overall Study|Other reasons off treatment|2|||
33627293|NCT01807923|63028391|FG000|Overall Study|Adverse Event|2|||
33627294|NCT01807923|63028392|FG001|Overall Study|Adverse Event|1|||
33627295|NCT01807923|63028393|FG002|Overall Study|Adverse Event|2|||
33627296|NCT01807923|63028391|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
33627297|NCT01807923|63028392|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
33627298|NCT01807923|63028393|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
33627299|NCT01807923|63028391|FG000|Overall Study|Physician Decision|0|||
33627300|NCT01807923|63028392|FG001|Overall Study|Physician Decision|0|||
33627301|NCT01807923|63028393|FG002|Overall Study|Physician Decision|1|||
33627302|NCT01807923|63028391|FG000|Overall Study|Not Eligible (Genotype)|0|||
33627303|NCT01807923|63028392|FG001|Overall Study|Not Eligible (Genotype)|0|||
33627304|NCT01807923|63028393|FG002|Overall Study|Not Eligible (Genotype)|1|||
33627305|NCT01807923|63028391|FG000|Overall Study|Randomized But Not Treated|3|||
33627306|NCT01807923|63028392|FG001|Overall Study|Randomized But Not Treated|2|||
33459609|NCT03605680|62833009|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
33459610|NCT03605680|62833010|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
33459611|NCT03605680|62833007|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
33459612|NCT03605680|62833008|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
33459613|NCT03605680|62833009|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
33459614|NCT03605680|62833010|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
33459615|NCT03605680|62833007|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
33459616|NCT03605680|62833008|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
33459617|NCT03605680|62833009|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
33459618|NCT03605680|62833010|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
33459619|NCT03605680|62833007|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
33459620|NCT03605680|62833008|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
33459621|NCT03605680|62833009|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
33459622|NCT03605680|62833010|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
33459623|NCT03605680|62833007|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
33459624|NCT03605680|62833008|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
33459625|NCT03605680|62833009|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
33459626|NCT03605680|62833010|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
33459627|NCT03605680|62833007|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
33459628|NCT03605680|62833008|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
33459629|NCT03605680|62833009|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
33459630|NCT03605680|62833010|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
33459631|NCT03605680|62833007|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
33459632|NCT03605680|62833008|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
33459633|NCT03605680|62833009|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
33459634|NCT03605680|62833010|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
33459635|NCT03605680|62833007|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
33459636|NCT03605680|62833008|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
33627307|NCT01807923|63028393|FG002|Overall Study|Randomized But Not Treated|5|||
33627308|NCT01966003|63028405|FG000|Overall Study|Death|43|||
33627309|NCT01966003|63028406|FG001|Overall Study|Death|36|||
33627310|NCT01966003|63028405|FG000|Overall Study|Protocol Violation|6|||
33627311|NCT01966003|63028406|FG001|Overall Study|Protocol Violation|4|||
33627312|NCT01966003|63028405|FG000|Overall Study|Lost to Follow-up|4|||
33627313|NCT01966003|63028406|FG001|Overall Study|Lost to Follow-up|3|||
33627314|NCT01966003|63028405|FG000|Overall Study|Physician Decision|12|||
33627315|NCT01966003|63028406|FG001|Overall Study|Physician Decision|13|||
33627316|NCT01966003|63028405|FG000|Overall Study|Withdrawal by Subject|29|||
33627317|NCT01966003|63028406|FG001|Overall Study|Withdrawal by Subject|19|||
33627318|NCT01966003|63028405|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
33627319|NCT01966003|63028406|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
33627320|NCT01966003|63028405|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
33627321|NCT01966003|63028406|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
33627322|NCT01966003|63028405|FG000|Overall Study|Other|1|||
33627323|NCT01966003|63028406|FG001|Overall Study|Other|1|||
33627324|NCT01839279|63028415|FG000|Overall Study|Adverse Event|4|||
33627325|NCT01839279|63028416|FG001|Overall Study|Adverse Event|1|||
33534153|NCT01669174|62924214|FG001|Overall Study|Subject withdrew consent|2|||
33534154|NCT01669174|62924213|FG000|Overall Study|Lost to Follow-up|1|||
33534155|NCT01669174|62924214|FG001|Overall Study|Lost to Follow-up|0|||
33534156|NCT01669174|62924213|FG000|Overall Study|Adverse Event|2|||
33534157|NCT01669174|62924214|FG001|Overall Study|Adverse Event|2|||
33534158|NCT01669174|62924213|FG000|Overall Study|Administrative problems|1|||
33534159|NCT01669174|62924214|FG001|Overall Study|Administrative problems|2|||
33534160|NCT02798835|62924223|FG000|Overall Study|Protocol Violation|0|||
33534161|NCT02798835|62924224|FG001|Overall Study|Protocol Violation|0|||
33534162|NCT02798835|62924225|FG002|Overall Study|Protocol Violation|3|||
33534163|NCT02611882|62924236|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
33627326|NCT01839279|63028417|FG002|Overall Study|Adverse Event|1|||
33627327|NCT01839279|63028415|FG000|Overall Study|Withdrawal by Subject|4|||
33627328|NCT01839279|63028416|FG001|Overall Study|Withdrawal by Subject|1|||
33627329|NCT01839279|63028417|FG002|Overall Study|Withdrawal by Subject|1|||
33627330|NCT01839279|63028415|FG000|Overall Study|Classified as 'Other'|5|||
33627331|NCT01839279|63028416|FG001|Overall Study|Classified as 'Other'|0|||
33627332|NCT01839279|63028417|FG002|Overall Study|Classified as 'Other'|0|||
33459637|NCT03605680|62833009|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
33459638|NCT03605680|62833010|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
33459639|NCT03605680|62833007|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
33459640|NCT03605680|62833008|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
33459641|NCT03605680|62833009|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
33459642|NCT03605680|62833010|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
33459643|NCT03605680|62833007|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33459644|NCT03605680|62833008|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33459645|NCT03605680|62833009|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33459646|NCT03605680|62833010|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
33534164|NCT02611882|62924237|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
33534165|NCT02611882|62924238|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
33534166|NCT02796963|62924249|FG000|Overall Study|Lost to Follow-up|89|||
33534167|NCT02796963|62924250|FG001|Overall Study|Lost to Follow-up|76|||
33534168|NCT02796963|62924251|FG002|Overall Study|Lost to Follow-up|69|||
33534169|NCT02796963|62924252|FG003|Overall Study|Lost to Follow-up|72|||
33534170|NCT02796651|62924262|FG000|Overall Study|Adverse Event|6|||
33534171|NCT02796651|62924262|FG000|Overall Study|Lost to Follow-up|1|||
33534172|NCT02796651|62924262|FG000|Overall Study|Withdrawal by Subject|4|||
33534173|NCT02796651|62924262|FG000|Overall Study|Protocol Violation|4|||
33534174|NCT02796651|62924262|FG000|Overall Study|Lack of Efficacy|1|||
33534175|NCT02796651|62924262|FG000|Overall Study|Other|10|||
33534176|NCT02613208|62924277|FG000|Overall Study|Withdrawal by Subject|1|||
33534177|NCT02613208|62924277|FG000|Overall Study|Change of address|2|||
33534178|NCT02613208|62924277|FG000|Overall Study|Physician Decision|2|||
33534179|NCT02613208|62924277|FG000|Overall Study|Lost to Follow-up|5|||
33627333|NCT01807299|63028436|FG000|Overall Study|Protocol Violation|3|||
33534180|NCT02613208|62924277|FG000|Overall Study|Death|37|||
33534181|NCT01668784|62924283|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
33534182|NCT01668784|62924284|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
33627334|NCT01807299|63028437|FG001|Overall Study|Protocol Violation|1|||
33627335|NCT01807299|63028438|FG002|Overall Study|Protocol Violation|0|||
33627336|NCT01807299|63028439|FG003|Overall Study|Protocol Violation|2|||
33627337|NCT01965535|63028451|FG000|Overall Study|Lack of Efficacy|2|||
33534183|NCT01668784|62924283|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
33627338|NCT01965535|63028452|FG001|Overall Study|Lack of Efficacy|1|||
33627339|NCT01964755|63028458|FG000|Overall Study|Death|2|||
33627340|NCT01964521|63028462|FG000|Overall Study|Lost to Follow-up|4|||
33627341|NCT01992757|63028467|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
33627342|NCT01991743|63028476|FG000|Overall Study|external cephalic version not performed|0|||
33627343|NCT01991743|63028477|FG001|Overall Study|external cephalic version not performed|0|||
33627344|NCT01991743|63028478|FG002|Overall Study|external cephalic version not performed|1|||
33627345|NCT01991743|63028479|FG003|Overall Study|external cephalic version not performed|0|||
33627346|NCT01991197|63028491|FG000|Overall Study|Lost to Follow-up|1|||
33627347|NCT01991197|63028492|FG001|Overall Study|Lost to Follow-up|1|||
33627348|NCT01991197|63028491|FG000|Overall Study|Physician Decision|0|||
33627349|NCT01991197|63028492|FG001|Overall Study|Physician Decision|2|||
33627350|NCT01991197|63028491|FG000|Overall Study|Withdrawal by Subject|2|||
33534184|NCT01668784|62924284|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
33534185|NCT01668784|62924283|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
33534186|NCT01668784|62924284|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
33534187|NCT01668784|62924283|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
33534188|NCT01668784|62924284|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
33534189|NCT01668784|62924283|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
33534190|NCT01668784|62924284|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
33534191|NCT01668784|62924283|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
33627351|NCT01991197|63028492|FG001|Overall Study|Withdrawal by Subject|0|||
33627352|NCT01990573|63028506|FG000|Overall Study|Physician Decision|0|||
33627353|NCT01990573|63028507|FG001|Overall Study|Physician Decision|0|||
33627354|NCT01990573|63028508|FG002|Overall Study|Physician Decision|1|||
33627355|NCT01990495|63028518|FG000|Overall Study|Physician Decision|5|||
33627356|NCT01990495|63028519|FG001|Overall Study|Physician Decision|4|||
33627357|NCT01990339|63028527|FG000|Overall Study|Data Not Available|49|||
33627358|NCT01990339|63028527|FG000|Overall Study|Voluntary Withdrawal|1402|||
33627359|NCT01990339|63028527|FG000|Overall Study|Lost to Follow-up|861|||
33627360|NCT02007577|63028533|FG000|Overall Study|Adverse Event|1|||
33627361|NCT02007577|63028534|FG001|Overall Study|Adverse Event|0|||
33627362|NCT02007577|63028533|FG000|Overall Study|Withdrawal by Subject|0|||
33627363|NCT02007577|63028534|FG001|Overall Study|Withdrawal by Subject|1|||
33627364|NCT01990261|63028540|FG000|Overall Study|Death Before Treatment Start|2|||
33627365|NCT01990261|63028540|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
33627366|NCT01990261|63028540|FG000|Overall Study|Death From other Causes|1|||
33627367|NCT01990261|63028540|FG000|Overall Study|Disease Progression (PD)|8|||
33627368|NCT01990261|63028540|FG000|Overall Study|PD Before Treatment Start|1|||
33627369|NCT01990261|63028540|FG000|Overall Study|Dossier not Approved|1|||
33627370|NCT01990261|63028540|FG000|Overall Study|Lost to Follow-up|2|||
33627371|NCT01963117|63028544|FG000|Overall Study|Death|1|||
33627372|NCT02007109|63028548|FG000|Overall Study|Diary not returned or excluded|102|||
33627373|NCT02007109|63028548|FG000|Overall Study|Excluded - Age<7yo|9|||
33627374|NCT02006719|63028557|FG000|Overall Study|Withdrawal by Subject|10|||
33627375|NCT02006719|63028558|FG001|Overall Study|Withdrawal by Subject|2|||
33627376|NCT02006719|63028557|FG000|Overall Study|Lost to Follow-up|5|||
33627377|NCT02006719|63028558|FG001|Overall Study|Lost to Follow-up|1|||
33627378|NCT02006719|63028557|FG000|Overall Study|Protocol Violation|2|||
33627379|NCT02006719|63028558|FG001|Overall Study|Protocol Violation|0|||
33627380|NCT02006719|63028557|FG000|Overall Study|Adverse Event|1|||
33627381|NCT02006719|63028558|FG001|Overall Study|Adverse Event|1|||
33534192|NCT01668784|62924284|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
33534193|NCT01668784|62924283|FG000|Treatment Period|Disease Progression|316|||
33534194|NCT01668784|62924284|FG001|Treatment Period|Disease Progression|293|||
33534195|NCT01668784|62924283|FG000|Treatment Period|Study Drug Toxicity|46|||
33534196|NCT01668784|62924284|FG001|Treatment Period|Study Drug Toxicity|53|||
33534197|NCT01668784|62924283|FG000|Treatment Period|Death|1|||
33534198|NCT01668784|62924284|FG001|Treatment Period|Death|1|||
33534199|NCT01668784|62924283|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
33534200|NCT01668784|62924284|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
33534201|NCT01668784|62924283|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
33534202|NCT01668784|62924284|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
33534203|NCT01668784|62924283|FG000|Treatment Period|Withdrawal by Subject|5|||
33627382|NCT02006719|63028557|FG000|Overall Study|Other/Unknown|0|||
33627383|NCT02006719|63028558|FG001|Overall Study|Other/Unknown|1|||
33627384|NCT01962493|63028566|FG000|Overall Study|Adverse Event|1|||
33627385|NCT01962493|63028567|FG001|Overall Study|Adverse Event|2|||
33627386|NCT01962493|63028566|FG000|Overall Study|Protocol Violation|0|||
33627387|NCT01962493|63028567|FG001|Overall Study|Protocol Violation|1|||
33627388|NCT01962493|63028566|FG000|Overall Study|Withdrawal by Subject|4|||
33627389|NCT01962493|63028567|FG001|Overall Study|Withdrawal by Subject|2|||
33627390|NCT01989169|63028575|FG000|Period 2|Adverse Event|0|||
33627391|NCT01989169|63028576|FG001|Period 2|Adverse Event|1|||
33627392|NCT01988779|63028584|FG000|Overall Study|Withdrawal by Subject|2|||
33627393|NCT01988779|63028585|FG001|Overall Study|Withdrawal by Subject|2|||
33627394|NCT01988779|63028584|FG000|Overall Study|Protocol Violation|1|||
33627395|NCT01988779|63028585|FG001|Overall Study|Protocol Violation|0|||
33627396|NCT01988233|63028593|FG000|Overall Study|Lost to Follow-up|64|||
33627397|NCT01988233|63028594|FG001|Overall Study|Lost to Follow-up|51|||
33627398|NCT01987765|63028600|FG000|Overall Study|Protocol Violation|65|||
33627399|NCT01987765|63028600|FG000|Overall Study|Lost to Follow-up|37|||
33627400|NCT01987609|63028604|FG000|Overall Study|Adverse Event|1|||
33627401|NCT02013674|63028620|FG000|Overall Study|Death|0|||
33627402|NCT02013674|63028621|FG001|Overall Study|Death|1|||
33627403|NCT02013674|63028620|FG000|Overall Study|Lost to Follow-up|1|||
33627404|NCT02013674|63028621|FG001|Overall Study|Lost to Follow-up|0|||
33627405|NCT01987232|63028632|FG000|Overall Study|Ongoing in Study|0|||
33627406|NCT01987232|63028633|FG001|Overall Study|Ongoing in Study|0|||
33627407|NCT01987232|63028634|FG002|Overall Study|Ongoing in Study|0|||
33627408|NCT01987232|63028635|FG003|Overall Study|Ongoing in Study|1|||
33627409|NCT01987232|63028636|FG004|Overall Study|Ongoing in Study|0|||
33627410|NCT01986920|63028650|FG000|A- 101 25%|Withdrawal by Subject|1|||
33627411|NCT01986920|63028651|FG001|A- 101 25%|Withdrawal by Subject|0|||
33627412|NCT01986920|63028652|FG002|A- 101 25%|Withdrawal by Subject|0|||
33627413|NCT01986920|63028653|FG003|A- 101 25%|Withdrawal by Subject|0|||
33627414|NCT01986920|63028650|FG000|A-101 32.5%|Withdrawal by Subject|0|||
33627415|NCT01986920|63028651|FG001|A-101 32.5%|Withdrawal by Subject|1|||
33627416|NCT01986920|63028652|FG002|A-101 32.5%|Withdrawal by Subject|0|||
33627417|NCT01986920|63028653|FG003|A-101 32.5%|Withdrawal by Subject|0|||
33627418|NCT01986920|63028650|FG000|A-101 40%|Withdrawal by Subject|0|||
33627419|NCT01986920|63028651|FG001|A-101 40%|Withdrawal by Subject|0|||
33627420|NCT01986920|63028652|FG002|A-101 40%|Withdrawal by Subject|1|||
33627421|NCT01986920|63028653|FG003|A-101 40%|Withdrawal by Subject|0|||
33627422|NCT01986920|63028650|FG000|Placebo|Withdrawal by Subject|0|||
33627423|NCT01986920|63028651|FG001|Placebo|Withdrawal by Subject|0|||
33627424|NCT01986920|63028652|FG002|Placebo|Withdrawal by Subject|0|||
33627425|NCT01986920|63028653|FG003|Placebo|Withdrawal by Subject|1|||
33627426|NCT02010632|63028663|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
33627427|NCT02010632|63028664|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
33627428|NCT01986140|63028672|FG000|Overall Study|Withdrawal by Subject|31|||
33627429|NCT01986140|63028673|FG001|Overall Study|Withdrawal by Subject|25|||
33627430|NCT01986140|63028672|FG000|Overall Study|alternative treatment|1|||
33627431|NCT01986140|63028673|FG001|Overall Study|alternative treatment|1|||
33627432|NCT01986140|63028672|FG000|Overall Study|found not eligible|3|||
33326030|NCT01161173|62702801|FG000|Overall Study|End of Study|2|||
33326031|NCT01161173|62702801|FG000|Overall Study|Reasons Not Specified|23|||
33326032|NCT01159769|62702805|FG000|Overall Study|Adverse Event|1|||
33326033|NCT01159691|62702809|FG000|Overall Study|Lost to Follow-up|2|||
33326034|NCT01159691|62702809|FG000|Overall Study|Unknown reasons|1|||
33326035|NCT01159691|62702809|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
33627433|NCT01986140|63028673|FG001|Overall Study|found not eligible|0|||
33627434|NCT01986140|63028672|FG000|Overall Study|Adverse Event|0|||
33627435|NCT01986140|63028673|FG001|Overall Study|Adverse Event|1|||
33627436|NCT01986140|63028672|FG000|Overall Study|progression disease|0|||
33627437|NCT01986140|63028673|FG001|Overall Study|progression disease|1|||
33627438|NCT01986062|63028681|FG000|Overall Study|Lost to Follow-up|1|||
33627439|NCT01986062|63028682|FG001|Overall Study|Lost to Follow-up|0|||
33627440|NCT01986062|63028681|FG000|Overall Study|Withdrawal by Subject|0|||
33627441|NCT01986062|63028682|FG001|Overall Study|Withdrawal by Subject|1|||
33627442|NCT01985360|63028690|FG000|Overall Study|Withdrawal by Subject|4|||
33627443|NCT01985360|63028691|FG001|Overall Study|Withdrawal by Subject|0|||
33627444|NCT01985360|63028690|FG000|Overall Study|Lost to Follow-up|5|||
33627445|NCT01985360|63028691|FG001|Overall Study|Lost to Follow-up|3|||
33627446|NCT02032706|63028697|FG000|Overall Study|Did not qualify|5|||
33326036|NCT01159691|62702809|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
33326037|NCT01159691|62702809|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
33326038|NCT01159691|62702809|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
33627447|NCT02032706|63028697|FG000|Overall Study|Protocol Violation|1|||
33627448|NCT02032238|63028703|FG000|Overall Study|Lost to Follow-up|2|||
33534204|NCT01668784|62924284|FG001|Treatment Period|Withdrawal by Subject|3|||
33534205|NCT01668784|62924283|FG000|Treatment Period|Maximal Clinical Benefit|3|||
33627449|NCT02032238|63028704|FG001|Overall Study|Lost to Follow-up|0|||
33627450|NCT02009930|63028710|FG000|Overall Study|withdrawn|5|||
33627451|NCT01985126|63028723|FG000|Overall Study|Death|15|||
33627452|NCT01985126|63028724|FG001|Overall Study|Death|69|||
33627453|NCT01985126|63028723|FG000|Overall Study|Lost to Follow-up|0|||
33627454|NCT01985126|63028724|FG001|Overall Study|Lost to Follow-up|8|||
33627455|NCT01985126|63028723|FG000|Overall Study|Study Terminated By Sponsor|1|||
33627456|NCT01985126|63028724|FG001|Overall Study|Study Terminated By Sponsor|22|||
33627457|NCT01985126|63028723|FG000|Overall Study|Withdrawal by Subject|2|||
33627458|NCT01985126|63028724|FG001|Overall Study|Withdrawal by Subject|7|||
33627459|NCT01984892|63028730|FG000|Overall Study|Progressive disease|7|||
33627460|NCT01807221|63028740|FG000|Overall Study|Progressive disease|1|||
33627461|NCT01807221|63028741|FG001|Overall Study|Progressive disease|0|||
33627462|NCT01807221|63028742|FG002|Overall Study|Progressive disease|1|||
33627463|NCT01807221|63028743|FG003|Overall Study|Progressive disease|0|||
33627464|NCT01807221|63028744|FG004|Overall Study|Progressive disease|0|||
33627465|NCT01807221|63028745|FG005|Overall Study|Progressive disease|0|||
33627466|NCT01807221|63028740|FG000|Overall Study|Death|7|||
33627467|NCT01807221|63028741|FG001|Overall Study|Death|9|||
33627468|NCT01807221|63028742|FG002|Overall Study|Death|4|||
33627469|NCT01807221|63028743|FG003|Overall Study|Death|2|||
33627470|NCT01807221|63028744|FG004|Overall Study|Death|1|||
33627471|NCT01807221|63028745|FG005|Overall Study|Death|6|||
33627472|NCT01807221|63028740|FG000|Overall Study|Physician Decision|2|||
33627473|NCT01807221|63028741|FG001|Overall Study|Physician Decision|1|||
33627474|NCT01807221|63028742|FG002|Overall Study|Physician Decision|0|||
33627475|NCT01807221|63028743|FG003|Overall Study|Physician Decision|0|||
33627476|NCT01807221|63028744|FG004|Overall Study|Physician Decision|0|||
33627477|NCT01807221|63028745|FG005|Overall Study|Physician Decision|0|||
33627478|NCT01807221|63028740|FG000|Overall Study|Adverse Event|33|||
33627479|NCT01807221|63028741|FG001|Overall Study|Adverse Event|22|||
33627480|NCT01807221|63028742|FG002|Overall Study|Adverse Event|26|||
33627481|NCT01807221|63028743|FG003|Overall Study|Adverse Event|25|||
33627482|NCT01807221|63028744|FG004|Overall Study|Adverse Event|18|||
33627483|NCT01807221|63028745|FG005|Overall Study|Adverse Event|21|||
33627484|NCT01807221|63028740|FG000|Overall Study|Protocol Violation|0|||
33627485|NCT01807221|63028741|FG001|Overall Study|Protocol Violation|2|||
33627486|NCT01807221|63028742|FG002|Overall Study|Protocol Violation|1|||
33627487|NCT01807221|63028743|FG003|Overall Study|Protocol Violation|2|||
33627488|NCT01807221|63028744|FG004|Overall Study|Protocol Violation|0|||
33627489|NCT01807221|63028745|FG005|Overall Study|Protocol Violation|1|||
33627490|NCT01807221|63028740|FG000|Overall Study|Non-compliance|1|||
33627491|NCT01807221|63028741|FG001|Overall Study|Non-compliance|2|||
33627492|NCT01807221|63028742|FG002|Overall Study|Non-compliance|0|||
33627493|NCT01807221|63028743|FG003|Overall Study|Non-compliance|1|||
33627494|NCT01807221|63028744|FG004|Overall Study|Non-compliance|0|||
33627495|NCT01807221|63028745|FG005|Overall Study|Non-compliance|0|||
33627496|NCT01807221|63028740|FG000|Overall Study|Logistical difficulties|0|||
33627497|NCT01807221|63028741|FG001|Overall Study|Logistical difficulties|1|||
33627498|NCT01807221|63028742|FG002|Overall Study|Logistical difficulties|0|||
33627499|NCT01807221|63028743|FG003|Overall Study|Logistical difficulties|0|||
33627500|NCT01807221|63028744|FG004|Overall Study|Logistical difficulties|1|||
33627501|NCT01807221|63028745|FG005|Overall Study|Logistical difficulties|0|||
33627502|NCT01807221|63028740|FG000|Overall Study|Withdrawal by Subject|33|||
33627503|NCT01807221|63028741|FG001|Overall Study|Withdrawal by Subject|15|||
33627504|NCT01807221|63028742|FG002|Overall Study|Withdrawal by Subject|8|||
33627505|NCT01807221|63028743|FG003|Overall Study|Withdrawal by Subject|14|||
33627506|NCT01807221|63028744|FG004|Overall Study|Withdrawal by Subject|16|||
33627507|NCT01807221|63028745|FG005|Overall Study|Withdrawal by Subject|13|||
33627508|NCT01807221|63028740|FG000|Overall Study|Sponsor decision|2|||
33627509|NCT01807221|63028741|FG001|Overall Study|Sponsor decision|0|||
33534206|NCT01668784|62924284|FG001|Treatment Period|Maximal Clinical Benefit|3|||
33534207|NCT01668784|62924283|FG000|Treatment Period|Other|2|||
33534208|NCT01668784|62924284|FG001|Treatment Period|Other|8|||
33534209|NCT01668784|62924283|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
33534210|NCT01668784|62924284|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
33534211|NCT02750514|62924295|FG000|Track 1|Disease progression|20|||
33534212|NCT02750514|62924296|FG001|Track 1|Disease progression|1|||
33534213|NCT02750514|62924297|FG002|Track 1|Disease progression|0|||
33534214|NCT02750514|62924298|FG003|Track 1|Disease progression|1|||
33534215|NCT02750514|62924299|FG004|Track 1|Disease progression|0|||
33534216|NCT02750514|62924295|FG000|Track 1|Adverse event unrelated to study drug|1|||
33534217|NCT02750514|62924296|FG001|Track 1|Adverse event unrelated to study drug|0|||
33534218|NCT02750514|62924297|FG002|Track 1|Adverse event unrelated to study drug|0|||
33534219|NCT02750514|62924298|FG003|Track 1|Adverse event unrelated to study drug|0|||
33534220|NCT02750514|62924299|FG004|Track 1|Adverse event unrelated to study drug|0|||
33534221|NCT02750514|62924295|FG000|Track 1|Study drug toxicity|4|||
33534222|NCT02750514|62924296|FG001|Track 1|Study drug toxicity|1|||
33534223|NCT02750514|62924297|FG002|Track 1|Study drug toxicity|0|||
33534224|NCT02750514|62924298|FG003|Track 1|Study drug toxicity|1|||
33534225|NCT02750514|62924299|FG004|Track 1|Study drug toxicity|0|||
33534226|NCT02750514|62924295|FG000|Track 1|Participant request to discontinue|1|||
33627510|NCT01807221|63028742|FG002|Overall Study|Sponsor decision|1|||
33627511|NCT01807221|63028743|FG003|Overall Study|Sponsor decision|1|||
33627512|NCT01807221|63028744|FG004|Overall Study|Sponsor decision|0|||
33627513|NCT01807221|63028745|FG005|Overall Study|Sponsor decision|0|||
33627514|NCT01807221|63028740|FG000|Overall Study|Lost to Follow-up|1|||
33627515|NCT01807221|63028741|FG001|Overall Study|Lost to Follow-up|0|||
33627516|NCT01807221|63028742|FG002|Overall Study|Lost to Follow-up|2|||
33627517|NCT01807221|63028743|FG003|Overall Study|Lost to Follow-up|1|||
33627518|NCT01807221|63028744|FG004|Overall Study|Lost to Follow-up|0|||
33627519|NCT01807221|63028745|FG005|Overall Study|Lost to Follow-up|0|||
33627520|NCT01838499|63028761|FG000|Overall Study|Protocol Violation|0|||
33627521|NCT01838499|63028762|FG001|Overall Study|Protocol Violation|1|||
33627522|NCT01838499|63028761|FG000|Overall Study|Lost to Follow-up|2|||
33627523|NCT01838499|63028762|FG001|Overall Study|Lost to Follow-up|4|||
33627524|NCT01838499|63028761|FG000|Overall Study|Lack of Efficacy|1|||
33627525|NCT01838499|63028762|FG001|Overall Study|Lack of Efficacy|2|||
33627526|NCT01838499|63028761|FG000|Overall Study|Adverse Event|2|||
33627527|NCT01838499|63028762|FG001|Overall Study|Adverse Event|1|||
33627528|NCT01838499|63028761|FG000|Overall Study|Withdrawal by Subject|19|||
33627529|NCT01838499|63028762|FG001|Overall Study|Withdrawal by Subject|9|||
33627530|NCT01807065|63028770|FG000|Overall Study|Receive no sip-T due to IV access|1|||
33627531|NCT01807065|63028771|FG001|Overall Study|Receive no sip-T due to IV access|1|||
33627532|NCT02031458|63028784|FG000|May 8, 2015 to January 11, 2019|Death|89|||
33627533|NCT02031458|63028785|FG001|May 8, 2015 to January 11, 2019|Death|193|||
33627534|NCT02031458|63028786|FG002|May 8, 2015 to January 11, 2019|Death|198|||
33627535|NCT02031458|63028784|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
33627536|NCT02031458|63028785|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
33627537|NCT02031458|63028786|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
33627538|NCT02031458|63028784|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
33627539|NCT02031458|63028785|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
33627540|NCT02031458|63028786|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
33627541|NCT02031458|63028784|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
33459647|NCT03605680|62833007|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
33459648|NCT03605680|62833008|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
33459649|NCT03605680|62833009|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
33459650|NCT03605680|62833010|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
33534227|NCT02750514|62924296|FG001|Track 1|Participant request to discontinue|0|||
33534228|NCT02750514|62924297|FG002|Track 1|Participant request to discontinue|0|||
33534229|NCT02750514|62924298|FG003|Track 1|Participant request to discontinue|0|||
33534230|NCT02750514|62924299|FG004|Track 1|Participant request to discontinue|0|||
33534231|NCT02750514|62924295|FG000|Track 1|Other reasons|1|||
33534232|NCT02750514|62924296|FG001|Track 1|Other reasons|0|||
33534233|NCT02750514|62924297|FG002|Track 1|Other reasons|0|||
33534234|NCT02750514|62924298|FG003|Track 1|Other reasons|0|||
33534235|NCT02750514|62924299|FG004|Track 1|Other reasons|0|||
33534236|NCT02750514|62924295|FG000|Track 2|Disease progression|4|||
33534237|NCT02750514|62924296|FG001|Track 2|Disease progression|5|||
33534238|NCT02750514|62924297|FG002|Track 2|Disease progression|2|||
33534239|NCT02750514|62924298|FG003|Track 2|Disease progression|5|||
33534240|NCT02750514|62924299|FG004|Track 2|Disease progression|0|||
33534241|NCT02750514|62924295|FG000|Track 2|Adverse event unrelated to study drug|1|||
33534242|NCT02750514|62924296|FG001|Track 2|Adverse event unrelated to study drug|0|||
33534243|NCT02750514|62924297|FG002|Track 2|Adverse event unrelated to study drug|0|||
33627542|NCT02031458|63028785|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
33627543|NCT02031458|63028786|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
33627544|NCT02031458|63028784|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
33459651|NCT03605680|62833007|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
33459652|NCT03605680|62833008|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
33459653|NCT03605680|62833009|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
33459654|NCT03605680|62833010|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
33459655|NCT03605680|62833007|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
33459656|NCT03605680|62833008|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
33459657|NCT03605680|62833009|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
33459658|NCT03605680|62833010|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
33459659|NCT03605680|62833007|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
33459660|NCT03605680|62833008|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
33627545|NCT02031458|63028785|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
33534244|NCT02750514|62924298|FG003|Track 2|Adverse event unrelated to study drug|0|||
33534245|NCT02750514|62924299|FG004|Track 2|Adverse event unrelated to study drug|0|||
33534246|NCT02750514|62924295|FG000|Track 2|Study drug toxicity|1|||
33534247|NCT02750514|62924296|FG001|Track 2|Study drug toxicity|2|||
33534248|NCT02750514|62924297|FG002|Track 2|Study drug toxicity|0|||
33534249|NCT02750514|62924298|FG003|Track 2|Study drug toxicity|2|||
33534250|NCT02750514|62924299|FG004|Track 2|Study drug toxicity|0|||
33627546|NCT02031458|63028786|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
33627547|NCT02031458|63028784|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
33459661|NCT03605680|62833009|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
33459662|NCT03605680|62833010|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
33459663|NCT03605680|62833007|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
33459664|NCT03605680|62833008|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
33534251|NCT02750514|62924295|FG000|Track 2|Participant withdrew consent|0|||
33534252|NCT02750514|62924296|FG001|Track 2|Participant withdrew consent|1|||
33534253|NCT02750514|62924297|FG002|Track 2|Participant withdrew consent|0|||
33534254|NCT02750514|62924298|FG003|Track 2|Participant withdrew consent|0|||
33627548|NCT02031458|63028785|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
33627549|NCT02031458|63028786|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
33627550|NCT02031458|63028784|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
33627551|NCT02031458|63028785|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
33627552|NCT02031458|63028786|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
33627553|NCT02031458|63028784|FG000|Baseline to May 8, 2015|Death|36|||
33627554|NCT02031458|63028785|FG001|Baseline to May 8, 2015|Death|87|||
33627555|NCT02031458|63028786|FG002|Baseline to May 8, 2015|Death|100|||
33627556|NCT02031458|63028784|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
33627557|NCT02031458|63028785|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
33627558|NCT02031458|63028786|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
33627559|NCT02031458|63028784|FG000|Baseline to May 8, 2015|Physician Decision|0|||
33627560|NCT02031458|63028785|FG001|Baseline to May 8, 2015|Physician Decision|1|||
33627561|NCT02031458|63028786|FG002|Baseline to May 8, 2015|Physician Decision|0|||
33627562|NCT02031458|63028784|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
33627563|NCT02031458|63028785|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
33627564|NCT02031458|63028786|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
33627565|NCT02031458|63028784|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
33627566|NCT02031458|63028785|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
33627567|NCT02031458|63028786|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
33627568|NCT02031458|63028784|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
33627569|NCT02031458|63028785|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
33627570|NCT02031458|63028786|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
33627571|NCT02031458|63028784|FG000|Baseline to May 8, 2015|On Treatment|43|||
33627572|NCT02031458|63028785|FG001|Baseline to May 8, 2015|On Treatment|81|||
33627573|NCT02031458|63028786|FG002|Baseline to May 8, 2015|On Treatment|73|||
33627574|NCT02031458|63028784|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
33627575|NCT02031458|63028785|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
33627576|NCT02031458|63028786|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
33627577|NCT02009696|63028796|FG000|Overall Study|Withdrawal by Subject|2|||
33627578|NCT01806597|63028803|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
33627579|NCT01806597|63028804|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
33627580|NCT01806597|63028805|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
33627581|NCT01806597|63028806|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
33627582|NCT01806597|63028807|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
33627583|NCT01806597|63028808|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
33459665|NCT03605680|62833009|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
33459666|NCT03605680|62833010|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
33534255|NCT02750514|62924299|FG004|Track 2|Participant withdrew consent|0|||
33534256|NCT02750514|62924295|FG000|Track 3|Disease progression|0|||
33534257|NCT02750514|62924296|FG001|Track 3|Disease progression|24|||
33534258|NCT02750514|62924297|FG002|Track 3|Disease progression|13|||
33534259|NCT02750514|62924298|FG003|Track 3|Disease progression|14|||
33534260|NCT02750514|62924299|FG004|Track 3|Disease progression|0|||
33534261|NCT02750514|62924295|FG000|Track 3|Adverse event unrelated to study drug|0|||
33534262|NCT02750514|62924296|FG001|Track 3|Adverse event unrelated to study drug|1|||
33534263|NCT02750514|62924297|FG002|Track 3|Adverse event unrelated to study drug|1|||
33534264|NCT02750514|62924298|FG003|Track 3|Adverse event unrelated to study drug|1|||
33534265|NCT02750514|62924299|FG004|Track 3|Adverse event unrelated to study drug|0|||
33534266|NCT02750514|62924295|FG000|Track 3|Study drug toxicity|0|||
33627584|NCT01806597|63028803|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
33459667|NCT03605680|62833007|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
33534267|NCT02750514|62924296|FG001|Track 3|Study drug toxicity|3|||
33534268|NCT02750514|62924297|FG002|Track 3|Study drug toxicity|0|||
33534269|NCT02750514|62924298|FG003|Track 3|Study drug toxicity|1|||
33534270|NCT02750514|62924299|FG004|Track 3|Study drug toxicity|0|||
33534271|NCT02750514|62924295|FG000|Track 3|Participant request to discontinue|0|||
33534272|NCT02750514|62924296|FG001|Track 3|Participant request to discontinue|2|||
33627585|NCT01806597|63028804|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
33627586|NCT01806597|63028805|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
33627587|NCT01806597|63028806|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
33627588|NCT01806597|63028807|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
33534273|NCT02750514|62924297|FG002|Track 3|Participant request to discontinue|0|||
33534274|NCT02750514|62924298|FG003|Track 3|Participant request to discontinue|0|||
33534275|NCT02750514|62924299|FG004|Track 3|Participant request to discontinue|0|||
33534276|NCT02750514|62924295|FG000|Track 3|Participant withdrew consent|0|||
33534277|NCT02750514|62924296|FG001|Track 3|Participant withdrew consent|3|||
33534278|NCT02750514|62924297|FG002|Track 3|Participant withdrew consent|1|||
33534279|NCT02750514|62924298|FG003|Track 3|Participant withdrew consent|0|||
33534280|NCT02750514|62924299|FG004|Track 3|Participant withdrew consent|0|||
33534281|NCT02750514|62924295|FG000|Track 3|Other reasons|0|||
33534282|NCT02750514|62924296|FG001|Track 3|Other reasons|3|||
33534283|NCT02750514|62924297|FG002|Track 3|Other reasons|0|||
33534284|NCT02750514|62924298|FG003|Track 3|Other reasons|0|||
33534285|NCT02750514|62924299|FG004|Track 3|Other reasons|0|||
33534286|NCT02750514|62924295|FG000|Track 4|Study drug toxicity|0|||
33534287|NCT02750514|62924296|FG001|Track 4|Study drug toxicity|6|||
33534288|NCT02750514|62924297|FG002|Track 4|Study drug toxicity|0|||
33534289|NCT02750514|62924298|FG003|Track 4|Study drug toxicity|5|||
33534290|NCT02750514|62924299|FG004|Track 4|Study drug toxicity|0|||
33534291|NCT02750514|62924295|FG000|Track 4|Participant request to discontinue|0|||
33534292|NCT02750514|62924296|FG001|Track 4|Participant request to discontinue|1|||
33534293|NCT02750514|62924297|FG002|Track 4|Participant request to discontinue|0|||
33534294|NCT02750514|62924298|FG003|Track 4|Participant request to discontinue|1|||
33534295|NCT02750514|62924299|FG004|Track 4|Participant request to discontinue|0|||
33534296|NCT02750514|62924295|FG000|Track 4|Participant withdrew consent|0|||
33534297|NCT02750514|62924296|FG001|Track 4|Participant withdrew consent|1|||
33534298|NCT02750514|62924297|FG002|Track 4|Participant withdrew consent|0|||
33534299|NCT02750514|62924298|FG003|Track 4|Participant withdrew consent|0|||
33534300|NCT02750514|62924299|FG004|Track 4|Participant withdrew consent|0|||
33534301|NCT02750514|62924295|FG000|Track 4|Other reasons|0|||
33534302|NCT02750514|62924296|FG001|Track 4|Other reasons|5|||
33534303|NCT02750514|62924297|FG002|Track 4|Other reasons|0|||
33534304|NCT02750514|62924298|FG003|Track 4|Other reasons|3|||
33534305|NCT02750514|62924299|FG004|Track 4|Other reasons|0|||
33534306|NCT02750514|62924295|FG000|Track 4|Disease progression|0|||
33534307|NCT02750514|62924296|FG001|Track 4|Disease progression|33|||
33534308|NCT02750514|62924297|FG002|Track 4|Disease progression|0|||
33534309|NCT02750514|62924298|FG003|Track 4|Disease progression|32|||
33534310|NCT02750514|62924299|FG004|Track 4|Disease progression|0|||
33534311|NCT02750514|62924295|FG000|Track 4|Adverse event unrelated to study drug|0|||
33534312|NCT02750514|62924296|FG001|Track 4|Adverse event unrelated to study drug|5|||
33534313|NCT02750514|62924297|FG002|Track 4|Adverse event unrelated to study drug|0|||
33534314|NCT02750514|62924298|FG003|Track 4|Adverse event unrelated to study drug|0|||
33627589|NCT01806597|63028808|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
33627590|NCT01806597|63028803|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
33627591|NCT01806597|63028804|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
33627592|NCT01806597|63028805|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
33627593|NCT01806597|63028806|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
33627594|NCT01806597|63028807|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
33627595|NCT01806597|63028808|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
33627596|NCT01806597|63028803|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
33627597|NCT01806597|63028804|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
33627598|NCT01806597|63028805|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
33627599|NCT01806597|63028806|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
33627600|NCT01806597|63028807|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
33627601|NCT01806597|63028808|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
33627602|NCT01806597|63028803|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
33459668|NCT03605680|62833008|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
33459669|NCT03605680|62833009|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
33459670|NCT03605680|62833010|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
33459671|NCT03605680|62833007|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
33459672|NCT03605680|62833008|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
33459673|NCT03605680|62833009|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
33459674|NCT03605680|62833010|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
33459675|NCT03572218|62833021|FG000|Overall Study|Lost to Follow-up|3|||
33459676|NCT03572218|62833022|FG001|Overall Study|Lost to Follow-up|2|||
33534315|NCT02750514|62924299|FG004|Track 4|Adverse event unrelated to study drug|0|||
33534316|NCT02750514|62924295|FG000|Track 4|Death|0|||
33459677|NCT03572218|62833021|FG000|Overall Study|No longer available for study visits|2|||
33534317|NCT02750514|62924296|FG001|Track 4|Death|0|||
33534318|NCT02750514|62924297|FG002|Track 4|Death|0|||
33534319|NCT02750514|62924298|FG003|Track 4|Death|1|||
33534320|NCT02750514|62924299|FG004|Track 4|Death|0|||
33627603|NCT01806597|63028804|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
33627604|NCT01806597|63028805|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
33627605|NCT01806597|63028806|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
33627606|NCT01806597|63028807|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
33627607|NCT01806597|63028808|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
33534321|NCT02750514|62924295|FG000|Track 5|Disease progression|0|||
33534322|NCT02750514|62924296|FG001|Track 5|Disease progression|0|||
33534323|NCT02750514|62924297|FG002|Track 5|Disease progression|0|||
33534324|NCT02750514|62924298|FG003|Track 5|Disease progression|0|||
33534325|NCT02750514|62924299|FG004|Track 5|Disease progression|34|||
33534326|NCT02750514|62924295|FG000|Track 5|Adverse event unrelated to study drug|0|||
33534327|NCT02750514|62924296|FG001|Track 5|Adverse event unrelated to study drug|0|||
33534328|NCT02750514|62924297|FG002|Track 5|Adverse event unrelated to study drug|0|||
33534329|NCT02750514|62924298|FG003|Track 5|Adverse event unrelated to study drug|0|||
33534330|NCT02750514|62924299|FG004|Track 5|Adverse event unrelated to study drug|2|||
33534331|NCT02750514|62924295|FG000|Track 5|Study drug toxicity|0|||
33534332|NCT02750514|62924296|FG001|Track 5|Study drug toxicity|0|||
33534333|NCT02750514|62924297|FG002|Track 5|Study drug toxicity|0|||
33534334|NCT02750514|62924298|FG003|Track 5|Study drug toxicity|0|||
33534335|NCT02750514|62924299|FG004|Track 5|Study drug toxicity|2|||
33534336|NCT02750514|62924295|FG000|Track 5|Participant request to discontinue|0|||
33534337|NCT02750514|62924296|FG001|Track 5|Participant request to discontinue|0|||
33534338|NCT02750514|62924297|FG002|Track 5|Participant request to discontinue|0|||
33534339|NCT02750514|62924298|FG003|Track 5|Participant request to discontinue|0|||
33534340|NCT02750514|62924299|FG004|Track 5|Participant request to discontinue|3|||
33534341|NCT02750514|62924295|FG000|Track 5|Other reasons|0|||
33534342|NCT02750514|62924296|FG001|Track 5|Other reasons|0|||
33534343|NCT02750514|62924297|FG002|Track 5|Other reasons|0|||
33534344|NCT02750514|62924298|FG003|Track 5|Other reasons|0|||
33534345|NCT02750514|62924299|FG004|Track 5|Other reasons|2|||
33534346|NCT02612428|62924321|FG000|VTL-308|Death|14|||
33534347|NCT02612428|62924322|FG001|VTL-308|Death|16|||
33534348|NCT02612428|62924321|FG000|VTL-308|Withdrawal by Subject|0|||
33534349|NCT02612428|62924322|FG001|VTL-308|Withdrawal by Subject|1|||
33534350|NCT02612428|62924321|FG000|VTL-308E|Death|9|||
33534351|NCT02612428|62924322|FG001|VTL-308E|Death|7|||
33534352|NCT02612428|62924321|FG000|VTL-308E|Lost to Follow-up|2|||
33534353|NCT02612428|62924322|FG001|VTL-308E|Lost to Follow-up|0|||
33534354|NCT03679884|62924333|FG000|Overall Study|Other|12|||
33534355|NCT03679884|62924334|FG001|Overall Study|Other|12|||
33534356|NCT03679884|62924335|FG002|Overall Study|Other|12|||
33534357|NCT03679884|62924336|FG003|Overall Study|Other|7|||
33534358|NCT03679884|62924337|FG004|Overall Study|Other|8|||
33534359|NCT03679884|62924333|FG000|Overall Study|Lack of Efficacy|15|||
33534360|NCT03679884|62924334|FG001|Overall Study|Lack of Efficacy|29|||
33534361|NCT03679884|62924335|FG002|Overall Study|Lack of Efficacy|13|||
33534362|NCT03679884|62924336|FG003|Overall Study|Lack of Efficacy|29|||
33534363|NCT03679884|62924337|FG004|Overall Study|Lack of Efficacy|10|||
33534364|NCT03679884|62924333|FG000|Overall Study|Death|1|||
33534365|NCT03679884|62924334|FG001|Overall Study|Death|0|||
33534366|NCT03679884|62924335|FG002|Overall Study|Death|0|||
33534367|NCT03679884|62924336|FG003|Overall Study|Death|0|||
33534368|NCT03679884|62924337|FG004|Overall Study|Death|0|||
33534369|NCT03679884|62924333|FG000|Overall Study|Adverse Event|2|||
33534370|NCT03679884|62924334|FG001|Overall Study|Adverse Event|10|||
33534371|NCT03679884|62924335|FG002|Overall Study|Adverse Event|9|||
33534372|NCT03679884|62924336|FG003|Overall Study|Adverse Event|6|||
33534373|NCT03679884|62924337|FG004|Overall Study|Adverse Event|6|||
33534374|NCT03679884|62924333|FG000|Overall Study|Withdrawal by Subject|12|||
33534375|NCT03679884|62924334|FG001|Overall Study|Withdrawal by Subject|23|||
33534376|NCT03679884|62924335|FG002|Overall Study|Withdrawal by Subject|8|||
33534377|NCT03679884|62924336|FG003|Overall Study|Withdrawal by Subject|8|||
33534378|NCT03679884|62924337|FG004|Overall Study|Withdrawal by Subject|9|||
33534379|NCT03679884|62924333|FG000|Overall Study|Lost to Follow-up|1|||
33534380|NCT03679884|62924334|FG001|Overall Study|Lost to Follow-up|4|||
33534381|NCT03679884|62924335|FG002|Overall Study|Lost to Follow-up|2|||
33534382|NCT03679884|62924336|FG003|Overall Study|Lost to Follow-up|0|||
33534383|NCT03679884|62924337|FG004|Overall Study|Lost to Follow-up|3|||
33534384|NCT01329978|62924352|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
33534385|NCT01329978|62924353|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
33534386|NCT01329978|62924354|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
33534387|NCT01329978|62924355|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
33534388|NCT01329978|62924356|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
33534389|NCT01329978|62924352|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
33534390|NCT01329978|62924353|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
33534391|NCT01329978|62924354|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
33534392|NCT01329978|62924355|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
33627608|NCT01806597|63028803|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
33534393|NCT01329978|62924356|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
33534394|NCT01329978|62924352|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
33534395|NCT01329978|62924353|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
33534396|NCT01329978|62924354|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
33534397|NCT01329978|62924355|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
33534398|NCT01329978|62924356|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
33534399|NCT01329978|62924352|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
33534400|NCT01329978|62924353|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
33534401|NCT01329978|62924354|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
33534402|NCT01329978|62924355|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
33534403|NCT01329978|62924356|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
33534404|NCT01329978|62924352|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
33534405|NCT01329978|62924353|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
33534406|NCT01329978|62924354|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
33534407|NCT01329978|62924355|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
33534408|NCT01329978|62924356|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
33534409|NCT01329978|62924352|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
33534410|NCT01329978|62924353|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
33534411|NCT01329978|62924354|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
33534412|NCT01329978|62924355|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
33534413|NCT01329978|62924356|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
33534414|NCT01329978|62924352|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
33534415|NCT01329978|62924353|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
33534416|NCT01329978|62924354|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
33534417|NCT01329978|62924355|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
33534418|NCT01329978|62924356|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
33627609|NCT01806597|63028804|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
33627610|NCT01806597|63028805|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
33627611|NCT01806597|63028806|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
33627612|NCT01806597|63028807|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
33627613|NCT01806597|63028808|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
33534419|NCT01338012|62924368|FG000|Overall Study|Death|4|||
33534420|NCT01338012|62924368|FG000|Overall Study|Study terminated|4|||
33534421|NCT04905498|62924374|FG000|Overall Study|Lost to Follow-up|0|||
33534422|NCT04905498|62924375|FG001|Overall Study|Lost to Follow-up|2|||
33534423|NCT04905498|62924374|FG000|Overall Study|COVID lockdown|1|||
33534424|NCT04905498|62924375|FG001|Overall Study|COVID lockdown|0|||
33534425|NCT02607280|62924383|FG000|Overall Study|Adverse Event|4|||
33627614|NCT01806597|63028803|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
33627615|NCT01806597|63028804|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
33627616|NCT01806597|63028805|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
33627617|NCT01806597|63028806|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
33627618|NCT01806597|63028807|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
33627619|NCT01806597|63028808|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
33627620|NCT01806597|63028803|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
33627621|NCT01806597|63028804|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
33627622|NCT01806597|63028805|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
33627623|NCT01806597|63028806|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
33627624|NCT01806597|63028807|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
33627625|NCT01806597|63028808|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
33534426|NCT02607280|62924384|FG001|Overall Study|Adverse Event|0|||
33534427|NCT02607280|62924383|FG000|Overall Study|Decrease in CrCl <15|0|||
33627626|NCT01806597|63028803|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
33627627|NCT01806597|63028804|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
33534428|NCT02607280|62924384|FG001|Overall Study|Decrease in CrCl <15|1|||
33534429|NCT02202434|62924394|FG000|Overall Study|Death|70|||
33534430|NCT02202434|62924395|FG001|Overall Study|Death|39|||
33534431|NCT02202434|62924396|FG002|Overall Study|Death|13|||
33627628|NCT01806597|63028805|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
33627629|NCT01806597|63028806|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
33627630|NCT01806597|63028807|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
33627631|NCT01806597|63028808|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
33627632|NCT01806597|63028803|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
33534432|NCT02202434|62924397|FG003|Overall Study|Death|27|||
33534433|NCT02202434|62924394|FG000|Overall Study|Lost to Follow-up|1|||
33534434|NCT02202434|62924395|FG001|Overall Study|Lost to Follow-up|1|||
33534435|NCT02202434|62924396|FG002|Overall Study|Lost to Follow-up|1|||
33534436|NCT02202434|62924397|FG003|Overall Study|Lost to Follow-up|0|||
33627633|NCT01806597|63028804|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
33534437|NCT02202434|62924394|FG000|Overall Study|Physician Decision|2|||
33534438|NCT02202434|62924395|FG001|Overall Study|Physician Decision|3|||
33627634|NCT01806597|63028805|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
33627635|NCT01806597|63028806|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
33627636|NCT01806597|63028807|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
33627637|NCT01806597|63028808|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
33627638|NCT01806597|63028803|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
33627639|NCT01806597|63028804|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
33627640|NCT01806597|63028805|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
33627641|NCT01806597|63028806|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
33627642|NCT01806597|63028807|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
33627643|NCT01806597|63028808|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
33627644|NCT01806597|63028803|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
33627645|NCT01806597|63028804|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
33627646|NCT01806597|63028805|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
33627647|NCT01806597|63028806|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
33627648|NCT01806597|63028807|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
33627649|NCT01806597|63028808|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
33627650|NCT01806597|63028803|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
33627651|NCT01806597|63028804|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
33627652|NCT01806597|63028805|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
33627653|NCT01806597|63028806|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
33627654|NCT01806597|63028807|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
33627655|NCT01806597|63028808|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
33627656|NCT01806597|63028803|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
33627657|NCT01806597|63028804|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
33627658|NCT01806597|63028805|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
33627659|NCT01806597|63028806|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
33627660|NCT01806597|63028807|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
33627661|NCT01806597|63028808|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
33627662|NCT01806597|63028803|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
33627663|NCT01806597|63028804|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
33627664|NCT01806597|63028805|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
33534439|NCT02202434|62924396|FG002|Overall Study|Physician Decision|0|||
33534440|NCT02202434|62924397|FG003|Overall Study|Physician Decision|0|||
33534441|NCT02202434|62924394|FG000|Overall Study|Withdrawal by Subject|13|||
33534442|NCT02202434|62924395|FG001|Overall Study|Withdrawal by Subject|14|||
33534443|NCT02202434|62924396|FG002|Overall Study|Withdrawal by Subject|1|||
33534444|NCT02202434|62924397|FG003|Overall Study|Withdrawal by Subject|4|||
33534445|NCT02202434|62924394|FG000|Overall Study|Completed Study|1|||
33534446|NCT02202434|62924395|FG001|Overall Study|Completed Study|0|||
33534447|NCT02202434|62924396|FG002|Overall Study|Completed Study|0|||
33534448|NCT02202434|62924397|FG003|Overall Study|Completed Study|0|||
33534449|NCT02202434|62924394|FG000|Overall Study|Visit Missed|21|||
33534450|NCT02202434|62924395|FG001|Overall Study|Visit Missed|12|||
33534451|NCT02202434|62924396|FG002|Overall Study|Visit Missed|0|||
33534452|NCT02202434|62924397|FG003|Overall Study|Visit Missed|5|||
33534453|NCT02202434|62924394|FG000|Overall Study|Other|1|||
33534454|NCT02202434|62924395|FG001|Overall Study|Other|0|||
33534455|NCT02202434|62924396|FG002|Overall Study|Other|0|||
33534456|NCT02202434|62924397|FG003|Overall Study|Other|1|||
33534457|NCT02784288|62924407|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
33534458|NCT01230242|62924412|FG000|Overall Study|Physician Decision|2|||
33534459|NCT01230242|62924412|FG000|Overall Study|Withdrawal by Subject|1|||
33534460|NCT02608450|62924418|FG000|Overall Study|Lost to Follow-up|39|||
33534461|NCT02608450|62924419|FG001|Overall Study|Lost to Follow-up|32|||
33534462|NCT02608450|62924418|FG000|Overall Study|Withdrawal by Subject|21|||
33534463|NCT02608450|62924419|FG001|Overall Study|Withdrawal by Subject|15|||
33534464|NCT02608450|62924418|FG000|Overall Study|Adverse Event|3|||
33534465|NCT02608450|62924419|FG001|Overall Study|Adverse Event|6|||
33534466|NCT02608450|62924418|FG000|Overall Study|Withdrawal by parent|2|||
33534467|NCT02608450|62924419|FG001|Overall Study|Withdrawal by parent|3|||
33534468|NCT02608450|62924418|FG000|Overall Study|Lack of Efficacy|0|||
33534469|NCT02608450|62924419|FG001|Overall Study|Lack of Efficacy|3|||
33534470|NCT02608450|62924418|FG000|Overall Study|Noncompliance with study drug|0|||
33534471|NCT02608450|62924419|FG001|Overall Study|Noncompliance with study drug|2|||
33534472|NCT02608450|62924418|FG000|Overall Study|Physician Decision|0|||
33534473|NCT02608450|62924419|FG001|Overall Study|Physician Decision|1|||
33534474|NCT02608450|62924418|FG000|Overall Study|Pregnancy|0|||
33534475|NCT02608450|62924419|FG001|Overall Study|Pregnancy|1|||
33534476|NCT02608450|62924418|FG000|Overall Study|Progressive disease|1|||
33534477|NCT02608450|62924419|FG001|Overall Study|Progressive disease|0|||
33534478|NCT02608450|62924418|FG000|Overall Study|Multiple reasons|0|||
33534479|NCT02608450|62924419|FG001|Overall Study|Multiple reasons|2|||
33534480|NCT04918784|62924472|FG000|Overall Study|Amputation - no longer eligible|1|||
33534481|NCT04918784|62924473|FG001|Overall Study|Amputation - no longer eligible|2|||
33534482|NCT04918784|62924472|FG000|Overall Study|Death|1|||
33534483|NCT04918784|62924473|FG001|Overall Study|Death|0|||
33534484|NCT04918784|62924472|FG000|Overall Study|patient non-compliance|3|||
33534485|NCT04918784|62924473|FG001|Overall Study|patient non-compliance|1|||
33534486|NCT04918784|62924472|FG000|Overall Study|Adverse Event|1|||
33534487|NCT04918784|62924473|FG001|Overall Study|Adverse Event|0|||
33534488|NCT04786444|62924515|FG000|Overall Study|Withdrawal by Subject|4|||
33534489|NCT04786444|62924516|FG001|Overall Study|Withdrawal by Subject|7|||
33534490|NCT04786444|62924517|FG002|Overall Study|Withdrawal by Subject|2|||
33534491|NCT04786444|62924515|FG000|Overall Study|Lost to Follow-up|11|||
33534492|NCT04786444|62924516|FG001|Overall Study|Lost to Follow-up|9|||
33534493|NCT04786444|62924517|FG002|Overall Study|Lost to Follow-up|10|||
33534494|NCT04786444|62924515|FG000|Overall Study|Subject would like to become pregnant|0|||
33534495|NCT04786444|62924516|FG001|Overall Study|Subject would like to become pregnant|1|||
33534496|NCT04786444|62924517|FG002|Overall Study|Subject would like to become pregnant|0|||
33534497|NCT04692155|62924534|FG000|Overall Study|Death|1|||
33627665|NCT01806597|63028806|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
33627666|NCT01806597|63028807|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
33627667|NCT01806597|63028808|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
33627668|NCT01806597|63028803|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
33627669|NCT01806597|63028804|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
33627670|NCT01806597|63028805|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
33534539|NCT04499963|62924601|FG000|Overall Study|Adverse Event|3|||
33534540|NCT04499963|62924602|FG001|Overall Study|Adverse Event|0|||
33534541|NCT04499963|62924601|FG000|Overall Study|Death|3|||
33534542|NCT04499963|62924602|FG001|Overall Study|Death|0|||
33534543|NCT04499963|62924601|FG000|Overall Study|Lack of Efficacy|7|||
33534544|NCT04499963|62924602|FG001|Overall Study|Lack of Efficacy|0|||
33534545|NCT04499963|62924601|FG000|Overall Study|Lost to Follow-up|2|||
33534546|NCT04499963|62924602|FG001|Overall Study|Lost to Follow-up|0|||
33627671|NCT01806597|63028806|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
33627672|NCT01806597|63028807|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
33627673|NCT01806597|63028808|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
33534581|NCT04330482|62924652|FG000|Overall Study|Lost to Follow-up|2|||
33534582|NCT04330482|62924653|FG001|Overall Study|Lost to Follow-up|1|||
33534583|NCT04330482|62924652|FG000|Overall Study|Withdrawal by Subject|0|||
33534584|NCT04330482|62924653|FG001|Overall Study|Withdrawal by Subject|3|||
33534585|NCT04325503|62924659|FG000|Overall Study|Withdrawal by Subject|1|||
33534586|NCT04325503|62924659|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
33326039|NCT01159691|62702809|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
33534621|NCT04109222|62924715|FG000|Overall Study|Adverse Event|1|||
33534622|NCT04109222|62924716|FG001|Overall Study|Adverse Event|0|||
33534623|NCT04109222|62924717|FG002|Overall Study|Adverse Event|0|||
33627674|NCT01806597|63028803|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
33627675|NCT01806597|63028804|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
33627676|NCT01806597|63028805|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
33627677|NCT01806597|63028806|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
33627678|NCT01806597|63028807|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
33627679|NCT01806597|63028808|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
33627680|NCT01806597|63028803|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
33627681|NCT01806597|63028804|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
33627682|NCT01806597|63028805|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
33627683|NCT01806597|63028806|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
33627684|NCT01806597|63028807|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
33627685|NCT01806597|63028808|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
33627686|NCT01806597|63028803|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
33627687|NCT01806597|63028804|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
33627688|NCT01806597|63028805|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
33627689|NCT01806597|63028806|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
33627690|NCT01806597|63028807|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
33627691|NCT01806597|63028808|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
33627692|NCT02031302|63028824|FG000|Overall Study|Death|115|||
33627693|NCT02031302|63028825|FG001|Overall Study|Death|0|||
33627694|NCT02031302|63028824|FG000|Overall Study|Not treated with study valve system|18|||
33627695|NCT02031302|63028825|FG001|Overall Study|Not treated with study valve system|0|||
33627696|NCT02031302|63028824|FG000|Overall Study|Missed Follow Up|27|||
33627697|NCT02031302|63028825|FG001|Overall Study|Missed Follow Up|0|||
33627698|NCT02031302|63028824|FG000|Overall Study|Lost to Follow-up|4|||
33627699|NCT02031302|63028825|FG001|Overall Study|Lost to Follow-up|0|||
33627700|NCT01610037|63028835|FG000|All Patients|Adverse Event|27|||
33459678|NCT03572218|62833022|FG001|Overall Study|No longer available for study visits|1|||
33459679|NCT03572218|62833021|FG000|Overall Study|No longer interested|1|||
33459680|NCT03572218|62833022|FG001|Overall Study|No longer interested|2|||
33459681|NCT00111813|62833028|FG000|Overall Study|Adverse Event|1|||
33459682|NCT00111813|62833029|FG001|Overall Study|Adverse Event|2|||
33459683|NCT00111813|62833030|FG002|Overall Study|Adverse Event|4|||
33459684|NCT00111813|62833031|FG003|Overall Study|Adverse Event|2|||
33459685|NCT00111813|62833032|FG004|Overall Study|Adverse Event|2|||
33459686|NCT00111813|62833033|FG005|Overall Study|Adverse Event|2|||
33459687|NCT00111813|62833028|FG000|Overall Study|Progressive disease|2|||
33459688|NCT00111813|62833029|FG001|Overall Study|Progressive disease|1|||
33459689|NCT00111813|62833030|FG002|Overall Study|Progressive disease|5|||
33459690|NCT00111813|62833031|FG003|Overall Study|Progressive disease|3|||
33627701|NCT01610037|63028836|FG001|All Patients|Adverse Event|22|||
33627702|NCT01610037|63028837|FG002|All Patients|Adverse Event|26|||
33627703|NCT01610037|63028835|FG000|All Patients|Withdrawal by Subject|12|||
33627704|NCT01610037|63028836|FG001|All Patients|Withdrawal by Subject|10|||
33459691|NCT00111813|62833032|FG004|Overall Study|Progressive disease|4|||
33459692|NCT00111813|62833033|FG005|Overall Study|Progressive disease|3|||
33627705|NCT01610037|63028837|FG002|All Patients|Withdrawal by Subject|20|||
33627706|NCT01610037|63028835|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
33627707|NCT01610037|63028836|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
33627708|NCT01610037|63028837|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
33627709|NCT01610037|63028835|FG000|All Patients|Death|4|||
33627710|NCT01610037|63028836|FG001|All Patients|Death|2|||
33627711|NCT01610037|63028837|FG002|All Patients|Death|1|||
33627712|NCT01610037|63028835|FG000|All Patients|Protocol deviation|4|||
33627713|NCT01610037|63028836|FG001|All Patients|Protocol deviation|3|||
33627714|NCT01610037|63028837|FG002|All Patients|Protocol deviation|3|||
33627715|NCT01610037|63028835|FG000|All Patients|Abnormal laboratory value|1|||
33627716|NCT01610037|63028836|FG001|All Patients|Abnormal laboratory value|1|||
33627717|NCT01610037|63028837|FG002|All Patients|Abnormal laboratory value|0|||
33627718|NCT01610037|63028835|FG000|All Patients|Administrative problems|1|||
33627719|NCT01610037|63028836|FG001|All Patients|Administrative problems|4|||
33627720|NCT01610037|63028837|FG002|All Patients|Administrative problems|4|||
33627721|NCT01610037|63028835|FG000|All Patients|Lost to Follow-up|1|||
33627722|NCT01610037|63028836|FG001|All Patients|Lost to Follow-up|0|||
33627723|NCT01610037|63028837|FG002|All Patients|Lost to Follow-up|0|||
33459693|NCT00111813|62833028|FG000|Overall Study|Lack of Efficacy|0|||
33459694|NCT00111813|62833029|FG001|Overall Study|Lack of Efficacy|0|||
33459695|NCT00111813|62833030|FG002|Overall Study|Lack of Efficacy|0|||
33459696|NCT00111813|62833031|FG003|Overall Study|Lack of Efficacy|0|||
33459697|NCT00111813|62833032|FG004|Overall Study|Lack of Efficacy|0|||
33459698|NCT00111813|62833033|FG005|Overall Study|Lack of Efficacy|1|||
33459699|NCT00111813|62833028|FG000|Overall Study|Other|0|||
33459700|NCT00111813|62833029|FG001|Overall Study|Other|0|||
33459701|NCT00111813|62833030|FG002|Overall Study|Other|1|||
33459702|NCT00111813|62833031|FG003|Overall Study|Other|0|||
33459703|NCT00111813|62833032|FG004|Overall Study|Other|0|||
33459704|NCT00111813|62833033|FG005|Overall Study|Other|0|||
33459705|NCT00118287|62833048|FG000|Overall Study|Intracranial haemorrhage|1|||
33459706|NCT00118287|62833048|FG000|Overall Study|Muscle pain|1|||
33459707|NCT00130689|62833052|FG000|Overall Study|Progressive Disease|29|||
33459708|NCT00130689|62833052|FG000|Overall Study|Death|1|||
33459709|NCT00130689|62833052|FG000|Overall Study|Clinical Deterioration|4|||
33459710|NCT00130689|62833052|FG000|Overall Study|Withdrawal by Subject|3|||
33459711|NCT00130689|62833052|FG000|Overall Study|Ineligible|6|||
33459712|NCT03605212|62833061|FG000|Treatment Period|Adverse Event|1|||
33459713|NCT03605212|62833062|FG001|Treatment Period|Adverse Event|0|||
33459714|NCT03605212|62833063|FG002|Treatment Period|Adverse Event|0|||
33459715|NCT03605212|62833064|FG003|Treatment Period|Adverse Event|0|||
33459716|NCT03605212|62833065|FG004|Treatment Period|Adverse Event|0|||
33459717|NCT03605212|62833061|FG000|Treatment Period|Physician Decision|0|||
33459718|NCT03605212|62833062|FG001|Treatment Period|Physician Decision|0|||
33627724|NCT01610037|63028835|FG000|All Patients|Abnormal test procedure result(s)|0|||
33627725|NCT01610037|63028836|FG001|All Patients|Abnormal test procedure result(s)|1|||
33627726|NCT01610037|63028837|FG002|All Patients|Abnormal test procedure result(s)|3|||
33459719|NCT03605212|62833063|FG002|Treatment Period|Physician Decision|0|||
33459720|NCT03605212|62833064|FG003|Treatment Period|Physician Decision|0|||
33459721|NCT03605212|62833065|FG004|Treatment Period|Physician Decision|1|||
33459722|NCT03603652|62833078|FG000|Overall Study|Death|2|||
33459723|NCT00117507|62833082|FG000|Overall Study|Adverse Event|4|||
33459724|NCT00117507|62833082|FG000|Overall Study|Abnormal laboratory values|3|||
33459725|NCT00117507|62833082|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33459726|NCT00117507|62833082|FG000|Overall Study|Patient withdrew consent|4|||
33459727|NCT00117507|62833082|FG000|Overall Study|Death|3|||
33459728|NCT03603496|62833089|FG000|Overall Study|Death|19|||
33627727|NCT01610037|63028835|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
33459729|NCT03603496|62833090|FG001|Overall Study|Death|24|||
33459730|NCT03603496|62833089|FG000|Overall Study|Lost to Follow-up|141|||
33459731|NCT03603496|62833090|FG001|Overall Study|Lost to Follow-up|141|||
33459732|NCT03603496|62833089|FG000|Overall Study|Withdrawal by Subject|26|||
33459733|NCT03603496|62833090|FG001|Overall Study|Withdrawal by Subject|20|||
33459734|NCT03603028|62833096|FG000|Overall Study|Withdrawal by Subject|1|||
33459735|NCT03602482|62833102|FG000|Overall Study|Withdrawal by Subject|6|||
33459736|NCT03602482|62833103|FG001|Overall Study|Withdrawal by Subject|7|||
33459737|NCT03602482|62833104|FG002|Overall Study|Withdrawal by Subject|0|||
33459738|NCT03602482|62833105|FG003|Overall Study|Withdrawal by Subject|0|||
33459739|NCT00096135|62833120|FG000|Overall Study|Physician Decision|20|||
33459740|NCT00096135|62833121|FG001|Overall Study|Physician Decision|4|||
33459741|NCT00096135|62833120|FG000|Overall Study|Refusal of further protocol therapy|4|||
33459742|NCT00096135|62833121|FG001|Overall Study|Refusal of further protocol therapy|1|||
33459743|NCT00096135|62833120|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
33459744|NCT00096135|62833121|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
33459745|NCT00096135|62833120|FG000|Overall Study|Other, specify|15|||
33459746|NCT00096135|62833121|FG001|Overall Study|Other, specify|3|||
33459747|NCT00096135|62833120|FG000|Overall Study|Ineligible|2|||
33459748|NCT00096135|62833121|FG001|Overall Study|Ineligible|0|||
33459749|NCT00116805|62833129|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
33459750|NCT00116805|62833130|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
33459751|NCT00116805|62833129|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
33459752|NCT00116805|62833130|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
33459753|NCT00116805|62833129|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
33459754|NCT00116805|62833130|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
33459755|NCT00116805|62833129|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
33459756|NCT00116805|62833130|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
33459757|NCT00116805|62833129|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
33459758|NCT00116805|62833130|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
33459759|NCT00116805|62833129|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
33459760|NCT00116805|62833130|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
33459761|NCT00116805|62833129|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
33459762|NCT00116805|62833130|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
33459763|NCT00116805|62833129|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
33459764|NCT00116805|62833130|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
33459765|NCT00116805|62833129|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
33459766|NCT00116805|62833130|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
33459767|NCT00116805|62833129|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
33459768|NCT00116805|62833130|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
33459769|NCT00116805|62833129|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
33459770|NCT00116805|62833130|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
33459771|NCT00116805|62833129|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
33459772|NCT00116805|62833130|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
33459773|NCT00116805|62833129|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
33459774|NCT00116805|62833130|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
33459775|NCT00116805|62833129|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
33459776|NCT00116805|62833130|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
33459777|NCT00116805|62833129|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
33459778|NCT00116805|62833130|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
33459779|NCT00116805|62833129|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
33459780|NCT00116805|62833130|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
33459781|NCT00116805|62833129|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
33459782|NCT00116805|62833130|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
33459783|NCT00116805|62833129|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
33459784|NCT00116805|62833130|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
33459785|NCT00116805|62833129|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
33459786|NCT00116805|62833130|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
33459787|NCT00116805|62833129|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
33459788|NCT00116805|62833130|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
33459789|NCT00116805|62833129|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
33459790|NCT00116805|62833130|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
33459791|NCT00116805|62833129|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
33459792|NCT00116805|62833130|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
33459793|NCT00116805|62833129|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
33627728|NCT01610037|63028836|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
33627729|NCT01610037|63028837|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
33627730|NCT01610037|63028835|FG000|Treatment and Follow up Period|Death|10|||
33627731|NCT01610037|63028836|FG001|Treatment and Follow up Period|Death|5|||
33627732|NCT01610037|63028837|FG002|Treatment and Follow up Period|Death|4|||
33627733|NCT01610037|63028835|FG000|Treatment and Follow up Period|Administrative problems|1|||
33627734|NCT01610037|63028836|FG001|Treatment and Follow up Period|Administrative problems|3|||
33627735|NCT01610037|63028837|FG002|Treatment and Follow up Period|Administrative problems|2|||
33627736|NCT01610037|63028835|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
33627737|NCT01610037|63028836|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
33627738|NCT01610037|63028837|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
33459794|NCT00116805|62833130|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
33459795|NCT00116805|62833129|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
33627739|NCT01806051|63028845|FG000|Overall Study|Withdrawal by Subject|6|||
33627740|NCT01837797|63028854|FG000|Period 1|Adverse Event|9|||
33627741|NCT01837797|63028855|FG001|Period 1|Adverse Event|0|||
33627742|NCT01837797|63028856|FG002|Period 1|Adverse Event|0|||
33627743|NCT01837797|63028857|FG003|Period 1|Adverse Event|0|||
33459796|NCT00116805|62833130|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
33459797|NCT00116805|62833129|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
33459798|NCT00116805|62833130|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
33459799|NCT00116805|62833129|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
33459800|NCT00116805|62833130|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
33459801|NCT00116805|62833129|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
33459802|NCT00116805|62833130|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
33459803|NCT00116805|62833129|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
33459804|NCT00116805|62833130|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
33326040|NCT01159691|62702809|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
33326041|NCT01157897|62702817|FG000|Overall Study|Lost to Follow-up|2|||
33326042|NCT01157897|62702818|FG001|Overall Study|Lost to Follow-up|0|||
33326043|NCT01157897|62702819|FG002|Overall Study|Lost to Follow-up|0|||
33326044|NCT01157897|62702820|FG003|Overall Study|Lost to Follow-up|1|||
33326045|NCT01157897|62702817|FG000|Overall Study|Relocated|0|||
33326046|NCT01157897|62702818|FG001|Overall Study|Relocated|2|||
33326047|NCT01157897|62702819|FG002|Overall Study|Relocated|0|||
33326048|NCT01157897|62702820|FG003|Overall Study|Relocated|0|||
33326049|NCT01185821|62702835|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33326050|NCT01185821|62702836|FG001|Overall Study|Abnormal laboratory value(s)|2|||
33326051|NCT01185821|62702837|FG002|Overall Study|Abnormal laboratory value(s)|1|||
33326052|NCT01185821|62702838|FG003|Overall Study|Abnormal laboratory value(s)|0|||
33326053|NCT01185821|62702839|FG004|Overall Study|Abnormal laboratory value(s)|0|||
33326054|NCT01185821|62702835|FG000|Overall Study|Protocol Violation|0|||
33326055|NCT01185821|62702836|FG001|Overall Study|Protocol Violation|0|||
33326056|NCT01185821|62702837|FG002|Overall Study|Protocol Violation|0|||
33326057|NCT01185821|62702838|FG003|Overall Study|Protocol Violation|1|||
33627744|NCT01837797|63028858|FG004|Period 1|Adverse Event|0|||
33627745|NCT01837797|63028854|FG000|Period 1|Withdrawal by Subject|6|||
33627746|NCT01837797|63028855|FG001|Period 1|Withdrawal by Subject|0|||
33627747|NCT01837797|63028856|FG002|Period 1|Withdrawal by Subject|0|||
33627748|NCT01837797|63028857|FG003|Period 1|Withdrawal by Subject|0|||
33627749|NCT01837797|63028858|FG004|Period 1|Withdrawal by Subject|0|||
33627750|NCT01837797|63028854|FG000|Period 1|Administrative reasons|76|||
33627751|NCT01837797|63028855|FG001|Period 1|Administrative reasons|0|||
33627752|NCT01837797|63028856|FG002|Period 1|Administrative reasons|0|||
33627753|NCT01837797|63028857|FG003|Period 1|Administrative reasons|0|||
33627754|NCT01837797|63028858|FG004|Period 1|Administrative reasons|0|||
33627755|NCT01837797|63028854|FG000|Period 1|Withdrawal of consent before treatment|1|||
33627756|NCT01837797|63028855|FG001|Period 1|Withdrawal of consent before treatment|0|||
33627757|NCT01837797|63028856|FG002|Period 1|Withdrawal of consent before treatment|0|||
33627758|NCT01837797|63028857|FG003|Period 1|Withdrawal of consent before treatment|0|||
33627759|NCT01837797|63028858|FG004|Period 1|Withdrawal of consent before treatment|0|||
33627760|NCT01837797|63028854|FG000|Period 1|Other|10|||
33627761|NCT01837797|63028855|FG001|Period 1|Other|0|||
33627762|NCT01837797|63028856|FG002|Period 1|Other|0|||
33627763|NCT01837797|63028857|FG003|Period 1|Other|0|||
33627764|NCT01837797|63028858|FG004|Period 1|Other|0|||
33627765|NCT01837797|63028854|FG000|Period 2|Administrative or other reasons|0|||
33627766|NCT01837797|63028855|FG001|Period 2|Administrative or other reasons|5|||
33627767|NCT01837797|63028856|FG002|Period 2|Administrative or other reasons|2|||
33326058|NCT01185821|62702839|FG004|Overall Study|Protocol Violation|1|||
33326059|NCT01185821|62702835|FG000|Overall Study|Abnormal test procedure result|0|||
33326060|NCT01185821|62702836|FG001|Overall Study|Abnormal test procedure result|0|||
33326061|NCT01185821|62702837|FG002|Overall Study|Abnormal test procedure result|0|||
33326062|NCT01185821|62702838|FG003|Overall Study|Abnormal test procedure result|0|||
33627768|NCT01837797|63028857|FG003|Period 2|Administrative or other reasons|4|||
33627769|NCT01837797|63028858|FG004|Period 2|Administrative or other reasons|0|||
33627770|NCT01837797|63028854|FG000|Period 2|Adverse Event|0|||
33627771|NCT01837797|63028855|FG001|Period 2|Adverse Event|0|||
33627772|NCT01837797|63028856|FG002|Period 2|Adverse Event|0|||
33627773|NCT01837797|63028857|FG003|Period 2|Adverse Event|1|||
33627774|NCT01837797|63028858|FG004|Period 2|Adverse Event|0|||
33627775|NCT01837797|63028854|FG000|Period 3|Adverse Event|0|||
33627776|NCT01837797|63028855|FG001|Period 3|Adverse Event|0|||
33627777|NCT01837797|63028856|FG002|Period 3|Adverse Event|0|||
33627778|NCT01837797|63028857|FG003|Period 3|Adverse Event|0|||
33627779|NCT01837797|63028858|FG004|Period 3|Adverse Event|1|||
33627780|NCT01837797|63028854|FG000|Period 3|Administrative reasons|0|||
33627781|NCT01837797|63028855|FG001|Period 3|Administrative reasons|0|||
33627782|NCT01837797|63028856|FG002|Period 3|Administrative reasons|0|||
33627783|NCT01837797|63028857|FG003|Period 3|Administrative reasons|0|||
33627784|NCT01837797|63028858|FG004|Period 3|Administrative reasons|20|||
33627785|NCT01837797|63028854|FG000|Period 3|Other|0|||
33627786|NCT01837797|63028855|FG001|Period 3|Other|0|||
33627787|NCT01837797|63028856|FG002|Period 3|Other|0|||
33627788|NCT01837797|63028857|FG003|Period 3|Other|0|||
33627789|NCT01837797|63028858|FG004|Period 3|Other|2|||
33627790|NCT01984424|63028868|FG000|Overall Study|Withdrawal by Subject|3|||
33627791|NCT01984424|63028869|FG001|Overall Study|Withdrawal by Subject|5|||
33459805|NCT00116805|62833129|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
33459806|NCT00116805|62833130|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
33459807|NCT00116805|62833129|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
33459808|NCT00116805|62833130|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
33459809|NCT00116805|62833129|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
33459810|NCT00116805|62833130|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
33459811|NCT00116805|62833129|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
33627792|NCT01984424|63028868|FG000|Overall Study|Sponsor Decision|0|||
33627793|NCT01984424|63028869|FG001|Overall Study|Sponsor Decision|1|||
33627794|NCT01984424|63028868|FG000|Overall Study|Lost to Follow-up|0|||
33627795|NCT01984424|63028869|FG001|Overall Study|Lost to Follow-up|1|||
33627796|NCT01837719|63028875|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
33627797|NCT01837719|63028875|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
33627798|NCT01984268|63028890|FG000|Overall Study|Study Terminated|15|||
33459812|NCT00116805|62833130|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
33459813|NCT00116805|62833129|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
33459814|NCT00116805|62833130|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
33459815|NCT00116805|62833129|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
33459816|NCT00116805|62833130|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
33459817|NCT00116805|62833129|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
33459818|NCT00116805|62833130|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
33459819|NCT00116805|62833129|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
33459820|NCT00116805|62833130|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
33459821|NCT00116805|62833129|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
33459822|NCT00116805|62833130|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
33459823|NCT00116805|62833129|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
33459824|NCT00116805|62833130|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
33459825|NCT00116805|62833129|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
33459826|NCT00116805|62833130|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
33534905|NCT03573297|62924931|FG000|Open Label Treatment Period|Adverse Event|67|||
33534906|NCT03573297|62924932|FG001|Open Label Treatment Period|Adverse Event|0|||
33534907|NCT03573297|62924933|FG002|Open Label Treatment Period|Adverse Event|0|||
33534908|NCT03573297|62924934|FG003|Open Label Treatment Period|Adverse Event|0|||
33534909|NCT03573297|62924931|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
33534910|NCT03573297|62924932|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
33534911|NCT03573297|62924933|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
33534912|NCT03573297|62924934|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
33534913|NCT03573297|62924931|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
33534914|NCT03573297|62924932|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
33534915|NCT03573297|62924933|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
33534916|NCT03573297|62924934|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
33534917|NCT03573297|62924931|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
33534918|NCT03573297|62924932|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
33534919|NCT03573297|62924933|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
33534920|NCT03573297|62924934|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
33534921|NCT03573297|62924931|FG000|Open Label Treatment Period|Pregnancy|1|||
33534922|NCT03573297|62924932|FG001|Open Label Treatment Period|Pregnancy|0|||
33534923|NCT03573297|62924933|FG002|Open Label Treatment Period|Pregnancy|0|||
33534924|NCT03573297|62924934|FG003|Open Label Treatment Period|Pregnancy|0|||
33534925|NCT03573297|62924931|FG000|Open Label Treatment Period|Protocol Violation|17|||
33534926|NCT03573297|62924932|FG001|Open Label Treatment Period|Protocol Violation|0|||
33534927|NCT03573297|62924933|FG002|Open Label Treatment Period|Protocol Violation|0|||
33534928|NCT03573297|62924934|FG003|Open Label Treatment Period|Protocol Violation|0|||
33534929|NCT03573297|62924931|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
33534930|NCT03573297|62924932|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
33534931|NCT03573297|62924933|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
33534932|NCT03573297|62924934|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
33534933|NCT03573297|62924931|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
33534934|NCT03573297|62924932|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
33534935|NCT03573297|62924933|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
33534936|NCT03573297|62924934|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
33534937|NCT03573297|62924931|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
33534938|NCT03573297|62924932|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
33534939|NCT03573297|62924933|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
33534940|NCT03573297|62924934|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
33534941|NCT03573297|62924931|FG000|Open Label Treatment Period|Other, Not Specified|7|||
33534942|NCT03573297|62924932|FG001|Open Label Treatment Period|Other, Not Specified|0|||
33534943|NCT03573297|62924933|FG002|Open Label Treatment Period|Other, Not Specified|0|||
33534944|NCT03573297|62924934|FG003|Open Label Treatment Period|Other, Not Specified|0|||
33534945|NCT03573297|62924931|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
33534946|NCT03573297|62924932|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
33534947|NCT03573297|62924933|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
33534948|NCT03573297|62924934|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
33534949|NCT03573297|62924931|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33534950|NCT03573297|62924932|FG001|Double-Blind Treatment Period|Adverse Event|1|||
33534951|NCT03573297|62924933|FG002|Double-Blind Treatment Period|Adverse Event|5|||
33534952|NCT03573297|62924934|FG003|Double-Blind Treatment Period|Adverse Event|1|||
33534953|NCT03573297|62924931|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
33534954|NCT03573297|62924932|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
33459827|NCT00116805|62833129|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
33459828|NCT00116805|62833130|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
33459829|NCT00116805|62833129|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
33459830|NCT00116805|62833130|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
33459831|NCT00116805|62833129|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
33459832|NCT00116805|62833130|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
33459833|NCT00116805|62833129|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
33459834|NCT00116805|62833130|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
33459835|NCT00116805|62833129|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
33459836|NCT00116805|62833130|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
33459837|NCT00116805|62833129|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
33534955|NCT03573297|62924933|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
33534956|NCT03573297|62924934|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
33534957|NCT03573297|62924931|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33534958|NCT03573297|62924932|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
33534959|NCT03573297|62924933|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
33534960|NCT03573297|62924934|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
33534961|NCT03573297|62924931|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33534962|NCT03573297|62924932|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
33534963|NCT03573297|62924933|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
33534964|NCT03573297|62924934|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
33534965|NCT03573297|62924931|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
33534966|NCT03573297|62924932|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
33534967|NCT03573297|62924933|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
33534968|NCT03573297|62924934|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
33534969|NCT03573297|62924931|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
33534970|NCT03573297|62924932|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
33534971|NCT03573297|62924933|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
33534972|NCT03573297|62924934|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
33534973|NCT03573297|62924931|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
33534974|NCT03573297|62924932|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
33534975|NCT03573297|62924933|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
33534976|NCT03573297|62924934|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
33534977|NCT03536884|62924945|FG000|Initial Treatment Period Week 0-16|Adverse Event|8|||
33534978|NCT03536884|62924946|FG001|Initial Treatment Period Week 0-16|Adverse Event|6|||
33534979|NCT03536884|62924947|FG002|Initial Treatment Period Week 0-16|Adverse Event|0|||
33534980|NCT03536884|62924948|FG003|Initial Treatment Period Week 0-16|Adverse Event|0|||
33534981|NCT03536884|62924949|FG004|Initial Treatment Period Week 0-16|Adverse Event|0|||
33534982|NCT03536884|62924945|FG000|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
33534983|NCT03536884|62924946|FG001|Initial Treatment Period Week 0-16|Lost to Follow-up|3|||
33534984|NCT03536884|62924947|FG002|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
33534985|NCT03536884|62924948|FG003|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
33534986|NCT03536884|62924949|FG004|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
33534987|NCT03536884|62924945|FG000|Initial Treatment Period Week 0-16|Withdrawal by Subject|3|||
33534988|NCT03536884|62924946|FG001|Initial Treatment Period Week 0-16|Withdrawal by Subject|4|||
33534989|NCT03536884|62924947|FG002|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
33534990|NCT03536884|62924948|FG003|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
33534991|NCT03536884|62924949|FG004|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
33534992|NCT03536884|62924945|FG000|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
33534993|NCT03536884|62924946|FG001|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|1|||
33534994|NCT03536884|62924947|FG002|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
33534995|NCT03536884|62924948|FG003|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
33534996|NCT03536884|62924949|FG004|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
33534997|NCT03536884|62924945|FG000|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
33534998|NCT03536884|62924946|FG001|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|1|||
33534999|NCT03536884|62924947|FG002|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
33535000|NCT03536884|62924948|FG003|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
33535001|NCT03536884|62924949|FG004|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
33535002|NCT03536884|62924945|FG000|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
33535003|NCT03536884|62924946|FG001|Initial Treatment Period Week 0-16|Unable to attend visits|1|||
33535004|NCT03536884|62924947|FG002|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
33459838|NCT00116805|62833130|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
33459839|NCT00116649|62833145|FG000|Overall Study|Adverse Event|20|||
33459840|NCT00116649|62833145|FG000|Overall Study|Lack of Efficacy|1|||
33459841|NCT00116649|62833145|FG000|Overall Study|Lost to Follow-up|32|||
33459842|NCT00116649|62833145|FG000|Overall Study|Withdrawal by Subject|68|||
33459843|NCT00116649|62833145|FG000|Overall Study|Local Skin Reaction|9|||
33459844|NCT00116649|62833145|FG000|Overall Study|Various Reasons|18|||
33459845|NCT00116649|62833145|FG000|Overall Study|Protocol Specified|7|||
33459846|NCT00083889|62833151|FG000|Overall Study|Adverse Event|76|||
33459847|NCT00083889|62833152|FG001|Overall Study|Adverse Event|86|||
33459848|NCT00083889|62833151|FG000|Overall Study|Protocol Violation|2|||
33459849|NCT00083889|62833152|FG001|Overall Study|Protocol Violation|2|||
33459850|NCT00083889|62833151|FG000|Overall Study|Withdrawal by Subject|22|||
33459851|NCT00083889|62833152|FG001|Overall Study|Withdrawal by Subject|24|||
33459852|NCT00083889|62833151|FG000|Overall Study|Lack of Efficacy|240|||
33459853|NCT00083889|62833152|FG001|Overall Study|Lack of Efficacy|219|||
33459854|NCT00083889|62833151|FG000|Overall Study|Decision of sponsor|32|||
33459855|NCT00083889|62833152|FG001|Overall Study|Decision of sponsor|4|||
33459856|NCT00083889|62833151|FG000|Overall Study|Randomized: did not take study drug|0|||
33535005|NCT03536884|62924948|FG003|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
33535006|NCT03536884|62924949|FG004|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
33535007|NCT03536884|62924945|FG000|Maintenance Treatment Period Week 16-48|Death|0|||
33535008|NCT03536884|62924946|FG001|Maintenance Treatment Period Week 16-48|Death|0|||
33535009|NCT03536884|62924947|FG002|Maintenance Treatment Period Week 16-48|Death|1|||
33535010|NCT03536884|62924948|FG003|Maintenance Treatment Period Week 16-48|Death|0|||
33535011|NCT03536884|62924949|FG004|Maintenance Treatment Period Week 16-48|Death|1|||
33535012|NCT03536884|62924945|FG000|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
33535013|NCT03536884|62924946|FG001|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
33535014|NCT03536884|62924947|FG002|Maintenance Treatment Period Week 16-48|Adverse Event|1|||
33535015|NCT03536884|62924948|FG003|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
33535016|NCT03536884|62924949|FG004|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
33535017|NCT03536884|62924945|FG000|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
33535018|NCT03536884|62924946|FG001|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
33535019|NCT03536884|62924947|FG002|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
33535020|NCT03536884|62924948|FG003|Maintenance Treatment Period Week 16-48|Lack of Efficacy|1|||
33535021|NCT03536884|62924949|FG004|Maintenance Treatment Period Week 16-48|Lack of Efficacy|4|||
33535022|NCT03536884|62924945|FG000|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
33535023|NCT03536884|62924946|FG001|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
33535024|NCT03536884|62924947|FG002|Maintenance Treatment Period Week 16-48|Lost to Follow-up|1|||
33535025|NCT03536884|62924948|FG003|Maintenance Treatment Period Week 16-48|Lost to Follow-up|2|||
33535026|NCT03536884|62924949|FG004|Maintenance Treatment Period Week 16-48|Lost to Follow-up|8|||
33535027|NCT03536884|62924945|FG000|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
33535028|NCT03536884|62924946|FG001|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
33535029|NCT03536884|62924947|FG002|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|7|||
33535030|NCT03536884|62924948|FG003|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|3|||
33535031|NCT03536884|62924949|FG004|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|12|||
33535032|NCT03536884|62924945|FG000|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
33535033|NCT03536884|62924946|FG001|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
33535034|NCT03536884|62924947|FG002|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
33535035|NCT03536884|62924948|FG003|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
33535036|NCT03536884|62924949|FG004|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|1|||
33535051|NCT03225287|62925033|FG000|Overall Study|Adverse Event|0|||
33535052|NCT03225287|62925034|FG001|Overall Study|Adverse Event|0|||
33459857|NCT00083889|62833152|FG001|Overall Study|Randomized: did not take study drug|15|||
33459858|NCT00083889|62833151|FG000|Overall Study|Completed on marketed sunitinub|3|||
33459859|NCT00083889|62833152|FG001|Overall Study|Completed on marketed sunitinub|0|||
33459860|NCT00083889|62833151|FG000|Overall Study|Crossover to SU011248|0|||
33459861|NCT00083889|62833152|FG001|Overall Study|Crossover to SU011248|25|||
33459862|NCT03572062|62833171|FG000|Overall Study|Adverse Event|0|||
33459863|NCT03572062|62833172|FG001|Overall Study|Adverse Event|0|||
33459864|NCT03572062|62833173|FG002|Overall Study|Adverse Event|0|||
33459865|NCT03572062|62833174|FG003|Overall Study|Adverse Event|0|||
33459866|NCT03572062|62833175|FG004|Overall Study|Adverse Event|0|||
33459867|NCT03572062|62833176|FG005|Overall Study|Adverse Event|0|||
33459868|NCT03572062|62833177|FG006|Overall Study|Adverse Event|0|||
33459869|NCT03572062|62833178|FG007|Overall Study|Adverse Event|0|||
33459870|NCT03572062|62833179|FG008|Overall Study|Adverse Event|1|||
33459871|NCT03572062|62833180|FG009|Overall Study|Adverse Event|3|||
33535053|NCT03225287|62925035|FG002|Overall Study|Adverse Event|1|||
33535054|NCT03225287|62925033|FG000|Overall Study|Protocol non-compliance|0|||
33535055|NCT03225287|62925034|FG001|Overall Study|Protocol non-compliance|0|||
33459872|NCT03572062|62833171|FG000|Overall Study|Death|0|||
33459873|NCT03572062|62833172|FG001|Overall Study|Death|0|||
33459874|NCT03572062|62833173|FG002|Overall Study|Death|0|||
33535056|NCT03225287|62925035|FG002|Overall Study|Protocol non-compliance|1|||
33535057|NCT03225287|62925033|FG000|Overall Study|Subject withdraws consent|3|||
33535058|NCT03225287|62925034|FG001|Overall Study|Subject withdraws consent|0|||
33535059|NCT03225287|62925035|FG002|Overall Study|Subject withdraws consent|0|||
33535060|NCT03225287|62925033|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
33535061|NCT03225287|62925034|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
33535062|NCT03225287|62925035|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
33535063|NCT03225287|62925033|FG000|Overall Study|Trial drug not effective|0|||
33535064|NCT03225287|62925034|FG001|Overall Study|Trial drug not effective|1|||
33535065|NCT03225287|62925035|FG002|Overall Study|Trial drug not effective|0|||
33535066|NCT03225287|62925033|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
33535067|NCT03225287|62925034|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
33535068|NCT03225287|62925035|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
33535069|NCT03225287|62925033|FG000|Overall Study|Stem cell transplantation|0|||
33535070|NCT03225287|62925034|FG001|Overall Study|Stem cell transplantation|1|||
33535071|NCT03225287|62925035|FG002|Overall Study|Stem cell transplantation|0|||
33535072|NCT03194646|62925047|FG000|Overall Study|Adverse Event|24|||
33535073|NCT03194646|62925048|FG001|Overall Study|Adverse Event|25|||
33535074|NCT03194646|62925049|FG002|Overall Study|Adverse Event|14|||
33535075|NCT03194646|62925050|FG003|Overall Study|Adverse Event|17|||
33535076|NCT03194646|62925047|FG000|Overall Study|Lack of Efficacy|4|||
33535077|NCT03194646|62925048|FG001|Overall Study|Lack of Efficacy|2|||
33535078|NCT03194646|62925049|FG002|Overall Study|Lack of Efficacy|2|||
33535079|NCT03194646|62925050|FG003|Overall Study|Lack of Efficacy|12|||
33535080|NCT03194646|62925047|FG000|Overall Study|Lost to Follow-up|30|||
33535081|NCT03194646|62925048|FG001|Overall Study|Lost to Follow-up|22|||
33535082|NCT03194646|62925049|FG002|Overall Study|Lost to Follow-up|12|||
33535083|NCT03194646|62925050|FG003|Overall Study|Lost to Follow-up|35|||
33535084|NCT03194646|62925047|FG000|Overall Study|Non-compliance with study drug|4|||
33535085|NCT03194646|62925048|FG001|Overall Study|Non-compliance with study drug|0|||
33535086|NCT03194646|62925049|FG002|Overall Study|Non-compliance with study drug|1|||
33535087|NCT03194646|62925050|FG003|Overall Study|Non-compliance with study drug|1|||
33535088|NCT03194646|62925047|FG000|Overall Study|Other|89|||
33535089|NCT03194646|62925048|FG001|Overall Study|Other|68|||
33535090|NCT03194646|62925049|FG002|Overall Study|Other|34|||
33535091|NCT03194646|62925050|FG003|Overall Study|Other|31|||
33535092|NCT03194646|62925047|FG000|Overall Study|Physician Decision|7|||
33535093|NCT03194646|62925048|FG001|Overall Study|Physician Decision|9|||
33535094|NCT03194646|62925049|FG002|Overall Study|Physician Decision|5|||
33535095|NCT03194646|62925050|FG003|Overall Study|Physician Decision|4|||
33535096|NCT03194646|62925047|FG000|Overall Study|Pregnancy|4|||
33535097|NCT03194646|62925048|FG001|Overall Study|Pregnancy|5|||
33535098|NCT03194646|62925049|FG002|Overall Study|Pregnancy|1|||
33535099|NCT03194646|62925050|FG003|Overall Study|Pregnancy|2|||
33535100|NCT03194646|62925047|FG000|Overall Study|Protocol Violation|4|||
33535101|NCT03194646|62925048|FG001|Overall Study|Protocol Violation|2|||
33535102|NCT03194646|62925049|FG002|Overall Study|Protocol Violation|1|||
33535103|NCT03194646|62925050|FG003|Overall Study|Protocol Violation|1|||
33535104|NCT03194646|62925047|FG000|Overall Study|Site terminated by sponsor|0|||
33535105|NCT03194646|62925048|FG001|Overall Study|Site terminated by sponsor|0|||
33535106|NCT03194646|62925049|FG002|Overall Study|Site terminated by sponsor|2|||
33535107|NCT03194646|62925050|FG003|Overall Study|Site terminated by sponsor|0|||
33535108|NCT03194646|62925047|FG000|Overall Study|Study terminated by sponsor|62|||
33535109|NCT03194646|62925048|FG001|Overall Study|Study terminated by sponsor|61|||
33459875|NCT03572062|62833174|FG003|Overall Study|Death|0|||
33535110|NCT03194646|62925049|FG002|Overall Study|Study terminated by sponsor|30|||
33535111|NCT03194646|62925050|FG003|Overall Study|Study terminated by sponsor|34|||
33535112|NCT03194646|62925047|FG000|Overall Study|Withdrawal by Subject|75|||
33535113|NCT03194646|62925048|FG001|Overall Study|Withdrawal by Subject|74|||
33535114|NCT03194646|62925049|FG002|Overall Study|Withdrawal by Subject|36|||
33535115|NCT03194646|62925050|FG003|Overall Study|Withdrawal by Subject|131|||
33535116|NCT03194646|62925047|FG000|Overall Study|Missing|1|||
33535117|NCT03194646|62925048|FG001|Overall Study|Missing|0|||
33535118|NCT03194646|62925049|FG002|Overall Study|Missing|1|||
33535119|NCT03194646|62925050|FG003|Overall Study|Missing|12|||
33627799|NCT02031146|63028896|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
33627800|NCT02031146|63028897|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
33627801|NCT02031146|63028898|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
33627802|NCT02031146|63028899|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
33627803|NCT02031146|63028900|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
33627804|NCT02031146|63028901|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
33627805|NCT02031146|63028902|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
33627806|NCT02009384|63028912|FG000|Overall Study|Death|2|||
33627807|NCT01805037|63028916|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
33627808|NCT01805037|63028917|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
33627809|NCT01805037|63028916|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
33627810|NCT01805037|63028917|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
33627811|NCT01805037|63028916|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
33627812|NCT01805037|63028917|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
33627813|NCT01805037|63028916|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
33627814|NCT01805037|63028917|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
33627815|NCT01805037|63028916|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
33627816|NCT01805037|63028917|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
33627817|NCT01805037|63028916|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
33627818|NCT01805037|63028917|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
33627819|NCT01805037|63028916|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
33627820|NCT01805037|63028917|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
33459876|NCT03572062|62833175|FG004|Overall Study|Death|0|||
33459877|NCT03572062|62833176|FG005|Overall Study|Death|1|||
33459878|NCT03572062|62833177|FG006|Overall Study|Death|0|||
33459879|NCT03572062|62833178|FG007|Overall Study|Death|0|||
33459880|NCT03572062|62833179|FG008|Overall Study|Death|0|||
33459881|NCT03572062|62833180|FG009|Overall Study|Death|0|||
33459882|NCT03572062|62833171|FG000|Overall Study|Lost to Follow-up|0|||
33459883|NCT03572062|62833172|FG001|Overall Study|Lost to Follow-up|0|||
33459884|NCT03572062|62833173|FG002|Overall Study|Lost to Follow-up|0|||
33459885|NCT03572062|62833174|FG003|Overall Study|Lost to Follow-up|0|||
33459886|NCT03572062|62833175|FG004|Overall Study|Lost to Follow-up|0|||
33459887|NCT03572062|62833176|FG005|Overall Study|Lost to Follow-up|1|||
33459888|NCT03572062|62833177|FG006|Overall Study|Lost to Follow-up|1|||
33459889|NCT03572062|62833178|FG007|Overall Study|Lost to Follow-up|0|||
33459890|NCT03572062|62833179|FG008|Overall Study|Lost to Follow-up|0|||
33459891|NCT03572062|62833180|FG009|Overall Study|Lost to Follow-up|0|||
33459892|NCT03572062|62833171|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33459893|NCT03572062|62833172|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33459894|NCT03572062|62833173|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
33459895|NCT03572062|62833174|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
33459896|NCT03572062|62833175|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
33459897|NCT03572062|62833176|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
33459898|NCT03572062|62833177|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
33459899|NCT03572062|62833178|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
33459900|NCT03572062|62833179|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
33459901|NCT03572062|62833180|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
33459902|NCT03572062|62833171|FG000|Overall Study|Study Terminated By Sponsor|0|||
33459903|NCT03572062|62833172|FG001|Overall Study|Study Terminated By Sponsor|0|||
33459904|NCT03572062|62833173|FG002|Overall Study|Study Terminated By Sponsor|0|||
33459905|NCT03572062|62833174|FG003|Overall Study|Study Terminated By Sponsor|0|||
33459906|NCT03572062|62833175|FG004|Overall Study|Study Terminated By Sponsor|0|||
33459907|NCT03572062|62833176|FG005|Overall Study|Study Terminated By Sponsor|0|||
33459908|NCT03572062|62833177|FG006|Overall Study|Study Terminated By Sponsor|0|||
33459909|NCT03572062|62833178|FG007|Overall Study|Study Terminated By Sponsor|0|||
33459910|NCT03572062|62833179|FG008|Overall Study|Study Terminated By Sponsor|29|||
33459911|NCT03572062|62833180|FG009|Overall Study|Study Terminated By Sponsor|27|||
33459912|NCT03572062|62833171|FG000|Overall Study|Physician Decision|0|||
33459913|NCT03572062|62833172|FG001|Overall Study|Physician Decision|0|||
33459914|NCT03572062|62833173|FG002|Overall Study|Physician Decision|0|||
33459915|NCT03572062|62833174|FG003|Overall Study|Physician Decision|0|||
33459916|NCT03572062|62833175|FG004|Overall Study|Physician Decision|0|||
33459917|NCT03572062|62833176|FG005|Overall Study|Physician Decision|0|||
33459918|NCT03572062|62833177|FG006|Overall Study|Physician Decision|0|||
33459919|NCT03572062|62833178|FG007|Overall Study|Physician Decision|0|||
33459920|NCT03572062|62833179|FG008|Overall Study|Physician Decision|1|||
33459921|NCT03572062|62833180|FG009|Overall Study|Physician Decision|0|||
33459922|NCT03572062|62833171|FG000|Overall Study|Withdrawal by Subject|0|||
33459923|NCT03572062|62833172|FG001|Overall Study|Withdrawal by Subject|0|||
33459924|NCT03572062|62833173|FG002|Overall Study|Withdrawal by Subject|0|||
33459925|NCT03572062|62833174|FG003|Overall Study|Withdrawal by Subject|0|||
33459926|NCT03572062|62833175|FG004|Overall Study|Withdrawal by Subject|0|||
33459927|NCT03572062|62833176|FG005|Overall Study|Withdrawal by Subject|0|||
33459928|NCT03572062|62833177|FG006|Overall Study|Withdrawal by Subject|0|||
33326063|NCT01185821|62702839|FG004|Overall Study|Abnormal test procedure result|1|||
33326064|NCT01185821|62702835|FG000|Overall Study|Death|0|||
33326065|NCT01185821|62702836|FG001|Overall Study|Death|1|||
33326066|NCT01185821|62702837|FG002|Overall Study|Death|0|||
33326067|NCT01185821|62702838|FG003|Overall Study|Death|0|||
33326068|NCT01185821|62702839|FG004|Overall Study|Death|0|||
33326069|NCT01185821|62702835|FG000|Overall Study|Condition no longer required study drug|0|||
33326070|NCT01185821|62702836|FG001|Overall Study|Condition no longer required study drug|0|||
33459929|NCT03572062|62833178|FG007|Overall Study|Withdrawal by Subject|0|||
33459930|NCT03572062|62833179|FG008|Overall Study|Withdrawal by Subject|0|||
33459931|NCT03572062|62833180|FG009|Overall Study|Withdrawal by Subject|1|||
33459932|NCT03572062|62833171|FG000|Overall Study|Randomized But Not Treated|0|||
33459933|NCT03572062|62833172|FG001|Overall Study|Randomized But Not Treated|0|||
33459934|NCT03572062|62833173|FG002|Overall Study|Randomized But Not Treated|0|||
33459935|NCT03572062|62833174|FG003|Overall Study|Randomized But Not Treated|0|||
33459936|NCT03572062|62833175|FG004|Overall Study|Randomized But Not Treated|1|||
33459937|NCT03572062|62833176|FG005|Overall Study|Randomized But Not Treated|2|||
33459938|NCT03572062|62833177|FG006|Overall Study|Randomized But Not Treated|0|||
33459939|NCT03572062|62833178|FG007|Overall Study|Randomized But Not Treated|1|||
33459940|NCT03572062|62833179|FG008|Overall Study|Randomized But Not Treated|0|||
33459941|NCT03572062|62833180|FG009|Overall Study|Randomized But Not Treated|0|||
33459942|NCT03571516|62833202|FG000|Overall Study|Severe diarrhea|1|||
33459943|NCT03571516|62833203|FG001|Overall Study|Severe diarrhea|0|||
33459944|NCT03571516|62833202|FG000|Overall Study|Withdrawal by Subject|0|||
33326071|NCT01185821|62702837|FG002|Overall Study|Condition no longer required study drug|0|||
33326072|NCT01185821|62702838|FG003|Overall Study|Condition no longer required study drug|0|||
33326073|NCT01185821|62702839|FG004|Overall Study|Condition no longer required study drug|1|||
33459945|NCT03571516|62833203|FG001|Overall Study|Withdrawal by Subject|1|||
33459946|NCT03600376|62833211|FG000|Overall Study|Adverse Event|1|||
33459947|NCT03600376|62833212|FG001|Overall Study|Adverse Event|1|||
33459948|NCT03600376|62833211|FG000|Overall Study|Transferred to other facility|1|||
33459949|NCT03600376|62833212|FG001|Overall Study|Transferred to other facility|0|||
33459950|NCT03600376|62833211|FG000|Overall Study|Investigator Decision|0|||
33535171|NCT03141177|62925081|FG000|Overall Study|Death|62|||
33535172|NCT03141177|62925082|FG001|Overall Study|Death|13|||
33535173|NCT03141177|62925083|FG002|Overall Study|Death|84|||
33535174|NCT03141177|62925081|FG000|Overall Study|Participant withdrew consent|9|||
33535175|NCT03141177|62925082|FG001|Overall Study|Participant withdrew consent|2|||
33535176|NCT03141177|62925083|FG002|Overall Study|Participant withdrew consent|13|||
33535177|NCT03141177|62925081|FG000|Overall Study|Not reported|1|||
33535178|NCT03141177|62925082|FG001|Overall Study|Not reported|0|||
33535179|NCT03141177|62925083|FG002|Overall Study|Not reported|1|||
33535180|NCT03141177|62925081|FG000|Overall Study|Lost to Follow-up|2|||
33535181|NCT03141177|62925082|FG001|Overall Study|Lost to Follow-up|1|||
33535182|NCT03141177|62925083|FG002|Overall Study|Lost to Follow-up|1|||
33535183|NCT03141177|62925081|FG000|Overall Study|Other reasons|4|||
33535184|NCT03141177|62925082|FG001|Overall Study|Other reasons|0|||
33535185|NCT03141177|62925083|FG002|Overall Study|Other reasons|11|||
33459951|NCT03600376|62833212|FG001|Overall Study|Investigator Decision|4|||
33459952|NCT03600376|62833211|FG000|Overall Study|Determined to be ineligible for study|0|||
33459953|NCT03600376|62833212|FG001|Overall Study|Determined to be ineligible for study|1|||
33459954|NCT03599362|62833218|FG000|Overall Study|Screen Failure|3|||
33535186|NCT03141177|62925081|FG000|Overall Study|Participants did not start treatment period|3|||
33535187|NCT03141177|62925082|FG001|Overall Study|Participants did not start treatment period|0|||
33535188|NCT03141177|62925083|FG002|Overall Study|Participants did not start treatment period|8|||
33535189|NCT03140670|62925092|FG000|Overall Study|Withdrawal by Subject|2|||
33535190|NCT03140670|62925092|FG000|Overall Study|Lost to Follow-up|1|||
33535191|NCT03140670|62925092|FG000|Overall Study|Physician Decision|1|||
33627821|NCT01805037|63028916|FG000|Follow Up (up to 3 Years)|Death|0|||
33627822|NCT01805037|63028917|FG001|Follow Up (up to 3 Years)|Death|2|||
33627823|NCT01805037|63028916|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
33459955|NCT03598036|62833224|FG000|Overall Study|Withdrawal by Subject|1|||
33459956|NCT03598036|62833225|FG001|Overall Study|Withdrawal by Subject|0|||
33459957|NCT00082407|62833235|FG000|Overall Study|Adverse Event|20|||
33459958|NCT00082407|62833236|FG001|Overall Study|Adverse Event|0|||
33459959|NCT00082407|62833235|FG000|Overall Study|Protocol Violation|14|||
33459960|NCT00082407|62833236|FG001|Overall Study|Protocol Violation|12|||
33627824|NCT01805037|63028917|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
33627825|NCT01805037|63028916|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
33627826|NCT01805037|63028917|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
33627827|NCT01803711|63028923|FG000|Overall Study|Adverse Event|1|||
33627828|NCT01803711|63028924|FG001|Overall Study|Adverse Event|1|||
33627829|NCT01836549|63028938|FG000|Overall Study|Did not receive study drug|0|||
33627830|NCT01836549|63028939|FG001|Overall Study|Did not receive study drug|0|||
33627831|NCT01836549|63028940|FG002|Overall Study|Did not receive study drug|1|||
33627832|NCT01836549|63028941|FG003|Overall Study|Did not receive study drug|0|||
33627833|NCT01836549|63028942|FG004|Overall Study|Did not receive study drug|0|||
33627834|NCT01836549|63028943|FG005|Overall Study|Did not receive study drug|0|||
33627835|NCT01836549|63028944|FG006|Overall Study|Did not receive study drug|0|||
33627836|NCT01836549|63028938|FG000|Overall Study|Patient declared ineligible|0|||
33627837|NCT01836549|63028939|FG001|Overall Study|Patient declared ineligible|0|||
33627838|NCT01836549|63028940|FG002|Overall Study|Patient declared ineligible|0|||
33627839|NCT01836549|63028941|FG003|Overall Study|Patient declared ineligible|1|||
33627840|NCT01836549|63028942|FG004|Overall Study|Patient declared ineligible|0|||
33627841|NCT01836549|63028943|FG005|Overall Study|Patient declared ineligible|0|||
33627842|NCT01836549|63028944|FG006|Overall Study|Patient declared ineligible|0|||
33627843|NCT01836549|63028938|FG000|Overall Study|Patient inevaluable to start therapy|0|||
33627844|NCT01836549|63028939|FG001|Overall Study|Patient inevaluable to start therapy|0|||
33627845|NCT01836549|63028940|FG002|Overall Study|Patient inevaluable to start therapy|0|||
33627846|NCT01836549|63028941|FG003|Overall Study|Patient inevaluable to start therapy|0|||
33627847|NCT01836549|63028942|FG004|Overall Study|Patient inevaluable to start therapy|0|||
33627848|NCT01836549|63028943|FG005|Overall Study|Patient inevaluable to start therapy|0|||
33627849|NCT01836549|63028944|FG006|Overall Study|Patient inevaluable to start therapy|1|||
33627850|NCT01836471|63028965|FG000|Overall Study|Pregnancy|1|||
33627851|NCT01836471|63028966|FG001|Overall Study|Pregnancy|0|||
33627852|NCT01836471|63028967|FG002|Overall Study|Pregnancy|0|||
33627853|NCT01836471|63028968|FG003|Overall Study|Pregnancy|0|||
33627854|NCT01836471|63028969|FG004|Overall Study|Pregnancy|0|||
33627855|NCT01836471|63028965|FG000|Overall Study|Withdrawal by Subject|3|||
33627856|NCT01836471|63028966|FG001|Overall Study|Withdrawal by Subject|4|||
33627857|NCT01836471|63028967|FG002|Overall Study|Withdrawal by Subject|1|||
33627858|NCT01836471|63028968|FG003|Overall Study|Withdrawal by Subject|0|||
33627859|NCT01836471|63028969|FG004|Overall Study|Withdrawal by Subject|2|||
33627860|NCT01836471|63028965|FG000|Overall Study|Physician Decision|0|||
33627861|NCT01836471|63028966|FG001|Overall Study|Physician Decision|1|||
33627862|NCT01836471|63028967|FG002|Overall Study|Physician Decision|0|||
33627863|NCT01836471|63028968|FG003|Overall Study|Physician Decision|0|||
33627864|NCT01836471|63028969|FG004|Overall Study|Physician Decision|0|||
33627865|NCT01836471|63028965|FG000|Overall Study|Lost to Follow-up|0|||
33627866|NCT01836471|63028966|FG001|Overall Study|Lost to Follow-up|0|||
33627867|NCT01836471|63028967|FG002|Overall Study|Lost to Follow-up|0|||
33627868|NCT01836471|63028968|FG003|Overall Study|Lost to Follow-up|1|||
33627869|NCT01836471|63028969|FG004|Overall Study|Lost to Follow-up|1|||
33627870|NCT01836471|63028965|FG000|Overall Study|Adverse Event|6|||
33627871|NCT01836471|63028966|FG001|Overall Study|Adverse Event|3|||
33627872|NCT01836471|63028967|FG002|Overall Study|Adverse Event|1|||
33627873|NCT01836471|63028968|FG003|Overall Study|Adverse Event|1|||
33627874|NCT01836471|63028969|FG004|Overall Study|Adverse Event|2|||
33627875|NCT01836471|63028965|FG000|Overall Study|Non compliance with tx|1|||
33627876|NCT01836471|63028966|FG001|Overall Study|Non compliance with tx|1|||
33627877|NCT01836471|63028967|FG002|Overall Study|Non compliance with tx|0|||
33627878|NCT01836471|63028968|FG003|Overall Study|Non compliance with tx|0|||
33627879|NCT01836471|63028969|FG004|Overall Study|Non compliance with tx|0|||
33627880|NCT02030600|63028984|FG000|Treatment Period 1|Adverse Event|5|||
33627881|NCT02030600|63028985|FG001|Treatment Period 1|Adverse Event|7|||
33627882|NCT02030600|63028984|FG000|Treatment Period 1|Lack of Efficacy|0|||
33627883|NCT02030600|63028985|FG001|Treatment Period 1|Lack of Efficacy|1|||
33627884|NCT02030600|63028984|FG000|Treatment Period 1|Lost to Follow-up|11|||
33627885|NCT02030600|63028985|FG001|Treatment Period 1|Lost to Follow-up|3|||
33627886|NCT02030600|63028984|FG000|Treatment Period 1|Protocol Violation|22|||
33627887|NCT02030600|63028985|FG001|Treatment Period 1|Protocol Violation|17|||
33627888|NCT02030600|63028984|FG000|Treatment Period 1|Withdrawal by Subject|13|||
33627889|NCT02030600|63028985|FG001|Treatment Period 1|Withdrawal by Subject|17|||
33627890|NCT02030600|63028984|FG000|Treatment Period 1|Casebook Unsigned|1|||
33627891|NCT02030600|63028985|FG001|Treatment Period 1|Casebook Unsigned|0|||
33627892|NCT02030600|63028984|FG000|Treatment Period 1|Unclassified|1|||
33627893|NCT02030600|63028985|FG001|Treatment Period 1|Unclassified|0|||
33627894|NCT02030600|63028984|FG000|Treatment Period 2|Adverse Event|4|||
33627895|NCT02030600|63028985|FG001|Treatment Period 2|Adverse Event|4|||
33627896|NCT02030600|63028984|FG000|Treatment Period 2|Lack of Efficacy|2|||
33627897|NCT02030600|63028985|FG001|Treatment Period 2|Lack of Efficacy|1|||
33627898|NCT02030600|63028984|FG000|Treatment Period 2|Lost to Follow-up|4|||
33627899|NCT02030600|63028985|FG001|Treatment Period 2|Lost to Follow-up|2|||
33627900|NCT02030600|63028984|FG000|Treatment Period 2|Protocol Violation|1|||
33627901|NCT02030600|63028985|FG001|Treatment Period 2|Protocol Violation|2|||
33627902|NCT02030600|63028984|FG000|Treatment Period 2|Withdrawal by Subject|13|||
33627903|NCT02030600|63028985|FG001|Treatment Period 2|Withdrawal by Subject|9|||
33627904|NCT02030600|63028984|FG000|Treatment Period 2|Unclassified|1|||
33627905|NCT02030600|63028985|FG001|Treatment Period 2|Unclassified|0|||
33627906|NCT01802775|63028995|FG000|Overall Study|Death|0|||
33627907|NCT01802775|63028996|FG001|Overall Study|Death|3|||
33627908|NCT01802775|63028995|FG000|Overall Study|Reason not provided|0|||
33627909|NCT01802775|63028996|FG001|Overall Study|Reason not provided|1|||
33627910|NCT01802775|63028995|FG000|Overall Study|Physician Decision|1|||
33627911|NCT01802775|63028996|FG001|Overall Study|Physician Decision|0|||
33627912|NCT01802775|63028995|FG000|Overall Study|Adverse Event|1|||
33627913|NCT01802775|63028996|FG001|Overall Study|Adverse Event|1|||
33627914|NCT01802775|63028995|FG000|Overall Study|Withdrawal by Subject|3|||
33627915|NCT01802775|63028996|FG001|Overall Study|Withdrawal by Subject|5|||
33627916|NCT01802775|63028995|FG000|Overall Study|Lost to Follow-up|1|||
33627917|NCT01802775|63028996|FG001|Overall Study|Lost to Follow-up|2|||
33627918|NCT01802385|63029004|FG000|Overall Study|Death|106|||
33627919|NCT01802385|63029005|FG001|Overall Study|Death|120|||
33627920|NCT01773993|63029011|FG000|Overall Study|No Visit After Treatment|35|||
33627921|NCT01802073|63029017|FG000|Overall Study|Lost to Follow-up|0|||
33627922|NCT01802073|63029018|FG001|Overall Study|Lost to Follow-up|1|||
33627923|NCT01802073|63029017|FG000|Overall Study|Non-compliant|4|||
33627924|NCT01802073|63029018|FG001|Overall Study|Non-compliant|2|||
33627925|NCT01802073|63029017|FG000|Overall Study|Withdrawal by Subject|1|||
33627926|NCT01802073|63029018|FG001|Overall Study|Withdrawal by Subject|1|||
33627927|NCT01802073|63029017|FG000|Overall Study|Physician Decision|0|||
33627928|NCT01802073|63029018|FG001|Overall Study|Physician Decision|7|||
33627929|NCT01607073|63029024|FG000|Overall Study|Adverse Event|1|||
33627930|NCT01773291|63029034|FG000|Overall Study|Protocol Violation|1|||
33627931|NCT01773291|63029035|FG001|Overall Study|Protocol Violation|0|||
33627932|NCT01773291|63029036|FG002|Overall Study|Protocol Violation|0|||
33627933|NCT01773291|63029034|FG000|Overall Study|Withdrawal by Subject|0|||
33627934|NCT01773291|63029035|FG001|Overall Study|Withdrawal by Subject|0|||
33627935|NCT01773291|63029036|FG002|Overall Study|Withdrawal by Subject|1|||
33627936|NCT01801917|63029049|FG000|Period 1 - Randomized|Adverse Event|1|||
33627937|NCT01801917|63029050|FG001|Period 1 - Randomized|Adverse Event|0|||
33627938|NCT01801917|63029051|FG002|Period 1 - Randomized|Adverse Event|1|||
33627939|NCT01801917|63029052|FG003|Period 1 - Randomized|Adverse Event|0|||
33627940|NCT02008916|63029066|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
33627941|NCT02008916|63029067|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
33627942|NCT02008916|63029068|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
33627943|NCT02008916|63029066|FG000|Week 16 - 156|Adverse Event|4|||
33627944|NCT02008916|63029067|FG001|Week 16 - 156|Adverse Event|2|||
33627945|NCT02008916|63029068|FG002|Week 16 - 156|Adverse Event|3|||
33627946|NCT02008916|63029066|FG000|Week 16 - 156|Withdrawal by Subject|7|||
33627947|NCT02008916|63029067|FG001|Week 16 - 156|Withdrawal by Subject|3|||
33627948|NCT02008916|63029068|FG002|Week 16 - 156|Withdrawal by Subject|5|||
33627949|NCT02008916|63029066|FG000|Week 16 - 156|No longer requires treatment|0|||
33627950|NCT02008916|63029067|FG001|Week 16 - 156|No longer requires treatment|1|||
33627951|NCT02008916|63029068|FG002|Week 16 - 156|No longer requires treatment|0|||
33627952|NCT02008916|63029066|FG000|Week 16 - 156|Lost to Follow-up|5|||
33627953|NCT02008916|63029067|FG001|Week 16 - 156|Lost to Follow-up|0|||
33627954|NCT02008916|63029068|FG002|Week 16 - 156|Lost to Follow-up|0|||
33627955|NCT02008916|63029066|FG000|Week 16 - 156|Lack of Efficacy|3|||
33627956|NCT02008916|63029067|FG001|Week 16 - 156|Lack of Efficacy|5|||
33627957|NCT02008916|63029068|FG002|Week 16 - 156|Lack of Efficacy|2|||
33627958|NCT02008916|63029066|FG000|Week 16 - 156|Pregnancy|0|||
33627959|NCT02008916|63029067|FG001|Week 16 - 156|Pregnancy|1|||
33627960|NCT02008916|63029068|FG002|Week 16 - 156|Pregnancy|0|||
33627961|NCT02008916|63029066|FG000|Week 16 - 156|Physician Decision|0|||
33627962|NCT02008916|63029067|FG001|Week 16 - 156|Physician Decision|1|||
33459961|NCT00082407|62833235|FG000|Overall Study|Patient Decision|13|||
33459962|NCT00082407|62833236|FG001|Overall Study|Patient Decision|6|||
33459963|NCT00082407|62833235|FG000|Overall Study|Physician Decision|5|||
33459964|NCT00082407|62833236|FG001|Overall Study|Physician Decision|3|||
33459965|NCT00082407|62833235|FG000|Overall Study|Loss of Glucose Control|2|||
33459966|NCT00082407|62833236|FG001|Overall Study|Loss of Glucose Control|2|||
33459967|NCT00082407|62833235|FG000|Overall Study|Death|2|||
33459968|NCT00082407|62833236|FG001|Overall Study|Death|1|||
33459969|NCT00082407|62833235|FG000|Overall Study|Lost to Follow-up|0|||
33459970|NCT00082407|62833236|FG001|Overall Study|Lost to Follow-up|3|||
33459971|NCT03643432|62833244|FG000|Overall Study|Lost to Follow-up|1|||
33459972|NCT03643432|62833245|FG001|Overall Study|Lost to Follow-up|0|||
33459973|NCT03810183|62833253|FG000|Overall Study|Study terminated by Sponsor|2|||
33459974|NCT03810183|62833254|FG001|Overall Study|Study terminated by Sponsor|1|||
33459975|NCT03597022|62833264|FG000|Overall Study|Premature termination of the study|7|||
33459976|NCT03597022|62833265|FG001|Overall Study|Premature termination of the study|7|||
33459977|NCT03597022|62833266|FG002|Overall Study|Premature termination of the study|8|||
33459978|NCT03597022|62833264|FG000|Overall Study|Serious adverse event|1|||
33459979|NCT03597022|62833265|FG001|Overall Study|Serious adverse event|1|||
33459980|NCT03597022|62833266|FG002|Overall Study|Serious adverse event|0|||
33627963|NCT02008916|63029068|FG002|Week 16 - 156|Physician Decision|0|||
33627964|NCT01772823|63029079|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
33627965|NCT01772823|63029080|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
33459981|NCT03571204|62833277|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
33459982|NCT03571204|62833278|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
33459983|NCT03571204|62833279|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
33459984|NCT03571204|62833277|FG000|Overall Study|Physician Decision|0|||
33459985|NCT03571204|62833278|FG001|Overall Study|Physician Decision|1|||
33459986|NCT03571204|62833279|FG002|Overall Study|Physician Decision|0|||
33627966|NCT01772823|63029079|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
33627967|NCT01772823|63029080|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
33627968|NCT01772823|63029079|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
33627969|NCT01772823|63029080|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
33459987|NCT03569098|62833291|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
33459988|NCT03569098|62833292|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
33459989|NCT03569098|62833293|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
33459990|NCT03569098|62833291|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
33627970|NCT01772823|63029079|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
33627971|NCT01772823|63029080|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
33627972|NCT01772823|63029079|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
33627973|NCT01772823|63029080|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
33627974|NCT01772823|63029079|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
33627975|NCT01772823|63029080|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
33627976|NCT01772823|63029079|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
33627977|NCT01772823|63029080|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
33627978|NCT01772823|63029079|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
33627979|NCT01772823|63029080|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
33627980|NCT01772823|63029079|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
33627981|NCT01772823|63029080|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
33627982|NCT01772823|63029079|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
33627983|NCT01772823|63029080|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
33627984|NCT01772823|63029079|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
33627985|NCT01772823|63029080|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
33627986|NCT01772823|63029079|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
33627987|NCT01772823|63029080|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
33627988|NCT01772823|63029079|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
33627989|NCT01772823|63029080|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
33627990|NCT01772823|63029079|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
33627991|NCT01772823|63029080|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
33627992|NCT01772823|63029079|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
33627993|NCT01772823|63029080|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
33627994|NCT01772823|63029079|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
33627995|NCT01772823|63029080|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
33627996|NCT02029976|63029093|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
33627997|NCT02029976|63029094|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
33627998|NCT02029976|63029093|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
33627999|NCT02029976|63029094|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
33628000|NCT02029976|63029093|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
33628001|NCT02029976|63029094|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
33628002|NCT02029976|63029093|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
33628003|NCT02029976|63029094|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
33459991|NCT03569098|62833292|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
33459992|NCT03569098|62833293|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
33459993|NCT03569098|62833291|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
33459994|NCT03569098|62833292|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
33459995|NCT03569098|62833293|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
33459996|NCT03569098|62833291|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
33459997|NCT03569098|62833292|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
33628004|NCT01983254|63029102|FG000|Overall Study|Death|6|||
33628005|NCT01983254|63029103|FG001|Overall Study|Death|6|||
33628006|NCT01983254|63029102|FG000|Overall Study|Lost to Follow-up|17|||
33628007|NCT01983254|63029103|FG001|Overall Study|Lost to Follow-up|16|||
33628008|NCT01983254|63029102|FG000|Overall Study|too ill|11|||
33628009|NCT01983254|63029103|FG001|Overall Study|too ill|8|||
33628010|NCT01771809|63029111|FG000|Overall Study|Adverse Event|4|||
33628011|NCT01771809|63029112|FG001|Overall Study|Adverse Event|12|||
33628012|NCT01771809|63029111|FG000|Overall Study|Protocol Violation|0|||
33628013|NCT01771809|63029112|FG001|Overall Study|Protocol Violation|1|||
33628014|NCT01771809|63029111|FG000|Overall Study|Withdrawal by Subject|34|||
33628015|NCT01771809|63029112|FG001|Overall Study|Withdrawal by Subject|42|||
33628016|NCT01771809|63029111|FG000|Overall Study|Lost to Follow-up|1|||
33628017|NCT01771809|63029112|FG001|Overall Study|Lost to Follow-up|3|||
33628018|NCT01771809|63029111|FG000|Overall Study|Other (Insufficient clinical response)|22|||
33628019|NCT01771809|63029112|FG001|Overall Study|Other (Insufficient clinical response)|20|||
33628020|NCT01771809|63029111|FG000|Overall Study|Death|1|||
33628021|NCT01771809|63029112|FG001|Overall Study|Death|0|||
33628022|NCT01771809|63029111|FG000|Overall Study|Other (other)|9|||
33628023|NCT01771809|63029112|FG001|Overall Study|Other (other)|5|||
33628024|NCT01771731|63029120|FG000|Overall Study|Physician Decision|1|||
33628025|NCT01771731|63029121|FG001|Overall Study|Physician Decision|0|||
33628026|NCT01771731|63029120|FG000|Overall Study|Protocol Violation|0|||
33628027|NCT01771731|63029121|FG001|Overall Study|Protocol Violation|1|||
33628028|NCT01771731|63029120|FG000|Overall Study|Adverse event: Pain Crisis|1|||
33628029|NCT01771731|63029121|FG001|Overall Study|Adverse event: Pain Crisis|1|||
33628030|NCT01982942|63029129|FG000|Overall Study|Adverse Event|10|||
33628031|NCT01982942|63029130|FG001|Overall Study|Adverse Event|5|||
33628032|NCT01982942|63029129|FG000|Overall Study|Lost to Follow-up|4|||
33628033|NCT01982942|63029130|FG001|Overall Study|Lost to Follow-up|3|||
33628034|NCT01982942|63029129|FG000|Overall Study|Multiple sclerosis progression|3|||
33628035|NCT01982942|63029130|FG001|Overall Study|Multiple sclerosis progression|2|||
33628036|NCT01982942|63029129|FG000|Overall Study|Wanted to try therapy not permitted|1|||
33628037|NCT01982942|63029130|FG001|Overall Study|Wanted to try therapy not permitted|0|||
33628038|NCT01982942|63029129|FG000|Overall Study|Subject declined future visits|0|||
33628039|NCT01982942|63029130|FG001|Overall Study|Subject declined future visits|1|||
33628040|NCT01982942|63029129|FG000|Overall Study|Left geographical area|2|||
33628041|NCT01982942|63029130|FG001|Overall Study|Left geographical area|0|||
33628042|NCT01982942|63029129|FG000|Overall Study|Too many pills|1|||
33628043|NCT01982942|63029130|FG001|Overall Study|Too many pills|0|||
33628044|NCT01982942|63029129|FG000|Overall Study|MS Relapse|0|||
33628045|NCT01982942|63029130|FG001|Overall Study|MS Relapse|1|||
33628046|NCT01982942|63029129|FG000|Overall Study|Chose to join a stem cell trial|0|||
33628047|NCT01982942|63029130|FG001|Overall Study|Chose to join a stem cell trial|1|||
33628048|NCT01982942|63029129|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
33628049|NCT01982942|63029130|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
33628050|NCT01769469|63029136|FG000|Overall Study|Consent Withdrawn|5|||
33628051|NCT01769469|63029136|FG000|Overall Study|Moved Out Of Area|3|||
33628052|NCT01769469|63029136|FG000|Overall Study|Lost to Follow-up|17|||
33628053|NCT01769469|63029136|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
33628054|NCT01769469|63029136|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
33628055|NCT02008526|63029145|FG000|Overall Study|Death|0|||
33628056|NCT02008526|63029146|FG001|Overall Study|Death|2|||
33628057|NCT02008526|63029147|FG002|Overall Study|Death|1|||
33628058|NCT02008526|63029145|FG000|Overall Study|Withdrawal by Subject|3|||
33628059|NCT02008526|63029146|FG001|Overall Study|Withdrawal by Subject|3|||
33628060|NCT02008526|63029147|FG002|Overall Study|Withdrawal by Subject|2|||
33628061|NCT02008526|63029145|FG000|Overall Study|Lost to Follow-up|5|||
33628062|NCT02008526|63029146|FG001|Overall Study|Lost to Follow-up|9|||
33628063|NCT02008526|63029147|FG002|Overall Study|Lost to Follow-up|6|||
33628064|NCT01769391|63029157|FG000|Overall Study|Death|10|||
33628065|NCT01769391|63029158|FG001|Overall Study|Death|1|||
33628066|NCT01769391|63029157|FG000|Overall Study|Adverse Event|0|||
33628067|NCT01769391|63029158|FG001|Overall Study|Adverse Event|3|||
33628068|NCT01769391|63029157|FG000|Overall Study|Progressive Disease|1|||
33628069|NCT01769391|63029158|FG001|Overall Study|Progressive Disease|2|||
33628070|NCT01769391|63029157|FG000|Overall Study|Withdrawal by Subject|4|||
33628071|NCT01769391|63029158|FG001|Overall Study|Withdrawal by Subject|3|||
33628072|NCT01769391|63029157|FG000|Overall Study|Investigator Decision|2|||
33628073|NCT01769391|63029158|FG001|Overall Study|Investigator Decision|0|||
33628074|NCT01800903|63029170|FG000|Second Test Period|unable to catheterise|1|||
33628075|NCT01800903|63029171|FG001|Second Test Period|unable to catheterise|0|||
33628076|NCT01800903|63029172|FG002|Second Test Period|unable to catheterise|0|||
33628077|NCT01800903|63029173|FG003|Second Test Period|unable to catheterise|0|||
33628078|NCT01800903|63029174|FG004|Second Test Period|unable to catheterise|0|||
33628079|NCT01800903|63029175|FG005|Second Test Period|unable to catheterise|0|||
33628080|NCT01767987|63029183|FG000|Overall Study|Physician Decision|4|||
33628081|NCT01767987|63029184|FG001|Overall Study|Physician Decision|1|||
33628082|NCT01800201|63029192|FG000|Overall Study|Withdrawal by Subject|2|||
33628083|NCT01800201|63029193|FG001|Overall Study|Withdrawal by Subject|0|||
33628084|NCT01800201|63029192|FG000|Overall Study|patient privacy concerns|1|||
33628085|NCT01800201|63029193|FG001|Overall Study|patient privacy concerns|1|||
33628086|NCT01800201|63029192|FG000|Overall Study|did not want to use device|0|||
33628087|NCT01800201|63029193|FG001|Overall Study|did not want to use device|1|||
33628088|NCT01800201|63029192|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
33628089|NCT01800201|63029193|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
33628090|NCT01767909|63029202|FG000|Overall Study|Withdrawal by Subject|4|||
33628091|NCT01767909|63029203|FG001|Overall Study|Withdrawal by Subject|7|||
33628092|NCT01767909|63029202|FG000|Overall Study|Adverse Event|3|||
33628093|NCT01767909|63029203|FG001|Overall Study|Adverse Event|1|||
33628094|NCT01767909|63029202|FG000|Overall Study|Withdrawal by Study Partner|3|||
33628095|NCT01767909|63029203|FG001|Overall Study|Withdrawal by Study Partner|1|||
33628096|NCT01767909|63029202|FG000|Overall Study|Non-Compliance|2|||
33628097|NCT01767909|63029203|FG001|Overall Study|Non-Compliance|0|||
33628098|NCT01767909|63029202|FG000|Overall Study|Perceived Lack of Efficacy|1|||
33628099|NCT01767909|63029203|FG001|Overall Study|Perceived Lack of Efficacy|0|||
33628100|NCT01767909|63029202|FG000|Overall Study|Investigator Recommendation|0|||
33628101|NCT01767909|63029203|FG001|Overall Study|Investigator Recommendation|1|||
33628102|NCT01767909|63029202|FG000|Overall Study|Lost to Follow-up|0|||
33628103|NCT01767909|63029203|FG001|Overall Study|Lost to Follow-up|1|||
33628104|NCT01767909|63029202|FG000|Overall Study|LP uncessessful|0|||
33628105|NCT01767909|63029203|FG001|Overall Study|LP uncessessful|1|||
33628106|NCT02029274|63029215|FG000|Overall Study|Adverse Event|1|||
33628107|NCT02029274|63029216|FG001|Overall Study|Adverse Event|0|||
33628108|NCT02029274|63029217|FG002|Overall Study|Adverse Event|2|||
33628109|NCT02029274|63029218|FG003|Overall Study|Adverse Event|2|||
33628110|NCT02008370|63029232|FG000|Overall Study|Lost to Follow-up|7|||
33628111|NCT01981616|63029238|FG000|Overall Study|Adverse Event|0|||
33628112|NCT01981616|63029239|FG001|Overall Study|Adverse Event|1|||
33628113|NCT01981616|63029238|FG000|Overall Study|Protocol Violation|1|||
33628114|NCT01981616|63029239|FG001|Overall Study|Protocol Violation|0|||
33628115|NCT02104817|63029247|FG000|Overall Study|Death|363|||
33628116|NCT02104817|63029248|FG001|Overall Study|Death|330|||
33628117|NCT02104817|63029247|FG000|Overall Study|Lost to Follow-up|3|||
33628118|NCT02104817|63029248|FG001|Overall Study|Lost to Follow-up|2|||
33628119|NCT02104817|63029247|FG000|Overall Study|Protocol Violation|0|||
33628120|NCT02104817|63029248|FG001|Overall Study|Protocol Violation|1|||
33628121|NCT02104817|63029247|FG000|Overall Study|Study terminated by sponsor|5854|||
33628122|NCT02104817|63029248|FG001|Overall Study|Study terminated by sponsor|5901|||
33628123|NCT02104817|63029247|FG000|Overall Study|Withdrawal by Subject|111|||
33628124|NCT02104817|63029248|FG001|Overall Study|Withdrawal by Subject|78|||
33628125|NCT02104817|63029247|FG000|Overall Study|Other reasons|128|||
33628126|NCT02104817|63029248|FG001|Overall Study|Other reasons|135|||
33628127|NCT01962103|63029263|FG000|Phase 1|Adverse Event|4|||
33628128|NCT01962103|63029264|FG001|Phase 1|Adverse Event|0|||
33628129|NCT01962103|63029265|FG002|Phase 1|Adverse Event|2|||
33628130|NCT01962103|63029266|FG003|Phase 1|Adverse Event|1|||
33628131|NCT01962103|63029267|FG004|Phase 1|Adverse Event|2|||
33628132|NCT01962103|63029268|FG005|Phase 1|Adverse Event|2|||
33628133|NCT01962103|63029269|FG006|Phase 1|Adverse Event|0|||
33628134|NCT01962103|63029270|FG007|Phase 1|Adverse Event|0|||
33459998|NCT03569098|62833293|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
33459999|NCT03569098|62833291|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
33460000|NCT03569098|62833292|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
33460001|NCT03569098|62833293|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
33460002|NCT03569098|62833291|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
33460003|NCT03569098|62833292|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
33460004|NCT03569098|62833293|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
33460005|NCT03569098|62833291|FG000|Double-Blind Treatment Cycle 1|Other|1|||
33460006|NCT03569098|62833292|FG001|Double-Blind Treatment Cycle 1|Other|0|||
33460007|NCT03569098|62833293|FG002|Double-Blind Treatment Cycle 1|Other|1|||
33460008|NCT03569098|62833291|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
33628135|NCT01962103|63029271|FG008|Phase 1|Adverse Event|0|||
33628136|NCT01962103|63029263|FG000|Phase 1|Progressive Disease|8|||
33628137|NCT01962103|63029264|FG001|Phase 1|Progressive Disease|6|||
33628138|NCT01962103|63029265|FG002|Phase 1|Progressive Disease|8|||
33628139|NCT01962103|63029266|FG003|Phase 1|Progressive Disease|4|||
33628140|NCT01962103|63029267|FG004|Phase 1|Progressive Disease|5|||
33628141|NCT01962103|63029268|FG005|Phase 1|Progressive Disease|4|||
33628142|NCT01962103|63029269|FG006|Phase 1|Progressive Disease|0|||
33628143|NCT01962103|63029270|FG007|Phase 1|Progressive Disease|0|||
33628144|NCT01962103|63029271|FG008|Phase 1|Progressive Disease|0|||
33628145|NCT01962103|63029263|FG000|Phase 1|Withdrawal by Subject|0|||
33628146|NCT01962103|63029264|FG001|Phase 1|Withdrawal by Subject|0|||
33535319|NCT02970318|62925164|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
33535320|NCT02970318|62925165|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
33535321|NCT02970318|62925166|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
33535322|NCT02970318|62925167|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
33535323|NCT02970318|62925164|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
33535324|NCT02970318|62925165|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
33535325|NCT02970318|62925166|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
33535326|NCT02970318|62925167|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
33535327|NCT02970318|62925164|FG000|Overall for Arm A & Main for Arm B|Death|41|||
33535328|NCT02970318|62925165|FG001|Overall for Arm A & Main for Arm B|Death|33|||
33535329|NCT02970318|62925166|FG002|Overall for Arm A & Main for Arm B|Death|0|||
33535330|NCT02970318|62925167|FG003|Overall for Arm A & Main for Arm B|Death|0|||
33535331|NCT02970318|62925164|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
33535332|NCT02970318|62925165|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
33535333|NCT02970318|62925166|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
33535334|NCT02970318|62925167|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
33535335|NCT02970318|62925164|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
33535336|NCT02970318|62925165|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
33535337|NCT02970318|62925166|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
33535338|NCT02970318|62925167|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
33535339|NCT02970318|62925164|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
33535340|NCT02970318|62925165|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
33535341|NCT02970318|62925166|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
33628147|NCT01962103|63029265|FG002|Phase 1|Withdrawal by Subject|0|||
33628148|NCT01962103|63029266|FG003|Phase 1|Withdrawal by Subject|2|||
33628149|NCT01962103|63029267|FG004|Phase 1|Withdrawal by Subject|0|||
33628150|NCT01962103|63029268|FG005|Phase 1|Withdrawal by Subject|0|||
33628151|NCT01962103|63029269|FG006|Phase 1|Withdrawal by Subject|0|||
33628152|NCT01962103|63029270|FG007|Phase 1|Withdrawal by Subject|0|||
33628153|NCT01962103|63029271|FG008|Phase 1|Withdrawal by Subject|0|||
33628154|NCT01962103|63029263|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
33628155|NCT01962103|63029264|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
33628156|NCT01962103|63029265|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
33628157|NCT01962103|63029266|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
33628158|NCT01962103|63029267|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
33628159|NCT01962103|63029268|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
33628160|NCT01962103|63029269|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
33535342|NCT02970318|62925167|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
33535343|NCT02970318|62925164|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
33535344|NCT02970318|62925165|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
33535345|NCT02970318|62925166|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
33535346|NCT02970318|62925167|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
33628161|NCT01962103|63029270|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
33628162|NCT01962103|63029271|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
33628163|NCT01962103|63029263|FG000|Phase 1|Physician Decision|0|||
33628164|NCT01962103|63029264|FG001|Phase 1|Physician Decision|0|||
33628165|NCT01962103|63029265|FG002|Phase 1|Physician Decision|0|||
33628166|NCT01962103|63029266|FG003|Phase 1|Physician Decision|1|||
33628167|NCT01962103|63029267|FG004|Phase 1|Physician Decision|0|||
33628168|NCT01962103|63029268|FG005|Phase 1|Physician Decision|0|||
33628169|NCT01962103|63029269|FG006|Phase 1|Physician Decision|0|||
33628170|NCT01962103|63029270|FG007|Phase 1|Physician Decision|0|||
33628171|NCT01962103|63029271|FG008|Phase 1|Physician Decision|0|||
33628172|NCT01962103|63029263|FG000|Phase 1|Symptomatic Deterioration|3|||
33628173|NCT01962103|63029264|FG001|Phase 1|Symptomatic Deterioration|2|||
33628174|NCT01962103|63029265|FG002|Phase 1|Symptomatic Deterioration|2|||
33628175|NCT01962103|63029266|FG003|Phase 1|Symptomatic Deterioration|2|||
33628176|NCT01962103|63029267|FG004|Phase 1|Symptomatic Deterioration|1|||
33628177|NCT01962103|63029268|FG005|Phase 1|Symptomatic Deterioration|1|||
33628178|NCT01962103|63029269|FG006|Phase 1|Symptomatic Deterioration|0|||
33628179|NCT01962103|63029270|FG007|Phase 1|Symptomatic Deterioration|0|||
33628180|NCT01962103|63029271|FG008|Phase 1|Symptomatic Deterioration|0|||
33628181|NCT01962103|63029263|FG000|Phase 1|Miscellaneous|1|||
33628182|NCT01962103|63029264|FG001|Phase 1|Miscellaneous|0|||
33628183|NCT01962103|63029265|FG002|Phase 1|Miscellaneous|0|||
33628184|NCT01962103|63029266|FG003|Phase 1|Miscellaneous|0|||
33628185|NCT01962103|63029267|FG004|Phase 1|Miscellaneous|0|||
33628186|NCT01962103|63029268|FG005|Phase 1|Miscellaneous|0|||
33628187|NCT01962103|63029269|FG006|Phase 1|Miscellaneous|0|||
33628188|NCT01962103|63029270|FG007|Phase 1|Miscellaneous|0|||
33628189|NCT01962103|63029271|FG008|Phase 1|Miscellaneous|0|||
33628190|NCT01962103|63029263|FG000|Phase 2|Adverse Event|0|||
33628191|NCT01962103|63029264|FG001|Phase 2|Adverse Event|0|||
33628192|NCT01962103|63029265|FG002|Phase 2|Adverse Event|0|||
33460009|NCT03569098|62833292|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
33460010|NCT03569098|62833293|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
33460011|NCT03569098|62833291|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
33460012|NCT03569098|62833292|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
33460013|NCT03569098|62833293|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
33460014|NCT03569098|62833291|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
33460015|NCT03569098|62833292|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
33460016|NCT03569098|62833293|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
33460017|NCT03569098|62833291|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
33460018|NCT03569098|62833292|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
33628193|NCT01962103|63029266|FG003|Phase 2|Adverse Event|0|||
33628194|NCT01962103|63029267|FG004|Phase 2|Adverse Event|0|||
33628195|NCT01962103|63029268|FG005|Phase 2|Adverse Event|0|||
33628196|NCT01962103|63029269|FG006|Phase 2|Adverse Event|1|||
33628197|NCT01962103|63029270|FG007|Phase 2|Adverse Event|0|||
33628198|NCT01962103|63029271|FG008|Phase 2|Adverse Event|3|||
33628199|NCT01962103|63029263|FG000|Phase 2|Progressive Disease|0|||
33628200|NCT01962103|63029264|FG001|Phase 2|Progressive Disease|0|||
33326074|NCT01185821|62702835|FG000|Overall Study|Adverse Event|2|||
33628201|NCT01962103|63029265|FG002|Phase 2|Progressive Disease|0|||
33460019|NCT03569098|62833293|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
33460020|NCT03569098|62833291|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
33460021|NCT03569098|62833292|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
33460022|NCT03569098|62833293|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
33460023|NCT03569098|62833291|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
33460024|NCT03569098|62833292|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
33460025|NCT03569098|62833293|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
33460026|NCT03568942|62833304|FG000|Overall Study|Family emergency|1|||
33460027|NCT03568942|62833304|FG000|Overall Study|Lost to Follow-up|1|||
33460028|NCT00110019|62833310|FG000|Overall Study|Lack of Efficacy|253|||
33460029|NCT00110019|62833311|FG001|Overall Study|Lack of Efficacy|285|||
33460030|NCT00110019|62833310|FG000|Overall Study|Adverse Event|61|||
33460031|NCT00110019|62833311|FG001|Overall Study|Adverse Event|40|||
33460032|NCT00110019|62833310|FG000|Overall Study|Death|13|||
33460033|NCT00110019|62833311|FG001|Overall Study|Death|15|||
33460034|NCT00110019|62833310|FG000|Overall Study|Withdrawal by Subject|21|||
33460035|NCT00110019|62833311|FG001|Overall Study|Withdrawal by Subject|9|||
33460036|NCT00110019|62833310|FG000|Overall Study|alternative therapy|5|||
33460037|NCT00110019|62833311|FG001|Overall Study|alternative therapy|1|||
33460038|NCT00110019|62833310|FG000|Overall Study|complicating disease|1|||
33460039|NCT00110019|62833311|FG001|Overall Study|complicating disease|1|||
33460040|NCT00110019|62833310|FG000|Overall Study|symptom deterioration|13|||
33460041|NCT00110019|62833311|FG001|Overall Study|symptom deterioration|16|||
33460042|NCT00110019|62833310|FG000|Overall Study|Not start protocol therapy|17|||
33460043|NCT00110019|62833311|FG001|Overall Study|Not start protocol therapy|16|||
33460044|NCT00110019|62833310|FG000|Overall Study|other reasons|22|||
33460045|NCT00110019|62833311|FG001|Overall Study|other reasons|30|||
33460046|NCT03595618|62833321|FG000|Overall Study|Adverse Event|16|||
33460047|NCT03595618|62833322|FG001|Overall Study|Adverse Event|17|||
33460048|NCT03595618|62833323|FG002|Overall Study|Adverse Event|20|||
33460049|NCT03595618|62833324|FG003|Overall Study|Adverse Event|8|||
33460050|NCT03595618|62833321|FG000|Overall Study|Withdrawal by Subject|12|||
33460051|NCT03595618|62833322|FG001|Overall Study|Withdrawal by Subject|14|||
33460052|NCT03595618|62833323|FG002|Overall Study|Withdrawal by Subject|14|||
33460053|NCT03595618|62833324|FG003|Overall Study|Withdrawal by Subject|10|||
33460054|NCT03595618|62833321|FG000|Overall Study|Lost to Follow-up|6|||
33460055|NCT03595618|62833322|FG001|Overall Study|Lost to Follow-up|4|||
33460056|NCT03595618|62833323|FG002|Overall Study|Lost to Follow-up|5|||
33460057|NCT03595618|62833324|FG003|Overall Study|Lost to Follow-up|6|||
33460058|NCT03595618|62833321|FG000|Overall Study|Protocol Violation|2|||
33460059|NCT03595618|62833322|FG001|Overall Study|Protocol Violation|0|||
33628202|NCT01962103|63029266|FG003|Phase 2|Progressive Disease|0|||
33460060|NCT03595618|62833323|FG002|Overall Study|Protocol Violation|6|||
33460061|NCT03595618|62833324|FG003|Overall Study|Protocol Violation|2|||
33628203|NCT01962103|63029267|FG004|Phase 2|Progressive Disease|0|||
33628204|NCT01962103|63029268|FG005|Phase 2|Progressive Disease|0|||
33628205|NCT01962103|63029269|FG006|Phase 2|Progressive Disease|11|||
33628206|NCT01962103|63029270|FG007|Phase 2|Progressive Disease|12|||
33628207|NCT01962103|63029271|FG008|Phase 2|Progressive Disease|11|||
33628208|NCT01962103|63029263|FG000|Phase 2|Symptomatic Deterioration|0|||
33628209|NCT01962103|63029264|FG001|Phase 2|Symptomatic Deterioration|0|||
33628210|NCT01962103|63029265|FG002|Phase 2|Symptomatic Deterioration|0|||
33628211|NCT01962103|63029266|FG003|Phase 2|Symptomatic Deterioration|0|||
33628212|NCT01962103|63029267|FG004|Phase 2|Symptomatic Deterioration|0|||
33628213|NCT01962103|63029268|FG005|Phase 2|Symptomatic Deterioration|0|||
33628214|NCT01962103|63029269|FG006|Phase 2|Symptomatic Deterioration|2|||
33628215|NCT01962103|63029270|FG007|Phase 2|Symptomatic Deterioration|2|||
33628216|NCT01962103|63029271|FG008|Phase 2|Symptomatic Deterioration|0|||
33628217|NCT01961323|63029291|FG000|Overall Study|Withdrawal by Subject|7|||
33628218|NCT01961323|63029291|FG000|Overall Study|Lost to Follow-up|8|||
33628219|NCT01961323|63029291|FG000|Overall Study|screen failure|34|||
33628220|NCT01960855|63029300|FG000|Overall Study|Subject noncompliant|1|||
33628221|NCT01960855|63029301|FG001|Overall Study|Subject noncompliant|0|||
33628222|NCT01960855|63029302|FG002|Overall Study|Subject noncompliant|0|||
33628223|NCT01960855|63029303|FG003|Overall Study|Subject noncompliant|0|||
33628224|NCT01960855|63029304|FG004|Overall Study|Subject noncompliant|0|||
33628225|NCT01960855|63029300|FG000|Overall Study|Adverse Event|2|||
33628226|NCT01960855|63029301|FG001|Overall Study|Adverse Event|0|||
33628227|NCT01960855|63029302|FG002|Overall Study|Adverse Event|6|||
33628228|NCT01960855|63029303|FG003|Overall Study|Adverse Event|2|||
33628229|NCT01960855|63029304|FG004|Overall Study|Adverse Event|2|||
33628230|NCT01960855|63029300|FG000|Overall Study|Lack of Efficacy|1|||
33628231|NCT01960855|63029301|FG001|Overall Study|Lack of Efficacy|1|||
33628232|NCT01960855|63029302|FG002|Overall Study|Lack of Efficacy|0|||
33628233|NCT01960855|63029303|FG003|Overall Study|Lack of Efficacy|0|||
33628234|NCT01960855|63029304|FG004|Overall Study|Lack of Efficacy|0|||
33628235|NCT01960855|63029300|FG000|Overall Study|Other|2|||
33628236|NCT01960855|63029301|FG001|Overall Study|Other|1|||
33628237|NCT01960855|63029302|FG002|Overall Study|Other|1|||
33628238|NCT01960855|63029303|FG003|Overall Study|Other|1|||
33628239|NCT01960855|63029304|FG004|Overall Study|Other|0|||
33628240|NCT01960855|63029300|FG000|Overall Study|Consent withdrawn by subject|3|||
33628241|NCT01960855|63029301|FG001|Overall Study|Consent withdrawn by subject|1|||
33628242|NCT01960855|63029302|FG002|Overall Study|Consent withdrawn by subject|2|||
33460062|NCT03595618|62833321|FG000|Overall Study|Physician Decision|0|||
33460063|NCT03595618|62833322|FG001|Overall Study|Physician Decision|0|||
33460064|NCT03595618|62833323|FG002|Overall Study|Physician Decision|1|||
33460065|NCT03595618|62833324|FG003|Overall Study|Physician Decision|2|||
33628243|NCT01960855|63029303|FG003|Overall Study|Consent withdrawn by subject|1|||
33628244|NCT01960855|63029304|FG004|Overall Study|Consent withdrawn by subject|1|||
33628245|NCT01960855|63029300|FG000|Overall Study|Lost to Follow-up|2|||
33460066|NCT03595618|62833321|FG000|Overall Study|Miscellaneous|7|||
33460067|NCT03595618|62833322|FG001|Overall Study|Miscellaneous|5|||
33460068|NCT03595618|62833323|FG002|Overall Study|Miscellaneous|10|||
33460069|NCT03595618|62833324|FG003|Overall Study|Miscellaneous|6|||
33460070|NCT02954848|62833336|FG000|Overall Study|Randomized but Not Treated|0|||
33460071|NCT02954848|62833337|FG001|Overall Study|Randomized but Not Treated|1|||
33460072|NCT02954848|62833336|FG000|Overall Study|Adverse Event|2|||
33460073|NCT02954848|62833337|FG001|Overall Study|Adverse Event|3|||
33535389|NCT02779855|62925195|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
33535390|NCT02779855|62925196|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
33535391|NCT02779855|62925197|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
33535392|NCT02682927|62925225|FG000|Overall Study|Adverse Event|0|||
33535393|NCT02682927|62925226|FG001|Overall Study|Adverse Event|0|||
33535394|NCT02682927|62925227|FG002|Overall Study|Adverse Event|5|||
33535395|NCT02682927|62925228|FG003|Overall Study|Adverse Event|1|||
33535396|NCT02682927|62925229|FG004|Overall Study|Adverse Event|0|||
33535397|NCT02682927|62925230|FG005|Overall Study|Adverse Event|2|||
33628246|NCT01960855|63029301|FG001|Overall Study|Lost to Follow-up|1|||
33628247|NCT01960855|63029302|FG002|Overall Study|Lost to Follow-up|0|||
33628248|NCT01960855|63029303|FG003|Overall Study|Lost to Follow-up|0|||
33628249|NCT01960855|63029304|FG004|Overall Study|Lost to Follow-up|2|||
33460074|NCT02954848|62833336|FG000|Overall Study|Withdrawal by Participant|0|||
33460075|NCT02954848|62833337|FG001|Overall Study|Withdrawal by Participant|1|||
33535398|NCT02682927|62925225|FG000|Overall Study|Death|0|||
33460076|NCT03642262|62833343|FG000|Period 1|Withdrawal by Subject|1|||
33535399|NCT02682927|62925226|FG001|Overall Study|Death|0|||
33628250|NCT02007434|63029324|FG000|Overall Study|Lost to Follow-up|0|||
33628251|NCT02007434|63029325|FG001|Overall Study|Lost to Follow-up|1|||
33628252|NCT02007434|63029326|FG002|Overall Study|Lost to Follow-up|0|||
33628253|NCT02007434|63029327|FG003|Overall Study|Lost to Follow-up|0|||
33628254|NCT02007434|63029328|FG004|Overall Study|Lost to Follow-up|0|||
33628255|NCT02007434|63029329|FG005|Overall Study|Lost to Follow-up|0|||
33628256|NCT02007434|63029330|FG006|Overall Study|Lost to Follow-up|0|||
33628257|NCT02007434|63029331|FG007|Overall Study|Lost to Follow-up|0|||
33628258|NCT02007434|63029324|FG000|Overall Study|Non-compliance|1|||
33628259|NCT02007434|63029325|FG001|Overall Study|Non-compliance|0|||
33628260|NCT02007434|63029326|FG002|Overall Study|Non-compliance|1|||
33628261|NCT02007434|63029327|FG003|Overall Study|Non-compliance|0|||
33628262|NCT02007434|63029328|FG004|Overall Study|Non-compliance|0|||
33628263|NCT02007434|63029329|FG005|Overall Study|Non-compliance|0|||
33628264|NCT02007434|63029330|FG006|Overall Study|Non-compliance|0|||
33628265|NCT02007434|63029331|FG007|Overall Study|Non-compliance|0|||
33628266|NCT01987453|63029353|FG000|Overall Study|Death|0|||
33628267|NCT01987453|63029354|FG001|Overall Study|Death|0|||
33628268|NCT01987453|63029355|FG002|Overall Study|Death|1|||
33628269|NCT01987453|63029353|FG000|Overall Study|Lack of Efficacy|1|||
33628270|NCT01987453|63029354|FG001|Overall Study|Lack of Efficacy|12|||
33628271|NCT01987453|63029355|FG002|Overall Study|Lack of Efficacy|0|||
33628272|NCT02006641|63029370|FG000|Overall Study|Withdrawal before treatment|2|||
33628273|NCT02006641|63029371|FG001|Overall Study|Withdrawal before treatment|5|||
33628274|NCT02006641|63029372|FG002|Overall Study|Withdrawal before treatment|3|||
33628275|NCT02006641|63029370|FG000|Overall Study|Adverse Event|15|||
33628276|NCT02006641|63029371|FG001|Overall Study|Adverse Event|11|||
33628277|NCT02006641|63029372|FG002|Overall Study|Adverse Event|15|||
33628278|NCT02006641|63029370|FG000|Overall Study|Protocol Violation|0|||
33628279|NCT02006641|63029371|FG001|Overall Study|Protocol Violation|2|||
33628280|NCT02006641|63029372|FG002|Overall Study|Protocol Violation|2|||
33628281|NCT02006641|63029370|FG000|Overall Study|Lost to Follow-up|0|||
33628282|NCT02006641|63029371|FG001|Overall Study|Lost to Follow-up|1|||
33628283|NCT02006641|63029372|FG002|Overall Study|Lost to Follow-up|0|||
33628284|NCT02006641|63029370|FG000|Overall Study|Withdrawal by Subject|7|||
33628285|NCT02006641|63029371|FG001|Overall Study|Withdrawal by Subject|12|||
33628286|NCT02006641|63029372|FG002|Overall Study|Withdrawal by Subject|11|||
33628287|NCT02006641|63029370|FG000|Overall Study|Other reason: patient didn't show up|1|||
33628288|NCT02006641|63029371|FG001|Overall Study|Other reason: patient didn't show up|0|||
33628289|NCT02006641|63029372|FG002|Overall Study|Other reason: patient didn't show up|0|||
33628290|NCT02006641|63029370|FG000|Overall Study|Other reason:patient didn't want to come|0|||
33628291|NCT02006641|63029371|FG001|Overall Study|Other reason:patient didn't want to come|0|||
33628292|NCT02006641|63029372|FG002|Overall Study|Other reason:patient didn't want to come|1|||
33628293|NCT02006641|63029370|FG000|Overall Study|Other reason: patient has moved|1|||
33628294|NCT02006641|63029371|FG001|Overall Study|Other reason: patient has moved|0|||
33628295|NCT02006641|63029372|FG002|Overall Study|Other reason: patient has moved|1|||
33628296|NCT02006641|63029370|FG000|Overall Study|Other reason: caregiver in hospital|0|||
33628297|NCT02006641|63029371|FG001|Overall Study|Other reason: caregiver in hospital|1|||
33628298|NCT02006641|63029372|FG002|Overall Study|Other reason: caregiver in hospital|0|||
33628299|NCT02006641|63029370|FG000|Overall Study|Other reason: patient's wife has died|0|||
33628300|NCT02006641|63029371|FG001|Overall Study|Other reason: patient's wife has died|0|||
33628301|NCT02006641|63029372|FG002|Overall Study|Other reason: patient's wife has died|1|||
33628302|NCT02006641|63029370|FG000|Overall Study|Other reason: hospitalisation|0|||
33628303|NCT02006641|63029371|FG001|Overall Study|Other reason: hospitalisation|1|||
33628304|NCT02006641|63029372|FG002|Overall Study|Other reason: hospitalisation|0|||
33628305|NCT02006641|63029370|FG000|Overall Study|Other reason: caregiver impossibility|0|||
33628306|NCT02006641|63029371|FG001|Overall Study|Other reason: caregiver impossibility|0|||
33628307|NCT02006641|63029372|FG002|Overall Study|Other reason: caregiver impossibility|1|||
33628308|NCT02006641|63029370|FG000|Overall Study|Other reason: protocol non-compliance|0|||
33628309|NCT02006641|63029371|FG001|Overall Study|Other reason: protocol non-compliance|0|||
33628310|NCT02006641|63029372|FG002|Overall Study|Other reason: protocol non-compliance|1|||
33628311|NCT01959919|63029380|FG000|Overall Study|Did not meet the eligibility criteria|2|||
33535400|NCT02682927|62925227|FG002|Overall Study|Death|0|||
33535401|NCT02682927|62925228|FG003|Overall Study|Death|1|||
33535402|NCT02682927|62925229|FG004|Overall Study|Death|0|||
33535403|NCT02682927|62925230|FG005|Overall Study|Death|0|||
33535404|NCT02682927|62925225|FG000|Overall Study|Lack of Efficacy|1|||
33535405|NCT02682927|62925226|FG001|Overall Study|Lack of Efficacy|0|||
33535406|NCT02682927|62925227|FG002|Overall Study|Lack of Efficacy|0|||
33535407|NCT02682927|62925228|FG003|Overall Study|Lack of Efficacy|1|||
33628312|NCT01986985|63029388|FG000|Overall Study|Withdrawal by Subject|4|||
33628313|NCT01986985|63029388|FG000|Overall Study|Scan not completed due to malfunction|3|||
33628314|NCT01986907|63029392|FG000|Overall Study|Adverse Event|11|||
33535408|NCT02682927|62925229|FG004|Overall Study|Lack of Efficacy|0|||
33628315|NCT01986907|63029392|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
33628316|NCT01986907|63029392|FG000|Overall Study|Protocol Violation|4|||
33535409|NCT02682927|62925230|FG005|Overall Study|Lack of Efficacy|0|||
33535410|NCT02682927|62925225|FG000|Overall Study|Other|0|||
33628317|NCT01986907|63029392|FG000|Overall Study|Withdrawal by Subject|76|||
33628318|NCT01986907|63029392|FG000|Overall Study|Lost to Follow-up|38|||
33628319|NCT01986907|63029392|FG000|Overall Study|Death|9|||
33628320|NCT01959841|63029402|FG000|Overall Study|Adverse Event|1|||
33628321|NCT01959841|63029403|FG001|Overall Study|Adverse Event|3|||
33628322|NCT01959841|63029404|FG002|Overall Study|Adverse Event|2|||
33628323|NCT01959841|63029402|FG000|Overall Study|Lack of Efficacy|5|||
33628324|NCT01959841|63029403|FG001|Overall Study|Lack of Efficacy|0|||
33628325|NCT01959841|63029404|FG002|Overall Study|Lack of Efficacy|0|||
33628326|NCT01959841|63029402|FG000|Overall Study|Lost to Follow-up|1|||
33628327|NCT01959841|63029403|FG001|Overall Study|Lost to Follow-up|1|||
33628328|NCT01959841|63029404|FG002|Overall Study|Lost to Follow-up|0|||
33628329|NCT01959841|63029402|FG000|Overall Study|Physician Decision|0|||
33628330|NCT01959841|63029403|FG001|Overall Study|Physician Decision|2|||
33628331|NCT01959841|63029404|FG002|Overall Study|Physician Decision|3|||
33628332|NCT01959841|63029402|FG000|Overall Study|Protocol Violation|16|||
33628333|NCT01959841|63029403|FG001|Overall Study|Protocol Violation|23|||
33628334|NCT01959841|63029404|FG002|Overall Study|Protocol Violation|16|||
33628335|NCT01959841|63029402|FG000|Overall Study|Withdrawal by Subject|7|||
33628336|NCT01959841|63029403|FG001|Overall Study|Withdrawal by Subject|7|||
33628337|NCT01959841|63029404|FG002|Overall Study|Withdrawal by Subject|5|||
33628338|NCT01959841|63029402|FG000|Overall Study|Clinical laboratory value|2|||
33628339|NCT01959841|63029403|FG001|Overall Study|Clinical laboratory value|6|||
33628340|NCT01959841|63029404|FG002|Overall Study|Clinical laboratory value|6|||
33628341|NCT01959841|63029402|FG000|Overall Study|Platelet count below on day1 or 4|11|||
33628342|NCT01959841|63029403|FG001|Overall Study|Platelet count below on day1 or 4|15|||
33628343|NCT01959841|63029404|FG002|Overall Study|Platelet count below on day1 or 4|11|||
33628344|NCT02005627|63029414|FG000|Overall Study|Lost to Follow-up|1|||
33628345|NCT02005627|63029415|FG001|Overall Study|Lost to Follow-up|2|||
33628346|NCT02005627|63029414|FG000|Overall Study|Withdrawal by Subject|1|||
33628347|NCT02005627|63029415|FG001|Overall Study|Withdrawal by Subject|2|||
33628348|NCT02104583|63029427|FG000|Overall Study|New ICD or CRT-D implanted|2|||
33628349|NCT02104583|63029428|FG001|Overall Study|New ICD or CRT-D implanted|0|||
33628350|NCT02104583|63029429|FG002|Overall Study|New ICD or CRT-D implanted|1|||
33628351|NCT02104583|63029430|FG003|Overall Study|New ICD or CRT-D implanted|0|||
33628352|NCT02104583|63029431|FG004|Overall Study|New ICD or CRT-D implanted|0|||
33628353|NCT02104583|63029427|FG000|Overall Study|Death|2|||
33628354|NCT02104583|63029428|FG001|Overall Study|Death|1|||
33628355|NCT02104583|63029429|FG002|Overall Study|Death|3|||
33628356|NCT02104583|63029430|FG003|Overall Study|Death|3|||
33628357|NCT02104583|63029431|FG004|Overall Study|Death|5|||
33628358|NCT02104583|63029427|FG000|Overall Study|Subject required cardiac ablation|6|||
33628359|NCT02104583|63029428|FG001|Overall Study|Subject required cardiac ablation|4|||
33628360|NCT02104583|63029429|FG002|Overall Study|Subject required cardiac ablation|4|||
33535411|NCT02682927|62925226|FG001|Overall Study|Other|0|||
33535412|NCT02682927|62925227|FG002|Overall Study|Other|0|||
33535413|NCT02682927|62925228|FG003|Overall Study|Other|2|||
33535414|NCT02682927|62925229|FG004|Overall Study|Other|0|||
33535415|NCT02682927|62925230|FG005|Overall Study|Other|0|||
33535416|NCT02682927|62925225|FG000|Overall Study|Withdrawal by Subject|2|||
33535417|NCT02682927|62925226|FG001|Overall Study|Withdrawal by Subject|0|||
33535418|NCT02682927|62925227|FG002|Overall Study|Withdrawal by Subject|1|||
33535419|NCT02682927|62925228|FG003|Overall Study|Withdrawal by Subject|0|||
33535420|NCT02682927|62925229|FG004|Overall Study|Withdrawal by Subject|1|||
33535421|NCT02682927|62925230|FG005|Overall Study|Withdrawal by Subject|1|||
33628361|NCT02104583|63029430|FG003|Overall Study|Subject required cardiac ablation|5|||
33628362|NCT02104583|63029431|FG004|Overall Study|Subject required cardiac ablation|4|||
33628363|NCT02104583|63029427|FG000|Overall Study|Subject required prohibited medication|0|||
33460077|NCT03642262|62833344|FG001|Period 1|Withdrawal by Subject|1|||
33460078|NCT03642262|62833343|FG000|Period 1|Adverse Event|0|||
33460079|NCT03642262|62833344|FG001|Period 1|Adverse Event|1|||
33460080|NCT00109707|62833354|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
33460081|NCT00109707|62833355|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
33460082|NCT00109707|62833356|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
33460083|NCT00109707|62833354|FG000|Overall Study|Abnormal laboratory values|1|||
33460084|NCT00109707|62833355|FG001|Overall Study|Abnormal laboratory values|0|||
33460085|NCT00109707|62833356|FG002|Overall Study|Abnormal laboratory values|0|||
33460086|NCT00109707|62833354|FG000|Overall Study|Administrative problems|2|||
33460087|NCT00109707|62833355|FG001|Overall Study|Administrative problems|0|||
33460088|NCT00109707|62833356|FG002|Overall Study|Administrative problems|1|||
33460089|NCT00109707|62833354|FG000|Overall Study|Adverse Event|10|||
33535490|NCT02614066|62925312|FG000|Overall Study|Initiated KTE-X19 and Died|5|||
33460090|NCT00109707|62833355|FG001|Overall Study|Adverse Event|2|||
33460091|NCT00109707|62833356|FG002|Overall Study|Adverse Event|3|||
33460092|NCT00109707|62833354|FG000|Overall Study|Death|4|||
33460093|NCT00109707|62833355|FG001|Overall Study|Death|0|||
33460094|NCT00109707|62833356|FG002|Overall Study|Death|0|||
33460095|NCT00109707|62833354|FG000|Overall Study|Disease progression|12|||
33460096|NCT00109707|62833355|FG001|Overall Study|Disease progression|4|||
33460097|NCT00109707|62833356|FG002|Overall Study|Disease progression|3|||
33460098|NCT00109707|62833354|FG000|Overall Study|Lost to Follow-up|3|||
33460099|NCT00109707|62833355|FG001|Overall Study|Lost to Follow-up|0|||
33460100|NCT00109707|62833356|FG002|Overall Study|Lost to Follow-up|0|||
33460101|NCT00109707|62833354|FG000|Overall Study|Protocol Violation|1|||
33460102|NCT00109707|62833355|FG001|Overall Study|Protocol Violation|0|||
33460103|NCT00109707|62833356|FG002|Overall Study|Protocol Violation|0|||
33460104|NCT00109707|62833354|FG000|Overall Study|Patient withdrew consent|6|||
33460105|NCT00109707|62833355|FG001|Overall Study|Patient withdrew consent|1|||
33460106|NCT00109707|62833356|FG002|Overall Study|Patient withdrew consent|0|||
33460107|NCT00095979|62833368|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
33460108|NCT00082173|62833379|FG000|Overall Study|Withdrawal by Subject|3|||
33460109|NCT00082173|62833380|FG001|Overall Study|Withdrawal by Subject|5|||
33535491|NCT02614066|62925313|FG001|Overall Study|Initiated KTE-X19 and Died|12|||
33535492|NCT02614066|62925314|FG002|Overall Study|Initiated KTE-X19 and Died|11|||
33535493|NCT02614066|62925315|FG003|Overall Study|Initiated KTE-X19 and Died|20|||
33535494|NCT02614066|62925312|FG000|Overall Study|Full Consent Withdrawn|0|||
33535495|NCT02614066|62925313|FG001|Overall Study|Full Consent Withdrawn|1|||
33535496|NCT02614066|62925314|FG002|Overall Study|Full Consent Withdrawn|0|||
33535497|NCT02614066|62925315|FG003|Overall Study|Full Consent Withdrawn|3|||
33535498|NCT02614066|62925312|FG000|Overall Study|Lost to Follow-up|0|||
33535499|NCT02614066|62925313|FG001|Overall Study|Lost to Follow-up|1|||
33535500|NCT02614066|62925314|FG002|Overall Study|Lost to Follow-up|0|||
33535501|NCT02614066|62925315|FG003|Overall Study|Lost to Follow-up|0|||
33535502|NCT02614066|62925312|FG000|Overall Study|Still on-study|1|||
33535503|NCT02614066|62925313|FG001|Overall Study|Still on-study|9|||
33535504|NCT02614066|62925314|FG002|Overall Study|Still on-study|5|||
33535505|NCT02614066|62925315|FG003|Overall Study|Still on-study|32|||
33535506|NCT02614066|62925312|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0|||
33535507|NCT02614066|62925313|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5|||
33535508|NCT02614066|62925314|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4|||
33535509|NCT02614066|62925315|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16|||
33460110|NCT00082173|62833379|FG000|Overall Study|Lost to Follow-up|1|||
33460111|NCT00082173|62833380|FG001|Overall Study|Lost to Follow-up|0|||
33460112|NCT00082173|62833379|FG000|Overall Study|Adverse Event|1|||
33460113|NCT00082173|62833380|FG001|Overall Study|Adverse Event|0|||
33460114|NCT00082173|62833379|FG000|Overall Study|Culture negative or resistant at baselin|5|||
33535533|NCT02566850|62925336|FG000|Overall Study|Protocol Violation|1|||
33535534|NCT02562235|62925340|FG000|Overall Study|Adverse Event|3|||
33535535|NCT02453282|62925365|FG000|Overall Study|Death|275|||
33535536|NCT02453282|62925366|FG001|Overall Study|Death|277|||
33628364|NCT02104583|63029428|FG001|Overall Study|Subject required prohibited medication|1|||
33628365|NCT02104583|63029429|FG002|Overall Study|Subject required prohibited medication|1|||
33628366|NCT02104583|63029430|FG003|Overall Study|Subject required prohibited medication|0|||
33628367|NCT02104583|63029431|FG004|Overall Study|Subject required prohibited medication|1|||
33628368|NCT02104583|63029427|FG000|Overall Study|Withdrew Consent|3|||
33628369|NCT02104583|63029428|FG001|Overall Study|Withdrew Consent|2|||
33628370|NCT02104583|63029429|FG002|Overall Study|Withdrew Consent|0|||
33628371|NCT02104583|63029430|FG003|Overall Study|Withdrew Consent|2|||
33628372|NCT02104583|63029431|FG004|Overall Study|Withdrew Consent|1|||
33628373|NCT02104583|63029427|FG000|Overall Study|Investigator's Discretion|1|||
33628374|NCT02104583|63029428|FG001|Overall Study|Investigator's Discretion|0|||
33628375|NCT02104583|63029429|FG002|Overall Study|Investigator's Discretion|0|||
33628376|NCT02104583|63029430|FG003|Overall Study|Investigator's Discretion|0|||
33628377|NCT02104583|63029431|FG004|Overall Study|Investigator's Discretion|0|||
33628378|NCT02104583|63029427|FG000|Overall Study|Protocol Violation|0|||
33628379|NCT02104583|63029428|FG001|Overall Study|Protocol Violation|0|||
33628380|NCT02104583|63029429|FG002|Overall Study|Protocol Violation|1|||
33628381|NCT02104583|63029430|FG003|Overall Study|Protocol Violation|0|||
33628382|NCT02104583|63029431|FG004|Overall Study|Protocol Violation|0|||
33628383|NCT02104583|63029427|FG000|Overall Study|Adverse Event|3|||
33628384|NCT02104583|63029428|FG001|Overall Study|Adverse Event|3|||
33628385|NCT02104583|63029429|FG002|Overall Study|Adverse Event|6|||
33628386|NCT02104583|63029430|FG003|Overall Study|Adverse Event|6|||
33628387|NCT02104583|63029431|FG004|Overall Study|Adverse Event|1|||
33628388|NCT02104583|63029427|FG000|Overall Study|Lost to Follow-up|1|||
33628389|NCT02104583|63029428|FG001|Overall Study|Lost to Follow-up|0|||
33628390|NCT02104583|63029429|FG002|Overall Study|Lost to Follow-up|0|||
33628391|NCT02104583|63029430|FG003|Overall Study|Lost to Follow-up|0|||
33628392|NCT02104583|63029431|FG004|Overall Study|Lost to Follow-up|0|||
33628393|NCT02104583|63029427|FG000|Overall Study|Randomized but Never Treated|0|||
33628394|NCT02104583|63029428|FG001|Overall Study|Randomized but Never Treated|0|||
33628395|NCT02104583|63029429|FG002|Overall Study|Randomized but Never Treated|0|||
33628396|NCT02104583|63029430|FG003|Overall Study|Randomized but Never Treated|1|||
33628397|NCT02104583|63029431|FG004|Overall Study|Randomized but Never Treated|0|||
33628398|NCT02074553|63029454|FG000|Intervention Period 1|Family Emergency|0|||
33628399|NCT02074553|63029455|FG001|Intervention Period 1|Family Emergency|0|||
33628400|NCT02074553|63029456|FG002|Intervention Period 1|Family Emergency|0|||
33628401|NCT02074553|63029457|FG003|Intervention Period 1|Family Emergency|1|||
33628402|NCT02074553|63029458|FG004|Intervention Period 1|Family Emergency|0|||
33628403|NCT02074553|63029459|FG005|Intervention Period 1|Family Emergency|0|||
33628404|NCT02074553|63029460|FG006|Intervention Period 1|Family Emergency|0|||
33628405|NCT02074553|63029461|FG007|Intervention Period 1|Family Emergency|0|||
33628406|NCT02074553|63029454|FG000|Washout Period 1|Adverse Event|1|||
33628407|NCT02074553|63029455|FG001|Washout Period 1|Adverse Event|0|||
33628408|NCT02074553|63029456|FG002|Washout Period 1|Adverse Event|0|||
33535537|NCT02453282|62925367|FG002|Overall Study|Death|296|||
33535538|NCT02453282|62925365|FG000|Overall Study|Lost to Follow-up|1|||
33535539|NCT02453282|62925366|FG001|Overall Study|Lost to Follow-up|0|||
33535540|NCT02453282|62925367|FG002|Overall Study|Lost to Follow-up|2|||
33535541|NCT02453282|62925365|FG000|Overall Study|Withdrawal by Subject|12|||
33535542|NCT02453282|62925366|FG001|Overall Study|Withdrawal by Subject|10|||
33535543|NCT02453282|62925367|FG002|Overall Study|Withdrawal by Subject|11|||
33628409|NCT02074553|63029457|FG003|Washout Period 1|Adverse Event|0|||
33460115|NCT00082173|62833380|FG001|Overall Study|Culture negative or resistant at baselin|6|||
33460116|NCT00108069|62833388|FG000|Overall Study|Never rec'd study drug|0|||
33460117|NCT00108069|62833389|FG001|Overall Study|Never rec'd study drug|1|||
33460118|NCT00108069|62833388|FG000|Overall Study|Adverse Event|1|||
33460119|NCT00108069|62833389|FG001|Overall Study|Adverse Event|1|||
33460120|NCT00108069|62833388|FG000|Overall Study|Withdrawal by Subject|1|||
33460121|NCT00108069|62833389|FG001|Overall Study|Withdrawal by Subject|0|||
33460122|NCT00108069|62833388|FG000|Overall Study|Death|1|||
33535544|NCT02453282|62925365|FG000|Overall Study|Participants ongoing at data cut-off|85|||
33628410|NCT02074553|63029458|FG004|Washout Period 1|Adverse Event|0|||
33628411|NCT02074553|63029459|FG005|Washout Period 1|Adverse Event|0|||
33628412|NCT02074553|63029460|FG006|Washout Period 1|Adverse Event|0|||
33628413|NCT02074553|63029461|FG007|Washout Period 1|Adverse Event|0|||
33628414|NCT02074553|63029454|FG000|Washout Period 1|Physician Decision|0|||
33628415|NCT02074553|63029455|FG001|Washout Period 1|Physician Decision|0|||
33628416|NCT02074553|63029456|FG002|Washout Period 1|Physician Decision|0|||
33628417|NCT02074553|63029457|FG003|Washout Period 1|Physician Decision|1|||
33628418|NCT02074553|63029458|FG004|Washout Period 1|Physician Decision|0|||
33460123|NCT00108069|62833389|FG001|Overall Study|Death|0|||
33535545|NCT02453282|62925366|FG001|Overall Study|Participants ongoing at data cut-off|84|||
33628419|NCT02074553|63029459|FG005|Washout Period 1|Physician Decision|0|||
33628420|NCT02074553|63029460|FG006|Washout Period 1|Physician Decision|0|||
33628421|NCT02074553|63029461|FG007|Washout Period 1|Physician Decision|0|||
33628422|NCT02074553|63029454|FG000|Washout Period 1|Other|0|||
33628423|NCT02074553|63029455|FG001|Washout Period 1|Other|0|||
33628424|NCT02074553|63029456|FG002|Washout Period 1|Other|0|||
33628425|NCT02074553|63029457|FG003|Washout Period 1|Other|0|||
33628426|NCT02074553|63029458|FG004|Washout Period 1|Other|0|||
33628427|NCT02074553|63029459|FG005|Washout Period 1|Other|1|||
33628428|NCT02074553|63029460|FG006|Washout Period 1|Other|0|||
33628429|NCT02074553|63029461|FG007|Washout Period 1|Other|0|||
33628430|NCT02074553|63029454|FG000|Washout Period 2|Adverse Event|0|||
33535546|NCT02453282|62925367|FG002|Overall Study|Participants ongoing at data cut-off|62|||
33535547|NCT02453282|62925365|FG000|Overall Study|Other|1|||
33535548|NCT02453282|62925366|FG001|Overall Study|Other|1|||
33535549|NCT02453282|62925367|FG002|Overall Study|Other|1|||
33628431|NCT02074553|63029455|FG001|Washout Period 2|Adverse Event|0|||
33628432|NCT02074553|63029456|FG002|Washout Period 2|Adverse Event|0|||
33628433|NCT02074553|63029457|FG003|Washout Period 2|Adverse Event|0|||
33628434|NCT02074553|63029458|FG004|Washout Period 2|Adverse Event|0|||
33628435|NCT02074553|63029459|FG005|Washout Period 2|Adverse Event|0|||
33628436|NCT02074553|63029460|FG006|Washout Period 2|Adverse Event|1|||
33628437|NCT02074553|63029461|FG007|Washout Period 2|Adverse Event|0|||
33628438|NCT02074553|63029454|FG000|Washout Period 2|Physician Decision|0|||
33628439|NCT02074553|63029455|FG001|Washout Period 2|Physician Decision|0|||
33628440|NCT02074553|63029456|FG002|Washout Period 2|Physician Decision|0|||
33628441|NCT02074553|63029457|FG003|Washout Period 2|Physician Decision|0|||
33628442|NCT02074553|63029458|FG004|Washout Period 2|Physician Decision|0|||
33628443|NCT02074553|63029459|FG005|Washout Period 2|Physician Decision|1|||
33628444|NCT02074553|63029460|FG006|Washout Period 2|Physician Decision|0|||
33628445|NCT02074553|63029461|FG007|Washout Period 2|Physician Decision|0|||
33628446|NCT02074553|63029454|FG000|Washout Period 2|Lost to Follow-up|0|||
33460124|NCT00108069|62833388|FG000|Overall Study|Progessive disease|27|||
33460125|NCT00108069|62833389|FG001|Overall Study|Progessive disease|11|||
33460126|NCT00079274|62833408|FG000|Overall Study|Withdrawal by Subject|111|||
33460127|NCT00079274|62833409|FG001|Overall Study|Withdrawal by Subject|10|||
33460128|NCT00079274|62833410|FG002|Overall Study|Withdrawal by Subject|12|||
33460129|NCT00079274|62833411|FG003|Overall Study|Withdrawal by Subject|163|||
33460130|NCT00079274|62833412|FG004|Overall Study|Withdrawal by Subject|7|||
33460131|NCT00079274|62833413|FG005|Overall Study|Withdrawal by Subject|8|||
33460132|NCT00079274|62833414|FG006|Overall Study|Withdrawal by Subject|0|||
33460133|NCT00079274|62833408|FG000|Overall Study|Adverse Event|130|||
33535562|NCT02408120|62925388|FG000|Overall Study|Withdrawal by Subject|0|||
33535563|NCT02408120|62925389|FG001|Overall Study|Withdrawal by Subject|1|||
33535564|NCT02408120|62925388|FG000|Overall Study|Treatment Refusal|1|||
33535565|NCT02408120|62925389|FG001|Overall Study|Treatment Refusal|0|||
33535566|NCT02408120|62925388|FG000|Overall Study|Received Steroids|1|||
33535567|NCT02408120|62925389|FG001|Overall Study|Received Steroids|1|||
33535568|NCT02408120|62925388|FG000|Overall Study|Discharged same day|1|||
33535569|NCT02408120|62925389|FG001|Overall Study|Discharged same day|1|||
33535570|NCT02408120|62925388|FG000|Overall Study|Did not receive insulin|1|||
33535571|NCT02408120|62925389|FG001|Overall Study|Did not receive insulin|2|||
33535572|NCT02391545|62925397|FG000|Overall Study|Death|0|||
33628447|NCT02074553|63029455|FG001|Washout Period 2|Lost to Follow-up|0|||
33628448|NCT02074553|63029456|FG002|Washout Period 2|Lost to Follow-up|1|||
33628449|NCT02074553|63029457|FG003|Washout Period 2|Lost to Follow-up|0|||
33628450|NCT02074553|63029458|FG004|Washout Period 2|Lost to Follow-up|0|||
33628451|NCT02074553|63029459|FG005|Washout Period 2|Lost to Follow-up|0|||
33628452|NCT02074553|63029460|FG006|Washout Period 2|Lost to Follow-up|0|||
33628453|NCT02074553|63029461|FG007|Washout Period 2|Lost to Follow-up|0|||
33460134|NCT00079274|62833409|FG001|Overall Study|Adverse Event|8|||
33535573|NCT02391545|62925398|FG001|Overall Study|Death|2|||
33535574|NCT02391545|62925397|FG000|Overall Study|Lost to Follow-up|0|||
33535575|NCT02391545|62925398|FG001|Overall Study|Lost to Follow-up|1|||
33628454|NCT02074553|63029454|FG000|Washout Period 3|Physician Decision|0|||
33460135|NCT00079274|62833410|FG002|Overall Study|Adverse Event|8|||
33460136|NCT00079274|62833411|FG003|Overall Study|Adverse Event|184|||
33460137|NCT00079274|62833412|FG004|Overall Study|Adverse Event|7|||
33460138|NCT00079274|62833413|FG005|Overall Study|Adverse Event|8|||
33460139|NCT00079274|62833414|FG006|Overall Study|Adverse Event|0|||
33460140|NCT00079274|62833408|FG000|Overall Study|Recurrence|21|||
33460141|NCT00079274|62833409|FG001|Overall Study|Recurrence|0|||
33460142|NCT00079274|62833410|FG002|Overall Study|Recurrence|1|||
33460143|NCT00079274|62833411|FG003|Overall Study|Recurrence|15|||
33460144|NCT00079274|62833412|FG004|Overall Study|Recurrence|0|||
33460145|NCT00079274|62833413|FG005|Overall Study|Recurrence|2|||
33460146|NCT00079274|62833414|FG006|Overall Study|Recurrence|0|||
33460147|NCT00079274|62833408|FG000|Overall Study|Alternate Treatment|6|||
33460148|NCT00079274|62833409|FG001|Overall Study|Alternate Treatment|1|||
33460149|NCT00079274|62833410|FG002|Overall Study|Alternate Treatment|0|||
33460150|NCT00079274|62833411|FG003|Overall Study|Alternate Treatment|3|||
33460151|NCT00079274|62833412|FG004|Overall Study|Alternate Treatment|0|||
33460152|NCT00079274|62833413|FG005|Overall Study|Alternate Treatment|0|||
33460153|NCT00079274|62833414|FG006|Overall Study|Alternate Treatment|0|||
33460154|NCT00079274|62833408|FG000|Overall Study|Other Medical Problems|6|||
33460155|NCT00079274|62833409|FG001|Overall Study|Other Medical Problems|1|||
33460156|NCT00079274|62833410|FG002|Overall Study|Other Medical Problems|0|||
33460157|NCT00079274|62833411|FG003|Overall Study|Other Medical Problems|7|||
33460158|NCT00079274|62833412|FG004|Overall Study|Other Medical Problems|0|||
33460159|NCT00079274|62833413|FG005|Overall Study|Other Medical Problems|0|||
33460160|NCT00079274|62833414|FG006|Overall Study|Other Medical Problems|0|||
33460161|NCT00079274|62833408|FG000|Overall Study|Death|4|||
33460162|NCT00079274|62833409|FG001|Overall Study|Death|0|||
33460163|NCT00079274|62833410|FG002|Overall Study|Death|1|||
33460164|NCT00079274|62833411|FG003|Overall Study|Death|15|||
33460165|NCT00079274|62833412|FG004|Overall Study|Death|0|||
33460166|NCT00079274|62833413|FG005|Overall Study|Death|0|||
33460167|NCT00079274|62833414|FG006|Overall Study|Death|0|||
33460168|NCT00079274|62833408|FG000|Overall Study|Cytogenetic resistance|0|||
33460169|NCT00079274|62833409|FG001|Overall Study|Cytogenetic resistance|0|||
33460170|NCT00079274|62833410|FG002|Overall Study|Cytogenetic resistance|0|||
33460171|NCT00079274|62833411|FG003|Overall Study|Cytogenetic resistance|2|||
33460172|NCT00079274|62833412|FG004|Overall Study|Cytogenetic resistance|0|||
33460173|NCT00079274|62833413|FG005|Overall Study|Cytogenetic resistance|0|||
33460174|NCT00079274|62833414|FG006|Overall Study|Cytogenetic resistance|0|||
33460175|NCT00079274|62833408|FG000|Overall Study|Other|43|||
33460176|NCT00079274|62833409|FG001|Overall Study|Other|7|||
33460177|NCT00079274|62833410|FG002|Overall Study|Other|5|||
33460178|NCT00079274|62833411|FG003|Overall Study|Other|55|||
33460179|NCT00079274|62833412|FG004|Overall Study|Other|1|||
33460180|NCT00079274|62833413|FG005|Overall Study|Other|2|||
33460181|NCT00079274|62833414|FG006|Overall Study|Other|0|||
33460182|NCT00079040|62833427|FG000|Overall Study|Withdrew before treatment|1|||
33460183|NCT00079040|62833427|FG000|Overall Study|Ineligible|1|||
33460184|NCT00078806|62833431|FG000|Part 1A|Adverse Event|2|||
33460185|NCT00078806|62833432|FG001|Part 1A|Adverse Event|0|||
33460186|NCT00078806|62833433|FG002|Part 1A|Adverse Event|0|||
33460187|NCT00078806|62833434|FG003|Part 1A|Adverse Event|0|||
33460188|NCT00078806|62833431|FG000|Part 1A|Lack of Efficacy|7|||
33460189|NCT00078806|62833432|FG001|Part 1A|Lack of Efficacy|0|||
33460190|NCT00078806|62833433|FG002|Part 1A|Lack of Efficacy|0|||
33460191|NCT00078806|62833434|FG003|Part 1A|Lack of Efficacy|0|||
33460192|NCT00078806|62833431|FG000|Part 1A|Other|1|||
33460193|NCT00078806|62833432|FG001|Part 1A|Other|0|||
33460194|NCT00078806|62833433|FG002|Part 1A|Other|0|||
33535576|NCT02391545|62925397|FG000|Overall Study|Termination of study by sponsor|20|||
33535577|NCT02391545|62925398|FG001|Overall Study|Termination of study by sponsor|20|||
33535578|NCT02391545|62925397|FG000|Overall Study|Withdrawal by Subject|0|||
33535579|NCT02391545|62925398|FG001|Overall Study|Withdrawal by Subject|1|||
33535580|NCT02391545|62925397|FG000|Overall Study|Other Reasons|6|||
33535581|NCT02391545|62925398|FG001|Overall Study|Other Reasons|4|||
33628455|NCT02074553|63029455|FG001|Washout Period 3|Physician Decision|0|||
33628456|NCT02074553|63029456|FG002|Washout Period 3|Physician Decision|0|||
33628457|NCT02074553|63029457|FG003|Washout Period 3|Physician Decision|0|||
33628458|NCT02074553|63029458|FG004|Washout Period 3|Physician Decision|0|||
33460195|NCT00078806|62833434|FG003|Part 1A|Other|0|||
33460196|NCT00078806|62833431|FG000|Part 1B|Adverse Event|1|||
33460197|NCT00078806|62833432|FG001|Part 1B|Adverse Event|0|||
33460198|NCT00078806|62833433|FG002|Part 1B|Adverse Event|0|||
33460199|NCT00078806|62833434|FG003|Part 1B|Adverse Event|0|||
33460200|NCT00078806|62833431|FG000|Part 1B|Lack of Efficacy|7|||
33460201|NCT00078806|62833432|FG001|Part 1B|Lack of Efficacy|0|||
33460202|NCT00078806|62833433|FG002|Part 1B|Lack of Efficacy|0|||
33460203|NCT00078806|62833434|FG003|Part 1B|Lack of Efficacy|0|||
33460204|NCT00078806|62833431|FG000|Part 2|Adverse Event|0|||
33460205|NCT00078806|62833432|FG001|Part 2|Adverse Event|1|||
33460206|NCT00078806|62833433|FG002|Part 2|Adverse Event|0|||
33460207|NCT00078806|62833434|FG003|Part 2|Adverse Event|0|||
33460208|NCT00078338|62833451|FG000|Overall Study|Adverse Event|31|||
33460209|NCT00078338|62833452|FG001|Overall Study|Adverse Event|24|||
33460210|NCT00078338|62833451|FG000|Overall Study|Lost to Follow-up|17|||
33460211|NCT00078338|62833452|FG001|Overall Study|Lost to Follow-up|2|||
33460212|NCT00078338|62833451|FG000|Overall Study|Protocol Violation|2|||
33460213|NCT00078338|62833452|FG001|Overall Study|Protocol Violation|2|||
33460214|NCT00078338|62833451|FG000|Overall Study|Disease Progression|4|||
33460215|NCT00078338|62833452|FG001|Overall Study|Disease Progression|7|||
33460216|NCT00078338|62833451|FG000|Overall Study|Other|28|||
33460217|NCT00078338|62833452|FG001|Overall Study|Other|16|||
33460218|NCT00078338|62833451|FG000|Overall Study|Subjects randomized, but not treated|3|||
33460219|NCT00078338|62833452|FG001|Overall Study|Subjects randomized, but not treated|3|||
33460220|NCT03808688|62833460|FG000|Overall Study|Adverse Event|13|||
33460221|NCT03808688|62833461|FG001|Overall Study|Adverse Event|17|||
33460222|NCT03808688|62833460|FG000|Overall Study|Lack of Efficacy|2|||
33460223|NCT03808688|62833461|FG001|Overall Study|Lack of Efficacy|0|||
33460224|NCT03808688|62833460|FG000|Overall Study|Lost to Follow-up|0|||
33460225|NCT03808688|62833461|FG001|Overall Study|Lost to Follow-up|2|||
33460226|NCT03808688|62833460|FG000|Overall Study|Withdrawal by Subject|1|||
33460227|NCT03808688|62833461|FG001|Overall Study|Withdrawal by Subject|0|||
33460228|NCT03808688|62833460|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
33460229|NCT03808688|62833461|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
33460230|NCT03808688|62833460|FG000|Overall Study|IOP Too High|1|||
33460231|NCT03808688|62833461|FG001|Overall Study|IOP Too High|1|||
33460232|NCT03808688|62833460|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
33460233|NCT03808688|62833461|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
33460234|NCT03808688|62833460|FG000|Overall Study|Visit Out of Window|0|||
33460235|NCT03808688|62833461|FG001|Overall Study|Visit Out of Window|1|||
33460236|NCT03808688|62833460|FG000|Overall Study|Medication Non-Compliance|0|||
33460237|NCT03808688|62833461|FG001|Overall Study|Medication Non-Compliance|1|||
33460238|NCT03808298|62833469|FG000|Overall Study|Adverse Event|3|||
33460239|NCT03808298|62833469|FG000|Overall Study|Physician Decision|1|||
33460240|NCT03808298|62833469|FG000|Overall Study|Withdrawal by Subject|1|||
33460241|NCT03808298|62833469|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
33628459|NCT02074553|63029459|FG005|Washout Period 3|Physician Decision|0|||
33628460|NCT02074553|63029460|FG006|Washout Period 3|Physician Decision|0|||
33628461|NCT02074553|63029461|FG007|Washout Period 3|Physician Decision|1|||
33460242|NCT00077636|62833500|FG000|Overall Study|Refused Treatment|9|||
33460243|NCT00077636|62833501|FG001|Overall Study|Refused Treatment|31|||
33628462|NCT02073929|63029481|FG000|Overall Study|Lost to Follow-up|2|||
33460244|NCT00077636|62833500|FG000|Overall Study|Admin|3|||
33460245|NCT00077636|62833501|FG001|Overall Study|Admin|3|||
33460246|NCT00077636|62833500|FG000|Overall Study|Withdrawal by Subject|2|||
33460247|NCT00077636|62833501|FG001|Overall Study|Withdrawal by Subject|2|||
33460248|NCT00077636|62833500|FG000|Overall Study|Adverse Event|17|||
33628463|NCT02073929|63029482|FG001|Overall Study|Lost to Follow-up|1|||
33628464|NCT02073929|63029481|FG000|Overall Study|Adverse Event|2|||
33628465|NCT02073929|63029482|FG001|Overall Study|Adverse Event|1|||
33628466|NCT02073929|63029481|FG000|Overall Study|Withdrawal by Subject|0|||
33628467|NCT02073929|63029482|FG001|Overall Study|Withdrawal by Subject|1|||
33628468|NCT02113007|63029488|FG000|Overall Study|Progressive disease|2|||
33628469|NCT02005471|63029494|FG000|Overall Study|Ongoing in Study|144|||
33628470|NCT02005471|63029495|FG001|Overall Study|Ongoing in Study|171|||
33628471|NCT02005471|63029494|FG000|Overall Study|Adverse Event|1|||
33460249|NCT00077636|62833501|FG001|Overall Study|Adverse Event|34|||
33460250|NCT00077636|62833500|FG000|Overall Study|Protocol Violation|0|||
33460251|NCT00077636|62833501|FG001|Overall Study|Protocol Violation|2|||
33460252|NCT00077636|62833500|FG000|Overall Study|Lost to Follow-up|10|||
33460253|NCT00077636|62833501|FG001|Overall Study|Lost to Follow-up|18|||
33460254|NCT00077636|62833500|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
33460255|NCT00077636|62833501|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
33460256|NCT00095199|62833512|FG000|Overall Study|Adverse Event|40|||
33460257|NCT00095199|62833513|FG001|Overall Study|Adverse Event|22|||
33460258|NCT00095199|62833514|FG002|Overall Study|Adverse Event|26|||
33460259|NCT00095199|62833515|FG003|Overall Study|Adverse Event|11|||
33460260|NCT00095199|62833512|FG000|Overall Study|Progressive disease|213|||
33460261|NCT00095199|62833513|FG001|Overall Study|Progressive disease|179|||
33460262|NCT00095199|62833514|FG002|Overall Study|Progressive disease|105|||
33460263|NCT00095199|62833515|FG003|Overall Study|Progressive disease|98|||
33460264|NCT00095199|62833512|FG000|Overall Study|Death|10|||
33460265|NCT00095199|62833513|FG001|Overall Study|Death|6|||
33460266|NCT00095199|62833514|FG002|Overall Study|Death|11|||
33460267|NCT00095199|62833515|FG003|Overall Study|Death|9|||
33460268|NCT00095199|62833512|FG000|Overall Study|Withdrawal by Subject|21|||
33460269|NCT00095199|62833513|FG001|Overall Study|Withdrawal by Subject|16|||
33460270|NCT00095199|62833514|FG002|Overall Study|Withdrawal by Subject|13|||
33460271|NCT00095199|62833515|FG003|Overall Study|Withdrawal by Subject|22|||
33460272|NCT00095199|62833512|FG000|Overall Study|Protocol Violation|4|||
33460273|NCT00095199|62833513|FG001|Overall Study|Protocol Violation|4|||
33460274|NCT00095199|62833514|FG002|Overall Study|Protocol Violation|2|||
33460275|NCT00095199|62833515|FG003|Overall Study|Protocol Violation|0|||
33460276|NCT00095199|62833512|FG000|Overall Study|Liver function test results elevated|0|||
33460277|NCT00095199|62833513|FG001|Overall Study|Liver function test results elevated|0|||
33460278|NCT00095199|62833514|FG002|Overall Study|Liver function test results elevated|1|||
33460279|NCT00095199|62833515|FG003|Overall Study|Liver function test results elevated|1|||
33460280|NCT00095199|62833512|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
33460281|NCT00095199|62833513|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
33460282|NCT00095199|62833514|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
33460283|NCT00095199|62833515|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
33460284|NCT00095199|62833512|FG000|Overall Study|Physician Decision|5|||
33460285|NCT00095199|62833513|FG001|Overall Study|Physician Decision|6|||
33460286|NCT00095199|62833514|FG002|Overall Study|Physician Decision|1|||
33460287|NCT00095199|62833515|FG003|Overall Study|Physician Decision|1|||
33460288|NCT00095199|62833512|FG000|Overall Study|Not eligible|1|||
33460289|NCT00095199|62833513|FG001|Overall Study|Not eligible|7|||
33460290|NCT00095199|62833514|FG002|Overall Study|Not eligible|0|||
33460291|NCT00095199|62833515|FG003|Overall Study|Not eligible|1|||
33460292|NCT00095199|62833512|FG000|Overall Study|Started Palliative Radiotherapy|1|||
33460293|NCT00095199|62833513|FG001|Overall Study|Started Palliative Radiotherapy|0|||
33460294|NCT00095199|62833514|FG002|Overall Study|Started Palliative Radiotherapy|0|||
33460295|NCT00095199|62833515|FG003|Overall Study|Started Palliative Radiotherapy|0|||
33460296|NCT00095199|62833512|FG000|Overall Study|Started radiotherapy regimen|0|||
33460297|NCT00095199|62833513|FG001|Overall Study|Started radiotherapy regimen|1|||
33460298|NCT00095199|62833514|FG002|Overall Study|Started radiotherapy regimen|0|||
33628472|NCT02005471|63029495|FG001|Overall Study|Adverse Event|0|||
33628473|NCT02005471|63029494|FG000|Overall Study|Death|26|||
33628474|NCT02005471|63029495|FG001|Overall Study|Death|15|||
33628475|NCT02005471|63029494|FG000|Overall Study|Lost to Follow-up|1|||
33628476|NCT02005471|63029495|FG001|Overall Study|Lost to Follow-up|0|||
33628477|NCT02005471|63029494|FG000|Overall Study|Physician Decision|2|||
33628478|NCT02005471|63029495|FG001|Overall Study|Physician Decision|1|||
33628479|NCT02005471|63029494|FG000|Overall Study|Progressive Disease|3|||
33628480|NCT02005471|63029495|FG001|Overall Study|Progressive Disease|0|||
33628481|NCT02005471|63029494|FG000|Overall Study|Withdrawal by Subject|18|||
33628482|NCT02005471|63029495|FG001|Overall Study|Withdrawal by Subject|7|||
33628483|NCT02104505|63029506|FG000|First Intervention (14 Days)|Adverse Event|2|||
33628484|NCT02104505|63029507|FG001|First Intervention (14 Days)|Adverse Event|0|||
33628485|NCT02104505|63029506|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
33628486|NCT02104505|63029507|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
33628487|NCT02104505|63029506|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
33628488|NCT02104505|63029507|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
33460299|NCT00095199|62833515|FG003|Overall Study|Started radiotherapy regimen|0|||
33460300|NCT00095199|62833512|FG000|Overall Study|Primary tumor removed in other surgery|0|||
33460301|NCT00095199|62833513|FG001|Overall Study|Primary tumor removed in other surgery|1|||
33460302|NCT00095199|62833514|FG002|Overall Study|Primary tumor removed in other surgery|0|||
33460303|NCT00095199|62833515|FG003|Overall Study|Primary tumor removed in other surgery|0|||
33460304|NCT00095199|62833512|FG000|Overall Study|Data inadvertently lost by site|1|||
33460305|NCT00095199|62833513|FG001|Overall Study|Data inadvertently lost by site|0|||
33460306|NCT00095199|62833514|FG002|Overall Study|Data inadvertently lost by site|0|||
33460307|NCT00095199|62833515|FG003|Overall Study|Data inadvertently lost by site|0|||
33628489|NCT02104505|63029506|FG000|First Intervention (14 Days)|exclusionary condition|0|||
33628490|NCT02104505|63029507|FG001|First Intervention (14 Days)|exclusionary condition|1|||
33460308|NCT00075764|62833532|FG000|Overall Study|Adverse Event|5|||
33460309|NCT00075764|62833533|FG001|Overall Study|Adverse Event|12|||
33460310|NCT00075764|62833532|FG000|Overall Study|Death|4|||
33460311|NCT00075764|62833533|FG001|Overall Study|Death|8|||
33460312|NCT00075764|62833532|FG000|Overall Study|Withdrawal by Subject|28|||
33460313|NCT00075764|62833533|FG001|Overall Study|Withdrawal by Subject|18|||
33460314|NCT00075764|62833532|FG000|Overall Study|Progression|269|||
33460315|NCT00075764|62833533|FG001|Overall Study|Progression|274|||
33460316|NCT00075764|62833532|FG000|Overall Study|Still on treatment|8|||
33460317|NCT00075764|62833533|FG001|Overall Study|Still on treatment|15|||
33628491|NCT02104505|63029506|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
33628492|NCT02104505|63029507|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
33628493|NCT02104505|63029506|FG000|Second Intervention (14 Days)|Adverse Event|2|||
33460318|NCT00075764|62833532|FG000|Overall Study|Delinquent|4|||
33460319|NCT00075764|62833533|FG001|Overall Study|Delinquent|2|||
33628494|NCT02104505|63029507|FG001|Second Intervention (14 Days)|Adverse Event|0|||
33628495|NCT02111993|63029516|FG000|Overall Study|Physician Decision|5|||
33628496|NCT02111993|63029517|FG001|Overall Study|Physician Decision|4|||
33628497|NCT01959607|63029527|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
33628498|NCT01959607|63029528|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
33628499|NCT01959607|63029529|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
33628500|NCT01959607|63029530|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
33628501|NCT02111603|63029539|FG000|Overall Study|Withdrawal by Subject|1|||
33628502|NCT02102399|63029545|FG000|Overall Study|Withdrawal by Subject|6|||
33628503|NCT02102399|63029546|FG001|Overall Study|Withdrawal by Subject|4|||
33628504|NCT02111369|63029557|FG000|Overall Study|Lost to Follow-up|2|||
33628505|NCT02111369|63029557|FG000|Overall Study|Withdrawal by Subject|1|||
33628506|NCT02111213|63029563|FG000|Overall Study|Withdrawal by Subject|3|||
33628507|NCT02111213|63029564|FG001|Overall Study|Withdrawal by Subject|2|||
33628508|NCT02111213|63029563|FG000|Overall Study|Lost to Follow-up|3|||
33628509|NCT02111213|63029564|FG001|Overall Study|Lost to Follow-up|4|||
33628510|NCT02110901|63029572|FG000|Overall Study|Death|6|||
33628511|NCT02110901|63029573|FG001|Overall Study|Death|3|||
33628512|NCT02110901|63029572|FG000|Overall Study|Lost to Follow-up|12|||
33628513|NCT02110901|63029573|FG001|Overall Study|Lost to Follow-up|8|||
33628514|NCT02110901|63029572|FG000|Overall Study|Withdrawal by Subject|7|||
33628515|NCT02110901|63029573|FG001|Overall Study|Withdrawal by Subject|3|||
33628516|NCT02110901|63029572|FG000|Overall Study|received a kidney transplant|5|||
33628517|NCT02110901|63029573|FG001|Overall Study|received a kidney transplant|0|||
33628518|NCT02070965|63029583|FG000|Overall Study|Lost to Follow-up|0|||
33628519|NCT02070965|63029584|FG001|Overall Study|Lost to Follow-up|1|||
33628520|NCT02070965|63029585|FG002|Overall Study|Lost to Follow-up|0|||
33628521|NCT02070965|63029583|FG000|Overall Study|Withdrawal by Subject|1|||
33628522|NCT02070965|63029584|FG001|Overall Study|Withdrawal by Subject|1|||
33628523|NCT02070965|63029585|FG002|Overall Study|Withdrawal by Subject|1|||
33628524|NCT02070965|63029583|FG000|Overall Study|Subject moved|1|||
33628525|NCT02070965|63029584|FG001|Overall Study|Subject moved|0|||
33628526|NCT02070965|63029585|FG002|Overall Study|Subject moved|0|||
33628527|NCT02109107|63029593|FG000|Overall Study|Lost to Follow-up|2|||
33628528|NCT02100839|63029599|FG000|Multiple Ascending Dose|Adverse Event|2|||
33628529|NCT02100839|63029600|FG001|Multiple Ascending Dose|Adverse Event|0|||
33628530|NCT02100839|63029599|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
33628531|NCT02100839|63029600|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
33628532|NCT02069093|63029606|FG000|Overall Study|Disease progression|14|||
33628533|NCT02069093|63029606|FG000|Overall Study|New cancer therapy|1|||
33628534|NCT02069093|63029606|FG000|Overall Study|Death|1|||
33628535|NCT02069093|63029606|FG000|Overall Study|Administrative problems|1|||
33628536|NCT02069093|63029606|FG000|Overall Study|Withdrawal by Subject|2|||
33460320|NCT00075764|62833532|FG000|Overall Study|Not protocol specified|27|||
33460321|NCT00075764|62833533|FG001|Overall Study|Not protocol specified|19|||
33460322|NCT00075764|62833532|FG000|Overall Study|Under review|0|||
33460323|NCT00075764|62833533|FG001|Overall Study|Under review|1|||
33460324|NCT03568162|62833547|FG000|Overall Study|Adverse Event|0|||
33460325|NCT03568162|62833548|FG001|Overall Study|Adverse Event|1|||
33460326|NCT03568162|62833549|FG002|Overall Study|Adverse Event|2|||
33460327|NCT03568162|62833550|FG003|Overall Study|Adverse Event|0|||
33460328|NCT03568162|62833551|FG004|Overall Study|Adverse Event|0|||
33460329|NCT03568162|62833552|FG005|Overall Study|Adverse Event|1|||
33460330|NCT03568162|62833547|FG000|Overall Study|Death|0|||
33460331|NCT03568162|62833548|FG001|Overall Study|Death|0|||
33460332|NCT03568162|62833549|FG002|Overall Study|Death|0|||
33460333|NCT03568162|62833550|FG003|Overall Study|Death|0|||
33460334|NCT03568162|62833551|FG004|Overall Study|Death|1|||
33460335|NCT03568162|62833552|FG005|Overall Study|Death|0|||
33460336|NCT03568162|62833547|FG000|Overall Study|Lost to Follow-up|3|||
33460337|NCT03568162|62833548|FG001|Overall Study|Lost to Follow-up|2|||
33460338|NCT03568162|62833549|FG002|Overall Study|Lost to Follow-up|4|||
33460339|NCT03568162|62833550|FG003|Overall Study|Lost to Follow-up|2|||
33460340|NCT03568162|62833551|FG004|Overall Study|Lost to Follow-up|3|||
33628537|NCT02069093|63029606|FG000|Overall Study|Abnormal laboratory values|1|||
33628538|NCT02069093|63029606|FG000|Overall Study|Adverse Event|10|||
33628539|NCT02109029|63029613|FG000|Part B|Adverse Event|0|||
33628540|NCT02109029|63029614|FG001|Part B|Adverse Event|0|||
33628541|NCT02109029|63029615|FG002|Part B|Adverse Event|0|||
33628542|NCT02109029|63029616|FG003|Part B|Adverse Event|0|||
33628543|NCT02109029|63029617|FG004|Part B|Adverse Event|1|||
33628544|NCT02109029|63029618|FG005|Part B|Adverse Event|1|||
33628545|NCT02069015|63029631|FG000|Overall Study|Lost to Follow-up|39|||
33460341|NCT03568162|62833552|FG005|Overall Study|Lost to Follow-up|2|||
33460342|NCT03568162|62833547|FG000|Overall Study|Physician Decision|0|||
33460343|NCT03568162|62833548|FG001|Overall Study|Physician Decision|1|||
33460344|NCT03568162|62833549|FG002|Overall Study|Physician Decision|1|||
33628546|NCT02069015|63029632|FG001|Overall Study|Lost to Follow-up|32|||
33628547|NCT02069015|63029631|FG000|Overall Study|Withdrawal by Subject|1|||
33628548|NCT02069015|63029632|FG001|Overall Study|Withdrawal by Subject|1|||
33628549|NCT01598129|63029639|FG000|Overall Study|Disease progression|6|||
33628550|NCT01598129|63029639|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
33628551|NCT01598129|63029639|FG000|Overall Study|Withdrawal by Subject|1|||
33628552|NCT02068547|63029646|FG000|Overall Study|Lost to Follow-up|3|||
33628553|NCT02068547|63029647|FG001|Overall Study|Lost to Follow-up|3|||
33628554|NCT02068547|63029646|FG000|Overall Study|Physician Decision|1|||
33628555|NCT02068547|63029647|FG001|Overall Study|Physician Decision|0|||
33628556|NCT02108951|63029653|FG000|Overall Study|Lost to Follow-up|1|||
33628557|NCT02108951|63029653|FG000|Overall Study|Patient's/guardian's decision|1|||
33628558|NCT02108951|63029653|FG000|Overall Study|Study Terminated by Sponsor|14|||
33628559|NCT02107859|63029657|FG000|Overall Study|Withdrawal by Subject|14|||
33628560|NCT02107859|63029657|FG000|Overall Study|Adverse Event|3|||
33628561|NCT02107859|63029657|FG000|Overall Study|Study closure|41|||
33628562|NCT02107859|63029657|FG000|Overall Study|Other than specified|3|||
33628563|NCT02007278|63029663|FG000|Overall Study|Failure to comply with an eligibility|0|||
33628564|NCT02007278|63029664|FG001|Overall Study|Failure to comply with an eligibility|1|||
33628565|NCT02007278|63029663|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
33628566|NCT02007278|63029664|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
33628567|NCT02007278|63029663|FG000|Overall Study|Incorrect medication administration|1|||
33628568|NCT02007278|63029664|FG001|Overall Study|Incorrect medication administration|0|||
33628569|NCT02007278|63029663|FG000|Overall Study|Mis-randomization|1|||
33628570|NCT02007278|63029664|FG001|Overall Study|Mis-randomization|1|||
33628571|NCT02107313|63029670|FG000|Overall Study|One participant did not do the FED cohor|0|||
33628572|NCT02107313|63029671|FG001|Overall Study|One participant did not do the FED cohor|1|||
33628573|NCT02028338|63029679|FG000|Overall Study|Withdrawal by Subject|3|||
33628574|NCT02028338|63029680|FG001|Overall Study|Withdrawal by Subject|1|||
33628575|NCT02028338|63029679|FG000|Overall Study|Unable to contact participant|1|||
33628576|NCT02028338|63029680|FG001|Overall Study|Unable to contact participant|0|||
33628577|NCT01625897|63029688|FG000|Overall Study|Adverse Event|27|||
33628578|NCT01625897|63029689|FG001|Overall Study|Adverse Event|10|||
33628579|NCT01625897|63029688|FG000|Overall Study|Physician Decision|0|||
33628580|NCT01625897|63029689|FG001|Overall Study|Physician Decision|1|||
33628581|NCT01625897|63029688|FG000|Overall Study|Withdrawal by Subject|25|||
33628582|NCT01625897|63029689|FG001|Overall Study|Withdrawal by Subject|3|||
33628583|NCT02106923|63029698|FG000|Overall Study|Protocol Violation|0|||
33628584|NCT02106923|63029699|FG001|Overall Study|Protocol Violation|0|||
33628585|NCT02106923|63029700|FG002|Overall Study|Protocol Violation|0|||
33628586|NCT02106923|63029701|FG003|Overall Study|Protocol Violation|0|||
33628587|NCT02106923|63029702|FG004|Overall Study|Protocol Violation|0|||
33628588|NCT02106923|63029703|FG005|Overall Study|Protocol Violation|1|||
33628589|NCT02006732|63029721|FG000|Overall Study|Adverse Event|10|||
33628590|NCT02006732|63029722|FG001|Overall Study|Adverse Event|7|||
33628591|NCT02006732|63029723|FG002|Overall Study|Adverse Event|4|||
33628592|NCT02006732|63029724|FG003|Overall Study|Adverse Event|2|||
33460345|NCT03568162|62833550|FG003|Overall Study|Physician Decision|0|||
33460346|NCT03568162|62833551|FG004|Overall Study|Physician Decision|1|||
33460347|NCT03568162|62833552|FG005|Overall Study|Physician Decision|0|||
33460348|NCT03568162|62833547|FG000|Overall Study|Pregnancy|0|||
33460349|NCT03568162|62833548|FG001|Overall Study|Pregnancy|0|||
33460350|NCT03568162|62833549|FG002|Overall Study|Pregnancy|0|||
33460351|NCT03568162|62833550|FG003|Overall Study|Pregnancy|1|||
33460352|NCT03568162|62833551|FG004|Overall Study|Pregnancy|0|||
33460353|NCT03568162|62833552|FG005|Overall Study|Pregnancy|0|||
33460354|NCT03568162|62833547|FG000|Overall Study|Protocol Violation|1|||
33460355|NCT03568162|62833548|FG001|Overall Study|Protocol Violation|0|||
33460356|NCT03568162|62833549|FG002|Overall Study|Protocol Violation|1|||
33628593|NCT02006732|63029721|FG000|Overall Study|Lack of Efficacy|6|||
33628594|NCT02006732|63029722|FG001|Overall Study|Lack of Efficacy|3|||
33628595|NCT02006732|63029723|FG002|Overall Study|Lack of Efficacy|1|||
33628596|NCT02006732|63029724|FG003|Overall Study|Lack of Efficacy|1|||
33628597|NCT02006732|63029721|FG000|Overall Study|Protocol Violation|1|||
33460357|NCT03568162|62833550|FG003|Overall Study|Protocol Violation|1|||
33460358|NCT03568162|62833551|FG004|Overall Study|Protocol Violation|1|||
33628598|NCT02006732|63029722|FG001|Overall Study|Protocol Violation|1|||
33628599|NCT02006732|63029723|FG002|Overall Study|Protocol Violation|0|||
33628600|NCT02006732|63029724|FG003|Overall Study|Protocol Violation|0|||
33628601|NCT02006732|63029721|FG000|Overall Study|Lost to Follow-up|0|||
33628602|NCT02006732|63029722|FG001|Overall Study|Lost to Follow-up|1|||
33628603|NCT02006732|63029723|FG002|Overall Study|Lost to Follow-up|0|||
33628604|NCT02006732|63029724|FG003|Overall Study|Lost to Follow-up|0|||
33628605|NCT02006732|63029721|FG000|Overall Study|Withdrawal by Subject|3|||
33628606|NCT02006732|63029722|FG001|Overall Study|Withdrawal by Subject|0|||
33628607|NCT02006732|63029723|FG002|Overall Study|Withdrawal by Subject|4|||
33628608|NCT02006732|63029724|FG003|Overall Study|Withdrawal by Subject|1|||
33628609|NCT02098733|63029734|FG000|Overall Study|Data Not Available|5|||
33628610|NCT02098733|63029734|FG000|Overall Study|Lost to Follow-up|5|||
33628611|NCT02028182|63029738|FG000|Overall Study|Protocol Violation|2|||
33628612|NCT02098109|63029745|FG000|Overall Study|Protocol Violation|3|||
33628613|NCT02098109|63029746|FG001|Overall Study|Protocol Violation|0|||
33628614|NCT02097719|63029754|FG000|Overall Study|Subject Withdrew Consent|1|||
33628615|NCT02097719|63029755|FG001|Overall Study|Subject Withdrew Consent|0|||
33628616|NCT02097719|63029754|FG000|Overall Study|Lost to Follow-up|0|||
33535911|NCT01920932|62925540|FG000|Overall Study|Death|1|||
33535912|NCT01920932|62925540|FG000|Overall Study|Withdrawal of consent|1|||
33535913|NCT01774253|62925561|FG000|Overall Study|Lack of Efficacy|4|||
33628617|NCT02097719|63029755|FG001|Overall Study|Lost to Follow-up|1|||
33628618|NCT02097719|63029754|FG000|Overall Study|Adverse Event|2|||
33628619|NCT02097719|63029755|FG001|Overall Study|Adverse Event|0|||
33628620|NCT01449370|63029786|FG000|Overall Study|Disease Progression|5|||
33535914|NCT01774253|62925561|FG000|Overall Study|Physician Decision|2|||
33535915|NCT01774253|62925561|FG000|Overall Study|Withdrawal by Subject|2|||
33535916|NCT01774253|62925561|FG000|Overall Study|Death|1|||
33535920|NCT01505608|62925625|FG000|Phase I|Lack of Efficacy|0|||
33535921|NCT01505608|62925626|FG001|Phase I|Lack of Efficacy|4|||
33535922|NCT01505608|62925625|FG000|Phase I|Adverse Event|0|||
33535923|NCT01505608|62925626|FG001|Phase I|Adverse Event|1|||
33535924|NCT01505608|62925625|FG000|Phase I|Withdrawal by Subject|0|||
33535925|NCT01505608|62925626|FG001|Phase I|Withdrawal by Subject|1|||
33535926|NCT01505608|62925625|FG000|Phase II|Lack of Efficacy|2|||
33535927|NCT01505608|62925626|FG001|Phase II|Lack of Efficacy|1|||
33535928|NCT01505608|62925625|FG000|Phase II|Protocol Violation|0|||
33535929|NCT01505608|62925626|FG001|Phase II|Protocol Violation|1|||
33535930|NCT01483820|62925664|FG000|Overall Study|Lack of Efficacy|6|||
33535931|NCT01483820|62925664|FG000|Overall Study|Adverse Event|1|||
33535932|NCT01483820|62925664|FG000|Overall Study|Death|1|||
33535933|NCT01364597|62925672|FG000|Overall Study|Adverse Event|4|||
33535934|NCT01364597|62925673|FG001|Overall Study|Adverse Event|5|||
33535935|NCT01364597|62925674|FG002|Overall Study|Adverse Event|16|||
33535936|NCT01364597|62925675|FG003|Overall Study|Adverse Event|7|||
33535937|NCT01364597|62925672|FG000|Overall Study|Lack of Efficacy|4|||
33535938|NCT01364597|62925673|FG001|Overall Study|Lack of Efficacy|4|||
33535939|NCT01364597|62925674|FG002|Overall Study|Lack of Efficacy|23|||
33535940|NCT01364597|62925675|FG003|Overall Study|Lack of Efficacy|8|||
33535941|NCT01364597|62925672|FG000|Overall Study|Protocol Violation|0|||
33535942|NCT01364597|62925673|FG001|Overall Study|Protocol Violation|0|||
33535943|NCT01364597|62925674|FG002|Overall Study|Protocol Violation|2|||
33535944|NCT01364597|62925675|FG003|Overall Study|Protocol Violation|0|||
33535945|NCT01364597|62925672|FG000|Overall Study|Lost to Follow-up|0|||
33535946|NCT01364597|62925673|FG001|Overall Study|Lost to Follow-up|0|||
33535947|NCT01364597|62925674|FG002|Overall Study|Lost to Follow-up|5|||
33535948|NCT01364597|62925675|FG003|Overall Study|Lost to Follow-up|3|||
33535949|NCT01364597|62925672|FG000|Overall Study|Withdrawal by Subject|4|||
33535950|NCT01364597|62925673|FG001|Overall Study|Withdrawal by Subject|1|||
33535951|NCT01364597|62925674|FG002|Overall Study|Withdrawal by Subject|18|||
33535952|NCT01364597|62925675|FG003|Overall Study|Withdrawal by Subject|6|||
33535953|NCT01364597|62925672|FG000|Overall Study|Non compliance|1|||
33535954|NCT01364597|62925673|FG001|Overall Study|Non compliance|0|||
33535955|NCT01364597|62925674|FG002|Overall Study|Non compliance|1|||
33535956|NCT01364597|62925675|FG003|Overall Study|Non compliance|0|||
33535957|NCT01364597|62925672|FG000|Overall Study|Lack of compliance|1|||
33628621|NCT01449370|63029787|FG001|Overall Study|Disease Progression|4|||
33628622|NCT01449370|63029788|FG002|Overall Study|Disease Progression|8|||
33628623|NCT01449370|63029789|FG003|Overall Study|Disease Progression|3|||
33628624|NCT01449370|63029790|FG004|Overall Study|Disease Progression|3|||
33628625|NCT01449370|63029791|FG005|Overall Study|Disease Progression|3|||
33628626|NCT01449370|63029792|FG006|Overall Study|Disease Progression|3|||
33628627|NCT01449370|63029793|FG007|Overall Study|Disease Progression|2|||
33628628|NCT01449370|63029794|FG008|Overall Study|Disease Progression|9|||
33628629|NCT01449370|63029795|FG009|Overall Study|Disease Progression|1|||
33628630|NCT01449370|63029796|FG010|Overall Study|Disease Progression|3|||
33326075|NCT01185821|62702836|FG001|Overall Study|Adverse Event|3|||
33326076|NCT01185821|62702837|FG002|Overall Study|Adverse Event|1|||
33326077|NCT01185821|62702838|FG003|Overall Study|Adverse Event|2|||
33326078|NCT01185821|62702839|FG004|Overall Study|Adverse Event|5|||
33326079|NCT01185821|62702835|FG000|Overall Study|Lack of Efficacy|0|||
33326080|NCT01185821|62702836|FG001|Overall Study|Lack of Efficacy|0|||
33326081|NCT01185821|62702837|FG002|Overall Study|Lack of Efficacy|3|||
33326082|NCT01185821|62702838|FG003|Overall Study|Lack of Efficacy|0|||
33326083|NCT01185821|62702839|FG004|Overall Study|Lack of Efficacy|9|||
33326084|NCT01185821|62702835|FG000|Overall Study|Withdrawal by Subject|3|||
33326085|NCT01185821|62702836|FG001|Overall Study|Withdrawal by Subject|2|||
33326086|NCT01185821|62702837|FG002|Overall Study|Withdrawal by Subject|2|||
33326087|NCT01185821|62702838|FG003|Overall Study|Withdrawal by Subject|1|||
33326088|NCT01185821|62702839|FG004|Overall Study|Withdrawal by Subject|3|||
33535958|NCT01364597|62925673|FG001|Overall Study|Lack of compliance|0|||
33535959|NCT01364597|62925674|FG002|Overall Study|Lack of compliance|0|||
33535960|NCT01364597|62925675|FG003|Overall Study|Lack of compliance|0|||
33535961|NCT01364597|62925672|FG000|Overall Study|End of treatment epilepsy|1|||
33535962|NCT01364597|62925673|FG001|Overall Study|End of treatment epilepsy|0|||
33535963|NCT01364597|62925674|FG002|Overall Study|End of treatment epilepsy|0|||
33535964|NCT01364597|62925675|FG003|Overall Study|End of treatment epilepsy|0|||
33535965|NCT01364597|62925672|FG000|Overall Study|No Seizures|1|||
33535966|NCT01364597|62925673|FG001|Overall Study|No Seizures|0|||
33628631|NCT01449370|63029797|FG011|Overall Study|Disease Progression|3|||
33628632|NCT01449370|63029798|FG012|Overall Study|Disease Progression|2|||
33628633|NCT01449370|63029799|FG013|Overall Study|Disease Progression|8|||
33628634|NCT01449370|63029800|FG014|Overall Study|Disease Progression|3|||
33628635|NCT01449370|63029801|FG015|Overall Study|Disease Progression|1|||
33628636|NCT01449370|63029802|FG016|Overall Study|Disease Progression|4|||
33628637|NCT01449370|63029803|FG017|Overall Study|Disease Progression|3|||
33628638|NCT01449370|63029804|FG018|Overall Study|Disease Progression|1|||
33535967|NCT01364597|62925674|FG002|Overall Study|No Seizures|0|||
33535968|NCT01364597|62925675|FG003|Overall Study|No Seizures|0|||
33535969|NCT01364597|62925672|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
33535970|NCT01364597|62925673|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
33535971|NCT01364597|62925674|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
33535972|NCT01364597|62925675|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
33535973|NCT01364597|62925672|FG000|Overall Study|Cure|1|||
33628639|NCT01449370|63029805|FG019|Overall Study|Disease Progression|2|||
33628640|NCT01449370|63029806|FG020|Overall Study|Disease Progression|5|||
33628641|NCT01449370|63029807|FG021|Overall Study|Disease Progression|2|||
33628642|NCT01449370|63029808|FG022|Overall Study|Disease Progression|3|||
33628643|NCT01449370|63029809|FG023|Overall Study|Disease Progression|7|||
33628644|NCT01449370|63029810|FG024|Overall Study|Disease Progression|3|||
33628645|NCT01449370|63029786|FG000|Overall Study|Adverse Event|1|||
33628646|NCT01449370|63029787|FG001|Overall Study|Adverse Event|2|||
33628647|NCT01449370|63029788|FG002|Overall Study|Adverse Event|0|||
33628648|NCT01449370|63029789|FG003|Overall Study|Adverse Event|1|||
33628649|NCT01449370|63029790|FG004|Overall Study|Adverse Event|0|||
33628650|NCT01449370|63029791|FG005|Overall Study|Adverse Event|0|||
33628651|NCT01449370|63029792|FG006|Overall Study|Adverse Event|0|||
33628652|NCT01449370|63029793|FG007|Overall Study|Adverse Event|0|||
33628653|NCT01449370|63029794|FG008|Overall Study|Adverse Event|1|||
33628654|NCT01449370|63029795|FG009|Overall Study|Adverse Event|1|||
33628655|NCT01449370|63029796|FG010|Overall Study|Adverse Event|0|||
33535974|NCT01364597|62925673|FG001|Overall Study|Cure|0|||
33535975|NCT01364597|62925674|FG002|Overall Study|Cure|0|||
33535976|NCT01364597|62925675|FG003|Overall Study|Cure|0|||
33535977|NCT01364597|62925672|FG000|Overall Study|Patient was moving|0|||
33535978|NCT01364597|62925673|FG001|Overall Study|Patient was moving|1|||
33535979|NCT01364597|62925674|FG002|Overall Study|Patient was moving|0|||
33535980|NCT01364597|62925675|FG003|Overall Study|Patient was moving|0|||
33535981|NCT01364597|62925672|FG000|Overall Study|Seizures resolved|0|||
33535982|NCT01364597|62925673|FG001|Overall Study|Seizures resolved|0|||
33535983|NCT01364597|62925674|FG002|Overall Study|Seizures resolved|1|||
33535984|NCT01364597|62925675|FG003|Overall Study|Seizures resolved|0|||
33535985|NCT01364597|62925672|FG000|Overall Study|Patient became seizure-free after surgery|0|||
33535986|NCT01364597|62925673|FG001|Overall Study|Patient became seizure-free after surgery|0|||
33535987|NCT01364597|62925674|FG002|Overall Study|Patient became seizure-free after surgery|1|||
33535988|NCT01364597|62925675|FG003|Overall Study|Patient became seizure-free after surgery|0|||
33535989|NCT01364597|62925672|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
33535990|NCT01364597|62925673|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
33535991|NCT01364597|62925674|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
33535992|NCT01364597|62925675|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
33535993|NCT01364597|62925672|FG000|Overall Study|Patient cured from Epilepsy|0|||
33535994|NCT01364597|62925673|FG001|Overall Study|Patient cured from Epilepsy|0|||
33535995|NCT01364597|62925674|FG002|Overall Study|Patient cured from Epilepsy|1|||
33535996|NCT01364597|62925675|FG003|Overall Study|Patient cured from Epilepsy|0|||
33535997|NCT01364597|62925672|FG000|Overall Study|Investigator decision|0|||
33535998|NCT01364597|62925673|FG001|Overall Study|Investigator decision|0|||
33535999|NCT01364597|62925674|FG002|Overall Study|Investigator decision|1|||
33536000|NCT01364597|62925675|FG003|Overall Study|Investigator decision|0|||
33536001|NCT01364597|62925672|FG000|Overall Study|Sponsor recommended discontinuation|0|||
33536002|NCT01364597|62925673|FG001|Overall Study|Sponsor recommended discontinuation|0|||
33536003|NCT01364597|62925674|FG002|Overall Study|Sponsor recommended discontinuation|0|||
33536004|NCT01364597|62925675|FG003|Overall Study|Sponsor recommended discontinuation|1|||
33536005|NCT01364597|62925672|FG000|Overall Study|Parents went abroad with the patient|0|||
33536006|NCT01364597|62925673|FG001|Overall Study|Parents went abroad with the patient|0|||
33536007|NCT01364597|62925674|FG002|Overall Study|Parents went abroad with the patient|1|||
33536008|NCT01364597|62925675|FG003|Overall Study|Parents went abroad with the patient|0|||
33536009|NCT01364597|62925672|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
33536010|NCT01364597|62925673|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
33628656|NCT01449370|63029797|FG011|Overall Study|Adverse Event|0|||
33628657|NCT01449370|63029798|FG012|Overall Study|Adverse Event|0|||
33628658|NCT01449370|63029799|FG013|Overall Study|Adverse Event|2|||
33628659|NCT01449370|63029800|FG014|Overall Study|Adverse Event|0|||
33628660|NCT01449370|63029801|FG015|Overall Study|Adverse Event|1|||
33628661|NCT01449370|63029802|FG016|Overall Study|Adverse Event|0|||
33628662|NCT01449370|63029803|FG017|Overall Study|Adverse Event|0|||
33536011|NCT01364597|62925674|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
33536012|NCT01364597|62925675|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
33536013|NCT01364597|62925672|FG000|Overall Study|BRV administration dropout|0|||
33536014|NCT01364597|62925673|FG001|Overall Study|BRV administration dropout|0|||
33536015|NCT01364597|62925674|FG002|Overall Study|BRV administration dropout|1|||
33536016|NCT01364597|62925675|FG003|Overall Study|BRV administration dropout|0|||
33536017|NCT01364597|62925672|FG000|Overall Study|Dropout|0|||
33536018|NCT01364597|62925673|FG001|Overall Study|Dropout|0|||
33536019|NCT01364597|62925674|FG002|Overall Study|Dropout|3|||
33536020|NCT01364597|62925675|FG003|Overall Study|Dropout|1|||
33536021|NCT01364597|62925672|FG000|Overall Study|Unreliable subject|0|||
33536022|NCT01364597|62925673|FG001|Overall Study|Unreliable subject|0|||
33536023|NCT01364597|62925674|FG002|Overall Study|Unreliable subject|0|||
33536024|NCT01364597|62925675|FG003|Overall Study|Unreliable subject|1|||
33536025|NCT01364597|62925672|FG000|Overall Study|Other|0|||
33536026|NCT01364597|62925673|FG001|Overall Study|Other|0|||
33536027|NCT01364597|62925674|FG002|Overall Study|Other|0|||
33628663|NCT01449370|63029804|FG018|Overall Study|Adverse Event|1|||
33628664|NCT01449370|63029805|FG019|Overall Study|Adverse Event|1|||
33628665|NCT01449370|63029806|FG020|Overall Study|Adverse Event|0|||
33628666|NCT01449370|63029807|FG021|Overall Study|Adverse Event|1|||
33628667|NCT01449370|63029808|FG022|Overall Study|Adverse Event|0|||
33628668|NCT01449370|63029809|FG023|Overall Study|Adverse Event|1|||
33628669|NCT01449370|63029810|FG024|Overall Study|Adverse Event|3|||
33628670|NCT01449370|63029786|FG000|Overall Study|Participant Decision|0|||
33628671|NCT01449370|63029787|FG001|Overall Study|Participant Decision|0|||
33628672|NCT01449370|63029788|FG002|Overall Study|Participant Decision|0|||
33536028|NCT01364597|62925675|FG003|Overall Study|Other|1|||
33536033|NCT01106898|62925721|FG000|Overall Study|Adverse Event|6|||
33536034|NCT01059071|62925729|FG000|Overall Study|Lack of Efficacy|1|||
33536035|NCT01059071|62925730|FG001|Overall Study|Lack of Efficacy|4|||
33536036|NCT01059071|62925731|FG002|Overall Study|Lack of Efficacy|2|||
33536037|NCT01059071|62925732|FG003|Overall Study|Lack of Efficacy|3|||
33536038|NCT01059071|62925729|FG000|Overall Study|Withdrawal by Subject|1|||
33536039|NCT01059071|62925730|FG001|Overall Study|Withdrawal by Subject|0|||
33536040|NCT01059071|62925731|FG002|Overall Study|Withdrawal by Subject|0|||
33536041|NCT01059071|62925732|FG003|Overall Study|Withdrawal by Subject|2|||
33536042|NCT01059071|62925729|FG000|Overall Study|Physician Decision|0|||
33536043|NCT01059071|62925730|FG001|Overall Study|Physician Decision|0|||
33536044|NCT01059071|62925731|FG002|Overall Study|Physician Decision|0|||
33536045|NCT01059071|62925732|FG003|Overall Study|Physician Decision|1|||
33536046|NCT00923702|62925745|FG000|Overall Study|Ongoing enrollment|0|||
33536047|NCT00923702|62925746|FG001|Overall Study|Ongoing enrollment|0|||
33536048|NCT00923702|62925747|FG002|Overall Study|Ongoing enrollment|0|||
33536049|NCT00923702|62925748|FG003|Overall Study|Ongoing enrollment|0|||
33536050|NCT00923702|62925749|FG004|Overall Study|Ongoing enrollment|354|||
33536051|NCT00867568|62925761|FG000|Overall Study|Lack of Efficacy|10|||
33536052|NCT00867568|62925761|FG000|Overall Study|Adverse Event|4|||
33536053|NCT00867568|62925761|FG000|Overall Study|Withdrawal by Subject|1|||
33628673|NCT01449370|63029789|FG003|Overall Study|Participant Decision|0|||
33628674|NCT01449370|63029790|FG004|Overall Study|Participant Decision|0|||
33628675|NCT01449370|63029791|FG005|Overall Study|Participant Decision|0|||
33628676|NCT01449370|63029792|FG006|Overall Study|Participant Decision|0|||
33628677|NCT01449370|63029793|FG007|Overall Study|Participant Decision|1|||
33628678|NCT01449370|63029794|FG008|Overall Study|Participant Decision|1|||
33628679|NCT01449370|63029795|FG009|Overall Study|Participant Decision|0|||
33628680|NCT01449370|63029796|FG010|Overall Study|Participant Decision|0|||
33536062|NCT00737698|62925797|FG000|Overall Study|Withdrawal by Subject|6|||
33536063|NCT00737698|62925798|FG001|Overall Study|Withdrawal by Subject|5|||
33628681|NCT01449370|63029797|FG011|Overall Study|Participant Decision|0|||
33536064|NCT00737698|62925799|FG002|Overall Study|Withdrawal by Subject|3|||
33628682|NCT01449370|63029798|FG012|Overall Study|Participant Decision|1|||
33628683|NCT01449370|63029799|FG013|Overall Study|Participant Decision|1|||
33628684|NCT01449370|63029800|FG014|Overall Study|Participant Decision|0|||
33536065|NCT00737698|62925797|FG000|Overall Study|Death|0|||
33536066|NCT00737698|62925798|FG001|Overall Study|Death|0|||
33536067|NCT00737698|62925799|FG002|Overall Study|Death|1|||
33460359|NCT03568162|62833552|FG005|Overall Study|Protocol Violation|1|||
33544236|NCT03012061|62935096|FG000|Overall Study|Withdrawal by Subject|1|||
33544237|NCT03012061|62935097|FG001|Overall Study|Withdrawal by Subject|5|||
33544238|NCT03012061|62935098|FG002|Overall Study|Withdrawal by Subject|4|||
33544239|NCT03012061|62935096|FG000|Overall Study|Investigator Site Closed|1|||
33460360|NCT03568162|62833547|FG000|Overall Study|Withdrawal by Subject|15|||
33460361|NCT03568162|62833548|FG001|Overall Study|Withdrawal by Subject|15|||
33460362|NCT03568162|62833549|FG002|Overall Study|Withdrawal by Subject|26|||
33460363|NCT03568162|62833550|FG003|Overall Study|Withdrawal by Subject|22|||
33460364|NCT03568162|62833551|FG004|Overall Study|Withdrawal by Subject|6|||
33460365|NCT03568162|62833552|FG005|Overall Study|Withdrawal by Subject|9|||
33460366|NCT03568162|62833547|FG000|Overall Study|Others|3|||
33460367|NCT03568162|62833548|FG001|Overall Study|Others|4|||
33460368|NCT03568162|62833549|FG002|Overall Study|Others|1|||
33460369|NCT03568162|62833550|FG003|Overall Study|Others|4|||
33460370|NCT03568162|62833551|FG004|Overall Study|Others|2|||
33460371|NCT03568162|62833552|FG005|Overall Study|Others|1|||
33460372|NCT03567616|62833571|FG000|Overall Study|Disease progression|4|||
33460373|NCT03567616|62833571|FG000|Overall Study|Withdrawal by Subject|1|||
33460374|NCT03567616|62833571|FG000|Overall Study|Physician Decision|1|||
33460375|NCT03567616|62833571|FG000|Overall Study|Death|1|||
33544240|NCT03012061|62935097|FG001|Overall Study|Investigator Site Closed|2|||
33460376|NCT03567616|62833571|FG000|Overall Study|Adverse Event|1|||
33460377|NCT03567382|62833580|FG000|Overall Study|Lost to Follow-up|1|||
33460378|NCT03567382|62833581|FG001|Overall Study|Lost to Follow-up|21|||
33544241|NCT03012061|62935098|FG002|Overall Study|Investigator Site Closed|0|||
33544242|NCT03012061|62935096|FG000|Overall Study|Lost to Follow-up|2|||
33544243|NCT03012061|62935097|FG001|Overall Study|Lost to Follow-up|1|||
33544244|NCT03012061|62935098|FG002|Overall Study|Lost to Follow-up|0|||
33544245|NCT03012061|62935096|FG000|Overall Study|Study closed/ Terminated|0|||
33544246|NCT03012061|62935097|FG001|Overall Study|Study closed/ Terminated|0|||
33544247|NCT03012061|62935098|FG002|Overall Study|Study closed/ Terminated|1|||
33544248|NCT03012061|62935096|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
33536107|NCT01668004|62925867|FG000|Overall Study|Adverse Event|7|||
33536108|NCT01668004|62925867|FG000|Overall Study|Withdrawal by Subject|2|||
33536109|NCT01668004|62925867|FG000|Overall Study|Lost to Follow-up|5|||
33536110|NCT01668004|62925867|FG000|Overall Study|Lack of Efficacy|9|||
33536111|NCT01668004|62925867|FG000|Overall Study|Non-compliance with treatment|2|||
33536112|NCT01667926|62925875|FG000|Overall Study|Withdrawal by Subject|1|||
33536113|NCT01667926|62925876|FG001|Overall Study|Withdrawal by Subject|2|||
33536114|NCT01667926|62925877|FG002|Overall Study|Withdrawal by Subject|2|||
33536115|NCT01667926|62925875|FG000|Overall Study|Physician Decision|0|||
33536116|NCT01667926|62925876|FG001|Overall Study|Physician Decision|0|||
33536117|NCT01667926|62925877|FG002|Overall Study|Physician Decision|1|||
33536118|NCT01667926|62925875|FG000|Overall Study|Time committment|0|||
33536119|NCT01667926|62925876|FG001|Overall Study|Time committment|0|||
33536120|NCT01667926|62925877|FG002|Overall Study|Time committment|2|||
33536121|NCT01667926|62925875|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
33536122|NCT01667926|62925876|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
33536123|NCT01667926|62925877|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
33536124|NCT01667926|62925875|FG000|Overall Study|Lost to Follow-up|1|||
33536125|NCT01667926|62925876|FG001|Overall Study|Lost to Follow-up|2|||
33536126|NCT01667926|62925877|FG002|Overall Study|Lost to Follow-up|1|||
33536127|NCT01667926|62925875|FG000|Overall Study|Side effects|3|||
33536128|NCT01667926|62925876|FG001|Overall Study|Side effects|0|||
33628685|NCT01449370|63029801|FG015|Overall Study|Participant Decision|1|||
33628686|NCT01449370|63029802|FG016|Overall Study|Participant Decision|3|||
33628687|NCT01449370|63029803|FG017|Overall Study|Participant Decision|0|||
33628688|NCT01449370|63029804|FG018|Overall Study|Participant Decision|1|||
33536129|NCT01667926|62925877|FG002|Overall Study|Side effects|0|||
33536130|NCT02604160|62925885|FG000|Overall Study|Protocol Violation|0|||
33536131|NCT02604160|62925886|FG001|Overall Study|Protocol Violation|1|||
33536132|NCT02604160|62925885|FG000|Overall Study|Physician Decision|0|||
33536133|NCT02604160|62925886|FG001|Overall Study|Physician Decision|1|||
33536134|NCT01359904|62925896|FG000|Overall Study|Withdrawal by Subject|1|||
33536135|NCT01359904|62925897|FG001|Overall Study|Withdrawal by Subject|0|||
33536136|NCT00157248|62925926|FG000|Overall Study|Adverse Event|36|||
33536137|NCT00157248|62925927|FG001|Overall Study|Adverse Event|25|||
33536138|NCT00157248|62925928|FG002|Overall Study|Adverse Event|13|||
33628689|NCT01449370|63029805|FG019|Overall Study|Participant Decision|0|||
33628690|NCT01449370|63029806|FG020|Overall Study|Participant Decision|0|||
33628691|NCT01449370|63029807|FG021|Overall Study|Participant Decision|1|||
33628692|NCT01449370|63029808|FG022|Overall Study|Participant Decision|0|||
33628693|NCT01449370|63029809|FG023|Overall Study|Participant Decision|0|||
33628694|NCT01449370|63029810|FG024|Overall Study|Participant Decision|1|||
33628695|NCT01449370|63029786|FG000|Overall Study|Lost to Follow-up|0|||
33628696|NCT01449370|63029787|FG001|Overall Study|Lost to Follow-up|0|||
33628697|NCT01449370|63029788|FG002|Overall Study|Lost to Follow-up|0|||
33628698|NCT01449370|63029789|FG003|Overall Study|Lost to Follow-up|0|||
33628699|NCT01449370|63029790|FG004|Overall Study|Lost to Follow-up|0|||
33628700|NCT01449370|63029791|FG005|Overall Study|Lost to Follow-up|0|||
33628701|NCT01449370|63029792|FG006|Overall Study|Lost to Follow-up|0|||
33628702|NCT01449370|63029793|FG007|Overall Study|Lost to Follow-up|0|||
33628703|NCT01449370|63029794|FG008|Overall Study|Lost to Follow-up|0|||
33628704|NCT01449370|63029795|FG009|Overall Study|Lost to Follow-up|0|||
33628705|NCT01449370|63029796|FG010|Overall Study|Lost to Follow-up|0|||
33628706|NCT01449370|63029797|FG011|Overall Study|Lost to Follow-up|0|||
33628707|NCT01449370|63029798|FG012|Overall Study|Lost to Follow-up|0|||
33628708|NCT01449370|63029799|FG013|Overall Study|Lost to Follow-up|0|||
33628709|NCT01449370|63029800|FG014|Overall Study|Lost to Follow-up|0|||
33628710|NCT01449370|63029801|FG015|Overall Study|Lost to Follow-up|0|||
33628711|NCT01449370|63029802|FG016|Overall Study|Lost to Follow-up|0|||
33628712|NCT01449370|63029803|FG017|Overall Study|Lost to Follow-up|0|||
33460379|NCT03567382|62833582|FG002|Overall Study|Lost to Follow-up|1|||
33536139|NCT00157248|62925929|FG003|Overall Study|Adverse Event|33|||
33628713|NCT01449370|63029804|FG018|Overall Study|Lost to Follow-up|0|||
33628714|NCT01449370|63029805|FG019|Overall Study|Lost to Follow-up|0|||
33628715|NCT01449370|63029806|FG020|Overall Study|Lost to Follow-up|1|||
33628716|NCT01449370|63029807|FG021|Overall Study|Lost to Follow-up|0|||
33460380|NCT03567382|62833583|FG003|Overall Study|Lost to Follow-up|21|||
33460381|NCT03567382|62833580|FG000|Overall Study|Withdrawal by Subject|2|||
33460382|NCT03567382|62833581|FG001|Overall Study|Withdrawal by Subject|14|||
33460383|NCT03567382|62833582|FG002|Overall Study|Withdrawal by Subject|1|||
33460384|NCT03567382|62833583|FG003|Overall Study|Withdrawal by Subject|12|||
33460385|NCT03595384|62833594|FG000|Overall Study|Other time commitments|8|||
33460386|NCT03595384|62833594|FG000|Overall Study|Changes to session time|7|||
33536140|NCT00157248|62925926|FG000|Overall Study|Protocol Violation|4|||
33536141|NCT00157248|62925927|FG001|Overall Study|Protocol Violation|0|||
33536142|NCT00157248|62925928|FG002|Overall Study|Protocol Violation|2|||
33628717|NCT01449370|63029808|FG022|Overall Study|Lost to Follow-up|0|||
33628718|NCT01449370|63029809|FG023|Overall Study|Lost to Follow-up|0|||
33628719|NCT01449370|63029810|FG024|Overall Study|Lost to Follow-up|0|||
33628720|NCT01449370|63029786|FG000|Overall Study|Other|0|||
33628721|NCT01449370|63029787|FG001|Overall Study|Other|0|||
33628722|NCT01449370|63029788|FG002|Overall Study|Other|0|||
33628723|NCT01449370|63029789|FG003|Overall Study|Other|0|||
33628724|NCT01449370|63029790|FG004|Overall Study|Other|0|||
33460387|NCT03595384|62833594|FG000|Overall Study|Relocation out of country|1|||
33460388|NCT03591874|62833600|FG000|Overall Study|Adverse Event|4|||
33460389|NCT03591874|62833601|FG001|Overall Study|Adverse Event|0|||
33460390|NCT03591874|62833600|FG000|Overall Study|Withdrawal by Subject|2|||
33460391|NCT03591874|62833601|FG001|Overall Study|Withdrawal by Subject|1|||
33460392|NCT03591874|62833600|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
33460393|NCT03591874|62833601|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
33460394|NCT03591874|62833600|FG000|Overall Study|On Study at Time of Study Termination|12|||
33460395|NCT03591874|62833601|FG001|Overall Study|On Study at Time of Study Termination|6|||
33460396|NCT03566680|62833607|FG000|Overall Study|Pregnancy|1|||
33460397|NCT03566680|62833607|FG000|Overall Study|Lost to Follow-up|13|||
33460398|NCT03566680|62833607|FG000|Overall Study|Withdrawal by Subject|3|||
33460399|NCT00106353|62833613|FG000|Part 1|Disease progression|3|||
33460400|NCT00106353|62833614|FG001|Part 1|Disease progression|4|||
33536143|NCT00157248|62925929|FG003|Overall Study|Protocol Violation|2|||
33536144|NCT00157248|62925926|FG000|Overall Study|Lost to Follow-up|0|||
33536145|NCT00157248|62925927|FG001|Overall Study|Lost to Follow-up|1|||
33460401|NCT00106353|62833615|FG002|Part 1|Disease progression|1|||
33460402|NCT00106353|62833616|FG003|Part 1|Disease progression|3|||
33460403|NCT00106353|62833617|FG004|Part 1|Disease progression|0|||
33460404|NCT00106353|62833618|FG005|Part 1|Disease progression|0|||
33460405|NCT00106353|62833619|FG006|Part 1|Disease progression|0|||
33460406|NCT00106353|62833613|FG000|Part 1|Withdrawal by Subject|0|||
33460407|NCT00106353|62833614|FG001|Part 1|Withdrawal by Subject|0|||
33460408|NCT00106353|62833615|FG002|Part 1|Withdrawal by Subject|1|||
33460409|NCT00106353|62833616|FG003|Part 1|Withdrawal by Subject|2|||
33460410|NCT00106353|62833617|FG004|Part 1|Withdrawal by Subject|0|||
33460411|NCT00106353|62833618|FG005|Part 1|Withdrawal by Subject|0|||
33460412|NCT00106353|62833619|FG006|Part 1|Withdrawal by Subject|0|||
33460413|NCT00106353|62833613|FG000|Part 1|Symptomatic deterioration|0|||
33460414|NCT00106353|62833614|FG001|Part 1|Symptomatic deterioration|0|||
33536146|NCT00157248|62925928|FG002|Overall Study|Lost to Follow-up|0|||
33536147|NCT00157248|62925929|FG003|Overall Study|Lost to Follow-up|0|||
33536148|NCT00157248|62925926|FG000|Overall Study|Withdrawal by Subject|1|||
33536149|NCT00157248|62925927|FG001|Overall Study|Withdrawal by Subject|4|||
33536150|NCT00157248|62925928|FG002|Overall Study|Withdrawal by Subject|3|||
33536151|NCT00157248|62925929|FG003|Overall Study|Withdrawal by Subject|3|||
33536152|NCT00157248|62925926|FG000|Overall Study|site closures, subject moving|7|||
33536153|NCT00157248|62925927|FG001|Overall Study|site closures, subject moving|7|||
33536154|NCT00157248|62925928|FG002|Overall Study|site closures, subject moving|3|||
33536155|NCT00157248|62925929|FG003|Overall Study|site closures, subject moving|9|||
33536156|NCT01328756|62925943|FG000|Overall Study|Protocol Violation|4|||
33536157|NCT01328756|62925943|FG000|Overall Study|Adverse Event|39|||
33536158|NCT01328756|62925943|FG000|Overall Study|Lack of Efficacy|5|||
33536159|NCT01328756|62925943|FG000|Overall Study|Withdrawal by Subject|41|||
33536160|NCT01328756|62925943|FG000|Overall Study|Lost to Follow-up|5|||
33536161|NCT01328756|62925943|FG000|Overall Study|Other|29|||
33536162|NCT03922308|62925950|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
33536163|NCT03922308|62925951|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
33536164|NCT03922308|62925952|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
33536165|NCT03922308|62925950|FG000|Overall Study|Lost to Follow-up|1|||
33536166|NCT03922308|62925951|FG001|Overall Study|Lost to Follow-up|0|||
33536167|NCT03922308|62925952|FG002|Overall Study|Lost to Follow-up|0|||
33536168|NCT03922308|62925950|FG000|Overall Study|Reason not Specified|0|||
33536169|NCT03922308|62925951|FG001|Overall Study|Reason not Specified|2|||
33536170|NCT03922308|62925952|FG002|Overall Study|Reason not Specified|1|||
33536171|NCT02607930|62925965|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
33536172|NCT02607930|62925966|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
33536173|NCT02607930|62925967|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
33536174|NCT02607930|62925968|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
33536175|NCT02607930|62925965|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
33536176|NCT02607930|62925966|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
33536177|NCT02607930|62925967|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
33460415|NCT00106353|62833615|FG002|Part 1|Symptomatic deterioration|1|||
33460416|NCT00106353|62833616|FG003|Part 1|Symptomatic deterioration|0|||
33460417|NCT00106353|62833617|FG004|Part 1|Symptomatic deterioration|0|||
33460418|NCT00106353|62833618|FG005|Part 1|Symptomatic deterioration|0|||
33536178|NCT02607930|62925968|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
33536179|NCT02607930|62925965|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
33628725|NCT01449370|63029791|FG005|Overall Study|Other|0|||
33628726|NCT01449370|63029792|FG006|Overall Study|Other|0|||
33628727|NCT01449370|63029793|FG007|Overall Study|Other|0|||
33628728|NCT01449370|63029794|FG008|Overall Study|Other|1|||
33628729|NCT01449370|63029795|FG009|Overall Study|Other|1|||
33628730|NCT01449370|63029796|FG010|Overall Study|Other|0|||
33628731|NCT01449370|63029797|FG011|Overall Study|Other|0|||
33628732|NCT01449370|63029798|FG012|Overall Study|Other|0|||
33628733|NCT01449370|63029799|FG013|Overall Study|Other|0|||
33628734|NCT01449370|63029800|FG014|Overall Study|Other|0|||
33628735|NCT01449370|63029801|FG015|Overall Study|Other|0|||
33628736|NCT01449370|63029802|FG016|Overall Study|Other|0|||
33628737|NCT01449370|63029803|FG017|Overall Study|Other|0|||
33628738|NCT01449370|63029804|FG018|Overall Study|Other|0|||
33628739|NCT01449370|63029805|FG019|Overall Study|Other|0|||
33628740|NCT01449370|63029806|FG020|Overall Study|Other|0|||
33628741|NCT01449370|63029807|FG021|Overall Study|Other|0|||
33628742|NCT01449370|63029808|FG022|Overall Study|Other|1|||
33628743|NCT01449370|63029809|FG023|Overall Study|Other|1|||
33628744|NCT01449370|63029810|FG024|Overall Study|Other|0|||
33628745|NCT01449370|63029786|FG000|Overall Study|Medication Prohibited by Protocol|0|||
33628746|NCT01449370|63029787|FG001|Overall Study|Medication Prohibited by Protocol|0|||
33628747|NCT01449370|63029788|FG002|Overall Study|Medication Prohibited by Protocol|0|||
33628748|NCT01449370|63029789|FG003|Overall Study|Medication Prohibited by Protocol|0|||
33628749|NCT01449370|63029790|FG004|Overall Study|Medication Prohibited by Protocol|0|||
33628750|NCT01449370|63029791|FG005|Overall Study|Medication Prohibited by Protocol|0|||
33628751|NCT01449370|63029792|FG006|Overall Study|Medication Prohibited by Protocol|0|||
33628752|NCT01449370|63029793|FG007|Overall Study|Medication Prohibited by Protocol|0|||
33628753|NCT01449370|63029794|FG008|Overall Study|Medication Prohibited by Protocol|0|||
33536180|NCT02607930|62925966|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
33536181|NCT02607930|62925967|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
33536182|NCT02607930|62925968|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
33536183|NCT02607930|62925965|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
33536184|NCT02607930|62925966|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
33536185|NCT02607930|62925967|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
33536186|NCT02607930|62925968|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
33536187|NCT02607930|62925965|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
33536188|NCT02607930|62925966|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
33536189|NCT02607930|62925967|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
33536190|NCT02607930|62925968|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
33536191|NCT02607930|62925965|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
33536192|NCT02607930|62925966|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
33628754|NCT01449370|63029795|FG009|Overall Study|Medication Prohibited by Protocol|0|||
33628755|NCT01449370|63029796|FG010|Overall Study|Medication Prohibited by Protocol|0|||
33628756|NCT01449370|63029797|FG011|Overall Study|Medication Prohibited by Protocol|0|||
33628757|NCT01449370|63029798|FG012|Overall Study|Medication Prohibited by Protocol|0|||
33628758|NCT01449370|63029799|FG013|Overall Study|Medication Prohibited by Protocol|0|||
33628759|NCT01449370|63029800|FG014|Overall Study|Medication Prohibited by Protocol|0|||
33628760|NCT01449370|63029801|FG015|Overall Study|Medication Prohibited by Protocol|0|||
33628761|NCT01449370|63029802|FG016|Overall Study|Medication Prohibited by Protocol|0|||
33628762|NCT01449370|63029803|FG017|Overall Study|Medication Prohibited by Protocol|0|||
33628763|NCT01449370|63029804|FG018|Overall Study|Medication Prohibited by Protocol|0|||
33628764|NCT01449370|63029805|FG019|Overall Study|Medication Prohibited by Protocol|0|||
33628765|NCT01449370|63029806|FG020|Overall Study|Medication Prohibited by Protocol|0|||
33628766|NCT01449370|63029807|FG021|Overall Study|Medication Prohibited by Protocol|0|||
33628767|NCT01449370|63029808|FG022|Overall Study|Medication Prohibited by Protocol|0|||
33628768|NCT01449370|63029809|FG023|Overall Study|Medication Prohibited by Protocol|1|||
33628769|NCT01449370|63029810|FG024|Overall Study|Medication Prohibited by Protocol|0|||
33628770|NCT01449370|63029786|FG000|Overall Study|Death|0|||
33628771|NCT01449370|63029787|FG001|Overall Study|Death|0|||
33628772|NCT01449370|63029788|FG002|Overall Study|Death|0|||
33628773|NCT01449370|63029789|FG003|Overall Study|Death|0|||
33628774|NCT01449370|63029790|FG004|Overall Study|Death|0|||
33628775|NCT01449370|63029791|FG005|Overall Study|Death|0|||
33628776|NCT01449370|63029792|FG006|Overall Study|Death|0|||
33536193|NCT02607930|62925967|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
33628777|NCT01449370|63029793|FG007|Overall Study|Death|0|||
33628778|NCT01449370|63029794|FG008|Overall Study|Death|0|||
33628779|NCT01449370|63029795|FG009|Overall Study|Death|0|||
33628780|NCT01449370|63029796|FG010|Overall Study|Death|0|||
33628781|NCT01449370|63029797|FG011|Overall Study|Death|0|||
33628782|NCT01449370|63029798|FG012|Overall Study|Death|0|||
33628783|NCT01449370|63029799|FG013|Overall Study|Death|0|||
33628784|NCT01449370|63029800|FG014|Overall Study|Death|0|||
33628785|NCT01449370|63029801|FG015|Overall Study|Death|0|||
33628786|NCT01449370|63029802|FG016|Overall Study|Death|0|||
33628787|NCT01449370|63029803|FG017|Overall Study|Death|0|||
33628788|NCT01449370|63029804|FG018|Overall Study|Death|0|||
33628789|NCT01449370|63029805|FG019|Overall Study|Death|0|||
33628790|NCT01449370|63029806|FG020|Overall Study|Death|0|||
33628791|NCT01449370|63029807|FG021|Overall Study|Death|0|||
33628792|NCT01449370|63029808|FG022|Overall Study|Death|0|||
33628793|NCT01449370|63029809|FG023|Overall Study|Death|0|||
33628794|NCT01449370|63029810|FG024|Overall Study|Death|1|||
33536194|NCT02607930|62925968|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
33536195|NCT02607930|62925965|FG000|Double-Blinded Treatment Phase|Death|2|||
33536196|NCT02607930|62925966|FG001|Double-Blinded Treatment Phase|Death|1|||
33536197|NCT02607930|62925967|FG002|Double-Blinded Treatment Phase|Death|0|||
33536198|NCT02607930|62925968|FG003|Double-Blinded Treatment Phase|Death|0|||
33536199|NCT02607930|62925965|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
33536200|NCT02607930|62925966|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
33628795|NCT02067533|63029885|FG000|Overall Study|Lost to Follow-up|4|||
33628796|NCT02067533|63029886|FG001|Overall Study|Lost to Follow-up|2|||
33628797|NCT02066129|63029894|FG000|Overall Study|Lost to Follow-up|13|||
33628798|NCT02066129|63029895|FG001|Overall Study|Lost to Follow-up|12|||
33628799|NCT02066129|63029894|FG000|Overall Study|Withdrawal by Subject|7|||
33628800|NCT02066129|63029895|FG001|Overall Study|Withdrawal by Subject|10|||
33628801|NCT02066129|63029894|FG000|Overall Study|Lack of Efficacy|8|||
33628802|NCT02066129|63029895|FG001|Overall Study|Lack of Efficacy|10|||
33536201|NCT02607930|62925967|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
33536202|NCT02607930|62925968|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
33536203|NCT02607930|62925965|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
33536204|NCT02607930|62925966|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
33628803|NCT02066129|63029894|FG000|Overall Study|Physician Decision|1|||
33628804|NCT02066129|63029895|FG001|Overall Study|Physician Decision|1|||
33628805|NCT02066051|63029901|FG000|Overall Study|Subject developed active GVHD|1|||
33326089|NCT01185821|62702835|FG000|Overall Study|Lost to Follow-up|1|||
33326090|NCT01185821|62702836|FG001|Overall Study|Lost to Follow-up|1|||
33460419|NCT00106353|62833619|FG006|Part 1|Symptomatic deterioration|0|||
33460420|NCT00106353|62833613|FG000|Part 1|Entered follow-up phase|1|||
33460421|NCT00106353|62833614|FG001|Part 1|Entered follow-up phase|1|||
33460422|NCT00106353|62833615|FG002|Part 1|Entered follow-up phase|0|||
33460423|NCT00106353|62833616|FG003|Part 1|Entered follow-up phase|1|||
33460424|NCT00106353|62833617|FG004|Part 1|Entered follow-up phase|0|||
33460425|NCT00106353|62833618|FG005|Part 1|Entered follow-up phase|0|||
33460426|NCT00106353|62833619|FG006|Part 1|Entered follow-up phase|0|||
33460427|NCT00106353|62833613|FG000|Part 1|Adverse Event|0|||
33460428|NCT00106353|62833614|FG001|Part 1|Adverse Event|0|||
33460429|NCT00106353|62833615|FG002|Part 1|Adverse Event|0|||
33460430|NCT00106353|62833616|FG003|Part 1|Adverse Event|1|||
33460431|NCT00106353|62833617|FG004|Part 1|Adverse Event|0|||
33460432|NCT00106353|62833618|FG005|Part 1|Adverse Event|0|||
33460433|NCT00106353|62833619|FG006|Part 1|Adverse Event|0|||
33460434|NCT00106353|62833613|FG000|Part 2|Disease progression|0|||
33460435|NCT00106353|62833614|FG001|Part 2|Disease progression|0|||
33460436|NCT00106353|62833615|FG002|Part 2|Disease progression|0|||
33460437|NCT00106353|62833616|FG003|Part 2|Disease progression|0|||
33460438|NCT00106353|62833617|FG004|Part 2|Disease progression|8|||
33628806|NCT01980992|63029907|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
33628807|NCT01980992|63029908|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
33628808|NCT01980992|63029907|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
33460439|NCT00106353|62833618|FG005|Part 2|Disease progression|14|||
33628809|NCT01980992|63029908|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
33628810|NCT01980992|63029907|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
33628811|NCT01980992|63029908|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
33536205|NCT02607930|62925967|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
33536206|NCT02607930|62925968|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
33536207|NCT02607930|62925965|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
33536208|NCT02607930|62925966|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
33536209|NCT02607930|62925967|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
33536210|NCT02607930|62925968|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
33536211|NCT02607930|62925965|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
33536212|NCT02607930|62925966|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
33536213|NCT02607930|62925967|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
33536214|NCT02607930|62925968|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
33536215|NCT02607930|62925965|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
33536216|NCT02607930|62925966|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
33536217|NCT02607930|62925967|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
33536218|NCT02607930|62925968|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
33536219|NCT02607930|62925965|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
33536220|NCT02607930|62925966|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
33536221|NCT02607930|62925967|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
33536222|NCT02607930|62925968|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
33536223|NCT02607930|62925965|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
33536224|NCT02607930|62925966|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
33536225|NCT02607930|62925967|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
33536226|NCT02607930|62925968|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
33536227|NCT02607930|62925965|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
33536228|NCT02607930|62925966|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
33536229|NCT02607930|62925967|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
33628812|NCT01980992|63029907|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
33536230|NCT02607930|62925968|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
33536231|NCT02607930|62925965|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
33536232|NCT02607930|62925966|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
33536233|NCT02607930|62925967|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
33536234|NCT02607930|62925968|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
33536235|NCT02101034|62925987|FG000|Overall Study|Enrolled but did not start treatment|0|||
33536236|NCT02101034|62925988|FG001|Overall Study|Enrolled but did not start treatment|0|||
33536237|NCT02101034|62925989|FG002|Overall Study|Enrolled but did not start treatment|1|||
33536238|NCT02101034|62925990|FG003|Overall Study|Enrolled but did not start treatment|0|||
33536239|NCT02101034|62925991|FG004|Overall Study|Enrolled but did not start treatment|0|||
33536240|NCT02736188|62926026|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
33628813|NCT01980992|63029908|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
33628814|NCT01980992|63029907|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
33628815|NCT01980992|63029908|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
33460440|NCT00106353|62833619|FG006|Part 2|Disease progression|13|||
33460441|NCT00106353|62833613|FG000|Part 2|Death|0|||
33460442|NCT00106353|62833614|FG001|Part 2|Death|0|||
33460443|NCT00106353|62833615|FG002|Part 2|Death|0|||
33460444|NCT00106353|62833616|FG003|Part 2|Death|0|||
33460445|NCT00106353|62833617|FG004|Part 2|Death|3|||
33460446|NCT00106353|62833618|FG005|Part 2|Death|0|||
33460447|NCT00106353|62833619|FG006|Part 2|Death|1|||
33460448|NCT00106353|62833613|FG000|Part 2|Symptomatic deterioration|0|||
33460449|NCT00106353|62833614|FG001|Part 2|Symptomatic deterioration|0|||
33460450|NCT00106353|62833615|FG002|Part 2|Symptomatic deterioration|0|||
33460451|NCT00106353|62833616|FG003|Part 2|Symptomatic deterioration|0|||
33460452|NCT00106353|62833617|FG004|Part 2|Symptomatic deterioration|3|||
33536241|NCT02736188|62926026|FG000|Overall Study|Adverse Event|1|||
33536242|NCT02736188|62926026|FG000|Overall Study|Withdrawal by Subject|1|||
33460453|NCT00106353|62833618|FG005|Part 2|Symptomatic deterioration|0|||
33536243|NCT02736188|62926026|FG000|Overall Study|Other|6|||
33536244|NCT00154284|62926034|FG000|Overall Study|Adverse Event|6|||
33536245|NCT00154284|62926035|FG001|Overall Study|Adverse Event|9|||
33536246|NCT00154284|62926034|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33536247|NCT00154284|62926035|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33536248|NCT00154284|62926034|FG000|Overall Study|Lack of Efficacy|1|||
33536249|NCT00154284|62926035|FG001|Overall Study|Lack of Efficacy|2|||
33536250|NCT00154284|62926034|FG000|Overall Study|Protocol Violation|0|||
33536251|NCT00154284|62926035|FG001|Overall Study|Protocol Violation|1|||
33536252|NCT02735096|62926043|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
33536253|NCT00905346|62926056|FG000|Period 1|Withdrawal by Subject|1|||
33536254|NCT00905346|62926057|FG001|Period 1|Withdrawal by Subject|0|||
33536255|NCT01328444|62926070|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
33628816|NCT01980992|63029907|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
33628817|NCT01980992|63029908|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
33628818|NCT02065895|63029921|FG000|Overall Study|Protocol Violation|1|||
33628819|NCT02065895|63029922|FG001|Overall Study|Protocol Violation|0|||
33628820|NCT02065895|63029923|FG002|Overall Study|Protocol Violation|0|||
33628821|NCT02065895|63029924|FG003|Overall Study|Protocol Violation|1|||
33628822|NCT02065895|63029925|FG004|Overall Study|Protocol Violation|0|||
33628823|NCT02065895|63029926|FG005|Overall Study|Protocol Violation|0|||
33628824|NCT02065895|63029921|FG000|Overall Study|Scheduling conflicts|0|||
33628825|NCT02065895|63029922|FG001|Overall Study|Scheduling conflicts|1|||
33628826|NCT02065895|63029923|FG002|Overall Study|Scheduling conflicts|0|||
33628827|NCT02065895|63029924|FG003|Overall Study|Scheduling conflicts|0|||
33628828|NCT02065895|63029925|FG004|Overall Study|Scheduling conflicts|0|||
33628829|NCT02065895|63029926|FG005|Overall Study|Scheduling conflicts|0|||
33628830|NCT02106455|63029943|FG000|Overall Study|Case Report Form Uncollected|6|||
33628831|NCT02106455|63029943|FG000|Overall Study|Protocol Deviation|2|||
33628832|NCT02006654|63029949|FG000|Overall Study|Withdrawal before treatment|4|||
33628833|NCT02006654|63029950|FG001|Overall Study|Withdrawal before treatment|2|||
33628834|NCT02006654|63029949|FG000|Overall Study|Adverse Event|16|||
33628835|NCT02006654|63029950|FG001|Overall Study|Adverse Event|17|||
33536256|NCT01328444|62926071|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
33536257|NCT01328444|62926072|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
33628836|NCT02006654|63029949|FG000|Overall Study|Death|1|||
33628837|NCT02006654|63029950|FG001|Overall Study|Death|0|||
33628838|NCT02006654|63029949|FG000|Overall Study|Withdrawal by Subject|14|||
33628839|NCT02006654|63029950|FG001|Overall Study|Withdrawal by Subject|12|||
33628840|NCT02006654|63029949|FG000|Overall Study|Protocol Violation|5|||
33628841|NCT02006654|63029950|FG001|Overall Study|Protocol Violation|8|||
33628842|NCT02006654|63029949|FG000|Overall Study|Lost to Follow-up|1|||
33628843|NCT02006654|63029950|FG001|Overall Study|Lost to Follow-up|0|||
33628844|NCT02006654|63029949|FG000|Overall Study|patient's will|2|||
33628845|NCT02006654|63029950|FG001|Overall Study|patient's will|1|||
33628846|NCT02006654|63029949|FG000|Overall Study|insufficient compliance|1|||
33628847|NCT02006654|63029950|FG001|Overall Study|insufficient compliance|0|||
33536258|NCT01328444|62926073|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
33536259|NCT01328444|62926074|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
33536260|NCT01328444|62926075|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
33536261|NCT01328444|62926070|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
33536262|NCT01328444|62926071|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
33536263|NCT01328444|62926072|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
33536264|NCT01328444|62926073|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
33536265|NCT01328444|62926074|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
33536266|NCT01328444|62926075|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
33536267|NCT01328444|62926070|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
33536268|NCT01328444|62926071|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
33536269|NCT01328444|62926072|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
33536270|NCT01328444|62926073|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
33536271|NCT01328444|62926074|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
33536272|NCT01328444|62926075|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
33628848|NCT02006654|63029949|FG000|Overall Study|worsening cognitive condition|0|||
33628849|NCT02006654|63029950|FG001|Overall Study|worsening cognitive condition|1|||
33628850|NCT02006654|63029949|FG000|Overall Study|faecal incontinence|0|||
33628851|NCT02006654|63029950|FG001|Overall Study|faecal incontinence|1|||
33628852|NCT02006654|63029949|FG000|Overall Study|mood disorder|0|||
33628853|NCT02006654|63029950|FG001|Overall Study|mood disorder|1|||
33628854|NCT02006654|63029949|FG000|Overall Study|disallowed medication|1|||
33536273|NCT01328444|62926070|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
33536274|NCT01328444|62926071|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
33628855|NCT02006654|63029950|FG001|Overall Study|disallowed medication|0|||
33628856|NCT02006654|63029949|FG000|Overall Study|moving out of state|0|||
33628857|NCT02006654|63029950|FG001|Overall Study|moving out of state|1|||
33628858|NCT01980056|63029960|FG000|Overall Study|Death|1|||
33628859|NCT01980056|63029961|FG001|Overall Study|Death|1|||
33628860|NCT01980056|63029962|FG002|Overall Study|Death|0|||
33628861|NCT02027558|63029976|FG000|Overall Study|Death|0|||
33628862|NCT02027558|63029977|FG001|Overall Study|Death|1|||
33628863|NCT02027558|63029976|FG000|Overall Study|Withdrawal by Subject|2|||
33628864|NCT02027558|63029977|FG001|Overall Study|Withdrawal by Subject|0|||
33628865|NCT02027558|63029976|FG000|Overall Study|Lost to Follow-up|4|||
33536275|NCT01328444|62926072|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
33536276|NCT01328444|62926073|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
33536277|NCT01328444|62926074|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
33460454|NCT00106353|62833619|FG006|Part 2|Symptomatic deterioration|0|||
33460455|NCT00106353|62833613|FG000|Part 2|Adverse Event|0|||
33460456|NCT00106353|62833614|FG001|Part 2|Adverse Event|0|||
33460457|NCT00106353|62833615|FG002|Part 2|Adverse Event|0|||
33460458|NCT00106353|62833616|FG003|Part 2|Adverse Event|0|||
33460459|NCT00106353|62833617|FG004|Part 2|Adverse Event|0|||
33460460|NCT00106353|62833618|FG005|Part 2|Adverse Event|2|||
33536278|NCT01328444|62926075|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
33536279|NCT01328444|62926070|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
33536280|NCT01328444|62926071|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33536281|NCT01328444|62926072|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33536282|NCT01328444|62926073|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
33536283|NCT01328444|62926074|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33536284|NCT01328444|62926075|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
33460461|NCT00106353|62833619|FG006|Part 2|Adverse Event|1|||
33536285|NCT01328444|62926070|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33536286|NCT01328444|62926071|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
33536287|NCT01328444|62926072|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
33536288|NCT01328444|62926073|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
33536289|NCT01328444|62926074|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
33536290|NCT01328444|62926075|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33536291|NCT01328444|62926070|FG000|Washout Period (14 Days)|Adverse Event|1|||
33536292|NCT01328444|62926071|FG001|Washout Period (14 Days)|Adverse Event|1|||
33536293|NCT01328444|62926072|FG002|Washout Period (14 Days)|Adverse Event|0|||
33536294|NCT01328444|62926073|FG003|Washout Period (14 Days)|Adverse Event|1|||
33536295|NCT01328444|62926074|FG004|Washout Period (14 Days)|Adverse Event|1|||
33536296|NCT01328444|62926075|FG005|Washout Period (14 Days)|Adverse Event|2|||
33536297|NCT01328444|62926070|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
33536298|NCT01328444|62926071|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
33536299|NCT01328444|62926072|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
33536300|NCT01328444|62926073|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
33536301|NCT01328444|62926074|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
33536302|NCT01328444|62926075|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
33536303|NCT01328444|62926070|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
33536304|NCT01328444|62926071|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
33536305|NCT01328444|62926072|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
33536306|NCT01328444|62926073|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
33536307|NCT01328444|62926074|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
33536308|NCT01328444|62926075|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
33536309|NCT01328444|62926070|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
33536310|NCT01328444|62926071|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
33536311|NCT01328444|62926072|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
33536312|NCT01328444|62926073|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
33628866|NCT02027558|63029977|FG001|Overall Study|Lost to Follow-up|1|||
33628867|NCT02027558|63029976|FG000|Overall Study|Refused assessment|3|||
33628868|NCT02027558|63029977|FG001|Overall Study|Refused assessment|0|||
33628869|NCT02006576|63029988|FG000|Overall Study|Withdrawal by Subject|4|||
33628870|NCT02006576|63029989|FG001|Overall Study|Withdrawal by Subject|6|||
33460462|NCT00106353|62833613|FG000|Part 2|Other|0|||
33536313|NCT01328444|62926074|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
33536314|NCT01328444|62926075|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
33536315|NCT01328444|62926070|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
33628871|NCT02006576|63029990|FG002|Overall Study|Withdrawal by Subject|2|||
33628872|NCT02006576|63029988|FG000|Overall Study|Death|0|||
33628873|NCT02006576|63029989|FG001|Overall Study|Death|0|||
33628874|NCT02006576|63029990|FG002|Overall Study|Death|1|||
33628875|NCT02006576|63029988|FG000|Overall Study|Lost to Follow-up|1|||
33460463|NCT00106353|62833614|FG001|Part 2|Other|0|||
33460464|NCT00106353|62833615|FG002|Part 2|Other|0|||
33460465|NCT00106353|62833616|FG003|Part 2|Other|0|||
33460466|NCT00106353|62833617|FG004|Part 2|Other|1|||
33460467|NCT00106353|62833618|FG005|Part 2|Other|1|||
33460468|NCT00106353|62833619|FG006|Part 2|Other|1|||
33460469|NCT00106353|62833613|FG000|Part 2|Withdrawal by Subject|0|||
33628876|NCT02006576|63029989|FG001|Overall Study|Lost to Follow-up|0|||
33628877|NCT02006576|63029990|FG002|Overall Study|Lost to Follow-up|1|||
33460470|NCT00106353|62833614|FG001|Part 2|Withdrawal by Subject|0|||
33460471|NCT00106353|62833615|FG002|Part 2|Withdrawal by Subject|0|||
33460472|NCT00106353|62833616|FG003|Part 2|Withdrawal by Subject|0|||
33460473|NCT00106353|62833617|FG004|Part 2|Withdrawal by Subject|1|||
33460474|NCT00106353|62833618|FG005|Part 2|Withdrawal by Subject|0|||
33460475|NCT00106353|62833619|FG006|Part 2|Withdrawal by Subject|0|||
33460476|NCT00106353|62833613|FG000|Part 2|Physician Decision|0|||
33460477|NCT00106353|62833614|FG001|Part 2|Physician Decision|0|||
33460478|NCT00106353|62833615|FG002|Part 2|Physician Decision|0|||
33460479|NCT00106353|62833616|FG003|Part 2|Physician Decision|0|||
33460480|NCT00106353|62833617|FG004|Part 2|Physician Decision|0|||
33460481|NCT00106353|62833618|FG005|Part 2|Physician Decision|1|||
33460482|NCT00106353|62833619|FG006|Part 2|Physician Decision|0|||
33628878|NCT02006576|63029988|FG000|Overall Study|Screen Failure, too sick, other|13|||
33460483|NCT00080301|62833642|FG000|Overall Study|Randomized but Never Treated|5|||
33460484|NCT00080301|62833643|FG001|Overall Study|Randomized but Never Treated|10|||
33628879|NCT02006576|63029989|FG001|Overall Study|Screen Failure, too sick, other|1|||
33628880|NCT02006576|63029990|FG002|Overall Study|Screen Failure, too sick, other|13|||
33628881|NCT02027402|63030000|FG000|Overall Study|Withdrawal by Subject|4|||
33628882|NCT02027402|63030001|FG001|Overall Study|Withdrawal by Subject|1|||
33628883|NCT01448824|63030017|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
33628884|NCT01448824|63030018|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
33628885|NCT01448824|63030019|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
33628886|NCT01448824|63030020|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
33628887|NCT01448824|63030021|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
33628888|NCT01448824|63030022|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
33628889|NCT01448824|63030023|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
33628890|NCT01448824|63030024|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
33628891|NCT01448824|63030017|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
33628892|NCT01448824|63030018|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
33628893|NCT01448824|63030019|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
33628894|NCT01448824|63030020|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
33628895|NCT01448824|63030021|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
33628896|NCT01448824|63030022|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
33628897|NCT01448824|63030023|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
33628898|NCT01448824|63030024|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
33628899|NCT01448824|63030017|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
33536316|NCT01328444|62926071|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
33536317|NCT01328444|62926072|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
33536318|NCT01328444|62926073|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
33536319|NCT01328444|62926074|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
33536320|NCT01328444|62926075|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
33628900|NCT01448824|63030018|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
33628901|NCT01448824|63030019|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
33628902|NCT01448824|63030020|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
33628903|NCT01448824|63030021|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
33628904|NCT01448824|63030022|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
33628905|NCT01448824|63030023|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
33628906|NCT01448824|63030024|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
33628907|NCT01448824|63030017|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
33628908|NCT01448824|63030018|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
33628909|NCT01448824|63030019|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
33628910|NCT01448824|63030020|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
33628911|NCT01448824|63030021|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
33628912|NCT01448824|63030022|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
33628913|NCT01448824|63030023|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
33628914|NCT01448824|63030024|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
33628915|NCT01448824|63030017|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
33628916|NCT01448824|63030018|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
33628917|NCT01448824|63030019|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
33628918|NCT01448824|63030020|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
33628919|NCT01448824|63030021|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
33628920|NCT01448824|63030022|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
33628921|NCT01448824|63030023|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
33628922|NCT01448824|63030024|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
33628923|NCT01448824|63030017|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
33628924|NCT01448824|63030018|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
33536321|NCT01328444|62926070|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
33536322|NCT01328444|62926071|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
33628925|NCT01448824|63030019|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
33326091|NCT01185821|62702837|FG002|Overall Study|Lost to Follow-up|2|||
33536323|NCT01328444|62926072|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
33536324|NCT01328444|62926073|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
33536325|NCT01328444|62926074|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
33536326|NCT01328444|62926075|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
33628926|NCT01448824|63030020|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
33628927|NCT01448824|63030021|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
33326092|NCT01185821|62702838|FG003|Overall Study|Lost to Follow-up|1|||
33536327|NCT01328444|62926070|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
33536328|NCT01328444|62926071|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
33536329|NCT01328444|62926072|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
33536330|NCT01328444|62926073|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
33536331|NCT01328444|62926074|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
33536332|NCT01328444|62926075|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
33536333|NCT01328444|62926070|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
33536334|NCT01328444|62926071|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
33536335|NCT01328444|62926072|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
33536336|NCT01328444|62926073|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
33536337|NCT01328444|62926074|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
33628928|NCT01448824|63030022|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
33628929|NCT01448824|63030023|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
33628930|NCT01448824|63030024|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
33628931|NCT01448824|63030017|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
33628932|NCT01448824|63030018|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
33628933|NCT01448824|63030019|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
33628934|NCT01448824|63030020|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
33628935|NCT01448824|63030021|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
33628936|NCT01448824|63030022|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
33628937|NCT01448824|63030023|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
33628938|NCT01448824|63030024|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
33628939|NCT01448824|63030017|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
33628940|NCT01448824|63030018|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
33628941|NCT01448824|63030019|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
33628942|NCT01448824|63030020|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
33628943|NCT01448824|63030021|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
33628944|NCT01448824|63030022|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
33628945|NCT01448824|63030023|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
33536338|NCT01328444|62926075|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
33536339|NCT01328444|62926070|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33536340|NCT01328444|62926071|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33536341|NCT01328444|62926072|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33536342|NCT01328444|62926073|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33536343|NCT01328444|62926074|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33536344|NCT01328444|62926075|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33326093|NCT01185821|62702839|FG004|Overall Study|Lost to Follow-up|2|||
33460485|NCT00080301|62833642|FG000|Overall Study|Still on Treatment as of CSR date|0|||
33460486|NCT00080301|62833643|FG001|Overall Study|Still on Treatment as of CSR date|1|||
33460487|NCT00079677|62833652|FG000|Overall Study|Adverse Event|5|||
33460488|NCT00079677|62833653|FG001|Overall Study|Adverse Event|6|||
33460489|NCT00079677|62833652|FG000|Overall Study|Lack of Efficacy|1|||
33460490|NCT00079677|62833653|FG001|Overall Study|Lack of Efficacy|0|||
33460491|NCT00079677|62833652|FG000|Overall Study|Lost to Follow-up|2|||
33536345|NCT00887250|62926092|FG000|Overall Study|Adverse Event|3|||
33536346|NCT00887250|62926093|FG001|Overall Study|Adverse Event|0|||
33536347|NCT00887250|62926094|FG002|Overall Study|Adverse Event|7|||
33460492|NCT00079677|62833653|FG001|Overall Study|Lost to Follow-up|2|||
33460493|NCT00079677|62833652|FG000|Overall Study|Physician Decision|3|||
33536348|NCT00887250|62926092|FG000|Overall Study|Lack of Efficacy|9|||
33536349|NCT00887250|62926093|FG001|Overall Study|Lack of Efficacy|6|||
33536350|NCT00887250|62926094|FG002|Overall Study|Lack of Efficacy|1|||
33326094|NCT01185821|62702835|FG000|Overall Study|Administrative problems|0|||
33326095|NCT01185821|62702836|FG001|Overall Study|Administrative problems|0|||
33326096|NCT01185821|62702837|FG002|Overall Study|Administrative problems|1|||
33460494|NCT00079677|62833653|FG001|Overall Study|Physician Decision|0|||
33460495|NCT00079677|62833652|FG000|Overall Study|Protocol Violation|2|||
33536351|NCT00887250|62926092|FG000|Overall Study|Lost to Follow-up|2|||
33536352|NCT00887250|62926093|FG001|Overall Study|Lost to Follow-up|3|||
33536353|NCT00887250|62926094|FG002|Overall Study|Lost to Follow-up|1|||
33628946|NCT01448824|63030024|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
33628947|NCT02005562|63030054|FG000|Overall Study|Death|2|||
33628948|NCT02005562|63030055|FG001|Overall Study|Death|2|||
33628949|NCT02005562|63030054|FG000|Overall Study|Graft loss|7|||
33628950|NCT02005562|63030055|FG001|Overall Study|Graft loss|6|||
33628951|NCT02005562|63030054|FG000|Overall Study|Withdrawal by Subject|2|||
33628952|NCT02005562|63030055|FG001|Overall Study|Withdrawal by Subject|2|||
33628953|NCT02005562|63030054|FG000|Overall Study|No transplant|1|||
33628954|NCT02005562|63030055|FG001|Overall Study|No transplant|4|||
33628955|NCT02005562|63030054|FG000|Overall Study|Physician Decision|0|||
33628956|NCT02005562|63030055|FG001|Overall Study|Physician Decision|1|||
33628957|NCT01448044|63030063|FG000|Treatment Period|Adverse Event|4|||
33536354|NCT00887250|62926092|FG000|Overall Study|Protocol Violation|2|||
33536355|NCT00887250|62926093|FG001|Overall Study|Protocol Violation|2|||
33536356|NCT00887250|62926094|FG002|Overall Study|Protocol Violation|1|||
33536357|NCT00887250|62926092|FG000|Overall Study|Withdrawal by Subject|2|||
33536358|NCT00887250|62926093|FG001|Overall Study|Withdrawal by Subject|1|||
33536359|NCT00887250|62926094|FG002|Overall Study|Withdrawal by Subject|2|||
33536360|NCT00887250|62926092|FG000|Overall Study|Patient uncooperative|0|||
33536361|NCT00887250|62926093|FG001|Overall Study|Patient uncooperative|0|||
33536362|NCT00887250|62926094|FG002|Overall Study|Patient uncooperative|1|||
33536363|NCT02599402|62926099|FG000|Overall Study|Disease progression|153|||
33536364|NCT02599402|62926099|FG000|Overall Study|Study drug toxicity|201|||
33536365|NCT02599402|62926099|FG000|Overall Study|Death|26|||
33536366|NCT02599402|62926099|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
33536367|NCT02599402|62926099|FG000|Overall Study|Participant request to discontinue study treatment|13|||
33536368|NCT02599402|62926099|FG000|Overall Study|Participant withdrew consent|5|||
33536369|NCT02599402|62926099|FG000|Overall Study|Lost to Follow-up|1|||
33536370|NCT02599402|62926099|FG000|Overall Study|Maximum Clinical Benefit|7|||
33536371|NCT02599402|62926099|FG000|Overall Study|Poor/non-compliance|1|||
33536372|NCT02599402|62926099|FG000|Overall Study|Pregnancy|1|||
33536373|NCT02599402|62926099|FG000|Overall Study|Participant no longer met study criteria|7|||
33536374|NCT02599402|62926099|FG000|Overall Study|Other Reasons|95|||
33536375|NCT02734862|62926139|FG000|Part A|Death|3|||
33536376|NCT02734862|62926140|FG001|Part A|Death|4|||
33536377|NCT02734862|62926141|FG002|Part A|Death|6|||
33536378|NCT02734862|62926139|FG000|Part A|Lost to Follow-up|2|||
33536379|NCT02734862|62926140|FG001|Part A|Lost to Follow-up|1|||
33536380|NCT02734862|62926141|FG002|Part A|Lost to Follow-up|1|||
33536381|NCT02734862|62926139|FG000|Part A|Withdrawal by Subject|1|||
33536382|NCT02734862|62926140|FG001|Part A|Withdrawal by Subject|1|||
33536383|NCT02734862|62926141|FG002|Part A|Withdrawal by Subject|2|||
33536384|NCT02734862|62926139|FG000|Part A|Physician Decision|2|||
33536385|NCT02734862|62926140|FG001|Part A|Physician Decision|0|||
33536386|NCT02734862|62926141|FG002|Part A|Physician Decision|1|||
33536387|NCT02734862|62926139|FG000|Part A|Adverse Event|2|||
33536388|NCT02734862|62926140|FG001|Part A|Adverse Event|0|||
33628958|NCT01448044|63030064|FG001|Treatment Period|Adverse Event|3|||
33628959|NCT01448044|63030063|FG000|Treatment Period|Lack of Efficacy|5|||
33628960|NCT01448044|63030064|FG001|Treatment Period|Lack of Efficacy|12|||
33536389|NCT02734862|62926141|FG002|Part A|Adverse Event|1|||
33536390|NCT02734862|62926139|FG000|Part A|Noncompliance|1|||
33536391|NCT02734862|62926140|FG001|Part A|Noncompliance|1|||
33536392|NCT02734862|62926141|FG002|Part A|Noncompliance|0|||
33536393|NCT02734862|62926139|FG000|Part A|Other|1|||
33536394|NCT02734862|62926140|FG001|Part A|Other|1|||
33536395|NCT02734862|62926141|FG002|Part A|Other|3|||
33628961|NCT01448044|63030063|FG000|Treatment Period|Subject requested discontinue study drug|1|||
33628962|NCT01448044|63030064|FG001|Treatment Period|Subject requested discontinue study drug|0|||
33628963|NCT01448044|63030063|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
33628964|NCT01448044|63030064|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
33628965|NCT01448044|63030063|FG000|Treatment Period|Participant does not meet study criteria|1|||
33628966|NCT01448044|63030064|FG001|Treatment Period|Participant does not meet study criteria|0|||
33628967|NCT01448044|63030063|FG000|Treatment Period|Lost to Follow-up|2|||
33628968|NCT01448044|63030064|FG001|Treatment Period|Lost to Follow-up|1|||
33628969|NCT01448044|63030063|FG000|Treatment Period|Other reason|2|||
33628970|NCT01448044|63030064|FG001|Treatment Period|Other reason|0|||
33628971|NCT01448044|63030063|FG000|Follow Up Period|Withdrawal by Subject|1|||
33628972|NCT01448044|63030064|FG001|Follow Up Period|Withdrawal by Subject|1|||
33628973|NCT01448044|63030063|FG000|Follow Up Period|Lost to Follow-up|6|||
33628974|NCT01448044|63030064|FG001|Follow Up Period|Lost to Follow-up|2|||
33628975|NCT01448044|63030063|FG000|Follow Up Period|Other|5|||
33628976|NCT01448044|63030064|FG001|Follow Up Period|Other|11|||
33628977|NCT02025530|63030072|FG000|Overall Study|No longer met elligibility criteria|5|||
33628978|NCT02025530|63030073|FG001|Overall Study|No longer met elligibility criteria|1|||
33628979|NCT01472380|63030079|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
33628980|NCT01472380|63030079|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
33628981|NCT01978262|63030086|FG000|Overall Study|Withdrawal by Subject|9|||
33628982|NCT01978262|63030086|FG000|Overall Study|Lost to Follow-up|2|||
33628983|NCT01447576|63030091|FG000|Overall Study|Lost to Follow-up|52|||
33628984|NCT01447576|63030091|FG000|Overall Study|Adverse Event|127|||
33628985|NCT01447576|63030091|FG000|Overall Study|Participant met withdrawal criteria|40|||
33628986|NCT01447576|63030091|FG000|Overall Study|Withdrawal by Subject|100|||
33628987|NCT01447576|63030091|FG000|Overall Study|Protocol deviation|83|||
33628988|NCT01447576|63030091|FG000|Overall Study|Lack of Efficacy|68|||
33628989|NCT01447576|63030091|FG000|Overall Study|Physician Decision|6|||
33326097|NCT01185821|62702838|FG003|Overall Study|Administrative problems|1|||
33326098|NCT01185821|62702839|FG004|Overall Study|Administrative problems|2|||
33326099|NCT00893464|62702861|FG000|Overall Study|Did not complete therapy/experience PD|0|||
33326100|NCT00893464|62702862|FG001|Overall Study|Did not complete therapy/experience PD|0|||
33326101|NCT00893464|62702863|FG002|Overall Study|Did not complete therapy/experience PD|0|||
33536396|NCT02734862|62926139|FG000|Part B|Death|8|||
33536397|NCT02734862|62926140|FG001|Part B|Death|3|||
33536398|NCT02734862|62926141|FG002|Part B|Death|5|||
33536399|NCT02734862|62926139|FG000|Part B|Lost to Follow-up|2|||
33536400|NCT02734862|62926140|FG001|Part B|Lost to Follow-up|2|||
33628990|NCT01447420|63030098|FG000|Overall Study|Adverse Event|2|||
33628991|NCT01447420|63030099|FG001|Overall Study|Adverse Event|4|||
33326102|NCT00893464|62702864|FG003|Overall Study|Did not complete therapy/experience PD|0|||
33326103|NCT00893464|62702865|FG004|Overall Study|Did not complete therapy/experience PD|0|||
33326104|NCT00893464|62702866|FG005|Overall Study|Did not complete therapy/experience PD|0|||
33326105|NCT00893464|62702867|FG006|Overall Study|Did not complete therapy/experience PD|2|||
33536401|NCT02734862|62926141|FG002|Part B|Lost to Follow-up|0|||
33628992|NCT01447420|63030100|FG002|Overall Study|Adverse Event|2|||
33628993|NCT01447420|63030098|FG000|Overall Study|Protocol Violation|3|||
33628994|NCT01447420|63030099|FG001|Overall Study|Protocol Violation|3|||
33628995|NCT01447420|63030100|FG002|Overall Study|Protocol Violation|0|||
33628996|NCT01447420|63030098|FG000|Overall Study|Withdrawal by Subject|4|||
33628997|NCT01447420|63030099|FG001|Overall Study|Withdrawal by Subject|1|||
33628998|NCT01447420|63030100|FG002|Overall Study|Withdrawal by Subject|0|||
33628999|NCT01447420|63030098|FG000|Overall Study|Lack of Efficacy|1|||
33629000|NCT01447420|63030099|FG001|Overall Study|Lack of Efficacy|19|||
33326106|NCT00893464|62702868|FG007|Overall Study|Did not complete therapy/experience PD|2|||
33629001|NCT01447420|63030100|FG002|Overall Study|Lack of Efficacy|8|||
33629002|NCT01446874|63030110|FG000|Overall Study|Not eligible|1|||
33629003|NCT01446874|63030111|FG001|Overall Study|Not eligible|0|||
33326107|NCT00891904|62702891|FG000|Overall Study|Death|1|||
33536402|NCT02734862|62926139|FG000|Part B|Withdrawal by Subject|3|||
33536403|NCT02734862|62926140|FG001|Part B|Withdrawal by Subject|1|||
33536404|NCT02734862|62926141|FG002|Part B|Withdrawal by Subject|0|||
33536405|NCT02734862|62926139|FG000|Part B|Other|0|||
33536406|NCT02734862|62926140|FG001|Part B|Other|1|||
33536407|NCT02734862|62926141|FG002|Part B|Other|0|||
33536408|NCT00858702|62926152|FG000|Overall Study|Lack of Efficacy|1|||
33536409|NCT00858702|62926153|FG001|Overall Study|Lack of Efficacy|0|||
33536410|NCT00858702|62926152|FG000|Overall Study|Protocol Violation|1|||
33536411|NCT00858702|62926153|FG001|Overall Study|Protocol Violation|1|||
33536412|NCT00858702|62926152|FG000|Overall Study|Other|2|||
33536413|NCT00858702|62926153|FG001|Overall Study|Other|1|||
33536414|NCT00858702|62926152|FG000|Overall Study|Withdrawal by Subject|1|||
33536415|NCT00858702|62926153|FG001|Overall Study|Withdrawal by Subject|0|||
33536416|NCT02598934|62926161|FG000|Overall Study|Adverse Event|11|||
33536417|NCT02598934|62926162|FG001|Overall Study|Adverse Event|13|||
33536418|NCT02598934|62926161|FG000|Overall Study|Failure to Return|3|||
33536419|NCT02598934|62926162|FG001|Overall Study|Failure to Return|3|||
33536420|NCT02598934|62926161|FG000|Overall Study|Withdrawal by Subject|2|||
33536421|NCT02598934|62926162|FG001|Overall Study|Withdrawal by Subject|3|||
33536422|NCT02598934|62926161|FG000|Overall Study|Administrative|2|||
33536423|NCT02598934|62926162|FG001|Overall Study|Administrative|1|||
33536424|NCT02598934|62926161|FG000|Overall Study|Protocol Violation|1|||
33536425|NCT02598934|62926162|FG001|Overall Study|Protocol Violation|2|||
33536426|NCT02598622|62926170|FG000|Overall Study|Withdrawal by Subject|3|||
33536427|NCT02598622|62926171|FG001|Overall Study|Withdrawal by Subject|0|||
33536428|NCT02598622|62926170|FG000|Overall Study|Physician Decision|3|||
33536429|NCT02598622|62926171|FG001|Overall Study|Physician Decision|0|||
33629004|NCT01446874|63030112|FG002|Overall Study|Not eligible|0|||
33629005|NCT01446874|63030110|FG000|Overall Study|No surgery/No qualifying surgery|1|||
33629006|NCT01446874|63030111|FG001|Overall Study|No surgery/No qualifying surgery|0|||
33629007|NCT01446874|63030112|FG002|Overall Study|No surgery/No qualifying surgery|12|||
33536430|NCT00841698|62926179|FG000|First Intervention|Withdrawal by Subject|1|||
33536431|NCT00841698|62926180|FG001|First Intervention|Withdrawal by Subject|0|||
33536432|NCT00841542|62926186|FG000|Period 1|Adverse Event|1|||
33536433|NCT00841542|62926187|FG001|Period 1|Adverse Event|0|||
33536434|NCT00840216|62926209|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
33536435|NCT00840216|62926210|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
33536436|NCT00836706|62926220|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
33536437|NCT00836706|62926221|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
33536438|NCT00836472|62926227|FG000|Washout|Adverse Event|1|||
33536439|NCT00836472|62926228|FG001|Washout|Adverse Event|2|||
33536440|NCT00836472|62926227|FG000|Washout|Withdrawal by Subject|1|||
33629008|NCT01446874|63030110|FG000|Overall Study|Non-compliance|0|||
33629009|NCT01446874|63030111|FG001|Overall Study|Non-compliance|4|||
33629010|NCT01446874|63030112|FG002|Overall Study|Non-compliance|0|||
33629011|NCT01446874|63030110|FG000|Overall Study|Antibiotics for pre-op infection|0|||
33629012|NCT01446874|63030111|FG001|Overall Study|Antibiotics for pre-op infection|0|||
33629013|NCT01446874|63030112|FG002|Overall Study|Antibiotics for pre-op infection|2|||
33629014|NCT01446874|63030110|FG000|Overall Study|Withdrawal by Subject|0|||
33629015|NCT01446874|63030111|FG001|Overall Study|Withdrawal by Subject|0|||
33629016|NCT01446874|63030112|FG002|Overall Study|Withdrawal by Subject|4|||
33629017|NCT01446796|63030120|FG000|Overall Study|Withdrawal by Subject|1|||
33629018|NCT01446796|63030121|FG001|Overall Study|Withdrawal by Subject|0|||
33629019|NCT01439074|63030131|FG000|Overall Study|Lost to Follow-up|3|||
33629020|NCT01439074|63030132|FG001|Overall Study|Lost to Follow-up|4|||
33629021|NCT01439074|63030131|FG000|Overall Study|Subject shedding|1|||
33460496|NCT00079677|62833653|FG001|Overall Study|Protocol Violation|3|||
33460497|NCT00079677|62833652|FG000|Overall Study|Withdrawal by Subject|5|||
33460498|NCT00079677|62833653|FG001|Overall Study|Withdrawal by Subject|3|||
33460499|NCT00079677|62833652|FG000|Overall Study|Miscellaneous|2|||
33460500|NCT00079677|62833653|FG001|Overall Study|Miscellaneous|0|||
33460501|NCT00095121|62833661|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
33460502|NCT00095121|62833662|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
33460503|NCT00095121|62833661|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
33460504|NCT00095121|62833662|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
33460505|NCT00094809|62833680|FG000|Overall Study|Protocol deviation|2|||
33460506|NCT00094809|62833681|FG001|Overall Study|Protocol deviation|2|||
33460507|NCT00094809|62833680|FG000|Overall Study|Noncompliance|1|||
33536441|NCT00836472|62926228|FG001|Washout|Withdrawal by Subject|1|||
33536442|NCT02598388|62926244|FG000|Overall Study|Lost to Follow-up|1|||
33536443|NCT02598388|62926245|FG001|Overall Study|Lost to Follow-up|0|||
33536444|NCT02598388|62926246|FG002|Overall Study|Lost to Follow-up|1|||
33536445|NCT02598388|62926247|FG003|Overall Study|Lost to Follow-up|0|||
33536446|NCT02598388|62926248|FG004|Overall Study|Lost to Follow-up|5|||
33536447|NCT02598388|62926249|FG005|Overall Study|Lost to Follow-up|1|||
33536448|NCT02598388|62926250|FG006|Overall Study|Lost to Follow-up|2|||
33536449|NCT02598388|62926251|FG007|Overall Study|Lost to Follow-up|1|||
33536450|NCT02598388|62926252|FG008|Overall Study|Lost to Follow-up|0|||
33536451|NCT02598388|62926253|FG009|Overall Study|Lost to Follow-up|0|||
33536452|NCT02598388|62926254|FG010|Overall Study|Lost to Follow-up|1|||
33536453|NCT02598388|62926255|FG011|Overall Study|Lost to Follow-up|0|||
33536454|NCT02598388|62926244|FG000|Overall Study|Withdrawal by Subject|0|||
33536455|NCT02598388|62926245|FG001|Overall Study|Withdrawal by Subject|0|||
33536456|NCT02598388|62926246|FG002|Overall Study|Withdrawal by Subject|0|||
33536457|NCT02598388|62926247|FG003|Overall Study|Withdrawal by Subject|0|||
33536458|NCT02598388|62926248|FG004|Overall Study|Withdrawal by Subject|2|||
33536459|NCT02598388|62926249|FG005|Overall Study|Withdrawal by Subject|0|||
33629022|NCT01439074|63030132|FG001|Overall Study|Subject shedding|0|||
33629023|NCT01439074|63030131|FG000|Overall Study|Withdrawal by Subject|1|||
33629024|NCT01439074|63030132|FG001|Overall Study|Withdrawal by Subject|5|||
33460508|NCT00094809|62833681|FG001|Overall Study|Noncompliance|0|||
33460509|NCT00094809|62833680|FG000|Overall Study|Adverse Event|3|||
33460510|NCT00094809|62833681|FG001|Overall Study|Adverse Event|1|||
33460511|NCT00094809|62833680|FG000|Overall Study|Withdrawal by Subject|8|||
33460512|NCT00094809|62833681|FG001|Overall Study|Withdrawal by Subject|9|||
33460513|NCT00094809|62833680|FG000|Overall Study|Disease progression|3|||
33460514|NCT00094809|62833681|FG001|Overall Study|Disease progression|3|||
33460515|NCT00094809|62833680|FG000|Overall Study|Physician Decision|3|||
33460516|NCT00094809|62833681|FG001|Overall Study|Physician Decision|5|||
33460517|NCT00094809|62833680|FG000|Overall Study|Lost to Follow-up|6|||
33460518|NCT00094809|62833681|FG001|Overall Study|Lost to Follow-up|6|||
33460519|NCT00094809|62833680|FG000|Overall Study|Death|19|||
33460520|NCT00094809|62833681|FG001|Overall Study|Death|25|||
33460521|NCT00094809|62833680|FG000|Overall Study|Protocol-specified criteria|1|||
33460522|NCT00094809|62833681|FG001|Overall Study|Protocol-specified criteria|1|||
33460523|NCT00094809|62833680|FG000|Overall Study|Other|2|||
33460524|NCT00094809|62833681|FG001|Overall Study|Other|4|||
33460525|NCT00094809|62833680|FG000|Overall Study|Informed consent signed after treatment|1|||
33460526|NCT00094809|62833681|FG001|Overall Study|Informed consent signed after treatment|0|||
33460527|NCT00094809|62833680|FG000|Overall Study|Study drug not received|2|||
33460528|NCT00094809|62833681|FG001|Overall Study|Study drug not received|8|||
33460529|NCT00094809|62833680|FG000|Overall Study|Other|1|||
33460530|NCT00094809|62833681|FG001|Overall Study|Other|1|||
33460531|NCT00075218|62833689|FG000|Double-Blind Treatment|Adverse Event|23|||
33460532|NCT00075218|62833690|FG001|Double-Blind Treatment|Adverse Event|4|||
33460533|NCT00075218|62833691|FG002|Double-Blind Treatment|Adverse Event|0|||
33629025|NCT01439074|63030131|FG000|Overall Study|Other|4|||
33629026|NCT01439074|63030132|FG001|Overall Study|Other|4|||
33629027|NCT01438996|63030141|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
33460534|NCT00075218|62833689|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
33460535|NCT00075218|62833690|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
33460536|NCT00075218|62833691|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
33460537|NCT00075218|62833689|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
33460538|NCT00075218|62833690|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
33460539|NCT00075218|62833691|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
33460540|NCT00075218|62833689|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
33460541|NCT00075218|62833690|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
33460542|NCT00075218|62833691|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
33460543|NCT00075218|62833689|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
33460544|NCT00075218|62833690|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
33460545|NCT00075218|62833691|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
33460546|NCT00075218|62833689|FG000|Double-Blind Treatment|No study medication taken|2|||
33460547|NCT00075218|62833690|FG001|Double-Blind Treatment|No study medication taken|0|||
33460548|NCT00075218|62833691|FG002|Double-Blind Treatment|No study medication taken|0|||
33536460|NCT02598388|62926250|FG006|Overall Study|Withdrawal by Subject|2|||
33536461|NCT02598388|62926251|FG007|Overall Study|Withdrawal by Subject|0|||
33536462|NCT02598388|62926252|FG008|Overall Study|Withdrawal by Subject|0|||
33536463|NCT02598388|62926253|FG009|Overall Study|Withdrawal by Subject|1|||
33536464|NCT02598388|62926254|FG010|Overall Study|Withdrawal by Subject|0|||
33536465|NCT02598388|62926255|FG011|Overall Study|Withdrawal by Subject|0|||
33536466|NCT02598388|62926244|FG000|Overall Study|Other|0|||
33460549|NCT00075218|62833689|FG000|Open-Label Treatment|Lack of Efficacy|0|||
33460550|NCT00075218|62833690|FG001|Open-Label Treatment|Lack of Efficacy|0|||
33460551|NCT00075218|62833691|FG002|Open-Label Treatment|Lack of Efficacy|174|||
33536467|NCT02598388|62926245|FG001|Overall Study|Other|0|||
33536468|NCT02598388|62926246|FG002|Overall Study|Other|1|||
33536469|NCT02598388|62926247|FG003|Overall Study|Other|0|||
33460552|NCT00075218|62833689|FG000|Open-Label Treatment|Adverse Event|0|||
33460553|NCT00075218|62833690|FG001|Open-Label Treatment|Adverse Event|0|||
33460554|NCT00075218|62833691|FG002|Open-Label Treatment|Adverse Event|51|||
33460555|NCT00075218|62833689|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
33460556|NCT00075218|62833690|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
33460557|NCT00075218|62833691|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
33460558|NCT00075218|62833689|FG000|Open-Label Treatment|Decision of Sponsor|0|||
33460559|NCT00075218|62833690|FG001|Open-Label Treatment|Decision of Sponsor|0|||
33460560|NCT00075218|62833691|FG002|Open-Label Treatment|Decision of Sponsor|8|||
33460561|NCT00075218|62833689|FG000|Open-Label Treatment|Protocol Violation|0|||
33536470|NCT02598388|62926248|FG004|Overall Study|Other|3|||
33536471|NCT02598388|62926249|FG005|Overall Study|Other|0|||
33536472|NCT02598388|62926250|FG006|Overall Study|Other|1|||
33536473|NCT02598388|62926251|FG007|Overall Study|Other|0|||
33536474|NCT02598388|62926252|FG008|Overall Study|Other|0|||
33536475|NCT02598388|62926253|FG009|Overall Study|Other|0|||
33536476|NCT02598388|62926254|FG010|Overall Study|Other|0|||
33536477|NCT02598388|62926255|FG011|Overall Study|Other|0|||
33536478|NCT00835692|62926295|FG000|First Intervention|Withdrawal by Subject|1|||
33536479|NCT00835692|62926296|FG001|First Intervention|Withdrawal by Subject|0|||
33536480|NCT00835536|62926309|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
33536481|NCT00835536|62926310|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
33536482|NCT03865316|62926314|FG000|Overall Study|Procedure Cancelled|4|||
33536483|NCT03865316|62926314|FG000|Overall Study|Equipment failure|4|||
33536484|NCT02598076|62926320|FG000|Overall Study|Lost to Follow-up|2|||
33536485|NCT02598076|62926321|FG001|Overall Study|Lost to Follow-up|3|||
33536486|NCT02602288|62926329|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
33536487|NCT02602288|62926330|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
33536488|NCT02602288|62926329|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
33536489|NCT02602288|62926330|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
33536490|NCT02602288|62926329|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
33536491|NCT02602288|62926330|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
33536492|NCT02602288|62926329|FG000|12 Month Follow-up|Lost to Follow-up|0|||
33536493|NCT02602288|62926330|FG001|12 Month Follow-up|Lost to Follow-up|4|||
33536494|NCT02602288|62926329|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
33536495|NCT02602288|62926330|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
33536496|NCT02601820|62926336|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
33536497|NCT02601820|62926336|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
33536498|NCT02601820|62926336|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
33536499|NCT02601820|62926336|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
33536500|NCT02807454|62926355|FG000|Overall Study|Adverse Event|1|||
33536501|NCT02807454|62926356|FG001|Overall Study|Adverse Event|0|||
33536502|NCT02807454|62926355|FG000|Overall Study|Withdrawal by Subject|0|||
33536503|NCT02807454|62926356|FG001|Overall Study|Withdrawal by Subject|1|||
33460562|NCT00075218|62833690|FG001|Open-Label Treatment|Protocol Violation|0|||
33460563|NCT00075218|62833691|FG002|Open-Label Treatment|Protocol Violation|1|||
33536504|NCT02807454|62926355|FG000|Overall Study|Progressive Disease|30|||
33536505|NCT02807454|62926356|FG001|Overall Study|Progressive Disease|3|||
33536506|NCT02807454|62926355|FG000|Overall Study|Other Reasons|1|||
33536507|NCT02807454|62926356|FG001|Overall Study|Other Reasons|1|||
33536508|NCT02597920|62926371|FG000|Overall Study|Worsening of other pre-existing disease|0|||
33536509|NCT02597920|62926372|FG001|Overall Study|Worsening of other pre-existing disease|1|||
33536510|NCT02597920|62926373|FG002|Overall Study|Worsening of other pre-existing disease|0|||
33536511|NCT02597920|62926371|FG000|Overall Study|Other adverse event|20|||
33536512|NCT02597920|62926372|FG001|Overall Study|Other adverse event|30|||
33536513|NCT02597920|62926373|FG002|Overall Study|Other adverse event|0|||
33536514|NCT02597920|62926371|FG000|Overall Study|Lost to Follow-up|7|||
33536515|NCT02597920|62926372|FG001|Overall Study|Lost to Follow-up|9|||
33536516|NCT02597920|62926373|FG002|Overall Study|Lost to Follow-up|0|||
33536517|NCT02597920|62926371|FG000|Overall Study|Refuse to continue in the study|3|||
33536518|NCT02597920|62926372|FG001|Overall Study|Refuse to continue in the study|13|||
33536519|NCT02597920|62926373|FG002|Overall Study|Refuse to continue in the study|1|||
33536520|NCT02597920|62926371|FG000|Overall Study|Other than specified|10|||
33629028|NCT01438996|63030142|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
33629029|NCT01438996|63030143|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
33629030|NCT01438840|63030153|FG000|Core Study|Adverse Event|0|||
33629031|NCT01438840|63030154|FG001|Core Study|Adverse Event|3|||
33629032|NCT01438840|63030155|FG002|Core Study|Adverse Event|0|||
33326108|NCT00891904|62702891|FG000|Overall Study|Adverse Event|1|||
33536521|NCT02597920|62926372|FG001|Overall Study|Other than specified|31|||
33536522|NCT02597920|62926373|FG002|Overall Study|Other than specified|5|||
33629033|NCT01438840|63030153|FG000|Core Study|Lack of Efficacy|15|||
33629034|NCT01438840|63030154|FG001|Core Study|Lack of Efficacy|7|||
33629035|NCT01438840|63030155|FG002|Core Study|Lack of Efficacy|0|||
33629036|NCT01438840|63030153|FG000|Core Study|Withdrawal of consent|1|||
33629037|NCT01438840|63030154|FG001|Core Study|Withdrawal of consent|0|||
33629038|NCT01438840|63030155|FG002|Core Study|Withdrawal of consent|0|||
33629039|NCT01438840|63030153|FG000|Extension Phase|Adverse Event|0|||
33629040|NCT01438840|63030154|FG001|Extension Phase|Adverse Event|0|||
33536523|NCT02597920|62926371|FG000|Overall Study|Other|1|||
33536524|NCT02597920|62926372|FG001|Overall Study|Other|0|||
33536525|NCT02597920|62926373|FG002|Overall Study|Other|0|||
33536526|NCT01235234|62926393|FG000|Overall Study|Adverse Event|2|||
33536527|NCT01235234|62926394|FG001|Overall Study|Adverse Event|2|||
33536528|NCT01235234|62926395|FG002|Overall Study|Adverse Event|1|||
33536529|NCT02597452|62926410|FG000|Overall Study|testing incomplete|30|||
33536530|NCT00834756|62926416|FG000|First Intervention|Adverse Event|1|||
33536531|NCT00834756|62926417|FG001|First Intervention|Adverse Event|0|||
33536532|NCT00834756|62926416|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
33536533|NCT00834756|62926417|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
33536534|NCT00828854|62926421|FG000|Overall Study|Disease Progression|17|||
33536535|NCT00828854|62926421|FG000|Overall Study|Adverse Event|9|||
33536536|NCT00828854|62926421|FG000|Overall Study|Reason not Specified|1|||
33536537|NCT00834522|62926427|FG000|Washout|Adverse Event|1|||
33536538|NCT00834522|62926428|FG001|Washout|Adverse Event|0|||
33536539|NCT00834522|62926427|FG000|Washout|Withdrawal by Subject|2|||
33536540|NCT00834522|62926428|FG001|Washout|Withdrawal by Subject|1|||
33536541|NCT00834444|62926434|FG000|First Intervention|Adverse Event|1|||
33536542|NCT00834444|62926435|FG001|First Intervention|Adverse Event|0|||
33536543|NCT00834444|62926434|FG000|First Intervention|Intolerance to Venopuncture|0|||
33536544|NCT00834444|62926435|FG001|First Intervention|Intolerance to Venopuncture|1|||
33536545|NCT00834444|62926434|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
33629041|NCT01438840|63030155|FG002|Extension Phase|Adverse Event|3|||
33629042|NCT01438840|63030153|FG000|Extension Phase|Lost to Follow-up|0|||
33629043|NCT01438840|63030154|FG001|Extension Phase|Lost to Follow-up|0|||
33629044|NCT01438840|63030155|FG002|Extension Phase|Lost to Follow-up|1|||
33629045|NCT01438840|63030153|FG000|Extension Phase|Withdrawal by Subject|0|||
33629046|NCT01438840|63030154|FG001|Extension Phase|Withdrawal by Subject|0|||
33629047|NCT01438840|63030155|FG002|Extension Phase|Withdrawal by Subject|3|||
33629048|NCT01438840|63030153|FG000|Extension Phase|Lack of Efficacy|0|||
33629049|NCT01438840|63030154|FG001|Extension Phase|Lack of Efficacy|0|||
33629050|NCT01438840|63030155|FG002|Extension Phase|Lack of Efficacy|2|||
33536546|NCT00834444|62926435|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
33536547|NCT00834444|62926434|FG000|Second Intervention|Adverse Event|1|||
33536548|NCT00834444|62926435|FG001|Second Intervention|Adverse Event|0|||
33536549|NCT02605954|62926455|FG000|Overall Study|Adverse Event|5|||
33536550|NCT02605954|62926456|FG001|Overall Study|Adverse Event|1|||
33536551|NCT02605954|62926455|FG000|Overall Study|Investigator's Discretion|1|||
33536552|NCT02605954|62926456|FG001|Overall Study|Investigator's Discretion|0|||
33536553|NCT02605954|62926455|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33536554|NCT02605954|62926456|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33536555|NCT02605954|62926455|FG000|Overall Study|Withdrew Consent|2|||
33629051|NCT01438840|63030153|FG000|Extension Phase|Other|0|||
33629052|NCT01438840|63030154|FG001|Extension Phase|Other|0|||
33536556|NCT02605954|62926456|FG001|Overall Study|Withdrew Consent|2|||
33536557|NCT02605954|62926455|FG000|Overall Study|Lost to Follow-up|3|||
33536558|NCT02605954|62926456|FG001|Overall Study|Lost to Follow-up|0|||
33536559|NCT02605954|62926455|FG000|Overall Study|Randomized but not treated|0|||
33536560|NCT02605954|62926456|FG001|Overall Study|Randomized but not treated|1|||
33536561|NCT00724698|62926465|FG000|Overall Study|Adverse Event|9|||
33536562|NCT00724698|62926465|FG000|Overall Study|Failure of Therapy|4|||
33536563|NCT00724698|62926465|FG000|Overall Study|Poor Compliance|16|||
33536564|NCT00724698|62926465|FG000|Overall Study|Lost to Follow-up|36|||
33536565|NCT00724698|62926465|FG000|Overall Study|No Info|25|||
33536566|NCT00829998|62926470|FG000|Washout|Adverse Event|0|||
33536567|NCT00829998|62926471|FG001|Washout|Adverse Event|1|||
33536568|NCT00829764|62926482|FG000|First Intervention|Adverse Event|1|||
33536569|NCT00829764|62926483|FG001|First Intervention|Adverse Event|0|||
33536570|NCT00829764|62926482|FG000|First Intervention|Withdrawal by Subject|1|||
33536571|NCT00829764|62926483|FG001|First Intervention|Withdrawal by Subject|1|||
33536572|NCT00829530|62926505|FG000|First Intervention|Adverse Event|0|||
33536573|NCT00829530|62926506|FG001|First Intervention|Adverse Event|1|||
33536574|NCT00829530|62926505|FG000|First Intervention|Intolerance to Venopuncture|0|||
33536575|NCT00829530|62926506|FG001|First Intervention|Intolerance to Venopuncture|1|||
33536576|NCT00829530|62926505|FG000|Second Intervention|Intolerance to Venopuncture|1|||
33536577|NCT00829530|62926506|FG001|Second Intervention|Intolerance to Venopuncture|0|||
33536578|NCT01377194|62926513|FG000|Overall Study|Adverse Event|3|||
33536579|NCT01377194|62926514|FG001|Overall Study|Adverse Event|12|||
33536580|NCT01377194|62926515|FG002|Overall Study|Adverse Event|19|||
33536581|NCT01377194|62926513|FG000|Overall Study|Lack of Efficacy|3|||
33536582|NCT01377194|62926514|FG001|Overall Study|Lack of Efficacy|3|||
33536583|NCT01377194|62926515|FG002|Overall Study|Lack of Efficacy|3|||
33536584|NCT01377194|62926513|FG000|Overall Study|Protocol Violation|4|||
33536585|NCT01377194|62926514|FG001|Overall Study|Protocol Violation|10|||
33536586|NCT01377194|62926515|FG002|Overall Study|Protocol Violation|6|||
33536587|NCT01377194|62926513|FG000|Overall Study|Withdrawal by Subject|8|||
33536588|NCT01377194|62926514|FG001|Overall Study|Withdrawal by Subject|10|||
33536589|NCT01377194|62926515|FG002|Overall Study|Withdrawal by Subject|7|||
33536590|NCT01377194|62926513|FG000|Overall Study|Lost to Follow-up|14|||
33536591|NCT01377194|62926514|FG001|Overall Study|Lost to Follow-up|8|||
33536592|NCT01377194|62926515|FG002|Overall Study|Lost to Follow-up|11|||
33536593|NCT00829452|62926528|FG000|First Intervention|Withdrawal by Subject|0|||
33536594|NCT00829452|62926529|FG001|First Intervention|Withdrawal by Subject|1|||
33536595|NCT00829452|62926528|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
33536596|NCT00829452|62926529|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
33536597|NCT00829452|62926528|FG000|Second Intervention|Physician Decision|0|||
33536598|NCT00829452|62926529|FG001|Second Intervention|Physician Decision|1|||
33536599|NCT04600076|62926533|FG000|Overall Study|Lost to Follow-up|3|||
33629053|NCT01438840|63030155|FG002|Extension Phase|Other|1|||
33536600|NCT02064387|62926549|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33536601|NCT02064387|62926550|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33536602|NCT02064387|62926551|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33536603|NCT02064387|62926552|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33536604|NCT02064387|62926553|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33629054|NCT01471054|63030164|FG000|Overall Study|Study terminated prematurely|4|||
33536605|NCT02064387|62926554|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33536606|NCT02064387|62926555|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33536607|NCT02064387|62926556|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
33536608|NCT02064387|62926557|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33460564|NCT00075218|62833689|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
33536609|NCT02064387|62926558|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
33536610|NCT02064387|62926559|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33536611|NCT02064387|62926560|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33536612|NCT02064387|62926549|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33536613|NCT02064387|62926550|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33536614|NCT02064387|62926551|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33536615|NCT02064387|62926552|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33536616|NCT02064387|62926553|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33536617|NCT02064387|62926554|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33536618|NCT02064387|62926555|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33536619|NCT02064387|62926556|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
33536620|NCT02064387|62926557|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33536621|NCT02064387|62926558|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33536622|NCT02064387|62926559|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33629055|NCT01471054|63030165|FG001|Overall Study|Study terminated prematurely|0|||
33629056|NCT01978184|63030183|FG000|Overall Study|Progressive disease|5|||
33629057|NCT01978184|63030184|FG001|Overall Study|Progressive disease|5|||
33629058|NCT01978184|63030183|FG000|Overall Study|Other than PDA|2|||
33629059|NCT01978184|63030184|FG001|Overall Study|Other than PDA|2|||
33629060|NCT01978184|63030183|FG000|Overall Study|Physician Decision|0|||
33629061|NCT01978184|63030184|FG001|Overall Study|Physician Decision|3|||
33629062|NCT01978184|63030183|FG000|Overall Study|Noncompliance|1|||
33629063|NCT01978184|63030184|FG001|Overall Study|Noncompliance|2|||
33629064|NCT01978184|63030183|FG000|Overall Study|Death|1|||
33629065|NCT01978184|63030184|FG001|Overall Study|Death|0|||
33629066|NCT01978184|63030183|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
33629067|NCT01978184|63030184|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
33629068|NCT01445548|63030190|FG000|Overall Study|Adverse Event|1|||
33629069|NCT01977794|63030196|FG000|Overall Study|Adverse Event|2|||
33629070|NCT01977794|63030197|FG001|Overall Study|Adverse Event|2|||
33629071|NCT01977794|63030196|FG000|Overall Study|Lost to Follow-up|2|||
33629072|NCT01977794|63030197|FG001|Overall Study|Lost to Follow-up|1|||
33629073|NCT01977794|63030196|FG000|Overall Study|Protocol Violation|1|||
33629074|NCT01977794|63030197|FG001|Overall Study|Protocol Violation|0|||
33629075|NCT01977794|63030196|FG000|Overall Study|Death|1|||
33629076|NCT01977794|63030197|FG001|Overall Study|Death|1|||
33629077|NCT01977794|63030196|FG000|Overall Study|Withdrew consent|2|||
33629078|NCT01977794|63030197|FG001|Overall Study|Withdrew consent|1|||
33629079|NCT01977794|63030196|FG000|Overall Study|Other|0|||
33629080|NCT01977794|63030197|FG001|Overall Study|Other|1|||
33629081|NCT02005484|63030203|FG000|Overall Study|Death|1|||
33460565|NCT00075218|62833690|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
33460566|NCT00075218|62833691|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
33460567|NCT00094653|62833701|FG000|Overall Study|Death|306|||
33460568|NCT00094653|62833702|FG001|Overall Study|Death|100|||
33460569|NCT00094653|62833703|FG002|Overall Study|Death|119|||
33460570|NCT00094653|62833701|FG000|Overall Study|Subject Withdrew Consent|10|||
33460571|NCT00094653|62833702|FG001|Overall Study|Subject Withdrew Consent|2|||
33460572|NCT00094653|62833703|FG002|Overall Study|Subject Withdrew Consent|3|||
33460573|NCT00094653|62833701|FG000|Overall Study|Other|2|||
33460574|NCT00094653|62833702|FG001|Overall Study|Other|2|||
33460575|NCT00094653|62833703|FG002|Overall Study|Other|2|||
33460576|NCT00094653|62833701|FG000|Overall Study|Lost to Follow-up|3|||
33460577|NCT00094653|62833702|FG001|Overall Study|Lost to Follow-up|2|||
33460578|NCT00094653|62833703|FG002|Overall Study|Lost to Follow-up|1|||
33460579|NCT00094653|62833701|FG000|Overall Study|Protocol Violation|0|||
33460580|NCT00094653|62833702|FG001|Overall Study|Protocol Violation|0|||
33536623|NCT02064387|62926560|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33536624|NCT02064387|62926549|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33629082|NCT02005484|63030203|FG000|Overall Study|Disease progression|1|||
33629083|NCT02005484|63030203|FG000|Overall Study|Changed to a Different Study|1|||
33460581|NCT00094653|62833703|FG002|Overall Study|Protocol Violation|1|||
33460582|NCT00104247|62833714|FG000|Overall Study|Withdrawal by Subject|1|||
33629084|NCT02005484|63030203|FG000|Overall Study|Sponsor decision|1|||
33629085|NCT02005250|63030209|FG000|Overall Study|Lost to Follow-up|15|||
33460583|NCT00104247|62833715|FG001|Overall Study|Withdrawal by Subject|0|||
33460584|NCT00104247|62833714|FG000|Overall Study|Noncompliant with dosing|0|||
33460585|NCT00104247|62833715|FG001|Overall Study|Noncompliant with dosing|1|||
33460586|NCT03591406|62833723|FG000|Overall Study|Adverse Event|5|||
33460587|NCT03591406|62833724|FG001|Overall Study|Adverse Event|3|||
33460588|NCT03591406|62833723|FG000|Overall Study|Protocol Violation|2|||
33629086|NCT02005250|63030210|FG001|Overall Study|Lost to Follow-up|5|||
33629087|NCT02024750|63030218|FG000|Overall Study|Withdrawal by Subject|2|||
33629088|NCT02024750|63030219|FG001|Overall Study|Withdrawal by Subject|1|||
33629089|NCT01597973|63030227|FG000|Overall Study|Found ineligible before study medication started|4|||
33629090|NCT01597973|63030228|FG001|Overall Study|Found ineligible before study medication started|2|||
33629091|NCT01597973|63030227|FG000|Overall Study|Eligible pathogen not confirmed|14|||
33629092|NCT01597973|63030228|FG001|Overall Study|Eligible pathogen not confirmed|15|||
33629093|NCT01597973|63030227|FG000|Overall Study|LAR not authorized to consent|0|||
33629094|NCT01597973|63030228|FG001|Overall Study|LAR not authorized to consent|1|||
33536625|NCT02064387|62926550|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33536626|NCT02064387|62926551|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33536627|NCT02064387|62926552|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33536628|NCT02064387|62926553|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33536629|NCT02064387|62926554|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33536630|NCT02064387|62926555|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33536631|NCT02064387|62926556|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33536632|NCT02064387|62926557|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
33536633|NCT02064387|62926558|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33536634|NCT02064387|62926559|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33536635|NCT02064387|62926560|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33536636|NCT02064387|62926549|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
33536637|NCT02064387|62926550|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
33536638|NCT02064387|62926551|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
33536639|NCT02064387|62926552|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
33536640|NCT02064387|62926553|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
33536641|NCT02064387|62926554|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
33536642|NCT02064387|62926555|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
33536643|NCT02064387|62926556|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
33326109|NCT01157351|62702897|FG000|Overall Study|Adverse Event|5|||
33326110|NCT01157351|62702898|FG001|Overall Study|Adverse Event|4|||
33326111|NCT01157351|62702897|FG000|Overall Study|Death|1|||
33326112|NCT01157351|62702898|FG001|Overall Study|Death|0|||
33326113|NCT01157351|62702897|FG000|Overall Study|Lost to Follow-up|53|||
33326114|NCT01157351|62702898|FG001|Overall Study|Lost to Follow-up|55|||
33326115|NCT01157351|62702897|FG000|Overall Study|Withdrawal by Subject|37|||
33326116|NCT01157351|62702898|FG001|Overall Study|Withdrawal by Subject|27|||
33326117|NCT01157351|62702897|FG000|Overall Study|Physician Decision|5|||
33326118|NCT01157351|62702898|FG001|Overall Study|Physician Decision|4|||
33326119|NCT01157351|62702897|FG000|Overall Study|Protocol Violation|0|||
33536644|NCT02064387|62926557|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
33536645|NCT02064387|62926558|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
33536646|NCT02064387|62926559|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
33536647|NCT02064387|62926560|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
33536648|NCT02064387|62926549|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33629095|NCT01597973|63030227|FG000|Overall Study|Ineligible due to early seizures|1|||
33326120|NCT01157351|62702898|FG001|Overall Study|Protocol Violation|1|||
33326121|NCT01157351|62702897|FG000|Overall Study|Other|32|||
33326122|NCT01157351|62702898|FG001|Overall Study|Other|36|||
33326123|NCT01157351|62702897|FG000|Overall Study|Noncompliance with Study Drug|0|||
33326124|NCT01157351|62702898|FG001|Overall Study|Noncompliance with Study Drug|3|||
33460589|NCT03591406|62833724|FG001|Overall Study|Protocol Violation|1|||
33460590|NCT03591406|62833723|FG000|Overall Study|Withdrawal by Subject|0|||
33460591|NCT03591406|62833724|FG001|Overall Study|Withdrawal by Subject|5|||
33460592|NCT03560986|62833732|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
33460593|NCT03560986|62833733|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
33460594|NCT03560986|62833732|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
33460595|NCT03560986|62833733|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
33460596|NCT03560986|62833732|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
33460597|NCT03560986|62833733|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
33460598|NCT03560986|62833732|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
33460599|NCT03560986|62833733|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
33460600|NCT03560986|62833732|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
33460601|NCT03560986|62833733|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
33326125|NCT01157351|62702897|FG000|Overall Study|Randomized but not Treated|4|||
33629096|NCT01597973|63030228|FG001|Overall Study|Ineligible due to early seizures|0|||
33629097|NCT01597973|63030227|FG000|Overall Study|Ineligible due to non-target infection|1|||
33629098|NCT01597973|63030228|FG001|Overall Study|Ineligible due to non-target infection|1|||
33629099|NCT02023268|63030238|FG000|Overall Study|Lack of Efficacy|0|||
33536649|NCT02064387|62926550|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33536650|NCT02064387|62926551|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33536651|NCT02064387|62926552|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33536652|NCT02064387|62926553|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33536653|NCT02064387|62926554|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33536654|NCT02064387|62926555|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33536655|NCT02064387|62926556|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33629100|NCT02023268|63030239|FG001|Overall Study|Lack of Efficacy|1|||
33629101|NCT02023268|63030238|FG000|Overall Study|Adverse Event|0|||
33629102|NCT02023268|63030239|FG001|Overall Study|Adverse Event|2|||
33629103|NCT02023268|63030238|FG000|Overall Study|Withdrawal by Subject|0|||
33629104|NCT02023268|63030239|FG001|Overall Study|Withdrawal by Subject|1|||
33629105|NCT02047253|63030245|FG000|Overall Study|Lost to Follow-up|8|||
33629106|NCT02096705|63030251|FG000|Treatment|Adverse Event|6|||
33629107|NCT02096705|63030252|FG001|Treatment|Adverse Event|3|||
33629108|NCT02096705|63030251|FG000|Treatment|Subject request to discontinue treatment|1|||
33629109|NCT02096705|63030252|FG001|Treatment|Subject request to discontinue treatment|1|||
33629110|NCT02096705|63030251|FG000|Treatment|Withdrawal by Subject|1|||
33629111|NCT02096705|63030252|FG001|Treatment|Withdrawal by Subject|0|||
33629112|NCT02096705|63030251|FG000|Treatment|Other|1|||
33629113|NCT02096705|63030252|FG001|Treatment|Other|1|||
33629114|NCT02096705|63030251|FG000|Follow-up|Withdrawal by Subject|1|||
33629115|NCT02096705|63030252|FG001|Follow-up|Withdrawal by Subject|0|||
33629116|NCT02096705|63030251|FG000|Follow-up|Adverse Event|2|||
33629117|NCT02096705|63030252|FG001|Follow-up|Adverse Event|2|||
33629118|NCT02096705|63030251|FG000|Follow-up|Subjects not reporting status|1|||
33629119|NCT02096705|63030252|FG001|Follow-up|Subjects not reporting status|2|||
33629120|NCT02096471|63030258|FG000|Overall Study|Adverse Event|1|||
33629121|NCT02096471|63030258|FG000|Overall Study|Lack of Efficacy|7|||
33326126|NCT01157351|62702898|FG001|Overall Study|Randomized but not Treated|2|||
33326127|NCT01157117|62702907|FG000|Overall Study|Dosing Symptoms|0|||
33326128|NCT01157117|62702908|FG001|Overall Study|Dosing Symptoms|4|||
33460602|NCT03560986|62833732|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
33460603|NCT03560986|62833733|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
33460604|NCT03560986|62833732|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
33460605|NCT03560986|62833733|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
33460606|NCT03560518|62833748|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
33460607|NCT03560518|62833749|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
33460608|NCT03560518|62833750|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
33536656|NCT02064387|62926557|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33536657|NCT02064387|62926558|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33536658|NCT02064387|62926559|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
33536659|NCT02064387|62926560|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33536660|NCT01328366|62926599|FG000|Overall Study|Death|1|||
33536661|NCT01328366|62926599|FG000|Overall Study|Withdrawal by Subject|2|||
33536662|NCT01328366|62926599|FG000|Overall Study|Lost to Follow-up|7|||
33536663|NCT03256344|62926605|FG000|Overall Study|Death|6|||
33536664|NCT03256344|62926606|FG001|Overall Study|Death|22|||
33536665|NCT03256344|62926605|FG000|Overall Study|Withdrawal by Subject|3|||
33536666|NCT03256344|62926606|FG001|Overall Study|Withdrawal by Subject|3|||
33536667|NCT03256344|62926605|FG000|Overall Study|Sponsor Decision|1|||
33536668|NCT03256344|62926606|FG001|Overall Study|Sponsor Decision|0|||
33536669|NCT01370499|62926614|FG000|Overall Study|Adverse Event|38|||
33536670|NCT01370499|62926615|FG001|Overall Study|Adverse Event|12|||
33536671|NCT01370499|62926614|FG000|Overall Study|Lack of Efficacy|4|||
33536672|NCT01370499|62926615|FG001|Overall Study|Lack of Efficacy|2|||
33536673|NCT01370499|62926614|FG000|Overall Study|Lost to Follow-up|2|||
33629122|NCT02096471|63030258|FG000|Overall Study|Withdrawal by Subject|3|||
33536674|NCT01370499|62926615|FG001|Overall Study|Lost to Follow-up|1|||
33629123|NCT02096471|63030258|FG000|Overall Study|Non-Compliant|2|||
33629124|NCT02096003|63030264|FG000|Overall Study|Protocol Violation|0|||
33629125|NCT02096003|63030265|FG001|Overall Study|Protocol Violation|2|||
33629126|NCT02096003|63030264|FG000|Overall Study|additional surgery|2|||
33629127|NCT02096003|63030265|FG001|Overall Study|additional surgery|1|||
33629128|NCT02062385|63030275|FG000|Overall Study|Adverse Event|19|||
33536675|NCT01370499|62926614|FG000|Overall Study|Physician Decision|3|||
33536676|NCT01370499|62926615|FG001|Overall Study|Physician Decision|3|||
33536677|NCT01370499|62926614|FG000|Overall Study|Protocol Violation|5|||
33536678|NCT01370499|62926615|FG001|Overall Study|Protocol Violation|4|||
33536679|NCT01370499|62926614|FG000|Overall Study|Withdrawal by Subject|18|||
33536680|NCT01370499|62926615|FG001|Overall Study|Withdrawal by Subject|7|||
33536681|NCT01370499|62926614|FG000|Overall Study|Sponsor Decision|41|||
33536682|NCT01370499|62926615|FG001|Overall Study|Sponsor Decision|15|||
33536683|NCT01370265|62926623|FG000|First Intervention|Adverse Event|1|||
33536684|NCT01370265|62926624|FG001|First Intervention|Adverse Event|1|||
33536685|NCT02792829|62926662|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
33536686|NCT02792829|62926663|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
33536687|NCT02792829|62926664|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
33536688|NCT02792829|62926665|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
33536689|NCT02792829|62926666|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
33536690|NCT02792829|62926667|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
33536691|NCT02792829|62926668|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
33536692|NCT02792829|62926669|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
33536693|NCT02792829|62926662|FG000|Treatment Period 2|Adverse Event|0|||
33536694|NCT02792829|62926663|FG001|Treatment Period 2|Adverse Event|0|||
33536695|NCT02792829|62926664|FG002|Treatment Period 2|Adverse Event|0|||
33536696|NCT02792829|62926665|FG003|Treatment Period 2|Adverse Event|0|||
33536697|NCT02792829|62926666|FG004|Treatment Period 2|Adverse Event|1|||
33536698|NCT02792829|62926667|FG005|Treatment Period 2|Adverse Event|0|||
33536699|NCT02792829|62926668|FG006|Treatment Period 2|Adverse Event|1|||
33536700|NCT02792829|62926669|FG007|Treatment Period 2|Adverse Event|1|||
33536701|NCT02792829|62926662|FG000|Treatment Period 2|Use of proscribed medications|0|||
33536702|NCT02792829|62926663|FG001|Treatment Period 2|Use of proscribed medications|0|||
33536703|NCT02792829|62926664|FG002|Treatment Period 2|Use of proscribed medications|0|||
33536704|NCT02792829|62926665|FG003|Treatment Period 2|Use of proscribed medications|0|||
33536705|NCT02792829|62926666|FG004|Treatment Period 2|Use of proscribed medications|0|||
33536706|NCT02792829|62926667|FG005|Treatment Period 2|Use of proscribed medications|0|||
33536707|NCT02792829|62926668|FG006|Treatment Period 2|Use of proscribed medications|0|||
33536708|NCT02792829|62926669|FG007|Treatment Period 2|Use of proscribed medications|1|||
33536709|NCT02867592|62926701|FG000|Overall Study|Adverse Event|3|||
33536710|NCT02867592|62926702|FG001|Overall Study|Adverse Event|0|||
33536711|NCT02867592|62926703|FG002|Overall Study|Adverse Event|2|||
33536712|NCT02867592|62926704|FG003|Overall Study|Adverse Event|1|||
33536713|NCT02867592|62926705|FG004|Overall Study|Adverse Event|1|||
33536714|NCT02867592|62926706|FG005|Overall Study|Adverse Event|5|||
33536715|NCT02867592|62926701|FG000|Overall Study|Death|0|||
33536716|NCT02867592|62926702|FG001|Overall Study|Death|0|||
33536717|NCT02867592|62926703|FG002|Overall Study|Death|0|||
33536718|NCT02867592|62926704|FG003|Overall Study|Death|1|||
33536719|NCT02867592|62926705|FG004|Overall Study|Death|0|||
33536720|NCT02867592|62926706|FG005|Overall Study|Death|1|||
33536721|NCT02867592|62926701|FG000|Overall Study|Lack of Efficacy|8|||
33629129|NCT02062385|63030276|FG001|Overall Study|Adverse Event|13|||
33629130|NCT02062385|63030277|FG002|Overall Study|Adverse Event|1|||
33460609|NCT03560518|62833748|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
33460610|NCT03560518|62833749|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
33460611|NCT03560518|62833750|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
33460612|NCT03560518|62833748|FG000|Double Blind Treatment Period|Protocol Violation|1|||
33460613|NCT03560518|62833749|FG001|Double Blind Treatment Period|Protocol Violation|2|||
33460614|NCT03560518|62833750|FG002|Double Blind Treatment Period|Protocol Violation|0|||
33460615|NCT03560518|62833748|FG000|Double Blind Treatment Period|Pregnancy|0|||
33460616|NCT03560518|62833749|FG001|Double Blind Treatment Period|Pregnancy|2|||
33460617|NCT03560518|62833750|FG002|Double Blind Treatment Period|Pregnancy|0|||
33460618|NCT03560518|62833748|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
33460619|NCT03560518|62833749|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
33460620|NCT03560518|62833750|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
33460621|NCT03560518|62833748|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
33460622|NCT03560518|62833749|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
33460623|NCT03560518|62833750|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
33460624|NCT03560518|62833748|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
33460625|NCT03560518|62833749|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
33460626|NCT03560518|62833750|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
33460627|NCT03560518|62833748|FG000|Double Blind Treatment Period|Adverse Event|0|||
33460628|NCT03560518|62833749|FG001|Double Blind Treatment Period|Adverse Event|3|||
33460629|NCT03560518|62833750|FG002|Double Blind Treatment Period|Adverse Event|1|||
33460630|NCT03560206|62833760|FG000|Overall Study|Lost to Follow-up|19|||
33460631|NCT03560206|62833761|FG001|Overall Study|Lost to Follow-up|11|||
33460632|NCT03560206|62833760|FG000|Overall Study|Withdrawal by Subject|2|||
33536722|NCT02867592|62926702|FG001|Overall Study|Lack of Efficacy|10|||
33536723|NCT02867592|62926703|FG002|Overall Study|Lack of Efficacy|8|||
33536724|NCT02867592|62926704|FG003|Overall Study|Lack of Efficacy|8|||
33536725|NCT02867592|62926705|FG004|Overall Study|Lack of Efficacy|12|||
33536726|NCT02867592|62926706|FG005|Overall Study|Lack of Efficacy|17|||
33536727|NCT02867592|62926701|FG000|Overall Study|Physician Decision|1|||
33536728|NCT02867592|62926702|FG001|Overall Study|Physician Decision|2|||
33536729|NCT02867592|62926703|FG002|Overall Study|Physician Decision|2|||
33536730|NCT02867592|62926704|FG003|Overall Study|Physician Decision|0|||
33536731|NCT02867592|62926705|FG004|Overall Study|Physician Decision|5|||
33536732|NCT02867592|62926706|FG005|Overall Study|Physician Decision|1|||
33536733|NCT02867592|62926701|FG000|Overall Study|Protocol Violation|0|||
33536734|NCT02867592|62926702|FG001|Overall Study|Protocol Violation|0|||
33536735|NCT02867592|62926703|FG002|Overall Study|Protocol Violation|0|||
33536736|NCT02867592|62926704|FG003|Overall Study|Protocol Violation|0|||
33536737|NCT02867592|62926705|FG004|Overall Study|Protocol Violation|1|||
33536738|NCT02867592|62926706|FG005|Overall Study|Protocol Violation|1|||
33536739|NCT02867592|62926701|FG000|Overall Study|Withdrawal by Subject|0|||
33536740|NCT02867592|62926702|FG001|Overall Study|Withdrawal by Subject|1|||
33536741|NCT02867592|62926703|FG002|Overall Study|Withdrawal by Subject|0|||
33326129|NCT01157117|62702909|FG002|Overall Study|Dosing Symptoms|0|||
33460633|NCT03560206|62833761|FG001|Overall Study|Withdrawal by Subject|4|||
33460634|NCT03560206|62833760|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
33460635|NCT03560206|62833761|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
33460636|NCT03560206|62833760|FG000|Overall Study|Busy schedule|14|||
33460637|NCT03560206|62833761|FG001|Overall Study|Busy schedule|2|||
33460638|NCT03560206|62833760|FG000|Overall Study|patients' new health condition such as cancer|10|||
33460639|NCT03560206|62833761|FG001|Overall Study|patients' new health condition such as cancer|1|||
33460640|NCT02892760|62833767|FG000|Overall Study|Withdrawal by Subject|3|||
33460641|NCT03635086|62833776|FG000|Overall Study|Withdrawal of consent|0|||
33460642|NCT03635086|62833777|FG001|Overall Study|Withdrawal of consent|0|||
33536742|NCT02867592|62926704|FG003|Overall Study|Withdrawal by Subject|1|||
33326130|NCT01157117|62702907|FG000|Overall Study|Withdrawal by Subject|4|||
33460643|NCT03635086|62833778|FG002|Overall Study|Withdrawal of consent|1|||
33460644|NCT03635086|62833779|FG003|Overall Study|Withdrawal of consent|0|||
33460645|NCT03635086|62833780|FG004|Overall Study|Withdrawal of consent|0|||
33536743|NCT02867592|62926705|FG004|Overall Study|Withdrawal by Subject|3|||
33536744|NCT02867592|62926706|FG005|Overall Study|Withdrawal by Subject|3|||
33536745|NCT02867592|62926701|FG000|Overall Study|Ineligible|1|||
33536746|NCT02867592|62926702|FG001|Overall Study|Ineligible|1|||
33536747|NCT02867592|62926703|FG002|Overall Study|Ineligible|0|||
33536748|NCT02867592|62926704|FG003|Overall Study|Ineligible|0|||
33328318|NCT01134263|62704714|FG002|Overall Study|Lost to Follow-up|5|||
33326131|NCT01157117|62702908|FG001|Overall Study|Withdrawal by Subject|1|||
33460646|NCT03635086|62833776|FG000|Overall Study|Adverse Event|0|||
33460647|NCT03635086|62833777|FG001|Overall Study|Adverse Event|1|||
33460648|NCT03635086|62833778|FG002|Overall Study|Adverse Event|0|||
33460649|NCT03635086|62833779|FG003|Overall Study|Adverse Event|0|||
33460650|NCT03635086|62833780|FG004|Overall Study|Adverse Event|0|||
33460651|NCT03635086|62833776|FG000|Overall Study|Lost to Follow-up|1|||
33460652|NCT03635086|62833777|FG001|Overall Study|Lost to Follow-up|0|||
33460653|NCT03635086|62833778|FG002|Overall Study|Lost to Follow-up|0|||
33460654|NCT03635086|62833779|FG003|Overall Study|Lost to Follow-up|0|||
33460655|NCT03635086|62833780|FG004|Overall Study|Lost to Follow-up|0|||
33460656|NCT03588910|62833795|FG000|Overall Study|Withdrawal by Subject|1|||
33460657|NCT03588910|62833796|FG001|Overall Study|Withdrawal by Subject|0|||
33460658|NCT03588910|62833795|FG000|Overall Study|Allergy|2|||
33460659|NCT03588910|62833796|FG001|Overall Study|Allergy|0|||
33460660|NCT03588910|62833795|FG000|Overall Study|Protocol Violation|0|||
33536749|NCT02867592|62926705|FG004|Overall Study|Ineligible|2|||
33536750|NCT02867592|62926706|FG005|Overall Study|Ineligible|0|||
33536751|NCT02867592|62926701|FG000|Overall Study|No Treatment|1|||
33536752|NCT02867592|62926702|FG001|Overall Study|No Treatment|0|||
33536753|NCT02867592|62926703|FG002|Overall Study|No Treatment|0|||
33536754|NCT02867592|62926704|FG003|Overall Study|No Treatment|0|||
33460661|NCT03588910|62833796|FG001|Overall Study|Protocol Violation|3|||
33460662|NCT03588910|62833795|FG000|Overall Study|Did not complete Day 1 Survey|5|||
33536755|NCT02867592|62926705|FG004|Overall Study|No Treatment|0|||
33536756|NCT02867592|62926706|FG005|Overall Study|No Treatment|0|||
33536757|NCT02867592|62926701|FG000|Overall Study|Still on Therapy|0|||
33536758|NCT02867592|62926702|FG001|Overall Study|Still on Therapy|0|||
33536759|NCT02867592|62926703|FG002|Overall Study|Still on Therapy|0|||
33536760|NCT02867592|62926704|FG003|Overall Study|Still on Therapy|0|||
33460663|NCT03588910|62833796|FG001|Overall Study|Did not complete Day 1 Survey|10|||
33460664|NCT03588910|62833795|FG000|Overall Study|Did not complete Day 7 Survey|5|||
33460665|NCT03588910|62833796|FG001|Overall Study|Did not complete Day 7 Survey|2|||
33460666|NCT03587974|62833804|FG000|Overall Study|caregiver demented, care recipient died|3|||
33460667|NCT03587974|62833805|FG001|Overall Study|caregiver demented, care recipient died|3|||
33536761|NCT02867592|62926705|FG004|Overall Study|Still on Therapy|1|||
33536762|NCT02867592|62926706|FG005|Overall Study|Still on Therapy|0|||
33536763|NCT02867592|62926701|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
33536764|NCT02867592|62926702|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
33536765|NCT02867592|62926703|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
33536766|NCT02867592|62926704|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
33536767|NCT02867592|62926705|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
33536768|NCT02867592|62926706|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
33536769|NCT02867592|62926701|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
33536770|NCT02867592|62926702|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
33536771|NCT02867592|62926703|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
33536772|NCT02867592|62926704|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
33536773|NCT02867592|62926705|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
33536774|NCT02867592|62926706|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
33536775|NCT00676494|62926722|FG000|Overall Study|Missed Visit|8|||
33536776|NCT00676494|62926722|FG000|Overall Study|Withdrawal by Subject|6|||
33536777|NCT02605642|62926727|FG000|Overall Study|Other|11|||
33536778|NCT02605642|62926728|FG001|Overall Study|Other|1|||
33536779|NCT02605642|62926727|FG000|Overall Study|Participant non-compliance|2|||
33326132|NCT01157117|62702909|FG002|Overall Study|Withdrawal by Subject|1|||
33326133|NCT01157117|62702907|FG000|Overall Study|Lack of Efficacy|1|||
33460668|NCT03587974|62833804|FG000|Overall Study|Withdrawal by Subject|2|||
33460669|NCT03587974|62833805|FG001|Overall Study|Withdrawal by Subject|1|||
33460670|NCT00103857|62833818|FG000|54-Week Base Study|Adverse Event|12|||
33460671|NCT00103857|62833819|FG001|54-Week Base Study|Adverse Event|9|||
33460672|NCT00103857|62833820|FG002|54-Week Base Study|Adverse Event|11|||
33536780|NCT02605642|62926728|FG001|Overall Study|Participant non-compliance|4|||
33536781|NCT02605642|62926727|FG000|Overall Study|Physician Decision|10|||
33536782|NCT02605642|62926728|FG001|Overall Study|Physician Decision|0|||
33536783|NCT02605642|62926727|FG000|Overall Study|Lost to Follow-up|12|||
33536784|NCT02605642|62926728|FG001|Overall Study|Lost to Follow-up|1|||
33629131|NCT02062385|63030278|FG003|Overall Study|Adverse Event|0|||
33326134|NCT01157117|62702908|FG001|Overall Study|Lack of Efficacy|1|||
33326135|NCT01157117|62702909|FG002|Overall Study|Lack of Efficacy|0|||
33326136|NCT01157117|62702907|FG000|Overall Study|Lost to Follow-up|0|||
33326137|NCT01157117|62702908|FG001|Overall Study|Lost to Follow-up|0|||
33326138|NCT01157117|62702909|FG002|Overall Study|Lost to Follow-up|1|||
33326139|NCT01157117|62702907|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
33326140|NCT01157117|62702908|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
33326141|NCT01157117|62702909|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
33326142|NCT00891202|62702919|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
33326143|NCT00891202|62702920|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
33326144|NCT00891202|62702921|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
33326145|NCT00891202|62702922|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
33326146|NCT00891202|62702919|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
33326147|NCT00891202|62702920|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
33326148|NCT00891202|62702921|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
33326149|NCT00891202|62702922|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
33326150|NCT00891202|62702919|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
33326151|NCT00891202|62702920|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
33326152|NCT00891202|62702921|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
33326153|NCT00891202|62702922|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
33326154|NCT00891202|62702919|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
33326155|NCT00891202|62702920|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
33326156|NCT00891202|62702921|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
33326157|NCT00891202|62702922|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
33326158|NCT01185509|62702932|FG000|Overall Study|Progression/Relapse|9|||
33326159|NCT01185509|62702933|FG001|Overall Study|Progression/Relapse|15|||
33326160|NCT01185509|62702932|FG000|Overall Study|Physician Decision|2|||
33326161|NCT01185509|62702933|FG001|Overall Study|Physician Decision|2|||
33460673|NCT00103857|62833821|FG003|54-Week Base Study|Adverse Event|6|||
33326162|NCT01185509|62702932|FG000|Overall Study|Withdrawal by Subject|0|||
33326163|NCT01185509|62702933|FG001|Overall Study|Withdrawal by Subject|1|||
33326164|NCT01185509|62702932|FG000|Overall Study|Death|0|||
33326165|NCT01185509|62702933|FG001|Overall Study|Death|1|||
33326166|NCT01185509|62702932|FG000|Overall Study|Intercurrent Illness|0|||
33326167|NCT01185509|62702933|FG001|Overall Study|Intercurrent Illness|1|||
33326168|NCT00891046|62702945|FG000|Overall Study|Protocol Violation|1|||
33326169|NCT00891046|62702946|FG001|Overall Study|Protocol Violation|1|||
33326170|NCT00891046|62702947|FG002|Overall Study|Protocol Violation|0|||
33326171|NCT00891046|62702948|FG003|Overall Study|Protocol Violation|0|||
33326172|NCT00891046|62702949|FG004|Overall Study|Protocol Violation|1|||
33326173|NCT00891046|62702945|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
33326174|NCT00891046|62702946|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33460674|NCT00103857|62833822|FG004|54-Week Base Study|Adverse Event|5|||
33460675|NCT00103857|62833823|FG005|54-Week Base Study|Adverse Event|11|||
33460676|NCT00103857|62833824|FG006|54-Week Base Study|Adverse Event|3|||
33460677|NCT00103857|62833818|FG000|54-Week Base Study|Death|0|||
33460678|NCT00103857|62833819|FG001|54-Week Base Study|Death|0|||
33460679|NCT00103857|62833820|FG002|54-Week Base Study|Death|0|||
33460680|NCT00103857|62833821|FG003|54-Week Base Study|Death|0|||
33460681|NCT00103857|62833822|FG004|54-Week Base Study|Death|1|||
33460682|NCT00103857|62833823|FG005|54-Week Base Study|Death|1|||
33460683|NCT00103857|62833824|FG006|54-Week Base Study|Death|0|||
33460684|NCT00103857|62833818|FG000|54-Week Base Study|Lack of Efficacy|11|||
33460685|NCT00103857|62833819|FG001|54-Week Base Study|Lack of Efficacy|14|||
33460686|NCT00103857|62833820|FG002|54-Week Base Study|Lack of Efficacy|8|||
33460687|NCT00103857|62833821|FG003|54-Week Base Study|Lack of Efficacy|4|||
33460688|NCT00103857|62833822|FG004|54-Week Base Study|Lack of Efficacy|3|||
33460689|NCT00103857|62833823|FG005|54-Week Base Study|Lack of Efficacy|14|||
33460690|NCT00103857|62833824|FG006|54-Week Base Study|Lack of Efficacy|19|||
33460691|NCT00103857|62833818|FG000|54-Week Base Study|Lost to Follow-up|5|||
33460692|NCT00103857|62833819|FG001|54-Week Base Study|Lost to Follow-up|4|||
33460693|NCT00103857|62833820|FG002|54-Week Base Study|Lost to Follow-up|7|||
33460694|NCT00103857|62833821|FG003|54-Week Base Study|Lost to Follow-up|5|||
33460695|NCT00103857|62833822|FG004|54-Week Base Study|Lost to Follow-up|10|||
33460696|NCT00103857|62833823|FG005|54-Week Base Study|Lost to Follow-up|9|||
33460697|NCT00103857|62833824|FG006|54-Week Base Study|Lost to Follow-up|3|||
33460698|NCT00103857|62833818|FG000|54-Week Base Study|Physician Decision|1|||
33460699|NCT00103857|62833819|FG001|54-Week Base Study|Physician Decision|1|||
33460700|NCT00103857|62833820|FG002|54-Week Base Study|Physician Decision|0|||
33460701|NCT00103857|62833821|FG003|54-Week Base Study|Physician Decision|0|||
33460702|NCT00103857|62833822|FG004|54-Week Base Study|Physician Decision|1|||
33460703|NCT00103857|62833823|FG005|54-Week Base Study|Physician Decision|0|||
33460704|NCT00103857|62833824|FG006|54-Week Base Study|Physician Decision|0|||
33460705|NCT00103857|62833818|FG000|54-Week Base Study|Pregnancy|1|||
33460706|NCT00103857|62833819|FG001|54-Week Base Study|Pregnancy|0|||
33460707|NCT00103857|62833820|FG002|54-Week Base Study|Pregnancy|0|||
33460708|NCT00103857|62833821|FG003|54-Week Base Study|Pregnancy|0|||
33460709|NCT00103857|62833822|FG004|54-Week Base Study|Pregnancy|1|||
33460710|NCT00103857|62833823|FG005|54-Week Base Study|Pregnancy|0|||
33460711|NCT00103857|62833824|FG006|54-Week Base Study|Pregnancy|1|||
33460712|NCT00103857|62833818|FG000|54-Week Base Study|Protocol Violation|6|||
33460713|NCT00103857|62833819|FG001|54-Week Base Study|Protocol Violation|4|||
33326175|NCT00891046|62702947|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
33326176|NCT00891046|62702948|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
33460714|NCT00103857|62833820|FG002|54-Week Base Study|Protocol Violation|2|||
33460715|NCT00103857|62833821|FG003|54-Week Base Study|Protocol Violation|4|||
33460716|NCT00103857|62833822|FG004|54-Week Base Study|Protocol Violation|0|||
33460717|NCT00103857|62833823|FG005|54-Week Base Study|Protocol Violation|3|||
33460718|NCT00103857|62833824|FG006|54-Week Base Study|Protocol Violation|3|||
33460719|NCT00103857|62833818|FG000|54-Week Base Study|Withdrawal by Subject|17|||
33460720|NCT00103857|62833819|FG001|54-Week Base Study|Withdrawal by Subject|16|||
33460721|NCT00103857|62833820|FG002|54-Week Base Study|Withdrawal by Subject|16|||
33326177|NCT00891046|62702949|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
33460722|NCT00103857|62833821|FG003|54-Week Base Study|Withdrawal by Subject|15|||
33460723|NCT00103857|62833822|FG004|54-Week Base Study|Withdrawal by Subject|10|||
33460724|NCT00103857|62833823|FG005|54-Week Base Study|Withdrawal by Subject|15|||
33460725|NCT00103857|62833824|FG006|54-Week Base Study|Withdrawal by Subject|4|||
33460726|NCT00103857|62833818|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
33460727|NCT00103857|62833819|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
33460728|NCT00103857|62833820|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
33460729|NCT00103857|62833821|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
33460730|NCT00103857|62833822|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
33460731|NCT00103857|62833823|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
33326178|NCT00891046|62702945|FG000|Overall Study|Administrative problems|0|||
33326179|NCT00891046|62702946|FG001|Overall Study|Administrative problems|0|||
33326180|NCT00891046|62702947|FG002|Overall Study|Administrative problems|0|||
33326181|NCT00891046|62702948|FG003|Overall Study|Administrative problems|0|||
33326182|NCT00891046|62702949|FG004|Overall Study|Administrative problems|1|||
33326183|NCT00891046|62702945|FG000|Overall Study|Participant no longer required drug|0|||
33328319|NCT01134263|62704715|FG003|Overall Study|Lost to Follow-up|3|||
33460732|NCT00103857|62833824|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
33536785|NCT02605642|62926727|FG000|Overall Study|Adverse Event|14|||
33536786|NCT02605642|62926728|FG001|Overall Study|Adverse Event|2|||
33536787|NCT02605642|62926727|FG000|Overall Study|Withdrawal by Subject|23|||
33536788|NCT02605642|62926728|FG001|Overall Study|Withdrawal by Subject|2|||
33536789|NCT02605642|62926727|FG000|Overall Study|Lack of response|24|||
33536790|NCT02605642|62926728|FG001|Overall Study|Lack of response|11|||
33536791|NCT02253810|62926736|FG000|Overall Study|Withdrawal by Subject|2|||
33536792|NCT02253810|62926737|FG001|Overall Study|Withdrawal by Subject|1|||
33536793|NCT02253810|62926736|FG000|Overall Study|Unknown concomitant procedure|3|||
33536794|NCT02253810|62926737|FG001|Overall Study|Unknown concomitant procedure|2|||
33536795|NCT03915470|62926758|FG000|Overall Study|Death|3|||
33536796|NCT03915470|62926759|FG001|Overall Study|Death|1|||
33536797|NCT03915470|62926758|FG000|Overall Study|Adverse Event|1|||
33536798|NCT03915470|62926759|FG001|Overall Study|Adverse Event|0|||
33536799|NCT03915470|62926758|FG000|Overall Study|Physician Decision|1|||
33536800|NCT03915470|62926759|FG001|Overall Study|Physician Decision|0|||
33536801|NCT03915470|62926758|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
33536802|NCT03915470|62926759|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
33536803|NCT02732912|62926770|FG000|Overall Study|Discharged before night|2|||
33629132|NCT02062385|63030275|FG000|Overall Study|Protocol Violation|1|||
33629133|NCT02062385|63030276|FG001|Overall Study|Protocol Violation|0|||
33460733|NCT00103857|62833818|FG000|54-Week Base Study|patient moved|0|||
33460734|NCT00103857|62833819|FG001|54-Week Base Study|patient moved|1|||
33460735|NCT00103857|62833820|FG002|54-Week Base Study|patient moved|1|||
33460736|NCT00103857|62833821|FG003|54-Week Base Study|patient moved|2|||
33460737|NCT00103857|62833822|FG004|54-Week Base Study|patient moved|3|||
33460738|NCT00103857|62833823|FG005|54-Week Base Study|patient moved|1|||
33460739|NCT00103857|62833824|FG006|54-Week Base Study|patient moved|0|||
33460740|NCT00103857|62833818|FG000|54-Week Base Study|non-compliance with study procedures|1|||
33536804|NCT02732912|62926771|FG001|Overall Study|Discharged before night|6|||
33460741|NCT00103857|62833819|FG001|54-Week Base Study|non-compliance with study procedures|2|||
33536805|NCT02732912|62926770|FG000|Overall Study|Incomplete completion of questionnaire|2|||
33536806|NCT02732912|62926771|FG001|Overall Study|Incomplete completion of questionnaire|3|||
33536807|NCT02732912|62926770|FG000|Overall Study|No outcome; discharged or refused|6|||
33536808|NCT02732912|62926771|FG001|Overall Study|No outcome; discharged or refused|9|||
33536809|NCT02792517|62926777|FG000|Overall Study|Withdrawal by Subject|10|||
33326184|NCT00891046|62702946|FG001|Overall Study|Participant no longer required drug|2|||
33326185|NCT00891046|62702947|FG002|Overall Study|Participant no longer required drug|0|||
33326186|NCT00891046|62702948|FG003|Overall Study|Participant no longer required drug|0|||
33536810|NCT02792517|62926777|FG000|Overall Study|Decision by Sponsor|7|||
33326187|NCT00891046|62702949|FG004|Overall Study|Participant no longer required drug|1|||
33326188|NCT00891046|62702945|FG000|Overall Study|Adverse Event|4|||
33326189|NCT00891046|62702946|FG001|Overall Study|Adverse Event|3|||
33536811|NCT02792517|62926777|FG000|Overall Study|Lost to Follow-up|3|||
33536812|NCT01369485|62926812|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
33536813|NCT01369485|62926813|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
33536814|NCT01369485|62926812|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
33536815|NCT01369485|62926813|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
33536816|NCT01369485|62926812|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
33536817|NCT01369485|62926813|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
33536818|NCT01369485|62926812|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
33536819|NCT01369485|62926813|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
33536820|NCT01369485|62926812|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
33536821|NCT01369485|62926813|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
33536822|NCT01369485|62926812|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
33536823|NCT01369485|62926813|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
33536824|NCT01369485|62926812|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
33536825|NCT01369485|62926813|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
33536826|NCT01369485|62926812|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
33536827|NCT01369485|62926813|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
33536828|NCT01369485|62926812|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
33536829|NCT01369485|62926813|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
33536830|NCT01369485|62926812|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
33536831|NCT01369485|62926813|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
33629134|NCT02062385|63030277|FG002|Overall Study|Protocol Violation|0|||
33629135|NCT02062385|63030278|FG003|Overall Study|Protocol Violation|0|||
33629136|NCT02062385|63030275|FG000|Overall Study|Incomplete EPI by database lock|2|||
33629137|NCT02062385|63030276|FG001|Overall Study|Incomplete EPI by database lock|0|||
33536832|NCT02886572|62926840|FG000|Overall Study|Death|8|||
33629138|NCT02062385|63030277|FG002|Overall Study|Incomplete EPI by database lock|0|||
33629139|NCT02062385|63030278|FG003|Overall Study|Incomplete EPI by database lock|0|||
33629140|NCT02062385|63030275|FG000|Overall Study|Moved|10|||
33629141|NCT02062385|63030276|FG001|Overall Study|Moved|11|||
33629142|NCT02062385|63030277|FG002|Overall Study|Moved|1|||
33629143|NCT02062385|63030278|FG003|Overall Study|Moved|0|||
33536833|NCT02741700|62926853|FG000|Overall Study|Lost to Follow-up|17|||
33536834|NCT02741700|62926854|FG001|Overall Study|Lost to Follow-up|8|||
33629144|NCT02062385|63030275|FG000|Overall Study|Withdrawn by parent/guardian|46|||
33629145|NCT02062385|63030276|FG001|Overall Study|Withdrawn by parent/guardian|41|||
33629146|NCT02062385|63030277|FG002|Overall Study|Withdrawn by parent/guardian|9|||
33629147|NCT02062385|63030278|FG003|Overall Study|Withdrawn by parent/guardian|8|||
33629148|NCT02062385|63030275|FG000|Overall Study|Death|0|||
33629149|NCT02062385|63030276|FG001|Overall Study|Death|0|||
33629150|NCT02062385|63030277|FG002|Overall Study|Death|0|||
33629151|NCT02062385|63030278|FG003|Overall Study|Death|1|||
33536835|NCT02741700|62926853|FG000|Overall Study|Withdrawal by Subject|2|||
33536836|NCT02741700|62926854|FG001|Overall Study|Withdrawal by Subject|5|||
33629152|NCT02062385|63030275|FG000|Overall Study|Lost to Follow-up|0|||
33629153|NCT02062385|63030276|FG001|Overall Study|Lost to Follow-up|0|||
33629154|NCT02062385|63030277|FG002|Overall Study|Lost to Follow-up|1|||
33629155|NCT02062385|63030278|FG003|Overall Study|Lost to Follow-up|0|||
33629156|NCT02062151|63030286|FG000|Overall Study|screen failure|1|||
33629157|NCT02060903|63030292|FG000|Overall Study|Lost to Follow-up|4|||
33629158|NCT02060903|63030293|FG001|Overall Study|Lost to Follow-up|0|||
33629159|NCT02060903|63030292|FG000|Overall Study|Withdrawal by Subject|0|||
33629160|NCT02060903|63030293|FG001|Overall Study|Withdrawal by Subject|7|||
33629161|NCT02095691|63030299|FG000|Overall Study|Physician Decision|1|||
33629162|NCT02095535|63030315|FG000|Recruitment|Protocol Violation|2|||
33629163|NCT02095223|63030321|FG000|Overall Study|Withdrawal by Subject|1|||
33629164|NCT02095223|63030322|FG001|Overall Study|Withdrawal by Subject|0|||
33629165|NCT02095145|63030330|FG000|Overall Study|Withdrawal by Subject|1|||
33629166|NCT02095145|63030331|FG001|Overall Study|Withdrawal by Subject|0|||
33629167|NCT02059187|63030341|FG000|Overall Study|Adverse Event|0|||
33629168|NCT02059187|63030342|FG001|Overall Study|Adverse Event|3|||
33629169|NCT02059187|63030341|FG000|Overall Study|Death|1|||
33629170|NCT02059187|63030342|FG001|Overall Study|Death|1|||
33629171|NCT02059187|63030341|FG000|Overall Study|Lost to Follow-up|9|||
33629172|NCT02059187|63030342|FG001|Overall Study|Lost to Follow-up|8|||
33629173|NCT02059187|63030341|FG000|Overall Study|Non-compliance with study drug|1|||
33629174|NCT02059187|63030342|FG001|Overall Study|Non-compliance with study drug|0|||
33629175|NCT02059187|63030341|FG000|Overall Study|Physician Decision|1|||
33536837|NCT02741700|62926853|FG000|Overall Study|Physician Decision|3|||
33629176|NCT02059187|63030342|FG001|Overall Study|Physician Decision|2|||
33629177|NCT02059187|63030341|FG000|Overall Study|Protocol Violation|1|||
33629178|NCT02059187|63030342|FG001|Overall Study|Protocol Violation|0|||
33629179|NCT02059187|63030341|FG000|Overall Study|Withdrawal by Subject|12|||
33629180|NCT02059187|63030342|FG001|Overall Study|Withdrawal by Subject|8|||
33629181|NCT02043899|63030348|FG000|Overall Study|Adverse Event|3|||
33629182|NCT02043899|63030348|FG000|Overall Study|Physician Decision|1|||
33629183|NCT02043899|63030348|FG000|Overall Study|Withdrawal by Subject|2|||
33629184|NCT02043899|63030348|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
33629185|NCT02043899|63030348|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
33629186|NCT02043899|63030348|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
33629187|NCT02043899|63030348|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
33629188|NCT02043899|63030348|FG000|Overall Study|Treatment delayed|1|||
33629189|NCT02043509|63030354|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
33326190|NCT00891046|62702947|FG002|Overall Study|Adverse Event|2|||
33536838|NCT02741700|62926854|FG001|Overall Study|Physician Decision|0|||
33536839|NCT02741700|62926853|FG000|Overall Study|Moved out of State|0|||
33536840|NCT02741700|62926854|FG001|Overall Study|Moved out of State|1|||
33536841|NCT02741700|62926853|FG000|Overall Study|Death|4|||
33536842|NCT02741700|62926854|FG001|Overall Study|Death|5|||
33536843|NCT00430950|62926862|FG000|Overall Study|Adverse Event|7|||
33536844|NCT00430950|62926863|FG001|Overall Study|Adverse Event|6|||
33536845|NCT00430950|62926862|FG000|Overall Study|Withdrawal by Subject|1|||
33536846|NCT00430950|62926863|FG001|Overall Study|Withdrawal by Subject|0|||
33536847|NCT00430950|62926862|FG000|Overall Study|concomitant medication,etc.|5|||
33536848|NCT00430950|62926863|FG001|Overall Study|concomitant medication,etc.|7|||
33629190|NCT02043509|63030355|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
33629191|NCT02043509|63030354|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
33629192|NCT02043509|63030355|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
33629193|NCT02043509|63030354|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
33536849|NCT02081391|62926871|FG000|12-hour Treatment|Withdrawal by Subject|3|||
33629194|NCT02043509|63030355|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
33536850|NCT02081391|62926872|FG001|12-hour Treatment|Withdrawal by Subject|2|||
33536851|NCT02081391|62926873|FG002|12-hour Treatment|Withdrawal by Subject|0|||
33326191|NCT00891046|62702948|FG003|Overall Study|Adverse Event|0|||
33326192|NCT00891046|62702949|FG004|Overall Study|Adverse Event|14|||
33326193|NCT00891046|62702945|FG000|Overall Study|Withdrawal by Subject|2|||
33460742|NCT00103857|62833820|FG002|54-Week Base Study|non-compliance with study procedures|0|||
33460743|NCT00103857|62833821|FG003|54-Week Base Study|non-compliance with study procedures|0|||
33460744|NCT00103857|62833822|FG004|54-Week Base Study|non-compliance with study procedures|0|||
33460745|NCT00103857|62833823|FG005|54-Week Base Study|non-compliance with study procedures|2|||
33460746|NCT00103857|62833824|FG006|54-Week Base Study|non-compliance with study procedures|0|||
33460747|NCT00103857|62833818|FG000|54-Week Base Study|patient incarcerated|0|||
33460748|NCT00103857|62833819|FG001|54-Week Base Study|patient incarcerated|0|||
33536852|NCT02081391|62926874|FG003|12-hour Treatment|Withdrawal by Subject|0|||
33536853|NCT02081391|62926871|FG000|12-hour Treatment|Physician Decision|4|||
33536854|NCT02081391|62926872|FG001|12-hour Treatment|Physician Decision|1|||
33536855|NCT02081391|62926873|FG002|12-hour Treatment|Physician Decision|0|||
33536856|NCT02081391|62926874|FG003|12-hour Treatment|Physician Decision|0|||
33460749|NCT00103857|62833820|FG002|54-Week Base Study|patient incarcerated|0|||
33460750|NCT00103857|62833821|FG003|54-Week Base Study|patient incarcerated|0|||
33460751|NCT00103857|62833822|FG004|54-Week Base Study|patient incarcerated|1|||
33460752|NCT00103857|62833823|FG005|54-Week Base Study|patient incarcerated|1|||
33460753|NCT00103857|62833824|FG006|54-Week Base Study|patient incarcerated|0|||
33460754|NCT00103857|62833818|FG000|54-Week Base Study|laboratory reporting error|0|||
33460755|NCT00103857|62833819|FG001|54-Week Base Study|laboratory reporting error|0|||
33460756|NCT00103857|62833820|FG002|54-Week Base Study|laboratory reporting error|0|||
33460757|NCT00103857|62833821|FG003|54-Week Base Study|laboratory reporting error|0|||
33460758|NCT00103857|62833822|FG004|54-Week Base Study|laboratory reporting error|1|||
33460759|NCT00103857|62833823|FG005|54-Week Base Study|laboratory reporting error|0|||
33460760|NCT00103857|62833824|FG006|54-Week Base Study|laboratory reporting error|0|||
33460761|NCT00103857|62833818|FG000|54-Week Base Study|site error|0|||
33460762|NCT00103857|62833819|FG001|54-Week Base Study|site error|0|||
33460763|NCT00103857|62833820|FG002|54-Week Base Study|site error|0|||
33460764|NCT00103857|62833821|FG003|54-Week Base Study|site error|0|||
33460765|NCT00103857|62833822|FG004|54-Week Base Study|site error|0|||
33460766|NCT00103857|62833823|FG005|54-Week Base Study|site error|1|||
33460767|NCT00103857|62833824|FG006|54-Week Base Study|site error|0|||
33460768|NCT00103857|62833818|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
33460769|NCT00103857|62833819|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
33460770|NCT00103857|62833820|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
33460771|NCT00103857|62833821|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
33460772|NCT00103857|62833822|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
33460773|NCT00103857|62833823|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
33460774|NCT00103857|62833824|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
33460775|NCT00103857|62833818|FG000|50-Week Extension Study|Adverse Event|2|||
33460776|NCT00103857|62833819|FG001|50-Week Extension Study|Adverse Event|3|||
33460777|NCT00103857|62833820|FG002|50-Week Extension Study|Adverse Event|2|||
33460778|NCT00103857|62833821|FG003|50-Week Extension Study|Adverse Event|0|||
33460779|NCT00103857|62833822|FG004|50-Week Extension Study|Adverse Event|1|||
33460780|NCT00103857|62833823|FG005|50-Week Extension Study|Adverse Event|1|||
33460781|NCT00103857|62833824|FG006|50-Week Extension Study|Adverse Event|0|||
33460782|NCT00103857|62833818|FG000|50-Week Extension Study|Death|0|||
33629195|NCT02043509|63030354|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
33629196|NCT02043509|63030355|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
33629197|NCT02058563|63030363|FG000|Overall Study|Lost to Follow-up|26|||
33629198|NCT02058563|63030364|FG001|Overall Study|Lost to Follow-up|22|||
33629199|NCT02058563|63030363|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
33629200|NCT02058563|63030364|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
33629201|NCT02058563|63030363|FG000|Overall Study|Consent Withdrawal|1|||
33629202|NCT02058563|63030364|FG001|Overall Study|Consent Withdrawal|1|||
33629203|NCT02058563|63030363|FG000|Overall Study|Other (patient incarcerated)|0|||
33629204|NCT02058563|63030364|FG001|Overall Study|Other (patient incarcerated)|1|||
33629205|NCT01622231|63030370|FG000|Overall Study|Physician Decision|1|||
33629206|NCT01622231|63030370|FG000|Overall Study|Withdrawal by Subject|1|||
33629207|NCT02042183|63030376|FG000|Overall Study|Physician Decision|7|||
33629208|NCT02042183|63030377|FG001|Overall Study|Physician Decision|2|||
33629209|NCT02042183|63030376|FG000|Overall Study|Lack of Efficacy|4|||
33629210|NCT02042183|63030377|FG001|Overall Study|Lack of Efficacy|3|||
33629211|NCT02042183|63030376|FG000|Overall Study|Non-compliance with Study Drug|2|||
33629212|NCT02042183|63030377|FG001|Overall Study|Non-compliance with Study Drug|3|||
33629213|NCT02042183|63030376|FG000|Overall Study|Adverse Event|17|||
33629214|NCT02042183|63030377|FG001|Overall Study|Adverse Event|6|||
33629215|NCT02042183|63030376|FG000|Overall Study|Other|3|||
33629216|NCT02042183|63030377|FG001|Overall Study|Other|3|||
33629217|NCT02042183|63030376|FG000|Overall Study|Withdrawal by Subject|21|||
33629218|NCT02042183|63030377|FG001|Overall Study|Withdrawal by Subject|16|||
33629219|NCT02042183|63030376|FG000|Overall Study|Site Terminated by Sponsor|2|||
33629220|NCT02042183|63030377|FG001|Overall Study|Site Terminated by Sponsor|1|||
33629221|NCT02042183|63030376|FG000|Overall Study|Lost to Follow-up|9|||
33629222|NCT02042183|63030377|FG001|Overall Study|Lost to Follow-up|2|||
33629223|NCT01977482|63030391|FG000|Overall Study|Adverse Event|0|||
33629224|NCT01977482|63030392|FG001|Overall Study|Adverse Event|1|||
33629225|NCT01977482|63030393|FG002|Overall Study|Adverse Event|1|||
33629226|NCT01977482|63030394|FG003|Overall Study|Adverse Event|0|||
33629227|NCT01977482|63030395|FG004|Overall Study|Adverse Event|2|||
33629228|NCT01977482|63030396|FG005|Overall Study|Adverse Event|0|||
33629229|NCT01977482|63030391|FG000|Overall Study|Lost to Follow-up|1|||
33536857|NCT02081391|62926871|FG000|12-hour Treatment|Lack of Efficacy|3|||
33536858|NCT02081391|62926872|FG001|12-hour Treatment|Lack of Efficacy|0|||
33536859|NCT02081391|62926873|FG002|12-hour Treatment|Lack of Efficacy|0|||
33536860|NCT02081391|62926874|FG003|12-hour Treatment|Lack of Efficacy|0|||
33536861|NCT02081391|62926871|FG000|12-hour Treatment|Adverse Event|4|||
33536862|NCT02081391|62926872|FG001|12-hour Treatment|Adverse Event|2|||
33629230|NCT01977482|63030392|FG001|Overall Study|Lost to Follow-up|0|||
33629231|NCT01977482|63030393|FG002|Overall Study|Lost to Follow-up|0|||
33326194|NCT00891046|62702946|FG001|Overall Study|Withdrawal by Subject|1|||
33536863|NCT02081391|62926873|FG002|12-hour Treatment|Adverse Event|0|||
33536864|NCT02081391|62926874|FG003|12-hour Treatment|Adverse Event|0|||
33536865|NCT02081391|62926871|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
33536866|NCT02081391|62926872|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
33536867|NCT02081391|62926873|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
33536868|NCT02081391|62926874|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
33536869|NCT02081391|62926871|FG000|12-hour Treatment|Further reasons|2|||
33629232|NCT01977482|63030394|FG003|Overall Study|Lost to Follow-up|0|||
33629233|NCT01977482|63030395|FG004|Overall Study|Lost to Follow-up|0|||
33629234|NCT01977482|63030396|FG005|Overall Study|Lost to Follow-up|0|||
33629235|NCT01977482|63030391|FG000|Overall Study|Physician Decision|0|||
33629236|NCT01977482|63030392|FG001|Overall Study|Physician Decision|1|||
33629237|NCT01977482|63030393|FG002|Overall Study|Physician Decision|0|||
33629238|NCT01977482|63030394|FG003|Overall Study|Physician Decision|0|||
33629239|NCT01977482|63030395|FG004|Overall Study|Physician Decision|0|||
33629240|NCT01977482|63030396|FG005|Overall Study|Physician Decision|0|||
33629241|NCT01977482|63030391|FG000|Overall Study|Protocol Violation|0|||
33536870|NCT02081391|62926872|FG001|12-hour Treatment|Further reasons|1|||
33629242|NCT01977482|63030392|FG001|Overall Study|Protocol Violation|0|||
33629243|NCT01977482|63030393|FG002|Overall Study|Protocol Violation|1|||
33629244|NCT01977482|63030394|FG003|Overall Study|Protocol Violation|0|||
33536871|NCT02081391|62926873|FG002|12-hour Treatment|Further reasons|0|||
33536872|NCT02081391|62926874|FG003|12-hour Treatment|Further reasons|0|||
33536873|NCT02081391|62926871|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
33536874|NCT02081391|62926872|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
33536875|NCT02081391|62926873|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
33536876|NCT02081391|62926874|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
33536877|NCT02081391|62926871|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
33536878|NCT02081391|62926872|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
33536879|NCT02081391|62926873|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
33536880|NCT02081391|62926874|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
33536881|NCT02081391|62926871|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
33536882|NCT02081391|62926872|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
33536883|NCT02081391|62926873|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
33536884|NCT02081391|62926874|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
33536885|NCT02081391|62926871|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
33536886|NCT02081391|62926872|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
33536887|NCT02081391|62926873|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
33536888|NCT02081391|62926874|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
33536889|NCT02081391|62926871|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
33536890|NCT02081391|62926872|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
33536891|NCT02081391|62926873|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
33536892|NCT02081391|62926874|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
33536893|NCT02081391|62926871|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
33536894|NCT02081391|62926872|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
33536895|NCT02081391|62926873|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
33460783|NCT00103857|62833819|FG001|50-Week Extension Study|Death|0|||
33326195|NCT00891046|62702947|FG002|Overall Study|Withdrawal by Subject|2|||
33460784|NCT00103857|62833820|FG002|50-Week Extension Study|Death|0|||
33460785|NCT00103857|62833821|FG003|50-Week Extension Study|Death|1|||
33460786|NCT00103857|62833822|FG004|50-Week Extension Study|Death|0|||
33460787|NCT00103857|62833823|FG005|50-Week Extension Study|Death|1|||
33460788|NCT00103857|62833824|FG006|50-Week Extension Study|Death|0|||
33460789|NCT00103857|62833818|FG000|50-Week Extension Study|Lack of Efficacy|26|||
33460790|NCT00103857|62833819|FG001|50-Week Extension Study|Lack of Efficacy|15|||
33460791|NCT00103857|62833820|FG002|50-Week Extension Study|Lack of Efficacy|13|||
33536896|NCT02081391|62926874|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
33536897|NCT00430092|62926897|FG000|Overall Study|Adverse Event|0|||
33460792|NCT00103857|62833821|FG003|50-Week Extension Study|Lack of Efficacy|16|||
33460793|NCT00103857|62833822|FG004|50-Week Extension Study|Lack of Efficacy|8|||
33536898|NCT00430092|62926898|FG001|Overall Study|Adverse Event|0|||
33536899|NCT00430092|62926899|FG002|Overall Study|Adverse Event|1|||
33536900|NCT00430092|62926897|FG000|Overall Study|Lack of Efficacy|5|||
33536901|NCT00430092|62926898|FG001|Overall Study|Lack of Efficacy|2|||
33460794|NCT00103857|62833823|FG005|50-Week Extension Study|Lack of Efficacy|8|||
33460795|NCT00103857|62833824|FG006|50-Week Extension Study|Lack of Efficacy|0|||
33460796|NCT00103857|62833818|FG000|50-Week Extension Study|Lost to Follow-up|4|||
33460797|NCT00103857|62833819|FG001|50-Week Extension Study|Lost to Follow-up|0|||
33460798|NCT00103857|62833820|FG002|50-Week Extension Study|Lost to Follow-up|1|||
33460799|NCT00103857|62833821|FG003|50-Week Extension Study|Lost to Follow-up|4|||
33460800|NCT00103857|62833822|FG004|50-Week Extension Study|Lost to Follow-up|3|||
33536902|NCT00430092|62926899|FG002|Overall Study|Lack of Efficacy|54|||
33536903|NCT00430092|62926897|FG000|Overall Study|Lost to Follow-up|1|||
33536904|NCT00430092|62926898|FG001|Overall Study|Lost to Follow-up|0|||
33536905|NCT00430092|62926899|FG002|Overall Study|Lost to Follow-up|0|||
33536906|NCT00430092|62926897|FG000|Overall Study|Protocol Violation|0|||
33536907|NCT00430092|62926898|FG001|Overall Study|Protocol Violation|1|||
33326196|NCT00891046|62702948|FG003|Overall Study|Withdrawal by Subject|1|||
33460801|NCT00103857|62833823|FG005|50-Week Extension Study|Lost to Follow-up|3|||
33460802|NCT00103857|62833824|FG006|50-Week Extension Study|Lost to Follow-up|0|||
33536908|NCT00430092|62926899|FG002|Overall Study|Protocol Violation|1|||
33536909|NCT00430092|62926897|FG000|Overall Study|Withdrawal by Subject|0|||
33536910|NCT00430092|62926898|FG001|Overall Study|Withdrawal by Subject|1|||
33629245|NCT01977482|63030395|FG004|Overall Study|Protocol Violation|0|||
33629246|NCT01977482|63030396|FG005|Overall Study|Protocol Violation|0|||
33629247|NCT01977482|63030391|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
33629248|NCT01977482|63030392|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
33629249|NCT01977482|63030393|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
33629250|NCT01977482|63030394|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
33629251|NCT01977482|63030395|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
33460803|NCT00103857|62833818|FG000|50-Week Extension Study|Physician Decision|0|||
33460804|NCT00103857|62833819|FG001|50-Week Extension Study|Physician Decision|1|||
33460805|NCT00103857|62833820|FG002|50-Week Extension Study|Physician Decision|1|||
33460806|NCT00103857|62833821|FG003|50-Week Extension Study|Physician Decision|0|||
33460807|NCT00103857|62833822|FG004|50-Week Extension Study|Physician Decision|0|||
33460808|NCT00103857|62833823|FG005|50-Week Extension Study|Physician Decision|0|||
33460809|NCT00103857|62833824|FG006|50-Week Extension Study|Physician Decision|0|||
33460810|NCT00103857|62833818|FG000|50-Week Extension Study|Pregnancy|0|||
33460811|NCT00103857|62833819|FG001|50-Week Extension Study|Pregnancy|0|||
33536911|NCT00430092|62926899|FG002|Overall Study|Withdrawal by Subject|1|||
33536912|NCT00425100|62926904|FG000|Overall Study|Adverse Event|36|||
33536913|NCT00425100|62926904|FG000|Overall Study|Lack of Efficacy|4|||
33536914|NCT00425100|62926904|FG000|Overall Study|Lost to Follow-up|2|||
33536915|NCT00425100|62926904|FG000|Overall Study|Protocol Violation|4|||
33536916|NCT00425100|62926904|FG000|Overall Study|Withdrawal by Subject|7|||
33536917|NCT00412932|62926909|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
33536918|NCT00412932|62926909|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
33536919|NCT00412932|62926909|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
33536920|NCT00412932|62926909|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
33536921|NCT00412932|62926909|FG000|Olmesartan (Olm) 20 mg|Other|1|||
33536922|NCT00412932|62926909|FG000|Olmesartan 40 mg|Adverse Event|4|||
33536923|NCT00412932|62926909|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
33536924|NCT00412932|62926909|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
33536925|NCT00412932|62926909|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
33536926|NCT00412932|62926909|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
33460812|NCT00103857|62833820|FG002|50-Week Extension Study|Pregnancy|1|||
33629252|NCT01977482|63030396|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
33460813|NCT00103857|62833821|FG003|50-Week Extension Study|Pregnancy|0|||
33460814|NCT00103857|62833822|FG004|50-Week Extension Study|Pregnancy|1|||
33460815|NCT00103857|62833823|FG005|50-Week Extension Study|Pregnancy|0|||
33460816|NCT00103857|62833824|FG006|50-Week Extension Study|Pregnancy|0|||
33460817|NCT00103857|62833818|FG000|50-Week Extension Study|Protocol Violation|1|||
33460818|NCT00103857|62833819|FG001|50-Week Extension Study|Protocol Violation|1|||
33460819|NCT00103857|62833820|FG002|50-Week Extension Study|Protocol Violation|1|||
33460820|NCT00103857|62833821|FG003|50-Week Extension Study|Protocol Violation|2|||
33460821|NCT00103857|62833822|FG004|50-Week Extension Study|Protocol Violation|0|||
33460822|NCT00103857|62833823|FG005|50-Week Extension Study|Protocol Violation|1|||
33460823|NCT00103857|62833824|FG006|50-Week Extension Study|Protocol Violation|0|||
33460824|NCT00103857|62833818|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
33536927|NCT00412932|62926909|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
33536928|NCT00412932|62926909|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
33536929|NCT02696031|62926915|FG000|Up to Week 24|Adverse Event|2|||
33536930|NCT02696031|62926916|FG001|Up to Week 24|Adverse Event|4|||
33536931|NCT02696031|62926917|FG002|Up to Week 24|Adverse Event|2|||
33536932|NCT02696031|62926918|FG003|Up to Week 24|Adverse Event|0|||
33536933|NCT02696031|62926919|FG004|Up to Week 24|Adverse Event|0|||
33629253|NCT01977482|63030391|FG000|Overall Study|Withdrawal by Subject|2|||
33629254|NCT01977482|63030392|FG001|Overall Study|Withdrawal by Subject|4|||
33629255|NCT01977482|63030393|FG002|Overall Study|Withdrawal by Subject|1|||
33629256|NCT01977482|63030394|FG003|Overall Study|Withdrawal by Subject|3|||
33629257|NCT01977482|63030395|FG004|Overall Study|Withdrawal by Subject|1|||
33629258|NCT01977482|63030396|FG005|Overall Study|Withdrawal by Subject|5|||
33629259|NCT02058095|63030417|FG000|Overall Study|Adverse Event|1|||
33629260|NCT02058095|63030418|FG001|Overall Study|Adverse Event|0|||
33460825|NCT00103857|62833819|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
33460826|NCT00103857|62833820|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
33536934|NCT02696031|62926920|FG005|Up to Week 24|Adverse Event|0|||
33629261|NCT02023112|63030426|FG000|Overall Study|Withdrawal by Subject|2|||
33536935|NCT02696031|62926915|FG000|Up to Week 24|Lack of Efficacy|2|||
33460827|NCT00103857|62833821|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
33629262|NCT02023112|63030427|FG001|Overall Study|Withdrawal by Subject|1|||
33629263|NCT01977092|63030437|FG000|Overall Study|Death|3|||
33629264|NCT01977092|63030438|FG001|Overall Study|Death|4|||
33629265|NCT01977092|63030437|FG000|Overall Study|Lost to Follow-up|23|||
33629266|NCT01977092|63030438|FG001|Overall Study|Lost to Follow-up|14|||
33629267|NCT01977092|63030437|FG000|Overall Study|Withdrawal by Subject|2|||
33629268|NCT01977092|63030438|FG001|Overall Study|Withdrawal by Subject|1|||
33629269|NCT01977092|63030437|FG000|Overall Study|In prison|3|||
33629270|NCT01977092|63030438|FG001|Overall Study|In prison|11|||
33629271|NCT01976624|63030444|FG000|Overall Study|Participants contraindicated|2|||
33629272|NCT01976624|63030444|FG000|Overall Study|Participants age less than 19 years|12|||
33629273|NCT02041091|63030450|FG000|Treatment|Adverse Event|3|||
33629274|NCT02041091|63030451|FG001|Treatment|Adverse Event|3|||
33629275|NCT02041091|63030450|FG000|Treatment|Withdrawal by Subject|2|||
33629276|NCT02041091|63030451|FG001|Treatment|Withdrawal by Subject|4|||
33629277|NCT02041091|63030450|FG000|Treatment|Physician Decision|1|||
33629278|NCT02041091|63030451|FG001|Treatment|Physician Decision|0|||
33629279|NCT02041091|63030450|FG000|Treatment|Sponsor Decision|15|||
33629280|NCT02041091|63030451|FG001|Treatment|Sponsor Decision|16|||
33629281|NCT02041091|63030450|FG000|Treatment|Lost to Follow-up|1|||
33629282|NCT02041091|63030451|FG001|Treatment|Lost to Follow-up|0|||
33629283|NCT02041091|63030450|FG000|Optional Safety Extension Period|Adverse Event|4|||
33629284|NCT02041091|63030451|FG001|Optional Safety Extension Period|Adverse Event|2|||
33629285|NCT02041091|63030450|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
33629286|NCT02041091|63030451|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
33629287|NCT02041091|63030450|FG000|Optional Safety Extension Period|Protocol Violation|2|||
33629288|NCT02041091|63030451|FG001|Optional Safety Extension Period|Protocol Violation|0|||
33629289|NCT02041091|63030450|FG000|Optional Safety Extension Period|Physician Decision|2|||
33629290|NCT02041091|63030451|FG001|Optional Safety Extension Period|Physician Decision|1|||
33629291|NCT02041091|63030450|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
33629292|NCT02041091|63030451|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
33629293|NCT02041091|63030450|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
33629294|NCT02041091|63030451|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
33629295|NCT02057549|63030465|FG000|Overall Study|Lost to Follow-up|1|||
33629296|NCT02057549|63030466|FG001|Overall Study|Lost to Follow-up|0|||
33629297|NCT02057549|63030465|FG000|Overall Study|Physician Decision|1|||
33629298|NCT02057549|63030466|FG001|Overall Study|Physician Decision|0|||
33629299|NCT02057549|63030465|FG000|Overall Study|Withdrawal by Subject|1|||
33629300|NCT02057549|63030466|FG001|Overall Study|Withdrawal by Subject|0|||
33629301|NCT02057393|63030472|FG000|Overall Study|Withdrawal by Subject|1|||
33629302|NCT02057393|63030472|FG000|Overall Study|Patient did not meet criteria|1|||
33629303|NCT02040779|63030479|FG000|Overall Study|Adverse Event|1|||
33629304|NCT02040779|63030480|FG001|Overall Study|Adverse Event|0|||
33629305|NCT02040779|63030481|FG002|Overall Study|Adverse Event|0|||
33629306|NCT02040779|63030479|FG000|Overall Study|Withdrawal by Subject|4|||
33629307|NCT02040779|63030480|FG001|Overall Study|Withdrawal by Subject|1|||
33629308|NCT02040779|63030481|FG002|Overall Study|Withdrawal by Subject|3|||
33629309|NCT02040779|63030479|FG000|Overall Study|Non-compliance|0|||
33629310|NCT02040779|63030480|FG001|Overall Study|Non-compliance|1|||
33629311|NCT02040779|63030481|FG002|Overall Study|Non-compliance|0|||
33629312|NCT02040779|63030479|FG000|Overall Study|Protocol Violation|2|||
33629313|NCT02040779|63030480|FG001|Overall Study|Protocol Violation|1|||
33629314|NCT02040779|63030481|FG002|Overall Study|Protocol Violation|0|||
33629315|NCT02040779|63030479|FG000|Overall Study|Lost to Follow-up|1|||
33629316|NCT02040779|63030480|FG001|Overall Study|Lost to Follow-up|2|||
33629317|NCT02040779|63030481|FG002|Overall Study|Lost to Follow-up|1|||
33629318|NCT02040779|63030479|FG000|Overall Study|Lack of Efficacy|4|||
33629319|NCT02040779|63030480|FG001|Overall Study|Lack of Efficacy|2|||
33629320|NCT02040779|63030481|FG002|Overall Study|Lack of Efficacy|0|||
33629321|NCT02056301|63030491|FG000|Overall Study|Protocol Violation|1|||
33629322|NCT02056301|63030492|FG001|Overall Study|Protocol Violation|2|||
33629323|NCT02056301|63030491|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
33629324|NCT02056301|63030492|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
33629325|NCT02056301|63030491|FG000|Overall Study|Withdrawal by Subject|0|||
33629326|NCT02056301|63030492|FG001|Overall Study|Withdrawal by Subject|1|||
33629327|NCT02056301|63030491|FG000|Overall Study|Issues with epidural|0|||
33629328|NCT02056301|63030492|FG001|Overall Study|Issues with epidural|3|||
33629329|NCT01967732|63030500|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
33629330|NCT01967732|63030501|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
33629331|NCT01967732|63030502|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
33629332|NCT01967732|63030503|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
33629333|NCT01967732|63030500|FG000|First Intervention (Day 1)|Poor venous access|0|||
33629334|NCT01967732|63030501|FG001|First Intervention (Day 1)|Poor venous access|1|||
33536936|NCT02696031|62926916|FG001|Up to Week 24|Lack of Efficacy|1|||
33536937|NCT02696031|62926917|FG002|Up to Week 24|Lack of Efficacy|2|||
33536938|NCT02696031|62926918|FG003|Up to Week 24|Lack of Efficacy|0|||
33536939|NCT02696031|62926919|FG004|Up to Week 24|Lack of Efficacy|0|||
33536940|NCT02696031|62926920|FG005|Up to Week 24|Lack of Efficacy|0|||
33536941|NCT02696031|62926915|FG000|Up to Week 24|Lost to Follow-up|0|||
33629335|NCT01967732|63030502|FG002|First Intervention (Day 1)|Poor venous access|0|||
33629336|NCT01967732|63030503|FG003|First Intervention (Day 1)|Poor venous access|0|||
33629337|NCT01967576|63030511|FG000|Overall Study|Withdrawal by Subject|3|||
33629338|NCT01967576|63030511|FG000|Overall Study|Progressed/Removed from treatment|1|||
33629339|NCT01967576|63030511|FG000|Overall Study|Study closing at site|1|||
33629340|NCT01967576|63030511|FG000|Overall Study|Adverse Event|1|||
33629341|NCT01967576|63030511|FG000|Overall Study|Refused further treatment|1|||
33629342|NCT02039687|63030519|FG000|Overall Study|Adverse Event|0|||
33629343|NCT02039687|63030520|FG001|Overall Study|Adverse Event|0|||
33629344|NCT02039687|63030521|FG002|Overall Study|Adverse Event|1|||
33629345|NCT02039687|63030522|FG003|Overall Study|Adverse Event|0|||
33629346|NCT02039687|63030519|FG000|Overall Study|Withdrawal by Subject|0|||
33629347|NCT02039687|63030520|FG001|Overall Study|Withdrawal by Subject|1|||
33536942|NCT02696031|62926916|FG001|Up to Week 24|Lost to Follow-up|1|||
33536943|NCT02696031|62926917|FG002|Up to Week 24|Lost to Follow-up|1|||
33629348|NCT02039687|63030521|FG002|Overall Study|Withdrawal by Subject|0|||
33629349|NCT02039687|63030522|FG003|Overall Study|Withdrawal by Subject|0|||
33629350|NCT02039687|63030519|FG000|Overall Study|treatment assignment could not be confir|0|||
33629351|NCT02039687|63030520|FG001|Overall Study|treatment assignment could not be confir|0|||
33629352|NCT02039687|63030521|FG002|Overall Study|treatment assignment could not be confir|2|||
33629353|NCT02039687|63030522|FG003|Overall Study|treatment assignment could not be confir|0|||
33629354|NCT02003534|63030532|FG000|Overall Study|Lost to Follow-up|47|||
33629355|NCT02055365|63030536|FG000|Overall Study|Prematurely Withdrawn|1|||
33536944|NCT02696031|62926918|FG003|Up to Week 24|Lost to Follow-up|0|||
33536945|NCT02696031|62926919|FG004|Up to Week 24|Lost to Follow-up|0|||
33536946|NCT02696031|62926920|FG005|Up to Week 24|Lost to Follow-up|0|||
33536947|NCT02696031|62926915|FG000|Up to Week 24|Physician Decision|1|||
33536948|NCT02696031|62926916|FG001|Up to Week 24|Physician Decision|0|||
33536949|NCT02696031|62926917|FG002|Up to Week 24|Physician Decision|1|||
33536950|NCT02696031|62926918|FG003|Up to Week 24|Physician Decision|0|||
33629356|NCT02039375|63030547|FG000|Overall Study|Lost to Follow-up|2|||
33629357|NCT02054897|63030554|FG000|Overall Study|Withdrawal by Subject|2|||
33536951|NCT02696031|62926919|FG004|Up to Week 24|Physician Decision|0|||
33536952|NCT02696031|62926920|FG005|Up to Week 24|Physician Decision|0|||
33536953|NCT02696031|62926915|FG000|Up to Week 24|Protocol Violation|1|||
33536954|NCT02696031|62926916|FG001|Up to Week 24|Protocol Violation|0|||
33536955|NCT02696031|62926917|FG002|Up to Week 24|Protocol Violation|0|||
33536956|NCT02696031|62926918|FG003|Up to Week 24|Protocol Violation|0|||
33536957|NCT02696031|62926919|FG004|Up to Week 24|Protocol Violation|0|||
33536958|NCT02696031|62926920|FG005|Up to Week 24|Protocol Violation|0|||
33536959|NCT02696031|62926915|FG000|Up to Week 24|Withdrawal by Subject|4|||
33629358|NCT02054897|63030555|FG001|Overall Study|Withdrawal by Subject|0|||
33629359|NCT02054897|63030556|FG002|Overall Study|Withdrawal by Subject|2|||
33629360|NCT02054897|63030554|FG000|Overall Study|Missing follow-up information|3|||
33629361|NCT02054897|63030555|FG001|Overall Study|Missing follow-up information|5|||
33629362|NCT02054897|63030556|FG002|Overall Study|Missing follow-up information|3|||
33629363|NCT02054897|63030554|FG000|Overall Study|Lost to Follow-up|4|||
33629364|NCT02054897|63030555|FG001|Overall Study|Lost to Follow-up|2|||
33629365|NCT02054897|63030556|FG002|Overall Study|Lost to Follow-up|7|||
33629366|NCT02054897|63030554|FG000|Overall Study|Randomized but not exposed|1|||
33629367|NCT02054897|63030555|FG001|Overall Study|Randomized but not exposed|0|||
33629368|NCT02054897|63030556|FG002|Overall Study|Randomized but not exposed|0|||
33629369|NCT01976312|63030566|FG000|Overall Study|Pregnancy|0|||
33629370|NCT01976312|63030567|FG001|Overall Study|Pregnancy|1|||
33629371|NCT01976312|63030566|FG000|Overall Study|Lost to Follow-up|2|||
33629372|NCT01976312|63030567|FG001|Overall Study|Lost to Follow-up|0|||
33629373|NCT01976312|63030566|FG000|Overall Study|Withdrawal by Subject|7|||
33629374|NCT01976312|63030567|FG001|Overall Study|Withdrawal by Subject|2|||
33629375|NCT01976312|63030566|FG000|Overall Study|Adverse Event|6|||
33629376|NCT01976312|63030567|FG001|Overall Study|Adverse Event|6|||
33629377|NCT01976312|63030566|FG000|Overall Study|Protocol Violation|2|||
33629378|NCT01976312|63030567|FG001|Overall Study|Protocol Violation|0|||
33629379|NCT02039219|63030576|FG000|Treatment|Withdrawal by Subject|1|||
33629380|NCT02039219|63030577|FG001|Treatment|Withdrawal by Subject|0|||
33629381|NCT02039219|63030576|FG000|Treatment|Adverse Event|0|||
33629382|NCT02039219|63030577|FG001|Treatment|Adverse Event|1|||
33629383|NCT02039219|63030576|FG000|Treatment|Physician Decision|1|||
33629384|NCT02039219|63030577|FG001|Treatment|Physician Decision|0|||
33629385|NCT02039219|63030576|FG000|Treatment|Lost to Follow-up|0|||
33629386|NCT02039219|63030577|FG001|Treatment|Lost to Follow-up|1|||
33629387|NCT02039219|63030576|FG000|Treatment|Protocol Violation|1|||
33629388|NCT02039219|63030577|FG001|Treatment|Protocol Violation|0|||
33629389|NCT02039219|63030576|FG000|Treatment|Death|1|||
33629390|NCT02039219|63030577|FG001|Treatment|Death|0|||
33629391|NCT02039219|63030576|FG000|Follow up|Adverse Event|0|||
33629392|NCT02039219|63030577|FG001|Follow up|Adverse Event|1|||
33629393|NCT02053493|63030585|FG000|Overall Study|Withdrawal by Subject|1|||
33629394|NCT02053493|63030586|FG001|Overall Study|Withdrawal by Subject|1|||
33629395|NCT02003144|63030594|FG000|Open Label Maintenance Phase|Other than specified|2|||
33629396|NCT02003144|63030595|FG001|Open Label Maintenance Phase|Other than specified|4|||
33629397|NCT02003144|63030594|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
33629398|NCT02003144|63030595|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
33629399|NCT02003144|63030594|FG000|Open Label Maintenance Phase|Pregnancy|0|||
33629400|NCT02003144|63030595|FG001|Open Label Maintenance Phase|Pregnancy|2|||
33629401|NCT02003144|63030594|FG000|Open Label Maintenance Phase|Physician Decision|1|||
33629402|NCT02003144|63030595|FG001|Open Label Maintenance Phase|Physician Decision|1|||
33629403|NCT02003144|63030594|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
33629404|NCT02003144|63030595|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
33629405|NCT02003144|63030594|FG000|Open Label Maintenance Phase|Adverse Event|2|||
33629406|NCT02003144|63030595|FG001|Open Label Maintenance Phase|Adverse Event|1|||
33629407|NCT02001194|63030606|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
33629408|NCT02001194|63030607|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
33629409|NCT02001194|63030608|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
33629410|NCT02001194|63030609|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
33629411|NCT02001194|63030606|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
33629412|NCT02001194|63030607|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
33629413|NCT02001194|63030608|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
33326197|NCT00891046|62702949|FG004|Overall Study|Withdrawal by Subject|1|||
33326198|NCT00891046|62702945|FG000|Overall Study|Lost to Follow-up|0|||
33629414|NCT02001194|63030609|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
33629415|NCT02038907|63030633|FG000|Overall Study|Protocol Violation|0|||
33629416|NCT02038907|63030634|FG001|Overall Study|Protocol Violation|0|||
33629417|NCT02038907|63030635|FG002|Overall Study|Protocol Violation|0|||
33629418|NCT02038907|63030636|FG003|Overall Study|Protocol Violation|0|||
33629419|NCT02038907|63030637|FG004|Overall Study|Protocol Violation|0|||
33629420|NCT02038907|63030638|FG005|Overall Study|Protocol Violation|0|||
33629421|NCT02038907|63030639|FG006|Overall Study|Protocol Violation|0|||
33629422|NCT02038907|63030640|FG007|Overall Study|Protocol Violation|0|||
33629423|NCT02038907|63030641|FG008|Overall Study|Protocol Violation|0|||
33629424|NCT02038907|63030642|FG009|Overall Study|Protocol Violation|0|||
33629425|NCT02038907|63030643|FG010|Overall Study|Protocol Violation|1|||
33629426|NCT02038907|63030644|FG011|Overall Study|Protocol Violation|0|||
33629427|NCT02038907|63030645|FG012|Overall Study|Protocol Violation|0|||
33629428|NCT02038907|63030646|FG013|Overall Study|Protocol Violation|0|||
33629429|NCT02038907|63030633|FG000|Overall Study|Withdrawal by Subject|0|||
33629430|NCT02038907|63030634|FG001|Overall Study|Withdrawal by Subject|0|||
33629431|NCT02038907|63030635|FG002|Overall Study|Withdrawal by Subject|0|||
33629432|NCT02038907|63030636|FG003|Overall Study|Withdrawal by Subject|0|||
33629433|NCT02038907|63030637|FG004|Overall Study|Withdrawal by Subject|0|||
33629434|NCT02038907|63030638|FG005|Overall Study|Withdrawal by Subject|0|||
33629435|NCT02038907|63030639|FG006|Overall Study|Withdrawal by Subject|0|||
33629436|NCT02038907|63030640|FG007|Overall Study|Withdrawal by Subject|0|||
33629437|NCT02038907|63030641|FG008|Overall Study|Withdrawal by Subject|0|||
33629438|NCT02038907|63030642|FG009|Overall Study|Withdrawal by Subject|0|||
33629439|NCT02038907|63030643|FG010|Overall Study|Withdrawal by Subject|1|||
33536960|NCT02696031|62926916|FG001|Up to Week 24|Withdrawal by Subject|1|||
33536961|NCT02696031|62926917|FG002|Up to Week 24|Withdrawal by Subject|5|||
33536962|NCT02696031|62926918|FG003|Up to Week 24|Withdrawal by Subject|0|||
33536963|NCT02696031|62926919|FG004|Up to Week 24|Withdrawal by Subject|0|||
33629440|NCT02038907|63030644|FG011|Overall Study|Withdrawal by Subject|0|||
33629441|NCT02038907|63030645|FG012|Overall Study|Withdrawal by Subject|0|||
33629442|NCT02038907|63030646|FG013|Overall Study|Withdrawal by Subject|0|||
33629443|NCT02038829|63030678|FG000|Washout Period 1|Death|0|||
33629444|NCT02038829|63030679|FG001|Washout Period 1|Death|0|||
33629445|NCT02038829|63030680|FG002|Washout Period 1|Death|0|||
33536964|NCT02696031|62926920|FG005|Up to Week 24|Withdrawal by Subject|0|||
33536965|NCT02696031|62926915|FG000|Up to Week 52|Adverse Event|4|||
33536966|NCT02696031|62926916|FG001|Up to Week 52|Adverse Event|5|||
33536967|NCT02696031|62926917|FG002|Up to Week 52|Adverse Event|3|||
33536968|NCT02696031|62926918|FG003|Up to Week 52|Adverse Event|0|||
33536969|NCT02696031|62926919|FG004|Up to Week 52|Adverse Event|0|||
33536970|NCT02696031|62926920|FG005|Up to Week 52|Adverse Event|0|||
33536971|NCT02696031|62926915|FG000|Up to Week 52|Lack of Efficacy|10|||
33536972|NCT02696031|62926916|FG001|Up to Week 52|Lack of Efficacy|7|||
33536973|NCT02696031|62926917|FG002|Up to Week 52|Lack of Efficacy|11|||
33536974|NCT02696031|62926918|FG003|Up to Week 52|Lack of Efficacy|0|||
33536975|NCT02696031|62926919|FG004|Up to Week 52|Lack of Efficacy|0|||
33536976|NCT02696031|62926920|FG005|Up to Week 52|Lack of Efficacy|0|||
33536977|NCT02696031|62926915|FG000|Up to Week 52|Lost to Follow-up|1|||
33629446|NCT02038829|63030681|FG003|Washout Period 1|Death|0|||
33629447|NCT02038829|63030682|FG004|Washout Period 1|Death|1|||
33629448|NCT02038829|63030683|FG005|Washout Period 1|Death|0|||
33629449|NCT02038829|63030684|FG006|Washout Period 1|Death|0|||
33629450|NCT02038829|63030685|FG007|Washout Period 1|Death|0|||
33629451|NCT02038829|63030686|FG008|Washout Period 1|Death|0|||
33629452|NCT02038829|63030687|FG009|Washout Period 1|Death|0|||
33629453|NCT02038829|63030688|FG010|Washout Period 1|Death|0|||
33629454|NCT02038829|63030689|FG011|Washout Period 1|Death|0|||
33629455|NCT02038829|63030678|FG000|Treatment Period 2|Adverse Event|0|||
33629456|NCT02038829|63030679|FG001|Treatment Period 2|Adverse Event|0|||
33629457|NCT02038829|63030680|FG002|Treatment Period 2|Adverse Event|0|||
33629458|NCT02038829|63030681|FG003|Treatment Period 2|Adverse Event|0|||
33629459|NCT02038829|63030682|FG004|Treatment Period 2|Adverse Event|0|||
33629460|NCT02038829|63030683|FG005|Treatment Period 2|Adverse Event|0|||
33629461|NCT02038829|63030684|FG006|Treatment Period 2|Adverse Event|0|||
33629462|NCT02038829|63030685|FG007|Treatment Period 2|Adverse Event|0|||
33629463|NCT02038829|63030686|FG008|Treatment Period 2|Adverse Event|0|||
33629464|NCT02038829|63030687|FG009|Treatment Period 2|Adverse Event|0|||
33629465|NCT02038829|63030688|FG010|Treatment Period 2|Adverse Event|1|||
33629466|NCT02038829|63030689|FG011|Treatment Period 2|Adverse Event|0|||
33629467|NCT02038829|63030678|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33629468|NCT02038829|63030679|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33629469|NCT02038829|63030680|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33629470|NCT02038829|63030681|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33629471|NCT02038829|63030682|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33629472|NCT02038829|63030683|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33629473|NCT02038829|63030684|FG006|Treatment Period 2|Withdrawal by Subject|0|||
33326199|NCT00891046|62702946|FG001|Overall Study|Lost to Follow-up|0|||
33536978|NCT02696031|62926916|FG001|Up to Week 52|Lost to Follow-up|1|||
33629474|NCT02038829|63030685|FG007|Treatment Period 2|Withdrawal by Subject|0|||
33629475|NCT02038829|63030686|FG008|Treatment Period 2|Withdrawal by Subject|0|||
33629476|NCT02038829|63030687|FG009|Treatment Period 2|Withdrawal by Subject|0|||
33629477|NCT02038829|63030688|FG010|Treatment Period 2|Withdrawal by Subject|0|||
33629478|NCT02038829|63030689|FG011|Treatment Period 2|Withdrawal by Subject|0|||
33536979|NCT02696031|62926917|FG002|Up to Week 52|Lost to Follow-up|1|||
33536980|NCT02696031|62926918|FG003|Up to Week 52|Lost to Follow-up|0|||
33536981|NCT02696031|62926919|FG004|Up to Week 52|Lost to Follow-up|0|||
33629479|NCT02038829|63030678|FG000|Washout Period 2|Adverse Event|0|||
33629480|NCT02038829|63030679|FG001|Washout Period 2|Adverse Event|0|||
33629481|NCT02038829|63030680|FG002|Washout Period 2|Adverse Event|0|||
33629482|NCT02038829|63030681|FG003|Washout Period 2|Adverse Event|0|||
33629483|NCT02038829|63030682|FG004|Washout Period 2|Adverse Event|0|||
33629484|NCT02038829|63030683|FG005|Washout Period 2|Adverse Event|0|||
33629485|NCT02038829|63030684|FG006|Washout Period 2|Adverse Event|0|||
33536982|NCT02696031|62926920|FG005|Up to Week 52|Lost to Follow-up|0|||
33629486|NCT02038829|63030685|FG007|Washout Period 2|Adverse Event|0|||
33629487|NCT02038829|63030686|FG008|Washout Period 2|Adverse Event|1|||
33629488|NCT02038829|63030687|FG009|Washout Period 2|Adverse Event|0|||
33629489|NCT02038829|63030688|FG010|Washout Period 2|Adverse Event|0|||
33629490|NCT02038829|63030689|FG011|Washout Period 2|Adverse Event|0|||
33629491|NCT02038829|63030678|FG000|Washout Period 2|Withdrawal by Subject|0|||
33629492|NCT02038829|63030679|FG001|Washout Period 2|Withdrawal by Subject|0|||
33629493|NCT02038829|63030680|FG002|Washout Period 2|Withdrawal by Subject|0|||
33629494|NCT02038829|63030681|FG003|Washout Period 2|Withdrawal by Subject|0|||
33629495|NCT02038829|63030682|FG004|Washout Period 2|Withdrawal by Subject|0|||
33629496|NCT02038829|63030683|FG005|Washout Period 2|Withdrawal by Subject|1|||
33629497|NCT02038829|63030684|FG006|Washout Period 2|Withdrawal by Subject|0|||
33629498|NCT02038829|63030685|FG007|Washout Period 2|Withdrawal by Subject|0|||
33629499|NCT02038829|63030686|FG008|Washout Period 2|Withdrawal by Subject|0|||
33629500|NCT02038829|63030687|FG009|Washout Period 2|Withdrawal by Subject|0|||
33629501|NCT02038829|63030688|FG010|Washout Period 2|Withdrawal by Subject|0|||
33629502|NCT02038829|63030689|FG011|Washout Period 2|Withdrawal by Subject|0|||
33629503|NCT02038829|63030678|FG000|Treatment Period 4|Adverse Event|0|||
33629504|NCT02038829|63030679|FG001|Treatment Period 4|Adverse Event|1|||
33629505|NCT02038829|63030680|FG002|Treatment Period 4|Adverse Event|0|||
33629506|NCT02038829|63030681|FG003|Treatment Period 4|Adverse Event|0|||
33629507|NCT02038829|63030682|FG004|Treatment Period 4|Adverse Event|0|||
33629508|NCT02038829|63030683|FG005|Treatment Period 4|Adverse Event|0|||
33629509|NCT02038829|63030684|FG006|Treatment Period 4|Adverse Event|0|||
33629510|NCT02038829|63030685|FG007|Treatment Period 4|Adverse Event|0|||
33629511|NCT02038829|63030686|FG008|Treatment Period 4|Adverse Event|0|||
33629512|NCT02038829|63030687|FG009|Treatment Period 4|Adverse Event|0|||
33629513|NCT02038829|63030688|FG010|Treatment Period 4|Adverse Event|0|||
33629514|NCT02038829|63030689|FG011|Treatment Period 4|Adverse Event|0|||
33629515|NCT02038829|63030678|FG000|Washout Period 4|Adverse Event|0|||
33629516|NCT02038829|63030679|FG001|Washout Period 4|Adverse Event|0|||
33536983|NCT02696031|62926915|FG000|Up to Week 52|Physician Decision|1|||
33536984|NCT02696031|62926916|FG001|Up to Week 52|Physician Decision|1|||
33536985|NCT02696031|62926917|FG002|Up to Week 52|Physician Decision|2|||
33536986|NCT02696031|62926918|FG003|Up to Week 52|Physician Decision|0|||
33536987|NCT02696031|62926919|FG004|Up to Week 52|Physician Decision|0|||
33536988|NCT02696031|62926920|FG005|Up to Week 52|Physician Decision|0|||
33536989|NCT02696031|62926915|FG000|Up to Week 52|Pregnancy|0|||
33536990|NCT02696031|62926916|FG001|Up to Week 52|Pregnancy|2|||
33536991|NCT02696031|62926917|FG002|Up to Week 52|Pregnancy|0|||
33536992|NCT02696031|62926918|FG003|Up to Week 52|Pregnancy|0|||
33536993|NCT02696031|62926919|FG004|Up to Week 52|Pregnancy|0|||
33536994|NCT02696031|62926920|FG005|Up to Week 52|Pregnancy|0|||
33536995|NCT02696031|62926915|FG000|Up to Week 52|Protocol Violation|1|||
33536996|NCT02696031|62926916|FG001|Up to Week 52|Protocol Violation|0|||
33536997|NCT02696031|62926917|FG002|Up to Week 52|Protocol Violation|0|||
33536998|NCT02696031|62926918|FG003|Up to Week 52|Protocol Violation|0|||
33536999|NCT02696031|62926919|FG004|Up to Week 52|Protocol Violation|0|||
33537000|NCT02696031|62926920|FG005|Up to Week 52|Protocol Violation|0|||
33537001|NCT02696031|62926915|FG000|Up to Week 52|Withdrawal by Subject|12|||
33537002|NCT02696031|62926916|FG001|Up to Week 52|Withdrawal by Subject|3|||
33537003|NCT02696031|62926917|FG002|Up to Week 52|Withdrawal by Subject|9|||
33537004|NCT02696031|62926918|FG003|Up to Week 52|Withdrawal by Subject|0|||
33537005|NCT02696031|62926919|FG004|Up to Week 52|Withdrawal by Subject|0|||
33537006|NCT02696031|62926920|FG005|Up to Week 52|Withdrawal by Subject|0|||
33537007|NCT02696031|62926915|FG000|Up to Week 104|Pregnancy|0|||
33537008|NCT02696031|62926916|FG001|Up to Week 104|Pregnancy|2|||
33537009|NCT02696031|62926917|FG002|Up to Week 104|Pregnancy|1|||
33629517|NCT02038829|63030680|FG002|Washout Period 4|Adverse Event|0|||
33629518|NCT02038829|63030681|FG003|Washout Period 4|Adverse Event|0|||
33629519|NCT02038829|63030682|FG004|Washout Period 4|Adverse Event|0|||
33629520|NCT02038829|63030683|FG005|Washout Period 4|Adverse Event|0|||
33629521|NCT02038829|63030684|FG006|Washout Period 4|Adverse Event|1|||
33537010|NCT02696031|62926918|FG003|Up to Week 104|Pregnancy|0|||
33537011|NCT02696031|62926919|FG004|Up to Week 104|Pregnancy|0|||
33537012|NCT02696031|62926920|FG005|Up to Week 104|Pregnancy|0|||
33537013|NCT02696031|62926915|FG000|Up to Week 104|Withdrawal by Subject|15|||
33629522|NCT02038829|63030685|FG007|Washout Period 4|Adverse Event|0|||
33629523|NCT02038829|63030686|FG008|Washout Period 4|Adverse Event|0|||
33629524|NCT02038829|63030687|FG009|Washout Period 4|Adverse Event|0|||
33629525|NCT02038829|63030688|FG010|Washout Period 4|Adverse Event|0|||
33629526|NCT02038829|63030689|FG011|Washout Period 4|Adverse Event|0|||
33629527|NCT02038829|63030678|FG000|Treatment Period 6|Adverse Event|0|||
33629528|NCT02038829|63030679|FG001|Treatment Period 6|Adverse Event|0|||
33629529|NCT02038829|63030680|FG002|Treatment Period 6|Adverse Event|1|||
33537014|NCT02696031|62926916|FG001|Up to Week 104|Withdrawal by Subject|10|||
33537015|NCT02696031|62926917|FG002|Up to Week 104|Withdrawal by Subject|16|||
33537016|NCT02696031|62926918|FG003|Up to Week 104|Withdrawal by Subject|0|||
33537017|NCT02696031|62926919|FG004|Up to Week 104|Withdrawal by Subject|0|||
33629530|NCT02038829|63030681|FG003|Treatment Period 6|Adverse Event|0|||
33460828|NCT00103857|62833822|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
33460829|NCT00103857|62833823|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
33460830|NCT00103857|62833824|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
33629531|NCT02038829|63030682|FG004|Treatment Period 6|Adverse Event|0|||
33629532|NCT02038829|63030683|FG005|Treatment Period 6|Adverse Event|0|||
33629533|NCT02038829|63030684|FG006|Treatment Period 6|Adverse Event|0|||
33629534|NCT02038829|63030685|FG007|Treatment Period 6|Adverse Event|0|||
33629535|NCT02038829|63030686|FG008|Treatment Period 6|Adverse Event|0|||
33629536|NCT02038829|63030687|FG009|Treatment Period 6|Adverse Event|0|||
33629537|NCT02038829|63030688|FG010|Treatment Period 6|Adverse Event|0|||
33629538|NCT02038829|63030689|FG011|Treatment Period 6|Adverse Event|0|||
33629539|NCT02038049|63030706|FG000|Overall Study|Lost to Follow-up|1|||
33460831|NCT00103857|62833818|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
33460832|NCT00103857|62833819|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
33460833|NCT00103857|62833820|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
33460834|NCT00103857|62833821|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
33460835|NCT00103857|62833822|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
33460836|NCT00103857|62833823|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
33460837|NCT00103857|62833824|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
33629540|NCT02038049|63030707|FG001|Overall Study|Lost to Follow-up|0|||
33460838|NCT00103857|62833818|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
33629541|NCT02052011|63030719|FG000|Overall Study|Lost to Follow-up|3|||
33629542|NCT02052011|63030720|FG001|Overall Study|Lost to Follow-up|0|||
33629543|NCT02052011|63030719|FG000|Overall Study|Withdrawal by Subject|1|||
33629544|NCT02052011|63030720|FG001|Overall Study|Withdrawal by Subject|2|||
33629545|NCT02036645|63030738|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33629546|NCT02036645|63030739|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33629547|NCT02036645|63030740|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33629548|NCT02036645|63030741|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33629549|NCT02036645|63030742|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33629550|NCT02036645|63030743|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33629551|NCT02036645|63030744|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
33629552|NCT02036645|63030745|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33629553|NCT02036645|63030746|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33537018|NCT02696031|62926920|FG005|Up to Week 104|Withdrawal by Subject|0|||
33537019|NCT02696031|62926915|FG000|Up to Week 104|Protocol Violation|1|||
33537020|NCT02696031|62926916|FG001|Up to Week 104|Protocol Violation|0|||
33537021|NCT02696031|62926917|FG002|Up to Week 104|Protocol Violation|0|||
33537022|NCT02696031|62926918|FG003|Up to Week 104|Protocol Violation|0|||
33537023|NCT02696031|62926919|FG004|Up to Week 104|Protocol Violation|0|||
33537024|NCT02696031|62926920|FG005|Up to Week 104|Protocol Violation|0|||
33629554|NCT02036645|63030747|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33629555|NCT02036645|63030748|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33537025|NCT02696031|62926915|FG000|Up to Week 104|Physician Decision|1|||
33629556|NCT02036645|63030749|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33537026|NCT02696031|62926916|FG001|Up to Week 104|Physician Decision|2|||
33537027|NCT02696031|62926917|FG002|Up to Week 104|Physician Decision|3|||
33629557|NCT02036645|63030738|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33326200|NCT00891046|62702947|FG002|Overall Study|Lost to Follow-up|0|||
33326201|NCT00891046|62702948|FG003|Overall Study|Lost to Follow-up|0|||
33460839|NCT00103857|62833819|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
33460840|NCT00103857|62833820|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
33460841|NCT00103857|62833821|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
33460842|NCT00103857|62833822|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
33460843|NCT00103857|62833823|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
33460844|NCT00103857|62833824|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
33460845|NCT00103857|62833818|FG000|50-Week Extension Study|patient moved|0|||
33460846|NCT00103857|62833819|FG001|50-Week Extension Study|patient moved|0|||
33537028|NCT02696031|62926918|FG003|Up to Week 104|Physician Decision|0|||
33537029|NCT02696031|62926919|FG004|Up to Week 104|Physician Decision|0|||
33537030|NCT02696031|62926920|FG005|Up to Week 104|Physician Decision|0|||
33537031|NCT02696031|62926915|FG000|Up to Week 104|Lost to Follow-up|2|||
33537032|NCT02696031|62926916|FG001|Up to Week 104|Lost to Follow-up|3|||
33537033|NCT02696031|62926917|FG002|Up to Week 104|Lost to Follow-up|1|||
33537034|NCT02696031|62926918|FG003|Up to Week 104|Lost to Follow-up|0|||
33537035|NCT02696031|62926919|FG004|Up to Week 104|Lost to Follow-up|0|||
33537036|NCT02696031|62926920|FG005|Up to Week 104|Lost to Follow-up|0|||
33629558|NCT02036645|63030739|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33629559|NCT02036645|63030740|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33629560|NCT02036645|63030741|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
33629561|NCT02036645|63030742|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33629562|NCT02036645|63030743|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33629563|NCT02036645|63030744|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33629564|NCT02036645|63030745|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33629565|NCT02036645|63030746|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33629566|NCT02036645|63030747|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33629567|NCT02036645|63030748|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33629568|NCT02036645|63030749|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33629569|NCT02051933|63030789|FG000|Overall Study|Physician Decision|0|||
33629570|NCT02051933|63030790|FG001|Overall Study|Physician Decision|1|||
33629571|NCT02050373|63030803|FG000|Overall Study|Adverse Event|4|||
33629572|NCT02050373|63030804|FG001|Overall Study|Adverse Event|7|||
33629573|NCT02050373|63030803|FG000|Overall Study|Death|3|||
33629574|NCT02050373|63030804|FG001|Overall Study|Death|3|||
33629575|NCT02049437|63030813|FG000|Period 1|Adverse Event|1|||
33629576|NCT02049437|63030814|FG001|Period 1|Adverse Event|1|||
33629577|NCT02049437|63030813|FG000|Period 1|Adverse Event|1|||
33629578|NCT02049437|63030814|FG001|Period 1|Adverse Event|0|||
33629579|NCT02035553|63030822|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
33629580|NCT02035553|63030823|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
33629581|NCT02035553|63030822|FG000|Overall Study|Adverse Event|10|||
33629582|NCT02035553|63030823|FG001|Overall Study|Adverse Event|6|||
33629583|NCT02035553|63030822|FG000|Overall Study|Physician Decision|3|||
33629584|NCT02035553|63030823|FG001|Overall Study|Physician Decision|2|||
33629585|NCT02035553|63030822|FG000|Overall Study|Lack of Efficacy|1|||
33629586|NCT02035553|63030823|FG001|Overall Study|Lack of Efficacy|1|||
33629587|NCT02035553|63030822|FG000|Overall Study|Withdrawal by Subject|4|||
33629588|NCT02035553|63030823|FG001|Overall Study|Withdrawal by Subject|7|||
33629589|NCT02035553|63030822|FG000|Overall Study|Non-compliance with Study Drug|0|||
33629590|NCT02035553|63030823|FG001|Overall Study|Non-compliance with Study Drug|1|||
33629591|NCT02035553|63030822|FG000|Overall Study|Lost to Follow-up|0|||
33629592|NCT02035553|63030823|FG001|Overall Study|Lost to Follow-up|1|||
33629593|NCT02035553|63030822|FG000|Overall Study|Other Reason|0|||
33629594|NCT02035553|63030823|FG001|Overall Study|Other Reason|4|||
33629595|NCT01445080|63030838|FG000|Overall Study|Adverse Event|5|||
33629596|NCT01445080|63030839|FG001|Overall Study|Adverse Event|3|||
33629597|NCT01445080|63030840|FG002|Overall Study|Adverse Event|11|||
33629598|NCT01445080|63030841|FG003|Overall Study|Adverse Event|6|||
33629599|NCT01445080|63030842|FG004|Overall Study|Adverse Event|2|||
33629600|NCT01445080|63030843|FG005|Overall Study|Adverse Event|3|||
33629601|NCT01445080|63030844|FG006|Overall Study|Adverse Event|0|||
33629602|NCT01445080|63030845|FG007|Overall Study|Adverse Event|3|||
33629603|NCT01445080|63030846|FG008|Overall Study|Adverse Event|10|||
33629604|NCT01445080|63030838|FG000|Overall Study|Physician Decision|0|||
33629605|NCT01445080|63030839|FG001|Overall Study|Physician Decision|0|||
33460847|NCT00103857|62833820|FG002|50-Week Extension Study|patient moved|1|||
33460848|NCT00103857|62833821|FG003|50-Week Extension Study|patient moved|2|||
33460849|NCT00103857|62833822|FG004|50-Week Extension Study|patient moved|0|||
33537037|NCT02696031|62926915|FG000|Up to Week 104|Lack of Efficacy|13|||
33537038|NCT02696031|62926916|FG001|Up to Week 104|Lack of Efficacy|12|||
33537039|NCT02696031|62926917|FG002|Up to Week 104|Lack of Efficacy|11|||
33537040|NCT02696031|62926918|FG003|Up to Week 104|Lack of Efficacy|0|||
33537041|NCT02696031|62926919|FG004|Up to Week 104|Lack of Efficacy|0|||
33537042|NCT02696031|62926920|FG005|Up to Week 104|Lack of Efficacy|0|||
33460850|NCT00103857|62833823|FG005|50-Week Extension Study|patient moved|0|||
33460851|NCT00103857|62833824|FG006|50-Week Extension Study|patient moved|0|||
33460852|NCT00103857|62833818|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
33460853|NCT00103857|62833819|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
33460854|NCT00103857|62833820|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
33460855|NCT00103857|62833821|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
33460856|NCT00103857|62833822|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
33460857|NCT00103857|62833823|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
33460858|NCT00103857|62833824|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
33537043|NCT02696031|62926915|FG000|Up to Week 104|Adverse Event|7|||
33537044|NCT02696031|62926916|FG001|Up to Week 104|Adverse Event|11|||
33537045|NCT02696031|62926917|FG002|Up to Week 104|Adverse Event|5|||
33537046|NCT02696031|62926918|FG003|Up to Week 104|Adverse Event|0|||
33629606|NCT01445080|63030840|FG002|Overall Study|Physician Decision|1|||
33629607|NCT01445080|63030841|FG003|Overall Study|Physician Decision|0|||
33629608|NCT01445080|63030842|FG004|Overall Study|Physician Decision|0|||
33629609|NCT01445080|63030843|FG005|Overall Study|Physician Decision|3|||
33629610|NCT01445080|63030844|FG006|Overall Study|Physician Decision|2|||
33629611|NCT01445080|63030845|FG007|Overall Study|Physician Decision|2|||
33629612|NCT01445080|63030846|FG008|Overall Study|Physician Decision|0|||
33629613|NCT01445080|63030838|FG000|Overall Study|Withdrawal by Subject|1|||
33629614|NCT01445080|63030839|FG001|Overall Study|Withdrawal by Subject|0|||
33537047|NCT02696031|62926919|FG004|Up to Week 104|Adverse Event|0|||
33537048|NCT02696031|62926920|FG005|Up to Week 104|Adverse Event|0|||
33537049|NCT02696031|62926915|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
33537050|NCT02696031|62926916|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
33537051|NCT02696031|62926917|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
33537052|NCT02696031|62926918|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
33537053|NCT02696031|62926919|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
33537054|NCT02696031|62926920|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
33537055|NCT02696031|62926915|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
33537056|NCT02696031|62926916|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
33537057|NCT02696031|62926917|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
33537058|NCT02696031|62926918|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
33537059|NCT02696031|62926919|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
33537060|NCT02696031|62926920|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
33537061|NCT02696031|62926915|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
33537062|NCT02696031|62926916|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
33537063|NCT02696031|62926917|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
33537064|NCT02696031|62926918|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
33537065|NCT02696031|62926919|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
33537066|NCT02696031|62926920|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
33537067|NCT02696031|62926915|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
33537068|NCT02696031|62926916|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
33629615|NCT01445080|63030840|FG002|Overall Study|Withdrawal by Subject|0|||
33629616|NCT01445080|63030841|FG003|Overall Study|Withdrawal by Subject|1|||
33629617|NCT01445080|63030842|FG004|Overall Study|Withdrawal by Subject|0|||
33629618|NCT01445080|63030843|FG005|Overall Study|Withdrawal by Subject|0|||
33629619|NCT01445080|63030844|FG006|Overall Study|Withdrawal by Subject|0|||
33629620|NCT01445080|63030845|FG007|Overall Study|Withdrawal by Subject|0|||
33629621|NCT01445080|63030846|FG008|Overall Study|Withdrawal by Subject|2|||
33629622|NCT01445080|63030838|FG000|Overall Study|Ineligible/Inevaluable|1|||
33629623|NCT01445080|63030839|FG001|Overall Study|Ineligible/Inevaluable|2|||
33629624|NCT01445080|63030840|FG002|Overall Study|Ineligible/Inevaluable|0|||
33629625|NCT01445080|63030841|FG003|Overall Study|Ineligible/Inevaluable|1|||
33629626|NCT01445080|63030842|FG004|Overall Study|Ineligible/Inevaluable|2|||
33629627|NCT01445080|63030843|FG005|Overall Study|Ineligible/Inevaluable|3|||
33629628|NCT01445080|63030844|FG006|Overall Study|Ineligible/Inevaluable|0|||
33629629|NCT01445080|63030845|FG007|Overall Study|Ineligible/Inevaluable|0|||
33629630|NCT01445080|63030846|FG008|Overall Study|Ineligible/Inevaluable|6|||
33629631|NCT02035475|63030881|FG000|Overall Study|Withdrawal by Subject|4|||
33629632|NCT02035475|63030881|FG000|Overall Study|Physician Decision|1|||
33629633|NCT02035475|63030881|FG000|Overall Study|Equipment Error|1|||
33629634|NCT01444456|63030887|FG000|Overall Study|Withdrawal by Subject|21|||
33629635|NCT01444456|63030887|FG000|Overall Study|Physician Decision|9|||
33629636|NCT01444456|63030887|FG000|Overall Study|Lost to Follow-up|37|||
33629637|NCT01444456|63030887|FG000|Overall Study|Death|73|||
33629638|NCT01444456|63030887|FG000|Overall Study|Ineligibility determined|23|||
33629639|NCT01444456|63030887|FG000|Overall Study|Other|18|||
33629640|NCT01444456|63030887|FG000|Overall Study|Not treated|104|||
33629641|NCT01438294|63030893|FG000|Overall Study|Lost to Follow-up|3|||
33629642|NCT01438294|63030894|FG001|Overall Study|Lost to Follow-up|7|||
33629643|NCT02033759|63030902|FG000|Overall Study|Withdrawal by Subject|2|||
33629644|NCT02033759|63030903|FG001|Overall Study|Withdrawal by Subject|1|||
33629645|NCT02033759|63030902|FG000|Overall Study|Protocol Violation|1|||
33629646|NCT02033759|63030903|FG001|Overall Study|Protocol Violation|1|||
33460859|NCT00103857|62833818|FG000|50-Week Extension Study|reason unspecified|0|||
33460860|NCT00103857|62833819|FG001|50-Week Extension Study|reason unspecified|0|||
33460861|NCT00103857|62833820|FG002|50-Week Extension Study|reason unspecified|0|||
33460862|NCT00103857|62833821|FG003|50-Week Extension Study|reason unspecified|0|||
33460863|NCT00103857|62833822|FG004|50-Week Extension Study|reason unspecified|1|||
33460864|NCT00103857|62833823|FG005|50-Week Extension Study|reason unspecified|0|||
33460865|NCT00103857|62833824|FG006|50-Week Extension Study|reason unspecified|0|||
33460866|NCT03587584|62833841|FG000|Overall Study|SOC deviations|4|||
33460867|NCT03587584|62833842|FG001|Overall Study|SOC deviations|6|||
33460868|NCT03587584|62833841|FG000|Overall Study|Incomplete data|0|||
33460869|NCT03587584|62833842|FG001|Overall Study|Incomplete data|3|||
33460870|NCT03586726|62833848|FG000|Overall Study|Withdrawal by Subject|1|||
33460871|NCT03586648|62833852|FG000|Period 1|Withdrawal by Subject|0|||
33460872|NCT03586648|62833853|FG001|Period 1|Withdrawal by Subject|1|||
33460873|NCT03586648|62833852|FG000|Period 1|Lost to Follow-up|1|||
33629647|NCT01959529|63030911|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
33629648|NCT01959529|63030912|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
33629649|NCT01959529|63030911|FG000|Overall Study|Lost to Follow-up|4|||
33629650|NCT01959529|63030912|FG001|Overall Study|Lost to Follow-up|1|||
33629651|NCT01959529|63030911|FG000|Overall Study|Other|70|||
33629652|NCT01959529|63030912|FG001|Overall Study|Other|68|||
33629653|NCT01959529|63030911|FG000|Overall Study|Hypoglycaemia|1|||
33629654|NCT01959529|63030912|FG001|Overall Study|Hypoglycaemia|1|||
33629655|NCT01959529|63030911|FG000|Overall Study|Lack of glycaemic control|1|||
33629656|NCT01959529|63030912|FG001|Overall Study|Lack of glycaemic control|1|||
33629657|NCT02033369|63030920|FG000|Overall Study|Physician Decision|1|||
33629658|NCT02033369|63030921|FG001|Overall Study|Physician Decision|2|||
33629659|NCT02033369|63030920|FG000|Overall Study|Not a good demographic match|0|||
33629660|NCT02033369|63030921|FG001|Overall Study|Not a good demographic match|2|||
33629661|NCT02033369|63030920|FG000|Overall Study|Withdrawal by Subject|1|||
33629662|NCT02033369|63030921|FG001|Overall Study|Withdrawal by Subject|1|||
33629663|NCT02033369|63030920|FG000|Overall Study|Lost to Follow-up|1|||
33629664|NCT02033369|63030921|FG001|Overall Study|Lost to Follow-up|0|||
33629665|NCT02033369|63030920|FG000|Overall Study|Protocol Violation|2|||
33629666|NCT02033369|63030921|FG001|Overall Study|Protocol Violation|0|||
33629667|NCT02032901|63030927|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
33629668|NCT02032901|63030928|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
33629669|NCT02032901|63030927|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
33629670|NCT02032901|63030928|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
33629671|NCT02020967|63030938|FG000|Overall Study|Withdrawal by Subject|51|||
33629672|NCT01986829|63030944|FG000|Overall Study|Death|1|||
33629673|NCT01986751|63030953|FG000|Overall Study|improperly consented|10|||
33629674|NCT01986751|63030954|FG001|Overall Study|improperly consented|2|||
33629675|NCT02004847|63030966|FG000|Overall Study|Protocol Violation|1|||
33537069|NCT02696031|62926917|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
33537070|NCT02696031|62926918|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
33537071|NCT02696031|62926919|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
33537072|NCT02696031|62926920|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
33537073|NCT02696031|62926915|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
33537074|NCT02696031|62926916|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
33537075|NCT02696031|62926917|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
33537076|NCT02696031|62926918|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
33537077|NCT02696031|62926919|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
33537078|NCT02696031|62926920|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
33537079|NCT02696031|62926915|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
33537080|NCT02696031|62926916|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
33537081|NCT02696031|62926917|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
33537082|NCT02696031|62926918|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
33537083|NCT02696031|62926919|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
33537084|NCT02696031|62926920|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
33629676|NCT02004847|63030967|FG001|Overall Study|Protocol Violation|1|||
33537085|NCT02696031|62926915|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
33537086|NCT02696031|62926916|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
33537087|NCT02696031|62926917|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
33537088|NCT02696031|62926918|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
33537089|NCT02696031|62926919|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
33629677|NCT01438060|63030984|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
33629678|NCT01438060|63030985|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
33629679|NCT01438060|63030984|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
33629680|NCT01438060|63030985|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
33629681|NCT01438060|63030984|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
33629682|NCT01438060|63030985|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
33629683|NCT01438060|63030984|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
33629684|NCT01438060|63030985|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
33629685|NCT01438060|63030984|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
33629686|NCT01438060|63030985|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
33537090|NCT02696031|62926920|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
33537091|NCT00397254|62926929|FG000|Overall Study|Lost to Follow-up|2|||
33537092|NCT00397254|62926930|FG001|Overall Study|Lost to Follow-up|2|||
33629687|NCT01438060|63030984|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
33629688|NCT01438060|63030985|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
33629689|NCT01438060|63030984|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
33629690|NCT01438060|63030985|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
33629691|NCT01438060|63030984|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
33629692|NCT01438060|63030985|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
33629693|NCT01438060|63030984|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
33629694|NCT01438060|63030985|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
33629695|NCT01438060|63030984|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
33629696|NCT01438060|63030985|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
33629697|NCT01438060|63030984|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
33629698|NCT01438060|63030985|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
33629699|NCT01438060|63030984|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
33629700|NCT01438060|63030985|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
33629701|NCT01438060|63030984|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
33629702|NCT01438060|63030985|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
33629703|NCT01438060|63030984|FG000|On Study Beyond Week 140|Adverse Event|0|||
33629704|NCT01438060|63030985|FG001|On Study Beyond Week 140|Adverse Event|2|||
33629705|NCT01438060|63030984|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
33629706|NCT01438060|63030985|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
33629707|NCT01438060|63030984|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
33629708|NCT01438060|63030985|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
33629709|NCT01438060|63030984|FG000|On Study Beyond Week 140|Death|0|||
33629710|NCT01438060|63030985|FG001|On Study Beyond Week 140|Death|1|||
33629711|NCT01438060|63030984|FG000|On Study Beyond Week 140|Other Reason|0|||
33629712|NCT01438060|63030985|FG001|On Study Beyond Week 140|Other Reason|3|||
33629713|NCT01469182|63030998|FG000|Overall Study|Adverse Event|21|||
33629714|NCT01469182|63030999|FG001|Overall Study|Adverse Event|3|||
33629715|NCT01469182|63030998|FG000|Overall Study|Lost to Follow-up|3|||
33629716|NCT01469182|63030999|FG001|Overall Study|Lost to Follow-up|0|||
33629717|NCT01469182|63030998|FG000|Overall Study|Withdrawal by Subject|4|||
33629718|NCT01469182|63030999|FG001|Overall Study|Withdrawal by Subject|1|||
33629719|NCT01469182|63030998|FG000|Overall Study|Protocol Violation|4|||
33629720|NCT01469182|63030999|FG001|Overall Study|Protocol Violation|2|||
33629721|NCT01469182|63030998|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
33629722|NCT01469182|63030999|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
33629723|NCT01444378|63031005|FG000|Overall Study|Lost to Follow-up|1|||
33629724|NCT01444378|63031005|FG000|Overall Study|Withdrawal by Subject|1|||
33629725|NCT01444378|63031005|FG000|Overall Study|Death|3|||
33629726|NCT01444378|63031005|FG000|Overall Study|Administrative Closure Of The Study|2|||
33629727|NCT01444378|63031005|FG000|Overall Study|Missed Visits|10|||
33629728|NCT02020889|63031014|FG000|Overall Study|Adverse Event|0|||
33629729|NCT02020889|63031015|FG001|Overall Study|Adverse Event|1|||
33629730|NCT02020889|63031014|FG000|Overall Study|Lack of Efficacy|1|||
33629731|NCT02020889|63031015|FG001|Overall Study|Lack of Efficacy|0|||
33629732|NCT02020889|63031014|FG000|Overall Study|Lost to Follow-up|1|||
33629733|NCT02020889|63031015|FG001|Overall Study|Lost to Follow-up|0|||
33460874|NCT03586648|62833853|FG001|Period 1|Lost to Follow-up|1|||
33460875|NCT03586648|62833852|FG000|Period 1|Adverse Event|1|||
33460876|NCT03586648|62833853|FG001|Period 1|Adverse Event|0|||
33460877|NCT03586648|62833852|FG000|Period 1|Study related symptoms or complaints|2|||
33460878|NCT03586648|62833853|FG001|Period 1|Study related symptoms or complaints|1|||
33460879|NCT03586648|62833852|FG000|Period 1|Physician Decision|0|||
33460880|NCT03586648|62833853|FG001|Period 1|Physician Decision|1|||
33460881|NCT03586648|62833852|FG000|Period 2|Adverse Event|1|||
33460882|NCT03586648|62833853|FG001|Period 2|Adverse Event|0|||
33460883|NCT02892448|62833862|FG000|Overall Study|Screening failure|2|||
33460884|NCT02892448|62833863|FG001|Overall Study|Screening failure|2|||
33629734|NCT02020889|63031014|FG000|Overall Study|Physician Decision|2|||
33629735|NCT02020889|63031015|FG001|Overall Study|Physician Decision|0|||
33629736|NCT02020889|63031014|FG000|Overall Study|Withdrawal by Subject|3|||
33629737|NCT02020889|63031015|FG001|Overall Study|Withdrawal by Subject|2|||
33629738|NCT01444300|63031023|FG000|Overall Study|Adverse Event|4|||
33629739|NCT01444300|63031024|FG001|Overall Study|Adverse Event|0|||
33629740|NCT01443364|63031031|FG000|Overall Study|Lack of Efficacy|14|||
33629741|NCT01443364|63031031|FG000|Overall Study|Lost to Follow-up|3|||
33460885|NCT02892448|62833864|FG002|Overall Study|Screening failure|1|||
33629742|NCT01443364|63031031|FG000|Overall Study|Withdrawal by Subject|5|||
33629743|NCT01443364|63031031|FG000|Overall Study|Other Reason|4|||
33629744|NCT01443364|63031031|FG000|Overall Study|SAE, non-fatal|6|||
33629745|NCT01443364|63031031|FG000|Overall Study|AE, non-serious non-fatal|8|||
33629746|NCT01443364|63031031|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33629747|NCT02020577|63031037|FG000|Overall Study|Progressive disease|3|||
33629748|NCT02020577|63031038|FG001|Overall Study|Progressive disease|38|||
33629749|NCT02020577|63031037|FG000|Overall Study|Other AE or clinical progression|0|||
33537093|NCT01369641|62926934|FG000|Overall Study|Withdrawal by Subject|1|||
33537094|NCT00529152|62926938|FG000|Overall Study|Adverse Event|2|||
33629750|NCT02020577|63031038|FG001|Overall Study|Other AE or clinical progression|15|||
33629751|NCT02020577|63031037|FG000|Overall Study|Withdrawal by Subject|0|||
33629752|NCT02020577|63031038|FG001|Overall Study|Withdrawal by Subject|1|||
33629753|NCT02020577|63031037|FG000|Overall Study|Other than stated above|0|||
33537095|NCT00529152|62926938|FG000|Overall Study|Withdrawal by Subject|2|||
33537096|NCT00529152|62926938|FG000|Overall Study|Lost to Follow-up|1|||
33537097|NCT02605174|62926945|FG000|Overall Study|Adverse Event|0|||
33537098|NCT02605174|62926946|FG001|Overall Study|Adverse Event|0|||
33537099|NCT02605174|62926947|FG002|Overall Study|Adverse Event|1|||
33537100|NCT02605174|62926948|FG003|Overall Study|Adverse Event|0|||
33537101|NCT02605174|62926949|FG004|Overall Study|Adverse Event|4|||
33537102|NCT02605174|62926950|FG005|Overall Study|Adverse Event|0|||
33629754|NCT02020577|63031038|FG001|Overall Study|Other than stated above|1|||
33537103|NCT02605174|62926951|FG006|Overall Study|Adverse Event|0|||
33629755|NCT02020031|63031048|FG000|Overall Study|Physician Decision|1|||
33629756|NCT02020031|63031049|FG001|Overall Study|Physician Decision|1|||
33629757|NCT04179305|63031059|FG000|Overall Study|Death|1|||
33629758|NCT04179305|63031060|FG001|Overall Study|Death|1|||
33629759|NCT04179305|63031061|FG002|Overall Study|Death|0|||
33629760|NCT04179305|63031062|FG003|Overall Study|Death|0|||
33629761|NCT04179305|63031059|FG000|Overall Study|Lost to Follow-up|1|||
33629762|NCT04179305|63031060|FG001|Overall Study|Lost to Follow-up|1|||
33629763|NCT04179305|63031061|FG002|Overall Study|Lost to Follow-up|0|||
33629764|NCT04179305|63031062|FG003|Overall Study|Lost to Follow-up|0|||
33629765|NCT04179305|63031059|FG000|Overall Study|Withdrawal by Subject|0|||
33629766|NCT04179305|63031060|FG001|Overall Study|Withdrawal by Subject|1|||
33629767|NCT04179305|63031061|FG002|Overall Study|Withdrawal by Subject|0|||
33629768|NCT04179305|63031062|FG003|Overall Study|Withdrawal by Subject|0|||
33629769|NCT04179305|63031059|FG000|Overall Study|Did not have scan|1|||
33629770|NCT04179305|63031060|FG001|Overall Study|Did not have scan|0|||
33326202|NCT00891046|62702949|FG004|Overall Study|Lost to Follow-up|1|||
33326203|NCT00889720|62702976|FG000|Overall Study|Withdrawal by Subject|4|||
33629771|NCT04179305|63031061|FG002|Overall Study|Did not have scan|0|||
33629772|NCT04179305|63031062|FG003|Overall Study|Did not have scan|0|||
33629773|NCT04179305|63031059|FG000|Overall Study|In hospice care|3|||
33629774|NCT04179305|63031060|FG001|Overall Study|In hospice care|0|||
33629775|NCT04179305|63031061|FG002|Overall Study|In hospice care|0|||
33537104|NCT02605174|62926945|FG000|Overall Study|Lost to Follow-up|20|||
33537105|NCT02605174|62926946|FG001|Overall Study|Lost to Follow-up|7|||
33537106|NCT02605174|62926947|FG002|Overall Study|Lost to Follow-up|27|||
33537107|NCT02605174|62926948|FG003|Overall Study|Lost to Follow-up|10|||
33537108|NCT02605174|62926949|FG004|Overall Study|Lost to Follow-up|20|||
33537109|NCT02605174|62926950|FG005|Overall Study|Lost to Follow-up|10|||
33537110|NCT02605174|62926951|FG006|Overall Study|Lost to Follow-up|29|||
33537111|NCT02605174|62926945|FG000|Overall Study|Protocol Violation|10|||
33537112|NCT02605174|62926946|FG001|Overall Study|Protocol Violation|4|||
33537113|NCT02605174|62926947|FG002|Overall Study|Protocol Violation|14|||
33629776|NCT04179305|63031062|FG003|Overall Study|In hospice care|0|||
33629777|NCT02019719|63031078|FG000|Overall Study|Adverse Event|1|||
33629778|NCT02019719|63031079|FG001|Overall Study|Adverse Event|0|||
33629779|NCT02019719|63031080|FG002|Overall Study|Adverse Event|0|||
33629780|NCT02019719|63031081|FG003|Overall Study|Adverse Event|1|||
33537114|NCT02605174|62926948|FG003|Overall Study|Protocol Violation|6|||
33537115|NCT02605174|62926949|FG004|Overall Study|Protocol Violation|7|||
33537116|NCT02605174|62926950|FG005|Overall Study|Protocol Violation|7|||
33537117|NCT02605174|62926951|FG006|Overall Study|Protocol Violation|12|||
33537118|NCT02605174|62926945|FG000|Overall Study|Pregnancy|1|||
33629781|NCT02019719|63031082|FG004|Overall Study|Adverse Event|1|||
33537119|NCT02605174|62926946|FG001|Overall Study|Pregnancy|0|||
33629782|NCT02019719|63031078|FG000|Overall Study|Protocol Violation|1|||
33460886|NCT03585712|62833872|FG000|Treatment Period 1|Protocol Violation|1|||
33460887|NCT03585712|62833873|FG001|Treatment Period 1|Protocol Violation|0|||
33537120|NCT02605174|62926947|FG002|Overall Study|Pregnancy|0|||
33537121|NCT02605174|62926948|FG003|Overall Study|Pregnancy|2|||
33537122|NCT02605174|62926949|FG004|Overall Study|Pregnancy|0|||
33537123|NCT02605174|62926950|FG005|Overall Study|Pregnancy|0|||
33537124|NCT02605174|62926951|FG006|Overall Study|Pregnancy|0|||
33537125|NCT02605174|62926945|FG000|Overall Study|Withdrawal by Subject|9|||
33537126|NCT02605174|62926946|FG001|Overall Study|Withdrawal by Subject|6|||
33537127|NCT02605174|62926947|FG002|Overall Study|Withdrawal by Subject|14|||
33537128|NCT02605174|62926948|FG003|Overall Study|Withdrawal by Subject|11|||
33537129|NCT02605174|62926949|FG004|Overall Study|Withdrawal by Subject|6|||
33537130|NCT02605174|62926950|FG005|Overall Study|Withdrawal by Subject|4|||
33537131|NCT02605174|62926951|FG006|Overall Study|Withdrawal by Subject|15|||
33537132|NCT02605174|62926945|FG000|Overall Study|Physician Decision|2|||
33537133|NCT02605174|62926946|FG001|Overall Study|Physician Decision|0|||
33537134|NCT02605174|62926947|FG002|Overall Study|Physician Decision|0|||
33629783|NCT02019719|63031079|FG001|Overall Study|Protocol Violation|1|||
33629784|NCT02019719|63031080|FG002|Overall Study|Protocol Violation|0|||
33460888|NCT03585712|62833874|FG002|Treatment Period 1|Protocol Violation|0|||
33460889|NCT03585712|62833872|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
33460890|NCT03585712|62833873|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
33460891|NCT03585712|62833874|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
33460892|NCT03585712|62833872|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
33460893|NCT03585712|62833873|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
33460894|NCT03585712|62833874|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
33460895|NCT03585712|62833872|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
33460896|NCT03585712|62833873|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
33460897|NCT03585712|62833874|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
33460898|NCT03585244|62833891|FG000|Overall Study|Withdrawal by Subject|15|||
33460899|NCT00074984|62833897|FG000|Overall Study|Death|1|||
33460900|NCT00074984|62833898|FG001|Overall Study|Death|2|||
33460901|NCT00074984|62833897|FG000|Overall Study|Withdrawal by Subject|2|||
33460902|NCT00074984|62833898|FG001|Overall Study|Withdrawal by Subject|3|||
33460903|NCT00074984|62833897|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
33460904|NCT00074984|62833898|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
33537135|NCT02605174|62926948|FG003|Overall Study|Physician Decision|0|||
33537136|NCT02605174|62926949|FG004|Overall Study|Physician Decision|0|||
33537137|NCT02605174|62926950|FG005|Overall Study|Physician Decision|0|||
33537138|NCT02605174|62926951|FG006|Overall Study|Physician Decision|3|||
33460905|NCT03583606|62833908|FG000|Overall Study|Lost to Follow-up|0|||
33326204|NCT00889720|62702976|FG000|Overall Study|Other|4|||
33326205|NCT01116648|62702995|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
33326206|NCT01116648|62702996|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
33326207|NCT01116648|62702997|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
33629785|NCT02019719|63031081|FG003|Overall Study|Protocol Violation|0|||
33629786|NCT02019719|63031082|FG004|Overall Study|Protocol Violation|0|||
33629787|NCT02019719|63031078|FG000|Overall Study|Protocol defined stopping criteria|2|||
33629788|NCT02019719|63031079|FG001|Overall Study|Protocol defined stopping criteria|0|||
33629789|NCT02019719|63031080|FG002|Overall Study|Protocol defined stopping criteria|0|||
33326208|NCT01116648|62702998|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
33326209|NCT01116648|62702999|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
33326210|NCT01116648|62703000|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
33537139|NCT02605174|62926945|FG000|Overall Study|Randomization Failure|22|||
33537140|NCT02605174|62926946|FG001|Overall Study|Randomization Failure|6|||
33537141|NCT02605174|62926947|FG002|Overall Study|Randomization Failure|20|||
33537142|NCT02605174|62926948|FG003|Overall Study|Randomization Failure|7|||
33537143|NCT02605174|62926949|FG004|Overall Study|Randomization Failure|16|||
33537144|NCT02605174|62926950|FG005|Overall Study|Randomization Failure|11|||
33537145|NCT02605174|62926951|FG006|Overall Study|Randomization Failure|30|||
33537146|NCT02604550|62926979|FG000|Overall Study|Lost to Follow-up|7|||
33537147|NCT02604550|62926980|FG001|Overall Study|Lost to Follow-up|6|||
33537148|NCT02604550|62926979|FG000|Overall Study|Withdrawal by Subject|0|||
33629790|NCT02019719|63031081|FG003|Overall Study|Protocol defined stopping criteria|1|||
33326211|NCT01116648|62703001|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
33326212|NCT01116648|62703002|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
33537149|NCT02604550|62926980|FG001|Overall Study|Withdrawal by Subject|1|||
33629791|NCT02019719|63031082|FG004|Overall Study|Protocol defined stopping criteria|1|||
33629792|NCT02019719|63031078|FG000|Overall Study|Physician Decision|2|||
33629793|NCT02019719|63031079|FG001|Overall Study|Physician Decision|0|||
33629794|NCT02019719|63031080|FG002|Overall Study|Physician Decision|0|||
33629795|NCT02019719|63031081|FG003|Overall Study|Physician Decision|0|||
33629796|NCT02019719|63031082|FG004|Overall Study|Physician Decision|0|||
33629797|NCT02030405|63031101|FG000|Overall Study|Withdrawal by Subject|1|||
33629798|NCT02030405|63031101|FG000|Overall Study|Lost to Follow-up|1|||
33629799|NCT01975376|63031108|FG000|Overall Study|Adverse Event|5|||
33629800|NCT01975376|63031109|FG001|Overall Study|Adverse Event|5|||
33629801|NCT01975376|63031108|FG000|Overall Study|Death|65|||
33629802|NCT01975376|63031109|FG001|Overall Study|Death|72|||
33629803|NCT01975376|63031108|FG000|Overall Study|Lost to Follow-up|70|||
33629804|NCT01975376|63031109|FG001|Overall Study|Lost to Follow-up|66|||
33629805|NCT01975376|63031108|FG000|Overall Study|Withdrew consent|68|||
33629806|NCT01975376|63031109|FG001|Overall Study|Withdrew consent|62|||
33629807|NCT01975376|63031108|FG000|Overall Study|Other|2|||
33629808|NCT01975376|63031109|FG001|Overall Study|Other|4|||
33629809|NCT01975376|63031108|FG000|Overall Study|Randomized, Not Treated|16|||
33629810|NCT01975376|63031109|FG001|Overall Study|Randomized, Not Treated|8|||
33629811|NCT01443130|63031121|FG000|Overall Study|Lost to Follow-up|44|||
33629812|NCT01443130|63031122|FG001|Overall Study|Lost to Follow-up|42|||
33629813|NCT01443130|63031123|FG002|Overall Study|Lost to Follow-up|50|||
33629814|NCT01443130|63031124|FG003|Overall Study|Lost to Follow-up|23|||
33629815|NCT01443130|63031125|FG004|Overall Study|Lost to Follow-up|25|||
33629816|NCT01443130|63031126|FG005|Overall Study|Lost to Follow-up|21|||
33629817|NCT01443130|63031121|FG000|Overall Study|Death|0|||
33629818|NCT01443130|63031122|FG001|Overall Study|Death|1|||
33629819|NCT01443130|63031123|FG002|Overall Study|Death|0|||
33629820|NCT01443130|63031124|FG003|Overall Study|Death|7|||
33629821|NCT01443130|63031125|FG004|Overall Study|Death|10|||
33629822|NCT01443130|63031126|FG005|Overall Study|Death|8|||
33629823|NCT01443130|63031121|FG000|Overall Study|Adverse Event|2|||
33629824|NCT01443130|63031122|FG001|Overall Study|Adverse Event|1|||
33629825|NCT01443130|63031123|FG002|Overall Study|Adverse Event|1|||
33460906|NCT03583606|62833909|FG001|Overall Study|Lost to Follow-up|1|||
33460907|NCT03583606|62833910|FG002|Overall Study|Lost to Follow-up|0|||
33460908|NCT03583606|62833908|FG000|Overall Study|Ineligible at baseline|1|||
33460909|NCT03583606|62833909|FG001|Overall Study|Ineligible at baseline|0|||
33460910|NCT03583606|62833910|FG002|Overall Study|Ineligible at baseline|0|||
33460911|NCT03583450|62833921|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
33460912|NCT03583450|62833922|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
33460913|NCT03583372|62833934|FG000|Overall Study|Withdrawal by Subject|6|||
33460914|NCT03583372|62833935|FG001|Overall Study|Withdrawal by Subject|11|||
33537150|NCT02604550|62926979|FG000|Overall Study|Incomplete data using paper journal|18|||
33537151|NCT02604550|62926980|FG001|Overall Study|Incomplete data using paper journal|19|||
33537152|NCT02591290|62926986|FG000|Overall Study|Withdrawal by Subject|2|||
33537153|NCT02791893|62926992|FG000|Blinded Phase|Lost to Follow-up|2|||
33537154|NCT02791893|62926993|FG001|Blinded Phase|Lost to Follow-up|2|||
33537155|NCT02791893|62926992|FG000|Blinded Phase|Withdrawal by Subject|1|||
33537156|NCT02791893|62926993|FG001|Blinded Phase|Withdrawal by Subject|2|||
33629826|NCT01443130|63031124|FG003|Overall Study|Adverse Event|0|||
33629827|NCT01443130|63031125|FG004|Overall Study|Adverse Event|0|||
33629828|NCT01443130|63031126|FG005|Overall Study|Adverse Event|0|||
33460915|NCT03583372|62833936|FG002|Overall Study|Withdrawal by Subject|7|||
33537157|NCT02791893|62926992|FG000|Open Label Phase|Lost to Follow-up|3|||
33629829|NCT01443130|63031121|FG000|Overall Study|Protocol Violation|2|||
33629830|NCT01443130|63031122|FG001|Overall Study|Protocol Violation|1|||
33629831|NCT01443130|63031123|FG002|Overall Study|Protocol Violation|3|||
33629832|NCT01443130|63031124|FG003|Overall Study|Protocol Violation|2|||
33629833|NCT01443130|63031125|FG004|Overall Study|Protocol Violation|2|||
33629834|NCT01443130|63031126|FG005|Overall Study|Protocol Violation|3|||
33629835|NCT01443130|63031121|FG000|Overall Study|Withdrawal by Subject|15|||
33629836|NCT01443130|63031122|FG001|Overall Study|Withdrawal by Subject|14|||
33629837|NCT01443130|63031123|FG002|Overall Study|Withdrawal by Subject|12|||
33629838|NCT01443130|63031124|FG003|Overall Study|Withdrawal by Subject|7|||
33629839|NCT01443130|63031125|FG004|Overall Study|Withdrawal by Subject|7|||
33629840|NCT01443130|63031126|FG005|Overall Study|Withdrawal by Subject|2|||
33629841|NCT01443130|63031121|FG000|Overall Study|Death of Subject's Infant|5|||
33629842|NCT01443130|63031122|FG001|Overall Study|Death of Subject's Infant|10|||
33629843|NCT01443130|63031123|FG002|Overall Study|Death of Subject's Infant|11|||
33629844|NCT01443130|63031124|FG003|Overall Study|Death of Subject's Infant|0|||
33629845|NCT01443130|63031125|FG004|Overall Study|Death of Subject's Infant|0|||
33629846|NCT01443130|63031126|FG005|Overall Study|Death of Subject's Infant|0|||
33629847|NCT01436500|63031142|FG000|Overall Study|Death|1|||
33629848|NCT01436500|63031143|FG001|Overall Study|Death|0|||
33629849|NCT01436500|63031144|FG002|Overall Study|Death|0|||
33629850|NCT01436500|63031145|FG003|Overall Study|Death|0|||
33629851|NCT01436500|63031146|FG004|Overall Study|Death|0|||
33629852|NCT01436500|63031142|FG000|Overall Study|Adverse Event|0|||
33629853|NCT01436500|63031143|FG001|Overall Study|Adverse Event|2|||
33629854|NCT01436500|63031144|FG002|Overall Study|Adverse Event|2|||
33629855|NCT01436500|63031145|FG003|Overall Study|Adverse Event|0|||
33629856|NCT01436500|63031146|FG004|Overall Study|Adverse Event|1|||
33629857|NCT01436500|63031142|FG000|Overall Study|Withdrawal by Subject|0|||
33629858|NCT01436500|63031143|FG001|Overall Study|Withdrawal by Subject|0|||
33629859|NCT01436500|63031144|FG002|Overall Study|Withdrawal by Subject|2|||
33629860|NCT01436500|63031145|FG003|Overall Study|Withdrawal by Subject|0|||
33629861|NCT01436500|63031146|FG004|Overall Study|Withdrawal by Subject|2|||
33629862|NCT01436500|63031142|FG000|Overall Study|Physician Decision|0|||
33629863|NCT01436500|63031143|FG001|Overall Study|Physician Decision|0|||
33629864|NCT01436500|63031144|FG002|Overall Study|Physician Decision|1|||
33629865|NCT01436500|63031145|FG003|Overall Study|Physician Decision|0|||
33629866|NCT01436500|63031146|FG004|Overall Study|Physician Decision|0|||
33629867|NCT01436500|63031142|FG000|Overall Study|liver transplant|1|||
33537158|NCT02791893|62926993|FG001|Open Label Phase|Lost to Follow-up|0|||
33537159|NCT02791893|62926992|FG000|Open Label Phase|Withdrawal by Subject|0|||
33537160|NCT02791893|62926993|FG001|Open Label Phase|Withdrawal by Subject|2|||
33537161|NCT00120042|62927002|FG000|Overall Study|all completed protocl|0|||
33537162|NCT00120042|62927003|FG001|Overall Study|all completed protocl|0|||
33460916|NCT03583372|62833937|FG003|Overall Study|Withdrawal by Subject|8|||
33460917|NCT03583372|62833934|FG000|Overall Study|Lost to Follow-up|4|||
33460918|NCT03583372|62833935|FG001|Overall Study|Lost to Follow-up|6|||
33460919|NCT03583372|62833936|FG002|Overall Study|Lost to Follow-up|3|||
33460920|NCT03583372|62833937|FG003|Overall Study|Lost to Follow-up|2|||
33460921|NCT03583372|62833934|FG000|Overall Study|Adverse Event|1|||
33460922|NCT03583372|62833935|FG001|Overall Study|Adverse Event|3|||
33460923|NCT03583372|62833936|FG002|Overall Study|Adverse Event|4|||
33460924|NCT03583372|62833937|FG003|Overall Study|Adverse Event|4|||
33460925|NCT03583372|62833934|FG000|Overall Study|Physician Decision|0|||
33460926|NCT03583372|62833935|FG001|Overall Study|Physician Decision|1|||
33460927|NCT03583372|62833936|FG002|Overall Study|Physician Decision|1|||
33460928|NCT03583372|62833937|FG003|Overall Study|Physician Decision|1|||
33460929|NCT03583372|62833934|FG000|Overall Study|Lack of Efficacy|0|||
33460930|NCT03583372|62833935|FG001|Overall Study|Lack of Efficacy|1|||
33460931|NCT03583372|62833936|FG002|Overall Study|Lack of Efficacy|0|||
33460932|NCT03583372|62833937|FG003|Overall Study|Lack of Efficacy|1|||
33460933|NCT03583372|62833934|FG000|Overall Study|Death|1|||
33460934|NCT03583372|62833935|FG001|Overall Study|Death|0|||
33460935|NCT03583372|62833936|FG002|Overall Study|Death|0|||
33460936|NCT03583372|62833937|FG003|Overall Study|Death|0|||
33460937|NCT03583372|62833934|FG000|Overall Study|Protocol Violation|0|||
33460938|NCT03583372|62833935|FG001|Overall Study|Protocol Violation|1|||
33537163|NCT00120042|62927004|FG002|Overall Study|all completed protocl|0|||
33537164|NCT02476851|62927011|FG000|Overall Study|Protocol Violation|1|||
33629868|NCT01436500|63031143|FG001|Overall Study|liver transplant|0|||
33460939|NCT03583372|62833936|FG002|Overall Study|Protocol Violation|0|||
33537165|NCT02476851|62927012|FG001|Overall Study|Protocol Violation|1|||
33537166|NCT02595970|62927018|FG000|Overall Study|Withdrawal by Subject|2|||
33537167|NCT02595970|62927018|FG000|Overall Study|Physician Decision|2|||
33629869|NCT01436500|63031144|FG002|Overall Study|liver transplant|0|||
33629870|NCT01436500|63031145|FG003|Overall Study|liver transplant|0|||
33460940|NCT03583372|62833937|FG003|Overall Study|Protocol Violation|0|||
33460941|NCT03583372|62833934|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
33460942|NCT03583372|62833935|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
33629871|NCT01436500|63031146|FG004|Overall Study|liver transplant|0|||
33629872|NCT01436500|63031142|FG000|Overall Study|initiation of dialysis|0|||
33629873|NCT01436500|63031143|FG001|Overall Study|initiation of dialysis|0|||
33629874|NCT01436500|63031144|FG002|Overall Study|initiation of dialysis|0|||
33629875|NCT01436500|63031145|FG003|Overall Study|initiation of dialysis|0|||
33629876|NCT01436500|63031146|FG004|Overall Study|initiation of dialysis|1|||
33629877|NCT01436500|63031142|FG000|Overall Study|discontinued study drug|1|||
33629878|NCT01436500|63031143|FG001|Overall Study|discontinued study drug|0|||
33629879|NCT01436500|63031144|FG002|Overall Study|discontinued study drug|0|||
33629880|NCT01436500|63031145|FG003|Overall Study|discontinued study drug|0|||
33629881|NCT01436500|63031146|FG004|Overall Study|discontinued study drug|0|||
33629882|NCT01436500|63031142|FG000|Overall Study|Other|0|||
33629883|NCT01436500|63031143|FG001|Overall Study|Other|1|||
33629884|NCT01436500|63031144|FG002|Overall Study|Other|0|||
33629885|NCT01436500|63031145|FG003|Overall Study|Other|1|||
33629886|NCT01436500|63031146|FG004|Overall Study|Other|0|||
33629887|NCT01958827|63031159|FG000|Overall Study|Adverse Event|3|||
33629888|NCT01958827|63031159|FG000|Overall Study|Lack of Efficacy|6|||
33629889|NCT01958827|63031159|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
33629890|NCT01620086|63031165|FG000|Overall Study|Withdrawal by Subject|3|||
33629891|NCT01620086|63031166|FG001|Overall Study|Withdrawal by Subject|3|||
33537168|NCT02595970|62927018|FG000|Overall Study|Protocol Violation|4|||
33537169|NCT02595970|62927018|FG000|Overall Study|Adverse Event|5|||
33537170|NCT02595970|62927018|FG000|Overall Study|Lack of Efficacy|7|||
33537171|NCT01866111|62927026|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
33537172|NCT01866111|62927027|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
33537173|NCT01866111|62927028|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
33629892|NCT01620086|63031167|FG002|Overall Study|Withdrawal by Subject|0|||
33629893|NCT01620086|63031165|FG000|Overall Study|failed study criteria|1|||
33629894|NCT01620086|63031166|FG001|Overall Study|failed study criteria|4|||
33629895|NCT01620086|63031167|FG002|Overall Study|failed study criteria|0|||
33460943|NCT03583372|62833936|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
33460944|NCT03583372|62833937|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
33460945|NCT03583372|62833934|FG000|Overall Study|Did Not Receive Study Drug|0|||
33460946|NCT03583372|62833935|FG001|Overall Study|Did Not Receive Study Drug|1|||
33460947|NCT03583372|62833936|FG002|Overall Study|Did Not Receive Study Drug|0|||
33537174|NCT01866111|62927029|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
33537175|NCT01866111|62927026|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
33537176|NCT01866111|62927027|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
33537177|NCT01866111|62927028|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
33537178|NCT01866111|62927029|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
33537179|NCT02595502|62927039|FG000|Period 1|Adverse Event|0|||
33537180|NCT02595502|62927040|FG001|Period 1|Adverse Event|1|||
33537181|NCT02595502|62927039|FG000|Period 1|Withdrawal by Subject|1|||
33537182|NCT02595502|62927040|FG001|Period 1|Withdrawal by Subject|0|||
33537183|NCT02595502|62927039|FG000|Period 1|Lost to Follow-up|0|||
33537184|NCT02595502|62927040|FG001|Period 1|Lost to Follow-up|1|||
33537185|NCT02595502|62927039|FG000|Period 2|Adverse Event|1|||
33537186|NCT02595502|62927040|FG001|Period 2|Adverse Event|1|||
33537187|NCT02595502|62927039|FG000|Period 2|Received incorrect lens at Period 1|0|||
33537188|NCT02595502|62927040|FG001|Period 2|Received incorrect lens at Period 1|1|||
33537189|NCT02595502|62927039|FG000|Period 3|Protocol Violation|0|||
33460948|NCT03583372|62833937|FG003|Overall Study|Did Not Receive Study Drug|0|||
33460949|NCT03583372|62833934|FG000|Overall Study|Captured as Other in the Database|1|||
33460950|NCT03583372|62833935|FG001|Overall Study|Captured as Other in the Database|2|||
33460951|NCT03583372|62833936|FG002|Overall Study|Captured as Other in the Database|4|||
33460952|NCT03583372|62833937|FG003|Overall Study|Captured as Other in the Database|1|||
33460953|NCT03582826|62833949|FG000|Overall Study|Lost to Follow-up|39|||
33460954|NCT03582826|62833950|FG001|Overall Study|Lost to Follow-up|0|||
33460955|NCT03582826|62833949|FG000|Overall Study|Withdrawal by Subject|2|||
33460956|NCT03582826|62833950|FG001|Overall Study|Withdrawal by Subject|0|||
33460957|NCT03518008|62833965|FG000|Period 2, Second Week of Wear|Family emergency|0|||
33460958|NCT03518008|62833966|FG001|Period 2, Second Week of Wear|Family emergency|1|||
33460959|NCT03810014|62833976|FG000|Overall Study|Pregnancy|2|||
33460960|NCT03810014|62833977|FG001|Overall Study|Pregnancy|2|||
33460961|NCT03810014|62833978|FG002|Overall Study|Pregnancy|0|||
33460962|NCT03810014|62833979|FG003|Overall Study|Pregnancy|2|||
33460963|NCT04978363|62834000|FG000|Overall Study|Other medical issues unrelated to the study|0|||
33460964|NCT04978363|62834001|FG001|Overall Study|Other medical issues unrelated to the study|0|||
33460965|NCT04978363|62834002|FG002|Overall Study|Other medical issues unrelated to the study|0|||
33460966|NCT04978363|62834003|FG003|Overall Study|Other medical issues unrelated to the study|0|||
33460967|NCT04978363|62834004|FG004|Overall Study|Other medical issues unrelated to the study|1|||
33460968|NCT04978363|62834005|FG005|Overall Study|Other medical issues unrelated to the study|0|||
33460969|NCT04978363|62834006|FG006|Overall Study|Other medical issues unrelated to the study|0|||
33460970|NCT04978363|62834007|FG007|Overall Study|Other medical issues unrelated to the study|0|||
33460971|NCT04978363|62834008|FG008|Overall Study|Other medical issues unrelated to the study|0|||
33460972|NCT04978363|62834009|FG009|Overall Study|Other medical issues unrelated to the study|0|||
33460973|NCT04978363|62834010|FG010|Overall Study|Other medical issues unrelated to the study|0|||
33460974|NCT04978363|62834000|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
33537190|NCT02595502|62927040|FG001|Period 3|Protocol Violation|1|||
33537191|NCT02595502|62927039|FG000|Period 3|Lost to Follow-up|1|||
33537192|NCT02595502|62927040|FG001|Period 3|Lost to Follow-up|0|||
33629896|NCT01620086|63031165|FG000|Overall Study|Physician Decision|1|||
33629897|NCT01620086|63031166|FG001|Overall Study|Physician Decision|0|||
33629898|NCT01620086|63031167|FG002|Overall Study|Physician Decision|0|||
33629899|NCT01436110|63031179|FG000|Overall Study|Lack of Efficacy|23|||
33629900|NCT01436110|63031180|FG001|Overall Study|Lack of Efficacy|14|||
33629901|NCT01436110|63031181|FG002|Overall Study|Lack of Efficacy|9|||
33629902|NCT01436110|63031179|FG000|Overall Study|Withdrawal by Subject|6|||
33629903|NCT01436110|63031180|FG001|Overall Study|Withdrawal by Subject|8|||
33537193|NCT02595502|62927039|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
33537194|NCT02595502|62927040|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
33537195|NCT01369329|62927049|FG000|Overall Study|Withdrawal by Subject|8|||
33537196|NCT01369329|62927050|FG001|Overall Study|Withdrawal by Subject|6|||
33537197|NCT01369329|62927051|FG002|Overall Study|Withdrawal by Subject|10|||
33537198|NCT01369329|62927049|FG000|Overall Study|Lost to Follow-up|2|||
33537199|NCT01369329|62927050|FG001|Overall Study|Lost to Follow-up|2|||
33537200|NCT01369329|62927051|FG002|Overall Study|Lost to Follow-up|2|||
33537201|NCT01369329|62927049|FG000|Overall Study|Other|2|||
33537202|NCT01369329|62927050|FG001|Overall Study|Other|3|||
33537203|NCT01369329|62927051|FG002|Overall Study|Other|2|||
33537204|NCT02791659|62927061|FG000|Overall Study|Protocol Violation|0|||
33537205|NCT02791659|62927062|FG001|Overall Study|Protocol Violation|1|||
33537206|NCT02594098|62927070|FG000|Overall Study|Lack of Efficacy|17|||
33537207|NCT02594098|62927071|FG001|Overall Study|Lack of Efficacy|6|||
33537208|NCT02594098|62927070|FG000|Overall Study|Withdrawal by Subject|1|||
33537209|NCT02594098|62927071|FG001|Overall Study|Withdrawal by Subject|3|||
33537210|NCT02594098|62927070|FG000|Overall Study|Terminated participation|6|||
33537211|NCT02594098|62927071|FG001|Overall Study|Terminated participation|2|||
33537212|NCT02594098|62927070|FG000|Overall Study|Seek alternative treatment|2|||
33537213|NCT02594098|62927071|FG001|Overall Study|Seek alternative treatment|1|||
33629904|NCT01436110|63031181|FG002|Overall Study|Withdrawal by Subject|4|||
33629905|NCT01436110|63031179|FG000|Overall Study|Adverse Event|2|||
33629906|NCT01436110|63031180|FG001|Overall Study|Adverse Event|1|||
33537214|NCT02594098|62927070|FG000|Overall Study|Other|0|||
33537215|NCT02594098|62927071|FG001|Overall Study|Other|1|||
33537216|NCT02593864|62927079|FG000|Overall Study|Withdrawal by Subject|3|||
33537217|NCT02593864|62927079|FG000|Overall Study|Lost to Follow-up|3|||
33537218|NCT02590588|62927083|FG000|Overall Study|Adverse Event|1|||
33537219|NCT01434602|62927092|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
33629907|NCT01436110|63031181|FG002|Overall Study|Adverse Event|2|||
33629908|NCT01436110|63031179|FG000|Overall Study|Physician Decision|3|||
33629909|NCT01436110|63031180|FG001|Overall Study|Physician Decision|1|||
33629910|NCT01436110|63031181|FG002|Overall Study|Physician Decision|1|||
33629911|NCT01436110|63031179|FG000|Overall Study|Lost to Follow-up|1|||
33629912|NCT01436110|63031180|FG001|Overall Study|Lost to Follow-up|1|||
33629913|NCT01436110|63031181|FG002|Overall Study|Lost to Follow-up|3|||
33629914|NCT01436110|63031179|FG000|Overall Study|Protocol Violation|3|||
33629915|NCT01436110|63031180|FG001|Overall Study|Protocol Violation|1|||
33460975|NCT04978363|62834001|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
33460976|NCT04978363|62834002|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
33460977|NCT04978363|62834003|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
33460978|NCT04978363|62834004|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
33460979|NCT04978363|62834005|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
33460980|NCT04978363|62834006|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
33460981|NCT04978363|62834007|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
33460982|NCT04978363|62834008|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
33629916|NCT01436110|63031181|FG002|Overall Study|Protocol Violation|1|||
33629917|NCT01436110|63031179|FG000|Overall Study|Did Not Receive Trial Medication|1|||
33629918|NCT01436110|63031180|FG001|Overall Study|Did Not Receive Trial Medication|0|||
33629919|NCT01436110|63031181|FG002|Overall Study|Did Not Receive Trial Medication|3|||
33629920|NCT01619852|63031191|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
33629921|NCT01619852|63031192|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
33629922|NCT01619852|63031191|FG000|3 Month Follow up|Lost to Follow-up|31|||
33460983|NCT04978363|62834009|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
33460984|NCT04978363|62834010|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
33460985|NCT04978363|62834000|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33629923|NCT01619852|63031192|FG001|3 Month Follow up|Lost to Follow-up|34|||
33326213|NCT01116648|62703003|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
33326214|NCT01116648|62703004|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
33326215|NCT01116648|62703005|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
33460986|NCT04978363|62834001|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
33460987|NCT04978363|62834002|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33460988|NCT04978363|62834003|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33460989|NCT04978363|62834004|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33460990|NCT04978363|62834005|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33460991|NCT04978363|62834006|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33460992|NCT04978363|62834007|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33460993|NCT04978363|62834008|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33460994|NCT04978363|62834009|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33460995|NCT04978363|62834010|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33460996|NCT04101422|62834090|FG000|Overall Study|Ineligible|1|||
33460997|NCT04101422|62834091|FG001|Overall Study|Ineligible|0|||
33460998|NCT04101422|62834092|FG002|Overall Study|Ineligible|9|||
33460999|NCT04101422|62834093|FG003|Overall Study|Ineligible|0|||
33461000|NCT04101422|62834090|FG000|Overall Study|Withdrawal by Subject|0|||
33461001|NCT04101422|62834091|FG001|Overall Study|Withdrawal by Subject|0|||
33461002|NCT04101422|62834092|FG002|Overall Study|Withdrawal by Subject|1|||
33537220|NCT01434602|62927093|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
33629924|NCT02000882|63031199|FG000|Overall Study|Adverse Event|3|||
33629925|NCT02000882|63031199|FG000|Overall Study|Physician Decision|2|||
33461003|NCT04101422|62834093|FG003|Overall Study|Withdrawal by Subject|0|||
33537221|NCT01434602|62927094|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
33537222|NCT01434602|62927095|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
33537223|NCT01434602|62927096|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
33537224|NCT01434602|62927092|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
33537225|NCT01434602|62927093|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
33537226|NCT01434602|62927094|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
33537227|NCT01434602|62927095|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
33537228|NCT01434602|62927096|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
33537229|NCT01434602|62927092|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
33537230|NCT01434602|62927093|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
33537231|NCT01434602|62927094|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
33629926|NCT02000882|63031199|FG000|Overall Study|Withdrawal by Subject|1|||
33461004|NCT04101422|62834090|FG000|Overall Study|Not attending to the stimuli|0|||
33461005|NCT04101422|62834091|FG001|Overall Study|Not attending to the stimuli|0|||
33461006|NCT04101422|62834092|FG002|Overall Study|Not attending to the stimuli|4|||
33461007|NCT04101422|62834093|FG003|Overall Study|Not attending to the stimuli|0|||
33461008|NCT04101422|62834090|FG000|Overall Study|Did not download app|0|||
33461009|NCT04101422|62834091|FG001|Overall Study|Did not download app|0|||
33461010|NCT04101422|62834092|FG002|Overall Study|Did not download app|0|||
33461011|NCT04101422|62834093|FG003|Overall Study|Did not download app|17|||
33461012|NCT04101422|62834090|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
33461013|NCT04101422|62834091|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
33461014|NCT04101422|62834092|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
33461015|NCT04101422|62834093|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
33461016|NCT03841604|62834105|FG000|Overall Study|Withdrawal by Subject|3|||
33461017|NCT03841604|62834106|FG001|Overall Study|Withdrawal by Subject|1|||
33461018|NCT03841604|62834105|FG000|Overall Study|Adverse Event|4|||
33461019|NCT03841604|62834106|FG001|Overall Study|Adverse Event|2|||
33461020|NCT03841604|62834105|FG000|Overall Study|Physician Decision|1|||
33461021|NCT03841604|62834106|FG001|Overall Study|Physician Decision|0|||
33461022|NCT03541187|62834123|FG000|Overall Study|Lost to Follow-up|2|||
33461023|NCT03541187|62834124|FG001|Overall Study|Lost to Follow-up|6|||
33461024|NCT03541187|62834123|FG000|Overall Study|Pregnancy|0|||
33461025|NCT03541187|62834124|FG001|Overall Study|Pregnancy|1|||
33461026|NCT03541187|62834123|FG000|Overall Study|Withdrawal by Subject|6|||
33461027|NCT03541187|62834124|FG001|Overall Study|Withdrawal by Subject|2|||
33461028|NCT03541187|62834123|FG000|Overall Study|Moved out of town|1|||
33461029|NCT03541187|62834124|FG001|Overall Study|Moved out of town|0|||
33461030|NCT03541187|62834123|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
33461031|NCT03541187|62834124|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
33461032|NCT03541187|62834123|FG000|Overall Study|Did not meet randomization criteria|1|||
33461033|NCT03541187|62834124|FG001|Overall Study|Did not meet randomization criteria|1|||
33461034|NCT03541187|62834123|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
33461035|NCT03541187|62834124|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
33461036|NCT03541187|62834123|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
33461037|NCT03541187|62834124|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
33461038|NCT03240081|62834145|FG000|Overall Study|Withdrawal by Subject|0|||
33461039|NCT03240081|62834146|FG001|Overall Study|Withdrawal by Subject|2|||
33461040|NCT03240081|62834145|FG000|Overall Study|Lost to Follow-up|0|||
33461041|NCT03240081|62834146|FG001|Overall Study|Lost to Follow-up|1|||
33461042|NCT03003520|62834167|FG000|Overall Study|Adverse Event|9|||
33461043|NCT03003520|62834168|FG001|Overall Study|Adverse Event|0|||
33629927|NCT01965938|63031205|FG000|Overall Study|Withdrawal by Subject|1|||
33629928|NCT01965938|63031206|FG001|Overall Study|Withdrawal by Subject|0|||
33461044|NCT03003520|62834167|FG000|Overall Study|Death|1|||
33461045|NCT03003520|62834168|FG001|Overall Study|Death|0|||
33461046|NCT03003520|62834167|FG000|Overall Study|Other reasons|4|||
33461047|NCT03003520|62834168|FG001|Overall Study|Other reasons|0|||
33461048|NCT03003520|62834167|FG000|Overall Study|Withdrawal by Subject|6|||
33461049|NCT03003520|62834168|FG001|Overall Study|Withdrawal by Subject|0|||
33461050|NCT03003520|62834167|FG000|Overall Study|Progressive disease|9|||
33537232|NCT01434602|62927095|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
33537233|NCT01434602|62927096|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
33537234|NCT01434602|62927092|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
33537235|NCT01434602|62927093|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
33537236|NCT01434602|62927094|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
33537237|NCT01434602|62927095|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
33537238|NCT01434602|62927096|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
33537239|NCT01434602|62927092|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
33537240|NCT01434602|62927093|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
33537241|NCT01434602|62927094|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
33537242|NCT01434602|62927095|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
33537243|NCT01434602|62927096|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
33629929|NCT01965860|63031217|FG000|Overall Study|Pregnancy|1|||
33629930|NCT01965860|63031218|FG001|Overall Study|Pregnancy|0|||
33629931|NCT01965860|63031219|FG002|Overall Study|Pregnancy|1|||
33326216|NCT01116648|62703006|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
33461051|NCT03003520|62834168|FG001|Overall Study|Progressive disease|1|||
33326217|NCT01116648|62703007|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
33461052|NCT02958527|62834191|FG000|Overall Study|Not collected CRFs|12|||
33461053|NCT02586025|62834213|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
33326218|NCT01116648|62703008|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
33461054|NCT02586025|62834214|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
33461055|NCT02586025|62834213|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
33461056|NCT02586025|62834214|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
33461057|NCT02586025|62834213|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
33461058|NCT02586025|62834214|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
33461059|NCT02586025|62834213|FG000|Neoadjuvant Treatment|Death|1|||
33461060|NCT02586025|62834214|FG001|Neoadjuvant Treatment|Death|0|||
33461061|NCT02586025|62834213|FG000|Neoadjuvant Treatment|Adverse Event|1|||
33461062|NCT02586025|62834214|FG001|Neoadjuvant Treatment|Adverse Event|0|||
33461063|NCT02586025|62834213|FG000|Neoadjuvant Treatment|Physician Decision|2|||
33461064|NCT02586025|62834214|FG001|Neoadjuvant Treatment|Physician Decision|1|||
33461065|NCT02586025|62834213|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
33461066|NCT02586025|62834214|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
33461067|NCT02586025|62834213|FG000|Adjuvant Treatment|Recurrent Disease|4|||
33461068|NCT02586025|62834214|FG001|Adjuvant Treatment|Recurrent Disease|5|||
33461069|NCT02586025|62834213|FG000|Adjuvant Treatment|Physician Decision|0|||
33461070|NCT02586025|62834214|FG001|Adjuvant Treatment|Physician Decision|1|||
33461071|NCT02586025|62834213|FG000|Adjuvant Treatment|Pregnancy|1|||
33461072|NCT02586025|62834214|FG001|Adjuvant Treatment|Pregnancy|0|||
33461073|NCT02586025|62834213|FG000|Treatment-Free Follow-Up|Death|11|||
33461074|NCT02586025|62834214|FG001|Treatment-Free Follow-Up|Death|11|||
33461075|NCT02586025|62834213|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
33461076|NCT02586025|62834214|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
33461077|NCT02586025|62834213|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
33461078|NCT02586025|62834214|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
33461079|NCT02586025|62834213|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
33461080|NCT02586025|62834214|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
33461081|NCT02586025|62834213|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
33461082|NCT02586025|62834214|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
33461083|NCT02446600|62834234|FG000|Overall Study|Never treated|20|||
33461084|NCT02446600|62834235|FG001|Overall Study|Never treated|2|||
33461085|NCT02446600|62834236|FG002|Overall Study|Never treated|6|||
33461086|NCT02446600|62834237|FG003|Overall Study|Never treated|0|||
33461087|NCT02446600|62834234|FG000|Overall Study|Withdrawal by Subject|19|||
33461088|NCT02446600|62834235|FG001|Overall Study|Withdrawal by Subject|5|||
33461089|NCT02446600|62834236|FG002|Overall Study|Withdrawal by Subject|17|||
33461090|NCT02446600|62834237|FG003|Overall Study|Withdrawal by Subject|0|||
33461091|NCT02446600|62834234|FG000|Overall Study|Ineligible|1|||
33461092|NCT02446600|62834235|FG001|Overall Study|Ineligible|4|||
33461093|NCT02446600|62834236|FG002|Overall Study|Ineligible|4|||
33461094|NCT02446600|62834237|FG003|Overall Study|Ineligible|1|||
33461095|NCT02446600|62834234|FG000|Overall Study|Duplicate Enrollment|0|||
33461096|NCT02446600|62834235|FG001|Overall Study|Duplicate Enrollment|1|||
33461097|NCT02446600|62834236|FG002|Overall Study|Duplicate Enrollment|0|||
33326219|NCT01116648|62703009|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
33461098|NCT02446600|62834237|FG003|Overall Study|Duplicate Enrollment|0|||
33461099|NCT02285114|62834250|FG000|Overall Study|Investigator's Discretion|0|||
33461100|NCT02285114|62834251|FG001|Overall Study|Investigator's Discretion|2|||
33461101|NCT02285114|62834252|FG002|Overall Study|Investigator's Discretion|0|||
33461102|NCT02285114|62834250|FG000|Overall Study|Withdrew Consent|0|||
33461103|NCT02285114|62834251|FG001|Overall Study|Withdrew Consent|0|||
33461104|NCT02285114|62834252|FG002|Overall Study|Withdrew Consent|1|||
33461105|NCT02285114|62834250|FG000|Overall Study|Enrolled but not treated|1|||
33629932|NCT01965860|63031217|FG000|Overall Study|Logistics|1|||
33629933|NCT01965860|63031218|FG001|Overall Study|Logistics|0|||
33629934|NCT01965860|63031219|FG002|Overall Study|Logistics|0|||
33629935|NCT01965704|63031240|FG000|Overall Study|Withdrawal by Subject|2|||
33629936|NCT01965704|63031241|FG001|Overall Study|Withdrawal by Subject|2|||
33629937|NCT01965704|63031242|FG002|Overall Study|Withdrawal by Subject|1|||
33537244|NCT01434602|62927092|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
33537245|NCT01434602|62927093|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
33537246|NCT01434602|62927094|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
33537247|NCT01434602|62927095|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
33537248|NCT01434602|62927096|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
33537249|NCT01434602|62927092|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
33537250|NCT01434602|62927093|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
33537251|NCT01434602|62927094|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
33537252|NCT01434602|62927095|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
33537253|NCT01434602|62927096|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
33537254|NCT01434602|62927092|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
33629938|NCT01965704|63031243|FG003|Overall Study|Withdrawal by Subject|1|||
33537255|NCT01434602|62927093|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
33537256|NCT01434602|62927094|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
33537257|NCT01434602|62927095|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
33537258|NCT01434602|62927096|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
33537259|NCT01434602|62927092|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
33537260|NCT01434602|62927093|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
33537261|NCT01434602|62927094|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
33537262|NCT01434602|62927095|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
33537263|NCT01434602|62927096|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
33537264|NCT01434602|62927092|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
33537265|NCT01434602|62927093|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
33537266|NCT01434602|62927094|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
33537267|NCT01434602|62927095|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
33537268|NCT01434602|62927096|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
33537269|NCT01767129|62927118|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
33537270|NCT01767129|62927119|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
33537271|NCT02791269|62927128|FG000|Overall Study|Lost to Follow-up|0|||
33537272|NCT02791269|62927129|FG001|Overall Study|Lost to Follow-up|1|||
33537273|NCT02696564|62927139|FG000|Overall Study|Death|1|||
33537274|NCT02696564|62927140|FG001|Overall Study|Death|2|||
33537275|NCT02696564|62927139|FG000|Overall Study|Withdrawal by Subject|3|||
33461106|NCT02285114|62834251|FG001|Overall Study|Enrolled but not treated|0|||
33461107|NCT02285114|62834252|FG002|Overall Study|Enrolled but not treated|0|||
33461108|NCT02285114|62834250|FG000|Overall Study|Still on study|21|||
33461109|NCT02285114|62834251|FG001|Overall Study|Still on study|5|||
33461110|NCT02285114|62834252|FG002|Overall Study|Still on study|2|||
33461111|NCT01721577|62834268|FG000|Overall Study|Lack of Efficacy|1|||
33461112|NCT01721577|62834269|FG001|Overall Study|Lack of Efficacy|0|||
33461113|NCT01721577|62834268|FG000|Overall Study|Death|1|||
33461114|NCT01721577|62834269|FG001|Overall Study|Death|0|||
33461115|NCT01721577|62834268|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
33461116|NCT01721577|62834269|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
33461117|NCT01721577|62834268|FG000|Overall Study|Adverse Event|0|||
33461118|NCT01721577|62834269|FG001|Overall Study|Adverse Event|2|||
33461119|NCT01411332|62834286|FG000|Enrollment|Protocol Violation|0|||
33461120|NCT01411332|62834287|FG001|Enrollment|Protocol Violation|1|||
33461121|NCT01411332|62834286|FG000|Enrollment|Withdrawal by Subject|0|||
33461122|NCT01411332|62834287|FG001|Enrollment|Withdrawal by Subject|1|||
33461123|NCT01411332|62834286|FG000|Treatment|Lost to Follow-up|1|||
33461124|NCT01411332|62834287|FG001|Treatment|Lost to Follow-up|0|||
33461125|NCT01194570|62834296|FG000|Overall Study|Death|1|||
33461126|NCT01194570|62834297|FG001|Overall Study|Death|3|||
33461127|NCT01194570|62834296|FG000|Overall Study|Ongoing at CCOD|162|||
33461128|NCT01194570|62834297|FG001|Overall Study|Ongoing at CCOD|387|||
33461129|NCT01194570|62834296|FG000|Overall Study|Physician Decision|2|||
33461130|NCT01194570|62834297|FG001|Overall Study|Physician Decision|6|||
33461131|NCT01194570|62834296|FG000|Overall Study|Reason not specified|13|||
33461132|NCT01194570|62834297|FG001|Overall Study|Reason not specified|20|||
33461133|NCT01194570|62834296|FG000|Overall Study|Protocol Violation|0|||
33461134|NCT01194570|62834297|FG001|Overall Study|Protocol Violation|2|||
33461135|NCT01194570|62834296|FG000|Overall Study|Non-compliance with study drug|2|||
33461136|NCT01194570|62834297|FG001|Overall Study|Non-compliance with study drug|2|||
33461137|NCT01194570|62834296|FG000|Overall Study|Adverse Event|12|||
33461138|NCT01194570|62834297|FG001|Overall Study|Adverse Event|18|||
33461139|NCT01194570|62834296|FG000|Overall Study|Non-compliance|2|||
33461140|NCT01194570|62834297|FG001|Overall Study|Non-compliance|2|||
33461141|NCT01194570|62834296|FG000|Overall Study|Lack of Efficacy|27|||
33461142|NCT01194570|62834297|FG001|Overall Study|Lack of Efficacy|21|||
33461143|NCT01194570|62834296|FG000|Overall Study|Withdrawal by Subject|21|||
33461144|NCT01194570|62834297|FG001|Overall Study|Withdrawal by Subject|22|||
33461145|NCT01194570|62834296|FG000|Overall Study|Pregnancy|1|||
33461146|NCT01194570|62834297|FG001|Overall Study|Pregnancy|1|||
33461147|NCT01194570|62834296|FG000|Overall Study|Lost to Follow-up|1|||
33461148|NCT01194570|62834297|FG001|Overall Study|Lost to Follow-up|4|||
33461149|NCT04881747|62834323|FG000|Period 2 Washout|Adverse Event|1|||
33461150|NCT04881747|62834324|FG001|Period 2 Washout|Adverse Event|0|||
33461151|NCT04881747|62834325|FG002|Period 2 Washout|Adverse Event|0|||
33461152|NCT04881747|62834326|FG003|Period 2 Washout|Adverse Event|0|||
33537276|NCT02696564|62927140|FG001|Overall Study|Withdrawal by Subject|2|||
33537277|NCT02696564|62927139|FG000|Overall Study|Lost to Follow-up|3|||
33537278|NCT02696564|62927140|FG001|Overall Study|Lost to Follow-up|3|||
33461153|NCT04881747|62834327|FG004|Period 2 Washout|Adverse Event|1|||
33461154|NCT04881747|62834328|FG005|Period 2 Washout|Adverse Event|0|||
33461155|NCT04881747|62834323|FG000|Period 2 Washout|Withdrawal by Subject|1|||
33461156|NCT04881747|62834324|FG001|Period 2 Washout|Withdrawal by Subject|0|||
33461157|NCT04881747|62834325|FG002|Period 2 Washout|Withdrawal by Subject|0|||
33537279|NCT02696564|62927139|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
33461158|NCT04881747|62834326|FG003|Period 2 Washout|Withdrawal by Subject|1|||
33461159|NCT04881747|62834327|FG004|Period 2 Washout|Withdrawal by Subject|0|||
33461160|NCT04881747|62834328|FG005|Period 2 Washout|Withdrawal by Subject|0|||
33461161|NCT04795622|62834338|FG000|Overall Study|Adverse Event|1|||
33537280|NCT02696564|62927140|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
33461162|NCT04795622|62834339|FG001|Overall Study|Adverse Event|0|||
33461163|NCT04795622|62834338|FG000|Overall Study|Withdrawal by Subject|3|||
33629939|NCT01965704|63031240|FG000|Overall Study|Delivered at home|1|||
33629940|NCT01965704|63031241|FG001|Overall Study|Delivered at home|1|||
33629941|NCT01965704|63031242|FG002|Overall Study|Delivered at home|0|||
33629942|NCT01965704|63031243|FG003|Overall Study|Delivered at home|0|||
33629943|NCT01965704|63031240|FG000|Overall Study|Experienced complications|0|||
33629944|NCT01965704|63031241|FG001|Overall Study|Experienced complications|0|||
33629945|NCT01965704|63031242|FG002|Overall Study|Experienced complications|2|||
33629946|NCT01965704|63031243|FG003|Overall Study|Experienced complications|2|||
33629947|NCT01965704|63031240|FG000|Overall Study|Adverse Event|0|||
33537281|NCT02696564|62927139|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
33537282|NCT02696564|62927140|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
33537283|NCT02696564|62927139|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
33537284|NCT02696564|62927140|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
33537285|NCT02696564|62927139|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
33537286|NCT02696564|62927140|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
33537287|NCT02696564|62927139|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
33537288|NCT02696564|62927140|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
33537289|NCT02640950|62927146|FG000|Overall Study|Adverse Event|1|||
33537290|NCT02640950|62927146|FG000|Overall Study|Withdrawal by Subject|1|||
33537291|NCT02593786|62927154|FG000|Overall Study|Disease progression|12|||
33537292|NCT02593786|62927155|FG001|Overall Study|Disease progression|16|||
33537293|NCT02593786|62927156|FG002|Overall Study|Disease progression|10|||
33629948|NCT01965704|63031241|FG001|Overall Study|Adverse Event|0|||
33629949|NCT01965704|63031242|FG002|Overall Study|Adverse Event|1|||
33629950|NCT01965704|63031243|FG003|Overall Study|Adverse Event|1|||
33629951|NCT01965704|63031240|FG000|Overall Study|Did not meet inclusion criteria|0|||
33629952|NCT01965704|63031241|FG001|Overall Study|Did not meet inclusion criteria|0|||
33629953|NCT01965704|63031242|FG002|Overall Study|Did not meet inclusion criteria|1|||
33629954|NCT01965704|63031243|FG003|Overall Study|Did not meet inclusion criteria|1|||
33629955|NCT02003365|63031254|FG000|Overall Study|Lost to Follow-up|0|||
33629956|NCT02003365|63031255|FG001|Overall Study|Lost to Follow-up|0|||
33629957|NCT02003365|63031256|FG002|Overall Study|Lost to Follow-up|1|||
33629958|NCT01975220|63031267|FG000|Test Period 1|Not treated|0|||
33629959|NCT01975220|63031268|FG001|Test Period 1|Not treated|1|||
33629960|NCT01975220|63031269|FG002|Test Period 1|Not treated|0|||
33629961|NCT01975220|63031270|FG003|Test Period 1|Not treated|0|||
33629962|NCT01975220|63031271|FG004|Test Period 1|Not treated|0|||
33629963|NCT01975220|63031272|FG005|Test Period 1|Not treated|0|||
33629964|NCT01958437|63031289|FG000|Overall Study|Incidental MRI findings|0|||
33629965|NCT01958437|63031290|FG001|Overall Study|Incidental MRI findings|0|||
33326220|NCT00880087|62703036|FG000|Overall Study|Lost to Follow-up|0|||
33461164|NCT04795622|62834339|FG001|Overall Study|Withdrawal by Subject|3|||
33461165|NCT04795622|62834338|FG000|Overall Study|Protocol Violation|0|||
33461166|NCT04795622|62834339|FG001|Overall Study|Protocol Violation|2|||
33461167|NCT04795622|62834338|FG000|Overall Study|Lost to Follow-up|2|||
33461168|NCT04795622|62834339|FG001|Overall Study|Lost to Follow-up|3|||
33461169|NCT04795622|62834338|FG000|Overall Study|Other|7|||
33461170|NCT04795622|62834339|FG001|Overall Study|Other|8|||
33461171|NCT04652245|62834360|FG000|Wash-Out Period|Adverse Event|0|||
33461172|NCT04652245|62834361|FG001|Wash-Out Period|Adverse Event|2|||
33461173|NCT04652245|62834360|FG000|Wash-Out Period|Withdrawal by Subject|0|||
33461174|NCT04652245|62834361|FG001|Wash-Out Period|Withdrawal by Subject|2|||
33461175|NCT04405739|62834378|FG000|Overall Study|Adverse Event|0|||
33461176|NCT04405739|62834379|FG001|Overall Study|Adverse Event|1|||
33537294|NCT02593786|62927157|FG003|Overall Study|Disease progression|7|||
33537295|NCT02593786|62927154|FG000|Overall Study|Study drug toxicity|1|||
33537296|NCT02593786|62927155|FG001|Overall Study|Study drug toxicity|0|||
33537297|NCT02593786|62927156|FG002|Overall Study|Study drug toxicity|0|||
33537298|NCT02593786|62927157|FG003|Overall Study|Study drug toxicity|0|||
33537299|NCT02593786|62927154|FG000|Overall Study|Adverse event unrelated to study drug|1|||
33537300|NCT02593786|62927155|FG001|Overall Study|Adverse event unrelated to study drug|1|||
33537301|NCT02593786|62927156|FG002|Overall Study|Adverse event unrelated to study drug|1|||
33537302|NCT02593786|62927157|FG003|Overall Study|Adverse event unrelated to study drug|0|||
33537303|NCT02593786|62927154|FG000|Overall Study|Participant request to discontinue study therapy|0|||
33537304|NCT02593786|62927155|FG001|Overall Study|Participant request to discontinue study therapy|2|||
33537305|NCT02593786|62927156|FG002|Overall Study|Participant request to discontinue study therapy|0|||
33537306|NCT02593786|62927157|FG003|Overall Study|Participant request to discontinue study therapy|0|||
33537307|NCT02593786|62927154|FG000|Overall Study|Other reasons|1|||
33537308|NCT02593786|62927155|FG001|Overall Study|Other reasons|1|||
33537309|NCT02593786|62927156|FG002|Overall Study|Other reasons|0|||
33537310|NCT02593786|62927157|FG003|Overall Study|Other reasons|5|||
33537311|NCT04829331|62927196|FG000|Overall Study|Lost to Follow-up|1|||
33629966|NCT01958437|63031291|FG002|Overall Study|Incidental MRI findings|1|||
33461177|NCT04405739|62834380|FG002|Overall Study|Adverse Event|0|||
33461178|NCT04405739|62834381|FG003|Overall Study|Adverse Event|0|||
33461179|NCT04405739|62834378|FG000|Overall Study|Lost to Follow-up|0|||
33629967|NCT01958437|63031292|FG003|Overall Study|Incidental MRI findings|1|||
33629968|NCT01974752|63031311|FG000|Overall Study|Death|33|||
33629969|NCT01974752|63031312|FG001|Overall Study|Death|11|||
33537312|NCT04829331|62927197|FG001|Overall Study|Lost to Follow-up|0|||
33537313|NCT04602546|62927212|FG000|Overall Study|Training|2|||
33537314|NCT04602546|62927213|FG001|Overall Study|Training|2|||
33537315|NCT04602546|62927214|FG002|Overall Study|Training|1|||
33537316|NCT04602546|62927215|FG003|Overall Study|Training|2|||
33537317|NCT04602546|62927216|FG004|Overall Study|Training|0|||
33537318|NCT04602546|62927212|FG000|Overall Study|Randomized with disqualified data|2|||
33537319|NCT04602546|62927213|FG001|Overall Study|Randomized with disqualified data|0|||
33537320|NCT04602546|62927214|FG002|Overall Study|Randomized with disqualified data|2|||
33629970|NCT01974752|63031311|FG000|Overall Study|Lost to Follow-up|2|||
33537321|NCT04602546|62927215|FG003|Overall Study|Randomized with disqualified data|5|||
33537322|NCT04602546|62927216|FG004|Overall Study|Randomized with disqualified data|3|||
33629971|NCT01974752|63031312|FG001|Overall Study|Lost to Follow-up|0|||
33537323|NCT04102189|62927246|FG000|Overall Study|Withdrawal by Subject|1|||
33537324|NCT04102189|62927247|FG001|Overall Study|Withdrawal by Subject|2|||
33629972|NCT01974752|63031311|FG000|Overall Study|Withdrawal by Subject|2|||
33629973|NCT01974752|63031312|FG001|Overall Study|Withdrawal by Subject|3|||
33629974|NCT01974752|63031311|FG000|Overall Study|Other Eligibility Criteria|0|||
33629975|NCT01974752|63031312|FG001|Overall Study|Other Eligibility Criteria|1|||
33629976|NCT01999946|63031321|FG000|Overall Study|Participant not released from jail|2|||
33629977|NCT01999946|63031322|FG001|Overall Study|Participant not released from jail|2|||
33537325|NCT04102189|62927246|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33629978|NCT01999946|63031323|FG002|Overall Study|Participant not released from jail|0|||
33629979|NCT01999946|63031321|FG000|Overall Study|Not included in primary outcome analysis|0|||
33629980|NCT01999946|63031322|FG001|Overall Study|Not included in primary outcome analysis|0|||
33629981|NCT01999946|63031323|FG002|Overall Study|Not included in primary outcome analysis|79|||
33629982|NCT01958281|63031333|FG000|Overall Study|Lack of Efficacy|5|||
33629983|NCT01958281|63031334|FG001|Overall Study|Lack of Efficacy|2|||
33629984|NCT01958281|63031335|FG002|Overall Study|Lack of Efficacy|0|||
33629985|NCT01958281|63031333|FG000|Overall Study|Adverse Event|0|||
33629986|NCT01958281|63031334|FG001|Overall Study|Adverse Event|2|||
33629987|NCT01958281|63031335|FG002|Overall Study|Adverse Event|0|||
33629988|NCT01958281|63031333|FG000|Overall Study|Withdrew Consent|1|||
33629989|NCT01958281|63031334|FG001|Overall Study|Withdrew Consent|0|||
33629990|NCT01958281|63031335|FG002|Overall Study|Withdrew Consent|0|||
33629991|NCT01958125|63031346|FG000|Overall Study|Missing diary data|2|||
33629992|NCT01958125|63031347|FG001|Overall Study|Missing diary data|6|||
33629993|NCT01958125|63031346|FG000|Overall Study|No headache attacks|0|||
33629994|NCT01958125|63031347|FG001|Overall Study|No headache attacks|2|||
33537326|NCT04102189|62927247|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33537327|NCT04102189|62927246|FG000|Overall Study|Lost to Follow-up|1|||
33537328|NCT04102189|62927247|FG001|Overall Study|Lost to Follow-up|0|||
33537329|NCT04004988|62927262|FG000|Period 1|Physician Decision|2|||
33629995|NCT02002975|63031353|FG000|Overall Study|Case Report Forms Uncollected|135|||
33629996|NCT02002975|63031353|FG000|Overall Study|Protocol Deviation|437|||
33629997|NCT02001181|63031359|FG000|Overall Study|Adverse Event|0|||
33629998|NCT02001181|63031360|FG001|Overall Study|Adverse Event|2|||
33629999|NCT02001181|63031359|FG000|Overall Study|Lost to Follow-up|1|||
33537330|NCT04004988|62927263|FG001|Period 1|Physician Decision|0|||
33630000|NCT02001181|63031360|FG001|Overall Study|Lost to Follow-up|0|||
33630001|NCT02001181|63031359|FG000|Overall Study|Withdrawal by Subject|0|||
33630002|NCT02001181|63031360|FG001|Overall Study|Withdrawal by Subject|1|||
33630003|NCT01999465|63031368|FG000|Overall Study|Lost to Follow-up|0|||
33630004|NCT01999465|63031369|FG001|Overall Study|Lost to Follow-up|2|||
33630005|NCT01999465|63031368|FG000|Overall Study|Protocol Violation|0|||
33630006|NCT01999465|63031369|FG001|Overall Study|Protocol Violation|1|||
33630007|NCT01982773|63031377|FG000|Overall Study|Withdrawal by Subject|1|||
33630008|NCT01982773|63031378|FG001|Overall Study|Withdrawal by Subject|3|||
33630009|NCT01982773|63031377|FG000|Overall Study|Lost to Follow-up|7|||
33630010|NCT01982773|63031378|FG001|Overall Study|Lost to Follow-up|1|||
33630011|NCT01974206|63031386|FG000|Overall Study|Did Not Take Study Drug|0|||
33630012|NCT01974206|63031387|FG001|Overall Study|Did Not Take Study Drug|1|||
33630013|NCT01974206|63031386|FG000|Overall Study|Physician Decision|1|||
33630014|NCT01974206|63031387|FG001|Overall Study|Physician Decision|0|||
33630015|NCT01974206|63031386|FG000|Overall Study|Withdrawal by Subject|3|||
33630016|NCT01974206|63031387|FG001|Overall Study|Withdrawal by Subject|0|||
33630017|NCT01974206|63031386|FG000|Overall Study|Lost to Follow-up|1|||
33630018|NCT01974206|63031387|FG001|Overall Study|Lost to Follow-up|0|||
33630019|NCT01974206|63031386|FG000|Overall Study|Death|1|||
33630020|NCT01974206|63031387|FG001|Overall Study|Death|0|||
33630021|NCT01999868|63031396|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
33630022|NCT01999868|63031397|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
33630023|NCT01999868|63031398|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
33630024|NCT01999868|63031396|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
33630025|NCT01999868|63031397|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
33630026|NCT01999868|63031398|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
33630027|NCT01999868|63031396|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
33630028|NCT01999868|63031397|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
33630029|NCT01999868|63031398|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
33630030|NCT01999868|63031396|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
33630031|NCT01999868|63031397|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
33630032|NCT01999868|63031398|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
33630033|NCT01999868|63031396|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
33630034|NCT01999868|63031397|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
33630035|NCT01999868|63031398|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
33630036|NCT01999868|63031396|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
33630037|NCT01999868|63031397|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
33630038|NCT01999868|63031398|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
33630039|NCT01999868|63031396|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
33630040|NCT01999868|63031397|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
33630041|NCT01999868|63031398|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
33630042|NCT01999868|63031396|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
33630043|NCT01999868|63031397|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
33326221|NCT00880087|62703037|FG001|Overall Study|Lost to Follow-up|2|||
33326222|NCT00889252|62703045|FG000|Overall Study|Adverse Event|2|||
33461180|NCT04405739|62834379|FG001|Overall Study|Lost to Follow-up|2|||
33326223|NCT00889252|62703046|FG001|Overall Study|Adverse Event|4|||
33461181|NCT04405739|62834380|FG002|Overall Study|Lost to Follow-up|1|||
33461182|NCT04405739|62834381|FG003|Overall Study|Lost to Follow-up|3|||
33461183|NCT04405739|62834378|FG000|Overall Study|Withdrawal by Subject|0|||
33461184|NCT04405739|62834379|FG001|Overall Study|Withdrawal by Subject|2|||
33461185|NCT04405739|62834380|FG002|Overall Study|Withdrawal by Subject|1|||
33461186|NCT04405739|62834381|FG003|Overall Study|Withdrawal by Subject|1|||
33461187|NCT04405739|62834378|FG000|Overall Study|Death|0|||
33461188|NCT04405739|62834379|FG001|Overall Study|Death|0|||
33461189|NCT04405739|62834380|FG002|Overall Study|Death|1|||
33461190|NCT04405739|62834381|FG003|Overall Study|Death|0|||
33461191|NCT04405739|62834378|FG000|Overall Study|Transferred to rehab|0|||
33461192|NCT04405739|62834379|FG001|Overall Study|Transferred to rehab|0|||
33461193|NCT04405739|62834380|FG002|Overall Study|Transferred to rehab|0|||
33630044|NCT01999868|63031398|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
33630045|NCT01999868|63031396|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
33461194|NCT04405739|62834381|FG003|Overall Study|Transferred to rehab|1|||
33461195|NCT04405739|62834378|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
33630046|NCT01999868|63031397|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
33630047|NCT01999868|63031398|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
33630048|NCT01999868|63031396|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
33630049|NCT01999868|63031397|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
33630050|NCT01999868|63031398|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
33630051|NCT01999868|63031396|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
33630052|NCT01999868|63031397|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
33630053|NCT01999868|63031398|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
33630054|NCT01999868|63031396|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
33630055|NCT01999868|63031397|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
33630056|NCT01999868|63031398|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
33630057|NCT01999868|63031396|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
33630058|NCT01999868|63031397|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
33630059|NCT01999868|63031398|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
33630060|NCT01999868|63031396|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
33630061|NCT01999868|63031397|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
33630062|NCT01999868|63031398|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
33630063|NCT01999868|63031396|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
33630064|NCT01999868|63031397|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
33630065|NCT01999868|63031398|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
33630066|NCT01957579|63031410|FG000|Overall Study|Withdrawal of concent|0|||
33630067|NCT01957579|63031411|FG001|Overall Study|Withdrawal of concent|1|||
33326224|NCT00889252|62703045|FG000|Overall Study|Withdrawal by Subject|3|||
33326225|NCT00889252|62703046|FG001|Overall Study|Withdrawal by Subject|0|||
33461196|NCT04405739|62834379|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
33461197|NCT04405739|62834380|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
33461198|NCT04405739|62834381|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
33461199|NCT04954326|62834414|FG000|Overall Study|Protocol Violation|0|||
33461200|NCT04954326|62834415|FG001|Overall Study|Protocol Violation|1|||
33461201|NCT04954326|62834414|FG000|Overall Study|Death|0|||
33461202|NCT04954326|62834415|FG001|Overall Study|Death|2|||
33461203|NCT04954326|62834414|FG000|Overall Study|Physician Decision|0|||
33461204|NCT04954326|62834415|FG001|Overall Study|Physician Decision|1|||
33461205|NCT04914819|62834423|FG000|Overall Study|Pregnancy|3|||
33461206|NCT04914819|62834424|FG001|Overall Study|Pregnancy|1|||
33461207|NCT04914819|62834423|FG000|Overall Study|Discontinued study|4|||
33461208|NCT04914819|62834424|FG001|Overall Study|Discontinued study|1|||
33461209|NCT04914819|62834423|FG000|Overall Study|Lost to Follow-up|7|||
33537331|NCT04004988|62927262|FG000|Period 1|Withdrawal by Subject|0|||
33537332|NCT04004988|62927263|FG001|Period 1|Withdrawal by Subject|1|||
33537333|NCT04004988|62927262|FG000|Period 1|Adverse Event|1|||
33537334|NCT04004988|62927263|FG001|Period 1|Adverse Event|2|||
33537335|NCT03898700|62927270|FG000|Overall Study|Withdrawal by Subject|2|||
33537336|NCT03693300|62927276|FG000|Overall Study|Patients ongoing study|43|||
33537337|NCT03693300|62927277|FG001|Overall Study|Patients ongoing study|1|||
33537338|NCT03586973|62927296|FG000|Overall Study|Death|15|||
33537339|NCT03586973|62927297|FG001|Overall Study|Death|8|||
33537340|NCT03586973|62927296|FG000|Overall Study|Site Terminated by Sponsor|3|||
33537341|NCT03586973|62927297|FG001|Overall Study|Site Terminated by Sponsor|6|||
33537342|NCT03586973|62927296|FG000|Overall Study|Withdrawal by Subject|1|||
33537343|NCT03586973|62927297|FG001|Overall Study|Withdrawal by Subject|0|||
33537344|NCT03586973|62927296|FG000|Overall Study|Lost to Follow-up|1|||
33326226|NCT00889252|62703045|FG000|Overall Study|Protocol Violation|2|||
33461210|NCT04914819|62834424|FG001|Overall Study|Lost to Follow-up|0|||
33461211|NCT04818346|62834439|FG000|24-Week Placebo-Controlled Period|Adverse Event|1|||
33461212|NCT04818346|62834440|FG001|24-Week Placebo-Controlled Period|Adverse Event|2|||
33461213|NCT04818346|62834441|FG002|24-Week Placebo-Controlled Period|Adverse Event|0|||
33461214|NCT04818346|62834442|FG003|24-Week Placebo-Controlled Period|Adverse Event|3|||
33461215|NCT04818346|62834439|FG000|24-Week Placebo-Controlled Period|Lost to Follow-up|3|||
33537345|NCT03586973|62927297|FG001|Overall Study|Lost to Follow-up|0|||
33537346|NCT02968849|62927305|FG000|Overall Study|Death|8|||
33630068|NCT01957579|63031412|FG002|Overall Study|Withdrawal of concent|0|||
33630069|NCT01957579|63031413|FG003|Overall Study|Withdrawal of concent|0|||
33630070|NCT01957579|63031410|FG000|Overall Study|Death|0|||
33630071|NCT01957579|63031411|FG001|Overall Study|Death|0|||
33630072|NCT01957579|63031412|FG002|Overall Study|Death|2|||
33630073|NCT01957579|63031413|FG003|Overall Study|Death|0|||
33630074|NCT01999322|63031442|FG000|Overall Study|Adverse Event|1|||
33630075|NCT01999322|63031443|FG001|Overall Study|Adverse Event|0|||
33630076|NCT01996982|63031449|FG000|Overall Study|PI/team left institution|7|||
33630077|NCT01965158|63031455|FG000|Overall Study|Adverse Event|14|||
33630078|NCT01965158|63031456|FG001|Overall Study|Adverse Event|5|||
33537347|NCT02968849|62927306|FG001|Overall Study|Death|10|||
33537348|NCT02968849|62927305|FG000|Overall Study|Lost to Follow-up|31|||
33537349|NCT02968849|62927306|FG001|Overall Study|Lost to Follow-up|29|||
33537350|NCT02968849|62927305|FG000|Overall Study|Withdrawal by Subject|73|||
33537351|NCT02968849|62927306|FG001|Overall Study|Withdrawal by Subject|64|||
33537352|NCT02968849|62927305|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
33630079|NCT01965158|63031455|FG000|Overall Study|Withdrawal by Subject|16|||
33630080|NCT01965158|63031456|FG001|Overall Study|Withdrawal by Subject|24|||
33630081|NCT01965158|63031455|FG000|Overall Study|Lost to Follow-up|7|||
33630082|NCT01965158|63031456|FG001|Overall Study|Lost to Follow-up|5|||
33630083|NCT01965158|63031455|FG000|Overall Study|Protocol Violation|1|||
33630084|NCT01965158|63031456|FG001|Overall Study|Protocol Violation|1|||
33630085|NCT01965158|63031455|FG000|Overall Study|Other - Miscellaneous|3|||
33630086|NCT01965158|63031456|FG001|Overall Study|Other - Miscellaneous|0|||
33630087|NCT01964924|63031462|FG000|Trametinib Monotherapy|Progression|19|||
33461216|NCT04818346|62834440|FG001|24-Week Placebo-Controlled Period|Lost to Follow-up|2|||
33461217|NCT04818346|62834441|FG002|24-Week Placebo-Controlled Period|Lost to Follow-up|3|||
33461218|NCT04818346|62834442|FG003|24-Week Placebo-Controlled Period|Lost to Follow-up|1|||
33461219|NCT04818346|62834439|FG000|24-Week Placebo-Controlled Period|Physician Decision|1|||
33461220|NCT04818346|62834440|FG001|24-Week Placebo-Controlled Period|Physician Decision|0|||
33461221|NCT04818346|62834441|FG002|24-Week Placebo-Controlled Period|Physician Decision|0|||
33461222|NCT04818346|62834442|FG003|24-Week Placebo-Controlled Period|Physician Decision|0|||
33461223|NCT04818346|62834439|FG000|24-Week Placebo-Controlled Period|Protocol Violation|0|||
33537353|NCT02968849|62927306|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
33537354|NCT02968849|62927305|FG000|Overall Study|Physician Decision|6|||
33537355|NCT02968849|62927306|FG001|Overall Study|Physician Decision|9|||
33537356|NCT02968849|62927305|FG000|Overall Study|Other|16|||
33537357|NCT02968849|62927306|FG001|Overall Study|Other|10|||
33537358|NCT02669212|62927317|FG000|Overall Study|Lost to Follow-up|1|||
33537359|NCT02669212|62927318|FG001|Overall Study|Lost to Follow-up|0|||
33630088|NCT01964924|63031463|FG001|Trametinib Monotherapy|Progression|0|||
33537360|NCT02669212|62927317|FG000|Overall Study|Medical Condition|3|||
33630089|NCT01964378|63031474|FG000|Overall Study|Disc. due to death before first dosing|0|||
33537361|NCT02669212|62927318|FG001|Overall Study|Medical Condition|4|||
33537362|NCT02669212|62927317|FG000|Overall Study|Withdrawal by Subject|0|||
33630090|NCT01964378|63031475|FG001|Overall Study|Disc. due to death before first dosing|1|||
33630091|NCT01964378|63031474|FG000|Overall Study|Disc. due to AE before first dosing|1|||
33630092|NCT01964378|63031475|FG001|Overall Study|Disc. due to AE before first dosing|0|||
33630093|NCT01964378|63031474|FG000|Overall Study|Death|3|||
33630094|NCT01964378|63031475|FG001|Overall Study|Death|2|||
33630095|NCT01964378|63031474|FG000|Overall Study|Adverse Event|12|||
33630096|NCT01964378|63031475|FG001|Overall Study|Adverse Event|5|||
33630097|NCT01964378|63031474|FG000|Overall Study|Lack of Efficacy|0|||
33630098|NCT01964378|63031475|FG001|Overall Study|Lack of Efficacy|1|||
33630099|NCT01964378|63031474|FG000|Overall Study|Protocol Violation|0|||
33630100|NCT01964378|63031475|FG001|Overall Study|Protocol Violation|1|||
33630101|NCT01964378|63031474|FG000|Overall Study|Lost to Follow-up|0|||
33630102|NCT01964378|63031475|FG001|Overall Study|Lost to Follow-up|1|||
33630103|NCT01964378|63031474|FG000|Overall Study|Withdrawal by Subject|7|||
33630104|NCT01964378|63031475|FG001|Overall Study|Withdrawal by Subject|5|||
33630105|NCT01964378|63031474|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
33537363|NCT02669212|62927318|FG001|Overall Study|Withdrawal by Subject|2|||
33630106|NCT01964378|63031475|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
33630107|NCT01964378|63031474|FG000|Overall Study|Other|1|||
33630108|NCT01964378|63031475|FG001|Overall Study|Other|2|||
33630109|NCT01442038|63031483|FG000|Overall Study|Death|35|||
33630110|NCT01442038|63031484|FG001|Overall Study|Death|29|||
33630111|NCT01442038|63031483|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
33630112|NCT01442038|63031484|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
33630113|NCT01442038|63031483|FG000|Overall Study|Participant Withdrew Consent|137|||
33537364|NCT02669212|62927317|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
33537365|NCT02669212|62927318|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
33630114|NCT01442038|63031484|FG001|Overall Study|Participant Withdrew Consent|102|||
33630115|NCT01442038|63031483|FG000|Overall Study|Lost to Follow-up|37|||
33630116|NCT01442038|63031484|FG001|Overall Study|Lost to Follow-up|51|||
33630117|NCT01442038|63031483|FG000|Overall Study|Adverse Event|26|||
33630118|NCT01442038|63031484|FG001|Overall Study|Adverse Event|15|||
33630119|NCT01442038|63031483|FG000|Overall Study|Protocol Deviation|9|||
33630120|NCT01442038|63031484|FG001|Overall Study|Protocol Deviation|20|||
33630121|NCT01442038|63031483|FG000|Overall Study|Investigator's Discretion|13|||
33630122|NCT01442038|63031484|FG001|Overall Study|Investigator's Discretion|16|||
33630123|NCT01442038|63031483|FG000|Overall Study|Study Terminated By Sponsor|2|||
33630124|NCT01442038|63031484|FG001|Overall Study|Study Terminated By Sponsor|3|||
33630125|NCT01998919|63031492|FG000|Overall Study|Death|2|||
33630126|NCT01998919|63031493|FG001|Overall Study|Death|2|||
33630127|NCT01998919|63031492|FG000|Overall Study|Adverse Event|0|||
33630128|NCT01998919|63031493|FG001|Overall Study|Adverse Event|5|||
33630129|NCT01998919|63031492|FG000|Overall Study|Disease progression|31|||
33630130|NCT01998919|63031493|FG001|Overall Study|Disease progression|22|||
33630131|NCT01998919|63031492|FG000|Overall Study|Withdrawal by Subject|2|||
33630132|NCT01998919|63031493|FG001|Overall Study|Withdrawal by Subject|4|||
33630133|NCT01998919|63031492|FG000|Overall Study|Lost to Follow-up|2|||
33630134|NCT01998919|63031493|FG001|Overall Study|Lost to Follow-up|0|||
33630135|NCT01998919|63031492|FG000|Overall Study|Other|5|||
33630136|NCT01998919|63031493|FG001|Overall Study|Other|2|||
33630137|NCT01957111|63031501|FG000|Overall Study|Withdrawal by Subject|1|||
33630138|NCT01957111|63031502|FG001|Overall Study|Withdrawal by Subject|1|||
33630139|NCT01964300|63031510|FG000|Overall Study|Ineligible after enrollment|0|||
33630140|NCT01964300|63031511|FG001|Overall Study|Ineligible after enrollment|1|||
33630141|NCT01964300|63031510|FG000|Overall Study|Adverse Event|1|||
33630142|NCT01964300|63031511|FG001|Overall Study|Adverse Event|1|||
33630143|NCT01964300|63031510|FG000|Overall Study|Lack of Efficacy|3|||
33630144|NCT01964300|63031511|FG001|Overall Study|Lack of Efficacy|5|||
33630145|NCT01964300|63031510|FG000|Overall Study|Withdrawal by Subject|0|||
33630146|NCT01964300|63031511|FG001|Overall Study|Withdrawal by Subject|1|||
33630147|NCT01964300|63031510|FG000|Overall Study|To receive alternative therapy|1|||
33630148|NCT01964300|63031511|FG001|Overall Study|To receive alternative therapy|2|||
33630149|NCT01964300|63031510|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
33630150|NCT01964300|63031511|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
33537366|NCT02536664|62927340|FG000|Overall Study|Inadequate completion of documentation|2|||
33537367|NCT02536664|62927341|FG001|Overall Study|Inadequate completion of documentation|4|||
33537368|NCT02536664|62927340|FG000|Overall Study|Progression|13|||
33537369|NCT02536664|62927341|FG001|Overall Study|Progression|18|||
33630151|NCT01964300|63031510|FG000|Overall Study|Weight criteria not met|0|||
33630152|NCT01964300|63031511|FG001|Overall Study|Weight criteria not met|1|||
33537370|NCT02536664|62927340|FG000|Overall Study|Death due to lymphoma|2|||
33630153|NCT01964222|63031519|FG000|Overall Study|Lost to Follow-up|7|||
33630154|NCT01964222|63031520|FG001|Overall Study|Lost to Follow-up|5|||
33537371|NCT02536664|62927341|FG001|Overall Study|Death due to lymphoma|1|||
33630155|NCT01964222|63031519|FG000|Overall Study|Withdrawal by Subject|6|||
33630156|NCT01964222|63031520|FG001|Overall Study|Withdrawal by Subject|6|||
33630157|NCT01964222|63031519|FG000|Overall Study|Screening Failure|2|||
33630158|NCT01964222|63031520|FG001|Overall Study|Screening Failure|0|||
33630159|NCT01467700|63031530|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
33630160|NCT01467700|63031531|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
33630161|NCT01467700|63031532|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
33630162|NCT01467700|63031533|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
33630163|NCT01467700|63031530|FG000|Overall Study|Major Protocol Deviation|3|||
33630164|NCT01467700|63031531|FG001|Overall Study|Major Protocol Deviation|3|||
33630165|NCT01467700|63031532|FG002|Overall Study|Major Protocol Deviation|2|||
33630166|NCT01467700|63031533|FG003|Overall Study|Major Protocol Deviation|3|||
33630167|NCT01467700|63031530|FG000|Overall Study|Lost to Follow-up|6|||
33630168|NCT01467700|63031531|FG001|Overall Study|Lost to Follow-up|5|||
33537372|NCT02536664|62927340|FG000|Overall Study|Death due to other reason|3|||
33537373|NCT02536664|62927341|FG001|Overall Study|Death due to other reason|2|||
33537374|NCT02536664|62927340|FG000|Overall Study|Intolerability|8|||
33537375|NCT02536664|62927341|FG001|Overall Study|Intolerability|6|||
33537376|NCT02536664|62927340|FG000|Overall Study|Withdrawal by Subject|8|||
33537377|NCT02536664|62927341|FG001|Overall Study|Withdrawal by Subject|5|||
33537378|NCT02536664|62927340|FG000|Overall Study|Other|18|||
33537379|NCT02536664|62927341|FG001|Overall Study|Other|24|||
33537380|NCT02536664|62927340|FG000|Overall Study|Missing|53|||
33537381|NCT02536664|62927341|FG001|Overall Study|Missing|20|||
33537382|NCT02426892|62927347|FG000|Overall Study|Adverse Event|2|||
33537383|NCT02426892|62927347|FG000|Overall Study|Lack of Efficacy|17|||
33537384|NCT02426892|62927347|FG000|Overall Study|Withdrawal by Subject|1|||
33537385|NCT02312687|62927351|FG000|Overall Study|Other, Not Specified|1|||
33537386|NCT02304367|62927355|FG000|Overall Study|Lack of Response to Bruosumab|1|||
33537387|NCT02304367|62927355|FG000|Overall Study|Sponsor Decision|3|||
33537388|NCT02304367|62927355|FG000|Overall Study|Death|2|||
33537389|NCT02304367|62927355|FG000|Overall Study|Physician Decision|1|||
33537390|NCT02304367|62927355|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
33537391|NCT02107703|62927368|FG000|Overall Study|Withdrawal by Subject|36|||
33537392|NCT02107703|62927369|FG001|Overall Study|Withdrawal by Subject|19|||
33537393|NCT02107703|62927368|FG000|Overall Study|Lost to Follow-up|6|||
33537394|NCT02107703|62927369|FG001|Overall Study|Lost to Follow-up|4|||
33537395|NCT02107703|62927368|FG000|Overall Study|On study treatment/follow up|319|||
33537396|NCT02107703|62927369|FG001|Overall Study|On study treatment/follow up|152|||
33537397|NCT02054520|62927384|FG000|Overall Study|Adverse Event|1|||
33537398|NCT02054520|62927385|FG001|Overall Study|Adverse Event|4|||
33537399|NCT02054520|62927386|FG002|Overall Study|Adverse Event|2|||
33537400|NCT02054520|62927387|FG003|Overall Study|Adverse Event|1|||
33537401|NCT02054520|62927388|FG004|Overall Study|Adverse Event|1|||
33537402|NCT02054520|62927389|FG005|Overall Study|Adverse Event|0|||
33537403|NCT02054520|62927384|FG000|Overall Study|Lack of Efficacy|7|||
33537404|NCT02054520|62927385|FG001|Overall Study|Lack of Efficacy|0|||
33537405|NCT02054520|62927386|FG002|Overall Study|Lack of Efficacy|2|||
33537406|NCT02054520|62927387|FG003|Overall Study|Lack of Efficacy|1|||
33537407|NCT02054520|62927388|FG004|Overall Study|Lack of Efficacy|3|||
33537408|NCT02054520|62927389|FG005|Overall Study|Lack of Efficacy|2|||
33537409|NCT02054520|62927384|FG000|Overall Study|Withdrawal by Subject|1|||
33630169|NCT01467700|63031532|FG002|Overall Study|Lost to Follow-up|2|||
33630170|NCT01467700|63031533|FG003|Overall Study|Lost to Follow-up|3|||
33461224|NCT04818346|62834440|FG001|24-Week Placebo-Controlled Period|Protocol Violation|0|||
33461225|NCT04818346|62834441|FG002|24-Week Placebo-Controlled Period|Protocol Violation|1|||
33461226|NCT04818346|62834442|FG003|24-Week Placebo-Controlled Period|Protocol Violation|1|||
33461227|NCT04818346|62834439|FG000|24-Week Placebo-Controlled Period|Withdrawal by Subject|1|||
33461228|NCT04818346|62834440|FG001|24-Week Placebo-Controlled Period|Withdrawal by Subject|1|||
33461229|NCT04818346|62834441|FG002|24-Week Placebo-Controlled Period|Withdrawal by Subject|6|||
33461230|NCT04818346|62834442|FG003|24-Week Placebo-Controlled Period|Withdrawal by Subject|2|||
33461231|NCT04818346|62834439|FG000|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|1|||
33461232|NCT04818346|62834440|FG001|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
33461233|NCT04818346|62834441|FG002|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
33461234|NCT04818346|62834442|FG003|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
33461235|NCT04818346|62834439|FG000|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
33461236|NCT04818346|62834440|FG001|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
33461237|NCT04818346|62834441|FG002|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
33461238|NCT04818346|62834442|FG003|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
33461239|NCT04818346|62834439|FG000|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
33537410|NCT02054520|62927385|FG001|Overall Study|Withdrawal by Subject|0|||
33537411|NCT02054520|62927386|FG002|Overall Study|Withdrawal by Subject|0|||
33630171|NCT01467700|63031530|FG000|Overall Study|Voluntary Withdrawal|5|||
33537412|NCT02054520|62927387|FG003|Overall Study|Withdrawal by Subject|2|||
33537413|NCT02054520|62927388|FG004|Overall Study|Withdrawal by Subject|1|||
33630172|NCT01467700|63031531|FG001|Overall Study|Voluntary Withdrawal|7|||
33537414|NCT02054520|62927389|FG005|Overall Study|Withdrawal by Subject|0|||
33537415|NCT02054520|62927384|FG000|Overall Study|Physician Decision|0|||
33537416|NCT02054520|62927385|FG001|Overall Study|Physician Decision|1|||
33537417|NCT02054520|62927386|FG002|Overall Study|Physician Decision|0|||
33537418|NCT02054520|62927387|FG003|Overall Study|Physician Decision|1|||
33537419|NCT02054520|62927388|FG004|Overall Study|Physician Decision|0|||
33537420|NCT02054520|62927389|FG005|Overall Study|Physician Decision|1|||
33537421|NCT02054520|62927384|FG000|Overall Study|Study terminated by Sponsor|0|||
33537422|NCT02054520|62927385|FG001|Overall Study|Study terminated by Sponsor|0|||
33537423|NCT02054520|62927386|FG002|Overall Study|Study terminated by Sponsor|2|||
33537424|NCT02054520|62927387|FG003|Overall Study|Study terminated by Sponsor|1|||
33537425|NCT02054520|62927388|FG004|Overall Study|Study terminated by Sponsor|0|||
33537426|NCT02054520|62927389|FG005|Overall Study|Study terminated by Sponsor|0|||
33537427|NCT01546987|62927418|FG000|Overall Study|Protocol Violation|3|||
33537428|NCT01546987|62927419|FG001|Overall Study|Protocol Violation|4|||
33537429|NCT00261443|62927442|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
33537430|NCT00261443|62927443|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
33537431|NCT00261443|62927444|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
33537432|NCT00261443|62927442|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
33537433|NCT00261443|62927443|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
33537434|NCT00261443|62927444|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
33537435|NCT00261443|62927442|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
33537436|NCT00261443|62927443|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
33537437|NCT00261443|62927444|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
33537438|NCT00261443|62927442|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
33537439|NCT00261443|62927443|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
33537440|NCT00261443|62927444|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
33537441|NCT00261443|62927442|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
33537442|NCT00261443|62927443|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
33537443|NCT00261443|62927444|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
33537444|NCT00261443|62927442|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
33537445|NCT00261443|62927443|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
33537446|NCT00261443|62927444|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
33537447|NCT00261443|62927442|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
33537448|NCT00261443|62927443|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
33630173|NCT01467700|63031532|FG002|Overall Study|Voluntary Withdrawal|6|||
33630174|NCT01467700|63031533|FG003|Overall Study|Voluntary Withdrawal|2|||
33630175|NCT01467700|63031530|FG000|Overall Study|Study Termination|6|||
33630176|NCT01467700|63031531|FG001|Overall Study|Study Termination|5|||
33630177|NCT01467700|63031532|FG002|Overall Study|Study Termination|10|||
33630178|NCT01467700|63031533|FG003|Overall Study|Study Termination|7|||
33630179|NCT01467700|63031530|FG000|Overall Study|Pregnancy|0|||
33630180|NCT01467700|63031531|FG001|Overall Study|Pregnancy|1|||
33630181|NCT01467700|63031532|FG002|Overall Study|Pregnancy|1|||
33630182|NCT01467700|63031533|FG003|Overall Study|Pregnancy|0|||
33630183|NCT01467700|63031530|FG000|Overall Study|Lack of Efficacy|2|||
33630184|NCT01467700|63031531|FG001|Overall Study|Lack of Efficacy|0|||
33630185|NCT01467700|63031532|FG002|Overall Study|Lack of Efficacy|2|||
33630186|NCT01467700|63031533|FG003|Overall Study|Lack of Efficacy|1|||
33630187|NCT01467700|63031530|FG000|Overall Study|Reason not Specified|1|||
33630188|NCT01467700|63031531|FG001|Overall Study|Reason not Specified|3|||
33630189|NCT01467700|63031532|FG002|Overall Study|Reason not Specified|2|||
33461240|NCT04818346|62834440|FG001|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
33461241|NCT04818346|62834441|FG002|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|1|||
33461242|NCT04818346|62834442|FG003|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
33461243|NCT04818346|62834439|FG000|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
33461244|NCT04818346|62834440|FG001|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
33461245|NCT04818346|62834441|FG002|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
33537449|NCT00261443|62927444|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
33537450|NCT00261443|62927442|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
33537451|NCT00261443|62927443|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
33537452|NCT00261443|62927444|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
33630190|NCT01467700|63031533|FG003|Overall Study|Reason not Specified|8|||
33630191|NCT01972724|63031546|FG000|Double-Blind|Rescue Criteria Met|1|||
33630192|NCT01972724|63031547|FG001|Double-Blind|Rescue Criteria Met|0|||
33630193|NCT01972724|63031548|FG002|Double-Blind|Rescue Criteria Met|0|||
33630194|NCT01972724|63031546|FG000|Double-Blind|Adverse Event|1|||
33630195|NCT01972724|63031547|FG001|Double-Blind|Adverse Event|0|||
33630196|NCT01972724|63031548|FG002|Double-Blind|Adverse Event|0|||
33630197|NCT01972724|63031546|FG000|Double-Blind|Withdrawal of Consent|2|||
33630198|NCT01972724|63031547|FG001|Double-Blind|Withdrawal of Consent|1|||
33630199|NCT01972724|63031548|FG002|Double-Blind|Withdrawal of Consent|0|||
33630200|NCT01972724|63031546|FG000|Double-Blind|Significant Protocol Deviation|5|||
33630201|NCT01972724|63031547|FG001|Double-Blind|Significant Protocol Deviation|8|||
33630202|NCT01972724|63031548|FG002|Double-Blind|Significant Protocol Deviation|0|||
33630203|NCT01972724|63031546|FG000|Open-Label|Withdrew Consent|0|||
33630204|NCT01972724|63031547|FG001|Open-Label|Withdrew Consent|0|||
33630205|NCT01972724|63031548|FG002|Open-Label|Withdrew Consent|3|||
33630206|NCT01972724|63031546|FG000|Open-Label|Significant Protocol Deviation|0|||
33630207|NCT01972724|63031547|FG001|Open-Label|Significant Protocol Deviation|0|||
33630208|NCT01972724|63031548|FG002|Open-Label|Significant Protocol Deviation|2|||
33630209|NCT01441960|63031556|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
33630210|NCT01441960|63031557|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
33630211|NCT01441960|63031556|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
33630212|NCT01441960|63031557|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
33630213|NCT01441960|63031556|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
33630214|NCT01441960|63031557|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
33630215|NCT01955707|63031569|FG000|Overall Study|Adverse Event|1|||
33630216|NCT01955707|63031570|FG001|Overall Study|Adverse Event|2|||
33537453|NCT00261443|62927442|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
33537454|NCT00261443|62927443|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
33537455|NCT00261443|62927444|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
33537456|NCT00261443|62927442|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
33537457|NCT00261443|62927443|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
33537458|NCT00261443|62927444|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
33537459|NCT00261443|62927442|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
33537460|NCT00261443|62927443|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
33630217|NCT01955707|63031569|FG000|Overall Study|Lost to Follow-up|2|||
33630218|NCT01955707|63031570|FG001|Overall Study|Lost to Follow-up|1|||
33630219|NCT01955707|63031569|FG000|Overall Study|Withdrawal by Subject|0|||
33630220|NCT01955707|63031570|FG001|Overall Study|Withdrawal by Subject|3|||
33630221|NCT01955707|63031569|FG000|Overall Study|Death|13|||
33630222|NCT01955707|63031570|FG001|Overall Study|Death|14|||
33630223|NCT01955707|63031569|FG000|Overall Study|Other|4|||
33630224|NCT01955707|63031570|FG001|Overall Study|Other|2|||
33630225|NCT01435798|63031576|FG000|Overall Study|Withdrawal by Subject|1|||
33630226|NCT01972568|63031589|FG000|Overall Study|Other events|3|||
33630227|NCT01972568|63031590|FG001|Overall Study|Other events|0|||
33630228|NCT01972568|63031591|FG002|Overall Study|Other events|0|||
33630229|NCT01972568|63031589|FG000|Overall Study|Lack of Efficacy|0|||
33630230|NCT01972568|63031590|FG001|Overall Study|Lack of Efficacy|1|||
33630231|NCT01972568|63031591|FG002|Overall Study|Lack of Efficacy|2|||
33630232|NCT01972568|63031589|FG000|Overall Study|Protocol Violation|1|||
33630233|NCT01972568|63031590|FG001|Overall Study|Protocol Violation|2|||
33630234|NCT01972568|63031591|FG002|Overall Study|Protocol Violation|2|||
33630235|NCT01972568|63031589|FG000|Overall Study|Withdrawal by Subject|6|||
33630236|NCT01972568|63031590|FG001|Overall Study|Withdrawal by Subject|3|||
33630237|NCT01972568|63031591|FG002|Overall Study|Withdrawal by Subject|7|||
33630238|NCT01972568|63031589|FG000|Overall Study|Lost to Follow-up|1|||
33630239|NCT01972568|63031590|FG001|Overall Study|Lost to Follow-up|0|||
33630240|NCT01972568|63031591|FG002|Overall Study|Lost to Follow-up|0|||
33630241|NCT01972568|63031589|FG000|Overall Study|Adverse Event|5|||
33630242|NCT01972568|63031590|FG001|Overall Study|Adverse Event|6|||
33630243|NCT01972568|63031591|FG002|Overall Study|Adverse Event|5|||
33630244|NCT01955161|63031602|FG000|Overall Study|Withdrawal before treatment|2|||
33630245|NCT01955161|63031603|FG001|Overall Study|Withdrawal before treatment|0|||
33461246|NCT04818346|62834442|FG003|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
33461247|NCT04723394|62834454|FG000|Overall Study|Adverse Event|0|||
33461248|NCT04723394|62834455|FG001|Overall Study|Adverse Event|3|||
33461249|NCT04723394|62834454|FG000|Overall Study|Death|8|||
33461250|NCT04723394|62834455|FG001|Overall Study|Death|8|||
33461251|NCT04723394|62834454|FG000|Overall Study|Lost to Follow-up|20|||
33461252|NCT04723394|62834455|FG001|Overall Study|Lost to Follow-up|17|||
33537461|NCT00261443|62927444|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
33630246|NCT01955161|63031604|FG002|Overall Study|Withdrawal before treatment|1|||
33630247|NCT01955161|63031602|FG000|Overall Study|Adverse Event|10|||
33630248|NCT01955161|63031603|FG001|Overall Study|Adverse Event|14|||
33630249|NCT01955161|63031604|FG002|Overall Study|Adverse Event|15|||
33630250|NCT01955161|63031602|FG000|Overall Study|Death|1|||
33630251|NCT01955161|63031603|FG001|Overall Study|Death|1|||
33630252|NCT01955161|63031604|FG002|Overall Study|Death|3|||
33630253|NCT01955161|63031602|FG000|Overall Study|Withdrawal by Subject|9|||
33461253|NCT04723394|62834454|FG000|Overall Study|Physician Decision|1|||
33461254|NCT04723394|62834455|FG001|Overall Study|Physician Decision|0|||
33461255|NCT04723394|62834454|FG000|Overall Study|Withdrawal by Subject|20|||
33630254|NCT01955161|63031603|FG001|Overall Study|Withdrawal by Subject|8|||
33630255|NCT01955161|63031604|FG002|Overall Study|Withdrawal by Subject|12|||
33630256|NCT01955161|63031602|FG000|Overall Study|Protocol Violation|2|||
33630257|NCT01955161|63031603|FG001|Overall Study|Protocol Violation|0|||
33630258|NCT01955161|63031604|FG002|Overall Study|Protocol Violation|0|||
33630259|NCT01955161|63031602|FG000|Overall Study|Other reason: physician decision|0|||
33630260|NCT01955161|63031603|FG001|Overall Study|Other reason: physician decision|1|||
33630261|NCT01955161|63031604|FG002|Overall Study|Other reason: physician decision|1|||
33537462|NCT00261443|62927442|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
33537463|NCT00261443|62927443|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
33537464|NCT00261443|62927444|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
33537465|NCT00261443|62927442|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
33461256|NCT04723394|62834455|FG001|Overall Study|Withdrawal by Subject|34|||
33461257|NCT04723394|62834454|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
33461258|NCT04723394|62834455|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
33461259|NCT04478266|62834467|FG000|Overall Study|Adverse Event|17|||
33461260|NCT04478266|62834468|FG001|Overall Study|Adverse Event|18|||
33461261|NCT04478266|62834467|FG000|Overall Study|Progressive disease|99|||
33461262|NCT04478266|62834468|FG001|Overall Study|Progressive disease|118|||
33630262|NCT01955161|63031602|FG000|Overall Study|Other reason: disallowed medication|1|||
33630263|NCT01955161|63031603|FG001|Overall Study|Other reason: disallowed medication|0|||
33630264|NCT01955161|63031604|FG002|Overall Study|Other reason: disallowed medication|1|||
33630265|NCT01955161|63031602|FG000|Overall Study|Other reason: caregiver unavailable|1|||
33630266|NCT01955161|63031603|FG001|Overall Study|Other reason: caregiver unavailable|0|||
33630267|NCT01955161|63031604|FG002|Overall Study|Other reason: caregiver unavailable|0|||
33630268|NCT01955161|63031602|FG000|Overall Study|Other reason: moved to nursing home|0|||
33461263|NCT04478266|62834467|FG000|Overall Study|Poor compliance to protocol|1|||
33537466|NCT00261443|62927443|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
33537467|NCT00261443|62927444|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
33537468|NCT00261443|62927442|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
33537469|NCT00261443|62927443|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
33537470|NCT00261443|62927444|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
33537471|NCT00261443|62927442|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
33537472|NCT00261443|62927443|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
33537473|NCT00261443|62927444|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
33537474|NCT00261443|62927442|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
33537475|NCT00261443|62927443|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
33537476|NCT00261443|62927444|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
33537477|NCT00261443|62927442|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
33537478|NCT00261443|62927443|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
33537479|NCT00261443|62927444|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
33537480|NCT00261443|62927442|FG000|3: Assessment of Relapse|Adverse Event|0|||
33537481|NCT00261443|62927443|FG001|3: Assessment of Relapse|Adverse Event|15|||
33537482|NCT00261443|62927444|FG002|3: Assessment of Relapse|Adverse Event|19|||
33537483|NCT00261443|62927442|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
33537484|NCT00261443|62927443|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
33537485|NCT00261443|62927444|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
33537486|NCT00261443|62927442|FG000|3: Assessment of Relapse|Death|0|||
33537487|NCT00261443|62927443|FG001|3: Assessment of Relapse|Death|0|||
33537488|NCT00261443|62927444|FG002|3: Assessment of Relapse|Death|1|||
33537489|NCT00261443|62927442|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
33537490|NCT00261443|62927443|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
33537491|NCT00261443|62927444|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
33537492|NCT00261443|62927442|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
33537493|NCT00261443|62927443|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
33537494|NCT00261443|62927444|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
33537495|NCT00261443|62927442|FG000|3: Assessment of Relapse|Pregnancy|0|||
33537496|NCT00261443|62927443|FG001|3: Assessment of Relapse|Pregnancy|2|||
33537497|NCT00261443|62927444|FG002|3: Assessment of Relapse|Pregnancy|1|||
33537498|NCT00261443|62927442|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
33537499|NCT00261443|62927443|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
33537500|NCT00261443|62927444|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
33537501|NCT00261443|62927442|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
33537502|NCT00261443|62927443|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
33537503|NCT00261443|62927444|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
33537504|NCT00261443|62927442|FG000|3: Assessment of Relapse|Other Reasons|0|||
33537505|NCT00261443|62927443|FG001|3: Assessment of Relapse|Other Reasons|4|||
33630269|NCT01955161|63031603|FG001|Overall Study|Other reason: moved to nursing home|1|||
33630270|NCT01955161|63031604|FG002|Overall Study|Other reason: moved to nursing home|0|||
33630271|NCT01955161|63031602|FG000|Overall Study|Other reason: insufficient compliance|0|||
33630272|NCT01955161|63031603|FG001|Overall Study|Other reason: insufficient compliance|0|||
33630273|NCT01955161|63031604|FG002|Overall Study|Other reason: insufficient compliance|1|||
33630274|NCT01955161|63031602|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
33630275|NCT01955161|63031603|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
33630276|NCT01955161|63031604|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
33630277|NCT01955161|63031602|FG000|Overall Study|Other reason: patient's will|0|||
33630278|NCT01955161|63031603|FG001|Overall Study|Other reason: patient's will|0|||
33630279|NCT01955161|63031604|FG002|Overall Study|Other reason: patient's will|1|||
33630280|NCT01441414|63031612|FG000|Overall Study|Participant died|9|||
33630281|NCT01441414|63031612|FG000|Overall Study|Other reasons|3|||
33630282|NCT01441414|63031612|FG000|Overall Study|Study terminated by sponsor|2|||
33630283|NCT01441414|63031612|FG000|Overall Study|Subject refused further follow-up|1|||
33630284|NCT01971554|63031632|FG000|Overall Study|Lost to Follow-up|1|||
33630285|NCT01971554|63031633|FG001|Overall Study|Lost to Follow-up|0|||
33630286|NCT01971554|63031634|FG002|Overall Study|Lost to Follow-up|0|||
33630287|NCT01971554|63031635|FG003|Overall Study|Lost to Follow-up|0|||
33630288|NCT01955083|63031647|FG000|Overall Study|Lost to Follow-up|1|||
33630289|NCT01955083|63031648|FG001|Overall Study|Lost to Follow-up|1|||
33630290|NCT01955005|63031680|FG000|Overall Study|Withdrawal by Subject|3|||
33630291|NCT01955005|63031681|FG001|Overall Study|Withdrawal by Subject|5|||
33630292|NCT01954927|63031689|FG000|Overall Study|Withdrawal by Subject|3|||
33630293|NCT01954927|63031690|FG001|Overall Study|Withdrawal by Subject|1|||
33630294|NCT01954771|63031699|FG000|Overall Study|Missing HbA1c of end-point|1|||
33630295|NCT01954771|63031700|FG001|Overall Study|Missing HbA1c of end-point|1|||
33630296|NCT01954771|63031701|FG002|Overall Study|Missing HbA1c of end-point|0|||
33630297|NCT01954771|63031699|FG000|Overall Study|Missing CGMS of end-point|1|||
33461264|NCT04478266|62834468|FG001|Overall Study|Poor compliance to protocol|0|||
33461265|NCT04478266|62834467|FG000|Overall Study|Withdrawal by Subject|14|||
33461266|NCT04478266|62834468|FG001|Overall Study|Withdrawal by Subject|16|||
33461267|NCT04478266|62834467|FG000|Overall Study|Other: unspecified|5|||
33461268|NCT04478266|62834468|FG001|Overall Study|Other: unspecified|4|||
33461269|NCT04478266|62834467|FG000|Overall Study|Randomized not treated|1|||
33537506|NCT00261443|62927444|FG002|3: Assessment of Relapse|Other Reasons|3|||
33537507|NCT00261443|62927442|FG000|4: Extension Phase|Adverse Event|0|||
33537508|NCT00261443|62927443|FG001|4: Extension Phase|Adverse Event|1|||
33537509|NCT00261443|62927444|FG002|4: Extension Phase|Adverse Event|0|||
33537510|NCT00261443|62927442|FG000|4: Extension Phase|Withdrawal by Subject|0|||
33537511|NCT00261443|62927443|FG001|4: Extension Phase|Withdrawal by Subject|1|||
33537512|NCT00261443|62927444|FG002|4: Extension Phase|Withdrawal by Subject|2|||
33537513|NCT00261443|62927442|FG000|4: Extension Phase|Lost to Follow-up|0|||
33537514|NCT00261443|62927443|FG001|4: Extension Phase|Lost to Follow-up|1|||
33537515|NCT00261443|62927444|FG002|4: Extension Phase|Lost to Follow-up|0|||
33537516|NCT02593318|62927461|FG000|Overall Study|Withdrawal by Subject|1|||
33537517|NCT02593318|62927462|FG001|Overall Study|Withdrawal by Subject|1|||
33537518|NCT02343302|62927476|FG000|Overall Study|Physician Decision|1|||
33537519|NCT02343302|62927477|FG001|Overall Study|Physician Decision|1|||
33537520|NCT02590432|62927485|FG000|Open-label Treatment Period|Adverse Event|97|||
33537521|NCT02590432|62927486|FG001|Open-label Treatment Period|Adverse Event|79|||
33537522|NCT02590432|62927487|FG002|Open-label Treatment Period|Adverse Event|0|||
33537523|NCT02590432|62927488|FG003|Open-label Treatment Period|Adverse Event|0|||
33537524|NCT02590432|62927489|FG004|Open-label Treatment Period|Adverse Event|0|||
33537525|NCT02590432|62927490|FG005|Open-label Treatment Period|Adverse Event|0|||
33537526|NCT02590432|62927491|FG006|Open-label Treatment Period|Adverse Event|0|||
33537527|NCT02590432|62927492|FG007|Open-label Treatment Period|Adverse Event|0|||
33537528|NCT02590432|62927493|FG008|Open-label Treatment Period|Adverse Event|0|||
33537529|NCT02590432|62927485|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
33537530|NCT02590432|62927486|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
33537531|NCT02590432|62927487|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
33537532|NCT02590432|62927488|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
33537533|NCT02590432|62927489|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
33537534|NCT02590432|62927490|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
33630298|NCT01954771|63031700|FG001|Overall Study|Missing CGMS of end-point|1|||
33537535|NCT02590432|62927491|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
33461270|NCT04478266|62834468|FG001|Overall Study|Randomized not treated|1|||
33461271|NCT04478266|62834467|FG000|Overall Study|Ongoing|397|||
33537536|NCT02590432|62927492|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
33630299|NCT01954771|63031701|FG002|Overall Study|Missing CGMS of end-point|0|||
33630300|NCT01954771|63031699|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
33630301|NCT01954771|63031700|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
33630302|NCT01954771|63031701|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
33630303|NCT01997281|63031714|FG000|Overall Study|Withdrawal by Subject|1|||
33461272|NCT04478266|62834468|FG001|Overall Study|Ongoing|377|||
33537537|NCT02590432|62927493|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
33630304|NCT01997281|63031715|FG001|Overall Study|Withdrawal by Subject|0|||
33630305|NCT01996033|63031721|FG000|Overall Study|Death|1|||
33630306|NCT01996033|63031721|FG000|Overall Study|Physician Decision|1|||
33630307|NCT01996033|63031721|FG000|Overall Study|Withdrawal by Subject|4|||
33630308|NCT01996033|63031721|FG000|Overall Study|Lost to Follow-up|3|||
33630309|NCT01953913|63031725|FG000|Overall Study|Disease Progression|349|||
33630310|NCT01953913|63031725|FG000|Overall Study|Worsening of underlying cancer|22|||
33630311|NCT01953913|63031725|FG000|Overall Study|Adverse Event|20|||
33630312|NCT01953913|63031725|FG000|Overall Study|Protocol Violation|6|||
33630313|NCT01953913|63031725|FG000|Overall Study|Lost to Follow-up|4|||
33630314|NCT01953913|63031725|FG000|Overall Study|Withdrawal by Subject|32|||
33630315|NCT01953913|63031725|FG000|Overall Study|Other than listed|108|||
33630316|NCT01953913|63031725|FG000|Overall Study|Not Treated|1|||
33630317|NCT01971476|63031732|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
33630318|NCT01971476|63031733|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
33630319|NCT01971476|63031734|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
33630320|NCT01971476|63031732|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
33630321|NCT01971476|63031733|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
33630322|NCT01971476|63031734|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
33630323|NCT01971476|63031732|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
33630324|NCT01971476|63031733|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
33630325|NCT01971476|63031734|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
33630326|NCT01996904|63031753|FG000|Overall Study|Lost to Follow-up|38|||
33630327|NCT01996904|63031754|FG001|Overall Study|Lost to Follow-up|27|||
33630328|NCT01970540|63031763|FG000|Overall Study|Non-treatment-related AE|0|||
33630329|NCT01970540|63031764|FG001|Overall Study|Non-treatment-related AE|0|||
33630330|NCT01970540|63031765|FG002|Overall Study|Non-treatment-related AE|1|||
33630331|NCT01970540|63031763|FG000|Overall Study|Progressive disease|55|||
33630332|NCT01970540|63031764|FG001|Overall Study|Progressive disease|23|||
33630333|NCT01970540|63031765|FG002|Overall Study|Progressive disease|10|||
33630334|NCT01970540|63031763|FG000|Overall Study|Treatment delay over protocol|0|||
33630335|NCT01970540|63031764|FG001|Overall Study|Treatment delay over protocol|0|||
33630336|NCT01970540|63031765|FG002|Overall Study|Treatment delay over protocol|1|||
33630337|NCT01970540|63031763|FG000|Overall Study|Physician Decision|7|||
33630338|NCT01970540|63031764|FG001|Overall Study|Physician Decision|2|||
33630339|NCT01970540|63031765|FG002|Overall Study|Physician Decision|0|||
33630340|NCT01970540|63031763|FG000|Overall Study|Clinical progression|0|||
33630341|NCT01970540|63031764|FG001|Overall Study|Clinical progression|1|||
33630342|NCT01970540|63031765|FG002|Overall Study|Clinical progression|1|||
33630343|NCT01970540|63031763|FG000|Overall Study|End of study|2|||
33630344|NCT01970540|63031764|FG001|Overall Study|End of study|0|||
33630345|NCT01970540|63031765|FG002|Overall Study|End of study|2|||
33630346|NCT01970540|63031763|FG000|Overall Study|Adverse Event|0|||
33630347|NCT01970540|63031764|FG001|Overall Study|Adverse Event|2|||
33630348|NCT01970540|63031765|FG002|Overall Study|Adverse Event|1|||
33630349|NCT01970540|63031763|FG000|Overall Study|Treatment-related AE|4|||
33630350|NCT01970540|63031764|FG001|Overall Study|Treatment-related AE|0|||
33630351|NCT01970540|63031765|FG002|Overall Study|Treatment-related AE|2|||
33630352|NCT01970540|63031763|FG000|Overall Study|Withdrawal by Subject|4|||
33630353|NCT01970540|63031764|FG001|Overall Study|Withdrawal by Subject|0|||
33630354|NCT01970540|63031765|FG002|Overall Study|Withdrawal by Subject|1|||
33630355|NCT01970540|63031763|FG000|Overall Study|Clinical deterioration|1|||
33630356|NCT01970540|63031764|FG001|Overall Study|Clinical deterioration|0|||
33630357|NCT01970540|63031765|FG002|Overall Study|Clinical deterioration|0|||
33630358|NCT01963676|63031786|FG000|Overall Study|Withdrawal by Subject|1|||
33630359|NCT01963676|63031787|FG001|Overall Study|Withdrawal by Subject|0|||
33630360|NCT01996826|63031795|FG000|Overall Study|Lost to Follow-up|6|||
33630361|NCT01996826|63031796|FG001|Overall Study|Lost to Follow-up|2|||
33630362|NCT01996826|63031795|FG000|Overall Study|Physician Decision|1|||
33630363|NCT01996826|63031796|FG001|Overall Study|Physician Decision|1|||
33630364|NCT01996748|63031804|FG000|Overall Study|Personal reason|1|||
33630365|NCT01996748|63031805|FG001|Overall Study|Personal reason|0|||
33630366|NCT01996748|63031804|FG000|Overall Study|Physician Decision|2|||
33630367|NCT01996748|63031805|FG001|Overall Study|Physician Decision|0|||
33630368|NCT01996748|63031804|FG000|Overall Study|Adverse Event|1|||
33537538|NCT02590432|62927485|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
33537539|NCT02590432|62927486|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
33630369|NCT01996748|63031805|FG001|Overall Study|Adverse Event|4|||
33630370|NCT01996748|63031804|FG000|Overall Study|Withdrawal by Subject|0|||
33630371|NCT01996748|63031805|FG001|Overall Study|Withdrawal by Subject|1|||
33630372|NCT01996748|63031804|FG000|Overall Study|Lost to Follow-up|4|||
33630373|NCT01996748|63031805|FG001|Overall Study|Lost to Follow-up|1|||
33630374|NCT01621178|63031816|FG000|Overall Study|Adverse Event|5|||
33630375|NCT01621178|63031817|FG001|Overall Study|Adverse Event|2|||
33630376|NCT01621178|63031818|FG002|Overall Study|Adverse Event|8|||
33630377|NCT01621178|63031816|FG000|Overall Study|Death|6|||
33630378|NCT01621178|63031817|FG001|Overall Study|Death|7|||
33630379|NCT01621178|63031818|FG002|Overall Study|Death|2|||
33630380|NCT01621178|63031816|FG000|Overall Study|Lost to Follow-up|1|||
33630381|NCT01621178|63031817|FG001|Overall Study|Lost to Follow-up|2|||
33630382|NCT01621178|63031818|FG002|Overall Study|Lost to Follow-up|1|||
33630383|NCT01621178|63031816|FG000|Overall Study|Withdrawal by Subject|14|||
33630384|NCT01621178|63031817|FG001|Overall Study|Withdrawal by Subject|17|||
33630385|NCT01621178|63031818|FG002|Overall Study|Withdrawal by Subject|18|||
33630386|NCT01621178|63031816|FG000|Overall Study|Physician Decision|5|||
33630387|NCT01621178|63031817|FG001|Overall Study|Physician Decision|2|||
33630388|NCT01621178|63031818|FG002|Overall Study|Physician Decision|7|||
33630389|NCT01962974|63031830|FG000|Overall Study|Study termination|7|||
33630390|NCT01996592|63031834|FG000|Overall Study|no response to text/no diary entry|32|||
33630391|NCT01996592|63031834|FG000|Overall Study|change in surgical date|4|||
33630392|NCT01996592|63031834|FG000|Overall Study|Withdrawal by Subject|5|||
33630393|NCT01996592|63031834|FG000|Overall Study|change in mode of delivery|4|||
33630394|NCT01962896|63031843|FG000|Overall Study|Lack of Efficacy|4|||
33630395|NCT01970462|63031850|FG000|Overall Study|Lost to Follow-up|0|||
33630396|NCT01970462|63031851|FG001|Overall Study|Lost to Follow-up|2|||
33630397|NCT01958671|63031860|FG000|Overall Study|Adverse Event|1|||
33630398|NCT01958671|63031861|FG001|Overall Study|Adverse Event|1|||
33630399|NCT01958671|63031862|FG002|Overall Study|Adverse Event|5|||
33630400|NCT01958671|63031860|FG000|Overall Study|Death|1|||
33630401|NCT01958671|63031861|FG001|Overall Study|Death|0|||
33630402|NCT01958671|63031862|FG002|Overall Study|Death|0|||
33630403|NCT01958671|63031860|FG000|Overall Study|Excluded medication|0|||
33630404|NCT01958671|63031861|FG001|Overall Study|Excluded medication|0|||
33630405|NCT01958671|63031862|FG002|Overall Study|Excluded medication|1|||
33630406|NCT01958671|63031860|FG000|Overall Study|Hyperglycemia|0|||
33630407|NCT01958671|63031861|FG001|Overall Study|Hyperglycemia|0|||
33630408|NCT01958671|63031862|FG002|Overall Study|Hyperglycemia|2|||
33630409|NCT01958671|63031860|FG000|Overall Study|Lost to Follow-up|7|||
33630410|NCT01958671|63031861|FG001|Overall Study|Lost to Follow-up|11|||
33630411|NCT01958671|63031862|FG002|Overall Study|Lost to Follow-up|7|||
33630412|NCT01958671|63031860|FG000|Overall Study|Non-compliance with study drug|1|||
33630413|NCT01958671|63031861|FG001|Overall Study|Non-compliance with study drug|1|||
33630414|NCT01958671|63031862|FG002|Overall Study|Non-compliance with study drug|1|||
33630415|NCT01958671|63031860|FG000|Overall Study|Pregnancy|0|||
33630416|NCT01958671|63031861|FG001|Overall Study|Pregnancy|0|||
33630417|NCT01958671|63031862|FG002|Overall Study|Pregnancy|1|||
33630418|NCT01958671|63031860|FG000|Overall Study|Protocol Violation|0|||
33630419|NCT01958671|63031861|FG001|Overall Study|Protocol Violation|1|||
33537540|NCT02590432|62927487|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
33537541|NCT02590432|62927488|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
33537542|NCT02590432|62927489|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
33537543|NCT02590432|62927490|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
33537544|NCT02590432|62927491|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
33537545|NCT02590432|62927492|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
33537546|NCT02590432|62927493|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
33537547|NCT02590432|62927485|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
33537548|NCT02590432|62927486|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
33537549|NCT02590432|62927487|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
33537550|NCT02590432|62927488|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
33537551|NCT02590432|62927489|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
33537552|NCT02590432|62927490|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
33537553|NCT02590432|62927491|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
33537554|NCT02590432|62927492|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
33537555|NCT02590432|62927493|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
33537556|NCT02590432|62927485|FG000|Open-label Treatment Period|Protocol Violation|10|||
33537557|NCT02590432|62927486|FG001|Open-label Treatment Period|Protocol Violation|4|||
33537558|NCT02590432|62927487|FG002|Open-label Treatment Period|Protocol Violation|0|||
33630420|NCT01958671|63031862|FG002|Overall Study|Protocol Violation|0|||
33630421|NCT01958671|63031860|FG000|Overall Study|Study site terminated by sponsor|1|||
33630422|NCT01958671|63031861|FG001|Overall Study|Study site terminated by sponsor|0|||
33630423|NCT01958671|63031862|FG002|Overall Study|Study site terminated by sponsor|1|||
33630424|NCT01958671|63031860|FG000|Overall Study|Participant moved|0|||
33630425|NCT01958671|63031861|FG001|Overall Study|Participant moved|0|||
33630426|NCT01958671|63031862|FG002|Overall Study|Participant moved|1|||
33630427|NCT01958671|63031860|FG000|Overall Study|Withdrawal by Subject|8|||
33630428|NCT01958671|63031861|FG001|Overall Study|Withdrawal by Subject|10|||
33630429|NCT01958671|63031862|FG002|Overall Study|Withdrawal by Subject|13|||
33630430|NCT01995266|63031874|FG000|Overall Study|Death|1|||
33630431|NCT01995266|63031874|FG000|Overall Study|Lack of Efficacy|6|||
33630432|NCT01995266|63031874|FG000|Overall Study|Adverse Event|2|||
33630433|NCT01969058|63031880|FG000|Overall Study|Withdrawal by Subject|2|||
33630434|NCT01969058|63031881|FG001|Overall Study|Withdrawal by Subject|0|||
33630435|NCT01969058|63031880|FG000|Overall Study|Adverse Event|1|||
33630436|NCT01969058|63031881|FG001|Overall Study|Adverse Event|0|||
33630437|NCT01968980|63031889|FG000|Overall Study|Death|0|||
33630438|NCT01968980|63031890|FG001|Overall Study|Death|1|||
33537559|NCT02590432|62927488|FG003|Open-label Treatment Period|Protocol Violation|0|||
33537560|NCT02590432|62927489|FG004|Open-label Treatment Period|Protocol Violation|0|||
33537561|NCT02590432|62927490|FG005|Open-label Treatment Period|Protocol Violation|0|||
33537562|NCT02590432|62927491|FG006|Open-label Treatment Period|Protocol Violation|0|||
33537563|NCT02590432|62927492|FG007|Open-label Treatment Period|Protocol Violation|0|||
33537564|NCT02590432|62927493|FG008|Open-label Treatment Period|Protocol Violation|0|||
33537565|NCT02590432|62927485|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
33537566|NCT02590432|62927486|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
33537567|NCT02590432|62927487|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
33537568|NCT02590432|62927488|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
33630439|NCT01968980|63031889|FG000|Overall Study|Adverse Event|1|||
33630440|NCT01968980|63031890|FG001|Overall Study|Adverse Event|3|||
33630441|NCT01968980|63031889|FG000|Overall Study|Does not meet entry criteria|1|||
33630442|NCT01968980|63031890|FG001|Overall Study|Does not meet entry criteria|3|||
33630443|NCT01968980|63031889|FG000|Overall Study|Withdrawal by Subject|13|||
33630444|NCT01968980|63031890|FG001|Overall Study|Withdrawal by Subject|5|||
33630445|NCT01968980|63031889|FG000|Overall Study|Other unspecified|1|||
33630446|NCT01968980|63031890|FG001|Overall Study|Other unspecified|2|||
33630447|NCT01961882|63031899|FG000|Overall Study|Adverse Event|3|||
33630448|NCT01961882|63031900|FG001|Overall Study|Adverse Event|2|||
33630449|NCT01961882|63031899|FG000|Overall Study|Physician Decision|1|||
33630450|NCT01961882|63031900|FG001|Overall Study|Physician Decision|0|||
33630451|NCT01961882|63031899|FG000|Overall Study|Withdrawal by Subject|4|||
33630452|NCT01961882|63031900|FG001|Overall Study|Withdrawal by Subject|1|||
33630453|NCT01961882|63031899|FG000|Overall Study|Relapse of AML|39|||
33630454|NCT01961882|63031900|FG001|Overall Study|Relapse of AML|37|||
33630455|NCT01961882|63031899|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
33630456|NCT01961882|63031900|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
33630457|NCT01961882|63031899|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
33630458|NCT01961882|63031900|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
33630459|NCT01968434|63031908|FG000|Overall Study|Lost to Follow-up|3|||
33630460|NCT01968434|63031909|FG001|Overall Study|Lost to Follow-up|6|||
33630461|NCT01946438|63031919|FG000|Overall Study|Adverse Event|0|||
33630462|NCT01946438|63031920|FG001|Overall Study|Adverse Event|0|||
33630463|NCT01946438|63031921|FG002|Overall Study|Adverse Event|0|||
33630464|NCT01946438|63031922|FG003|Overall Study|Adverse Event|1|||
33630465|NCT01946438|63031919|FG000|Overall Study|Serious Adverse event|1|||
33630466|NCT01946438|63031920|FG001|Overall Study|Serious Adverse event|0|||
33630467|NCT01946438|63031921|FG002|Overall Study|Serious Adverse event|0|||
33630468|NCT01946438|63031922|FG003|Overall Study|Serious Adverse event|0|||
33630469|NCT01946438|63031919|FG000|Overall Study|Protocol Violation|0|||
33630470|NCT01946438|63031920|FG001|Overall Study|Protocol Violation|0|||
33630471|NCT01946438|63031921|FG002|Overall Study|Protocol Violation|1|||
33630472|NCT01946438|63031922|FG003|Overall Study|Protocol Violation|0|||
33630473|NCT01946438|63031919|FG000|Overall Study|Withdrawal by Subject|1|||
33630474|NCT01946438|63031920|FG001|Overall Study|Withdrawal by Subject|0|||
33630475|NCT01946438|63031921|FG002|Overall Study|Withdrawal by Subject|0|||
33537569|NCT02590432|62927489|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
33537570|NCT02590432|62927490|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
33537571|NCT02590432|62927491|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
33537572|NCT02590432|62927492|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
33537573|NCT02590432|62927493|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
33537574|NCT02590432|62927485|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
33537575|NCT02590432|62927486|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
33537576|NCT02590432|62927487|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
33537577|NCT02590432|62927488|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
33537578|NCT02590432|62927489|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
33537579|NCT02590432|62927490|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
33537580|NCT02590432|62927491|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
33537581|NCT02590432|62927492|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
33537582|NCT02590432|62927493|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
33630476|NCT01946438|63031922|FG003|Overall Study|Withdrawal by Subject|0|||
33630477|NCT01946282|63031941|FG000|Year 1|Did not return FIT kit|4186|||
33630478|NCT01946282|63031942|FG001|Year 1|Did not return FIT kit|608|||
33630479|NCT01946282|63031943|FG002|Year 1|Did not return FIT kit|654|||
33630480|NCT01946282|63031941|FG000|Year 2|Did not return FIT kit|803|||
33630481|NCT01946282|63031942|FG001|Year 2|Did not return FIT kit|131|||
33630482|NCT01946282|63031943|FG002|Year 2|Did not return FIT kit|115|||
33630483|NCT01946282|63031941|FG000|Year 3|Did not return FIT kit|288|||
33630484|NCT01946282|63031942|FG001|Year 3|Did not return FIT kit|43|||
33630485|NCT01946282|63031943|FG002|Year 3|Did not return FIT kit|30|||
33630486|NCT01945580|63031955|FG000|Overall Study|Withdrawal by Subject|13|||
33630487|NCT01945580|63031956|FG001|Overall Study|Withdrawal by Subject|35|||
33630488|NCT01945580|63031955|FG000|Overall Study|Physician Decision|3|||
33630489|NCT01945580|63031956|FG001|Overall Study|Physician Decision|2|||
33630490|NCT01945580|63031955|FG000|Overall Study|Lost to Follow-up|26|||
33630491|NCT01945580|63031956|FG001|Overall Study|Lost to Follow-up|39|||
33630492|NCT01945580|63031955|FG000|Overall Study|Death|7|||
33537583|NCT02590432|62927485|FG000|Double-blind Treatment Period|Adverse Event|0|||
33537584|NCT02590432|62927486|FG001|Double-blind Treatment Period|Adverse Event|0|||
33537585|NCT02590432|62927487|FG002|Double-blind Treatment Period|Adverse Event|14|||
33537586|NCT02590432|62927488|FG003|Double-blind Treatment Period|Adverse Event|12|||
33537587|NCT02590432|62927489|FG004|Double-blind Treatment Period|Adverse Event|6|||
33537588|NCT02590432|62927490|FG005|Double-blind Treatment Period|Adverse Event|22|||
33630493|NCT01945580|63031956|FG001|Overall Study|Death|2|||
33630494|NCT01945580|63031955|FG000|Overall Study|Patient moved out of state|0|||
33630495|NCT01945580|63031956|FG001|Overall Study|Patient moved out of state|1|||
33630496|NCT01945580|63031955|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
33630497|NCT01945580|63031956|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
33630498|NCT01945580|63031955|FG000|Overall Study|Family illness - unable to return|0|||
33630499|NCT01945580|63031956|FG001|Overall Study|Family illness - unable to return|1|||
33630500|NCT01945580|63031955|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
33630501|NCT01945580|63031956|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
33630502|NCT01945580|63031955|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
33630503|NCT01945580|63031956|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
33630504|NCT01945580|63031955|FG000|Overall Study|Noncompliance with 36 month visit|1|||
33630505|NCT01945580|63031956|FG001|Overall Study|Noncompliance with 36 month visit|0|||
33630506|NCT01945580|63031955|FG000|Overall Study|The patient moved.|1|||
33630507|NCT01945580|63031956|FG001|Overall Study|The patient moved.|0|||
33630508|NCT01945580|63031955|FG000|Overall Study|No data available|0|||
33630509|NCT01945580|63031956|FG001|Overall Study|No data available|2|||
33630510|NCT01945034|63031969|FG000|Overall Study|Medication Error|0|||
33630511|NCT01945034|63031970|FG001|Overall Study|Medication Error|1|||
33630512|NCT01945034|63031971|FG002|Overall Study|Medication Error|0|||
33630513|NCT01945034|63031969|FG000|Overall Study|Withdrawal by Subject|0|||
33630514|NCT01945034|63031970|FG001|Overall Study|Withdrawal by Subject|3|||
33630515|NCT01945034|63031971|FG002|Overall Study|Withdrawal by Subject|1|||
33630516|NCT01945034|63031969|FG000|Overall Study|Other|0|||
33630517|NCT01945034|63031970|FG001|Overall Study|Other|1|||
33630518|NCT01945034|63031971|FG002|Overall Study|Other|3|||
33630519|NCT01945034|63031969|FG000|Overall Study|Lost to Follow-up|0|||
33630520|NCT01945034|63031970|FG001|Overall Study|Lost to Follow-up|0|||
33630521|NCT01945034|63031971|FG002|Overall Study|Lost to Follow-up|2|||
33630522|NCT01945034|63031969|FG000|Overall Study|Protocol Violation|1|||
33630523|NCT01945034|63031970|FG001|Overall Study|Protocol Violation|0|||
33630524|NCT01945034|63031971|FG002|Overall Study|Protocol Violation|1|||
33630525|NCT01960790|63031979|FG000|Overall Study|Survey forms could not be recovered|3|||
33630526|NCT01960790|63031979|FG000|Overall Study|Treat with Humira outside survey period|3|||
33630527|NCT01960790|63031979|FG000|Overall Study|Transferred to another hospital|4|||
33630528|NCT01960790|63031979|FG000|Overall Study|Unevaluable for safety|1|||
33630529|NCT01618214|63031985|FG000|Overall Study|Adverse Event|3|||
33630530|NCT01618214|63031986|FG001|Overall Study|Adverse Event|1|||
33630531|NCT01618214|63031985|FG000|Overall Study|Lack of Efficacy|1|||
33630532|NCT01618214|63031986|FG001|Overall Study|Lack of Efficacy|1|||
33630533|NCT01618214|63031985|FG000|Overall Study|Protocol Violation|1|||
33630534|NCT01618214|63031986|FG001|Overall Study|Protocol Violation|4|||
33630535|NCT01618214|63031985|FG000|Overall Study|Withdrawal Criteria|1|||
33537589|NCT02590432|62927491|FG006|Double-blind Treatment Period|Adverse Event|20|||
33537590|NCT02590432|62927492|FG007|Double-blind Treatment Period|Adverse Event|0|||
33537591|NCT02590432|62927493|FG008|Double-blind Treatment Period|Adverse Event|0|||
33537592|NCT02590432|62927485|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
33630536|NCT01618214|63031986|FG001|Overall Study|Withdrawal Criteria|2|||
33630537|NCT01618214|63031985|FG000|Overall Study|Unclassified|4|||
33630538|NCT01618214|63031986|FG001|Overall Study|Unclassified|5|||
33630539|NCT01917968|63031994|FG000|Overall Study|Death|3|||
33630540|NCT01917968|63031995|FG001|Overall Study|Death|2|||
33630541|NCT01917968|63031994|FG000|Overall Study|Lost to Follow-up|21|||
33630542|NCT01917968|63031995|FG001|Overall Study|Lost to Follow-up|39|||
33630543|NCT01917968|63031994|FG000|Overall Study|Physician Decision|1|||
33630544|NCT01917968|63031995|FG001|Overall Study|Physician Decision|2|||
33630545|NCT01917968|63031994|FG000|Overall Study|Withdrawal by Subject|20|||
33630546|NCT01917968|63031995|FG001|Overall Study|Withdrawal by Subject|35|||
33630547|NCT01917968|63031994|FG000|Overall Study|Subject Relocation|5|||
33630548|NCT01917968|63031995|FG001|Overall Study|Subject Relocation|1|||
33630549|NCT01917968|63031994|FG000|Overall Study|36M Missed Visit|3|||
33630550|NCT01917968|63031995|FG001|Overall Study|36M Missed Visit|2|||
33630551|NCT01917968|63031994|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
33630552|NCT01917968|63031995|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
33630553|NCT01917968|63031994|FG000|Overall Study|Change in Family Circumstances|0|||
33630554|NCT01917968|63031995|FG001|Overall Study|Change in Family Circumstances|1|||
33630555|NCT01917968|63031994|FG000|Overall Study|No Data Available|0|||
33630556|NCT01917968|63031995|FG001|Overall Study|No Data Available|2|||
33630557|NCT01917656|63032010|FG000|Overall Study|Adverse Event|11|||
33630558|NCT01917656|63032011|FG001|Overall Study|Adverse Event|0|||
33630559|NCT01917656|63032010|FG000|Overall Study|Withdrawal criteria|8|||
33630560|NCT01917656|63032011|FG001|Overall Study|Withdrawal criteria|14|||
33630561|NCT01917656|63032010|FG000|Overall Study|Unclassified|0|||
33630562|NCT01917656|63032011|FG001|Overall Study|Unclassified|3|||
33630563|NCT01917656|63032010|FG000|Overall Study|Withdrawal by Subject|4|||
33630564|NCT01917656|63032011|FG001|Overall Study|Withdrawal by Subject|3|||
33630565|NCT01917656|63032010|FG000|Overall Study|Lost to Follow-up|3|||
33630566|NCT01917656|63032011|FG001|Overall Study|Lost to Follow-up|4|||
33630567|NCT01944722|63032019|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
33630568|NCT01944722|63032019|FG000|Overall Study|Specimen Shipping Issues|34|||
33630569|NCT01944722|63032019|FG000|Overall Study|Improper Storage/Transport|5|||
33630570|NCT01944722|63032019|FG000|Overall Study|Insufficient Volume for Test|1|||
33630571|NCT01944722|63032019|FG000|Overall Study|Missing Specimens|3|||
33630572|NCT01944722|63032019|FG000|Overall Study|Specimens Mislabeled|2|||
33630573|NCT01944722|63032019|FG000|Overall Study|Withdrawal by Subject|8|||
33630574|NCT01944722|63032019|FG000|Overall Study|NILM Subjects <30 years old|8106|||
33630575|NCT01944722|63032019|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
33630576|NCT01944722|63032019|FG000|Overall Study|>ASCUS Cytology|1122|||
33630577|NCT01917344|63032028|FG000|Overall Study|Withdrawal by Subject|1|||
33630578|NCT02017535|63032036|FG000|Overall Study|Withdrawal by Subject|1|||
33630579|NCT02017535|63032037|FG001|Overall Study|Withdrawal by Subject|0|||
33630580|NCT02017535|63032038|FG002|Overall Study|Withdrawal by Subject|0|||
33630581|NCT02017535|63032039|FG003|Overall Study|Withdrawal by Subject|0|||
33630582|NCT01944098|63032051|FG000|Overall Study|Physician Decision|1|||
33630583|NCT01944098|63032052|FG001|Overall Study|Physician Decision|0|||
33630584|NCT02017223|63032058|FG000|Overall Study|Algorithm problems|2|||
33630585|NCT01944020|63032064|FG000|Overall Study|Withdrawal by Subject|5|||
33630586|NCT01944020|63032065|FG001|Overall Study|Withdrawal by Subject|0|||
33630587|NCT01943552|63032073|FG000|Overall Study|Adverse Event|3|||
33630588|NCT01943552|63032074|FG001|Overall Study|Adverse Event|2|||
33630589|NCT01943552|63032073|FG000|Overall Study|Withdrawal by Subject|6|||
33630590|NCT01943552|63032074|FG001|Overall Study|Withdrawal by Subject|6|||
33630591|NCT01943552|63032073|FG000|Overall Study|Other Reasons|16|||
33630592|NCT01943552|63032074|FG001|Overall Study|Other Reasons|17|||
33630593|NCT01915940|63032082|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
33630594|NCT01915940|63032083|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
33630595|NCT01915940|63032084|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
33537593|NCT02590432|62927486|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
33537594|NCT02590432|62927487|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
33537595|NCT02590432|62927488|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
33537596|NCT02590432|62927489|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
33537597|NCT02590432|62927490|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
33537598|NCT02590432|62927491|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
33537599|NCT02590432|62927492|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
33537600|NCT02590432|62927493|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
33537601|NCT02590432|62927485|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
33537602|NCT02590432|62927486|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
33537603|NCT02590432|62927487|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
33537604|NCT02590432|62927488|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
33537605|NCT02590432|62927489|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
33537606|NCT02590432|62927490|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
33537607|NCT02590432|62927491|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
33537608|NCT02590432|62927492|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
33630596|NCT01915940|63032082|FG000|Treatment Period|Decision of Participant|0|||
33630597|NCT01915940|63032083|FG001|Treatment Period|Decision of Participant|1|||
33630598|NCT01915940|63032084|FG002|Treatment Period|Decision of Participant|3|||
33630599|NCT01915940|63032082|FG000|Treatment Period|Adverse Event|0|||
33630600|NCT01915940|63032083|FG001|Treatment Period|Adverse Event|9|||
33630601|NCT01915940|63032084|FG002|Treatment Period|Adverse Event|1|||
33537609|NCT02590432|62927493|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
33630602|NCT01915940|63032082|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
33630603|NCT01915940|63032083|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
33630604|NCT01915940|63032084|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
33630605|NCT01914926|63032092|FG000|Overall Study|Adverse Event|1|||
33461273|NCT04409002|62834476|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
33461274|NCT04325828|62834480|FG000|Overall Study|Ongoing|26|||
33461275|NCT04289363|62834486|FG000|Overall Study|Lost to Follow-up|14|||
33461276|NCT04289363|62834487|FG001|Overall Study|Lost to Follow-up|0|||
33461277|NCT04235959|62834496|FG000|Overall Study|Protocol Violation|0|||
33461278|NCT04235959|62834497|FG001|Overall Study|Protocol Violation|1|||
33461279|NCT04235959|62834498|FG002|Overall Study|Protocol Violation|0|||
33461280|NCT04235959|62834496|FG000|Overall Study|Adverse Event|1|||
33461281|NCT04235959|62834497|FG001|Overall Study|Adverse Event|0|||
33537610|NCT02590432|62927485|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
33537611|NCT02590432|62927486|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
33537612|NCT02590432|62927487|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
33537613|NCT02590432|62927488|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
33537614|NCT02590432|62927489|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
33537615|NCT02590432|62927490|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
33537616|NCT02590432|62927491|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
33537617|NCT02590432|62927492|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
33537618|NCT02590432|62927493|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
33537619|NCT02590432|62927485|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33537620|NCT02590432|62927486|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33537621|NCT02590432|62927487|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33537622|NCT02590432|62927488|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33537623|NCT02590432|62927489|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33537624|NCT02590432|62927490|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
33537625|NCT02590432|62927491|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33537626|NCT02590432|62927492|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33537627|NCT02590432|62927493|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33537628|NCT02590432|62927485|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
33537629|NCT02590432|62927486|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
33537630|NCT02590432|62927487|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
33537631|NCT02590432|62927488|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
33537632|NCT02590432|62927489|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
33537633|NCT02590432|62927490|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
33537634|NCT02590432|62927491|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
33537635|NCT02590432|62927492|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
33537636|NCT02590432|62927493|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
33537637|NCT02590432|62927485|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33537638|NCT02590432|62927486|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33537639|NCT02590432|62927487|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33537640|NCT02590432|62927488|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33537641|NCT02590432|62927489|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33537642|NCT02590432|62927490|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33537643|NCT02590432|62927491|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33537644|NCT02590432|62927492|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
33537645|NCT02590432|62927493|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33537646|NCT02590432|62927485|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
33537647|NCT02590432|62927486|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
33537648|NCT02590432|62927487|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
33537649|NCT02590432|62927488|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
33537650|NCT02590432|62927489|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
33537651|NCT02590432|62927490|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
33537652|NCT02590432|62927491|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
33537653|NCT02590432|62927492|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
33537654|NCT02590432|62927493|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
33537655|NCT02590432|62927485|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33537656|NCT02590432|62927486|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33537657|NCT02590432|62927487|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33537658|NCT02590432|62927488|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33537659|NCT02590432|62927489|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33537660|NCT02590432|62927490|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33537661|NCT02590432|62927491|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33630606|NCT01914926|63032093|FG001|Overall Study|Adverse Event|0|||
33630607|NCT01914926|63032092|FG000|Overall Study|uncooperative, agitated and removed|0|||
33630608|NCT01914926|63032093|FG001|Overall Study|uncooperative, agitated and removed|1|||
33461282|NCT04235959|62834498|FG002|Overall Study|Adverse Event|0|||
33461283|NCT03735121|62834539|FG000|Overall Study|Death|3|||
33630609|NCT02016755|63032099|FG000|Overall Study|Major amputation of index limb|2|||
33630610|NCT02016755|63032099|FG000|Overall Study|Adverse Event|2|||
33630611|NCT02016755|63032099|FG000|Overall Study|Physician Decision|1|||
33630612|NCT02016755|63032099|FG000|Overall Study|Death|2|||
33630613|NCT01942148|63032103|FG000|Overall Study|Adverse Event|4|||
33630614|NCT01942148|63032103|FG000|Overall Study|Lack of Efficacy|2|||
33630615|NCT01942148|63032103|FG000|Overall Study|Physician Decision|11|||
33630616|NCT01942148|63032103|FG000|Overall Study|Protocol Violation|1|||
33630617|NCT01942148|63032103|FG000|Overall Study|Withdrawal by Subject|8|||
33630618|NCT01942148|63032103|FG000|Overall Study|Use of the prohibition medicine|1|||
33630619|NCT02030015|63032107|FG000|Overall Study|Withdrawal by Subject|3|||
33630620|NCT02030015|63032107|FG000|Overall Study|Death|13|||
33630621|NCT02029235|63032113|FG000|Overall Study|Non-compliance with study meds or diary|4|||
33630622|NCT02029235|63032114|FG001|Overall Study|Non-compliance with study meds or diary|1|||
33630623|NCT01617434|63032122|FG000|Overall Study|Adverse Event|12|||
33630624|NCT01617434|63032123|FG001|Overall Study|Adverse Event|3|||
33630625|NCT01617434|63032122|FG000|Overall Study|Protocol Violation|8|||
33630626|NCT01617434|63032123|FG001|Overall Study|Protocol Violation|7|||
33630627|NCT01617434|63032122|FG000|Overall Study|Withdrawal Criteria|12|||
33630628|NCT01617434|63032123|FG001|Overall Study|Withdrawal Criteria|37|||
33630629|NCT01617434|63032122|FG000|Overall Study|Unclassified|3|||
33630630|NCT01617434|63032123|FG001|Overall Study|Unclassified|4|||
33630631|NCT01940900|63032131|FG000|Overall Study|Physician Decision|4|||
33630632|NCT01940900|63032132|FG001|Overall Study|Physician Decision|0|||
33630633|NCT01940900|63032131|FG000|Overall Study|Adverse Event|10|||
33630634|NCT01940900|63032132|FG001|Overall Study|Adverse Event|15|||
33630635|NCT01940900|63032131|FG000|Overall Study|Withdrawal by Subject|11|||
33630636|NCT01940900|63032132|FG001|Overall Study|Withdrawal by Subject|15|||
33630637|NCT01940900|63032131|FG000|Overall Study|Lost to Follow-up|1|||
33630638|NCT01940900|63032132|FG001|Overall Study|Lost to Follow-up|0|||
33630639|NCT01940900|63032131|FG000|Overall Study|Sponsor Decision|1|||
33630640|NCT01940900|63032132|FG001|Overall Study|Sponsor Decision|0|||
33630641|NCT01940900|63032131|FG000|Overall Study|subject non-compliance|1|||
33630642|NCT01940900|63032132|FG001|Overall Study|subject non-compliance|1|||
33630643|NCT01940900|63032131|FG000|Overall Study|other|1|||
33630644|NCT01940900|63032132|FG001|Overall Study|other|0|||
33630645|NCT01940354|63032140|FG000|Overall Study|Withdrawal by Subject|4|||
33630646|NCT01940354|63032141|FG001|Overall Study|Withdrawal by Subject|2|||
33630647|NCT01940120|63032147|FG000|Overall Study|Death|40|||
33630648|NCT01940120|63032147|FG000|Overall Study|Withdrawal by Subject|8|||
33630649|NCT01911260|63032156|FG000|Supplementation Period|transference or evasion of school|7|||
33630650|NCT01911260|63032157|FG001|Supplementation Period|transference or evasion of school|9|||
33630651|NCT01911260|63032158|FG002|Supplementation Period|transference or evasion of school|7|||
33630652|NCT01911260|63032159|FG003|Supplementation Period|transference or evasion of school|6|||
33630653|NCT01911260|63032156|FG000|Supplementation Period|Adverse Event|2|||
33630654|NCT01911260|63032157|FG001|Supplementation Period|Adverse Event|0|||
33630655|NCT01911260|63032158|FG002|Supplementation Period|Adverse Event|1|||
33630656|NCT01911260|63032159|FG003|Supplementation Period|Adverse Event|0|||
33630657|NCT01911260|63032156|FG000|Supplementation Period|refused to receive supplement|1|||
33630658|NCT01911260|63032157|FG001|Supplementation Period|refused to receive supplement|0|||
33630659|NCT01911260|63032158|FG002|Supplementation Period|refused to receive supplement|1|||
33630660|NCT01911260|63032159|FG003|Supplementation Period|refused to receive supplement|0|||
33630661|NCT01911260|63032156|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
33630662|NCT01911260|63032157|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
33630663|NCT01911260|63032158|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
33630664|NCT01911260|63032159|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
33630665|NCT01911260|63032156|FG000|Follow-up Period|transference or evasion of school|13|||
33630666|NCT01911260|63032157|FG001|Follow-up Period|transference or evasion of school|20|||
33630667|NCT01911260|63032158|FG002|Follow-up Period|transference or evasion of school|15|||
33630668|NCT01911260|63032159|FG003|Follow-up Period|transference or evasion of school|12|||
33630669|NCT02015819|63032173|FG000|Overall Study|Rickham catheter was misaligned|0|||
33630670|NCT02015819|63032174|FG001|Overall Study|Rickham catheter was misaligned|0|||
33630671|NCT02015819|63032175|FG002|Overall Study|Rickham catheter was misaligned|0|||
33630672|NCT02015819|63032176|FG003|Overall Study|Rickham catheter was misaligned|1|||
33630673|NCT01939496|63032193|FG000|Overall Study|Adverse Event|2|||
33630674|NCT01939496|63032194|FG001|Overall Study|Adverse Event|0|||
33630675|NCT01939496|63032195|FG002|Overall Study|Adverse Event|0|||
33630676|NCT01939496|63032193|FG000|Overall Study|Lost to Follow-up|1|||
33630677|NCT01939496|63032194|FG001|Overall Study|Lost to Follow-up|1|||
33630678|NCT01939496|63032195|FG002|Overall Study|Lost to Follow-up|0|||
33630679|NCT01939496|63032193|FG000|Overall Study|Physician Decision|1|||
33630680|NCT01939496|63032194|FG001|Overall Study|Physician Decision|0|||
33630681|NCT01939496|63032195|FG002|Overall Study|Physician Decision|0|||
33630682|NCT01939496|63032193|FG000|Overall Study|Protocol Violation|3|||
33630683|NCT01939496|63032194|FG001|Overall Study|Protocol Violation|0|||
33630684|NCT01939496|63032195|FG002|Overall Study|Protocol Violation|0|||
33630685|NCT01939496|63032193|FG000|Overall Study|Withdrawal by Subject|0|||
33630686|NCT01939496|63032194|FG001|Overall Study|Withdrawal by Subject|1|||
33630687|NCT01939496|63032195|FG002|Overall Study|Withdrawal by Subject|1|||
33630688|NCT01939496|63032193|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
33630689|NCT01939496|63032194|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
33630690|NCT01939496|63032195|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
33630691|NCT01939496|63032193|FG000|Overall Study|Other|2|||
33630692|NCT01939496|63032194|FG001|Overall Study|Other|0|||
33630693|NCT01939496|63032195|FG002|Overall Study|Other|1|||
33630694|NCT01939028|63032203|FG000|Overall Study|Withdrawal by Subject|5|||
33630695|NCT01939028|63032203|FG000|Overall Study|Physician Decision|7|||
33630696|NCT01938716|63032207|FG000|Overall Study|Physician Decision|2|||
33630697|NCT01938716|63032207|FG000|Overall Study|Withdrawal by Subject|2|||
33630698|NCT01937390|63032211|FG000|Overall Study|Death|2|||
33630699|NCT01937390|63032211|FG000|Overall Study|Lost to Follow-up|7|||
33630700|NCT01937390|63032211|FG000|Overall Study|Withdrawal by Subject|5|||
33630701|NCT01937390|63032211|FG000|Overall Study|Fail to return|21|||
33630702|NCT02028767|63032215|FG000|Treatment Period 2|Non compliant with protocol|1|||
33630703|NCT02028767|63032216|FG001|Treatment Period 2|Non compliant with protocol|0|||
33630704|NCT02028767|63032215|FG000|Treatment Period 2|Reason other than those specified above|1|||
33630705|NCT02028767|63032216|FG001|Treatment Period 2|Reason other than those specified above|0|||
33630706|NCT01959932|63032225|FG000|Overall Study|Withdrawal by Subject|1|||
33630707|NCT01959932|63032226|FG001|Overall Study|Withdrawal by Subject|0|||
33630708|NCT01959932|63032227|FG002|Overall Study|Withdrawal by Subject|0|||
33630709|NCT02028065|63032239|FG000|Randomization Through Start Treatment|Not treated|1|||
33630710|NCT02028065|63032240|FG001|Randomization Through Start Treatment|Not treated|3|||
33630711|NCT02028065|63032241|FG002|Randomization Through Start Treatment|Not treated|3|||
33630712|NCT02028065|63032239|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
33630713|NCT02028065|63032240|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
33630714|NCT02028065|63032241|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
33630715|NCT02028065|63032239|FG000|Treatment Through Study Completion|Physician Decision|1|||
33630716|NCT02028065|63032240|FG001|Treatment Through Study Completion|Physician Decision|0|||
33630717|NCT02028065|63032241|FG002|Treatment Through Study Completion|Physician Decision|0|||
33630718|NCT02028065|63032239|FG000|Treatment Through Study Completion|Protocol Violation|1|||
33630719|NCT02028065|63032240|FG001|Treatment Through Study Completion|Protocol Violation|4|||
33630720|NCT02028065|63032241|FG002|Treatment Through Study Completion|Protocol Violation|0|||
33630721|NCT02028065|63032239|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
33630722|NCT02028065|63032240|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
33630723|NCT02028065|63032241|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
33630724|NCT02028065|63032239|FG000|Treatment Through Study Completion|Adverse Event|3|||
33537662|NCT02590432|62927492|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33537663|NCT02590432|62927493|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
33537664|NCT02590432|62927485|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33630725|NCT02028065|63032240|FG001|Treatment Through Study Completion|Adverse Event|3|||
33630726|NCT02028065|63032241|FG002|Treatment Through Study Completion|Adverse Event|5|||
33537665|NCT02590432|62927486|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33537666|NCT02590432|62927487|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33537667|NCT02590432|62927488|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33537668|NCT02590432|62927489|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33630727|NCT02015195|63032256|FG000|Overall Study|Adverse Event|0|||
33630728|NCT02015195|63032257|FG001|Overall Study|Adverse Event|0|||
33630729|NCT02015195|63032258|FG002|Overall Study|Adverse Event|0|||
33630730|NCT02015195|63032259|FG003|Overall Study|Adverse Event|1|||
33630731|NCT02015195|63032260|FG004|Overall Study|Adverse Event|0|||
33630732|NCT02015195|63032261|FG005|Overall Study|Adverse Event|0|||
33630733|NCT02015195|63032262|FG006|Overall Study|Adverse Event|0|||
33461284|NCT03735121|62834540|FG001|Overall Study|Death|6|||
33630734|NCT02015039|63032279|FG000|Overall Study|Not eligible|0|||
33461285|NCT03735121|62834541|FG002|Overall Study|Death|8|||
33461286|NCT03735121|62834542|FG003|Overall Study|Death|37|||
33461287|NCT03735121|62834543|FG004|Overall Study|Death|86|||
33461288|NCT03735121|62834539|FG000|Overall Study|Withdrawal by Subject|1|||
33461289|NCT03735121|62834540|FG001|Overall Study|Withdrawal by Subject|1|||
33461290|NCT03735121|62834541|FG002|Overall Study|Withdrawal by Subject|3|||
33461291|NCT03735121|62834542|FG003|Overall Study|Withdrawal by Subject|4|||
33461292|NCT03735121|62834543|FG004|Overall Study|Withdrawal by Subject|2|||
33461293|NCT03735121|62834539|FG000|Overall Study|Progressive Disease|0|||
33461294|NCT03735121|62834540|FG001|Overall Study|Progressive Disease|0|||
33461295|NCT03735121|62834541|FG002|Overall Study|Progressive Disease|1|||
33461296|NCT03735121|62834542|FG003|Overall Study|Progressive Disease|0|||
33461297|NCT03735121|62834543|FG004|Overall Study|Progressive Disease|0|||
33630735|NCT02015039|63032280|FG001|Overall Study|Not eligible|1|||
33630736|NCT02025725|63032288|FG000|Overall Study|Adverse Event|5|||
33630737|NCT02025725|63032289|FG001|Overall Study|Adverse Event|0|||
33630738|NCT02025725|63032288|FG000|Overall Study|Lost to Follow-up|2|||
33630739|NCT02025725|63032289|FG001|Overall Study|Lost to Follow-up|0|||
33630740|NCT02025725|63032288|FG000|Overall Study|Protocol Violation|1|||
33630741|NCT02025725|63032289|FG001|Overall Study|Protocol Violation|1|||
33630742|NCT02025725|63032288|FG000|Overall Study|Withdrawal by Subject|3|||
33630743|NCT02025725|63032289|FG001|Overall Study|Withdrawal by Subject|2|||
33630744|NCT02025725|63032288|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
33630745|NCT02025725|63032289|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
33630746|NCT02025179|63032300|FG000|Overall Study|Lost to Follow-up|0|||
33630747|NCT02025179|63032301|FG001|Overall Study|Lost to Follow-up|0|||
33630748|NCT02025179|63032302|FG002|Overall Study|Lost to Follow-up|1|||
33630749|NCT02013791|63032319|FG000|Period 1|Lost to Follow-up|0|||
33630750|NCT02013791|63032320|FG001|Period 1|Lost to Follow-up|0|||
33630751|NCT02013791|63032321|FG002|Period 1|Lost to Follow-up|0|||
33630752|NCT02013791|63032322|FG003|Period 1|Lost to Follow-up|1|||
33630753|NCT02013791|63032323|FG004|Period 1|Lost to Follow-up|0|||
33630754|NCT02013791|63032324|FG005|Period 1|Lost to Follow-up|0|||
33630755|NCT02013791|63032325|FG006|Period 1|Lost to Follow-up|1|||
33630756|NCT02013791|63032326|FG007|Period 1|Lost to Follow-up|1|||
33630757|NCT02013791|63032327|FG008|Period 1|Lost to Follow-up|0|||
33630758|NCT02013791|63032319|FG000|Period 1|Other Miscellaneous Reasons|0|||
33630759|NCT02013791|63032320|FG001|Period 1|Other Miscellaneous Reasons|2|||
33630760|NCT02013791|63032321|FG002|Period 1|Other Miscellaneous Reasons|0|||
33630761|NCT02013791|63032322|FG003|Period 1|Other Miscellaneous Reasons|0|||
33630762|NCT02013791|63032323|FG004|Period 1|Other Miscellaneous Reasons|0|||
33630763|NCT02013791|63032324|FG005|Period 1|Other Miscellaneous Reasons|0|||
33630764|NCT02013791|63032325|FG006|Period 1|Other Miscellaneous Reasons|0|||
33630765|NCT02013791|63032326|FG007|Period 1|Other Miscellaneous Reasons|0|||
33630766|NCT02013791|63032327|FG008|Period 1|Other Miscellaneous Reasons|0|||
33630767|NCT02024867|63032350|FG000|Overall Study|Protocol Violation|3|||
33630768|NCT02024867|63032351|FG001|Overall Study|Protocol Violation|3|||
33630769|NCT02024867|63032350|FG000|Overall Study|Lost to Follow-up|6|||
33630770|NCT02024867|63032351|FG001|Overall Study|Lost to Follow-up|4|||
33630771|NCT01953601|63032360|FG000|Part 1 (Base Study)|Adverse Event|24|||
33630772|NCT01953601|63032361|FG001|Part 1 (Base Study)|Adverse Event|37|||
33630773|NCT01953601|63032362|FG002|Part 1 (Base Study)|Adverse Event|15|||
33630774|NCT01953601|63032360|FG000|Part 1 (Base Study)|Death|2|||
33630775|NCT01953601|63032361|FG001|Part 1 (Base Study)|Death|0|||
33461298|NCT03735121|62834539|FG000|Overall Study|Lost to Follow-up|0|||
33461299|NCT03735121|62834540|FG001|Overall Study|Lost to Follow-up|0|||
33461300|NCT03735121|62834541|FG002|Overall Study|Lost to Follow-up|0|||
33461301|NCT03735121|62834542|FG003|Overall Study|Lost to Follow-up|0|||
33461302|NCT03735121|62834543|FG004|Overall Study|Lost to Follow-up|1|||
33461303|NCT03735121|62834539|FG000|Overall Study|Ongoing|3|||
33461304|NCT03735121|62834540|FG001|Overall Study|Ongoing|3|||
33461305|NCT03735121|62834541|FG002|Overall Study|Ongoing|26|||
33461306|NCT03735121|62834542|FG003|Overall Study|Ongoing|83|||
33461307|NCT03735121|62834543|FG004|Overall Study|Ongoing|158|||
33461308|NCT03525613|62834570|FG000|Overall Study|Adverse Event|11|||
33461309|NCT03525613|62834571|FG001|Overall Study|Adverse Event|8|||
33461310|NCT03525613|62834572|FG002|Overall Study|Adverse Event|3|||
33537669|NCT02590432|62927490|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33537670|NCT02590432|62927491|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33537671|NCT02590432|62927492|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33537672|NCT02590432|62927493|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
33537673|NCT02590432|62927485|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33537674|NCT02590432|62927486|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33537675|NCT02590432|62927487|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33537676|NCT02590432|62927488|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33537677|NCT02590432|62927489|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33537678|NCT02590432|62927490|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33630776|NCT01953601|63032362|FG002|Part 1 (Base Study)|Death|3|||
33630777|NCT01953601|63032360|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
33630778|NCT01953601|63032361|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
33630779|NCT01953601|63032362|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
33461311|NCT03525613|62834573|FG003|Overall Study|Adverse Event|3|||
33461312|NCT03525613|62834570|FG000|Overall Study|Lost to Follow-up|4|||
33461313|NCT03525613|62834571|FG001|Overall Study|Lost to Follow-up|5|||
33630780|NCT01953601|63032360|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
33630781|NCT01953601|63032361|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
33630782|NCT01953601|63032362|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
33630783|NCT01953601|63032360|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
33630784|NCT01953601|63032361|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
33630785|NCT01953601|63032362|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
33630786|NCT01953601|63032360|FG000|Part 1 (Base Study)|Physician Decision|3|||
33630787|NCT01953601|63032361|FG001|Part 1 (Base Study)|Physician Decision|7|||
33630788|NCT01953601|63032362|FG002|Part 1 (Base Study)|Physician Decision|4|||
33630789|NCT01953601|63032360|FG000|Part 1 (Base Study)|Screen failure|1|||
33630790|NCT01953601|63032361|FG001|Part 1 (Base Study)|Screen failure|0|||
33630791|NCT01953601|63032362|FG002|Part 1 (Base Study)|Screen failure|1|||
33630792|NCT01953601|63032360|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
33630793|NCT01953601|63032361|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
33630794|NCT01953601|63032362|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
33630795|NCT01953601|63032360|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
33630796|NCT01953601|63032361|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
33630797|NCT01953601|63032362|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
33630798|NCT01953601|63032360|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
33630799|NCT01953601|63032361|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
33630800|NCT01953601|63032362|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
33630801|NCT01953601|63032360|FG000|Part 1 (Base Study)|Subject moved|2|||
33630802|NCT01953601|63032361|FG001|Part 1 (Base Study)|Subject moved|2|||
33630803|NCT01953601|63032362|FG002|Part 1 (Base Study)|Subject moved|1|||
33630804|NCT01953601|63032360|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
33630805|NCT01953601|63032361|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
33630806|NCT01953601|63032362|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
33326227|NCT00889252|62703046|FG001|Overall Study|Protocol Violation|0|||
33326228|NCT01110330|62703055|FG000|Overall Study|Adverse Event|0|||
33537679|NCT02590432|62927491|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33537680|NCT02590432|62927492|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
33537681|NCT02590432|62927493|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33537682|NCT02590432|62927485|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33537683|NCT02590432|62927486|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33537684|NCT02590432|62927487|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33537685|NCT02590432|62927488|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33630807|NCT01953601|63032360|FG000|Part 2 (Extension Study)|Adverse Event|1|||
33630808|NCT01953601|63032361|FG001|Part 2 (Extension Study)|Adverse Event|1|||
33630809|NCT01953601|63032362|FG002|Part 2 (Extension Study)|Adverse Event|10|||
33630810|NCT01953601|63032360|FG000|Part 2 (Extension Study)|Death|0|||
33630811|NCT01953601|63032361|FG001|Part 2 (Extension Study)|Death|3|||
33326229|NCT01110330|62703056|FG001|Overall Study|Adverse Event|4|||
33461314|NCT03525613|62834572|FG002|Overall Study|Lost to Follow-up|3|||
33461315|NCT03525613|62834573|FG003|Overall Study|Lost to Follow-up|2|||
33461316|NCT03525613|62834570|FG000|Overall Study|Physician Decision|0|||
33461317|NCT03525613|62834571|FG001|Overall Study|Physician Decision|1|||
33461318|NCT03525613|62834572|FG002|Overall Study|Physician Decision|0|||
33461319|NCT03525613|62834573|FG003|Overall Study|Physician Decision|1|||
33461320|NCT03525613|62834570|FG000|Overall Study|Consent Withdrawal|25|||
33461321|NCT03525613|62834571|FG001|Overall Study|Consent Withdrawal|16|||
33461322|NCT03525613|62834572|FG002|Overall Study|Consent Withdrawal|12|||
33461323|NCT03525613|62834573|FG003|Overall Study|Consent Withdrawal|9|||
33461324|NCT03525613|62834570|FG000|Overall Study|Death|20|||
33461325|NCT03525613|62834571|FG001|Overall Study|Death|9|||
33461326|NCT03525613|62834572|FG002|Overall Study|Death|7|||
33461327|NCT03525613|62834573|FG003|Overall Study|Death|1|||
33326230|NCT01110330|62703057|FG002|Overall Study|Adverse Event|3|||
33537686|NCT02590432|62927489|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33537687|NCT02590432|62927490|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33537688|NCT02590432|62927491|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33537689|NCT02590432|62927492|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
33537690|NCT02590432|62927493|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33537691|NCT02590354|62927505|FG000|Phase 1|Active hepatitis B or C infection|1|||
33537692|NCT02590354|62927505|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
33537693|NCT02590354|62927505|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
33537694|NCT02590354|62927505|FG000|Phase 1|Subject does not want to participate|20|||
33537695|NCT02590354|62927505|FG000|Phase 1|Lost to Follow-up|1|||
33537696|NCT02590354|62927505|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
33537697|NCT01667224|62927512|FG000|Overall Study|Withdrawal by Subject|3|||
33537698|NCT01667224|62927513|FG001|Overall Study|Withdrawal by Subject|1|||
33537699|NCT01667224|62927512|FG000|Overall Study|Protocol Violation|1|||
33537700|NCT01667224|62927513|FG001|Overall Study|Protocol Violation|1|||
33537701|NCT03923738|62927521|FG000|Period 1|Adverse Event|1|||
33537702|NCT03923738|62927521|FG000|Period 1|Withdrawal by Subject|1|||
33537703|NCT02588248|62927529|FG000|Overall Study|Physician Decision|4|||
33537704|NCT02588248|62927530|FG001|Overall Study|Physician Decision|3|||
33537705|NCT01328054|62927541|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
33537706|NCT01328054|62927542|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
33537707|NCT01328054|62927541|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
33537708|NCT01328054|62927542|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
33537709|NCT01328054|62927541|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
33537710|NCT01328054|62927542|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
33537711|NCT01849250|62927565|FG000|Overall Study|Withdrawal by Subject|1|||
33537712|NCT01849250|62927566|FG001|Overall Study|Withdrawal by Subject|0|||
33537713|NCT01849250|62927565|FG000|Overall Study|Not Evaluable|5|||
33537714|NCT01849250|62927566|FG001|Overall Study|Not Evaluable|3|||
33537715|NCT01849250|62927565|FG000|Overall Study|Screen Failure|1|||
33537716|NCT01849250|62927566|FG001|Overall Study|Screen Failure|0|||
33630812|NCT01953601|63032362|FG002|Part 2 (Extension Study)|Death|0|||
33630813|NCT01953601|63032360|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
33630814|NCT01953601|63032361|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
33630815|NCT01953601|63032362|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
33630816|NCT01953601|63032360|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
33630817|NCT01953601|63032361|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
33630818|NCT01953601|63032362|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
33630819|NCT01953601|63032360|FG000|Part 2 (Extension Study)|Physician Decision|2|||
33630820|NCT01953601|63032361|FG001|Part 2 (Extension Study)|Physician Decision|0|||
33630821|NCT01953601|63032362|FG002|Part 2 (Extension Study)|Physician Decision|2|||
33630822|NCT01953601|63032360|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
33630823|NCT01953601|63032361|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
33630824|NCT01953601|63032362|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
33630825|NCT01953601|63032360|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
33630826|NCT01953601|63032361|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
33630827|NCT01953601|63032362|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
33630828|NCT01953601|63032360|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
33630829|NCT01953601|63032361|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
33630830|NCT01953601|63032362|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
33630831|NCT01953601|63032360|FG000|Part 2 (Extension Study)|Subject moved|0|||
33630832|NCT01953601|63032361|FG001|Part 2 (Extension Study)|Subject moved|0|||
33630833|NCT01953601|63032362|FG002|Part 2 (Extension Study)|Subject moved|1|||
33630834|NCT01953601|63032360|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
33630835|NCT01953601|63032361|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
33630836|NCT01953601|63032362|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
33630837|NCT01952665|63032375|FG000|Overall Study|Physician Decision|3|||
33630838|NCT01952665|63032376|FG001|Overall Study|Physician Decision|2|||
33630839|NCT01952665|63032375|FG000|Overall Study|Lost to Follow-up|1|||
33630840|NCT01952665|63032376|FG001|Overall Study|Lost to Follow-up|2|||
33630841|NCT01952665|63032375|FG000|Overall Study|Adverse Event|2|||
33630842|NCT01952665|63032376|FG001|Overall Study|Adverse Event|1|||
33630843|NCT01952665|63032375|FG000|Overall Study|Protocol Violation|0|||
33630844|NCT01952665|63032376|FG001|Overall Study|Protocol Violation|1|||
33630845|NCT01952041|63032387|FG000|Overall Study|Lost to Follow-up|9|||
33630846|NCT01952041|63032388|FG001|Overall Study|Lost to Follow-up|16|||
33630847|NCT01952041|63032387|FG000|Overall Study|Withdrawal by Subject|7|||
33630848|NCT01952041|63032388|FG001|Overall Study|Withdrawal by Subject|5|||
33630849|NCT01952041|63032387|FG000|Overall Study|Death|1|||
33630850|NCT01952041|63032388|FG001|Overall Study|Death|0|||
33630851|NCT01951573|63032394|FG000|Washout Period|Adverse Event|0|||
33630852|NCT01951573|63032395|FG001|Washout Period|Adverse Event|1|||
33630853|NCT02023697|63032404|FG000|Treatment Period|Radiological progression|13|||
33630854|NCT02023697|63032405|FG001|Treatment Period|Radiological progression|17|||
33630855|NCT02023697|63032406|FG002|Treatment Period|Radiological progression|26|||
33630856|NCT02023697|63032404|FG000|Treatment Period|Never Treated|5|||
33630857|NCT02023697|63032405|FG001|Treatment Period|Never Treated|6|||
33630858|NCT02023697|63032406|FG002|Treatment Period|Never Treated|10|||
33630859|NCT02023697|63032404|FG000|Treatment Period|Adverse Event|13|||
33630860|NCT02023697|63032405|FG001|Treatment Period|Adverse Event|25|||
33630861|NCT02023697|63032406|FG002|Treatment Period|Adverse Event|23|||
33630862|NCT02023697|63032404|FG000|Treatment Period|Logistical difficulties|1|||
33630863|NCT02023697|63032405|FG001|Treatment Period|Logistical difficulties|1|||
33630864|NCT02023697|63032406|FG002|Treatment Period|Logistical difficulties|1|||
33461328|NCT03525613|62834570|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
33461329|NCT03525613|62834571|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
33461330|NCT03525613|62834572|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
33461331|NCT03525613|62834573|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
33461332|NCT03500692|62834587|FG000|Overall Study|Death|163|||
33461333|NCT03500692|62834587|FG000|Overall Study|Lost to Follow-up|76|||
33461334|NCT03500692|62834587|FG000|Overall Study|Termination Reasons|3|||
33461335|NCT03404960|62834606|FG000|Overall Study|Adverse Event|0|||
33461336|NCT03404960|62834607|FG001|Overall Study|Adverse Event|2|||
33461337|NCT03404960|62834606|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
33461338|NCT03404960|62834607|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
33461339|NCT03404960|62834606|FG000|Overall Study|Bowel obstruction|0|||
33461340|NCT03404960|62834607|FG001|Overall Study|Bowel obstruction|1|||
33461341|NCT03404960|62834606|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
33461342|NCT03404960|62834607|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
33461343|NCT03381274|62834618|FG000|Overall Study|Death|2|||
33461344|NCT03381274|62834619|FG001|Overall Study|Death|9|||
33461345|NCT03381274|62834620|FG002|Overall Study|Death|3|||
33461346|NCT03381274|62834621|FG003|Overall Study|Death|2|||
33537717|NCT02791191|62927576|FG000|Overall Study|Adverse Event|2|||
33537718|NCT02791191|62927577|FG001|Overall Study|Adverse Event|4|||
33537719|NCT02791191|62927578|FG002|Overall Study|Adverse Event|5|||
33537720|NCT02791191|62927576|FG000|Overall Study|Lack of Efficacy|0|||
33537721|NCT02791191|62927577|FG001|Overall Study|Lack of Efficacy|1|||
33630865|NCT02023697|63032404|FG000|Treatment Period|Clinical progression|10|||
33630866|NCT02023697|63032405|FG001|Treatment Period|Clinical progression|8|||
33630867|NCT02023697|63032406|FG002|Treatment Period|Clinical progression|28|||
33630868|NCT02023697|63032404|FG000|Treatment Period|Withdrawal by Subject|4|||
33461347|NCT03381274|62834622|FG004|Overall Study|Death|3|||
33537722|NCT02791191|62927578|FG002|Overall Study|Lack of Efficacy|0|||
33537723|NCT02791191|62927576|FG000|Overall Study|Study Drug Non-Compliance|0|||
33537724|NCT02791191|62927577|FG001|Overall Study|Study Drug Non-Compliance|2|||
33537725|NCT02791191|62927578|FG002|Overall Study|Study Drug Non-Compliance|0|||
33630869|NCT02023697|63032405|FG001|Treatment Period|Withdrawal by Subject|5|||
33461348|NCT03381274|62834618|FG000|Overall Study|Lost to Follow-up|0|||
33630870|NCT02023697|63032406|FG002|Treatment Period|Withdrawal by Subject|13|||
33461349|NCT03381274|62834619|FG001|Overall Study|Lost to Follow-up|0|||
33461350|NCT03381274|62834620|FG002|Overall Study|Lost to Follow-up|0|||
33537726|NCT02791191|62927576|FG000|Overall Study|Site Closed by Sponsor|1|||
33630871|NCT02023697|63032404|FG000|Treatment Period|Safety outcome reached|0|||
33630872|NCT02023697|63032405|FG001|Treatment Period|Safety outcome reached|1|||
33630873|NCT02023697|63032406|FG002|Treatment Period|Safety outcome reached|0|||
33630874|NCT02023697|63032404|FG000|Treatment Period|Physician Decision|0|||
33630875|NCT02023697|63032405|FG001|Treatment Period|Physician Decision|0|||
33630876|NCT02023697|63032406|FG002|Treatment Period|Physician Decision|1|||
33630877|NCT02023697|63032404|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
33630878|NCT02023697|63032405|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
33630879|NCT02023697|63032406|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
33630880|NCT02023697|63032404|FG000|Active Follow-up Period|Lost to Follow-up|1|||
33630881|NCT02023697|63032405|FG001|Active Follow-up Period|Lost to Follow-up|1|||
33630882|NCT02023697|63032406|FG002|Active Follow-up Period|Lost to Follow-up|1|||
33630883|NCT02023697|63032404|FG000|Active Follow-up Period|Deterioration of general condition|1|||
33630884|NCT02023697|63032405|FG001|Active Follow-up Period|Deterioration of general condition|1|||
33630885|NCT02023697|63032406|FG002|Active Follow-up Period|Deterioration of general condition|1|||
33630886|NCT02023697|63032404|FG000|Active Follow-up Period|Other unspecified|2|||
33630887|NCT02023697|63032405|FG001|Active Follow-up Period|Other unspecified|0|||
33630888|NCT02023697|63032406|FG002|Active Follow-up Period|Other unspecified|1|||
33630889|NCT02023697|63032404|FG000|Active Follow-up Period|Clinical progression|0|||
33630890|NCT02023697|63032405|FG001|Active Follow-up Period|Clinical progression|2|||
33630891|NCT02023697|63032406|FG002|Active Follow-up Period|Clinical progression|1|||
33630892|NCT02023697|63032404|FG000|Active Follow-up Period|Radiological progression|0|||
33630893|NCT02023697|63032405|FG001|Active Follow-up Period|Radiological progression|0|||
33630894|NCT02023697|63032406|FG002|Active Follow-up Period|Radiological progression|1|||
33630895|NCT02023697|63032404|FG000|Active Follow-up Period|Death|83|||
33630896|NCT02023697|63032405|FG001|Active Follow-up Period|Death|82|||
33630897|NCT02023697|63032406|FG002|Active Follow-up Period|Death|87|||
33630898|NCT02023697|63032404|FG000|Long-term Follow-up Period|Death|9|||
33630899|NCT02023697|63032405|FG001|Long-term Follow-up Period|Death|6|||
33630900|NCT02023697|63032406|FG002|Long-term Follow-up Period|Death|4|||
33630901|NCT02023697|63032404|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
33630902|NCT02023697|63032405|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
33630903|NCT02023697|63032406|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
33630904|NCT02023697|63032404|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
33630905|NCT02023697|63032405|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
33630906|NCT02023697|63032406|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
33630907|NCT02023697|63032404|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
33630908|NCT02023697|63032405|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
33630909|NCT02023697|63032406|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
33630910|NCT02023697|63032404|FG000|Long-term Follow-up Period|Technical problems|0|||
33630911|NCT02023697|63032405|FG001|Long-term Follow-up Period|Technical problems|0|||
33630912|NCT02023697|63032406|FG002|Long-term Follow-up Period|Technical problems|1|||
33630913|NCT02023697|63032404|FG000|Long-term Follow-up Period|Other unspecified|6|||
33630914|NCT02023697|63032405|FG001|Long-term Follow-up Period|Other unspecified|3|||
33630915|NCT02023697|63032406|FG002|Long-term Follow-up Period|Other unspecified|5|||
33630916|NCT01951417|63032421|FG000|Overall Study|Withdrawal by Subject|1|||
33630917|NCT01951417|63032421|FG000|Overall Study|Protocol Violation|2|||
33630918|NCT01951417|63032421|FG000|Overall Study|Lost to Follow-up|6|||
33630919|NCT01951261|63032431|FG000|Overall Study|Death|1|||
33630920|NCT01951261|63032432|FG001|Overall Study|Death|0|||
33630921|NCT01951261|63032431|FG000|Overall Study|Lost to Follow-up|4|||
33630922|NCT01951261|63032432|FG001|Overall Study|Lost to Follow-up|3|||
33630923|NCT01951261|63032431|FG000|Overall Study|Protocol Violation|4|||
33630924|NCT01951261|63032432|FG001|Overall Study|Protocol Violation|3|||
33630925|NCT02023151|63032438|FG000|Overall Study|Lost to Follow-up|4|||
33630926|NCT01979185|63032444|FG000|Period 2|Other|0|||
33630927|NCT01979185|63032445|FG001|Period 2|Other|1|||
33630928|NCT01946425|63032453|FG000|Overall Study|Protocol Violation|1|||
33630929|NCT01946425|63032454|FG001|Overall Study|Protocol Violation|0|||
33630930|NCT01946425|63032453|FG000|Overall Study|Withdrawal by Subject|1|||
33630931|NCT01946425|63032454|FG001|Overall Study|Withdrawal by Subject|0|||
33630932|NCT01946191|63032463|FG000|Allocation|Did not complete orientation|1|||
33630933|NCT01946191|63032464|FG001|Allocation|Did not complete orientation|1|||
33630934|NCT01946191|63032463|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
33630935|NCT01946191|63032464|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
33630936|NCT01946191|63032463|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
33630937|NCT01946191|63032464|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
33630938|NCT01946191|63032463|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
33630939|NCT01946191|63032464|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
33630940|NCT01937312|63032473|FG000|Overall Study|Adverse Event|10|||
33630941|NCT01937312|63032474|FG001|Overall Study|Adverse Event|1|||
33630942|NCT01937312|63032473|FG000|Overall Study|Lack of Efficacy|0|||
33630943|NCT01937312|63032474|FG001|Overall Study|Lack of Efficacy|1|||
33630944|NCT01937312|63032473|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
33630945|NCT01937312|63032474|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
33630946|NCT01935128|63032481|FG000|Overall Study|Death|1|||
33630947|NCT01935128|63032481|FG000|Overall Study|Adverse Event|6|||
33630948|NCT01934972|63032487|FG000|Overall Study|Withdrawal by Subject|9|||
33630949|NCT01934972|63032488|FG001|Overall Study|Withdrawal by Subject|6|||
33630950|NCT01959230|63032496|FG000|Overall Study|Failure to follow study procedures|0|||
33630951|NCT01959230|63032497|FG001|Overall Study|Failure to follow study procedures|1|||
33630952|NCT01959230|63032496|FG000|Overall Study|Administrative reasons|2|||
33630953|NCT01959230|63032497|FG001|Overall Study|Administrative reasons|0|||
33537727|NCT02791191|62927577|FG001|Overall Study|Site Closed by Sponsor|1|||
33537728|NCT02791191|62927578|FG002|Overall Study|Site Closed by Sponsor|3|||
33537729|NCT02791191|62927576|FG000|Overall Study|Progressive Disease|1|||
33537730|NCT02791191|62927577|FG001|Overall Study|Progressive Disease|0|||
33537731|NCT02791191|62927578|FG002|Overall Study|Progressive Disease|0|||
33537732|NCT02791191|62927576|FG000|Overall Study|Study Terminated by Sponsor|29|||
33537733|NCT02791191|62927577|FG001|Overall Study|Study Terminated by Sponsor|101|||
33537734|NCT02791191|62927578|FG002|Overall Study|Study Terminated by Sponsor|109|||
33537735|NCT02791191|62927576|FG000|Overall Study|Withdrawal by Subject|3|||
33537736|NCT02791191|62927577|FG001|Overall Study|Withdrawal by Subject|1|||
33537737|NCT02791191|62927578|FG002|Overall Study|Withdrawal by Subject|3|||
33537738|NCT02791191|62927576|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
33537739|NCT02791191|62927577|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
33537740|NCT02791191|62927578|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
33537741|NCT02114697|62927601|FG000|Overall Study|Study terminated|5|||
33537742|NCT02114697|62927602|FG001|Overall Study|Study terminated|4|||
33537743|NCT01330017|62927613|FG000|Overall Study|Adverse Event|0|||
33537744|NCT01330017|62927614|FG001|Overall Study|Adverse Event|1|||
33537745|NCT01330017|62927615|FG002|Overall Study|Adverse Event|1|||
33537746|NCT01330017|62927616|FG003|Overall Study|Adverse Event|4|||
33537747|NCT01330017|62927617|FG004|Overall Study|Adverse Event|0|||
33537748|NCT01330017|62927613|FG000|Overall Study|Withdrawal by Subject|0|||
33537749|NCT01330017|62927614|FG001|Overall Study|Withdrawal by Subject|0|||
33537750|NCT01330017|62927615|FG002|Overall Study|Withdrawal by Subject|1|||
33537751|NCT01330017|62927616|FG003|Overall Study|Withdrawal by Subject|0|||
33537752|NCT01330017|62927617|FG004|Overall Study|Withdrawal by Subject|1|||
33537753|NCT01330017|62927613|FG000|Overall Study|Lost to Follow-up|0|||
33537754|NCT01330017|62927614|FG001|Overall Study|Lost to Follow-up|0|||
33537755|NCT01330017|62927615|FG002|Overall Study|Lost to Follow-up|1|||
33537756|NCT01330017|62927616|FG003|Overall Study|Lost to Follow-up|0|||
33537757|NCT01330017|62927617|FG004|Overall Study|Lost to Follow-up|0|||
33537758|NCT01330017|62927613|FG000|Overall Study|Protocol Violation|0|||
33537759|NCT01330017|62927614|FG001|Overall Study|Protocol Violation|0|||
33537760|NCT01330017|62927615|FG002|Overall Study|Protocol Violation|0|||
33537761|NCT01330017|62927616|FG003|Overall Study|Protocol Violation|1|||
33537762|NCT01330017|62927617|FG004|Overall Study|Protocol Violation|0|||
33537763|NCT01330017|62927613|FG000|Overall Study|Unknown Reason|5|||
33537764|NCT01330017|62927614|FG001|Overall Study|Unknown Reason|3|||
33537765|NCT01330017|62927615|FG002|Overall Study|Unknown Reason|5|||
33537766|NCT01330017|62927616|FG003|Overall Study|Unknown Reason|7|||
33537767|NCT01330017|62927617|FG004|Overall Study|Unknown Reason|2|||
33537768|NCT00150462|62927640|FG000|Overall Study|Disease Progression or Relapse|3|||
33537769|NCT00150462|62927641|FG001|Overall Study|Disease Progression or Relapse|1|||
33537770|NCT00150462|62927642|FG002|Overall Study|Disease Progression or Relapse|2|||
33537771|NCT00150462|62927643|FG003|Overall Study|Disease Progression or Relapse|1|||
33537772|NCT00150462|62927644|FG004|Overall Study|Disease Progression or Relapse|2|||
33537773|NCT00150462|62927645|FG005|Overall Study|Disease Progression or Relapse|2|||
33537774|NCT00150462|62927646|FG006|Overall Study|Disease Progression or Relapse|3|||
33630954|NCT01959230|63032496|FG000|Overall Study|Withdrawal by Subject|2|||
33537775|NCT00150462|62927647|FG007|Overall Study|Disease Progression or Relapse|5|||
33537776|NCT00150462|62927648|FG008|Overall Study|Disease Progression or Relapse|5|||
33630955|NCT01959230|63032497|FG001|Overall Study|Withdrawal by Subject|0|||
33630956|NCT01909778|63032503|FG000|Overall Study|failed screening|1|||
33630957|NCT01977937|63032511|FG000|Overall Study|Withdrawal by Subject|2|||
33630958|NCT01977937|63032512|FG001|Overall Study|Withdrawal by Subject|1|||
33630959|NCT01977937|63032511|FG000|Overall Study|Adverse Event|1|||
33630960|NCT01977937|63032512|FG001|Overall Study|Adverse Event|0|||
33630961|NCT01977937|63032511|FG000|Overall Study|Physician Decision|0|||
33630962|NCT01977937|63032512|FG001|Overall Study|Physician Decision|1|||
33630963|NCT02015663|63032520|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
33630964|NCT02015663|63032521|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
33630965|NCT02015663|63032520|FG000|Overall Study|Withdrawal by Subject|1|||
33630966|NCT02015663|63032521|FG001|Overall Study|Withdrawal by Subject|0|||
33630967|NCT02015663|63032520|FG000|Overall Study|Protocol Violation|0|||
33630968|NCT02015663|63032521|FG001|Overall Study|Protocol Violation|1|||
33630969|NCT02015663|63032520|FG000|Overall Study|Adverse Event|3|||
33630970|NCT02015663|63032521|FG001|Overall Study|Adverse Event|0|||
33630971|NCT02015663|63032520|FG000|Overall Study|Administrative problems|10|||
33630972|NCT02015663|63032521|FG001|Overall Study|Administrative problems|11|||
33630973|NCT01978093|63032530|FG000|Overall Study|Death|1|||
33630974|NCT01978093|63032531|FG001|Overall Study|Death|0|||
33630975|NCT01978093|63032530|FG000|Overall Study|Adverse Event|0|||
33630976|NCT01978093|63032531|FG001|Overall Study|Adverse Event|5|||
33630977|NCT01978093|63032530|FG000|Overall Study|Protocol Violation|8|||
33630978|NCT01978093|63032531|FG001|Overall Study|Protocol Violation|2|||
33630979|NCT01978093|63032530|FG000|Overall Study|Withdrawal by Subject|29|||
33630980|NCT01978093|63032531|FG001|Overall Study|Withdrawal by Subject|25|||
33630981|NCT01978093|63032530|FG000|Overall Study|Lost to Follow-up|11|||
33630982|NCT01978093|63032531|FG001|Overall Study|Lost to Follow-up|15|||
33630983|NCT01978093|63032530|FG000|Overall Study|Migrated/moved from study area|11|||
33630984|NCT01978093|63032531|FG001|Overall Study|Migrated/moved from study area|13|||
33630985|NCT01978093|63032530|FG000|Overall Study|Loss of kaiser coverage|4|||
33630986|NCT01978093|63032531|FG001|Overall Study|Loss of kaiser coverage|10|||
33630987|NCT01978093|63032530|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
33630988|NCT01978093|63032531|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
33630989|NCT01978093|63032530|FG000|Overall Study|Mother lost custody of child|0|||
33630990|NCT01978093|63032531|FG001|Overall Study|Mother lost custody of child|1|||
33630991|NCT01978093|63032530|FG000|Overall Study|Child was in care of grandmother|0|||
33630992|NCT01978093|63032531|FG001|Overall Study|Child was in care of grandmother|1|||
33630993|NCT01978093|63032530|FG000|Overall Study|N/A for vaccine administration|0|||
33630994|NCT01978093|63032531|FG001|Overall Study|N/A for vaccine administration|1|||
33630995|NCT01951105|63032543|FG000|Overall Study|Adverse Event|0|||
33537777|NCT00150462|62927649|FG009|Overall Study|Disease Progression or Relapse|3|||
33537778|NCT00150462|62927650|FG010|Overall Study|Disease Progression or Relapse|2|||
33537779|NCT00150462|62927640|FG000|Overall Study|Withdrawal by Subject|0|||
33537780|NCT00150462|62927641|FG001|Overall Study|Withdrawal by Subject|1|||
33537781|NCT00150462|62927642|FG002|Overall Study|Withdrawal by Subject|1|||
33537782|NCT00150462|62927643|FG003|Overall Study|Withdrawal by Subject|0|||
33537783|NCT00150462|62927644|FG004|Overall Study|Withdrawal by Subject|1|||
33537784|NCT00150462|62927645|FG005|Overall Study|Withdrawal by Subject|2|||
33537785|NCT00150462|62927646|FG006|Overall Study|Withdrawal by Subject|0|||
33537786|NCT00150462|62927647|FG007|Overall Study|Withdrawal by Subject|1|||
33537787|NCT00150462|62927648|FG008|Overall Study|Withdrawal by Subject|0|||
33537788|NCT00150462|62927649|FG009|Overall Study|Withdrawal by Subject|1|||
33537789|NCT00150462|62927650|FG010|Overall Study|Withdrawal by Subject|0|||
33537790|NCT00150462|62927640|FG000|Overall Study|Death|0|||
33537791|NCT00150462|62927641|FG001|Overall Study|Death|1|||
33537792|NCT00150462|62927642|FG002|Overall Study|Death|0|||
33537793|NCT00150462|62927643|FG003|Overall Study|Death|0|||
33537794|NCT00150462|62927644|FG004|Overall Study|Death|0|||
33537795|NCT00150462|62927645|FG005|Overall Study|Death|0|||
33537796|NCT00150462|62927646|FG006|Overall Study|Death|0|||
33537797|NCT00150462|62927647|FG007|Overall Study|Death|0|||
33537798|NCT00150462|62927648|FG008|Overall Study|Death|1|||
33537799|NCT00150462|62927649|FG009|Overall Study|Death|0|||
33537800|NCT00150462|62927650|FG010|Overall Study|Death|0|||
33537801|NCT00150462|62927640|FG000|Overall Study|Adverse Event|0|||
33537802|NCT00150462|62927641|FG001|Overall Study|Adverse Event|0|||
33630996|NCT01951105|63032544|FG001|Overall Study|Adverse Event|5|||
33630997|NCT01951105|63032545|FG002|Overall Study|Adverse Event|0|||
33630998|NCT01951105|63032543|FG000|Overall Study|Lost to Follow-up|0|||
33630999|NCT01951105|63032544|FG001|Overall Study|Lost to Follow-up|1|||
33631000|NCT01951105|63032545|FG002|Overall Study|Lost to Follow-up|0|||
33631001|NCT01951105|63032543|FG000|Overall Study|Protocol Violation|1|||
33537803|NCT00150462|62927642|FG002|Overall Study|Adverse Event|0|||
33537804|NCT00150462|62927643|FG003|Overall Study|Adverse Event|1|||
33537805|NCT00150462|62927644|FG004|Overall Study|Adverse Event|0|||
33537806|NCT00150462|62927645|FG005|Overall Study|Adverse Event|0|||
33537807|NCT00150462|62927646|FG006|Overall Study|Adverse Event|0|||
33537808|NCT00150462|62927647|FG007|Overall Study|Adverse Event|2|||
33537809|NCT00150462|62927648|FG008|Overall Study|Adverse Event|0|||
33537810|NCT00150462|62927649|FG009|Overall Study|Adverse Event|1|||
33537811|NCT00150462|62927650|FG010|Overall Study|Adverse Event|0|||
33537812|NCT00150462|62927640|FG000|Overall Study|Physician Decision|0|||
33537813|NCT00150462|62927641|FG001|Overall Study|Physician Decision|0|||
33537814|NCT00150462|62927642|FG002|Overall Study|Physician Decision|1|||
33537815|NCT00150462|62927643|FG003|Overall Study|Physician Decision|1|||
33537816|NCT00150462|62927644|FG004|Overall Study|Physician Decision|0|||
33537817|NCT00150462|62927645|FG005|Overall Study|Physician Decision|0|||
33537818|NCT00150462|62927646|FG006|Overall Study|Physician Decision|0|||
33537819|NCT00150462|62927647|FG007|Overall Study|Physician Decision|0|||
33537820|NCT00150462|62927648|FG008|Overall Study|Physician Decision|0|||
33537821|NCT00150462|62927649|FG009|Overall Study|Physician Decision|0|||
33537822|NCT00150462|62927650|FG010|Overall Study|Physician Decision|0|||
33537823|NCT00150462|62927640|FG000|Overall Study|Other|0|||
33537824|NCT00150462|62927641|FG001|Overall Study|Other|0|||
33537825|NCT00150462|62927642|FG002|Overall Study|Other|0|||
33537826|NCT00150462|62927643|FG003|Overall Study|Other|0|||
33537827|NCT00150462|62927644|FG004|Overall Study|Other|0|||
33537828|NCT00150462|62927645|FG005|Overall Study|Other|0|||
33537829|NCT00150462|62927646|FG006|Overall Study|Other|0|||
33537830|NCT00150462|62927647|FG007|Overall Study|Other|0|||
33537831|NCT00150462|62927648|FG008|Overall Study|Other|0|||
33537832|NCT00150462|62927649|FG009|Overall Study|Other|1|||
33537833|NCT00150462|62927650|FG010|Overall Study|Other|1|||
33537834|NCT01368081|62927690|FG000|Overall Study|Adverse Event|4|||
33537835|NCT01368081|62927691|FG001|Overall Study|Adverse Event|4|||
33537836|NCT01368081|62927692|FG002|Overall Study|Adverse Event|3|||
33537837|NCT01368081|62927693|FG003|Overall Study|Adverse Event|2|||
33537838|NCT01368081|62927694|FG004|Overall Study|Adverse Event|2|||
33537839|NCT01368081|62927695|FG005|Overall Study|Adverse Event|5|||
33537840|NCT01368081|62927696|FG006|Overall Study|Adverse Event|6|||
33537841|NCT01368081|62927697|FG007|Overall Study|Adverse Event|2|||
33537842|NCT01368081|62927698|FG008|Overall Study|Adverse Event|3|||
33537843|NCT01368081|62927699|FG009|Overall Study|Adverse Event|5|||
33537844|NCT01368081|62927700|FG010|Overall Study|Adverse Event|6|||
33537845|NCT01368081|62927701|FG011|Overall Study|Adverse Event|1|||
33537846|NCT01368081|62927702|FG012|Overall Study|Adverse Event|3|||
33537847|NCT01368081|62927690|FG000|Overall Study|Lack of Efficacy|0|||
33537848|NCT01368081|62927691|FG001|Overall Study|Lack of Efficacy|1|||
33537849|NCT01368081|62927692|FG002|Overall Study|Lack of Efficacy|0|||
33537850|NCT01368081|62927693|FG003|Overall Study|Lack of Efficacy|1|||
33537851|NCT01368081|62927694|FG004|Overall Study|Lack of Efficacy|0|||
33537852|NCT01368081|62927695|FG005|Overall Study|Lack of Efficacy|0|||
33537853|NCT01368081|62927696|FG006|Overall Study|Lack of Efficacy|0|||
33537854|NCT01368081|62927697|FG007|Overall Study|Lack of Efficacy|2|||
33537855|NCT01368081|62927698|FG008|Overall Study|Lack of Efficacy|0|||
33537856|NCT01368081|62927699|FG009|Overall Study|Lack of Efficacy|0|||
33537857|NCT01368081|62927700|FG010|Overall Study|Lack of Efficacy|0|||
33537858|NCT01368081|62927701|FG011|Overall Study|Lack of Efficacy|0|||
33537859|NCT01368081|62927702|FG012|Overall Study|Lack of Efficacy|0|||
33537860|NCT01368081|62927690|FG000|Overall Study|Protocol Violation|0|||
33537861|NCT01368081|62927691|FG001|Overall Study|Protocol Violation|0|||
33537862|NCT01368081|62927692|FG002|Overall Study|Protocol Violation|0|||
33537863|NCT01368081|62927693|FG003|Overall Study|Protocol Violation|0|||
33537864|NCT01368081|62927694|FG004|Overall Study|Protocol Violation|0|||
33537865|NCT01368081|62927695|FG005|Overall Study|Protocol Violation|1|||
33537866|NCT01368081|62927696|FG006|Overall Study|Protocol Violation|0|||
33537867|NCT01368081|62927697|FG007|Overall Study|Protocol Violation|1|||
33537868|NCT01368081|62927698|FG008|Overall Study|Protocol Violation|0|||
33537869|NCT01368081|62927699|FG009|Overall Study|Protocol Violation|0|||
33537870|NCT01368081|62927700|FG010|Overall Study|Protocol Violation|0|||
33537871|NCT01368081|62927701|FG011|Overall Study|Protocol Violation|0|||
33537872|NCT01368081|62927702|FG012|Overall Study|Protocol Violation|0|||
33537873|NCT01368081|62927690|FG000|Overall Study|Lost to Follow-up|0|||
33537874|NCT01368081|62927691|FG001|Overall Study|Lost to Follow-up|0|||
33537875|NCT01368081|62927692|FG002|Overall Study|Lost to Follow-up|0|||
33631002|NCT01951105|63032544|FG001|Overall Study|Protocol Violation|1|||
33631003|NCT01951105|63032545|FG002|Overall Study|Protocol Violation|1|||
33537876|NCT01368081|62927693|FG003|Overall Study|Lost to Follow-up|0|||
33537877|NCT01368081|62927694|FG004|Overall Study|Lost to Follow-up|0|||
33537878|NCT01368081|62927695|FG005|Overall Study|Lost to Follow-up|0|||
33537879|NCT01368081|62927696|FG006|Overall Study|Lost to Follow-up|0|||
33537880|NCT01368081|62927697|FG007|Overall Study|Lost to Follow-up|0|||
33537881|NCT01368081|62927698|FG008|Overall Study|Lost to Follow-up|0|||
33537882|NCT01368081|62927699|FG009|Overall Study|Lost to Follow-up|0|||
33537883|NCT01368081|62927700|FG010|Overall Study|Lost to Follow-up|0|||
33537884|NCT01368081|62927701|FG011|Overall Study|Lost to Follow-up|0|||
33537885|NCT01368081|62927702|FG012|Overall Study|Lost to Follow-up|1|||
33631004|NCT01951105|63032543|FG000|Overall Study|Withdrawal by Subject|0|||
33631005|NCT01951105|63032544|FG001|Overall Study|Withdrawal by Subject|3|||
33631006|NCT01951105|63032545|FG002|Overall Study|Withdrawal by Subject|1|||
33631007|NCT01958918|63032561|FG000|Overall Study|Death|1|||
33631008|NCT01958918|63032562|FG001|Overall Study|Death|3|||
33631009|NCT01958918|63032561|FG000|Overall Study|Lost to Follow-up|4|||
33631010|NCT01958918|63032562|FG001|Overall Study|Lost to Follow-up|7|||
33631011|NCT01958918|63032561|FG000|Overall Study|Withdrawal by Subject|13|||
33631012|NCT01958918|63032562|FG001|Overall Study|Withdrawal by Subject|8|||
33631013|NCT01958918|63032561|FG000|Overall Study|Lack of Efficacy|13|||
33631014|NCT01958918|63032562|FG001|Overall Study|Lack of Efficacy|10|||
33631015|NCT01958918|63032561|FG000|Overall Study|Adverse Event|12|||
33631016|NCT01958918|63032562|FG001|Overall Study|Adverse Event|12|||
33631017|NCT01958918|63032561|FG000|Overall Study|administrative problems|0|||
33631018|NCT01958918|63032562|FG001|Overall Study|administrative problems|2|||
33631019|NCT01945489|63032570|FG000|Cycle 1|Adverse Event|2|||
33631020|NCT01945489|63032571|FG001|Cycle 1|Adverse Event|0|||
33631021|NCT01945489|63032570|FG000|Cycle 1|Lost to Follow-up|4|||
33631022|NCT01945489|63032571|FG001|Cycle 1|Lost to Follow-up|0|||
33631023|NCT01945489|63032570|FG000|Cycle 1|Personal Reasons|4|||
33631024|NCT01945489|63032571|FG001|Cycle 1|Personal Reasons|2|||
33631025|NCT01945489|63032570|FG000|Cycle 1|Protocol Violation|0|||
33631026|NCT01945489|63032571|FG001|Cycle 1|Protocol Violation|1|||
33631027|NCT01945489|63032570|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
33631028|NCT01945489|63032571|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
33631029|NCT01945489|63032570|FG000|Cycle 2|Adverse Event|1|||
33631030|NCT01945489|63032571|FG001|Cycle 2|Adverse Event|0|||
33631031|NCT01945489|63032570|FG000|Cycle 2|Lost to Follow-up|0|||
33631032|NCT01945489|63032571|FG001|Cycle 2|Lost to Follow-up|1|||
33631033|NCT01934894|63032580|FG000|Overall Study|Adverse Event|1|||
33631034|NCT01934894|63032581|FG001|Overall Study|Adverse Event|2|||
33631035|NCT01934894|63032580|FG000|Overall Study|Death|2|||
33631036|NCT01934894|63032581|FG001|Overall Study|Death|0|||
33631037|NCT01934894|63032580|FG000|Overall Study|Withdrawal by Subject|0|||
33631038|NCT01934894|63032581|FG001|Overall Study|Withdrawal by Subject|1|||
33631039|NCT01934894|63032580|FG000|Overall Study|Progressive Disease|3|||
33631040|NCT01934894|63032581|FG001|Overall Study|Progressive Disease|2|||
33631041|NCT01950169|63032593|FG000|Overall Study|Withdrawal by Subject|2|||
33631042|NCT01950169|63032594|FG001|Overall Study|Withdrawal by Subject|8|||
33631043|NCT01950169|63032595|FG002|Overall Study|Withdrawal by Subject|1|||
33631044|NCT01950169|63032593|FG000|Overall Study|Death|1|||
33631045|NCT01950169|63032594|FG001|Overall Study|Death|0|||
33631046|NCT01950169|63032595|FG002|Overall Study|Death|0|||
33631047|NCT01934504|63032608|FG000|Overall Study|Protocol Deviation|0|||
33631048|NCT01934504|63032609|FG001|Overall Study|Protocol Deviation|0|||
33631049|NCT01934504|63032610|FG002|Overall Study|Protocol Deviation|0|||
33631050|NCT01934504|63032611|FG003|Overall Study|Protocol Deviation|2|||
33631051|NCT01934504|63032608|FG000|Overall Study|Study Terminated by Sponsor|1|||
33631052|NCT01934504|63032609|FG001|Overall Study|Study Terminated by Sponsor|0|||
33631053|NCT01934504|63032610|FG002|Overall Study|Study Terminated by Sponsor|5|||
33631054|NCT01934504|63032611|FG003|Overall Study|Study Terminated by Sponsor|5|||
33631055|NCT01950013|63032624|FG000|Overall Study|Withdrawal by Subject|0|||
33537886|NCT01368081|62927690|FG000|Overall Study|Withdrawal by Subject|4|||
33537887|NCT01368081|62927691|FG001|Overall Study|Withdrawal by Subject|4|||
33537888|NCT01368081|62927692|FG002|Overall Study|Withdrawal by Subject|1|||
33537889|NCT01368081|62927693|FG003|Overall Study|Withdrawal by Subject|1|||
33537890|NCT01368081|62927694|FG004|Overall Study|Withdrawal by Subject|0|||
33537891|NCT01368081|62927695|FG005|Overall Study|Withdrawal by Subject|3|||
33537892|NCT01368081|62927696|FG006|Overall Study|Withdrawal by Subject|4|||
33537893|NCT01368081|62927697|FG007|Overall Study|Withdrawal by Subject|2|||
33537894|NCT01368081|62927698|FG008|Overall Study|Withdrawal by Subject|5|||
33537895|NCT01368081|62927699|FG009|Overall Study|Withdrawal by Subject|4|||
33631056|NCT01950013|63032625|FG001|Overall Study|Withdrawal by Subject|2|||
33631057|NCT01950013|63032626|FG002|Overall Study|Withdrawal by Subject|0|||
33631058|NCT01949155|63032636|FG000|Overall Study|Lost to Follow-up|1|||
33631059|NCT01949155|63032637|FG001|Overall Study|Lost to Follow-up|0|||
33631060|NCT01949155|63032636|FG000|Overall Study|Protocol Violation|1|||
33631061|NCT01949155|63032637|FG001|Overall Study|Protocol Violation|0|||
33631062|NCT01909466|63032644|FG000|Overall Study|Lost to Follow-up|5|||
33631063|NCT01909466|63032645|FG001|Overall Study|Lost to Follow-up|7|||
33631064|NCT01909466|63032644|FG000|Overall Study|Adverse Event|3|||
33631065|NCT01909466|63032645|FG001|Overall Study|Adverse Event|4|||
33631066|NCT01909466|63032644|FG000|Overall Study|Met Withdrawal Criteria|0|||
33631067|NCT01909466|63032645|FG001|Overall Study|Met Withdrawal Criteria|3|||
33631068|NCT01909466|63032644|FG000|Overall Study|Physician Decision|2|||
33631069|NCT01909466|63032645|FG001|Overall Study|Physician Decision|0|||
33631070|NCT01909466|63032644|FG000|Overall Study|Withdrawal by Subject|11|||
33631071|NCT01909466|63032645|FG001|Overall Study|Withdrawal by Subject|9|||
33631072|NCT01909466|63032644|FG000|Overall Study|Lack of Efficacy|1|||
33631073|NCT01909466|63032645|FG001|Overall Study|Lack of Efficacy|0|||
33631074|NCT01977625|63032649|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
33631075|NCT01977625|63032650|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
33631076|NCT01977625|63032649|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
33631077|NCT01977625|63032650|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
33631078|NCT01944631|63032660|FG000|Overall Study|Adverse Event|1|||
33631079|NCT01944631|63032661|FG001|Overall Study|Adverse Event|0|||
33631080|NCT01944631|63032660|FG000|Overall Study|Lost to Follow-up|3|||
33631081|NCT01944631|63032661|FG001|Overall Study|Lost to Follow-up|1|||
33631082|NCT01944631|63032660|FG000|Overall Study|Withdrawal by Subject|0|||
33631083|NCT01944631|63032661|FG001|Overall Study|Withdrawal by Subject|1|||
33631084|NCT01948063|63032669|FG000|Overall Study|Boston MCI halted research protocol|0|||
33631085|NCT01948063|63032670|FG001|Overall Study|Boston MCI halted research protocol|1|||
33631086|NCT01948063|63032669|FG000|Overall Study|Discovered an enrollment in other study|0|||
33631087|NCT01948063|63032670|FG001|Overall Study|Discovered an enrollment in other study|1|||
33631088|NCT01948063|63032669|FG000|Overall Study|Blood samples were accidentally thawed|1|||
33631089|NCT01948063|63032670|FG001|Overall Study|Blood samples were accidentally thawed|0|||
33326231|NCT01110330|62703055|FG000|Overall Study|Lack of Efficacy|3|||
33326232|NCT01110330|62703056|FG001|Overall Study|Lack of Efficacy|1|||
33461351|NCT03381274|62834621|FG003|Overall Study|Lost to Follow-up|1|||
33461352|NCT03381274|62834622|FG004|Overall Study|Lost to Follow-up|0|||
33461353|NCT03381274|62834618|FG000|Overall Study|Withdrawal by Subject|2|||
33537896|NCT01368081|62927700|FG010|Overall Study|Withdrawal by Subject|3|||
33537897|NCT01368081|62927701|FG011|Overall Study|Withdrawal by Subject|2|||
33537898|NCT01368081|62927702|FG012|Overall Study|Withdrawal by Subject|0|||
33537899|NCT01368081|62927690|FG000|Overall Study|Other reason not defined above|2|||
33537900|NCT01368081|62927691|FG001|Overall Study|Other reason not defined above|0|||
33537901|NCT01368081|62927692|FG002|Overall Study|Other reason not defined above|0|||
33537902|NCT01368081|62927693|FG003|Overall Study|Other reason not defined above|1|||
33537903|NCT01368081|62927694|FG004|Overall Study|Other reason not defined above|0|||
33537904|NCT01368081|62927695|FG005|Overall Study|Other reason not defined above|1|||
33537905|NCT01368081|62927696|FG006|Overall Study|Other reason not defined above|2|||
33537906|NCT01368081|62927697|FG007|Overall Study|Other reason not defined above|0|||
33537907|NCT01368081|62927698|FG008|Overall Study|Other reason not defined above|0|||
33537908|NCT01368081|62927699|FG009|Overall Study|Other reason not defined above|1|||
33537909|NCT01368081|62927700|FG010|Overall Study|Other reason not defined above|0|||
33537910|NCT01368081|62927701|FG011|Overall Study|Other reason not defined above|0|||
33537911|NCT01368081|62927702|FG012|Overall Study|Other reason not defined above|3|||
33537912|NCT00303498|62927732|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
33537913|NCT00303498|62927733|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
33537914|NCT00303498|62927732|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
33537915|NCT00303498|62927733|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
33537916|NCT00303498|62927732|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
33537917|NCT00303498|62927733|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
33537918|NCT00303498|62927732|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
33537919|NCT00303498|62927733|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
33537920|NCT00303498|62927732|FG000|Run-In-Phase (10 Weeks)|Other|4|||
33537921|NCT00303498|62927733|FG001|Run-In-Phase (10 Weeks)|Other|1|||
33537922|NCT00303498|62927732|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
33537923|NCT00303498|62927733|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
33537924|NCT00303498|62927732|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
33537925|NCT00303498|62927733|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
33537926|NCT00303498|62927732|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
33537927|NCT00303498|62927733|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
33537928|NCT00303498|62927732|FG000|Maintenance Phase (24 Weeks)|Death|1|||
33537929|NCT00303498|62927733|FG001|Maintenance Phase (24 Weeks)|Death|0|||
33537930|NCT00303498|62927732|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
33461354|NCT03381274|62834619|FG001|Overall Study|Withdrawal by Subject|1|||
33461355|NCT03381274|62834620|FG002|Overall Study|Withdrawal by Subject|3|||
33461356|NCT03381274|62834621|FG003|Overall Study|Withdrawal by Subject|1|||
33461357|NCT03381274|62834622|FG004|Overall Study|Withdrawal by Subject|0|||
33461358|NCT03381274|62834618|FG000|Overall Study|Other|1|||
33461359|NCT03381274|62834619|FG001|Overall Study|Other|11|||
33461360|NCT03381274|62834620|FG002|Overall Study|Other|0|||
33461361|NCT03381274|62834621|FG003|Overall Study|Other|2|||
33461362|NCT03381274|62834622|FG004|Overall Study|Other|2|||
33461363|NCT03298022|62834638|FG000|Overall Study|Lack of Efficacy|4|||
33537931|NCT00303498|62927733|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
33631090|NCT01995071|63032688|FG000|Overall Study|Adverse Event|0|||
33631091|NCT01995071|63032689|FG001|Overall Study|Adverse Event|0|||
33631092|NCT01995071|63032690|FG002|Overall Study|Adverse Event|0|||
33631093|NCT01995071|63032691|FG003|Overall Study|Adverse Event|0|||
33631094|NCT01995071|63032692|FG004|Overall Study|Adverse Event|0|||
33631095|NCT01995071|63032693|FG005|Overall Study|Adverse Event|0|||
33631096|NCT01995071|63032694|FG006|Overall Study|Adverse Event|1|||
33631097|NCT01995071|63032695|FG007|Overall Study|Adverse Event|0|||
33631098|NCT01995071|63032696|FG008|Overall Study|Adverse Event|0|||
33631099|NCT01995071|63032697|FG009|Overall Study|Adverse Event|0|||
33631100|NCT01995071|63032698|FG010|Overall Study|Adverse Event|0|||
33461364|NCT03298022|62834638|FG000|Overall Study|Withdrawal by Subject|7|||
33461365|NCT03298022|62834638|FG000|Overall Study|Adverse Event|1|||
33461366|NCT03298022|62834638|FG000|Overall Study|disease relapse|1|||
33537932|NCT00303498|62927732|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
33537933|NCT00303498|62927733|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
33537934|NCT00303498|62927732|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
33537935|NCT00303498|62927733|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
33537936|NCT00303498|62927732|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
33537937|NCT00303498|62927733|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
33537938|NCT00303498|62927732|FG000|Maintenance Phase (24 Weeks)|Other|1|||
33537939|NCT00303498|62927733|FG001|Maintenance Phase (24 Weeks)|Other|0|||
33537940|NCT00303498|62927732|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
33537941|NCT00303498|62927733|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
33537942|NCT00303498|62927732|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
33537943|NCT00303498|62927733|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
33537944|NCT02588092|62927749|FG000|Overall Study|Death|4|||
33537945|NCT02588092|62927750|FG001|Overall Study|Death|3|||
33537946|NCT02588092|62927751|FG002|Overall Study|Death|3|||
33537947|NCT02588092|62927752|FG003|Overall Study|Death|3|||
33537948|NCT02588092|62927753|FG004|Overall Study|Death|2|||
33537949|NCT02588092|62927754|FG005|Overall Study|Death|2|||
33537950|NCT02588092|62927755|FG006|Overall Study|Death|2|||
33537951|NCT02588092|62927756|FG007|Overall Study|Death|1|||
33461367|NCT03264404|62834648|FG000|Overall Study|Death|2|||
33461368|NCT03264404|62834648|FG000|Overall Study|Physician Decision|1|||
33461369|NCT03264404|62834648|FG000|Overall Study|Disease Progression|28|||
33461370|NCT03264404|62834648|FG000|Overall Study|Adverse Event|1|||
33461371|NCT03264404|62834648|FG000|Overall Study|Off study prior to treatment|2|||
33464877|NCT00040664|62838369|FG001|Overall Study|Withdrawal by Subject|0|||
33464878|NCT00040664|62838370|FG002|Overall Study|Withdrawal by Subject|3|||
33464879|NCT00040664|62838371|FG003|Overall Study|Withdrawal by Subject|4|||
33464880|NCT00040664|62838368|FG000|Overall Study|Pregnancy|3|||
33464881|NCT00040664|62838369|FG001|Overall Study|Pregnancy|0|||
33464882|NCT00040664|62838370|FG002|Overall Study|Pregnancy|0|||
33464883|NCT00040664|62838371|FG003|Overall Study|Pregnancy|3|||
33464884|NCT00040664|62838368|FG000|Overall Study|Medication adherence/compliance problems|8|||
33464885|NCT00040664|62838369|FG001|Overall Study|Medication adherence/compliance problems|2|||
33464886|NCT00040664|62838370|FG002|Overall Study|Medication adherence/compliance problems|1|||
33464887|NCT00040664|62838371|FG003|Overall Study|Medication adherence/compliance problems|5|||
33464888|NCT00040664|62838368|FG000|Overall Study|Poor taste|2|||
33464889|NCT00040664|62838369|FG001|Overall Study|Poor taste|0|||
33464890|NCT00040664|62838370|FG002|Overall Study|Poor taste|2|||
33464891|NCT00040664|62838371|FG003|Overall Study|Poor taste|0|||
33464892|NCT00040664|62838368|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
33464893|NCT00040664|62838369|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
33464894|NCT00040664|62838370|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
33464895|NCT00040664|62838371|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
33464896|NCT00040664|62838368|FG000|Overall Study|Change of formulation|2|||
33464897|NCT00040664|62838369|FG001|Overall Study|Change of formulation|2|||
33464898|NCT00040664|62838370|FG002|Overall Study|Change of formulation|0|||
33464899|NCT00040664|62838371|FG003|Overall Study|Change of formulation|0|||
33464900|NCT00040664|62838368|FG000|Overall Study|Non-viability of oral suspension|1|||
33464901|NCT00040664|62838369|FG001|Overall Study|Non-viability of oral suspension|0|||
33537952|NCT02588092|62927757|FG008|Overall Study|Death|5|||
33537953|NCT02588092|62927758|FG009|Overall Study|Death|2|||
33326233|NCT01110330|62703057|FG002|Overall Study|Lack of Efficacy|1|||
33326234|NCT01110330|62703055|FG000|Overall Study|Lost to Follow-up|9|||
33464902|NCT00040664|62838370|FG002|Overall Study|Non-viability of oral suspension|1|||
33537954|NCT02588092|62927749|FG000|Overall Study|Withdrawal by Subject|0|||
33537955|NCT02588092|62927750|FG001|Overall Study|Withdrawal by Subject|0|||
33537956|NCT02588092|62927751|FG002|Overall Study|Withdrawal by Subject|0|||
33631101|NCT01995071|63032699|FG011|Overall Study|Adverse Event|0|||
33631102|NCT01995071|63032688|FG000|Overall Study|Moved|0|||
33464903|NCT00040664|62838371|FG003|Overall Study|Non-viability of oral suspension|0|||
33464904|NCT02952586|62838391|FG000|Lead-In Phase (7 Days)|Death|0|||
33631103|NCT01995071|63032689|FG001|Overall Study|Moved|0|||
33537957|NCT02588092|62927752|FG003|Overall Study|Withdrawal by Subject|0|||
33537958|NCT02588092|62927753|FG004|Overall Study|Withdrawal by Subject|0|||
33537959|NCT02588092|62927754|FG005|Overall Study|Withdrawal by Subject|1|||
33537960|NCT02588092|62927755|FG006|Overall Study|Withdrawal by Subject|1|||
33631104|NCT01995071|63032690|FG002|Overall Study|Moved|1|||
33631105|NCT01995071|63032691|FG003|Overall Study|Moved|0|||
33631106|NCT01995071|63032692|FG004|Overall Study|Moved|1|||
33631107|NCT01995071|63032693|FG005|Overall Study|Moved|0|||
33631108|NCT01995071|63032694|FG006|Overall Study|Moved|0|||
33631109|NCT01995071|63032695|FG007|Overall Study|Moved|0|||
33631110|NCT01995071|63032696|FG008|Overall Study|Moved|0|||
33631111|NCT01995071|63032697|FG009|Overall Study|Moved|0|||
33631112|NCT01995071|63032698|FG010|Overall Study|Moved|1|||
33631113|NCT01995071|63032699|FG011|Overall Study|Moved|0|||
33631114|NCT01995071|63032688|FG000|Overall Study|Lost to Follow-up|1|||
33631115|NCT01995071|63032689|FG001|Overall Study|Lost to Follow-up|0|||
33631116|NCT01995071|63032690|FG002|Overall Study|Lost to Follow-up|0|||
33631117|NCT01995071|63032691|FG003|Overall Study|Lost to Follow-up|0|||
33631118|NCT01995071|63032692|FG004|Overall Study|Lost to Follow-up|0|||
33631119|NCT01995071|63032693|FG005|Overall Study|Lost to Follow-up|0|||
33631120|NCT01995071|63032694|FG006|Overall Study|Lost to Follow-up|0|||
33631121|NCT01995071|63032695|FG007|Overall Study|Lost to Follow-up|1|||
33537961|NCT02588092|62927756|FG007|Overall Study|Withdrawal by Subject|2|||
33537962|NCT02588092|62927757|FG008|Overall Study|Withdrawal by Subject|0|||
33537963|NCT02588092|62927758|FG009|Overall Study|Withdrawal by Subject|0|||
33537964|NCT02588092|62927749|FG000|Overall Study|Started Another Treatment|0|||
33631122|NCT01995071|63032696|FG008|Overall Study|Lost to Follow-up|1|||
33631123|NCT01995071|63032697|FG009|Overall Study|Lost to Follow-up|0|||
33631124|NCT01995071|63032698|FG010|Overall Study|Lost to Follow-up|0|||
33631125|NCT01995071|63032699|FG011|Overall Study|Lost to Follow-up|0|||
33631126|NCT01995071|63032688|FG000|Overall Study|Incarcerated|0|||
33631127|NCT01995071|63032689|FG001|Overall Study|Incarcerated|0|||
33631128|NCT01995071|63032690|FG002|Overall Study|Incarcerated|0|||
33631129|NCT01995071|63032691|FG003|Overall Study|Incarcerated|0|||
33631130|NCT01995071|63032692|FG004|Overall Study|Incarcerated|0|||
33631131|NCT01995071|63032693|FG005|Overall Study|Incarcerated|0|||
33631132|NCT01995071|63032694|FG006|Overall Study|Incarcerated|0|||
33631133|NCT01995071|63032695|FG007|Overall Study|Incarcerated|1|||
33631134|NCT01995071|63032696|FG008|Overall Study|Incarcerated|0|||
33631135|NCT01995071|63032697|FG009|Overall Study|Incarcerated|0|||
33631136|NCT01995071|63032698|FG010|Overall Study|Incarcerated|0|||
33631137|NCT01995071|63032699|FG011|Overall Study|Incarcerated|0|||
33631138|NCT01994837|63032731|FG000|Overall Study|Progressive disease per protocol|23|||
33631139|NCT01994837|63032731|FG000|Overall Study|Adv event related to progressive disease|3|||
33631140|NCT01994837|63032731|FG000|Overall Study|Fatal progressive disease|2|||
33631141|NCT01994837|63032731|FG000|Overall Study|Adverse event not related to progression|1|||
33631142|NCT01994837|63032731|FG000|Overall Study|Chose palliative care|1|||
33631143|NCT01994837|63032731|FG000|Overall Study|Proceeded to transplant|1|||
33631144|NCT01994837|63032731|FG000|Overall Study|Removed from study due to no response|1|||
33631145|NCT02010593|63032737|FG000|Overall Study|Lost to Follow-up|1|||
33631146|NCT02010593|63032738|FG001|Overall Study|Lost to Follow-up|0|||
33631147|NCT02010593|63032737|FG000|Overall Study|Physician Decision|1|||
33631148|NCT02010593|63032738|FG001|Overall Study|Physician Decision|0|||
33631149|NCT02010593|63032737|FG000|Overall Study|Unable to adhere to visit schedule|0|||
33631150|NCT02010593|63032738|FG001|Overall Study|Unable to adhere to visit schedule|2|||
33631151|NCT01994291|63032747|FG000|Overall Study|Adverse Event|4|||
33461372|NCT03118570|62834666|FG000|Overall Study|Adverse Event|2|||
33461373|NCT03118570|62834667|FG001|Overall Study|Adverse Event|0|||
33461374|NCT03118570|62834668|FG002|Overall Study|Adverse Event|0|||
33631152|NCT01994291|63032748|FG001|Overall Study|Adverse Event|1|||
33461375|NCT03118570|62834669|FG003|Overall Study|Adverse Event|0|||
33461376|NCT03118570|62834670|FG004|Overall Study|Adverse Event|3|||
33461377|NCT03118570|62834666|FG000|Overall Study|Withdrawal by Subject|0|||
33461378|NCT03118570|62834667|FG001|Overall Study|Withdrawal by Subject|1|||
33461379|NCT03118570|62834668|FG002|Overall Study|Withdrawal by Subject|4|||
33461380|NCT03118570|62834669|FG003|Overall Study|Withdrawal by Subject|0|||
33461381|NCT03118570|62834670|FG004|Overall Study|Withdrawal by Subject|1|||
33461382|NCT03118570|62834666|FG000|Overall Study|Lost to Follow-up|2|||
33537965|NCT02588092|62927750|FG001|Overall Study|Started Another Treatment|0|||
33631153|NCT01994291|63032749|FG002|Overall Study|Adverse Event|3|||
33631154|NCT01994291|63032747|FG000|Overall Study|Lost to Follow-up|1|||
33631155|NCT01994291|63032748|FG001|Overall Study|Lost to Follow-up|1|||
33631156|NCT01994291|63032749|FG002|Overall Study|Lost to Follow-up|0|||
33631157|NCT01994291|63032747|FG000|Overall Study|Does not meet entrance criteria|1|||
33631158|NCT01994291|63032748|FG001|Overall Study|Does not meet entrance criteria|0|||
33631159|NCT01994291|63032749|FG002|Overall Study|Does not meet entrance criteria|0|||
33631160|NCT01994291|63032747|FG000|Overall Study|Medication error without associated AE|1|||
33537966|NCT02588092|62927751|FG002|Overall Study|Started Another Treatment|0|||
33537967|NCT02588092|62927752|FG003|Overall Study|Started Another Treatment|0|||
33537968|NCT02588092|62927753|FG004|Overall Study|Started Another Treatment|1|||
33537969|NCT02588092|62927754|FG005|Overall Study|Started Another Treatment|0|||
33537970|NCT02588092|62927755|FG006|Overall Study|Started Another Treatment|0|||
33537971|NCT02588092|62927756|FG007|Overall Study|Started Another Treatment|1|||
33537972|NCT02588092|62927757|FG008|Overall Study|Started Another Treatment|0|||
33537973|NCT02588092|62927758|FG009|Overall Study|Started Another Treatment|0|||
33537974|NCT02588092|62927749|FG000|Overall Study|Sponsor Decision|0|||
33537975|NCT02588092|62927750|FG001|Overall Study|Sponsor Decision|0|||
33537976|NCT02588092|62927751|FG002|Overall Study|Sponsor Decision|0|||
33537977|NCT02588092|62927752|FG003|Overall Study|Sponsor Decision|0|||
33537978|NCT02588092|62927753|FG004|Overall Study|Sponsor Decision|0|||
33537979|NCT02588092|62927754|FG005|Overall Study|Sponsor Decision|0|||
33537980|NCT02588092|62927755|FG006|Overall Study|Sponsor Decision|0|||
33537981|NCT02588092|62927756|FG007|Overall Study|Sponsor Decision|0|||
33537982|NCT02588092|62927757|FG008|Overall Study|Sponsor Decision|1|||
33537983|NCT02588092|62927758|FG009|Overall Study|Sponsor Decision|1|||
33537984|NCT01367847|62927786|FG000|Overall Study|Withdrawal by Subject|2|||
33537985|NCT01367847|62927787|FG001|Overall Study|Withdrawal by Subject|2|||
33537986|NCT00150618|62927799|FG000|Overall Study|Adverse Event|2|||
33537987|NCT00150618|62927800|FG001|Overall Study|Adverse Event|2|||
33537988|NCT00150618|62927801|FG002|Overall Study|Adverse Event|6|||
33537989|NCT00150618|62927802|FG003|Overall Study|Adverse Event|9|||
33537990|NCT00150618|62927803|FG004|Overall Study|Adverse Event|5|||
33537991|NCT00150618|62927799|FG000|Overall Study|Withdrawal by Subject|6|||
33537992|NCT00150618|62927800|FG001|Overall Study|Withdrawal by Subject|8|||
33537993|NCT00150618|62927801|FG002|Overall Study|Withdrawal by Subject|8|||
33537994|NCT00150618|62927802|FG003|Overall Study|Withdrawal by Subject|4|||
33537995|NCT00150618|62927803|FG004|Overall Study|Withdrawal by Subject|5|||
33537996|NCT00150618|62927799|FG000|Overall Study|Lost to Follow-up|4|||
33537997|NCT00150618|62927800|FG001|Overall Study|Lost to Follow-up|1|||
33537998|NCT00150618|62927801|FG002|Overall Study|Lost to Follow-up|5|||
33537999|NCT00150618|62927802|FG003|Overall Study|Lost to Follow-up|8|||
33538000|NCT00150618|62927803|FG004|Overall Study|Lost to Follow-up|4|||
33538001|NCT00150618|62927799|FG000|Overall Study|Protocol Violation|1|||
33538002|NCT00150618|62927800|FG001|Overall Study|Protocol Violation|0|||
33538003|NCT00150618|62927801|FG002|Overall Study|Protocol Violation|0|||
33538004|NCT00150618|62927802|FG003|Overall Study|Protocol Violation|0|||
33538005|NCT00150618|62927803|FG004|Overall Study|Protocol Violation|1|||
33538006|NCT00150618|62927799|FG000|Overall Study|Lack of Efficacy|1|||
33538007|NCT00150618|62927800|FG001|Overall Study|Lack of Efficacy|4|||
33538008|NCT00150618|62927801|FG002|Overall Study|Lack of Efficacy|7|||
33538009|NCT00150618|62927802|FG003|Overall Study|Lack of Efficacy|4|||
33538010|NCT00150618|62927803|FG004|Overall Study|Lack of Efficacy|6|||
33538011|NCT00150618|62927799|FG000|Overall Study|No study meds|0|||
33538012|NCT00150618|62927800|FG001|Overall Study|No study meds|0|||
33538013|NCT00150618|62927801|FG002|Overall Study|No study meds|0|||
33538014|NCT00150618|62927802|FG003|Overall Study|No study meds|0|||
33538015|NCT00150618|62927803|FG004|Overall Study|No study meds|2|||
33538016|NCT00150618|62927799|FG000|Overall Study|Physician Decision|0|||
33538017|NCT00150618|62927800|FG001|Overall Study|Physician Decision|2|||
33538018|NCT00150618|62927801|FG002|Overall Study|Physician Decision|0|||
33538019|NCT00150618|62927802|FG003|Overall Study|Physician Decision|0|||
33538020|NCT00150618|62927803|FG004|Overall Study|Physician Decision|1|||
33538021|NCT00150618|62927799|FG000|Overall Study|Lack of compliance|2|||
33538022|NCT00150618|62927800|FG001|Overall Study|Lack of compliance|1|||
33538023|NCT00150618|62927801|FG002|Overall Study|Lack of compliance|1|||
33538024|NCT00150618|62927802|FG003|Overall Study|Lack of compliance|0|||
33538025|NCT00150618|62927803|FG004|Overall Study|Lack of compliance|1|||
33538026|NCT00150618|62927799|FG000|Overall Study|Abnormal ECG|1|||
33538027|NCT00150618|62927800|FG001|Overall Study|Abnormal ECG|0|||
33538028|NCT00150618|62927801|FG002|Overall Study|Abnormal ECG|0|||
33538029|NCT00150618|62927802|FG003|Overall Study|Abnormal ECG|0|||
33538030|NCT00150618|62927803|FG004|Overall Study|Abnormal ECG|0|||
33538031|NCT00150618|62927799|FG000|Overall Study|Sponsor's decision|0|||
33538032|NCT00150618|62927800|FG001|Overall Study|Sponsor's decision|0|||
33538033|NCT00150618|62927801|FG002|Overall Study|Sponsor's decision|0|||
33538034|NCT00150618|62927802|FG003|Overall Study|Sponsor's decision|1|||
33538035|NCT00150618|62927803|FG004|Overall Study|Sponsor's decision|0|||
33538036|NCT01359046|62927817|FG000|Overall Study|Did not receive allocated intervention|6|||
33538037|NCT01359046|62927818|FG001|Overall Study|Did not receive allocated intervention|6|||
33538038|NCT01359046|62927817|FG000|Overall Study|Physician Decision|1|||
33538039|NCT01359046|62927818|FG001|Overall Study|Physician Decision|11|||
33538040|NCT02741310|62927826|FG000|Overall Study|Sponsor Decision|2|||
33538041|NCT02741310|62927827|FG001|Overall Study|Sponsor Decision|2|||
33538042|NCT01367457|62927844|FG000|Overall Study|Death|2|||
33538043|NCT01367457|62927845|FG001|Overall Study|Death|0|||
33538044|NCT01367457|62927846|FG002|Overall Study|Death|0|||
33538045|NCT01367457|62927844|FG000|Overall Study|Investigator's decision|2|||
33631161|NCT01994291|63032748|FG001|Overall Study|Medication error without associated AE|0|||
33631162|NCT01994291|63032749|FG002|Overall Study|Medication error without associated AE|1|||
33631163|NCT01994291|63032747|FG000|Overall Study|Protocol Violation|1|||
33631164|NCT01994291|63032748|FG001|Overall Study|Protocol Violation|0|||
33631165|NCT01994291|63032749|FG002|Overall Study|Protocol Violation|0|||
33631166|NCT01994291|63032747|FG000|Overall Study|Withdrawal by Subject|6|||
33631167|NCT01994291|63032748|FG001|Overall Study|Withdrawal by Subject|3|||
33631168|NCT01994291|63032749|FG002|Overall Study|Withdrawal by Subject|5|||
33631169|NCT01994291|63032747|FG000|Overall Study|Other|1|||
33631170|NCT01994291|63032748|FG001|Overall Study|Other|2|||
33631171|NCT01994291|63032749|FG002|Overall Study|Other|0|||
33631172|NCT02094677|63032760|FG000|Overall Study|Screening|3|||
33631173|NCT02094677|63032761|FG001|Overall Study|Screening|1|||
33631174|NCT01993823|63032776|FG000|Overall Study|Requested by the patient|6|||
33631175|NCT01993823|63032777|FG001|Overall Study|Requested by the patient|11|||
33631176|NCT01993823|63032776|FG000|Overall Study|Protocol Violation|0|||
33631177|NCT01993823|63032777|FG001|Overall Study|Protocol Violation|1|||
33631178|NCT01993823|63032776|FG000|Overall Study|Lost to Follow-up|1|||
33631179|NCT01993823|63032777|FG001|Overall Study|Lost to Follow-up|4|||
33631180|NCT01993667|63032785|FG000|Overall Study|Insufficient data to analyze|16|||
33631181|NCT01993667|63032786|FG001|Overall Study|Insufficient data to analyze|16|||
33631182|NCT01993667|63032785|FG000|Overall Study|Insufficient altitude reached|3|||
33631183|NCT01993667|63032786|FG001|Overall Study|Insufficient altitude reached|1|||
33631184|NCT01993667|63032785|FG000|Overall Study|Lost to Follow-up|2|||
33631185|NCT01993667|63032786|FG001|Overall Study|Lost to Follow-up|2|||
33631186|NCT01992107|63032795|FG000|Overall Study|Administrative reasons|2|||
33631187|NCT01992107|63032796|FG001|Overall Study|Administrative reasons|0|||
33631188|NCT01992107|63032797|FG002|Overall Study|Administrative reasons|0|||
33631189|NCT01992107|63032795|FG000|Overall Study|Adverse Event|0|||
33631190|NCT01992107|63032796|FG001|Overall Study|Adverse Event|1|||
33631191|NCT01992107|63032797|FG002|Overall Study|Adverse Event|0|||
33631192|NCT01992107|63032795|FG000|Overall Study|Lost to Follow-up|46|||
33631193|NCT01992107|63032796|FG001|Overall Study|Lost to Follow-up|22|||
33631194|NCT01992107|63032797|FG002|Overall Study|Lost to Follow-up|26|||
33631195|NCT01992107|63032795|FG000|Overall Study|noncompliance and were unavailable|7|||
33631196|NCT01992107|63032796|FG001|Overall Study|noncompliance and were unavailable|3|||
33631197|NCT01992107|63032797|FG002|Overall Study|noncompliance and were unavailable|2|||
33631198|NCT01992107|63032795|FG000|Overall Study|Withdrawal by Subject|13|||
33631199|NCT01992107|63032796|FG001|Overall Study|Withdrawal by Subject|7|||
33631200|NCT01992107|63032797|FG002|Overall Study|Withdrawal by Subject|8|||
33631201|NCT01934192|63032826|FG000|Overall Study|Protocol Violation|0|||
33631202|NCT01934192|63032827|FG001|Overall Study|Protocol Violation|0|||
33631203|NCT01934192|63032828|FG002|Overall Study|Protocol Violation|0|||
33631204|NCT01934192|63032829|FG003|Overall Study|Protocol Violation|1|||
33631205|NCT01934192|63032826|FG000|Overall Study|Other: reached stopping criteria|6|||
33631206|NCT01934192|63032827|FG001|Overall Study|Other: reached stopping criteria|5|||
33631207|NCT01934192|63032828|FG002|Overall Study|Other: reached stopping criteria|1|||
33631208|NCT01934192|63032829|FG003|Overall Study|Other: reached stopping criteria|0|||
33631209|NCT01934192|63032826|FG000|Overall Study|Physician Decision|3|||
33631210|NCT01934192|63032827|FG001|Overall Study|Physician Decision|2|||
33631211|NCT01934192|63032828|FG002|Overall Study|Physician Decision|0|||
33326235|NCT01110330|62703056|FG001|Overall Study|Lost to Follow-up|10|||
33326236|NCT01110330|62703057|FG002|Overall Study|Lost to Follow-up|15|||
33538046|NCT01367457|62927845|FG001|Overall Study|Investigator's decision|0|||
33538047|NCT01367457|62927846|FG002|Overall Study|Investigator's decision|0|||
33538048|NCT01367457|62927844|FG000|Overall Study|Clinical decline (CD)|2|||
33538049|NCT01367457|62927845|FG001|Overall Study|Clinical decline (CD)|0|||
33538050|NCT01367457|62927846|FG002|Overall Study|Clinical decline (CD)|0|||
33538051|NCT01367457|62927844|FG000|Overall Study|Progression and death|8|||
33538052|NCT01367457|62927845|FG001|Overall Study|Progression and death|0|||
33538053|NCT01367457|62927846|FG002|Overall Study|Progression and death|0|||
33538054|NCT01367457|62927844|FG000|Overall Study|Toxicity|16|||
33538055|NCT01367457|62927845|FG001|Overall Study|Toxicity|0|||
33631212|NCT01934192|63032829|FG003|Overall Study|Physician Decision|0|||
33631213|NCT01933880|63032852|FG000|Overall Study|Withdrawal by Subject|5|||
33631214|NCT01933880|63032853|FG001|Overall Study|Withdrawal by Subject|0|||
33538056|NCT01367457|62927846|FG002|Overall Study|Toxicity|0|||
33538057|NCT01367457|62927844|FG000|Overall Study|Progression|137|||
33631215|NCT01933880|63032852|FG000|Overall Study|Lack of Efficacy|1|||
33631216|NCT01933880|63032853|FG001|Overall Study|Lack of Efficacy|0|||
33631217|NCT01933880|63032852|FG000|Overall Study|Concomitant medication Interference|0|||
33631218|NCT01933880|63032853|FG001|Overall Study|Concomitant medication Interference|1|||
33631219|NCT01933880|63032852|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
33631220|NCT01933880|63032853|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
33631221|NCT01933880|63032852|FG000|Overall Study|Other|4|||
33631222|NCT01933880|63032853|FG001|Overall Study|Other|0|||
33631223|NCT01933880|63032852|FG000|Overall Study|Protocol Violation|1|||
33326237|NCT01110330|62703055|FG000|Overall Study|Physician Decision|0|||
33326238|NCT01110330|62703056|FG001|Overall Study|Physician Decision|1|||
33326239|NCT01110330|62703057|FG002|Overall Study|Physician Decision|0|||
33461383|NCT03118570|62834667|FG001|Overall Study|Lost to Follow-up|3|||
33461384|NCT03118570|62834668|FG002|Overall Study|Lost to Follow-up|1|||
33461385|NCT03118570|62834669|FG003|Overall Study|Lost to Follow-up|0|||
33461386|NCT03118570|62834670|FG004|Overall Study|Lost to Follow-up|1|||
33461387|NCT03118570|62834666|FG000|Overall Study|Other, Not Specified|1|||
33461388|NCT03118570|62834667|FG001|Overall Study|Other, Not Specified|3|||
33461389|NCT03118570|62834668|FG002|Overall Study|Other, Not Specified|0|||
33461390|NCT03118570|62834669|FG003|Overall Study|Other, Not Specified|0|||
33461391|NCT03118570|62834670|FG004|Overall Study|Other, Not Specified|0|||
33461392|NCT02971683|62834685|FG000|Overall Study|Other reasons|0|||
33461393|NCT02971683|62834686|FG001|Overall Study|Other reasons|1|||
33461394|NCT02971683|62834685|FG000|Overall Study|Poor/Non-Compliance|0|||
33461395|NCT02971683|62834686|FG001|Overall Study|Poor/Non-Compliance|1|||
33461396|NCT02971683|62834685|FG000|Overall Study|Lost to Follow-up|1|||
33538058|NCT01367457|62927845|FG001|Overall Study|Progression|0|||
33538059|NCT01367457|62927846|FG002|Overall Study|Progression|0|||
33538060|NCT01367457|62927844|FG000|Overall Study|Patient asks for rest + slow progression|1|||
33538061|NCT01367457|62927845|FG001|Overall Study|Patient asks for rest + slow progression|0|||
33538062|NCT01367457|62927846|FG002|Overall Study|Patient asks for rest + slow progression|0|||
33538063|NCT01367457|62927844|FG000|Overall Study|Investigator's opinion, stable disease|1|||
33538064|NCT01367457|62927845|FG001|Overall Study|Investigator's opinion, stable disease|0|||
33538065|NCT01367457|62927846|FG002|Overall Study|Investigator's opinion, stable disease|0|||
33538066|NCT01367457|62927844|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
33538067|NCT01367457|62927845|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
33538068|NCT01367457|62927846|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
33538069|NCT01367457|62927844|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
33538070|NCT01367457|62927845|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
33538071|NCT01367457|62927846|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
33538072|NCT01367457|62927844|FG000|Overall Study|low grade toxicities + stable disease|1|||
33538073|NCT01367457|62927845|FG001|Overall Study|low grade toxicities + stable disease|0|||
33538074|NCT01367457|62927846|FG002|Overall Study|low grade toxicities + stable disease|0|||
33538075|NCT01367457|62927844|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
33538076|NCT01367457|62927845|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
33538077|NCT01367457|62927846|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
33538078|NCT01367457|62927844|FG000|Overall Study|Withdrawal by Subject|1|||
33538079|NCT01367457|62927845|FG001|Overall Study|Withdrawal by Subject|0|||
33538080|NCT01367457|62927846|FG002|Overall Study|Withdrawal by Subject|0|||
33538081|NCT01367457|62927844|FG000|Overall Study|CD, associated leukaemia|1|||
33538082|NCT01367457|62927845|FG001|Overall Study|CD, associated leukaemia|0|||
33538083|NCT01367457|62927846|FG002|Overall Study|CD, associated leukaemia|0|||
33538084|NCT01367457|62927844|FG000|Overall Study|Uncontrolled pain|1|||
33538085|NCT01367457|62927845|FG001|Overall Study|Uncontrolled pain|0|||
33538086|NCT01367457|62927846|FG002|Overall Study|Uncontrolled pain|0|||
33538087|NCT01367457|62927844|FG000|Overall Study|Overall status worsens to grade 4|1|||
33538088|NCT01367457|62927845|FG001|Overall Study|Overall status worsens to grade 4|0|||
33538089|NCT01367457|62927846|FG002|Overall Study|Overall status worsens to grade 4|0|||
33538090|NCT01367457|62927844|FG000|Overall Study|Stabilisation + frequent infections|1|||
33538091|NCT01367457|62927845|FG001|Overall Study|Stabilisation + frequent infections|0|||
33538092|NCT01367457|62927846|FG002|Overall Study|Stabilisation + frequent infections|0|||
33538093|NCT01367457|62927844|FG000|Overall Study|No clinical benefit|1|||
33538094|NCT01367457|62927845|FG001|Overall Study|No clinical benefit|0|||
33538095|NCT01367457|62927846|FG002|Overall Study|No clinical benefit|0|||
33538096|NCT01367457|62927844|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
33538097|NCT01367457|62927845|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
33538098|NCT01367457|62927846|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
33538099|NCT01367457|62927844|FG000|Overall Study|Overall decline|1|||
33538100|NCT01367457|62927845|FG001|Overall Study|Overall decline|0|||
33538101|NCT01367457|62927846|FG002|Overall Study|Overall decline|0|||
33538102|NCT01367457|62927844|FG000|Overall Study|Rejection of treatment|1|||
33538103|NCT01367457|62927845|FG001|Overall Study|Rejection of treatment|0|||
33538104|NCT01367457|62927846|FG002|Overall Study|Rejection of treatment|0|||
33538105|NCT01367457|62927844|FG000|Overall Study|Lost to Follow-up|1|||
33538106|NCT01367457|62927845|FG001|Overall Study|Lost to Follow-up|0|||
33538107|NCT01367457|62927846|FG002|Overall Study|Lost to Follow-up|0|||
33538108|NCT01367457|62927844|FG000|Overall Study|Death from septic shock|1|||
33538109|NCT01367457|62927845|FG001|Overall Study|Death from septic shock|0|||
33538110|NCT01367457|62927846|FG002|Overall Study|Death from septic shock|0|||
33631224|NCT01933880|63032853|FG001|Overall Study|Protocol Violation|0|||
33631225|NCT02008877|63032864|FG000|Overall Study|Inevaluable|0|||
33631226|NCT02008877|63032865|FG001|Overall Study|Inevaluable|1|||
33631227|NCT02008877|63032866|FG002|Overall Study|Inevaluable|0|||
33631228|NCT01933334|63032877|FG000|Overall Study|Adverse Event|5|||
33631229|NCT01933334|63032878|FG001|Overall Study|Adverse Event|1|||
33631230|NCT01933334|63032877|FG000|Overall Study|Withdrawal by Subject|0|||
33631231|NCT01933334|63032878|FG001|Overall Study|Withdrawal by Subject|1|||
33631232|NCT01908140|63032886|FG000|Overall Study|Other or Progressive Disease|5|||
33631233|NCT01908140|63032887|FG001|Overall Study|Other or Progressive Disease|12|||
33631234|NCT01908140|63032886|FG000|Overall Study|Lack of Efficacy|7|||
33461397|NCT02971683|62834686|FG001|Overall Study|Lost to Follow-up|0|||
33461398|NCT02971683|62834685|FG000|Overall Study|Participant withdrew consent|1|||
33461399|NCT02971683|62834686|FG001|Overall Study|Participant withdrew consent|1|||
33461400|NCT02971683|62834685|FG000|Overall Study|Participant request to discontinue study treatment|1|||
33461401|NCT02971683|62834686|FG001|Overall Study|Participant request to discontinue study treatment|1|||
33461402|NCT02971683|62834685|FG000|Overall Study|Adverse Event|1|||
33461403|NCT02971683|62834686|FG001|Overall Study|Adverse Event|2|||
33461404|NCT02971683|62834685|FG000|Overall Study|Lack of Efficacy|2|||
33538111|NCT01367457|62927844|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
33538112|NCT01367457|62927845|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
33538113|NCT01367457|62927846|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
33538114|NCT01367457|62927844|FG000|Overall Study|Patient's Wish|1|||
33538115|NCT01367457|62927845|FG001|Overall Study|Patient's Wish|0|||
33538116|NCT01367457|62927846|FG002|Overall Study|Patient's Wish|0|||
33538117|NCT01367457|62927844|FG000|Overall Study|Palliative. Overall decline|1|||
33538118|NCT01367457|62927845|FG001|Overall Study|Palliative. Overall decline|0|||
33538119|NCT01367457|62927846|FG002|Overall Study|Palliative. Overall decline|0|||
33538120|NCT01367457|62927844|FG000|Overall Study|Suspected DP/suspected active infection|1|||
33538121|NCT01367457|62927845|FG001|Overall Study|Suspected DP/suspected active infection|0|||
33538122|NCT01367457|62927846|FG002|Overall Study|Suspected DP/suspected active infection|0|||
33538123|NCT00235326|62927856|FG000|Overall Study|Lost to Follow-up|746|||
33538124|NCT00235326|62927857|FG001|Overall Study|Lost to Follow-up|1400|||
33538125|NCT00162942|62927867|FG000|Overall Study|Adverse Event|10|||
33538126|NCT00162942|62927868|FG001|Overall Study|Adverse Event|6|||
33538127|NCT00162942|62927867|FG000|Overall Study|Death|1|||
33538128|NCT00162942|62927868|FG001|Overall Study|Death|0|||
33538129|NCT00162942|62927867|FG000|Overall Study|Withdrawal by Subject|3|||
33538130|NCT00162942|62927868|FG001|Overall Study|Withdrawal by Subject|6|||
33538131|NCT00162942|62927867|FG000|Overall Study|Physician Decision|1|||
33538132|NCT00162942|62927868|FG001|Overall Study|Physician Decision|0|||
33538133|NCT00162942|62927867|FG000|Overall Study|Enter Open-Label Study|76|||
33538134|NCT00162942|62927868|FG001|Overall Study|Enter Open-Label Study|35|||
33538135|NCT00162942|62927867|FG000|Overall Study|Alternate Therapy|6|||
33538136|NCT00162942|62927868|FG001|Overall Study|Alternate Therapy|2|||
33538137|NCT00162942|62927867|FG000|Overall Study|Lack of Efficacy|1|||
33538138|NCT00162942|62927868|FG001|Overall Study|Lack of Efficacy|0|||
33538139|NCT00162942|62927867|FG000|Overall Study|Flare During Active Treatment|7|||
33538140|NCT00162942|62927868|FG001|Overall Study|Flare During Active Treatment|3|||
33538141|NCT00162942|62927867|FG000|Overall Study|2 or more consecutive treatments missed|1|||
33538142|NCT00162942|62927868|FG001|Overall Study|2 or more consecutive treatments missed|0|||
33538143|NCT02786901|62927898|FG000|Overall Study|Adverse Event|1|||
33538144|NCT02786901|62927899|FG001|Overall Study|Adverse Event|1|||
33538145|NCT02786901|62927900|FG002|Overall Study|Adverse Event|2|||
33538146|NCT02786901|62927898|FG000|Overall Study|Physician Decision|1|||
33538147|NCT02786901|62927899|FG001|Overall Study|Physician Decision|0|||
33538148|NCT02786901|62927900|FG002|Overall Study|Physician Decision|0|||
33538149|NCT02786901|62927898|FG000|Overall Study|Rescue Therapy Use|71|||
33538150|NCT02786901|62927899|FG001|Overall Study|Rescue Therapy Use|49|||
33538151|NCT02786901|62927900|FG002|Overall Study|Rescue Therapy Use|33|||
33538152|NCT02786901|62927898|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
33538153|NCT02786901|62927899|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
33538154|NCT02786901|62927900|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
33538155|NCT02786901|62927898|FG000|Overall Study|Disallowed medication|1|||
33538156|NCT02786901|62927899|FG001|Overall Study|Disallowed medication|1|||
33538157|NCT02786901|62927900|FG002|Overall Study|Disallowed medication|0|||
33631235|NCT01908140|63032887|FG001|Overall Study|Lack of Efficacy|5|||
33538158|NCT02786901|62927898|FG000|Overall Study|Randomized in error|2|||
33538159|NCT02786901|62927899|FG001|Overall Study|Randomized in error|0|||
33538160|NCT02786901|62927900|FG002|Overall Study|Randomized in error|1|||
33538161|NCT02137239|62927910|FG000|Overall Study|Discontinued Study Treatment|0|||
33538162|NCT02137239|62927911|FG001|Overall Study|Discontinued Study Treatment|3|||
33538163|NCT02137239|62927910|FG000|Overall Study|Withdrew Consent|1|||
33631236|NCT01908140|63032886|FG000|Overall Study|Withdrawal by Subject|23|||
33538164|NCT02137239|62927911|FG001|Overall Study|Withdrew Consent|1|||
33538165|NCT02137239|62927910|FG000|Overall Study|Adverse Event|2|||
33538166|NCT02137239|62927911|FG001|Overall Study|Adverse Event|2|||
33631237|NCT01908140|63032887|FG001|Overall Study|Withdrawal by Subject|24|||
33631238|NCT01908140|63032886|FG000|Overall Study|Lost to Follow-up|1|||
33631239|NCT01908140|63032887|FG001|Overall Study|Lost to Follow-up|6|||
33631240|NCT01908140|63032886|FG000|Overall Study|Protocol Violation|8|||
33631241|NCT01908140|63032887|FG001|Overall Study|Protocol Violation|9|||
33631242|NCT01908140|63032886|FG000|Overall Study|Adverse Event|22|||
33538167|NCT02741076|62927930|FG000|Overall Study|Adverse Event|0|||
33538168|NCT02741076|62927931|FG001|Overall Study|Adverse Event|1|||
33538169|NCT02741076|62927932|FG002|Overall Study|Adverse Event|1|||
33538170|NCT02741076|62927933|FG003|Overall Study|Adverse Event|0|||
33538171|NCT02741076|62927930|FG000|Overall Study|Lack of Efficacy|1|||
33538172|NCT02741076|62927931|FG001|Overall Study|Lack of Efficacy|0|||
33538173|NCT02741076|62927932|FG002|Overall Study|Lack of Efficacy|0|||
33538174|NCT02741076|62927933|FG003|Overall Study|Lack of Efficacy|0|||
33538175|NCT02741076|62927930|FG000|Overall Study|Withdrawal by Subject|0|||
33538176|NCT02741076|62927931|FG001|Overall Study|Withdrawal by Subject|1|||
33538177|NCT02741076|62927932|FG002|Overall Study|Withdrawal by Subject|0|||
33538178|NCT02741076|62927933|FG003|Overall Study|Withdrawal by Subject|0|||
33538179|NCT02741076|62927930|FG000|Overall Study|Sponsor Request|2|||
33538180|NCT02741076|62927931|FG001|Overall Study|Sponsor Request|3|||
33538181|NCT02741076|62927932|FG002|Overall Study|Sponsor Request|0|||
33538182|NCT02741076|62927933|FG003|Overall Study|Sponsor Request|1|||
33538183|NCT02741076|62927930|FG000|Overall Study|No additional information available|0|||
33538184|NCT02741076|62927931|FG001|Overall Study|No additional information available|0|||
33538185|NCT02741076|62927932|FG002|Overall Study|No additional information available|1|||
33538186|NCT02741076|62927933|FG003|Overall Study|No additional information available|1|||
33538187|NCT01666444|62927946|FG000|Overall Study|Did not initiate treatment|2|||
33538188|NCT01666444|62927947|FG001|Overall Study|Did not initiate treatment|1|||
33538189|NCT05159622|62927955|FG000|Overall Study|Lost to Follow-up|4|||
33538190|NCT05159622|62927956|FG001|Overall Study|Lost to Follow-up|5|||
33538191|NCT01665430|62927968|FG000|Overall Study|Adverse Event|1|||
33538192|NCT01665430|62927968|FG000|Overall Study|Withdrawal by Subject|6|||
33538193|NCT01665430|62927968|FG000|Overall Study|Other Unspecified|2|||
33538194|NCT02739594|62927974|FG000|Overall Study|Undesired Event|3|||
33538195|NCT02739594|62927975|FG001|Overall Study|Undesired Event|4|||
33538196|NCT02739594|62927974|FG000|Overall Study|Violation of Eligibility Criteria|1|||
33538197|NCT02739594|62927975|FG001|Overall Study|Violation of Eligibility Criteria|2|||
33538198|NCT02739594|62927974|FG000|Overall Study|Protocol Violation|5|||
33538199|NCT02739594|62927975|FG001|Overall Study|Protocol Violation|6|||
33538200|NCT02739594|62927974|FG000|Overall Study|Death|4|||
33538201|NCT02739594|62927975|FG001|Overall Study|Death|2|||
33538202|NCT02739594|62927974|FG000|Overall Study|Renal Insufficiency|4|||
33538203|NCT02739594|62927975|FG001|Overall Study|Renal Insufficiency|6|||
33538204|NCT02739594|62927974|FG000|Overall Study|Administrative Reasons|1|||
33538205|NCT02739594|62927975|FG001|Overall Study|Administrative Reasons|3|||
33538206|NCT02739594|62927974|FG000|Overall Study|Withdrawal by Subject|1|||
33538207|NCT02739594|62927975|FG001|Overall Study|Withdrawal by Subject|1|||
33538208|NCT02739594|62927974|FG000|Overall Study|Lost to Follow-up|0|||
33538209|NCT02739594|62927975|FG001|Overall Study|Lost to Follow-up|1|||
33538210|NCT02739594|62927974|FG000|Overall Study|Elevated Serum Creatinine|0|||
33538211|NCT02739594|62927975|FG001|Overall Study|Elevated Serum Creatinine|1|||
33538212|NCT02739594|62927974|FG000|Overall Study|Other|6|||
33538213|NCT02739594|62927975|FG001|Overall Study|Other|2|||
33538214|NCT03989232|62927984|FG000|Overall Study|Lost to Follow-up|3|||
33538215|NCT03989232|62927985|FG001|Overall Study|Lost to Follow-up|10|||
33538216|NCT03989232|62927984|FG000|Overall Study|Withdrawal by Subject|6|||
33538217|NCT03989232|62927985|FG001|Overall Study|Withdrawal by Subject|6|||
33538218|NCT03989232|62927984|FG000|Overall Study|Death|1|||
33538219|NCT03989232|62927985|FG001|Overall Study|Death|2|||
33538220|NCT02585830|62927991|FG000|Overall Study|Withdrawal by Subject|3|||
33538221|NCT02584504|62927998|FG000|Double-blind Treatment|Participant withdrew consent|0|||
33538222|NCT02584504|62927999|FG001|Double-blind Treatment|Participant withdrew consent|0|||
33538223|NCT02584504|62928000|FG002|Double-blind Treatment|Participant withdrew consent|1|||
33538224|NCT02584504|62927998|FG000|Double-blind Treatment|Adverse Event|0|||
33538225|NCT02584504|62927999|FG001|Double-blind Treatment|Adverse Event|1|||
33631243|NCT01908140|63032887|FG001|Overall Study|Adverse Event|23|||
33538226|NCT02584504|62928000|FG002|Double-blind Treatment|Adverse Event|0|||
33538227|NCT02584504|62927998|FG000|Double-blind Treatment|Family Matter|0|||
33538228|NCT02584504|62927999|FG001|Double-blind Treatment|Family Matter|1|||
33538229|NCT02584504|62928000|FG002|Double-blind Treatment|Family Matter|0|||
33538230|NCT02584504|62927998|FG000|Open-label Treatment|Participant withdrew consent|0|||
33538231|NCT02584504|62927999|FG001|Open-label Treatment|Participant withdrew consent|0|||
33538232|NCT02584504|62928000|FG002|Open-label Treatment|Participant withdrew consent|4|||
33538233|NCT02584504|62927998|FG000|Open-label Treatment|Adverse Event|2|||
33538234|NCT02584504|62927999|FG001|Open-label Treatment|Adverse Event|2|||
33538235|NCT02584504|62928000|FG002|Open-label Treatment|Adverse Event|3|||
33538236|NCT02584504|62927998|FG000|Open-label Treatment|Physician Decision|0|||
33631244|NCT02008565|63032897|FG000|Overall Study|Protocol Violation|1|||
33631245|NCT02008565|63032898|FG001|Overall Study|Protocol Violation|1|||
33631246|NCT02008565|63032899|FG002|Overall Study|Protocol Violation|2|||
33631247|NCT02008565|63032900|FG003|Overall Study|Protocol Violation|0|||
33631248|NCT01907906|63032914|FG000|Overall Study|Withdrawal by Subject|1|||
33631249|NCT01907906|63032915|FG001|Overall Study|Withdrawal by Subject|0|||
33631250|NCT01907906|63032914|FG000|Overall Study|Physician Decision|3|||
33631251|NCT01907906|63032915|FG001|Overall Study|Physician Decision|1|||
33631252|NCT01907828|63032925|FG000|Overall Study|Exclusion criteria not met|0|||
33631253|NCT01907828|63032926|FG001|Overall Study|Exclusion criteria not met|1|||
33631254|NCT01907828|63032925|FG000|Overall Study|Withdrawal by Subject|3|||
33631255|NCT01907828|63032926|FG001|Overall Study|Withdrawal by Subject|4|||
33631256|NCT01907828|63032925|FG000|Overall Study|Lost to Follow-up|3|||
33631257|NCT01907828|63032926|FG001|Overall Study|Lost to Follow-up|0|||
33631258|NCT01907828|63032925|FG000|Overall Study|Participant refused 24-month follow-up|1|||
33631259|NCT01907828|63032926|FG001|Overall Study|Participant refused 24-month follow-up|0|||
33631260|NCT01907828|63032925|FG000|Overall Study|Participant met exclusion criteria|0|||
33631261|NCT01907828|63032926|FG001|Overall Study|Participant met exclusion criteria|1|||
33631262|NCT01907516|63032934|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
33631263|NCT01907516|63032935|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
33631264|NCT01907516|63032934|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
33631265|NCT01907516|63032935|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
33631266|NCT01907516|63032934|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
33631267|NCT01907516|63032935|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
33631268|NCT01907516|63032934|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
33631269|NCT01907516|63032935|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
33631270|NCT01931462|63032942|FG000|Overall Study|Withdrawal by Subject|1|||
33631271|NCT01931150|63032948|FG000|Overall Study|Withdrawal by Subject|1|||
33631272|NCT01931150|63032949|FG001|Overall Study|Withdrawal by Subject|2|||
33631273|NCT01930214|63032958|FG000|Overall Study|Death|4|||
33631274|NCT01930214|63032959|FG001|Overall Study|Death|4|||
33631275|NCT01930214|63032960|FG002|Overall Study|Death|11|||
33631276|NCT01930214|63032958|FG000|Overall Study|Lost to Follow-up|12|||
33631277|NCT01930214|63032959|FG001|Overall Study|Lost to Follow-up|13|||
33631278|NCT01930214|63032960|FG002|Overall Study|Lost to Follow-up|12|||
33631279|NCT01930214|63032958|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
33631280|NCT01930214|63032959|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
33631281|NCT01930214|63032960|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
33631282|NCT01930214|63032958|FG000|Overall Study|Physician Decision|2|||
33631283|NCT01930214|63032959|FG001|Overall Study|Physician Decision|0|||
33631284|NCT01930214|63032960|FG002|Overall Study|Physician Decision|0|||
33631285|NCT01958294|63032968|FG000|Overall Study|Clinical Circumstances|2|||
33631286|NCT01906346|63032972|FG000|Overall Study|AEs|1|||
33631287|NCT01958060|63032984|FG000|Overall Study|Not treated|2|||
33631288|NCT01958060|63032985|FG001|Overall Study|Not treated|0|||
33631289|NCT01958060|63032986|FG002|Overall Study|Not treated|0|||
33631290|NCT01958060|63032987|FG003|Overall Study|Not treated|0|||
33631291|NCT01958060|63032988|FG004|Overall Study|Not treated|1|||
33631292|NCT01958060|63032989|FG005|Overall Study|Not treated|0|||
33631293|NCT01929980|63033008|FG000|Overall Study|Physician Decision|1|||
33631294|NCT01363076|63033014|FG000|Overall Study|Withdrawal by Subject|0|||
33538237|NCT02584504|62927999|FG001|Open-label Treatment|Physician Decision|1|||
33538238|NCT02584504|62928000|FG002|Open-label Treatment|Physician Decision|0|||
33538239|NCT02584504|62927998|FG000|Open-label Treatment|Entered but not treated|0|||
33538240|NCT02584504|62927999|FG001|Open-label Treatment|Entered but not treated|1|||
33538241|NCT02584504|62928000|FG002|Open-label Treatment|Entered but not treated|1|||
33538242|NCT04354155|62928025|FG000|Overall Study|Withdrawal by Subject|1|||
33538243|NCT04354155|62928025|FG000|Overall Study|Did not meet criteria for study intervention|1|||
33538244|NCT02586064|62928031|FG000|Overall Study|Other Obligations|6|||
33538245|NCT02586064|62928032|FG001|Overall Study|Other Obligations|6|||
33538246|NCT02586064|62928031|FG000|Overall Study|Other|3|||
33538247|NCT02586064|62928032|FG001|Overall Study|Other|7|||
33538248|NCT02586064|62928031|FG000|Overall Study|Never Started|3|||
33538249|NCT02586064|62928032|FG001|Overall Study|Never Started|3|||
33538250|NCT02586064|62928031|FG000|Overall Study|Lost Interest|1|||
33631295|NCT01363076|63033015|FG001|Overall Study|Withdrawal by Subject|1|||
33631296|NCT01929044|63033023|FG000|Overall Study|Adverse Event|1|||
33631297|NCT01929044|63033024|FG001|Overall Study|Adverse Event|0|||
33631298|NCT01929044|63033023|FG000|Overall Study|Protocol Violation|9|||
33631299|NCT01929044|63033024|FG001|Overall Study|Protocol Violation|14|||
33538251|NCT02586064|62928032|FG001|Overall Study|Lost Interest|4|||
33631300|NCT01929044|63033023|FG000|Overall Study|Not Treated|1|||
33631301|NCT01929044|63033024|FG001|Overall Study|Not Treated|3|||
33631302|NCT01903460|63033034|FG000|Overall Study|Adverse Event|0|||
33631303|NCT01903460|63033035|FG001|Overall Study|Adverse Event|0|||
33631304|NCT01903460|63033036|FG002|Overall Study|Adverse Event|0|||
33631305|NCT01903460|63033037|FG003|Overall Study|Adverse Event|1|||
33631306|NCT01957202|63033046|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33631307|NCT01957202|63033047|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
33631308|NCT01957202|63033048|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33631309|NCT01957202|63033049|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33461405|NCT02971683|62834686|FG001|Overall Study|Lack of Efficacy|2|||
33461406|NCT02949219|62834692|FG000|Overall Study|Withdrawal by Subject|1|||
33461407|NCT02899299|62834698|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
33538252|NCT02586064|62928031|FG000|Overall Study|Miscellaneous Life Issues|0|||
33538253|NCT02586064|62928032|FG001|Overall Study|Miscellaneous Life Issues|5|||
33538254|NCT02586064|62928031|FG000|Overall Study|Infrequent Attendance|2|||
33538255|NCT02586064|62928032|FG001|Overall Study|Infrequent Attendance|1|||
33538256|NCT02586064|62928031|FG000|Overall Study|Timed Out|2|||
33538257|NCT02586064|62928032|FG001|Overall Study|Timed Out|0|||
33538258|NCT02586064|62928031|FG000|Overall Study|AUD relapse|0|||
33538259|NCT02586064|62928032|FG001|Overall Study|AUD relapse|2|||
33538260|NCT02586064|62928031|FG000|Overall Study|Legal Issue|1|||
33538261|NCT02586064|62928032|FG001|Overall Study|Legal Issue|0|||
33538262|NCT03810495|62928041|FG000|Overall Study|Lost to Follow-up|2|||
33538263|NCT03810495|62928041|FG000|Overall Study|Withdrawal by Subject|1|||
33461408|NCT02899299|62834699|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
33461409|NCT02899299|62834698|FG000|Pre-treatment|Participant withdrew consent|1|||
33461410|NCT02899299|62834699|FG001|Pre-treatment|Participant withdrew consent|11|||
33461411|NCT02899299|62834698|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
33461412|NCT02899299|62834699|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
33538264|NCT02782923|62928045|FG000|Overall Study|Lost to Follow-up|15|||
33538265|NCT03760458|62928054|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
33538266|NCT03760458|62928055|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
33538267|NCT03760458|62928056|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
33538268|NCT03760458|62928057|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
33538269|NCT03760458|62928058|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
33538270|NCT02066415|62928073|FG000|Overall Study|Decision by Sponsor|5|||
33538271|NCT02066415|62928074|FG001|Overall Study|Decision by Sponsor|4|||
33538272|NCT02066415|62928075|FG002|Overall Study|Decision by Sponsor|2|||
33538273|NCT02066415|62928073|FG000|Overall Study|Withdrawal by Subject|9|||
33538274|NCT02066415|62928074|FG001|Overall Study|Withdrawal by Subject|1|||
33538275|NCT02066415|62928075|FG002|Overall Study|Withdrawal by Subject|4|||
33538276|NCT02066415|62928073|FG000|Overall Study|Lost to Follow-up|7|||
33538277|NCT02066415|62928074|FG001|Overall Study|Lost to Follow-up|2|||
33538278|NCT02066415|62928075|FG002|Overall Study|Lost to Follow-up|2|||
33538279|NCT02583256|62928087|FG000|Overall Study|Withdrawal by Subject|0|||
33538280|NCT02583256|62928088|FG001|Overall Study|Withdrawal by Subject|1|||
33538281|NCT02583256|62928089|FG002|Overall Study|Withdrawal by Subject|1|||
33538282|NCT02583256|62928090|FG003|Overall Study|Withdrawal by Subject|0|||
33538283|NCT02583256|62928087|FG000|Overall Study|Lost to Follow-up|1|||
33538284|NCT02583256|62928088|FG001|Overall Study|Lost to Follow-up|1|||
33538285|NCT02583256|62928089|FG002|Overall Study|Lost to Follow-up|0|||
33538286|NCT02583256|62928090|FG003|Overall Study|Lost to Follow-up|1|||
33538287|NCT02583256|62928087|FG000|Overall Study|Administrative/Other|2|||
33538288|NCT02583256|62928088|FG001|Overall Study|Administrative/Other|0|||
33538289|NCT02583256|62928089|FG002|Overall Study|Administrative/Other|1|||
33538290|NCT02583256|62928090|FG003|Overall Study|Administrative/Other|2|||
33538291|NCT01981551|62928111|FG000|Overall Study|Refused further treatment|8|||
33538292|NCT01981551|62928111|FG000|Overall Study|Adverse Event|1|||
33538293|NCT02584660|62928117|FG000|Overall Study|Adverse Event|4|||
33538294|NCT02584660|62928118|FG001|Overall Study|Adverse Event|0|||
33538295|NCT02584660|62928117|FG000|Overall Study|Lost to Follow-up|3|||
33538296|NCT02584660|62928118|FG001|Overall Study|Lost to Follow-up|4|||
33538297|NCT02584660|62928117|FG000|Overall Study|Protocol Violation|0|||
33538298|NCT02584660|62928118|FG001|Overall Study|Protocol Violation|1|||
33538299|NCT02584660|62928117|FG000|Overall Study|Withdrawal by Subject|0|||
33538300|NCT02584660|62928118|FG001|Overall Study|Withdrawal by Subject|2|||
33538301|NCT02584660|62928117|FG000|Overall Study|Other|0|||
33538302|NCT02584660|62928118|FG001|Overall Study|Other|1|||
33538303|NCT02582632|62928140|FG000|Overall Study|Other|1|||
33538304|NCT02178722|62928149|FG000|Overall Study|Withdrawal by Subject|0|||
33538305|NCT02178722|62928150|FG001|Overall Study|Withdrawal by Subject|0|||
33538306|NCT02178722|62928151|FG002|Overall Study|Withdrawal by Subject|0|||
33538307|NCT02178722|62928152|FG003|Overall Study|Withdrawal by Subject|2|||
33538308|NCT02178722|62928153|FG004|Overall Study|Withdrawal by Subject|33|||
33538309|NCT02178722|62928149|FG000|Overall Study|Death|2|||
33538310|NCT02178722|62928150|FG001|Overall Study|Death|13|||
33538311|NCT02178722|62928151|FG002|Overall Study|Death|12|||
33538312|NCT02178722|62928152|FG003|Overall Study|Death|12|||
33538313|NCT02178722|62928153|FG004|Overall Study|Death|205|||
33631310|NCT01957202|63033050|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33538314|NCT02178722|62928149|FG000|Overall Study|Lost to Follow-up|0|||
33538315|NCT02178722|62928150|FG001|Overall Study|Lost to Follow-up|0|||
33631311|NCT01957202|63033051|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33631312|NCT01957202|63033052|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33631313|NCT01957202|63033053|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33631314|NCT01957202|63033054|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33631315|NCT01957202|63033055|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33631316|NCT01957202|63033056|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33631317|NCT01957202|63033057|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33631318|NCT01957202|63033058|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33631319|NCT01957202|63033059|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33631320|NCT01957202|63033060|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33631321|NCT01957202|63033061|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33631322|NCT01957202|63033062|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
33631323|NCT01957202|63033063|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33631324|NCT01957202|63033046|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631325|NCT01957202|63033047|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631326|NCT01957202|63033048|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631327|NCT01957202|63033049|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631328|NCT01957202|63033050|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631329|NCT01957202|63033051|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631330|NCT01957202|63033052|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631331|NCT01957202|63033053|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631332|NCT01957202|63033054|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631333|NCT01957202|63033055|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631334|NCT01957202|63033056|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631335|NCT01957202|63033057|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631336|NCT01957202|63033058|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631337|NCT01957202|63033059|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631338|NCT01957202|63033060|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631339|NCT01957202|63033061|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631340|NCT01957202|63033062|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
33631341|NCT01957202|63033063|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
33631342|NCT01616654|63033078|FG000|Overall Study|Lack of Efficacy|1|||
33631343|NCT01616654|63033079|FG001|Overall Study|Lack of Efficacy|0|||
33631344|NCT01616654|63033080|FG002|Overall Study|Lack of Efficacy|0|||
33631345|NCT01616654|63033081|FG003|Overall Study|Lack of Efficacy|0|||
33631346|NCT01616654|63033082|FG004|Overall Study|Lack of Efficacy|1|||
33631347|NCT01616654|63033078|FG000|Overall Study|Adverse Event|0|||
33631348|NCT01616654|63033079|FG001|Overall Study|Adverse Event|1|||
33631349|NCT01616654|63033080|FG002|Overall Study|Adverse Event|2|||
33631350|NCT01616654|63033081|FG003|Overall Study|Adverse Event|1|||
33631351|NCT01616654|63033082|FG004|Overall Study|Adverse Event|0|||
33631352|NCT01616654|63033078|FG000|Overall Study|Withdrawal by Subject|2|||
33631353|NCT01616654|63033079|FG001|Overall Study|Withdrawal by Subject|2|||
33631354|NCT01616654|63033080|FG002|Overall Study|Withdrawal by Subject|3|||
33538316|NCT02178722|62928151|FG002|Overall Study|Lost to Follow-up|0|||
33538317|NCT02178722|62928152|FG003|Overall Study|Lost to Follow-up|2|||
33538318|NCT02178722|62928153|FG004|Overall Study|Lost to Follow-up|11|||
33538319|NCT02178722|62928149|FG000|Overall Study|Study terminated by Sponsor|2|||
33538320|NCT02178722|62928150|FG001|Overall Study|Study terminated by Sponsor|7|||
33538321|NCT02178722|62928151|FG002|Overall Study|Study terminated by Sponsor|6|||
33538322|NCT02178722|62928152|FG003|Overall Study|Study terminated by Sponsor|4|||
33538323|NCT02178722|62928153|FG004|Overall Study|Study terminated by Sponsor|128|||
33538324|NCT02178722|62928149|FG000|Overall Study|Physician Decision|0|||
33538325|NCT02178722|62928150|FG001|Overall Study|Physician Decision|0|||
33538326|NCT02178722|62928151|FG002|Overall Study|Physician Decision|0|||
33538327|NCT02178722|62928152|FG003|Overall Study|Physician Decision|0|||
33538328|NCT02178722|62928153|FG004|Overall Study|Physician Decision|3|||
33538329|NCT02178722|62928149|FG000|Overall Study|Other|0|||
33538330|NCT02178722|62928150|FG001|Overall Study|Other|0|||
33538331|NCT02178722|62928151|FG002|Overall Study|Other|0|||
33631355|NCT01616654|63033081|FG003|Overall Study|Withdrawal by Subject|1|||
33326240|NCT01110330|62703055|FG000|Overall Study|Protocol Violation|2|||
33538332|NCT02178722|62928152|FG003|Overall Study|Other|0|||
33538333|NCT02178722|62928153|FG004|Overall Study|Other|2|||
33538334|NCT00972309|62928170|FG000|Overall Study|Switched to alternative treatment|0|||
33631356|NCT01616654|63033082|FG004|Overall Study|Withdrawal by Subject|5|||
33538335|NCT00972309|62928171|FG001|Overall Study|Switched to alternative treatment|2|||
33538336|NCT00972309|62928170|FG000|Overall Study|Refused further treatment|0|||
33631357|NCT01616654|63033078|FG000|Overall Study|Protocol Violation|0|||
33631358|NCT01616654|63033079|FG001|Overall Study|Protocol Violation|5|||
33631359|NCT01616654|63033080|FG002|Overall Study|Protocol Violation|2|||
33631360|NCT01616654|63033081|FG003|Overall Study|Protocol Violation|4|||
33631361|NCT01616654|63033082|FG004|Overall Study|Protocol Violation|4|||
33631362|NCT01616654|63033078|FG000|Overall Study|Lost to Follow-up|1|||
33631363|NCT01616654|63033079|FG001|Overall Study|Lost to Follow-up|0|||
33631364|NCT01616654|63033080|FG002|Overall Study|Lost to Follow-up|3|||
33631365|NCT01616654|63033081|FG003|Overall Study|Lost to Follow-up|2|||
33631366|NCT01616654|63033082|FG004|Overall Study|Lost to Follow-up|1|||
33631367|NCT01616654|63033078|FG000|Overall Study|Pregnancy|1|||
33631368|NCT01616654|63033079|FG001|Overall Study|Pregnancy|0|||
33631369|NCT01616654|63033080|FG002|Overall Study|Pregnancy|0|||
33326241|NCT01110330|62703056|FG001|Overall Study|Protocol Violation|0|||
33538337|NCT00972309|62928171|FG001|Overall Study|Refused further treatment|1|||
33538338|NCT00972309|62928170|FG000|Overall Study|Late determination of ineligibility|0|||
33538339|NCT00972309|62928171|FG001|Overall Study|Late determination of ineligibility|1|||
33538340|NCT00972309|62928170|FG000|Overall Study|Second malignancy|1|||
33538341|NCT00972309|62928171|FG001|Overall Study|Second malignancy|1|||
33538342|NCT00972309|62928170|FG000|Overall Study|Visa issues|0|||
33538343|NCT00972309|62928171|FG001|Overall Study|Visa issues|1|||
33538344|NCT00972309|62928170|FG000|Overall Study|Secondary cancer (SCC)|0|||
33538345|NCT00972309|62928171|FG001|Overall Study|Secondary cancer (SCC)|1|||
33538346|NCT00972309|62928170|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
33538347|NCT00972309|62928171|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
33538348|NCT00972309|62928170|FG000|Overall Study|Lost to Follow-up|1|||
33538349|NCT00972309|62928171|FG001|Overall Study|Lost to Follow-up|1|||
33538350|NCT00972309|62928170|FG000|Overall Study|Disease progression on study|10|||
33538351|NCT00972309|62928171|FG001|Overall Study|Disease progression on study|4|||
33538352|NCT02582242|62928190|FG000|Overall Study|Adverse Event|4|||
33538353|NCT02582242|62928191|FG001|Overall Study|Adverse Event|3|||
33538354|NCT02582242|62928190|FG000|Overall Study|Protocol Violation|3|||
33326242|NCT01110330|62703057|FG002|Overall Study|Protocol Violation|4|||
33326243|NCT01110330|62703055|FG000|Overall Study|Withdrawal by Subject|0|||
33326244|NCT01110330|62703056|FG001|Overall Study|Withdrawal by Subject|6|||
33326245|NCT01110330|62703057|FG002|Overall Study|Withdrawal by Subject|2|||
33538355|NCT02582242|62928191|FG001|Overall Study|Protocol Violation|1|||
33631370|NCT01616654|63033081|FG003|Overall Study|Pregnancy|0|||
33631371|NCT01616654|63033082|FG004|Overall Study|Pregnancy|1|||
33631372|NCT01902290|63033097|FG000|Overall Study|Withdrawal by Subject|19|||
33631373|NCT01902290|63033098|FG001|Overall Study|Withdrawal by Subject|27|||
33631374|NCT01902290|63033097|FG000|Overall Study|Lost to Follow-up|2|||
33631375|NCT01902290|63033098|FG001|Overall Study|Lost to Follow-up|2|||
33631376|NCT01902290|63033097|FG000|Overall Study|Death|1|||
33631377|NCT01902290|63033098|FG001|Overall Study|Death|0|||
33631378|NCT01902290|63033097|FG000|Overall Study|Sponsor Decision|26|||
33631379|NCT01902290|63033098|FG001|Overall Study|Sponsor Decision|24|||
33631380|NCT01927562|63033105|FG000|Overall Study|Lost to Follow-up|30|||
33631381|NCT01927562|63033105|FG000|Overall Study|Withdrawal by Subject|3|||
33631382|NCT01927562|63033105|FG000|Overall Study|Physician Decision|5|||
33631383|NCT01467466|63033113|FG000|Overall Study|Withdrawal by Subject|15|||
33631384|NCT01467466|63033114|FG001|Overall Study|Withdrawal by Subject|18|||
33631385|NCT01467466|63033115|FG002|Overall Study|Withdrawal by Subject|13|||
33631386|NCT01467466|63033116|FG003|Overall Study|Withdrawal by Subject|11|||
33631387|NCT01467466|63033113|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
33631388|NCT01467466|63033114|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
33631389|NCT01467466|63033115|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
33631390|NCT01467466|63033116|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
33631391|NCT01467466|63033113|FG000|Overall Study|Procedure Cancelled|46|||
33631392|NCT01467466|63033114|FG001|Overall Study|Procedure Cancelled|45|||
33631393|NCT01467466|63033115|FG002|Overall Study|Procedure Cancelled|25|||
33631394|NCT01467466|63033116|FG003|Overall Study|Procedure Cancelled|29|||
33631395|NCT01467466|63033113|FG000|Overall Study|No Endpoint Blood Draw|38|||
33631396|NCT01467466|63033114|FG001|Overall Study|No Endpoint Blood Draw|32|||
33631397|NCT01467466|63033115|FG002|Overall Study|No Endpoint Blood Draw|51|||
33538356|NCT02582242|62928190|FG000|Overall Study|Lost to Follow-up|0|||
33538357|NCT02582242|62928191|FG001|Overall Study|Lost to Follow-up|1|||
33538358|NCT02582242|62928190|FG000|Overall Study|Withdrawal by Subject|11|||
33631398|NCT01467466|63033116|FG003|Overall Study|No Endpoint Blood Draw|43|||
33631399|NCT01441180|63033129|FG000|Overall Study|Lost to Follow-up|1|||
33631400|NCT01441180|63033130|FG001|Overall Study|Lost to Follow-up|1|||
33631401|NCT01441180|63033131|FG002|Overall Study|Lost to Follow-up|1|||
33631402|NCT01441180|63033129|FG000|Overall Study|Discontinued|0|||
33326246|NCT01110330|62703055|FG000|Overall Study|Other|1|||
33538359|NCT02582242|62928191|FG001|Overall Study|Withdrawal by Subject|11|||
33538360|NCT02582242|62928190|FG000|Overall Study|Unclassified|2|||
33631403|NCT01441180|63033130|FG001|Overall Study|Discontinued|0|||
33631404|NCT01441180|63033131|FG002|Overall Study|Discontinued|2|||
33631405|NCT01441102|63033142|FG000|Overall Study|Adverse Event|1|||
33631406|NCT01441102|63033142|FG000|Overall Study|Withdrawal by Subject|2|||
33538361|NCT02582242|62928191|FG001|Overall Study|Unclassified|1|||
33538362|NCT00663351|62928199|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
33538363|NCT00663351|62928200|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
33538364|NCT00663351|62928199|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
33538365|NCT00663351|62928200|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
33538366|NCT00663351|62928199|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
33538367|NCT00663351|62928200|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
33538368|NCT00663351|62928199|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
33538369|NCT00663351|62928200|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
33631407|NCT01467076|63033149|FG000|Overall Study|Lost to Follow-up|1|||
33631408|NCT01467076|63033150|FG001|Overall Study|Lost to Follow-up|0|||
33631409|NCT01467076|63033151|FG002|Overall Study|Lost to Follow-up|0|||
33538370|NCT00663351|62928199|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
33538371|NCT00663351|62928200|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
33538372|NCT00663351|62928199|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
33538373|NCT00663351|62928200|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
33538374|NCT00616941|62928209|FG000|Overall Study|Progressive Disease|1|||
33538375|NCT00616941|62928210|FG001|Overall Study|Progressive Disease|2|||
33538376|NCT00616941|62928211|FG002|Overall Study|Progressive Disease|1|||
33538377|NCT00616941|62928209|FG000|Overall Study|Adverse Event|0|||
33538378|NCT00616941|62928210|FG001|Overall Study|Adverse Event|1|||
33538379|NCT00616941|62928211|FG002|Overall Study|Adverse Event|1|||
33538380|NCT00616941|62928209|FG000|Overall Study|Subject Non-compliance|0|||
33538381|NCT00616941|62928210|FG001|Overall Study|Subject Non-compliance|0|||
33538382|NCT00616941|62928211|FG002|Overall Study|Subject Non-compliance|1|||
33538383|NCT00616941|62928209|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
33538384|NCT00616941|62928210|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
33538385|NCT00616941|62928211|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
33538386|NCT00616941|62928209|FG000|Overall Study|Vaccination Suspended|0|||
33538387|NCT00616941|62928210|FG001|Overall Study|Vaccination Suspended|0|||
33538388|NCT00616941|62928211|FG002|Overall Study|Vaccination Suspended|3|||
33538389|NCT00105560|62928219|FG000|Overall Study|Lost to Follow-up|1|||
33538390|NCT02577718|62928232|FG000|Overall Study|Death|6|||
33538391|NCT02577718|62928232|FG000|Overall Study|Withdrawal by Subject|2|||
33538392|NCT00520533|62928238|FG000|Overall Study|Death|1|||
33538393|NCT00520533|62928238|FG000|Overall Study|Suspension of the study for safety reasons|1|||
33538394|NCT00520533|62928238|FG000|Overall Study|Withdrawal by Subject|1|||
33538395|NCT00520533|62928238|FG000|Overall Study|Physician Decision|1|||
33538396|NCT01664104|62928247|FG000|Overall Study|Adverse Event|6|||
33538397|NCT01664104|62928247|FG000|Overall Study|Lack of Efficacy|2|||
33538398|NCT01664104|62928247|FG000|Overall Study|Withdrawal by Subject|1|||
33538399|NCT01664104|62928247|FG000|Overall Study|Lost to Follow-up|4|||
33538400|NCT01664104|62928247|FG000|Overall Study|Other|1|||
33538401|NCT01664104|62928247|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
33538402|NCT02739984|62928255|FG000|Overall Study|Sponsor Decision|1|||
33538403|NCT02739984|62928256|FG001|Overall Study|Sponsor Decision|0|||
33538404|NCT02739984|62928255|FG000|Overall Study|Withdrawal by Subject|1|||
33538405|NCT02739984|62928256|FG001|Overall Study|Withdrawal by Subject|1|||
33538406|NCT02739984|62928255|FG000|Overall Study|Death|0|||
33538407|NCT02739984|62928256|FG001|Overall Study|Death|1|||
33538408|NCT02739984|62928255|FG000|Overall Study|Lost to Follow-up|3|||
33538409|NCT02739984|62928256|FG001|Overall Study|Lost to Follow-up|0|||
33538410|NCT00496730|62928264|FG000|Overall Study|Lost to Follow-up|4|||
33538411|NCT00496730|62928265|FG001|Overall Study|Lost to Follow-up|3|||
33538412|NCT00496730|62928264|FG000|Overall Study|Withdrawal by Subject|2|||
33538413|NCT00496730|62928265|FG001|Overall Study|Withdrawal by Subject|2|||
33538414|NCT02739828|62928271|FG000|Overall Study|Adverse Event|1|||
33538415|NCT02739828|62928271|FG000|Overall Study|Lost to Follow-up|4|||
33538416|NCT04435808|62928277|FG000|Overall Study|Study stopped by DSMB|0|||
33538417|NCT04435808|62928278|FG001|Overall Study|Study stopped by DSMB|1|||
33538418|NCT01664494|62928301|FG000|Overall Study|Withdrawal by Subject|27|||
33538419|NCT01664494|62928301|FG000|Overall Study|Death|18|||
33538420|NCT01664494|62928301|FG000|Overall Study|Other|49|||
33538421|NCT01664494|62928301|FG000|Overall Study|Lost to Follow-up|99|||
33538422|NCT02577016|62928307|FG000|Overall Study|Adverse Event|2|||
33538423|NCT02577016|62928308|FG001|Overall Study|Adverse Event|1|||
33538424|NCT02577016|62928307|FG000|Overall Study|Physician Decision|0|||
33538425|NCT02577016|62928308|FG001|Overall Study|Physician Decision|1|||
33538426|NCT05101252|62928316|FG000|Overall Study|Unsatisfactory Test Article|1|||
33538427|NCT05101252|62928317|FG001|Overall Study|Unsatisfactory Test Article|0|||
33544249|NCT03012061|62935097|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
33544250|NCT03012061|62935098|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
33544251|NCT03012061|62935096|FG000|Overall Study|Protocol Violation|0|||
33544252|NCT03012061|62935097|FG001|Overall Study|Protocol Violation|0|||
33544253|NCT03012061|62935098|FG002|Overall Study|Protocol Violation|2|||
33631410|NCT01466062|63033159|FG000|Overall Study|Adverse Event|1|||
33631411|NCT01466062|63033159|FG000|Overall Study|Withdrawal by Subject|1|||
33631412|NCT01435018|63033166|FG000|Overall Study|Death|37|||
33631413|NCT01435018|63033167|FG001|Overall Study|Death|18|||
33631414|NCT01435018|63033168|FG002|Overall Study|Death|25|||
33631415|NCT01435018|63033166|FG000|Overall Study|Site is closing|4|||
33631416|NCT01435018|63033167|FG001|Overall Study|Site is closing|9|||
33631417|NCT01435018|63033168|FG002|Overall Study|Site is closing|7|||
33631418|NCT01435018|63033166|FG000|Overall Study|Withdrew consent|0|||
33631419|NCT01435018|63033167|FG001|Overall Study|Withdrew consent|3|||
33631420|NCT01435018|63033168|FG002|Overall Study|Withdrew consent|1|||
33631421|NCT01435018|63033166|FG000|Overall Study|Not willing to adhere to requirements|0|||
33631422|NCT01435018|63033167|FG001|Overall Study|Not willing to adhere to requirements|2|||
33631423|NCT01435018|63033168|FG002|Overall Study|Not willing to adhere to requirements|3|||
33631424|NCT01435018|63033166|FG000|Overall Study|Not able to get to clinic|2|||
33631425|NCT01435018|63033167|FG001|Overall Study|Not able to get to clinic|0|||
33631426|NCT01435018|63033168|FG002|Overall Study|Not able to get to clinic|2|||
33631427|NCT01435018|63033166|FG000|Overall Study|Severe debilitation, unable to continue|0|||
33631428|NCT01435018|63033167|FG001|Overall Study|Severe debilitation, unable to continue|0|||
33631429|NCT01435018|63033168|FG002|Overall Study|Severe debilitation, unable to continue|1|||
33631430|NCT01435018|63033166|FG000|Overall Study|Unable to contact participant/parent|1|||
33631431|NCT01435018|63033167|FG001|Overall Study|Unable to contact participant/parent|1|||
33631432|NCT01435018|63033168|FG002|Overall Study|Unable to contact participant/parent|1|||
33631433|NCT01435018|63033166|FG000|Overall Study|Enrollment Violation|0|||
33631434|NCT01435018|63033167|FG001|Overall Study|Enrollment Violation|1|||
33631435|NCT01435018|63033168|FG002|Overall Study|Enrollment Violation|0|||
33631436|NCT01435018|63033166|FG000|Overall Study|Never started chemotherapy|3|||
33631437|NCT01435018|63033167|FG001|Overall Study|Never started chemotherapy|0|||
33631438|NCT01435018|63033168|FG002|Overall Study|Never started chemotherapy|1|||
33631439|NCT01419184|63033180|FG000|Overall Study|Site data not available|3|||
33631440|NCT01419184|63033181|FG001|Overall Study|Site data not available|2|||
33631441|NCT01419184|63033180|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
33631442|NCT01419184|63033181|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
33631443|NCT01419184|63033180|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
33631444|NCT01419184|63033181|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
33631445|NCT01419184|63033180|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
33631446|NCT01419184|63033181|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
33631447|NCT01419184|63033180|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
33631448|NCT01419184|63033181|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
33631449|NCT01419184|63033180|FG000|Overall Study|Participant randomized, not treated|1|||
33631450|NCT01419184|63033181|FG001|Overall Study|Participant randomized, not treated|0|||
33631451|NCT01417234|63033187|FG000|Overall Study|Subject non-compliant|3|||
33631452|NCT01417156|63033191|FG000|Overall Study|Adverse Event|12|||
33631453|NCT01417156|63033191|FG000|Overall Study|Protocol Violation|2|||
33631454|NCT01417078|63033195|FG000|Overall Study|Withdrawal by Subject|1|||
33631455|NCT01954394|63033203|FG000|Overall Study|Enrolled but not treated|1|||
33631456|NCT01954394|63033204|FG001|Overall Study|Enrolled but not treated|0|||
33631457|NCT01954394|63033203|FG000|Overall Study|Adverse Event|10|||
33631458|NCT01954394|63033204|FG001|Overall Study|Adverse Event|23|||
33631459|NCT01954394|63033203|FG000|Overall Study|Poor compliance to protocol|7|||
33631460|NCT01954394|63033204|FG001|Overall Study|Poor compliance to protocol|7|||
33631461|NCT01954394|63033203|FG000|Overall Study|Participant Moved|0|||
33631462|NCT01954394|63033204|FG001|Overall Study|Participant Moved|4|||
33631463|NCT01954394|63033203|FG000|Overall Study|Related to Study Drug administration|2|||
33631464|NCT01954394|63033204|FG001|Overall Study|Related to Study Drug administration|2|||
33631465|NCT01954394|63033203|FG000|Overall Study|Other than specified above|10|||
33326247|NCT01110330|62703056|FG001|Overall Study|Other|1|||
33326248|NCT01110330|62703057|FG002|Overall Study|Other|1|||
33326249|NCT00596947|62703067|FG000|Overall Study|study halted due to low enrollment|5|||
33326250|NCT00596947|62703068|FG001|Overall Study|study halted due to low enrollment|3|||
33326251|NCT00596947|62703067|FG000|Overall Study|Lost to Follow-up|1|||
33326252|NCT00596947|62703068|FG001|Overall Study|Lost to Follow-up|0|||
33326253|NCT00888940|62703076|FG000|Overall Study|Adverse Event|12|||
33326254|NCT00888940|62703077|FG001|Overall Study|Adverse Event|3|||
33631466|NCT01954394|63033204|FG001|Overall Study|Other than specified above|21|||
33631467|NCT01464424|63033212|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
33631468|NCT01464424|63033213|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
33631469|NCT01902134|63033225|FG000|Overall Study|Adverse Event|3|||
33631470|NCT01902134|63033226|FG001|Overall Study|Adverse Event|1|||
33631471|NCT01902134|63033227|FG002|Overall Study|Adverse Event|2|||
33326255|NCT00888940|62703076|FG000|Overall Study|Lost to Follow-up|5|||
33326256|NCT00888940|62703077|FG001|Overall Study|Lost to Follow-up|5|||
33326257|NCT00888940|62703076|FG000|Overall Study|Randomized Not Treated|11|||
33631472|NCT01902134|63033228|FG003|Overall Study|Adverse Event|1|||
33631473|NCT01902134|63033229|FG004|Overall Study|Adverse Event|1|||
33631474|NCT01902134|63033230|FG005|Overall Study|Adverse Event|3|||
33631475|NCT01902134|63033225|FG000|Overall Study|Lack of Efficacy|0|||
33538428|NCT05101252|62928316|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
33538429|NCT05101252|62928317|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
33631476|NCT01902134|63033226|FG001|Overall Study|Lack of Efficacy|0|||
33631477|NCT01902134|63033227|FG002|Overall Study|Lack of Efficacy|2|||
33461413|NCT02899299|62834698|FG000|Pre-treatment|Not reported|0|||
33461414|NCT02899299|62834699|FG001|Pre-treatment|Not reported|1|||
33461415|NCT02899299|62834698|FG000|Treatment|Disease Progression|182|||
33461416|NCT02899299|62834699|FG001|Treatment|Disease Progression|44|||
33461417|NCT02899299|62834698|FG000|Treatment|Study Drug Toxicity|59|||
33461418|NCT02899299|62834699|FG001|Treatment|Study Drug Toxicity|24|||
33461419|NCT02899299|62834698|FG000|Treatment|Adverse Event unrelated to Study Drug|12|||
33461420|NCT02899299|62834699|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
33461421|NCT02899299|62834698|FG000|Treatment|Participant request to discontinue Study treatment|4|||
33461422|NCT02899299|62834699|FG001|Treatment|Participant request to discontinue Study treatment|10|||
33461423|NCT02899299|62834698|FG000|Treatment|Participant withdrew consent|6|||
33538430|NCT05101252|62928316|FG000|Overall Study|Withdrew Consent during study|0|||
33538431|NCT05101252|62928317|FG001|Overall Study|Withdrew Consent during study|1|||
33538432|NCT05101252|62928316|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
33538433|NCT05101252|62928317|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
33538434|NCT03316586|62928323|FG000|Overall Study|Adverse Event|2|||
33538435|NCT03316586|62928323|FG000|Overall Study|Physician Decision|3|||
33538436|NCT03316586|62928323|FG000|Overall Study|Lack of Efficacy|10|||
33538437|NCT03316586|62928323|FG000|Overall Study|still on treatment|1|||
33538438|NCT03316586|62928323|FG000|Overall Study|Patient needed radiation therapy|1|||
33538439|NCT03316586|62928323|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
33538440|NCT00107991|62928327|FG000|Eligibility Assessment|Disease not severe enough|7|||
33538441|NCT00107991|62928327|FG000|Eligibility Assessment|Unwilling to participate|7|||
33538442|NCT00107991|62928327|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
33538443|NCT00107991|62928327|FG000|Eligibility Assessment|Abnormal labs|2|||
33538444|NCT00107991|62928327|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
33538445|NCT00107991|62928327|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
33538446|NCT00107991|62928327|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
33538447|NCT00107991|62928327|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
33538448|NCT00107991|62928327|FG000|12 Week Treatment Period|Adverse Event|1|||
33538449|NCT00107991|62928327|FG000|12 Week Treatment Period|Protocol Violation|1|||
33538450|NCT00107991|62928327|FG000|12 Week Treatment Period|Incarcerated|1|||
33538451|NCT00107991|62928327|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
33538452|NCT00492856|62928331|FG000|Induction|Adverse Event|2|||
33538453|NCT00492856|62928332|FG001|Induction|Adverse Event|0|||
33538454|NCT00492856|62928333|FG002|Induction|Adverse Event|0|||
33538455|NCT00492856|62928334|FG003|Induction|Adverse Event|0|||
33538456|NCT00492856|62928331|FG000|Induction|Withdrawal by Subject|1|||
33538457|NCT00492856|62928332|FG001|Induction|Withdrawal by Subject|0|||
33538458|NCT00492856|62928333|FG002|Induction|Withdrawal by Subject|0|||
33538459|NCT00492856|62928334|FG003|Induction|Withdrawal by Subject|0|||
33538460|NCT00492856|62928331|FG000|Induction|Death|3|||
33538461|NCT00492856|62928332|FG001|Induction|Death|0|||
33538462|NCT00492856|62928333|FG002|Induction|Death|0|||
33538463|NCT00492856|62928334|FG003|Induction|Death|0|||
33538464|NCT00492856|62928331|FG000|Consolidation|Adverse Event|6|||
33538465|NCT00492856|62928332|FG001|Consolidation|Adverse Event|0|||
33538466|NCT00492856|62928333|FG002|Consolidation|Adverse Event|0|||
33538467|NCT00492856|62928334|FG003|Consolidation|Adverse Event|0|||
33461424|NCT02899299|62834699|FG001|Treatment|Participant withdrew consent|3|||
33461425|NCT02899299|62834698|FG000|Treatment|Lost to Follow-up|0|||
33461426|NCT02899299|62834699|FG001|Treatment|Lost to Follow-up|1|||
33538468|NCT00492856|62928331|FG000|Consolidation|Not protocol specified|2|||
33538469|NCT00492856|62928332|FG001|Consolidation|Not protocol specified|0|||
33538470|NCT00492856|62928333|FG002|Consolidation|Not protocol specified|0|||
33538471|NCT00492856|62928334|FG003|Consolidation|Not protocol specified|0|||
33631478|NCT01902134|63033228|FG003|Overall Study|Lack of Efficacy|0|||
33631479|NCT01902134|63033229|FG004|Overall Study|Lack of Efficacy|0|||
33631480|NCT01902134|63033230|FG005|Overall Study|Lack of Efficacy|1|||
33631481|NCT01902134|63033225|FG000|Overall Study|Physician Decision|0|||
33461427|NCT02899299|62834698|FG000|Treatment|Maximum Clinical Benefit|10|||
33461428|NCT02899299|62834699|FG001|Treatment|Maximum Clinical Benefit|2|||
33461429|NCT02899299|62834698|FG000|Treatment|Poor/Non-compliance|1|||
33461430|NCT02899299|62834699|FG001|Treatment|Poor/Non-compliance|0|||
33461431|NCT02899299|62834698|FG000|Treatment|Participant no longer meets Study criteria|4|||
33461432|NCT02899299|62834699|FG001|Treatment|Participant no longer meets Study criteria|0|||
33461433|NCT02899299|62834698|FG000|Treatment|Administrative reason by Sponsor|2|||
33461434|NCT02899299|62834699|FG001|Treatment|Administrative reason by Sponsor|0|||
33461435|NCT02899299|62834698|FG000|Treatment|Other reasons|11|||
33538472|NCT00492856|62928331|FG000|Consolidation|Lost to Follow-up|1|||
33538473|NCT00492856|62928332|FG001|Consolidation|Lost to Follow-up|0|||
33538474|NCT00492856|62928333|FG002|Consolidation|Lost to Follow-up|0|||
33538475|NCT00492856|62928334|FG003|Consolidation|Lost to Follow-up|0|||
33538476|NCT00492856|62928331|FG000|Post-consolidation|Adverse Event|0|||
33538477|NCT00492856|62928332|FG001|Post-consolidation|Adverse Event|4|||
33538478|NCT00492856|62928333|FG002|Post-consolidation|Adverse Event|0|||
33538479|NCT00492856|62928334|FG003|Post-consolidation|Adverse Event|1|||
33538480|NCT00492856|62928331|FG000|Post-consolidation|Withdrawal by Subject|0|||
33538481|NCT00492856|62928332|FG001|Post-consolidation|Withdrawal by Subject|4|||
33538482|NCT00492856|62928333|FG002|Post-consolidation|Withdrawal by Subject|0|||
33538483|NCT00492856|62928334|FG003|Post-consolidation|Withdrawal by Subject|0|||
33538484|NCT00492856|62928331|FG000|Post-consolidation|Death|0|||
33538485|NCT00492856|62928332|FG001|Post-consolidation|Death|1|||
33538486|NCT00492856|62928333|FG002|Post-consolidation|Death|0|||
33538487|NCT00492856|62928334|FG003|Post-consolidation|Death|0|||
33538488|NCT00492856|62928331|FG000|Post-consolidation|Not protocol specified|0|||
33538489|NCT00492856|62928332|FG001|Post-consolidation|Not protocol specified|1|||
33538490|NCT00492856|62928333|FG002|Post-consolidation|Not protocol specified|0|||
33538491|NCT00492856|62928334|FG003|Post-consolidation|Not protocol specified|0|||
33538492|NCT00492856|62928331|FG000|Post-consolidation|Lost to Follow-up|0|||
33538493|NCT00492856|62928332|FG001|Post-consolidation|Lost to Follow-up|2|||
33538494|NCT00492856|62928333|FG002|Post-consolidation|Lost to Follow-up|0|||
33538495|NCT00492856|62928334|FG003|Post-consolidation|Lost to Follow-up|0|||
33538496|NCT00492856|62928331|FG000|Post-consolidation|Observation Arm|0|||
33538497|NCT00492856|62928332|FG001|Post-consolidation|Observation Arm|0|||
33538498|NCT00492856|62928333|FG002|Post-consolidation|Observation Arm|27|||
33538499|NCT00492856|62928334|FG003|Post-consolidation|Observation Arm|0|||
33538500|NCT02782377|62928346|FG000|Overall Study|Physician Decision|5|||
33538501|NCT02410629|62928353|FG000|Overall Study|Family cannot commit to the study|2|||
33538502|NCT02410629|62928354|FG001|Overall Study|Family cannot commit to the study|1|||
33538503|NCT02410629|62928353|FG000|Overall Study|Subject returned to work|1|||
33538504|NCT02410629|62928354|FG001|Overall Study|Subject returned to work|0|||
33538505|NCT02410629|62928353|FG000|Overall Study|Subject moved back to home country|0|||
33538506|NCT02410629|62928354|FG001|Overall Study|Subject moved back to home country|1|||
33538507|NCT02410629|62928353|FG000|Overall Study|Subject underwent heart surgery|0|||
33538508|NCT02410629|62928354|FG001|Overall Study|Subject underwent heart surgery|1|||
33538509|NCT02252211|62928362|FG000|Overall Study|Adverse Event|0|||
33538510|NCT02252211|62928363|FG001|Overall Study|Adverse Event|1|||
33538511|NCT02252211|62928364|FG002|Overall Study|Adverse Event|0|||
33538512|NCT02252211|62928362|FG000|Overall Study|Progressive disease|3|||
33538513|NCT02252211|62928363|FG001|Overall Study|Progressive disease|2|||
33538514|NCT02252211|62928364|FG002|Overall Study|Progressive disease|0|||
33538515|NCT02252211|62928362|FG000|Overall Study|Withdrawal by Subject|1|||
33538516|NCT02252211|62928363|FG001|Overall Study|Withdrawal by Subject|0|||
33538517|NCT02252211|62928364|FG002|Overall Study|Withdrawal by Subject|0|||
33631482|NCT01902134|63033226|FG001|Overall Study|Physician Decision|1|||
33461436|NCT02899299|62834699|FG001|Treatment|Other reasons|2|||
33538518|NCT02252211|62928362|FG000|Overall Study|Serious Adverse Event During Screening|1|||
33538519|NCT02252211|62928363|FG001|Overall Study|Serious Adverse Event During Screening|0|||
33631483|NCT01902134|63033227|FG002|Overall Study|Physician Decision|0|||
33631484|NCT01902134|63033228|FG003|Overall Study|Physician Decision|0|||
33464905|NCT02952586|62838392|FG001|Lead-In Phase (7 Days)|Death|1|||
33538520|NCT02252211|62928364|FG002|Overall Study|Serious Adverse Event During Screening|1|||
33538521|NCT02776683|62928371|FG000|Pre-switch Period|Protocol Violation|1|||
33538522|NCT02776683|62928372|FG001|Pre-switch Period|Protocol Violation|0|||
33538523|NCT02776683|62928371|FG000|Pre-switch Period|Adverse Event|21|||
33538524|NCT02776683|62928372|FG001|Pre-switch Period|Adverse Event|0|||
33538525|NCT02776683|62928371|FG000|Pre-switch Period|Withdrawal by Subject|9|||
33631485|NCT01902134|63033229|FG004|Overall Study|Physician Decision|0|||
33631486|NCT01902134|63033230|FG005|Overall Study|Physician Decision|0|||
33631487|NCT01902134|63033225|FG000|Overall Study|Protocol Violation|0|||
33631488|NCT01902134|63033226|FG001|Overall Study|Protocol Violation|0|||
33631489|NCT01902134|63033227|FG002|Overall Study|Protocol Violation|0|||
33631490|NCT01902134|63033228|FG003|Overall Study|Protocol Violation|0|||
33631491|NCT01902134|63033229|FG004|Overall Study|Protocol Violation|0|||
33631492|NCT01902134|63033230|FG005|Overall Study|Protocol Violation|1|||
33631493|NCT01902134|63033225|FG000|Overall Study|Withdrawal by Subject|4|||
33631494|NCT01902134|63033226|FG001|Overall Study|Withdrawal by Subject|8|||
33631495|NCT01902134|63033227|FG002|Overall Study|Withdrawal by Subject|9|||
33631496|NCT01902134|63033228|FG003|Overall Study|Withdrawal by Subject|1|||
33631497|NCT01902134|63033229|FG004|Overall Study|Withdrawal by Subject|5|||
33631498|NCT01902134|63033230|FG005|Overall Study|Withdrawal by Subject|4|||
33631499|NCT01902134|63033225|FG000|Overall Study|no compliance|1|||
33631500|NCT01902134|63033226|FG001|Overall Study|no compliance|0|||
33631501|NCT01902134|63033227|FG002|Overall Study|no compliance|0|||
33631502|NCT01902134|63033228|FG003|Overall Study|no compliance|0|||
33631503|NCT01902134|63033229|FG004|Overall Study|no compliance|0|||
33631504|NCT01902134|63033230|FG005|Overall Study|no compliance|0|||
33631505|NCT01902134|63033225|FG000|Overall Study|Other|0|||
33631506|NCT01902134|63033226|FG001|Overall Study|Other|1|||
33631507|NCT01902134|63033227|FG002|Overall Study|Other|2|||
33631508|NCT01902134|63033228|FG003|Overall Study|Other|0|||
33631509|NCT01902134|63033229|FG004|Overall Study|Other|1|||
33631510|NCT01902134|63033230|FG005|Overall Study|Other|0|||
33631511|NCT01954082|63033248|FG000|Overall Study|Study Suspension|42|||
33631512|NCT01954082|63033249|FG001|Overall Study|Study Suspension|36|||
33631513|NCT01954082|63033248|FG000|Overall Study|Adverse Event|10|||
33631514|NCT01954082|63033249|FG001|Overall Study|Adverse Event|4|||
33631515|NCT01954082|63033248|FG000|Overall Study|Intolerance|0|||
33631516|NCT01954082|63033249|FG001|Overall Study|Intolerance|1|||
33631517|NCT01954082|63033248|FG000|Overall Study|Non-compliance|6|||
33631518|NCT01954082|63033249|FG001|Overall Study|Non-compliance|4|||
33631519|NCT01954082|63033248|FG000|Overall Study|Physician Decision|2|||
33631520|NCT01954082|63033249|FG001|Overall Study|Physician Decision|0|||
33631521|NCT01954082|63033248|FG000|Overall Study|Parent Decision|1|||
33631522|NCT01954082|63033249|FG001|Overall Study|Parent Decision|0|||
33631523|NCT01954082|63033248|FG000|Overall Study|Withdrawal by Subject|0|||
33631524|NCT01954082|63033249|FG001|Overall Study|Withdrawal by Subject|1|||
33631525|NCT01954082|63033248|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
33631526|NCT01954082|63033249|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
33631527|NCT01954082|63033248|FG000|Overall Study|Redirection of Care|0|||
33631528|NCT01954082|63033249|FG001|Overall Study|Redirection of Care|2|||
33631529|NCT01954082|63033248|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
33631530|NCT01954082|63033249|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
33631531|NCT01954082|63033248|FG000|Overall Study|Comfort Care|0|||
33631532|NCT01954082|63033249|FG001|Overall Study|Comfort Care|1|||
33631533|NCT01954082|63033248|FG000|Overall Study|Infant Moved|0|||
33631534|NCT01954082|63033249|FG001|Overall Study|Infant Moved|1|||
33631535|NCT01954082|63033248|FG000|Overall Study|Randomized not Treated|4|||
33631536|NCT01954082|63033249|FG001|Overall Study|Randomized not Treated|2|||
33631537|NCT01417000|63033257|FG000|Overall Study|Death|59|||
33631538|NCT01417000|63033258|FG001|Overall Study|Death|28|||
33631539|NCT01417000|63033257|FG000|Overall Study|Lost to Follow-up|1|||
33631540|NCT01417000|63033258|FG001|Overall Study|Lost to Follow-up|0|||
33631541|NCT01417000|63033257|FG000|Overall Study|Study Terminated by Sponsor|1|||
33631542|NCT01417000|63033258|FG001|Overall Study|Study Terminated by Sponsor|1|||
33631543|NCT01416610|63033264|FG000|Overall Study|Adverse Event|4|||
33631544|NCT01416610|63033264|FG000|Overall Study|Adverse Event -Patient decision|3|||
33631545|NCT01416610|63033264|FG000|Overall Study|Lack of Efficacy|4|||
33631546|NCT01416610|63033264|FG000|Overall Study|No reason given|5|||
33631547|NCT01416610|63033264|FG000|Overall Study|Withdrawal by Subject|13|||
33631548|NCT01416610|63033264|FG000|Overall Study|Lost to Follow-up|7|||
33631549|NCT01416610|63033264|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
33631550|NCT01416142|63033272|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
33631551|NCT01416142|63033273|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
33631552|NCT01416142|63033274|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
33631553|NCT01415986|63033282|FG000|Overall Study|Lost to Follow-up|1|||
33631554|NCT01415908|63033289|FG000|Overall Study|Withdrawal by Subject|1|||
33631555|NCT01415908|63033290|FG001|Overall Study|Withdrawal by Subject|0|||
33631556|NCT01415518|63033298|FG000|Overall Study|Withdrawal by Subject|2|||
33631557|NCT01415518|63033299|FG001|Overall Study|Withdrawal by Subject|12|||
33631558|NCT01415518|63033298|FG000|Overall Study|Protocol Violation|6|||
33631559|NCT01415518|63033299|FG001|Overall Study|Protocol Violation|8|||
33631560|NCT01415518|63033298|FG000|Overall Study|Lost to Follow-up|3|||
33631561|NCT01415518|63033299|FG001|Overall Study|Lost to Follow-up|5|||
33631562|NCT01415518|63033298|FG000|Overall Study|Adverse Event|3|||
33631563|NCT01415518|63033299|FG001|Overall Study|Adverse Event|4|||
33631564|NCT01415518|63033298|FG000|Overall Study|Death|1|||
33631565|NCT01415518|63033299|FG001|Overall Study|Death|1|||
33631566|NCT01415518|63033298|FG000|Overall Study|Condition under Investigation Worsened|1|||
33631567|NCT01415518|63033299|FG001|Overall Study|Condition under Investigation Worsened|1|||
33631568|NCT01393600|63033305|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
33631569|NCT01393600|63033306|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
33538526|NCT02776683|62928372|FG001|Pre-switch Period|Withdrawal by Subject|0|||
33538527|NCT02776683|62928371|FG000|Pre-switch Period|Physician Decision|7|||
33538528|NCT02776683|62928372|FG001|Pre-switch Period|Physician Decision|0|||
33538529|NCT02776683|62928371|FG000|Pre-switch Period|Progressive disease|39|||
33538530|NCT02776683|62928372|FG001|Pre-switch Period|Progressive disease|0|||
33538531|NCT02776683|62928371|FG000|Pre-switch Period|Other than listed|3|||
33538532|NCT02776683|62928372|FG001|Pre-switch Period|Other than listed|0|||
33538533|NCT02776683|62928371|FG000|Post-switch Period|Adverse Event|0|||
33538534|NCT02776683|62928372|FG001|Post-switch Period|Adverse Event|3|||
33538535|NCT02776683|62928371|FG000|Post-switch Period|Withdrawal by Subject|0|||
33538536|NCT02776683|62928372|FG001|Post-switch Period|Withdrawal by Subject|2|||
33538537|NCT02776683|62928371|FG000|Post-switch Period|Physician Decision|0|||
33538538|NCT02776683|62928372|FG001|Post-switch Period|Physician Decision|3|||
33631570|NCT01393600|63033307|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
33631571|NCT01393600|63033308|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
33631572|NCT01393600|63033305|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
33631573|NCT01393600|63033306|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
33631574|NCT01393600|63033307|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
33631575|NCT01393600|63033308|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
33631576|NCT01393600|63033305|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
33631577|NCT01393600|63033306|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
33631578|NCT01393600|63033307|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
33631579|NCT01393600|63033308|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
33631580|NCT01393600|63033305|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
33631581|NCT01393600|63033306|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
33631582|NCT01393600|63033307|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
33631583|NCT01393600|63033308|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
33631584|NCT01393600|63033305|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
33631585|NCT01393600|63033306|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
33631586|NCT01393600|63033307|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
33631587|NCT01393600|63033308|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
33631588|NCT01393600|63033305|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
33631589|NCT01393600|63033306|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
33631590|NCT01393600|63033307|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
33631591|NCT01393600|63033308|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
33631592|NCT01393600|63033305|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
33631593|NCT01393600|63033306|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
33631594|NCT01393600|63033307|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
33631595|NCT01393600|63033308|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
33631596|NCT01432756|63033324|FG000|Overall Study|Lost to Follow-up|1|||
33631597|NCT01432756|63033325|FG001|Overall Study|Lost to Follow-up|0|||
33631598|NCT01432756|63033326|FG002|Overall Study|Lost to Follow-up|2|||
33631599|NCT01432756|63033327|FG003|Overall Study|Lost to Follow-up|1|||
33631600|NCT01432600|63033338|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
33631601|NCT01432600|63033339|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
33631602|NCT01432600|63033340|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
33631603|NCT01432444|63033350|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
33631604|NCT01432444|63033351|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
33631605|NCT01432444|63033352|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
33631606|NCT01432444|63033350|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
33631607|NCT01432444|63033351|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
33631608|NCT01432444|63033352|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
33631609|NCT01432444|63033350|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
33631610|NCT01432444|63033351|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
33538539|NCT02776683|62928371|FG000|Post-switch Period|Progressive disease|0|||
33538540|NCT02776683|62928372|FG001|Post-switch Period|Progressive disease|20|||
33538541|NCT02776683|62928371|FG000|Post-switch Period|Other than listed|0|||
33538542|NCT02776683|62928372|FG001|Post-switch Period|Other than listed|15|||
33631611|NCT01432444|63033352|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
33631612|NCT01432444|63033350|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
33631613|NCT01432444|63033351|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
33631614|NCT01432444|63033352|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
33631615|NCT01432444|63033350|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
33631616|NCT01432444|63033351|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
33631617|NCT01432444|63033352|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
33631618|NCT01432444|63033350|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
33631619|NCT01432444|63033351|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
33631620|NCT01432444|63033352|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
33631621|NCT01432444|63033350|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
33631622|NCT01432444|63033351|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
33631623|NCT01432444|63033352|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
33631624|NCT01432444|63033350|FG000|Treatment Phase|Lost to Follow-up|0|||
33631625|NCT01432444|63033351|FG001|Treatment Phase|Lost to Follow-up|33|||
33631626|NCT01432444|63033352|FG002|Treatment Phase|Lost to Follow-up|0|||
33631627|NCT01432444|63033350|FG000|Treatment Phase|Adverse Event|0|||
33631628|NCT01432444|63033351|FG001|Treatment Phase|Adverse Event|37|||
33631629|NCT01432444|63033352|FG002|Treatment Phase|Adverse Event|0|||
33461437|NCT02899299|62834698|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4|||
33461438|NCT02899299|62834699|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189|||
33461439|NCT02899195|62834705|FG000|Concurrent Durvalumab|Adverse Event|4|||
33461440|NCT02899195|62834705|FG000|Concurrent Durvalumab|Physician Decision|1|||
33538543|NCT02731742|62928380|FG000|Overall Study|Death|1|||
33538544|NCT02731742|62928381|FG001|Overall Study|Death|2|||
33538545|NCT02731742|62928382|FG002|Overall Study|Death|5|||
33538546|NCT02731742|62928383|FG003|Overall Study|Death|0|||
33538547|NCT02731742|62928380|FG000|Overall Study|Physician Decision|0|||
33538548|NCT02731742|62928381|FG001|Overall Study|Physician Decision|0|||
33538549|NCT02731742|62928382|FG002|Overall Study|Physician Decision|0|||
33538550|NCT02731742|62928383|FG003|Overall Study|Physician Decision|1|||
33538551|NCT02731742|62928380|FG000|Overall Study|Study Terminated by Sponsor|2|||
33461441|NCT02899195|62834705|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
33461442|NCT02899195|62834705|FG000|Concurrent Durvalumab|Progressive Disease|5|||
33461443|NCT02899195|62834705|FG000|Maintenance Durvalumab|Adverse Event|1|||
33461444|NCT02899195|62834705|FG000|Maintenance Durvalumab|Physician Decision|1|||
33538552|NCT02731742|62928381|FG001|Overall Study|Study Terminated by Sponsor|1|||
33538553|NCT02731742|62928382|FG002|Overall Study|Study Terminated by Sponsor|1|||
33538554|NCT02731742|62928383|FG003|Overall Study|Study Terminated by Sponsor|1|||
33538555|NCT00104871|62928406|FG000|Overall Study|Not evaluable|1|||
33538556|NCT03487796|62928414|FG000|Overall Study|Lost to Follow-up|18|||
33538557|NCT03487796|62928415|FG001|Overall Study|Lost to Follow-up|6|||
33538558|NCT02148705|62928430|FG000|Overall Study|Death|2|||
33538559|NCT02148705|62928431|FG001|Overall Study|Death|0|||
33538560|NCT02148705|62928432|FG002|Overall Study|Death|0|||
33538561|NCT02148705|62928430|FG000|Overall Study|Lost to Follow-up|13|||
33538562|NCT02148705|62928431|FG001|Overall Study|Lost to Follow-up|4|||
33538563|NCT02148705|62928432|FG002|Overall Study|Lost to Follow-up|10|||
33538564|NCT02148705|62928430|FG000|Overall Study|Withdrawal by Subject|3|||
33538565|NCT02148705|62928431|FG001|Overall Study|Withdrawal by Subject|0|||
33538566|NCT02148705|62928432|FG002|Overall Study|Withdrawal by Subject|2|||
33538567|NCT02148705|62928430|FG000|Overall Study|Not Treated|0|||
33538568|NCT02148705|62928431|FG001|Overall Study|Not Treated|1|||
33538569|NCT02148705|62928432|FG002|Overall Study|Not Treated|5|||
33538570|NCT03446612|62928442|FG000|Overall Study|Protocol defined stopping criteria|0|||
33538571|NCT03446612|62928443|FG001|Overall Study|Protocol defined stopping criteria|1|||
33538572|NCT02730728|62928454|FG000|Overall Study|Withdrawal by Subject|0|||
33538573|NCT02730728|62928455|FG001|Overall Study|Withdrawal by Subject|1|||
33538574|NCT02730728|62928456|FG002|Overall Study|Withdrawal by Subject|0|||
33538575|NCT02730728|62928454|FG000|Overall Study|Lack of Efficacy|0|||
33538576|NCT02730728|62928455|FG001|Overall Study|Lack of Efficacy|1|||
33538577|NCT02730728|62928456|FG002|Overall Study|Lack of Efficacy|1|||
33538578|NCT00104637|62928464|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
33538579|NCT00104637|62928465|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
33538580|NCT02768103|62928474|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
33631630|NCT01432444|63033350|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
33631631|NCT01432444|63033351|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
33461445|NCT02899195|62834705|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
33538581|NCT02767323|62928483|FG000|Overall Study|Withdrawal by Subject|17|||
33538582|NCT02767323|62928484|FG001|Overall Study|Withdrawal by Subject|5|||
33538583|NCT02767323|62928485|FG002|Overall Study|Withdrawal by Subject|13|||
33538584|NCT02767323|62928486|FG003|Overall Study|Withdrawal by Subject|0|||
33538585|NCT02767323|62928483|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
33544254|NCT03012061|62935096|FG000|Overall Study|Lack of Efficacy|0|||
33631632|NCT01432444|63033352|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
33631633|NCT01432444|63033350|FG000|Treatment Phase|Physician Decision|0|||
33631634|NCT01432444|63033351|FG001|Treatment Phase|Physician Decision|5|||
33631635|NCT01432444|63033352|FG002|Treatment Phase|Physician Decision|0|||
33631636|NCT01432444|63033350|FG000|Treatment Phase|Withdrawal by Subject|0|||
33631637|NCT01432444|63033351|FG001|Treatment Phase|Withdrawal by Subject|41|||
33631638|NCT01432444|63033352|FG002|Treatment Phase|Withdrawal by Subject|0|||
33538586|NCT02767323|62928484|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
33538587|NCT02767323|62928485|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
33538588|NCT02767323|62928486|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
33631639|NCT01432444|63033350|FG000|Treatment Phase|Protocol Deviation|0|||
33631640|NCT01432444|63033351|FG001|Treatment Phase|Protocol Deviation|3|||
33631641|NCT01432444|63033352|FG002|Treatment Phase|Protocol Deviation|0|||
33631642|NCT01432444|63033350|FG000|Treatment Phase|Lack of Efficacy|0|||
33631643|NCT01432444|63033351|FG001|Treatment Phase|Lack of Efficacy|10|||
33631644|NCT01432444|63033352|FG002|Treatment Phase|Lack of Efficacy|0|||
33631645|NCT01432444|63033350|FG000|Extension Phase|Lost to Follow-up|0|||
33631646|NCT01432444|63033351|FG001|Extension Phase|Lost to Follow-up|0|||
33631647|NCT01432444|63033352|FG002|Extension Phase|Lost to Follow-up|17|||
33538589|NCT04304950|62928501|FG000|Overall Study|Lost to Follow-up|1|||
33538590|NCT04304950|62928502|FG001|Overall Study|Lost to Follow-up|1|||
33538591|NCT02780115|62928516|FG000|Overall Study|Withdrawal by Subject|0|||
33538592|NCT02780115|62928517|FG001|Overall Study|Withdrawal by Subject|1|||
33538593|NCT02780115|62928518|FG002|Overall Study|Withdrawal by Subject|1|||
33538594|NCT02780115|62928519|FG003|Overall Study|Withdrawal by Subject|0|||
33538595|NCT02780115|62928520|FG004|Overall Study|Withdrawal by Subject|0|||
33538596|NCT02780115|62928516|FG000|Overall Study|Adverse Event|0|||
33538597|NCT02780115|62928517|FG001|Overall Study|Adverse Event|0|||
33538598|NCT02780115|62928518|FG002|Overall Study|Adverse Event|0|||
33538599|NCT02780115|62928519|FG003|Overall Study|Adverse Event|1|||
33538600|NCT02780115|62928520|FG004|Overall Study|Adverse Event|1|||
33538601|NCT02766777|62928532|FG000|Overall Study|Adverse Event|12|||
33538602|NCT02766777|62928532|FG000|Overall Study|Lost to Follow-up|16|||
33538603|NCT02766777|62928532|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33538604|NCT02766777|62928532|FG000|Overall Study|Protocol Violation|1|||
33538605|NCT02766777|62928532|FG000|Overall Study|Withdrawal by Subject|4|||
33538606|NCT00157014|62928540|FG000|Overall Study|Death|4|||
33538607|NCT00157014|62928541|FG001|Overall Study|Death|2|||
33538608|NCT00157014|62928542|FG002|Overall Study|Death|1|||
33538609|NCT00157014|62928543|FG003|Overall Study|Death|1|||
33538610|NCT00157014|62928540|FG000|Overall Study|Physician Decision|0|||
33538611|NCT00157014|62928541|FG001|Overall Study|Physician Decision|1|||
33538612|NCT00157014|62928542|FG002|Overall Study|Physician Decision|0|||
33538613|NCT00157014|62928543|FG003|Overall Study|Physician Decision|0|||
33538614|NCT00157014|62928540|FG000|Overall Study|Medications withdrawn on family request|0|||
33538615|NCT00157014|62928541|FG001|Overall Study|Medications withdrawn on family request|1|||
33538616|NCT00157014|62928542|FG002|Overall Study|Medications withdrawn on family request|0|||
33538617|NCT00157014|62928543|FG003|Overall Study|Medications withdrawn on family request|0|||
33538618|NCT00157014|62928540|FG000|Overall Study|Patient withdrawn by investigator|1|||
33538619|NCT00157014|62928541|FG001|Overall Study|Patient withdrawn by investigator|0|||
33538620|NCT00157014|62928542|FG002|Overall Study|Patient withdrawn by investigator|0|||
33538621|NCT00157014|62928543|FG003|Overall Study|Patient withdrawn by investigator|0|||
33538622|NCT00157014|62928540|FG000|Overall Study|Patient unable to return in nursing home|1|||
33538623|NCT00157014|62928541|FG001|Overall Study|Patient unable to return in nursing home|0|||
33538624|NCT00157014|62928542|FG002|Overall Study|Patient unable to return in nursing home|0|||
33538625|NCT00157014|62928543|FG003|Overall Study|Patient unable to return in nursing home|0|||
33538626|NCT00157014|62928540|FG000|Overall Study|Patient would not receive transplant|0|||
33538627|NCT00157014|62928541|FG001|Overall Study|Patient would not receive transplant|1|||
33538628|NCT00157014|62928542|FG002|Overall Study|Patient would not receive transplant|0|||
33538629|NCT00157014|62928543|FG003|Overall Study|Patient would not receive transplant|0|||
33538630|NCT00157014|62928540|FG000|Overall Study|Withdrawal by Subject|1|||
33538631|NCT00157014|62928541|FG001|Overall Study|Withdrawal by Subject|0|||
33538632|NCT00157014|62928542|FG002|Overall Study|Withdrawal by Subject|0|||
33538633|NCT00157014|62928543|FG003|Overall Study|Withdrawal by Subject|0|||
33538634|NCT02778867|62928555|FG000|Phase 1|Withdrawal by Subject|2|||
33538635|NCT02778867|62928556|FG001|Phase 1|Withdrawal by Subject|3|||
33538636|NCT02778867|62928557|FG002|Phase 1|Withdrawal by Subject|0|||
33538637|NCT02778867|62928558|FG003|Phase 1|Withdrawal by Subject|0|||
33538638|NCT02778867|62928555|FG000|Phase 2|Withdrawal by Subject|0|||
33538639|NCT02778867|62928556|FG001|Phase 2|Withdrawal by Subject|0|||
33538640|NCT02778867|62928557|FG002|Phase 2|Withdrawal by Subject|1|||
33538641|NCT02778867|62928558|FG003|Phase 2|Withdrawal by Subject|0|||
33538642|NCT02778867|62928555|FG000|Phase 2|Physician Decision|0|||
33631648|NCT01432444|63033350|FG000|Extension Phase|Adverse Event|0|||
33631649|NCT01432444|63033351|FG001|Extension Phase|Adverse Event|0|||
33631650|NCT01432444|63033352|FG002|Extension Phase|Adverse Event|10|||
33631651|NCT01432444|63033350|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
33631652|NCT01432444|63033351|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
33631653|NCT01432444|63033352|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
33631654|NCT01432444|63033350|FG000|Extension Phase|Met Withdrawal Criteria|0|||
33631655|NCT01432444|63033351|FG001|Extension Phase|Met Withdrawal Criteria|0|||
33631656|NCT01432444|63033352|FG002|Extension Phase|Met Withdrawal Criteria|144|||
33631657|NCT01432444|63033350|FG000|Extension Phase|Physician Decision|0|||
33631658|NCT01432444|63033351|FG001|Extension Phase|Physician Decision|0|||
33631659|NCT01432444|63033352|FG002|Extension Phase|Physician Decision|1|||
33631660|NCT01432444|63033350|FG000|Extension Phase|Withdrawal by Subject|0|||
33631661|NCT01432444|63033351|FG001|Extension Phase|Withdrawal by Subject|0|||
33631662|NCT01432444|63033352|FG002|Extension Phase|Withdrawal by Subject|13|||
33631663|NCT01432366|63033357|FG000|Overall Study|Non-Responder|7|||
33631664|NCT01432366|63033357|FG000|Overall Study|Adverse Event|8|||
33631665|NCT01432366|63033357|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
33631666|NCT01432366|63033357|FG000|Overall Study|Pregnancy|1|||
33631667|NCT01432366|63033357|FG000|Overall Study|Lost to Follow-up|13|||
33631668|NCT01432366|63033357|FG000|Overall Study|Lack of Efficacy|1|||
33631669|NCT01432366|63033357|FG000|Overall Study|Site Closed|20|||
33631670|NCT01432366|63033357|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
33631671|NCT01432366|63033357|FG000|Overall Study|Other|14|||
33631672|NCT01415440|63033364|FG000|Overall Study|Lost to Follow-up|0|||
33631673|NCT01415440|63033365|FG001|Overall Study|Lost to Follow-up|1|||
33631674|NCT01415440|63033366|FG002|Overall Study|Lost to Follow-up|2|||
33631675|NCT01415440|63033364|FG000|Overall Study|Physician Decision|3|||
33631676|NCT01415440|63033365|FG001|Overall Study|Physician Decision|0|||
33631677|NCT01415440|63033366|FG002|Overall Study|Physician Decision|0|||
33631678|NCT01415440|63033364|FG000|Overall Study|Withdrawal by Subject|1|||
33631679|NCT01415440|63033365|FG001|Overall Study|Withdrawal by Subject|0|||
33631680|NCT01415440|63033366|FG002|Overall Study|Withdrawal by Subject|0|||
33631681|NCT01932788|63033384|FG000|Overall Study|Protocol Violation|18|||
33631682|NCT01932788|63033385|FG001|Overall Study|Protocol Violation|0|||
33631683|NCT01932788|63033384|FG000|Overall Study|Lost to Follow-up|18|||
33631684|NCT01932788|63033385|FG001|Overall Study|Lost to Follow-up|46|||
33631685|NCT01932788|63033384|FG000|Overall Study|Lack of Efficacy|2|||
33631686|NCT01932788|63033385|FG001|Overall Study|Lack of Efficacy|0|||
33631687|NCT01932788|63033384|FG000|Overall Study|Withdrawal by Subject|0|||
33631688|NCT01932788|63033385|FG001|Overall Study|Withdrawal by Subject|5|||
33631689|NCT01414738|63033391|FG000|Overall Study|Death|26|||
33631690|NCT01414738|63033391|FG000|Overall Study|Refused testing|5|||
33631691|NCT01414738|63033391|FG000|Overall Study|Lost to Follow-up|2|||
33631692|NCT01414738|63033391|FG000|Overall Study|Refused, disease progression|8|||
33631693|NCT01414738|63033391|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
33631694|NCT01414114|63033395|FG000|Overall Study|Adverse Event|2|||
33631695|NCT01414114|63033395|FG000|Overall Study|Withdrawal by Subject|1|||
33631696|NCT01414114|63033395|FG000|Overall Study|Other|2|||
33631697|NCT01393444|63033401|FG000|Overall Study|Withdrawal by Subject|1|||
33631698|NCT01393444|63033401|FG000|Overall Study|Determined ineligible during screening.|2|||
33631699|NCT01431976|63033405|FG000|Overall Study|Adverse Event|6|||
33631700|NCT01431976|63033405|FG000|Overall Study|Lack of Efficacy|2|||
33631701|NCT01431976|63033405|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
33631702|NCT01431976|63033405|FG000|Overall Study|Physician Decision|1|||
33631703|NCT01431976|63033405|FG000|Overall Study|Withdrawal by Subject|1|||
33631704|NCT01392742|63033409|FG000|Overall Study|Premature study termination|42|||
33631705|NCT01392742|63033409|FG000|Overall Study|Failure to return|35|||
33631706|NCT01392742|63033409|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
33631707|NCT01392742|63033409|FG000|Overall Study|Lost to Follow-up|34|||
33631708|NCT01392742|63033409|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
33631709|NCT01392742|63033409|FG000|Overall Study|ITR and Protocol deviation|1|||
33631710|NCT01392742|63033409|FG000|Overall Study|Adverse event/intercurrent illness|17|||
33631711|NCT01392742|63033409|FG000|Overall Study|Protocol Violation|14|||
33631712|NCT01392742|63033409|FG000|Overall Study|Other|3|||
33631713|NCT01392742|63033409|FG000|Overall Study|Missing information|13|||
33631714|NCT01413958|63033415|FG000|Overall Study|Lost to Follow-up|0|||
33631715|NCT01413958|63033416|FG001|Overall Study|Lost to Follow-up|1|||
33631716|NCT01413178|63033425|FG000|Overall Study|Toxicity|1|||
33631717|NCT01413178|63033426|FG001|Overall Study|Toxicity|0|||
33631718|NCT01413178|63033425|FG000|Overall Study|Ineligible|0|||
33538643|NCT02778867|62928556|FG001|Phase 2|Physician Decision|0|||
33631719|NCT01413178|63033426|FG001|Overall Study|Ineligible|2|||
33631720|NCT01799889|63033444|FG000|Overall Study|Adverse Event|4|||
33631721|NCT01799889|63033445|FG001|Overall Study|Adverse Event|4|||
33631722|NCT01799889|63033446|FG002|Overall Study|Adverse Event|5|||
33631723|NCT01799889|63033447|FG003|Overall Study|Adverse Event|1|||
33631724|NCT01799889|63033448|FG004|Overall Study|Adverse Event|11|||
33631725|NCT01799889|63033449|FG005|Overall Study|Adverse Event|1|||
33631726|NCT01799889|63033450|FG006|Overall Study|Adverse Event|5|||
33631727|NCT01799889|63033451|FG007|Overall Study|Adverse Event|2|||
33631728|NCT01799889|63033452|FG008|Overall Study|Adverse Event|3|||
33631729|NCT01799889|63033453|FG009|Overall Study|Adverse Event|1|||
33631730|NCT01799889|63033454|FG010|Overall Study|Adverse Event|1|||
33631731|NCT01799889|63033455|FG011|Overall Study|Adverse Event|0|||
33631732|NCT01799889|63033444|FG000|Overall Study|Death|1|||
33631733|NCT01799889|63033445|FG001|Overall Study|Death|0|||
33631734|NCT01799889|63033446|FG002|Overall Study|Death|5|||
33631735|NCT01799889|63033447|FG003|Overall Study|Death|3|||
33631736|NCT01799889|63033448|FG004|Overall Study|Death|1|||
33631737|NCT01799889|63033449|FG005|Overall Study|Death|0|||
33631738|NCT01799889|63033450|FG006|Overall Study|Death|0|||
33631739|NCT01799889|63033451|FG007|Overall Study|Death|0|||
33631740|NCT01799889|63033452|FG008|Overall Study|Death|1|||
33631741|NCT01799889|63033453|FG009|Overall Study|Death|0|||
33631742|NCT01799889|63033454|FG010|Overall Study|Death|1|||
33631743|NCT01799889|63033455|FG011|Overall Study|Death|0|||
33631744|NCT01799889|63033444|FG000|Overall Study|Lack of Efficacy|1|||
33631745|NCT01799889|63033445|FG001|Overall Study|Lack of Efficacy|1|||
33631746|NCT01799889|63033446|FG002|Overall Study|Lack of Efficacy|0|||
33631747|NCT01799889|63033447|FG003|Overall Study|Lack of Efficacy|1|||
33631748|NCT01799889|63033448|FG004|Overall Study|Lack of Efficacy|2|||
33631749|NCT01799889|63033449|FG005|Overall Study|Lack of Efficacy|2|||
33631750|NCT01799889|63033450|FG006|Overall Study|Lack of Efficacy|0|||
33631751|NCT01799889|63033451|FG007|Overall Study|Lack of Efficacy|0|||
33631752|NCT01799889|63033452|FG008|Overall Study|Lack of Efficacy|2|||
33631753|NCT01799889|63033453|FG009|Overall Study|Lack of Efficacy|0|||
33631754|NCT01799889|63033454|FG010|Overall Study|Lack of Efficacy|1|||
33631755|NCT01799889|63033455|FG011|Overall Study|Lack of Efficacy|0|||
33631756|NCT01799889|63033444|FG000|Overall Study|Lost to Follow-up|0|||
33631757|NCT01799889|63033445|FG001|Overall Study|Lost to Follow-up|1|||
33631758|NCT01799889|63033446|FG002|Overall Study|Lost to Follow-up|0|||
33631759|NCT01799889|63033447|FG003|Overall Study|Lost to Follow-up|0|||
33631760|NCT01799889|63033448|FG004|Overall Study|Lost to Follow-up|0|||
33631761|NCT01799889|63033449|FG005|Overall Study|Lost to Follow-up|0|||
33631762|NCT01799889|63033450|FG006|Overall Study|Lost to Follow-up|0|||
33631763|NCT01799889|63033451|FG007|Overall Study|Lost to Follow-up|0|||
33631764|NCT01799889|63033452|FG008|Overall Study|Lost to Follow-up|0|||
33631765|NCT01799889|63033453|FG009|Overall Study|Lost to Follow-up|0|||
33631766|NCT01799889|63033454|FG010|Overall Study|Lost to Follow-up|0|||
33631767|NCT01799889|63033455|FG011|Overall Study|Lost to Follow-up|0|||
33631768|NCT01799889|63033444|FG000|Overall Study|Physician Decision|3|||
33631769|NCT01799889|63033445|FG001|Overall Study|Physician Decision|2|||
33631770|NCT01799889|63033446|FG002|Overall Study|Physician Decision|4|||
33631771|NCT01799889|63033447|FG003|Overall Study|Physician Decision|4|||
33631772|NCT01799889|63033448|FG004|Overall Study|Physician Decision|5|||
33631773|NCT01799889|63033449|FG005|Overall Study|Physician Decision|5|||
33631774|NCT01799889|63033450|FG006|Overall Study|Physician Decision|5|||
33631775|NCT01799889|63033451|FG007|Overall Study|Physician Decision|2|||
33631776|NCT01799889|63033452|FG008|Overall Study|Physician Decision|6|||
33631777|NCT01799889|63033453|FG009|Overall Study|Physician Decision|0|||
33631778|NCT01799889|63033454|FG010|Overall Study|Physician Decision|0|||
33631779|NCT01799889|63033455|FG011|Overall Study|Physician Decision|1|||
33631780|NCT01799889|63033444|FG000|Overall Study|Progressive Disease|30|||
33631781|NCT01799889|63033445|FG001|Overall Study|Progressive Disease|26|||
33631782|NCT01799889|63033446|FG002|Overall Study|Progressive Disease|25|||
33631783|NCT01799889|63033447|FG003|Overall Study|Progressive Disease|30|||
33631784|NCT01799889|63033448|FG004|Overall Study|Progressive Disease|23|||
33631785|NCT01799889|63033449|FG005|Overall Study|Progressive Disease|9|||
33631786|NCT01799889|63033450|FG006|Overall Study|Progressive Disease|8|||
33631787|NCT01799889|63033451|FG007|Overall Study|Progressive Disease|13|||
33631788|NCT01799889|63033452|FG008|Overall Study|Progressive Disease|18|||
33631789|NCT01799889|63033453|FG009|Overall Study|Progressive Disease|5|||
33631790|NCT01799889|63033454|FG010|Overall Study|Progressive Disease|3|||
33631791|NCT01799889|63033455|FG011|Overall Study|Progressive Disease|1|||
33631792|NCT01799889|63033444|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
33631793|NCT01799889|63033445|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
33631794|NCT01799889|63033446|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
33631795|NCT01799889|63033447|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
33631796|NCT01799889|63033448|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
33631797|NCT01799889|63033449|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
33631798|NCT01799889|63033450|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
33631799|NCT01799889|63033451|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
33631800|NCT01799889|63033452|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
33631801|NCT01799889|63033453|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
33631802|NCT01799889|63033454|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
33631803|NCT01799889|63033455|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
33631804|NCT01799889|63033444|FG000|Overall Study|Study Terminated By Sponsor|1|||
33631805|NCT01799889|63033445|FG001|Overall Study|Study Terminated By Sponsor|0|||
33631806|NCT01799889|63033446|FG002|Overall Study|Study Terminated By Sponsor|0|||
33631807|NCT01799889|63033447|FG003|Overall Study|Study Terminated By Sponsor|0|||
33631808|NCT01799889|63033448|FG004|Overall Study|Study Terminated By Sponsor|2|||
33631809|NCT01799889|63033449|FG005|Overall Study|Study Terminated By Sponsor|1|||
33631810|NCT01799889|63033450|FG006|Overall Study|Study Terminated By Sponsor|0|||
33631811|NCT01799889|63033451|FG007|Overall Study|Study Terminated By Sponsor|2|||
33631812|NCT01799889|63033452|FG008|Overall Study|Study Terminated By Sponsor|1|||
33631813|NCT01799889|63033453|FG009|Overall Study|Study Terminated By Sponsor|1|||
33631814|NCT01799889|63033454|FG010|Overall Study|Study Terminated By Sponsor|0|||
33631815|NCT01799889|63033455|FG011|Overall Study|Study Terminated By Sponsor|0|||
33631816|NCT01799889|63033444|FG000|Overall Study|Withdrawal by Subject|1|||
33631817|NCT01799889|63033445|FG001|Overall Study|Withdrawal by Subject|6|||
33631818|NCT01799889|63033446|FG002|Overall Study|Withdrawal by Subject|4|||
33631819|NCT01799889|63033447|FG003|Overall Study|Withdrawal by Subject|0|||
33631820|NCT01799889|63033448|FG004|Overall Study|Withdrawal by Subject|5|||
33631821|NCT01799889|63033449|FG005|Overall Study|Withdrawal by Subject|1|||
33631822|NCT01799889|63033450|FG006|Overall Study|Withdrawal by Subject|3|||
33631823|NCT01799889|63033451|FG007|Overall Study|Withdrawal by Subject|1|||
33631824|NCT01799889|63033452|FG008|Overall Study|Withdrawal by Subject|2|||
33631825|NCT01799889|63033453|FG009|Overall Study|Withdrawal by Subject|1|||
33631826|NCT01799889|63033454|FG010|Overall Study|Withdrawal by Subject|1|||
33631827|NCT01799889|63033455|FG011|Overall Study|Withdrawal by Subject|1|||
33631828|NCT01799889|63033444|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33631829|NCT01799889|63033445|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33631830|NCT01799889|63033446|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33631831|NCT01799889|63033447|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33631832|NCT01799889|63033448|FG004|Overall Study|Non-Compliance With Study Drug|0|||
33631833|NCT01799889|63033449|FG005|Overall Study|Non-Compliance With Study Drug|1|||
33631834|NCT01799889|63033450|FG006|Overall Study|Non-Compliance With Study Drug|0|||
33631835|NCT01799889|63033451|FG007|Overall Study|Non-Compliance With Study Drug|0|||
33631836|NCT01799889|63033452|FG008|Overall Study|Non-Compliance With Study Drug|0|||
33631837|NCT01799889|63033453|FG009|Overall Study|Non-Compliance With Study Drug|0|||
33631838|NCT01799889|63033454|FG010|Overall Study|Non-Compliance With Study Drug|0|||
33631839|NCT01799889|63033455|FG011|Overall Study|Non-Compliance With Study Drug|0|||
33631840|NCT01412944|63033494|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
33631841|NCT01412944|63033495|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
33631842|NCT01412944|63033496|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
33631843|NCT01412944|63033497|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
33631844|NCT01412944|63033498|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
33631845|NCT01412944|63033499|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
33631846|NCT01412944|63033494|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
33631847|NCT01412944|63033495|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
33631848|NCT01412944|63033496|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
33631849|NCT01412944|63033497|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
33631850|NCT01412944|63033498|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
33631851|NCT01412944|63033499|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
33631852|NCT01412944|63033494|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
33631853|NCT01412944|63033495|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
33631854|NCT01412944|63033496|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
33631855|NCT01412944|63033497|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
33631856|NCT01412944|63033498|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
33631857|NCT01412944|63033499|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
33631858|NCT01412944|63033494|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
33631859|NCT01412944|63033495|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
33631860|NCT01412944|63033496|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
33631861|NCT01412944|63033497|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
33631862|NCT01412944|63033498|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
33631863|NCT01412944|63033499|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
33631864|NCT01412944|63033494|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
33631865|NCT01412944|63033495|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
33631866|NCT01412944|63033496|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
33631867|NCT01412944|63033497|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
33631868|NCT01412944|63033498|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
33631869|NCT01412944|63033499|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
33631870|NCT01412944|63033494|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
33631871|NCT01412944|63033495|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
33631872|NCT01412944|63033496|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
33631873|NCT01412944|63033497|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
33631874|NCT01412944|63033498|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
33631875|NCT01412944|63033499|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
33631876|NCT01412944|63033494|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
33631877|NCT01412944|63033495|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
33631878|NCT01412944|63033496|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
33631879|NCT01412944|63033497|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
33631880|NCT01412944|63033498|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
33631881|NCT01412944|63033499|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
33631882|NCT01412944|63033494|FG000|Entire: IV + Maintenance|Adverse Event|0|||
33631883|NCT01412944|63033495|FG001|Entire: IV + Maintenance|Adverse Event|0|||
33631884|NCT01412944|63033496|FG002|Entire: IV + Maintenance|Adverse Event|0|||
33631885|NCT01412944|63033497|FG003|Entire: IV + Maintenance|Adverse Event|0|||
33631886|NCT01412944|63033498|FG004|Entire: IV + Maintenance|Adverse Event|1|||
33631887|NCT01412944|63033499|FG005|Entire: IV + Maintenance|Adverse Event|0|||
33631888|NCT01412944|63033494|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
33631889|NCT01412944|63033495|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
33631890|NCT01412944|63033496|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
33631891|NCT01412944|63033497|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
33631892|NCT01412944|63033498|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
33631893|NCT01412944|63033499|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
33631894|NCT01412944|63033494|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
33631895|NCT01412944|63033495|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
33631896|NCT01412944|63033496|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
33631897|NCT01412944|63033497|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
33631898|NCT01412944|63033498|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
33631899|NCT01412944|63033499|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
33631900|NCT01412944|63033494|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
33631901|NCT01412944|63033495|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
33631902|NCT01412944|63033496|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
33631903|NCT01412944|63033497|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
33631904|NCT01412944|63033498|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
33631905|NCT01412944|63033499|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
33631906|NCT01412944|63033494|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
33631907|NCT01412944|63033495|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
33631908|NCT01412944|63033496|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
33631909|NCT01412944|63033497|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
33631910|NCT01412944|63033498|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
33631911|NCT01412944|63033499|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
33631912|NCT01412944|63033494|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
33631913|NCT01412944|63033495|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
33631914|NCT01412944|63033496|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
33631915|NCT01412944|63033497|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
33631916|NCT01412944|63033498|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
33631917|NCT01412944|63033499|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
33631918|NCT01412944|63033494|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
33631919|NCT01412944|63033495|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
33631920|NCT01412944|63033496|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
33631921|NCT01412944|63033497|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
33631922|NCT01412944|63033498|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
33631923|NCT01412944|63033499|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
33631924|NCT01412944|63033494|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
33631925|NCT01412944|63033495|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
33631926|NCT01412944|63033496|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
33631927|NCT01412944|63033497|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
33631928|NCT01412944|63033498|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
33631929|NCT01412944|63033499|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
33631930|NCT01412944|63033494|FG000|Entire: IV + Maintenance|Adverse Event|0|||
33631931|NCT01412944|63033495|FG001|Entire: IV + Maintenance|Adverse Event|1|||
33631932|NCT01412944|63033496|FG002|Entire: IV + Maintenance|Adverse Event|0|||
33631933|NCT01412944|63033497|FG003|Entire: IV + Maintenance|Adverse Event|0|||
33631934|NCT01412944|63033498|FG004|Entire: IV + Maintenance|Adverse Event|0|||
33631935|NCT01412944|63033499|FG005|Entire: IV + Maintenance|Adverse Event|0|||
33631936|NCT01798485|63033517|FG000|Overall Study|Adverse Event|32|||
33631937|NCT01798485|63033518|FG001|Overall Study|Adverse Event|40|||
33631938|NCT01798485|63033517|FG000|Overall Study|Withdrawal by Subject|27|||
33631939|NCT01798485|63033518|FG001|Overall Study|Withdrawal by Subject|31|||
33631940|NCT01798485|63033517|FG000|Overall Study|Lost to Follow-up|0|||
33631941|NCT01798485|63033518|FG001|Overall Study|Lost to Follow-up|3|||
33631942|NCT01798485|63033517|FG000|Overall Study|Physician Decision|14|||
33631943|NCT01798485|63033518|FG001|Overall Study|Physician Decision|10|||
33631944|NCT01798485|63033517|FG000|Overall Study|Objective Disease Progression|152|||
33631945|NCT01798485|63033518|FG001|Overall Study|Objective Disease Progression|106|||
33631946|NCT01798485|63033517|FG000|Overall Study|Death|25|||
33631947|NCT01798485|63033518|FG001|Overall Study|Death|22|||
33631948|NCT01798485|63033517|FG000|Overall Study|Sponsor Decision|61|||
33631949|NCT01798485|63033518|FG001|Overall Study|Sponsor Decision|54|||
33631950|NCT01798485|63033517|FG000|Overall Study|Clinical Progression|35|||
33631951|NCT01798485|63033518|FG001|Overall Study|Clinical Progression|24|||
33631952|NCT01767597|63033526|FG000|Overall Study|Incomplete intervention|3|||
33631953|NCT01767597|63033527|FG001|Overall Study|Incomplete intervention|1|||
33631954|NCT01767597|63033526|FG000|Overall Study|Withdrawal by Subject|1|||
33631955|NCT01767597|63033527|FG001|Overall Study|Withdrawal by Subject|0|||
33631956|NCT01767519|63033536|FG000|Overall Study|Other Reasons|4|||
33631957|NCT01767519|63033537|FG001|Overall Study|Other Reasons|4|||
33631958|NCT01767519|63033538|FG002|Overall Study|Other Reasons|2|||
33631959|NCT01767519|63033536|FG000|Overall Study|Protocol Violation|0|||
33631960|NCT01767519|63033537|FG001|Overall Study|Protocol Violation|3|||
33631961|NCT01767519|63033538|FG002|Overall Study|Protocol Violation|0|||
33631962|NCT01767519|63033536|FG000|Overall Study|Personal Reasons|1|||
33631963|NCT01767519|63033537|FG001|Overall Study|Personal Reasons|0|||
33631964|NCT01767519|63033538|FG002|Overall Study|Personal Reasons|0|||
33631965|NCT01767519|63033536|FG000|Overall Study|Lost to Follow-up|3|||
33538644|NCT02778867|62928557|FG002|Phase 2|Physician Decision|0|||
33538645|NCT02778867|62928558|FG003|Phase 2|Physician Decision|1|||
33538646|NCT02778867|62928555|FG000|Phase 2|Adverse Event|0|||
33538647|NCT02778867|62928556|FG001|Phase 2|Adverse Event|0|||
33538648|NCT02778867|62928557|FG002|Phase 2|Adverse Event|0|||
33538649|NCT02778867|62928558|FG003|Phase 2|Adverse Event|1|||
33538650|NCT02778555|62928571|FG000|Overall Study|Withdrawal by Subject|55|||
33538651|NCT02778555|62928572|FG001|Overall Study|Withdrawal by Subject|32|||
33538652|NCT02778555|62928573|FG002|Overall Study|Withdrawal by Subject|107|||
33631966|NCT01767519|63033537|FG001|Overall Study|Lost to Follow-up|1|||
33631967|NCT01767519|63033538|FG002|Overall Study|Lost to Follow-up|2|||
33631968|NCT01767519|63033536|FG000|Overall Study|Lack of Efficacy|1|||
33326258|NCT00888940|62703077|FG001|Overall Study|Randomized Not Treated|13|||
33326259|NCT00595621|62703085|FG000|Open Label Run in|Adverse Event|1|||
33326260|NCT00595621|62703086|FG001|Open Label Run in|Adverse Event|0|||
33326261|NCT00595621|62703085|FG000|Open Label Run in|Physician Decision|1|||
33326262|NCT00595621|62703086|FG001|Open Label Run in|Physician Decision|0|||
33326263|NCT00595621|62703085|FG000|Open Label Run in|Withdrawal by Subject|1|||
33326264|NCT00595621|62703086|FG001|Open Label Run in|Withdrawal by Subject|0|||
33326265|NCT00595621|62703085|FG000|Randomization and Study|Adverse Event|2|||
33326266|NCT00595621|62703086|FG001|Randomization and Study|Adverse Event|0|||
33326267|NCT00595621|62703085|FG000|Randomization and Study|Withdrawal by Subject|0|||
33631969|NCT01767519|63033537|FG001|Overall Study|Lack of Efficacy|0|||
33631970|NCT01767519|63033538|FG002|Overall Study|Lack of Efficacy|0|||
33631971|NCT01767519|63033536|FG000|Overall Study|Adverse Event|5|||
33631972|NCT01767519|63033537|FG001|Overall Study|Adverse Event|5|||
33631973|NCT01767519|63033538|FG002|Overall Study|Adverse Event|1|||
33631974|NCT01797783|63033548|FG000|Overall Study|Adverse Event|1|||
33631975|NCT01797783|63033549|FG001|Overall Study|Adverse Event|1|||
33631976|NCT01797783|63033548|FG000|Overall Study|Withdrawal by Subject|1|||
33631977|NCT01797783|63033549|FG001|Overall Study|Withdrawal by Subject|0|||
33631978|NCT01766817|63033566|FG000|Overall Study|Drug-related adverse event|1|||
33631979|NCT01766817|63033567|FG001|Overall Study|Drug-related adverse event|2|||
33631980|NCT01766817|63033568|FG002|Overall Study|Drug-related adverse event|1|||
33631981|NCT01766817|63033566|FG000|Overall Study|Drug-unrelated adverse event|3|||
33631982|NCT01766817|63033567|FG001|Overall Study|Drug-unrelated adverse event|3|||
33631983|NCT01766817|63033568|FG002|Overall Study|Drug-unrelated adverse event|3|||
33631984|NCT01766817|63033566|FG000|Overall Study|Death|1|||
33631985|NCT01766817|63033567|FG001|Overall Study|Death|1|||
33631986|NCT01766817|63033568|FG002|Overall Study|Death|0|||
33631987|NCT01766817|63033566|FG000|Overall Study|Unable to take study drug|0|||
33631988|NCT01766817|63033567|FG001|Overall Study|Unable to take study drug|1|||
33631989|NCT01766817|63033568|FG002|Overall Study|Unable to take study drug|0|||
33631990|NCT01766817|63033566|FG000|Overall Study|Withdrawal by Subject|2|||
33631991|NCT01766817|63033567|FG001|Overall Study|Withdrawal by Subject|0|||
33631992|NCT01766817|63033568|FG002|Overall Study|Withdrawal by Subject|3|||
33631993|NCT01766817|63033566|FG000|Overall Study|Subject non-compliance|0|||
33631994|NCT01766817|63033567|FG001|Overall Study|Subject non-compliance|1|||
33631995|NCT01766817|63033568|FG002|Overall Study|Subject non-compliance|2|||
33631996|NCT01766817|63033566|FG000|Overall Study|Physician Decision|3|||
33326268|NCT00595621|62703086|FG001|Randomization and Study|Withdrawal by Subject|1|||
33326269|NCT00888238|62703093|FG000|Washout Period After Period 2|Adverse Event|0|||
33538653|NCT02778399|62928587|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
33326270|NCT00888238|62703094|FG001|Washout Period After Period 2|Adverse Event|0|||
33326271|NCT00888238|62703095|FG002|Washout Period After Period 2|Adverse Event|1|||
33631997|NCT01766817|63033567|FG001|Overall Study|Physician Decision|3|||
33631998|NCT01766817|63033568|FG002|Overall Study|Physician Decision|4|||
33631999|NCT01766817|63033566|FG000|Overall Study|Other|1|||
33632000|NCT01766817|63033567|FG001|Overall Study|Other|0|||
33632001|NCT01766817|63033568|FG002|Overall Study|Other|0|||
33632002|NCT01797705|63033576|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
33632003|NCT01797705|63033576|FG000|Overall Study|Withdrawal by Subject|1|||
33632004|NCT01797081|63033584|FG000|Overall Study|Adverse Event|1|||
33632005|NCT01797081|63033585|FG001|Overall Study|Adverse Event|0|||
33632006|NCT01797081|63033586|FG002|Overall Study|Adverse Event|1|||
33632007|NCT01797081|63033587|FG003|Overall Study|Adverse Event|0|||
33632008|NCT01797081|63033584|FG000|Overall Study|Pregnancy|1|||
33632009|NCT01797081|63033585|FG001|Overall Study|Pregnancy|0|||
33632010|NCT01797081|63033586|FG002|Overall Study|Pregnancy|0|||
33632011|NCT01797081|63033587|FG003|Overall Study|Pregnancy|0|||
33632012|NCT01797081|63033584|FG000|Overall Study|Personal Reasons|12|||
33632013|NCT01797081|63033585|FG001|Overall Study|Personal Reasons|4|||
33632014|NCT01797081|63033586|FG002|Overall Study|Personal Reasons|4|||
33632015|NCT01797081|63033587|FG003|Overall Study|Personal Reasons|8|||
33632016|NCT01797081|63033584|FG000|Overall Study|Protocol Violation|0|||
33632017|NCT01797081|63033585|FG001|Overall Study|Protocol Violation|0|||
33632018|NCT01797081|63033586|FG002|Overall Study|Protocol Violation|0|||
33632019|NCT01797081|63033587|FG003|Overall Study|Protocol Violation|1|||
33632020|NCT01794117|63033599|FG000|Overall Study|Adverse Event|1|||
33632021|NCT01794117|63033600|FG001|Overall Study|Adverse Event|0|||
33632022|NCT01794117|63033601|FG002|Overall Study|Adverse Event|0|||
33632023|NCT01794117|63033602|FG003|Overall Study|Adverse Event|0|||
33632024|NCT01794117|63033599|FG000|Overall Study|Participant noncompliance|0|||
33632025|NCT01794117|63033600|FG001|Overall Study|Participant noncompliance|1|||
33632026|NCT01794117|63033601|FG002|Overall Study|Participant noncompliance|0|||
33632027|NCT01794117|63033602|FG003|Overall Study|Participant noncompliance|0|||
33632028|NCT01794117|63033599|FG000|Overall Study|Refused further treatment|0|||
33632029|NCT01794117|63033600|FG001|Overall Study|Refused further treatment|2|||
33632030|NCT01794117|63033601|FG002|Overall Study|Refused further treatment|0|||
33632031|NCT01794117|63033602|FG003|Overall Study|Refused further treatment|0|||
33632032|NCT01766037|63033615|FG000|Overall Study|Adverse Event|1|||
33632033|NCT01766037|63033616|FG001|Overall Study|Adverse Event|0|||
33632034|NCT01766037|63033615|FG000|Overall Study|Lack of Efficacy|1|||
33632035|NCT01766037|63033616|FG001|Overall Study|Lack of Efficacy|0|||
33632036|NCT01766037|63033615|FG000|Overall Study|Lost to Follow-up|0|||
33632037|NCT01766037|63033616|FG001|Overall Study|Lost to Follow-up|10|||
33632038|NCT01766037|63033615|FG000|Overall Study|Physician Decision|0|||
33632039|NCT01766037|63033616|FG001|Overall Study|Physician Decision|1|||
33632040|NCT01766037|63033615|FG000|Overall Study|Withdrawal by Subject|18|||
33632041|NCT01766037|63033616|FG001|Overall Study|Withdrawal by Subject|16|||
33632042|NCT01766037|63033615|FG000|Overall Study|Moved from area|5|||
33632043|NCT01766037|63033616|FG001|Overall Study|Moved from area|0|||
33632044|NCT01766037|63033615|FG000|Overall Study|medical - unrelated|1|||
33632045|NCT01766037|63033616|FG001|Overall Study|medical - unrelated|2|||
33632046|NCT01766037|63033615|FG000|Overall Study|nausea / discomfort|3|||
33632047|NCT01766037|63033616|FG001|Overall Study|nausea / discomfort|0|||
33632048|NCT01765569|63033622|FG000|Period B|Withdrawal by Subject|1|||
33632049|NCT01765569|63033622|FG000|Period C|Death|1|||
33632050|NCT01609257|63033631|FG000|Overall Study|Lost to Follow-up|2|||
33632051|NCT01609257|63033632|FG001|Overall Study|Lost to Follow-up|1|||
33632052|NCT01609257|63033631|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
33632053|NCT01609257|63033632|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
33632054|NCT01609257|63033631|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
33632055|NCT01609257|63033632|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
33632056|NCT01609023|63033641|FG000|Overall Study|Lack of Efficacy|3|||
33632057|NCT01609023|63033641|FG000|Overall Study|Withdrawal by Subject|4|||
33632058|NCT01609023|63033641|FG000|Overall Study|Lost to Follow-up|8|||
33632059|NCT01609023|63033641|FG000|Overall Study|Toxicity|3|||
33632060|NCT01609023|63033641|FG000|Overall Study|Disease progression|10|||
33632061|NCT01609023|63033641|FG000|Overall Study|Physician Decision|2|||
33632062|NCT01609023|63033641|FG000|Overall Study|Death|2|||
33632063|NCT01609023|63033641|FG000|Overall Study|Personal reasons|1|||
33632064|NCT01765179|63033645|FG000|Overall Study|Adverse Event|3|||
33632065|NCT01765179|63033645|FG000|Overall Study|Lost to Follow-up|5|||
33632066|NCT01765179|63033645|FG000|Overall Study|Non-compliance with study drug|2|||
33632067|NCT01765179|63033645|FG000|Overall Study|Protocol Violation|1|||
33632068|NCT01765179|63033645|FG000|Overall Study|Withdrawal by Subject|8|||
33632069|NCT01765179|63033645|FG000|Overall Study|Hematocrit >54%|3|||
33632070|NCT01765179|63033645|FG000|Overall Study|prohibited med|1|||
33632071|NCT01765179|63033645|FG000|Overall Study|Out of country unable to finish study|1|||
33632072|NCT01765179|63033645|FG000|Overall Study|lack of venous access|1|||
33544255|NCT03012061|62935097|FG001|Overall Study|Lack of Efficacy|1|||
33632073|NCT01765179|63033645|FG000|Overall Study|work conflict|1|||
33632074|NCT01765179|63033645|FG000|Overall Study|Ca elevated 10.6|1|||
33632075|NCT01764945|63033657|FG000|Overall Study|Adverse Event|0|||
33632076|NCT01764945|63033658|FG001|Overall Study|Adverse Event|1|||
33632077|NCT01764945|63033659|FG002|Overall Study|Adverse Event|0|||
33632078|NCT01764945|63033660|FG003|Overall Study|Adverse Event|0|||
33632079|NCT01764945|63033661|FG004|Overall Study|Adverse Event|0|||
33632080|NCT01764945|63033662|FG005|Overall Study|Adverse Event|0|||
33326272|NCT00595465|62703104|FG000|Overall Study|Adverse Event|4|||
33326273|NCT00595465|62703105|FG001|Overall Study|Adverse Event|3|||
33538654|NCT02778399|62928588|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
33538655|NCT02778399|62928589|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
33538656|NCT02778399|62928590|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
33538657|NCT02778399|62928591|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
33538658|NCT02778399|62928592|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
33538659|NCT02778399|62928587|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
33538660|NCT02778399|62928588|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
33538661|NCT02778399|62928589|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
33538662|NCT02778399|62928590|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
33538663|NCT02778399|62928591|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
33538664|NCT02778399|62928592|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
33538665|NCT02778399|62928587|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
33538666|NCT02778399|62928588|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
33538667|NCT02778399|62928589|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
33538668|NCT02778399|62928590|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
33538669|NCT02778399|62928591|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
33538670|NCT02778399|62928592|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
33538671|NCT02778399|62928587|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
33538672|NCT02778399|62928588|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
33538673|NCT02778399|62928589|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
33538674|NCT02778399|62928590|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
33538675|NCT02778399|62928591|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
33538676|NCT02778399|62928592|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
33538677|NCT02778399|62928587|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
33538678|NCT02778399|62928588|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
33538679|NCT02778399|62928589|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
33538680|NCT02778399|62928590|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
33538681|NCT02778399|62928591|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
33538682|NCT02778399|62928592|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
33538683|NCT02778399|62928587|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
33538684|NCT02778399|62928588|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
33538685|NCT02778399|62928589|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
33538686|NCT02778399|62928590|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
33538687|NCT02778399|62928591|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
33538688|NCT02778399|62928592|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
33538689|NCT02778399|62928587|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
33538690|NCT02778399|62928588|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
33538691|NCT02778399|62928589|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
33538692|NCT02778399|62928590|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
33538693|NCT02778399|62928591|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
33538694|NCT02778399|62928592|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
33538695|NCT02778399|62928587|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
33538696|NCT02778399|62928588|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
33538697|NCT02778399|62928589|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
33538698|NCT02778399|62928590|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
33538699|NCT02778399|62928591|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
33538700|NCT02778399|62928592|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
33538701|NCT02778399|62928587|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
33538702|NCT02778399|62928588|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
33538703|NCT02778399|62928589|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
33538704|NCT02778399|62928590|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
33538705|NCT02778399|62928591|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
33538706|NCT02778399|62928592|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
33538707|NCT02778399|62928587|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
33538708|NCT02778399|62928588|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
33538709|NCT02778399|62928589|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
33538710|NCT02778399|62928590|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
33538711|NCT02778399|62928591|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
33538712|NCT02778399|62928592|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
33538713|NCT02778399|62928587|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
33632081|NCT01764945|63033663|FG006|Overall Study|Adverse Event|1|||
33632082|NCT01764945|63033664|FG007|Overall Study|Adverse Event|0|||
33326274|NCT00595465|62703106|FG002|Overall Study|Adverse Event|3|||
33632083|NCT01793883|63033685|FG000|Overall Study|Withdrawal by Subject|3|||
33632084|NCT01793883|63033686|FG001|Overall Study|Withdrawal by Subject|7|||
33632085|NCT01793883|63033687|FG002|Overall Study|Withdrawal by Subject|3|||
33632086|NCT01793883|63033685|FG000|Overall Study|Subject noncompliance|0|||
33632087|NCT01793883|63033686|FG001|Overall Study|Subject noncompliance|1|||
33632088|NCT01793883|63033687|FG002|Overall Study|Subject noncompliance|1|||
33632089|NCT01793883|63033685|FG000|Overall Study|Lost to Follow-up|5|||
33632090|NCT01793883|63033686|FG001|Overall Study|Lost to Follow-up|1|||
33632091|NCT01793883|63033687|FG002|Overall Study|Lost to Follow-up|3|||
33632092|NCT01793883|63033685|FG000|Overall Study|Randomized in error|1|||
33632093|NCT01793883|63033686|FG001|Overall Study|Randomized in error|0|||
33632094|NCT01793883|63033687|FG002|Overall Study|Randomized in error|0|||
33632095|NCT01793883|63033685|FG000|Overall Study|Unable to complete spriometry|1|||
33632096|NCT01793883|63033686|FG001|Overall Study|Unable to complete spriometry|0|||
33632097|NCT01793883|63033687|FG002|Overall Study|Unable to complete spriometry|0|||
33632098|NCT01793883|63033685|FG000|Overall Study|Unable to complete measurements|1|||
33632099|NCT01793883|63033686|FG001|Overall Study|Unable to complete measurements|0|||
33632100|NCT01793883|63033687|FG002|Overall Study|Unable to complete measurements|0|||
33632101|NCT01793883|63033685|FG000|Overall Study|Met exclusion criteria|1|||
33632102|NCT01793883|63033686|FG001|Overall Study|Met exclusion criteria|0|||
33632103|NCT01793883|63033687|FG002|Overall Study|Met exclusion criteria|0|||
33632104|NCT01793883|63033685|FG000|Overall Study|Dosing error|0|||
33632105|NCT01793883|63033686|FG001|Overall Study|Dosing error|1|||
33632106|NCT01793883|63033687|FG002|Overall Study|Dosing error|0|||
33632107|NCT01793883|63033685|FG000|Overall Study|Respiratory distress during spirometry|0|||
33632108|NCT01793883|63033686|FG001|Overall Study|Respiratory distress during spirometry|0|||
33632109|NCT01793883|63033687|FG002|Overall Study|Respiratory distress during spirometry|1|||
33632110|NCT01792635|63033698|FG000|Part B|Adverse Event|0|||
33632111|NCT01792635|63033699|FG001|Part B|Adverse Event|0|||
33632112|NCT01792635|63033700|FG002|Part B|Adverse Event|1|||
33632113|NCT01792635|63033698|FG000|Part B|Study terminated|0|||
33632114|NCT01792635|63033699|FG001|Part B|Study terminated|4|||
33632115|NCT01792635|63033700|FG002|Part B|Study terminated|3|||
33632116|NCT01953692|63033718|FG000|Overall Study|Adverse Event|5|||
33632117|NCT01953692|63033719|FG001|Overall Study|Adverse Event|2|||
33632118|NCT01953692|63033720|FG002|Overall Study|Adverse Event|4|||
33632119|NCT01953692|63033721|FG003|Overall Study|Adverse Event|2|||
33632120|NCT01953692|63033722|FG004|Overall Study|Adverse Event|1|||
33632121|NCT01953692|63033723|FG005|Overall Study|Adverse Event|2|||
33632122|NCT01953692|63033724|FG006|Overall Study|Adverse Event|0|||
33632123|NCT01953692|63033725|FG007|Overall Study|Adverse Event|0|||
33632124|NCT01953692|63033726|FG008|Overall Study|Adverse Event|0|||
33632125|NCT01953692|63033718|FG000|Overall Study|Clinical Progression|0|||
33632126|NCT01953692|63033719|FG001|Overall Study|Clinical Progression|15|||
33632127|NCT01953692|63033720|FG002|Overall Study|Clinical Progression|7|||
33632128|NCT01953692|63033721|FG003|Overall Study|Clinical Progression|5|||
33632129|NCT01953692|63033722|FG004|Overall Study|Clinical Progression|0|||
33538714|NCT02778399|62928588|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
33538715|NCT02778399|62928589|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
33538716|NCT02778399|62928590|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
33326275|NCT00595465|62703104|FG000|Overall Study|Pregnancy|0|||
33538717|NCT02778399|62928591|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
33538718|NCT02778399|62928592|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
33538719|NCT03656744|62928641|FG000|Overall Study|Adverse Event|1|||
33538720|NCT03656744|62928642|FG001|Overall Study|Adverse Event|4|||
33538721|NCT03656744|62928643|FG002|Overall Study|Adverse Event|1|||
33538722|NCT03656744|62928641|FG000|Overall Study|Protocol Violation|1|||
33538723|NCT03656744|62928642|FG001|Overall Study|Protocol Violation|0|||
33538724|NCT03656744|62928643|FG002|Overall Study|Protocol Violation|0|||
33538725|NCT03656744|62928641|FG000|Overall Study|Lost to Follow-up|2|||
33538726|NCT03656744|62928642|FG001|Overall Study|Lost to Follow-up|2|||
33632130|NCT01953692|63033723|FG005|Overall Study|Clinical Progression|7|||
33632131|NCT01953692|63033724|FG006|Overall Study|Clinical Progression|20|||
33632132|NCT01953692|63033725|FG007|Overall Study|Clinical Progression|3|||
33632133|NCT01953692|63033726|FG008|Overall Study|Clinical Progression|3|||
33632134|NCT01953692|63033718|FG000|Overall Study|Death|5|||
33632135|NCT01953692|63033719|FG001|Overall Study|Death|0|||
33632136|NCT01953692|63033720|FG002|Overall Study|Death|2|||
33632137|NCT01953692|63033721|FG003|Overall Study|Death|2|||
33632138|NCT01953692|63033722|FG004|Overall Study|Death|1|||
33538727|NCT03656744|62928643|FG002|Overall Study|Lost to Follow-up|0|||
33538728|NCT03656744|62928641|FG000|Overall Study|Withdrawal by Subject|0|||
33632139|NCT01953692|63033723|FG005|Overall Study|Death|3|||
33632140|NCT01953692|63033724|FG006|Overall Study|Death|6|||
33632141|NCT01953692|63033725|FG007|Overall Study|Death|2|||
33632142|NCT01953692|63033726|FG008|Overall Study|Death|1|||
33632143|NCT01953692|63033718|FG000|Overall Study|Excluded Medication|1|||
33632144|NCT01953692|63033719|FG001|Overall Study|Excluded Medication|0|||
33632145|NCT01953692|63033720|FG002|Overall Study|Excluded Medication|0|||
33632146|NCT01953692|63033721|FG003|Overall Study|Excluded Medication|0|||
33632147|NCT01953692|63033722|FG004|Overall Study|Excluded Medication|0|||
33632148|NCT01953692|63033723|FG005|Overall Study|Excluded Medication|0|||
33632149|NCT01953692|63033724|FG006|Overall Study|Excluded Medication|0|||
33632150|NCT01953692|63033725|FG007|Overall Study|Excluded Medication|0|||
33632151|NCT01953692|63033726|FG008|Overall Study|Excluded Medication|0|||
33632152|NCT01953692|63033718|FG000|Overall Study|Lost to Follow-up|1|||
33632153|NCT01953692|63033719|FG001|Overall Study|Lost to Follow-up|0|||
33632154|NCT01953692|63033720|FG002|Overall Study|Lost to Follow-up|3|||
33632155|NCT01953692|63033721|FG003|Overall Study|Lost to Follow-up|1|||
33632156|NCT01953692|63033722|FG004|Overall Study|Lost to Follow-up|0|||
33632157|NCT01953692|63033723|FG005|Overall Study|Lost to Follow-up|1|||
33632158|NCT01953692|63033724|FG006|Overall Study|Lost to Follow-up|0|||
33632159|NCT01953692|63033725|FG007|Overall Study|Lost to Follow-up|0|||
33632160|NCT01953692|63033726|FG008|Overall Study|Lost to Follow-up|0|||
33632161|NCT01953692|63033718|FG000|Overall Study|Physician Decision|11|||
33632162|NCT01953692|63033719|FG001|Overall Study|Physician Decision|4|||
33326276|NCT00595465|62703105|FG001|Overall Study|Pregnancy|0|||
33326277|NCT00595465|62703106|FG002|Overall Study|Pregnancy|1|||
33326278|NCT00595465|62703104|FG000|Overall Study|Protocol Violation|2|||
33326279|NCT00595465|62703105|FG001|Overall Study|Protocol Violation|1|||
33326280|NCT00595465|62703106|FG002|Overall Study|Protocol Violation|0|||
33326281|NCT00595465|62703104|FG000|Overall Study|Lost to Follow-up|0|||
33326282|NCT00595465|62703105|FG001|Overall Study|Lost to Follow-up|0|||
33326283|NCT00595465|62703106|FG002|Overall Study|Lost to Follow-up|2|||
33326284|NCT00595465|62703104|FG000|Overall Study|administrative reason|0|||
33326285|NCT00595465|62703105|FG001|Overall Study|administrative reason|0|||
33326286|NCT00595465|62703106|FG002|Overall Study|administrative reason|1|||
33326287|NCT01205438|62703117|FG000|Overall Study|Adverse Event|19|||
33326288|NCT01205438|62703118|FG001|Overall Study|Adverse Event|17|||
33326289|NCT01205438|62703119|FG002|Overall Study|Adverse Event|24|||
33326290|NCT01205438|62703117|FG000|Overall Study|Death|1|||
33326291|NCT01205438|62703118|FG001|Overall Study|Death|1|||
33326292|NCT01205438|62703119|FG002|Overall Study|Death|3|||
33326293|NCT01205438|62703117|FG000|Overall Study|Entry Criteria Not Met|16|||
33326294|NCT01205438|62703118|FG001|Overall Study|Entry Criteria Not Met|15|||
33326295|NCT01205438|62703119|FG002|Overall Study|Entry Criteria Not Met|13|||
33326296|NCT01205438|62703117|FG000|Overall Study|Lack of Efficacy|14|||
33326297|NCT01205438|62703118|FG001|Overall Study|Lack of Efficacy|11|||
33326298|NCT01205438|62703119|FG002|Overall Study|Lack of Efficacy|14|||
33326299|NCT01205438|62703117|FG000|Overall Study|Lost to Follow-up|6|||
33326300|NCT01205438|62703118|FG001|Overall Study|Lost to Follow-up|7|||
33326301|NCT01205438|62703119|FG002|Overall Study|Lost to Follow-up|8|||
33326302|NCT01205438|62703117|FG000|Overall Study|Withdrawal by Subject|19|||
33326303|NCT01205438|62703118|FG001|Overall Study|Withdrawal by Subject|25|||
33326304|NCT01205438|62703119|FG002|Overall Study|Withdrawal by Subject|19|||
33326305|NCT01205438|62703117|FG000|Overall Study|Physician Decision|0|||
33632163|NCT01953692|63033720|FG002|Overall Study|Physician Decision|2|||
33632164|NCT01953692|63033721|FG003|Overall Study|Physician Decision|2|||
33326306|NCT01205438|62703118|FG001|Overall Study|Physician Decision|3|||
33326307|NCT01205438|62703119|FG002|Overall Study|Physician Decision|2|||
33326308|NCT01205438|62703117|FG000|Overall Study|Protocol Violation|2|||
33326309|NCT01205438|62703118|FG001|Overall Study|Protocol Violation|7|||
33326310|NCT01205438|62703119|FG002|Overall Study|Protocol Violation|4|||
33326311|NCT01205438|62703117|FG000|Overall Study|Sponsor Decision|0|||
33326312|NCT01205438|62703118|FG001|Overall Study|Sponsor Decision|1|||
33326313|NCT01205438|62703119|FG002|Overall Study|Sponsor Decision|1|||
33326314|NCT01104870|62703133|FG000|Overall Study|Adverse Event|1|||
33326315|NCT01104870|62703134|FG001|Overall Study|Adverse Event|1|||
33326316|NCT01104870|62703135|FG002|Overall Study|Adverse Event|0|||
33326317|NCT01104870|62703133|FG000|Overall Study|Death|0|||
33326318|NCT01104870|62703134|FG001|Overall Study|Death|0|||
33326319|NCT01104870|62703135|FG002|Overall Study|Death|1|||
33326320|NCT01104870|62703133|FG000|Overall Study|Withdrawal by Subject|0|||
33326321|NCT01104870|62703134|FG001|Overall Study|Withdrawal by Subject|0|||
33326322|NCT01104870|62703135|FG002|Overall Study|Withdrawal by Subject|1|||
33326323|NCT01104792|62703143|FG000|Overall Study|Adverse Event|77|||
33326324|NCT01104792|62703143|FG000|Overall Study|Insufficient Therapeutic Response|22|||
33326325|NCT01104792|62703143|FG000|Overall Study|Protocol Violation|45|||
33326326|NCT01104792|62703143|FG000|Overall Study|Withdrawal of Consent|179|||
33326327|NCT01104792|62703143|FG000|Overall Study|Lost to Follow-up|43|||
33326328|NCT01104792|62703143|FG000|Overall Study|Reasons Not Specified|27|||
33326329|NCT01104792|62703143|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
33326330|NCT01205126|62703149|FG000|Titration Phase|Adverse Event|5|||
33326331|NCT01205126|62703150|FG001|Titration Phase|Adverse Event|3|||
33326332|NCT01205126|62703149|FG000|Titration Phase|Withdrawal by Subject|5|||
33326333|NCT01205126|62703150|FG001|Titration Phase|Withdrawal by Subject|5|||
33326334|NCT01205126|62703149|FG000|Titration Phase|Lost to Follow-up|2|||
33632165|NCT01953692|63033722|FG004|Overall Study|Physician Decision|1|||
33538729|NCT03656744|62928642|FG001|Overall Study|Withdrawal by Subject|1|||
33538730|NCT03656744|62928643|FG002|Overall Study|Withdrawal by Subject|0|||
33632166|NCT01953692|63033723|FG005|Overall Study|Physician Decision|2|||
33632167|NCT01953692|63033724|FG006|Overall Study|Physician Decision|4|||
33632168|NCT01953692|63033725|FG007|Overall Study|Physician Decision|1|||
33632169|NCT01953692|63033726|FG008|Overall Study|Physician Decision|0|||
33326335|NCT01205126|62703150|FG001|Titration Phase|Lost to Follow-up|2|||
33326336|NCT01205126|62703149|FG000|Titration Phase|No stable titration dose|1|||
33461446|NCT02899195|62834705|FG000|Maintenance Durvalumab|Progressive Disease|31|||
33461447|NCT02527200|62834795|FG000|Overall Study|Withdrawal by Subject|3|||
33461448|NCT02527200|62834796|FG001|Overall Study|Withdrawal by Subject|2|||
33461449|NCT02527200|62834797|FG002|Overall Study|Withdrawal by Subject|1|||
33461450|NCT02527200|62834798|FG003|Overall Study|Withdrawal by Subject|0|||
33461451|NCT02527200|62834795|FG000|Overall Study|Unclassified|0|||
33461452|NCT02527200|62834796|FG001|Overall Study|Unclassified|1|||
33461453|NCT02527200|62834797|FG002|Overall Study|Unclassified|0|||
33461454|NCT02527200|62834798|FG003|Overall Study|Unclassified|0|||
33461455|NCT02527200|62834795|FG000|Overall Study|Lost to Follow-up|0|||
33461456|NCT02527200|62834796|FG001|Overall Study|Lost to Follow-up|0|||
33461457|NCT02527200|62834797|FG002|Overall Study|Lost to Follow-up|1|||
33461458|NCT02527200|62834798|FG003|Overall Study|Lost to Follow-up|0|||
33538731|NCT03656744|62928641|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
33538732|NCT03656744|62928642|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
33538733|NCT03656744|62928643|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
33538734|NCT02739360|62928651|FG000|Overall Study|Adverse Event|1|||
33538735|NCT02739360|62928651|FG000|Overall Study|Study terminated by Sponsor|2|||
33538736|NCT01822522|62928661|FG000|Overall Study|Adverse Event|1|||
33538737|NCT01822522|62928662|FG001|Overall Study|Adverse Event|1|||
33538738|NCT01822522|62928663|FG002|Overall Study|Adverse Event|1|||
33538739|NCT01822522|62928664|FG003|Overall Study|Adverse Event|0|||
33538740|NCT01822522|62928665|FG004|Overall Study|Adverse Event|0|||
33632170|NCT01953692|63033718|FG000|Overall Study|Protocol Violation|0|||
33326337|NCT01205126|62703150|FG001|Titration Phase|No stable titration dose|0|||
33461459|NCT02510040|62834815|FG000|Overall Study|Deemed no longer eligible|18|||
33538741|NCT01822522|62928666|FG005|Overall Study|Adverse Event|1|||
33538742|NCT01822522|62928661|FG000|Overall Study|Death|3|||
33538743|NCT01822522|62928662|FG001|Overall Study|Death|0|||
33632171|NCT01953692|63033719|FG001|Overall Study|Protocol Violation|2|||
33326338|NCT01205126|62703149|FG000|Titration Phase|More than maximum dosage required|2|||
33326339|NCT01205126|62703150|FG001|Titration Phase|More than maximum dosage required|3|||
33326340|NCT01205126|62703149|FG000|Titration Phase|Other|8|||
33326341|NCT01205126|62703150|FG001|Titration Phase|Other|6|||
33461460|NCT02510040|62834816|FG001|Overall Study|Deemed no longer eligible|3|||
33461461|NCT02510040|62834817|FG002|Overall Study|Deemed no longer eligible|1|||
33632172|NCT01953692|63033720|FG002|Overall Study|Protocol Violation|1|||
33461462|NCT02296125|62834841|FG000|Overall Study|Withdrawal by Subject|18|||
33461463|NCT02296125|62834842|FG001|Overall Study|Withdrawal by Subject|8|||
33461464|NCT02296125|62834843|FG002|Overall Study|Withdrawal by Subject|6|||
33461465|NCT02296125|62834844|FG003|Overall Study|Withdrawal by Subject|2|||
33461466|NCT02296125|62834841|FG000|Overall Study|Adverse Event|41|||
33461467|NCT02296125|62834842|FG001|Overall Study|Adverse Event|52|||
33461468|NCT02296125|62834843|FG002|Overall Study|Adverse Event|9|||
33461469|NCT02296125|62834844|FG003|Overall Study|Adverse Event|4|||
33461470|NCT02296125|62834841|FG000|Overall Study|Severe non-compliance to protocol|0|||
33461471|NCT02296125|62834842|FG001|Overall Study|Severe non-compliance to protocol|1|||
33461472|NCT02296125|62834843|FG002|Overall Study|Severe non-compliance to protocol|0|||
33461473|NCT02296125|62834844|FG003|Overall Study|Severe non-compliance to protocol|0|||
33461474|NCT02296125|62834841|FG000|Overall Study|Condition under investigation worsened|153|||
33461475|NCT02296125|62834842|FG001|Overall Study|Condition under investigation worsened|199|||
33461476|NCT02296125|62834843|FG002|Overall Study|Condition under investigation worsened|39|||
33461477|NCT02296125|62834844|FG003|Overall Study|Condition under investigation worsened|56|||
33461478|NCT02296125|62834841|FG000|Overall Study|Any reason not specifically recorded|6|||
33461479|NCT02296125|62834842|FG001|Overall Study|Any reason not specifically recorded|4|||
33461480|NCT02296125|62834843|FG002|Overall Study|Any reason not specifically recorded|2|||
33461481|NCT02296125|62834844|FG003|Overall Study|Any reason not specifically recorded|0|||
33461482|NCT01935089|62834859|FG000|Overall Study|Adverse Event|2|||
33461483|NCT01935089|62834859|FG000|Overall Study|Withdrawal by Subject|1|||
33461484|NCT00770809|62834898|FG000|Overall Study|Adverse Event|9|||
33461485|NCT00770809|62834899|FG001|Overall Study|Adverse Event|1|||
33461486|NCT00770809|62834900|FG002|Overall Study|Adverse Event|12|||
33461487|NCT00770809|62834898|FG000|Overall Study|Death|1|||
33461488|NCT00770809|62834899|FG001|Overall Study|Death|0|||
33461489|NCT00770809|62834900|FG002|Overall Study|Death|0|||
33461490|NCT00770809|62834898|FG000|Overall Study|Withdrawal by Subject|3|||
33461491|NCT00770809|62834899|FG001|Overall Study|Withdrawal by Subject|3|||
33461492|NCT00770809|62834900|FG002|Overall Study|Withdrawal by Subject|7|||
33461493|NCT00770809|62834898|FG000|Overall Study|Progression|2|||
33461494|NCT00770809|62834899|FG001|Overall Study|Progression|2|||
33461495|NCT00770809|62834900|FG002|Overall Study|Progression|0|||
33461496|NCT00770809|62834898|FG000|Overall Study|Complicating illness|0|||
33461497|NCT00770809|62834899|FG001|Overall Study|Complicating illness|0|||
33461498|NCT00770809|62834900|FG002|Overall Study|Complicating illness|1|||
33461499|NCT00770809|62834898|FG000|Overall Study|Other Medical Reasons|2|||
33461500|NCT00770809|62834899|FG001|Overall Study|Other Medical Reasons|4|||
33461501|NCT00770809|62834900|FG002|Overall Study|Other Medical Reasons|3|||
33461502|NCT00571727|62834908|FG000|Overall Study|Did not enter in this study|1|||
33461503|NCT00571727|62834908|FG000|Overall Study|Non-compliance|4|||
33461504|NCT00571727|62834908|FG000|Overall Study|Lost to Follow-up|30|||
33461505|NCT00571727|62834908|FG000|Overall Study|Poor growth|1|||
33461506|NCT00571727|62834908|FG000|Overall Study|Parent/patient decision|2|||
33461507|NCT00571727|62834908|FG000|Overall Study|Participant transferred to commercial drug|14|||
33461508|NCT00571727|62834908|FG000|Overall Study|Unable to provide study drug|6|||
33461509|NCT00571727|62834908|FG000|Overall Study|On-treatment at end of study|8|||
33461510|NCT00489307|62834914|FG000|Overall Study|Death|1|||
33461511|NCT00489307|62834915|FG001|Overall Study|Death|1|||
33461512|NCT00489307|62834914|FG000|Overall Study|Lost to Follow-up|2|||
33461513|NCT00489307|62834915|FG001|Overall Study|Lost to Follow-up|2|||
33461514|NCT00489307|62834914|FG000|Overall Study|Physician Decision|1|||
33461515|NCT00489307|62834915|FG001|Overall Study|Physician Decision|0|||
33461516|NCT00489307|62834914|FG000|Overall Study|Withdrawal by Subject|2|||
33461517|NCT00489307|62834915|FG001|Overall Study|Withdrawal by Subject|4|||
33461518|NCT00489307|62834914|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
33461519|NCT00489307|62834915|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
33461520|NCT00489307|62834914|FG000|Overall Study|Surgery after assignment|1|||
33538744|NCT01822522|62928663|FG002|Overall Study|Death|2|||
33538745|NCT01822522|62928664|FG003|Overall Study|Death|0|||
33538746|NCT01822522|62928665|FG004|Overall Study|Death|0|||
33538747|NCT01822522|62928666|FG005|Overall Study|Death|0|||
33538748|NCT01822522|62928661|FG000|Overall Study|Lost to Follow-up|0|||
33538749|NCT01822522|62928662|FG001|Overall Study|Lost to Follow-up|0|||
33538750|NCT01822522|62928663|FG002|Overall Study|Lost to Follow-up|1|||
33461521|NCT00489307|62834915|FG001|Overall Study|Surgery after assignment|0|||
33461522|NCT00489307|62834914|FG000|Overall Study|Did not fill up the forms|2|||
33461523|NCT00489307|62834915|FG001|Overall Study|Did not fill up the forms|1|||
33461524|NCT00489307|62834914|FG000|Overall Study|Patient or family refusal|5|||
33461525|NCT00489307|62834915|FG001|Overall Study|Patient or family refusal|9|||
33461526|NCT00427349|62834921|FG000|Overall Study|Lack of Efficacy|23|||
33461527|NCT00427349|62834921|FG000|Overall Study|Adverse Event|14|||
33538751|NCT01822522|62928664|FG003|Overall Study|Lost to Follow-up|1|||
33461528|NCT00427349|62834921|FG000|Overall Study|Death|1|||
33538752|NCT01822522|62928665|FG004|Overall Study|Lost to Follow-up|0|||
33538753|NCT01822522|62928666|FG005|Overall Study|Lost to Follow-up|1|||
33538754|NCT01822522|62928661|FG000|Overall Study|Withdrawal by Subject|0|||
33538755|NCT01822522|62928662|FG001|Overall Study|Withdrawal by Subject|0|||
33538756|NCT01822522|62928663|FG002|Overall Study|Withdrawal by Subject|0|||
33538757|NCT01822522|62928664|FG003|Overall Study|Withdrawal by Subject|1|||
33538758|NCT01822522|62928665|FG004|Overall Study|Withdrawal by Subject|0|||
33538759|NCT01822522|62928666|FG005|Overall Study|Withdrawal by Subject|0|||
33538760|NCT01822522|62928661|FG000|Overall Study|Lack of Efficacy|0|||
33538761|NCT01822522|62928662|FG001|Overall Study|Lack of Efficacy|0|||
33538762|NCT01822522|62928663|FG002|Overall Study|Lack of Efficacy|0|||
33538763|NCT01822522|62928664|FG003|Overall Study|Lack of Efficacy|0|||
33538764|NCT01822522|62928665|FG004|Overall Study|Lack of Efficacy|0|||
33538765|NCT01822522|62928666|FG005|Overall Study|Lack of Efficacy|2|||
33538766|NCT00102687|62928710|FG000|Initial Period|Withdrawal by Subject|6|||
33538767|NCT00102687|62928711|FG001|Initial Period|Withdrawal by Subject|3|||
33538768|NCT00102687|62928712|FG002|Initial Period|Withdrawal by Subject|5|||
33538769|NCT00102687|62928713|FG003|Initial Period|Withdrawal by Subject|0|||
33538770|NCT00102687|62928714|FG004|Initial Period|Withdrawal by Subject|0|||
33538771|NCT00102687|62928710|FG000|Initial Period|Adverse Event|4|||
33538772|NCT00102687|62928711|FG001|Initial Period|Adverse Event|7|||
33538773|NCT00102687|62928712|FG002|Initial Period|Adverse Event|9|||
33538774|NCT00102687|62928713|FG003|Initial Period|Adverse Event|0|||
33538775|NCT00102687|62928714|FG004|Initial Period|Adverse Event|0|||
33538776|NCT00102687|62928710|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
33538777|NCT00102687|62928711|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
33538778|NCT00102687|62928712|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
33538779|NCT00102687|62928713|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
33538780|NCT00102687|62928714|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
33538781|NCT00102687|62928710|FG000|Initial Period|Protocol Violation|0|||
33538782|NCT00102687|62928711|FG001|Initial Period|Protocol Violation|0|||
33538783|NCT00102687|62928712|FG002|Initial Period|Protocol Violation|2|||
33538784|NCT00102687|62928713|FG003|Initial Period|Protocol Violation|0|||
33538785|NCT00102687|62928714|FG004|Initial Period|Protocol Violation|0|||
33538786|NCT00102687|62928710|FG000|Initial Period|Physician Decision|2|||
33538787|NCT00102687|62928711|FG001|Initial Period|Physician Decision|9|||
33538788|NCT00102687|62928712|FG002|Initial Period|Physician Decision|6|||
33538789|NCT00102687|62928713|FG003|Initial Period|Physician Decision|0|||
33538790|NCT00102687|62928714|FG004|Initial Period|Physician Decision|0|||
33538791|NCT00102687|62928710|FG000|Initial Period|Sponsor's decision|0|||
33538792|NCT00102687|62928711|FG001|Initial Period|Sponsor's decision|1|||
33538793|NCT00102687|62928712|FG002|Initial Period|Sponsor's decision|1|||
33538794|NCT00102687|62928713|FG003|Initial Period|Sponsor's decision|0|||
33538795|NCT00102687|62928714|FG004|Initial Period|Sponsor's decision|0|||
33538796|NCT00102687|62928710|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
33538797|NCT00102687|62928711|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
33538798|NCT00102687|62928712|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
33538799|NCT00102687|62928713|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
33538800|NCT00102687|62928714|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
33326342|NCT01205126|62703149|FG000|Between Titration & Maintenance Phase|Other|0|||
33326343|NCT01205126|62703150|FG001|Between Titration & Maintenance Phase|Other|4|||
33326344|NCT01205126|62703149|FG000|Maintenance Phase|Adverse Event|3|||
33326345|NCT01205126|62703150|FG001|Maintenance Phase|Adverse Event|7|||
33326346|NCT01205126|62703149|FG000|Maintenance Phase|Death|4|||
33326347|NCT01205126|62703150|FG001|Maintenance Phase|Death|4|||
33326348|NCT01205126|62703149|FG000|Maintenance Phase|More than the maximum dosage required|5|||
33326349|NCT01205126|62703150|FG001|Maintenance Phase|More than the maximum dosage required|5|||
33461529|NCT00427349|62834921|FG000|Overall Study|Withdrawal by Subject|3|||
33461530|NCT00427349|62834921|FG000|Overall Study|Alternative therapy|1|||
33461531|NCT00427349|62834921|FG000|Overall Study|Other|2|||
33461532|NCT00427349|62834921|FG000|Overall Study|Ineligible|1|||
33461533|NCT00427349|62834921|FG000|Overall Study|Never started therapy|1|||
33461534|NCT00309985|62834927|FG000|Overall Study|Disease progression|12|||
33461535|NCT00309985|62834928|FG001|Overall Study|Disease progression|0|||
33461536|NCT00309985|62834927|FG000|Overall Study|Adverse Event|30|||
33461537|NCT00309985|62834928|FG001|Overall Study|Adverse Event|0|||
33461538|NCT00309985|62834927|FG000|Overall Study|Death|2|||
33538801|NCT00102687|62928710|FG000|Initial Period|Death|1|||
33538802|NCT00102687|62928711|FG001|Initial Period|Death|1|||
33461539|NCT00309985|62834928|FG001|Overall Study|Death|0|||
33538803|NCT00102687|62928712|FG002|Initial Period|Death|1|||
33538804|NCT00102687|62928713|FG003|Initial Period|Death|0|||
33538805|NCT00102687|62928714|FG004|Initial Period|Death|0|||
33538806|NCT00102687|62928710|FG000|Maintenance Period|Withdrawal by Subject|4|||
33538807|NCT00102687|62928711|FG001|Maintenance Period|Withdrawal by Subject|0|||
33544256|NCT03012061|62935098|FG002|Overall Study|Lack of Efficacy|0|||
33326350|NCT01205126|62703149|FG000|Maintenance Phase|Prohibited drugs used|1|||
33326351|NCT01205126|62703150|FG001|Maintenance Phase|Prohibited drugs used|0|||
33632173|NCT01953692|63033721|FG003|Overall Study|Protocol Violation|0|||
33632174|NCT01953692|63033722|FG004|Overall Study|Protocol Violation|0|||
33632175|NCT01953692|63033723|FG005|Overall Study|Protocol Violation|0|||
33632176|NCT01953692|63033724|FG006|Overall Study|Protocol Violation|0|||
33632177|NCT01953692|63033725|FG007|Overall Study|Protocol Violation|1|||
33632178|NCT01953692|63033726|FG008|Overall Study|Protocol Violation|0|||
33632179|NCT01953692|63033718|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33632180|NCT01953692|63033719|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33632181|NCT01953692|63033720|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33632182|NCT01953692|63033721|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33632183|NCT01953692|63033722|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33632184|NCT01953692|63033723|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33632185|NCT01953692|63033724|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33632186|NCT01953692|63033725|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
33632187|NCT01953692|63033726|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33632188|NCT01953692|63033718|FG000|Overall Study|Withdrawal by Subject|4|||
33632189|NCT01953692|63033719|FG001|Overall Study|Withdrawal by Subject|2|||
33632190|NCT01953692|63033720|FG002|Overall Study|Withdrawal by Subject|1|||
33632191|NCT01953692|63033721|FG003|Overall Study|Withdrawal by Subject|2|||
33632192|NCT01953692|63033722|FG004|Overall Study|Withdrawal by Subject|0|||
33632193|NCT01953692|63033723|FG005|Overall Study|Withdrawal by Subject|3|||
33632194|NCT01953692|63033724|FG006|Overall Study|Withdrawal by Subject|2|||
33632195|NCT01953692|63033725|FG007|Overall Study|Withdrawal by Subject|1|||
33632196|NCT01953692|63033726|FG008|Overall Study|Withdrawal by Subject|1|||
33632197|NCT01791153|63033760|FG000|Part 1: Blinded Period|Adverse Event|7|||
33632198|NCT01791153|63033761|FG001|Part 1: Blinded Period|Adverse Event|3|||
33632199|NCT01791153|63033762|FG002|Part 1: Blinded Period|Adverse Event|2|||
33632200|NCT01791153|63033763|FG003|Part 1: Blinded Period|Adverse Event|0|||
33632201|NCT01791153|63033764|FG004|Part 1: Blinded Period|Adverse Event|0|||
33632202|NCT01791153|63033765|FG005|Part 1: Blinded Period|Adverse Event|0|||
33632203|NCT01791153|63033766|FG006|Part 1: Blinded Period|Adverse Event|0|||
33632204|NCT01791153|63033767|FG007|Part 1: Blinded Period|Adverse Event|0|||
33632205|NCT01791153|63033760|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
33632206|NCT01791153|63033761|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
33632207|NCT01791153|63033762|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
33632208|NCT01791153|63033763|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
33632209|NCT01791153|63033764|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
33632210|NCT01791153|63033765|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
33632211|NCT01791153|63033766|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
33632212|NCT01791153|63033767|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
33632213|NCT01791153|63033760|FG000|Part 1: Blinded Period|Non-Compliance|1|||
33632214|NCT01791153|63033761|FG001|Part 1: Blinded Period|Non-Compliance|0|||
33632215|NCT01791153|63033762|FG002|Part 1: Blinded Period|Non-Compliance|0|||
33632216|NCT01791153|63033763|FG003|Part 1: Blinded Period|Non-Compliance|0|||
33632217|NCT01791153|63033764|FG004|Part 1: Blinded Period|Non-Compliance|0|||
33632218|NCT01791153|63033765|FG005|Part 1: Blinded Period|Non-Compliance|0|||
33632219|NCT01791153|63033766|FG006|Part 1: Blinded Period|Non-Compliance|0|||
33632220|NCT01791153|63033767|FG007|Part 1: Blinded Period|Non-Compliance|0|||
33632221|NCT01791153|63033760|FG000|Part 1: Blinded Period|Physician Decision|0|||
33632222|NCT01791153|63033761|FG001|Part 1: Blinded Period|Physician Decision|0|||
33632223|NCT01791153|63033762|FG002|Part 1: Blinded Period|Physician Decision|0|||
33632224|NCT01791153|63033763|FG003|Part 1: Blinded Period|Physician Decision|1|||
33632225|NCT01791153|63033764|FG004|Part 1: Blinded Period|Physician Decision|0|||
33632226|NCT01791153|63033765|FG005|Part 1: Blinded Period|Physician Decision|0|||
33538808|NCT00102687|62928712|FG002|Maintenance Period|Withdrawal by Subject|2|||
33538809|NCT00102687|62928713|FG003|Maintenance Period|Withdrawal by Subject|3|||
33538810|NCT00102687|62928714|FG004|Maintenance Period|Withdrawal by Subject|1|||
33538811|NCT00102687|62928710|FG000|Maintenance Period|Adverse Event|1|||
33538812|NCT00102687|62928711|FG001|Maintenance Period|Adverse Event|0|||
33538813|NCT00102687|62928712|FG002|Maintenance Period|Adverse Event|0|||
33538814|NCT00102687|62928713|FG003|Maintenance Period|Adverse Event|1|||
33538815|NCT00102687|62928714|FG004|Maintenance Period|Adverse Event|3|||
33538816|NCT00102687|62928710|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
33538817|NCT00102687|62928711|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
33538818|NCT00102687|62928712|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
33538819|NCT00102687|62928713|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
33538820|NCT00102687|62928714|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
33538821|NCT00102687|62928710|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
33632227|NCT01791153|63033766|FG006|Part 1: Blinded Period|Physician Decision|0|||
33632228|NCT01791153|63033767|FG007|Part 1: Blinded Period|Physician Decision|0|||
33632229|NCT01791153|63033760|FG000|Part 1: Blinded Period|Protocol Violation|0|||
33538822|NCT00102687|62928711|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
33632230|NCT01791153|63033761|FG001|Part 1: Blinded Period|Protocol Violation|0|||
33632231|NCT01791153|63033762|FG002|Part 1: Blinded Period|Protocol Violation|0|||
33632232|NCT01791153|63033763|FG003|Part 1: Blinded Period|Protocol Violation|1|||
33632233|NCT01791153|63033764|FG004|Part 1: Blinded Period|Protocol Violation|0|||
33632234|NCT01791153|63033765|FG005|Part 1: Blinded Period|Protocol Violation|0|||
33632235|NCT01791153|63033766|FG006|Part 1: Blinded Period|Protocol Violation|0|||
33632236|NCT01791153|63033767|FG007|Part 1: Blinded Period|Protocol Violation|0|||
33632237|NCT01791153|63033760|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
33632238|NCT01791153|63033761|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
33632239|NCT01791153|63033762|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
33632240|NCT01791153|63033763|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
33632241|NCT01791153|63033764|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
33632242|NCT01791153|63033765|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
33632243|NCT01791153|63033766|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
33632244|NCT01791153|63033767|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
33632245|NCT01791153|63033760|FG000|Part 2: Open-label Period|Adverse Event|0|||
33632246|NCT01791153|63033761|FG001|Part 2: Open-label Period|Adverse Event|0|||
33632247|NCT01791153|63033762|FG002|Part 2: Open-label Period|Adverse Event|0|||
33632248|NCT01791153|63033763|FG003|Part 2: Open-label Period|Adverse Event|0|||
33632249|NCT01791153|63033764|FG004|Part 2: Open-label Period|Adverse Event|0|||
33632250|NCT01791153|63033765|FG005|Part 2: Open-label Period|Adverse Event|1|||
33632251|NCT01791153|63033766|FG006|Part 2: Open-label Period|Adverse Event|1|||
33632252|NCT01791153|63033767|FG007|Part 2: Open-label Period|Adverse Event|2|||
33632253|NCT01791153|63033760|FG000|Part 2: Open-label Period|Death|0|||
33632254|NCT01791153|63033761|FG001|Part 2: Open-label Period|Death|0|||
33632255|NCT01791153|63033762|FG002|Part 2: Open-label Period|Death|0|||
33632256|NCT01791153|63033763|FG003|Part 2: Open-label Period|Death|0|||
33632257|NCT01791153|63033764|FG004|Part 2: Open-label Period|Death|0|||
33632258|NCT01791153|63033765|FG005|Part 2: Open-label Period|Death|1|||
33632259|NCT01791153|63033766|FG006|Part 2: Open-label Period|Death|1|||
33632260|NCT01791153|63033767|FG007|Part 2: Open-label Period|Death|1|||
33632261|NCT01791153|63033760|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
33632262|NCT01791153|63033761|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
33632263|NCT01791153|63033762|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
33632264|NCT01791153|63033763|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
33632265|NCT01791153|63033764|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
33632266|NCT01791153|63033765|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
33632267|NCT01791153|63033766|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
33538823|NCT00102687|62928712|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
33538824|NCT00102687|62928713|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
33538825|NCT00102687|62928714|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
33538826|NCT00102687|62928710|FG000|Maintenance Period|Death|0|||
33538827|NCT00102687|62928711|FG001|Maintenance Period|Death|0|||
33538828|NCT00102687|62928712|FG002|Maintenance Period|Death|0|||
33632268|NCT01791153|63033767|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
33632269|NCT01791153|63033760|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
33632270|NCT01791153|63033761|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
33632271|NCT01791153|63033762|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
33632272|NCT01791153|63033763|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
33632273|NCT01791153|63033764|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
33632274|NCT01791153|63033765|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
33632275|NCT01791153|63033766|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
33632276|NCT01791153|63033767|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
33632277|NCT01791153|63033760|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
33632278|NCT01791153|63033761|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
33538829|NCT00102687|62928713|FG003|Maintenance Period|Death|1|||
33538830|NCT00102687|62928714|FG004|Maintenance Period|Death|1|||
33538831|NCT00102687|62928710|FG000|Maintenance Period|Physician Decision|1|||
33538832|NCT00102687|62928711|FG001|Maintenance Period|Physician Decision|2|||
33632279|NCT01791153|63033762|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
33632280|NCT01791153|63033763|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
33632281|NCT01791153|63033764|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
33632282|NCT01791153|63033765|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
33632283|NCT01791153|63033766|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
33632284|NCT01791153|63033767|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
33632285|NCT01791153|63033760|FG000|Part 2: Open-label Period|Physician Decision|0|||
33632286|NCT01791153|63033761|FG001|Part 2: Open-label Period|Physician Decision|0|||
33632287|NCT01791153|63033762|FG002|Part 2: Open-label Period|Physician Decision|0|||
33326352|NCT01205126|62703149|FG000|Maintenance Phase|Other|11|||
33326353|NCT01205126|62703150|FG001|Maintenance Phase|Other|8|||
33538833|NCT00102687|62928712|FG002|Maintenance Period|Physician Decision|3|||
33538834|NCT00102687|62928713|FG003|Maintenance Period|Physician Decision|0|||
33538835|NCT00102687|62928714|FG004|Maintenance Period|Physician Decision|4|||
33538836|NCT00102531|62928732|FG000|Overall Study|Adverse Event|0|||
33632288|NCT01791153|63033763|FG003|Part 2: Open-label Period|Physician Decision|0|||
33632289|NCT01791153|63033764|FG004|Part 2: Open-label Period|Physician Decision|1|||
33632290|NCT01791153|63033765|FG005|Part 2: Open-label Period|Physician Decision|1|||
33632291|NCT01791153|63033766|FG006|Part 2: Open-label Period|Physician Decision|0|||
33632292|NCT01791153|63033767|FG007|Part 2: Open-label Period|Physician Decision|0|||
33632293|NCT01926782|63033788|FG000|Overall Study|Participant moved|2|||
33632294|NCT01926782|63033789|FG001|Overall Study|Participant moved|0|||
33632295|NCT01926782|63033790|FG002|Overall Study|Participant moved|1|||
33632296|NCT01926782|63033791|FG003|Overall Study|Participant moved|1|||
33632297|NCT01926782|63033792|FG004|Overall Study|Participant moved|0|||
33632298|NCT01926782|63033793|FG005|Overall Study|Participant moved|3|||
33632299|NCT01926782|63033788|FG000|Overall Study|Physician Decision|0|||
33632300|NCT01926782|63033789|FG001|Overall Study|Physician Decision|2|||
33632301|NCT01926782|63033790|FG002|Overall Study|Physician Decision|1|||
33632302|NCT01926782|63033791|FG003|Overall Study|Physician Decision|1|||
33632303|NCT01926782|63033792|FG004|Overall Study|Physician Decision|0|||
33632304|NCT01926782|63033793|FG005|Overall Study|Physician Decision|0|||
33632305|NCT01926782|63033788|FG000|Overall Study|Other than specified|2|||
33632306|NCT01926782|63033789|FG001|Overall Study|Other than specified|3|||
33326354|NCT01205126|62703149|FG000|Maintenance Phase|Lost to Follow-up|5|||
33326355|NCT01205126|62703150|FG001|Maintenance Phase|Lost to Follow-up|5|||
33326356|NCT01205126|62703149|FG000|Maintenance Phase|Withdrawal by Subject|8|||
33326357|NCT01205126|62703150|FG001|Maintenance Phase|Withdrawal by Subject|11|||
33326358|NCT00946647|62703161|FG000|Phase 1 Part|Adverse Event|2|||
33326359|NCT00946647|62703162|FG001|Phase 1 Part|Adverse Event|5|||
33461540|NCT00309985|62834927|FG000|Overall Study|Withdrawal by Subject|5|||
33461541|NCT00309985|62834928|FG001|Overall Study|Withdrawal by Subject|1|||
33461542|NCT00309985|62834927|FG000|Overall Study|Physician Decision|3|||
33461543|NCT00309985|62834928|FG001|Overall Study|Physician Decision|0|||
33461544|NCT00309985|62834927|FG000|Overall Study|Never started treatment|7|||
33461545|NCT00309985|62834928|FG001|Overall Study|Never started treatment|0|||
33538837|NCT00102531|62928733|FG001|Overall Study|Adverse Event|1|||
33538838|NCT00102531|62928732|FG000|Overall Study|Disease Progression|5|||
33538839|NCT00102531|62928733|FG001|Overall Study|Disease Progression|9|||
33538840|NCT00102531|62928732|FG000|Overall Study|Physician Decision|0|||
33538841|NCT00102531|62928733|FG001|Overall Study|Physician Decision|1|||
33538842|NCT02771145|62928739|FG000|Overall Study|Adverse Event|3|||
33538843|NCT02771145|62928739|FG000|Overall Study|Lost to Follow-up|1|||
33538844|NCT02578186|62928759|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
33538845|NCT02578186|62928760|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
33538846|NCT02578186|62928759|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
33538847|NCT02578186|62928760|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
33538848|NCT00103311|62928768|FG000|Overall Study|Lost to Follow-up|1|||
33538849|NCT00103311|62928769|FG001|Overall Study|Lost to Follow-up|0|||
33538850|NCT00103311|62928768|FG000|Overall Study|Withdrawal by Subject|2|||
33538851|NCT00103311|62928769|FG001|Overall Study|Withdrawal by Subject|1|||
33538852|NCT00103311|62928768|FG000|Overall Study|Adverse Event|1|||
33538853|NCT00103311|62928769|FG001|Overall Study|Adverse Event|0|||
33538854|NCT02576938|62928782|FG000|Overall Study|Adverse Event|5|||
33538855|NCT02576938|62928783|FG001|Overall Study|Adverse Event|3|||
33538856|NCT02576938|62928784|FG002|Overall Study|Adverse Event|6|||
33538857|NCT02576938|62928782|FG000|Overall Study|Protocol Violation|1|||
33538858|NCT02576938|62928783|FG001|Overall Study|Protocol Violation|1|||
33538859|NCT02576938|62928784|FG002|Overall Study|Protocol Violation|1|||
33538860|NCT02576938|62928782|FG000|Overall Study|Withdrawal by Subject|3|||
33538861|NCT02576938|62928783|FG001|Overall Study|Withdrawal by Subject|2|||
33461546|NCT00309985|62834927|FG000|Overall Study|Complicating disease|1|||
33461547|NCT00309985|62834928|FG001|Overall Study|Complicating disease|0|||
33461548|NCT00309985|62834927|FG000|Overall Study|Non-compliance|1|||
33461549|NCT00309985|62834928|FG001|Overall Study|Non-compliance|0|||
33538862|NCT02576938|62928784|FG002|Overall Study|Withdrawal by Subject|4|||
33538863|NCT02576938|62928782|FG000|Overall Study|Lack of Efficacy|9|||
33538864|NCT02576938|62928783|FG001|Overall Study|Lack of Efficacy|4|||
33632307|NCT01926782|63033790|FG002|Overall Study|Other than specified|5|||
33632308|NCT01926782|63033791|FG003|Overall Study|Other than specified|12|||
33632309|NCT01926782|63033792|FG004|Overall Study|Other than specified|4|||
33632310|NCT01926782|63033793|FG005|Overall Study|Other than specified|11|||
33632311|NCT01926782|63033788|FG000|Overall Study|Adverse Event|13|||
33538865|NCT02576938|62928784|FG002|Overall Study|Lack of Efficacy|0|||
33632312|NCT01926782|63033789|FG001|Overall Study|Adverse Event|4|||
33326360|NCT00946647|62703163|FG002|Phase 1 Part|Adverse Event|3|||
33632313|NCT01926782|63033790|FG002|Overall Study|Adverse Event|17|||
33632314|NCT01926782|63033791|FG003|Overall Study|Adverse Event|4|||
33632315|NCT01926782|63033792|FG004|Overall Study|Adverse Event|3|||
33632316|NCT01926782|63033793|FG005|Overall Study|Adverse Event|14|||
33632317|NCT01926782|63033788|FG000|Overall Study|Poor compliance to protocol|5|||
33632318|NCT01926782|63033789|FG001|Overall Study|Poor compliance to protocol|3|||
33632319|NCT01926782|63033790|FG002|Overall Study|Poor compliance to protocol|8|||
33632320|NCT01926782|63033791|FG003|Overall Study|Poor compliance to protocol|0|||
33632321|NCT01926782|63033792|FG004|Overall Study|Poor compliance to protocol|1|||
33632322|NCT01926782|63033793|FG005|Overall Study|Poor compliance to protocol|6|||
33632323|NCT01926782|63033788|FG000|Overall Study|Randomized and not treated|0|||
33632324|NCT01926782|63033789|FG001|Overall Study|Randomized and not treated|0|||
33632325|NCT01926782|63033790|FG002|Overall Study|Randomized and not treated|0|||
33632326|NCT01926782|63033791|FG003|Overall Study|Randomized and not treated|1|||
33632327|NCT01926782|63033792|FG004|Overall Study|Randomized and not treated|0|||
33632328|NCT01926782|63033793|FG005|Overall Study|Randomized and not treated|0|||
33632329|NCT01926782|63033788|FG000|Overall Study|Withdrawal by Subject|6|||
33632330|NCT01926782|63033789|FG001|Overall Study|Withdrawal by Subject|1|||
33632331|NCT01926782|63033790|FG002|Overall Study|Withdrawal by Subject|8|||
33632332|NCT01926782|63033791|FG003|Overall Study|Withdrawal by Subject|1|||
33632333|NCT01926782|63033792|FG004|Overall Study|Withdrawal by Subject|0|||
33632334|NCT01926782|63033793|FG005|Overall Study|Withdrawal by Subject|5|||
33632335|NCT01926782|63033788|FG000|Overall Study|Related to study drug administration|0|||
33632336|NCT01926782|63033789|FG001|Overall Study|Related to study drug administration|0|||
33632337|NCT01926782|63033790|FG002|Overall Study|Related to study drug administration|0|||
33632338|NCT01926782|63033791|FG003|Overall Study|Related to study drug administration|0|||
33632339|NCT01926782|63033792|FG004|Overall Study|Related to study drug administration|0|||
33632340|NCT01926782|63033793|FG005|Overall Study|Related to study drug administration|2|||
33632341|NCT01926626|63033808|FG000|Overall Study|Withdrawal by Subject|15|||
33632342|NCT01926626|63033808|FG000|Overall Study|Lost to Follow-up|7|||
33632343|NCT01953224|63033814|FG000|Overall Study|Lost to Follow-up|1|||
33632344|NCT01953224|63033815|FG001|Overall Study|Lost to Follow-up|1|||
33632345|NCT01953224|63033814|FG000|Overall Study|Withdrawal by Subject|1|||
33632346|NCT01953224|63033815|FG001|Overall Study|Withdrawal by Subject|2|||
33632347|NCT01900730|63033823|FG000|Overall Study|Withdrawal by Subject|1|||
33632348|NCT01900730|63033824|FG001|Overall Study|Withdrawal by Subject|0|||
33632349|NCT01900730|63033823|FG000|Overall Study|Screen Failure|1|||
33632350|NCT01900730|63033824|FG001|Overall Study|Screen Failure|0|||
33632351|NCT01952834|63033830|FG000|Overall Study|Adverse Event|1|||
33632352|NCT01952366|63033835|FG000|Overall Study|Death|22|||
33632353|NCT01952366|63033835|FG000|Overall Study|Withdrawal by Subject|9|||
33632354|NCT01952054|63033842|FG000|Overall Study|Physician Decision|1|||
33632355|NCT01925768|63033848|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
33632356|NCT01925768|63033849|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33632357|NCT01925768|63033848|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
33632358|NCT01925768|63033849|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
33632359|NCT01925768|63033848|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
33632360|NCT01925768|63033849|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
33632361|NCT01925768|63033848|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
33632362|NCT01925768|63033849|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
33632363|NCT01925768|63033848|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
33632364|NCT01925768|63033849|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
33632365|NCT01925768|63033848|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
33632366|NCT01925768|63033849|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
33632367|NCT01925768|63033848|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
33632368|NCT01925768|63033849|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
33632369|NCT01925768|63033848|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
33632370|NCT01925768|63033849|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
33632371|NCT01925768|63033848|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
33632372|NCT01925768|63033849|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
33632373|NCT01925768|63033848|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
33632374|NCT01925768|63033849|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
33632375|NCT01925768|63033848|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
33326361|NCT00946647|62703164|FG003|Phase 1 Part|Adverse Event|0|||
33632376|NCT01925768|63033849|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
33632377|NCT01431274|63033864|FG000|Overall Study|Adverse Event|51|||
33632378|NCT01431274|63033865|FG001|Overall Study|Adverse Event|37|||
33632379|NCT01431274|63033866|FG002|Overall Study|Adverse Event|43|||
33326362|NCT00946647|62703165|FG004|Phase 1 Part|Adverse Event|0|||
33326363|NCT00946647|62703161|FG000|Phase 1 Part|Disease progression|3|||
33632380|NCT01431274|63033867|FG003|Overall Study|Adverse Event|30|||
33632381|NCT01431274|63033868|FG004|Overall Study|Adverse Event|37|||
33632382|NCT01431274|63033864|FG000|Overall Study|Consent withdrawn not due to AE|29|||
33632383|NCT01431274|63033865|FG001|Overall Study|Consent withdrawn not due to AE|20|||
33632384|NCT01431274|63033866|FG002|Overall Study|Consent withdrawn not due to AE|17|||
33632385|NCT01431274|63033867|FG003|Overall Study|Consent withdrawn not due to AE|20|||
33632386|NCT01431274|63033868|FG004|Overall Study|Consent withdrawn not due to AE|11|||
33632387|NCT01431274|63033864|FG000|Overall Study|Non compliant with protocol|5|||
33632388|NCT01431274|63033865|FG001|Overall Study|Non compliant with protocol|8|||
33632389|NCT01431274|63033866|FG002|Overall Study|Non compliant with protocol|4|||
33326364|NCT00946647|62703162|FG001|Phase 1 Part|Disease progression|6|||
33538866|NCT02576938|62928782|FG000|Overall Study|Lost to Follow-up|2|||
33538867|NCT02576938|62928783|FG001|Overall Study|Lost to Follow-up|0|||
33538868|NCT02576938|62928784|FG002|Overall Study|Lost to Follow-up|1|||
33538869|NCT02576938|62928782|FG000|Overall Study|Physician Decision|0|||
33538870|NCT02576938|62928783|FG001|Overall Study|Physician Decision|1|||
33538871|NCT02576938|62928784|FG002|Overall Study|Physician Decision|0|||
33538872|NCT02576938|62928782|FG000|Overall Study|Met Exclusion Criteria|0|||
33538873|NCT02576938|62928783|FG001|Overall Study|Met Exclusion Criteria|1|||
33538874|NCT02576938|62928784|FG002|Overall Study|Met Exclusion Criteria|0|||
33538875|NCT02576860|62928796|FG000|Overall Study|Adverse Event|6|||
33538876|NCT02576860|62928797|FG001|Overall Study|Adverse Event|6|||
33538877|NCT02576860|62928796|FG000|Overall Study|Lost to Follow-up|5|||
33538878|NCT02576860|62928797|FG001|Overall Study|Lost to Follow-up|7|||
33538879|NCT02576860|62928796|FG000|Overall Study|Physician Decision|0|||
33538880|NCT02576860|62928797|FG001|Overall Study|Physician Decision|1|||
33538881|NCT02576860|62928796|FG000|Overall Study|Protocol Violation|0|||
33538882|NCT02576860|62928797|FG001|Overall Study|Protocol Violation|2|||
33538883|NCT02576860|62928796|FG000|Overall Study|Withdrawal by Subject|13|||
33538884|NCT02576860|62928797|FG001|Overall Study|Withdrawal by Subject|8|||
33538885|NCT02576860|62928796|FG000|Overall Study|Disallowed medication|1|||
33538886|NCT02576860|62928797|FG001|Overall Study|Disallowed medication|0|||
33538887|NCT02572570|62928804|FG000|Overall Study|Study Terminated|27|||
33538888|NCT00709202|62928813|FG000|Overall Study|Withdrawal by Subject|6|||
33538889|NCT00709202|62928814|FG001|Overall Study|Withdrawal by Subject|6|||
33538890|NCT00709124|62928823|FG000|Overall Study|Death|3|||
33538891|NCT00709124|62928824|FG001|Overall Study|Death|1|||
33538892|NCT00709124|62928823|FG000|Overall Study|encephalopathy; can't do assessment|1|||
33538893|NCT00709124|62928824|FG001|Overall Study|encephalopathy; can't do assessment|0|||
33538894|NCT02738580|62928836|FG000|Overall Study|Adverse Event|1|||
33538895|NCT02738580|62928837|FG001|Overall Study|Adverse Event|0|||
33538896|NCT02738580|62928836|FG000|Overall Study|Lack of Efficacy|3|||
33538897|NCT02738580|62928837|FG001|Overall Study|Lack of Efficacy|2|||
33538898|NCT02738580|62928836|FG000|Overall Study|Withdrawal by Subject|0|||
33538899|NCT02738580|62928837|FG001|Overall Study|Withdrawal by Subject|1|||
33538900|NCT02738580|62928836|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
33538901|NCT02738580|62928837|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
33538902|NCT02571244|62928845|FG000|Overall Study|Lost to Follow-up|0|||
33538903|NCT02571244|62928846|FG001|Overall Study|Lost to Follow-up|1|||
33538904|NCT02571244|62928845|FG000|Overall Study|Unable to reach out post discharge|3|||
33538905|NCT02571244|62928846|FG001|Overall Study|Unable to reach out post discharge|0|||
33538906|NCT02573350|62928857|FG000|Overall Study|Lost to Follow-up|2|||
33538907|NCT02573350|62928858|FG001|Overall Study|Lost to Follow-up|1|||
33538908|NCT02573350|62928857|FG000|Overall Study|Adverse Event|3|||
33538909|NCT02573350|62928858|FG001|Overall Study|Adverse Event|4|||
33538910|NCT02573350|62928857|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
33538911|NCT02573350|62928858|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
33538912|NCT02573350|62928857|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
33538913|NCT02573350|62928858|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
33538914|NCT02573350|62928857|FG000|Overall Study|Subject withdrew consent to participate|6|||
33538915|NCT02573350|62928858|FG001|Overall Study|Subject withdrew consent to participate|1|||
33538916|NCT02573350|62928857|FG000|Overall Study|Protocol Deviation|1|||
33538917|NCT02573350|62928858|FG001|Overall Study|Protocol Deviation|1|||
33538918|NCT01376804|62928867|FG000|Treatment Period|Withdrawal by Subject|1|||
33538919|NCT01376804|62928867|FG000|Treatment Period|Adverse Event|6|||
33538920|NCT01376804|62928867|FG000|Treatment Period|Patient did not receive study drug|1|||
33538921|NCT02574520|62928875|FG000|Overall Study|Not dosed|2|||
33538922|NCT02574520|62928876|FG001|Overall Study|Not dosed|0|||
33538923|NCT02574520|62928877|FG002|Overall Study|Not dosed|5|||
33538924|NCT02574520|62928878|FG003|Overall Study|Not dosed|4|||
33538925|NCT02574520|62928875|FG000|Overall Study|Adverse Event|0|||
33538926|NCT02574520|62928876|FG001|Overall Study|Adverse Event|0|||
33538927|NCT02574520|62928877|FG002|Overall Study|Adverse Event|0|||
33632390|NCT01431274|63033867|FG003|Overall Study|Non compliant with protocol|4|||
33538928|NCT02574520|62928878|FG003|Overall Study|Adverse Event|1|||
33538929|NCT02574520|62928875|FG000|Overall Study|Withdrawal by Subject|0|||
33538930|NCT02574520|62928876|FG001|Overall Study|Withdrawal by Subject|0|||
33632391|NCT01431274|63033868|FG004|Overall Study|Non compliant with protocol|4|||
33632392|NCT01431274|63033864|FG000|Overall Study|Lost to Follow-up|6|||
33632393|NCT01431274|63033865|FG001|Overall Study|Lost to Follow-up|7|||
33632394|NCT01431274|63033866|FG002|Overall Study|Lost to Follow-up|1|||
33632395|NCT01431274|63033867|FG003|Overall Study|Lost to Follow-up|4|||
33632396|NCT01431274|63033868|FG004|Overall Study|Lost to Follow-up|0|||
33632397|NCT01431274|63033864|FG000|Overall Study|Other reason not stated above|6|||
33632398|NCT01431274|63033865|FG001|Overall Study|Other reason not stated above|5|||
33632399|NCT01431274|63033866|FG002|Overall Study|Other reason not stated above|7|||
33632400|NCT01431274|63033867|FG003|Overall Study|Other reason not stated above|2|||
33632401|NCT01431274|63033868|FG004|Overall Study|Other reason not stated above|4|||
33632402|NCT01991795|63033882|FG000|Overall Study|Lost to Follow-up|6|||
33632403|NCT01991795|63033883|FG001|Overall Study|Lost to Follow-up|4|||
33632404|NCT01991795|63033882|FG000|Overall Study|Withdrawal by Subject|117|||
33632405|NCT01991795|63033883|FG001|Overall Study|Withdrawal by Subject|94|||
33632406|NCT01991795|63033882|FG000|Overall Study|Site prematurely closed by sponsor|26|||
33632407|NCT01991795|63033883|FG001|Overall Study|Site prematurely closed by sponsor|25|||
33632408|NCT01411852|63033924|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
33632409|NCT01411852|63033925|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
33632410|NCT01411852|63033924|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
33632411|NCT01411852|63033925|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
33632412|NCT01411852|63033924|FG000|Prehospital Intervention Phase|Found to be under age|0|||
33632413|NCT01411852|63033925|FG001|Prehospital Intervention Phase|Found to be under age|1|||
33632414|NCT01411852|63033924|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
33632415|NCT01411852|63033925|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
33632416|NCT01411852|63033924|FG000|Hospital Intervention Phase|Severe head injury|5|||
33632417|NCT01411852|63033925|FG001|Hospital Intervention Phase|Severe head injury|4|||
33632418|NCT01411852|63033924|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
33632419|NCT01411852|63033925|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
33632420|NCT01411852|63033924|FG000|Hospital Intervention Phase|Miscommunication error|1|||
33632421|NCT01411852|63033925|FG001|Hospital Intervention Phase|Miscommunication error|2|||
33632422|NCT01411852|63033924|FG000|Hospital Intervention Phase|CPR administered|3|||
33326365|NCT00946647|62703163|FG002|Phase 1 Part|Disease progression|1|||
33538931|NCT02574520|62928877|FG002|Overall Study|Withdrawal by Subject|0|||
33538932|NCT02574520|62928878|FG003|Overall Study|Withdrawal by Subject|1|||
33538933|NCT02574520|62928875|FG000|Overall Study|Other|0|||
33538934|NCT02574520|62928876|FG001|Overall Study|Other|0|||
33538935|NCT02574520|62928877|FG002|Overall Study|Other|0|||
33538936|NCT02574520|62928878|FG003|Overall Study|Other|2|||
33538937|NCT00709592|62928890|FG000|Overall Study|Unable to proceed to transplant|0|||
33538938|NCT00709592|62928891|FG001|Overall Study|Unable to proceed to transplant|1|||
33538939|NCT02570152|62928897|FG000|Overall Study|Protocol Violation|2|||
33538940|NCT02570152|62928897|FG000|Overall Study|Migrated/moved from study area|13|||
33538941|NCT02570074|62928903|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
33538942|NCT02570074|62928904|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
33538943|NCT02569996|62928922|FG000|Overall Study|Adverse Event|6|||
33538944|NCT02569996|62928922|FG000|Overall Study|Physician Decision|3|||
33538945|NCT02569996|62928922|FG000|Overall Study|Progression of the disease|18|||
33538946|NCT02569996|62928922|FG000|Overall Study|New anti-lymphoma treatment|1|||
33538947|NCT02569996|62928922|FG000|Overall Study|Non-compliance|9|||
33538948|NCT02569996|62928922|FG000|Overall Study|Withdrawal by Subject|5|||
33538949|NCT02569996|62928922|FG000|Overall Study|Lost to Follow-up|5|||
33538950|NCT02569996|62928922|FG000|Overall Study|Complete remission|7|||
33538951|NCT02569996|62928922|FG000|Overall Study|Unknown reason|1|||
33538952|NCT02572882|62928926|FG000|Overall Study|Withdrawal by Subject|1|||
33538953|NCT02572882|62928926|FG000|Overall Study|Participant received kidney transplant|1|||
33538954|NCT00708500|62928956|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
33538955|NCT00708500|62928957|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
33538956|NCT00708500|62928958|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
33538957|NCT00708500|62928956|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
33538958|NCT00708500|62928957|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
33538959|NCT00708500|62928958|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
33538960|NCT00708500|62928956|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
33538961|NCT00708500|62928957|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
33538962|NCT00708500|62928958|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
33538963|NCT00708500|62928956|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
33632423|NCT01411852|63033925|FG001|Hospital Intervention Phase|CPR administered|1|||
33632424|NCT01411852|63033924|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
33632425|NCT01411852|63033925|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
33632426|NCT01411852|63033924|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
33632427|NCT01411852|63033925|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
33632428|NCT01411852|63033924|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
33632429|NCT01411852|63033925|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
33632430|NCT01411852|63033924|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
33632431|NCT01411852|63033925|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
33632432|NCT01411852|63033924|FG000|Hospital Intervention Phase|Other ineligible|2|||
33632433|NCT01411852|63033925|FG001|Hospital Intervention Phase|Other ineligible|2|||
33632434|NCT01411852|63033924|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
33632435|NCT01411852|63033925|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
33632436|NCT01411852|63033924|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
33632437|NCT01411852|63033925|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
33632438|NCT01411852|63033924|FG000|Hospital Intervention Phase|Vascular access failed|1|||
33632439|NCT01411852|63033925|FG001|Hospital Intervention Phase|Vascular access failed|0|||
33632440|NCT01411774|63033935|FG000|Overall Study|Withdrawal by Subject|0|||
33632441|NCT01411774|63033936|FG001|Overall Study|Withdrawal by Subject|3|||
33326366|NCT00946647|62703164|FG003|Phase 1 Part|Disease progression|0|||
33461550|NCT00309985|62834927|FG000|Overall Study|Chemotherapy discontinued only|1|||
33461551|NCT00309985|62834928|FG001|Overall Study|Chemotherapy discontinued only|0|||
33461552|NCT00098787|62834950|FG000|Overall Study|Never started treatment|3|||
33461553|NCT00098787|62834951|FG001|Overall Study|Never started treatment|2|||
33461554|NCT00098787|62834952|FG002|Overall Study|Never started treatment|1|||
33461555|NCT00098787|62834950|FG000|Overall Study|Ineligible|9|||
33461556|NCT00098787|62834951|FG001|Overall Study|Ineligible|7|||
33461557|NCT00098787|62834952|FG002|Overall Study|Ineligible|3|||
33461558|NCT00098787|62834950|FG000|Overall Study|Disease progression|28|||
33461559|NCT00098787|62834951|FG001|Overall Study|Disease progression|17|||
33461560|NCT00098787|62834952|FG002|Overall Study|Disease progression|23|||
33461561|NCT00098787|62834950|FG000|Overall Study|Adverse Event|8|||
33461562|NCT00098787|62834951|FG001|Overall Study|Adverse Event|17|||
33461563|NCT00098787|62834952|FG002|Overall Study|Adverse Event|8|||
33461564|NCT00098787|62834950|FG000|Overall Study|Death|6|||
33461565|NCT00098787|62834951|FG001|Overall Study|Death|1|||
33461566|NCT00098787|62834952|FG002|Overall Study|Death|0|||
33461567|NCT00098787|62834950|FG000|Overall Study|Withdrawal by Subject|4|||
33538964|NCT00708500|62928957|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
33538965|NCT00708500|62928958|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
33538966|NCT00708500|62928956|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
33538967|NCT00708500|62928957|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
33538968|NCT00708500|62928958|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
33538969|NCT00708500|62928956|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
33538970|NCT00708500|62928957|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
33538971|NCT00708500|62928958|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
33538972|NCT00708500|62928956|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
33538973|NCT00708500|62928957|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
33538974|NCT00708500|62928958|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
33538975|NCT00708500|62928956|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
33538976|NCT00708500|62928957|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
33538977|NCT00708500|62928958|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
33538978|NCT00708500|62928956|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
33538979|NCT00708500|62928957|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
33538980|NCT00708500|62928958|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
33538981|NCT00708500|62928956|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
33538982|NCT00708500|62928957|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
33538983|NCT00708500|62928958|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
33538984|NCT00708500|62928956|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
33538985|NCT00708500|62928957|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
33538986|NCT00708500|62928958|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
33538987|NCT00708500|62928956|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
33538988|NCT00708500|62928957|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
33538989|NCT00708500|62928958|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
33538990|NCT00708500|62928956|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
33538991|NCT00708500|62928957|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
33538992|NCT00708500|62928958|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
33538993|NCT00708500|62928956|FG000|FOLLOWUP|Adverse Event|0|||
33538994|NCT00708500|62928957|FG001|FOLLOWUP|Adverse Event|1|||
33632442|NCT01411228|63033945|FG000|Overall Study|Lost to Follow-up|0|||
33632443|NCT01411228|63033946|FG001|Overall Study|Lost to Follow-up|0|||
33632444|NCT01411228|63033947|FG002|Overall Study|Lost to Follow-up|1|||
33632445|NCT01411228|63033945|FG000|Overall Study|Withdrawal by Subject|1|||
33461568|NCT00098787|62834951|FG001|Overall Study|Withdrawal by Subject|12|||
33461569|NCT00098787|62834952|FG002|Overall Study|Withdrawal by Subject|6|||
33632446|NCT01411228|63033946|FG001|Overall Study|Withdrawal by Subject|0|||
33632447|NCT01411228|63033947|FG002|Overall Study|Withdrawal by Subject|0|||
33632448|NCT01410604|63033957|FG000|Overall Study|Adverse Event|2|||
33632449|NCT01410604|63033958|FG001|Overall Study|Adverse Event|1|||
33632450|NCT01410604|63033957|FG000|Overall Study|Lost to Follow-up|1|||
33632451|NCT01410604|63033958|FG001|Overall Study|Lost to Follow-up|0|||
33632452|NCT01410604|63033957|FG000|Overall Study|Physician Decision|0|||
33632453|NCT01410604|63033958|FG001|Overall Study|Physician Decision|1|||
33632454|NCT01991483|63033968|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
33632455|NCT01991483|63033969|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
33632456|NCT01991483|63033970|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
33632457|NCT01991483|63033971|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
33632458|NCT01991483|63033968|FG000|Dose Level 600 mg|Physician Decision|0|||
33632459|NCT01991483|63033969|FG001|Dose Level 600 mg|Physician Decision|0|||
33632460|NCT01991483|63033970|FG002|Dose Level 600 mg|Physician Decision|1|||
33632461|NCT01991483|63033971|FG003|Dose Level 600 mg|Physician Decision|0|||
33632462|NCT01991483|63033968|FG000|Dose Level 1000 mg|Protocol Violation|0|||
33632463|NCT01991483|63033969|FG001|Dose Level 1000 mg|Protocol Violation|0|||
33632464|NCT01991483|63033970|FG002|Dose Level 1000 mg|Protocol Violation|0|||
33632465|NCT01991483|63033971|FG003|Dose Level 1000 mg|Protocol Violation|1|||
33632466|NCT01410448|63033986|FG000|Overall Study|No conversion to everolimus|0|||
33632467|NCT01410448|63033987|FG001|Overall Study|No conversion to everolimus|24|||
33632468|NCT01410448|63033986|FG000|Overall Study|Graft loss|4|||
33632469|NCT01410448|63033987|FG001|Overall Study|Graft loss|1|||
33632470|NCT01410448|63033986|FG000|Overall Study|Administrative issues|2|||
33632471|NCT01410448|63033987|FG001|Overall Study|Administrative issues|1|||
33632472|NCT01410448|63033986|FG000|Overall Study|Lost to Follow-up|1|||
33632473|NCT01410448|63033987|FG001|Overall Study|Lost to Follow-up|0|||
33632474|NCT01410448|63033986|FG000|Overall Study|Withdrawal by Subject|3|||
33632475|NCT01410448|63033987|FG001|Overall Study|Withdrawal by Subject|2|||
33632476|NCT01410448|63033986|FG000|Overall Study|Protocol Violation|0|||
33632477|NCT01410448|63033987|FG001|Overall Study|Protocol Violation|4|||
33632478|NCT01410448|63033986|FG000|Overall Study|Death|2|||
33632479|NCT01410448|63033987|FG001|Overall Study|Death|3|||
33632480|NCT01943851|63034011|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33632481|NCT01943851|63034012|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33632482|NCT01943851|63034013|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33632483|NCT01943851|63034014|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
33632484|NCT01943851|63034015|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33632485|NCT01943851|63034016|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33632486|NCT01943851|63034017|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
33632487|NCT01943851|63034018|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
33632488|NCT01943851|63034019|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
33632489|NCT01943851|63034020|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33632490|NCT01943851|63034021|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33632491|NCT01943851|63034022|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33632492|NCT01943851|63034023|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33461570|NCT00098787|62834950|FG000|Overall Study|Alternative therapy|8|||
33461571|NCT00098787|62834951|FG001|Overall Study|Alternative therapy|13|||
33461572|NCT00098787|62834952|FG002|Overall Study|Alternative therapy|13|||
33461573|NCT00098787|62834950|FG000|Overall Study|Other|7|||
33461574|NCT00098787|62834951|FG001|Overall Study|Other|6|||
33461575|NCT00098787|62834952|FG002|Overall Study|Other|9|||
33538995|NCT00708500|62928958|FG002|FOLLOWUP|Adverse Event|0|||
33538996|NCT00708500|62928956|FG000|FOLLOWUP|Lost to Follow-up|1|||
33538997|NCT00708500|62928957|FG001|FOLLOWUP|Lost to Follow-up|6|||
33538998|NCT00708500|62928958|FG002|FOLLOWUP|Lost to Follow-up|4|||
33538999|NCT00708500|62928956|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
33539000|NCT00708500|62928957|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
33461576|NCT00091169|62834962|FG000|Overall Study|Disease progression|3|||
33461577|NCT00091169|62834963|FG001|Overall Study|Disease progression|1|||
33539001|NCT00708500|62928958|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
33539002|NCT00708500|62928956|FG000|FOLLOWUP|Subject withdrew consent|31|||
33539003|NCT00708500|62928957|FG001|FOLLOWUP|Subject withdrew consent|4|||
33632493|NCT01943851|63034024|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33632494|NCT01943851|63034025|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33632495|NCT01943851|63034026|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33632496|NCT01943851|63034027|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33461578|NCT00091169|62834962|FG000|Overall Study|Adverse Event|11|||
33461579|NCT00091169|62834963|FG001|Overall Study|Adverse Event|17|||
33539004|NCT00708500|62928958|FG002|FOLLOWUP|Subject withdrew consent|5|||
33632497|NCT01943851|63034028|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33632498|NCT01943851|63034011|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33539005|NCT00708500|62928956|FG000|FOLLOWUP|Non-compliance with protocol|5|||
33539006|NCT00708500|62928957|FG001|FOLLOWUP|Non-compliance with protocol|0|||
33461580|NCT00091169|62834962|FG000|Overall Study|Death|4|||
33539007|NCT00708500|62928958|FG002|FOLLOWUP|Non-compliance with protocol|1|||
33539008|NCT00708734|62928975|FG000|Overall Study|scheduling conflict|2|||
33539009|NCT00708734|62928975|FG000|Overall Study|moved|1|||
33539010|NCT00708734|62928975|FG000|Overall Study|leg injury|1|||
33539011|NCT00708734|62928975|FG000|Overall Study|knee replacement|1|||
33539012|NCT00708734|62928975|FG000|Overall Study|vertigo|1|||
33539013|NCT00708734|62928975|FG000|Overall Study|leg fracture|1|||
33539014|NCT04834362|62928981|FG000|Overall Study|Death|1|||
33539015|NCT04834362|62928982|FG001|Overall Study|Death|2|||
33539016|NCT00101907|62928994|FG000|Overall Study|Adverse Event|1|||
33539017|NCT00101907|62928995|FG001|Overall Study|Adverse Event|0|||
33539018|NCT00101907|62928996|FG002|Overall Study|Adverse Event|0|||
33539019|NCT00101907|62928997|FG003|Overall Study|Adverse Event|0|||
33539020|NCT00101907|62928998|FG004|Overall Study|Adverse Event|0|||
33539021|NCT00101907|62928999|FG005|Overall Study|Adverse Event|0|||
33539022|NCT00101907|62928994|FG000|Overall Study|Death|0|||
33539023|NCT00101907|62928995|FG001|Overall Study|Death|1|||
33539024|NCT00101907|62928996|FG002|Overall Study|Death|0|||
33539025|NCT00101907|62928997|FG003|Overall Study|Death|0|||
33539026|NCT00101907|62928998|FG004|Overall Study|Death|3|||
33539027|NCT00101907|62928999|FG005|Overall Study|Death|0|||
33539028|NCT00101907|62928994|FG000|Overall Study|Physician Decision|0|||
33539029|NCT00101907|62928995|FG001|Overall Study|Physician Decision|0|||
33539030|NCT00101907|62928996|FG002|Overall Study|Physician Decision|0|||
33539031|NCT00101907|62928997|FG003|Overall Study|Physician Decision|1|||
33539032|NCT00101907|62928998|FG004|Overall Study|Physician Decision|1|||
33539033|NCT00101907|62928999|FG005|Overall Study|Physician Decision|0|||
33539034|NCT00101907|62928994|FG000|Overall Study|Withdrawal by Subject|1|||
33539035|NCT00101907|62928995|FG001|Overall Study|Withdrawal by Subject|0|||
33539036|NCT00101907|62928996|FG002|Overall Study|Withdrawal by Subject|1|||
33539037|NCT00101907|62928997|FG003|Overall Study|Withdrawal by Subject|0|||
33539038|NCT00101907|62928998|FG004|Overall Study|Withdrawal by Subject|1|||
33539039|NCT00101907|62928999|FG005|Overall Study|Withdrawal by Subject|0|||
33539040|NCT02565784|62929020|FG000|First Treatment|Adverse Event|1|||
33539041|NCT02565784|62929020|FG000|First Treatment|Withdrawal by Subject|1|||
33539042|NCT02565784|62929020|FG000|Second Treatment|Withdrawal by Subject|2|||
33539043|NCT04650204|62929067|FG000|Overall Study|Study was Terminated|2|||
33539044|NCT04650204|62929068|FG001|Overall Study|Study was Terminated|1|||
33539045|NCT02761629|62929076|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
33539046|NCT02761629|62929077|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
33539047|NCT02761629|62929076|FG000|Overall Study|Insufficient Therapeutic Response|2|||
33539048|NCT02761629|62929077|FG001|Overall Study|Insufficient Therapeutic Response|7|||
33539049|NCT02761629|62929076|FG000|Overall Study|Failure to Return|2|||
33539050|NCT02761629|62929077|FG001|Overall Study|Failure to Return|4|||
33539051|NCT02761629|62929076|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
33539052|NCT02761629|62929077|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
33539053|NCT02761629|62929076|FG000|Overall Study|Protocol Violation|2|||
33539054|NCT02761629|62929077|FG001|Overall Study|Protocol Violation|2|||
33539055|NCT02761629|62929076|FG000|Overall Study|Withdrawal by Subject|0|||
33539056|NCT02761629|62929077|FG001|Overall Study|Withdrawal by Subject|3|||
33539057|NCT02761629|62929076|FG000|Overall Study|Other|0|||
33461581|NCT00091169|62834963|FG001|Overall Study|Death|1|||
33461582|NCT00091169|62834962|FG000|Overall Study|Withdrawal by Subject|10|||
33461583|NCT00091169|62834963|FG001|Overall Study|Withdrawal by Subject|13|||
33461584|NCT00091169|62834962|FG000|Overall Study|Other|3|||
33461585|NCT00091169|62834963|FG001|Overall Study|Other|4|||
33461586|NCT00091169|62834962|FG000|Overall Study|Not start protocol therapy|26|||
33461587|NCT00091169|62834963|FG001|Overall Study|Not start protocol therapy|17|||
33461588|NCT00075946|62834975|FG000|Overall Study|Path ineligible: undetermined histology|0|||
33461589|NCT00075946|62834976|FG001|Overall Study|Path ineligible: undetermined histology|0|||
33461590|NCT00075946|62834977|FG002|Overall Study|Path ineligible: undetermined histology|0|||
33461591|NCT00075946|62834978|FG003|Overall Study|Path ineligible: undetermined histology|0|||
33461592|NCT00075946|62834979|FG004|Overall Study|Path ineligible: undetermined histology|6|||
33461593|NCT00075946|62834975|FG000|Overall Study|Did not achieve response after induction|0|||
33461594|NCT00075946|62834976|FG001|Overall Study|Did not achieve response after induction|0|||
33539058|NCT02761629|62929077|FG001|Overall Study|Other|2|||
33539059|NCT02761629|62929076|FG000|Overall Study|Lost to Follow-up|4|||
33539060|NCT02761629|62929077|FG001|Overall Study|Lost to Follow-up|1|||
33539061|NCT02761629|62929076|FG000|Overall Study|Randomized But Not Treated|8|||
33539062|NCT02761629|62929077|FG001|Overall Study|Randomized But Not Treated|4|||
33539063|NCT02760927|62929083|FG000|Overall Study|Tube Slippage from Device|1|||
33539064|NCT00101439|62929089|FG000|Period 2|Withdrawal by Subject|0|||
33539065|NCT00101439|62929090|FG001|Period 2|Withdrawal by Subject|2|||
33539066|NCT04033068|62929100|FG000|Overall Study|Withdrawal by Subject|0|||
33539067|NCT04033068|62929101|FG001|Overall Study|Withdrawal by Subject|0|||
33632499|NCT01943851|63034012|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33632500|NCT01943851|63034013|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33632501|NCT01943851|63034014|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33632502|NCT01943851|63034015|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
33632503|NCT01943851|63034016|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33632504|NCT01943851|63034017|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33632505|NCT01943851|63034018|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
33632506|NCT01943851|63034019|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33632507|NCT01943851|63034020|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33632508|NCT01943851|63034021|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33632509|NCT01943851|63034022|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33632510|NCT01943851|63034023|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33632511|NCT01943851|63034024|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33632512|NCT01943851|63034025|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33632513|NCT01943851|63034026|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33632514|NCT01943851|63034027|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33632515|NCT01943851|63034028|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33632516|NCT01943851|63034011|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632517|NCT01943851|63034012|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632518|NCT01943851|63034013|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632519|NCT01943851|63034014|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632520|NCT01943851|63034015|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632521|NCT01943851|63034016|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632522|NCT01943851|63034017|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632523|NCT01943851|63034018|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632524|NCT01943851|63034019|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632525|NCT01943851|63034020|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632526|NCT01943851|63034021|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632527|NCT01943851|63034022|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632528|NCT01943851|63034023|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632529|NCT01943851|63034024|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
33632530|NCT01943851|63034025|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632531|NCT01943851|63034026|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632532|NCT01943851|63034027|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632533|NCT01943851|63034028|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33632534|NCT01943851|63034011|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33632535|NCT01943851|63034012|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33632536|NCT01943851|63034013|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33632537|NCT01943851|63034014|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33632538|NCT01943851|63034015|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33632539|NCT01943851|63034016|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33632540|NCT01943851|63034017|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33632541|NCT01943851|63034018|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33539068|NCT04033068|62929102|FG002|Overall Study|Withdrawal by Subject|1|||
33539069|NCT04033068|62929103|FG003|Overall Study|Withdrawal by Subject|0|||
33539070|NCT04033068|62929100|FG000|Overall Study|Lost to Follow-up|0|||
33539071|NCT04033068|62929101|FG001|Overall Study|Lost to Follow-up|1|||
33539072|NCT04033068|62929102|FG002|Overall Study|Lost to Follow-up|0|||
33539073|NCT04033068|62929103|FG003|Overall Study|Lost to Follow-up|0|||
33539074|NCT04033068|62929100|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
33539075|NCT04033068|62929101|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
33539076|NCT04033068|62929102|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
33539077|NCT04033068|62929103|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
33539078|NCT02762565|62929113|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
33539079|NCT02757963|62929126|FG000|Overall Study|Adverse Event|3|||
33539080|NCT02757963|62929126|FG000|Overall Study|Reached Stopping Criteria|1054|||
33539081|NCT02757963|62929126|FG000|Overall Study|Lost to Follow-up|5|||
33539082|NCT02757963|62929126|FG000|Overall Study|Physician Decision|1|||
33539083|NCT02757963|62929126|FG000|Overall Study|Withdrawal by Subject|34|||
33539084|NCT03111732|62929141|FG000|Overall Study|Enrolled in different study|1|||
33539085|NCT03111732|62929141|FG000|Overall Study|Progressive disease|3|||
33539086|NCT03111732|62929141|FG000|Overall Study|Withdrawal by Subject|1|||
33539087|NCT01663714|62929150|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
33539088|NCT01663714|62929150|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
33539089|NCT01663714|62929150|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
33539090|NCT01663714|62929150|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
33632542|NCT01943851|63034019|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33539091|NCT01663714|62929150|FG000|Long-Term Follow-Up|Death|4|||
33539092|NCT01663714|62929150|FG000|Long-Term Follow-Up|Non-compliance|1|||
33632543|NCT01943851|63034020|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33632544|NCT01943851|63034021|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33632545|NCT01943851|63034022|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33632546|NCT01943851|63034023|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33632547|NCT01943851|63034024|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33632548|NCT01943851|63034025|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33632549|NCT01943851|63034026|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
33632550|NCT01943851|63034027|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33632551|NCT01943851|63034028|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33632552|NCT01943851|63034011|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33632553|NCT01943851|63034012|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33632554|NCT01943851|63034013|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33632555|NCT01943851|63034014|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33632556|NCT01943851|63034015|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33632557|NCT01943851|63034016|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33632558|NCT01943851|63034017|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33632559|NCT01943851|63034018|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33632560|NCT01943851|63034019|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33632561|NCT01943851|63034020|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33632562|NCT01943851|63034021|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33632563|NCT01943851|63034022|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33632564|NCT01943851|63034023|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33632565|NCT01943851|63034024|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33632566|NCT01943851|63034025|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33632567|NCT01943851|63034026|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
33632568|NCT01943851|63034027|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
33632569|NCT01943851|63034028|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
33632570|NCT01430104|63034069|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
33632571|NCT01990859|63034076|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
33632572|NCT01990859|63034076|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
33632573|NCT02093897|63034081|FG000|Overall Study|Physician Decision|1|||
33632574|NCT02093897|63034081|FG000|Overall Study|Planned age group closure - no's reached|17|||
33632575|NCT02093897|63034081|FG000|Overall Study|Adverse event, non-fatal|1|||
33632576|NCT01990313|63034092|FG000|Overall Study|Lost to Follow-up|1|||
33632577|NCT01947517|63034098|FG000|Overall Study|Withdrawal by Subject|1|||
33632578|NCT01947517|63034099|FG001|Overall Study|Withdrawal by Subject|1|||
33632579|NCT02006927|63034105|FG000|Overall Study|Adverse Event|2|||
33632580|NCT02006927|63034105|FG000|Overall Study|Withdrawal by Subject|1|||
33632581|NCT01947283|63034116|FG000|Overall Study|Death|1|||
33632582|NCT01947283|63034117|FG001|Overall Study|Death|1|||
33632583|NCT01947283|63034118|FG002|Overall Study|Death|1|||
33632584|NCT01947283|63034119|FG003|Overall Study|Death|0|||
33632585|NCT01947283|63034120|FG004|Overall Study|Death|0|||
33632586|NCT01947283|63034121|FG005|Overall Study|Death|0|||
33632587|NCT01947283|63034122|FG006|Overall Study|Death|0|||
33632588|NCT01947283|63034116|FG000|Overall Study|Lost to Follow-up|4|||
33632589|NCT01947283|63034117|FG001|Overall Study|Lost to Follow-up|6|||
33632590|NCT01947283|63034118|FG002|Overall Study|Lost to Follow-up|5|||
33632591|NCT01947283|63034119|FG003|Overall Study|Lost to Follow-up|5|||
33632592|NCT01947283|63034120|FG004|Overall Study|Lost to Follow-up|0|||
33632593|NCT01947283|63034121|FG005|Overall Study|Lost to Follow-up|2|||
33632594|NCT01947283|63034122|FG006|Overall Study|Lost to Follow-up|5|||
33632595|NCT01947283|63034116|FG000|Overall Study|Withdrawal by Subject|10|||
33461595|NCT00075946|62834977|FG002|Overall Study|Did not achieve response after induction|0|||
33461596|NCT00075946|62834978|FG003|Overall Study|Did not achieve response after induction|0|||
33461597|NCT00075946|62834979|FG004|Overall Study|Did not achieve response after induction|182|||
33461598|NCT00075946|62834975|FG000|Overall Study|Incorrectly randomized (no response)|5|||
33461599|NCT00075946|62834976|FG001|Overall Study|Incorrectly randomized (no response)|5|||
33461600|NCT00075946|62834977|FG002|Overall Study|Incorrectly randomized (no response)|5|||
33461601|NCT00075946|62834978|FG003|Overall Study|Incorrectly randomized (no response)|1|||
33461602|NCT00075946|62834979|FG004|Overall Study|Incorrectly randomized (no response)|0|||
33461603|NCT00075946|62834975|FG000|Overall Study|Still on treatment at time of analysis|52|||
33461604|NCT00075946|62834976|FG001|Overall Study|Still on treatment at time of analysis|19|||
33461605|NCT00075946|62834977|FG002|Overall Study|Still on treatment at time of analysis|3|||
33461606|NCT00075946|62834978|FG003|Overall Study|Still on treatment at time of analysis|9|||
33461607|NCT00075946|62834979|FG004|Overall Study|Still on treatment at time of analysis|0|||
33461608|NCT00075946|62834975|FG000|Overall Study|Adverse Event|2|||
33461609|NCT00075946|62834976|FG001|Overall Study|Adverse Event|10|||
33461610|NCT00075946|62834977|FG002|Overall Study|Adverse Event|0|||
33461611|NCT00075946|62834978|FG003|Overall Study|Adverse Event|2|||
33632596|NCT01947283|63034117|FG001|Overall Study|Withdrawal by Subject|8|||
33632597|NCT01947283|63034118|FG002|Overall Study|Withdrawal by Subject|4|||
33632598|NCT01947283|63034119|FG003|Overall Study|Withdrawal by Subject|1|||
33632599|NCT01947283|63034120|FG004|Overall Study|Withdrawal by Subject|0|||
33632600|NCT01947283|63034121|FG005|Overall Study|Withdrawal by Subject|0|||
33632601|NCT01947283|63034122|FG006|Overall Study|Withdrawal by Subject|2|||
33632602|NCT01947283|63034116|FG000|Overall Study|No Clinical Recording|12|||
33632603|NCT01947283|63034117|FG001|Overall Study|No Clinical Recording|6|||
33632604|NCT01947283|63034118|FG002|Overall Study|No Clinical Recording|8|||
33632605|NCT01947283|63034119|FG003|Overall Study|No Clinical Recording|10|||
33632606|NCT01947283|63034120|FG004|Overall Study|No Clinical Recording|0|||
33461612|NCT00075946|62834979|FG004|Overall Study|Adverse Event|0|||
33461613|NCT00075946|62834975|FG000|Overall Study|Death|0|||
33461614|NCT00075946|62834976|FG001|Overall Study|Death|1|||
33461615|NCT00075946|62834977|FG002|Overall Study|Death|0|||
33461616|NCT00075946|62834978|FG003|Overall Study|Death|0|||
33632607|NCT01947283|63034121|FG005|Overall Study|No Clinical Recording|0|||
33632608|NCT01947283|63034122|FG006|Overall Study|No Clinical Recording|0|||
33632609|NCT01947283|63034116|FG000|Overall Study|Non-coding Clinical Recording language|0|||
33632610|NCT01947283|63034117|FG001|Overall Study|Non-coding Clinical Recording language|0|||
33632611|NCT01947283|63034118|FG002|Overall Study|Non-coding Clinical Recording language|0|||
33632612|NCT01947283|63034119|FG003|Overall Study|Non-coding Clinical Recording language|1|||
33632613|NCT01947283|63034120|FG004|Overall Study|Non-coding Clinical Recording language|0|||
33632614|NCT01947283|63034121|FG005|Overall Study|Non-coding Clinical Recording language|0|||
33632615|NCT01947283|63034122|FG006|Overall Study|Non-coding Clinical Recording language|0|||
33632616|NCT01947283|63034116|FG000|Overall Study|Missing Follow-up Assessment|2|||
33632617|NCT01947283|63034117|FG001|Overall Study|Missing Follow-up Assessment|2|||
33632618|NCT01947283|63034118|FG002|Overall Study|Missing Follow-up Assessment|3|||
33632619|NCT01947283|63034119|FG003|Overall Study|Missing Follow-up Assessment|0|||
33632620|NCT01947283|63034120|FG004|Overall Study|Missing Follow-up Assessment|0|||
33632621|NCT01947283|63034121|FG005|Overall Study|Missing Follow-up Assessment|2|||
33632622|NCT01947283|63034122|FG006|Overall Study|Missing Follow-up Assessment|0|||
33632623|NCT01947283|63034116|FG000|Overall Study|No patients were enrolled in study|0|||
33632624|NCT01947283|63034117|FG001|Overall Study|No patients were enrolled in study|0|||
33632625|NCT01947283|63034118|FG002|Overall Study|No patients were enrolled in study|0|||
33632626|NCT01947283|63034119|FG003|Overall Study|No patients were enrolled in study|0|||
33632627|NCT01947283|63034120|FG004|Overall Study|No patients were enrolled in study|0|||
33632628|NCT01947283|63034121|FG005|Overall Study|No patients were enrolled in study|3|||
33632629|NCT01947283|63034122|FG006|Overall Study|No patients were enrolled in study|1|||
33632630|NCT02006693|63034141|FG000|Overall Study|No Reason Specified|6|||
33632631|NCT02006693|63034142|FG001|Overall Study|No Reason Specified|8|||
33632632|NCT02006693|63034141|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
33632633|NCT02006693|63034142|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
33632634|NCT02006693|63034141|FG000|Overall Study|XEN Implant Explantation|0|||
33632635|NCT02006693|63034142|FG001|Overall Study|XEN Implant Explantation|1|||
33632636|NCT02006693|63034141|FG000|Overall Study|Death|2|||
33632637|NCT02006693|63034142|FG001|Overall Study|Death|2|||
33632638|NCT02006693|63034141|FG000|Overall Study|Lost to Follow-up|4|||
33632639|NCT02006693|63034142|FG001|Overall Study|Lost to Follow-up|1|||
33632640|NCT02006693|63034141|FG000|Overall Study|Patient Decision|4|||
33632641|NCT02006693|63034142|FG001|Overall Study|Patient Decision|0|||
33632642|NCT01947127|63034150|FG000|Overall Study|Protocol Violation|18|||
33632643|NCT01947127|63034151|FG001|Overall Study|Protocol Violation|38|||
33632644|NCT01947127|63034150|FG000|Overall Study|Withdrawal by Subject|1|||
33632645|NCT01947127|63034151|FG001|Overall Study|Withdrawal by Subject|1|||
33632646|NCT01947127|63034150|FG000|Overall Study|Data loss|4|||
33632647|NCT01947127|63034151|FG001|Overall Study|Data loss|4|||
33632648|NCT01976845|63034160|FG000|Overall Study|Physician Decision|8|||
33632649|NCT01976845|63034161|FG001|Overall Study|Physician Decision|8|||
33632650|NCT01976845|63034162|FG002|Overall Study|Physician Decision|3|||
33632651|NCT01989689|63034172|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
33632652|NCT01989689|63034173|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
33632653|NCT01989689|63034172|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
33632654|NCT01989689|63034173|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
33632655|NCT01943539|63034181|FG000|Overall Study|Non-compliance with at-home intervention|4|||
33632656|NCT01943539|63034182|FG001|Overall Study|Non-compliance with at-home intervention|0|||
33632657|NCT01942993|63034189|FG000|Overall Study|Lost to Follow-up|1|||
33632658|NCT01942993|63034189|FG000|Overall Study|Physician Decision|1|||
33632659|NCT01989455|63034198|FG000|Overall Study|Adverse Event|0|||
33632660|NCT01989455|63034199|FG001|Overall Study|Adverse Event|1|||
33461617|NCT00075946|62834979|FG004|Overall Study|Death|0|||
33632661|NCT01989455|63034200|FG002|Overall Study|Adverse Event|0|||
33632662|NCT01989455|63034201|FG003|Overall Study|Adverse Event|0|||
33632663|NCT01989455|63034202|FG004|Overall Study|Adverse Event|0|||
33632664|NCT01989455|63034198|FG000|Overall Study|Withdrawal by Subject|0|||
33632665|NCT01989455|63034199|FG001|Overall Study|Withdrawal by Subject|1|||
33461618|NCT00075946|62834975|FG000|Overall Study|Withdrawal by Subject|23|||
33539093|NCT01663636|62929172|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
33539094|NCT01663636|62929173|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
33539095|NCT03065244|62929181|FG000|Overall Study|Lost to Follow-up|1|||
33539096|NCT03065244|62929182|FG001|Overall Study|Lost to Follow-up|1|||
33539097|NCT03065244|62929181|FG000|Overall Study|Diagnosed with a different disease|1|||
33539098|NCT03065244|62929182|FG001|Overall Study|Diagnosed with a different disease|1|||
33539099|NCT03065244|62929181|FG000|Overall Study|Protocol Violation|0|||
33539100|NCT03065244|62929182|FG001|Overall Study|Protocol Violation|1|||
33539101|NCT03065244|62929181|FG000|Overall Study|Withdrawal by Subject|1|||
33539102|NCT03065244|62929182|FG001|Overall Study|Withdrawal by Subject|1|||
33539103|NCT00100815|62929188|FG000|Overall Study|Progression|24|||
33539104|NCT00100815|62929188|FG000|Overall Study|Adverse Event|18|||
33539105|NCT00100815|62929188|FG000|Overall Study|Death|4|||
33539106|NCT00100815|62929188|FG000|Overall Study|Other|3|||
33539107|NCT00708422|62929194|FG000|Overall Study|Adverse Event|3|||
33632666|NCT01989455|63034200|FG002|Overall Study|Withdrawal by Subject|0|||
33632667|NCT01989455|63034201|FG003|Overall Study|Withdrawal by Subject|0|||
33632668|NCT01989455|63034202|FG004|Overall Study|Withdrawal by Subject|0|||
33632669|NCT01989455|63034198|FG000|Overall Study|Technical problems with infusion|0|||
33632670|NCT01989455|63034199|FG001|Overall Study|Technical problems with infusion|0|||
33632671|NCT01989455|63034200|FG002|Overall Study|Technical problems with infusion|1|||
33632672|NCT01989455|63034201|FG003|Overall Study|Technical problems with infusion|0|||
33632673|NCT01989455|63034202|FG004|Overall Study|Technical problems with infusion|1|||
33632674|NCT01942837|63034218|FG000|Overall Study|Death|1|||
33632675|NCT01942837|63034218|FG000|Overall Study|Symptomatic or radiographic progression|49|||
33632676|NCT01942837|63034218|FG000|Overall Study|Adverse Event|6|||
33539108|NCT00708422|62929195|FG001|Overall Study|Adverse Event|1|||
33539109|NCT00708422|62929194|FG000|Overall Study|Withdrawal by Subject|1|||
33539110|NCT00708422|62929195|FG001|Overall Study|Withdrawal by Subject|0|||
33539111|NCT02760069|62929204|FG000|Overall Study|Withdrawal by Subject|0|||
33539112|NCT02760069|62929205|FG001|Overall Study|Withdrawal by Subject|1|||
33539113|NCT02760069|62929206|FG002|Overall Study|Withdrawal by Subject|1|||
33539114|NCT00707486|62929214|FG000|Overall Study|Withdrawal by Subject|1|||
33539115|NCT02759055|62929222|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
33632677|NCT01942837|63034218|FG000|Overall Study|Physician Decision|3|||
33632678|NCT01942837|63034218|FG000|Overall Study|Withdrawal by Subject|2|||
33632679|NCT01942837|63034218|FG000|Overall Study|Intercurrent Illness|1|||
33632680|NCT01942837|63034218|FG000|Overall Study|On treatment|3|||
33632681|NCT01942837|63034218|FG000|Overall Study|Never initiate the treatment|2|||
33632682|NCT01987895|63034225|FG000|Overall Study|Withdrawal by Subject|12|||
33632683|NCT01987895|63034226|FG001|Overall Study|Withdrawal by Subject|7|||
33632684|NCT01987895|63034225|FG000|Overall Study|Physician Decision|8|||
33632685|NCT01987895|63034226|FG001|Overall Study|Physician Decision|10|||
33632686|NCT01987895|63034225|FG000|Overall Study|Death|7|||
33632687|NCT01987895|63034226|FG001|Overall Study|Death|7|||
33539116|NCT02759055|62929223|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
33539117|NCT00708032|62929231|FG000|Overall Study|Adverse Event|0|||
33539118|NCT00708032|62929232|FG001|Overall Study|Adverse Event|2|||
33632688|NCT01987895|63034225|FG000|Overall Study|Lost to Follow-up|3|||
33632689|NCT01987895|63034226|FG001|Overall Study|Lost to Follow-up|5|||
33632690|NCT01987895|63034225|FG000|Overall Study|randomized before giving IC|0|||
33632691|NCT01987895|63034226|FG001|Overall Study|randomized before giving IC|1|||
33632692|NCT02005445|63034234|FG000|Overall Study|Dual study enrollment|0|||
33632693|NCT02005445|63034235|FG001|Overall Study|Dual study enrollment|1|||
33632694|NCT01618669|63034243|FG000|Overall Study|Lost to Follow-up|1|||
33632695|NCT01618669|63034244|FG001|Overall Study|Lost to Follow-up|1|||
33632696|NCT01618669|63034243|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
33632697|NCT01618669|63034244|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
33632698|NCT01618669|63034243|FG000|Overall Study|Adverse Event|16|||
33632699|NCT01618669|63034244|FG001|Overall Study|Adverse Event|7|||
33632700|NCT01618669|63034243|FG000|Overall Study|Protocol Violation|5|||
33632701|NCT01618669|63034244|FG001|Overall Study|Protocol Violation|3|||
33632702|NCT01618669|63034243|FG000|Overall Study|Withdrawal by Subject|9|||
33632703|NCT01618669|63034244|FG001|Overall Study|Withdrawal by Subject|9|||
33632704|NCT01618669|63034243|FG000|Overall Study|Miscellaneous Reason|0|||
33632705|NCT01618669|63034244|FG001|Overall Study|Miscellaneous Reason|1|||
33539119|NCT00708032|62929231|FG000|Overall Study|Lost to Follow-up|1|||
33632706|NCT01390948|63034265|FG000|Overall Study|End of Study|1|||
33632707|NCT01390948|63034266|FG001|Overall Study|End of Study|0|||
33632708|NCT01390948|63034267|FG002|Overall Study|End of Study|0|||
33632709|NCT01390948|63034265|FG000|Overall Study|Withdrew consent|2|||
33632710|NCT01390948|63034266|FG001|Overall Study|Withdrew consent|2|||
33632711|NCT01390948|63034267|FG002|Overall Study|Withdrew consent|0|||
33632712|NCT01390948|63034265|FG000|Overall Study|Progressive Disease|2|||
33632713|NCT01390948|63034266|FG001|Overall Study|Progressive Disease|5|||
33632714|NCT01390948|63034267|FG002|Overall Study|Progressive Disease|0|||
33632715|NCT01390948|63034265|FG000|Overall Study|Death during follow-up|10|||
33632716|NCT01390948|63034266|FG001|Overall Study|Death during follow-up|11|||
33632717|NCT01390948|63034267|FG002|Overall Study|Death during follow-up|1|||
33632718|NCT02005211|63034281|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
33632719|NCT02005211|63034282|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
33632720|NCT02005211|63034283|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
33632721|NCT02005211|63034284|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
33632722|NCT02005211|63034285|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
33632723|NCT02005211|63034286|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
33632724|NCT02005211|63034287|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
33632725|NCT01429792|63034310|FG000|Overall Study|Other Reasons|67|||
33632726|NCT01429792|63034310|FG000|Overall Study|Unknown Disposition|94|||
33632727|NCT01429792|63034310|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
33632728|NCT01429792|63034310|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
33632729|NCT01429792|63034310|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
33632730|NCT01429792|63034310|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
33632731|NCT01429792|63034310|FG000|Overall Study|Withdrawal by Subject|70|||
33632732|NCT01429792|63034310|FG000|Overall Study|Lost to Follow-up|88|||
33632733|NCT01409434|63034314|FG000|Overall Study|Protocol Violation|4|||
33632734|NCT01940887|63034320|FG000|Year 1|Protocol Violation|0|||
33632735|NCT01940887|63034321|FG001|Year 1|Protocol Violation|1|||
33632736|NCT01940887|63034320|FG000|Year 1|Physician Decision|7|||
33632737|NCT01940887|63034321|FG001|Year 1|Physician Decision|3|||
33632738|NCT01940887|63034320|FG000|Year 1|Death|5|||
33632739|NCT01940887|63034321|FG001|Year 1|Death|3|||
33632740|NCT01940887|63034320|FG000|Year 1|Adverse Event|7|||
33632741|NCT01940887|63034321|FG001|Year 1|Adverse Event|6|||
33539120|NCT00708032|62929232|FG001|Overall Study|Lost to Follow-up|2|||
33539121|NCT00708032|62929231|FG000|Overall Study|Pregnancy|0|||
33539122|NCT00708032|62929232|FG001|Overall Study|Pregnancy|1|||
33539123|NCT00708032|62929231|FG000|Overall Study|Poor vision|0|||
33539124|NCT00708032|62929232|FG001|Overall Study|Poor vision|6|||
33539125|NCT00708032|62929231|FG000|Overall Study|Visit out of range at month 12|4|||
33539126|NCT00708032|62929232|FG001|Overall Study|Visit out of range at month 12|1|||
33539127|NCT00708032|62929231|FG000|Overall Study|Did not meet protocol criteria|1|||
33632742|NCT01940887|63034320|FG000|Year 1|Withdrawal by Subject|18|||
33632743|NCT01940887|63034321|FG001|Year 1|Withdrawal by Subject|9|||
33632744|NCT01940887|63034320|FG000|Year 1|Lost to Follow-up|2|||
33632745|NCT01940887|63034321|FG001|Year 1|Lost to Follow-up|1|||
33632746|NCT01940887|63034320|FG000|Year 2|Physician Decision|8|||
33632747|NCT01940887|63034321|FG001|Year 2|Physician Decision|1|||
33632748|NCT01940887|63034320|FG000|Year 2|Death|0|||
33632749|NCT01940887|63034321|FG001|Year 2|Death|2|||
33632750|NCT01940887|63034320|FG000|Year 2|Sponsor Decision, early termination|192|||
33632751|NCT01940887|63034321|FG001|Year 2|Sponsor Decision, early termination|203|||
33632752|NCT01940887|63034320|FG000|Year 2|Adverse Event|8|||
33632753|NCT01940887|63034321|FG001|Year 2|Adverse Event|2|||
33632754|NCT01940887|63034320|FG000|Year 2|Withdrawal by Subject|8|||
33632755|NCT01940887|63034321|FG001|Year 2|Withdrawal by Subject|8|||
33632756|NCT01940887|63034320|FG000|Year 2|Lost to Follow-up|1|||
33632757|NCT01940887|63034321|FG001|Year 2|Lost to Follow-up|6|||
33632758|NCT01925612|63034332|FG000|Overall Study|Progressive Disease|1|||
33632759|NCT01925612|63034333|FG001|Overall Study|Progressive Disease|1|||
33539128|NCT00708032|62929232|FG001|Overall Study|Did not meet protocol criteria|2|||
33539129|NCT00708032|62929231|FG000|Overall Study|Protocol Violation|4|||
33461619|NCT00075946|62834976|FG001|Overall Study|Withdrawal by Subject|58|||
33461620|NCT00075946|62834977|FG002|Overall Study|Withdrawal by Subject|4|||
33461621|NCT00075946|62834978|FG003|Overall Study|Withdrawal by Subject|9|||
33461622|NCT00075946|62834979|FG004|Overall Study|Withdrawal by Subject|0|||
33461623|NCT00075946|62834975|FG000|Overall Study|Alternative therapy|16|||
33461624|NCT00075946|62834976|FG001|Overall Study|Alternative therapy|2|||
33461625|NCT00075946|62834977|FG002|Overall Study|Alternative therapy|5|||
33632760|NCT01925612|63034334|FG002|Overall Study|Progressive Disease|1|||
33632761|NCT01925612|63034335|FG003|Overall Study|Progressive Disease|0|||
33632762|NCT01925612|63034336|FG004|Overall Study|Progressive Disease|0|||
33632763|NCT01925612|63034332|FG000|Overall Study|Adverse Event|3|||
33632764|NCT01925612|63034333|FG001|Overall Study|Adverse Event|3|||
33632765|NCT01925612|63034334|FG002|Overall Study|Adverse Event|0|||
33632766|NCT01925612|63034335|FG003|Overall Study|Adverse Event|1|||
33632767|NCT01925612|63034336|FG004|Overall Study|Adverse Event|2|||
33632768|NCT02093663|63034348|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
33632769|NCT02093663|63034349|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
33632770|NCT02093663|63034350|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
33632771|NCT02093663|63034351|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
33632772|NCT02093663|63034352|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
33461626|NCT00075946|62834978|FG003|Overall Study|Alternative therapy|0|||
33461627|NCT00075946|62834979|FG004|Overall Study|Alternative therapy|0|||
33461628|NCT00075946|62834975|FG000|Overall Study|Other complicating disease|7|||
33461629|NCT00075946|62834976|FG001|Overall Study|Other complicating disease|13|||
33461630|NCT00075946|62834977|FG002|Overall Study|Other complicating disease|1|||
33461631|NCT00075946|62834978|FG003|Overall Study|Other complicating disease|4|||
33461632|NCT00075946|62834979|FG004|Overall Study|Other complicating disease|0|||
33461633|NCT00075946|62834975|FG000|Overall Study|No response to retreatment|23|||
33461634|NCT00075946|62834976|FG001|Overall Study|No response to retreatment|0|||
33461635|NCT00075946|62834977|FG002|Overall Study|No response to retreatment|2|||
33461636|NCT00075946|62834978|FG003|Overall Study|No response to retreatment|0|||
33461637|NCT00075946|62834979|FG004|Overall Study|No response to retreatment|0|||
33461638|NCT00075946|62834975|FG000|Overall Study|Time to progression less than 6 months|15|||
33461639|NCT00075946|62834976|FG001|Overall Study|Time to progression less than 6 months|30|||
33461640|NCT00075946|62834977|FG002|Overall Study|Time to progression less than 6 months|8|||
33461641|NCT00075946|62834978|FG003|Overall Study|Time to progression less than 6 months|3|||
33461642|NCT00075946|62834979|FG004|Overall Study|Time to progression less than 6 months|0|||
33461643|NCT00075946|62834975|FG000|Overall Study|Other|5|||
33461644|NCT00075946|62834976|FG001|Overall Study|Other|13|||
33461645|NCT00075946|62834977|FG002|Overall Study|Other|0|||
33461646|NCT00075946|62834978|FG003|Overall Study|Other|2|||
33461647|NCT00075946|62834979|FG004|Overall Study|Other|0|||
33461648|NCT00057876|62834996|FG000|Overall Study|Adverse Event|8|||
33461649|NCT00057876|62834997|FG001|Overall Study|Adverse Event|8|||
33461650|NCT00057876|62834996|FG000|Overall Study|Death|2|||
33461651|NCT00057876|62834997|FG001|Overall Study|Death|1|||
33461652|NCT00057876|62834996|FG000|Overall Study|Withdrawal by Subject|5|||
33461653|NCT00057876|62834997|FG001|Overall Study|Withdrawal by Subject|6|||
33461654|NCT00057876|62834996|FG000|Overall Study|Lack of Efficacy|10|||
33461655|NCT00057876|62834997|FG001|Overall Study|Lack of Efficacy|8|||
33461656|NCT00057876|62834996|FG000|Overall Study|Ineligible|1|||
33461657|NCT00057876|62834997|FG001|Overall Study|Ineligible|2|||
33461658|NCT00057876|62834996|FG000|Overall Study|other reason|2|||
33461659|NCT00057876|62834997|FG001|Overall Study|other reason|2|||
33461660|NCT00057876|62834996|FG000|Overall Study|other complicating disease|1|||
33461661|NCT00057876|62834997|FG001|Overall Study|other complicating disease|0|||
33461662|NCT00057837|62835005|FG000|Overall Study|Progression/relapse|12|||
33461663|NCT00057837|62835006|FG001|Overall Study|Progression/relapse|14|||
33461664|NCT00057837|62835005|FG000|Overall Study|Adverse Event|2|||
33461665|NCT00057837|62835006|FG001|Overall Study|Adverse Event|12|||
33461666|NCT00057837|62835005|FG000|Overall Study|Death|5|||
33461667|NCT00057837|62835006|FG001|Overall Study|Death|4|||
33461668|NCT00057837|62835005|FG000|Overall Study|Withdrawal by Subject|5|||
33461669|NCT00057837|62835006|FG001|Overall Study|Withdrawal by Subject|3|||
33461670|NCT00057837|62835005|FG000|Overall Study|Alternative therapy|0|||
33461671|NCT00057837|62835006|FG001|Overall Study|Alternative therapy|1|||
33461672|NCT00057837|62835005|FG000|Overall Study|Other complicating disease|2|||
33461673|NCT00057837|62835006|FG001|Overall Study|Other complicating disease|1|||
33461674|NCT00057837|62835005|FG000|Overall Study|Physician Decision|1|||
33461675|NCT00057837|62835006|FG001|Overall Study|Physician Decision|0|||
33461676|NCT00057837|62835005|FG000|Overall Study|Ineligible|3|||
33461677|NCT00057837|62835006|FG001|Overall Study|Ineligible|3|||
33461678|NCT00057837|62835005|FG000|Overall Study|Never started treatment|1|||
33461679|NCT00057837|62835006|FG001|Overall Study|Never started treatment|1|||
33461680|NCT00046930|62835014|FG000|Overall Study|Ineligible|12|||
33461681|NCT00046930|62835015|FG001|Overall Study|Ineligible|4|||
33461682|NCT00042939|62835026|FG000|Overall Study|Adverse Event|6|||
33461683|NCT00042939|62835027|FG001|Overall Study|Adverse Event|7|||
33461684|NCT00042939|62835026|FG000|Overall Study|Death|3|||
33461685|NCT00042939|62835027|FG001|Overall Study|Death|2|||
33461686|NCT00042939|62835026|FG000|Overall Study|Withdrawal by Subject|3|||
33461687|NCT00042939|62835027|FG001|Overall Study|Withdrawal by Subject|4|||
33539130|NCT00708032|62929232|FG001|Overall Study|Protocol Violation|1|||
33539131|NCT00708032|62929231|FG000|Overall Study|Withdrawal by Subject|0|||
33539132|NCT00708032|62929232|FG001|Overall Study|Withdrawal by Subject|1|||
33539133|NCT00707174|62929240|FG000|Overall Study|Adverse Event|1|||
33461688|NCT00042939|62835026|FG000|Overall Study|Other disease|1|||
33539134|NCT00707174|62929241|FG001|Overall Study|Adverse Event|6|||
33539135|NCT00707174|62929240|FG000|Overall Study|Withdrawal by Subject|4|||
33539136|NCT00707174|62929241|FG001|Overall Study|Withdrawal by Subject|1|||
33461689|NCT00042939|62835027|FG001|Overall Study|Other disease|0|||
33461690|NCT00042939|62835026|FG000|Overall Study|Ineligible|2|||
33461691|NCT00042939|62835027|FG001|Overall Study|Ineligible|2|||
33461692|NCT00042939|62835026|FG000|Overall Study|Deterioration of health|3|||
33461693|NCT00042939|62835027|FG001|Overall Study|Deterioration of health|4|||
33461694|NCT00042939|62835026|FG000|Overall Study|QOL diminished|1|||
33461695|NCT00042939|62835027|FG001|Overall Study|QOL diminished|0|||
33539137|NCT02756403|62929251|FG000|Overall Study|Unable to swallow medication|0|||
33461696|NCT00042939|62835026|FG000|Overall Study|Rising ca 19-9|1|||
33632773|NCT02093663|63034348|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
33632774|NCT02093663|63034349|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33632775|NCT02093663|63034350|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33632776|NCT02093663|63034351|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33632777|NCT02093663|63034352|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33632778|NCT02093663|63034348|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
33632779|NCT02093663|63034349|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
33632780|NCT02093663|63034350|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
33632781|NCT02093663|63034351|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
33632782|NCT02093663|63034352|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
33632783|NCT02093663|63034348|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
33632784|NCT02093663|63034349|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
33632785|NCT02093663|63034350|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
33632786|NCT02093663|63034351|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
33632787|NCT02093663|63034352|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
33632788|NCT02093663|63034348|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33632789|NCT02093663|63034349|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33632790|NCT02093663|63034350|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
33632791|NCT02093663|63034351|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33632792|NCT02093663|63034352|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33632793|NCT02093663|63034348|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
33632794|NCT02093663|63034349|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
33632795|NCT02093663|63034350|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
33632796|NCT02093663|63034351|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
33632797|NCT02093663|63034352|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
33632798|NCT02093663|63034348|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
33632799|NCT02093663|63034349|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
33632800|NCT02093663|63034350|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
33632801|NCT02093663|63034351|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
33632802|NCT02093663|63034352|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
33632803|NCT02093663|63034348|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
33632804|NCT02093663|63034349|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
33632805|NCT02093663|63034350|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
33632806|NCT02093663|63034351|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
33539138|NCT02756403|62929252|FG001|Overall Study|Unable to swallow medication|1|||
33632807|NCT02093663|63034352|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
33632808|NCT02093663|63034348|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
33632809|NCT02093663|63034349|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
33632810|NCT02093663|63034350|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
33632811|NCT02093663|63034351|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
33632812|NCT02093663|63034352|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
33632813|NCT01408888|63034369|FG000|First Intervention|Adverse Event|0|||
33632814|NCT01408888|63034370|FG001|First Intervention|Adverse Event|1|||
33632815|NCT01408888|63034369|FG000|First Intervention|Withdrawal by Subject|0|||
33632816|NCT01408888|63034370|FG001|First Intervention|Withdrawal by Subject|2|||
33632817|NCT01408888|63034369|FG000|Second Intervention|Withdrawal by Subject|1|||
33632818|NCT01408888|63034370|FG001|Second Intervention|Withdrawal by Subject|0|||
33461697|NCT00042939|62835027|FG001|Overall Study|Rising ca 19-9|0|||
33461698|NCT00042939|62835026|FG000|Overall Study|Patient non-compliance|1|||
33461699|NCT00042939|62835027|FG001|Overall Study|Patient non-compliance|0|||
33461700|NCT00042939|62835026|FG000|Overall Study|Still on treatment|1|||
33461701|NCT00042939|62835027|FG001|Overall Study|Still on treatment|0|||
33461702|NCT00042939|62835026|FG000|Overall Study|Treatment break > 4 weeks|0|||
33461703|NCT00042939|62835027|FG001|Overall Study|Treatment break > 4 weeks|1|||
33461704|NCT00042939|62835026|FG000|Overall Study|Did not start treatment|2|||
33461705|NCT00042939|62835027|FG001|Overall Study|Did not start treatment|1|||
33461706|NCT00008385|62835035|FG000|Overall Study|Off treatment reasons not reported|79|||
33461707|NCT00008385|62835036|FG001|Overall Study|Off treatment reasons not reported|70|||
33539139|NCT02756403|62929253|FG002|Overall Study|Unable to swallow medication|1|||
33539140|NCT02756403|62929254|FG003|Overall Study|Unable to swallow medication|1|||
33539141|NCT02756403|62929251|FG000|Overall Study|Did not complete Procedure|0|||
33539142|NCT02756403|62929252|FG001|Overall Study|Did not complete Procedure|1|||
33539143|NCT02756403|62929253|FG002|Overall Study|Did not complete Procedure|0|||
33539144|NCT02756403|62929254|FG003|Overall Study|Did not complete Procedure|0|||
33539145|NCT02756403|62929251|FG000|Overall Study|Changed Mind About Procedure|0|||
33632819|NCT01408888|63034369|FG000|Second Intervention|Adverse Event|1|||
33461708|NCT00008385|62835035|FG000|Overall Study|Progressive disease|52|||
33461709|NCT00008385|62835036|FG001|Overall Study|Progressive disease|117|||
33461710|NCT00008385|62835035|FG000|Overall Study|Adverse Event|8|||
33632820|NCT01408888|63034370|FG001|Second Intervention|Adverse Event|0|||
33632821|NCT01918033|63034389|FG000|Overall Study|Adverse Event|1|||
33632822|NCT01918033|63034390|FG001|Overall Study|Adverse Event|0|||
33632823|NCT01918033|63034391|FG002|Overall Study|Adverse Event|2|||
33632824|NCT01918033|63034389|FG000|Overall Study|Lost to Follow-up|0|||
33632825|NCT01918033|63034390|FG001|Overall Study|Lost to Follow-up|1|||
33632826|NCT01918033|63034391|FG002|Overall Study|Lost to Follow-up|0|||
33632827|NCT01918033|63034389|FG000|Overall Study|Protocol Violation|2|||
33632828|NCT01918033|63034390|FG001|Overall Study|Protocol Violation|0|||
33632829|NCT01918033|63034391|FG002|Overall Study|Protocol Violation|1|||
33632830|NCT01918033|63034389|FG000|Overall Study|Withdrawal by Subject|2|||
33632831|NCT01918033|63034390|FG001|Overall Study|Withdrawal by Subject|1|||
33632832|NCT01918033|63034391|FG002|Overall Study|Withdrawal by Subject|0|||
33632833|NCT01408732|63034399|FG000|Overall Study|Withdrawal by Subject|2|||
33632834|NCT01408732|63034400|FG001|Overall Study|Withdrawal by Subject|2|||
33632835|NCT01390402|63034406|FG000|Overall Study|Death|1|||
33632836|NCT01390402|63034406|FG000|Overall Study|Disease Progression|4|||
33632837|NCT01976299|63034412|FG000|Overall Study|Withdrawal by Subject|3|||
33632838|NCT01976299|63034413|FG001|Overall Study|Withdrawal by Subject|1|||
33632839|NCT01976299|63034412|FG000|Overall Study|Death|4|||
33632840|NCT01976299|63034413|FG001|Overall Study|Death|2|||
33632841|NCT01976299|63034412|FG000|Overall Study|Lost to Follow-up|7|||
33632842|NCT01976299|63034413|FG001|Overall Study|Lost to Follow-up|1|||
33632843|NCT01976299|63034412|FG000|Overall Study|See clarification above in comments|9|||
33632844|NCT01976299|63034413|FG001|Overall Study|See clarification above in comments|2|||
33632845|NCT01428076|63034421|FG000|Overall Study|Adverse Event|0|||
33632846|NCT01428076|63034422|FG001|Overall Study|Adverse Event|1|||
33632847|NCT01900652|63034432|FG000|Overall Study|Progressive Disease|1|||
33632848|NCT01900652|63034433|FG001|Overall Study|Progressive Disease|0|||
33632849|NCT01900652|63034432|FG000|Overall Study|Consent withdrawn by subject|1|||
33632850|NCT01900652|63034433|FG001|Overall Study|Consent withdrawn by subject|1|||
33632851|NCT01900652|63034432|FG000|Overall Study|Death|3|||
33632852|NCT01900652|63034433|FG001|Overall Study|Death|0|||
33632853|NCT01900652|63034432|FG000|Overall Study|Adverse Event|2|||
33632854|NCT01900652|63034433|FG001|Overall Study|Adverse Event|1|||
33632855|NCT01900652|63034432|FG000|Overall Study|Physician Decision|1|||
33461711|NCT00008385|62835036|FG001|Overall Study|Adverse Event|20|||
33461712|NCT00008385|62835035|FG000|Overall Study|Death|12|||
33461713|NCT00008385|62835036|FG001|Overall Study|Death|18|||
33461714|NCT00008385|62835035|FG000|Overall Study|Withdrawal by Subject|67|||
33461715|NCT00008385|62835036|FG001|Overall Study|Withdrawal by Subject|157|||
33461716|NCT00008385|62835035|FG000|Overall Study|Start non-protocol therapy|3|||
33461717|NCT00008385|62835036|FG001|Overall Study|Start non-protocol therapy|1|||
33461718|NCT00008385|62835035|FG000|Overall Study|Other complicating disease|17|||
33461719|NCT00008385|62835036|FG001|Overall Study|Other complicating disease|30|||
33461720|NCT00008385|62835035|FG000|Overall Study|Maximum dose reached|0|||
33461721|NCT00008385|62835036|FG001|Overall Study|Maximum dose reached|2|||
33461722|NCT00008385|62835035|FG000|Overall Study|Other|105|||
33632856|NCT01900652|63034433|FG001|Overall Study|Physician Decision|1|||
33632857|NCT02093351|63034447|FG000|Part A|Adverse Event|0|||
33632858|NCT02093351|63034448|FG001|Part A|Adverse Event|1|||
33632859|NCT02093351|63034449|FG002|Part A|Adverse Event|1|||
33632860|NCT02093351|63034450|FG003|Part A|Adverse Event|0|||
33461723|NCT00008385|62835036|FG001|Overall Study|Other|212|||
33461724|NCT00008385|62835035|FG000|Overall Study|Not start protocol therapy|44|||
33461725|NCT00008385|62835036|FG001|Overall Study|Not start protocol therapy|175|||
33461726|NCT00003907|62835051|FG000|Overall Study|Adverse Event|2|||
33461727|NCT00003907|62835052|FG001|Overall Study|Adverse Event|11|||
33461728|NCT00003907|62835051|FG000|Overall Study|Death|2|||
33461729|NCT00003907|62835052|FG001|Overall Study|Death|0|||
33461730|NCT00003907|62835051|FG000|Overall Study|Withdrawal by Subject|1|||
33461731|NCT00003907|62835052|FG001|Overall Study|Withdrawal by Subject|3|||
33461732|NCT00003907|62835051|FG000|Overall Study|Progressive disease|4|||
33461733|NCT00003907|62835052|FG001|Overall Study|Progressive disease|4|||
33461734|NCT00003907|62835051|FG000|Overall Study|Complicating disease|1|||
33461735|NCT00003907|62835052|FG001|Overall Study|Complicating disease|0|||
33632861|NCT02093351|63034447|FG000|Part A|Condition under investigation worsened|2|||
33632862|NCT02093351|63034448|FG001|Part A|Condition under investigation worsened|0|||
33632863|NCT02093351|63034449|FG002|Part A|Condition under investigation worsened|2|||
33632864|NCT02093351|63034450|FG003|Part A|Condition under investigation worsened|0|||
33632865|NCT02093351|63034447|FG000|Part A|Death|0|||
33632866|NCT02093351|63034448|FG001|Part A|Death|1|||
33632867|NCT02093351|63034449|FG002|Part A|Death|0|||
33632868|NCT02093351|63034450|FG003|Part A|Death|0|||
33632869|NCT02093351|63034447|FG000|Part B|Patient decision|0|||
33632870|NCT02093351|63034448|FG001|Part B|Patient decision|0|||
33632871|NCT02093351|63034449|FG002|Part B|Patient decision|0|||
33632872|NCT02093351|63034450|FG003|Part B|Patient decision|3|||
33632873|NCT02093351|63034447|FG000|Part B|Disease progression|0|||
33632874|NCT02093351|63034448|FG001|Part B|Disease progression|0|||
33632875|NCT02093351|63034449|FG002|Part B|Disease progression|0|||
33632876|NCT02093351|63034450|FG003|Part B|Disease progression|4|||
33632877|NCT02093351|63034447|FG000|Part B|Complete response|0|||
33632878|NCT02093351|63034448|FG001|Part B|Complete response|0|||
33632879|NCT02093351|63034449|FG002|Part B|Complete response|0|||
33632880|NCT02093351|63034450|FG003|Part B|Complete response|1|||
33632881|NCT02093351|63034447|FG000|Part B|Adverse event + disease progression|0|||
33632882|NCT02093351|63034448|FG001|Part B|Adverse event + disease progression|0|||
33632883|NCT02093351|63034449|FG002|Part B|Adverse event + disease progression|0|||
33632884|NCT02093351|63034450|FG003|Part B|Adverse event + disease progression|1|||
33632885|NCT02093351|63034447|FG000|Part B|Lack of therapeutic response|0|||
33632886|NCT02093351|63034448|FG001|Part B|Lack of therapeutic response|0|||
33632887|NCT02093351|63034449|FG002|Part B|Lack of therapeutic response|0|||
33632888|NCT02093351|63034450|FG003|Part B|Lack of therapeutic response|12|||
33632889|NCT02093351|63034447|FG000|Part B|Condition under investigation worsened|0|||
33632890|NCT02093351|63034448|FG001|Part B|Condition under investigation worsened|0|||
33632891|NCT02093351|63034449|FG002|Part B|Condition under investigation worsened|0|||
33632892|NCT02093351|63034450|FG003|Part B|Condition under investigation worsened|39|||
33632893|NCT02093351|63034447|FG000|Part B|Adverse Event|0|||
33632894|NCT02093351|63034448|FG001|Part B|Adverse Event|0|||
33632895|NCT02093351|63034449|FG002|Part B|Adverse Event|0|||
33632896|NCT02093351|63034450|FG003|Part B|Adverse Event|2|||
33632897|NCT02093351|63034447|FG000|Part B|Death|0|||
33632898|NCT02093351|63034448|FG001|Part B|Death|0|||
33632899|NCT02093351|63034449|FG002|Part B|Death|0|||
33632900|NCT02093351|63034450|FG003|Part B|Death|1|||
33632901|NCT02092961|63034489|FG000|Overall Study|Not reported|1|||
33632902|NCT02092961|63034490|FG001|Overall Study|Not reported|0|||
33632903|NCT02092961|63034491|FG002|Overall Study|Not reported|1|||
33632904|NCT02092961|63034489|FG000|Overall Study|Study stopped|13|||
33632905|NCT02092961|63034490|FG001|Overall Study|Study stopped|9|||
33632906|NCT02092961|63034491|FG002|Overall Study|Study stopped|12|||
33632907|NCT02092961|63034489|FG000|Overall Study|Lack of therapeutic response|2|||
33632908|NCT02092961|63034490|FG001|Overall Study|Lack of therapeutic response|1|||
33632909|NCT02092961|63034491|FG002|Overall Study|Lack of therapeutic response|3|||
33632910|NCT02092961|63034489|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
33632911|NCT02092961|63034490|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
33632912|NCT02092961|63034491|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
33632913|NCT02092961|63034489|FG000|Overall Study|Adverse Event|2|||
33632914|NCT02092961|63034490|FG001|Overall Study|Adverse Event|4|||
33632915|NCT02092961|63034491|FG002|Overall Study|Adverse Event|0|||
33632916|NCT01898078|63034502|FG000|Overall Study|Progressive Disease|1|||
33632917|NCT01898078|63034503|FG001|Overall Study|Progressive Disease|5|||
33632918|NCT01898078|63034502|FG000|Overall Study|Adverse Event|2|||
33632919|NCT01898078|63034503|FG001|Overall Study|Adverse Event|1|||
33632920|NCT01898078|63034502|FG000|Overall Study|Withdrawal by Subject|1|||
33632921|NCT01898078|63034503|FG001|Overall Study|Withdrawal by Subject|1|||
33632922|NCT01898078|63034502|FG000|Overall Study|Symptomatic Deterioration|2|||
33632923|NCT01898078|63034503|FG001|Overall Study|Symptomatic Deterioration|0|||
33632924|NCT01898078|63034502|FG000|Overall Study|Reason not Specified|0|||
33632925|NCT01898078|63034503|FG001|Overall Study|Reason not Specified|1|||
33632926|NCT01987817|63034513|FG000|Overall Study|Adverse Event|4|||
33632927|NCT01987817|63034514|FG001|Overall Study|Adverse Event|0|||
33632928|NCT01987817|63034513|FG000|Overall Study|Withdrawal by Subject|1|||
33632929|NCT01987817|63034514|FG001|Overall Study|Withdrawal by Subject|1|||
33632930|NCT01987817|63034513|FG000|Overall Study|Physician Decision|1|||
33326367|NCT00946647|62703165|FG004|Phase 1 Part|Disease progression|0|||
33326368|NCT00946647|62703161|FG000|Phase 1 Part|Withdrawal by Subject|1|||
33326369|NCT00946647|62703162|FG001|Phase 1 Part|Withdrawal by Subject|4|||
33461736|NCT00003907|62835051|FG000|Overall Study|Other|1|||
33461737|NCT00003907|62835052|FG001|Overall Study|Other|3|||
33461738|NCT00003907|62835051|FG000|Overall Study|ineligible or not treated|2|||
33461739|NCT00003907|62835052|FG001|Overall Study|ineligible or not treated|2|||
33461740|NCT04241315|62835060|FG000|Overall Study|Withdrawal by Subject|0|||
33461741|NCT04241315|62835061|FG001|Overall Study|Withdrawal by Subject|1|||
33461742|NCT04225026|62835067|FG000|Overall Study|Withdrawal by Subject|4|||
33539146|NCT02756403|62929252|FG001|Overall Study|Changed Mind About Procedure|0|||
33632931|NCT01987817|63034514|FG001|Overall Study|Physician Decision|0|||
33632932|NCT01940497|63034523|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
33632933|NCT01940497|63034524|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
33632934|NCT01940497|63034523|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
33632935|NCT01940497|63034524|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
33632936|NCT01940497|63034523|FG000|Overall Study|Violation of Entry Criteria|1|||
33461743|NCT04225026|62835067|FG000|Overall Study|Adverse Event|1|||
33632937|NCT01940497|63034524|FG001|Overall Study|Violation of Entry Criteria|1|||
33632938|NCT01940497|63034523|FG000|Overall Study|Refused Treatment|1|||
33632939|NCT01940497|63034524|FG001|Overall Study|Refused Treatment|3|||
33632940|NCT01940497|63034523|FG000|Overall Study|Withdrew Consent|6|||
33632941|NCT01940497|63034524|FG001|Overall Study|Withdrew Consent|2|||
33632942|NCT01940497|63034523|FG000|Overall Study|Administrative/Other|1|||
33632943|NCT01940497|63034524|FG001|Overall Study|Administrative/Other|1|||
33632944|NCT01924754|63034544|FG000|Overall Study|Lost to Follow-up|1|||
33632945|NCT01924754|63034545|FG001|Overall Study|Lost to Follow-up|2|||
33632946|NCT01924754|63034546|FG002|Overall Study|Lost to Follow-up|1|||
33632947|NCT01924754|63034544|FG000|Overall Study|Pregnancy|0|||
33632948|NCT01924754|63034545|FG001|Overall Study|Pregnancy|1|||
33632949|NCT01924754|63034546|FG002|Overall Study|Pregnancy|2|||
33632950|NCT01924364|63034557|FG000|Overall Study|Physician Decision|3|||
33632951|NCT01987505|63034574|FG000|Overall Study|Other|9|||
33632952|NCT01987505|63034574|FG000|Overall Study|Withdrawal by Subject|2|||
33632953|NCT01987505|63034574|FG000|Overall Study|Other Reason|2|||
33632954|NCT01987505|63034574|FG000|Overall Study|Lost to Follow-up|15|||
33632955|NCT01987505|63034574|FG000|Overall Study|Investigator Decision|2|||
33632956|NCT01987505|63034574|FG000|Overall Study|Death|4|||
33632957|NCT01923896|63034582|FG000|Overall Study|Adverse Event|1|||
33632958|NCT01923896|63034583|FG001|Overall Study|Adverse Event|0|||
33632959|NCT02004353|63034589|FG000|Overall Study|Voluntary participation|1334|||
33632960|NCT01938625|63034595|FG000|Overall Study|Withdrawal by Subject|0|||
33632961|NCT01938625|63034596|FG001|Overall Study|Withdrawal by Subject|1|||
33632962|NCT01938625|63034595|FG000|Overall Study|Adverse Event|0|||
33632963|NCT01938625|63034596|FG001|Overall Study|Adverse Event|1|||
33632964|NCT01975675|63034606|FG000|Overall Study|Death|0|||
33632965|NCT01975675|63034607|FG001|Overall Study|Death|1|||
33632966|NCT01975675|63034608|FG002|Overall Study|Death|0|||
33632967|NCT01975675|63034609|FG003|Overall Study|Death|0|||
33632968|NCT01975285|63034621|FG000|Overall Study|Failed Block and follow up|2|||
33632969|NCT01975285|63034622|FG001|Overall Study|Failed Block and follow up|2|||
33632970|NCT01974895|63034630|FG000|Overall Study|Protocol Violation|1|||
33632971|NCT01974895|63034631|FG001|Overall Study|Protocol Violation|0|||
33632972|NCT01974895|63034630|FG000|Overall Study|Lost to Follow-up|4|||
33632973|NCT01974895|63034631|FG001|Overall Study|Lost to Follow-up|6|||
33632974|NCT01974895|63034630|FG000|Overall Study|Withdrawal by Subject|0|||
33632975|NCT01974895|63034631|FG001|Overall Study|Withdrawal by Subject|1|||
33632976|NCT01974895|63034630|FG000|Overall Study|Other (Missed Visit)|1|||
33632977|NCT01974895|63034631|FG001|Overall Study|Other (Missed Visit)|0|||
33632978|NCT01974895|63034630|FG000|Overall Study|Other (Reason unknown)|9|||
33632979|NCT01974895|63034631|FG001|Overall Study|Other (Reason unknown)|8|||
33632980|NCT01974817|63034637|FG000|Overall Study|Death|4|||
33632981|NCT01974817|63034637|FG000|Overall Study|Lost to Follow-up|2|||
33632982|NCT01974817|63034637|FG000|Overall Study|Protocol Violation|2|||
33632983|NCT01915849|63034645|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
33632984|NCT01915849|63034646|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
33632985|NCT01915849|63034647|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
33632986|NCT01915849|63034648|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
33632987|NCT01915849|63034645|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
33632988|NCT01915849|63034646|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
33632989|NCT01915849|63034647|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
33632990|NCT01915849|63034648|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
33632991|NCT01915771|63034658|FG000|Day 1|Withdrawal by Subject|1|||
33632992|NCT01915771|63034658|FG000|Day 15|Withdrawal by Subject|1|||
33632993|NCT01938391|63034666|FG000|6 Month Follow up|Withdrawal by Subject|1|||
33632994|NCT01938391|63034666|FG000|12 Month Follow up|Physician Decision|1|||
33632995|NCT01938391|63034666|FG000|12 Month Follow up|Withdrawal by Subject|1|||
33632996|NCT01915303|63034670|FG000|Core Phase|Adverse Event|7|||
33632997|NCT01915303|63034670|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
33632998|NCT01915303|63034670|FG000|Core Phase|Death|2|||
33632999|NCT01915303|63034670|FG000|Core Phase|Protocol Violation|2|||
33633000|NCT01915303|63034670|FG000|Core Phase|Abnormal lab value|1|||
33633001|NCT01915303|63034670|FG000|Core Phase|Withdrawal by Subject|1|||
33633002|NCT01915303|63034670|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
33633003|NCT01915303|63034670|FG000|Extension Phase|Withdrawal by Subject|4|||
33633004|NCT01915303|63034670|FG000|Extension Phase|Adverse Event|3|||
33633005|NCT01915303|63034670|FG000|Extension Phase|Death|1|||
33633006|NCT01915303|63034670|FG000|Extension Phase|Protocol Violation|1|||
33633007|NCT01987427|63034677|FG000|Overall Study|Adverse Event|4|||
33633008|NCT01987427|63034678|FG001|Overall Study|Adverse Event|2|||
33633009|NCT01987427|63034679|FG002|Overall Study|Adverse Event|8|||
33633010|NCT01987427|63034677|FG000|Overall Study|Lost to Follow-up|6|||
33633011|NCT01987427|63034678|FG001|Overall Study|Lost to Follow-up|6|||
33633012|NCT01987427|63034679|FG002|Overall Study|Lost to Follow-up|9|||
33633013|NCT01987427|63034677|FG000|Overall Study|Withdrawal by Subject|2|||
33633014|NCT01987427|63034678|FG001|Overall Study|Withdrawal by Subject|1|||
33633015|NCT01987427|63034679|FG002|Overall Study|Withdrawal by Subject|3|||
33633016|NCT01987427|63034677|FG000|Overall Study|Lack of Efficacy|1|||
33633017|NCT01987427|63034678|FG001|Overall Study|Lack of Efficacy|0|||
33633018|NCT01987427|63034679|FG002|Overall Study|Lack of Efficacy|0|||
33633019|NCT01987427|63034677|FG000|Overall Study|Other|1|||
33633020|NCT01987427|63034678|FG001|Overall Study|Other|1|||
33633021|NCT01987427|63034679|FG002|Overall Study|Other|0|||
33633022|NCT01937299|63034689|FG000|Overall Study|Adverse Event|13|||
33633023|NCT01937299|63034690|FG001|Overall Study|Adverse Event|0|||
33633024|NCT01937299|63034689|FG000|Overall Study|Lack of Efficacy|0|||
33633025|NCT01937299|63034690|FG001|Overall Study|Lack of Efficacy|4|||
33633026|NCT01937299|63034689|FG000|Overall Study|Withdrawal by Subject|1|||
33633027|NCT01937299|63034690|FG001|Overall Study|Withdrawal by Subject|0|||
33633028|NCT02003963|63034699|FG000|Overall Study|Lost to Follow-up|2|||
33633029|NCT02003963|63034700|FG001|Overall Study|Lost to Follow-up|1|||
33633030|NCT01606761|63034711|FG000|Prior to Week 24|Lost to Follow-up|0|||
33633031|NCT01606761|63034712|FG001|Prior to Week 24|Lost to Follow-up|3|||
33633032|NCT01606761|63034713|FG002|Prior to Week 24|Lost to Follow-up|2|||
33633033|NCT01606761|63034714|FG003|Prior to Week 24|Lost to Follow-up|0|||
33633034|NCT01606761|63034715|FG004|Prior to Week 24|Lost to Follow-up|0|||
33633035|NCT01606761|63034711|FG000|Prior to Week 24|Withdrawal by Subject|12|||
33633036|NCT01606761|63034712|FG001|Prior to Week 24|Withdrawal by Subject|10|||
33633037|NCT01606761|63034713|FG002|Prior to Week 24|Withdrawal by Subject|9|||
33633038|NCT01606761|63034714|FG003|Prior to Week 24|Withdrawal by Subject|0|||
33633039|NCT01606761|63034715|FG004|Prior to Week 24|Withdrawal by Subject|0|||
33633040|NCT01606761|63034711|FG000|Prior to Week 24|Adverse Event|11|||
33633041|NCT01606761|63034712|FG001|Prior to Week 24|Adverse Event|18|||
33633042|NCT01606761|63034713|FG002|Prior to Week 24|Adverse Event|22|||
33633043|NCT01606761|63034714|FG003|Prior to Week 24|Adverse Event|0|||
33633044|NCT01606761|63034715|FG004|Prior to Week 24|Adverse Event|0|||
33633045|NCT01606761|63034711|FG000|Prior to Week 24|Lack of Efficacy|15|||
33633046|NCT01606761|63034712|FG001|Prior to Week 24|Lack of Efficacy|14|||
33633047|NCT01606761|63034713|FG002|Prior to Week 24|Lack of Efficacy|8|||
33633048|NCT01606761|63034714|FG003|Prior to Week 24|Lack of Efficacy|0|||
33633049|NCT01606761|63034715|FG004|Prior to Week 24|Lack of Efficacy|0|||
33633050|NCT01606761|63034711|FG000|Prior to Week 24|Physician Decision|0|||
33633051|NCT01606761|63034712|FG001|Prior to Week 24|Physician Decision|3|||
33633052|NCT01606761|63034713|FG002|Prior to Week 24|Physician Decision|1|||
33633053|NCT01606761|63034714|FG003|Prior to Week 24|Physician Decision|0|||
33633054|NCT01606761|63034715|FG004|Prior to Week 24|Physician Decision|0|||
33633055|NCT01606761|63034711|FG000|Prior to Week 24|Other|4|||
33633056|NCT01606761|63034712|FG001|Prior to Week 24|Other|7|||
33633057|NCT01606761|63034713|FG002|Prior to Week 24|Other|5|||
33633058|NCT01606761|63034714|FG003|Prior to Week 24|Other|0|||
33633059|NCT01606761|63034715|FG004|Prior to Week 24|Other|0|||
33539147|NCT02756403|62929253|FG002|Overall Study|Changed Mind About Procedure|1|||
33539148|NCT02756403|62929254|FG003|Overall Study|Changed Mind About Procedure|0|||
33539149|NCT02756403|62929251|FG000|Overall Study|Protocol Violation|0|||
33539150|NCT02756403|62929252|FG001|Overall Study|Protocol Violation|1|||
33539151|NCT02756403|62929253|FG002|Overall Study|Protocol Violation|0|||
33539152|NCT02756403|62929254|FG003|Overall Study|Protocol Violation|1|||
33539153|NCT02753595|62929266|FG000|Overall Study|Sponsor termination|2|||
33539154|NCT02753595|62929267|FG001|Overall Study|Sponsor termination|2|||
33539155|NCT00707954|62929290|FG000|Overall Study|Physician Decision|0|||
33539156|NCT00707954|62929291|FG001|Overall Study|Physician Decision|0|||
33539157|NCT00707954|62929292|FG002|Overall Study|Physician Decision|0|||
33539158|NCT00707954|62929293|FG003|Overall Study|Physician Decision|0|||
33539159|NCT00707954|62929294|FG004|Overall Study|Physician Decision|1|||
33539160|NCT02561962|62929315|FG000|Overall Study|Ongoing in study|1|||
33633060|NCT01606761|63034711|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
33633061|NCT01606761|63034712|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
33539161|NCT02561962|62929316|FG001|Overall Study|Ongoing in study|0|||
33539162|NCT02561962|62929317|FG002|Overall Study|Ongoing in study|0|||
33539163|NCT02561962|62929318|FG003|Overall Study|Ongoing in study|1|||
33539164|NCT02561962|62929319|FG004|Overall Study|Ongoing in study|0|||
33633062|NCT01606761|63034713|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
33633063|NCT01606761|63034714|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
33633064|NCT01606761|63034715|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
33633065|NCT01606761|63034711|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
33633066|NCT01606761|63034712|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
33539165|NCT02561962|62929320|FG005|Overall Study|Ongoing in study|1|||
33539166|NCT02561962|62929321|FG006|Overall Study|Ongoing in study|0|||
33633067|NCT01606761|63034713|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
33633068|NCT01606761|63034714|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
33633069|NCT01606761|63034715|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
33633070|NCT01606761|63034711|FG000|Week 24 to Week 52|Adverse Event|0|||
33539167|NCT02561962|62929322|FG007|Overall Study|Ongoing in study|4|||
33539168|NCT02561962|62929323|FG008|Overall Study|Ongoing in study|1|||
33539169|NCT02561962|62929315|FG000|Overall Study|Withdrawal by Subject|1|||
33539170|NCT02561962|62929316|FG001|Overall Study|Withdrawal by Subject|0|||
33539171|NCT02561962|62929317|FG002|Overall Study|Withdrawal by Subject|0|||
33539172|NCT02561962|62929318|FG003|Overall Study|Withdrawal by Subject|0|||
33539173|NCT02561962|62929319|FG004|Overall Study|Withdrawal by Subject|1|||
33539174|NCT02561962|62929320|FG005|Overall Study|Withdrawal by Subject|1|||
33539175|NCT02561962|62929321|FG006|Overall Study|Withdrawal by Subject|2|||
33539176|NCT02561962|62929322|FG007|Overall Study|Withdrawal by Subject|1|||
33539177|NCT02561962|62929323|FG008|Overall Study|Withdrawal by Subject|0|||
33539178|NCT02561962|62929315|FG000|Overall Study|Decision by sponsor|0|||
33539179|NCT02561962|62929316|FG001|Overall Study|Decision by sponsor|0|||
33539180|NCT02561962|62929317|FG002|Overall Study|Decision by sponsor|0|||
33539181|NCT02561962|62929318|FG003|Overall Study|Decision by sponsor|0|||
33633071|NCT01606761|63034712|FG001|Week 24 to Week 52|Adverse Event|11|||
33633072|NCT01606761|63034713|FG002|Week 24 to Week 52|Adverse Event|14|||
33633073|NCT01606761|63034714|FG003|Week 24 to Week 52|Adverse Event|3|||
33633074|NCT01606761|63034715|FG004|Week 24 to Week 52|Adverse Event|15|||
33633075|NCT01606761|63034711|FG000|Week 24 to Week 52|Death|0|||
33633076|NCT01606761|63034712|FG001|Week 24 to Week 52|Death|0|||
33633077|NCT01606761|63034713|FG002|Week 24 to Week 52|Death|2|||
33633078|NCT01606761|63034714|FG003|Week 24 to Week 52|Death|1|||
33633079|NCT01606761|63034715|FG004|Week 24 to Week 52|Death|0|||
33633080|NCT01606761|63034711|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
33633081|NCT01606761|63034712|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
33633082|NCT01606761|63034713|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
33633083|NCT01606761|63034714|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
33633084|NCT01606761|63034715|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
33633085|NCT01606761|63034711|FG000|Week 24 to Week 52|Physician Decision|0|||
33633086|NCT01606761|63034712|FG001|Week 24 to Week 52|Physician Decision|1|||
33633087|NCT01606761|63034713|FG002|Week 24 to Week 52|Physician Decision|1|||
33633088|NCT01606761|63034714|FG003|Week 24 to Week 52|Physician Decision|0|||
33633089|NCT01606761|63034715|FG004|Week 24 to Week 52|Physician Decision|0|||
33633090|NCT01606761|63034711|FG000|Week 24 to Week 52|Other|0|||
33633091|NCT01606761|63034712|FG001|Week 24 to Week 52|Other|1|||
33633092|NCT01606761|63034713|FG002|Week 24 to Week 52|Other|5|||
33633093|NCT01606761|63034714|FG003|Week 24 to Week 52|Other|2|||
33633094|NCT01606761|63034715|FG004|Week 24 to Week 52|Other|2|||
33633095|NCT01606761|63034711|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
33633096|NCT01606761|63034712|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
33633097|NCT01606761|63034713|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
33633098|NCT01606761|63034714|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
33633099|NCT01606761|63034715|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
33633100|NCT01606761|63034711|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
33633101|NCT01606761|63034712|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
33633102|NCT01606761|63034713|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
33633103|NCT01606761|63034714|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
33633104|NCT01606761|63034715|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
33633105|NCT01606761|63034711|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
33633106|NCT01606761|63034712|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
33633107|NCT01606761|63034713|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
33633108|NCT01606761|63034714|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
33633109|NCT01606761|63034715|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
33633110|NCT01606761|63034711|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
33461744|NCT04225026|62835067|FG000|Overall Study|Other|1|||
33461745|NCT04225026|62835067|FG000|Overall Study|Death|11|||
33461746|NCT04225026|62835067|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
33461747|NCT03493958|62835473|FG000|Overall Study|Withdrawal by Subject|6|||
33461748|NCT03493958|62835473|FG000|Overall Study|Lost to Follow-up|7|||
33461749|NCT03493958|62835473|FG000|Overall Study|Did not complete all required study procedures|2|||
33461750|NCT03486223|62835479|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
33461751|NCT03486223|62835480|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
33461752|NCT03482024|62835491|FG000|Overall Study|Physician Decision|1|||
33461753|NCT03482024|62835492|FG001|Overall Study|Physician Decision|0|||
33461754|NCT03482024|62835493|FG002|Overall Study|Physician Decision|0|||
33539182|NCT02561962|62929319|FG004|Overall Study|Decision by sponsor|1|||
33633111|NCT01606761|63034712|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
33539183|NCT02561962|62929320|FG005|Overall Study|Decision by sponsor|1|||
33633112|NCT01606761|63034713|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
33633113|NCT01606761|63034714|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
33461755|NCT03482024|62835494|FG003|Overall Study|Physician Decision|0|||
33461756|NCT03482024|62835495|FG004|Overall Study|Physician Decision|0|||
33461757|NCT03468309|62835507|FG000|Overall Study|Lost to Follow-up|4|||
33461758|NCT03468309|62835507|FG000|Overall Study|Withdrawal by Subject|2|||
33633114|NCT01606761|63034715|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
33633115|NCT01790295|63034730|FG000|Overall Study|Adverse Event|1|||
33633116|NCT01790295|63034730|FG000|Overall Study|Death|4|||
33633117|NCT01790295|63034730|FG000|Overall Study|Lack of Efficacy|2|||
33633118|NCT01790295|63034730|FG000|Overall Study|Study closure|4|||
33633119|NCT01597557|63034737|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
33633120|NCT01597557|63034738|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
33633121|NCT01760733|63034744|FG000|Waiting List|Death|18|||
33633122|NCT01760733|63034744|FG000|Waiting List|Removed from waiting list|41|||
33633123|NCT01760733|63034744|FG000|Waiting List|Not received a transplant yet|13|||
33633124|NCT01760733|63034744|FG000|Transplanted|Not reached 10 years post transplant|184|||
33633125|NCT01760733|63034744|FG000|Transplanted|Death|26|||
33633126|NCT01760733|63034744|FG000|Transplanted|Graft loss|7|||
33633127|NCT01914757|63034752|FG000|Overall Study|Severe non-compliance to protocol|3|||
33633128|NCT01914757|63034753|FG001|Overall Study|Severe non-compliance to protocol|1|||
33633129|NCT01914757|63034754|FG002|Overall Study|Severe non-compliance to protocol|2|||
33633130|NCT01914757|63034752|FG000|Overall Study|Lost to Follow-up|5|||
33633131|NCT01914757|63034753|FG001|Overall Study|Lost to Follow-up|8|||
33633132|NCT01914757|63034754|FG002|Overall Study|Lost to Follow-up|6|||
33633133|NCT01914757|63034752|FG000|Overall Study|Withdrawal by Subject|15|||
33633134|NCT01914757|63034753|FG001|Overall Study|Withdrawal by Subject|27|||
33633135|NCT01914757|63034754|FG002|Overall Study|Withdrawal by Subject|19|||
33633136|NCT01914757|63034752|FG000|Overall Study|Death|2|||
33633137|NCT01914757|63034753|FG001|Overall Study|Death|2|||
33633138|NCT01914757|63034754|FG002|Overall Study|Death|1|||
33633139|NCT01914757|63034752|FG000|Overall Study|Adverse Event|4|||
33633140|NCT01914757|63034753|FG001|Overall Study|Adverse Event|3|||
33633141|NCT01914757|63034754|FG002|Overall Study|Adverse Event|4|||
33633142|NCT01914757|63034752|FG000|Overall Study|Study specific withdrawal criteria|0|||
33633143|NCT01914757|63034753|FG001|Overall Study|Study specific withdrawal criteria|1|||
33633144|NCT01914757|63034754|FG002|Overall Study|Study specific withdrawal criteria|0|||
33633145|NCT01914757|63034752|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33633146|NCT01914757|63034753|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33633147|NCT01914757|63034754|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
33633148|NCT01914757|63034752|FG000|Overall Study|Other reasons|5|||
33633149|NCT01914757|63034753|FG001|Overall Study|Other reasons|9|||
33539184|NCT02561962|62929321|FG006|Overall Study|Decision by sponsor|0|||
33539185|NCT02561962|62929322|FG007|Overall Study|Decision by sponsor|3|||
33633150|NCT01914757|63034754|FG002|Overall Study|Other reasons|4|||
33633151|NCT02003573|63034765|FG000|Overall Study|Progressive disease|2|||
33633152|NCT02003573|63034766|FG001|Overall Study|Progressive disease|0|||
33633153|NCT02003573|63034767|FG002|Overall Study|Progressive disease|1|||
33633154|NCT02003573|63034765|FG000|Overall Study|Other Adverse event|0|||
33461759|NCT03423147|62835513|FG000|Overall Study|Lost to Follow-up|5|||
33461760|NCT03423147|62835514|FG001|Overall Study|Lost to Follow-up|8|||
33461761|NCT03423147|62835513|FG000|Overall Study|Withdrawal by Subject|1|||
33461762|NCT03423147|62835514|FG001|Overall Study|Withdrawal by Subject|0|||
33461763|NCT03423147|62835513|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
33539186|NCT02561962|62929323|FG008|Overall Study|Decision by sponsor|0|||
33539187|NCT02561962|62929315|FG000|Overall Study|Lost to Follow-up|0|||
33539188|NCT02561962|62929316|FG001|Overall Study|Lost to Follow-up|0|||
33539189|NCT02561962|62929317|FG002|Overall Study|Lost to Follow-up|0|||
33539190|NCT02561962|62929318|FG003|Overall Study|Lost to Follow-up|0|||
33539191|NCT02561962|62929319|FG004|Overall Study|Lost to Follow-up|0|||
33539192|NCT02561962|62929320|FG005|Overall Study|Lost to Follow-up|1|||
33539193|NCT02561962|62929321|FG006|Overall Study|Lost to Follow-up|0|||
33539194|NCT02561962|62929322|FG007|Overall Study|Lost to Follow-up|0|||
33539195|NCT02561962|62929323|FG008|Overall Study|Lost to Follow-up|0|||
33539196|NCT02565706|62929347|FG000|Overall Study|Withdrawal by Subject|5|||
33633155|NCT02003573|63034766|FG001|Overall Study|Other Adverse event|1|||
33633156|NCT02003573|63034767|FG002|Overall Study|Other Adverse event|1|||
33633157|NCT02003573|63034765|FG000|Overall Study|Refuse to take trial medication|0|||
33633158|NCT02003573|63034766|FG001|Overall Study|Refuse to take trial medication|1|||
33633159|NCT02003573|63034767|FG002|Overall Study|Refuse to take trial medication|1|||
33633160|NCT02003573|63034765|FG000|Overall Study|Other than specified|1|||
33633161|NCT02003573|63034766|FG001|Overall Study|Other than specified|2|||
33633162|NCT02003573|63034767|FG002|Overall Study|Other than specified|3|||
33461764|NCT03423147|62835514|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
33461765|NCT03423147|62835513|FG000|Overall Study|Age < 18|1|||
33461766|NCT03423147|62835514|FG001|Overall Study|Age < 18|0|||
33461767|NCT03423147|62835513|FG000|Overall Study|No Trial of Labor|0|||
33461768|NCT03423147|62835514|FG001|Overall Study|No Trial of Labor|1|||
33461769|NCT03322631|62835524|FG000|Overall Study|Withdrawal by Subject|0|||
33633163|NCT01914679|63034777|FG000|Overall Study|Lack of Efficacy|1|||
33633164|NCT01914679|63034777|FG000|Overall Study|Sponsor terminated study|4|||
33633165|NCT01789281|63034783|FG000|Overall Study|Disease progression|15|||
33539197|NCT02565706|62929348|FG001|Overall Study|Withdrawal by Subject|7|||
33539198|NCT02565706|62929349|FG002|Overall Study|Withdrawal by Subject|7|||
33539199|NCT02565706|62929350|FG003|Overall Study|Withdrawal by Subject|11|||
33539200|NCT02565706|62929347|FG000|Overall Study|Lost to Follow-up|72|||
33539201|NCT02565706|62929348|FG001|Overall Study|Lost to Follow-up|75|||
33539202|NCT02565706|62929349|FG002|Overall Study|Lost to Follow-up|82|||
33539203|NCT02565706|62929350|FG003|Overall Study|Lost to Follow-up|74|||
33539204|NCT00706628|62929369|FG000|Overall Study|Other Adverse Event|16|||
33539205|NCT00706628|62929370|FG001|Overall Study|Other Adverse Event|5|||
33539206|NCT00706628|62929371|FG002|Overall Study|Other Adverse Event|5|||
33539207|NCT00706628|62929372|FG003|Overall Study|Other Adverse Event|2|||
33633166|NCT01789281|63034784|FG001|Overall Study|Disease progression|4|||
33633167|NCT01789281|63034783|FG000|Overall Study|Adverse Event|5|||
33633168|NCT01789281|63034784|FG001|Overall Study|Adverse Event|5|||
33633169|NCT01789281|63034783|FG000|Overall Study|Withdrawal by Subject|1|||
33633170|NCT01789281|63034784|FG001|Overall Study|Withdrawal by Subject|0|||
33633171|NCT01789281|63034783|FG000|Overall Study|Lost to Follow-up|1|||
33633172|NCT01789281|63034784|FG001|Overall Study|Lost to Follow-up|0|||
33633173|NCT01789281|63034783|FG000|Overall Study|Administrative problems|0|||
33633174|NCT01789281|63034784|FG001|Overall Study|Administrative problems|1|||
33633175|NCT01923740|63034793|FG000|Overall Study|Lost to Follow-up|4|||
33633176|NCT01923740|63034794|FG001|Overall Study|Lost to Follow-up|9|||
33633177|NCT01923740|63034793|FG000|Overall Study|Withdrawal by Subject|2|||
33633178|NCT01923740|63034794|FG001|Overall Study|Withdrawal by Subject|0|||
33633179|NCT01789203|63034802|FG000|Overall Study|Adverse Event|2|||
33539208|NCT00706628|62929369|FG000|Overall Study|Non compliant with protocol|0|||
33539209|NCT00706628|62929370|FG001|Overall Study|Non compliant with protocol|1|||
33633180|NCT01789203|63034803|FG001|Overall Study|Adverse Event|2|||
33633181|NCT01789203|63034802|FG000|Overall Study|Withdrawal by Subject|1|||
33633182|NCT01789203|63034803|FG001|Overall Study|Withdrawal by Subject|0|||
33633183|NCT01789203|63034802|FG000|Overall Study|Death|1|||
33633184|NCT01789203|63034803|FG001|Overall Study|Death|0|||
33633185|NCT01789203|63034802|FG000|Overall Study|Protocol Violation|2|||
33633186|NCT01789203|63034803|FG001|Overall Study|Protocol Violation|1|||
33633187|NCT01789203|63034802|FG000|Overall Study|Other|1|||
33633188|NCT01789203|63034803|FG001|Overall Study|Other|1|||
33633189|NCT01789203|63034802|FG000|Overall Study|patient non-adherent|2|||
33633190|NCT01789203|63034803|FG001|Overall Study|patient non-adherent|0|||
33633191|NCT01789047|63034813|FG000|Overall Study|Adverse Event|3|||
33633192|NCT01789047|63034814|FG001|Overall Study|Adverse Event|2|||
33633193|NCT01789047|63034813|FG000|Overall Study|Withdrawal by Subject|1|||
33633194|NCT01789047|63034814|FG001|Overall Study|Withdrawal by Subject|2|||
33633195|NCT01788423|63034823|FG000|Overall Study|See Comments in Completed (above)|0|||
33633196|NCT01788423|63034824|FG001|Overall Study|See Comments in Completed (above)|4|||
33633197|NCT01788423|63034825|FG002|Overall Study|See Comments in Completed (above)|5|||
33461770|NCT03322631|62835525|FG001|Overall Study|Withdrawal by Subject|1|||
33461771|NCT03322631|62835526|FG002|Overall Study|Withdrawal by Subject|0|||
33461772|NCT03322631|62835527|FG003|Overall Study|Withdrawal by Subject|0|||
33461773|NCT03322631|62835524|FG000|Overall Study|Adverse Event|0|||
33461774|NCT03322631|62835525|FG001|Overall Study|Adverse Event|0|||
33461775|NCT03322631|62835526|FG002|Overall Study|Adverse Event|1|||
33461776|NCT03322631|62835527|FG003|Overall Study|Adverse Event|0|||
33461777|NCT03018704|62835546|FG000|Overall Study|Lost to Follow-up|1|||
33461778|NCT03018704|62835547|FG001|Overall Study|Lost to Follow-up|1|||
33461779|NCT02663349|62835553|FG000|Overall Study|Withdrawal by Subject|6|||
33461780|NCT02558491|62835557|FG000|First Invention|Withdrawal by Subject|3|||
33461781|NCT02558491|62835558|FG001|First Invention|Withdrawal by Subject|1|||
33461782|NCT02558491|62835557|FG000|First Invention|Data collection issues|1|||
33461783|NCT02558491|62835558|FG001|First Invention|Data collection issues|0|||
33461784|NCT02558491|62835557|FG000|First Invention|Stopping criteria|0|||
33539210|NCT00706628|62929371|FG002|Overall Study|Non compliant with protocol|0|||
33539211|NCT00706628|62929372|FG003|Overall Study|Non compliant with protocol|0|||
33539212|NCT00706628|62929369|FG000|Overall Study|Consent withdrawn|6|||
33539213|NCT00706628|62929370|FG001|Overall Study|Consent withdrawn|1|||
33539214|NCT00706628|62929371|FG002|Overall Study|Consent withdrawn|3|||
33539215|NCT00706628|62929372|FG003|Overall Study|Consent withdrawn|0|||
33633198|NCT01617187|63034837|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
33633199|NCT01617187|63034838|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
33633200|NCT01617187|63034839|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
33461785|NCT02558491|62835558|FG001|First Invention|Stopping criteria|1|||
33461786|NCT02558491|62835557|FG000|First Invention|Changed parameters during trial|1|||
33461787|NCT02558491|62835558|FG001|First Invention|Changed parameters during trial|0|||
33633201|NCT01617187|63034840|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
33633202|NCT01617187|63034837|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
33633203|NCT01617187|63034838|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
33633204|NCT01617187|63034839|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
33633205|NCT01617187|63034840|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
33633206|NCT01617187|63034837|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
33633207|NCT01617187|63034838|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
33633208|NCT01617187|63034839|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
33633209|NCT01617187|63034840|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
33633210|NCT01617187|63034837|FG000|Treatment Through Study Completion|Adverse Event|1|||
33633211|NCT01617187|63034838|FG001|Treatment Through Study Completion|Adverse Event|1|||
33633212|NCT01617187|63034839|FG002|Treatment Through Study Completion|Adverse Event|0|||
33633213|NCT01617187|63034840|FG003|Treatment Through Study Completion|Adverse Event|1|||
33633214|NCT01617187|63034837|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
33633215|NCT01617187|63034838|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
33633216|NCT01617187|63034839|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
33633217|NCT01617187|63034840|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
33633218|NCT01617187|63034837|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
33633219|NCT01617187|63034838|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
33633220|NCT01617187|63034839|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
33633221|NCT01617187|63034840|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
33633222|NCT01617187|63034837|FG000|Treatment Through Study Completion|Protocol Violation|1|||
33633223|NCT01617187|63034838|FG001|Treatment Through Study Completion|Protocol Violation|0|||
33633224|NCT01617187|63034839|FG002|Treatment Through Study Completion|Protocol Violation|0|||
33633225|NCT01617187|63034840|FG003|Treatment Through Study Completion|Protocol Violation|1|||
33633226|NCT01759407|63034852|FG000|Overall Study|Protocol Violation|0|||
33633227|NCT01759407|63034853|FG001|Overall Study|Protocol Violation|2|||
33633228|NCT01787331|63034859|FG000|Overall Study|Physician Decision|1|||
33633229|NCT01787331|63034859|FG000|Overall Study|Withdrawal by Subject|1|||
33633230|NCT01757847|63034865|FG000|Overall Study|Withdrawal by Subject|3|||
33633231|NCT01757847|63034866|FG001|Overall Study|Withdrawal by Subject|4|||
33633232|NCT01787097|63034872|FG000|Overall Study|Withdrawal by Subject|1|||
33633233|NCT01787097|63034873|FG001|Overall Study|Withdrawal by Subject|0|||
33633234|NCT01787097|63034874|FG002|Overall Study|Withdrawal by Subject|0|||
33633235|NCT01787097|63034875|FG003|Overall Study|Withdrawal by Subject|0|||
33633236|NCT01757691|63034895|FG000|Overall Study|Administrative problems|2|||
33633237|NCT01757691|63034896|FG001|Overall Study|Administrative problems|0|||
33633238|NCT01786707|63034904|FG000|Overall Study|Lost to Follow-up|1|||
33633239|NCT01786707|63034905|FG001|Overall Study|Lost to Follow-up|1|||
33633240|NCT01786629|63034913|FG000|Overall Study|Lack of Efficacy|0|||
33633241|NCT01786629|63034914|FG001|Overall Study|Lack of Efficacy|4|||
33633242|NCT01786629|63034913|FG000|Overall Study|Adverse Event|0|||
33633243|NCT01786629|63034914|FG001|Overall Study|Adverse Event|1|||
33633244|NCT01786551|63034920|FG000|Overall Study|Participant withdrew consent|2|||
33539216|NCT00706628|62929369|FG000|Overall Study|Progressive disease|20|||
33539217|NCT00706628|62929370|FG001|Overall Study|Progressive disease|13|||
33539218|NCT00706628|62929371|FG002|Overall Study|Progressive disease|8|||
33539219|NCT00706628|62929372|FG003|Overall Study|Progressive disease|1|||
33539220|NCT00706628|62929369|FG000|Overall Study|Other than those stated above|4|||
33539221|NCT00706628|62929370|FG001|Overall Study|Other than those stated above|0|||
33539222|NCT00706628|62929371|FG002|Overall Study|Other than those stated above|0|||
33539223|NCT00706628|62929372|FG003|Overall Study|Other than those stated above|0|||
33539224|NCT00706628|62929369|FG000|Overall Study|Not treated|1|||
33633245|NCT01973569|63034927|FG000|Overall Study|Adverse Event|9|||
33633246|NCT01973569|63034928|FG001|Overall Study|Adverse Event|2|||
33633247|NCT01973569|63034929|FG002|Overall Study|Adverse Event|4|||
33633248|NCT01973569|63034927|FG000|Overall Study|Protocol Violation|2|||
33633249|NCT01973569|63034928|FG001|Overall Study|Protocol Violation|1|||
33633250|NCT01973569|63034929|FG002|Overall Study|Protocol Violation|3|||
33633251|NCT01973569|63034927|FG000|Overall Study|Withdrawal by Subject|7|||
33633252|NCT01973569|63034928|FG001|Overall Study|Withdrawal by Subject|5|||
33633253|NCT01973569|63034929|FG002|Overall Study|Withdrawal by Subject|2|||
33633254|NCT01973569|63034927|FG000|Overall Study|Invasive dental treatment|3|||
33633255|NCT01973569|63034928|FG001|Overall Study|Invasive dental treatment|5|||
33633256|NCT01973569|63034929|FG002|Overall Study|Invasive dental treatment|6|||
33539225|NCT00706628|62929370|FG001|Overall Study|Not treated|1|||
33539226|NCT00706628|62929371|FG002|Overall Study|Not treated|0|||
33539227|NCT00706628|62929372|FG003|Overall Study|Not treated|0|||
33539228|NCT02561806|62929387|FG000|Induction Period|Adverse Event|0|||
33539229|NCT02561806|62929388|FG001|Induction Period|Adverse Event|2|||
33539230|NCT02561806|62929387|FG000|Induction Period|Lack of Efficacy|1|||
33539231|NCT02561806|62929388|FG001|Induction Period|Lack of Efficacy|0|||
33539232|NCT02561806|62929387|FG000|Induction Period|Withdrawal by Subject|0|||
33633257|NCT01973569|63034927|FG000|Overall Study|Prohibited concomitant d|1|||
33633258|NCT01973569|63034928|FG001|Overall Study|Prohibited concomitant d|5|||
33633259|NCT01973569|63034929|FG002|Overall Study|Prohibited concomitant d|0|||
33633260|NCT01973569|63034927|FG000|Overall Study|Disease progression|0|||
33633261|NCT01973569|63034928|FG001|Overall Study|Disease progression|3|||
33633262|NCT01973569|63034929|FG002|Overall Study|Disease progression|0|||
33633263|NCT01973569|63034927|FG000|Overall Study|Other|1|||
33633264|NCT01973569|63034928|FG001|Overall Study|Other|1|||
33633265|NCT01973569|63034929|FG002|Overall Study|Other|0|||
33633266|NCT01973569|63034927|FG000|Overall Study|Did not receive study drug|6|||
33633267|NCT01973569|63034928|FG001|Overall Study|Did not receive study drug|3|||
33633268|NCT01973569|63034929|FG002|Overall Study|Did not receive study drug|3|||
33633269|NCT01973491|63034937|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
33633270|NCT01973491|63034937|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
33633271|NCT01973491|63034937|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
33633272|NCT01951586|63034943|FG000|Overall Study|Death|61|||
33633273|NCT01951586|63034944|FG001|Overall Study|Death|120|||
33633274|NCT01951586|63034943|FG000|Overall Study|Withdrawal by Subject|8|||
33633275|NCT01951586|63034944|FG001|Overall Study|Withdrawal by Subject|17|||
33633276|NCT01951586|63034943|FG000|Overall Study|Lost to Follow-up|0|||
33633277|NCT01951586|63034944|FG001|Overall Study|Lost to Follow-up|1|||
33633278|NCT01951586|63034943|FG000|Overall Study|Sponsor Decision|9|||
33633279|NCT01951586|63034944|FG001|Overall Study|Sponsor Decision|10|||
33633280|NCT01785849|63034953|FG000|Overall Study|Death|7|||
33633281|NCT01785849|63034954|FG001|Overall Study|Death|9|||
33633282|NCT01785849|63034953|FG000|Overall Study|Protocol Specified Criteria|29|||
33633283|NCT01785849|63034954|FG001|Overall Study|Protocol Specified Criteria|1|||
33633284|NCT01785849|63034953|FG000|Overall Study|Withdrawal by Subject|15|||
33633285|NCT01785849|63034954|FG001|Overall Study|Withdrawal by Subject|12|||
33633286|NCT01785849|63034953|FG000|Overall Study|Sponsor Decision|0|||
33633287|NCT01785849|63034954|FG001|Overall Study|Sponsor Decision|1|||
33633288|NCT01785849|63034953|FG000|Overall Study|Lost to Follow-up|10|||
33633289|NCT01785849|63034954|FG001|Overall Study|Lost to Follow-up|11|||
33633290|NCT01756833|63034962|FG000|Overall Study|Withdrawal by Subject|4|||
33633291|NCT01756833|63034963|FG001|Overall Study|Withdrawal by Subject|3|||
33633292|NCT01617967|63034975|FG000|Overall Study|Protocol Violation|0|||
33633293|NCT01617967|63034976|FG001|Overall Study|Protocol Violation|0|||
33633294|NCT01617967|63034977|FG002|Overall Study|Protocol Violation|0|||
33633295|NCT01617967|63034978|FG003|Overall Study|Protocol Violation|1|||
33633296|NCT01617967|63034979|FG004|Overall Study|Protocol Violation|0|||
33633297|NCT01617967|63034980|FG005|Overall Study|Protocol Violation|0|||
33633298|NCT01617967|63034975|FG000|Overall Study|Withdrawal by Subject|0|||
33633299|NCT01617967|63034976|FG001|Overall Study|Withdrawal by Subject|0|||
33633300|NCT01617967|63034977|FG002|Overall Study|Withdrawal by Subject|0|||
33633301|NCT01617967|63034978|FG003|Overall Study|Withdrawal by Subject|0|||
33633302|NCT01617967|63034979|FG004|Overall Study|Withdrawal by Subject|0|||
33633303|NCT01617967|63034980|FG005|Overall Study|Withdrawal by Subject|1|||
33633304|NCT01617967|63034975|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
33633305|NCT01617967|63034976|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
33633306|NCT01617967|63034977|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
33633307|NCT01617967|63034978|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
33633308|NCT01617967|63034979|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
33633309|NCT01617967|63034980|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
33633310|NCT01785615|63034998|FG000|Dietary Phase|Lost to Follow-up|0|||
33633311|NCT01785615|63034999|FG001|Dietary Phase|Lost to Follow-up|0|||
33539233|NCT02561806|62929388|FG001|Induction Period|Withdrawal by Subject|2|||
33539234|NCT02561806|62929387|FG000|Induction Period|Site staff became unblinded|1|||
33539235|NCT02561806|62929388|FG001|Induction Period|Site staff became unblinded|0|||
33539236|NCT02561806|62929387|FG000|Induction Period|Randomized but not treated|0|||
33539237|NCT02561806|62929388|FG001|Induction Period|Randomized but not treated|1|||
33539238|NCT02561806|62929387|FG000|Maintenance Period|Adverse Event|2|||
33633312|NCT01785615|63035000|FG002|Dietary Phase|Lost to Follow-up|0|||
33633313|NCT01785615|63035001|FG003|Dietary Phase|Lost to Follow-up|24|||
33633314|NCT01913041|63035013|FG000|Overall Study|Protocol Violation|35|||
33633315|NCT01913041|63035013|FG000|Overall Study|Withdrawal by Subject|3|||
33633316|NCT01913041|63035013|FG000|Overall Study|Physician Decision|1|||
33633317|NCT01756053|63035017|FG000|Period 1 (10 Days)|Protocol Violation|1|||
33539239|NCT02561806|62929388|FG001|Maintenance Period|Adverse Event|1|||
33539240|NCT02561806|62929387|FG000|Maintenance Period|Lack of Efficacy|3|||
33539241|NCT02561806|62929388|FG001|Maintenance Period|Lack of Efficacy|1|||
33539242|NCT02561806|62929387|FG000|Maintenance Period|Lost to Follow-up|2|||
33633318|NCT01756053|63035018|FG001|Period 1 (10 Days)|Protocol Violation|1|||
33633319|NCT01756053|63035017|FG000|Period 2 (10 Days)|Protocol Violation|0|||
33633320|NCT01756053|63035018|FG001|Period 2 (10 Days)|Protocol Violation|2|||
33633321|NCT01785069|63035028|FG000|Overall Study|Implanted with nonstudy device|1|||
33633322|NCT01785069|63035029|FG001|Overall Study|Implanted with nonstudy device|2|||
33633323|NCT01785069|63035030|FG002|Overall Study|Implanted with nonstudy device|1|||
33633324|NCT01785069|63035031|FG003|Overall Study|Implanted with nonstudy device|0|||
33633325|NCT01785069|63035028|FG000|Overall Study|Death|0|||
33539243|NCT02561806|62929388|FG001|Maintenance Period|Lost to Follow-up|2|||
33539244|NCT02561806|62929387|FG000|Maintenance Period|Protocol Violation|1|||
33461788|NCT02558491|62835557|FG000|Second Intervention|Withdrawal by Subject|1|||
33461789|NCT02558491|62835558|FG001|Second Intervention|Withdrawal by Subject|0|||
33461790|NCT02558491|62835557|FG000|Second Intervention|Stopping Criteria|1|||
33461791|NCT02558491|62835558|FG001|Second Intervention|Stopping Criteria|0|||
33461792|NCT02490878|62835567|FG000|Overall Study|deemed ineligible|0|||
33539245|NCT02561806|62929388|FG001|Maintenance Period|Protocol Violation|0|||
33539246|NCT02561806|62929387|FG000|Maintenance Period|Withdrawal by Subject|5|||
33539247|NCT02561806|62929388|FG001|Maintenance Period|Withdrawal by Subject|3|||
33539248|NCT02561806|62929387|FG000|Maintenance Period|Site staff became unblinded|0|||
33633326|NCT01785069|63035029|FG001|Overall Study|Death|0|||
33633327|NCT01785069|63035030|FG002|Overall Study|Death|2|||
33633328|NCT01785069|63035031|FG003|Overall Study|Death|0|||
33633329|NCT01785069|63035028|FG000|Overall Study|Subject choice|2|||
33633330|NCT01785069|63035029|FG001|Overall Study|Subject choice|2|||
33633331|NCT01785069|63035030|FG002|Overall Study|Subject choice|0|||
33633332|NCT01785069|63035031|FG003|Overall Study|Subject choice|1|||
33633333|NCT01785069|63035028|FG000|Overall Study|Lost to Follow-up|1|||
33633334|NCT01785069|63035029|FG001|Overall Study|Lost to Follow-up|2|||
33633335|NCT01785069|63035030|FG002|Overall Study|Lost to Follow-up|4|||
33633336|NCT01785069|63035031|FG003|Overall Study|Lost to Follow-up|1|||
33633337|NCT01785069|63035028|FG000|Overall Study|Reason not Specified|1|||
33633338|NCT01785069|63035029|FG001|Overall Study|Reason not Specified|2|||
33633339|NCT01785069|63035030|FG002|Overall Study|Reason not Specified|1|||
33633340|NCT01785069|63035031|FG003|Overall Study|Reason not Specified|4|||
33633341|NCT01785069|63035028|FG000|Overall Study|Not evaluable|7|||
33633342|NCT01785069|63035029|FG001|Overall Study|Not evaluable|4|||
33633343|NCT01785069|63035030|FG002|Overall Study|Not evaluable|5|||
33633344|NCT01785069|63035031|FG003|Overall Study|Not evaluable|8|||
33633345|NCT01784523|63035043|FG000|Overall Study|Study closed early|7|||
33633346|NCT01784523|63035044|FG001|Overall Study|Study closed early|4|||
33633347|NCT01784211|63035052|FG000|Part A (Days 1-15)|Adverse Event|1|||
33633348|NCT01784211|63035053|FG001|Part A (Days 1-15)|Adverse Event|1|||
33633349|NCT01784211|63035054|FG002|Part A (Days 1-15)|Adverse Event|0|||
33633350|NCT01784211|63035055|FG003|Part A (Days 1-15)|Adverse Event|0|||
33633351|NCT01784211|63035056|FG004|Part A (Days 1-15)|Adverse Event|0|||
33633352|NCT01784211|63035057|FG005|Part A (Days 1-15)|Adverse Event|0|||
33633353|NCT01784211|63035052|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
33633354|NCT01784211|63035053|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
33633355|NCT01784211|63035054|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
33461793|NCT02490878|62835568|FG001|Overall Study|deemed ineligible|1|||
33461794|NCT02490878|62835567|FG000|Overall Study|progression prior to treatment|0|||
33461795|NCT02490878|62835568|FG001|Overall Study|progression prior to treatment|1|||
33461796|NCT02490878|62835567|FG000|Overall Study|only submitted baseline QOL|0|||
33461797|NCT02490878|62835568|FG001|Overall Study|only submitted baseline QOL|1|||
33539249|NCT02561806|62929388|FG001|Maintenance Period|Site staff became unblinded|1|||
33539250|NCT02561806|62929387|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
33539251|NCT02561806|62929388|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
33539252|NCT02561806|62929387|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
33539253|NCT02561806|62929388|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
33539254|NCT02561572|62929411|FG000|Overall Study|Inadequate time before surgery|2|||
33539255|NCT02561572|62929412|FG001|Overall Study|Inadequate time before surgery|1|||
33539256|NCT02561572|62929411|FG000|Overall Study|Protocol Violation|0|||
33539257|NCT02561572|62929412|FG001|Overall Study|Protocol Violation|1|||
33539258|NCT02180217|62929421|FG000|Overall Study|Adverse Event|3|||
33539259|NCT02180217|62929422|FG001|Overall Study|Adverse Event|2|||
33539260|NCT02180217|62929423|FG002|Overall Study|Adverse Event|22|||
33539261|NCT02180217|62929421|FG000|Overall Study|Death|1|||
33539262|NCT02180217|62929422|FG001|Overall Study|Death|1|||
33633356|NCT01784211|63035055|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
33633357|NCT01784211|63035056|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
33633358|NCT01784211|63035057|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
33633359|NCT01783821|63035071|FG000|Overall Study|Screen Failure|1|||
33633360|NCT01783821|63035072|FG001|Overall Study|Screen Failure|1|||
33633361|NCT01783743|63035080|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
33633362|NCT01783743|63035081|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
33633363|NCT01783743|63035080|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
33461798|NCT02421601|62835574|FG000|Overall Study|Adverse Event|4|||
33539263|NCT02180217|62929423|FG002|Overall Study|Death|0|||
33461799|NCT02421601|62835574|FG000|Overall Study|Lack of Efficacy|5|||
33539264|NCT02180217|62929421|FG000|Overall Study|Withdrawal by Subject|1|||
33539265|NCT02180217|62929422|FG001|Overall Study|Withdrawal by Subject|1|||
33633364|NCT01783743|63035081|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
33633365|NCT01783743|63035080|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
33633366|NCT01783743|63035081|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
33461800|NCT02421601|62835574|FG000|Overall Study|Physician Decision|1|||
33461801|NCT02421601|62835574|FG000|Overall Study|Withdrawal by Subject|31|||
33461802|NCT02421601|62835574|FG000|Overall Study|Others|41|||
33633367|NCT01608321|63035089|FG000|Overall Study|Withdrawal by Subject|1|||
33633368|NCT01608321|63035090|FG001|Overall Study|Withdrawal by Subject|0|||
33633369|NCT01608087|63035099|FG000|Overall Study|Lost to Follow-up|0|||
33633370|NCT01608087|63035100|FG001|Overall Study|Lost to Follow-up|1|||
33633371|NCT01608087|63035101|FG002|Overall Study|Lost to Follow-up|0|||
33633372|NCT01608087|63035099|FG000|Overall Study|Other Reason|0|||
33633373|NCT01608087|63035100|FG001|Overall Study|Other Reason|1|||
33633374|NCT01608087|63035101|FG002|Overall Study|Other Reason|0|||
33633375|NCT01912963|63035112|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
33633376|NCT01912963|63035113|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
33633377|NCT01912963|63035114|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
33633378|NCT01912963|63035112|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
33633379|NCT01912963|63035113|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
33633380|NCT01912963|63035114|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
33633381|NCT01912963|63035112|FG000|Overall Study|Adverse Event|0|||
33633382|NCT01912963|63035113|FG001|Overall Study|Adverse Event|1|||
33633383|NCT01912963|63035114|FG002|Overall Study|Adverse Event|1|||
33633384|NCT01912963|63035112|FG000|Overall Study|Withdrawal by Subject|0|||
33633385|NCT01912963|63035113|FG001|Overall Study|Withdrawal by Subject|1|||
33633386|NCT01912963|63035114|FG002|Overall Study|Withdrawal by Subject|0|||
33633387|NCT01912963|63035112|FG000|Overall Study|Sought treatment locally|0|||
33633388|NCT01912963|63035113|FG001|Overall Study|Sought treatment locally|1|||
33633389|NCT01912963|63035114|FG002|Overall Study|Sought treatment locally|0|||
33633390|NCT01754727|63035122|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
33633391|NCT01912807|63035128|FG000|Overall Study|Did not meet elegibility criteria|6|||
33633392|NCT01912807|63035129|FG001|Overall Study|Did not meet elegibility criteria|4|||
33633393|NCT01912807|63035128|FG000|Overall Study|Lost to Follow-up|36|||
33633394|NCT01912807|63035129|FG001|Overall Study|Lost to Follow-up|37|||
33633395|NCT01782885|63035137|FG000|Overall Study|Lost to Follow-up|4|||
33633396|NCT01782885|63035138|FG001|Overall Study|Lost to Follow-up|6|||
33633397|NCT01912729|63035146|FG000|Overall Study|Withdrawal by Subject|0|||
33633398|NCT01912729|63035147|FG001|Overall Study|Withdrawal by Subject|1|||
33633399|NCT01754493|63035153|FG000|Overall Study|Adverse Event|1|||
33633400|NCT01754493|63035153|FG000|Overall Study|Lost to Follow-up|3|||
33633401|NCT01754493|63035153|FG000|Overall Study|Withdrawal by Subject|1|||
33633402|NCT01754493|63035153|FG000|Overall Study|Moved out of town|1|||
33633403|NCT01754493|63035153|FG000|Overall Study|Scheduling conflict|1|||
33633404|NCT01972789|63035159|FG000|Overall Study|Adverse Event|11|||
33633405|NCT01972789|63035160|FG001|Overall Study|Adverse Event|4|||
33633406|NCT01972789|63035159|FG000|Overall Study|Subject withdrew consent|14|||
33633407|NCT01972789|63035160|FG001|Overall Study|Subject withdrew consent|12|||
33633408|NCT01972789|63035159|FG000|Overall Study|Lost to Follow-up|4|||
33633409|NCT01972789|63035160|FG001|Overall Study|Lost to Follow-up|7|||
33633410|NCT01972789|63035159|FG000|Overall Study|Death|7|||
33633411|NCT01972789|63035160|FG001|Overall Study|Death|5|||
33633412|NCT01972789|63035159|FG000|Overall Study|Protocol deviation|1|||
33633413|NCT01972789|63035160|FG001|Overall Study|Protocol deviation|0|||
33633414|NCT01972789|63035159|FG000|Overall Study|Physician Decision|3|||
33633415|NCT01972789|63035160|FG001|Overall Study|Physician Decision|2|||
33633416|NCT01934335|63035168|FG000|Overall Study|Withdrawal by Subject|1|||
33633417|NCT01934335|63035169|FG001|Overall Study|Withdrawal by Subject|1|||
33633418|NCT01912339|63035177|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
33633419|NCT01912339|63035178|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
33633420|NCT01912339|63035179|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
33633421|NCT01912339|63035177|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
33633422|NCT01912339|63035178|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
33633423|NCT01912339|63035179|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
33633424|NCT01912339|63035177|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
33461803|NCT01934218|62835580|FG000|Double-blind Phase|Adverse Event|8|||
33461804|NCT01934218|62835581|FG001|Double-blind Phase|Adverse Event|8|||
33633425|NCT01912339|63035178|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
33461805|NCT01934218|62835580|FG000|Double-blind Phase|Lack of Efficacy|6|||
33461806|NCT01934218|62835581|FG001|Double-blind Phase|Lack of Efficacy|7|||
33461807|NCT01934218|62835580|FG000|Double-blind Phase|Lost to Follow-up|7|||
33633426|NCT01912339|63035179|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
33633427|NCT01912339|63035177|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
33633428|NCT01912339|63035178|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
33633429|NCT01912339|63035179|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
33633430|NCT01912339|63035177|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
33633431|NCT01912339|63035178|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
33633432|NCT01912339|63035179|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
33633433|NCT01912339|63035177|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
33633434|NCT01912339|63035178|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
33633435|NCT01912339|63035179|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
33633436|NCT01912339|63035177|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
33633437|NCT01912339|63035178|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
33539266|NCT02180217|62929423|FG002|Overall Study|Withdrawal by Subject|4|||
33539267|NCT02180217|62929421|FG000|Overall Study|Subject/Guardian decision|5|||
33539268|NCT02180217|62929422|FG001|Overall Study|Subject/Guardian decision|3|||
33539269|NCT02180217|62929423|FG002|Overall Study|Subject/Guardian decision|6|||
33539270|NCT02180217|62929421|FG000|Overall Study|Physician Decision|1|||
33539271|NCT02180217|62929422|FG001|Overall Study|Physician Decision|1|||
33539272|NCT02180217|62929423|FG002|Overall Study|Physician Decision|6|||
33539273|NCT02180217|62929421|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33539274|NCT02180217|62929422|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33539275|NCT02180217|62929423|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33539276|NCT02560558|62929440|FG000|Overall Study|Adverse Event|1|||
33539277|NCT02560558|62929441|FG001|Overall Study|Adverse Event|0|||
33539278|NCT02560558|62929440|FG000|Overall Study|Death|0|||
33539279|NCT02560558|62929441|FG001|Overall Study|Death|2|||
33539280|NCT02560558|62929440|FG000|Overall Study|Lost to Follow-up|0|||
33539281|NCT02560558|62929441|FG001|Overall Study|Lost to Follow-up|4|||
33633438|NCT01912339|63035179|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
33633439|NCT01912339|63035177|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
33633440|NCT01912339|63035178|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
33633441|NCT01912339|63035179|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
33633442|NCT01912339|63035177|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
33633443|NCT01912339|63035178|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
33633444|NCT01912339|63035179|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
33633445|NCT01912339|63035177|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
33633446|NCT01912339|63035178|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
33633447|NCT01912339|63035179|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
33633448|NCT01912339|63035177|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
33633449|NCT01912339|63035178|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
33633450|NCT01912339|63035179|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
33633451|NCT01912339|63035177|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
33633452|NCT01912339|63035178|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
33633453|NCT01912339|63035179|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
33633454|NCT01912339|63035177|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
33633455|NCT01912339|63035178|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
33633456|NCT01912339|63035179|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
33633457|NCT01911793|63035187|FG000|Overall Study|Physician Decision|1|||
33633458|NCT01911793|63035188|FG001|Overall Study|Physician Decision|5|||
33633459|NCT01933789|63035203|FG000|Overall Study|Death|0|||
33633460|NCT01933789|63035204|FG001|Overall Study|Death|0|||
33633461|NCT01933789|63035205|FG002|Overall Study|Death|0|||
33633462|NCT01933789|63035206|FG003|Overall Study|Death|0|||
33633463|NCT01933789|63035207|FG004|Overall Study|Death|21|||
33633464|NCT01933789|63035208|FG005|Overall Study|Death|32|||
33633465|NCT01933789|63035209|FG006|Overall Study|Death|0|||
33633466|NCT01933789|63035210|FG007|Overall Study|Death|0|||
33633467|NCT01933789|63035211|FG008|Overall Study|Death|0|||
33633468|NCT01933789|63035203|FG000|Overall Study|Lost to Follow-up|0|||
33633469|NCT01933789|63035204|FG001|Overall Study|Lost to Follow-up|0|||
33633470|NCT01933789|63035205|FG002|Overall Study|Lost to Follow-up|0|||
33633471|NCT01933789|63035206|FG003|Overall Study|Lost to Follow-up|1|||
33633472|NCT01933789|63035207|FG004|Overall Study|Lost to Follow-up|8|||
33633473|NCT01933789|63035208|FG005|Overall Study|Lost to Follow-up|9|||
33633474|NCT01933789|63035209|FG006|Overall Study|Lost to Follow-up|1|||
33633475|NCT01933789|63035210|FG007|Overall Study|Lost to Follow-up|4|||
33633476|NCT01933789|63035211|FG008|Overall Study|Lost to Follow-up|0|||
33633477|NCT01933789|63035203|FG000|Overall Study|Withdrawal by Subject|2|||
33539282|NCT02560558|62929440|FG000|Overall Study|Protocol Violation|3|||
33539283|NCT02560558|62929441|FG001|Overall Study|Protocol Violation|0|||
33539284|NCT02560558|62929440|FG000|Overall Study|Withdrawal by Subject|3|||
33539285|NCT02560558|62929441|FG001|Overall Study|Withdrawal by Subject|0|||
33539286|NCT02568046|62929449|FG000|Overall Study|Adverse Event|0|||
33633478|NCT01933789|63035204|FG001|Overall Study|Withdrawal by Subject|1|||
33633479|NCT01933789|63035205|FG002|Overall Study|Withdrawal by Subject|0|||
33633480|NCT01933789|63035206|FG003|Overall Study|Withdrawal by Subject|0|||
33633481|NCT01933789|63035207|FG004|Overall Study|Withdrawal by Subject|17|||
33633482|NCT01933789|63035208|FG005|Overall Study|Withdrawal by Subject|16|||
33633483|NCT01933789|63035209|FG006|Overall Study|Withdrawal by Subject|1|||
33633484|NCT01933789|63035210|FG007|Overall Study|Withdrawal by Subject|4|||
33633485|NCT01933789|63035211|FG008|Overall Study|Withdrawal by Subject|0|||
33633486|NCT01933789|63035203|FG000|Overall Study|Became Ineligible|4|||
33633487|NCT01933789|63035204|FG001|Overall Study|Became Ineligible|0|||
33633488|NCT01933789|63035205|FG002|Overall Study|Became Ineligible|0|||
33633489|NCT01933789|63035206|FG003|Overall Study|Became Ineligible|0|||
33633490|NCT01933789|63035207|FG004|Overall Study|Became Ineligible|13|||
33461808|NCT01934218|62835581|FG001|Double-blind Phase|Lost to Follow-up|14|||
33461809|NCT01934218|62835580|FG000|Double-blind Phase|Physician Decision|1|||
33539287|NCT02568046|62929450|FG001|Overall Study|Adverse Event|1|||
33539288|NCT02568046|62929449|FG000|Overall Study|Death|2|||
33539289|NCT02568046|62929450|FG001|Overall Study|Death|0|||
33539290|NCT02568046|62929449|FG000|Overall Study|Progressive Disease|1|||
33539291|NCT02568046|62929450|FG001|Overall Study|Progressive Disease|0|||
33539292|NCT02568046|62929449|FG000|Overall Study|Withdrawal by Subject|2|||
33539293|NCT02568046|62929450|FG001|Overall Study|Withdrawal by Subject|1|||
33539294|NCT02568046|62929449|FG000|Overall Study|Other Events|0|||
33539295|NCT02568046|62929450|FG001|Overall Study|Other Events|1|||
33539296|NCT02567656|62929462|FG000|Overall Study|Premature discontinuation due to PD|1|||
33461810|NCT01934218|62835581|FG001|Double-blind Phase|Physician Decision|2|||
33461811|NCT01934218|62835580|FG000|Double-blind Phase|Protocol Violation|4|||
33461812|NCT01934218|62835581|FG001|Double-blind Phase|Protocol Violation|0|||
33461813|NCT01934218|62835580|FG000|Double-blind Phase|Withdrawal by Subject|16|||
33461814|NCT01934218|62835581|FG001|Double-blind Phase|Withdrawal by Subject|13|||
33461815|NCT01934218|62835580|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
33461816|NCT01934218|62835581|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
33461817|NCT01934218|62835580|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
33461818|NCT01934218|62835581|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
33461819|NCT01934218|62835580|FG000|Open-Label Phase|Adverse Event|2|||
33539297|NCT02567656|62929463|FG001|Overall Study|Premature discontinuation due to PD|1|||
33539298|NCT02567656|62929464|FG002|Overall Study|Premature discontinuation due to PD|2|||
33539299|NCT02567656|62929465|FG003|Overall Study|Premature discontinuation due to PD|0|||
33539300|NCT02567656|62929466|FG004|Overall Study|Premature discontinuation due to PD|0|||
33539301|NCT02567656|62929467|FG005|Overall Study|Premature discontinuation due to PD|0|||
33539302|NCT02560012|62929481|FG000|Overall Study|Study Terminated|2|||
33539303|NCT02567266|62929488|FG000|Overall Study|Withdrawal by Subject|10|||
33539304|NCT02567266|62929489|FG001|Overall Study|Withdrawal by Subject|7|||
33539305|NCT02567266|62929490|FG002|Overall Study|Withdrawal by Subject|6|||
33539306|NCT02567266|62929488|FG000|Overall Study|Lost to Follow-up|13|||
33539307|NCT02567266|62929489|FG001|Overall Study|Lost to Follow-up|8|||
33539308|NCT02567266|62929490|FG002|Overall Study|Lost to Follow-up|10|||
33539309|NCT02567188|62929498|FG000|Overall Study|Death|10|||
33539310|NCT02567188|62929498|FG000|Overall Study|Terminated Mircera Treatment|9|||
33539311|NCT02567188|62929498|FG000|Overall Study|Lost to Follow-up|5|||
33539312|NCT02567188|62929498|FG000|Overall Study|Adverse Event|1|||
33539313|NCT02567188|62929498|FG000|Overall Study|Withdrawal by Subject|1|||
33539314|NCT02567188|62929498|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
33539315|NCT02567188|62929498|FG000|Overall Study|Moved and Changed Clinic|1|||
33539316|NCT02567188|62929498|FG000|Overall Study|Started Hemodialysis|2|||
33539317|NCT02567188|62929498|FG000|Overall Study|Protocol Violation|5|||
33539318|NCT00706238|62929503|FG000|Overall Study|Disease progression|4|||
33539319|NCT00706238|62929503|FG000|Overall Study|Other|1|||
33539320|NCT03321968|62929510|FG000|Overall Study|Withdrawal by Subject|1|||
33539321|NCT03321968|62929511|FG001|Overall Study|Withdrawal by Subject|2|||
33539322|NCT03321968|62929512|FG002|Overall Study|Withdrawal by Subject|1|||
33539323|NCT03321968|62929510|FG000|Overall Study|Lost to Follow-up|2|||
33539324|NCT03321968|62929511|FG001|Overall Study|Lost to Follow-up|0|||
33539325|NCT03321968|62929512|FG002|Overall Study|Lost to Follow-up|1|||
33539326|NCT03321968|62929510|FG000|Overall Study|Other than specified|0|||
33633491|NCT01933789|63035208|FG005|Overall Study|Became Ineligible|10|||
33633492|NCT01933789|63035209|FG006|Overall Study|Became Ineligible|13|||
33461820|NCT01934218|62835581|FG001|Open-Label Phase|Adverse Event|4|||
33633493|NCT01933789|63035210|FG007|Overall Study|Became Ineligible|6|||
33461821|NCT01934218|62835580|FG000|Open-Label Phase|Lack of Efficacy|1|||
33539327|NCT03321968|62929511|FG001|Overall Study|Other than specified|0|||
33539328|NCT03321968|62929512|FG002|Overall Study|Other than specified|1|||
33539329|NCT05338333|62929526|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
33539330|NCT05338333|62929527|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
33539331|NCT05051579|62929543|FG000|Overall Study|Withdrawal by Subject|3|||
33539332|NCT05051579|62929544|FG001|Overall Study|Withdrawal by Subject|5|||
33539333|NCT05051579|62929545|FG002|Overall Study|Withdrawal by Subject|2|||
33539334|NCT05051579|62929546|FG003|Overall Study|Withdrawal by Subject|1|||
33539335|NCT05051579|62929547|FG004|Overall Study|Withdrawal by Subject|4|||
33633494|NCT01933789|63035211|FG008|Overall Study|Became Ineligible|0|||
33633495|NCT01910389|63035233|FG000|Overall Study|Withdrawal by Subject|2|||
33539336|NCT05051579|62929548|FG005|Overall Study|Withdrawal by Subject|0|||
33539337|NCT05051579|62929549|FG006|Overall Study|Withdrawal by Subject|4|||
33539338|NCT05051579|62929543|FG000|Overall Study|Lost to Follow-up|1|||
33539339|NCT05051579|62929544|FG001|Overall Study|Lost to Follow-up|0|||
33539340|NCT05051579|62929545|FG002|Overall Study|Lost to Follow-up|0|||
33539341|NCT05051579|62929546|FG003|Overall Study|Lost to Follow-up|0|||
33539342|NCT05051579|62929547|FG004|Overall Study|Lost to Follow-up|1|||
33539343|NCT05051579|62929548|FG005|Overall Study|Lost to Follow-up|0|||
33539344|NCT05051579|62929549|FG006|Overall Study|Lost to Follow-up|1|||
33539345|NCT05051579|62929543|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
33539346|NCT05051579|62929544|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
33539347|NCT05051579|62929545|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
33633496|NCT01910389|63035234|FG001|Overall Study|Withdrawal by Subject|0|||
33633497|NCT01910389|63035233|FG000|Overall Study|Study Closed|13|||
33633498|NCT01910389|63035234|FG001|Overall Study|Study Closed|8|||
33633499|NCT01970995|63035243|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
33633500|NCT01970995|63035244|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
33633501|NCT01970995|63035245|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
33633502|NCT01970995|63035243|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
33633503|NCT01970995|63035244|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
33633504|NCT01970995|63035245|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
33633505|NCT01970527|63035255|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
33633506|NCT01970527|63035256|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
33633507|NCT01970527|63035255|FG000|Treatment|Disease progression|0|||
33633508|NCT01970527|63035256|FG001|Treatment|Disease progression|1|||
33633509|NCT01970527|63035255|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
33461822|NCT01934218|62835581|FG001|Open-Label Phase|Lack of Efficacy|4|||
33461823|NCT01934218|62835580|FG000|Open-Label Phase|Lost to Follow-up|4|||
33461824|NCT01934218|62835581|FG001|Open-Label Phase|Lost to Follow-up|2|||
33461825|NCT01934218|62835580|FG000|Open-Label Phase|Physician Decision|1|||
33461826|NCT01934218|62835581|FG001|Open-Label Phase|Physician Decision|0|||
33461827|NCT01934218|62835580|FG000|Open-Label Phase|Protocol Violation|1|||
33461828|NCT01934218|62835581|FG001|Open-Label Phase|Protocol Violation|0|||
33461829|NCT01934218|62835580|FG000|Open-Label Phase|Withdrawal by Subject|13|||
33461830|NCT01934218|62835581|FG001|Open-Label Phase|Withdrawal by Subject|11|||
33461831|NCT01934218|62835580|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
33461832|NCT01934218|62835581|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
33461833|NCT01934218|62835580|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
33461834|NCT01934218|62835581|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
33539348|NCT05051579|62929546|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
33539349|NCT05051579|62929547|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
33539350|NCT05051579|62929548|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
33539351|NCT05051579|62929549|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
33539352|NCT05051579|62929543|FG000|Overall Study|Adverse Event|2|||
33539353|NCT05051579|62929544|FG001|Overall Study|Adverse Event|1|||
33539354|NCT05051579|62929545|FG002|Overall Study|Adverse Event|0|||
33539355|NCT05051579|62929546|FG003|Overall Study|Adverse Event|4|||
33539356|NCT05051579|62929547|FG004|Overall Study|Adverse Event|1|||
33539357|NCT05051579|62929548|FG005|Overall Study|Adverse Event|2|||
33539358|NCT05051579|62929549|FG006|Overall Study|Adverse Event|0|||
33539359|NCT05051579|62929543|FG000|Overall Study|Inadvertent Enrollment|0|||
33539360|NCT05051579|62929544|FG001|Overall Study|Inadvertent Enrollment|0|||
33539361|NCT05051579|62929545|FG002|Overall Study|Inadvertent Enrollment|0|||
33539362|NCT05051579|62929546|FG003|Overall Study|Inadvertent Enrollment|0|||
33539363|NCT05051579|62929547|FG004|Overall Study|Inadvertent Enrollment|0|||
33539364|NCT05051579|62929548|FG005|Overall Study|Inadvertent Enrollment|0|||
33539365|NCT05051579|62929549|FG006|Overall Study|Inadvertent Enrollment|1|||
33539366|NCT05051579|62929543|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
33539367|NCT05051579|62929544|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
33539368|NCT05051579|62929545|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
33539369|NCT05051579|62929546|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
33633510|NCT01970527|63035256|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
33633511|NCT01970527|63035255|FG000|Treatment|Death|0|||
33633512|NCT01970527|63035256|FG001|Treatment|Death|1|||
33461835|NCT01702805|62835589|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
33539370|NCT05051579|62929547|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
33539371|NCT05051579|62929548|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
33539372|NCT05051579|62929549|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
33539373|NCT05051579|62929543|FG000|Overall Study|Sponsor Decision|0|||
33539374|NCT05051579|62929544|FG001|Overall Study|Sponsor Decision|0|||
33633513|NCT01970527|63035255|FG000|Follow-up Clinic Visit|Disease progression|1|||
33633514|NCT01970527|63035256|FG001|Follow-up Clinic Visit|Disease progression|1|||
33633515|NCT01970527|63035255|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
33633516|NCT01970527|63035256|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
33633517|NCT01970527|63035255|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
33633518|NCT01970527|63035256|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
33633519|NCT01931995|63035267|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
33633520|NCT01931995|63035268|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
33633521|NCT01931995|63035267|FG000|First Intervention (1 Day)|Physician Decision|1|||
33633522|NCT01931995|63035268|FG001|First Intervention (1 Day)|Physician Decision|1|||
33633523|NCT01931995|63035267|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
33633524|NCT01931995|63035268|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
33633525|NCT01408576|63035277|FG000|Overall Study|Lack of Efficacy|17|||
33633526|NCT01408576|63035278|FG001|Overall Study|Lack of Efficacy|30|||
33633527|NCT01408576|63035279|FG002|Overall Study|Lack of Efficacy|48|||
33633528|NCT01408576|63035277|FG000|Overall Study|Protocol Violation|1|||
33633529|NCT01408576|63035278|FG001|Overall Study|Protocol Violation|2|||
33633530|NCT01408576|63035279|FG002|Overall Study|Protocol Violation|2|||
33633531|NCT01408576|63035277|FG000|Overall Study|Lost to Follow-up|10|||
33633532|NCT01408576|63035278|FG001|Overall Study|Lost to Follow-up|9|||
33633533|NCT01408576|63035279|FG002|Overall Study|Lost to Follow-up|17|||
33633534|NCT01408576|63035277|FG000|Overall Study|Withdrawal by Subject|34|||
33633535|NCT01408576|63035278|FG001|Overall Study|Withdrawal by Subject|60|||
33633536|NCT01408576|63035279|FG002|Overall Study|Withdrawal by Subject|66|||
33633537|NCT01408576|63035277|FG000|Overall Study|Sponsor terminated study|89|||
33633538|NCT01408576|63035278|FG001|Overall Study|Sponsor terminated study|333|||
33633539|NCT01408576|63035279|FG002|Overall Study|Sponsor terminated study|330|||
33633540|NCT01408576|63035277|FG000|Overall Study|AE, serious fatal|4|||
33633541|NCT01408576|63035278|FG001|Overall Study|AE, serious fatal|4|||
33633542|NCT01408576|63035279|FG002|Overall Study|AE, serious fatal|1|||
33633543|NCT01408576|63035277|FG000|Overall Study|SAE, non-fatal|11|||
33633544|NCT01408576|63035278|FG001|Overall Study|SAE, non-fatal|23|||
33633545|NCT01408576|63035279|FG002|Overall Study|SAE, non-fatal|14|||
33633546|NCT01408576|63035277|FG000|Overall Study|AE, non-serious non-fatal|12|||
33633547|NCT01408576|63035278|FG001|Overall Study|AE, non-serious non-fatal|19|||
33633548|NCT01408576|63035279|FG002|Overall Study|AE, non-serious non-fatal|11|||
33633549|NCT01408576|63035277|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
33633550|NCT01408576|63035278|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33633551|NCT01408576|63035279|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33633552|NCT01408576|63035277|FG000|Overall Study|AE, unknown type|0|||
33633553|NCT01408576|63035278|FG001|Overall Study|AE, unknown type|1|||
33633554|NCT01408576|63035279|FG002|Overall Study|AE, unknown type|0|||
33633555|NCT01408576|63035277|FG000|Overall Study|Other|10|||
33633556|NCT01408576|63035278|FG001|Overall Study|Other|16|||
33633557|NCT01408576|63035279|FG002|Overall Study|Other|18|||
33633558|NCT01427920|63035301|FG000|Overall Study|Adverse Event|1|||
33461836|NCT01702805|62835590|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
33461837|NCT01702805|62835589|FG000|Overall Study|Incomplete Follow-up|18|||
33461838|NCT01702805|62835590|FG001|Overall Study|Incomplete Follow-up|15|||
33461839|NCT01702805|62835589|FG000|Overall Study|Vital Status Assessment Only|40|||
33461840|NCT01702805|62835590|FG001|Overall Study|Vital Status Assessment Only|39|||
33461841|NCT01702805|62835589|FG000|Overall Study|Lost to Follow-up|5|||
33461842|NCT01702805|62835590|FG001|Overall Study|Lost to Follow-up|5|||
33461843|NCT00097370|62835613|FG000|Stage 1|Adverse Event|3|||
33461844|NCT00097370|62835613|FG000|Stage 1|Withdrawal by Subject|1|||
33461845|NCT00097370|62835613|FG000|Stage 1|Lack of Efficacy|2|||
33461846|NCT00097370|62835613|FG000|Stage 2|Adverse Event|5|||
33461847|NCT00097370|62835613|FG000|Stage 2|Withdrawal by Subject|1|||
33461848|NCT00097370|62835613|FG000|Stage 2|Lack of Efficacy|3|||
33461849|NCT00097370|62835613|FG000|Stage 2|Pregnancy|1|||
33461850|NCT00097370|62835613|FG000|Stage 2|Sponsor Terminated Study|2|||
33461851|NCT00097370|62835613|FG000|Stage 2|Lost to Follow-up|1|||
33633559|NCT01427920|63035302|FG001|Overall Study|Adverse Event|2|||
33633560|NCT01427920|63035301|FG000|Overall Study|Lack of Efficacy|1|||
33633561|NCT01427920|63035302|FG001|Overall Study|Lack of Efficacy|0|||
33633562|NCT01427920|63035301|FG000|Overall Study|Protocol Violation|1|||
33633563|NCT01427920|63035302|FG001|Overall Study|Protocol Violation|3|||
33633564|NCT01427920|63035301|FG000|Overall Study|Withdrawal Criteria|4|||
33461852|NCT00097370|62835613|FG000|Stage 3|Adverse Event|2|||
33461853|NCT00097370|62835613|FG000|Stage 3|Withdrawal by Subject|3|||
33461854|NCT00097370|62835613|FG000|Stage 3|Lack of Efficacy|1|||
33461855|NCT00097370|62835613|FG000|Stage 3|Sponsor Terminated Study|52|||
33633565|NCT01427920|63035302|FG001|Overall Study|Withdrawal Criteria|4|||
33461856|NCT00097370|62835613|FG000|Stage 3|Lost to Follow-up|1|||
33461857|NCT03515824|62835620|FG000|Overall Study|Death|3|||
33633566|NCT01427920|63035301|FG000|Overall Study|Unclassified|2|||
33633567|NCT01427920|63035302|FG001|Overall Study|Unclassified|8|||
33633568|NCT01427608|63035310|FG000|Overall Study|Death|1|||
33633569|NCT01427608|63035311|FG001|Overall Study|Death|0|||
33633570|NCT01427608|63035310|FG000|Overall Study|Withdrawal by Subject|7|||
33633571|NCT01427608|63035311|FG001|Overall Study|Withdrawal by Subject|3|||
33633572|NCT01427608|63035310|FG000|Overall Study|Relapsed-all cause|13|||
33633573|NCT01427608|63035311|FG001|Overall Study|Relapsed-all cause|34|||
33633574|NCT01427608|63035310|FG000|Overall Study|Events not attributed to study meds|0|||
33633575|NCT01427608|63035311|FG001|Overall Study|Events not attributed to study meds|1|||
33633576|NCT01408030|63035323|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
33633577|NCT01408030|63035324|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
33633578|NCT01408030|63035325|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
33633579|NCT01408030|63035326|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
33633580|NCT01408030|63035323|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
33633581|NCT01408030|63035324|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
33633582|NCT01408030|63035325|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
33633583|NCT01408030|63035326|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
33633584|NCT01408030|63035323|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
33633585|NCT01408030|63035324|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
33633586|NCT01408030|63035325|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
33633587|NCT01408030|63035326|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
33633588|NCT01408030|63035323|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
33539375|NCT05051579|62929545|FG002|Overall Study|Sponsor Decision|0|||
33539376|NCT05051579|62929546|FG003|Overall Study|Sponsor Decision|0|||
33539377|NCT05051579|62929547|FG004|Overall Study|Sponsor Decision|1|||
33539378|NCT05051579|62929548|FG005|Overall Study|Sponsor Decision|0|||
33539379|NCT05051579|62929549|FG006|Overall Study|Sponsor Decision|0|||
33539380|NCT05051579|62929543|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
33539381|NCT05051579|62929544|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
33633589|NCT01408030|63035324|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
33633590|NCT01408030|63035325|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
33633591|NCT01408030|63035326|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
33461858|NCT03515824|62835621|FG001|Overall Study|Death|2|||
33461859|NCT03515824|62835622|FG002|Overall Study|Death|6|||
33461860|NCT03515824|62835623|FG003|Overall Study|Death|0|||
33461861|NCT03515824|62835620|FG000|Overall Study|Lost to Follow-up|0|||
33461862|NCT03515824|62835621|FG001|Overall Study|Lost to Follow-up|1|||
33461863|NCT03515824|62835622|FG002|Overall Study|Lost to Follow-up|1|||
33461864|NCT03515824|62835623|FG003|Overall Study|Lost to Follow-up|0|||
33461865|NCT03515824|62835620|FG000|Overall Study|Study terminated by sponsor|0|||
33461866|NCT03515824|62835621|FG001|Overall Study|Study terminated by sponsor|1|||
33461867|NCT03515824|62835622|FG002|Overall Study|Study terminated by sponsor|6|||
33461868|NCT03515824|62835623|FG003|Overall Study|Study terminated by sponsor|0|||
33461869|NCT03515824|62835620|FG000|Overall Study|Status not recorded|0|||
33461870|NCT03515824|62835621|FG001|Overall Study|Status not recorded|0|||
33461871|NCT03515824|62835622|FG002|Overall Study|Status not recorded|2|||
33461872|NCT03515824|62835623|FG003|Overall Study|Status not recorded|0|||
33461873|NCT01089374|62835633|FG000|Overall Study|Lost to Follow-up|3|||
33461874|NCT01089374|62835634|FG001|Overall Study|Lost to Follow-up|0|||
33461875|NCT01089374|62835633|FG000|Overall Study|Withdrawal by Subject|1|||
33461876|NCT01089374|62835634|FG001|Overall Study|Withdrawal by Subject|0|||
33461877|NCT01089374|62835633|FG000|Overall Study|Study closed early - low accrual|6|||
33461878|NCT01089374|62835634|FG001|Overall Study|Study closed early - low accrual|0|||
33461879|NCT03511378|62835641|FG000|Overall Study|Withdrawal by Subject|2|||
33461880|NCT03511378|62835642|FG001|Overall Study|Withdrawal by Subject|2|||
33461881|NCT03511378|62835641|FG000|Overall Study|Patient not coming or schedule visit|1|||
33461882|NCT03511378|62835642|FG001|Overall Study|Patient not coming or schedule visit|0|||
33461883|NCT03511066|62835651|FG000|Overall Study|Withdrawal by Subject|1|||
33461884|NCT03511066|62835652|FG001|Overall Study|Withdrawal by Subject|2|||
33461885|NCT03511066|62835653|FG002|Overall Study|Withdrawal by Subject|3|||
33461886|NCT03511066|62835651|FG000|Overall Study|Lost to Follow-up|2|||
33461887|NCT03511066|62835652|FG001|Overall Study|Lost to Follow-up|3|||
33461888|NCT03511066|62835653|FG002|Overall Study|Lost to Follow-up|0|||
33461889|NCT03510910|62835663|FG000|Overall Study|Incomplete Survey|2|||
33461890|NCT03510910|62835664|FG001|Overall Study|Incomplete Survey|3|||
33461891|NCT03509350|62835672|FG000|Overall Study|Withdrawal by Subject|0|||
33461892|NCT03509350|62835673|FG001|Overall Study|Withdrawal by Subject|2|||
33461893|NCT00072410|62835681|FG000|Overall Study|Progressive disease|0|||
33633592|NCT01408030|63035323|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
33633593|NCT01408030|63035324|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
33633594|NCT01408030|63035325|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
33633595|NCT01408030|63035326|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
33633596|NCT01408030|63035323|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
33633597|NCT01408030|63035324|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
33633598|NCT01408030|63035325|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
33633599|NCT01408030|63035326|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
33633600|NCT01408030|63035323|FG000|Observation Phase (Off Drug)|Other|1|||
33326370|NCT00946647|62703163|FG002|Phase 1 Part|Withdrawal by Subject|3|||
33326371|NCT00946647|62703164|FG003|Phase 1 Part|Withdrawal by Subject|0|||
33326372|NCT00946647|62703165|FG004|Phase 1 Part|Withdrawal by Subject|0|||
33326373|NCT00946647|62703161|FG000|Phase 1 Part|Abnormal values|0|||
33326374|NCT00946647|62703162|FG001|Phase 1 Part|Abnormal values|2|||
33326375|NCT00946647|62703163|FG002|Phase 1 Part|Abnormal values|0|||
33326376|NCT00946647|62703164|FG003|Phase 1 Part|Abnormal values|0|||
33326377|NCT00946647|62703165|FG004|Phase 1 Part|Abnormal values|0|||
33326378|NCT00946647|62703161|FG000|Phase 1 Part|Reason missing|0|||
33326379|NCT00946647|62703162|FG001|Phase 1 Part|Reason missing|1|||
33326380|NCT00946647|62703163|FG002|Phase 1 Part|Reason missing|0|||
33326381|NCT00946647|62703164|FG003|Phase 1 Part|Reason missing|0|||
33326382|NCT00946647|62703165|FG004|Phase 1 Part|Reason missing|0|||
33326383|NCT00946647|62703161|FG000|Phase ll Part|Untreated|0|||
33326384|NCT00946647|62703162|FG001|Phase ll Part|Untreated|0|||
33326385|NCT00946647|62703163|FG002|Phase ll Part|Untreated|0|||
33326386|NCT00946647|62703164|FG003|Phase ll Part|Untreated|0|||
33461894|NCT00072410|62835682|FG001|Overall Study|Progressive disease|3|||
33633601|NCT01408030|63035324|FG001|Observation Phase (Off Drug)|Other|1|||
33633602|NCT01408030|63035325|FG002|Observation Phase (Off Drug)|Other|1|||
33633603|NCT01408030|63035326|FG003|Observation Phase (Off Drug)|Other|1|||
33633604|NCT01897532|63035338|FG000|Discontinuation From Treatment|Not Treated|7|||
33633605|NCT01897532|63035339|FG001|Discontinuation From Treatment|Not Treated|5|||
33633606|NCT01897532|63035338|FG000|Discontinuation From Treatment|Other reason than specified|196|||
33633607|NCT01897532|63035339|FG001|Discontinuation From Treatment|Other reason than specified|176|||
33633608|NCT01897532|63035338|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
33633609|NCT01897532|63035339|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
33633610|NCT01897532|63035338|FG000|Discontinuation From Treatment|Non compliance|24|||
33633611|NCT01897532|63035339|FG001|Discontinuation From Treatment|Non compliance|15|||
33633612|NCT01897532|63035338|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
33633613|NCT01897532|63035339|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
33633614|NCT01897532|63035338|FG000|Discontinuation From Trial|Not Treated|7|||
33633615|NCT01897532|63035339|FG001|Discontinuation From Trial|Not Treated|5|||
33633616|NCT01897532|63035338|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
33633617|NCT01897532|63035339|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
33633618|NCT01923428|63035349|FG000|Overall Study|Adverse Event|8|||
33633619|NCT01923428|63035350|FG001|Overall Study|Adverse Event|6|||
33633620|NCT01923428|63035351|FG002|Overall Study|Adverse Event|3|||
33633621|NCT01923428|63035352|FG003|Overall Study|Adverse Event|3|||
33633622|NCT01923428|63035349|FG000|Overall Study|Withdrawal by Subject|5|||
33633623|NCT01923428|63035350|FG001|Overall Study|Withdrawal by Subject|3|||
33633624|NCT01923428|63035351|FG002|Overall Study|Withdrawal by Subject|0|||
33633625|NCT01923428|63035352|FG003|Overall Study|Withdrawal by Subject|4|||
33633626|NCT01923428|63035349|FG000|Overall Study|Lost to Follow-up|2|||
33633627|NCT01923428|63035350|FG001|Overall Study|Lost to Follow-up|1|||
33633628|NCT01923428|63035351|FG002|Overall Study|Lost to Follow-up|5|||
33461895|NCT03478696|62835690|FG000|Overall Study|Adverse Event|1|||
33461896|NCT03478696|62835691|FG001|Overall Study|Adverse Event|5|||
33461897|NCT03478696|62835690|FG000|Overall Study|Lost to Follow-up|1|||
33461898|NCT03478696|62835691|FG001|Overall Study|Lost to Follow-up|0|||
33461899|NCT03478696|62835690|FG000|Overall Study|Physician Decision|6|||
33461900|NCT03478696|62835691|FG001|Overall Study|Physician Decision|3|||
33461901|NCT03478696|62835690|FG000|Overall Study|Withdrawal by Subject|9|||
33633629|NCT01923428|63035352|FG003|Overall Study|Lost to Follow-up|0|||
33633630|NCT01923428|63035349|FG000|Overall Study|Protocol Violation|3|||
33633631|NCT01923428|63035350|FG001|Overall Study|Protocol Violation|0|||
33461902|NCT03478696|62835691|FG001|Overall Study|Withdrawal by Subject|4|||
33633632|NCT01923428|63035351|FG002|Overall Study|Protocol Violation|2|||
33633633|NCT01923428|63035352|FG003|Overall Study|Protocol Violation|1|||
33461903|NCT03477838|62835697|FG000|Overall Study|Lost to Follow-up|14|||
33633634|NCT01923428|63035349|FG000|Overall Study|Non Compliance to treatment|1|||
33326387|NCT00946647|62703165|FG004|Phase ll Part|Untreated|2|||
33461904|NCT00072176|62835703|FG000|Overall Study|Withdrawal by Subject|1|||
33633635|NCT01923428|63035350|FG001|Overall Study|Non Compliance to treatment|2|||
33633636|NCT01923428|63035351|FG002|Overall Study|Non Compliance to treatment|0|||
33633637|NCT01923428|63035352|FG003|Overall Study|Non Compliance to treatment|1|||
33633638|NCT01923428|63035349|FG000|Overall Study|Lack of Efficacy|0|||
33633639|NCT01923428|63035350|FG001|Overall Study|Lack of Efficacy|0|||
33633640|NCT01923428|63035351|FG002|Overall Study|Lack of Efficacy|1|||
33633641|NCT01923428|63035352|FG003|Overall Study|Lack of Efficacy|1|||
33633642|NCT01896986|63035364|FG000|Overall Study|samples lost|14|||
33633643|NCT01896986|63035365|FG001|Overall Study|samples lost|23|||
33633644|NCT01896128|63035373|FG000|Overall Study|Withdrawal by Subject|3|||
33633645|NCT01896128|63035374|FG001|Overall Study|Withdrawal by Subject|3|||
33633646|NCT01949870|63035380|FG000|Overall Study|Lack of Efficacy|2|||
33633647|NCT01949870|63035380|FG000|Overall Study|Adverse Event|1|||
33633648|NCT01949870|63035380|FG000|Overall Study|Study termination|1|||
33633649|NCT01949870|63035380|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
33633650|NCT01949480|63035386|FG000|Overall Study|Physician Decision|5|||
33633651|NCT01949480|63035387|FG001|Overall Study|Physician Decision|8|||
33633652|NCT01949090|63035398|FG000|Overall Study|Serious Adverse Event|0|||
33633653|NCT01949090|63035399|FG001|Overall Study|Serious Adverse Event|1|||
33633654|NCT01949090|63035400|FG002|Overall Study|Serious Adverse Event|2|||
33633655|NCT01949090|63035401|FG003|Overall Study|Serious Adverse Event|0|||
33633656|NCT01949090|63035402|FG004|Overall Study|Serious Adverse Event|1|||
33633657|NCT01949090|63035398|FG000|Overall Study|Withdrawal by Subject|2|||
33633658|NCT01949090|63035399|FG001|Overall Study|Withdrawal by Subject|0|||
33633659|NCT01949090|63035400|FG002|Overall Study|Withdrawal by Subject|0|||
33633660|NCT01949090|63035401|FG003|Overall Study|Withdrawal by Subject|0|||
33633661|NCT01949090|63035402|FG004|Overall Study|Withdrawal by Subject|1|||
33633662|NCT01949090|63035398|FG000|Overall Study|Protocol non-compliance|0|||
33633663|NCT01949090|63035399|FG001|Overall Study|Protocol non-compliance|0|||
33633664|NCT01949090|63035400|FG002|Overall Study|Protocol non-compliance|0|||
33633665|NCT01949090|63035401|FG003|Overall Study|Protocol non-compliance|0|||
33633666|NCT01949090|63035402|FG004|Overall Study|Protocol non-compliance|1|||
33633667|NCT01949090|63035398|FG000|Overall Study|Lost to Follow-up|2|||
33461905|NCT00072176|62835704|FG001|Overall Study|Withdrawal by Subject|0|||
33461906|NCT00072176|62835703|FG000|Overall Study|Protocol Violation|0|||
33461907|NCT00072176|62835704|FG001|Overall Study|Protocol Violation|1|||
33461908|NCT00071396|62835710|FG000|Overall Study|Withdrawal by Subject|1|||
33461909|NCT00071396|62835710|FG000|Overall Study|Physician Decision|2|||
33461910|NCT03473236|62835724|FG000|Overall Study|Withdrawal by Subject|0|||
33539382|NCT05051579|62929545|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
33539383|NCT05051579|62929546|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
33539384|NCT05051579|62929547|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
33539385|NCT05051579|62929548|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
33539386|NCT05051579|62929549|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
33539387|NCT04995419|62929573|FG000|Overall Study|Withdrawal by Subject|3|||
33539388|NCT04995419|62929573|FG000|Overall Study|Progressive Disease|19|||
33539389|NCT04995419|62929573|FG000|Overall Study|Adverse Event|2|||
33539390|NCT04995419|62929573|FG000|Overall Study|Ongoing|16|||
33539391|NCT04964128|62929577|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
33539392|NCT04964128|62929577|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
33539393|NCT04881760|62929592|FG000|Overall Study|Adverse Event|0|||
33633668|NCT01949090|63035399|FG001|Overall Study|Lost to Follow-up|1|||
33633669|NCT01949090|63035400|FG002|Overall Study|Lost to Follow-up|0|||
33633670|NCT01949090|63035401|FG003|Overall Study|Lost to Follow-up|1|||
33633671|NCT01949090|63035402|FG004|Overall Study|Lost to Follow-up|1|||
33633672|NCT01948076|63035417|FG000|Overall Study|Withdrawal by Subject|0|||
33633673|NCT01948076|63035418|FG001|Overall Study|Withdrawal by Subject|1|||
33461911|NCT03473236|62835725|FG001|Overall Study|Withdrawal by Subject|0|||
33461912|NCT03473236|62835726|FG002|Overall Study|Withdrawal by Subject|0|||
33461913|NCT03473236|62835727|FG003|Overall Study|Withdrawal by Subject|0|||
33461914|NCT03473236|62835728|FG004|Overall Study|Withdrawal by Subject|0|||
33461915|NCT03473236|62835729|FG005|Overall Study|Withdrawal by Subject|1|||
33461916|NCT03473236|62835730|FG006|Overall Study|Withdrawal by Subject|0|||
33461917|NCT03473236|62835731|FG007|Overall Study|Withdrawal by Subject|0|||
33461918|NCT03473236|62835732|FG008|Overall Study|Withdrawal by Subject|1|||
33461919|NCT03473236|62835733|FG009|Overall Study|Withdrawal by Subject|0|||
33461920|NCT03550378|62835765|FG000|Overall Study|Death|0|||
33461921|NCT03550378|62835766|FG001|Overall Study|Death|1|||
33461922|NCT03472534|62835773|FG000|Overall Study|Withdrawal by Subject|9|||
33461923|NCT03472534|62835773|FG000|Overall Study|Adverse Event|2|||
33461924|NCT03549130|62835779|FG000|Overall Study|Adverse Event|0|||
33461925|NCT03549130|62835780|FG001|Overall Study|Adverse Event|1|||
33633674|NCT01922258|63035428|FG000|Overall Study|Lost to Follow-up|1|||
33633675|NCT01922258|63035429|FG001|Overall Study|Lost to Follow-up|1|||
33633676|NCT01922258|63035428|FG000|Overall Study|Adverse Event|9|||
33633677|NCT01922258|63035429|FG001|Overall Study|Adverse Event|2|||
33633678|NCT01922258|63035428|FG000|Overall Study|Met Withdrawal Criteria|0|||
33633679|NCT01922258|63035429|FG001|Overall Study|Met Withdrawal Criteria|4|||
33633680|NCT01922258|63035428|FG000|Overall Study|Withdrawn by the Investigator|1|||
33633681|NCT01922258|63035429|FG001|Overall Study|Withdrawn by the Investigator|4|||
33633682|NCT01922258|63035428|FG000|Overall Study|Withdrawal by participant|5|||
33633683|NCT01922258|63035429|FG001|Overall Study|Withdrawal by participant|5|||
33633684|NCT01406938|63035437|FG000|Induction Period|Subject/guardian decision|6|||
33633685|NCT01406938|63035438|FG001|Induction Period|Subject/guardian decision|8|||
33539394|NCT04881760|62929593|FG001|Overall Study|Adverse Event|1|||
33633686|NCT01406938|63035439|FG002|Induction Period|Subject/guardian decision|0|||
33633687|NCT01406938|63035440|FG003|Induction Period|Subject/guardian decision|0|||
33633688|NCT01406938|63035441|FG004|Induction Period|Subject/guardian decision|0|||
33633689|NCT01406938|63035442|FG005|Induction Period|Subject/guardian decision|0|||
33633690|NCT01406938|63035437|FG000|Induction Period|Protocol deviation|1|||
33633691|NCT01406938|63035438|FG001|Induction Period|Protocol deviation|0|||
33539395|NCT04881760|62929594|FG002|Overall Study|Adverse Event|1|||
33539396|NCT04881760|62929595|FG003|Overall Study|Adverse Event|0|||
33539397|NCT04881760|62929596|FG004|Overall Study|Adverse Event|1|||
33539398|NCT04881760|62929597|FG005|Overall Study|Adverse Event|1|||
33539399|NCT04881760|62929598|FG006|Overall Study|Adverse Event|2|||
33539400|NCT04881760|62929592|FG000|Overall Study|Death|0|||
33539401|NCT04881760|62929593|FG001|Overall Study|Death|0|||
33539402|NCT04881760|62929594|FG002|Overall Study|Death|0|||
33633692|NCT01406938|63035439|FG002|Induction Period|Protocol deviation|0|||
33539403|NCT04881760|62929595|FG003|Overall Study|Death|1|||
33539404|NCT04881760|62929596|FG004|Overall Study|Death|0|||
33539405|NCT04881760|62929597|FG005|Overall Study|Death|0|||
33539406|NCT04881760|62929598|FG006|Overall Study|Death|0|||
33539407|NCT04881760|62929592|FG000|Overall Study|Lost to Follow-up|5|||
33539408|NCT04881760|62929593|FG001|Overall Study|Lost to Follow-up|7|||
33539409|NCT04881760|62929594|FG002|Overall Study|Lost to Follow-up|5|||
33539410|NCT04881760|62929595|FG003|Overall Study|Lost to Follow-up|1|||
33539411|NCT04881760|62929596|FG004|Overall Study|Lost to Follow-up|2|||
33539412|NCT04881760|62929597|FG005|Overall Study|Lost to Follow-up|4|||
33539413|NCT04881760|62929598|FG006|Overall Study|Lost to Follow-up|4|||
33539414|NCT04881760|62929592|FG000|Overall Study|Withdrawal by Subject|13|||
33539415|NCT04881760|62929593|FG001|Overall Study|Withdrawal by Subject|1|||
33539416|NCT04881760|62929594|FG002|Overall Study|Withdrawal by Subject|1|||
33539417|NCT04881760|62929595|FG003|Overall Study|Withdrawal by Subject|4|||
33539418|NCT04881760|62929596|FG004|Overall Study|Withdrawal by Subject|2|||
33539419|NCT04881760|62929597|FG005|Overall Study|Withdrawal by Subject|1|||
33539420|NCT04881760|62929598|FG006|Overall Study|Withdrawal by Subject|2|||
33539421|NCT04881760|62929592|FG000|Overall Study|Randomized but Never Treated|0|||
33539422|NCT04881760|62929593|FG001|Overall Study|Randomized but Never Treated|0|||
33539423|NCT04881760|62929594|FG002|Overall Study|Randomized but Never Treated|0|||
33539424|NCT04881760|62929595|FG003|Overall Study|Randomized but Never Treated|1|||
33539425|NCT04881760|62929596|FG004|Overall Study|Randomized but Never Treated|0|||
33539426|NCT04881760|62929597|FG005|Overall Study|Randomized but Never Treated|0|||
33539427|NCT04881760|62929598|FG006|Overall Study|Randomized but Never Treated|0|||
33539428|NCT04881760|62929592|FG000|Overall Study|Inadvertent Enrollment|2|||
33539429|NCT04881760|62929593|FG001|Overall Study|Inadvertent Enrollment|0|||
33539430|NCT04881760|62929594|FG002|Overall Study|Inadvertent Enrollment|0|||
33539431|NCT04881760|62929595|FG003|Overall Study|Inadvertent Enrollment|0|||
33539432|NCT04881760|62929596|FG004|Overall Study|Inadvertent Enrollment|0|||
33539433|NCT04881760|62929597|FG005|Overall Study|Inadvertent Enrollment|0|||
33633693|NCT01406938|63035440|FG003|Induction Period|Protocol deviation|0|||
33633694|NCT01406938|63035441|FG004|Induction Period|Protocol deviation|0|||
33633695|NCT01406938|63035442|FG005|Induction Period|Protocol deviation|0|||
33633696|NCT01406938|63035437|FG000|Induction Period|Adverse Event|8|||
33539434|NCT04881760|62929598|FG006|Overall Study|Inadvertent Enrollment|0|||
33539435|NCT04881760|62929592|FG000|Overall Study|Site Closure|0|||
33539436|NCT04881760|62929593|FG001|Overall Study|Site Closure|0|||
33539437|NCT04881760|62929594|FG002|Overall Study|Site Closure|0|||
33539438|NCT04881760|62929595|FG003|Overall Study|Site Closure|1|||
33633697|NCT01406938|63035438|FG001|Induction Period|Adverse Event|9|||
33633698|NCT01406938|63035439|FG002|Induction Period|Adverse Event|0|||
33539439|NCT04881760|62929596|FG004|Overall Study|Site Closure|0|||
33539440|NCT04881760|62929597|FG005|Overall Study|Site Closure|0|||
33539441|NCT04881760|62929598|FG006|Overall Study|Site Closure|0|||
33633699|NCT01406938|63035440|FG003|Induction Period|Adverse Event|0|||
33633700|NCT01406938|63035441|FG004|Induction Period|Adverse Event|0|||
33633701|NCT01406938|63035442|FG005|Induction Period|Adverse Event|0|||
33633702|NCT01406938|63035437|FG000|Induction Period|Lack of Efficacy|1|||
33633703|NCT01406938|63035438|FG001|Induction Period|Lack of Efficacy|0|||
33633704|NCT01406938|63035439|FG002|Induction Period|Lack of Efficacy|0|||
33633705|NCT01406938|63035440|FG003|Induction Period|Lack of Efficacy|0|||
33633706|NCT01406938|63035441|FG004|Induction Period|Lack of Efficacy|0|||
33633707|NCT01406938|63035442|FG005|Induction Period|Lack of Efficacy|0|||
33633708|NCT01406938|63035437|FG000|Induction Period|Lost to Follow-up|2|||
33633709|NCT01406938|63035438|FG001|Induction Period|Lost to Follow-up|3|||
33633710|NCT01406938|63035439|FG002|Induction Period|Lost to Follow-up|0|||
33633711|NCT01406938|63035440|FG003|Induction Period|Lost to Follow-up|0|||
33633712|NCT01406938|63035441|FG004|Induction Period|Lost to Follow-up|0|||
33633713|NCT01406938|63035442|FG005|Induction Period|Lost to Follow-up|0|||
33633714|NCT01406938|63035437|FG000|Maintenance Period|Adverse Event|0|||
33633715|NCT01406938|63035438|FG001|Maintenance Period|Adverse Event|0|||
33633716|NCT01406938|63035439|FG002|Maintenance Period|Adverse Event|2|||
33633717|NCT01406938|63035440|FG003|Maintenance Period|Adverse Event|8|||
33633718|NCT01406938|63035441|FG004|Maintenance Period|Adverse Event|4|||
33633719|NCT01406938|63035442|FG005|Maintenance Period|Adverse Event|2|||
33633720|NCT01406938|63035437|FG000|Maintenance Period|Death|0|||
33633721|NCT01406938|63035438|FG001|Maintenance Period|Death|0|||
33633722|NCT01406938|63035439|FG002|Maintenance Period|Death|0|||
33633723|NCT01406938|63035440|FG003|Maintenance Period|Death|0|||
33633724|NCT01406938|63035441|FG004|Maintenance Period|Death|1|||
33633725|NCT01406938|63035442|FG005|Maintenance Period|Death|0|||
33633726|NCT01406938|63035437|FG000|Maintenance Period|Subject/guardian decision|0|||
33633727|NCT01406938|63035438|FG001|Maintenance Period|Subject/guardian decision|0|||
33633728|NCT01406938|63035439|FG002|Maintenance Period|Subject/guardian decision|11|||
33633729|NCT01406938|63035440|FG003|Maintenance Period|Subject/guardian decision|7|||
33633730|NCT01406938|63035441|FG004|Maintenance Period|Subject/guardian decision|10|||
33633731|NCT01406938|63035442|FG005|Maintenance Period|Subject/guardian decision|7|||
33633732|NCT01406938|63035437|FG000|Maintenance Period|Protocol Violation|0|||
33633733|NCT01406938|63035438|FG001|Maintenance Period|Protocol Violation|0|||
33539442|NCT04749797|62929617|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
33539443|NCT04749797|62929618|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
33539444|NCT04749797|62929619|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
33539445|NCT04747275|62929629|FG000|Overall Study|Study terminated|0|||
33539446|NCT04747275|62929630|FG001|Overall Study|Study terminated|1|||
33539447|NCT04654468|62929636|FG000|Overall Study|Death|1|||
33539448|NCT04654468|62929636|FG000|Overall Study|Ongoing in the Study|50|||
33539449|NCT04556552|62929642|FG000|Overall Study|Lost to Follow-up|1|||
33539450|NCT04556552|62929643|FG001|Overall Study|Lost to Follow-up|0|||
33539451|NCT04556552|62929642|FG000|Overall Study|Claustrophobia|0|||
33539452|NCT04556552|62929643|FG001|Overall Study|Claustrophobia|1|||
33539453|NCT04556552|62929642|FG000|Overall Study|Inability to continue|0|||
33539454|NCT04556552|62929643|FG001|Overall Study|Inability to continue|1|||
33539455|NCT04496167|62929651|FG000|Overall Study|Adverse Event|6|||
33539456|NCT04496167|62929652|FG001|Overall Study|Adverse Event|2|||
33539457|NCT04496167|62929651|FG000|Overall Study|Withdrawal by Subject|7|||
33539458|NCT04496167|62929652|FG001|Overall Study|Withdrawal by Subject|6|||
33539459|NCT04496167|62929651|FG000|Overall Study|Lost to Follow-up|3|||
33539460|NCT04496167|62929652|FG001|Overall Study|Lost to Follow-up|5|||
33539461|NCT04496167|62929651|FG000|Overall Study|Not Treated|1|||
33539462|NCT04496167|62929652|FG001|Overall Study|Not Treated|2|||
33539463|NCT04496167|62929651|FG000|Overall Study|Other Than Specified|1|||
33539464|NCT04496167|62929652|FG001|Overall Study|Other Than Specified|1|||
33539465|NCT04423718|62929686|FG000|Overall Study|Adverse Event|5|||
33539466|NCT04423718|62929687|FG001|Overall Study|Adverse Event|1|||
33539467|NCT04423718|62929688|FG002|Overall Study|Adverse Event|5|||
33539468|NCT04423718|62929686|FG000|Overall Study|Physician Decision|1|||
33539469|NCT04423718|62929687|FG001|Overall Study|Physician Decision|3|||
33539470|NCT04423718|62929688|FG002|Overall Study|Physician Decision|2|||
33633734|NCT01406938|63035439|FG002|Maintenance Period|Protocol Violation|2|||
33539471|NCT04423718|62929686|FG000|Overall Study|Protocol Violation|0|||
33539472|NCT04423718|62929687|FG001|Overall Study|Protocol Violation|1|||
33539473|NCT04423718|62929688|FG002|Overall Study|Protocol Violation|1|||
33539474|NCT04423718|62929686|FG000|Overall Study|Lost to Follow-up|1|||
33539475|NCT04423718|62929687|FG001|Overall Study|Lost to Follow-up|1|||
33633735|NCT01406938|63035440|FG003|Maintenance Period|Protocol Violation|2|||
33539476|NCT04423718|62929688|FG002|Overall Study|Lost to Follow-up|0|||
33539477|NCT04423718|62929686|FG000|Overall Study|Lack of Efficacy|2|||
33539478|NCT04423718|62929687|FG001|Overall Study|Lack of Efficacy|0|||
33539479|NCT04423718|62929688|FG002|Overall Study|Lack of Efficacy|0|||
33633736|NCT01406938|63035441|FG004|Maintenance Period|Protocol Violation|2|||
33633737|NCT01406938|63035442|FG005|Maintenance Period|Protocol Violation|2|||
33633738|NCT01406938|63035437|FG000|Maintenance Period|Pregnancy|0|||
33633739|NCT01406938|63035438|FG001|Maintenance Period|Pregnancy|0|||
33539480|NCT04423718|62929686|FG000|Overall Study|Withdrawal by Subject|5|||
33633740|NCT01406938|63035439|FG002|Maintenance Period|Pregnancy|0|||
33633741|NCT01406938|63035440|FG003|Maintenance Period|Pregnancy|0|||
33633742|NCT01406938|63035441|FG004|Maintenance Period|Pregnancy|1|||
33633743|NCT01406938|63035442|FG005|Maintenance Period|Pregnancy|0|||
33633744|NCT01406938|63035437|FG000|Maintenance Period|Lost to Follow-up|0|||
33633745|NCT01406938|63035438|FG001|Maintenance Period|Lost to Follow-up|0|||
33633746|NCT01406938|63035439|FG002|Maintenance Period|Lost to Follow-up|0|||
33633747|NCT01406938|63035440|FG003|Maintenance Period|Lost to Follow-up|0|||
33633748|NCT01406938|63035441|FG004|Maintenance Period|Lost to Follow-up|4|||
33633749|NCT01406938|63035442|FG005|Maintenance Period|Lost to Follow-up|0|||
33633750|NCT01406938|63035437|FG000|Maintenance Period|Lack of Efficacy|0|||
33633751|NCT01406938|63035438|FG001|Maintenance Period|Lack of Efficacy|0|||
33633752|NCT01406938|63035439|FG002|Maintenance Period|Lack of Efficacy|2|||
33633753|NCT01406938|63035440|FG003|Maintenance Period|Lack of Efficacy|1|||
33633754|NCT01406938|63035441|FG004|Maintenance Period|Lack of Efficacy|3|||
33633755|NCT01406938|63035442|FG005|Maintenance Period|Lack of Efficacy|5|||
33633756|NCT01406938|63035437|FG000|Follow up|Lack of Efficacy|3|||
33633757|NCT01406938|63035438|FG001|Follow up|Lack of Efficacy|2|||
33633758|NCT01406938|63035439|FG002|Follow up|Lack of Efficacy|1|||
33633759|NCT01406938|63035440|FG003|Follow up|Lack of Efficacy|0|||
33633760|NCT01406938|63035441|FG004|Follow up|Lack of Efficacy|0|||
33633761|NCT01406938|63035442|FG005|Follow up|Lack of Efficacy|0|||
33633762|NCT01406938|63035437|FG000|Follow up|Patient/guardian decision|4|||
33633763|NCT01406938|63035438|FG001|Follow up|Patient/guardian decision|2|||
33633764|NCT01406938|63035439|FG002|Follow up|Patient/guardian decision|4|||
33633765|NCT01406938|63035440|FG003|Follow up|Patient/guardian decision|2|||
33633766|NCT01406938|63035441|FG004|Follow up|Patient/guardian decision|4|||
33633767|NCT01406938|63035442|FG005|Follow up|Patient/guardian decision|1|||
33633768|NCT01406938|63035437|FG000|Follow up|Protocol Violation|0|||
33633769|NCT01406938|63035438|FG001|Follow up|Protocol Violation|0|||
33633770|NCT01406938|63035439|FG002|Follow up|Protocol Violation|1|||
33633771|NCT01406938|63035440|FG003|Follow up|Protocol Violation|0|||
33633772|NCT01406938|63035441|FG004|Follow up|Protocol Violation|0|||
33633773|NCT01406938|63035442|FG005|Follow up|Protocol Violation|0|||
33633774|NCT01406938|63035437|FG000|Follow up|Physician Decision|0|||
33633775|NCT01406938|63035438|FG001|Follow up|Physician Decision|0|||
33633776|NCT01406938|63035439|FG002|Follow up|Physician Decision|2|||
33633777|NCT01406938|63035440|FG003|Follow up|Physician Decision|0|||
33633778|NCT01406938|63035441|FG004|Follow up|Physician Decision|3|||
33633779|NCT01406938|63035442|FG005|Follow up|Physician Decision|1|||
33633780|NCT01406938|63035437|FG000|Follow up|Lost to Follow-up|1|||
33633781|NCT01406938|63035438|FG001|Follow up|Lost to Follow-up|1|||
33633782|NCT01406938|63035439|FG002|Follow up|Lost to Follow-up|0|||
33633783|NCT01406938|63035440|FG003|Follow up|Lost to Follow-up|1|||
33633784|NCT01406938|63035441|FG004|Follow up|Lost to Follow-up|2|||
33633785|NCT01406938|63035442|FG005|Follow up|Lost to Follow-up|1|||
33633786|NCT01405924|63035462|FG000|Overall Study|Protocol Violation|8|||
33633787|NCT01405924|63035462|FG000|Overall Study|Missing/Incomplete Data|2|||
33633788|NCT01426438|63035470|FG000|Overall Study|Lost to Follow-up|1|||
33633789|NCT01426438|63035471|FG001|Overall Study|Lost to Follow-up|3|||
33633790|NCT01426438|63035470|FG000|Overall Study|Off study Treatment|9|||
33633791|NCT01426438|63035471|FG001|Overall Study|Off study Treatment|3|||
33633792|NCT01426438|63035470|FG000|Overall Study|Poor scan quality|3|||
33633793|NCT01426438|63035471|FG001|Overall Study|Poor scan quality|2|||
33633794|NCT01426438|63035470|FG000|Overall Study|Missed Scan|2|||
33633795|NCT01426438|63035471|FG001|Overall Study|Missed Scan|2|||
33633796|NCT01425814|63035477|FG000|Period 1|Stability criteria not fulfilled|0|||
33633797|NCT01425814|63035478|FG001|Period 1|Stability criteria not fulfilled|1|||
33633798|NCT01425814|63035479|FG002|Period 1|Stability criteria not fulfilled|0|||
33633799|NCT01425814|63035480|FG003|Period 1|Stability criteria not fulfilled|0|||
33633800|NCT01425814|63035481|FG004|Period 1|Stability criteria not fulfilled|0|||
33633801|NCT01425814|63035482|FG005|Period 1|Stability criteria not fulfilled|0|||
33633802|NCT01425814|63035477|FG000|Period 2|Stability criteria not fulfilled|0|||
33633803|NCT01425814|63035478|FG001|Period 2|Stability criteria not fulfilled|1|||
33461926|NCT03549130|62835779|FG000|Overall Study|Lost to Follow-up|0|||
33633804|NCT01425814|63035479|FG002|Period 2|Stability criteria not fulfilled|0|||
33633805|NCT01425814|63035480|FG003|Period 2|Stability criteria not fulfilled|0|||
33633806|NCT01425814|63035481|FG004|Period 2|Stability criteria not fulfilled|0|||
33633807|NCT01425814|63035482|FG005|Period 2|Stability criteria not fulfilled|0|||
33633808|NCT01425814|63035477|FG000|Period 3|Adverse Event|0|||
33633809|NCT01425814|63035478|FG001|Period 3|Adverse Event|0|||
33633810|NCT01425814|63035479|FG002|Period 3|Adverse Event|0|||
33633811|NCT01425814|63035480|FG003|Period 3|Adverse Event|0|||
33633812|NCT01425814|63035481|FG004|Period 3|Adverse Event|0|||
33633813|NCT01425814|63035482|FG005|Period 3|Adverse Event|1|||
33633814|NCT01425814|63035477|FG000|Period 4|Adverse Event|1|||
33633815|NCT01425814|63035478|FG001|Period 4|Adverse Event|0|||
33633816|NCT01425814|63035479|FG002|Period 4|Adverse Event|1|||
33633817|NCT01425814|63035480|FG003|Period 4|Adverse Event|0|||
33633818|NCT01425814|63035481|FG004|Period 4|Adverse Event|0|||
33633819|NCT01425814|63035482|FG005|Period 4|Adverse Event|0|||
33633820|NCT01425814|63035477|FG000|Period 5|Stability criteria not fulfilled|0|||
33633821|NCT01425814|63035478|FG001|Period 5|Stability criteria not fulfilled|0|||
33633822|NCT01425814|63035479|FG002|Period 5|Stability criteria not fulfilled|1|||
33633823|NCT01425814|63035480|FG003|Period 5|Stability criteria not fulfilled|0|||
33633824|NCT01425814|63035481|FG004|Period 5|Stability criteria not fulfilled|0|||
33633825|NCT01425814|63035482|FG005|Period 5|Stability criteria not fulfilled|1|||
33633826|NCT01782495|63035507|FG000|Overall Study|Adverse Event|0|||
33633827|NCT01782495|63035508|FG001|Overall Study|Adverse Event|0|||
33633828|NCT01782495|63035509|FG002|Overall Study|Adverse Event|0|||
33633829|NCT01782495|63035510|FG003|Overall Study|Adverse Event|0|||
33633830|NCT01782495|63035511|FG004|Overall Study|Adverse Event|0|||
33633831|NCT01782495|63035512|FG005|Overall Study|Adverse Event|0|||
33633832|NCT01782495|63035513|FG006|Overall Study|Adverse Event|0|||
33633833|NCT01782495|63035514|FG007|Overall Study|Adverse Event|2|||
33633834|NCT01782495|63035515|FG008|Overall Study|Adverse Event|0|||
33633835|NCT01782495|63035516|FG009|Overall Study|Adverse Event|0|||
33633836|NCT01782495|63035517|FG010|Overall Study|Adverse Event|0|||
33633837|NCT01782495|63035507|FG000|Overall Study|Withdrew Consent|0|||
33633838|NCT01782495|63035508|FG001|Overall Study|Withdrew Consent|1|||
33633839|NCT01782495|63035509|FG002|Overall Study|Withdrew Consent|0|||
33633840|NCT01782495|63035510|FG003|Overall Study|Withdrew Consent|0|||
33633841|NCT01782495|63035511|FG004|Overall Study|Withdrew Consent|0|||
33633842|NCT01782495|63035512|FG005|Overall Study|Withdrew Consent|0|||
33633843|NCT01782495|63035513|FG006|Overall Study|Withdrew Consent|0|||
33633844|NCT01782495|63035514|FG007|Overall Study|Withdrew Consent|1|||
33633845|NCT01782495|63035515|FG008|Overall Study|Withdrew Consent|0|||
33633846|NCT01782495|63035516|FG009|Overall Study|Withdrew Consent|0|||
33633847|NCT01782495|63035517|FG010|Overall Study|Withdrew Consent|0|||
33633848|NCT01922102|63035544|FG000|Overall Study|Withdrawal by Subject|7|||
33633849|NCT01922102|63035545|FG001|Overall Study|Withdrawal by Subject|3|||
33633850|NCT01922102|63035546|FG002|Overall Study|Withdrawal by Subject|7|||
33633851|NCT01922102|63035544|FG000|Overall Study|Physician Decision|0|||
33633852|NCT01922102|63035545|FG001|Overall Study|Physician Decision|2|||
33633853|NCT01922102|63035546|FG002|Overall Study|Physician Decision|1|||
33539481|NCT04423718|62929687|FG001|Overall Study|Withdrawal by Subject|5|||
33539482|NCT04423718|62929688|FG002|Overall Study|Withdrawal by Subject|12|||
33633854|NCT01922102|63035544|FG000|Overall Study|Adverse Event|1|||
33633855|NCT01922102|63035545|FG001|Overall Study|Adverse Event|2|||
33633856|NCT01922102|63035546|FG002|Overall Study|Adverse Event|0|||
33633857|NCT01922102|63035544|FG000|Overall Study|Lost to Follow-up|1|||
33633858|NCT01922102|63035545|FG001|Overall Study|Lost to Follow-up|0|||
33633859|NCT01922102|63035546|FG002|Overall Study|Lost to Follow-up|0|||
33633860|NCT01922102|63035544|FG000|Overall Study|Administrative problems|0|||
33633861|NCT01922102|63035545|FG001|Overall Study|Administrative problems|2|||
33633862|NCT01922102|63035546|FG002|Overall Study|Administrative problems|0|||
33633863|NCT01405768|63035560|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
33633864|NCT01405768|63035561|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
33633865|NCT01913353|63035569|FG000|Overall Study|Adverse Event|2|||
33633866|NCT01913353|63035570|FG001|Overall Study|Adverse Event|0|||
33633867|NCT01913353|63035569|FG000|Overall Study|Physician Decision|0|||
33461927|NCT03549130|62835780|FG001|Overall Study|Lost to Follow-up|1|||
33539483|NCT04423718|62929686|FG000|Overall Study|Death|5|||
33539484|NCT04423718|62929687|FG001|Overall Study|Death|3|||
33539485|NCT04423718|62929688|FG002|Overall Study|Death|1|||
33633868|NCT01913353|63035570|FG001|Overall Study|Physician Decision|2|||
33461928|NCT03470194|62835790|FG000|Overall Study|Lost to Follow-up|11|||
33461929|NCT03470194|62835791|FG001|Overall Study|Lost to Follow-up|17|||
33461930|NCT03469336|62835797|FG000|Overall Study|Adverse Event|1|||
33461931|NCT03469258|62835807|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
33461932|NCT03503188|62835813|FG000|Overall Study|Non eligible in the sub study|0|||
33461933|NCT03503188|62835814|FG001|Overall Study|Non eligible in the sub study|1|||
33461934|NCT03502798|62835822|FG000|Overall Study|equipment failure|0|||
33539486|NCT04423718|62929686|FG000|Overall Study|COVID-19 pandemic|2|||
33539487|NCT04423718|62929687|FG001|Overall Study|COVID-19 pandemic|2|||
33633869|NCT01913353|63035569|FG000|Overall Study|Withdrawal by Subject|20|||
33633870|NCT01913353|63035570|FG001|Overall Study|Withdrawal by Subject|6|||
33633871|NCT01913353|63035569|FG000|Overall Study|multiple reasons|10|||
33326388|NCT00946647|62703161|FG000|Phase ll Part|Adverse Event|0|||
33633872|NCT01913353|63035570|FG001|Overall Study|multiple reasons|7|||
33633873|NCT01754259|63035585|FG000|Overall Study|Withdrawal by Subject|2|||
33461935|NCT03502798|62835823|FG001|Overall Study|equipment failure|7|||
33461936|NCT00066170|62835833|FG000|Overall Study|Adverse Event|2|||
33461937|NCT00066170|62835834|FG001|Overall Study|Adverse Event|4|||
33633874|NCT01754259|63035586|FG001|Overall Study|Withdrawal by Subject|4|||
33633875|NCT01754259|63035585|FG000|Overall Study|Adverse Event|3|||
33539488|NCT04423718|62929688|FG002|Overall Study|COVID-19 pandemic|2|||
33539489|NCT04423718|62929686|FG000|Overall Study|Other|4|||
33539490|NCT04423718|62929687|FG001|Overall Study|Other|2|||
33539491|NCT04423718|62929688|FG002|Overall Study|Other|2|||
33539492|NCT04423718|62929686|FG000|Overall Study|Unknown if completed study until Week 48|3|||
33539493|NCT04423718|62929687|FG001|Overall Study|Unknown if completed study until Week 48|2|||
33539494|NCT04423718|62929688|FG002|Overall Study|Unknown if completed study until Week 48|1|||
33539495|NCT04238481|62929712|FG000|Overall Study|Miscellaneous|0|||
33539496|NCT04238481|62929713|FG001|Overall Study|Miscellaneous|1|||
33539497|NCT04238481|62929714|FG002|Overall Study|Miscellaneous|0|||
33539498|NCT04238481|62929715|FG003|Overall Study|Miscellaneous|0|||
33539499|NCT04145700|62929727|FG000|Overall Study|Withdrawal by Subject|8|||
33539500|NCT04145700|62929728|FG001|Overall Study|Withdrawal by Subject|3|||
33539501|NCT04079738|62929734|FG000|Study Treatment|Death|1|||
33633876|NCT01754259|63035586|FG001|Overall Study|Adverse Event|1|||
33633877|NCT01754259|63035585|FG000|Overall Study|Lost to Follow-up|0|||
33633878|NCT01754259|63035586|FG001|Overall Study|Lost to Follow-up|1|||
33633879|NCT01405456|63035594|FG000|Overall Study|Lost to Follow-up|2|||
33633880|NCT01405456|63035595|FG001|Overall Study|Lost to Follow-up|1|||
33633881|NCT01405456|63035594|FG000|Overall Study|Physician Decision|1|||
33633882|NCT01405456|63035595|FG001|Overall Study|Physician Decision|0|||
33633883|NCT01404988|63035604|FG000|Overall Study|Death|2|||
33633884|NCT01404988|63035605|FG001|Overall Study|Death|0|||
33633885|NCT01404988|63035606|FG002|Overall Study|Death|2|||
33633886|NCT01404988|63035604|FG000|Overall Study|Adverse Event|1|||
33633887|NCT01404988|63035605|FG001|Overall Study|Adverse Event|0|||
33633888|NCT01404988|63035606|FG002|Overall Study|Adverse Event|0|||
33633889|NCT01404988|63035604|FG000|Overall Study|Withdrawal by Subject|2|||
33633890|NCT01404988|63035605|FG001|Overall Study|Withdrawal by Subject|2|||
33633891|NCT01404988|63035606|FG002|Overall Study|Withdrawal by Subject|0|||
33633892|NCT01404988|63035604|FG000|Overall Study|Lost to Follow-up|1|||
33633893|NCT01404988|63035605|FG001|Overall Study|Lost to Follow-up|2|||
33633894|NCT01404988|63035606|FG002|Overall Study|Lost to Follow-up|1|||
33633895|NCT01389232|63035617|FG000|Overall Study|Had scaffold removed|15|||
33633896|NCT01389232|63035617|FG000|Overall Study|Personal reasons|2|||
33633897|NCT01389232|63035617|FG000|Overall Study|Adverse Event|1|||
33633898|NCT01389232|63035617|FG000|Overall Study|Death|1|||
33633899|NCT01404208|63035633|FG000|Overall Study|Discontinued|3|||
33633900|NCT01404208|63035634|FG001|Overall Study|Discontinued|0|||
33633901|NCT01617668|63035642|FG000|Overall Study|Adverse Event|7|||
33633902|NCT01617668|63035643|FG001|Overall Study|Adverse Event|0|||
33633903|NCT01617668|63035644|FG002|Overall Study|Adverse Event|12|||
33633904|NCT01617668|63035645|FG003|Overall Study|Adverse Event|5|||
33633905|NCT01617668|63035642|FG000|Overall Study|Physician Decision|1|||
33633906|NCT01617668|63035643|FG001|Overall Study|Physician Decision|2|||
33633907|NCT01617668|63035644|FG002|Overall Study|Physician Decision|3|||
33633908|NCT01617668|63035645|FG003|Overall Study|Physician Decision|0|||
33633909|NCT01617668|63035642|FG000|Overall Study|Progressive Disease|4|||
33633910|NCT01617668|63035643|FG001|Overall Study|Progressive Disease|4|||
33633911|NCT01617668|63035644|FG002|Overall Study|Progressive Disease|6|||
33633912|NCT01617668|63035645|FG003|Overall Study|Progressive Disease|9|||
33633913|NCT01617668|63035642|FG000|Overall Study|Subject/guardian decision|1|||
33633914|NCT01617668|63035643|FG001|Overall Study|Subject/guardian decision|3|||
33633915|NCT01617668|63035644|FG002|Overall Study|Subject/guardian decision|2|||
33633916|NCT01617668|63035645|FG003|Overall Study|Subject/guardian decision|1|||
33633917|NCT01425268|63035661|FG000|Overall Study|Withdrawal by Subject|2|||
33633918|NCT01425268|63035662|FG001|Overall Study|Withdrawal by Subject|0|||
33633919|NCT01425268|63035661|FG000|Overall Study|Sponsor Decision|5|||
33633920|NCT01425268|63035662|FG001|Overall Study|Sponsor Decision|0|||
33633921|NCT01425268|63035661|FG000|Overall Study|Physician Decision|1|||
33633922|NCT01425268|63035662|FG001|Overall Study|Physician Decision|0|||
33539502|NCT04079738|62929735|FG001|Study Treatment|Death|0|||
33539503|NCT04079738|62929736|FG002|Study Treatment|Death|0|||
33539504|NCT04079738|62929737|FG003|Study Treatment|Death|0|||
33539505|NCT04079738|62929734|FG000|Study Treatment|Adverse Event|2|||
33539506|NCT04079738|62929735|FG001|Study Treatment|Adverse Event|0|||
33539507|NCT04079738|62929736|FG002|Study Treatment|Adverse Event|0|||
33633923|NCT01425190|63035671|FG000|Overall Study|Full dose not consumed.|1|||
33633924|NCT01425190|63035672|FG001|Overall Study|Full dose not consumed.|0|||
33633925|NCT01425190|63035673|FG002|Overall Study|Full dose not consumed.|0|||
33633926|NCT01388530|63035681|FG000|Overall Study|Lost to Follow-up|5|||
33633927|NCT01895270|63035687|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
33633928|NCT01895270|63035688|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
33633929|NCT01895270|63035687|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
33633930|NCT01895270|63035688|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
33539508|NCT04079738|62929737|FG003|Study Treatment|Adverse Event|0|||
33539509|NCT04079738|62929734|FG000|Study Treatment|withdrawal before treatment|1|||
33633931|NCT01895270|63035687|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
33633932|NCT01895270|63035688|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
33633933|NCT01895270|63035687|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
33633934|NCT01895270|63035688|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
33326389|NCT00946647|62703162|FG001|Phase ll Part|Adverse Event|0|||
33326390|NCT00946647|62703163|FG002|Phase ll Part|Adverse Event|0|||
33326391|NCT00946647|62703164|FG003|Phase ll Part|Adverse Event|10|||
33326392|NCT00946647|62703165|FG004|Phase ll Part|Adverse Event|6|||
33326393|NCT00946647|62703161|FG000|Phase ll Part|Withdrawal by Subject|0|||
33326394|NCT00946647|62703162|FG001|Phase ll Part|Withdrawal by Subject|0|||
33326395|NCT00946647|62703163|FG002|Phase ll Part|Withdrawal by Subject|0|||
33326396|NCT00946647|62703164|FG003|Phase ll Part|Withdrawal by Subject|8|||
33326397|NCT00946647|62703165|FG004|Phase ll Part|Withdrawal by Subject|6|||
33539510|NCT04079738|62929735|FG001|Study Treatment|withdrawal before treatment|0|||
33539511|NCT04079738|62929736|FG002|Study Treatment|withdrawal before treatment|0|||
33539512|NCT04079738|62929737|FG003|Study Treatment|withdrawal before treatment|0|||
33633935|NCT01895270|63035687|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
33633936|NCT01895270|63035688|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
33633937|NCT01895270|63035687|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
33633938|NCT01895270|63035688|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
33539513|NCT04079738|62929734|FG000|Study Treatment|symptomatic deterioration|2|||
33633939|NCT01895270|63035687|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
33633940|NCT01895270|63035688|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
33633941|NCT01424722|63035694|FG000|Overall Study|Sponsor terminated investigation|2258|||
33633942|NCT01424644|63035700|FG000|Overall Study|Adverse Event|2|||
33633943|NCT01424644|63035701|FG001|Overall Study|Adverse Event|0|||
33633944|NCT01424644|63035700|FG000|Overall Study|Withdrawal by Subject|9|||
33633945|NCT01424644|63035701|FG001|Overall Study|Withdrawal by Subject|12|||
33633946|NCT01424644|63035700|FG000|Overall Study|Lost to Follow-up|16|||
33633947|NCT01424644|63035701|FG001|Overall Study|Lost to Follow-up|12|||
33633948|NCT01424644|63035700|FG000|Overall Study|Protocol Violation|4|||
33633949|NCT01424644|63035701|FG001|Overall Study|Protocol Violation|3|||
33633950|NCT01424644|63035700|FG000|Overall Study|Administrative Reason|1|||
33633951|NCT01424644|63035701|FG001|Overall Study|Administrative Reason|0|||
33633952|NCT01424644|63035700|FG000|Overall Study|Unable to Classify|1|||
33633953|NCT01424644|63035701|FG001|Overall Study|Unable to Classify|0|||
33633954|NCT01920854|63035714|FG000|Overall Study|Withdrawal by Subject|1|||
33633955|NCT01920854|63035715|FG001|Overall Study|Withdrawal by Subject|0|||
33633956|NCT01920854|63035716|FG002|Overall Study|Withdrawal by Subject|0|||
33633957|NCT01920854|63035717|FG003|Overall Study|Withdrawal by Subject|0|||
33633958|NCT01920854|63035718|FG004|Overall Study|Withdrawal by Subject|1|||
33633959|NCT01920854|63035719|FG005|Overall Study|Withdrawal by Subject|0|||
33633960|NCT01920854|63035720|FG006|Overall Study|Withdrawal by Subject|1|||
33633961|NCT01403194|63035755|FG000|Overall Study|Screen Failure|2|||
33633962|NCT01403194|63035755|FG000|Overall Study|Lost to Follow-up|8|||
33633963|NCT01403116|63035761|FG000|Overall Study|Adverse Event|7|||
33633964|NCT01403116|63035762|FG001|Overall Study|Adverse Event|4|||
33633965|NCT01403116|63035761|FG000|Overall Study|Lost to Follow-up|7|||
33633966|NCT01403116|63035762|FG001|Overall Study|Lost to Follow-up|5|||
33633967|NCT01403116|63035761|FG000|Overall Study|Withdrawal by Subject|12|||
33633968|NCT01403116|63035762|FG001|Overall Study|Withdrawal by Subject|15|||
33633969|NCT01403116|63035761|FG000|Overall Study|Non-compliance of study drug|3|||
33633970|NCT01403116|63035762|FG001|Overall Study|Non-compliance of study drug|0|||
33633971|NCT01403116|63035761|FG000|Overall Study|Protocol Violation|0|||
33633972|NCT01403116|63035762|FG001|Overall Study|Protocol Violation|1|||
33633973|NCT01403116|63035761|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
33461938|NCT00066170|62835835|FG002|Overall Study|Adverse Event|1|||
33461939|NCT00066170|62835836|FG003|Overall Study|Adverse Event|7|||
33461940|NCT00066170|62835833|FG000|Overall Study|Serious Adverse Event|0|||
33461941|NCT00066170|62835834|FG001|Overall Study|Serious Adverse Event|0|||
33461942|NCT00066170|62835835|FG002|Overall Study|Serious Adverse Event|1|||
33461943|NCT00066170|62835836|FG003|Overall Study|Serious Adverse Event|1|||
33461944|NCT00066170|62835833|FG000|Overall Study|Lost to Follow-up|0|||
33461945|NCT00066170|62835834|FG001|Overall Study|Lost to Follow-up|1|||
33461946|NCT00066170|62835835|FG002|Overall Study|Lost to Follow-up|0|||
33461947|NCT00066170|62835836|FG003|Overall Study|Lost to Follow-up|0|||
33633974|NCT01403116|63035762|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
33633975|NCT01403116|63035761|FG000|Overall Study|Hct >54%|2|||
33633976|NCT01403116|63035762|FG001|Overall Study|Hct >54%|0|||
33633977|NCT01403116|63035761|FG000|Overall Study|unable to keep appointments|0|||
33633978|NCT01403116|63035762|FG001|Overall Study|unable to keep appointments|2|||
33326398|NCT00946647|62703161|FG000|Phase ll Part|Administrative problems|0|||
33326399|NCT00946647|62703162|FG001|Phase ll Part|Administrative problems|0|||
33326400|NCT00946647|62703163|FG002|Phase ll Part|Administrative problems|0|||
33326401|NCT00946647|62703164|FG003|Phase ll Part|Administrative problems|3|||
33633979|NCT01402570|63035768|FG000|Overall Study|Adverse Event|1|||
33633980|NCT01753401|63035775|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
33633981|NCT01753401|63035776|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
33633982|NCT01753401|63035777|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
33539514|NCT04079738|62929735|FG001|Study Treatment|symptomatic deterioration|0|||
33539515|NCT04079738|62929736|FG002|Study Treatment|symptomatic deterioration|0|||
33539516|NCT04079738|62929737|FG003|Study Treatment|symptomatic deterioration|0|||
33539517|NCT04079738|62929734|FG000|Study Treatment|Disease Progression|1|||
33539518|NCT04079738|62929735|FG001|Study Treatment|Disease Progression|0|||
33539519|NCT04079738|62929736|FG002|Study Treatment|Disease Progression|0|||
33539520|NCT04079738|62929737|FG003|Study Treatment|Disease Progression|0|||
33539521|NCT04079738|62929734|FG000|Study Treatment|withdrawal after treatment|1|||
33539522|NCT04079738|62929735|FG001|Study Treatment|withdrawal after treatment|0|||
33539523|NCT04079738|62929736|FG002|Study Treatment|withdrawal after treatment|0|||
33539524|NCT04079738|62929737|FG003|Study Treatment|withdrawal after treatment|0|||
33539525|NCT04079738|62929734|FG000|Follow up|Withdrawal by Subject|3|||
33539526|NCT04079738|62929735|FG001|Follow up|Withdrawal by Subject|0|||
33539527|NCT04079738|62929736|FG002|Follow up|Withdrawal by Subject|0|||
33539528|NCT04079738|62929737|FG003|Follow up|Withdrawal by Subject|0|||
33539529|NCT04079738|62929734|FG000|Follow up|Death|5|||
33539530|NCT04079738|62929735|FG001|Follow up|Death|0|||
33539531|NCT04079738|62929736|FG002|Follow up|Death|0|||
33539532|NCT04079738|62929737|FG003|Follow up|Death|0|||
33539533|NCT04054635|62929746|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
33539534|NCT04054635|62929747|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
33539535|NCT04054635|62929748|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
33539536|NCT04054635|62929746|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
33539537|NCT04054635|62929747|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
33539538|NCT04054635|62929748|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
33539539|NCT03820726|62929756|FG000|Overall Study|Other than listed|23|||
33539540|NCT03820726|62929756|FG000|Overall Study|Withdrawal by Subject|37|||
33539541|NCT03820726|62929756|FG000|Overall Study|Lost to Follow-up|3|||
33539542|NCT03820726|62929756|FG000|Overall Study|Protocol deviation|1|||
33539543|NCT03820726|62929756|FG000|Overall Study|Adverse Event|146|||
33539544|NCT03820726|62929756|FG000|Overall Study|Not treated|1|||
33539545|NCT03744312|62929762|FG000|Overall Study|Withdrawal by Subject|0|||
33539546|NCT03744312|62929763|FG001|Overall Study|Withdrawal by Subject|1|||
33539547|NCT03744312|62929762|FG000|Overall Study|Screen fail|0|||
33539548|NCT03744312|62929763|FG001|Overall Study|Screen fail|1|||
33539549|NCT03737123|62929771|FG000|Study Treatment|Adverse Event|2|||
33539550|NCT03737123|62929772|FG001|Study Treatment|Adverse Event|0|||
33539551|NCT03737123|62929771|FG000|Study Treatment|Disease Progression|2|||
33539552|NCT03737123|62929772|FG001|Study Treatment|Disease Progression|0|||
33539553|NCT03737123|62929771|FG000|Study Treatment|Withdrawal by Subject|2|||
33539554|NCT03737123|62929772|FG001|Study Treatment|Withdrawal by Subject|0|||
33539555|NCT03737123|62929771|FG000|Follow up|Death|1|||
33539556|NCT03737123|62929772|FG001|Follow up|Death|0|||
33539557|NCT03737123|62929771|FG000|Follow up|Withdrawal by Subject|1|||
33539558|NCT03737123|62929772|FG001|Follow up|Withdrawal by Subject|0|||
33539559|NCT03737123|62929771|FG000|Follow up|Termination of study|4|||
33539560|NCT03737123|62929772|FG001|Follow up|Termination of study|0|||
33539561|NCT03502707|62929804|FG000|Overall Study|Adverse Event|0|||
33539562|NCT03502707|62929805|FG001|Overall Study|Adverse Event|0|||
33539563|NCT03502707|62929806|FG002|Overall Study|Adverse Event|0|||
33539564|NCT03502707|62929807|FG003|Overall Study|Adverse Event|0|||
33539565|NCT03502707|62929808|FG004|Overall Study|Adverse Event|0|||
33633983|NCT01753401|63035778|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
33633984|NCT01753401|63035775|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
33633985|NCT01753401|63035776|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
33633986|NCT01753401|63035777|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
33539566|NCT03502707|62929809|FG005|Overall Study|Adverse Event|0|||
33539567|NCT03502707|62929810|FG006|Overall Study|Adverse Event|0|||
33539568|NCT03502707|62929811|FG007|Overall Study|Adverse Event|0|||
33539569|NCT03502707|62929812|FG008|Overall Study|Adverse Event|0|||
33539570|NCT03502707|62929813|FG009|Overall Study|Adverse Event|0|||
33539571|NCT03502707|62929814|FG010|Overall Study|Adverse Event|0|||
33539572|NCT03502707|62929815|FG011|Overall Study|Adverse Event|0|||
33539573|NCT03502707|62929816|FG012|Overall Study|Adverse Event|0|||
33539574|NCT03502707|62929817|FG013|Overall Study|Adverse Event|0|||
33539575|NCT03502707|62929818|FG014|Overall Study|Adverse Event|0|||
33539576|NCT03502707|62929819|FG015|Overall Study|Adverse Event|1|||
33539577|NCT03502707|62929820|FG016|Overall Study|Adverse Event|5|||
33539578|NCT03502707|62929821|FG017|Overall Study|Adverse Event|0|||
33539579|NCT03502707|62929804|FG000|Overall Study|Death|0|||
33539580|NCT03502707|62929805|FG001|Overall Study|Death|0|||
33539581|NCT03502707|62929806|FG002|Overall Study|Death|0|||
33539582|NCT03502707|62929807|FG003|Overall Study|Death|1|||
33539583|NCT03502707|62929808|FG004|Overall Study|Death|0|||
33539584|NCT03502707|62929809|FG005|Overall Study|Death|0|||
33539585|NCT03502707|62929810|FG006|Overall Study|Death|0|||
33539586|NCT03502707|62929811|FG007|Overall Study|Death|0|||
33539587|NCT03502707|62929812|FG008|Overall Study|Death|1|||
33539588|NCT03502707|62929813|FG009|Overall Study|Death|1|||
33539589|NCT03502707|62929814|FG010|Overall Study|Death|0|||
33539590|NCT03502707|62929815|FG011|Overall Study|Death|0|||
33539591|NCT03502707|62929816|FG012|Overall Study|Death|1|||
33539592|NCT03502707|62929817|FG013|Overall Study|Death|0|||
33539593|NCT03502707|62929818|FG014|Overall Study|Death|0|||
33539594|NCT03502707|62929819|FG015|Overall Study|Death|1|||
33539595|NCT03502707|62929820|FG016|Overall Study|Death|0|||
33539596|NCT03502707|62929821|FG017|Overall Study|Death|0|||
33539597|NCT03502707|62929804|FG000|Overall Study|Lost to Follow-up|0|||
33539598|NCT03502707|62929805|FG001|Overall Study|Lost to Follow-up|0|||
33539599|NCT03502707|62929806|FG002|Overall Study|Lost to Follow-up|0|||
33539600|NCT03502707|62929807|FG003|Overall Study|Lost to Follow-up|0|||
33539601|NCT03502707|62929808|FG004|Overall Study|Lost to Follow-up|0|||
33539602|NCT03502707|62929809|FG005|Overall Study|Lost to Follow-up|0|||
33539603|NCT03502707|62929810|FG006|Overall Study|Lost to Follow-up|0|||
33539604|NCT03502707|62929811|FG007|Overall Study|Lost to Follow-up|5|||
33539605|NCT03502707|62929812|FG008|Overall Study|Lost to Follow-up|0|||
33539606|NCT03502707|62929813|FG009|Overall Study|Lost to Follow-up|2|||
33539607|NCT03502707|62929814|FG010|Overall Study|Lost to Follow-up|1|||
33539608|NCT03502707|62929815|FG011|Overall Study|Lost to Follow-up|2|||
33539609|NCT03502707|62929816|FG012|Overall Study|Lost to Follow-up|1|||
33539610|NCT03502707|62929817|FG013|Overall Study|Lost to Follow-up|1|||
33539611|NCT03502707|62929818|FG014|Overall Study|Lost to Follow-up|0|||
33539612|NCT03502707|62929819|FG015|Overall Study|Lost to Follow-up|4|||
33539613|NCT03502707|62929820|FG016|Overall Study|Lost to Follow-up|9|||
33539614|NCT03502707|62929821|FG017|Overall Study|Lost to Follow-up|2|||
33539615|NCT03502707|62929804|FG000|Overall Study|Physician Decision|0|||
33539616|NCT03502707|62929805|FG001|Overall Study|Physician Decision|0|||
33539617|NCT03502707|62929806|FG002|Overall Study|Physician Decision|0|||
33539618|NCT03502707|62929807|FG003|Overall Study|Physician Decision|0|||
33539619|NCT03502707|62929808|FG004|Overall Study|Physician Decision|0|||
33539620|NCT03502707|62929809|FG005|Overall Study|Physician Decision|0|||
33539621|NCT03502707|62929810|FG006|Overall Study|Physician Decision|0|||
33539622|NCT03502707|62929811|FG007|Overall Study|Physician Decision|0|||
33461948|NCT00066170|62835833|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
33461949|NCT00066170|62835834|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
33461950|NCT00066170|62835835|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
33461951|NCT00066170|62835836|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
33461952|NCT00066170|62835833|FG000|Overall Study|Protocol Violation|3|||
33461953|NCT00066170|62835834|FG001|Overall Study|Protocol Violation|0|||
33461954|NCT00066170|62835835|FG002|Overall Study|Protocol Violation|0|||
33461955|NCT00066170|62835836|FG003|Overall Study|Protocol Violation|0|||
33461956|NCT00066170|62835833|FG000|Overall Study|Other|1|||
33461957|NCT00066170|62835834|FG001|Overall Study|Other|5|||
33461958|NCT00066170|62835835|FG002|Overall Study|Other|2|||
33461959|NCT00066170|62835836|FG003|Overall Study|Other|0|||
33461960|NCT00065468|62835849|FG000|Overall Study|Death|172|||
33461961|NCT00065468|62835850|FG001|Overall Study|Death|169|||
33461962|NCT00065468|62835851|FG002|Overall Study|Death|171|||
33461963|NCT00065468|62835849|FG000|Overall Study|Withdrawal by Subject|3|||
33461964|NCT00065468|62835850|FG001|Overall Study|Withdrawal by Subject|4|||
33461965|NCT00065468|62835851|FG002|Overall Study|Withdrawal by Subject|5|||
33461966|NCT00065468|62835849|FG000|Overall Study|Lost to Follow-up|5|||
33461967|NCT00065468|62835850|FG001|Overall Study|Lost to Follow-up|3|||
33461968|NCT00065468|62835851|FG002|Overall Study|Lost to Follow-up|2|||
33461969|NCT00065468|62835849|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
33461970|NCT00065468|62835850|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
33461971|NCT00065468|62835851|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
33461972|NCT00065468|62835849|FG000|Overall Study|Disease progression|0|||
33461973|NCT00065468|62835850|FG001|Overall Study|Disease progression|0|||
33461974|NCT00065468|62835851|FG002|Overall Study|Disease progression|1|||
33461975|NCT00065468|62835849|FG000|Overall Study|Other|14|||
33539623|NCT03502707|62929812|FG008|Overall Study|Physician Decision|2|||
33539624|NCT03502707|62929813|FG009|Overall Study|Physician Decision|1|||
33539625|NCT03502707|62929814|FG010|Overall Study|Physician Decision|0|||
33539626|NCT03502707|62929815|FG011|Overall Study|Physician Decision|0|||
33539627|NCT03502707|62929816|FG012|Overall Study|Physician Decision|0|||
33539628|NCT03502707|62929817|FG013|Overall Study|Physician Decision|0|||
33539629|NCT03502707|62929818|FG014|Overall Study|Physician Decision|1|||
33539630|NCT03502707|62929819|FG015|Overall Study|Physician Decision|3|||
33539631|NCT03502707|62929820|FG016|Overall Study|Physician Decision|0|||
33539632|NCT03502707|62929821|FG017|Overall Study|Physician Decision|0|||
33461976|NCT00065468|62835850|FG001|Overall Study|Other|24|||
33539633|NCT03502707|62929804|FG000|Overall Study|Protocol Violation|0|||
33539634|NCT03502707|62929805|FG001|Overall Study|Protocol Violation|0|||
33539635|NCT03502707|62929806|FG002|Overall Study|Protocol Violation|0|||
33539636|NCT03502707|62929807|FG003|Overall Study|Protocol Violation|0|||
33539637|NCT03502707|62929808|FG004|Overall Study|Protocol Violation|0|||
33539638|NCT03502707|62929809|FG005|Overall Study|Protocol Violation|0|||
33539639|NCT03502707|62929810|FG006|Overall Study|Protocol Violation|0|||
33539640|NCT03502707|62929811|FG007|Overall Study|Protocol Violation|0|||
33539641|NCT03502707|62929812|FG008|Overall Study|Protocol Violation|0|||
33539642|NCT03502707|62929813|FG009|Overall Study|Protocol Violation|0|||
33539643|NCT03502707|62929814|FG010|Overall Study|Protocol Violation|0|||
33539644|NCT03502707|62929815|FG011|Overall Study|Protocol Violation|0|||
33539645|NCT03502707|62929816|FG012|Overall Study|Protocol Violation|0|||
33539646|NCT03502707|62929817|FG013|Overall Study|Protocol Violation|0|||
33539647|NCT03502707|62929818|FG014|Overall Study|Protocol Violation|0|||
33539648|NCT03502707|62929819|FG015|Overall Study|Protocol Violation|1|||
33539649|NCT03502707|62929820|FG016|Overall Study|Protocol Violation|0|||
33539650|NCT03502707|62929821|FG017|Overall Study|Protocol Violation|0|||
33539651|NCT03502707|62929804|FG000|Overall Study|Withdrawal by Subject|1|||
33539652|NCT03502707|62929805|FG001|Overall Study|Withdrawal by Subject|1|||
33539653|NCT03502707|62929806|FG002|Overall Study|Withdrawal by Subject|0|||
33539654|NCT03502707|62929807|FG003|Overall Study|Withdrawal by Subject|0|||
33539655|NCT03502707|62929808|FG004|Overall Study|Withdrawal by Subject|0|||
33539656|NCT03502707|62929809|FG005|Overall Study|Withdrawal by Subject|2|||
33539657|NCT03502707|62929810|FG006|Overall Study|Withdrawal by Subject|0|||
33539658|NCT03502707|62929811|FG007|Overall Study|Withdrawal by Subject|3|||
33539659|NCT03502707|62929812|FG008|Overall Study|Withdrawal by Subject|1|||
33539660|NCT03502707|62929813|FG009|Overall Study|Withdrawal by Subject|2|||
33539661|NCT03502707|62929814|FG010|Overall Study|Withdrawal by Subject|12|||
33539662|NCT03502707|62929815|FG011|Overall Study|Withdrawal by Subject|23|||
33539663|NCT03502707|62929816|FG012|Overall Study|Withdrawal by Subject|5|||
33539664|NCT03502707|62929817|FG013|Overall Study|Withdrawal by Subject|3|||
33539665|NCT03502707|62929818|FG014|Overall Study|Withdrawal by Subject|3|||
33539666|NCT03502707|62929819|FG015|Overall Study|Withdrawal by Subject|43|||
33539667|NCT03502707|62929820|FG016|Overall Study|Withdrawal by Subject|44|||
33539668|NCT03502707|62929821|FG017|Overall Study|Withdrawal by Subject|18|||
33539669|NCT03502707|62929804|FG000|Overall Study|Sponsor's Decision|1|||
33539670|NCT03502707|62929805|FG001|Overall Study|Sponsor's Decision|0|||
33539671|NCT03502707|62929806|FG002|Overall Study|Sponsor's Decision|0|||
33539672|NCT03502707|62929807|FG003|Overall Study|Sponsor's Decision|0|||
33539673|NCT03502707|62929808|FG004|Overall Study|Sponsor's Decision|0|||
33539674|NCT03502707|62929809|FG005|Overall Study|Sponsor's Decision|0|||
33539675|NCT03502707|62929810|FG006|Overall Study|Sponsor's Decision|0|||
33539676|NCT03502707|62929811|FG007|Overall Study|Sponsor's Decision|0|||
33539677|NCT03502707|62929812|FG008|Overall Study|Sponsor's Decision|0|||
33539678|NCT03502707|62929813|FG009|Overall Study|Sponsor's Decision|1|||
33539679|NCT03502707|62929814|FG010|Overall Study|Sponsor's Decision|0|||
33539680|NCT03502707|62929815|FG011|Overall Study|Sponsor's Decision|0|||
33539681|NCT03502707|62929816|FG012|Overall Study|Sponsor's Decision|0|||
33539682|NCT03502707|62929817|FG013|Overall Study|Sponsor's Decision|0|||
33539683|NCT03502707|62929818|FG014|Overall Study|Sponsor's Decision|0|||
33539684|NCT03502707|62929819|FG015|Overall Study|Sponsor's Decision|2|||
33539685|NCT03502707|62929820|FG016|Overall Study|Sponsor's Decision|1|||
33539686|NCT03502707|62929821|FG017|Overall Study|Sponsor's Decision|0|||
33539687|NCT03502707|62929804|FG000|Overall Study|Initiated Prohibited Medication|0|||
33539688|NCT03502707|62929805|FG001|Overall Study|Initiated Prohibited Medication|0|||
33539689|NCT03502707|62929806|FG002|Overall Study|Initiated Prohibited Medication|0|||
33539690|NCT03502707|62929807|FG003|Overall Study|Initiated Prohibited Medication|0|||
33539691|NCT03502707|62929808|FG004|Overall Study|Initiated Prohibited Medication|0|||
33539692|NCT03502707|62929809|FG005|Overall Study|Initiated Prohibited Medication|0|||
33539693|NCT03502707|62929810|FG006|Overall Study|Initiated Prohibited Medication|0|||
33539694|NCT03502707|62929811|FG007|Overall Study|Initiated Prohibited Medication|0|||
33539695|NCT03502707|62929812|FG008|Overall Study|Initiated Prohibited Medication|0|||
33539696|NCT03502707|62929813|FG009|Overall Study|Initiated Prohibited Medication|0|||
33539697|NCT03502707|62929814|FG010|Overall Study|Initiated Prohibited Medication|0|||
33539698|NCT03502707|62929815|FG011|Overall Study|Initiated Prohibited Medication|0|||
33539699|NCT03502707|62929816|FG012|Overall Study|Initiated Prohibited Medication|0|||
33539700|NCT03502707|62929817|FG013|Overall Study|Initiated Prohibited Medication|0|||
33539701|NCT03502707|62929818|FG014|Overall Study|Initiated Prohibited Medication|0|||
33539702|NCT03502707|62929819|FG015|Overall Study|Initiated Prohibited Medication|0|||
33539703|NCT03502707|62929820|FG016|Overall Study|Initiated Prohibited Medication|1|||
33539704|NCT03502707|62929821|FG017|Overall Study|Initiated Prohibited Medication|0|||
33539705|NCT03502707|62929804|FG000|Overall Study|Other|0|||
33539706|NCT03502707|62929805|FG001|Overall Study|Other|0|||
33539707|NCT03502707|62929806|FG002|Overall Study|Other|0|||
33539708|NCT03502707|62929807|FG003|Overall Study|Other|0|||
33539709|NCT03502707|62929808|FG004|Overall Study|Other|0|||
33539710|NCT03502707|62929809|FG005|Overall Study|Other|0|||
33539711|NCT03502707|62929810|FG006|Overall Study|Other|0|||
33539712|NCT03502707|62929811|FG007|Overall Study|Other|0|||
33539713|NCT03502707|62929812|FG008|Overall Study|Other|1|||
33539714|NCT03502707|62929813|FG009|Overall Study|Other|1|||
33539715|NCT03502707|62929814|FG010|Overall Study|Other|2|||
33539716|NCT03502707|62929815|FG011|Overall Study|Other|0|||
33539717|NCT03502707|62929816|FG012|Overall Study|Other|0|||
33539718|NCT03502707|62929817|FG013|Overall Study|Other|0|||
33539719|NCT03502707|62929818|FG014|Overall Study|Other|0|||
33539720|NCT03502707|62929819|FG015|Overall Study|Other|4|||
33539721|NCT03502707|62929820|FG016|Overall Study|Other|1|||
33539722|NCT03502707|62929821|FG017|Overall Study|Other|0|||
33539723|NCT03502707|62929804|FG000|Overall Study|Randomized but not vaccinated|0|||
33539724|NCT03502707|62929805|FG001|Overall Study|Randomized but not vaccinated|0|||
33539725|NCT03502707|62929806|FG002|Overall Study|Randomized but not vaccinated|0|||
33539726|NCT03502707|62929807|FG003|Overall Study|Randomized but not vaccinated|0|||
33539727|NCT03502707|62929808|FG004|Overall Study|Randomized but not vaccinated|0|||
33539728|NCT03502707|62929809|FG005|Overall Study|Randomized but not vaccinated|0|||
33539729|NCT03502707|62929810|FG006|Overall Study|Randomized but not vaccinated|0|||
33539730|NCT03502707|62929811|FG007|Overall Study|Randomized but not vaccinated|0|||
33539731|NCT03502707|62929812|FG008|Overall Study|Randomized but not vaccinated|0|||
33539732|NCT03502707|62929813|FG009|Overall Study|Randomized but not vaccinated|0|||
33539733|NCT03502707|62929814|FG010|Overall Study|Randomized but not vaccinated|0|||
33539734|NCT03502707|62929815|FG011|Overall Study|Randomized but not vaccinated|1|||
33539735|NCT03502707|62929816|FG012|Overall Study|Randomized but not vaccinated|0|||
33539736|NCT03502707|62929817|FG013|Overall Study|Randomized but not vaccinated|0|||
33539737|NCT03502707|62929818|FG014|Overall Study|Randomized but not vaccinated|0|||
33539738|NCT03502707|62929819|FG015|Overall Study|Randomized but not vaccinated|0|||
33539739|NCT03502707|62929820|FG016|Overall Study|Randomized but not vaccinated|0|||
33539740|NCT03502707|62929821|FG017|Overall Study|Randomized but not vaccinated|1|||
33539741|NCT03425006|62929871|FG000|Overall Study|Withdrawal by Subject|1|||
33539742|NCT03425006|62929871|FG000|Overall Study|Physician Decision|1|||
33539743|NCT03425006|62929871|FG000|Overall Study|Death|1|||
33539744|NCT03401073|62929877|FG000|Overall Study|Lost to Follow-up|1|||
33539745|NCT03401073|62929878|FG001|Overall Study|Lost to Follow-up|2|||
33539746|NCT03299049|62929886|FG000|Overall Study|On-going|486|||
33539747|NCT03299049|62929887|FG001|Overall Study|On-going|481|||
33539748|NCT03299049|62929886|FG000|Overall Study|Withdrawal by Subject|6|||
33539749|NCT03299049|62929887|FG001|Overall Study|Withdrawal by Subject|21|||
33539750|NCT03299049|62929886|FG000|Overall Study|Physician Decision|5|||
33539751|NCT03299049|62929887|FG001|Overall Study|Physician Decision|1|||
33539752|NCT03299049|62929886|FG000|Overall Study|Lost to Follow-up|2|||
33539753|NCT03299049|62929887|FG001|Overall Study|Lost to Follow-up|0|||
33539754|NCT03299049|62929886|FG000|Overall Study|Pregnancy|1|||
33539755|NCT03299049|62929887|FG001|Overall Study|Pregnancy|3|||
33539756|NCT03299049|62929886|FG000|Overall Study|Protocol Violation|1|||
33539757|NCT03299049|62929887|FG001|Overall Study|Protocol Violation|1|||
33539758|NCT03299049|62929886|FG000|Overall Study|Lack of Efficacy|9|||
33539759|NCT03299049|62929887|FG001|Overall Study|Lack of Efficacy|3|||
33539760|NCT03299049|62929886|FG000|Overall Study|Adverse Event|12|||
33539761|NCT03299049|62929887|FG001|Overall Study|Adverse Event|13|||
33539762|NCT03253679|62929904|FG000|Overall Study|Screen Failure|1|||
33539763|NCT03173560|62929910|FG000|Overall Study|Ongoing on Treatment|38|||
33539764|NCT03173560|62929911|FG001|Overall Study|Ongoing on Treatment|50|||
33539765|NCT03173560|62929910|FG000|Overall Study|Ongoing Survival Follow-up|56|||
33539766|NCT03173560|62929911|FG001|Overall Study|Ongoing Survival Follow-up|57|||
33539767|NCT03173560|62929910|FG000|Overall Study|Lost to Follow-up|1|||
33539768|NCT03173560|62929911|FG001|Overall Study|Lost to Follow-up|4|||
33539769|NCT03173560|62929910|FG000|Overall Study|Withdrawal by Subject|10|||
33539770|NCT03173560|62929911|FG001|Overall Study|Withdrawal by Subject|5|||
33539771|NCT03173560|62929910|FG000|Overall Study|Other|0|||
33539772|NCT03173560|62929911|FG001|Overall Study|Other|1|||
33539773|NCT02915263|62929932|FG000|Overall Study|Covid|3|||
33539774|NCT02915263|62929933|FG001|Overall Study|Covid|2|||
33539775|NCT02343952|62929939|FG000|Study Treatment|Disease Progression|23|||
33539776|NCT02343952|62929939|FG000|Study Treatment|Death|3|||
33539777|NCT02343952|62929939|FG000|Study Treatment|Adverse Event|19|||
33539778|NCT02343952|62929939|FG000|Study Treatment|Withdrawal by Subject|7|||
33539779|NCT02343952|62929939|FG000|Study Treatment|other complicating Diseases|1|||
33539780|NCT02343952|62929939|FG000|Follow up|Withdrawal by Subject|3|||
33539781|NCT02343952|62929939|FG000|Follow up|Death|33|||
33539782|NCT02343952|62929939|FG000|Follow up|Patient does not meet eligibility for study.|1|||
33539783|NCT02343952|62929939|FG000|Follow up|Research department closed by the practice.|5|||
33539784|NCT02343952|62929939|FG000|Follow up|Patient went home to Russia|1|||
33539785|NCT02343952|62929939|FG000|Follow up|Disease Progression|1|||
33539786|NCT02343952|62929939|FG000|Follow up|study terminated|1|||
33539787|NCT01592370|62929950|FG000|Overall Study|Disease Progression|62|||
33539788|NCT01592370|62929951|FG001|Overall Study|Disease Progression|16|||
33539789|NCT01592370|62929952|FG002|Overall Study|Disease Progression|52|||
33539790|NCT01592370|62929953|FG003|Overall Study|Disease Progression|3|||
33539791|NCT01592370|62929954|FG004|Overall Study|Disease Progression|3|||
33539792|NCT01592370|62929955|FG005|Overall Study|Disease Progression|31|||
33539793|NCT01592370|62929956|FG006|Overall Study|Disease Progression|14|||
33539794|NCT01592370|62929950|FG000|Overall Study|Study Drug Toxicity|14|||
33539795|NCT01592370|62929951|FG001|Overall Study|Study Drug Toxicity|3|||
33539796|NCT01592370|62929952|FG002|Overall Study|Study Drug Toxicity|0|||
33539797|NCT01592370|62929953|FG003|Overall Study|Study Drug Toxicity|0|||
33539798|NCT01592370|62929954|FG004|Overall Study|Study Drug Toxicity|0|||
33539799|NCT01592370|62929955|FG005|Overall Study|Study Drug Toxicity|0|||
33539800|NCT01592370|62929956|FG006|Overall Study|Study Drug Toxicity|1|||
33539801|NCT01592370|62929950|FG000|Overall Study|AE unrelated to study drug|4|||
33539802|NCT01592370|62929951|FG001|Overall Study|AE unrelated to study drug|3|||
33539803|NCT01592370|62929952|FG002|Overall Study|AE unrelated to study drug|0|||
33539804|NCT01592370|62929953|FG003|Overall Study|AE unrelated to study drug|0|||
33539805|NCT01592370|62929954|FG004|Overall Study|AE unrelated to study drug|0|||
33539806|NCT01592370|62929955|FG005|Overall Study|AE unrelated to study drug|0|||
33539807|NCT01592370|62929956|FG006|Overall Study|AE unrelated to study drug|1|||
33539808|NCT01592370|62929950|FG000|Overall Study|Request to discontinue study treatment|5|||
33539809|NCT01592370|62929951|FG001|Overall Study|Request to discontinue study treatment|0|||
33539810|NCT01592370|62929952|FG002|Overall Study|Request to discontinue study treatment|2|||
33539811|NCT01592370|62929953|FG003|Overall Study|Request to discontinue study treatment|0|||
33539812|NCT01592370|62929954|FG004|Overall Study|Request to discontinue study treatment|1|||
33539813|NCT01592370|62929955|FG005|Overall Study|Request to discontinue study treatment|2|||
33539814|NCT01592370|62929956|FG006|Overall Study|Request to discontinue study treatment|0|||
33539815|NCT01592370|62929950|FG000|Overall Study|Withdrew consent|1|||
33539816|NCT01592370|62929951|FG001|Overall Study|Withdrew consent|2|||
33539817|NCT01592370|62929952|FG002|Overall Study|Withdrew consent|1|||
33539818|NCT01592370|62929953|FG003|Overall Study|Withdrew consent|1|||
33539819|NCT01592370|62929954|FG004|Overall Study|Withdrew consent|0|||
33539820|NCT01592370|62929955|FG005|Overall Study|Withdrew consent|0|||
33539821|NCT01592370|62929956|FG006|Overall Study|Withdrew consent|0|||
33539822|NCT01592370|62929950|FG000|Overall Study|Maximum clinical benefit|11|||
33539823|NCT01592370|62929951|FG001|Overall Study|Maximum clinical benefit|1|||
33539824|NCT01592370|62929952|FG002|Overall Study|Maximum clinical benefit|7|||
33539825|NCT01592370|62929953|FG003|Overall Study|Maximum clinical benefit|1|||
33539826|NCT01592370|62929954|FG004|Overall Study|Maximum clinical benefit|0|||
33539827|NCT01592370|62929955|FG005|Overall Study|Maximum clinical benefit|0|||
33539828|NCT01592370|62929956|FG006|Overall Study|Maximum clinical benefit|0|||
33539829|NCT01592370|62929950|FG000|Overall Study|No longer meets study criteria|1|||
33539830|NCT01592370|62929951|FG001|Overall Study|No longer meets study criteria|0|||
33539831|NCT01592370|62929952|FG002|Overall Study|No longer meets study criteria|0|||
33539832|NCT01592370|62929953|FG003|Overall Study|No longer meets study criteria|0|||
33539833|NCT01592370|62929954|FG004|Overall Study|No longer meets study criteria|0|||
33539834|NCT01592370|62929955|FG005|Overall Study|No longer meets study criteria|0|||
33539835|NCT01592370|62929956|FG006|Overall Study|No longer meets study criteria|0|||
33539836|NCT01592370|62929950|FG000|Overall Study|Other Reasons|6|||
33539837|NCT01592370|62929951|FG001|Overall Study|Other Reasons|0|||
33539838|NCT01592370|62929952|FG002|Overall Study|Other Reasons|10|||
33539839|NCT01592370|62929953|FG003|Overall Study|Other Reasons|0|||
33539840|NCT01592370|62929954|FG004|Overall Study|Other Reasons|0|||
33539841|NCT01592370|62929955|FG005|Overall Study|Other Reasons|1|||
33539842|NCT01592370|62929956|FG006|Overall Study|Other Reasons|0|||
33539843|NCT00777036|62929984|FG000|On Treatment|Reason Not Specified|4|||
33539844|NCT00777036|62929985|FG001|On Treatment|Reason Not Specified|7|||
33539845|NCT00777036|62929986|FG002|On Treatment|Reason Not Specified|12|||
33539846|NCT00777036|62929984|FG000|On Treatment|Failure to Meet Study Criteria|0|||
33539847|NCT00777036|62929985|FG001|On Treatment|Failure to Meet Study Criteria|1|||
33539848|NCT00777036|62929986|FG002|On Treatment|Failure to Meet Study Criteria|0|||
33539849|NCT00777036|62929984|FG000|On Treatment|Non-compliance with Study Drug|1|||
33539850|NCT00777036|62929985|FG001|On Treatment|Non-compliance with Study Drug|0|||
33539851|NCT00777036|62929986|FG002|On Treatment|Non-compliance with Study Drug|0|||
33539852|NCT00777036|62929984|FG000|On Treatment|Maximum Clinical Benefit|2|||
33539853|NCT00777036|62929985|FG001|On Treatment|Maximum Clinical Benefit|0|||
33539854|NCT00777036|62929986|FG002|On Treatment|Maximum Clinical Benefit|1|||
33539855|NCT00777036|62929984|FG000|On Treatment|Withdrawal by Subject|3|||
33539856|NCT00777036|62929985|FG001|On Treatment|Withdrawal by Subject|2|||
33539857|NCT00777036|62929986|FG002|On Treatment|Withdrawal by Subject|3|||
33539858|NCT00777036|62929984|FG000|On Treatment|Death|0|||
33539859|NCT00777036|62929985|FG001|On Treatment|Death|2|||
33539860|NCT00777036|62929986|FG002|On Treatment|Death|0|||
33539861|NCT00777036|62929984|FG000|On Treatment|Study Drug Toxicity|0|||
33539862|NCT00777036|62929985|FG001|On Treatment|Study Drug Toxicity|0|||
33539863|NCT00777036|62929986|FG002|On Treatment|Study Drug Toxicity|1|||
33539864|NCT00777036|62929984|FG000|On Treatment|Progressive Disease|5|||
33539865|NCT00777036|62929985|FG001|On Treatment|Progressive Disease|4|||
33539866|NCT00777036|62929986|FG002|On Treatment|Progressive Disease|6|||
33539867|NCT00777036|62929984|FG000|Follow-Up|Lost to Follow-up|1|||
33539868|NCT00777036|62929985|FG001|Follow-Up|Lost to Follow-up|0|||
33539869|NCT00777036|62929986|FG002|Follow-Up|Lost to Follow-up|0|||
33539870|NCT00777036|62929984|FG000|Follow-Up|Reason Not Specified|2|||
33539871|NCT00777036|62929985|FG001|Follow-Up|Reason Not Specified|0|||
33539872|NCT00777036|62929986|FG002|Follow-Up|Reason Not Specified|0|||
33539873|NCT00777036|62929984|FG000|Follow-Up|Withdrawal by Subject|1|||
33539874|NCT00777036|62929985|FG001|Follow-Up|Withdrawal by Subject|0|||
33539875|NCT00777036|62929986|FG002|Follow-Up|Withdrawal by Subject|4|||
33539876|NCT00777036|62929984|FG000|Follow-Up|Death|1|||
33539877|NCT00777036|62929985|FG001|Follow-Up|Death|8|||
33539878|NCT00777036|62929986|FG002|Follow-Up|Death|0|||
33539879|NCT00176644|62930001|FG000|Overall Study|Withdrawal by Subject|1|||
33539880|NCT04649164|62930019|FG000|Overall Study|Withdrawal by Subject|1|||
33539881|NCT04649164|62930020|FG001|Overall Study|Withdrawal by Subject|1|||
33539882|NCT04649164|62930021|FG002|Overall Study|Withdrawal by Subject|2|||
33539883|NCT04649164|62930019|FG000|Overall Study|Participant's care recipient expired|0|||
33539884|NCT04649164|62930020|FG001|Overall Study|Participant's care recipient expired|0|||
33539885|NCT04649164|62930021|FG002|Overall Study|Participant's care recipient expired|2|||
33539886|NCT02753127|62930031|FG000|Overall Study|Lost to Follow-up|13|||
33539887|NCT02753127|62930032|FG001|Overall Study|Lost to Follow-up|11|||
33539888|NCT02753127|62930031|FG000|Overall Study|Withdrawal by Subject|37|||
33539889|NCT02753127|62930032|FG001|Overall Study|Withdrawal by Subject|47|||
33539890|NCT02753127|62930031|FG000|Overall Study|Other|3|||
33539891|NCT02753127|62930032|FG001|Overall Study|Other|8|||
33539892|NCT02753127|62930031|FG000|Overall Study|Hospice|0|||
33539893|NCT02753127|62930032|FG001|Overall Study|Hospice|2|||
33539894|NCT00706004|62930079|FG000|Overall Study|Did not meet eligibility criteria|2|||
33539895|NCT02724644|62930086|FG000|Overall Study|Adverse Event|7|||
33539896|NCT02724644|62930087|FG001|Overall Study|Adverse Event|1|||
33539897|NCT02724644|62930086|FG000|Overall Study|Lost to Follow-up|6|||
33539898|NCT02724644|62930087|FG001|Overall Study|Lost to Follow-up|2|||
33539899|NCT02724644|62930086|FG000|Overall Study|Withdrawal by Subject|7|||
33539900|NCT02724644|62930087|FG001|Overall Study|Withdrawal by Subject|1|||
33539901|NCT02724644|62930086|FG000|Overall Study|Administrative|1|||
33539902|NCT02724644|62930087|FG001|Overall Study|Administrative|0|||
33539903|NCT02725268|62930097|FG000|Overall Study|Death|58|||
33539904|NCT02725268|62930098|FG001|Overall Study|Death|59|||
33539905|NCT02725268|62930099|FG002|Overall Study|Death|30|||
33539906|NCT02725268|62930100|FG003|Overall Study|Death|16|||
33539907|NCT02725268|62930097|FG000|Overall Study|Lost to Follow-up|4|||
33539908|NCT02725268|62930098|FG001|Overall Study|Lost to Follow-up|3|||
33539909|NCT02725268|62930099|FG002|Overall Study|Lost to Follow-up|0|||
33539910|NCT02725268|62930100|FG003|Overall Study|Lost to Follow-up|1|||
33539911|NCT02725268|62930097|FG000|Overall Study|Site Terminated by Sponsor|0|||
33539912|NCT02725268|62930098|FG001|Overall Study|Site Terminated by Sponsor|1|||
33539913|NCT02725268|62930099|FG002|Overall Study|Site Terminated by Sponsor|0|||
33539914|NCT02725268|62930100|FG003|Overall Study|Site Terminated by Sponsor|0|||
33539915|NCT02725268|62930097|FG000|Overall Study|Withdrawal by Subject|8|||
33539916|NCT02725268|62930098|FG001|Overall Study|Withdrawal by Subject|6|||
33539917|NCT02725268|62930099|FG002|Overall Study|Withdrawal by Subject|8|||
33539918|NCT02725268|62930100|FG003|Overall Study|Withdrawal by Subject|1|||
33539919|NCT02725268|62930097|FG000|Overall Study|Reason not Specified|2|||
33539920|NCT02725268|62930098|FG001|Overall Study|Reason not Specified|1|||
33461977|NCT00065468|62835851|FG002|Overall Study|Other|18|||
33461978|NCT00071006|62835859|FG000|Overall Study|Lack of Efficacy|7|||
33461979|NCT00071006|62835859|FG000|Overall Study|Adverse Event|1|||
33461980|NCT00071006|62835859|FG000|Overall Study|Withdrawal by Subject|1|||
33461981|NCT00071006|62835859|FG000|Overall Study|Other|3|||
33461982|NCT00094575|62835865|FG000|Overall Study|Death|146|||
33461983|NCT00094575|62835866|FG001|Overall Study|Death|146|||
33461984|NCT00057746|62835877|FG000|Overall Study|Withdrawal by Subject|0|||
33461985|NCT00057746|62835878|FG001|Overall Study|Withdrawal by Subject|0|||
33461986|NCT00057746|62835879|FG002|Overall Study|Withdrawal by Subject|1|||
33539921|NCT02725268|62930099|FG002|Overall Study|Reason not Specified|0|||
33539922|NCT02725268|62930100|FG003|Overall Study|Reason not Specified|0|||
33539923|NCT02724956|62930112|FG000|Overall Study|Physician Decision|1|||
33461987|NCT00094107|62835887|FG000|Overall Study|Lack of Efficacy|23|||
33539924|NCT02724956|62930113|FG001|Overall Study|Physician Decision|0|||
33539925|NCT02724956|62930112|FG000|Overall Study|Lack of Efficacy|0|||
33539926|NCT02724956|62930113|FG001|Overall Study|Lack of Efficacy|1|||
33461988|NCT00094107|62835887|FG000|Overall Study|Death|5|||
33461989|NCT00094107|62835887|FG000|Overall Study|Adverse Event|3|||
33539927|NCT02724956|62930112|FG000|Overall Study|Withdrawal by Subject|0|||
33539928|NCT02724956|62930113|FG001|Overall Study|Withdrawal by Subject|1|||
33539929|NCT00705536|62930121|FG000|Start Period 1|Withdrawal by Subject|0|||
33539930|NCT00705536|62930122|FG001|Start Period 1|Withdrawal by Subject|0|||
33539931|NCT00705536|62930123|FG002|Start Period 1|Withdrawal by Subject|0|||
33539932|NCT00705536|62930124|FG003|Start Period 1|Withdrawal by Subject|1|||
33539933|NCT02724020|62930146|FG000|Overall Study|Death|16|||
33539934|NCT02724020|62930147|FG001|Overall Study|Death|18|||
33539935|NCT02724020|62930148|FG002|Overall Study|Death|19|||
33539936|NCT02724020|62930146|FG000|Overall Study|Lost to Follow-up|0|||
33539937|NCT02724020|62930147|FG001|Overall Study|Lost to Follow-up|3|||
33539938|NCT02724020|62930148|FG002|Overall Study|Lost to Follow-up|0|||
33539939|NCT02724020|62930146|FG000|Overall Study|Site Terminated by Sponsor|15|||
33539940|NCT02724020|62930147|FG001|Overall Study|Site Terminated by Sponsor|8|||
33539941|NCT02724020|62930148|FG002|Overall Study|Site Terminated by Sponsor|8|||
33539942|NCT02724020|62930146|FG000|Overall Study|Withdrawal by Subject|1|||
33539943|NCT02724020|62930147|FG001|Overall Study|Withdrawal by Subject|3|||
33539944|NCT02724020|62930148|FG002|Overall Study|Withdrawal by Subject|5|||
33539945|NCT02660034|62930170|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
33539946|NCT02660034|62930171|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
33539947|NCT02660034|62930172|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
33539948|NCT02660034|62930173|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
33539949|NCT02660034|62930174|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
33539950|NCT02660034|62930175|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
33539951|NCT02660034|62930176|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
33539952|NCT02660034|62930177|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
33539953|NCT02660034|62930178|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
33539954|NCT02660034|62930179|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
33539955|NCT02660034|62930180|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
33539956|NCT02660034|62930181|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
33539957|NCT02660034|62930182|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
33539958|NCT02660034|62930183|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
33539959|NCT02660034|62930170|FG000|Overall Study|Progressive Disease (Clinical)|7|||
33539960|NCT02660034|62930171|FG001|Overall Study|Progressive Disease (Clinical)|8|||
33539961|NCT02660034|62930172|FG002|Overall Study|Progressive Disease (Clinical)|3|||
33539962|NCT02660034|62930173|FG003|Overall Study|Progressive Disease (Clinical)|9|||
33539963|NCT02660034|62930174|FG004|Overall Study|Progressive Disease (Clinical)|3|||
33539964|NCT02660034|62930175|FG005|Overall Study|Progressive Disease (Clinical)|0|||
33539965|NCT02660034|62930176|FG006|Overall Study|Progressive Disease (Clinical)|0|||
33539966|NCT02660034|62930177|FG007|Overall Study|Progressive Disease (Clinical)|0|||
33539967|NCT02660034|62930178|FG008|Overall Study|Progressive Disease (Clinical)|0|||
33539968|NCT02660034|62930179|FG009|Overall Study|Progressive Disease (Clinical)|0|||
33539969|NCT02660034|62930180|FG010|Overall Study|Progressive Disease (Clinical)|0|||
33539970|NCT02660034|62930181|FG011|Overall Study|Progressive Disease (Clinical)|0|||
33539971|NCT02660034|62930182|FG012|Overall Study|Progressive Disease (Clinical)|0|||
33539972|NCT02660034|62930183|FG013|Overall Study|Progressive Disease (Clinical)|0|||
33539973|NCT02660034|62930170|FG000|Overall Study|Lost to Follow-up|0|||
33539974|NCT02660034|62930171|FG001|Overall Study|Lost to Follow-up|0|||
33539975|NCT02660034|62930172|FG002|Overall Study|Lost to Follow-up|1|||
33539976|NCT02660034|62930173|FG003|Overall Study|Lost to Follow-up|1|||
33539977|NCT02660034|62930174|FG004|Overall Study|Lost to Follow-up|0|||
33539978|NCT02660034|62930175|FG005|Overall Study|Lost to Follow-up|0|||
33539979|NCT02660034|62930176|FG006|Overall Study|Lost to Follow-up|0|||
33539980|NCT02660034|62930177|FG007|Overall Study|Lost to Follow-up|0|||
33539981|NCT02660034|62930178|FG008|Overall Study|Lost to Follow-up|0|||
33539982|NCT02660034|62930179|FG009|Overall Study|Lost to Follow-up|1|||
33539983|NCT02660034|62930180|FG010|Overall Study|Lost to Follow-up|1|||
33539984|NCT02660034|62930181|FG011|Overall Study|Lost to Follow-up|1|||
33539985|NCT02660034|62930182|FG012|Overall Study|Lost to Follow-up|0|||
33539986|NCT02660034|62930183|FG013|Overall Study|Lost to Follow-up|0|||
33461990|NCT00094107|62835887|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
33461991|NCT00102063|62835894|FG000|Overall Study|Lack of Efficacy|5|||
33461992|NCT00102063|62835895|FG001|Overall Study|Lack of Efficacy|1|||
33461993|NCT00102063|62835896|FG002|Overall Study|Lack of Efficacy|1|||
33461994|NCT00102063|62835894|FG000|Overall Study|Adverse Event|7|||
33461995|NCT00102063|62835895|FG001|Overall Study|Adverse Event|4|||
33461996|NCT00102063|62835896|FG002|Overall Study|Adverse Event|2|||
33461997|NCT00102063|62835894|FG000|Overall Study|Withdrawal by Subject|4|||
33539987|NCT02660034|62930170|FG000|Overall Study|Participant moved into special access scheme|1|||
33539988|NCT02660034|62930171|FG001|Overall Study|Participant moved into special access scheme|2|||
33539989|NCT02660034|62930172|FG002|Overall Study|Participant moved into special access scheme|0|||
33539990|NCT02660034|62930173|FG003|Overall Study|Participant moved into special access scheme|0|||
33539991|NCT02660034|62930174|FG004|Overall Study|Participant moved into special access scheme|0|||
33539992|NCT02660034|62930175|FG005|Overall Study|Participant moved into special access scheme|0|||
33539993|NCT02660034|62930176|FG006|Overall Study|Participant moved into special access scheme|0|||
33539994|NCT02660034|62930177|FG007|Overall Study|Participant moved into special access scheme|0|||
33539995|NCT02660034|62930178|FG008|Overall Study|Participant moved into special access scheme|0|||
33539996|NCT02660034|62930179|FG009|Overall Study|Participant moved into special access scheme|0|||
33539997|NCT02660034|62930180|FG010|Overall Study|Participant moved into special access scheme|0|||
33539998|NCT02660034|62930181|FG011|Overall Study|Participant moved into special access scheme|0|||
33539999|NCT02660034|62930182|FG012|Overall Study|Participant moved into special access scheme|0|||
33540000|NCT02660034|62930183|FG013|Overall Study|Participant moved into special access scheme|0|||
33540001|NCT02660034|62930170|FG000|Overall Study|Adverse Event|1|||
33540002|NCT02660034|62930171|FG001|Overall Study|Adverse Event|0|||
33540003|NCT02660034|62930172|FG002|Overall Study|Adverse Event|0|||
33540004|NCT02660034|62930173|FG003|Overall Study|Adverse Event|0|||
33540005|NCT02660034|62930174|FG004|Overall Study|Adverse Event|0|||
33540006|NCT02660034|62930175|FG005|Overall Study|Adverse Event|0|||
33540007|NCT02660034|62930176|FG006|Overall Study|Adverse Event|0|||
33540008|NCT02660034|62930177|FG007|Overall Study|Adverse Event|0|||
33540009|NCT02660034|62930178|FG008|Overall Study|Adverse Event|0|||
33540010|NCT02660034|62930179|FG009|Overall Study|Adverse Event|0|||
33540011|NCT02660034|62930180|FG010|Overall Study|Adverse Event|0|||
33540012|NCT02660034|62930181|FG011|Overall Study|Adverse Event|0|||
33540013|NCT02660034|62930182|FG012|Overall Study|Adverse Event|0|||
33540014|NCT02660034|62930183|FG013|Overall Study|Adverse Event|0|||
33540015|NCT02660034|62930170|FG000|Overall Study|Sponsor Decision|0|||
33540016|NCT02660034|62930171|FG001|Overall Study|Sponsor Decision|1|||
33540017|NCT02660034|62930172|FG002|Overall Study|Sponsor Decision|2|||
33540018|NCT02660034|62930173|FG003|Overall Study|Sponsor Decision|2|||
33540019|NCT02660034|62930174|FG004|Overall Study|Sponsor Decision|3|||
33540020|NCT02660034|62930175|FG005|Overall Study|Sponsor Decision|0|||
33540021|NCT02660034|62930176|FG006|Overall Study|Sponsor Decision|0|||
33540022|NCT02660034|62930177|FG007|Overall Study|Sponsor Decision|0|||
33540023|NCT02660034|62930178|FG008|Overall Study|Sponsor Decision|0|||
33540024|NCT02660034|62930179|FG009|Overall Study|Sponsor Decision|0|||
33540025|NCT02660034|62930180|FG010|Overall Study|Sponsor Decision|0|||
33633987|NCT01753401|63035778|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
33633988|NCT01753401|63035775|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
33633989|NCT01753401|63035776|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
33633990|NCT01753401|63035777|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
33633991|NCT01753401|63035778|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
33633992|NCT01753401|63035775|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
33633993|NCT01753401|63035776|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
33633994|NCT01753401|63035777|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
33633995|NCT01753401|63035778|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
33633996|NCT01753401|63035775|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
33633997|NCT01753401|63035776|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
33633998|NCT01753401|63035777|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
33633999|NCT01753401|63035778|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
33634000|NCT01753401|63035775|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
33634001|NCT01753401|63035776|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
33634002|NCT01753401|63035777|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
33634003|NCT01753401|63035778|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
33634004|NCT01753401|63035775|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
33634005|NCT01753401|63035776|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
33634006|NCT01753401|63035777|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
33634007|NCT01753401|63035778|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
33634008|NCT01618916|63035794|FG000|Overall Study|Adverse Event|1|||
33634009|NCT01618916|63035795|FG001|Overall Study|Adverse Event|0|||
33634010|NCT01618916|63035796|FG002|Overall Study|Adverse Event|0|||
33634011|NCT01618916|63035797|FG003|Overall Study|Adverse Event|0|||
33634012|NCT01618916|63035798|FG004|Overall Study|Adverse Event|0|||
33634013|NCT01618916|63035799|FG005|Overall Study|Adverse Event|0|||
33461998|NCT00102063|62835895|FG001|Overall Study|Withdrawal by Subject|12|||
33461999|NCT00102063|62835896|FG002|Overall Study|Withdrawal by Subject|5|||
33462000|NCT00102063|62835894|FG000|Overall Study|Lost to Follow-up|0|||
33462001|NCT00102063|62835895|FG001|Overall Study|Lost to Follow-up|0|||
33462002|NCT00102063|62835896|FG002|Overall Study|Lost to Follow-up|1|||
33462003|NCT00102063|62835894|FG000|Overall Study|Protocol Violation|0|||
33462004|NCT00102063|62835895|FG001|Overall Study|Protocol Violation|1|||
33462005|NCT00102063|62835896|FG002|Overall Study|Protocol Violation|1|||
33462006|NCT00065156|62835904|FG000|Overall Study|Adverse Event|37|||
33540026|NCT02660034|62930181|FG011|Overall Study|Sponsor Decision|0|||
33540027|NCT02660034|62930182|FG012|Overall Study|Sponsor Decision|0|||
33540028|NCT02660034|62930183|FG013|Overall Study|Sponsor Decision|1|||
33540029|NCT02660034|62930170|FG000|Overall Study|Withdrawal by Subject|0|||
33540030|NCT02660034|62930171|FG001|Overall Study|Withdrawal by Subject|0|||
33540031|NCT02660034|62930172|FG002|Overall Study|Withdrawal by Subject|0|||
33540032|NCT02660034|62930173|FG003|Overall Study|Withdrawal by Subject|0|||
33462007|NCT00065156|62835904|FG000|Overall Study|Lack of Efficacy|52|||
33634014|NCT01618916|63035794|FG000|Overall Study|Withdrawal by Subject|0|||
33634015|NCT01618916|63035795|FG001|Overall Study|Withdrawal by Subject|1|||
33634016|NCT01618916|63035796|FG002|Overall Study|Withdrawal by Subject|1|||
33634017|NCT01618916|63035797|FG003|Overall Study|Withdrawal by Subject|0|||
33634018|NCT01618916|63035798|FG004|Overall Study|Withdrawal by Subject|1|||
33634019|NCT01618916|63035799|FG005|Overall Study|Withdrawal by Subject|0|||
33634020|NCT01618916|63035794|FG000|Overall Study|Lost to Follow-up|1|||
33634021|NCT01618916|63035795|FG001|Overall Study|Lost to Follow-up|0|||
33634022|NCT01618916|63035796|FG002|Overall Study|Lost to Follow-up|0|||
33634023|NCT01618916|63035797|FG003|Overall Study|Lost to Follow-up|2|||
33634024|NCT01618916|63035798|FG004|Overall Study|Lost to Follow-up|0|||
33634025|NCT01618916|63035799|FG005|Overall Study|Lost to Follow-up|0|||
33634026|NCT01753323|63035815|FG000|Overall Study|Lack of Efficacy|0|||
33634027|NCT01753323|63035816|FG001|Overall Study|Lack of Efficacy|0|||
33634028|NCT01753323|63035817|FG002|Overall Study|Lack of Efficacy|8|||
33634029|NCT01753323|63035815|FG000|Overall Study|Protocol deviation|1|||
33634030|NCT01753323|63035816|FG001|Overall Study|Protocol deviation|0|||
33462008|NCT00065156|62835904|FG000|Overall Study|Withdrawal by Subject|8|||
33462009|NCT00065156|62835904|FG000|Overall Study|Lost to Follow-up|1|||
33462010|NCT00065156|62835904|FG000|Overall Study|Death|11|||
33540033|NCT02660034|62930174|FG004|Overall Study|Withdrawal by Subject|0|||
33540034|NCT02660034|62930175|FG005|Overall Study|Withdrawal by Subject|0|||
33540035|NCT02660034|62930176|FG006|Overall Study|Withdrawal by Subject|1|||
33540036|NCT02660034|62930177|FG007|Overall Study|Withdrawal by Subject|1|||
33540037|NCT02660034|62930178|FG008|Overall Study|Withdrawal by Subject|1|||
33540038|NCT02660034|62930179|FG009|Overall Study|Withdrawal by Subject|0|||
33540039|NCT02660034|62930180|FG010|Overall Study|Withdrawal by Subject|0|||
33540040|NCT02660034|62930181|FG011|Overall Study|Withdrawal by Subject|1|||
33540041|NCT02660034|62930182|FG012|Overall Study|Withdrawal by Subject|2|||
33540042|NCT02660034|62930183|FG013|Overall Study|Withdrawal by Subject|0|||
33540043|NCT02660034|62930170|FG000|Overall Study|Death|0|||
33540044|NCT02660034|62930171|FG001|Overall Study|Death|0|||
33540045|NCT02660034|62930172|FG002|Overall Study|Death|0|||
33540046|NCT02660034|62930173|FG003|Overall Study|Death|0|||
33540047|NCT02660034|62930174|FG004|Overall Study|Death|0|||
33540048|NCT02660034|62930175|FG005|Overall Study|Death|13|||
33540049|NCT02660034|62930176|FG006|Overall Study|Death|14|||
33540050|NCT02660034|62930177|FG007|Overall Study|Death|10|||
33540051|NCT02660034|62930178|FG008|Overall Study|Death|9|||
33540052|NCT02660034|62930179|FG009|Overall Study|Death|21|||
33540053|NCT02660034|62930180|FG010|Overall Study|Death|17|||
33540054|NCT02660034|62930181|FG011|Overall Study|Death|15|||
33540055|NCT02660034|62930182|FG012|Overall Study|Death|18|||
33540056|NCT02660034|62930183|FG013|Overall Study|Death|7|||
33540057|NCT02660034|62930170|FG000|Overall Study|Physician Decision|0|||
33540058|NCT02660034|62930171|FG001|Overall Study|Physician Decision|0|||
33540059|NCT02660034|62930172|FG002|Overall Study|Physician Decision|0|||
33540060|NCT02660034|62930173|FG003|Overall Study|Physician Decision|0|||
33540061|NCT02660034|62930174|FG004|Overall Study|Physician Decision|0|||
33540062|NCT02660034|62930175|FG005|Overall Study|Physician Decision|0|||
33540063|NCT02660034|62930176|FG006|Overall Study|Physician Decision|0|||
33540064|NCT02660034|62930177|FG007|Overall Study|Physician Decision|0|||
33540065|NCT02660034|62930178|FG008|Overall Study|Physician Decision|0|||
33540066|NCT02660034|62930179|FG009|Overall Study|Physician Decision|0|||
33634031|NCT01753323|63035817|FG002|Overall Study|Protocol deviation|0|||
33634032|NCT01753323|63035815|FG000|Overall Study|Adverse Event|0|||
33634033|NCT01753323|63035816|FG001|Overall Study|Adverse Event|0|||
33462011|NCT00065156|62835904|FG000|Overall Study|Study Closed by Sponsor|2|||
33462012|NCT00065156|62835904|FG000|Overall Study|Disease Progression|7|||
33462013|NCT00065156|62835904|FG000|Overall Study|Investigator Decision|2|||
33462014|NCT00065156|62835904|FG000|Overall Study|Non-Compliance|2|||
33462015|NCT00065156|62835904|FG000|Overall Study|Loss of Response|1|||
33462016|NCT00065156|62835904|FG000|Overall Study|Secondary Malign Disease|1|||
33462017|NCT00064298|62835910|FG000|Overall Study|Withdrawal by Subject|2|||
33462018|NCT00064298|62835911|FG001|Overall Study|Withdrawal by Subject|1|||
33540067|NCT02660034|62930180|FG010|Overall Study|Physician Decision|0|||
33540068|NCT02660034|62930181|FG011|Overall Study|Physician Decision|0|||
33540069|NCT02660034|62930182|FG012|Overall Study|Physician Decision|0|||
33540070|NCT02660034|62930183|FG013|Overall Study|Physician Decision|1|||
33540071|NCT02660034|62930170|FG000|Overall Study|Participants transferred to LTE|0|||
33540072|NCT02660034|62930171|FG001|Overall Study|Participants transferred to LTE|0|||
33540073|NCT02660034|62930172|FG002|Overall Study|Participants transferred to LTE|0|||
33634034|NCT01753323|63035817|FG002|Overall Study|Adverse Event|1|||
33634035|NCT01894568|63035828|FG000|Overall Study|Adverse Event|2|||
33462019|NCT00064298|62835910|FG000|Overall Study|Lost to Follow-up|2|||
33540074|NCT02660034|62930173|FG003|Overall Study|Participants transferred to LTE|0|||
33540075|NCT02660034|62930174|FG004|Overall Study|Participants transferred to LTE|0|||
33634036|NCT01894568|63035829|FG001|Overall Study|Adverse Event|3|||
33634037|NCT01894568|63035828|FG000|Overall Study|Protocol required discontinuation|2|||
33540076|NCT02660034|62930175|FG005|Overall Study|Participants transferred to LTE|10|||
33540077|NCT02660034|62930176|FG006|Overall Study|Participants transferred to LTE|8|||
33540078|NCT02660034|62930177|FG007|Overall Study|Participants transferred to LTE|8|||
33540079|NCT02660034|62930178|FG008|Overall Study|Participants transferred to LTE|10|||
33540080|NCT02660034|62930179|FG009|Overall Study|Participants transferred to LTE|1|||
33540081|NCT02660034|62930180|FG010|Overall Study|Participants transferred to LTE|2|||
33540082|NCT02660034|62930181|FG011|Overall Study|Participants transferred to LTE|4|||
33540083|NCT02660034|62930182|FG012|Overall Study|Participants transferred to LTE|1|||
33540084|NCT02660034|62930183|FG013|Overall Study|Participants transferred to LTE|1|||
33540085|NCT02193867|62930226|FG000|Overall Study|Death|2|||
33540086|NCT02193867|62930226|FG000|Overall Study|Sponsor Study Termination|2|||
33540087|NCT02200770|62930254|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
33540088|NCT02200770|62930255|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
33540089|NCT02200770|62930254|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
33540090|NCT02200770|62930255|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
33540091|NCT02200770|62930254|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
33540092|NCT02200770|62930255|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
33540093|NCT02200770|62930254|FG000|Randomized-controlled Period (RCP)|Other|1|||
33540094|NCT02200770|62930255|FG001|Randomized-controlled Period (RCP)|Other|2|||
33540095|NCT02200770|62930254|FG000|Open-label Period (OLP)|Adverse Event|1|||
33540096|NCT02200770|62930255|FG001|Open-label Period (OLP)|Adverse Event|2|||
33540097|NCT02200770|62930254|FG000|Open-label Period (OLP)|Death|1|||
33540098|NCT02200770|62930255|FG001|Open-label Period (OLP)|Death|2|||
33540099|NCT02200770|62930254|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
33540100|NCT02200770|62930255|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
33540101|NCT02200770|62930254|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
33540102|NCT02200770|62930255|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
33540103|NCT02200770|62930254|FG000|Open-label Period (OLP)|Other|6|||
33540104|NCT02200770|62930255|FG001|Open-label Period (OLP)|Other|15|||
33540105|NCT01186848|62930277|FG000|Overall Study|Lost to Follow-up|4|||
33540106|NCT01186848|62930277|FG000|Overall Study|Withdrawal by Subject|2|||
33540107|NCT01186848|62930277|FG000|Overall Study|Adverse Event|2|||
33540108|NCT01024608|62930285|FG000|Overall Study|Adverse Event|1|||
33540109|NCT01024608|62930286|FG001|Overall Study|Adverse Event|0|||
33540110|NCT01024608|62930285|FG000|Overall Study|Withdrawal by Subject|1|||
33540111|NCT01024608|62930286|FG001|Overall Study|Withdrawal by Subject|0|||
33540112|NCT01024608|62930285|FG000|Overall Study|Lost to Follow-up|0|||
33540113|NCT01024608|62930286|FG001|Overall Study|Lost to Follow-up|1|||
33540114|NCT01024608|62930285|FG000|Overall Study|Protocol Violation|0|||
33540115|NCT01024608|62930286|FG001|Overall Study|Protocol Violation|3|||
33634038|NCT01894568|63035829|FG001|Overall Study|Protocol required discontinuation|1|||
33634039|NCT01894568|63035828|FG000|Overall Study|Withdrawal by Subject|5|||
33634040|NCT01894568|63035829|FG001|Overall Study|Withdrawal by Subject|5|||
33634041|NCT01894568|63035828|FG000|Overall Study|Physician Decision|1|||
33634042|NCT01894568|63035829|FG001|Overall Study|Physician Decision|0|||
33634043|NCT01894568|63035828|FG000|Overall Study|Lost to Follow-up|0|||
33634044|NCT01894568|63035829|FG001|Overall Study|Lost to Follow-up|1|||
33634045|NCT01618838|63035836|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
33634046|NCT01920152|63035843|FG000|Overall Study|Withdrawal by Subject|1|||
33634047|NCT01920152|63035844|FG001|Overall Study|Withdrawal by Subject|2|||
33634048|NCT01752933|63035852|FG000|Treatment|Disease Progression|3|||
33634049|NCT01752933|63035853|FG001|Treatment|Disease Progression|29|||
33634050|NCT01752933|63035852|FG000|Treatment|Withdrawal by Subject|0|||
33634051|NCT01752933|63035853|FG001|Treatment|Withdrawal by Subject|5|||
33634052|NCT01752933|63035852|FG000|Treatment|Adverse Event|1|||
33634053|NCT01752933|63035853|FG001|Treatment|Adverse Event|4|||
33634054|NCT01752933|63035852|FG000|Treatment|Physician Decision|0|||
33634055|NCT01752933|63035853|FG001|Treatment|Physician Decision|3|||
33634056|NCT01752933|63035852|FG000|Treatment|Death|0|||
33634057|NCT01752933|63035853|FG001|Treatment|Death|2|||
33634058|NCT01752933|63035852|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
33634059|NCT01752933|63035853|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
33326402|NCT00946647|62703165|FG004|Phase ll Part|Administrative problems|8|||
33326403|NCT00946647|62703161|FG000|Phase ll Part|Death|0|||
33540116|NCT01024608|62930285|FG000|Overall Study|Never received study treatment|2|||
33540117|NCT01024608|62930286|FG001|Overall Study|Never received study treatment|0|||
33540118|NCT00910650|62930292|FG000|Overall Study|Death|2|||
33634060|NCT01752933|63035852|FG000|Treatment|Patient noncompliant|0|||
33634061|NCT01752933|63035853|FG001|Treatment|Patient noncompliant|1|||
33634062|NCT01752933|63035852|FG000|Treatment|Patient unable to travel to appointments|0|||
33540119|NCT03996876|62930327|FG000|Overall Study|Incomplete Data|2|||
33634063|NCT01752933|63035853|FG001|Treatment|Patient unable to travel to appointments|1|||
33634064|NCT01752933|63035852|FG000|Overall Study and Follow-up|Death|4|||
33634065|NCT01752933|63035853|FG001|Overall Study and Follow-up|Death|34|||
33634066|NCT01752933|63035852|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
33634067|NCT01752933|63035853|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
33634068|NCT01752933|63035852|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
33634069|NCT01752933|63035853|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
33634070|NCT01752933|63035852|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
33634071|NCT01752933|63035853|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
33634072|NCT01752855|63035862|FG000|Overall Study|Adverse Event|1|||
33634073|NCT01752855|63035863|FG001|Overall Study|Adverse Event|0|||
33634074|NCT01752855|63035862|FG000|Overall Study|Withdrew Consent|0|||
33634075|NCT01752855|63035863|FG001|Overall Study|Withdrew Consent|2|||
33634076|NCT01752855|63035862|FG000|Overall Study|Lack of Efficacy|0|||
33634077|NCT01752855|63035863|FG001|Overall Study|Lack of Efficacy|2|||
33634078|NCT01402492|63035872|FG000|Overall Study|Withdrawal by Subject|17|||
33634079|NCT01402492|63035873|FG001|Overall Study|Withdrawal by Subject|11|||
33634080|NCT01402492|63035874|FG002|Overall Study|Withdrawal by Subject|11|||
33634081|NCT01402492|63035872|FG000|Overall Study|Adverse Event|2|||
33634082|NCT01402492|63035873|FG001|Overall Study|Adverse Event|3|||
33634083|NCT01402492|63035874|FG002|Overall Study|Adverse Event|4|||
33634084|NCT01402492|63035872|FG000|Overall Study|Physician Decision|0|||
33634085|NCT01402492|63035873|FG001|Overall Study|Physician Decision|3|||
33634086|NCT01402492|63035874|FG002|Overall Study|Physician Decision|0|||
33634087|NCT01402492|63035872|FG000|Overall Study|Incarcerated (N=3)|2|||
33634088|NCT01402492|63035873|FG001|Overall Study|Incarcerated (N=3)|0|||
33634089|NCT01402492|63035874|FG002|Overall Study|Incarcerated (N=3)|1|||
33634090|NCT01402102|63035884|FG000|Overall Study|Protocol Violation|1|||
33634091|NCT01402102|63035885|FG001|Overall Study|Protocol Violation|0|||
33634092|NCT01402102|63035884|FG000|Overall Study|Insufficiency of compliance|1|||
33634093|NCT01402102|63035885|FG001|Overall Study|Insufficiency of compliance|1|||
33634094|NCT01402102|63035884|FG000|Overall Study|Withdrawal by Subject|0|||
33634095|NCT01402102|63035885|FG001|Overall Study|Withdrawal by Subject|2|||
33462020|NCT00064298|62835911|FG001|Overall Study|Lost to Follow-up|2|||
33462021|NCT00064298|62835910|FG000|Overall Study|Death|0|||
33634096|NCT01423084|63035895|FG000|Overall Study|Adverse Event|0|||
33634097|NCT01423084|63035896|FG001|Overall Study|Adverse Event|1|||
33634098|NCT01423084|63035895|FG000|Overall Study|Withdrawal by Subject|2|||
33634099|NCT01423084|63035896|FG001|Overall Study|Withdrawal by Subject|3|||
33634100|NCT01894256|63035906|FG000|Part A|Adverse Event|0|||
33634101|NCT01894256|63035907|FG001|Part A|Adverse Event|1|||
33634102|NCT01894256|63035908|FG002|Part A|Adverse Event|0|||
33634103|NCT01894256|63035906|FG000|Part B|Death|0|||
33462022|NCT00064298|62835911|FG001|Overall Study|Death|1|||
33462023|NCT00064298|62835910|FG000|Overall Study|Disease Progression|2|||
33634104|NCT01894256|63035907|FG001|Part B|Death|1|||
33634105|NCT01894256|63035908|FG002|Part B|Death|1|||
33634106|NCT01894256|63035906|FG000|Part B|Withdrawal by Subject|0|||
33634107|NCT01894256|63035907|FG001|Part B|Withdrawal by Subject|1|||
33634108|NCT01894256|63035908|FG002|Part B|Withdrawal by Subject|0|||
33634109|NCT01894256|63035906|FG000|Part B|Lack of Efficacy|15|||
33634110|NCT01894256|63035907|FG001|Part B|Lack of Efficacy|12|||
33634111|NCT01894256|63035908|FG002|Part B|Lack of Efficacy|13|||
33462024|NCT00064298|62835911|FG001|Overall Study|Disease Progression|1|||
33634112|NCT01780935|63035921|FG000|Overall Study|Admin problems due to early termination|321|||
33634113|NCT01780935|63035922|FG001|Overall Study|Admin problems due to early termination|309|||
33634114|NCT01780935|63035921|FG000|Overall Study|Adverse Event|2|||
33634115|NCT01780935|63035922|FG001|Overall Study|Adverse Event|4|||
33634116|NCT01780935|63035921|FG000|Overall Study|Death|1|||
33634117|NCT01780935|63035922|FG001|Overall Study|Death|6|||
33634118|NCT01780935|63035921|FG000|Overall Study|Lost to Follow-up|2|||
33634119|NCT01780935|63035922|FG001|Overall Study|Lost to Follow-up|6|||
33634120|NCT01780935|63035921|FG000|Overall Study|Physician Decision|1|||
33634121|NCT01780935|63035922|FG001|Overall Study|Physician Decision|1|||
33634122|NCT01780935|63035921|FG000|Overall Study|Protocol deviation|0|||
33634123|NCT01780935|63035922|FG001|Overall Study|Protocol deviation|1|||
33634124|NCT01780935|63035921|FG000|Overall Study|Patient withdrew consent|8|||
33634125|NCT01780935|63035922|FG001|Overall Study|Patient withdrew consent|9|||
33634126|NCT01894100|63035930|FG000|Overall Study|Lost to Follow-up|0|||
33634127|NCT01894100|63035931|FG001|Overall Study|Lost to Follow-up|1|||
33634128|NCT01894100|63035930|FG000|Overall Study|Withdrawal by Subject|3|||
33634129|NCT01894100|63035931|FG001|Overall Study|Withdrawal by Subject|0|||
33634130|NCT01401478|63035977|FG000|Overall Study|Study drug not available|6|||
33634131|NCT01401478|63035977|FG000|Overall Study|Adverse Event|5|||
33634132|NCT01401478|63035977|FG000|Overall Study|Hyperphosphatemia|5|||
33634133|NCT01401478|63035977|FG000|Overall Study|Lost to Follow-up|5|||
33634134|NCT01401478|63035977|FG000|Overall Study|Kidney transplantation|3|||
33634135|NCT01401478|63035977|FG000|Overall Study|Withdrawal by Subject|3|||
33634136|NCT01401478|63035977|FG000|Overall Study|Blood samples not available|1|||
33634137|NCT01401478|63035977|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
33634138|NCT01401478|63035977|FG000|Overall Study|Low intact parathyroid hormone|1|||
33634139|NCT01401478|63035977|FG000|Overall Study|Serious adverse event|1|||
33634140|NCT01422850|63035981|FG000|Overall Study|Physician Decision|3|||
33634141|NCT01422538|63035990|FG000|Overall Study|Lost to Follow-up|0|||
33634142|NCT01422538|63035991|FG001|Overall Study|Lost to Follow-up|1|||
33634143|NCT01422538|63035992|FG002|Overall Study|Lost to Follow-up|1|||
33634144|NCT01422538|63035990|FG000|Overall Study|Missed visit|0|||
33634145|NCT01422538|63035991|FG001|Overall Study|Missed visit|1|||
33634146|NCT01422538|63035992|FG002|Overall Study|Missed visit|1|||
33634147|NCT01422382|63036001|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
33634148|NCT01401322|63036005|FG000|Overall Study|Withdrawal by Subject|1|||
33634149|NCT01401322|63036005|FG000|Overall Study|Physician Decision|1|||
33634150|NCT01387594|63036011|FG000|Overall Study|Withdrawal by Subject|0|||
33634151|NCT01387594|63036012|FG001|Overall Study|Withdrawal by Subject|2|||
33634152|NCT01387594|63036011|FG000|Overall Study|Lost to Follow-up|0|||
33462025|NCT00078819|62835919|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
33462026|NCT00078819|62835920|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
33462027|NCT00078819|62835921|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
33462028|NCT00078819|62835922|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
33540120|NCT03996876|62930328|FG001|Overall Study|Incomplete Data|4|||
33540121|NCT01460160|62930335|FG000|Treatment Phase|Lack of Efficacy|3|||
33462029|NCT00078819|62835919|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
33462030|NCT00078819|62835920|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
33462031|NCT00078819|62835921|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
33462032|NCT00078819|62835922|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
33540122|NCT01460160|62930335|FG000|Treatment Phase|Study Drug Toxicity|2|||
33540123|NCT01460160|62930335|FG000|Treatment Phase|Adverse Event|8|||
33540124|NCT01460160|62930335|FG000|Treatment Phase|Withdrawal by Subject|4|||
33540125|NCT01460160|62930335|FG000|Treatment Phase|Death|2|||
33540126|NCT01460160|62930335|FG000|Treatment Phase|Other reasons|9|||
33540127|NCT01460160|62930335|FG000|Follow-up Phase|Withdrawal by Subject|4|||
33634153|NCT01387594|63036012|FG001|Overall Study|Lost to Follow-up|1|||
33634154|NCT01401010|63036023|FG000|Overall Study|Could not interpret assay results|1|||
33634155|NCT01401010|63036024|FG001|Overall Study|Could not interpret assay results|0|||
33634156|NCT01400932|63036037|FG000|Overall Study|Adverse Event|10|||
33634157|NCT01400932|63036038|FG001|Overall Study|Adverse Event|5|||
33462033|NCT00078819|62835919|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
33634158|NCT01400932|63036037|FG000|Overall Study|Lack of Efficacy|0|||
33634159|NCT01400932|63036038|FG001|Overall Study|Lack of Efficacy|3|||
33634160|NCT01400932|63036037|FG000|Overall Study|Withdrawal by Subject|2|||
33634161|NCT01400932|63036038|FG001|Overall Study|Withdrawal by Subject|6|||
33462034|NCT00078819|62835920|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
33540128|NCT01460160|62930335|FG000|Follow-up Phase|Death|14|||
33540129|NCT01460160|62930335|FG000|Follow-up Phase|Lost to Follow-up|7|||
33634162|NCT01400932|63036037|FG000|Overall Study|Lost to Follow-up|1|||
33634163|NCT01400932|63036038|FG001|Overall Study|Lost to Follow-up|0|||
33634164|NCT01400932|63036037|FG000|Overall Study|Protocol Deviation|0|||
33634165|NCT01400932|63036038|FG001|Overall Study|Protocol Deviation|1|||
33634166|NCT01400932|63036037|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33634167|NCT01400932|63036038|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
33634168|NCT01400698|63036048|FG000|Overall Study|Lost to Follow-up|2|||
33634169|NCT01400698|63036049|FG001|Overall Study|Lost to Follow-up|5|||
33634170|NCT01400698|63036050|FG002|Overall Study|Lost to Follow-up|2|||
33634171|NCT01400698|63036051|FG003|Overall Study|Lost to Follow-up|1|||
33634172|NCT01400698|63036052|FG004|Overall Study|Lost to Follow-up|4|||
33634173|NCT01400698|63036053|FG005|Overall Study|Lost to Follow-up|3|||
33634174|NCT01400698|63036048|FG000|Overall Study|Withdrawal by Subject|8|||
33634175|NCT01400698|63036049|FG001|Overall Study|Withdrawal by Subject|2|||
33634176|NCT01400698|63036050|FG002|Overall Study|Withdrawal by Subject|0|||
33634177|NCT01400698|63036051|FG003|Overall Study|Withdrawal by Subject|4|||
33634178|NCT01400698|63036052|FG004|Overall Study|Withdrawal by Subject|1|||
33634179|NCT01400698|63036053|FG005|Overall Study|Withdrawal by Subject|3|||
33634180|NCT01400698|63036048|FG000|Overall Study|Protocol Violation|0|||
33634181|NCT01400698|63036049|FG001|Overall Study|Protocol Violation|1|||
33634182|NCT01400698|63036050|FG002|Overall Study|Protocol Violation|0|||
33634183|NCT01400698|63036051|FG003|Overall Study|Protocol Violation|0|||
33634184|NCT01400698|63036052|FG004|Overall Study|Protocol Violation|1|||
33634185|NCT01400698|63036053|FG005|Overall Study|Protocol Violation|0|||
33634186|NCT01400698|63036048|FG000|Overall Study|Non-compliance|0|||
33634187|NCT01400698|63036049|FG001|Overall Study|Non-compliance|1|||
33634188|NCT01400698|63036050|FG002|Overall Study|Non-compliance|0|||
33634189|NCT01400698|63036051|FG003|Overall Study|Non-compliance|1|||
33634190|NCT01400698|63036052|FG004|Overall Study|Non-compliance|0|||
33634191|NCT01400698|63036053|FG005|Overall Study|Non-compliance|0|||
33634192|NCT01400698|63036048|FG000|Overall Study|Adverse Event|1|||
33540130|NCT01460160|62930335|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
33540131|NCT01460160|62930335|FG000|Follow-up Phase|Other and not reported reasons|5|||
33540132|NCT01170702|62930343|FG000|Overall Study|Exclusion criteria met after consent|1|||
33540133|NCT01170702|62930344|FG001|Overall Study|Exclusion criteria met after consent|2|||
33634193|NCT01400698|63036049|FG001|Overall Study|Adverse Event|0|||
33634194|NCT01400698|63036050|FG002|Overall Study|Adverse Event|0|||
33634195|NCT01400698|63036051|FG003|Overall Study|Adverse Event|0|||
33634196|NCT01400698|63036052|FG004|Overall Study|Adverse Event|0|||
33634197|NCT01400698|63036053|FG005|Overall Study|Adverse Event|0|||
33634198|NCT01400698|63036048|FG000|Overall Study|Other|4|||
33634199|NCT01400698|63036049|FG001|Overall Study|Other|2|||
33634200|NCT01400698|63036050|FG002|Overall Study|Other|0|||
33634201|NCT01400698|63036051|FG003|Overall Study|Other|2|||
33634202|NCT01400698|63036052|FG004|Overall Study|Other|1|||
33634203|NCT01400698|63036053|FG005|Overall Study|Other|0|||
33634204|NCT01890746|63036065|FG000|Overall Study|Death|39|||
33540134|NCT01170702|62930345|FG002|Overall Study|Exclusion criteria met after consent|0|||
33540135|NCT01170702|62930346|FG003|Overall Study|Exclusion criteria met after consent|2|||
33540136|NCT02723864|62930385|FG000|Overall Study|Refused further treatment|1|||
33634205|NCT01890746|63036066|FG001|Overall Study|Death|30|||
33634206|NCT01890746|63036065|FG000|Overall Study|Adverse Event|1|||
33634207|NCT01890746|63036066|FG001|Overall Study|Adverse Event|0|||
33634208|NCT01890746|63036065|FG000|Overall Study|Lost to Follow-up|4|||
33634209|NCT01890746|63036066|FG001|Overall Study|Lost to Follow-up|1|||
33634210|NCT01890746|63036065|FG000|Overall Study|Physician Decision|3|||
33634211|NCT01890746|63036066|FG001|Overall Study|Physician Decision|2|||
33634212|NCT01890746|63036065|FG000|Overall Study|Withdrawal by Subject|5|||
33634213|NCT01890746|63036066|FG001|Overall Study|Withdrawal by Subject|8|||
33634214|NCT01422304|63036074|FG000|Overall Study|Adverse Event|0|||
33634215|NCT01422304|63036075|FG001|Overall Study|Adverse Event|1|||
33634216|NCT01422304|63036074|FG000|Overall Study|Lost to Follow-up|14|||
33634217|NCT01422304|63036075|FG001|Overall Study|Lost to Follow-up|20|||
33634218|NCT01422304|63036074|FG000|Overall Study|Never Entered Follow-up|2|||
33634219|NCT01422304|63036075|FG001|Overall Study|Never Entered Follow-up|1|||
33634220|NCT01422304|63036074|FG000|Overall Study|Protocol Violation|1|||
33540137|NCT02723864|62930386|FG001|Overall Study|Refused further treatment|0|||
33634221|NCT01422304|63036075|FG001|Overall Study|Protocol Violation|0|||
33634222|NCT01422304|63036074|FG000|Overall Study|Withdrawal by Subject|4|||
33634223|NCT01422304|63036075|FG001|Overall Study|Withdrawal by Subject|2|||
33634224|NCT01422304|63036074|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
33634225|NCT01422304|63036075|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
33634226|NCT01422304|63036074|FG000|Overall Study|Not Treated|3|||
33634227|NCT01422304|63036075|FG001|Overall Study|Not Treated|11|||
33634228|NCT01387516|63036085|FG000|Overall Study|Lost to Follow-up|4|||
33634229|NCT01387516|63036086|FG001|Overall Study|Lost to Follow-up|4|||
33634230|NCT01387516|63036087|FG002|Overall Study|Lost to Follow-up|2|||
33634231|NCT01387516|63036088|FG003|Overall Study|Lost to Follow-up|3|||
33634232|NCT01387516|63036085|FG000|Overall Study|Withdrawal by Subject|1|||
33634233|NCT01387516|63036086|FG001|Overall Study|Withdrawal by Subject|1|||
33634234|NCT01387516|63036087|FG002|Overall Study|Withdrawal by Subject|2|||
33634235|NCT01387516|63036088|FG003|Overall Study|Withdrawal by Subject|0|||
33634236|NCT01387516|63036085|FG000|Overall Study|Death|0|||
33634237|NCT01387516|63036086|FG001|Overall Study|Death|0|||
33634238|NCT01387516|63036087|FG002|Overall Study|Death|0|||
33634239|NCT01387516|63036088|FG003|Overall Study|Death|1|||
33634240|NCT01421134|63036109|FG000|Overall Study|Adverse Event|3|||
33634241|NCT01421134|63036110|FG001|Overall Study|Adverse Event|5|||
33634242|NCT01421134|63036109|FG000|Overall Study|Lack of Efficacy|2|||
33634243|NCT01421134|63036110|FG001|Overall Study|Lack of Efficacy|4|||
33634244|NCT01421134|63036109|FG000|Overall Study|Protocol Violation|0|||
33634245|NCT01421134|63036110|FG001|Overall Study|Protocol Violation|3|||
33634246|NCT01421134|63036109|FG000|Overall Study|Withdrawal by Subject|1|||
33634247|NCT01421134|63036110|FG001|Overall Study|Withdrawal by Subject|1|||
33634248|NCT01421134|63036109|FG000|Overall Study|Administrative|0|||
33634249|NCT01421134|63036110|FG001|Overall Study|Administrative|1|||
33634250|NCT01421134|63036109|FG000|Overall Study|Lost to Follow-up|1|||
33634251|NCT01421134|63036110|FG001|Overall Study|Lost to Follow-up|1|||
33634252|NCT01894022|63036118|FG000|Overall Study|Death|1|||
33634253|NCT01894022|63036119|FG001|Overall Study|Death|0|||
33634254|NCT01894022|63036118|FG000|Overall Study|Adverse Event, non-fatal|1|||
33634255|NCT01894022|63036119|FG001|Overall Study|Adverse Event, non-fatal|0|||
33634256|NCT01894022|63036118|FG000|Overall Study|Study Closed/terminated|7|||
33634257|NCT01894022|63036119|FG001|Overall Study|Study Closed/terminated|10|||
33634258|NCT01615328|63036128|FG000|Overall Study|Lost to Follow-up|3|||
33634259|NCT01615328|63036129|FG001|Overall Study|Lost to Follow-up|5|||
33634260|NCT01890512|63036139|FG000|Overall Study|Physician Decision|1|||
33634261|NCT01890512|63036139|FG000|Overall Study|Withdrawal by Subject|1|||
33634262|NCT01890512|63036139|FG000|Overall Study|Protocol Violation|1|||
33634263|NCT01387282|63036145|FG000|Overall Study|Death|47|||
33634264|NCT01387282|63036146|FG001|Overall Study|Death|16|||
33634265|NCT01387282|63036145|FG000|Overall Study|Other|5|||
33634266|NCT01387282|63036146|FG001|Overall Study|Other|1|||
33634267|NCT01387282|63036145|FG000|Overall Study|Unrelated AE|6|||
33634268|NCT01387282|63036146|FG001|Overall Study|Unrelated AE|4|||
33634269|NCT01387282|63036145|FG000|Overall Study|Withdrawal by patient|33|||
33634270|NCT01387282|63036146|FG001|Overall Study|Withdrawal by patient|23|||
33634271|NCT01387282|63036145|FG000|Overall Study|Study drug-related AE|2|||
33634272|NCT01387282|63036146|FG001|Overall Study|Study drug-related AE|2|||
33634273|NCT01387282|63036145|FG000|Overall Study|Lost to Follow-up|4|||
33634274|NCT01387282|63036146|FG001|Overall Study|Lost to Follow-up|1|||
33540138|NCT02723864|62930387|FG002|Overall Study|Refused further treatment|0|||
33540139|NCT02723864|62930388|FG003|Overall Study|Refused further treatment|0|||
33540140|NCT02723864|62930389|FG004|Overall Study|Refused further treatment|1|||
33540141|NCT02723864|62930390|FG005|Overall Study|Refused further treatment|2|||
33540142|NCT02723864|62930391|FG006|Overall Study|Refused further treatment|0|||
33540143|NCT02723864|62930385|FG000|Overall Study|Exceed treatment hold time|0|||
33540144|NCT02723864|62930386|FG001|Overall Study|Exceed treatment hold time|1|||
33540145|NCT02723864|62930387|FG002|Overall Study|Exceed treatment hold time|0|||
33540146|NCT02723864|62930388|FG003|Overall Study|Exceed treatment hold time|0|||
33540147|NCT02723864|62930389|FG004|Overall Study|Exceed treatment hold time|0|||
33540148|NCT02723864|62930390|FG005|Overall Study|Exceed treatment hold time|0|||
33540149|NCT02723864|62930391|FG006|Overall Study|Exceed treatment hold time|0|||
33540150|NCT02723864|62930385|FG000|Overall Study|Clinical progression|0|||
33634275|NCT01386970|63036154|FG000|Overall Study|Withdrawal by Subject|0|||
33634276|NCT01386970|63036155|FG001|Overall Study|Withdrawal by Subject|1|||
33634277|NCT01386970|63036154|FG000|Overall Study|Adverse Event|4|||
33634278|NCT01386970|63036155|FG001|Overall Study|Adverse Event|1|||
33634279|NCT01890434|63036163|FG000|Overall Study|Adverse Event|8|||
33634280|NCT01890434|63036163|FG000|Overall Study|PCI at external hospital|1|||
33634281|NCT01890434|63036163|FG000|Overall Study|Assessment discrepancy|1|||
33634282|NCT01890434|63036163|FG000|Overall Study|CRC didn't contact participant for FU|1|||
33634283|NCT01890434|63036163|FG000|Overall Study|Could not get whole set of images|1|||
33634284|NCT01890434|63036163|FG000|Overall Study|Decline to return for GSPECT|1|||
33634285|NCT01890434|63036163|FG000|Overall Study|GSPECT at rest was not done|1|||
33634286|NCT01890434|63036163|FG000|Overall Study|Participant didn't complete MRI|1|||
33634287|NCT01890434|63036163|FG000|Overall Study|Uncontactable by phone|1|||
33634288|NCT01890434|63036163|FG000|Overall Study|Moved out of position|1|||
33540151|NCT02723864|62930386|FG001|Overall Study|Clinical progression|0|||
33634289|NCT01890434|63036163|FG000|Overall Study|Unable to contact|1|||
33634290|NCT01890434|63036163|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
33634291|NCT01385566|63036173|FG000|Overall Study|Lost to Follow-up|1|||
33634292|NCT01385566|63036174|FG001|Overall Study|Lost to Follow-up|0|||
33634293|NCT01385566|63036175|FG002|Overall Study|Lost to Follow-up|0|||
33634294|NCT01385566|63036176|FG003|Overall Study|Lost to Follow-up|0|||
33634295|NCT01385566|63036177|FG004|Overall Study|Lost to Follow-up|0|||
33634296|NCT01385566|63036178|FG005|Overall Study|Lost to Follow-up|0|||
33634297|NCT01385566|63036173|FG000|Overall Study|Withdrawal by Subject|0|||
33634298|NCT01385566|63036174|FG001|Overall Study|Withdrawal by Subject|0|||
33634299|NCT01385566|63036175|FG002|Overall Study|Withdrawal by Subject|0|||
33540152|NCT02723864|62930387|FG002|Overall Study|Clinical progression|1|||
33634300|NCT01385566|63036176|FG003|Overall Study|Withdrawal by Subject|1|||
33634301|NCT01385566|63036177|FG004|Overall Study|Withdrawal by Subject|0|||
33634302|NCT01385566|63036178|FG005|Overall Study|Withdrawal by Subject|0|||
33634303|NCT01780545|63036196|FG000|Overall Study|Withdrawal by Subject|3|||
33634304|NCT01780545|63036197|FG001|Overall Study|Withdrawal by Subject|1|||
33634305|NCT01780545|63036196|FG000|Overall Study|Lost to Follow-up|1|||
33634306|NCT01780545|63036197|FG001|Overall Study|Lost to Follow-up|1|||
33634307|NCT01780389|63036206|FG000|Overall Study|Adverse Event|1|||
33634308|NCT01778985|63036213|FG000|Overall Study|Lost to Follow-up|1|||
33634309|NCT01778985|63036214|FG001|Overall Study|Lost to Follow-up|0|||
33634310|NCT01778985|63036213|FG000|Overall Study|Physician Decision|2|||
33634311|NCT01778985|63036214|FG001|Overall Study|Physician Decision|2|||
33634312|NCT01778985|63036213|FG000|Overall Study|Protocol Violation|4|||
33634313|NCT01778985|63036214|FG001|Overall Study|Protocol Violation|1|||
33634314|NCT01778751|63036222|FG000|Overall Study|Lost to Follow-up|1|||
33634315|NCT01778751|63036223|FG001|Overall Study|Lost to Follow-up|0|||
33634316|NCT01778751|63036222|FG000|Overall Study|Withdrawal by Subject|0|||
33540153|NCT02723864|62930388|FG003|Overall Study|Clinical progression|0|||
33540154|NCT02723864|62930389|FG004|Overall Study|Clinical progression|0|||
33540155|NCT02723864|62930390|FG005|Overall Study|Clinical progression|3|||
33540156|NCT02723864|62930391|FG006|Overall Study|Clinical progression|1|||
33540157|NCT02723864|62930385|FG000|Overall Study|Physician Decision|0|||
33540158|NCT02723864|62930386|FG001|Overall Study|Physician Decision|0|||
33540159|NCT02723864|62930387|FG002|Overall Study|Physician Decision|0|||
33540160|NCT02723864|62930388|FG003|Overall Study|Physician Decision|0|||
33540161|NCT02723864|62930389|FG004|Overall Study|Physician Decision|0|||
33540162|NCT02723864|62930390|FG005|Overall Study|Physician Decision|0|||
33540163|NCT02723864|62930391|FG006|Overall Study|Physician Decision|1|||
33540164|NCT02723864|62930385|FG000|Overall Study|Changes in patient condition|0|||
33540165|NCT02723864|62930386|FG001|Overall Study|Changes in patient condition|0|||
33540166|NCT02723864|62930387|FG002|Overall Study|Changes in patient condition|0|||
33540167|NCT02723864|62930388|FG003|Overall Study|Changes in patient condition|0|||
33540168|NCT02723864|62930389|FG004|Overall Study|Changes in patient condition|0|||
33540169|NCT02723864|62930390|FG005|Overall Study|Changes in patient condition|1|||
33540170|NCT02723864|62930391|FG006|Overall Study|Changes in patient condition|0|||
33540171|NCT02723864|62930385|FG000|Overall Study|Patient choice|0|||
33540172|NCT02723864|62930386|FG001|Overall Study|Patient choice|0|||
33540173|NCT02723864|62930387|FG002|Overall Study|Patient choice|0|||
33540174|NCT02723864|62930388|FG003|Overall Study|Patient choice|0|||
33540175|NCT02723864|62930389|FG004|Overall Study|Patient choice|0|||
33540176|NCT02723864|62930390|FG005|Overall Study|Patient choice|1|||
33540177|NCT02723864|62930391|FG006|Overall Study|Patient choice|0|||
33540178|NCT02723864|62930385|FG000|Overall Study|Adverse Event|0|||
33540179|NCT02723864|62930386|FG001|Overall Study|Adverse Event|0|||
33540180|NCT02723864|62930387|FG002|Overall Study|Adverse Event|0|||
33540181|NCT02723864|62930388|FG003|Overall Study|Adverse Event|0|||
33540182|NCT02723864|62930389|FG004|Overall Study|Adverse Event|0|||
33540183|NCT02723864|62930390|FG005|Overall Study|Adverse Event|1|||
33540184|NCT02723864|62930391|FG006|Overall Study|Adverse Event|0|||
33540185|NCT02723864|62930385|FG000|Overall Study|Started new treatment|0|||
33540186|NCT02723864|62930386|FG001|Overall Study|Started new treatment|0|||
33540187|NCT02723864|62930387|FG002|Overall Study|Started new treatment|0|||
33540188|NCT02723864|62930388|FG003|Overall Study|Started new treatment|0|||
33540189|NCT02723864|62930389|FG004|Overall Study|Started new treatment|0|||
33540190|NCT02723864|62930390|FG005|Overall Study|Started new treatment|1|||
33540191|NCT02723864|62930391|FG006|Overall Study|Started new treatment|0|||
33540192|NCT02723864|62930385|FG000|Overall Study|Switched to alternative treatment|0|||
33540193|NCT02723864|62930386|FG001|Overall Study|Switched to alternative treatment|0|||
33540194|NCT02723864|62930387|FG002|Overall Study|Switched to alternative treatment|0|||
33634317|NCT01778751|63036223|FG001|Overall Study|Withdrawal by Subject|2|||
33540195|NCT02723864|62930388|FG003|Overall Study|Switched to alternative treatment|0|||
33540196|NCT02723864|62930389|FG004|Overall Study|Switched to alternative treatment|0|||
33540197|NCT02723864|62930390|FG005|Overall Study|Switched to alternative treatment|1|||
33540198|NCT02723864|62930391|FG006|Overall Study|Switched to alternative treatment|0|||
33634318|NCT01778751|63036222|FG000|Overall Study|Transfered care|1|||
33634319|NCT01778751|63036223|FG001|Overall Study|Transfered care|0|||
33634320|NCT01865084|63036232|FG000|Double Blind Period (DB)|Adverse Event|2|||
33634321|NCT01865084|63036233|FG001|Double Blind Period (DB)|Adverse Event|2|||
33540199|NCT02723864|62930385|FG000|Overall Study|Late determination of ineligibility|0|||
33634322|NCT01865084|63036234|FG002|Double Blind Period (DB)|Adverse Event|1|||
33634323|NCT01865084|63036232|FG000|Double Blind Period (DB)|Protocol Violation|0|||
33634324|NCT01865084|63036233|FG001|Double Blind Period (DB)|Protocol Violation|0|||
33634325|NCT01865084|63036234|FG002|Double Blind Period (DB)|Protocol Violation|1|||
33540200|NCT02723864|62930386|FG001|Overall Study|Late determination of ineligibility|0|||
33540201|NCT02723864|62930387|FG002|Overall Study|Late determination of ineligibility|0|||
33544257|NCT03012061|62935096|FG000|Overall Study|Adverse Event|2|||
33634326|NCT01865084|63036232|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
33634327|NCT01865084|63036233|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
33540202|NCT02723864|62930388|FG003|Overall Study|Late determination of ineligibility|0|||
33540203|NCT02723864|62930389|FG004|Overall Study|Late determination of ineligibility|0|||
33540204|NCT02723864|62930390|FG005|Overall Study|Late determination of ineligibility|1|||
33634328|NCT01865084|63036234|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
33634329|NCT01865084|63036232|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
33634330|NCT01865084|63036233|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
33634331|NCT01865084|63036234|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
33634332|NCT01865084|63036232|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
33634333|NCT01865084|63036233|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
33634334|NCT01865084|63036234|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
33634335|NCT01865084|63036232|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
33634336|NCT01865084|63036233|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
33634337|NCT01865084|63036234|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
33634338|NCT01865084|63036232|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
33634339|NCT01865084|63036233|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
33634340|NCT01865084|63036234|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
33634341|NCT01865084|63036232|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
33634342|NCT01865084|63036233|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
33634343|NCT01865084|63036234|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
33634344|NCT01865084|63036232|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
33634345|NCT01865084|63036233|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
33634346|NCT01865084|63036234|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
33634347|NCT01778127|63036249|FG000|Overall Study|Lost to Follow-up|5|||
33634348|NCT01778127|63036250|FG001|Overall Study|Lost to Follow-up|1|||
33634349|NCT01778127|63036251|FG002|Overall Study|Lost to Follow-up|2|||
33634350|NCT01778127|63036249|FG000|Overall Study|Withdrawal by Subject|3|||
33634351|NCT01778127|63036250|FG001|Overall Study|Withdrawal by Subject|1|||
33634352|NCT01778127|63036251|FG002|Overall Study|Withdrawal by Subject|4|||
33634353|NCT01892540|63036262|FG000|Overall Study|Did not complete PET/MRI|0|||
33634354|NCT01892540|63036263|FG001|Overall Study|Did not complete PET/MRI|0|||
33634355|NCT01892540|63036264|FG002|Overall Study|Did not complete PET/MRI|2|||
33634356|NCT01892540|63036262|FG000|Overall Study|Did not fit in scanner|0|||
33634357|NCT01892540|63036263|FG001|Overall Study|Did not fit in scanner|0|||
33634358|NCT01892540|63036264|FG002|Overall Study|Did not fit in scanner|1|||
33634359|NCT01385098|63036272|FG000|Overall Study|Adverse Event|10|||
33634360|NCT01385098|63036272|FG000|Overall Study|Lost to Follow-up|4|||
33634361|NCT01398514|63036280|FG000|Overall Study|Adverse Event|1|||
33634362|NCT01398514|63036281|FG001|Overall Study|Adverse Event|0|||
33634363|NCT01398514|63036280|FG000|Overall Study|Non-compliance with study procedures|2|||
33634364|NCT01398514|63036281|FG001|Overall Study|Non-compliance with study procedures|0|||
33634365|NCT01398514|63036280|FG000|Overall Study|Physiologic non-responsiveness|1|||
33634366|NCT01398514|63036281|FG001|Overall Study|Physiologic non-responsiveness|3|||
33634367|NCT01398514|63036280|FG000|Overall Study|Failure to show a conditioned response|4|||
33634368|NCT01398514|63036281|FG001|Overall Study|Failure to show a conditioned response|3|||
33634369|NCT01398358|63036292|FG000|Overall Study|Lost to Follow-up|11|||
33634370|NCT01398358|63036293|FG001|Overall Study|Lost to Follow-up|21|||
33634371|NCT01398358|63036294|FG002|Overall Study|Lost to Follow-up|18|||
33634372|NCT01398358|63036292|FG000|Overall Study|Withdrawal by Subject|3|||
33634373|NCT01398358|63036293|FG001|Overall Study|Withdrawal by Subject|2|||
33634374|NCT01398358|63036294|FG002|Overall Study|Withdrawal by Subject|2|||
33634375|NCT01398358|63036292|FG000|Overall Study|no longer eligible|1|||
33634376|NCT01398358|63036293|FG001|Overall Study|no longer eligible|0|||
33634377|NCT01398358|63036294|FG002|Overall Study|no longer eligible|1|||
33634378|NCT01778049|63036304|FG000|Open Label Treatment Period|Adverse Event|5|||
33634379|NCT01778049|63036305|FG001|Open Label Treatment Period|Adverse Event|15|||
33634380|NCT01778049|63036306|FG002|Open Label Treatment Period|Adverse Event|0|||
33634381|NCT01778049|63036307|FG003|Open Label Treatment Period|Adverse Event|0|||
33634382|NCT01778049|63036308|FG004|Open Label Treatment Period|Adverse Event|0|||
33634383|NCT01778049|63036309|FG005|Open Label Treatment Period|Adverse Event|0|||
33634384|NCT01778049|63036304|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
33634385|NCT01778049|63036305|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
33634386|NCT01778049|63036306|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
33634387|NCT01778049|63036307|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
33540205|NCT02723864|62930391|FG006|Overall Study|Late determination of ineligibility|0|||
33540206|NCT00705146|62930430|FG000|Overall Study|Lost to Follow-up|1|||
33540207|NCT00705146|62930431|FG001|Overall Study|Lost to Follow-up|1|||
33540208|NCT03203642|62930439|FG000|Overall Study|Adverse Event|3|||
33634388|NCT01778049|63036308|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
33634389|NCT01778049|63036309|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
33634390|NCT01778049|63036304|FG000|Open Label Treatment Period|Protocol Violation|5|||
33634391|NCT01778049|63036305|FG001|Open Label Treatment Period|Protocol Violation|5|||
33634392|NCT01778049|63036306|FG002|Open Label Treatment Period|Protocol Violation|0|||
33634393|NCT01778049|63036307|FG003|Open Label Treatment Period|Protocol Violation|0|||
33634394|NCT01778049|63036308|FG004|Open Label Treatment Period|Protocol Violation|0|||
33634395|NCT01778049|63036309|FG005|Open Label Treatment Period|Protocol Violation|0|||
33634396|NCT01778049|63036304|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
33634397|NCT01778049|63036305|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
33634398|NCT01778049|63036306|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
33634399|NCT01778049|63036307|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
33634400|NCT01778049|63036308|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
33634401|NCT01778049|63036309|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
33634402|NCT01778049|63036304|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
33634403|NCT01778049|63036305|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
33634404|NCT01778049|63036306|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
33634405|NCT01778049|63036307|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
33634406|NCT01778049|63036308|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
33634407|NCT01778049|63036309|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
33634408|NCT01778049|63036304|FG000|Open Label Treatment Period|Not treated|2|||
33634409|NCT01778049|63036305|FG001|Open Label Treatment Period|Not treated|1|||
33634410|NCT01778049|63036306|FG002|Open Label Treatment Period|Not treated|0|||
33634411|NCT01778049|63036307|FG003|Open Label Treatment Period|Not treated|0|||
33634412|NCT01778049|63036308|FG004|Open Label Treatment Period|Not treated|0|||
33634413|NCT01778049|63036309|FG005|Open Label Treatment Period|Not treated|0|||
33634414|NCT01778049|63036304|FG000|Open Label Treatment Period|Other reason not defined above|77|||
33634415|NCT01778049|63036305|FG001|Open Label Treatment Period|Other reason not defined above|94|||
33634416|NCT01778049|63036306|FG002|Open Label Treatment Period|Other reason not defined above|0|||
33634417|NCT01778049|63036307|FG003|Open Label Treatment Period|Other reason not defined above|0|||
33634418|NCT01778049|63036308|FG004|Open Label Treatment Period|Other reason not defined above|0|||
33634419|NCT01778049|63036309|FG005|Open Label Treatment Period|Other reason not defined above|0|||
33634420|NCT01778049|63036304|FG000|Double Blind Treatment Period|Adverse Event|0|||
33634421|NCT01778049|63036305|FG001|Double Blind Treatment Period|Adverse Event|0|||
33634422|NCT01778049|63036306|FG002|Double Blind Treatment Period|Adverse Event|4|||
33634423|NCT01778049|63036307|FG003|Double Blind Treatment Period|Adverse Event|5|||
33634424|NCT01778049|63036308|FG004|Double Blind Treatment Period|Adverse Event|3|||
33634425|NCT01778049|63036309|FG005|Double Blind Treatment Period|Adverse Event|2|||
33634426|NCT01778049|63036304|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
33634427|NCT01778049|63036305|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
33634428|NCT01778049|63036306|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
33634429|NCT01778049|63036307|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
33634430|NCT01778049|63036308|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
33634431|NCT01778049|63036309|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
33634432|NCT01778049|63036304|FG000|Double Blind Treatment Period|Protocol Violation|0|||
33634433|NCT01778049|63036305|FG001|Double Blind Treatment Period|Protocol Violation|0|||
33634434|NCT01778049|63036306|FG002|Double Blind Treatment Period|Protocol Violation|2|||
33540209|NCT03203642|62930440|FG001|Overall Study|Adverse Event|1|||
33540210|NCT03203642|62930439|FG000|Overall Study|Withdrawal by Subject|6|||
33540211|NCT03203642|62930440|FG001|Overall Study|Withdrawal by Subject|6|||
33540212|NCT03203642|62930439|FG000|Overall Study|Lost to Follow-up|2|||
33540213|NCT03203642|62930440|FG001|Overall Study|Lost to Follow-up|1|||
33540214|NCT03203642|62930439|FG000|Overall Study|Termination of the study by sponsor|1|||
33540215|NCT03203642|62930440|FG001|Overall Study|Termination of the study by sponsor|1|||
33540216|NCT03203642|62930439|FG000|Overall Study|Participant moved|0|||
33540217|NCT03203642|62930440|FG001|Overall Study|Participant moved|1|||
33540218|NCT03203642|62930439|FG000|Overall Study|Investigator's decision|3|||
33540219|NCT03203642|62930440|FG001|Overall Study|Investigator's decision|0|||
33540220|NCT03203642|62930439|FG000|Overall Study|Other than above specified|0|||
33540221|NCT03203642|62930440|FG001|Overall Study|Other than above specified|1|||
33540222|NCT02737722|62930450|FG000|Overall Study|Physician Decision|0|||
33540223|NCT02737722|62930451|FG001|Overall Study|Physician Decision|0|||
33540224|NCT02737722|62930452|FG002|Overall Study|Physician Decision|1|||
33540225|NCT02737722|62930453|FG003|Overall Study|Physician Decision|0|||
33540226|NCT03792750|62930463|FG000|Overall Study|Death|3|||
33540227|NCT02750709|62930468|FG000|Treatment Period 1|Adverse Event|0|||
33540228|NCT02750709|62930469|FG001|Treatment Period 1|Adverse Event|0|||
33540229|NCT02750709|62930470|FG002|Treatment Period 1|Adverse Event|0|||
33634435|NCT01778049|63036307|FG003|Double Blind Treatment Period|Protocol Violation|0|||
33634436|NCT01778049|63036308|FG004|Double Blind Treatment Period|Protocol Violation|0|||
33634437|NCT01778049|63036309|FG005|Double Blind Treatment Period|Protocol Violation|0|||
33540230|NCT02750709|62930471|FG003|Treatment Period 1|Adverse Event|0|||
33540231|NCT02750709|62930472|FG004|Treatment Period 1|Adverse Event|0|||
33540232|NCT02750709|62930473|FG005|Treatment Period 1|Adverse Event|1|||
33540233|NCT02723786|62930481|FG000|Overall Study|Lost to Follow-up|1|||
33540234|NCT02723084|62930500|FG000|Overall Study|Withdrawal by Subject|1|||
33634438|NCT01778049|63036304|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
33634439|NCT01778049|63036305|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
33634440|NCT01778049|63036306|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
33634441|NCT01778049|63036307|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
33634442|NCT01778049|63036308|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
33634443|NCT01778049|63036309|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
33634444|NCT01778049|63036304|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
33634445|NCT01778049|63036305|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
33634446|NCT01778049|63036306|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
33634447|NCT01778049|63036307|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
33540235|NCT02723084|62930501|FG001|Overall Study|Withdrawal by Subject|1|||
33540236|NCT02723084|62930500|FG000|Overall Study|Lost to Follow-up|3|||
33540237|NCT02723084|62930501|FG001|Overall Study|Lost to Follow-up|0|||
33540238|NCT02750943|62930509|FG000|Overall Study|Lost to Follow-up|1|||
33540239|NCT02750943|62930510|FG001|Overall Study|Lost to Follow-up|2|||
33540240|NCT02750943|62930509|FG000|Overall Study|Withdrawal by Subject|5|||
33540241|NCT02750943|62930510|FG001|Overall Study|Withdrawal by Subject|7|||
33540242|NCT04730349|62930527|FG000|Overall Study|Participant withdrew consent|1|||
33540243|NCT04730349|62930528|FG001|Overall Study|Participant withdrew consent|0|||
33540244|NCT04730349|62930527|FG000|Overall Study|Disease progression|6|||
33540245|NCT04730349|62930528|FG001|Overall Study|Disease progression|4|||
33540246|NCT04730349|62930527|FG000|Overall Study|Study drug toxicity|0|||
33540247|NCT04730349|62930528|FG001|Overall Study|Study drug toxicity|1|||
33540248|NCT04307394|62930547|FG000|Overall Study|Lost to Follow-up|3|||
33540249|NCT04307394|62930547|FG000|Overall Study|Withdrawal by Subject|2|||
33540250|NCT03940742|62930573|FG000|Overall Study|Lost to Follow-up|0|||
33540251|NCT03940742|62930574|FG001|Overall Study|Lost to Follow-up|0|||
33540252|NCT03940742|62930575|FG002|Overall Study|Lost to Follow-up|0|||
33540253|NCT03940742|62930576|FG003|Overall Study|Lost to Follow-up|1|||
33540254|NCT03917654|62930598|FG000|Year 1|Withdrawal by Subject|1|||
33540255|NCT03917654|62930599|FG001|Year 1|Withdrawal by Subject|0|||
33540256|NCT03917654|62930600|FG002|Year 1|Withdrawal by Subject|0|||
33540257|NCT03917654|62930601|FG003|Year 1|Withdrawal by Subject|0|||
33540258|NCT03917654|62930602|FG004|Year 1|Withdrawal by Subject|0|||
33540259|NCT03917654|62930603|FG005|Year 1|Withdrawal by Subject|1|||
33540260|NCT03917654|62930604|FG006|Year 1|Withdrawal by Subject|6|||
33540261|NCT03917654|62930605|FG007|Year 1|Withdrawal by Subject|2|||
33540262|NCT03917654|62930606|FG008|Year 1|Withdrawal by Subject|5|||
33540263|NCT03917654|62930607|FG009|Year 1|Withdrawal by Subject|3|||
33540264|NCT03917654|62930608|FG010|Year 1|Withdrawal by Subject|1|||
33540265|NCT03917654|62930609|FG011|Year 1|Withdrawal by Subject|0|||
33540266|NCT03917654|62930598|FG000|Year 1|Travel|0|||
33540267|NCT03917654|62930599|FG001|Year 1|Travel|1|||
33540268|NCT03917654|62930600|FG002|Year 1|Travel|1|||
33540269|NCT03917654|62930601|FG003|Year 1|Travel|0|||
33540270|NCT03917654|62930602|FG004|Year 1|Travel|4|||
33540271|NCT03917654|62930603|FG005|Year 1|Travel|4|||
33540272|NCT03917654|62930604|FG006|Year 1|Travel|10|||
33540273|NCT03917654|62930605|FG007|Year 1|Travel|8|||
33540274|NCT03917654|62930606|FG008|Year 1|Travel|2|||
33540275|NCT03917654|62930607|FG009|Year 1|Travel|5|||
33540276|NCT03917654|62930608|FG010|Year 1|Travel|3|||
33540277|NCT03917654|62930609|FG011|Year 1|Travel|3|||
33540278|NCT03917654|62930598|FG000|Year 1|Subject moved away from site|0|||
33540279|NCT03917654|62930599|FG001|Year 1|Subject moved away from site|1|||
33540280|NCT03917654|62930600|FG002|Year 1|Subject moved away from site|0|||
33540281|NCT03917654|62930601|FG003|Year 1|Subject moved away from site|0|||
33540282|NCT03917654|62930602|FG004|Year 1|Subject moved away from site|0|||
33540283|NCT03917654|62930603|FG005|Year 1|Subject moved away from site|0|||
33634448|NCT01778049|63036308|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
33634449|NCT01778049|63036309|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
33634450|NCT01778049|63036304|FG000|Double Blind Treatment Period|Not treated|0|||
33540284|NCT03917654|62930604|FG006|Year 1|Subject moved away from site|1|||
33540285|NCT03917654|62930605|FG007|Year 1|Subject moved away from site|2|||
33540286|NCT03917654|62930606|FG008|Year 1|Subject moved away from site|1|||
33540287|NCT03917654|62930607|FG009|Year 1|Subject moved away from site|0|||
33540288|NCT03917654|62930608|FG010|Year 1|Subject moved away from site|0|||
33540289|NCT03917654|62930609|FG011|Year 1|Subject moved away from site|3|||
33540290|NCT03917654|62930598|FG000|Year 1|Spouse/Family member request|0|||
33540291|NCT03917654|62930599|FG001|Year 1|Spouse/Family member request|0|||
33540292|NCT03917654|62930600|FG002|Year 1|Spouse/Family member request|1|||
33540293|NCT03917654|62930601|FG003|Year 1|Spouse/Family member request|0|||
33540294|NCT03917654|62930602|FG004|Year 1|Spouse/Family member request|1|||
33634451|NCT01778049|63036305|FG001|Double Blind Treatment Period|Not treated|0|||
33634452|NCT01778049|63036306|FG002|Double Blind Treatment Period|Not treated|0|||
33634453|NCT01778049|63036307|FG003|Double Blind Treatment Period|Not treated|2|||
33634454|NCT01778049|63036308|FG004|Double Blind Treatment Period|Not treated|2|||
33634455|NCT01778049|63036309|FG005|Double Blind Treatment Period|Not treated|0|||
33634456|NCT01778049|63036304|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
33634457|NCT01778049|63036305|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
33634458|NCT01778049|63036306|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
33634459|NCT01778049|63036307|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
33634460|NCT01778049|63036308|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
33634461|NCT01778049|63036309|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
33634462|NCT01777581|63036323|FG000|Overall Study|Lost to Follow-up|1|||
33634463|NCT01777581|63036324|FG001|Overall Study|Lost to Follow-up|1|||
33634464|NCT01777581|63036323|FG000|Overall Study|Adverse Event|2|||
33634465|NCT01777581|63036324|FG001|Overall Study|Adverse Event|0|||
33634466|NCT01777581|63036323|FG000|Overall Study|Lack of Efficacy|0|||
33634467|NCT01777581|63036324|FG001|Overall Study|Lack of Efficacy|1|||
33634468|NCT01864148|63036335|FG000|Overall Study|Other|2|||
33634469|NCT01864148|63036336|FG001|Overall Study|Other|1|||
33634470|NCT01864148|63036337|FG002|Overall Study|Other|1|||
33634471|NCT01864148|63036338|FG003|Overall Study|Other|3|||
33634472|NCT01864148|63036339|FG004|Overall Study|Other|1|||
33634473|NCT01864148|63036335|FG000|Overall Study|Death|0|||
33634474|NCT01864148|63036336|FG001|Overall Study|Death|0|||
33634475|NCT01864148|63036337|FG002|Overall Study|Death|0|||
33634476|NCT01864148|63036338|FG003|Overall Study|Death|1|||
33634477|NCT01864148|63036339|FG004|Overall Study|Death|0|||
33634478|NCT01864148|63036335|FG000|Overall Study|Investigator Decision|5|||
33634479|NCT01864148|63036336|FG001|Overall Study|Investigator Decision|0|||
33634480|NCT01864148|63036337|FG002|Overall Study|Investigator Decision|0|||
33634481|NCT01864148|63036338|FG003|Overall Study|Investigator Decision|4|||
33634482|NCT01864148|63036339|FG004|Overall Study|Investigator Decision|6|||
33634483|NCT01864148|63036335|FG000|Overall Study|Withdrawal by Subject|9|||
33634484|NCT01864148|63036336|FG001|Overall Study|Withdrawal by Subject|2|||
33634485|NCT01864148|63036337|FG002|Overall Study|Withdrawal by Subject|6|||
33634486|NCT01864148|63036338|FG003|Overall Study|Withdrawal by Subject|8|||
33634487|NCT01864148|63036339|FG004|Overall Study|Withdrawal by Subject|8|||
33634488|NCT01864148|63036335|FG000|Overall Study|Lost to Follow-up|0|||
33634489|NCT01864148|63036336|FG001|Overall Study|Lost to Follow-up|0|||
33634490|NCT01864148|63036337|FG002|Overall Study|Lost to Follow-up|0|||
33634491|NCT01864148|63036338|FG003|Overall Study|Lost to Follow-up|2|||
33634492|NCT01864148|63036339|FG004|Overall Study|Lost to Follow-up|1|||
33634493|NCT01864148|63036335|FG000|Overall Study|Adverse Event|4|||
33634494|NCT01864148|63036336|FG001|Overall Study|Adverse Event|2|||
33634495|NCT01864148|63036337|FG002|Overall Study|Adverse Event|4|||
33634496|NCT01864148|63036338|FG003|Overall Study|Adverse Event|7|||
33634497|NCT01864148|63036339|FG004|Overall Study|Adverse Event|7|||
33634498|NCT01864148|63036335|FG000|Overall Study|Not Dosed|0|||
33634499|NCT01864148|63036336|FG001|Overall Study|Not Dosed|0|||
33634500|NCT01864148|63036337|FG002|Overall Study|Not Dosed|0|||
33634501|NCT01864148|63036338|FG003|Overall Study|Not Dosed|1|||
33634502|NCT01864148|63036339|FG004|Overall Study|Not Dosed|0|||
33634503|NCT01751139|63036356|FG000|Overall Study|Other|135|||
33634504|NCT01751139|63036356|FG000|Overall Study|Sponsor study termination|1609|||
33634505|NCT01751139|63036356|FG000|Overall Study|Lost to Follow-up|240|||
33634506|NCT01751139|63036356|FG000|Overall Study|Withdrawal by Subject|251|||
33634507|NCT01751139|63036356|FG000|Overall Study|Adverse Event|1|||
33634508|NCT01751139|63036356|FG000|Overall Study|Death|31|||
33634509|NCT01890122|63036364|FG000|Overall Study|Adverse Event|1|||
33634510|NCT01890122|63036365|FG001|Overall Study|Adverse Event|1|||
33634511|NCT01890122|63036366|FG002|Overall Study|Adverse Event|1|||
33634512|NCT01890122|63036367|FG003|Overall Study|Adverse Event|2|||
33634513|NCT01890122|63036364|FG000|Overall Study|Major Protocol Deviation|3|||
33634514|NCT01890122|63036365|FG001|Overall Study|Major Protocol Deviation|1|||
33634515|NCT01890122|63036366|FG002|Overall Study|Major Protocol Deviation|0|||
33634516|NCT01890122|63036367|FG003|Overall Study|Major Protocol Deviation|1|||
33634517|NCT01890122|63036364|FG000|Overall Study|Lost to Follow-up|0|||
33634518|NCT01890122|63036365|FG001|Overall Study|Lost to Follow-up|1|||
33634519|NCT01890122|63036366|FG002|Overall Study|Lost to Follow-up|2|||
33634520|NCT01890122|63036367|FG003|Overall Study|Lost to Follow-up|2|||
33634521|NCT01890122|63036364|FG000|Overall Study|Voluntary Withdrawal|8|||
33634522|NCT01890122|63036365|FG001|Overall Study|Voluntary Withdrawal|8|||
33634523|NCT01890122|63036366|FG002|Overall Study|Voluntary Withdrawal|2|||
33634524|NCT01890122|63036367|FG003|Overall Study|Voluntary Withdrawal|11|||
33634525|NCT01890122|63036364|FG000|Overall Study|Lack of Efficacy|14|||
33634526|NCT01890122|63036365|FG001|Overall Study|Lack of Efficacy|24|||
33634527|NCT01890122|63036366|FG002|Overall Study|Lack of Efficacy|7|||
33634528|NCT01890122|63036367|FG003|Overall Study|Lack of Efficacy|41|||
33634529|NCT01890122|63036364|FG000|Overall Study|Reason not Specified|0|||
33634530|NCT01890122|63036365|FG001|Overall Study|Reason not Specified|1|||
33634531|NCT01890122|63036366|FG002|Overall Study|Reason not Specified|1|||
33634532|NCT01890122|63036367|FG003|Overall Study|Reason not Specified|2|||
33634533|NCT01890122|63036364|FG000|Overall Study|Randomized but not Treated|1|||
33634534|NCT01890122|63036365|FG001|Overall Study|Randomized but not Treated|1|||
33634535|NCT01890122|63036366|FG002|Overall Study|Randomized but not Treated|0|||
33634536|NCT01890122|63036367|FG003|Overall Study|Randomized but not Treated|0|||
33634537|NCT01397890|63036379|FG000|Overall Study|Withdrawal by Subject|7|||
33634538|NCT01397890|63036380|FG001|Overall Study|Withdrawal by Subject|11|||
33634539|NCT01397890|63036379|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
33634540|NCT01397890|63036380|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
33634541|NCT01397890|63036379|FG000|Overall Study|Death|2|||
33634542|NCT01397890|63036380|FG001|Overall Study|Death|3|||
33634543|NCT01397890|63036379|FG000|Overall Study|Lost to Follow-up|1|||
33634544|NCT01397890|63036380|FG001|Overall Study|Lost to Follow-up|4|||
33634545|NCT01397890|63036379|FG000|Overall Study|Condition under Investigation Worsened|1|||
33634546|NCT01397890|63036380|FG001|Overall Study|Condition under Investigation Worsened|3|||
33634547|NCT01397890|63036379|FG000|Overall Study|Adverse Event|1|||
33634548|NCT01397890|63036380|FG001|Overall Study|Adverse Event|2|||
33634549|NCT01397890|63036379|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
33634550|NCT01397890|63036380|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
33634551|NCT01397890|63036379|FG000|Overall Study|Others|2|||
33634552|NCT01397890|63036380|FG001|Overall Study|Others|1|||
33634553|NCT01777269|63036388|FG000|Overall Study|Adverse Event|24|||
33634554|NCT01777269|63036389|FG001|Overall Study|Adverse Event|33|||
33634555|NCT01777269|63036388|FG000|Overall Study|Lack of Efficacy|8|||
33634556|NCT01777269|63036389|FG001|Overall Study|Lack of Efficacy|10|||
33634557|NCT01777269|63036388|FG000|Overall Study|Protocol Violation|4|||
33634558|NCT01777269|63036389|FG001|Overall Study|Protocol Violation|4|||
33634559|NCT01777269|63036388|FG000|Overall Study|Participants reached stopping criteria|1|||
33634560|NCT01777269|63036389|FG001|Overall Study|Participants reached stopping criteria|1|||
33634561|NCT01777269|63036388|FG000|Overall Study|Lost to Follow-up|4|||
33634562|NCT01777269|63036389|FG001|Overall Study|Lost to Follow-up|0|||
33634563|NCT01777269|63036388|FG000|Overall Study|Physician Decision|5|||
33634564|NCT01777269|63036389|FG001|Overall Study|Physician Decision|2|||
33634565|NCT01777269|63036388|FG000|Overall Study|Withdrawal by Subject|9|||
33634566|NCT01777269|63036389|FG001|Overall Study|Withdrawal by Subject|9|||
33634567|NCT04016272|63036397|FG000|Overall Study|Withdrawal by Subject|1|||
33634568|NCT04016272|63036398|FG001|Overall Study|Withdrawal by Subject|2|||
33634569|NCT01751061|63036406|FG000|Overall Study|Death|1|||
33634570|NCT01751061|63036407|FG001|Overall Study|Death|0|||
33540295|NCT03917654|62930603|FG005|Year 1|Spouse/Family member request|0|||
33540296|NCT03917654|62930604|FG006|Year 1|Spouse/Family member request|0|||
33540297|NCT03917654|62930605|FG007|Year 1|Spouse/Family member request|2|||
33540298|NCT03917654|62930606|FG008|Year 1|Spouse/Family member request|0|||
33540299|NCT03917654|62930607|FG009|Year 1|Spouse/Family member request|0|||
33540300|NCT03917654|62930608|FG010|Year 1|Spouse/Family member request|0|||
33540301|NCT03917654|62930609|FG011|Year 1|Spouse/Family member request|1|||
33540302|NCT03917654|62930598|FG000|Year 1|Death|0|||
33540303|NCT03917654|62930599|FG001|Year 1|Death|0|||
33540304|NCT03917654|62930600|FG002|Year 1|Death|0|||
33540305|NCT03917654|62930601|FG003|Year 1|Death|0|||
33634571|NCT01751061|63036406|FG000|Overall Study|patient death|5|||
33634572|NCT01751061|63036407|FG001|Overall Study|patient death|0|||
33634573|NCT01751061|63036406|FG000|Overall Study|Lost to Follow-up|40|||
33462035|NCT00078819|62835921|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
33462036|NCT00078819|62835922|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
33462037|NCT00078819|62835919|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
33462038|NCT00078819|62835920|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
33462039|NCT00078819|62835921|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
33462040|NCT00078819|62835922|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
33462041|NCT00078819|62835919|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
33540306|NCT03917654|62930602|FG004|Year 1|Death|0|||
33540307|NCT03917654|62930603|FG005|Year 1|Death|0|||
33540308|NCT03917654|62930604|FG006|Year 1|Death|0|||
33540309|NCT03917654|62930605|FG007|Year 1|Death|0|||
33634574|NCT01751061|63036407|FG001|Overall Study|Lost to Follow-up|25|||
33634575|NCT01751061|63036406|FG000|Overall Study|patient regained decisional capacity|4|||
33540310|NCT03917654|62930606|FG008|Year 1|Death|1|||
33540311|NCT03917654|62930607|FG009|Year 1|Death|1|||
33634576|NCT01751061|63036407|FG001|Overall Study|patient regained decisional capacity|8|||
33634577|NCT01751061|63036406|FG000|Overall Study|Withdrawal by Subject|4|||
33634578|NCT01751061|63036407|FG001|Overall Study|Withdrawal by Subject|1|||
33634579|NCT01751061|63036406|FG000|Overall Study|Physician Decision|2|||
33634580|NCT01751061|63036407|FG001|Overall Study|Physician Decision|0|||
33634581|NCT01777191|63036415|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
33634582|NCT01777191|63036416|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
33634583|NCT01777191|63036415|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
33634584|NCT01777191|63036416|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
33634585|NCT01777191|63036415|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
33634586|NCT01777191|63036416|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
33634587|NCT01777191|63036415|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
33634588|NCT01777191|63036416|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
33634589|NCT01777191|63036415|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
33634590|NCT01777191|63036416|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
33634591|NCT01777191|63036415|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
33540312|NCT03917654|62930608|FG010|Year 1|Death|0|||
33540313|NCT03917654|62930609|FG011|Year 1|Death|0|||
33540314|NCT03917654|62930598|FG000|Year 1|Lost to Follow-up|0|||
33540315|NCT03917654|62930599|FG001|Year 1|Lost to Follow-up|0|||
33540316|NCT03917654|62930600|FG002|Year 1|Lost to Follow-up|0|||
33540317|NCT03917654|62930601|FG003|Year 1|Lost to Follow-up|0|||
33540318|NCT03917654|62930602|FG004|Year 1|Lost to Follow-up|0|||
33540319|NCT03917654|62930603|FG005|Year 1|Lost to Follow-up|0|||
33540320|NCT03917654|62930604|FG006|Year 1|Lost to Follow-up|2|||
33540321|NCT03917654|62930605|FG007|Year 1|Lost to Follow-up|0|||
33634592|NCT01777191|63036416|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
33634593|NCT01777191|63036415|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
33634594|NCT01777191|63036416|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
33634595|NCT01777191|63036415|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
33634596|NCT01777191|63036416|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
33634597|NCT01777191|63036415|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
33634598|NCT01777191|63036416|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
33634599|NCT01777191|63036415|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
33634600|NCT01777191|63036416|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
33634601|NCT01777191|63036415|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
33634602|NCT01777191|63036416|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
33634603|NCT01896050|63036427|FG000|Overall Study|Adverse Event|37|||
33634604|NCT01896050|63036428|FG001|Overall Study|Adverse Event|2|||
33634605|NCT01896050|63036427|FG000|Overall Study|Death|1|||
33634606|NCT01896050|63036428|FG001|Overall Study|Death|0|||
33634607|NCT01775787|63036436|FG000|First 7-10 Days|Adverse Event|0|||
33634608|NCT01775787|63036437|FG001|First 7-10 Days|Adverse Event|1|||
33634609|NCT01775787|63036436|FG000|First 7-10 Days|family emergency|0|||
33634610|NCT01775787|63036437|FG001|First 7-10 Days|family emergency|1|||
33634611|NCT01775787|63036436|FG000|First 7-10 Days|time commitment|0|||
33634612|NCT01775787|63036437|FG001|First 7-10 Days|time commitment|2|||
33634613|NCT01775787|63036436|FG000|First 7-10 Days|concerns with using IV|1|||
33634614|NCT01775787|63036437|FG001|First 7-10 Days|concerns with using IV|2|||
33634615|NCT01775787|63036436|FG000|Second 7-10 Days|time commitment|0|||
33634616|NCT01775787|63036437|FG001|Second 7-10 Days|time commitment|1|||
33634617|NCT01775787|63036436|FG000|Second 7-10 Days|concerns with using IV|0|||
33634618|NCT01775787|63036437|FG001|Second 7-10 Days|concerns with using IV|1|||
33634619|NCT01775553|63036445|FG000|Overall Study|Adverse Event|1|||
33634620|NCT01775553|63036445|FG000|Overall Study|Disease Progression|12|||
33634621|NCT01775475|63036451|FG000|Overall Study|Death|3|||
33634622|NCT01775475|63036452|FG001|Overall Study|Death|3|||
33540322|NCT03917654|62930606|FG008|Year 1|Lost to Follow-up|0|||
33540323|NCT03917654|62930607|FG009|Year 1|Lost to Follow-up|0|||
33634623|NCT01774929|63036458|FG000|Overall Study|Adverse Event|3|||
33634624|NCT01888874|63036469|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
33634625|NCT01888874|63036470|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
33634626|NCT01888874|63036471|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
33634627|NCT01888874|63036472|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
33634628|NCT01888874|63036473|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
33634629|NCT01888874|63036474|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
33634630|NCT01888874|63036475|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
33326404|NCT00946647|62703162|FG001|Phase ll Part|Death|0|||
33634631|NCT01888874|63036469|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
33634632|NCT01888874|63036470|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
33326405|NCT00946647|62703163|FG002|Phase ll Part|Death|0|||
33326406|NCT00946647|62703164|FG003|Phase ll Part|Death|7|||
33326407|NCT00946647|62703165|FG004|Phase ll Part|Death|4|||
33326408|NCT00946647|62703161|FG000|Phase ll Part|Disease progression|0|||
33540324|NCT03917654|62930608|FG010|Year 1|Lost to Follow-up|0|||
33326409|NCT00946647|62703162|FG001|Phase ll Part|Disease progression|0|||
33540325|NCT03917654|62930609|FG011|Year 1|Lost to Follow-up|0|||
33326410|NCT00946647|62703163|FG002|Phase ll Part|Disease progression|0|||
33540326|NCT03917654|62930598|FG000|Year 1|Missed visits|0|||
33540327|NCT03917654|62930599|FG001|Year 1|Missed visits|0|||
33634633|NCT01888874|63036471|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
33634634|NCT01888874|63036472|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
33634635|NCT01888874|63036473|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
33634636|NCT01888874|63036474|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
33634637|NCT01888874|63036475|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
33634638|NCT01888874|63036469|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
33634639|NCT01888874|63036470|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
33634640|NCT01888874|63036471|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
33634641|NCT01888874|63036472|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
33634642|NCT01888874|63036473|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
33634643|NCT01888874|63036474|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
33634644|NCT01888874|63036475|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
33634645|NCT01888874|63036469|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
33634646|NCT01888874|63036470|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
33634647|NCT01888874|63036471|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
33634648|NCT01888874|63036472|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
33634649|NCT01888874|63036473|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
33634650|NCT01888874|63036474|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
33634651|NCT01888874|63036475|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
33634652|NCT01888874|63036469|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33634653|NCT01888874|63036470|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33634654|NCT01888874|63036471|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33634655|NCT01888874|63036472|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33540328|NCT03917654|62930600|FG002|Year 1|Missed visits|0|||
33634656|NCT01888874|63036473|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
33634657|NCT01888874|63036474|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33634658|NCT01888874|63036475|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33634659|NCT01888874|63036469|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
33634660|NCT01888874|63036470|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
33634661|NCT01888874|63036471|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
33634662|NCT01888874|63036472|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
33326411|NCT00946647|62703164|FG003|Phase ll Part|Disease progression|6|||
33326412|NCT00946647|62703165|FG004|Phase ll Part|Disease progression|14|||
33326413|NCT00946647|62703161|FG000|Phase ll Part|Protocol Violation|0|||
33540329|NCT03917654|62930601|FG003|Year 1|Missed visits|0|||
33540330|NCT03917654|62930602|FG004|Year 1|Missed visits|0|||
33540331|NCT03917654|62930603|FG005|Year 1|Missed visits|0|||
33540332|NCT03917654|62930604|FG006|Year 1|Missed visits|0|||
33540333|NCT03917654|62930605|FG007|Year 1|Missed visits|0|||
33540334|NCT03917654|62930606|FG008|Year 1|Missed visits|0|||
33540335|NCT03917654|62930607|FG009|Year 1|Missed visits|0|||
33540336|NCT03917654|62930608|FG010|Year 1|Missed visits|1|||
33540337|NCT03917654|62930609|FG011|Year 1|Missed visits|1|||
33540338|NCT03917654|62930598|FG000|Year 1|Pregnancy|0|||
33540339|NCT03917654|62930599|FG001|Year 1|Pregnancy|0|||
33540340|NCT03917654|62930600|FG002|Year 1|Pregnancy|0|||
33540341|NCT03917654|62930601|FG003|Year 1|Pregnancy|0|||
33540342|NCT03917654|62930602|FG004|Year 1|Pregnancy|0|||
33540343|NCT03917654|62930603|FG005|Year 1|Pregnancy|0|||
33540344|NCT03917654|62930604|FG006|Year 1|Pregnancy|0|||
33540345|NCT03917654|62930605|FG007|Year 1|Pregnancy|1|||
33540346|NCT03917654|62930606|FG008|Year 1|Pregnancy|0|||
33540347|NCT03917654|62930607|FG009|Year 1|Pregnancy|1|||
33540348|NCT03917654|62930608|FG010|Year 1|Pregnancy|0|||
33540349|NCT03917654|62930609|FG011|Year 1|Pregnancy|0|||
33540350|NCT03917654|62930598|FG000|Year 2|Travel|1|||
33540351|NCT03917654|62930599|FG001|Year 2|Travel|0|||
33540352|NCT03917654|62930600|FG002|Year 2|Travel|0|||
33540353|NCT03917654|62930601|FG003|Year 2|Travel|0|||
33540354|NCT03917654|62930602|FG004|Year 2|Travel|1|||
33540355|NCT03917654|62930603|FG005|Year 2|Travel|1|||
33540356|NCT03917654|62930604|FG006|Year 2|Travel|2|||
33540357|NCT03917654|62930605|FG007|Year 2|Travel|1|||
33540358|NCT03917654|62930606|FG008|Year 2|Travel|0|||
33540359|NCT03917654|62930607|FG009|Year 2|Travel|1|||
33540360|NCT03917654|62930608|FG010|Year 2|Travel|0|||
33540361|NCT03917654|62930609|FG011|Year 2|Travel|1|||
33540362|NCT03917654|62930598|FG000|Year 2|Married|1|||
33634663|NCT01888874|63036473|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
33634664|NCT01888874|63036474|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
33326414|NCT00946647|62703162|FG001|Phase ll Part|Protocol Violation|0|||
33540363|NCT03917654|62930599|FG001|Year 2|Married|0|||
33540364|NCT03917654|62930600|FG002|Year 2|Married|0|||
33540365|NCT03917654|62930601|FG003|Year 2|Married|0|||
33540366|NCT03917654|62930602|FG004|Year 2|Married|0|||
33540367|NCT03917654|62930603|FG005|Year 2|Married|0|||
33540368|NCT03917654|62930604|FG006|Year 2|Married|1|||
33540369|NCT03917654|62930605|FG007|Year 2|Married|1|||
33540370|NCT03917654|62930606|FG008|Year 2|Married|0|||
33540371|NCT03917654|62930607|FG009|Year 2|Married|0|||
33540372|NCT03917654|62930608|FG010|Year 2|Married|0|||
33540373|NCT03917654|62930609|FG011|Year 2|Married|0|||
33540374|NCT03917654|62930598|FG000|Year 2|Subject moved away from site|1|||
33540375|NCT03917654|62930599|FG001|Year 2|Subject moved away from site|0|||
33540376|NCT03917654|62930600|FG002|Year 2|Subject moved away from site|0|||
33540377|NCT03917654|62930601|FG003|Year 2|Subject moved away from site|0|||
33540378|NCT03917654|62930602|FG004|Year 2|Subject moved away from site|1|||
33540379|NCT03917654|62930603|FG005|Year 2|Subject moved away from site|0|||
33540380|NCT03917654|62930604|FG006|Year 2|Subject moved away from site|2|||
33540381|NCT03917654|62930605|FG007|Year 2|Subject moved away from site|3|||
33540382|NCT03917654|62930606|FG008|Year 2|Subject moved away from site|0|||
33540383|NCT03917654|62930607|FG009|Year 2|Subject moved away from site|2|||
33540384|NCT03917654|62930608|FG010|Year 2|Subject moved away from site|0|||
33540385|NCT03917654|62930609|FG011|Year 2|Subject moved away from site|1|||
33634665|NCT01888874|63036475|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
33634666|NCT01888874|63036469|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
33634667|NCT01888874|63036470|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
33634668|NCT01888874|63036471|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
33634669|NCT01888874|63036472|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
33634670|NCT01888874|63036473|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
33634671|NCT01888874|63036474|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
33634672|NCT01888874|63036475|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
33634673|NCT01888874|63036469|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
33634674|NCT01888874|63036470|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
33634675|NCT01888874|63036471|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
33634676|NCT01888874|63036472|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
33634677|NCT01888874|63036473|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
33634678|NCT01888874|63036474|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
33634679|NCT01888874|63036475|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
33634680|NCT01888874|63036469|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
33634681|NCT01888874|63036470|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
33540386|NCT03917654|62930598|FG000|Year 2|Year 2 Screening failure|0|||
33540387|NCT03917654|62930599|FG001|Year 2|Year 2 Screening failure|1|||
33540388|NCT03917654|62930600|FG002|Year 2|Year 2 Screening failure|0|||
33540389|NCT03917654|62930601|FG003|Year 2|Year 2 Screening failure|0|||
33540390|NCT03917654|62930602|FG004|Year 2|Year 2 Screening failure|2|||
33540391|NCT03917654|62930603|FG005|Year 2|Year 2 Screening failure|0|||
33540392|NCT03917654|62930604|FG006|Year 2|Year 2 Screening failure|4|||
33540393|NCT03917654|62930605|FG007|Year 2|Year 2 Screening failure|3|||
33540394|NCT03917654|62930606|FG008|Year 2|Year 2 Screening failure|10|||
33540395|NCT03917654|62930607|FG009|Year 2|Year 2 Screening failure|2|||
33540396|NCT03917654|62930608|FG010|Year 2|Year 2 Screening failure|1|||
33540397|NCT03917654|62930609|FG011|Year 2|Year 2 Screening failure|1|||
33540398|NCT03917654|62930598|FG000|Year 2|Death|0|||
33540399|NCT03917654|62930599|FG001|Year 2|Death|0|||
33540400|NCT03917654|62930600|FG002|Year 2|Death|0|||
33634682|NCT01888874|63036471|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
33634683|NCT01888874|63036472|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
33634684|NCT01888874|63036473|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
33634685|NCT01888874|63036474|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
33634686|NCT01888874|63036475|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
33634687|NCT01888874|63036469|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
33634688|NCT01888874|63036470|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
33634689|NCT01888874|63036471|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
33634690|NCT01888874|63036472|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
33634691|NCT01888874|63036473|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
33634692|NCT01888874|63036474|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
33634693|NCT01888874|63036475|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
33634694|NCT01888874|63036469|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
33634695|NCT01888874|63036470|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
33634696|NCT01888874|63036471|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
33326415|NCT00946647|62703163|FG002|Phase ll Part|Protocol Violation|0|||
33540401|NCT03917654|62930601|FG003|Year 2|Death|0|||
33540402|NCT03917654|62930602|FG004|Year 2|Death|0|||
33326416|NCT00946647|62703164|FG003|Phase ll Part|Protocol Violation|4|||
33326417|NCT00946647|62703165|FG004|Phase ll Part|Protocol Violation|2|||
33540403|NCT03917654|62930603|FG005|Year 2|Death|1|||
33540404|NCT03917654|62930604|FG006|Year 2|Death|0|||
33540405|NCT03917654|62930605|FG007|Year 2|Death|0|||
33540406|NCT03917654|62930606|FG008|Year 2|Death|1|||
33634697|NCT01888874|63036472|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
33634698|NCT01888874|63036473|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
33634699|NCT01888874|63036474|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
33634700|NCT01888874|63036475|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
33634701|NCT01888874|63036469|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
33634702|NCT01888874|63036470|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
33634703|NCT01888874|63036471|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
33634704|NCT01888874|63036472|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
33634705|NCT01888874|63036473|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
33634706|NCT01888874|63036474|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
33634707|NCT01888874|63036475|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
33634708|NCT01888874|63036469|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
33634709|NCT01888874|63036470|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
33634710|NCT01888874|63036471|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
33634711|NCT01888874|63036472|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
33634712|NCT01888874|63036473|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
33634713|NCT01888874|63036474|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
33634714|NCT01888874|63036475|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
33634715|NCT01749735|63036494|FG000|Overall Study|Withdrawal by Subject|1|||
33634716|NCT01749735|63036495|FG001|Overall Study|Withdrawal by Subject|0|||
33634717|NCT01749033|63036504|FG000|Overall Study|Did not receive allocated intervention|3|||
33634718|NCT01749033|63036505|FG001|Overall Study|Did not receive allocated intervention|3|||
33634719|NCT01749033|63036506|FG002|Overall Study|Did not receive allocated intervention|0|||
33634720|NCT01749033|63036504|FG000|Overall Study|Lost to Follow-up|0|||
33634721|NCT01749033|63036505|FG001|Overall Study|Lost to Follow-up|2|||
33634722|NCT01749033|63036506|FG002|Overall Study|Lost to Follow-up|1|||
33634723|NCT01774305|63036517|FG000|Overall Study|Physician Decision|1|||
33634724|NCT01774305|63036518|FG001|Overall Study|Physician Decision|0|||
33634725|NCT01737021|63036526|FG000|Overall Study|Lost to Follow-up|5|||
33634726|NCT01737021|63036527|FG001|Overall Study|Lost to Follow-up|3|||
33634727|NCT01397422|63036537|FG000|Overall Study|Adverse Event|0|||
33634728|NCT01397422|63036538|FG001|Overall Study|Adverse Event|3|||
33634729|NCT01397422|63036539|FG002|Overall Study|Adverse Event|3|||
33634730|NCT01397422|63036540|FG003|Overall Study|Adverse Event|8|||
33634731|NCT01397422|63036537|FG000|Overall Study|Withdrawal by Subject|1|||
33634732|NCT01397422|63036538|FG001|Overall Study|Withdrawal by Subject|0|||
33634733|NCT01397422|63036539|FG002|Overall Study|Withdrawal by Subject|0|||
33634734|NCT01397422|63036540|FG003|Overall Study|Withdrawal by Subject|0|||
33634735|NCT01397422|63036537|FG000|Overall Study|Increased bradykinesia related to PD|1|||
33634736|NCT01397422|63036538|FG001|Overall Study|Increased bradykinesia related to PD|0|||
33634737|NCT01397422|63036539|FG002|Overall Study|Increased bradykinesia related to PD|0|||
33634738|NCT01397422|63036540|FG003|Overall Study|Increased bradykinesia related to PD|0|||
33634739|NCT01736553|63036554|FG000|Overall Study|Death|12|||
33634740|NCT01736553|63036555|FG001|Overall Study|Death|0|||
33326418|NCT00946647|62703161|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
33540407|NCT03917654|62930607|FG009|Year 2|Death|1|||
33540408|NCT03917654|62930608|FG010|Year 2|Death|0|||
33540409|NCT03917654|62930609|FG011|Year 2|Death|0|||
33540410|NCT03917654|62930598|FG000|Year 2|Withdrawal by Subject|0|||
33540411|NCT03917654|62930599|FG001|Year 2|Withdrawal by Subject|0|||
33540412|NCT03917654|62930600|FG002|Year 2|Withdrawal by Subject|0|||
33540413|NCT03917654|62930601|FG003|Year 2|Withdrawal by Subject|0|||
33540414|NCT03917654|62930602|FG004|Year 2|Withdrawal by Subject|0|||
33540415|NCT03917654|62930603|FG005|Year 2|Withdrawal by Subject|0|||
33540416|NCT03917654|62930604|FG006|Year 2|Withdrawal by Subject|3|||
33540417|NCT03917654|62930605|FG007|Year 2|Withdrawal by Subject|0|||
33540418|NCT03917654|62930606|FG008|Year 2|Withdrawal by Subject|2|||
33540419|NCT03917654|62930607|FG009|Year 2|Withdrawal by Subject|5|||
33540420|NCT03917654|62930608|FG010|Year 2|Withdrawal by Subject|0|||
33540421|NCT03917654|62930609|FG011|Year 2|Withdrawal by Subject|0|||
33540422|NCT03917654|62930598|FG000|Year 2|Spouse/family member request|0|||
33634741|NCT01736553|63036554|FG000|Overall Study|Withdrawal by Subject|5|||
33634742|NCT01736553|63036555|FG001|Overall Study|Withdrawal by Subject|2|||
33634743|NCT01736553|63036554|FG000|Overall Study|Lost to Follow-up|2|||
33634744|NCT01736553|63036555|FG001|Overall Study|Lost to Follow-up|2|||
33634745|NCT01888640|63036582|FG000|Overall Study|Lost to Follow-up|1|||
33634746|NCT01888640|63036583|FG001|Overall Study|Lost to Follow-up|2|||
33634747|NCT01888640|63036584|FG002|Overall Study|Lost to Follow-up|0|||
33634748|NCT01888640|63036582|FG000|Overall Study|Withdrawal by Subject|15|||
33634749|NCT01888640|63036583|FG001|Overall Study|Withdrawal by Subject|11|||
33540423|NCT03917654|62930599|FG001|Year 2|Spouse/family member request|0|||
33540424|NCT03917654|62930600|FG002|Year 2|Spouse/family member request|0|||
33540425|NCT03917654|62930601|FG003|Year 2|Spouse/family member request|0|||
33634750|NCT01888640|63036584|FG002|Overall Study|Withdrawal by Subject|4|||
33634751|NCT01888640|63036582|FG000|Overall Study|Minimum dose not met|10|||
33634752|NCT01888640|63036583|FG001|Overall Study|Minimum dose not met|16|||
33634753|NCT01888640|63036584|FG002|Overall Study|Minimum dose not met|0|||
33634754|NCT01888640|63036582|FG000|Overall Study|Given wrong unit (placebo)|1|||
33634755|NCT01888640|63036583|FG001|Overall Study|Given wrong unit (placebo)|0|||
33634756|NCT01888640|63036584|FG002|Overall Study|Given wrong unit (placebo)|0|||
33326419|NCT00946647|62703162|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
33326420|NCT00946647|62703163|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
33462042|NCT00078819|62835920|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
33462043|NCT00078819|62835921|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
33462044|NCT00078819|62835922|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
33462045|NCT00078819|62835919|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
33462046|NCT00078819|62835920|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
33462047|NCT00078819|62835921|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
33462048|NCT00078819|62835922|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
33462049|NCT00078819|62835919|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
33462050|NCT00078819|62835920|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
33462051|NCT00078819|62835921|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
33462052|NCT00078819|62835922|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
33462053|NCT00078819|62835919|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
33462054|NCT00078819|62835920|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
33462055|NCT00078819|62835921|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
33462056|NCT00078819|62835922|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
33462057|NCT00098865|62835939|FG000|Overall Study|Progressive Disease|6|||
33462058|NCT00098865|62835939|FG000|Overall Study|Adverse Event|2|||
33462059|NCT00098865|62835939|FG000|Overall Study|Alternative Therapy|1|||
33462060|NCT02954458|62835947|FG000|Overall Study|Adverse Event|0|||
33462061|NCT02954458|62835948|FG001|Overall Study|Adverse Event|0|||
33462062|NCT02954458|62835949|FG002|Overall Study|Adverse Event|0|||
33462063|NCT02954458|62835950|FG003|Overall Study|Adverse Event|1|||
33462064|NCT02954458|62835947|FG000|Overall Study|Withdrawal by Subject|0|||
33462065|NCT02954458|62835948|FG001|Overall Study|Withdrawal by Subject|0|||
33462066|NCT02954458|62835949|FG002|Overall Study|Withdrawal by Subject|0|||
33462067|NCT02954458|62835950|FG003|Overall Study|Withdrawal by Subject|1|||
33634757|NCT01888640|63036582|FG000|Overall Study|Excluded for prior TENS|0|||
33634758|NCT01888640|63036583|FG001|Overall Study|Excluded for prior TENS|1|||
33634759|NCT01888640|63036584|FG002|Overall Study|Excluded for prior TENS|0|||
33634760|NCT01888640|63036582|FG000|Overall Study|Researcher Termination of Participant|0|||
33634761|NCT01888640|63036583|FG001|Overall Study|Researcher Termination of Participant|1|||
33634762|NCT01888640|63036584|FG002|Overall Study|Researcher Termination of Participant|1|||
33634763|NCT01736475|63036597|FG000|Overall Study|Adverse Event|4|||
33634764|NCT01736475|63036598|FG001|Overall Study|Adverse Event|0|||
33634765|NCT01736475|63036597|FG000|Overall Study|Withdrawal by Subject|2|||
33634766|NCT01736475|63036598|FG001|Overall Study|Withdrawal by Subject|0|||
33634767|NCT01736475|63036597|FG000|Overall Study|Protocol Violation|4|||
33634768|NCT01736475|63036598|FG001|Overall Study|Protocol Violation|0|||
33634769|NCT01736475|63036597|FG000|Overall Study|Other - Screen failure|1|||
33326421|NCT00946647|62703164|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
33462068|NCT02954458|62835947|FG000|Overall Study|Physician Decision|0|||
33462069|NCT02954458|62835948|FG001|Overall Study|Physician Decision|0|||
33462070|NCT02954458|62835949|FG002|Overall Study|Physician Decision|1|||
33462071|NCT02954458|62835950|FG003|Overall Study|Physician Decision|1|||
33462072|NCT02954458|62835947|FG000|Overall Study|Lost to Follow-up|1|||
33462073|NCT02954458|62835948|FG001|Overall Study|Lost to Follow-up|0|||
33462074|NCT02954458|62835949|FG002|Overall Study|Lost to Follow-up|0|||
33462075|NCT02954458|62835950|FG003|Overall Study|Lost to Follow-up|1|||
33462076|NCT02954458|62835947|FG000|Overall Study|Death|0|||
33462077|NCT02954458|62835948|FG001|Overall Study|Death|0|||
33462078|NCT02954458|62835949|FG002|Overall Study|Death|0|||
33634770|NCT01736475|63036598|FG001|Overall Study|Other - Screen failure|0|||
33634771|NCT01736475|63036597|FG000|Overall Study|Other - Surgical procedure|1|||
33634772|NCT01736475|63036598|FG001|Overall Study|Other - Surgical procedure|0|||
33634773|NCT01863758|63036615|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
33634774|NCT01863758|63036615|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
33634775|NCT01863680|63036619|FG000|Overall Study|Adverse Event|17|||
33634776|NCT01863680|63036619|FG000|Overall Study|Risk of OHSS|17|||
33634777|NCT01863680|63036619|FG000|Overall Study|Spontaneous pregnancy|2|||
33634778|NCT01863680|63036619|FG000|Overall Study|Withdrawal by Subject|1|||
33634779|NCT01863680|63036619|FG000|Overall Study|Did not undergo IVF/ET|14|||
33634780|NCT01863680|63036619|FG000|Overall Study|Other|6|||
33634781|NCT01747629|63036625|FG000|Overall Study|Adverse Event|1|||
33634782|NCT01747629|63036626|FG001|Overall Study|Adverse Event|2|||
33634783|NCT01747629|63036625|FG000|Overall Study|Withdrawal by Subject|2|||
33634784|NCT01747629|63036626|FG001|Overall Study|Withdrawal by Subject|2|||
33634785|NCT01747629|63036625|FG000|Overall Study|Noncompliance|1|||
33634786|NCT01747629|63036626|FG001|Overall Study|Noncompliance|1|||
33634787|NCT01747629|63036625|FG000|Overall Study|Inclusion criteria not met|1|||
33326422|NCT00946647|62703165|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
33462079|NCT02954458|62835950|FG003|Overall Study|Death|1|||
33462080|NCT02954458|62835947|FG000|Overall Study|Other|0|||
33462081|NCT02954458|62835948|FG001|Overall Study|Other|0|||
33634788|NCT01747629|63036626|FG001|Overall Study|Inclusion criteria not met|0|||
33634789|NCT01747629|63036625|FG000|Overall Study|Not treated|1|||
33634790|NCT01747629|63036626|FG001|Overall Study|Not treated|0|||
33634791|NCT01747629|63036625|FG000|Overall Study|Other|2|||
33634792|NCT01747629|63036626|FG001|Overall Study|Other|1|||
33634793|NCT01863368|63036634|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
33634794|NCT01863368|63036635|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
33634795|NCT01863368|63036634|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
33634796|NCT01863368|63036635|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
33634797|NCT01863368|63036634|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
33634798|NCT01863368|63036635|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
33634799|NCT01863368|63036634|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
33634800|NCT01863368|63036635|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
33634801|NCT01863368|63036634|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
33634802|NCT01863368|63036635|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
33634803|NCT01863368|63036634|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
33634804|NCT01863368|63036635|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
33634805|NCT01886690|63036644|FG000|Overall Study|Protocol Violation|0|||
33634806|NCT01886690|63036645|FG001|Overall Study|Protocol Violation|1|||
33634807|NCT01886690|63036644|FG000|Overall Study|Personal Reasons|0|||
33634808|NCT01886690|63036645|FG001|Overall Study|Personal Reasons|1|||
33634809|NCT01886378|63036651|FG000|Overall Study|Adverse Event|1|||
33634810|NCT01886378|63036651|FG000|Overall Study|Withdrawal by Subject|4|||
33634811|NCT01886300|63036655|FG000|Overall Study|Trial terminated by sponsor|16|||
33634812|NCT01885208|63036661|FG000|Overall Study|Unclassified|32|||
33634813|NCT01885208|63036662|FG001|Overall Study|Unclassified|38|||
33634814|NCT01859702|63036668|FG000|Overall Study|Protocol deviation|3|||
33634815|NCT01859702|63036668|FG000|Overall Study|Adverse Event|2|||
33634816|NCT01835132|63036672|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
33634817|NCT01747551|63036678|FG000|Overall Study|Progressive Disease|24|||
33634818|NCT01747551|63036679|FG001|Overall Study|Progressive Disease|17|||
33540426|NCT03917654|62930602|FG004|Year 2|Spouse/family member request|0|||
33540427|NCT03917654|62930603|FG005|Year 2|Spouse/family member request|0|||
33634819|NCT01747551|63036678|FG000|Overall Study|Death|3|||
33634820|NCT01747551|63036679|FG001|Overall Study|Death|1|||
33326423|NCT00946101|62703180|FG000|Overall Study|Lost to Follow-up|2|||
33462082|NCT02954458|62835949|FG002|Overall Study|Other|0|||
33462083|NCT02954458|62835950|FG003|Overall Study|Other|7|||
33462084|NCT03500224|62835964|FG000|Overall Study|Withdrawal by Subject|2|||
33462085|NCT00077649|62835972|FG000|Overall Study|Adverse Event|5|||
33462086|NCT00077649|62835973|FG001|Overall Study|Adverse Event|1|||
33462087|NCT00077649|62835974|FG002|Overall Study|Adverse Event|7|||
33462088|NCT00077649|62835975|FG003|Overall Study|Adverse Event|9|||
33462089|NCT00077649|62835972|FG000|Overall Study|Lack of Efficacy|5|||
33462090|NCT00077649|62835973|FG001|Overall Study|Lack of Efficacy|3|||
33462091|NCT00077649|62835974|FG002|Overall Study|Lack of Efficacy|3|||
33462092|NCT00077649|62835975|FG003|Overall Study|Lack of Efficacy|2|||
33540428|NCT03917654|62930604|FG006|Year 2|Spouse/family member request|1|||
33634821|NCT01747551|63036678|FG000|Overall Study|Adverse Event|7|||
33634822|NCT01747551|63036679|FG001|Overall Study|Adverse Event|1|||
33634823|NCT01747551|63036678|FG000|Overall Study|Prolonged Treatment Delay|2|||
33634824|NCT01747551|63036679|FG001|Overall Study|Prolonged Treatment Delay|0|||
33634825|NCT01747551|63036678|FG000|Overall Study|Withdrawal by Subject|3|||
33634826|NCT01747551|63036679|FG001|Overall Study|Withdrawal by Subject|1|||
33634827|NCT01747551|63036678|FG000|Overall Study|Physician Decision|2|||
33634828|NCT01747551|63036679|FG001|Overall Study|Physician Decision|1|||
33634829|NCT01747551|63036678|FG000|Overall Study|Other|2|||
33634830|NCT01747551|63036679|FG001|Overall Study|Other|0|||
33634831|NCT01736397|63036687|FG000|Overall Study|Lack of Efficacy|1|||
33634832|NCT01736397|63036688|FG001|Overall Study|Lack of Efficacy|11|||
33634833|NCT01736397|63036687|FG000|Overall Study|Withdrawal by Subject|6|||
33634834|NCT01736397|63036688|FG001|Overall Study|Withdrawal by Subject|5|||
33634835|NCT01736397|63036687|FG000|Overall Study|Lost to Follow-up|0|||
33634836|NCT01736397|63036688|FG001|Overall Study|Lost to Follow-up|1|||
33634837|NCT01736397|63036687|FG000|Overall Study|Adverse Event|6|||
33634838|NCT01736397|63036688|FG001|Overall Study|Adverse Event|3|||
33634839|NCT01736397|63036687|FG000|Overall Study|Not stated|1|||
33634840|NCT01736397|63036688|FG001|Overall Study|Not stated|4|||
33634841|NCT01859390|63036696|FG000|Overall Study|Insufficient Sputum Collected|1|||
33634842|NCT01859390|63036697|FG001|Overall Study|Insufficient Sputum Collected|3|||
33634843|NCT01859390|63036696|FG000|Overall Study|Sample Missing Collection Date|0|||
33634844|NCT01859390|63036697|FG001|Overall Study|Sample Missing Collection Date|1|||
33634845|NCT01859390|63036696|FG000|Overall Study|Tube Cracked|0|||
33634846|NCT01859390|63036697|FG001|Overall Study|Tube Cracked|2|||
33634847|NCT01859390|63036696|FG000|Overall Study|Shipment Error|0|||
33634848|NCT01859390|63036697|FG001|Overall Study|Shipment Error|1|||
33634849|NCT01858766|63036722|FG000|Overall Study|Randomized but Never Treated|0|||
33634850|NCT01858766|63036723|FG001|Overall Study|Randomized but Never Treated|0|||
33634851|NCT01858766|63036724|FG002|Overall Study|Randomized but Never Treated|0|||
33634852|NCT01858766|63036725|FG003|Overall Study|Randomized but Never Treated|0|||
33634853|NCT01858766|63036726|FG004|Overall Study|Randomized but Never Treated|0|||
33634854|NCT01858766|63036727|FG005|Overall Study|Randomized but Never Treated|1|||
33634855|NCT01858766|63036728|FG006|Overall Study|Randomized but Never Treated|0|||
33634856|NCT01858766|63036729|FG007|Overall Study|Randomized but Never Treated|0|||
33634857|NCT01858766|63036730|FG008|Overall Study|Randomized but Never Treated|0|||
33634858|NCT01858766|63036731|FG009|Overall Study|Randomized but Never Treated|0|||
33634859|NCT01858766|63036732|FG010|Overall Study|Randomized but Never Treated|0|||
33634860|NCT01858766|63036733|FG011|Overall Study|Randomized but Never Treated|0|||
33634861|NCT01858766|63036734|FG012|Overall Study|Randomized but Never Treated|0|||
33634862|NCT01858766|63036735|FG013|Overall Study|Randomized but Never Treated|0|||
33634863|NCT01858766|63036736|FG014|Overall Study|Randomized but Never Treated|0|||
33634864|NCT01858766|63036737|FG015|Overall Study|Randomized but Never Treated|0|||
33634865|NCT01858766|63036738|FG016|Overall Study|Randomized but Never Treated|0|||
33634866|NCT01858766|63036739|FG017|Overall Study|Randomized but Never Treated|1|||
33634867|NCT01858766|63036740|FG018|Overall Study|Randomized but Never Treated|0|||
33634868|NCT01858766|63036722|FG000|Overall Study|Death|0|||
33634869|NCT01858766|63036723|FG001|Overall Study|Death|0|||
33634870|NCT01858766|63036724|FG002|Overall Study|Death|1|||
33634871|NCT01858766|63036725|FG003|Overall Study|Death|0|||
33540429|NCT03917654|62930605|FG007|Year 2|Spouse/family member request|0|||
33634872|NCT01858766|63036726|FG004|Overall Study|Death|0|||
33634873|NCT01858766|63036727|FG005|Overall Study|Death|0|||
33634874|NCT01858766|63036728|FG006|Overall Study|Death|0|||
33634875|NCT01858766|63036729|FG007|Overall Study|Death|0|||
33634876|NCT01858766|63036730|FG008|Overall Study|Death|0|||
33634877|NCT01858766|63036731|FG009|Overall Study|Death|0|||
33634878|NCT01858766|63036732|FG010|Overall Study|Death|0|||
33634879|NCT01858766|63036733|FG011|Overall Study|Death|0|||
33634880|NCT01858766|63036734|FG012|Overall Study|Death|0|||
33540430|NCT03917654|62930606|FG008|Year 2|Spouse/family member request|0|||
33634881|NCT01858766|63036735|FG013|Overall Study|Death|0|||
33634882|NCT01858766|63036736|FG014|Overall Study|Death|0|||
33634883|NCT01858766|63036737|FG015|Overall Study|Death|0|||
33634884|NCT01858766|63036738|FG016|Overall Study|Death|0|||
33634885|NCT01858766|63036739|FG017|Overall Study|Death|0|||
33634886|NCT01858766|63036740|FG018|Overall Study|Death|0|||
33462093|NCT00077649|62835972|FG000|Overall Study|Withdrawal by Subject|0|||
33462094|NCT00077649|62835973|FG001|Overall Study|Withdrawal by Subject|1|||
33462095|NCT00077649|62835974|FG002|Overall Study|Withdrawal by Subject|1|||
33462096|NCT00077649|62835975|FG003|Overall Study|Withdrawal by Subject|2|||
33462097|NCT00077649|62835972|FG000|Overall Study|Lost to Follow-up|2|||
33462098|NCT00077649|62835973|FG001|Overall Study|Lost to Follow-up|2|||
33462099|NCT00077649|62835974|FG002|Overall Study|Lost to Follow-up|3|||
33462100|NCT00077649|62835975|FG003|Overall Study|Lost to Follow-up|2|||
33462101|NCT00077649|62835972|FG000|Overall Study|Abnormality of Laboratory Test|1|||
33462102|NCT00077649|62835973|FG001|Overall Study|Abnormality of Laboratory Test|2|||
33462103|NCT00077649|62835974|FG002|Overall Study|Abnormality of Laboratory Test|1|||
33462104|NCT00077649|62835975|FG003|Overall Study|Abnormality of Laboratory Test|2|||
33462105|NCT00077649|62835972|FG000|Overall Study|Randomized but never dosed|1|||
33462106|NCT00077649|62835973|FG001|Overall Study|Randomized but never dosed|0|||
33540431|NCT03917654|62930607|FG009|Year 2|Spouse/family member request|0|||
33540432|NCT03917654|62930608|FG010|Year 2|Spouse/family member request|0|||
33634887|NCT01858766|63036722|FG000|Overall Study|Lack of Efficacy|1|||
33634888|NCT01858766|63036723|FG001|Overall Study|Lack of Efficacy|0|||
33634889|NCT01858766|63036724|FG002|Overall Study|Lack of Efficacy|0|||
33634890|NCT01858766|63036725|FG003|Overall Study|Lack of Efficacy|0|||
33634891|NCT01858766|63036726|FG004|Overall Study|Lack of Efficacy|1|||
33634892|NCT01858766|63036727|FG005|Overall Study|Lack of Efficacy|2|||
33634893|NCT01858766|63036728|FG006|Overall Study|Lack of Efficacy|0|||
33634894|NCT01858766|63036729|FG007|Overall Study|Lack of Efficacy|0|||
33634895|NCT01858766|63036730|FG008|Overall Study|Lack of Efficacy|0|||
33634896|NCT01858766|63036731|FG009|Overall Study|Lack of Efficacy|0|||
33634897|NCT01858766|63036732|FG010|Overall Study|Lack of Efficacy|0|||
33634898|NCT01858766|63036733|FG011|Overall Study|Lack of Efficacy|3|||
33634899|NCT01858766|63036734|FG012|Overall Study|Lack of Efficacy|5|||
33634900|NCT01858766|63036735|FG013|Overall Study|Lack of Efficacy|3|||
33634901|NCT01858766|63036736|FG014|Overall Study|Lack of Efficacy|5|||
33634902|NCT01858766|63036737|FG015|Overall Study|Lack of Efficacy|5|||
33634903|NCT01858766|63036738|FG016|Overall Study|Lack of Efficacy|2|||
33634904|NCT01858766|63036739|FG017|Overall Study|Lack of Efficacy|3|||
33634905|NCT01858766|63036740|FG018|Overall Study|Lack of Efficacy|3|||
33634906|NCT01858766|63036722|FG000|Overall Study|Lost to Follow-up|0|||
33634907|NCT01858766|63036723|FG001|Overall Study|Lost to Follow-up|0|||
33634908|NCT01858766|63036724|FG002|Overall Study|Lost to Follow-up|0|||
33634909|NCT01858766|63036725|FG003|Overall Study|Lost to Follow-up|0|||
33634910|NCT01858766|63036726|FG004|Overall Study|Lost to Follow-up|0|||
33634911|NCT01858766|63036727|FG005|Overall Study|Lost to Follow-up|1|||
33634912|NCT01858766|63036728|FG006|Overall Study|Lost to Follow-up|0|||
33634913|NCT01858766|63036729|FG007|Overall Study|Lost to Follow-up|2|||
33634914|NCT01858766|63036730|FG008|Overall Study|Lost to Follow-up|0|||
33634915|NCT01858766|63036731|FG009|Overall Study|Lost to Follow-up|0|||
33634916|NCT01858766|63036732|FG010|Overall Study|Lost to Follow-up|0|||
33634917|NCT01858766|63036733|FG011|Overall Study|Lost to Follow-up|1|||
33634918|NCT01858766|63036734|FG012|Overall Study|Lost to Follow-up|0|||
33634919|NCT01858766|63036735|FG013|Overall Study|Lost to Follow-up|0|||
33634920|NCT01858766|63036736|FG014|Overall Study|Lost to Follow-up|3|||
33634921|NCT01858766|63036737|FG015|Overall Study|Lost to Follow-up|1|||
33634922|NCT01858766|63036738|FG016|Overall Study|Lost to Follow-up|1|||
33462107|NCT00077649|62835974|FG002|Overall Study|Randomized but never dosed|0|||
33462108|NCT00077649|62835975|FG003|Overall Study|Randomized but never dosed|0|||
33462109|NCT00038948|62835991|FG000|Overall Study|Adverse Event|131|||
33462110|NCT00038948|62835992|FG001|Overall Study|Adverse Event|43|||
33462111|NCT00038948|62835991|FG000|Overall Study|Lost to Follow-up|4|||
33462112|NCT00038948|62835992|FG001|Overall Study|Lost to Follow-up|4|||
33462113|NCT00038948|62835991|FG000|Overall Study|Nonmedical event|5|||
33462114|NCT00038948|62835992|FG001|Overall Study|Nonmedical event|7|||
33462115|NCT00038948|62835991|FG000|Overall Study|Withdrawal by Subject|23|||
33462116|NCT00038948|62835992|FG001|Overall Study|Withdrawal by Subject|10|||
33462117|NCT00038948|62835991|FG000|Overall Study|Protocol Violation|3|||
33462118|NCT00038948|62835992|FG001|Overall Study|Protocol Violation|7|||
33462119|NCT00038948|62835991|FG000|Overall Study|Lack of Efficacy|3|||
33462120|NCT00038948|62835992|FG001|Overall Study|Lack of Efficacy|6|||
33462121|NCT00054704|62836006|FG000|Overall Study|Lack of Efficacy|2|||
33462122|NCT00054704|62836007|FG001|Overall Study|Lack of Efficacy|3|||
33462123|NCT00054704|62836006|FG000|Overall Study|Adverse Event|3|||
33462124|NCT00054704|62836007|FG001|Overall Study|Adverse Event|1|||
33462125|NCT00054704|62836006|FG000|Overall Study|Lost to Follow-up|0|||
33462126|NCT00054704|62836007|FG001|Overall Study|Lost to Follow-up|1|||
33462127|NCT00031694|62836013|FG000|Overall Study|Adverse Event|12|||
33462128|NCT00031694|62836013|FG000|Overall Study|Death|2|||
33462129|NCT00031694|62836013|FG000|Overall Study|Withdrawal by Subject|5|||
33540433|NCT03917654|62930609|FG011|Year 2|Spouse/family member request|0|||
33540434|NCT03917654|62930598|FG000|Year 2|Lost to Follow-up|0|||
33540435|NCT03917654|62930599|FG001|Year 2|Lost to Follow-up|0|||
33540436|NCT03917654|62930600|FG002|Year 2|Lost to Follow-up|0|||
33540437|NCT03917654|62930601|FG003|Year 2|Lost to Follow-up|0|||
33540438|NCT03917654|62930602|FG004|Year 2|Lost to Follow-up|0|||
33634923|NCT01858766|63036739|FG017|Overall Study|Lost to Follow-up|0|||
33634924|NCT01858766|63036740|FG018|Overall Study|Lost to Follow-up|1|||
33634925|NCT01858766|63036722|FG000|Overall Study|Withdrew Consent|0|||
33462130|NCT00093795|62836021|FG000|Overall Study|No follow up data|20|||
33634926|NCT01858766|63036723|FG001|Overall Study|Withdrew Consent|0|||
33634927|NCT01858766|63036724|FG002|Overall Study|Withdrew Consent|0|||
33634928|NCT01858766|63036725|FG003|Overall Study|Withdrew Consent|0|||
33634929|NCT01858766|63036726|FG004|Overall Study|Withdrew Consent|0|||
33462131|NCT00093795|62836022|FG001|Overall Study|No follow up data|16|||
33462132|NCT00093795|62836023|FG002|Overall Study|No follow up data|17|||
33462133|NCT03467152|62836033|FG000|Overall Study|Adverse Event|4|||
33462134|NCT03467152|62836034|FG001|Overall Study|Adverse Event|5|||
33634930|NCT01858766|63036727|FG005|Overall Study|Withdrew Consent|0|||
33634931|NCT01858766|63036728|FG006|Overall Study|Withdrew Consent|0|||
33634932|NCT01858766|63036729|FG007|Overall Study|Withdrew Consent|0|||
33462135|NCT03467152|62836035|FG002|Overall Study|Adverse Event|0|||
33540439|NCT03917654|62930603|FG005|Year 2|Lost to Follow-up|0|||
33634933|NCT01858766|63036730|FG008|Overall Study|Withdrew Consent|0|||
33634934|NCT01858766|63036731|FG009|Overall Study|Withdrew Consent|0|||
33634935|NCT01858766|63036732|FG010|Overall Study|Withdrew Consent|0|||
33634936|NCT01858766|63036733|FG011|Overall Study|Withdrew Consent|1|||
33634937|NCT01858766|63036734|FG012|Overall Study|Withdrew Consent|0|||
33634938|NCT01858766|63036735|FG013|Overall Study|Withdrew Consent|0|||
33634939|NCT01858766|63036736|FG014|Overall Study|Withdrew Consent|0|||
33634940|NCT01858766|63036737|FG015|Overall Study|Withdrew Consent|0|||
33634941|NCT01858766|63036738|FG016|Overall Study|Withdrew Consent|0|||
33540440|NCT03917654|62930604|FG006|Year 2|Lost to Follow-up|1|||
33540441|NCT03917654|62930605|FG007|Year 2|Lost to Follow-up|0|||
33540442|NCT03917654|62930606|FG008|Year 2|Lost to Follow-up|1|||
33540443|NCT03917654|62930607|FG009|Year 2|Lost to Follow-up|0|||
33540444|NCT03917654|62930608|FG010|Year 2|Lost to Follow-up|0|||
33540445|NCT03917654|62930609|FG011|Year 2|Lost to Follow-up|1|||
33540446|NCT03917654|62930598|FG000|Year 2|Adverse Event|0|||
33540447|NCT03917654|62930599|FG001|Year 2|Adverse Event|0|||
33540448|NCT03917654|62930600|FG002|Year 2|Adverse Event|0|||
33540449|NCT03917654|62930601|FG003|Year 2|Adverse Event|0|||
33540450|NCT03917654|62930602|FG004|Year 2|Adverse Event|0|||
33540451|NCT03917654|62930603|FG005|Year 2|Adverse Event|0|||
33540452|NCT03917654|62930604|FG006|Year 2|Adverse Event|0|||
33540453|NCT03917654|62930605|FG007|Year 2|Adverse Event|0|||
33540454|NCT03917654|62930606|FG008|Year 2|Adverse Event|0|||
33540455|NCT03917654|62930607|FG009|Year 2|Adverse Event|1|||
33540456|NCT03917654|62930608|FG010|Year 2|Adverse Event|0|||
33540457|NCT03917654|62930609|FG011|Year 2|Adverse Event|0|||
33540458|NCT03060577|62930655|FG000|Overall Study|Withdrawal by Subject|25|||
33540459|NCT03060577|62930656|FG001|Overall Study|Withdrawal by Subject|5|||
33540460|NCT03060577|62930655|FG000|Overall Study|Physician Decision|4|||
33540461|NCT03060577|62930656|FG001|Overall Study|Physician Decision|3|||
33540462|NCT03060577|62930655|FG000|Overall Study|Lost to Follow-up|3|||
33540463|NCT03060577|62930656|FG001|Overall Study|Lost to Follow-up|0|||
33540464|NCT03060577|62930655|FG000|Overall Study|Death|7|||
33540465|NCT03060577|62930656|FG001|Overall Study|Death|1|||
33540466|NCT03060577|62930655|FG000|Overall Study|Adverse Event|9|||
33540467|NCT03060577|62930656|FG001|Overall Study|Adverse Event|1|||
33540468|NCT03060577|62930655|FG000|Overall Study|Inclusion/Exclusion|1|||
33540469|NCT03060577|62930656|FG001|Overall Study|Inclusion/Exclusion|0|||
33540470|NCT03060577|62930655|FG000|Overall Study|Other|8|||
33540471|NCT03060577|62930656|FG001|Overall Study|Other|2|||
33540472|NCT02872714|62930667|FG000|Overall Study|Progressive Disease|1|||
33540473|NCT02872714|62930668|FG001|Overall Study|Progressive Disease|2|||
33540474|NCT02872714|62930669|FG002|Overall Study|Progressive Disease|0|||
33540475|NCT02872714|62930670|FG003|Overall Study|Progressive Disease|0|||
33540476|NCT02872714|62930671|FG004|Overall Study|Progressive Disease|0|||
33540477|NCT02872714|62930667|FG000|Overall Study|Death|87|||
33540478|NCT02872714|62930668|FG001|Overall Study|Death|36|||
33540479|NCT02872714|62930669|FG002|Overall Study|Death|8|||
33540480|NCT02872714|62930670|FG003|Overall Study|Death|81|||
33540481|NCT02872714|62930671|FG004|Overall Study|Death|2|||
33540482|NCT02872714|62930667|FG000|Overall Study|Lost to Follow-up|2|||
33540483|NCT02872714|62930668|FG001|Overall Study|Lost to Follow-up|1|||
33540484|NCT02872714|62930669|FG002|Overall Study|Lost to Follow-up|0|||
33540485|NCT02872714|62930670|FG003|Overall Study|Lost to Follow-up|3|||
33540486|NCT02872714|62930671|FG004|Overall Study|Lost to Follow-up|0|||
33540487|NCT02872714|62930667|FG000|Overall Study|Physician Decision|0|||
33540488|NCT02872714|62930668|FG001|Overall Study|Physician Decision|0|||
33540489|NCT02872714|62930669|FG002|Overall Study|Physician Decision|0|||
33540490|NCT02872714|62930670|FG003|Overall Study|Physician Decision|1|||
33540491|NCT02872714|62930671|FG004|Overall Study|Physician Decision|0|||
33540492|NCT02872714|62930667|FG000|Overall Study|Withdrawal by Subject|1|||
33540493|NCT02872714|62930668|FG001|Overall Study|Withdrawal by Subject|3|||
33540494|NCT02872714|62930669|FG002|Overall Study|Withdrawal by Subject|0|||
33540495|NCT02872714|62930670|FG003|Overall Study|Withdrawal by Subject|2|||
33540496|NCT02872714|62930671|FG004|Overall Study|Withdrawal by Subject|0|||
33540497|NCT02872714|62930667|FG000|Overall Study|Captured as Other|2|||
33540498|NCT02872714|62930668|FG001|Overall Study|Captured as Other|0|||
33540499|NCT02872714|62930669|FG002|Overall Study|Captured as Other|0|||
33540500|NCT02872714|62930670|FG003|Overall Study|Captured as Other|1|||
33634942|NCT01858766|63036739|FG017|Overall Study|Withdrew Consent|0|||
33540501|NCT02872714|62930671|FG004|Overall Study|Captured as Other|0|||
33540502|NCT02787005|62930691|FG000|Overall Study|Adverse Event|24|||
33540503|NCT02787005|62930692|FG001|Overall Study|Adverse Event|9|||
33540504|NCT02787005|62930693|FG002|Overall Study|Adverse Event|9|||
33540505|NCT02787005|62930694|FG003|Overall Study|Adverse Event|7|||
33540506|NCT02787005|62930695|FG004|Overall Study|Adverse Event|2|||
33540507|NCT02787005|62930691|FG000|Overall Study|Death|100|||
33540508|NCT02787005|62930692|FG001|Overall Study|Death|53|||
33540509|NCT02787005|62930693|FG002|Overall Study|Death|48|||
33540510|NCT02787005|62930694|FG003|Overall Study|Death|69|||
33540511|NCT02787005|62930695|FG004|Overall Study|Death|38|||
33540512|NCT02787005|62930691|FG000|Overall Study|Sponsor Decision|7|||
33634943|NCT01858766|63036740|FG018|Overall Study|Withdrew Consent|0|||
33634944|NCT01734993|63036773|FG000|Overall Study|Adverse Event|1|||
33634945|NCT01734993|63036773|FG000|Overall Study|Lack of Efficacy|1|||
33634946|NCT01745367|63036780|FG000|Overall Study|Death|1|||
33634947|NCT01745367|63036781|FG001|Overall Study|Death|0|||
33634948|NCT01745367|63036780|FG000|Overall Study|Withdrawal by Subject|1|||
33634949|NCT01745367|63036781|FG001|Overall Study|Withdrawal by Subject|2|||
33634950|NCT01745367|63036780|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
33634951|NCT01745367|63036781|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
33634952|NCT01745367|63036780|FG000|Overall Study|Other Reasons Unspecified|0|||
33634953|NCT01745367|63036781|FG001|Overall Study|Other Reasons Unspecified|2|||
33634954|NCT01733121|63036789|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
33634955|NCT01733121|63036790|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
33634956|NCT01733121|63036789|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
33634957|NCT01733121|63036790|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
33634958|NCT01733121|63036789|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
33634959|NCT01733121|63036790|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
33634960|NCT01733121|63036789|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
33634961|NCT01733121|63036790|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
33634962|NCT01744977|63036800|FG000|Overall Study|Withdrawal by Subject|1|||
33634963|NCT01744977|63036801|FG001|Overall Study|Withdrawal by Subject|2|||
33634964|NCT01744977|63036800|FG000|Overall Study|Death|2|||
33634965|NCT01744977|63036801|FG001|Overall Study|Death|3|||
33634966|NCT01744977|63036800|FG000|Overall Study|Lost to Follow-up|2|||
33634967|NCT01744977|63036801|FG001|Overall Study|Lost to Follow-up|0|||
33634968|NCT01744977|63036800|FG000|Overall Study|No longer meets inclusion|6|||
33634969|NCT01744977|63036801|FG001|Overall Study|No longer meets inclusion|0|||
33634970|NCT01383928|63036810|FG000|Overall Study|Initiation of ASCT|2|||
33634971|NCT01383928|63036811|FG001|Overall Study|Initiation of ASCT|1|||
33634972|NCT01383928|63036812|FG002|Overall Study|Initiation of ASCT|18|||
33634973|NCT01383928|63036810|FG000|Overall Study|Adverse Event|1|||
33634974|NCT01383928|63036811|FG001|Overall Study|Adverse Event|2|||
33634975|NCT01383928|63036812|FG002|Overall Study|Adverse Event|8|||
33634976|NCT01383928|63036810|FG000|Overall Study|Other|1|||
33634977|NCT01383928|63036811|FG001|Overall Study|Other|3|||
33634978|NCT01383928|63036812|FG002|Overall Study|Other|4|||
33634979|NCT01383928|63036810|FG000|Overall Study|Progressive Disease|1|||
33634980|NCT01383928|63036811|FG001|Overall Study|Progressive Disease|1|||
33634981|NCT01383928|63036812|FG002|Overall Study|Progressive Disease|5|||
33634982|NCT01383928|63036810|FG000|Overall Study|Withdrawal by Subject|0|||
33634983|NCT01383928|63036811|FG001|Overall Study|Withdrawal by Subject|0|||
33634984|NCT01383928|63036812|FG002|Overall Study|Withdrawal by Subject|4|||
33634985|NCT01383928|63036810|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
33540513|NCT02787005|62930692|FG001|Overall Study|Sponsor Decision|4|||
33540514|NCT02787005|62930693|FG002|Overall Study|Sponsor Decision|0|||
33540515|NCT02787005|62930694|FG003|Overall Study|Sponsor Decision|4|||
33540516|NCT02787005|62930695|FG004|Overall Study|Sponsor Decision|5|||
33540517|NCT02787005|62930691|FG000|Overall Study|Withdrawal by Subject|2|||
33540518|NCT02787005|62930692|FG001|Overall Study|Withdrawal by Subject|1|||
33540519|NCT02787005|62930693|FG002|Overall Study|Withdrawal by Subject|1|||
33540520|NCT02787005|62930694|FG003|Overall Study|Withdrawal by Subject|0|||
33540521|NCT02787005|62930695|FG004|Overall Study|Withdrawal by Subject|1|||
33540522|NCT02787005|62930691|FG000|Overall Study|Screen Failure|0|||
33540523|NCT02787005|62930692|FG001|Overall Study|Screen Failure|2|||
33540524|NCT02787005|62930693|FG002|Overall Study|Screen Failure|0|||
33540525|NCT02787005|62930694|FG003|Overall Study|Screen Failure|0|||
33540526|NCT02787005|62930695|FG004|Overall Study|Screen Failure|1|||
33540527|NCT02787005|62930691|FG000|Overall Study|Lost to Follow-up|0|||
33540528|NCT02787005|62930692|FG001|Overall Study|Lost to Follow-up|0|||
33540529|NCT02787005|62930693|FG002|Overall Study|Lost to Follow-up|0|||
33540530|NCT02787005|62930694|FG003|Overall Study|Lost to Follow-up|1|||
33540531|NCT02787005|62930695|FG004|Overall Study|Lost to Follow-up|0|||
33540532|NCT02601313|62930729|FG000|Overall Study|Death|2|||
33540533|NCT02601313|62930730|FG001|Overall Study|Death|16|||
33540534|NCT02601313|62930731|FG002|Overall Study|Death|4|||
33540535|NCT02601313|62930729|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
33634986|NCT01383928|63036811|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
33634987|NCT01383928|63036812|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
33634988|NCT01382602|63036824|FG000|Overall Study|Protocol Violation|0|||
33540536|NCT02601313|62930730|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
33634989|NCT01382602|63036825|FG001|Overall Study|Protocol Violation|3|||
33634990|NCT01382602|63036824|FG000|Overall Study|Withdrawal by Subject|0|||
33634991|NCT01382602|63036825|FG001|Overall Study|Withdrawal by Subject|1|||
33634992|NCT04801420|63036834|FG000|Overall Study|Other|1|||
33634993|NCT04801420|63036835|FG001|Overall Study|Other|2|||
33634994|NCT04801420|63036836|FG002|Overall Study|Other|1|||
33634995|NCT04801420|63036834|FG000|Overall Study|Lost to Follow-up|7|||
33540537|NCT02601313|62930731|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
33634996|NCT04801420|63036835|FG001|Overall Study|Lost to Follow-up|9|||
33634997|NCT04801420|63036836|FG002|Overall Study|Lost to Follow-up|10|||
33634998|NCT04801420|63036834|FG000|Overall Study|Moved from study area|0|||
33634999|NCT04801420|63036835|FG001|Overall Study|Moved from study area|1|||
33635000|NCT04801420|63036836|FG002|Overall Study|Moved from study area|1|||
33635001|NCT04801420|63036834|FG000|Overall Study|Withdrawal by Subject|5|||
33635002|NCT04801420|63036835|FG001|Overall Study|Withdrawal by Subject|1|||
33635003|NCT04801420|63036836|FG002|Overall Study|Withdrawal by Subject|4|||
33635004|NCT04801420|63036834|FG000|Overall Study|Individual stopping criteria reached|0|||
33635005|NCT04801420|63036835|FG001|Overall Study|Individual stopping criteria reached|1|||
33635006|NCT04801420|63036836|FG002|Overall Study|Individual stopping criteria reached|0|||
33635007|NCT04801420|63036834|FG000|Overall Study|Ongoing in the study|195|||
33635008|NCT04801420|63036835|FG001|Overall Study|Ongoing in the study|195|||
33635009|NCT04801420|63036836|FG002|Overall Study|Ongoing in the study|192|||
33635010|NCT04294472|63036851|FG000|Overall Study|Adverse Event|0|||
33635011|NCT04294472|63036852|FG001|Overall Study|Adverse Event|1|||
33635012|NCT04294472|63036853|FG002|Overall Study|Adverse Event|1|||
33635013|NCT04294472|63036851|FG000|Overall Study|Randomized but not treated|0|||
33635014|NCT04294472|63036852|FG001|Overall Study|Randomized but not treated|1|||
33635015|NCT04294472|63036853|FG002|Overall Study|Randomized but not treated|1|||
33635016|NCT04233918|63036863|FG000|Part C (Extension Period)|Ongoing in study|0|||
33635017|NCT04233918|63036864|FG001|Part C (Extension Period)|Ongoing in study|0|||
33635018|NCT04233918|63036865|FG002|Part C (Extension Period)|Ongoing in study|15|||
33635019|NCT04060251|63036877|FG000|Overall Study|Study terminated due to low enrollment.|7|||
33635020|NCT04060251|63036878|FG001|Overall Study|Study terminated due to low enrollment.|5|||
33635021|NCT04060251|63036879|FG002|Overall Study|Study terminated due to low enrollment.|7|||
33635022|NCT04060251|63036877|FG000|Overall Study|Adverse Event|1|||
33635023|NCT04060251|63036878|FG001|Overall Study|Adverse Event|1|||
33635024|NCT04060251|63036879|FG002|Overall Study|Adverse Event|0|||
33635025|NCT04048876|63036891|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
33635026|NCT04048876|63036892|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
33635027|NCT04048876|63036893|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
33635028|NCT04048876|63036894|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
33635029|NCT04048876|63036891|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
33635030|NCT04048876|63036892|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
33635031|NCT04048876|63036893|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
33635032|NCT04048876|63036894|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
33635033|NCT04048876|63036891|FG000|Placebo Controlled Phase|Adverse Event|0|||
33635034|NCT04048876|63036892|FG001|Placebo Controlled Phase|Adverse Event|1|||
33635035|NCT04048876|63036893|FG002|Placebo Controlled Phase|Adverse Event|0|||
33635036|NCT04048876|63036894|FG003|Placebo Controlled Phase|Adverse Event|0|||
33635037|NCT04048876|63036891|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
33635038|NCT04048876|63036892|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
33635039|NCT04048876|63036893|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
33635040|NCT04048876|63036894|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
33635041|NCT03921424|63036921|FG000|Overall Study|Lost to Follow-up|0|||
33635042|NCT03921424|63036922|FG001|Overall Study|Lost to Follow-up|1|||
33635043|NCT03921424|63036921|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
33635044|NCT03921424|63036922|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
33635045|NCT03852628|63036945|FG000|Overall Study|Lost to Follow-up|7|||
33635046|NCT03852628|63036946|FG001|Overall Study|Lost to Follow-up|6|||
33635047|NCT03852628|63036945|FG000|Overall Study|Lack of Efficacy|6|||
33635048|NCT03852628|63036946|FG001|Overall Study|Lack of Efficacy|6|||
33635049|NCT03602976|63036952|FG000|Overall Study|Withdrawal by Subject|1|||
33635050|NCT03474107|63036961|FG000|Overall Study|Adverse Event|42|||
33635051|NCT03474107|63036962|FG001|Overall Study|Adverse Event|46|||
33635052|NCT03474107|63036961|FG000|Overall Study|Death|2|||
33635053|NCT03474107|63036962|FG001|Overall Study|Death|2|||
33635054|NCT03474107|63036961|FG000|Overall Study|Lost to Follow-up|0|||
33635055|NCT03474107|63036962|FG001|Overall Study|Lost to Follow-up|1|||
33635056|NCT03474107|63036961|FG000|Overall Study|Progressive Disease|177|||
33635057|NCT03474107|63036962|FG001|Overall Study|Progressive Disease|180|||
33635058|NCT03474107|63036961|FG000|Overall Study|Protocol Violation|1|||
33635059|NCT03474107|63036962|FG001|Overall Study|Protocol Violation|1|||
33635060|NCT03474107|63036961|FG000|Overall Study|Withdrawal by Subject|15|||
33635061|NCT03474107|63036962|FG001|Overall Study|Withdrawal by Subject|27|||
33635062|NCT03474107|63036961|FG000|Overall Study|Physician Decision|7|||
33635063|NCT03474107|63036962|FG001|Overall Study|Physician Decision|22|||
33635064|NCT03474107|63036961|FG000|Overall Study|Miscellaneous|1|||
33635065|NCT03474107|63036962|FG001|Overall Study|Miscellaneous|6|||
33635066|NCT03278106|63036977|FG000|Overall Study|No protocol treatment|1|||
33635067|NCT03214198|63036981|FG000|Overall Study|Case Report Forms Uncollected|18|||
33635068|NCT03214198|63036981|FG000|Overall Study|Protocol Deviation|18|||
33635069|NCT03052608|63036994|FG000|Treatment Phase|Adverse Event|10|||
33635070|NCT03052608|63036995|FG001|Treatment Phase|Adverse Event|12|||
33635071|NCT03052608|63036994|FG000|Treatment Phase|Death|6|||
33635072|NCT03052608|63036995|FG001|Treatment Phase|Death|4|||
33635073|NCT03052608|63036994|FG000|Treatment Phase|Withdrawal by Subject|4|||
33635074|NCT03052608|63036995|FG001|Treatment Phase|Withdrawal by Subject|12|||
33635075|NCT03052608|63036994|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
33635076|NCT03052608|63036995|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
33635077|NCT03052608|63036994|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
33635078|NCT03052608|63036995|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
33635079|NCT03052608|63036994|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
33635080|NCT03052608|63036995|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
33635081|NCT03052608|63036994|FG000|Treatment Phase|Ongoing|103|||
33635082|NCT03052608|63036995|FG001|Treatment Phase|Ongoing|31|||
33540538|NCT02601313|62930729|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
33540539|NCT02601313|62930730|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
33540540|NCT02601313|62930731|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
33540541|NCT02601313|62930729|FG000|Overall Study|Still on study|0|||
33540542|NCT02601313|62930730|FG001|Overall Study|Still on study|52|||
33540543|NCT02601313|62930731|FG002|Overall Study|Still on study|10|||
33540544|NCT02601313|62930729|FG000|Overall Study|Enrolled, did not initiate AC|4|||
33540545|NCT02601313|62930730|FG001|Overall Study|Enrolled, did not initiate AC|0|||
33540546|NCT02601313|62930731|FG002|Overall Study|Enrolled, did not initiate AC|0|||
33540547|NCT02514083|62930739|FG000|Overall Study|Adverse Event|1|||
33540548|NCT02395848|62930743|FG000|Overall Study|Lost to Follow-up|2|||
33540549|NCT02061761|62930760|FG000|Overall Study|Disease progression|2|||
33540550|NCT02061761|62930761|FG001|Overall Study|Disease progression|8|||
33540551|NCT02061761|62930762|FG002|Overall Study|Disease progression|4|||
33540552|NCT02061761|62930763|FG003|Overall Study|Disease progression|5|||
33540553|NCT02061761|62930764|FG004|Overall Study|Disease progression|9|||
33635083|NCT03052608|63036994|FG000|Long-Term Follow-up Phase|Death|23|||
33635084|NCT03052608|63036995|FG001|Long-Term Follow-up Phase|Death|28|||
33635085|NCT03052608|63036994|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
33635086|NCT03052608|63036995|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
33635087|NCT03052608|63036994|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
33635088|NCT03052608|63036995|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
33635089|NCT03052608|63036994|FG000|Long-Term Follow-up Phase|Ongoing|122|||
33635090|NCT03052608|63036995|FG001|Long-Term Follow-up Phase|Ongoing|99|||
33635091|NCT02914639|63037003|FG000|Overall Study|Withdrawal by Subject|0|||
33635092|NCT02914639|63037004|FG001|Overall Study|Withdrawal by Subject|2|||
33635093|NCT02865018|63037011|FG000|Overall Study|Withdrawal by Subject|1|||
33635094|NCT02704208|63037026|FG000|Overall Study|Lost to Follow-up|42|||
33635095|NCT02704208|63037027|FG001|Overall Study|Lost to Follow-up|37|||
33635096|NCT02618408|63037036|FG000|Overall Study|Withdrawal by Subject|1|||
33635097|NCT02618408|63037037|FG001|Overall Study|Withdrawal by Subject|0|||
33540554|NCT02061761|62930765|FG005|Overall Study|Disease progression|3|||
33540555|NCT02061761|62930766|FG006|Overall Study|Disease progression|1|||
33540556|NCT02061761|62930767|FG007|Overall Study|Disease progression|2|||
33540557|NCT02061761|62930768|FG008|Overall Study|Disease progression|28|||
33540558|NCT02061761|62930760|FG000|Overall Study|Study Drug toxicity|0|||
33540559|NCT02061761|62930761|FG001|Overall Study|Study Drug toxicity|0|||
33540560|NCT02061761|62930762|FG002|Overall Study|Study Drug toxicity|0|||
33540561|NCT02061761|62930763|FG003|Overall Study|Study Drug toxicity|0|||
33540562|NCT02061761|62930764|FG004|Overall Study|Study Drug toxicity|0|||
33540563|NCT02061761|62930765|FG005|Overall Study|Study Drug toxicity|1|||
33540564|NCT02061761|62930766|FG006|Overall Study|Study Drug toxicity|0|||
33635098|NCT02618408|63037038|FG002|Overall Study|Withdrawal by Subject|4|||
33635099|NCT02618408|63037036|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
33635100|NCT02618408|63037037|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
33635101|NCT02618408|63037038|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
33635102|NCT02618408|63037036|FG000|Overall Study|Lost to Follow-up|4|||
33635103|NCT02618408|63037037|FG001|Overall Study|Lost to Follow-up|2|||
33635104|NCT02618408|63037038|FG002|Overall Study|Lost to Follow-up|6|||
33635105|NCT02618408|63037036|FG000|Overall Study|Adverse Event|4|||
33635106|NCT02618408|63037037|FG001|Overall Study|Adverse Event|0|||
33326424|NCT00946101|62703181|FG001|Overall Study|Lost to Follow-up|1|||
33326425|NCT00946101|62703180|FG000|Overall Study|Withdrawal of consent|2|||
33540565|NCT02061761|62930767|FG007|Overall Study|Study Drug toxicity|2|||
33635107|NCT02618408|63037038|FG002|Overall Study|Adverse Event|10|||
33635108|NCT02618408|63037036|FG000|Overall Study|Physician Decision|1|||
33635109|NCT02618408|63037037|FG001|Overall Study|Physician Decision|1|||
33540566|NCT02061761|62930768|FG008|Overall Study|Study Drug toxicity|6|||
33540567|NCT02061761|62930760|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
33540568|NCT02061761|62930761|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
33540569|NCT02061761|62930762|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
33544258|NCT03012061|62935097|FG001|Overall Study|Adverse Event|0|||
33635110|NCT02618408|63037038|FG002|Overall Study|Physician Decision|2|||
33635111|NCT02618408|63037036|FG000|Overall Study|Protocol Violation|1|||
33635112|NCT02618408|63037037|FG001|Overall Study|Protocol Violation|1|||
33635113|NCT02618408|63037038|FG002|Overall Study|Protocol Violation|2|||
33635114|NCT02618408|63037036|FG000|Overall Study|Other, Multiple Categories|0|||
33635115|NCT02618408|63037037|FG001|Overall Study|Other, Multiple Categories|0|||
33635116|NCT02618408|63037038|FG002|Overall Study|Other, Multiple Categories|4|||
33635117|NCT02553460|63037049|FG000|Overall Study|Death|3|||
33635118|NCT02553460|63037049|FG000|Overall Study|Withdrawal by Subject|1|||
33635119|NCT02553460|63037049|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
33635120|NCT02553460|63037049|FG000|Overall Study|Relapse or Transplant|14|||
33635121|NCT02553460|63037049|FG000|Overall Study|No response to treatment|2|||
33635122|NCT02553460|63037049|FG000|Overall Study|Still on therapy|7|||
33635123|NCT02553460|63037049|FG000|Overall Study|CAR T cells|1|||
33635124|NCT02157883|63037062|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
33635125|NCT02157883|63037062|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
33635126|NCT02157883|63037062|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
33635127|NCT02157883|63037062|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
33635128|NCT02157883|63037062|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
33635129|NCT02071290|63037071|FG000|Overall Study|Death|1|||
33635130|NCT02071290|63037072|FG001|Overall Study|Death|0|||
33635131|NCT02071290|63037071|FG000|Overall Study|Withdrawal by Subject|0|||
33635132|NCT02071290|63037072|FG001|Overall Study|Withdrawal by Subject|1|||
33635133|NCT02071290|63037071|FG000|Overall Study|Protocol Violation|3|||
33635134|NCT02071290|63037072|FG001|Overall Study|Protocol Violation|5|||
33635135|NCT02071290|63037071|FG000|Overall Study|Physician Decision|0|||
33635136|NCT02071290|63037072|FG001|Overall Study|Physician Decision|1|||
33635137|NCT02066181|63037080|FG000|Overall Study|Withdrawal by Subject|1|||
33635138|NCT02066181|63037081|FG001|Overall Study|Withdrawal by Subject|1|||
33635139|NCT01972217|63037094|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
33635140|NCT01972217|63037095|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
33635141|NCT01972217|63037096|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
33635142|NCT01972217|63037097|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
33635143|NCT01972217|63037094|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
33540570|NCT02061761|62930763|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
33540571|NCT02061761|62930764|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
33540572|NCT02061761|62930765|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
33540573|NCT02061761|62930766|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
33540574|NCT02061761|62930767|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
33540575|NCT02061761|62930768|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
33540576|NCT02061761|62930760|FG000|Overall Study|Participant request to discontinue study treatment|0|||
33540577|NCT02061761|62930761|FG001|Overall Study|Participant request to discontinue study treatment|0|||
33540578|NCT02061761|62930762|FG002|Overall Study|Participant request to discontinue study treatment|2|||
33540579|NCT02061761|62930763|FG003|Overall Study|Participant request to discontinue study treatment|2|||
33540580|NCT02061761|62930764|FG004|Overall Study|Participant request to discontinue study treatment|0|||
33635144|NCT01972217|63037095|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
33635145|NCT01972217|63037096|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
33635146|NCT01972217|63037097|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
33635147|NCT01972217|63037094|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
33635148|NCT01972217|63037095|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
33635149|NCT01972217|63037096|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
33635150|NCT01972217|63037097|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
33635151|NCT01972217|63037094|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
33635152|NCT01972217|63037095|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
33635153|NCT01972217|63037096|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
33635154|NCT01972217|63037097|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
33635155|NCT01972217|63037094|FG000|Part B Double-blind, Randomised Period|Death|0|||
33635156|NCT01972217|63037095|FG001|Part B Double-blind, Randomised Period|Death|0|||
33635157|NCT01972217|63037096|FG002|Part B Double-blind, Randomised Period|Death|43|||
33635158|NCT01972217|63037097|FG003|Part B Double-blind, Randomised Period|Death|44|||
33635159|NCT01972217|63037094|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
33635160|NCT01972217|63037095|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
33635161|NCT01972217|63037096|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
33635162|NCT01972217|63037097|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
33635163|NCT01972217|63037094|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
33635164|NCT01972217|63037095|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
33635165|NCT01972217|63037096|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
33635166|NCT01972217|63037097|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
33635167|NCT01972217|63037094|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
33635168|NCT01972217|63037095|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
33635169|NCT01972217|63037096|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
33635170|NCT01972217|63037097|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
33635171|NCT01972217|63037094|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
33635172|NCT01972217|63037095|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
33635173|NCT01972217|63037096|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
33635174|NCT01972217|63037097|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
33635175|NCT01970865|63037126|FG000|Overall Study|Death|3|||
33635176|NCT01970865|63037127|FG001|Overall Study|Death|1|||
33635177|NCT01970865|63037128|FG002|Overall Study|Death|3|||
33635178|NCT01970865|63037129|FG003|Overall Study|Death|4|||
33635179|NCT01970865|63037130|FG004|Overall Study|Death|6|||
33635180|NCT01970865|63037131|FG005|Overall Study|Death|3|||
33635181|NCT01970865|63037132|FG006|Overall Study|Death|1|||
33635182|NCT01970865|63037133|FG007|Overall Study|Death|3|||
33635183|NCT01970865|63037134|FG008|Overall Study|Death|2|||
33635184|NCT01970865|63037135|FG009|Overall Study|Death|1|||
33635185|NCT01970865|63037136|FG010|Overall Study|Death|1|||
33635186|NCT01970865|63037137|FG011|Overall Study|Death|4|||
33635187|NCT01970865|63037138|FG012|Overall Study|Death|14|||
33635188|NCT01970865|63037139|FG013|Overall Study|Death|19|||
33635189|NCT01970865|63037140|FG014|Overall Study|Death|15|||
33635190|NCT01970865|63037141|FG015|Overall Study|Death|10|||
33635191|NCT01970865|63037142|FG016|Overall Study|Death|1|||
33635192|NCT01970865|63037126|FG000|Overall Study|Lost to Follow-up|0|||
33635193|NCT01970865|63037127|FG001|Overall Study|Lost to Follow-up|0|||
33635194|NCT01970865|63037128|FG002|Overall Study|Lost to Follow-up|0|||
33635195|NCT01970865|63037129|FG003|Overall Study|Lost to Follow-up|1|||
33635196|NCT01970865|63037130|FG004|Overall Study|Lost to Follow-up|1|||
33635197|NCT01970865|63037131|FG005|Overall Study|Lost to Follow-up|0|||
33635198|NCT01970865|63037132|FG006|Overall Study|Lost to Follow-up|0|||
33635199|NCT01970865|63037133|FG007|Overall Study|Lost to Follow-up|0|||
33635200|NCT01970865|63037134|FG008|Overall Study|Lost to Follow-up|0|||
33635201|NCT01970865|63037135|FG009|Overall Study|Lost to Follow-up|0|||
33635202|NCT01970865|63037136|FG010|Overall Study|Lost to Follow-up|0|||
33635203|NCT01970865|63037137|FG011|Overall Study|Lost to Follow-up|0|||
33635204|NCT01970865|63037138|FG012|Overall Study|Lost to Follow-up|1|||
33635205|NCT01970865|63037139|FG013|Overall Study|Lost to Follow-up|0|||
33635206|NCT01970865|63037140|FG014|Overall Study|Lost to Follow-up|0|||
33635207|NCT01970865|63037141|FG015|Overall Study|Lost to Follow-up|0|||
33635208|NCT01970865|63037142|FG016|Overall Study|Lost to Follow-up|0|||
33635209|NCT01970865|63037126|FG000|Overall Study|Withdrawal by Subject|0|||
33635210|NCT01970865|63037127|FG001|Overall Study|Withdrawal by Subject|0|||
33635211|NCT01970865|63037128|FG002|Overall Study|Withdrawal by Subject|0|||
33635212|NCT01970865|63037129|FG003|Overall Study|Withdrawal by Subject|1|||
33635213|NCT01970865|63037130|FG004|Overall Study|Withdrawal by Subject|2|||
33635214|NCT01970865|63037131|FG005|Overall Study|Withdrawal by Subject|0|||
33635215|NCT01970865|63037132|FG006|Overall Study|Withdrawal by Subject|0|||
33635216|NCT01970865|63037133|FG007|Overall Study|Withdrawal by Subject|0|||
33635217|NCT01970865|63037134|FG008|Overall Study|Withdrawal by Subject|0|||
33635218|NCT01970865|63037135|FG009|Overall Study|Withdrawal by Subject|0|||
33635219|NCT01970865|63037136|FG010|Overall Study|Withdrawal by Subject|0|||
33635220|NCT01970865|63037137|FG011|Overall Study|Withdrawal by Subject|1|||
33635221|NCT01970865|63037138|FG012|Overall Study|Withdrawal by Subject|2|||
33635222|NCT01970865|63037139|FG013|Overall Study|Withdrawal by Subject|5|||
33635223|NCT01970865|63037140|FG014|Overall Study|Withdrawal by Subject|2|||
33635224|NCT01970865|63037141|FG015|Overall Study|Withdrawal by Subject|7|||
33635225|NCT01970865|63037142|FG016|Overall Study|Withdrawal by Subject|0|||
33635226|NCT01970865|63037126|FG000|Overall Study|Other|0|||
33635227|NCT01970865|63037127|FG001|Overall Study|Other|0|||
33635228|NCT01970865|63037128|FG002|Overall Study|Other|0|||
33635229|NCT01970865|63037129|FG003|Overall Study|Other|1|||
33635230|NCT01970865|63037130|FG004|Overall Study|Other|0|||
33635231|NCT01970865|63037131|FG005|Overall Study|Other|0|||
33635232|NCT01970865|63037132|FG006|Overall Study|Other|0|||
33635233|NCT01970865|63037133|FG007|Overall Study|Other|0|||
33635234|NCT01970865|63037134|FG008|Overall Study|Other|0|||
33635235|NCT01970865|63037135|FG009|Overall Study|Other|0|||
33635236|NCT01970865|63037136|FG010|Overall Study|Other|0|||
33635237|NCT01970865|63037137|FG011|Overall Study|Other|0|||
33635238|NCT01970865|63037138|FG012|Overall Study|Other|0|||
33635239|NCT01970865|63037139|FG013|Overall Study|Other|1|||
33635240|NCT01970865|63037140|FG014|Overall Study|Other|0|||
33635241|NCT01970865|63037141|FG015|Overall Study|Other|1|||
33635242|NCT01970865|63037142|FG016|Overall Study|Other|0|||
33635243|NCT01970865|63037126|FG000|Overall Study|Study ongoing|0|||
33635244|NCT01970865|63037127|FG001|Overall Study|Study ongoing|2|||
33635245|NCT01970865|63037128|FG002|Overall Study|Study ongoing|0|||
33635246|NCT01970865|63037129|FG003|Overall Study|Study ongoing|6|||
33635247|NCT01970865|63037130|FG004|Overall Study|Study ongoing|8|||
33635248|NCT01970865|63037131|FG005|Overall Study|Study ongoing|0|||
33635249|NCT01970865|63037132|FG006|Overall Study|Study ongoing|2|||
33635250|NCT01970865|63037133|FG007|Overall Study|Study ongoing|0|||
33635251|NCT01970865|63037134|FG008|Overall Study|Study ongoing|1|||
33635252|NCT01970865|63037135|FG009|Overall Study|Study ongoing|3|||
33635253|NCT01970865|63037136|FG010|Overall Study|Study ongoing|29|||
33635254|NCT01970865|63037137|FG011|Overall Study|Study ongoing|22|||
33635255|NCT01970865|63037138|FG012|Overall Study|Study ongoing|43|||
33635256|NCT01970865|63037139|FG013|Overall Study|Study ongoing|41|||
33635257|NCT01970865|63037140|FG014|Overall Study|Study ongoing|29|||
33635258|NCT01970865|63037141|FG015|Overall Study|Study ongoing|29|||
33635259|NCT01970865|63037142|FG016|Overall Study|Study ongoing|2|||
33635260|NCT01711541|63037217|FG000|Overall Study|Cancel prior to treatment|0|||
33635261|NCT01711541|63037218|FG001|Overall Study|Cancel prior to treatment|0|||
33635262|NCT01711541|63037219|FG002|Overall Study|Cancel prior to treatment|0|||
33635263|NCT01711541|63037220|FG003|Overall Study|Cancel prior to treatment|1|||
33635264|NCT01711541|63037221|FG004|Overall Study|Cancel prior to treatment|0|||
33635265|NCT01711541|63037217|FG000|Overall Study|Ineligible|0|||
33635266|NCT01711541|63037218|FG001|Overall Study|Ineligible|1|||
33635267|NCT01711541|63037219|FG002|Overall Study|Ineligible|0|||
33635268|NCT01711541|63037220|FG003|Overall Study|Ineligible|0|||
33635269|NCT01711541|63037221|FG004|Overall Study|Ineligible|0|||
33635270|NCT01382446|63037257|FG000|Overall Study|Withdrawal by Subject|0|||
33635271|NCT01382446|63037258|FG001|Overall Study|Withdrawal by Subject|1|||
33635272|NCT01382446|63037257|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
33635273|NCT01382446|63037258|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
33635274|NCT01382212|63037264|FG000|Overall Study|Kidney transplant|1|||
33635275|NCT01382212|63037264|FG000|Overall Study|Withdrew consent|1|||
33635276|NCT01381900|63037271|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
33635277|NCT01381900|63037272|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
33635278|NCT01381900|63037273|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
33635279|NCT01381900|63037271|FG000|Overall Study|Adverse Event|4|||
33635280|NCT01381900|63037272|FG001|Overall Study|Adverse Event|6|||
33635281|NCT01381900|63037273|FG002|Overall Study|Adverse Event|7|||
33635282|NCT01381900|63037271|FG000|Overall Study|Noncompliance with study drug|0|||
33635283|NCT01381900|63037272|FG001|Overall Study|Noncompliance with study drug|0|||
33635284|NCT01381900|63037273|FG002|Overall Study|Noncompliance with study drug|1|||
33635285|NCT01381900|63037271|FG000|Overall Study|Physician Decision|0|||
33635286|NCT01381900|63037272|FG001|Overall Study|Physician Decision|1|||
33635287|NCT01381900|63037273|FG002|Overall Study|Physician Decision|1|||
33635288|NCT01381900|63037271|FG000|Overall Study|Protocol Violation|0|||
33462136|NCT03467152|62836033|FG000|Overall Study|Subject Choice|1|||
33540581|NCT02061761|62930765|FG005|Overall Study|Participant request to discontinue study treatment|1|||
33540582|NCT02061761|62930766|FG006|Overall Study|Participant request to discontinue study treatment|0|||
33540583|NCT02061761|62930767|FG007|Overall Study|Participant request to discontinue study treatment|0|||
33540584|NCT02061761|62930768|FG008|Overall Study|Participant request to discontinue study treatment|2|||
33540585|NCT02061761|62930760|FG000|Overall Study|Withdrawal by Subject|0|||
33540586|NCT02061761|62930761|FG001|Overall Study|Withdrawal by Subject|0|||
33462137|NCT03467152|62836034|FG001|Overall Study|Subject Choice|3|||
33462138|NCT03467152|62836035|FG002|Overall Study|Subject Choice|0|||
33462139|NCT03467152|62836033|FG000|Overall Study|Lost to Follow-up|1|||
33462140|NCT03467152|62836034|FG001|Overall Study|Lost to Follow-up|0|||
33462141|NCT03467152|62836035|FG002|Overall Study|Lost to Follow-up|0|||
33540587|NCT02061761|62930762|FG002|Overall Study|Withdrawal by Subject|0|||
33540588|NCT02061761|62930763|FG003|Overall Study|Withdrawal by Subject|0|||
33540589|NCT02061761|62930764|FG004|Overall Study|Withdrawal by Subject|0|||
33540590|NCT02061761|62930765|FG005|Overall Study|Withdrawal by Subject|0|||
33540591|NCT02061761|62930766|FG006|Overall Study|Withdrawal by Subject|0|||
33635289|NCT01381900|63037272|FG001|Overall Study|Protocol Violation|1|||
33462142|NCT03467152|62836033|FG000|Overall Study|Withdrawal by Subject|4|||
33462143|NCT03467152|62836034|FG001|Overall Study|Withdrawal by Subject|2|||
33462144|NCT03467152|62836035|FG002|Overall Study|Withdrawal by Subject|0|||
33540592|NCT02061761|62930767|FG007|Overall Study|Withdrawal by Subject|0|||
33635290|NCT01381900|63037273|FG002|Overall Study|Protocol Violation|1|||
33635291|NCT01381900|63037271|FG000|Overall Study|Withdrawal by Subject|0|||
33635292|NCT01381900|63037272|FG001|Overall Study|Withdrawal by Subject|0|||
33635293|NCT01381900|63037273|FG002|Overall Study|Withdrawal by Subject|1|||
33635294|NCT01381900|63037271|FG000|Overall Study|Early withdraw|3|||
33462145|NCT03467152|62836033|FG000|Overall Study|Others|3|||
33635295|NCT01381900|63037272|FG001|Overall Study|Early withdraw|1|||
33635296|NCT01381900|63037273|FG002|Overall Study|Early withdraw|1|||
33635297|NCT01744665|63037281|FG000|Monitoring Phase|Adverse Event|4|||
33635298|NCT01744665|63037281|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
33635299|NCT01744665|63037281|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
33635300|NCT01744665|63037281|FG000|Monitoring Phase|Withdrawal by Subject|5|||
33635301|NCT01744665|63037281|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
33635302|NCT01744665|63037281|FG000|Consolidation Phase|Adverse Event|2|||
33635303|NCT01744665|63037281|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
33635304|NCT01744665|63037281|FG000|Consolidation Phase|Withdrawal by Subject|4|||
33635305|NCT01744665|63037281|FG000|Consolidation Phase|Administrative problems|9|||
33635306|NCT01744665|63037281|FG000|Re-initiation Phase|Administrative problems|10|||
33635307|NCT01744665|63037281|FG000|Re-initiation Phase|Adverse Event|1|||
33635308|NCT01744665|63037281|FG000|Re-initiation Phase|No longer required treatment|1|||
33635309|NCT01744665|63037281|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
33635310|NCT01744197|63037290|FG000|Overall Study|Received 1 patch|2|||
33635311|NCT01744197|63037291|FG001|Overall Study|Received 1 patch|1|||
33635312|NCT01744197|63037290|FG000|Overall Study|No patch received|2|||
33635313|NCT01744197|63037291|FG001|Overall Study|No patch received|2|||
33635314|NCT01732107|63037297|FG000|Overall Study|Adverse Event|2|||
33635315|NCT01732107|63037297|FG000|Overall Study|Disease Progression|8|||
33635316|NCT01732107|63037297|FG000|Overall Study|Physician Decision|1|||
33635317|NCT01732107|63037297|FG000|Overall Study|Withdrawal by Subject|2|||
33635318|NCT01743027|63037305|FG000|Overall Study|Adverse Event|2|||
33635319|NCT01743027|63037306|FG001|Overall Study|Adverse Event|0|||
33635320|NCT01743027|63037307|FG002|Overall Study|Adverse Event|0|||
33635321|NCT01743027|63037308|FG003|Overall Study|Adverse Event|0|||
33635322|NCT01743027|63037305|FG000|Overall Study|Lost to Follow-up|0|||
33635323|NCT01743027|63037306|FG001|Overall Study|Lost to Follow-up|0|||
33635324|NCT01743027|63037307|FG002|Overall Study|Lost to Follow-up|2|||
33635325|NCT01743027|63037308|FG003|Overall Study|Lost to Follow-up|0|||
33635326|NCT01743027|63037305|FG000|Overall Study|Progressive Disease|1|||
33635327|NCT01743027|63037306|FG001|Overall Study|Progressive Disease|4|||
33635328|NCT01743027|63037307|FG002|Overall Study|Progressive Disease|3|||
33635329|NCT01743027|63037308|FG003|Overall Study|Progressive Disease|0|||
33635330|NCT01743027|63037305|FG000|Overall Study|Protocol Violation|1|||
33635331|NCT01743027|63037306|FG001|Overall Study|Protocol Violation|1|||
33635332|NCT01743027|63037307|FG002|Overall Study|Protocol Violation|1|||
33635333|NCT01743027|63037308|FG003|Overall Study|Protocol Violation|0|||
33635334|NCT01743027|63037305|FG000|Overall Study|Withdrawal by Subject|1|||
33635335|NCT01743027|63037306|FG001|Overall Study|Withdrawal by Subject|0|||
33635336|NCT01743027|63037307|FG002|Overall Study|Withdrawal by Subject|3|||
33635337|NCT01743027|63037308|FG003|Overall Study|Withdrawal by Subject|1|||
33635338|NCT01380730|63037326|FG000|Overall Study|Death|0|||
33635339|NCT01380730|63037327|FG001|Overall Study|Death|0|||
33635340|NCT01380730|63037328|FG002|Overall Study|Death|0|||
33635341|NCT01380730|63037329|FG003|Overall Study|Death|0|||
33635342|NCT01380730|63037330|FG004|Overall Study|Death|1|||
33635343|NCT01380730|63037331|FG005|Overall Study|Death|0|||
33635344|NCT01380730|63037332|FG006|Overall Study|Death|0|||
33462146|NCT03467152|62836034|FG001|Overall Study|Others|0|||
33462147|NCT03467152|62836035|FG002|Overall Study|Others|0|||
33462148|NCT03467152|62836033|FG000|Overall Study|Not treated|3|||
33462149|NCT03467152|62836034|FG001|Overall Study|Not treated|1|||
33462150|NCT03467152|62836035|FG002|Overall Study|Not treated|6|||
33635345|NCT01380730|63037333|FG007|Overall Study|Death|0|||
33635346|NCT01395784|63037351|FG000|Overall Study|Lost to Follow-up|7|||
33635347|NCT01395784|63037351|FG000|Overall Study|Withdrawal by Subject|3|||
33635348|NCT01395784|63037351|FG000|Overall Study|Physician Decision|5|||
33635349|NCT01380184|63037355|FG000|Part 1 (19 Days)|Adverse Event|1|||
33635350|NCT01380184|63037355|FG000|Part 2|Adverse Event|5|||
33635351|NCT01380184|63037355|FG000|Part 2|Disease Progression|8|||
33635352|NCT01380184|63037355|FG000|Part 2|Lost to Follow-up|1|||
33635353|NCT01395394|63037362|FG000|Baseline Study Visit|Protocol Violation|1|||
33635354|NCT01395394|63037363|FG001|Baseline Study Visit|Protocol Violation|0|||
33635355|NCT01395394|63037364|FG002|Baseline Study Visit|Protocol Violation|0|||
33635356|NCT01395316|63037372|FG000|Overall Study|Lost to Follow-up|2|||
33635357|NCT01395316|63037372|FG000|Overall Study|poor MRI quality|1|||
33635358|NCT01742091|63037382|FG000|Overall Study|Adverse Event|0|||
33635359|NCT01742091|63037383|FG001|Overall Study|Adverse Event|0|||
33635360|NCT01742091|63037384|FG002|Overall Study|Adverse Event|0|||
33635361|NCT01742091|63037385|FG003|Overall Study|Adverse Event|0|||
33635362|NCT01742091|63037386|FG004|Overall Study|Adverse Event|1|||
33635363|NCT01742091|63037387|FG005|Overall Study|Adverse Event|0|||
33544259|NCT03012061|62935098|FG002|Overall Study|Adverse Event|0|||
33635364|NCT01742091|63037382|FG000|Overall Study|Physician Decision|0|||
33635365|NCT01742091|63037383|FG001|Overall Study|Physician Decision|0|||
33635366|NCT01742091|63037384|FG002|Overall Study|Physician Decision|0|||
33326426|NCT00946101|62703181|FG001|Overall Study|Withdrawal of consent|0|||
33635367|NCT01742091|63037385|FG003|Overall Study|Physician Decision|0|||
33635368|NCT01742091|63037386|FG004|Overall Study|Physician Decision|0|||
33635369|NCT01742091|63037387|FG005|Overall Study|Physician Decision|1|||
33635370|NCT01742091|63037382|FG000|Overall Study|Withdrawal by Subject|0|||
33635371|NCT01742091|63037383|FG001|Overall Study|Withdrawal by Subject|0|||
33462151|NCT03466060|62836044|FG000|Period 1|Test Lens Damage|0|||
33462152|NCT03466060|62836045|FG001|Period 1|Test Lens Damage|2|||
33635372|NCT01742091|63037384|FG002|Overall Study|Withdrawal by Subject|0|||
33635373|NCT01742091|63037385|FG003|Overall Study|Withdrawal by Subject|1|||
33635374|NCT01742091|63037386|FG004|Overall Study|Withdrawal by Subject|0|||
33635375|NCT01742091|63037387|FG005|Overall Study|Withdrawal by Subject|0|||
33635376|NCT01742091|63037382|FG000|Overall Study|Lost to Follow-up|0|||
33635377|NCT01742091|63037383|FG001|Overall Study|Lost to Follow-up|0|||
33635378|NCT01742091|63037384|FG002|Overall Study|Lost to Follow-up|0|||
33635379|NCT01742091|63037385|FG003|Overall Study|Lost to Follow-up|0|||
33635380|NCT01742091|63037386|FG004|Overall Study|Lost to Follow-up|0|||
33635381|NCT01742091|63037387|FG005|Overall Study|Lost to Follow-up|1|||
33635382|NCT01731951|63037407|FG000|Overall Study|Documented Disease Progression|1|||
33635383|NCT01731951|63037408|FG001|Overall Study|Documented Disease Progression|0|||
33635384|NCT01731951|63037409|FG002|Overall Study|Documented Disease Progression|0|||
33635385|NCT01731951|63037410|FG003|Overall Study|Documented Disease Progression|0|||
33635386|NCT01731951|63037411|FG004|Overall Study|Documented Disease Progression|0|||
33635387|NCT01731951|63037412|FG005|Overall Study|Documented Disease Progression|0|||
33635388|NCT01731951|63037407|FG000|Overall Study|Lost to Follow-up|2|||
33635389|NCT01731951|63037408|FG001|Overall Study|Lost to Follow-up|0|||
33635390|NCT01731951|63037409|FG002|Overall Study|Lost to Follow-up|0|||
33635391|NCT01731951|63037410|FG003|Overall Study|Lost to Follow-up|1|||
33635392|NCT01731951|63037411|FG004|Overall Study|Lost to Follow-up|3|||
33635393|NCT01731951|63037412|FG005|Overall Study|Lost to Follow-up|1|||
33635394|NCT01731951|63037407|FG000|Overall Study|Withdrawal of Consent|1|||
33635395|NCT01731951|63037408|FG001|Overall Study|Withdrawal of Consent|0|||
33635396|NCT01731951|63037409|FG002|Overall Study|Withdrawal of Consent|0|||
33635397|NCT01731951|63037410|FG003|Overall Study|Withdrawal of Consent|0|||
33635398|NCT01731951|63037411|FG004|Overall Study|Withdrawal of Consent|0|||
33635399|NCT01731951|63037412|FG005|Overall Study|Withdrawal of Consent|2|||
33635400|NCT01731951|63037407|FG000|Overall Study|Death|13|||
33635401|NCT01731951|63037408|FG001|Overall Study|Death|15|||
33635402|NCT01731951|63037409|FG002|Overall Study|Death|9|||
33635403|NCT01731951|63037410|FG003|Overall Study|Death|8|||
33635404|NCT01731951|63037411|FG004|Overall Study|Death|9|||
33635405|NCT01731951|63037412|FG005|Overall Study|Death|6|||
33635406|NCT01731171|63037432|FG000|Overall Study|Withdrawal by Subject|4|||
33635407|NCT01731171|63037433|FG001|Overall Study|Withdrawal by Subject|1|||
33635408|NCT01731171|63037432|FG000|Overall Study|Lost to Follow-up|3|||
33635409|NCT01731171|63037433|FG001|Overall Study|Lost to Follow-up|2|||
33635410|NCT01731171|63037432|FG000|Overall Study|Moved out of Area|0|||
33635411|NCT01731171|63037433|FG001|Overall Study|Moved out of Area|2|||
33635412|NCT01731171|63037432|FG000|Overall Study|Terminated for Lack of Adherence|0|||
33635413|NCT01731171|63037433|FG001|Overall Study|Terminated for Lack of Adherence|1|||
33635414|NCT01731171|63037432|FG000|Overall Study|Terminated for Safety Reasons|0|||
33635415|NCT01731171|63037433|FG001|Overall Study|Terminated for Safety Reasons|1|||
33635416|NCT01741701|63037441|FG000|Overall Study|Adverse Event|5|||
33635417|NCT01741701|63037442|FG001|Overall Study|Adverse Event|1|||
33635418|NCT01741701|63037441|FG000|Overall Study|Withdrawal by Subject|0|||
33635419|NCT01741701|63037442|FG001|Overall Study|Withdrawal by Subject|1|||
33635420|NCT01741545|63037450|FG000|Treatment Period|Lack of Efficacy|0|||
33635421|NCT01741545|63037451|FG001|Treatment Period|Lack of Efficacy|1|||
33635422|NCT01741545|63037450|FG000|Treatment Period|Adverse event, non-fatal|1|||
33635423|NCT01741545|63037451|FG001|Treatment Period|Adverse event, non-fatal|3|||
33635424|NCT01741545|63037450|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
33635425|NCT01741545|63037451|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
33635426|NCT01741545|63037450|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
33635427|NCT01741545|63037451|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
33635428|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
33635429|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
33635430|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
33635431|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
33635432|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
33326427|NCT00946101|62703180|FG000|Overall Study|Physician Decision|0|||
33326428|NCT00946101|62703181|FG001|Overall Study|Physician Decision|1|||
33635433|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
33635434|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
33635435|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
33635436|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
33635437|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
33635438|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
33635439|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
33635440|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
33635441|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
33635442|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
33326429|NCT01109940|62703195|FG000|Overall Study|Administrative problems|2|||
33635443|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
33635444|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
33635445|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
33635446|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
33635447|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
33635448|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
33635449|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
33635450|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
33635451|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
33635452|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
33635453|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
33635454|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
33635455|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
33635456|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
33635457|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
33635458|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
33635459|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
33635460|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
33635461|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
33635462|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
33635463|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
33635464|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
33635465|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
33635466|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
33635467|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
33635468|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
33635469|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
33635470|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
33635471|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
33635472|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
33635473|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
33635474|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
33635475|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
33635476|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
33635477|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
33635478|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
33635479|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
33635480|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
33635481|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
33635482|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
33635483|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
33635484|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
33635485|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
33462153|NCT03466060|62836046|FG002|Period 1|Test Lens Damage|0|||
33462154|NCT03466060|62836047|FG003|Period 1|Test Lens Damage|0|||
33462155|NCT03466060|62836048|FG004|Period 1|Test Lens Damage|0|||
33462156|NCT03466060|62836049|FG005|Period 1|Test Lens Damage|0|||
33462157|NCT03466060|62836044|FG000|Period 1|Withdrawal by Subject|0|||
33462158|NCT03466060|62836045|FG001|Period 1|Withdrawal by Subject|0|||
33462159|NCT03466060|62836046|FG002|Period 1|Withdrawal by Subject|2|||
33462160|NCT03466060|62836047|FG003|Period 1|Withdrawal by Subject|0|||
33462161|NCT03466060|62836048|FG004|Period 1|Withdrawal by Subject|0|||
33462162|NCT03466060|62836049|FG005|Period 1|Withdrawal by Subject|0|||
33462163|NCT03466060|62836044|FG000|Period 1|Lost to Follow-up|0|||
33462164|NCT03466060|62836045|FG001|Period 1|Lost to Follow-up|0|||
33635486|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
33462165|NCT03466060|62836046|FG002|Period 1|Lost to Follow-up|0|||
33462166|NCT03466060|62836047|FG003|Period 1|Lost to Follow-up|1|||
33462167|NCT03466060|62836048|FG004|Period 1|Lost to Follow-up|0|||
33462168|NCT03466060|62836049|FG005|Period 1|Lost to Follow-up|0|||
33462169|NCT03466060|62836044|FG000|Period 1|Grade 2 Conjunctivitis|0|||
33462170|NCT03466060|62836045|FG001|Period 1|Grade 2 Conjunctivitis|0|||
33462171|NCT03466060|62836046|FG002|Period 1|Grade 2 Conjunctivitis|1|||
33462172|NCT03466060|62836047|FG003|Period 1|Grade 2 Conjunctivitis|0|||
33462173|NCT03466060|62836048|FG004|Period 1|Grade 2 Conjunctivitis|0|||
33540593|NCT02061761|62930768|FG008|Overall Study|Withdrawal by Subject|2|||
33540594|NCT02061761|62930760|FG000|Overall Study|Maximum clinical benefit|0|||
33540595|NCT02061761|62930761|FG001|Overall Study|Maximum clinical benefit|0|||
33635487|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
33635488|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
33635489|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
33635490|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
33635491|NCT01884350|63037459|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
33635492|NCT01884350|63037460|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
33635493|NCT01884350|63037461|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
33635494|NCT01614795|63037475|FG000|Overall Study|Adverse Event|0|||
33635495|NCT01614795|63037476|FG001|Overall Study|Adverse Event|0|||
33635496|NCT01614795|63037477|FG002|Overall Study|Adverse Event|1|||
33635497|NCT01614795|63037478|FG003|Overall Study|Adverse Event|1|||
33635498|NCT01614795|63037475|FG000|Overall Study|Lack of Efficacy|10|||
33635499|NCT01614795|63037476|FG001|Overall Study|Lack of Efficacy|10|||
33635500|NCT01614795|63037477|FG002|Overall Study|Lack of Efficacy|9|||
33635501|NCT01614795|63037478|FG003|Overall Study|Lack of Efficacy|8|||
33635502|NCT01614795|63037475|FG000|Overall Study|Physician Decision|1|||
33635503|NCT01614795|63037476|FG001|Overall Study|Physician Decision|0|||
33635504|NCT01614795|63037477|FG002|Overall Study|Physician Decision|1|||
33635505|NCT01614795|63037478|FG003|Overall Study|Physician Decision|1|||
33635506|NCT01614795|63037475|FG000|Overall Study|Withdrawal by Subject|0|||
33635507|NCT01614795|63037476|FG001|Overall Study|Withdrawal by Subject|1|||
33635508|NCT01614795|63037477|FG002|Overall Study|Withdrawal by Subject|0|||
33635509|NCT01614795|63037478|FG003|Overall Study|Withdrawal by Subject|2|||
33635510|NCT01614795|63037475|FG000|Overall Study|Ineligible|0|||
33635511|NCT01614795|63037476|FG001|Overall Study|Ineligible|1|||
33635512|NCT01614795|63037477|FG002|Overall Study|Ineligible|0|||
33635513|NCT01614795|63037478|FG003|Overall Study|Ineligible|0|||
33635514|NCT01834586|63037489|FG000|Overall Study|Adverse Event|1|||
33635515|NCT01614249|63037495|FG000|Overall Study|Lost to Follow-up|11|||
33635516|NCT01614249|63037496|FG001|Overall Study|Lost to Follow-up|23|||
33635517|NCT01597778|63037504|FG000|Overall Study|Death|7|||
33635518|NCT01597778|63037505|FG001|Overall Study|Death|10|||
33635519|NCT01597778|63037504|FG000|Overall Study|Withdrawal by Subject|3|||
33635520|NCT01597778|63037505|FG001|Overall Study|Withdrawal by Subject|4|||
33635521|NCT01597778|63037504|FG000|Overall Study|Adverse Event|1|||
33635522|NCT01597778|63037505|FG001|Overall Study|Adverse Event|1|||
33635523|NCT01597778|63037504|FG000|Overall Study|Protocol Violation|1|||
33635524|NCT01597778|63037505|FG001|Overall Study|Protocol Violation|11|||
33635525|NCT01597778|63037504|FG000|Overall Study|Transplanted off protocol|2|||
33635526|NCT01597778|63037505|FG001|Overall Study|Transplanted off protocol|3|||
33635527|NCT01614093|63037511|FG000|Overall Study|Withdrawal by Subject|1|||
33635528|NCT01834274|63037518|FG000|Overall Study|Study Termination|41|||
33635529|NCT01834274|63037519|FG001|Overall Study|Study Termination|38|||
33635530|NCT01834274|63037518|FG000|Overall Study|Withdrawal by Subject|1|||
33635531|NCT01834274|63037519|FG001|Overall Study|Withdrawal by Subject|1|||
33635532|NCT01834274|63037518|FG000|Overall Study|Lost to Follow-up|3|||
33328320|NCT01134263|62704716|FG004|Overall Study|Lost to Follow-up|1|||
33462174|NCT03466060|62836049|FG005|Period 1|Grade 2 Conjunctivitis|0|||
33540596|NCT02061761|62930762|FG002|Overall Study|Maximum clinical benefit|0|||
33540597|NCT02061761|62930763|FG003|Overall Study|Maximum clinical benefit|1|||
33540598|NCT02061761|62930764|FG004|Overall Study|Maximum clinical benefit|0|||
33540599|NCT02061761|62930765|FG005|Overall Study|Maximum clinical benefit|0|||
33540600|NCT02061761|62930766|FG006|Overall Study|Maximum clinical benefit|0|||
33540601|NCT02061761|62930767|FG007|Overall Study|Maximum clinical benefit|0|||
33462175|NCT03466060|62836044|FG000|Period 2|Lens Handling Difficulties|0|||
33462176|NCT03466060|62836045|FG001|Period 2|Lens Handling Difficulties|0|||
33540602|NCT02061761|62930768|FG008|Overall Study|Maximum clinical benefit|6|||
33540603|NCT02061761|62930760|FG000|Overall Study|Participant no longer meets study criteria|0|||
33635533|NCT01834274|63037519|FG001|Overall Study|Lost to Follow-up|1|||
33635534|NCT01834274|63037518|FG000|Overall Study|Other|2|||
33635535|NCT01834274|63037519|FG001|Overall Study|Other|1|||
33635536|NCT01739595|63037528|FG000|Overall Study|Adverse Event|3|||
33635537|NCT01739595|63037529|FG001|Overall Study|Adverse Event|0|||
33635538|NCT01739595|63037530|FG002|Overall Study|Adverse Event|0|||
33635539|NCT01739595|63037528|FG000|Overall Study|Lost to Follow-up|2|||
33635540|NCT01739595|63037529|FG001|Overall Study|Lost to Follow-up|0|||
33635541|NCT01739595|63037530|FG002|Overall Study|Lost to Follow-up|0|||
33635542|NCT01739595|63037528|FG000|Overall Study|Withdrawal by Subject|2|||
33635543|NCT01739595|63037529|FG001|Overall Study|Withdrawal by Subject|1|||
33635544|NCT01739595|63037530|FG002|Overall Study|Withdrawal by Subject|2|||
33635545|NCT01739595|63037528|FG000|Overall Study|Eligibility issue|3|||
33635546|NCT01739595|63037529|FG001|Overall Study|Eligibility issue|0|||
33635547|NCT01739595|63037530|FG002|Overall Study|Eligibility issue|0|||
33635548|NCT01739595|63037528|FG000|Overall Study|Protocol Violation|1|||
33635549|NCT01739595|63037529|FG001|Overall Study|Protocol Violation|0|||
33635550|NCT01739595|63037530|FG002|Overall Study|Protocol Violation|0|||
33635551|NCT01739595|63037528|FG000|Overall Study|Lab assessment|1|||
33635552|NCT01739595|63037529|FG001|Overall Study|Lab assessment|0|||
33635553|NCT01739595|63037530|FG002|Overall Study|Lab assessment|0|||
33635554|NCT01739595|63037528|FG000|Overall Study|Drug discrepancy|1|||
33635555|NCT01739595|63037529|FG001|Overall Study|Drug discrepancy|0|||
33635556|NCT01739595|63037530|FG002|Overall Study|Drug discrepancy|0|||
33635557|NCT01833494|63037537|FG000|Overall Study|Adverse Event|24|||
33635558|NCT01833494|63037537|FG000|Overall Study|Physician Decision|6|||
33635559|NCT01833494|63037537|FG000|Overall Study|Withdrawal by Subject|6|||
33635560|NCT01833494|63037537|FG000|Overall Study|Decrease in serum phosphorus|4|||
33635561|NCT01833494|63037537|FG000|Overall Study|Decrease in serum calcium|4|||
33635562|NCT01833494|63037537|FG000|Overall Study|Increase in serum ferritin|1|||
33635563|NCT01738971|63037544|FG000|Overall Study|Lost to Follow-up|19|||
33635564|NCT01738971|63037545|FG001|Overall Study|Lost to Follow-up|30|||
33635565|NCT01738971|63037546|FG002|Overall Study|Lost to Follow-up|17|||
33635566|NCT01738581|63037556|FG000|Overall Study|Lost to Follow-up|1|||
33635567|NCT01738581|63037557|FG001|Overall Study|Lost to Follow-up|0|||
33635568|NCT01738503|63037569|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
33635569|NCT01738503|63037570|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
33635570|NCT01738503|63037571|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
33635571|NCT01738503|63037572|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
33635572|NCT01738503|63037573|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
33635573|NCT01738503|63037574|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
33635574|NCT01738503|63037575|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
33635575|NCT01738503|63037569|FG000|Treatment Period|Adverse Event|0|||
33635576|NCT01738503|63037570|FG001|Treatment Period|Adverse Event|1|||
33635577|NCT01738503|63037571|FG002|Treatment Period|Adverse Event|0|||
33635578|NCT01738503|63037572|FG003|Treatment Period|Adverse Event|1|||
33635579|NCT01738503|63037573|FG004|Treatment Period|Adverse Event|2|||
33635580|NCT01738503|63037574|FG005|Treatment Period|Adverse Event|2|||
33635581|NCT01738503|63037575|FG006|Treatment Period|Adverse Event|2|||
33635582|NCT01738503|63037569|FG000|Treatment Period|Lost to Follow-up|0|||
33635583|NCT01738503|63037570|FG001|Treatment Period|Lost to Follow-up|0|||
33540604|NCT02061761|62930761|FG001|Overall Study|Participant no longer meets study criteria|0|||
33540605|NCT02061761|62930762|FG002|Overall Study|Participant no longer meets study criteria|0|||
33540606|NCT02061761|62930763|FG003|Overall Study|Participant no longer meets study criteria|0|||
33540607|NCT02061761|62930764|FG004|Overall Study|Participant no longer meets study criteria|0|||
33540608|NCT02061761|62930765|FG005|Overall Study|Participant no longer meets study criteria|0|||
33540609|NCT02061761|62930766|FG006|Overall Study|Participant no longer meets study criteria|0|||
33540610|NCT02061761|62930767|FG007|Overall Study|Participant no longer meets study criteria|0|||
33540611|NCT02061761|62930768|FG008|Overall Study|Participant no longer meets study criteria|1|||
33540612|NCT02061761|62930760|FG000|Overall Study|Other reasons|0|||
33540613|NCT02061761|62930761|FG001|Overall Study|Other reasons|0|||
33540614|NCT02061761|62930762|FG002|Overall Study|Other reasons|0|||
33540615|NCT02061761|62930763|FG003|Overall Study|Other reasons|0|||
33540616|NCT02061761|62930764|FG004|Overall Study|Other reasons|2|||
33540617|NCT02061761|62930765|FG005|Overall Study|Other reasons|0|||
33540618|NCT02061761|62930766|FG006|Overall Study|Other reasons|0|||
33540619|NCT02061761|62930767|FG007|Overall Study|Other reasons|0|||
33540620|NCT02061761|62930768|FG008|Overall Study|Other reasons|6|||
33540621|NCT01927068|62930796|FG000|Overall Study|Death|37|||
33540622|NCT01927068|62930797|FG001|Overall Study|Death|3|||
33540623|NCT01927068|62930796|FG000|Overall Study|Withdrawal by Subject|50|||
33540624|NCT01927068|62930797|FG001|Overall Study|Withdrawal by Subject|3|||
33540625|NCT01927068|62930796|FG000|Overall Study|Lost to Follow-up|10|||
33540626|NCT01927068|62930797|FG001|Overall Study|Lost to Follow-up|2|||
33540627|NCT01927068|62930796|FG000|Overall Study|Physician Decision|9|||
33635584|NCT01738503|63037571|FG002|Treatment Period|Lost to Follow-up|3|||
33540628|NCT01927068|62930797|FG001|Overall Study|Physician Decision|0|||
33635585|NCT01738503|63037572|FG003|Treatment Period|Lost to Follow-up|4|||
33635586|NCT01738503|63037573|FG004|Treatment Period|Lost to Follow-up|1|||
33635587|NCT01738503|63037574|FG005|Treatment Period|Lost to Follow-up|1|||
33635588|NCT01738503|63037575|FG006|Treatment Period|Lost to Follow-up|5|||
33635589|NCT01738503|63037569|FG000|Treatment Period|Withdrawal by Subject|0|||
33635590|NCT01738503|63037570|FG001|Treatment Period|Withdrawal by Subject|1|||
33635591|NCT01738503|63037571|FG002|Treatment Period|Withdrawal by Subject|0|||
33635592|NCT01738503|63037572|FG003|Treatment Period|Withdrawal by Subject|1|||
33635593|NCT01738503|63037573|FG004|Treatment Period|Withdrawal by Subject|1|||
33635594|NCT01738503|63037574|FG005|Treatment Period|Withdrawal by Subject|1|||
33635595|NCT01738503|63037575|FG006|Treatment Period|Withdrawal by Subject|1|||
33635596|NCT01738503|63037569|FG000|Treatment Period|Protocol Violation|0|||
33635597|NCT01738503|63037570|FG001|Treatment Period|Protocol Violation|3|||
33635598|NCT01738503|63037571|FG002|Treatment Period|Protocol Violation|1|||
33635599|NCT01738503|63037572|FG003|Treatment Period|Protocol Violation|0|||
33635600|NCT01738503|63037573|FG004|Treatment Period|Protocol Violation|4|||
33635601|NCT01738503|63037574|FG005|Treatment Period|Protocol Violation|2|||
33635602|NCT01738503|63037575|FG006|Treatment Period|Protocol Violation|0|||
33635603|NCT01738503|63037569|FG000|Treatment Period|Other|0|||
33635604|NCT01738503|63037570|FG001|Treatment Period|Other|0|||
33635605|NCT01738503|63037571|FG002|Treatment Period|Other|1|||
33635606|NCT01738503|63037572|FG003|Treatment Period|Other|0|||
33635607|NCT01738503|63037573|FG004|Treatment Period|Other|0|||
33635608|NCT01738503|63037574|FG005|Treatment Period|Other|0|||
33635609|NCT01738503|63037575|FG006|Treatment Period|Other|0|||
33635610|NCT01738503|63037569|FG000|PET Imaging Sub-study|Adverse Event|0|||
33635611|NCT01738503|63037570|FG001|PET Imaging Sub-study|Adverse Event|0|||
33635612|NCT01738503|63037571|FG002|PET Imaging Sub-study|Adverse Event|0|||
33635613|NCT01738503|63037572|FG003|PET Imaging Sub-study|Adverse Event|0|||
33635614|NCT01738503|63037573|FG004|PET Imaging Sub-study|Adverse Event|0|||
33635615|NCT01738503|63037574|FG005|PET Imaging Sub-study|Adverse Event|1|||
33635616|NCT01738503|63037575|FG006|PET Imaging Sub-study|Adverse Event|0|||
33635617|NCT01738503|63037569|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
33635618|NCT01738503|63037570|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
33635619|NCT01738503|63037571|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
33635620|NCT01738503|63037572|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
33635621|NCT01738503|63037573|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
33635622|NCT01738503|63037574|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
33635623|NCT01738503|63037575|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
33635624|NCT01738191|63037599|FG000|Overall Study|Withdrawal by Subject|4|||
33635625|NCT01738191|63037600|FG001|Overall Study|Withdrawal by Subject|1|||
33635626|NCT01737879|63037606|FG000|Overall Study|Death|1|||
33635627|NCT01737879|63037606|FG000|Overall Study|Sponsor decision|40|||
33635628|NCT01879683|63037610|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
33635629|NCT01605825|63037616|FG000|Overall Study|Adverse Event|4|||
33635630|NCT01605825|63037617|FG001|Overall Study|Adverse Event|2|||
33635631|NCT01605825|63037616|FG000|Overall Study|Withdrawal by Subject|0|||
33635632|NCT01605825|63037617|FG001|Overall Study|Withdrawal by Subject|1|||
33635633|NCT01605825|63037616|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
33635634|NCT01605825|63037617|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
33635635|NCT01605825|63037616|FG000|Overall Study|Non-Compliance with Protocol|3|||
33635636|NCT01605825|63037617|FG001|Overall Study|Non-Compliance with Protocol|0|||
33635637|NCT01727505|63037623|FG000|First 24 Hours|Adverse Event|0|||
33635638|NCT01727505|63037624|FG001|First 24 Hours|Adverse Event|1|||
33635639|NCT01727505|63037623|FG000|Second 24 Hours|Missing data|0|||
33635640|NCT01727505|63037624|FG001|Second 24 Hours|Missing data|1|||
33635641|NCT01726803|63037632|FG000|Overall Study|Lost to Follow-up|6|||
33635642|NCT01726803|63037633|FG001|Overall Study|Lost to Follow-up|1|||
33635643|NCT01726803|63037632|FG000|Overall Study|Withdrawal by Subject|1|||
33635644|NCT01726803|63037633|FG001|Overall Study|Withdrawal by Subject|0|||
33635645|NCT01726335|63037639|FG000|Overall Study|Lost to Follow-up|2|||
33635646|NCT01726335|63037639|FG000|Overall Study|Withdrawal by Subject|15|||
33635647|NCT01726335|63037639|FG000|Overall Study|Adverse Event|4|||
33635648|NCT01726335|63037639|FG000|Overall Study|Lost to Follow-up|2|||
33635649|NCT01726335|63037639|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
33635650|NCT01877421|63037675|FG000|Phase 2|Lost to Follow-up|0|||
33635651|NCT01877421|63037676|FG001|Phase 2|Lost to Follow-up|0|||
33635652|NCT01877421|63037677|FG002|Phase 2|Lost to Follow-up|0|||
33635653|NCT01877421|63037678|FG003|Phase 2|Lost to Follow-up|0|||
33635654|NCT01877421|63037679|FG004|Phase 2|Lost to Follow-up|0|||
33635655|NCT01877421|63037680|FG005|Phase 2|Lost to Follow-up|0|||
33635656|NCT01877421|63037681|FG006|Phase 2|Lost to Follow-up|1|||
33635657|NCT01877421|63037682|FG007|Phase 2|Lost to Follow-up|0|||
33635658|NCT01877421|63037683|FG008|Phase 2|Lost to Follow-up|0|||
33635659|NCT01877421|63037684|FG009|Phase 2|Lost to Follow-up|0|||
33635660|NCT01877421|63037685|FG010|Phase 2|Lost to Follow-up|0|||
33635661|NCT01877421|63037686|FG011|Phase 2|Lost to Follow-up|0|||
33635662|NCT01877421|63037687|FG012|Phase 2|Lost to Follow-up|0|||
33635663|NCT01877421|63037688|FG013|Phase 2|Lost to Follow-up|0|||
33635664|NCT01877421|63037689|FG014|Phase 2|Lost to Follow-up|0|||
33635665|NCT01877421|63037690|FG015|Phase 2|Lost to Follow-up|0|||
33635666|NCT01877421|63037691|FG016|Phase 2|Lost to Follow-up|0|||
33635667|NCT01877421|63037692|FG017|Phase 2|Lost to Follow-up|0|||
33635668|NCT01877421|63037675|FG000|Phase 2|Withdrawal by Subject|0|||
33635669|NCT01877421|63037676|FG001|Phase 2|Withdrawal by Subject|0|||
33635670|NCT01877421|63037677|FG002|Phase 2|Withdrawal by Subject|0|||
33635671|NCT01877421|63037678|FG003|Phase 2|Withdrawal by Subject|0|||
33635672|NCT01877421|63037679|FG004|Phase 2|Withdrawal by Subject|0|||
33635673|NCT01877421|63037680|FG005|Phase 2|Withdrawal by Subject|0|||
33635674|NCT01877421|63037681|FG006|Phase 2|Withdrawal by Subject|0|||
33635675|NCT01877421|63037682|FG007|Phase 2|Withdrawal by Subject|0|||
33635676|NCT01877421|63037683|FG008|Phase 2|Withdrawal by Subject|1|||
33635677|NCT01877421|63037684|FG009|Phase 2|Withdrawal by Subject|0|||
33635678|NCT01877421|63037685|FG010|Phase 2|Withdrawal by Subject|1|||
33326430|NCT01109940|62703196|FG001|Overall Study|Administrative problems|0|||
33326431|NCT01109940|62703197|FG002|Overall Study|Administrative problems|0|||
33326432|NCT01109940|62703198|FG003|Overall Study|Administrative problems|0|||
33326433|NCT01109940|62703195|FG000|Overall Study|Serious Adverse Event|2|||
33326434|NCT01109940|62703196|FG001|Overall Study|Serious Adverse Event|1|||
33326435|NCT01109940|62703197|FG002|Overall Study|Serious Adverse Event|0|||
33326436|NCT01109940|62703198|FG003|Overall Study|Serious Adverse Event|0|||
33326437|NCT01109940|62703195|FG000|Overall Study|Lost to Follow-up|1|||
33326438|NCT01109940|62703196|FG001|Overall Study|Lost to Follow-up|0|||
33326439|NCT01109940|62703197|FG002|Overall Study|Lost to Follow-up|0|||
33326440|NCT01109940|62703198|FG003|Overall Study|Lost to Follow-up|0|||
33326441|NCT01109940|62703195|FG000|Overall Study|Patient withdrew consent|1|||
33326442|NCT01109940|62703196|FG001|Overall Study|Patient withdrew consent|1|||
33326443|NCT01109940|62703197|FG002|Overall Study|Patient withdrew consent|0|||
33326444|NCT01109940|62703198|FG003|Overall Study|Patient withdrew consent|0|||
33326445|NCT01109940|62703195|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33326446|NCT01109940|62703196|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33326447|NCT01109940|62703197|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
33326448|NCT01109940|62703198|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
33326449|NCT00595309|62703208|FG000|Overall Study|Lost to Follow-up|1|||
33326450|NCT00595309|62703208|FG000|Overall Study|planned vaccination against yellow fever|1|||
33326451|NCT00595309|62703208|FG000|Overall Study|acute infection after V0|1|||
33326452|NCT00595309|62703208|FG000|Overall Study|personal reason|1|||
33326453|NCT00595075|62703214|FG000|Overall Study|Withdrawal by Subject|1|||
33326454|NCT00595075|62703215|FG001|Overall Study|Withdrawal by Subject|0|||
33326455|NCT00887224|62703224|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
33326456|NCT00887224|62703225|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
33326457|NCT00887224|62703226|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
33326458|NCT00887224|62703224|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
33326459|NCT00887224|62703225|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
33326460|NCT00887224|62703226|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
33326461|NCT00887224|62703224|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
33326462|NCT00887224|62703225|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
33326463|NCT00887224|62703226|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
33326464|NCT00887224|62703224|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
33326465|NCT00887224|62703225|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
33326466|NCT00887224|62703226|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
33326467|NCT00887224|62703224|FG000|Open-label Response (OLR) Phase|Other|1|||
33326468|NCT00887224|62703225|FG001|Open-label Response (OLR) Phase|Other|0|||
33326469|NCT00887224|62703226|FG002|Open-label Response (OLR) Phase|Other|0|||
33326470|NCT00887224|62703224|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
33326471|NCT00887224|62703225|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
33326472|NCT00887224|62703226|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
33326473|NCT00887224|62703224|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
33326474|NCT00887224|62703225|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
33326475|NCT00887224|62703226|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
33326476|NCT00887224|62703224|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
33540629|NCT01927068|62930796|FG000|Overall Study|Missed last follow-up visit|2|||
33540630|NCT01927068|62930797|FG001|Overall Study|Missed last follow-up visit|0|||
33635679|NCT01877421|63037686|FG011|Phase 2|Withdrawal by Subject|0|||
33635680|NCT01877421|63037687|FG012|Phase 2|Withdrawal by Subject|1|||
33635681|NCT01877421|63037688|FG013|Phase 2|Withdrawal by Subject|0|||
33635682|NCT01877421|63037689|FG014|Phase 2|Withdrawal by Subject|0|||
33635683|NCT01877421|63037690|FG015|Phase 2|Withdrawal by Subject|1|||
33635684|NCT01877421|63037691|FG016|Phase 2|Withdrawal by Subject|0|||
33635685|NCT01877421|63037692|FG017|Phase 2|Withdrawal by Subject|0|||
33635686|NCT01877421|63037675|FG000|Phase 2|Protocol Violation|0|||
33635687|NCT01877421|63037676|FG001|Phase 2|Protocol Violation|0|||
33635688|NCT01877421|63037677|FG002|Phase 2|Protocol Violation|0|||
33326477|NCT00887224|62703225|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
33326478|NCT00887224|62703226|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
33326479|NCT00887224|62703224|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
33326480|NCT00887224|62703225|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
33635689|NCT01877421|63037678|FG003|Phase 2|Protocol Violation|0|||
33635690|NCT01877421|63037679|FG004|Phase 2|Protocol Violation|0|||
33635691|NCT01877421|63037680|FG005|Phase 2|Protocol Violation|0|||
33635692|NCT01877421|63037681|FG006|Phase 2|Protocol Violation|0|||
33635693|NCT01877421|63037682|FG007|Phase 2|Protocol Violation|0|||
33540631|NCT01309230|62930806|FG000|Overall Study|Withdrawal by Subject|0|||
33540632|NCT01309230|62930807|FG001|Overall Study|Withdrawal by Subject|2|||
33540633|NCT01309230|62930806|FG000|Overall Study|Observation arm closed|0|||
33540634|NCT01309230|62930807|FG001|Overall Study|Observation arm closed|2|||
33635694|NCT01877421|63037683|FG008|Phase 2|Protocol Violation|0|||
33635695|NCT01877421|63037684|FG009|Phase 2|Protocol Violation|0|||
33635696|NCT01877421|63037685|FG010|Phase 2|Protocol Violation|1|||
33635697|NCT01877421|63037686|FG011|Phase 2|Protocol Violation|0|||
33635698|NCT01877421|63037687|FG012|Phase 2|Protocol Violation|0|||
33540635|NCT00819832|62930819|FG000|Overall Study|Sponsor Termination of Study|3|||
33540636|NCT00819832|62930820|FG001|Overall Study|Sponsor Termination of Study|0|||
33540637|NCT00819832|62930821|FG002|Overall Study|Sponsor Termination of Study|0|||
33635699|NCT01877421|63037688|FG013|Phase 2|Protocol Violation|0|||
33635700|NCT01877421|63037689|FG014|Phase 2|Protocol Violation|0|||
33635701|NCT01877421|63037690|FG015|Phase 2|Protocol Violation|0|||
33635702|NCT01877421|63037691|FG016|Phase 2|Protocol Violation|0|||
33635703|NCT01877421|63037692|FG017|Phase 2|Protocol Violation|0|||
33635704|NCT01726023|63037774|FG000|Overall Study|Death|1|||
33635705|NCT01726023|63037775|FG001|Overall Study|Death|1|||
33635706|NCT01726023|63037774|FG000|Overall Study|Lost to Follow-up|5|||
33635707|NCT01726023|63037775|FG001|Overall Study|Lost to Follow-up|10|||
33635708|NCT01726023|63037774|FG000|Overall Study|Other Eligibility criteria|7|||
33635709|NCT01726023|63037775|FG001|Overall Study|Other Eligibility criteria|7|||
33635710|NCT01726023|63037774|FG000|Overall Study|Withdrawal by Subject|16|||
33635711|NCT01726023|63037775|FG001|Overall Study|Withdrawal by Subject|8|||
33635712|NCT01877265|63037788|FG000|Treatment Period 1|Sponsor Decision|0|||
33635713|NCT01877265|63037789|FG001|Treatment Period 1|Sponsor Decision|0|||
33635714|NCT01877265|63037790|FG002|Treatment Period 1|Sponsor Decision|1|||
33635715|NCT01877265|63037791|FG003|Treatment Period 1|Sponsor Decision|0|||
33635716|NCT01877265|63037792|FG004|Treatment Period 1|Sponsor Decision|0|||
33635717|NCT01877265|63037793|FG005|Treatment Period 1|Sponsor Decision|0|||
33635718|NCT01877265|63037788|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
33635719|NCT01877265|63037789|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
33635720|NCT01877265|63037790|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
33635721|NCT01877265|63037791|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
33635722|NCT01877265|63037792|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
33635723|NCT01877265|63037793|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
33635724|NCT01877265|63037788|FG000|Treatment Period 3|Lost to Follow-up|1|||
33635725|NCT01877265|63037789|FG001|Treatment Period 3|Lost to Follow-up|0|||
33635726|NCT01877265|63037790|FG002|Treatment Period 3|Lost to Follow-up|0|||
33635727|NCT01877265|63037791|FG003|Treatment Period 3|Lost to Follow-up|0|||
33635728|NCT01877265|63037792|FG004|Treatment Period 3|Lost to Follow-up|0|||
33635729|NCT01877265|63037793|FG005|Treatment Period 3|Lost to Follow-up|0|||
33635730|NCT01877187|63037804|FG000|Overall Study|Death|2|||
33635731|NCT01877187|63037804|FG000|Overall Study|Withdrawal by Subject|4|||
33540638|NCT00819832|62930822|FG003|Overall Study|Sponsor Termination of Study|0|||
33540639|NCT00819832|62930823|FG004|Overall Study|Sponsor Termination of Study|0|||
33540640|NCT00819832|62930824|FG005|Overall Study|Sponsor Termination of Study|0|||
33540641|NCT00704522|62930840|FG000|Overall Study|Lack of Efficacy|65|||
33326481|NCT00887224|62703226|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
33326482|NCT00887224|62703224|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
33540642|NCT00704522|62930841|FG001|Overall Study|Lack of Efficacy|17|||
33540643|NCT00704522|62930840|FG000|Overall Study|Failure to appear again at hospital|56|||
33540644|NCT00704522|62930841|FG001|Overall Study|Failure to appear again at hospital|10|||
33540645|NCT00704522|62930840|FG000|Overall Study|Withdrawal by Subject|17|||
33540646|NCT00704522|62930841|FG001|Overall Study|Withdrawal by Subject|8|||
33540647|NCT00704522|62930840|FG000|Overall Study|Adverse Event|9|||
33540648|NCT00704522|62930841|FG001|Overall Study|Adverse Event|1|||
33540649|NCT00704522|62930840|FG000|Overall Study|Undefined causes|9|||
33635732|NCT01877187|63037804|FG000|Overall Study|Lost to Follow-up|3|||
33635733|NCT01877187|63037804|FG000|Overall Study|Declining clinical status|11|||
33635734|NCT01877187|63037804|FG000|Overall Study|Liver transplant|2|||
33635735|NCT01858532|63037815|FG000|Overall Study|Adverse Event|58|||
33635736|NCT01858532|63037816|FG001|Overall Study|Adverse Event|50|||
33635737|NCT01858532|63037817|FG002|Overall Study|Adverse Event|23|||
33635738|NCT01858532|63037818|FG003|Overall Study|Adverse Event|28|||
33635739|NCT01858532|63037815|FG000|Overall Study|Withdrew consent|71|||
33635740|NCT01858532|63037816|FG001|Overall Study|Withdrew consent|93|||
33635741|NCT01858532|63037817|FG002|Overall Study|Withdrew consent|46|||
33635742|NCT01858532|63037818|FG003|Overall Study|Withdrew consent|27|||
33635743|NCT01858532|63037815|FG000|Overall Study|Lost to Follow-up|17|||
33635744|NCT01858532|63037816|FG001|Overall Study|Lost to Follow-up|26|||
33635745|NCT01858532|63037817|FG002|Overall Study|Lost to Follow-up|11|||
33635746|NCT01858532|63037818|FG003|Overall Study|Lost to Follow-up|14|||
33635747|NCT01858532|63037815|FG000|Overall Study|Deterioration of medical status|3|||
33635748|NCT01858532|63037816|FG001|Overall Study|Deterioration of medical status|4|||
33635749|NCT01858532|63037817|FG002|Overall Study|Deterioration of medical status|3|||
33635750|NCT01858532|63037818|FG003|Overall Study|Deterioration of medical status|7|||
33635751|NCT01858532|63037815|FG000|Overall Study|Investigator request|3|||
33635752|NCT01858532|63037816|FG001|Overall Study|Investigator request|4|||
33635753|NCT01858532|63037817|FG002|Overall Study|Investigator request|2|||
33635754|NCT01858532|63037818|FG003|Overall Study|Investigator request|6|||
33635755|NCT01858532|63037815|FG000|Overall Study|Other, not specified|29|||
33635756|NCT01858532|63037816|FG001|Overall Study|Other, not specified|15|||
33635757|NCT01858532|63037817|FG002|Overall Study|Other, not specified|13|||
33635758|NCT01858532|63037818|FG003|Overall Study|Other, not specified|11|||
33635759|NCT01883492|63037830|FG000|Overall Study|Lost to Follow-up|3|||
33635760|NCT01883492|63037831|FG001|Overall Study|Lost to Follow-up|4|||
33635761|NCT01883492|63037830|FG000|Overall Study|Surgery on contra-lateral hip|0|||
33635762|NCT01883492|63037831|FG001|Overall Study|Surgery on contra-lateral hip|1|||
33635763|NCT01883492|63037830|FG000|Overall Study|Poor X-ray quality|7|||
33635764|NCT01883492|63037831|FG001|Overall Study|Poor X-ray quality|4|||
33635765|NCT01883492|63037830|FG000|Overall Study|Withdrawal by Subject|1|||
33635766|NCT01883492|63037831|FG001|Overall Study|Withdrawal by Subject|0|||
33635767|NCT01883492|63037830|FG000|Overall Study|inappropriate implant used|1|||
33635768|NCT01883492|63037831|FG001|Overall Study|inappropriate implant used|1|||
33635769|NCT01883492|63037830|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
33635770|NCT01883492|63037831|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
33635771|NCT01832480|63037839|FG000|Overall Study|Lost to Follow-up|33|||
33635772|NCT01832480|63037840|FG001|Overall Study|Lost to Follow-up|30|||
33635773|NCT01832480|63037839|FG000|Overall Study|Withdrawal by Subject|0|||
33635774|NCT01832480|63037840|FG001|Overall Study|Withdrawal by Subject|2|||
33635775|NCT01832480|63037839|FG000|Overall Study|post randomization ineligible|8|||
33635776|NCT01832480|63037840|FG001|Overall Study|post randomization ineligible|10|||
33635777|NCT01858376|63037846|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
33635778|NCT01831856|63037852|FG000|Overall Study|Adverse Event|5|||
33635779|NCT01831856|63037853|FG001|Overall Study|Adverse Event|8|||
33635780|NCT01831856|63037852|FG000|Overall Study|Lack of Efficacy|13|||
33635781|NCT01831856|63037853|FG001|Overall Study|Lack of Efficacy|11|||
33635782|NCT01831856|63037852|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
33635783|NCT01831856|63037853|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
33635784|NCT01831544|63037859|FG000|Overall Study|Death|1|||
33635785|NCT01831544|63037859|FG000|Overall Study|Still on original MVAD device|2|||
33635786|NCT01857206|63037865|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
33635787|NCT01857206|63037866|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
33635788|NCT01857206|63037865|FG000|Overall Study|Lost to Follow-up|9|||
33635789|NCT01857206|63037866|FG001|Overall Study|Lost to Follow-up|6|||
33635790|NCT01857206|63037865|FG000|Overall Study|Unclassified|3|||
33635791|NCT01857206|63037866|FG001|Overall Study|Unclassified|3|||
33635792|NCT01857206|63037865|FG000|Overall Study|Withdrawal by Subject|1|||
33635793|NCT01857206|63037866|FG001|Overall Study|Withdrawal by Subject|0|||
33635794|NCT01882088|63037876|FG000|Overall Study|Intolerance of esophageal manometry|1|||
33635795|NCT01882088|63037876|FG000|Overall Study|no possibility to place the catheter|1|||
33635796|NCT01882088|63037876|FG000|Overall Study|Protocol Violation|1|||
33635797|NCT01882088|63037876|FG000|Overall Study|inadequate pH-impedance tracings|2|||
33635798|NCT01881776|63037883|FG000|Overall Study|Lost to Follow-up|1|||
33635799|NCT01881776|63037884|FG001|Overall Study|Lost to Follow-up|2|||
33635800|NCT01881776|63037885|FG002|Overall Study|Lost to Follow-up|1|||
33635801|NCT01881776|63037883|FG000|Overall Study|Protocol Violation|0|||
33635802|NCT01881776|63037884|FG001|Overall Study|Protocol Violation|2|||
33635803|NCT01881776|63037885|FG002|Overall Study|Protocol Violation|1|||
33635804|NCT01708161|63037899|FG000|Overall Study|Adverse Event|1|||
33635805|NCT01708161|63037900|FG001|Overall Study|Adverse Event|3|||
33635806|NCT01708161|63037901|FG002|Overall Study|Adverse Event|4|||
33635807|NCT01708161|63037902|FG003|Overall Study|Adverse Event|2|||
33540650|NCT00704522|62930841|FG001|Overall Study|Undefined causes|7|||
33635808|NCT01708161|63037903|FG004|Overall Study|Adverse Event|3|||
33635809|NCT01708161|63037904|FG005|Overall Study|Adverse Event|0|||
33635810|NCT01708161|63037899|FG000|Overall Study|Death|0|||
33635811|NCT01708161|63037900|FG001|Overall Study|Death|0|||
33635812|NCT01708161|63037901|FG002|Overall Study|Death|0|||
33635813|NCT01708161|63037902|FG003|Overall Study|Death|1|||
33635814|NCT01708161|63037903|FG004|Overall Study|Death|0|||
33635815|NCT01708161|63037904|FG005|Overall Study|Death|1|||
33635816|NCT01708161|63037899|FG000|Overall Study|Withdrawal by Subject|0|||
33635817|NCT01708161|63037900|FG001|Overall Study|Withdrawal by Subject|1|||
33635818|NCT01708161|63037901|FG002|Overall Study|Withdrawal by Subject|1|||
33635819|NCT01708161|63037902|FG003|Overall Study|Withdrawal by Subject|0|||
33635820|NCT01708161|63037903|FG004|Overall Study|Withdrawal by Subject|0|||
33635821|NCT01708161|63037904|FG005|Overall Study|Withdrawal by Subject|0|||
33635822|NCT01708161|63037899|FG000|Overall Study|Administrative problems|0|||
33635823|NCT01708161|63037900|FG001|Overall Study|Administrative problems|1|||
33635824|NCT01708161|63037901|FG002|Overall Study|Administrative problems|0|||
33635825|NCT01708161|63037902|FG003|Overall Study|Administrative problems|0|||
33635826|NCT01708161|63037903|FG004|Overall Study|Administrative problems|0|||
33635827|NCT01708161|63037904|FG005|Overall Study|Administrative problems|0|||
33635828|NCT01708161|63037899|FG000|Overall Study|Disease progression|3|||
33635829|NCT01708161|63037900|FG001|Overall Study|Disease progression|5|||
33635830|NCT01708161|63037901|FG002|Overall Study|Disease progression|5|||
33635831|NCT01708161|63037902|FG003|Overall Study|Disease progression|13|||
33635832|NCT01708161|63037903|FG004|Overall Study|Disease progression|3|||
33635833|NCT01708161|63037904|FG005|Overall Study|Disease progression|0|||
33635834|NCT01707693|63037920|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
33635835|NCT01707693|63037921|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
33635836|NCT01707693|63037920|FG000|Overall Study Allocation|Protocol Violation|4|||
33635837|NCT01707693|63037921|FG001|Overall Study Allocation|Protocol Violation|3|||
33635838|NCT01707693|63037920|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
33635839|NCT01707693|63037921|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
33635840|NCT01707693|63037920|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
33635841|NCT01707693|63037921|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
33635842|NCT01722669|63037934|FG000|Overall Study|Withdrawal by Subject|0|||
33635843|NCT01722669|63037935|FG001|Overall Study|Withdrawal by Subject|0|||
33635844|NCT01722669|63037936|FG002|Overall Study|Withdrawal by Subject|0|||
33635845|NCT01722669|63037937|FG003|Overall Study|Withdrawal by Subject|0|||
33635846|NCT01722669|63037938|FG004|Overall Study|Withdrawal by Subject|0|||
33635847|NCT01722669|63037939|FG005|Overall Study|Withdrawal by Subject|2|||
33635848|NCT01707147|63037959|FG000|Overall Study|Administered Trajenta prior to contract|5|||
33635849|NCT01707147|63037959|FG000|Overall Study|Patients who have not taken Trajenta|1|||
33635850|NCT01707147|63037959|FG000|Overall Study|Follow-up failure|17|||
33635851|NCT01707147|63037959|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
33635852|NCT01876251|63037966|FG000|Overall Study|Clinical progression|1|||
33635853|NCT01876251|63037967|FG001|Overall Study|Clinical progression|0|||
33635854|NCT01876251|63037968|FG002|Overall Study|Clinical progression|0|||
33635855|NCT01876251|63037966|FG000|Overall Study|Death|2|||
33635856|NCT01876251|63037967|FG001|Overall Study|Death|0|||
33635857|NCT01876251|63037968|FG002|Overall Study|Death|1|||
33635858|NCT01876251|63037966|FG000|Overall Study|Participant started new treatment|1|||
33635859|NCT01876251|63037967|FG001|Overall Study|Participant started new treatment|0|||
33635860|NCT01876251|63037968|FG002|Overall Study|Participant started new treatment|1|||
33635861|NCT01876251|63037966|FG000|Overall Study|Participant refused further follow-up|0|||
33540651|NCT00704522|62930840|FG000|Overall Study|No information on therapy end|27|||
33540652|NCT00704522|62930841|FG001|Overall Study|No information on therapy end|2|||
33540653|NCT02723630|62930852|FG000|Intervention Period 1|Adverse Event|1|||
33540654|NCT02723630|62930853|FG001|Intervention Period 1|Adverse Event|0|||
33540655|NCT02723630|62930854|FG002|Intervention Period 1|Adverse Event|0|||
33540656|NCT02723630|62930855|FG003|Intervention Period 1|Adverse Event|0|||
33540657|NCT02723630|62930856|FG004|Intervention Period 1|Adverse Event|0|||
33540658|NCT02723630|62930857|FG005|Intervention Period 1|Adverse Event|0|||
33540659|NCT02723630|62930852|FG000|Intervention Period 3|consumption of restricted item|0|||
33540660|NCT02723630|62930853|FG001|Intervention Period 3|consumption of restricted item|1|||
33540661|NCT02723630|62930854|FG002|Intervention Period 3|consumption of restricted item|0|||
33540662|NCT02723630|62930855|FG003|Intervention Period 3|consumption of restricted item|0|||
33540663|NCT02723630|62930856|FG004|Intervention Period 3|consumption of restricted item|0|||
33540664|NCT02723630|62930857|FG005|Intervention Period 3|consumption of restricted item|0|||
33540665|NCT04089735|62930900|FG000|Overall Study|Adverse Event|1|||
33540666|NCT04089735|62930901|FG001|Overall Study|Adverse Event|0|||
33540667|NCT04089735|62930902|FG002|Overall Study|Adverse Event|1|||
33540668|NCT04089735|62930903|FG003|Overall Study|Adverse Event|1|||
33540669|NCT04089735|62930904|FG004|Overall Study|Adverse Event|0|||
33540670|NCT04089735|62930905|FG005|Overall Study|Adverse Event|0|||
33540671|NCT04089735|62930900|FG000|Overall Study|Physician Decision|0|||
33540672|NCT04089735|62930901|FG001|Overall Study|Physician Decision|3|||
33635862|NCT01876251|63037967|FG001|Overall Study|Participant refused further follow-up|0|||
33635863|NCT01876251|63037968|FG002|Overall Study|Participant refused further follow-up|1|||
33540673|NCT04089735|62930902|FG002|Overall Study|Physician Decision|0|||
33540674|NCT04089735|62930903|FG003|Overall Study|Physician Decision|0|||
33540675|NCT04089735|62930904|FG004|Overall Study|Physician Decision|0|||
33635864|NCT01876251|63037966|FG000|Overall Study|Study terminated|1|||
33635865|NCT01876251|63037967|FG001|Overall Study|Study terminated|0|||
33635866|NCT01876251|63037968|FG002|Overall Study|Study terminated|0|||
33635867|NCT01876251|63037966|FG000|Overall Study|Objective progression or relapse|10|||
33635868|NCT01876251|63037967|FG001|Overall Study|Objective progression or relapse|3|||
33635869|NCT01876251|63037968|FG002|Overall Study|Objective progression or relapse|8|||
33635870|NCT01875471|63037979|FG000|Overall Study|Adverse Event|0|||
33635871|NCT01875471|63037980|FG001|Overall Study|Adverse Event|1|||
33635872|NCT01875471|63037979|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
33635873|NCT01875471|63037980|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
33635874|NCT01875237|63037988|FG000|Overall Study|GVDH before DLI|1|||
33635875|NCT01875237|63037989|FG001|Overall Study|GVDH before DLI|0|||
33635876|NCT01875237|63037988|FG000|Overall Study|DLI cells could not be produced|1|||
33635877|NCT01875237|63037989|FG001|Overall Study|DLI cells could not be produced|0|||
33635878|NCT01874535|63037999|FG000|Overall Study|Lost to Follow-up|10|||
33635879|NCT01874535|63038000|FG001|Overall Study|Lost to Follow-up|9|||
33635880|NCT01874535|63037999|FG000|Overall Study|incomplete symptom resolution|45|||
33635881|NCT01874535|63038000|FG001|Overall Study|incomplete symptom resolution|35|||
33635882|NCT01722045|63038006|FG000|Overall Study|Adverse Event|8|||
33635883|NCT01722045|63038006|FG000|Overall Study|Death|3|||
33635884|NCT01722045|63038006|FG000|Overall Study|Withdrawal by Subject|8|||
33635885|NCT01722045|63038006|FG000|Overall Study|Lost to Follow-up|4|||
33635886|NCT01722045|63038006|FG000|Overall Study|Protocol Deviation|1|||
33635887|NCT01722045|63038006|FG000|Overall Study|Physician Decision|3|||
33635888|NCT01722045|63038006|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
33635889|NCT01721109|63038010|FG000|Overall Study|Lack of Efficacy|1|||
33635890|NCT01721109|63038010|FG000|Overall Study|Non- Compliance with Study Drug|3|||
33635891|NCT01721109|63038010|FG000|Overall Study|Withdrew Consent|1|||
33635892|NCT01721109|63038010|FG000|Overall Study|Lost to Follow-up|2|||
33635893|NCT01874145|63038016|FG000|Core Period|Non-compliance|1|||
33635894|NCT01874145|63038017|FG001|Core Period|Non-compliance|0|||
33635895|NCT01874145|63038016|FG000|Core Period|Protocol Violation|1|||
33635896|NCT01874145|63038017|FG001|Core Period|Protocol Violation|1|||
33635897|NCT01874145|63038016|FG000|Core Period|Physician Decision|1|||
33635898|NCT01874145|63038017|FG001|Core Period|Physician Decision|1|||
33635899|NCT01874145|63038016|FG000|Core Period|Adverse Event|0|||
33635900|NCT01874145|63038017|FG001|Core Period|Adverse Event|1|||
33540676|NCT04089735|62930905|FG005|Overall Study|Physician Decision|0|||
33540677|NCT04089735|62930900|FG000|Overall Study|Withdrawal by Subject|0|||
33540678|NCT04089735|62930901|FG001|Overall Study|Withdrawal by Subject|0|||
33540679|NCT04089735|62930902|FG002|Overall Study|Withdrawal by Subject|1|||
33635901|NCT01874145|63038016|FG000|Core Period|Withdrawal by Subject|0|||
33635902|NCT01874145|63038017|FG001|Core Period|Withdrawal by Subject|4|||
33635903|NCT01874145|63038016|FG000|Extension Period|Adverse Event|3|||
33635904|NCT01874145|63038017|FG001|Extension Period|Adverse Event|2|||
33635905|NCT01874145|63038016|FG000|Extension Period|Withdrawal by Subject|2|||
33635906|NCT01874145|63038017|FG001|Extension Period|Withdrawal by Subject|1|||
33635907|NCT01874145|63038016|FG000|Extension Period|Lost to Follow-up|1|||
33635908|NCT01874145|63038017|FG001|Extension Period|Lost to Follow-up|1|||
33635909|NCT01720797|63038029|FG000|Overall Study|Withdrawal by Subject|3|||
33635910|NCT01720797|63038030|FG001|Overall Study|Withdrawal by Subject|0|||
33635911|NCT01831466|63038048|FG000|Overall Study|Protocol Violation|1|||
33635912|NCT01831466|63038049|FG001|Overall Study|Protocol Violation|1|||
33635913|NCT01831466|63038050|FG002|Overall Study|Protocol Violation|2|||
33635914|NCT01831466|63038051|FG003|Overall Study|Protocol Violation|0|||
33635915|NCT01831466|63038052|FG004|Overall Study|Protocol Violation|0|||
33635916|NCT01831466|63038053|FG005|Overall Study|Protocol Violation|1|||
33635917|NCT01831466|63038054|FG006|Overall Study|Protocol Violation|0|||
33635918|NCT01831466|63038055|FG007|Overall Study|Protocol Violation|0|||
33635919|NCT01831466|63038056|FG008|Overall Study|Protocol Violation|0|||
33635920|NCT01831466|63038057|FG009|Overall Study|Protocol Violation|0|||
33635921|NCT01831466|63038058|FG010|Overall Study|Protocol Violation|0|||
33326483|NCT00887224|62703225|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
33326484|NCT00887224|62703226|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
33540680|NCT04089735|62930903|FG003|Overall Study|Withdrawal by Subject|0|||
33635922|NCT01831466|63038059|FG011|Overall Study|Protocol Violation|0|||
33635923|NCT01831466|63038048|FG000|Overall Study|Other|2|||
33635924|NCT01831466|63038049|FG001|Overall Study|Other|3|||
33635925|NCT01831466|63038050|FG002|Overall Study|Other|2|||
33635926|NCT01831466|63038051|FG003|Overall Study|Other|2|||
33635927|NCT01831466|63038052|FG004|Overall Study|Other|2|||
33635928|NCT01831466|63038053|FG005|Overall Study|Other|1|||
33635929|NCT01831466|63038054|FG006|Overall Study|Other|0|||
33540681|NCT04089735|62930904|FG004|Overall Study|Withdrawal by Subject|0|||
33635930|NCT01831466|63038055|FG007|Overall Study|Other|0|||
33635931|NCT01831466|63038056|FG008|Overall Study|Other|0|||
33635932|NCT01831466|63038057|FG009|Overall Study|Other|0|||
33635933|NCT01831466|63038058|FG010|Overall Study|Other|0|||
33635934|NCT01831466|63038059|FG011|Overall Study|Other|0|||
33635935|NCT01831466|63038048|FG000|Overall Study|Non-compliance with study treatment|2|||
33635936|NCT01831466|63038049|FG001|Overall Study|Non-compliance with study treatment|1|||
33635937|NCT01831466|63038050|FG002|Overall Study|Non-compliance with study treatment|1|||
33635938|NCT01831466|63038051|FG003|Overall Study|Non-compliance with study treatment|0|||
33635939|NCT01831466|63038052|FG004|Overall Study|Non-compliance with study treatment|0|||
33635940|NCT01831466|63038053|FG005|Overall Study|Non-compliance with study treatment|1|||
33635941|NCT01831466|63038054|FG006|Overall Study|Non-compliance with study treatment|0|||
33635942|NCT01831466|63038055|FG007|Overall Study|Non-compliance with study treatment|0|||
33635943|NCT01831466|63038056|FG008|Overall Study|Non-compliance with study treatment|0|||
33635944|NCT01831466|63038057|FG009|Overall Study|Non-compliance with study treatment|0|||
33635945|NCT01831466|63038058|FG010|Overall Study|Non-compliance with study treatment|0|||
33635946|NCT01831466|63038059|FG011|Overall Study|Non-compliance with study treatment|0|||
33635947|NCT01831466|63038048|FG000|Overall Study|Death|0|||
33635948|NCT01831466|63038049|FG001|Overall Study|Death|1|||
33635949|NCT01831466|63038050|FG002|Overall Study|Death|0|||
33635950|NCT01831466|63038051|FG003|Overall Study|Death|0|||
33635951|NCT01831466|63038052|FG004|Overall Study|Death|0|||
33635952|NCT01831466|63038053|FG005|Overall Study|Death|0|||
33635953|NCT01831466|63038054|FG006|Overall Study|Death|0|||
33635954|NCT01831466|63038055|FG007|Overall Study|Death|0|||
33635955|NCT01831466|63038056|FG008|Overall Study|Death|0|||
33635956|NCT01831466|63038057|FG009|Overall Study|Death|0|||
33635957|NCT01831466|63038058|FG010|Overall Study|Death|0|||
33635958|NCT01831466|63038059|FG011|Overall Study|Death|0|||
33635959|NCT01831466|63038048|FG000|Overall Study|Withdrawal by Subject|6|||
33635960|NCT01831466|63038049|FG001|Overall Study|Withdrawal by Subject|3|||
33635961|NCT01831466|63038050|FG002|Overall Study|Withdrawal by Subject|3|||
33635962|NCT01831466|63038051|FG003|Overall Study|Withdrawal by Subject|3|||
33635963|NCT01831466|63038052|FG004|Overall Study|Withdrawal by Subject|3|||
33635964|NCT01831466|63038053|FG005|Overall Study|Withdrawal by Subject|5|||
33635965|NCT01831466|63038054|FG006|Overall Study|Withdrawal by Subject|0|||
33635966|NCT01831466|63038055|FG007|Overall Study|Withdrawal by Subject|0|||
33635967|NCT01831466|63038056|FG008|Overall Study|Withdrawal by Subject|0|||
33635968|NCT01831466|63038057|FG009|Overall Study|Withdrawal by Subject|1|||
33635969|NCT01831466|63038058|FG010|Overall Study|Withdrawal by Subject|0|||
33635970|NCT01831466|63038059|FG011|Overall Study|Withdrawal by Subject|1|||
33635971|NCT01831466|63038048|FG000|Overall Study|Lost to Follow-up|0|||
33635972|NCT01831466|63038049|FG001|Overall Study|Lost to Follow-up|1|||
33635973|NCT01831466|63038050|FG002|Overall Study|Lost to Follow-up|4|||
33635974|NCT01831466|63038051|FG003|Overall Study|Lost to Follow-up|2|||
33635975|NCT01831466|63038052|FG004|Overall Study|Lost to Follow-up|0|||
33635976|NCT01831466|63038053|FG005|Overall Study|Lost to Follow-up|3|||
33635977|NCT01831466|63038054|FG006|Overall Study|Lost to Follow-up|0|||
33635978|NCT01831466|63038055|FG007|Overall Study|Lost to Follow-up|0|||
33635979|NCT01831466|63038056|FG008|Overall Study|Lost to Follow-up|0|||
33635980|NCT01831466|63038057|FG009|Overall Study|Lost to Follow-up|1|||
33635981|NCT01831466|63038058|FG010|Overall Study|Lost to Follow-up|0|||
33635982|NCT01831466|63038059|FG011|Overall Study|Lost to Follow-up|1|||
33635983|NCT01831466|63038048|FG000|Overall Study|Lack of Efficacy|5|||
33635984|NCT01831466|63038049|FG001|Overall Study|Lack of Efficacy|8|||
33635985|NCT01831466|63038050|FG002|Overall Study|Lack of Efficacy|7|||
33540682|NCT04089735|62930905|FG005|Overall Study|Withdrawal by Subject|0|||
33540683|NCT04089735|62930900|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
33635986|NCT01831466|63038051|FG003|Overall Study|Lack of Efficacy|6|||
33635987|NCT01831466|63038052|FG004|Overall Study|Lack of Efficacy|9|||
33540684|NCT04089735|62930901|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
33540685|NCT04089735|62930902|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
33540686|NCT04089735|62930903|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
33540687|NCT04089735|62930904|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
33540688|NCT04089735|62930905|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
33540689|NCT01876784|62930921|FG000|Overall Study|Withdrawal by Subject|17|||
33540690|NCT01876784|62930922|FG001|Overall Study|Withdrawal by Subject|2|||
33540691|NCT01876784|62930921|FG000|Overall Study|Adverse Event|15|||
33540692|NCT01876784|62930922|FG001|Overall Study|Adverse Event|2|||
33540693|NCT01876784|62930921|FG000|Overall Study|Protocol Violation|1|||
33540694|NCT01876784|62930922|FG001|Overall Study|Protocol Violation|0|||
33540695|NCT01876784|62930921|FG000|Overall Study|Disease progression|37|||
33540696|NCT01876784|62930922|FG001|Overall Study|Disease progression|67|||
33540697|NCT01876784|62930921|FG000|Overall Study|Lost to Follow-up|0|||
33540698|NCT01876784|62930922|FG001|Overall Study|Lost to Follow-up|1|||
33635988|NCT01831466|63038053|FG005|Overall Study|Lack of Efficacy|8|||
33635989|NCT01831466|63038054|FG006|Overall Study|Lack of Efficacy|1|||
33635990|NCT01831466|63038055|FG007|Overall Study|Lack of Efficacy|1|||
33635991|NCT01831466|63038056|FG008|Overall Study|Lack of Efficacy|2|||
33635992|NCT01831466|63038057|FG009|Overall Study|Lack of Efficacy|2|||
33635993|NCT01831466|63038058|FG010|Overall Study|Lack of Efficacy|2|||
33635994|NCT01831466|63038059|FG011|Overall Study|Lack of Efficacy|0|||
33635995|NCT01831466|63038048|FG000|Overall Study|Adverse Event|0|||
33635996|NCT01831466|63038049|FG001|Overall Study|Adverse Event|0|||
33635997|NCT01831466|63038050|FG002|Overall Study|Adverse Event|4|||
33635998|NCT01831466|63038051|FG003|Overall Study|Adverse Event|6|||
33635999|NCT01831466|63038052|FG004|Overall Study|Adverse Event|3|||
33636000|NCT01831466|63038053|FG005|Overall Study|Adverse Event|7|||
33636001|NCT01831466|63038054|FG006|Overall Study|Adverse Event|0|||
33636002|NCT01831466|63038055|FG007|Overall Study|Adverse Event|1|||
33636003|NCT01831466|63038056|FG008|Overall Study|Adverse Event|1|||
33636004|NCT01831466|63038057|FG009|Overall Study|Adverse Event|1|||
33636005|NCT01831466|63038058|FG010|Overall Study|Adverse Event|0|||
33636006|NCT01831466|63038059|FG011|Overall Study|Adverse Event|2|||
33636007|NCT01881620|63038079|FG000|Overall Study|Protocol Violation|4|||
33636008|NCT01830920|63038088|FG000|Overall Study|Adverse Event|1|||
33636009|NCT01830920|63038089|FG001|Overall Study|Adverse Event|0|||
33636010|NCT01830920|63038090|FG002|Overall Study|Adverse Event|1|||
33636011|NCT01830920|63038091|FG003|Overall Study|Adverse Event|0|||
33636012|NCT01830920|63038092|FG004|Overall Study|Adverse Event|0|||
33636013|NCT01830920|63038088|FG000|Overall Study|Withdrawal by Subject|2|||
33636014|NCT01830920|63038089|FG001|Overall Study|Withdrawal by Subject|2|||
33636015|NCT01830920|63038090|FG002|Overall Study|Withdrawal by Subject|1|||
33326485|NCT00887224|62703224|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
33462177|NCT03466060|62836046|FG002|Period 2|Lens Handling Difficulties|1|||
33636016|NCT01830920|63038091|FG003|Overall Study|Withdrawal by Subject|7|||
33636017|NCT01830920|63038092|FG004|Overall Study|Withdrawal by Subject|1|||
33636018|NCT01830920|63038088|FG000|Overall Study|Death|3|||
33636019|NCT01830920|63038089|FG001|Overall Study|Death|3|||
33636020|NCT01830920|63038090|FG002|Overall Study|Death|5|||
33636021|NCT01830920|63038091|FG003|Overall Study|Death|4|||
33636022|NCT01830920|63038092|FG004|Overall Study|Death|4|||
33636023|NCT01830920|63038088|FG000|Overall Study|Other|15|||
33636024|NCT01830920|63038089|FG001|Overall Study|Other|1|||
33636025|NCT01830920|63038090|FG002|Overall Study|Other|1|||
33636026|NCT01830920|63038091|FG003|Overall Study|Other|5|||
33636027|NCT01830920|63038092|FG004|Overall Study|Other|3|||
33636028|NCT01881230|63038107|FG000|Overall Study|Death|2|||
33636029|NCT01881230|63038108|FG001|Overall Study|Death|0|||
33636030|NCT01881230|63038109|FG002|Overall Study|Death|1|||
33636031|NCT01881230|63038107|FG000|Overall Study|Adverse Event|9|||
33636032|NCT01881230|63038108|FG001|Overall Study|Adverse Event|13|||
33636033|NCT01881230|63038109|FG002|Overall Study|Adverse Event|12|||
33636034|NCT01881230|63038107|FG000|Overall Study|Progressive Disease|31|||
33636035|NCT01881230|63038108|FG001|Overall Study|Progressive Disease|35|||
33636036|NCT01881230|63038109|FG002|Overall Study|Progressive Disease|36|||
33636037|NCT01881230|63038107|FG000|Overall Study|Symptomatic Deterioration|3|||
33636038|NCT01881230|63038108|FG001|Overall Study|Symptomatic Deterioration|3|||
33636039|NCT01881230|63038109|FG002|Overall Study|Symptomatic Deterioration|1|||
33636040|NCT01881230|63038107|FG000|Overall Study|Withdrawal by Subject|6|||
33636041|NCT01881230|63038108|FG001|Overall Study|Withdrawal by Subject|4|||
33636042|NCT01881230|63038109|FG002|Overall Study|Withdrawal by Subject|6|||
33636043|NCT01881230|63038107|FG000|Overall Study|Physician Decision|4|||
33636044|NCT01881230|63038108|FG001|Overall Study|Physician Decision|3|||
33636045|NCT01881230|63038109|FG002|Overall Study|Physician Decision|6|||
33636046|NCT01881230|63038107|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33636047|NCT01881230|63038108|FG001|Overall Study|Non-Compliance with Study Drug|2|||
33636048|NCT01881230|63038109|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33636049|NCT01881230|63038107|FG000|Overall Study|Given Commercially Available Drug|0|||
33636050|NCT01881230|63038108|FG001|Overall Study|Given Commercially Available Drug|0|||
33636051|NCT01881230|63038109|FG002|Overall Study|Given Commercially Available Drug|2|||
33636052|NCT01881230|63038107|FG000|Overall Study|Protocol Violation|1|||
33462178|NCT03466060|62836047|FG003|Period 2|Lens Handling Difficulties|0|||
33462179|NCT03466060|62836048|FG004|Period 2|Lens Handling Difficulties|0|||
33462180|NCT03466060|62836049|FG005|Period 2|Lens Handling Difficulties|0|||
33462181|NCT00092547|62836065|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
33636053|NCT01881230|63038108|FG001|Overall Study|Protocol Violation|1|||
33636054|NCT01881230|63038109|FG002|Overall Study|Protocol Violation|0|||
33636055|NCT01881230|63038107|FG000|Overall Study|Miscellaneous|3|||
33636056|NCT01881230|63038108|FG001|Overall Study|Miscellaneous|3|||
33636057|NCT01881230|63038109|FG002|Overall Study|Miscellaneous|0|||
33636058|NCT01881230|63038107|FG000|Overall Study|Untreated: Other|0|||
33636059|NCT01881230|63038108|FG001|Overall Study|Untreated: Other|0|||
33636060|NCT01881230|63038109|FG002|Overall Study|Untreated: Other|1|||
33636061|NCT01881230|63038107|FG000|Overall Study|Untreated: Death|0|||
33462182|NCT00092547|62836066|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
33636062|NCT01881230|63038108|FG001|Overall Study|Untreated: Death|0|||
33636063|NCT01881230|63038109|FG002|Overall Study|Untreated: Death|1|||
33636064|NCT01881230|63038107|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
33636065|NCT01881230|63038108|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
33636066|NCT01881230|63038109|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
33636067|NCT01856582|63038117|FG000|Overall Study|Died prior to Boost infusion|1|||
33636068|NCT01829360|63038125|FG000|Overall Study|Protocol Violation|0|||
33636069|NCT01829360|63038126|FG001|Overall Study|Protocol Violation|0|||
33636070|NCT01829360|63038127|FG002|Overall Study|Protocol Violation|1|||
33636071|NCT01829360|63038128|FG003|Overall Study|Protocol Violation|0|||
33636072|NCT01856114|63038144|FG000|Overall Study|Withdrawal by Subject|1|||
33636073|NCT01856114|63038145|FG001|Overall Study|Withdrawal by Subject|0|||
33636074|NCT01856114|63038144|FG000|Overall Study|Adverse Event|1|||
33636075|NCT01856114|63038145|FG001|Overall Study|Adverse Event|0|||
33636076|NCT01855958|63038153|FG000|Overall Study|Withdrawal by Subject|1|||
33636077|NCT01855958|63038154|FG001|Overall Study|Withdrawal by Subject|0|||
33636078|NCT01855412|63038165|FG000|Overall Study|Death|77|||
33636079|NCT01855412|63038166|FG001|Overall Study|Death|123|||
33636080|NCT01855412|63038167|FG002|Overall Study|Death|30|||
33636081|NCT01855412|63038165|FG000|Overall Study|Lost to Follow-up|28|||
33636082|NCT01855412|63038166|FG001|Overall Study|Lost to Follow-up|46|||
33636083|NCT01855412|63038167|FG002|Overall Study|Lost to Follow-up|15|||
33636084|NCT01855412|63038165|FG000|Overall Study|Withdrawal by Subject|77|||
33636085|NCT01855412|63038166|FG001|Overall Study|Withdrawal by Subject|123|||
33636086|NCT01855412|63038167|FG002|Overall Study|Withdrawal by Subject|24|||
33636087|NCT01855412|63038165|FG000|Overall Study|Physician Decision|25|||
33636088|NCT01855412|63038166|FG001|Overall Study|Physician Decision|31|||
33636089|NCT01855412|63038167|FG002|Overall Study|Physician Decision|3|||
33636090|NCT01855412|63038165|FG000|Overall Study|Site Closure|4|||
33462183|NCT00092547|62836067|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
33462184|NCT00092547|62836065|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
33462185|NCT00092547|62836066|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
33326486|NCT00887224|62703225|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
33326487|NCT00887224|62703226|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
33636091|NCT01855412|63038166|FG001|Overall Study|Site Closure|18|||
33636092|NCT01855412|63038167|FG002|Overall Study|Site Closure|1|||
33636093|NCT01855412|63038165|FG000|Overall Study|Reason not Specified|1|||
33636094|NCT01855412|63038166|FG001|Overall Study|Reason not Specified|2|||
33636095|NCT01855412|63038167|FG002|Overall Study|Reason not Specified|3|||
33636096|NCT01614470|63038183|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
33636097|NCT01614470|63038184|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
33636098|NCT01614470|63038185|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
33636099|NCT01614470|63038183|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
33636100|NCT01614470|63038184|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
33636101|NCT01614470|63038185|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
33636102|NCT01880528|63038196|FG000|Overall Study|Other|1|||
33636103|NCT01880528|63038197|FG001|Overall Study|Other|1|||
33636104|NCT01854944|63038206|FG000|Overall Study|Withdrawal by Subject|0|||
33636105|NCT01854944|63038207|FG001|Overall Study|Withdrawal by Subject|0|||
33636106|NCT01854944|63038208|FG002|Overall Study|Withdrawal by Subject|1|||
33636107|NCT01829048|63038235|FG000|Overall Study|Withdrawal by Subject|0|||
33636108|NCT01829048|63038236|FG001|Overall Study|Withdrawal by Subject|0|||
33636109|NCT01829048|63038237|FG002|Overall Study|Withdrawal by Subject|0|||
33636110|NCT01829048|63038238|FG003|Overall Study|Withdrawal by Subject|2|||
33636111|NCT01829048|63038239|FG004|Overall Study|Withdrawal by Subject|0|||
33636112|NCT01854710|63038252|FG000|Overall Study|Withdrawal by Subject|2|||
33636113|NCT01854710|63038253|FG001|Overall Study|Withdrawal by Subject|1|||
33636114|NCT01854710|63038254|FG002|Overall Study|Withdrawal by Subject|0|||
33636115|NCT01854710|63038255|FG003|Overall Study|Withdrawal by Subject|0|||
33540699|NCT01876784|62930921|FG000|Overall Study|Death|1|||
33540700|NCT01876784|62930922|FG001|Overall Study|Death|0|||
33540701|NCT01876784|62930921|FG000|Overall Study|Randomized but not treated|2|||
33636116|NCT01854710|63038256|FG004|Overall Study|Withdrawal by Subject|0|||
33636117|NCT01854710|63038257|FG005|Overall Study|Withdrawal by Subject|0|||
33636118|NCT01854710|63038252|FG000|Overall Study|CRI procedural error|2|||
33636119|NCT01854710|63038253|FG001|Overall Study|CRI procedural error|2|||
33636120|NCT01854710|63038254|FG002|Overall Study|CRI procedural error|2|||
33636121|NCT01854710|63038255|FG003|Overall Study|CRI procedural error|2|||
33636122|NCT01854710|63038256|FG004|Overall Study|CRI procedural error|2|||
33462186|NCT00092547|62836067|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
33462187|NCT00092547|62836065|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
33462188|NCT00092547|62836066|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
33462189|NCT00092547|62836067|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
33462190|NCT00092547|62836065|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
33462191|NCT00092547|62836066|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
33462192|NCT00092547|62836067|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
33462193|NCT00092547|62836065|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
33462194|NCT00092547|62836066|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
33462195|NCT00092547|62836067|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
33636123|NCT01854710|63038257|FG005|Overall Study|CRI procedural error|2|||
33636124|NCT01828034|63038271|FG000|Overall Study|Withdrawal by Subject|0|||
33636125|NCT01828034|63038272|FG001|Overall Study|Withdrawal by Subject|0|||
33636126|NCT01828034|63038273|FG002|Overall Study|Withdrawal by Subject|0|||
33636127|NCT01828034|63038274|FG003|Overall Study|Withdrawal by Subject|1|||
33636128|NCT01853696|63038283|FG000|Overall Study|Withdrawal by Subject|1|||
33636129|NCT01853696|63038284|FG001|Overall Study|Withdrawal by Subject|1|||
33636130|NCT01853696|63038283|FG000|Overall Study|Lost to Follow-up|5|||
33636131|NCT01853696|63038284|FG001|Overall Study|Lost to Follow-up|4|||
33636132|NCT01871805|63038296|FG000|Phase I|Death|7|||
33636133|NCT01871805|63038297|FG001|Phase I|Death|4|||
33636134|NCT01871805|63038298|FG002|Phase I|Death|6|||
33636135|NCT01871805|63038299|FG003|Phase I|Death|2|||
33636136|NCT01871805|63038300|FG004|Phase I|Death|9|||
33636137|NCT01871805|63038301|FG005|Phase I|Death|0|||
33636138|NCT01871805|63038296|FG000|Phase I|Alive in Survival Follow-up|0|||
33636139|NCT01871805|63038297|FG001|Phase I|Alive in Survival Follow-up|2|||
33636140|NCT01871805|63038298|FG002|Phase I|Alive in Survival Follow-up|4|||
33636141|NCT01871805|63038299|FG003|Phase I|Alive in Survival Follow-up|5|||
33636142|NCT01871805|63038300|FG004|Phase I|Alive in Survival Follow-up|4|||
33636143|NCT01871805|63038301|FG005|Phase I|Alive in Survival Follow-up|0|||
33636144|NCT01871805|63038296|FG000|Phase I|Lost to Follow-up|0|||
33636145|NCT01871805|63038297|FG001|Phase I|Lost to Follow-up|1|||
33636146|NCT01871805|63038298|FG002|Phase I|Lost to Follow-up|3|||
33636147|NCT01871805|63038299|FG003|Phase I|Lost to Follow-up|0|||
33636148|NCT01871805|63038300|FG004|Phase I|Lost to Follow-up|0|||
33636149|NCT01871805|63038301|FG005|Phase I|Lost to Follow-up|0|||
33636150|NCT01871805|63038296|FG000|Phase II|Death|0|||
33636151|NCT01871805|63038297|FG001|Phase II|Death|0|||
33636152|NCT01871805|63038298|FG002|Phase II|Death|0|||
33540702|NCT01876784|62930922|FG001|Overall Study|Randomized but not treated|1|||
33540703|NCT01876784|62930921|FG000|Overall Study|Other than specified above|5|||
33636153|NCT01871805|63038299|FG003|Phase II|Death|0|||
33636154|NCT01871805|63038300|FG004|Phase II|Death|0|||
33636155|NCT01871805|63038301|FG005|Phase II|Death|45|||
33636156|NCT01871805|63038296|FG000|Phase II|Alive in Survival Follow-up|0|||
33636157|NCT01871805|63038297|FG001|Phase II|Alive in Survival Follow-up|0|||
33636158|NCT01871805|63038298|FG002|Phase II|Alive in Survival Follow-up|0|||
33636159|NCT01871805|63038299|FG003|Phase II|Alive in Survival Follow-up|0|||
33636160|NCT01871805|63038300|FG004|Phase II|Alive in Survival Follow-up|0|||
33636161|NCT01871805|63038301|FG005|Phase II|Alive in Survival Follow-up|29|||
33636162|NCT01871805|63038296|FG000|Phase II|Lost to Follow-up|0|||
33636163|NCT01871805|63038297|FG001|Phase II|Lost to Follow-up|0|||
33636164|NCT01871805|63038298|FG002|Phase II|Lost to Follow-up|0|||
33636165|NCT01871805|63038299|FG003|Phase II|Lost to Follow-up|0|||
33636166|NCT01871805|63038300|FG004|Phase II|Lost to Follow-up|0|||
33636167|NCT01871805|63038301|FG005|Phase II|Lost to Follow-up|13|||
33636168|NCT01719861|63038332|FG000|Cycle 1|Death|4|||
33636169|NCT01719861|63038332|FG000|Cycle 2|Death|1|||
33636170|NCT01853618|63038342|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
33636171|NCT01853618|63038343|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
33636172|NCT01853618|63038344|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
33636173|NCT01853618|63038345|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
33636174|NCT01853618|63038346|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
33636175|NCT01853618|63038342|FG000|Overall Study|Progressive disease|1|||
33636176|NCT01853618|63038343|FG001|Overall Study|Progressive disease|1|||
33636177|NCT01853618|63038344|FG002|Overall Study|Progressive disease|1|||
33636178|NCT01853618|63038345|FG003|Overall Study|Progressive disease|1|||
33636179|NCT01853618|63038346|FG004|Overall Study|Progressive disease|2|||
33636180|NCT01853618|63038342|FG000|Overall Study|Physician Decision|0|||
33636181|NCT01853618|63038343|FG001|Overall Study|Physician Decision|1|||
33540704|NCT01876784|62930922|FG001|Overall Study|Other than specified above|6|||
33540705|NCT01876784|62930921|FG000|Overall Study|Ongoing|41|||
33540706|NCT01876784|62930922|FG001|Overall Study|Ongoing|40|||
33636182|NCT01853618|63038344|FG002|Overall Study|Physician Decision|1|||
33636183|NCT01853618|63038345|FG003|Overall Study|Physician Decision|0|||
33636184|NCT01853618|63038346|FG004|Overall Study|Physician Decision|0|||
33540707|NCT04205162|62930930|FG000|Overall Study|Lost to Follow-up|1|||
33540708|NCT04205162|62930931|FG001|Overall Study|Lost to Follow-up|0|||
33636185|NCT01853618|63038342|FG000|Overall Study|Refused further treatment|0|||
33636186|NCT01853618|63038343|FG001|Overall Study|Refused further treatment|0|||
33636187|NCT01853618|63038344|FG002|Overall Study|Refused further treatment|0|||
33636188|NCT01853618|63038345|FG003|Overall Study|Refused further treatment|0|||
33636189|NCT01853618|63038346|FG004|Overall Study|Refused further treatment|1|||
33636190|NCT01853462|63038361|FG000|Overall Study|Withdrawal by Subject|1|||
33636191|NCT01853462|63038362|FG001|Overall Study|Withdrawal by Subject|1|||
33636192|NCT01719783|63038372|FG000|Dose 2|Physician Decision|1|||
33636193|NCT01719783|63038373|FG001|Dose 2|Physician Decision|0|||
33636194|NCT01853384|63038401|FG000|Randomized|Adverse Event|5|||
33636195|NCT01853384|63038402|FG001|Randomized|Adverse Event|3|||
33636196|NCT01853384|63038401|FG000|Randomized|Death|1|||
33636197|NCT01853384|63038402|FG001|Randomized|Death|2|||
33636198|NCT01853384|63038401|FG000|Randomized|Lost to Follow-up|1|||
33636199|NCT01853384|63038402|FG001|Randomized|Lost to Follow-up|1|||
33636200|NCT01853384|63038401|FG000|Randomized|Withdrawal by Subject|5|||
33636201|NCT01853384|63038402|FG001|Randomized|Withdrawal by Subject|3|||
33636202|NCT01853384|63038401|FG000|Randomized|Sponsor Decision|47|||
33636203|NCT01853384|63038402|FG001|Randomized|Sponsor Decision|34|||
33636204|NCT01853384|63038401|FG000|Randomized|Other|3|||
33636205|NCT01853384|63038402|FG001|Randomized|Other|3|||
33636206|NCT01853384|63038401|FG000|Completed Follow up Visit 1|Early Termination|13|||
33636207|NCT01853384|63038402|FG001|Completed Follow up Visit 1|Early Termination|9|||
33636208|NCT01853384|63038401|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
33636209|NCT01853384|63038402|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
33636210|NCT01853384|63038401|FG000|Completed Follow up Visit 2|Adverse Event|1|||
33636211|NCT01853384|63038402|FG001|Completed Follow up Visit 2|Adverse Event|0|||
33636212|NCT01853384|63038401|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
33636213|NCT01853384|63038402|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
33636214|NCT01853384|63038401|FG000|Completed Follow up Visit 2|Death|1|||
33636215|NCT01853384|63038402|FG001|Completed Follow up Visit 2|Death|0|||
33636216|NCT01853384|63038401|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
33636217|NCT01853384|63038402|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
33636218|NCT01878890|63038412|FG000|Overall Study|Protocol Violation|0|||
33636219|NCT01878890|63038413|FG001|Overall Study|Protocol Violation|1|||
33636220|NCT01878890|63038414|FG002|Overall Study|Protocol Violation|0|||
33636221|NCT01878890|63038415|FG003|Overall Study|Protocol Violation|0|||
33636222|NCT01827332|63038428|FG000|Overall Study|Lost to Follow-up|2|||
33636223|NCT01827332|63038429|FG001|Overall Study|Lost to Follow-up|1|||
33636224|NCT01719003|63038443|FG000|Overall Study|Non compliant with protocol|1|||
33636225|NCT01719003|63038444|FG001|Overall Study|Non compliant with protocol|1|||
33636226|NCT01719003|63038445|FG002|Overall Study|Non compliant with protocol|0|||
33636227|NCT01719003|63038446|FG003|Overall Study|Non compliant with protocol|1|||
33636228|NCT01719003|63038447|FG004|Overall Study|Non compliant with protocol|2|||
33636229|NCT01719003|63038448|FG005|Overall Study|Non compliant with protocol|1|||
33636230|NCT01719003|63038449|FG006|Overall Study|Non compliant with protocol|2|||
33636231|NCT01719003|63038450|FG007|Overall Study|Non compliant with protocol|3|||
33636232|NCT01719003|63038451|FG008|Overall Study|Non compliant with protocol|0|||
33636233|NCT01719003|63038443|FG000|Overall Study|Adverse Event|6|||
33636234|NCT01719003|63038444|FG001|Overall Study|Adverse Event|5|||
33462196|NCT00092547|62836065|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
33462197|NCT00092547|62836066|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
33462198|NCT00092547|62836067|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
33462199|NCT00092547|62836065|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
33462200|NCT00092547|62836066|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
33462201|NCT00092547|62836067|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
33540709|NCT04205162|62930930|FG000|Overall Study|Withdrawal by Subject|2|||
33540710|NCT04205162|62930931|FG001|Overall Study|Withdrawal by Subject|0|||
33540711|NCT04205162|62930930|FG000|Overall Study|University closure due to COVID-19|1|||
33540712|NCT04205162|62930931|FG001|Overall Study|University closure due to COVID-19|0|||
33540713|NCT01329939|62930942|FG000|Overall Study|Lost to Follow-up|3|||
33540714|NCT01329939|62930943|FG001|Overall Study|Lost to Follow-up|0|||
33540715|NCT01329939|62930944|FG002|Overall Study|Lost to Follow-up|1|||
33540716|NCT01329939|62930945|FG003|Overall Study|Lost to Follow-up|2|||
33540717|NCT01329939|62930942|FG000|Overall Study|Withdrawal by Subject|0|||
33540718|NCT01329939|62930943|FG001|Overall Study|Withdrawal by Subject|1|||
33540719|NCT01329939|62930944|FG002|Overall Study|Withdrawal by Subject|0|||
33540720|NCT01329939|62930945|FG003|Overall Study|Withdrawal by Subject|0|||
33540721|NCT01329939|62930942|FG000|Overall Study|Adverse Event|0|||
33540722|NCT01329939|62930943|FG001|Overall Study|Adverse Event|0|||
33540723|NCT01329939|62930944|FG002|Overall Study|Adverse Event|0|||
33540724|NCT01329939|62930945|FG003|Overall Study|Adverse Event|3|||
33540725|NCT02499900|62930957|FG000|Core Study Period|Other|1|||
33540726|NCT02499900|62930958|FG001|Core Study Period|Other|4|||
33636235|NCT01719003|63038445|FG002|Overall Study|Adverse Event|4|||
33636236|NCT01719003|63038446|FG003|Overall Study|Adverse Event|3|||
33636237|NCT01719003|63038447|FG004|Overall Study|Adverse Event|4|||
33636238|NCT01719003|63038448|FG005|Overall Study|Adverse Event|3|||
33636239|NCT01719003|63038449|FG006|Overall Study|Adverse Event|6|||
33636240|NCT01719003|63038450|FG007|Overall Study|Adverse Event|5|||
33636241|NCT01719003|63038451|FG008|Overall Study|Adverse Event|0|||
33636242|NCT01719003|63038443|FG000|Overall Study|Lost to Follow-up|0|||
33636243|NCT01719003|63038444|FG001|Overall Study|Lost to Follow-up|6|||
33636244|NCT01719003|63038445|FG002|Overall Study|Lost to Follow-up|7|||
33636245|NCT01719003|63038446|FG003|Overall Study|Lost to Follow-up|2|||
33636246|NCT01719003|63038447|FG004|Overall Study|Lost to Follow-up|3|||
33636247|NCT01719003|63038448|FG005|Overall Study|Lost to Follow-up|4|||
33636248|NCT01719003|63038449|FG006|Overall Study|Lost to Follow-up|3|||
33636249|NCT01719003|63038450|FG007|Overall Study|Lost to Follow-up|2|||
33636250|NCT01719003|63038451|FG008|Overall Study|Lost to Follow-up|2|||
33636251|NCT01719003|63038443|FG000|Overall Study|Refusal to continue, not due to AE|2|||
33636252|NCT01719003|63038444|FG001|Overall Study|Refusal to continue, not due to AE|5|||
33636253|NCT01719003|63038445|FG002|Overall Study|Refusal to continue, not due to AE|4|||
33636254|NCT01719003|63038446|FG003|Overall Study|Refusal to continue, not due to AE|4|||
33636255|NCT01719003|63038447|FG004|Overall Study|Refusal to continue, not due to AE|4|||
33636256|NCT01719003|63038448|FG005|Overall Study|Refusal to continue, not due to AE|3|||
33636257|NCT01719003|63038449|FG006|Overall Study|Refusal to continue, not due to AE|8|||
33540727|NCT02499900|62930957|FG000|Core Study Period|Lost to Follow-up|1|||
33540728|NCT02499900|62930958|FG001|Core Study Period|Lost to Follow-up|2|||
33540729|NCT02499900|62930957|FG000|Core Study Period|Per sponsor request|0|||
33540730|NCT02499900|62930958|FG001|Core Study Period|Per sponsor request|1|||
33540731|NCT02499900|62930957|FG000|Core Study Period|Pregnancy|1|||
33540732|NCT02499900|62930958|FG001|Core Study Period|Pregnancy|0|||
33540733|NCT02499900|62930957|FG000|Core Study Period|Protocol Violation|3|||
33540734|NCT02499900|62930958|FG001|Core Study Period|Protocol Violation|0|||
33540735|NCT02499900|62930957|FG000|Core Study Period|Withdrawal by Subject|11|||
33540736|NCT02499900|62930958|FG001|Core Study Period|Withdrawal by Subject|10|||
33636258|NCT01719003|63038450|FG007|Overall Study|Refusal to continue, not due to AE|7|||
33636259|NCT01719003|63038451|FG008|Overall Study|Refusal to continue, not due to AE|1|||
33636260|NCT01719003|63038443|FG000|Overall Study|Reason other than those specified|0|||
33636261|NCT01719003|63038444|FG001|Overall Study|Reason other than those specified|0|||
33636262|NCT01719003|63038445|FG002|Overall Study|Reason other than those specified|2|||
33636263|NCT01719003|63038446|FG003|Overall Study|Reason other than those specified|3|||
33636264|NCT01719003|63038447|FG004|Overall Study|Reason other than those specified|4|||
33636265|NCT01719003|63038448|FG005|Overall Study|Reason other than those specified|1|||
33636266|NCT01719003|63038449|FG006|Overall Study|Reason other than those specified|0|||
33636267|NCT01719003|63038450|FG007|Overall Study|Reason other than those specified|3|||
33636268|NCT01719003|63038451|FG008|Overall Study|Reason other than those specified|1|||
33636269|NCT01719003|63038443|FG000|Overall Study|Lack of Efficacy|0|||
33636270|NCT01719003|63038444|FG001|Overall Study|Lack of Efficacy|0|||
33636271|NCT01719003|63038445|FG002|Overall Study|Lack of Efficacy|0|||
33636272|NCT01719003|63038446|FG003|Overall Study|Lack of Efficacy|0|||
33636273|NCT01719003|63038447|FG004|Overall Study|Lack of Efficacy|0|||
33636274|NCT01719003|63038448|FG005|Overall Study|Lack of Efficacy|0|||
33636275|NCT01719003|63038449|FG006|Overall Study|Lack of Efficacy|1|||
33636276|NCT01719003|63038450|FG007|Overall Study|Lack of Efficacy|0|||
33636277|NCT01719003|63038451|FG008|Overall Study|Lack of Efficacy|0|||
33462202|NCT00092547|62836065|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
33462203|NCT00092547|62836066|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
33462204|NCT00092547|62836067|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
33540737|NCT02499900|62930957|FG000|Core Study Period|Adverse Event|18|||
33540738|NCT02499900|62930958|FG001|Core Study Period|Adverse Event|14|||
33540739|NCT02499900|62930957|FG000|Core Study Period|Death|0|||
33462205|NCT00092547|62836065|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
33462206|NCT00092547|62836066|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
33462207|NCT00092547|62836067|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
33462208|NCT00092547|62836065|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
33462209|NCT00092547|62836066|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
33462210|NCT00092547|62836067|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
33462211|NCT00092547|62836065|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
33462212|NCT00092547|62836066|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
33462213|NCT00092547|62836067|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
33462214|NCT00092547|62836065|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
33462215|NCT00092547|62836066|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
33462216|NCT00092547|62836067|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
33462217|NCT00092547|62836065|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
33462218|NCT00092547|62836066|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
33462219|NCT00092547|62836067|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
33540740|NCT02499900|62930958|FG001|Core Study Period|Death|1|||
33540741|NCT02499900|62930957|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
33540742|NCT02499900|62930958|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
33540743|NCT02499900|62930957|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
33540744|NCT02499900|62930958|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
33636278|NCT01853228|63038470|FG000|Phase 1|Lack of Efficacy|8|||
33636279|NCT01853228|63038471|FG001|Phase 1|Lack of Efficacy|0|||
33636280|NCT01853228|63038470|FG000|Phase 1|Other|1|||
33636281|NCT01853228|63038471|FG001|Phase 1|Other|0|||
33636282|NCT01853228|63038470|FG000|Phase 2|Physician Decision|0|||
33636283|NCT01853228|63038471|FG001|Phase 2|Physician Decision|1|||
33636284|NCT01853228|63038470|FG000|Phase 2|Proceed To Transplant|0|||
33636285|NCT01853228|63038471|FG001|Phase 2|Proceed To Transplant|3|||
33636286|NCT01853228|63038470|FG000|Phase 2|Lack of Efficacy|0|||
33636287|NCT01853228|63038471|FG001|Phase 2|Lack of Efficacy|4|||
33636288|NCT01705587|63038478|FG000|Overall Study|Withdrawal by Subject|0|||
33636289|NCT01705587|63038479|FG001|Overall Study|Withdrawal by Subject|1|||
33636290|NCT01718535|63038495|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
33636291|NCT01718535|63038496|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
33636292|NCT01718535|63038497|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
33636293|NCT01718535|63038498|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
33636294|NCT01718535|63038499|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
33636295|NCT01718535|63038500|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
33636296|NCT01718535|63038501|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
33636297|NCT01718535|63038502|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
33636298|NCT01718535|63038503|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
33636299|NCT01718535|63038504|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
33636300|NCT01717989|63038526|FG000|Overall Study|Ineligibility determined|6|||
33636301|NCT01717989|63038526|FG000|Overall Study|Protocol deviation|6|||
33636302|NCT01717989|63038526|FG000|Overall Study|Withdrawal by Subject|11|||
33636303|NCT01717989|63038526|FG000|Overall Study|Physician Decision|2|||
33636304|NCT01717989|63038526|FG000|Overall Study|Lost to Follow-up|11|||
33636305|NCT01717989|63038526|FG000|Overall Study|Death|439|||
33636306|NCT01717989|63038526|FG000|Overall Study|Protocol-specified criteria|551|||
33636307|NCT01717989|63038526|FG000|Overall Study|Other|40|||
33636308|NCT01705509|63038545|FG000|Inclusion CPET|Screen Failure|5|||
33636309|NCT01705509|63038545|FG000|Inclusion CPET|Withdrawal by Subject|2|||
33636310|NCT01705509|63038545|FG000|CPET w/ Ranexa|Screen Failure|2|||
33636311|NCT01853072|63038551|FG000|Overall Study|Adverse event prior to treatment|0|||
33636312|NCT01853072|63038552|FG001|Overall Study|Adverse event prior to treatment|1|||
33636313|NCT01853072|63038551|FG000|Overall Study|Adverse Event|0|||
33636314|NCT01853072|63038552|FG001|Overall Study|Adverse Event|3|||
33636315|NCT01853072|63038551|FG000|Overall Study|Death|1|||
33636316|NCT01853072|63038552|FG001|Overall Study|Death|4|||
33636317|NCT01853072|63038551|FG000|Overall Study|Lost to Follow-up|0|||
33636318|NCT01853072|63038552|FG001|Overall Study|Lost to Follow-up|3|||
33636319|NCT01853072|63038551|FG000|Overall Study|Non-compliance with study drug|0|||
33636320|NCT01853072|63038552|FG001|Overall Study|Non-compliance with study drug|1|||
33636321|NCT01853072|63038551|FG000|Overall Study|Physician Decision|1|||
33636322|NCT01853072|63038552|FG001|Overall Study|Physician Decision|1|||
33636323|NCT01853072|63038551|FG000|Overall Study|Withdrawal by Subject|1|||
33636324|NCT01853072|63038552|FG001|Overall Study|Withdrawal by Subject|2|||
33636325|NCT01853072|63038551|FG000|Overall Study|Reason not specified|9|||
33636326|NCT01853072|63038552|FG001|Overall Study|Reason not specified|6|||
33636327|NCT01877720|63038560|FG000|Overall Study|Adverse Event|1|||
33636328|NCT01877720|63038561|FG001|Overall Study|Adverse Event|0|||
33636329|NCT01870869|63038571|FG000|Overall Study|Implanted with nonstudy device|1|||
33636330|NCT01870869|63038572|FG001|Overall Study|Implanted with nonstudy device|3|||
33636331|NCT01870869|63038573|FG002|Overall Study|Implanted with nonstudy device|14|||
33636332|NCT01870869|63038574|FG003|Overall Study|Implanted with nonstudy device|4|||
33636333|NCT01870869|63038571|FG000|Overall Study|Death|0|||
33636334|NCT01870869|63038572|FG001|Overall Study|Death|0|||
33636335|NCT01870869|63038573|FG002|Overall Study|Death|7|||
33636336|NCT01870869|63038574|FG003|Overall Study|Death|1|||
33636337|NCT01870869|63038571|FG000|Overall Study|Subject choice|6|||
33636338|NCT01870869|63038572|FG001|Overall Study|Subject choice|2|||
33636339|NCT01870869|63038573|FG002|Overall Study|Subject choice|22|||
33636340|NCT01870869|63038574|FG003|Overall Study|Subject choice|8|||
33540745|NCT02499900|62930957|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
33540746|NCT02499900|62930958|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
33540747|NCT02499900|62930957|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
33636341|NCT01870869|63038571|FG000|Overall Study|Lost to Follow-up|10|||
33636342|NCT01870869|63038572|FG001|Overall Study|Lost to Follow-up|2|||
33636343|NCT01870869|63038573|FG002|Overall Study|Lost to Follow-up|25|||
33636344|NCT01870869|63038574|FG003|Overall Study|Lost to Follow-up|3|||
33636345|NCT01870869|63038571|FG000|Overall Study|Reason not Specified|1|||
33636346|NCT01870869|63038572|FG001|Overall Study|Reason not Specified|2|||
33636347|NCT01870869|63038573|FG002|Overall Study|Reason not Specified|20|||
33636348|NCT01870869|63038574|FG003|Overall Study|Reason not Specified|4|||
33636349|NCT01870869|63038571|FG000|Overall Study|Not evaluable|10|||
33636350|NCT01870869|63038572|FG001|Overall Study|Not evaluable|5|||
33636351|NCT01870869|63038573|FG002|Overall Study|Not evaluable|42|||
33636352|NCT01870869|63038574|FG003|Overall Study|Not evaluable|10|||
33636353|NCT01877408|63038586|FG000|Overall Study|Lost to Follow-up|0|||
33636354|NCT01877408|63038587|FG001|Overall Study|Lost to Follow-up|2|||
33636355|NCT01717287|63038596|FG000|Overall Study|Lost to Follow-up|0|||
33636356|NCT01717287|63038597|FG001|Overall Study|Lost to Follow-up|2|||
33636357|NCT01717287|63038596|FG000|Overall Study|Protocol Violation|0|||
33636358|NCT01717287|63038597|FG001|Overall Study|Protocol Violation|1|||
33636359|NCT01827254|63038603|FG000|Overall Study|Death|10|||
33636360|NCT01827254|63038603|FG000|Overall Study|Case report form not completed|4|||
33636361|NCT01827254|63038603|FG000|Overall Study|Invalidated centre|3|||
33636362|NCT01827254|63038603|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
33636363|NCT01827254|63038603|FG000|Overall Study|Did not complete re-challenge|1|||
33636364|NCT01827254|63038603|FG000|Overall Study|Disease progression|36|||
33636365|NCT01827254|63038603|FG000|Overall Study|Intolerance to treatment|4|||
33636366|NCT01824602|63038615|FG000|Overall Study|Withdrawal by Subject|0|||
33636367|NCT01824602|63038616|FG001|Overall Study|Withdrawal by Subject|0|||
33636368|NCT01824602|63038617|FG002|Overall Study|Withdrawal by Subject|1|||
33636369|NCT01824602|63038618|FG003|Overall Study|Withdrawal by Subject|2|||
33636370|NCT01824602|63038615|FG000|Overall Study|Patient non-compliance|0|||
33636371|NCT01824602|63038616|FG001|Overall Study|Patient non-compliance|0|||
33636372|NCT01824602|63038617|FG002|Overall Study|Patient non-compliance|1|||
33636373|NCT01824602|63038618|FG003|Overall Study|Patient non-compliance|0|||
33636374|NCT01824602|63038615|FG000|Overall Study|Adverse Event|1|||
33636375|NCT01824602|63038616|FG001|Overall Study|Adverse Event|0|||
33636376|NCT01824602|63038617|FG002|Overall Study|Adverse Event|2|||
33636377|NCT01824602|63038618|FG003|Overall Study|Adverse Event|2|||
33636378|NCT01824602|63038615|FG000|Overall Study|Treatment failure|0|||
33636379|NCT01824602|63038616|FG001|Overall Study|Treatment failure|0|||
33636380|NCT01824602|63038617|FG002|Overall Study|Treatment failure|0|||
33636381|NCT01824602|63038618|FG003|Overall Study|Treatment failure|1|||
33636382|NCT01704651|63038630|FG000|Overall Study|Pre-op withdrawal by subject|1|||
33636383|NCT01704651|63038631|FG001|Overall Study|Pre-op withdrawal by subject|1|||
33636384|NCT01704651|63038630|FG000|Overall Study|Pre-op change in treatment plan|1|||
33636385|NCT01704651|63038631|FG001|Overall Study|Pre-op change in treatment plan|4|||
33636386|NCT01704651|63038630|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
33636387|NCT01704651|63038631|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
33636388|NCT01704651|63038630|FG000|Overall Study|Post-op did not have laparotomy|2|||
33636389|NCT01704651|63038631|FG001|Overall Study|Post-op did not have laparotomy|1|||
33636390|NCT01876706|63038637|FG000|Overall Study|BPH Intervention|9|||
33636391|NCT01876706|63038637|FG000|Overall Study|Lost to Follow-up|7|||
33636392|NCT01876706|63038637|FG000|Overall Study|Withdrawals|6|||
33636393|NCT01876706|63038637|FG000|Overall Study|Death|3|||
33636394|NCT01876082|63038643|FG000|Overall Study|Withdrawal by Subject|0|||
33636395|NCT01876082|63038644|FG001|Overall Study|Withdrawal by Subject|2|||
33636396|NCT01876082|63038643|FG000|Overall Study|Protocol Violation|1|||
33636397|NCT01876082|63038644|FG001|Overall Study|Protocol Violation|0|||
33636398|NCT01876082|63038643|FG000|Overall Study|Adverse Event|1|||
33636399|NCT01876082|63038644|FG001|Overall Study|Adverse Event|1|||
33636400|NCT01876082|63038643|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
33636401|NCT01876082|63038644|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
33636402|NCT01704495|63038654|FG000|Subjects Randomized|Other Reason|3|||
33636403|NCT01704495|63038655|FG001|Subjects Randomized|Other Reason|2|||
33636404|NCT01704495|63038656|FG002|Subjects Randomized|Other Reason|3|||
33636405|NCT01704495|63038657|FG003|Subjects Randomized|Other Reason|2|||
33636406|NCT01704495|63038654|FG000|Subjects Randomized|Discontinuation criteria met|4|||
33636407|NCT01704495|63038655|FG001|Subjects Randomized|Discontinuation criteria met|2|||
33636408|NCT01704495|63038656|FG002|Subjects Randomized|Discontinuation criteria met|2|||
33636409|NCT01704495|63038657|FG003|Subjects Randomized|Discontinuation criteria met|0|||
33636410|NCT01704495|63038654|FG000|Subjects Randomized|Adverse Event|8|||
33636411|NCT01704495|63038655|FG001|Subjects Randomized|Adverse Event|2|||
33636412|NCT01704495|63038656|FG002|Subjects Randomized|Adverse Event|0|||
33636413|NCT01704495|63038657|FG003|Subjects Randomized|Adverse Event|7|||
33636414|NCT01704495|63038654|FG000|Subjects Randomized|Withdrawal by Subject|5|||
33636415|NCT01704495|63038655|FG001|Subjects Randomized|Withdrawal by Subject|5|||
33636416|NCT01704495|63038656|FG002|Subjects Randomized|Withdrawal by Subject|5|||
33636417|NCT01704495|63038657|FG003|Subjects Randomized|Withdrawal by Subject|5|||
33636418|NCT01704495|63038654|FG000|Subjects Randomized|Protocol Violation|1|||
33636419|NCT01704495|63038655|FG001|Subjects Randomized|Protocol Violation|1|||
33636420|NCT01704495|63038656|FG002|Subjects Randomized|Protocol Violation|2|||
33636421|NCT01704495|63038657|FG003|Subjects Randomized|Protocol Violation|0|||
33462220|NCT00092547|62836065|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
33636422|NCT01704495|63038654|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
33636423|NCT01704495|63038655|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
33636424|NCT01704495|63038656|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
33636425|NCT01704495|63038657|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
33636426|NCT01704495|63038654|FG000|Optional Safety Extension|Adverse Event|0|||
33636427|NCT01704495|63038655|FG001|Optional Safety Extension|Adverse Event|4|||
33636428|NCT01704495|63038656|FG002|Optional Safety Extension|Adverse Event|0|||
33636429|NCT01704495|63038657|FG003|Optional Safety Extension|Adverse Event|1|||
33636430|NCT01704495|63038654|FG000|Optional Safety Extension|Other reason|27|||
33636431|NCT01704495|63038655|FG001|Optional Safety Extension|Other reason|29|||
33636432|NCT01704495|63038656|FG002|Optional Safety Extension|Other reason|30|||
33636433|NCT01704495|63038657|FG003|Optional Safety Extension|Other reason|28|||
33636434|NCT01704495|63038654|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
33636435|NCT01704495|63038655|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
33636436|NCT01704495|63038656|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
33636437|NCT01704495|63038657|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
33636438|NCT01716663|63038667|FG000|Overall Study|Withdrawn prior to procedure|4|||
33636439|NCT01716663|63038667|FG000|Overall Study|Treated with non-study catheter|2|||
33636440|NCT01716585|63038673|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
33636441|NCT01716585|63038674|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
33636442|NCT01716585|63038673|FG000|Double-blind Treatment|Adverse Event|2|||
33636443|NCT01716585|63038674|FG001|Double-blind Treatment|Adverse Event|1|||
33636444|NCT01716585|63038673|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
33636445|NCT01716585|63038674|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
33636446|NCT01716585|63038673|FG000|Double-blind Treatment|Lost to Follow-up|2|||
33636447|NCT01716585|63038674|FG001|Double-blind Treatment|Lost to Follow-up|0|||
33636448|NCT01716585|63038673|FG000|Double-blind Treatment|Subject Noncompliant|1|||
33636449|NCT01716585|63038674|FG001|Double-blind Treatment|Subject Noncompliant|0|||
33636450|NCT01716585|63038673|FG000|Double-blind Treatment|Other|1|||
33636451|NCT01716585|63038674|FG001|Double-blind Treatment|Other|0|||
33636452|NCT01716585|63038673|FG000|Open-label Treatment|Adverse Event|0|||
33636453|NCT01716585|63038674|FG001|Open-label Treatment|Adverse Event|2|||
33636454|NCT01716585|63038673|FG000|Open-label Treatment|Virologic Failure|0|||
33636455|NCT01716585|63038674|FG001|Open-label Treatment|Virologic Failure|2|||
33636456|NCT01716585|63038673|FG000|Open-label Treatment|Withdrawal by Subject|0|||
33636457|NCT01716585|63038674|FG001|Open-label Treatment|Withdrawal by Subject|3|||
33636458|NCT01852292|63038683|FG000|Overall Study|Untreated - did not receive study drug|3|||
33636459|NCT01852292|63038684|FG001|Overall Study|Untreated - did not receive study drug|1|||
33636460|NCT01852292|63038683|FG000|Overall Study|Death|9|||
33636461|NCT01852292|63038684|FG001|Overall Study|Death|8|||
33636462|NCT01852292|63038683|FG000|Overall Study|Patient/guardian decision|8|||
33636463|NCT01852292|63038684|FG001|Overall Study|Patient/guardian decision|4|||
33636464|NCT01852292|63038683|FG000|Overall Study|Adverse Event|8|||
33636465|NCT01852292|63038684|FG001|Overall Study|Adverse Event|11|||
33636466|NCT01852292|63038683|FG000|Overall Study|Physician Decision|6|||
33636467|NCT01852292|63038684|FG001|Overall Study|Physician Decision|2|||
33636468|NCT01852292|63038683|FG000|Overall Study|Protocol Violation|2|||
33636469|NCT01852292|63038684|FG001|Overall Study|Protocol Violation|0|||
33636470|NCT01852292|63038683|FG000|Overall Study|Non-compliance with study treatment|1|||
33636471|NCT01852292|63038684|FG001|Overall Study|Non-compliance with study treatment|0|||
33636472|NCT01852292|63038683|FG000|Overall Study|Study terminated by Sponsor|0|||
33636473|NCT01852292|63038684|FG001|Overall Study|Study terminated by Sponsor|1|||
33636474|NCT01852292|63038683|FG000|Overall Study|Progressive disease|42|||
33636475|NCT01852292|63038684|FG001|Overall Study|Progressive disease|52|||
33636476|NCT01715805|63038690|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
33636477|NCT01715805|63038691|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
33636478|NCT01715805|63038692|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
33636479|NCT01715805|63038693|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
33636480|NCT01715805|63038690|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
33636481|NCT01715805|63038691|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
33636482|NCT01715805|63038692|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
33636483|NCT01715805|63038693|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
33636484|NCT01715805|63038690|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
33636485|NCT01715805|63038691|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
33636486|NCT01715805|63038692|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
33636487|NCT01715805|63038693|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
33636488|NCT01715805|63038690|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
33636489|NCT01715805|63038691|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
33636490|NCT01715805|63038692|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
33636491|NCT01715805|63038693|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
33636492|NCT01715805|63038690|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
33636493|NCT01715805|63038691|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
33636494|NCT01715805|63038692|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
33636495|NCT01715805|63038693|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
33636496|NCT01715805|63038690|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
33636497|NCT01715805|63038691|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
33636498|NCT01715805|63038692|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
33636499|NCT01715805|63038693|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
33636500|NCT01715805|63038690|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
33636501|NCT01715805|63038691|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
33636502|NCT01715805|63038692|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
33636503|NCT01715805|63038693|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
33636504|NCT01715805|63038690|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
33636505|NCT01715805|63038691|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
33636506|NCT01715805|63038692|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
33636507|NCT01715805|63038693|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
33636508|NCT01715805|63038690|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
33636509|NCT01715805|63038691|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
33636510|NCT01715805|63038692|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
33636511|NCT01715805|63038693|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
33636512|NCT01715805|63038690|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
33636513|NCT01715805|63038691|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
33636514|NCT01715805|63038692|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
33636515|NCT01715805|63038693|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
33636516|NCT01715805|63038690|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
33636517|NCT01715805|63038691|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
33636518|NCT01715805|63038692|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
33636519|NCT01715805|63038693|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
33636520|NCT01715805|63038690|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
33636521|NCT01715805|63038691|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
33636522|NCT01715805|63038692|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
33636523|NCT01715805|63038693|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
33636524|NCT01715805|63038690|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
33636525|NCT01715805|63038691|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
33636526|NCT01715805|63038692|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
33636527|NCT01715805|63038693|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
33636528|NCT01715805|63038690|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
33636529|NCT01715805|63038691|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
33636530|NCT01715805|63038692|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
33636531|NCT01715805|63038693|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
33636532|NCT01852214|63038701|FG000|Period 1|Adverse Event|1|||
33636533|NCT01852214|63038702|FG001|Period 1|Adverse Event|2|||
33636534|NCT01852214|63038701|FG000|Period 1|Withdrawal by Subject|0|||
33636535|NCT01852214|63038702|FG001|Period 1|Withdrawal by Subject|1|||
33636536|NCT01852214|63038701|FG000|Washout Period|Withdrawal by Subject|0|||
33636537|NCT01852214|63038702|FG001|Washout Period|Withdrawal by Subject|1|||
33636538|NCT01393990|63038727|FG000|Overall Study|Adverse Event|0|||
33636539|NCT01393990|63038728|FG001|Overall Study|Adverse Event|0|||
33636540|NCT01393990|63038729|FG002|Overall Study|Adverse Event|0|||
33636541|NCT01393990|63038730|FG003|Overall Study|Adverse Event|0|||
33636542|NCT01393990|63038731|FG004|Overall Study|Adverse Event|0|||
33636543|NCT01393990|63038732|FG005|Overall Study|Adverse Event|0|||
33636544|NCT01393990|63038733|FG006|Overall Study|Adverse Event|0|||
33636545|NCT01393990|63038734|FG007|Overall Study|Adverse Event|0|||
33636546|NCT01393990|63038735|FG008|Overall Study|Adverse Event|0|||
33636547|NCT01393990|63038736|FG009|Overall Study|Adverse Event|0|||
33636548|NCT01393990|63038737|FG010|Overall Study|Adverse Event|0|||
33636549|NCT01393990|63038738|FG011|Overall Study|Adverse Event|0|||
33636550|NCT01393990|63038739|FG012|Overall Study|Adverse Event|0|||
33636551|NCT01393990|63038740|FG013|Overall Study|Adverse Event|0|||
33462221|NCT00092547|62836066|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
33462222|NCT00092547|62836067|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
33636552|NCT01393990|63038741|FG014|Overall Study|Adverse Event|1|||
33636553|NCT01393990|63038742|FG015|Overall Study|Adverse Event|1|||
33636554|NCT01393990|63038743|FG016|Overall Study|Adverse Event|0|||
33636555|NCT01393990|63038744|FG017|Overall Study|Adverse Event|0|||
33636556|NCT01393990|63038727|FG000|Overall Study|Progressive Disease|1|||
33636557|NCT01393990|63038728|FG001|Overall Study|Progressive Disease|0|||
33636558|NCT01393990|63038729|FG002|Overall Study|Progressive Disease|0|||
33636559|NCT01393990|63038730|FG003|Overall Study|Progressive Disease|1|||
33636560|NCT01393990|63038731|FG004|Overall Study|Progressive Disease|1|||
33636561|NCT01393990|63038732|FG005|Overall Study|Progressive Disease|1|||
33636562|NCT01393990|63038733|FG006|Overall Study|Progressive Disease|1|||
33636563|NCT01393990|63038734|FG007|Overall Study|Progressive Disease|1|||
33636564|NCT01393990|63038735|FG008|Overall Study|Progressive Disease|3|||
33636565|NCT01393990|63038736|FG009|Overall Study|Progressive Disease|1|||
33636566|NCT01393990|63038737|FG010|Overall Study|Progressive Disease|0|||
33636567|NCT01393990|63038738|FG011|Overall Study|Progressive Disease|0|||
33636568|NCT01393990|63038739|FG012|Overall Study|Progressive Disease|0|||
33636569|NCT01393990|63038740|FG013|Overall Study|Progressive Disease|1|||
33636570|NCT01393990|63038741|FG014|Overall Study|Progressive Disease|6|||
33636571|NCT01393990|63038742|FG015|Overall Study|Progressive Disease|1|||
33636572|NCT01393990|63038743|FG016|Overall Study|Progressive Disease|0|||
33636573|NCT01393990|63038744|FG017|Overall Study|Progressive Disease|0|||
33636574|NCT01393990|63038727|FG000|Overall Study|Death|0|||
33636575|NCT01393990|63038728|FG001|Overall Study|Death|0|||
33636576|NCT01393990|63038729|FG002|Overall Study|Death|0|||
33636577|NCT01393990|63038730|FG003|Overall Study|Death|0|||
33636578|NCT01393990|63038731|FG004|Overall Study|Death|1|||
33636579|NCT01393990|63038732|FG005|Overall Study|Death|0|||
33636580|NCT01393990|63038733|FG006|Overall Study|Death|0|||
33636581|NCT01393990|63038734|FG007|Overall Study|Death|0|||
33636582|NCT01393990|63038735|FG008|Overall Study|Death|0|||
33636583|NCT01393990|63038736|FG009|Overall Study|Death|0|||
33636584|NCT01393990|63038737|FG010|Overall Study|Death|0|||
33636585|NCT01393990|63038738|FG011|Overall Study|Death|0|||
33636586|NCT01393990|63038739|FG012|Overall Study|Death|0|||
33636587|NCT01393990|63038740|FG013|Overall Study|Death|1|||
33636588|NCT01393990|63038741|FG014|Overall Study|Death|1|||
33636589|NCT01393990|63038742|FG015|Overall Study|Death|0|||
33636590|NCT01393990|63038743|FG016|Overall Study|Death|0|||
33636591|NCT01393990|63038744|FG017|Overall Study|Death|0|||
33636592|NCT01393990|63038727|FG000|Overall Study|Withdrawal by Subject|0|||
33636593|NCT01393990|63038728|FG001|Overall Study|Withdrawal by Subject|0|||
33636594|NCT01393990|63038729|FG002|Overall Study|Withdrawal by Subject|0|||
33636595|NCT01393990|63038730|FG003|Overall Study|Withdrawal by Subject|0|||
33636596|NCT01393990|63038731|FG004|Overall Study|Withdrawal by Subject|0|||
33636597|NCT01393990|63038732|FG005|Overall Study|Withdrawal by Subject|0|||
33636598|NCT01393990|63038733|FG006|Overall Study|Withdrawal by Subject|0|||
33636599|NCT01393990|63038734|FG007|Overall Study|Withdrawal by Subject|0|||
33540748|NCT02499900|62930958|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
33540749|NCT02499900|62930957|FG000|Extension Study Period|Adverse Event|2|||
33540750|NCT02499900|62930958|FG001|Extension Study Period|Adverse Event|4|||
33540751|NCT02499900|62930957|FG000|Extension Study Period|Withdrawal by Subject|5|||
33540752|NCT02499900|62930958|FG001|Extension Study Period|Withdrawal by Subject|2|||
33540753|NCT02499900|62930957|FG000|Extension Study Period|Physician Decision|2|||
33540754|NCT02499900|62930958|FG001|Extension Study Period|Physician Decision|5|||
33540755|NCT02499900|62930957|FG000|Extension Study Period|Pregnancy|1|||
33540756|NCT02499900|62930958|FG001|Extension Study Period|Pregnancy|2|||
33540757|NCT02499900|62930957|FG000|Extension Study Period|Lost to Follow-up|2|||
33540758|NCT02499900|62930958|FG001|Extension Study Period|Lost to Follow-up|5|||
33540759|NCT02499900|62930957|FG000|Extension Study Period|Other|0|||
33540760|NCT02499900|62930958|FG001|Extension Study Period|Other|2|||
33540761|NCT03505749|62930972|FG000|Overall Study|Lost to Follow-up|7|||
33540762|NCT03505749|62930973|FG001|Overall Study|Lost to Follow-up|11|||
33540763|NCT03505749|62930972|FG000|Overall Study|Withdrawal by Subject|6|||
33540764|NCT03505749|62930973|FG001|Overall Study|Withdrawal by Subject|0|||
33540765|NCT03505749|62930972|FG000|Overall Study|Discharged from treatment|3|||
33540766|NCT03505749|62930973|FG001|Overall Study|Discharged from treatment|6|||
33540767|NCT03710642|62930997|FG000|Overall Study|Adverse Event|5|||
33540768|NCT03710642|62930998|FG001|Overall Study|Adverse Event|1|||
33540769|NCT03710642|62930997|FG000|Overall Study|non-site physician recommendation|1|||
33540770|NCT03710642|62930998|FG001|Overall Study|non-site physician recommendation|0|||
33540771|NCT03710642|62930997|FG000|Overall Study|Participant unwilling or unable to participate|1|||
33540772|NCT03710642|62930998|FG001|Overall Study|Participant unwilling or unable to participate|1|||
33636600|NCT01393990|63038735|FG008|Overall Study|Withdrawal by Subject|0|||
33636601|NCT01393990|63038736|FG009|Overall Study|Withdrawal by Subject|0|||
33540773|NCT03710642|62930997|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
33540774|NCT03710642|62930998|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
33636602|NCT01393990|63038737|FG010|Overall Study|Withdrawal by Subject|0|||
33540775|NCT03710642|62930997|FG000|Overall Study|NA-no code provided|1|||
33540776|NCT03710642|62930998|FG001|Overall Study|NA-no code provided|0|||
33540777|NCT03710642|62930997|FG000|Overall Study|Withdrawal by Subject|1|||
33636603|NCT01393990|63038738|FG011|Overall Study|Withdrawal by Subject|0|||
33636604|NCT01393990|63038739|FG012|Overall Study|Withdrawal by Subject|0|||
33636605|NCT01393990|63038740|FG013|Overall Study|Withdrawal by Subject|0|||
33636606|NCT01393990|63038741|FG014|Overall Study|Withdrawal by Subject|1|||
33636607|NCT01393990|63038742|FG015|Overall Study|Withdrawal by Subject|1|||
33636608|NCT01393990|63038743|FG016|Overall Study|Withdrawal by Subject|0|||
33636609|NCT01393990|63038744|FG017|Overall Study|Withdrawal by Subject|0|||
33651451|NCT01746901|63062907|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33636610|NCT00210184|63038793|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
33636611|NCT00210106|63038797|FG000|Overall Study|Death|1|||
33636612|NCT00210106|63038797|FG000|Overall Study|Protocol Violation|13|||
33636613|NCT01851590|63038805|FG000|Overall Study|Withdrawal by Subject|0|||
33636614|NCT01851590|63038806|FG001|Overall Study|Withdrawal by Subject|0|||
33636615|NCT01851590|63038807|FG002|Overall Study|Withdrawal by Subject|1|||
33636616|NCT01851590|63038805|FG000|Overall Study|Adverse Event|0|||
33636617|NCT01851590|63038806|FG001|Overall Study|Adverse Event|0|||
33636618|NCT01851590|63038807|FG002|Overall Study|Adverse Event|2|||
33636619|NCT01851590|63038805|FG000|Overall Study|Lack of Efficacy|0|||
33636620|NCT01851590|63038806|FG001|Overall Study|Lack of Efficacy|1|||
33636621|NCT01851590|63038807|FG002|Overall Study|Lack of Efficacy|0|||
33636622|NCT01852058|63038822|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
33636623|NCT01852058|63038823|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33636624|NCT01852058|63038824|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33636625|NCT01852058|63038825|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33636626|NCT01852058|63038826|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33636627|NCT01852058|63038827|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33636628|NCT01852058|63038828|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33636629|NCT01852058|63038829|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33636630|NCT01852058|63038830|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33636631|NCT01852058|63038831|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33636632|NCT01852058|63038832|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33636633|NCT01852058|63038833|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33462223|NCT00092547|62836065|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
33462224|NCT00092547|62836066|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
33462225|NCT00092547|62836067|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
33462226|NCT00092547|62836065|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
33462227|NCT00092547|62836066|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
33462228|NCT00092547|62836067|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
33462229|NCT00092547|62836065|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
33462230|NCT00092547|62836066|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
33462231|NCT00092547|62836067|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
33462232|NCT00092547|62836065|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
33462233|NCT00092547|62836066|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
33462234|NCT00092547|62836067|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
33462235|NCT00092547|62836065|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
33462236|NCT00092547|62836066|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
33462237|NCT00092547|62836067|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
33462238|NCT00092547|62836065|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
33462239|NCT00092547|62836066|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
33462240|NCT00092547|62836067|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
33462241|NCT00092547|62836065|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
33462242|NCT00092547|62836066|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
33462243|NCT00092547|62836067|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
33462244|NCT03802994|62836083|FG000|Overall Study|Lost to Follow-up|0|||
33462245|NCT03802994|62836084|FG001|Overall Study|Lost to Follow-up|2|||
33462246|NCT03802994|62836085|FG002|Overall Study|Lost to Follow-up|3|||
33462247|NCT03802994|62836086|FG003|Overall Study|Lost to Follow-up|2|||
33462248|NCT03802994|62836087|FG004|Overall Study|Lost to Follow-up|2|||
33462249|NCT03465904|62836112|FG000|Overall Study|Withdrawal by Subject|9|||
33462250|NCT03465904|62836113|FG001|Overall Study|Withdrawal by Subject|5|||
33462251|NCT03465904|62836112|FG000|Overall Study|Lost to Follow-up|10|||
33462252|NCT03465904|62836113|FG001|Overall Study|Lost to Follow-up|9|||
33462253|NCT03465904|62836112|FG000|Overall Study|Protocol Violation|8|||
33462254|NCT03465904|62836113|FG001|Overall Study|Protocol Violation|5|||
33462255|NCT03465904|62836112|FG000|Overall Study|Ineligible for mITT analysis|62|||
33462256|NCT03465904|62836113|FG001|Overall Study|Ineligible for mITT analysis|47|||
33462257|NCT03802916|62836121|FG000|Overall Study|Adverse Event|0|||
33462258|NCT03802916|62836122|FG001|Overall Study|Adverse Event|1|||
33462259|NCT03802916|62836121|FG000|Overall Study|Withdrawal by Subject|0|||
33462260|NCT03802916|62836122|FG001|Overall Study|Withdrawal by Subject|1|||
33636634|NCT01852058|63038822|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33636635|NCT01852058|63038823|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33636636|NCT01852058|63038824|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33462261|NCT00076011|62836130|FG000|Overall Study|Death|1|||
33462262|NCT00076011|62836130|FG000|Overall Study|Adverse Event|10|||
33462263|NCT00076011|62836130|FG000|Overall Study|Lack of Efficacy|25|||
33462264|NCT00076011|62836130|FG000|Overall Study|Withdrawal by Subject|1|||
33540778|NCT03710642|62930998|FG001|Overall Study|Withdrawal by Subject|0|||
33540779|NCT00705224|62931004|FG000|Overall Study|Adverse Event|1|||
33540780|NCT00705224|62931004|FG000|Overall Study|Lack of Efficacy|2|||
33540781|NCT00705224|62931004|FG000|Overall Study|Withdrawal by Subject|3|||
33540782|NCT00705224|62931004|FG000|Overall Study|Lost to Follow-up|5|||
33540783|NCT02722148|62931011|FG000|Overall Study|Lost to Follow-up|2|||
33540784|NCT02722148|62931011|FG000|Overall Study|Non compliant with treatment regimen|3|||
33540785|NCT00704132|62931017|FG000|Overall Study|Clinical Adverse Experience|1|||
33540786|NCT00704132|62931018|FG001|Overall Study|Clinical Adverse Experience|0|||
33540787|NCT00704132|62931017|FG000|Overall Study|Lack of Efficacy|0|||
33540788|NCT00704132|62931018|FG001|Overall Study|Lack of Efficacy|1|||
33540789|NCT00704132|62931017|FG000|Overall Study|Withdrawal by Subject|0|||
33540790|NCT00704132|62931018|FG001|Overall Study|Withdrawal by Subject|1|||
33540791|NCT01329549|62931033|FG000|Overall Study|Withdrawal by Subject|1|||
33326488|NCT00887224|62703224|FG000|Open-label Stability (OLS) Phase|Other|1|||
33326489|NCT00887224|62703225|FG001|Open-label Stability (OLS) Phase|Other|0|||
33326490|NCT00887224|62703226|FG002|Open-label Stability (OLS) Phase|Other|0|||
33462265|NCT00076011|62836130|FG000|Overall Study|Study terminated by sponsor|3|||
33462266|NCT00076011|62836130|FG000|Overall Study|Other|11|||
33636637|NCT01852058|63038825|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33636638|NCT01852058|63038826|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
33636639|NCT01852058|63038827|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33636640|NCT01852058|63038828|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33636641|NCT01852058|63038829|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33636642|NCT01852058|63038830|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33636643|NCT01852058|63038831|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33636644|NCT01852058|63038832|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33462267|NCT00076011|62836130|FG000|Overall Study|Ongoing|1|||
33462268|NCT03465436|62836138|FG000|Period 1|Protocol Violation|0|||
33462269|NCT03465436|62836139|FG001|Period 1|Protocol Violation|0|||
33462270|NCT03465436|62836140|FG002|Period 1|Protocol Violation|1|||
33462271|NCT03465436|62836141|FG003|Period 1|Protocol Violation|0|||
33462272|NCT03465436|62836138|FG000|Period 2|Protocol Violation|0|||
33462273|NCT03465436|62836139|FG001|Period 2|Protocol Violation|1|||
33462274|NCT03465436|62836140|FG002|Period 2|Protocol Violation|0|||
33540792|NCT01329549|62931033|FG000|Overall Study|Adverse Event|1|||
33540793|NCT02736474|62931039|FG000|Overall Study|Lost to Follow-up|0|||
33540794|NCT02736474|62931040|FG001|Overall Study|Lost to Follow-up|1|||
33540795|NCT00702650|62931062|FG000|Overall Study|Withdrawal by Subject|9|||
33540796|NCT00702650|62931062|FG000|Overall Study|Non-Compliance of Study Drug|3|||
33540797|NCT00702650|62931062|FG000|Overall Study|Lost to Follow-up|2|||
33540798|NCT00702650|62931062|FG000|Overall Study|Non-Compliance with Site Directives|1|||
33540799|NCT00702650|62931062|FG000|Overall Study|Sponsor Request|1|||
33540800|NCT00702650|62931062|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
33540801|NCT00702650|62931062|FG000|Overall Study|Adverse Event|3|||
33540802|NCT03230916|62931077|FG000|Overall Study|Withdrawal by Subject|0|||
33540803|NCT03230916|62931078|FG001|Overall Study|Withdrawal by Subject|0|||
33540804|NCT03230916|62931079|FG002|Overall Study|Withdrawal by Subject|0|||
33540805|NCT03230916|62931080|FG003|Overall Study|Withdrawal by Subject|0|||
33540806|NCT03230916|62931081|FG004|Overall Study|Withdrawal by Subject|0|||
33540807|NCT03230916|62931082|FG005|Overall Study|Withdrawal by Subject|1|||
33540808|NCT03230916|62931083|FG006|Overall Study|Withdrawal by Subject|0|||
33540809|NCT03230916|62931084|FG007|Overall Study|Withdrawal by Subject|0|||
33540810|NCT03230916|62931085|FG008|Overall Study|Withdrawal by Subject|0|||
33540811|NCT03230916|62931086|FG009|Overall Study|Withdrawal by Subject|0|||
33540812|NCT03230916|62931087|FG010|Overall Study|Withdrawal by Subject|0|||
33540813|NCT01337115|62931130|FG000|Overall Study|Protocol Violation|2|||
33540814|NCT01337115|62931131|FG001|Overall Study|Protocol Violation|0|||
33540815|NCT03761784|62931141|FG000|Overall Study|Adverse Event|4|||
33462275|NCT03465436|62836141|FG003|Period 2|Protocol Violation|0|||
33540816|NCT03761784|62931142|FG001|Overall Study|Adverse Event|0|||
33540817|NCT03761784|62931141|FG000|Overall Study|Lost to Follow-up|10|||
33540818|NCT03761784|62931142|FG001|Overall Study|Lost to Follow-up|7|||
33540819|NCT03761784|62931141|FG000|Overall Study|Pregnancy|1|||
33540820|NCT03761784|62931142|FG001|Overall Study|Pregnancy|0|||
33462276|NCT03465436|62836138|FG000|Period 3|Protocol Violation|1|||
33462277|NCT03465436|62836139|FG001|Period 3|Protocol Violation|1|||
33636645|NCT01852058|63038833|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33636646|NCT01852058|63038822|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33636647|NCT01852058|63038823|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33636648|NCT01852058|63038824|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33636649|NCT01852058|63038825|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33636650|NCT01852058|63038826|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
33636651|NCT01852058|63038827|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
33636652|NCT01852058|63038828|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33636653|NCT01852058|63038829|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33636654|NCT01852058|63038830|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33636655|NCT01852058|63038831|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33636656|NCT01852058|63038832|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33636657|NCT01852058|63038833|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33636658|NCT01852058|63038822|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33636659|NCT01852058|63038823|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33462278|NCT03465436|62836140|FG002|Period 3|Protocol Violation|0|||
33462279|NCT03465436|62836141|FG003|Period 3|Protocol Violation|0|||
33462280|NCT03465436|62836138|FG000|Period 4|Protocol Violation|0|||
33462281|NCT03465436|62836139|FG001|Period 4|Protocol Violation|0|||
33462282|NCT03465436|62836140|FG002|Period 4|Protocol Violation|1|||
33462283|NCT03465436|62836141|FG003|Period 4|Protocol Violation|0|||
33462284|NCT00053846|62836155|FG000|Overall Study|Changed mind|8|||
33462285|NCT00053846|62836156|FG001|Overall Study|Changed mind|13|||
33462286|NCT00053846|62836155|FG000|Overall Study|Became too ill|8|||
33462287|NCT00053846|62836156|FG001|Overall Study|Became too ill|7|||
33462288|NCT00053846|62836155|FG000|Overall Study|Expired|5|||
33462289|NCT00053846|62836156|FG001|Overall Study|Expired|0|||
33462290|NCT00053846|62836155|FG000|Overall Study|Became ineligible|3|||
33462291|NCT00053846|62836156|FG001|Overall Study|Became ineligible|1|||
33462292|NCT00053846|62836155|FG000|Overall Study|Did not return data|1|||
33462293|NCT00053846|62836156|FG001|Overall Study|Did not return data|2|||
33462294|NCT00053846|62836155|FG000|Overall Study|Quit due to side effects|1|||
33462295|NCT00053846|62836156|FG001|Overall Study|Quit due to side effects|3|||
33462296|NCT00053846|62836155|FG000|Overall Study|Pills too large|0|||
33462297|NCT00053846|62836156|FG001|Overall Study|Pills too large|1|||
33462298|NCT00090987|62836162|FG000|Overall Study|Adverse Event|5|||
33462299|NCT00090987|62836162|FG000|Overall Study|Lack of Efficacy|7|||
33462300|NCT00090987|62836162|FG000|Overall Study|Withdrawal by Subject|3|||
33462301|NCT00090987|62836162|FG000|Overall Study|alternative therapy|1|||
33462302|NCT00090987|62836162|FG000|Overall Study|Non-compliance|4|||
33462303|NCT00090987|62836162|FG000|Overall Study|Incarcerated|1|||
33462304|NCT03464422|62836166|FG000|Overall Study|Lost to Follow-up|2|||
33462305|NCT03464422|62836166|FG000|Overall Study|Withdrawal by Subject|2|||
33462306|NCT03489304|62836172|FG000|Overall Study|Lost to Follow-up|4|||
33462307|NCT03543358|62836176|FG000|Overall Study|Death|1|||
33462308|NCT03543358|62836177|FG001|Overall Study|Death|0|||
33462309|NCT03543358|62836176|FG000|Overall Study|Disease Progression|1|||
33462310|NCT03543358|62836177|FG001|Overall Study|Disease Progression|0|||
33462311|NCT03543358|62836176|FG000|Overall Study|Parent Study Closure|1|||
33636660|NCT01852058|63038824|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33636661|NCT01852058|63038825|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33462312|NCT03543358|62836177|FG001|Overall Study|Parent Study Closure|0|||
33462313|NCT03485950|62836183|FG000|Overall Study|Adverse Event|1|||
33462314|NCT03485950|62836184|FG001|Overall Study|Adverse Event|0|||
33462315|NCT03485950|62836183|FG000|Overall Study|Death|3|||
33462316|NCT03485950|62836184|FG001|Overall Study|Death|2|||
33462317|NCT03485950|62836183|FG000|Overall Study|Withdrawal by Subject|3|||
33462318|NCT03485950|62836184|FG001|Overall Study|Withdrawal by Subject|0|||
33462319|NCT00060944|62836192|FG000|Overall Study|Adverse Event|12|||
33636662|NCT01852058|63038826|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
33636663|NCT01852058|63038827|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33636664|NCT01852058|63038828|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33636665|NCT01852058|63038829|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33636666|NCT01852058|63038830|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33636667|NCT01852058|63038831|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33636668|NCT01852058|63038832|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33636669|NCT01852058|63038833|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33636670|NCT01852058|63038822|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33636671|NCT01852058|63038823|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33636672|NCT01852058|63038824|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33636673|NCT01852058|63038825|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33636674|NCT01852058|63038826|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
33636675|NCT01852058|63038827|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
33636676|NCT01852058|63038828|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33636677|NCT01852058|63038829|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33636678|NCT01852058|63038830|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33636679|NCT01852058|63038831|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33636680|NCT01852058|63038832|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33636681|NCT01852058|63038833|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33636682|NCT01852058|63038822|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33636683|NCT01852058|63038823|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33636684|NCT01852058|63038824|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33636685|NCT01852058|63038825|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
33636686|NCT01852058|63038826|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33636687|NCT01852058|63038827|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33636688|NCT01852058|63038828|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33636689|NCT01852058|63038829|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33636690|NCT01852058|63038830|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33636691|NCT01852058|63038831|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33636692|NCT01852058|63038832|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33636693|NCT01852058|63038833|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33636694|NCT01852058|63038822|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33636695|NCT01852058|63038823|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33636696|NCT01852058|63038824|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33540821|NCT03761784|62931141|FG000|Overall Study|Protocol Violation|2|||
33540822|NCT03761784|62931142|FG001|Overall Study|Protocol Violation|0|||
33540823|NCT03761784|62931141|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
33540824|NCT03761784|62931142|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
33540825|NCT03761784|62931141|FG000|Overall Study|Withdrawal by Subject|9|||
33540826|NCT03761784|62931142|FG001|Overall Study|Withdrawal by Subject|4|||
33636697|NCT01852058|63038825|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33636698|NCT01852058|63038826|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
33636699|NCT01852058|63038827|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
33636700|NCT01852058|63038828|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33636701|NCT01852058|63038829|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33636702|NCT01852058|63038830|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33636703|NCT01852058|63038831|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33636704|NCT01852058|63038832|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33636705|NCT01852058|63038833|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33326491|NCT00887224|62703224|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
33326492|NCT00887224|62703225|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
33326493|NCT00887224|62703226|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
33326494|NCT00887224|62703224|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
33462320|NCT00060944|62836193|FG001|Overall Study|Adverse Event|10|||
33462321|NCT00060944|62836192|FG000|Overall Study|Death|2|||
33462322|NCT00060944|62836193|FG001|Overall Study|Death|3|||
33462323|NCT00060944|62836192|FG000|Overall Study|Withdrawal by Subject|18|||
33462324|NCT00060944|62836193|FG001|Overall Study|Withdrawal by Subject|5|||
33462325|NCT00060944|62836192|FG000|Overall Study|Disease Progression|93|||
33462326|NCT00060944|62836193|FG001|Overall Study|Disease Progression|94|||
33462327|NCT00060944|62836192|FG000|Overall Study|Lost to Follow-up|1|||
33540827|NCT03761784|62931141|FG000|Overall Study|Physician Decision|1|||
33540828|NCT03761784|62931142|FG001|Overall Study|Physician Decision|0|||
33462328|NCT00060944|62836193|FG001|Overall Study|Lost to Follow-up|0|||
33326495|NCT00887224|62703225|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
33326496|NCT00887224|62703226|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
33326497|NCT00887224|62703224|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
33326498|NCT00887224|62703225|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
33326499|NCT00887224|62703226|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
33326500|NCT00887224|62703224|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
33326501|NCT00887224|62703225|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
33326502|NCT00887224|62703226|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
33326503|NCT00887224|62703224|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
33326504|NCT00887224|62703225|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
33326505|NCT00887224|62703226|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
33326506|NCT00887224|62703224|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
33326507|NCT00887224|62703225|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
33326508|NCT00887224|62703226|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
33326509|NCT00887224|62703224|FG000|OL Taper Phase / OL Follow Up|Other|30|||
33326510|NCT00887224|62703225|FG001|OL Taper Phase / OL Follow Up|Other|0|||
33326511|NCT00887224|62703226|FG002|OL Taper Phase / OL Follow Up|Other|0|||
33326512|NCT00887224|62703224|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
33326513|NCT00887224|62703225|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
33326514|NCT00887224|62703226|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
33326515|NCT00887224|62703224|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
33636706|NCT01852058|63038822|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33636707|NCT01852058|63038823|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33636708|NCT01852058|63038824|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33636709|NCT01852058|63038825|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33636710|NCT01852058|63038826|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33636711|NCT01852058|63038827|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33636712|NCT01852058|63038828|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33636713|NCT01852058|63038829|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
33636714|NCT01852058|63038830|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33636715|NCT01852058|63038831|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33636716|NCT01852058|63038832|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33636717|NCT01852058|63038833|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33636718|NCT01852058|63038822|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33636719|NCT01852058|63038823|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33636720|NCT01852058|63038824|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33636721|NCT01852058|63038825|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33636722|NCT01852058|63038826|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33636723|NCT01852058|63038827|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33636724|NCT01852058|63038828|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33636725|NCT01852058|63038829|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33636726|NCT01852058|63038830|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
33636727|NCT01852058|63038831|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33636728|NCT01852058|63038832|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33636729|NCT01852058|63038833|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33636730|NCT00218296|63038870|FG000|Overall Study|Lost to Follow-up|9|||
33636731|NCT00218296|63038871|FG001|Overall Study|Lost to Follow-up|7|||
33636732|NCT00218296|63038870|FG000|Overall Study|Withdrawal by Subject|36|||
33636733|NCT00218296|63038871|FG001|Overall Study|Withdrawal by Subject|47|||
33636734|NCT00218296|63038870|FG000|Overall Study|Randomized but did not enter treatment|66|||
33636735|NCT00218296|63038871|FG001|Overall Study|Randomized but did not enter treatment|67|||
33636736|NCT00217672|63038879|FG000|Allocation|Ineligible|2|||
33636737|NCT00217672|63038880|FG001|Allocation|Ineligible|0|||
33636738|NCT00217672|63038879|FG000|Treatment|disease progression|33|||
33636739|NCT00217672|63038880|FG001|Treatment|disease progression|4|||
33636740|NCT00217672|63038879|FG000|Treatment|Adverse Event|18|||
33636741|NCT00217672|63038880|FG001|Treatment|Adverse Event|2|||
33636742|NCT00217672|63038879|FG000|Treatment|reqd treatment not permitted by protocol|6|||
33636743|NCT00217672|63038880|FG001|Treatment|reqd treatment not permitted by protocol|0|||
33636744|NCT00217672|63038879|FG000|Treatment|Physician Decision|6|||
33636745|NCT00217672|63038880|FG001|Treatment|Physician Decision|0|||
33636746|NCT00217672|63038879|FG000|Treatment|insurance issues|1|||
33636747|NCT00217672|63038880|FG001|Treatment|insurance issues|1|||
33636748|NCT00217672|63038879|FG000|Treatment|Death|2|||
33326516|NCT00887224|62703225|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
33326517|NCT00887224|62703226|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
33326518|NCT00887224|62703224|FG000|Double-blind (DB) Phase|Adverse Event|0|||
33326519|NCT00887224|62703225|FG001|Double-blind (DB) Phase|Adverse Event|7|||
33326520|NCT00887224|62703226|FG002|Double-blind (DB) Phase|Adverse Event|2|||
33636749|NCT00217672|63038880|FG001|Treatment|Death|0|||
33636750|NCT00217672|63038879|FG000|Treatment|secondary malignancy|1|||
33636751|NCT00217672|63038880|FG001|Treatment|secondary malignancy|0|||
33636752|NCT00217672|63038879|FG000|Follow-up|Withdrawal by Subject|4|||
33636753|NCT00217672|63038880|FG001|Follow-up|Withdrawal by Subject|0|||
33636754|NCT00217672|63038879|FG000|Follow-up|Lost to Follow-up|1|||
33636755|NCT00217672|63038880|FG001|Follow-up|Lost to Follow-up|0|||
33636756|NCT00216736|63038886|FG000|Overall Study|Lost to Follow-up|1|||
33636757|NCT00216736|63038887|FG001|Overall Study|Lost to Follow-up|1|||
33636758|NCT01850030|63038895|FG000|Overall Study|Adverse Event|64|||
33636759|NCT01850030|63038896|FG001|Overall Study|Adverse Event|82|||
33636760|NCT01850030|63038895|FG000|Overall Study|Lack of Efficacy|3|||
33636761|NCT01850030|63038896|FG001|Overall Study|Lack of Efficacy|1|||
33636762|NCT01850030|63038895|FG000|Overall Study|Lost to Follow-up|5|||
33636763|NCT01850030|63038896|FG001|Overall Study|Lost to Follow-up|5|||
33636764|NCT01850030|63038895|FG000|Overall Study|Withdrawal by Subject|3|||
33636765|NCT01850030|63038896|FG001|Overall Study|Withdrawal by Subject|4|||
33636766|NCT01850030|63038895|FG000|Overall Study|Protocol Violation|24|||
33636767|NCT01850030|63038896|FG001|Overall Study|Protocol Violation|28|||
33636768|NCT01850030|63038895|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
33636769|NCT01850030|63038896|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
33636770|NCT00215644|63038904|FG000|Overall Study|Disease Progression|28|||
33636771|NCT00215644|63038905|FG001|Overall Study|Disease Progression|10|||
33636772|NCT00215644|63038904|FG000|Overall Study|Adverse Event|2|||
33636773|NCT00215644|63038905|FG001|Overall Study|Adverse Event|9|||
33636774|NCT00215644|63038904|FG000|Overall Study|Death|1|||
33636775|NCT00215644|63038905|FG001|Overall Study|Death|2|||
33636776|NCT00215644|63038904|FG000|Overall Study|Withdrawal by Subject|1|||
33636777|NCT00215644|63038905|FG001|Overall Study|Withdrawal by Subject|0|||
33636778|NCT00215644|63038904|FG000|Overall Study|Other|3|||
33636779|NCT00215644|63038905|FG001|Overall Study|Other|15|||
33636780|NCT00215644|63038904|FG000|Overall Study|Randomized but Not Treated|1|||
33636781|NCT00215644|63038905|FG001|Overall Study|Randomized but Not Treated|0|||
33636782|NCT01870401|63038913|FG000|Overall Study|Death|48|||
33636783|NCT01870401|63038914|FG001|Overall Study|Death|24|||
33636784|NCT01870401|63038913|FG000|Overall Study|Withdrawal by Subject|39|||
33636785|NCT01870401|63038914|FG001|Overall Study|Withdrawal by Subject|26|||
33636786|NCT01870401|63038913|FG000|Overall Study|Lost to Follow-up|19|||
33636787|NCT01870401|63038914|FG001|Overall Study|Lost to Follow-up|14|||
33636788|NCT01870401|63038913|FG000|Overall Study|Other|9|||
33636789|NCT01870401|63038914|FG001|Overall Study|Other|7|||
33636790|NCT01870401|63038913|FG000|Overall Study|On-going in the Study|35|||
33636791|NCT01870401|63038914|FG001|Overall Study|On-going in the Study|25|||
33636792|NCT00213148|63038926|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
33636793|NCT00213148|63038927|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
33636794|NCT00213148|63038928|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
33636795|NCT00213148|63038929|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
33636796|NCT00213148|63038930|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
33636797|NCT00213148|63038926|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
33636798|NCT00213148|63038927|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
33636799|NCT00213148|63038928|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
33636800|NCT00213148|63038929|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
33636801|NCT00213148|63038930|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
33462329|NCT00060944|62836192|FG000|Overall Study|Subject Ineligible To Continue|2|||
33462330|NCT00060944|62836193|FG001|Overall Study|Subject Ineligible To Continue|1|||
33462331|NCT00060944|62836192|FG000|Overall Study|Treatment Switch|0|||
33462332|NCT00060944|62836193|FG001|Overall Study|Treatment Switch|13|||
33462333|NCT00060944|62836192|FG000|Overall Study|Other|2|||
33462334|NCT00060944|62836193|FG001|Overall Study|Other|4|||
33462335|NCT00060944|62836192|FG000|Overall Study|randomized but not treated|6|||
33462336|NCT00060944|62836193|FG001|Overall Study|randomized but not treated|4|||
33462337|NCT03462082|62836199|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
33462338|NCT03462082|62836200|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
33462339|NCT03462082|62836201|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
33462340|NCT03462082|62836202|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
33462341|NCT03462082|62836203|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
33462342|NCT03462082|62836204|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
33462343|NCT03462082|62836205|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
33462344|NCT03462082|62836206|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
33636802|NCT00213148|63038926|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
33636803|NCT00213148|63038927|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
33636804|NCT00213148|63038928|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
33636805|NCT00213148|63038929|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
33636806|NCT00213148|63038930|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
33636807|NCT00213148|63038926|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
33636808|NCT00213148|63038927|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
33636809|NCT00213148|63038928|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
33636810|NCT00213148|63038929|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
33636811|NCT00213148|63038930|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
33636812|NCT00213148|63038926|FG000|Cycle 1 (1 Month)|Other|3|||
33636813|NCT00213148|63038927|FG001|Cycle 1 (1 Month)|Other|0|||
33636814|NCT00213148|63038928|FG002|Cycle 1 (1 Month)|Other|2|||
33636815|NCT00213148|63038929|FG003|Cycle 1 (1 Month)|Other|2|||
33636816|NCT00213148|63038930|FG004|Cycle 1 (1 Month)|Other|7|||
33636817|NCT00213148|63038926|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33636818|NCT00213148|63038927|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33636819|NCT00213148|63038928|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33636820|NCT00213148|63038929|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
33636821|NCT00213148|63038930|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33636822|NCT00213148|63038926|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
33636823|NCT00213148|63038927|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
33636824|NCT00213148|63038928|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
33636825|NCT00213148|63038929|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
33636826|NCT00213148|63038930|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
33636827|NCT00213148|63038926|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
33636828|NCT00213148|63038927|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
33636829|NCT00213148|63038928|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
33636830|NCT00213148|63038929|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
33636831|NCT00213148|63038930|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
33636832|NCT00213148|63038926|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
33636833|NCT00213148|63038927|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
33636834|NCT00213148|63038928|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
33636835|NCT00213148|63038929|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
33636836|NCT00213148|63038930|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
33636837|NCT00213148|63038926|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
33636838|NCT00213148|63038927|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
33636839|NCT00213148|63038928|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
33636840|NCT00213148|63038929|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
33636841|NCT00213148|63038930|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
33636842|NCT00213148|63038926|FG000|Cycle 2 (1 Month)|Other|2|||
33636843|NCT00213148|63038927|FG001|Cycle 2 (1 Month)|Other|1|||
33636844|NCT00213148|63038928|FG002|Cycle 2 (1 Month)|Other|2|||
33636845|NCT00213148|63038929|FG003|Cycle 2 (1 Month)|Other|8|||
33636846|NCT00213148|63038930|FG004|Cycle 2 (1 Month)|Other|7|||
33636847|NCT00213148|63038926|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33636848|NCT00213148|63038927|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
33636849|NCT00213148|63038928|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33636850|NCT00213148|63038929|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33636851|NCT00213148|63038930|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33636852|NCT00213148|63038926|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
33636853|NCT00213148|63038927|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
33636854|NCT00213148|63038928|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
33636855|NCT00213148|63038929|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
33636856|NCT00213148|63038930|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
33636857|NCT00213148|63038926|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
33636858|NCT00213148|63038927|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
33636859|NCT00213148|63038928|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
33636860|NCT00213148|63038929|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
33636861|NCT00213148|63038930|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
33636862|NCT00213148|63038926|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
33636863|NCT00213148|63038927|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
33636864|NCT00213148|63038928|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
33636865|NCT00213148|63038929|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
33636866|NCT00213148|63038930|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
33636867|NCT00213148|63038926|FG000|Cycle 3 (1 Month)|Other|0|||
33636868|NCT00213148|63038927|FG001|Cycle 3 (1 Month)|Other|0|||
33636869|NCT00213148|63038928|FG002|Cycle 3 (1 Month)|Other|1|||
33636870|NCT00213148|63038929|FG003|Cycle 3 (1 Month)|Other|1|||
33636871|NCT00213148|63038930|FG004|Cycle 3 (1 Month)|Other|0|||
33636872|NCT01704261|63038952|FG000|Overall Study|Withdrawal by Subject|12|||
33636873|NCT01704261|63038953|FG001|Overall Study|Withdrawal by Subject|15|||
33636874|NCT01704261|63038952|FG000|Overall Study|Lost to Follow-up|1|||
33636875|NCT01704261|63038953|FG001|Overall Study|Lost to Follow-up|0|||
33636876|NCT01715571|63038959|FG000|Overall Study|Lost to Follow-up|8|||
33636877|NCT00212758|63038963|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
33636878|NCT00212758|63038964|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
33636879|NCT00212758|63038963|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
33636880|NCT00212758|63038964|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
33636881|NCT01824290|63038972|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
33636882|NCT01824290|63038973|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
33636883|NCT01824290|63038974|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
33636884|NCT01824290|63038975|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
33636885|NCT01824290|63038972|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
33636886|NCT01824290|63038973|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
33636887|NCT01824290|63038974|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
33636888|NCT01824290|63038975|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
33636889|NCT01824290|63038972|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
33636890|NCT01824290|63038973|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
33636891|NCT01824290|63038974|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
33636892|NCT01824290|63038975|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
33636893|NCT01824290|63038972|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
33636894|NCT01824290|63038973|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
33636895|NCT01824290|63038974|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
33636896|NCT01824290|63038975|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
33636897|NCT01824290|63038972|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
33636898|NCT01824290|63038973|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
33636899|NCT01824290|63038974|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
33326521|NCT00887224|62703224|FG000|Double-blind (DB) Phase|Failed to return|0|||
33540829|NCT03761784|62931141|FG000|Overall Study|Other Than Specified|1|||
33636900|NCT01824290|63038975|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
33462345|NCT03461146|62836216|FG000|Overall Study|Adverse Event|2|||
33462346|NCT03461146|62836216|FG000|Overall Study|Physician Decision|1|||
33462347|NCT03541252|62836220|FG000|Overall Study|Withdrawal by Subject|1|||
33462348|NCT00031460|62836226|FG000|Overall Study|Lost to Follow-up|0|||
33462349|NCT00031460|62836227|FG001|Overall Study|Lost to Follow-up|1|||
33462350|NCT00031460|62836226|FG000|Overall Study|Withdrawal by Subject|1|||
33462351|NCT00031460|62836227|FG001|Overall Study|Withdrawal by Subject|1|||
33462352|NCT00031460|62836226|FG000|Overall Study|Non-Compliant|1|||
33462353|NCT00031460|62836227|FG001|Overall Study|Non-Compliant|1|||
33462354|NCT00031460|62836226|FG000|Overall Study|Death|0|||
33462355|NCT00031460|62836227|FG001|Overall Study|Death|1|||
33462356|NCT00031460|62836226|FG000|Overall Study|Reactivation of Disease|5|||
33462357|NCT00031460|62836227|FG001|Overall Study|Reactivation of Disease|9|||
33462358|NCT00031460|62836226|FG000|Overall Study|Disruption of blinded drug supply|2|||
33462359|NCT00031460|62836227|FG001|Overall Study|Disruption of blinded drug supply|0|||
33462360|NCT00031460|62836226|FG000|Overall Study|Confirmed unevaluable|0|||
33462361|NCT00031460|62836227|FG001|Overall Study|Confirmed unevaluable|1|||
33462362|NCT03540160|62836233|FG000|Overall Study|Protocol Violation|1|||
33462363|NCT03540160|62836233|FG000|Overall Study|Physician Decision|8|||
33462364|NCT03540160|62836233|FG000|Overall Study|Lack of Efficacy|60|||
33462365|NCT03540160|62836233|FG000|Overall Study|Pregnancy|1|||
33462366|NCT03540160|62836233|FG000|Overall Study|Adverse Event|20|||
33462367|NCT03540160|62836233|FG000|Overall Study|Withdrawal by Subject|68|||
33462368|NCT03540160|62836233|FG000|Overall Study|COVID-19|2|||
33462369|NCT03540160|62836233|FG000|Overall Study|Study Closure|10|||
33462370|NCT03540160|62836233|FG000|Overall Study|Lost to Follow-up|18|||
33462371|NCT03540160|62836233|FG000|Overall Study|Sponsor decision|191|||
33462372|NCT03459196|62836237|FG000|Overall Study|Subject didn't receive study catheter|2|||
33462373|NCT03459040|62836241|FG000|Overall Study|Death|8|||
33462374|NCT03459040|62836241|FG000|Overall Study|Withdrawal by Subject|1|||
33462375|NCT03457636|62836246|FG000|Overall Study|Lost to Follow-up|2|||
33462376|NCT03481816|62836252|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
33462377|NCT03481816|62836253|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
33462378|NCT03481816|62836252|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
33462379|NCT03481816|62836253|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
33462380|NCT03481816|62836252|FG000|Dose Expansion|Withdrawal by Subject|0|||
33462381|NCT03481816|62836253|FG001|Dose Expansion|Withdrawal by Subject|2|||
33462382|NCT03481816|62836252|FG000|Dose Expansion|Physician Decision|0|||
33462383|NCT03481816|62836253|FG001|Dose Expansion|Physician Decision|5|||
33462384|NCT03538054|62836261|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
33462385|NCT03538054|62836261|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
33462386|NCT03538054|62836261|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
33462387|NCT03480802|62836269|FG000|Overall Study|Lost to Follow-up|5|||
33462388|NCT03480802|62836270|FG001|Overall Study|Lost to Follow-up|1|||
33540830|NCT03761784|62931142|FG001|Overall Study|Other Than Specified|0|||
33462389|NCT03480802|62836269|FG000|Overall Study|Withdrawal by Subject|2|||
33462390|NCT03480802|62836270|FG001|Overall Study|Withdrawal by Subject|1|||
33462391|NCT03480802|62836269|FG000|Overall Study|Relocated|0|||
33462392|NCT03480802|62836270|FG001|Overall Study|Relocated|1|||
33462393|NCT00050960|62836280|FG000|Overall Study|Progressive Disease|137|||
33462394|NCT00050960|62836281|FG001|Overall Study|Progressive Disease|93|||
33636901|NCT01824290|63038972|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
33636902|NCT01824290|63038973|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
33636903|NCT01824290|63038974|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
33636904|NCT01824290|63038975|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
33636905|NCT01715415|63038989|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
33636906|NCT01715415|63038990|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
33636907|NCT01715415|63038989|FG000|Double-blind Treatment|Adverse Event|3|||
33636908|NCT01715415|63038990|FG001|Double-blind Treatment|Adverse Event|0|||
33636909|NCT01715415|63038989|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
33636910|NCT01715415|63038990|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
33636911|NCT01715415|63038989|FG000|Double-blind Treatment|Other|1|||
33636912|NCT01715415|63038990|FG001|Double-blind Treatment|Other|0|||
33636913|NCT01715415|63038989|FG000|Open-label Treatment|Adverse Event|0|||
33636914|NCT01715415|63038990|FG001|Open-label Treatment|Adverse Event|1|||
33636915|NCT01715415|63038989|FG000|Open-label Treatment|Subject Noncompliant|0|||
33636916|NCT01715415|63038990|FG001|Open-label Treatment|Subject Noncompliant|1|||
33636917|NCT00211510|63038999|FG000|Overall Study|Physician Decision|3|||
33636918|NCT00211510|63039000|FG001|Overall Study|Physician Decision|1|||
33636919|NCT00211510|63038999|FG000|Overall Study|Withdrawal by Subject|3|||
33540831|NCT03195894|62931150|FG000|Overall Study|"An example is Started other treatment."|4|||
33540832|NCT03195894|62931151|FG001|Overall Study|"An example is Started other treatment."|5|||
33540833|NCT03195894|62931150|FG000|Overall Study|Withdrawal by Subject|15|||
33540834|NCT03195894|62931151|FG001|Overall Study|Withdrawal by Subject|4|||
33540835|NCT03195894|62931150|FG000|Overall Study|Lost to Follow-up|14|||
33636920|NCT00211510|63039000|FG001|Overall Study|Withdrawal by Subject|1|||
33636921|NCT01869777|63039009|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
33636922|NCT01714947|63039013|FG000|Part B|Progressive Disease|3|||
33636923|NCT01869699|63039019|FG000|Overall Study|Withdrawal by Subject|1|||
33636924|NCT01869699|63039020|FG001|Overall Study|Withdrawal by Subject|0|||
33636925|NCT01714635|63039029|FG000|Overall Study|Discontinued|1|||
33636926|NCT01714635|63039030|FG001|Overall Study|Discontinued|0|||
33636927|NCT01714635|63039031|FG002|Overall Study|Discontinued|2|||
33636928|NCT01714635|63039029|FG000|Overall Study|Missed 6-month exam|1|||
33636929|NCT01714635|63039030|FG001|Overall Study|Missed 6-month exam|0|||
33636930|NCT01714635|63039031|FG002|Overall Study|Missed 6-month exam|0|||
33636931|NCT01849874|63039041|FG000|Overall Study|Death|34|||
33636932|NCT01849874|63039042|FG001|Overall Study|Death|16|||
33636933|NCT01849874|63039041|FG000|Overall Study|Withdrawal by Subject|4|||
33636934|NCT01849874|63039042|FG001|Overall Study|Withdrawal by Subject|8|||
33636935|NCT01849874|63039041|FG000|Overall Study|Lost to Follow-up|0|||
33636936|NCT01849874|63039042|FG001|Overall Study|Lost to Follow-up|1|||
33636937|NCT01849874|63039041|FG000|Overall Study|Randomized but Never Treated|1|||
33636938|NCT01849874|63039042|FG001|Overall Study|Randomized but Never Treated|8|||
33636939|NCT01849874|63039041|FG000|Overall Study|Ongoing|162|||
33636940|NCT01849874|63039042|FG001|Overall Study|Ongoing|69|||
33636941|NCT01713933|63039048|FG000|Overall Study|Lost to Follow-up|2|||
33636942|NCT01713933|63039048|FG000|Overall Study|Withdrawal by Subject|3|||
33636943|NCT01713933|63039048|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
33636944|NCT01868997|63039054|FG000|Overall Study|Adverse Event|2|||
33636945|NCT01868997|63039055|FG001|Overall Study|Adverse Event|5|||
33636946|NCT01868997|63039054|FG000|Overall Study|Lack of Efficacy|2|||
33636947|NCT01868997|63039055|FG001|Overall Study|Lack of Efficacy|0|||
33636948|NCT01868997|63039054|FG000|Overall Study|Other|3|||
33636949|NCT01868997|63039055|FG001|Overall Study|Other|1|||
33636950|NCT01875848|63039063|FG000|Overall Study|Withdrawal by Subject|2|||
33636951|NCT01875848|63039064|FG001|Overall Study|Withdrawal by Subject|0|||
33636952|NCT04191382|63039073|FG000|Overall Study|Withdrawal by Subject|1|||
33636953|NCT04191382|63039074|FG001|Overall Study|Withdrawal by Subject|0|||
33636954|NCT04191382|63039075|FG002|Overall Study|Withdrawal by Subject|0|||
33636955|NCT01703091|63039085|FG000|Overall Study|Adverse Event|5|||
33636956|NCT01703091|63039086|FG001|Overall Study|Adverse Event|3|||
33540836|NCT03195894|62931151|FG001|Overall Study|Lost to Follow-up|19|||
33540837|NCT01337973|62931163|FG000|Overall Study|Lost to Follow-up|2|||
33540838|NCT01337973|62931164|FG001|Overall Study|Lost to Follow-up|4|||
33540839|NCT01337973|62931165|FG002|Overall Study|Lost to Follow-up|3|||
33540840|NCT01337973|62931163|FG000|Overall Study|Death|1|||
33540841|NCT01337973|62931164|FG001|Overall Study|Death|2|||
33636957|NCT01703091|63039085|FG000|Overall Study|Physician Decision|2|||
33540842|NCT01337973|62931165|FG002|Overall Study|Death|1|||
33540843|NCT01337973|62931163|FG000|Overall Study|Withdrawal by Subject|10|||
33540844|NCT01337973|62931164|FG001|Overall Study|Withdrawal by Subject|8|||
33540845|NCT01337973|62931165|FG002|Overall Study|Withdrawal by Subject|4|||
33636958|NCT01703091|63039086|FG001|Overall Study|Physician Decision|1|||
33636959|NCT01703091|63039085|FG000|Overall Study|Withdrawal by Subject|1|||
33636960|NCT01703091|63039086|FG001|Overall Study|Withdrawal by Subject|0|||
33636961|NCT01703091|63039085|FG000|Overall Study|Sponsor Decision|1|||
33636962|NCT01703091|63039086|FG001|Overall Study|Sponsor Decision|0|||
33636963|NCT01712685|63039092|FG000|Overall Study|pt declined to participate before trmt|1|||
33636964|NCT01867671|63039098|FG000|Overall Study|Adverse Event|5|||
33636965|NCT01867671|63039099|FG001|Overall Study|Adverse Event|3|||
33636966|NCT01867671|63039098|FG000|Overall Study|Anaphylaxis|0|||
33636967|NCT01867671|63039099|FG001|Overall Study|Anaphylaxis|1|||
33636968|NCT01867671|63039098|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
33636969|NCT01867671|63039099|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
33636970|NCT01867671|63039098|FG000|Overall Study|Lost to Follow-up|0|||
33636971|NCT01867671|63039099|FG001|Overall Study|Lost to Follow-up|1|||
33636972|NCT01867671|63039098|FG000|Overall Study|Non-compliance with Study Drug|1|||
33636973|NCT01867671|63039099|FG001|Overall Study|Non-compliance with Study Drug|2|||
33636974|NCT01867671|63039098|FG000|Overall Study|Withdrawal by Subject|21|||
33636975|NCT01867671|63039099|FG001|Overall Study|Withdrawal by Subject|21|||
33636976|NCT01702311|63039107|FG000|Overall Study|Withdrawal by Subject|3|||
33636977|NCT01702311|63039108|FG001|Overall Study|Withdrawal by Subject|2|||
33636978|NCT01702311|63039107|FG000|Overall Study|Discharge less than 24 hours|10|||
33636979|NCT01702311|63039108|FG001|Overall Study|Discharge less than 24 hours|7|||
33636980|NCT01702311|63039107|FG000|Overall Study|Physician Decision|3|||
33636981|NCT01702311|63039108|FG001|Overall Study|Physician Decision|4|||
33636982|NCT01712061|63039124|FG000|Overall Study|Adverse Event|4|||
33636983|NCT01712061|63039125|FG001|Overall Study|Adverse Event|9|||
33636984|NCT01712061|63039126|FG002|Overall Study|Adverse Event|5|||
33636985|NCT01712061|63039124|FG000|Overall Study|Death|0|||
33636986|NCT01712061|63039125|FG001|Overall Study|Death|0|||
33636987|NCT01712061|63039126|FG002|Overall Study|Death|1|||
33636988|NCT01712061|63039124|FG000|Overall Study|Lost to Follow-up|1|||
33636989|NCT01712061|63039125|FG001|Overall Study|Lost to Follow-up|0|||
33636990|NCT01712061|63039126|FG002|Overall Study|Lost to Follow-up|1|||
33636991|NCT01712061|63039124|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
33636992|NCT01712061|63039125|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
33636993|NCT01712061|63039126|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
33636994|NCT01712061|63039124|FG000|Overall Study|Medication Error Without Associated AE|0|||
33636995|NCT01712061|63039125|FG001|Overall Study|Medication Error Without Associated AE|1|||
33636996|NCT01712061|63039126|FG002|Overall Study|Medication Error Without Associated AE|0|||
33636997|NCT01712061|63039124|FG000|Overall Study|Withdrawal by Subject|1|||
33636998|NCT01712061|63039125|FG001|Overall Study|Withdrawal by Subject|7|||
33636999|NCT01712061|63039126|FG002|Overall Study|Withdrawal by Subject|1|||
33637000|NCT01712061|63039124|FG000|Overall Study|Other|0|||
33637001|NCT01712061|63039125|FG001|Overall Study|Other|3|||
33637002|NCT01712061|63039126|FG002|Overall Study|Other|0|||
33637003|NCT03592186|63039137|FG000|Overall Study|Withdrawal by Subject|1|||
33637004|NCT03592186|63039138|FG001|Overall Study|Withdrawal by Subject|0|||
33637005|NCT03592186|63039137|FG000|Overall Study|Lost to Follow-up|16|||
33637006|NCT03592186|63039138|FG001|Overall Study|Lost to Follow-up|11|||
33637007|NCT03598114|63039146|FG000|Overall Study|Staff turnover/left the program|3|||
33637008|NCT03598114|63039147|FG001|Overall Study|Staff turnover/left the program|39|||
33637009|NCT01711983|63039174|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
33637010|NCT01711983|63039174|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
33637011|NCT01711983|63039174|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
33637012|NCT01711983|63039174|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
33637013|NCT01874288|63039188|FG000|Overall Study|Withdrawal by Subject|1|||
33540846|NCT01337973|62931163|FG000|Overall Study|missing data on primary outcome|3|||
33637014|NCT01874288|63039189|FG001|Overall Study|Withdrawal by Subject|0|||
33637015|NCT01874288|63039190|FG002|Overall Study|Withdrawal by Subject|2|||
33637016|NCT01874288|63039191|FG003|Overall Study|Withdrawal by Subject|1|||
33637017|NCT01874288|63039192|FG004|Overall Study|Withdrawal by Subject|1|||
33540847|NCT01337973|62931164|FG001|Overall Study|missing data on primary outcome|1|||
33637018|NCT01874288|63039188|FG000|Overall Study|Physician Decision|0|||
33637019|NCT01874288|63039189|FG001|Overall Study|Physician Decision|0|||
33637020|NCT01874288|63039190|FG002|Overall Study|Physician Decision|0|||
33637021|NCT01874288|63039191|FG003|Overall Study|Physician Decision|1|||
33637022|NCT01874288|63039192|FG004|Overall Study|Physician Decision|0|||
33637023|NCT01874288|63039188|FG000|Overall Study|Progressive disease|2|||
33637024|NCT01874288|63039189|FG001|Overall Study|Progressive disease|0|||
33637025|NCT01874288|63039190|FG002|Overall Study|Progressive disease|3|||
33540848|NCT01337973|62931165|FG002|Overall Study|missing data on primary outcome|3|||
33637026|NCT01874288|63039191|FG003|Overall Study|Progressive disease|5|||
33637027|NCT01874288|63039192|FG004|Overall Study|Progressive disease|1|||
33637028|NCT01874054|63039221|FG000|Overall Study|Withdrawal by Subject|3|||
33637029|NCT01874054|63039221|FG000|Overall Study|Study Termination by Sponsor|42|||
33637030|NCT01874054|63039221|FG000|Overall Study|Lost to Follow-up|5|||
33637031|NCT01874054|63039221|FG000|Overall Study|Death|5|||
33637032|NCT01873742|63039227|FG000|Overall Study|Lost to Follow-up|68|||
33637033|NCT01873742|63039228|FG001|Overall Study|Lost to Follow-up|76|||
33637034|NCT01873586|63039234|FG000|Overall Study|Lost to Follow-up|3|||
33637035|NCT04027348|63039268|FG000|Overall Study|Adverse Event|2|||
33637036|NCT04196686|63039281|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
33637037|NCT04196686|63039282|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
33637038|NCT02708680|63039291|FG000|Overall Study|Withdrawal by Subject|4|||
33637039|NCT02708680|63039292|FG001|Overall Study|Withdrawal by Subject|12|||
33637040|NCT02708680|63039293|FG002|Overall Study|Withdrawal by Subject|12|||
33637041|NCT02708680|63039291|FG000|Overall Study|Death|4|||
33637042|NCT02708680|63039292|FG001|Overall Study|Death|19|||
33637043|NCT02708680|63039293|FG002|Overall Study|Death|21|||
33637044|NCT02708680|63039291|FG000|Overall Study|Lost to Follow-up|0|||
33637045|NCT02708680|63039292|FG001|Overall Study|Lost to Follow-up|3|||
33637046|NCT02708680|63039293|FG002|Overall Study|Lost to Follow-up|3|||
33637047|NCT02708680|63039291|FG000|Overall Study|Study Terminated By Sponsor|0|||
33637048|NCT02708680|63039292|FG001|Overall Study|Study Terminated By Sponsor|5|||
33540849|NCT02929056|62931175|FG000|Overall Study|Lost to Follow-up|0|||
33540850|NCT02929056|62931176|FG001|Overall Study|Lost to Follow-up|1|||
33540851|NCT00157755|62931195|FG000|Overall Study|Death|2|||
33540852|NCT00157755|62931196|FG001|Overall Study|Death|3|||
33540853|NCT00157755|62931197|FG002|Overall Study|Death|3|||
33540854|NCT00157755|62931198|FG003|Overall Study|Death|2|||
33540855|NCT00157755|62931199|FG004|Overall Study|Death|0|||
33540856|NCT00157755|62931200|FG005|Overall Study|Death|0|||
33540857|NCT00157755|62931195|FG000|Overall Study|Lost to Follow-up|0|||
33540858|NCT00157755|62931196|FG001|Overall Study|Lost to Follow-up|0|||
33540859|NCT00157755|62931197|FG002|Overall Study|Lost to Follow-up|1|||
33540860|NCT00157755|62931198|FG003|Overall Study|Lost to Follow-up|0|||
33540861|NCT00157755|62931199|FG004|Overall Study|Lost to Follow-up|0|||
33540862|NCT00157755|62931200|FG005|Overall Study|Lost to Follow-up|0|||
33540863|NCT00157755|62931195|FG000|Overall Study|Withdrawal by Subject|0|||
33540864|NCT00157755|62931196|FG001|Overall Study|Withdrawal by Subject|0|||
33540865|NCT00157755|62931197|FG002|Overall Study|Withdrawal by Subject|1|||
33540866|NCT00157755|62931198|FG003|Overall Study|Withdrawal by Subject|1|||
33540867|NCT00157755|62931199|FG004|Overall Study|Withdrawal by Subject|1|||
33540868|NCT00157755|62931200|FG005|Overall Study|Withdrawal by Subject|2|||
33540869|NCT00157755|62931195|FG000|Overall Study|Explant due to infection|0|||
33540870|NCT00157755|62931196|FG001|Overall Study|Explant due to infection|0|||
33540871|NCT00157755|62931197|FG002|Overall Study|Explant due to infection|1|||
33540872|NCT00157755|62931198|FG003|Overall Study|Explant due to infection|0|||
33540873|NCT00157755|62931199|FG004|Overall Study|Explant due to infection|0|||
33540874|NCT00157755|62931200|FG005|Overall Study|Explant due to infection|0|||
33540875|NCT00157755|62931195|FG000|Overall Study|Medical reason|0|||
33540876|NCT00157755|62931196|FG001|Overall Study|Medical reason|0|||
33540877|NCT00157755|62931197|FG002|Overall Study|Medical reason|1|||
33540878|NCT00157755|62931198|FG003|Overall Study|Medical reason|1|||
33540879|NCT00157755|62931199|FG004|Overall Study|Medical reason|0|||
33540880|NCT00157755|62931200|FG005|Overall Study|Medical reason|0|||
33540881|NCT00157755|62931195|FG000|Overall Study|Study site closure|0|||
33540882|NCT00157755|62931196|FG001|Overall Study|Study site closure|1|||
33540883|NCT00157755|62931197|FG002|Overall Study|Study site closure|0|||
33540884|NCT00157755|62931198|FG003|Overall Study|Study site closure|0|||
33540885|NCT00157755|62931199|FG004|Overall Study|Study site closure|0|||
33540886|NCT00157755|62931200|FG005|Overall Study|Study site closure|0|||
33540887|NCT00157755|62931195|FG000|Overall Study|Subject non-compliance|0|||
33540888|NCT00157755|62931196|FG001|Overall Study|Subject non-compliance|0|||
33540889|NCT00157755|62931197|FG002|Overall Study|Subject non-compliance|0|||
33637049|NCT02708680|63039293|FG002|Overall Study|Study Terminated By Sponsor|4|||
33637050|NCT02708680|63039291|FG000|Overall Study|Other than Specified|0|||
33637051|NCT02708680|63039292|FG001|Overall Study|Other than Specified|0|||
33637052|NCT02708680|63039293|FG002|Overall Study|Other than Specified|1|||
33637053|NCT02708680|63039291|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
33540890|NCT00157755|62931198|FG003|Overall Study|Subject non-compliance|0|||
33540891|NCT00157755|62931199|FG004|Overall Study|Subject non-compliance|0|||
33540892|NCT00157755|62931200|FG005|Overall Study|Subject non-compliance|1|||
33540893|NCT00157755|62931195|FG000|Overall Study|Study completion|0|||
33540894|NCT00157755|62931196|FG001|Overall Study|Study completion|0|||
33540895|NCT00157755|62931197|FG002|Overall Study|Study completion|0|||
33540896|NCT00157755|62931198|FG003|Overall Study|Study completion|0|||
33540897|NCT00157755|62931199|FG004|Overall Study|Study completion|1|||
33540898|NCT00157755|62931200|FG005|Overall Study|Study completion|2|||
33540899|NCT02723006|62931209|FG000|Overall Study|Withdrawal by Subject|0|||
33540900|NCT02723006|62931210|FG001|Overall Study|Withdrawal by Subject|1|||
33540901|NCT02723006|62931211|FG002|Overall Study|Withdrawal by Subject|1|||
33540902|NCT02723006|62931209|FG000|Overall Study|Study Terminated by Sponsor|1|||
33637054|NCT02708680|63039292|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
33540903|NCT02723006|62931210|FG001|Overall Study|Study Terminated by Sponsor|6|||
33540904|NCT02723006|62931211|FG002|Overall Study|Study Terminated by Sponsor|6|||
33540905|NCT00702962|62931221|FG000|Overall Study|Progressive disease|0|||
33540906|NCT00702962|62931222|FG001|Overall Study|Progressive disease|1|||
33540907|NCT00702962|62931221|FG000|Overall Study|Hospitalized for other health disorder|1|||
33540908|NCT00702962|62931222|FG001|Overall Study|Hospitalized for other health disorder|0|||
33540909|NCT01379508|62931234|FG000|Treatment to Week 104|Adverse Event|2|||
33540910|NCT01379508|62931235|FG001|Treatment to Week 104|Adverse Event|0|||
33540911|NCT01379508|62931236|FG002|Treatment to Week 104|Adverse Event|5|||
33540912|NCT01379508|62931237|FG003|Treatment to Week 104|Adverse Event|0|||
33540913|NCT01379508|62931234|FG000|Treatment to Week 104|Abnormal lab value|1|||
33540914|NCT01379508|62931235|FG001|Treatment to Week 104|Abnormal lab value|0|||
33540915|NCT01379508|62931236|FG002|Treatment to Week 104|Abnormal lab value|0|||
33540916|NCT01379508|62931237|FG003|Treatment to Week 104|Abnormal lab value|0|||
33540917|NCT01379508|62931234|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
33540918|NCT01379508|62931235|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
33540919|NCT01379508|62931236|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
33637055|NCT02708680|63039293|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
33637056|NCT01611974|63039307|FG000|Overall Study|Death|10|||
33637057|NCT01611974|63039308|FG001|Overall Study|Death|12|||
33637058|NCT01611974|63039309|FG002|Overall Study|Death|10|||
33637059|NCT01611974|63039307|FG000|Overall Study|Lost to Follow-up|0|||
33637060|NCT01611974|63039308|FG001|Overall Study|Lost to Follow-up|1|||
33637061|NCT01611974|63039309|FG002|Overall Study|Lost to Follow-up|0|||
33637062|NCT01611974|63039307|FG000|Overall Study|Physician Decision|5|||
33637063|NCT01611974|63039308|FG001|Overall Study|Physician Decision|1|||
33637064|NCT01611974|63039309|FG002|Overall Study|Physician Decision|2|||
33637065|NCT01611974|63039307|FG000|Overall Study|Withdrawal by Subject|0|||
33637066|NCT01611974|63039308|FG001|Overall Study|Withdrawal by Subject|1|||
33637067|NCT01611974|63039309|FG002|Overall Study|Withdrawal by Subject|4|||
33637068|NCT01848938|63039319|FG000|Overall Study|Lost to Follow-up|1|||
33637069|NCT01848938|63039320|FG001|Overall Study|Lost to Follow-up|1|||
33637070|NCT01871870|63039326|FG000|Overall Study|Hardware issues|7|||
33637071|NCT01871870|63039326|FG000|Overall Study|hyperglycemia|2|||
33637072|NCT01871558|63039339|FG000|Overall Study|Other reason|0|||
33637073|NCT01871558|63039340|FG001|Overall Study|Other reason|1|||
33637074|NCT01871558|63039339|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
33637075|NCT01871558|63039340|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
33637076|NCT01871558|63039339|FG000|Overall Study|Withdrawal by Subject|2|||
33637077|NCT01871558|63039340|FG001|Overall Study|Withdrawal by Subject|0|||
33637078|NCT01711359|63039349|FG000|Treatment Period|Withdrawal by Subject|18|||
33637079|NCT01711359|63039350|FG001|Treatment Period|Withdrawal by Subject|7|||
33637080|NCT01711359|63039351|FG002|Treatment Period|Withdrawal by Subject|13|||
33637081|NCT01711359|63039349|FG000|Treatment Period|Lack of Efficacy|13|||
33637082|NCT01711359|63039350|FG001|Treatment Period|Lack of Efficacy|2|||
33637083|NCT01711359|63039351|FG002|Treatment Period|Lack of Efficacy|2|||
33637084|NCT01711359|63039349|FG000|Treatment Period|Adverse Event|8|||
33637085|NCT01711359|63039350|FG001|Treatment Period|Adverse Event|10|||
33637086|NCT01711359|63039351|FG002|Treatment Period|Adverse Event|24|||
33637087|NCT01711359|63039349|FG000|Treatment Period|Physician Decision|4|||
33637088|NCT01711359|63039350|FG001|Treatment Period|Physician Decision|3|||
33637089|NCT01711359|63039351|FG002|Treatment Period|Physician Decision|2|||
33637090|NCT01711359|63039349|FG000|Treatment Period|Death|3|||
33637091|NCT01711359|63039350|FG001|Treatment Period|Death|0|||
33637092|NCT01711359|63039351|FG002|Treatment Period|Death|0|||
33637093|NCT01711359|63039349|FG000|Treatment Period|Entry Criteria Not Met|1|||
33637094|NCT01711359|63039350|FG001|Treatment Period|Entry Criteria Not Met|0|||
33637095|NCT01711359|63039351|FG002|Treatment Period|Entry Criteria Not Met|0|||
33637096|NCT01711359|63039349|FG000|Treatment Period|Sponsor Decision|1|||
33637097|NCT01711359|63039350|FG001|Treatment Period|Sponsor Decision|0|||
33540920|NCT01379508|62931237|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
33540921|NCT01379508|62931234|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
33540922|NCT01379508|62931235|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
33540923|NCT01379508|62931236|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
33637098|NCT01711359|63039351|FG002|Treatment Period|Sponsor Decision|0|||
33637099|NCT01711359|63039349|FG000|Treatment Period|Lost to Follow-up|1|||
33637100|NCT01711359|63039350|FG001|Treatment Period|Lost to Follow-up|1|||
33637101|NCT01711359|63039351|FG002|Treatment Period|Lost to Follow-up|1|||
33637102|NCT01711359|63039349|FG000|Treatment Period|Randomized, Not Treated|3|||
33637103|NCT01711359|63039350|FG001|Treatment Period|Randomized, Not Treated|1|||
33637104|NCT01711359|63039351|FG002|Treatment Period|Randomized, Not Treated|0|||
33637105|NCT01710657|63039378|FG000|Overall Study|Lost to Follow-up|2|||
33637106|NCT01710657|63039379|FG001|Overall Study|Lost to Follow-up|0|||
33540924|NCT01379508|62931237|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
33637107|NCT01710657|63039380|FG002|Overall Study|Lost to Follow-up|1|||
33637108|NCT01710657|63039378|FG000|Overall Study|Protocol Violation|2|||
33637109|NCT01710657|63039379|FG001|Overall Study|Protocol Violation|2|||
33637110|NCT01710657|63039380|FG002|Overall Study|Protocol Violation|0|||
33637111|NCT01710657|63039378|FG000|Overall Study|Adverse Event|14|||
33637112|NCT01710657|63039379|FG001|Overall Study|Adverse Event|8|||
33637113|NCT01710657|63039380|FG002|Overall Study|Adverse Event|28|||
33637114|NCT01710657|63039378|FG000|Overall Study|Withdrawal by Subject|0|||
33637115|NCT01710657|63039379|FG001|Overall Study|Withdrawal by Subject|1|||
33637116|NCT01710657|63039380|FG002|Overall Study|Withdrawal by Subject|2|||
33637117|NCT01710657|63039378|FG000|Overall Study|Lack of Efficacy|0|||
33637118|NCT01710657|63039379|FG001|Overall Study|Lack of Efficacy|1|||
33637119|NCT01710657|63039380|FG002|Overall Study|Lack of Efficacy|1|||
33637120|NCT01701063|63039391|FG000|Overall Study|Lost to Follow-up|0|||
33540925|NCT01379508|62931234|FG000|Treatment to Week 104|Lost to Follow-up|5|||
33540926|NCT01379508|62931235|FG001|Treatment to Week 104|Lost to Follow-up|0|||
33540927|NCT01379508|62931236|FG002|Treatment to Week 104|Lost to Follow-up|3|||
33540928|NCT01379508|62931237|FG003|Treatment to Week 104|Lost to Follow-up|0|||
33540929|NCT01379508|62931234|FG000|Treatment to Week 104|Administrative problems|3|||
33540930|NCT01379508|62931235|FG001|Treatment to Week 104|Administrative problems|1|||
33540931|NCT01379508|62931236|FG002|Treatment to Week 104|Administrative problems|0|||
33540932|NCT01379508|62931237|FG003|Treatment to Week 104|Administrative problems|0|||
33540933|NCT01379508|62931234|FG000|Treatment to Week 104|Protocol Violation|1|||
33540934|NCT01379508|62931235|FG001|Treatment to Week 104|Protocol Violation|1|||
33540935|NCT01379508|62931236|FG002|Treatment to Week 104|Protocol Violation|1|||
33540936|NCT01379508|62931237|FG003|Treatment to Week 104|Protocol Violation|0|||
33540937|NCT01379508|62931234|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
33540938|NCT01379508|62931235|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
33540939|NCT01379508|62931236|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
33637121|NCT01701063|63039392|FG001|Overall Study|Lost to Follow-up|1|||
33637122|NCT01701063|63039393|FG002|Overall Study|Lost to Follow-up|0|||
33637123|NCT01701063|63039391|FG000|Overall Study|Withdrawal by Subject|0|||
33637124|NCT01701063|63039392|FG001|Overall Study|Withdrawal by Subject|0|||
33637125|NCT01701063|63039393|FG002|Overall Study|Withdrawal by Subject|1|||
33637126|NCT01701063|63039391|FG000|Overall Study|Other|0|||
33637127|NCT01701063|63039392|FG001|Overall Study|Other|0|||
33637128|NCT01701063|63039393|FG002|Overall Study|Other|1|||
33637129|NCT01700985|63039404|FG000|Overall Study|Incarcerated|0|||
33637130|NCT01700985|63039405|FG001|Overall Study|Incarcerated|1|||
33637131|NCT01710501|63039414|FG000|Overall Study|Lost to Follow-up|2|||
33637132|NCT01710501|63039415|FG001|Overall Study|Lost to Follow-up|0|||
33637133|NCT01710501|63039416|FG002|Overall Study|Lost to Follow-up|0|||
33637134|NCT01700829|63039426|FG000|Overall Study|Withdrawal by Subject|1|||
33637135|NCT01700829|63039427|FG001|Overall Study|Withdrawal by Subject|1|||
33637136|NCT01710345|63039436|FG000|Overall Study|Adverse Event|0|||
33637137|NCT01710345|63039437|FG001|Overall Study|Adverse Event|2|||
33637138|NCT01710345|63039438|FG002|Overall Study|Adverse Event|0|||
33637139|NCT01710345|63039436|FG000|Overall Study|Lack of Efficacy|2|||
33637140|NCT01710345|63039437|FG001|Overall Study|Lack of Efficacy|3|||
33637141|NCT01710345|63039438|FG002|Overall Study|Lack of Efficacy|1|||
33637142|NCT01710345|63039436|FG000|Overall Study|Drug Dosing Error|1|||
33637143|NCT01710345|63039437|FG001|Overall Study|Drug Dosing Error|0|||
33637144|NCT01710345|63039438|FG002|Overall Study|Drug Dosing Error|0|||
33462395|NCT00050960|62836280|FG000|Overall Study|Stable Disease|19|||
33462396|NCT00050960|62836281|FG001|Overall Study|Stable Disease|48|||
33462397|NCT00050960|62836280|FG000|Overall Study|Partial Response|14|||
33462398|NCT00050960|62836281|FG001|Overall Study|Partial Response|19|||
33462399|NCT00050960|62836280|FG000|Overall Study|Complete Response|0|||
33462400|NCT00050960|62836281|FG001|Overall Study|Complete Response|2|||
33462401|NCT00050960|62836280|FG000|Overall Study|Adverse Event|62|||
33462402|NCT00050960|62836281|FG001|Overall Study|Adverse Event|61|||
33462403|NCT00050960|62836280|FG000|Overall Study|Lost to Follow-up|0|||
33462404|NCT00050960|62836281|FG001|Overall Study|Lost to Follow-up|1|||
33462405|NCT00050960|62836280|FG000|Overall Study|Withdrawal by Subject|23|||
33462406|NCT00050960|62836281|FG001|Overall Study|Withdrawal by Subject|18|||
33462407|NCT00050960|62836280|FG000|Overall Study|Administrative|31|||
33462408|NCT00050960|62836281|FG001|Overall Study|Administrative|46|||
33462409|NCT00050960|62836280|FG000|Overall Study|Non-compliance|3|||
33462410|NCT00050960|62836281|FG001|Overall Study|Non-compliance|1|||
33637145|NCT01710033|63039454|FG000|Stage 2|Adverse Event|0|||
33637146|NCT01710033|63039455|FG001|Stage 2|Adverse Event|0|||
33637147|NCT01710033|63039456|FG002|Stage 2|Adverse Event|0|||
33637148|NCT01710033|63039457|FG003|Stage 2|Adverse Event|0|||
33637149|NCT01710033|63039458|FG004|Stage 2|Adverse Event|1|||
33637150|NCT01822496|63039475|FG000|Overall Study|Protocol Violation|2|||
33462411|NCT00050960|62836280|FG000|Overall Study|Death|13|||
33462412|NCT00050960|62836281|FG001|Overall Study|Death|15|||
33462413|NCT03456856|62836287|FG000|Overall Study|Lost to Follow-up|2|||
33637151|NCT01822496|63039476|FG001|Overall Study|Protocol Violation|2|||
33637152|NCT01822496|63039477|FG002|Overall Study|Protocol Violation|0|||
33637153|NCT01822496|63039478|FG003|Overall Study|Protocol Violation|1|||
33637154|NCT01822496|63039475|FG000|Overall Study|Withdrawal by Subject|0|||
33637155|NCT01822496|63039476|FG001|Overall Study|Withdrawal by Subject|0|||
33637156|NCT01822496|63039477|FG002|Overall Study|Withdrawal by Subject|0|||
33637157|NCT01822496|63039478|FG003|Overall Study|Withdrawal by Subject|3|||
33637158|NCT01867047|63039490|FG000|Overall Study|Lost to Follow-up|3|||
33637159|NCT01867047|63039491|FG001|Overall Study|Lost to Follow-up|3|||
33637160|NCT01867047|63039490|FG000|Overall Study|Withdrawal by Subject|2|||
33637161|NCT01867047|63039491|FG001|Overall Study|Withdrawal by Subject|0|||
33637162|NCT01867047|63039490|FG000|Overall Study|Physician Decision|2|||
33637163|NCT01867047|63039491|FG001|Overall Study|Physician Decision|0|||
33637164|NCT01867047|63039490|FG000|Overall Study|surgery not indicated in protocol|1|||
33637165|NCT01867047|63039491|FG001|Overall Study|surgery not indicated in protocol|2|||
33637166|NCT01821560|63039503|FG000|Overall Study|Lost to Follow-up|5|||
33637167|NCT01821560|63039504|FG001|Overall Study|Lost to Follow-up|5|||
33637168|NCT01821560|63039503|FG000|Overall Study|Withdrawal by Subject|1|||
33637169|NCT01821560|63039504|FG001|Overall Study|Withdrawal by Subject|1|||
33637170|NCT01821560|63039503|FG000|Overall Study|Protocol Violation|0|||
33637171|NCT01821560|63039504|FG001|Overall Study|Protocol Violation|1|||
33637172|NCT01871402|63039512|FG000|Overall Study|Lost to Follow-up|1|||
33637173|NCT01871402|63039513|FG001|Overall Study|Lost to Follow-up|0|||
33637174|NCT01871402|63039512|FG000|Overall Study|Withdrawal by Subject|0|||
33637175|NCT01871402|63039513|FG001|Overall Study|Withdrawal by Subject|2|||
33637176|NCT01871402|63039512|FG000|Overall Study|Non-compliance|0|||
33637177|NCT01871402|63039513|FG001|Overall Study|Non-compliance|1|||
33637178|NCT01846442|63039532|FG000|Overall Study|Adverse Event|2|||
33637179|NCT01846442|63039533|FG001|Overall Study|Adverse Event|4|||
33637180|NCT01846442|63039534|FG002|Overall Study|Adverse Event|2|||
33637181|NCT01846442|63039535|FG003|Overall Study|Adverse Event|1|||
33637182|NCT01846442|63039532|FG000|Overall Study|Lost to Follow-up|0|||
33637183|NCT01846442|63039533|FG001|Overall Study|Lost to Follow-up|0|||
33637184|NCT01846442|63039534|FG002|Overall Study|Lost to Follow-up|1|||
33637185|NCT01846442|63039535|FG003|Overall Study|Lost to Follow-up|0|||
33637186|NCT01846442|63039532|FG000|Overall Study|Withdrawal by Subject|3|||
33637187|NCT01846442|63039533|FG001|Overall Study|Withdrawal by Subject|2|||
33540940|NCT01379508|62931237|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
33540941|NCT01379508|62931234|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
33540942|NCT01379508|62931235|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
33540943|NCT01379508|62931236|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
33540944|NCT01379508|62931237|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
33540945|NCT01379508|62931234|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
33540946|NCT01379508|62931235|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
33540947|NCT01379508|62931236|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
33540948|NCT01379508|62931237|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
33637188|NCT01846442|63039534|FG002|Overall Study|Withdrawal by Subject|0|||
33637189|NCT01846442|63039535|FG003|Overall Study|Withdrawal by Subject|1|||
33637190|NCT01846442|63039532|FG000|Overall Study|Left the city/Lost medication|1|||
33637191|NCT01846442|63039533|FG001|Overall Study|Left the city/Lost medication|0|||
33637192|NCT01846442|63039534|FG002|Overall Study|Left the city/Lost medication|1|||
33637193|NCT01846442|63039535|FG003|Overall Study|Left the city/Lost medication|1|||
33637194|NCT01709721|63039548|FG000|Open Label Phase|Withdrawal by Subject|0|||
33637195|NCT01709721|63039549|FG001|Open Label Phase|Withdrawal by Subject|0|||
33462414|NCT03456856|62836287|FG000|Overall Study|Withdrawal by Subject|1|||
33462415|NCT00058214|62836291|FG000|Overall Study|Adverse Event|1|||
33462416|NCT00097773|62836299|FG000|Overall Study|Lost to Follow-up|2|||
33462417|NCT00097773|62836300|FG001|Overall Study|Lost to Follow-up|2|||
33462418|NCT00097773|62836301|FG002|Overall Study|Lost to Follow-up|0|||
33462419|NCT00097773|62836302|FG003|Overall Study|Lost to Follow-up|1|||
33462420|NCT00097773|62836299|FG000|Overall Study|Physician Decision|2|||
33462421|NCT00097773|62836300|FG001|Overall Study|Physician Decision|2|||
33462422|NCT00097773|62836301|FG002|Overall Study|Physician Decision|3|||
33462423|NCT00097773|62836302|FG003|Overall Study|Physician Decision|1|||
33462424|NCT00097773|62836299|FG000|Overall Study|Withdrawal by Subject|3|||
33462425|NCT00097773|62836300|FG001|Overall Study|Withdrawal by Subject|3|||
33462426|NCT00097773|62836301|FG002|Overall Study|Withdrawal by Subject|3|||
33462427|NCT00097773|62836302|FG003|Overall Study|Withdrawal by Subject|1|||
33462428|NCT00097773|62836299|FG000|Overall Study|Adverse Event|0|||
33462429|NCT00097773|62836300|FG001|Overall Study|Adverse Event|1|||
33462430|NCT00097773|62836301|FG002|Overall Study|Adverse Event|0|||
33462431|NCT00097773|62836302|FG003|Overall Study|Adverse Event|0|||
33462432|NCT00097773|62836299|FG000|Overall Study|Other|1|||
33462433|NCT00097773|62836300|FG001|Overall Study|Other|0|||
33462434|NCT00097773|62836301|FG002|Overall Study|Other|2|||
33637196|NCT01709721|63039550|FG002|Open Label Phase|Withdrawal by Subject|5|||
33637197|NCT01709721|63039548|FG000|Open Label Phase|Adverse Event|0|||
33637198|NCT01709721|63039549|FG001|Open Label Phase|Adverse Event|0|||
33540949|NCT01379508|62931234|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
33462435|NCT00097773|62836302|FG003|Overall Study|Other|0|||
33462436|NCT03480022|62836319|FG000|Overall Study|Pregnancy|2|||
33462437|NCT03480022|62836320|FG001|Overall Study|Pregnancy|0|||
33462438|NCT03480022|62836319|FG000|Overall Study|Adverse Event|6|||
33462439|NCT03480022|62836320|FG001|Overall Study|Adverse Event|0|||
33462440|NCT03480022|62836319|FG000|Overall Study|Lack of Efficacy|0|||
33462441|NCT03480022|62836320|FG001|Overall Study|Lack of Efficacy|2|||
33462442|NCT03480022|62836319|FG000|Overall Study|Physician Decision|0|||
33462443|NCT03480022|62836320|FG001|Overall Study|Physician Decision|1|||
33462444|NCT03480022|62836319|FG000|Overall Study|Withdrawal by Subject|2|||
33462445|NCT03480022|62836320|FG001|Overall Study|Withdrawal by Subject|0|||
33462446|NCT03480022|62836319|FG000|Overall Study|Medication concerns|1|||
33462447|NCT03480022|62836320|FG001|Overall Study|Medication concerns|0|||
33462448|NCT03480022|62836319|FG000|Overall Study|Family member COVID exposure|0|||
33462449|NCT03480022|62836320|FG001|Overall Study|Family member COVID exposure|1|||
33462450|NCT03533608|62836326|FG000|Overall Study|Withdrawal by Subject|3|||
33462451|NCT03533608|62836326|FG000|Overall Study|Physician Decision|2|||
33462452|NCT00049322|62836333|FG000|Overall Study|disease burden|0|||
33462453|NCT00049322|62836334|FG001|Overall Study|disease burden|3|||
33462454|NCT00049322|62836333|FG000|Overall Study|Adverse Event|1|||
33462455|NCT00049322|62836334|FG001|Overall Study|Adverse Event|0|||
33462456|NCT00049322|62836333|FG000|Overall Study|refused angio|0|||
33540950|NCT01379508|62931235|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
33540951|NCT01379508|62931236|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
33540952|NCT01379508|62931237|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
33540953|NCT02722928|62931253|FG000|Overall Study|Standard CT was not as required per prot|5|||
33540954|NCT02722928|62931254|FG001|Overall Study|Standard CT was not as required per prot|13|||
33540955|NCT02722928|62931253|FG000|Overall Study|Required Intraoperative MRI|5|||
33540956|NCT02722928|62931254|FG001|Overall Study|Required Intraoperative MRI|7|||
33540957|NCT02722304|62931269|FG000|Overall Study|Study Terminated by Sponsor|1|||
33540958|NCT02722304|62931270|FG001|Overall Study|Study Terminated by Sponsor|0|||
33540959|NCT02722304|62931271|FG002|Overall Study|Study Terminated by Sponsor|2|||
33540960|NCT02722304|62931272|FG003|Overall Study|Study Terminated by Sponsor|1|||
33540961|NCT02722304|62931273|FG004|Overall Study|Study Terminated by Sponsor|1|||
33540962|NCT02722304|62931269|FG000|Overall Study|Other|0|||
33540963|NCT02722304|62931270|FG001|Overall Study|Other|0|||
33540964|NCT02722304|62931271|FG002|Overall Study|Other|0|||
33540965|NCT02722304|62931272|FG003|Overall Study|Other|1|||
33540966|NCT02722304|62931273|FG004|Overall Study|Other|1|||
33540967|NCT00709956|62931289|FG000|Overall Study|Withdrawal by Subject|1|||
33540968|NCT00709956|62931290|FG001|Overall Study|Withdrawal by Subject|1|||
33540969|NCT00709956|62931289|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
33540970|NCT00709956|62931290|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
33540971|NCT02719028|62931320|FG000|Overall Study|Adverse Event|2|||
33540972|NCT02719028|62931321|FG001|Overall Study|Adverse Event|1|||
33540973|NCT02719028|62931322|FG002|Overall Study|Adverse Event|4|||
33540974|NCT02719028|62931323|FG003|Overall Study|Adverse Event|8|||
33540975|NCT02719028|62931320|FG000|Overall Study|Physician Decision|0|||
33637199|NCT01709721|63039550|FG002|Open Label Phase|Adverse Event|8|||
33637200|NCT01709721|63039548|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
33637201|NCT01709721|63039549|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
33637202|NCT01709721|63039550|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
33637203|NCT01709721|63039548|FG000|Open Label Phase|Investigator Decision|0|||
33637204|NCT01709721|63039549|FG001|Open Label Phase|Investigator Decision|0|||
33637205|NCT01709721|63039550|FG002|Open Label Phase|Investigator Decision|1|||
33637206|NCT01709721|63039548|FG000|Open Label Phase|Sponsor Decision|0|||
33540976|NCT02719028|62931321|FG001|Overall Study|Physician Decision|1|||
33540977|NCT02719028|62931322|FG002|Overall Study|Physician Decision|1|||
33540978|NCT02719028|62931323|FG003|Overall Study|Physician Decision|1|||
33540979|NCT02719028|62931320|FG000|Overall Study|Use of prohibited medication|0|||
33540980|NCT02719028|62931321|FG001|Overall Study|Use of prohibited medication|0|||
33540981|NCT02719028|62931322|FG002|Overall Study|Use of prohibited medication|1|||
33540982|NCT02719028|62931323|FG003|Overall Study|Use of prohibited medication|0|||
33637207|NCT01709721|63039549|FG001|Open Label Phase|Sponsor Decision|0|||
33637208|NCT01709721|63039550|FG002|Open Label Phase|Sponsor Decision|2|||
33462457|NCT00049322|62836334|FG001|Overall Study|refused angio|3|||
33462458|NCT03437512|62836344|FG000|Randomized|Withdrawal by Subject|0|||
33462459|NCT03437512|62836345|FG001|Randomized|Withdrawal by Subject|2|||
33462460|NCT03437512|62836344|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
33462461|NCT03437512|62836345|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
33462462|NCT00058058|62836351|FG000|Overall Study|Withdrawal by Subject|4|||
33462463|NCT00058058|62836351|FG000|Overall Study|Ineligible|20|||
33540983|NCT02719028|62931320|FG000|Overall Study|Protocol Violation|0|||
33540984|NCT02719028|62931321|FG001|Overall Study|Protocol Violation|0|||
33540985|NCT02719028|62931322|FG002|Overall Study|Protocol Violation|0|||
33637209|NCT01709721|63039548|FG000|Open Label Phase|Protocol Violation|0|||
33462464|NCT00058058|62836351|FG000|Overall Study|Claustrophobic|5|||
33540986|NCT02719028|62931323|FG003|Overall Study|Protocol Violation|1|||
33540987|NCT02720510|62931335|FG000|Overall Study|Study Terminated by the sponsor|2|||
33540988|NCT02720510|62931336|FG001|Overall Study|Study Terminated by the sponsor|0|||
33540989|NCT02720510|62931335|FG000|Overall Study|Adverse Event|0|||
33540990|NCT02720510|62931336|FG001|Overall Study|Adverse Event|1|||
33540991|NCT02720510|62931335|FG000|Overall Study|Physician Decision|1|||
33540992|NCT02720510|62931336|FG001|Overall Study|Physician Decision|2|||
33540993|NCT02720198|62931344|FG000|Overall Study|Withdrawal by Subject|0|||
33540994|NCT02720198|62931345|FG001|Overall Study|Withdrawal by Subject|1|||
33540995|NCT00703118|62931367|FG000|Overall Study|Adverse Event|1|||
33540996|NCT00703118|62931368|FG001|Overall Study|Adverse Event|2|||
33540997|NCT00703118|62931369|FG002|Overall Study|Adverse Event|2|||
33540998|NCT00703118|62931367|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
33540999|NCT00703118|62931368|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
33637210|NCT01709721|63039549|FG001|Open Label Phase|Protocol Violation|0|||
33637211|NCT01709721|63039550|FG002|Open Label Phase|Protocol Violation|1|||
33637212|NCT01709721|63039548|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
33637213|NCT01709721|63039549|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
33637214|NCT01709721|63039550|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
33637215|NCT01709721|63039548|FG000|Open Label Phase|Inadequate Pain Control|0|||
33637216|NCT01709721|63039549|FG001|Open Label Phase|Inadequate Pain Control|0|||
33637217|NCT01709721|63039550|FG002|Open Label Phase|Inadequate Pain Control|37|||
33637218|NCT01709721|63039548|FG000|Open Label Phase|Other, Specify in text field in database|0|||
33637219|NCT01709721|63039549|FG001|Open Label Phase|Other, Specify in text field in database|0|||
33637220|NCT01709721|63039550|FG002|Open Label Phase|Other, Specify in text field in database|14|||
33637221|NCT01709721|63039548|FG000|Randomized Phase|Adverse Event|0|||
33637222|NCT01709721|63039549|FG001|Randomized Phase|Adverse Event|1|||
33637223|NCT01709721|63039550|FG002|Randomized Phase|Adverse Event|0|||
33637224|NCT01709721|63039548|FG000|Randomized Phase|Lost to Follow-up|1|||
33637225|NCT01709721|63039549|FG001|Randomized Phase|Lost to Follow-up|0|||
33637226|NCT01709721|63039550|FG002|Randomized Phase|Lost to Follow-up|0|||
33637227|NCT01709721|63039548|FG000|Randomized Phase|Inadequate Pain Control|1|||
33462465|NCT00058058|62836351|FG000|Overall Study|technical issues|6|||
33462466|NCT00058058|62836351|FG000|Overall Study|Poor positioning, illness,pain|3|||
33462467|NCT03532048|62836358|FG000|Overall Study|Lost to Follow-up|12|||
33462468|NCT03532048|62836359|FG001|Overall Study|Lost to Follow-up|17|||
33462469|NCT03532048|62836358|FG000|Overall Study|Withdrawal by Subject|7|||
33462470|NCT03532048|62836359|FG001|Overall Study|Withdrawal by Subject|0|||
33462471|NCT00008138|62836365|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
33462472|NCT00008138|62836365|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
33462473|NCT00008138|62836365|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
33462474|NCT00008138|62836365|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
33462475|NCT00008138|62836365|FG000|Interval Debulking|Withdrawal by Subject|2|||
33462476|NCT00008138|62836365|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
33462477|NCT00008138|62836365|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
33462478|NCT00008138|62836365|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
33462479|NCT03436732|62836372|FG000|Overall Study|Not treated-enrolled in different study|1|||
33462480|NCT03436732|62836373|FG001|Overall Study|Not treated-enrolled in different study|0|||
33462481|NCT03436732|62836372|FG000|Overall Study|Off study after cycle 1|1|||
33462482|NCT03436732|62836373|FG001|Overall Study|Off study after cycle 1|0|||
33462483|NCT03436732|62836372|FG000|Overall Study|Adverse Event|2|||
33462484|NCT03436732|62836373|FG001|Overall Study|Adverse Event|0|||
33462485|NCT03436732|62836372|FG000|Overall Study|Death|0|||
33462486|NCT03436732|62836373|FG001|Overall Study|Death|1|||
33462487|NCT03436420|62836380|FG000|Overall Study|Lack of Efficacy|3|||
33462488|NCT00027560|62836384|FG000|Overall Study|Withdrawal by Subject|1|||
33462489|NCT03451084|62836394|FG000|Overall Study|Withdrawal by Subject|2|||
33541000|NCT00703118|62931369|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
33637228|NCT01709721|63039549|FG001|Randomized Phase|Inadequate Pain Control|2|||
33637229|NCT01709721|63039550|FG002|Randomized Phase|Inadequate Pain Control|0|||
33637230|NCT01709721|63039548|FG000|Randomized Phase|Other, Specify text field in database|1|||
33637231|NCT01709721|63039549|FG001|Randomized Phase|Other, Specify text field in database|3|||
33637232|NCT01709721|63039550|FG002|Randomized Phase|Other, Specify text field in database|0|||
33637233|NCT01866657|63039560|FG000|Overall Study|Surgery canceled|2|||
33637234|NCT01866657|63039561|FG001|Overall Study|Surgery canceled|0|||
33637235|NCT01700205|63039569|FG000|Overall Study|Withdrawal by Subject|13|||
33637236|NCT01700205|63039570|FG001|Overall Study|Withdrawal by Subject|13|||
33637237|NCT01700205|63039569|FG000|Overall Study|Protocol Violation|2|||
33637238|NCT01700205|63039570|FG001|Overall Study|Protocol Violation|2|||
33637239|NCT01700049|63039576|FG000|Overall Study|Withdrawal by Subject|1|||
33637240|NCT01699815|63039583|FG000|Overall Study|Protocol Violation|4|||
33637241|NCT01699815|63039584|FG001|Overall Study|Protocol Violation|7|||
33637242|NCT01699815|63039583|FG000|Overall Study|record could not be located|1|||
33637243|NCT01699815|63039584|FG001|Overall Study|record could not be located|0|||
33637244|NCT01699815|63039583|FG000|Overall Study|Adverse Event|0|||
33637245|NCT01699815|63039584|FG001|Overall Study|Adverse Event|1|||
33637246|NCT01866423|63039590|FG000|Overall Study|Lack of Efficacy|3|||
33637247|NCT01866423|63039590|FG000|Overall Study|Sponsor Decision|1|||
33637248|NCT01846208|63039597|FG000|Overall Study|Withdrew prior to treatment|1|||
33637249|NCT01846208|63039598|FG001|Overall Study|Withdrew prior to treatment|1|||
33637250|NCT01846208|63039599|FG002|Overall Study|Withdrew prior to treatment|1|||
33637251|NCT01846208|63039597|FG000|Overall Study|Dosing Symptoms|1|||
33637252|NCT01846208|63039598|FG001|Overall Study|Dosing Symptoms|2|||
33462490|NCT03451084|62836395|FG001|Overall Study|Withdrawal by Subject|1|||
33462491|NCT03451084|62836396|FG002|Overall Study|Withdrawal by Subject|2|||
33462492|NCT03451084|62836397|FG003|Overall Study|Withdrawal by Subject|1|||
33462493|NCT03451084|62836394|FG000|Overall Study|Disease recurrence|0|||
33541001|NCT00703118|62931367|FG000|Overall Study|Lost to Follow-up|6|||
33637253|NCT01846208|63039599|FG002|Overall Study|Dosing Symptoms|6|||
33637254|NCT01846208|63039597|FG000|Overall Study|Withdrawal by Subject|5|||
33637255|NCT01846208|63039598|FG001|Overall Study|Withdrawal by Subject|0|||
33637256|NCT01846208|63039599|FG002|Overall Study|Withdrawal by Subject|0|||
33637257|NCT01846208|63039597|FG000|Overall Study|Non-compliance|1|||
33637258|NCT01846208|63039598|FG001|Overall Study|Non-compliance|1|||
33637259|NCT01846208|63039599|FG002|Overall Study|Non-compliance|0|||
33462494|NCT03451084|62836395|FG001|Overall Study|Disease recurrence|2|||
33462495|NCT03451084|62836396|FG002|Overall Study|Disease recurrence|0|||
33541002|NCT00703118|62931368|FG001|Overall Study|Lost to Follow-up|4|||
33541003|NCT00703118|62931369|FG002|Overall Study|Lost to Follow-up|4|||
33541004|NCT00703118|62931367|FG000|Overall Study|Withdrawal by Subject|8|||
33462496|NCT03451084|62836397|FG003|Overall Study|Disease recurrence|0|||
33462497|NCT03451084|62836394|FG000|Overall Study|Lack of Efficacy|0|||
33541005|NCT00703118|62931368|FG001|Overall Study|Withdrawal by Subject|7|||
33541006|NCT00703118|62931369|FG002|Overall Study|Withdrawal by Subject|13|||
33541007|NCT00703118|62931367|FG000|Overall Study|Other|0|||
33541008|NCT00703118|62931368|FG001|Overall Study|Other|0|||
33541009|NCT00703118|62931369|FG002|Overall Study|Other|1|||
33541010|NCT00909753|62931391|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
33541011|NCT00909753|62931392|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
33541012|NCT00909753|62931391|FG000|Period: Second Intervention|Protocol Violation|1|||
33541013|NCT00909753|62931392|FG001|Period: Second Intervention|Protocol Violation|0|||
33541014|NCT03715764|62931398|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
33541015|NCT03715764|62931399|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
33637260|NCT01846208|63039597|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
33462498|NCT03451084|62836395|FG001|Overall Study|Lack of Efficacy|3|||
33462499|NCT03451084|62836396|FG002|Overall Study|Lack of Efficacy|0|||
33541016|NCT03715764|62931398|FG000|3 Month Follow-up|Lost to Follow-up|2|||
33541017|NCT03715764|62931399|FG001|3 Month Follow-up|Lost to Follow-up|2|||
33462500|NCT03451084|62836397|FG003|Overall Study|Lack of Efficacy|1|||
33462501|NCT03451084|62836394|FG000|Overall Study|Death|1|||
33541018|NCT03715764|62931398|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
33541019|NCT03715764|62931399|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
33541020|NCT03715764|62931398|FG000|6 Month Follow-up|Lost to Follow-up|3|||
33637261|NCT01846208|63039598|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
33462502|NCT03451084|62836395|FG001|Overall Study|Death|0|||
33462503|NCT03451084|62836396|FG002|Overall Study|Death|2|||
33541021|NCT03715764|62931399|FG001|6 Month Follow-up|Lost to Follow-up|0|||
33541022|NCT03715764|62931398|FG000|12 Month Follow-up|Lost to Follow-up|2|||
33541023|NCT03715764|62931399|FG001|12 Month Follow-up|Lost to Follow-up|3|||
33541024|NCT03715764|62931398|FG000|12 Month Follow-up|Pregnancy|0|||
33541025|NCT03715764|62931399|FG001|12 Month Follow-up|Pregnancy|1|||
33541026|NCT03715764|62931398|FG000|12 Month Follow-up|Surgery|2|||
33541027|NCT03715764|62931399|FG001|12 Month Follow-up|Surgery|0|||
33637262|NCT01846208|63039599|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
33637263|NCT01846208|63039597|FG000|Overall Study|Refused SU OFC|0|||
33637264|NCT01846208|63039598|FG001|Overall Study|Refused SU OFC|0|||
33637265|NCT01846208|63039599|FG002|Overall Study|Refused SU OFC|1|||
33541028|NCT03715764|62931398|FG000|12 Month Follow-up|Wrong address|1|||
33541029|NCT03715764|62931399|FG001|12 Month Follow-up|Wrong address|0|||
33541030|NCT03715764|62931398|FG000|12 Month Follow-up|No symptoms|1|||
33541031|NCT03715764|62931399|FG001|12 Month Follow-up|No symptoms|0|||
33541032|NCT03715764|62931398|FG000|12 Month Follow-up|Changed primary care centre|0|||
33541033|NCT03715764|62931399|FG001|12 Month Follow-up|Changed primary care centre|1|||
33541034|NCT02718326|62931408|FG000|Overall Study|Adverse Event|4|||
33541035|NCT02718326|62931409|FG001|Overall Study|Adverse Event|9|||
33541036|NCT02718326|62931410|FG002|Overall Study|Adverse Event|0|||
33541037|NCT02718326|62931408|FG000|Overall Study|Death|8|||
33541038|NCT02718326|62931409|FG001|Overall Study|Death|1|||
33541039|NCT02718326|62931410|FG002|Overall Study|Death|2|||
33541040|NCT02718326|62931408|FG000|Overall Study|Withdrawal by Subject|4|||
33541041|NCT02718326|62931409|FG001|Overall Study|Withdrawal by Subject|9|||
33541042|NCT02718326|62931410|FG002|Overall Study|Withdrawal by Subject|6|||
33541043|NCT02718326|62931408|FG000|Overall Study|Lost to Follow-up|18|||
33541044|NCT02718326|62931409|FG001|Overall Study|Lost to Follow-up|5|||
33541045|NCT02718326|62931410|FG002|Overall Study|Lost to Follow-up|14|||
33541046|NCT02718326|62931408|FG000|Overall Study|Protocol Deviation|1|||
33541047|NCT02718326|62931409|FG001|Overall Study|Protocol Deviation|0|||
33541048|NCT02718326|62931410|FG002|Overall Study|Protocol Deviation|0|||
33541049|NCT02718326|62931408|FG000|Overall Study|Pregnancy|1|||
33541050|NCT02718326|62931409|FG001|Overall Study|Pregnancy|0|||
33541051|NCT02718326|62931410|FG002|Overall Study|Pregnancy|0|||
33541052|NCT03600714|62931420|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
33541053|NCT02720042|62931459|FG000|Overall Study|Death|3|||
33541054|NCT02720042|62931459|FG000|Overall Study|Lost to Follow-up|4|||
33541055|NCT02720042|62931459|FG000|Overall Study|Withdrawal by Subject|1|||
33541056|NCT02720042|62931459|FG000|Overall Study|Physician Decision|3|||
33541057|NCT02720042|62931459|FG000|Overall Study|Phasix Mesh explanted|1|||
33541058|NCT02720042|62931459|FG000|Overall Study|unable due to non-study-related illness|3|||
33541059|NCT01352793|62931465|FG000|Overall Study|Lost to Follow-up|289|||
33541060|NCT01352793|62931466|FG001|Overall Study|Lost to Follow-up|125|||
33541061|NCT01352793|62931465|FG000|Overall Study|Withdrawal by Subject|120|||
33541062|NCT01352793|62931466|FG001|Overall Study|Withdrawal by Subject|55|||
33637266|NCT01845974|63039609|FG000|Overall Study|screen failure|1|||
33637267|NCT01845974|63039610|FG001|Overall Study|screen failure|0|||
33637268|NCT01865487|63039622|FG000|Overall Study|Lost to Follow-up|0|||
33637269|NCT01865487|63039623|FG001|Overall Study|Lost to Follow-up|0|||
33637270|NCT01865487|63039624|FG002|Overall Study|Lost to Follow-up|0|||
33637271|NCT01865487|63039625|FG003|Overall Study|Lost to Follow-up|1|||
33637272|NCT01865487|63039626|FG004|Overall Study|Lost to Follow-up|0|||
33637273|NCT01865487|63039627|FG005|Overall Study|Lost to Follow-up|0|||
33637274|NCT01865487|63039628|FG006|Overall Study|Lost to Follow-up|1|||
33637275|NCT01865487|63039629|FG007|Overall Study|Lost to Follow-up|0|||
33637276|NCT01865487|63039630|FG008|Overall Study|Lost to Follow-up|0|||
33637277|NCT01865487|63039631|FG009|Overall Study|Lost to Follow-up|0|||
33637278|NCT01865487|63039622|FG000|Overall Study|Withdrawal by Subject|0|||
33637279|NCT01865487|63039623|FG001|Overall Study|Withdrawal by Subject|0|||
33637280|NCT01865487|63039624|FG002|Overall Study|Withdrawal by Subject|0|||
33637281|NCT01865487|63039625|FG003|Overall Study|Withdrawal by Subject|0|||
33637282|NCT01865487|63039626|FG004|Overall Study|Withdrawal by Subject|1|||
33637283|NCT01865487|63039627|FG005|Overall Study|Withdrawal by Subject|0|||
33637284|NCT01865487|63039628|FG006|Overall Study|Withdrawal by Subject|0|||
33637285|NCT01865487|63039629|FG007|Overall Study|Withdrawal by Subject|0|||
33637286|NCT01865487|63039630|FG008|Overall Study|Withdrawal by Subject|0|||
33637287|NCT01865487|63039631|FG009|Overall Study|Withdrawal by Subject|0|||
33326522|NCT00887224|62703225|FG001|Double-blind (DB) Phase|Failed to return|2|||
33541063|NCT01352793|62931465|FG000|Overall Study|Protocol Violation|44|||
33541064|NCT01352793|62931466|FG001|Overall Study|Protocol Violation|23|||
33541065|NCT01352793|62931465|FG000|Overall Study|Adverse Event|44|||
33541066|NCT01352793|62931466|FG001|Overall Study|Adverse Event|10|||
33541067|NCT01352793|62931465|FG000|Overall Study|Physician Decision|1|||
33541068|NCT01352793|62931466|FG001|Overall Study|Physician Decision|0|||
33541069|NCT01352793|62931465|FG000|Overall Study|Pregnancy|26|||
33541070|NCT01352793|62931466|FG001|Overall Study|Pregnancy|8|||
33541071|NCT01352793|62931465|FG000|Overall Study|Other|25|||
33541072|NCT01352793|62931466|FG001|Overall Study|Other|7|||
33541073|NCT01352793|62931465|FG000|Overall Study|Medication error|2|||
33541074|NCT01352793|62931466|FG001|Overall Study|Medication error|2|||
33462504|NCT03451084|62836397|FG003|Overall Study|Death|0|||
33462505|NCT03451084|62836394|FG000|Overall Study|Physician Decision|0|||
33462506|NCT03451084|62836395|FG001|Overall Study|Physician Decision|0|||
33541075|NCT01352793|62931465|FG000|Overall Study|Death|1|||
33541076|NCT01352793|62931466|FG001|Overall Study|Death|0|||
33541077|NCT01352793|62931465|FG000|Overall Study|Randomized but not vaccinated|8|||
33541078|NCT01352793|62931466|FG001|Overall Study|Randomized but not vaccinated|0|||
33541079|NCT01352793|62931465|FG000|Overall Study|No longer meets eligibility criteria|25|||
33541080|NCT01352793|62931466|FG001|Overall Study|No longer meets eligibility criteria|15|||
33541081|NCT02717546|62931472|FG000|Overall Study|Lost to Follow-up|12|||
33541082|NCT01378962|62931476|FG000|Overall Study|Death|14|||
33541083|NCT01378962|62931476|FG000|Overall Study|Lost to Follow-up|1|||
33541084|NCT01378962|62931476|FG000|Overall Study|Other|2|||
33541085|NCT00890409|62931482|FG000|Overall Study|Lost to Follow-up|20|||
33541086|NCT00890409|62931483|FG001|Overall Study|Lost to Follow-up|21|||
33541087|NCT04495478|62931494|FG000|Overall Study|Withdrawal by Subject|0|||
33541088|NCT04495478|62931495|FG001|Overall Study|Withdrawal by Subject|0|||
33541089|NCT04495478|62931496|FG002|Overall Study|Withdrawal by Subject|0|||
33541090|NCT04495478|62931497|FG003|Overall Study|Withdrawal by Subject|1|||
33541091|NCT04495478|62931498|FG004|Overall Study|Withdrawal by Subject|0|||
33541092|NCT04495478|62931499|FG005|Overall Study|Withdrawal by Subject|0|||
33541093|NCT04495478|62931500|FG006|Overall Study|Withdrawal by Subject|0|||
33541094|NCT04495478|62931494|FG000|Overall Study|Physician Decision|0|||
33541095|NCT04495478|62931495|FG001|Overall Study|Physician Decision|1|||
33541096|NCT04495478|62931496|FG002|Overall Study|Physician Decision|0|||
33541097|NCT04495478|62931497|FG003|Overall Study|Physician Decision|0|||
33541098|NCT04495478|62931498|FG004|Overall Study|Physician Decision|1|||
33541099|NCT04495478|62931499|FG005|Overall Study|Physician Decision|0|||
33541100|NCT04495478|62931500|FG006|Overall Study|Physician Decision|0|||
33462507|NCT03451084|62836396|FG002|Overall Study|Physician Decision|2|||
33462508|NCT03451084|62836397|FG003|Overall Study|Physician Decision|2|||
33462509|NCT03451084|62836394|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
33462510|NCT03451084|62836395|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
33462511|NCT03451084|62836396|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
33462512|NCT03451084|62836397|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
33462513|NCT03451006|62836409|FG000|Overall Study|Withdrawal by Subject|2|||
33462514|NCT03451006|62836410|FG001|Overall Study|Withdrawal by Subject|2|||
33462515|NCT03450070|62836416|FG000|Overall Study|Withdrawal by Subject|8|||
33462516|NCT03449758|62836420|FG000|Overall Study|Major protocol deviation|1|||
33462517|NCT03449758|62836420|FG000|Overall Study|Treatment inefficacy|5|||
33462518|NCT03449758|62836420|FG000|Overall Study|Adverse Event|9|||
33462519|NCT03449758|62836420|FG000|Overall Study|Consent withdrawal|1|||
33462520|NCT03449758|62836420|FG000|Overall Study|Other unspecified reason|3|||
33541101|NCT00152763|62931526|FG000|Overall Study|Death|4|||
33541102|NCT00152763|62931527|FG001|Overall Study|Death|1|||
33541103|NCT00152763|62931528|FG002|Overall Study|Death|2|||
33541104|NCT00152763|62931529|FG003|Overall Study|Death|1|||
33541105|NCT00152763|62931526|FG000|Overall Study|Lost to Follow-up|6|||
33541106|NCT00152763|62931527|FG001|Overall Study|Lost to Follow-up|4|||
33541107|NCT00152763|62931528|FG002|Overall Study|Lost to Follow-up|2|||
33541108|NCT00152763|62931529|FG003|Overall Study|Lost to Follow-up|13|||
33541109|NCT03181542|62931543|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
33541110|NCT03181542|62931544|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
33541111|NCT00806403|62931552|FG000|Overall Study|Death|4|||
33541112|NCT00806403|62931553|FG001|Overall Study|Death|3|||
33541113|NCT00701558|62931570|FG000|Overall Study|Death|7|||
33541114|NCT00701558|62931570|FG000|Overall Study|Lost to Follow-up|8|||
33541115|NCT01663402|62931593|FG000|Overall Study|Randomized but not treated|19|||
33541116|NCT01663402|62931594|FG001|Overall Study|Randomized but not treated|11|||
33541117|NCT01663402|62931593|FG000|Overall Study|Adverse Event|347|||
33541118|NCT01663402|62931594|FG001|Overall Study|Adverse Event|362|||
33541119|NCT01663402|62931593|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
33541120|NCT01663402|62931594|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
33541121|NCT01663402|62931593|FG000|Overall Study|Poor compliance to protocol|529|||
33541122|NCT01663402|62931594|FG001|Overall Study|Poor compliance to protocol|454|||
33541123|NCT01663402|62931593|FG000|Overall Study|Physician Decision|77|||
33541124|NCT01663402|62931594|FG001|Overall Study|Physician Decision|62|||
33462521|NCT03449446|62836432|FG000|Overall Study|Randomized but Never Treated|0|||
33462522|NCT03449446|62836433|FG001|Overall Study|Randomized but Never Treated|0|||
33462523|NCT03449446|62836434|FG002|Overall Study|Randomized but Never Treated|1|||
33462524|NCT03449446|62836435|FG003|Overall Study|Randomized but Never Treated|1|||
33462525|NCT03449446|62836436|FG004|Overall Study|Randomized but Never Treated|1|||
33541125|NCT01663402|62931593|FG000|Overall Study|Site terminated by sponsor|1|||
33541126|NCT01663402|62931594|FG001|Overall Study|Site terminated by sponsor|3|||
33541127|NCT01663402|62931593|FG000|Overall Study|Participant moved|139|||
33541128|NCT01663402|62931594|FG001|Overall Study|Participant moved|104|||
33541129|NCT01663402|62931593|FG000|Overall Study|Withdrawal by Subject|118|||
33541130|NCT01663402|62931594|FG001|Overall Study|Withdrawal by Subject|91|||
33637288|NCT01699503|63039661|FG000|Overall Study|Death|31|||
33637289|NCT01699503|63039662|FG001|Overall Study|Death|40|||
33637290|NCT01699503|63039661|FG000|Overall Study|Withdrawal by Subject|65|||
33637291|NCT01699503|63039662|FG001|Overall Study|Withdrawal by Subject|57|||
33637292|NCT01699503|63039661|FG000|Overall Study|Lost to Follow-up|121|||
33637293|NCT01699503|63039662|FG001|Overall Study|Lost to Follow-up|117|||
33637294|NCT01699503|63039661|FG000|Overall Study|Excluded due to quality|783|||
33637295|NCT01699503|63039662|FG001|Overall Study|Excluded due to quality|791|||
33637296|NCT01709409|63039670|FG000|Overall Study|Protocol Violation|1|||
33637297|NCT01709409|63039671|FG001|Overall Study|Protocol Violation|0|||
33637298|NCT01698879|63039680|FG000|Overall Study|Withdrawal by Subject|1|||
33637299|NCT01698879|63039681|FG001|Overall Study|Withdrawal by Subject|0|||
33637300|NCT01698879|63039682|FG002|Overall Study|Withdrawal by Subject|0|||
33637301|NCT01698801|63039721|FG000|Treatment Phase|Adverse Event|4|||
33637302|NCT01698801|63039721|FG000|Treatment Phase|Protocol Violation|1|||
33637303|NCT01698801|63039721|FG000|Treatment Phase|Other|4|||
33637304|NCT01698801|63039721|FG000|Treatment Phase|Withdrawal by Subject|1|||
33637305|NCT01698801|63039721|FG000|Treatment Phase|Disease progression|1|||
33637306|NCT01698801|63039721|FG000|Follow Up Phase|Withdrawal by Subject|1|||
33637307|NCT01698801|63039721|FG000|Follow Up Phase|Death|4|||
33637308|NCT01682811|63039733|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
33637309|NCT01682811|63039734|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
33637310|NCT01682811|63039735|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
33637311|NCT01682811|63039736|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
33637312|NCT01682811|63039737|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
33637313|NCT01682811|63039738|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
33637314|NCT01682811|63039739|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
33637315|NCT01682811|63039733|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
33637316|NCT01682811|63039734|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
33637317|NCT01682811|63039735|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
33541131|NCT01663402|62931593|FG000|Overall Study|Related to study drug administration|96|||
33541132|NCT01663402|62931594|FG001|Overall Study|Related to study drug administration|105|||
33541133|NCT01663402|62931593|FG000|Overall Study|Lost to Follow-up|17|||
33541134|NCT01663402|62931594|FG001|Overall Study|Lost to Follow-up|15|||
33541135|NCT01663402|62931593|FG000|Overall Study|Other than specified above|172|||
33541136|NCT01663402|62931594|FG001|Overall Study|Other than specified above|147|||
33541137|NCT00859521|62931611|FG000|Washout|Withdrawal by Subject|0|||
33541138|NCT00859521|62931612|FG001|Washout|Withdrawal by Subject|1|||
33541139|NCT00841815|62931627|FG000|Washout|Withdrawal by Subject|0|||
33541140|NCT00841815|62931628|FG001|Washout|Withdrawal by Subject|1|||
33541141|NCT00841659|62931635|FG000|Washout: 2 Weeks|Protocol Violation|1|||
33541142|NCT00841659|62931636|FG001|Washout: 2 Weeks|Protocol Violation|0|||
33541143|NCT02716298|62931640|FG000|First Intervention (1 Month)|Lens discomfort|1|||
33541144|NCT02716298|62931641|FG001|First Intervention (1 Month)|Lens discomfort|1|||
33541145|NCT00840879|62931654|FG000|Second Intervention|Withdrawal by Subject|1|||
33541146|NCT00840879|62931655|FG001|Second Intervention|Withdrawal by Subject|0|||
33541147|NCT00840411|62931670|FG000|First Intervention|Adverse Event|1|||
33541148|NCT00840411|62931671|FG001|First Intervention|Adverse Event|0|||
33637318|NCT01682811|63039736|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
33637319|NCT01682811|63039737|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
33637320|NCT01682811|63039738|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
33637321|NCT01682811|63039739|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
33637322|NCT01682811|63039733|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
33637323|NCT01682811|63039734|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
33637324|NCT01682811|63039735|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
33637325|NCT01682811|63039736|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
33637326|NCT01682811|63039737|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
33637327|NCT01682811|63039738|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
33637328|NCT01682811|63039739|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
33637329|NCT01682811|63039733|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
33637330|NCT01682811|63039734|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
33637331|NCT01682811|63039735|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
33637332|NCT01682811|63039736|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
33637333|NCT01682811|63039737|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
33637334|NCT01682811|63039738|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
33541149|NCT00840411|62931670|FG000|Washout|Withdrawal by Subject|1|||
33541150|NCT00840411|62931671|FG001|Washout|Withdrawal by Subject|0|||
33541151|NCT00836901|62931684|FG000|First Intervention|Withdrawal by Subject|1|||
33541152|NCT00836901|62931685|FG001|First Intervention|Withdrawal by Subject|0|||
33637335|NCT01682811|63039739|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
33541153|NCT04466384|62931689|FG000|First Phase|Protocol Violation|1|||
33637336|NCT01682031|63039760|FG000|Overall Study|Withdrawal by Subject|0|||
33637337|NCT01682031|63039761|FG001|Overall Study|Withdrawal by Subject|1|||
33637338|NCT01682031|63039760|FG000|Overall Study|Adverse Event|0|||
33637339|NCT01682031|63039761|FG001|Overall Study|Adverse Event|2|||
33637340|NCT01682031|63039760|FG000|Overall Study|MRI results indicate increased nodul|0|||
33637341|NCT01682031|63039761|FG001|Overall Study|MRI results indicate increased nodul|1|||
33637342|NCT01682031|63039760|FG000|Overall Study|Patient could not swallow tablets|1|||
33637343|NCT01682031|63039761|FG001|Overall Study|Patient could not swallow tablets|0|||
33637344|NCT01682031|63039760|FG000|Overall Study|Patient stopped selenium on his own|0|||
33637345|NCT01682031|63039761|FG001|Overall Study|Patient stopped selenium on his own|1|||
33637346|NCT01567527|63039782|FG000|Conversion Phase.|Protocol deviation|3|||
33637347|NCT01567527|63039783|FG001|Conversion Phase.|Protocol deviation|0|||
33637348|NCT01567527|63039784|FG002|Conversion Phase.|Protocol deviation|0|||
33637349|NCT01567527|63039785|FG003|Conversion Phase.|Protocol deviation|0|||
33637350|NCT01567527|63039786|FG004|Conversion Phase.|Protocol deviation|0|||
33637351|NCT01567527|63039782|FG000|Conversion Phase.|Met withdrawal criteria|10|||
33637352|NCT01567527|63039783|FG001|Conversion Phase.|Met withdrawal criteria|0|||
33637353|NCT01567527|63039784|FG002|Conversion Phase.|Met withdrawal criteria|0|||
33637354|NCT01567527|63039785|FG003|Conversion Phase.|Met withdrawal criteria|0|||
33637355|NCT01567527|63039786|FG004|Conversion Phase.|Met withdrawal criteria|0|||
33637356|NCT01567527|63039782|FG000|Conversion Phase.|Withdrawal by Subject|32|||
33637357|NCT01567527|63039783|FG001|Conversion Phase.|Withdrawal by Subject|0|||
33637358|NCT01567527|63039784|FG002|Conversion Phase.|Withdrawal by Subject|0|||
33637359|NCT01567527|63039785|FG003|Conversion Phase.|Withdrawal by Subject|0|||
33637360|NCT01567527|63039786|FG004|Conversion Phase.|Withdrawal by Subject|0|||
33637361|NCT01567527|63039782|FG000|Conversion Phase.|Lost to Follow-up|16|||
33637362|NCT01567527|63039783|FG001|Conversion Phase.|Lost to Follow-up|0|||
33637363|NCT01567527|63039784|FG002|Conversion Phase.|Lost to Follow-up|0|||
33637364|NCT01567527|63039785|FG003|Conversion Phase.|Lost to Follow-up|0|||
33637365|NCT01567527|63039786|FG004|Conversion Phase.|Lost to Follow-up|0|||
33637366|NCT01567527|63039782|FG000|Conversion Phase.|Lack of Efficacy|2|||
33637367|NCT01567527|63039783|FG001|Conversion Phase.|Lack of Efficacy|0|||
33637368|NCT01567527|63039784|FG002|Conversion Phase.|Lack of Efficacy|0|||
33637369|NCT01567527|63039785|FG003|Conversion Phase.|Lack of Efficacy|0|||
33637370|NCT01567527|63039786|FG004|Conversion Phase.|Lack of Efficacy|0|||
33637371|NCT01567527|63039782|FG000|Conversion Phase.|Adverse Event|33|||
33637372|NCT01567527|63039783|FG001|Conversion Phase.|Adverse Event|0|||
33637373|NCT01567527|63039784|FG002|Conversion Phase.|Adverse Event|0|||
33637374|NCT01567527|63039785|FG003|Conversion Phase.|Adverse Event|0|||
33637375|NCT01567527|63039786|FG004|Conversion Phase.|Adverse Event|0|||
33637376|NCT01567527|63039782|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
33637377|NCT01567527|63039783|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
33637378|NCT01567527|63039784|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
33637379|NCT01567527|63039785|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
33637380|NCT01567527|63039786|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
33637381|NCT01567527|63039782|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
33637382|NCT01567527|63039783|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
33637383|NCT01567527|63039784|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
33637384|NCT01567527|63039785|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
33637385|NCT01567527|63039786|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
33637386|NCT01567527|63039782|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
33637387|NCT01567527|63039783|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
33462526|NCT03449446|62836437|FG005|Overall Study|Randomized but Never Treated|0|||
33462527|NCT03449446|62836438|FG006|Overall Study|Randomized but Never Treated|0|||
33541154|NCT04466384|62931690|FG001|First Phase|Protocol Violation|0|||
33541155|NCT04466384|62931689|FG000|First Phase|Missing data|1|||
33541156|NCT04466384|62931690|FG001|First Phase|Missing data|0|||
33541157|NCT04466384|62931689|FG000|Cross Over Phase|Physician Decision|1|||
33541158|NCT04466384|62931690|FG001|Cross Over Phase|Physician Decision|0|||
33541159|NCT04466384|62931689|FG000|Cross Over Phase|Withdrawal by Subject|0|||
33541160|NCT04466384|62931690|FG001|Cross Over Phase|Withdrawal by Subject|1|||
33541161|NCT03050814|62931701|FG000|Overall Study|Screen failures|0|||
33541162|NCT03050814|62931702|FG001|Overall Study|Screen failures|0|||
33541163|NCT03050814|62931703|FG002|Overall Study|Screen failures|4|||
33541164|NCT00835575|62931711|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
33462528|NCT03449446|62836432|FG000|Overall Study|Unknown Reason|33|||
33462529|NCT03449446|62836433|FG001|Overall Study|Unknown Reason|1|||
33462530|NCT03449446|62836434|FG002|Overall Study|Unknown Reason|1|||
33462531|NCT03449446|62836435|FG003|Overall Study|Unknown Reason|1|||
33541165|NCT00835575|62931712|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
33637388|NCT01567527|63039784|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
33637389|NCT01567527|63039785|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
33462532|NCT03449446|62836436|FG004|Overall Study|Unknown Reason|2|||
33462533|NCT03449446|62836437|FG005|Overall Study|Unknown Reason|2|||
33462534|NCT03449446|62836438|FG006|Overall Study|Unknown Reason|0|||
33462535|NCT03449446|62836432|FG000|Overall Study|Withdrew Consent|1|||
33541166|NCT04601194|62931716|FG000|Overall Study|Lost to Follow-up|7|||
33541167|NCT00835263|62931729|FG000|Second Intervention|Adverse Event|1|||
33541168|NCT00835263|62931730|FG001|Second Intervention|Adverse Event|0|||
33637390|NCT01567527|63039786|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
33637391|NCT01567527|63039782|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
33637392|NCT01567527|63039783|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
33637393|NCT01567527|63039784|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
33637394|NCT01567527|63039785|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
33637395|NCT01567527|63039786|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
33637396|NCT01567527|63039782|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
33637397|NCT01567527|63039783|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
33637398|NCT01567527|63039784|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
33637399|NCT01567527|63039785|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
33637400|NCT01567527|63039786|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
33637401|NCT01567527|63039782|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
33637402|NCT01567527|63039783|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
33637403|NCT01567527|63039784|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
33637404|NCT01567527|63039785|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
33637405|NCT01567527|63039786|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
33637406|NCT01567527|63039782|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
33637407|NCT01567527|63039783|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
33637408|NCT01567527|63039784|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
33637409|NCT01567527|63039785|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
33637410|NCT01567527|63039786|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
33637411|NCT01567527|63039782|FG000|IM Depot Stabilization.|Protocol deviation|0|||
33637412|NCT01567527|63039783|FG001|IM Depot Stabilization.|Protocol deviation|0|||
33637413|NCT01567527|63039784|FG002|IM Depot Stabilization.|Protocol deviation|5|||
33637414|NCT01567527|63039785|FG003|IM Depot Stabilization.|Protocol deviation|0|||
33637415|NCT01567527|63039786|FG004|IM Depot Stabilization.|Protocol deviation|0|||
33637416|NCT01567527|63039782|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
33637417|NCT01567527|63039783|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
33637418|NCT01567527|63039784|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
33637419|NCT01567527|63039785|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
33637420|NCT01567527|63039786|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
33637421|NCT01567527|63039782|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
33637422|NCT01567527|63039783|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
33637423|NCT01567527|63039784|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
33637424|NCT01567527|63039785|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
33637425|NCT01567527|63039786|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
33637426|NCT01567527|63039782|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
33637427|NCT01567527|63039783|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
33637428|NCT01567527|63039784|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
33637429|NCT01567527|63039785|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
33637430|NCT01567527|63039786|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
33637431|NCT01567527|63039782|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
33637432|NCT01567527|63039783|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
33637433|NCT01567527|63039784|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
33637434|NCT01567527|63039785|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
33637435|NCT01567527|63039786|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
33637436|NCT01567527|63039782|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
33637437|NCT01567527|63039783|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
33637438|NCT01567527|63039784|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
33637439|NCT01567527|63039785|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
33637440|NCT01567527|63039786|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
33637441|NCT01567527|63039782|FG000|IM Depot Stabilization.|Adverse Event|0|||
33637442|NCT01567527|63039783|FG001|IM Depot Stabilization.|Adverse Event|0|||
33637443|NCT01567527|63039784|FG002|IM Depot Stabilization.|Adverse Event|37|||
33637444|NCT01567527|63039785|FG003|IM Depot Stabilization.|Adverse Event|0|||
33462536|NCT03449446|62836433|FG001|Overall Study|Withdrew Consent|3|||
33462537|NCT03449446|62836434|FG002|Overall Study|Withdrew Consent|1|||
33462538|NCT03449446|62836435|FG003|Overall Study|Withdrew Consent|4|||
33462539|NCT03449446|62836436|FG004|Overall Study|Withdrew Consent|4|||
33462540|NCT03449446|62836437|FG005|Overall Study|Withdrew Consent|4|||
33462541|NCT03449446|62836438|FG006|Overall Study|Withdrew Consent|1|||
33462542|NCT03449446|62836432|FG000|Overall Study|Adverse Event|1|||
33462543|NCT03449446|62836433|FG001|Overall Study|Adverse Event|2|||
33462544|NCT03449446|62836434|FG002|Overall Study|Adverse Event|1|||
33462545|NCT03449446|62836435|FG003|Overall Study|Adverse Event|0|||
33541169|NCT01963208|62931768|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
33637445|NCT01567527|63039786|FG004|IM Depot Stabilization.|Adverse Event|0|||
33637446|NCT01567527|63039782|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
33637447|NCT01567527|63039783|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
33637448|NCT01567527|63039784|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
33637449|NCT01567527|63039785|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
33637450|NCT01567527|63039786|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
33637451|NCT01567527|63039782|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
33637452|NCT01567527|63039783|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
33637453|NCT01567527|63039784|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
33637454|NCT01567527|63039785|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
33637455|NCT01567527|63039786|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
33637456|NCT01567527|63039782|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
33637457|NCT01567527|63039783|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
33637458|NCT01567527|63039784|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
33637459|NCT01567527|63039785|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
33637460|NCT01567527|63039786|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
33637461|NCT01567527|63039782|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
33637462|NCT01567527|63039783|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
33637463|NCT01567527|63039784|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
33637464|NCT01567527|63039785|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
33637465|NCT01567527|63039786|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
33637466|NCT01567527|63039782|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
33637467|NCT01567527|63039783|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
33637468|NCT01567527|63039784|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
33637469|NCT01567527|63039785|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
33637470|NCT01567527|63039786|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
33637471|NCT01567527|63039782|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33637472|NCT01567527|63039783|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33637473|NCT01567527|63039784|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33637474|NCT01567527|63039785|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
33637475|NCT01567527|63039786|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
33637476|NCT01567527|63039782|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
33637477|NCT01567527|63039783|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
33637478|NCT01567527|63039784|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
33637479|NCT01567527|63039785|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
33637480|NCT01567527|63039786|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
33637481|NCT01567527|63039782|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
33637482|NCT01567527|63039783|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
33637483|NCT01567527|63039784|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
33637484|NCT01567527|63039785|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
33637485|NCT01567527|63039786|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
33637486|NCT01567527|63039782|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33637487|NCT01567527|63039783|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33637488|NCT01567527|63039784|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33637489|NCT01567527|63039785|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
33637490|NCT01567527|63039786|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
33637491|NCT01818752|63039797|FG000|Overall Study|Adverse Event|64|||
33637492|NCT01818752|63039798|FG001|Overall Study|Adverse Event|74|||
33637493|NCT01818752|63039797|FG000|Overall Study|Death|14|||
33637494|NCT01818752|63039798|FG001|Overall Study|Death|18|||
33637495|NCT01818752|63039797|FG000|Overall Study|Non-compliance|16|||
33637496|NCT01818752|63039798|FG001|Overall Study|Non-compliance|20|||
33637497|NCT01818752|63039797|FG000|Overall Study|Withdrawal by Subject|15|||
33637498|NCT01818752|63039798|FG001|Overall Study|Withdrawal by Subject|14|||
33637499|NCT01818752|63039797|FG000|Overall Study|Physician Decision|9|||
33637500|NCT01818752|63039798|FG001|Overall Study|Physician Decision|8|||
33637501|NCT01818752|63039797|FG000|Overall Study|Disease Progression|54|||
33637502|NCT01818752|63039798|FG001|Overall Study|Disease Progression|48|||
33637503|NCT01818752|63039797|FG000|Overall Study|Other|7|||
33637504|NCT01818752|63039798|FG001|Overall Study|Other|8|||
33637505|NCT01818752|63039797|FG000|Overall Study|Continuing Treatment|1|||
33637506|NCT01818752|63039798|FG001|Overall Study|Continuing Treatment|4|||
33637507|NCT01818752|63039797|FG000|Overall Study|Randomized but not Dosed|7|||
33637508|NCT01818752|63039798|FG001|Overall Study|Randomized but not Dosed|4|||
33462546|NCT03449446|62836436|FG004|Overall Study|Adverse Event|0|||
33637509|NCT01845818|63039806|FG000|Overall Study|Withdrawal by Subject|0|||
33637510|NCT01845818|63039807|FG001|Overall Study|Withdrawal by Subject|1|||
33637511|NCT01845818|63039806|FG000|Overall Study|Lost to Follow-up|7|||
33637512|NCT01845818|63039807|FG001|Overall Study|Lost to Follow-up|5|||
33637513|NCT01845818|63039806|FG000|Overall Study|Administrative Reasons|3|||
33637514|NCT01845818|63039807|FG001|Overall Study|Administrative Reasons|1|||
33637515|NCT01845818|63039806|FG000|Overall Study|Serious Adverse Event|1|||
33637516|NCT01845818|63039807|FG001|Overall Study|Serious Adverse Event|1|||
33637517|NCT01845818|63039806|FG000|Overall Study|Other|25|||
33637518|NCT01845818|63039807|FG001|Overall Study|Other|8|||
33637519|NCT01845818|63039806|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
33637520|NCT01845818|63039807|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
33637521|NCT01845818|63039806|FG000|Overall Study|No Follow-Up Data Available|4|||
33637522|NCT01845818|63039807|FG001|Overall Study|No Follow-Up Data Available|1|||
33541170|NCT01963208|62931769|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
33541171|NCT01963208|62931770|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
33541172|NCT01963208|62931771|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
33541173|NCT01963208|62931772|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
33541174|NCT01963208|62931773|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
33541175|NCT01963208|62931768|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
33541176|NCT01963208|62931769|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
33541177|NCT01963208|62931770|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
33637523|NCT01362608|63039817|FG000|Overall Study|Protocol Violation|0|||
33637524|NCT01362608|63039818|FG001|Overall Study|Protocol Violation|1|||
33637525|NCT01362608|63039817|FG000|Overall Study|Lost to Follow-up|3|||
33637526|NCT01362608|63039818|FG001|Overall Study|Lost to Follow-up|1|||
33637527|NCT01362608|63039817|FG000|Overall Study|Withdrawal by Subject|1|||
33637528|NCT01362608|63039818|FG001|Overall Study|Withdrawal by Subject|2|||
33637529|NCT01362608|63039817|FG000|Overall Study|Lack of Efficacy|0|||
33637530|NCT01362608|63039818|FG001|Overall Study|Lack of Efficacy|2|||
33541178|NCT01963208|62931771|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
33541179|NCT01963208|62931772|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
33541180|NCT01963208|62931773|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
33541181|NCT01963208|62931768|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
33541182|NCT01963208|62931769|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
33541183|NCT01963208|62931770|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
33541184|NCT01963208|62931771|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
33541185|NCT01963208|62931772|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
33541186|NCT01963208|62931773|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
33541187|NCT01963208|62931768|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
33541188|NCT01963208|62931769|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
33541189|NCT01963208|62931770|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
33541190|NCT01963208|62931771|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
33541191|NCT01963208|62931772|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
33541192|NCT01963208|62931773|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
33541193|NCT01963208|62931768|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
33541194|NCT01963208|62931769|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
33541195|NCT01963208|62931770|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
33541196|NCT01963208|62931771|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
33541197|NCT01963208|62931772|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
33541198|NCT01963208|62931773|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
33541199|NCT01963208|62931768|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
33541200|NCT01963208|62931769|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
33541201|NCT01963208|62931770|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
33541202|NCT01963208|62931771|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
33541203|NCT01963208|62931772|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
33541204|NCT01963208|62931773|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
33541205|NCT01963208|62931768|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
33541206|NCT01963208|62931769|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
33541207|NCT01963208|62931770|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
33637531|NCT01362608|63039817|FG000|Overall Study|Adverse Event|0|||
33637532|NCT01362608|63039818|FG001|Overall Study|Adverse Event|2|||
33637533|NCT01871090|63039826|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
33637534|NCT01871090|63039827|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
33637535|NCT01871090|63039826|FG000|Overall Study|Interrogation not completed correctly|1|||
33637536|NCT01871090|63039827|FG001|Overall Study|Interrogation not completed correctly|0|||
33637537|NCT01871090|63039826|FG000|Overall Study|Subject Non-Compliance|0|||
33637538|NCT01871090|63039827|FG001|Overall Study|Subject Non-Compliance|1|||
33637539|NCT01818596|63039835|FG000|Overall Study|Enrolled but Not Treated|4|||
33637540|NCT01818596|63039836|FG001|Overall Study|Enrolled but Not Treated|0|||
33637541|NCT01818596|63039835|FG000|Overall Study|Adverse Event|7|||
33541208|NCT01963208|62931771|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
33541209|NCT01963208|62931772|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
33541210|NCT01963208|62931773|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
33541211|NCT01963208|62931768|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
33541212|NCT01963208|62931769|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
33541213|NCT01963208|62931770|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
33541214|NCT01963208|62931771|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
33541215|NCT01963208|62931772|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
33462547|NCT03449446|62836437|FG005|Overall Study|Adverse Event|2|||
33462548|NCT03449446|62836438|FG006|Overall Study|Adverse Event|0|||
33462549|NCT03449446|62836432|FG000|Overall Study|Lost to Follow-up|0|||
33462550|NCT03449446|62836433|FG001|Overall Study|Lost to Follow-up|0|||
33462551|NCT03449446|62836434|FG002|Overall Study|Lost to Follow-up|2|||
33462552|NCT03449446|62836435|FG003|Overall Study|Lost to Follow-up|1|||
33462553|NCT03449446|62836436|FG004|Overall Study|Lost to Follow-up|3|||
33541216|NCT01963208|62931773|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
33541217|NCT01963208|62931768|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
33541218|NCT01963208|62931769|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
33541219|NCT01963208|62931770|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
33541220|NCT01963208|62931771|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
33541221|NCT01963208|62931772|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
33541222|NCT01963208|62931773|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
33637542|NCT01818596|63039836|FG001|Overall Study|Adverse Event|0|||
33637543|NCT01818596|63039835|FG000|Overall Study|Death|3|||
33637544|NCT01818596|63039836|FG001|Overall Study|Death|0|||
33637545|NCT01818596|63039835|FG000|Overall Study|Investigator's Discretion|4|||
33637546|NCT01818596|63039836|FG001|Overall Study|Investigator's Discretion|0|||
33637547|NCT01818596|63039835|FG000|Overall Study|Protocol Violation|1|||
33637548|NCT01818596|63039836|FG001|Overall Study|Protocol Violation|0|||
33637549|NCT01818596|63039835|FG000|Overall Study|Withdrew Consent|5|||
33637550|NCT01818596|63039836|FG001|Overall Study|Withdrew Consent|0|||
33637551|NCT01818596|63039835|FG000|Overall Study|Lost to Follow-up|7|||
33541223|NCT01963208|62931768|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
33541224|NCT01963208|62931769|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
33637552|NCT01818596|63039836|FG001|Overall Study|Lost to Follow-up|0|||
33637553|NCT04577794|63039849|FG000|Overall Study|Adverse Event|1|||
33637554|NCT04577794|63039850|FG001|Overall Study|Adverse Event|1|||
33637555|NCT01594281|63039867|FG000|Interventional Core Phase|Protocol Deviation|1|||
33637556|NCT01594281|63039868|FG001|Interventional Core Phase|Protocol Deviation|0|||
33637557|NCT01594281|63039869|FG002|Interventional Core Phase|Protocol Deviation|0|||
33637558|NCT01594281|63039867|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
33637559|NCT01594281|63039868|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
33637560|NCT01594281|63039869|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
33637561|NCT01594281|63039867|FG000|Interventional Core Phase|Death|1|||
33637562|NCT01594281|63039868|FG001|Interventional Core Phase|Death|1|||
33637563|NCT01594281|63039869|FG002|Interventional Core Phase|Death|2|||
33462554|NCT03449446|62836437|FG005|Overall Study|Lost to Follow-up|0|||
33637564|NCT01594281|63039867|FG000|Interventional Core Phase|Lost to Follow-up|1|||
33637565|NCT01594281|63039868|FG001|Interventional Core Phase|Lost to Follow-up|4|||
33462555|NCT03449446|62836438|FG006|Overall Study|Lost to Follow-up|0|||
33462556|NCT03449446|62836432|FG000|Overall Study|Investigator's Discretion|0|||
33462557|NCT03449446|62836433|FG001|Overall Study|Investigator's Discretion|1|||
33462558|NCT03449446|62836434|FG002|Overall Study|Investigator's Discretion|1|||
33637566|NCT01594281|63039869|FG002|Interventional Core Phase|Lost to Follow-up|1|||
33541225|NCT01963208|62931770|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
33637567|NCT01594281|63039867|FG000|Interventional Core Phase|Adverse Event|4|||
33637568|NCT01594281|63039868|FG001|Interventional Core Phase|Adverse Event|4|||
33462559|NCT03449446|62836435|FG003|Overall Study|Investigator's Discretion|2|||
33541226|NCT01963208|62931771|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
33541227|NCT01963208|62931772|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
33637569|NCT01594281|63039869|FG002|Interventional Core Phase|Adverse Event|4|||
33637570|NCT01594281|63039867|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
33637571|NCT01594281|63039868|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
33637572|NCT01594281|63039869|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
33637573|NCT01594281|63039867|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
33637574|NCT01594281|63039868|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
33637575|NCT01594281|63039869|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
33637576|NCT01594281|63039867|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
33637577|NCT01594281|63039868|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
33637578|NCT01594281|63039869|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
33637579|NCT01566981|63039882|FG000|Overall Study|Lost to Follow-up|5|||
33637580|NCT01566981|63039883|FG001|Overall Study|Lost to Follow-up|8|||
33637581|NCT01870778|63039893|FG000|Overall Study|Withdrawal by Subject|8|||
33637582|NCT01870778|63039894|FG001|Overall Study|Withdrawal by Subject|7|||
33637583|NCT01870778|63039893|FG000|Overall Study|Lost to Follow-up|0|||
33637584|NCT01870778|63039894|FG001|Overall Study|Lost to Follow-up|2|||
33637585|NCT01818284|63039907|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
33637586|NCT01818284|63039908|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
33637587|NCT01818284|63039907|FG000|Overall Study|Death|0|||
33637588|NCT01818284|63039908|FG001|Overall Study|Death|2|||
33637589|NCT01610492|63039944|FG000|Overall Study|Adverse Event|1|||
33637590|NCT01610492|63039944|FG000|Overall Study|Lack of Efficacy|3|||
33637591|NCT01610492|63039944|FG000|Overall Study|Other: Reached stopping criteria|1|||
33637592|NCT01610492|63039944|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
33637593|NCT01817582|63039951|FG000|Overall Study|Withdrawal by Subject|0|||
33637594|NCT01817582|63039952|FG001|Overall Study|Withdrawal by Subject|1|||
33637595|NCT01817582|63039953|FG002|Overall Study|Withdrawal by Subject|0|||
33637596|NCT01817582|63039951|FG000|Overall Study|Participant revealed masked treatment|1|||
33637597|NCT01817582|63039952|FG001|Overall Study|Participant revealed masked treatment|0|||
33637598|NCT01817582|63039953|FG002|Overall Study|Participant revealed masked treatment|0|||
33637599|NCT01817582|63039951|FG000|Overall Study|Randomized but exclusion criteria met|1|||
33637600|NCT01817582|63039952|FG001|Overall Study|Randomized but exclusion criteria met|0|||
33637601|NCT01817582|63039953|FG002|Overall Study|Randomized but exclusion criteria met|0|||
33637602|NCT01594125|63039966|FG000|Overall Study|Withdrawal by Subject|1|||
33637603|NCT01594125|63039967|FG001|Overall Study|Withdrawal by Subject|0|||
33637604|NCT01594125|63039968|FG002|Overall Study|Withdrawal by Subject|0|||
33637605|NCT01594125|63039969|FG003|Overall Study|Withdrawal by Subject|1|||
33637606|NCT01594125|63039970|FG004|Overall Study|Withdrawal by Subject|0|||
33637607|NCT01594125|63039966|FG000|Overall Study|Progressive Disease|3|||
33637608|NCT01594125|63039967|FG001|Overall Study|Progressive Disease|12|||
33637609|NCT01594125|63039968|FG002|Overall Study|Progressive Disease|3|||
33637610|NCT01594125|63039969|FG003|Overall Study|Progressive Disease|3|||
33637611|NCT01594125|63039970|FG004|Overall Study|Progressive Disease|7|||
33637612|NCT01870076|63039986|FG000|Overall Study|Withdrawal by Subject|1|||
33637613|NCT01870076|63039987|FG001|Overall Study|Withdrawal by Subject|0|||
33637614|NCT01870076|63039988|FG002|Overall Study|Withdrawal by Subject|1|||
33637615|NCT01870076|63039989|FG003|Overall Study|Withdrawal by Subject|0|||
33637616|NCT01592721|63039999|FG000|Long-term Follow-up|Death|1|||
33637617|NCT01613378|63040003|FG000|Overall Study|Lack of Efficacy|13|||
33637618|NCT01613378|63040003|FG000|Overall Study|Adverse Event|11|||
33637619|NCT01613378|63040003|FG000|Overall Study|Withdrawal by Subject|8|||
33637620|NCT01613378|63040003|FG000|Overall Study|Death|2|||
33637621|NCT01613378|63040003|FG000|Overall Study|Lost to Follow-up|1|||
33637622|NCT01613378|63040003|FG000|Overall Study|Other Reason|4|||
33637623|NCT01592409|63040009|FG000|Overall Study|Withdrawal by Subject|0|||
33637624|NCT01592409|63040010|FG001|Overall Study|Withdrawal by Subject|1|||
33637625|NCT01697319|63040029|FG000|Primary Phase|Withdrawal by Subject|1|||
33637626|NCT01697319|63040029|FG000|Extension Phase|Terminated by Sponsor|15|||
33637627|NCT01566435|63040044|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
33637628|NCT01696929|63040052|FG000|Overall Study|Physician Decision|1|||
33637629|NCT01696773|63040062|FG000|Days 15-27, Washout|Adverse Event|1|||
33637630|NCT01696773|63040063|FG001|Days 15-27, Washout|Adverse Event|0|||
33637631|NCT01696695|63040069|FG000|Overall Study|Disease progression|373|||
33637632|NCT01696695|63040069|FG000|Overall Study|Death|29|||
33637633|NCT01696695|63040069|FG000|Overall Study|Adverse Event|74|||
33637634|NCT01696695|63040069|FG000|Overall Study|Withdrawal by Subject|92|||
33637635|NCT01696695|63040069|FG000|Overall Study|Lost to Follow-up|48|||
33637636|NCT01696695|63040069|FG000|Overall Study|Other|74|||
33637637|NCT01696695|63040069|FG000|Overall Study|Major Protocol Violation|192|||
33637638|NCT01565889|63040088|FG000|Part A|Withdrawal by Subject|1|||
33637639|NCT01565889|63040089|FG001|Part A|Withdrawal by Subject|0|||
33637640|NCT01565889|63040090|FG002|Part A|Withdrawal by Subject|0|||
33637641|NCT01565889|63040091|FG003|Part A|Withdrawal by Subject|0|||
33637642|NCT01565889|63040092|FG004|Part A|Withdrawal by Subject|0|||
33637643|NCT01565889|63040093|FG005|Part A|Withdrawal by Subject|0|||
33637644|NCT01565889|63040088|FG000|Part B|Withdrawal by Subject|0|||
33637645|NCT01565889|63040089|FG001|Part B|Withdrawal by Subject|0|||
33637646|NCT01565889|63040090|FG002|Part B|Withdrawal by Subject|0|||
33637647|NCT01565889|63040091|FG003|Part B|Withdrawal by Subject|0|||
33637648|NCT01565889|63040092|FG004|Part B|Withdrawal by Subject|0|||
33637649|NCT01565889|63040093|FG005|Part B|Withdrawal by Subject|1|||
33637650|NCT01565889|63040088|FG000|Part B|Lack of Efficacy|0|||
33637651|NCT01565889|63040089|FG001|Part B|Lack of Efficacy|0|||
33637652|NCT01565889|63040090|FG002|Part B|Lack of Efficacy|0|||
33637653|NCT01565889|63040091|FG003|Part B|Lack of Efficacy|0|||
33637654|NCT01565889|63040092|FG004|Part B|Lack of Efficacy|0|||
33637655|NCT01565889|63040093|FG005|Part B|Lack of Efficacy|2|||
33637656|NCT01565889|63040088|FG000|Part B|Lost to Follow-up|0|||
33637657|NCT01565889|63040089|FG001|Part B|Lost to Follow-up|0|||
33637658|NCT01565889|63040090|FG002|Part B|Lost to Follow-up|0|||
33637659|NCT01565889|63040091|FG003|Part B|Lost to Follow-up|0|||
33637660|NCT01565889|63040092|FG004|Part B|Lost to Follow-up|0|||
33637661|NCT01565889|63040093|FG005|Part B|Lost to Follow-up|1|||
33637662|NCT01696071|63040108|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
33541228|NCT01963208|62931773|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
33541229|NCT01963208|62931768|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
33541230|NCT01963208|62931769|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
33541231|NCT01963208|62931770|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
33541232|NCT01963208|62931771|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
33541233|NCT01963208|62931772|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
33541234|NCT01963208|62931773|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
33541235|NCT01963208|62931768|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
33541236|NCT01963208|62931769|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
33541237|NCT01963208|62931770|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
33541238|NCT01963208|62931771|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
33541239|NCT01963208|62931772|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
33541240|NCT01963208|62931773|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
33541241|NCT01963208|62931768|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
33541242|NCT01963208|62931769|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
33541243|NCT01963208|62931770|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
33541244|NCT01963208|62931771|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
33541245|NCT01963208|62931772|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
33541246|NCT01963208|62931773|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
33541247|NCT01963208|62931768|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
33541248|NCT01963208|62931769|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
33541249|NCT01963208|62931770|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
33541250|NCT01963208|62931771|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
33541251|NCT01963208|62931772|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
33541252|NCT01963208|62931773|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
33541253|NCT00834873|62931785|FG000|First Intervention|Adverse Event|0|||
33541254|NCT00834873|62931786|FG001|First Intervention|Adverse Event|1|||
33541255|NCT01377480|62931794|FG000|Overall Study|Protocol Violation|0|||
33541256|NCT01377480|62931795|FG001|Overall Study|Protocol Violation|0|||
33541257|NCT01377480|62931796|FG002|Overall Study|Protocol Violation|0|||
33541258|NCT01377480|62931797|FG003|Overall Study|Protocol Violation|4|||
33541259|NCT01377480|62931794|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
33541260|NCT01377480|62931795|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
33541261|NCT01377480|62931796|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
33541262|NCT01377480|62931797|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
33541263|NCT01377480|62931794|FG000|Overall Study|Withdrawal by Subject|0|||
33541264|NCT01377480|62931795|FG001|Overall Study|Withdrawal by Subject|0|||
33541265|NCT01377480|62931796|FG002|Overall Study|Withdrawal by Subject|1|||
33541266|NCT01377480|62931797|FG003|Overall Study|Withdrawal by Subject|0|||
33637663|NCT01696071|63040109|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
33637664|NCT01591863|63040120|FG000|Overall Study|Adverse Event|3|||
33637665|NCT01591863|63040120|FG000|Overall Study|Withdrawal by Subject|1|||
33637666|NCT01591863|63040120|FG000|Overall Study|recurrence|9|||
33637667|NCT01591863|63040120|FG000|Overall Study|Lack of Efficacy|1|||
33637668|NCT01591785|63040126|FG000|Overall Study|worsening condition|1|||
33637669|NCT01591785|63040127|FG001|Overall Study|worsening condition|2|||
33637670|NCT01591785|63040126|FG000|Overall Study|Protocol Violation|2|||
33541267|NCT01377480|62931794|FG000|Overall Study|Serious adverse event|0|||
33541268|NCT01377480|62931795|FG001|Overall Study|Serious adverse event|0|||
33541269|NCT01377480|62931796|FG002|Overall Study|Serious adverse event|1|||
33541270|NCT01377480|62931797|FG003|Overall Study|Serious adverse event|1|||
33637671|NCT01591785|63040127|FG001|Overall Study|Protocol Violation|0|||
33637672|NCT01591785|63040126|FG000|Overall Study|Lost to Follow-up|1|||
33637673|NCT01591785|63040127|FG001|Overall Study|Lost to Follow-up|0|||
33637674|NCT01695993|63040136|FG000|Overall Study|Lost to Follow-up|2|||
33637675|NCT01695993|63040137|FG001|Overall Study|Lost to Follow-up|1|||
33637676|NCT01695993|63040138|FG002|Overall Study|Lost to Follow-up|3|||
33637677|NCT01695993|63040136|FG000|Overall Study|Withdrawal by Subject|2|||
33637678|NCT01695993|63040137|FG001|Overall Study|Withdrawal by Subject|2|||
33462560|NCT03449446|62836436|FG004|Overall Study|Investigator's Discretion|0|||
33637679|NCT01695993|63040138|FG002|Overall Study|Withdrawal by Subject|2|||
33637680|NCT01695993|63040136|FG000|Overall Study|To ill to continue|1|||
33637681|NCT01695993|63040137|FG001|Overall Study|To ill to continue|2|||
33637682|NCT01695993|63040138|FG002|Overall Study|To ill to continue|0|||
33637683|NCT01695993|63040136|FG000|Overall Study|Changed Medical Facility|0|||
33637684|NCT01695993|63040137|FG001|Overall Study|Changed Medical Facility|0|||
33637685|NCT01695993|63040138|FG002|Overall Study|Changed Medical Facility|1|||
33637686|NCT01565343|63040149|FG000|Overall Study|Administrative decision/technical issues|1|||
33637687|NCT01565343|63040150|FG001|Overall Study|Administrative decision/technical issues|0|||
33637688|NCT01565343|63040151|FG002|Overall Study|Administrative decision/technical issues|0|||
33637689|NCT01695135|63040176|FG000|Double-blind Treatment Phase|Progressive disease|50|||
33637690|NCT01695135|63040177|FG001|Double-blind Treatment Phase|Progressive disease|110|||
33637691|NCT01695135|63040178|FG002|Double-blind Treatment Phase|Progressive disease|0|||
33637692|NCT01695135|63040179|FG003|Double-blind Treatment Phase|Progressive disease|0|||
33637693|NCT01695135|63040176|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
33637694|NCT01695135|63040177|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
33637695|NCT01695135|63040178|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33637696|NCT01695135|63040179|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33637697|NCT01695135|63040176|FG000|Double-blind Treatment Phase|Adverse Event|7|||
33637698|NCT01695135|63040177|FG001|Double-blind Treatment Phase|Adverse Event|7|||
33637699|NCT01695135|63040178|FG002|Double-blind Treatment Phase|Adverse Event|0|||
33637700|NCT01695135|63040179|FG003|Double-blind Treatment Phase|Adverse Event|0|||
33637701|NCT01695135|63040176|FG000|Double-blind Treatment Phase|Other|1|||
33637702|NCT01695135|63040177|FG001|Double-blind Treatment Phase|Other|3|||
33637703|NCT01695135|63040178|FG002|Double-blind Treatment Phase|Other|0|||
33637704|NCT01695135|63040179|FG003|Double-blind Treatment Phase|Other|0|||
33637705|NCT01695135|63040176|FG000|Double-blind Treatment Phase|Physician Decision|6|||
33637706|NCT01695135|63040177|FG001|Double-blind Treatment Phase|Physician Decision|3|||
33637707|NCT01695135|63040178|FG002|Double-blind Treatment Phase|Physician Decision|0|||
33541271|NCT01377480|62931794|FG000|Overall Study|Other|0|||
33541272|NCT01377480|62931795|FG001|Overall Study|Other|0|||
33541273|NCT01377480|62931796|FG002|Overall Study|Other|7|||
33541274|NCT01377480|62931797|FG003|Overall Study|Other|6|||
33541275|NCT00834795|62931809|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
33541276|NCT00834795|62931810|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
33541277|NCT00834795|62931809|FG000|Second Intervention|Adverse Event|1|||
33637708|NCT01695135|63040179|FG003|Double-blind Treatment Phase|Physician Decision|0|||
33637709|NCT01695135|63040176|FG000|Double-blind Treatment Phase|Death|1|||
33637710|NCT01695135|63040177|FG001|Double-blind Treatment Phase|Death|1|||
33637711|NCT01695135|63040178|FG002|Double-blind Treatment Phase|Death|0|||
33637712|NCT01695135|63040179|FG003|Double-blind Treatment Phase|Death|0|||
33637713|NCT01695135|63040176|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
33637714|NCT01695135|63040177|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
33637715|NCT01695135|63040178|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
33637716|NCT01695135|63040179|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
33637717|NCT01695135|63040176|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
33637718|NCT01695135|63040177|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
33637719|NCT01695135|63040178|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
33637720|NCT01695135|63040179|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
33637721|NCT01695135|63040176|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
33637722|NCT01695135|63040177|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
33637723|NCT01695135|63040178|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
33637724|NCT01695135|63040179|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
33637725|NCT01695135|63040176|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
33637726|NCT01695135|63040177|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
33637727|NCT01695135|63040178|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
33637728|NCT01695135|63040179|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
33462561|NCT03449446|62836437|FG005|Overall Study|Investigator's Discretion|0|||
33462562|NCT03449446|62836438|FG006|Overall Study|Investigator's Discretion|0|||
33462563|NCT03449446|62836432|FG000|Overall Study|Non Compliance with Study Drug|1|||
33462564|NCT03449446|62836433|FG001|Overall Study|Non Compliance with Study Drug|0|||
33462565|NCT03449446|62836434|FG002|Overall Study|Non Compliance with Study Drug|0|||
33462566|NCT03449446|62836435|FG003|Overall Study|Non Compliance with Study Drug|0|||
33462567|NCT03449446|62836436|FG004|Overall Study|Non Compliance with Study Drug|0|||
33462568|NCT03449446|62836437|FG005|Overall Study|Non Compliance with Study Drug|0|||
33462569|NCT03449446|62836438|FG006|Overall Study|Non Compliance with Study Drug|0|||
33541278|NCT00834795|62931810|FG001|Second Intervention|Adverse Event|0|||
33637729|NCT01695135|63040176|FG000|Open Label Extension Treatment Phase|Other|0|||
33637730|NCT01695135|63040177|FG001|Open Label Extension Treatment Phase|Other|0|||
33462570|NCT03449446|62836432|FG000|Overall Study|Protocol Violation|0|||
33462571|NCT03449446|62836433|FG001|Overall Study|Protocol Violation|0|||
33541279|NCT00834717|62931816|FG000|First Intervention|Adverse Event|1|||
33541280|NCT00834717|62931817|FG001|First Intervention|Adverse Event|0|||
33541281|NCT00834717|62931816|FG000|First Intervention|Withdrawal by Subject|0|||
33541282|NCT00834717|62931817|FG001|First Intervention|Withdrawal by Subject|1|||
33541283|NCT00834639|62931823|FG000|Second Intervention|Physician Decision|0|||
33541284|NCT00834639|62931824|FG001|Second Intervention|Physician Decision|2|||
33541285|NCT00834249|62931844|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
33541286|NCT00834249|62931845|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
33541287|NCT00834249|62931844|FG000|Second Intervention|Adverse Event|1|||
33541288|NCT00834249|62931845|FG001|Second Intervention|Adverse Event|0|||
33541289|NCT00833937|62931851|FG000|Washout|Withdrawal by Subject|1|||
33541290|NCT00833937|62931852|FG001|Washout|Withdrawal by Subject|0|||
33541291|NCT00924170|62931858|FG000|Overall Study|Refused further treatment|0|||
33541292|NCT00924170|62931859|FG001|Overall Study|Refused further treatment|1|||
33541293|NCT00924170|62931858|FG000|Overall Study|Physician Decision|0|||
33541294|NCT00924170|62931859|FG001|Overall Study|Physician Decision|1|||
33541295|NCT00924170|62931858|FG000|Overall Study|Progressive disease|3|||
33541296|NCT00924170|62931859|FG001|Overall Study|Progressive disease|6|||
33541297|NCT00924170|62931858|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
33541298|NCT00924170|62931859|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
33541299|NCT00924170|62931858|FG000|Overall Study|Death|1|||
33541300|NCT00924170|62931859|FG001|Overall Study|Death|0|||
33541301|NCT00828321|62931873|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
33541302|NCT00828321|62931874|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
33541303|NCT00828321|62931873|FG000|Second Intervention|Protocol Violation|0|||
33541304|NCT00828321|62931874|FG001|Second Intervention|Protocol Violation|1|||
33541305|NCT01352715|62931880|FG000|Overall Study|Death|3|||
33541306|NCT01352715|62931881|FG001|Overall Study|Death|3|||
33541307|NCT01352715|62931880|FG000|Overall Study|Lost to Follow-up|5|||
33541308|NCT01352715|62931881|FG001|Overall Study|Lost to Follow-up|7|||
33541309|NCT01352715|62931880|FG000|Overall Study|Withdrawal by Subject|4|||
33541310|NCT01352715|62931881|FG001|Overall Study|Withdrawal by Subject|8|||
33541311|NCT01352715|62931880|FG000|Overall Study|site closure|16|||
33541312|NCT01352715|62931881|FG001|Overall Study|site closure|15|||
33541313|NCT01352715|62931880|FG000|Overall Study|no final visit in closeout period|15|||
33541314|NCT01352715|62931881|FG001|Overall Study|no final visit in closeout period|12|||
33541315|NCT01352715|62931880|FG000|Overall Study|major ineligibility|2|||
33541316|NCT01352715|62931881|FG001|Overall Study|major ineligibility|1|||
33541317|NCT00919893|62931892|FG000|Overall Study|Protocol Violation|19|||
33541318|NCT00919893|62931893|FG001|Overall Study|Protocol Violation|9|||
33541319|NCT02559622|62931901|FG000|Overall Study|Progressive disease|0|||
33541320|NCT02559622|62931902|FG001|Overall Study|Progressive disease|1|||
33541321|NCT02559622|62931903|FG002|Overall Study|Progressive disease|0|||
33541322|NCT02559622|62931904|FG003|Overall Study|Progressive disease|0|||
33541323|NCT02559622|62931901|FG000|Overall Study|Adverse Event|0|||
33462572|NCT03449446|62836434|FG002|Overall Study|Protocol Violation|0|||
33462573|NCT03449446|62836435|FG003|Overall Study|Protocol Violation|0|||
33462574|NCT03449446|62836436|FG004|Overall Study|Protocol Violation|1|||
33462575|NCT03449446|62836437|FG005|Overall Study|Protocol Violation|1|||
33462576|NCT03449446|62836438|FG006|Overall Study|Protocol Violation|0|||
33462577|NCT03449446|62836432|FG000|Overall Study|Death|0|||
33462578|NCT03449446|62836433|FG001|Overall Study|Death|0|||
33462579|NCT03449446|62836434|FG002|Overall Study|Death|0|||
33462580|NCT03449446|62836435|FG003|Overall Study|Death|0|||
33462581|NCT03449446|62836436|FG004|Overall Study|Death|1|||
33462582|NCT03449446|62836437|FG005|Overall Study|Death|0|||
33462583|NCT03449446|62836438|FG006|Overall Study|Death|0|||
33462584|NCT03449134|62836457|FG000|52-Week Treatment Period|Death|2|||
33462585|NCT03449134|62836458|FG001|52-Week Treatment Period|Death|1|||
33462586|NCT03449134|62836459|FG002|52-Week Treatment Period|Death|0|||
33541324|NCT02559622|62931902|FG001|Overall Study|Adverse Event|2|||
33541325|NCT02559622|62931903|FG002|Overall Study|Adverse Event|2|||
33541326|NCT02559622|62931904|FG003|Overall Study|Adverse Event|2|||
33541327|NCT02559622|62931901|FG000|Overall Study|Patient/guardian decision|1|||
33541328|NCT02559622|62931902|FG001|Overall Study|Patient/guardian decision|2|||
33541329|NCT02559622|62931903|FG002|Overall Study|Patient/guardian decision|0|||
33541330|NCT02559622|62931904|FG003|Overall Study|Patient/guardian decision|1|||
33541331|NCT02559310|62931920|FG000|Overall Study|Death|4|||
33541332|NCT02559310|62931921|FG001|Overall Study|Death|3|||
33541333|NCT02559310|62931920|FG000|Overall Study|Lost to Follow-up|5|||
33637731|NCT01695135|63040178|FG002|Open Label Extension Treatment Phase|Other|4|||
33637732|NCT01695135|63040179|FG003|Open Label Extension Treatment Phase|Other|7|||
33637733|NCT01695135|63040176|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
33637734|NCT01695135|63040177|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
33637735|NCT01695135|63040178|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
33637736|NCT01695135|63040179|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
33637737|NCT01695135|63040176|FG000|Open Label Extension Treatment Phase|Death|0|||
33637738|NCT01695135|63040177|FG001|Open Label Extension Treatment Phase|Death|0|||
33637739|NCT01695135|63040178|FG002|Open Label Extension Treatment Phase|Death|2|||
33637740|NCT01695135|63040179|FG003|Open Label Extension Treatment Phase|Death|7|||
33637741|NCT01695135|63040176|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
33637742|NCT01695135|63040177|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
33637743|NCT01695135|63040178|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
33637744|NCT01695135|63040179|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
33637745|NCT01610414|63040189|FG000|Study Start - Month 13|Serious Adverse Event|65|||
33637746|NCT01610414|63040190|FG001|Study Start - Month 13|Serious Adverse Event|67|||
33637747|NCT01610414|63040189|FG000|Study Start - Month 13|Adverse Event|14|||
33637748|NCT01610414|63040190|FG001|Study Start - Month 13|Adverse Event|14|||
33637749|NCT01610414|63040189|FG000|Study Start - Month 13|Protocol Violation|3|||
33637750|NCT01610414|63040190|FG001|Study Start - Month 13|Protocol Violation|1|||
33637751|NCT01610414|63040189|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
33637752|NCT01610414|63040190|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
33637753|NCT01610414|63040189|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
33637754|NCT01610414|63040190|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
33637755|NCT01610414|63040189|FG000|Study Start - Month 13|Lost to Follow-up|4|||
33637756|NCT01610414|63040190|FG001|Study Start - Month 13|Lost to Follow-up|6|||
33637757|NCT01610414|63040189|FG000|Study Start - Month 13|Suspected HZ episode|1|||
33637758|NCT01610414|63040190|FG001|Study Start - Month 13|Suspected HZ episode|3|||
33637759|NCT01610414|63040189|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
33637760|NCT01610414|63040190|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
33637761|NCT01610414|63040189|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
33637762|NCT01610414|63040190|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
33637763|NCT01610414|63040189|FG000|Month 13 - Month 25|Adverse Event|8|||
33637764|NCT01610414|63040190|FG001|Month 13 - Month 25|Adverse Event|4|||
33637765|NCT01610414|63040189|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
33637766|NCT01610414|63040190|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
33541334|NCT02559310|62931921|FG001|Overall Study|Lost to Follow-up|3|||
33541335|NCT02559310|62931920|FG000|Overall Study|Physician Decision|2|||
33541336|NCT02559310|62931921|FG001|Overall Study|Physician Decision|1|||
33541337|NCT02559310|62931920|FG000|Overall Study|Withdrawal by Subject|13|||
33541338|NCT02559310|62931921|FG001|Overall Study|Withdrawal by Subject|9|||
33541339|NCT02559310|62931920|FG000|Overall Study|Sponsor Decision|0|||
33637767|NCT01610414|63040189|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
33637768|NCT01610414|63040190|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
33637769|NCT01610414|63040189|FG000|Month 13 - Month 25|Protocol Violation|0|||
33637770|NCT01610414|63040190|FG001|Month 13 - Month 25|Protocol Violation|2|||
33462587|NCT03449134|62836457|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
33462588|NCT03449134|62836458|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
33462589|NCT03449134|62836459|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
33462590|NCT03449134|62836457|FG000|52-Week Treatment Period|Physician Decision|2|||
33462591|NCT03449134|62836458|FG001|52-Week Treatment Period|Physician Decision|3|||
33462592|NCT03449134|62836459|FG002|52-Week Treatment Period|Physician Decision|3|||
33637771|NCT01610414|63040189|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
33637772|NCT01610414|63040190|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
33637773|NCT01610414|63040189|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
33637774|NCT01610414|63040190|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
33637775|NCT01610414|63040189|FG000|After Month 25|Study end not reached|48|||
33637776|NCT01610414|63040190|FG001|After Month 25|Study end not reached|53|||
33637777|NCT01564407|63040218|FG000|Overall Study|Lost to Follow-up|0|||
33637778|NCT01564407|63040219|FG001|Overall Study|Lost to Follow-up|1|||
33637779|NCT01564407|63040220|FG002|Overall Study|Lost to Follow-up|0|||
33637780|NCT01564407|63040221|FG003|Overall Study|Lost to Follow-up|0|||
33541340|NCT02559310|62931921|FG001|Overall Study|Sponsor Decision|1|||
33541341|NCT02559310|62931920|FG000|Overall Study|Randomized but not treated|3|||
33326523|NCT00887224|62703226|FG002|Double-blind (DB) Phase|Failed to return|2|||
33326524|NCT00887224|62703224|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
33326525|NCT00887224|62703225|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
33462593|NCT03449134|62836457|FG000|52-Week Treatment Period|Screen Failure|1|||
33462594|NCT03449134|62836458|FG001|52-Week Treatment Period|Screen Failure|0|||
33462595|NCT03449134|62836459|FG002|52-Week Treatment Period|Screen Failure|1|||
33541342|NCT02559310|62931921|FG001|Overall Study|Randomized but not treated|2|||
33326526|NCT00887224|62703226|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
33326527|NCT00887224|62703224|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
33326528|NCT00887224|62703225|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
33326529|NCT00887224|62703226|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
33326530|NCT00887224|62703224|FG000|Double-blind (DB) Phase|Other|0|||
33326531|NCT00887224|62703225|FG001|Double-blind (DB) Phase|Other|2|||
33326532|NCT00887224|62703226|FG002|Double-blind (DB) Phase|Other|0|||
33326533|NCT00887224|62703224|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
33326534|NCT00887224|62703225|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
33637781|NCT01564407|63040222|FG004|Overall Study|Lost to Follow-up|0|||
33326535|NCT00887224|62703226|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
33326536|NCT00887224|62703224|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
33326537|NCT00887224|62703225|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
33326538|NCT00887224|62703226|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
33326539|NCT00887224|62703224|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
33326540|NCT00887224|62703225|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
33326541|NCT00887224|62703226|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
33326542|NCT00887224|62703224|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
33326543|NCT00887224|62703225|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
33326544|NCT00887224|62703226|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
33326545|NCT00887224|62703224|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
33326546|NCT00887224|62703225|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
33326547|NCT00887224|62703226|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
33326548|NCT00887224|62703224|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
33326549|NCT00887224|62703225|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
33326550|NCT00887224|62703226|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
33326551|NCT00887224|62703224|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
33326552|NCT00887224|62703225|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
33326553|NCT00887224|62703226|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
33326554|NCT00887224|62703224|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
33637782|NCT01564407|63040218|FG000|Overall Study|Withdrawal by Subject|0|||
33637783|NCT01564407|63040219|FG001|Overall Study|Withdrawal by Subject|1|||
33637784|NCT01564407|63040220|FG002|Overall Study|Withdrawal by Subject|0|||
33637785|NCT01564407|63040221|FG003|Overall Study|Withdrawal by Subject|0|||
33637786|NCT01564407|63040222|FG004|Overall Study|Withdrawal by Subject|0|||
33637787|NCT01564407|63040218|FG000|Overall Study|funding lost, study ended|0|||
33637788|NCT01564407|63040219|FG001|Overall Study|funding lost, study ended|0|||
33637789|NCT01564407|63040220|FG002|Overall Study|funding lost, study ended|0|||
33637790|NCT01564407|63040221|FG003|Overall Study|funding lost, study ended|1|||
33637791|NCT01564407|63040222|FG004|Overall Study|funding lost, study ended|0|||
33637792|NCT01590771|63040245|FG000|Overall Study|Other Protocol Specified Criteria|5|||
33637793|NCT01590771|63040246|FG001|Overall Study|Other Protocol Specified Criteria|14|||
33637794|NCT01590771|63040245|FG000|Overall Study|Withdrawal by Subject|8|||
33637795|NCT01590771|63040246|FG001|Overall Study|Withdrawal by Subject|15|||
33637796|NCT01590771|63040245|FG000|Overall Study|Protocol Violation|1|||
33637797|NCT01590771|63040246|FG001|Overall Study|Protocol Violation|2|||
33637798|NCT01590771|63040245|FG000|Overall Study|Lost to Follow-up|1|||
33637799|NCT01590771|63040246|FG001|Overall Study|Lost to Follow-up|1|||
33637800|NCT01590771|63040245|FG000|Overall Study|Lack of Efficacy|1|||
33326555|NCT00887224|62703225|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
33326556|NCT00887224|62703226|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
33326557|NCT00887224|62703224|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
33326558|NCT00887224|62703225|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
33462596|NCT03449134|62836457|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
33462597|NCT03449134|62836458|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
33462598|NCT03449134|62836459|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
33462599|NCT03449134|62836457|FG000|52-Week Treatment Period|Site Closure|1|||
33462600|NCT03449134|62836458|FG001|52-Week Treatment Period|Site Closure|0|||
33462601|NCT03449134|62836459|FG002|52-Week Treatment Period|Site Closure|0|||
33462602|NCT03529162|62836472|FG000|Overall Study|Lost to Follow-up|2|||
33462603|NCT03529162|62836473|FG001|Overall Study|Lost to Follow-up|2|||
33462604|NCT03447730|62836484|FG000|Overall Study|Adverse Event|0|||
33462605|NCT03447730|62836485|FG001|Overall Study|Adverse Event|2|||
33462606|NCT03447730|62836486|FG002|Overall Study|Adverse Event|0|||
33637801|NCT01590771|63040246|FG001|Overall Study|Lack of Efficacy|0|||
33637802|NCT01590771|63040245|FG000|Overall Study|Adverse Event|3|||
33637803|NCT01590771|63040246|FG001|Overall Study|Adverse Event|7|||
33462607|NCT03429556|62836498|FG000|Overall Study|Lost to Follow-up|0|||
33462608|NCT03429556|62836499|FG001|Overall Study|Lost to Follow-up|1|||
33637804|NCT01563237|63040252|FG000|Overall Study|Lost to Follow-up|6|||
33637805|NCT01563237|63040253|FG001|Overall Study|Lost to Follow-up|0|||
33637806|NCT01563237|63040252|FG000|Overall Study|Withdrawal by Subject|1|||
33637807|NCT01563237|63040253|FG001|Overall Study|Withdrawal by Subject|0|||
33462609|NCT03429556|62836500|FG002|Overall Study|Lost to Follow-up|0|||
33637808|NCT01563237|63040252|FG000|Overall Study|Adverse Event|1|||
33637809|NCT01563237|63040253|FG001|Overall Study|Adverse Event|0|||
33637810|NCT01563237|63040252|FG000|Overall Study|Medical Reasons|1|||
33637811|NCT01563237|63040253|FG001|Overall Study|Medical Reasons|0|||
33637812|NCT01563237|63040252|FG000|Overall Study|Death|1|||
33637813|NCT01563237|63040253|FG001|Overall Study|Death|0|||
33637814|NCT01694433|63040269|FG000|Overall Study|Adverse Event|7|||
33637815|NCT01694433|63040270|FG001|Overall Study|Adverse Event|0|||
33637816|NCT01694433|63040269|FG000|Overall Study|Physician Decision|1|||
33637817|NCT01694433|63040270|FG001|Overall Study|Physician Decision|0|||
33637818|NCT01694433|63040269|FG000|Overall Study|Withdrawal by Subject|3|||
33637819|NCT01694433|63040270|FG001|Overall Study|Withdrawal by Subject|4|||
33637820|NCT01694121|63040278|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
33637821|NCT01694121|63040279|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
33637822|NCT01562613|63040285|FG000|Overall Study|Lost to Follow-up|2|||
33637823|NCT01562613|63040285|FG000|Overall Study|Withdrawal by Subject|2|||
33637824|NCT01693185|63040291|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
33541343|NCT03517449|62931929|FG000|Overall Study|Death|184|||
33637825|NCT01693185|63040292|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
33637826|NCT01693029|63040307|FG000|Overall Study|Withdrawal by Subject|15|||
33637827|NCT01693029|63040308|FG001|Overall Study|Withdrawal by Subject|22|||
33637828|NCT01693029|63040307|FG000|Overall Study|Kidney transplantation|7|||
33637829|NCT01693029|63040308|FG001|Overall Study|Kidney transplantation|7|||
33637830|NCT01693029|63040307|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
33637831|NCT01693029|63040308|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
33637832|NCT01693029|63040307|FG000|Overall Study|Protocol Violation|6|||
33637833|NCT01693029|63040308|FG001|Overall Study|Protocol Violation|7|||
33637834|NCT01693029|63040307|FG000|Overall Study|Change in dialysis modality|2|||
33637835|NCT01693029|63040308|FG001|Overall Study|Change in dialysis modality|1|||
33637836|NCT01693029|63040307|FG000|Overall Study|Physician Decision|0|||
33637837|NCT01693029|63040308|FG001|Overall Study|Physician Decision|2|||
33637838|NCT01693029|63040307|FG000|Overall Study|Lost to Follow-up|0|||
33637839|NCT01693029|63040308|FG001|Overall Study|Lost to Follow-up|1|||
33637840|NCT01693029|63040307|FG000|Overall Study|Adverse Event|1|||
33637841|NCT01693029|63040308|FG001|Overall Study|Adverse Event|6|||
33637842|NCT01693029|63040307|FG000|Overall Study|Death|5|||
33637843|NCT01693029|63040308|FG001|Overall Study|Death|8|||
33637844|NCT01693029|63040307|FG000|Overall Study|Non-compliance|2|||
33637845|NCT01693029|63040308|FG001|Overall Study|Non-compliance|1|||
33637846|NCT01589445|63040314|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
33637847|NCT01589445|63040314|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
33637848|NCT01589445|63040314|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
33637849|NCT01589445|63040314|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
33637850|NCT01589445|63040314|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
33637851|NCT01589445|63040314|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
33637852|NCT01589445|63040314|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
33637853|NCT01589445|63040314|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
33637854|NCT01589445|63040314|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
33637855|NCT01589445|63040314|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
33637856|NCT01588509|63040324|FG000|Overall Study|Lost to Follow-up|1|||
33637857|NCT01588509|63040325|FG001|Overall Study|Lost to Follow-up|0|||
33462610|NCT03429556|62836501|FG003|Overall Study|Lost to Follow-up|0|||
33462611|NCT03428152|62836513|FG000|Overall Study|Physician Decision|4|||
33462612|NCT03428152|62836514|FG001|Overall Study|Physician Decision|2|||
33462613|NCT03428152|62836513|FG000|Overall Study|Protocol Violation|3|||
33462614|NCT03428152|62836514|FG001|Overall Study|Protocol Violation|5|||
33462615|NCT03428152|62836513|FG000|Overall Study|Lack of Efficacy|0|||
33462616|NCT03428152|62836514|FG001|Overall Study|Lack of Efficacy|4|||
33462617|NCT03444766|62836520|FG000|Overall Study|Other Reasons|2|||
33541344|NCT03517449|62931930|FG001|Overall Study|Death|236|||
33637858|NCT01588353|63040334|FG000|Step2|Withdrawal by Subject|0|||
33637859|NCT01588353|63040335|FG001|Step2|Withdrawal by Subject|1|||
33637860|NCT01588353|63040336|FG002|Step2|Withdrawal by Subject|0|||
33637861|NCT01588353|63040334|FG000|Step3|Adverse Event|0|||
33637862|NCT01588353|63040335|FG001|Step3|Adverse Event|0|||
33637863|NCT01588353|63040336|FG002|Step3|Adverse Event|2|||
33637864|NCT01588197|63040345|FG000|Overall Study|Lack of Efficacy|0|||
33637865|NCT01588197|63040346|FG001|Overall Study|Lack of Efficacy|1|||
33637866|NCT01588197|63040345|FG000|Overall Study|No MRI|1|||
33637867|NCT01588197|63040346|FG001|Overall Study|No MRI|0|||
33637868|NCT01561989|63040354|FG000|Overall Study|accural target not met.|5|||
33541345|NCT03517449|62931929|FG000|Overall Study|Lost to Follow-up|0|||
33637869|NCT01561989|63040355|FG001|Overall Study|accural target not met.|6|||
33637870|NCT01587885|63040370|FG000|Treatment Period 1|Failure to Return|0|||
33637871|NCT01587885|63040371|FG001|Treatment Period 1|Failure to Return|1|||
33637872|NCT01587885|63040370|FG000|Treatment Period 1|Protocol Violation|0|||
33637873|NCT01587885|63040371|FG001|Treatment Period 1|Protocol Violation|2|||
33637874|NCT01587651|63040381|FG000|Overall Study|Adverse Event|0|||
33637875|NCT01587651|63040382|FG001|Overall Study|Adverse Event|1|||
33637876|NCT01587651|63040383|FG002|Overall Study|Adverse Event|0|||
33637877|NCT01587651|63040381|FG000|Overall Study|Protocol Violation|0|||
33637878|NCT01587651|63040382|FG001|Overall Study|Protocol Violation|1|||
33637879|NCT01587651|63040383|FG002|Overall Study|Protocol Violation|1|||
33637880|NCT01587651|63040381|FG000|Overall Study|Withdrawal by Subject|0|||
33637881|NCT01587651|63040382|FG001|Overall Study|Withdrawal by Subject|1|||
33637882|NCT01587651|63040383|FG002|Overall Study|Withdrawal by Subject|0|||
33637883|NCT01691859|63040405|FG000|Overall Study|Adverse Event|19|||
33637884|NCT01691859|63040405|FG000|Overall Study|Lack of Efficacy|11|||
33637885|NCT01691859|63040405|FG000|Overall Study|Protocol Violation|4|||
33637886|NCT01691859|63040405|FG000|Overall Study|Product commercially available|221|||
33637887|NCT01691859|63040405|FG000|Overall Study|Study closed/terminated|50|||
33637888|NCT01691859|63040405|FG000|Overall Study|Lost to Follow-up|5|||
33637889|NCT01691859|63040405|FG000|Overall Study|Physician Decision|6|||
33637890|NCT01691859|63040405|FG000|Overall Study|Withdrawal by Subject|31|||
33637891|NCT01691781|63040449|FG000|Overall Study|Withdrawal by Subject|4|||
33637892|NCT01691781|63040450|FG001|Overall Study|Withdrawal by Subject|3|||
33637893|NCT01691781|63040449|FG000|Overall Study|Physician Decision|1|||
33637894|NCT01691781|63040450|FG001|Overall Study|Physician Decision|1|||
33637895|NCT01691781|63040449|FG000|Overall Study|Protocol Violation|2|||
33637896|NCT01691781|63040450|FG001|Overall Study|Protocol Violation|2|||
33637897|NCT01691781|63040449|FG000|Overall Study|Adverse Event|0|||
33637898|NCT01691781|63040450|FG001|Overall Study|Adverse Event|1|||
33637899|NCT01561755|63040458|FG000|Overall Study|Lost to Follow-up|0|||
33637900|NCT01561755|63040459|FG001|Overall Study|Lost to Follow-up|1|||
33637901|NCT01585155|63040479|FG000|Overall Study|Adverse Event|1|||
33637902|NCT01585155|63040479|FG000|Overall Study|Lack of Efficacy|2|||
33637903|NCT01585155|63040479|FG000|Overall Study|Worsening ulcerative colitis|2|||
33637904|NCT01560507|63040486|FG000|Overall Study|Lost to Follow-up|3|||
33637905|NCT01560507|63040487|FG001|Overall Study|Lost to Follow-up|1|||
33637906|NCT01560507|63040488|FG002|Overall Study|Lost to Follow-up|2|||
33637907|NCT01560507|63040486|FG000|Overall Study|Withdrawal by Subject|1|||
33637908|NCT01560507|63040487|FG001|Overall Study|Withdrawal by Subject|1|||
33637909|NCT01560507|63040488|FG002|Overall Study|Withdrawal by Subject|0|||
33637910|NCT01584843|63040503|FG000|First Treatment Period|Adverse Event|0|||
33637911|NCT01584843|63040504|FG001|First Treatment Period|Adverse Event|0|||
33637912|NCT01584843|63040505|FG002|First Treatment Period|Adverse Event|1|||
33637913|NCT01584843|63040506|FG003|First Treatment Period|Adverse Event|0|||
33637914|NCT01584843|63040507|FG004|First Treatment Period|Adverse Event|0|||
33637915|NCT01584843|63040508|FG005|First Treatment Period|Adverse Event|0|||
33637916|NCT01584843|63040503|FG000|First Treatment Period|Protocol Violation|0|||
33462618|NCT03444766|62836520|FG000|Overall Study|Participant Withdrew Consent|5|||
33462619|NCT03444766|62836520|FG000|Overall Study|Lost to Follow-up|2|||
33462620|NCT03444766|62836520|FG000|Overall Study|Death|2|||
33462621|NCT03444766|62836520|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
33462622|NCT03444766|62836520|FG000|Overall Study|Disease Progression|49|||
33462623|NCT03426436|62836524|FG000|Overall Study|Incorrect lead placement|12|||
33462624|NCT03426436|62836524|FG000|Overall Study|Withdrawal by Subject|2|||
33462625|NCT03426436|62836524|FG000|Overall Study|Consent issue|1|||
33462626|NCT03426436|62836524|FG000|Overall Study|ECGs not saved|4|||
33462627|NCT03425188|62836528|FG000|Overall Study|Withdrawal by Subject|1|||
33462628|NCT03423238|62836535|FG000|Overall Study|Lost to Follow-up|1|||
33462629|NCT03423238|62836536|FG001|Overall Study|Lost to Follow-up|0|||
33462630|NCT03423238|62836535|FG000|Overall Study|Withdrawal by Subject|1|||
33462631|NCT03423238|62836536|FG001|Overall Study|Withdrawal by Subject|0|||
33462632|NCT02953678|62836543|FG000|Overall Study|Adverse Event|20|||
33637917|NCT01584843|63040504|FG001|First Treatment Period|Protocol Violation|0|||
33637918|NCT01584843|63040505|FG002|First Treatment Period|Protocol Violation|0|||
33462633|NCT02953678|62836543|FG000|Overall Study|Death|7|||
33637919|NCT01584843|63040506|FG003|First Treatment Period|Protocol Violation|0|||
33637920|NCT01584843|63040507|FG004|First Treatment Period|Protocol Violation|0|||
33637921|NCT01584843|63040508|FG005|First Treatment Period|Protocol Violation|1|||
33637922|NCT01584843|63040503|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
33637923|NCT01584843|63040504|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
33637924|NCT01584843|63040505|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
33637925|NCT01584843|63040506|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
33637926|NCT01584843|63040507|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
33637927|NCT01584843|63040508|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
33637928|NCT01584843|63040503|FG000|Second Treatment Period|Withdrawal by Subject|0|||
33637929|NCT01584843|63040504|FG001|Second Treatment Period|Withdrawal by Subject|0|||
33637930|NCT01584843|63040505|FG002|Second Treatment Period|Withdrawal by Subject|0|||
33637931|NCT01584843|63040506|FG003|Second Treatment Period|Withdrawal by Subject|0|||
33637932|NCT01584843|63040507|FG004|Second Treatment Period|Withdrawal by Subject|0|||
33637933|NCT01584843|63040508|FG005|Second Treatment Period|Withdrawal by Subject|1|||
33637934|NCT01560429|63040526|FG000|Overall Study|Protocol Violation|3|||
33637935|NCT01560429|63040527|FG001|Overall Study|Protocol Violation|6|||
33637936|NCT01582971|63040537|FG000|Overall Study|Death|2|||
33637937|NCT01582971|63040538|FG001|Overall Study|Death|1|||
33637938|NCT01582971|63040537|FG000|Overall Study|Lost to Follow-up|18|||
33637939|NCT01582971|63040538|FG001|Overall Study|Lost to Follow-up|21|||
33637940|NCT01582971|63040537|FG000|Overall Study|Withdrawal by Subject|4|||
33637941|NCT01582971|63040538|FG001|Overall Study|Withdrawal by Subject|2|||
33637942|NCT01582971|63040537|FG000|Overall Study|Other|15|||
33637943|NCT01582971|63040538|FG001|Overall Study|Other|13|||
33637944|NCT01690299|63040553|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
33637945|NCT01690299|63040554|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
33637946|NCT01690299|63040555|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
33637947|NCT01690299|63040556|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
33637948|NCT01690299|63040557|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
33637949|NCT01690299|63040558|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
33637950|NCT01690299|63040553|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
33637951|NCT01690299|63040554|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33637952|NCT01690299|63040555|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33637953|NCT01690299|63040556|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33637954|NCT01690299|63040557|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33637955|NCT01690299|63040558|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33637956|NCT01690299|63040553|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
33637957|NCT01690299|63040554|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
33637958|NCT01690299|63040555|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33637959|NCT01690299|63040556|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33637960|NCT01690299|63040557|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33637961|NCT01690299|63040558|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33637962|NCT01690299|63040553|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
33637963|NCT01690299|63040554|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
33637964|NCT01690299|63040555|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
33637965|NCT01690299|63040556|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
33637966|NCT01690299|63040557|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
33637967|NCT01690299|63040558|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
33637968|NCT01690299|63040553|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
33637969|NCT01690299|63040554|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
33637970|NCT01690299|63040555|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
33637971|NCT01690299|63040556|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
33637972|NCT01690299|63040557|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
33637973|NCT01690299|63040558|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
33637974|NCT01690299|63040553|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
33637975|NCT01690299|63040554|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
33637976|NCT01690299|63040555|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
33637977|NCT01690299|63040556|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
33541346|NCT03517449|62931930|FG001|Overall Study|Lost to Follow-up|2|||
33541347|NCT03517449|62931929|FG000|Overall Study|Withdrawal by Subject|7|||
33541348|NCT03517449|62931930|FG001|Overall Study|Withdrawal by Subject|26|||
33637978|NCT01690299|63040557|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
33637979|NCT01690299|63040558|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
33637980|NCT01690299|63040553|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
33462634|NCT02953678|62836543|FG000|Overall Study|Physician Decision|23|||
33462635|NCT02953678|62836543|FG000|Overall Study|Progressive Disease of GVHD|7|||
33462636|NCT02953678|62836543|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
33462637|NCT02953678|62836543|FG000|Overall Study|Withdrawal by participant|3|||
33462638|NCT02953678|62836543|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
33462639|NCT02953678|62836543|FG000|Overall Study|Participants were transferred to commercial product.|3|||
33462640|NCT03412084|62836550|FG000|Overall Study|Withdrawal by Subject|2|||
33462641|NCT03412084|62836551|FG001|Overall Study|Withdrawal by Subject|0|||
33462642|NCT03412084|62836550|FG000|Overall Study|Participant moved|1|||
33637981|NCT01690299|63040554|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
33637982|NCT01690299|63040555|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
33637983|NCT01690299|63040556|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
33637984|NCT01690299|63040557|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
33637985|NCT01690299|63040558|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
33637986|NCT01690299|63040553|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
33637987|NCT01690299|63040554|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
33637988|NCT01690299|63040555|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
33637989|NCT01690299|63040556|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
33637990|NCT01690299|63040557|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
33637991|NCT01690299|63040558|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
33637992|NCT01690299|63040553|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
33637993|NCT01690299|63040554|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
33637994|NCT01690299|63040555|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
33637995|NCT01690299|63040556|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
33326559|NCT00887224|62703226|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
33637996|NCT01690299|63040557|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
33637997|NCT01690299|63040558|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
33637998|NCT01690299|63040553|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
33637999|NCT01690299|63040554|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
33638000|NCT01690299|63040555|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
33638001|NCT01690299|63040556|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
33638002|NCT01690299|63040557|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
33638003|NCT01690299|63040558|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
33638004|NCT01690143|63040587|FG000|Overall Study|Withdrawal by Subject|1|||
33638005|NCT01559259|63040606|FG000|Overall Study|Withdrawal by Subject|0|||
33638006|NCT01559259|63040607|FG001|Overall Study|Withdrawal by Subject|0|||
33638007|NCT01559259|63040608|FG002|Overall Study|Withdrawal by Subject|0|||
33638008|NCT01559259|63040609|FG003|Overall Study|Withdrawal by Subject|1|||
33638009|NCT01559259|63040610|FG004|Overall Study|Withdrawal by Subject|0|||
33638010|NCT01559259|63040606|FG000|Overall Study|Adverse Event|0|||
33638011|NCT01559259|63040607|FG001|Overall Study|Adverse Event|1|||
33638012|NCT01559259|63040608|FG002|Overall Study|Adverse Event|1|||
33638013|NCT01559259|63040609|FG003|Overall Study|Adverse Event|0|||
33638014|NCT01559259|63040610|FG004|Overall Study|Adverse Event|0|||
33638015|NCT01670500|63040634|FG000|Overall Study|Withdrawal by Subject|1|||
33638016|NCT01670500|63040635|FG001|Overall Study|Withdrawal by Subject|0|||
33638017|NCT02400736|63040643|FG000|Overall Study|Lost to Follow-up|6|||
33638018|NCT02400736|63040644|FG001|Overall Study|Lost to Follow-up|6|||
33638019|NCT02400736|63040643|FG000|Overall Study|Withdrawal by Subject|2|||
33638020|NCT02400736|63040644|FG001|Overall Study|Withdrawal by Subject|1|||
33638021|NCT02400736|63040643|FG000|Overall Study|Moved from the area|3|||
33638022|NCT02400736|63040644|FG001|Overall Study|Moved from the area|1|||
33638023|NCT01689519|63040656|FG000|Intent to Treat|Death|157|||
33638024|NCT01689519|63040657|FG001|Intent to Treat|Death|167|||
33638025|NCT01689519|63040656|FG000|Intent to Treat|Lost to Follow-up|4|||
33638026|NCT01689519|63040657|FG001|Intent to Treat|Lost to Follow-up|8|||
33638027|NCT01689519|63040656|FG000|Intent to Treat|Other|2|||
33638028|NCT01689519|63040657|FG001|Intent to Treat|Other|4|||
33638029|NCT01689519|63040656|FG000|Intent to Treat|Physician Decision|4|||
33638030|NCT01689519|63040657|FG001|Intent to Treat|Physician Decision|1|||
33638031|NCT01689519|63040656|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
33638032|NCT01689519|63040657|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
33638033|NCT01689519|63040656|FG000|Intent to Treat|Withdrawal by Subject|21|||
33638034|NCT01689519|63040657|FG001|Intent to Treat|Withdrawal by Subject|20|||
33638035|NCT01689519|63040656|FG000|Safety Population|Death|158|||
33638036|NCT01689519|63040657|FG001|Safety Population|Death|165|||
33638037|NCT01689519|63040656|FG000|Safety Population|Lost to Follow-up|4|||
33638038|NCT01689519|63040657|FG001|Safety Population|Lost to Follow-up|8|||
33638039|NCT01689519|63040656|FG000|Safety Population|Other|2|||
33638040|NCT01689519|63040657|FG001|Safety Population|Other|4|||
33638041|NCT01689519|63040656|FG000|Safety Population|Physician Decision|4|||
33638042|NCT01689519|63040657|FG001|Safety Population|Physician Decision|1|||
33638043|NCT01689519|63040656|FG000|Safety Population|Study Terminated By Sponsor|60|||
33638044|NCT01689519|63040657|FG001|Safety Population|Study Terminated By Sponsor|47|||
33638045|NCT01689519|63040656|FG000|Safety Population|Withdrawal by Subject|20|||
33638046|NCT01689519|63040657|FG001|Safety Population|Withdrawal by Subject|20|||
33638047|NCT01689363|63040663|FG000|Overall Study|Protocol Violation|0|||
33638048|NCT01689363|63040664|FG001|Overall Study|Protocol Violation|1|||
33638049|NCT01689363|63040665|FG002|Overall Study|Protocol Violation|0|||
33462643|NCT03412084|62836551|FG001|Overall Study|Participant moved|0|||
33462644|NCT03412084|62836550|FG000|Overall Study|Lost to Follow-up|1|||
33462645|NCT03412084|62836551|FG001|Overall Study|Lost to Follow-up|1|||
33462646|NCT00090753|62836559|FG000|First Treatment Period|Adverse Event|20|||
33462647|NCT00090753|62836560|FG001|First Treatment Period|Adverse Event|8|||
33462648|NCT00090753|62836559|FG000|First Treatment Period|Death|88|||
33462649|NCT00090753|62836560|FG001|First Treatment Period|Death|62|||
33462650|NCT00090753|62836559|FG000|First Treatment Period|Lack of Efficacy|2|||
33462651|NCT00090753|62836560|FG001|First Treatment Period|Lack of Efficacy|1|||
33462652|NCT00090753|62836559|FG000|First Treatment Period|Refused Treatment|32|||
33462653|NCT00090753|62836560|FG001|First Treatment Period|Refused Treatment|25|||
33462654|NCT00090753|62836559|FG000|First Treatment Period|Lost to Follow-up|4|||
33462655|NCT00090753|62836560|FG001|First Treatment Period|Lost to Follow-up|4|||
33462656|NCT00090753|62836559|FG000|First Treatment Period|Renal Transplant|70|||
33638050|NCT01689363|63040666|FG003|Overall Study|Protocol Violation|0|||
33638051|NCT01689363|63040667|FG004|Overall Study|Protocol Violation|0|||
33462657|NCT00090753|62836560|FG001|First Treatment Period|Renal Transplant|50|||
33462658|NCT00090753|62836559|FG000|First Treatment Period|Mircera Commercialization|1|||
33462659|NCT00090753|62836560|FG001|First Treatment Period|Mircera Commercialization|0|||
33462660|NCT00090753|62836559|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
33462661|NCT00090753|62836560|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
33462662|NCT00090753|62836559|FG000|Extended Treatment Period|Adverse Event|11|||
33462663|NCT00090753|62836560|FG001|Extended Treatment Period|Adverse Event|0|||
33462664|NCT00090753|62836559|FG000|Extended Treatment Period|Death|58|||
33462665|NCT00090753|62836560|FG001|Extended Treatment Period|Death|30|||
33462666|NCT00090753|62836559|FG000|Extended Treatment Period|Lack of Efficacy|1|||
33462667|NCT00090753|62836560|FG001|Extended Treatment Period|Lack of Efficacy|0|||
33462668|NCT00090753|62836559|FG000|Extended Treatment Period|Refused Treatment|18|||
33462669|NCT00090753|62836560|FG001|Extended Treatment Period|Refused Treatment|12|||
33462670|NCT00090753|62836559|FG000|Extended Treatment Period|Lost to Follow-up|3|||
33462671|NCT00090753|62836560|FG001|Extended Treatment Period|Lost to Follow-up|1|||
33638052|NCT01689363|63040668|FG005|Overall Study|Protocol Violation|0|||
33638053|NCT01689363|63040669|FG006|Overall Study|Protocol Violation|0|||
33638054|NCT01689363|63040670|FG007|Overall Study|Protocol Violation|0|||
33638055|NCT01558635|63040686|FG000|Overall Study|Death|1|||
33638056|NCT01558635|63040686|FG000|Overall Study|Withdrawal by Subject|2|||
33638057|NCT01558635|63040686|FG000|Overall Study|Physician Decision|1|||
33638058|NCT01558635|63040686|FG000|Overall Study|Subject received other treatment|1|||
33638059|NCT01558635|63040686|FG000|Overall Study|Reveal XT was explanted|1|||
33638060|NCT00089986|63040700|FG000|Overall Study|Adverse Event|6|||
33638061|NCT00089986|63040701|FG001|Overall Study|Adverse Event|9|||
33638062|NCT00089986|63040702|FG002|Overall Study|Adverse Event|6|||
33638063|NCT00089986|63040700|FG000|Overall Study|Lost to Follow-up|3|||
33638064|NCT00089986|63040701|FG001|Overall Study|Lost to Follow-up|1|||
33638065|NCT00089986|63040702|FG002|Overall Study|Lost to Follow-up|1|||
33638066|NCT00089986|63040700|FG000|Overall Study|Protocol Violation|0|||
33638067|NCT00089986|63040701|FG001|Overall Study|Protocol Violation|1|||
33638068|NCT00089986|63040702|FG002|Overall Study|Protocol Violation|0|||
33638069|NCT00089986|63040700|FG000|Overall Study|Patient transferred to another hospital|2|||
33638070|NCT00089986|63040701|FG001|Overall Study|Patient transferred to another hospital|1|||
33638071|NCT00089986|63040702|FG002|Overall Study|Patient transferred to another hospital|0|||
33638072|NCT00089986|63040700|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
33638073|NCT00089986|63040701|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
33638074|NCT00089986|63040702|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
33638075|NCT00089986|63040700|FG000|Overall Study|Hemohlobin stopping rule|0|||
33638076|NCT00089986|63040701|FG001|Overall Study|Hemohlobin stopping rule|1|||
33638077|NCT00089986|63040702|FG002|Overall Study|Hemohlobin stopping rule|0|||
33638078|NCT00089986|63040700|FG000|Overall Study|Investigator decision to withdrew|0|||
33638079|NCT00089986|63040701|FG001|Overall Study|Investigator decision to withdrew|1|||
33638080|NCT00089986|63040702|FG002|Overall Study|Investigator decision to withdrew|0|||
33638081|NCT00089986|63040700|FG000|Overall Study|Enrollment in another study|0|||
33638082|NCT00089986|63040701|FG001|Overall Study|Enrollment in another study|1|||
33638083|NCT00089986|63040702|FG002|Overall Study|Enrollment in another study|0|||
33638084|NCT00089986|63040700|FG000|Overall Study|Family decision|0|||
33638085|NCT00089986|63040701|FG001|Overall Study|Family decision|1|||
33638086|NCT00089986|63040702|FG002|Overall Study|Family decision|0|||
33638087|NCT00089986|63040700|FG000|Overall Study|Do not resuscitate (DNR)|0|||
33638088|NCT00089986|63040701|FG001|Overall Study|Do not resuscitate (DNR)|0|||
33638089|NCT00089986|63040702|FG002|Overall Study|Do not resuscitate (DNR)|1|||
33638090|NCT00089986|63040700|FG000|Overall Study|Withdrawal by Subject|3|||
33638091|NCT00089986|63040701|FG001|Overall Study|Withdrawal by Subject|6|||
33638092|NCT00089986|63040702|FG002|Overall Study|Withdrawal by Subject|2|||
33638093|NCT01689207|63040725|FG000|Overall Study|Adverse Event|0|||
33638094|NCT01689207|63040726|FG001|Overall Study|Adverse Event|1|||
33638095|NCT01689207|63040727|FG002|Overall Study|Adverse Event|0|||
33638096|NCT01689207|63040728|FG003|Overall Study|Adverse Event|0|||
33638097|NCT01689207|63040729|FG004|Overall Study|Adverse Event|2|||
33638098|NCT01689207|63040730|FG005|Overall Study|Adverse Event|1|||
33638099|NCT01689207|63040731|FG006|Overall Study|Adverse Event|0|||
33638100|NCT01689207|63040732|FG007|Overall Study|Adverse Event|0|||
33638101|NCT01689207|63040733|FG008|Overall Study|Adverse Event|1|||
33638102|NCT01689207|63040734|FG009|Overall Study|Adverse Event|0|||
33638103|NCT01689207|63040735|FG010|Overall Study|Adverse Event|0|||
33638104|NCT00089284|63040770|FG000|Overall Study|Adverse event before starting treatment|0|||
33638105|NCT00089284|63040771|FG001|Overall Study|Adverse event before starting treatment|0|||
33638106|NCT00089284|63040772|FG002|Overall Study|Adverse event before starting treatment|0|||
33541349|NCT03517449|62931929|FG000|Overall Study|Participants Ongoing|220|||
33541350|NCT03517449|62931930|FG001|Overall Study|Participants Ongoing|152|||
33541351|NCT02555878|62931938|FG000|Overall Study|Lost to Follow-up|2|||
33541352|NCT02555878|62931939|FG001|Overall Study|Lost to Follow-up|3|||
33541353|NCT02555878|62931938|FG000|Overall Study|Withdrawal by Subject|48|||
33541354|NCT02555878|62931939|FG001|Overall Study|Withdrawal by Subject|48|||
33638107|NCT00089284|63040773|FG003|Overall Study|Adverse event before starting treatment|0|||
33638108|NCT00089284|63040774|FG004|Overall Study|Adverse event before starting treatment|0|||
33638109|NCT00089284|63040775|FG005|Overall Study|Adverse event before starting treatment|0|||
33638110|NCT00089284|63040776|FG006|Overall Study|Adverse event before starting treatment|1|||
33638111|NCT01688973|63040800|FG000|Overall Study|Ineligible|2|||
33638112|NCT01688973|63040801|FG001|Overall Study|Ineligible|3|||
33638113|NCT00087646|63040812|FG000|Overall Study|Adverse Event|37|||
33638114|NCT00087646|63040813|FG001|Overall Study|Adverse Event|6|||
33638115|NCT00087646|63040814|FG002|Overall Study|Adverse Event|18|||
33638116|NCT00087646|63040815|FG003|Overall Study|Adverse Event|20|||
33638117|NCT00087646|63040812|FG000|Overall Study|Death|0|||
33638118|NCT00087646|63040813|FG001|Overall Study|Death|1|||
33638119|NCT00087646|63040814|FG002|Overall Study|Death|0|||
33638120|NCT00087646|63040815|FG003|Overall Study|Death|0|||
33638121|NCT00087646|63040812|FG000|Overall Study|Withdrawal by Subject|6|||
33638122|NCT00087646|63040813|FG001|Overall Study|Withdrawal by Subject|1|||
33638123|NCT00087646|63040814|FG002|Overall Study|Withdrawal by Subject|2|||
33638124|NCT00087646|63040815|FG003|Overall Study|Withdrawal by Subject|2|||
33638125|NCT00087646|63040812|FG000|Overall Study|Insufficient therapeutic response|64|||
33638126|NCT00087646|63040813|FG001|Overall Study|Insufficient therapeutic response|24|||
33638127|NCT00087646|63040814|FG002|Overall Study|Insufficient therapeutic response|38|||
33638128|NCT00087646|63040815|FG003|Overall Study|Insufficient therapeutic response|51|||
33638129|NCT00087646|63040812|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
33638130|NCT00087646|63040813|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
33638131|NCT00087646|63040814|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
33638132|NCT00087646|63040815|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
33638133|NCT00087646|63040812|FG000|Overall Study|Failure to Return|5|||
33638134|NCT00087646|63040813|FG001|Overall Study|Failure to Return|2|||
33638135|NCT00087646|63040814|FG002|Overall Study|Failure to Return|2|||
33638136|NCT00087646|63040815|FG003|Overall Study|Failure to Return|3|||
33638137|NCT00087646|63040812|FG000|Overall Study|Administrative/Other|6|||
33638138|NCT00087646|63040813|FG001|Overall Study|Administrative/Other|1|||
33638139|NCT00087646|63040814|FG002|Overall Study|Administrative/Other|1|||
33638140|NCT00087646|63040815|FG003|Overall Study|Administrative/Other|2|||
33638141|NCT00087646|63040812|FG000|Overall Study|Other Protocol Violation|3|||
33638142|NCT00087646|63040813|FG001|Overall Study|Other Protocol Violation|1|||
33638143|NCT00087646|63040814|FG002|Overall Study|Other Protocol Violation|0|||
33326560|NCT01109316|62703244|FG000|Study Period 1|Adverse Event|0|||
33326561|NCT01109316|62703245|FG001|Study Period 1|Adverse Event|0|||
33638144|NCT00087646|63040815|FG003|Overall Study|Other Protocol Violation|0|||
33638145|NCT00087646|63040812|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
33638146|NCT00087646|63040813|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
33638147|NCT00087646|63040814|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
33638148|NCT00087646|63040815|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
33638149|NCT00087568|63040832|FG000|Overall Study|Adverse Event|4|||
33638150|NCT00087568|63040833|FG001|Overall Study|Adverse Event|0|||
33638151|NCT00087568|63040832|FG000|Overall Study|Withdrawal by Subject|1|||
33638152|NCT00087568|63040833|FG001|Overall Study|Withdrawal by Subject|1|||
33326562|NCT01109316|62703246|FG002|Study Period 1|Adverse Event|1|||
33462672|NCT00090753|62836559|FG000|Extended Treatment Period|Renal Transplant|15|||
33462673|NCT00090753|62836560|FG001|Extended Treatment Period|Renal Transplant|12|||
33462674|NCT00090753|62836559|FG000|Extended Treatment Period|Mircera Commercialization|188|||
33462675|NCT00090753|62836560|FG001|Extended Treatment Period|Mircera Commercialization|93|||
33462676|NCT00090753|62836559|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
33462677|NCT00090753|62836560|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
33462678|NCT00048932|62836568|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
33462679|NCT00048932|62836569|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
33462680|NCT00048932|62836570|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
33462681|NCT00048932|62836568|FG000|Double Blind Period (DB)|Adverse Event|51|||
33462682|NCT00048932|62836569|FG001|Double Blind Period (DB)|Adverse Event|19|||
33462683|NCT00048932|62836570|FG002|Double Blind Period (DB)|Adverse Event|0|||
33462684|NCT00048932|62836568|FG000|Double Blind Period (DB)|Death|5|||
33462685|NCT00048932|62836569|FG001|Double Blind Period (DB)|Death|3|||
33462686|NCT00048932|62836570|FG002|Double Blind Period (DB)|Death|0|||
33462687|NCT00048932|62836568|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
33462688|NCT00048932|62836569|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
33462689|NCT00048932|62836570|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
33462690|NCT00048932|62836568|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
33462691|NCT00048932|62836569|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
33638153|NCT00087568|63040832|FG000|Overall Study|Lost to Follow-up|1|||
33638154|NCT00087568|63040833|FG001|Overall Study|Lost to Follow-up|0|||
33541355|NCT02555878|62931938|FG000|Overall Study|Adverse Event|12|||
33638155|NCT00087568|63040832|FG000|Overall Study|Lack of Efficacy|24|||
33638156|NCT00087568|63040833|FG001|Overall Study|Lack of Efficacy|1|||
33638157|NCT00085540|63040841|FG000|Overall Study|Withdrawal by Subject|0|||
33638158|NCT00085540|63040842|FG001|Overall Study|Withdrawal by Subject|1|||
33638159|NCT00085540|63040841|FG000|Overall Study|Protocol Violation|0|||
33638160|NCT00085540|63040842|FG001|Overall Study|Protocol Violation|1|||
33638161|NCT01688739|63040858|FG000|Overall Study|Administrative Decision|1|||
33638162|NCT01688739|63040859|FG001|Overall Study|Administrative Decision|0|||
33638163|NCT01688739|63040860|FG002|Overall Study|Administrative Decision|0|||
33638164|NCT01688739|63040861|FG003|Overall Study|Administrative Decision|0|||
33638165|NCT01688739|63040862|FG004|Overall Study|Administrative Decision|0|||
33638166|NCT01688739|63040863|FG005|Overall Study|Administrative Decision|0|||
33638167|NCT01688739|63040864|FG006|Overall Study|Administrative Decision|0|||
33638168|NCT01688739|63040865|FG007|Overall Study|Administrative Decision|0|||
33638169|NCT01688739|63040866|FG008|Overall Study|Administrative Decision|0|||
33638170|NCT01688739|63040867|FG009|Overall Study|Administrative Decision|0|||
33638171|NCT00084838|63040897|FG000|Overall Study|Death|1|||
33638172|NCT00084838|63040897|FG000|Overall Study|Adverse Event|2|||
33638173|NCT00084838|63040897|FG000|Overall Study|Withdrawal by Subject|1|||
33638174|NCT00084838|63040897|FG000|Overall Study|Progressive Disease|4|||
33638175|NCT00084838|63040897|FG000|Overall Study|Pt Non-Compliance|1|||
33638176|NCT00084838|63040897|FG000|Overall Study|Ineligible|4|||
33638177|NCT01558089|63040903|FG000|Overall Study|Adverse Event|1|||
33638178|NCT01558089|63040903|FG000|Overall Study|Lack of Efficacy|1|||
33638179|NCT01558089|63040903|FG000|Overall Study|Lost to Follow-up|5|||
33638180|NCT01558089|63040903|FG000|Overall Study|Withdrawal by Subject|6|||
33638181|NCT01581021|63040909|FG000|Overall Study|Lost to Follow-up|4|||
33638182|NCT01581021|63040910|FG001|Overall Study|Lost to Follow-up|6|||
33638183|NCT01581021|63040909|FG000|Overall Study|More than 2 hooks in thoracic|3|||
33638184|NCT01581021|63040910|FG001|Overall Study|More than 2 hooks in thoracic|0|||
33638185|NCT01581021|63040909|FG000|Overall Study|Neuromuscular|2|||
33638186|NCT01581021|63040910|FG001|Overall Study|Neuromuscular|1|||
33638187|NCT01581021|63040909|FG000|Overall Study|Not Randomized|1|||
33638188|NCT01581021|63040910|FG001|Overall Study|Not Randomized|2|||
33638189|NCT01581021|63040909|FG000|Overall Study|Lenke 6 Classification|0|||
33638190|NCT01581021|63040910|FG001|Overall Study|Lenke 6 Classification|1|||
33638191|NCT01581021|63040909|FG000|Overall Study|Lack of Efficacy|0|||
33638192|NCT01581021|63040910|FG001|Overall Study|Lack of Efficacy|1|||
33638193|NCT00084682|63040916|FG000|Overall Study|Withdrawal by Subject|1|||
33638194|NCT01556997|63040924|FG000|Overall Study|Adverse Event|10|||
33638195|NCT01556997|63040925|FG001|Overall Study|Adverse Event|12|||
33638196|NCT01556997|63040926|FG002|Overall Study|Adverse Event|12|||
33541356|NCT02555878|62931939|FG001|Overall Study|Adverse Event|8|||
33541357|NCT02555878|62931938|FG000|Overall Study|Death|74|||
33541358|NCT02555878|62931939|FG001|Overall Study|Death|59|||
33541359|NCT02555878|62931938|FG000|Overall Study|Protocol Violation|1|||
33541360|NCT02555878|62931939|FG001|Overall Study|Protocol Violation|2|||
33541361|NCT02555878|62931938|FG000|Overall Study|Physician Decision|12|||
33541362|NCT02555878|62931939|FG001|Overall Study|Physician Decision|13|||
33541363|NCT02555878|62931938|FG000|Overall Study|Other|17|||
33541364|NCT02555878|62931939|FG001|Overall Study|Other|17|||
33541365|NCT02555722|62931947|FG000|Week 2|Adverse Event|0|||
33541366|NCT02555722|62931948|FG001|Week 2|Adverse Event|1|||
33541367|NCT02555722|62931947|FG000|Week 2|Withdrawal by Subject|1|||
33541368|NCT02555722|62931948|FG001|Week 2|Withdrawal by Subject|0|||
33541369|NCT02555722|62931947|FG000|Month 1|Lens Discomfort|1|||
33541370|NCT02555722|62931948|FG001|Month 1|Lens Discomfort|0|||
33541371|NCT02555722|62931947|FG000|Month 2|Withdrawal by Subject|3|||
33541372|NCT02555722|62931948|FG001|Month 2|Withdrawal by Subject|0|||
33541373|NCT02555722|62931947|FG000|Month 2|Lost to Follow-up|1|||
33541374|NCT02555722|62931948|FG001|Month 2|Lost to Follow-up|0|||
33541375|NCT03287960|62932000|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
33541376|NCT03287960|62932000|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
33541377|NCT02558296|62932007|FG000|Completed the Study Through Week 24|Adverse Event|9|||
33541378|NCT02558296|62932008|FG001|Completed the Study Through Week 24|Adverse Event|3|||
33541379|NCT02558296|62932007|FG000|Completed the Study Through Week 24|Death|7|||
33541380|NCT02558296|62932008|FG001|Completed the Study Through Week 24|Death|7|||
33541381|NCT02558296|62932007|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
33541382|NCT02558296|62932008|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
33541383|NCT02558296|62932007|FG000|Completed the Study Through Week 24|Physician Decision|1|||
33638197|NCT01556997|63040924|FG000|Overall Study|Lost to Follow-up|6|||
33638198|NCT01556997|63040925|FG001|Overall Study|Lost to Follow-up|6|||
33638199|NCT01556997|63040926|FG002|Overall Study|Lost to Follow-up|4|||
33638200|NCT01556997|63040924|FG000|Overall Study|Physician Decision|1|||
33541384|NCT02558296|62932008|FG001|Completed the Study Through Week 24|Physician Decision|0|||
33541385|NCT02558296|62932007|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
33541386|NCT02558296|62932008|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
33541387|NCT02558296|62932007|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
33541388|NCT02558296|62932008|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
33541389|NCT02558296|62932007|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
33541390|NCT02558296|62932008|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
33541391|NCT02558296|62932007|FG000|Completed the Study|Adverse Event|14|||
33541392|NCT02558296|62932008|FG001|Completed the Study|Adverse Event|5|||
33541393|NCT02558296|62932007|FG000|Completed the Study|Death|39|||
33541394|NCT02558296|62932008|FG001|Completed the Study|Death|25|||
33541395|NCT02558296|62932007|FG000|Completed the Study|Lost to Follow-up|31|||
33541396|NCT02558296|62932008|FG001|Completed the Study|Lost to Follow-up|23|||
33541397|NCT02558296|62932007|FG000|Completed the Study|Physician Decision|6|||
33541398|NCT02558296|62932008|FG001|Completed the Study|Physician Decision|0|||
33541399|NCT02558296|62932007|FG000|Completed the Study|Protocol Violation|2|||
33326563|NCT01109316|62703247|FG003|Study Period 1|Adverse Event|0|||
33326564|NCT01109316|62703248|FG004|Study Period 1|Adverse Event|0|||
33541400|NCT02558296|62932008|FG001|Completed the Study|Protocol Violation|1|||
33541401|NCT02558296|62932007|FG000|Completed the Study|Withdrawal by Subject|53|||
33541402|NCT02558296|62932008|FG001|Completed the Study|Withdrawal by Subject|31|||
33541403|NCT02558296|62932007|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
33541404|NCT02558296|62932008|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
33541405|NCT02737475|62932045|FG000|Overall Study|Other reasons|0|||
33541406|NCT02737475|62932046|FG001|Overall Study|Other reasons|0|||
33541407|NCT02737475|62932047|FG002|Overall Study|Other reasons|0|||
33541408|NCT02737475|62932048|FG003|Overall Study|Other reasons|0|||
33541409|NCT02737475|62932049|FG004|Overall Study|Other reasons|1|||
33541410|NCT02737475|62932050|FG005|Overall Study|Other reasons|1|||
33541411|NCT02737475|62932051|FG006|Overall Study|Other reasons|0|||
33541412|NCT02737475|62932052|FG007|Overall Study|Other reasons|0|||
33541413|NCT02737475|62932053|FG008|Overall Study|Other reasons|1|||
33541414|NCT02737475|62932054|FG009|Overall Study|Other reasons|0|||
33541415|NCT02737475|62932055|FG010|Overall Study|Other reasons|1|||
33541416|NCT02737475|62932056|FG011|Overall Study|Other reasons|0|||
33541417|NCT02737475|62932057|FG012|Overall Study|Other reasons|0|||
33541418|NCT02737475|62932058|FG013|Overall Study|Other reasons|0|||
33541419|NCT02737475|62932059|FG014|Overall Study|Other reasons|0|||
33541420|NCT02737475|62932060|FG015|Overall Study|Other reasons|0|||
33541421|NCT02737475|62932061|FG016|Overall Study|Other reasons|0|||
33541422|NCT02737475|62932062|FG017|Overall Study|Other reasons|0|||
33541423|NCT02737475|62932063|FG018|Overall Study|Other reasons|0|||
33541424|NCT02737475|62932064|FG019|Overall Study|Other reasons|0|||
33541425|NCT02737475|62932065|FG020|Overall Study|Other reasons|0|||
33541426|NCT02737475|62932066|FG021|Overall Study|Other reasons|1|||
33541427|NCT02737475|62932067|FG022|Overall Study|Other reasons|0|||
33541428|NCT02737475|62932068|FG023|Overall Study|Other reasons|1|||
33541429|NCT02737475|62932069|FG024|Overall Study|Other reasons|1|||
33541430|NCT02737475|62932070|FG025|Overall Study|Other reasons|1|||
33541431|NCT02737475|62932071|FG026|Overall Study|Other reasons|0|||
33541432|NCT02737475|62932045|FG000|Overall Study|Death|1|||
33541433|NCT02737475|62932046|FG001|Overall Study|Death|0|||
33541434|NCT02737475|62932047|FG002|Overall Study|Death|0|||
33541435|NCT02737475|62932048|FG003|Overall Study|Death|1|||
33541436|NCT02737475|62932049|FG004|Overall Study|Death|0|||
33541437|NCT02737475|62932050|FG005|Overall Study|Death|0|||
33638201|NCT01556997|63040925|FG001|Overall Study|Physician Decision|1|||
33462692|NCT00048932|62836570|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
33462693|NCT00048932|62836568|FG000|Double Blind Period (DB)|Relocation|1|||
33462694|NCT00048932|62836569|FG001|Double Blind Period (DB)|Relocation|0|||
33462695|NCT00048932|62836570|FG002|Double Blind Period (DB)|Relocation|0|||
33462696|NCT00048932|62836568|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
33462697|NCT00048932|62836569|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
33462698|NCT00048932|62836570|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
33462699|NCT00048932|62836568|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
33541438|NCT02737475|62932051|FG006|Overall Study|Death|0|||
33541439|NCT02737475|62932052|FG007|Overall Study|Death|2|||
33541440|NCT02737475|62932053|FG008|Overall Study|Death|0|||
33541441|NCT02737475|62932054|FG009|Overall Study|Death|0|||
33541442|NCT02737475|62932055|FG010|Overall Study|Death|0|||
33541443|NCT02737475|62932056|FG011|Overall Study|Death|4|||
33541444|NCT02737475|62932057|FG012|Overall Study|Death|2|||
33541445|NCT02737475|62932058|FG013|Overall Study|Death|2|||
33541446|NCT02737475|62932059|FG014|Overall Study|Death|0|||
33541447|NCT02737475|62932060|FG015|Overall Study|Death|2|||
33541448|NCT02737475|62932061|FG016|Overall Study|Death|2|||
33638202|NCT01556997|63040926|FG002|Overall Study|Physician Decision|1|||
33326565|NCT01109316|62703249|FG005|Study Period 1|Adverse Event|0|||
33326566|NCT01109316|62703244|FG000|Study Period 1|Lost to Follow-up|0|||
33326567|NCT01109316|62703245|FG001|Study Period 1|Lost to Follow-up|0|||
33326568|NCT01109316|62703246|FG002|Study Period 1|Lost to Follow-up|1|||
33326569|NCT01109316|62703247|FG003|Study Period 1|Lost to Follow-up|1|||
33326570|NCT01109316|62703248|FG004|Study Period 1|Lost to Follow-up|0|||
33326571|NCT01109316|62703249|FG005|Study Period 1|Lost to Follow-up|0|||
33326572|NCT01109316|62703244|FG000|Study Period 1|Withdrawal by Subject|0|||
33326573|NCT01109316|62703245|FG001|Study Period 1|Withdrawal by Subject|0|||
33326574|NCT01109316|62703246|FG002|Study Period 1|Withdrawal by Subject|1|||
33326575|NCT01109316|62703247|FG003|Study Period 1|Withdrawal by Subject|0|||
33326576|NCT01109316|62703248|FG004|Study Period 1|Withdrawal by Subject|2|||
33541449|NCT02737475|62932062|FG017|Overall Study|Death|2|||
33541450|NCT02737475|62932063|FG018|Overall Study|Death|1|||
33541451|NCT02737475|62932064|FG019|Overall Study|Death|0|||
33541452|NCT02737475|62932065|FG020|Overall Study|Death|0|||
33541453|NCT02737475|62932066|FG021|Overall Study|Death|0|||
33541454|NCT02737475|62932067|FG022|Overall Study|Death|0|||
33541455|NCT02737475|62932068|FG023|Overall Study|Death|0|||
33541456|NCT02737475|62932069|FG024|Overall Study|Death|0|||
33541457|NCT02737475|62932070|FG025|Overall Study|Death|0|||
33541458|NCT02737475|62932071|FG026|Overall Study|Death|0|||
33541459|NCT02737475|62932045|FG000|Overall Study|Participant withdrew consent|0|||
33541460|NCT02737475|62932046|FG001|Overall Study|Participant withdrew consent|0|||
33541461|NCT02737475|62932047|FG002|Overall Study|Participant withdrew consent|0|||
33541462|NCT02737475|62932048|FG003|Overall Study|Participant withdrew consent|0|||
33541463|NCT02737475|62932049|FG004|Overall Study|Participant withdrew consent|0|||
33541464|NCT02737475|62932050|FG005|Overall Study|Participant withdrew consent|2|||
33541465|NCT02737475|62932051|FG006|Overall Study|Participant withdrew consent|0|||
33541466|NCT02737475|62932052|FG007|Overall Study|Participant withdrew consent|0|||
33541467|NCT02737475|62932053|FG008|Overall Study|Participant withdrew consent|0|||
33541468|NCT02737475|62932054|FG009|Overall Study|Participant withdrew consent|0|||
33541469|NCT02737475|62932055|FG010|Overall Study|Participant withdrew consent|0|||
33541470|NCT02737475|62932056|FG011|Overall Study|Participant withdrew consent|0|||
33541471|NCT02737475|62932057|FG012|Overall Study|Participant withdrew consent|0|||
33541472|NCT02737475|62932058|FG013|Overall Study|Participant withdrew consent|0|||
33541473|NCT02737475|62932059|FG014|Overall Study|Participant withdrew consent|1|||
33541474|NCT02737475|62932060|FG015|Overall Study|Participant withdrew consent|0|||
33541475|NCT02737475|62932061|FG016|Overall Study|Participant withdrew consent|0|||
33541476|NCT02737475|62932062|FG017|Overall Study|Participant withdrew consent|2|||
33541477|NCT02737475|62932063|FG018|Overall Study|Participant withdrew consent|1|||
33541478|NCT02737475|62932064|FG019|Overall Study|Participant withdrew consent|0|||
33541479|NCT02737475|62932065|FG020|Overall Study|Participant withdrew consent|2|||
33541480|NCT02737475|62932066|FG021|Overall Study|Participant withdrew consent|0|||
33541481|NCT02737475|62932067|FG022|Overall Study|Participant withdrew consent|0|||
33541482|NCT02737475|62932068|FG023|Overall Study|Participant withdrew consent|0|||
33541483|NCT02737475|62932069|FG024|Overall Study|Participant withdrew consent|0|||
33541484|NCT02737475|62932070|FG025|Overall Study|Participant withdrew consent|0|||
33541485|NCT02737475|62932071|FG026|Overall Study|Participant withdrew consent|0|||
33541486|NCT02737475|62932045|FG000|Overall Study|Lost to Follow-up|0|||
33541487|NCT02737475|62932046|FG001|Overall Study|Lost to Follow-up|0|||
33541488|NCT02737475|62932047|FG002|Overall Study|Lost to Follow-up|0|||
33541489|NCT02737475|62932048|FG003|Overall Study|Lost to Follow-up|0|||
33541490|NCT02737475|62932049|FG004|Overall Study|Lost to Follow-up|0|||
33541491|NCT02737475|62932050|FG005|Overall Study|Lost to Follow-up|0|||
33638203|NCT01556997|63040924|FG000|Overall Study|Withdrawal by Subject|7|||
33638204|NCT01556997|63040925|FG001|Overall Study|Withdrawal by Subject|6|||
33638205|NCT01556997|63040926|FG002|Overall Study|Withdrawal by Subject|8|||
33638206|NCT01556997|63040924|FG000|Overall Study|Other|2|||
33638207|NCT01556997|63040925|FG001|Overall Study|Other|3|||
33638208|NCT01556997|63040926|FG002|Overall Study|Other|7|||
33638209|NCT00082888|63040937|FG000|Overall Study|Ineligible|1|||
33638210|NCT00082888|63040938|FG001|Overall Study|Ineligible|0|||
33638211|NCT00082888|63040939|FG002|Overall Study|Ineligible|0|||
33638212|NCT00082810|63040948|FG000|Overall Study|Adverse Event|3|||
33638213|NCT00082810|63040948|FG000|Overall Study|Progressive disease|24|||
33638214|NCT00082810|63040948|FG000|Overall Study|Withdrawal by Subject|4|||
33638215|NCT01577745|63040959|FG000|Overall Study|Withdrawal by Subject|0|||
33638216|NCT01577745|63040960|FG001|Overall Study|Withdrawal by Subject|1|||
33638217|NCT01577745|63040961|FG002|Overall Study|Withdrawal by Subject|0|||
33541492|NCT02737475|62932051|FG006|Overall Study|Lost to Follow-up|0|||
33541493|NCT02737475|62932052|FG007|Overall Study|Lost to Follow-up|0|||
33541494|NCT02737475|62932053|FG008|Overall Study|Lost to Follow-up|0|||
33541495|NCT02737475|62932054|FG009|Overall Study|Lost to Follow-up|0|||
33638218|NCT01577745|63040962|FG003|Overall Study|Withdrawal by Subject|3|||
33638219|NCT01577745|63040963|FG004|Overall Study|Withdrawal by Subject|2|||
33638220|NCT01577745|63040964|FG005|Overall Study|Withdrawal by Subject|0|||
33638221|NCT01577745|63040959|FG000|Overall Study|Death|3|||
33462700|NCT00048932|62836569|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
33541496|NCT02737475|62932055|FG010|Overall Study|Lost to Follow-up|0|||
33541497|NCT02737475|62932056|FG011|Overall Study|Lost to Follow-up|0|||
33541498|NCT02737475|62932057|FG012|Overall Study|Lost to Follow-up|0|||
33541499|NCT02737475|62932058|FG013|Overall Study|Lost to Follow-up|0|||
33541500|NCT02737475|62932059|FG014|Overall Study|Lost to Follow-up|0|||
33541501|NCT02737475|62932060|FG015|Overall Study|Lost to Follow-up|1|||
33541502|NCT02737475|62932061|FG016|Overall Study|Lost to Follow-up|0|||
33541503|NCT02737475|62932062|FG017|Overall Study|Lost to Follow-up|0|||
33541504|NCT02737475|62932063|FG018|Overall Study|Lost to Follow-up|0|||
33541505|NCT02737475|62932064|FG019|Overall Study|Lost to Follow-up|0|||
33541506|NCT02737475|62932065|FG020|Overall Study|Lost to Follow-up|0|||
33541507|NCT02737475|62932066|FG021|Overall Study|Lost to Follow-up|0|||
33541508|NCT02737475|62932067|FG022|Overall Study|Lost to Follow-up|0|||
33541509|NCT02737475|62932068|FG023|Overall Study|Lost to Follow-up|0|||
33541510|NCT02737475|62932069|FG024|Overall Study|Lost to Follow-up|0|||
33541511|NCT02737475|62932070|FG025|Overall Study|Lost to Follow-up|0|||
33462701|NCT00048932|62836570|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
33462702|NCT00048932|62836568|FG000|Double Blind Period (DB)|Pregnancy|1|||
33462703|NCT00048932|62836569|FG001|Double Blind Period (DB)|Pregnancy|0|||
33462704|NCT00048932|62836570|FG002|Double Blind Period (DB)|Pregnancy|0|||
33541512|NCT02737475|62932071|FG026|Overall Study|Lost to Follow-up|0|||
33541513|NCT02737475|62932045|FG000|Overall Study|Disease Progression|0|||
33541514|NCT02737475|62932046|FG001|Overall Study|Disease Progression|0|||
33541515|NCT02737475|62932047|FG002|Overall Study|Disease Progression|0|||
33541516|NCT02737475|62932048|FG003|Overall Study|Disease Progression|0|||
33541517|NCT02737475|62932049|FG004|Overall Study|Disease Progression|0|||
33541518|NCT02737475|62932050|FG005|Overall Study|Disease Progression|0|||
33541519|NCT02737475|62932051|FG006|Overall Study|Disease Progression|0|||
33541520|NCT02737475|62932052|FG007|Overall Study|Disease Progression|0|||
33541521|NCT02737475|62932053|FG008|Overall Study|Disease Progression|0|||
33541522|NCT02737475|62932054|FG009|Overall Study|Disease Progression|0|||
33541523|NCT02737475|62932055|FG010|Overall Study|Disease Progression|0|||
33541524|NCT02737475|62932056|FG011|Overall Study|Disease Progression|0|||
33541525|NCT02737475|62932057|FG012|Overall Study|Disease Progression|0|||
33541526|NCT02737475|62932058|FG013|Overall Study|Disease Progression|0|||
33541527|NCT02737475|62932059|FG014|Overall Study|Disease Progression|0|||
33541528|NCT02737475|62932060|FG015|Overall Study|Disease Progression|0|||
33541529|NCT02737475|62932061|FG016|Overall Study|Disease Progression|0|||
33541530|NCT02737475|62932062|FG017|Overall Study|Disease Progression|0|||
33541531|NCT02737475|62932063|FG018|Overall Study|Disease Progression|0|||
33541532|NCT02737475|62932064|FG019|Overall Study|Disease Progression|0|||
33541533|NCT02737475|62932065|FG020|Overall Study|Disease Progression|0|||
33638222|NCT01577745|63040960|FG001|Overall Study|Death|2|||
33462705|NCT00048932|62836568|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
33462706|NCT00048932|62836569|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
33462707|NCT00048932|62836570|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
33462708|NCT00048932|62836568|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
33462709|NCT00048932|62836569|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
33462710|NCT00048932|62836570|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
33462711|NCT00048932|62836568|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
33462712|NCT00048932|62836569|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
33462713|NCT00048932|62836570|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
33462714|NCT00048932|62836568|FG000|Open Label Period (OL)|Death|0|||
33462715|NCT00048932|62836569|FG001|Open Label Period (OL)|Death|0|||
33462716|NCT00048932|62836570|FG002|Open Label Period (OL)|Death|25|||
33462717|NCT00048932|62836568|FG000|Open Label Period (OL)|Adverse Event|0|||
33462718|NCT00048932|62836569|FG001|Open Label Period (OL)|Adverse Event|0|||
33462719|NCT00048932|62836570|FG002|Open Label Period (OL)|Adverse Event|103|||
33462720|NCT00048932|62836568|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
33462721|NCT00048932|62836569|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
33462722|NCT00048932|62836570|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
33462723|NCT00048932|62836568|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
33462724|NCT00048932|62836569|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
33462725|NCT00048932|62836570|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
33462726|NCT00048932|62836568|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
33462727|NCT00048932|62836569|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
33462728|NCT00048932|62836570|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
33541534|NCT02737475|62932066|FG021|Overall Study|Disease Progression|0|||
33541535|NCT02737475|62932067|FG022|Overall Study|Disease Progression|0|||
33541536|NCT02737475|62932068|FG023|Overall Study|Disease Progression|0|||
33541537|NCT02737475|62932069|FG024|Overall Study|Disease Progression|0|||
33541538|NCT02737475|62932070|FG025|Overall Study|Disease Progression|0|||
33541539|NCT02737475|62932071|FG026|Overall Study|Disease Progression|1|||
33541540|NCT02557672|62932161|FG000|Overall Study|Withdrawal by Subject|4|||
33541541|NCT02557672|62932162|FG001|Overall Study|Withdrawal by Subject|2|||
33638223|NCT01577745|63040961|FG002|Overall Study|Death|2|||
33541542|NCT02714426|62932174|FG000|Overall Study|Withdrawal by Subject|2|||
33541543|NCT02714426|62932175|FG001|Overall Study|Withdrawal by Subject|2|||
33638224|NCT01577745|63040962|FG003|Overall Study|Death|1|||
33638225|NCT01577745|63040963|FG004|Overall Study|Death|1|||
33638226|NCT01577745|63040964|FG005|Overall Study|Death|3|||
33638227|NCT01577745|63040959|FG000|Overall Study|Physician Decision|0|||
33638228|NCT01577745|63040960|FG001|Overall Study|Physician Decision|0|||
33638229|NCT01577745|63040961|FG002|Overall Study|Physician Decision|0|||
33638230|NCT01577745|63040962|FG003|Overall Study|Physician Decision|1|||
33638231|NCT01577745|63040963|FG004|Overall Study|Physician Decision|1|||
33638232|NCT01577745|63040964|FG005|Overall Study|Physician Decision|0|||
33638233|NCT01577745|63040959|FG000|Overall Study|Lost to Follow-up|0|||
33638234|NCT01577745|63040960|FG001|Overall Study|Lost to Follow-up|0|||
33638235|NCT01577745|63040961|FG002|Overall Study|Lost to Follow-up|0|||
33638236|NCT01577745|63040962|FG003|Overall Study|Lost to Follow-up|0|||
33638237|NCT01577745|63040963|FG004|Overall Study|Lost to Follow-up|0|||
33638238|NCT01577745|63040964|FG005|Overall Study|Lost to Follow-up|1|||
33638239|NCT01577745|63040959|FG000|Overall Study|Alternative Therapy|0|||
33638240|NCT01577745|63040960|FG001|Overall Study|Alternative Therapy|0|||
33638241|NCT01577745|63040961|FG002|Overall Study|Alternative Therapy|0|||
33638242|NCT01577745|63040962|FG003|Overall Study|Alternative Therapy|1|||
33638243|NCT01577745|63040963|FG004|Overall Study|Alternative Therapy|1|||
33638244|NCT01577745|63040964|FG005|Overall Study|Alternative Therapy|0|||
33638245|NCT01688037|63040986|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
33541544|NCT02925923|62932188|FG000|Overall Study|blood samples hemolyzed|0|||
33541545|NCT02925923|62932189|FG001|Overall Study|blood samples hemolyzed|2|||
33541546|NCT02410343|62932197|FG000|Core Period (24 Weeks)|Adverse Event|1|||
33541547|NCT02410343|62932198|FG001|Core Period (24 Weeks)|Adverse Event|0|||
33541548|NCT02410343|62932197|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
33541549|NCT02410343|62932198|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
33541550|NCT02410343|62932197|FG000|Extension Period (12 Months)|Adverse Event|1|||
33541551|NCT02410343|62932198|FG001|Extension Period (12 Months)|Adverse Event|0|||
33541552|NCT02410343|62932197|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
33541553|NCT02410343|62932198|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
33541554|NCT03064841|62932205|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
33541555|NCT03064841|62932205|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
33638246|NCT01688037|63040987|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
33638247|NCT01688037|63040988|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
33638248|NCT01688037|63040986|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
33638249|NCT01688037|63040987|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
33638250|NCT01688037|63040988|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
33638251|NCT01688037|63040986|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
33638252|NCT01688037|63040987|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
33638253|NCT01688037|63040988|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
33638254|NCT01688037|63040986|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
33638255|NCT01688037|63040987|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
33638256|NCT01688037|63040988|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
33638257|NCT01688037|63040986|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
33638258|NCT01688037|63040987|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
33638259|NCT01688037|63040988|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
33638260|NCT01688037|63040986|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
33462729|NCT00048932|62836568|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
33462730|NCT00048932|62836569|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
33462731|NCT00048932|62836570|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
33462732|NCT00048932|62836568|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
33462733|NCT00048932|62836569|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
33462734|NCT00048932|62836570|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
33462735|NCT00048932|62836568|FG000|Open Label Period (OL)|Pregnancy|0|||
33541556|NCT03064841|62932205|FG000|Overall Study|Screen failure|2|||
33541557|NCT02045303|62932211|FG000|Overall Study|Protocol Violation|2|||
33541558|NCT02045303|62932212|FG001|Overall Study|Protocol Violation|1|||
33541559|NCT02045303|62932213|FG002|Overall Study|Protocol Violation|0|||
33541560|NCT02045303|62932211|FG000|Overall Study|Withdrawal by Subject|0|||
33541561|NCT02045303|62932212|FG001|Overall Study|Withdrawal by Subject|2|||
33541562|NCT02045303|62932213|FG002|Overall Study|Withdrawal by Subject|0|||
33541563|NCT03434379|62932224|FG000|Global Period|Lost to Follow-up|3|||
33638261|NCT01688037|63040987|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
33638262|NCT01688037|63040988|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
33638263|NCT01688037|63040986|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
33638264|NCT01688037|63040987|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
33638265|NCT01688037|63040988|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
33638266|NCT01688037|63040986|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
33638267|NCT01688037|63040987|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
33638268|NCT01688037|63040988|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
33638269|NCT01688037|63040986|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
33638270|NCT01688037|63040987|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
33638271|NCT01688037|63040988|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
33638272|NCT01688037|63040986|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
33638273|NCT01688037|63040987|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
33638274|NCT01688037|63040988|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
33638275|NCT01610336|63041016|FG000|Overall Study|Progressive Disease|4|||
33638276|NCT01610336|63041017|FG001|Overall Study|Progressive Disease|6|||
33638277|NCT01610336|63041018|FG002|Overall Study|Progressive Disease|6|||
33638278|NCT01610336|63041019|FG003|Overall Study|Progressive Disease|5|||
33638279|NCT01610336|63041020|FG004|Overall Study|Progressive Disease|3|||
33638280|NCT01610336|63041021|FG005|Overall Study|Progressive Disease|10|||
33638281|NCT01610336|63041022|FG006|Overall Study|Progressive Disease|1|||
33638282|NCT01610336|63041023|FG007|Overall Study|Progressive Disease|6|||
33638283|NCT01610336|63041024|FG008|Overall Study|Progressive Disease|6|||
33638284|NCT01610336|63041025|FG009|Overall Study|Progressive Disease|40|||
33638285|NCT01610336|63041026|FG010|Overall Study|Progressive Disease|36|||
33638286|NCT01610336|63041016|FG000|Overall Study|Adverse Event|0|||
33638287|NCT01610336|63041017|FG001|Overall Study|Adverse Event|0|||
33638288|NCT01610336|63041018|FG002|Overall Study|Adverse Event|0|||
33638289|NCT01610336|63041019|FG003|Overall Study|Adverse Event|1|||
33638290|NCT01610336|63041020|FG004|Overall Study|Adverse Event|1|||
33638291|NCT01610336|63041021|FG005|Overall Study|Adverse Event|1|||
33638292|NCT01610336|63041022|FG006|Overall Study|Adverse Event|0|||
33638293|NCT01610336|63041023|FG007|Overall Study|Adverse Event|0|||
33638294|NCT01610336|63041024|FG008|Overall Study|Adverse Event|2|||
33638295|NCT01610336|63041025|FG009|Overall Study|Adverse Event|8|||
33638296|NCT01610336|63041026|FG010|Overall Study|Adverse Event|6|||
33638297|NCT01610336|63041016|FG000|Overall Study|Subject/Guardian decision|1|||
33638298|NCT01610336|63041017|FG001|Overall Study|Subject/Guardian decision|1|||
33638299|NCT01610336|63041018|FG002|Overall Study|Subject/Guardian decision|0|||
33638300|NCT01610336|63041019|FG003|Overall Study|Subject/Guardian decision|1|||
33638301|NCT01610336|63041020|FG004|Overall Study|Subject/Guardian decision|0|||
33638302|NCT01610336|63041021|FG005|Overall Study|Subject/Guardian decision|0|||
33638303|NCT01610336|63041022|FG006|Overall Study|Subject/Guardian decision|0|||
33638304|NCT01610336|63041023|FG007|Overall Study|Subject/Guardian decision|1|||
33541564|NCT03434379|62932225|FG001|Global Period|Lost to Follow-up|1|||
33541565|NCT03434379|62932226|FG002|Global Period|Lost to Follow-up|0|||
33541566|NCT03434379|62932227|FG003|Global Period|Lost to Follow-up|0|||
33541567|NCT03434379|62932224|FG000|Global Period|Death|99|||
33541568|NCT03434379|62932225|FG001|Global Period|Death|179|||
33541569|NCT03434379|62932226|FG002|Global Period|Death|0|||
33541570|NCT03434379|62932227|FG003|Global Period|Death|0|||
33541571|NCT03434379|62932224|FG000|Global Period|Withdrawal by Subject|20|||
33541572|NCT03434379|62932225|FG001|Global Period|Withdrawal by Subject|20|||
33541573|NCT03434379|62932226|FG002|Global Period|Withdrawal by Subject|0|||
33541574|NCT03434379|62932227|FG003|Global Period|Withdrawal by Subject|0|||
33541575|NCT03434379|62932224|FG000|Global Period|On Study|43|||
33638305|NCT01610336|63041024|FG008|Overall Study|Subject/Guardian decision|0|||
33638306|NCT01610336|63041025|FG009|Overall Study|Subject/Guardian decision|2|||
33638307|NCT01610336|63041026|FG010|Overall Study|Subject/Guardian decision|2|||
33638308|NCT01610336|63041016|FG000|Overall Study|Death|0|||
33638309|NCT01610336|63041017|FG001|Overall Study|Death|0|||
33638310|NCT01610336|63041018|FG002|Overall Study|Death|0|||
33638311|NCT01610336|63041019|FG003|Overall Study|Death|0|||
33638312|NCT01610336|63041020|FG004|Overall Study|Death|0|||
33638313|NCT01610336|63041021|FG005|Overall Study|Death|1|||
33638314|NCT01610336|63041022|FG006|Overall Study|Death|3|||
33638315|NCT01610336|63041023|FG007|Overall Study|Death|0|||
33638316|NCT01610336|63041024|FG008|Overall Study|Death|0|||
33638317|NCT01610336|63041025|FG009|Overall Study|Death|1|||
33638318|NCT01610336|63041026|FG010|Overall Study|Death|2|||
33638319|NCT01610336|63041016|FG000|Overall Study|Non-Compliance with study treatment|0|||
33541576|NCT03434379|62932225|FG001|Global Period|On Study|136|||
33541577|NCT03434379|62932226|FG002|Global Period|On Study|0|||
33541578|NCT03434379|62932227|FG003|Global Period|On Study|0|||
33541579|NCT03434379|62932224|FG000|China Extension Period|Lost to Follow-up|0|||
33638320|NCT01610336|63041017|FG001|Overall Study|Non-Compliance with study treatment|0|||
33638321|NCT01610336|63041018|FG002|Overall Study|Non-Compliance with study treatment|0|||
33638322|NCT01610336|63041019|FG003|Overall Study|Non-Compliance with study treatment|0|||
33638323|NCT01610336|63041020|FG004|Overall Study|Non-Compliance with study treatment|0|||
33638324|NCT01610336|63041021|FG005|Overall Study|Non-Compliance with study treatment|0|||
33638325|NCT01610336|63041022|FG006|Overall Study|Non-Compliance with study treatment|0|||
33638326|NCT01610336|63041023|FG007|Overall Study|Non-Compliance with study treatment|0|||
33541580|NCT03434379|62932225|FG001|China Extension Period|Lost to Follow-up|0|||
33541581|NCT03434379|62932226|FG002|China Extension Period|Lost to Follow-up|1|||
33541582|NCT03434379|62932227|FG003|China Extension Period|Lost to Follow-up|0|||
33541583|NCT03434379|62932224|FG000|China Extension Period|Death|0|||
33541584|NCT03434379|62932225|FG001|China Extension Period|Death|0|||
33541585|NCT03434379|62932226|FG002|China Extension Period|Death|38|||
33541586|NCT03434379|62932227|FG003|China Extension Period|Death|61|||
33541587|NCT03434379|62932224|FG000|China Extension Period|Withdrawal by Subject|0|||
33541588|NCT03434379|62932225|FG001|China Extension Period|Withdrawal by Subject|0|||
33541589|NCT03434379|62932226|FG002|China Extension Period|Withdrawal by Subject|7|||
33541590|NCT03434379|62932227|FG003|China Extension Period|Withdrawal by Subject|6|||
33541591|NCT03434379|62932224|FG000|China Extension Period|On Study|0|||
33638327|NCT01610336|63041024|FG008|Overall Study|Non-Compliance with study treatment|0|||
33638328|NCT01610336|63041025|FG009|Overall Study|Non-Compliance with study treatment|1|||
33638329|NCT01610336|63041026|FG010|Overall Study|Non-Compliance with study treatment|0|||
33638330|NCT01610336|63041016|FG000|Overall Study|Physician Decision|0|||
33638331|NCT01610336|63041017|FG001|Overall Study|Physician Decision|0|||
33638332|NCT01610336|63041018|FG002|Overall Study|Physician Decision|0|||
33541592|NCT03434379|62932225|FG001|China Extension Period|On Study|0|||
33541593|NCT03434379|62932226|FG002|China Extension Period|On Study|15|||
33638333|NCT01610336|63041019|FG003|Overall Study|Physician Decision|0|||
33638334|NCT01610336|63041020|FG004|Overall Study|Physician Decision|0|||
33638335|NCT01610336|63041021|FG005|Overall Study|Physician Decision|0|||
33638336|NCT01610336|63041022|FG006|Overall Study|Physician Decision|1|||
33638337|NCT01610336|63041023|FG007|Overall Study|Physician Decision|0|||
33638338|NCT01610336|63041024|FG008|Overall Study|Physician Decision|0|||
33638339|NCT01610336|63041025|FG009|Overall Study|Physician Decision|0|||
33638340|NCT01610336|63041026|FG010|Overall Study|Physician Decision|0|||
33638341|NCT01610336|63041016|FG000|Overall Study|Protocol Deviation|0|||
33638342|NCT01610336|63041017|FG001|Overall Study|Protocol Deviation|0|||
33638343|NCT01610336|63041018|FG002|Overall Study|Protocol Deviation|0|||
33638344|NCT01610336|63041019|FG003|Overall Study|Protocol Deviation|0|||
33638345|NCT01610336|63041020|FG004|Overall Study|Protocol Deviation|0|||
33638346|NCT01610336|63041021|FG005|Overall Study|Protocol Deviation|0|||
33638347|NCT01610336|63041022|FG006|Overall Study|Protocol Deviation|0|||
33638348|NCT01610336|63041023|FG007|Overall Study|Protocol Deviation|0|||
33638349|NCT01610336|63041024|FG008|Overall Study|Protocol Deviation|0|||
33638350|NCT01610336|63041025|FG009|Overall Study|Protocol Deviation|1|||
33638351|NCT01610336|63041026|FG010|Overall Study|Protocol Deviation|0|||
33638352|NCT01610336|63041016|FG000|Overall Study|Transfer to another trial|0|||
33638353|NCT01610336|63041017|FG001|Overall Study|Transfer to another trial|0|||
33638354|NCT01610336|63041018|FG002|Overall Study|Transfer to another trial|0|||
33638355|NCT01610336|63041019|FG003|Overall Study|Transfer to another trial|0|||
33638356|NCT01610336|63041020|FG004|Overall Study|Transfer to another trial|0|||
33638357|NCT01610336|63041021|FG005|Overall Study|Transfer to another trial|0|||
33638358|NCT01610336|63041022|FG006|Overall Study|Transfer to another trial|0|||
33638359|NCT01610336|63041023|FG007|Overall Study|Transfer to another trial|0|||
33638360|NCT01610336|63041024|FG008|Overall Study|Transfer to another trial|0|||
33638361|NCT01610336|63041025|FG009|Overall Study|Transfer to another trial|0|||
33638362|NCT01610336|63041026|FG010|Overall Study|Transfer to another trial|1|||
33638363|NCT01613222|63041054|FG000|Overall Study|Physician Decision|1|||
33638364|NCT01613222|63041054|FG000|Overall Study|Unable to place arterial line|1|||
33638365|NCT01613222|63041054|FG000|Overall Study|Reused disposable sensors|10|||
33638366|NCT01612676|63041101|FG000|Overall Study|Adverse Event|2|||
33638367|NCT01612676|63041102|FG001|Overall Study|Adverse Event|3|||
33638368|NCT01612676|63041103|FG002|Overall Study|Adverse Event|1|||
33638369|NCT01612676|63041104|FG003|Overall Study|Adverse Event|3|||
33638370|NCT01612676|63041101|FG000|Overall Study|Protocol Violation|0|||
33638371|NCT01612676|63041102|FG001|Overall Study|Protocol Violation|1|||
33638372|NCT01612676|63041103|FG002|Overall Study|Protocol Violation|0|||
33638373|NCT01612676|63041104|FG003|Overall Study|Protocol Violation|0|||
33638374|NCT01869764|63041118|FG000|Overall Study|Withdrawal by Subject|0|||
33638375|NCT01869764|63041119|FG001|Overall Study|Withdrawal by Subject|2|||
33638376|NCT01842620|63041125|FG000|Period 1|Withdrawal by Subject|1|||
33541594|NCT03434379|62932227|FG003|China Extension Period|On Study|66|||
33541595|NCT03064451|62932243|FG000|Overall Study|Lost to Follow-up|1|||
33541596|NCT03064451|62932243|FG000|Overall Study|Mapping Failure|4|||
33541597|NCT03064451|62932243|FG000|Overall Study|Exited prior to procedure|8|||
33541598|NCT03064451|62932243|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
33541599|NCT03058679|62932249|FG000|Baseline to Week 6|Lost to Follow-up|3|||
33638377|NCT01842620|63041126|FG001|Period 1|Withdrawal by Subject|0|||
33638378|NCT01931839|63041152|FG000|Overall Study|Death|0|||
33638379|NCT01931839|63041153|FG001|Overall Study|Death|1|||
33638380|NCT01931839|63041154|FG002|Overall Study|Death|2|||
33638381|NCT01931839|63041155|FG003|Overall Study|Death|0|||
33638382|NCT01931839|63041156|FG004|Overall Study|Death|0|||
33638383|NCT01931839|63041157|FG005|Overall Study|Death|0|||
33638384|NCT01931839|63041158|FG006|Overall Study|Death|0|||
33638385|NCT01931839|63041152|FG000|Overall Study|Physician Decision|1|||
33638386|NCT01931839|63041153|FG001|Overall Study|Physician Decision|0|||
33638387|NCT01931839|63041154|FG002|Overall Study|Physician Decision|1|||
33638388|NCT01931839|63041155|FG003|Overall Study|Physician Decision|0|||
33638389|NCT01931839|63041156|FG004|Overall Study|Physician Decision|0|||
33638390|NCT01931839|63041157|FG005|Overall Study|Physician Decision|0|||
33638391|NCT01931839|63041158|FG006|Overall Study|Physician Decision|1|||
33638392|NCT01931839|63041152|FG000|Overall Study|Withdrawal of consent|0|||
33638393|NCT01931839|63041153|FG001|Overall Study|Withdrawal of consent|0|||
33638394|NCT01931839|63041154|FG002|Overall Study|Withdrawal of consent|0|||
33638395|NCT01931839|63041155|FG003|Overall Study|Withdrawal of consent|0|||
33638396|NCT01931839|63041156|FG004|Overall Study|Withdrawal of consent|1|||
33638397|NCT01931839|63041157|FG005|Overall Study|Withdrawal of consent|0|||
33638398|NCT01931839|63041158|FG006|Overall Study|Withdrawal of consent|0|||
33638399|NCT01931839|63041152|FG000|Overall Study|Adverse Event|9|||
33638400|NCT01931839|63041153|FG001|Overall Study|Adverse Event|4|||
33638401|NCT01931839|63041154|FG002|Overall Study|Adverse Event|1|||
33638402|NCT01931839|63041155|FG003|Overall Study|Adverse Event|3|||
33638403|NCT01931839|63041156|FG004|Overall Study|Adverse Event|0|||
33638404|NCT01931839|63041157|FG005|Overall Study|Adverse Event|0|||
33638405|NCT01931839|63041158|FG006|Overall Study|Adverse Event|1|||
33638406|NCT01931839|63041152|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
33638407|NCT01931839|63041153|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
33638408|NCT01931839|63041154|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
33638409|NCT01931839|63041155|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
33638410|NCT01931839|63041156|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
33638411|NCT01931839|63041157|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
33638412|NCT01931839|63041158|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
33638413|NCT01931839|63041152|FG000|Overall Study|Other non-compliance|15|||
33638414|NCT01931839|63041153|FG001|Overall Study|Other non-compliance|9|||
33638415|NCT01931839|63041154|FG002|Overall Study|Other non-compliance|12|||
33638416|NCT01931839|63041155|FG003|Overall Study|Other non-compliance|3|||
33638417|NCT01931839|63041156|FG004|Overall Study|Other non-compliance|0|||
33638418|NCT01931839|63041157|FG005|Overall Study|Other non-compliance|3|||
33638419|NCT01931839|63041158|FG006|Overall Study|Other non-compliance|0|||
33638420|NCT01931839|63041152|FG000|Overall Study|Lost to Follow-up|1|||
33638421|NCT01931839|63041153|FG001|Overall Study|Lost to Follow-up|2|||
33638422|NCT01931839|63041154|FG002|Overall Study|Lost to Follow-up|4|||
33638423|NCT01931839|63041155|FG003|Overall Study|Lost to Follow-up|5|||
33638424|NCT01931839|63041156|FG004|Overall Study|Lost to Follow-up|0|||
33638425|NCT01931839|63041157|FG005|Overall Study|Lost to Follow-up|0|||
33638426|NCT01931839|63041158|FG006|Overall Study|Lost to Follow-up|0|||
33638427|NCT01931839|63041152|FG000|Overall Study|Other|4|||
33638428|NCT01931839|63041153|FG001|Overall Study|Other|2|||
33638429|NCT01931839|63041154|FG002|Overall Study|Other|6|||
33638430|NCT01931839|63041155|FG003|Overall Study|Other|0|||
33638431|NCT01931839|63041156|FG004|Overall Study|Other|0|||
33638432|NCT01931839|63041157|FG005|Overall Study|Other|0|||
33638433|NCT01931839|63041158|FG006|Overall Study|Other|0|||
33638434|NCT01842308|63041183|FG000|Overall Study|Withdrawal by Subject|0|||
33638435|NCT01842308|63041184|FG001|Overall Study|Withdrawal by Subject|0|||
33638436|NCT01842308|63041185|FG002|Overall Study|Withdrawal by Subject|0|||
33462736|NCT00048932|62836569|FG001|Open Label Period (OL)|Pregnancy|0|||
33462737|NCT00048932|62836570|FG002|Open Label Period (OL)|Pregnancy|6|||
33462738|NCT00048932|62836568|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
33462739|NCT00048932|62836569|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
33541600|NCT03058679|62932250|FG001|Baseline to Week 6|Lost to Follow-up|2|||
33638437|NCT01842308|63041186|FG003|Overall Study|Withdrawal by Subject|0|||
33462740|NCT00048932|62836570|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
33462741|NCT00048932|62836568|FG000|Open Label Period (OL)|Investigator Retiring|0|||
33462742|NCT00048932|62836569|FG001|Open Label Period (OL)|Investigator Retiring|0|||
33462743|NCT00048932|62836570|FG002|Open Label Period (OL)|Investigator Retiring|2|||
33541601|NCT03058679|62932249|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
33541602|NCT03058679|62932250|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
33541603|NCT03058679|62932249|FG000|Baseline to Week 6|Adverse Event|6|||
33541604|NCT03058679|62932250|FG001|Baseline to Week 6|Adverse Event|6|||
33638438|NCT01842308|63041187|FG004|Overall Study|Withdrawal by Subject|1|||
33462744|NCT00048932|62836568|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
33541605|NCT03058679|62932249|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
33638439|NCT01931059|63041202|FG000|Day 1|Pregnancy|0|||
33638440|NCT01931059|63041203|FG001|Day 1|Pregnancy|1|||
33638441|NCT01931059|63041202|FG000|Day3|Lost to Follow-up|1|||
33638442|NCT01931059|63041203|FG001|Day3|Lost to Follow-up|0|||
33638443|NCT01841762|63041215|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
33638444|NCT01841762|63041215|FG000|Treatment Period|Adverse Event|16|||
33638445|NCT01841762|63041215|FG000|Treatment Period|Death|1|||
33638446|NCT01841762|63041215|FG000|Treatment Period|Withdrawal by Subject|7|||
33638447|NCT01841762|63041215|FG000|Treatment Period|Lost to Follow-up|1|||
33638448|NCT01841762|63041215|FG000|Treatment Period|Physician Decision|2|||
33638449|NCT01841762|63041215|FG000|Treatment Period|Other, including non-compliance|5|||
33638450|NCT01841762|63041215|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
33638451|NCT01841762|63041215|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
33638452|NCT01841762|63041215|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
33638453|NCT01841762|63041215|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
33638454|NCT01841060|63041232|FG000|Overall Study|Protocol Violation|10|||
33638455|NCT01814696|63041238|FG000|Overall Study|Withdrawal by Subject|1|||
33638456|NCT01814696|63041239|FG001|Overall Study|Withdrawal by Subject|0|||
33638457|NCT01814696|63041238|FG000|Overall Study|Randomized to wrong group|1|||
33638458|NCT01814696|63041239|FG001|Overall Study|Randomized to wrong group|0|||
33638459|NCT01970371|63041248|FG000|Overall Study|Death|8|||
33638460|NCT01970371|63041249|FG001|Overall Study|Death|13|||
33638461|NCT01970371|63041250|FG002|Overall Study|Death|12|||
33638462|NCT01970371|63041248|FG000|Overall Study|Lost to Follow-up|0|||
33638463|NCT01970371|63041249|FG001|Overall Study|Lost to Follow-up|0|||
33638464|NCT01970371|63041250|FG002|Overall Study|Lost to Follow-up|1|||
33638465|NCT01868594|63041271|FG000|Overall Study|Do not meet inclusion criteria|4|||
33638466|NCT01868594|63041272|FG001|Overall Study|Do not meet inclusion criteria|3|||
33638467|NCT01616953|63041282|FG000|Overall Study|Lost to Follow-up|1|||
33638468|NCT01616953|63041283|FG001|Overall Study|Lost to Follow-up|0|||
33638469|NCT01616953|63041282|FG000|Overall Study|lack of bone and soft tissue|1|||
33638470|NCT01616953|63041283|FG001|Overall Study|lack of bone and soft tissue|0|||
33638471|NCT01867658|63041289|FG000|Overall Study|Withdrawal by Subject|6|||
33541606|NCT03058679|62932250|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
33541607|NCT03058679|62932249|FG000|Baseline to Week 6|Difficulty following the diet|0|||
33541608|NCT03058679|62932250|FG001|Baseline to Week 6|Difficulty following the diet|2|||
33541609|NCT03058679|62932249|FG000|Baseline to Week 6|Physician Decision|1|||
33541610|NCT03058679|62932250|FG001|Baseline to Week 6|Physician Decision|0|||
33541611|NCT03058679|62932249|FG000|Week 6 to Week 12|Change in medication|5|||
33541612|NCT03058679|62932250|FG001|Week 6 to Week 12|Change in medication|7|||
33541613|NCT03058679|62932249|FG000|Week 6 to Week 12|Adverse Event|4|||
33541614|NCT03058679|62932250|FG001|Week 6 to Week 12|Adverse Event|3|||
33541615|NCT03058679|62932249|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
33541616|NCT03058679|62932250|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
33541617|NCT03058679|62932249|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
33541618|NCT03058679|62932250|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
33541619|NCT03382821|62932258|FG000|Overall Study|Did not receive allocated intervention.|0|||
33541620|NCT03382821|62932259|FG001|Overall Study|Did not receive allocated intervention.|3|||
33541621|NCT02557516|62932270|FG000|Overall Study|Adverse Event|1|||
33541622|NCT02557516|62932271|FG001|Overall Study|Adverse Event|0|||
33541623|NCT02557516|62932272|FG002|Overall Study|Adverse Event|2|||
33541624|NCT02557516|62932273|FG003|Overall Study|Adverse Event|1|||
33638472|NCT01867658|63041289|FG000|Overall Study|Death|2|||
33638473|NCT01867658|63041289|FG000|Overall Study|Subject could not be contacted|1|||
33638474|NCT01867580|63041295|FG000|Overall Study|Withdrawal by Subject|2|||
33638475|NCT01867580|63041296|FG001|Overall Study|Withdrawal by Subject|3|||
33462745|NCT00048932|62836569|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
33462746|NCT00048932|62836570|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
33462747|NCT00048932|62836568|FG000|Open Label Period (OL)|Participant Relocated|0|||
33462748|NCT00048932|62836569|FG001|Open Label Period (OL)|Participant Relocated|0|||
33462749|NCT00048932|62836570|FG002|Open Label Period (OL)|Participant Relocated|6|||
33462750|NCT00048932|62836568|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
33462751|NCT00048932|62836569|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
33462752|NCT00048932|62836570|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
33462753|NCT00048932|62836568|FG000|Open Label Period (OL)|Site Closure|0|||
33462754|NCT00048932|62836569|FG001|Open Label Period (OL)|Site Closure|0|||
33462755|NCT00048932|62836570|FG002|Open Label Period (OL)|Site Closure|3|||
33462756|NCT00048932|62836568|FG000|Open Label Period (OL)|Trial Terminated|0|||
33541625|NCT02557516|62932270|FG000|Overall Study|Disease progression|0|||
33541626|NCT02557516|62932271|FG001|Overall Study|Disease progression|2|||
33541627|NCT02557516|62932272|FG002|Overall Study|Disease progression|0|||
33638476|NCT01867580|63041295|FG000|Overall Study|Physician Decision|17|||
33638477|NCT01867580|63041296|FG001|Overall Study|Physician Decision|12|||
33638478|NCT01867580|63041295|FG000|Overall Study|Lost to Follow-up|3|||
33638479|NCT01867580|63041296|FG001|Overall Study|Lost to Follow-up|5|||
33541628|NCT02557516|62932273|FG003|Overall Study|Disease progression|0|||
33638480|NCT01867580|63041295|FG000|Overall Study|Sponsor terminated study|1|||
33638481|NCT01867580|63041296|FG001|Overall Study|Sponsor terminated study|0|||
33638482|NCT01867580|63041295|FG000|Overall Study|Missed follow-up assessment|2|||
33638483|NCT01867580|63041296|FG001|Overall Study|Missed follow-up assessment|1|||
33638484|NCT01867580|63041295|FG000|Overall Study|Interruption to therapy|3|||
33638485|NCT01867580|63041296|FG001|Overall Study|Interruption to therapy|0|||
33541629|NCT02557516|62932270|FG000|Overall Study|Physician Decision|0|||
33541630|NCT02557516|62932271|FG001|Overall Study|Physician Decision|2|||
33541631|NCT02557516|62932272|FG002|Overall Study|Physician Decision|0|||
33541632|NCT02557516|62932273|FG003|Overall Study|Physician Decision|0|||
33541633|NCT02557516|62932270|FG000|Overall Study|Sponsor decision|0|||
33638486|NCT01867580|63041295|FG000|Overall Study|Osteomyelitis|0|||
33638487|NCT01867580|63041296|FG001|Overall Study|Osteomyelitis|1|||
33638488|NCT01867580|63041295|FG000|Overall Study|Continuation of therapy|0|||
33638489|NCT01867580|63041296|FG001|Overall Study|Continuation of therapy|1|||
33638490|NCT01867580|63041295|FG000|Overall Study|Wound recurrence|0|||
33638491|NCT01867580|63041296|FG001|Overall Study|Wound recurrence|1|||
33638492|NCT01839656|63041310|FG000|Overall Study|Withdrawal by Subject|1|||
33638493|NCT01839656|63041311|FG001|Overall Study|Withdrawal by Subject|1|||
33638494|NCT01839656|63041310|FG000|Overall Study|Adverse event, serious fatal|1|||
33638495|NCT01839656|63041311|FG001|Overall Study|Adverse event, serious fatal|4|||
33638496|NCT01839656|63041310|FG000|Overall Study|Early study closure|0|||
33638497|NCT01839656|63041311|FG001|Overall Study|Early study closure|11|||
33638498|NCT01839656|63041310|FG000|Overall Study|Adverse Event|1|||
33541634|NCT02557516|62932271|FG001|Overall Study|Sponsor decision|1|||
33541635|NCT02557516|62932272|FG002|Overall Study|Sponsor decision|2|||
33541636|NCT02557516|62932273|FG003|Overall Study|Sponsor decision|8|||
33541637|NCT00711555|62932292|FG000|Overall Study|Adverse Event|3|||
33541638|NCT02713490|62932297|FG000|Overall Study|Withdrawal by Subject|2|||
33541639|NCT02713490|62932298|FG001|Overall Study|Withdrawal by Subject|1|||
33541640|NCT02713490|62932297|FG000|Overall Study|Did not receive study drug|1|||
33638499|NCT01839656|63041311|FG001|Overall Study|Adverse Event|0|||
33638500|NCT01839188|63041317|FG000|Overall Study|Withdrawal by Subject|1|||
33638501|NCT01838876|63041326|FG000|Overall Study|Adverse Event|49|||
33638502|NCT01838876|63041326|FG000|Overall Study|Insufficient Therapeutic Response|10|||
33638503|NCT01838876|63041326|FG000|Overall Study|Protocol Violation|34|||
33638504|NCT01838876|63041326|FG000|Overall Study|Withdrawal of Consent|33|||
33638505|NCT01838876|63041326|FG000|Overall Study|Lost to Follow-up|21|||
33638506|NCT01838876|63041326|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
33638507|NCT01838876|63041326|FG000|Overall Study|Reason not Specified|7|||
33638508|NCT01838876|63041326|FG000|Overall Study|Did not meet eligibility criteria|78|||
33638509|NCT01838642|63041341|FG000|Overall Study|Died on study|1|||
33638510|NCT01611194|63041348|FG000|Overall Study|Lost to Follow-up|0|||
33638511|NCT01611194|63041349|FG001|Overall Study|Lost to Follow-up|1|||
33638512|NCT01611194|63041348|FG000|Overall Study|Withdrawal by Subject|0|||
33462757|NCT00048932|62836569|FG001|Open Label Period (OL)|Trial Terminated|0|||
33462758|NCT00048932|62836570|FG002|Open Label Period (OL)|Trial Terminated|1|||
33541641|NCT02713490|62932298|FG001|Overall Study|Did not receive study drug|0|||
33541642|NCT02713490|62932297|FG000|Overall Study|Met exclusion criteria|0|||
33541643|NCT02713490|62932298|FG001|Overall Study|Met exclusion criteria|1|||
33541644|NCT03772574|62932307|FG000|Overall Study|Protocol Violation|2|||
33541645|NCT03772574|62932308|FG001|Overall Study|Protocol Violation|0|||
33541646|NCT03772574|62932309|FG002|Overall Study|Protocol Violation|0|||
33541647|NCT03772574|62932307|FG000|Overall Study|Discomfort|0|||
33541648|NCT03772574|62932308|FG001|Overall Study|Discomfort|5|||
33541649|NCT03772574|62932309|FG002|Overall Study|Discomfort|4|||
33541650|NCT02743221|62932319|FG000|Overall Study|Progressive disease|29|||
33541651|NCT02743221|62932320|FG001|Overall Study|Progressive disease|38|||
33638513|NCT01611194|63041349|FG001|Overall Study|Withdrawal by Subject|1|||
33638514|NCT01611194|63041348|FG000|Overall Study|drug use|0|||
33462759|NCT00048932|62836568|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
33462760|NCT00048932|62836569|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
33462761|NCT00048932|62836570|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
33462762|NCT00048932|62836568|FG000|Open Label Period (OL)|Patient Decision|0|||
33462763|NCT00048932|62836569|FG001|Open Label Period (OL)|Patient Decision|0|||
33462764|NCT00048932|62836570|FG002|Open Label Period (OL)|Patient Decision|4|||
33462765|NCT00048932|62836568|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
33462766|NCT00048932|62836569|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
33541652|NCT02743221|62932319|FG000|Overall Study|Adverse Event|17|||
33541653|NCT02743221|62932320|FG001|Overall Study|Adverse Event|14|||
33638515|NCT01611194|63041349|FG001|Overall Study|drug use|1|||
33638516|NCT01813058|63041357|FG000|Overall Study|Withdrawal by Subject|5|||
33638517|NCT01813058|63041358|FG001|Overall Study|Withdrawal by Subject|4|||
33541654|NCT02743221|62932319|FG000|Overall Study|non medical reason|8|||
33541655|NCT02743221|62932320|FG001|Overall Study|non medical reason|2|||
33638518|NCT01867424|63041366|FG000|Overall Study|Patient noncompliance|2|||
33638519|NCT01867424|63041367|FG001|Overall Study|Patient noncompliance|1|||
33541656|NCT02743221|62932319|FG000|Overall Study|Physician Decision|2|||
33541657|NCT02743221|62932320|FG001|Overall Study|Physician Decision|5|||
33541658|NCT02743221|62932319|FG000|Overall Study|Patient not eligible, not treated|0|||
33541659|NCT02743221|62932320|FG001|Overall Study|Patient not eligible, not treated|1|||
33638520|NCT01811732|63041375|FG000|Overall Study|Lost to Follow-up|24|||
33638521|NCT01811732|63041376|FG001|Overall Study|Lost to Follow-up|30|||
33638522|NCT01811732|63041375|FG000|Overall Study|Withdrawal by Subject|16|||
33638523|NCT01811732|63041376|FG001|Overall Study|Withdrawal by Subject|10|||
33638524|NCT01811732|63041375|FG000|Overall Study|Adverse Event|3|||
33638525|NCT01811732|63041376|FG001|Overall Study|Adverse Event|9|||
33638526|NCT01811732|63041375|FG000|Overall Study|Lack of Efficacy|3|||
33638527|NCT01811732|63041376|FG001|Overall Study|Lack of Efficacy|1|||
33638528|NCT01811732|63041375|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
33638529|NCT01811732|63041376|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
33638530|NCT01811732|63041375|FG000|Overall Study|Physician Decision|2|||
33638531|NCT01811732|63041376|FG001|Overall Study|Physician Decision|0|||
33638532|NCT01811732|63041375|FG000|Overall Study|Death|1|||
33638533|NCT01811732|63041376|FG001|Overall Study|Death|1|||
33638534|NCT01811732|63041375|FG000|Overall Study|Insufficient venous access|0|||
33638535|NCT01811732|63041376|FG001|Overall Study|Insufficient venous access|1|||
33638536|NCT01811732|63041375|FG000|Overall Study|Protocol Violation|0|||
33638537|NCT01811732|63041376|FG001|Overall Study|Protocol Violation|1|||
33638538|NCT01811732|63041375|FG000|Overall Study|Subject incarcerated|1|||
33638539|NCT01811732|63041376|FG001|Overall Study|Subject incarcerated|2|||
33638540|NCT01811732|63041375|FG000|Overall Study|Admitted to another facility|1|||
33638541|NCT01811732|63041376|FG001|Overall Study|Admitted to another facility|0|||
33638542|NCT01811732|63041375|FG000|Overall Study|Correct study drug not available on site|1|||
33638543|NCT01811732|63041376|FG001|Overall Study|Correct study drug not available on site|0|||
33638544|NCT01836458|63041387|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
33638545|NCT01836458|63041388|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33638546|NCT01836458|63041389|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
33541660|NCT03929757|62932328|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
33541661|NCT03929757|62932329|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
33541662|NCT03929757|62932330|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
33541663|NCT03929757|62932328|FG000|Main Study: Up to Day 365|Other|1|||
33541664|NCT03929757|62932329|FG001|Main Study: Up to Day 365|Other|0|||
33541665|NCT03929757|62932330|FG002|Main Study: Up to Day 365|Other|0|||
33541666|NCT03929757|62932328|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
33541667|NCT03929757|62932329|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
33541668|NCT03929757|62932330|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
33541669|NCT03836625|62932339|FG000|Overall Study|Lost to Follow-up|9|||
33541670|NCT03836625|62932340|FG001|Overall Study|Lost to Follow-up|9|||
33541671|NCT03836625|62932339|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
33541672|NCT03836625|62932340|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
33541673|NCT03836625|62932339|FG000|Overall Study|Death|0|||
33541674|NCT03836625|62932340|FG001|Overall Study|Death|1|||
33541675|NCT03836625|62932339|FG000|Overall Study|Refused follow-up|0|||
33541676|NCT03836625|62932340|FG001|Overall Study|Refused follow-up|1|||
33541677|NCT01358968|62932346|FG000|Period 2|Adverse Event|0|||
33541678|NCT01358968|62932347|FG001|Period 2|Adverse Event|1|||
33541679|NCT01358968|62932348|FG002|Period 2|Adverse Event|0|||
33541680|NCT01358968|62932349|FG003|Period 2|Adverse Event|0|||
33541681|NCT01358968|62932346|FG000|Continued Access Phase|Progression of Disease|0|||
33541682|NCT01358968|62932347|FG001|Continued Access Phase|Progression of Disease|0|||
33541683|NCT01358968|62932348|FG002|Continued Access Phase|Progression of Disease|8|||
33541684|NCT01358968|62932349|FG003|Continued Access Phase|Progression of Disease|4|||
33541685|NCT01358968|62932346|FG000|Continued Access Phase|Protocol Violation|0|||
33541686|NCT01358968|62932347|FG001|Continued Access Phase|Protocol Violation|0|||
33541687|NCT01358968|62932348|FG002|Continued Access Phase|Protocol Violation|0|||
33541688|NCT01358968|62932349|FG003|Continued Access Phase|Protocol Violation|2|||
33541689|NCT01358968|62932346|FG000|Continued Access Phase|Withdrawal by Subject|0|||
33638547|NCT01836458|63041390|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
33326577|NCT01109316|62703249|FG005|Study Period 1|Withdrawal by Subject|0|||
33326578|NCT01109316|62703244|FG000|Study Period 1|Sponsor Decision|0|||
33541690|NCT01358968|62932347|FG001|Continued Access Phase|Withdrawal by Subject|0|||
33541691|NCT01358968|62932348|FG002|Continued Access Phase|Withdrawal by Subject|3|||
33638548|NCT01811186|63041402|FG000|Overall Study|Adverse Event|54|||
33638549|NCT01811186|63041403|FG001|Overall Study|Adverse Event|38|||
33638550|NCT01811186|63041402|FG000|Overall Study|Protocol Violation|5|||
33638551|NCT01811186|63041403|FG001|Overall Study|Protocol Violation|6|||
33638552|NCT01811186|63041402|FG000|Overall Study|Withdrawal by Subject|5|||
33541692|NCT01358968|62932349|FG003|Continued Access Phase|Withdrawal by Subject|0|||
33541693|NCT01358968|62932346|FG000|Continued Access Phase|Death|0|||
33541694|NCT01358968|62932347|FG001|Continued Access Phase|Death|0|||
33541695|NCT01358968|62932348|FG002|Continued Access Phase|Death|1|||
33541696|NCT01358968|62932349|FG003|Continued Access Phase|Death|1|||
33541697|NCT00701090|62932361|FG000|Overall Study|Adverse Event|11|||
33638553|NCT01811186|63041403|FG001|Overall Study|Withdrawal by Subject|10|||
33541698|NCT00701090|62932362|FG001|Overall Study|Adverse Event|2|||
33541699|NCT00701090|62932361|FG000|Overall Study|Death|0|||
33541700|NCT00701090|62932362|FG001|Overall Study|Death|1|||
33638554|NCT01811186|63041402|FG000|Overall Study|Lack of Efficacy|3|||
33638555|NCT01811186|63041403|FG001|Overall Study|Lack of Efficacy|6|||
33638556|NCT01811186|63041402|FG000|Overall Study|Lost to Follow-up|4|||
33638557|NCT01811186|63041403|FG001|Overall Study|Lost to Follow-up|2|||
33638558|NCT01866098|63041416|FG000|Overall Study|Lost to Follow-up|11|||
33638559|NCT01866098|63041417|FG001|Overall Study|Lost to Follow-up|18|||
33638560|NCT01866098|63041418|FG002|Overall Study|Lost to Follow-up|13|||
33638561|NCT01866098|63041416|FG000|Overall Study|Physician Decision|0|||
33638562|NCT01866098|63041417|FG001|Overall Study|Physician Decision|1|||
33638563|NCT01866098|63041418|FG002|Overall Study|Physician Decision|2|||
33638564|NCT01866098|63041416|FG000|Overall Study|Adverse Event|1|||
33638565|NCT01866098|63041417|FG001|Overall Study|Adverse Event|5|||
33638566|NCT01866098|63041418|FG002|Overall Study|Adverse Event|4|||
33638567|NCT01866098|63041416|FG000|Overall Study|Protocol Violation|1|||
33638568|NCT01866098|63041417|FG001|Overall Study|Protocol Violation|0|||
33638569|NCT01866098|63041418|FG002|Overall Study|Protocol Violation|0|||
33638570|NCT01866098|63041416|FG000|Overall Study|Withdrawal by Subject|1|||
33638571|NCT01866098|63041417|FG001|Overall Study|Withdrawal by Subject|2|||
33638572|NCT01866098|63041418|FG002|Overall Study|Withdrawal by Subject|0|||
33462767|NCT00048932|62836570|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
33462768|NCT00048932|62836568|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
33462769|NCT00048932|62836569|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
33462770|NCT00048932|62836570|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
33462771|NCT00048932|62836568|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
33462772|NCT00048932|62836569|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
33462773|NCT00048932|62836570|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
33541701|NCT00701090|62932361|FG000|Overall Study|Lack of Efficacy|5|||
33541702|NCT00701090|62932362|FG001|Overall Study|Lack of Efficacy|4|||
33541703|NCT00701090|62932361|FG000|Overall Study|Lost to Follow-up|9|||
33541704|NCT00701090|62932362|FG001|Overall Study|Lost to Follow-up|9|||
33541705|NCT00701090|62932361|FG000|Overall Study|Physician Decision|3|||
33541706|NCT00701090|62932362|FG001|Overall Study|Physician Decision|4|||
33541707|NCT00701090|62932361|FG000|Overall Study|Protocol Violation|2|||
33541708|NCT00701090|62932362|FG001|Overall Study|Protocol Violation|3|||
33541709|NCT00701090|62932361|FG000|Overall Study|Withdrawal by Subject|11|||
33541710|NCT00701090|62932362|FG001|Overall Study|Withdrawal by Subject|16|||
33541711|NCT00701090|62932361|FG000|Overall Study|Other|7|||
33541712|NCT00701090|62932362|FG001|Overall Study|Other|12|||
33541713|NCT03057977|62932370|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
33541714|NCT03057977|62932371|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
33541715|NCT03057977|62932370|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
33541716|NCT03057977|62932371|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
33541717|NCT03057977|62932370|FG000|Discontinuation From Treatment|Protocol Violation|6|||
33541718|NCT03057977|62932371|FG001|Discontinuation From Treatment|Protocol Violation|5|||
33541719|NCT03057977|62932370|FG000|Discontinuation From Treatment|Not treated|4|||
33638573|NCT01866098|63041416|FG000|Overall Study|Unrelated Hospitalization|2|||
33638574|NCT01866098|63041417|FG001|Overall Study|Unrelated Hospitalization|0|||
33638575|NCT01866098|63041418|FG002|Overall Study|Unrelated Hospitalization|1|||
33638576|NCT01866098|63041416|FG000|Overall Study|Non-compliance|1|||
33638577|NCT01866098|63041417|FG001|Overall Study|Non-compliance|0|||
33638578|NCT01866098|63041418|FG002|Overall Study|Non-compliance|1|||
33638579|NCT01866098|63041416|FG000|Overall Study|Pregnancy|2|||
33638580|NCT01866098|63041417|FG001|Overall Study|Pregnancy|0|||
33638581|NCT01866098|63041418|FG002|Overall Study|Pregnancy|0|||
33638582|NCT01866098|63041416|FG000|Overall Study|Death|0|||
33638583|NCT01866098|63041417|FG001|Overall Study|Death|1|||
33638584|NCT01866098|63041418|FG002|Overall Study|Death|0|||
33638585|NCT01865552|63041432|FG000|Period 1|Adverse Event|1|||
33638586|NCT01865552|63041433|FG001|Period 1|Adverse Event|0|||
33326579|NCT01109316|62703245|FG001|Study Period 1|Sponsor Decision|0|||
33462774|NCT00048932|62836568|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
33541720|NCT03057977|62932371|FG001|Discontinuation From Treatment|Not treated|0|||
33541721|NCT03057977|62932370|FG000|Discontinuation From Treatment|Adverse Event|343|||
33541722|NCT03057977|62932371|FG001|Discontinuation From Treatment|Adverse Event|337|||
33541723|NCT03057977|62932370|FG000|Discontinuation From Treatment|Reason Unknown|0|||
33541724|NCT03057977|62932371|FG001|Discontinuation From Treatment|Reason Unknown|1|||
33638587|NCT01865552|63041434|FG002|Period 1|Adverse Event|0|||
33638588|NCT01865552|63041435|FG003|Period 1|Adverse Event|1|||
33638589|NCT01865552|63041436|FG004|Period 1|Adverse Event|1|||
33638590|NCT01865552|63041437|FG005|Period 1|Adverse Event|1|||
33638591|NCT01865552|63041432|FG000|Period 1|Pathological lab|0|||
33638592|NCT01865552|63041433|FG001|Period 1|Pathological lab|0|||
33638593|NCT01865552|63041434|FG002|Period 1|Pathological lab|0|||
33638594|NCT01865552|63041435|FG003|Period 1|Pathological lab|0|||
33638595|NCT01865552|63041436|FG004|Period 1|Pathological lab|1|||
33638596|NCT01865552|63041437|FG005|Period 1|Pathological lab|0|||
33638597|NCT01865552|63041432|FG000|Period 1|Other|0|||
33638598|NCT01865552|63041433|FG001|Period 1|Other|0|||
33638599|NCT01865552|63041434|FG002|Period 1|Other|0|||
33638600|NCT01865552|63041435|FG003|Period 1|Other|0|||
33638601|NCT01865552|63041436|FG004|Period 1|Other|1|||
33638602|NCT01865552|63041437|FG005|Period 1|Other|0|||
33638603|NCT01809314|63041451|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
33638604|NCT01809314|63041451|FG000|Overall Study|Adverse Event|6|||
33638605|NCT01809314|63041451|FG000|Overall Study|Insufficient Therapeutic Response|14|||
33638606|NCT01809314|63041451|FG000|Overall Study|Lost to Follow-up|724|||
33638607|NCT01803464|63041459|FG000|Overall Study|Incomplete data|0|||
33638608|NCT01803464|63041460|FG001|Overall Study|Incomplete data|0|||
33638609|NCT01803464|63041461|FG002|Overall Study|Incomplete data|4|||
33638610|NCT01803464|63041462|FG003|Overall Study|Incomplete data|0|||
33638611|NCT01803464|63041459|FG000|Overall Study|Withdrawal by Subject|1|||
33638612|NCT01803464|63041460|FG001|Overall Study|Withdrawal by Subject|0|||
33638613|NCT01803464|63041461|FG002|Overall Study|Withdrawal by Subject|0|||
33638614|NCT01803464|63041462|FG003|Overall Study|Withdrawal by Subject|0|||
33638615|NCT01808690|63041478|FG000|Overall Study|Withdrawal by Subject|1|||
33638616|NCT01808690|63041479|FG001|Overall Study|Withdrawal by Subject|2|||
33638617|NCT01363297|63041490|FG000|Overall Study|Other|0|||
33638618|NCT01363297|63041491|FG001|Overall Study|Other|0|||
33638619|NCT01363297|63041492|FG002|Overall Study|Other|0|||
33638620|NCT01363297|63041493|FG003|Overall Study|Other|0|||
33638621|NCT01363297|63041494|FG004|Overall Study|Other|1|||
33638622|NCT01363297|63041490|FG000|Overall Study|Death|3|||
33638623|NCT01363297|63041491|FG001|Overall Study|Death|6|||
33638624|NCT01363297|63041492|FG002|Overall Study|Death|6|||
33638625|NCT01363297|63041493|FG003|Overall Study|Death|10|||
33638626|NCT01363297|63041494|FG004|Overall Study|Death|30|||
33638627|NCT01908907|63041513|FG000|Overall Study|Physician Decision|1|||
33638628|NCT01908907|63041514|FG001|Overall Study|Physician Decision|0|||
33638629|NCT01908907|63041513|FG000|Overall Study|Protocol Violation|1|||
33638630|NCT01908907|63041514|FG001|Overall Study|Protocol Violation|0|||
33638631|NCT01808612|63041527|FG000|Treatment Period|Adverse Event|8|||
33638632|NCT01808612|63041528|FG001|Treatment Period|Adverse Event|4|||
33638633|NCT01808612|63041529|FG002|Treatment Period|Adverse Event|3|||
33638634|NCT01808612|63041527|FG000|Treatment Period|Lost to Follow-up|2|||
33638635|NCT01808612|63041528|FG001|Treatment Period|Lost to Follow-up|2|||
33638636|NCT01808612|63041529|FG002|Treatment Period|Lost to Follow-up|1|||
33638637|NCT01808612|63041527|FG000|Treatment Period|Protocol Violation|1|||
33638638|NCT01808612|63041528|FG001|Treatment Period|Protocol Violation|0|||
33638639|NCT01808612|63041529|FG002|Treatment Period|Protocol Violation|0|||
33638640|NCT01808612|63041527|FG000|Treatment Period|Withdrawal by Subject|1|||
33638641|NCT01808612|63041528|FG001|Treatment Period|Withdrawal by Subject|0|||
33638642|NCT01808612|63041529|FG002|Treatment Period|Withdrawal by Subject|4|||
33638643|NCT01808612|63041527|FG000|Treatment Period|Physician Decision|1|||
33638644|NCT01808612|63041528|FG001|Treatment Period|Physician Decision|0|||
33638645|NCT01808612|63041529|FG002|Treatment Period|Physician Decision|4|||
33638646|NCT01808612|63041527|FG000|Treatment Period|Sponsor Decision|1|||
33638647|NCT01808612|63041528|FG001|Treatment Period|Sponsor Decision|0|||
33638648|NCT01808612|63041529|FG002|Treatment Period|Sponsor Decision|0|||
33638649|NCT01808612|63041527|FG000|Treatment Period|Lack of Efficacy|1|||
33638650|NCT01808612|63041528|FG001|Treatment Period|Lack of Efficacy|1|||
33638651|NCT01808612|63041529|FG002|Treatment Period|Lack of Efficacy|2|||
33638652|NCT01808612|63041527|FG000|Discontinuation Period|Adverse Event|1|||
33638653|NCT01808612|63041528|FG001|Discontinuation Period|Adverse Event|0|||
33638654|NCT01808612|63041529|FG002|Discontinuation Period|Adverse Event|0|||
33638655|NCT01808612|63041527|FG000|Discontinuation Period|Physician Decision|1|||
33638656|NCT01808612|63041528|FG001|Discontinuation Period|Physician Decision|0|||
33638657|NCT01808612|63041529|FG002|Discontinuation Period|Physician Decision|0|||
33326580|NCT01109316|62703246|FG002|Study Period 1|Sponsor Decision|0|||
33638658|NCT01808612|63041527|FG000|Discontinuation Period|Lost to Follow-up|0|||
33326581|NCT01109316|62703247|FG003|Study Period 1|Sponsor Decision|0|||
33541725|NCT03057977|62932370|FG000|Discontinuation From Treatment|Personal Reasons|1|||
33638659|NCT01808612|63041528|FG001|Discontinuation Period|Lost to Follow-up|1|||
33638660|NCT01808612|63041529|FG002|Discontinuation Period|Lost to Follow-up|0|||
33638661|NCT01908829|63041543|FG000|Overall Study|Adverse Event|13|||
33638662|NCT01908829|63041544|FG001|Overall Study|Adverse Event|11|||
33638663|NCT01908829|63041545|FG002|Overall Study|Adverse Event|13|||
33638664|NCT01908829|63041543|FG000|Overall Study|Lost to Follow-up|4|||
33638665|NCT01908829|63041544|FG001|Overall Study|Lost to Follow-up|2|||
33638666|NCT01908829|63041545|FG002|Overall Study|Lost to Follow-up|1|||
33638667|NCT01908829|63041543|FG000|Overall Study|Randomized no double-blind drug received|1|||
33638668|NCT01908829|63041544|FG001|Overall Study|Randomized no double-blind drug received|0|||
33638669|NCT01908829|63041545|FG002|Overall Study|Randomized no double-blind drug received|1|||
33638670|NCT01908829|63041543|FG000|Overall Study|Discontinued (no EoT page)|2|||
33638671|NCT01908829|63041544|FG001|Overall Study|Discontinued (no EoT page)|0|||
33638672|NCT01908829|63041545|FG002|Overall Study|Discontinued (no EoT page)|0|||
33638673|NCT01908829|63041543|FG000|Overall Study|Miscellaneous|0|||
33638674|NCT01908829|63041544|FG001|Overall Study|Miscellaneous|2|||
33638675|NCT01908829|63041545|FG002|Overall Study|Miscellaneous|0|||
33638676|NCT01908829|63041543|FG000|Overall Study|Protocol Violation|2|||
33541726|NCT03057977|62932371|FG001|Discontinuation From Treatment|Personal Reasons|1|||
33541727|NCT03057977|62932370|FG000|Discontinuation From Treatment|Unblinded medication|1|||
33541728|NCT03057977|62932371|FG001|Discontinuation From Treatment|Unblinded medication|0|||
33541729|NCT03057977|62932370|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
33541730|NCT03057977|62932371|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
33541731|NCT03057977|62932370|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
33541732|NCT03057977|62932371|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
33541733|NCT03057977|62932370|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
33541734|NCT03057977|62932371|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
33541735|NCT03057977|62932370|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
33541736|NCT03057977|62932371|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
33541737|NCT03057977|62932370|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
33541738|NCT03057977|62932371|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
33541739|NCT03057977|62932370|FG000|Discontinuation From Treatment|Not attending study visit|3|||
33541740|NCT03057977|62932371|FG001|Discontinuation From Treatment|Not attending study visit|10|||
33541741|NCT03057977|62932370|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
33638677|NCT01908829|63041544|FG001|Overall Study|Protocol Violation|2|||
33638678|NCT01908829|63041545|FG002|Overall Study|Protocol Violation|0|||
33638679|NCT01908829|63041543|FG000|Overall Study|Lack of Efficacy|1|||
33638680|NCT01908829|63041544|FG001|Overall Study|Lack of Efficacy|3|||
33638681|NCT01908829|63041545|FG002|Overall Study|Lack of Efficacy|2|||
33638682|NCT01908829|63041543|FG000|Overall Study|Withdrawal by Subject|26|||
33638683|NCT01908829|63041544|FG001|Overall Study|Withdrawal by Subject|29|||
33638684|NCT01908829|63041545|FG002|Overall Study|Withdrawal by Subject|22|||
33638685|NCT01773122|63041557|FG000|Overall Study|Due to amended age eligibility criteria|3|||
33638686|NCT01773122|63041558|FG001|Overall Study|Due to amended age eligibility criteria|1|||
33638687|NCT01773122|63041559|FG002|Overall Study|Due to amended age eligibility criteria|0|||
33638688|NCT01773122|63041560|FG003|Overall Study|Due to amended age eligibility criteria|1|||
33541742|NCT03057977|62932371|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
33638689|NCT01808534|63041570|FG000|Overall Study|Disease progression|3|||
33638690|NCT01808534|63041570|FG000|Overall Study|Physician Decision|1|||
33638691|NCT01808222|63041574|FG000|Overall Study|mpMR scan was not performed|1|||
33638692|NCT01772576|63041578|FG000|Overall Study|Death|15|||
33638693|NCT01772576|63041578|FG000|Overall Study|Protocol Violation|1|||
33638694|NCT01772576|63041578|FG000|Overall Study|Lost to Follow-up|3|||
33638695|NCT01772576|63041578|FG000|Overall Study|Study device not used|3|||
33638696|NCT01772576|63041578|FG000|Overall Study|Adverse Event|6|||
33638697|NCT01772576|63041578|FG000|Overall Study|Withdrawal by Subject|6|||
33638698|NCT01802216|63041605|FG000|4 Month Visit|Participant did not show to visit|3|||
33638699|NCT01802216|63041606|FG001|4 Month Visit|Participant did not show to visit|4|||
33638700|NCT01802216|63041605|FG000|8 Month Visit|Participant did not show to visit|3|||
33638701|NCT01802216|63041606|FG001|8 Month Visit|Participant did not show to visit|5|||
33638702|NCT01802216|63041605|FG000|12 Month Visit|Participant did not show to visit|3|||
33638703|NCT01802216|63041606|FG001|12 Month Visit|Participant did not show to visit|4|||
33638704|NCT01808144|63041614|FG000|Overall Study|Death|1|||
33638705|NCT01808144|63041615|FG001|Overall Study|Death|0|||
33638706|NCT01808144|63041614|FG000|Overall Study|Withdrawal by Subject|16|||
33638707|NCT01808144|63041615|FG001|Overall Study|Withdrawal by Subject|23|||
33638708|NCT01808144|63041614|FG000|Overall Study|Lost to Follow-up|6|||
33638709|NCT01808144|63041615|FG001|Overall Study|Lost to Follow-up|3|||
33638710|NCT01808144|63041614|FG000|Overall Study|Protocol Violation|6|||
33638711|NCT01808144|63041615|FG001|Overall Study|Protocol Violation|6|||
33638712|NCT01808144|63041614|FG000|Overall Study|Gout flare|0|||
33638713|NCT01808144|63041615|FG001|Overall Study|Gout flare|1|||
33638714|NCT01808144|63041614|FG000|Overall Study|Adverse Event|11|||
33326582|NCT01109316|62703248|FG004|Study Period 1|Sponsor Decision|0|||
33638715|NCT01808144|63041615|FG001|Overall Study|Adverse Event|15|||
33638716|NCT01801982|63041621|FG000|Overall Study|Lost to Follow-up|1|||
33638717|NCT01808066|63041634|FG000|Overall Study|Withdrawal by Subject|15|||
33638718|NCT01604343|63041642|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
33638719|NCT01604343|63041643|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
33638720|NCT01604343|63041644|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
33638721|NCT01604343|63041645|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
33326583|NCT01109316|62703249|FG005|Study Period 1|Sponsor Decision|2|||
33326584|NCT01109316|62703244|FG000|Study Period 2|Entry Criteria Not Met|0|||
33638722|NCT01604343|63041646|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
33462775|NCT00048932|62836569|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
33462776|NCT00048932|62836570|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
33462777|NCT00048932|62836568|FG000|Open Label Period (OL)|Investigator Decision|0|||
33462778|NCT00048932|62836569|FG001|Open Label Period (OL)|Investigator Decision|0|||
33462779|NCT00048932|62836570|FG002|Open Label Period (OL)|Investigator Decision|4|||
33462780|NCT00048932|62836568|FG000|Open Label Period (OL)|Site Staff Issues|0|||
33462781|NCT00048932|62836569|FG001|Open Label Period (OL)|Site Staff Issues|0|||
33462782|NCT00048932|62836570|FG002|Open Label Period (OL)|Site Staff Issues|2|||
33462783|NCT00048932|62836568|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
33462784|NCT00048932|62836569|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
33462785|NCT00048932|62836570|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
33462786|NCT00048932|62836568|FG000|Open Label Period (OL)|Participant Surgery|0|||
33462787|NCT00048932|62836569|FG001|Open Label Period (OL)|Participant Surgery|0|||
33462788|NCT00048932|62836570|FG002|Open Label Period (OL)|Participant Surgery|1|||
33462789|NCT00073983|62836579|FG000|Overall Study|not evaluable|1|||
33462790|NCT03812679|62836585|FG000|Overall Study|Adverse Event|2|||
33462791|NCT03812679|62836585|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
33462792|NCT03812679|62836585|FG000|Overall Study|Renal transplant|1|||
33462793|NCT03812679|62836585|FG000|Overall Study|Withdrawal by Subject|1|||
33462794|NCT03812679|62836585|FG000|Overall Study|Termination of study|2|||
33462795|NCT03812679|62836585|FG000|Overall Study|Water device replacement|1|||
33326585|NCT01109316|62703245|FG001|Study Period 2|Entry Criteria Not Met|1|||
33326586|NCT01109316|62703246|FG002|Study Period 2|Entry Criteria Not Met|0|||
33326587|NCT01109316|62703247|FG003|Study Period 2|Entry Criteria Not Met|0|||
33326588|NCT01109316|62703248|FG004|Study Period 2|Entry Criteria Not Met|0|||
33326589|NCT01109316|62703249|FG005|Study Period 2|Entry Criteria Not Met|0|||
33326590|NCT01109316|62703244|FG000|Study Period 2|Physician Decision|0|||
33326591|NCT01109316|62703245|FG001|Study Period 2|Physician Decision|0|||
33638723|NCT01604343|63041642|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
33638724|NCT01604343|63041643|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
33638725|NCT01604343|63041644|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
33638726|NCT01604343|63041645|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
33638727|NCT01604343|63041646|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
33638728|NCT01604343|63041642|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
33638729|NCT01604343|63041643|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
33638730|NCT01604343|63041644|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
33638731|NCT01604343|63041645|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
33638732|NCT01604343|63041646|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
33638733|NCT01604343|63041642|FG000|Prior to W52 Administration(Through W52)|Death|5|||
33638734|NCT01604343|63041643|FG001|Prior to W52 Administration(Through W52)|Death|0|||
33638735|NCT01604343|63041644|FG002|Prior to W52 Administration(Through W52)|Death|2|||
33638736|NCT01604343|63041645|FG003|Prior to W52 Administration(Through W52)|Death|0|||
33638737|NCT01604343|63041646|FG004|Prior to W52 Administration(Through W52)|Death|4|||
33638738|NCT01604343|63041642|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
33638739|NCT01604343|63041643|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
33638740|NCT01604343|63041644|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
33638741|NCT01604343|63041645|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
33638742|NCT01604343|63041646|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
33638743|NCT01604343|63041642|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
33326592|NCT01109316|62703246|FG002|Study Period 2|Physician Decision|0|||
33326593|NCT01109316|62703247|FG003|Study Period 2|Physician Decision|1|||
33326594|NCT01109316|62703248|FG004|Study Period 2|Physician Decision|0|||
33541743|NCT03057977|62932370|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
33541744|NCT03057977|62932371|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
33541745|NCT03057977|62932370|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
33541746|NCT03057977|62932371|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
33638744|NCT01604343|63041643|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
33638745|NCT01604343|63041644|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
33638746|NCT01604343|63041645|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
33638747|NCT01604343|63041646|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
33638748|NCT01604343|63041642|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
33326595|NCT01109316|62703249|FG005|Study Period 2|Physician Decision|0|||
33462796|NCT02952820|62836592|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
33462797|NCT02952820|62836593|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
33462798|NCT02952820|62836594|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
33462799|NCT02952820|62836592|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
33462800|NCT02952820|62836593|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
33541747|NCT03057977|62932370|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
33541748|NCT03057977|62932371|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
33541749|NCT03057977|62932370|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
33541750|NCT03057977|62932371|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
33541751|NCT03062891|62932383|FG000|Overall Study|Withdrawal by Subject|2|||
33541752|NCT03062891|62932384|FG001|Overall Study|Withdrawal by Subject|0|||
33541753|NCT03062891|62932383|FG000|Overall Study|Lost to Follow-up|50|||
33541754|NCT03062891|62932384|FG001|Overall Study|Lost to Follow-up|38|||
33541755|NCT02552212|62932393|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
33638749|NCT01604343|63041643|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
33638750|NCT01604343|63041644|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
33638751|NCT01604343|63041645|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
33638752|NCT01604343|63041646|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
33541756|NCT02552212|62932394|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
33541757|NCT02552212|62932395|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
33541758|NCT02552212|62932393|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
33541759|NCT02552212|62932394|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
33638753|NCT01604343|63041642|FG000|Prior to W52 Administration(Through W52)|Other|15|||
33462801|NCT02952820|62836594|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
33462802|NCT02952820|62836592|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
33462803|NCT02952820|62836593|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
33462804|NCT02952820|62836594|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
33462805|NCT02952820|62836592|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
33462806|NCT02952820|62836593|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
33462807|NCT02952820|62836594|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
33462808|NCT02952820|62836592|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
33462809|NCT02952820|62836593|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
33462810|NCT02952820|62836594|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
33462811|NCT02952820|62836592|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
33462812|NCT02952820|62836593|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
33462813|NCT02952820|62836594|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
33462814|NCT02952820|62836592|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
33462815|NCT02952820|62836593|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
33462816|NCT02952820|62836594|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
33462817|NCT02952820|62836592|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
33462818|NCT02952820|62836593|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
33462819|NCT02952820|62836594|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
33462820|NCT02952820|62836592|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
33462821|NCT02952820|62836593|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
33462822|NCT02952820|62836594|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
33462823|NCT02952820|62836592|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
33462824|NCT02952820|62836593|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
33462825|NCT02952820|62836594|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
33462826|NCT02952820|62836592|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
33462827|NCT02952820|62836593|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
33462828|NCT02952820|62836594|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
33462829|NCT02952820|62836592|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
33462830|NCT02952820|62836593|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
33462831|NCT02952820|62836594|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
33462832|NCT02952820|62836592|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
33462833|NCT02952820|62836593|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
33462834|NCT02952820|62836594|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
33462835|NCT02952820|62836592|FG000|Active Treatment Period (6 Months)|Not treated|0|||
33462836|NCT02952820|62836593|FG001|Active Treatment Period (6 Months)|Not treated|0|||
33462837|NCT02952820|62836594|FG002|Active Treatment Period (6 Months)|Not treated|1|||
33462838|NCT00006392|62836609|FG000|Overall Study|Ineligible|11|||
33541760|NCT02552212|62932395|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
33541761|NCT02552212|62932393|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
33541762|NCT02552212|62932394|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
33541763|NCT02552212|62932395|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
33541764|NCT02552212|62932393|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
33541765|NCT02552212|62932394|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
33541766|NCT02552212|62932395|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
33638754|NCT01604343|63041643|FG001|Prior to W52 Administration(Through W52)|Other|0|||
33326596|NCT01109316|62703244|FG000|Study Period 2|Protocol Violation|1|||
33462839|NCT00006392|62836610|FG001|Overall Study|Ineligible|3|||
33462840|NCT00006392|62836611|FG002|Overall Study|Ineligible|5|||
33638755|NCT01604343|63041644|FG002|Prior to W52 Administration(Through W52)|Other|10|||
33638756|NCT01604343|63041645|FG003|Prior to W52 Administration(Through W52)|Other|0|||
33638757|NCT01604343|63041646|FG004|Prior to W52 Administration(Through W52)|Other|6|||
33638758|NCT01604343|63041642|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
33638759|NCT01604343|63041643|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
33638760|NCT01604343|63041644|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
33638761|NCT01604343|63041645|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
33638762|NCT01604343|63041646|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
33638763|NCT01604343|63041642|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
33638764|NCT01604343|63041643|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
33638765|NCT01604343|63041644|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
33638766|NCT01604343|63041645|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
33638767|NCT01604343|63041646|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
33638768|NCT01604343|63041642|FG000|Week 52 to Week 104|Adverse Event|0|||
33638769|NCT01604343|63041643|FG001|Week 52 to Week 104|Adverse Event|12|||
33638770|NCT01604343|63041644|FG002|Week 52 to Week 104|Adverse Event|26|||
33638771|NCT01604343|63041645|FG003|Week 52 to Week 104|Adverse Event|21|||
33638772|NCT01604343|63041646|FG004|Week 52 to Week 104|Adverse Event|27|||
33638773|NCT01604343|63041642|FG000|Week 52 to Week 104|Death|0|||
33638774|NCT01604343|63041643|FG001|Week 52 to Week 104|Death|4|||
33638775|NCT01604343|63041644|FG002|Week 52 to Week 104|Death|2|||
33638776|NCT01604343|63041645|FG003|Week 52 to Week 104|Death|5|||
33638777|NCT01604343|63041646|FG004|Week 52 to Week 104|Death|0|||
33638778|NCT01604343|63041642|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
33638779|NCT01604343|63041643|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
33638780|NCT01604343|63041644|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
33638781|NCT01604343|63041645|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
33638782|NCT01604343|63041646|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
33638783|NCT01604343|63041642|FG000|Week 52 to Week 104|Physician Decision|0|||
33638784|NCT01604343|63041643|FG001|Week 52 to Week 104|Physician Decision|1|||
33638785|NCT01604343|63041644|FG002|Week 52 to Week 104|Physician Decision|0|||
33638786|NCT01604343|63041645|FG003|Week 52 to Week 104|Physician Decision|0|||
33638787|NCT01604343|63041646|FG004|Week 52 to Week 104|Physician Decision|2|||
33638788|NCT01604343|63041642|FG000|Week 52 to Week 104|Pregnancy|0|||
33638789|NCT01604343|63041643|FG001|Week 52 to Week 104|Pregnancy|0|||
33638790|NCT01604343|63041644|FG002|Week 52 to Week 104|Pregnancy|1|||
33638791|NCT01604343|63041645|FG003|Week 52 to Week 104|Pregnancy|2|||
33638792|NCT01604343|63041646|FG004|Week 52 to Week 104|Pregnancy|1|||
33638793|NCT01604343|63041642|FG000|Week 52 to Week 104|Other|0|||
33638794|NCT01604343|63041643|FG001|Week 52 to Week 104|Other|11|||
33638795|NCT01604343|63041644|FG002|Week 52 to Week 104|Other|11|||
33638796|NCT01604343|63041645|FG003|Week 52 to Week 104|Other|6|||
33638797|NCT01604343|63041646|FG004|Week 52 to Week 104|Other|3|||
33638798|NCT01604343|63041642|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
33638799|NCT01604343|63041643|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
33638800|NCT01604343|63041644|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
33638801|NCT01604343|63041645|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
33638802|NCT01604343|63041646|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
33638803|NCT01604343|63041642|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
33638804|NCT01604343|63041643|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
33638805|NCT01604343|63041644|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
33638806|NCT01604343|63041645|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
33638807|NCT01604343|63041646|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
33638808|NCT01604343|63041642|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
33638809|NCT01604343|63041643|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
33638810|NCT01604343|63041644|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
33638811|NCT01604343|63041645|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
33638812|NCT01604343|63041646|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
33638813|NCT01801436|63041656|FG000|Overall Study|Withdrawal by Subject|3|||
33638814|NCT01801436|63041656|FG000|Overall Study|Adverse Event|2|||
33638815|NCT01801436|63041656|FG000|Overall Study|Progressive disease|4|||
33638816|NCT01771250|63041660|FG000|Period 1|Met exclusion criteria|1|||
33638817|NCT01771250|63041661|FG001|Period 1|Met exclusion criteria|0|||
33638818|NCT01770860|63041667|FG000|Overall Study|Withdrawal by Subject|4|||
33638819|NCT01770860|63041667|FG000|Overall Study|Lost to Follow-up|1|||
33638820|NCT01770860|63041667|FG000|Overall Study|Administrative decision made by the PI|1|||
33638821|NCT01603875|63041678|FG000|Overall Study|Preexisting rabies antibody|3|||
33638822|NCT01603875|63041679|FG001|Overall Study|Preexisting rabies antibody|4|||
33638823|NCT01603875|63041680|FG002|Overall Study|Preexisting rabies antibody|3|||
33638824|NCT01603875|63041678|FG000|Overall Study|Lost to Follow-up|4|||
33638825|NCT01603875|63041679|FG001|Overall Study|Lost to Follow-up|3|||
33638826|NCT01603875|63041680|FG002|Overall Study|Lost to Follow-up|6|||
33638827|NCT01603875|63041678|FG000|Overall Study|Protocol Violation|0|||
33638828|NCT01603875|63041679|FG001|Overall Study|Protocol Violation|1|||
33638829|NCT01603875|63041680|FG002|Overall Study|Protocol Violation|0|||
33638830|NCT01770392|63041688|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
33638831|NCT01603641|63041698|FG000|Overall Study|Did not Receive Treatment|3|||
33638832|NCT01603641|63041698|FG000|Overall Study|Adverse Event|1|||
33638833|NCT01603641|63041698|FG000|Overall Study|Lack of Efficacy|1|||
33638834|NCT01603641|63041698|FG000|Overall Study|Lost to Follow-up|6|||
33638835|NCT01603641|63041698|FG000|Overall Study|Personal Reasons|18|||
33638836|NCT01603641|63041698|FG000|Overall Study|Other Miscellaneous Reasons|6|||
33638837|NCT01556763|63041705|FG000|Overall Study|Withdrawal by Subject|0|||
33638838|NCT01556763|63041706|FG001|Overall Study|Withdrawal by Subject|1|||
33638839|NCT01556763|63041707|FG002|Overall Study|Withdrawal by Subject|0|||
33638840|NCT01576575|63041717|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
33638841|NCT01576575|63041717|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
33638842|NCT01576575|63041717|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
33541767|NCT02552212|62932393|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
33541768|NCT02552212|62932394|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
33541769|NCT02552212|62932395|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
33638843|NCT01555983|63041727|FG000|Overall Study|Withdrawal by Subject|1|||
33638844|NCT01555983|63041728|FG001|Overall Study|Withdrawal by Subject|0|||
33638845|NCT01555983|63041729|FG002|Overall Study|Withdrawal by Subject|0|||
33638846|NCT01555983|63041730|FG003|Overall Study|Withdrawal by Subject|0|||
33638847|NCT01555983|63041731|FG004|Overall Study|Withdrawal by Subject|1|||
33638848|NCT01555983|63041732|FG005|Overall Study|Withdrawal by Subject|1|||
33638849|NCT01576341|63041740|FG000|Overall Study|Withdrawal by Subject|24|||
33638850|NCT01576341|63041740|FG000|Overall Study|Adverse Event|10|||
33638851|NCT01576341|63041740|FG000|Overall Study|Death|21|||
33638852|NCT01576341|63041740|FG000|Overall Study|Physician Decision|2|||
33638853|NCT01576341|63041740|FG000|Overall Study|Lost to Follow-up|2|||
33638854|NCT01576341|63041740|FG000|Overall Study|Kidney transplantation|10|||
33638855|NCT01576341|63041740|FG000|Overall Study|Protocol Violation|12|||
33638856|NCT01576341|63041740|FG000|Overall Study|Other|12|||
33638857|NCT01687413|63041758|FG000|Overall Study|Withdrawal by Subject|0|||
33638858|NCT01687413|63041759|FG001|Overall Study|Withdrawal by Subject|2|||
33638859|NCT01687413|63041758|FG000|Overall Study|Not eligible|0|||
33638860|NCT01687413|63041759|FG001|Overall Study|Not eligible|2|||
33638861|NCT01687413|63041758|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
33638862|NCT01687413|63041759|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
33638863|NCT01555671|63041785|FG000|Overall Study|Physician Decision|20|||
33638864|NCT01555671|63041786|FG001|Overall Study|Physician Decision|25|||
33638865|NCT01801358|63041800|FG000|Overall Study|Adverse Event|0|||
33638866|NCT01801358|63041801|FG001|Overall Study|Adverse Event|2|||
33638867|NCT01801358|63041802|FG002|Overall Study|Adverse Event|1|||
33638868|NCT01801358|63041803|FG003|Overall Study|Adverse Event|0|||
33638869|NCT01801358|63041804|FG004|Overall Study|Adverse Event|0|||
33638870|NCT01801358|63041805|FG005|Overall Study|Adverse Event|1|||
33638871|NCT01801358|63041800|FG000|Overall Study|Physician Decision|0|||
33638872|NCT01801358|63041801|FG001|Overall Study|Physician Decision|0|||
33638873|NCT01801358|63041802|FG002|Overall Study|Physician Decision|1|||
33638874|NCT01801358|63041803|FG003|Overall Study|Physician Decision|0|||
33462841|NCT00006392|62836612|FG003|Overall Study|Ineligible|5|||
33462842|NCT00006392|62836609|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
33638875|NCT01801358|63041804|FG004|Overall Study|Physician Decision|0|||
33638876|NCT01801358|63041805|FG005|Overall Study|Physician Decision|0|||
33638877|NCT01801358|63041800|FG000|Overall Study|Progressive Disease|6|||
33462843|NCT00006392|62836610|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
33462844|NCT00006392|62836611|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
33462845|NCT00006392|62836612|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
33462846|NCT00379769|62836626|FG000|Main Study|Death|57|||
33462847|NCT00379769|62836627|FG001|Main Study|Death|67|||
33462848|NCT00379769|62836628|FG002|Main Study|Death|54|||
33462849|NCT00379769|62836629|FG003|Main Study|Death|72|||
33462850|NCT00379769|62836630|FG004|Main Study|Death|0|||
33462851|NCT00379769|62836631|FG005|Main Study|Death|0|||
33541770|NCT02552212|62932393|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
33638878|NCT01801358|63041801|FG001|Overall Study|Progressive Disease|4|||
33638879|NCT01801358|63041802|FG002|Overall Study|Progressive Disease|4|||
33638880|NCT01801358|63041803|FG003|Overall Study|Progressive Disease|5|||
33638881|NCT01801358|63041804|FG004|Overall Study|Progressive Disease|6|||
33462852|NCT00379769|62836626|FG000|Main Study|Adverse Event|5|||
33638882|NCT01801358|63041805|FG005|Overall Study|Progressive Disease|5|||
33462853|NCT00379769|62836627|FG001|Main Study|Adverse Event|8|||
33638883|NCT01801358|63041800|FG000|Overall Study|Withdrawal by Subject|0|||
33638884|NCT01801358|63041801|FG001|Overall Study|Withdrawal by Subject|0|||
33638885|NCT01801358|63041802|FG002|Overall Study|Withdrawal by Subject|0|||
33638886|NCT01801358|63041803|FG003|Overall Study|Withdrawal by Subject|1|||
33638887|NCT01801358|63041804|FG004|Overall Study|Withdrawal by Subject|0|||
33638888|NCT01801358|63041805|FG005|Overall Study|Withdrawal by Subject|2|||
33638889|NCT01807598|63041840|FG000|Overall Study|Withdrawal by Subject|4|||
33638890|NCT01807598|63041840|FG000|Overall Study|Adverse Event|1|||
33638891|NCT01807598|63041840|FG000|Overall Study|Other Physician Decision|1|||
33638892|NCT01801280|63041848|FG000|Period 1|Withdrawal by Subject|0|||
33638893|NCT01801280|63041849|FG001|Period 1|Withdrawal by Subject|1|||
33638894|NCT01801280|63041850|FG002|Period 1|Withdrawal by Subject|0|||
33638895|NCT01801280|63041851|FG003|Period 1|Withdrawal by Subject|0|||
33638896|NCT01801280|63041848|FG000|Period 2|Withdrawal by Subject|1|||
33638897|NCT01801280|63041849|FG001|Period 2|Withdrawal by Subject|0|||
33638898|NCT01801280|63041850|FG002|Period 2|Withdrawal by Subject|0|||
33638899|NCT01801280|63041851|FG003|Period 2|Withdrawal by Subject|0|||
33638900|NCT01801280|63041848|FG000|Period 4|Protocol Violation|0|||
33638901|NCT01801280|63041849|FG001|Period 4|Protocol Violation|0|||
33638902|NCT01801280|63041850|FG002|Period 4|Protocol Violation|1|||
33638903|NCT01801280|63041851|FG003|Period 4|Protocol Violation|0|||
33638904|NCT01769456|63041861|FG000|Overall Study|Lost to Follow-up|19|||
33326597|NCT01109316|62703245|FG001|Study Period 2|Protocol Violation|0|||
33638905|NCT01769456|63041861|FG000|Overall Study|Withdrawal by Subject|3|||
33638906|NCT01769456|63041861|FG000|Overall Study|Did not receive PCC intervention|6|||
33638907|NCT01769456|63041861|FG000|Overall Study|Moved out of the area|3|||
33638908|NCT01769456|63041861|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
33638909|NCT01769456|63041861|FG000|Overall Study|Parental request to youth to withdraw|1|||
33638910|NCT01769378|63041868|FG000|Overall Study|Adverse Event|10|||
33638911|NCT01769378|63041869|FG001|Overall Study|Adverse Event|0|||
33638912|NCT01769378|63041868|FG000|Overall Study|Entry criteria not met|1|||
33638913|NCT01769378|63041869|FG001|Overall Study|Entry criteria not met|0|||
33638914|NCT01769378|63041868|FG000|Overall Study|Protocol Violation|1|||
33638915|NCT01769378|63041869|FG001|Overall Study|Protocol Violation|1|||
33638916|NCT01769378|63041868|FG000|Overall Study|Withdrawal by Subject|10|||
33638917|NCT01769378|63041869|FG001|Overall Study|Withdrawal by Subject|3|||
33638918|NCT01769378|63041868|FG000|Overall Study|Sponsor Decision|1|||
33638919|NCT01769378|63041869|FG001|Overall Study|Sponsor Decision|0|||
33638920|NCT01769378|63041868|FG000|Overall Study|Lost to Follow-up|2|||
33638921|NCT01769378|63041869|FG001|Overall Study|Lost to Follow-up|0|||
33638922|NCT01807520|63041878|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
33638923|NCT01807520|63041879|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
33638924|NCT01807520|63041880|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
33638925|NCT01807520|63041881|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
33638926|NCT01807520|63041882|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
33638927|NCT01807520|63041883|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
33638928|NCT01807520|63041884|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
33638929|NCT01807520|63041878|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
33638930|NCT01807520|63041879|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
33638931|NCT01807520|63041880|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
33638932|NCT01807520|63041881|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
33638933|NCT01807520|63041882|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
33638934|NCT01807520|63041883|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
33638935|NCT01807520|63041884|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
33638936|NCT01807520|63041878|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
33638937|NCT01807520|63041879|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
33638938|NCT01807520|63041880|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
33638939|NCT01807520|63041881|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
33638940|NCT01807520|63041882|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
33638941|NCT01807520|63041883|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
33638942|NCT01807520|63041884|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
33638943|NCT01807520|63041878|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
33638944|NCT01807520|63041879|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
33638945|NCT01807520|63041880|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
33638946|NCT01807520|63041881|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
33638947|NCT01807520|63041882|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
33638948|NCT01807520|63041883|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
33638949|NCT01807520|63041884|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
33638950|NCT01807520|63041878|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
33638951|NCT01807520|63041879|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
33638952|NCT01807520|63041880|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
33638953|NCT01807520|63041881|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
33638954|NCT01807520|63041882|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
33638955|NCT01807520|63041883|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
33638956|NCT01807520|63041884|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
33638957|NCT01807520|63041878|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
33638958|NCT01807520|63041879|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
33638959|NCT01807520|63041880|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
33638960|NCT01807520|63041881|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
33638961|NCT01807520|63041882|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
33638962|NCT01807520|63041883|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
33638963|NCT01807520|63041884|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
33541771|NCT02552212|62932394|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
33541772|NCT02552212|62932395|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
33541773|NCT02552212|62932393|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
33541774|NCT02552212|62932394|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
33541775|NCT02552212|62932395|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
33541776|NCT02552212|62932393|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
33638964|NCT01807520|63041878|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
33638965|NCT01807520|63041879|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
33638966|NCT01807520|63041880|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
33638967|NCT01807520|63041881|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
33638968|NCT01807520|63041882|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
33638969|NCT01807520|63041883|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
33638970|NCT01807520|63041884|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
33638971|NCT01807520|63041878|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
33638972|NCT01807520|63041879|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
33638973|NCT01807520|63041880|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
33638974|NCT01807520|63041881|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
33638975|NCT01807520|63041882|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
33638976|NCT01807520|63041883|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
33638977|NCT01807520|63041884|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
33638978|NCT01807520|63041878|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
33326598|NCT01109316|62703246|FG002|Study Period 2|Protocol Violation|0|||
33326599|NCT01109316|62703247|FG003|Study Period 2|Protocol Violation|0|||
33462854|NCT00379769|62836628|FG002|Main Study|Adverse Event|10|||
33462855|NCT00379769|62836629|FG003|Main Study|Adverse Event|11|||
33541777|NCT02552212|62932394|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
33541778|NCT02552212|62932395|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
33541779|NCT02552212|62932393|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
33541780|NCT02552212|62932394|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
33541781|NCT02552212|62932395|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
33541782|NCT02552212|62932393|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
33541783|NCT02552212|62932394|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
33541784|NCT02552212|62932395|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
33541785|NCT02552212|62932393|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
33541786|NCT02552212|62932394|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
33541787|NCT02552212|62932395|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
33541788|NCT02552212|62932393|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
33541789|NCT02552212|62932394|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
33541790|NCT02552212|62932395|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
33462856|NCT00379769|62836630|FG004|Main Study|Adverse Event|0|||
33462857|NCT00379769|62836631|FG005|Main Study|Adverse Event|0|||
33462858|NCT00379769|62836626|FG000|Main Study|Lost to Follow-up|29|||
33462859|NCT00379769|62836627|FG001|Main Study|Lost to Follow-up|29|||
33462860|NCT00379769|62836628|FG002|Main Study|Lost to Follow-up|25|||
33462861|NCT00379769|62836629|FG003|Main Study|Lost to Follow-up|26|||
33462862|NCT00379769|62836630|FG004|Main Study|Lost to Follow-up|0|||
33462863|NCT00379769|62836631|FG005|Main Study|Lost to Follow-up|0|||
33462864|NCT00379769|62836626|FG000|Main Study|Withdrawal by Subject|46|||
33462865|NCT00379769|62836627|FG001|Main Study|Withdrawal by Subject|56|||
33462866|NCT00379769|62836628|FG002|Main Study|Withdrawal by Subject|72|||
33462867|NCT00379769|62836629|FG003|Main Study|Withdrawal by Subject|70|||
33462868|NCT00379769|62836630|FG004|Main Study|Withdrawal by Subject|0|||
33462869|NCT00379769|62836631|FG005|Main Study|Withdrawal by Subject|0|||
33462870|NCT00379769|62836626|FG000|Main Study|Moved to survival status follow-up only|27|||
33541791|NCT02552212|62932393|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
33541792|NCT02552212|62932394|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
33541793|NCT02552212|62932395|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
33541794|NCT02552212|62932393|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
33541795|NCT02552212|62932394|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
33541796|NCT02552212|62932395|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
33638979|NCT01807520|63041879|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
33462871|NCT00379769|62836627|FG001|Main Study|Moved to survival status follow-up only|25|||
33462872|NCT00379769|62836628|FG002|Main Study|Moved to survival status follow-up only|32|||
33462873|NCT00379769|62836629|FG003|Main Study|Moved to survival status follow-up only|36|||
33462874|NCT00379769|62836630|FG004|Main Study|Moved to survival status follow-up only|0|||
33462875|NCT00379769|62836631|FG005|Main Study|Moved to survival status follow-up only|0|||
33638980|NCT01807520|63041880|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
33638981|NCT01807520|63041881|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
33638982|NCT01807520|63041882|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
33638983|NCT01807520|63041883|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
33638984|NCT01807520|63041884|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
33638985|NCT01807520|63041878|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
33638986|NCT01807520|63041879|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
33638987|NCT01807520|63041880|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
33638988|NCT01807520|63041881|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
33638989|NCT01807520|63041882|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
33638990|NCT01807520|63041883|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
33638991|NCT01807520|63041884|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
33638992|NCT01807520|63041878|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
33638993|NCT01807520|63041879|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
33638994|NCT01807520|63041880|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
33638995|NCT01807520|63041881|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
33638996|NCT01807520|63041882|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
33638997|NCT01807520|63041883|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
33638998|NCT01807520|63041884|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
33638999|NCT01807520|63041878|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
33639000|NCT01807520|63041879|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
33639001|NCT01807520|63041880|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
33639002|NCT01807520|63041881|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
33639003|NCT01807520|63041882|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
33639004|NCT01807520|63041883|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
33639005|NCT01807520|63041884|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
33639006|NCT01807520|63041878|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
33639007|NCT01807520|63041879|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
33639008|NCT01807520|63041880|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
33639009|NCT01807520|63041881|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
33639010|NCT01807520|63041882|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
33639011|NCT01807520|63041883|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
33639012|NCT01807520|63041884|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
33639013|NCT01807520|63041878|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
33639014|NCT01807520|63041879|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
33639015|NCT01807520|63041880|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
33639016|NCT01807520|63041881|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
33639017|NCT01807520|63041882|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
33639018|NCT01807520|63041883|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
33639019|NCT01807520|63041884|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
33639020|NCT01807520|63041878|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
33639021|NCT01807520|63041879|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
33639022|NCT01807520|63041880|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
33639023|NCT01807520|63041881|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
33639024|NCT01807520|63041882|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
33639025|NCT01807520|63041883|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
33639026|NCT01807520|63041884|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
33639027|NCT01807520|63041878|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
33639028|NCT01807520|63041879|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
33639029|NCT01807520|63041880|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
33639030|NCT01807520|63041881|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
33639031|NCT01807520|63041882|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
33639032|NCT01807520|63041883|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
33639033|NCT01807520|63041884|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
33639034|NCT01807520|63041878|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
33639035|NCT01807520|63041879|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
33462876|NCT00379769|62836626|FG000|Main Study|Participant moved|3|||
33462877|NCT00379769|62836627|FG001|Main Study|Participant moved|2|||
33462878|NCT00379769|62836628|FG002|Main Study|Participant moved|3|||
33462879|NCT00379769|62836629|FG003|Main Study|Participant moved|3|||
33462880|NCT00379769|62836630|FG004|Main Study|Participant moved|0|||
33462881|NCT00379769|62836631|FG005|Main Study|Participant moved|0|||
33462882|NCT00379769|62836626|FG000|Main Study|Poor compliance|3|||
33462883|NCT00379769|62836627|FG001|Main Study|Poor compliance|2|||
33462884|NCT00379769|62836628|FG002|Main Study|Poor compliance|2|||
33462885|NCT00379769|62836629|FG003|Main Study|Poor compliance|1|||
33462886|NCT00379769|62836630|FG004|Main Study|Poor compliance|0|||
33462887|NCT00379769|62836631|FG005|Main Study|Poor compliance|0|||
33462888|NCT00379769|62836626|FG000|Main Study|Prohibited glucose lowering medication|0|||
33541797|NCT02552212|62932393|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
33541798|NCT02552212|62932394|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
33541799|NCT02552212|62932395|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
33541800|NCT02552212|62932393|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
33541801|NCT02552212|62932394|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
33541802|NCT02552212|62932395|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
33541803|NCT02552212|62932393|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
33541804|NCT02552212|62932394|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
33541805|NCT02552212|62932395|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
33541806|NCT02552212|62932393|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
33541807|NCT02552212|62932394|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
33541808|NCT02552212|62932395|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
33541809|NCT02552212|62932393|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
33541810|NCT02552212|62932394|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
33541811|NCT02552212|62932395|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
33541812|NCT02552212|62932393|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
33541813|NCT02552212|62932394|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
33541814|NCT02552212|62932395|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
33541815|NCT02552212|62932393|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
33541816|NCT02552212|62932394|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
33541817|NCT02552212|62932395|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
33541818|NCT00685919|62932415|FG000|Overall Study|Withdrawal by Subject|0|||
33541819|NCT00685919|62932416|FG001|Overall Study|Withdrawal by Subject|0|||
33541820|NCT00685919|62932417|FG002|Overall Study|Withdrawal by Subject|1|||
33541821|NCT00685919|62932418|FG003|Overall Study|Withdrawal by Subject|0|||
33541822|NCT00685919|62932415|FG000|Overall Study|Physician Decision|1|||
33541823|NCT00685919|62932416|FG001|Overall Study|Physician Decision|0|||
33541824|NCT00685919|62932417|FG002|Overall Study|Physician Decision|0|||
33541825|NCT00685919|62932418|FG003|Overall Study|Physician Decision|0|||
33541826|NCT03061331|62932430|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
33639036|NCT01807520|63041880|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
33639037|NCT01807520|63041881|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
33639038|NCT01807520|63041882|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
33639039|NCT01807520|63041883|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
33639040|NCT01807520|63041884|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
33639041|NCT01806896|63041897|FG000|Overall Study|Adverse Event|2|||
33639042|NCT01806896|63041898|FG001|Overall Study|Adverse Event|0|||
33639043|NCT01806896|63041897|FG000|Overall Study|Other|1|||
33639044|NCT01806896|63041898|FG001|Overall Study|Other|0|||
33639045|NCT01768676|63041906|FG000|Overall Study|Adverse Event|3|||
33639046|NCT01768676|63041907|FG001|Overall Study|Adverse Event|3|||
33639047|NCT01768676|63041906|FG000|Overall Study|Lost to Follow-up|13|||
33639048|NCT01768676|63041907|FG001|Overall Study|Lost to Follow-up|16|||
33639049|NCT01768676|63041906|FG000|Overall Study|Protocol Violation|1|||
33639050|NCT01768676|63041907|FG001|Overall Study|Protocol Violation|1|||
33639051|NCT01768676|63041906|FG000|Overall Study|Physician Decision|4|||
33639052|NCT01768676|63041907|FG001|Overall Study|Physician Decision|1|||
33639053|NCT01768676|63041906|FG000|Overall Study|Withdrawal by Subject|3|||
33639054|NCT01768676|63041907|FG001|Overall Study|Withdrawal by Subject|10|||
33639055|NCT01555125|63041916|FG000|Induction Period|Lost to Follow-up|0|||
33639056|NCT01555125|63041917|FG001|Induction Period|Lost to Follow-up|2|||
33639057|NCT01555125|63041918|FG002|Induction Period|Lost to Follow-up|0|||
33639058|NCT01555125|63041919|FG003|Induction Period|Lost to Follow-up|0|||
33639059|NCT01555125|63041920|FG004|Induction Period|Lost to Follow-up|0|||
33639060|NCT01555125|63041916|FG000|Induction Period|Adverse Event|0|||
33639061|NCT01555125|63041917|FG001|Induction Period|Adverse Event|1|||
33326600|NCT01109316|62703248|FG004|Study Period 2|Protocol Violation|0|||
33326601|NCT01109316|62703249|FG005|Study Period 2|Protocol Violation|0|||
33326602|NCT01109316|62703244|FG000|Study Period 2|Withdrawal by Subject|0|||
33326603|NCT01109316|62703245|FG001|Study Period 2|Withdrawal by Subject|0|||
33326604|NCT01109316|62703246|FG002|Study Period 2|Withdrawal by Subject|1|||
33326605|NCT01109316|62703247|FG003|Study Period 2|Withdrawal by Subject|0|||
33326606|NCT01109316|62703248|FG004|Study Period 2|Withdrawal by Subject|0|||
33541827|NCT03061331|62932431|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
33541828|NCT00700778|62932437|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
33326607|NCT01109316|62703249|FG005|Study Period 2|Withdrawal by Subject|1|||
33326608|NCT01109316|62703244|FG000|Study Period 3|Lost to Follow-up|0|||
33326609|NCT01109316|62703245|FG001|Study Period 3|Lost to Follow-up|0|||
33326610|NCT01109316|62703246|FG002|Study Period 3|Lost to Follow-up|0|||
33326611|NCT01109316|62703247|FG003|Study Period 3|Lost to Follow-up|0|||
33639062|NCT01555125|63041918|FG002|Induction Period|Adverse Event|0|||
33639063|NCT01555125|63041919|FG003|Induction Period|Adverse Event|0|||
33326612|NCT01109316|62703248|FG004|Study Period 3|Lost to Follow-up|1|||
33326613|NCT01109316|62703249|FG005|Study Period 3|Lost to Follow-up|0|||
33326614|NCT01109316|62703244|FG000|Study Period 3|Withdrawal by Subject|1|||
33326615|NCT01109316|62703245|FG001|Study Period 3|Withdrawal by Subject|0|||
33326616|NCT01109316|62703246|FG002|Study Period 3|Withdrawal by Subject|0|||
33326617|NCT01109316|62703247|FG003|Study Period 3|Withdrawal by Subject|0|||
33326618|NCT01109316|62703248|FG004|Study Period 3|Withdrawal by Subject|1|||
33326619|NCT01109316|62703249|FG005|Study Period 3|Withdrawal by Subject|0|||
33326620|NCT00887068|62703259|FG000|Overall Study|Withdrawal by Subject|2|||
33326621|NCT00887068|62703260|FG001|Overall Study|Withdrawal by Subject|0|||
33326622|NCT00887068|62703259|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
33326623|NCT00887068|62703260|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
33326624|NCT00941031|62703270|FG000|Induction Period|Lack of Efficacy|2|||
33326625|NCT00941031|62703271|FG001|Induction Period|Lack of Efficacy|1|||
33326626|NCT00941031|62703272|FG002|Induction Period|Lack of Efficacy|0|||
33326627|NCT00941031|62703273|FG003|Induction Period|Lack of Efficacy|5|||
33326628|NCT00941031|62703274|FG004|Induction Period|Lack of Efficacy|0|||
33326629|NCT00941031|62703275|FG005|Induction Period|Lack of Efficacy|0|||
33326630|NCT00941031|62703276|FG006|Induction Period|Lack of Efficacy|0|||
33326631|NCT00941031|62703270|FG000|Induction Period|Withdrawal by Subject|1|||
33326632|NCT00941031|62703271|FG001|Induction Period|Withdrawal by Subject|2|||
33326633|NCT00941031|62703272|FG002|Induction Period|Withdrawal by Subject|2|||
33326634|NCT00941031|62703273|FG003|Induction Period|Withdrawal by Subject|2|||
33326635|NCT00941031|62703274|FG004|Induction Period|Withdrawal by Subject|0|||
33326636|NCT00941031|62703275|FG005|Induction Period|Withdrawal by Subject|0|||
33462889|NCT00379769|62836627|FG001|Main Study|Prohibited glucose lowering medication|3|||
33462890|NCT00379769|62836628|FG002|Main Study|Prohibited glucose lowering medication|0|||
33639064|NCT01555125|63041920|FG004|Induction Period|Adverse Event|1|||
33639065|NCT01555125|63041916|FG000|Induction Period|Subject / guardian decision|0|||
33639066|NCT01555125|63041917|FG001|Induction Period|Subject / guardian decision|0|||
33639067|NCT01555125|63041918|FG002|Induction Period|Subject / guardian decision|0|||
33639068|NCT01555125|63041919|FG003|Induction Period|Subject / guardian decision|0|||
33639069|NCT01555125|63041920|FG004|Induction Period|Subject / guardian decision|2|||
33639070|NCT01555125|63041916|FG000|Induction Period|Death|1|||
33639071|NCT01555125|63041917|FG001|Induction Period|Death|0|||
33639072|NCT01555125|63041918|FG002|Induction Period|Death|0|||
33639073|NCT01555125|63041919|FG003|Induction Period|Death|0|||
33639074|NCT01555125|63041920|FG004|Induction Period|Death|0|||
33639075|NCT01555125|63041916|FG000|Maintenance Period|Adverse Event|1|||
33639076|NCT01555125|63041917|FG001|Maintenance Period|Adverse Event|1|||
33639077|NCT01555125|63041918|FG002|Maintenance Period|Adverse Event|0|||
33639078|NCT01555125|63041919|FG003|Maintenance Period|Adverse Event|0|||
33639079|NCT01555125|63041920|FG004|Maintenance Period|Adverse Event|0|||
33639080|NCT01555125|63041916|FG000|Maintenance Period|Subject / guardian decision|1|||
33639081|NCT01555125|63041917|FG001|Maintenance Period|Subject / guardian decision|2|||
33639082|NCT01555125|63041918|FG002|Maintenance Period|Subject / guardian decision|0|||
33639083|NCT01555125|63041919|FG003|Maintenance Period|Subject / guardian decision|0|||
33639084|NCT01555125|63041920|FG004|Maintenance Period|Subject / guardian decision|0|||
33639085|NCT01555125|63041916|FG000|Maintenance Period|Lost to Follow-up|2|||
33639086|NCT01555125|63041917|FG001|Maintenance Period|Lost to Follow-up|0|||
33639087|NCT01555125|63041918|FG002|Maintenance Period|Lost to Follow-up|0|||
33639088|NCT01555125|63041919|FG003|Maintenance Period|Lost to Follow-up|1|||
33639089|NCT01555125|63041920|FG004|Maintenance Period|Lost to Follow-up|0|||
33639090|NCT01555125|63041916|FG000|Maintenance Period|Lack of Efficacy|6|||
33639091|NCT01555125|63041917|FG001|Maintenance Period|Lack of Efficacy|1|||
33639092|NCT01555125|63041918|FG002|Maintenance Period|Lack of Efficacy|3|||
33639093|NCT01555125|63041919|FG003|Maintenance Period|Lack of Efficacy|0|||
33639094|NCT01555125|63041920|FG004|Maintenance Period|Lack of Efficacy|0|||
33639095|NCT01555125|63041916|FG000|Maintenance Period|Physician Decision|0|||
33639096|NCT01555125|63041917|FG001|Maintenance Period|Physician Decision|0|||
33639097|NCT01555125|63041918|FG002|Maintenance Period|Physician Decision|1|||
33639098|NCT01555125|63041919|FG003|Maintenance Period|Physician Decision|0|||
33639099|NCT01555125|63041920|FG004|Maintenance Period|Physician Decision|0|||
33639100|NCT01555125|63041916|FG000|Maintenance Period|Death|0|||
33639101|NCT01555125|63041917|FG001|Maintenance Period|Death|0|||
33462891|NCT00379769|62836629|FG003|Main Study|Prohibited glucose lowering medication|1|||
33639102|NCT01555125|63041918|FG002|Maintenance Period|Death|0|||
33639103|NCT01555125|63041919|FG003|Maintenance Period|Death|1|||
33639104|NCT01555125|63041920|FG004|Maintenance Period|Death|0|||
33639105|NCT01555125|63041916|FG000|Extension|Adverse Event|1|||
33639106|NCT01555125|63041917|FG001|Extension|Adverse Event|2|||
33639107|NCT01555125|63041918|FG002|Extension|Adverse Event|1|||
33639108|NCT01555125|63041919|FG003|Extension|Adverse Event|1|||
33639109|NCT01555125|63041920|FG004|Extension|Adverse Event|0|||
33639110|NCT01555125|63041916|FG000|Extension|Protocol deviation|1|||
33639111|NCT01555125|63041917|FG001|Extension|Protocol deviation|0|||
33326637|NCT00941031|62703276|FG006|Induction Period|Withdrawal by Subject|0|||
33639112|NCT01555125|63041918|FG002|Extension|Protocol deviation|0|||
33639113|NCT01555125|63041919|FG003|Extension|Protocol deviation|0|||
33639114|NCT01555125|63041920|FG004|Extension|Protocol deviation|0|||
33639115|NCT01555125|63041916|FG000|Extension|Lack of Efficacy|7|||
33541829|NCT02551666|62932443|FG000|Overall Study|Withdrawal by Subject|1|||
33541830|NCT02551666|62932444|FG001|Overall Study|Withdrawal by Subject|3|||
33541831|NCT03061175|62932456|FG000|Baseline|Participant was deemed ineligible|1|||
33541832|NCT03061175|62932457|FG001|Baseline|Participant was deemed ineligible|0|||
33541833|NCT03061175|62932456|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
33541834|NCT03061175|62932457|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
33541835|NCT03061175|62932456|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
33541836|NCT03061175|62932457|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
33541837|NCT03061175|62932456|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
33541838|NCT03061175|62932457|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
33541839|NCT02554474|62932474|FG000|Overall Study|Protocol Violation|1|||
33541840|NCT02554474|62932475|FG001|Overall Study|Protocol Violation|1|||
33541841|NCT02554474|62932474|FG000|Overall Study|Health issue not related to the study|1|||
33541842|NCT02554474|62932475|FG001|Overall Study|Health issue not related to the study|0|||
33541843|NCT02554474|62932474|FG000|Overall Study|Withdrawal by Subject|1|||
33541844|NCT02554474|62932475|FG001|Overall Study|Withdrawal by Subject|1|||
33541845|NCT03061097|62932483|FG000|Overall Study|Withdrawal by Subject|0|||
33541846|NCT03061097|62932484|FG001|Overall Study|Withdrawal by Subject|3|||
33541847|NCT02554318|62932492|FG000|Overall Study|Withdrawal by Subject|10|||
33541848|NCT02554318|62932493|FG001|Overall Study|Withdrawal by Subject|8|||
33541849|NCT02550106|62932499|FG000|Overall Study|Adverse Event|1|||
33541850|NCT02550106|62932499|FG000|Overall Study|Lack of Efficacy|3|||
33541851|NCT02550106|62932499|FG000|Overall Study|Protocol Violation|6|||
33541852|NCT02550106|62932499|FG000|Overall Study|Withdrawal by Subject|2|||
33541853|NCT03060551|62932505|FG000|Overall Study|Withdrawal by Subject|1|||
33541854|NCT03060551|62932505|FG000|Overall Study|Adverse Event|1|||
33541855|NCT01662310|62932509|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
33541856|NCT01662310|62932510|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
33541857|NCT01662310|62932511|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
33541858|NCT01662310|62932512|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
33541859|NCT01662310|62932513|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
33639116|NCT01555125|63041917|FG001|Extension|Lack of Efficacy|6|||
33639117|NCT01555125|63041918|FG002|Extension|Lack of Efficacy|3|||
33639118|NCT01555125|63041919|FG003|Extension|Lack of Efficacy|0|||
33639119|NCT01555125|63041920|FG004|Extension|Lack of Efficacy|0|||
33639120|NCT01555125|63041916|FG000|Extension|Lost to Follow-up|2|||
33639121|NCT01555125|63041917|FG001|Extension|Lost to Follow-up|1|||
33639122|NCT01555125|63041918|FG002|Extension|Lost to Follow-up|2|||
33639123|NCT01555125|63041919|FG003|Extension|Lost to Follow-up|0|||
33639124|NCT01555125|63041920|FG004|Extension|Lost to Follow-up|0|||
33639125|NCT01555125|63041916|FG000|Extension|Study terminated by sponsor|32|||
33639126|NCT01555125|63041917|FG001|Extension|Study terminated by sponsor|33|||
33639127|NCT01555125|63041918|FG002|Extension|Study terminated by sponsor|16|||
33639128|NCT01555125|63041919|FG003|Extension|Study terminated by sponsor|20|||
33639129|NCT01555125|63041920|FG004|Extension|Study terminated by sponsor|0|||
33639130|NCT01555125|63041916|FG000|Extension|Subject/guardian decision|1|||
33639131|NCT01555125|63041917|FG001|Extension|Subject/guardian decision|9|||
33639132|NCT01555125|63041918|FG002|Extension|Subject/guardian decision|1|||
33639133|NCT01555125|63041919|FG003|Extension|Subject/guardian decision|0|||
33639134|NCT01555125|63041920|FG004|Extension|Subject/guardian decision|0|||
33639135|NCT01555125|63041916|FG000|Extension|Technical Problems|1|||
33639136|NCT01555125|63041917|FG001|Extension|Technical Problems|0|||
33639137|NCT01555125|63041918|FG002|Extension|Technical Problems|0|||
33639138|NCT01555125|63041919|FG003|Extension|Technical Problems|1|||
33639139|NCT01555125|63041920|FG004|Extension|Technical Problems|0|||
33639140|NCT01555125|63041916|FG000|Follow-Up Period|Lost to Follow-up|1|||
33639141|NCT01555125|63041917|FG001|Follow-Up Period|Lost to Follow-up|0|||
33639142|NCT01555125|63041918|FG002|Follow-Up Period|Lost to Follow-up|0|||
33639143|NCT01555125|63041919|FG003|Follow-Up Period|Lost to Follow-up|0|||
33639144|NCT01555125|63041920|FG004|Follow-Up Period|Lost to Follow-up|0|||
33639145|NCT01555125|63041916|FG000|Follow-Up Period|Subject / guardian decision|3|||
33541860|NCT01662310|62932509|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
33541861|NCT01662310|62932510|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
33541862|NCT01662310|62932511|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
33541863|NCT01662310|62932512|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
33639146|NCT01555125|63041917|FG001|Follow-Up Period|Subject / guardian decision|1|||
33639147|NCT01555125|63041918|FG002|Follow-Up Period|Subject / guardian decision|1|||
33639148|NCT01555125|63041919|FG003|Follow-Up Period|Subject / guardian decision|1|||
33639149|NCT01555125|63041920|FG004|Follow-Up Period|Subject / guardian decision|0|||
33639150|NCT01768286|63041939|FG000|Overall Study|Randomized But Not Treated|0|||
33639151|NCT01768286|63041940|FG001|Overall Study|Randomized But Not Treated|0|||
33639152|NCT01768286|63041941|FG002|Overall Study|Randomized But Not Treated|1|||
33639153|NCT01768286|63041942|FG003|Overall Study|Randomized But Not Treated|0|||
33639154|NCT01768286|63041939|FG000|Overall Study|Lack of Efficacy|7|||
33639155|NCT01768286|63041940|FG001|Overall Study|Lack of Efficacy|4|||
33639156|NCT01768286|63041941|FG002|Overall Study|Lack of Efficacy|0|||
33639157|NCT01768286|63041942|FG003|Overall Study|Lack of Efficacy|1|||
33639158|NCT01768286|63041939|FG000|Overall Study|Withdrew Consent|0|||
33639159|NCT01768286|63041940|FG001|Overall Study|Withdrew Consent|0|||
33639160|NCT01768286|63041941|FG002|Overall Study|Withdrew Consent|1|||
33639161|NCT01768286|63041942|FG003|Overall Study|Withdrew Consent|0|||
33639162|NCT01800968|63041954|FG000|Overall Study|Death|23|||
33639163|NCT01800968|63041955|FG001|Overall Study|Death|16|||
33639164|NCT01800968|63041954|FG000|Overall Study|Lost to Follow-up|5|||
33639165|NCT01800968|63041955|FG001|Overall Study|Lost to Follow-up|7|||
33639166|NCT01800968|63041954|FG000|Overall Study|Withdrawal by Subject|7|||
33639167|NCT01800968|63041955|FG001|Overall Study|Withdrawal by Subject|9|||
33639168|NCT01800968|63041954|FG000|Overall Study|Physician Decision|1|||
33639169|NCT01800968|63041955|FG001|Overall Study|Physician Decision|0|||
33639170|NCT01799720|63041964|FG000|Overall Study|Withdrawal by Subject|3|||
33639171|NCT01799720|63041965|FG001|Overall Study|Withdrawal by Subject|0|||
33639172|NCT01799720|63041966|FG002|Overall Study|Withdrawal by Subject|0|||
33639173|NCT01799720|63041964|FG000|Overall Study|Protocol Violation|0|||
33639174|NCT01799720|63041965|FG001|Overall Study|Protocol Violation|1|||
33639175|NCT01799720|63041966|FG002|Overall Study|Protocol Violation|0|||
33639176|NCT01799720|63041964|FG000|Overall Study|Pregnancy|0|||
33639177|NCT01799720|63041965|FG001|Overall Study|Pregnancy|0|||
33639178|NCT01799720|63041966|FG002|Overall Study|Pregnancy|1|||
33639179|NCT01687257|63041976|FG000|Overall Study|Efficacy Failure|6|||
33639180|NCT01687257|63041977|FG001|Overall Study|Efficacy Failure|0|||
33639181|NCT01687257|63041978|FG002|Overall Study|Efficacy Failure|5|||
33639182|NCT01687257|63041976|FG000|Overall Study|Subject Withdrew Consent|1|||
33639183|NCT01687257|63041977|FG001|Overall Study|Subject Withdrew Consent|1|||
33639184|NCT01687257|63041978|FG002|Overall Study|Subject Withdrew Consent|1|||
33639185|NCT01687257|63041976|FG000|Overall Study|Adverse Event|1|||
33639186|NCT01687257|63041977|FG001|Overall Study|Adverse Event|0|||
33639187|NCT01687257|63041978|FG002|Overall Study|Adverse Event|0|||
33639188|NCT01687257|63041976|FG000|Overall Study|Investigator's Discretion|0|||
33639189|NCT01687257|63041977|FG001|Overall Study|Investigator's Discretion|3|||
33639190|NCT01687257|63041978|FG002|Overall Study|Investigator's Discretion|0|||
33639191|NCT01806740|63041992|FG000|Overall Study|Withdrawal by Subject|4|||
33639192|NCT01806740|63041992|FG000|Overall Study|Physician Decision|1|||
33639193|NCT01806740|63041992|FG000|Overall Study|Patient's refusal of treatment|1|||
33639194|NCT01687101|63041999|FG000|Overall Study|Lost to Follow-up|7|||
33639195|NCT01968967|63042005|FG000|Treatment Period|Other|22|||
33639196|NCT01968967|63042006|FG001|Treatment Period|Other|22|||
33639197|NCT01968967|63042007|FG002|Treatment Period|Other|0|||
33639198|NCT01968967|63042008|FG003|Treatment Period|Other|0|||
33639199|NCT01968967|63042009|FG004|Treatment Period|Other|0|||
33639200|NCT01968967|63042005|FG000|Treatment Period|Withdrawal by Subject|71|||
33639201|NCT01968967|63042006|FG001|Treatment Period|Withdrawal by Subject|61|||
33639202|NCT01968967|63042007|FG002|Treatment Period|Withdrawal by Subject|0|||
33639203|NCT01968967|63042008|FG003|Treatment Period|Withdrawal by Subject|0|||
33639204|NCT01968967|63042009|FG004|Treatment Period|Withdrawal by Subject|0|||
33639205|NCT01968967|63042005|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
33639206|NCT01968967|63042006|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
33639207|NCT01968967|63042007|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
33639208|NCT01968967|63042008|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
33639209|NCT01968967|63042009|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
33639210|NCT01968967|63042005|FG000|Treatment Period|Lost to Follow-up|26|||
33639211|NCT01968967|63042006|FG001|Treatment Period|Lost to Follow-up|31|||
33639212|NCT01968967|63042007|FG002|Treatment Period|Lost to Follow-up|0|||
33639213|NCT01968967|63042008|FG003|Treatment Period|Lost to Follow-up|0|||
33639214|NCT01968967|63042009|FG004|Treatment Period|Lost to Follow-up|0|||
33639215|NCT01968967|63042005|FG000|Treatment Period|Protocol Violation|1|||
33639216|NCT01968967|63042006|FG001|Treatment Period|Protocol Violation|2|||
33639217|NCT01968967|63042007|FG002|Treatment Period|Protocol Violation|0|||
33639218|NCT01968967|63042008|FG003|Treatment Period|Protocol Violation|0|||
33639219|NCT01968967|63042009|FG004|Treatment Period|Protocol Violation|0|||
33639220|NCT01968967|63042005|FG000|Treatment Period|Adverse Event|9|||
33639221|NCT01968967|63042006|FG001|Treatment Period|Adverse Event|8|||
33639222|NCT01968967|63042007|FG002|Treatment Period|Adverse Event|0|||
33639223|NCT01968967|63042008|FG003|Treatment Period|Adverse Event|0|||
33639224|NCT01968967|63042009|FG004|Treatment Period|Adverse Event|0|||
33639225|NCT01968967|63042005|FG000|Treatment Period|Death|9|||
33639226|NCT01968967|63042006|FG001|Treatment Period|Death|2|||
33639227|NCT01968967|63042007|FG002|Treatment Period|Death|0|||
33639228|NCT01968967|63042008|FG003|Treatment Period|Death|0|||
33639229|NCT01968967|63042009|FG004|Treatment Period|Death|0|||
33639230|NCT01968967|63042005|FG000|Treatment Period|Randomized Not Treated|6|||
33639231|NCT01968967|63042006|FG001|Treatment Period|Randomized Not Treated|5|||
33326638|NCT00941031|62703270|FG000|Induction Period|Adminstative Problems|1|||
33326639|NCT00941031|62703271|FG001|Induction Period|Adminstative Problems|1|||
33326640|NCT00941031|62703272|FG002|Induction Period|Adminstative Problems|1|||
33326641|NCT00941031|62703273|FG003|Induction Period|Adminstative Problems|0|||
33326642|NCT00941031|62703274|FG004|Induction Period|Adminstative Problems|0|||
33326643|NCT00941031|62703275|FG005|Induction Period|Adminstative Problems|0|||
33326644|NCT00941031|62703276|FG006|Induction Period|Adminstative Problems|0|||
33326645|NCT00941031|62703270|FG000|Induction Period|Adverse Event|1|||
33326646|NCT00941031|62703271|FG001|Induction Period|Adverse Event|0|||
33326647|NCT00941031|62703272|FG002|Induction Period|Adverse Event|3|||
33326648|NCT00941031|62703273|FG003|Induction Period|Adverse Event|2|||
33541864|NCT01662310|62932513|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
33541865|NCT01662310|62932509|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
33541866|NCT01662310|62932510|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
33541867|NCT01662310|62932511|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
33541868|NCT01662310|62932512|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
33541869|NCT01662310|62932513|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
33541870|NCT01662310|62932509|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
33541871|NCT01662310|62932510|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
33541872|NCT01662310|62932511|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
33541873|NCT01662310|62932512|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
33541874|NCT01662310|62932513|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
33541875|NCT01662310|62932509|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
33541876|NCT01662310|62932510|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
33541877|NCT01662310|62932511|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
33541878|NCT01662310|62932512|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
33639232|NCT01968967|63042007|FG002|Treatment Period|Randomized Not Treated|0|||
33326649|NCT00941031|62703274|FG004|Induction Period|Adverse Event|0|||
33326650|NCT00941031|62703275|FG005|Induction Period|Adverse Event|0|||
33639233|NCT01968967|63042008|FG003|Treatment Period|Randomized Not Treated|0|||
33639234|NCT01968967|63042009|FG004|Treatment Period|Randomized Not Treated|0|||
33639235|NCT01968967|63042005|FG000|Extension Period|Withdrew Consent|0|||
33639236|NCT01968967|63042006|FG001|Extension Period|Withdrew Consent|0|||
33639237|NCT01968967|63042007|FG002|Extension Period|Withdrew Consent|2|||
33639238|NCT01968967|63042008|FG003|Extension Period|Withdrew Consent|0|||
33639239|NCT01968967|63042009|FG004|Extension Period|Withdrew Consent|5|||
33639240|NCT01554579|63042025|FG000|Overall Study|Adverse Event|6|||
33639241|NCT01554579|63042026|FG001|Overall Study|Adverse Event|25|||
33326651|NCT00941031|62703276|FG006|Induction Period|Adverse Event|0|||
33326652|NCT00941031|62703270|FG000|Maintenance Period|Withdrawal by Subject|0|||
33326653|NCT00941031|62703271|FG001|Maintenance Period|Withdrawal by Subject|0|||
33326654|NCT00941031|62703272|FG002|Maintenance Period|Withdrawal by Subject|0|||
33326655|NCT00941031|62703273|FG003|Maintenance Period|Withdrawal by Subject|0|||
33326656|NCT00941031|62703274|FG004|Maintenance Period|Withdrawal by Subject|6|||
33326657|NCT00941031|62703275|FG005|Maintenance Period|Withdrawal by Subject|2|||
33326658|NCT00941031|62703276|FG006|Maintenance Period|Withdrawal by Subject|13|||
33326659|NCT00941031|62703270|FG000|Maintenance Period|Administrative Problems|0|||
33326660|NCT00941031|62703271|FG001|Maintenance Period|Administrative Problems|0|||
33326661|NCT00941031|62703272|FG002|Maintenance Period|Administrative Problems|0|||
33326662|NCT00941031|62703273|FG003|Maintenance Period|Administrative Problems|0|||
33326663|NCT00941031|62703274|FG004|Maintenance Period|Administrative Problems|1|||
33541879|NCT01662310|62932513|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
33639242|NCT01554579|63042025|FG000|Overall Study|Lack of Efficacy|2|||
33326664|NCT00941031|62703275|FG005|Maintenance Period|Administrative Problems|0|||
33326665|NCT00941031|62703276|FG006|Maintenance Period|Administrative Problems|1|||
33326666|NCT00941031|62703270|FG000|Maintenance Period|Protocol Violation|0|||
33326667|NCT00941031|62703271|FG001|Maintenance Period|Protocol Violation|0|||
33326668|NCT00941031|62703272|FG002|Maintenance Period|Protocol Violation|0|||
33326669|NCT00941031|62703273|FG003|Maintenance Period|Protocol Violation|0|||
33326670|NCT00941031|62703274|FG004|Maintenance Period|Protocol Violation|0|||
33326671|NCT00941031|62703275|FG005|Maintenance Period|Protocol Violation|0|||
33541880|NCT01662310|62932509|FG000|Run-In or Stabilization Phase|Other|1|||
33639243|NCT01554579|63042026|FG001|Overall Study|Lack of Efficacy|1|||
33639244|NCT01554579|63042025|FG000|Overall Study|Withdrawal by Subject|2|||
33639245|NCT01554579|63042026|FG001|Overall Study|Withdrawal by Subject|1|||
33639246|NCT01806662|63042033|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
33326672|NCT00941031|62703276|FG006|Maintenance Period|Protocol Violation|1|||
33541881|NCT01662310|62932510|FG001|Run-In or Stabilization Phase|Other|0|||
33639247|NCT01806662|63042034|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
33639248|NCT01806662|63042033|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
33639249|NCT01806662|63042034|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
33639250|NCT01806662|63042033|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
33639251|NCT01806662|63042034|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
33639252|NCT01806662|63042033|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
33639253|NCT01806662|63042034|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
33639254|NCT01930123|63042042|FG000|Overall Study|Adverse Event|1|||
33639255|NCT01930123|63042043|FG001|Overall Study|Adverse Event|0|||
33639256|NCT01930123|63042042|FG000|Overall Study|Physician Decision|21|||
33639257|NCT01930123|63042043|FG001|Overall Study|Physician Decision|8|||
33639258|NCT01930123|63042042|FG000|Overall Study|Withdrawal by Subject|1|||
33639259|NCT01930123|63042043|FG001|Overall Study|Withdrawal by Subject|0|||
33639260|NCT01930045|63042049|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
33541882|NCT01662310|62932511|FG002|Run-In or Stabilization Phase|Other|0|||
33541883|NCT01662310|62932512|FG003|Run-In or Stabilization Phase|Other|0|||
33541884|NCT01662310|62932513|FG004|Run-In or Stabilization Phase|Other|0|||
33541885|NCT01662310|62932509|FG000|Double-Blind Phase|Adverse Event|0|||
33541886|NCT01662310|62932510|FG001|Double-Blind Phase|Adverse Event|0|||
33541887|NCT01662310|62932511|FG002|Double-Blind Phase|Adverse Event|1|||
33639261|NCT01930045|63042050|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
33639262|NCT01930045|63042051|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
33639263|NCT01930045|63042052|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
33541888|NCT01662310|62932512|FG003|Double-Blind Phase|Adverse Event|0|||
33541889|NCT01662310|62932513|FG004|Double-Blind Phase|Adverse Event|0|||
33541890|NCT01662310|62932509|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33541891|NCT01662310|62932510|FG001|Double-Blind Phase|Lost to Follow-up|3|||
33541892|NCT01662310|62932511|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33541893|NCT01662310|62932512|FG003|Double-Blind Phase|Lost to Follow-up|0|||
33541894|NCT01662310|62932513|FG004|Double-Blind Phase|Lost to Follow-up|0|||
33541895|NCT01662310|62932509|FG000|Double-Blind Phase|Pregnancy|0|||
33541896|NCT01662310|62932510|FG001|Double-Blind Phase|Pregnancy|2|||
33541897|NCT01662310|62932511|FG002|Double-Blind Phase|Pregnancy|0|||
33541898|NCT01662310|62932512|FG003|Double-Blind Phase|Pregnancy|0|||
33541899|NCT01662310|62932513|FG004|Double-Blind Phase|Pregnancy|0|||
33541900|NCT01662310|62932509|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
33541901|NCT01662310|62932510|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
33541902|NCT01662310|62932511|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
33541903|NCT01662310|62932512|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
33541904|NCT01662310|62932513|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
33541905|NCT01662310|62932509|FG000|Double-Blind Phase|Other|0|||
33541906|NCT01662310|62932510|FG001|Double-Blind Phase|Other|0|||
33541907|NCT01662310|62932511|FG002|Double-Blind Phase|Other|1|||
33639264|NCT01930045|63042053|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
33326673|NCT00941031|62703270|FG000|Maintenance Period|Adverse Event|0|||
33326674|NCT00941031|62703271|FG001|Maintenance Period|Adverse Event|0|||
33326675|NCT00941031|62703272|FG002|Maintenance Period|Adverse Event|0|||
33326676|NCT00941031|62703273|FG003|Maintenance Period|Adverse Event|0|||
33326677|NCT00941031|62703274|FG004|Maintenance Period|Adverse Event|0|||
33462892|NCT00379769|62836630|FG004|Main Study|Prohibited glucose lowering medication|0|||
33639265|NCT01930045|63042054|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
33639266|NCT01930045|63042049|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
33462893|NCT00379769|62836631|FG005|Main Study|Prohibited glucose lowering medication|0|||
33462894|NCT00379769|62836626|FG000|Main Study|Site closed|4|||
33462895|NCT00379769|62836627|FG001|Main Study|Site closed|4|||
33462896|NCT00379769|62836628|FG002|Main Study|Site closed|4|||
33462897|NCT00379769|62836629|FG003|Main Study|Site closed|8|||
33462898|NCT00379769|62836630|FG004|Main Study|Site closed|0|||
33462899|NCT00379769|62836631|FG005|Main Study|Site closed|0|||
33462900|NCT00379769|62836626|FG000|Main Study|Entry criteria violation|0|||
33462901|NCT00379769|62836627|FG001|Main Study|Entry criteria violation|0|||
33462902|NCT00379769|62836628|FG002|Main Study|Entry criteria violation|1|||
33462903|NCT00379769|62836629|FG003|Main Study|Entry criteria violation|1|||
33462904|NCT00379769|62836630|FG004|Main Study|Entry criteria violation|0|||
33462905|NCT00379769|62836631|FG005|Main Study|Entry criteria violation|0|||
33462906|NCT00379769|62836626|FG000|Main Study|Participant did not take study drug|0|||
33462907|NCT00379769|62836627|FG001|Main Study|Participant did not take study drug|0|||
33462908|NCT00379769|62836628|FG002|Main Study|Participant did not take study drug|1|||
33462909|NCT00379769|62836629|FG003|Main Study|Participant did not take study drug|0|||
33462910|NCT00379769|62836630|FG004|Main Study|Participant did not take study drug|0|||
33462911|NCT00379769|62836631|FG005|Main Study|Participant did not take study drug|0|||
33462912|NCT00379769|62836626|FG000|Main Study|Physician Decision|2|||
33462913|NCT00379769|62836627|FG001|Main Study|Physician Decision|2|||
33541908|NCT01662310|62932512|FG003|Double-Blind Phase|Other|0|||
33541909|NCT01662310|62932513|FG004|Double-Blind Phase|Other|0|||
33541910|NCT01662310|62932509|FG000|Double-Blind Phase|Randomized but not treated|0|||
33639267|NCT01930045|63042050|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
33639268|NCT01930045|63042051|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
33639269|NCT01930045|63042052|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
33639270|NCT01930045|63042053|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
33639271|NCT01930045|63042054|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
33639272|NCT01929343|63042069|FG000|Overall Study|Physician Decision|0|||
33639273|NCT01929343|63042070|FG001|Overall Study|Physician Decision|2|||
33639274|NCT01929343|63042071|FG002|Overall Study|Physician Decision|0|||
33639275|NCT01929343|63042069|FG000|Overall Study|Withdrawal by Subject|1|||
33639276|NCT01929343|63042070|FG001|Overall Study|Withdrawal by Subject|0|||
33639277|NCT01929343|63042071|FG002|Overall Study|Withdrawal by Subject|0|||
33639278|NCT01968811|63042079|FG000|Overall Study|Protocol Violation|4|||
33639279|NCT01968811|63042079|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
33639280|NCT01806584|63042085|FG000|Overall Study|Adverse Event|2|||
33639281|NCT01806584|63042086|FG001|Overall Study|Adverse Event|1|||
33639282|NCT01806584|63042085|FG000|Overall Study|Death|1|||
33639283|NCT01806584|63042086|FG001|Overall Study|Death|0|||
33639284|NCT01806584|63042085|FG000|Overall Study|Lost to Follow-up|0|||
33639285|NCT01806584|63042086|FG001|Overall Study|Lost to Follow-up|2|||
33639286|NCT01806584|63042085|FG000|Overall Study|Study terminated by sponsor|9|||
33639287|NCT01806584|63042086|FG001|Overall Study|Study terminated by sponsor|14|||
33639288|NCT01806584|63042085|FG000|Overall Study|Withdrawal by Subject|1|||
33639289|NCT01806584|63042086|FG001|Overall Study|Withdrawal by Subject|1|||
33639290|NCT01806584|63042085|FG000|Overall Study|Other unspecified|1|||
33639291|NCT01806584|63042086|FG001|Overall Study|Other unspecified|0|||
33639292|NCT01798706|63042094|FG000|Overall Study|Adverse Event|15|||
33639293|NCT01798706|63042095|FG001|Overall Study|Adverse Event|10|||
33639294|NCT01798706|63042094|FG000|Overall Study|Lack of Efficacy|0|||
33639295|NCT01798706|63042095|FG001|Overall Study|Lack of Efficacy|2|||
33639296|NCT01798706|63042094|FG000|Overall Study|Poor compliance to protocol|1|||
33639297|NCT01798706|63042095|FG001|Overall Study|Poor compliance to protocol|0|||
33639298|NCT01798706|63042094|FG000|Overall Study|Other than specified above|5|||
33639299|NCT01798706|63042095|FG001|Overall Study|Other than specified above|9|||
33639300|NCT01767194|63042103|FG000|Overall Study|Adverse Event|1|||
33639301|NCT01767194|63042104|FG001|Overall Study|Adverse Event|1|||
33639302|NCT01767194|63042103|FG000|Overall Study|Death|0|||
33639303|NCT01767194|63042104|FG001|Overall Study|Death|1|||
33639304|NCT01767194|63042103|FG000|Overall Study|Lack of Efficacy|12|||
33639305|NCT01767194|63042104|FG001|Overall Study|Lack of Efficacy|11|||
33639306|NCT01767194|63042103|FG000|Overall Study|Physician Decision|2|||
33639307|NCT01767194|63042104|FG001|Overall Study|Physician Decision|23|||
33639308|NCT01767194|63042103|FG000|Overall Study|Withdrawal by Subject|0|||
33639309|NCT01767194|63042104|FG001|Overall Study|Withdrawal by Subject|1|||
33639310|NCT01767194|63042103|FG000|Overall Study|Ineligible|1|||
33639311|NCT01767194|63042104|FG001|Overall Study|Ineligible|1|||
33639312|NCT01767194|63042103|FG000|Overall Study|Refusal by patient/parent|2|||
33639313|NCT01767194|63042104|FG001|Overall Study|Refusal by patient/parent|4|||
33639314|NCT01767194|63042103|FG000|Overall Study|Criteria not met on time for next cycle|0|||
33639315|NCT01767194|63042104|FG001|Overall Study|Criteria not met on time for next cycle|1|||
33639316|NCT01575873|63042115|FG000|Overall Study|Withdrawal by Subject|15|||
33639317|NCT01575873|63042116|FG001|Overall Study|Withdrawal by Subject|20|||
33639318|NCT01575873|63042117|FG002|Overall Study|Withdrawal by Subject|34|||
33639319|NCT01575873|63042118|FG003|Overall Study|Withdrawal by Subject|34|||
33639320|NCT01575873|63042115|FG000|Overall Study|Adverse Event|7|||
33639321|NCT01575873|63042116|FG001|Overall Study|Adverse Event|7|||
33639322|NCT01575873|63042117|FG002|Overall Study|Adverse Event|9|||
33639323|NCT01575873|63042118|FG003|Overall Study|Adverse Event|12|||
33639324|NCT01575873|63042115|FG000|Overall Study|Lost to Follow-up|1|||
33639325|NCT01575873|63042116|FG001|Overall Study|Lost to Follow-up|3|||
33639326|NCT01575873|63042117|FG002|Overall Study|Lost to Follow-up|13|||
33639327|NCT01575873|63042118|FG003|Overall Study|Lost to Follow-up|5|||
33639328|NCT01575873|63042115|FG000|Overall Study|Death|3|||
33639329|NCT01575873|63042116|FG001|Overall Study|Death|2|||
33639330|NCT01575873|63042117|FG002|Overall Study|Death|8|||
33639331|NCT01575873|63042118|FG003|Overall Study|Death|9|||
33639332|NCT01575873|63042115|FG000|Overall Study|Noncompliance|1|||
33639333|NCT01575873|63042116|FG001|Overall Study|Noncompliance|2|||
33639334|NCT01575873|63042117|FG002|Overall Study|Noncompliance|4|||
33639335|NCT01575873|63042118|FG003|Overall Study|Noncompliance|3|||
33639336|NCT01575873|63042115|FG000|Overall Study|Administrative decision|1|||
33639337|NCT01575873|63042116|FG001|Overall Study|Administrative decision|1|||
33639338|NCT01575873|63042117|FG002|Overall Study|Administrative decision|1|||
33639339|NCT01575873|63042118|FG003|Overall Study|Administrative decision|0|||
33639340|NCT01575873|63042115|FG000|Overall Study|Protocol deviation|0|||
33639341|NCT01575873|63042116|FG001|Overall Study|Protocol deviation|1|||
33639342|NCT01575873|63042117|FG002|Overall Study|Protocol deviation|0|||
33639343|NCT01575873|63042118|FG003|Overall Study|Protocol deviation|1|||
33639344|NCT01575873|63042115|FG000|Overall Study|Requirement for Alternative Therapy|0|||
33639345|NCT01575873|63042116|FG001|Overall Study|Requirement for Alternative Therapy|0|||
33639346|NCT01575873|63042117|FG002|Overall Study|Requirement for Alternative Therapy|1|||
33639347|NCT01575873|63042118|FG003|Overall Study|Requirement for Alternative Therapy|1|||
33639348|NCT01575873|63042115|FG000|Overall Study|Other|0|||
33639349|NCT01575873|63042116|FG001|Overall Study|Other|0|||
33639350|NCT01575873|63042117|FG002|Overall Study|Other|4|||
33639351|NCT01575873|63042118|FG003|Overall Study|Other|2|||
33639352|NCT01575561|63042126|FG000|Overall Study|Adverse Event|9|||
33639353|NCT01575561|63042126|FG000|Overall Study|Lack of Efficacy|8|||
33639354|NCT01575561|63042126|FG000|Overall Study|Lost to Follow-up|6|||
33639355|NCT01575561|63042126|FG000|Overall Study|Protocol Violation|4|||
33639356|NCT01575561|63042126|FG000|Overall Study|Withdrawal by Subject|11|||
33639357|NCT01575561|63042126|FG000|Overall Study|administration|1|||
33639358|NCT01609790|63042133|FG000|Overall Study|Protocol Violation|1|||
33639359|NCT01609790|63042134|FG001|Overall Study|Protocol Violation|7|||
33639360|NCT01609790|63042135|FG002|Overall Study|Protocol Violation|8|||
33639361|NCT01767116|63042145|FG000|Overall Study|Lost to Follow-up|2|||
33639362|NCT01767116|63042146|FG001|Overall Study|Lost to Follow-up|2|||
33639363|NCT01574703|63042156|FG000|Overall Study|Adverse Event|0|||
33639364|NCT01574703|63042157|FG001|Overall Study|Adverse Event|2|||
33639365|NCT01574703|63042158|FG002|Overall Study|Adverse Event|1|||
33639366|NCT01574703|63042159|FG003|Overall Study|Adverse Event|1|||
33639367|NCT01574703|63042156|FG000|Overall Study|Protocol Violation|0|||
33541911|NCT01662310|62932510|FG001|Double-Blind Phase|Randomized but not treated|1|||
33541912|NCT01662310|62932511|FG002|Double-Blind Phase|Randomized but not treated|0|||
33541913|NCT01662310|62932512|FG003|Double-Blind Phase|Randomized but not treated|0|||
33541914|NCT01662310|62932513|FG004|Double-Blind Phase|Randomized but not treated|0|||
33541915|NCT01662310|62932509|FG000|Open-Label Extension Phase|Adverse Event|0|||
33541916|NCT01662310|62932510|FG001|Open-Label Extension Phase|Adverse Event|0|||
33541917|NCT01662310|62932511|FG002|Open-Label Extension Phase|Adverse Event|0|||
33541918|NCT01662310|62932512|FG003|Open-Label Extension Phase|Adverse Event|3|||
33541919|NCT01662310|62932513|FG004|Open-Label Extension Phase|Adverse Event|0|||
33541920|NCT01662310|62932509|FG000|Open-Label Extension Phase|Death|0|||
33541921|NCT01662310|62932510|FG001|Open-Label Extension Phase|Death|0|||
33541922|NCT01662310|62932511|FG002|Open-Label Extension Phase|Death|0|||
33639368|NCT01574703|63042157|FG001|Overall Study|Protocol Violation|0|||
33639369|NCT01574703|63042158|FG002|Overall Study|Protocol Violation|0|||
33639370|NCT01574703|63042159|FG003|Overall Study|Protocol Violation|1|||
33639371|NCT01574703|63042156|FG000|Overall Study|Unspecified Reason|27|||
33639372|NCT01574703|63042157|FG001|Overall Study|Unspecified Reason|15|||
33639373|NCT01574703|63042158|FG002|Overall Study|Unspecified Reason|20|||
33639374|NCT01574703|63042159|FG003|Overall Study|Unspecified Reason|16|||
33639375|NCT01574703|63042156|FG000|Overall Study|Withdrawal by Subject|53|||
33639376|NCT01574703|63042157|FG001|Overall Study|Withdrawal by Subject|52|||
33639377|NCT01574703|63042158|FG002|Overall Study|Withdrawal by Subject|36|||
33639378|NCT01574703|63042159|FG003|Overall Study|Withdrawal by Subject|61|||
33639379|NCT01574703|63042156|FG000|Overall Study|Met Withdrawal Criteria|0|||
33639380|NCT01574703|63042157|FG001|Overall Study|Met Withdrawal Criteria|1|||
33326678|NCT00941031|62703275|FG005|Maintenance Period|Adverse Event|2|||
33541923|NCT01662310|62932512|FG003|Open-Label Extension Phase|Death|1|||
33541924|NCT01662310|62932513|FG004|Open-Label Extension Phase|Death|0|||
33541925|NCT01662310|62932509|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
33541926|NCT01662310|62932510|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
33541927|NCT01662310|62932511|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
33541928|NCT01662310|62932512|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
33541929|NCT01662310|62932513|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
33639381|NCT01574703|63042158|FG002|Overall Study|Met Withdrawal Criteria|1|||
33639382|NCT01574703|63042159|FG003|Overall Study|Met Withdrawal Criteria|0|||
33639383|NCT01574703|63042156|FG000|Overall Study|Lost to Follow-up|43|||
33639384|NCT01574703|63042157|FG001|Overall Study|Lost to Follow-up|41|||
33326679|NCT00941031|62703276|FG006|Maintenance Period|Adverse Event|8|||
33326680|NCT00941031|62703270|FG000|Maintenance Period|Lost to Follow-up|0|||
33326681|NCT00941031|62703271|FG001|Maintenance Period|Lost to Follow-up|0|||
33326682|NCT00941031|62703272|FG002|Maintenance Period|Lost to Follow-up|0|||
33541930|NCT01662310|62932509|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
33639385|NCT01574703|63042158|FG002|Overall Study|Lost to Follow-up|46|||
33639386|NCT01574703|63042159|FG003|Overall Study|Lost to Follow-up|35|||
33639387|NCT01574703|63042156|FG000|Overall Study|Death|2|||
33639388|NCT01574703|63042157|FG001|Overall Study|Death|1|||
33639389|NCT01574703|63042158|FG002|Overall Study|Death|1|||
33639390|NCT01574703|63042159|FG003|Overall Study|Death|0|||
33541931|NCT01662310|62932510|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
33541932|NCT01662310|62932511|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
33639391|NCT01686633|63042172|FG000|Overall Study|Lack of Efficacy|33|||
33639392|NCT01686633|63042173|FG001|Overall Study|Lack of Efficacy|13|||
33639393|NCT01686633|63042174|FG002|Overall Study|Lack of Efficacy|11|||
33639394|NCT01686633|63042172|FG000|Overall Study|Withdrawal by Subject|8|||
33541933|NCT01662310|62932512|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
33541934|NCT01662310|62932513|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
33541935|NCT01662310|62932509|FG000|Open-Label Extension Phase|Pregnancy|0|||
33541936|NCT01662310|62932510|FG001|Open-Label Extension Phase|Pregnancy|0|||
33541937|NCT01662310|62932511|FG002|Open-Label Extension Phase|Pregnancy|0|||
33541938|NCT01662310|62932512|FG003|Open-Label Extension Phase|Pregnancy|1|||
33541939|NCT01662310|62932513|FG004|Open-Label Extension Phase|Pregnancy|0|||
33541940|NCT01662310|62932509|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
33541941|NCT01662310|62932510|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
33541942|NCT01662310|62932511|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
33541943|NCT01662310|62932512|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
33541944|NCT01662310|62932513|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
33541945|NCT00700622|62932527|FG000|Overall Study|Adverse Event|4|||
33541946|NCT00700622|62932528|FG001|Overall Study|Adverse Event|0|||
33541947|NCT00700622|62932527|FG000|Overall Study|Lost to Follow-up|0|||
33541948|NCT00700622|62932528|FG001|Overall Study|Lost to Follow-up|1|||
33541949|NCT00700622|62932527|FG000|Overall Study|Physician Decision|2|||
33541950|NCT00700622|62932528|FG001|Overall Study|Physician Decision|1|||
33541951|NCT00700622|62932527|FG000|Overall Study|Protocol Violation|0|||
33541952|NCT00700622|62932528|FG001|Overall Study|Protocol Violation|1|||
33541953|NCT00700622|62932527|FG000|Overall Study|Withdrawal by Subject|4|||
33541954|NCT00700622|62932528|FG001|Overall Study|Withdrawal by Subject|1|||
33541955|NCT00700622|62932527|FG000|Overall Study|Other|3|||
33541956|NCT00700622|62932528|FG001|Overall Study|Other|1|||
33541957|NCT02553928|62932536|FG000|Overall Study|Adverse Event|2|||
33541958|NCT02553928|62932537|FG001|Overall Study|Adverse Event|1|||
33541959|NCT02553928|62932536|FG000|Overall Study|Lost to Follow-up|0|||
33541960|NCT02553928|62932537|FG001|Overall Study|Lost to Follow-up|1|||
33639395|NCT01686633|63042173|FG001|Overall Study|Withdrawal by Subject|8|||
33639396|NCT01686633|63042174|FG002|Overall Study|Withdrawal by Subject|5|||
33541961|NCT02553928|62932536|FG000|Overall Study|Administrative reason(s)|0|||
33541962|NCT02553928|62932537|FG001|Overall Study|Administrative reason(s)|1|||
33541963|NCT03076775|62932546|FG000|Overall Study|Lost to Follow-up|1|||
33541964|NCT03076775|62932547|FG001|Overall Study|Lost to Follow-up|0|||
33639397|NCT01686633|63042172|FG000|Overall Study|Physician Decision|3|||
33639398|NCT01686633|63042173|FG001|Overall Study|Physician Decision|4|||
33639399|NCT01686633|63042174|FG002|Overall Study|Physician Decision|4|||
33639400|NCT01686633|63042172|FG000|Overall Study|Adverse Event|4|||
33639401|NCT01686633|63042173|FG001|Overall Study|Adverse Event|3|||
33639402|NCT01686633|63042174|FG002|Overall Study|Adverse Event|3|||
33639403|NCT01686633|63042172|FG000|Overall Study|Protocol Violation|2|||
33639404|NCT01686633|63042173|FG001|Overall Study|Protocol Violation|3|||
33639405|NCT01686633|63042174|FG002|Overall Study|Protocol Violation|0|||
33639406|NCT01686633|63042172|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
33639407|NCT01686633|63042173|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
33639408|NCT01686633|63042174|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
33639409|NCT01686633|63042172|FG000|Overall Study|Lost to Follow-up|0|||
33639410|NCT01686633|63042173|FG001|Overall Study|Lost to Follow-up|1|||
33639411|NCT01686633|63042174|FG002|Overall Study|Lost to Follow-up|1|||
33639412|NCT01685697|63042184|FG000|Overall Study|Protocol Violation|3|||
33639413|NCT01685697|63042185|FG001|Overall Study|Protocol Violation|3|||
33639414|NCT02395120|63042196|FG000|Overall Study|Missed follow-up dental exam|57|||
33639415|NCT02395120|63042197|FG001|Overall Study|Missed follow-up dental exam|62|||
33639416|NCT02395120|63042198|FG002|Overall Study|Missed follow-up dental exam|6|||
33541965|NCT03058991|62932564|FG000|Overall Study|Lost to Follow-up|17|||
33541966|NCT03058991|62932565|FG001|Overall Study|Lost to Follow-up|12|||
33541967|NCT03058991|62932566|FG002|Overall Study|Lost to Follow-up|12|||
33541968|NCT03058991|62932564|FG000|Overall Study|Withdrawal by Subject|1|||
33541969|NCT03058991|62932565|FG001|Overall Study|Withdrawal by Subject|0|||
33541970|NCT03058991|62932566|FG002|Overall Study|Withdrawal by Subject|0|||
33541971|NCT00700310|62932578|FG000|Overall Study|Adverse Event|6|||
33541972|NCT00700310|62932579|FG001|Overall Study|Adverse Event|10|||
33541973|NCT00700310|62932580|FG002|Overall Study|Adverse Event|5|||
33541974|NCT00700310|62932581|FG003|Overall Study|Adverse Event|11|||
33541975|NCT00700310|62932578|FG000|Overall Study|Lost to Follow-up|4|||
33541976|NCT00700310|62932579|FG001|Overall Study|Lost to Follow-up|1|||
33541977|NCT00700310|62932580|FG002|Overall Study|Lost to Follow-up|0|||
33639417|NCT02395120|63042199|FG003|Overall Study|Missed follow-up dental exam|6|||
33639418|NCT02395120|63042200|FG004|Overall Study|Missed follow-up dental exam|51|||
33639419|NCT01685229|63042214|FG000|Overall Study|Subjects missing Study Exit form|3|||
33639420|NCT01685229|63042215|FG001|Overall Study|Subjects missing Study Exit form|1|||
33639421|NCT01685229|63042214|FG000|Overall Study|Lost to Follow-up|16|||
33639422|NCT01685229|63042215|FG001|Overall Study|Lost to Follow-up|10|||
33541978|NCT00700310|62932581|FG003|Overall Study|Lost to Follow-up|1|||
33541979|NCT00700310|62932578|FG000|Overall Study|Withdrawal by Subject|8|||
33541980|NCT00700310|62932579|FG001|Overall Study|Withdrawal by Subject|9|||
33541981|NCT00700310|62932580|FG002|Overall Study|Withdrawal by Subject|8|||
33541982|NCT00700310|62932581|FG003|Overall Study|Withdrawal by Subject|8|||
33541983|NCT00700310|62932578|FG000|Overall Study|Lack of Efficacy|0|||
33541984|NCT00700310|62932579|FG001|Overall Study|Lack of Efficacy|3|||
33541985|NCT00700310|62932580|FG002|Overall Study|Lack of Efficacy|0|||
33541986|NCT00700310|62932581|FG003|Overall Study|Lack of Efficacy|1|||
33541987|NCT00700310|62932578|FG000|Overall Study|Administrative/Other|1|||
33541988|NCT00700310|62932579|FG001|Overall Study|Administrative/Other|3|||
33541989|NCT00700310|62932580|FG002|Overall Study|Administrative/Other|1|||
33541990|NCT00700310|62932581|FG003|Overall Study|Administrative/Other|3|||
33541991|NCT00700310|62932578|FG000|Overall Study|Randomized, Not Treated|2|||
33541992|NCT00700310|62932579|FG001|Overall Study|Randomized, Not Treated|0|||
33541993|NCT00700310|62932580|FG002|Overall Study|Randomized, Not Treated|2|||
33541994|NCT00700310|62932581|FG003|Overall Study|Randomized, Not Treated|2|||
33541995|NCT01575548|62932602|FG000|Overall Study|Adverse Event|15|||
33541996|NCT01575548|62932603|FG001|Overall Study|Adverse Event|2|||
33541997|NCT01575548|62932602|FG000|Overall Study|Disease progression|12|||
33541998|NCT01575548|62932603|FG001|Overall Study|Disease progression|25|||
33541999|NCT01575548|62932602|FG000|Overall Study|Death|1|||
33542000|NCT01575548|62932603|FG001|Overall Study|Death|0|||
33542001|NCT01575548|62932602|FG000|Overall Study|Other complicating disease|1|||
33542002|NCT01575548|62932603|FG001|Overall Study|Other complicating disease|0|||
33542003|NCT01575548|62932602|FG000|Overall Study|Withdrawal by Subject|7|||
33326683|NCT00941031|62703273|FG003|Maintenance Period|Lost to Follow-up|0|||
33326684|NCT00941031|62703274|FG004|Maintenance Period|Lost to Follow-up|2|||
33326685|NCT00941031|62703275|FG005|Maintenance Period|Lost to Follow-up|2|||
33326686|NCT00941031|62703276|FG006|Maintenance Period|Lost to Follow-up|7|||
33639423|NCT01685229|63042214|FG000|Overall Study|Withdrawal by Subject|6|||
33639424|NCT01685229|63042215|FG001|Overall Study|Withdrawal by Subject|5|||
33639425|NCT01685229|63042214|FG000|Overall Study|Death|1|||
33639426|NCT01685229|63042215|FG001|Overall Study|Death|0|||
33639427|NCT01551693|63042226|FG000|Overall Study|Disease Progression|1|||
33639428|NCT01551693|63042227|FG001|Overall Study|Disease Progression|0|||
33639429|NCT01551693|63042226|FG000|Overall Study|Adverse Event|0|||
33639430|NCT01551693|63042227|FG001|Overall Study|Adverse Event|1|||
33639431|NCT01551693|63042226|FG000|Overall Study|Withdrawal by Subject|0|||
33639432|NCT01551693|63042227|FG001|Overall Study|Withdrawal by Subject|1|||
33639433|NCT01574157|63042235|FG000|Overall Study|Withdrawal by Subject|4|||
33639434|NCT01574157|63042236|FG001|Overall Study|Withdrawal by Subject|5|||
33326687|NCT00941031|62703270|FG000|Maintenance Period|Lack of Efficacy|0|||
33326688|NCT00941031|62703271|FG001|Maintenance Period|Lack of Efficacy|0|||
33326689|NCT00941031|62703272|FG002|Maintenance Period|Lack of Efficacy|0|||
33326690|NCT00941031|62703273|FG003|Maintenance Period|Lack of Efficacy|0|||
33542004|NCT01575548|62932603|FG001|Overall Study|Withdrawal by Subject|3|||
33542005|NCT01575548|62932602|FG000|Overall Study|Noncompliance|1|||
33542006|NCT01575548|62932603|FG001|Overall Study|Noncompliance|0|||
33542007|NCT01575548|62932602|FG000|Overall Study|Anticipated surgery|0|||
33542008|NCT01575548|62932603|FG001|Overall Study|Anticipated surgery|1|||
33542009|NCT01575548|62932602|FG000|Overall Study|Never started protocol therapy|3|||
33542010|NCT01575548|62932603|FG001|Overall Study|Never started protocol therapy|2|||
33542011|NCT01750281|62932612|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
33542012|NCT01750281|62932613|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
33542013|NCT01750281|62932614|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
33542014|NCT01750281|62932612|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
33542015|NCT01750281|62932613|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
33542016|NCT01750281|62932614|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
33542017|NCT01750281|62932612|FG000|Overall Study|Did not receive treatment|0|||
33542018|NCT01750281|62932613|FG001|Overall Study|Did not receive treatment|1|||
33542019|NCT01750281|62932614|FG002|Overall Study|Did not receive treatment|0|||
33542020|NCT03000569|62932641|FG000|Overall Study|Withdrawal by Subject|1|||
33542021|NCT03000569|62932642|FG001|Overall Study|Withdrawal by Subject|0|||
33542022|NCT02554786|62932661|FG000|Overall Study|Subject/guardian decision|29|||
33542023|NCT02554786|62932662|FG001|Overall Study|Subject/guardian decision|17|||
33542024|NCT02554786|62932663|FG002|Overall Study|Subject/guardian decision|18|||
33542025|NCT02554786|62932664|FG003|Overall Study|Subject/guardian decision|30|||
33639435|NCT01574157|63042235|FG000|Overall Study|Lost to Follow-up|0|||
33542026|NCT02554786|62932665|FG004|Overall Study|Subject/guardian decision|20|||
33542027|NCT02554786|62932661|FG000|Overall Study|Lost to Follow-up|4|||
33542028|NCT02554786|62932662|FG001|Overall Study|Lost to Follow-up|3|||
33639436|NCT01574157|63042236|FG001|Overall Study|Lost to Follow-up|3|||
33639437|NCT01574079|63042248|FG000|Overall Study|Physician Decision|0|||
33639438|NCT01574079|63042249|FG001|Overall Study|Physician Decision|2|||
33326691|NCT00941031|62703274|FG004|Maintenance Period|Lack of Efficacy|0|||
33542029|NCT02554786|62932663|FG002|Overall Study|Lost to Follow-up|4|||
33542030|NCT02554786|62932664|FG003|Overall Study|Lost to Follow-up|2|||
33542031|NCT02554786|62932665|FG004|Overall Study|Lost to Follow-up|2|||
33542032|NCT02554786|62932661|FG000|Overall Study|Protocol deviation|1|||
33639439|NCT01574079|63042248|FG000|Overall Study|Lost to Follow-up|1|||
33542033|NCT02554786|62932662|FG001|Overall Study|Protocol deviation|3|||
33542034|NCT02554786|62932663|FG002|Overall Study|Protocol deviation|3|||
33542035|NCT02554786|62932664|FG003|Overall Study|Protocol deviation|4|||
33542036|NCT02554786|62932665|FG004|Overall Study|Protocol deviation|2|||
33542037|NCT02554786|62932661|FG000|Overall Study|Technical problems|1|||
33542038|NCT02554786|62932662|FG001|Overall Study|Technical problems|1|||
33639440|NCT01574079|63042249|FG001|Overall Study|Lost to Follow-up|0|||
33639441|NCT01573767|63042259|FG000|Overall Study|Adverse Event|0|||
33639442|NCT01573767|63042260|FG001|Overall Study|Adverse Event|1|||
33639443|NCT01573767|63042261|FG002|Overall Study|Adverse Event|0|||
33639444|NCT01573767|63042262|FG003|Overall Study|Adverse Event|1|||
33639445|NCT01573767|63042259|FG000|Overall Study|Lack of Efficacy|18|||
33542039|NCT02554786|62932663|FG002|Overall Study|Technical problems|0|||
33542040|NCT02554786|62932664|FG003|Overall Study|Technical problems|2|||
33542041|NCT02554786|62932665|FG004|Overall Study|Technical problems|1|||
33639446|NCT01573767|63042260|FG001|Overall Study|Lack of Efficacy|15|||
33639447|NCT01573767|63042261|FG002|Overall Study|Lack of Efficacy|12|||
33462914|NCT00379769|62836628|FG002|Main Study|Physician Decision|1|||
33462915|NCT00379769|62836629|FG003|Main Study|Physician Decision|1|||
33462916|NCT00379769|62836630|FG004|Main Study|Physician Decision|0|||
33462917|NCT00379769|62836631|FG005|Main Study|Physician Decision|0|||
33462918|NCT00379769|62836626|FG000|Main Study|Participant completed study at visit 27|1|||
33462919|NCT00379769|62836627|FG001|Main Study|Participant completed study at visit 27|0|||
33542042|NCT02554786|62932661|FG000|Overall Study|Adverse Event|0|||
33542043|NCT02554786|62932662|FG001|Overall Study|Adverse Event|0|||
33542044|NCT02554786|62932663|FG002|Overall Study|Adverse Event|0|||
33542045|NCT02554786|62932664|FG003|Overall Study|Adverse Event|0|||
33542046|NCT02554786|62932665|FG004|Overall Study|Adverse Event|2|||
33542047|NCT02554786|62932661|FG000|Overall Study|Death|0|||
33542048|NCT02554786|62932662|FG001|Overall Study|Death|0|||
33542049|NCT02554786|62932663|FG002|Overall Study|Death|0|||
33542050|NCT02554786|62932664|FG003|Overall Study|Death|1|||
33462920|NCT00379769|62836628|FG002|Main Study|Participant completed study at visit 27|0|||
33462921|NCT00379769|62836629|FG003|Main Study|Participant completed study at visit 27|0|||
33462922|NCT00379769|62836630|FG004|Main Study|Participant completed study at visit 27|0|||
33462923|NCT00379769|62836631|FG005|Main Study|Participant completed study at visit 27|0|||
33462924|NCT00379769|62836626|FG000|Main Study|Personal reasons|1|||
33462925|NCT00379769|62836627|FG001|Main Study|Personal reasons|0|||
33462926|NCT00379769|62836628|FG002|Main Study|Personal reasons|0|||
33462927|NCT00379769|62836629|FG003|Main Study|Personal reasons|0|||
33462928|NCT00379769|62836630|FG004|Main Study|Personal reasons|0|||
33462929|NCT00379769|62836631|FG005|Main Study|Personal reasons|0|||
33462930|NCT00379769|62836626|FG000|Main Study|Risk of heart failure|0|||
33462931|NCT00379769|62836627|FG001|Main Study|Risk of heart failure|1|||
33462932|NCT00379769|62836628|FG002|Main Study|Risk of heart failure|0|||
33462933|NCT00379769|62836629|FG003|Main Study|Risk of heart failure|0|||
33462934|NCT00379769|62836630|FG004|Main Study|Risk of heart failure|0|||
33462935|NCT00379769|62836631|FG005|Main Study|Risk of heart failure|0|||
33462936|NCT00379769|62836626|FG000|Main Study|Investigator refused to log temperature|0|||
33542051|NCT02554786|62932665|FG004|Overall Study|Death|0|||
33542052|NCT02554786|62932661|FG000|Overall Study|Non-compliance with study treatment|0|||
33542053|NCT02554786|62932662|FG001|Overall Study|Non-compliance with study treatment|1|||
33542054|NCT02554786|62932663|FG002|Overall Study|Non-compliance with study treatment|1|||
33639448|NCT01573767|63042262|FG003|Overall Study|Lack of Efficacy|17|||
33639449|NCT01573767|63042259|FG000|Overall Study|Protocol Violation|3|||
33639450|NCT01573767|63042260|FG001|Overall Study|Protocol Violation|1|||
33639451|NCT01573767|63042261|FG002|Overall Study|Protocol Violation|1|||
33639452|NCT01573767|63042262|FG003|Overall Study|Protocol Violation|3|||
33639453|NCT01573767|63042259|FG000|Overall Study|Lost to Follow-up|0|||
33542055|NCT02554786|62932664|FG003|Overall Study|Non-compliance with study treatment|0|||
33542056|NCT02554786|62932665|FG004|Overall Study|Non-compliance with study treatment|1|||
33462937|NCT00379769|62836627|FG001|Main Study|Investigator refused to log temperature|0|||
33462938|NCT00379769|62836628|FG002|Main Study|Investigator refused to log temperature|1|||
33462939|NCT00379769|62836629|FG003|Main Study|Investigator refused to log temperature|0|||
33462940|NCT00379769|62836630|FG004|Main Study|Investigator refused to log temperature|0|||
33462941|NCT00379769|62836631|FG005|Main Study|Investigator refused to log temperature|0|||
33462942|NCT00379769|62836626|FG000|Main Study|Reason unspecified|0|||
33462943|NCT00379769|62836627|FG001|Main Study|Reason unspecified|0|||
33542057|NCT02554786|62932661|FG000|Overall Study|Physician Decision|0|||
33542058|NCT02554786|62932662|FG001|Overall Study|Physician Decision|1|||
33542059|NCT02554786|62932663|FG002|Overall Study|Physician Decision|4|||
33542060|NCT02554786|62932664|FG003|Overall Study|Physician Decision|1|||
33542061|NCT02554786|62932665|FG004|Overall Study|Physician Decision|1|||
33542062|NCT02554786|62932661|FG000|Overall Study|Pregnancy|0|||
33639454|NCT01573767|63042260|FG001|Overall Study|Lost to Follow-up|1|||
33639455|NCT01573767|63042261|FG002|Overall Study|Lost to Follow-up|1|||
33639456|NCT01573767|63042262|FG003|Overall Study|Lost to Follow-up|1|||
33639457|NCT01573767|63042259|FG000|Overall Study|Physician Decision|1|||
33639458|NCT01573767|63042260|FG001|Overall Study|Physician Decision|2|||
33639459|NCT01573767|63042261|FG002|Overall Study|Physician Decision|0|||
33639460|NCT01573767|63042262|FG003|Overall Study|Physician Decision|2|||
33639461|NCT01573767|63042259|FG000|Overall Study|Withdrawal by Subject|0|||
33639462|NCT01573767|63042260|FG001|Overall Study|Withdrawal by Subject|1|||
33639463|NCT01573767|63042261|FG002|Overall Study|Withdrawal by Subject|0|||
33639464|NCT01573767|63042262|FG003|Overall Study|Withdrawal by Subject|0|||
33639465|NCT01551303|63042274|FG000|Overall Study|failed awareness check on vision test|4|||
33639466|NCT01551303|63042275|FG001|Overall Study|failed awareness check on vision test|7|||
33639467|NCT00638404|63042283|FG000|Overall Study|Physician Decision|8|||
33639468|NCT00638404|63042284|FG001|Overall Study|Physician Decision|0|||
33639469|NCT01550757|63042298|FG000|Overall Study|Lost to Follow-up|21|||
33639470|NCT01550757|63042299|FG001|Overall Study|Lost to Follow-up|14|||
33639471|NCT01550757|63042300|FG002|Overall Study|Lost to Follow-up|42|||
33639472|NCT01550757|63042301|FG003|Overall Study|Lost to Follow-up|53|||
33639473|NCT01550757|63042298|FG000|Overall Study|Withdrawal by Subject|2|||
33639474|NCT01550757|63042299|FG001|Overall Study|Withdrawal by Subject|0|||
33542063|NCT02554786|62932662|FG001|Overall Study|Pregnancy|0|||
33542064|NCT02554786|62932663|FG002|Overall Study|Pregnancy|0|||
33542065|NCT02554786|62932664|FG003|Overall Study|Pregnancy|1|||
33542066|NCT02554786|62932665|FG004|Overall Study|Pregnancy|1|||
33542067|NCT02893930|62932681|FG000|Overall Study|Adverse Event|3|||
33542068|NCT02893930|62932681|FG000|Overall Study|Death|1|||
33542069|NCT02893930|62932681|FG000|Overall Study|Disease progression|5|||
33542070|NCT02893930|62932681|FG000|Overall Study|Withdrawal by Subject|2|||
33542071|NCT02893930|62932681|FG000|Overall Study|Physician Decision|1|||
33542072|NCT02893930|62932681|FG000|Overall Study|Ineligible|1|||
33542073|NCT01347645|62932690|FG000|Overall Study|Death|1|||
33542074|NCT01347645|62932691|FG001|Overall Study|Death|5|||
33542075|NCT01347645|62932692|FG002|Overall Study|Death|2|||
33542076|NCT01347645|62932693|FG003|Overall Study|Death|7|||
33542077|NCT01347645|62932694|FG004|Overall Study|Death|7|||
33542078|NCT01347645|62932690|FG000|Overall Study|Lost to Follow-up|1|||
33542079|NCT01347645|62932691|FG001|Overall Study|Lost to Follow-up|1|||
33542080|NCT01347645|62932692|FG002|Overall Study|Lost to Follow-up|0|||
33542081|NCT01347645|62932693|FG003|Overall Study|Lost to Follow-up|1|||
33542082|NCT01347645|62932694|FG004|Overall Study|Lost to Follow-up|1|||
33542083|NCT01347645|62932690|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
33542084|NCT01347645|62932691|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
33542085|NCT01347645|62932692|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
33542086|NCT01347645|62932693|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
33542087|NCT01347645|62932694|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
33542088|NCT01347645|62932690|FG000|Overall Study|Other|1|||
33542089|NCT01347645|62932691|FG001|Overall Study|Other|0|||
33542090|NCT01347645|62932692|FG002|Overall Study|Other|0|||
33542091|NCT01347645|62932693|FG003|Overall Study|Other|0|||
33542092|NCT01347645|62932694|FG004|Overall Study|Other|1|||
33542093|NCT01347645|62932690|FG000|Overall Study|Withdrawal by Subject|0|||
33542094|NCT01347645|62932691|FG001|Overall Study|Withdrawal by Subject|0|||
33542095|NCT01347645|62932692|FG002|Overall Study|Withdrawal by Subject|0|||
33542096|NCT01347645|62932693|FG003|Overall Study|Withdrawal by Subject|3|||
33542097|NCT01347645|62932694|FG004|Overall Study|Withdrawal by Subject|3|||
33542098|NCT01347645|62932690|FG000|Overall Study|Physician Decision|0|||
33542099|NCT01347645|62932691|FG001|Overall Study|Physician Decision|0|||
33542100|NCT01347645|62932692|FG002|Overall Study|Physician Decision|0|||
33542101|NCT01347645|62932693|FG003|Overall Study|Physician Decision|0|||
33542102|NCT01347645|62932694|FG004|Overall Study|Physician Decision|1|||
33542103|NCT01347645|62932690|FG000|Overall Study|Adverse Event|0|||
33542104|NCT01347645|62932691|FG001|Overall Study|Adverse Event|0|||
33639475|NCT01550757|63042300|FG002|Overall Study|Withdrawal by Subject|3|||
33639476|NCT01550757|63042301|FG003|Overall Study|Withdrawal by Subject|1|||
33639477|NCT01685073|63042313|FG000|Overall Study|Lost to Follow-up|6|||
33639478|NCT01685073|63042314|FG001|Overall Study|Lost to Follow-up|8|||
33639479|NCT01685073|63042313|FG000|Overall Study|Withdrawal by Subject|24|||
33542105|NCT01347645|62932692|FG002|Overall Study|Adverse Event|0|||
33542106|NCT01347645|62932693|FG003|Overall Study|Adverse Event|1|||
33542107|NCT01347645|62932694|FG004|Overall Study|Adverse Event|1|||
33542108|NCT00484419|62932732|FG000|Overall Study|Adverse Event|3|||
33542109|NCT00484419|62932733|FG001|Overall Study|Adverse Event|0|||
33542110|NCT00484419|62932734|FG002|Overall Study|Adverse Event|0|||
33542111|NCT00484419|62932732|FG000|Overall Study|Lost to Follow-up|1|||
33542112|NCT00484419|62932733|FG001|Overall Study|Lost to Follow-up|0|||
33542113|NCT00484419|62932734|FG002|Overall Study|Lost to Follow-up|2|||
33542114|NCT00484419|62932732|FG000|Overall Study|Withdrawal by Subject|3|||
33639480|NCT01685073|63042314|FG001|Overall Study|Withdrawal by Subject|24|||
33639481|NCT01572909|63042322|FG000|Overall Study|Adverse Event|7|||
33639482|NCT01572909|63042323|FG001|Overall Study|Adverse Event|2|||
33542115|NCT00484419|62932733|FG001|Overall Study|Withdrawal by Subject|1|||
33542116|NCT00484419|62932734|FG002|Overall Study|Withdrawal by Subject|1|||
33542117|NCT00484419|62932732|FG000|Overall Study|subject met discontinuation criteria|2|||
33542118|NCT00484419|62932733|FG001|Overall Study|subject met discontinuation criteria|2|||
33542119|NCT00484419|62932734|FG002|Overall Study|subject met discontinuation criteria|4|||
33542120|NCT00484419|62932732|FG000|Overall Study|required restricted medication|1|||
33542121|NCT00484419|62932733|FG001|Overall Study|required restricted medication|0|||
33542122|NCT00484419|62932734|FG002|Overall Study|required restricted medication|1|||
33542123|NCT00484419|62932732|FG000|Overall Study|Physician Decision|1|||
33542124|NCT00484419|62932733|FG001|Overall Study|Physician Decision|1|||
33542125|NCT00484419|62932734|FG002|Overall Study|Physician Decision|1|||
33639483|NCT01572909|63042322|FG000|Overall Study|Death|3|||
33639484|NCT01572909|63042323|FG001|Overall Study|Death|1|||
33639485|NCT01572909|63042322|FG000|Overall Study|Lost to Follow-up|8|||
33639486|NCT01572909|63042323|FG001|Overall Study|Lost to Follow-up|7|||
33639487|NCT01572909|63042322|FG000|Overall Study|Physician Decision|1|||
33639488|NCT01572909|63042323|FG001|Overall Study|Physician Decision|1|||
33639489|NCT01572909|63042322|FG000|Overall Study|Technical Issues|1|||
33639490|NCT01572909|63042323|FG001|Overall Study|Technical Issues|0|||
33542126|NCT00484419|62932732|FG000|Overall Study|subject unable to receive medication|1|||
33542127|NCT00484419|62932733|FG001|Overall Study|subject unable to receive medication|0|||
33542128|NCT00484419|62932734|FG002|Overall Study|subject unable to receive medication|0|||
33542129|NCT00484419|62932732|FG000|Overall Study|subject relocated|0|||
33542130|NCT00484419|62932733|FG001|Overall Study|subject relocated|1|||
33542131|NCT00484419|62932734|FG002|Overall Study|subject relocated|0|||
33542132|NCT00484419|62932732|FG000|Overall Study|sponsor decision, randomized in error|0|||
33542133|NCT00484419|62932733|FG001|Overall Study|sponsor decision, randomized in error|0|||
33542134|NCT00484419|62932734|FG002|Overall Study|sponsor decision, randomized in error|2|||
33542135|NCT03220724|62932743|FG000|Overall Study|Lost to Follow-up|2|||
33542136|NCT03220724|62932744|FG001|Overall Study|Lost to Follow-up|1|||
33542137|NCT03220724|62932745|FG002|Overall Study|Lost to Follow-up|0|||
33542138|NCT03220724|62932746|FG003|Overall Study|Lost to Follow-up|3|||
33542139|NCT03220724|62932743|FG000|Overall Study|Withdrawal by Subject|1|||
33542140|NCT03220724|62932744|FG001|Overall Study|Withdrawal by Subject|1|||
33542141|NCT03220724|62932745|FG002|Overall Study|Withdrawal by Subject|1|||
33542142|NCT03220724|62932746|FG003|Overall Study|Withdrawal by Subject|0|||
33542143|NCT02549092|62932758|FG000|Treatment Period|Adverse Event|2|||
33542144|NCT02549092|62932759|FG001|Treatment Period|Adverse Event|2|||
33542145|NCT02549092|62932758|FG000|Treatment Period|Withdrawal by Subject|1|||
33542146|NCT02549092|62932759|FG001|Treatment Period|Withdrawal by Subject|3|||
33542147|NCT02549092|62932758|FG000|Treatment Period|Lack of Efficacy|0|||
33542148|NCT02549092|62932759|FG001|Treatment Period|Lack of Efficacy|2|||
33542149|NCT02549092|62932758|FG000|Extension/Transition Period|Still in Extension/Transition Period|4|||
33542150|NCT02549092|62932759|FG001|Extension/Transition Period|Still in Extension/Transition Period|8|||
33542151|NCT02549092|62932758|FG000|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1|||
33639491|NCT01572909|63042322|FG000|Overall Study|Withdrawal by Subject|12|||
33639492|NCT01572909|63042323|FG001|Overall Study|Withdrawal by Subject|11|||
33462944|NCT00379769|62836628|FG002|Main Study|Reason unspecified|1|||
33462945|NCT00379769|62836629|FG003|Main Study|Reason unspecified|0|||
33462946|NCT00379769|62836630|FG004|Main Study|Reason unspecified|0|||
33462947|NCT00379769|62836631|FG005|Main Study|Reason unspecified|0|||
33462948|NCT00379769|62836626|FG000|Observational Follow-up|Death|0|||
33462949|NCT00379769|62836627|FG001|Observational Follow-up|Death|0|||
33462950|NCT00379769|62836628|FG002|Observational Follow-up|Death|0|||
33462951|NCT00379769|62836629|FG003|Observational Follow-up|Death|0|||
33462952|NCT00379769|62836630|FG004|Observational Follow-up|Death|78|||
33462953|NCT00379769|62836631|FG005|Observational Follow-up|Death|70|||
33462954|NCT00379769|62836626|FG000|Observational Follow-up|Adverse Event|0|||
33462955|NCT00379769|62836627|FG001|Observational Follow-up|Adverse Event|0|||
33462956|NCT00379769|62836628|FG002|Observational Follow-up|Adverse Event|0|||
33462957|NCT00379769|62836629|FG003|Observational Follow-up|Adverse Event|0|||
33542152|NCT02549092|62932759|FG001|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1|||
33542153|NCT03056573|62932770|FG000|Overall Study|Death|2|||
33542154|NCT03056573|62932771|FG001|Overall Study|Death|4|||
33542155|NCT03056573|62932770|FG000|Overall Study|Withdrawal by Subject|2|||
33639493|NCT01572909|63042322|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
33639494|NCT01572909|63042323|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
33639495|NCT01572675|63042333|FG000|Overall Study|End of prescribed treatment|140|||
33639496|NCT01572675|63042334|FG001|Overall Study|End of prescribed treatment|118|||
33639497|NCT01572675|63042333|FG000|Overall Study|Recovery|16|||
33639498|NCT01572675|63042334|FG001|Overall Study|Recovery|23|||
33639499|NCT01572675|63042333|FG000|Overall Study|Lack of Efficacy|31|||
33639500|NCT01572675|63042334|FG001|Overall Study|Lack of Efficacy|31|||
33639501|NCT01572675|63042333|FG000|Overall Study|Intolerance|6|||
33639502|NCT01572675|63042334|FG001|Overall Study|Intolerance|5|||
33639503|NCT01572675|63042333|FG000|Overall Study|Improved symptoms|8|||
33542156|NCT03056573|62932771|FG001|Overall Study|Withdrawal by Subject|0|||
33542157|NCT03056573|62932770|FG000|Overall Study|Lost to Follow-up|1|||
33542158|NCT03056573|62932771|FG001|Overall Study|Lost to Follow-up|1|||
33542159|NCT02553772|62932779|FG000|Overall Study|Adverse Event|2|||
33639504|NCT01572675|63042334|FG001|Overall Study|Improved symptoms|2|||
33639505|NCT01572675|63042333|FG000|Overall Study|Surgical intervention|3|||
33639506|NCT01572675|63042334|FG001|Overall Study|Surgical intervention|6|||
33639507|NCT01572675|63042333|FG000|Overall Study|Withdrawal by Subject|5|||
33639508|NCT01572675|63042334|FG001|Overall Study|Withdrawal by Subject|1|||
33639509|NCT01572675|63042333|FG000|Overall Study|Physician Decision|2|||
33639510|NCT01572675|63042334|FG001|Overall Study|Physician Decision|2|||
33639511|NCT01572675|63042333|FG000|Overall Study|Death unrelated to coxibs|1|||
33639512|NCT01572675|63042334|FG001|Overall Study|Death unrelated to coxibs|1|||
33639513|NCT01572675|63042333|FG000|Overall Study|Other disease detected|1|||
33639514|NCT01572675|63042334|FG001|Overall Study|Other disease detected|1|||
33639515|NCT01572675|63042333|FG000|Overall Study|Unknown reason|1|||
33639516|NCT01572675|63042334|FG001|Overall Study|Unknown reason|1|||
33639517|NCT01572675|63042333|FG000|Overall Study|Rheumatologist new evaluation|0|||
33639518|NCT01572675|63042334|FG001|Overall Study|Rheumatologist new evaluation|1|||
33639519|NCT01572675|63042333|FG000|Overall Study|Missing data|1|||
33639520|NCT01572675|63042334|FG001|Overall Study|Missing data|4|||
33639521|NCT01572675|63042333|FG000|Overall Study|Lost to Follow-up|22|||
33639522|NCT01572675|63042334|FG001|Overall Study|Lost to Follow-up|27|||
33639523|NCT05065983|63042353|FG000|Overall Study|Lost to Follow-up|2|||
33639524|NCT04797650|63042360|FG000|Overall Study|Reason Not Specified|5|||
33639525|NCT04797650|63042361|FG001|Overall Study|Reason Not Specified|12|||
33639526|NCT04797650|63042362|FG002|Overall Study|Reason Not Specified|5|||
33639527|NCT04797650|63042360|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
33639528|NCT04797650|63042361|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
33639529|NCT04797650|63042362|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
33639530|NCT04797650|63042360|FG000|Overall Study|Lack of Efficacy|1|||
33639531|NCT04797650|63042361|FG001|Overall Study|Lack of Efficacy|0|||
33639532|NCT04797650|63042362|FG002|Overall Study|Lack of Efficacy|1|||
33639533|NCT04797650|63042360|FG000|Overall Study|Non-compliance with Study Drug|0|||
33639534|NCT04797650|63042361|FG001|Overall Study|Non-compliance with Study Drug|0|||
33639535|NCT04797650|63042362|FG002|Overall Study|Non-compliance with Study Drug|2|||
33639536|NCT04797650|63042360|FG000|Overall Study|Lost to Follow-up|4|||
33639537|NCT04797650|63042361|FG001|Overall Study|Lost to Follow-up|6|||
33462958|NCT00379769|62836630|FG004|Observational Follow-up|Adverse Event|1|||
33462959|NCT00379769|62836631|FG005|Observational Follow-up|Adverse Event|0|||
33462960|NCT00379769|62836626|FG000|Observational Follow-up|Lost to Follow-up|0|||
33462961|NCT00379769|62836627|FG001|Observational Follow-up|Lost to Follow-up|0|||
33462962|NCT00379769|62836628|FG002|Observational Follow-up|Lost to Follow-up|0|||
33462963|NCT00379769|62836629|FG003|Observational Follow-up|Lost to Follow-up|0|||
33462964|NCT00379769|62836630|FG004|Observational Follow-up|Lost to Follow-up|25|||
33542160|NCT02553772|62932780|FG001|Overall Study|Adverse Event|3|||
33639538|NCT04797650|63042362|FG002|Overall Study|Lost to Follow-up|1|||
33639539|NCT04705597|63042374|FG000|Overall Study|Death|16|||
33639540|NCT04705597|63042375|FG001|Overall Study|Death|9|||
33639541|NCT04705597|63042374|FG000|Overall Study|Lost to Follow-up|1|||
33639542|NCT04705597|63042375|FG001|Overall Study|Lost to Follow-up|0|||
33639543|NCT04705597|63042374|FG000|Overall Study|Withdrawal by Subject|1|||
33639544|NCT04705597|63042375|FG001|Overall Study|Withdrawal by Subject|2|||
33639545|NCT04534114|63042389|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
33639546|NCT04534114|63042390|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
33639547|NCT04534114|63042391|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
33639548|NCT04534114|63042392|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
33639549|NCT04534114|63042389|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
33639550|NCT04534114|63042390|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
33639551|NCT04534114|63042391|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
33639552|NCT04534114|63042392|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
33639553|NCT04534114|63042389|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
33639554|NCT04534114|63042390|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
33639555|NCT04534114|63042391|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
33639556|NCT04534114|63042392|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
33639557|NCT04534114|63042389|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
33639558|NCT04534114|63042390|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
33639559|NCT04534114|63042391|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
33639560|NCT04534114|63042392|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
33639561|NCT04534114|63042389|FG000|Main Treatment Period|Physician Decision|0|||
33639562|NCT04534114|63042390|FG001|Main Treatment Period|Physician Decision|0|||
33639563|NCT04534114|63042391|FG002|Main Treatment Period|Physician Decision|0|||
33639564|NCT04534114|63042392|FG003|Main Treatment Period|Physician Decision|1|||
33542161|NCT02553772|62932779|FG000|Overall Study|Lost to Follow-up|2|||
33542162|NCT02553772|62932780|FG001|Overall Study|Lost to Follow-up|1|||
33542163|NCT02553772|62932779|FG000|Overall Study|Withdrawal of Consent|1|||
33542164|NCT02553772|62932780|FG001|Overall Study|Withdrawal of Consent|1|||
33542165|NCT02553772|62932779|FG000|Overall Study|Lack of Efficacy|1|||
33542166|NCT02553772|62932780|FG001|Overall Study|Lack of Efficacy|0|||
33542167|NCT02553772|62932779|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33542168|NCT02553772|62932780|FG001|Overall Study|Other Miscellaneous Reasons|1|||
33542169|NCT02553538|62932788|FG000|Overall Study|Could Not Reach by Telephone|133|||
33542170|NCT02553538|62932789|FG001|Overall Study|Could Not Reach by Telephone|0|||
33542171|NCT02553538|62932788|FG000|Overall Study|Died or Left Network|54|||
33542172|NCT02553538|62932789|FG001|Overall Study|Died or Left Network|56|||
33542173|NCT02548156|62932795|FG000|Washout Period 1|Lost to Follow-up|0|||
33542174|NCT02548156|62932796|FG001|Washout Period 1|Lost to Follow-up|0|||
33542175|NCT02548156|62932797|FG002|Washout Period 1|Lost to Follow-up|0|||
33462965|NCT00379769|62836631|FG005|Observational Follow-up|Lost to Follow-up|27|||
33542176|NCT02548156|62932798|FG003|Washout Period 1|Lost to Follow-up|0|||
33542177|NCT02548156|62932799|FG004|Washout Period 1|Lost to Follow-up|1|||
33542178|NCT02548156|62932800|FG005|Washout Period 1|Lost to Follow-up|0|||
33542179|NCT01503515|62932810|FG000|Overall Study|Adverse Event|4|||
33542180|NCT01503515|62932811|FG001|Overall Study|Adverse Event|5|||
33542181|NCT01503515|62932810|FG000|Overall Study|Death|0|||
33542182|NCT01503515|62932811|FG001|Overall Study|Death|1|||
33542183|NCT01503515|62932810|FG000|Overall Study|Physician Decision|14|||
33542184|NCT01503515|62932811|FG001|Overall Study|Physician Decision|23|||
33542185|NCT01503515|62932810|FG000|Overall Study|Withdrawal by Subject|0|||
33542186|NCT01503515|62932811|FG001|Overall Study|Withdrawal by Subject|1|||
33462966|NCT00379769|62836626|FG000|Observational Follow-up|Withdrawal by Subject|0|||
33462967|NCT00379769|62836627|FG001|Observational Follow-up|Withdrawal by Subject|0|||
33462968|NCT00379769|62836628|FG002|Observational Follow-up|Withdrawal by Subject|0|||
33462969|NCT00379769|62836629|FG003|Observational Follow-up|Withdrawal by Subject|0|||
33462970|NCT00379769|62836630|FG004|Observational Follow-up|Withdrawal by Subject|12|||
33462971|NCT00379769|62836631|FG005|Observational Follow-up|Withdrawal by Subject|12|||
33462972|NCT00379769|62836626|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
33462973|NCT00379769|62836627|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
33462974|NCT00379769|62836628|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
33462975|NCT00379769|62836629|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
33542187|NCT01503515|62932810|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
33542188|NCT01503515|62932811|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
33639565|NCT04534114|63042389|FG000|Main Treatment Period|Death|1|||
33639566|NCT04534114|63042390|FG001|Main Treatment Period|Death|0|||
33542189|NCT01503515|62932810|FG000|Overall Study|Ineligible|1|||
33542190|NCT01503515|62932811|FG001|Overall Study|Ineligible|1|||
33542191|NCT02742519|62932819|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
33542192|NCT02742519|62932820|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
33542193|NCT02742519|62932821|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
33542194|NCT02742519|62932819|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
33542195|NCT02742519|62932820|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
33542196|NCT02742519|62932821|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
33542197|NCT02742519|62932819|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
33542198|NCT02742519|62932820|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
33542199|NCT02742519|62932821|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
33542200|NCT01375010|62932831|FG000|Overall Study|Lost to Follow-up|8|||
33542201|NCT01375010|62932832|FG001|Overall Study|Lost to Follow-up|2|||
33542202|NCT01375010|62932831|FG000|Overall Study|Withdrawal by Subject|4|||
33542203|NCT01375010|62932832|FG001|Overall Study|Withdrawal by Subject|2|||
33542204|NCT00659061|62932856|FG000|Overall Study|Migration due to political unrest|21|||
33542205|NCT00659061|62932857|FG001|Overall Study|Migration due to political unrest|15|||
33542206|NCT02548078|62932874|FG000|Overall Study|Serious adverse event/Adverse event|1|||
33542207|NCT02548078|62932875|FG001|Overall Study|Serious adverse event/Adverse event|0|||
33542208|NCT02548078|62932874|FG000|Overall Study|Moved from study area|3|||
33542209|NCT02548078|62932875|FG001|Overall Study|Moved from study area|3|||
33542210|NCT02548078|62932874|FG000|Overall Study|Lost to Follow-up|1|||
33542211|NCT02548078|62932875|FG001|Overall Study|Lost to Follow-up|3|||
33542212|NCT02671435|62932903|FG000|Overall Study|Death|1|||
33542213|NCT02671435|62932904|FG001|Overall Study|Death|3|||
33542214|NCT02671435|62932905|FG002|Overall Study|Death|0|||
33542215|NCT02671435|62932906|FG003|Overall Study|Death|16|||
33542216|NCT02671435|62932907|FG004|Overall Study|Death|14|||
33542217|NCT02671435|62932908|FG005|Overall Study|Death|29|||
33542218|NCT02671435|62932909|FG006|Overall Study|Death|34|||
33542219|NCT02671435|62932910|FG007|Overall Study|Death|28|||
33542220|NCT02671435|62932911|FG008|Overall Study|Death|19|||
33542221|NCT02671435|62932912|FG009|Overall Study|Death|10|||
33542222|NCT02671435|62932913|FG010|Overall Study|Death|8|||
33542223|NCT02671435|62932914|FG011|Overall Study|Death|29|||
33542224|NCT02671435|62932915|FG012|Overall Study|Death|29|||
33542225|NCT02671435|62932916|FG013|Overall Study|Death|29|||
33542226|NCT02671435|62932917|FG014|Overall Study|Death|27|||
33542227|NCT02671435|62932903|FG000|Overall Study|Lost to Follow-up|0|||
33542228|NCT02671435|62932904|FG001|Overall Study|Lost to Follow-up|0|||
33542229|NCT02671435|62932905|FG002|Overall Study|Lost to Follow-up|1|||
33542230|NCT02671435|62932906|FG003|Overall Study|Lost to Follow-up|0|||
33542231|NCT02671435|62932907|FG004|Overall Study|Lost to Follow-up|1|||
33542232|NCT02671435|62932908|FG005|Overall Study|Lost to Follow-up|1|||
33542233|NCT02671435|62932909|FG006|Overall Study|Lost to Follow-up|2|||
33542234|NCT02671435|62932910|FG007|Overall Study|Lost to Follow-up|2|||
33542235|NCT02671435|62932911|FG008|Overall Study|Lost to Follow-up|0|||
33542236|NCT02671435|62932912|FG009|Overall Study|Lost to Follow-up|2|||
33639567|NCT04534114|63042391|FG002|Main Treatment Period|Death|0|||
33639568|NCT04534114|63042392|FG003|Main Treatment Period|Death|1|||
33639569|NCT04534114|63042389|FG000|Main Treatment Period|Other reason|1|||
33639570|NCT04534114|63042390|FG001|Main Treatment Period|Other reason|1|||
33639571|NCT04534114|63042391|FG002|Main Treatment Period|Other reason|0|||
33639572|NCT04534114|63042392|FG003|Main Treatment Period|Other reason|0|||
33462976|NCT00379769|62836630|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
33462977|NCT00379769|62836631|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
33462978|NCT00379769|62836626|FG000|Observational Follow-up|Physician Decision|0|||
33462979|NCT00379769|62836627|FG001|Observational Follow-up|Physician Decision|0|||
33462980|NCT00379769|62836628|FG002|Observational Follow-up|Physician Decision|0|||
33462981|NCT00379769|62836629|FG003|Observational Follow-up|Physician Decision|0|||
33462982|NCT00379769|62836630|FG004|Observational Follow-up|Physician Decision|8|||
33462983|NCT00379769|62836631|FG005|Observational Follow-up|Physician Decision|8|||
33542237|NCT02671435|62932913|FG010|Overall Study|Lost to Follow-up|0|||
33542238|NCT02671435|62932914|FG011|Overall Study|Lost to Follow-up|3|||
33542239|NCT02671435|62932915|FG012|Overall Study|Lost to Follow-up|3|||
33542240|NCT02671435|62932916|FG013|Overall Study|Lost to Follow-up|2|||
33542241|NCT02671435|62932917|FG014|Overall Study|Lost to Follow-up|0|||
33542242|NCT02671435|62932903|FG000|Overall Study|Withdrawal by Subject|2|||
33542243|NCT02671435|62932904|FG001|Overall Study|Withdrawal by Subject|0|||
33542244|NCT02671435|62932905|FG002|Overall Study|Withdrawal by Subject|2|||
33542245|NCT02671435|62932906|FG003|Overall Study|Withdrawal by Subject|2|||
33542246|NCT02671435|62932907|FG004|Overall Study|Withdrawal by Subject|2|||
33542247|NCT02671435|62932908|FG005|Overall Study|Withdrawal by Subject|7|||
33542248|NCT02671435|62932909|FG006|Overall Study|Withdrawal by Subject|2|||
33542249|NCT02671435|62932910|FG007|Overall Study|Withdrawal by Subject|7|||
33542250|NCT02671435|62932911|FG008|Overall Study|Withdrawal by Subject|1|||
33542251|NCT02671435|62932912|FG009|Overall Study|Withdrawal by Subject|1|||
33542252|NCT02671435|62932913|FG010|Overall Study|Withdrawal by Subject|2|||
33639573|NCT04534114|63042389|FG000|Main Treatment Period|Participant decision|1|||
33639574|NCT04534114|63042390|FG001|Main Treatment Period|Participant decision|3|||
33639575|NCT04534114|63042391|FG002|Main Treatment Period|Participant decision|3|||
33639576|NCT04534114|63042392|FG003|Main Treatment Period|Participant decision|1|||
33639577|NCT04534114|63042389|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
33639578|NCT04534114|63042390|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
33639579|NCT04534114|63042391|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
33639580|NCT04534114|63042392|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
33639581|NCT04534114|63042389|FG000|Main Treatment Period|Adverse Event|4|||
33639582|NCT04534114|63042390|FG001|Main Treatment Period|Adverse Event|2|||
33639583|NCT04534114|63042391|FG002|Main Treatment Period|Adverse Event|1|||
33639584|NCT04534114|63042392|FG003|Main Treatment Period|Adverse Event|2|||
33639585|NCT04534114|63042389|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
33639586|NCT04534114|63042390|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
33639587|NCT04534114|63042391|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
33639588|NCT04534114|63042392|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
33639589|NCT04534114|63042389|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
33639590|NCT04534114|63042390|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
33639591|NCT04534114|63042391|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
33639592|NCT04534114|63042392|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
33639593|NCT04534114|63042389|FG000|Extension Treatment Period|Other reason|0|||
33639594|NCT04534114|63042390|FG001|Extension Treatment Period|Other reason|1|||
33639595|NCT04534114|63042391|FG002|Extension Treatment Period|Other reason|0|||
33639596|NCT04534114|63042392|FG003|Extension Treatment Period|Other reason|0|||
33639597|NCT04534114|63042389|FG000|Extension Treatment Period|Death|0|||
33462984|NCT00379769|62836626|FG000|Observational Follow-up|Site Closed Early|0|||
33462985|NCT00379769|62836627|FG001|Observational Follow-up|Site Closed Early|0|||
33542253|NCT02671435|62932914|FG011|Overall Study|Withdrawal by Subject|4|||
33542254|NCT02671435|62932915|FG012|Overall Study|Withdrawal by Subject|4|||
33462986|NCT00379769|62836628|FG002|Observational Follow-up|Site Closed Early|0|||
33462987|NCT00379769|62836629|FG003|Observational Follow-up|Site Closed Early|0|||
33462988|NCT00379769|62836630|FG004|Observational Follow-up|Site Closed Early|6|||
33462989|NCT00379769|62836631|FG005|Observational Follow-up|Site Closed Early|7|||
33462990|NCT00379769|62836626|FG000|Observational Follow-up|Participant Moved|0|||
33462991|NCT00379769|62836627|FG001|Observational Follow-up|Participant Moved|0|||
33462992|NCT00379769|62836628|FG002|Observational Follow-up|Participant Moved|0|||
33462993|NCT00379769|62836629|FG003|Observational Follow-up|Participant Moved|0|||
33542255|NCT02671435|62932916|FG013|Overall Study|Withdrawal by Subject|4|||
33542256|NCT02671435|62932917|FG014|Overall Study|Withdrawal by Subject|2|||
33542257|NCT02671435|62932903|FG000|Overall Study|Un-specified|0|||
33542258|NCT02671435|62932904|FG001|Overall Study|Un-specified|0|||
33542259|NCT02671435|62932905|FG002|Overall Study|Un-specified|0|||
33542260|NCT02671435|62932906|FG003|Overall Study|Un-specified|0|||
33542261|NCT02671435|62932907|FG004|Overall Study|Un-specified|1|||
33542262|NCT02671435|62932908|FG005|Overall Study|Un-specified|3|||
33542263|NCT02671435|62932909|FG006|Overall Study|Un-specified|2|||
33542264|NCT02671435|62932910|FG007|Overall Study|Un-specified|3|||
33542265|NCT02671435|62932911|FG008|Overall Study|Un-specified|0|||
33542266|NCT02671435|62932912|FG009|Overall Study|Un-specified|5|||
33542267|NCT02671435|62932913|FG010|Overall Study|Un-specified|8|||
33542268|NCT02671435|62932914|FG011|Overall Study|Un-specified|4|||
33542269|NCT02671435|62932915|FG012|Overall Study|Un-specified|5|||
33542270|NCT02671435|62932916|FG013|Overall Study|Un-specified|9|||
33542271|NCT02671435|62932917|FG014|Overall Study|Un-specified|8|||
33542272|NCT02916433|62932972|FG000|Overall Study|Withdrawal by Subject|1|||
33542273|NCT02916433|62932973|FG001|Overall Study|Withdrawal by Subject|0|||
33542274|NCT02916433|62932972|FG000|Overall Study|Physician Decision|1|||
33542275|NCT02916433|62932973|FG001|Overall Study|Physician Decision|0|||
33542276|NCT00526227|62932982|FG000|Overall Study|Device not implanted|1|||
33542277|NCT00526227|62932982|FG000|Overall Study|Death|1|||
33542278|NCT02547922|62932990|FG000|Overall Study|Withdrawal by Subject|9|||
33542279|NCT02547922|62932991|FG001|Overall Study|Withdrawal by Subject|6|||
33542280|NCT02547922|62932992|FG002|Overall Study|Withdrawal by Subject|10|||
33639598|NCT04534114|63042390|FG001|Extension Treatment Period|Death|0|||
33639599|NCT04534114|63042391|FG002|Extension Treatment Period|Death|1|||
33462994|NCT00379769|62836630|FG004|Observational Follow-up|Participant Moved|0|||
33639600|NCT04534114|63042392|FG003|Extension Treatment Period|Death|2|||
33639601|NCT04534114|63042389|FG000|Extension Treatment Period|Adverse Event|0|||
33542281|NCT02547922|62932990|FG000|Overall Study|Adverse Event|3|||
33542282|NCT02547922|62932991|FG001|Overall Study|Adverse Event|1|||
33542283|NCT02547922|62932992|FG002|Overall Study|Adverse Event|2|||
33542284|NCT02547922|62932990|FG000|Overall Study|Lost to Follow-up|1|||
33542285|NCT02547922|62932991|FG001|Overall Study|Lost to Follow-up|0|||
33542286|NCT02547922|62932992|FG002|Overall Study|Lost to Follow-up|0|||
33542287|NCT02547922|62932990|FG000|Overall Study|Lack of Efficacy|5|||
33542288|NCT02547922|62932991|FG001|Overall Study|Lack of Efficacy|7|||
33542289|NCT02547922|62932992|FG002|Overall Study|Lack of Efficacy|4|||
33542290|NCT02547922|62932990|FG000|Overall Study|Death|1|||
33542291|NCT02547922|62932991|FG001|Overall Study|Death|0|||
33542292|NCT02547922|62932992|FG002|Overall Study|Death|0|||
33542293|NCT02547922|62932990|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
33542294|NCT02547922|62932991|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
33326692|NCT00941031|62703275|FG005|Maintenance Period|Lack of Efficacy|0|||
33326693|NCT00941031|62703276|FG006|Maintenance Period|Lack of Efficacy|13|||
33326694|NCT00886834|62703297|FG000|Overall Study|Protocol Violation|0|||
33326695|NCT00886834|62703298|FG001|Overall Study|Protocol Violation|3|||
33326696|NCT00880009|62703304|FG000|Overall Study|Study terminated by sponsor|14|||
33326697|NCT00880009|62703304|FG000|Overall Study|Withdrawal by Subject|1|||
33326698|NCT00880009|62703304|FG000|Overall Study|Protocol Violation|1|||
33326699|NCT01104636|62703311|FG000|Overall Study|Lack of Efficacy|43|||
33326700|NCT01104636|62703311|FG000|Overall Study|Lost to Follow-up|24|||
33326701|NCT01104636|62703311|FG000|Overall Study|Withdrawal by Subject|4|||
33326702|NCT01104636|62703311|FG000|Overall Study|Other|43|||
33326703|NCT01104636|62703311|FG000|Overall Study|Study terminated by sponsor|1|||
33326704|NCT01104636|62703311|FG000|Overall Study|Pregnancy|2|||
33326705|NCT01104636|62703311|FG000|Overall Study|Adverse Event|40|||
33326706|NCT01104636|62703311|FG000|Overall Study|Ongoing|21|||
33326707|NCT01104558|62703315|FG000|Overall Study|Protocol Violation|6|||
33326708|NCT01104558|62703315|FG000|Overall Study|Missing of primary efficacy assessment|10|||
33326709|NCT01104558|62703315|FG000|Overall Study|Missing of genetic analysis results|1|||
33326710|NCT00886288|62703321|FG000|Overall Study|no respect of the 12 weeks period|657|||
33326711|NCT00886288|62703322|FG001|Overall Study|no respect of the 12 weeks period|227|||
33326712|NCT00886288|62703321|FG000|Overall Study|Lost to Follow-up|86|||
33326713|NCT00886288|62703322|FG001|Overall Study|Lost to Follow-up|0|||
33326714|NCT01204658|62703334|FG000|Primary Phase|Adverse Event|0|||
33326715|NCT01204658|62703335|FG001|Primary Phase|Adverse Event|0|||
33326716|NCT01204658|62703336|FG002|Primary Phase|Adverse Event|1|||
33326717|NCT01204658|62703337|FG003|Primary Phase|Adverse Event|0|||
33326718|NCT00951483|62703352|FG000|Overall Study|Physician Decision|4|||
33326719|NCT00951483|62703353|FG001|Overall Study|Physician Decision|0|||
33326720|NCT00951483|62703352|FG000|Overall Study|Withdrawal by Subject|15|||
33326721|NCT00951483|62703353|FG001|Overall Study|Withdrawal by Subject|0|||
33326722|NCT01104246|62703361|FG000|Overall Study|Withdrawal by Subject|1|||
33326723|NCT01104246|62703361|FG000|Overall Study|did not meet inclusion criteria|4|||
33326724|NCT01103778|62703365|FG000|Overall Study|Lost to Follow-up|1|||
33326725|NCT01103778|62703365|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
33326726|NCT01103778|62703365|FG000|Overall Study|Screen failure|1|||
33326727|NCT01103466|62703371|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
33326728|NCT01103466|62703372|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
33326729|NCT01103466|62703373|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
33326730|NCT01103466|62703371|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
33326731|NCT01103466|62703372|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
33326732|NCT01103466|62703373|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
33326733|NCT01103466|62703371|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
33326734|NCT01103466|62703372|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
33326735|NCT01103466|62703373|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
33326736|NCT01103466|62703371|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
33326737|NCT01103466|62703372|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
33326738|NCT01103466|62703373|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
33326739|NCT01103466|62703371|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
33326740|NCT01103466|62703372|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
33326741|NCT01103466|62703373|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
33326742|NCT01103466|62703371|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
33326743|NCT01103466|62703372|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
33326744|NCT01103466|62703373|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
33326745|NCT00945945|62703383|FG000|Overall Study|Adverse Event|15|||
33326746|NCT00945945|62703384|FG001|Overall Study|Adverse Event|35|||
33326747|NCT00945945|62703383|FG000|Overall Study|Withdrawal by Subject|7|||
33326748|NCT00945945|62703384|FG001|Overall Study|Withdrawal by Subject|10|||
33326749|NCT00945945|62703383|FG000|Overall Study|Lost to Follow-up|4|||
33326750|NCT00945945|62703384|FG001|Overall Study|Lost to Follow-up|5|||
33326751|NCT00945945|62703383|FG000|Overall Study|Lack of Efficacy|6|||
33326752|NCT00945945|62703384|FG001|Overall Study|Lack of Efficacy|2|||
33326753|NCT00945945|62703383|FG000|Overall Study|Protocol Violation|4|||
33326754|NCT00945945|62703384|FG001|Overall Study|Protocol Violation|2|||
33544260|NCT03010501|62935106|FG000|Study Week 1|Withdrawal by Subject|2|||
33462995|NCT00379769|62836631|FG005|Observational Follow-up|Participant Moved|1|||
33639602|NCT04534114|63042390|FG001|Extension Treatment Period|Adverse Event|1|||
33639603|NCT04534114|63042391|FG002|Extension Treatment Period|Adverse Event|0|||
33639604|NCT04534114|63042392|FG003|Extension Treatment Period|Adverse Event|1|||
33639605|NCT04534114|63042389|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
33639606|NCT04534114|63042390|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
33639607|NCT04534114|63042391|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
33639608|NCT04534114|63042392|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
33639609|NCT04474366|63042413|FG000|Overall Study|Lost to Follow-up|2|||
33639610|NCT04474366|63042414|FG001|Overall Study|Lost to Follow-up|5|||
33639611|NCT04422431|63042420|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
33639612|NCT04422431|63042420|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
33639613|NCT04422431|63042420|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
33639614|NCT04422431|63042420|FG000|Extension Period (48 Weeks)|ongoing in the Extension Period|25|||
33639615|NCT04115488|63042431|FG000|Overall Study|Adverse Event|8|||
33639616|NCT04115488|63042432|FG001|Overall Study|Adverse Event|4|||
33639617|NCT04115488|63042431|FG000|Overall Study|Withdrawal by Subject|3|||
33639618|NCT04115488|63042432|FG001|Overall Study|Withdrawal by Subject|6|||
33639619|NCT04115488|63042431|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
33639620|NCT04115488|63042432|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
33639621|NCT04115488|63042431|FG000|Overall Study|Patient 's location change|1|||
33639622|NCT04115488|63042432|FG001|Overall Study|Patient 's location change|0|||
33639623|NCT04115488|63042431|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
33639624|NCT04115488|63042432|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
33462996|NCT00379769|62836626|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
33462997|NCT00379769|62836627|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
33639625|NCT04080752|63042456|FG000|Overall Study|Adverse Event|2|||
33639626|NCT04080752|63042457|FG001|Overall Study|Adverse Event|3|||
33639627|NCT04080752|63042456|FG000|Overall Study|Lack of Efficacy|1|||
33639628|NCT04080752|63042457|FG001|Overall Study|Lack of Efficacy|0|||
33639629|NCT04080752|63042456|FG000|Overall Study|Lost to Follow-up|1|||
33639630|NCT04080752|63042457|FG001|Overall Study|Lost to Follow-up|0|||
33639631|NCT04080752|63042456|FG000|Overall Study|Pregnancy|0|||
33639632|NCT04080752|63042457|FG001|Overall Study|Pregnancy|1|||
33639633|NCT04080752|63042456|FG000|Overall Study|Withdrawal by Subject|7|||
33639634|NCT04080752|63042457|FG001|Overall Study|Withdrawal by Subject|0|||
33639635|NCT04080752|63042456|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33639636|NCT04080752|63042457|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33639637|NCT04080752|63042456|FG000|Overall Study|Other|2|||
33639638|NCT04080752|63042457|FG001|Overall Study|Other|1|||
33639639|NCT03968419|63042467|FG000|Treatment Period|Adverse Event|0|||
33639640|NCT03968419|63042468|FG001|Treatment Period|Adverse Event|0|||
33639641|NCT03968419|63042469|FG002|Treatment Period|Adverse Event|1|||
33639642|NCT03968419|63042467|FG000|Safety Follow-up Period|Death|3|||
33639643|NCT03968419|63042468|FG001|Safety Follow-up Period|Death|2|||
33639644|NCT03968419|63042469|FG002|Safety Follow-up Period|Death|1|||
33639645|NCT03968419|63042467|FG000|Safety Follow-up Period|Subject Decision|2|||
33639646|NCT03968419|63042468|FG001|Safety Follow-up Period|Subject Decision|1|||
33639647|NCT03968419|63042469|FG002|Safety Follow-up Period|Subject Decision|0|||
33639648|NCT03816332|63042489|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
33639649|NCT03816332|63042489|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
33639650|NCT03784846|63042498|FG000|Pre-COVID Study|Lost to Follow-up|3|||
33462998|NCT00379769|62836628|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
33462999|NCT00379769|62836629|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
33463000|NCT00379769|62836630|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
33463001|NCT00379769|62836631|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
33463002|NCT00006164|62836660|FG000|Overall Study|Withdrew or lost to follow-up|70|||
33463003|NCT00006164|62836661|FG001|Overall Study|Withdrew or lost to follow-up|81|||
33639651|NCT03784846|63042499|FG001|Pre-COVID Study|Lost to Follow-up|3|||
33639652|NCT03784846|63042500|FG002|Pre-COVID Study|Lost to Follow-up|2|||
33639653|NCT03784846|63042498|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
33639654|NCT03784846|63042499|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
33639655|NCT03784846|63042500|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
33639656|NCT03784846|63042498|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
33639657|NCT03784846|63042499|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
33639658|NCT03784846|63042500|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
33639659|NCT03784846|63042498|FG000|Post-COVID Study|Lost to Follow-up|3|||
33639660|NCT03784846|63042499|FG001|Post-COVID Study|Lost to Follow-up|5|||
33639661|NCT03784846|63042500|FG002|Post-COVID Study|Lost to Follow-up|1|||
33639662|NCT03784846|63042498|FG000|Post-COVID Study|Withdrawal by Subject|1|||
33639663|NCT03784846|63042499|FG001|Post-COVID Study|Withdrawal by Subject|2|||
33639664|NCT03784846|63042500|FG002|Post-COVID Study|Withdrawal by Subject|0|||
33639665|NCT03756350|63042508|FG000|Overall Study|Lost to Follow-up|1|||
33639666|NCT03648996|63042530|FG000|Overall Study|Withdrawal by Subject|0|||
33639667|NCT03648996|63042531|FG001|Overall Study|Withdrawal by Subject|2|||
33639668|NCT03648996|63042532|FG002|Overall Study|Withdrawal by Subject|2|||
33639669|NCT03648996|63042530|FG000|Overall Study|Physician Decision|2|||
33639670|NCT03648996|63042531|FG001|Overall Study|Physician Decision|0|||
33639671|NCT03648996|63042532|FG002|Overall Study|Physician Decision|0|||
33639672|NCT03483961|63042557|FG000|Overall Study|Lost to Follow-up|7|||
33639673|NCT03483961|63042558|FG001|Overall Study|Lost to Follow-up|6|||
33639674|NCT03483961|63042559|FG002|Overall Study|Lost to Follow-up|6|||
33639675|NCT03483961|63042560|FG003|Overall Study|Lost to Follow-up|6|||
33639676|NCT03483961|63042561|FG004|Overall Study|Lost to Follow-up|6|||
33639677|NCT03483961|63042562|FG005|Overall Study|Lost to Follow-up|4|||
33639678|NCT03483961|63042563|FG006|Overall Study|Lost to Follow-up|4|||
33639679|NCT03483961|63042564|FG007|Overall Study|Lost to Follow-up|11|||
33639680|NCT03483961|63042565|FG008|Overall Study|Lost to Follow-up|1|||
33639681|NCT03483961|63042566|FG009|Overall Study|Lost to Follow-up|0|||
33639682|NCT03483961|63042557|FG000|Overall Study|Withdrawal by Subject|3|||
33639683|NCT03483961|63042558|FG001|Overall Study|Withdrawal by Subject|4|||
33639684|NCT03483961|63042559|FG002|Overall Study|Withdrawal by Subject|5|||
33639685|NCT03483961|63042560|FG003|Overall Study|Withdrawal by Subject|3|||
33639686|NCT03483961|63042561|FG004|Overall Study|Withdrawal by Subject|4|||
33639687|NCT03483961|63042562|FG005|Overall Study|Withdrawal by Subject|2|||
33639688|NCT03483961|63042563|FG006|Overall Study|Withdrawal by Subject|1|||
33639689|NCT03483961|63042564|FG007|Overall Study|Withdrawal by Subject|2|||
33639690|NCT03483961|63042565|FG008|Overall Study|Withdrawal by Subject|1|||
33639691|NCT03483961|63042566|FG009|Overall Study|Withdrawal by Subject|0|||
33639692|NCT03483961|63042557|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
33639693|NCT03483961|63042558|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33639694|NCT03483961|63042559|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33639695|NCT03483961|63042560|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33463004|NCT00378599|62836667|FG000|Overall Study|Adverse Event|38|||
33463005|NCT00378599|62836667|FG000|Overall Study|Protocol Violation|2|||
33639696|NCT03483961|63042561|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33639697|NCT03483961|63042562|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33639698|NCT03483961|63042563|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33639699|NCT03483961|63042564|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33639700|NCT03483961|63042565|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33639701|NCT03483961|63042566|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33639702|NCT03483961|63042557|FG000|Overall Study|Adverse Event|0|||
33639703|NCT03483961|63042558|FG001|Overall Study|Adverse Event|0|||
33639704|NCT03483961|63042559|FG002|Overall Study|Adverse Event|1|||
33639705|NCT03483961|63042560|FG003|Overall Study|Adverse Event|0|||
33639706|NCT03483961|63042561|FG004|Overall Study|Adverse Event|0|||
33639707|NCT03483961|63042562|FG005|Overall Study|Adverse Event|0|||
33639708|NCT03483961|63042563|FG006|Overall Study|Adverse Event|0|||
33639709|NCT03483961|63042564|FG007|Overall Study|Adverse Event|0|||
33639710|NCT03483961|63042565|FG008|Overall Study|Adverse Event|0|||
33639711|NCT03483961|63042566|FG009|Overall Study|Adverse Event|0|||
33639712|NCT03459807|63042593|FG000|Overall Study|Withdrawal due to transplant|0|||
33639713|NCT03459807|63042594|FG001|Overall Study|Withdrawal due to transplant|1|||
33639714|NCT03439293|63042607|FG000|Overall Study|Ongoing on Treatment|15|||
33639715|NCT03439293|63042607|FG000|Overall Study|Ongoing off Treatment|19|||
33639716|NCT03439293|63042607|FG000|Overall Study|Death|18|||
33639717|NCT03439293|63042607|FG000|Overall Study|Withdrawal by Subject|7|||
33639718|NCT03439293|63042607|FG000|Overall Study|Lost to Follow-up|2|||
33326755|NCT00945945|62703383|FG000|Overall Study|Entry Criteria Not Met|0|||
33463006|NCT00378599|62836667|FG000|Overall Study|Treatment failure|7|||
33463007|NCT00378599|62836667|FG000|Overall Study|Withdrawal by Subject|5|||
33463008|NCT00378209|62836671|FG000|Overall Study|Progressive disease|11|||
33463009|NCT00378209|62836671|FG000|Overall Study|Adverse Event|3|||
33639719|NCT03423979|63042612|FG000|Overall Study|Death|1|||
33639720|NCT03239210|63042618|FG000|Overall Study|Lost to Follow-up|2|||
33639721|NCT03239210|63042619|FG001|Overall Study|Lost to Follow-up|2|||
33639722|NCT03239210|63042618|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
33639723|NCT03239210|63042619|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
33639724|NCT03239210|63042618|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
33639725|NCT03239210|63042619|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
33639726|NCT03227224|63042629|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
33639727|NCT03227224|63042630|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
33639728|NCT03227224|63042631|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
33639729|NCT03227224|63042632|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
33639730|NCT03227224|63042629|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
33639731|NCT03227224|63042630|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
33639732|NCT03227224|63042631|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
33639733|NCT03227224|63042632|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
33639734|NCT03227224|63042629|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
33639735|NCT03227224|63042630|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
33639736|NCT03227224|63042631|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
33639737|NCT03227224|63042632|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
33639738|NCT03227224|63042629|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
33326756|NCT00945945|62703384|FG001|Overall Study|Entry Criteria Not Met|1|||
33326757|NCT01203956|62703390|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
33326758|NCT01203956|62703391|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
33326759|NCT01103232|62703400|FG000|Overall Study|Withdrawal by Subject|1|||
33326760|NCT01103232|62703401|FG001|Overall Study|Withdrawal by Subject|1|||
33326761|NCT01103232|62703400|FG000|Overall Study|Protocol Violation|0|||
33326762|NCT01103232|62703401|FG001|Overall Study|Protocol Violation|1|||
33326763|NCT01112982|62703407|FG000|Overall Study|Withdrawal by Subject|1|||
33639739|NCT03227224|63042630|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33639740|NCT03227224|63042631|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33639741|NCT03227224|63042632|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33639742|NCT03227224|63042629|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
33639743|NCT03227224|63042630|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
33639744|NCT03227224|63042631|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
33639745|NCT03227224|63042632|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
33639746|NCT03227224|63042629|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
33639747|NCT03227224|63042630|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
33639748|NCT03227224|63042631|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
33463010|NCT00378209|62836671|FG000|Overall Study|Initiation of non-protocol therapy|3|||
33463011|NCT00378209|62836671|FG000|Overall Study|Physician Decision|3|||
33463012|NCT00378209|62836671|FG000|Overall Study|Death|1|||
33463013|NCT00378209|62836671|FG000|Overall Study|Treatment delay|1|||
33463014|NCT03410992|62836678|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33463015|NCT03410992|62836679|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
33463016|NCT03410992|62836680|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33463017|NCT03410992|62836681|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33463018|NCT03410992|62836682|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33463019|NCT03410992|62836683|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33463020|NCT03410992|62836684|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33463021|NCT03410992|62836685|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33463022|NCT03410992|62836686|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33463023|NCT03410992|62836687|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33463024|NCT03410992|62836688|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33463025|NCT03410992|62836678|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
33463026|NCT03410992|62836679|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
33463027|NCT03410992|62836680|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33463028|NCT03410992|62836681|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33463029|NCT03410992|62836682|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33463030|NCT03410992|62836683|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33463031|NCT03410992|62836684|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33463032|NCT03410992|62836685|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33463033|NCT03410992|62836686|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33326764|NCT01112982|62703407|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
33326765|NCT01203878|62703417|FG000|Overall Study|Withdrawal by Subject|0|||
33326766|NCT01203878|62703418|FG001|Overall Study|Withdrawal by Subject|0|||
33326767|NCT01203878|62703419|FG002|Overall Study|Withdrawal by Subject|1|||
33326768|NCT01203878|62703417|FG000|Overall Study|Adverse Event|0|||
33326769|NCT01203878|62703418|FG001|Overall Study|Adverse Event|0|||
33326770|NCT01203878|62703419|FG002|Overall Study|Adverse Event|2|||
33326771|NCT01112514|62703426|FG000|Overall Study|Lost to Follow-up|1|||
33326772|NCT01203098|62703433|FG000|Overall Study|Adverse Event|3|||
33326773|NCT01203098|62703434|FG001|Overall Study|Adverse Event|1|||
33326774|NCT01203098|62703435|FG002|Overall Study|Adverse Event|7|||
33326775|NCT01203098|62703433|FG000|Overall Study|Lost to Follow-up|0|||
33326776|NCT01203098|62703434|FG001|Overall Study|Lost to Follow-up|0|||
33326777|NCT01203098|62703435|FG002|Overall Study|Lost to Follow-up|1|||
33326778|NCT01203098|62703433|FG000|Overall Study|Physician Decision|2|||
33326779|NCT01203098|62703434|FG001|Overall Study|Physician Decision|2|||
33326780|NCT01203098|62703435|FG002|Overall Study|Physician Decision|0|||
33326781|NCT01203098|62703433|FG000|Overall Study|Withdrawal by Subject|1|||
33326782|NCT01203098|62703434|FG001|Overall Study|Withdrawal by Subject|1|||
33639749|NCT03227224|63042632|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
33639750|NCT03227224|63042629|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
33639751|NCT03227224|63042630|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
33639752|NCT03227224|63042631|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
33463034|NCT03410992|62836687|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33326783|NCT01203098|62703435|FG002|Overall Study|Withdrawal by Subject|3|||
33326784|NCT00945555|62703443|FG000|Overall Study|Referred to another hospital|5|||
33326785|NCT00945555|62703443|FG000|Overall Study|Worsening condition, intensive care unit|1|||
33326786|NCT00945555|62703443|FG000|Overall Study|Withdrawal by Subject|2|||
33326787|NCT00945555|62703443|FG000|Overall Study|Participant continued treatment at home|1|||
33326788|NCT00945555|62703443|FG000|Overall Study|Death|18|||
33326789|NCT00945555|62703443|FG000|Overall Study|Other|1|||
33326790|NCT01108458|62703447|FG000|Overall Study|Withdrawal by Subject|1|||
33326791|NCT01108068|62703453|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
33326792|NCT01108068|62703454|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
33326793|NCT01201850|62703461|FG000|Overall Study|Tumor progression|4|||
33326794|NCT00951171|62703467|FG000|Overall Study|Adverse Event|2|||
33326795|NCT00951171|62703468|FG001|Overall Study|Adverse Event|0|||
33326796|NCT01200992|62703476|FG000|Overall Study|Study terminated early|35|||
33326797|NCT01200992|62703477|FG001|Overall Study|Study terminated early|41|||
33326798|NCT01200992|62703476|FG000|Overall Study|Randomized but not treated|2|||
33326799|NCT01200992|62703477|FG001|Overall Study|Randomized but not treated|0|||
33326800|NCT00878215|62703489|FG000|Overall Study|Determined to be ineligible|0|||
33326801|NCT00878215|62703490|FG001|Overall Study|Determined to be ineligible|10|||
33326802|NCT00878215|62703491|FG002|Overall Study|Determined to be ineligible|0|||
33326803|NCT00878215|62703492|FG003|Overall Study|Determined to be ineligible|0|||
33326804|NCT01200758|62703504|FG000|Stage I|Death|0|||
33326805|NCT01200758|62703505|FG001|Stage I|Death|1|||
33639753|NCT03227224|63042632|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
33639754|NCT03227224|63042629|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
33639755|NCT03227224|63042630|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
33639756|NCT03227224|63042631|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
33639757|NCT03227224|63042632|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
33326806|NCT01200758|62703506|FG002|Stage I|Death|0|||
33463035|NCT03410992|62836688|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33463036|NCT03410992|62836678|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
33463037|NCT03410992|62836679|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
33463038|NCT03410992|62836680|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33463039|NCT03410992|62836681|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33463040|NCT03410992|62836682|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33463041|NCT03410992|62836683|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33463042|NCT03410992|62836684|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33463043|NCT03410992|62836685|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33326807|NCT01200758|62703507|FG003|Stage I|Death|0|||
33326808|NCT01200758|62703504|FG000|Stage I|Physician Decision|1|||
33326809|NCT01200758|62703505|FG001|Stage I|Physician Decision|1|||
33326810|NCT01200758|62703506|FG002|Stage I|Physician Decision|0|||
33326811|NCT01200758|62703507|FG003|Stage I|Physician Decision|0|||
33326812|NCT01200758|62703504|FG000|Stage I|Lack of Efficacy|2|||
33326813|NCT01200758|62703505|FG001|Stage I|Lack of Efficacy|1|||
33326814|NCT01200758|62703506|FG002|Stage I|Lack of Efficacy|0|||
33463044|NCT03410992|62836686|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33639758|NCT03227224|63042629|FG000|Follow-up Phase (2 Weeks)|Other|4|||
33639759|NCT03227224|63042630|FG001|Follow-up Phase (2 Weeks)|Other|4|||
33639760|NCT03227224|63042631|FG002|Follow-up Phase (2 Weeks)|Other|6|||
33639761|NCT03227224|63042632|FG003|Follow-up Phase (2 Weeks)|Other|3|||
33639762|NCT03086343|63042651|FG000|Overall Study|Adverse Event|7|||
33639763|NCT03086343|63042652|FG001|Overall Study|Adverse Event|7|||
33639764|NCT03086343|63042651|FG000|Overall Study|Withdrawal by Subject|10|||
33639765|NCT03086343|63042652|FG001|Overall Study|Withdrawal by Subject|6|||
33639766|NCT03086343|63042651|FG000|Overall Study|Lost to Follow-up|3|||
33639767|NCT03086343|63042652|FG001|Overall Study|Lost to Follow-up|1|||
33639768|NCT03086343|63042651|FG000|Overall Study|Lack of Efficacy|4|||
33639769|NCT03086343|63042652|FG001|Overall Study|Lack of Efficacy|6|||
33639770|NCT03086343|63042651|FG000|Overall Study|Other, not specified|8|||
33639771|NCT03086343|63042652|FG001|Overall Study|Other, not specified|4|||
33639772|NCT03086343|63042651|FG000|Overall Study|Missing|0|||
33639773|NCT03086343|63042652|FG001|Overall Study|Missing|1|||
33639774|NCT02788045|63042696|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
33639775|NCT02788045|63042697|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
33639776|NCT02788045|63042698|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
33639777|NCT02788045|63042696|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
33639778|NCT02788045|63042697|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
33639779|NCT02788045|63042698|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
33639780|NCT02788045|63042696|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
33639781|NCT02788045|63042697|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
33639782|NCT02788045|63042698|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
33639783|NCT02788045|63042696|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
33639784|NCT02788045|63042697|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
33639785|NCT02788045|63042698|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
33639786|NCT02788045|63042696|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
33639787|NCT02788045|63042697|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
33639788|NCT02788045|63042698|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
33639789|NCT02788045|63042696|FG000|Main Study (Up to Week 72)|Other|3|||
33639790|NCT02788045|63042697|FG001|Main Study (Up to Week 72)|Other|0|||
33639791|NCT02788045|63042698|FG002|Main Study (Up to Week 72)|Other|0|||
33639792|NCT02788045|63042696|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
33639793|NCT02788045|63042697|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
33639794|NCT02788045|63042698|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
33639795|NCT02788045|63042696|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
33639796|NCT02788045|63042697|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
33639797|NCT02788045|63042698|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
33639798|NCT02788045|63042696|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
33639799|NCT02788045|63042697|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
33639800|NCT02788045|63042698|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
33639801|NCT02466685|63042726|FG000|Overall Study|Adverse Event|6|||
33639802|NCT02466685|63042727|FG001|Overall Study|Adverse Event|2|||
33639803|NCT02466685|63042726|FG000|Overall Study|Lost to Follow-up|0|||
33639804|NCT02466685|63042727|FG001|Overall Study|Lost to Follow-up|2|||
33639805|NCT02466685|63042726|FG000|Overall Study|Withdrawal by Subject|1|||
33639806|NCT02466685|63042727|FG001|Overall Study|Withdrawal by Subject|1|||
33639807|NCT02437318|63042738|FG000|Overall Study|Progressive disease|173|||
33639808|NCT02437318|63042739|FG001|Overall Study|Progressive disease|208|||
33639809|NCT02437318|63042738|FG000|Overall Study|Subject/guardian decision|22|||
33639810|NCT02437318|63042739|FG001|Overall Study|Subject/guardian decision|10|||
33639811|NCT02437318|63042738|FG000|Overall Study|Physician Decision|11|||
33639812|NCT02437318|63042739|FG001|Overall Study|Physician Decision|10|||
33639813|NCT02437318|63042738|FG000|Overall Study|Adverse Event|14|||
33639814|NCT02437318|63042739|FG001|Overall Study|Adverse Event|3|||
33639815|NCT02437318|63042738|FG000|Overall Study|Death|4|||
33463045|NCT03410992|62836687|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33639816|NCT02437318|63042739|FG001|Overall Study|Death|4|||
33639817|NCT02437318|63042738|FG000|Overall Study|Protocol Violation|5|||
33639818|NCT02437318|63042739|FG001|Overall Study|Protocol Violation|6|||
33639819|NCT02437318|63042738|FG000|Overall Study|Untreated|0|||
33639820|NCT02437318|63042739|FG001|Overall Study|Untreated|1|||
33639821|NCT02315703|63042753|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
33639822|NCT02315703|63042754|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
33639823|NCT02315703|63042755|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
33639824|NCT02315703|63042756|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
33639825|NCT02315703|63042757|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
33639826|NCT02315703|63042758|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
33639827|NCT02315703|63042759|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
33639828|NCT02315703|63042760|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
33639829|NCT02315703|63042753|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
33639830|NCT02315703|63042754|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
33639831|NCT02315703|63042755|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
33639832|NCT02315703|63042756|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
33639833|NCT02315703|63042757|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
33639834|NCT02315703|63042758|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
33639835|NCT02315703|63042759|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
33639836|NCT02315703|63042760|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
33639837|NCT02315703|63042753|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
33639838|NCT02315703|63042754|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
33639839|NCT02315703|63042755|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
33639840|NCT02315703|63042756|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
33639841|NCT02315703|63042757|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
33639842|NCT02315703|63042758|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
33639843|NCT02315703|63042759|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
33639844|NCT02315703|63042760|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
33639845|NCT02315703|63042753|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
33639846|NCT02315703|63042754|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
33639847|NCT02315703|63042755|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
33639848|NCT02315703|63042756|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
33639849|NCT02315703|63042757|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
33639850|NCT02315703|63042758|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
33639851|NCT02315703|63042759|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
33639852|NCT02315703|63042760|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
33639853|NCT02315703|63042753|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
33639854|NCT02315703|63042754|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
33639855|NCT02315703|63042755|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
33639856|NCT02315703|63042756|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
33639857|NCT02315703|63042757|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
33639858|NCT02315703|63042758|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
33639859|NCT02315703|63042759|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
33639860|NCT02315703|63042760|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
33639861|NCT02315703|63042753|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
33639862|NCT02315703|63042754|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
33639863|NCT02315703|63042755|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
33639864|NCT02315703|63042756|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
33639865|NCT02315703|63042757|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
33639866|NCT02315703|63042758|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
33639867|NCT02315703|63042759|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
33639868|NCT02315703|63042760|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
33639869|NCT02315703|63042753|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
33639870|NCT02315703|63042754|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
33639871|NCT02315703|63042755|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
33639872|NCT02315703|63042756|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
33639873|NCT02315703|63042757|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
33639874|NCT02315703|63042758|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
33639875|NCT02315703|63042759|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
33639876|NCT02315703|63042760|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
33639877|NCT02315703|63042753|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
33639878|NCT02315703|63042754|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
33639879|NCT02315703|63042755|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
33639880|NCT02315703|63042756|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
33639881|NCT02315703|63042757|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
33639882|NCT02315703|63042758|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
33326815|NCT01200758|62703507|FG003|Stage I|Lack of Efficacy|0|||
33639883|NCT02315703|63042759|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
33639884|NCT02315703|63042760|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
33326816|NCT01200758|62703504|FG000|Stage I|Adverse Event|5|||
33463046|NCT03410992|62836688|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33463047|NCT03410992|62836678|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
33463048|NCT03410992|62836679|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33463049|NCT03410992|62836680|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33463050|NCT03410992|62836681|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33463051|NCT03410992|62836682|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33463052|NCT03410992|62836683|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33463053|NCT03410992|62836684|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33463054|NCT03410992|62836685|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33463055|NCT03410992|62836686|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33326817|NCT01200758|62703505|FG001|Stage I|Adverse Event|5|||
33326818|NCT01200758|62703506|FG002|Stage I|Adverse Event|0|||
33326819|NCT01200758|62703507|FG003|Stage I|Adverse Event|0|||
33326820|NCT01200758|62703504|FG000|Stage I|Withdrawal by Subject|1|||
33326821|NCT01200758|62703505|FG001|Stage I|Withdrawal by Subject|2|||
33326822|NCT01200758|62703506|FG002|Stage I|Withdrawal by Subject|0|||
33326823|NCT01200758|62703507|FG003|Stage I|Withdrawal by Subject|0|||
33326824|NCT01200758|62703504|FG000|Stage I|Disease Progression|9|||
33326825|NCT01200758|62703505|FG001|Stage I|Disease Progression|7|||
33326826|NCT01200758|62703506|FG002|Stage I|Disease Progression|0|||
33326827|NCT01200758|62703507|FG003|Stage I|Disease Progression|0|||
33326828|NCT01200758|62703504|FG000|Stage 2|Disease Progression|0|||
33326829|NCT01200758|62703505|FG001|Stage 2|Disease Progression|0|||
33326830|NCT01200758|62703506|FG002|Stage 2|Disease Progression|16|||
33326831|NCT01200758|62703507|FG003|Stage 2|Disease Progression|21|||
33326832|NCT01200758|62703504|FG000|Stage 2|Lack of Efficacy|0|||
33326833|NCT01200758|62703505|FG001|Stage 2|Lack of Efficacy|0|||
33326834|NCT01200758|62703506|FG002|Stage 2|Lack of Efficacy|4|||
33326835|NCT01200758|62703507|FG003|Stage 2|Lack of Efficacy|2|||
33326836|NCT01200758|62703504|FG000|Stage 2|Physician Decision|0|||
33326837|NCT01200758|62703505|FG001|Stage 2|Physician Decision|0|||
33326838|NCT01200758|62703506|FG002|Stage 2|Physician Decision|5|||
33326839|NCT01200758|62703507|FG003|Stage 2|Physician Decision|7|||
33326840|NCT01200758|62703504|FG000|Stage 2|Adverse Event|0|||
33326841|NCT01200758|62703505|FG001|Stage 2|Adverse Event|0|||
33326842|NCT01200758|62703506|FG002|Stage 2|Adverse Event|5|||
33326843|NCT01200758|62703507|FG003|Stage 2|Adverse Event|9|||
33326844|NCT01200758|62703504|FG000|Stage 2|Withdrawal by Subject|0|||
33326845|NCT01200758|62703505|FG001|Stage 2|Withdrawal by Subject|0|||
33326846|NCT01200758|62703506|FG002|Stage 2|Withdrawal by Subject|4|||
33326847|NCT01200758|62703507|FG003|Stage 2|Withdrawal by Subject|1|||
33326848|NCT01200758|62703504|FG000|Stage 2|Lost to Follow-up|0|||
33326849|NCT01200758|62703505|FG001|Stage 2|Lost to Follow-up|0|||
33326850|NCT01200758|62703506|FG002|Stage 2|Lost to Follow-up|3|||
33326851|NCT01200758|62703507|FG003|Stage 2|Lost to Follow-up|1|||
33326852|NCT01200758|62703504|FG000|Stage 2|Protocol Violation|0|||
33326853|NCT01200758|62703505|FG001|Stage 2|Protocol Violation|0|||
33326854|NCT01200758|62703506|FG002|Stage 2|Protocol Violation|1|||
33326855|NCT01200758|62703507|FG003|Stage 2|Protocol Violation|4|||
33326856|NCT01200758|62703504|FG000|Stage 2|Death|0|||
33326857|NCT01200758|62703505|FG001|Stage 2|Death|0|||
33326858|NCT01200758|62703506|FG002|Stage 2|Death|3|||
33326859|NCT01200758|62703507|FG003|Stage 2|Death|5|||
33326860|NCT00876343|62703522|FG000|Overall Study|Adverse Event|7|||
33326861|NCT00876343|62703523|FG001|Overall Study|Adverse Event|8|||
33326862|NCT00876343|62703524|FG002|Overall Study|Adverse Event|2|||
33326863|NCT00876343|62703522|FG000|Overall Study|Withdrawal by Subject|4|||
33326864|NCT00876343|62703523|FG001|Overall Study|Withdrawal by Subject|4|||
33326865|NCT00876343|62703524|FG002|Overall Study|Withdrawal by Subject|3|||
33326866|NCT00876343|62703522|FG000|Overall Study|Lack of Efficacy|0|||
33326867|NCT00876343|62703523|FG001|Overall Study|Lack of Efficacy|0|||
33326868|NCT00876343|62703524|FG002|Overall Study|Lack of Efficacy|1|||
33326869|NCT00876343|62703522|FG000|Overall Study|Protocol Violation|4|||
33326870|NCT00876343|62703523|FG001|Overall Study|Protocol Violation|1|||
33326871|NCT00876343|62703524|FG002|Overall Study|Protocol Violation|1|||
33326872|NCT00876343|62703522|FG000|Overall Study|Physician Decision|0|||
33326873|NCT00876343|62703523|FG001|Overall Study|Physician Decision|1|||
33326874|NCT00876343|62703524|FG002|Overall Study|Physician Decision|1|||
33326875|NCT00876343|62703522|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
33326876|NCT00876343|62703523|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
33326877|NCT00876343|62703524|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
33326878|NCT00876343|62703522|FG000|Overall Study|Change of residence or other commitments|2|||
33326879|NCT00876343|62703523|FG001|Overall Study|Change of residence or other commitments|2|||
33326880|NCT00876343|62703524|FG002|Overall Study|Change of residence or other commitments|3|||
33326881|NCT01107912|62703536|FG000|Period 1|Adverse Event|0|||
33326882|NCT01107912|62703537|FG001|Period 1|Adverse Event|0|||
33326883|NCT01107912|62703538|FG002|Period 1|Adverse Event|0|||
33326884|NCT01107912|62703539|FG003|Period 1|Adverse Event|0|||
33326885|NCT01107912|62703540|FG004|Period 1|Adverse Event|2|||
33326886|NCT01107912|62703541|FG005|Period 1|Adverse Event|0|||
33326887|NCT01107912|62703536|FG000|Period 1|Physician Decision|0|||
33326888|NCT01107912|62703537|FG001|Period 1|Physician Decision|0|||
33326889|NCT01107912|62703538|FG002|Period 1|Physician Decision|0|||
33326890|NCT01107912|62703539|FG003|Period 1|Physician Decision|0|||
33326891|NCT01107912|62703540|FG004|Period 1|Physician Decision|1|||
33326892|NCT01107912|62703541|FG005|Period 1|Physician Decision|0|||
33326893|NCT01107912|62703536|FG000|Period 1|Withdrawal by Subject|1|||
33326894|NCT01107912|62703537|FG001|Period 1|Withdrawal by Subject|0|||
33326895|NCT01107912|62703538|FG002|Period 1|Withdrawal by Subject|0|||
33326896|NCT01107912|62703539|FG003|Period 1|Withdrawal by Subject|0|||
33326897|NCT01107912|62703540|FG004|Period 1|Withdrawal by Subject|0|||
33326898|NCT01107912|62703541|FG005|Period 1|Withdrawal by Subject|0|||
33326899|NCT01107912|62703536|FG000|Period 2|Physician Decision|0|||
33326900|NCT01107912|62703537|FG001|Period 2|Physician Decision|0|||
33326901|NCT01107912|62703538|FG002|Period 2|Physician Decision|1|||
33326902|NCT01107912|62703539|FG003|Period 2|Physician Decision|0|||
33326903|NCT01107912|62703540|FG004|Period 2|Physician Decision|0|||
33326904|NCT01107912|62703541|FG005|Period 2|Physician Decision|0|||
33326905|NCT01107912|62703536|FG000|Period 3|Adverse Event|0|||
33326906|NCT01107912|62703537|FG001|Period 3|Adverse Event|1|||
33326907|NCT01107912|62703538|FG002|Period 3|Adverse Event|1|||
33326908|NCT01107912|62703539|FG003|Period 3|Adverse Event|0|||
33326909|NCT01107912|62703540|FG004|Period 3|Adverse Event|0|||
33326910|NCT01107912|62703541|FG005|Period 3|Adverse Event|0|||
33326911|NCT01107912|62703536|FG000|Period 3|Withdrawal by Subject|0|||
33326912|NCT01107912|62703537|FG001|Period 3|Withdrawal by Subject|0|||
33326913|NCT01107912|62703538|FG002|Period 3|Withdrawal by Subject|0|||
33326914|NCT01107912|62703539|FG003|Period 3|Withdrawal by Subject|1|||
33326915|NCT01107912|62703540|FG004|Period 3|Withdrawal by Subject|0|||
33326916|NCT01107912|62703541|FG005|Period 3|Withdrawal by Subject|0|||
33326917|NCT01200524|62703559|FG000|Overall Study|Withdrawal by Subject|1|||
33326918|NCT01200524|62703560|FG001|Overall Study|Withdrawal by Subject|1|||
33326919|NCT01200524|62703561|FG002|Overall Study|Withdrawal by Subject|3|||
33326920|NCT01200524|62703559|FG000|Overall Study|Adverse Event|1|||
33326921|NCT01200524|62703560|FG001|Overall Study|Adverse Event|0|||
33326922|NCT01200524|62703561|FG002|Overall Study|Adverse Event|0|||
33326923|NCT01200524|62703559|FG000|Overall Study|Non availability of study nurse|0|||
33326924|NCT01200524|62703560|FG001|Overall Study|Non availability of study nurse|0|||
33326925|NCT01200524|62703561|FG002|Overall Study|Non availability of study nurse|1|||
33326926|NCT01100034|62703569|FG000|Overall Study|Lost to Follow-up|11|||
33326927|NCT01100034|62703569|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
33326928|NCT01100034|62703569|FG000|Overall Study|Withdrawal by Subject|4|||
33326929|NCT01100034|62703569|FG000|Overall Study|Sponsor decision|21|||
33326930|NCT01100034|62703569|FG000|Overall Study|Participated in another clinical trial|1|||
33326931|NCT01100034|62703569|FG000|Overall Study|Participants moved to another hospital|4|||
33326932|NCT01100034|62703569|FG000|Overall Study|Site closed due to non-responsiveness|1|||
33326933|NCT00876265|62703573|FG000|Overall Study|Miscellaneous reasons|4|||
33326934|NCT00876265|62703573|FG000|Overall Study|Lost to Follow-up|6|||
33326935|NCT00876265|62703573|FG000|Overall Study|Withdrawal by Subject|2|||
33326936|NCT01107444|62703581|FG000|Overall Study|Withdrawal by Subject|8|||
33326937|NCT01107444|62703582|FG001|Overall Study|Withdrawal by Subject|12|||
33326938|NCT01107444|62703581|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
33326939|NCT01107444|62703582|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
33326940|NCT00876187|62703596|FG000|Overall Study|Adverse Event|14|||
33326941|NCT00876187|62703597|FG001|Overall Study|Adverse Event|12|||
33326942|NCT00876187|62703598|FG002|Overall Study|Adverse Event|19|||
33326943|NCT00876187|62703599|FG003|Overall Study|Adverse Event|29|||
33326944|NCT00876187|62703600|FG004|Overall Study|Adverse Event|10|||
33326945|NCT00876187|62703596|FG000|Overall Study|Lack of Efficacy|59|||
33326946|NCT00876187|62703597|FG001|Overall Study|Lack of Efficacy|34|||
33326947|NCT00876187|62703598|FG002|Overall Study|Lack of Efficacy|45|||
33326948|NCT00876187|62703599|FG003|Overall Study|Lack of Efficacy|34|||
33326949|NCT00876187|62703600|FG004|Overall Study|Lack of Efficacy|59|||
33326950|NCT00876187|62703596|FG000|Overall Study|Lost to Follow-up|9|||
33326951|NCT00876187|62703597|FG001|Overall Study|Lost to Follow-up|10|||
33326952|NCT00876187|62703598|FG002|Overall Study|Lost to Follow-up|8|||
33326953|NCT00876187|62703599|FG003|Overall Study|Lost to Follow-up|8|||
33326954|NCT00876187|62703600|FG004|Overall Study|Lost to Follow-up|11|||
33326955|NCT00876187|62703596|FG000|Overall Study|Protocol Violation|6|||
33326956|NCT00876187|62703597|FG001|Overall Study|Protocol Violation|7|||
33326957|NCT00876187|62703598|FG002|Overall Study|Protocol Violation|7|||
33326958|NCT00876187|62703599|FG003|Overall Study|Protocol Violation|6|||
33326959|NCT00876187|62703600|FG004|Overall Study|Protocol Violation|3|||
33326960|NCT00876187|62703596|FG000|Overall Study|Withdrawal by Subject|16|||
33326961|NCT00876187|62703597|FG001|Overall Study|Withdrawal by Subject|26|||
33326962|NCT00876187|62703598|FG002|Overall Study|Withdrawal by Subject|32|||
33639885|NCT02315703|63042753|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
33639886|NCT02315703|63042754|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
33326963|NCT00876187|62703599|FG003|Overall Study|Withdrawal by Subject|38|||
33326964|NCT00876187|62703600|FG004|Overall Study|Withdrawal by Subject|37|||
33326965|NCT00876187|62703596|FG000|Overall Study|Entered extension study|101|||
33326966|NCT00876187|62703597|FG001|Overall Study|Entered extension study|120|||
33326967|NCT00876187|62703598|FG002|Overall Study|Entered extension study|156|||
33326968|NCT00876187|62703599|FG003|Overall Study|Entered extension study|151|||
33326969|NCT00876187|62703600|FG004|Overall Study|Entered extension study|144|||
33326970|NCT00876187|62703596|FG000|Overall Study|Randomized but not treated|3|||
33326971|NCT00876187|62703597|FG001|Overall Study|Randomized but not treated|1|||
33326972|NCT00876187|62703598|FG002|Overall Study|Randomized but not treated|3|||
33326973|NCT00876187|62703599|FG003|Overall Study|Randomized but not treated|2|||
33326974|NCT00876187|62703600|FG004|Overall Study|Randomized but not treated|3|||
33639887|NCT02315703|63042755|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
33639888|NCT02315703|63042756|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
33639889|NCT02315703|63042757|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
33639890|NCT02315703|63042758|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
33639891|NCT02315703|63042759|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
33639892|NCT02315703|63042760|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
33639893|NCT02125461|63042780|FG000|Overall Study|Withdrawal by Subject|30|||
33639894|NCT02125461|63042781|FG001|Overall Study|Withdrawal by Subject|16|||
33639895|NCT02125461|63042780|FG000|Overall Study|Lost to Follow-up|8|||
33639896|NCT02125461|63042781|FG001|Overall Study|Lost to Follow-up|3|||
33639897|NCT02125461|63042780|FG000|Overall Study|Death|260|||
33639898|NCT02125461|63042781|FG001|Overall Study|Death|149|||
33639899|NCT02125461|63042780|FG000|Overall Study|Missing Termination Reason|0|||
33639900|NCT02125461|63042781|FG001|Overall Study|Missing Termination Reason|1|||
33639901|NCT02049359|63042789|FG000|Overall Study|Lost to Follow-up|26|||
33639902|NCT02049359|63042790|FG001|Overall Study|Lost to Follow-up|19|||
33639903|NCT01933932|63042818|FG000|Overall Study|Death|173|||
33639904|NCT01933932|63042819|FG001|Overall Study|Death|163|||
33639905|NCT01933932|63042818|FG000|Overall Study|Withdrawal by Subject|11|||
33639906|NCT01933932|63042819|FG001|Overall Study|Withdrawal by Subject|14|||
33639907|NCT01933932|63042818|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33639908|NCT01933932|63042819|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33639909|NCT01698905|63042829|FG000|Overall Study|Adverse Event|4|||
33639910|NCT01698905|63042829|FG000|Overall Study|Physician Decision|2|||
33639911|NCT01698905|63042829|FG000|Overall Study|Pregnancy|1|||
33639912|NCT01698905|63042829|FG000|Overall Study|Protocol Violation|1|||
33639913|NCT01698905|63042829|FG000|Overall Study|Subject/guardian decision|2|||
33639914|NCT01698905|63042829|FG000|Overall Study|Death|1|||
33639915|NCT01466686|63042840|FG000|Overall Study|Withdrawal by Subject|1|||
33639916|NCT01550289|63042846|FG000|Overall Study|Protocol Violation|1|||
33639917|NCT01550289|63042847|FG001|Overall Study|Protocol Violation|0|||
33639918|NCT01550289|63042846|FG000|Overall Study|Lost to Follow-up|1|||
33639919|NCT01550289|63042847|FG001|Overall Study|Lost to Follow-up|1|||
33639920|NCT01550289|63042846|FG000|Overall Study|Withdrawal by Subject|11|||
33639921|NCT01550289|63042847|FG001|Overall Study|Withdrawal by Subject|3|||
33639922|NCT01968031|63042858|FG000|Overall Study|Adverse Event|13|||
33639923|NCT01968031|63042859|FG001|Overall Study|Adverse Event|10|||
33639924|NCT01968031|63042860|FG002|Overall Study|Adverse Event|22|||
33639925|NCT01968031|63042858|FG000|Overall Study|Withdrawal by Subject|3|||
33639926|NCT01968031|63042859|FG001|Overall Study|Withdrawal by Subject|7|||
33639927|NCT01968031|63042860|FG002|Overall Study|Withdrawal by Subject|3|||
33639928|NCT01968031|63042858|FG000|Overall Study|Did not meet entry criteria|1|||
33639929|NCT01968031|63042859|FG001|Overall Study|Did not meet entry criteria|1|||
33639930|NCT01968031|63042860|FG002|Overall Study|Did not meet entry criteria|1|||
33639931|NCT01968031|63042858|FG000|Overall Study|Noncompliance|0|||
33639932|NCT01968031|63042859|FG001|Overall Study|Noncompliance|0|||
33326975|NCT00876187|62703596|FG000|Overall Study|Other|2|||
33326976|NCT00876187|62703597|FG001|Overall Study|Other|5|||
33326977|NCT00876187|62703598|FG002|Overall Study|Other|9|||
33326978|NCT00876187|62703599|FG003|Overall Study|Other|7|||
33326979|NCT00876187|62703600|FG004|Overall Study|Other|4|||
33463056|NCT03410992|62836687|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33463057|NCT03410992|62836688|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33463058|NCT03410992|62836678|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
33463059|NCT03410992|62836679|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
33463060|NCT03410992|62836680|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33463061|NCT03410992|62836681|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33463062|NCT03410992|62836682|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33463063|NCT03410992|62836683|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33463064|NCT03410992|62836684|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33463065|NCT03410992|62836685|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33463066|NCT03410992|62836686|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33463067|NCT03410992|62836687|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33463068|NCT03410992|62836688|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33463069|NCT03410992|62836678|FG000|Week 16 Assessment|Incorrect escapers|0|||
33326980|NCT01102374|62703617|FG000|Overall Study|Death|9|||
33542295|NCT02547922|62932992|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
33639933|NCT01968031|63042860|FG002|Overall Study|Noncompliance|2|||
33639934|NCT01968031|63042858|FG000|Overall Study|Failed inclusion criteria|0|||
33639935|NCT01968031|63042859|FG001|Overall Study|Failed inclusion criteria|2|||
33639936|NCT01968031|63042860|FG002|Overall Study|Failed inclusion criteria|0|||
33639937|NCT01968031|63042858|FG000|Overall Study|Death|0|||
33326981|NCT01102374|62703618|FG001|Overall Study|Death|13|||
33639938|NCT01968031|63042859|FG001|Overall Study|Death|0|||
33639939|NCT01968031|63042860|FG002|Overall Study|Death|1|||
33463070|NCT03410992|62836679|FG001|Week 16 Assessment|Incorrect escapers|6|||
33326982|NCT01102374|62703617|FG000|Overall Study|Lost to Follow-up|7|||
33326983|NCT01102374|62703618|FG001|Overall Study|Lost to Follow-up|6|||
33326984|NCT01106976|62703624|FG000|Overall Study|Lost to Follow-up|8|||
33326985|NCT00875485|62703630|FG000|Challenge Dose Epoch|Pregnancy|1|||
33463071|NCT03410992|62836680|FG002|Week 16 Assessment|Incorrect escapers|0|||
33639940|NCT01968031|63042858|FG000|Overall Study|Prohibited concomitant medication|1|||
33639941|NCT01968031|63042859|FG001|Overall Study|Prohibited concomitant medication|0|||
33639942|NCT01968031|63042860|FG002|Overall Study|Prohibited concomitant medication|0|||
33639943|NCT01684215|63042872|FG000|Phase 1, Part 1|Adverse Event|1|||
33639944|NCT01684215|63042873|FG001|Phase 1, Part 1|Adverse Event|0|||
33639945|NCT01684215|63042874|FG002|Phase 1, Part 1|Adverse Event|0|||
33639946|NCT01684215|63042875|FG003|Phase 1, Part 1|Adverse Event|0|||
33639947|NCT01684215|63042872|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
33639948|NCT01684215|63042873|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
33639949|NCT01684215|63042874|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
33639950|NCT01684215|63042875|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
33639951|NCT01684215|63042872|FG000|Phase 1, Part 2|Adverse Event|0|||
33639952|NCT01684215|63042873|FG001|Phase 1, Part 2|Adverse Event|0|||
33639953|NCT01684215|63042874|FG002|Phase 1, Part 2|Adverse Event|1|||
33639954|NCT01684215|63042875|FG003|Phase 1, Part 2|Adverse Event|0|||
33639955|NCT01684215|63042872|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
33639956|NCT01684215|63042873|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
33639957|NCT01684215|63042874|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
33639958|NCT01684215|63042875|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
33639959|NCT01684215|63042872|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
33639960|NCT01684215|63042873|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
33639961|NCT01684215|63042874|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
33639962|NCT01684215|63042875|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
33639963|NCT01684215|63042872|FG000|Phase 2|Death|0|||
33639964|NCT01684215|63042873|FG001|Phase 2|Death|0|||
33639965|NCT01684215|63042874|FG002|Phase 2|Death|0|||
33639966|NCT01684215|63042875|FG003|Phase 2|Death|8|||
33639967|NCT01684215|63042872|FG000|Phase 2|Study terminated by sponsor|0|||
33639968|NCT01684215|63042873|FG001|Phase 2|Study terminated by sponsor|0|||
33639969|NCT01684215|63042874|FG002|Phase 2|Study terminated by sponsor|0|||
33639970|NCT01684215|63042875|FG003|Phase 2|Study terminated by sponsor|30|||
33639971|NCT01684215|63042872|FG000|Phase 2|Enrolled but not treated|0|||
33639972|NCT01684215|63042873|FG001|Phase 2|Enrolled but not treated|0|||
33639973|NCT01684215|63042874|FG002|Phase 2|Enrolled but not treated|0|||
33639974|NCT01684215|63042875|FG003|Phase 2|Enrolled but not treated|1|||
33639975|NCT01684215|63042872|FG000|Phase 2|Lost to Follow-up|0|||
33639976|NCT01684215|63042873|FG001|Phase 2|Lost to Follow-up|0|||
33639977|NCT01684215|63042874|FG002|Phase 2|Lost to Follow-up|0|||
33639978|NCT01684215|63042875|FG003|Phase 2|Lost to Follow-up|4|||
33639979|NCT01549275|63042890|FG000|Overall Study|Lost to Follow-up|1|||
33639980|NCT01549275|63042891|FG001|Overall Study|Lost to Follow-up|0|||
33639981|NCT01908205|63042903|FG000|Overall Study|Lost to Follow-up|2|||
33639982|NCT01908205|63042904|FG001|Overall Study|Lost to Follow-up|0|||
33639983|NCT01908205|63042903|FG000|Overall Study|Withdrawal by Subject|3|||
33639984|NCT01908205|63042904|FG001|Overall Study|Withdrawal by Subject|1|||
33639985|NCT01549041|63042925|FG000|Overall Study|Lack of Efficacy|2|||
33639986|NCT01549041|63042926|FG001|Overall Study|Lack of Efficacy|4|||
33639987|NCT01549041|63042925|FG000|Overall Study|Adverse Event|0|||
33639988|NCT01549041|63042926|FG001|Overall Study|Adverse Event|4|||
33639989|NCT01907815|63042934|FG000|Overall Study|Withdrawal by Subject|1|||
33639990|NCT01907815|63042935|FG001|Overall Study|Withdrawal by Subject|0|||
33639991|NCT01548573|63042943|FG000|Overall Study|Death|3|||
33639992|NCT01548573|63042943|FG000|Overall Study|Withdrawal by Subject|2|||
33639993|NCT01907737|63042948|FG000|Overall Study|Withdrawal by Subject|1|||
33639994|NCT01570491|63042960|FG000|Overall Study|Lost to Follow-up|3|||
33326986|NCT00875485|62703631|FG001|Challenge Dose Epoch|Pregnancy|0|||
33639995|NCT01570491|63042961|FG001|Overall Study|Lost to Follow-up|1|||
33639996|NCT01570491|63042960|FG000|Overall Study|treatment: not given or discontinued|2|||
33639997|NCT01570491|63042961|FG001|Overall Study|treatment: not given or discontinued|0|||
33639998|NCT01929109|63042972|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
33639999|NCT01929109|63042973|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
33640000|NCT01929109|63042974|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
33640001|NCT01929109|63042975|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
33640002|NCT01929109|63042976|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
33326987|NCT04547140|62703639|FG000|Overall Study|Adverse Event|0|||
33640003|NCT01518153|63042991|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
33640004|NCT01518153|63042992|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
33640005|NCT01518153|63042993|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
33640006|NCT01518153|63042991|FG000|Stem Cell Transplant|Death|2|||
33640007|NCT01518153|63042992|FG001|Stem Cell Transplant|Death|0|||
33640008|NCT01518153|63042993|FG002|Stem Cell Transplant|Death|0|||
33640009|NCT01518153|63042991|FG000|Stem Cell Transplant|Secondary graft failure|1|||
33640010|NCT01518153|63042992|FG001|Stem Cell Transplant|Secondary graft failure|0|||
33640011|NCT01518153|63042993|FG002|Stem Cell Transplant|Secondary graft failure|0|||
33640012|NCT01518153|63042991|FG000|Stem Cell Transplant|Adverse Event|1|||
33640013|NCT01518153|63042992|FG001|Stem Cell Transplant|Adverse Event|0|||
33640014|NCT01518153|63042993|FG002|Stem Cell Transplant|Adverse Event|0|||
33640015|NCT01518153|63042991|FG000|Donor Lymphocyte Infusion|Death|0|||
33640016|NCT01518153|63042992|FG001|Donor Lymphocyte Infusion|Death|2|||
33640017|NCT01518153|63042993|FG002|Donor Lymphocyte Infusion|Death|1|||
33640018|NCT01906489|63043003|FG000|Overall Study|Adverse Event|10|||
33640019|NCT01906489|63043004|FG001|Overall Study|Adverse Event|3|||
33463072|NCT03410992|62836681|FG003|Week 16 Assessment|Incorrect escapers|0|||
33640020|NCT01906489|63043003|FG000|Overall Study|Worsening of CKD|6|||
33640021|NCT01906489|63043004|FG001|Overall Study|Worsening of CKD|4|||
33640022|NCT01906489|63043003|FG000|Overall Study|Withdrawal by Subject|5|||
33640023|NCT01906489|63043004|FG001|Overall Study|Withdrawal by Subject|0|||
33640024|NCT01906489|63043003|FG000|Overall Study|Worsening of Anemia|1|||
33640025|NCT01906489|63043004|FG001|Overall Study|Worsening of Anemia|0|||
33640026|NCT01906489|63043003|FG000|Overall Study|Protocol Violation|0|||
33640027|NCT01906489|63043004|FG001|Overall Study|Protocol Violation|1|||
33640028|NCT01906489|63043003|FG000|Overall Study|Non- Compliance|1|||
33640029|NCT01906489|63043004|FG001|Overall Study|Non- Compliance|0|||
33640030|NCT01906489|63043003|FG000|Overall Study|Sponsor Decision|1|||
33640031|NCT01906489|63043004|FG001|Overall Study|Sponsor Decision|0|||
33640032|NCT01906489|63043003|FG000|Overall Study|Lost to Follow-up|1|||
33640033|NCT01906489|63043004|FG001|Overall Study|Lost to Follow-up|1|||
33640034|NCT01906489|63043003|FG000|Overall Study|Other|1|||
33640035|NCT01906489|63043004|FG001|Overall Study|Other|0|||
33640036|NCT01517373|63043015|FG000|Run-in Period|Death|1|||
33640037|NCT01517373|63043016|FG001|Run-in Period|Death|0|||
33640038|NCT01517373|63043017|FG002|Run-in Period|Death|0|||
33640039|NCT01517373|63043018|FG003|Run-in Period|Death|0|||
33640040|NCT01517373|63043019|FG004|Run-in Period|Death|0|||
33640041|NCT01517373|63043020|FG005|Run-in Period|Death|0|||
33640042|NCT01517373|63043015|FG000|Run-in Period|Adverse Event|5|||
33640043|NCT01517373|63043016|FG001|Run-in Period|Adverse Event|0|||
33640044|NCT01517373|63043017|FG002|Run-in Period|Adverse Event|0|||
33640045|NCT01517373|63043018|FG003|Run-in Period|Adverse Event|0|||
33640046|NCT01517373|63043019|FG004|Run-in Period|Adverse Event|0|||
33640047|NCT01517373|63043020|FG005|Run-in Period|Adverse Event|0|||
33640048|NCT01517373|63043015|FG000|Run-in Period|Did not meet eligibility criteria|34|||
33640049|NCT01517373|63043016|FG001|Run-in Period|Did not meet eligibility criteria|0|||
33640050|NCT01517373|63043017|FG002|Run-in Period|Did not meet eligibility criteria|0|||
33640051|NCT01517373|63043018|FG003|Run-in Period|Did not meet eligibility criteria|0|||
33640052|NCT01517373|63043019|FG004|Run-in Period|Did not meet eligibility criteria|0|||
33640053|NCT01517373|63043020|FG005|Run-in Period|Did not meet eligibility criteria|0|||
33640054|NCT01517373|63043015|FG000|Run-in Period|Lost to Follow-up|1|||
33640055|NCT01517373|63043016|FG001|Run-in Period|Lost to Follow-up|0|||
33640056|NCT01517373|63043017|FG002|Run-in Period|Lost to Follow-up|0|||
33640057|NCT01517373|63043018|FG003|Run-in Period|Lost to Follow-up|0|||
33640058|NCT01517373|63043019|FG004|Run-in Period|Lost to Follow-up|0|||
33640059|NCT01517373|63043020|FG005|Run-in Period|Lost to Follow-up|0|||
33640060|NCT01517373|63043015|FG000|Run-in Period|Withdrawal by Subject|12|||
33640061|NCT01517373|63043016|FG001|Run-in Period|Withdrawal by Subject|0|||
33640062|NCT01517373|63043017|FG002|Run-in Period|Withdrawal by Subject|0|||
33640063|NCT01517373|63043018|FG003|Run-in Period|Withdrawal by Subject|0|||
33640064|NCT01517373|63043019|FG004|Run-in Period|Withdrawal by Subject|0|||
33640065|NCT01517373|63043020|FG005|Run-in Period|Withdrawal by Subject|0|||
33640066|NCT01517373|63043015|FG000|Run-in Period|Sponsor Decision|3|||
33640067|NCT01517373|63043016|FG001|Run-in Period|Sponsor Decision|0|||
33640068|NCT01517373|63043017|FG002|Run-in Period|Sponsor Decision|0|||
33640069|NCT01517373|63043018|FG003|Run-in Period|Sponsor Decision|0|||
33640070|NCT01517373|63043019|FG004|Run-in Period|Sponsor Decision|0|||
33640071|NCT01517373|63043020|FG005|Run-in Period|Sponsor Decision|0|||
33640072|NCT01517373|63043015|FG000|Run-in Period|Other|1|||
33640073|NCT01517373|63043016|FG001|Run-in Period|Other|0|||
33640074|NCT01517373|63043017|FG002|Run-in Period|Other|0|||
33640075|NCT01517373|63043018|FG003|Run-in Period|Other|0|||
33640076|NCT01517373|63043019|FG004|Run-in Period|Other|0|||
33640077|NCT01517373|63043020|FG005|Run-in Period|Other|0|||
33640078|NCT01517373|63043015|FG000|Treatment Period|Adverse Event|0|||
33640079|NCT01517373|63043016|FG001|Treatment Period|Adverse Event|0|||
33640080|NCT01517373|63043017|FG002|Treatment Period|Adverse Event|0|||
33640081|NCT01517373|63043018|FG003|Treatment Period|Adverse Event|0|||
33640082|NCT01517373|63043019|FG004|Treatment Period|Adverse Event|0|||
33640083|NCT01517373|63043020|FG005|Treatment Period|Adverse Event|2|||
33640084|NCT01517373|63043015|FG000|Treatment Period|Lost to Follow-up|0|||
33640085|NCT01517373|63043016|FG001|Treatment Period|Lost to Follow-up|0|||
33640086|NCT01517373|63043017|FG002|Treatment Period|Lost to Follow-up|1|||
33640087|NCT01517373|63043018|FG003|Treatment Period|Lost to Follow-up|1|||
33640088|NCT01517373|63043019|FG004|Treatment Period|Lost to Follow-up|0|||
33640089|NCT01517373|63043020|FG005|Treatment Period|Lost to Follow-up|0|||
33640090|NCT01517373|63043015|FG000|Treatment Period|Withdrawal by Subject|0|||
33640091|NCT01517373|63043016|FG001|Treatment Period|Withdrawal by Subject|3|||
33640092|NCT01517373|63043017|FG002|Treatment Period|Withdrawal by Subject|2|||
33640093|NCT01517373|63043018|FG003|Treatment Period|Withdrawal by Subject|2|||
33640094|NCT01517373|63043019|FG004|Treatment Period|Withdrawal by Subject|2|||
33640095|NCT01517373|63043020|FG005|Treatment Period|Withdrawal by Subject|3|||
33640096|NCT01517373|63043015|FG000|Treatment Period|Other|0|||
33640097|NCT01517373|63043016|FG001|Treatment Period|Other|0|||
33640098|NCT01517373|63043017|FG002|Treatment Period|Other|0|||
33640099|NCT01517373|63043018|FG003|Treatment Period|Other|0|||
33640100|NCT01517373|63043019|FG004|Treatment Period|Other|1|||
33640101|NCT01517373|63043020|FG005|Treatment Period|Other|0|||
33640102|NCT01517373|63043015|FG000|Treatment Period|Protocol Violation|0|||
33640103|NCT01517373|63043016|FG001|Treatment Period|Protocol Violation|0|||
33640104|NCT01517373|63043017|FG002|Treatment Period|Protocol Violation|0|||
33640105|NCT01517373|63043018|FG003|Treatment Period|Protocol Violation|0|||
33640106|NCT01517373|63043019|FG004|Treatment Period|Protocol Violation|1|||
33640107|NCT01517373|63043020|FG005|Treatment Period|Protocol Violation|0|||
33640108|NCT01517373|63043015|FG000|Treatment Period|Lack of Efficacy|0|||
33640109|NCT01517373|63043016|FG001|Treatment Period|Lack of Efficacy|1|||
33640110|NCT01517373|63043017|FG002|Treatment Period|Lack of Efficacy|1|||
33640111|NCT01517373|63043018|FG003|Treatment Period|Lack of Efficacy|3|||
33640112|NCT01517373|63043019|FG004|Treatment Period|Lack of Efficacy|2|||
33640113|NCT01517373|63043020|FG005|Treatment Period|Lack of Efficacy|0|||
33640114|NCT01517373|63043015|FG000|Treatment Period|Medication error without AEs|0|||
33640115|NCT01517373|63043016|FG001|Treatment Period|Medication error without AEs|0|||
33640116|NCT01517373|63043017|FG002|Treatment Period|Medication error without AEs|2|||
33640117|NCT01517373|63043018|FG003|Treatment Period|Medication error without AEs|1|||
33640118|NCT01517373|63043019|FG004|Treatment Period|Medication error without AEs|0|||
33640119|NCT01517373|63043020|FG005|Treatment Period|Medication error without AEs|2|||
33640120|NCT01517295|63043035|FG000|Overall Study|Physician Decision|1|||
33640121|NCT01517295|63043036|FG001|Overall Study|Physician Decision|0|||
33640122|NCT01541865|63043042|FG000|Overall Study|Lost to Follow-up|11|||
33640123|NCT01541865|63043042|FG000|Overall Study|Withdrawal by Subject|9|||
33640124|NCT01541865|63043042|FG000|Overall Study|Adverse Event|1|||
33640125|NCT01541865|63043042|FG000|Overall Study|Protocol Violation|1|||
33640126|NCT01541397|63043048|FG000|Overall Study|Study ended prior to data collection|4|||
33640127|NCT01541397|63043049|FG001|Overall Study|Study ended prior to data collection|2|||
33640128|NCT01548417|63043057|FG000|Overall Study|Withdrawal by Subject|0|||
33640129|NCT01548417|63043058|FG001|Overall Study|Withdrawal by Subject|2|||
33640130|NCT01546857|63043066|FG000|Overall Study|Withdrawal by Subject|2|||
33640131|NCT01546857|63043067|FG001|Overall Study|Withdrawal by Subject|3|||
33640132|NCT01540851|63043076|FG000|Overall Study|Lost to Follow-up|14|||
33640133|NCT01540851|63043077|FG001|Overall Study|Lost to Follow-up|15|||
33640134|NCT01540851|63043076|FG000|Overall Study|Withdrawal by Subject|7|||
33640135|NCT01540851|63043077|FG001|Overall Study|Withdrawal by Subject|3|||
33640136|NCT01516749|63043085|FG000|Active Therapy|Lost to Follow-up|1|||
33640137|NCT01516749|63043085|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
33640138|NCT01516437|63043093|FG000|Overall Study|Reason not specified|0|||
33640139|NCT01516437|63043094|FG001|Overall Study|Reason not specified|0|||
33640140|NCT01516437|63043095|FG002|Overall Study|Reason not specified|1|||
33640141|NCT01516437|63043096|FG003|Overall Study|Reason not specified|1|||
33640142|NCT01515423|63043110|FG000|Open Label Phase|Adverse Event|57|||
33640143|NCT01515423|63043111|FG001|Open Label Phase|Adverse Event|0|||
33640144|NCT01515423|63043112|FG002|Open Label Phase|Adverse Event|0|||
33640145|NCT01515423|63043110|FG000|Open Label Phase|Death|2|||
33640146|NCT01515423|63043111|FG001|Open Label Phase|Death|0|||
33640147|NCT01515423|63043112|FG002|Open Label Phase|Death|0|||
33640148|NCT01515423|63043110|FG000|Open Label Phase|Lack of Efficacy|117|||
33640149|NCT01515423|63043111|FG001|Open Label Phase|Lack of Efficacy|0|||
33640150|NCT01515423|63043112|FG002|Open Label Phase|Lack of Efficacy|0|||
33640151|NCT01515423|63043110|FG000|Open Label Phase|Lost to Follow-up|21|||
33640152|NCT01515423|63043111|FG001|Open Label Phase|Lost to Follow-up|0|||
33463073|NCT03410992|62836682|FG004|Week 16 Assessment|Incorrect escapers|0|||
33640153|NCT01515423|63043112|FG002|Open Label Phase|Lost to Follow-up|0|||
33640154|NCT01515423|63043110|FG000|Open Label Phase|Withdrawal by Subject|118|||
33463074|NCT03410992|62836683|FG005|Week 16 Assessment|Incorrect escapers|0|||
33542296|NCT02547922|62932990|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
33640155|NCT01515423|63043111|FG001|Open Label Phase|Withdrawal by Subject|0|||
33640156|NCT01515423|63043112|FG002|Open Label Phase|Withdrawal by Subject|0|||
33640157|NCT01515423|63043110|FG000|Open Label Phase|excluded from DB Phase|70|||
33640158|NCT01515423|63043111|FG001|Open Label Phase|excluded from DB Phase|0|||
33640159|NCT01515423|63043112|FG002|Open Label Phase|excluded from DB Phase|0|||
33640160|NCT01515423|63043110|FG000|Open Label Phase|Other|28|||
33640161|NCT01515423|63043111|FG001|Open Label Phase|Other|0|||
33640162|NCT01515423|63043112|FG002|Open Label Phase|Other|0|||
33640163|NCT01515423|63043110|FG000|DOUBLE BLIND|Adverse Event|0|||
33640164|NCT01515423|63043111|FG001|DOUBLE BLIND|Adverse Event|15|||
33640165|NCT01515423|63043112|FG002|DOUBLE BLIND|Adverse Event|13|||
33640166|NCT01515423|63043110|FG000|DOUBLE BLIND|Death|0|||
33640167|NCT01515423|63043111|FG001|DOUBLE BLIND|Death|1|||
33640168|NCT01515423|63043112|FG002|DOUBLE BLIND|Death|2|||
33640169|NCT01515423|63043110|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
33640170|NCT01515423|63043111|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
33640171|NCT01515423|63043112|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
33640172|NCT01515423|63043110|FG000|DOUBLE BLIND|Pregnancy|0|||
33640173|NCT01515423|63043111|FG001|DOUBLE BLIND|Pregnancy|2|||
33640174|NCT01515423|63043112|FG002|DOUBLE BLIND|Pregnancy|0|||
33640175|NCT01515423|63043110|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
33640176|NCT01515423|63043111|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
33640177|NCT01515423|63043112|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
33640178|NCT01515423|63043110|FG000|DOUBLE BLIND|Other|0|||
33640179|NCT01515423|63043111|FG001|DOUBLE BLIND|Other|6|||
33640180|NCT01515423|63043112|FG002|DOUBLE BLIND|Other|12|||
33640181|NCT01515423|63043110|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
33640182|NCT01515423|63043111|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
33640183|NCT01515423|63043112|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
33640184|NCT00637156|63043121|FG000|Overall Study|Withdrawal by Subject|0|||
33640185|NCT00637156|63043122|FG001|Overall Study|Withdrawal by Subject|7|||
33640186|NCT00637156|63043121|FG000|Overall Study|Death|0|||
33640187|NCT00637156|63043122|FG001|Overall Study|Death|1|||
33640188|NCT00637156|63043121|FG000|Overall Study|Lost to Follow-up|10|||
33640189|NCT00637156|63043122|FG001|Overall Study|Lost to Follow-up|16|||
33640190|NCT00637000|63043130|FG000|Overall Study|Withdrawal by Subject|4|||
33640191|NCT00637000|63043131|FG001|Overall Study|Withdrawal by Subject|3|||
33640192|NCT01515189|63043139|FG000|Induction|Disease Progression|109|||
33640193|NCT01515189|63043140|FG001|Induction|Disease Progression|155|||
33640194|NCT01515189|63043139|FG000|Induction|Study drug toxicity|86|||
33640195|NCT01515189|63043140|FG001|Induction|Study drug toxicity|36|||
33640196|NCT01515189|63043139|FG000|Induction|Death|24|||
33640197|NCT01515189|63043140|FG001|Induction|Death|17|||
33640198|NCT01515189|63043139|FG000|Induction|Adverse Event|14|||
33640199|NCT01515189|63043140|FG001|Induction|Adverse Event|9|||
33640200|NCT01515189|63043139|FG000|Induction|Withdrawal by Subject|3|||
33640201|NCT01515189|63043140|FG001|Induction|Withdrawal by Subject|9|||
33640202|NCT01515189|63043139|FG000|Induction|No longer meets study criteria|0|||
33640203|NCT01515189|63043140|FG001|Induction|No longer meets study criteria|2|||
33640204|NCT01515189|63043139|FG000|Induction|Lost to Follow-up|1|||
33640205|NCT01515189|63043140|FG001|Induction|Lost to Follow-up|0|||
33640206|NCT01515189|63043139|FG000|Induction|Other|0|||
33640207|NCT01515189|63043140|FG001|Induction|Other|4|||
33640208|NCT01515189|63043139|FG000|First Re-Induction Phase|Disease progression|6|||
33640209|NCT01515189|63043140|FG001|First Re-Induction Phase|Disease progression|14|||
33640210|NCT01515189|63043139|FG000|First Re-Induction Phase|Study drug toxicity|5|||
33326988|NCT04547140|62703640|FG001|Overall Study|Adverse Event|1|||
33326989|NCT04547140|62703639|FG000|Overall Study|Withdrawal by Subject|0|||
33326990|NCT04547140|62703640|FG001|Overall Study|Withdrawal by Subject|1|||
33326991|NCT04547140|62703639|FG000|Overall Study|Lost to Follow-up|3|||
33326992|NCT04547140|62703640|FG001|Overall Study|Lost to Follow-up|1|||
33326993|NCT04547140|62703639|FG000|Overall Study|Death|2|||
33326994|NCT04547140|62703640|FG001|Overall Study|Death|1|||
33326995|NCT04547140|62703639|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
33326996|NCT04547140|62703640|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
33326997|NCT04547140|62703639|FG000|Overall Study|Pregnancy|1|||
33326998|NCT04547140|62703640|FG001|Overall Study|Pregnancy|0|||
33326999|NCT04547140|62703639|FG000|Overall Study|Reason Not Specified|4|||
33327000|NCT04547140|62703640|FG001|Overall Study|Reason Not Specified|1|||
33327001|NCT01098474|62703652|FG000|Active Phase|Other|0|||
33327002|NCT01098474|62703653|FG001|Active Phase|Other|0|||
33327003|NCT01098474|62703654|FG002|Active Phase|Other|3|||
33327004|NCT01098474|62703655|FG003|Active Phase|Other|0|||
33327005|NCT01098474|62703656|FG004|Active Phase|Other|0|||
33640211|NCT01515189|63043140|FG001|First Re-Induction Phase|Study drug toxicity|0|||
33640212|NCT01515189|63043139|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
33640213|NCT01515189|63043140|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
33640214|NCT01515189|63043139|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
33640215|NCT01515189|63043140|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
33640216|NCT01515189|63043139|FG000|First Re-Induction Phase|Other|1|||
33640217|NCT01515189|63043140|FG001|First Re-Induction Phase|Other|0|||
33640218|NCT01546623|63043148|FG000|Overall Study|Adverse Event|2|||
33640219|NCT01546623|63043149|FG001|Overall Study|Adverse Event|3|||
33640220|NCT01546623|63043148|FG000|Overall Study|Major Protocol Deviation|1|||
33640221|NCT01546623|63043149|FG001|Overall Study|Major Protocol Deviation|1|||
33327006|NCT01098474|62703657|FG005|Active Phase|Other|0|||
33327007|NCT01098474|62703652|FG000|Active Phase|Withdrawal by Subject|1|||
33327008|NCT01098474|62703653|FG001|Active Phase|Withdrawal by Subject|1|||
33327009|NCT01098474|62703654|FG002|Active Phase|Withdrawal by Subject|2|||
33327010|NCT01098474|62703655|FG003|Active Phase|Withdrawal by Subject|0|||
33327011|NCT01098474|62703656|FG004|Active Phase|Withdrawal by Subject|0|||
33327012|NCT01098474|62703657|FG005|Active Phase|Withdrawal by Subject|0|||
33327013|NCT01098474|62703652|FG000|Active Phase|Lost to Follow-up|1|||
33640222|NCT01546623|63043148|FG000|Overall Study|High Prostate specific antigen|2|||
33640223|NCT01546623|63043149|FG001|Overall Study|High Prostate specific antigen|1|||
33640224|NCT01546623|63043148|FG000|Overall Study|Did Not Receive Study Drug|1|||
33640225|NCT01546623|63043149|FG001|Overall Study|Did Not Receive Study Drug|1|||
33640226|NCT01546155|63043155|FG000|Overall Study|could not tolerate long scan duration|3|||
33640227|NCT00636610|63043161|FG000|Overall Study|Adverse Event|4|||
33640228|NCT00636610|63043162|FG001|Overall Study|Adverse Event|4|||
33640229|NCT00636610|63043161|FG000|Overall Study|Death|6|||
33640230|NCT00636610|63043162|FG001|Overall Study|Death|3|||
33640231|NCT00636610|63043161|FG000|Overall Study|Physician decision to withdraw patient|15|||
33640232|NCT00636610|63043162|FG001|Overall Study|Physician decision to withdraw patient|9|||
33640233|NCT00636610|63043161|FG000|Overall Study|Subject decision to withdraw|15|||
33640234|NCT00636610|63043162|FG001|Overall Study|Subject decision to withdraw|11|||
33640235|NCT00636610|63043161|FG000|Overall Study|Disease progression - radiographic|41|||
33640236|NCT00636610|63043162|FG001|Overall Study|Disease progression - radiographic|51|||
33640237|NCT00636610|63043161|FG000|Overall Study|Disease progression - clinical|8|||
33640238|NCT00636610|63043162|FG001|Overall Study|Disease progression - clinical|3|||
33640239|NCT00636610|63043161|FG000|Overall Study|Reason for discontinuation not available|3|||
33640240|NCT00636610|63043162|FG001|Overall Study|Reason for discontinuation not available|2|||
33640241|NCT00635050|63043170|FG000|Overall Study|Withdrawal by Subject|1|||
33640242|NCT00634504|63043179|FG000|Overall Study|Protocol Violation|1|||
33640243|NCT00634504|63043180|FG001|Overall Study|Protocol Violation|0|||
33640244|NCT00634114|63043189|FG000|Overall Study|Adverse Event|6|||
33640245|NCT00634114|63043190|FG001|Overall Study|Adverse Event|8|||
33640246|NCT00634114|63043191|FG002|Overall Study|Adverse Event|3|||
33640247|NCT00634114|63043189|FG000|Overall Study|Withdrawal by Subject|9|||
33640248|NCT00634114|63043190|FG001|Overall Study|Withdrawal by Subject|6|||
33640249|NCT00634114|63043191|FG002|Overall Study|Withdrawal by Subject|11|||
33640250|NCT00634114|63043189|FG000|Overall Study|Lost to Follow-up|0|||
33640251|NCT00634114|63043190|FG001|Overall Study|Lost to Follow-up|0|||
33640252|NCT00634114|63043191|FG002|Overall Study|Lost to Follow-up|1|||
33640253|NCT00634114|63043189|FG000|Overall Study|Protocol Violation|3|||
33640254|NCT00634114|63043190|FG001|Overall Study|Protocol Violation|3|||
33640255|NCT00634114|63043191|FG002|Overall Study|Protocol Violation|1|||
33640256|NCT00634114|63043189|FG000|Overall Study|Pregnancy|1|||
33640257|NCT00634114|63043190|FG001|Overall Study|Pregnancy|0|||
33640258|NCT00634114|63043191|FG002|Overall Study|Pregnancy|0|||
33640259|NCT00634114|63043189|FG000|Overall Study|Incorrect enrolment|0|||
33640260|NCT00634114|63043190|FG001|Overall Study|Incorrect enrolment|1|||
33640261|NCT00634114|63043191|FG002|Overall Study|Incorrect enrolment|0|||
33640262|NCT00634114|63043189|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
33640263|NCT00634114|63043190|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
33640264|NCT00634114|63043191|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
33640265|NCT00634114|63043189|FG000|Overall Study|Difficult to continue|3|||
33640266|NCT00634114|63043190|FG001|Overall Study|Difficult to continue|1|||
33640267|NCT00634114|63043191|FG002|Overall Study|Difficult to continue|1|||
33640268|NCT00634114|63043189|FG000|Overall Study|Other reason|1|||
33640269|NCT00634114|63043190|FG001|Overall Study|Other reason|1|||
33640270|NCT00634114|63043191|FG002|Overall Study|Other reason|1|||
33640271|NCT00634036|63043201|FG000|Overall Study|Lost to Follow-up|1|||
33640272|NCT00634036|63043202|FG001|Overall Study|Lost to Follow-up|1|||
33640273|NCT00634036|63043201|FG000|Overall Study|Withdrawal by Subject|1|||
33640274|NCT00634036|63043202|FG001|Overall Study|Withdrawal by Subject|1|||
33640275|NCT01545375|63043210|FG000|Overall Study|Adverse Event|2|||
33640276|NCT01545375|63043211|FG001|Overall Study|Adverse Event|1|||
33640277|NCT01545375|63043210|FG000|Overall Study|Lost to Follow-up|34|||
33640278|NCT01545375|63043211|FG001|Overall Study|Lost to Follow-up|31|||
33640279|NCT01545375|63043210|FG000|Overall Study|Protocol Violation|3|||
33327014|NCT01098474|62703653|FG001|Active Phase|Lost to Follow-up|0|||
33327015|NCT01098474|62703654|FG002|Active Phase|Lost to Follow-up|0|||
33640280|NCT01545375|63043211|FG001|Overall Study|Protocol Violation|3|||
33640281|NCT01545375|63043210|FG000|Overall Study|Withdrawal by Subject|58|||
33640282|NCT01545375|63043211|FG001|Overall Study|Withdrawal by Subject|55|||
33640283|NCT01539837|63043220|FG000|Overall Study|reduce neutrophil level|0|||
33640284|NCT01539837|63043221|FG001|Overall Study|reduce neutrophil level|1|||
33640285|NCT01539837|63043222|FG002|Overall Study|reduce neutrophil level|1|||
33640286|NCT01539837|63043220|FG000|Overall Study|bad compliance|0|||
33640287|NCT01539837|63043221|FG001|Overall Study|bad compliance|0|||
33640288|NCT01539837|63043222|FG002|Overall Study|bad compliance|1|||
33327016|NCT01098474|62703655|FG003|Active Phase|Lost to Follow-up|0|||
33640289|NCT01539759|63043232|FG000|Overall Study|Lost to Follow-up|6|||
33640290|NCT01539759|63043233|FG001|Overall Study|Lost to Follow-up|8|||
33640291|NCT00633022|63043242|FG000|Overall Study|Adverse Event|1|||
33640292|NCT00633022|63043243|FG001|Overall Study|Adverse Event|0|||
33640293|NCT00633022|63043244|FG002|Overall Study|Adverse Event|5|||
33640294|NCT00633022|63043242|FG000|Overall Study|Physician Decision|0|||
33640295|NCT00633022|63043243|FG001|Overall Study|Physician Decision|1|||
33640296|NCT00633022|63043244|FG002|Overall Study|Physician Decision|0|||
33640297|NCT00630994|63043252|FG000|Overall Study|Adverse Event|1|||
33640298|NCT00630994|63043252|FG000|Overall Study|Disease Progression|1|||
33640299|NCT00630994|63043252|FG000|Overall Study|Lack of Efficacy|1|||
33640300|NCT00630994|63043252|FG000|Overall Study|Other|1|||
33640301|NCT00630838|63043258|FG000|Overall Study|Death|0|||
33640302|NCT00630838|63043259|FG001|Overall Study|Death|1|||
33640303|NCT00630838|63043258|FG000|Overall Study|Lost to Follow-up|0|||
33640304|NCT00630838|63043259|FG001|Overall Study|Lost to Follow-up|1|||
33640305|NCT00630058|63043269|FG000|Overall Study|Adverse Event|1|||
33640306|NCT00630058|63043270|FG001|Overall Study|Adverse Event|1|||
33640307|NCT00630058|63043269|FG000|Overall Study|Withdrawal by Subject|0|||
33640308|NCT00630058|63043270|FG001|Overall Study|Withdrawal by Subject|1|||
33640309|NCT00630058|63043269|FG000|Overall Study|stopping criteria|3|||
33640310|NCT00630058|63043270|FG001|Overall Study|stopping criteria|2|||
33640311|NCT01925794|63043276|FG000|180 Days|Death|2|||
33640312|NCT01925794|63043276|FG000|180 Days|Withdrawal by Subject|2|||
33640313|NCT01925794|63043276|FG000|270 Days|Death|2|||
33640314|NCT01925794|63043276|FG000|270 Days|Protocol Violation|3|||
33640315|NCT00989950|63043288|FG000|Randomized Phase|Protocol Violation|1|||
33640316|NCT00989950|63043289|FG001|Randomized Phase|Protocol Violation|0|||
33640317|NCT00989950|63043290|FG002|Randomized Phase|Protocol Violation|0|||
33640318|NCT00989950|63043291|FG003|Randomized Phase|Protocol Violation|0|||
33640319|NCT00989950|63043288|FG000|Randomized Phase|Adverse Event|0|||
33640320|NCT00989950|63043289|FG001|Randomized Phase|Adverse Event|1|||
33640321|NCT00989950|63043290|FG002|Randomized Phase|Adverse Event|0|||
33640322|NCT00989950|63043291|FG003|Randomized Phase|Adverse Event|0|||
33640323|NCT01905943|63043301|FG000|Overall Study|Withdrawal of consent|90|||
33640324|NCT01905943|63043301|FG000|Overall Study|Lost to Follow-up|16|||
33640325|NCT01905943|63043301|FG000|Overall Study|Investigator discretion|7|||
33640326|NCT01905943|63043301|FG000|Overall Study|Death|186|||
33640327|NCT01905943|63043301|FG000|Overall Study|Adverse Event|3|||
33640328|NCT01905943|63043301|FG000|Overall Study|Other|12|||
33640329|NCT01905553|63043322|FG000|Period 2|Adverse Event|1|||
33640330|NCT01905553|63043323|FG001|Period 2|Adverse Event|0|||
33640331|NCT01929031|63043333|FG000|Overall Study|Adverse Event|3|||
33640332|NCT01929031|63043334|FG001|Overall Study|Adverse Event|1|||
33640333|NCT01929031|63043335|FG002|Overall Study|Adverse Event|1|||
33640334|NCT01929031|63043336|FG003|Overall Study|Adverse Event|0|||
33640335|NCT01929031|63043337|FG004|Overall Study|Adverse Event|0|||
33640336|NCT01929031|63043338|FG005|Overall Study|Adverse Event|0|||
33640337|NCT01929031|63043333|FG000|Overall Study|Protocol Violation|1|||
33640338|NCT01929031|63043334|FG001|Overall Study|Protocol Violation|0|||
33640339|NCT01929031|63043335|FG002|Overall Study|Protocol Violation|0|||
33640340|NCT01929031|63043336|FG003|Overall Study|Protocol Violation|0|||
33640341|NCT01929031|63043337|FG004|Overall Study|Protocol Violation|0|||
33640342|NCT01929031|63043338|FG005|Overall Study|Protocol Violation|1|||
33640343|NCT01929031|63043333|FG000|Overall Study|Reason other than specified above|0|||
33640344|NCT01929031|63043334|FG001|Overall Study|Reason other than specified above|1|||
33640345|NCT01929031|63043335|FG002|Overall Study|Reason other than specified above|0|||
33640346|NCT01929031|63043336|FG003|Overall Study|Reason other than specified above|0|||
33640347|NCT01929031|63043337|FG004|Overall Study|Reason other than specified above|1|||
33327017|NCT01098474|62703656|FG004|Active Phase|Lost to Follow-up|0|||
33463075|NCT03410992|62836684|FG006|Week 16 Assessment|Incorrect escapers|0|||
33463076|NCT03410992|62836685|FG007|Week 16 Assessment|Incorrect escapers|0|||
33463077|NCT03410992|62836686|FG008|Week 16 Assessment|Incorrect escapers|0|||
33463078|NCT03410992|62836687|FG009|Week 16 Assessment|Incorrect escapers|0|||
33463079|NCT03410992|62836688|FG010|Week 16 Assessment|Incorrect escapers|0|||
33463080|NCT03410992|62836678|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33463081|NCT03410992|62836679|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33463082|NCT03410992|62836680|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33640348|NCT01929031|63043338|FG005|Overall Study|Reason other than specified above|0|||
33640349|NCT00989092|63043350|FG000|Overall Study|Physician Decision|9|||
33640350|NCT00989092|63043351|FG001|Overall Study|Physician Decision|6|||
33640351|NCT00989092|63043350|FG000|Overall Study|Adverse Event|20|||
33640352|NCT00989092|63043351|FG001|Overall Study|Adverse Event|1|||
33640353|NCT00989092|63043350|FG000|Overall Study|Chemotherapy initiated|12|||
33640354|NCT00989092|63043351|FG001|Overall Study|Chemotherapy initiated|4|||
33640355|NCT00989092|63043350|FG000|Overall Study|Withdrawal by Subject|17|||
33640356|NCT00989092|63043351|FG001|Overall Study|Withdrawal by Subject|9|||
33640357|NCT00989092|63043350|FG000|Overall Study|Death|14|||
33640358|NCT00989092|63043351|FG001|Overall Study|Death|2|||
33640359|NCT00989092|63043350|FG000|Overall Study|Ineligibility determined|3|||
33640360|NCT00989092|63043351|FG001|Overall Study|Ineligibility determined|3|||
33640361|NCT00989092|63043350|FG000|Overall Study|Lost to Follow-up|6|||
33640362|NCT00989092|63043351|FG001|Overall Study|Lost to Follow-up|2|||
33640363|NCT00989092|63043350|FG000|Overall Study|Other|3|||
33640364|NCT00989092|63043351|FG001|Overall Study|Other|1|||
33640365|NCT00989092|63043350|FG000|Overall Study|Protocol deviation|2|||
33640366|NCT00989092|63043351|FG001|Overall Study|Protocol deviation|0|||
33640367|NCT00989092|63043350|FG000|Overall Study|Erythropoietin therapy initiated|2|||
33640368|NCT00989092|63043351|FG001|Overall Study|Erythropoietin therapy initiated|0|||
33640369|NCT00989092|63043350|FG000|Overall Study|Did not receive study drug|2|||
33640370|NCT00989092|63043351|FG001|Overall Study|Did not receive study drug|0|||
33640371|NCT00988858|63043358|FG000|Overall Study|Adverse Event|7|||
33640372|NCT00988858|63043358|FG000|Overall Study|Death|1|||
33640373|NCT00988858|63043358|FG000|Overall Study|Physician Decision|1|||
33640374|NCT00988858|63043358|FG000|Overall Study|Sponsor Decision|1|||
33640375|NCT00986986|63043364|FG000|Overall Study|Lost to Follow-up|0|||
33640376|NCT00986986|63043365|FG001|Overall Study|Lost to Follow-up|1|||
33640377|NCT01904773|63043372|FG000|Screen|Screen failure|3|||
33640378|NCT01904773|63043373|FG001|Screen|Screen failure|0|||
33640379|NCT01904773|63043374|FG002|Screen|Screen failure|0|||
33640380|NCT01904773|63043375|FG003|Screen|Screen failure|0|||
33640381|NCT01904773|63043376|FG004|Screen|Screen failure|0|||
33640382|NCT01904773|63043377|FG005|Screen|Screen failure|0|||
33640383|NCT01904773|63043378|FG006|Screen|Screen failure|0|||
33640384|NCT01904773|63043379|FG007|Screen|Screen failure|0|||
33640385|NCT01904773|63043380|FG008|Screen|Screen failure|0|||
33640386|NCT01904773|63043372|FG000|Screen|Withdrawal by Subject|1|||
33640387|NCT01904773|63043373|FG001|Screen|Withdrawal by Subject|0|||
33640388|NCT01904773|63043374|FG002|Screen|Withdrawal by Subject|0|||
33640389|NCT01904773|63043375|FG003|Screen|Withdrawal by Subject|0|||
33640390|NCT01904773|63043376|FG004|Screen|Withdrawal by Subject|0|||
33640391|NCT01904773|63043377|FG005|Screen|Withdrawal by Subject|0|||
33640392|NCT01904773|63043378|FG006|Screen|Withdrawal by Subject|0|||
33640393|NCT01904773|63043379|FG007|Screen|Withdrawal by Subject|0|||
33640394|NCT01904773|63043380|FG008|Screen|Withdrawal by Subject|0|||
33640395|NCT01904773|63043372|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
33640396|NCT01904773|63043373|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33640397|NCT01904773|63043374|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33640398|NCT01904773|63043375|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33640399|NCT01904773|63043376|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33640400|NCT01904773|63043377|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33640401|NCT01904773|63043378|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33640402|NCT01904773|63043379|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33640403|NCT01904773|63043380|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33640404|NCT01904773|63043372|FG000|First Intervention|Adverse Event|0|||
33640405|NCT01904773|63043373|FG001|First Intervention|Adverse Event|0|||
33640406|NCT01904773|63043374|FG002|First Intervention|Adverse Event|0|||
33327018|NCT01098474|62703657|FG005|Active Phase|Lost to Follow-up|0|||
33327019|NCT01098474|62703652|FG000|Follow Up Phase|Travelled out of study area|0|||
33327020|NCT01098474|62703653|FG001|Follow Up Phase|Travelled out of study area|0|||
33327021|NCT01098474|62703654|FG002|Follow Up Phase|Travelled out of study area|0|||
33327022|NCT01098474|62703655|FG003|Follow Up Phase|Travelled out of study area|0|||
33327023|NCT01098474|62703656|FG004|Follow Up Phase|Travelled out of study area|1|||
33327024|NCT01098474|62703657|FG005|Follow Up Phase|Travelled out of study area|0|||
33327025|NCT01098474|62703652|FG000|Follow Up Phase|Other|0|||
33542297|NCT02547922|62932991|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
33542298|NCT02547922|62932992|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
33542299|NCT02547922|62932990|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
33542300|NCT02547922|62932991|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
33542301|NCT02547922|62932992|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
33542302|NCT02547922|62932990|FG000|Overall Study|Physician Decision|2|||
33542303|NCT02547922|62932991|FG001|Overall Study|Physician Decision|1|||
33542304|NCT02547922|62932992|FG002|Overall Study|Physician Decision|2|||
33542305|NCT02547922|62932990|FG000|Overall Study|Patients did not receive IP|1|||
33542306|NCT02547922|62932991|FG001|Overall Study|Patients did not receive IP|1|||
33542307|NCT02547922|62932992|FG002|Overall Study|Patients did not receive IP|0|||
33542308|NCT02547766|62933006|FG000|Overall Study|Withdrawal by Subject|1|||
33542309|NCT02742441|62933019|FG000|Overall Study|Lost to Follow-up|4|||
33542310|NCT02742441|62933020|FG001|Overall Study|Lost to Follow-up|4|||
33542311|NCT02742441|62933019|FG000|Overall Study|Withdrawal by Subject|2|||
33542312|NCT02742441|62933020|FG001|Overall Study|Withdrawal by Subject|2|||
33542313|NCT02742441|62933019|FG000|Overall Study|Adverse Event|0|||
33542314|NCT02742441|62933020|FG001|Overall Study|Adverse Event|2|||
33542315|NCT02547220|62933028|FG000|Overall Study|Withdrawal by Subject|1|||
33542316|NCT02547220|62933029|FG001|Overall Study|Withdrawal by Subject|0|||
33640407|NCT01904773|63043375|FG003|First Intervention|Adverse Event|0|||
33640408|NCT01904773|63043376|FG004|First Intervention|Adverse Event|0|||
33640409|NCT01904773|63043377|FG005|First Intervention|Adverse Event|0|||
33640410|NCT01904773|63043378|FG006|First Intervention|Adverse Event|1|||
33640411|NCT01904773|63043379|FG007|First Intervention|Adverse Event|0|||
33640412|NCT01904773|63043380|FG008|First Intervention|Adverse Event|0|||
33640413|NCT01904773|63043372|FG000|Placebo Washout First Intervention|Condition worsened|0|||
33640414|NCT01904773|63043373|FG001|Placebo Washout First Intervention|Condition worsened|1|||
33640415|NCT01904773|63043374|FG002|Placebo Washout First Intervention|Condition worsened|0|||
33640416|NCT01904773|63043375|FG003|Placebo Washout First Intervention|Condition worsened|0|||
33640417|NCT01904773|63043376|FG004|Placebo Washout First Intervention|Condition worsened|0|||
33640418|NCT01904773|63043377|FG005|Placebo Washout First Intervention|Condition worsened|0|||
33640419|NCT01904773|63043378|FG006|Placebo Washout First Intervention|Condition worsened|0|||
33640420|NCT01904773|63043379|FG007|Placebo Washout First Intervention|Condition worsened|0|||
33640421|NCT01904773|63043380|FG008|Placebo Washout First Intervention|Condition worsened|0|||
33640422|NCT01904773|63043372|FG000|Fifth Intervention|Adverse Event|0|||
33640423|NCT01904773|63043373|FG001|Fifth Intervention|Adverse Event|0|||
33640424|NCT01904773|63043374|FG002|Fifth Intervention|Adverse Event|0|||
33640425|NCT01904773|63043375|FG003|Fifth Intervention|Adverse Event|0|||
33640426|NCT01904773|63043376|FG004|Fifth Intervention|Adverse Event|0|||
33640427|NCT01904773|63043377|FG005|Fifth Intervention|Adverse Event|0|||
33640428|NCT01904773|63043378|FG006|Fifth Intervention|Adverse Event|0|||
33640429|NCT01904773|63043379|FG007|Fifth Intervention|Adverse Event|1|||
33640430|NCT01904773|63043380|FG008|Fifth Intervention|Adverse Event|0|||
33640431|NCT01904773|63043372|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33640432|NCT01904773|63043373|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
33640433|NCT01904773|63043374|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33640434|NCT01904773|63043375|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33640435|NCT01904773|63043376|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33640436|NCT01904773|63043377|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33640437|NCT01904773|63043378|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33640438|NCT01904773|63043379|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33640439|NCT01904773|63043380|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33640440|NCT01928719|63043394|FG000|Overall Study|Lost to Follow-up|26|||
33640441|NCT01928719|63043395|FG001|Overall Study|Lost to Follow-up|11|||
33640442|NCT01928719|63043394|FG000|Overall Study|Withdrawal by Subject|22|||
33640443|NCT01928719|63043395|FG001|Overall Study|Withdrawal by Subject|7|||
33640444|NCT01928719|63043394|FG000|Overall Study|Protocol Violation|3|||
33640445|NCT01928719|63043395|FG001|Overall Study|Protocol Violation|1|||
33640446|NCT01928719|63043394|FG000|Overall Study|Adverse Event|1|||
33640447|NCT01928719|63043395|FG001|Overall Study|Adverse Event|0|||
33640448|NCT00986674|63043406|FG000|Overall Study|Lack of Efficacy|28|||
33640449|NCT00986674|63043407|FG001|Overall Study|Lack of Efficacy|25|||
33640450|NCT00986674|63043408|FG002|Overall Study|Lack of Efficacy|23|||
33640451|NCT00986674|63043406|FG000|Overall Study|Adverse Event|4|||
33640452|NCT00986674|63043407|FG001|Overall Study|Adverse Event|8|||
33640453|NCT00986674|63043408|FG002|Overall Study|Adverse Event|9|||
33640454|NCT00986674|63043406|FG000|Overall Study|Death|5|||
33463083|NCT03410992|62836681|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
33463084|NCT03410992|62836682|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
33463085|NCT03410992|62836683|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33463086|NCT03410992|62836684|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33463087|NCT03410992|62836685|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33640455|NCT00986674|63043407|FG001|Overall Study|Death|0|||
33542317|NCT02547220|62933028|FG000|Overall Study|Study terminated by sponsor|18|||
33542318|NCT02547220|62933029|FG001|Overall Study|Study terminated by sponsor|20|||
33542319|NCT02542072|62933037|FG000|First Intervention (1 Month)|Adverse Event|1|||
33542320|NCT02542072|62933038|FG001|First Intervention (1 Month)|Adverse Event|1|||
33542321|NCT02542072|62933037|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
33640456|NCT00986674|63043408|FG002|Overall Study|Death|4|||
33640457|NCT00986674|63043406|FG000|Overall Study|Withdrawal by Subject|6|||
33463088|NCT03410992|62836686|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33463089|NCT03410992|62836687|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33463090|NCT03410992|62836688|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33463091|NCT03410992|62836678|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33463092|NCT03410992|62836679|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33640458|NCT00986674|63043407|FG001|Overall Study|Withdrawal by Subject|2|||
33640459|NCT00986674|63043408|FG002|Overall Study|Withdrawal by Subject|1|||
33640460|NCT00986674|63043406|FG000|Overall Study|alternative therapy|0|||
33640461|NCT00986674|63043407|FG001|Overall Study|alternative therapy|0|||
33640462|NCT00986674|63043408|FG002|Overall Study|alternative therapy|1|||
33640463|NCT00986674|63043406|FG000|Overall Study|not start protocol therapy|4|||
33542322|NCT02542072|62933038|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
33542323|NCT02542072|62933037|FG000|First Intervention (1 Month)|Lens discomfort|1|||
33542324|NCT02542072|62933038|FG001|First Intervention (1 Month)|Lens discomfort|2|||
33542325|NCT02542072|62933037|FG000|First Intervention (1 Month)|Protocol Violation|1|||
33542326|NCT02542072|62933038|FG001|First Intervention (1 Month)|Protocol Violation|0|||
33542327|NCT02542072|62933037|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
33640464|NCT00986674|63043407|FG001|Overall Study|not start protocol therapy|3|||
33640465|NCT00986674|63043408|FG002|Overall Study|not start protocol therapy|1|||
33640466|NCT00986674|63043406|FG000|Overall Study|unknown/not specify|0|||
33640467|NCT00986674|63043407|FG001|Overall Study|unknown/not specify|7|||
33640468|NCT00986674|63043408|FG002|Overall Study|unknown/not specify|9|||
33640469|NCT00986440|63043418|FG000|Overall Study|Progressive disease|27|||
33640470|NCT00986440|63043419|FG001|Overall Study|Progressive disease|37|||
33640471|NCT00986440|63043418|FG000|Overall Study|Serious adverse event or adverse event|9|||
33640472|NCT00986440|63043419|FG001|Overall Study|Serious adverse event or adverse event|2|||
33640473|NCT00986440|63043418|FG000|Overall Study|Withdrawal by Subject|1|||
33640474|NCT00986440|63043419|FG001|Overall Study|Withdrawal by Subject|2|||
33640475|NCT00986440|63043418|FG000|Overall Study|Screen failure (not dosed)|4|||
33640476|NCT00986440|63043419|FG001|Overall Study|Screen failure (not dosed)|2|||
33640477|NCT01904383|63043425|FG000|Overall Study|CRF not collected|117|||
33640478|NCT01904383|63043425|FG000|Overall Study|Reason not listed|147|||
33640479|NCT01904383|63043425|FG000|Overall Study|Lost to Follow-up|674|||
33640480|NCT01904383|63043425|FG000|Overall Study|Lack of Efficacy|370|||
33640481|NCT01904383|63043425|FG000|Overall Study|Improvement|141|||
33640482|NCT01904383|63043425|FG000|Overall Study|Adverse Event|271|||
33640483|NCT01904383|63043425|FG000|Overall Study|No patient visit after entry|54|||
33640484|NCT01904149|63043435|FG000|Overall Study|Adverse Event|3|||
33640485|NCT01904149|63043436|FG001|Overall Study|Adverse Event|4|||
33640486|NCT01904149|63043437|FG002|Overall Study|Adverse Event|0|||
33640487|NCT01904149|63043438|FG003|Overall Study|Adverse Event|1|||
33640488|NCT01904149|63043439|FG004|Overall Study|Adverse Event|1|||
33640489|NCT01904149|63043440|FG005|Overall Study|Adverse Event|2|||
33640490|NCT01904149|63043435|FG000|Overall Study|Lack of Efficacy|0|||
33640491|NCT01904149|63043436|FG001|Overall Study|Lack of Efficacy|3|||
33640492|NCT01904149|63043437|FG002|Overall Study|Lack of Efficacy|1|||
33640493|NCT01904149|63043438|FG003|Overall Study|Lack of Efficacy|3|||
33640494|NCT01904149|63043439|FG004|Overall Study|Lack of Efficacy|3|||
33640495|NCT01904149|63043440|FG005|Overall Study|Lack of Efficacy|1|||
33640496|NCT01904149|63043435|FG000|Overall Study|Withdrawal by Subject|1|||
33640497|NCT01904149|63043436|FG001|Overall Study|Withdrawal by Subject|3|||
33640498|NCT01904149|63043437|FG002|Overall Study|Withdrawal by Subject|1|||
33640499|NCT01904149|63043438|FG003|Overall Study|Withdrawal by Subject|0|||
33640500|NCT01904149|63043439|FG004|Overall Study|Withdrawal by Subject|1|||
33640501|NCT01904149|63043440|FG005|Overall Study|Withdrawal by Subject|0|||
33640502|NCT01904149|63043435|FG000|Overall Study|Protocol Violation|0|||
33640503|NCT01904149|63043436|FG001|Overall Study|Protocol Violation|1|||
33640504|NCT01904149|63043437|FG002|Overall Study|Protocol Violation|0|||
33640505|NCT01904149|63043438|FG003|Overall Study|Protocol Violation|0|||
33640506|NCT01904149|63043439|FG004|Overall Study|Protocol Violation|0|||
33640507|NCT01904149|63043440|FG005|Overall Study|Protocol Violation|0|||
33640508|NCT01904149|63043435|FG000|Overall Study|non compliance with study drug|1|||
33640509|NCT01904149|63043436|FG001|Overall Study|non compliance with study drug|0|||
33640510|NCT01904149|63043437|FG002|Overall Study|non compliance with study drug|0|||
33640511|NCT01904149|63043438|FG003|Overall Study|non compliance with study drug|0|||
33640512|NCT01904149|63043439|FG004|Overall Study|non compliance with study drug|0|||
33463093|NCT03410992|62836680|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33463094|NCT03410992|62836681|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
33463095|NCT03410992|62836682|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
33463096|NCT03410992|62836683|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
33463097|NCT03410992|62836684|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33463098|NCT03410992|62836685|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33463099|NCT03410992|62836686|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33463100|NCT03410992|62836687|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33463101|NCT03410992|62836688|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33542328|NCT02542072|62933038|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
33542329|NCT02542072|62933037|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
33640513|NCT01904149|63043440|FG005|Overall Study|non compliance with study drug|0|||
33640514|NCT00986362|63043458|FG000|Overall Study|Death|2|||
33640515|NCT00986362|63043459|FG001|Overall Study|Death|0|||
33640516|NCT00986362|63043458|FG000|Overall Study|Lost to Follow-up|0|||
33640517|NCT00986362|63043459|FG001|Overall Study|Lost to Follow-up|1|||
33640518|NCT01890421|63043465|FG000|Overall Study|Adverse Event|1|||
33640519|NCT01890421|63043465|FG000|Overall Study|Other reason|10|||
33640520|NCT00985738|63043471|FG000|Overall Study|Study closed prematurely|8|||
33640521|NCT00985738|63043472|FG001|Overall Study|Study closed prematurely|8|||
33327026|NCT01098474|62703653|FG001|Follow Up Phase|Other|0|||
33327027|NCT01098474|62703654|FG002|Follow Up Phase|Other|0|||
33327028|NCT01098474|62703655|FG003|Follow Up Phase|Other|0|||
33327029|NCT01098474|62703656|FG004|Follow Up Phase|Other|0|||
33640522|NCT01928485|63043480|FG000|Overall Study|Physician Decision|0|||
33640523|NCT01928485|63043481|FG001|Overall Study|Physician Decision|1|||
33640524|NCT00985504|63043489|FG000|Acute Treatment Period|Adverse Event|3|||
33640525|NCT00985504|63043490|FG001|Acute Treatment Period|Adverse Event|4|||
33640526|NCT00985504|63043489|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
33640527|NCT00985504|63043490|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
33640528|NCT00985504|63043489|FG000|Acute Treatment Period|Protocol Violation|2|||
33640529|NCT00985504|63043490|FG001|Acute Treatment Period|Protocol Violation|0|||
33640530|NCT00985504|63043489|FG000|Acute Treatment Period|Sponsor Decision|0|||
33640531|NCT00985504|63043490|FG001|Acute Treatment Period|Sponsor Decision|1|||
33640532|NCT00985504|63043489|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
33640533|NCT00985504|63043490|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
33640534|NCT00985504|63043489|FG000|Optimization Period|Adverse Event|7|||
33640535|NCT00985504|63043490|FG001|Optimization Period|Adverse Event|9|||
33542330|NCT02542072|62933038|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
33542331|NCT02547454|62933064|FG000|Overall Study|Due to hemodialysis|53|||
33542332|NCT02547454|62933064|FG000|Overall Study|Due to transplantation|1|||
33542333|NCT02547454|62933064|FG000|Overall Study|Due to no further need to treat|4|||
33542334|NCT02547454|62933064|FG000|Overall Study|Death|38|||
33542335|NCT02547454|62933064|FG000|Overall Study|Lost to Follow-up|26|||
33542336|NCT02547454|62933064|FG000|Overall Study|Other|39|||
33542337|NCT02547454|62933064|FG000|Overall Study|No data|11|||
33542338|NCT00415623|62933070|FG000|Overall Study|Adverse Event|3|||
33542339|NCT00415623|62933071|FG001|Overall Study|Adverse Event|4|||
33542340|NCT00415623|62933070|FG000|Overall Study|Death|1|||
33542341|NCT00415623|62933071|FG001|Overall Study|Death|0|||
33542342|NCT00415623|62933070|FG000|Overall Study|Withdrawal by Subject|1|||
33542343|NCT00415623|62933071|FG001|Overall Study|Withdrawal by Subject|1|||
33542344|NCT01969409|62933080|FG000|Overall Study|Death|2|||
33542345|NCT01969409|62933081|FG001|Overall Study|Death|2|||
33542346|NCT01969409|62933080|FG000|Overall Study|Transplant|1|||
33542347|NCT01969409|62933081|FG001|Overall Study|Transplant|1|||
33542348|NCT01969409|62933080|FG000|Overall Study|Withdrawal by Subject|0|||
33640536|NCT00985504|63043489|FG000|Optimization Period|Death|0|||
33640537|NCT00985504|63043490|FG001|Optimization Period|Death|1|||
33640538|NCT00985504|63043489|FG000|Optimization Period|Lack of Efficacy|5|||
33640539|NCT00985504|63043490|FG001|Optimization Period|Lack of Efficacy|3|||
33327030|NCT01098474|62703657|FG005|Follow Up Phase|Other|4|||
33327031|NCT01098474|62703652|FG000|Follow Up Phase|Withdrawal by Subject|0|||
33327032|NCT01098474|62703653|FG001|Follow Up Phase|Withdrawal by Subject|0|||
33327033|NCT01098474|62703654|FG002|Follow Up Phase|Withdrawal by Subject|0|||
33327034|NCT01098474|62703655|FG003|Follow Up Phase|Withdrawal by Subject|2|||
33327035|NCT01098474|62703656|FG004|Follow Up Phase|Withdrawal by Subject|0|||
33327036|NCT01098474|62703657|FG005|Follow Up Phase|Withdrawal by Subject|1|||
33327037|NCT01098474|62703652|FG000|Follow Up Phase|Lost to Follow-up|0|||
33327038|NCT01098474|62703653|FG001|Follow Up Phase|Lost to Follow-up|0|||
33327039|NCT01098474|62703654|FG002|Follow Up Phase|Lost to Follow-up|0|||
33327040|NCT01098474|62703655|FG003|Follow Up Phase|Lost to Follow-up|0|||
33327041|NCT01098474|62703656|FG004|Follow Up Phase|Lost to Follow-up|1|||
33327042|NCT01098474|62703657|FG005|Follow Up Phase|Lost to Follow-up|0|||
33463102|NCT03410992|62836678|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33463103|NCT03410992|62836679|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33463104|NCT03410992|62836680|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33463105|NCT03410992|62836681|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33463106|NCT03410992|62836682|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33463107|NCT03410992|62836683|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
33463108|NCT03410992|62836684|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33463109|NCT03410992|62836685|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33463110|NCT03410992|62836686|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33463111|NCT03410992|62836687|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33463112|NCT03410992|62836688|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33463113|NCT03410992|62836678|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33542349|NCT01969409|62933081|FG001|Overall Study|Withdrawal by Subject|1|||
33542350|NCT00150813|62933087|FG000|Overall Study|Adverse Event|1|||
33542351|NCT00150813|62933087|FG000|Overall Study|Lack of Efficacy|1|||
33542352|NCT00150813|62933087|FG000|Overall Study|Lost to Follow-up|5|||
33542353|NCT00150813|62933087|FG000|Overall Study|Withdrawal by Subject|5|||
33640540|NCT00985504|63043489|FG000|Optimization Period|Lost to Follow-up|0|||
33327044|NCT00876733|62703689|FG000|Overall Study|Adverse Event|34|||
33640541|NCT00985504|63043490|FG001|Optimization Period|Lost to Follow-up|1|||
33640542|NCT00985504|63043489|FG000|Optimization Period|Physician Decision|1|||
33640543|NCT00985504|63043490|FG001|Optimization Period|Physician Decision|0|||
33542354|NCT00150813|62933087|FG000|Overall Study|Remission|3|||
33542355|NCT00150813|62933087|FG000|Overall Study|Planned pregancy|1|||
33542356|NCT00150813|62933087|FG000|Overall Study|Switch to commercially available LEV|2|||
33542357|NCT02712788|62933093|FG000|Overall Study|Physician Decision|1|||
33542358|NCT02712788|62933094|FG001|Overall Study|Physician Decision|0|||
33640544|NCT00985504|63043489|FG000|Optimization Period|Protocol Violation|3|||
33640545|NCT00985504|63043490|FG001|Optimization Period|Protocol Violation|1|||
33640546|NCT00985504|63043489|FG000|Optimization Period|Withdrawal by Subject|10|||
33640547|NCT00985504|63043490|FG001|Optimization Period|Withdrawal by Subject|8|||
33640548|NCT00985426|63043498|FG000|Overall Study|Adverse Event|0|||
33640549|NCT00985426|63043499|FG001|Overall Study|Adverse Event|1|||
33640550|NCT00985426|63043498|FG000|Overall Study|Subject Non-Compliance|3|||
33640551|NCT00985426|63043499|FG001|Overall Study|Subject Non-Compliance|3|||
33640552|NCT00985426|63043498|FG000|Overall Study|Withdrawal by Subject|12|||
33640553|NCT00985426|63043499|FG001|Overall Study|Withdrawal by Subject|16|||
33640554|NCT00985426|63043498|FG000|Overall Study|Lost to Follow-up|8|||
33640555|NCT00985426|63043499|FG001|Overall Study|Lost to Follow-up|10|||
33640556|NCT00985426|63043498|FG000|Overall Study|Death|7|||
33640557|NCT00985426|63043499|FG001|Overall Study|Death|3|||
33640558|NCT00985426|63043498|FG000|Overall Study|Protocol Violation|2|||
33640559|NCT00985426|63043499|FG001|Overall Study|Protocol Violation|0|||
33640560|NCT00985426|63043498|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
33640561|NCT00985426|63043499|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
33640562|NCT00985192|63043505|FG000|Overall Study|Withdrawal by Subject|1|||
33640563|NCT00985192|63043505|FG000|Overall Study|Disease Progression|1|||
33640564|NCT00985192|63043505|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
33640565|NCT00985114|63043511|FG000|Overall Study|Adverse Event|1|||
33640566|NCT00985114|63043512|FG001|Overall Study|Adverse Event|0|||
33640567|NCT00985114|63043511|FG000|Overall Study|Withdrawal by Subject|0|||
33542359|NCT02712788|62933093|FG000|Overall Study|Protocol Violation|1|||
33542360|NCT02712788|62933094|FG001|Overall Study|Protocol Violation|0|||
33542361|NCT02308111|62933102|FG000|Overall Study|Adverse Event|31|||
33640568|NCT00985114|63043512|FG001|Overall Study|Withdrawal by Subject|2|||
33640569|NCT00984568|63043520|FG000|Overall Study|Withdrawal by Subject|1|||
33640570|NCT00984568|63043521|FG001|Overall Study|Withdrawal by Subject|2|||
33640571|NCT00984568|63043520|FG000|Overall Study|Lack of Efficacy|2|||
33640572|NCT00984568|63043521|FG001|Overall Study|Lack of Efficacy|0|||
33640573|NCT00984568|63043520|FG000|Overall Study|Adverse Event|2|||
33640574|NCT00984568|63043521|FG001|Overall Study|Adverse Event|0|||
33640575|NCT00984568|63043520|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
33640576|NCT00984568|63043521|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
33640577|NCT00984568|63043520|FG000|Overall Study|Lost to Follow-up|0|||
33640578|NCT00984568|63043521|FG001|Overall Study|Lost to Follow-up|1|||
33640579|NCT00984568|63043520|FG000|Overall Study|Opportunistic Infection|1|||
33640580|NCT00984568|63043521|FG001|Overall Study|Opportunistic Infection|0|||
33640581|NCT00984568|63043520|FG000|Overall Study|Unknown Reason|1|||
33640582|NCT00984568|63043521|FG001|Overall Study|Unknown Reason|3|||
33640583|NCT00984256|63043529|FG000|Overall Study|Withdrawal by Subject|0|||
33542362|NCT02308111|62933103|FG001|Overall Study|Adverse Event|19|||
33640584|NCT00984256|63043530|FG001|Overall Study|Withdrawal by Subject|1|||
33640585|NCT00984022|63043547|FG000|Overall Study|Lost to Follow-up|10|||
33640586|NCT00984022|63043548|FG001|Overall Study|Lost to Follow-up|14|||
33640587|NCT01890265|63043560|FG000|Overall Study|Other (Unspecified reason)|0|||
33640588|NCT01890265|63043561|FG001|Overall Study|Other (Unspecified reason)|1|||
33640589|NCT01890265|63043562|FG002|Overall Study|Other (Unspecified reason)|0|||
33640590|NCT01890265|63043563|FG003|Overall Study|Other (Unspecified reason)|0|||
33640591|NCT01890265|63043564|FG004|Overall Study|Other (Unspecified reason)|0|||
33640592|NCT01890265|63043565|FG005|Overall Study|Other (Unspecified reason)|0|||
33640593|NCT01890265|63043560|FG000|Overall Study|Progressive disease|6|||
33640594|NCT01890265|63043561|FG001|Overall Study|Progressive disease|6|||
33640595|NCT01890265|63043562|FG002|Overall Study|Progressive disease|0|||
33640596|NCT01890265|63043563|FG003|Overall Study|Progressive disease|0|||
33542363|NCT02308111|62933102|FG000|Overall Study|Death|9|||
33542364|NCT02308111|62933103|FG001|Overall Study|Death|6|||
33542365|NCT02308111|62933102|FG000|Overall Study|Lost to Follow-up|2|||
33542366|NCT02308111|62933103|FG001|Overall Study|Lost to Follow-up|7|||
33640597|NCT01890265|63043564|FG004|Overall Study|Progressive disease|0|||
33640598|NCT01890265|63043565|FG005|Overall Study|Progressive disease|0|||
33640599|NCT01890265|63043560|FG000|Overall Study|Adverse Event|2|||
33640600|NCT01890265|63043561|FG001|Overall Study|Adverse Event|1|||
33640601|NCT01890265|63043562|FG002|Overall Study|Adverse Event|0|||
33640602|NCT01890265|63043563|FG003|Overall Study|Adverse Event|0|||
33640603|NCT01890265|63043564|FG004|Overall Study|Adverse Event|0|||
33640604|NCT01890265|63043565|FG005|Overall Study|Adverse Event|0|||
33640605|NCT01890265|63043560|FG000|Overall Study|Death|2|||
33640606|NCT01890265|63043561|FG001|Overall Study|Death|3|||
33640607|NCT01890265|63043562|FG002|Overall Study|Death|1|||
33542367|NCT02308111|62933102|FG000|Overall Study|Physician Decision|6|||
33640608|NCT01890265|63043563|FG003|Overall Study|Death|0|||
33542368|NCT02308111|62933103|FG001|Overall Study|Physician Decision|17|||
33542369|NCT02308111|62933102|FG000|Overall Study|Protocol Violation|0|||
33542370|NCT02308111|62933103|FG001|Overall Study|Protocol Violation|1|||
33542371|NCT02308111|62933102|FG000|Overall Study|Withdrawal by Subject|28|||
33640609|NCT01890265|63043564|FG004|Overall Study|Death|0|||
33640610|NCT01890265|63043565|FG005|Overall Study|Death|0|||
33640611|NCT01890265|63043560|FG000|Overall Study|Withdrawal by Subject|0|||
33640612|NCT01890265|63043561|FG001|Overall Study|Withdrawal by Subject|2|||
33640613|NCT01890265|63043562|FG002|Overall Study|Withdrawal by Subject|3|||
33640614|NCT01890265|63043563|FG003|Overall Study|Withdrawal by Subject|0|||
33640615|NCT01890265|63043564|FG004|Overall Study|Withdrawal by Subject|2|||
33640616|NCT01890265|63043565|FG005|Overall Study|Withdrawal by Subject|0|||
33640617|NCT01928329|63043586|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
33640618|NCT01928329|63043587|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
33542372|NCT02308111|62933103|FG001|Overall Study|Withdrawal by Subject|38|||
33542373|NCT02308111|62933102|FG000|Overall Study|Study Terminated by Sponsor|72|||
33542374|NCT02308111|62933103|FG001|Overall Study|Study Terminated by Sponsor|61|||
33542375|NCT02308111|62933102|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
33542376|NCT02308111|62933103|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
33542377|NCT02308111|62933102|FG000|Overall Study|Site Closure|3|||
33542378|NCT02308111|62933103|FG001|Overall Study|Site Closure|3|||
33542379|NCT02308111|62933102|FG000|Overall Study|Non-compliance with Study Drug|3|||
33542380|NCT02308111|62933103|FG001|Overall Study|Non-compliance with Study Drug|1|||
33542381|NCT02308111|62933102|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
33542382|NCT02308111|62933103|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
33542383|NCT02308111|62933102|FG000|Overall Study|Liver Transplant|3|||
33542384|NCT02308111|62933103|FG001|Overall Study|Liver Transplant|3|||
33542385|NCT02308111|62933102|FG000|Overall Study|Liver Transplant Waitlist|2|||
33542386|NCT02308111|62933103|FG001|Overall Study|Liver Transplant Waitlist|2|||
33542387|NCT02308111|62933102|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
33542388|NCT02308111|62933103|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
33542389|NCT01346189|62933114|FG000|Overall Study|Withdrawal by Subject|7|||
33542390|NCT01346189|62933115|FG001|Overall Study|Withdrawal by Subject|5|||
33542391|NCT01346189|62933116|FG002|Overall Study|Withdrawal by Subject|3|||
33542392|NCT01346189|62933117|FG003|Overall Study|Withdrawal by Subject|5|||
33542393|NCT01346189|62933114|FG000|Overall Study|Physician Decision|4|||
33542394|NCT01346189|62933115|FG001|Overall Study|Physician Decision|0|||
33542395|NCT01346189|62933116|FG002|Overall Study|Physician Decision|0|||
33542396|NCT01346189|62933117|FG003|Overall Study|Physician Decision|0|||
33542397|NCT01346189|62933114|FG000|Overall Study|Moved|3|||
33542398|NCT01346189|62933115|FG001|Overall Study|Moved|0|||
33542399|NCT01346189|62933116|FG002|Overall Study|Moved|4|||
33542400|NCT01346189|62933117|FG003|Overall Study|Moved|0|||
33542401|NCT01346189|62933114|FG000|Overall Study|Other|2|||
33542402|NCT01346189|62933115|FG001|Overall Study|Other|4|||
33542403|NCT01346189|62933116|FG002|Overall Study|Other|7|||
33542404|NCT01346189|62933117|FG003|Overall Study|Other|3|||
33542405|NCT01346189|62933114|FG000|Overall Study|Death|0|||
33542406|NCT01346189|62933115|FG001|Overall Study|Death|3|||
33542407|NCT01346189|62933116|FG002|Overall Study|Death|0|||
33542408|NCT01346189|62933117|FG003|Overall Study|Death|0|||
33542409|NCT01346189|62933114|FG000|Overall Study|Non-health system primary care physician|0|||
33542410|NCT01346189|62933115|FG001|Overall Study|Non-health system primary care physician|5|||
33542411|NCT01346189|62933116|FG002|Overall Study|Non-health system primary care physician|0|||
33542412|NCT01346189|62933117|FG003|Overall Study|Non-health system primary care physician|0|||
33542413|NCT01346189|62933114|FG000|Overall Study|Travel|0|||
33542414|NCT01346189|62933115|FG001|Overall Study|Travel|0|||
33542415|NCT01346189|62933116|FG002|Overall Study|Travel|0|||
33542416|NCT01346189|62933117|FG003|Overall Study|Travel|3|||
33542417|NCT00369317|62933127|FG000|Overall Study|Adverse Event|3|||
33542418|NCT00369317|62933127|FG000|Overall Study|Death|1|||
33327045|NCT00876733|62703690|FG001|Overall Study|Adverse Event|20|||
33327046|NCT00876733|62703691|FG002|Overall Study|Adverse Event|10|||
33327047|NCT00876733|62703692|FG003|Overall Study|Adverse Event|3|||
33327048|NCT00876733|62703689|FG000|Overall Study|Lack of Efficacy|17|||
33327049|NCT00876733|62703690|FG001|Overall Study|Lack of Efficacy|9|||
33640619|NCT01928329|63043586|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
33327050|NCT00876733|62703691|FG002|Overall Study|Lack of Efficacy|10|||
33640620|NCT01928329|63043587|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
33327051|NCT00876733|62703692|FG003|Overall Study|Lack of Efficacy|1|||
33327052|NCT00876733|62703689|FG000|Overall Study|Lost to Follow-up|26|||
33542419|NCT00369317|62933127|FG000|Overall Study|Lack of Efficacy|5|||
33542420|NCT00369317|62933127|FG000|Overall Study|Physician Decision|2|||
33327053|NCT00876733|62703690|FG001|Overall Study|Lost to Follow-up|10|||
33327054|NCT00876733|62703691|FG002|Overall Study|Lost to Follow-up|3|||
33327055|NCT00876733|62703692|FG003|Overall Study|Lost to Follow-up|2|||
33327056|NCT00876733|62703689|FG000|Overall Study|Data not available|14|||
33327057|NCT00876733|62703690|FG001|Overall Study|Data not available|3|||
33327058|NCT00876733|62703691|FG002|Overall Study|Data not available|7|||
33327059|NCT00876733|62703692|FG003|Overall Study|Data not available|1|||
33327060|NCT00875017|62703712|FG000|First Intervention|Withdrawal by Subject|1|||
33327061|NCT00875017|62703713|FG001|First Intervention|Withdrawal by Subject|0|||
33327062|NCT00875017|62703714|FG002|First Intervention|Withdrawal by Subject|1|||
33327063|NCT00875017|62703715|FG003|First Intervention|Withdrawal by Subject|0|||
33542421|NCT00369317|62933127|FG000|Overall Study|Withdrawal by Subject|8|||
33542422|NCT00369317|62933127|FG000|Overall Study|Ineligible|1|||
33542423|NCT03193021|62933134|FG000|Overall Study|Lost to Follow-up|1|||
33542424|NCT03193021|62933135|FG001|Overall Study|Lost to Follow-up|1|||
33542425|NCT03913091|62933143|FG000|Overall Study|Lost to Follow-up|18|||
33542426|NCT03913091|62933144|FG001|Overall Study|Lost to Follow-up|11|||
33542427|NCT03913091|62933143|FG000|Overall Study|Required additional meds/surgery|1|||
33542428|NCT03913091|62933144|FG001|Overall Study|Required additional meds/surgery|2|||
33542429|NCT03913091|62933143|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
33542430|NCT03913091|62933144|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
33542431|NCT01318499|62933168|FG000|Overall Study|Adverse Event|16|||
33542432|NCT01318499|62933169|FG001|Overall Study|Adverse Event|11|||
33542433|NCT01318499|62933170|FG002|Overall Study|Adverse Event|6|||
33542434|NCT01318499|62933168|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
33542435|NCT01318499|62933169|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
33542436|NCT01318499|62933170|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
33542437|NCT01318499|62933168|FG000|Overall Study|Noncompliance|2|||
33542438|NCT01318499|62933169|FG001|Overall Study|Noncompliance|3|||
33542439|NCT01318499|62933170|FG002|Overall Study|Noncompliance|0|||
33542440|NCT01318499|62933168|FG000|Overall Study|Treatment Failure|19|||
33542441|NCT01318499|62933169|FG001|Overall Study|Treatment Failure|19|||
33542442|NCT01318499|62933170|FG002|Overall Study|Treatment Failure|101|||
33542443|NCT01318499|62933168|FG000|Overall Study|Protocol Violation|2|||
33542444|NCT01318499|62933169|FG001|Overall Study|Protocol Violation|4|||
33542445|NCT01318499|62933170|FG002|Overall Study|Protocol Violation|2|||
33640621|NCT01928329|63043586|FG000|Overall Study|Adverse Event|5|||
33640622|NCT01928329|63043587|FG001|Overall Study|Adverse Event|3|||
33640623|NCT01928329|63043586|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
33640624|NCT01928329|63043587|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
33640625|NCT01928329|63043586|FG000|Overall Study|Withdrawal by Subject|1|||
33640626|NCT01928329|63043587|FG001|Overall Study|Withdrawal by Subject|5|||
33640627|NCT01928329|63043586|FG000|Overall Study|Physician Decision|1|||
33640628|NCT01928329|63043587|FG001|Overall Study|Physician Decision|1|||
33640629|NCT01890109|63043595|FG000|Overall Study|Withdrawal by Subject|0|||
33640630|NCT01890109|63043596|FG001|Overall Study|Withdrawal by Subject|3|||
33640631|NCT01890109|63043595|FG000|Overall Study|Lost to Follow-up|1|||
33640632|NCT01890109|63043596|FG001|Overall Study|Lost to Follow-up|2|||
33640633|NCT00982930|63043603|FG000|Overall Study|Adverse Event|1|||
33640634|NCT00982930|63043603|FG000|Overall Study|Withdrawal by Subject|1|||
33640635|NCT00982930|63043603|FG000|Overall Study|Administrative Problems|2|||
33640636|NCT00981682|63043607|FG000|Overall Study|Adverse Event|48|||
33640637|NCT00981682|63043607|FG000|Overall Study|Withdrawal by Subject|52|||
33640638|NCT00981682|63043607|FG000|Overall Study|Lost to Follow-up|14|||
33640639|NCT00981682|63043607|FG000|Overall Study|Lack of Efficacy|13|||
33640640|NCT00981682|63043607|FG000|Overall Study|Protocol Violation|6|||
33640641|NCT00981682|63043607|FG000|Overall Study|administrative|9|||
33640642|NCT01903993|63043613|FG000|Overall Study|Death|118|||
33640643|NCT01903993|63043614|FG001|Overall Study|Death|121|||
33640644|NCT01903993|63043613|FG000|Overall Study|Withdrawal by Subject|15|||
33640645|NCT01903993|63043614|FG001|Overall Study|Withdrawal by Subject|4|||
33640646|NCT01903993|63043613|FG000|Overall Study|Lost to Follow-up|2|||
33640647|NCT01903993|63043614|FG001|Overall Study|Lost to Follow-up|3|||
33640648|NCT01903993|63043613|FG000|Overall Study|Study Terminated by Sponsor|8|||
33640649|NCT01903993|63043614|FG001|Overall Study|Study Terminated by Sponsor|14|||
33542446|NCT01318499|62933168|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
33542447|NCT01318499|62933169|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
33542448|NCT01318499|62933170|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
33542449|NCT01318499|62933168|FG000|Overall Study|Other|7|||
33542450|NCT01318499|62933169|FG001|Overall Study|Other|10|||
33542451|NCT01318499|62933170|FG002|Overall Study|Other|22|||
33542452|NCT02285595|62933204|FG000|Overall Study|Lost to Follow-up|14|||
33542453|NCT02285595|62933204|FG000|Overall Study|Withdrawal by Subject|1|||
33542454|NCT02712398|62933227|FG000|Overall Study|Withdrawal by Subject|6|||
33640650|NCT01903993|63043613|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
33640651|NCT01903993|63043614|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
33640652|NCT00981292|63043627|FG000|Day 1|Protocol Violation|1|||
33640653|NCT00981292|63043628|FG001|Day 1|Protocol Violation|0|||
33640654|NCT00981292|63043629|FG002|Day 1|Protocol Violation|0|||
33640655|NCT00981292|63043630|FG003|Day 1|Protocol Violation|0|||
33640656|NCT00981292|63043631|FG004|Day 1|Protocol Violation|0|||
33640657|NCT00981292|63043632|FG005|Day 1|Protocol Violation|2|||
33640658|NCT00981292|63043627|FG000|Day 2|Protocol Violation|2|||
33640659|NCT00981292|63043628|FG001|Day 2|Protocol Violation|0|||
33640660|NCT00981292|63043629|FG002|Day 2|Protocol Violation|0|||
33640661|NCT00981292|63043630|FG003|Day 2|Protocol Violation|0|||
33640662|NCT00981292|63043631|FG004|Day 2|Protocol Violation|0|||
33640663|NCT00981292|63043632|FG005|Day 2|Protocol Violation|0|||
33640664|NCT00981292|63043627|FG000|Day 3|Protocol Violation|0|||
33640665|NCT00981292|63043628|FG001|Day 3|Protocol Violation|0|||
33640666|NCT00981292|63043629|FG002|Day 3|Protocol Violation|0|||
33640667|NCT00981292|63043630|FG003|Day 3|Protocol Violation|0|||
33640668|NCT00981292|63043631|FG004|Day 3|Protocol Violation|0|||
33640669|NCT00981292|63043632|FG005|Day 3|Protocol Violation|1|||
33640670|NCT00980044|63043647|FG000|Overall Study|Withdrawal by Subject|5|||
33640671|NCT00980044|63043648|FG001|Overall Study|Withdrawal by Subject|7|||
33640672|NCT00980044|63043649|FG002|Overall Study|Withdrawal by Subject|3|||
33640673|NCT00980044|63043647|FG000|Overall Study|Protocol Violation|0|||
33640674|NCT00980044|63043648|FG001|Overall Study|Protocol Violation|0|||
33640675|NCT00980044|63043649|FG002|Overall Study|Protocol Violation|2|||
33640676|NCT01903837|63043664|FG000|Part A|Withdrawal by Subject|4|||
33640677|NCT01903837|63043665|FG001|Part A|Withdrawal by Subject|9|||
33640678|NCT01903837|63043666|FG002|Part A|Withdrawal by Subject|8|||
33640679|NCT01903837|63043667|FG003|Part A|Withdrawal by Subject|5|||
33640680|NCT01903837|63043664|FG000|Part A|Adverse Event|3|||
33640681|NCT01903837|63043665|FG001|Part A|Adverse Event|6|||
33640682|NCT01903837|63043666|FG002|Part A|Adverse Event|9|||
33640683|NCT01903837|63043667|FG003|Part A|Adverse Event|6|||
33640684|NCT01903837|63043664|FG000|Part A|Lost to Follow-up|9|||
33640685|NCT01903837|63043665|FG001|Part A|Lost to Follow-up|7|||
33640686|NCT01903837|63043666|FG002|Part A|Lost to Follow-up|7|||
33640687|NCT01903837|63043667|FG003|Part A|Lost to Follow-up|2|||
33640688|NCT01903837|63043664|FG000|Part A|Non-compliance with study drug|1|||
33640689|NCT01903837|63043665|FG001|Part A|Non-compliance with study drug|4|||
33640690|NCT01903837|63043666|FG002|Part A|Non-compliance with study drug|4|||
33640691|NCT01903837|63043667|FG003|Part A|Non-compliance with study drug|0|||
33640692|NCT01903837|63043664|FG000|Part A|Physician Decision|1|||
33640693|NCT01903837|63043665|FG001|Part A|Physician Decision|1|||
33640694|NCT01903837|63043666|FG002|Part A|Physician Decision|0|||
33640695|NCT01903837|63043667|FG003|Part A|Physician Decision|0|||
33640696|NCT01903837|63043664|FG000|Part A|Protocol Violation|1|||
33640697|NCT01903837|63043665|FG001|Part A|Protocol Violation|1|||
33640698|NCT01903837|63043666|FG002|Part A|Protocol Violation|0|||
33640699|NCT01903837|63043667|FG003|Part A|Protocol Violation|0|||
33640700|NCT01903837|63043664|FG000|Part B|Lost to Follow-up|0|||
33640701|NCT01903837|63043665|FG001|Part B|Lost to Follow-up|3|||
33463114|NCT03410992|62836679|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33463115|NCT03410992|62836680|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33463116|NCT03410992|62836681|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
33463117|NCT03410992|62836682|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
33463118|NCT03410992|62836683|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
33463119|NCT03410992|62836684|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33463120|NCT03410992|62836685|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33463121|NCT03410992|62836686|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33463122|NCT03410992|62836687|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33463123|NCT03410992|62836688|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33463124|NCT03410992|62836678|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
33463125|NCT03410992|62836679|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
33640702|NCT01903837|63043666|FG002|Part B|Lost to Follow-up|3|||
33640703|NCT01903837|63043667|FG003|Part B|Lost to Follow-up|4|||
33640704|NCT01903837|63043664|FG000|Part B|Withdrawal by Subject|1|||
33640705|NCT01903837|63043665|FG001|Part B|Withdrawal by Subject|2|||
33640706|NCT01903837|63043666|FG002|Part B|Withdrawal by Subject|0|||
33640707|NCT01903837|63043667|FG003|Part B|Withdrawal by Subject|3|||
33640708|NCT01903837|63043664|FG000|Part B|Adverse Event|3|||
33640709|NCT01903837|63043665|FG001|Part B|Adverse Event|0|||
33640710|NCT01903837|63043666|FG002|Part B|Adverse Event|2|||
33640711|NCT01903837|63043667|FG003|Part B|Adverse Event|0|||
33640712|NCT01903837|63043664|FG000|Part B|Non-compliance with study drug|2|||
33640713|NCT01903837|63043665|FG001|Part B|Non-compliance with study drug|0|||
33640714|NCT01903837|63043666|FG002|Part B|Non-compliance with study drug|0|||
33640715|NCT01903837|63043667|FG003|Part B|Non-compliance with study drug|1|||
33640716|NCT01903837|63043664|FG000|Part B|Incarceration|2|||
33640717|NCT01903837|63043665|FG001|Part B|Incarceration|0|||
33640718|NCT01903837|63043666|FG002|Part B|Incarceration|0|||
33640719|NCT01903837|63043667|FG003|Part B|Incarceration|1|||
33640720|NCT01903837|63043664|FG000|Part B|Physician Decision|1|||
33640721|NCT01903837|63043665|FG001|Part B|Physician Decision|0|||
33640722|NCT01903837|63043666|FG002|Part B|Physician Decision|0|||
33640723|NCT01903837|63043667|FG003|Part B|Physician Decision|2|||
33640724|NCT01903837|63043664|FG000|Part B|Lack of Efficacy|0|||
33640725|NCT01903837|63043665|FG001|Part B|Lack of Efficacy|1|||
33640726|NCT01903837|63043666|FG002|Part B|Lack of Efficacy|0|||
33640727|NCT01903837|63043667|FG003|Part B|Lack of Efficacy|0|||
33640728|NCT01903525|63043700|FG000|Overall Study|Lost to Follow-up|5|||
33640729|NCT01903525|63043701|FG001|Overall Study|Lost to Follow-up|9|||
33640730|NCT01903525|63043700|FG000|Overall Study|Adverse Event|0|||
33640731|NCT01903525|63043701|FG001|Overall Study|Adverse Event|1|||
33640732|NCT00981526|63043709|FG000|Overall Study|Withdrawal by Subject|0|||
33640733|NCT00981526|63043710|FG001|Overall Study|Withdrawal by Subject|2|||
33640734|NCT00981526|63043709|FG000|Overall Study|Physician Decision|4|||
33640735|NCT00981526|63043710|FG001|Overall Study|Physician Decision|4|||
33640736|NCT01927861|63043720|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
33640737|NCT01927861|63043721|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
33640738|NCT01927861|63043720|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
33640739|NCT01927861|63043721|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
33640740|NCT01927627|63043727|FG000|Overall Study|Adverse Event|3|||
33640741|NCT01927627|63043727|FG000|Overall Study|Lack of Efficacy|1|||
33640742|NCT01927627|63043727|FG000|Overall Study|Financial Concerns|1|||
33640743|NCT01889251|63043733|FG000|Overall Study|Adverse Event|1|||
33640744|NCT01889251|63043734|FG001|Overall Study|Adverse Event|0|||
33640745|NCT01616563|63043740|FG000|Overall Study|Lost to Follow-up|40|||
33640746|NCT01616173|63043748|FG000|Overall Study|Lost to Follow-up|0|||
33640747|NCT01616173|63043749|FG001|Overall Study|Lost to Follow-up|2|||
33640748|NCT01616173|63043750|FG002|Overall Study|Lost to Follow-up|0|||
33640749|NCT01544595|63043764|FG000|Status at Week 68|Adverse Event|3|||
33640750|NCT01544595|63043765|FG001|Status at Week 68|Adverse Event|2|||
33640751|NCT01544595|63043766|FG002|Status at Week 68|Adverse Event|1|||
33640752|NCT01544595|63043767|FG003|Status at Week 68|Adverse Event|0|||
33640753|NCT01544595|63043768|FG004|Status at Week 68|Adverse Event|0|||
33640754|NCT01544595|63043769|FG005|Status at Week 68|Adverse Event|0|||
33640755|NCT01544595|63043764|FG000|Status at Week 68|Lack of Efficacy|1|||
33640756|NCT01544595|63043765|FG001|Status at Week 68|Lack of Efficacy|0|||
33640757|NCT01544595|63043766|FG002|Status at Week 68|Lack of Efficacy|0|||
33640758|NCT01544595|63043767|FG003|Status at Week 68|Lack of Efficacy|0|||
33640759|NCT01544595|63043768|FG004|Status at Week 68|Lack of Efficacy|0|||
33640760|NCT01544595|63043769|FG005|Status at Week 68|Lack of Efficacy|0|||
33463126|NCT03410992|62836680|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
33542455|NCT02712398|62933227|FG000|Overall Study|Lost to Follow-up|6|||
33542456|NCT02712398|62933227|FG000|Overall Study|Sponsor Decision|1|||
33542457|NCT02712398|62933227|FG000|Overall Study|Physician Decision|1|||
33542458|NCT02712398|62933227|FG000|Overall Study|Death|2|||
33542459|NCT02712398|62933227|FG000|Overall Study|Re-operation|21|||
33542460|NCT00282867|62933234|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
33542461|NCT00282867|62933235|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
33542462|NCT00282867|62933236|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
33542463|NCT00151281|62933241|FG000|Overall Study|Not evaluable|3|||
33640761|NCT01544595|63043764|FG000|Status at Week 68|Lost to Follow-up|1|||
33640762|NCT01544595|63043765|FG001|Status at Week 68|Lost to Follow-up|1|||
33640763|NCT01544595|63043766|FG002|Status at Week 68|Lost to Follow-up|0|||
33640764|NCT01544595|63043767|FG003|Status at Week 68|Lost to Follow-up|0|||
33640765|NCT01544595|63043768|FG004|Status at Week 68|Lost to Follow-up|0|||
33640766|NCT01544595|63043769|FG005|Status at Week 68|Lost to Follow-up|0|||
33640767|NCT01544595|63043764|FG000|Status at Week 68|Non-compliance with study treatment|1|||
33640768|NCT01544595|63043765|FG001|Status at Week 68|Non-compliance with study treatment|0|||
33640769|NCT01544595|63043766|FG002|Status at Week 68|Non-compliance with study treatment|0|||
33640770|NCT01544595|63043767|FG003|Status at Week 68|Non-compliance with study treatment|1|||
33640771|NCT01544595|63043768|FG004|Status at Week 68|Non-compliance with study treatment|0|||
33640772|NCT01544595|63043769|FG005|Status at Week 68|Non-compliance with study treatment|0|||
33640773|NCT01544595|63043764|FG000|Status at Week 68|Protocol Violation|2|||
33463127|NCT03410992|62836681|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
33463128|NCT03410992|62836682|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
33463129|NCT03410992|62836683|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
33463130|NCT03410992|62836684|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
33463131|NCT03410992|62836685|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
33463132|NCT03410992|62836686|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
33463133|NCT03410992|62836687|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
33463134|NCT03410992|62836688|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
33463135|NCT03410992|62836678|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33463136|NCT03410992|62836679|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33463137|NCT03410992|62836680|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33640774|NCT01544595|63043765|FG001|Status at Week 68|Protocol Violation|0|||
33640775|NCT01544595|63043766|FG002|Status at Week 68|Protocol Violation|1|||
33640776|NCT01544595|63043767|FG003|Status at Week 68|Protocol Violation|1|||
33640777|NCT01544595|63043768|FG004|Status at Week 68|Protocol Violation|0|||
33640778|NCT01544595|63043769|FG005|Status at Week 68|Protocol Violation|0|||
33640779|NCT01544595|63043764|FG000|Status at Week 68|Technical problems|1|||
33640780|NCT01544595|63043765|FG001|Status at Week 68|Technical problems|0|||
33640781|NCT01544595|63043766|FG002|Status at Week 68|Technical problems|0|||
33542464|NCT01318109|62933256|FG000|Overall Study|Adverse Event|0|||
33542465|NCT01318109|62933257|FG001|Overall Study|Adverse Event|2|||
33542466|NCT01318109|62933258|FG002|Overall Study|Adverse Event|0|||
33542467|NCT01318109|62933256|FG000|Overall Study|Withdrawal by Subject|1|||
33542468|NCT01318109|62933257|FG001|Overall Study|Withdrawal by Subject|0|||
33542469|NCT01318109|62933258|FG002|Overall Study|Withdrawal by Subject|0|||
33542470|NCT01318109|62933256|FG000|Overall Study|Schedule Conflict|0|||
33542471|NCT01318109|62933257|FG001|Overall Study|Schedule Conflict|1|||
33542472|NCT01318109|62933258|FG002|Overall Study|Schedule Conflict|0|||
33542473|NCT02712554|62933268|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
33542474|NCT02712554|62933269|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
33542475|NCT02712554|62933268|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
33542476|NCT02712554|62933269|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
33542477|NCT02712554|62933268|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
33542478|NCT02712554|62933269|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
33542479|NCT02712554|62933268|FG000|Part B: Qualification Phase|Adverse Event|0|||
33542480|NCT02712554|62933269|FG001|Part B: Qualification Phase|Adverse Event|1|||
33542481|NCT02712554|62933268|FG000|Part B: Treatment Phase|Adverse Event|0|||
33542482|NCT02712554|62933269|FG001|Part B: Treatment Phase|Adverse Event|1|||
33640782|NCT01544595|63043767|FG003|Status at Week 68|Technical problems|1|||
33640783|NCT01544595|63043768|FG004|Status at Week 68|Technical problems|0|||
33640784|NCT01544595|63043769|FG005|Status at Week 68|Technical problems|0|||
33640785|NCT01544595|63043764|FG000|Status at Week 68|Withdrawal by Subject|0|||
33640786|NCT01544595|63043765|FG001|Status at Week 68|Withdrawal by Subject|1|||
33640787|NCT01544595|63043766|FG002|Status at Week 68|Withdrawal by Subject|1|||
33640788|NCT01544595|63043767|FG003|Status at Week 68|Withdrawal by Subject|2|||
33640789|NCT01544595|63043768|FG004|Status at Week 68|Withdrawal by Subject|0|||
33640790|NCT01544595|63043769|FG005|Status at Week 68|Withdrawal by Subject|0|||
33640791|NCT01544595|63043764|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
33640792|NCT01544595|63043765|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
33463138|NCT03410992|62836681|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33463139|NCT03410992|62836682|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33640793|NCT01544595|63043766|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
33640794|NCT01544595|63043767|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
33463140|NCT03410992|62836683|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33463141|NCT03410992|62836684|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33640795|NCT01544595|63043768|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
33463142|NCT03410992|62836685|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33463143|NCT03410992|62836686|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
33463144|NCT03410992|62836687|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33463145|NCT03410992|62836688|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33463146|NCT00377819|62836720|FG000|Overall Study|Adverse Event|2|||
33463147|NCT00377819|62836721|FG001|Overall Study|Adverse Event|3|||
33640796|NCT01544595|63043769|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
33640797|NCT01544595|63043764|FG000|Status at Week 156|Withdrawal by Subject|9|||
33640798|NCT01544595|63043765|FG001|Status at Week 156|Withdrawal by Subject|10|||
33640799|NCT01544595|63043766|FG002|Status at Week 156|Withdrawal by Subject|4|||
33640800|NCT01544595|63043767|FG003|Status at Week 156|Withdrawal by Subject|9|||
33640801|NCT01544595|63043768|FG004|Status at Week 156|Withdrawal by Subject|20|||
33640802|NCT01544595|63043769|FG005|Status at Week 156|Withdrawal by Subject|6|||
33640803|NCT01544595|63043764|FG000|Status at Week 156|Adverse Event|9|||
33640804|NCT01544595|63043765|FG001|Status at Week 156|Adverse Event|11|||
33463148|NCT00377819|62836720|FG000|Overall Study|Withdrawal by Subject|10|||
33463149|NCT00377819|62836721|FG001|Overall Study|Withdrawal by Subject|4|||
33463150|NCT00377819|62836720|FG000|Overall Study|Death|0|||
33463151|NCT00377819|62836721|FG001|Overall Study|Death|1|||
33542483|NCT02712554|62933268|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
33542484|NCT02712554|62933269|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
33542485|NCT02712554|62933268|FG000|Part B: Treatment Phase|Other|0|||
33542486|NCT02712554|62933269|FG001|Part B: Treatment Phase|Other|1|||
33542487|NCT02712320|62933292|FG000|Overall Study|Lost to Follow-up|1|||
33542488|NCT02712320|62933292|FG000|Overall Study|Withdrawal by Subject|1|||
33542489|NCT02712320|62933292|FG000|Overall Study|Transferred to another facility|1|||
33640805|NCT01544595|63043766|FG002|Status at Week 156|Adverse Event|1|||
33640806|NCT01544595|63043767|FG003|Status at Week 156|Adverse Event|3|||
33463152|NCT00377819|62836720|FG000|Overall Study|Lost to Follow-up|0|||
33542490|NCT02712320|62933292|FG000|Overall Study|Treating with the prohibited medications|2|||
33542491|NCT03052751|62933298|FG000|Dosing Period 1|Adverse Event|0|||
33640807|NCT01544595|63043768|FG004|Status at Week 156|Adverse Event|4|||
33463153|NCT00377819|62836721|FG001|Overall Study|Lost to Follow-up|1|||
33463154|NCT00377819|62836720|FG000|Overall Study|Protocol Violation|1|||
33463155|NCT00377819|62836721|FG001|Overall Study|Protocol Violation|1|||
33463156|NCT03419962|62836727|FG000|Overall Study|Change to other medication|1|||
33542492|NCT03052751|62933299|FG001|Dosing Period 1|Adverse Event|1|||
33640808|NCT01544595|63043769|FG005|Status at Week 156|Adverse Event|2|||
33640809|NCT01544595|63043764|FG000|Status at Week 156|Lost to Follow-up|4|||
33640810|NCT01544595|63043765|FG001|Status at Week 156|Lost to Follow-up|4|||
33640811|NCT01544595|63043766|FG002|Status at Week 156|Lost to Follow-up|0|||
33640812|NCT01544595|63043767|FG003|Status at Week 156|Lost to Follow-up|1|||
33640813|NCT01544595|63043768|FG004|Status at Week 156|Lost to Follow-up|4|||
33640814|NCT01544595|63043769|FG005|Status at Week 156|Lost to Follow-up|1|||
33640815|NCT01544595|63043764|FG000|Status at Week 156|Non-compliance with study treatement|0|||
33640816|NCT01544595|63043765|FG001|Status at Week 156|Non-compliance with study treatement|1|||
33640817|NCT01544595|63043766|FG002|Status at Week 156|Non-compliance with study treatement|0|||
33640818|NCT01544595|63043767|FG003|Status at Week 156|Non-compliance with study treatement|1|||
33640819|NCT01544595|63043768|FG004|Status at Week 156|Non-compliance with study treatement|0|||
33327064|NCT00875017|62703716|FG004|First Intervention|Withdrawal by Subject|0|||
33327065|NCT00875017|62703717|FG005|First Intervention|Withdrawal by Subject|0|||
33327066|NCT00875017|62703712|FG000|First Intervention|Adverse Event|0|||
33327067|NCT00875017|62703713|FG001|First Intervention|Adverse Event|0|||
33327068|NCT00875017|62703714|FG002|First Intervention|Adverse Event|0|||
33327069|NCT00875017|62703715|FG003|First Intervention|Adverse Event|1|||
33327070|NCT00875017|62703716|FG004|First Intervention|Adverse Event|0|||
33327071|NCT00875017|62703717|FG005|First Intervention|Adverse Event|0|||
33327072|NCT00875017|62703712|FG000|First Intervention|Problems collecting rectal effluent|1|||
33327073|NCT00875017|62703713|FG001|First Intervention|Problems collecting rectal effluent|0|||
33327074|NCT00875017|62703714|FG002|First Intervention|Problems collecting rectal effluent|0|||
33327075|NCT00875017|62703715|FG003|First Intervention|Problems collecting rectal effluent|0|||
33327076|NCT00875017|62703716|FG004|First Intervention|Problems collecting rectal effluent|0|||
33327077|NCT00875017|62703717|FG005|First Intervention|Problems collecting rectal effluent|0|||
33327078|NCT00875017|62703712|FG000|First Intervention|Intolerance to nasogastric tube|0|||
33327079|NCT00875017|62703713|FG001|First Intervention|Intolerance to nasogastric tube|0|||
33327080|NCT00875017|62703714|FG002|First Intervention|Intolerance to nasogastric tube|0|||
33327081|NCT00875017|62703715|FG003|First Intervention|Intolerance to nasogastric tube|0|||
33463157|NCT03419962|62836727|FG000|Overall Study|Refusal of continuing with trial drug|1|||
33463158|NCT03419962|62836727|FG000|Overall Study|Lost to Follow-up|3|||
33463159|NCT03419962|62836727|FG000|Overall Study|Difficulty in inhaling the doses|1|||
33463160|NCT03419962|62836727|FG000|Overall Study|Missing completion data|31|||
33463161|NCT00377429|62836731|FG000|Overall Study|Withdrawal by Subject|5|||
33463162|NCT00377429|62836731|FG000|Overall Study|Adverse Event|8|||
33463163|NCT00377429|62836731|FG000|Overall Study|Physician Decision|1|||
33463164|NCT00377429|62836731|FG000|Overall Study|Patient non-compliance|1|||
33463165|NCT00376961|62836735|FG000|Initial Registration|Adverse Event|1|||
33542493|NCT03052751|62933300|FG002|Dosing Period 1|Adverse Event|0|||
33542494|NCT03052751|62933301|FG003|Dosing Period 1|Adverse Event|0|||
33327082|NCT00875017|62703716|FG004|First Intervention|Intolerance to nasogastric tube|1|||
33542495|NCT03052751|62933302|FG004|Dosing Period 1|Adverse Event|0|||
33542496|NCT03052751|62933303|FG005|Dosing Period 1|Adverse Event|0|||
33542497|NCT03052751|62933298|FG000|Dosing Period 2|Adverse Event|0|||
33542498|NCT03052751|62933299|FG001|Dosing Period 2|Adverse Event|0|||
33542499|NCT03052751|62933300|FG002|Dosing Period 2|Adverse Event|3|||
33542500|NCT03052751|62933301|FG003|Dosing Period 2|Adverse Event|0|||
33542501|NCT03052751|62933302|FG004|Dosing Period 2|Adverse Event|0|||
33542502|NCT03052751|62933303|FG005|Dosing Period 2|Adverse Event|0|||
33542503|NCT03052751|62933298|FG000|Observation Period|Adverse Event|0|||
33542504|NCT03052751|62933299|FG001|Observation Period|Adverse Event|0|||
33542505|NCT03052751|62933300|FG002|Observation Period|Adverse Event|0|||
33542506|NCT03052751|62933301|FG003|Observation Period|Adverse Event|0|||
33542507|NCT03052751|62933302|FG004|Observation Period|Adverse Event|1|||
33542508|NCT03052751|62933303|FG005|Observation Period|Adverse Event|0|||
33542509|NCT01317797|62933316|FG000|Overall Study|Other|0|||
33542510|NCT01317797|62933317|FG001|Overall Study|Other|1|||
33542511|NCT01317797|62933318|FG002|Overall Study|Other|0|||
33542512|NCT01317797|62933316|FG000|Overall Study|Withdrawal of Patient|0|||
33542513|NCT01317797|62933317|FG001|Overall Study|Withdrawal of Patient|0|||
33542514|NCT01317797|62933318|FG002|Overall Study|Withdrawal of Patient|1|||
33542515|NCT01343693|62933326|FG000|Overall Study|Lost to Follow-up|9|||
33542516|NCT02712008|62933333|FG000|Baseline (Day 1) up to Week 12|Death|3|||
33542517|NCT02712008|62933334|FG001|Baseline (Day 1) up to Week 12|Death|0|||
33542518|NCT02712008|62933335|FG002|Baseline (Day 1) up to Week 12|Death|0|||
33542519|NCT02712008|62933336|FG003|Baseline (Day 1) up to Week 12|Death|0|||
33542520|NCT02712008|62933337|FG004|Baseline (Day 1) up to Week 12|Death|0|||
33327083|NCT00875017|62703717|FG005|First Intervention|Intolerance to nasogastric tube|0|||
33327084|NCT00875017|62703712|FG000|Washout|Problem collecting rectal effluent|0|||
33327085|NCT00875017|62703713|FG001|Washout|Problem collecting rectal effluent|0|||
33327086|NCT00875017|62703714|FG002|Washout|Problem collecting rectal effluent|1|||
33327087|NCT00875017|62703715|FG003|Washout|Problem collecting rectal effluent|0|||
33327088|NCT00875017|62703716|FG004|Washout|Problem collecting rectal effluent|0|||
33327089|NCT00875017|62703717|FG005|Washout|Problem collecting rectal effluent|0|||
33542521|NCT02712008|62933338|FG005|Baseline (Day 1) up to Week 12|Death|0|||
33327090|NCT00875017|62703712|FG000|Second Intervention|Adverse Event|0|||
33327091|NCT00875017|62703713|FG001|Second Intervention|Adverse Event|0|||
33327092|NCT00875017|62703714|FG002|Second Intervention|Adverse Event|0|||
33327093|NCT00875017|62703715|FG003|Second Intervention|Adverse Event|1|||
33327094|NCT00875017|62703716|FG004|Second Intervention|Adverse Event|0|||
33327095|NCT00875017|62703717|FG005|Second Intervention|Adverse Event|0|||
33327096|NCT00875017|62703712|FG000|Washout|Problems collecting rectal effluent|0|||
33327097|NCT00875017|62703713|FG001|Washout|Problems collecting rectal effluent|1|||
33327098|NCT00875017|62703714|FG002|Washout|Problems collecting rectal effluent|0|||
33327099|NCT00875017|62703715|FG003|Washout|Problems collecting rectal effluent|0|||
33327100|NCT00875017|62703716|FG004|Washout|Problems collecting rectal effluent|0|||
33327101|NCT00875017|62703717|FG005|Washout|Problems collecting rectal effluent|0|||
33327102|NCT00875017|62703712|FG000|Third Intervention|Adverse Event|0|||
33327103|NCT00875017|62703713|FG001|Third Intervention|Adverse Event|1|||
33327104|NCT00875017|62703714|FG002|Third Intervention|Adverse Event|1|||
33327105|NCT00875017|62703715|FG003|Third Intervention|Adverse Event|0|||
33327106|NCT00875017|62703716|FG004|Third Intervention|Adverse Event|0|||
33327107|NCT00875017|62703717|FG005|Third Intervention|Adverse Event|0|||
33327108|NCT00875017|62703712|FG000|Washout|Withdrawal by Subject|0|||
33327109|NCT00875017|62703713|FG001|Washout|Withdrawal by Subject|0|||
33327110|NCT00875017|62703714|FG002|Washout|Withdrawal by Subject|0|||
33327111|NCT00875017|62703715|FG003|Washout|Withdrawal by Subject|0|||
33327112|NCT00875017|62703716|FG004|Washout|Withdrawal by Subject|1|||
33327113|NCT00875017|62703717|FG005|Washout|Withdrawal by Subject|0|||
33327114|NCT00875017|62703712|FG000|Fourth Intervention|Inability to comply with fasting|0|||
33542522|NCT02712008|62933339|FG006|Baseline (Day 1) up to Week 12|Death|0|||
33542523|NCT02712008|62933340|FG007|Baseline (Day 1) up to Week 12|Death|0|||
33542524|NCT02712008|62933333|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33542525|NCT02712008|62933334|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
33542526|NCT02712008|62933335|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
33542527|NCT02712008|62933336|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33542528|NCT02712008|62933337|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33542529|NCT02712008|62933338|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33542530|NCT02712008|62933339|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33542531|NCT02712008|62933340|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33542532|NCT02712008|62933333|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
33542533|NCT02712008|62933334|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33542534|NCT02712008|62933335|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
33542535|NCT02712008|62933336|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33542536|NCT02712008|62933337|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33542537|NCT02712008|62933338|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33542538|NCT02712008|62933339|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33542539|NCT02712008|62933340|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33542540|NCT02712008|62933333|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
33542541|NCT02712008|62933334|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
33542542|NCT02712008|62933335|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
33542543|NCT02712008|62933336|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
33542544|NCT02712008|62933337|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
33327115|NCT00875017|62703713|FG001|Fourth Intervention|Inability to comply with fasting|0|||
33327116|NCT00875017|62703714|FG002|Fourth Intervention|Inability to comply with fasting|0|||
33463166|NCT00376961|62836736|FG001|Initial Registration|Adverse Event|0|||
33327117|NCT00875017|62703715|FG003|Fourth Intervention|Inability to comply with fasting|0|||
33327118|NCT00875017|62703716|FG004|Fourth Intervention|Inability to comply with fasting|0|||
33327119|NCT00875017|62703717|FG005|Fourth Intervention|Inability to comply with fasting|1|||
33327120|NCT00875797|62703742|FG000|Overall Study|Protocol Violation|6|||
33463167|NCT00376961|62836735|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
33463168|NCT00376961|62836736|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
33463169|NCT00376961|62836735|FG000|Initial Registration|Progression/relapse|1|||
33463170|NCT00376961|62836736|FG001|Initial Registration|Progression/relapse|0|||
33463171|NCT00376961|62836735|FG000|Initial Registration|Ineligible|3|||
33463172|NCT00376961|62836736|FG001|Initial Registration|Ineligible|0|||
33463173|NCT00376961|62836735|FG000|Maintenance|Adverse Event|0|||
33463174|NCT00376961|62836736|FG001|Maintenance|Adverse Event|1|||
33463175|NCT00376961|62836735|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
33542545|NCT02712008|62933338|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
33542546|NCT02712008|62933339|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
33542547|NCT02712008|62933340|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
33542548|NCT02712008|62933333|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
33542549|NCT02712008|62933334|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
33542550|NCT02712008|62933335|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
33542551|NCT02712008|62933336|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
33542552|NCT02712008|62933337|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
33542553|NCT02712008|62933338|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
33542554|NCT02712008|62933339|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
33327121|NCT00875797|62703743|FG001|Overall Study|Protocol Violation|3|||
33327122|NCT00874939|62703769|FG000|Overall Study|Study terminated|4|||
33327123|NCT00875563|62703779|FG000|Overall Study|Death|4|||
33327124|NCT00875563|62703779|FG000|Overall Study|Withdrawal by Subject|7|||
33327125|NCT00875563|62703779|FG000|Overall Study|No long-term (3-5 year) consent|6|||
33327126|NCT00875563|62703779|FG000|Overall Study|Still be eligible for follow-up|7|||
33327127|NCT01155869|62703785|FG000|Overall Study|Lost to Follow-up|3|||
33327128|NCT01155869|62703786|FG001|Overall Study|Lost to Follow-up|1|||
33542555|NCT02712008|62933340|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
33542556|NCT02712008|62933333|FG000|From Week 12 up to Week 36|Adverse Event|0|||
33542557|NCT02712008|62933334|FG001|From Week 12 up to Week 36|Adverse Event|0|||
33542558|NCT02712008|62933335|FG002|From Week 12 up to Week 36|Adverse Event|0|||
33542559|NCT02712008|62933336|FG003|From Week 12 up to Week 36|Adverse Event|0|||
33542560|NCT02712008|62933337|FG004|From Week 12 up to Week 36|Adverse Event|1|||
33542561|NCT02712008|62933338|FG005|From Week 12 up to Week 36|Adverse Event|0|||
33542562|NCT02712008|62933339|FG006|From Week 12 up to Week 36|Adverse Event|0|||
33542563|NCT02712008|62933340|FG007|From Week 12 up to Week 36|Adverse Event|2|||
33542564|NCT02712008|62933333|FG000|From Week 12 up to Week 36|Death|1|||
33542565|NCT02712008|62933334|FG001|From Week 12 up to Week 36|Death|0|||
33542566|NCT02712008|62933335|FG002|From Week 12 up to Week 36|Death|0|||
33542567|NCT02712008|62933336|FG003|From Week 12 up to Week 36|Death|0|||
33542568|NCT02712008|62933337|FG004|From Week 12 up to Week 36|Death|0|||
33542569|NCT02712008|62933338|FG005|From Week 12 up to Week 36|Death|0|||
33542570|NCT02712008|62933339|FG006|From Week 12 up to Week 36|Death|1|||
33542571|NCT02712008|62933340|FG007|From Week 12 up to Week 36|Death|0|||
33542572|NCT02712008|62933333|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
33542573|NCT02712008|62933334|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
33327129|NCT01185353|62703797|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
33327130|NCT01185353|62703798|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
33327131|NCT01185353|62703799|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
33327132|NCT01185353|62703800|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
33327133|NCT01185353|62703801|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
33327134|NCT01185353|62703802|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
33327135|NCT01185353|62703803|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
33327136|NCT01185353|62703804|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
33327137|NCT01185353|62703805|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
33327138|NCT01185353|62703806|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
33327139|NCT01185353|62703797|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33327140|NCT01185353|62703798|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33327141|NCT01185353|62703799|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33327142|NCT01185353|62703800|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33327143|NCT01185353|62703801|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
33327144|NCT01185353|62703802|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33542574|NCT02712008|62933335|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
33542575|NCT02712008|62933336|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
33542576|NCT02712008|62933337|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
33542577|NCT02712008|62933338|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
33542578|NCT02712008|62933339|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
33542579|NCT02712008|62933340|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
33327145|NCT01185353|62703803|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33542580|NCT02712008|62933333|FG000|From Week 12 up to Week 36|Physician Decision|0|||
33327146|NCT01185353|62703804|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33327147|NCT01185353|62703805|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33327148|NCT01185353|62703806|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33327149|NCT01185353|62703797|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
33327150|NCT01185353|62703798|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33327151|NCT01185353|62703799|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33327152|NCT01185353|62703800|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33327153|NCT01185353|62703801|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
33327154|NCT01185353|62703802|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33327155|NCT01185353|62703803|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33327156|NCT01185353|62703804|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33327157|NCT01185353|62703805|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33327158|NCT01185353|62703806|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33327159|NCT01185353|62703797|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33542581|NCT02712008|62933334|FG001|From Week 12 up to Week 36|Physician Decision|0|||
33542582|NCT02712008|62933335|FG002|From Week 12 up to Week 36|Physician Decision|0|||
33542583|NCT02712008|62933336|FG003|From Week 12 up to Week 36|Physician Decision|1|||
33542584|NCT02712008|62933337|FG004|From Week 12 up to Week 36|Physician Decision|1|||
33542585|NCT02712008|62933338|FG005|From Week 12 up to Week 36|Physician Decision|0|||
33542586|NCT02712008|62933339|FG006|From Week 12 up to Week 36|Physician Decision|0|||
33542587|NCT02712008|62933340|FG007|From Week 12 up to Week 36|Physician Decision|0|||
33542588|NCT02712008|62933333|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
33542589|NCT02712008|62933334|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
33542590|NCT02712008|62933335|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
33542591|NCT02712008|62933336|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
33542592|NCT02712008|62933337|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
33542593|NCT02712008|62933338|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
33542594|NCT02712008|62933339|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
33542595|NCT02712008|62933340|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
33542596|NCT02711306|62933360|FG000|Overall Study|Withdrawal by Subject|2|||
33542597|NCT02711306|62933361|FG001|Overall Study|Withdrawal by Subject|2|||
33542598|NCT02710292|62933367|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
33542599|NCT02710292|62933368|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
33542600|NCT02710292|62933367|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
33542601|NCT02710292|62933368|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
33542602|NCT02710214|62933377|FG000|Overall Study|Lost to Follow-up|1|||
33542603|NCT02710214|62933378|FG001|Overall Study|Lost to Follow-up|0|||
33542604|NCT02710214|62933377|FG000|Overall Study|Lack of Efficacy|0|||
33542605|NCT02710214|62933378|FG001|Overall Study|Lack of Efficacy|1|||
33542606|NCT02710214|62933377|FG000|Overall Study|Death|0|||
33542607|NCT02710214|62933378|FG001|Overall Study|Death|1|||
33542608|NCT03052517|62933387|FG000|Overall Study|Study Terminated By Sponsor|928|||
33327160|NCT01185353|62703798|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33327161|NCT01185353|62703799|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
33327162|NCT01185353|62703800|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33327163|NCT01185353|62703801|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
33327164|NCT01185353|62703802|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33327165|NCT01185353|62703803|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33327166|NCT01185353|62703804|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33327167|NCT01185353|62703805|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33327168|NCT01185353|62703806|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33542609|NCT03052517|62933388|FG001|Overall Study|Study Terminated By Sponsor|938|||
33542610|NCT03052517|62933389|FG002|Overall Study|Study Terminated By Sponsor|296|||
33640820|NCT01544595|63043769|FG005|Status at Week 156|Non-compliance with study treatement|1|||
33640821|NCT01544595|63043764|FG000|Status at Week 156|Physician Decision|0|||
33640822|NCT01544595|63043765|FG001|Status at Week 156|Physician Decision|3|||
33640823|NCT01544595|63043766|FG002|Status at Week 156|Physician Decision|1|||
33640824|NCT01544595|63043767|FG003|Status at Week 156|Physician Decision|0|||
33640825|NCT01544595|63043768|FG004|Status at Week 156|Physician Decision|0|||
33640826|NCT01544595|63043769|FG005|Status at Week 156|Physician Decision|0|||
33640827|NCT01544595|63043764|FG000|Status at Week 156|Pregnancy|2|||
33542611|NCT03052517|62933387|FG000|Overall Study|Subject/Guardian Decision|50|||
33542612|NCT03052517|62933388|FG001|Overall Study|Subject/Guardian Decision|45|||
33542613|NCT03052517|62933389|FG002|Overall Study|Subject/Guardian Decision|22|||
33542614|NCT03052517|62933387|FG000|Overall Study|Lack of Efficacy|23|||
33640828|NCT01544595|63043765|FG001|Status at Week 156|Pregnancy|3|||
33640829|NCT01544595|63043766|FG002|Status at Week 156|Pregnancy|0|||
33542615|NCT03052517|62933388|FG001|Overall Study|Lack of Efficacy|14|||
33640830|NCT01544595|63043767|FG003|Status at Week 156|Pregnancy|0|||
33640831|NCT01544595|63043768|FG004|Status at Week 156|Pregnancy|0|||
33640832|NCT01544595|63043769|FG005|Status at Week 156|Pregnancy|0|||
33640833|NCT01544595|63043764|FG000|Status at Week 156|Protocol Violation|3|||
33542616|NCT03052517|62933389|FG002|Overall Study|Lack of Efficacy|7|||
33542617|NCT03052517|62933387|FG000|Overall Study|Adverse Event|6|||
33542618|NCT03052517|62933388|FG001|Overall Study|Adverse Event|5|||
33542619|NCT03052517|62933389|FG002|Overall Study|Adverse Event|0|||
33542620|NCT03052517|62933387|FG000|Overall Study|Physician Decision|4|||
33542621|NCT03052517|62933388|FG001|Overall Study|Physician Decision|5|||
33542622|NCT03052517|62933389|FG002|Overall Study|Physician Decision|1|||
33542623|NCT03052517|62933387|FG000|Overall Study|Death|3|||
33542624|NCT03052517|62933388|FG001|Overall Study|Death|0|||
33542625|NCT03052517|62933389|FG002|Overall Study|Death|1|||
33542626|NCT03052517|62933387|FG000|Overall Study|Lost to Follow-up|2|||
33542627|NCT03052517|62933388|FG001|Overall Study|Lost to Follow-up|4|||
33542628|NCT03052517|62933389|FG002|Overall Study|Lost to Follow-up|0|||
33542629|NCT03052517|62933387|FG000|Overall Study|Pregnancy|1|||
33542630|NCT03052517|62933388|FG001|Overall Study|Pregnancy|0|||
33542631|NCT03052517|62933389|FG002|Overall Study|Pregnancy|1|||
33542632|NCT03052517|62933387|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
33542633|NCT03052517|62933388|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
33542634|NCT03052517|62933389|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
33542635|NCT03052517|62933387|FG000|Overall Study|Technical Problems|0|||
33542636|NCT03052517|62933388|FG001|Overall Study|Technical Problems|1|||
33542637|NCT03052517|62933389|FG002|Overall Study|Technical Problems|0|||
33542638|NCT02708498|62933405|FG000|Overall Study|Death|20|||
33542639|NCT02708498|62933406|FG001|Overall Study|Death|19|||
33542640|NCT02708498|62933407|FG002|Overall Study|Death|0|||
33542641|NCT02708498|62933408|FG003|Overall Study|Death|0|||
33542642|NCT02708498|62933409|FG004|Overall Study|Death|1|||
33542643|NCT02708498|62933410|FG005|Overall Study|Death|0|||
33542644|NCT02708498|62933411|FG006|Overall Study|Death|0|||
33542645|NCT02708498|62933412|FG007|Overall Study|Death|0|||
33542646|NCT02708498|62933405|FG000|Overall Study|Unknown reason, missing data|0|||
33542647|NCT02708498|62933406|FG001|Overall Study|Unknown reason, missing data|0|||
33542648|NCT02708498|62933407|FG002|Overall Study|Unknown reason, missing data|62|||
33542649|NCT02708498|62933408|FG003|Overall Study|Unknown reason, missing data|51|||
33542650|NCT02708498|62933409|FG004|Overall Study|Unknown reason, missing data|195|||
33542651|NCT02708498|62933410|FG005|Overall Study|Unknown reason, missing data|132|||
33542652|NCT02708498|62933411|FG006|Overall Study|Unknown reason, missing data|0|||
33542653|NCT02708498|62933412|FG007|Overall Study|Unknown reason, missing data|0|||
33542654|NCT02710136|62933430|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
33542655|NCT02710136|62933431|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
33542656|NCT03702231|62933441|FG000|Overall Study|Withdrawal by Subject|1|||
33542657|NCT03702231|62933442|FG001|Overall Study|Withdrawal by Subject|0|||
33542658|NCT03702231|62933443|FG002|Overall Study|Withdrawal by Subject|0|||
33542659|NCT03702231|62933441|FG000|Overall Study|Protocol Violation|0|||
33542660|NCT03702231|62933442|FG001|Overall Study|Protocol Violation|0|||
33542661|NCT03702231|62933443|FG002|Overall Study|Protocol Violation|1|||
33542662|NCT03702231|62933441|FG000|Overall Study|Change in CLL Treatment|0|||
33542663|NCT03702231|62933442|FG001|Overall Study|Change in CLL Treatment|0|||
33542664|NCT03702231|62933443|FG002|Overall Study|Change in CLL Treatment|1|||
33542665|NCT03702231|62933441|FG000|Overall Study|COVID Pandemic|1|||
33542666|NCT03702231|62933442|FG001|Overall Study|COVID Pandemic|4|||
33542667|NCT03702231|62933443|FG002|Overall Study|COVID Pandemic|1|||
33542668|NCT03702231|62933441|FG000|Overall Study|Non-compliance|0|||
33542669|NCT03702231|62933442|FG001|Overall Study|Non-compliance|0|||
33542670|NCT03702231|62933443|FG002|Overall Study|Non-compliance|1|||
33542671|NCT02741271|62933453|FG000|Overall Study|Lost to Follow-up|2|||
33542672|NCT02741271|62933454|FG001|Overall Study|Lost to Follow-up|0|||
33542673|NCT02741271|62933453|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33463176|NCT00376961|62836736|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
33463177|NCT00376961|62836735|FG000|Maintenance|Progression/relapse|0|||
33463178|NCT00376961|62836736|FG001|Maintenance|Progression/relapse|18|||
33463179|NCT00376961|62836735|FG000|Maintenance|Ineligible|0|||
33463180|NCT00376961|62836736|FG001|Maintenance|Ineligible|3|||
33463181|NCT03418324|62836746|FG000|Overall Study|Death|0|||
33463182|NCT03418324|62836747|FG001|Overall Study|Death|1|||
33463183|NCT03418324|62836746|FG000|Overall Study|Physician Decision|1|||
33463184|NCT03418324|62836747|FG001|Overall Study|Physician Decision|1|||
33463185|NCT00376259|62836755|FG000|Overall Study|Sponsor request - study termination|21|||
33463186|NCT00376259|62836756|FG001|Overall Study|Sponsor request - study termination|21|||
33463187|NCT00376259|62836755|FG000|Overall Study|Patient request|1|||
33463188|NCT00376259|62836756|FG001|Overall Study|Patient request|0|||
33463189|NCT03410056|62836766|FG000|Overall Study|Decision by Sponsor|0|||
33463190|NCT03410056|62836767|FG001|Overall Study|Decision by Sponsor|0|||
33463191|NCT03410056|62836768|FG002|Overall Study|Decision by Sponsor|3|||
33463192|NCT03410056|62836769|FG003|Overall Study|Decision by Sponsor|0|||
33463193|NCT03410056|62836770|FG004|Overall Study|Decision by Sponsor|0|||
33463194|NCT03410056|62836771|FG005|Overall Study|Decision by Sponsor|0|||
33463195|NCT03410056|62836772|FG006|Overall Study|Decision by Sponsor|0|||
33463196|NCT03410056|62836766|FG000|Overall Study|Withdrawal by Subject|0|||
33463197|NCT03410056|62836767|FG001|Overall Study|Withdrawal by Subject|2|||
33463198|NCT03410056|62836768|FG002|Overall Study|Withdrawal by Subject|5|||
33542674|NCT02741271|62933454|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
33542675|NCT02709746|62933467|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
33542676|NCT02709746|62933468|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
33542677|NCT02709746|62933469|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
33542678|NCT02709746|62933470|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
33542679|NCT02709746|62933471|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
33542680|NCT02709746|62933467|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
33542681|NCT02709746|62933468|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
33542682|NCT02709746|62933469|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
33542683|NCT02709746|62933470|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
33542684|NCT02709746|62933471|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
33542685|NCT02709746|62933467|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
33542686|NCT02709746|62933468|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
33640834|NCT01544595|63043765|FG001|Status at Week 156|Protocol Violation|1|||
33640835|NCT01544595|63043766|FG002|Status at Week 156|Protocol Violation|2|||
33640836|NCT01544595|63043767|FG003|Status at Week 156|Protocol Violation|2|||
33640837|NCT01544595|63043768|FG004|Status at Week 156|Protocol Violation|0|||
33640838|NCT01544595|63043769|FG005|Status at Week 156|Protocol Violation|0|||
33640839|NCT01544595|63043764|FG000|Status at Week 156|Technical problems|3|||
33640840|NCT01544595|63043765|FG001|Status at Week 156|Technical problems|1|||
33640841|NCT01544595|63043766|FG002|Status at Week 156|Technical problems|0|||
33640842|NCT01544595|63043767|FG003|Status at Week 156|Technical problems|1|||
33640843|NCT01544595|63043768|FG004|Status at Week 156|Technical problems|0|||
33640844|NCT01544595|63043769|FG005|Status at Week 156|Technical problems|0|||
33640845|NCT01544595|63043764|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
33640846|NCT01544595|63043765|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
33542687|NCT02709746|62933469|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
33542688|NCT02709746|62933470|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
33542689|NCT02709746|62933471|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
33542690|NCT02709746|62933467|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
33542691|NCT02709746|62933468|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
33542692|NCT02709746|62933469|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
33542693|NCT02709746|62933470|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
33542694|NCT02709746|62933471|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
33542695|NCT02709746|62933467|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
33542696|NCT02709746|62933468|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
33542697|NCT02709746|62933469|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
33542698|NCT02709746|62933470|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
33542699|NCT02709746|62933471|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
33542700|NCT02709746|62933467|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
33542701|NCT02709746|62933468|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
33542702|NCT02709746|62933469|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
33542703|NCT02709746|62933470|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
33542704|NCT02709746|62933471|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
33542705|NCT02709746|62933467|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
33542706|NCT02709746|62933468|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
33542707|NCT02709746|62933469|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
33542708|NCT02709746|62933470|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
33542709|NCT02709746|62933471|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
33542710|NCT02709746|62933467|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
33542711|NCT02709746|62933468|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
33542712|NCT02709746|62933469|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
33542713|NCT02709746|62933470|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
33542714|NCT02709746|62933471|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
33542715|NCT02709746|62933467|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
33542716|NCT02709746|62933468|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
33542717|NCT02709746|62933469|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
33542718|NCT02709746|62933470|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
33544261|NCT03010501|62935107|FG001|Study Week 1|Withdrawal by Subject|1|||
33640847|NCT01544595|63043766|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
33640848|NCT01544595|63043767|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
33640849|NCT01544595|63043768|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
33327169|NCT01185353|62703797|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33640850|NCT01544595|63043769|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
33640851|NCT01544595|63043764|FG000|Status at Week 156|Lack of Efficacy|1|||
33640852|NCT01544595|63043765|FG001|Status at Week 156|Lack of Efficacy|0|||
33640853|NCT01544595|63043766|FG002|Status at Week 156|Lack of Efficacy|1|||
33640854|NCT01544595|63043767|FG003|Status at Week 156|Lack of Efficacy|4|||
33640855|NCT01544595|63043768|FG004|Status at Week 156|Lack of Efficacy|10|||
33640856|NCT01544595|63043769|FG005|Status at Week 156|Lack of Efficacy|5|||
33640857|NCT01539525|63043790|FG000|Overall Study|Lost to Follow-up|19|||
33640858|NCT01539525|63043791|FG001|Overall Study|Lost to Follow-up|12|||
33640859|NCT01539525|63043792|FG002|Overall Study|Lost to Follow-up|11|||
33640860|NCT01539525|63043790|FG000|Overall Study|Withdrawal by Subject|0|||
33640861|NCT01539525|63043791|FG001|Overall Study|Withdrawal by Subject|3|||
33640862|NCT01539525|63043792|FG002|Overall Study|Withdrawal by Subject|2|||
33640863|NCT01539525|63043790|FG000|Overall Study|Protocol Violation|1|||
33640864|NCT01539525|63043791|FG001|Overall Study|Protocol Violation|1|||
33640865|NCT01539525|63043792|FG002|Overall Study|Protocol Violation|4|||
33640866|NCT01513551|63043806|FG000|Overall Study|Death|0|||
33640867|NCT01513551|63043807|FG001|Overall Study|Death|1|||
33640868|NCT01513551|63043808|FG002|Overall Study|Death|0|||
33640869|NCT01513551|63043806|FG000|Overall Study|Lost to Follow-up|3|||
33640870|NCT01513551|63043807|FG001|Overall Study|Lost to Follow-up|5|||
33640871|NCT01513551|63043808|FG002|Overall Study|Lost to Follow-up|2|||
33640872|NCT01513551|63043806|FG000|Overall Study|Withdrawal by Subject|1|||
33640873|NCT01513551|63043807|FG001|Overall Study|Withdrawal by Subject|0|||
33640874|NCT01513551|63043808|FG002|Overall Study|Withdrawal by Subject|2|||
33640875|NCT01513551|63043806|FG000|Overall Study|Randomized but not vaccinated|0|||
33640876|NCT01513551|63043807|FG001|Overall Study|Randomized but not vaccinated|0|||
33640877|NCT01513551|63043808|FG002|Overall Study|Randomized but not vaccinated|1|||
33640878|NCT01513473|63043818|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
33640879|NCT01513473|63043819|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
33640880|NCT01513473|63043818|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
33640881|NCT01513473|63043819|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
33640882|NCT01513473|63043818|FG000|Main Trial (26 Weeks)|Unclassified|0|||
33640883|NCT01513473|63043819|FG001|Main Trial (26 Weeks)|Unclassified|2|||
33640884|NCT01513473|63043818|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
33640885|NCT01513473|63043819|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
33640886|NCT01513473|63043818|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
33640887|NCT01513473|63043819|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
33640888|NCT01513317|63043827|FG000|Overall Study|Withdrawal by Subject|15|||
33640889|NCT01513317|63043828|FG001|Overall Study|Withdrawal by Subject|4|||
33640890|NCT01513317|63043827|FG000|Overall Study|Death|1|||
33640891|NCT01513317|63043828|FG001|Overall Study|Death|1|||
33640892|NCT01513317|63043827|FG000|Overall Study|Study terminated by sponsor|18|||
33640893|NCT01513317|63043828|FG001|Overall Study|Study terminated by sponsor|18|||
33640894|NCT01513317|63043827|FG000|Overall Study|Other|0|||
33640895|NCT01513317|63043828|FG001|Overall Study|Other|1|||
33640896|NCT03824392|63043838|FG000|Overall Study|Adverse Event|1|||
33640897|NCT03824392|63043839|FG001|Overall Study|Adverse Event|0|||
33640898|NCT03824392|63043840|FG002|Overall Study|Adverse Event|0|||
33463199|NCT03410056|62836769|FG003|Overall Study|Withdrawal by Subject|5|||
33463200|NCT03410056|62836770|FG004|Overall Study|Withdrawal by Subject|0|||
33463201|NCT03410056|62836771|FG005|Overall Study|Withdrawal by Subject|0|||
33542719|NCT02709746|62933471|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
33463202|NCT03410056|62836772|FG006|Overall Study|Withdrawal by Subject|0|||
33463203|NCT03409666|62836790|FG000|Overall Study|Physician Decision|0|||
33463204|NCT03409666|62836791|FG001|Overall Study|Physician Decision|1|||
33463205|NCT03409666|62836790|FG000|Overall Study|Protocol Violation|0|||
33463206|NCT03409666|62836791|FG001|Overall Study|Protocol Violation|3|||
33463207|NCT03440944|62836799|FG000|Overall Study|Physician Decision|1|||
33463208|NCT03440944|62836800|FG001|Overall Study|Physician Decision|0|||
33463209|NCT03440944|62836799|FG000|Overall Study|No Acceptable Vasculature|0|||
33463210|NCT03440944|62836800|FG001|Overall Study|No Acceptable Vasculature|1|||
33542720|NCT02709746|62933467|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
33640899|NCT03824392|63043841|FG003|Overall Study|Adverse Event|0|||
33327170|NCT01185353|62703798|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33463211|NCT00365105|62836809|FG000|Overall Study|Protocol Violation|5|||
33463212|NCT00365105|62836810|FG001|Overall Study|Protocol Violation|8|||
33640900|NCT03824392|63043838|FG000|Overall Study|Investigator Decision|0|||
33640901|NCT03824392|63043839|FG001|Overall Study|Investigator Decision|1|||
33640902|NCT03824392|63043840|FG002|Overall Study|Investigator Decision|0|||
33640903|NCT03824392|63043841|FG003|Overall Study|Investigator Decision|0|||
33640904|NCT03824392|63043838|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
33327171|NCT01185353|62703799|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33640905|NCT03824392|63043839|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
33463213|NCT00399893|62836818|FG000|Overall Study|Withdrawal by Subject|1|||
33640906|NCT03824392|63043840|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
33640907|NCT03824392|63043841|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
33640908|NCT01901653|63043864|FG000|Overall Study|Death|2|||
33640909|NCT01901653|63043865|FG001|Overall Study|Death|1|||
33640910|NCT01901653|63043866|FG002|Overall Study|Death|8|||
33640911|NCT01901653|63043867|FG003|Overall Study|Death|3|||
33640912|NCT01901653|63043868|FG004|Overall Study|Death|2|||
33640913|NCT01901653|63043869|FG005|Overall Study|Death|2|||
33640914|NCT01901653|63043870|FG006|Overall Study|Death|6|||
33640915|NCT01901653|63043871|FG007|Overall Study|Death|9|||
33640916|NCT01901653|63043872|FG008|Overall Study|Death|1|||
33640917|NCT01901653|63043873|FG009|Overall Study|Death|16|||
33640918|NCT01901653|63043874|FG010|Overall Study|Death|2|||
33640919|NCT01901653|63043875|FG011|Overall Study|Death|15|||
33640920|NCT01901653|63043876|FG012|Overall Study|Death|4|||
33640921|NCT01901653|63043864|FG000|Overall Study|Lost to Follow-up|1|||
33640922|NCT01901653|63043865|FG001|Overall Study|Lost to Follow-up|0|||
33640923|NCT01901653|63043866|FG002|Overall Study|Lost to Follow-up|2|||
33640924|NCT01901653|63043867|FG003|Overall Study|Lost to Follow-up|0|||
33640925|NCT01901653|63043868|FG004|Overall Study|Lost to Follow-up|0|||
33640926|NCT01901653|63043869|FG005|Overall Study|Lost to Follow-up|1|||
33640927|NCT01901653|63043870|FG006|Overall Study|Lost to Follow-up|0|||
33640928|NCT01901653|63043871|FG007|Overall Study|Lost to Follow-up|1|||
33640929|NCT01901653|63043872|FG008|Overall Study|Lost to Follow-up|0|||
33640930|NCT01901653|63043873|FG009|Overall Study|Lost to Follow-up|0|||
33640931|NCT01901653|63043874|FG010|Overall Study|Lost to Follow-up|0|||
33640932|NCT01901653|63043875|FG011|Overall Study|Lost to Follow-up|0|||
33640933|NCT01901653|63043876|FG012|Overall Study|Lost to Follow-up|0|||
33640934|NCT01901653|63043864|FG000|Overall Study|Withdrawal by Subject|0|||
33640935|NCT01901653|63043865|FG001|Overall Study|Withdrawal by Subject|0|||
33640936|NCT01901653|63043866|FG002|Overall Study|Withdrawal by Subject|0|||
33640937|NCT01901653|63043867|FG003|Overall Study|Withdrawal by Subject|0|||
33640938|NCT01901653|63043868|FG004|Overall Study|Withdrawal by Subject|0|||
33640939|NCT01901653|63043869|FG005|Overall Study|Withdrawal by Subject|0|||
33640940|NCT01901653|63043870|FG006|Overall Study|Withdrawal by Subject|1|||
33640941|NCT01901653|63043871|FG007|Overall Study|Withdrawal by Subject|0|||
33640942|NCT01901653|63043872|FG008|Overall Study|Withdrawal by Subject|0|||
33640943|NCT01901653|63043873|FG009|Overall Study|Withdrawal by Subject|0|||
33640944|NCT01901653|63043874|FG010|Overall Study|Withdrawal by Subject|0|||
33640945|NCT01901653|63043875|FG011|Overall Study|Withdrawal by Subject|0|||
33640946|NCT01901653|63043876|FG012|Overall Study|Withdrawal by Subject|0|||
33640947|NCT01901653|63043864|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
33640948|NCT01901653|63043865|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
33640949|NCT01901653|63043866|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
33640950|NCT01901653|63043867|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
33640951|NCT01901653|63043868|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
33640952|NCT01901653|63043869|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
33640953|NCT01901653|63043870|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
33640954|NCT01901653|63043871|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
33640955|NCT01901653|63043872|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
33640956|NCT01901653|63043873|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
33640957|NCT01901653|63043874|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
33640958|NCT01901653|63043875|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
33640959|NCT01901653|63043876|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
33640960|NCT01925989|63043904|FG000|Period 1|Sponsor Decision|1|||
33640961|NCT01925989|63043905|FG001|Period 1|Sponsor Decision|1|||
33463214|NCT00399893|62836819|FG001|Overall Study|Withdrawal by Subject|0|||
33463215|NCT00048542|62836829|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
33640962|NCT01925989|63043906|FG002|Period 1|Sponsor Decision|0|||
33640963|NCT01925989|63043904|FG000|Period 1|Withdrawal by Subject|0|||
33640964|NCT01925989|63043905|FG001|Period 1|Withdrawal by Subject|1|||
33640965|NCT01925989|63043906|FG002|Period 1|Withdrawal by Subject|0|||
33640966|NCT01901419|63043920|FG000|Overall Study|Protocol Violation|2|||
33463216|NCT00048542|62836830|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
33640967|NCT01901419|63043921|FG001|Overall Study|Protocol Violation|6|||
33640968|NCT01901419|63043920|FG000|Overall Study|unavailable researchers|6|||
33640969|NCT01901419|63043921|FG001|Overall Study|unavailable researchers|3|||
33640970|NCT01901341|63043948|FG000|Overall Study|Adverse Event|4|||
33640971|NCT01901341|63043949|FG001|Overall Study|Adverse Event|2|||
33640972|NCT01901341|63043948|FG000|Overall Study|Lack of Efficacy|0|||
33640973|NCT01901341|63043949|FG001|Overall Study|Lack of Efficacy|2|||
33640974|NCT01901341|63043948|FG000|Overall Study|Lost to Follow-up|0|||
33640975|NCT01901341|63043949|FG001|Overall Study|Lost to Follow-up|1|||
33640976|NCT01901341|63043948|FG000|Overall Study|Protocol Violation|2|||
33640977|NCT01901341|63043949|FG001|Overall Study|Protocol Violation|0|||
33640978|NCT01901341|63043948|FG000|Overall Study|Study Terminated by Sponsor|13|||
33640979|NCT01901341|63043949|FG001|Overall Study|Study Terminated by Sponsor|15|||
33640980|NCT01901341|63043948|FG000|Overall Study|Withdrawal by Subject|1|||
33640981|NCT01901341|63043949|FG001|Overall Study|Withdrawal by Subject|1|||
33640982|NCT01615939|63043958|FG000|Overall Study|Lost to Follow-up|5|||
33640983|NCT01615939|63043959|FG001|Overall Study|Lost to Follow-up|0|||
33640984|NCT01901185|63043965|FG000|Overall Study|Withdrawal by Subject|2|||
33640985|NCT01888003|63043972|FG000|Overall Study|Study Terminated|5|||
33640986|NCT01888003|63043973|FG001|Overall Study|Study Terminated|6|||
33463217|NCT00048542|62836831|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
33463218|NCT00048542|62836832|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
33463219|NCT00048542|62836833|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
33463220|NCT00048542|62836834|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
33463221|NCT00048542|62836835|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
33463222|NCT00048542|62836836|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
33463223|NCT00048542|62836829|FG000|Double-Blind Phase|Protocol Violation|0|||
33463224|NCT00048542|62836830|FG001|Double-Blind Phase|Protocol Violation|0|||
33463225|NCT00048542|62836831|FG002|Double-Blind Phase|Protocol Violation|1|||
33542721|NCT02709746|62933468|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
33640987|NCT01888003|63043974|FG002|Overall Study|Study Terminated|40|||
33640988|NCT01925209|63044031|FG000|Treatment Epoch|Physician Decision|1|||
33640989|NCT01925209|63044032|FG001|Treatment Epoch|Physician Decision|0|||
33640990|NCT01925209|63044033|FG002|Treatment Epoch|Physician Decision|0|||
33640991|NCT01925209|63044034|FG003|Treatment Epoch|Physician Decision|0|||
33640992|NCT01925209|63044031|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
33640993|NCT01925209|63044032|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
33640994|NCT01925209|63044033|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
33640995|NCT01925209|63044034|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
33640996|NCT01925209|63044031|FG000|Treatment Epoch|Death|1|||
33640997|NCT01925209|63044032|FG001|Treatment Epoch|Death|0|||
33640998|NCT01925209|63044033|FG002|Treatment Epoch|Death|0|||
33640999|NCT01925209|63044034|FG003|Treatment Epoch|Death|0|||
33641000|NCT01925209|63044031|FG000|Treatment Epoch|Protocol deviation|0|||
33641001|NCT01925209|63044032|FG001|Treatment Epoch|Protocol deviation|0|||
33641002|NCT01925209|63044033|FG002|Treatment Epoch|Protocol deviation|1|||
33641003|NCT01925209|63044034|FG003|Treatment Epoch|Protocol deviation|1|||
33641004|NCT01925209|63044031|FG000|Treatment Epoch|Withdrawal by Subject|4|||
33641005|NCT01925209|63044032|FG001|Treatment Epoch|Withdrawal by Subject|3|||
33641006|NCT01925209|63044033|FG002|Treatment Epoch|Withdrawal by Subject|3|||
33641007|NCT01925209|63044034|FG003|Treatment Epoch|Withdrawal by Subject|2|||
33641008|NCT01925209|63044031|FG000|Treatment Epoch|Adverse Event|3|||
33641009|NCT01925209|63044032|FG001|Treatment Epoch|Adverse Event|5|||
33641010|NCT01925209|63044033|FG002|Treatment Epoch|Adverse Event|3|||
33641011|NCT01925209|63044034|FG003|Treatment Epoch|Adverse Event|1|||
33641012|NCT01925209|63044031|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
33641013|NCT01925209|63044032|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
33641014|NCT01925209|63044033|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
33641015|NCT01925209|63044034|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
33641016|NCT01925209|63044031|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
33641017|NCT01925209|63044032|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
33641018|NCT01925209|63044033|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
33641019|NCT01925209|63044034|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
33641020|NCT01925209|63044031|FG000|Follow-up|Adverse Event|1|||
33641021|NCT01925209|63044032|FG001|Follow-up|Adverse Event|4|||
33641022|NCT01925209|63044033|FG002|Follow-up|Adverse Event|0|||
33641023|NCT01925209|63044034|FG003|Follow-up|Adverse Event|1|||
33641024|NCT01925209|63044031|FG000|Follow-up|Physician Decision|0|||
33641025|NCT01925209|63044032|FG001|Follow-up|Physician Decision|0|||
33641026|NCT01925209|63044033|FG002|Follow-up|Physician Decision|1|||
33463226|NCT00048542|62836832|FG003|Double-Blind Phase|Protocol Violation|0|||
33463227|NCT00048542|62836833|FG004|Double-Blind Phase|Protocol Violation|0|||
33542722|NCT02709746|62933469|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
33542723|NCT02709746|62933470|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
33641027|NCT01925209|63044034|FG003|Follow-up|Physician Decision|0|||
33641028|NCT01925209|63044031|FG000|Follow-up|Non-compliance with study treatment|0|||
33641029|NCT01925209|63044032|FG001|Follow-up|Non-compliance with study treatment|0|||
33641030|NCT01925209|63044033|FG002|Follow-up|Non-compliance with study treatment|0|||
33641031|NCT01925209|63044034|FG003|Follow-up|Non-compliance with study treatment|1|||
33641032|NCT01925209|63044031|FG000|Follow-up|Withdrawal by Subject|0|||
33641033|NCT01925209|63044032|FG001|Follow-up|Withdrawal by Subject|2|||
33641034|NCT01925209|63044033|FG002|Follow-up|Withdrawal by Subject|0|||
33641035|NCT01925209|63044034|FG003|Follow-up|Withdrawal by Subject|2|||
33641036|NCT01614925|63044046|FG000|Overall Study|Withdrawal by Subject|1|||
33641037|NCT01614925|63044047|FG001|Overall Study|Withdrawal by Subject|0|||
33641038|NCT01614925|63044046|FG000|Overall Study|Protocol Violation|3|||
33641039|NCT01614925|63044047|FG001|Overall Study|Protocol Violation|2|||
33641040|NCT01886833|63044053|FG000|Overall Study|IgA not available from both periods|204|||
33641041|NCT01898923|63044062|FG000|Overall Study|Lack of Efficacy|5|||
33641042|NCT01898923|63044063|FG001|Overall Study|Lack of Efficacy|6|||
33641043|NCT01898923|63044062|FG000|Overall Study|Adverse Event|3|||
33641044|NCT01898923|63044063|FG001|Overall Study|Adverse Event|1|||
33641045|NCT01898923|63044062|FG000|Overall Study|Lost to Follow-up|0|||
33641046|NCT01898923|63044063|FG001|Overall Study|Lost to Follow-up|1|||
33641047|NCT01898923|63044062|FG000|Overall Study|Withdrawal by Subject|4|||
33641048|NCT01898923|63044063|FG001|Overall Study|Withdrawal by Subject|7|||
33641049|NCT01898923|63044062|FG000|Overall Study|Physician Decision|3|||
33641050|NCT01898923|63044063|FG001|Overall Study|Physician Decision|4|||
33641051|NCT01898923|63044062|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
33641052|NCT01898923|63044063|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
33641053|NCT01924429|63044071|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
33641054|NCT01924429|63044072|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
33641055|NCT01898299|63044082|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
33641056|NCT01898299|63044083|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
33641057|NCT01886287|63044089|FG000|Overall Study|Radiographic disease progression|1|||
33641058|NCT01886287|63044089|FG000|Overall Study|Clinical progression due to disease|1|||
33641059|NCT01885195|63044093|FG000|Overall Study|Adverse Event|29|||
33641060|NCT01885195|63044093|FG000|Overall Study|Death|1|||
33641061|NCT01885195|63044093|FG000|Overall Study|Disease Progression|67|||
33641062|NCT01885195|63044093|FG000|Overall Study|Protocol Deviation|2|||
33641063|NCT01885195|63044093|FG000|Overall Study|Physician Decision|3|||
33641064|NCT01885195|63044093|FG000|Overall Study|Patient/guardian decision|8|||
33641065|NCT01896895|63044100|FG000|Double-blind MP|Physician Decision|0|||
33641066|NCT01896895|63044101|FG001|Double-blind MP|Physician Decision|0|||
33641067|NCT01896895|63044102|FG002|Double-blind MP|Physician Decision|1|||
33641068|NCT01896895|63044103|FG003|Double-blind MP|Physician Decision|0|||
33641069|NCT01896895|63044100|FG000|Double-blind MP|Withdrawal by Subject|0|||
33641070|NCT01896895|63044101|FG001|Double-blind MP|Withdrawal by Subject|2|||
33641071|NCT01896895|63044102|FG002|Double-blind MP|Withdrawal by Subject|1|||
33641072|NCT01896895|63044103|FG003|Double-blind MP|Withdrawal by Subject|0|||
33641073|NCT01896895|63044100|FG000|Double-blind MP|Lost to Follow-up|1|||
33641074|NCT01896895|63044101|FG001|Double-blind MP|Lost to Follow-up|0|||
33641075|NCT01896895|63044102|FG002|Double-blind MP|Lost to Follow-up|1|||
33641076|NCT01896895|63044103|FG003|Double-blind MP|Lost to Follow-up|0|||
33641077|NCT01923181|63044139|FG000|Overall Study|Protocol Violation|2|||
33641078|NCT01923181|63044140|FG001|Overall Study|Protocol Violation|2|||
33641079|NCT01923181|63044141|FG002|Overall Study|Protocol Violation|0|||
33641080|NCT01923181|63044142|FG003|Overall Study|Protocol Violation|2|||
33641081|NCT01923181|63044143|FG004|Overall Study|Protocol Violation|2|||
33641082|NCT01923181|63044144|FG005|Overall Study|Protocol Violation|1|||
33641083|NCT01923181|63044145|FG006|Overall Study|Protocol Violation|1|||
33641084|NCT01923181|63044146|FG007|Overall Study|Protocol Violation|2|||
33641085|NCT01923181|63044147|FG008|Overall Study|Protocol Violation|1|||
33641086|NCT01923181|63044139|FG000|Overall Study|Withdrawal by Subject|0|||
33641087|NCT01923181|63044140|FG001|Overall Study|Withdrawal by Subject|1|||
33641088|NCT01923181|63044141|FG002|Overall Study|Withdrawal by Subject|0|||
33641089|NCT01923181|63044142|FG003|Overall Study|Withdrawal by Subject|1|||
33641090|NCT01923181|63044143|FG004|Overall Study|Withdrawal by Subject|4|||
33641091|NCT01923181|63044144|FG005|Overall Study|Withdrawal by Subject|2|||
33641092|NCT01923181|63044145|FG006|Overall Study|Withdrawal by Subject|4|||
33641093|NCT01923181|63044146|FG007|Overall Study|Withdrawal by Subject|3|||
33641094|NCT01923181|63044147|FG008|Overall Study|Withdrawal by Subject|1|||
33641095|NCT01923181|63044139|FG000|Overall Study|Other|1|||
33641096|NCT01923181|63044140|FG001|Overall Study|Other|0|||
33641097|NCT01923181|63044141|FG002|Overall Study|Other|0|||
33641098|NCT01923181|63044142|FG003|Overall Study|Other|1|||
33641099|NCT01923181|63044143|FG004|Overall Study|Other|0|||
33641100|NCT01923181|63044144|FG005|Overall Study|Other|0|||
33641101|NCT01923181|63044145|FG006|Overall Study|Other|0|||
33463228|NCT00048542|62836834|FG005|Double-Blind Phase|Protocol Violation|0|||
33463229|NCT00048542|62836835|FG006|Double-Blind Phase|Protocol Violation|0|||
33463230|NCT00048542|62836836|FG007|Double-Blind Phase|Protocol Violation|0|||
33641102|NCT01923181|63044146|FG007|Overall Study|Other|0|||
33641103|NCT01923181|63044147|FG008|Overall Study|Other|0|||
33641104|NCT01923181|63044139|FG000|Overall Study|Lost to Follow-up|0|||
33641105|NCT01923181|63044140|FG001|Overall Study|Lost to Follow-up|3|||
33641106|NCT01923181|63044141|FG002|Overall Study|Lost to Follow-up|2|||
33641107|NCT01923181|63044142|FG003|Overall Study|Lost to Follow-up|1|||
33641108|NCT01923181|63044143|FG004|Overall Study|Lost to Follow-up|2|||
33641109|NCT01923181|63044144|FG005|Overall Study|Lost to Follow-up|1|||
33641110|NCT01923181|63044145|FG006|Overall Study|Lost to Follow-up|3|||
33641111|NCT01923181|63044146|FG007|Overall Study|Lost to Follow-up|3|||
33641112|NCT01923181|63044147|FG008|Overall Study|Lost to Follow-up|1|||
33641113|NCT01896271|63044170|FG000|Overall Study|Physician Decision|10|||
33641114|NCT01884571|63044183|FG000|Overall Study|Adverse Event|1|||
33641115|NCT01884571|63044183|FG000|Overall Study|Death|2|||
33641116|NCT01884571|63044183|FG000|Overall Study|Withdrawal by Subject|2|||
33641117|NCT01884571|63044183|FG000|Overall Study|Disease progression|3|||
33641118|NCT01884337|63044189|FG000|Treatment|Adverse Event|2|||
33641119|NCT01884337|63044190|FG001|Treatment|Adverse Event|2|||
33641120|NCT01884337|63044189|FG000|Treatment|Subj. request to discont. treatment|2|||
33641121|NCT01884337|63044190|FG001|Treatment|Subj. request to discont. treatment|0|||
33641122|NCT01884337|63044189|FG000|Follow-up Period|Lost to Follow-up|1|||
33641123|NCT01884337|63044190|FG001|Follow-up Period|Lost to Follow-up|1|||
33641124|NCT01922089|63044198|FG000|Overall Study|Adverse Event|18|||
33641125|NCT01922089|63044199|FG001|Overall Study|Adverse Event|13|||
33641126|NCT01922089|63044198|FG000|Overall Study|Protocol Deviation|10|||
33641127|NCT01922089|63044199|FG001|Overall Study|Protocol Deviation|7|||
33641128|NCT01922089|63044198|FG000|Overall Study|Withdrawal by Subject|3|||
33641129|NCT01922089|63044199|FG001|Overall Study|Withdrawal by Subject|4|||
33641130|NCT01922089|63044198|FG000|Overall Study|administrative problems|4|||
33641131|NCT01922089|63044199|FG001|Overall Study|administrative problems|1|||
33641132|NCT01922089|63044198|FG000|Overall Study|Physician Decision|2|||
33641133|NCT01922089|63044199|FG001|Overall Study|Physician Decision|3|||
33641134|NCT01922089|63044198|FG000|Overall Study|Death|2|||
33641135|NCT01922089|63044199|FG001|Overall Study|Death|1|||
33641136|NCT01922089|63044198|FG000|Overall Study|Lost to Follow-up|0|||
33641137|NCT01922089|63044199|FG001|Overall Study|Lost to Follow-up|1|||
33641138|NCT01884025|63044207|FG000|Overall Study|Lost to Follow-up|3|||
33641139|NCT01884025|63044208|FG001|Overall Study|Lost to Follow-up|4|||
33641140|NCT01896193|63044218|FG000|Overall Study|Lack of Efficacy|20|||
33641141|NCT01896193|63044219|FG001|Overall Study|Lack of Efficacy|11|||
33641142|NCT01896193|63044218|FG000|Overall Study|Protocol Violation|0|||
33641143|NCT01896193|63044219|FG001|Overall Study|Protocol Violation|1|||
33641144|NCT01896193|63044218|FG000|Overall Study|Withdrew Consent|1|||
33641145|NCT01896193|63044219|FG001|Overall Study|Withdrew Consent|0|||
33641146|NCT01922011|63044229|FG000|Overall Study|Protocol Violation|0|||
33641147|NCT01922011|63044230|FG001|Overall Study|Protocol Violation|1|||
33641148|NCT01922011|63044229|FG000|Overall Study|Physician Decision|0|||
33641149|NCT01922011|63044230|FG001|Overall Study|Physician Decision|1|||
33641150|NCT01922011|63044229|FG000|Overall Study|Parent/Guardian Decision|3|||
33641151|NCT01922011|63044230|FG001|Overall Study|Parent/Guardian Decision|0|||
33641152|NCT01922011|63044229|FG000|Overall Study|Lost to Follow-up|0|||
33641153|NCT01922011|63044230|FG001|Overall Study|Lost to Follow-up|1|||
33641154|NCT01922011|63044229|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
33641155|NCT01922011|63044230|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
33641156|NCT01922011|63044229|FG000|Overall Study|Not Treated|1|||
33641157|NCT01922011|63044230|FG001|Overall Study|Not Treated|0|||
33641158|NCT01922011|63044229|FG000|Overall Study|Lack of willing home health agency|1|||
33641159|NCT01922011|63044230|FG001|Overall Study|Lack of willing home health agency|0|||
33641160|NCT01922011|63044229|FG000|Overall Study|Randomized in error|1|||
33641161|NCT01922011|63044230|FG001|Overall Study|Randomized in error|0|||
33641162|NCT01883635|63044244|FG000|Overall Study|Withdrawal by Subject|4|||
33641163|NCT01883635|63044245|FG001|Overall Study|Withdrawal by Subject|0|||
33641164|NCT01921387|63044253|FG000|Overall Study|Adverse Event|1|||
33641165|NCT01895335|63044257|FG000|Overall Study|Adverse Event|106|||
33641166|NCT01895335|63044257|FG000|Overall Study|Lack of Efficacy|53|||
33641167|NCT01895335|63044257|FG000|Overall Study|Poor Compliance to Protocol|11|||
33641168|NCT01895335|63044257|FG000|Overall Study|Included But Not treated|1|||
33641169|NCT01895335|63044257|FG000|Overall Study|Other than Specified Above|44|||
33641170|NCT01617655|63044263|FG000|Overall Study|Adverse Event|2|||
33641171|NCT01617655|63044264|FG001|Overall Study|Adverse Event|3|||
33641172|NCT01617655|63044263|FG000|Overall Study|Poor compliance to protocol|1|||
33641173|NCT01617655|63044264|FG001|Overall Study|Poor compliance to protocol|4|||
33641174|NCT01617655|63044263|FG000|Overall Study|Participants moved|0|||
33641175|NCT01617655|63044264|FG001|Overall Study|Participants moved|4|||
33641176|NCT01617655|63044263|FG000|Overall Study|Consent withdrawn by participant|1|||
33641177|NCT01617655|63044264|FG001|Overall Study|Consent withdrawn by participant|1|||
33641178|NCT01617655|63044263|FG000|Overall Study|Last visit outside protocol visit window|1|||
33641179|NCT01617655|63044264|FG001|Overall Study|Last visit outside protocol visit window|10|||
33641180|NCT01617655|63044263|FG000|Overall Study|Site closure|3|||
33641181|NCT01617655|63044264|FG001|Overall Study|Site closure|5|||
33641182|NCT01617655|63044263|FG000|Overall Study|Other than specified above|1|||
33641183|NCT01617655|63044264|FG001|Overall Study|Other than specified above|2|||
33641184|NCT01895101|63044275|FG000|Overall Study|OPCAB procedure|1|||
33641185|NCT01895101|63044276|FG001|Overall Study|OPCAB procedure|1|||
33641186|NCT01895101|63044277|FG002|Overall Study|OPCAB procedure|3|||
33641187|NCT01895101|63044275|FG000|Overall Study|Withdrawal by Subject|0|||
33641188|NCT01895101|63044276|FG001|Overall Study|Withdrawal by Subject|1|||
33641189|NCT01895101|63044277|FG002|Overall Study|Withdrawal by Subject|2|||
33542724|NCT02709746|62933471|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
33542725|NCT02709746|62933467|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
33542726|NCT02709746|62933468|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
33542727|NCT02709746|62933469|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
33542728|NCT02709746|62933470|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
33542729|NCT02709746|62933471|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
33542730|NCT02709746|62933467|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
33542731|NCT02709746|62933468|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
33542732|NCT02709746|62933469|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
33542733|NCT02709746|62933470|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
33542734|NCT02709746|62933471|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
33542735|NCT02709746|62933467|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
33542736|NCT02709746|62933468|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
33542737|NCT02709746|62933469|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
33542738|NCT02709746|62933470|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
33542739|NCT02709746|62933471|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
33542740|NCT02709746|62933467|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
33542741|NCT02709746|62933468|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
33542742|NCT02709746|62933469|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
33542743|NCT02709746|62933470|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
33542744|NCT02709746|62933471|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
33542745|NCT02709746|62933467|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
33542746|NCT02709746|62933468|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
33542747|NCT02709746|62933469|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
33542748|NCT02709746|62933470|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
33542749|NCT02709746|62933471|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
33542750|NCT02709746|62933467|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
33542751|NCT02709746|62933468|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
33542752|NCT02709746|62933469|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
33542753|NCT02709746|62933470|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
33542754|NCT02709746|62933471|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
33542755|NCT02709746|62933467|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
33542756|NCT02709746|62933468|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
33542757|NCT02709746|62933469|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
33542758|NCT02709746|62933470|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
33542759|NCT02709746|62933471|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
33542760|NCT01317641|62933492|FG000|Overall Study|Not treated|0|||
33542761|NCT01317641|62933493|FG001|Overall Study|Not treated|0|||
33542762|NCT01317641|62933494|FG002|Overall Study|Not treated|0|||
33542763|NCT01317641|62933495|FG003|Overall Study|Not treated|0|||
33542764|NCT01317641|62933496|FG004|Overall Study|Not treated|0|||
33542765|NCT01317641|62933497|FG005|Overall Study|Not treated|0|||
33542766|NCT01317641|62933498|FG006|Overall Study|Not treated|0|||
33542767|NCT01317641|62933499|FG007|Overall Study|Not treated|1|||
33542768|NCT01317641|62933500|FG008|Overall Study|Not treated|1|||
33542769|NCT01317641|62933492|FG000|Overall Study|Adverse Event|0|||
33542770|NCT01317641|62933493|FG001|Overall Study|Adverse Event|1|||
33542771|NCT01317641|62933494|FG002|Overall Study|Adverse Event|0|||
33542772|NCT01317641|62933495|FG003|Overall Study|Adverse Event|1|||
33542773|NCT01317641|62933496|FG004|Overall Study|Adverse Event|0|||
33542774|NCT01317641|62933497|FG005|Overall Study|Adverse Event|0|||
33542775|NCT01317641|62933498|FG006|Overall Study|Adverse Event|2|||
33542776|NCT01317641|62933499|FG007|Overall Study|Adverse Event|1|||
33542777|NCT01317641|62933500|FG008|Overall Study|Adverse Event|0|||
33542778|NCT01317641|62933492|FG000|Overall Study|Protocol Violation|1|||
33542779|NCT01317641|62933493|FG001|Overall Study|Protocol Violation|0|||
33542780|NCT01317641|62933494|FG002|Overall Study|Protocol Violation|0|||
33542781|NCT01317641|62933495|FG003|Overall Study|Protocol Violation|0|||
33542782|NCT01317641|62933496|FG004|Overall Study|Protocol Violation|0|||
33542783|NCT01317641|62933497|FG005|Overall Study|Protocol Violation|0|||
33542784|NCT01317641|62933498|FG006|Overall Study|Protocol Violation|0|||
33542785|NCT01317641|62933499|FG007|Overall Study|Protocol Violation|0|||
33542786|NCT01317641|62933500|FG008|Overall Study|Protocol Violation|0|||
33542787|NCT01317641|62933492|FG000|Overall Study|Disease progression|0|||
33542788|NCT01317641|62933493|FG001|Overall Study|Disease progression|0|||
33542789|NCT01317641|62933494|FG002|Overall Study|Disease progression|0|||
33542790|NCT01317641|62933495|FG003|Overall Study|Disease progression|0|||
33641190|NCT01895101|63044275|FG000|Overall Study|another study, enrolled in other study|0|||
33542791|NCT01317641|62933496|FG004|Overall Study|Disease progression|0|||
33542792|NCT01317641|62933497|FG005|Overall Study|Disease progression|0|||
33542793|NCT01317641|62933498|FG006|Overall Study|Disease progression|0|||
33542794|NCT01317641|62933499|FG007|Overall Study|Disease progression|3|||
33641191|NCT01895101|63044276|FG001|Overall Study|another study, enrolled in other study|1|||
33641192|NCT01895101|63044277|FG002|Overall Study|another study, enrolled in other study|0|||
33641193|NCT01895101|63044275|FG000|Overall Study|Death|0|||
33641194|NCT01895101|63044276|FG001|Overall Study|Death|1|||
33641195|NCT01895101|63044277|FG002|Overall Study|Death|0|||
33641196|NCT01895101|63044275|FG000|Overall Study|coagulation disorder|0|||
33641197|NCT01895101|63044276|FG001|Overall Study|coagulation disorder|1|||
33641198|NCT01895101|63044277|FG002|Overall Study|coagulation disorder|0|||
33641199|NCT01894477|63044287|FG000|Overall Study|Protocol Violation|0|||
33641200|NCT01894477|63044288|FG001|Overall Study|Protocol Violation|1|||
33641201|NCT01894477|63044287|FG000|Overall Study|protocol changed due SC changed to cord|0|||
33641202|NCT01894477|63044288|FG001|Overall Study|protocol changed due SC changed to cord|1|||
33641203|NCT01894243|63044297|FG000|Overall Study|Adverse Event|0|||
33641204|NCT01894243|63044298|FG001|Overall Study|Adverse Event|1|||
33641205|NCT01894243|63044299|FG002|Overall Study|Adverse Event|2|||
33641206|NCT01894243|63044297|FG000|Overall Study|Death|0|||
33641207|NCT01894243|63044298|FG001|Overall Study|Death|0|||
33641208|NCT01894243|63044299|FG002|Overall Study|Death|3|||
33641209|NCT01894243|63044297|FG000|Overall Study|Lack of Efficacy|3|||
33641210|NCT01894243|63044298|FG001|Overall Study|Lack of Efficacy|3|||
33641211|NCT01894243|63044299|FG002|Overall Study|Lack of Efficacy|1|||
33641212|NCT01894243|63044297|FG000|Overall Study|Condition under investigation worsened|8|||
33641213|NCT01894243|63044298|FG001|Overall Study|Condition under investigation worsened|6|||
33641214|NCT01894243|63044299|FG002|Overall Study|Condition under investigation worsened|2|||
33641215|NCT01894243|63044297|FG000|Overall Study|Subject decision|1|||
33641216|NCT01894243|63044298|FG001|Overall Study|Subject decision|0|||
33641217|NCT01894243|63044299|FG002|Overall Study|Subject decision|0|||
33641218|NCT01894243|63044297|FG000|Overall Study|Other|1|||
33641219|NCT01894243|63044298|FG001|Overall Study|Other|0|||
33641220|NCT01894243|63044299|FG002|Overall Study|Other|0|||
33641221|NCT03822832|63044316|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
33641222|NCT03822832|63044317|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
33641223|NCT03822832|63044316|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
33641224|NCT03822832|63044317|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
33641225|NCT03822832|63044316|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
33641226|NCT03822832|63044317|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
33641227|NCT03822832|63044316|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
33641228|NCT03822832|63044317|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
33641229|NCT03822832|63044316|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
33641230|NCT03822832|63044317|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
33641231|NCT03822832|63044316|FG000|Re-allocation|Not re-allocated to open label period|2|||
33641232|NCT03822832|63044317|FG001|Re-allocation|Not re-allocated to open label period|6|||
33641233|NCT03822832|63044316|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
33641234|NCT03822832|63044317|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
33641235|NCT03822832|63044316|FG000|Period 2 - Open Label Period|Adverse Event|0|||
33641236|NCT03822832|63044317|FG001|Period 2 - Open Label Period|Adverse Event|3|||
33641237|NCT01513239|63044327|FG000|Period 1: Main Phase|Adverse Event|1|||
33641238|NCT01513239|63044328|FG001|Period 1: Main Phase|Adverse Event|1|||
33641239|NCT01513239|63044329|FG002|Period 1: Main Phase|Adverse Event|2|||
33641240|NCT01513239|63044330|FG003|Period 1: Main Phase|Adverse Event|0|||
33641241|NCT01513239|63044331|FG004|Period 1: Main Phase|Adverse Event|0|||
33641242|NCT01513239|63044332|FG005|Period 1: Main Phase|Adverse Event|0|||
33641243|NCT01513239|63044327|FG000|Period 1: Main Phase|Death|29|||
33641244|NCT01513239|63044328|FG001|Period 1: Main Phase|Death|22|||
33641245|NCT01513239|63044329|FG002|Period 1: Main Phase|Death|32|||
33641246|NCT01513239|63044330|FG003|Period 1: Main Phase|Death|0|||
33641247|NCT01513239|63044331|FG004|Period 1: Main Phase|Death|0|||
33641248|NCT01513239|63044332|FG005|Period 1: Main Phase|Death|0|||
33641249|NCT01513239|63044327|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
33641250|NCT01513239|63044328|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
33641251|NCT01513239|63044329|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
33641252|NCT01513239|63044330|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
33641253|NCT01513239|63044331|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
33641254|NCT01513239|63044332|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
33641255|NCT01513239|63044327|FG000|Period 1: Main Phase|Physician Decision|4|||
33641256|NCT01513239|63044328|FG001|Period 1: Main Phase|Physician Decision|4|||
33641257|NCT01513239|63044329|FG002|Period 1: Main Phase|Physician Decision|4|||
33641258|NCT01513239|63044330|FG003|Period 1: Main Phase|Physician Decision|0|||
33641259|NCT01513239|63044331|FG004|Period 1: Main Phase|Physician Decision|0|||
33641260|NCT01513239|63044332|FG005|Period 1: Main Phase|Physician Decision|0|||
33641261|NCT01513239|63044327|FG000|Period 1: Main Phase|Protocol Violation|2|||
33641262|NCT01513239|63044328|FG001|Period 1: Main Phase|Protocol Violation|2|||
33641263|NCT01513239|63044329|FG002|Period 1: Main Phase|Protocol Violation|2|||
33641264|NCT01513239|63044330|FG003|Period 1: Main Phase|Protocol Violation|0|||
33641265|NCT01513239|63044331|FG004|Period 1: Main Phase|Protocol Violation|0|||
33641266|NCT01513239|63044332|FG005|Period 1: Main Phase|Protocol Violation|0|||
33641267|NCT01513239|63044327|FG000|Period 1: Main Phase|Technical Problems|1|||
33641268|NCT01513239|63044328|FG001|Period 1: Main Phase|Technical Problems|2|||
33641269|NCT01513239|63044329|FG002|Period 1: Main Phase|Technical Problems|0|||
33641270|NCT01513239|63044330|FG003|Period 1: Main Phase|Technical Problems|0|||
33641271|NCT01513239|63044331|FG004|Period 1: Main Phase|Technical Problems|0|||
33641272|NCT01513239|63044332|FG005|Period 1: Main Phase|Technical Problems|0|||
33641273|NCT01513239|63044327|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
33641274|NCT01513239|63044328|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
33641275|NCT01513239|63044329|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
33641276|NCT01513239|63044330|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
33641277|NCT01513239|63044331|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
33641278|NCT01513239|63044332|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
33641279|NCT01513239|63044327|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
33641280|NCT01513239|63044328|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
33641281|NCT01513239|63044329|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
33641282|NCT01513239|63044330|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
33641283|NCT01513239|63044331|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
33641284|NCT01513239|63044332|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
33641285|NCT01513239|63044327|FG000|Period 2: 9 Month Extension Phase|Death|0|||
33641286|NCT01513239|63044328|FG001|Period 2: 9 Month Extension Phase|Death|0|||
33641287|NCT01513239|63044329|FG002|Period 2: 9 Month Extension Phase|Death|0|||
33641288|NCT01513239|63044330|FG003|Period 2: 9 Month Extension Phase|Death|2|||
33641289|NCT01513239|63044331|FG004|Period 2: 9 Month Extension Phase|Death|5|||
33641290|NCT01513239|63044332|FG005|Period 2: 9 Month Extension Phase|Death|2|||
33641291|NCT01513239|63044327|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
33641292|NCT01513239|63044328|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
33641293|NCT01513239|63044329|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
33641294|NCT01513239|63044330|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
33641295|NCT01513239|63044331|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
33641296|NCT01513239|63044332|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
33641297|NCT01513239|63044327|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
33641298|NCT01513239|63044328|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
33641299|NCT01513239|63044329|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
33641300|NCT01513239|63044330|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
33641301|NCT01513239|63044331|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
33641302|NCT01513239|63044332|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
33641303|NCT01513239|63044327|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
33641304|NCT01513239|63044328|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
33641305|NCT01513239|63044329|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
33641306|NCT01513239|63044330|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
33641307|NCT01513239|63044331|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
33641308|NCT01513239|63044332|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
33641309|NCT01544127|63044347|FG000|Overall Study|Lost to Follow-up|4|||
33641310|NCT01544127|63044348|FG001|Overall Study|Lost to Follow-up|2|||
33641311|NCT01544127|63044349|FG002|Overall Study|Lost to Follow-up|9|||
33641312|NCT01544127|63044347|FG000|Overall Study|Withdrawal by Subject|2|||
33641313|NCT01544127|63044348|FG001|Overall Study|Withdrawal by Subject|2|||
33641314|NCT01544127|63044349|FG002|Overall Study|Withdrawal by Subject|1|||
33641315|NCT01544127|63044347|FG000|Overall Study|Discharged out of catchment area|1|||
33641316|NCT01544127|63044348|FG001|Overall Study|Discharged out of catchment area|1|||
33641317|NCT01544127|63044349|FG002|Overall Study|Discharged out of catchment area|1|||
33641318|NCT01544127|63044347|FG000|Overall Study|Death|1|||
33641319|NCT01544127|63044348|FG001|Overall Study|Death|0|||
33641320|NCT01544127|63044349|FG002|Overall Study|Death|0|||
33641321|NCT01544127|63044347|FG000|Overall Study|Jail or Prison|1|||
33641322|NCT01544127|63044348|FG001|Overall Study|Jail or Prison|1|||
33641323|NCT01544127|63044349|FG002|Overall Study|Jail or Prison|2|||
33641324|NCT01544127|63044347|FG000|Overall Study|Became Psychotic|1|||
33641325|NCT01544127|63044348|FG001|Overall Study|Became Psychotic|0|||
33463231|NCT00048542|62836829|FG000|Double-Blind Phase|Sponsor request or decision|2|||
33463232|NCT00048542|62836830|FG001|Double-Blind Phase|Sponsor request or decision|0|||
33542795|NCT01317641|62933500|FG008|Overall Study|Disease progression|4|||
33641326|NCT01544127|63044349|FG002|Overall Study|Became Psychotic|0|||
33641327|NCT01544127|63044347|FG000|Overall Study|Researcher withdrew|1|||
33641328|NCT01544127|63044348|FG001|Overall Study|Researcher withdrew|0|||
33641329|NCT01544127|63044349|FG002|Overall Study|Researcher withdrew|0|||
33641330|NCT01544127|63044347|FG000|Overall Study|Went active duty|0|||
33641331|NCT01544127|63044348|FG001|Overall Study|Went active duty|0|||
33641332|NCT01544127|63044349|FG002|Overall Study|Went active duty|1|||
33641333|NCT01512693|63044360|FG000|Overall Study|Withdrawal by Subject|0|||
33542796|NCT01317641|62933492|FG000|Overall Study|Withdrawal by Subject|0|||
33641334|NCT01512693|63044361|FG001|Overall Study|Withdrawal by Subject|1|||
33641335|NCT01458340|63044370|FG000|Overall Study|Adverse Event|5|||
33641336|NCT01458340|63044371|FG001|Overall Study|Adverse Event|4|||
33641337|NCT01458340|63044372|FG002|Overall Study|Adverse Event|2|||
33641338|NCT01458340|63044370|FG000|Overall Study|Lost to Follow-up|3|||
33641339|NCT01458340|63044371|FG001|Overall Study|Lost to Follow-up|3|||
33641340|NCT01458340|63044372|FG002|Overall Study|Lost to Follow-up|10|||
33641341|NCT01458340|63044370|FG000|Overall Study|Miscellaneous|0|||
33641342|NCT01458340|63044371|FG001|Overall Study|Miscellaneous|1|||
33641343|NCT01458340|63044372|FG002|Overall Study|Miscellaneous|0|||
33641344|NCT01458340|63044370|FG000|Overall Study|Physician Decision|1|||
33641345|NCT01458340|63044371|FG001|Overall Study|Physician Decision|1|||
33641346|NCT01458340|63044372|FG002|Overall Study|Physician Decision|2|||
33641347|NCT01458340|63044370|FG000|Overall Study|Protocol Violation|6|||
33641348|NCT01458340|63044371|FG001|Overall Study|Protocol Violation|6|||
33641349|NCT01458340|63044372|FG002|Overall Study|Protocol Violation|5|||
33641350|NCT01458340|63044370|FG000|Overall Study|Withdrawal by Subject|12|||
33641351|NCT01458340|63044371|FG001|Overall Study|Withdrawal by Subject|6|||
33641352|NCT01458340|63044372|FG002|Overall Study|Withdrawal by Subject|4|||
33641353|NCT01539291|63044418|FG000|Study GS-US-312-0116|Adverse Event|9|||
33641354|NCT01539291|63044419|FG001|Study GS-US-312-0116|Adverse Event|0|||
33641355|NCT01539291|63044420|FG002|Study GS-US-312-0116|Adverse Event|0|||
33641356|NCT01539291|63044421|FG003|Study GS-US-312-0116|Adverse Event|0|||
33641357|NCT01539291|63044418|FG000|Study GS-US-312-0116|Physician Decision|1|||
33641358|NCT01539291|63044419|FG001|Study GS-US-312-0116|Physician Decision|0|||
33641359|NCT01539291|63044420|FG002|Study GS-US-312-0116|Physician Decision|0|||
33641360|NCT01539291|63044421|FG003|Study GS-US-312-0116|Physician Decision|0|||
33641361|NCT01539291|63044418|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
33641362|NCT01539291|63044419|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
33641363|NCT01539291|63044420|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
33641364|NCT01539291|63044421|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
33641365|NCT01539291|63044418|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
33641366|NCT01539291|63044419|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
33641367|NCT01539291|63044420|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
33641368|NCT01539291|63044421|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
33641369|NCT01539291|63044418|FG000|Study GS-US-312-0116|Other|1|||
33641370|NCT01539291|63044419|FG001|Study GS-US-312-0116|Other|0|||
33641371|NCT01539291|63044420|FG002|Study GS-US-312-0116|Other|0|||
33641372|NCT01539291|63044421|FG003|Study GS-US-312-0116|Other|0|||
33641373|NCT01539291|63044418|FG000|Study GS-US-312-0117|Adverse Event|22|||
33641374|NCT01539291|63044419|FG001|Study GS-US-312-0117|Adverse Event|1|||
33641375|NCT01539291|63044420|FG002|Study GS-US-312-0117|Adverse Event|9|||
33641376|NCT01539291|63044421|FG003|Study GS-US-312-0117|Adverse Event|12|||
33641377|NCT01539291|63044418|FG000|Study GS-US-312-0117|Physician Decision|9|||
33641378|NCT01539291|63044419|FG001|Study GS-US-312-0117|Physician Decision|0|||
33641379|NCT01539291|63044420|FG002|Study GS-US-312-0117|Physician Decision|6|||
33641380|NCT01539291|63044421|FG003|Study GS-US-312-0117|Physician Decision|4|||
33641381|NCT01539291|63044418|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
33641382|NCT01539291|63044419|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
33641383|NCT01539291|63044420|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
33641384|NCT01539291|63044421|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
33641385|NCT01539291|63044418|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
33641386|NCT01539291|63044419|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
33641387|NCT01539291|63044420|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
33641388|NCT01539291|63044421|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
33641389|NCT01539291|63044418|FG000|Study GS-US-312-0117|Other|2|||
33641390|NCT01539291|63044419|FG001|Study GS-US-312-0117|Other|1|||
33641391|NCT01539291|63044420|FG002|Study GS-US-312-0117|Other|1|||
33641392|NCT01539291|63044421|FG003|Study GS-US-312-0117|Other|1|||
33641393|NCT01538199|63044444|FG000|Overall Study|Lost to Follow-up|1|||
33641394|NCT01538199|63044445|FG001|Overall Study|Lost to Follow-up|2|||
33641395|NCT01538199|63044446|FG002|Overall Study|Lost to Follow-up|1|||
33641396|NCT01538199|63044447|FG003|Overall Study|Lost to Follow-up|0|||
33641397|NCT01538199|63044444|FG000|Overall Study|participant did not have time|1|||
33641398|NCT01538199|63044445|FG001|Overall Study|participant did not have time|0|||
33641399|NCT01538199|63044446|FG002|Overall Study|participant did not have time|0|||
33641400|NCT01538199|63044447|FG003|Overall Study|participant did not have time|2|||
33641401|NCT01538199|63044444|FG000|Overall Study|Lack of Efficacy|0|||
33641402|NCT01538199|63044445|FG001|Overall Study|Lack of Efficacy|1|||
33641403|NCT01538199|63044446|FG002|Overall Study|Lack of Efficacy|0|||
33641404|NCT01538199|63044447|FG003|Overall Study|Lack of Efficacy|0|||
33641405|NCT01511445|63044466|FG000|Overall Study|Lost to Follow-up|3|||
33641406|NCT01511445|63044467|FG001|Overall Study|Lost to Follow-up|1|||
33641407|NCT01511445|63044466|FG000|Overall Study|Protocol Violation|1|||
33641408|NCT01511445|63044467|FG001|Overall Study|Protocol Violation|3|||
33641409|NCT01511445|63044466|FG000|Overall Study|Protocol Violation|1|||
33641410|NCT01511445|63044467|FG001|Overall Study|Protocol Violation|0|||
33641411|NCT01543503|63044475|FG000|Overall Study|Lost to Follow-up|32|||
33641412|NCT01543503|63044476|FG001|Overall Study|Lost to Follow-up|36|||
33641413|NCT01543503|63044475|FG000|Overall Study|Adverse Event|9|||
33641414|NCT01543503|63044476|FG001|Overall Study|Adverse Event|13|||
33641415|NCT01543503|63044475|FG000|Overall Study|Lack of Efficacy|4|||
33641416|NCT01543503|63044476|FG001|Overall Study|Lack of Efficacy|16|||
33641417|NCT01543503|63044475|FG000|Overall Study|Participant withdrew informed consent|8|||
33641418|NCT01543503|63044476|FG001|Overall Study|Participant withdrew informed consent|10|||
33641419|NCT01543503|63044475|FG000|Overall Study|Change of jobs|0|||
33641420|NCT01543503|63044476|FG001|Overall Study|Change of jobs|1|||
33641421|NCT01543503|63044475|FG000|Overall Study|Intolerance to the biologic treatment|0|||
33641422|NCT01543503|63044476|FG001|Overall Study|Intolerance to the biologic treatment|1|||
33641423|NCT01543503|63044475|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
33641424|NCT01543503|63044476|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
33641425|NCT01543503|63044475|FG000|Overall Study|Participant did not complete last visit|0|||
33641426|NCT01543503|63044476|FG001|Overall Study|Participant did not complete last visit|2|||
33641427|NCT01543503|63044475|FG000|Overall Study|Refused to continue treatment|7|||
33641428|NCT01543503|63044476|FG001|Overall Study|Refused to continue treatment|0|||
33641429|NCT01543503|63044475|FG000|Overall Study|Incorrect medication received|1|||
33641430|NCT01543503|63044476|FG001|Overall Study|Incorrect medication received|0|||
33641431|NCT01543503|63044475|FG000|Overall Study|Participant moved to another city|2|||
33641432|NCT01543503|63044476|FG001|Overall Study|Participant moved to another city|0|||
33641433|NCT01543503|63044475|FG000|Overall Study|Participant will not return for visits|0|||
33641434|NCT01543503|63044476|FG001|Overall Study|Participant will not return for visits|2|||
33641435|NCT01543503|63044475|FG000|Overall Study|Participant transferred to another city|1|||
33641436|NCT01543503|63044476|FG001|Overall Study|Participant transferred to another city|0|||
33641437|NCT01543503|63044475|FG000|Overall Study|Participant moved to Scotland|1|||
33641438|NCT01543503|63044476|FG001|Overall Study|Participant moved to Scotland|0|||
33641439|NCT01543503|63044475|FG000|Overall Study|Participant decision to stop treatment|1|||
33641440|NCT01543503|63044476|FG001|Overall Study|Participant decision to stop treatment|0|||
33641441|NCT01543503|63044475|FG000|Overall Study|Investigator did not wish to participate|1|||
33641442|NCT01543503|63044476|FG001|Overall Study|Investigator did not wish to participate|1|||
33641443|NCT01543503|63044475|FG000|Overall Study|Participant recruited after closing date|0|||
33641444|NCT01543503|63044476|FG001|Overall Study|Participant recruited after closing date|1|||
33641445|NCT01543503|63044475|FG000|Overall Study|Site stopped participation|5|||
33641446|NCT01543503|63044476|FG001|Overall Study|Site stopped participation|1|||
33641447|NCT01543503|63044475|FG000|Overall Study|Participant did not attend a visit|1|||
33641448|NCT01543503|63044476|FG001|Overall Study|Participant did not attend a visit|0|||
33641449|NCT01543503|63044475|FG000|Overall Study|Moved to other rheumatologic site|0|||
33641450|NCT01543503|63044476|FG001|Overall Study|Moved to other rheumatologic site|1|||
33641451|NCT01543503|63044475|FG000|Overall Study|Participant consented to another study|0|||
33641452|NCT01543503|63044476|FG001|Overall Study|Participant consented to another study|2|||
33641453|NCT01543503|63044475|FG000|Overall Study|Participant went to United States|1|||
33641454|NCT01543503|63044476|FG001|Overall Study|Participant went to United States|0|||
33641455|NCT01543503|63044475|FG000|Overall Study|Screen failure|1|||
33641456|NCT01543503|63044476|FG001|Overall Study|Screen failure|0|||
33641457|NCT01511055|63044482|FG000|Overall Study|Withdrawal by Subject|6|||
33641458|NCT01537887|63044486|FG000|Period 1|Physician Decision|0|||
33641459|NCT01537887|63044487|FG001|Period 1|Physician Decision|0|||
33641460|NCT01537887|63044488|FG002|Period 1|Physician Decision|0|||
33641461|NCT01537887|63044489|FG003|Period 1|Physician Decision|0|||
33641462|NCT01537887|63044490|FG004|Period 1|Physician Decision|1|||
33641463|NCT01537887|63044491|FG005|Period 1|Physician Decision|1|||
33641464|NCT01537887|63044486|FG000|Period 1|Did not receive treatment|0|||
33641465|NCT01537887|63044487|FG001|Period 1|Did not receive treatment|0|||
33641466|NCT01537887|63044488|FG002|Period 1|Did not receive treatment|1|||
33641467|NCT01537887|63044489|FG003|Period 1|Did not receive treatment|0|||
33641468|NCT01537887|63044490|FG004|Period 1|Did not receive treatment|0|||
33641469|NCT01537887|63044491|FG005|Period 1|Did not receive treatment|0|||
33641470|NCT01537887|63044486|FG000|Period 2|Withdrawal by Subject|0|||
33641471|NCT01537887|63044487|FG001|Period 2|Withdrawal by Subject|1|||
33641472|NCT01537887|63044488|FG002|Period 2|Withdrawal by Subject|0|||
33641473|NCT01537887|63044489|FG003|Period 2|Withdrawal by Subject|0|||
33641474|NCT01537887|63044490|FG004|Period 2|Withdrawal by Subject|0|||
33641475|NCT01537887|63044491|FG005|Period 2|Withdrawal by Subject|0|||
33641476|NCT01537887|63044486|FG000|Period 3|Adverse Event|0|||
33641477|NCT01537887|63044487|FG001|Period 3|Adverse Event|0|||
33641478|NCT01537887|63044488|FG002|Period 3|Adverse Event|1|||
33641479|NCT01537887|63044489|FG003|Period 3|Adverse Event|0|||
33641480|NCT01537887|63044490|FG004|Period 3|Adverse Event|0|||
33641481|NCT01537887|63044491|FG005|Period 3|Adverse Event|0|||
33641482|NCT01537887|63044486|FG000|Period 3|Withdrawal by Subject|0|||
33641483|NCT01537887|63044487|FG001|Period 3|Withdrawal by Subject|1|||
33641484|NCT01537887|63044488|FG002|Period 3|Withdrawal by Subject|0|||
33641485|NCT01537887|63044489|FG003|Period 3|Withdrawal by Subject|0|||
33641486|NCT01537887|63044490|FG004|Period 3|Withdrawal by Subject|0|||
33641487|NCT01537887|63044491|FG005|Period 3|Withdrawal by Subject|0|||
33641488|NCT01489527|63044501|FG000|Overall Study|Pregnancy|9|||
33641489|NCT01489527|63044502|FG001|Overall Study|Pregnancy|14|||
33641490|NCT01489527|63044501|FG000|Overall Study|Participant moved|6|||
33641491|NCT01489527|63044502|FG001|Overall Study|Participant moved|7|||
33641492|NCT01489527|63044501|FG000|Overall Study|Withdrawal by Subject|0|||
33641493|NCT01489527|63044502|FG001|Overall Study|Withdrawal by Subject|4|||
33641494|NCT01489527|63044501|FG000|Overall Study|Lost to Follow-up|5|||
33641495|NCT01489527|63044502|FG001|Overall Study|Lost to Follow-up|1|||
33641496|NCT01489527|63044501|FG000|Overall Study|Procedures|1|||
33641497|NCT01489527|63044502|FG001|Overall Study|Procedures|0|||
33641498|NCT01489527|63044501|FG000|Overall Study|Not compliant|1|||
33641499|NCT01489527|63044502|FG001|Overall Study|Not compliant|0|||
33641500|NCT01487577|63044515|FG000|Overall Study|Became ineligible after signing consent|1|||
33641501|NCT01536951|63044521|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33641502|NCT01536951|63044522|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33641503|NCT01536951|63044523|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
33641504|NCT01536951|63044524|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33641505|NCT01536951|63044525|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33641506|NCT01536951|63044526|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33641507|NCT01536951|63044527|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33641508|NCT01536951|63044528|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33641509|NCT01536951|63044529|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33641510|NCT01536951|63044521|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
33641511|NCT01536951|63044522|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
33641512|NCT01536951|63044523|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
33641513|NCT01536951|63044524|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
33641514|NCT01536951|63044525|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
33641515|NCT01536951|63044526|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
33641516|NCT01536951|63044527|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
33641517|NCT01536951|63044528|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
33641518|NCT01536951|63044529|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
33641519|NCT01536795|63044554|FG000|Overall Study|Lost to Follow-up|0|||
33641520|NCT01536795|63044555|FG001|Overall Study|Lost to Follow-up|2|||
33641521|NCT01536795|63044554|FG000|Overall Study|Lack of Efficacy|1|||
33641522|NCT01536795|63044555|FG001|Overall Study|Lack of Efficacy|0|||
33641523|NCT01536561|63044565|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
33641524|NCT01536561|63044565|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
33641525|NCT01536561|63044565|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
33641526|NCT01536561|63044565|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
33641527|NCT01536561|63044565|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
33641528|NCT01536561|63044565|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
33641529|NCT01536405|63044583|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
33641530|NCT01536405|63044584|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
33641531|NCT01536405|63044583|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
33641532|NCT01536405|63044584|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
33641533|NCT01536405|63044583|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
33641534|NCT01536405|63044584|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
33641535|NCT01536405|63044583|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
33641536|NCT01536405|63044584|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
33641537|NCT01536405|63044583|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
33641538|NCT01536405|63044584|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
33641539|NCT01536405|63044583|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
33641540|NCT01536405|63044584|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
33641541|NCT01536405|63044583|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
33641542|NCT01536405|63044584|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
33641543|NCT01536405|63044583|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
33641544|NCT01536405|63044584|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
33641545|NCT01536405|63044583|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
33641546|NCT01536405|63044584|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
33641547|NCT01536405|63044583|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
33641548|NCT01536405|63044584|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
33641549|NCT01536405|63044583|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
33641550|NCT01536405|63044584|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
33641551|NCT01536405|63044583|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
33641552|NCT01536405|63044584|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
33641553|NCT01536405|63044583|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
33641554|NCT01536405|63044584|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
33641555|NCT01487265|63044590|FG000|Overall Study|Adverse Event|8|||
33641556|NCT01487265|63044590|FG000|Overall Study|Withdrawal by Subject|5|||
33641557|NCT01487265|63044590|FG000|Overall Study|Disease Progression|21|||
33641558|NCT01487265|63044590|FG000|Overall Study|Death|2|||
33641559|NCT01487265|63044590|FG000|Overall Study|Still on Treatment|1|||
33641560|NCT01485627|63044596|FG000|Overall Study|Patient withdrew|6|||
33641561|NCT01485627|63044597|FG001|Overall Study|Patient withdrew|5|||
33641562|NCT01485627|63044596|FG000|Overall Study|Patient died|3|||
33641563|NCT01485627|63044597|FG001|Overall Study|Patient died|1|||
33641564|NCT01485627|63044596|FG000|Overall Study|Patient lost to followup|0|||
33641565|NCT01485627|63044597|FG001|Overall Study|Patient lost to followup|1|||
33641566|NCT01485627|63044596|FG000|Overall Study|Caregiver withdrew|3|||
33641567|NCT01485627|63044597|FG001|Overall Study|Caregiver withdrew|3|||
33641568|NCT01485627|63044596|FG000|Overall Study|Caregiver lost to follow up|11|||
33641569|NCT01485627|63044597|FG001|Overall Study|Caregiver lost to follow up|12|||
33641570|NCT01485627|63044596|FG000|Overall Study|Caregiver died|1|||
33641571|NCT01485627|63044597|FG001|Overall Study|Caregiver died|0|||
33641572|NCT01485627|63044596|FG000|Overall Study|caregiver was not bereaved|42|||
33641573|NCT01485627|63044597|FG001|Overall Study|caregiver was not bereaved|35|||
33641574|NCT01508325|63044620|FG000|Overall Study|Withdrawal by Subject|8|||
33641575|NCT01508325|63044621|FG001|Overall Study|Withdrawal by Subject|9|||
33641576|NCT01508325|63044620|FG000|Overall Study|Protocol Violation|0|||
33641577|NCT01508325|63044621|FG001|Overall Study|Protocol Violation|3|||
33641578|NCT01508325|63044620|FG000|Overall Study|Physician Decision|2|||
33641579|NCT01508325|63044621|FG001|Overall Study|Physician Decision|1|||
33641580|NCT01508325|63044620|FG000|Overall Study|Adverse Event|1|||
33641581|NCT01508325|63044621|FG001|Overall Study|Adverse Event|0|||
33641582|NCT01508325|63044620|FG000|Overall Study|Lost to Follow-up|5|||
33641583|NCT01508325|63044621|FG001|Overall Study|Lost to Follow-up|6|||
33641584|NCT01508325|63044620|FG000|Overall Study|Other|2|||
33641585|NCT01508325|63044621|FG001|Overall Study|Other|2|||
33641586|NCT01508169|63044629|FG000|Overall Study|Adverse Event|1|||
33641587|NCT01508169|63044630|FG001|Overall Study|Adverse Event|0|||
33641588|NCT01508169|63044629|FG000|Overall Study|Withdrawal by Subject|1|||
33641589|NCT01508169|63044630|FG001|Overall Study|Withdrawal by Subject|0|||
33641590|NCT01508169|63044629|FG000|Overall Study|Lost to Follow-up|1|||
33641591|NCT01508169|63044630|FG001|Overall Study|Lost to Follow-up|2|||
33641592|NCT01536171|63044642|FG000|Overall Study|Withdrawal by Subject|1|||
33641593|NCT01536093|63044649|FG000|Overall Study|Death|1|||
33641594|NCT01536093|63044650|FG001|Overall Study|Death|2|||
33641595|NCT01536093|63044649|FG000|Overall Study|absence of maternal colostrum|2|||
33641596|NCT01536093|63044650|FG001|Overall Study|absence of maternal colostrum|0|||
33641597|NCT01536093|63044649|FG000|Overall Study|Withdrawal by Subject|0|||
33641598|NCT01536093|63044650|FG001|Overall Study|Withdrawal by Subject|1|||
33641599|NCT01536015|63044658|FG000|Overall Study|Adverse Event|1|||
33641600|NCT01536015|63044659|FG001|Overall Study|Adverse Event|4|||
33641601|NCT01536015|63044658|FG000|Overall Study|Lost to Follow-up|0|||
33641602|NCT01536015|63044659|FG001|Overall Study|Lost to Follow-up|1|||
33641603|NCT01536015|63044658|FG000|Overall Study|Inclusion Criterion not met|2|||
33641604|NCT01536015|63044659|FG001|Overall Study|Inclusion Criterion not met|0|||
33641605|NCT01536015|63044658|FG000|Overall Study|Study closure|5|||
33641606|NCT01536015|63044659|FG001|Overall Study|Study closure|5|||
33641607|NCT01484691|63044668|FG000|Overall Study|Withdrawal by Subject|1|||
33641608|NCT01484691|63044669|FG001|Overall Study|Withdrawal by Subject|1|||
33641609|NCT01484691|63044670|FG002|Overall Study|Withdrawal by Subject|1|||
33641610|NCT01484691|63044668|FG000|Overall Study|Physician Decision|0|||
33641611|NCT01484691|63044669|FG001|Overall Study|Physician Decision|2|||
33641612|NCT01484691|63044670|FG002|Overall Study|Physician Decision|1|||
33641613|NCT01535235|63044681|FG000|Overall Study|Adverse Event|1|||
33641614|NCT01535235|63044682|FG001|Overall Study|Adverse Event|0|||
33641615|NCT01483599|63044726|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
33641616|NCT01483599|63044727|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33641617|NCT01483599|63044728|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33641618|NCT01483599|63044729|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
33641619|NCT01483599|63044730|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
33641620|NCT01483599|63044731|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
33641621|NCT01483599|63044732|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
33641622|NCT01483599|63044733|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33641623|NCT01483599|63044734|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33641624|NCT01483599|63044735|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33641625|NCT01483599|63044736|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33641626|NCT01483599|63044737|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33641627|NCT01483599|63044738|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33641628|NCT01483599|63044739|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33641629|NCT01483599|63044726|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33641630|NCT01483599|63044727|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
33641631|NCT01483599|63044728|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33641632|NCT01483599|63044729|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
33641633|NCT01483599|63044730|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33641634|NCT01483599|63044731|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33641635|NCT01483599|63044732|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
33641636|NCT01483599|63044733|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33641637|NCT01483599|63044734|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33641638|NCT01483599|63044735|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33641639|NCT01483599|63044736|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33641640|NCT01483599|63044737|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33641641|NCT01483599|63044738|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33641642|NCT01483599|63044739|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33641643|NCT01483599|63044726|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
33641644|NCT01483599|63044727|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33641645|NCT01483599|63044728|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33641646|NCT01483599|63044729|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33641647|NCT01483599|63044730|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33641648|NCT01483599|63044731|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33641649|NCT01483599|63044732|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33641650|NCT01483599|63044733|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33641651|NCT01483599|63044734|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33641652|NCT01483599|63044735|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33641653|NCT01483599|63044736|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33641654|NCT01483599|63044737|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33641655|NCT01483599|63044738|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33641656|NCT01483599|63044739|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33641657|NCT01483599|63044726|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
33641658|NCT01483599|63044727|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
33641659|NCT01483599|63044728|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
33641660|NCT01483599|63044729|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
33641661|NCT01483599|63044730|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
33641662|NCT01483599|63044731|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
33641663|NCT01483599|63044732|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
33641664|NCT01483599|63044733|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
33641665|NCT01483599|63044734|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
33641666|NCT01483599|63044735|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
33641667|NCT01483599|63044736|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
33641668|NCT01483599|63044737|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
33641669|NCT01483599|63044738|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
33641670|NCT01483599|63044739|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
33641671|NCT01483599|63044726|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
33641672|NCT01483599|63044727|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
33641673|NCT01483599|63044728|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
33641674|NCT01483599|63044729|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
33641675|NCT01483599|63044730|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
33641676|NCT01483599|63044731|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
33641677|NCT01483599|63044732|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
33641678|NCT01483599|63044733|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
33641679|NCT01483599|63044734|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
33641680|NCT01483599|63044735|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
33641681|NCT01483599|63044736|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
33641682|NCT01483599|63044737|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
33641683|NCT01483599|63044738|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
33641684|NCT01483599|63044739|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
33641685|NCT01483599|63044726|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33641686|NCT01483599|63044727|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33542797|NCT01317641|62933493|FG001|Overall Study|Withdrawal by Subject|0|||
33641687|NCT01483599|63044728|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33641688|NCT01483599|63044729|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33641689|NCT01483599|63044730|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33641690|NCT01483599|63044731|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33641691|NCT01483599|63044732|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33641692|NCT01483599|63044733|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
33641693|NCT01483599|63044734|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
33641694|NCT01483599|63044735|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33641695|NCT01483599|63044736|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33641696|NCT01483599|63044737|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33641697|NCT01483599|63044738|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
33641698|NCT01483599|63044739|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
33641699|NCT01483599|63044726|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33641700|NCT01483599|63044727|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33641701|NCT01483599|63044728|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33641702|NCT01483599|63044729|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33641703|NCT01483599|63044730|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33641704|NCT01483599|63044731|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33641705|NCT01483599|63044732|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33641706|NCT01483599|63044733|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33641707|NCT01483599|63044734|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
33641708|NCT01483599|63044735|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33641709|NCT01483599|63044736|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33641710|NCT01483599|63044737|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
33641711|NCT01483599|63044738|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33641712|NCT01483599|63044739|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
33641713|NCT01483599|63044726|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33641714|NCT01483599|63044727|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33641715|NCT01483599|63044728|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33641716|NCT01483599|63044729|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33641717|NCT01483599|63044730|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33641718|NCT01483599|63044731|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33641719|NCT01483599|63044732|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33641720|NCT01483599|63044733|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33641721|NCT01483599|63044734|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
33641722|NCT01483599|63044735|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33641723|NCT01483599|63044736|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
33641724|NCT01483599|63044737|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33641725|NCT01483599|63044738|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33641726|NCT01483599|63044739|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
33641727|NCT01483599|63044726|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33641728|NCT01483599|63044727|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33641729|NCT01483599|63044728|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33641730|NCT01483599|63044729|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33641731|NCT01483599|63044730|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33641732|NCT01483599|63044731|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33641733|NCT01483599|63044732|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33641734|NCT01483599|63044733|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33641735|NCT01483599|63044734|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
33641736|NCT01483599|63044735|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33641737|NCT01483599|63044736|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33641738|NCT01483599|63044737|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33641739|NCT01483599|63044738|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
33641740|NCT01483599|63044739|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
33641741|NCT01483599|63044726|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
33641742|NCT01483599|63044727|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
33641743|NCT01483599|63044728|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
33641744|NCT01483599|63044729|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
33641745|NCT01483599|63044730|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
33641746|NCT01483599|63044731|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
33641747|NCT01483599|63044732|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
33641748|NCT01483599|63044733|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
33641749|NCT01483599|63044734|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
33641750|NCT01483599|63044735|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
33641751|NCT01483599|63044736|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
33641752|NCT01483599|63044737|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
33641753|NCT01483599|63044738|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
33641754|NCT01483599|63044739|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
33641755|NCT01507545|63044815|FG000|Overall Study|Withdrawal by Subject|6|||
33641756|NCT01507545|63044816|FG001|Overall Study|Withdrawal by Subject|2|||
33641757|NCT01507545|63044815|FG000|Overall Study|Lost to Follow-up|1|||
33641758|NCT01507545|63044816|FG001|Overall Study|Lost to Follow-up|0|||
33641759|NCT01507545|63044815|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
33641760|NCT01507545|63044816|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
33641761|NCT01507545|63044815|FG000|Overall Study|Progressive disease|60|||
33641762|NCT01507545|63044816|FG001|Overall Study|Progressive disease|27|||
33641763|NCT01507545|63044815|FG000|Overall Study|Other|6|||
33641764|NCT01507545|63044816|FG001|Overall Study|Other|4|||
33641765|NCT01482819|63044822|FG000|Overall Study|Lost to Follow-up|2|||
33641766|NCT01534533|63044834|FG000|Overall Study|Lost to Follow-up|3|||
33641767|NCT01534533|63044835|FG001|Overall Study|Lost to Follow-up|0|||
33641768|NCT01534533|63044836|FG002|Overall Study|Lost to Follow-up|4|||
33641769|NCT01534533|63044837|FG003|Overall Study|Lost to Follow-up|3|||
33641770|NCT01534533|63044834|FG000|Overall Study|Withdrawal by Subject|5|||
33641771|NCT01534533|63044835|FG001|Overall Study|Withdrawal by Subject|3|||
33641772|NCT01534533|63044836|FG002|Overall Study|Withdrawal by Subject|4|||
33641773|NCT01534533|63044837|FG003|Overall Study|Withdrawal by Subject|1|||
33641774|NCT01506609|63044971|FG000|Overall Study|Adverse Event Related to Progression|0|||
33641775|NCT01506609|63044972|FG001|Overall Study|Adverse Event Related to Progression|0|||
33641776|NCT01506609|63044973|FG002|Overall Study|Adverse Event Related to Progression|0|||
33641777|NCT01506609|63044974|FG003|Overall Study|Adverse Event Related to Progression|3|||
33641778|NCT01506609|63044975|FG004|Overall Study|Adverse Event Related to Progression|7|||
33641779|NCT01506609|63044976|FG005|Overall Study|Adverse Event Related to Progression|3|||
33641780|NCT01506609|63044971|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
33641781|NCT01506609|63044972|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
33641782|NCT01506609|63044973|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
33641783|NCT01506609|63044974|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
33641784|NCT01506609|63044975|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
33641785|NCT01506609|63044976|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
33641786|NCT01506609|63044971|FG000|Overall Study|Withdrawal by Subject|0|||
33641787|NCT01506609|63044972|FG001|Overall Study|Withdrawal by Subject|0|||
33641788|NCT01506609|63044973|FG002|Overall Study|Withdrawal by Subject|0|||
33641789|NCT01506609|63044974|FG003|Overall Study|Withdrawal by Subject|9|||
33641790|NCT01506609|63044975|FG004|Overall Study|Withdrawal by Subject|7|||
33641791|NCT01506609|63044976|FG005|Overall Study|Withdrawal by Subject|7|||
33641792|NCT01506609|63044971|FG000|Overall Study|Lost to Follow-up|0|||
33641793|NCT01506609|63044972|FG001|Overall Study|Lost to Follow-up|0|||
33641794|NCT01506609|63044973|FG002|Overall Study|Lost to Follow-up|0|||
33641795|NCT01506609|63044974|FG003|Overall Study|Lost to Follow-up|1|||
33641796|NCT01506609|63044975|FG004|Overall Study|Lost to Follow-up|2|||
33641797|NCT01506609|63044976|FG005|Overall Study|Lost to Follow-up|0|||
33641798|NCT01506609|63044971|FG000|Overall Study|Sponsor Discontinued Study|0|||
33641799|NCT01506609|63044972|FG001|Overall Study|Sponsor Discontinued Study|0|||
33641800|NCT01506609|63044973|FG002|Overall Study|Sponsor Discontinued Study|0|||
33641801|NCT01506609|63044974|FG003|Overall Study|Sponsor Discontinued Study|2|||
33641802|NCT01506609|63044975|FG004|Overall Study|Sponsor Discontinued Study|2|||
33641803|NCT01506609|63044976|FG005|Overall Study|Sponsor Discontinued Study|0|||
33641804|NCT01506609|63044971|FG000|Overall Study|Progressive Disease per Protocol|1|||
33641805|NCT01506609|63044972|FG001|Overall Study|Progressive Disease per Protocol|0|||
33641806|NCT01506609|63044973|FG002|Overall Study|Progressive Disease per Protocol|0|||
33641807|NCT01506609|63044974|FG003|Overall Study|Progressive Disease per Protocol|64|||
33641808|NCT01506609|63044975|FG004|Overall Study|Progressive Disease per Protocol|57|||
33641809|NCT01506609|63044976|FG005|Overall Study|Progressive Disease per Protocol|74|||
33641810|NCT01506609|63044971|FG000|Overall Study|Other, Not Specified|0|||
33641811|NCT01506609|63044972|FG001|Overall Study|Other, Not Specified|0|||
33641812|NCT01506609|63044973|FG002|Overall Study|Other, Not Specified|0|||
33641813|NCT01506609|63044974|FG003|Overall Study|Other, Not Specified|10|||
33641814|NCT01506609|63044975|FG004|Overall Study|Other, Not Specified|7|||
33641815|NCT01506609|63044976|FG005|Overall Study|Other, Not Specified|3|||
33641816|NCT01506609|63044971|FG000|Overall Study|Missing / Unknown Reason|1|||
33641817|NCT01506609|63044972|FG001|Overall Study|Missing / Unknown Reason|0|||
33641818|NCT01506609|63044973|FG002|Overall Study|Missing / Unknown Reason|1|||
33641819|NCT01506609|63044974|FG003|Overall Study|Missing / Unknown Reason|4|||
33641820|NCT01506609|63044975|FG004|Overall Study|Missing / Unknown Reason|4|||
33641821|NCT01506609|63044976|FG005|Overall Study|Missing / Unknown Reason|2|||
33641822|NCT01506453|63045000|FG000|Overall Study|Withdrawal prior to treatment|0|||
33641823|NCT01506453|63045001|FG001|Overall Study|Withdrawal prior to treatment|2|||
33641824|NCT01482429|63045009|FG000|Care Usual|Protocol Violation|0|||
33641825|NCT01482429|63045010|FG001|Care Usual|Protocol Violation|172|||
33641826|NCT01482429|63045009|FG000|Care Usual|Lost to Follow-up|0|||
33641827|NCT01482429|63045010|FG001|Care Usual|Lost to Follow-up|1|||
33641828|NCT01482429|63045009|FG000|Protocol|Protocol Violation|275|||
33641829|NCT01482429|63045010|FG001|Protocol|Protocol Violation|0|||
33641830|NCT01504971|63045016|FG000|Overall Study|Physician Decision|13|||
33641831|NCT01479777|63045024|FG000|Overall Study|Physician Decision|2|||
33641832|NCT01479621|63045034|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
33641833|NCT01479621|63045035|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33641834|NCT01479621|63045036|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33641835|NCT01479621|63045037|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33641836|NCT01479621|63045038|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33641837|NCT01479621|63045039|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33641838|NCT01479621|63045040|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33641839|NCT01479621|63045034|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
33641840|NCT01479621|63045035|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33641841|NCT01479621|63045036|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33641842|NCT01479621|63045037|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33641843|NCT01479621|63045038|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33641844|NCT01479621|63045039|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33641845|NCT01479621|63045040|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33641846|NCT01479621|63045034|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
33641847|NCT01479621|63045035|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33641848|NCT01479621|63045036|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33641849|NCT01479621|63045037|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33641850|NCT01479621|63045038|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33641851|NCT01479621|63045039|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33641852|NCT01479621|63045040|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33641853|NCT01479621|63045034|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
33641854|NCT01479621|63045035|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33641855|NCT01479621|63045036|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33641856|NCT01479621|63045037|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33641857|NCT01479621|63045038|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33641858|NCT01479621|63045039|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33641859|NCT01479621|63045040|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33641860|NCT01479621|63045034|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
33641861|NCT01479621|63045035|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33641862|NCT01479621|63045036|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33641863|NCT01479621|63045037|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33641864|NCT01479621|63045038|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33641865|NCT01479621|63045039|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33641866|NCT01479621|63045040|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33641867|NCT01479621|63045034|FG000|Treatment Period|Adverse Event|0|||
33641868|NCT01479621|63045035|FG001|Treatment Period|Adverse Event|0|||
33641869|NCT01479621|63045036|FG002|Treatment Period|Adverse Event|0|||
33641870|NCT01479621|63045037|FG003|Treatment Period|Adverse Event|0|||
33641871|NCT01479621|63045038|FG004|Treatment Period|Adverse Event|1|||
33641872|NCT01479621|63045039|FG005|Treatment Period|Adverse Event|2|||
33641873|NCT01479621|63045040|FG006|Treatment Period|Adverse Event|2|||
33641874|NCT01479621|63045034|FG000|Treatment Period|Withdrawal by Subject|0|||
33641875|NCT01479621|63045035|FG001|Treatment Period|Withdrawal by Subject|4|||
33641876|NCT01479621|63045036|FG002|Treatment Period|Withdrawal by Subject|2|||
33641877|NCT01479621|63045037|FG003|Treatment Period|Withdrawal by Subject|2|||
33641878|NCT01479621|63045038|FG004|Treatment Period|Withdrawal by Subject|5|||
33641879|NCT01479621|63045039|FG005|Treatment Period|Withdrawal by Subject|5|||
33641880|NCT01479621|63045040|FG006|Treatment Period|Withdrawal by Subject|1|||
33641881|NCT01479621|63045034|FG000|Treatment Period|Physician Decision|0|||
33641882|NCT01479621|63045035|FG001|Treatment Period|Physician Decision|0|||
33641883|NCT01479621|63045036|FG002|Treatment Period|Physician Decision|0|||
33641884|NCT01479621|63045037|FG003|Treatment Period|Physician Decision|0|||
33641885|NCT01479621|63045038|FG004|Treatment Period|Physician Decision|1|||
33641886|NCT01479621|63045039|FG005|Treatment Period|Physician Decision|1|||
33641887|NCT01479621|63045040|FG006|Treatment Period|Physician Decision|0|||
33641888|NCT01479621|63045034|FG000|Treatment Period|Non-compliance to study drug|0|||
33641889|NCT01479621|63045035|FG001|Treatment Period|Non-compliance to study drug|1|||
33641890|NCT01479621|63045036|FG002|Treatment Period|Non-compliance to study drug|0|||
33641891|NCT01479621|63045037|FG003|Treatment Period|Non-compliance to study drug|0|||
33641892|NCT01479621|63045038|FG004|Treatment Period|Non-compliance to study drug|0|||
33641893|NCT01479621|63045039|FG005|Treatment Period|Non-compliance to study drug|0|||
33641894|NCT01479621|63045040|FG006|Treatment Period|Non-compliance to study drug|1|||
33641895|NCT01479621|63045034|FG000|Treatment Period|Protocol Violation|0|||
33327172|NCT01185353|62703800|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33327173|NCT01185353|62703801|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
33641896|NCT01479621|63045035|FG001|Treatment Period|Protocol Violation|9|||
33641897|NCT01479621|63045036|FG002|Treatment Period|Protocol Violation|6|||
33641898|NCT01479621|63045037|FG003|Treatment Period|Protocol Violation|5|||
33641899|NCT01479621|63045038|FG004|Treatment Period|Protocol Violation|2|||
33641900|NCT01479621|63045039|FG005|Treatment Period|Protocol Violation|10|||
33641901|NCT01479621|63045040|FG006|Treatment Period|Protocol Violation|6|||
33641902|NCT01479621|63045034|FG000|Treatment Period|Pregnancy|0|||
33641903|NCT01479621|63045035|FG001|Treatment Period|Pregnancy|0|||
33641904|NCT01479621|63045036|FG002|Treatment Period|Pregnancy|2|||
33641905|NCT01479621|63045037|FG003|Treatment Period|Pregnancy|0|||
33641906|NCT01479621|63045038|FG004|Treatment Period|Pregnancy|0|||
33641907|NCT01479621|63045039|FG005|Treatment Period|Pregnancy|0|||
33641908|NCT01479621|63045040|FG006|Treatment Period|Pregnancy|0|||
33641909|NCT01479621|63045034|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
33641910|NCT01479621|63045035|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
33641911|NCT01479621|63045036|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
33641912|NCT01479621|63045037|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
33641913|NCT01479621|63045038|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
33641914|NCT01479621|63045039|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
33641915|NCT01479621|63045040|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
33641916|NCT01479621|63045034|FG000|Treatment Period|Lost to Follow-up|0|||
33641917|NCT01479621|63045035|FG001|Treatment Period|Lost to Follow-up|0|||
33641918|NCT01479621|63045036|FG002|Treatment Period|Lost to Follow-up|1|||
33641919|NCT01479621|63045037|FG003|Treatment Period|Lost to Follow-up|0|||
33641920|NCT01479621|63045038|FG004|Treatment Period|Lost to Follow-up|2|||
33641921|NCT01479621|63045039|FG005|Treatment Period|Lost to Follow-up|2|||
33641922|NCT01479621|63045040|FG006|Treatment Period|Lost to Follow-up|1|||
33641923|NCT01479621|63045034|FG000|Treatment Period|Met stopping criteria|0|||
33641924|NCT01479621|63045035|FG001|Treatment Period|Met stopping criteria|8|||
33641925|NCT01479621|63045036|FG002|Treatment Period|Met stopping criteria|7|||
33641926|NCT01479621|63045037|FG003|Treatment Period|Met stopping criteria|4|||
33641927|NCT01479621|63045038|FG004|Treatment Period|Met stopping criteria|9|||
33641928|NCT01479621|63045039|FG005|Treatment Period|Met stopping criteria|20|||
33641929|NCT01479621|63045040|FG006|Treatment Period|Met stopping criteria|6|||
33641930|NCT01479465|63045088|FG000|Overall Study|Disease Progression|9|||
33641931|NCT01479465|63045089|FG001|Overall Study|Disease Progression|61|||
33641932|NCT01479465|63045090|FG002|Overall Study|Disease Progression|65|||
33641933|NCT01479465|63045091|FG003|Overall Study|Disease Progression|70|||
33641934|NCT01479465|63045088|FG000|Overall Study|Study Discontinued by Sponsor|0|||
33641935|NCT01479465|63045089|FG001|Overall Study|Study Discontinued by Sponsor|7|||
33641936|NCT01479465|63045090|FG002|Overall Study|Study Discontinued by Sponsor|5|||
33641937|NCT01479465|63045091|FG003|Overall Study|Study Discontinued by Sponsor|3|||
33641938|NCT01479465|63045088|FG000|Overall Study|Adverse Event|0|||
33641939|NCT01479465|63045089|FG001|Overall Study|Adverse Event|3|||
33641940|NCT01479465|63045090|FG002|Overall Study|Adverse Event|6|||
33641941|NCT01479465|63045091|FG003|Overall Study|Adverse Event|4|||
33641942|NCT01479465|63045088|FG000|Overall Study|Investigator Discretion|1|||
33641943|NCT01479465|63045089|FG001|Overall Study|Investigator Discretion|4|||
33641944|NCT01479465|63045090|FG002|Overall Study|Investigator Discretion|2|||
33641945|NCT01479465|63045091|FG003|Overall Study|Investigator Discretion|4|||
33641946|NCT01479465|63045088|FG000|Overall Study|Subject Request|1|||
33641947|NCT01479465|63045089|FG001|Overall Study|Subject Request|3|||
33641948|NCT01479465|63045090|FG002|Overall Study|Subject Request|4|||
33641949|NCT01479465|63045091|FG003|Overall Study|Subject Request|2|||
33641950|NCT01479465|63045088|FG000|Overall Study|Subject Withdrew Consent|0|||
33641951|NCT01479465|63045089|FG001|Overall Study|Subject Withdrew Consent|5|||
33641952|NCT01479465|63045090|FG002|Overall Study|Subject Withdrew Consent|2|||
33641953|NCT01479465|63045091|FG003|Overall Study|Subject Withdrew Consent|1|||
33641954|NCT01479465|63045088|FG000|Overall Study|Protocol Violation|0|||
33641955|NCT01479465|63045089|FG001|Overall Study|Protocol Violation|1|||
33641956|NCT01479465|63045090|FG002|Overall Study|Protocol Violation|1|||
33641957|NCT01479465|63045091|FG003|Overall Study|Protocol Violation|0|||
33463233|NCT00048542|62836831|FG002|Double-Blind Phase|Sponsor request or decision|0|||
33463234|NCT00048542|62836832|FG003|Double-Blind Phase|Sponsor request or decision|0|||
33463235|NCT00048542|62836833|FG004|Double-Blind Phase|Sponsor request or decision|0|||
33641958|NCT01479465|63045088|FG000|Overall Study|Death|0|||
33641959|NCT01479465|63045089|FG001|Overall Study|Death|0|||
33641960|NCT01479465|63045090|FG002|Overall Study|Death|0|||
33641961|NCT01479465|63045091|FG003|Overall Study|Death|1|||
33641962|NCT01479465|63045088|FG000|Overall Study|Lost to Follow-up|0|||
33641963|NCT01479465|63045089|FG001|Overall Study|Lost to Follow-up|0|||
33641964|NCT01479465|63045090|FG002|Overall Study|Lost to Follow-up|1|||
33641965|NCT01479465|63045091|FG003|Overall Study|Lost to Follow-up|0|||
33641966|NCT01503021|63045155|FG000|Overall Study|Adverse Event|7|||
33641967|NCT01503021|63045156|FG001|Overall Study|Adverse Event|6|||
33641968|NCT01503021|63045155|FG000|Overall Study|Death|0|||
33641969|NCT01503021|63045156|FG001|Overall Study|Death|2|||
33641970|NCT01503021|63045155|FG000|Overall Study|Lost to Follow-up|2|||
33641971|NCT01503021|63045156|FG001|Overall Study|Lost to Follow-up|0|||
33641972|NCT01503021|63045155|FG000|Overall Study|Physician Decision|3|||
33641973|NCT01503021|63045156|FG001|Overall Study|Physician Decision|0|||
33641974|NCT01503021|63045155|FG000|Overall Study|Protocol Violation|1|||
33641975|NCT01503021|63045156|FG001|Overall Study|Protocol Violation|3|||
33641976|NCT01503021|63045155|FG000|Overall Study|Withdrawal by Subject|9|||
33641977|NCT01503021|63045156|FG001|Overall Study|Withdrawal by Subject|8|||
33641978|NCT01503021|63045155|FG000|Overall Study|Moved, received transplant, etc.|5|||
33641979|NCT01503021|63045156|FG001|Overall Study|Moved, received transplant, etc.|7|||
33641980|NCT01531725|63045167|FG000|Overall Study|Protocol Violation|5|||
33641981|NCT01478373|63045171|FG000|Treatment Phase|Protocol Violation|1|||
33641982|NCT01478373|63045171|FG000|Survival Phase|Adverse Event|8|||
33641983|NCT01478373|63045171|FG000|Survival Phase|Protocol Violation|1|||
33641984|NCT01478373|63045171|FG000|Survival Phase|crossover to another study|2|||
33641985|NCT01478373|63045171|FG000|Survival Phase|Progressive Disease|27|||
33641986|NCT01502709|63045177|FG000|Overall Study|Lost to Follow-up|4|||
33641987|NCT01502709|63045178|FG001|Overall Study|Lost to Follow-up|0|||
33641988|NCT01477749|63045185|FG000|Overall Study|Physician Decision|4|||
33641989|NCT01502631|63045215|FG000|Overall Study|Adverse Event|5|||
33641990|NCT01502631|63045216|FG001|Overall Study|Adverse Event|8|||
33641991|NCT01502631|63045215|FG000|Overall Study|Lost to Follow-up|2|||
33641992|NCT01502631|63045216|FG001|Overall Study|Lost to Follow-up|2|||
33641993|NCT01502631|63045215|FG000|Overall Study|Participant withdrew consent|2|||
33641994|NCT01502631|63045216|FG001|Overall Study|Participant withdrew consent|4|||
33641995|NCT01502631|63045215|FG000|Overall Study|Participant non-compliant|1|||
33641996|NCT01502631|63045216|FG001|Overall Study|Participant non-compliant|0|||
33641997|NCT01502631|63045215|FG000|Overall Study|Investigator's decision|0|||
33641998|NCT01502631|63045216|FG001|Overall Study|Investigator's decision|1|||
33641999|NCT01502631|63045215|FG000|Overall Study|Other|10|||
33642000|NCT01502631|63045216|FG001|Overall Study|Other|5|||
33642001|NCT01475721|63045272|FG000|Overall Study|Death|3|||
33642002|NCT01475721|63045273|FG001|Overall Study|Death|6|||
33642003|NCT01475721|63045272|FG000|Overall Study|Withdrawal by Subject|8|||
33642004|NCT01475721|63045273|FG001|Overall Study|Withdrawal by Subject|8|||
33642005|NCT01530087|63045297|FG000|Overall Study|Physician Decision|2|||
33642006|NCT01475487|63045315|FG000|Overall Study|had to leave early for personal reasons|2|||
33642007|NCT01475487|63045316|FG001|Overall Study|had to leave early for personal reasons|1|||
33642008|NCT01475331|63045324|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
33642009|NCT01475331|63045325|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
33642010|NCT01475331|63045324|FG000|Overall Study|excessive main duct communication|1|||
33642011|NCT01475331|63045325|FG001|Overall Study|excessive main duct communication|1|||
33642012|NCT01475331|63045324|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
33642013|NCT01475331|63045325|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
33642014|NCT01475331|63045324|FG000|Overall Study|Sign of malignancy during the procedure|2|||
33642015|NCT01475331|63045325|FG001|Overall Study|Sign of malignancy during the procedure|0|||
33642016|NCT01475331|63045324|FG000|Overall Study|cyst found to be prohibitively small|0|||
33642017|NCT01475331|63045325|FG001|Overall Study|cyst found to be prohibitively small|1|||
33642018|NCT01500213|63045333|FG000|Overall Study|Adverse Event|35|||
33642019|NCT01500213|63045334|FG001|Overall Study|Adverse Event|35|||
33642020|NCT01500213|63045333|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
33642021|NCT01500213|63045334|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
33642022|NCT01500213|63045333|FG000|Overall Study|Withdrawal by Subject|28|||
33642023|NCT01500213|63045334|FG001|Overall Study|Withdrawal by Subject|37|||
33642024|NCT01500213|63045333|FG000|Overall Study|Death|7|||
33642025|NCT01500213|63045334|FG001|Overall Study|Death|3|||
33642026|NCT01500213|63045333|FG000|Overall Study|Disease Progression|13|||
33642027|NCT01500213|63045334|FG001|Overall Study|Disease Progression|21|||
33642028|NCT01500213|63045333|FG000|Overall Study|Protocol Violation|19|||
33642029|NCT01500213|63045334|FG001|Overall Study|Protocol Violation|19|||
33642030|NCT01500213|63045333|FG000|Overall Study|Physician Decision|12|||
33642031|NCT01500213|63045334|FG001|Overall Study|Physician Decision|10|||
33642032|NCT01500213|63045333|FG000|Overall Study|Lack of Efficacy|9|||
33642033|NCT01500213|63045334|FG001|Overall Study|Lack of Efficacy|7|||
33642034|NCT01500213|63045333|FG000|Overall Study|Lost to Follow-up|3|||
33642035|NCT01500213|63045334|FG001|Overall Study|Lost to Follow-up|6|||
33642036|NCT01500213|63045333|FG000|Overall Study|Other Reasons|7|||
33642037|NCT01500213|63045334|FG001|Overall Study|Other Reasons|5|||
33642038|NCT01475253|63045364|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
33642039|NCT01475253|63045365|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
33642040|NCT01475253|63045366|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
33642041|NCT01475253|63045367|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
33642042|NCT01475253|63045364|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
33642043|NCT01475253|63045365|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
33642044|NCT01475253|63045366|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
33642045|NCT01475253|63045367|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
33642046|NCT01500135|63045425|FG000|Overall Study|Withdrawal of Consent|4|||
33642047|NCT01500135|63045426|FG001|Overall Study|Withdrawal of Consent|0|||
33642048|NCT01500135|63045425|FG000|Overall Study|Lost to Follow-up|6|||
33642049|NCT01500135|63045426|FG001|Overall Study|Lost to Follow-up|4|||
33642050|NCT01500135|63045425|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
33642051|NCT01500135|63045426|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
33642052|NCT01500135|63045425|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
33642053|NCT01500135|63045426|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
33642054|NCT01500135|63045425|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
33642055|NCT01500135|63045426|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
33642056|NCT01500135|63045425|FG000|Overall Study|Participant was a Safety Concern|1|||
33642057|NCT01500135|63045426|FG001|Overall Study|Participant was a Safety Concern|0|||
33642058|NCT01500135|63045425|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
33642059|NCT01500135|63045426|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
33642060|NCT01475097|63045438|FG000|Overall Study|Protocol Violation|1|||
33642061|NCT01475097|63045439|FG001|Overall Study|Protocol Violation|1|||
33642062|NCT01529385|63045447|FG000|Overall Study|Lost to Follow-up|2|||
33642063|NCT01529385|63045448|FG001|Overall Study|Lost to Follow-up|1|||
33642064|NCT01474551|63045454|FG000|Overall Study|Death|1|||
33642065|NCT01500057|63045489|FG000|Overall Study|Lost to Follow-up|6|||
33642066|NCT01500057|63045490|FG001|Overall Study|Lost to Follow-up|4|||
33642067|NCT01499667|63045508|FG000|Overall Study|administrative problems|4|||
33642068|NCT01499667|63045509|FG001|Overall Study|administrative problems|5|||
33642069|NCT01499667|63045510|FG002|Overall Study|administrative problems|5|||
33642070|NCT01499667|63045508|FG000|Overall Study|Protocol Violation|1|||
33642071|NCT01499667|63045509|FG001|Overall Study|Protocol Violation|3|||
33642072|NCT01499667|63045510|FG002|Overall Study|Protocol Violation|2|||
33642073|NCT01499667|63045508|FG000|Overall Study|Adverse Event|0|||
33642074|NCT01499667|63045509|FG001|Overall Study|Adverse Event|2|||
33642075|NCT01499667|63045510|FG002|Overall Study|Adverse Event|2|||
33642076|NCT01499667|63045508|FG000|Overall Study|Withdrawal by Subject|2|||
33642077|NCT01499667|63045509|FG001|Overall Study|Withdrawal by Subject|1|||
33642078|NCT01499667|63045510|FG002|Overall Study|Withdrawal by Subject|1|||
33642079|NCT01499667|63045508|FG000|Overall Study|Lack of Efficacy|2|||
33642080|NCT01499667|63045509|FG001|Overall Study|Lack of Efficacy|0|||
33642081|NCT01499667|63045510|FG002|Overall Study|Lack of Efficacy|0|||
33642082|NCT01499511|63045520|FG000|Overall Study|Death|1|||
33642083|NCT01499511|63045521|FG001|Overall Study|Death|0|||
33642084|NCT01474317|63045541|FG000|Overall Study|Adverse Event|1|||
33642085|NCT01474317|63045541|FG000|Overall Study|Subject ineligible for study|1|||
33642086|NCT01499355|63045637|FG000|Run-In Period|Study Termination|15|||
33642087|NCT01499355|63045638|FG001|Run-In Period|Study Termination|0|||
33642088|NCT01499355|63045639|FG002|Run-In Period|Study Termination|0|||
33642089|NCT01499355|63045640|FG003|Run-In Period|Study Termination|0|||
33642090|NCT01499355|63045637|FG000|Run-In Period|Other|3|||
33642091|NCT01499355|63045638|FG001|Run-In Period|Other|0|||
33642092|NCT01499355|63045639|FG002|Run-In Period|Other|0|||
33642093|NCT01499355|63045640|FG003|Run-In Period|Other|0|||
33642094|NCT01499355|63045637|FG000|Run-In Period|Death|2|||
33642095|NCT01499355|63045638|FG001|Run-In Period|Death|0|||
33642096|NCT01499355|63045639|FG002|Run-In Period|Death|0|||
33642097|NCT01499355|63045640|FG003|Run-In Period|Death|0|||
33642098|NCT01499355|63045637|FG000|Run-In Period|Investigator Decision|2|||
33642099|NCT01499355|63045638|FG001|Run-In Period|Investigator Decision|0|||
33642100|NCT01499355|63045639|FG002|Run-In Period|Investigator Decision|0|||
33642101|NCT01499355|63045640|FG003|Run-In Period|Investigator Decision|0|||
33642102|NCT01499355|63045637|FG000|Run-In Period|Consent Withdrawn|1|||
33642103|NCT01499355|63045638|FG001|Run-In Period|Consent Withdrawn|0|||
33642104|NCT01499355|63045639|FG002|Run-In Period|Consent Withdrawn|0|||
33642105|NCT01499355|63045640|FG003|Run-In Period|Consent Withdrawn|0|||
33642106|NCT01499355|63045637|FG000|Run-In Period|Adverse Event|8|||
33642107|NCT01499355|63045638|FG001|Run-In Period|Adverse Event|0|||
33642108|NCT01499355|63045639|FG002|Run-In Period|Adverse Event|0|||
33642109|NCT01499355|63045640|FG003|Run-In Period|Adverse Event|0|||
33542798|NCT01317641|62933494|FG002|Overall Study|Withdrawal by Subject|0|||
33642110|NCT01499355|63045637|FG000|Double-Blind Period|Adverse Event|0|||
33642111|NCT01499355|63045638|FG001|Double-Blind Period|Adverse Event|2|||
33642112|NCT01499355|63045639|FG002|Double-Blind Period|Adverse Event|3|||
33642113|NCT01499355|63045640|FG003|Double-Blind Period|Adverse Event|2|||
33642114|NCT01499355|63045637|FG000|Double-Blind Period|Study Termination|0|||
33642115|NCT01499355|63045638|FG001|Double-Blind Period|Study Termination|18|||
33642116|NCT01499355|63045639|FG002|Double-Blind Period|Study Termination|16|||
33642117|NCT01499355|63045640|FG003|Double-Blind Period|Study Termination|14|||
33542799|NCT01317641|62933495|FG003|Overall Study|Withdrawal by Subject|0|||
33642118|NCT01499355|63045637|FG000|Double-Blind Period|Other|0|||
33642119|NCT01499355|63045638|FG001|Double-Blind Period|Other|1|||
33642120|NCT01499355|63045639|FG002|Double-Blind Period|Other|2|||
33642121|NCT01499355|63045640|FG003|Double-Blind Period|Other|2|||
33642122|NCT01499355|63045637|FG000|Double-Blind Period|Death|0|||
33642123|NCT01499355|63045638|FG001|Double-Blind Period|Death|1|||
33642124|NCT01499355|63045639|FG002|Double-Blind Period|Death|0|||
33642125|NCT01499355|63045640|FG003|Double-Blind Period|Death|0|||
33642126|NCT01499355|63045637|FG000|Double-Blind Period|Investigator Decision|0|||
33642127|NCT01499355|63045638|FG001|Double-Blind Period|Investigator Decision|0|||
33642128|NCT01499355|63045639|FG002|Double-Blind Period|Investigator Decision|3|||
33642129|NCT01499355|63045640|FG003|Double-Blind Period|Investigator Decision|3|||
33642130|NCT01499355|63045637|FG000|Double-Blind Period|Consent Withdrawn|0|||
33642131|NCT01499355|63045638|FG001|Double-Blind Period|Consent Withdrawn|0|||
33642132|NCT01499355|63045639|FG002|Double-Blind Period|Consent Withdrawn|1|||
33642133|NCT01499355|63045640|FG003|Double-Blind Period|Consent Withdrawn|2|||
33642134|NCT01499355|63045637|FG000|Double-Blind Period|Lost to Follow-up|0|||
33642135|NCT01499355|63045638|FG001|Double-Blind Period|Lost to Follow-up|1|||
33642136|NCT01499355|63045639|FG002|Double-Blind Period|Lost to Follow-up|0|||
33642137|NCT01499355|63045640|FG003|Double-Blind Period|Lost to Follow-up|0|||
33642138|NCT01474239|63045661|FG000|Overall Study|Disease Progression|37|||
33642139|NCT01474239|63045662|FG001|Overall Study|Disease Progression|25|||
33642140|NCT01474239|63045661|FG000|Overall Study|Adverse Event|12|||
33642141|NCT01474239|63045662|FG001|Overall Study|Adverse Event|3|||
33642142|NCT01474239|63045661|FG000|Overall Study|Withdrawal by Subject|1|||
33642143|NCT01474239|63045662|FG001|Overall Study|Withdrawal by Subject|2|||
33642144|NCT01474239|63045661|FG000|Overall Study|Death|1|||
33642145|NCT01474239|63045662|FG001|Overall Study|Death|1|||
33642146|NCT01474239|63045661|FG000|Overall Study|Clinical Disease Progression|7|||
33642147|NCT01474239|63045662|FG001|Overall Study|Clinical Disease Progression|1|||
33642148|NCT01474239|63045661|FG000|Overall Study|Withdrawal for Economic Reason|1|||
33642149|NCT01474239|63045662|FG001|Overall Study|Withdrawal for Economic Reason|0|||
33642150|NCT01473381|63045672|FG000|Overall Study|Adverse Event|8|||
33642151|NCT01473381|63045673|FG001|Overall Study|Adverse Event|20|||
33642152|NCT01473381|63045674|FG002|Overall Study|Adverse Event|25|||
33642153|NCT01473381|63045675|FG003|Overall Study|Adverse Event|17|||
33642154|NCT01473381|63045672|FG000|Overall Study|Insufficient Therapeutic Response|10|||
33642155|NCT01473381|63045673|FG001|Overall Study|Insufficient Therapeutic Response|1|||
33642156|NCT01473381|63045674|FG002|Overall Study|Insufficient Therapeutic Response|2|||
33642157|NCT01473381|63045675|FG003|Overall Study|Insufficient Therapeutic Response|3|||
33642158|NCT01473381|63045672|FG000|Overall Study|Protocol Violation|17|||
33642159|NCT01473381|63045673|FG001|Overall Study|Protocol Violation|23|||
33642160|NCT01473381|63045674|FG002|Overall Study|Protocol Violation|19|||
33642161|NCT01473381|63045675|FG003|Overall Study|Protocol Violation|17|||
33642162|NCT01473381|63045672|FG000|Overall Study|Withdrawal of Consent|20|||
33642163|NCT01473381|63045673|FG001|Overall Study|Withdrawal of Consent|21|||
33642164|NCT01473381|63045674|FG002|Overall Study|Withdrawal of Consent|20|||
33642165|NCT01473381|63045675|FG003|Overall Study|Withdrawal of Consent|26|||
33642166|NCT01473381|63045672|FG000|Overall Study|Lost to Follow-up|25|||
33642167|NCT01473381|63045673|FG001|Overall Study|Lost to Follow-up|28|||
33642168|NCT01473381|63045674|FG002|Overall Study|Lost to Follow-up|35|||
33642169|NCT01473381|63045675|FG003|Overall Study|Lost to Follow-up|23|||
33642170|NCT01473381|63045672|FG000|Overall Study|Other Reasons|0|||
33542800|NCT01317641|62933496|FG004|Overall Study|Withdrawal by Subject|0|||
33542801|NCT01317641|62933497|FG005|Overall Study|Withdrawal by Subject|0|||
33642171|NCT01473381|63045673|FG001|Overall Study|Other Reasons|0|||
33642172|NCT01473381|63045674|FG002|Overall Study|Other Reasons|1|||
33642173|NCT01473381|63045675|FG003|Overall Study|Other Reasons|3|||
33642174|NCT01499277|63045717|FG000|Overall Study|Adverse Event|3|||
33642175|NCT01499277|63045718|FG001|Overall Study|Adverse Event|6|||
33642176|NCT01499277|63045717|FG000|Overall Study|Death|3|||
33642177|NCT01499277|63045718|FG001|Overall Study|Death|2|||
33642178|NCT01499277|63045717|FG000|Overall Study|Lost to Follow-up|15|||
33642179|NCT01499277|63045718|FG001|Overall Study|Lost to Follow-up|8|||
33642180|NCT01499277|63045717|FG000|Overall Study|Protocol Violation|2|||
33642181|NCT01499277|63045718|FG001|Overall Study|Protocol Violation|3|||
33642182|NCT01499277|63045717|FG000|Overall Study|Withdrawal by Subject|16|||
33642183|NCT01499277|63045718|FG001|Overall Study|Withdrawal by Subject|6|||
33642184|NCT01499277|63045717|FG000|Overall Study|Lack of therapeutic response and other|8|||
33642185|NCT01499277|63045718|FG001|Overall Study|Lack of therapeutic response and other|7|||
33642186|NCT01499199|63045743|FG000|Overall Study|Adverse Event|1|||
33642187|NCT01499199|63045743|FG000|Overall Study|Lack of Efficacy|1|||
33642188|NCT01499043|63045747|FG000|Overall Study|Progressive disease (radiographic)|2|||
33642189|NCT01499043|63045747|FG000|Overall Study|Progressive disease (clinical)|1|||
33642190|NCT01499043|63045747|FG000|Overall Study|Withdrawal by Subject|2|||
33642191|NCT01499043|63045747|FG000|Overall Study|Adverse Event|1|||
33642192|NCT01498887|63045821|FG000|Overall Study|Administrative problems|1|||
33642193|NCT01498887|63045822|FG001|Overall Study|Administrative problems|0|||
33642194|NCT01498887|63045821|FG000|Overall Study|Lost to Follow-up|1|||
33642195|NCT01498887|63045822|FG001|Overall Study|Lost to Follow-up|1|||
33642196|NCT01498887|63045821|FG000|Overall Study|Withdrawal by Subject|1|||
33642197|NCT01498887|63045822|FG001|Overall Study|Withdrawal by Subject|0|||
33642198|NCT01498887|63045821|FG000|Overall Study|Protocol Violation|1|||
33642199|NCT01498887|63045822|FG001|Overall Study|Protocol Violation|3|||
33642200|NCT01498887|63045821|FG000|Overall Study|Lack of Efficacy|5|||
33642201|NCT01498887|63045822|FG001|Overall Study|Lack of Efficacy|3|||
33642202|NCT01498887|63045821|FG000|Overall Study|Abnormal result from test procedure|1|||
33642203|NCT01498887|63045822|FG001|Overall Study|Abnormal result from test procedure|1|||
33642204|NCT01498887|63045821|FG000|Overall Study|Abnormal laboratory value|2|||
33642205|NCT01498887|63045822|FG001|Overall Study|Abnormal laboratory value|2|||
33642206|NCT01498887|63045821|FG000|Overall Study|Adverse Event|4|||
33642207|NCT01498887|63045822|FG001|Overall Study|Adverse Event|1|||
33642208|NCT01498653|63045831|FG000|Overall Study|Adverse Event|2|||
33642209|NCT01498653|63045832|FG001|Overall Study|Adverse Event|2|||
33642210|NCT01498653|63045831|FG000|Overall Study|Lack of Efficacy|12|||
33642211|NCT01498653|63045832|FG001|Overall Study|Lack of Efficacy|26|||
33642212|NCT01498653|63045831|FG000|Overall Study|Protocol Violation|0|||
33642213|NCT01498653|63045832|FG001|Overall Study|Protocol Violation|4|||
33642214|NCT01498653|63045831|FG000|Overall Study|Lost to Follow-up|1|||
33642215|NCT01498653|63045832|FG001|Overall Study|Lost to Follow-up|0|||
33642216|NCT01498653|63045831|FG000|Overall Study|Physician Decision|2|||
33642217|NCT01498653|63045832|FG001|Overall Study|Physician Decision|0|||
33642218|NCT01498653|63045831|FG000|Overall Study|Withdrawal by Subject|2|||
33642219|NCT01498653|63045832|FG001|Overall Study|Withdrawal by Subject|3|||
33642220|NCT01498575|63045840|FG000|Overall Sample|Withdrawal by Subject|60|||
33642221|NCT01498575|63045841|FG001|Overall Sample|Withdrawal by Subject|14|||
33642222|NCT01498575|63045840|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
33642223|NCT01498575|63045841|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
33642224|NCT01498575|63045840|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
33463236|NCT00048542|62836834|FG005|Double-Blind Phase|Sponsor request or decision|0|||
33542802|NCT01317641|62933498|FG006|Overall Study|Withdrawal by Subject|1|||
33542803|NCT01317641|62933499|FG007|Overall Study|Withdrawal by Subject|0|||
33542804|NCT01317641|62933500|FG008|Overall Study|Withdrawal by Subject|0|||
33542805|NCT03186794|62933536|FG000|Overall Study|Physician Decision|2|||
33542806|NCT03186794|62933536|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
33542807|NCT02290431|62933541|FG000|Overall Study|Adverse Event|20|||
33542808|NCT02290431|62933541|FG000|Overall Study|Progressive disease|4|||
33542809|NCT02290431|62933541|FG000|Overall Study|Study terminated by Sponsor|1|||
33542810|NCT02290431|62933541|FG000|Overall Study|Physician Decision|2|||
33542811|NCT02707952|62933549|FG000|Overall Study|Adverse Event|1|||
33542812|NCT02707952|62933550|FG001|Overall Study|Adverse Event|0|||
33542813|NCT02707952|62933551|FG002|Overall Study|Adverse Event|0|||
33642225|NCT01498575|63045841|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
33642226|NCT01498185|63045852|FG000|Overall Study|Adverse Event|0|||
33642227|NCT01498185|63045853|FG001|Overall Study|Adverse Event|0|||
33642228|NCT01498185|63045854|FG002|Overall Study|Adverse Event|0|||
33642229|NCT01498185|63045855|FG003|Overall Study|Adverse Event|1|||
33642230|NCT01498185|63045856|FG004|Overall Study|Adverse Event|0|||
33642231|NCT01498185|63045852|FG000|Overall Study|Withdrawal by Subject|1|||
33642232|NCT01498185|63045853|FG001|Overall Study|Withdrawal by Subject|1|||
33642233|NCT01498185|63045854|FG002|Overall Study|Withdrawal by Subject|0|||
33642234|NCT01498185|63045855|FG003|Overall Study|Withdrawal by Subject|2|||
33463237|NCT00048542|62836835|FG006|Double-Blind Phase|Sponsor request or decision|0|||
33463238|NCT00048542|62836836|FG007|Double-Blind Phase|Sponsor request or decision|0|||
33463239|NCT00048542|62836829|FG000|Double-Blind Phase|Randomized in error|1|||
33463240|NCT00048542|62836830|FG001|Double-Blind Phase|Randomized in error|0|||
33463241|NCT00048542|62836831|FG002|Double-Blind Phase|Randomized in error|0|||
33463242|NCT00048542|62836832|FG003|Double-Blind Phase|Randomized in error|0|||
33463243|NCT00048542|62836833|FG004|Double-Blind Phase|Randomized in error|0|||
33463244|NCT00048542|62836834|FG005|Double-Blind Phase|Randomized in error|0|||
33463245|NCT00048542|62836835|FG006|Double-Blind Phase|Randomized in error|0|||
33463246|NCT00048542|62836836|FG007|Double-Blind Phase|Randomized in error|0|||
33463247|NCT00048542|62836829|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
33463248|NCT00048542|62836830|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
33542814|NCT02707952|62933552|FG003|Overall Study|Adverse Event|0|||
33542815|NCT02707952|62933549|FG000|Overall Study|Lost to Follow-up|1|||
33542816|NCT02707952|62933550|FG001|Overall Study|Lost to Follow-up|0|||
33542817|NCT02707952|62933551|FG002|Overall Study|Lost to Follow-up|0|||
33542818|NCT02707952|62933552|FG003|Overall Study|Lost to Follow-up|0|||
33542819|NCT02707952|62933549|FG000|Overall Study|Withdrawal by Subject|0|||
33542820|NCT02707952|62933550|FG001|Overall Study|Withdrawal by Subject|1|||
33542821|NCT02707952|62933551|FG002|Overall Study|Withdrawal by Subject|2|||
33642235|NCT01498185|63045856|FG004|Overall Study|Withdrawal by Subject|1|||
33642236|NCT01498185|63045852|FG000|Overall Study|No longer met criteria, etc|0|||
33642237|NCT01498185|63045853|FG001|Overall Study|No longer met criteria, etc|0|||
33642238|NCT01498185|63045854|FG002|Overall Study|No longer met criteria, etc|0|||
33642239|NCT01498185|63045855|FG003|Overall Study|No longer met criteria, etc|0|||
33642240|NCT01498185|63045856|FG004|Overall Study|No longer met criteria, etc|2|||
33327174|NCT01185353|62703802|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33327175|NCT01185353|62703803|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33327176|NCT01185353|62703804|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33327177|NCT01185353|62703805|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33327178|NCT01185353|62703806|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33327179|NCT01185353|62703797|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
33327180|NCT01185353|62703798|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33327181|NCT01185353|62703799|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33327182|NCT01185353|62703800|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33463249|NCT00048542|62836831|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
33542822|NCT02707952|62933552|FG003|Overall Study|Withdrawal by Subject|0|||
33542823|NCT03050801|62933570|FG000|Experiment 1|Lost to Follow-up|0|||
33642241|NCT01528605|63045878|FG000|Overall Study|Lost to Follow-up|1|||
33642242|NCT01528605|63045879|FG001|Overall Study|Lost to Follow-up|0|||
33642243|NCT01528605|63045880|FG002|Overall Study|Lost to Follow-up|1|||
33642244|NCT01528605|63045881|FG003|Overall Study|Lost to Follow-up|1|||
33642245|NCT01528605|63045882|FG004|Overall Study|Lost to Follow-up|0|||
33642246|NCT01528605|63045883|FG005|Overall Study|Lost to Follow-up|0|||
33642247|NCT01528605|63045878|FG000|Overall Study|Death|1|||
33642248|NCT01528605|63045879|FG001|Overall Study|Death|0|||
33642249|NCT01528605|63045880|FG002|Overall Study|Death|0|||
33642250|NCT01528605|63045881|FG003|Overall Study|Death|0|||
33642251|NCT01528605|63045882|FG004|Overall Study|Death|0|||
33642252|NCT01528605|63045883|FG005|Overall Study|Death|0|||
33642253|NCT01528215|63045899|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
33642254|NCT01528215|63045900|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
33642255|NCT01528215|63045899|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
33642256|NCT01528215|63045900|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
33642257|NCT01528215|63045899|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
33642258|NCT01528215|63045900|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
33642259|NCT01528215|63045899|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
33642260|NCT01528215|63045900|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
33542824|NCT03050801|62933571|FG001|Experiment 1|Lost to Follow-up|1|||
33542825|NCT03050801|62933572|FG002|Experiment 1|Lost to Follow-up|0|||
33542826|NCT03050801|62933573|FG003|Experiment 1|Lost to Follow-up|0|||
33542827|NCT03050801|62933574|FG004|Experiment 1|Lost to Follow-up|0|||
33642261|NCT01527357|63045908|FG000|Overall Study|Death|8|||
33642262|NCT01527357|63045909|FG001|Overall Study|Death|2|||
33642263|NCT01527357|63045908|FG000|Overall Study|Lost to Follow-up|6|||
33642264|NCT01527357|63045909|FG001|Overall Study|Lost to Follow-up|4|||
33642265|NCT01527357|63045908|FG000|Overall Study|Withdrew Consent|1|||
33642266|NCT01527357|63045909|FG001|Overall Study|Withdrew Consent|1|||
33642267|NCT01527357|63045908|FG000|Overall Study|Non-compliance|0|||
33642268|NCT01527357|63045909|FG001|Overall Study|Non-compliance|1|||
33642269|NCT01527357|63045908|FG000|Overall Study|No Day 29 Visit|0|||
33642270|NCT01527357|63045909|FG001|Overall Study|No Day 29 Visit|1|||
33642271|NCT01527357|63045908|FG000|Overall Study|Did Not Receive Treatment|2|||
33642272|NCT01527357|63045909|FG001|Overall Study|Did Not Receive Treatment|0|||
33642273|NCT01526889|63045928|FG000|Treatment Period|Adverse Event|2|||
33642274|NCT01526889|63045929|FG001|Treatment Period|Adverse Event|0|||
33642275|NCT01526889|63045928|FG000|Treatment Extension Period|Administrative problems|1|||
33642276|NCT01526889|63045929|FG001|Treatment Extension Period|Administrative problems|0|||
33642277|NCT01472835|63045941|FG000|Overall Study|Lost to Follow-up|2|||
33327183|NCT01185353|62703801|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
33327184|NCT01185353|62703802|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33463250|NCT00048542|62836832|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
33463251|NCT00048542|62836833|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
33463252|NCT00048542|62836834|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
33463253|NCT00048542|62836835|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
33463254|NCT00048542|62836836|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
33463255|NCT00048542|62836829|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
33642278|NCT01472835|63045942|FG001|Overall Study|Lost to Follow-up|0|||
33642279|NCT01526733|63045955|FG000|Phase 1|Protocol Violation|1|||
33642280|NCT01526733|63045956|FG001|Phase 1|Protocol Violation|0|||
33642281|NCT01526733|63045955|FG000|Phase 1|Withdrawal by Subject|1|||
33642282|NCT01526733|63045956|FG001|Phase 1|Withdrawal by Subject|1|||
33642283|NCT01472757|63046001|FG000|Overall Study|Withdrawal by Subject|1|||
33642284|NCT01472757|63046002|FG001|Overall Study|Withdrawal by Subject|2|||
33642285|NCT01472757|63046003|FG002|Overall Study|Withdrawal by Subject|2|||
33642286|NCT01472757|63046004|FG003|Overall Study|Withdrawal by Subject|0|||
33642287|NCT01472757|63046001|FG000|Overall Study|Asthma exacerbation|4|||
33642288|NCT01472757|63046002|FG001|Overall Study|Asthma exacerbation|1|||
33642289|NCT01472757|63046003|FG002|Overall Study|Asthma exacerbation|2|||
33642290|NCT01472757|63046004|FG003|Overall Study|Asthma exacerbation|1|||
33642291|NCT01472757|63046001|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
33642292|NCT01472757|63046002|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
33642293|NCT01472757|63046003|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
33642294|NCT01472757|63046004|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
33642295|NCT01472757|63046001|FG000|Overall Study|Protocol Violation|3|||
33642296|NCT01472757|63046002|FG001|Overall Study|Protocol Violation|2|||
33642297|NCT01472757|63046003|FG002|Overall Study|Protocol Violation|4|||
33642298|NCT01472757|63046004|FG003|Overall Study|Protocol Violation|4|||
33642299|NCT01472757|63046001|FG000|Overall Study|Other reasons|1|||
33642300|NCT01472757|63046002|FG001|Overall Study|Other reasons|0|||
33642301|NCT01472757|63046003|FG002|Overall Study|Other reasons|2|||
33642302|NCT01472757|63046004|FG003|Overall Study|Other reasons|2|||
33642303|NCT01472289|63046023|FG000|Overall Study|Death|2|||
33642304|NCT01525875|63046042|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
33642305|NCT01525875|63046043|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
33642306|NCT01525875|63046042|FG000|Open-label Period|Lost to Follow-up|0|||
33642307|NCT01525875|63046043|FG001|Open-label Period|Lost to Follow-up|2|||
33642308|NCT01525641|63046049|FG000|Overall Study|Case report form not collected|25|||
33642309|NCT01525641|63046049|FG000|Overall Study|No visit since the first visit|16|||
33642310|NCT01525641|63046049|FG000|Overall Study|Adverse Event|73|||
33642311|NCT01525641|63046049|FG000|Overall Study|Lack of Efficacy|24|||
33642312|NCT01525641|63046049|FG000|Overall Study|Improvement|5|||
33642313|NCT01525641|63046049|FG000|Overall Study|Lost to follow-up (relocation)|1|||
33642314|NCT01525641|63046049|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
33642315|NCT01525641|63046049|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
33642316|NCT01525641|63046049|FG000|Overall Study|Other than stated above|7|||
33642317|NCT01496469|63046064|FG000|Overall Study|Adverse Event|1|||
33642318|NCT01496469|63046065|FG001|Overall Study|Adverse Event|0|||
33642319|NCT01496469|63046064|FG000|Overall Study|Protocol Violation|2|||
33642320|NCT01496469|63046065|FG001|Overall Study|Protocol Violation|0|||
33642321|NCT01496469|63046064|FG000|Overall Study|Lost to Follow-up|1|||
33642322|NCT01496469|63046065|FG001|Overall Study|Lost to Follow-up|1|||
33642323|NCT01496469|63046064|FG000|Overall Study|Withdrawal by Subject|4|||
33642324|NCT01496469|63046065|FG001|Overall Study|Withdrawal by Subject|4|||
33642325|NCT01496469|63046064|FG000|Overall Study|BP exceeds protocol limits|1|||
33642326|NCT01496469|63046065|FG001|Overall Study|BP exceeds protocol limits|2|||
33642327|NCT01496469|63046064|FG000|Overall Study|Other|1|||
33642328|NCT01496469|63046065|FG001|Overall Study|Other|1|||
33651452|NCT01746901|63062908|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33651453|NCT01746901|63062909|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33651454|NCT01746901|63062910|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33651455|NCT01746901|63062911|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33651456|NCT01746901|63062912|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33651457|NCT01746901|63062904|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
33651458|NCT01746901|63062905|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
33651459|NCT01746901|63062906|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
33651460|NCT01746901|63062907|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
33651461|NCT01746901|63062908|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
33651462|NCT01746901|63062909|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
33651463|NCT01746901|63062910|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
33651464|NCT01746901|63062911|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
33651465|NCT01746901|63062912|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
33651466|NCT01746901|63062904|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33651467|NCT01746901|63062905|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33651468|NCT01746901|63062906|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33651469|NCT01746901|63062907|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33651470|NCT01746901|63062908|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33642329|NCT01471353|63046080|FG000|Overall Study|remain on study|3|||
33642330|NCT01525407|63046086|FG000|Overall Study|Change in recipient treatment plan|2|||
33642331|NCT01525407|63046087|FG001|Overall Study|Change in recipient treatment plan|2|||
33642332|NCT01525407|63046086|FG000|Overall Study|Withdrawal by Subject|0|||
33642333|NCT01525407|63046087|FG001|Overall Study|Withdrawal by Subject|1|||
33642334|NCT01525407|63046086|FG000|Overall Study|Transplant was delayed|0|||
33642335|NCT01525407|63046087|FG001|Overall Study|Transplant was delayed|1|||
33642336|NCT01525407|63046086|FG000|Overall Study|Delay in Transplant|1|||
33642337|NCT01525407|63046087|FG001|Overall Study|Delay in Transplant|0|||
33642338|NCT01471197|63046095|FG000|Overall Study|Disease Progression|4|||
33642339|NCT01471197|63046096|FG001|Overall Study|Disease Progression|2|||
33642340|NCT01471197|63046095|FG000|Overall Study|Death|1|||
33642341|NCT01471197|63046096|FG001|Overall Study|Death|0|||
33642342|NCT01471197|63046095|FG000|Overall Study|Study Drug Toxicity|1|||
33642343|NCT01471197|63046096|FG001|Overall Study|Study Drug Toxicity|0|||
33642344|NCT01524783|63046130|FG000|Blinded Period|Adverse Event|64|||
33642345|NCT01524783|63046131|FG001|Blinded Period|Adverse Event|7|||
33642346|NCT01524783|63046132|FG002|Blinded Period|Adverse Event|0|||
33642347|NCT01524783|63046130|FG000|Blinded Period|Disease Progression|89|||
33642348|NCT01524783|63046131|FG001|Blinded Period|Disease Progression|75|||
33642349|NCT01524783|63046132|FG002|Blinded Period|Disease Progression|0|||
33642350|NCT01524783|63046130|FG000|Blinded Period|Withdrawal by Subject|19|||
33642351|NCT01524783|63046131|FG001|Blinded Period|Withdrawal by Subject|6|||
33642352|NCT01524783|63046132|FG002|Blinded Period|Withdrawal by Subject|0|||
33642353|NCT01524783|63046130|FG000|Blinded Period|Protocol deviation|2|||
33642354|NCT01524783|63046131|FG001|Blinded Period|Protocol deviation|1|||
33642355|NCT01524783|63046132|FG002|Blinded Period|Protocol deviation|0|||
33642356|NCT01524783|63046130|FG000|Blinded Period|Death|5|||
33642357|NCT01524783|63046131|FG001|Blinded Period|Death|2|||
33642358|NCT01524783|63046132|FG002|Blinded Period|Death|0|||
33642359|NCT01524783|63046130|FG000|Open-label Period|Disease progression|13|||
33642360|NCT01524783|63046131|FG001|Open-label Period|Disease progression|0|||
33642361|NCT01524783|63046132|FG002|Open-label Period|Disease progression|2|||
33642362|NCT01524783|63046130|FG000|Open-label Period|Administrative problems|5|||
33642363|NCT01524783|63046131|FG001|Open-label Period|Administrative problems|0|||
33642364|NCT01524783|63046132|FG002|Open-label Period|Administrative problems|2|||
33642365|NCT01524783|63046130|FG000|Open-label Period|Adverse Event|5|||
33642366|NCT01524783|63046131|FG001|Open-label Period|Adverse Event|0|||
33642367|NCT01524783|63046132|FG002|Open-label Period|Adverse Event|1|||
33642368|NCT01524783|63046130|FG000|Open-label Period|Withdrawal by Subject|2|||
33542828|NCT03050801|62933575|FG005|Experiment 1|Lost to Follow-up|0|||
33542829|NCT03050801|62933570|FG000|Experiment 1|Physician Decision|0|||
33542830|NCT03050801|62933571|FG001|Experiment 1|Physician Decision|3|||
33542831|NCT03050801|62933572|FG002|Experiment 1|Physician Decision|0|||
33542832|NCT03050801|62933573|FG003|Experiment 1|Physician Decision|0|||
33542833|NCT03050801|62933574|FG004|Experiment 1|Physician Decision|0|||
33542834|NCT03050801|62933575|FG005|Experiment 1|Physician Decision|0|||
33542835|NCT03050801|62933570|FG000|Experiment 1|Change of experimental design|0|||
33542836|NCT03050801|62933571|FG001|Experiment 1|Change of experimental design|3|||
33542837|NCT03050801|62933572|FG002|Experiment 1|Change of experimental design|0|||
33542838|NCT03050801|62933573|FG003|Experiment 1|Change of experimental design|0|||
33542839|NCT03050801|62933574|FG004|Experiment 1|Change of experimental design|0|||
33542840|NCT03050801|62933575|FG005|Experiment 1|Change of experimental design|0|||
33542841|NCT03050801|62933570|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
33542842|NCT03050801|62933571|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
33542843|NCT03050801|62933572|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
33542844|NCT03050801|62933573|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
33542845|NCT03050801|62933574|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
33542846|NCT03050801|62933575|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
33542847|NCT03050801|62933570|FG000|Experiment 2|Lost to Follow-up|0|||
33542848|NCT03050801|62933571|FG001|Experiment 2|Lost to Follow-up|0|||
33542849|NCT03050801|62933572|FG002|Experiment 2|Lost to Follow-up|0|||
33542850|NCT03050801|62933573|FG003|Experiment 2|Lost to Follow-up|1|||
33542851|NCT03050801|62933574|FG004|Experiment 2|Lost to Follow-up|1|||
33542852|NCT03050801|62933575|FG005|Experiment 2|Lost to Follow-up|0|||
33542853|NCT03050801|62933570|FG000|Experiment 2|Physician Decision|0|||
33542854|NCT03050801|62933571|FG001|Experiment 2|Physician Decision|0|||
33542855|NCT03050801|62933572|FG002|Experiment 2|Physician Decision|0|||
33542856|NCT03050801|62933573|FG003|Experiment 2|Physician Decision|0|||
33642369|NCT01524783|63046131|FG001|Open-label Period|Withdrawal by Subject|0|||
33642370|NCT01524783|63046132|FG002|Open-label Period|Withdrawal by Subject|1|||
33642371|NCT01524783|63046130|FG000|Open-label Period|Protocol deviation|1|||
33642372|NCT01524783|63046131|FG001|Open-label Period|Protocol deviation|0|||
33642373|NCT01524783|63046132|FG002|Open-label Period|Protocol deviation|0|||
33642374|NCT01494987|63046146|FG000|Overall Study|Adverse Event|6|||
33642375|NCT01494987|63046147|FG001|Overall Study|Adverse Event|5|||
33642376|NCT01494987|63046146|FG000|Overall Study|Hyperglycemia|6|||
33542857|NCT03050801|62933574|FG004|Experiment 2|Physician Decision|1|||
33542858|NCT03050801|62933575|FG005|Experiment 2|Physician Decision|0|||
33542859|NCT03050801|62933570|FG000|Experiment 2|Pregnancy|0|||
33542860|NCT03050801|62933571|FG001|Experiment 2|Pregnancy|0|||
33542861|NCT03050801|62933572|FG002|Experiment 2|Pregnancy|0|||
33542862|NCT03050801|62933573|FG003|Experiment 2|Pregnancy|0|||
33542863|NCT03050801|62933574|FG004|Experiment 2|Pregnancy|1|||
33542864|NCT03050801|62933575|FG005|Experiment 2|Pregnancy|0|||
33542865|NCT03050801|62933570|FG000|Experiment 2|Withdrawal by Subject|0|||
33542866|NCT03050801|62933571|FG001|Experiment 2|Withdrawal by Subject|0|||
33542867|NCT03050801|62933572|FG002|Experiment 2|Withdrawal by Subject|0|||
33542868|NCT03050801|62933573|FG003|Experiment 2|Withdrawal by Subject|1|||
33542869|NCT03050801|62933574|FG004|Experiment 2|Withdrawal by Subject|0|||
33542870|NCT03050801|62933575|FG005|Experiment 2|Withdrawal by Subject|0|||
33542871|NCT03050801|62933570|FG000|Experiment 2|Poor data quality|0|||
33542872|NCT03050801|62933571|FG001|Experiment 2|Poor data quality|0|||
33542873|NCT03050801|62933572|FG002|Experiment 2|Poor data quality|0|||
33542874|NCT03050801|62933573|FG003|Experiment 2|Poor data quality|4|||
33642377|NCT01494987|63046147|FG001|Overall Study|Hyperglycemia|4|||
33642378|NCT01494987|63046146|FG000|Overall Study|Investigator's Discretion|1|||
33642379|NCT01494987|63046147|FG001|Overall Study|Investigator's Discretion|2|||
33642380|NCT01494987|63046146|FG000|Overall Study|Lost to Follow-up|1|||
33642381|NCT01494987|63046147|FG001|Overall Study|Lost to Follow-up|1|||
33642382|NCT01494987|63046146|FG000|Overall Study|Protocol Violation|3|||
33642383|NCT01494987|63046147|FG001|Overall Study|Protocol Violation|3|||
33642384|NCT01494987|63046146|FG000|Overall Study|Subject Non-Compliance|9|||
33642385|NCT01494987|63046147|FG001|Overall Study|Subject Non-Compliance|10|||
33642386|NCT01494987|63046146|FG000|Overall Study|Subject Withdrew Consent|2|||
33642387|NCT01494987|63046147|FG001|Overall Study|Subject Withdrew Consent|3|||
33642388|NCT01524627|63046155|FG000|Overall Study|Physician Decision|0|||
33642389|NCT01524627|63046156|FG001|Overall Study|Physician Decision|1|||
33642390|NCT01524627|63046155|FG000|Overall Study|Lost to Follow-up|1|||
33642391|NCT01524627|63046156|FG001|Overall Study|Lost to Follow-up|1|||
33642392|NCT01469637|63046164|FG000|First Intervention|Unacceptable behavior|0|||
33642393|NCT01469637|63046165|FG001|First Intervention|Unacceptable behavior|1|||
33642394|NCT01469637|63046164|FG000|Second Intervention|Incarcerated|1|||
33642395|NCT01469637|63046165|FG001|Second Intervention|Incarcerated|0|||
33642396|NCT04842747|63046585|FG000|Overall Study|Withdrawal by Subject|6|||
33642397|NCT04842747|63046586|FG001|Overall Study|Withdrawal by Subject|2|||
33642398|NCT04842747|63046585|FG000|Overall Study|Lost to Follow-up|1|||
33642399|NCT04842747|63046586|FG001|Overall Study|Lost to Follow-up|2|||
33642400|NCT04842747|63046585|FG000|Overall Study|Physician Decision|1|||
33642401|NCT04842747|63046586|FG001|Overall Study|Physician Decision|0|||
33642402|NCT04842747|63046585|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
33642403|NCT04842747|63046586|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
33642404|NCT04810481|63046594|FG000|Overall Study|Disqualified data sets|10|||
33642405|NCT04810481|63046595|FG001|Overall Study|Disqualified data sets|28|||
33642406|NCT04664400|63046614|FG000|Overall Study|Withdrawal by Subject|2|||
33642407|NCT04657770|63046619|FG000|Overall Study|Withdrawal by Subject|3|||
33642408|NCT04657770|63046619|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
33642409|NCT04496453|63046623|FG000|Overall Study|Lost to Follow-up|6|||
33642410|NCT04482647|63046627|FG000|Overall Study|Time constraints|2|||
33642411|NCT04482647|63046627|FG000|Overall Study|Health issues|1|||
33642412|NCT04482647|63046627|FG000|Overall Study|Death in the family|1|||
33642413|NCT04482647|63046627|FG000|Overall Study|Disliked the intervention|1|||
33642414|NCT04482647|63046627|FG000|Overall Study|No reasons specified|7|||
33642415|NCT04440163|63046639|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
33642416|NCT04440163|63046640|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
33642417|NCT04440163|63046641|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
33642418|NCT04440163|63046642|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
33642419|NCT04440163|63046643|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
33463256|NCT00048542|62836830|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
33463257|NCT00048542|62836831|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
33463258|NCT00048542|62836832|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
33463259|NCT00048542|62836833|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
33463260|NCT00048542|62836834|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
33463261|NCT00048542|62836835|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
33463262|NCT00048542|62836836|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
33463263|NCT00048542|62836829|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
33463264|NCT00048542|62836830|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
33463265|NCT00048542|62836831|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
33542875|NCT03050801|62933574|FG004|Experiment 2|Poor data quality|1|||
33642420|NCT04440163|63046644|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
33642421|NCT04440163|63046645|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
33642422|NCT04440163|63046646|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
33642423|NCT04440163|63046639|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
33642424|NCT04440163|63046640|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
33642425|NCT04440163|63046641|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
33642426|NCT04440163|63046642|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
33642427|NCT04440163|63046643|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
33642428|NCT04440163|63046644|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
33642429|NCT04440163|63046645|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
33642430|NCT04440163|63046646|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
33642431|NCT04440163|63046639|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
33642432|NCT04440163|63046640|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
33642433|NCT04440163|63046641|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
33642434|NCT04440163|63046642|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
33642435|NCT04440163|63046643|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
33642436|NCT04440163|63046644|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
33642437|NCT04440163|63046645|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
33642438|NCT04440163|63046646|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
33642439|NCT04440163|63046639|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
33642440|NCT04440163|63046640|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
33642441|NCT04440163|63046641|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
33642442|NCT04440163|63046642|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
33642443|NCT04440163|63046643|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
33642444|NCT04440163|63046644|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
33642445|NCT04440163|63046645|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
33642446|NCT04440163|63046646|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
33642447|NCT04440163|63046639|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
33642448|NCT04440163|63046640|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
33642449|NCT04440163|63046641|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
33642450|NCT04440163|63046642|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
33642451|NCT04440163|63046643|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
33642452|NCT04440163|63046644|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
33642453|NCT04440163|63046645|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
33642454|NCT04440163|63046646|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
33542876|NCT03050801|62933575|FG005|Experiment 2|Poor data quality|0|||
33542877|NCT03050801|62933570|FG000|Experiment 2|Discomfort during stimulation|0|||
33642455|NCT04440163|63046639|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
33463266|NCT00048542|62836832|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
33542878|NCT03050801|62933571|FG001|Experiment 2|Discomfort during stimulation|0|||
33542879|NCT03050801|62933572|FG002|Experiment 2|Discomfort during stimulation|0|||
33542880|NCT03050801|62933573|FG003|Experiment 2|Discomfort during stimulation|0|||
33542881|NCT03050801|62933574|FG004|Experiment 2|Discomfort during stimulation|0|||
33542882|NCT03050801|62933575|FG005|Experiment 2|Discomfort during stimulation|2|||
33542883|NCT02707640|62933594|FG000|Overall Study|Adverse Event|4|||
33542884|NCT02707640|62933595|FG001|Overall Study|Adverse Event|2|||
33542885|NCT02707640|62933594|FG000|Overall Study|Death|1|||
33542886|NCT02707640|62933595|FG001|Overall Study|Death|2|||
33542887|NCT02707640|62933594|FG000|Overall Study|Physician Decision|2|||
33542888|NCT02707640|62933595|FG001|Overall Study|Physician Decision|0|||
33542889|NCT02707640|62933594|FG000|Overall Study|Withdrawal by Subject|0|||
33542890|NCT02707640|62933595|FG001|Overall Study|Withdrawal by Subject|1|||
33542891|NCT02707640|62933594|FG000|Overall Study|Participant's Personal Decision|1|||
33542892|NCT02707640|62933595|FG001|Overall Study|Participant's Personal Decision|2|||
33542893|NCT02707640|62933594|FG000|Overall Study|Sponsor Discretion|1|||
33542894|NCT02707640|62933595|FG001|Overall Study|Sponsor Discretion|0|||
33542895|NCT02708966|62933603|FG000|Overall Study|Lost to Follow-up|2|||
33542896|NCT02708966|62933604|FG001|Overall Study|Lost to Follow-up|2|||
33463267|NCT00048542|62836833|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
33463268|NCT00048542|62836834|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
33463269|NCT00048542|62836835|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
33463270|NCT00048542|62836836|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
33463271|NCT00048542|62836829|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
33463272|NCT00048542|62836830|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
33542897|NCT02706938|62933612|FG000|First Period, 6 Weeks|Adverse Event|8|||
33542898|NCT02706938|62933613|FG001|First Period, 6 Weeks|Adverse Event|0|||
33642456|NCT04440163|63046640|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
33642457|NCT04440163|63046641|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
33642458|NCT04440163|63046642|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
33642459|NCT04440163|63046643|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
33642460|NCT04440163|63046644|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
33642461|NCT04440163|63046645|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
33642462|NCT04440163|63046646|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
33642463|NCT04440163|63046639|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
33642464|NCT04440163|63046640|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
33642465|NCT04440163|63046641|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
33642466|NCT04440163|63046642|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
33642467|NCT04440163|63046643|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
33642468|NCT04440163|63046644|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
33642469|NCT04440163|63046645|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
33642470|NCT04440163|63046646|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
33642471|NCT04440163|63046639|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
33642472|NCT04440163|63046640|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
33642473|NCT04440163|63046641|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
33642474|NCT04440163|63046642|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
33642475|NCT04440163|63046643|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
33642476|NCT04440163|63046644|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
33642477|NCT04440163|63046645|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
33642478|NCT04440163|63046646|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
33642479|NCT04440163|63046639|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
33642480|NCT04440163|63046640|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
33642481|NCT04440163|63046641|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
33642482|NCT04440163|63046642|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
33642483|NCT04440163|63046643|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
33642484|NCT04440163|63046644|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
33642485|NCT04440163|63046645|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
33642486|NCT04440163|63046646|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
33642487|NCT04440163|63046639|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
33642488|NCT04440163|63046640|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
33642489|NCT04440163|63046641|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
33642490|NCT04440163|63046642|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
33642491|NCT04440163|63046643|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
33642492|NCT04440163|63046644|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
33642493|NCT04440163|63046645|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
33642494|NCT04440163|63046646|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
33642495|NCT04440163|63046639|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
33642496|NCT04440163|63046640|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
33642497|NCT04440163|63046641|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
33642498|NCT04440163|63046642|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
33642499|NCT04440163|63046643|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
33642500|NCT04440163|63046644|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
33642501|NCT04440163|63046645|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
33642502|NCT04440163|63046646|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
33642503|NCT04440163|63046639|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
33642504|NCT04440163|63046640|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
33642505|NCT04440163|63046641|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
33642506|NCT04440163|63046642|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
33327185|NCT01185353|62703803|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33327186|NCT01185353|62703804|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33642507|NCT04440163|63046643|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
33642508|NCT04440163|63046644|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
33642509|NCT04440163|63046645|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
33642510|NCT04440163|63046646|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
33642511|NCT04304508|63046677|FG000|Overall Study|Subject Decision|29|||
33642512|NCT04304508|63046678|FG001|Overall Study|Subject Decision|39|||
33642513|NCT04304508|63046679|FG002|Overall Study|Subject Decision|37|||
33642514|NCT04304508|63046680|FG003|Overall Study|Subject Decision|48|||
33642515|NCT04304508|63046677|FG000|Overall Study|Death|6|||
33642516|NCT04304508|63046678|FG001|Overall Study|Death|1|||
33327187|NCT01185353|62703805|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33642517|NCT04304508|63046679|FG002|Overall Study|Death|8|||
33642518|NCT04304508|63046680|FG003|Overall Study|Death|5|||
33642519|NCT04304508|63046677|FG000|Overall Study|Non-compliance With Study Drug|3|||
33642520|NCT04304508|63046678|FG001|Overall Study|Non-compliance With Study Drug|1|||
33642521|NCT04304508|63046679|FG002|Overall Study|Non-compliance With Study Drug|2|||
33642522|NCT04304508|63046680|FG003|Overall Study|Non-compliance With Study Drug|0|||
33642523|NCT04304508|63046677|FG000|Overall Study|Switching To Other Therapy|1|||
33642524|NCT04304508|63046678|FG001|Overall Study|Switching To Other Therapy|1|||
33642525|NCT04304508|63046679|FG002|Overall Study|Switching To Other Therapy|1|||
33642526|NCT04304508|63046680|FG003|Overall Study|Switching To Other Therapy|2|||
33642527|NCT04304508|63046677|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
33642528|NCT04304508|63046678|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
33642529|NCT04304508|63046679|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
33642530|NCT04304508|63046680|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
33642531|NCT04304508|63046677|FG000|Overall Study|Withdrawal by Subject|7|||
33642532|NCT04304508|63046678|FG001|Overall Study|Withdrawal by Subject|5|||
33642533|NCT04304508|63046679|FG002|Overall Study|Withdrawal by Subject|11|||
33642534|NCT04304508|63046680|FG003|Overall Study|Withdrawal by Subject|6|||
33642535|NCT04304508|63046677|FG000|Overall Study|Logistical Difficulties|2|||
33642536|NCT04304508|63046678|FG001|Overall Study|Logistical Difficulties|2|||
33642537|NCT04304508|63046679|FG002|Overall Study|Logistical Difficulties|3|||
33642538|NCT04304508|63046680|FG003|Overall Study|Logistical Difficulties|2|||
33642539|NCT04304508|63046677|FG000|Overall Study|Missing Information|1|||
33642540|NCT04304508|63046678|FG001|Overall Study|Missing Information|2|||
33642541|NCT04304508|63046679|FG002|Overall Study|Missing Information|1|||
33642542|NCT04304508|63046680|FG003|Overall Study|Missing Information|3|||
33642543|NCT04304508|63046677|FG000|Overall Study|Other|7|||
33642544|NCT04304508|63046678|FG001|Overall Study|Other|6|||
33642545|NCT04304508|63046679|FG002|Overall Study|Other|5|||
33642546|NCT04304508|63046680|FG003|Overall Study|Other|4|||
33642547|NCT04304508|63046677|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
33642548|NCT04304508|63046678|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
33642549|NCT04304508|63046679|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
33642550|NCT04304508|63046680|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
33642551|NCT04304508|63046677|FG000|Overall Study|Physician Decision|3|||
33642552|NCT04304508|63046678|FG001|Overall Study|Physician Decision|4|||
33642553|NCT04304508|63046679|FG002|Overall Study|Physician Decision|9|||
33642554|NCT04304508|63046680|FG003|Overall Study|Physician Decision|7|||
33642555|NCT04304508|63046677|FG000|Overall Study|Study drug never administered|10|||
33642556|NCT04304508|63046678|FG001|Overall Study|Study drug never administered|4|||
33642557|NCT04304508|63046679|FG002|Overall Study|Study drug never administered|4|||
33642558|NCT04304508|63046680|FG003|Overall Study|Study drug never administered|4|||
33642559|NCT04304508|63046677|FG000|Overall Study|Adverse Event|49|||
33642560|NCT04304508|63046678|FG001|Overall Study|Adverse Event|50|||
33642561|NCT04304508|63046679|FG002|Overall Study|Adverse Event|51|||
33642562|NCT04304508|63046680|FG003|Overall Study|Adverse Event|56|||
33642563|NCT04304508|63046677|FG000|Overall Study|Lost to Follow-up|1|||
33642564|NCT04304508|63046678|FG001|Overall Study|Lost to Follow-up|5|||
33642565|NCT04304508|63046679|FG002|Overall Study|Lost to Follow-up|2|||
33642566|NCT04304508|63046680|FG003|Overall Study|Lost to Follow-up|3|||
33642567|NCT04206332|63046709|FG000|Part A|Lost to Follow-up|0|||
33642568|NCT04206332|63046710|FG001|Part A|Lost to Follow-up|1|||
33642569|NCT04206332|63046711|FG002|Part A|Lost to Follow-up|0|||
33642570|NCT04206332|63046712|FG003|Part A|Lost to Follow-up|0|||
33642571|NCT04206332|63046713|FG004|Part A|Lost to Follow-up|0|||
33642572|NCT04206332|63046714|FG005|Part A|Lost to Follow-up|0|||
33642573|NCT04206332|63046715|FG006|Part A|Lost to Follow-up|0|||
33642574|NCT04206332|63046716|FG007|Part A|Lost to Follow-up|0|||
33642575|NCT04206332|63046717|FG008|Part A|Lost to Follow-up|0|||
33642576|NCT04206332|63046718|FG009|Part A|Lost to Follow-up|0|||
33642577|NCT04206332|63046719|FG010|Part A|Lost to Follow-up|0|||
33642578|NCT04206332|63046720|FG011|Part A|Lost to Follow-up|0|||
33642579|NCT04206332|63046721|FG012|Part A|Lost to Follow-up|0|||
33642580|NCT04206332|63046722|FG013|Part A|Lost to Follow-up|0|||
33642581|NCT04206332|63046723|FG014|Part A|Lost to Follow-up|0|||
33327188|NCT01185353|62703806|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33642582|NCT04206332|63046724|FG015|Part A|Lost to Follow-up|0|||
33642583|NCT04206332|63046725|FG016|Part A|Lost to Follow-up|0|||
33642584|NCT04206332|63046709|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33642585|NCT04206332|63046710|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33642586|NCT04206332|63046711|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33642587|NCT04206332|63046712|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33642588|NCT04206332|63046713|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33651471|NCT01746901|63062909|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33642589|NCT04206332|63046714|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
33642590|NCT04206332|63046715|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33642591|NCT04206332|63046716|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33642592|NCT04206332|63046717|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33642593|NCT04206332|63046718|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33642594|NCT04206332|63046719|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33642595|NCT04206332|63046720|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33642596|NCT04206332|63046721|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33642597|NCT04206332|63046722|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33642598|NCT04206332|63046723|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33642599|NCT04206332|63046724|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33642600|NCT04206332|63046725|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33642601|NCT04206332|63046709|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642602|NCT04206332|63046710|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642603|NCT04206332|63046711|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642604|NCT04206332|63046712|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642605|NCT04206332|63046713|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642606|NCT04206332|63046714|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642607|NCT04206332|63046715|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642608|NCT04206332|63046716|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
33642609|NCT04206332|63046717|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642610|NCT04206332|63046718|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642611|NCT04206332|63046719|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
33642612|NCT04206332|63046720|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642613|NCT04206332|63046721|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642614|NCT04206332|63046722|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642615|NCT04206332|63046723|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642616|NCT04206332|63046724|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642617|NCT04206332|63046725|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642618|NCT04206332|63046709|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642619|NCT04206332|63046710|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642620|NCT04206332|63046711|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642621|NCT04206332|63046712|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642622|NCT04206332|63046713|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642623|NCT04206332|63046714|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642624|NCT04206332|63046715|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642625|NCT04206332|63046716|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642626|NCT04206332|63046717|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642627|NCT04206332|63046718|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642628|NCT04206332|63046719|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642629|NCT04206332|63046720|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642630|NCT04206332|63046721|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642631|NCT04206332|63046722|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642632|NCT04206332|63046723|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642633|NCT04206332|63046724|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33642634|NCT04206332|63046725|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
33642635|NCT04206332|63046709|FG000|Part C|Withdrawal by Subject|0|||
33642636|NCT04206332|63046710|FG001|Part C|Withdrawal by Subject|0|||
33642637|NCT04206332|63046711|FG002|Part C|Withdrawal by Subject|0|||
33642638|NCT04206332|63046712|FG003|Part C|Withdrawal by Subject|0|||
33642639|NCT04206332|63046713|FG004|Part C|Withdrawal by Subject|0|||
33642640|NCT04206332|63046714|FG005|Part C|Withdrawal by Subject|0|||
33642641|NCT04206332|63046715|FG006|Part C|Withdrawal by Subject|0|||
33642642|NCT04206332|63046716|FG007|Part C|Withdrawal by Subject|0|||
33642643|NCT04206332|63046717|FG008|Part C|Withdrawal by Subject|0|||
33642644|NCT04206332|63046718|FG009|Part C|Withdrawal by Subject|0|||
33642645|NCT04206332|63046719|FG010|Part C|Withdrawal by Subject|0|||
33642646|NCT04206332|63046720|FG011|Part C|Withdrawal by Subject|0|||
33642647|NCT04206332|63046721|FG012|Part C|Withdrawal by Subject|0|||
33642648|NCT04206332|63046722|FG013|Part C|Withdrawal by Subject|0|||
33642649|NCT04206332|63046723|FG014|Part C|Withdrawal by Subject|2|||
33642650|NCT04206332|63046724|FG015|Part C|Withdrawal by Subject|0|||
33642651|NCT04206332|63046725|FG016|Part C|Withdrawal by Subject|0|||
33642652|NCT03790111|63046808|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
33642653|NCT03780543|63046815|FG000|Overall Study|Adverse Event|1|||
33642654|NCT03780543|63046816|FG001|Overall Study|Adverse Event|0|||
33642655|NCT03780543|63046817|FG002|Overall Study|Adverse Event|2|||
33642656|NCT03780543|63046815|FG000|Overall Study|Lost to Follow-up|2|||
33642657|NCT03780543|63046816|FG001|Overall Study|Lost to Follow-up|0|||
33642658|NCT03780543|63046817|FG002|Overall Study|Lost to Follow-up|1|||
33642659|NCT03780543|63046815|FG000|Overall Study|Study terminated by Sponsor|8|||
33642660|NCT03780543|63046816|FG001|Overall Study|Study terminated by Sponsor|7|||
33642661|NCT03780543|63046817|FG002|Overall Study|Study terminated by Sponsor|13|||
33642662|NCT03780543|63046815|FG000|Overall Study|Withdrawal by Subject|1|||
33642663|NCT03780543|63046816|FG001|Overall Study|Withdrawal by Subject|8|||
33642664|NCT03780543|63046817|FG002|Overall Study|Withdrawal by Subject|1|||
33642665|NCT03780543|63046815|FG000|Overall Study|Noncompliance with study drug|1|||
33642666|NCT03780543|63046816|FG001|Overall Study|Noncompliance with study drug|0|||
33642667|NCT03780543|63046817|FG002|Overall Study|Noncompliance with study drug|0|||
33642668|NCT03745820|63046830|FG000|Overall Study|Adverse Event|0|||
33542899|NCT02706938|62933612|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
33542900|NCT02706938|62933613|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
33642669|NCT03745820|63046831|FG001|Overall Study|Adverse Event|3|||
33642670|NCT03745820|63046832|FG002|Overall Study|Adverse Event|2|||
33642671|NCT03745820|63046830|FG000|Overall Study|Non-Compliance with Study Drug|4|||
33642672|NCT03745820|63046831|FG001|Overall Study|Non-Compliance with Study Drug|3|||
33642673|NCT03745820|63046832|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33642674|NCT03745820|63046830|FG000|Overall Study|Withdrawal by Subject|4|||
33642675|NCT03745820|63046831|FG001|Overall Study|Withdrawal by Subject|4|||
33642676|NCT03745820|63046832|FG002|Overall Study|Withdrawal by Subject|4|||
33642677|NCT03745820|63046830|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
33642678|NCT03745820|63046831|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
33642679|NCT03745820|63046832|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
33642680|NCT03745820|63046830|FG000|Overall Study|Lost to Follow-up|2|||
33642681|NCT03745820|63046831|FG001|Overall Study|Lost to Follow-up|0|||
33642682|NCT03745820|63046832|FG002|Overall Study|Lost to Follow-up|3|||
33642683|NCT03745820|63046830|FG000|Overall Study|Reason not Specified|2|||
33642684|NCT03745820|63046831|FG001|Overall Study|Reason not Specified|4|||
33642685|NCT03745820|63046832|FG002|Overall Study|Reason not Specified|1|||
33642686|NCT03699631|63046840|FG000|Overall Study|Adverse Event|3|||
33642687|NCT03686150|63046850|FG000|Overall Study|Withdrawal by Subject|1|||
33642688|NCT03686150|63046851|FG001|Overall Study|Withdrawal by Subject|1|||
33642689|NCT03686150|63046852|FG002|Overall Study|Withdrawal by Subject|1|||
33642690|NCT03686150|63046853|FG003|Overall Study|Withdrawal by Subject|0|||
33642691|NCT03686150|63046854|FG004|Overall Study|Withdrawal by Subject|1|||
33642692|NCT03686150|63046855|FG005|Overall Study|Withdrawal by Subject|2|||
33642693|NCT03686150|63046850|FG000|Overall Study|Physician Decision|1|||
33642694|NCT03686150|63046851|FG001|Overall Study|Physician Decision|0|||
33542901|NCT02706938|62933612|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
33542902|NCT02706938|62933613|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
33642695|NCT03686150|63046852|FG002|Overall Study|Physician Decision|0|||
33642696|NCT03686150|63046853|FG003|Overall Study|Physician Decision|0|||
33642697|NCT03686150|63046854|FG004|Overall Study|Physician Decision|0|||
33642698|NCT03686150|63046855|FG005|Overall Study|Physician Decision|1|||
33642699|NCT03686150|63046850|FG000|Overall Study|Lost to Follow-up|0|||
33642700|NCT03686150|63046851|FG001|Overall Study|Lost to Follow-up|1|||
33642701|NCT03686150|63046852|FG002|Overall Study|Lost to Follow-up|0|||
33642702|NCT03686150|63046853|FG003|Overall Study|Lost to Follow-up|0|||
33642703|NCT03686150|63046854|FG004|Overall Study|Lost to Follow-up|0|||
33642704|NCT03686150|63046855|FG005|Overall Study|Lost to Follow-up|0|||
33642705|NCT03604172|63046872|FG000|Overall Study|Lost to Follow-up|1|||
33642706|NCT03604172|63046873|FG001|Overall Study|Lost to Follow-up|2|||
33642707|NCT03530124|63046881|FG000|Overall Study|Withdrawal by Subject|0|||
33642708|NCT03530124|63046882|FG001|Overall Study|Withdrawal by Subject|1|||
33642709|NCT03530124|63046881|FG000|Overall Study|Protocol Violation|1|||
33642710|NCT03530124|63046882|FG001|Overall Study|Protocol Violation|0|||
33642711|NCT03530124|63046881|FG000|Overall Study|Discharged prior to study completion|1|||
33642712|NCT03530124|63046882|FG001|Overall Study|Discharged prior to study completion|0|||
33642713|NCT03496207|63046891|FG000|Base Study|Adverse Event|0|||
33642714|NCT03496207|63046892|FG001|Base Study|Adverse Event|0|||
33642715|NCT03496207|63046893|FG002|Base Study|Adverse Event|1|||
33642716|NCT03496207|63046894|FG003|Base Study|Adverse Event|1|||
33642717|NCT03496207|63046895|FG004|Base Study|Adverse Event|4|||
33642718|NCT03496207|63046891|FG000|Base Study|Death|0|||
33642719|NCT03496207|63046892|FG001|Base Study|Death|0|||
33642720|NCT03496207|63046893|FG002|Base Study|Death|0|||
33642721|NCT03496207|63046894|FG003|Base Study|Death|0|||
33642722|NCT03496207|63046895|FG004|Base Study|Death|1|||
33642723|NCT03496207|63046891|FG000|Base Study|Withdrawal by Subject|0|||
33642724|NCT03496207|63046892|FG001|Base Study|Withdrawal by Subject|0|||
33642725|NCT03496207|63046893|FG002|Base Study|Withdrawal by Subject|1|||
33642726|NCT03496207|63046894|FG003|Base Study|Withdrawal by Subject|0|||
33642727|NCT03496207|63046895|FG004|Base Study|Withdrawal by Subject|1|||
33642728|NCT03496207|63046891|FG000|Extension Period|Adverse Event|0|||
33642729|NCT03496207|63046892|FG001|Extension Period|Adverse Event|0|||
33642730|NCT03496207|63046893|FG002|Extension Period|Adverse Event|0|||
33642731|NCT03496207|63046894|FG003|Extension Period|Adverse Event|1|||
33642732|NCT03496207|63046895|FG004|Extension Period|Adverse Event|1|||
33642733|NCT03496207|63046891|FG000|Extension Period|Death|1|||
33642734|NCT03496207|63046892|FG001|Extension Period|Death|0|||
33642735|NCT03496207|63046893|FG002|Extension Period|Death|0|||
33642736|NCT03496207|63046894|FG003|Extension Period|Death|1|||
33642737|NCT03496207|63046895|FG004|Extension Period|Death|2|||
33642738|NCT03496207|63046891|FG000|Extension Period|Withdrawal by Subject|1|||
33642739|NCT03496207|63046892|FG001|Extension Period|Withdrawal by Subject|0|||
33642740|NCT03496207|63046893|FG002|Extension Period|Withdrawal by Subject|0|||
33642741|NCT03496207|63046894|FG003|Extension Period|Withdrawal by Subject|1|||
33642742|NCT03496207|63046895|FG004|Extension Period|Withdrawal by Subject|1|||
33642743|NCT03496207|63046891|FG000|Extension Period|Elevated hemoglobin levels|0|||
33642744|NCT03496207|63046892|FG001|Extension Period|Elevated hemoglobin levels|0|||
33642745|NCT03496207|63046893|FG002|Extension Period|Elevated hemoglobin levels|0|||
33642746|NCT03496207|63046894|FG003|Extension Period|Elevated hemoglobin levels|0|||
33642747|NCT03496207|63046895|FG004|Extension Period|Elevated hemoglobin levels|1|||
33642748|NCT03204188|63046925|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
33642749|NCT03204188|63046925|FG000|Immunotherapy Phase (1 Year)|Death|1|||
33642750|NCT03204188|63046925|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
33642751|NCT03204188|63046925|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
33642752|NCT03112590|63046932|FG000|Overall Study|Adverse Event|0|||
33642753|NCT03112590|63046933|FG001|Overall Study|Adverse Event|1|||
33642754|NCT03112590|63046934|FG002|Overall Study|Adverse Event|0|||
33642755|NCT03060629|63046944|FG000|Overall Study|Death|4|||
33642756|NCT03060629|63046945|FG001|Overall Study|Death|5|||
33642757|NCT03060629|63046944|FG000|Overall Study|Withdrawal by Subject|50|||
33642758|NCT03060629|63046945|FG001|Overall Study|Withdrawal by Subject|35|||
33642759|NCT03060629|63046944|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
33642760|NCT03060629|63046945|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
33642761|NCT03060629|63046944|FG000|Overall Study|Participant Relocate|15|||
33642762|NCT03060629|63046945|FG001|Overall Study|Participant Relocate|15|||
33642763|NCT03060629|63046944|FG000|Overall Study|Unable to Contact Participant|34|||
33642764|NCT03060629|63046945|FG001|Overall Study|Unable to Contact Participant|23|||
33642765|NCT03060629|63046944|FG000|Overall Study|Investigator Decision|7|||
33642766|NCT03060629|63046945|FG001|Overall Study|Investigator Decision|7|||
33642767|NCT03060629|63046944|FG000|Overall Study|Study Terminated by Sponsor|1100|||
33642768|NCT03060629|63046945|FG001|Overall Study|Study Terminated by Sponsor|1123|||
33642769|NCT03060629|63046944|FG000|Overall Study|Other|4|||
33642770|NCT03060629|63046945|FG001|Overall Study|Other|4|||
33642771|NCT03021486|63046954|FG000|Overall Study|Withdrawal by Subject|1|||
33642772|NCT03021486|63046955|FG001|Overall Study|Withdrawal by Subject|1|||
33642773|NCT03021486|63046956|FG002|Overall Study|Withdrawal by Subject|3|||
33642774|NCT03021486|63046954|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
33642775|NCT03021486|63046955|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
33642776|NCT03021486|63046956|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
33642777|NCT02999789|63046968|FG000|Overall Study|Withdrawal by Subject|0|||
33642778|NCT02999789|63046969|FG001|Overall Study|Withdrawal by Subject|1|||
33642779|NCT02999789|63046968|FG000|Overall Study|Became ineligible|1|||
33642780|NCT02999789|63046969|FG001|Overall Study|Became ineligible|2|||
33642781|NCT02949128|63046976|FG000|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2|||
33642782|NCT02949128|63046976|FG000|Initial Evaluation Period|Adverse Event|3|||
33642783|NCT02949128|63046976|FG000|Initial Evaluation Period|Death|2|||
33642784|NCT02949128|63046976|FG000|Initial Evaluation Period|Physician Decision|1|||
33642785|NCT02949128|63046976|FG000|Initial Evaluation Period|Protocol Violation|1|||
33642786|NCT02949128|63046976|FG000|Extension Period|Withdrawal by Subject|5|||
33642787|NCT02949128|63046976|FG000|Extension Period|Protocol Violation|1|||
33642788|NCT02949128|63046976|FG000|Extension Period|Physician Decision|2|||
33642789|NCT02949128|63046976|FG000|Extension Period|Ongoing in Extension Period as of 07/02/2019|41|||
33642790|NCT02923115|63046995|FG000|Overall Study|Lost to Follow-up|0|||
33642791|NCT02923115|63046996|FG001|Overall Study|Lost to Follow-up|0|||
33642792|NCT02923115|63046997|FG002|Overall Study|Lost to Follow-up|0|||
33642793|NCT02923115|63046998|FG003|Overall Study|Lost to Follow-up|1|||
33642794|NCT02923115|63046999|FG004|Overall Study|Lost to Follow-up|0|||
33642795|NCT02923115|63047000|FG005|Overall Study|Lost to Follow-up|0|||
33642796|NCT02923115|63046995|FG000|Overall Study|Withdrawal by Subject|0|||
33642797|NCT02923115|63046996|FG001|Overall Study|Withdrawal by Subject|1|||
33642798|NCT02923115|63046997|FG002|Overall Study|Withdrawal by Subject|0|||
33642799|NCT02923115|63046998|FG003|Overall Study|Withdrawal by Subject|0|||
33642800|NCT02923115|63046999|FG004|Overall Study|Withdrawal by Subject|0|||
33642801|NCT02923115|63047000|FG005|Overall Study|Withdrawal by Subject|0|||
33642802|NCT02923115|63046995|FG000|Overall Study|Randomized, but not dosed|0|||
33642803|NCT02923115|63046996|FG001|Overall Study|Randomized, but not dosed|0|||
33642804|NCT02923115|63046997|FG002|Overall Study|Randomized, but not dosed|3|||
33642805|NCT02923115|63046998|FG003|Overall Study|Randomized, but not dosed|1|||
33642806|NCT02923115|63046999|FG004|Overall Study|Randomized, but not dosed|5|||
33642807|NCT02923115|63047000|FG005|Overall Study|Randomized, but not dosed|0|||
33642808|NCT02910583|63047016|FG000|Overall Study|Withdrawal by Subject|6|||
33642809|NCT02910583|63047017|FG001|Overall Study|Withdrawal by Subject|7|||
33642810|NCT02910583|63047016|FG000|Overall Study|Other, Not Specified|1|||
33642811|NCT02910583|63047017|FG001|Overall Study|Other, Not Specified|0|||
33642812|NCT02487394|63047062|FG000|Phase 1|Withdrawal by Subject|0|||
33642813|NCT02487394|63047063|FG001|Phase 1|Withdrawal by Subject|1|||
33642814|NCT02063724|63047082|FG000|Overall Study|Disease progression|1|||
33642815|NCT02029846|63047088|FG000|Overall Study|n=1 each arm|1|||
33642816|NCT02029846|63047089|FG001|Overall Study|n=1 each arm|1|||
33642817|NCT05419908|63047097|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
33642818|NCT05419908|63047098|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
33642819|NCT05419908|63047097|FG000|Overall Study|Serious Adverse Event|0|||
33642820|NCT05419908|63047098|FG001|Overall Study|Serious Adverse Event|2|||
33642821|NCT05419908|63047097|FG000|Overall Study|Withdrawal by Subject|2|||
33642822|NCT05419908|63047098|FG001|Overall Study|Withdrawal by Subject|0|||
33642823|NCT05419908|63047097|FG000|Overall Study|Miscellaneous|1|||
33642824|NCT05419908|63047098|FG001|Overall Study|Miscellaneous|1|||
33642825|NCT05091060|63047104|FG000|Overall Study|Lost to Follow-up|1|||
33642826|NCT05056311|63047108|FG000|Overall Study|Lost to Follow-up|14|||
33642827|NCT05056311|63047108|FG000|Overall Study|Withdrawal by Subject|1|||
33642828|NCT05056311|63047108|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
33642829|NCT04806503|63047146|FG000|Overall Study|Lost to Follow-up|0|||
33642830|NCT04806503|63047147|FG001|Overall Study|Lost to Follow-up|0|||
33642831|NCT04806503|63047148|FG002|Overall Study|Lost to Follow-up|1|||
33642832|NCT04806503|63047149|FG003|Overall Study|Lost to Follow-up|0|||
33642833|NCT04806503|63047150|FG004|Overall Study|Lost to Follow-up|0|||
33642834|NCT04806503|63047146|FG000|Overall Study|Withdrawal by Subject|1|||
33642835|NCT04806503|63047147|FG001|Overall Study|Withdrawal by Subject|0|||
33642836|NCT04806503|63047148|FG002|Overall Study|Withdrawal by Subject|1|||
33642837|NCT04806503|63047149|FG003|Overall Study|Withdrawal by Subject|1|||
33642838|NCT04806503|63047150|FG004|Overall Study|Withdrawal by Subject|1|||
33642839|NCT04806503|63047146|FG000|Overall Study|Adverse Event|1|||
33642840|NCT04806503|63047147|FG001|Overall Study|Adverse Event|1|||
33642841|NCT04806503|63047148|FG002|Overall Study|Adverse Event|0|||
33642842|NCT04806503|63047149|FG003|Overall Study|Adverse Event|1|||
33642843|NCT04806503|63047150|FG004|Overall Study|Adverse Event|0|||
33642844|NCT04508751|63047166|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
33642845|NCT04508751|63047167|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
33642846|NCT04508751|63047168|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
33642847|NCT04473482|63047178|FG000|Overall Study|Death|0|||
33642848|NCT04473482|63047179|FG001|Overall Study|Death|3|||
33642849|NCT04473482|63047178|FG000|Overall Study|Lost to Follow-up|9|||
33642850|NCT04473482|63047179|FG001|Overall Study|Lost to Follow-up|7|||
33642851|NCT04473482|63047178|FG000|Overall Study|Withdrawal by Subject|2|||
33642852|NCT04473482|63047179|FG001|Overall Study|Withdrawal by Subject|1|||
33642853|NCT04439318|63047186|FG000|Overall Study|Ineligible|1|||
33642854|NCT04439318|63047186|FG000|Overall Study|Never Started Treatment|3|||
33642855|NCT04439318|63047186|FG000|Overall Study|Adverse Event|10|||
33642856|NCT04439318|63047186|FG000|Overall Study|Death|2|||
33642857|NCT04439318|63047186|FG000|Overall Study|Disease Progression|25|||
33642858|NCT04439318|63047186|FG000|Overall Study|Other Complicating Disease|2|||
33642859|NCT04439318|63047186|FG000|Overall Study|Withdrawal by Subject|4|||
33642860|NCT04439318|63047186|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
33642861|NCT04439318|63047186|FG000|Overall Study|Non-Compliance|1|||
33642862|NCT04439318|63047186|FG000|Overall Study|Still on Treatment|1|||
33642863|NCT03919799|63047193|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
33642864|NCT03919799|63047194|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
33642865|NCT03919799|63047195|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
33642866|NCT03919799|63047196|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
33642867|NCT03919799|63047197|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
33642868|NCT03919799|63047193|FG000|DB Period (28 Weeks)|Adverse Event|1|||
33642869|NCT03919799|63047194|FG001|DB Period (28 Weeks)|Adverse Event|1|||
33642870|NCT03919799|63047195|FG002|DB Period (28 Weeks)|Adverse Event|1|||
33642871|NCT03919799|63047196|FG003|DB Period (28 Weeks)|Adverse Event|0|||
33642872|NCT03919799|63047197|FG004|DB Period (28 Weeks)|Adverse Event|0|||
33642873|NCT03919799|63047193|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
33642874|NCT03919799|63047194|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
33642875|NCT03919799|63047195|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
33642876|NCT03919799|63047196|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
33642877|NCT03919799|63047197|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
33642878|NCT03919799|63047193|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
33642879|NCT03919799|63047194|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
33642880|NCT03919799|63047195|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
33642881|NCT03919799|63047196|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
33642882|NCT03919799|63047197|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
33642883|NCT03919799|63047193|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
33642884|NCT03919799|63047194|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
33642885|NCT03919799|63047195|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
33642886|NCT03919799|63047196|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
33642887|NCT03919799|63047197|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
33642888|NCT03621735|63047242|FG000|Overall Study|Withdrawal by Subject|13|||
33642889|NCT03621735|63047243|FG001|Overall Study|Withdrawal by Subject|13|||
33642890|NCT03547908|63047267|FG000|Overall Study|Still On Study|115|||
33642891|NCT03547908|63047268|FG001|Overall Study|Still On Study|118|||
33642892|NCT03547908|63047267|FG000|Overall Study|Lost to Follow-up|2|||
33642893|NCT03547908|63047268|FG001|Overall Study|Lost to Follow-up|2|||
33642894|NCT03547908|63047267|FG000|Overall Study|Withdrew Consent|2|||
33642895|NCT03547908|63047268|FG001|Overall Study|Withdrew Consent|1|||
33642896|NCT03547908|63047267|FG000|Overall Study|Adverse Event|1|||
33642897|NCT03547908|63047268|FG001|Overall Study|Adverse Event|0|||
33642898|NCT03547908|63047267|FG000|Overall Study|Death|1|||
33642899|NCT03547908|63047268|FG001|Overall Study|Death|0|||
33642900|NCT03547908|63047267|FG000|Overall Study|Investigator's Discretion|0|||
33642901|NCT03547908|63047268|FG001|Overall Study|Investigator's Discretion|1|||
33642902|NCT03547908|63047267|FG000|Overall Study|Randomized But Never Treated|1|||
33642903|NCT03547908|63047268|FG001|Overall Study|Randomized But Never Treated|0|||
33642904|NCT03462719|63047291|FG000|Overall Study|Withdrawal by Subject|4|||
33642905|NCT03462719|63047292|FG001|Overall Study|Withdrawal by Subject|3|||
33642906|NCT03462719|63047291|FG000|Overall Study|Ongoing|87|||
33642907|NCT03462719|63047292|FG001|Overall Study|Ongoing|72|||
33642908|NCT03245151|63047321|FG000|Overall Study|Withdrawal by Subject|2|||
33642909|NCT03245151|63047322|FG001|Overall Study|Withdrawal by Subject|0|||
33642910|NCT03245151|63047323|FG002|Overall Study|Withdrawal by Subject|0|||
33642911|NCT03245151|63047324|FG003|Overall Study|Withdrawal by Subject|2|||
33642912|NCT03245151|63047325|FG004|Overall Study|Withdrawal by Subject|1|||
33642913|NCT03245151|63047321|FG000|Overall Study|Death|3|||
33642914|NCT03245151|63047322|FG001|Overall Study|Death|14|||
33642915|NCT03245151|63047323|FG002|Overall Study|Death|9|||
33642916|NCT03245151|63047324|FG003|Overall Study|Death|16|||
33642917|NCT03245151|63047325|FG004|Overall Study|Death|7|||
33642918|NCT03245151|63047321|FG000|Overall Study|Sponsor's decision|0|||
33642919|NCT03245151|63047322|FG001|Overall Study|Sponsor's decision|1|||
33642920|NCT03245151|63047323|FG002|Overall Study|Sponsor's decision|0|||
33642921|NCT03245151|63047324|FG003|Overall Study|Sponsor's decision|0|||
33642922|NCT03245151|63047325|FG004|Overall Study|Sponsor's decision|0|||
33642923|NCT03075527|63047338|FG000|Overall Study|Ongoing treatment|2|||
33642924|NCT02227199|63047363|FG000|Overall Study|Physician Decision|0|||
33642925|NCT02227199|63047364|FG001|Overall Study|Physician Decision|0|||
33642926|NCT02227199|63047365|FG002|Overall Study|Physician Decision|1|||
33642927|NCT02227199|63047363|FG000|Overall Study|Adverse Event|0|||
33642928|NCT02227199|63047364|FG001|Overall Study|Adverse Event|0|||
33642929|NCT02227199|63047365|FG002|Overall Study|Adverse Event|3|||
33642930|NCT02087865|63047380|FG000|Overall Study|Withdrawal by Subject|6|||
33642931|NCT02087865|63047381|FG001|Overall Study|Withdrawal by Subject|0|||
33642932|NCT02087865|63047382|FG002|Overall Study|Withdrawal by Subject|1|||
33642933|NCT02087865|63047380|FG000|Overall Study|Lost to Follow-up|0|||
33642934|NCT02087865|63047381|FG001|Overall Study|Lost to Follow-up|0|||
33642935|NCT02087865|63047382|FG002|Overall Study|Lost to Follow-up|1|||
33642936|NCT02087865|63047380|FG000|Overall Study|Drug Non-compliance|0|||
33642937|NCT02087865|63047381|FG001|Overall Study|Drug Non-compliance|2|||
33642938|NCT02087865|63047382|FG002|Overall Study|Drug Non-compliance|0|||
33642939|NCT02087865|63047380|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
33642940|NCT02087865|63047381|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
33642941|NCT02087865|63047382|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
33642942|NCT01682083|63047402|FG000|Overall Study|Lost to Follow-up|11|||
33642943|NCT01682083|63047403|FG001|Overall Study|Lost to Follow-up|18|||
33642944|NCT01682083|63047402|FG000|Overall Study|Withdrawal by Subject|31|||
33642945|NCT01682083|63047403|FG001|Overall Study|Withdrawal by Subject|40|||
33642946|NCT01682083|63047402|FG000|Overall Study|Death|60|||
33642947|NCT01682083|63047403|FG001|Overall Study|Death|93|||
33642948|NCT01682083|63047402|FG000|Overall Study|Physician Decision|5|||
33642949|NCT01682083|63047403|FG001|Overall Study|Physician Decision|4|||
33642950|NCT01180790|63047420|FG000|Overall Study|Adverse Event|1|||
33642951|NCT01180790|63047421|FG001|Overall Study|Adverse Event|1|||
33642952|NCT01180790|63047422|FG002|Overall Study|Adverse Event|2|||
33642953|NCT01180790|63047423|FG003|Overall Study|Adverse Event|0|||
33642954|NCT01180790|63047424|FG004|Overall Study|Adverse Event|1|||
33642955|NCT01180790|63047425|FG005|Overall Study|Adverse Event|3|||
33642956|NCT01180790|63047426|FG006|Overall Study|Adverse Event|0|||
33642957|NCT01180790|63047420|FG000|Overall Study|Withdrawal by Subject|3|||
33642958|NCT01180790|63047421|FG001|Overall Study|Withdrawal by Subject|0|||
33642959|NCT01180790|63047422|FG002|Overall Study|Withdrawal by Subject|5|||
33642960|NCT01180790|63047423|FG003|Overall Study|Withdrawal by Subject|0|||
33642961|NCT01180790|63047424|FG004|Overall Study|Withdrawal by Subject|2|||
33642962|NCT01180790|63047425|FG005|Overall Study|Withdrawal by Subject|1|||
33642963|NCT01180790|63047426|FG006|Overall Study|Withdrawal by Subject|0|||
33642964|NCT01180790|63047420|FG000|Overall Study|Lost to Follow-up|3|||
33642965|NCT01180790|63047421|FG001|Overall Study|Lost to Follow-up|1|||
33642966|NCT01180790|63047422|FG002|Overall Study|Lost to Follow-up|0|||
33642967|NCT01180790|63047423|FG003|Overall Study|Lost to Follow-up|2|||
33642968|NCT01180790|63047424|FG004|Overall Study|Lost to Follow-up|1|||
33642969|NCT01180790|63047425|FG005|Overall Study|Lost to Follow-up|0|||
33642970|NCT01180790|63047426|FG006|Overall Study|Lost to Follow-up|1|||
33642971|NCT01180790|63047420|FG000|Overall Study|Physician Decision|1|||
33642972|NCT01180790|63047421|FG001|Overall Study|Physician Decision|0|||
33642973|NCT01180790|63047422|FG002|Overall Study|Physician Decision|0|||
33642974|NCT01180790|63047423|FG003|Overall Study|Physician Decision|1|||
33642975|NCT01180790|63047424|FG004|Overall Study|Physician Decision|0|||
33642976|NCT01180790|63047425|FG005|Overall Study|Physician Decision|0|||
33642977|NCT01180790|63047426|FG006|Overall Study|Physician Decision|0|||
33642978|NCT01180790|63047420|FG000|Overall Study|Lack of Efficacy|1|||
33642979|NCT01180790|63047421|FG001|Overall Study|Lack of Efficacy|2|||
33642980|NCT01180790|63047422|FG002|Overall Study|Lack of Efficacy|5|||
33642981|NCT01180790|63047423|FG003|Overall Study|Lack of Efficacy|6|||
33642982|NCT01180790|63047424|FG004|Overall Study|Lack of Efficacy|1|||
33642983|NCT01180790|63047425|FG005|Overall Study|Lack of Efficacy|3|||
33642984|NCT01180790|63047426|FG006|Overall Study|Lack of Efficacy|0|||
33642985|NCT01180790|63047420|FG000|Overall Study|compliance|0|||
33642986|NCT01180790|63047421|FG001|Overall Study|compliance|1|||
33642987|NCT01180790|63047422|FG002|Overall Study|compliance|0|||
33642988|NCT01180790|63047423|FG003|Overall Study|compliance|0|||
33642989|NCT01180790|63047424|FG004|Overall Study|compliance|0|||
33642990|NCT01180790|63047425|FG005|Overall Study|compliance|0|||
33642991|NCT01180790|63047426|FG006|Overall Study|compliance|0|||
33642992|NCT01180790|63047420|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
33642993|NCT01180790|63047421|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
33642994|NCT01180790|63047422|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
33642995|NCT01180790|63047423|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
33642996|NCT01180790|63047424|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
33642997|NCT01180790|63047425|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
33642998|NCT01180790|63047426|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
33642999|NCT01112306|63047471|FG000|Overall Study|Death|175|||
33643000|NCT01112306|63047471|FG000|Overall Study|Lost to Follow-up|9|||
33643001|NCT01112306|63047471|FG000|Overall Study|Withdrawal by Subject|31|||
33643002|NCT01112306|63047471|FG000|Overall Study|Other|70|||
33643003|NCT00679042|63047479|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
33643004|NCT00679042|63047479|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
33643005|NCT00679042|63047479|FG000|5-Year Follow Up|Death|1|||
33643006|NCT00679042|63047479|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
33643007|NCT00679042|63047479|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
33643008|NCT00350272|63047509|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
33643009|NCT00350272|63047510|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
33643010|NCT00350272|63047509|FG000|Blinded 12-Week Treatment|Death|1|||
33643011|NCT00350272|63047510|FG001|Blinded 12-Week Treatment|Death|0|||
33643012|NCT00350272|63047509|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
33643013|NCT00350272|63047510|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
33643014|NCT00350272|63047509|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
33643015|NCT00350272|63047510|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
33643016|NCT00350272|63047509|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
33643017|NCT00350272|63047510|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
33643018|NCT00350272|63047509|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
33643019|NCT00350272|63047510|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
33643020|NCT00350272|63047509|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
33643021|NCT00350272|63047510|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
33643022|NCT00350272|63047509|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
33643023|NCT00350272|63047510|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
33643024|NCT00350272|63047509|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
33643025|NCT00350272|63047510|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
33643026|NCT00350272|63047509|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
33643027|NCT00350272|63047510|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
33643028|NCT00350272|63047509|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
33643029|NCT00350272|63047510|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
33643030|NCT02028884|63047521|FG000|Double-blind Period|Adverse Event|5|||
33643031|NCT02028884|63047522|FG001|Double-blind Period|Adverse Event|3|||
33643032|NCT02028884|63047523|FG002|Double-blind Period|Adverse Event|0|||
33643033|NCT02028884|63047521|FG000|Double-blind Period|Eligibility Violation|1|||
33643034|NCT02028884|63047522|FG001|Double-blind Period|Eligibility Violation|0|||
33643035|NCT02028884|63047523|FG002|Double-blind Period|Eligibility Violation|0|||
33643036|NCT02028884|63047521|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
33643037|NCT02028884|63047522|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
33643038|NCT02028884|63047523|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
33643039|NCT02028884|63047521|FG000|Double-blind Period|Withdrawal by Subject|2|||
33643040|NCT02028884|63047522|FG001|Double-blind Period|Withdrawal by Subject|0|||
33643041|NCT02028884|63047523|FG002|Double-blind Period|Withdrawal by Subject|0|||
33643042|NCT02028884|63047521|FG000|Open-label Extension Period|Adverse Event|3|||
33643043|NCT02028884|63047522|FG001|Open-label Extension Period|Adverse Event|1|||
33643044|NCT02028884|63047523|FG002|Open-label Extension Period|Adverse Event|0|||
33643045|NCT02028884|63047521|FG000|Open-label Extension Period|Lack of Efficacy|3|||
33643046|NCT02028884|63047522|FG001|Open-label Extension Period|Lack of Efficacy|0|||
33643047|NCT02028884|63047523|FG002|Open-label Extension Period|Lack of Efficacy|0|||
33643048|NCT02028884|63047521|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
33643049|NCT02028884|63047522|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
33643050|NCT02028884|63047523|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
33643051|NCT02028884|63047521|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
33643052|NCT02028884|63047522|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
33643053|NCT02028884|63047523|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
33643054|NCT02028884|63047521|FG000|Open-label Extension Period|Switched to another treatment option|3|||
33542903|NCT02706938|62933612|FG000|Second Period, 6 Weeks|Adverse Event|0|||
33542904|NCT02706938|62933613|FG001|Second Period, 6 Weeks|Adverse Event|7|||
33542905|NCT02706938|62933612|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
33542906|NCT02706938|62933613|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
33542907|NCT03053063|62933623|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
33542908|NCT03053063|62933624|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
33542909|NCT03053063|62933625|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
33542910|NCT03053063|62933626|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
33542911|NCT03053063|62933623|FG000|Randomized Phase|Withdrew consent|8|||
33542912|NCT03053063|62933624|FG001|Randomized Phase|Withdrew consent|11|||
33542913|NCT03053063|62933625|FG002|Randomized Phase|Withdrew consent|5|||
33542914|NCT03053063|62933626|FG003|Randomized Phase|Withdrew consent|0|||
33542915|NCT03053063|62933623|FG000|Randomized Phase|Investigator's Discretion|8|||
33542916|NCT03053063|62933624|FG001|Randomized Phase|Investigator's Discretion|6|||
33542917|NCT03053063|62933625|FG002|Randomized Phase|Investigator's Discretion|2|||
33542918|NCT03053063|62933626|FG003|Randomized Phase|Investigator's Discretion|0|||
33643055|NCT02028884|63047522|FG001|Open-label Extension Period|Switched to another treatment option|0|||
33643056|NCT02028884|63047523|FG002|Open-label Extension Period|Switched to another treatment option|0|||
33643057|NCT01467427|63047575|FG000|Overall Study|Withdrawal by Subject|1|||
33643058|NCT01467427|63047576|FG001|Overall Study|Withdrawal by Subject|0|||
33643059|NCT01467427|63047575|FG000|Overall Study|Entered extension phase|11|||
33643060|NCT01467427|63047576|FG001|Overall Study|Entered extension phase|11|||
33643061|NCT01467427|63047575|FG000|Overall Study|Not continuing in extension phase|0|||
33643062|NCT01467427|63047576|FG001|Overall Study|Not continuing in extension phase|2|||
33643063|NCT01422187|63047585|FG000|Overall Study|Personal reason|1|||
33643064|NCT01422187|63047586|FG001|Overall Study|Personal reason|0|||
33643065|NCT01422187|63047587|FG002|Overall Study|Personal reason|0|||
33643066|NCT01422187|63047585|FG000|Overall Study|Lost to Follow-up|0|||
33643067|NCT01422187|63047586|FG001|Overall Study|Lost to Follow-up|1|||
33643068|NCT01422187|63047587|FG002|Overall Study|Lost to Follow-up|0|||
33643069|NCT00472212|63047597|FG000|Overall Study|Lost to Follow-up|6|||
33643070|NCT00472212|63047598|FG001|Overall Study|Lost to Follow-up|4|||
33643071|NCT00378105|63047606|FG000|Overall Study|Adverse Event|3|||
33643072|NCT00378105|63047607|FG001|Overall Study|Adverse Event|1|||
33643073|NCT00378105|63047606|FG000|Overall Study|Withdrawal by Subject|3|||
33643074|NCT00378105|63047607|FG001|Overall Study|Withdrawal by Subject|3|||
33643075|NCT00378105|63047606|FG000|Overall Study|Death|1|||
33643076|NCT00378105|63047607|FG001|Overall Study|Death|0|||
33643077|NCT00378105|63047606|FG000|Overall Study|Going to transplant|7|||
33643078|NCT00378105|63047607|FG001|Overall Study|Going to transplant|8|||
33643079|NCT00378105|63047606|FG000|Overall Study|Progressive disease|3|||
33643080|NCT00378105|63047607|FG001|Overall Study|Progressive disease|3|||
33643081|NCT00378105|63047606|FG000|Overall Study|remain on study|3|||
33643082|NCT00378105|63047607|FG001|Overall Study|remain on study|11|||
33643083|NCT00378105|63047606|FG000|Overall Study|Physician Decision|0|||
33643084|NCT00378105|63047607|FG001|Overall Study|Physician Decision|2|||
33643085|NCT00378105|63047606|FG000|Overall Study|Going non-protocol therapy|0|||
33643086|NCT00378105|63047607|FG001|Overall Study|Going non-protocol therapy|1|||
33643087|NCT00378105|63047606|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
33643088|NCT00378105|63047607|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
33643089|NCT00139477|63047616|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
33643090|NCT00139477|63047617|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
33643091|NCT00139477|63047616|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
33643092|NCT00139477|63047617|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
33643093|NCT00139477|63047616|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
33643094|NCT00139477|63047617|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
33643095|NCT00139477|63047616|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
33643096|NCT00139477|63047617|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
33643097|NCT00139477|63047616|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
33643098|NCT00139477|63047617|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
33643099|NCT00139477|63047616|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
33643100|NCT00139477|63047617|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
33643101|NCT00139477|63047616|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
33643102|NCT00139477|63047617|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
33643103|NCT01469013|63047937|FG000|Part A (Treatment Period)|Adverse Event|1|||
33643104|NCT01469013|63047938|FG001|Part A (Treatment Period)|Adverse Event|0|||
33643105|NCT01469013|63047939|FG002|Part A (Treatment Period)|Adverse Event|0|||
33643106|NCT01469013|63047940|FG003|Part A (Treatment Period)|Adverse Event|0|||
33643107|NCT01469013|63047941|FG004|Part A (Treatment Period)|Adverse Event|1|||
33643108|NCT01469013|63047942|FG005|Part A (Treatment Period)|Adverse Event|0|||
33643109|NCT01469013|63047943|FG006|Part A (Treatment Period)|Adverse Event|0|||
33643110|NCT01469013|63047944|FG007|Part A (Treatment Period)|Adverse Event|0|||
33327189|NCT01185353|62703797|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33327190|NCT01185353|62703798|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33327191|NCT01185353|62703799|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
33327192|NCT01185353|62703800|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33327193|NCT01185353|62703801|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33643111|NCT01469013|63047945|FG008|Part A (Treatment Period)|Adverse Event|0|||
33643112|NCT01469013|63047946|FG009|Part A (Treatment Period)|Adverse Event|0|||
33643113|NCT01469013|63047947|FG010|Part A (Treatment Period)|Adverse Event|0|||
33643114|NCT01469013|63047948|FG011|Part A (Treatment Period)|Adverse Event|0|||
33643115|NCT01469013|63047949|FG012|Part A (Treatment Period)|Adverse Event|0|||
33643116|NCT01469013|63047937|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
33327194|NCT01185353|62703802|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
33327195|NCT01185353|62703803|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33643117|NCT01469013|63047938|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
33643118|NCT01469013|63047939|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
33327196|NCT01185353|62703804|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33327197|NCT01185353|62703805|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33327198|NCT01185353|62703806|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33463273|NCT00048542|62836831|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
33643119|NCT01469013|63047940|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
33643120|NCT01469013|63047941|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
33643121|NCT01469013|63047942|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
33643122|NCT01469013|63047943|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
33643123|NCT01469013|63047944|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
33463274|NCT00048542|62836832|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
33463275|NCT00048542|62836833|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
33643124|NCT01469013|63047945|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
33643125|NCT01469013|63047946|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
33643126|NCT01469013|63047947|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
33643127|NCT01469013|63047948|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
33643128|NCT01469013|63047949|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
33643129|NCT01469013|63047937|FG000|Part B (Extension Period)|Adverse Event|0|||
33643130|NCT01469013|63047938|FG001|Part B (Extension Period)|Adverse Event|0|||
33643131|NCT01469013|63047939|FG002|Part B (Extension Period)|Adverse Event|0|||
33643132|NCT01469013|63047940|FG003|Part B (Extension Period)|Adverse Event|0|||
33643133|NCT01469013|63047941|FG004|Part B (Extension Period)|Adverse Event|0|||
33643134|NCT01469013|63047942|FG005|Part B (Extension Period)|Adverse Event|2|||
33643135|NCT01469013|63047943|FG006|Part B (Extension Period)|Adverse Event|5|||
33643136|NCT01469013|63047944|FG007|Part B (Extension Period)|Adverse Event|5|||
33643137|NCT01469013|63047945|FG008|Part B (Extension Period)|Adverse Event|3|||
33643138|NCT01469013|63047946|FG009|Part B (Extension Period)|Adverse Event|3|||
33643139|NCT01469013|63047947|FG010|Part B (Extension Period)|Adverse Event|1|||
33643140|NCT01469013|63047948|FG011|Part B (Extension Period)|Adverse Event|6|||
33643141|NCT01469013|63047949|FG012|Part B (Extension Period)|Adverse Event|3|||
33643142|NCT01469013|63047937|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
33643143|NCT01469013|63047938|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
33643144|NCT01469013|63047939|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
33643145|NCT01469013|63047940|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
33643146|NCT01469013|63047941|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
33643147|NCT01469013|63047942|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
33643148|NCT01469013|63047943|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
33643149|NCT01469013|63047944|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
33643150|NCT01469013|63047945|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
33643151|NCT01469013|63047946|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
33643152|NCT01469013|63047947|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
33643153|NCT01469013|63047948|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
33643154|NCT01469013|63047949|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
33643155|NCT01493427|63047976|FG000|Overall Study|Adverse Event|10|||
33643156|NCT01493427|63047976|FG000|Overall Study|Personal Reasons|4|||
33643157|NCT01493427|63047976|FG000|Overall Study|Lost to Follow-up|2|||
33643158|NCT01493427|63047976|FG000|Overall Study|Inability to Follow Instructions|2|||
33643159|NCT01493427|63047976|FG000|Overall Study|Other|2|||
33643160|NCT01523457|63047982|FG000|Overall Study|Withdrawal by Subject|7|||
33643161|NCT01523457|63047983|FG001|Overall Study|Withdrawal by Subject|2|||
33643162|NCT01523301|63047991|FG000|Overall Study|Adverse Event|25|||
33327199|NCT01185353|62703797|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33463276|NCT00048542|62836834|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
33463277|NCT00048542|62836835|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
33463278|NCT00048542|62836836|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
33463279|NCT00048542|62836829|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
33463280|NCT00048542|62836830|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
33463281|NCT00048542|62836831|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
33463282|NCT00048542|62836832|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
33542919|NCT03053063|62933623|FG000|Randomized Phase|Lost to Follow-up|3|||
33542920|NCT03053063|62933624|FG001|Randomized Phase|Lost to Follow-up|5|||
33542921|NCT03053063|62933625|FG002|Randomized Phase|Lost to Follow-up|1|||
33542922|NCT03053063|62933626|FG003|Randomized Phase|Lost to Follow-up|0|||
33542923|NCT03053063|62933623|FG000|Randomized Phase|Adverse Event|0|||
33542924|NCT03053063|62933624|FG001|Randomized Phase|Adverse Event|1|||
33542925|NCT03053063|62933625|FG002|Randomized Phase|Adverse Event|0|||
33542926|NCT03053063|62933626|FG003|Randomized Phase|Adverse Event|0|||
33542927|NCT03053063|62933623|FG000|Randomized Phase|Randomized but Never Treated|1|||
33542928|NCT03053063|62933624|FG001|Randomized Phase|Randomized but Never Treated|3|||
33542929|NCT03053063|62933625|FG002|Randomized Phase|Randomized but Never Treated|2|||
33643163|NCT01523301|63047992|FG001|Overall Study|Adverse Event|16|||
33643164|NCT01523301|63047991|FG000|Overall Study|Lack of Efficacy|0|||
33643165|NCT01523301|63047992|FG001|Overall Study|Lack of Efficacy|2|||
33643166|NCT01523301|63047991|FG000|Overall Study|Protocol Violation|3|||
33643167|NCT01523301|63047992|FG001|Overall Study|Protocol Violation|4|||
33643168|NCT01523301|63047991|FG000|Overall Study|Lost to Follow-up|1|||
33643169|NCT01523301|63047992|FG001|Overall Study|Lost to Follow-up|0|||
33643170|NCT01523301|63047991|FG000|Overall Study|Withdrawal by Subject|6|||
33643171|NCT01523301|63047992|FG001|Overall Study|Withdrawal by Subject|8|||
33643172|NCT01523301|63047991|FG000|Overall Study|Other Reason|0|||
33643173|NCT01523301|63047992|FG001|Overall Study|Other Reason|2|||
33643174|NCT01806506|63048000|FG000|Overall Study|Lost to Follow-up|2|||
33643175|NCT01806506|63048001|FG001|Overall Study|Lost to Follow-up|1|||
33643176|NCT01766336|63048009|FG000|Overall Study|Adverse Event|11|||
33643177|NCT01766336|63048010|FG001|Overall Study|Adverse Event|8|||
33643178|NCT01766336|63048009|FG000|Overall Study|Death|4|||
33643179|NCT01766336|63048010|FG001|Overall Study|Death|3|||
33643180|NCT01766336|63048009|FG000|Overall Study|Lost to Follow-up|1|||
33643181|NCT01766336|63048010|FG001|Overall Study|Lost to Follow-up|3|||
33643182|NCT01766336|63048009|FG000|Overall Study|Physician Decision|4|||
33643183|NCT01766336|63048010|FG001|Overall Study|Physician Decision|2|||
33643184|NCT01766336|63048009|FG000|Overall Study|Protocol Violation|0|||
33643185|NCT01766336|63048010|FG001|Overall Study|Protocol Violation|1|||
33643186|NCT01766336|63048009|FG000|Overall Study|Sponsor Decision|52|||
33643187|NCT01766336|63048010|FG001|Overall Study|Sponsor Decision|43|||
33643188|NCT01766336|63048009|FG000|Overall Study|Withdrawal by Subject|18|||
33643189|NCT01766336|63048010|FG001|Overall Study|Withdrawal by Subject|15|||
33643190|NCT01797536|63048020|FG000|Overall Study|Adverse Event|0|||
33643191|NCT01797536|63048021|FG001|Overall Study|Adverse Event|1|||
33643192|NCT01797536|63048022|FG002|Overall Study|Adverse Event|0|||
33643193|NCT01797536|63048023|FG003|Overall Study|Adverse Event|0|||
33643194|NCT01797302|63048036|FG000|Overall Study|Lost to Follow-up|16|||
33643195|NCT01797302|63048037|FG001|Overall Study|Lost to Follow-up|23|||
33643196|NCT01797302|63048038|FG002|Overall Study|Lost to Follow-up|22|||
33643197|NCT01797302|63048036|FG000|Overall Study|Withdrawal by Subject|1|||
33643198|NCT01797302|63048037|FG001|Overall Study|Withdrawal by Subject|3|||
33643199|NCT01797302|63048038|FG002|Overall Study|Withdrawal by Subject|4|||
33643200|NCT01805180|63048048|FG000|Lead-in Donor Phase|screen failure|1|||
33643201|NCT01805180|63048049|FG001|Lead-in Donor Phase|screen failure|0|||
33643202|NCT01805180|63048050|FG002|Lead-in Donor Phase|screen failure|0|||
33643203|NCT01804946|63048060|FG000|Overall Study|Protocol Violation|1|||
33643204|NCT01804946|63048061|FG001|Overall Study|Protocol Violation|0|||
33643205|NCT01804946|63048060|FG000|Overall Study|Adverse Event|0|||
33643206|NCT01804946|63048061|FG001|Overall Study|Adverse Event|1|||
33643207|NCT01804946|63048060|FG000|Overall Study|Insufficient data available|0|||
33643208|NCT01804946|63048061|FG001|Overall Study|Insufficient data available|1|||
33643209|NCT01804946|63048060|FG000|Overall Study|Do not meet inclusion criteria|1|||
33643210|NCT01804946|63048061|FG001|Overall Study|Do not meet inclusion criteria|2|||
33643211|NCT01737398|63048071|FG000|Overall Study|Adverse event or SAE|16|||
33643212|NCT01737398|63048072|FG001|Overall Study|Adverse event or SAE|1|||
33643213|NCT01737398|63048071|FG000|Overall Study|Stopping rule met|2|||
33643214|NCT01737398|63048072|FG001|Overall Study|Stopping rule met|1|||
33643215|NCT01737398|63048071|FG000|Overall Study|Voluntary withdrawal|2|||
33643216|NCT01737398|63048072|FG001|Overall Study|Voluntary withdrawal|3|||
33643217|NCT01737398|63048071|FG000|Overall Study|Ineligibility|1|||
33643218|NCT01737398|63048072|FG001|Overall Study|Ineligibility|0|||
33643219|NCT01737398|63048071|FG000|Overall Study|Liver transplant|1|||
33643220|NCT01737398|63048072|FG001|Overall Study|Liver transplant|0|||
33643221|NCT01737398|63048071|FG000|Overall Study|Disease progression|2|||
33643222|NCT01737398|63048072|FG001|Overall Study|Disease progression|3|||
33542930|NCT03053063|62933626|FG003|Randomized Phase|Randomized but Never Treated|0|||
33542931|NCT03053063|62933623|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
33542932|NCT03053063|62933624|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
33542933|NCT03053063|62933625|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
33542934|NCT03053063|62933626|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
33542935|NCT03053063|62933623|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
33542936|NCT03053063|62933624|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
33542937|NCT03053063|62933625|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
33643223|NCT01737398|63048071|FG000|Overall Study|Sponsor's decision|2|||
33643224|NCT01737398|63048072|FG001|Overall Study|Sponsor's decision|0|||
33643225|NCT01795898|63048081|FG000|Overall Study|Adverse Event|27|||
33643226|NCT01795898|63048081|FG000|Overall Study|Lost to Follow-up|20|||
33643227|NCT01795898|63048081|FG000|Overall Study|Withdrawal of consent|6|||
33643228|NCT01795898|63048081|FG000|Overall Study|Diagnosed with metastasis|1|||
33643229|NCT01795898|63048081|FG000|Overall Study|No pain|1|||
33643230|NCT01795898|63048081|FG000|Overall Study|Death|1|||
33643231|NCT01795898|63048081|FG000|Overall Study|Withdrew consent & had adverse events|3|||
33643232|NCT01795898|63048081|FG000|Overall Study|Physician Decision|1|||
33643233|NCT01736696|63048092|FG000|Overall Study|Withdrawal by Subject|0|||
33643234|NCT01736696|63048093|FG001|Overall Study|Withdrawal by Subject|0|||
33643235|NCT01736696|63048094|FG002|Overall Study|Withdrawal by Subject|1|||
33643236|NCT01736696|63048095|FG003|Overall Study|Withdrawal by Subject|0|||
33643237|NCT01736696|63048096|FG004|Overall Study|Withdrawal by Subject|0|||
33463283|NCT00048542|62836833|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
33643238|NCT01736696|63048097|FG005|Overall Study|Withdrawal by Subject|0|||
33643239|NCT01736696|63048098|FG006|Overall Study|Withdrawal by Subject|0|||
33643240|NCT01736540|63048122|FG000|Overall Study|Did not complete scan within 45 days|2|||
33643241|NCT01736540|63048122|FG000|Overall Study|Death|1|||
33643242|NCT01736540|63048122|FG000|Overall Study|Abnormal test procedure|1|||
33643243|NCT01736540|63048122|FG000|Overall Study|Withdrawal by Subject|5|||
33643244|NCT01736540|63048122|FG000|Overall Study|Protocol Violation|1|||
33643245|NCT01736540|63048122|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
33643246|NCT01736540|63048122|FG000|Overall Study|No show for MRI appointment|1|||
33643247|NCT01736540|63048122|FG000|Overall Study|Unable to make MRI appointment|3|||
33643248|NCT01794338|63048135|FG000|Overall Study|Death|2|||
33643249|NCT01794338|63048136|FG001|Overall Study|Death|0|||
33643250|NCT01794338|63048135|FG000|Overall Study|Lost to Follow-up|6|||
33643251|NCT01794338|63048136|FG001|Overall Study|Lost to Follow-up|9|||
33643252|NCT01609478|63048145|FG000|Overall Study|Adverse Event|3|||
33643253|NCT01609478|63048146|FG001|Overall Study|Adverse Event|1|||
33643254|NCT01609478|63048147|FG002|Overall Study|Adverse Event|5|||
33643255|NCT01609478|63048145|FG000|Overall Study|Protocol Deviation|0|||
33643256|NCT01609478|63048146|FG001|Overall Study|Protocol Deviation|1|||
33643257|NCT01609478|63048147|FG002|Overall Study|Protocol Deviation|1|||
33643258|NCT01609478|63048145|FG000|Overall Study|Non-Compliance with study treatment|1|||
33643259|NCT01609478|63048146|FG001|Overall Study|Non-Compliance with study treatment|0|||
33643260|NCT01609478|63048147|FG002|Overall Study|Non-Compliance with study treatment|0|||
33643261|NCT01609478|63048145|FG000|Overall Study|Physician Decision|1|||
33643262|NCT01609478|63048146|FG001|Overall Study|Physician Decision|0|||
33643263|NCT01609478|63048147|FG002|Overall Study|Physician Decision|1|||
33643264|NCT01609478|63048145|FG000|Overall Study|Withdrawal by Subject|2|||
33643265|NCT01609478|63048146|FG001|Overall Study|Withdrawal by Subject|0|||
33643266|NCT01609478|63048147|FG002|Overall Study|Withdrawal by Subject|2|||
33643267|NCT01764854|63048159|FG000|Overall Study|Adverse Event|0|||
33643268|NCT01764854|63048160|FG001|Overall Study|Adverse Event|0|||
33542938|NCT03053063|62933626|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
33542939|NCT03053063|62933623|FG000|Open-Label Phase|Death|0|||
33542940|NCT03053063|62933624|FG001|Open-Label Phase|Death|0|||
33542941|NCT03053063|62933625|FG002|Open-Label Phase|Death|0|||
33542942|NCT03053063|62933626|FG003|Open-Label Phase|Death|2|||
33542943|NCT03053063|62933623|FG000|Open-Label Phase|Investigator's discretion|0|||
33542944|NCT03053063|62933624|FG001|Open-Label Phase|Investigator's discretion|0|||
33542945|NCT03053063|62933625|FG002|Open-Label Phase|Investigator's discretion|0|||
33542946|NCT03053063|62933626|FG003|Open-Label Phase|Investigator's discretion|2|||
33643269|NCT01764854|63048161|FG002|Overall Study|Adverse Event|2|||
33643270|NCT01764854|63048162|FG003|Overall Study|Adverse Event|0|||
33643271|NCT01764854|63048159|FG000|Overall Study|Withdrawal by Subject|0|||
33643272|NCT01764854|63048160|FG001|Overall Study|Withdrawal by Subject|0|||
33643273|NCT01764854|63048161|FG002|Overall Study|Withdrawal by Subject|1|||
33643274|NCT01764854|63048162|FG003|Overall Study|Withdrawal by Subject|0|||
33643275|NCT01764854|63048159|FG000|Overall Study|relocation|0|||
33643276|NCT01764854|63048160|FG001|Overall Study|relocation|0|||
33643277|NCT01764854|63048161|FG002|Overall Study|relocation|2|||
33643278|NCT01764854|63048162|FG003|Overall Study|relocation|0|||
33643279|NCT01764854|63048159|FG000|Overall Study|Protocol Violation|0|||
33643280|NCT01764854|63048160|FG001|Overall Study|Protocol Violation|0|||
33643281|NCT01764854|63048161|FG002|Overall Study|Protocol Violation|1|||
33463284|NCT00048542|62836834|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
33463285|NCT00048542|62836835|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
33463286|NCT00048542|62836836|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
33463287|NCT00048542|62836829|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
33463288|NCT00048542|62836830|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
33463289|NCT00048542|62836831|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
33463290|NCT00048542|62836832|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
33463291|NCT00048542|62836833|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
33463292|NCT00048542|62836834|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
33463293|NCT00048542|62836835|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
33463294|NCT00048542|62836836|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
33542947|NCT01316939|62933648|FG000|Overall Study|Study closed/terminated|26|||
33643282|NCT01764854|63048162|FG003|Overall Study|Protocol Violation|2|||
33643283|NCT01764464|63048174|FG000|First Intervention|Withdrawal by Subject|1|||
33643284|NCT01764464|63048175|FG001|First Intervention|Withdrawal by Subject|0|||
33643285|NCT01764464|63048174|FG000|First Intervention|Lost to Follow-up|1|||
33643286|NCT01764464|63048175|FG001|First Intervention|Lost to Follow-up|0|||
33643287|NCT01764464|63048174|FG000|First Intervention|Adverse Event|0|||
33643288|NCT01764464|63048175|FG001|First Intervention|Adverse Event|2|||
33643289|NCT01764464|63048174|FG000|First Intervention|did not receive study drug|0|||
33643290|NCT01764464|63048175|FG001|First Intervention|did not receive study drug|1|||
33643291|NCT01764464|63048174|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
33643292|NCT01764464|63048175|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
33643293|NCT01764386|63048183|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
33643294|NCT01764386|63048184|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
33643295|NCT01764386|63048183|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
33643296|NCT01764386|63048184|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
33643297|NCT01764386|63048183|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
33643298|NCT01764386|63048184|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
33643299|NCT01764386|63048183|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
33643300|NCT01764386|63048184|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
33643301|NCT01764386|63048183|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
33643302|NCT01764386|63048184|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
33643303|NCT01764386|63048183|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
33643304|NCT01764386|63048184|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
33643305|NCT01764386|63048183|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
33643306|NCT01764386|63048184|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
33643307|NCT01764386|63048183|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
33643308|NCT01764386|63048184|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
33643309|NCT01763918|63048195|FG000|Overall Study|Withdrawal by Subject|2|||
33643310|NCT01763918|63048196|FG001|Overall Study|Withdrawal by Subject|1|||
33643311|NCT01763918|63048197|FG002|Overall Study|Withdrawal by Subject|1|||
33643312|NCT01763918|63048198|FG003|Overall Study|Withdrawal by Subject|2|||
33643313|NCT01763918|63048195|FG000|Overall Study|Sponsor Decision|4|||
33643314|NCT01763918|63048196|FG001|Overall Study|Sponsor Decision|0|||
33643315|NCT01763918|63048197|FG002|Overall Study|Sponsor Decision|9|||
33643316|NCT01763918|63048198|FG003|Overall Study|Sponsor Decision|0|||
33643317|NCT01763684|63048210|FG000|Overall Study|Study terminated early due to low enrollment|126|||
33643318|NCT01763684|63048211|FG001|Overall Study|Study terminated early due to low enrollment|127|||
33643319|NCT01763684|63048210|FG000|Overall Study|Study surgery not performed|7|||
33643320|NCT01763684|63048211|FG001|Overall Study|Study surgery not performed|6|||
33643321|NCT01606748|63048219|FG000|Overall Study|Adverse Event|1|||
33643322|NCT01606748|63048220|FG001|Overall Study|Adverse Event|0|||
33643323|NCT01606748|63048219|FG000|Overall Study|Progressive Disease|1|||
33643324|NCT01606748|63048220|FG001|Overall Study|Progressive Disease|0|||
33643325|NCT01606748|63048219|FG000|Overall Study|Withdrawal by Subject|1|||
33643326|NCT01606748|63048220|FG001|Overall Study|Withdrawal by Subject|0|||
33643327|NCT01597622|63048238|FG000|Overall Study|Adverse Event|7|||
33643328|NCT01597622|63048238|FG000|Overall Study|Lack of Efficacy|3|||
33643329|NCT01597622|63048238|FG000|Overall Study|Protocol Violation|1|||
33643330|NCT01597622|63048238|FG000|Overall Study|Lost to Follow-up|1|||
33643331|NCT01597622|63048238|FG000|Overall Study|Investigator Discretion|5|||
33643332|NCT01597622|63048238|FG000|Overall Study|Withdrawal by Subject|20|||
33643333|NCT01597622|63048238|FG000|Overall Study|Death|1|||
33643334|NCT01761266|63048244|FG000|Overall Study|Death|415|||
33643335|NCT01761266|63048245|FG001|Overall Study|Death|402|||
33643336|NCT01761266|63048244|FG000|Overall Study|Lost to Follow-up|8|||
33643337|NCT01761266|63048245|FG001|Overall Study|Lost to Follow-up|12|||
33643338|NCT01761266|63048244|FG000|Overall Study|Withdrawal by Subject|14|||
33643339|NCT01761266|63048245|FG001|Overall Study|Withdrawal by Subject|10|||
33643340|NCT01761266|63048244|FG000|Overall Study|Sponsor Decision|41|||
33643341|NCT01761266|63048245|FG001|Overall Study|Sponsor Decision|52|||
33643342|NCT01760954|63048258|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
33643343|NCT01760954|63048259|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
33643344|NCT01760954|63048260|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
33643345|NCT01760954|63048261|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
33643346|NCT01760954|63048258|FG000|Treatment Period (6 Months)|Adverse Event|5|||
33643347|NCT01760954|63048259|FG001|Treatment Period (6 Months)|Adverse Event|3|||
33643348|NCT01760954|63048260|FG002|Treatment Period (6 Months)|Adverse Event|4|||
33643349|NCT01760954|63048261|FG003|Treatment Period (6 Months)|Adverse Event|10|||
33643350|NCT01760954|63048258|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
33643351|NCT01760954|63048259|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
33643352|NCT01760954|63048260|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
33643353|NCT01760954|63048261|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
33643354|NCT01760954|63048258|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
33643355|NCT01760954|63048259|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
33643356|NCT01760954|63048260|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
33643357|NCT01760954|63048261|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
33643358|NCT01760954|63048258|FG000|Treatment Period (6 Months)|Pregnancy|5|||
33643359|NCT01760954|63048259|FG001|Treatment Period (6 Months)|Pregnancy|0|||
33643360|NCT01760954|63048260|FG002|Treatment Period (6 Months)|Pregnancy|3|||
33643361|NCT01760954|63048261|FG003|Treatment Period (6 Months)|Pregnancy|2|||
33643362|NCT01760954|63048258|FG000|Treatment Period (6 Months)|Non-compliance|1|||
33643363|NCT01760954|63048259|FG001|Treatment Period (6 Months)|Non-compliance|4|||
33643364|NCT01760954|63048260|FG002|Treatment Period (6 Months)|Non-compliance|0|||
33643365|NCT01760954|63048261|FG003|Treatment Period (6 Months)|Non-compliance|3|||
33643366|NCT01760954|63048258|FG000|Treatment Period (6 Months)|Other|0|||
33643367|NCT01760954|63048259|FG001|Treatment Period (6 Months)|Other|3|||
33643368|NCT01760954|63048260|FG002|Treatment Period (6 Months)|Other|3|||
33643369|NCT01760954|63048261|FG003|Treatment Period (6 Months)|Other|1|||
33643370|NCT01760954|63048258|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
33643371|NCT01760954|63048259|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
33643372|NCT01760954|63048260|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
33643373|NCT01760954|63048261|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
33643374|NCT01760954|63048258|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
33643375|NCT01760954|63048259|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
33643376|NCT01760954|63048260|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
33643377|NCT01760954|63048261|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
33643378|NCT01760954|63048258|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
33643379|NCT01760954|63048259|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
33643380|NCT01760954|63048260|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
33643381|NCT01760954|63048261|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
33643382|NCT01760954|63048258|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
33643383|NCT01760954|63048259|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
33643384|NCT01760954|63048260|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
33643385|NCT01760954|63048261|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
33643386|NCT01760954|63048258|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
33643387|NCT01760954|63048259|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
33643388|NCT01760954|63048260|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
33643389|NCT01760954|63048261|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
33643390|NCT01760954|63048258|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
33643391|NCT01760954|63048259|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
33643392|NCT01760954|63048260|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
33643393|NCT01760954|63048261|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
33643394|NCT01760954|63048258|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
33643395|NCT01760954|63048259|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
33643396|NCT01760954|63048260|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
33643397|NCT01760954|63048261|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
33643398|NCT01760954|63048258|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
33643399|NCT01760954|63048259|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
33643400|NCT01760954|63048260|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
33643401|NCT01760954|63048261|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
33643402|NCT01760876|63048271|FG000|Overall Study|Non-cardiac death (head injury)|1|||
33643403|NCT01760876|63048271|FG000|Overall Study|Carcinoma of prostate|1|||
33643404|NCT01760876|63048271|FG000|Overall Study|Impaired renal function|1|||
33643405|NCT01760876|63048271|FG000|Overall Study|Major depression|1|||
33643406|NCT01760876|63048271|FG000|Overall Study|Very poor baseline OCT quality|2|||
33643407|NCT01759862|63048277|FG000|Overall Study|Physician Decision|3|||
33643408|NCT01759862|63048278|FG001|Overall Study|Physician Decision|1|||
33643409|NCT01759862|63048277|FG000|Overall Study|Adverse Event|0|||
33643410|NCT01759862|63048278|FG001|Overall Study|Adverse Event|1|||
33643411|NCT01606670|63048284|FG000|Overall Study|Adverse Event|6|||
33643412|NCT01606670|63048284|FG000|Overall Study|Lack of Efficacy|2|||
33643413|NCT01606670|63048284|FG000|Overall Study|Lost to Follow-up|3|||
33643414|NCT01606670|63048284|FG000|Overall Study|Withdrawal by Subject|3|||
33643415|NCT01606670|63048284|FG000|Overall Study|Other Reason|2|||
33643416|NCT01793792|63048288|FG000|Overall Study|Death|5|||
33643417|NCT01793792|63048288|FG000|Overall Study|Lost to Follow-up|5|||
33643418|NCT01793792|63048288|FG000|Overall Study|Withdrawal by Subject|1|||
33643419|NCT01793792|63048288|FG000|Overall Study|Device Not Implanted|1|||
33643420|NCT01790984|63048294|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
33643421|NCT01790984|63048295|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
33643422|NCT01790984|63048296|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
33643423|NCT01790984|63048297|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
33643424|NCT01735994|63048322|FG000|Overall Study|Withdrawal by Subject|6|||
33643425|NCT01735994|63048323|FG001|Overall Study|Withdrawal by Subject|4|||
33643426|NCT01735994|63048322|FG000|Overall Study|Injury|2|||
33643427|NCT01735994|63048323|FG001|Overall Study|Injury|0|||
33643428|NCT01735994|63048322|FG000|Overall Study|Kicked off team|5|||
33643429|NCT01735994|63048323|FG001|Overall Study|Kicked off team|0|||
33643430|NCT01735994|63048322|FG000|Overall Study|Lost to Follow-up|50|||
33643431|NCT01735994|63048323|FG001|Overall Study|Lost to Follow-up|62|||
33643432|NCT01790828|63048329|FG000|Overall Study|Other|34|||
33643433|NCT01790594|63048335|FG000|Overall Study|Death|1|||
33643434|NCT01790594|63048336|FG001|Overall Study|Death|0|||
33643435|NCT01790594|63048337|FG002|Overall Study|Death|0|||
33643436|NCT01790594|63048335|FG000|Overall Study|Physician Decision|2|||
33643437|NCT01790594|63048336|FG001|Overall Study|Physician Decision|1|||
33643438|NCT01790594|63048337|FG002|Overall Study|Physician Decision|0|||
33643439|NCT01790594|63048335|FG000|Overall Study|Withdrawal by Subject|2|||
33643440|NCT01790594|63048336|FG001|Overall Study|Withdrawal by Subject|0|||
33643441|NCT01790594|63048337|FG002|Overall Study|Withdrawal by Subject|0|||
33643442|NCT01790594|63048335|FG000|Overall Study|Transplant was not done|0|||
33643443|NCT01790594|63048336|FG001|Overall Study|Transplant was not done|0|||
33643444|NCT01790594|63048337|FG002|Overall Study|Transplant was not done|3|||
33643445|NCT01790594|63048335|FG000|Overall Study|Terminated prior to week 76|0|||
33643446|NCT01790594|63048336|FG001|Overall Study|Terminated prior to week 76|2|||
33643447|NCT01790594|63048337|FG002|Overall Study|Terminated prior to week 76|0|||
33643448|NCT01790516|63048346|FG000|Overall Study|Physician Decision|1|||
33643449|NCT01790516|63048347|FG001|Overall Study|Physician Decision|0|||
33643450|NCT01790438|63048355|FG000|Overall Study|Adverse Event|3|||
33643451|NCT01790438|63048356|FG001|Overall Study|Adverse Event|2|||
33643452|NCT01790438|63048355|FG000|Overall Study|Death|4|||
33643453|NCT01790438|63048356|FG001|Overall Study|Death|0|||
33643454|NCT01790438|63048355|FG000|Overall Study|Lost to Follow-up|5|||
33643455|NCT01790438|63048356|FG001|Overall Study|Lost to Follow-up|2|||
33643456|NCT01790438|63048355|FG000|Overall Study|Withdrawal by Subject|13|||
33643457|NCT01790438|63048356|FG001|Overall Study|Withdrawal by Subject|2|||
33643458|NCT01790438|63048355|FG000|Overall Study|Physician Decision|3|||
33643459|NCT01790438|63048356|FG001|Overall Study|Physician Decision|1|||
33643460|NCT01790438|63048355|FG000|Overall Study|Sponsor Decision|0|||
33542948|NCT01316939|62933649|FG001|Overall Study|Study closed/terminated|25|||
33542949|NCT01316939|62933650|FG002|Overall Study|Study closed/terminated|23|||
33542950|NCT01316939|62933648|FG000|Overall Study|Lack of Efficacy|24|||
33542951|NCT01316939|62933649|FG001|Overall Study|Lack of Efficacy|25|||
33542952|NCT01316939|62933650|FG002|Overall Study|Lack of Efficacy|25|||
33542953|NCT01316939|62933648|FG000|Overall Study|Adverse Event|9|||
33542954|NCT01316939|62933649|FG001|Overall Study|Adverse Event|12|||
33542955|NCT01316939|62933650|FG002|Overall Study|Adverse Event|11|||
33542956|NCT01316939|62933648|FG000|Overall Study|Withdrawal by Subject|1|||
33542957|NCT01316939|62933649|FG001|Overall Study|Withdrawal by Subject|3|||
33542958|NCT01316939|62933650|FG002|Overall Study|Withdrawal by Subject|6|||
33542959|NCT01316939|62933648|FG000|Overall Study|Physician Decision|2|||
33542960|NCT01316939|62933649|FG001|Overall Study|Physician Decision|2|||
33542961|NCT01316939|62933650|FG002|Overall Study|Physician Decision|1|||
33542962|NCT01316939|62933648|FG000|Overall Study|Lost to Follow-up|0|||
33542963|NCT01316939|62933649|FG001|Overall Study|Lost to Follow-up|0|||
33542964|NCT01316939|62933650|FG002|Overall Study|Lost to Follow-up|2|||
33542965|NCT01316939|62933648|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
33542966|NCT01316939|62933649|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
33542967|NCT01316939|62933650|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
33542968|NCT01316939|62933648|FG000|Overall Study|Protocol Violation|0|||
33542969|NCT01316939|62933649|FG001|Overall Study|Protocol Violation|1|||
33542970|NCT01316939|62933650|FG002|Overall Study|Protocol Violation|0|||
33643461|NCT01790438|63048356|FG001|Overall Study|Sponsor Decision|3|||
33643462|NCT01790438|63048355|FG000|Overall Study|Protocol Required Discontinuation|7|||
33643463|NCT01790438|63048356|FG001|Overall Study|Protocol Required Discontinuation|1|||
33643464|NCT01735916|63048367|FG000|Overall Study|Subject not eligible to be randomized|11|||
33643465|NCT01735916|63048368|FG001|Overall Study|Subject not eligible to be randomized|0|||
33643466|NCT01735916|63048369|FG002|Overall Study|Subject not eligible to be randomized|0|||
33643467|NCT01735916|63048367|FG000|Overall Study|Early termination of study by sponsor|4|||
33643468|NCT01735916|63048368|FG001|Overall Study|Early termination of study by sponsor|19|||
33643469|NCT01735916|63048369|FG002|Overall Study|Early termination of study by sponsor|7|||
33643470|NCT01735916|63048367|FG000|Overall Study|Withdrawal by Subject|3|||
33643471|NCT01735916|63048368|FG001|Overall Study|Withdrawal by Subject|0|||
33643472|NCT01735916|63048369|FG002|Overall Study|Withdrawal by Subject|0|||
33643473|NCT01790126|63048379|FG000|Overall Study|PSA Progression|12|||
33643474|NCT01790126|63048380|FG001|Overall Study|PSA Progression|16|||
33643475|NCT01790126|63048381|FG002|Overall Study|PSA Progression|16|||
33643476|NCT01790126|63048379|FG000|Overall Study|Other|5|||
33643477|NCT01790126|63048380|FG001|Overall Study|Other|4|||
33643478|NCT01790126|63048381|FG002|Overall Study|Other|8|||
33643479|NCT01790126|63048379|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
33643480|NCT01790126|63048380|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
33643481|NCT01790126|63048381|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
33643482|NCT01790126|63048379|FG000|Overall Study|Withdrawal by Physician|1|||
33643483|NCT01790126|63048380|FG001|Overall Study|Withdrawal by Physician|1|||
33643484|NCT01790126|63048381|FG002|Overall Study|Withdrawal by Physician|2|||
33643485|NCT01790126|63048379|FG000|Overall Study|Withdrawal by Subject|3|||
33643486|NCT01790126|63048380|FG001|Overall Study|Withdrawal by Subject|1|||
33643487|NCT01790126|63048381|FG002|Overall Study|Withdrawal by Subject|2|||
33643488|NCT01790126|63048379|FG000|Overall Study|Lost to Follow-up|1|||
33643489|NCT01790126|63048380|FG001|Overall Study|Lost to Follow-up|0|||
33643490|NCT01790126|63048381|FG002|Overall Study|Lost to Follow-up|1|||
33643491|NCT01790126|63048379|FG000|Overall Study|Adverse Event|0|||
33643492|NCT01790126|63048380|FG001|Overall Study|Adverse Event|2|||
33643493|NCT01790126|63048381|FG002|Overall Study|Adverse Event|0|||
33643494|NCT01790126|63048379|FG000|Overall Study|Death|2|||
33643495|NCT01790126|63048380|FG001|Overall Study|Death|0|||
33643496|NCT01790126|63048381|FG002|Overall Study|Death|0|||
33643497|NCT01790126|63048379|FG000|Overall Study|Radiographic Progression|3|||
33643498|NCT01790126|63048380|FG001|Overall Study|Radiographic Progression|1|||
33643499|NCT01790126|63048381|FG002|Overall Study|Radiographic Progression|0|||
33643500|NCT01734902|63048392|FG000|Overall Study|Other than listed|0|||
33643501|NCT01734902|63048393|FG001|Overall Study|Other than listed|2|||
33643502|NCT01790048|63048401|FG000|Overall Study|Incorrect Age|9|||
33643503|NCT01790048|63048402|FG001|Overall Study|Incorrect Age|14|||
33643504|NCT01790048|63048401|FG000|Overall Study|data entry error|0|||
33643505|NCT01790048|63048402|FG001|Overall Study|data entry error|1|||
33643506|NCT01790048|63048401|FG000|Overall Study|Other|0|||
33643507|NCT01790048|63048402|FG001|Overall Study|Other|2|||
33643508|NCT01790048|63048401|FG000|Overall Study|SAM at Enrollment|2|||
33643509|NCT01790048|63048402|FG001|Overall Study|SAM at Enrollment|0|||
33643510|NCT01790048|63048401|FG000|Overall Study|Measurement error|1|||
33643511|NCT01790048|63048402|FG001|Overall Study|Measurement error|0|||
33643512|NCT01789970|63048412|FG000|Open-label Titration Period|Adverse Event|68|||
33643513|NCT01789970|63048413|FG001|Open-label Titration Period|Adverse Event|0|||
33643514|NCT01789970|63048414|FG002|Open-label Titration Period|Adverse Event|0|||
33643515|NCT01789970|63048412|FG000|Open-label Titration Period|Lack of Efficacy|31|||
33643516|NCT01789970|63048413|FG001|Open-label Titration Period|Lack of Efficacy|0|||
33643517|NCT01789970|63048414|FG002|Open-label Titration Period|Lack of Efficacy|0|||
33643518|NCT01789970|63048412|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
33643519|NCT01789970|63048413|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
33643520|NCT01789970|63048414|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
33643521|NCT01789970|63048412|FG000|Open-label Titration Period|Protocol Violation|18|||
33643522|NCT01789970|63048413|FG001|Open-label Titration Period|Protocol Violation|0|||
33643523|NCT01789970|63048414|FG002|Open-label Titration Period|Protocol Violation|0|||
33643524|NCT01789970|63048412|FG000|Open-label Titration Period|Lost to Follow-up|5|||
33643525|NCT01789970|63048413|FG001|Open-label Titration Period|Lost to Follow-up|0|||
33643526|NCT01789970|63048414|FG002|Open-label Titration Period|Lost to Follow-up|0|||
33643527|NCT01789970|63048412|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
33643528|NCT01789970|63048413|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
33643529|NCT01789970|63048414|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
33643530|NCT01789970|63048412|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
33643531|NCT01789970|63048413|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
33643532|NCT01789970|63048414|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
33643533|NCT01789970|63048412|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
33643534|NCT01789970|63048413|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
33643535|NCT01789970|63048414|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
33643536|NCT01789970|63048412|FG000|Open-label Titration Period|Pregnancy|2|||
33643537|NCT01789970|63048413|FG001|Open-label Titration Period|Pregnancy|0|||
33643538|NCT01789970|63048414|FG002|Open-label Titration Period|Pregnancy|0|||
33643539|NCT01789970|63048412|FG000|Open-label Titration Period|Other|76|||
33643540|NCT01789970|63048413|FG001|Open-label Titration Period|Other|0|||
33643541|NCT01789970|63048414|FG002|Open-label Titration Period|Other|0|||
33643542|NCT01789970|63048412|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
33643543|NCT01789970|63048413|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
33643544|NCT01789970|63048414|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
33643545|NCT01789970|63048412|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
33643546|NCT01789970|63048413|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
33643547|NCT01789970|63048414|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
33643548|NCT01789970|63048412|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
33643549|NCT01789970|63048413|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
33643550|NCT01789970|63048414|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
33643551|NCT01789970|63048412|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
33643552|NCT01789970|63048413|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
33643553|NCT01789970|63048414|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
33643554|NCT01789970|63048412|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
33643555|NCT01789970|63048413|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
33643556|NCT01789970|63048414|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
33643557|NCT01789970|63048412|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
33643558|NCT01789970|63048413|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
33643559|NCT01789970|63048414|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
33643560|NCT01789970|63048412|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
33643561|NCT01789970|63048413|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
33643562|NCT01789970|63048414|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
33643563|NCT01789970|63048412|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
33643564|NCT01789970|63048413|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
33643565|NCT01789970|63048414|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
33643566|NCT01789970|63048412|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
33643567|NCT01789970|63048413|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
33643568|NCT01789970|63048414|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
33643569|NCT01789970|63048412|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
33643570|NCT01789970|63048413|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
33643571|NCT01789970|63048414|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
33643572|NCT01789970|63048412|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
33643573|NCT01789970|63048413|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
33643574|NCT01789970|63048414|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
33643575|NCT01734434|63048432|FG000|Overall Study|Death Infant|3|||
33643576|NCT01734434|63048433|FG001|Overall Study|Death Infant|1|||
33643577|NCT01734434|63048434|FG002|Overall Study|Death Infant|17|||
33643578|NCT01734434|63048435|FG003|Overall Study|Death Infant|5|||
33643579|NCT01734434|63048432|FG000|Overall Study|Lost to Follow-up|2|||
33643580|NCT01734434|63048433|FG001|Overall Study|Lost to Follow-up|9|||
33643581|NCT01734434|63048434|FG002|Overall Study|Lost to Follow-up|67|||
33643582|NCT01734434|63048435|FG003|Overall Study|Lost to Follow-up|11|||
33643583|NCT01734434|63048432|FG000|Overall Study|No Live Birth|1|||
33643584|NCT01734434|63048433|FG001|Overall Study|No Live Birth|2|||
33643585|NCT01734434|63048434|FG002|Overall Study|No Live Birth|32|||
33643586|NCT01734434|63048435|FG003|Overall Study|No Live Birth|6|||
33643587|NCT01734434|63048432|FG000|Overall Study|Withdrawal by Subject|4|||
33643588|NCT01734434|63048433|FG001|Overall Study|Withdrawal by Subject|0|||
33643589|NCT01734434|63048434|FG002|Overall Study|Withdrawal by Subject|8|||
33643590|NCT01734434|63048435|FG003|Overall Study|Withdrawal by Subject|1|||
33643591|NCT01734434|63048432|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
33643592|NCT01734434|63048433|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
33643593|NCT01734434|63048434|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
33643594|NCT01734434|63048435|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
33643595|NCT01734434|63048432|FG000|Overall Study|Subject Not Reachable|0|||
33643596|NCT01734434|63048433|FG001|Overall Study|Subject Not Reachable|0|||
33643597|NCT01734434|63048434|FG002|Overall Study|Subject Not Reachable|1|||
33643598|NCT01734434|63048435|FG003|Overall Study|Subject Not Reachable|0|||
33643599|NCT01734434|63048432|FG000|Overall Study|Treatment Defaulter|0|||
33643600|NCT01734434|63048433|FG001|Overall Study|Treatment Defaulter|0|||
33643601|NCT01734434|63048434|FG002|Overall Study|Treatment Defaulter|1|||
33643602|NCT01734434|63048435|FG003|Overall Study|Treatment Defaulter|0|||
33643603|NCT01734434|63048432|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
33643604|NCT01734434|63048433|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
33643605|NCT01734434|63048434|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
33643606|NCT01734434|63048435|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
33643607|NCT01734434|63048432|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
33643608|NCT01734434|63048433|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
33643609|NCT01734434|63048434|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
33643610|NCT01734434|63048435|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
33643611|NCT01788566|63048453|FG000|Overall Study|Death|4|||
33643612|NCT01788566|63048453|FG000|Overall Study|Adverse Event|1|||
33643613|NCT01788566|63048453|FG000|Overall Study|Clinical Progressive Disease|3|||
33643614|NCT01733732|63048459|FG000|Overall Study|Adverse Event|1|||
33643615|NCT01733732|63048460|FG001|Overall Study|Adverse Event|0|||
33643616|NCT01733732|63048459|FG000|Overall Study|Did not attend all study visits|1|||
33643617|NCT01733732|63048460|FG001|Overall Study|Did not attend all study visits|0|||
33643618|NCT01732874|63048478|FG000|Overall Study|Withdrawal by Subject|5|||
33643619|NCT01732874|63048479|FG001|Overall Study|Withdrawal by Subject|1|||
33643620|NCT01732874|63048478|FG000|Overall Study|Death of Infant|3|||
33643621|NCT01732874|63048479|FG001|Overall Study|Death of Infant|2|||
33643622|NCT01732796|63048488|FG000|Overall Study|Adverse Event|16|||
33643623|NCT01732796|63048489|FG001|Overall Study|Adverse Event|16|||
33643624|NCT01732796|63048490|FG002|Overall Study|Adverse Event|4|||
33643625|NCT01732796|63048488|FG000|Overall Study|Lack of Efficacy|21|||
33643626|NCT01732796|63048489|FG001|Overall Study|Lack of Efficacy|18|||
33643627|NCT01732796|63048490|FG002|Overall Study|Lack of Efficacy|5|||
33643628|NCT01732796|63048488|FG000|Overall Study|Lost to Follow-up|2|||
33643629|NCT01732796|63048489|FG001|Overall Study|Lost to Follow-up|0|||
33643630|NCT01732796|63048490|FG002|Overall Study|Lost to Follow-up|0|||
33643631|NCT01732796|63048488|FG000|Overall Study|Withdrawal by Subject|6|||
33643632|NCT01732796|63048489|FG001|Overall Study|Withdrawal by Subject|8|||
33643633|NCT01732796|63048490|FG002|Overall Study|Withdrawal by Subject|2|||
33643634|NCT01732796|63048488|FG000|Overall Study|Other reason not defined above|1|||
33643635|NCT01732796|63048489|FG001|Overall Study|Other reason not defined above|0|||
33643636|NCT01732796|63048490|FG002|Overall Study|Other reason not defined above|2|||
33643637|NCT01732640|63048500|FG000|Overall Study|Adverse Event|0|||
33643638|NCT01732640|63048501|FG001|Overall Study|Adverse Event|1|||
33643639|NCT01732640|63048500|FG000|Overall Study|Death|0|||
33643640|NCT01732640|63048501|FG001|Overall Study|Death|1|||
33643641|NCT01732484|63048511|FG000|Overall Study|Death|7|||
33643642|NCT01732484|63048511|FG000|Overall Study|Lost to Follow-up|14|||
33643643|NCT01732484|63048511|FG000|Overall Study|chronical illness|5|||
33643644|NCT01786148|63048519|FG000|Overall Study|Lost to Follow-up|21|||
33643645|NCT01786148|63048520|FG001|Overall Study|Lost to Follow-up|13|||
33643646|NCT01786148|63048519|FG000|Overall Study|Death|0|||
33643647|NCT01786148|63048520|FG001|Overall Study|Death|1|||
33643648|NCT01786148|63048519|FG000|Overall Study|Withdrawal by Subject|0|||
33643649|NCT01786148|63048520|FG001|Overall Study|Withdrawal by Subject|7|||
33643650|NCT01786148|63048519|FG000|Overall Study|Incarceration|1|||
33542971|NCT03044249|62933660|FG000|Overall Study|Adverse Event|4|||
33643651|NCT01786148|63048520|FG001|Overall Study|Incarceration|1|||
33643652|NCT01785602|63048532|FG000|Overall Study|Withdrawal by Subject|2|||
33542972|NCT03044249|62933661|FG001|Overall Study|Adverse Event|9|||
33643653|NCT01785602|63048533|FG001|Overall Study|Withdrawal by Subject|0|||
33643654|NCT01785602|63048532|FG000|Overall Study|Lost to Follow-up|1|||
33643655|NCT01785602|63048533|FG001|Overall Study|Lost to Follow-up|1|||
33643656|NCT01785602|63048532|FG000|Overall Study|Adverse Event|3|||
33643657|NCT01785602|63048533|FG001|Overall Study|Adverse Event|5|||
33643658|NCT01785602|63048532|FG000|Overall Study|Administrative problems|7|||
33643659|NCT01785602|63048533|FG001|Overall Study|Administrative problems|3|||
33643660|NCT01785524|63048541|FG000|Overall Study|Withdrawal by Subject|2|||
33643661|NCT01785524|63048542|FG001|Overall Study|Withdrawal by Subject|2|||
33643662|NCT01757288|63048551|FG000|Overall Study|Consent withdrawal|0|||
33643663|NCT01757288|63048552|FG001|Overall Study|Consent withdrawal|4|||
33643664|NCT01757288|63048553|FG002|Overall Study|Consent withdrawal|4|||
33643665|NCT01757288|63048551|FG000|Overall Study|Patient off study, IRB hold.|0|||
33643666|NCT01757288|63048552|FG001|Overall Study|Patient off study, IRB hold.|0|||
33643667|NCT01757288|63048553|FG002|Overall Study|Patient off study, IRB hold.|1|||
33643668|NCT01757288|63048551|FG000|Overall Study|Patient death prior to starting treatment|0|||
33643669|NCT01757288|63048552|FG001|Overall Study|Patient death prior to starting treatment|0|||
33643670|NCT01757288|63048553|FG002|Overall Study|Patient death prior to starting treatment|1|||
33643671|NCT01757288|63048551|FG000|Overall Study|Wrong medication administered|0|||
33643672|NCT01757288|63048552|FG001|Overall Study|Wrong medication administered|1|||
33643673|NCT01757288|63048553|FG002|Overall Study|Wrong medication administered|0|||
33643674|NCT01757288|63048551|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
33643675|NCT01757288|63048552|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
33643676|NCT01757288|63048553|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
33643677|NCT01757288|63048551|FG000|Overall Study|Not meeting protocol constraints|0|||
33643678|NCT01757288|63048552|FG001|Overall Study|Not meeting protocol constraints|1|||
33643679|NCT01757288|63048553|FG002|Overall Study|Not meeting protocol constraints|1|||
33643680|NCT01757288|63048551|FG000|Overall Study|Multiple missed appointments|0|||
33643681|NCT01757288|63048552|FG001|Overall Study|Multiple missed appointments|1|||
33643682|NCT01757288|63048553|FG002|Overall Study|Multiple missed appointments|0|||
33643683|NCT01757288|63048551|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
33643684|NCT01757288|63048552|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
33643685|NCT01757288|63048553|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
33643686|NCT01757288|63048551|FG000|Overall Study|>2 weeks treatment break|0|||
33643687|NCT01757288|63048552|FG001|Overall Study|>2 weeks treatment break|0|||
33643688|NCT01757288|63048553|FG002|Overall Study|>2 weeks treatment break|1|||
33643689|NCT01756898|63048566|FG000|Overall Study|Adverse Event|7|||
33643690|NCT01756898|63048567|FG001|Overall Study|Adverse Event|1|||
33643691|NCT01756898|63048568|FG002|Overall Study|Adverse Event|0|||
33643692|NCT01756898|63048569|FG003|Overall Study|Adverse Event|0|||
33643693|NCT01756898|63048566|FG000|Overall Study|Lack of Efficacy|4|||
33643694|NCT01756898|63048567|FG001|Overall Study|Lack of Efficacy|7|||
33643695|NCT01756898|63048568|FG002|Overall Study|Lack of Efficacy|6|||
33643696|NCT01756898|63048569|FG003|Overall Study|Lack of Efficacy|6|||
33643697|NCT01756898|63048566|FG000|Overall Study|Lost to Follow-up|2|||
33643698|NCT01756898|63048567|FG001|Overall Study|Lost to Follow-up|4|||
33643699|NCT01756898|63048568|FG002|Overall Study|Lost to Follow-up|2|||
33643700|NCT01756898|63048569|FG003|Overall Study|Lost to Follow-up|3|||
33643701|NCT01756898|63048566|FG000|Overall Study|Protocol Violation|1|||
33643702|NCT01756898|63048567|FG001|Overall Study|Protocol Violation|2|||
33643703|NCT01756898|63048568|FG002|Overall Study|Protocol Violation|2|||
33643704|NCT01756898|63048569|FG003|Overall Study|Protocol Violation|1|||
33643705|NCT01756898|63048566|FG000|Overall Study|Withdrew Consent|5|||
33643706|NCT01756898|63048567|FG001|Overall Study|Withdrew Consent|3|||
33643707|NCT01756898|63048568|FG002|Overall Study|Withdrew Consent|5|||
33643708|NCT01756898|63048569|FG003|Overall Study|Withdrew Consent|6|||
33643709|NCT01756898|63048566|FG000|Overall Study|Other|0|||
33643710|NCT01756898|63048567|FG001|Overall Study|Other|2|||
33643711|NCT01756898|63048568|FG002|Overall Study|Other|2|||
33643712|NCT01756898|63048569|FG003|Overall Study|Other|0|||
33643713|NCT01731938|63048586|FG000|Preliminary Part I|Withdrawal by Subject|2|||
33643714|NCT01731938|63048587|FG001|Preliminary Part I|Withdrawal by Subject|2|||
33643715|NCT01731938|63048586|FG000|Preliminary Part I|Physician Decision|1|||
33643716|NCT01731938|63048587|FG001|Preliminary Part I|Physician Decision|0|||
33643717|NCT01731938|63048586|FG000|Preliminary Part I|Lost to Follow-up|0|||
33643718|NCT01731938|63048587|FG001|Preliminary Part I|Lost to Follow-up|3|||
33643719|NCT01731938|63048586|FG000|Preliminary Part I|Missed Week 6 visit|0|||
33643720|NCT01731938|63048587|FG001|Preliminary Part I|Missed Week 6 visit|3|||
33643721|NCT01731938|63048586|FG000|Primary Part II|Withdrawal by Subject|5|||
33643722|NCT01731938|63048587|FG001|Primary Part II|Withdrawal by Subject|4|||
33643723|NCT01731938|63048586|FG000|Primary Part II|Lost to Follow-up|4|||
33643724|NCT01731938|63048587|FG001|Primary Part II|Lost to Follow-up|5|||
33643725|NCT01731938|63048586|FG000|Primary Part II|Death|2|||
33643726|NCT01731938|63048587|FG001|Primary Part II|Death|1|||
33643727|NCT01731938|63048586|FG000|Primary Part II|Missed Week 6 visit|2|||
33643728|NCT01731938|63048587|FG001|Primary Part II|Missed Week 6 visit|3|||
33643729|NCT01731470|63048594|FG000|Overall Study|Withdrawal by Subject|1|||
33643730|NCT01731470|63048594|FG000|Overall Study|Did not meet study criteria|1|||
33643731|NCT01756352|63048598|FG000|Overall Study|moved away and lost to followup|1|||
33643732|NCT01756274|63048602|FG000|Overall Study|Protocol Violation|2|||
33643733|NCT01756274|63048602|FG000|Overall Study|Laboratory error|1|||
33643734|NCT01731002|63048610|FG000|Overall Study|Adverse Event|0|||
33643735|NCT01731002|63048611|FG001|Overall Study|Adverse Event|2|||
33643736|NCT01731002|63048612|FG002|Overall Study|Adverse Event|2|||
33643737|NCT01731002|63048610|FG000|Overall Study|Non-Compliant|0|||
33643738|NCT01731002|63048611|FG001|Overall Study|Non-Compliant|1|||
33643739|NCT01731002|63048612|FG002|Overall Study|Non-Compliant|0|||
33643740|NCT01731002|63048610|FG000|Overall Study|Lost to Follow-up|1|||
33643741|NCT01731002|63048611|FG001|Overall Study|Lost to Follow-up|0|||
33643742|NCT01731002|63048612|FG002|Overall Study|Lost to Follow-up|0|||
33643743|NCT01731002|63048610|FG000|Overall Study|Test Agent Discontinuation|0|||
33643744|NCT01731002|63048611|FG001|Overall Study|Test Agent Discontinuation|1|||
33643745|NCT01731002|63048612|FG002|Overall Study|Test Agent Discontinuation|0|||
33643746|NCT01731002|63048610|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
33643747|NCT01731002|63048611|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
33643748|NCT01731002|63048612|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
33643749|NCT01731002|63048610|FG000|Overall Study|Elevated IOP|1|||
33643750|NCT01731002|63048611|FG001|Overall Study|Elevated IOP|0|||
33643751|NCT01731002|63048612|FG002|Overall Study|Elevated IOP|0|||
33643752|NCT01731002|63048610|FG000|Overall Study|Inappropriate use of study medications|0|||
33643753|NCT01731002|63048611|FG001|Overall Study|Inappropriate use of study medications|0|||
33643754|NCT01731002|63048612|FG002|Overall Study|Inappropriate use of study medications|1|||
33643755|NCT01783886|63048623|FG000|Overall Study|Lost to Follow-up|0|||
33643756|NCT01783886|63048624|FG001|Overall Study|Lost to Follow-up|3|||
33643757|NCT01783886|63048625|FG002|Overall Study|Lost to Follow-up|0|||
33643758|NCT01783886|63048623|FG000|Overall Study|Protocol deviation|0|||
33643759|NCT01783886|63048624|FG001|Overall Study|Protocol deviation|0|||
33643760|NCT01783886|63048625|FG002|Overall Study|Protocol deviation|2|||
33643761|NCT01783886|63048623|FG000|Overall Study|Withdrawal of consent by participant|1|||
33643762|NCT01783886|63048624|FG001|Overall Study|Withdrawal of consent by participant|3|||
33643763|NCT01783886|63048625|FG002|Overall Study|Withdrawal of consent by participant|4|||
33643764|NCT01783886|63048623|FG000|Overall Study|Adverse Event|4|||
33643765|NCT01783886|63048624|FG001|Overall Study|Adverse Event|5|||
33643766|NCT01783886|63048625|FG002|Overall Study|Adverse Event|4|||
33643767|NCT01609556|63048649|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33643768|NCT01609556|63048650|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33643769|NCT01609556|63048651|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33643770|NCT01609556|63048652|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33643771|NCT01609556|63048653|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
33643772|NCT01609556|63048654|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33643773|NCT01609556|63048655|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33643774|NCT01609556|63048656|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
33643775|NCT01609556|63048657|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
33643776|NCT01609556|63048658|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33643777|NCT01609556|63048659|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
33643778|NCT01609556|63048660|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
33643779|NCT01609556|63048661|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33643780|NCT01609556|63048662|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33643781|NCT01609556|63048663|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33643782|NCT01609556|63048664|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33643783|NCT01609556|63048649|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
33643784|NCT01609556|63048650|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
33643785|NCT01609556|63048651|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
33643786|NCT01609556|63048652|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
33643787|NCT01609556|63048653|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
33643788|NCT01609556|63048654|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
33643789|NCT01609556|63048655|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
33643790|NCT01609556|63048656|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
33643791|NCT01609556|63048657|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
33643792|NCT01609556|63048658|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
33643793|NCT01609556|63048659|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
33643794|NCT01609556|63048660|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
33643795|NCT01609556|63048661|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
33643796|NCT01609556|63048662|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
33643797|NCT01609556|63048663|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
33643798|NCT01609556|63048664|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
33643799|NCT01609556|63048649|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33643800|NCT01609556|63048650|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33643801|NCT01609556|63048651|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33643802|NCT01609556|63048652|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33643803|NCT01609556|63048653|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33643804|NCT01609556|63048654|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
33643805|NCT01609556|63048655|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
33643806|NCT01609556|63048656|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33643807|NCT01609556|63048657|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33643808|NCT01609556|63048658|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
33643809|NCT01609556|63048659|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
33643810|NCT01609556|63048660|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
33643811|NCT01609556|63048661|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33643812|NCT01609556|63048662|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33643813|NCT01609556|63048663|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33643814|NCT01609556|63048664|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33643815|NCT01609556|63048649|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33643816|NCT01609556|63048650|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33643817|NCT01609556|63048651|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33643818|NCT01609556|63048652|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33643819|NCT01609556|63048653|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33643820|NCT01609556|63048654|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
33643821|NCT01609556|63048655|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33643822|NCT01609556|63048656|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33643823|NCT01609556|63048657|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33643824|NCT01609556|63048658|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33643825|NCT01609556|63048659|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33643826|NCT01609556|63048660|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
33643827|NCT01609556|63048661|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33643828|NCT01609556|63048662|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33643829|NCT01609556|63048663|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33643830|NCT01609556|63048664|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33643831|NCT01609556|63048649|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33643832|NCT01609556|63048650|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33643833|NCT01609556|63048651|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33643834|NCT01609556|63048652|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33643835|NCT01609556|63048653|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33643836|NCT01609556|63048654|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
33643837|NCT01609556|63048655|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33643838|NCT01609556|63048656|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33643839|NCT01609556|63048657|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33643840|NCT01609556|63048658|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33643841|NCT01609556|63048659|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33643842|NCT01609556|63048660|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33463295|NCT00048542|62836829|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
33463296|NCT00048542|62836830|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
33463297|NCT00048542|62836831|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
33463298|NCT00048542|62836832|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
33463299|NCT00048542|62836833|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
33463300|NCT00048542|62836834|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
33463301|NCT00048542|62836835|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
33463302|NCT00048542|62836836|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
33463303|NCT00048542|62836829|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
33463304|NCT00048542|62836830|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
33463305|NCT00048542|62836831|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
33463306|NCT00048542|62836832|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
33463307|NCT00048542|62836833|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
33463308|NCT00048542|62836834|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
33463309|NCT00048542|62836835|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
33463310|NCT00048542|62836836|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
33463311|NCT00048542|62836829|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
33542973|NCT03044249|62933660|FG000|Overall Study|Lost to Follow-up|1|||
33643843|NCT01609556|63048661|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33643844|NCT01609556|63048662|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33643845|NCT01609556|63048663|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33643846|NCT01609556|63048664|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33643847|NCT01609556|63048649|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33643848|NCT01609556|63048650|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33643849|NCT01609556|63048651|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33643850|NCT01609556|63048652|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33643851|NCT01609556|63048653|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33643852|NCT01609556|63048654|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33643853|NCT01609556|63048655|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33643854|NCT01609556|63048656|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33643855|NCT01609556|63048657|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
33643856|NCT01609556|63048658|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33643857|NCT01609556|63048659|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33643858|NCT01609556|63048660|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33643859|NCT01609556|63048661|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33643860|NCT01609556|63048662|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33643861|NCT01609556|63048663|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33643862|NCT01609556|63048664|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33643863|NCT01609556|63048649|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
33643864|NCT01609556|63048650|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33643865|NCT01609556|63048651|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33643866|NCT01609556|63048652|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33643867|NCT01609556|63048653|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33643868|NCT01609556|63048654|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
33643869|NCT01609556|63048655|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33643870|NCT01609556|63048656|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33643871|NCT01609556|63048657|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33643872|NCT01609556|63048658|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33643873|NCT01609556|63048659|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
33643874|NCT01609556|63048660|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33643875|NCT01609556|63048661|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33643876|NCT01609556|63048662|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33643877|NCT01609556|63048663|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33643878|NCT01609556|63048664|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33643879|NCT01609556|63048649|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33643880|NCT01609556|63048650|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33643881|NCT01609556|63048651|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33643882|NCT01609556|63048652|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33643883|NCT01609556|63048653|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33643884|NCT01609556|63048654|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33643885|NCT01609556|63048655|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33643886|NCT01609556|63048656|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33643887|NCT01609556|63048657|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33643888|NCT01609556|63048658|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33643889|NCT01609556|63048659|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33643890|NCT01609556|63048660|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33643891|NCT01609556|63048661|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
33643892|NCT01609556|63048662|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
33643893|NCT01609556|63048663|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
33643894|NCT01609556|63048664|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
33643895|NCT01609556|63048649|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33643896|NCT01609556|63048650|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33643897|NCT01609556|63048651|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33643898|NCT01609556|63048652|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33643899|NCT01609556|63048653|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33643900|NCT01609556|63048654|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33643901|NCT01609556|63048655|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33643902|NCT01609556|63048656|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33643903|NCT01609556|63048657|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33643904|NCT01609556|63048658|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33542974|NCT03044249|62933661|FG001|Overall Study|Lost to Follow-up|0|||
33643905|NCT01609556|63048659|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33643906|NCT01609556|63048660|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33643907|NCT01609556|63048661|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
33643908|NCT01609556|63048662|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
33643909|NCT01609556|63048663|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
33643910|NCT01609556|63048664|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
33643911|NCT01609556|63048649|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33643912|NCT01609556|63048650|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33643913|NCT01609556|63048651|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33643914|NCT01609556|63048652|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33643915|NCT01609556|63048653|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33643916|NCT01609556|63048654|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33643917|NCT01609556|63048655|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33643918|NCT01609556|63048656|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33643919|NCT01609556|63048657|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33643920|NCT01609556|63048658|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33643921|NCT01609556|63048659|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33643922|NCT01609556|63048660|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33643923|NCT01609556|63048661|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
33643924|NCT01609556|63048662|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
33643925|NCT01609556|63048663|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
33643926|NCT01609556|63048664|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
33643927|NCT01609556|63048649|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33643928|NCT01609556|63048650|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33643929|NCT01609556|63048651|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33643930|NCT01609556|63048652|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33643931|NCT01609556|63048653|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33643932|NCT01609556|63048654|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33643933|NCT01609556|63048655|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33643934|NCT01609556|63048656|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33643935|NCT01609556|63048657|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33643936|NCT01609556|63048658|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33643937|NCT01609556|63048659|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33643938|NCT01609556|63048660|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33643939|NCT01609556|63048661|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
33643940|NCT01609556|63048662|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33643941|NCT01609556|63048663|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33643942|NCT01609556|63048664|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33643943|NCT01609556|63048649|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33643944|NCT01609556|63048650|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33643945|NCT01609556|63048651|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33643946|NCT01609556|63048652|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33643947|NCT01609556|63048653|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33643948|NCT01609556|63048654|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33643949|NCT01609556|63048655|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33643950|NCT01609556|63048656|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33643951|NCT01609556|63048657|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33643952|NCT01609556|63048658|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33643953|NCT01609556|63048659|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33643954|NCT01609556|63048660|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33643955|NCT01609556|63048661|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
33643956|NCT01609556|63048662|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
33643957|NCT01609556|63048663|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
33643958|NCT01609556|63048664|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
33643959|NCT01609556|63048649|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33643960|NCT01609556|63048650|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33643961|NCT01609556|63048651|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33643962|NCT01609556|63048652|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33643963|NCT01609556|63048653|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33643964|NCT01609556|63048654|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33643965|NCT01609556|63048655|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33643966|NCT01609556|63048656|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33643967|NCT01609556|63048657|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33643968|NCT01609556|63048658|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33643969|NCT01609556|63048659|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33643970|NCT01609556|63048660|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33643971|NCT01609556|63048661|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33643972|NCT01609556|63048662|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33643973|NCT01609556|63048663|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33643974|NCT01609556|63048664|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
33643975|NCT01609556|63048649|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
33643976|NCT01609556|63048650|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
33643977|NCT01609556|63048651|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
33643978|NCT01609556|63048652|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
33643979|NCT01609556|63048653|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
33643980|NCT01609556|63048654|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
33643981|NCT01609556|63048655|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
33643982|NCT01609556|63048656|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
33643983|NCT01609556|63048657|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
33643984|NCT01609556|63048658|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
33643985|NCT01609556|63048659|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
33643986|NCT01609556|63048660|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
33643987|NCT01609556|63048661|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
33643988|NCT01609556|63048662|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
33643989|NCT01609556|63048663|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
33643990|NCT01609556|63048664|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
33643991|NCT01609556|63048649|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33643992|NCT01609556|63048650|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33643993|NCT01609556|63048651|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33643994|NCT01609556|63048652|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33643995|NCT01609556|63048653|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33643996|NCT01609556|63048654|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33643997|NCT01609556|63048655|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33643998|NCT01609556|63048656|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33643999|NCT01609556|63048657|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33644000|NCT01609556|63048658|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33644001|NCT01609556|63048659|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33644002|NCT01609556|63048660|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33644003|NCT01609556|63048661|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
33644004|NCT01609556|63048662|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33644005|NCT01609556|63048663|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33644006|NCT01609556|63048664|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33644007|NCT01763996|63049038|FG000|Treatment Period 2|Adverse Event|0|||
33644008|NCT01763996|63049039|FG001|Treatment Period 2|Adverse Event|1|||
33644009|NCT01468701|63049482|FG000|Overall Study|Not eligible|91|||
33644010|NCT01468701|63049483|FG001|Overall Study|Not eligible|140|||
33644011|NCT01468701|63049484|FG002|Overall Study|Not eligible|29|||
33644012|NCT01468701|63049485|FG003|Overall Study|Not eligible|12|||
33644013|NCT01468701|63049486|FG004|Overall Study|Not eligible|22|||
33644014|NCT01468701|63049487|FG005|Overall Study|Not eligible|2|||
33644015|NCT01468701|63049488|FG006|Overall Study|Not eligible|39|||
33644016|NCT01468701|63049489|FG007|Overall Study|Not eligible|1|||
33644017|NCT01468701|63049490|FG008|Overall Study|Not eligible|40|||
33644018|NCT01468701|63049491|FG009|Overall Study|Not eligible|126|||
33644019|NCT01468701|63049492|FG010|Overall Study|Not eligible|39|||
33644020|NCT01468701|63049493|FG011|Overall Study|Not eligible|33|||
33644021|NCT01468701|63049494|FG012|Overall Study|Not eligible|1|||
33644022|NCT01468701|63049495|FG013|Overall Study|Not eligible|19|||
33644023|NCT01468701|63049496|FG014|Overall Study|Not eligible|1|||
33644024|NCT01468701|63049497|FG015|Overall Study|Not eligible|32|||
33463312|NCT00048542|62836830|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
33463313|NCT00048542|62836831|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
33463314|NCT00048542|62836832|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
33463315|NCT00048542|62836833|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
33463316|NCT00048542|62836834|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
33644025|NCT01468701|63049498|FG016|Overall Study|Not eligible|0|||
33644026|NCT01468701|63049482|FG000|Overall Study|Lost to Follow-up|306|||
33542975|NCT03044249|62933660|FG000|Overall Study|Non-compliance with Study Drug|1|||
33644027|NCT01468701|63049483|FG001|Overall Study|Lost to Follow-up|0|||
33644028|NCT01468701|63049484|FG002|Overall Study|Lost to Follow-up|0|||
33644029|NCT01468701|63049485|FG003|Overall Study|Lost to Follow-up|0|||
33463317|NCT00048542|62836835|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
33463318|NCT00048542|62836836|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
33463319|NCT00048542|62836829|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
33463320|NCT00048542|62836830|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
33463321|NCT00048542|62836831|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
33463322|NCT00048542|62836832|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
33463323|NCT00048542|62836833|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
33463324|NCT00048542|62836834|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
33463325|NCT00048542|62836835|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
33644030|NCT01468701|63049486|FG004|Overall Study|Lost to Follow-up|0|||
33644031|NCT01468701|63049487|FG005|Overall Study|Lost to Follow-up|0|||
33644032|NCT01468701|63049488|FG006|Overall Study|Lost to Follow-up|0|||
33644033|NCT01468701|63049489|FG007|Overall Study|Lost to Follow-up|0|||
33644034|NCT01468701|63049490|FG008|Overall Study|Lost to Follow-up|215|||
33644035|NCT01468701|63049491|FG009|Overall Study|Lost to Follow-up|309|||
33644036|NCT01468701|63049492|FG010|Overall Study|Lost to Follow-up|224|||
33644037|NCT01468701|63049493|FG011|Overall Study|Lost to Follow-up|212|||
33644038|NCT01468701|63049494|FG012|Overall Study|Lost to Follow-up|11|||
33644039|NCT01468701|63049495|FG013|Overall Study|Lost to Follow-up|164|||
33644040|NCT01468701|63049496|FG014|Overall Study|Lost to Follow-up|17|||
33644041|NCT01468701|63049497|FG015|Overall Study|Lost to Follow-up|127|||
33644042|NCT01468701|63049498|FG016|Overall Study|Lost to Follow-up|1|||
33644043|NCT01468701|63049482|FG000|Overall Study|Withdrawal by Subject|165|||
33644044|NCT01468701|63049483|FG001|Overall Study|Withdrawal by Subject|0|||
33644045|NCT01468701|63049484|FG002|Overall Study|Withdrawal by Subject|0|||
33644046|NCT01468701|63049485|FG003|Overall Study|Withdrawal by Subject|0|||
33644047|NCT01468701|63049486|FG004|Overall Study|Withdrawal by Subject|0|||
33644048|NCT01468701|63049487|FG005|Overall Study|Withdrawal by Subject|0|||
33644049|NCT01468701|63049488|FG006|Overall Study|Withdrawal by Subject|0|||
33644050|NCT01468701|63049489|FG007|Overall Study|Withdrawal by Subject|0|||
33644051|NCT01468701|63049490|FG008|Overall Study|Withdrawal by Subject|83|||
33644052|NCT01468701|63049491|FG009|Overall Study|Withdrawal by Subject|88|||
33644053|NCT01468701|63049492|FG010|Overall Study|Withdrawal by Subject|100|||
33644054|NCT01468701|63049493|FG011|Overall Study|Withdrawal by Subject|114|||
33644055|NCT01468701|63049494|FG012|Overall Study|Withdrawal by Subject|9|||
33644056|NCT01468701|63049495|FG013|Overall Study|Withdrawal by Subject|47|||
33644057|NCT01468701|63049496|FG014|Overall Study|Withdrawal by Subject|6|||
33644058|NCT01468701|63049497|FG015|Overall Study|Withdrawal by Subject|31|||
33644059|NCT01468701|63049498|FG016|Overall Study|Withdrawal by Subject|0|||
33644060|NCT01468701|63049482|FG000|Overall Study|Other reasons than listed|437|||
33644061|NCT01468701|63049483|FG001|Overall Study|Other reasons than listed|0|||
33644062|NCT01468701|63049484|FG002|Overall Study|Other reasons than listed|0|||
33644063|NCT01468701|63049485|FG003|Overall Study|Other reasons than listed|0|||
33644064|NCT01468701|63049486|FG004|Overall Study|Other reasons than listed|0|||
33644065|NCT01468701|63049487|FG005|Overall Study|Other reasons than listed|0|||
33644066|NCT01468701|63049488|FG006|Overall Study|Other reasons than listed|0|||
33644067|NCT01468701|63049489|FG007|Overall Study|Other reasons than listed|0|||
33644068|NCT01468701|63049490|FG008|Overall Study|Other reasons than listed|318|||
33644069|NCT01468701|63049491|FG009|Overall Study|Other reasons than listed|658|||
33644070|NCT01468701|63049492|FG010|Overall Study|Other reasons than listed|433|||
33644071|NCT01468701|63049493|FG011|Overall Study|Other reasons than listed|504|||
33644072|NCT01468701|63049494|FG012|Overall Study|Other reasons than listed|28|||
33644073|NCT01468701|63049495|FG013|Overall Study|Other reasons than listed|239|||
33644074|NCT01468701|63049496|FG014|Overall Study|Other reasons than listed|39|||
33644075|NCT01468701|63049497|FG015|Overall Study|Other reasons than listed|172|||
33644076|NCT01468701|63049498|FG016|Overall Study|Other reasons than listed|0|||
33644077|NCT01468701|63049482|FG000|Overall Study|No end of study case report form|0|||
33644078|NCT01468701|63049483|FG001|Overall Study|No end of study case report form|0|||
33644079|NCT01468701|63049484|FG002|Overall Study|No end of study case report form|0|||
33644080|NCT01468701|63049485|FG003|Overall Study|No end of study case report form|0|||
33644081|NCT01468701|63049486|FG004|Overall Study|No end of study case report form|0|||
33644082|NCT01468701|63049487|FG005|Overall Study|No end of study case report form|0|||
33644083|NCT01468701|63049488|FG006|Overall Study|No end of study case report form|0|||
33644084|NCT01468701|63049489|FG007|Overall Study|No end of study case report form|0|||
33644085|NCT01468701|63049490|FG008|Overall Study|No end of study case report form|4|||
33644086|NCT01468701|63049491|FG009|Overall Study|No end of study case report form|1|||
33644087|NCT01468701|63049492|FG010|Overall Study|No end of study case report form|2|||
33644088|NCT01468701|63049493|FG011|Overall Study|No end of study case report form|3|||
33644089|NCT01468701|63049494|FG012|Overall Study|No end of study case report form|0|||
33644090|NCT01468701|63049495|FG013|Overall Study|No end of study case report form|1|||
33644091|NCT01468701|63049496|FG014|Overall Study|No end of study case report form|0|||
33644092|NCT01468701|63049497|FG015|Overall Study|No end of study case report form|0|||
33644093|NCT01468701|63049498|FG016|Overall Study|No end of study case report form|0|||
33644094|NCT01468701|63049482|FG000|Overall Study|Not being followed up|0|||
33644095|NCT01468701|63049483|FG001|Overall Study|Not being followed up|4963|||
33644096|NCT01468701|63049484|FG002|Overall Study|Not being followed up|1755|||
33644097|NCT01468701|63049485|FG003|Overall Study|Not being followed up|703|||
33644098|NCT01468701|63049486|FG004|Overall Study|Not being followed up|1714|||
33644099|NCT01468701|63049487|FG005|Overall Study|Not being followed up|126|||
33644100|NCT01468701|63049488|FG006|Overall Study|Not being followed up|1170|||
33644101|NCT01468701|63049489|FG007|Overall Study|Not being followed up|4|||
33644102|NCT01468701|63049490|FG008|Overall Study|Not being followed up|0|||
33644103|NCT01468701|63049491|FG009|Overall Study|Not being followed up|0|||
33644104|NCT01468701|63049492|FG010|Overall Study|Not being followed up|0|||
33644105|NCT01468701|63049493|FG011|Overall Study|Not being followed up|0|||
33463326|NCT00048542|62836836|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
33463327|NCT00048542|62836829|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
33463328|NCT00048542|62836830|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
33463329|NCT00048542|62836831|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
33463330|NCT00048542|62836832|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
33463331|NCT00048542|62836833|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
33463332|NCT00048542|62836834|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
33463333|NCT00048542|62836835|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
33463334|NCT00048542|62836836|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
33463335|NCT03814590|62836879|FG000|Overall Study|Adverse Event|0|||
33463336|NCT03814590|62836880|FG001|Overall Study|Adverse Event|0|||
33463337|NCT03814590|62836881|FG002|Overall Study|Adverse Event|0|||
33463338|NCT03814590|62836882|FG003|Overall Study|Adverse Event|0|||
33463339|NCT03814590|62836883|FG004|Overall Study|Adverse Event|0|||
33463340|NCT03814590|62836884|FG005|Overall Study|Adverse Event|1|||
33463341|NCT03814590|62836885|FG006|Overall Study|Adverse Event|1|||
33463342|NCT03814590|62836886|FG007|Overall Study|Adverse Event|1|||
33463343|NCT03814590|62836887|FG008|Overall Study|Adverse Event|0|||
33463344|NCT03814590|62836888|FG009|Overall Study|Adverse Event|0|||
33463345|NCT03814590|62836889|FG010|Overall Study|Adverse Event|1|||
33463346|NCT03814590|62836890|FG011|Overall Study|Adverse Event|0|||
33463347|NCT03814590|62836891|FG012|Overall Study|Adverse Event|3|||
33463348|NCT03814590|62836892|FG013|Overall Study|Adverse Event|0|||
33463349|NCT03814590|62836879|FG000|Overall Study|Lost to Follow-up|0|||
33463350|NCT03814590|62836880|FG001|Overall Study|Lost to Follow-up|2|||
33463351|NCT03814590|62836881|FG002|Overall Study|Lost to Follow-up|1|||
33463352|NCT03814590|62836882|FG003|Overall Study|Lost to Follow-up|0|||
33463353|NCT03814590|62836883|FG004|Overall Study|Lost to Follow-up|1|||
33463354|NCT03814590|62836884|FG005|Overall Study|Lost to Follow-up|1|||
33463355|NCT03814590|62836885|FG006|Overall Study|Lost to Follow-up|1|||
33463356|NCT03814590|62836886|FG007|Overall Study|Lost to Follow-up|1|||
33463357|NCT03814590|62836887|FG008|Overall Study|Lost to Follow-up|0|||
33463358|NCT03814590|62836888|FG009|Overall Study|Lost to Follow-up|0|||
33463359|NCT03814590|62836889|FG010|Overall Study|Lost to Follow-up|1|||
33463360|NCT03814590|62836890|FG011|Overall Study|Lost to Follow-up|0|||
33463361|NCT03814590|62836891|FG012|Overall Study|Lost to Follow-up|0|||
33463362|NCT03814590|62836892|FG013|Overall Study|Lost to Follow-up|1|||
33463363|NCT03814590|62836879|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33463364|NCT03814590|62836880|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33463365|NCT03814590|62836881|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33463366|NCT03814590|62836882|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33463367|NCT03814590|62836883|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33463368|NCT03814590|62836884|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33463369|NCT03814590|62836885|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33463370|NCT03814590|62836886|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33463371|NCT03814590|62836887|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33463372|NCT03814590|62836888|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
33463373|NCT03814590|62836889|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33463374|NCT03814590|62836890|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33463375|NCT03814590|62836891|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33463376|NCT03814590|62836892|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33463377|NCT03814590|62836879|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
33644106|NCT01468701|63049494|FG012|Overall Study|Not being followed up|0|||
33463378|NCT03814590|62836880|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
33644107|NCT01468701|63049495|FG013|Overall Study|Not being followed up|0|||
33644108|NCT01468701|63049496|FG014|Overall Study|Not being followed up|0|||
33644109|NCT01468701|63049497|FG015|Overall Study|Not being followed up|0|||
33644110|NCT01468701|63049498|FG016|Overall Study|Not being followed up|0|||
33644111|NCT01492101|63049513|FG000|Overall Study|Death|323|||
33463379|NCT03814590|62836881|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
33463380|NCT03814590|62836882|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
33463381|NCT03814590|62836883|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
33463382|NCT03814590|62836884|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
33644112|NCT01492101|63049514|FG001|Overall Study|Death|322|||
33644113|NCT01492101|63049513|FG000|Overall Study|Withdrawal by Subject|14|||
33644114|NCT01492101|63049514|FG001|Overall Study|Withdrawal by Subject|18|||
33644115|NCT01492101|63049513|FG000|Overall Study|Lost to Follow-up|0|||
33644116|NCT01492101|63049514|FG001|Overall Study|Lost to Follow-up|2|||
33644117|NCT01468311|63049520|FG000|Overall Study|mobilization failure|1|||
33644118|NCT01468311|63049520|FG000|Overall Study|Withdrawal by Subject|1|||
33644119|NCT01730534|63049631|FG000|Overall Study|Withdrawal by Subject|97|||
33644120|NCT01730534|63049632|FG001|Overall Study|Withdrawal by Subject|127|||
33644121|NCT01730534|63049631|FG000|Overall Study|Lost to Follow-up|12|||
33644122|NCT01730534|63049632|FG001|Overall Study|Lost to Follow-up|18|||
33644123|NCT01783730|63049652|FG000|Overall Study|Failed to meet inclusion criteria|6|||
33644124|NCT01730378|63049658|FG000|Overall Study|Lost to Follow-up|1|||
33644125|NCT01730378|63049659|FG001|Overall Study|Lost to Follow-up|0|||
33644126|NCT01783496|63049672|FG000|Overall Study|Lost to Follow-up|0|||
33644127|NCT01783496|63049673|FG001|Overall Study|Lost to Follow-up|0|||
33644128|NCT01783496|63049674|FG002|Overall Study|Lost to Follow-up|0|||
33644129|NCT01783496|63049675|FG003|Overall Study|Lost to Follow-up|2|||
33644130|NCT01783496|63049676|FG004|Overall Study|Lost to Follow-up|0|||
33644131|NCT01783496|63049677|FG005|Overall Study|Lost to Follow-up|1|||
33644132|NCT01783496|63049672|FG000|Overall Study|Withdrawal by Subject|1|||
33644133|NCT01783496|63049673|FG001|Overall Study|Withdrawal by Subject|0|||
33644134|NCT01783496|63049674|FG002|Overall Study|Withdrawal by Subject|0|||
33644135|NCT01783496|63049675|FG003|Overall Study|Withdrawal by Subject|0|||
33644136|NCT01783496|63049676|FG004|Overall Study|Withdrawal by Subject|0|||
33644137|NCT01783496|63049677|FG005|Overall Study|Withdrawal by Subject|0|||
33644138|NCT01729208|63049702|FG000|Baseline|Physician Decision|5|||
33644139|NCT01729208|63049703|FG001|Baseline|Physician Decision|4|||
33644140|NCT01729208|63049702|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
33644141|NCT01729208|63049703|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
33644142|NCT01729208|63049702|FG000|12 Months Follow-up|Lost to Follow-up|3|||
33644143|NCT01729208|63049703|FG001|12 Months Follow-up|Lost to Follow-up|3|||
33644144|NCT01729208|63049702|FG000|24 Months Follow-up|Lost to Follow-up|3|||
33644145|NCT01729208|63049703|FG001|24 Months Follow-up|Lost to Follow-up|0|||
33644146|NCT01729208|63049702|FG000|36 Months Follow-up|Physician Decision|1|||
33644147|NCT01729208|63049703|FG001|36 Months Follow-up|Physician Decision|0|||
33644148|NCT01729208|63049702|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
33463383|NCT03814590|62836885|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
33463384|NCT03814590|62836886|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
33463385|NCT03814590|62836887|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
33463386|NCT03814590|62836888|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
33463387|NCT03814590|62836889|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
33463388|NCT03814590|62836890|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
33463389|NCT03814590|62836891|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
33463390|NCT03814590|62836892|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
33463391|NCT03814590|62836879|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33327200|NCT01185353|62703798|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
33644149|NCT01729208|63049703|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
33644150|NCT01609010|63049720|FG000|Overall Study|Stable disease (SD)|22|||
33327201|NCT01185353|62703799|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33327202|NCT01185353|62703800|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
33327203|NCT01185353|62703801|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33327204|NCT01185353|62703802|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33327205|NCT01185353|62703803|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33463392|NCT03814590|62836880|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33644151|NCT01609010|63049721|FG001|Overall Study|Stable disease (SD)|16|||
33644152|NCT01609010|63049720|FG000|Overall Study|Progressive disease (PD)|8|||
33644153|NCT01609010|63049721|FG001|Overall Study|Progressive disease (PD)|10|||
33644154|NCT01609010|63049720|FG000|Overall Study|Adverse Event|3|||
33644155|NCT01609010|63049721|FG001|Overall Study|Adverse Event|6|||
33644156|NCT01609010|63049720|FG000|Overall Study|Withdrawal by Subject|2|||
33644157|NCT01609010|63049721|FG001|Overall Study|Withdrawal by Subject|2|||
33644158|NCT01609010|63049720|FG000|Overall Study|Other|2|||
33327206|NCT01185353|62703804|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33644159|NCT01609010|63049721|FG001|Overall Study|Other|0|||
33644160|NCT01609010|63049720|FG000|Overall Study|Other malignancy|1|||
33644161|NCT01609010|63049721|FG001|Overall Study|Other malignancy|0|||
33644162|NCT01609010|63049720|FG000|Overall Study|Pathology review|2|||
33644163|NCT01609010|63049721|FG001|Overall Study|Pathology review|1|||
33644164|NCT01609010|63049720|FG000|Overall Study|Protocol Violation|1|||
33644165|NCT01609010|63049721|FG001|Overall Study|Protocol Violation|1|||
33644166|NCT01609010|63049720|FG000|Overall Study|New cancer|1|||
33644167|NCT01609010|63049721|FG001|Overall Study|New cancer|0|||
33644168|NCT01609010|63049720|FG000|Overall Study|Lost to Follow-up|1|||
33644169|NCT01609010|63049721|FG001|Overall Study|Lost to Follow-up|1|||
33644170|NCT01608308|63049729|FG000|Overall Study|pretreatment medical and billing reasons|0|||
33644171|NCT01608308|63049730|FG001|Overall Study|pretreatment medical and billing reasons|2|||
33644172|NCT01755416|63049761|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
33644173|NCT01755416|63049762|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
33644174|NCT01755026|63049770|FG000|Overall Study|Adverse Event|1|||
33644175|NCT01755026|63049771|FG001|Overall Study|Adverse Event|0|||
33644176|NCT01755026|63049770|FG000|Overall Study|Withdrawal by Subject|1|||
33644177|NCT01755026|63049771|FG001|Overall Study|Withdrawal by Subject|1|||
33644178|NCT01491945|63049786|FG000|Overall Study|Death|30|||
33644179|NCT01491945|63049786|FG000|Overall Study|Withdrwan/LTF|16|||
33644180|NCT01491945|63049786|FG000|Overall Study|Conversion|4|||
33644181|NCT01491945|63049786|FG000|Overall Study|Missed Visit|1|||
33644182|NCT01728584|63049808|FG000|Overall Study|Adverse Event|1|||
33644183|NCT01728584|63049809|FG001|Overall Study|Adverse Event|0|||
33644184|NCT01728584|63049810|FG002|Overall Study|Adverse Event|0|||
33644185|NCT01728584|63049811|FG003|Overall Study|Adverse Event|0|||
33644186|NCT01728584|63049808|FG000|Overall Study|Physician Decision|4|||
33644187|NCT01728584|63049809|FG001|Overall Study|Physician Decision|0|||
33644188|NCT01728584|63049810|FG002|Overall Study|Physician Decision|1|||
33644189|NCT01728584|63049811|FG003|Overall Study|Physician Decision|0|||
33644190|NCT01728584|63049808|FG000|Overall Study|Withdrawal by Subject|1|||
33644191|NCT01728584|63049809|FG001|Overall Study|Withdrawal by Subject|0|||
33644192|NCT01728584|63049810|FG002|Overall Study|Withdrawal by Subject|0|||
33644193|NCT01728584|63049811|FG003|Overall Study|Withdrawal by Subject|0|||
33644194|NCT01728584|63049808|FG000|Overall Study|Screen failure|1|||
33644195|NCT01728584|63049809|FG001|Overall Study|Screen failure|0|||
33644196|NCT01728584|63049810|FG002|Overall Study|Screen failure|0|||
33644197|NCT01728584|63049811|FG003|Overall Study|Screen failure|0|||
33644198|NCT01728584|63049808|FG000|Overall Study|Other reason (not specified)|1|||
33463393|NCT03814590|62836881|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33463394|NCT03814590|62836882|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33463395|NCT03814590|62836883|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33463396|NCT03814590|62836884|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33463397|NCT03814590|62836885|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33463398|NCT03814590|62836886|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33463399|NCT03814590|62836887|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33463400|NCT03814590|62836888|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33463401|NCT03814590|62836889|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33463402|NCT03814590|62836890|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33463403|NCT03814590|62836891|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33463404|NCT03814590|62836892|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33463405|NCT03814590|62836879|FG000|Overall Study|UNKNOWN REASON|0|||
33463406|NCT03814590|62836880|FG001|Overall Study|UNKNOWN REASON|0|||
33463407|NCT03814590|62836881|FG002|Overall Study|UNKNOWN REASON|0|||
33463408|NCT03814590|62836882|FG003|Overall Study|UNKNOWN REASON|0|||
33463409|NCT03814590|62836883|FG004|Overall Study|UNKNOWN REASON|0|||
33463410|NCT03814590|62836884|FG005|Overall Study|UNKNOWN REASON|0|||
33463411|NCT03814590|62836885|FG006|Overall Study|UNKNOWN REASON|0|||
33463412|NCT03814590|62836886|FG007|Overall Study|UNKNOWN REASON|1|||
33463413|NCT03814590|62836887|FG008|Overall Study|UNKNOWN REASON|0|||
33463414|NCT03814590|62836888|FG009|Overall Study|UNKNOWN REASON|0|||
33542976|NCT03044249|62933661|FG001|Overall Study|Non-compliance with Study Drug|0|||
33542977|NCT03044249|62933660|FG000|Overall Study|Study Terminated by Sponsor|2|||
33644199|NCT01728584|63049809|FG001|Overall Study|Other reason (not specified)|0|||
33644200|NCT01728584|63049810|FG002|Overall Study|Other reason (not specified)|0|||
33644201|NCT01728584|63049811|FG003|Overall Study|Other reason (not specified)|1|||
33644202|NCT01522443|63049844|FG000|Overall Study|No longer receiving clinical benefit|36|||
33644203|NCT01522443|63049845|FG001|Overall Study|No longer receiving clinical benefit|28|||
33463415|NCT03814590|62836889|FG010|Overall Study|UNKNOWN REASON|0|||
33644204|NCT01522443|63049844|FG000|Overall Study|Adverse Event|10|||
33644205|NCT01522443|63049845|FG001|Overall Study|Adverse Event|15|||
33644206|NCT01522443|63049844|FG000|Overall Study|Withdrawal by Subject|5|||
33644207|NCT01522443|63049845|FG001|Overall Study|Withdrawal by Subject|8|||
33644208|NCT01522443|63049844|FG000|Overall Study|No study treatment given|1|||
33644209|NCT01522443|63049845|FG001|Overall Study|No study treatment given|1|||
33644210|NCT01522443|63049844|FG000|Overall Study|Other|1|||
33644211|NCT01522443|63049845|FG001|Overall Study|Other|3|||
33644212|NCT01468233|63049866|FG000|Treatment Period 1|Adverse Event|5|||
33644213|NCT01468233|63049867|FG001|Treatment Period 1|Adverse Event|3|||
33644214|NCT01468233|63049868|FG002|Treatment Period 1|Adverse Event|0|||
33644215|NCT01468233|63049869|FG003|Treatment Period 1|Adverse Event|0|||
33644216|NCT01468233|63049870|FG004|Treatment Period 1|Adverse Event|0|||
33644217|NCT01468233|63049871|FG005|Treatment Period 1|Adverse Event|0|||
33644218|NCT01468233|63049866|FG000|Treatment Period 1|Withdrawal by Subject|3|||
33644219|NCT01468233|63049867|FG001|Treatment Period 1|Withdrawal by Subject|4|||
33644220|NCT01468233|63049868|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33644221|NCT01468233|63049869|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33644222|NCT01468233|63049870|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33644223|NCT01468233|63049871|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33644224|NCT01468233|63049866|FG000|Treatment Period 1|Lost to Follow-up|3|||
33644225|NCT01468233|63049867|FG001|Treatment Period 1|Lost to Follow-up|0|||
33644226|NCT01468233|63049868|FG002|Treatment Period 1|Lost to Follow-up|0|||
33644227|NCT01468233|63049869|FG003|Treatment Period 1|Lost to Follow-up|0|||
33644228|NCT01468233|63049870|FG004|Treatment Period 1|Lost to Follow-up|0|||
33644229|NCT01468233|63049871|FG005|Treatment Period 1|Lost to Follow-up|0|||
33644230|NCT01468233|63049866|FG000|Treatment Period 1|Other|1|||
33644231|NCT01468233|63049867|FG001|Treatment Period 1|Other|1|||
33644232|NCT01468233|63049868|FG002|Treatment Period 1|Other|0|||
33644233|NCT01468233|63049869|FG003|Treatment Period 1|Other|0|||
33644234|NCT01468233|63049870|FG004|Treatment Period 1|Other|0|||
33644235|NCT01468233|63049871|FG005|Treatment Period 1|Other|0|||
33644236|NCT01468233|63049866|FG000|Treatment Period 2|Adverse Event|0|||
33644237|NCT01468233|63049867|FG001|Treatment Period 2|Adverse Event|0|||
33644238|NCT01468233|63049868|FG002|Treatment Period 2|Adverse Event|3|||
33644239|NCT01468233|63049869|FG003|Treatment Period 2|Adverse Event|0|||
33644240|NCT01468233|63049870|FG004|Treatment Period 2|Adverse Event|2|||
33644241|NCT01468233|63049871|FG005|Treatment Period 2|Adverse Event|1|||
33644242|NCT01468233|63049866|FG000|Treatment Period 2|Lack of Efficacy|0|||
33644243|NCT01468233|63049867|FG001|Treatment Period 2|Lack of Efficacy|0|||
33644244|NCT01468233|63049868|FG002|Treatment Period 2|Lack of Efficacy|9|||
33644245|NCT01468233|63049869|FG003|Treatment Period 2|Lack of Efficacy|2|||
33644246|NCT01468233|63049870|FG004|Treatment Period 2|Lack of Efficacy|0|||
33644247|NCT01468233|63049871|FG005|Treatment Period 2|Lack of Efficacy|1|||
33644248|NCT01468233|63049866|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33644249|NCT01468233|63049867|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33644250|NCT01468233|63049868|FG002|Treatment Period 2|Withdrawal by Subject|9|||
33644251|NCT01468233|63049869|FG003|Treatment Period 2|Withdrawal by Subject|1|||
33644252|NCT01468233|63049870|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33644253|NCT01468233|63049871|FG005|Treatment Period 2|Withdrawal by Subject|1|||
33644254|NCT01468233|63049866|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
33644255|NCT01468233|63049867|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
33644256|NCT01468233|63049868|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
33463416|NCT03814590|62836890|FG011|Overall Study|UNKNOWN REASON|0|||
33463417|NCT03814590|62836891|FG012|Overall Study|UNKNOWN REASON|0|||
33463418|NCT03814590|62836892|FG013|Overall Study|UNKNOWN REASON|0|||
33463419|NCT00048074|62836935|FG000|Overall Study|Adverse Event|46|||
33463420|NCT00048074|62836936|FG001|Overall Study|Adverse Event|41|||
33463421|NCT00048074|62836937|FG002|Overall Study|Adverse Event|53|||
33463422|NCT00048074|62836935|FG000|Overall Study|Death|3|||
33463423|NCT00048074|62836936|FG001|Overall Study|Death|3|||
33463424|NCT00048074|62836937|FG002|Overall Study|Death|2|||
33463425|NCT00048074|62836935|FG000|Overall Study|Lost to Follow-up|2|||
33463426|NCT00048074|62836936|FG001|Overall Study|Lost to Follow-up|6|||
33463427|NCT00048074|62836937|FG002|Overall Study|Lost to Follow-up|6|||
33463428|NCT00048074|62836935|FG000|Overall Study|Withdrawal by Subject|28|||
33463429|NCT00048074|62836936|FG001|Overall Study|Withdrawal by Subject|30|||
33463430|NCT00048074|62836937|FG002|Overall Study|Withdrawal by Subject|35|||
33463431|NCT00048074|62836935|FG000|Overall Study|Protocol Violation|1|||
33644257|NCT01468233|63049869|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
33644258|NCT01468233|63049870|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
33644259|NCT01468233|63049871|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
33644260|NCT01468233|63049866|FG000|Treatment Period 2|Lost to Follow-up|0|||
33644261|NCT01468233|63049867|FG001|Treatment Period 2|Lost to Follow-up|0|||
33644262|NCT01468233|63049868|FG002|Treatment Period 2|Lost to Follow-up|3|||
33644263|NCT01468233|63049869|FG003|Treatment Period 2|Lost to Follow-up|0|||
33644264|NCT01468233|63049870|FG004|Treatment Period 2|Lost to Follow-up|2|||
33463432|NCT00048074|62836936|FG001|Overall Study|Protocol Violation|3|||
33463433|NCT00048074|62836937|FG002|Overall Study|Protocol Violation|0|||
33463434|NCT00048074|62836935|FG000|Overall Study|Study participation was terminated|0|||
33463435|NCT00048074|62836936|FG001|Overall Study|Study participation was terminated|1|||
33644265|NCT01468233|63049871|FG005|Treatment Period 2|Lost to Follow-up|0|||
33644266|NCT01468233|63049866|FG000|Treatment Period 2|Other|0|||
33644267|NCT01468233|63049867|FG001|Treatment Period 2|Other|0|||
33644268|NCT01468233|63049868|FG002|Treatment Period 2|Other|3|||
33644269|NCT01468233|63049869|FG003|Treatment Period 2|Other|0|||
33644270|NCT01468233|63049870|FG004|Treatment Period 2|Other|1|||
33644271|NCT01468233|63049871|FG005|Treatment Period 2|Other|0|||
33644272|NCT01468077|63049891|FG000|Overall Study|Adverse Event|2|||
33644273|NCT01468077|63049892|FG001|Overall Study|Adverse Event|2|||
33644274|NCT01468077|63049891|FG000|Overall Study|Lack of Efficacy|1|||
33644275|NCT01468077|63049892|FG001|Overall Study|Lack of Efficacy|1|||
33644276|NCT01468077|63049891|FG000|Overall Study|Physician Decision|1|||
33644277|NCT01468077|63049892|FG001|Overall Study|Physician Decision|0|||
33644278|NCT01522365|63049900|FG000|Overall Study|Withdrawal by Subject|1|||
33644279|NCT01522365|63049901|FG001|Overall Study|Withdrawal by Subject|1|||
33644280|NCT01522365|63049900|FG000|Overall Study|Lost to Follow-up|1|||
33644281|NCT01522365|63049901|FG001|Overall Study|Lost to Follow-up|1|||
33644282|NCT01754402|63049911|FG000|Overall Study|Death|0|||
33644283|NCT01754402|63049912|FG001|Overall Study|Death|0|||
33644284|NCT01754402|63049913|FG002|Overall Study|Death|1|||
33644285|NCT01754402|63049911|FG000|Overall Study|Adverse Event|2|||
33644286|NCT01754402|63049912|FG001|Overall Study|Adverse Event|2|||
33644287|NCT01754402|63049913|FG002|Overall Study|Adverse Event|1|||
33644288|NCT01754402|63049911|FG000|Overall Study|Withdrawal by Subject|0|||
33644289|NCT01754402|63049912|FG001|Overall Study|Withdrawal by Subject|0|||
33644290|NCT01754402|63049913|FG002|Overall Study|Withdrawal by Subject|1|||
33644291|NCT01754402|63049911|FG000|Overall Study|Lack of Efficacy|0|||
33644292|NCT01754402|63049912|FG001|Overall Study|Lack of Efficacy|0|||
33644293|NCT01754402|63049913|FG002|Overall Study|Lack of Efficacy|1|||
33644294|NCT01783418|63049924|FG000|Overall Study|Withdrawal by Subject|1|||
33644295|NCT01783418|63049925|FG001|Overall Study|Withdrawal by Subject|0|||
33644296|NCT01521897|63049931|FG000|Overall Study|Protocol Violation|18|||
33644297|NCT01521897|63049931|FG000|Overall Study|Lost to Follow-up|5|||
33644298|NCT01782872|63049939|FG000|Overall Study|Protocol Violation|0|||
33644299|NCT01782872|63049940|FG001|Overall Study|Protocol Violation|0|||
33644300|NCT01782872|63049941|FG002|Overall Study|Protocol Violation|0|||
33644301|NCT01782872|63049942|FG003|Overall Study|Protocol Violation|1|||
33644302|NCT01782872|63049939|FG000|Overall Study|Withdrawal by Subject|0|||
33644303|NCT01782872|63049940|FG001|Overall Study|Withdrawal by Subject|1|||
33644304|NCT01782872|63049941|FG002|Overall Study|Withdrawal by Subject|0|||
33644305|NCT01782872|63049942|FG003|Overall Study|Withdrawal by Subject|0|||
33644306|NCT01490697|63049954|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
33644307|NCT01490697|63049955|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
33644308|NCT01728194|63049963|FG000|Overall Study|Lost to Follow-up|4|||
33644309|NCT01728194|63049964|FG001|Overall Study|Lost to Follow-up|3|||
33644310|NCT01728194|63049963|FG000|Overall Study|Physician Decision|4|||
33644311|NCT01728194|63049964|FG001|Overall Study|Physician Decision|0|||
33644312|NCT01728194|63049963|FG000|Overall Study|Withdrawal by Subject|7|||
33644313|NCT01728194|63049964|FG001|Overall Study|Withdrawal by Subject|3|||
33644314|NCT01728194|63049963|FG000|Overall Study|Perceived Medication Side Effects|4|||
33644315|NCT01728194|63049964|FG001|Overall Study|Perceived Medication Side Effects|0|||
33644316|NCT01728194|63049963|FG000|Overall Study|Family Member Request|1|||
33644317|NCT01728194|63049964|FG001|Overall Study|Family Member Request|0|||
33644318|NCT01782482|63049972|FG000|Overall Study|Adverse Event|2|||
33644319|NCT01782482|63049973|FG001|Overall Study|Adverse Event|1|||
33644320|NCT01782482|63049972|FG000|Overall Study|Lost to Follow-up|2|||
33644321|NCT01782482|63049973|FG001|Overall Study|Lost to Follow-up|3|||
33644322|NCT01782482|63049972|FG000|Overall Study|Physician Decision|1|||
33644323|NCT01782482|63049973|FG001|Overall Study|Physician Decision|0|||
33644324|NCT01782482|63049972|FG000|Overall Study|Protocol Violation|1|||
33644325|NCT01782482|63049973|FG001|Overall Study|Protocol Violation|0|||
33644326|NCT01782482|63049972|FG000|Overall Study|Withdrawal by Subject|2|||
33542978|NCT03044249|62933661|FG001|Overall Study|Study Terminated by Sponsor|0|||
33542979|NCT03044249|62933660|FG000|Overall Study|Withdrawal by Subject|2|||
33644327|NCT01782482|63049973|FG001|Overall Study|Withdrawal by Subject|3|||
33644328|NCT01782482|63049972|FG000|Overall Study|Randomized in Error|2|||
33644329|NCT01782482|63049973|FG001|Overall Study|Randomized in Error|2|||
33644330|NCT01782482|63049972|FG000|Overall Study|Habitually wearing toric lens OS|0|||
33644331|NCT01782482|63049973|FG001|Overall Study|Habitually wearing toric lens OS|1|||
33644332|NCT01466673|63049981|FG000|Overall Study|Non-compliance with study treatment|2|||
33644333|NCT01466673|63049982|FG001|Overall Study|Non-compliance with study treatment|0|||
33644334|NCT01466673|63049981|FG000|Overall Study|Lost to Follow-up|3|||
33644335|NCT01466673|63049982|FG001|Overall Study|Lost to Follow-up|5|||
33644336|NCT01466673|63049981|FG000|Overall Study|Adverse Event|2|||
33644337|NCT01466673|63049982|FG001|Overall Study|Adverse Event|1|||
33644338|NCT01753856|63049990|FG000|Overall Study|Adverse Event|1|||
33644339|NCT01753856|63049991|FG001|Overall Study|Adverse Event|0|||
33644340|NCT01753856|63049990|FG000|Overall Study|Withdrawal by Subject|0|||
33644341|NCT01753856|63049991|FG001|Overall Study|Withdrawal by Subject|2|||
33644342|NCT01753856|63049990|FG000|Overall Study|Sponsor Decision|2|||
33644343|NCT01753856|63049991|FG001|Overall Study|Sponsor Decision|0|||
33644344|NCT01464333|63050000|FG000|Overall Study|Adverse Event|34|||
33644345|NCT01464333|63050000|FG000|Overall Study|Lack of Efficacy|72|||
33644346|NCT01464333|63050000|FG000|Overall Study|Withdrawal by Subject|11|||
33644347|NCT01464333|63050000|FG000|Overall Study|Other|4|||
33644348|NCT01464333|63050000|FG000|Overall Study|No Hospital Visit|42|||
33644349|NCT01464255|63050006|FG000|Overall Study|unresolve corneal staining|0|||
33644350|NCT01464255|63050007|FG001|Overall Study|unresolve corneal staining|1|||
33644351|NCT01464021|63050014|FG000|Overall Study|Withdrawal by Subject|13|||
33644352|NCT01464021|63050014|FG000|Overall Study|Lost to Follow-up|1|||
33644353|NCT01464021|63050014|FG000|Overall Study|Lack of Efficacy|1|||
33644354|NCT01464021|63050014|FG000|Overall Study|various|11|||
33644355|NCT01753310|63050020|FG000|Overall Study|Entered into open label extension study|25|||
33644356|NCT01753310|63050021|FG001|Overall Study|Entered into open label extension study|22|||
33644357|NCT01753310|63050020|FG000|Overall Study|Adverse Event|1|||
33644358|NCT01753310|63050021|FG001|Overall Study|Adverse Event|0|||
33644359|NCT01753310|63050020|FG000|Overall Study|Lost to Follow-up|2|||
33644360|NCT01753310|63050021|FG001|Overall Study|Lost to Follow-up|0|||
33644361|NCT01753310|63050020|FG000|Overall Study|Subject decision|2|||
33644362|NCT01753310|63050021|FG001|Overall Study|Subject decision|2|||
33644363|NCT01753310|63050020|FG000|Overall Study|Sponsor decision|1|||
33644364|NCT01753310|63050021|FG001|Overall Study|Sponsor decision|0|||
33644365|NCT01753310|63050020|FG000|Overall Study|Withdrawal by Subject|1|||
33644366|NCT01753310|63050021|FG001|Overall Study|Withdrawal by Subject|0|||
33644367|NCT01463631|63050031|FG000|Overall Study|Withdrawal by Subject|0|||
33644368|NCT01463631|63050032|FG001|Overall Study|Withdrawal by Subject|0|||
33644369|NCT01463631|63050033|FG002|Overall Study|Withdrawal by Subject|0|||
33644370|NCT01463631|63050034|FG003|Overall Study|Withdrawal by Subject|1|||
33644371|NCT01463631|63050031|FG000|Overall Study|Death|0|||
33644372|NCT01463631|63050032|FG001|Overall Study|Death|0|||
33644373|NCT01463631|63050033|FG002|Overall Study|Death|1|||
33644374|NCT01463631|63050034|FG003|Overall Study|Death|0|||
33644375|NCT01463631|63050031|FG000|Overall Study|Progressive Disease|0|||
33644376|NCT01463631|63050032|FG001|Overall Study|Progressive Disease|0|||
33644377|NCT01463631|63050033|FG002|Overall Study|Progressive Disease|0|||
33644378|NCT01463631|63050034|FG003|Overall Study|Progressive Disease|5|||
33644379|NCT01521507|63050048|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
33644380|NCT01521507|63050049|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
33644381|NCT01521507|63050048|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
33644382|NCT01521507|63050049|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
33644383|NCT01521507|63050048|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
33644384|NCT01521507|63050049|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
33644385|NCT01521507|63050048|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
33644386|NCT01521507|63050049|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
33644387|NCT01521507|63050048|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
33644388|NCT01521507|63050049|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
33644389|NCT01521507|63050048|FG000|Stage 2: Observational Design|Physician Decision|1|||
33644390|NCT01521507|63050049|FG001|Stage 2: Observational Design|Physician Decision|0|||
33644391|NCT01521117|63050062|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
33644392|NCT01521117|63050063|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
33644393|NCT01521117|63050062|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
33644394|NCT01521117|63050063|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
33644395|NCT01521117|63050062|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
33644396|NCT01521117|63050063|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
33644397|NCT01466595|63050071|FG000|Overall Study|Withdrawal by Subject|0|||
33644398|NCT01466595|63050072|FG001|Overall Study|Withdrawal by Subject|1|||
33644399|NCT01728116|63050089|FG000|Overall Study|Sponsor Terminated Study|106|||
33644400|NCT01728116|63050090|FG001|Overall Study|Sponsor Terminated Study|35|||
33644401|NCT01728116|63050089|FG000|Overall Study|Withdrawal by Subject|16|||
33644402|NCT01728116|63050090|FG001|Overall Study|Withdrawal by Subject|9|||
33644403|NCT01728116|63050089|FG000|Overall Study|Adverse Event|13|||
33644404|NCT01728116|63050090|FG001|Overall Study|Adverse Event|0|||
33644405|NCT01728116|63050089|FG000|Overall Study|Procedure/device failure|7|||
33644406|NCT01728116|63050090|FG001|Overall Study|Procedure/device failure|0|||
33644407|NCT01728116|63050089|FG000|Overall Study|Lost to Follow-up|9|||
33644408|NCT01728116|63050090|FG001|Overall Study|Lost to Follow-up|2|||
33644409|NCT01728116|63050089|FG000|Overall Study|Physician Decision|2|||
33644410|NCT01728116|63050090|FG001|Overall Study|Physician Decision|0|||
33644411|NCT01728116|63050089|FG000|Overall Study|Subject Non-Compliance|2|||
33644412|NCT01728116|63050090|FG001|Overall Study|Subject Non-Compliance|0|||
33644413|NCT01728116|63050089|FG000|Overall Study|Inter-current finding at procedure|1|||
33644414|NCT01728116|63050090|FG001|Overall Study|Inter-current finding at procedure|0|||
33644415|NCT01728116|63050089|FG000|Overall Study|Incorrectly enrolled in Study|0|||
33644416|NCT01728116|63050090|FG001|Overall Study|Incorrectly enrolled in Study|1|||
33644417|NCT01728116|63050089|FG000|Overall Study|various not noted previously|5|||
33644418|NCT01728116|63050090|FG001|Overall Study|various not noted previously|0|||
33644419|NCT01465659|63050101|FG000|Completed 1 Cycle of Treatment|Death|0|||
33644420|NCT01465659|63050102|FG001|Completed 1 Cycle of Treatment|Death|1|||
33644421|NCT01465659|63050103|FG002|Completed 1 Cycle of Treatment|Death|0|||
33644422|NCT01465659|63050104|FG003|Completed 1 Cycle of Treatment|Death|0|||
33644423|NCT01465659|63050101|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
33644424|NCT01465659|63050102|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
33644425|NCT01465659|63050103|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
33644426|NCT01465659|63050104|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
33644427|NCT01465659|63050101|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
33644428|NCT01465659|63050102|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
33644429|NCT01465659|63050103|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
33644430|NCT01465659|63050104|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
33644431|NCT01465659|63050101|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
33644432|NCT01465659|63050102|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
33644433|NCT01465659|63050103|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
33644434|NCT01465659|63050104|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
33644435|NCT01465659|63050101|FG000|Completed Follow for 1 Year|Death|6|||
33644436|NCT01465659|63050102|FG001|Completed Follow for 1 Year|Death|3|||
33644437|NCT01465659|63050103|FG002|Completed Follow for 1 Year|Death|2|||
33644438|NCT01465659|63050104|FG003|Completed Follow for 1 Year|Death|4|||
33644439|NCT01753076|63050119|FG000|Overall Study|Adverse Event|17|||
33644440|NCT01753076|63050120|FG001|Overall Study|Adverse Event|18|||
33644441|NCT01753076|63050119|FG000|Overall Study|Lack of Efficacy|3|||
33644442|NCT01753076|63050120|FG001|Overall Study|Lack of Efficacy|1|||
33644443|NCT01753076|63050119|FG000|Overall Study|Lost to Follow-up|2|||
33644444|NCT01753076|63050120|FG001|Overall Study|Lost to Follow-up|1|||
33644445|NCT01753076|63050119|FG000|Overall Study|Physician Decision|4|||
33644446|NCT01753076|63050120|FG001|Overall Study|Physician Decision|2|||
33542980|NCT03044249|62933661|FG001|Overall Study|Withdrawal by Subject|5|||
33542981|NCT02704130|62933674|FG000|Overall Study|Physician Decision|5|||
33542982|NCT02704130|62933675|FG001|Overall Study|Physician Decision|3|||
33542983|NCT03740009|62933681|FG000|Overall Study|Physician Decision|9|||
33542984|NCT03740009|62933681|FG000|Overall Study|Lost to Follow-up|1|||
33542985|NCT03649217|62933685|FG000|Overall Study|subject had severe ataxia not initially found|1|||
33542986|NCT03649217|62933685|FG000|Overall Study|subject had cognitive issues not initially found|1|||
33542987|NCT03138889|62933714|FG000|Overall Study|Withdrawal by Subject|5|||
33542988|NCT03138889|62933715|FG001|Overall Study|Withdrawal by Subject|5|||
33542989|NCT03138889|62933716|FG002|Overall Study|Withdrawal by Subject|0|||
33542990|NCT03138889|62933717|FG003|Overall Study|Withdrawal by Subject|2|||
33542991|NCT03138889|62933718|FG004|Overall Study|Withdrawal by Subject|1|||
33542992|NCT03138889|62933719|FG005|Overall Study|Withdrawal by Subject|3|||
33542993|NCT03138889|62933720|FG006|Overall Study|Withdrawal by Subject|0|||
33542994|NCT03138889|62933721|FG007|Overall Study|Withdrawal by Subject|1|||
33542995|NCT02706392|62933773|FG000|Overall Study|Death|1|||
33542996|NCT02706392|62933774|FG001|Overall Study|Death|0|||
33542997|NCT02706392|62933775|FG002|Overall Study|Death|2|||
33542998|NCT02706392|62933776|FG003|Overall Study|Death|2|||
33542999|NCT02706392|62933777|FG004|Overall Study|Death|5|||
33543000|NCT02706392|62933778|FG005|Overall Study|Death|2|||
33543001|NCT03042767|62933794|FG000|Overall Study|Lost to Follow-up|1|||
33543002|NCT03042767|62933795|FG001|Overall Study|Lost to Follow-up|2|||
33543003|NCT00703820|62933803|FG000|Overall Study|Adverse Event|12|||
33543004|NCT00703820|62933804|FG001|Overall Study|Adverse Event|17|||
33543005|NCT00703820|62933803|FG000|Overall Study|Death|5|||
33543006|NCT00703820|62933804|FG001|Overall Study|Death|0|||
33644447|NCT01753076|63050119|FG000|Overall Study|Withdrawal by Subject|14|||
33644448|NCT01753076|63050120|FG001|Overall Study|Withdrawal by Subject|24|||
33543007|NCT00703820|62933803|FG000|Overall Study|Lack of Efficacy|11|||
33543008|NCT00703820|62933804|FG001|Overall Study|Lack of Efficacy|11|||
33543009|NCT00703820|62933803|FG000|Overall Study|Received non-protocol therapy|1|||
33543010|NCT00703820|62933804|FG001|Overall Study|Received non-protocol therapy|0|||
33543011|NCT00703820|62933803|FG000|Overall Study|Physician Decision|4|||
33543012|NCT00703820|62933804|FG001|Overall Study|Physician Decision|5|||
33644449|NCT01753076|63050119|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
33644450|NCT01753076|63050120|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
33644451|NCT01463007|63050128|FG000|Overall Study|Physician Decision|1|||
33644452|NCT01462929|63050136|FG000|Overall Study|Adverse Event|3|||
33644453|NCT01462929|63050137|FG001|Overall Study|Adverse Event|3|||
33644454|NCT01462929|63050138|FG002|Overall Study|Adverse Event|4|||
33543013|NCT00703820|62933803|FG000|Overall Study|Withdrawal by Subject|2|||
33543014|NCT00703820|62933804|FG001|Overall Study|Withdrawal by Subject|1|||
33644455|NCT01462929|63050136|FG000|Overall Study|Withdrawal by Subject|2|||
33644456|NCT01462929|63050137|FG001|Overall Study|Withdrawal by Subject|1|||
33644457|NCT01462929|63050138|FG002|Overall Study|Withdrawal by Subject|0|||
33644458|NCT01462929|63050136|FG000|Overall Study|Lack of Efficacy|0|||
33644459|NCT01462929|63050137|FG001|Overall Study|Lack of Efficacy|0|||
33644460|NCT01462929|63050138|FG002|Overall Study|Lack of Efficacy|1|||
33644461|NCT01462695|63050148|FG000|Overall Study|Adverse Event|1|||
33644462|NCT01462695|63050149|FG001|Overall Study|Adverse Event|1|||
33644463|NCT01462695|63050148|FG000|Overall Study|Death|2|||
33644464|NCT01462695|63050149|FG001|Overall Study|Death|0|||
33644465|NCT01462695|63050148|FG000|Overall Study|Lack of Efficacy|6|||
33644466|NCT01462695|63050149|FG001|Overall Study|Lack of Efficacy|12|||
33644467|NCT01462695|63050148|FG000|Overall Study|Physician Decision|5|||
33644468|NCT01462695|63050149|FG001|Overall Study|Physician Decision|0|||
33644469|NCT01462695|63050148|FG000|Overall Study|Withdrawal by Subject|2|||
33644470|NCT01462695|63050149|FG001|Overall Study|Withdrawal by Subject|0|||
33644471|NCT01462695|63050148|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
33644472|NCT01462695|63050149|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
33644473|NCT01465347|63050155|FG000|Overall Study|Withdrawal by Subject|1|||
33644474|NCT01465347|63050156|FG001|Overall Study|Withdrawal by Subject|1|||
33644475|NCT01465347|63050155|FG000|Overall Study|Physician Decision|0|||
33644476|NCT01465347|63050156|FG001|Overall Study|Physician Decision|1|||
33644477|NCT01465347|63050155|FG000|Overall Study|Admitted to hospice|0|||
33644478|NCT01465347|63050156|FG001|Overall Study|Admitted to hospice|1|||
33644479|NCT01465191|63050168|FG000|Overall Study|Protocol Violation|6|||
33644480|NCT01465191|63050169|FG001|Overall Study|Protocol Violation|3|||
33644481|NCT01465191|63050170|FG002|Overall Study|Protocol Violation|3|||
33644482|NCT01465191|63050168|FG000|Overall Study|Lost to Follow-up|3|||
33644483|NCT01465191|63050169|FG001|Overall Study|Lost to Follow-up|6|||
33644484|NCT01465191|63050170|FG002|Overall Study|Lost to Follow-up|4|||
33644485|NCT01519947|63050185|FG000|Overall Study|Death|0|||
33644486|NCT01519947|63050186|FG001|Overall Study|Death|0|||
33644487|NCT01519947|63050187|FG002|Overall Study|Death|0|||
33644488|NCT01519947|63050188|FG003|Overall Study|Death|1|||
33644489|NCT01519947|63050185|FG000|Overall Study|Protocol Violation|0|||
33644490|NCT01519947|63050186|FG001|Overall Study|Protocol Violation|0|||
33644491|NCT01519947|63050187|FG002|Overall Study|Protocol Violation|2|||
33644492|NCT01519947|63050188|FG003|Overall Study|Protocol Violation|1|||
33644493|NCT01519947|63050185|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
33644494|NCT01519947|63050186|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
33644495|NCT01519947|63050187|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
33644496|NCT01519947|63050188|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
33644497|NCT01519947|63050185|FG000|Overall Study|Development of Anemia|0|||
33644498|NCT01519947|63050186|FG001|Overall Study|Development of Anemia|1|||
33644499|NCT01519947|63050187|FG002|Overall Study|Development of Anemia|0|||
33644500|NCT01519947|63050188|FG003|Overall Study|Development of Anemia|1|||
33644501|NCT01519947|63050185|FG000|Overall Study|Blood Transfusion|0|||
33644502|NCT01519947|63050186|FG001|Overall Study|Blood Transfusion|1|||
33644503|NCT01519947|63050187|FG002|Overall Study|Blood Transfusion|1|||
33644504|NCT01519947|63050188|FG003|Overall Study|Blood Transfusion|0|||
33644505|NCT01519947|63050185|FG000|Overall Study|Withdrawal by Subject|0|||
33644506|NCT01519947|63050186|FG001|Overall Study|Withdrawal by Subject|1|||
33644507|NCT01519947|63050187|FG002|Overall Study|Withdrawal by Subject|0|||
33644508|NCT01519947|63050188|FG003|Overall Study|Withdrawal by Subject|1|||
33644509|NCT01519947|63050185|FG000|Overall Study|Lost to Follow-up|0|||
33644510|NCT01519947|63050186|FG001|Overall Study|Lost to Follow-up|0|||
33644511|NCT01519947|63050187|FG002|Overall Study|Lost to Follow-up|3|||
33644512|NCT01519947|63050188|FG003|Overall Study|Lost to Follow-up|2|||
33644513|NCT01519947|63050185|FG000|Overall Study|Poor Response|1|||
33644514|NCT01519947|63050186|FG001|Overall Study|Poor Response|0|||
33644515|NCT01519947|63050187|FG002|Overall Study|Poor Response|0|||
33644516|NCT01519947|63050188|FG003|Overall Study|Poor Response|1|||
33644517|NCT01519947|63050185|FG000|Overall Study|Adverse Event|1|||
33644518|NCT01519947|63050186|FG001|Overall Study|Adverse Event|0|||
33644519|NCT01519947|63050187|FG002|Overall Study|Adverse Event|1|||
33644520|NCT01519947|63050188|FG003|Overall Study|Adverse Event|1|||
33644521|NCT01462227|63050200|FG000|Second Assignment|Lost to Follow-up|1|||
33644522|NCT01462227|63050201|FG001|Second Assignment|Lost to Follow-up|0|||
33644523|NCT01462227|63050202|FG002|Second Assignment|Lost to Follow-up|0|||
33644524|NCT01462227|63050203|FG003|Second Assignment|Lost to Follow-up|0|||
33644525|NCT01462227|63050200|FG000|Second Assignment|Protocol Violation|0|||
33644526|NCT01462227|63050201|FG001|Second Assignment|Protocol Violation|1|||
33644527|NCT01462227|63050202|FG002|Second Assignment|Protocol Violation|1|||
33644528|NCT01462227|63050203|FG003|Second Assignment|Protocol Violation|0|||
33644529|NCT01464879|63050211|FG000|Overall Study|Physician Decision|1|||
33644530|NCT01464879|63050211|FG000|Overall Study|Non-compliance|1|||
33644531|NCT01519869|63050221|FG000|Overall Study|Lost to Follow-up|1|||
33644532|NCT01519791|63050227|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
33644533|NCT01519791|63050228|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
33644534|NCT01519791|63050227|FG000|Overall Study|Protocol Violation|6|||
33644535|NCT01519791|63050228|FG001|Overall Study|Protocol Violation|19|||
33644536|NCT01519791|63050227|FG000|Overall Study|Other Reason|87|||
33644537|NCT01519791|63050228|FG001|Overall Study|Other Reason|222|||
33644538|NCT01519791|63050227|FG000|Overall Study|subjects randomized in error|2|||
33644539|NCT01519791|63050228|FG001|Overall Study|subjects randomized in error|0|||
33644540|NCT01519791|63050227|FG000|Overall Study|Lack of Efficacy|16|||
33644541|NCT01519791|63050228|FG001|Overall Study|Lack of Efficacy|20|||
33644542|NCT01519791|63050227|FG000|Overall Study|SAE, non-fatal|6|||
33644543|NCT01519791|63050228|FG001|Overall Study|SAE, non-fatal|22|||
33644544|NCT01519791|63050227|FG000|Overall Study|AE, serious fatal|0|||
33644545|NCT01519791|63050228|FG001|Overall Study|AE, serious fatal|1|||
33644546|NCT01519791|63050227|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
33644547|NCT01519791|63050228|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
33644548|NCT01519791|63050227|FG000|Overall Study|AE, non-serious non-fatal|12|||
33644549|NCT01519791|63050228|FG001|Overall Study|AE, non-serious non-fatal|31|||
33644550|NCT01519791|63050227|FG000|Overall Study|Withdrawal by Subject|15|||
33644551|NCT01519791|63050228|FG001|Overall Study|Withdrawal by Subject|37|||
33644552|NCT01519791|63050227|FG000|Overall Study|Lost to Follow-up|6|||
33644553|NCT01519791|63050228|FG001|Overall Study|Lost to Follow-up|14|||
33644554|NCT01461993|63050239|FG000|Overall Study|Withdrawal by Subject|60|||
33644555|NCT01461993|63050240|FG001|Overall Study|Withdrawal by Subject|53|||
33644556|NCT01461993|63050241|FG002|Overall Study|Withdrawal by Subject|16|||
33644557|NCT01461993|63050239|FG000|Overall Study|Lost to Follow-up|44|||
33644558|NCT01461993|63050240|FG001|Overall Study|Lost to Follow-up|48|||
33644559|NCT01461993|63050241|FG002|Overall Study|Lost to Follow-up|22|||
33644560|NCT01461993|63050239|FG000|Overall Study|Protocol Violation|10|||
33644561|NCT01461993|63050240|FG001|Overall Study|Protocol Violation|9|||
33644562|NCT01461993|63050241|FG002|Overall Study|Protocol Violation|7|||
33644563|NCT01461993|63050239|FG000|Overall Study|Adverse Event|9|||
33644564|NCT01461993|63050240|FG001|Overall Study|Adverse Event|11|||
33644565|NCT01461993|63050241|FG002|Overall Study|Adverse Event|3|||
33644566|NCT01461993|63050239|FG000|Overall Study|No longer met eligibility criteria|13|||
33644567|NCT01461993|63050240|FG001|Overall Study|No longer met eligibility criteria|18|||
33644568|NCT01461993|63050241|FG002|Overall Study|No longer met eligibility criteria|10|||
33644569|NCT01461993|63050239|FG000|Overall Study|Did not meet entrance criteria|2|||
33644570|NCT01461993|63050240|FG001|Overall Study|Did not meet entrance criteria|3|||
33644571|NCT01461993|63050241|FG002|Overall Study|Did not meet entrance criteria|0|||
33644572|NCT01461993|63050239|FG000|Overall Study|Other|13|||
33644573|NCT01461993|63050240|FG001|Overall Study|Other|15|||
33644574|NCT01461993|63050241|FG002|Overall Study|Other|6|||
33644575|NCT01782326|63050252|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
33644576|NCT01782326|63050253|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
33644577|NCT01782326|63050252|FG000|Planned Treatment Epoch|Death|29|||
33644578|NCT01782326|63050253|FG001|Planned Treatment Epoch|Death|30|||
33644579|NCT01782326|63050252|FG000|Planned Treatment Epoch|Physician Decision|18|||
33644580|NCT01782326|63050253|FG001|Planned Treatment Epoch|Physician Decision|16|||
33644581|NCT01782326|63050252|FG000|Planned Treatment Epoch|Protocol deviation|2|||
33644582|NCT01782326|63050253|FG001|Planned Treatment Epoch|Protocol deviation|3|||
33644583|NCT01782326|63050252|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
33644584|NCT01782326|63050253|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
33644585|NCT01782326|63050252|FG000|Planned Treatment Epoch|Technical problems|0|||
33644586|NCT01782326|63050253|FG001|Planned Treatment Epoch|Technical problems|4|||
33644587|NCT01782326|63050252|FG000|Double-blind Treatment|Adverse Event|129|||
33644588|NCT01782326|63050253|FG001|Double-blind Treatment|Adverse Event|145|||
33644589|NCT01782326|63050252|FG000|Double-blind Treatment|Subject/guardian decision|111|||
33644590|NCT01782326|63050253|FG001|Double-blind Treatment|Subject/guardian decision|125|||
33543015|NCT03045887|62933822|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
33644591|NCT01782326|63050252|FG000|Double-blind Treatment|Lack of Efficacy|17|||
33644592|NCT01782326|63050253|FG001|Double-blind Treatment|Lack of Efficacy|22|||
33644593|NCT01782326|63050252|FG000|Double-blind Treatment|Physician Decision|13|||
33644594|NCT01782326|63050253|FG001|Double-blind Treatment|Physician Decision|16|||
33644595|NCT01782326|63050252|FG000|Double-blind Treatment|Protocol deviation|8|||
33644596|NCT01782326|63050253|FG001|Double-blind Treatment|Protocol deviation|7|||
33644597|NCT01782326|63050252|FG000|Double-blind Treatment|Technical problems|0|||
33644598|NCT01782326|63050253|FG001|Double-blind Treatment|Technical problems|5|||
33644599|NCT01439373|63050261|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
33644600|NCT01439373|63050262|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
33644601|NCT01439373|63050261|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
33644602|NCT01439373|63050262|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
33644603|NCT01461369|63050275|FG000|Overall Study|Lack of Efficacy|2|||
33644604|NCT01461369|63050276|FG001|Overall Study|Lack of Efficacy|0|||
33644605|NCT01461369|63050277|FG002|Overall Study|Lack of Efficacy|6|||
33644606|NCT01461369|63050275|FG000|Overall Study|Lost to Follow-up|0|||
33644607|NCT01461369|63050276|FG001|Overall Study|Lost to Follow-up|0|||
33644608|NCT01461369|63050277|FG002|Overall Study|Lost to Follow-up|3|||
33644609|NCT01461369|63050275|FG000|Overall Study|Adverse Event|9|||
33644610|NCT01461369|63050276|FG001|Overall Study|Adverse Event|12|||
33644611|NCT01461369|63050277|FG002|Overall Study|Adverse Event|4|||
33644612|NCT01461369|63050275|FG000|Overall Study|Protocol Violation|1|||
33644613|NCT01461369|63050276|FG001|Overall Study|Protocol Violation|2|||
33644614|NCT01461369|63050277|FG002|Overall Study|Protocol Violation|2|||
33644615|NCT01461369|63050275|FG000|Overall Study|Withdrawal by Subject|1|||
33644616|NCT01461369|63050276|FG001|Overall Study|Withdrawal by Subject|3|||
33644617|NCT01461369|63050277|FG002|Overall Study|Withdrawal by Subject|2|||
33644618|NCT01727258|63050288|FG000|Overall Study|Adverse Event|0|||
33644619|NCT01727258|63050289|FG001|Overall Study|Adverse Event|2|||
33644620|NCT01727258|63050290|FG002|Overall Study|Adverse Event|0|||
33644621|NCT01727258|63050288|FG000|Overall Study|Noncompliance with Study Drug|0|||
33644622|NCT01727258|63050289|FG001|Overall Study|Noncompliance with Study Drug|0|||
33644623|NCT01727258|63050290|FG002|Overall Study|Noncompliance with Study Drug|1|||
33644624|NCT01727258|63050288|FG000|Overall Study|Withdrawal by Subject|1|||
33644625|NCT01727258|63050289|FG001|Overall Study|Withdrawal by Subject|1|||
33644626|NCT01727258|63050290|FG002|Overall Study|Withdrawal by Subject|0|||
33644627|NCT01727258|63050288|FG000|Overall Study|Lost to Follow-up|1|||
33644628|NCT01727258|63050289|FG001|Overall Study|Lost to Follow-up|0|||
33644629|NCT01727258|63050290|FG002|Overall Study|Lost to Follow-up|0|||
33644630|NCT01781390|63050301|FG000|Overall Study|Withdrawal of Consent|0|||
33644631|NCT01781390|63050302|FG001|Overall Study|Withdrawal of Consent|3|||
33644632|NCT01781390|63050303|FG002|Overall Study|Withdrawal of Consent|1|||
33644633|NCT01781390|63050301|FG000|Overall Study|Lost to Follow-up|1|||
33644634|NCT01781390|63050302|FG001|Overall Study|Lost to Follow-up|1|||
33644635|NCT01781390|63050303|FG002|Overall Study|Lost to Follow-up|1|||
33644636|NCT01781390|63050301|FG000|Overall Study|Adverse Event|1|||
33644637|NCT01781390|63050302|FG001|Overall Study|Adverse Event|2|||
33644638|NCT01781390|63050303|FG002|Overall Study|Adverse Event|1|||
33644639|NCT01781390|63050301|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
33644640|NCT01781390|63050302|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
33644641|NCT01781390|63050303|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
33644642|NCT01781234|63050313|FG000|Overall Study|Adverse Event|2|||
33644643|NCT01781234|63050314|FG001|Overall Study|Adverse Event|0|||
33644644|NCT01781234|63050313|FG000|Overall Study|Protocol Violation|3|||
33644645|NCT01781234|63050314|FG001|Overall Study|Protocol Violation|0|||
33644646|NCT01781234|63050313|FG000|Overall Study|Withdrawal by Subject|4|||
33644647|NCT01781234|63050314|FG001|Overall Study|Withdrawal by Subject|3|||
33644648|NCT01752842|63050324|FG000|Overall Study|Adverse Event|3|||
33644649|NCT01752842|63050325|FG001|Overall Study|Adverse Event|0|||
33644650|NCT01752842|63050324|FG000|Overall Study|Withdrawal by Subject|0|||
33644651|NCT01752842|63050325|FG001|Overall Study|Withdrawal by Subject|2|||
33644652|NCT01461057|63050333|FG000|Overall Study|Death|10|||
33644653|NCT01461057|63050334|FG001|Overall Study|Death|9|||
33644654|NCT01461057|63050333|FG000|Overall Study|Withdrawal by Subject|2|||
33644655|NCT01461057|63050334|FG001|Overall Study|Withdrawal by Subject|3|||
33644656|NCT01461057|63050333|FG000|Overall Study|Physician Decision|0|||
33644657|NCT01461057|63050334|FG001|Overall Study|Physician Decision|2|||
33644658|NCT01461057|63050333|FG000|Overall Study|Adverse Event|0|||
33644659|NCT01461057|63050334|FG001|Overall Study|Adverse Event|1|||
33644660|NCT01461057|63050333|FG000|Overall Study|Progression of Disease|1|||
33644661|NCT01461057|63050334|FG001|Overall Study|Progression of Disease|0|||
33644662|NCT01461057|63050333|FG000|Overall Study|Study Terminated by Sponsor|2|||
33644663|NCT01461057|63050334|FG001|Overall Study|Study Terminated by Sponsor|0|||
33644664|NCT01460901|63050340|FG000|Overall Study|Withdrawal by Subject|2|||
33644665|NCT01519635|63050349|FG000|Overall Study|Withdrawal by Subject|0|||
33644666|NCT01519635|63050350|FG001|Overall Study|Withdrawal by Subject|1|||
33644667|NCT01519635|63050349|FG000|Overall Study|No possibility to put a catheter|1|||
33644668|NCT01519635|63050350|FG001|Overall Study|No possibility to put a catheter|2|||
33644669|NCT01519323|63050356|FG000|Overall Study|Death|3|||
33644670|NCT01519323|63050357|FG001|Overall Study|Death|2|||
33644671|NCT01519323|63050356|FG000|Overall Study|Study terminated by sponsor|0|||
33644672|NCT01519323|63050357|FG001|Overall Study|Study terminated by sponsor|1|||
33644673|NCT01519245|63050365|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
33644674|NCT01519245|63050366|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
33644675|NCT01519167|63050376|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
33644676|NCT01519167|63050377|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
33644677|NCT01519167|63050376|FG000|Overall Study|Adverse Event|0|||
33644678|NCT01519167|63050377|FG001|Overall Study|Adverse Event|1|||
33644679|NCT01519167|63050376|FG000|Overall Study|Lack of Efficacy|0|||
33644680|NCT01519167|63050377|FG001|Overall Study|Lack of Efficacy|1|||
33644681|NCT01519167|63050376|FG000|Overall Study|Medical condition changes&deep sedation|0|||
33644682|NCT01519167|63050377|FG001|Overall Study|Medical condition changes&deep sedation|2|||
33644683|NCT01519167|63050376|FG000|Overall Study|Physician Decision|0|||
33644684|NCT01519167|63050377|FG001|Overall Study|Physician Decision|1|||
33644685|NCT01519089|63050618|FG000|Overall Study|Adverse Event|4|||
33644686|NCT01519089|63050619|FG001|Overall Study|Adverse Event|4|||
33644687|NCT01519089|63050618|FG000|Overall Study|Lack of Efficacy|0|||
33644688|NCT01519089|63050619|FG001|Overall Study|Lack of Efficacy|2|||
33644689|NCT01519089|63050618|FG000|Overall Study|Lost to Follow-up|1|||
33644690|NCT01519089|63050619|FG001|Overall Study|Lost to Follow-up|0|||
33644691|NCT01519089|63050618|FG000|Overall Study|Withdrawal by Subject|0|||
33644692|NCT01519089|63050619|FG001|Overall Study|Withdrawal by Subject|2|||
33644693|NCT01519089|63050618|FG000|Overall Study|Other|2|||
33644694|NCT01519089|63050619|FG001|Overall Study|Other|6|||
33644695|NCT01519089|63050618|FG000|Overall Study|Not received study drug|0|||
33644696|NCT01519089|63050619|FG001|Overall Study|Not received study drug|1|||
33644697|NCT01518699|63050641|FG000|Period 2|Protocol Violation|1|||
33644698|NCT01518699|63050642|FG001|Period 2|Protocol Violation|1|||
33644699|NCT01518699|63050643|FG002|Period 2|Protocol Violation|0|||
33644700|NCT01518699|63050644|FG003|Period 2|Protocol Violation|0|||
33644701|NCT01518699|63050645|FG004|Period 2|Protocol Violation|0|||
33644702|NCT01518699|63050646|FG005|Period 2|Protocol Violation|0|||
33644703|NCT01518699|63050641|FG000|Period 2|Lost to Follow-up|0|||
33644704|NCT01518699|63050642|FG001|Period 2|Lost to Follow-up|1|||
33644705|NCT01518699|63050643|FG002|Period 2|Lost to Follow-up|0|||
33644706|NCT01518699|63050644|FG003|Period 2|Lost to Follow-up|0|||
33644707|NCT01518699|63050645|FG004|Period 2|Lost to Follow-up|0|||
33644708|NCT01518699|63050646|FG005|Period 2|Lost to Follow-up|0|||
33644709|NCT01518699|63050641|FG000|Period 2|Adverse Event|1|||
33644710|NCT01518699|63050642|FG001|Period 2|Adverse Event|0|||
33644711|NCT01518699|63050643|FG002|Period 2|Adverse Event|0|||
33644712|NCT01518699|63050644|FG003|Period 2|Adverse Event|0|||
33644713|NCT01518699|63050645|FG004|Period 2|Adverse Event|0|||
33644714|NCT01518699|63050646|FG005|Period 2|Adverse Event|0|||
33644715|NCT01518309|63050654|FG000|Overall Study|Adverse Event|6|||
33644716|NCT01518309|63050654|FG000|Overall Study|Death|6|||
33644717|NCT01518309|63050654|FG000|Overall Study|Lack of Efficacy|7|||
33644718|NCT01518309|63050654|FG000|Overall Study|Withdrawal by Subject|6|||
33644719|NCT01518309|63050654|FG000|Overall Study|Physician Decision|3|||
33644720|NCT01518309|63050654|FG000|Overall Study|Sponsor Decision|2|||
33644721|NCT01518309|63050654|FG000|Overall Study|Not in Predefined Categories|9|||
33644722|NCT01419717|63050658|FG000|Overall Study|Protocol-specified Criteria|62|||
33644723|NCT01419717|63050658|FG000|Overall Study|Adverse Event|19|||
33644724|NCT01419717|63050658|FG000|Overall Study|Death|17|||
33644725|NCT01419717|63050658|FG000|Overall Study|Withdrawal by Subject|10|||
33644726|NCT01419717|63050658|FG000|Overall Study|Disease Progression|9|||
33644727|NCT01419717|63050658|FG000|Overall Study|Other|4|||
33644728|NCT01419717|63050658|FG000|Overall Study|Lost to Follow-up|2|||
33644729|NCT01419717|63050658|FG000|Overall Study|Administrative Decision|1|||
33644730|NCT01419717|63050658|FG000|Overall Study|Noncompliance|1|||
33644731|NCT01458951|63050665|FG000|Overall Study|Other|1|||
33644732|NCT01458951|63050666|FG001|Overall Study|Other|0|||
33644733|NCT01458951|63050667|FG002|Overall Study|Other|0|||
33644734|NCT01458951|63050665|FG000|Overall Study|Protocol Violation|5|||
33644735|NCT01458951|63050666|FG001|Overall Study|Protocol Violation|1|||
33644736|NCT01458951|63050667|FG002|Overall Study|Protocol Violation|0|||
33644737|NCT01458951|63050665|FG000|Overall Study|Withdrawal by Subject|2|||
33644738|NCT01458951|63050666|FG001|Overall Study|Withdrawal by Subject|0|||
33644739|NCT01458951|63050667|FG002|Overall Study|Withdrawal by Subject|2|||
33644740|NCT01458951|63050665|FG000|Overall Study|Adverse Event|7|||
33644741|NCT01458951|63050666|FG001|Overall Study|Adverse Event|0|||
33644742|NCT01458951|63050667|FG002|Overall Study|Adverse Event|2|||
33644743|NCT01458951|63050665|FG000|Overall Study|Insufficient Clinical Response|17|||
33644744|NCT01458951|63050666|FG001|Overall Study|Insufficient Clinical Response|0|||
33644745|NCT01458951|63050667|FG002|Overall Study|Insufficient Clinical Response|11|||
33644746|NCT01458639|63050674|FG000|Overall Study|Physician Decision|4|||
33644747|NCT01458639|63050674|FG000|Overall Study|Equipment issue|1|||
33644748|NCT01458639|63050674|FG000|Overall Study|Inability to obtain subject blood sample|1|||
33644749|NCT01437423|63050678|FG000|Overall Study|Lost to Follow-up|12|||
33644750|NCT01437423|63050678|FG000|Overall Study|Off label usage|3|||
33644751|NCT01458249|63050709|FG000|Overall Study|Not treated|1|||
33644752|NCT01458249|63050709|FG000|Overall Study|Adverse Event|4|||
33644753|NCT01458249|63050709|FG000|Overall Study|Other|2|||
33644754|NCT01458249|63050709|FG000|Overall Study|Ongoing|1|||
33644755|NCT01458171|63050725|FG000|Overall Study|Adverse Event|1|||
33644756|NCT01457703|63050742|FG000|Overall Study|Screen Failure|5|||
33644757|NCT01457703|63050743|FG001|Overall Study|Screen Failure|7|||
33644758|NCT01457703|63050742|FG000|Overall Study|Withdrawal by Subject|1|||
33644759|NCT01457703|63050743|FG001|Overall Study|Withdrawal by Subject|4|||
33644760|NCT01419015|63050761|FG000|Overall Study|Death|2|||
33644761|NCT01418937|63050782|FG000|Overall Study|Lost to Follow-up|5|||
33644762|NCT01418937|63050782|FG000|Overall Study|Protocol Violation|1|||
33644763|NCT01418937|63050782|FG000|Overall Study|Pregnancy|1|||
33644764|NCT01418937|63050782|FG000|Overall Study|Withdrawal by Subject|1|||
33644765|NCT01417377|63050795|FG000|Overall Study|Lost to Follow-up|12|||
33644766|NCT01417377|63050795|FG000|Overall Study|Enrolled, but not treated|1|||
33644767|NCT01437267|63050842|FG000|Overall Study|Withdrawal by Subject|0|||
33644768|NCT01437267|63050843|FG001|Overall Study|Withdrawal by Subject|0|||
33644769|NCT01437267|63050844|FG002|Overall Study|Withdrawal by Subject|0|||
33644770|NCT01437267|63050845|FG003|Overall Study|Withdrawal by Subject|1|||
33644771|NCT01437267|63050846|FG004|Overall Study|Withdrawal by Subject|0|||
33644772|NCT01437267|63050847|FG005|Overall Study|Withdrawal by Subject|0|||
33644773|NCT01437267|63050842|FG000|Overall Study|Protocol Violation|0|||
33644774|NCT01437267|63050843|FG001|Overall Study|Protocol Violation|1|||
33644775|NCT01437267|63050844|FG002|Overall Study|Protocol Violation|0|||
33644776|NCT01437267|63050845|FG003|Overall Study|Protocol Violation|0|||
33644777|NCT01437267|63050846|FG004|Overall Study|Protocol Violation|0|||
33644778|NCT01437267|63050847|FG005|Overall Study|Protocol Violation|0|||
33644779|NCT01456221|63050876|FG000|Overall Study|Withdrawal by Subject|56|||
33644780|NCT01456221|63050877|FG001|Overall Study|Withdrawal by Subject|49|||
33644781|NCT01456221|63050876|FG000|Overall Study|Lost to Follow-up|1|||
33644782|NCT01456221|63050877|FG001|Overall Study|Lost to Follow-up|4|||
33644783|NCT01456221|63050876|FG000|Overall Study|Received medication|3|||
33644784|NCT01456221|63050877|FG001|Overall Study|Received medication|2|||
33644785|NCT01456221|63050876|FG000|Overall Study|Incomplete data|4|||
33644786|NCT01456221|63050877|FG001|Overall Study|Incomplete data|2|||
33644787|NCT01437111|63050883|FG000|Overall Study|Adverse Event|2|||
33644788|NCT01437111|63050883|FG000|Overall Study|Withdrawal by Subject|4|||
33644789|NCT01437111|63050883|FG000|Overall Study|Not reported|5|||
33644790|NCT01437111|63050883|FG000|Overall Study|Physician Decision|1|||
33644791|NCT01437111|63050883|FG000|Overall Study|Lost to Follow-up|5|||
33644792|NCT01437111|63050883|FG000|Overall Study|Protocol Violation|1|||
33644793|NCT01436643|63050931|FG000|2-week Pre-treatment|Abnormal test result|0|||
33644794|NCT01436643|63050932|FG001|2-week Pre-treatment|Abnormal test result|0|||
33644795|NCT01436643|63050933|FG002|2-week Pre-treatment|Abnormal test result|0|||
33644796|NCT01436643|63050934|FG003|2-week Pre-treatment|Abnormal test result|1|||
33644797|NCT01436643|63050931|FG000|2-week Pre-treatment|Adverse Event|0|||
33644798|NCT01436643|63050932|FG001|2-week Pre-treatment|Adverse Event|0|||
33644799|NCT01436643|63050933|FG002|2-week Pre-treatment|Adverse Event|0|||
33644800|NCT01436643|63050934|FG003|2-week Pre-treatment|Adverse Event|5|||
33644801|NCT01436643|63050931|FG000|2-week Pre-treatment|Protocol Violation|0|||
33644802|NCT01436643|63050932|FG001|2-week Pre-treatment|Protocol Violation|0|||
33644803|NCT01436643|63050933|FG002|2-week Pre-treatment|Protocol Violation|0|||
33644804|NCT01436643|63050934|FG003|2-week Pre-treatment|Protocol Violation|4|||
33644805|NCT01436643|63050931|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
33644806|NCT01436643|63050932|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
33644807|NCT01436643|63050933|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
33644808|NCT01436643|63050934|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
33644809|NCT01436643|63050931|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
33644810|NCT01436643|63050932|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
33644811|NCT01436643|63050933|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
33644812|NCT01436643|63050934|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
33644813|NCT01436643|63050931|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
33644814|NCT01436643|63050932|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
33644815|NCT01436643|63050933|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
33644816|NCT01436643|63050934|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
33644817|NCT01454739|63051032|FG000|Overall Study|Protocol Violation|2|||
33644818|NCT01454739|63051033|FG001|Overall Study|Protocol Violation|3|||
33644819|NCT01454739|63051032|FG000|Overall Study|Withdrawal by Subject|2|||
33644820|NCT01454739|63051033|FG001|Overall Study|Withdrawal by Subject|6|||
33644821|NCT01454739|63051032|FG000|Overall Study|Other|3|||
33644822|NCT01454739|63051033|FG001|Overall Study|Other|5|||
33644823|NCT01454739|63051032|FG000|Overall Study|Physician Decision|0|||
33644824|NCT01454739|63051033|FG001|Overall Study|Physician Decision|5|||
33644825|NCT01454739|63051032|FG000|Overall Study|Lost to Follow-up|0|||
33644826|NCT01454739|63051033|FG001|Overall Study|Lost to Follow-up|1|||
33644827|NCT01454739|63051032|FG000|Overall Study|Adverse Event|0|||
33644828|NCT01454739|63051033|FG001|Overall Study|Adverse Event|1|||
33644829|NCT01416441|63051071|FG000|Overall Study|Lost to Follow-up|5|||
33644830|NCT01416441|63051071|FG000|Overall Study|Adverse Event|6|||
33644831|NCT01416441|63051071|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
33644832|NCT01416441|63051071|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
33644833|NCT01416441|63051071|FG000|Overall Study|Investigator Withdrew Subject|2|||
33644834|NCT01416441|63051071|FG000|Overall Study|Subject Withdrew Consent|12|||
33644835|NCT01416441|63051071|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
33644836|NCT01436253|63051080|FG000|Overall Study|Lost to Follow-up|182|||
33644837|NCT01436253|63051080|FG000|Overall Study|Not meeting all eligibility criteria|117|||
33644838|NCT01454583|63051993|FG000|1st Year|Lost to Follow-up|1057|||
33644839|NCT01454583|63051994|FG001|1st Year|Lost to Follow-up|318|||
33644840|NCT01454583|63051995|FG002|1st Year|Lost to Follow-up|180|||
33644841|NCT01454583|63051993|FG000|2nd Year|Lost to Follow-up|3965|||
33644842|NCT01454583|63051994|FG001|2nd Year|Lost to Follow-up|1049|||
33644843|NCT01454583|63051995|FG002|2nd Year|Lost to Follow-up|737|||
33644844|NCT01454583|63051993|FG000|3rd Year|Lost to Follow-up|1959|||
33644845|NCT01454583|63051994|FG001|3rd Year|Lost to Follow-up|512|||
33644846|NCT01454583|63051995|FG002|3rd Year|Lost to Follow-up|297|||
33644847|NCT01436175|63052018|FG000|Overall Study|Adverse Event|111|||
33644848|NCT01436175|63052018|FG000|Overall Study|Protocol Violation|49|||
33644849|NCT01436175|63052018|FG000|Overall Study|Withdrawal by Subject|108|||
33644850|NCT01436175|63052018|FG000|Overall Study|Lost to Follow-up|89|||
33644851|NCT01436175|63052018|FG000|Overall Study|Lack of Efficacy|24|||
33644852|NCT01436175|63052018|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
33644853|NCT01436175|63052018|FG000|Overall Study|Other|826|||
33644854|NCT01453725|63052046|FG000|Overall Study|Adverse Event|3|||
33644855|NCT01453725|63052047|FG001|Overall Study|Adverse Event|3|||
33644856|NCT01453725|63052046|FG000|Overall Study|Lost to Follow-up|4|||
33644857|NCT01453725|63052047|FG001|Overall Study|Lost to Follow-up|0|||
33644858|NCT01453725|63052046|FG000|Overall Study|Non-compliance With Protocol|1|||
33644859|NCT01453725|63052047|FG001|Overall Study|Non-compliance With Protocol|2|||
33644860|NCT01453725|63052046|FG000|Overall Study|Protocol Violation|1|||
33644861|NCT01453725|63052047|FG001|Overall Study|Protocol Violation|0|||
33644862|NCT01453725|63052046|FG000|Overall Study|Withdrawal by Subject|2|||
33644863|NCT01453725|63052047|FG001|Overall Study|Withdrawal by Subject|3|||
33644864|NCT01453725|63052046|FG000|Overall Study|Pregnancy Wish|0|||
33644865|NCT01453725|63052047|FG001|Overall Study|Pregnancy Wish|2|||
33644866|NCT01453725|63052046|FG000|Overall Study|Pregnancy|1|||
33644867|NCT01453725|63052047|FG001|Overall Study|Pregnancy|0|||
33644868|NCT01453725|63052046|FG000|Overall Study|Physician Decision|1|||
33644869|NCT01453725|63052047|FG001|Overall Study|Physician Decision|1|||
33644870|NCT01415349|63052086|FG000|Treatment Period 1|Adverse Event|0|||
33644871|NCT01415349|63052087|FG001|Treatment Period 1|Adverse Event|1|||
33644872|NCT01415349|63052086|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33644873|NCT01415349|63052087|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33644874|NCT01453023|63052141|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
33644875|NCT01453023|63052142|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
33644876|NCT01453023|63052141|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
33644877|NCT01453023|63052142|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
33644878|NCT01453023|63052141|FG000|Treatment Period 2|Protocol Violation|0|||
33644879|NCT01453023|63052142|FG001|Treatment Period 2|Protocol Violation|1|||
33644880|NCT01452789|63052150|FG000|Overall Study|Withdrawal by Subject|3|||
33644881|NCT01452789|63052151|FG001|Overall Study|Withdrawal by Subject|2|||
33644882|NCT01451931|63052160|FG000|Overall Study|Lost to Follow-up|17|||
33644883|NCT01451931|63052161|FG001|Overall Study|Lost to Follow-up|36|||
33644884|NCT01451931|63052162|FG002|Overall Study|Lost to Follow-up|21|||
33644885|NCT01451931|63052160|FG000|Overall Study|Withdrawal by Subject|16|||
33644886|NCT01451931|63052161|FG001|Overall Study|Withdrawal by Subject|22|||
33644887|NCT01451931|63052162|FG002|Overall Study|Withdrawal by Subject|22|||
33644888|NCT01414257|63052185|FG000|Overall Study|No Visit After First Day of Treatment|12|||
33644889|NCT01414257|63052185|FG000|Overall Study|Protocol Violation|10|||
33644890|NCT01434693|63052228|FG000|Overall Study|Adverse Event|1|||
33644891|NCT01434693|63052229|FG001|Overall Study|Adverse Event|0|||
33644892|NCT01434693|63052230|FG002|Overall Study|Adverse Event|0|||
33644893|NCT01434693|63052231|FG003|Overall Study|Adverse Event|0|||
33644894|NCT01434693|63052228|FG000|Overall Study|Withdrawal by Subject|1|||
33463436|NCT00048074|62836937|FG002|Overall Study|Study participation was terminated|0|||
33644895|NCT01434693|63052229|FG001|Overall Study|Withdrawal by Subject|0|||
33644896|NCT01434693|63052230|FG002|Overall Study|Withdrawal by Subject|1|||
33644897|NCT01434693|63052231|FG003|Overall Study|Withdrawal by Subject|1|||
33644898|NCT01434693|63052228|FG000|Overall Study|Lost to Follow-up|1|||
33463437|NCT00048074|62836935|FG000|Overall Study|Husband ill|0|||
33644899|NCT01434693|63052229|FG001|Overall Study|Lost to Follow-up|0|||
33644900|NCT01434693|63052230|FG002|Overall Study|Lost to Follow-up|0|||
33644901|NCT01434693|63052231|FG003|Overall Study|Lost to Follow-up|0|||
33644902|NCT01451541|63052248|FG000|Overall Study|Adverse Event|4|||
33644903|NCT01451541|63052249|FG001|Overall Study|Adverse Event|3|||
33644904|NCT01451541|63052250|FG002|Overall Study|Adverse Event|6|||
33644905|NCT01451541|63052248|FG000|Overall Study|Lack of Efficacy|2|||
33644906|NCT01451541|63052249|FG001|Overall Study|Lack of Efficacy|0|||
33644907|NCT01451541|63052250|FG002|Overall Study|Lack of Efficacy|0|||
33644908|NCT01451541|63052248|FG000|Overall Study|Lost to Follow-up|4|||
33644909|NCT01451541|63052249|FG001|Overall Study|Lost to Follow-up|4|||
33644910|NCT01451541|63052250|FG002|Overall Study|Lost to Follow-up|7|||
33644911|NCT01451541|63052248|FG000|Overall Study|Withdrawal by Subject|15|||
33644912|NCT01451541|63052249|FG001|Overall Study|Withdrawal by Subject|8|||
33644913|NCT01451541|63052250|FG002|Overall Study|Withdrawal by Subject|6|||
33644914|NCT01451541|63052248|FG000|Overall Study|randomization error, noncompliance|11|||
33644915|NCT01451541|63052249|FG001|Overall Study|randomization error, noncompliance|10|||
33644916|NCT01451541|63052250|FG002|Overall Study|randomization error, noncompliance|8|||
33644917|NCT01450761|63052378|FG000|Randomization|Subject no longer meets study criteria|1|||
33644918|NCT01450761|63052379|FG001|Randomization|Subject no longer meets study criteria|2|||
33644919|NCT01450761|63052378|FG000|Randomization|Withdrawal by Subject|2|||
33644920|NCT01450761|63052379|FG001|Randomization|Withdrawal by Subject|0|||
33644921|NCT01450761|63052378|FG000|Randomization|Disease progression|0|||
33644922|NCT01450761|63052379|FG001|Randomization|Disease progression|2|||
33644923|NCT01450761|63052378|FG000|Randomization|Adverse Event unrelated to study drug|1|||
33644924|NCT01450761|63052379|FG001|Randomization|Adverse Event unrelated to study drug|0|||
33644925|NCT01450761|63052378|FG000|Randomization|Other|0|||
33644926|NCT01450761|63052379|FG001|Randomization|Other|1|||
33644927|NCT01450761|63052378|FG000|Lead-in Chemotherapy|Disease progression|33|||
33644928|NCT01450761|63052379|FG001|Lead-in Chemotherapy|Disease progression|32|||
33644929|NCT01450761|63052378|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
33644930|NCT01450761|63052379|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
33644931|NCT01450761|63052378|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
33644932|NCT01450761|63052379|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
33644933|NCT01450761|63052378|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
33644934|NCT01450761|63052379|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
33644935|NCT01450761|63052378|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
33644936|NCT01450761|63052379|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
33644937|NCT01450761|63052378|FG000|Lead-in Chemotherapy|Death|3|||
33644938|NCT01450761|63052379|FG001|Lead-in Chemotherapy|Death|3|||
33644939|NCT01450761|63052378|FG000|Lead-in Chemotherapy|Other|2|||
33463438|NCT00048074|62836936|FG001|Overall Study|Husband ill|1|||
33463439|NCT00048074|62836937|FG002|Overall Study|Husband ill|0|||
33463440|NCT00048074|62836935|FG000|Overall Study|Poor compliance|0|||
33463441|NCT00048074|62836936|FG001|Overall Study|Poor compliance|1|||
33463442|NCT00048074|62836937|FG002|Overall Study|Poor compliance|0|||
33463443|NCT00048074|62836935|FG000|Overall Study|Out of station|0|||
33463444|NCT00048074|62836936|FG001|Overall Study|Out of station|1|||
33463445|NCT00048074|62836937|FG002|Overall Study|Out of station|1|||
33463446|NCT00048074|62836935|FG000|Overall Study|Social reasons|1|||
33463447|NCT00048074|62836936|FG001|Overall Study|Social reasons|0|||
33543016|NCT03045887|62933823|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33543017|NCT03045887|62933824|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33543018|NCT03045887|62933825|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33543019|NCT03045887|62933826|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33543020|NCT03045887|62933827|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33543021|NCT03045887|62933828|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33543022|NCT03045887|62933829|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33543023|NCT03045887|62933830|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33543024|NCT03045887|62933831|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33543025|NCT03045887|62933822|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33543026|NCT03045887|62933823|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33543027|NCT03045887|62933824|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33543028|NCT03045887|62933825|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
33543029|NCT03045887|62933826|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33543030|NCT03045887|62933827|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33543031|NCT03045887|62933828|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33543032|NCT03045887|62933829|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33543033|NCT03045887|62933830|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33543034|NCT03045887|62933831|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33463448|NCT00048074|62836937|FG002|Overall Study|Social reasons|0|||
33644940|NCT01450761|63052379|FG001|Lead-in Chemotherapy|Other|2|||
33644941|NCT01450761|63052378|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
33644942|NCT01450761|63052379|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
33644943|NCT01450761|63052378|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
33644944|NCT01450761|63052379|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
33644945|NCT01450761|63052378|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
33644946|NCT01450761|63052379|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
33644947|NCT01450761|63052378|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
33644948|NCT01450761|63052379|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
33644949|NCT01450761|63052378|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
33644950|NCT01450761|63052379|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
33644951|NCT01450761|63052378|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
33644952|NCT01450761|63052379|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
33644953|NCT01450761|63052378|FG000|Treatment With Blinded Study Therapy|Death|5|||
33644954|NCT01450761|63052379|FG001|Treatment With Blinded Study Therapy|Death|6|||
33644955|NCT01450761|63052378|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
33644956|NCT01450761|63052379|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
33644957|NCT01450761|63052378|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
33644958|NCT01450761|63052379|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
33644959|NCT01450761|63052378|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
33644960|NCT01450761|63052379|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
33644961|NCT01450761|63052378|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
33644962|NCT01450761|63052379|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
33644963|NCT01450761|63052378|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
33644964|NCT01450761|63052379|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
33644965|NCT01450761|63052378|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
33644966|NCT01450761|63052379|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
33644967|NCT01450761|63052378|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
33644968|NCT01450761|63052379|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
33644969|NCT01433991|63052429|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
33644970|NCT01433991|63052430|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
33644971|NCT01433991|63052431|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
33644972|NCT01433991|63052432|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
33644973|NCT01433991|63052429|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
33644974|NCT01433991|63052430|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
33644975|NCT01433991|63052431|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
33644976|NCT01433991|63052432|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
33644977|NCT01433991|63052429|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
33644978|NCT01433991|63052430|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
33644979|NCT01433991|63052431|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
33644980|NCT01433991|63052432|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
33644981|NCT01433991|63052429|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
33644982|NCT01433991|63052430|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
33644983|NCT01433991|63052431|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
33644984|NCT01433991|63052432|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
33644985|NCT01433991|63052429|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
33644986|NCT01433991|63052430|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
33644987|NCT01433991|63052431|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
33644988|NCT01433991|63052432|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
33644989|NCT01433991|63052429|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
33644990|NCT01433991|63052430|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
33644991|NCT01433991|63052431|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
33644992|NCT01433991|63052432|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
33644993|NCT01433991|63052429|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
33644994|NCT01433991|63052430|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
33644995|NCT01433991|63052431|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
33644996|NCT01433991|63052432|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
33644997|NCT01450683|63052448|FG000|Overall Study|Adverse Event|2|||
33644998|NCT01433055|63052454|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
33644999|NCT01433055|63052455|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
33645000|NCT01433055|63052454|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
33645001|NCT01433055|63052455|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
33645002|NCT01450137|63052463|FG000|Up to Week 12|Adverse Event|2|||
33645003|NCT01450137|63052464|FG001|Up to Week 12|Adverse Event|1|||
33645004|NCT01450137|63052463|FG000|Up to Week 12|Withdrawal by Subject|0|||
33645005|NCT01450137|63052464|FG001|Up to Week 12|Withdrawal by Subject|2|||
33645006|NCT01450137|63052463|FG000|Week 12 to Study End|Death|0|||
33645007|NCT01450137|63052464|FG001|Week 12 to Study End|Death|1|||
33645008|NCT01450137|63052463|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
33645009|NCT01450137|63052464|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
33645010|NCT01412229|63052470|FG000|Overall Study|Physician Decision|1|||
33645011|NCT01412151|63052475|FG000|Week 0 - 306 - Treatment Period|Death|1|||
33645012|NCT01412151|63052475|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
33645013|NCT01412151|63052475|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
33645014|NCT01412151|63052475|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
33645015|NCT01432275|63052481|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
33645016|NCT01432275|63052482|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
33645017|NCT01432275|63052481|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
33645018|NCT01432275|63052482|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
33645019|NCT01432275|63052481|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
33645020|NCT01432275|63052482|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
33645021|NCT01432275|63052481|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
33645022|NCT01432275|63052482|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
33645023|NCT01432275|63052481|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
33645024|NCT01432275|63052482|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
33645025|NCT01432275|63052481|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
33645026|NCT01432275|63052482|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
33645027|NCT01432275|63052481|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
33645028|NCT01432275|63052482|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
33645029|NCT01432275|63052481|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
33645030|NCT01432275|63052482|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
33645031|NCT01432275|63052481|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
33645032|NCT01432275|63052482|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
33645033|NCT01411995|63052490|FG000|Overall Study|Failed IUD insertion|0|||
33645034|NCT01411995|63052491|FG001|Overall Study|Failed IUD insertion|1|||
33463449|NCT03831191|62836949|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
33463450|NCT03831191|62836950|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
33463451|NCT03831191|62836951|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
33463452|NCT03831191|62836952|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
33463453|NCT03831191|62836953|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
33463454|NCT03831191|62836954|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
33463455|NCT03831191|62836955|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
33463456|NCT03831191|62836956|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
33463457|NCT03831191|62836957|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
33463458|NCT03831191|62836958|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
33463459|NCT03831191|62836959|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
33463460|NCT03831191|62836960|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
33463461|NCT03831191|62836961|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
33463462|NCT03831191|62836962|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
33463463|NCT03831191|62836963|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
33463464|NCT03831191|62836949|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
33463465|NCT03831191|62836950|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
33463466|NCT03831191|62836951|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33463467|NCT03831191|62836952|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33463468|NCT03831191|62836953|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33543035|NCT03045887|62933822|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
33543036|NCT03045887|62933823|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
33543037|NCT03045887|62933824|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
33543038|NCT03045887|62933825|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
33543039|NCT03045887|62933826|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
33543040|NCT03045887|62933827|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
33543041|NCT03045887|62933828|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
33543042|NCT03045887|62933829|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
33543043|NCT03045887|62933830|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
33543044|NCT03045887|62933831|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
33543045|NCT03045887|62933822|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33543046|NCT03045887|62933823|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33543047|NCT03045887|62933824|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
33543048|NCT03045887|62933825|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
33543049|NCT03045887|62933826|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33543050|NCT03045887|62933827|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33543051|NCT03045887|62933828|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33645035|NCT01411917|63052499|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
33463469|NCT03831191|62836954|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33463470|NCT03831191|62836955|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33645036|NCT01411917|63052500|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
33463471|NCT03831191|62836956|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33543052|NCT03045887|62933829|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33543053|NCT03045887|62933830|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33543054|NCT03045887|62933831|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33463472|NCT03831191|62836957|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33645037|NCT01411839|63052508|FG000|Overall Study|Lost to Follow-up|4|||
33645038|NCT01411839|63052509|FG001|Overall Study|Lost to Follow-up|3|||
33645039|NCT01411215|63052517|FG000|Overall Study|Adverse Event|1|||
33645040|NCT01411215|63052518|FG001|Overall Study|Adverse Event|2|||
33645041|NCT01411215|63052517|FG000|Overall Study|Lack of Efficacy|2|||
33645042|NCT01411215|63052518|FG001|Overall Study|Lack of Efficacy|4|||
33645043|NCT01411215|63052517|FG000|Overall Study|Lost to Follow-up|12|||
33645044|NCT01411215|63052518|FG001|Overall Study|Lost to Follow-up|18|||
33645045|NCT01411215|63052517|FG000|Overall Study|Did not meet entrance criteria|0|||
33645046|NCT01411215|63052518|FG001|Overall Study|Did not meet entrance criteria|1|||
33645047|NCT01411215|63052517|FG000|Overall Study|Study terminated by sponsor|2|||
33645048|NCT01411215|63052518|FG001|Overall Study|Study terminated by sponsor|15|||
33645049|NCT01411215|63052517|FG000|Overall Study|Protocol Violation|3|||
33645050|NCT01411215|63052518|FG001|Overall Study|Protocol Violation|5|||
33645051|NCT01411215|63052517|FG000|Overall Study|Withdrawal by Subject|34|||
33645052|NCT01411215|63052518|FG001|Overall Study|Withdrawal by Subject|21|||
33645053|NCT01411215|63052517|FG000|Overall Study|Other|12|||
33645054|NCT01411215|63052518|FG001|Overall Study|Other|17|||
33645055|NCT01411215|63052517|FG000|Overall Study|Screen failure|0|||
33645056|NCT01411215|63052518|FG001|Overall Study|Screen failure|1|||
33645057|NCT01449279|63052524|FG000|Overall Study|Lack of Efficacy|5|||
33645058|NCT01449279|63052524|FG000|Overall Study|Toxicity|2|||
33645059|NCT01447719|63052528|FG000|Overall Study|Image acquisition failure|2|||
33645060|NCT01447719|63052528|FG000|Overall Study|Invalid image or not imaged|3|||
33645061|NCT01447719|63052528|FG000|Overall Study|Subject still living at end of study|79|||
33645062|NCT01447719|63052528|FG000|Overall Study|Withdrawal by Subject|2|||
33645063|NCT01447719|63052528|FG000|Overall Study|Family withdrew autopsy consent|7|||
33645064|NCT01431963|63052537|FG000|Overall Study|Adverse Event|18|||
33645065|NCT01431963|63052537|FG000|Overall Study|Lack of Efficacy|7|||
33645066|NCT01431963|63052537|FG000|Overall Study|Protocol Violation|1|||
33645067|NCT01431963|63052537|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
33645068|NCT01431963|63052537|FG000|Overall Study|Physician Decision|4|||
33645069|NCT01431963|63052537|FG000|Overall Study|Withdrawal by Subject|3|||
33645070|NCT01447407|63052545|FG000|Overall Study|Withdrawal by Subject|2|||
33645071|NCT01447407|63052546|FG001|Overall Study|Withdrawal by Subject|0|||
33645072|NCT01447407|63052547|FG002|Overall Study|Withdrawal by Subject|0|||
33645073|NCT01447407|63052548|FG003|Overall Study|Withdrawal by Subject|1|||
33645074|NCT01447407|63052545|FG000|Overall Study|Physician Decision|0|||
33645075|NCT01447407|63052546|FG001|Overall Study|Physician Decision|0|||
33645076|NCT01447407|63052547|FG002|Overall Study|Physician Decision|1|||
33645077|NCT01447407|63052548|FG003|Overall Study|Physician Decision|1|||
33645078|NCT01446237|63052558|FG000|Overall Study|Adverse Event|1|||
33645079|NCT01446237|63052558|FG000|Overall Study|Lost to Follow-up|2|||
33645080|NCT01446237|63052558|FG000|Overall Study|Withdrawal by Subject|7|||
33645081|NCT01446159|63052702|FG000|Overall Study|Withdrawal by Subject|1|||
33645082|NCT01446159|63052703|FG001|Overall Study|Withdrawal by Subject|0|||
33645083|NCT01446159|63052704|FG002|Overall Study|Withdrawal by Subject|14|||
33645084|NCT01446159|63052705|FG003|Overall Study|Withdrawal by Subject|11|||
33645085|NCT01446159|63052702|FG000|Overall Study|Lost to Follow-up|0|||
33645086|NCT01446159|63052703|FG001|Overall Study|Lost to Follow-up|0|||
33645087|NCT01446159|63052704|FG002|Overall Study|Lost to Follow-up|1|||
33645088|NCT01446159|63052705|FG003|Overall Study|Lost to Follow-up|2|||
33543055|NCT03045887|62933822|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33543056|NCT03045887|62933823|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33543057|NCT03045887|62933824|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33543058|NCT03045887|62933825|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
33543059|NCT03045887|62933826|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33543060|NCT03045887|62933827|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33543061|NCT03045887|62933828|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33543062|NCT03045887|62933829|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33645089|NCT01446159|63052702|FG000|Overall Study|Death|2|||
33645090|NCT01446159|63052703|FG001|Overall Study|Death|3|||
33645091|NCT01446159|63052704|FG002|Overall Study|Death|43|||
33645092|NCT01446159|63052705|FG003|Overall Study|Death|36|||
33645093|NCT01446159|63052702|FG000|Overall Study|Other|0|||
33645094|NCT01446159|63052703|FG001|Overall Study|Other|0|||
33645095|NCT01446159|63052704|FG002|Overall Study|Other|13|||
33645096|NCT01446159|63052705|FG003|Overall Study|Other|13|||
33645097|NCT01446003|63052741|FG000|Period 1|Protocol Violation|2|||
33645098|NCT01446003|63052742|FG001|Period 1|Protocol Violation|0|||
33645099|NCT01446003|63052741|FG000|Period 2|Adverse Event|1|||
33543063|NCT03045887|62933830|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33645100|NCT01446003|63052742|FG001|Period 2|Adverse Event|0|||
33645101|NCT01430559|63052759|FG000|Overall Study|Adverse Event|7|||
33645102|NCT01430559|63052760|FG001|Overall Study|Adverse Event|3|||
33645103|NCT01430559|63052759|FG000|Overall Study|Entry criteria not met|1|||
33645104|NCT01430559|63052760|FG001|Overall Study|Entry criteria not met|1|||
33645105|NCT01430559|63052759|FG000|Overall Study|Lost to Follow-up|1|||
33645106|NCT01430559|63052760|FG001|Overall Study|Lost to Follow-up|0|||
33645107|NCT01430559|63052759|FG000|Overall Study|Medication error|1|||
33645108|NCT01430559|63052760|FG001|Overall Study|Medication error|0|||
33645109|NCT01430559|63052759|FG000|Overall Study|Withdrawal by Subject|3|||
33645110|NCT01430559|63052760|FG001|Overall Study|Withdrawal by Subject|2|||
33645111|NCT01430559|63052759|FG000|Overall Study|Protocol Violation|1|||
33645112|NCT01430559|63052760|FG001|Overall Study|Protocol Violation|0|||
33645113|NCT01430559|63052759|FG000|Overall Study|Other|3|||
33645114|NCT01430559|63052760|FG001|Overall Study|Other|3|||
33645115|NCT01430559|63052759|FG000|Overall Study|Randomized, Not Treated|3|||
33645116|NCT01430559|63052760|FG001|Overall Study|Randomized, Not Treated|3|||
33645117|NCT01410357|63052773|FG000|Overall Study|Death|2|||
33463473|NCT03831191|62836958|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33463474|NCT03831191|62836959|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33463475|NCT03831191|62836960|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33463476|NCT03831191|62836961|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33463477|NCT03831191|62836962|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33463478|NCT03831191|62836963|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33463479|NCT03831191|62836949|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
33463480|NCT03831191|62836950|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
33463481|NCT03831191|62836951|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
33463482|NCT03831191|62836952|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
33463483|NCT03831191|62836953|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
33463484|NCT03831191|62836954|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
33463485|NCT03831191|62836955|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
33463486|NCT03831191|62836956|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
33463487|NCT03831191|62836957|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
33463488|NCT03831191|62836958|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
33463489|NCT03831191|62836959|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
33463490|NCT03831191|62836960|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
33463491|NCT03831191|62836961|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
33463492|NCT03831191|62836962|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
33463493|NCT03831191|62836963|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
33463494|NCT03831191|62836949|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
33463495|NCT03831191|62836950|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
33463496|NCT03831191|62836951|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
33463497|NCT03831191|62836952|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
33463498|NCT03831191|62836953|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
33463499|NCT03831191|62836954|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
33463500|NCT03831191|62836955|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
33463501|NCT03831191|62836956|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
33463502|NCT03831191|62836957|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
33463503|NCT03831191|62836958|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
33463504|NCT03831191|62836959|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
33463505|NCT03831191|62836960|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
33463506|NCT03831191|62836961|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
33463507|NCT03831191|62836962|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
33463508|NCT03831191|62836963|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
33463509|NCT03831191|62836949|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
33463510|NCT03831191|62836950|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
33463511|NCT03831191|62836951|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
33463512|NCT03831191|62836952|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
33463513|NCT03831191|62836953|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33463514|NCT03831191|62836954|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33463515|NCT03831191|62836955|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33463516|NCT03831191|62836956|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33463517|NCT03831191|62836957|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33463518|NCT03831191|62836958|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33463519|NCT03831191|62836959|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33463520|NCT03831191|62836960|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33463521|NCT03831191|62836961|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33463522|NCT03831191|62836962|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33645118|NCT01410357|63052774|FG001|Overall Study|Death|1|||
33645119|NCT01410357|63052773|FG000|Overall Study|Withdrawal by Subject|1|||
33463523|NCT03831191|62836963|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33463524|NCT03831191|62836949|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
33645120|NCT01410357|63052774|FG001|Overall Study|Withdrawal by Subject|2|||
33645121|NCT01410357|63052773|FG000|Overall Study|Lost to Follow-up|23|||
33645122|NCT01410357|63052774|FG001|Overall Study|Lost to Follow-up|21|||
33645123|NCT01409811|63052799|FG000|Overall Study|Insurance denial|1|||
33645124|NCT01445847|63052805|FG000|Overall Study|Protocol Violation|13|||
33645125|NCT01445847|63052806|FG001|Overall Study|Protocol Violation|14|||
33645126|NCT01445847|63052805|FG000|Overall Study|Missed Data|1|||
33645127|NCT01445847|63052806|FG001|Overall Study|Missed Data|0|||
33645128|NCT01445769|63052825|FG000|Overall Study|Consent Withdrawn|2|||
33645129|NCT01445769|63052825|FG000|Overall Study|Disease Progression|1|||
33645130|NCT01445769|63052825|FG000|Overall Study|Lost to Follow-up|5|||
33645131|NCT01445613|63052907|FG000|30-day Follow-up|Withdrawal by Subject|6|||
33645132|NCT01445613|63052907|FG000|30-day Follow-up|Physician Decision|3|||
33645133|NCT01445613|63052907|FG000|30-day Follow-up|Missed visit|23|||
33645134|NCT01445613|63052907|FG000|30-day Follow-up|Death|3|||
33645135|NCT01445613|63052907|FG000|1-year Follow-up|Withdrawal by Subject|12|||
33645136|NCT01445613|63052907|FG000|1-year Follow-up|Missed visit|29|||
33645137|NCT01445613|63052907|FG000|1-year Follow-up|Lost to Follow-up|2|||
33645138|NCT01445613|63052907|FG000|1-year Follow-up|Death|30|||
33645139|NCT01445613|63052907|FG000|1-year Follow-up|Physician Decision|2|||
33645140|NCT01445613|63052907|FG000|1-year Follow-up|Received a non-study stent|2|||
33645141|NCT01445535|63053011|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
33645142|NCT01445535|63053012|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
33645143|NCT01445535|63053013|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
33645144|NCT01445535|63053014|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
33645145|NCT01445535|63053011|FG000|Overall Study|Disease progression|1|||
33645146|NCT01445535|63053012|FG001|Overall Study|Disease progression|0|||
33645147|NCT01445535|63053013|FG002|Overall Study|Disease progression|1|||
33645148|NCT01445535|63053014|FG003|Overall Study|Disease progression|0|||
33645149|NCT01445535|63053011|FG000|Overall Study|PI discretion|0|||
33645150|NCT01445535|63053012|FG001|Overall Study|PI discretion|0|||
33645151|NCT01445535|63053013|FG002|Overall Study|PI discretion|0|||
33645152|NCT01445535|63053014|FG003|Overall Study|PI discretion|1|||
33645153|NCT01445301|63053028|FG000|Overall Study|Adverse Event|15|||
33645154|NCT01445301|63053029|FG001|Overall Study|Adverse Event|25|||
33645155|NCT01445301|63053030|FG002|Overall Study|Adverse Event|4|||
33645156|NCT01445301|63053028|FG000|Overall Study|Lack of Efficacy|0|||
33645157|NCT01445301|63053029|FG001|Overall Study|Lack of Efficacy|1|||
33645158|NCT01445301|63053030|FG002|Overall Study|Lack of Efficacy|0|||
33645159|NCT01445301|63053028|FG000|Overall Study|Protocol Violation|1|||
33645160|NCT01445301|63053029|FG001|Overall Study|Protocol Violation|0|||
33645161|NCT01445301|63053030|FG002|Overall Study|Protocol Violation|0|||
33645162|NCT01445301|63053028|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
33645163|NCT01445301|63053029|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
33645164|NCT01445301|63053030|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
33645165|NCT01445301|63053028|FG000|Overall Study|Physician Decision|0|||
33645166|NCT01445301|63053029|FG001|Overall Study|Physician Decision|2|||
33645167|NCT01445301|63053030|FG002|Overall Study|Physician Decision|0|||
33645168|NCT01445301|63053028|FG000|Overall Study|Withdrawal by Subject|5|||
33463525|NCT03831191|62836950|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
33645169|NCT01445301|63053029|FG001|Overall Study|Withdrawal by Subject|6|||
33645170|NCT01445301|63053030|FG002|Overall Study|Withdrawal by Subject|4|||
33645171|NCT01409031|63053040|FG000|Overall Study|transferred to other hosp|1|||
33645172|NCT01409031|63053041|FG001|Overall Study|transferred to other hosp|0|||
33645173|NCT01430403|63053050|FG000|Overall Study|Lost to Follow-up|5|||
33543064|NCT03045887|62933831|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33645174|NCT01430403|63053051|FG001|Overall Study|Lost to Follow-up|5|||
33645175|NCT01430403|63053052|FG002|Overall Study|Lost to Follow-up|3|||
33645176|NCT01430403|63053050|FG000|Overall Study|Physician Decision|1|||
33645177|NCT01430403|63053051|FG001|Overall Study|Physician Decision|0|||
33645178|NCT01430403|63053052|FG002|Overall Study|Physician Decision|0|||
33645179|NCT01430403|63053050|FG000|Overall Study|Protocol Violation|2|||
33645180|NCT01430403|63053051|FG001|Overall Study|Protocol Violation|3|||
33645181|NCT01430403|63053052|FG002|Overall Study|Protocol Violation|2|||
33645182|NCT01430403|63053050|FG000|Overall Study|Withdrawal by Subject|9|||
33645183|NCT01430403|63053051|FG001|Overall Study|Withdrawal by Subject|1|||
33463526|NCT03831191|62836951|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
33463527|NCT03831191|62836952|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
33463528|NCT03831191|62836953|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33463529|NCT03831191|62836954|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33463530|NCT03831191|62836955|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33645184|NCT01430403|63053052|FG002|Overall Study|Withdrawal by Subject|3|||
33645185|NCT01429623|63053067|FG000|Overall Study|Death|1|||
33645186|NCT01429623|63053068|FG001|Overall Study|Death|0|||
33463531|NCT03831191|62836956|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33645187|NCT01429623|63053067|FG000|Overall Study|Adverse Event|7|||
33645188|NCT01429623|63053068|FG001|Overall Study|Adverse Event|14|||
33645189|NCT01429623|63053067|FG000|Overall Study|Withdrawal by Subject|19|||
33645190|NCT01429623|63053068|FG001|Overall Study|Withdrawal by Subject|13|||
33463532|NCT03831191|62836957|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33543065|NCT01564537|62933860|FG000|Overall Study|Site Terminated by Sponsor|1|||
33543066|NCT01564537|62933861|FG001|Overall Study|Site Terminated by Sponsor|0|||
33543067|NCT01564537|62933860|FG000|Overall Study|Withdrawal by Subject|12|||
33543068|NCT01564537|62933861|FG001|Overall Study|Withdrawal by Subject|14|||
33543069|NCT01564537|62933860|FG000|Overall Study|Lost to Follow-up|7|||
33543070|NCT01564537|62933861|FG001|Overall Study|Lost to Follow-up|3|||
33543071|NCT01564537|62933860|FG000|Overall Study|Reason not specified|81|||
33543072|NCT01564537|62933861|FG001|Overall Study|Reason not specified|82|||
33543073|NCT03042611|62933872|FG000|Core Phase|Withdrawal by Subject|13|||
33543074|NCT03042611|62933873|FG001|Core Phase|Withdrawal by Subject|4|||
33543075|NCT03042611|62933874|FG002|Core Phase|Withdrawal by Subject|0|||
33543076|NCT03042611|62933875|FG003|Core Phase|Withdrawal by Subject|0|||
33543077|NCT03042611|62933872|FG000|Core Phase|Death|232|||
33543078|NCT03042611|62933873|FG001|Core Phase|Death|110|||
33543079|NCT03042611|62933874|FG002|Core Phase|Death|0|||
33543080|NCT03042611|62933875|FG003|Core Phase|Death|0|||
33543081|NCT03042611|62933872|FG000|Core Phase|Lost to Follow-up|4|||
33543082|NCT03042611|62933873|FG001|Core Phase|Lost to Follow-up|7|||
33543083|NCT03042611|62933874|FG002|Core Phase|Lost to Follow-up|0|||
33543084|NCT03042611|62933875|FG003|Core Phase|Lost to Follow-up|0|||
33543085|NCT03042611|62933872|FG000|Core Phase|Physician Decision|7|||
33543086|NCT03042611|62933873|FG001|Core Phase|Physician Decision|2|||
33543087|NCT03042611|62933874|FG002|Core Phase|Physician Decision|0|||
33543088|NCT03042611|62933875|FG003|Core Phase|Physician Decision|0|||
33543089|NCT03042611|62933872|FG000|Core Phase|Study Closed|0|||
33543090|NCT03042611|62933873|FG001|Core Phase|Study Closed|1|||
33543091|NCT03042611|62933874|FG002|Core Phase|Study Closed|0|||
33543092|NCT03042611|62933875|FG003|Core Phase|Study Closed|0|||
33543093|NCT03042611|62933872|FG000|Extension Phase|Death|0|||
33543094|NCT03042611|62933873|FG001|Extension Phase|Death|0|||
33543095|NCT03042611|62933874|FG002|Extension Phase|Death|34|||
33543096|NCT03042611|62933875|FG003|Extension Phase|Death|16|||
33543097|NCT03042611|62933872|FG000|Extension Phase|Lost to Follow-up|0|||
33543098|NCT03042611|62933873|FG001|Extension Phase|Lost to Follow-up|0|||
33543099|NCT03042611|62933874|FG002|Extension Phase|Lost to Follow-up|1|||
33543100|NCT03042611|62933875|FG003|Extension Phase|Lost to Follow-up|1|||
33543101|NCT03042611|62933872|FG000|Extension Phase|Study Closed|0|||
33543102|NCT03042611|62933873|FG001|Extension Phase|Study Closed|0|||
33543103|NCT03042611|62933874|FG002|Extension Phase|Study Closed|17|||
33543104|NCT03042611|62933875|FG003|Extension Phase|Study Closed|11|||
33543105|NCT02701634|62933883|FG000|Overall Study|Adverse Event|2|||
33645191|NCT01429623|63053067|FG000|Overall Study|Physician Decision|2|||
33645192|NCT01429623|63053068|FG001|Overall Study|Physician Decision|3|||
33543106|NCT02701634|62933884|FG001|Overall Study|Adverse Event|3|||
33543107|NCT02701634|62933883|FG000|Overall Study|Death|1|||
33543108|NCT02701634|62933884|FG001|Overall Study|Death|0|||
33543109|NCT02701634|62933883|FG000|Overall Study|Investigator's Discretion|7|||
33645193|NCT01429623|63053067|FG000|Overall Study|Protocol Violation|3|||
33645194|NCT01429623|63053068|FG001|Overall Study|Protocol Violation|2|||
33645195|NCT01429623|63053067|FG000|Overall Study|Assorted|1|||
33645196|NCT01429623|63053068|FG001|Overall Study|Assorted|2|||
33645197|NCT01429623|63053067|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
33645198|NCT01429623|63053068|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
33645199|NCT01429623|63053067|FG000|Overall Study|No post baseline data|4|||
33645200|NCT01429623|63053068|FG001|Overall Study|No post baseline data|4|||
33645201|NCT01408641|63053076|FG000|Overall Study|Physician Decision|1|||
33645202|NCT01408641|63053077|FG001|Overall Study|Physician Decision|0|||
33645203|NCT01429077|63053085|FG000|Overall Study|Lost to Follow-up|0|||
33645204|NCT01429077|63053086|FG001|Overall Study|Lost to Follow-up|3|||
33645205|NCT01428453|63053094|FG000|Overall Study|Adverse Event|2|||
33645206|NCT01428453|63053095|FG001|Overall Study|Adverse Event|7|||
33645207|NCT01428453|63053094|FG000|Overall Study|Protocol Violation|1|||
33645208|NCT01428453|63053095|FG001|Overall Study|Protocol Violation|0|||
33645209|NCT01428453|63053094|FG000|Overall Study|Lost to Follow-up|0|||
33645210|NCT01428453|63053095|FG001|Overall Study|Lost to Follow-up|1|||
33645211|NCT01428453|63053094|FG000|Overall Study|Withdrawal by Subject|3|||
33645212|NCT01428453|63053095|FG001|Overall Study|Withdrawal by Subject|1|||
33645213|NCT01408563|63053103|FG000|Overall Study|Ineligible after consent/ registration|2|||
33645214|NCT01442493|63053109|FG000|Overall Study|withdrawn from study|3|||
33645215|NCT01442493|63053110|FG001|Overall Study|withdrawn from study|2|||
33645216|NCT01442181|63053118|FG000|Overall Study|patient refused surgery|1|||
33645217|NCT01442181|63053119|FG001|Overall Study|patient refused surgery|0|||
33645218|NCT01442181|63053118|FG000|Overall Study|no insurance for surgery|1|||
33645219|NCT01442181|63053119|FG001|Overall Study|no insurance for surgery|0|||
33645220|NCT01442181|63053118|FG000|Overall Study|low ejection factor|0|||
33645221|NCT01442181|63053119|FG001|Overall Study|low ejection factor|1|||
33645222|NCT01442181|63053118|FG000|Overall Study|Lost to Follow-up|1|||
33645223|NCT01442181|63053119|FG001|Overall Study|Lost to Follow-up|1|||
33645224|NCT01442181|63053118|FG000|Overall Study|patient in an additional study|1|||
33645225|NCT01442181|63053119|FG001|Overall Study|patient in an additional study|0|||
33645226|NCT01442181|63053118|FG000|Overall Study|atrial fibrillation not noted|0|||
33645227|NCT01442181|63053119|FG001|Overall Study|atrial fibrillation not noted|1|||
33645228|NCT01442103|63053126|FG000|Overall Study|Lost to Follow-up|2|||
33645229|NCT01428219|63053130|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
33645230|NCT01428063|63053137|FG000|Overall Study|Lack of Efficacy|8|||
33645231|NCT01428063|63053138|FG001|Overall Study|Lack of Efficacy|4|||
33645232|NCT01428063|63053139|FG002|Overall Study|Lack of Efficacy|1|||
33645233|NCT01428063|63053137|FG000|Overall Study|Adverse Event|2|||
33645234|NCT01428063|63053138|FG001|Overall Study|Adverse Event|3|||
33645235|NCT01428063|63053139|FG002|Overall Study|Adverse Event|0|||
33645236|NCT01428063|63053137|FG000|Overall Study|Lost to Follow-up|0|||
33645237|NCT01428063|63053138|FG001|Overall Study|Lost to Follow-up|2|||
33645238|NCT01428063|63053139|FG002|Overall Study|Lost to Follow-up|0|||
33645239|NCT01428063|63053137|FG000|Overall Study|No longer meets study criteria|0|||
33645240|NCT01428063|63053138|FG001|Overall Study|No longer meets study criteria|1|||
33645241|NCT01428063|63053139|FG002|Overall Study|No longer meets study criteria|0|||
33645242|NCT01441635|63053303|FG000|Overall Study|Adverse Event|4|||
33645243|NCT01441635|63053304|FG001|Overall Study|Adverse Event|3|||
33645244|NCT01441635|63053305|FG002|Overall Study|Adverse Event|1|||
33645245|NCT01441635|63053306|FG003|Overall Study|Adverse Event|5|||
33645246|NCT01441635|63053307|FG004|Overall Study|Adverse Event|1|||
33645247|NCT01441635|63053308|FG005|Overall Study|Adverse Event|2|||
33645248|NCT01441635|63053309|FG006|Overall Study|Adverse Event|2|||
33645249|NCT01441635|63053310|FG007|Overall Study|Adverse Event|2|||
33645250|NCT01441635|63053311|FG008|Overall Study|Adverse Event|1|||
33645251|NCT01441635|63053312|FG009|Overall Study|Adverse Event|0|||
33645252|NCT01441635|63053303|FG000|Overall Study|Withdrawal by Subject|1|||
33645253|NCT01441635|63053304|FG001|Overall Study|Withdrawal by Subject|1|||
33645254|NCT01441635|63053305|FG002|Overall Study|Withdrawal by Subject|0|||
33463533|NCT03831191|62836958|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33463534|NCT03831191|62836959|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33463535|NCT03831191|62836960|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33543110|NCT02701634|62933884|FG001|Overall Study|Investigator's Discretion|4|||
33645255|NCT01441635|63053306|FG003|Overall Study|Withdrawal by Subject|1|||
33645256|NCT01441635|63053307|FG004|Overall Study|Withdrawal by Subject|0|||
33645257|NCT01441635|63053308|FG005|Overall Study|Withdrawal by Subject|0|||
33645258|NCT01441635|63053309|FG006|Overall Study|Withdrawal by Subject|2|||
33645259|NCT01441635|63053310|FG007|Overall Study|Withdrawal by Subject|0|||
33645260|NCT01441635|63053311|FG008|Overall Study|Withdrawal by Subject|1|||
33645261|NCT01441635|63053312|FG009|Overall Study|Withdrawal by Subject|1|||
33645262|NCT01441635|63053303|FG000|Overall Study|Lost to Follow-up|0|||
33645263|NCT01441635|63053304|FG001|Overall Study|Lost to Follow-up|1|||
33645264|NCT01441635|63053305|FG002|Overall Study|Lost to Follow-up|1|||
33645265|NCT01441635|63053306|FG003|Overall Study|Lost to Follow-up|1|||
33645266|NCT01441635|63053307|FG004|Overall Study|Lost to Follow-up|1|||
33645267|NCT01441635|63053308|FG005|Overall Study|Lost to Follow-up|3|||
33645268|NCT01441635|63053309|FG006|Overall Study|Lost to Follow-up|1|||
33645269|NCT01441635|63053310|FG007|Overall Study|Lost to Follow-up|1|||
33645270|NCT01441635|63053311|FG008|Overall Study|Lost to Follow-up|0|||
33645271|NCT01441635|63053312|FG009|Overall Study|Lost to Follow-up|1|||
33645272|NCT01441635|63053303|FG000|Overall Study|Noncompliance|0|||
33645273|NCT01441635|63053304|FG001|Overall Study|Noncompliance|1|||
33645274|NCT01441635|63053305|FG002|Overall Study|Noncompliance|0|||
33645275|NCT01441635|63053306|FG003|Overall Study|Noncompliance|0|||
33645276|NCT01441635|63053307|FG004|Overall Study|Noncompliance|0|||
33645277|NCT01441635|63053308|FG005|Overall Study|Noncompliance|0|||
33645278|NCT01441635|63053309|FG006|Overall Study|Noncompliance|1|||
33645279|NCT01441635|63053310|FG007|Overall Study|Noncompliance|0|||
33645280|NCT01441635|63053311|FG008|Overall Study|Noncompliance|0|||
33645281|NCT01441635|63053312|FG009|Overall Study|Noncompliance|0|||
33645282|NCT01441635|63053303|FG000|Overall Study|Surgery or Invasive Intervention|0|||
33645283|NCT01441635|63053304|FG001|Overall Study|Surgery or Invasive Intervention|0|||
33645284|NCT01441635|63053305|FG002|Overall Study|Surgery or Invasive Intervention|1|||
33645285|NCT01441635|63053306|FG003|Overall Study|Surgery or Invasive Intervention|0|||
33645286|NCT01441635|63053307|FG004|Overall Study|Surgery or Invasive Intervention|0|||
33645287|NCT01441635|63053308|FG005|Overall Study|Surgery or Invasive Intervention|0|||
33645288|NCT01441635|63053309|FG006|Overall Study|Surgery or Invasive Intervention|0|||
33645289|NCT01441635|63053310|FG007|Overall Study|Surgery or Invasive Intervention|0|||
33645290|NCT01441635|63053311|FG008|Overall Study|Surgery or Invasive Intervention|0|||
33645291|NCT01441635|63053312|FG009|Overall Study|Surgery or Invasive Intervention|0|||
33645292|NCT01441635|63053303|FG000|Overall Study|Received Exclusionary Medication|1|||
33645293|NCT01441635|63053304|FG001|Overall Study|Received Exclusionary Medication|0|||
33645294|NCT01441635|63053305|FG002|Overall Study|Received Exclusionary Medication|0|||
33645295|NCT01441635|63053306|FG003|Overall Study|Received Exclusionary Medication|0|||
33645296|NCT01441635|63053307|FG004|Overall Study|Received Exclusionary Medication|0|||
33645297|NCT01441635|63053308|FG005|Overall Study|Received Exclusionary Medication|0|||
33645298|NCT01441635|63053309|FG006|Overall Study|Received Exclusionary Medication|0|||
33645299|NCT01441635|63053310|FG007|Overall Study|Received Exclusionary Medication|0|||
33645300|NCT01441635|63053311|FG008|Overall Study|Received Exclusionary Medication|0|||
33645301|NCT01441635|63053312|FG009|Overall Study|Received Exclusionary Medication|0|||
33645302|NCT01441635|63053303|FG000|Overall Study|Other|0|||
33645303|NCT01441635|63053304|FG001|Overall Study|Other|0|||
33645304|NCT01441635|63053305|FG002|Overall Study|Other|0|||
33645305|NCT01441635|63053306|FG003|Overall Study|Other|0|||
33645306|NCT01441635|63053307|FG004|Overall Study|Other|0|||
33645307|NCT01441635|63053308|FG005|Overall Study|Other|0|||
33645308|NCT01441635|63053309|FG006|Overall Study|Other|0|||
33645309|NCT01441635|63053310|FG007|Overall Study|Other|1|||
33645310|NCT01441635|63053311|FG008|Overall Study|Other|0|||
33645311|NCT01441635|63053312|FG009|Overall Study|Other|0|||
33645312|NCT01408485|63053334|FG000|Overall Study|Withdrawal by Subject|21|||
33645313|NCT01427907|63053340|FG000|Overall Study|Withdrawal by Subject|3|||
33645314|NCT01427907|63053341|FG001|Overall Study|Withdrawal by Subject|4|||
33645315|NCT01427751|63053349|FG000|Overall Study|Adverse Event|18|||
33645316|NCT01427751|63053350|FG001|Overall Study|Adverse Event|2|||
33645317|NCT01427751|63053349|FG000|Overall Study|No further treatment benefit expected|5|||
33645318|NCT01427751|63053350|FG001|Overall Study|No further treatment benefit expected|1|||
33645319|NCT01427751|63053349|FG000|Overall Study|Lost to Follow-up|3|||
33645320|NCT01427751|63053350|FG001|Overall Study|Lost to Follow-up|1|||
33645321|NCT01427751|63053349|FG000|Overall Study|Withdrawal of consent|2|||
33645322|NCT01427751|63053350|FG001|Overall Study|Withdrawal of consent|2|||
33645323|NCT01427751|63053349|FG000|Overall Study|Protocol Violation|6|||
33645324|NCT01427751|63053350|FG001|Overall Study|Protocol Violation|4|||
33645325|NCT01427751|63053349|FG000|Overall Study|Death|2|||
33645326|NCT01427751|63053350|FG001|Overall Study|Death|0|||
33645327|NCT01427751|63053349|FG000|Overall Study|Other miscellaneous reasons|6|||
33645328|NCT01427751|63053350|FG001|Overall Study|Other miscellaneous reasons|4|||
33645329|NCT01920061|63053376|FG000|Overall Study|Death|1|||
33645330|NCT01920061|63053377|FG001|Overall Study|Death|1|||
33645331|NCT01920061|63053378|FG002|Overall Study|Death|0|||
33645332|NCT01920061|63053379|FG003|Overall Study|Death|1|||
33645333|NCT01920061|63053380|FG004|Overall Study|Death|1|||
33645334|NCT01920061|63053381|FG005|Overall Study|Death|0|||
33645335|NCT01920061|63053382|FG006|Overall Study|Death|0|||
33645336|NCT01920061|63053383|FG007|Overall Study|Death|1|||
33645337|NCT01920061|63053384|FG008|Overall Study|Death|0|||
33645338|NCT01920061|63053385|FG009|Overall Study|Death|1|||
33645339|NCT01920061|63053386|FG010|Overall Study|Death|0|||
33645340|NCT01920061|63053387|FG011|Overall Study|Death|1|||
33645341|NCT01920061|63053388|FG012|Overall Study|Death|0|||
33645342|NCT01920061|63053389|FG013|Overall Study|Death|2|||
33645343|NCT01920061|63053390|FG014|Overall Study|Death|0|||
33645344|NCT01920061|63053391|FG015|Overall Study|Death|0|||
33645345|NCT01920061|63053392|FG016|Overall Study|Death|0|||
33645346|NCT01920061|63053393|FG017|Overall Study|Death|0|||
33645347|NCT01920061|63053394|FG018|Overall Study|Death|1|||
33645348|NCT01920061|63053395|FG019|Overall Study|Death|0|||
33645349|NCT01920061|63053376|FG000|Overall Study|Lost to Follow-up|0|||
33645350|NCT01920061|63053377|FG001|Overall Study|Lost to Follow-up|2|||
33645351|NCT01920061|63053378|FG002|Overall Study|Lost to Follow-up|0|||
33645352|NCT01920061|63053379|FG003|Overall Study|Lost to Follow-up|0|||
33645353|NCT01920061|63053380|FG004|Overall Study|Lost to Follow-up|0|||
33645354|NCT01920061|63053381|FG005|Overall Study|Lost to Follow-up|0|||
33645355|NCT01920061|63053382|FG006|Overall Study|Lost to Follow-up|1|||
33645356|NCT01920061|63053383|FG007|Overall Study|Lost to Follow-up|0|||
33645357|NCT01920061|63053384|FG008|Overall Study|Lost to Follow-up|0|||
33645358|NCT01920061|63053385|FG009|Overall Study|Lost to Follow-up|0|||
33645359|NCT01920061|63053386|FG010|Overall Study|Lost to Follow-up|3|||
33645360|NCT01920061|63053387|FG011|Overall Study|Lost to Follow-up|0|||
33645361|NCT01920061|63053388|FG012|Overall Study|Lost to Follow-up|0|||
33645362|NCT01920061|63053389|FG013|Overall Study|Lost to Follow-up|0|||
33645363|NCT01920061|63053390|FG014|Overall Study|Lost to Follow-up|0|||
33645364|NCT01920061|63053391|FG015|Overall Study|Lost to Follow-up|0|||
33645365|NCT01920061|63053392|FG016|Overall Study|Lost to Follow-up|0|||
33645366|NCT01920061|63053393|FG017|Overall Study|Lost to Follow-up|1|||
33645367|NCT01920061|63053394|FG018|Overall Study|Lost to Follow-up|4|||
33645368|NCT01920061|63053395|FG019|Overall Study|Lost to Follow-up|3|||
33645369|NCT01920061|63053376|FG000|Overall Study|Other|1|||
33645370|NCT01920061|63053377|FG001|Overall Study|Other|1|||
33645371|NCT01920061|63053378|FG002|Overall Study|Other|2|||
33645372|NCT01920061|63053379|FG003|Overall Study|Other|1|||
33645373|NCT01920061|63053380|FG004|Overall Study|Other|0|||
33645374|NCT01920061|63053381|FG005|Overall Study|Other|1|||
33645375|NCT01920061|63053382|FG006|Overall Study|Other|0|||
33645376|NCT01920061|63053383|FG007|Overall Study|Other|0|||
33645377|NCT01920061|63053384|FG008|Overall Study|Other|0|||
33645378|NCT01920061|63053385|FG009|Overall Study|Other|1|||
33645379|NCT01920061|63053386|FG010|Overall Study|Other|1|||
33645380|NCT01920061|63053387|FG011|Overall Study|Other|2|||
33645381|NCT01920061|63053388|FG012|Overall Study|Other|1|||
33645382|NCT01920061|63053389|FG013|Overall Study|Other|4|||
33645383|NCT01920061|63053390|FG014|Overall Study|Other|0|||
33645384|NCT01920061|63053391|FG015|Overall Study|Other|1|||
33645385|NCT01920061|63053392|FG016|Overall Study|Other|1|||
33645386|NCT01920061|63053393|FG017|Overall Study|Other|0|||
33645387|NCT01920061|63053394|FG018|Overall Study|Other|1|||
33645388|NCT01920061|63053395|FG019|Overall Study|Other|1|||
33645389|NCT01920061|63053376|FG000|Overall Study|Participant refused further follow-up|0|||
33645390|NCT01920061|63053377|FG001|Overall Study|Participant refused further follow-up|0|||
33645391|NCT01920061|63053378|FG002|Overall Study|Participant refused further follow-up|0|||
33645392|NCT01920061|63053379|FG003|Overall Study|Participant refused further follow-up|0|||
33645393|NCT01920061|63053380|FG004|Overall Study|Participant refused further follow-up|1|||
33645394|NCT01920061|63053381|FG005|Overall Study|Participant refused further follow-up|1|||
33645395|NCT01920061|63053382|FG006|Overall Study|Participant refused further follow-up|0|||
33645396|NCT01920061|63053383|FG007|Overall Study|Participant refused further follow-up|0|||
33645397|NCT01920061|63053384|FG008|Overall Study|Participant refused further follow-up|1|||
33645398|NCT01920061|63053385|FG009|Overall Study|Participant refused further follow-up|0|||
33645399|NCT01920061|63053386|FG010|Overall Study|Participant refused further follow-up|1|||
33645400|NCT01920061|63053387|FG011|Overall Study|Participant refused further follow-up|0|||
33645401|NCT01920061|63053388|FG012|Overall Study|Participant refused further follow-up|1|||
33645402|NCT01920061|63053389|FG013|Overall Study|Participant refused further follow-up|0|||
33645403|NCT01920061|63053390|FG014|Overall Study|Participant refused further follow-up|1|||
33645404|NCT01920061|63053391|FG015|Overall Study|Participant refused further follow-up|2|||
33645405|NCT01920061|63053392|FG016|Overall Study|Participant refused further follow-up|1|||
33645406|NCT01920061|63053393|FG017|Overall Study|Participant refused further follow-up|1|||
33645407|NCT01920061|63053394|FG018|Overall Study|Participant refused further follow-up|0|||
33645408|NCT01920061|63053395|FG019|Overall Study|Participant refused further follow-up|0|||
33645409|NCT01426425|63053458|FG000|Overall Study|Exited prior to EP study|22|||
33645410|NCT01426425|63053458|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
33645411|NCT01426425|63053458|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
33645412|NCT01426347|63053471|FG000|Overall Study|Lost to Follow-up|0|||
33645413|NCT01426347|63053472|FG001|Overall Study|Lost to Follow-up|3|||
33645414|NCT01426347|63053471|FG000|Overall Study|Protocol Violation|2|||
33645415|NCT01426347|63053472|FG001|Overall Study|Protocol Violation|0|||
33645416|NCT01426347|63053471|FG000|Overall Study|Withdrawal by Subject|5|||
33645417|NCT01426347|63053472|FG001|Overall Study|Withdrawal by Subject|0|||
33645418|NCT01882465|63053478|FG000|Period 1|Lens Discomfort|0|||
33645419|NCT01882465|63053479|FG001|Period 1|Lens Discomfort|0|||
33645420|NCT01882465|63053480|FG002|Period 1|Lens Discomfort|0|||
33645421|NCT01882465|63053481|FG003|Period 1|Lens Discomfort|1|||
33645422|NCT01882465|63053482|FG004|Period 1|Lens Discomfort|0|||
33645423|NCT01882465|63053483|FG005|Period 1|Lens Discomfort|0|||
33645424|NCT01882465|63053484|FG006|Period 1|Lens Discomfort|0|||
33645425|NCT01882465|63053478|FG000|Period 1|Withdrawal by Subject|0|||
33645426|NCT01882465|63053479|FG001|Period 1|Withdrawal by Subject|0|||
33645427|NCT01882465|63053480|FG002|Period 1|Withdrawal by Subject|0|||
33645428|NCT01882465|63053481|FG003|Period 1|Withdrawal by Subject|0|||
33645429|NCT01882465|63053482|FG004|Period 1|Withdrawal by Subject|0|||
33645430|NCT01882465|63053483|FG005|Period 1|Withdrawal by Subject|0|||
33645431|NCT01882465|63053484|FG006|Period 1|Withdrawal by Subject|1|||
33645432|NCT01882465|63053478|FG000|Period 2|Protocol Violation|0|||
33645433|NCT01882465|63053479|FG001|Period 2|Protocol Violation|0|||
33645434|NCT01882465|63053480|FG002|Period 2|Protocol Violation|0|||
33645435|NCT01882465|63053481|FG003|Period 2|Protocol Violation|0|||
33645436|NCT01882465|63053482|FG004|Period 2|Protocol Violation|1|||
33645437|NCT01882465|63053483|FG005|Period 2|Protocol Violation|0|||
33645438|NCT01882465|63053484|FG006|Period 2|Protocol Violation|0|||
33645439|NCT01426269|63053492|FG000|Period 1: 12 Weeks|Adverse Event|5|||
33645440|NCT01426269|63053493|FG001|Period 1: 12 Weeks|Adverse Event|0|||
33645441|NCT01426269|63053494|FG002|Period 1: 12 Weeks|Adverse Event|0|||
33645442|NCT01426269|63053492|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
33645443|NCT01426269|63053493|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
33645444|NCT01426269|63053494|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
33645445|NCT01426269|63053492|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
33645446|NCT01426269|63053493|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
33645447|NCT01426269|63053494|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
33645448|NCT01426269|63053492|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
33645449|NCT01426269|63053493|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
33645450|NCT01426269|63053494|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
33645451|NCT01426269|63053492|FG000|Period 1: 12 Weeks|Pregnancy|1|||
33645452|NCT01426269|63053493|FG001|Period 1: 12 Weeks|Pregnancy|0|||
33645453|NCT01426269|63053494|FG002|Period 1: 12 Weeks|Pregnancy|0|||
33645454|NCT01426269|63053492|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
33645455|NCT01426269|63053493|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
33645456|NCT01426269|63053494|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
33645457|NCT01426269|63053492|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
33645458|NCT01426269|63053493|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
33645459|NCT01426269|63053494|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
33645460|NCT01426269|63053492|FG000|Period 2: 40 Weeks|Adverse Event|0|||
33645461|NCT01426269|63053493|FG001|Period 2: 40 Weeks|Adverse Event|1|||
33645462|NCT01426269|63053494|FG002|Period 2: 40 Weeks|Adverse Event|2|||
33645463|NCT01426269|63053492|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
33645464|NCT01426269|63053493|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
33645465|NCT01426269|63053494|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
33645466|NCT01426269|63053492|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
33645467|NCT01426269|63053493|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
33645468|NCT01426269|63053494|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
33645469|NCT01426269|63053492|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
33645470|NCT01426269|63053493|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
33645471|NCT01426269|63053494|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
33645472|NCT01426269|63053492|FG000|Period 2: 40 Weeks|Site closed|0|||
33645473|NCT01426269|63053493|FG001|Period 2: 40 Weeks|Site closed|6|||
33645474|NCT01426269|63053494|FG002|Period 2: 40 Weeks|Site closed|5|||
33645475|NCT01426269|63053492|FG000|Period 2: 40 Weeks|Relapsed|0|||
33645476|NCT01426269|63053493|FG001|Period 2: 40 Weeks|Relapsed|9|||
33645477|NCT01426269|63053494|FG002|Period 2: 40 Weeks|Relapsed|18|||
33645478|NCT01426113|63053507|FG000|Overall Study|Study Discontinued|1|||
33645479|NCT01426113|63053508|FG001|Overall Study|Study Discontinued|1|||
33645480|NCT01426113|63053507|FG000|Overall Study|Adverse Event|0|||
33645481|NCT01426113|63053508|FG001|Overall Study|Adverse Event|1|||
33645482|NCT01864603|63053516|FG000|Stage 2|DSMB design modification|86056|||
33645483|NCT01864603|63053517|FG001|Stage 2|DSMB design modification|92558|||
33645484|NCT01892293|63053528|FG000|Overall Study|Apheresed but not treated|4|||
33645485|NCT01393899|63053535|FG000|Overall Study|Study terminated by sponsor|1|||
33645486|NCT01393899|63053536|FG001|Overall Study|Study terminated by sponsor|0|||
33645487|NCT01393899|63053537|FG002|Overall Study|Study terminated by sponsor|1|||
33645488|NCT01393899|63053535|FG000|Overall Study|Other|1|||
33645489|NCT01393899|63053536|FG001|Overall Study|Other|0|||
33645490|NCT01393899|63053537|FG002|Overall Study|Other|0|||
33645491|NCT01393899|63053535|FG000|Overall Study|Withdrawal by Subject|2|||
33645492|NCT01393899|63053536|FG001|Overall Study|Withdrawal by Subject|2|||
33645493|NCT01393899|63053537|FG002|Overall Study|Withdrawal by Subject|1|||
33645494|NCT01393899|63053535|FG000|Overall Study|Lost to Follow-up|0|||
33645495|NCT01393899|63053536|FG001|Overall Study|Lost to Follow-up|0|||
33645496|NCT01393899|63053537|FG002|Overall Study|Lost to Follow-up|1|||
33645497|NCT01393899|63053535|FG000|Overall Study|Does not meet entrance criteria|1|||
33645498|NCT01393899|63053536|FG001|Overall Study|Does not meet entrance criteria|0|||
33645499|NCT01393899|63053537|FG002|Overall Study|Does not meet entrance criteria|1|||
33645500|NCT01393899|63053535|FG000|Overall Study|Lack of Efficacy|26|||
33645501|NCT01393899|63053536|FG001|Overall Study|Lack of Efficacy|21|||
33645502|NCT01393899|63053537|FG002|Overall Study|Lack of Efficacy|16|||
33645503|NCT01393899|63053535|FG000|Overall Study|Adverse Event|1|||
33645504|NCT01393899|63053536|FG001|Overall Study|Adverse Event|5|||
33645505|NCT01393899|63053537|FG002|Overall Study|Adverse Event|3|||
33645506|NCT01393743|63053549|FG000|Core Study|Adverse Event|5|||
33645507|NCT01393743|63053550|FG001|Core Study|Adverse Event|9|||
33645508|NCT01393743|63053551|FG002|Core Study|Adverse Event|0|||
33645509|NCT01393743|63053549|FG000|Core Study|Lost to Follow-up|1|||
33645510|NCT01393743|63053550|FG001|Core Study|Lost to Follow-up|1|||
33645511|NCT01393743|63053551|FG002|Core Study|Lost to Follow-up|0|||
33645512|NCT01393743|63053549|FG000|Core Study|Participant's Choice|2|||
33645513|NCT01393743|63053550|FG001|Core Study|Participant's Choice|3|||
33645514|NCT01393743|63053551|FG002|Core Study|Participant's Choice|0|||
33645515|NCT01393743|63053549|FG000|Core Study|Inadequate therapeutic effect|2|||
33645516|NCT01393743|63053550|FG001|Core Study|Inadequate therapeutic effect|0|||
33645517|NCT01393743|63053551|FG002|Core Study|Inadequate therapeutic effect|0|||
33645518|NCT01393743|63053549|FG000|Extension Phase|Adverse Event|0|||
33645519|NCT01393743|63053550|FG001|Extension Phase|Adverse Event|0|||
33645520|NCT01393743|63053551|FG002|Extension Phase|Adverse Event|12|||
33645521|NCT01393743|63053549|FG000|Extension Phase|Lost to Follow-up|0|||
33645522|NCT01393743|63053550|FG001|Extension Phase|Lost to Follow-up|0|||
33645523|NCT01393743|63053551|FG002|Extension Phase|Lost to Follow-up|2|||
33645524|NCT01393743|63053549|FG000|Extension Phase|Participant choice|0|||
33645525|NCT01393743|63053550|FG001|Extension Phase|Participant choice|0|||
33645526|NCT01393743|63053551|FG002|Extension Phase|Participant choice|16|||
33645527|NCT01393743|63053549|FG000|Extension Phase|Inadequate therapeutic effect|0|||
33645528|NCT01393743|63053550|FG001|Extension Phase|Inadequate therapeutic effect|0|||
33645529|NCT01393743|63053551|FG002|Extension Phase|Inadequate therapeutic effect|7|||
33645530|NCT01393743|63053549|FG000|Extension Phase|Withdrawal by Subject|0|||
33645531|NCT01393743|63053550|FG001|Extension Phase|Withdrawal by Subject|0|||
33645532|NCT01393743|63053551|FG002|Extension Phase|Withdrawal by Subject|8|||
33645533|NCT01393743|63053549|FG000|Extension Phase|Pregnancy|0|||
33645534|NCT01393743|63053550|FG001|Extension Phase|Pregnancy|0|||
33645535|NCT01393743|63053551|FG002|Extension Phase|Pregnancy|1|||
33645536|NCT01393743|63053549|FG000|Extension Phase|Other|0|||
33645537|NCT01393743|63053550|FG001|Extension Phase|Other|0|||
33645538|NCT01393743|63053551|FG002|Extension Phase|Other|14|||
33645539|NCT01405911|63053570|FG000|Overall Study|Pre-treatment lab AE|0|||
33645540|NCT01405911|63053571|FG001|Overall Study|Pre-treatment lab AE|1|||
33645541|NCT01405911|63053572|FG002|Overall Study|Pre-treatment lab AE|0|||
33645542|NCT01405911|63053570|FG000|Overall Study|Lost to Follow-up|0|||
33645543|NCT01405911|63053571|FG001|Overall Study|Lost to Follow-up|1|||
33645544|NCT01405911|63053572|FG002|Overall Study|Lost to Follow-up|0|||
33645545|NCT01405911|63053570|FG000|Overall Study|Protocol Violation|1|||
33645546|NCT01405911|63053571|FG001|Overall Study|Protocol Violation|0|||
33645547|NCT01405911|63053572|FG002|Overall Study|Protocol Violation|0|||
33645548|NCT01405911|63053570|FG000|Overall Study|Withdrawal by Subject|3|||
33645549|NCT01405911|63053571|FG001|Overall Study|Withdrawal by Subject|1|||
33645550|NCT01405911|63053572|FG002|Overall Study|Withdrawal by Subject|1|||
33645551|NCT01425801|63053580|FG000|Period 1|Withdrawal by Subject|0|||
33645552|NCT01425801|63053581|FG001|Period 1|Withdrawal by Subject|0|||
33645553|NCT01425801|63053582|FG002|Period 1|Withdrawal by Subject|0|||
33645554|NCT01425801|63053583|FG003|Period 1|Withdrawal by Subject|0|||
33645555|NCT01425801|63053584|FG004|Period 1|Withdrawal by Subject|1|||
33645556|NCT01425801|63053585|FG005|Period 1|Withdrawal by Subject|0|||
33645557|NCT01425801|63053580|FG000|Period 2|Withdrawal by Subject|0|||
33645558|NCT01425801|63053581|FG001|Period 2|Withdrawal by Subject|0|||
33645559|NCT01425801|63053582|FG002|Period 2|Withdrawal by Subject|0|||
33645560|NCT01425801|63053583|FG003|Period 2|Withdrawal by Subject|0|||
33645561|NCT01425801|63053584|FG004|Period 2|Withdrawal by Subject|1|||
33645562|NCT01425801|63053585|FG005|Period 2|Withdrawal by Subject|0|||
33645563|NCT01425801|63053580|FG000|Period 3|Stability criteria not fullfilled|0|||
33645564|NCT01425801|63053581|FG001|Period 3|Stability criteria not fullfilled|0|||
33645565|NCT01425801|63053582|FG002|Period 3|Stability criteria not fullfilled|1|||
33645566|NCT01425801|63053583|FG003|Period 3|Stability criteria not fullfilled|0|||
33645567|NCT01425801|63053584|FG004|Period 3|Stability criteria not fullfilled|0|||
33645568|NCT01425801|63053585|FG005|Period 3|Stability criteria not fullfilled|0|||
33645569|NCT01425801|63053580|FG000|Period 4|Not able to maintain visit schedule|0|||
33645570|NCT01425801|63053581|FG001|Period 4|Not able to maintain visit schedule|0|||
33645571|NCT01425801|63053582|FG002|Period 4|Not able to maintain visit schedule|1|||
33645572|NCT01425801|63053583|FG003|Period 4|Not able to maintain visit schedule|0|||
33645573|NCT01425801|63053584|FG004|Period 4|Not able to maintain visit schedule|0|||
33645574|NCT01425801|63053585|FG005|Period 4|Not able to maintain visit schedule|0|||
33645575|NCT01425723|63053610|FG000|Overall Study|Lack of Efficacy|0|||
33645576|NCT01425723|63053611|FG001|Overall Study|Lack of Efficacy|1|||
33645577|NCT01425723|63053610|FG000|Overall Study|Withdrawal by Subject|1|||
33645578|NCT01425723|63053611|FG001|Overall Study|Withdrawal by Subject|4|||
33645579|NCT01425723|63053610|FG000|Overall Study|Lost to Follow-up|0|||
33645580|NCT01425723|63053611|FG001|Overall Study|Lost to Follow-up|3|||
33645581|NCT01425723|63053610|FG000|Overall Study|Physician Decision|2|||
33645582|NCT01425723|63053611|FG001|Overall Study|Physician Decision|0|||
33645583|NCT01425723|63053610|FG000|Overall Study|Other|1|||
33645584|NCT01425723|63053611|FG001|Overall Study|Other|10|||
33645585|NCT01424397|63053642|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
33645586|NCT01424397|63053643|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
33645587|NCT01424397|63053644|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
33645588|NCT01424397|63053645|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
33645589|NCT01424397|63053646|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
33645590|NCT01424397|63053647|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
33645591|NCT01424397|63053648|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
33645592|NCT01424397|63053649|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
33645593|NCT01424397|63053650|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
33645594|NCT01424397|63053651|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
33645595|NCT01424397|63053652|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
33645596|NCT01424397|63053653|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
33327207|NCT01185353|62703805|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33327208|NCT01185353|62703806|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33327209|NCT01185353|62703797|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33327210|NCT01185353|62703798|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33543111|NCT02701634|62933883|FG000|Overall Study|Study terminated by Sponsor|15|||
33543112|NCT02701634|62933884|FG001|Overall Study|Study terminated by Sponsor|17|||
33543113|NCT02701634|62933883|FG000|Overall Study|Withdrew Consent|6|||
33543114|NCT02701634|62933884|FG001|Overall Study|Withdrew Consent|7|||
33543115|NCT02701634|62933883|FG000|Overall Study|Randomized but not treated|1|||
33543116|NCT02701634|62933884|FG001|Overall Study|Randomized but not treated|0|||
33543117|NCT02442765|62933894|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
33543118|NCT02442765|62933895|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
33543119|NCT02442765|62933896|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
33543120|NCT02442765|62933897|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
33543121|NCT02442765|62933898|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
33543122|NCT02442765|62933899|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
33543123|NCT02442765|62933900|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
33543124|NCT02442765|62933901|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
33543125|NCT02442765|62933894|FG000|Stage 2- (Days 43 to 85)|Death|0|||
33543126|NCT02442765|62933895|FG001|Stage 2- (Days 43 to 85)|Death|0|||
33543127|NCT02442765|62933896|FG002|Stage 2- (Days 43 to 85)|Death|0|||
33543128|NCT02442765|62933897|FG003|Stage 2- (Days 43 to 85)|Death|1|||
33543129|NCT02442765|62933898|FG004|Stage 2- (Days 43 to 85)|Death|1|||
33543130|NCT02442765|62933899|FG005|Stage 2- (Days 43 to 85)|Death|0|||
33543131|NCT02442765|62933900|FG006|Stage 2- (Days 43 to 85)|Death|2|||
33645597|NCT01392963|63053669|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
33645598|NCT01392963|63053670|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
33327211|NCT01185353|62703799|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33327212|NCT01185353|62703800|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
33327213|NCT01185353|62703801|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33327214|NCT01185353|62703802|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33327215|NCT01185353|62703803|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
33327216|NCT01185353|62703804|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33327217|NCT01185353|62703805|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33327218|NCT01185353|62703806|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33327219|NCT01185353|62703797|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
33327220|NCT01185353|62703798|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
33327221|NCT01185353|62703799|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
33327222|NCT01185353|62703800|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
33327223|NCT01185353|62703801|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
33543132|NCT02442765|62933901|FG007|Stage 2- (Days 43 to 85)|Death|0|||
33645599|NCT01392963|63053669|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
33645600|NCT01392963|63053670|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
33645601|NCT01392963|63053669|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
33645602|NCT01392963|63053670|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
33543133|NCT02442765|62933894|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
33543134|NCT02442765|62933895|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
33543135|NCT02442765|62933896|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
33645603|NCT01392573|63053680|FG000|Overall Study|Adverse Event|1|||
33645604|NCT01392573|63053681|FG001|Overall Study|Adverse Event|3|||
33645605|NCT01392573|63053680|FG000|Overall Study|Lack of Efficacy|1|||
33645606|NCT01392573|63053681|FG001|Overall Study|Lack of Efficacy|2|||
33645607|NCT01392573|63053680|FG000|Overall Study|Protocol Violation|0|||
33645608|NCT01392573|63053681|FG001|Overall Study|Protocol Violation|2|||
33645609|NCT01392573|63053680|FG000|Overall Study|Withdrawal Criteria|13|||
33645610|NCT01392573|63053681|FG001|Overall Study|Withdrawal Criteria|15|||
33645611|NCT01392573|63053680|FG000|Overall Study|Site closure|8|||
33645612|NCT01392573|63053681|FG001|Overall Study|Site closure|7|||
33645613|NCT01392573|63053680|FG000|Overall Study|Unclassified|9|||
33645614|NCT01392573|63053681|FG001|Overall Study|Unclassified|6|||
33645615|NCT01392495|63053687|FG000|Overall Study|Death|3|||
33645616|NCT01392495|63053687|FG000|Overall Study|Administrative problems|8|||
33645617|NCT01392495|63053687|FG000|Overall Study|Withdrawal by Subject|2|||
33645618|NCT01392495|63053687|FG000|Overall Study|Adverse Event|3|||
33645619|NCT01405053|63053695|FG000|Overall Study|Adverse Event|3|||
33645620|NCT01405053|63053696|FG001|Overall Study|Adverse Event|0|||
33645621|NCT01405053|63053695|FG000|Overall Study|Lost to Follow-up|0|||
33645622|NCT01405053|63053696|FG001|Overall Study|Lost to Follow-up|1|||
33645623|NCT01405053|63053695|FG000|Overall Study|Participant choice|2|||
33645624|NCT01405053|63053696|FG001|Overall Study|Participant choice|1|||
33645625|NCT01405053|63053695|FG000|Overall Study|Inadequate therapeutic effect|2|||
33645626|NCT01405053|63053696|FG001|Overall Study|Inadequate therapeutic effect|1|||
33645627|NCT01405053|63053695|FG000|Overall Study|Withdrawal by Subject|3|||
33645628|NCT01405053|63053696|FG001|Overall Study|Withdrawal by Subject|4|||
33645629|NCT01405053|63053695|FG000|Overall Study|Other|0|||
33645630|NCT01405053|63053696|FG001|Overall Study|Other|1|||
33645631|NCT01403805|63053704|FG000|Overall Study|Withdrawal by Subject|0|||
33645632|NCT01403805|63053705|FG001|Overall Study|Withdrawal by Subject|4|||
33645633|NCT01403805|63053704|FG000|Overall Study|Lost to Follow-up|0|||
33645634|NCT01403805|63053705|FG001|Overall Study|Lost to Follow-up|2|||
33645635|NCT01403805|63053704|FG000|Overall Study|Death|0|||
33645636|NCT01403805|63053705|FG001|Overall Study|Death|1|||
33645637|NCT01423617|63053717|FG000|Overall Study|Lost to Follow-up|0|||
33645638|NCT01423617|63053718|FG001|Overall Study|Lost to Follow-up|1|||
33645639|NCT01392183|63053726|FG000|First Drug Administration|Adverse Event|3|||
33645640|NCT01392183|63053727|FG001|First Drug Administration|Adverse Event|2|||
33645641|NCT01392183|63053726|FG000|First Drug Administration|Death|1|||
33645642|NCT01392183|63053727|FG001|First Drug Administration|Death|0|||
33645643|NCT01392183|63053726|FG000|First Drug Administration|Withdrawal by Subject|10|||
33645644|NCT01392183|63053727|FG001|First Drug Administration|Withdrawal by Subject|17|||
33645645|NCT01751906|63053737|FG000|Overall Study|Lost to Follow-up|151|||
33645646|NCT01751906|63053738|FG001|Overall Study|Lost to Follow-up|68|||
33645647|NCT01751906|63053737|FG000|Overall Study|Withdrawal by Subject|22|||
33645648|NCT01751906|63053738|FG001|Overall Study|Withdrawal by Subject|18|||
33645649|NCT01751906|63053737|FG000|Overall Study|Physician Decision|5|||
33645650|NCT01751906|63053738|FG001|Overall Study|Physician Decision|2|||
33645651|NCT01751906|63053737|FG000|Overall Study|Death|84|||
33645652|NCT01751906|63053738|FG001|Overall Study|Death|43|||
33645653|NCT01751906|63053737|FG000|Overall Study|Denied on premises for follow-up by law|1|||
33645654|NCT01751906|63053738|FG001|Overall Study|Denied on premises for follow-up by law|0|||
33645655|NCT01402947|63053746|FG000|First Intervention|Adverse Event|0|||
33645656|NCT01402947|63053747|FG001|First Intervention|Adverse Event|1|||
33645657|NCT01402869|63053756|FG000|Overall Study|Required Tooth Extraction|0|||
33645658|NCT01402869|63053757|FG001|Overall Study|Required Tooth Extraction|0|||
33543136|NCT02442765|62933897|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
33543137|NCT02442765|62933898|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
33543138|NCT02442765|62933899|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
33543139|NCT02442765|62933900|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
33543140|NCT02442765|62933901|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
33543141|NCT02442765|62933894|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
33543142|NCT02442765|62933895|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
33543143|NCT02442765|62933896|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
33645659|NCT01402869|63053758|FG002|Overall Study|Required Tooth Extraction|1|||
33645660|NCT01391793|63053768|FG000|Overall Study|Ineligible|3|||
33645661|NCT01391793|63053769|FG001|Overall Study|Ineligible|0|||
33645662|NCT01391793|63053768|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
33645663|NCT01391793|63053769|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
33645664|NCT01391793|63053768|FG000|Overall Study|No DMSA|73|||
33645665|NCT01391793|63053769|FG001|Overall Study|No DMSA|57|||
33645666|NCT01422915|63053775|FG000|Overall Study|Adverse Event|1|||
33645667|NCT01727024|63053780|FG000|Period 1|Lost to Follow-up|1|||
33645668|NCT01727024|63053781|FG001|Period 1|Lost to Follow-up|1|||
33645669|NCT01727024|63053780|FG000|Period 1|Withdrawal by Subject|2|||
33645670|NCT01727024|63053781|FG001|Period 1|Withdrawal by Subject|3|||
33645671|NCT01422213|63053790|FG000|Overall Study|Adverse Event|8|||
33543144|NCT02442765|62933897|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
33645672|NCT01422213|63053791|FG001|Overall Study|Adverse Event|7|||
33645673|NCT01422213|63053792|FG002|Overall Study|Adverse Event|11|||
33645674|NCT01422213|63053790|FG000|Overall Study|Lack of Efficacy|10|||
33645675|NCT01422213|63053791|FG001|Overall Study|Lack of Efficacy|2|||
33645676|NCT01422213|63053792|FG002|Overall Study|Lack of Efficacy|2|||
33645677|NCT01422213|63053790|FG000|Overall Study|Non-compliance with study drug|0|||
33645678|NCT01422213|63053791|FG001|Overall Study|Non-compliance with study drug|1|||
33645679|NCT01422213|63053792|FG002|Overall Study|Non-compliance with study drug|0|||
33645680|NCT01422213|63053790|FG000|Overall Study|Protocol Violation|0|||
33645681|NCT01422213|63053791|FG001|Overall Study|Protocol Violation|2|||
33645682|NCT01422213|63053792|FG002|Overall Study|Protocol Violation|4|||
33645683|NCT01422213|63053790|FG000|Overall Study|Withdrawal of Consent|7|||
33645684|NCT01422213|63053791|FG001|Overall Study|Withdrawal of Consent|3|||
33645685|NCT01422213|63053792|FG002|Overall Study|Withdrawal of Consent|5|||
33645686|NCT01422213|63053790|FG000|Overall Study|Lost to Follow-up|3|||
33645687|NCT01422213|63053791|FG001|Overall Study|Lost to Follow-up|3|||
33645688|NCT01422213|63053792|FG002|Overall Study|Lost to Follow-up|5|||
33645689|NCT01422213|63053790|FG000|Overall Study|Administrative or Other Reason(s)|5|||
33645690|NCT01422213|63053791|FG001|Overall Study|Administrative or Other Reason(s)|4|||
33645691|NCT01422213|63053792|FG002|Overall Study|Administrative or Other Reason(s)|2|||
33645692|NCT01390857|63053800|FG000|Overall Study|Protocol Violation|2|||
33645693|NCT01390857|63053800|FG000|Overall Study|Lost to Follow-up|1|||
33645694|NCT01390857|63053800|FG000|Overall Study|No Visit after the First Visit|7|||
33645695|NCT01725386|63053806|FG000|Overall Study|Death|84|||
33645696|NCT01725386|63053807|FG001|Overall Study|Death|40|||
33645697|NCT01725386|63053806|FG000|Overall Study|Lost to Follow-up|81|||
33645698|NCT01725386|63053807|FG001|Overall Study|Lost to Follow-up|6|||
33645699|NCT01725386|63053806|FG000|Overall Study|Withdrawal by Subject|10|||
33645700|NCT01725386|63053807|FG001|Overall Study|Withdrawal by Subject|0|||
33645701|NCT01402011|63053816|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
33645702|NCT01402011|63053817|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
33645703|NCT01402011|63053818|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
33645704|NCT01402011|63053816|FG000|Active Treatment Period|Withdrawal by Subject|1|||
33645705|NCT01402011|63053817|FG001|Active Treatment Period|Withdrawal by Subject|3|||
33645706|NCT01402011|63053818|FG002|Active Treatment Period|Withdrawal by Subject|0|||
33645707|NCT01402011|63053816|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
33645708|NCT01402011|63053817|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
33645709|NCT01402011|63053818|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
33645710|NCT01421667|63053833|FG000|Overall Study|Withdrawal by Subject|0|||
33645711|NCT01421667|63053834|FG001|Overall Study|Withdrawal by Subject|1|||
33645712|NCT01421667|63053835|FG002|Overall Study|Withdrawal by Subject|2|||
33645713|NCT01421667|63053836|FG003|Overall Study|Withdrawal by Subject|1|||
33645714|NCT01421667|63053833|FG000|Overall Study|Lost to Follow-up|0|||
33645715|NCT01421667|63053834|FG001|Overall Study|Lost to Follow-up|1|||
33645716|NCT01421667|63053835|FG002|Overall Study|Lost to Follow-up|0|||
33645717|NCT01421667|63053836|FG003|Overall Study|Lost to Follow-up|0|||
33645718|NCT01390779|63053854|FG000|Overall Study|Physician Decision|1|||
33645719|NCT01891669|63053868|FG000|Overall Study|Death|0|||
33645720|NCT01891669|63053869|FG001|Overall Study|Death|0|||
33645721|NCT01891669|63053870|FG002|Overall Study|Death|0|||
33645722|NCT01891669|63053871|FG003|Overall Study|Death|0|||
33645723|NCT01891669|63053872|FG004|Overall Study|Death|0|||
33645724|NCT01891669|63053873|FG005|Overall Study|Death|0|||
33645725|NCT01891669|63053874|FG006|Overall Study|Death|0|||
33645726|NCT01891669|63053875|FG007|Overall Study|Death|1|||
33645727|NCT01891669|63053876|FG008|Overall Study|Death|0|||
33645728|NCT01891669|63053877|FG009|Overall Study|Death|1|||
33543145|NCT02442765|62933898|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
33543146|NCT02442765|62933899|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
33543147|NCT02442765|62933900|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
33543148|NCT02442765|62933901|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
33543149|NCT02442765|62933894|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
33543150|NCT02442765|62933895|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
33543151|NCT02442765|62933896|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
33543152|NCT02442765|62933897|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
33645729|NCT01891669|63053868|FG000|Overall Study|Withdrawal by Subject|1|||
33645730|NCT01891669|63053869|FG001|Overall Study|Withdrawal by Subject|1|||
33645731|NCT01891669|63053870|FG002|Overall Study|Withdrawal by Subject|0|||
33645732|NCT01891669|63053871|FG003|Overall Study|Withdrawal by Subject|0|||
33645733|NCT01891669|63053872|FG004|Overall Study|Withdrawal by Subject|0|||
33645734|NCT01891669|63053873|FG005|Overall Study|Withdrawal by Subject|0|||
33645735|NCT01891669|63053874|FG006|Overall Study|Withdrawal by Subject|1|||
33645736|NCT01891669|63053875|FG007|Overall Study|Withdrawal by Subject|2|||
33645737|NCT01891669|63053876|FG008|Overall Study|Withdrawal by Subject|1|||
33645738|NCT01891669|63053877|FG009|Overall Study|Withdrawal by Subject|1|||
33645739|NCT01891669|63053868|FG000|Overall Study|Other|1|||
33645740|NCT01891669|63053869|FG001|Overall Study|Other|0|||
33645741|NCT01891669|63053870|FG002|Overall Study|Other|0|||
33645742|NCT01891669|63053871|FG003|Overall Study|Other|0|||
33645743|NCT01891669|63053872|FG004|Overall Study|Other|0|||
33645744|NCT01891669|63053873|FG005|Overall Study|Other|0|||
33645745|NCT01891669|63053874|FG006|Overall Study|Other|0|||
33645746|NCT01891669|63053875|FG007|Overall Study|Other|1|||
33645747|NCT01891669|63053876|FG008|Overall Study|Other|0|||
33645748|NCT01891669|63053877|FG009|Overall Study|Other|0|||
33645749|NCT01421511|63053910|FG000|Overall Study|Lost to Follow-up|11|||
33645750|NCT01421511|63053911|FG001|Overall Study|Lost to Follow-up|14|||
33645751|NCT01421511|63053910|FG000|Overall Study|Randomized but didn't receive study drug|1|||
33645752|NCT01421511|63053911|FG001|Overall Study|Randomized but didn't receive study drug|7|||
33645753|NCT01421511|63053910|FG000|Overall Study|Physician Decision|0|||
33645754|NCT01421511|63053911|FG001|Overall Study|Physician Decision|1|||
33645755|NCT01421511|63053910|FG000|Overall Study|Withdrawal by Subject|6|||
33645756|NCT01421511|63053911|FG001|Overall Study|Withdrawal by Subject|5|||
33645757|NCT01421511|63053910|FG000|Overall Study|Death|1|||
33645758|NCT01421511|63053911|FG001|Overall Study|Death|1|||
33645759|NCT01864525|63053920|FG000|Overall Study|Adverse Event|1|||
33645760|NCT01864525|63053921|FG001|Overall Study|Adverse Event|0|||
33645761|NCT01421277|63053929|FG000|Overall Study|Lack of qualifying event|0|||
33645762|NCT01421277|63053930|FG001|Overall Study|Lack of qualifying event|61|||
33645763|NCT01421277|63053929|FG000|Overall Study|Incomplete baseline data|0|||
33645764|NCT01421277|63053930|FG001|Overall Study|Incomplete baseline data|31|||
33645765|NCT01891357|63053936|FG000|Overall Study|Protocol Violation|3|||
33645766|NCT01420965|63053943|FG000|Overall Study|Withdrawal by Subject|1|||
33645767|NCT01420965|63053944|FG001|Overall Study|Withdrawal by Subject|0|||
33645768|NCT01420965|63053945|FG002|Overall Study|Withdrawal by Subject|0|||
33645769|NCT01420965|63053943|FG000|Overall Study|Adverse Event|0|||
33645770|NCT01420965|63053944|FG001|Overall Study|Adverse Event|1|||
33645771|NCT01420965|63053945|FG002|Overall Study|Adverse Event|0|||
33645772|NCT01390389|63053955|FG000|Overall Study|Withdrawal by Subject|2|||
33645773|NCT01390389|63053956|FG001|Overall Study|Withdrawal by Subject|0|||
33645774|NCT01390389|63053955|FG000|Overall Study|Screen Fail|2|||
33645775|NCT01390389|63053956|FG001|Overall Study|Screen Fail|1|||
33645776|NCT01401465|63053968|FG000|Treatment Period 1|Adverse Event|4|||
33645777|NCT01401465|63053969|FG001|Treatment Period 1|Adverse Event|1|||
33645778|NCT01401465|63053968|FG000|Treatment Period 1|Pregnancy|0|||
33645779|NCT01401465|63053969|FG001|Treatment Period 1|Pregnancy|1|||
33645780|NCT01401465|63053968|FG000|Treatment Period 1|Protocol Violation|5|||
33645781|NCT01401465|63053969|FG001|Treatment Period 1|Protocol Violation|0|||
33645782|NCT01401465|63053968|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33645783|NCT01401465|63053969|FG001|Treatment Period 1|Withdrawal by Subject|4|||
33645784|NCT01401465|63053968|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
33645785|NCT01401465|63053969|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
33645786|NCT01401465|63053968|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
33645787|NCT01401465|63053969|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
33645788|NCT01401465|63053968|FG000|Treatment Period 1|Scheduling Difficulties|1|||
33645789|NCT01401465|63053969|FG001|Treatment Period 1|Scheduling Difficulties|1|||
33645790|NCT01401465|63053968|FG000|Treatment Period 2|Lost to Follow-up|0|||
33645791|NCT01401465|63053969|FG001|Treatment Period 2|Lost to Follow-up|1|||
33645792|NCT01401465|63053968|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33645793|NCT01401465|63053969|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33645794|NCT01401153|63053980|FG000|First Test Day|Learning disabilities; illness|1|||
33645795|NCT01401153|63053981|FG001|First Test Day|Learning disabilities; illness|10|||
33645796|NCT01401153|63053980|FG000|Second Test Day|illness|0|||
33645797|NCT01401153|63053981|FG001|Second Test Day|illness|5|||
33645798|NCT01890967|63053994|FG000|Overall Study|Adverse Event|3|||
33645799|NCT01890967|63053995|FG001|Overall Study|Adverse Event|3|||
33645800|NCT01890967|63053996|FG002|Overall Study|Adverse Event|3|||
33645801|NCT01890967|63053997|FG003|Overall Study|Adverse Event|2|||
33645802|NCT01890967|63053998|FG004|Overall Study|Adverse Event|1|||
33645803|NCT01890967|63053999|FG005|Overall Study|Adverse Event|7|||
33645804|NCT01890967|63053994|FG000|Overall Study|Death|1|||
33645805|NCT01890967|63053995|FG001|Overall Study|Death|0|||
33645806|NCT01890967|63053996|FG002|Overall Study|Death|0|||
33645807|NCT01890967|63053997|FG003|Overall Study|Death|0|||
33645808|NCT01890967|63053998|FG004|Overall Study|Death|0|||
33645809|NCT01890967|63053999|FG005|Overall Study|Death|0|||
33645810|NCT01890967|63053994|FG000|Overall Study|Lost to Follow-up|1|||
33645811|NCT01890967|63053995|FG001|Overall Study|Lost to Follow-up|1|||
33645812|NCT01890967|63053996|FG002|Overall Study|Lost to Follow-up|1|||
33645813|NCT01890967|63053997|FG003|Overall Study|Lost to Follow-up|1|||
33645814|NCT01890967|63053998|FG004|Overall Study|Lost to Follow-up|0|||
33645815|NCT01890967|63053999|FG005|Overall Study|Lost to Follow-up|1|||
33645816|NCT01890967|63053994|FG000|Overall Study|Protocol Violation|0|||
33645817|NCT01890967|63053995|FG001|Overall Study|Protocol Violation|3|||
33645818|NCT01890967|63053996|FG002|Overall Study|Protocol Violation|3|||
33645819|NCT01890967|63053997|FG003|Overall Study|Protocol Violation|2|||
33645820|NCT01890967|63053998|FG004|Overall Study|Protocol Violation|4|||
33645821|NCT01890967|63053999|FG005|Overall Study|Protocol Violation|1|||
33645822|NCT01890967|63053994|FG000|Overall Study|Sponsor Decision|2|||
33645823|NCT01890967|63053995|FG001|Overall Study|Sponsor Decision|0|||
33645824|NCT01890967|63053996|FG002|Overall Study|Sponsor Decision|1|||
33645825|NCT01890967|63053997|FG003|Overall Study|Sponsor Decision|3|||
33645826|NCT01890967|63053998|FG004|Overall Study|Sponsor Decision|2|||
33645827|NCT01890967|63053999|FG005|Overall Study|Sponsor Decision|3|||
33645828|NCT01890967|63053994|FG000|Overall Study|Withdrawal by Subject|3|||
33645829|NCT01890967|63053995|FG001|Overall Study|Withdrawal by Subject|4|||
33645830|NCT01890967|63053996|FG002|Overall Study|Withdrawal by Subject|2|||
33645831|NCT01890967|63053997|FG003|Overall Study|Withdrawal by Subject|3|||
33645832|NCT01890967|63053998|FG004|Overall Study|Withdrawal by Subject|3|||
33645833|NCT01890967|63053999|FG005|Overall Study|Withdrawal by Subject|1|||
33645834|NCT01400919|63054018|FG000|Overall Study|Withdrawal by Subject|4|||
33645835|NCT01400919|63054018|FG000|Overall Study|Lost to Follow-up|2|||
33645836|NCT01400919|63054018|FG000|Overall Study|Missed visit|2|||
33645837|NCT01864291|63054022|FG000|Overall Study|need for revision surgery|2|||
33645838|NCT01400841|63054026|FG000|Initial Study Phase (6 Months)|Death|1|||
33645839|NCT01400841|63054026|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
33645840|NCT01863667|63054032|FG000|Overall Study|Adverse Event|1|||
33645841|NCT01863667|63054033|FG001|Overall Study|Adverse Event|0|||
33645842|NCT01863667|63054032|FG000|Overall Study|Study terminated by Sponsor|30|||
33645843|NCT01863667|63054033|FG001|Overall Study|Study terminated by Sponsor|30|||
33645844|NCT01863667|63054032|FG000|Overall Study|Withdrawal by Subject|2|||
33645845|NCT01863667|63054033|FG001|Overall Study|Withdrawal by Subject|2|||
33645846|NCT01614769|63054039|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
33645847|NCT01614769|63054040|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
33645848|NCT01614769|63054041|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
33645849|NCT01614769|63054042|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
33645850|NCT01614769|63054043|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
33645851|NCT01614769|63054044|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
33645852|NCT01614769|63054039|FG000|Period 1|Protocol Violation|0|||
33645853|NCT01614769|63054040|FG001|Period 1|Protocol Violation|0|||
33645854|NCT01614769|63054041|FG002|Period 1|Protocol Violation|0|||
33645855|NCT01614769|63054042|FG003|Period 1|Protocol Violation|1|||
33645856|NCT01614769|63054043|FG004|Period 1|Protocol Violation|0|||
33645857|NCT01614769|63054044|FG005|Period 1|Protocol Violation|0|||
33645858|NCT01614769|63054039|FG000|Period 1|Withdrawal by Subject|1|||
33645859|NCT01614769|63054040|FG001|Period 1|Withdrawal by Subject|0|||
33645860|NCT01614769|63054041|FG002|Period 1|Withdrawal by Subject|0|||
33645861|NCT01614769|63054042|FG003|Period 1|Withdrawal by Subject|0|||
33645862|NCT01614769|63054043|FG004|Period 1|Withdrawal by Subject|0|||
33645863|NCT01614769|63054044|FG005|Period 1|Withdrawal by Subject|0|||
33645864|NCT01614769|63054039|FG000|Period 3|Withdrawal by Subject|0|||
33645865|NCT01614769|63054040|FG001|Period 3|Withdrawal by Subject|0|||
33645866|NCT01614769|63054041|FG002|Period 3|Withdrawal by Subject|1|||
33645867|NCT01614769|63054042|FG003|Period 3|Withdrawal by Subject|0|||
33645868|NCT01614769|63054043|FG004|Period 3|Withdrawal by Subject|0|||
33645869|NCT01614769|63054044|FG005|Period 3|Withdrawal by Subject|0|||
33645870|NCT01614457|63054054|FG000|Overall Study|Non-Compliance|1|||
33645871|NCT01614457|63054055|FG001|Overall Study|Non-Compliance|0|||
33645872|NCT01614457|63054054|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
33645873|NCT01614457|63054055|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
33645874|NCT01863433|63054061|FG000|Overall Study|Protocol Violation|1|||
33645875|NCT01862029|63054065|FG000|Overall Study|Physician Decision|1|||
33645876|NCT01835431|63054072|FG000|Overall Study|Adverse Event|1|||
33645877|NCT01835431|63054073|FG001|Overall Study|Adverse Event|0|||
33645878|NCT01835431|63054072|FG000|Overall Study|other|0|||
33645879|NCT01835431|63054073|FG001|Overall Study|other|2|||
33645880|NCT01835431|63054072|FG000|Overall Study|Withdrawal by Subject|6|||
33645881|NCT01835431|63054073|FG001|Overall Study|Withdrawal by Subject|10|||
33645882|NCT01835431|63054072|FG000|Overall Study|Protocol Violation|1|||
33645883|NCT01835431|63054073|FG001|Overall Study|Protocol Violation|0|||
33645884|NCT01880593|63054081|FG000|Overall Study|Adverse Event|1|||
33645885|NCT01880593|63054082|FG001|Overall Study|Adverse Event|0|||
33645886|NCT01880593|63054081|FG000|Overall Study|Lack of Efficacy|1|||
33645887|NCT01880593|63054082|FG001|Overall Study|Lack of Efficacy|5|||
33645888|NCT01880593|63054081|FG000|Overall Study|Withdrawal by Subject|6|||
33645889|NCT01880593|63054082|FG001|Overall Study|Withdrawal by Subject|1|||
33645890|NCT01400451|63054091|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
33645891|NCT01400451|63054092|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
33645892|NCT01400451|63054093|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
33645893|NCT01400451|63054091|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
33645894|NCT01400451|63054092|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
33543153|NCT02442765|62933898|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
33544262|NCT03010501|62935108|FG002|Study Week 1|Withdrawal by Subject|0|||
33645895|NCT01400451|63054093|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
33645896|NCT01400451|63054091|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
33645897|NCT01400451|63054092|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
33645898|NCT01400451|63054093|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
33645899|NCT01400451|63054091|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
33645900|NCT01400451|63054092|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
33645901|NCT01400451|63054093|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
33645902|NCT01400451|63054091|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
33645903|NCT01400451|63054092|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
33645904|NCT01400451|63054093|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
33645905|NCT01400139|63054106|FG000|HYD Core Study|Adverse Event|210|||
33645906|NCT01400139|63054106|FG000|HYD Core Study|Lack of Efficacy|59|||
33645907|NCT01400139|63054106|FG000|HYD Core Study|Withdrawal by Subject|114|||
33645908|NCT01400139|63054106|FG000|HYD Core Study|Lost to Follow-up|39|||
33645909|NCT01400139|63054106|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
33645910|NCT01400139|63054106|FG000|HYD Core Study|Administrative|56|||
33645911|NCT01400139|63054106|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
33645912|NCT01400139|63054106|FG000|HYD Extension Period|Adverse Event|8|||
33645913|NCT01400139|63054106|FG000|HYD Extension Period|Withdrawal by Subject|5|||
33645914|NCT01400139|63054106|FG000|HYD Extension Period|Administrative|10|||
33645915|NCT01399905|63054114|FG000|Overall Study|Withdrawal by Subject|1|||
33645916|NCT01399905|63054115|FG001|Overall Study|Withdrawal by Subject|1|||
33645917|NCT01725308|63054129|FG000|Treatment Period I|Did Not Receive Drug|1|||
33645918|NCT01725308|63054130|FG001|Treatment Period I|Did Not Receive Drug|0|||
33645919|NCT01725308|63054131|FG002|Treatment Period I|Did Not Receive Drug|0|||
33645920|NCT01725308|63054129|FG000|Treatment Period I|Adverse Event|5|||
33645921|NCT01725308|63054130|FG001|Treatment Period I|Adverse Event|4|||
33645922|NCT01725308|63054131|FG002|Treatment Period I|Adverse Event|21|||
33645923|NCT01725308|63054129|FG000|Treatment Period I|Insufficient Response|7|||
33645924|NCT01725308|63054130|FG001|Treatment Period I|Insufficient Response|0|||
33645925|NCT01725308|63054131|FG002|Treatment Period I|Insufficient Response|5|||
33645926|NCT01725308|63054129|FG000|Treatment Period I|Worsening of the Target Disease|8|||
33645927|NCT01725308|63054130|FG001|Treatment Period I|Worsening of the Target Disease|0|||
33645928|NCT01725308|63054131|FG002|Treatment Period I|Worsening of the Target Disease|2|||
33645929|NCT01725308|63054129|FG000|Treatment Period I|Changes in the Episodes|3|||
33645930|NCT01725308|63054130|FG001|Treatment Period I|Changes in the Episodes|0|||
33645931|NCT01725308|63054131|FG002|Treatment Period I|Changes in the Episodes|2|||
33645932|NCT01725308|63054129|FG000|Treatment Period I|Withdrawal of Consent|12|||
33645933|NCT01725308|63054130|FG001|Treatment Period I|Withdrawal of Consent|7|||
33645934|NCT01725308|63054131|FG002|Treatment Period I|Withdrawal of Consent|5|||
33645935|NCT01725308|63054129|FG000|Treatment Period I|Lost to Follow-up|3|||
33645936|NCT01725308|63054130|FG001|Treatment Period I|Lost to Follow-up|2|||
33645937|NCT01725308|63054131|FG002|Treatment Period I|Lost to Follow-up|2|||
33645938|NCT01725308|63054129|FG000|Treatment Period I|Protocol Deviations|3|||
33645939|NCT01725308|63054130|FG001|Treatment Period I|Protocol Deviations|1|||
33645940|NCT01725308|63054131|FG002|Treatment Period I|Protocol Deviations|1|||
33645941|NCT01725308|63054129|FG000|Treatment Period I|Miscellaneous|2|||
33645942|NCT01725308|63054130|FG001|Treatment Period I|Miscellaneous|0|||
33645943|NCT01725308|63054131|FG002|Treatment Period I|Miscellaneous|3|||
33645944|NCT01725308|63054129|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
33645945|NCT01725308|63054130|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
33645946|NCT01725308|63054131|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
33645947|NCT01725308|63054129|FG000|Treatment Period II|Did Not Receive Drug|4|||
33645948|NCT01725308|63054130|FG001|Treatment Period II|Did Not Receive Drug|0|||
33645949|NCT01725308|63054131|FG002|Treatment Period II|Did Not Receive Drug|0|||
33645950|NCT01725308|63054129|FG000|Treatment Period II|Adverse Event|13|||
33645951|NCT01725308|63054130|FG001|Treatment Period II|Adverse Event|8|||
33645952|NCT01725308|63054131|FG002|Treatment Period II|Adverse Event|20|||
33645953|NCT01725308|63054129|FG000|Treatment Period II|Insufficient Response|2|||
33645954|NCT01725308|63054130|FG001|Treatment Period II|Insufficient Response|4|||
33645955|NCT01725308|63054131|FG002|Treatment Period II|Insufficient Response|6|||
33645956|NCT01725308|63054129|FG000|Treatment Period II|Worsening of the Target Disease|1|||
33645957|NCT01725308|63054130|FG001|Treatment Period II|Worsening of the Target Disease|4|||
33645958|NCT01725308|63054131|FG002|Treatment Period II|Worsening of the Target Disease|2|||
33645959|NCT01725308|63054129|FG000|Treatment Period II|Changes in the Episodes|1|||
33645960|NCT01725308|63054130|FG001|Treatment Period II|Changes in the Episodes|0|||
33645961|NCT01725308|63054131|FG002|Treatment Period II|Changes in the Episodes|5|||
33645962|NCT01725308|63054129|FG000|Treatment Period II|Withdrawal of Consent|28|||
33645963|NCT01725308|63054130|FG001|Treatment Period II|Withdrawal of Consent|2|||
33645964|NCT01725308|63054131|FG002|Treatment Period II|Withdrawal of Consent|16|||
33645965|NCT01725308|63054129|FG000|Treatment Period II|Lost to Follow-up|1|||
33645966|NCT01725308|63054130|FG001|Treatment Period II|Lost to Follow-up|5|||
33645967|NCT01725308|63054131|FG002|Treatment Period II|Lost to Follow-up|3|||
33645968|NCT01725308|63054129|FG000|Treatment Period II|Protocol Deviations|0|||
33645969|NCT01725308|63054130|FG001|Treatment Period II|Protocol Deviations|0|||
33645970|NCT01725308|63054131|FG002|Treatment Period II|Protocol Deviations|1|||
33645971|NCT01725308|63054129|FG000|Treatment Period II|Miscellaneous|5|||
33645972|NCT01725308|63054130|FG001|Treatment Period II|Miscellaneous|3|||
33645973|NCT01725308|63054131|FG002|Treatment Period II|Miscellaneous|7|||
33645974|NCT01724528|63054148|FG000|Overall Study|Death|3|||
33645975|NCT01724528|63054149|FG001|Overall Study|Death|0|||
33645976|NCT01724528|63054148|FG000|Overall Study|Withdrawal by Subject|0|||
33645977|NCT01724528|63054149|FG001|Overall Study|Withdrawal by Subject|2|||
33645978|NCT01724528|63054148|FG000|Overall Study|Protocol Violation|0|||
33645979|NCT01724528|63054149|FG001|Overall Study|Protocol Violation|1|||
33645980|NCT01724528|63054148|FG000|Overall Study|Patient refused to attend last visit|1|||
33645981|NCT01724528|63054149|FG001|Overall Study|Patient refused to attend last visit|0|||
33645982|NCT01779440|63054157|FG000|Overall Study|Withdrawal by Subject|3|||
33645983|NCT01779440|63054158|FG001|Overall Study|Withdrawal by Subject|5|||
33645984|NCT01750346|63054167|FG000|Overall Study|Adverse Event|1|||
33645985|NCT01750346|63054168|FG001|Overall Study|Adverse Event|0|||
33645986|NCT01750346|63054169|FG002|Overall Study|Adverse Event|0|||
33645987|NCT01750268|63054179|FG000|Overall Study|Lost to Follow-up|0|||
33645988|NCT01750268|63054180|FG001|Overall Study|Lost to Follow-up|2|||
33645989|NCT01750268|63054179|FG000|Overall Study|Physician Decision|0|||
33645990|NCT01750268|63054180|FG001|Overall Study|Physician Decision|3|||
33645991|NCT01750268|63054179|FG000|Overall Study|Withdrawal by Subject|2|||
33645992|NCT01750268|63054180|FG001|Overall Study|Withdrawal by Subject|0|||
33645993|NCT01880437|63054189|FG000|Overall Study|Death|12|||
33645994|NCT01880437|63054190|FG001|Overall Study|Death|4|||
33645995|NCT01880437|63054191|FG002|Overall Study|Death|17|||
33645996|NCT01880437|63054189|FG000|Overall Study|Study terminated by Sponsor|3|||
33645997|NCT01880437|63054190|FG001|Overall Study|Study terminated by Sponsor|0|||
33645998|NCT01880437|63054191|FG002|Overall Study|Study terminated by Sponsor|2|||
33645999|NCT01861717|63054201|FG000|Overall Study|Lost to Follow-up|1|||
33646000|NCT01861717|63054201|FG000|Overall Study|Withdrawal by Subject|1|||
33646001|NCT01834729|63054210|FG000|Overall Study|Did not return bowel diaries|0|||
33646002|NCT01834729|63054211|FG001|Overall Study|Did not return bowel diaries|0|||
33646003|NCT01834729|63054212|FG002|Overall Study|Did not return bowel diaries|3|||
33646004|NCT01834729|63054213|FG003|Overall Study|Did not return bowel diaries|0|||
33646005|NCT01834729|63054210|FG000|Overall Study|Withdrawal by Subject|1|||
33646006|NCT01834729|63054211|FG001|Overall Study|Withdrawal by Subject|1|||
33646007|NCT01834729|63054212|FG002|Overall Study|Withdrawal by Subject|0|||
33646008|NCT01834729|63054213|FG003|Overall Study|Withdrawal by Subject|0|||
33646009|NCT01834729|63054210|FG000|Overall Study|Adverse Event|0|||
33646010|NCT01834729|63054211|FG001|Overall Study|Adverse Event|0|||
33646011|NCT01834729|63054212|FG002|Overall Study|Adverse Event|0|||
33646012|NCT01834729|63054213|FG003|Overall Study|Adverse Event|2|||
33646013|NCT01860703|63054224|FG000|Overall Study|Adverse Event|1|||
33646014|NCT01860703|63054225|FG001|Overall Study|Adverse Event|4|||
33646015|NCT01860703|63054226|FG002|Overall Study|Adverse Event|0|||
33646016|NCT01860703|63054227|FG003|Overall Study|Adverse Event|2|||
33646017|NCT01860703|63054224|FG000|Overall Study|Withdrawal by Subject|0|||
33646018|NCT01860703|63054225|FG001|Overall Study|Withdrawal by Subject|1|||
33543154|NCT02442765|62933899|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
33543155|NCT02442765|62933900|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
33646019|NCT01860703|63054226|FG002|Overall Study|Withdrawal by Subject|0|||
33646020|NCT01860703|63054227|FG003|Overall Study|Withdrawal by Subject|0|||
33646021|NCT01860703|63054224|FG000|Overall Study|Personal reason|1|||
33646022|NCT01860703|63054225|FG001|Overall Study|Personal reason|0|||
33646023|NCT01860703|63054226|FG002|Overall Study|Personal reason|1|||
33543156|NCT02442765|62933901|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
33646024|NCT01860703|63054227|FG003|Overall Study|Personal reason|0|||
33646025|NCT01399593|63054245|FG000|Overall Study|Physician Decision|1|||
33646026|NCT01399593|63054246|FG001|Overall Study|Physician Decision|0|||
33646027|NCT01399593|63054245|FG000|Overall Study|Adverse Event|1|||
33646028|NCT01399593|63054246|FG001|Overall Study|Adverse Event|0|||
33646029|NCT01399593|63054245|FG000|Overall Study|Death|1|||
33646030|NCT01399593|63054246|FG001|Overall Study|Death|1|||
33646031|NCT01399593|63054245|FG000|Overall Study|Transplantectomy|0|||
33646032|NCT01399593|63054246|FG001|Overall Study|Transplantectomy|1|||
33646033|NCT01833169|63054252|FG000|Overall Study|Disease Progression|99|||
33646034|NCT01833169|63054252|FG000|Overall Study|Adverse Event|33|||
33646035|NCT01833169|63054252|FG000|Overall Study|Withdrawal by Subject|9|||
33646036|NCT01833169|63054252|FG000|Overall Study|Death|3|||
33646037|NCT01833169|63054252|FG000|Overall Study|Physician Decision|2|||
33646038|NCT01860079|63054258|FG000|Overall Study|Physician Decision|14|||
33646039|NCT01860079|63054259|FG001|Overall Study|Physician Decision|22|||
33646040|NCT01388985|63054267|FG000|Overall Study|Death|0|||
33646041|NCT01388985|63054268|FG001|Overall Study|Death|1|||
33646042|NCT01388985|63054267|FG000|Overall Study|Lost to Follow-up|30|||
33646043|NCT01388985|63054268|FG001|Overall Study|Lost to Follow-up|30|||
33646044|NCT01388985|63054267|FG000|Overall Study|Withdrawal by Subject|13|||
33646045|NCT01388985|63054268|FG001|Overall Study|Withdrawal by Subject|4|||
33646046|NCT01388985|63054267|FG000|Overall Study|Subject unavailable|1|||
33646047|NCT01388985|63054268|FG001|Overall Study|Subject unavailable|1|||
33646048|NCT01388985|63054267|FG000|Overall Study|Other (no reason)|0|||
33646049|NCT01388985|63054268|FG001|Overall Study|Other (no reason)|1|||
33646050|NCT01388985|63054267|FG000|Overall Study|Error of nurse|5|||
33646051|NCT01388985|63054268|FG001|Overall Study|Error of nurse|1|||
33646052|NCT01388907|63054276|FG000|Overall Study|Adverse Event|2|||
33646053|NCT01388907|63054277|FG001|Overall Study|Adverse Event|0|||
33646054|NCT01388361|63054288|FG000|Overall Study|Adverse Event|0|||
33646055|NCT01388361|63054289|FG001|Overall Study|Adverse Event|5|||
33646056|NCT01388361|63054290|FG002|Overall Study|Adverse Event|1|||
33646057|NCT01388361|63054288|FG000|Overall Study|Protocol Violation|0|||
33646058|NCT01388361|63054289|FG001|Overall Study|Protocol Violation|0|||
33646059|NCT01388361|63054290|FG002|Overall Study|Protocol Violation|2|||
33646060|NCT01388361|63054288|FG000|Overall Study|Withdrawal criteria|12|||
33646061|NCT01388361|63054289|FG001|Overall Study|Withdrawal criteria|7|||
33646062|NCT01388361|63054290|FG002|Overall Study|Withdrawal criteria|10|||
33646063|NCT01388361|63054288|FG000|Overall Study|Unclassified|0|||
33646064|NCT01388361|63054289|FG001|Overall Study|Unclassified|0|||
33646065|NCT01388361|63054290|FG002|Overall Study|Unclassified|1|||
33646066|NCT01399125|63054300|FG000|Overall Study|Adverse Event|32|||
33646067|NCT01399125|63054301|FG001|Overall Study|Adverse Event|30|||
33646068|NCT01399125|63054300|FG000|Overall Study|Abnormal Lab values|0|||
33646069|NCT01399125|63054301|FG001|Overall Study|Abnormal Lab values|1|||
33646070|NCT01399125|63054300|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33646071|NCT01399125|63054301|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
33646072|NCT01399125|63054300|FG000|Overall Study|Withdrawal by Subject|5|||
33646073|NCT01399125|63054301|FG001|Overall Study|Withdrawal by Subject|8|||
33646074|NCT01399125|63054300|FG000|Overall Study|Lost to Follow-up|2|||
33646075|NCT01399125|63054301|FG001|Overall Study|Lost to Follow-up|3|||
33646076|NCT01399125|63054300|FG000|Overall Study|Administrative Problems|7|||
33646077|NCT01399125|63054301|FG001|Overall Study|Administrative Problems|11|||
33646078|NCT01399125|63054300|FG000|Overall Study|Death|0|||
33646079|NCT01399125|63054301|FG001|Overall Study|Death|1|||
33646080|NCT01399125|63054300|FG000|Overall Study|Protocol Deviation|5|||
33646081|NCT01399125|63054301|FG001|Overall Study|Protocol Deviation|2|||
33646082|NCT01399047|63054309|FG000|Overall Study|Withdrawal by Subject|0|||
33646083|NCT01399047|63054310|FG001|Overall Study|Withdrawal by Subject|1|||
33646084|NCT01387737|63054320|FG000|Overall Study|Adverse Event|20|||
33646085|NCT01387737|63054321|FG001|Overall Study|Adverse Event|30|||
33646086|NCT01387737|63054320|FG000|Overall Study|Lack of Efficacy|1|||
33646087|NCT01387737|63054321|FG001|Overall Study|Lack of Efficacy|0|||
33646088|NCT01387737|63054320|FG000|Overall Study|Physician Decision|3|||
33646089|NCT01387737|63054321|FG001|Overall Study|Physician Decision|10|||
33646090|NCT01387737|63054320|FG000|Overall Study|Withdrawal by Subject|27|||
33646091|NCT01387737|63054321|FG001|Overall Study|Withdrawal by Subject|31|||
33646092|NCT01387737|63054320|FG000|Overall Study|Clearly not eligible for the study|1|||
33646093|NCT01387737|63054321|FG001|Overall Study|Clearly not eligible for the study|3|||
33646094|NCT01387347|63054329|FG000|Overall Study|Lost to Follow-up|2|||
33646095|NCT01387347|63054330|FG001|Overall Study|Lost to Follow-up|1|||
33646096|NCT01859923|63054344|FG000|Overall Study|Adverse Event|0|||
33646097|NCT01859923|63054345|FG001|Overall Study|Adverse Event|0|||
33646098|NCT01859923|63054346|FG002|Overall Study|Adverse Event|1|||
33646099|NCT01859923|63054347|FG003|Overall Study|Adverse Event|1|||
33646100|NCT01832155|63054362|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
33646101|NCT01832155|63054363|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
33646102|NCT01832155|63054362|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
33646103|NCT01832155|63054363|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
33646104|NCT01879579|63054377|FG000|Overall Study|Phone incompatible with texting platform|3|||
33646105|NCT01879579|63054378|FG001|Overall Study|Phone incompatible with texting platform|0|||
33646106|NCT01879579|63054377|FG000|Overall Study|Did not enroll in texting platform|1|||
33646107|NCT01879579|63054378|FG001|Overall Study|Did not enroll in texting platform|0|||
33646108|NCT01879579|63054377|FG000|Overall Study|Did not initiate insulin treatment|1|||
33646109|NCT01879579|63054378|FG001|Overall Study|Did not initiate insulin treatment|0|||
33646110|NCT01879579|63054377|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
33646111|NCT01879579|63054378|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
33646112|NCT01879579|63054377|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
33646113|NCT01879579|63054378|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
33646114|NCT01386645|63054390|FG000|Overall Study|Physician Decision|0|||
33646115|NCT01386645|63054391|FG001|Overall Study|Physician Decision|0|||
33646116|NCT01386645|63054392|FG002|Overall Study|Physician Decision|1|||
33646117|NCT01386645|63054390|FG000|Overall Study|Withdrawal by Subject|0|||
33646118|NCT01386645|63054391|FG001|Overall Study|Withdrawal by Subject|1|||
33646119|NCT01386645|63054392|FG002|Overall Study|Withdrawal by Subject|1|||
33646120|NCT01387269|63054402|FG000|Overall Study|Death|38|||
33646121|NCT01387269|63054403|FG001|Overall Study|Death|20|||
33646122|NCT01387269|63054402|FG000|Overall Study|Other|8|||
33646123|NCT01387269|63054403|FG001|Overall Study|Other|7|||
33646124|NCT01387269|63054402|FG000|Overall Study|Unrelated AE|12|||
33646125|NCT01387269|63054403|FG001|Overall Study|Unrelated AE|3|||
33646126|NCT01387269|63054402|FG000|Overall Study|Withdrawal by patient|32|||
33646127|NCT01387269|63054403|FG001|Overall Study|Withdrawal by patient|10|||
33646128|NCT01387269|63054402|FG000|Overall Study|Study drug-related AE|1|||
33646129|NCT01387269|63054403|FG001|Overall Study|Study drug-related AE|0|||
33646130|NCT01387269|63054402|FG000|Overall Study|Lost to Follow-up|1|||
33646131|NCT01387269|63054403|FG001|Overall Study|Lost to Follow-up|0|||
33646132|NCT01859143|63054411|FG000|Overall Study|Lost to Follow-up|2|||
33646133|NCT01859143|63054412|FG001|Overall Study|Lost to Follow-up|0|||
33646134|NCT01878253|63054419|FG000|Overall Study|Death|1|||
33646135|NCT01878253|63054419|FG000|Overall Study|SIdus System Removal|3|||
33646136|NCT01878253|63054419|FG000|Overall Study|Withdrawal by Subject|1|||
33646137|NCT01878253|63054419|FG000|Overall Study|Lost to Follow-up|2|||
33646138|NCT01878253|63054419|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
33646139|NCT01878175|63054428|FG000|Overall Study|Developed contraindicated health problem|2|||
33646140|NCT01878097|63054435|FG000|Baseline|Surveys not fully completed|2497|||
33646141|NCT01878097|63054436|FG001|Baseline|Surveys not fully completed|1800|||
33646142|NCT01878097|63054435|FG000|Implementation Year 1|Surveys not fully completed|3202|||
33646143|NCT01878097|63054436|FG001|Implementation Year 1|Surveys not fully completed|2549|||
33646144|NCT01878097|63054435|FG000|Implementation Year 2|Surveys not fully completed|3281|||
33646145|NCT01878097|63054436|FG001|Implementation Year 2|Surveys not fully completed|2841|||
33646146|NCT01878097|63054435|FG000|Implementation Year 3|Surveys not fully completed|3494|||
33646147|NCT01878097|63054436|FG001|Implementation Year 3|Surveys not fully completed|2980|||
33646148|NCT01878097|63054435|FG000|Implementation Year 4|Surveys not fully completed|3604|||
33646149|NCT01878097|63054436|FG001|Implementation Year 4|Surveys not fully completed|3007|||
33646150|NCT01750190|63054444|FG000|Overall Study|Adverse Event|47|||
33646151|NCT01750190|63054445|FG001|Overall Study|Adverse Event|19|||
33646152|NCT01750190|63054444|FG000|Overall Study|Death|38|||
33646153|NCT01750190|63054445|FG001|Overall Study|Death|11|||
33646154|NCT01750190|63054444|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
33646155|NCT01750190|63054445|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
33646156|NCT01750190|63054444|FG000|Overall Study|Lost to Follow-up|28|||
33646157|NCT01750190|63054445|FG001|Overall Study|Lost to Follow-up|7|||
33646158|NCT01750190|63054444|FG000|Overall Study|Physician Decision|16|||
33646159|NCT01750190|63054445|FG001|Overall Study|Physician Decision|17|||
33646160|NCT01750190|63054444|FG000|Overall Study|Protocol Violation|6|||
33646161|NCT01750190|63054445|FG001|Overall Study|Protocol Violation|5|||
33646162|NCT01750190|63054444|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
33646163|NCT01750190|63054445|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
33646164|NCT01750190|63054444|FG000|Overall Study|Withdrawal by Subject|83|||
33646165|NCT01750190|63054445|FG001|Overall Study|Withdrawal by Subject|89|||
33646166|NCT01750190|63054444|FG000|Overall Study|Kidney Transplant|8|||
33646167|NCT01750190|63054445|FG001|Overall Study|Kidney Transplant|4|||
33646168|NCT01750190|63054444|FG000|Overall Study|Dialysis|22|||
33646169|NCT01750190|63054445|FG001|Overall Study|Dialysis|8|||
33646170|NCT01750190|63054444|FG000|Overall Study|Other than Specified|13|||
33646171|NCT01750190|63054445|FG001|Overall Study|Other than Specified|4|||
33646172|NCT01831765|63054454|FG000|Overall Study|Lack of Efficacy|1|||
33646173|NCT01831765|63054455|FG001|Overall Study|Lack of Efficacy|0|||
33646174|NCT01831765|63054456|FG002|Overall Study|Lack of Efficacy|0|||
33646175|NCT01831765|63054454|FG000|Overall Study|Other, sponsor withdrew subject|0|||
33646176|NCT01831765|63054455|FG001|Overall Study|Other, sponsor withdrew subject|1|||
33646177|NCT01831765|63054456|FG002|Overall Study|Other, sponsor withdrew subject|0|||
33646178|NCT01831765|63054454|FG000|Overall Study|Pregnancy|1|||
33646179|NCT01831765|63054455|FG001|Overall Study|Pregnancy|1|||
33646180|NCT01831765|63054456|FG002|Overall Study|Pregnancy|2|||
33646181|NCT01831765|63054454|FG000|Overall Study|Death|0|||
33646182|NCT01831765|63054455|FG001|Overall Study|Death|1|||
33646183|NCT01831765|63054456|FG002|Overall Study|Death|1|||
33646184|NCT01831765|63054454|FG000|Overall Study|Other, site closed|1|||
33646185|NCT01831765|63054455|FG001|Overall Study|Other, site closed|1|||
33646186|NCT01831765|63054456|FG002|Overall Study|Other, site closed|0|||
33646187|NCT01831765|63054454|FG000|Overall Study|Adverse Event|5|||
33646188|NCT01831765|63054455|FG001|Overall Study|Adverse Event|3|||
33646189|NCT01831765|63054456|FG002|Overall Study|Adverse Event|3|||
33646190|NCT01831765|63054454|FG000|Overall Study|Withdrawal by Subject|22|||
33646191|NCT01831765|63054455|FG001|Overall Study|Withdrawal by Subject|7|||
33646192|NCT01831765|63054456|FG002|Overall Study|Withdrawal by Subject|17|||
33646193|NCT01831765|63054454|FG000|Overall Study|Withdrawal criteria|12|||
33646194|NCT01831765|63054455|FG001|Overall Study|Withdrawal criteria|10|||
33646195|NCT01831765|63054456|FG002|Overall Study|Withdrawal criteria|16|||
33646196|NCT01831765|63054454|FG000|Overall Study|Lost to Follow-up|2|||
33646197|NCT01831765|63054455|FG001|Overall Study|Lost to Follow-up|3|||
33646198|NCT01831765|63054456|FG002|Overall Study|Lost to Follow-up|3|||
33646199|NCT01749800|63054469|FG000|Overall Study|not meeting inclusion criteria|3|||
33646200|NCT01749800|63054470|FG001|Overall Study|not meeting inclusion criteria|0|||
33646201|NCT01749800|63054471|FG002|Overall Study|not meeting inclusion criteria|0|||
33646202|NCT01749800|63054469|FG000|Overall Study|Withdrawal by Subject|0|||
33646203|NCT01749800|63054470|FG001|Overall Study|Withdrawal by Subject|1|||
33646204|NCT01749800|63054471|FG002|Overall Study|Withdrawal by Subject|0|||
33646205|NCT01830595|63054479|FG000|First Period|Withdrawal by Subject|1|||
33646206|NCT01830595|63054480|FG001|First Period|Withdrawal by Subject|3|||
33646207|NCT01830595|63054479|FG000|Washout|Withdrawal by Subject|2|||
33646208|NCT01830595|63054480|FG001|Washout|Withdrawal by Subject|2|||
33646209|NCT01748552|63054498|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
33646210|NCT01748552|63054499|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
33646211|NCT01748552|63054500|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
33646212|NCT01748552|63054501|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
33646213|NCT01748552|63054502|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
33646214|NCT01748552|63054503|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
33646215|NCT01748552|63054504|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
33646216|NCT01748552|63054505|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
33646217|NCT01748552|63054506|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
33646218|NCT01748552|63054507|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
33646219|NCT01748552|63054508|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
33646220|NCT01748552|63054509|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
33646221|NCT01748552|63054498|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33646222|NCT01748552|63054499|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33646223|NCT01748552|63054500|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33646224|NCT01748552|63054501|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33646225|NCT01748552|63054502|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33646226|NCT01748552|63054503|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33646227|NCT01748552|63054504|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
33646228|NCT01748552|63054505|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
33646229|NCT01748552|63054506|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
33646230|NCT01748552|63054507|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33646231|NCT01748552|63054508|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33646232|NCT01748552|63054509|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33463536|NCT03831191|62836961|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33463537|NCT03831191|62836962|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33463538|NCT03831191|62836963|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33463539|NCT03831191|62836949|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
33463540|NCT03831191|62836950|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
33463541|NCT03831191|62836951|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
33463542|NCT03831191|62836952|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
33463543|NCT03831191|62836953|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
33463544|NCT03831191|62836954|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
33646233|NCT01748162|63054551|FG000|Overall Study|no additional croup episodes to evaluate|2|||
33646234|NCT01748162|63054552|FG001|Overall Study|no additional croup episodes to evaluate|2|||
33646235|NCT01748162|63054551|FG000|Overall Study|participant consented but did not begin|0|||
33646236|NCT01748162|63054552|FG001|Overall Study|participant consented but did not begin|1|||
33646237|NCT01748162|63054551|FG000|Overall Study|reasons not available|3|||
33646238|NCT01748162|63054552|FG001|Overall Study|reasons not available|2|||
33646239|NCT01724216|63054558|FG000|Overall Study|Scan was not completed|1|||
33646240|NCT01723904|63054562|FG000|Overall Study|Noncompliant|3|||
33646241|NCT01723904|63054562|FG000|Overall Study|Adverse Event|5|||
33646242|NCT01723904|63054562|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
33646243|NCT01747772|63054566|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
33646244|NCT01830127|63054576|FG000|Overall Study|Adverse Event|1|||
33646245|NCT01830127|63054577|FG001|Overall Study|Adverse Event|6|||
33646246|NCT01830127|63054576|FG000|Overall Study|Lack of Efficacy|3|||
33646247|NCT01830127|63054577|FG001|Overall Study|Lack of Efficacy|0|||
33646248|NCT01830127|63054576|FG000|Overall Study|Withdrawal by Subject|1|||
33646249|NCT01830127|63054577|FG001|Overall Study|Withdrawal by Subject|1|||
33646250|NCT01830127|63054576|FG000|Overall Study|Other reason not defined above|0|||
33646251|NCT01830127|63054577|FG001|Overall Study|Other reason not defined above|2|||
33646252|NCT01614067|63054585|FG000|Overall Study|Pregnancy|1|||
33646253|NCT01614067|63054586|FG001|Overall Study|Pregnancy|0|||
33646254|NCT01614067|63054585|FG000|Overall Study|Physician Decision|6|||
33646255|NCT01614067|63054586|FG001|Overall Study|Physician Decision|5|||
33646256|NCT01614067|63054585|FG000|Overall Study|Withdrawal by Subject|0|||
33646257|NCT01614067|63054586|FG001|Overall Study|Withdrawal by Subject|1|||
33646258|NCT01614067|63054585|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
33646259|NCT01614067|63054586|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
33646260|NCT01777490|63054596|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
33646261|NCT01777490|63054597|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
33646262|NCT01777490|63054598|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
33646263|NCT01777490|63054599|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
33646264|NCT01397409|63054621|FG000|Stage 2|Adverse Event|0|||
33646265|NCT01397409|63054622|FG001|Stage 2|Adverse Event|0|||
33646266|NCT01397409|63054623|FG002|Stage 2|Adverse Event|0|||
33646267|NCT01397409|63054624|FG003|Stage 2|Adverse Event|0|||
33646268|NCT01397409|63054625|FG004|Stage 2|Adverse Event|6|||
33646269|NCT01397409|63054626|FG005|Stage 2|Adverse Event|3|||
33646270|NCT01397409|63054627|FG006|Stage 2|Adverse Event|0|||
33646271|NCT01397409|63054628|FG007|Stage 2|Adverse Event|0|||
33646272|NCT01397409|63054629|FG008|Stage 2|Adverse Event|0|||
33646273|NCT01397409|63054630|FG009|Stage 2|Adverse Event|0|||
33646274|NCT01397409|63054621|FG000|Stage 2|Personal Reasons|0|||
33646275|NCT01397409|63054622|FG001|Stage 2|Personal Reasons|0|||
33646276|NCT01397409|63054623|FG002|Stage 2|Personal Reasons|0|||
33646277|NCT01397409|63054624|FG003|Stage 2|Personal Reasons|0|||
33327224|NCT01185353|62703802|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
33463545|NCT03831191|62836955|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
33463546|NCT03831191|62836956|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
33463547|NCT03831191|62836957|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
33463548|NCT03831191|62836958|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
33463549|NCT03831191|62836959|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
33463550|NCT03831191|62836960|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
33463551|NCT03831191|62836961|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
33463552|NCT03831191|62836962|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
33463553|NCT03831191|62836963|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
33463554|NCT03831191|62836949|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
33463555|NCT03831191|62836950|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
33463556|NCT03831191|62836951|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
33463557|NCT03831191|62836952|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
33463558|NCT03831191|62836953|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
33463559|NCT03831191|62836954|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
33463560|NCT03831191|62836955|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
33463561|NCT03831191|62836956|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
33463562|NCT03831191|62836957|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
33463563|NCT03831191|62836958|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
33463564|NCT03831191|62836959|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
33463565|NCT03831191|62836960|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
33543157|NCT02442765|62933894|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
33327225|NCT01185353|62703803|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
33646278|NCT01397409|63054625|FG004|Stage 2|Personal Reasons|1|||
33646279|NCT01397409|63054626|FG005|Stage 2|Personal Reasons|0|||
33327226|NCT01185353|62703804|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
33327227|NCT01185353|62703805|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
33327228|NCT01185353|62703806|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
33327229|NCT01185353|62703797|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33646280|NCT01397409|63054627|FG006|Stage 2|Personal Reasons|0|||
33646281|NCT01397409|63054628|FG007|Stage 2|Personal Reasons|0|||
33646282|NCT01397409|63054629|FG008|Stage 2|Personal Reasons|0|||
33327230|NCT01185353|62703798|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33327231|NCT01185353|62703799|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33646283|NCT01397409|63054630|FG009|Stage 2|Personal Reasons|0|||
33646284|NCT01397409|63054621|FG000|Stage 2|Other Miscellaneous Reasons|0|||
33646285|NCT01397409|63054622|FG001|Stage 2|Other Miscellaneous Reasons|0|||
33646286|NCT01397409|63054623|FG002|Stage 2|Other Miscellaneous Reasons|0|||
33646287|NCT01397409|63054624|FG003|Stage 2|Other Miscellaneous Reasons|0|||
33646288|NCT01397409|63054625|FG004|Stage 2|Other Miscellaneous Reasons|1|||
33646289|NCT01397409|63054626|FG005|Stage 2|Other Miscellaneous Reasons|1|||
33646290|NCT01397409|63054627|FG006|Stage 2|Other Miscellaneous Reasons|0|||
33646291|NCT01397409|63054628|FG007|Stage 2|Other Miscellaneous Reasons|0|||
33646292|NCT01397409|63054629|FG008|Stage 2|Other Miscellaneous Reasons|0|||
33646293|NCT01397409|63054630|FG009|Stage 2|Other Miscellaneous Reasons|0|||
33646294|NCT01397409|63054621|FG000|Stage 3|Adverse Event|0|||
33646295|NCT01397409|63054622|FG001|Stage 3|Adverse Event|0|||
33646296|NCT01397409|63054623|FG002|Stage 3|Adverse Event|0|||
33646297|NCT01397409|63054624|FG003|Stage 3|Adverse Event|0|||
33646298|NCT01397409|63054625|FG004|Stage 3|Adverse Event|0|||
33646299|NCT01397409|63054626|FG005|Stage 3|Adverse Event|0|||
33646300|NCT01397409|63054627|FG006|Stage 3|Adverse Event|0|||
33646301|NCT01397409|63054628|FG007|Stage 3|Adverse Event|1|||
33646302|NCT01397409|63054629|FG008|Stage 3|Adverse Event|0|||
33646303|NCT01397409|63054630|FG009|Stage 3|Adverse Event|0|||
33646304|NCT01397409|63054621|FG000|Stage 3|Other Miscellaneous Reasons|0|||
33646305|NCT01397409|63054622|FG001|Stage 3|Other Miscellaneous Reasons|0|||
33646306|NCT01397409|63054623|FG002|Stage 3|Other Miscellaneous Reasons|0|||
33646307|NCT01397409|63054624|FG003|Stage 3|Other Miscellaneous Reasons|0|||
33646308|NCT01397409|63054625|FG004|Stage 3|Other Miscellaneous Reasons|0|||
33646309|NCT01397409|63054626|FG005|Stage 3|Other Miscellaneous Reasons|0|||
33327232|NCT01185353|62703800|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33327233|NCT01185353|62703801|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33327234|NCT01185353|62703802|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33327235|NCT01185353|62703803|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
33543158|NCT02442765|62933895|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
33646310|NCT01397409|63054627|FG006|Stage 3|Other Miscellaneous Reasons|0|||
33646311|NCT01397409|63054628|FG007|Stage 3|Other Miscellaneous Reasons|1|||
33646312|NCT01397409|63054629|FG008|Stage 3|Other Miscellaneous Reasons|0|||
33646313|NCT01397409|63054630|FG009|Stage 3|Other Miscellaneous Reasons|0|||
33646314|NCT01397253|63054655|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
33646315|NCT01397253|63054656|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
33646316|NCT01777334|63054664|FG000|Overall Study|Adverse Event|18|||
33646317|NCT01777334|63054665|FG001|Overall Study|Adverse Event|14|||
33646318|NCT01777334|63054664|FG000|Overall Study|Lack of Efficacy|15|||
33646319|NCT01777334|63054665|FG001|Overall Study|Lack of Efficacy|29|||
33646320|NCT01777334|63054664|FG000|Overall Study|Protocol Violation|3|||
33646321|NCT01777334|63054665|FG001|Overall Study|Protocol Violation|7|||
33646322|NCT01777334|63054664|FG000|Overall Study|Lost to Follow-up|3|||
33646323|NCT01777334|63054665|FG001|Overall Study|Lost to Follow-up|2|||
33646324|NCT01777334|63054664|FG000|Overall Study|Withdrawal by Subject|14|||
33646325|NCT01777334|63054665|FG001|Overall Study|Withdrawal by Subject|11|||
33646326|NCT01383993|63054674|FG000|Overall Study|Adverse Event|1|||
33646327|NCT01383993|63054675|FG001|Overall Study|Adverse Event|1|||
33646328|NCT01383993|63054676|FG002|Overall Study|Adverse Event|0|||
33646329|NCT01383993|63054674|FG000|Overall Study|Withdrawal by Subject|0|||
33646330|NCT01383993|63054675|FG001|Overall Study|Withdrawal by Subject|0|||
33646331|NCT01383993|63054676|FG002|Overall Study|Withdrawal by Subject|1|||
33646332|NCT01383993|63054674|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
33646333|NCT01383993|63054675|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
33646334|NCT01383993|63054676|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
33646335|NCT01396395|63054687|FG000|Overall Study|Withdrawal by Subject|10|||
33646336|NCT01396395|63054688|FG001|Overall Study|Withdrawal by Subject|12|||
33646337|NCT01396395|63054687|FG000|Overall Study|Protocol Violation|3|||
33646338|NCT01396395|63054688|FG001|Overall Study|Protocol Violation|1|||
33646339|NCT01396395|63054687|FG000|Overall Study|Adverse Event|10|||
33646340|NCT01396395|63054688|FG001|Overall Study|Adverse Event|2|||
33646341|NCT01396395|63054687|FG000|Overall Study|Lost to Follow-up|17|||
33646342|NCT01396395|63054688|FG001|Overall Study|Lost to Follow-up|11|||
33463566|NCT03831191|62836961|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
33646343|NCT01396395|63054687|FG000|Overall Study|Other|0|||
33646344|NCT01396395|63054688|FG001|Overall Study|Other|1|||
33543159|NCT02442765|62933896|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
33646345|NCT01396317|63054698|FG000|Overall Study|Adverse Event|1|||
33646346|NCT01396317|63054699|FG001|Overall Study|Adverse Event|0|||
33646347|NCT01396161|63054714|FG000|Overall Study|Withdrawal by Subject|0|||
33646348|NCT01396161|63054715|FG001|Overall Study|Withdrawal by Subject|0|||
33646349|NCT01396161|63054716|FG002|Overall Study|Withdrawal by Subject|0|||
33646350|NCT01396161|63054717|FG003|Overall Study|Withdrawal by Subject|0|||
33646351|NCT01396161|63054718|FG004|Overall Study|Withdrawal by Subject|1|||
33646352|NCT01396161|63054719|FG005|Overall Study|Withdrawal by Subject|0|||
33646353|NCT01396161|63054720|FG006|Overall Study|Withdrawal by Subject|0|||
33646354|NCT01396161|63054714|FG000|Overall Study|Other|0|||
33646355|NCT01396161|63054715|FG001|Overall Study|Other|0|||
33646356|NCT01396161|63054716|FG002|Overall Study|Other|0|||
33646357|NCT01396161|63054717|FG003|Overall Study|Other|0|||
33646358|NCT01396161|63054718|FG004|Overall Study|Other|0|||
33646359|NCT01396161|63054719|FG005|Overall Study|Other|0|||
33646360|NCT01396161|63054720|FG006|Overall Study|Other|1|||
33646361|NCT01396083|63054743|FG000|Overall Study|Adverse Event|2|||
33646362|NCT01396083|63054744|FG001|Overall Study|Adverse Event|28|||
33646363|NCT01396083|63054743|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33646364|NCT01396083|63054744|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
33646365|NCT01396083|63054743|FG000|Overall Study|Consent withdrawn|4|||
33646366|NCT01396083|63054744|FG001|Overall Study|Consent withdrawn|5|||
33646367|NCT01396083|63054743|FG000|Overall Study|Protocol deviation(s)|0|||
33646368|NCT01396083|63054744|FG001|Overall Study|Protocol deviation(s)|1|||
33646369|NCT01396083|63054743|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33646370|NCT01396083|63054744|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33646371|NCT01396083|63054743|FG000|Overall Study|Administrative problems|1|||
33646372|NCT01396083|63054744|FG001|Overall Study|Administrative problems|0|||
33646373|NCT01396083|63054743|FG000|Overall Study|Lost to Follow-up|1|||
33646374|NCT01396083|63054744|FG001|Overall Study|Lost to Follow-up|0|||
33646375|NCT01723826|63054754|FG000|Overall Study|Adverse Event|4|||
33646376|NCT01723826|63054755|FG001|Overall Study|Adverse Event|1|||
33646377|NCT01723826|63054756|FG002|Overall Study|Adverse Event|4|||
33646378|NCT01723826|63054757|FG003|Overall Study|Adverse Event|5|||
33646379|NCT01723826|63054754|FG000|Overall Study|Death according to AE eCRF|2|||
33646380|NCT01723826|63054755|FG001|Overall Study|Death according to AE eCRF|3|||
33646381|NCT01723826|63054756|FG002|Overall Study|Death according to AE eCRF|3|||
33646382|NCT01723826|63054757|FG003|Overall Study|Death according to AE eCRF|7|||
33646383|NCT01723826|63054754|FG000|Overall Study|Lost to Follow-up|1|||
33646384|NCT01723826|63054755|FG001|Overall Study|Lost to Follow-up|3|||
33646385|NCT01723826|63054756|FG002|Overall Study|Lost to Follow-up|1|||
33646386|NCT01723826|63054757|FG003|Overall Study|Lost to Follow-up|1|||
33646387|NCT01723826|63054754|FG000|Overall Study|Non-compliance|0|||
33646388|NCT01723826|63054755|FG001|Overall Study|Non-compliance|1|||
33646389|NCT01723826|63054756|FG002|Overall Study|Non-compliance|3|||
33646390|NCT01723826|63054757|FG003|Overall Study|Non-compliance|3|||
33646391|NCT01723826|63054754|FG000|Overall Study|Non-compliance With Study Drug|0|||
33646392|NCT01723826|63054755|FG001|Overall Study|Non-compliance With Study Drug|1|||
33646393|NCT01723826|63054756|FG002|Overall Study|Non-compliance With Study Drug|0|||
33646394|NCT01723826|63054757|FG003|Overall Study|Non-compliance With Study Drug|0|||
33646395|NCT01723826|63054754|FG000|Overall Study|Other Reason|8|||
33646396|NCT01723826|63054755|FG001|Overall Study|Other Reason|6|||
33646397|NCT01723826|63054756|FG002|Overall Study|Other Reason|12|||
33646398|NCT01723826|63054757|FG003|Overall Study|Other Reason|14|||
33646399|NCT01723826|63054754|FG000|Overall Study|Physician Decision|1|||
33646400|NCT01723826|63054755|FG001|Overall Study|Physician Decision|3|||
33646401|NCT01723826|63054756|FG002|Overall Study|Physician Decision|4|||
33646402|NCT01723826|63054757|FG003|Overall Study|Physician Decision|11|||
33646403|NCT01723826|63054754|FG000|Overall Study|Protocol Violation|1|||
33646404|NCT01723826|63054755|FG001|Overall Study|Protocol Violation|1|||
33646405|NCT01723826|63054756|FG002|Overall Study|Protocol Violation|3|||
33646406|NCT01723826|63054757|FG003|Overall Study|Protocol Violation|1|||
33646407|NCT01723826|63054754|FG000|Overall Study|Withdrawal by Subject|10|||
33646408|NCT01723826|63054755|FG001|Overall Study|Withdrawal by Subject|17|||
33646409|NCT01723826|63054756|FG002|Overall Study|Withdrawal by Subject|27|||
33646410|NCT01723826|63054757|FG003|Overall Study|Withdrawal by Subject|48|||
33646411|NCT01721954|63054769|FG000|Overall Study|Death|58|||
33646412|NCT01721954|63054770|FG001|Overall Study|Death|64|||
33646413|NCT01721954|63054769|FG000|Overall Study|Withdrawal by Subject|8|||
33646414|NCT01721954|63054770|FG001|Overall Study|Withdrawal by Subject|4|||
33646415|NCT01721954|63054769|FG000|Overall Study|Adverse Event|2|||
33646416|NCT01721954|63054770|FG001|Overall Study|Adverse Event|0|||
33646417|NCT01721954|63054769|FG000|Overall Study|Lost to Follow-up|2|||
33646418|NCT01721954|63054770|FG001|Overall Study|Lost to Follow-up|1|||
33646419|NCT01776554|63054778|FG000|Overall Study|Adverse Event|1|||
33646420|NCT01776554|63054779|FG001|Overall Study|Adverse Event|0|||
33646421|NCT01776554|63054778|FG000|Overall Study|Withdrawal by Subject|3|||
33646422|NCT01776554|63054779|FG001|Overall Study|Withdrawal by Subject|8|||
33646423|NCT01776554|63054778|FG000|Overall Study|Lost to Follow-up|6|||
33646424|NCT01776554|63054779|FG001|Overall Study|Lost to Follow-up|9|||
33646425|NCT01776554|63054778|FG000|Overall Study|Administrative Reason|2|||
33646426|NCT01776554|63054779|FG001|Overall Study|Administrative Reason|5|||
33646427|NCT01776554|63054778|FG000|Overall Study|Protocol Violation|1|||
33646428|NCT01776554|63054779|FG001|Overall Study|Protocol Violation|0|||
33646429|NCT01776554|63054778|FG000|Overall Study|Unclassified|4|||
33646430|NCT01776554|63054779|FG001|Overall Study|Unclassified|1|||
33646431|NCT01776008|63054786|FG000|Overall Study|ineligible|2|||
33646432|NCT01746368|63054792|FG000|Overall Study|Lost to Follow-up|2|||
33646433|NCT01746368|63054793|FG001|Overall Study|Lost to Follow-up|0|||
33646434|NCT01746368|63054792|FG000|Overall Study|Withdrawal by Subject|0|||
33646435|NCT01746368|63054793|FG001|Overall Study|Withdrawal by Subject|1|||
33646436|NCT01381575|63054802|FG000|Overall Study|Serious Adverse Event|1|||
33646437|NCT01381575|63054803|FG001|Overall Study|Serious Adverse Event|0|||
33646438|NCT01381575|63054804|FG002|Overall Study|Serious Adverse Event|0|||
33646439|NCT01381575|63054802|FG000|Overall Study|Non-Serious Adverse Event|0|||
33646440|NCT01381575|63054803|FG001|Overall Study|Non-Serious Adverse Event|0|||
33646441|NCT01381575|63054804|FG002|Overall Study|Non-Serious Adverse Event|1|||
33646442|NCT01381575|63054802|FG000|Overall Study|Protocol Violation|0|||
33646443|NCT01381575|63054803|FG001|Overall Study|Protocol Violation|1|||
33646444|NCT01381575|63054804|FG002|Overall Study|Protocol Violation|1|||
33646445|NCT01381575|63054802|FG000|Overall Study|Withdrawal by Subject|15|||
33646446|NCT01381575|63054803|FG001|Overall Study|Withdrawal by Subject|9|||
33646447|NCT01381575|63054804|FG002|Overall Study|Withdrawal by Subject|7|||
33646448|NCT01381575|63054802|FG000|Overall Study|Migrated/moved from study area|2|||
33646449|NCT01381575|63054803|FG001|Overall Study|Migrated/moved from study area|12|||
33646450|NCT01381575|63054804|FG002|Overall Study|Migrated/moved from study area|2|||
33646451|NCT01381575|63054802|FG000|Overall Study|Lost to Follow-up|8|||
33646452|NCT01381575|63054803|FG001|Overall Study|Lost to Follow-up|17|||
33646453|NCT01381575|63054804|FG002|Overall Study|Lost to Follow-up|9|||
33646454|NCT01858363|63054815|FG000|Overall Study|Death|35|||
33646455|NCT01858363|63054816|FG001|Overall Study|Death|9|||
33646456|NCT01858363|63054815|FG000|Overall Study|Withdrawal by Subject|28|||
33646457|NCT01858363|63054816|FG001|Overall Study|Withdrawal by Subject|14|||
33646458|NCT01858363|63054815|FG000|Overall Study|Lost to Follow-up|13|||
33646459|NCT01858363|63054816|FG001|Overall Study|Lost to Follow-up|3|||
33646460|NCT01877551|63054824|FG000|Overall Study|Physician Decision|0|||
33646461|NCT01877551|63054825|FG001|Overall Study|Physician Decision|1|||
33646462|NCT01396005|63054833|FG000|Overall Study|Withdrawal by Subject|0|||
33646463|NCT01396005|63054834|FG001|Overall Study|Withdrawal by Subject|1|||
33646464|NCT01396005|63054833|FG000|Overall Study|Non-compliance with protocol|0|||
33646465|NCT01396005|63054834|FG001|Overall Study|Non-compliance with protocol|1|||
33646466|NCT01877239|63054842|FG000|Overall Study|Adverse Event|4|||
33646467|NCT01877239|63054842|FG000|Overall Study|Disease Remission|1|||
33646468|NCT01877239|63054842|FG000|Overall Study|Withdrawal by Subject|4|||
33646469|NCT01877239|63054842|FG000|Overall Study|Other|2|||
33646470|NCT01877239|63054842|FG000|Overall Study|Lack of Efficacy|4|||
33646471|NCT01877239|63054842|FG000|Overall Study|Data not available|35|||
33646472|NCT01877083|63054846|FG000|Treatment Phase|Disease Progression|10|||
33646473|NCT01877083|63054846|FG000|Treatment Phase|Clinical Progression|1|||
33646474|NCT01877083|63054846|FG000|Treatment Phase|Adverse Event|6|||
33646475|NCT01877083|63054846|FG000|Treatment Phase|Withdrawal by Subject|2|||
33646476|NCT01877083|63054846|FG000|Treatment Phase|Lost to Follow-up|1|||
33646477|NCT01877083|63054846|FG000|Extension Phase|Disease Progression|3|||
33646478|NCT01877083|63054846|FG000|Extension Phase|Adverse Event|2|||
33646479|NCT01380327|63054853|FG000|Overall Study|Lost to Follow-up|0|||
33646480|NCT01380327|63054854|FG001|Overall Study|Lost to Follow-up|1|||
33646481|NCT01380327|63054855|FG002|Overall Study|Lost to Follow-up|1|||
33646482|NCT01380327|63054853|FG000|Overall Study|Protocol Violation|3|||
33646483|NCT01380327|63054854|FG001|Overall Study|Protocol Violation|2|||
33646484|NCT01380327|63054855|FG002|Overall Study|Protocol Violation|3|||
33646485|NCT01380327|63054853|FG000|Overall Study|Withdrawal by Subject|0|||
33646486|NCT01380327|63054854|FG001|Overall Study|Withdrawal by Subject|0|||
33646487|NCT01380327|63054855|FG002|Overall Study|Withdrawal by Subject|1|||
33646488|NCT01380327|63054853|FG000|Overall Study|Housing situation precluded ability to k|0|||
33646489|NCT01380327|63054854|FG001|Overall Study|Housing situation precluded ability to k|0|||
33646490|NCT01380327|63054855|FG002|Overall Study|Housing situation precluded ability to k|1|||
33646491|NCT01380327|63054853|FG000|Overall Study|Questionable onset of epilepsy|0|||
33646492|NCT01380327|63054854|FG001|Overall Study|Questionable onset of epilepsy|0|||
33646493|NCT01380327|63054855|FG002|Overall Study|Questionable onset of epilepsy|1|||
33646494|NCT01829425|63054865|FG000|Overall Study|Withdrawal by Subject|4|||
33646495|NCT01829425|63054866|FG001|Overall Study|Withdrawal by Subject|3|||
33646496|NCT01829425|63054865|FG000|Overall Study|Lost to Follow-up|2|||
33646497|NCT01829425|63054866|FG001|Overall Study|Lost to Follow-up|1|||
33646498|NCT01394991|63054883|FG000|Overall Study|Adverse Event|0|||
33646499|NCT01394991|63054884|FG001|Overall Study|Adverse Event|4|||
33646500|NCT01394991|63054883|FG000|Overall Study|Lack of Efficacy|5|||
33646501|NCT01394991|63054884|FG001|Overall Study|Lack of Efficacy|7|||
33646502|NCT01394991|63054883|FG000|Overall Study|Lost to Follow-up|6|||
33646503|NCT01394991|63054884|FG001|Overall Study|Lost to Follow-up|8|||
33646504|NCT01394991|63054883|FG000|Overall Study|Physician Decision|1|||
33646505|NCT01394991|63054884|FG001|Overall Study|Physician Decision|3|||
33646506|NCT01394991|63054883|FG000|Overall Study|Protocol Violation|1|||
33646507|NCT01394991|63054884|FG001|Overall Study|Protocol Violation|1|||
33646508|NCT01394991|63054883|FG000|Overall Study|Withdrawal by Subject|20|||
33646509|NCT01394991|63054884|FG001|Overall Study|Withdrawal by Subject|17|||
33646510|NCT01394991|63054883|FG000|Overall Study|Chemotherapy Termination|10|||
33646511|NCT01394991|63054884|FG001|Overall Study|Chemotherapy Termination|15|||
33646512|NCT01394991|63054883|FG000|Overall Study|Disease Progression|7|||
33646513|NCT01394991|63054884|FG001|Overall Study|Disease Progression|7|||
33646514|NCT01394991|63054883|FG000|Overall Study|Prematurely Termination of Trial|9|||
33646515|NCT01394991|63054884|FG001|Overall Study|Prematurely Termination of Trial|10|||
33646516|NCT01829347|63054892|FG000|VTI-210|Death|5|||
33646517|NCT01829347|63054893|FG001|VTI-210|Death|3|||
33646518|NCT01829347|63054892|FG000|VTI-210|Withdrawal by Subject|1|||
33646519|NCT01829347|63054893|FG001|VTI-210|Withdrawal by Subject|0|||
33646520|NCT01829347|63054892|FG000|VTI-210E|Death|2|||
33646521|NCT01829347|63054893|FG001|VTI-210E|Death|1|||
33463567|NCT03831191|62836962|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
33463568|NCT03831191|62836963|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
33646522|NCT01829347|63054892|FG000|VTI-210E|Study terminated prematurely|1|||
33646523|NCT01829347|63054893|FG001|VTI-210E|Study terminated prematurely|5|||
33646524|NCT01394523|63054902|FG000|Overall Study|Unable to place block|1|||
33646525|NCT01394523|63054903|FG001|Overall Study|Unable to place block|0|||
33646526|NCT01394523|63054904|FG002|Overall Study|Unable to place block|0|||
33646527|NCT01857973|63054912|FG000|Overall Study|Subject did not meet required BG range|3|||
33646528|NCT01857973|63054912|FG000|Overall Study|drop out after 3 failed attempts|1|||
33646529|NCT01857973|63054912|FG000|Overall Study|Physician Decision|1|||
33646530|NCT01857583|63054920|FG000|Overall Study|Adverse Event|0|||
33646531|NCT01857583|63054921|FG001|Overall Study|Adverse Event|0|||
33646532|NCT01857583|63054922|FG002|Overall Study|Adverse Event|1|||
33646533|NCT01857583|63054923|FG003|Overall Study|Adverse Event|1|||
33646534|NCT01857583|63054920|FG000|Overall Study|Death|0|||
33646535|NCT01857583|63054921|FG001|Overall Study|Death|1|||
33646536|NCT01857583|63054922|FG002|Overall Study|Death|1|||
33646537|NCT01857583|63054923|FG003|Overall Study|Death|0|||
33646538|NCT01857583|63054920|FG000|Overall Study|Physician Decision|0|||
33646539|NCT01857583|63054921|FG001|Overall Study|Physician Decision|0|||
33646540|NCT01857583|63054922|FG002|Overall Study|Physician Decision|0|||
33646541|NCT01857583|63054923|FG003|Overall Study|Physician Decision|1|||
33646542|NCT01857583|63054920|FG000|Overall Study|Withdrawal by Subject|1|||
33646543|NCT01857583|63054921|FG001|Overall Study|Withdrawal by Subject|0|||
33646544|NCT01857583|63054922|FG002|Overall Study|Withdrawal by Subject|1|||
33646545|NCT01857583|63054923|FG003|Overall Study|Withdrawal by Subject|2|||
33646546|NCT01829191|63054935|FG000|Overall Study|Relocation|0|||
33646547|NCT01829191|63054936|FG001|Overall Study|Relocation|1|||
33646548|NCT01829191|63054935|FG000|Overall Study|Lens discomfort|0|||
33646549|NCT01829191|63054936|FG001|Overall Study|Lens discomfort|3|||
33646550|NCT01829191|63054935|FG000|Overall Study|Lens handling difficulty|1|||
33646551|NCT01829191|63054936|FG001|Overall Study|Lens handling difficulty|4|||
33646552|NCT01829191|63054935|FG000|Overall Study|Protocol Violation|4|||
33646553|NCT01829191|63054936|FG001|Overall Study|Protocol Violation|1|||
33646554|NCT01829191|63054935|FG000|Overall Study|Withdrawal by Subject|2|||
33646555|NCT01829191|63054936|FG001|Overall Study|Withdrawal by Subject|3|||
33646556|NCT01829191|63054935|FG000|Overall Study|Lost to Follow-up|0|||
33646557|NCT01829191|63054936|FG001|Overall Study|Lost to Follow-up|1|||
33646558|NCT01829191|63054935|FG000|Overall Study|Subject was fit for ortho - k|0|||
33646559|NCT01829191|63054936|FG001|Overall Study|Subject was fit for ortho - k|1|||
33463569|NCT03831191|62836949|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33463570|NCT03831191|62836950|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33646560|NCT00211185|63054941|FG000|Overall Study|Death|2|||
33646561|NCT00211185|63054941|FG000|Overall Study|Disease progression|7|||
33646562|NCT00211185|63054941|FG000|Overall Study|Withdrawal by Subject|6|||
33646563|NCT00211185|63054941|FG000|Overall Study|Physician Decision|5|||
33646564|NCT00210639|63054947|FG000|Overall Study|Lost to Follow-up|37|||
33646565|NCT00210639|63054948|FG001|Overall Study|Lost to Follow-up|29|||
33646566|NCT00210639|63054947|FG000|Overall Study|Withdrawal by Subject|8|||
33646567|NCT00210639|63054948|FG001|Overall Study|Withdrawal by Subject|1|||
33646568|NCT00210639|63054947|FG000|Overall Study|Other|18|||
33646569|NCT00210639|63054948|FG001|Overall Study|Other|12|||
33646570|NCT01829113|63054956|FG000|Overall Study|Disease Progression|37|||
33646571|NCT01829113|63054957|FG001|Overall Study|Disease Progression|48|||
33646572|NCT01829113|63054956|FG000|Overall Study|Adverse Event|14|||
33646573|NCT01829113|63054957|FG001|Overall Study|Adverse Event|10|||
33646574|NCT01829113|63054956|FG000|Overall Study|Withdrawal by Subject|17|||
33646575|NCT01829113|63054957|FG001|Overall Study|Withdrawal by Subject|10|||
33646576|NCT01829113|63054956|FG000|Overall Study|Death|4|||
33646577|NCT01829113|63054957|FG001|Overall Study|Death|6|||
33646578|NCT01829113|63054956|FG000|Overall Study|Sponsor Decision|1|||
33646579|NCT01829113|63054957|FG001|Overall Study|Sponsor Decision|1|||
33646580|NCT01829113|63054956|FG000|Overall Study|No Study Treatment Received|3|||
33646581|NCT01829113|63054957|FG001|Overall Study|No Study Treatment Received|2|||
33646582|NCT01829113|63054956|FG000|Overall Study|Physician Decision|1|||
33646583|NCT01829113|63054957|FG001|Overall Study|Physician Decision|1|||
33646584|NCT01857271|63054965|FG000|Overall Study|Lost to Follow-up|1|||
33646585|NCT01745120|63054971|FG000|Overall Study|Investigator decision|1|||
33646586|NCT01745120|63054972|FG001|Overall Study|Investigator decision|0|||
33646587|NCT01828567|63054983|FG000|Overall Study|Lost to Follow-up|27|||
33646588|NCT01828567|63054984|FG001|Overall Study|Lost to Follow-up|9|||
33646589|NCT01828567|63054983|FG000|Overall Study|Excluded - did not meet criteria|4|||
33646590|NCT01828567|63054984|FG001|Overall Study|Excluded - did not meet criteria|1|||
33646591|NCT01721486|63054992|FG000|Overall Study|Protocol Violation|1|||
33646592|NCT01721486|63054993|FG001|Overall Study|Protocol Violation|0|||
33646593|NCT01721486|63054992|FG000|Overall Study|Physician Decision|0|||
33646594|NCT01721486|63054993|FG001|Overall Study|Physician Decision|1|||
33646595|NCT01775930|63054999|FG000|Overall Study|Futility stopping boundary met|1|||
33646596|NCT01856569|63055003|FG000|Overall Study|Other|1|||
33646597|NCT01856569|63055003|FG000|Overall Study|Changed Site/Structure|1|||
33646598|NCT01856569|63055003|FG000|Overall Study|Lost to Follow-up|3|||
33646599|NCT01856569|63055003|FG000|Overall Study|Did not met inclusion criteria|8|||
33646600|NCT01721408|63055009|FG000|Overall Study|Adverse Event|6|||
33646601|NCT01721408|63055010|FG001|Overall Study|Adverse Event|1|||
33646602|NCT01721408|63055009|FG000|Overall Study|Death|1|||
33646603|NCT01721408|63055010|FG001|Overall Study|Death|0|||
33646604|NCT01721408|63055009|FG000|Overall Study|Insufficient clinical response|15|||
33646605|NCT01721408|63055010|FG001|Overall Study|Insufficient clinical response|6|||
33646606|NCT01721408|63055009|FG000|Overall Study|No longer willing to participate study|9|||
33646607|NCT01721408|63055010|FG001|Overall Study|No longer willing to participate study|10|||
33646608|NCT01721408|63055009|FG000|Overall Study|Protocol Violation|0|||
33646609|NCT01721408|63055010|FG001|Overall Study|Protocol Violation|2|||
33646610|NCT01721408|63055009|FG000|Overall Study|Other|3|||
33646611|NCT01721408|63055010|FG001|Overall Study|Other|3|||
33646612|NCT01721408|63055009|FG000|Overall Study|Lost to Follow-up|1|||
33646613|NCT01721408|63055010|FG001|Overall Study|Lost to Follow-up|2|||
33646614|NCT01721408|63055009|FG000|Overall Study|Does not meet entrance criteria|1|||
33646615|NCT01721408|63055010|FG001|Overall Study|Does not meet entrance criteria|0|||
33646616|NCT01744496|63055018|FG000|Titration Period|Adverse Event|2|||
33646617|NCT01744496|63055019|FG001|Titration Period|Adverse Event|1|||
33646618|NCT01744496|63055018|FG000|Titration Period|Personal reasons|0|||
33646619|NCT01744496|63055019|FG001|Titration Period|Personal reasons|1|||
33646620|NCT01744496|63055018|FG000|Maintenance Period|Adverse Event|1|||
33646621|NCT01744496|63055019|FG001|Maintenance Period|Adverse Event|3|||
33646622|NCT01744496|63055018|FG000|Maintenance Period|Protocol Violation|1|||
33646623|NCT01744496|63055019|FG001|Maintenance Period|Protocol Violation|0|||
33646624|NCT01744496|63055018|FG000|Maintenance Period|Withdrawal by Subject|1|||
33646625|NCT01744496|63055019|FG001|Maintenance Period|Withdrawal by Subject|1|||
33646626|NCT01744496|63055018|FG000|Maintenance Period|Subject left town|1|||
33646627|NCT01744496|63055019|FG001|Maintenance Period|Subject left town|0|||
33646628|NCT01721330|63055027|FG000|Overall Study|Withdrawal by Subject|0|||
33646629|NCT01721330|63055028|FG001|Overall Study|Withdrawal by Subject|1|||
33646630|NCT01828021|63055044|FG000|Overall Study|Adverse Event|5|||
33646631|NCT01828021|63055044|FG000|Overall Study|Lack of Efficacy|17|||
33646632|NCT01828021|63055044|FG000|Overall Study|Withdrawal by Subject|2|||
33646633|NCT01828021|63055044|FG000|Overall Study|Ileal obstruction, unrelated|1|||
33646634|NCT01827943|63055048|FG000|Overall Study|Protocol Violation|8|||
33646635|NCT01827943|63055048|FG000|Overall Study|Never treated because of an rapid progression|1|||
33646636|NCT00217971|63055054|FG000|Overall Study|Adverse Event|1|||
33646637|NCT00217971|63055055|FG001|Overall Study|Adverse Event|1|||
33646638|NCT00217971|63055054|FG000|Overall Study|Lost to Follow-up|15|||
33646639|NCT00217971|63055055|FG001|Overall Study|Lost to Follow-up|19|||
33646640|NCT00217971|63055054|FG000|Overall Study|Physician Decision|0|||
33646641|NCT00217971|63055055|FG001|Overall Study|Physician Decision|1|||
33646642|NCT00217971|63055054|FG000|Overall Study|Withdrawal by Subject|7|||
33646643|NCT00217971|63055055|FG001|Overall Study|Withdrawal by Subject|12|||
33646644|NCT00217971|63055054|FG000|Overall Study|non compliant|1|||
33646645|NCT00217971|63055055|FG001|Overall Study|non compliant|0|||
33646646|NCT00217581|63055061|FG000|Overall Study|Withdrawal by Subject|1|||
33646647|NCT01856257|63055069|FG000|Overall Study|Death|2|||
33646648|NCT01856257|63055070|FG001|Overall Study|Death|0|||
33646649|NCT01856257|63055071|FG002|Overall Study|Death|0|||
33646650|NCT01856257|63055072|FG003|Overall Study|Death|0|||
33646651|NCT01856257|63055069|FG000|Overall Study|Physician Decision|0|||
33463571|NCT03831191|62836951|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33463572|NCT03831191|62836952|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33543160|NCT02442765|62933897|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
33543161|NCT02442765|62933898|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
33543162|NCT02442765|62933899|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
33543163|NCT02442765|62933900|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
33543164|NCT02442765|62933901|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
33543165|NCT02442765|62933894|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
33543166|NCT02442765|62933895|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
33543167|NCT02442765|62933896|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
33543168|NCT02442765|62933897|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
33543169|NCT02442765|62933898|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
33463573|NCT03831191|62836953|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33463574|NCT03831191|62836954|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33463575|NCT03831191|62836955|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33463576|NCT03831191|62836956|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33463577|NCT03831191|62836957|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33463578|NCT03831191|62836958|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33463579|NCT03831191|62836959|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33463580|NCT03831191|62836960|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33463581|NCT03831191|62836961|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33543170|NCT02442765|62933899|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
33543171|NCT02442765|62933900|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
33543172|NCT02442765|62933901|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
33543173|NCT02442765|62933894|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
33463582|NCT03831191|62836962|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33543174|NCT02442765|62933895|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
33543175|NCT02442765|62933896|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
33463583|NCT03831191|62836963|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
33463584|NCT03831191|62836949|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33463585|NCT03831191|62836950|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33463586|NCT03831191|62836951|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33463587|NCT03831191|62836952|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33463588|NCT03831191|62836953|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33463589|NCT03831191|62836954|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33463590|NCT03831191|62836955|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33543176|NCT02442765|62933897|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
33543177|NCT02442765|62933898|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
33543178|NCT02442765|62933899|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
33543179|NCT02442765|62933900|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
33543180|NCT02442765|62933901|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
33543181|NCT02699684|62933932|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
33543182|NCT02699684|62933933|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
33543183|NCT02700698|62933942|FG000|Overall Study|Withdrawal by Subject|1|||
33543184|NCT02700698|62933943|FG001|Overall Study|Withdrawal by Subject|0|||
33543185|NCT01774721|62933951|FG000|Overall Study|Death|76|||
33543186|NCT01774721|62933952|FG001|Overall Study|Death|91|||
33463591|NCT03831191|62836956|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33463592|NCT03831191|62836957|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33543187|NCT01774721|62933951|FG000|Overall Study|Withdrawal by Subject|14|||
33543188|NCT01774721|62933952|FG001|Overall Study|Withdrawal by Subject|10|||
33543189|NCT01774721|62933951|FG000|Overall Study|Lost to Follow-up|1|||
33543190|NCT01774721|62933952|FG001|Overall Study|Lost to Follow-up|1|||
33543191|NCT01774721|62933951|FG000|Overall Study|Did not meet eligibility criteria|0|||
33543192|NCT01774721|62933952|FG001|Overall Study|Did not meet eligibility criteria|3|||
33543193|NCT01774721|62933951|FG000|Overall Study|Ongoing in study|136|||
33543194|NCT01774721|62933952|FG001|Overall Study|Ongoing in study|120|||
33646652|NCT01856257|63055070|FG001|Overall Study|Physician Decision|0|||
33646653|NCT01856257|63055071|FG002|Overall Study|Physician Decision|0|||
33646654|NCT01856257|63055072|FG003|Overall Study|Physician Decision|1|||
33646655|NCT01856257|63055069|FG000|Overall Study|Withdrawal by Subject|1|||
33463593|NCT03831191|62836958|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33463594|NCT03831191|62836959|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33463595|NCT03831191|62836960|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33543195|NCT02699450|62933963|FG000|Overall Study|Death|2|||
33543196|NCT02699450|62933964|FG001|Overall Study|Death|1|||
33543197|NCT02699450|62933965|FG002|Overall Study|Death|2|||
33543198|NCT02699450|62933963|FG000|Overall Study|Met Criteria for Study Exit|0|||
33543199|NCT02699450|62933964|FG001|Overall Study|Met Criteria for Study Exit|0|||
33543200|NCT02699450|62933965|FG002|Overall Study|Met Criteria for Study Exit|1|||
33646656|NCT01856257|63055070|FG001|Overall Study|Withdrawal by Subject|1|||
33646657|NCT01856257|63055071|FG002|Overall Study|Withdrawal by Subject|0|||
33646658|NCT01856257|63055072|FG003|Overall Study|Withdrawal by Subject|0|||
33646659|NCT01856257|63055069|FG000|Overall Study|Donor complication|0|||
33646660|NCT01856257|63055070|FG001|Overall Study|Donor complication|0|||
33646661|NCT01856257|63055071|FG002|Overall Study|Donor complication|0|||
33646662|NCT01856257|63055072|FG003|Overall Study|Donor complication|1|||
33646663|NCT00215943|63055083|FG000|Overall Study|Disease Progression|3|||
33646664|NCT00215943|63055084|FG001|Overall Study|Disease Progression|5|||
33646665|NCT00215943|63055083|FG000|Overall Study|Alternate therapy|0|||
33646666|NCT00215943|63055084|FG001|Overall Study|Alternate therapy|1|||
33646667|NCT00215943|63055083|FG000|Overall Study|Adverse Event|3|||
33646668|NCT00215943|63055084|FG001|Overall Study|Adverse Event|6|||
33646669|NCT00215943|63055083|FG000|Overall Study|Other disease|0|||
33646670|NCT00215943|63055084|FG001|Overall Study|Other disease|1|||
33646671|NCT00215943|63055083|FG000|Overall Study|Other complications|3|||
33646672|NCT00215943|63055084|FG001|Overall Study|Other complications|1|||
33646673|NCT01827319|63055090|FG000|Overall Study|Lost to Follow-up|3|||
33646674|NCT01827163|63055094|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
33646675|NCT01827163|63055094|FG000|Overall Study|Adverse Event|9|||
33646676|NCT00215553|63055105|FG000|Overall Study|Adverse Event|0|||
33646677|NCT00215553|63055106|FG001|Overall Study|Adverse Event|1|||
33646678|NCT00215553|63055107|FG002|Overall Study|Adverse Event|2|||
33646679|NCT00215553|63055108|FG003|Overall Study|Adverse Event|1|||
33646680|NCT00215553|63055109|FG004|Overall Study|Adverse Event|2|||
33646681|NCT00215553|63055110|FG005|Overall Study|Adverse Event|6|||
33646682|NCT00215553|63055111|FG006|Overall Study|Adverse Event|0|||
33646683|NCT00214461|63055131|FG000|Overall Study|Adverse Event|0|||
33646684|NCT00214461|63055132|FG001|Overall Study|Adverse Event|0|||
33646685|NCT00214461|63055133|FG002|Overall Study|Adverse Event|1|||
33646686|NCT00214461|63055134|FG003|Overall Study|Adverse Event|1|||
33646687|NCT00214461|63055131|FG000|Overall Study|Withdrawal by Subject|0|||
33646688|NCT00214461|63055132|FG001|Overall Study|Withdrawal by Subject|0|||
33646689|NCT00214461|63055133|FG002|Overall Study|Withdrawal by Subject|1|||
33646690|NCT00214461|63055134|FG003|Overall Study|Withdrawal by Subject|0|||
33646691|NCT00214383|63055146|FG000|Overall Study|Lost to Follow-up|16|||
33646692|NCT00214383|63055147|FG001|Overall Study|Lost to Follow-up|26|||
33646693|NCT00212355|63055153|FG000|Overall Study|Adverse Event|1|||
33646694|NCT00212355|63055153|FG000|Overall Study|Withdrawal by Subject|1|||
33646695|NCT00212355|63055153|FG000|Overall Study|A change of address|1|||
33646696|NCT00211887|63055160|FG000|Overall Study|Adverse Event|8|||
33646697|NCT00211887|63055161|FG001|Overall Study|Adverse Event|4|||
33646698|NCT00211887|63055162|FG002|Overall Study|Adverse Event|6|||
33646699|NCT00211887|63055160|FG000|Overall Study|Death|1|||
33646700|NCT00211887|63055161|FG001|Overall Study|Death|1|||
33646701|NCT00211887|63055162|FG002|Overall Study|Death|1|||
33646702|NCT00211887|63055160|FG000|Overall Study|Lost to Follow-up|28|||
33646703|NCT00211887|63055161|FG001|Overall Study|Lost to Follow-up|13|||
33646704|NCT00211887|63055162|FG002|Overall Study|Lost to Follow-up|9|||
33646705|NCT00211887|63055160|FG000|Overall Study|Non-medical reason|31|||
33646706|NCT00211887|63055161|FG001|Overall Study|Non-medical reason|14|||
33646707|NCT00211887|63055162|FG002|Overall Study|Non-medical reason|8|||
33646708|NCT00211887|63055160|FG000|Overall Study|Other medical reason|15|||
33646709|NCT00211887|63055161|FG001|Overall Study|Other medical reason|11|||
33646710|NCT00211887|63055162|FG002|Overall Study|Other medical reason|7|||
33646711|NCT00211887|63055160|FG000|Overall Study|Side effects|19|||
33646712|NCT00211887|63055161|FG001|Overall Study|Side effects|13|||
33646713|NCT00211887|63055162|FG002|Overall Study|Side effects|5|||
33646714|NCT01855945|63055182|FG000|Overall Study|Adverse Event|0|||
33646715|NCT01855945|63055183|FG001|Overall Study|Adverse Event|0|||
33646716|NCT01855945|63055184|FG002|Overall Study|Adverse Event|0|||
33646717|NCT01855945|63055185|FG003|Overall Study|Adverse Event|0|||
33646718|NCT01855945|63055186|FG004|Overall Study|Adverse Event|0|||
33646719|NCT01855945|63055187|FG005|Overall Study|Adverse Event|0|||
33646720|NCT01855945|63055188|FG006|Overall Study|Adverse Event|1|||
33646721|NCT01855945|63055189|FG007|Overall Study|Adverse Event|0|||
33646722|NCT01855945|63055190|FG008|Overall Study|Adverse Event|0|||
33646723|NCT01855945|63055191|FG009|Overall Study|Adverse Event|0|||
33646724|NCT01855945|63055192|FG010|Overall Study|Adverse Event|0|||
33646725|NCT01855945|63055193|FG011|Overall Study|Adverse Event|0|||
33646726|NCT01855945|63055182|FG000|Overall Study|Death|0|||
33646727|NCT01855945|63055183|FG001|Overall Study|Death|0|||
33646728|NCT01855945|63055184|FG002|Overall Study|Death|0|||
33646729|NCT01855945|63055185|FG003|Overall Study|Death|0|||
33646730|NCT01855945|63055186|FG004|Overall Study|Death|0|||
33646731|NCT01855945|63055187|FG005|Overall Study|Death|0|||
33646732|NCT01855945|63055188|FG006|Overall Study|Death|2|||
33646733|NCT01855945|63055189|FG007|Overall Study|Death|0|||
33646734|NCT01855945|63055190|FG008|Overall Study|Death|0|||
33646735|NCT01855945|63055191|FG009|Overall Study|Death|0|||
33646736|NCT01855945|63055192|FG010|Overall Study|Death|0|||
33646737|NCT01855945|63055193|FG011|Overall Study|Death|0|||
33646738|NCT01855945|63055182|FG000|Overall Study|Lost to Follow-up|11|||
33646739|NCT01855945|63055183|FG001|Overall Study|Lost to Follow-up|10|||
33646740|NCT01855945|63055184|FG002|Overall Study|Lost to Follow-up|7|||
33646741|NCT01855945|63055185|FG003|Overall Study|Lost to Follow-up|3|||
33646742|NCT01855945|63055186|FG004|Overall Study|Lost to Follow-up|0|||
33646743|NCT01855945|63055187|FG005|Overall Study|Lost to Follow-up|3|||
33646744|NCT01855945|63055188|FG006|Overall Study|Lost to Follow-up|4|||
33646745|NCT01855945|63055189|FG007|Overall Study|Lost to Follow-up|7|||
33646746|NCT01855945|63055190|FG008|Overall Study|Lost to Follow-up|2|||
33646747|NCT01855945|63055191|FG009|Overall Study|Lost to Follow-up|0|||
33646748|NCT01855945|63055192|FG010|Overall Study|Lost to Follow-up|0|||
33646749|NCT01855945|63055193|FG011|Overall Study|Lost to Follow-up|2|||
33646750|NCT01855945|63055182|FG000|Overall Study|Other - Unclassified|1|||
33646751|NCT01855945|63055183|FG001|Overall Study|Other - Unclassified|1|||
33646752|NCT01855945|63055184|FG002|Overall Study|Other - Unclassified|1|||
33646753|NCT01855945|63055185|FG003|Overall Study|Other - Unclassified|0|||
33646754|NCT01855945|63055186|FG004|Overall Study|Other - Unclassified|0|||
33646755|NCT01855945|63055187|FG005|Overall Study|Other - Unclassified|0|||
33646756|NCT01855945|63055188|FG006|Overall Study|Other - Unclassified|2|||
33646757|NCT01855945|63055189|FG007|Overall Study|Other - Unclassified|1|||
33646758|NCT01855945|63055190|FG008|Overall Study|Other - Unclassified|0|||
33646759|NCT01855945|63055191|FG009|Overall Study|Other - Unclassified|0|||
33646760|NCT01855945|63055192|FG010|Overall Study|Other - Unclassified|1|||
33646761|NCT01855945|63055193|FG011|Overall Study|Other - Unclassified|0|||
33646762|NCT01855945|63055182|FG000|Overall Study|Withdrawal by Subject|4|||
33646763|NCT01855945|63055183|FG001|Overall Study|Withdrawal by Subject|0|||
33646764|NCT01855945|63055184|FG002|Overall Study|Withdrawal by Subject|4|||
33646765|NCT01855945|63055185|FG003|Overall Study|Withdrawal by Subject|1|||
33646766|NCT01855945|63055186|FG004|Overall Study|Withdrawal by Subject|1|||
33646767|NCT01855945|63055187|FG005|Overall Study|Withdrawal by Subject|0|||
33646768|NCT01855945|63055188|FG006|Overall Study|Withdrawal by Subject|1|||
33646769|NCT01855945|63055189|FG007|Overall Study|Withdrawal by Subject|0|||
33646770|NCT01855945|63055190|FG008|Overall Study|Withdrawal by Subject|0|||
33646771|NCT01855945|63055191|FG009|Overall Study|Withdrawal by Subject|2|||
33646772|NCT01855945|63055192|FG010|Overall Study|Withdrawal by Subject|4|||
33646773|NCT01855945|63055193|FG011|Overall Study|Withdrawal by Subject|1|||
33646774|NCT01855789|63055256|FG000|1) Baseline up to Week 24|Adverse Event|37|||
33646775|NCT01855789|63055257|FG001|1) Baseline up to Week 24|Adverse Event|0|||
33646776|NCT01855789|63055258|FG002|1) Baseline up to Week 24|Adverse Event|0|||
33646777|NCT01855789|63055259|FG003|1) Baseline up to Week 24|Adverse Event|0|||
33646778|NCT01855789|63055256|FG000|1) Baseline up to Week 24|Death|2|||
33646779|NCT01855789|63055257|FG001|1) Baseline up to Week 24|Death|0|||
33646780|NCT01855789|63055258|FG002|1) Baseline up to Week 24|Death|0|||
33646781|NCT01855789|63055259|FG003|1) Baseline up to Week 24|Death|0|||
33646782|NCT01855789|63055256|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
33646783|NCT01855789|63055257|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
33646784|NCT01855789|63055258|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
33646785|NCT01855789|63055259|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
33646786|NCT01855789|63055256|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
33646787|NCT01855789|63055257|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
33646788|NCT01855789|63055258|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
33646789|NCT01855789|63055259|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
33543201|NCT02699450|62933963|FG000|Overall Study|Protocol Violation|4|||
33646790|NCT01855789|63055256|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
33646791|NCT01855789|63055257|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
33646792|NCT01855789|63055258|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
33646793|NCT01855789|63055259|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
33646794|NCT01855789|63055256|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
33463596|NCT03831191|62836961|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33463597|NCT03831191|62836962|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33463598|NCT03831191|62836963|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
33463599|NCT00005906|62836996|FG000|Overall Study|Lack of Efficacy|3|||
33463600|NCT00066690|62837003|FG000|Overall Study|Adverse Event|145|||
33463601|NCT00066690|62837004|FG001|Overall Study|Adverse Event|58|||
33463602|NCT00066690|62837005|FG002|Overall Study|Adverse Event|126|||
33463603|NCT00066690|62837003|FG000|Overall Study|Death|3|||
33463604|NCT00066690|62837004|FG001|Overall Study|Death|0|||
33463605|NCT00066690|62837005|FG002|Overall Study|Death|2|||
33463606|NCT00066690|62837003|FG000|Overall Study|Lack of Efficacy|114|||
33646795|NCT01855789|63055257|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
33646796|NCT01855789|63055258|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
33646797|NCT01855789|63055259|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
33646798|NCT01855789|63055256|FG000|1) Baseline up to Week 24|Physician Decision|4|||
33646799|NCT01855789|63055257|FG001|1) Baseline up to Week 24|Physician Decision|0|||
33646800|NCT01855789|63055258|FG002|1) Baseline up to Week 24|Physician Decision|0|||
33646801|NCT01855789|63055259|FG003|1) Baseline up to Week 24|Physician Decision|0|||
33646802|NCT01855789|63055256|FG000|1) Baseline up to Week 24|Pregnancy|1|||
33646803|NCT01855789|63055257|FG001|1) Baseline up to Week 24|Pregnancy|0|||
33646804|NCT01855789|63055258|FG002|1) Baseline up to Week 24|Pregnancy|0|||
33646805|NCT01855789|63055259|FG003|1) Baseline up to Week 24|Pregnancy|0|||
33646806|NCT01855789|63055256|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
33646807|NCT01855789|63055257|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
33646808|NCT01855789|63055258|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
33646809|NCT01855789|63055259|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
33646810|NCT01855789|63055256|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
33646811|NCT01855789|63055257|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
33646812|NCT01855789|63055258|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
33646813|NCT01855789|63055259|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
33646814|NCT01855789|63055256|FG000|1) Baseline up to Week 24|Other|4|||
33646815|NCT01855789|63055257|FG001|1) Baseline up to Week 24|Other|0|||
33646816|NCT01855789|63055258|FG002|1) Baseline up to Week 24|Other|0|||
33646817|NCT01855789|63055259|FG003|1) Baseline up to Week 24|Other|0|||
33646818|NCT01855789|63055256|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
33646819|NCT01855789|63055257|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
33646820|NCT01855789|63055258|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
33646821|NCT01855789|63055259|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
33646822|NCT01855789|63055256|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
33646823|NCT01855789|63055257|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
33646824|NCT01855789|63055258|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
33646825|NCT01855789|63055259|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
33646826|NCT01855789|63055256|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
33646827|NCT01855789|63055257|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
33646828|NCT01855789|63055258|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
33646829|NCT01855789|63055259|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
33646830|NCT01855789|63055256|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
33646831|NCT01855789|63055257|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
33646832|NCT01855789|63055258|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
33646833|NCT01855789|63055259|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
33646834|NCT01855789|63055256|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
33646835|NCT01855789|63055257|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
33646836|NCT01855789|63055258|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
33646837|NCT01855789|63055259|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
33646838|NCT01855789|63055256|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
33646839|NCT01855789|63055257|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
33646840|NCT01855789|63055258|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
33646841|NCT01855789|63055259|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
33646842|NCT01855789|63055256|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
33646843|NCT01855789|63055257|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
33646844|NCT01855789|63055258|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
33646845|NCT01855789|63055259|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
33646846|NCT01855789|63055256|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
33646847|NCT01855789|63055257|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
33646848|NCT01855789|63055258|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
33646849|NCT01855789|63055259|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
33646850|NCT01855789|63055256|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
33646851|NCT01855789|63055257|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
33646852|NCT01855789|63055258|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
33646853|NCT01855789|63055259|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
33646854|NCT01855789|63055256|FG000|2) Week 24 up to End of Study|Other|0|||
33646855|NCT01855789|63055257|FG001|2) Week 24 up to End of Study|Other|0|||
33646856|NCT01855789|63055258|FG002|2) Week 24 up to End of Study|Other|0|||
33646857|NCT01855789|63055259|FG003|2) Week 24 up to End of Study|Other|1|||
33646858|NCT01610791|63055265|FG000|Overall Study|Lost to Follow-up|7|||
33646859|NCT01610791|63055265|FG000|Overall Study|Adverse Event|6|||
33646860|NCT01610791|63055265|FG000|Overall Study|Physician Decision|1|||
33646861|NCT01610791|63055265|FG000|Overall Study|Adverse event and Investigator decision|1|||
33646862|NCT01610791|63055265|FG000|Overall Study|Death|1|||
33646863|NCT01610791|63055265|FG000|Overall Study|Not determined|5|||
33646864|NCT01876381|63055269|FG000|Overall Study|Lack of Efficacy|5|||
33646865|NCT01876381|63055269|FG000|Overall Study|Physician Decision|1|||
33646866|NCT01876381|63055269|FG000|Overall Study|Withdrawal by Subject|1|||
33646867|NCT01855399|63055284|FG000|6 Month|Lost to Follow-up|12|||
33646868|NCT01855399|63055285|FG001|6 Month|Lost to Follow-up|9|||
33646869|NCT01855399|63055284|FG000|6 Month|Withdrawal by Subject|8|||
33646870|NCT01855399|63055285|FG001|6 Month|Withdrawal by Subject|6|||
33646871|NCT01855399|63055284|FG000|12 Month|Lost to Follow-up|7|||
33646872|NCT01855399|63055285|FG001|12 Month|Lost to Follow-up|11|||
33646873|NCT01875991|63055293|FG000|Overall Study|Withdrawal by Subject|6|||
33646874|NCT01875991|63055294|FG001|Overall Study|Withdrawal by Subject|6|||
33646875|NCT01875991|63055293|FG000|Overall Study|Sponsor Decision|1|||
33646876|NCT01875991|63055294|FG001|Overall Study|Sponsor Decision|0|||
33646877|NCT01855243|63055306|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
33646878|NCT01855243|63055307|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
33646879|NCT01855243|63055308|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
33646880|NCT01825837|63055320|FG000|PART I|Withdrawal by Subject|0|||
33646881|NCT01825837|63055321|FG001|PART I|Withdrawal by Subject|0|||
33646882|NCT01825837|63055322|FG002|PART I|Withdrawal by Subject|0|||
33646883|NCT01825837|63055323|FG003|PART I|Withdrawal by Subject|6|||
33646884|NCT01825837|63055320|FG000|PART I|Patient non-compliance|0|||
33646885|NCT01825837|63055321|FG001|PART I|Patient non-compliance|0|||
33646886|NCT01825837|63055322|FG002|PART I|Patient non-compliance|0|||
33646887|NCT01825837|63055323|FG003|PART I|Patient non-compliance|1|||
33646888|NCT01825837|63055320|FG000|PART I|Treatment failure|0|||
33646889|NCT01825837|63055321|FG001|PART I|Treatment failure|0|||
33646890|NCT01825837|63055322|FG002|PART I|Treatment failure|0|||
33646891|NCT01825837|63055323|FG003|PART I|Treatment failure|7|||
33646892|NCT01825837|63055320|FG000|PART I|reason unspecified|0|||
33646893|NCT01825837|63055321|FG001|PART I|reason unspecified|0|||
33646894|NCT01825837|63055322|FG002|PART I|reason unspecified|0|||
33646895|NCT01825837|63055323|FG003|PART I|reason unspecified|3|||
33646896|NCT01825837|63055320|FG000|PART II|Withdrawal by Subject|3|||
33646897|NCT01825837|63055321|FG001|PART II|Withdrawal by Subject|3|||
33646898|NCT01825837|63055322|FG002|PART II|Withdrawal by Subject|7|||
33646899|NCT01825837|63055323|FG003|PART II|Withdrawal by Subject|0|||
33646900|NCT01825837|63055320|FG000|PART II|Patient non-compliance|5|||
33646901|NCT01825837|63055321|FG001|PART II|Patient non-compliance|2|||
33646902|NCT01825837|63055322|FG002|PART II|Patient non-compliance|4|||
33646903|NCT01825837|63055323|FG003|PART II|Patient non-compliance|0|||
33646904|NCT01825837|63055320|FG000|PART II|Adverse Event|3|||
33646905|NCT01825837|63055321|FG001|PART II|Adverse Event|3|||
33646906|NCT01825837|63055322|FG002|PART II|Adverse Event|1|||
33646907|NCT01825837|63055323|FG003|PART II|Adverse Event|0|||
33646908|NCT01825837|63055320|FG000|PART II|Treatment failure|6|||
33646909|NCT01825837|63055321|FG001|PART II|Treatment failure|4|||
33646910|NCT01825837|63055322|FG002|PART II|Treatment failure|5|||
33646911|NCT01825837|63055323|FG003|PART II|Treatment failure|0|||
33646912|NCT01825837|63055320|FG000|PART II|reason unspecified|2|||
33646913|NCT01825837|63055321|FG001|PART II|reason unspecified|2|||
33646914|NCT01825837|63055322|FG002|PART II|reason unspecified|2|||
33646915|NCT01825837|63055323|FG003|PART II|reason unspecified|0|||
33646916|NCT01854697|63055336|FG000|Overall Study|Adverse Event|1|||
33646917|NCT01854697|63055337|FG001|Overall Study|Adverse Event|0|||
33646918|NCT01854697|63055338|FG002|Overall Study|Adverse Event|0|||
33646919|NCT01854697|63055339|FG003|Overall Study|Adverse Event|0|||
33646920|NCT01854697|63055340|FG004|Overall Study|Adverse Event|1|||
33646921|NCT01854697|63055336|FG000|Overall Study|Lost to Follow-up|4|||
33646922|NCT01854697|63055337|FG001|Overall Study|Lost to Follow-up|1|||
33646923|NCT01854697|63055338|FG002|Overall Study|Lost to Follow-up|1|||
33646924|NCT01854697|63055339|FG003|Overall Study|Lost to Follow-up|2|||
33327236|NCT01185353|62703804|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33327237|NCT01185353|62703805|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33327238|NCT01185353|62703806|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33543202|NCT02699450|62933964|FG001|Overall Study|Protocol Violation|3|||
33646925|NCT01854697|63055340|FG004|Overall Study|Lost to Follow-up|0|||
33646926|NCT01854697|63055336|FG000|Overall Study|To enter another AbbVie study|1|||
33646927|NCT01854697|63055337|FG001|Overall Study|To enter another AbbVie study|0|||
33646928|NCT01854697|63055338|FG002|Overall Study|To enter another AbbVie study|0|||
33646929|NCT01854697|63055339|FG003|Overall Study|To enter another AbbVie study|0|||
33646930|NCT01854697|63055340|FG004|Overall Study|To enter another AbbVie study|1|||
33646931|NCT01854697|63055336|FG000|Overall Study|Withdrew Consent|0|||
33646932|NCT01854697|63055337|FG001|Overall Study|Withdrew Consent|1|||
33646933|NCT01854697|63055338|FG002|Overall Study|Withdrew Consent|0|||
33646934|NCT01854697|63055339|FG003|Overall Study|Withdrew Consent|1|||
33646935|NCT01854697|63055340|FG004|Overall Study|Withdrew Consent|0|||
33646936|NCT01854697|63055336|FG000|Overall Study|Other|0|||
33327239|NCT01185353|62703797|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
33327240|NCT01185353|62703798|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
33327241|NCT01185353|62703799|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
33646937|NCT01854697|63055337|FG001|Overall Study|Other|1|||
33646938|NCT01854697|63055338|FG002|Overall Study|Other|1|||
33646939|NCT01854697|63055339|FG003|Overall Study|Other|0|||
33646940|NCT01854697|63055340|FG004|Overall Study|Other|0|||
33646941|NCT01824979|63055352|FG000|Overall Study|Withdrawal by Subject|5|||
33646942|NCT01824979|63055353|FG001|Overall Study|Withdrawal by Subject|0|||
33646943|NCT01824979|63055352|FG000|Overall Study|Physician Decision|2|||
33646944|NCT01824979|63055353|FG001|Overall Study|Physician Decision|0|||
33646945|NCT01824979|63055352|FG000|Overall Study|Protocol Violation|6|||
33646946|NCT01824979|63055353|FG001|Overall Study|Protocol Violation|13|||
33646947|NCT01824823|63055361|FG000|Overall Study|Lack of Efficacy|1|||
33646948|NCT01824823|63055362|FG001|Overall Study|Lack of Efficacy|1|||
33646949|NCT01824823|63055361|FG000|Overall Study|Off-treatment reason not submitted|1|||
33646950|NCT01824823|63055362|FG001|Overall Study|Off-treatment reason not submitted|0|||
33646951|NCT01875367|63055370|FG000|Overall Study|Not complete at least 2 questionaries|4|||
33646952|NCT01875367|63055371|FG001|Overall Study|Not complete at least 2 questionaries|2|||
33646953|NCT01875367|63055370|FG000|Overall Study|Not receive study treatment|1|||
33646954|NCT01875367|63055371|FG001|Overall Study|Not receive study treatment|0|||
33646955|NCT01853839|63055381|FG000|Overall Study|Violated inclusion criteria|2|||
33646956|NCT01853839|63055381|FG000|Overall Study|Not meet ITT population definition|58|||
33646957|NCT01853839|63055381|FG000|Overall Study|End of treatment visit too early|33|||
33646958|NCT01853839|63055381|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
33646959|NCT01874665|63055391|FG000|Overall Study|Adverse Event|6|||
33646960|NCT01874665|63055392|FG001|Overall Study|Adverse Event|2|||
33646961|NCT01874665|63055391|FG000|Overall Study|Withdrawal by Subject|4|||
33646962|NCT01874665|63055392|FG001|Overall Study|Withdrawal by Subject|1|||
33646963|NCT01874665|63055391|FG000|Overall Study|Physician Decision|3|||
33646964|NCT01874665|63055392|FG001|Overall Study|Physician Decision|0|||
33646965|NCT01874665|63055391|FG000|Overall Study|Clinical Progressive Disease|4|||
33646966|NCT01874665|63055392|FG001|Overall Study|Clinical Progressive Disease|3|||
33646967|NCT01874665|63055391|FG000|Overall Study|Study Terminated by Sponsor|0|||
33646968|NCT01874665|63055392|FG001|Overall Study|Study Terminated by Sponsor|2|||
33646969|NCT01874665|63055391|FG000|Overall Study|Documented Progressive Disease|11|||
33646970|NCT01874665|63055392|FG001|Overall Study|Documented Progressive Disease|7|||
33646971|NCT01874665|63055391|FG000|Overall Study|Other|2|||
33646972|NCT01874665|63055392|FG001|Overall Study|Other|0|||
33646973|NCT01874431|63055407|FG000|Overall Study|Physician Decision|0|||
33646974|NCT01874431|63055408|FG001|Overall Study|Physician Decision|0|||
33646975|NCT01874431|63055409|FG002|Overall Study|Physician Decision|1|||
33646976|NCT01874431|63055410|FG003|Overall Study|Physician Decision|0|||
33646977|NCT01874431|63055411|FG004|Overall Study|Physician Decision|0|||
33646978|NCT01874431|63055412|FG005|Overall Study|Physician Decision|0|||
33646979|NCT01874431|63055413|FG006|Overall Study|Physician Decision|0|||
33646980|NCT01874431|63055414|FG007|Overall Study|Physician Decision|0|||
33646981|NCT01874431|63055407|FG000|Overall Study|Adverse Event|5|||
33646982|NCT01874431|63055408|FG001|Overall Study|Adverse Event|4|||
33646983|NCT01874431|63055409|FG002|Overall Study|Adverse Event|6|||
33646984|NCT01874431|63055410|FG003|Overall Study|Adverse Event|5|||
33646985|NCT01874431|63055411|FG004|Overall Study|Adverse Event|2|||
33646986|NCT01874431|63055412|FG005|Overall Study|Adverse Event|8|||
33646987|NCT01874431|63055413|FG006|Overall Study|Adverse Event|2|||
33646988|NCT01874431|63055414|FG007|Overall Study|Adverse Event|3|||
33646989|NCT01874431|63055407|FG000|Overall Study|Protocol Violation|1|||
33646990|NCT01874431|63055408|FG001|Overall Study|Protocol Violation|1|||
33646991|NCT01874431|63055409|FG002|Overall Study|Protocol Violation|1|||
33646992|NCT01874431|63055410|FG003|Overall Study|Protocol Violation|0|||
33646993|NCT01874431|63055411|FG004|Overall Study|Protocol Violation|3|||
33646994|NCT01874431|63055412|FG005|Overall Study|Protocol Violation|2|||
33646995|NCT01874431|63055413|FG006|Overall Study|Protocol Violation|1|||
33646996|NCT01874431|63055414|FG007|Overall Study|Protocol Violation|1|||
33646997|NCT01874431|63055407|FG000|Overall Study|Non-compliance|0|||
33646998|NCT01874431|63055408|FG001|Overall Study|Non-compliance|0|||
33646999|NCT01874431|63055409|FG002|Overall Study|Non-compliance|0|||
33647000|NCT01874431|63055410|FG003|Overall Study|Non-compliance|0|||
33647001|NCT01874431|63055411|FG004|Overall Study|Non-compliance|1|||
33647002|NCT01874431|63055412|FG005|Overall Study|Non-compliance|0|||
33647003|NCT01874431|63055413|FG006|Overall Study|Non-compliance|1|||
33647004|NCT01874431|63055414|FG007|Overall Study|Non-compliance|0|||
33647005|NCT01874431|63055407|FG000|Overall Study|Logistical difficulties|0|||
33647006|NCT01874431|63055408|FG001|Overall Study|Logistical difficulties|0|||
33647007|NCT01874431|63055409|FG002|Overall Study|Logistical difficulties|0|||
33647008|NCT01874431|63055410|FG003|Overall Study|Logistical difficulties|0|||
33647009|NCT01874431|63055411|FG004|Overall Study|Logistical difficulties|0|||
33647010|NCT01874431|63055412|FG005|Overall Study|Logistical difficulties|0|||
33647011|NCT01874431|63055413|FG006|Overall Study|Logistical difficulties|1|||
33647012|NCT01874431|63055414|FG007|Overall Study|Logistical difficulties|0|||
33647013|NCT01874431|63055407|FG000|Overall Study|Withdrawal by Subject|0|||
33647014|NCT01874431|63055408|FG001|Overall Study|Withdrawal by Subject|0|||
33647015|NCT01874431|63055409|FG002|Overall Study|Withdrawal by Subject|1|||
33647016|NCT01874431|63055410|FG003|Overall Study|Withdrawal by Subject|2|||
33647017|NCT01874431|63055411|FG004|Overall Study|Withdrawal by Subject|1|||
33647018|NCT01874431|63055412|FG005|Overall Study|Withdrawal by Subject|1|||
33647019|NCT01874431|63055413|FG006|Overall Study|Withdrawal by Subject|3|||
33647020|NCT01874431|63055414|FG007|Overall Study|Withdrawal by Subject|0|||
33647021|NCT01874431|63055407|FG000|Overall Study|Sponsor decision|0|||
33647022|NCT01874431|63055408|FG001|Overall Study|Sponsor decision|0|||
33647023|NCT01874431|63055409|FG002|Overall Study|Sponsor decision|0|||
33647024|NCT01874431|63055410|FG003|Overall Study|Sponsor decision|0|||
33647025|NCT01874431|63055411|FG004|Overall Study|Sponsor decision|1|||
33647026|NCT01874431|63055412|FG005|Overall Study|Sponsor decision|0|||
33647027|NCT01874431|63055413|FG006|Overall Study|Sponsor decision|0|||
33647028|NCT01874431|63055414|FG007|Overall Study|Sponsor decision|0|||
33647029|NCT01874431|63055407|FG000|Overall Study|Lost to Follow-up|0|||
33647030|NCT01874431|63055408|FG001|Overall Study|Lost to Follow-up|0|||
33647031|NCT01874431|63055409|FG002|Overall Study|Lost to Follow-up|1|||
33647032|NCT01874431|63055410|FG003|Overall Study|Lost to Follow-up|0|||
33647033|NCT01874431|63055411|FG004|Overall Study|Lost to Follow-up|0|||
33647034|NCT01874431|63055412|FG005|Overall Study|Lost to Follow-up|0|||
33647035|NCT01874431|63055413|FG006|Overall Study|Lost to Follow-up|0|||
33647036|NCT01874431|63055414|FG007|Overall Study|Lost to Follow-up|0|||
33463607|NCT00066690|62837004|FG001|Overall Study|Lack of Efficacy|110|||
33463608|NCT00066690|62837005|FG002|Overall Study|Lack of Efficacy|76|||
33463609|NCT00066690|62837003|FG000|Overall Study|Lost to Follow-up|40|||
33463610|NCT00066690|62837004|FG001|Overall Study|Lost to Follow-up|21|||
33543203|NCT02699450|62933965|FG002|Overall Study|Protocol Violation|5|||
33543204|NCT02699450|62933963|FG000|Overall Study|Lost to Follow-up|3|||
33543205|NCT02699450|62933964|FG001|Overall Study|Lost to Follow-up|0|||
33543206|NCT02699450|62933965|FG002|Overall Study|Lost to Follow-up|5|||
33543207|NCT02699450|62933963|FG000|Overall Study|Physician Decision|2|||
33543208|NCT02699450|62933964|FG001|Overall Study|Physician Decision|0|||
33543209|NCT02699450|62933965|FG002|Overall Study|Physician Decision|0|||
33543210|NCT02699450|62933963|FG000|Overall Study|Withdrawal by Subject|3|||
33543211|NCT02699450|62933964|FG001|Overall Study|Withdrawal by Subject|1|||
33543212|NCT02699450|62933965|FG002|Overall Study|Withdrawal by Subject|2|||
33543213|NCT02699450|62933963|FG000|Overall Study|Adverse Event|1|||
33543214|NCT02699450|62933964|FG001|Overall Study|Adverse Event|0|||
33543215|NCT02699450|62933965|FG002|Overall Study|Adverse Event|0|||
33647037|NCT01824355|63055432|FG000|Overall Study|Adverse Event|2|||
33647038|NCT01824355|63055432|FG000|Overall Study|unevaluable reference method results per|1|||
33463611|NCT00066690|62837005|FG002|Overall Study|Lost to Follow-up|29|||
33463612|NCT00066690|62837003|FG000|Overall Study|Withdrawal by Subject|50|||
33463613|NCT00066690|62837004|FG001|Overall Study|Withdrawal by Subject|55|||
33463614|NCT00066690|62837005|FG002|Overall Study|Withdrawal by Subject|49|||
33463615|NCT00066690|62837003|FG000|Overall Study|Treatment Ongoing|246|||
33463616|NCT00066690|62837004|FG001|Overall Study|Treatment Ongoing|278|||
33463617|NCT00066690|62837005|FG002|Overall Study|Treatment Ongoing|282|||
33463618|NCT03409276|62837021|FG000|Overall Study|Withdrawal by Subject|0|||
33463619|NCT03409276|62837022|FG001|Overall Study|Withdrawal by Subject|0|||
33463620|NCT03409276|62837023|FG002|Overall Study|Withdrawal by Subject|0|||
33463621|NCT03409276|62837024|FG003|Overall Study|Withdrawal by Subject|0|||
33463622|NCT03409276|62837025|FG004|Overall Study|Withdrawal by Subject|1|||
33463623|NCT03409276|62837021|FG000|Overall Study|Lost to Follow-up|0|||
33463624|NCT03409276|62837022|FG001|Overall Study|Lost to Follow-up|0|||
33463625|NCT03409276|62837023|FG002|Overall Study|Lost to Follow-up|0|||
33463626|NCT03409276|62837024|FG003|Overall Study|Lost to Follow-up|2|||
33463627|NCT03409276|62837025|FG004|Overall Study|Lost to Follow-up|2|||
33463628|NCT00004562|62837043|FG000|Overall Study|Lost to Follow-up|102|||
33463629|NCT00004562|62837044|FG001|Overall Study|Lost to Follow-up|91|||
33463630|NCT00004412|62837053|FG000|Randomized Period|Moved to Crossover Period|3|||
33463631|NCT00004412|62837054|FG001|Randomized Period|Moved to Crossover Period|0|||
33463632|NCT00004412|62837055|FG002|Randomized Period|Moved to Crossover Period|0|||
33463633|NCT03440320|62837065|FG000|Overall Study|Withdrawal by Subject|0|||
33463634|NCT03440320|62837066|FG001|Overall Study|Withdrawal by Subject|1|||
33647039|NCT01823341|63055440|FG000|Overall Study|Failed run-in|7|||
33647040|NCT01823341|63055440|FG000|Overall Study|Withdrawal by Subject|7|||
33647041|NCT01823341|63055440|FG000|Overall Study|Adverse Event|1|||
33647042|NCT01853137|63055449|FG000|Overall Study|Lost to Follow-up|4|||
33647043|NCT01853137|63055450|FG001|Overall Study|Lost to Follow-up|1|||
33647044|NCT01823107|63055457|FG000|Overall Study|Withdrawal by Subject|1|||
33463635|NCT00004088|62837074|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
33463636|NCT00004088|62837074|FG000|Overall Study|Withdrawal by Subject|1|||
33463637|NCT00004088|62837074|FG000|Overall Study|Protocol Violation|3|||
33463638|NCT00004088|62837074|FG000|Overall Study|Physician Decision|1|||
33647045|NCT01874275|63055463|FG000|Overall Study|Lost to Follow-up|1|||
33647046|NCT01874275|63055464|FG001|Overall Study|Lost to Follow-up|0|||
33463639|NCT03439072|62837078|FG000|Overall Study|Withdrawal by Subject|2|||
33463640|NCT03439072|62837079|FG001|Overall Study|Withdrawal by Subject|3|||
33463641|NCT03439072|62837078|FG000|Overall Study|Physician Decision|0|||
33543216|NCT02699996|62933976|FG000|Overall Study|Withdrawal by Subject|5|||
33543217|NCT02699996|62933977|FG001|Overall Study|Withdrawal by Subject|2|||
33543218|NCT02739321|62933986|FG000|Overall Study|Lack of Efficacy|1|||
33543219|NCT02739321|62933987|FG001|Overall Study|Lack of Efficacy|1|||
33647047|NCT01873729|63055476|FG000|Overall Study|Withdrawal by Subject|1|||
33647048|NCT01873495|63055480|FG000|Overall Study|Withdrawal by Subject|1|||
33647049|NCT01873495|63055480|FG000|Overall Study|Physician Decision|3|||
33647050|NCT01873495|63055480|FG000|Overall Study|Adverse Event|1|||
33647051|NCT01873495|63055480|FG000|Overall Study|Removed for Transplantation|1|||
33647052|NCT01873495|63055480|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
33647053|NCT01852825|63055487|FG000|Overall Study|Withdrawal by Subject|2|||
33647054|NCT01852825|63055488|FG001|Overall Study|Withdrawal by Subject|0|||
33647055|NCT01852825|63055489|FG002|Overall Study|Withdrawal by Subject|0|||
33647056|NCT01822561|63055497|FG000|Overall Study|Withdrawal by Subject|2|||
33647057|NCT01852591|63055522|FG000|Overall Study|Withdrawal by Subject|2|||
33647058|NCT01852591|63055522|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
33647059|NCT01852045|63055529|FG000|Overall Study|Adverse Event|1|||
33647060|NCT01852045|63055530|FG001|Overall Study|Adverse Event|0|||
33647061|NCT01852045|63055531|FG002|Overall Study|Adverse Event|0|||
33647062|NCT01852045|63055529|FG000|Overall Study|Lack of Efficacy|3|||
33647063|NCT01852045|63055530|FG001|Overall Study|Lack of Efficacy|0|||
33647064|NCT01852045|63055531|FG002|Overall Study|Lack of Efficacy|0|||
33647065|NCT01852045|63055529|FG000|Overall Study|Lost to Follow-up|0|||
33647066|NCT01852045|63055530|FG001|Overall Study|Lost to Follow-up|1|||
33647067|NCT01852045|63055531|FG002|Overall Study|Lost to Follow-up|1|||
33647068|NCT01852045|63055529|FG000|Overall Study|Withdrawal by Subject|1|||
33647069|NCT01852045|63055530|FG001|Overall Study|Withdrawal by Subject|0|||
33647070|NCT01852045|63055531|FG002|Overall Study|Withdrawal by Subject|1|||
33647071|NCT01852045|63055529|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33647072|NCT01852045|63055530|FG001|Overall Study|Other Miscellaneous Reasons|3|||
33647073|NCT01852045|63055531|FG002|Overall Study|Other Miscellaneous Reasons|2|||
33647074|NCT01821937|63055550|FG000|Overall Study|Adverse Event|0|||
33647075|NCT01821937|63055551|FG001|Overall Study|Adverse Event|3|||
33647076|NCT01821625|63055559|FG000|Overall Study|Withdrawal by Subject|2|||
33647077|NCT01821625|63055559|FG000|Overall Study|Lack of Efficacy|2|||
33647078|NCT01821625|63055559|FG000|Overall Study|Adverse Event|1|||
33647079|NCT01821625|63055559|FG000|Overall Study|Medical contraindication|1|||
33647080|NCT01821391|63055565|FG000|Overall Study|Adverse Event|1|||
33647081|NCT01821391|63055566|FG001|Overall Study|Adverse Event|0|||
33647082|NCT01873417|63055574|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
33647083|NCT01873417|63055574|FG000|Overall Study|Adverse Event|24|||
33647084|NCT01873417|63055574|FG000|Overall Study|Lost to Follow-up|2|||
33647085|NCT01873417|63055574|FG000|Overall Study|Withdrawal by Subject|2|||
33647086|NCT01873417|63055574|FG000|Overall Study|Physician Decision|3|||
33647087|NCT01872715|63055578|FG000|Overall Study|Adverse Event|1|||
33647088|NCT01872715|63055578|FG000|Overall Study|Protocol Violation|1|||
33647089|NCT01872715|63055578|FG000|Overall Study|Withdrawal by Subject|2|||
33647090|NCT01871545|63055594|FG000|Overall Study|Death|2|||
33647091|NCT01871545|63055595|FG001|Overall Study|Death|0|||
33647092|NCT01871545|63055594|FG000|Overall Study|Lack of Efficacy|11|||
33647093|NCT01871545|63055595|FG001|Overall Study|Lack of Efficacy|2|||
33647094|NCT01871545|63055594|FG000|Overall Study|Physician Decision|4|||
33647095|NCT01871545|63055595|FG001|Overall Study|Physician Decision|0|||
33647096|NCT01871545|63055594|FG000|Overall Study|Withdrawal by Subject|0|||
33647097|NCT01871545|63055595|FG001|Overall Study|Withdrawal by Subject|1|||
33647098|NCT01613599|63055604|FG000|Overall Study|Death|9|||
33647099|NCT01613599|63055604|FG000|Overall Study|Lost to Follow-up|5|||
33647100|NCT01613599|63055604|FG000|Overall Study|Withdrawal by Subject|8|||
33647101|NCT01613599|63055604|FG000|Overall Study|Reason not specified|3|||
33647102|NCT01850641|63055608|FG000|Overall Study|Physician Decision|1|||
33647103|NCT01850641|63055608|FG000|Overall Study|Decrease in serum phosphorus|1|||
33647104|NCT01850641|63055608|FG000|Overall Study|Decrease in serum calcium|2|||
33647105|NCT01850641|63055608|FG000|Overall Study|Increase in serum ferritin|1|||
33647106|NCT01850563|63055614|FG000|Overall Study|Not eligible|3|||
33647107|NCT01850563|63055615|FG001|Overall Study|Not eligible|0|||
33647108|NCT05144945|63055655|FG000|Overall Study|Withdrawal by Subject|1|||
33647109|NCT05144945|63055656|FG001|Overall Study|Withdrawal by Subject|0|||
33647110|NCT04999839|63055685|FG000|Overall Study|Adverse Event|1|||
33647111|NCT04999839|63055686|FG001|Overall Study|Adverse Event|1|||
33647112|NCT04999839|63055687|FG002|Overall Study|Adverse Event|1|||
33647113|NCT04999839|63055688|FG003|Overall Study|Adverse Event|1|||
33647114|NCT04999839|63055689|FG004|Overall Study|Adverse Event|1|||
33647115|NCT04999839|63055685|FG000|Overall Study|Lost to Follow-up|2|||
33647116|NCT04999839|63055686|FG001|Overall Study|Lost to Follow-up|0|||
33647117|NCT04999839|63055687|FG002|Overall Study|Lost to Follow-up|2|||
33647118|NCT04999839|63055688|FG003|Overall Study|Lost to Follow-up|4|||
33647119|NCT04999839|63055689|FG004|Overall Study|Lost to Follow-up|1|||
33647120|NCT04999839|63055685|FG000|Overall Study|Withdrawal by Subject|6|||
33647121|NCT04999839|63055686|FG001|Overall Study|Withdrawal by Subject|5|||
33647122|NCT04999839|63055687|FG002|Overall Study|Withdrawal by Subject|3|||
33647123|NCT04999839|63055688|FG003|Overall Study|Withdrawal by Subject|2|||
33647124|NCT04999839|63055689|FG004|Overall Study|Withdrawal by Subject|2|||
33647125|NCT04999839|63055685|FG000|Overall Study|Lack of Efficacy|0|||
33647126|NCT04999839|63055686|FG001|Overall Study|Lack of Efficacy|1|||
33647127|NCT04999839|63055687|FG002|Overall Study|Lack of Efficacy|0|||
33647128|NCT04999839|63055688|FG003|Overall Study|Lack of Efficacy|0|||
33647129|NCT04999839|63055689|FG004|Overall Study|Lack of Efficacy|0|||
33647130|NCT04999839|63055685|FG000|Overall Study|Physician Decision|0|||
33647131|NCT04999839|63055686|FG001|Overall Study|Physician Decision|0|||
33647132|NCT04999839|63055687|FG002|Overall Study|Physician Decision|0|||
33647133|NCT04999839|63055688|FG003|Overall Study|Physician Decision|0|||
33647134|NCT04999839|63055689|FG004|Overall Study|Physician Decision|1|||
33647135|NCT04999839|63055685|FG000|Overall Study|Sponsor request|0|||
33647136|NCT04999839|63055686|FG001|Overall Study|Sponsor request|1|||
33647137|NCT04999839|63055687|FG002|Overall Study|Sponsor request|0|||
33647138|NCT04999839|63055688|FG003|Overall Study|Sponsor request|0|||
33647139|NCT04999839|63055689|FG004|Overall Study|Sponsor request|0|||
33647140|NCT04999839|63055685|FG000|Overall Study|Other|0|||
33647141|NCT04999839|63055686|FG001|Overall Study|Other|0|||
33647142|NCT04999839|63055687|FG002|Overall Study|Other|1|||
33647143|NCT04999839|63055688|FG003|Overall Study|Other|0|||
33647144|NCT04999839|63055689|FG004|Overall Study|Other|0|||
33647145|NCT04696146|63055733|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
33647146|NCT04696146|63055734|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
33647147|NCT04696146|63055733|FG000|Overall Study|Off hours issue with product|1|||
33647148|NCT04696146|63055734|FG001|Overall Study|Off hours issue with product|0|||
33647149|NCT04658940|63055740|FG000|Overall Study|Withdrawal by Subject|1|||
33647150|NCT04629066|63055746|FG000|Overall Study|Lost to Follow-up|3|||
33647151|NCT04629066|63055747|FG001|Overall Study|Lost to Follow-up|2|||
33647152|NCT04598269|63055755|FG000|Overall Study|Adverse Event|0|||
33647153|NCT04598269|63055756|FG001|Overall Study|Adverse Event|3|||
33647154|NCT04598269|63055755|FG000|Overall Study|Withdrawal by Subject|1|||
33647155|NCT04598269|63055756|FG001|Overall Study|Withdrawal by Subject|4|||
33647156|NCT04598269|63055755|FG000|Overall Study|Lost to Follow-up|1|||
33647157|NCT04598269|63055756|FG001|Overall Study|Lost to Follow-up|0|||
33647158|NCT04598269|63055755|FG000|Overall Study|Not Treated|2|||
33647159|NCT04598269|63055756|FG001|Overall Study|Not Treated|0|||
33647160|NCT04591015|63055764|FG000|Overall Study|Death|6|||
33647161|NCT04591015|63055765|FG001|Overall Study|Death|4|||
33647162|NCT04591015|63055764|FG000|Overall Study|Withdrawal by Subject|6|||
33647163|NCT04591015|63055765|FG001|Overall Study|Withdrawal by Subject|3|||
33647164|NCT04591015|63055764|FG000|Overall Study|Lost to Follow-up|16|||
33647165|NCT04591015|63055765|FG001|Overall Study|Lost to Follow-up|11|||
33647166|NCT04566692|63055773|FG000|Overall Study|Adverse Event|2|||
33647167|NCT04566692|63055774|FG001|Overall Study|Adverse Event|0|||
33647168|NCT04566692|63055773|FG000|Overall Study|Withdrawal by Subject|1|||
33647169|NCT04566692|63055774|FG001|Overall Study|Withdrawal by Subject|1|||
33647170|NCT04533412|63055789|FG000|Overall Study|Withdrawal by Subject|1|||
33647171|NCT04533412|63055790|FG001|Overall Study|Withdrawal by Subject|1|||
33647172|NCT04533412|63055789|FG000|Overall Study|Lost to Follow-up|1|||
33647173|NCT04533412|63055790|FG001|Overall Study|Lost to Follow-up|4|||
33647174|NCT04515147|63055802|FG000|Overall Study|Withdrawal by Subject|1|||
33647175|NCT04515147|63055803|FG001|Overall Study|Withdrawal by Subject|0|||
33647176|NCT04515147|63055804|FG002|Overall Study|Withdrawal by Subject|10|||
33647177|NCT04515147|63055805|FG003|Overall Study|Withdrawal by Subject|18|||
33647178|NCT04515147|63055806|FG004|Overall Study|Withdrawal by Subject|1|||
33647179|NCT04515147|63055807|FG005|Overall Study|Withdrawal by Subject|8|||
33647180|NCT04515147|63055802|FG000|Overall Study|Lost to Follow-up|0|||
33647181|NCT04515147|63055803|FG001|Overall Study|Lost to Follow-up|1|||
33647182|NCT04515147|63055804|FG002|Overall Study|Lost to Follow-up|5|||
33647183|NCT04515147|63055805|FG003|Overall Study|Lost to Follow-up|6|||
33647184|NCT04515147|63055806|FG004|Overall Study|Lost to Follow-up|2|||
33647185|NCT04515147|63055807|FG005|Overall Study|Lost to Follow-up|1|||
33647186|NCT04515147|63055802|FG000|Overall Study|Adverse Event|0|||
33647187|NCT04515147|63055803|FG001|Overall Study|Adverse Event|0|||
33647188|NCT04515147|63055804|FG002|Overall Study|Adverse Event|0|||
33647189|NCT04515147|63055805|FG003|Overall Study|Adverse Event|2|||
33647190|NCT04515147|63055806|FG004|Overall Study|Adverse Event|0|||
33647191|NCT04515147|63055807|FG005|Overall Study|Adverse Event|0|||
33647192|NCT04515147|63055802|FG000|Overall Study|Miscellaneous|0|||
33463642|NCT03439072|62837079|FG001|Overall Study|Physician Decision|1|||
33647193|NCT04515147|63055803|FG001|Overall Study|Miscellaneous|0|||
33647194|NCT04515147|63055804|FG002|Overall Study|Miscellaneous|0|||
33647195|NCT04515147|63055805|FG003|Overall Study|Miscellaneous|1|||
33647196|NCT04515147|63055806|FG004|Overall Study|Miscellaneous|0|||
33647197|NCT04515147|63055807|FG005|Overall Study|Miscellaneous|1|||
33463643|NCT00078312|62837085|FG000|Overall Study|Adverse Event|43|||
33647198|NCT04490018|63055829|FG000|Overall Study|Protocol Violation|0|||
33647199|NCT04490018|63055830|FG001|Overall Study|Protocol Violation|2|||
33647200|NCT04490018|63055831|FG002|Overall Study|Protocol Violation|1|||
33647201|NCT04490018|63055829|FG000|Overall Study|Lost to Follow-up|2|||
33647202|NCT04490018|63055830|FG001|Overall Study|Lost to Follow-up|2|||
33647203|NCT04490018|63055831|FG002|Overall Study|Lost to Follow-up|0|||
33647204|NCT04490018|63055829|FG000|Overall Study|Withdrawal by Subject|2|||
33647205|NCT04490018|63055830|FG001|Overall Study|Withdrawal by Subject|1|||
33647206|NCT04490018|63055831|FG002|Overall Study|Withdrawal by Subject|0|||
33647207|NCT04490018|63055829|FG000|Overall Study|Withdrawal by parent/guardian|2|||
33647208|NCT04490018|63055830|FG001|Overall Study|Withdrawal by parent/guardian|3|||
33647209|NCT04490018|63055831|FG002|Overall Study|Withdrawal by parent/guardian|0|||
33647210|NCT04479618|63055844|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
33647211|NCT04479618|63055845|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
33647212|NCT04479618|63055846|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
33647213|NCT04479618|63055844|FG000|Overall Study|Lack of Efficacy|1|||
33647214|NCT04479618|63055845|FG001|Overall Study|Lack of Efficacy|0|||
33647215|NCT04479618|63055846|FG002|Overall Study|Lack of Efficacy|0|||
33647216|NCT04479618|63055844|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
33647217|NCT04479618|63055845|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
33647218|NCT04479618|63055846|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
33647219|NCT04479618|63055844|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
33647220|NCT04479618|63055845|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
33647221|NCT04479618|63055846|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
33647222|NCT04479618|63055844|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
33647223|NCT04479618|63055845|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
33647224|NCT04479618|63055846|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
33647225|NCT04479618|63055844|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
33647226|NCT04479618|63055845|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
33647227|NCT04479618|63055846|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
33647228|NCT04476043|63055861|FG000|Overall Study|Withdrawal by Subject|1|||
33647229|NCT04476043|63055862|FG001|Overall Study|Withdrawal by Subject|3|||
33647230|NCT04476043|63055863|FG002|Overall Study|Withdrawal by Subject|4|||
33647231|NCT04476043|63055864|FG003|Overall Study|Withdrawal by Subject|1|||
33647232|NCT04476043|63055861|FG000|Overall Study|Lost to Follow-up|1|||
33647233|NCT04476043|63055862|FG001|Overall Study|Lost to Follow-up|1|||
33647234|NCT04476043|63055863|FG002|Overall Study|Lost to Follow-up|2|||
33647235|NCT04476043|63055864|FG003|Overall Study|Lost to Follow-up|1|||
33647236|NCT04476043|63055861|FG000|Overall Study|Adverse Event|2|||
33647237|NCT04476043|63055862|FG001|Overall Study|Adverse Event|0|||
33647238|NCT04476043|63055863|FG002|Overall Study|Adverse Event|1|||
33647239|NCT04476043|63055864|FG003|Overall Study|Adverse Event|0|||
33647240|NCT04476043|63055861|FG000|Overall Study|Protocol Violation|0|||
33647241|NCT04476043|63055862|FG001|Overall Study|Protocol Violation|1|||
33647242|NCT04476043|63055863|FG002|Overall Study|Protocol Violation|0|||
33647243|NCT04476043|63055864|FG003|Overall Study|Protocol Violation|0|||
33647244|NCT04418765|63055877|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
33647245|NCT04418765|63055878|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
33647246|NCT04418765|63055879|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
33647247|NCT04418765|63055877|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
33647248|NCT04418765|63055878|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
33647249|NCT04418765|63055879|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
33647250|NCT04418765|63055877|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
33647251|NCT04418765|63055878|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
33647252|NCT04418765|63055879|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
33647253|NCT04418765|63055877|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
33647254|NCT04418765|63055878|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
33647255|NCT04418765|63055879|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
33647256|NCT04418765|63055877|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
33647257|NCT04418765|63055878|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
33647258|NCT04418765|63055879|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
33647259|NCT04418765|63055877|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
33647260|NCT04418765|63055878|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
33647261|NCT04418765|63055879|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
33647262|NCT04418765|63055877|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
33463644|NCT00078312|62837085|FG000|Overall Study|Lack of Efficacy|15|||
33463645|NCT00078312|62837085|FG000|Overall Study|Lost to Follow-up|41|||
33463646|NCT00078312|62837085|FG000|Overall Study|Physician Decision|9|||
33543220|NCT02739321|62933986|FG000|Overall Study|Lost to Follow-up|1|||
33647263|NCT04418765|63055878|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
33647264|NCT04418765|63055879|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
33647265|NCT04418765|63055877|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
33647266|NCT04418765|63055878|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
33647267|NCT04418765|63055879|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
33647268|NCT04418765|63055877|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
33647269|NCT04418765|63055878|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
33647270|NCT04418765|63055879|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
33647271|NCT04418765|63055877|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
33647272|NCT04418765|63055878|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
33647273|NCT04418765|63055879|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
33647274|NCT04418765|63055877|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
33647275|NCT04418765|63055878|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
33647276|NCT04418765|63055879|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
33647277|NCT04418765|63055877|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
33647278|NCT04418765|63055878|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
33647279|NCT04418765|63055879|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
33647280|NCT04418765|63055877|FG000|Extension Period (48 Weeks)|Other than specified|0|||
33647281|NCT04418765|63055878|FG001|Extension Period (48 Weeks)|Other than specified|5|||
33647282|NCT04418765|63055879|FG002|Extension Period (48 Weeks)|Other than specified|2|||
33647283|NCT04359758|63055897|FG000|Overall Study|Protocol Violation|3|||
33647284|NCT04359758|63055898|FG001|Overall Study|Protocol Violation|2|||
33647285|NCT04266795|63055906|FG000|Overall Study|Adverse Event|10|||
33647286|NCT04266795|63055907|FG001|Overall Study|Adverse Event|19|||
33647287|NCT04266795|63055906|FG000|Overall Study|Death|7|||
33647288|NCT04266795|63055907|FG001|Overall Study|Death|8|||
33647289|NCT04266795|63055906|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
33647290|NCT04266795|63055907|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
33647291|NCT04266795|63055906|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
33647292|NCT04266795|63055907|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33647293|NCT04266795|63055906|FG000|Overall Study|Progressive Disease|12|||
33647294|NCT04266795|63055907|FG001|Overall Study|Progressive Disease|9|||
33647295|NCT04266795|63055906|FG000|Overall Study|Withdrawal by Patient|5|||
33647296|NCT04266795|63055907|FG001|Overall Study|Withdrawal by Patient|6|||
33647297|NCT04266795|63055906|FG000|Overall Study|Disease Relapse|3|||
33647298|NCT04266795|63055907|FG001|Overall Study|Disease Relapse|6|||
33647299|NCT04266795|63055906|FG000|Overall Study|Reason not Specified|12|||
33647300|NCT04266795|63055907|FG001|Overall Study|Reason not Specified|10|||
33647301|NCT04266795|63055906|FG000|Overall Study|Participants Ongoing on Treatment|25|||
33647302|NCT04266795|63055907|FG001|Overall Study|Participants Ongoing on Treatment|23|||
33647303|NCT04212169|63055917|FG000|Overall Study|Adverse Event|0|||
33647304|NCT04212169|63055918|FG001|Overall Study|Adverse Event|0|||
33647305|NCT04212169|63055919|FG002|Overall Study|Adverse Event|0|||
33647306|NCT04212169|63055920|FG003|Overall Study|Adverse Event|2|||
33647307|NCT04212169|63055917|FG000|Overall Study|Lost to Follow-up|1|||
33647308|NCT04212169|63055918|FG001|Overall Study|Lost to Follow-up|0|||
33647309|NCT04212169|63055919|FG002|Overall Study|Lost to Follow-up|0|||
33647310|NCT04212169|63055920|FG003|Overall Study|Lost to Follow-up|2|||
33647311|NCT04212169|63055917|FG000|Overall Study|Withdrawal by Subject|10|||
33647312|NCT04212169|63055918|FG001|Overall Study|Withdrawal by Subject|2|||
33647313|NCT04212169|63055919|FG002|Overall Study|Withdrawal by Subject|5|||
33647314|NCT04212169|63055920|FG003|Overall Study|Withdrawal by Subject|7|||
33647315|NCT04212169|63055917|FG000|Overall Study|Other reason, unspecified|3|||
33647316|NCT04212169|63055918|FG001|Overall Study|Other reason, unspecified|1|||
33647317|NCT04212169|63055919|FG002|Overall Study|Other reason, unspecified|0|||
33647318|NCT04212169|63055920|FG003|Overall Study|Other reason, unspecified|2|||
33647319|NCT04109313|63055949|FG000|Overall Study|Pregnancy|1|||
33647320|NCT04109313|63055949|FG000|Overall Study|Adverse Event|11|||
33647321|NCT04109313|63055949|FG000|Overall Study|Lack of Efficacy|11|||
33647322|NCT04109313|63055949|FG000|Overall Study|Lost to Follow-up|1|||
33647323|NCT04109313|63055949|FG000|Overall Study|Physician Decision|2|||
33647324|NCT04109313|63055949|FG000|Overall Study|Subject Decision|13|||
33647325|NCT04109313|63055949|FG000|Overall Study|Covid-19 situation|2|||
33647326|NCT04089865|63055958|FG000|Overall Study|Withdrawal by Subject|2|||
33647327|NCT04089865|63055959|FG001|Overall Study|Withdrawal by Subject|2|||
33647328|NCT04089865|63055960|FG002|Overall Study|Withdrawal by Subject|7|||
33647329|NCT04089865|63055961|FG003|Overall Study|Withdrawal by Subject|2|||
33647330|NCT04059484|63055973|FG000|Overall Study|Adverse Event|2|||
33647331|NCT04059484|63055974|FG001|Overall Study|Adverse Event|5|||
33647332|NCT04059484|63055973|FG000|Overall Study|Withdrawal by Subject|5|||
33543221|NCT02739321|62933987|FG001|Overall Study|Lost to Follow-up|1|||
33327242|NCT01185353|62703800|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
33647333|NCT04059484|63055974|FG001|Overall Study|Withdrawal by Subject|3|||
33647334|NCT04059484|63055973|FG000|Overall Study|Progressive disease|112|||
33647335|NCT04059484|63055974|FG001|Overall Study|Progressive disease|112|||
33647336|NCT04059484|63055973|FG000|Overall Study|Other|8|||
33647337|NCT04059484|63055974|FG001|Overall Study|Other|3|||
33647338|NCT04059484|63055973|FG000|Overall Study|Ongoing|20|||
33647339|NCT04059484|63055974|FG001|Overall Study|Ongoing|20|||
33647340|NCT04033003|63055985|FG000|T1 3rd Trimester|Lost to Follow-up|113|||
33647341|NCT04033003|63055986|FG001|T1 3rd Trimester|Lost to Follow-up|190|||
33647342|NCT04033003|63055985|FG000|T1 3rd Trimester|Protocol Violation|115|||
33647343|NCT04033003|63055986|FG001|T1 3rd Trimester|Protocol Violation|0|||
33647344|NCT04033003|63055985|FG000|T1 3rd Trimester|Withdrawal by Subject|2|||
33647345|NCT04033003|63055986|FG001|T1 3rd Trimester|Withdrawal by Subject|6|||
33647346|NCT04033003|63055985|FG000|T1 3rd Trimester|No longer meets criteria|30|||
33647347|NCT04033003|63055986|FG001|T1 3rd Trimester|No longer meets criteria|19|||
33647348|NCT04033003|63055985|FG000|T1 3rd Trimester|Death|0|||
33647349|NCT04033003|63055986|FG001|T1 3rd Trimester|Death|1|||
33647350|NCT04033003|63055985|FG000|T2 Post Delivery|Lost to Follow-up|133|||
33647351|NCT04033003|63055986|FG001|T2 Post Delivery|Lost to Follow-up|247|||
33647352|NCT04033003|63055985|FG000|T2 Post Delivery|Protocol Violation|4|||
33647353|NCT04033003|63055986|FG001|T2 Post Delivery|Protocol Violation|0|||
33647354|NCT04033003|63055985|FG000|T2 Post Delivery|Withdrawal by Subject|5|||
33647355|NCT04033003|63055986|FG001|T2 Post Delivery|Withdrawal by Subject|3|||
33647356|NCT04033003|63055985|FG000|T2 Post Delivery|No longer meets criteria|1|||
33647357|NCT04033003|63055986|FG001|T2 Post Delivery|No longer meets criteria|10|||
33647358|NCT04033003|63055985|FG000|T2 Post Delivery|Death|2|||
33647359|NCT04033003|63055986|FG001|T2 Post Delivery|Death|2|||
33647360|NCT04017832|63056010|FG000|Overall Study|Withdrawal by Subject|13|||
33647361|NCT04017832|63056011|FG001|Overall Study|Withdrawal by Subject|12|||
33647362|NCT04017832|63056012|FG002|Overall Study|Withdrawal by Subject|21|||
33647363|NCT04017832|63056013|FG003|Overall Study|Withdrawal by Subject|7|||
33647364|NCT04017832|63056010|FG000|Overall Study|Lost to Follow-up|0|||
33647365|NCT04017832|63056011|FG001|Overall Study|Lost to Follow-up|3|||
33647366|NCT04017832|63056012|FG002|Overall Study|Lost to Follow-up|3|||
33647367|NCT04017832|63056013|FG003|Overall Study|Lost to Follow-up|1|||
33647368|NCT04017832|63056010|FG000|Overall Study|Physician Decision|1|||
33647369|NCT04017832|63056011|FG001|Overall Study|Physician Decision|1|||
33647370|NCT04017832|63056012|FG002|Overall Study|Physician Decision|1|||
33647371|NCT04017832|63056013|FG003|Overall Study|Physician Decision|1|||
33647372|NCT04017832|63056010|FG000|Overall Study|Death|2|||
33647373|NCT04017832|63056011|FG001|Overall Study|Death|2|||
33647374|NCT04017832|63056012|FG002|Overall Study|Death|1|||
33647375|NCT04017832|63056013|FG003|Overall Study|Death|0|||
33647376|NCT03952806|63056029|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
33647377|NCT03952806|63056030|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
33647378|NCT03952806|63056029|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
33647379|NCT03952806|63056030|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
33647380|NCT03952806|63056029|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
33647381|NCT03952806|63056030|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
33647382|NCT03952806|63056029|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
33647383|NCT03952806|63056030|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
33647384|NCT03952806|63056029|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
33647385|NCT03952806|63056030|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
33647386|NCT03952806|63056029|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
33463647|NCT00078312|62837085|FG000|Overall Study|Protocol Violation|3|||
33463648|NCT00078312|62837085|FG000|Overall Study|Withdrawal by Subject|33|||
33463649|NCT00078312|62837085|FG000|Overall Study|Miscellaneous|33|||
33463650|NCT00003896|62837089|FG000|Overall Study|Adverse Event|16|||
33647387|NCT03952806|63056030|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
33647388|NCT03952806|63056029|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
33647389|NCT03952806|63056030|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
33647390|NCT03952806|63056029|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
33647391|NCT03952806|63056030|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
33647392|NCT03952806|63056029|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
33463651|NCT00003896|62837089|FG000|Overall Study|Withdrawal by Subject|1|||
33463652|NCT00003896|62837089|FG000|Overall Study|Lack of Efficacy|1|||
33647393|NCT03952806|63056030|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
33463653|NCT00003896|62837089|FG000|Overall Study|Death|3|||
33647394|NCT03952806|63056029|FG000|OLE Phase (48 Weeks)|Other|16|||
33647395|NCT03952806|63056030|FG001|OLE Phase (48 Weeks)|Other|13|||
33647396|NCT03924947|63056055|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
33647397|NCT03924947|63056056|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
33647398|NCT03924947|63056057|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
33647399|NCT03924947|63056058|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
33647400|NCT03924947|63056059|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
33647401|NCT03924947|63056060|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
33647402|NCT03891901|63056081|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
33647403|NCT03891901|63056082|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33647404|NCT03891901|63056083|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33647405|NCT03891901|63056084|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33647406|NCT03891901|63056085|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33647407|NCT03891901|63056086|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33647408|NCT03891901|63056087|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33647409|NCT03891901|63056088|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33647410|NCT03891901|63056089|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33647411|NCT03891901|63056081|FG000|Overall Study|Adverse Event|2|||
33647412|NCT03891901|63056082|FG001|Overall Study|Adverse Event|2|||
33647413|NCT03891901|63056083|FG002|Overall Study|Adverse Event|0|||
33647414|NCT03891901|63056084|FG003|Overall Study|Adverse Event|0|||
33647415|NCT03891901|63056085|FG004|Overall Study|Adverse Event|0|||
33647416|NCT03891901|63056086|FG005|Overall Study|Adverse Event|0|||
33647417|NCT03891901|63056087|FG006|Overall Study|Adverse Event|0|||
33647418|NCT03891901|63056088|FG007|Overall Study|Adverse Event|0|||
33647419|NCT03891901|63056089|FG008|Overall Study|Adverse Event|0|||
33647420|NCT03891901|63056081|FG000|Overall Study|Poor venous access|1|||
33647421|NCT03891901|63056082|FG001|Overall Study|Poor venous access|0|||
33647422|NCT03891901|63056083|FG002|Overall Study|Poor venous access|0|||
33647423|NCT03891901|63056084|FG003|Overall Study|Poor venous access|0|||
33647424|NCT03891901|63056085|FG004|Overall Study|Poor venous access|0|||
33647425|NCT03891901|63056086|FG005|Overall Study|Poor venous access|0|||
33647426|NCT03891901|63056087|FG006|Overall Study|Poor venous access|0|||
33647427|NCT03891901|63056088|FG007|Overall Study|Poor venous access|0|||
33647428|NCT03891901|63056089|FG008|Overall Study|Poor venous access|0|||
33647429|NCT03891901|63056081|FG000|Overall Study|Withdrawal by Subject|0|||
33647430|NCT03891901|63056082|FG001|Overall Study|Withdrawal by Subject|2|||
33647431|NCT03891901|63056083|FG002|Overall Study|Withdrawal by Subject|0|||
33647432|NCT03891901|63056084|FG003|Overall Study|Withdrawal by Subject|0|||
33647433|NCT03891901|63056085|FG004|Overall Study|Withdrawal by Subject|0|||
33647434|NCT03891901|63056086|FG005|Overall Study|Withdrawal by Subject|0|||
33647435|NCT03891901|63056087|FG006|Overall Study|Withdrawal by Subject|0|||
33647436|NCT03891901|63056088|FG007|Overall Study|Withdrawal by Subject|0|||
33647437|NCT03891901|63056089|FG008|Overall Study|Withdrawal by Subject|0|||
33647438|NCT03845985|63056106|FG000|Overall Study|Lost to Follow-up|2|||
33647439|NCT03845985|63056107|FG001|Overall Study|Lost to Follow-up|1|||
33647440|NCT03845985|63056106|FG000|Overall Study|Physician Decision|1|||
33647441|NCT03845985|63056107|FG001|Overall Study|Physician Decision|0|||
33647442|NCT03845985|63056106|FG000|Overall Study|Withdrawal by Subject|4|||
33647443|NCT03845985|63056107|FG001|Overall Study|Withdrawal by Subject|1|||
33647444|NCT03745651|63056116|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
33647445|NCT03745651|63056117|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
33647446|NCT03745651|63056118|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33647447|NCT03745651|63056119|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33647448|NCT03745651|63056120|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33647449|NCT03745651|63056121|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33647450|NCT03745651|63056122|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33647451|NCT03745651|63056116|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
33647452|NCT03745651|63056117|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
33647453|NCT03745651|63056118|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
33647454|NCT03745651|63056119|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33647455|NCT03745651|63056120|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33647456|NCT03745651|63056121|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33647457|NCT03745651|63056122|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33647458|NCT03745651|63056116|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
33647459|NCT03745651|63056117|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33647460|NCT03745651|63056118|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
33647461|NCT03745651|63056119|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33647462|NCT03745651|63056120|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33647463|NCT03745651|63056121|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33647464|NCT03745651|63056122|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33647465|NCT03745651|63056116|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33647466|NCT03745651|63056117|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
33647467|NCT03745651|63056118|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33543222|NCT02739321|62933986|FG000|Overall Study|Withdrawal by Subject|1|||
33647468|NCT03745651|63056119|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33647469|NCT03745651|63056120|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33647470|NCT03745651|63056121|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33647471|NCT03745651|63056122|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33647472|NCT03745651|63056116|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
33647473|NCT03745651|63056117|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
33647474|NCT03745651|63056118|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
33647475|NCT03745651|63056119|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33647476|NCT03745651|63056120|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33647477|NCT03745651|63056121|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33647478|NCT03745651|63056122|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33647479|NCT03745651|63056116|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
33647480|NCT03745651|63056117|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
33647481|NCT03745651|63056118|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
33647482|NCT03745651|63056119|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
33647483|NCT03745651|63056120|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
33647484|NCT03745651|63056121|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
33647485|NCT03745651|63056122|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
33647486|NCT03745651|63056116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33647487|NCT03745651|63056117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33647488|NCT03745651|63056118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33647489|NCT03745651|63056119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33647490|NCT03745651|63056120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33647491|NCT03745651|63056121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
33647492|NCT03745651|63056122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33647493|NCT03745651|63056116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33647494|NCT03745651|63056117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33647495|NCT03745651|63056118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33647496|NCT03745651|63056119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
33647497|NCT03745651|63056120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33647498|NCT03745651|63056121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
33647499|NCT03745651|63056122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
33647500|NCT03745651|63056116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
33647501|NCT03745651|63056117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
33647502|NCT03745651|63056118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
33647503|NCT03745651|63056119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
33647504|NCT03745651|63056120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
33647505|NCT03745651|63056121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
33647506|NCT03745651|63056122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
33647507|NCT03745651|63056116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33647508|NCT03745651|63056117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33647509|NCT03745651|63056118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33647510|NCT03745651|63056119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
33647511|NCT03745651|63056120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33647512|NCT03745651|63056121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
33647513|NCT03745651|63056122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
33647514|NCT03745651|63056116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
33647515|NCT03745651|63056117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
33647516|NCT03745651|63056118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
33647517|NCT03745651|63056119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
33647518|NCT03745651|63056120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
33647519|NCT03745651|63056121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
33647520|NCT03745651|63056122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
33647521|NCT03745651|63056116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33647522|NCT03745651|63056117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33647523|NCT03745651|63056118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33647524|NCT03745651|63056119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33647525|NCT03745651|63056120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33647526|NCT03745651|63056121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
33463654|NCT00003896|62837089|FG000|Overall Study|not protocol specified|3|||
33543223|NCT02739321|62933987|FG001|Overall Study|Withdrawal by Subject|2|||
33647527|NCT03745651|63056122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33647528|NCT03745651|63056116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
33647529|NCT03745651|63056117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
33647530|NCT03745651|63056118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
33647531|NCT03745651|63056119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
33647532|NCT03745651|63056120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
33647533|NCT03745651|63056121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
33647534|NCT03745651|63056122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
33647535|NCT03745651|63056116|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
33647536|NCT03745651|63056117|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
33647537|NCT03745651|63056118|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
33647538|NCT03745651|63056119|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
33647539|NCT03745651|63056120|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
33647540|NCT03745651|63056121|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
33647541|NCT03745651|63056122|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
33647542|NCT03745638|63056141|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
33647543|NCT03745638|63056142|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
33647544|NCT03745638|63056143|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
33647545|NCT03745638|63056144|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33647546|NCT03745638|63056145|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33647547|NCT03745638|63056146|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33647548|NCT03745638|63056147|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33647549|NCT03745638|63056141|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
33647550|NCT03745638|63056142|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33647551|NCT03745638|63056143|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33647552|NCT03745638|63056144|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33647553|NCT03745638|63056145|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33647554|NCT03745638|63056146|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33647555|NCT03745638|63056147|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33647556|NCT03745638|63056141|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
33647557|NCT03745638|63056142|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
33647558|NCT03745638|63056143|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
33647559|NCT03745638|63056144|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33647560|NCT03745638|63056145|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33647561|NCT03745638|63056146|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33647562|NCT03745638|63056147|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33647563|NCT03745638|63056141|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
33647564|NCT03745638|63056142|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
33647565|NCT03745638|63056143|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33647566|NCT03745638|63056144|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33647567|NCT03745638|63056145|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33647568|NCT03745638|63056146|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33647569|NCT03745638|63056147|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33647570|NCT03745638|63056141|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
33647571|NCT03745638|63056142|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
33647572|NCT03745638|63056143|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
33647573|NCT03745638|63056144|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
33647574|NCT03745638|63056145|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
33647575|NCT03745638|63056146|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
33647576|NCT03745638|63056147|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
33647577|NCT03745638|63056141|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33647578|NCT03745638|63056142|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
33647579|NCT03745638|63056143|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33647580|NCT03745638|63056144|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33647581|NCT03745638|63056145|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33647582|NCT03745638|63056146|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33647583|NCT03745638|63056147|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33647584|NCT03745638|63056141|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
33647585|NCT03745638|63056142|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
33647586|NCT03745638|63056143|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
33647587|NCT03745638|63056144|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33463655|NCT00003896|62837089|FG000|Overall Study|ineligible|5|||
33647588|NCT03745638|63056145|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33647589|NCT03745638|63056146|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33647590|NCT03745638|63056147|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33647591|NCT03745638|63056141|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
33647592|NCT03745638|63056142|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
33647593|NCT03745638|63056143|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
33647594|NCT03745638|63056144|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
33647595|NCT03745638|63056145|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
33647596|NCT03745638|63056146|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
33647597|NCT03745638|63056147|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
33647598|NCT03745638|63056141|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33647599|NCT03745638|63056142|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33647600|NCT03745638|63056143|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33647601|NCT03745638|63056144|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33647602|NCT03745638|63056145|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33647603|NCT03745638|63056146|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
33647604|NCT03745638|63056147|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
33647605|NCT03745638|63056141|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33647606|NCT03745638|63056142|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33647607|NCT03745638|63056143|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33647608|NCT03745638|63056144|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
33647609|NCT03745638|63056145|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33647610|NCT03745638|63056146|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
33647611|NCT03745638|63056147|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
33647612|NCT03745638|63056141|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
33647613|NCT03745638|63056142|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
33647614|NCT03745638|63056143|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
33647615|NCT03745638|63056144|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
33463656|NCT00003830|62837096|FG000|Overall Study|No follow up data|3|||
33463657|NCT00003830|62837097|FG001|Overall Study|No follow up data|0|||
33463658|NCT00003830|62837096|FG000|Overall Study|Sentinel node positive patients|829|||
33463659|NCT00003830|62837097|FG001|Overall Study|Sentinel node positive patients|793|||
33463660|NCT03407482|62837105|FG000|Overall Study|Adverse Event|12|||
33463661|NCT03407482|62837105|FG000|Overall Study|Disease Relapse|1|||
33463662|NCT03407482|62837105|FG000|Overall Study|Lost to Follow-up|1|||
33543224|NCT02696798|62934005|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
33543225|NCT02696798|62934006|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
33543226|NCT02696798|62934007|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
33543227|NCT02696798|62934005|FG000|Blinded Treatment Dosing Period|Death|0|||
33543228|NCT02696798|62934006|FG001|Blinded Treatment Dosing Period|Death|0|||
33543229|NCT02696798|62934007|FG002|Blinded Treatment Dosing Period|Death|1|||
33543230|NCT02696798|62934005|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
33543231|NCT02696798|62934006|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
33543232|NCT02696798|62934007|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
33543233|NCT02696798|62934005|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
33543234|NCT02696798|62934006|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
33543235|NCT02696798|62934007|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
33543236|NCT02696798|62934005|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
33543237|NCT02696798|62934006|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
33543238|NCT02696798|62934007|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
33543239|NCT02696798|62934005|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
33543240|NCT02696798|62934006|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
33543241|NCT02696798|62934007|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
33543242|NCT02696798|62934005|FG000|Extended Treatment Period|Adverse Event|1|||
33543243|NCT02696798|62934006|FG001|Extended Treatment Period|Adverse Event|4|||
33543244|NCT02696798|62934007|FG002|Extended Treatment Period|Adverse Event|5|||
33463663|NCT03407482|62837105|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33463664|NCT03407482|62837105|FG000|Overall Study|Pregnancy|2|||
33463665|NCT03407482|62837105|FG000|Overall Study|Protocol Violation|1|||
33463666|NCT03407482|62837105|FG000|Overall Study|Study Terminated By Sponsor|106|||
33463667|NCT03407482|62837105|FG000|Overall Study|Withdrawal by Subject|6|||
33463668|NCT03407482|62837105|FG000|Overall Study|Data Entry Error|1|||
33543245|NCT02696798|62934005|FG000|Extended Treatment Period|Lack of Efficacy|7|||
33543246|NCT02696798|62934006|FG001|Extended Treatment Period|Lack of Efficacy|2|||
33463669|NCT00003782|62837112|FG000|Overall Study|No follow up data|30|||
33463670|NCT00003782|62837113|FG001|Overall Study|No follow up data|31|||
33463671|NCT00003782|62837114|FG002|Overall Study|No follow up data|26|||
33463672|NCT03389308|62837122|FG000|Overall Study|Withdrawal by Subject|5|||
33463673|NCT03389308|62837122|FG000|Overall Study|Lost to Follow-up|3|||
33463674|NCT03389308|62837122|FG000|Overall Study|Adverse Event|2|||
33463675|NCT03389308|62837122|FG000|Overall Study|Sponsor Request|2|||
33463676|NCT03407170|62837126|FG000|Overall Study|Adverse Event|1|||
33463677|NCT03406858|62837130|FG000|Overall Study|Failure to receive treatment drug.|1|||
33543247|NCT02696798|62934007|FG002|Extended Treatment Period|Lack of Efficacy|2|||
33543248|NCT02696798|62934005|FG000|Extended Treatment Period|Lost to Follow-up|1|||
33543249|NCT02696798|62934006|FG001|Extended Treatment Period|Lost to Follow-up|0|||
33543250|NCT02696798|62934007|FG002|Extended Treatment Period|Lost to Follow-up|0|||
33543251|NCT02696798|62934005|FG000|Extended Treatment Period|Physician Decision|0|||
33543252|NCT02696798|62934006|FG001|Extended Treatment Period|Physician Decision|1|||
33543253|NCT02696798|62934007|FG002|Extended Treatment Period|Physician Decision|0|||
33543254|NCT02696798|62934005|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
33543255|NCT02696798|62934006|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
33543256|NCT02696798|62934007|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
33543257|NCT02696798|62934005|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
33543258|NCT02696798|62934006|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
33543259|NCT02696798|62934007|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
33543260|NCT02696798|62934005|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
33543261|NCT02696798|62934006|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
33543262|NCT02696798|62934007|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
33543263|NCT02696798|62934005|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
33543264|NCT02696798|62934006|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
33543265|NCT02696798|62934007|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
33543266|NCT02696798|62934005|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
33543267|NCT02696798|62934006|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
33543268|NCT02696798|62934007|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
33543269|NCT02696798|62934005|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
33543270|NCT02696798|62934006|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
33543271|NCT02696798|62934007|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
33543272|NCT02696798|62934005|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
33543273|NCT02696798|62934006|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
33543274|NCT02696798|62934007|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
33463678|NCT03406858|62837130|FG000|Overall Study|ineligible|1|||
33463679|NCT03406702|62837134|FG000|Overall Study|Missed Day 27 Dosing|1|||
33463680|NCT00003656|62837152|FG000|Overall Study|Adverse Event|0|||
33463681|NCT00003656|62837153|FG001|Overall Study|Adverse Event|1|||
33463682|NCT00003590|62837160|FG000|Overall Study|Ineligible Patient|1|||
33463683|NCT00003590|62837160|FG000|Overall Study|Adverse Event|7|||
33463684|NCT00003590|62837160|FG000|Overall Study|Withdrawal by Subject|1|||
33463685|NCT00003590|62837160|FG000|Overall Study|Lack of Efficacy|11|||
33463686|NCT00003590|62837160|FG000|Overall Study|Death|1|||
33463687|NCT00003590|62837160|FG000|Overall Study|Physician Decision|1|||
33543275|NCT02698826|62934029|FG000|Overall Study|Death|13|||
33543276|NCT02698826|62934029|FG000|Overall Study|Adverse Event|1|||
33543277|NCT02541604|62934047|FG000|Overall Study|Death|6|||
33543278|NCT02541604|62934048|FG001|Overall Study|Death|5|||
33543279|NCT02541604|62934049|FG002|Overall Study|Death|7|||
33543280|NCT02541604|62934050|FG003|Overall Study|Death|2|||
33543281|NCT02541604|62934051|FG004|Overall Study|Death|9|||
33327243|NCT01185353|62703801|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
33327244|NCT01185353|62703802|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
33543282|NCT02541604|62934052|FG005|Overall Study|Death|8|||
33543283|NCT02541604|62934053|FG006|Overall Study|Death|9|||
33543284|NCT02541604|62934054|FG007|Overall Study|Death|9|||
33543285|NCT02541604|62934055|FG008|Overall Study|Death|3|||
33543286|NCT02541604|62934056|FG009|Overall Study|Death|4|||
33543287|NCT02541604|62934057|FG010|Overall Study|Death|2|||
33327245|NCT01185353|62703803|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
33327246|NCT01185353|62703804|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
33327247|NCT01185353|62703805|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
33327248|NCT01185353|62703806|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
33327249|NCT01185353|62703797|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
33327250|NCT01185353|62703798|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
33463688|NCT03416374|62837166|FG000|Between Treatment Period I and II|Other|0|||
33463689|NCT03416374|62837167|FG001|Between Treatment Period I and II|Other|9|||
33543288|NCT02541604|62934058|FG011|Overall Study|Death|3|||
33463690|NCT03416374|62837166|FG000|Treatment Period II|Lack of Efficacy|3|||
33463691|NCT03416374|62837167|FG001|Treatment Period II|Lack of Efficacy|11|||
33463692|NCT03416374|62837166|FG000|Treatment Period II|Adverse Event|1|||
33463693|NCT03416374|62837167|FG001|Treatment Period II|Adverse Event|4|||
33647616|NCT03745638|63056145|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
33647617|NCT03745638|63056146|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
33647618|NCT03745638|63056147|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
33647619|NCT03745638|63056141|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33647620|NCT03745638|63056142|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33647621|NCT03745638|63056143|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33647622|NCT03745638|63056144|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33647623|NCT03745638|63056145|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
33647624|NCT03745638|63056146|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
33647625|NCT03745638|63056147|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33647626|NCT03745638|63056141|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33647627|NCT03745638|63056142|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33647628|NCT03745638|63056143|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33647629|NCT03745638|63056144|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33647630|NCT03745638|63056145|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33647631|NCT03745638|63056146|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
33647632|NCT03745638|63056147|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33647633|NCT03745638|63056141|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
33647634|NCT03745638|63056142|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
33647635|NCT03745638|63056143|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
33647636|NCT03745638|63056144|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
33647637|NCT03745638|63056145|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
33647638|NCT03745638|63056146|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
33647639|NCT03745638|63056147|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
33647640|NCT03745638|63056141|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
33647641|NCT03745638|63056142|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
33647642|NCT03745638|63056143|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
33647643|NCT03745638|63056144|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
33647644|NCT03745638|63056145|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
33647645|NCT03745638|63056146|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
33647646|NCT03745638|63056147|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
33647647|NCT03699475|63056177|FG000|Overall Study|Death|1|||
33647648|NCT03668613|63056183|FG000|Overall Study|Adverse Event|0|||
33647649|NCT03668613|63056184|FG001|Overall Study|Adverse Event|2|||
33647650|NCT03668613|63056183|FG000|Overall Study|Lack of Efficacy|0|||
33647651|NCT03668613|63056184|FG001|Overall Study|Lack of Efficacy|1|||
33647652|NCT03650413|63056191|FG000|Overall Study|Adverse Event|1|||
33647653|NCT03650413|63056191|FG000|Overall Study|Lack of Efficacy|17|||
33647654|NCT03650413|63056191|FG000|Overall Study|Other|9|||
33647655|NCT03650413|63056191|FG000|Overall Study|Physician Decision|2|||
33647656|NCT03650413|63056191|FG000|Overall Study|Study Terminated By Sponsor|16|||
33647657|NCT03650413|63056191|FG000|Overall Study|Withdrawal by Subject|16|||
33647658|NCT03596242|63056201|FG000|Overall Study|Lost to Follow-up|2|||
33647659|NCT03596242|63056202|FG001|Overall Study|Lost to Follow-up|2|||
33647660|NCT03514017|63056208|FG000|Overall Study|Death|1|||
33647661|NCT03514017|63056208|FG000|Overall Study|Adverse Event|1|||
33647662|NCT03471078|63056214|FG000|Overall Study|Withdrawal by Subject|9|||
33647663|NCT03471078|63056215|FG001|Overall Study|Withdrawal by Subject|1|||
33647664|NCT03471078|63056214|FG000|Overall Study|Adverse Event|4|||
33647665|NCT03471078|63056215|FG001|Overall Study|Adverse Event|1|||
33647666|NCT03471078|63056214|FG000|Overall Study|Physician Decision|3|||
33647667|NCT03471078|63056215|FG001|Overall Study|Physician Decision|2|||
33647668|NCT03471078|63056214|FG000|Overall Study|Death|2|||
33647669|NCT03471078|63056215|FG001|Overall Study|Death|0|||
33647670|NCT03471078|63056214|FG000|Overall Study|Other|3|||
33647671|NCT03471078|63056215|FG001|Overall Study|Other|2|||
33647672|NCT03308188|63056253|FG000|Overall Study|Withdrawal by Subject|0|||
33647673|NCT03308188|63056254|FG001|Overall Study|Withdrawal by Subject|3|||
33647674|NCT03308188|63056253|FG000|Overall Study|Death|0|||
33647675|NCT03308188|63056254|FG001|Overall Study|Death|1|||
33647676|NCT03143153|63056272|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
33647677|NCT03143153|63056273|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
33647678|NCT03143153|63056274|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
33647679|NCT03143153|63056272|FG000|Pre-Treatment|Participant withdrew consent|0|||
33647680|NCT03143153|63056273|FG001|Pre-Treatment|Participant withdrew consent|1|||
33647681|NCT03143153|63056274|FG002|Pre-Treatment|Participant withdrew consent|12|||
33647682|NCT03143153|63056272|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
33647683|NCT03143153|63056273|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
33647684|NCT03143153|63056274|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
33647685|NCT03143153|63056272|FG000|Pre-Treatment|Other Reasons|1|||
33647686|NCT03143153|63056273|FG001|Pre-Treatment|Other Reasons|2|||
33647687|NCT03143153|63056274|FG002|Pre-Treatment|Other Reasons|1|||
33647688|NCT03143153|63056272|FG000|Pre-Treatment|Disease Progression|1|||
33647689|NCT03143153|63056273|FG001|Pre-Treatment|Disease Progression|1|||
33647690|NCT03143153|63056274|FG002|Pre-Treatment|Disease Progression|2|||
33647691|NCT03143153|63056272|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
33647692|NCT03143153|63056273|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
33647693|NCT03143153|63056274|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
33647694|NCT03143153|63056272|FG000|Treatment|Disease progression|174|||
33647695|NCT03143153|63056273|FG001|Treatment|Disease progression|184|||
33647696|NCT03143153|63056274|FG002|Treatment|Disease progression|193|||
33543289|NCT02541604|62934047|FG000|Overall Study|Lost to Follow-up|2|||
33543290|NCT02541604|62934048|FG001|Overall Study|Lost to Follow-up|0|||
33647697|NCT03143153|63056272|FG000|Treatment|Study drug toxicity|59|||
33647698|NCT03143153|63056273|FG001|Treatment|Study drug toxicity|33|||
33647699|NCT03143153|63056274|FG002|Treatment|Study drug toxicity|40|||
33647700|NCT03143153|63056272|FG000|Treatment|Death|5|||
33647701|NCT03143153|63056273|FG001|Treatment|Death|3|||
33647702|NCT03143153|63056274|FG002|Treatment|Death|4|||
33647703|NCT03143153|63056272|FG000|Treatment|Adverse event unrelated to study drug|19|||
33647704|NCT03143153|63056273|FG001|Treatment|Adverse event unrelated to study drug|28|||
33647705|NCT03143153|63056274|FG002|Treatment|Adverse event unrelated to study drug|12|||
33647706|NCT03143153|63056272|FG000|Treatment|Participant request to discontinue study treatment|13|||
33647707|NCT03143153|63056273|FG001|Treatment|Participant request to discontinue study treatment|15|||
33647708|NCT03143153|63056274|FG002|Treatment|Participant request to discontinue study treatment|20|||
33647709|NCT03143153|63056272|FG000|Treatment|Participant withdrew consent|3|||
33647710|NCT03143153|63056273|FG001|Treatment|Participant withdrew consent|4|||
33647711|NCT03143153|63056274|FG002|Treatment|Participant withdrew consent|12|||
33647712|NCT03143153|63056272|FG000|Treatment|Pregnancy|1|||
33543291|NCT02541604|62934049|FG002|Overall Study|Lost to Follow-up|1|||
33543292|NCT02541604|62934050|FG003|Overall Study|Lost to Follow-up|0|||
33543293|NCT02541604|62934051|FG004|Overall Study|Lost to Follow-up|0|||
33543294|NCT02541604|62934052|FG005|Overall Study|Lost to Follow-up|1|||
33543295|NCT02541604|62934053|FG006|Overall Study|Lost to Follow-up|1|||
33543296|NCT02541604|62934054|FG007|Overall Study|Lost to Follow-up|0|||
33543297|NCT02541604|62934055|FG008|Overall Study|Lost to Follow-up|0|||
33543298|NCT02541604|62934056|FG009|Overall Study|Lost to Follow-up|0|||
33543299|NCT02541604|62934057|FG010|Overall Study|Lost to Follow-up|0|||
33543300|NCT02541604|62934058|FG011|Overall Study|Lost to Follow-up|0|||
33543301|NCT02541604|62934047|FG000|Overall Study|Withdrawal by Subject|2|||
33543302|NCT02541604|62934048|FG001|Overall Study|Withdrawal by Subject|0|||
33543303|NCT02541604|62934049|FG002|Overall Study|Withdrawal by Subject|1|||
33543304|NCT02541604|62934050|FG003|Overall Study|Withdrawal by Subject|0|||
33543305|NCT02541604|62934051|FG004|Overall Study|Withdrawal by Subject|1|||
33543306|NCT02541604|62934052|FG005|Overall Study|Withdrawal by Subject|1|||
33543307|NCT02541604|62934053|FG006|Overall Study|Withdrawal by Subject|0|||
33543308|NCT02541604|62934054|FG007|Overall Study|Withdrawal by Subject|0|||
33543309|NCT02541604|62934055|FG008|Overall Study|Withdrawal by Subject|1|||
33543310|NCT02541604|62934056|FG009|Overall Study|Withdrawal by Subject|0|||
33543311|NCT02541604|62934057|FG010|Overall Study|Withdrawal by Subject|0|||
33543312|NCT02541604|62934058|FG011|Overall Study|Withdrawal by Subject|0|||
33543313|NCT02541604|62934047|FG000|Overall Study|Study Terminated by Sponsor|1|||
33543314|NCT02541604|62934048|FG001|Overall Study|Study Terminated by Sponsor|4|||
33543315|NCT02541604|62934049|FG002|Overall Study|Study Terminated by Sponsor|2|||
33543316|NCT02541604|62934050|FG003|Overall Study|Study Terminated by Sponsor|1|||
33543317|NCT02541604|62934051|FG004|Overall Study|Study Terminated by Sponsor|0|||
33647713|NCT03143153|63056273|FG001|Treatment|Pregnancy|0|||
33647714|NCT03143153|63056274|FG002|Treatment|Pregnancy|0|||
33647715|NCT03143153|63056272|FG000|Treatment|Maximum clinical benefit|1|||
33647716|NCT03143153|63056273|FG001|Treatment|Maximum clinical benefit|3|||
33647717|NCT03143153|63056274|FG002|Treatment|Maximum clinical benefit|4|||
33647718|NCT03143153|63056272|FG000|Treatment|Completed treatment as per Protocol|13|||
33647719|NCT03143153|63056273|FG001|Treatment|Completed treatment as per Protocol|8|||
33647720|NCT03143153|63056274|FG002|Treatment|Completed treatment as per Protocol|0|||
33647721|NCT03143153|63056272|FG000|Treatment|Other reasons|12|||
33647722|NCT03143153|63056273|FG001|Treatment|Other reasons|7|||
33543318|NCT02541604|62934052|FG005|Overall Study|Study Terminated by Sponsor|0|||
33543319|NCT02541604|62934053|FG006|Overall Study|Study Terminated by Sponsor|0|||
33543320|NCT02541604|62934054|FG007|Overall Study|Study Terminated by Sponsor|0|||
33543321|NCT02541604|62934055|FG008|Overall Study|Study Terminated by Sponsor|0|||
33543322|NCT02541604|62934056|FG009|Overall Study|Study Terminated by Sponsor|0|||
33543323|NCT02541604|62934057|FG010|Overall Study|Study Terminated by Sponsor|0|||
33647723|NCT03143153|63056274|FG002|Treatment|Other reasons|15|||
33647724|NCT03143153|63056272|FG000|Treatment|Not reported|1|||
33647725|NCT03143153|63056273|FG001|Treatment|Not reported|0|||
33647726|NCT03143153|63056274|FG002|Treatment|Not reported|0|||
33647727|NCT03113968|63056288|FG000|Overall Study|Withdrawal by Subject|31|||
33647728|NCT03113968|63056289|FG001|Overall Study|Withdrawal by Subject|4|||
33647729|NCT03064126|63056299|FG000|Overall Study|Death|6|||
33647730|NCT03064126|63056300|FG001|Overall Study|Death|2|||
33647731|NCT03064126|63056301|FG002|Overall Study|Death|2|||
33647732|NCT03064126|63056302|FG003|Overall Study|Death|1|||
33647733|NCT03064126|63056299|FG000|Overall Study|Investigator Discretion|1|||
33647734|NCT03064126|63056300|FG001|Overall Study|Investigator Discretion|0|||
33647735|NCT03064126|63056301|FG002|Overall Study|Investigator Discretion|0|||
33647736|NCT03064126|63056302|FG003|Overall Study|Investigator Discretion|0|||
33647737|NCT03064126|63056299|FG000|Overall Study|Withdrawal by Subject|7|||
33647738|NCT03064126|63056300|FG001|Overall Study|Withdrawal by Subject|4|||
33647739|NCT03064126|63056301|FG002|Overall Study|Withdrawal by Subject|0|||
33647740|NCT03064126|63056302|FG003|Overall Study|Withdrawal by Subject|0|||
33647741|NCT03064126|63056299|FG000|Overall Study|Subject moved|1|||
33647742|NCT03064126|63056300|FG001|Overall Study|Subject moved|0|||
33647743|NCT03064126|63056301|FG002|Overall Study|Subject moved|0|||
33647744|NCT03064126|63056302|FG003|Overall Study|Subject moved|0|||
33647745|NCT03064126|63056299|FG000|Overall Study|Protocol Violation|11|||
33647746|NCT03064126|63056300|FG001|Overall Study|Protocol Violation|1|||
33647747|NCT03064126|63056301|FG002|Overall Study|Protocol Violation|1|||
33647748|NCT03064126|63056302|FG003|Overall Study|Protocol Violation|0|||
33647749|NCT02985957|63056320|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33647750|NCT02985957|63056321|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33647751|NCT02985957|63056322|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33647752|NCT02985957|63056323|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33647753|NCT02985957|63056324|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
33647754|NCT02985957|63056325|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33647755|NCT02985957|63056326|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33647756|NCT02985957|63056320|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
33647757|NCT02985957|63056321|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
33647758|NCT02985957|63056322|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
33647759|NCT02985957|63056323|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
33647760|NCT02985957|63056324|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
33647761|NCT02985957|63056325|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
33647762|NCT02985957|63056326|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
33647763|NCT02985957|63056320|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33647764|NCT02985957|63056321|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33647765|NCT02985957|63056322|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33463694|NCT03416374|62837166|FG000|Treatment Period II|Death|0|||
33647766|NCT02985957|63056323|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33647767|NCT02985957|63056324|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33647768|NCT02985957|63056325|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33647769|NCT02985957|63056326|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
33647770|NCT02985957|63056320|FG000|Treatment Period|Death|0|||
33647771|NCT02985957|63056321|FG001|Treatment Period|Death|0|||
33647772|NCT02985957|63056322|FG002|Treatment Period|Death|0|||
33647773|NCT02985957|63056323|FG003|Treatment Period|Death|0|||
33647774|NCT02985957|63056324|FG004|Treatment Period|Death|1|||
33647775|NCT02985957|63056325|FG005|Treatment Period|Death|0|||
33647776|NCT02985957|63056326|FG006|Treatment Period|Death|0|||
33647777|NCT02985957|63056320|FG000|Treatment Period|Participant withdrew consent|0|||
33647778|NCT02985957|63056321|FG001|Treatment Period|Participant withdrew consent|0|||
33647779|NCT02985957|63056322|FG002|Treatment Period|Participant withdrew consent|0|||
33647780|NCT02985957|63056323|FG003|Treatment Period|Participant withdrew consent|1|||
33647781|NCT02985957|63056324|FG004|Treatment Period|Participant withdrew consent|3|||
33647782|NCT02985957|63056325|FG005|Treatment Period|Participant withdrew consent|0|||
33647783|NCT02985957|63056326|FG006|Treatment Period|Participant withdrew consent|1|||
33327251|NCT01185353|62703799|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
33647784|NCT02985957|63056320|FG000|Treatment Period|Lost to Follow-up|0|||
33647785|NCT02985957|63056321|FG001|Treatment Period|Lost to Follow-up|0|||
33647786|NCT02985957|63056322|FG002|Treatment Period|Lost to Follow-up|0|||
33647787|NCT02985957|63056323|FG003|Treatment Period|Lost to Follow-up|0|||
33647788|NCT02985957|63056324|FG004|Treatment Period|Lost to Follow-up|1|||
33647789|NCT02985957|63056325|FG005|Treatment Period|Lost to Follow-up|0|||
33647790|NCT02985957|63056326|FG006|Treatment Period|Lost to Follow-up|0|||
33647791|NCT02985957|63056320|FG000|Treatment Period|Other reasons|0|||
33327252|NCT01185353|62703800|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
33647792|NCT02985957|63056321|FG001|Treatment Period|Other reasons|0|||
33647793|NCT02985957|63056322|FG002|Treatment Period|Other reasons|1|||
33647794|NCT02985957|63056323|FG003|Treatment Period|Other reasons|3|||
33647795|NCT02985957|63056324|FG004|Treatment Period|Other reasons|6|||
33647796|NCT02985957|63056325|FG005|Treatment Period|Other reasons|0|||
33647797|NCT02985957|63056326|FG006|Treatment Period|Other reasons|1|||
33463695|NCT03416374|62837167|FG001|Treatment Period II|Death|1|||
33463696|NCT03416374|62837166|FG000|Treatment Period II|Other|0|||
33463697|NCT03416374|62837167|FG001|Treatment Period II|Other|2|||
33463698|NCT03799952|62837178|FG000|Overall Study|Program was too easy, discontinued|1|||
33463699|NCT03799952|62837179|FG001|Overall Study|Program was too easy, discontinued|0|||
33463700|NCT03799952|62837178|FG000|Overall Study|Lost to Follow-up|0|||
33463701|NCT03799952|62837179|FG001|Overall Study|Lost to Follow-up|2|||
33463702|NCT00077766|62837187|FG000|Overall Study|Adverse Event|1|||
33463703|NCT00077766|62837188|FG001|Overall Study|Adverse Event|1|||
33463704|NCT00077766|62837187|FG000|Overall Study|Withdrawal by Subject|4|||
33463705|NCT00077766|62837188|FG001|Overall Study|Withdrawal by Subject|3|||
33463706|NCT00077766|62837187|FG000|Overall Study|Death|12|||
33463707|NCT00077766|62837188|FG001|Overall Study|Death|10|||
33463708|NCT00077766|62837187|FG000|Overall Study|Lost to Follow-up|2|||
33463709|NCT00077766|62837188|FG001|Overall Study|Lost to Follow-up|0|||
33463710|NCT00077766|62837187|FG000|Overall Study|Protocol Violation|1|||
33463711|NCT00077766|62837188|FG001|Overall Study|Protocol Violation|0|||
33463712|NCT00077766|62837187|FG000|Overall Study|Kidney Transplantation|9|||
33463713|NCT00077766|62837188|FG001|Overall Study|Kidney Transplantation|5|||
33463714|NCT00077766|62837187|FG000|Overall Study|Transplantation|5|||
33463715|NCT00077766|62837188|FG001|Overall Study|Transplantation|1|||
33463716|NCT00077766|62837187|FG000|Overall Study|Investigators Discretion|1|||
33463717|NCT00077766|62837188|FG001|Overall Study|Investigators Discretion|0|||
33463718|NCT00077766|62837187|FG000|Overall Study|Participant's decision|1|||
33463719|NCT00077766|62837188|FG001|Overall Study|Participant's decision|0|||
33463720|NCT00077766|62837187|FG000|Overall Study|Dialysis Discontinued|1|||
33463721|NCT00077766|62837188|FG001|Overall Study|Dialysis Discontinued|0|||
33463722|NCT00077766|62837187|FG000|Overall Study|Dialysis|0|||
33463723|NCT00077766|62837188|FG001|Overall Study|Dialysis|1|||
33463724|NCT00077766|62837187|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
33463725|NCT00077766|62837188|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
33463726|NCT00077766|62837187|FG000|Overall Study|Started Nocturnal Dialysis|0|||
33463727|NCT00077766|62837188|FG001|Overall Study|Started Nocturnal Dialysis|1|||
33463728|NCT00077766|62837187|FG000|Overall Study|Stop Dialysis|0|||
33463729|NCT00077766|62837188|FG001|Overall Study|Stop Dialysis|1|||
33463730|NCT00077766|62837187|FG000|Overall Study|Participants Vacation|2|||
33463731|NCT00077766|62837188|FG001|Overall Study|Participants Vacation|1|||
33463732|NCT03799718|62837195|FG000|Overall Study|Adverse Event|2|||
33463733|NCT03388138|62837201|FG000|Overall Study|Protocol Violation|1|||
33463734|NCT03388138|62837202|FG001|Overall Study|Protocol Violation|0|||
33463735|NCT02952898|62837211|FG000|Overall Study|Withdrawal by Subject|10|||
33463736|NCT02952898|62837212|FG001|Overall Study|Withdrawal by Subject|8|||
33463737|NCT02952898|62837213|FG002|Overall Study|Withdrawal by Subject|8|||
33463738|NCT02952898|62837211|FG000|Overall Study|Adverse Event|8|||
33463739|NCT02952898|62837212|FG001|Overall Study|Adverse Event|8|||
33463740|NCT02952898|62837213|FG002|Overall Study|Adverse Event|3|||
33463741|NCT02952898|62837211|FG000|Overall Study|Lost to Follow-up|3|||
33463742|NCT02952898|62837212|FG001|Overall Study|Lost to Follow-up|2|||
33463743|NCT02952898|62837213|FG002|Overall Study|Lost to Follow-up|2|||
33463744|NCT02952898|62837211|FG000|Overall Study|Non-compliance with study drug|1|||
33327253|NCT01185353|62703801|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
33463745|NCT02952898|62837212|FG001|Overall Study|Non-compliance with study drug|1|||
33463746|NCT02952898|62837213|FG002|Overall Study|Non-compliance with study drug|2|||
33463747|NCT00045734|62837221|FG000|Overall Study|Protocol Violation|1|||
33463748|NCT03387046|62837227|FG000|Overall Study|Adverse Event|1|||
33463749|NCT03387046|62837228|FG001|Overall Study|Adverse Event|1|||
33463750|NCT00045110|62837237|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
33463751|NCT00045110|62837238|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
33647798|NCT02985957|63056320|FG000|Treatment Period|Not reported|0|||
33647799|NCT02985957|63056321|FG001|Treatment Period|Not reported|1|||
33647800|NCT02985957|63056322|FG002|Treatment Period|Not reported|2|||
33647801|NCT02985957|63056323|FG003|Treatment Period|Not reported|5|||
33647802|NCT02985957|63056324|FG004|Treatment Period|Not reported|0|||
33647803|NCT02985957|63056325|FG005|Treatment Period|Not reported|0|||
33647804|NCT02985957|63056326|FG006|Treatment Period|Not reported|0|||
33647805|NCT02985957|63056320|FG000|Treatment Period|Maximum clinical benefit|0|||
33647806|NCT02985957|63056321|FG001|Treatment Period|Maximum clinical benefit|0|||
33647807|NCT02985957|63056322|FG002|Treatment Period|Maximum clinical benefit|1|||
33647808|NCT02985957|63056323|FG003|Treatment Period|Maximum clinical benefit|1|||
33647809|NCT02985957|63056324|FG004|Treatment Period|Maximum clinical benefit|0|||
33647810|NCT02985957|63056325|FG005|Treatment Period|Maximum clinical benefit|0|||
33647811|NCT02985957|63056326|FG006|Treatment Period|Maximum clinical benefit|2|||
33647812|NCT02985957|63056320|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
33647813|NCT02985957|63056321|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
33647814|NCT02985957|63056322|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
33647815|NCT02985957|63056323|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
33647816|NCT02985957|63056324|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
33647817|NCT02985957|63056325|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
33647818|NCT02985957|63056326|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
33647819|NCT02985957|63056320|FG000|Treatment Period|Study drug toxicity|1|||
33647820|NCT02985957|63056321|FG001|Treatment Period|Study drug toxicity|23|||
33647821|NCT02985957|63056322|FG002|Treatment Period|Study drug toxicity|20|||
33647822|NCT02985957|63056323|FG003|Treatment Period|Study drug toxicity|11|||
33647823|NCT02985957|63056324|FG004|Treatment Period|Study drug toxicity|19|||
33647824|NCT02985957|63056325|FG005|Treatment Period|Study drug toxicity|3|||
33647825|NCT02985957|63056326|FG006|Treatment Period|Study drug toxicity|5|||
33647826|NCT02985957|63056320|FG000|Treatment Period|Disease progression|0|||
33647827|NCT02985957|63056321|FG001|Treatment Period|Disease progression|16|||
33647828|NCT02985957|63056322|FG002|Treatment Period|Disease progression|20|||
33647829|NCT02985957|63056323|FG003|Treatment Period|Disease progression|39|||
33647830|NCT02985957|63056324|FG004|Treatment Period|Disease progression|29|||
33647831|NCT02985957|63056325|FG005|Treatment Period|Disease progression|11|||
33647832|NCT02985957|63056326|FG006|Treatment Period|Disease progression|28|||
33647833|NCT02985957|63056320|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
33647834|NCT02985957|63056321|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
33647835|NCT02985957|63056322|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
33647836|NCT02985957|63056323|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
33647837|NCT02985957|63056324|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
33647838|NCT02985957|63056325|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
33647839|NCT02985957|63056326|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
33647840|NCT02985957|63056320|FG000|Treatment Period|Poor/Non-Compliance|0|||
33647841|NCT02985957|63056321|FG001|Treatment Period|Poor/Non-Compliance|0|||
33647842|NCT02985957|63056322|FG002|Treatment Period|Poor/Non-Compliance|0|||
33647843|NCT02985957|63056323|FG003|Treatment Period|Poor/Non-Compliance|0|||
33647844|NCT02985957|63056324|FG004|Treatment Period|Poor/Non-Compliance|1|||
33647845|NCT02985957|63056325|FG005|Treatment Period|Poor/Non-Compliance|1|||
33647846|NCT02985957|63056326|FG006|Treatment Period|Poor/Non-Compliance|0|||
33647847|NCT02985957|63056320|FG000|Treatment Period|Continuing in Treatment Period|0|||
33647848|NCT02985957|63056321|FG001|Treatment Period|Continuing in Treatment Period|1|||
33647849|NCT02985957|63056322|FG002|Treatment Period|Continuing in Treatment Period|0|||
33647850|NCT02985957|63056323|FG003|Treatment Period|Continuing in Treatment Period|4|||
33647851|NCT02985957|63056324|FG004|Treatment Period|Continuing in Treatment Period|4|||
33647852|NCT02985957|63056325|FG005|Treatment Period|Continuing in Treatment Period|0|||
33647853|NCT02985957|63056326|FG006|Treatment Period|Continuing in Treatment Period|0|||
33647854|NCT02864251|63056351|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
33647855|NCT02864251|63056352|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
33647856|NCT02864251|63056353|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
33647857|NCT02864251|63056351|FG000|Pre-Treatment|Withdrawal by Participant|0|||
33647858|NCT02864251|63056352|FG001|Pre-Treatment|Withdrawal by Participant|0|||
33647859|NCT02864251|63056353|FG002|Pre-Treatment|Withdrawal by Participant|4|||
33647860|NCT02864251|63056351|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
33647861|NCT02864251|63056352|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
33647862|NCT02864251|63056353|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
33647863|NCT02864251|63056351|FG000|Pre-Treatment|Other Reasons|0|||
33647864|NCT02864251|63056352|FG001|Pre-Treatment|Other Reasons|1|||
33647865|NCT02864251|63056353|FG002|Pre-Treatment|Other Reasons|1|||
33647866|NCT02864251|63056351|FG000|Treatment|Disease Progression|109|||
33647867|NCT02864251|63056352|FG001|Treatment|Disease Progression|52|||
33647868|NCT02864251|63056353|FG002|Treatment|Disease Progression|101|||
33647869|NCT02864251|63056351|FG000|Treatment|Study Drug Toxicity|9|||
33647870|NCT02864251|63056352|FG001|Treatment|Study Drug Toxicity|4|||
33647871|NCT02864251|63056353|FG002|Treatment|Study Drug Toxicity|10|||
33647872|NCT02864251|63056351|FG000|Treatment|Death|0|||
33647873|NCT02864251|63056352|FG001|Treatment|Death|2|||
33647874|NCT02864251|63056353|FG002|Treatment|Death|3|||
33647875|NCT02864251|63056351|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
33647876|NCT02864251|63056352|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
33647877|NCT02864251|63056353|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
33647878|NCT02864251|63056351|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
33647879|NCT02864251|63056352|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
33647880|NCT02864251|63056353|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
33647881|NCT02864251|63056351|FG000|Treatment|Withdrawal by Participant|8|||
33647882|NCT02864251|63056352|FG001|Treatment|Withdrawal by Participant|5|||
33647883|NCT02864251|63056353|FG002|Treatment|Withdrawal by Participant|13|||
33647884|NCT02864251|63056351|FG000|Treatment|Maximum Clinical Benefit|1|||
33647885|NCT02864251|63056352|FG001|Treatment|Maximum Clinical Benefit|0|||
33647886|NCT02864251|63056353|FG002|Treatment|Maximum Clinical Benefit|1|||
33647887|NCT02864251|63056351|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
33647888|NCT02864251|63056352|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
33647889|NCT02864251|63056353|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
33647890|NCT02864251|63056351|FG000|Treatment|Other Reasons|1|||
33647891|NCT02864251|63056352|FG001|Treatment|Other Reasons|1|||
33647892|NCT02864251|63056353|FG002|Treatment|Other Reasons|4|||
33647893|NCT02864251|63056351|FG000|Treatment|Administrative Reason by Sponsor|1|||
33647894|NCT02864251|63056352|FG001|Treatment|Administrative Reason by Sponsor|0|||
33647895|NCT02864251|63056353|FG002|Treatment|Administrative Reason by Sponsor|0|||
33647896|NCT02667587|63056389|FG000|Pre-Treatment|Not reported|1|||
33647897|NCT02667587|63056390|FG001|Pre-Treatment|Not reported|0|||
33647898|NCT02667587|63056389|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
33543324|NCT02541604|62934058|FG011|Overall Study|Study Terminated by Sponsor|0|||
33543325|NCT02541604|62934047|FG000|Overall Study|Medical condition may jeopardize safety|0|||
33543326|NCT02541604|62934048|FG001|Overall Study|Medical condition may jeopardize safety|0|||
33543327|NCT02541604|62934049|FG002|Overall Study|Medical condition may jeopardize safety|0|||
33543328|NCT02541604|62934050|FG003|Overall Study|Medical condition may jeopardize safety|0|||
33543329|NCT02541604|62934051|FG004|Overall Study|Medical condition may jeopardize safety|0|||
33543330|NCT02541604|62934052|FG005|Overall Study|Medical condition may jeopardize safety|0|||
33543331|NCT02541604|62934053|FG006|Overall Study|Medical condition may jeopardize safety|0|||
33543332|NCT02541604|62934054|FG007|Overall Study|Medical condition may jeopardize safety|1|||
33647899|NCT02667587|63056390|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
33647900|NCT02667587|63056389|FG000|Pre-Treatment|Participant withdrew consent|0|||
33647901|NCT02667587|63056390|FG001|Pre-Treatment|Participant withdrew consent|1|||
33647902|NCT02667587|63056389|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
33647903|NCT02667587|63056390|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
33543333|NCT02541604|62934055|FG008|Overall Study|Medical condition may jeopardize safety|0|||
33647904|NCT02667587|63056389|FG000|End of Treatment|Other reasons|11|||
33647905|NCT02667587|63056390|FG001|End of Treatment|Other reasons|8|||
33647906|NCT02667587|63056389|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
33647907|NCT02667587|63056390|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
33647908|NCT02667587|63056389|FG000|End of Treatment|Poor/Non-Compliance|0|||
33647909|NCT02667587|63056390|FG001|End of Treatment|Poor/Non-Compliance|1|||
33647910|NCT02667587|63056389|FG000|End of Treatment|Maximum Clinical Benefit|3|||
33647911|NCT02667587|63056390|FG001|End of Treatment|Maximum Clinical Benefit|3|||
33647912|NCT02667587|63056389|FG000|End of Treatment|Participant Withdrew Consent|5|||
33647913|NCT02667587|63056390|FG001|End of Treatment|Participant Withdrew Consent|6|||
33647914|NCT02667587|63056389|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
33647915|NCT02667587|63056390|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
33647916|NCT02667587|63056389|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
33647917|NCT02667587|63056390|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
33647918|NCT02667587|63056389|FG000|End of Treatment|Death|2|||
33647919|NCT02667587|63056390|FG001|End of Treatment|Death|1|||
33647920|NCT02667587|63056389|FG000|End of Treatment|Study Drug Toxicity|74|||
33647921|NCT02667587|63056390|FG001|End of Treatment|Study Drug Toxicity|18|||
33647922|NCT02667587|63056389|FG000|End of Treatment|Disease progression|177|||
33647923|NCT02667587|63056390|FG001|End of Treatment|Disease progression|222|||
33647924|NCT02667587|63056389|FG000|End of Treatment|Lost to Follow-up|1|||
33647925|NCT02667587|63056390|FG001|End of Treatment|Lost to Follow-up|3|||
33647926|NCT02658487|63056396|FG000|Overall Study|Death|2|||
33647927|NCT02658487|63056396|FG000|Overall Study|Disease progression|10|||
33647928|NCT02658487|63056396|FG000|Overall Study|Alternative therapy|1|||
33647929|NCT02658487|63056396|FG000|Overall Study|Adverse Event|1|||
33647930|NCT02658487|63056396|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
33543334|NCT02541604|62934056|FG009|Overall Study|Medical condition may jeopardize safety|0|||
33543335|NCT02541604|62934057|FG010|Overall Study|Medical condition may jeopardize safety|0|||
33543336|NCT02541604|62934058|FG011|Overall Study|Medical condition may jeopardize safety|0|||
33647931|NCT02658487|63056396|FG000|Overall Study|Refractory AML|1|||
33647932|NCT02632409|63056403|FG000|Randomized|AE unrelated to study Drug|0|||
33647933|NCT02632409|63056404|FG001|Randomized|AE unrelated to study Drug|1|||
33647934|NCT02632409|63056403|FG000|Randomized|Participant withdrew consent|2|||
33647935|NCT02632409|63056404|FG001|Randomized|Participant withdrew consent|1|||
33647936|NCT02632409|63056403|FG000|Randomized|No Longer meets study criteria|5|||
33647937|NCT02632409|63056404|FG001|Randomized|No Longer meets study criteria|0|||
33647938|NCT02632409|63056403|FG000|Randomized|other reasons|1|||
33647939|NCT02632409|63056404|FG001|Randomized|other reasons|0|||
33647940|NCT02632409|63056403|FG000|Treatment Period|Ongoing Treatment|20|||
33647941|NCT02632409|63056404|FG001|Treatment Period|Ongoing Treatment|21|||
33647942|NCT02632409|63056403|FG000|Treatment Period|Disease Recurrence|147|||
33647943|NCT02632409|63056404|FG001|Treatment Period|Disease Recurrence|90|||
33647944|NCT02632409|63056403|FG000|Treatment Period|Study Drug Toxicity|8|||
33647945|NCT02632409|63056404|FG001|Treatment Period|Study Drug Toxicity|49|||
33647946|NCT02632409|63056403|FG000|Treatment Period|Death|1|||
33647947|NCT02632409|63056404|FG001|Treatment Period|Death|0|||
33647948|NCT02632409|63056403|FG000|Treatment Period|AE unrelated to study drug|15|||
33647949|NCT02632409|63056404|FG001|Treatment Period|AE unrelated to study drug|16|||
33647950|NCT02632409|63056403|FG000|Treatment Period|Request to discontinue treatment|4|||
33647951|NCT02632409|63056404|FG001|Treatment Period|Request to discontinue treatment|19|||
33647952|NCT02632409|63056403|FG000|Treatment Period|Participant withdrew consent|7|||
33647953|NCT02632409|63056404|FG001|Treatment Period|Participant withdrew consent|5|||
33647954|NCT02632409|63056403|FG000|Treatment Period|Lost to Follow-up|0|||
33647955|NCT02632409|63056404|FG001|Treatment Period|Lost to Follow-up|1|||
33647956|NCT02632409|63056403|FG000|Treatment Period|Maximum clinical benefit|1|||
33647957|NCT02632409|63056404|FG001|Treatment Period|Maximum clinical benefit|0|||
33647958|NCT02632409|63056403|FG000|Treatment Period|No longer meets study criteria|3|||
33647959|NCT02632409|63056404|FG001|Treatment Period|No longer meets study criteria|0|||
33647960|NCT02632409|63056403|FG000|Treatment Period|Administrative Reason by sponsor|0|||
33543337|NCT02546674|62934107|FG000|Overall Study|Adverse Event|19|||
33647961|NCT02632409|63056404|FG001|Treatment Period|Administrative Reason by sponsor|1|||
33647962|NCT02632409|63056403|FG000|Treatment Period|Other Reasons|10|||
33647963|NCT02632409|63056404|FG001|Treatment Period|Other Reasons|6|||
33647964|NCT02613507|63056412|FG000|Overall Study|Disease Progression|237|||
33647965|NCT02613507|63056413|FG001|Overall Study|Disease Progression|109|||
33647966|NCT02613507|63056412|FG000|Overall Study|Study Drug Toxicity|15|||
33647967|NCT02613507|63056413|FG001|Overall Study|Study Drug Toxicity|14|||
33647968|NCT02613507|63056412|FG000|Overall Study|Death|3|||
33647969|NCT02613507|63056413|FG001|Overall Study|Death|0|||
33647970|NCT02613507|63056412|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17|||
33647971|NCT02613507|63056413|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
33647972|NCT02613507|63056412|FG000|Overall Study|Request to Discontinue Study Treatment|8|||
33647973|NCT02613507|63056413|FG001|Overall Study|Request to Discontinue Study Treatment|17|||
33647974|NCT02613507|63056412|FG000|Overall Study|Participant Withdrew Consent|0|||
33647975|NCT02613507|63056413|FG001|Overall Study|Participant Withdrew Consent|2|||
33647976|NCT02613507|63056412|FG000|Overall Study|Lost to Follow-up|1|||
33647977|NCT02613507|63056413|FG001|Overall Study|Lost to Follow-up|0|||
33647978|NCT02613507|63056412|FG000|Overall Study|Maximum Clinical Benefit|4|||
33647979|NCT02613507|63056413|FG001|Overall Study|Maximum Clinical Benefit|10|||
33647980|NCT02613507|63056412|FG000|Overall Study|Brain Radiotherapy Activity Limited|1|||
33647981|NCT02613507|63056413|FG001|Overall Study|Brain Radiotherapy Activity Limited|0|||
33647982|NCT02613507|63056412|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
33647983|NCT02613507|63056413|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
33647984|NCT02613507|63056412|FG000|Overall Study|Randomized but not Treated|1|||
33647985|NCT02613507|63056413|FG001|Overall Study|Randomized but not Treated|10|||
33647986|NCT02570113|63056419|FG000|Overall Study|Withdrawal by Subject|3|||
33647987|NCT02565914|63056423|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
33647988|NCT02565914|63056423|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
33647989|NCT02565914|63056423|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
33647990|NCT02565914|63056423|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
33647991|NCT02565914|63056423|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
33647992|NCT02565914|63056423|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
33647993|NCT02565914|63056423|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
33647994|NCT02565914|63056423|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
33647995|NCT02565914|63056423|FG000|Part A (Up to 96 Weeks)|Other|18|||
33647996|NCT02565914|63056423|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
33647997|NCT02565914|63056423|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
33647998|NCT02565914|63056423|FG000|Part B (Up to 96 Weeks)|Other|1|||
33647999|NCT02565914|63056423|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
33648000|NCT02565914|63056423|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
33648001|NCT02565914|63056423|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
33648002|NCT02565914|63056423|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
33648003|NCT02565914|63056423|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
33648004|NCT02565914|63056423|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
33648005|NCT02565914|63056423|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
33648006|NCT02565914|63056423|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
33648007|NCT02565914|63056423|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
33648008|NCT02565914|63056423|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
33648009|NCT02565914|63056423|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
33648010|NCT02565914|63056423|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
33648011|NCT02435849|63056433|FG000|Overall Study|Death|23|||
33648012|NCT02435849|63056434|FG001|Overall Study|Death|0|||
33648013|NCT02435849|63056433|FG000|Overall Study|Lack of Efficacy|10|||
33648014|NCT02435849|63056434|FG001|Overall Study|Lack of Efficacy|0|||
33648015|NCT02435849|63056433|FG000|Overall Study|New therapy for study indication|8|||
33648016|NCT02435849|63056434|FG001|Overall Study|New therapy for study indication|0|||
33648017|NCT02435849|63056433|FG000|Overall Study|Subject/guardian decision|5|||
33648018|NCT02435849|63056434|FG001|Overall Study|Subject/guardian decision|1|||
33648019|NCT02435849|63056433|FG000|Overall Study|Lost to Follow-up|1|||
33648020|NCT02435849|63056434|FG001|Overall Study|Lost to Follow-up|0|||
33648021|NCT02435849|63056433|FG000|Overall Study|Physician Decision|1|||
33648022|NCT02435849|63056434|FG001|Overall Study|Physician Decision|0|||
33648023|NCT02426658|63056440|FG000|Overall Study|Withdrawal by Subject|1|||
33648024|NCT02426658|63056440|FG000|Overall Study|Patient expired before treatment|2|||
33648025|NCT02248701|63056446|FG000|Overall Study|Withdrawal by Subject|2|||
33648026|NCT02248701|63056447|FG001|Overall Study|Withdrawal by Subject|1|||
33543338|NCT02546674|62934107|FG000|Overall Study|Death|1|||
33648027|NCT02248701|63056446|FG000|Overall Study|Physician Decision|0|||
33648028|NCT02248701|63056447|FG001|Overall Study|Physician Decision|1|||
33648029|NCT02248701|63056446|FG000|Overall Study|Adverse Event|1|||
33648030|NCT02248701|63056447|FG001|Overall Study|Adverse Event|0|||
33648031|NCT02248701|63056446|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
33648032|NCT02248701|63056447|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
33648033|NCT02204982|63056455|FG000|Overall Study|Patient ineligible-medical monitor|1|||
33648034|NCT02204982|63056456|FG001|Overall Study|Patient ineligible-medical monitor|0|||
33648035|NCT02204982|63056455|FG000|Overall Study|Withdrawal by Subject|1|||
33543339|NCT02546674|62934107|FG000|Overall Study|Lost to Follow-up|1|||
33648036|NCT02204982|63056456|FG001|Overall Study|Withdrawal by Subject|0|||
33648037|NCT02204982|63056455|FG000|Overall Study|Adverse Event|1|||
33648038|NCT02204982|63056456|FG001|Overall Study|Adverse Event|0|||
33648039|NCT02204982|63056455|FG000|Overall Study|Adverse Event and Investigator decision|1|||
33648040|NCT02204982|63056456|FG001|Overall Study|Adverse Event and Investigator decision|0|||
33648041|NCT02204982|63056455|FG000|Overall Study|Physician Decision|0|||
33648042|NCT02204982|63056456|FG001|Overall Study|Physician Decision|2|||
33648043|NCT02204982|63056455|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
33648044|NCT02204982|63056456|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
33648045|NCT02204982|63056455|FG000|Overall Study|Termination of Study bySponsor|0|||
33648046|NCT02204982|63056456|FG001|Overall Study|Termination of Study bySponsor|1|||
33648047|NCT02101385|63056464|FG000|Study Treatment|Disease Progression|9|||
33648048|NCT02101385|63056465|FG001|Study Treatment|Disease Progression|3|||
33648049|NCT02101385|63056464|FG000|Study Treatment|Alternative therapy|0|||
33648050|NCT02101385|63056465|FG001|Study Treatment|Alternative therapy|1|||
33648051|NCT02101385|63056464|FG000|Study Treatment|No treatment, per protocol criteria|0|||
33648052|NCT02101385|63056465|FG001|Study Treatment|No treatment, per protocol criteria|4|||
33648053|NCT02101385|63056464|FG000|Study Treatment|Patient Non compliance|0|||
33648054|NCT02101385|63056465|FG001|Study Treatment|Patient Non compliance|2|||
33648055|NCT02101385|63056464|FG000|Study Treatment|Withdrawal by Subject|5|||
33648056|NCT02101385|63056465|FG001|Study Treatment|Withdrawal by Subject|2|||
33648057|NCT02101385|63056464|FG000|Study Treatment|screen failure|1|||
33648058|NCT02101385|63056465|FG001|Study Treatment|screen failure|0|||
33648059|NCT02101385|63056464|FG000|Study Treatment|AE/Side Effects/Complications|8|||
33648060|NCT02101385|63056465|FG001|Study Treatment|AE/Side Effects/Complications|0|||
33648061|NCT02101385|63056464|FG000|Study Treatment|Lost to Follow-up|1|||
33648062|NCT02101385|63056465|FG001|Study Treatment|Lost to Follow-up|0|||
33648063|NCT02101385|63056464|FG000|Study Treatment|Disease Progression before treatment|1|||
33648064|NCT02101385|63056465|FG001|Study Treatment|Disease Progression before treatment|0|||
33648065|NCT02101385|63056464|FG000|Study Treatment|Death|1|||
33648066|NCT02101385|63056465|FG001|Study Treatment|Death|0|||
33648067|NCT02101385|63056464|FG000|Follow up|Lost to Follow-up|4|||
33648068|NCT02101385|63056465|FG001|Follow up|Lost to Follow-up|9|||
33648069|NCT02101385|63056464|FG000|Follow up|Refused to follow up|5|||
33648070|NCT02101385|63056465|FG001|Follow up|Refused to follow up|4|||
33648071|NCT02101385|63056464|FG000|Follow up|Death|21|||
33648072|NCT02101385|63056465|FG001|Follow up|Death|39|||
33648073|NCT02101385|63056464|FG000|Follow up|study completed|33|||
33648074|NCT02101385|63056465|FG001|Follow up|study completed|52|||
33648075|NCT02101385|63056464|FG000|Follow up|screen failure|2|||
33648076|NCT02101385|63056465|FG001|Follow up|screen failure|0|||
33648077|NCT02101385|63056464|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
33648078|NCT02101385|63056465|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
33648079|NCT02101385|63056464|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
33648080|NCT02101385|63056465|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
33648081|NCT02101385|63056464|FG000|Follow up|Withdrawal by Subject|2|||
33648082|NCT02101385|63056465|FG001|Follow up|Withdrawal by Subject|2|||
33648083|NCT02101385|63056464|FG000|Follow up|PI requested closure of site|0|||
33648084|NCT02101385|63056465|FG001|Follow up|PI requested closure of site|5|||
33648085|NCT02068443|63056480|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33648086|NCT02068443|63056481|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
33648087|NCT02068443|63056482|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
33648088|NCT02068443|63056480|FG000|Overall Study|Voluntary Withdrawal|4|||
33648089|NCT02068443|63056481|FG001|Overall Study|Voluntary Withdrawal|0|||
33648090|NCT02068443|63056482|FG002|Overall Study|Voluntary Withdrawal|1|||
33648091|NCT02068443|63056480|FG000|Overall Study|Lack of Efficacy|2|||
33648092|NCT02068443|63056481|FG001|Overall Study|Lack of Efficacy|1|||
33648093|NCT02068443|63056482|FG002|Overall Study|Lack of Efficacy|0|||
33648094|NCT02068443|63056480|FG000|Overall Study|Other Reason Not Specified|1|||
33648095|NCT02068443|63056481|FG001|Overall Study|Other Reason Not Specified|0|||
33648096|NCT02068443|63056482|FG002|Overall Study|Other Reason Not Specified|0|||
33648097|NCT02065869|63056490|FG000|Overall Study|Death|7|||
33648098|NCT02065869|63056490|FG000|Overall Study|Disease relapse|16|||
33648099|NCT02065869|63056490|FG000|Overall Study|Lost to Follow-up|4|||
33648100|NCT02065869|63056490|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
33648101|NCT02065869|63056490|FG000|Overall Study|Withdrawal by Subject|1|||
33648102|NCT02018861|63056505|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
33648103|NCT02018861|63056506|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
33648104|NCT02018861|63056507|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
33648105|NCT02018861|63056508|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
33648106|NCT02018861|63056509|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
33648107|NCT02018861|63056510|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
33648108|NCT02018861|63056511|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
33648109|NCT02018861|63056512|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
33648110|NCT02018861|63056513|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
33648111|NCT02018861|63056514|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
33648112|NCT02018861|63056505|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33648113|NCT02018861|63056506|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33648114|NCT02018861|63056507|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33648115|NCT02018861|63056508|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
33648116|NCT02018861|63056509|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
33648117|NCT02018861|63056510|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33648118|NCT02018861|63056511|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33648119|NCT02018861|63056512|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33648120|NCT02018861|63056513|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33648121|NCT02018861|63056514|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33648122|NCT02018861|63056505|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
33648123|NCT02018861|63056506|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
33648124|NCT02018861|63056507|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
33648125|NCT02018861|63056508|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
33648126|NCT02018861|63056509|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
33648127|NCT02018861|63056510|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
33648128|NCT02018861|63056511|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
33648129|NCT02018861|63056512|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
33648130|NCT02018861|63056513|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
33648131|NCT02018861|63056514|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
33648132|NCT02018861|63056505|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
33648133|NCT02018861|63056506|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
33463752|NCT00045110|62837239|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
33463753|NCT00045110|62837237|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
33463754|NCT00045110|62837238|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
33463755|NCT00045110|62837239|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
33463756|NCT00045110|62837237|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
33463757|NCT00045110|62837238|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
33463758|NCT00045110|62837239|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
33463759|NCT03353740|62837256|FG000|Overall Study|Images for these participants not viable|52|||
33543340|NCT02546674|62934107|FG000|Overall Study|Physician Decision|13|||
33543341|NCT02546674|62934107|FG000|Overall Study|Pregnancy|1|||
33543342|NCT02546674|62934107|FG000|Overall Study|Progressive Disease|2|||
33543343|NCT02546674|62934107|FG000|Overall Study|Protocol Deviation|2|||
33463760|NCT00003476|62837260|FG000|Overall Study|Not evaluable|1|||
33463761|NCT00003470|62837264|FG000|Overall Study|Not evaluable|6|||
33463762|NCT03386344|62837271|FG000|Overall Study|Adverse Event|6|||
33463763|NCT03386344|62837272|FG001|Overall Study|Adverse Event|3|||
33463764|NCT03386344|62837273|FG002|Overall Study|Adverse Event|1|||
33463765|NCT03386344|62837271|FG000|Overall Study|Poor Compliance to Protocol|0|||
33463766|NCT03386344|62837272|FG001|Overall Study|Poor Compliance to Protocol|1|||
33463767|NCT03386344|62837273|FG002|Overall Study|Poor Compliance to Protocol|0|||
33463768|NCT03386344|62837271|FG000|Overall Study|Study Terminated by Sponsor|101|||
33463769|NCT03386344|62837272|FG001|Overall Study|Study Terminated by Sponsor|102|||
33463770|NCT03386344|62837273|FG002|Overall Study|Study Terminated by Sponsor|106|||
33463771|NCT03386344|62837271|FG000|Overall Study|Lost to Follow-up|3|||
33543344|NCT02546674|62934107|FG000|Overall Study|Subject/Guardian Decision|6|||
33543345|NCT02546674|62934107|FG000|Overall Study|Withdrawal of Informed Consent|3|||
33543346|NCT02546362|62934112|FG000|4-week Treatment Period|Lost to Follow-up|1|||
33543347|NCT02546362|62934112|FG000|4-week Treatment Period|Change in medication|2|||
33543348|NCT02546362|62934112|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
33543349|NCT02546362|62934112|FG000|12-week Treatment Period|Lost to Follow-up|2|||
33543350|NCT02546362|62934112|FG000|12-week Treatment Period|Change in medication|1|||
33543351|NCT02698436|62934118|FG000|Overall Study|Adverse Event|1|||
33543352|NCT02698436|62934119|FG001|Overall Study|Adverse Event|0|||
33543353|NCT02698436|62934118|FG000|Overall Study|Withdrawal by Subject|3|||
33543354|NCT02698436|62934119|FG001|Overall Study|Withdrawal by Subject|3|||
33543355|NCT02698436|62934118|FG000|Overall Study|Lost to Follow-up|2|||
33463772|NCT03386344|62837272|FG001|Overall Study|Lost to Follow-up|2|||
33463773|NCT03386344|62837273|FG002|Overall Study|Lost to Follow-up|1|||
33463774|NCT03386344|62837271|FG000|Overall Study|At the Participant's own Request|7|||
33543356|NCT02698436|62934119|FG001|Overall Study|Lost to Follow-up|4|||
33543357|NCT02698436|62934118|FG000|Overall Study|Non-compliance with study regimen|1|||
33543358|NCT02698436|62934119|FG001|Overall Study|Non-compliance with study regimen|0|||
33543359|NCT02694536|62934125|FG000|Overall Study|Progressive Disease|40|||
33543360|NCT02694536|62934125|FG000|Overall Study|Lost to Follow-up|1|||
33543361|NCT02694536|62934125|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
33543362|NCT02694536|62934125|FG000|Overall Study|Withdrawal by Subject|8|||
33543363|NCT02694536|62934125|FG000|Overall Study|Death|8|||
33543364|NCT02694536|62934125|FG000|Overall Study|Other|22|||
33543365|NCT01661686|62934131|FG000|Overall Study|Lost to Follow-up|2|||
33648134|NCT02018861|63056507|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
33648135|NCT02018861|63056508|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
33648136|NCT02018861|63056509|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
33648137|NCT02018861|63056510|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
33648138|NCT02018861|63056511|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
33648139|NCT02018861|63056512|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
33648140|NCT02018861|63056513|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
33648141|NCT02018861|63056514|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
33648142|NCT02018861|63056505|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33648143|NCT02018861|63056506|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33648144|NCT02018861|63056507|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
33648145|NCT02018861|63056508|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
33463775|NCT03386344|62837272|FG001|Overall Study|At the Participant's own Request|7|||
33543366|NCT01661686|62934132|FG001|Overall Study|Lost to Follow-up|1|||
33543367|NCT01661686|62934131|FG000|Overall Study|did not receive allocated intervention|0|||
33543368|NCT01661686|62934132|FG001|Overall Study|did not receive allocated intervention|1|||
33543369|NCT02696096|62934138|FG000|Overall Study|ruled out at screening|1|||
33543370|NCT02696096|62934138|FG000|Overall Study|did not attend second fMRI|1|||
33543371|NCT02695628|62934146|FG000|Overall Study|Withdrawal by Subject|1|||
33543372|NCT02693834|62934150|FG000|Baseline Measurement|Withdrawal by Subject|1|||
33543373|NCT02693834|62934151|FG001|Baseline Measurement|Withdrawal by Subject|0|||
33543374|NCT02693834|62934150|FG000|Baseline Measurement|Adverse Event|1|||
33543375|NCT02693834|62934151|FG001|Baseline Measurement|Adverse Event|0|||
33543376|NCT02693834|62934150|FG000|Week 2 Practice|Adverse Event|0|||
33543377|NCT02693834|62934151|FG001|Week 2 Practice|Adverse Event|1|||
33543378|NCT02545504|62934159|FG000|Overall Study|Death|174|||
33543379|NCT02545504|62934160|FG001|Overall Study|Death|168|||
33543380|NCT02545504|62934159|FG000|Overall Study|Unknown reason|30|||
33543381|NCT02545504|62934160|FG001|Overall Study|Unknown reason|32|||
33543382|NCT02545504|62934159|FG000|Overall Study|Withdrew consent|9|||
33543383|NCT02545504|62934160|FG001|Overall Study|Withdrew consent|11|||
33543384|NCT02545504|62934159|FG000|Overall Study|Investigator's discretion|3|||
33543385|NCT02545504|62934160|FG001|Overall Study|Investigator's discretion|1|||
33543386|NCT02545504|62934159|FG000|Overall Study|Lost to Follow-up|2|||
33543387|NCT02545504|62934160|FG001|Overall Study|Lost to Follow-up|2|||
33543388|NCT02545270|62934173|FG000|Overall Study|technical difficulties|0|||
33543389|NCT02545270|62934174|FG001|Overall Study|technical difficulties|1|||
33648146|NCT02018861|63056509|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33648147|NCT02018861|63056510|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33463776|NCT03386344|62837273|FG002|Overall Study|At the Participant's own Request|8|||
33463777|NCT03386344|62837271|FG000|Overall Study|Reason not Specified|0|||
33463778|NCT03386344|62837272|FG001|Overall Study|Reason not Specified|1|||
33463779|NCT03386344|62837273|FG002|Overall Study|Reason not Specified|0|||
33463780|NCT00399035|62837284|FG000|Overall Study|Death|289|||
33463781|NCT00399035|62837285|FG001|Overall Study|Death|141|||
33648148|NCT02018861|63056511|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33463782|NCT00399035|62837286|FG002|Overall Study|Death|234|||
33463783|NCT00399035|62837284|FG000|Overall Study|Lost to Follow-up|2|||
33463784|NCT00399035|62837285|FG001|Overall Study|Lost to Follow-up|1|||
33463785|NCT00399035|62837286|FG002|Overall Study|Lost to Follow-up|5|||
33463786|NCT00399035|62837284|FG000|Overall Study|Withdrawal by Subject|19|||
33463787|NCT00399035|62837285|FG001|Overall Study|Withdrawal by Subject|15|||
33463788|NCT00399035|62837286|FG002|Overall Study|Withdrawal by Subject|12|||
33463789|NCT00399035|62837284|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
33463790|NCT00399035|62837285|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
33463791|NCT00399035|62837286|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
33463792|NCT00399035|62837284|FG000|Overall Study|Severe non-compliance with protocol|2|||
33463793|NCT00399035|62837285|FG001|Overall Study|Severe non-compliance with protocol|1|||
33543390|NCT02545270|62934175|FG002|Overall Study|technical difficulties|0|||
33543391|NCT02545270|62934173|FG000|Overall Study|Videos being too similar to other|0|||
33543392|NCT02545270|62934174|FG001|Overall Study|Videos being too similar to other|0|||
33543393|NCT02545270|62934175|FG002|Overall Study|Videos being too similar to other|2|||
33543394|NCT02540668|62934184|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
33543395|NCT02540668|62934185|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
33463794|NCT00399035|62837286|FG002|Overall Study|Severe non-compliance with protocol|0|||
33463795|NCT00073749|62837300|FG000|Overall Study|Disease Progression|2|||
33543396|NCT02339740|62934194|FG000|Overall Study|Death|1|||
33543397|NCT02339740|62934195|FG001|Overall Study|Death|0|||
33543398|NCT02339740|62934194|FG000|Overall Study|Physician Decision|0|||
33648149|NCT02018861|63056512|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33648150|NCT02018861|63056513|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33648151|NCT02018861|63056514|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33648152|NCT02018861|63056505|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33648153|NCT02018861|63056506|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33648154|NCT02018861|63056507|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33648155|NCT02018861|63056508|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33648156|NCT02018861|63056509|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
33648157|NCT02018861|63056510|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33648158|NCT02018861|63056511|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33648159|NCT02018861|63056512|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33648160|NCT02018861|63056513|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33648161|NCT02018861|63056514|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33648162|NCT02018861|63056505|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
33648163|NCT02018861|63056506|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
33648164|NCT02018861|63056507|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
33648165|NCT02018861|63056508|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
33648166|NCT02018861|63056509|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
33543399|NCT02339740|62934195|FG001|Overall Study|Physician Decision|2|||
33543400|NCT02339740|62934194|FG000|Overall Study|Withdrawal by Subject|5|||
33543401|NCT02339740|62934195|FG001|Overall Study|Withdrawal by Subject|1|||
33543402|NCT02339740|62934194|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
33543403|NCT02339740|62934195|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
33543404|NCT02535364|62934218|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
33543405|NCT02535364|62934218|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
33543406|NCT02535364|62934218|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
33543407|NCT02535364|62934218|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
33543408|NCT02535364|62934218|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
33543409|NCT02535364|62934218|FG000|Part B Screening|Death|2|||
33543410|NCT02535364|62934218|FG000|Part B Screening|Physician Decision|1|||
33543411|NCT02535364|62934218|FG000|Part B Screening|Withdrawal by Subject|1|||
33648167|NCT02018861|63056510|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
33648168|NCT02018861|63056511|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
33648169|NCT02018861|63056512|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
33648170|NCT02018861|63056513|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
33648171|NCT02018861|63056514|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
33648172|NCT02018861|63056505|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33648173|NCT02018861|63056506|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33648174|NCT02018861|63056507|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33648175|NCT02018861|63056508|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
33648176|NCT02018861|63056509|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
33648177|NCT02018861|63056510|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33648178|NCT02018861|63056511|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33648179|NCT02018861|63056512|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33648180|NCT02018861|63056513|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33648181|NCT02018861|63056514|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33648182|NCT02018861|63056505|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33648183|NCT02018861|63056506|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33648184|NCT02018861|63056507|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33648185|NCT02018861|63056508|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33463796|NCT00073749|62837301|FG001|Overall Study|Disease Progression|0|||
33463797|NCT00073749|62837302|FG002|Overall Study|Disease Progression|3|||
33463798|NCT00073749|62837303|FG003|Overall Study|Disease Progression|2|||
33463799|NCT00073749|62837304|FG004|Overall Study|Disease Progression|3|||
33463800|NCT00073749|62837305|FG005|Overall Study|Disease Progression|1|||
33463801|NCT00073749|62837306|FG006|Overall Study|Disease Progression|3|||
33463802|NCT00073749|62837300|FG000|Overall Study|Death|0|||
33543412|NCT02535364|62934218|FG000|Part B Screening|Adverse Event|1|||
33543413|NCT02535364|62934218|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
33543414|NCT02535364|62934218|FG000|Study Treatment|Death|1|||
33543415|NCT02535364|62934218|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
33543416|NCT02535364|62934218|FG000|12-Month Follow-up Period|Disease progression|22|||
33463803|NCT00073749|62837301|FG001|Overall Study|Death|1|||
33463804|NCT00073749|62837302|FG002|Overall Study|Death|1|||
33463805|NCT00073749|62837303|FG003|Overall Study|Death|0|||
33463806|NCT00073749|62837304|FG004|Overall Study|Death|0|||
33463807|NCT00073749|62837305|FG005|Overall Study|Death|0|||
33463808|NCT00073749|62837306|FG006|Overall Study|Death|29|||
33463809|NCT00073749|62837300|FG000|Overall Study|Adverse Event|0|||
33463810|NCT00073749|62837301|FG001|Overall Study|Adverse Event|3|||
33463811|NCT00073749|62837302|FG002|Overall Study|Adverse Event|6|||
33463812|NCT00073749|62837303|FG003|Overall Study|Adverse Event|4|||
33463813|NCT00073749|62837304|FG004|Overall Study|Adverse Event|2|||
33463814|NCT00073749|62837305|FG005|Overall Study|Adverse Event|1|||
33463815|NCT00073749|62837306|FG006|Overall Study|Adverse Event|0|||
33648186|NCT02018861|63056509|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33648187|NCT02018861|63056510|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33648188|NCT02018861|63056511|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
33648189|NCT02018861|63056512|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
33648190|NCT02018861|63056513|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33463816|NCT00073749|62837300|FG000|Overall Study|Physician Decision|0|||
33463817|NCT00073749|62837301|FG001|Overall Study|Physician Decision|0|||
33463818|NCT00073749|62837302|FG002|Overall Study|Physician Decision|1|||
33463819|NCT00073749|62837303|FG003|Overall Study|Physician Decision|0|||
33463820|NCT00073749|62837304|FG004|Overall Study|Physician Decision|0|||
33463821|NCT00073749|62837305|FG005|Overall Study|Physician Decision|2|||
33463822|NCT00073749|62837306|FG006|Overall Study|Physician Decision|0|||
33463823|NCT00073749|62837300|FG000|Overall Study|Withdrawal by Subject|0|||
33463824|NCT00073749|62837301|FG001|Overall Study|Withdrawal by Subject|1|||
33463825|NCT00073749|62837302|FG002|Overall Study|Withdrawal by Subject|0|||
33463826|NCT00073749|62837303|FG003|Overall Study|Withdrawal by Subject|0|||
33463827|NCT00073749|62837304|FG004|Overall Study|Withdrawal by Subject|1|||
33463828|NCT00073749|62837305|FG005|Overall Study|Withdrawal by Subject|0|||
33463829|NCT00073749|62837306|FG006|Overall Study|Withdrawal by Subject|2|||
33463830|NCT00073749|62837300|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
33463831|NCT00073749|62837301|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
33463832|NCT00073749|62837302|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
33463833|NCT00073749|62837303|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
33463834|NCT00073749|62837304|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
33463835|NCT00073749|62837305|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
33463836|NCT00073749|62837306|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
33463837|NCT00073749|62837300|FG000|Overall Study|Lost to Follow-up|0|||
33463838|NCT00073749|62837301|FG001|Overall Study|Lost to Follow-up|0|||
33463839|NCT00073749|62837302|FG002|Overall Study|Lost to Follow-up|0|||
33463840|NCT00073749|62837303|FG003|Overall Study|Lost to Follow-up|0|||
33463841|NCT00073749|62837304|FG004|Overall Study|Lost to Follow-up|0|||
33463842|NCT00073749|62837305|FG005|Overall Study|Lost to Follow-up|0|||
33463843|NCT00073749|62837306|FG006|Overall Study|Lost to Follow-up|2|||
33463844|NCT00073749|62837300|FG000|Overall Study|Other|0|||
33463845|NCT00073749|62837301|FG001|Overall Study|Other|0|||
33463846|NCT00073749|62837302|FG002|Overall Study|Other|0|||
33463847|NCT00073749|62837303|FG003|Overall Study|Other|0|||
33463848|NCT00073749|62837304|FG004|Overall Study|Other|0|||
33463849|NCT00073749|62837305|FG005|Overall Study|Other|2|||
33463850|NCT00073749|62837306|FG006|Overall Study|Other|0|||
33463851|NCT00398567|62837328|FG000|Overall Study|Disease Progression|3|||
33463852|NCT00398567|62837329|FG001|Overall Study|Disease Progression|4|||
33463853|NCT00398567|62837330|FG002|Overall Study|Disease Progression|27|||
33463854|NCT00398567|62837328|FG000|Overall Study|Withdrawal by Subject|1|||
33463855|NCT00398567|62837329|FG001|Overall Study|Withdrawal by Subject|0|||
33463856|NCT00398567|62837330|FG002|Overall Study|Withdrawal by Subject|4|||
33463857|NCT00398567|62837328|FG000|Overall Study|Adverse Event|0|||
33463858|NCT00398567|62837329|FG001|Overall Study|Adverse Event|0|||
33463859|NCT00398567|62837330|FG002|Overall Study|Adverse Event|2|||
33463860|NCT00398567|62837328|FG000|Overall Study|Protocol Violation|0|||
33463861|NCT00398567|62837329|FG001|Overall Study|Protocol Violation|0|||
33463862|NCT00398567|62837330|FG002|Overall Study|Protocol Violation|1|||
33463863|NCT05249569|62837336|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
33463864|NCT04779879|62837359|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
33463865|NCT04779879|62837360|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
33543417|NCT02535364|62934218|FG000|12-Month Follow-up Period|Death|5|||
33463866|NCT04779879|62837361|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
33463867|NCT04779879|62837362|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
33463868|NCT04779879|62837363|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
33463869|NCT04779879|62837364|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
33463870|NCT04779879|62837359|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
33463871|NCT04779879|62837360|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
33463872|NCT04779879|62837361|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
33463873|NCT04779879|62837362|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
33463874|NCT04779879|62837363|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
33463875|NCT04779879|62837364|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
33463876|NCT04779879|62837359|FG000|Part C: Up to Week 36|Death|0|||
33463877|NCT04779879|62837360|FG001|Part C: Up to Week 36|Death|0|||
33463878|NCT04779879|62837361|FG002|Part C: Up to Week 36|Death|0|||
33463879|NCT04779879|62837362|FG003|Part C: Up to Week 36|Death|0|||
33463880|NCT04779879|62837363|FG004|Part C: Up to Week 36|Death|0|||
33463881|NCT04779879|62837364|FG005|Part C: Up to Week 36|Death|1|||
33463882|NCT04779879|62837359|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
33463883|NCT04779879|62837360|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
33463884|NCT04779879|62837361|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
33463885|NCT04779879|62837362|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
33463886|NCT04779879|62837363|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
33463887|NCT04779879|62837364|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
33463888|NCT04535167|62837405|FG000|Treatment|Adverse Event|0|||
33463889|NCT04535167|62837406|FG001|Treatment|Adverse Event|0|||
33463890|NCT04535167|62837407|FG002|Treatment|Adverse Event|0|||
33463891|NCT04535167|62837408|FG003|Treatment|Adverse Event|0|||
33463892|NCT04535167|62837409|FG004|Treatment|Adverse Event|0|||
33463893|NCT04535167|62837410|FG005|Treatment|Adverse Event|0|||
33463894|NCT04535167|62837411|FG006|Treatment|Adverse Event|1|||
33463895|NCT04535167|62837405|FG000|Follow-Up|Death|0|||
33463896|NCT04535167|62837406|FG001|Follow-Up|Death|0|||
33463897|NCT04535167|62837407|FG002|Follow-Up|Death|0|||
33463898|NCT04535167|62837408|FG003|Follow-Up|Death|0|||
33463899|NCT04535167|62837409|FG004|Follow-Up|Death|0|||
33463900|NCT04535167|62837410|FG005|Follow-Up|Death|0|||
33543418|NCT02535364|62934218|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
33543419|NCT02535364|62934218|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
33543420|NCT02535364|62934218|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
33543421|NCT02540356|62934224|FG000|Overall Study|Terminated due to disease progression|1|||
33543422|NCT02540356|62934225|FG001|Overall Study|Terminated due to disease progression|0|||
33543423|NCT02534896|62934233|FG000|Overall Study|Adverse Event|2|||
33543424|NCT02534896|62934234|FG001|Overall Study|Adverse Event|1|||
33543425|NCT02534896|62934235|FG002|Overall Study|Adverse Event|1|||
33543426|NCT02534896|62934233|FG000|Overall Study|Insufficient therapeutic response|2|||
33543427|NCT02534896|62934234|FG001|Overall Study|Insufficient therapeutic response|0|||
33543428|NCT02534896|62934235|FG002|Overall Study|Insufficient therapeutic response|0|||
33543429|NCT02697734|62934245|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
33648191|NCT02018861|63056514|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33648192|NCT02018861|63056505|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33648193|NCT02018861|63056506|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33648194|NCT02018861|63056507|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33648195|NCT02018861|63056508|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33648196|NCT02018861|63056509|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33648197|NCT02018861|63056510|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33648198|NCT02018861|63056511|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
33648199|NCT02018861|63056512|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
33648200|NCT02018861|63056513|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33648201|NCT02018861|63056514|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33648202|NCT02018861|63056505|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33648203|NCT02018861|63056506|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33648204|NCT02018861|63056507|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33463901|NCT04535167|62837411|FG006|Follow-Up|Death|1|||
33463902|NCT04535167|62837405|FG000|Follow-Up|Lost to Follow-up|0|||
33463903|NCT04535167|62837406|FG001|Follow-Up|Lost to Follow-up|0|||
33463904|NCT04535167|62837407|FG002|Follow-Up|Lost to Follow-up|0|||
33463905|NCT04535167|62837408|FG003|Follow-Up|Lost to Follow-up|1|||
33463906|NCT04535167|62837409|FG004|Follow-Up|Lost to Follow-up|0|||
33463907|NCT04535167|62837410|FG005|Follow-Up|Lost to Follow-up|0|||
33543430|NCT02697734|62934246|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
33543431|NCT02697734|62934245|FG000|Core Phase - up to Week 48|Adverse Event|1|||
33543432|NCT02697734|62934246|FG001|Core Phase - up to Week 48|Adverse Event|2|||
33463908|NCT04535167|62837411|FG006|Follow-Up|Lost to Follow-up|0|||
33463909|NCT04223791|62837429|FG000|Overall Study|Lost to Follow-up|0|||
33463910|NCT04223791|62837430|FG001|Overall Study|Lost to Follow-up|4|||
33543433|NCT02697734|62934245|FG000|Core Phase - up to Week 48|Physician Decision|1|||
33463911|NCT04223791|62837429|FG000|Overall Study|Physician Decision|5|||
33463912|NCT04223791|62837430|FG001|Overall Study|Physician Decision|1|||
33463913|NCT04223791|62837429|FG000|Overall Study|Protocol Violation|1|||
33463914|NCT04223791|62837430|FG001|Overall Study|Protocol Violation|1|||
33648205|NCT02018861|63056508|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33648206|NCT02018861|63056509|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33648207|NCT02018861|63056510|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33648208|NCT02018861|63056511|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33648209|NCT02018861|63056512|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33648210|NCT02018861|63056513|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
33648211|NCT02018861|63056514|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33648212|NCT02018861|63056505|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33648213|NCT02018861|63056506|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33648214|NCT02018861|63056507|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33648215|NCT02018861|63056508|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33648216|NCT02018861|63056509|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33648217|NCT02018861|63056510|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33648218|NCT02018861|63056511|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33648219|NCT02018861|63056512|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33648220|NCT02018861|63056513|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
33648221|NCT02018861|63056514|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33648222|NCT02018861|63056505|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33648223|NCT02018861|63056506|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33648224|NCT02018861|63056507|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33648225|NCT02018861|63056508|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33648226|NCT02018861|63056509|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33648227|NCT02018861|63056510|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33648228|NCT02018861|63056511|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33648229|NCT02018861|63056512|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33648230|NCT02018861|63056513|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
33648231|NCT02018861|63056514|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33648232|NCT02017717|63056552|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33648233|NCT02017717|63056553|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33648234|NCT02017717|63056554|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33648235|NCT02017717|63056555|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
33648236|NCT02017717|63056556|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33648237|NCT02017717|63056557|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33648238|NCT02017717|63056558|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33648239|NCT02017717|63056559|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33648240|NCT02017717|63056560|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33648241|NCT02017717|63056552|FG000|Before Treatment Period|Participant request to stop therapy|0|||
33648242|NCT02017717|63056553|FG001|Before Treatment Period|Participant request to stop therapy|0|||
33648243|NCT02017717|63056554|FG002|Before Treatment Period|Participant request to stop therapy|0|||
33648244|NCT02017717|63056555|FG003|Before Treatment Period|Participant request to stop therapy|0|||
33648245|NCT02017717|63056556|FG004|Before Treatment Period|Participant request to stop therapy|5|||
33648246|NCT02017717|63056557|FG005|Before Treatment Period|Participant request to stop therapy|0|||
33648247|NCT02017717|63056558|FG006|Before Treatment Period|Participant request to stop therapy|0|||
33648248|NCT02017717|63056559|FG007|Before Treatment Period|Participant request to stop therapy|0|||
33648249|NCT02017717|63056560|FG008|Before Treatment Period|Participant request to stop therapy|0|||
33648250|NCT02017717|63056552|FG000|Before Treatment Period|Participant withdrew consent|0|||
33648251|NCT02017717|63056553|FG001|Before Treatment Period|Participant withdrew consent|0|||
33648252|NCT02017717|63056554|FG002|Before Treatment Period|Participant withdrew consent|0|||
33648253|NCT02017717|63056555|FG003|Before Treatment Period|Participant withdrew consent|0|||
33648254|NCT02017717|63056556|FG004|Before Treatment Period|Participant withdrew consent|11|||
33648255|NCT02017717|63056557|FG005|Before Treatment Period|Participant withdrew consent|0|||
33648256|NCT02017717|63056558|FG006|Before Treatment Period|Participant withdrew consent|0|||
33648257|NCT02017717|63056559|FG007|Before Treatment Period|Participant withdrew consent|0|||
33648258|NCT02017717|63056560|FG008|Before Treatment Period|Participant withdrew consent|2|||
33648259|NCT02017717|63056552|FG000|Before Treatment Period|Lost to Follow-up|0|||
33648260|NCT02017717|63056553|FG001|Before Treatment Period|Lost to Follow-up|0|||
33648261|NCT02017717|63056554|FG002|Before Treatment Period|Lost to Follow-up|0|||
33648262|NCT02017717|63056555|FG003|Before Treatment Period|Lost to Follow-up|0|||
33648263|NCT02017717|63056556|FG004|Before Treatment Period|Lost to Follow-up|1|||
33648264|NCT02017717|63056557|FG005|Before Treatment Period|Lost to Follow-up|0|||
33543434|NCT02697734|62934246|FG001|Core Phase - up to Week 48|Physician Decision|0|||
33648265|NCT02017717|63056558|FG006|Before Treatment Period|Lost to Follow-up|0|||
33648266|NCT02017717|63056559|FG007|Before Treatment Period|Lost to Follow-up|0|||
33648267|NCT02017717|63056560|FG008|Before Treatment Period|Lost to Follow-up|0|||
33648268|NCT02017717|63056552|FG000|Before Treatment Period|Participant no longer met criteria|0|||
33648269|NCT02017717|63056553|FG001|Before Treatment Period|Participant no longer met criteria|0|||
33648270|NCT02017717|63056554|FG002|Before Treatment Period|Participant no longer met criteria|0|||
33648271|NCT02017717|63056555|FG003|Before Treatment Period|Participant no longer met criteria|1|||
33648272|NCT02017717|63056556|FG004|Before Treatment Period|Participant no longer met criteria|2|||
33648273|NCT02017717|63056557|FG005|Before Treatment Period|Participant no longer met criteria|0|||
33648274|NCT02017717|63056558|FG006|Before Treatment Period|Participant no longer met criteria|0|||
33648275|NCT02017717|63056559|FG007|Before Treatment Period|Participant no longer met criteria|1|||
33648276|NCT02017717|63056560|FG008|Before Treatment Period|Participant no longer met criteria|0|||
33648277|NCT02017717|63056552|FG000|Before Treatment Period|other reason|0|||
33648278|NCT02017717|63056553|FG001|Before Treatment Period|other reason|0|||
33648279|NCT02017717|63056554|FG002|Before Treatment Period|other reason|0|||
33648280|NCT02017717|63056555|FG003|Before Treatment Period|other reason|0|||
33648281|NCT02017717|63056556|FG004|Before Treatment Period|other reason|1|||
33648282|NCT02017717|63056557|FG005|Before Treatment Period|other reason|0|||
33648283|NCT02017717|63056558|FG006|Before Treatment Period|other reason|0|||
33648284|NCT02017717|63056559|FG007|Before Treatment Period|other reason|0|||
33648285|NCT02017717|63056560|FG008|Before Treatment Period|other reason|0|||
33648286|NCT02017717|63056552|FG000|Treatment Period|Disease progression|7|||
33648287|NCT02017717|63056553|FG001|Treatment Period|Disease progression|9|||
33648288|NCT02017717|63056554|FG002|Treatment Period|Disease progression|12|||
33648289|NCT02017717|63056555|FG003|Treatment Period|Disease progression|165|||
33648290|NCT02017717|63056556|FG004|Treatment Period|Disease progression|134|||
33648291|NCT02017717|63056557|FG005|Treatment Period|Disease progression|20|||
33648292|NCT02017717|63056558|FG006|Treatment Period|Disease progression|26|||
33648293|NCT02017717|63056559|FG007|Treatment Period|Disease progression|17|||
33648294|NCT02017717|63056560|FG008|Treatment Period|Disease progression|22|||
33648295|NCT02017717|63056552|FG000|Treatment Period|Study drug toxicity|3|||
33327254|NCT01185353|62703802|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
33327255|NCT01185353|62703803|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
33327256|NCT01185353|62703804|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
33327257|NCT01185353|62703805|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
33327258|NCT01185353|62703806|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
33327259|NCT01185353|62703797|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
33327260|NCT01185353|62703798|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
33327261|NCT01185353|62703799|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
33327262|NCT01185353|62703800|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
33327263|NCT01185353|62703801|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
33327264|NCT01185353|62703802|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
33327265|NCT01185353|62703803|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
33327266|NCT01185353|62703804|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
33327267|NCT01185353|62703805|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
33327268|NCT01185353|62703806|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
33327269|NCT01185353|62703797|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33327270|NCT01185353|62703798|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33327271|NCT01185353|62703799|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33327272|NCT01185353|62703800|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33327273|NCT01185353|62703801|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33327274|NCT01185353|62703802|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33327275|NCT01185353|62703803|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33327276|NCT01185353|62703804|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33327277|NCT01185353|62703805|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
33327278|NCT01185353|62703806|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33327279|NCT01185353|62703797|FG000|Part C (Weeks 24 Through 76)|Death|0|||
33648296|NCT02017717|63056553|FG001|Treatment Period|Study drug toxicity|0|||
33648297|NCT02017717|63056554|FG002|Treatment Period|Study drug toxicity|1|||
33648298|NCT02017717|63056555|FG003|Treatment Period|Study drug toxicity|7|||
33648299|NCT02017717|63056556|FG004|Treatment Period|Study drug toxicity|11|||
33648300|NCT02017717|63056557|FG005|Treatment Period|Study drug toxicity|4|||
33648301|NCT02017717|63056558|FG006|Treatment Period|Study drug toxicity|4|||
33648302|NCT02017717|63056559|FG007|Treatment Period|Study drug toxicity|5|||
33648303|NCT02017717|63056560|FG008|Treatment Period|Study drug toxicity|3|||
33648304|NCT02017717|63056552|FG000|Treatment Period|Death|0|||
33648305|NCT02017717|63056553|FG001|Treatment Period|Death|0|||
33648306|NCT02017717|63056554|FG002|Treatment Period|Death|1|||
33648307|NCT02017717|63056555|FG003|Treatment Period|Death|0|||
33648308|NCT02017717|63056556|FG004|Treatment Period|Death|0|||
33327280|NCT01185353|62703798|FG001|Part C (Weeks 24 Through 76)|Death|0|||
33327281|NCT01185353|62703799|FG002|Part C (Weeks 24 Through 76)|Death|0|||
33648309|NCT02017717|63056557|FG005|Treatment Period|Death|0|||
33648310|NCT02017717|63056558|FG006|Treatment Period|Death|0|||
33648311|NCT02017717|63056559|FG007|Treatment Period|Death|1|||
33648312|NCT02017717|63056560|FG008|Treatment Period|Death|0|||
33648313|NCT02017717|63056552|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
33648314|NCT02017717|63056553|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
33648315|NCT02017717|63056554|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
33648316|NCT02017717|63056555|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
33648317|NCT02017717|63056556|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
33648318|NCT02017717|63056557|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
33648319|NCT02017717|63056558|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
33648320|NCT02017717|63056559|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
33648321|NCT02017717|63056560|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
33648322|NCT02017717|63056552|FG000|Treatment Period|Participant request to stop therapy|0|||
33648323|NCT02017717|63056553|FG001|Treatment Period|Participant request to stop therapy|0|||
33648324|NCT02017717|63056554|FG002|Treatment Period|Participant request to stop therapy|3|||
33648325|NCT02017717|63056555|FG003|Treatment Period|Participant request to stop therapy|4|||
33648326|NCT02017717|63056556|FG004|Treatment Period|Participant request to stop therapy|7|||
33648327|NCT02017717|63056557|FG005|Treatment Period|Participant request to stop therapy|5|||
33648328|NCT02017717|63056558|FG006|Treatment Period|Participant request to stop therapy|0|||
33648329|NCT02017717|63056559|FG007|Treatment Period|Participant request to stop therapy|2|||
33648330|NCT02017717|63056560|FG008|Treatment Period|Participant request to stop therapy|1|||
33648331|NCT02017717|63056552|FG000|Treatment Period|Participant withdrew consent|0|||
33648332|NCT02017717|63056553|FG001|Treatment Period|Participant withdrew consent|0|||
33648333|NCT02017717|63056554|FG002|Treatment Period|Participant withdrew consent|1|||
33648334|NCT02017717|63056555|FG003|Treatment Period|Participant withdrew consent|1|||
33648335|NCT02017717|63056556|FG004|Treatment Period|Participant withdrew consent|4|||
33648336|NCT02017717|63056557|FG005|Treatment Period|Participant withdrew consent|0|||
33648337|NCT02017717|63056558|FG006|Treatment Period|Participant withdrew consent|0|||
33648338|NCT02017717|63056559|FG007|Treatment Period|Participant withdrew consent|2|||
33648339|NCT02017717|63056560|FG008|Treatment Period|Participant withdrew consent|0|||
33648340|NCT02017717|63056552|FG000|Treatment Period|Participant no longer met criteria|0|||
33648341|NCT02017717|63056553|FG001|Treatment Period|Participant no longer met criteria|0|||
33648342|NCT02017717|63056554|FG002|Treatment Period|Participant no longer met criteria|0|||
33648343|NCT02017717|63056555|FG003|Treatment Period|Participant no longer met criteria|0|||
33648344|NCT02017717|63056556|FG004|Treatment Period|Participant no longer met criteria|1|||
33648345|NCT02017717|63056557|FG005|Treatment Period|Participant no longer met criteria|0|||
33648346|NCT02017717|63056558|FG006|Treatment Period|Participant no longer met criteria|0|||
33648347|NCT02017717|63056559|FG007|Treatment Period|Participant no longer met criteria|0|||
33648348|NCT02017717|63056560|FG008|Treatment Period|Participant no longer met criteria|0|||
33648349|NCT02017717|63056552|FG000|Treatment Period|other reasons|0|||
33648350|NCT02017717|63056553|FG001|Treatment Period|other reasons|0|||
33648351|NCT02017717|63056554|FG002|Treatment Period|other reasons|0|||
33648352|NCT02017717|63056555|FG003|Treatment Period|other reasons|0|||
33648353|NCT02017717|63056556|FG004|Treatment Period|other reasons|1|||
33648354|NCT02017717|63056557|FG005|Treatment Period|other reasons|0|||
33648355|NCT02017717|63056558|FG006|Treatment Period|other reasons|0|||
33648356|NCT02017717|63056559|FG007|Treatment Period|other reasons|1|||
33648357|NCT02017717|63056560|FG008|Treatment Period|other reasons|1|||
33648358|NCT02017717|63056552|FG000|Treatment Period|Maximum clinical benefit|0|||
33648359|NCT02017717|63056553|FG001|Treatment Period|Maximum clinical benefit|0|||
33648360|NCT02017717|63056554|FG002|Treatment Period|Maximum clinical benefit|0|||
33648361|NCT02017717|63056555|FG003|Treatment Period|Maximum clinical benefit|0|||
33648362|NCT02017717|63056556|FG004|Treatment Period|Maximum clinical benefit|1|||
33648363|NCT02017717|63056557|FG005|Treatment Period|Maximum clinical benefit|0|||
33648364|NCT02017717|63056558|FG006|Treatment Period|Maximum clinical benefit|0|||
33648365|NCT02017717|63056559|FG007|Treatment Period|Maximum clinical benefit|0|||
33648366|NCT02017717|63056560|FG008|Treatment Period|Maximum clinical benefit|0|||
33648367|NCT01827384|63056607|FG000|Overall Study|Switched to alternative treatment|0|||
33648368|NCT01827384|63056608|FG001|Overall Study|Switched to alternative treatment|0|||
33648369|NCT01827384|63056609|FG002|Overall Study|Switched to alternative treatment|0|||
33648370|NCT01827384|63056610|FG003|Overall Study|Switched to alternative treatment|0|||
33648371|NCT01827384|63056611|FG004|Overall Study|Switched to alternative treatment|0|||
33327282|NCT01185353|62703800|FG003|Part C (Weeks 24 Through 76)|Death|0|||
33327283|NCT01185353|62703801|FG004|Part C (Weeks 24 Through 76)|Death|0|||
33327284|NCT01185353|62703802|FG005|Part C (Weeks 24 Through 76)|Death|0|||
33327285|NCT01185353|62703803|FG006|Part C (Weeks 24 Through 76)|Death|0|||
33648372|NCT01827384|63056612|FG005|Overall Study|Switched to alternative treatment|0|||
33648373|NCT01827384|63056613|FG006|Overall Study|Switched to alternative treatment|0|||
33648374|NCT01827384|63056614|FG007|Overall Study|Switched to alternative treatment|0|||
33648375|NCT01827384|63056615|FG008|Overall Study|Switched to alternative treatment|0|||
33648376|NCT01827384|63056616|FG009|Overall Study|Switched to alternative treatment|0|||
33543435|NCT02697734|62934245|FG000|Optional Extension Phase|Adverse Event|5|||
33543436|NCT02697734|62934246|FG001|Optional Extension Phase|Adverse Event|1|||
33543437|NCT02697734|62934245|FG000|Optional Extension Phase|Physician Decision|0|||
33543438|NCT02697734|62934246|FG001|Optional Extension Phase|Physician Decision|1|||
33543439|NCT02692586|62934260|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
33543440|NCT02692586|62934260|FG000|Overall Study|Received adjunctive thrombolytics|2|||
33543441|NCT02534350|62934266|FG000|Overall Study|Randomized But Not Treated|1|||
33543442|NCT02534350|62934267|FG001|Overall Study|Randomized But Not Treated|0|||
33543443|NCT02534350|62934266|FG000|Overall Study|Protocol Violation|1|||
33543444|NCT02534350|62934267|FG001|Overall Study|Protocol Violation|0|||
33543445|NCT02534350|62934266|FG000|Overall Study|Withdrew Consent|2|||
33543446|NCT02534350|62934267|FG001|Overall Study|Withdrew Consent|0|||
33543447|NCT02688764|62934275|FG000|Overall Study|Adverse Event|3|||
33543448|NCT02688764|62934276|FG001|Overall Study|Adverse Event|3|||
33543449|NCT02688764|62934275|FG000|Overall Study|AE/Kidney transplant|1|||
33543450|NCT02688764|62934276|FG001|Overall Study|AE/Kidney transplant|0|||
33543451|NCT02688764|62934275|FG000|Overall Study|AE/Lack of efficacy|1|||
33543452|NCT02688764|62934276|FG001|Overall Study|AE/Lack of efficacy|0|||
33543453|NCT02688764|62934275|FG000|Overall Study|AE/Non-compl.|1|||
33543454|NCT02688764|62934276|FG001|Overall Study|AE/Non-compl.|0|||
33543455|NCT02688764|62934275|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
33543456|NCT02688764|62934276|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
33543457|NCT02688764|62934275|FG000|Overall Study|AE/Other|0|||
33543458|NCT02688764|62934276|FG001|Overall Study|AE/Other|1|||
33543459|NCT02688764|62934275|FG000|Overall Study|AE/Physician decision|1|||
33543460|NCT02688764|62934276|FG001|Overall Study|AE/Physician decision|0|||
33543461|NCT02688764|62934275|FG000|Overall Study|AE/Withd. parent|3|||
33543462|NCT02688764|62934276|FG001|Overall Study|AE/Withd. parent|0|||
33543463|NCT02688764|62934275|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
33543464|NCT02688764|62934276|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
33543465|NCT02688764|62934275|FG000|Overall Study|AE/Withd. subject|1|||
33543466|NCT02688764|62934276|FG001|Overall Study|AE/Withd. subject|0|||
33543467|NCT02688764|62934275|FG000|Overall Study|Kidney transplant|10|||
33543468|NCT02688764|62934276|FG001|Overall Study|Kidney transplant|4|||
33543469|NCT02688764|62934275|FG000|Overall Study|Lack of Efficacy|3|||
33543470|NCT02688764|62934276|FG001|Overall Study|Lack of Efficacy|2|||
33543471|NCT02688764|62934275|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
33543472|NCT02688764|62934276|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
33543473|NCT02688764|62934275|FG000|Overall Study|Non-compliance with study drug|4|||
33543474|NCT02688764|62934276|FG001|Overall Study|Non-compliance with study drug|0|||
33543475|NCT02688764|62934275|FG000|Overall Study|Non-compl./Physician decision|2|||
33543476|NCT02688764|62934276|FG001|Overall Study|Non-compl./Physician decision|0|||
33543477|NCT02688764|62934275|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
33543478|NCT02688764|62934276|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
33543479|NCT02688764|62934275|FG000|Overall Study|Non-compl./Withd. subject|0|||
33543480|NCT02688764|62934276|FG001|Overall Study|Non-compl./Withd. subject|2|||
33543481|NCT02688764|62934275|FG000|Overall Study|Phosphorus level outside safe range|0|||
33543482|NCT02688764|62934276|FG001|Overall Study|Phosphorus level outside safe range|1|||
33543483|NCT02688764|62934275|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
33543484|NCT02688764|62934276|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
33543485|NCT02688764|62934275|FG000|Overall Study|Study drug taste/Withd. parent|1|||
33543486|NCT02688764|62934276|FG001|Overall Study|Study drug taste/Withd. parent|0|||
33543487|NCT02688764|62934275|FG000|Overall Study|Subject moving out|2|||
33543488|NCT02688764|62934276|FG001|Overall Study|Subject moving out|0|||
33543489|NCT02688764|62934275|FG000|Overall Study|Subject taken off dialysis|1|||
33543490|NCT02688764|62934276|FG001|Overall Study|Subject taken off dialysis|0|||
33648377|NCT01827384|63056617|FG010|Overall Study|Switched to alternative treatment|0|||
33463915|NCT04223791|62837429|FG000|Overall Study|Withdrawal by Subject|10|||
33463916|NCT04223791|62837430|FG001|Overall Study|Withdrawal by Subject|12|||
33463917|NCT04223791|62837429|FG000|Overall Study|Pregnancy|1|||
33463918|NCT04223791|62837430|FG001|Overall Study|Pregnancy|1|||
33463919|NCT04223791|62837429|FG000|Overall Study|Ongoing in Study|305|||
33463920|NCT04223791|62837430|FG001|Overall Study|Ongoing in Study|302|||
33463921|NCT04115293|62837438|FG000|Overall Study|Adverse Event|0|||
33463922|NCT04115293|62837439|FG001|Overall Study|Adverse Event|2|||
33648378|NCT01827384|63056618|FG011|Overall Study|Switched to alternative treatment|0|||
33463923|NCT04115293|62837438|FG000|Overall Study|Withdrawal by Subject|2|||
33463924|NCT04115293|62837439|FG001|Overall Study|Withdrawal by Subject|1|||
33463925|NCT04115293|62837438|FG000|Overall Study|Physician Decision|1|||
33543491|NCT02688764|62934275|FG000|Overall Study|Withdrawal by parent|3|||
33543492|NCT02688764|62934276|FG001|Overall Study|Withdrawal by parent|0|||
33543493|NCT02688608|62934285|FG000|Overall Study|Lost to Follow-up|1|||
33543494|NCT02688530|62934293|FG000|Overall Study|Withdrawal by Subject|0|||
33648379|NCT01827384|63056619|FG012|Overall Study|Switched to alternative treatment|0|||
33648380|NCT01827384|63056620|FG013|Overall Study|Switched to alternative treatment|2|||
33648381|NCT01827384|63056607|FG000|Overall Study|Disease progression before treatment|0|||
33648382|NCT01827384|63056608|FG001|Overall Study|Disease progression before treatment|0|||
33648383|NCT01827384|63056609|FG002|Overall Study|Disease progression before treatment|0|||
33648384|NCT01827384|63056610|FG003|Overall Study|Disease progression before treatment|0|||
33648385|NCT01827384|63056611|FG004|Overall Study|Disease progression before treatment|0|||
33648386|NCT01827384|63056612|FG005|Overall Study|Disease progression before treatment|0|||
33648387|NCT01827384|63056613|FG006|Overall Study|Disease progression before treatment|0|||
33648388|NCT01827384|63056614|FG007|Overall Study|Disease progression before treatment|0|||
33648389|NCT01827384|63056615|FG008|Overall Study|Disease progression before treatment|0|||
33648390|NCT01827384|63056616|FG009|Overall Study|Disease progression before treatment|0|||
33648391|NCT01827384|63056617|FG010|Overall Study|Disease progression before treatment|0|||
33648392|NCT01827384|63056618|FG011|Overall Study|Disease progression before treatment|0|||
33648393|NCT01827384|63056619|FG012|Overall Study|Disease progression before treatment|0|||
33648394|NCT01827384|63056620|FG013|Overall Study|Disease progression before treatment|4|||
33648395|NCT01827384|63056607|FG000|Overall Study|Ineligible|0|||
33648396|NCT01827384|63056608|FG001|Overall Study|Ineligible|0|||
33648397|NCT01827384|63056609|FG002|Overall Study|Ineligible|0|||
33648398|NCT01827384|63056610|FG003|Overall Study|Ineligible|0|||
33648399|NCT01827384|63056611|FG004|Overall Study|Ineligible|0|||
33648400|NCT01827384|63056612|FG005|Overall Study|Ineligible|0|||
33648401|NCT01827384|63056613|FG006|Overall Study|Ineligible|0|||
33648402|NCT01827384|63056614|FG007|Overall Study|Ineligible|0|||
33648403|NCT01827384|63056615|FG008|Overall Study|Ineligible|0|||
33648404|NCT01827384|63056616|FG009|Overall Study|Ineligible|0|||
33648405|NCT01827384|63056617|FG010|Overall Study|Ineligible|0|||
33648406|NCT01827384|63056618|FG011|Overall Study|Ineligible|0|||
33648407|NCT01827384|63056619|FG012|Overall Study|Ineligible|0|||
33648408|NCT01827384|63056620|FG013|Overall Study|Ineligible|19|||
33648409|NCT01827384|63056607|FG000|Overall Study|Participant died before treatment|0|||
33648410|NCT01827384|63056608|FG001|Overall Study|Participant died before treatment|0|||
33648411|NCT01827384|63056609|FG002|Overall Study|Participant died before treatment|0|||
33648412|NCT01827384|63056610|FG003|Overall Study|Participant died before treatment|0|||
33648413|NCT01827384|63056611|FG004|Overall Study|Participant died before treatment|0|||
33648414|NCT01827384|63056612|FG005|Overall Study|Participant died before treatment|0|||
33648415|NCT01827384|63056613|FG006|Overall Study|Participant died before treatment|0|||
33648416|NCT01827384|63056614|FG007|Overall Study|Participant died before treatment|0|||
33648417|NCT01827384|63056615|FG008|Overall Study|Participant died before treatment|0|||
33648418|NCT01827384|63056616|FG009|Overall Study|Participant died before treatment|0|||
33648419|NCT01827384|63056617|FG010|Overall Study|Participant died before treatment|0|||
33648420|NCT01827384|63056618|FG011|Overall Study|Participant died before treatment|0|||
33648421|NCT01827384|63056619|FG012|Overall Study|Participant died before treatment|0|||
33648422|NCT01827384|63056620|FG013|Overall Study|Participant died before treatment|5|||
33648423|NCT01827384|63056607|FG000|Overall Study|Insufficient tumor cells|0|||
33648424|NCT01827384|63056608|FG001|Overall Study|Insufficient tumor cells|0|||
33648425|NCT01827384|63056609|FG002|Overall Study|Insufficient tumor cells|0|||
33648426|NCT01827384|63056610|FG003|Overall Study|Insufficient tumor cells|0|||
33648427|NCT01827384|63056611|FG004|Overall Study|Insufficient tumor cells|0|||
33648428|NCT01827384|63056612|FG005|Overall Study|Insufficient tumor cells|0|||
33648429|NCT01827384|63056613|FG006|Overall Study|Insufficient tumor cells|0|||
33648430|NCT01827384|63056614|FG007|Overall Study|Insufficient tumor cells|0|||
33648431|NCT01827384|63056615|FG008|Overall Study|Insufficient tumor cells|0|||
33648432|NCT01827384|63056616|FG009|Overall Study|Insufficient tumor cells|0|||
33648433|NCT01827384|63056617|FG010|Overall Study|Insufficient tumor cells|0|||
33648434|NCT01827384|63056618|FG011|Overall Study|Insufficient tumor cells|0|||
33648435|NCT01827384|63056619|FG012|Overall Study|Insufficient tumor cells|0|||
33648436|NCT01827384|63056620|FG013|Overall Study|Insufficient tumor cells|13|||
33648437|NCT01827384|63056607|FG000|Overall Study|No actionable mutation|0|||
33648438|NCT01827384|63056608|FG001|Overall Study|No actionable mutation|0|||
33648439|NCT01827384|63056609|FG002|Overall Study|No actionable mutation|0|||
33648440|NCT01827384|63056610|FG003|Overall Study|No actionable mutation|0|||
33648441|NCT01827384|63056611|FG004|Overall Study|No actionable mutation|0|||
33648442|NCT01827384|63056612|FG005|Overall Study|No actionable mutation|0|||
33648443|NCT01827384|63056613|FG006|Overall Study|No actionable mutation|0|||
33648444|NCT01827384|63056614|FG007|Overall Study|No actionable mutation|0|||
33648445|NCT01827384|63056615|FG008|Overall Study|No actionable mutation|0|||
33463926|NCT04115293|62837439|FG001|Overall Study|Physician Decision|0|||
33648446|NCT01827384|63056616|FG009|Overall Study|No actionable mutation|0|||
33648447|NCT01827384|63056617|FG010|Overall Study|No actionable mutation|0|||
33648448|NCT01827384|63056618|FG011|Overall Study|No actionable mutation|0|||
33648449|NCT01827384|63056619|FG012|Overall Study|No actionable mutation|0|||
33648450|NCT01827384|63056620|FG013|Overall Study|No actionable mutation|73|||
33648451|NCT01827384|63056607|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
33648452|NCT01827384|63056608|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
33648453|NCT01827384|63056609|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
33648454|NCT01827384|63056610|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
33648455|NCT01827384|63056611|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
33648456|NCT01827384|63056612|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
33648457|NCT01827384|63056613|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
33648458|NCT01827384|63056614|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
33648459|NCT01827384|63056615|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
33648460|NCT01827384|63056616|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
33648461|NCT01827384|63056617|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
33648462|NCT01827384|63056618|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
33648463|NCT01827384|63056619|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
33648464|NCT01827384|63056620|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
33648465|NCT01585194|63056655|FG000|Overall Study|Withdrawal by Subject|1|||
33648466|NCT01585194|63056655|FG000|Overall Study|Physician Decision|2|||
33648467|NCT01585194|63056655|FG000|Overall Study|Lack of insurance|1|||
33648468|NCT01377389|63056663|FG000|Overall Study|Withdrawal by Subject|1|||
33648469|NCT01377389|63056663|FG000|Overall Study|Screen failure|2|||
33648470|NCT01287611|63056669|FG000|Overall Study|Lost to Follow-up|29|||
33648471|NCT01287611|63056670|FG001|Overall Study|Lost to Follow-up|16|||
33648472|NCT01287611|63056669|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
33648473|NCT01287611|63056670|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
33648474|NCT01194271|63056678|FG000|Overall Study|Withdrawal by Subject|1|||
33648475|NCT01194271|63056678|FG000|Overall Study|Ineligible, Screen Failure|1|||
33648476|NCT01194271|63056678|FG000|Overall Study|Death|1|||
33648477|NCT01119508|63056693|FG000|Overall Study|Adverse Event|56|||
33648478|NCT01119508|63056693|FG000|Overall Study|Withdrawal by Subject|2|||
33648479|NCT01119508|63056693|FG000|Overall Study|Died before tumor response evaluation|1|||
33648480|NCT00754338|63056705|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
33648481|NCT00754338|63056706|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
33648482|NCT00754338|63056707|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
33648483|NCT00754338|63056708|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
33648484|NCT00754338|63056705|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
33648485|NCT00754338|63056706|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
33648486|NCT00754338|63056707|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
33648487|NCT00754338|63056708|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
33648488|NCT00574496|63056734|FG000|Overall Study|Withdrawal by Subject|1|||
33648489|NCT00542451|63056738|FG000|Overall Study|Adverse Event|31|||
33648490|NCT00542451|63056738|FG000|Overall Study|Withdrawal by Subject|30|||
33648491|NCT00542451|63056738|FG000|Overall Study|Physician Decision|4|||
33648492|NCT00542451|63056738|FG000|Overall Study|Recurrent disease|1|||
33648493|NCT00542451|63056738|FG000|Overall Study|unknown reason|1|||
33648494|NCT00542451|63056738|FG000|Overall Study|Death|2|||
33648495|NCT00542451|63056738|FG000|Overall Study|Lost to Follow-up|10|||
33648496|NCT00499083|63056745|FG000|Overall Study|Not evaluable|3|||
33648497|NCT00418886|63056751|FG000|Overall Study|discontinue treatment survival follow up|90|||
33648498|NCT00418886|63056752|FG001|Overall Study|discontinue treatment survival follow up|91|||
33648499|NCT00418886|63056751|FG000|Overall Study|Death|122|||
33648500|NCT00418886|63056752|FG001|Overall Study|Death|147|||
33648501|NCT00418886|63056751|FG000|Overall Study|Withdrawal by Subject|9|||
33648502|NCT00418886|63056752|FG001|Overall Study|Withdrawal by Subject|10|||
33648503|NCT00418886|63056751|FG000|Overall Study|Lost to Follow-up|4|||
33648504|NCT00418886|63056752|FG001|Overall Study|Lost to Follow-up|6|||
33648505|NCT00418886|63056751|FG000|Overall Study|withdrawn due to other reason|1|||
33648506|NCT00418886|63056752|FG001|Overall Study|withdrawn due to other reason|0|||
33648507|NCT00418886|63056751|FG000|Overall Study|randomised but no treatment received|0|||
33648508|NCT00418886|63056752|FG001|Overall Study|randomised but no treatment received|1|||
33648509|NCT00026312|63056764|FG000|Overall Study|Adverse Event|0|||
33648510|NCT00026312|63056765|FG001|Overall Study|Adverse Event|32|||
33648511|NCT00026312|63056764|FG000|Overall Study|Death|1|||
33648512|NCT00026312|63056765|FG001|Overall Study|Death|7|||
33648513|NCT00026312|63056764|FG000|Overall Study|Lack of Efficacy|19|||
33648514|NCT00026312|63056765|FG001|Overall Study|Lack of Efficacy|114|||
33648515|NCT00026312|63056764|FG000|Overall Study|Lost to Follow-up|0|||
33648516|NCT00026312|63056765|FG001|Overall Study|Lost to Follow-up|5|||
33648517|NCT00026312|63056764|FG000|Overall Study|Physician Decision|1|||
33648518|NCT00026312|63056765|FG001|Overall Study|Physician Decision|37|||
33648519|NCT00026312|63056764|FG000|Overall Study|Protocol Violation|0|||
33648520|NCT00026312|63056765|FG001|Overall Study|Protocol Violation|3|||
33648521|NCT00026312|63056764|FG000|Overall Study|Withdrawal by Subject|1|||
33648522|NCT00026312|63056765|FG001|Overall Study|Withdrawal by Subject|6|||
33648523|NCT00026312|63056764|FG000|Overall Study|Ineligible|4|||
33648524|NCT00026312|63056765|FG001|Overall Study|Ineligible|5|||
33648525|NCT00026312|63056764|FG000|Overall Study|Entry onto another COG study|0|||
33648526|NCT00026312|63056765|FG001|Overall Study|Entry onto another COG study|1|||
33648527|NCT00026312|63056764|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
33648528|NCT00026312|63056765|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
33651472|NCT01746901|63062910|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33651473|NCT01746901|63062911|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
33651474|NCT01746901|63062912|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33651475|NCT01746901|63062904|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
33651476|NCT01746901|63062905|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
33651477|NCT01746901|63062906|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
33651478|NCT01746901|63062907|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
33651479|NCT01746901|63062908|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
33651480|NCT01746901|63062909|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
33651481|NCT01746901|63062910|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
33651482|NCT01746901|63062911|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
33651483|NCT01746901|63062912|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
33651484|NCT01746901|63062904|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33651485|NCT01746901|63062905|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33651486|NCT01746901|63062906|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33651487|NCT01746901|63062907|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
33651488|NCT01746901|63062908|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33651489|NCT01746901|63062909|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33651490|NCT01746901|63062910|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33651491|NCT01746901|63062911|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33651492|NCT01746901|63062912|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33651493|NCT01746901|63062904|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
33651494|NCT01746901|63062905|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
33651495|NCT01746901|63062906|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
33651496|NCT01746901|63062907|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
33651497|NCT01746901|63062908|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
33651498|NCT01746901|63062909|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
33651499|NCT01746901|63062910|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
33651500|NCT01746901|63062911|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
33651501|NCT01746901|63062912|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
33651502|NCT01746901|63062904|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
33651503|NCT01746901|63062905|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
33651504|NCT01746901|63062906|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
33651505|NCT01746901|63062907|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
33651506|NCT01746901|63062908|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
33651507|NCT01746901|63062909|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
33651508|NCT01746901|63062910|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
33651509|NCT01746901|63062911|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
33651510|NCT01746901|63062912|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
33651511|NCT01968551|63062951|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
33651512|NCT01968551|63062952|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
33651513|NCT01968551|63062953|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
33651514|NCT01968551|63062951|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
33651515|NCT01968551|63062952|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
33651516|NCT01968551|63062953|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
33651517|NCT01968551|63062951|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
33651518|NCT01968551|63062952|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
33651519|NCT01968551|63062953|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
33651520|NCT01968551|63062951|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
33651521|NCT01968551|63062952|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
33651522|NCT01968551|63062953|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
33651523|NCT01968551|63062951|FG000|Extension Phase|Adverse Event|0|||
33651524|NCT01968551|63062952|FG001|Extension Phase|Adverse Event|0|||
33651525|NCT01968551|63062953|FG002|Extension Phase|Adverse Event|2|||
33651526|NCT01968551|63062951|FG000|Extension Phase|Death|0|||
33651527|NCT01968551|63062952|FG001|Extension Phase|Death|1|||
33651528|NCT01968551|63062953|FG002|Extension Phase|Death|0|||
33651529|NCT01968551|63062951|FG000|Extension Phase|Withdrew Consent|0|||
33651530|NCT01968551|63062952|FG001|Extension Phase|Withdrew Consent|0|||
33651531|NCT01968551|63062953|FG002|Extension Phase|Withdrew Consent|1|||
33463927|NCT04115293|62837438|FG000|Overall Study|Death|1|||
33543495|NCT02688530|62934294|FG001|Overall Study|Withdrawal by Subject|1|||
33648529|NCT01819129|63056777|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
33648530|NCT01819129|63056778|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
33648531|NCT01819129|63056777|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
33648532|NCT01819129|63056778|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
33648533|NCT01819129|63056777|FG000|Overall Study|Other, Subject moved out of the country|0|||
33648534|NCT01819129|63056778|FG001|Overall Study|Other, Subject moved out of the country|1|||
33648535|NCT01819129|63056777|FG000|Overall Study|Withdrawal by Subject|15|||
33648536|NCT01819129|63056778|FG001|Overall Study|Withdrawal by Subject|15|||
33648537|NCT01819129|63056777|FG000|Overall Study|Lost to Follow-up|5|||
33648538|NCT01819129|63056778|FG001|Overall Study|Lost to Follow-up|2|||
33648539|NCT01819129|63056777|FG000|Overall Study|Lack of Efficacy|0|||
33648540|NCT01819129|63056778|FG001|Overall Study|Lack of Efficacy|1|||
33648541|NCT01819129|63056777|FG000|Overall Study|Adverse Event|1|||
33648542|NCT01819129|63056778|FG001|Overall Study|Adverse Event|4|||
33648543|NCT01819129|63056777|FG000|Overall Study|Death|1|||
33648544|NCT01819129|63056778|FG001|Overall Study|Death|1|||
33648545|NCT01819129|63056777|FG000|Overall Study|Withdrawal Criteria|20|||
33648546|NCT01819129|63056778|FG001|Overall Study|Withdrawal Criteria|15|||
33648547|NCT04022889|63056786|FG000|Stage 1: Period 1|Adverse Event|1|||
33648548|NCT04022889|63056787|FG001|Stage 1: Period 1|Adverse Event|0|||
33648549|NCT04022889|63056788|FG002|Stage 1: Period 1|Adverse Event|0|||
33648550|NCT04022889|63056786|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
33648551|NCT04022889|63056787|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
33648552|NCT04022889|63056788|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
33648553|NCT04022889|63056786|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
33648554|NCT04022889|63056787|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
33648555|NCT04022889|63056788|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
33648556|NCT04022889|63056786|FG000|Stage 2|Screen Failure|0|||
33648557|NCT04022889|63056787|FG001|Stage 2|Screen Failure|0|||
33648558|NCT04022889|63056788|FG002|Stage 2|Screen Failure|3|||
33648559|NCT04022889|63056786|FG000|Stage 2|Ineligible for apheresis donation|0|||
33648560|NCT04022889|63056787|FG001|Stage 2|Ineligible for apheresis donation|0|||
33648561|NCT04022889|63056788|FG002|Stage 2|Ineligible for apheresis donation|2|||
33648562|NCT04022889|63056786|FG000|Stage 2|Adverse Event|0|||
33648563|NCT04022889|63056787|FG001|Stage 2|Adverse Event|0|||
33648564|NCT04022889|63056788|FG002|Stage 2|Adverse Event|2|||
33648565|NCT04022889|63056786|FG000|Stage 2|Protocol Violation|0|||
33648566|NCT04022889|63056787|FG001|Stage 2|Protocol Violation|0|||
33648567|NCT04022889|63056788|FG002|Stage 2|Protocol Violation|1|||
33648568|NCT04022889|63056786|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
33648569|NCT04022889|63056787|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
33648570|NCT04022889|63056788|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
33648571|NCT01849783|63056820|FG000|Overall Study|Adverse Event|5|||
33648572|NCT01849783|63056820|FG000|Overall Study|Death|2|||
33648573|NCT01849783|63056820|FG000|Overall Study|Physician Decision|1|||
33648574|NCT01849783|63056820|FG000|Overall Study|Withdrawal by Subject|1|||
33648575|NCT01849783|63056820|FG000|Overall Study|Unable to comply|2|||
33648576|NCT01849783|63056820|FG000|Overall Study|Disease progression|11|||
33648577|NCT01611883|63056832|FG000|Overall Study|Adverse Event|1|||
33648578|NCT01611883|63056833|FG001|Overall Study|Adverse Event|1|||
33648579|NCT01848457|63056843|FG000|Overall Study|Death|1|||
33648580|NCT01848457|63056844|FG001|Overall Study|Death|0|||
33648581|NCT01848457|63056845|FG002|Overall Study|Death|0|||
33648582|NCT01848457|63056846|FG003|Overall Study|Death|0|||
33648583|NCT01817959|63056866|FG000|Overall Study|Graft loss|1|||
33648584|NCT01817959|63056867|FG001|Overall Study|Graft loss|1|||
33648585|NCT01817959|63056866|FG000|Overall Study|forbidden medication|1|||
33648586|NCT01817959|63056867|FG001|Overall Study|forbidden medication|1|||
33648587|NCT01817959|63056866|FG000|Overall Study|Adverse Event|1|||
33648588|NCT01817959|63056867|FG001|Overall Study|Adverse Event|0|||
33648589|NCT01817959|63056866|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
33648590|NCT01817959|63056867|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
33648591|NCT01817725|63056873|FG000|Overall Study|Withdrawal by Subject|1|||
33648592|NCT01870999|63056880|FG000|Overall Study|Adverse Event|0|||
33648593|NCT01870999|63056881|FG001|Overall Study|Adverse Event|4|||
33648594|NCT01870999|63056882|FG002|Overall Study|Adverse Event|1|||
33648595|NCT01870999|63056880|FG000|Overall Study|Subject met withdrawal criteria|3|||
33648596|NCT01870999|63056881|FG001|Overall Study|Subject met withdrawal criteria|2|||
33648597|NCT01870999|63056882|FG002|Overall Study|Subject met withdrawal criteria|0|||
33648598|NCT01870999|63056880|FG000|Overall Study|Subject withdrawn by Investigator|1|||
33648599|NCT01870999|63056881|FG001|Overall Study|Subject withdrawn by Investigator|0|||
33648600|NCT01870999|63056882|FG002|Overall Study|Subject withdrawn by Investigator|0|||
33648601|NCT01870999|63056880|FG000|Overall Study|Withdrawal by Subject|0|||
33648602|NCT01870999|63056881|FG001|Overall Study|Withdrawal by Subject|2|||
33648603|NCT01870999|63056882|FG002|Overall Study|Withdrawal by Subject|5|||
33648604|NCT01870999|63056880|FG000|Overall Study|Protocol Violation|0|||
33648605|NCT01870999|63056881|FG001|Overall Study|Protocol Violation|0|||
33648606|NCT01870999|63056882|FG002|Overall Study|Protocol Violation|1|||
33648607|NCT01870921|63056890|FG000|Overall Study|Subject decision|80|||
33648608|NCT01870921|63056890|FG000|Overall Study|Severe non-compliance to protocol|7|||
33648609|NCT01870921|63056890|FG000|Overall Study|Subject Lost to Follow up|2|||
33648610|NCT01870921|63056890|FG000|Overall Study|Other|1|||
33648611|NCT01848145|63056903|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
33648612|NCT01848145|63056903|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
33648613|NCT01848145|63056903|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
33648614|NCT01848145|63056903|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
33648615|NCT01848145|63056903|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
33648616|NCT01848145|63056903|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
33648617|NCT01848145|63056903|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
33648618|NCT01847755|63056907|FG000|Overall Study|Adverse Event|2|||
33648619|NCT01847755|63056907|FG000|Overall Study|Withdrawal by Subject|2|||
33648620|NCT01847755|63056907|FG000|Overall Study|Physician Decision|1|||
33648621|NCT01847443|63056938|FG000|Study Period 1|Withdrawal by Subject|0|||
33648622|NCT01847443|63056939|FG001|Study Period 1|Withdrawal by Subject|1|||
33648623|NCT01847443|63056940|FG002|Study Period 1|Withdrawal by Subject|0|||
33648624|NCT01847443|63056941|FG003|Study Period 1|Withdrawal by Subject|0|||
33648625|NCT01847443|63056938|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
33648626|NCT01847443|63056939|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
33648627|NCT01847443|63056940|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
33648628|NCT01847443|63056941|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
33648629|NCT01847443|63056938|FG000|Washout Period Before Study Period 2|Other reason|1|||
33648630|NCT01847443|63056939|FG001|Washout Period Before Study Period 2|Other reason|0|||
33648631|NCT01847443|63056940|FG002|Washout Period Before Study Period 2|Other reason|0|||
33648632|NCT01847443|63056941|FG003|Washout Period Before Study Period 2|Other reason|0|||
33648633|NCT01847443|63056938|FG000|Washout Period Before Study Period 3|Other reason|1|||
33648634|NCT01847443|63056939|FG001|Washout Period Before Study Period 3|Other reason|0|||
33648635|NCT01847443|63056940|FG002|Washout Period Before Study Period 3|Other reason|0|||
33648636|NCT01847443|63056941|FG003|Washout Period Before Study Period 3|Other reason|0|||
33648637|NCT01847443|63056938|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
33648638|NCT01847443|63056939|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
33648639|NCT01847443|63056940|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
33648640|NCT01847443|63056941|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
33648641|NCT01847443|63056938|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
33648642|NCT01847443|63056939|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
33648643|NCT01847443|63056940|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
33648644|NCT01847443|63056941|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
33648645|NCT01847209|63056960|FG000|Overall Study|Withdrawal by Subject|1|||
33648646|NCT01847209|63056960|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
33648647|NCT01846741|63056964|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
33648648|NCT01870843|63057003|FG000|Overall Study|Adverse Event|10|||
33648649|NCT01870843|63057003|FG000|Overall Study|Lost to Follow-up|24|||
33648650|NCT01870843|63057003|FG000|Overall Study|Death|1|||
33648651|NCT01870843|63057003|FG000|Overall Study|Withdrawal by Subject|18|||
33648652|NCT01816477|63057009|FG000|Overall Study|Withdrawal by Subject|13|||
33648653|NCT01816477|63057010|FG001|Overall Study|Withdrawal by Subject|1|||
33648654|NCT01816477|63057009|FG000|Overall Study|Unable to tolerate catheter placement|3|||
33648655|NCT01816477|63057010|FG001|Overall Study|Unable to tolerate catheter placement|0|||
33648656|NCT01846507|63057016|FG000|Overall Study|Lost to Follow-up|4|||
33648657|NCT01846507|63057016|FG000|Overall Study|Protocol Violation|1|||
33648658|NCT01846507|63057016|FG000|Overall Study|Missing data|2|||
33648659|NCT01846039|63057022|FG000|Overall Study|Protocol Violation|1|||
33648660|NCT01846039|63057022|FG000|Overall Study|Subject Withdrew Consent|1|||
33648661|NCT01610167|63057029|FG000|Overall Study|Scheduling conflict.|0|||
33648662|NCT01610167|63057030|FG001|Overall Study|Scheduling conflict.|0|||
33648663|NCT01610167|63057031|FG002|Overall Study|Scheduling conflict.|2|||
33327286|NCT01185353|62703804|FG007|Part C (Weeks 24 Through 76)|Death|0|||
33648664|NCT01816243|63057039|FG000|Overall Study|Adverse Event|6|||
33327287|NCT01185353|62703805|FG008|Part C (Weeks 24 Through 76)|Death|0|||
33463928|NCT04115293|62837439|FG001|Overall Study|Death|1|||
33648665|NCT01816243|63057039|FG000|Overall Study|Lost to Follow-up|1|||
33648666|NCT01816243|63057039|FG000|Overall Study|Lack of Efficacy|1|||
33648667|NCT01816243|63057039|FG000|Overall Study|Not eligible for the study|1|||
33648668|NCT01816243|63057039|FG000|Overall Study|Amputation|3|||
33648669|NCT01845805|63057045|FG000|Overall Study|Withdrawal by Subject|1|||
33648670|NCT01845805|63057046|FG001|Overall Study|Withdrawal by Subject|2|||
33648671|NCT01845805|63057045|FG000|Overall Study|Disease Progression|13|||
33648672|NCT01845805|63057046|FG001|Overall Study|Disease Progression|14|||
33648673|NCT01845805|63057045|FG000|Overall Study|Drug-related Toxicity|4|||
33648674|NCT01845805|63057046|FG001|Overall Study|Drug-related Toxicity|0|||
33648675|NCT01845025|63057054|FG000|Overall Study|Adverse Event|6|||
33648676|NCT01845025|63057055|FG001|Overall Study|Adverse Event|3|||
33648677|NCT01845025|63057054|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33648678|NCT01845025|63057055|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33648679|NCT01845025|63057054|FG000|Overall Study|Withdrawal by Subject|48|||
33648680|NCT01845025|63057055|FG001|Overall Study|Withdrawal by Subject|44|||
33648681|NCT01845025|63057054|FG000|Overall Study|Lost to Follow-up|13|||
33648682|NCT01845025|63057055|FG001|Overall Study|Lost to Follow-up|13|||
33648683|NCT01845025|63057054|FG000|Overall Study|Administrative problems|8|||
33648684|NCT01845025|63057055|FG001|Overall Study|Administrative problems|8|||
33648685|NCT01845025|63057054|FG000|Overall Study|Death|2|||
33648686|NCT01845025|63057055|FG001|Overall Study|Death|0|||
33648687|NCT01845025|63057054|FG000|Overall Study|Protocol deviation|3|||
33648688|NCT01845025|63057055|FG001|Overall Study|Protocol deviation|6|||
33648689|NCT01845025|63057054|FG000|Overall Study|Missing|1|||
33648690|NCT01845025|63057055|FG001|Overall Study|Missing|1|||
33648691|NCT01870297|63057096|FG000|Overall Study|Adverse Event|0|||
33648692|NCT01870297|63057097|FG001|Overall Study|Adverse Event|0|||
33648693|NCT01870297|63057098|FG002|Overall Study|Adverse Event|0|||
33648694|NCT01870297|63057099|FG003|Overall Study|Adverse Event|0|||
33648695|NCT01870297|63057100|FG004|Overall Study|Adverse Event|2|||
33648696|NCT01870297|63057101|FG005|Overall Study|Adverse Event|0|||
33648697|NCT01870297|63057102|FG006|Overall Study|Adverse Event|0|||
33648698|NCT01870297|63057096|FG000|Overall Study|Lost to Follow-up|0|||
33648699|NCT01870297|63057097|FG001|Overall Study|Lost to Follow-up|1|||
33648700|NCT01870297|63057098|FG002|Overall Study|Lost to Follow-up|1|||
33648701|NCT01870297|63057099|FG003|Overall Study|Lost to Follow-up|0|||
33648702|NCT01870297|63057100|FG004|Overall Study|Lost to Follow-up|0|||
33648703|NCT01870297|63057101|FG005|Overall Study|Lost to Follow-up|0|||
33648704|NCT01870297|63057102|FG006|Overall Study|Lost to Follow-up|0|||
33648705|NCT01870297|63057096|FG000|Overall Study|Withdrawal by Subject|0|||
33648706|NCT01870297|63057097|FG001|Overall Study|Withdrawal by Subject|0|||
33648707|NCT01870297|63057098|FG002|Overall Study|Withdrawal by Subject|0|||
33648708|NCT01870297|63057099|FG003|Overall Study|Withdrawal by Subject|0|||
33648709|NCT01870297|63057100|FG004|Overall Study|Withdrawal by Subject|1|||
33648710|NCT01870297|63057101|FG005|Overall Study|Withdrawal by Subject|1|||
33648711|NCT01870297|63057102|FG006|Overall Study|Withdrawal by Subject|1|||
33648712|NCT01870297|63057096|FG000|Overall Study|Sponsor Decision|0|||
33648713|NCT01870297|63057097|FG001|Overall Study|Sponsor Decision|6|||
33648714|NCT01870297|63057098|FG002|Overall Study|Sponsor Decision|0|||
33648715|NCT01870297|63057099|FG003|Overall Study|Sponsor Decision|0|||
33648716|NCT01870297|63057100|FG004|Overall Study|Sponsor Decision|0|||
33648717|NCT01870297|63057101|FG005|Overall Study|Sponsor Decision|0|||
33648718|NCT01870297|63057102|FG006|Overall Study|Sponsor Decision|1|||
33648719|NCT01814761|63057129|FG000|Overall Study|Other Reasons|1|||
33648720|NCT01814761|63057130|FG001|Overall Study|Other Reasons|10|||
33648721|NCT01814761|63057129|FG000|Overall Study|Ocular Adverse Event|6|||
33648722|NCT01814761|63057130|FG001|Overall Study|Ocular Adverse Event|15|||
33648723|NCT01814761|63057129|FG000|Overall Study|Lost to Follow-up|1|||
33327288|NCT01185353|62703806|FG009|Part C (Weeks 24 Through 76)|Death|1|||
33648724|NCT01814761|63057130|FG001|Overall Study|Lost to Follow-up|5|||
33648725|NCT01843933|63057138|FG000|Overall Study|Data lost|6|||
33543496|NCT02688530|62934295|FG002|Overall Study|Withdrawal by Subject|0|||
33648726|NCT01843933|63057139|FG001|Overall Study|Data lost|4|||
33648727|NCT01814371|63057147|FG000|Overall Study|Lost to Follow-up|30|||
33648728|NCT01814371|63057148|FG001|Overall Study|Lost to Follow-up|27|||
33648729|NCT01814137|63057222|FG000|Overall Study|Adverse Event|0|||
33648730|NCT01814137|63057223|FG001|Overall Study|Adverse Event|1|||
33648731|NCT01814137|63057222|FG000|Overall Study|Withdrawal by Subject|2|||
33648732|NCT01814137|63057223|FG001|Overall Study|Withdrawal by Subject|2|||
33648733|NCT01814137|63057222|FG000|Overall Study|Physician Decision|1|||
33648734|NCT01814137|63057223|FG001|Overall Study|Physician Decision|1|||
33648735|NCT01814137|63057222|FG000|Overall Study|Unclassified|2|||
33648736|NCT01814137|63057223|FG001|Overall Study|Unclassified|1|||
33648737|NCT01813435|63057240|FG000|Overall Study|did not finish experimental regimen|1902|||
33648738|NCT01813435|63057241|FG001|Overall Study|did not finish experimental regimen|770|||
33648739|NCT01813435|63057240|FG000|Overall Study|Lost to Follow-up|268|||
33648740|NCT01813435|63057241|FG001|Overall Study|Lost to Follow-up|237|||
33648741|NCT01813357|63057249|FG000|Overall Study|Lost to Follow-up|5|||
33648742|NCT01813357|63057250|FG001|Overall Study|Lost to Follow-up|6|||
33648743|NCT01812655|63057259|FG000|Overall Study|Protocol Violation|1|||
33648744|NCT01812655|63057260|FG001|Overall Study|Protocol Violation|1|||
33648745|NCT01812655|63057261|FG002|Overall Study|Protocol Violation|0|||
33648746|NCT01812109|63057282|FG000|Overall Study|research personnel delay|16|||
33648747|NCT01812109|63057282|FG000|Overall Study|NIRS Unattainable|17|||
33648748|NCT01811953|63057292|FG000|Overall Study|Adverse Event|0|||
33648749|NCT01811953|63057293|FG001|Overall Study|Adverse Event|0|||
33648750|NCT01811953|63057294|FG002|Overall Study|Adverse Event|0|||
33648751|NCT01811953|63057295|FG003|Overall Study|Adverse Event|1|||
33648752|NCT01811953|63057296|FG004|Overall Study|Adverse Event|0|||
33648753|NCT01811953|63057297|FG005|Overall Study|Adverse Event|1|||
33648754|NCT01811953|63057292|FG000|Overall Study|Protocol Violation|0|||
33648755|NCT01811953|63057293|FG001|Overall Study|Protocol Violation|0|||
33648756|NCT01811953|63057294|FG002|Overall Study|Protocol Violation|0|||
33648757|NCT01811953|63057295|FG003|Overall Study|Protocol Violation|0|||
33648758|NCT01811953|63057296|FG004|Overall Study|Protocol Violation|1|||
33648759|NCT01811953|63057297|FG005|Overall Study|Protocol Violation|0|||
33648760|NCT01811563|63057313|FG000|Overall Study|Lost to Follow-up|5|||
33648761|NCT01811563|63057314|FG001|Overall Study|Lost to Follow-up|2|||
33648762|NCT01811563|63057313|FG000|Overall Study|Incorrect Randomization procedure|0|||
33648763|NCT01811563|63057314|FG001|Overall Study|Incorrect Randomization procedure|1|||
33648764|NCT01811485|63057323|FG000|Overall Study|Adverse Event|1|||
33648765|NCT01811485|63057324|FG001|Overall Study|Adverse Event|3|||
33648766|NCT01811485|63057325|FG002|Overall Study|Adverse Event|2|||
33648767|NCT01811485|63057323|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33648768|NCT01811485|63057324|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33648769|NCT01811485|63057325|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
33648770|NCT01811485|63057323|FG000|Overall Study|Administrative problems|1|||
33648771|NCT01811485|63057324|FG001|Overall Study|Administrative problems|0|||
33648772|NCT01811485|63057325|FG002|Overall Study|Administrative problems|0|||
33648773|NCT01811485|63057323|FG000|Overall Study|Protocol Deviation|0|||
33648774|NCT01811485|63057324|FG001|Overall Study|Protocol Deviation|1|||
33648775|NCT01811485|63057325|FG002|Overall Study|Protocol Deviation|0|||
33648776|NCT01810939|63057336|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
33648777|NCT01810939|63057337|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
33648778|NCT01810939|63057338|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
33648779|NCT01810939|63057336|FG000|Part A Treatment Period|Protocol Violation|2|||
33648780|NCT01810939|63057337|FG001|Part A Treatment Period|Protocol Violation|0|||
33648781|NCT01810939|63057338|FG002|Part A Treatment Period|Protocol Violation|0|||
33648782|NCT01810939|63057336|FG000|Part A Treatment Period|Adverse Event|10|||
33648783|NCT01810939|63057337|FG001|Part A Treatment Period|Adverse Event|0|||
33648784|NCT01810939|63057338|FG002|Part A Treatment Period|Adverse Event|0|||
33648785|NCT01810939|63057336|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
33648786|NCT01810939|63057337|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
33648787|NCT01810939|63057338|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
33648788|NCT01810939|63057336|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
33648789|NCT01810939|63057337|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
33648790|NCT01810939|63057338|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
33648791|NCT01810939|63057336|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
33648792|NCT01810939|63057337|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
33648793|NCT01810939|63057338|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
33648794|NCT01810939|63057336|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
33648795|NCT01810939|63057337|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
33648796|NCT01810939|63057338|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
33648797|NCT01810939|63057336|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
33648798|NCT01810939|63057337|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
33648799|NCT01810939|63057338|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
33648800|NCT01810939|63057336|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
33648801|NCT01810939|63057337|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
33648802|NCT01810939|63057338|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
33648803|NCT01810939|63057336|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
33651532|NCT01968551|63062951|FG000|Extension Phase|Lost to Follow-up|1|||
33648804|NCT01810939|63057337|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
33648805|NCT01810939|63057338|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
33648806|NCT01810939|63057336|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
33648807|NCT01810939|63057337|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
33648808|NCT01810939|63057338|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
33648809|NCT01810939|63057336|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
33648810|NCT01810939|63057337|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
33648811|NCT01810939|63057338|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
33648812|NCT01810939|63057336|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
33648813|NCT01810939|63057337|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
33648814|NCT01810939|63057338|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
33648815|NCT01810939|63057336|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
33648816|NCT01810939|63057337|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
33648817|NCT01810939|63057338|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
33648818|NCT01810939|63057336|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
33648819|NCT01810939|63057337|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
33648820|NCT01810939|63057338|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
33648821|NCT01810939|63057336|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
33648822|NCT01810939|63057337|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
33648823|NCT01810939|63057338|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
33648824|NCT01810939|63057336|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
33648825|NCT01810939|63057337|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
33648826|NCT01810939|63057338|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
33648827|NCT01810783|63057357|FG000|Overall Study|Adverse Event|32|||
33648828|NCT01810783|63057357|FG000|Overall Study|Withdrawal by Subject|22|||
33648829|NCT01810783|63057357|FG000|Overall Study|Lack of Efficacy|12|||
33648830|NCT01810783|63057357|FG000|Overall Study|Lost to Follow-up|10|||
33648831|NCT01810783|63057357|FG000|Overall Study|Protocol Violation|5|||
33648832|NCT01810783|63057357|FG000|Overall Study|Non-compliance with IMP|4|||
33648833|NCT01810783|63057357|FG000|Overall Study|Adminstrative or other reason(s)|23|||
33648834|NCT01810783|63057357|FG000|Overall Study|Enrolled, not treated|1|||
33648835|NCT01808209|63057378|FG000|Overall Study|Lost to Follow-up|0|||
33648836|NCT01808209|63057379|FG001|Overall Study|Lost to Follow-up|1|||
33648837|NCT01807117|63057389|FG000|Overall Study|Physician Decision|2|||
33648838|NCT01807117|63057389|FG000|Overall Study|Disease diagnosis not a study disease|1|||
33648839|NCT01806961|63057395|FG000|Overall Study|sponsor decision|16|||
33648840|NCT01613131|63057401|FG000|Overall Study|Withdrawal by Subject|3|||
33648841|NCT01613131|63057402|FG001|Overall Study|Withdrawal by Subject|5|||
33648842|NCT01868893|63057408|FG000|Overall Study|Adverse Event|2|||
33648843|NCT01868893|63057408|FG000|Overall Study|Commercial availability of study drug|17|||
33648844|NCT01868893|63057408|FG000|Overall Study|Neutropenia|1|||
33648845|NCT01868503|63057414|FG000|Overall Study|Withdrawal by Subject|1|||
33648846|NCT01868503|63057414|FG000|Overall Study|Protocol Violation|1|||
33648847|NCT01868035|63057424|FG000|Overall Study|Lost to Follow-up|3|||
33648848|NCT01868035|63057424|FG000|Overall Study|Withdrawal by Subject|1|||
33648849|NCT01868035|63057424|FG000|Overall Study|Progressive Disease|2|||
33648850|NCT01868035|63057424|FG000|Overall Study|Non-compliance|1|||
33648851|NCT01609933|63057428|FG000|Overall Study|Adverse Event|1|||
33648852|NCT01609933|63057428|FG000|Overall Study|Withdrawal by Subject|3|||
33648853|NCT01843777|63057436|FG000|Overall Study|Withdrawal by Subject|1|||
33648854|NCT01843777|63057437|FG001|Overall Study|Withdrawal by Subject|0|||
33648855|NCT01842607|63057443|FG000|Overall Study|Adverse Event|11|||
33648856|NCT01842607|63057443|FG000|Overall Study|Lack of Efficacy|19|||
33648857|NCT01842607|63057443|FG000|Overall Study|Protocol Violation|8|||
33648858|NCT01842607|63057443|FG000|Overall Study|Protocol defined stopping criteria|2|||
33648859|NCT01842607|63057443|FG000|Overall Study|Lost to Follow-up|3|||
33648860|NCT01842607|63057443|FG000|Overall Study|Physician Decision|9|||
33648861|NCT01842607|63057443|FG000|Overall Study|Withdrawal by Subject|14|||
33648862|NCT01803607|63057449|FG000|Overall Study|Adverse Event|5|||
33648863|NCT01803607|63057450|FG001|Overall Study|Adverse Event|3|||
33648864|NCT01803607|63057449|FG000|Overall Study|Lack of Efficacy|0|||
33648865|NCT01803607|63057450|FG001|Overall Study|Lack of Efficacy|1|||
33648866|NCT01803607|63057449|FG000|Overall Study|Protocol Violation|3|||
33648867|NCT01803607|63057450|FG001|Overall Study|Protocol Violation|2|||
33648868|NCT01803607|63057449|FG000|Overall Study|Study terminated by sponsor|54|||
33648869|NCT01803607|63057450|FG001|Overall Study|Study terminated by sponsor|56|||
33648870|NCT01803607|63057449|FG000|Overall Study|Withdrawal by Subject|6|||
33648871|NCT01803607|63057450|FG001|Overall Study|Withdrawal by Subject|5|||
33463929|NCT04035499|62837445|FG000|Overall Study|Death|2|||
33648872|NCT01867021|63057458|FG000|Overall Study|Adverse Event|0|||
33648873|NCT01867021|63057459|FG001|Overall Study|Adverse Event|1|||
33648874|NCT01867021|63057458|FG000|Overall Study|Not Eligible|0|||
33648875|NCT01867021|63057459|FG001|Overall Study|Not Eligible|1|||
33648876|NCT01867021|63057458|FG000|Overall Study|Death|1|||
33648877|NCT01867021|63057459|FG001|Overall Study|Death|0|||
33648878|NCT01867021|63057458|FG000|Overall Study|Lost to Follow-up|0|||
33648879|NCT01867021|63057459|FG001|Overall Study|Lost to Follow-up|2|||
33648880|NCT01867021|63057458|FG000|Overall Study|Withdrawal by Subject|1|||
33648881|NCT01867021|63057459|FG001|Overall Study|Withdrawal by Subject|6|||
33648882|NCT01866709|63057472|FG000|Overall Study|Adverse Event|1|||
33648883|NCT01866709|63057473|FG001|Overall Study|Adverse Event|0|||
33648884|NCT01841593|63057481|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
33648885|NCT01841593|63057482|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
33648886|NCT01841593|63057481|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
33648887|NCT01841593|63057482|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
33648888|NCT01866319|63057750|FG000|Overall Study|Adverse Event|12|||
33648889|NCT01866319|63057751|FG001|Overall Study|Adverse Event|5|||
33648890|NCT01866319|63057752|FG002|Overall Study|Adverse Event|9|||
33648891|NCT01866319|63057750|FG000|Overall Study|Clinical progression|3|||
33648892|NCT01866319|63057751|FG001|Overall Study|Clinical progression|2|||
33648893|NCT01866319|63057752|FG002|Overall Study|Clinical progression|2|||
33648894|NCT01866319|63057750|FG000|Overall Study|Death|153|||
33648895|NCT01866319|63057751|FG001|Overall Study|Death|154|||
33648896|NCT01866319|63057752|FG002|Overall Study|Death|147|||
33648897|NCT01866319|63057750|FG000|Overall Study|Lost to Follow-up|6|||
33648898|NCT01866319|63057751|FG001|Overall Study|Lost to Follow-up|3|||
33648899|NCT01866319|63057752|FG002|Overall Study|Lost to Follow-up|8|||
33648900|NCT01866319|63057750|FG000|Overall Study|Physician Decision|1|||
33648901|NCT01866319|63057751|FG001|Overall Study|Physician Decision|0|||
33648902|NCT01866319|63057752|FG002|Overall Study|Physician Decision|1|||
33648903|NCT01866319|63057750|FG000|Overall Study|Protocol Violation|0|||
33648904|NCT01866319|63057751|FG001|Overall Study|Protocol Violation|0|||
33648905|NCT01866319|63057752|FG002|Overall Study|Protocol Violation|1|||
33648906|NCT01866319|63057750|FG000|Overall Study|Withdrawal by Subject|32|||
33648907|NCT01866319|63057751|FG001|Overall Study|Withdrawal by Subject|14|||
33648908|NCT01866319|63057752|FG002|Overall Study|Withdrawal by Subject|12|||
33648909|NCT01802515|63057779|FG000|Overall Study|Withdrawal by Subject|3|||
33648910|NCT01802515|63057780|FG001|Overall Study|Withdrawal by Subject|0|||
33648911|NCT01802515|63057781|FG002|Overall Study|Withdrawal by Subject|0|||
33648912|NCT01802437|63057791|FG000|Overall Study|Lost to Follow-up|1|||
33648913|NCT01802437|63057792|FG001|Overall Study|Lost to Follow-up|0|||
33648914|NCT01802437|63057791|FG000|Overall Study|Withdrawal by Subject|3|||
33648915|NCT01802437|63057792|FG001|Overall Study|Withdrawal by Subject|4|||
33648916|NCT01801735|63057899|FG000|Overall Study|Adverse Event|79|||
33648917|NCT01801735|63057899|FG000|Overall Study|Lack of Efficacy|28|||
33648918|NCT01801735|63057899|FG000|Overall Study|Withdrawal by Subject|27|||
33648919|NCT01801735|63057899|FG000|Overall Study|Protocol Violation|25|||
33648920|NCT01801735|63057899|FG000|Overall Study|Lost to Follow-up|15|||
33648921|NCT01801735|63057899|FG000|Overall Study|Non-compliance with Trial Drug|13|||
33648922|NCT01801735|63057899|FG000|Overall Study|Physician Decision|3|||
33648923|NCT01801735|63057899|FG000|Overall Study|Death|1|||
33648924|NCT01801735|63057899|FG000|Overall Study|Other, including site closure|19|||
33648925|NCT01840579|63058665|FG000|Overall Study|Status not recorded|0|||
33648926|NCT01840579|63058666|FG001|Overall Study|Status not recorded|0|||
33648927|NCT01840579|63058667|FG002|Overall Study|Status not recorded|2|||
33648928|NCT01840579|63058668|FG003|Overall Study|Status not recorded|3|||
33648929|NCT01840579|63058669|FG004|Overall Study|Status not recorded|4|||
33648930|NCT01840579|63058670|FG005|Overall Study|Status not recorded|3|||
33648931|NCT01840579|63058671|FG006|Overall Study|Status not recorded|0|||
33648932|NCT01840579|63058672|FG007|Overall Study|Status not recorded|3|||
33648933|NCT01840579|63058673|FG008|Overall Study|Status not recorded|3|||
33648934|NCT01840579|63058674|FG009|Overall Study|Status not recorded|3|||
33648935|NCT01840579|63058665|FG000|Overall Study|Progressive disease|3|||
33648936|NCT01840579|63058666|FG001|Overall Study|Progressive disease|5|||
33648937|NCT01840579|63058667|FG002|Overall Study|Progressive disease|0|||
33648938|NCT01840579|63058668|FG003|Overall Study|Progressive disease|0|||
33543497|NCT02688530|62934296|FG003|Overall Study|Withdrawal by Subject|0|||
33543498|NCT02688530|62934293|FG000|Overall Study|Lost to Follow-up|0|||
33648939|NCT01840579|63058669|FG004|Overall Study|Progressive disease|0|||
33648940|NCT01840579|63058670|FG005|Overall Study|Progressive disease|0|||
33648941|NCT01840579|63058671|FG006|Overall Study|Progressive disease|0|||
33648942|NCT01840579|63058672|FG007|Overall Study|Progressive disease|0|||
33648943|NCT01840579|63058673|FG008|Overall Study|Progressive disease|0|||
33648944|NCT01840579|63058674|FG009|Overall Study|Progressive disease|0|||
33648945|NCT01840579|63058665|FG000|Overall Study|Ongoing in study|0|||
33648946|NCT01840579|63058666|FG001|Overall Study|Ongoing in study|1|||
33648947|NCT01840579|63058667|FG002|Overall Study|Ongoing in study|0|||
33648948|NCT01840579|63058668|FG003|Overall Study|Ongoing in study|0|||
33648949|NCT01840579|63058669|FG004|Overall Study|Ongoing in study|0|||
33648950|NCT01840579|63058670|FG005|Overall Study|Ongoing in study|0|||
33648951|NCT01840579|63058671|FG006|Overall Study|Ongoing in study|0|||
33648952|NCT01840579|63058672|FG007|Overall Study|Ongoing in study|0|||
33648953|NCT01840579|63058673|FG008|Overall Study|Ongoing in study|0|||
33648954|NCT01840579|63058674|FG009|Overall Study|Ongoing in study|0|||
33648955|NCT01840579|63058665|FG000|Overall Study|Death|0|||
33648956|NCT01840579|63058666|FG001|Overall Study|Death|0|||
33648957|NCT01840579|63058667|FG002|Overall Study|Death|0|||
33648958|NCT01840579|63058668|FG003|Overall Study|Death|0|||
33648959|NCT01840579|63058669|FG004|Overall Study|Death|0|||
33648960|NCT01840579|63058670|FG005|Overall Study|Death|1|||
33648961|NCT01840579|63058671|FG006|Overall Study|Death|0|||
33648962|NCT01840579|63058672|FG007|Overall Study|Death|0|||
33648963|NCT01840579|63058673|FG008|Overall Study|Death|0|||
33648964|NCT01840579|63058674|FG009|Overall Study|Death|0|||
33648965|NCT01840579|63058665|FG000|Overall Study|Adverse Event|0|||
33648966|NCT01840579|63058666|FG001|Overall Study|Adverse Event|1|||
33648967|NCT01840579|63058667|FG002|Overall Study|Adverse Event|0|||
33648968|NCT01840579|63058668|FG003|Overall Study|Adverse Event|0|||
33648969|NCT01840579|63058669|FG004|Overall Study|Adverse Event|0|||
33648970|NCT01840579|63058670|FG005|Overall Study|Adverse Event|0|||
33648971|NCT01840579|63058671|FG006|Overall Study|Adverse Event|0|||
33648972|NCT01840579|63058672|FG007|Overall Study|Adverse Event|0|||
33648973|NCT01840579|63058673|FG008|Overall Study|Adverse Event|0|||
33648974|NCT01840579|63058674|FG009|Overall Study|Adverse Event|0|||
33648975|NCT01840579|63058665|FG000|Overall Study|Follow-up ended by Sponsor|0|||
33648976|NCT01840579|63058666|FG001|Overall Study|Follow-up ended by Sponsor|0|||
33648977|NCT01840579|63058667|FG002|Overall Study|Follow-up ended by Sponsor|0|||
33648978|NCT01840579|63058668|FG003|Overall Study|Follow-up ended by Sponsor|0|||
33648979|NCT01840579|63058669|FG004|Overall Study|Follow-up ended by Sponsor|0|||
33648980|NCT01840579|63058670|FG005|Overall Study|Follow-up ended by Sponsor|0|||
33648981|NCT01840579|63058671|FG006|Overall Study|Follow-up ended by Sponsor|2|||
33648982|NCT01840579|63058672|FG007|Overall Study|Follow-up ended by Sponsor|0|||
33648983|NCT01840579|63058673|FG008|Overall Study|Follow-up ended by Sponsor|0|||
33648984|NCT01840579|63058674|FG009|Overall Study|Follow-up ended by Sponsor|0|||
33648985|NCT01801111|63058753|FG000|Overall Study|Adverse Event|12|||
33648986|NCT01801111|63058753|FG000|Overall Study|Death|8|||
33327289|NCT01185353|62703797|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33648987|NCT01801111|63058753|FG000|Overall Study|Physician Decision|5|||
33648988|NCT01801111|63058753|FG000|Overall Study|Other|1|||
33648989|NCT01801111|63058753|FG000|Overall Study|Withdrawal by Subject|4|||
33648990|NCT01801111|63058753|FG000|Overall Study|Study Terminated by Sponsor|27|||
33648991|NCT01801111|63058753|FG000|Overall Study|Progressive Disease|81|||
33648992|NCT01773967|63058785|FG000|Overall Study|Lost to Follow-up|15|||
33648993|NCT01773967|63058786|FG001|Overall Study|Lost to Follow-up|13|||
33648994|NCT01773889|63058796|FG000|Overall Study|lack of funding|2|||
33648995|NCT01839487|63058974|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
33648996|NCT01839487|63058975|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
33648997|NCT01839487|63058976|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
33648998|NCT01839487|63058977|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
33648999|NCT01839487|63058978|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
33649000|NCT01839487|63058979|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
33649001|NCT01839487|63058974|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
33649002|NCT01839487|63058975|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
33649003|NCT01839487|63058976|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
33649004|NCT01839487|63058977|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
33649005|NCT01839487|63058978|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
33649006|NCT01839487|63058979|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
33649007|NCT01839487|63058974|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
33649008|NCT01839487|63058975|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
33649009|NCT01839487|63058976|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
33649010|NCT01839487|63058977|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
33649011|NCT01839487|63058978|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
33649012|NCT01839487|63058979|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
33649013|NCT01839487|63058974|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
33649014|NCT01839487|63058975|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
33649015|NCT01839487|63058976|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
33649016|NCT01839487|63058977|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
33649017|NCT01839487|63058978|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
33649018|NCT01839487|63058979|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
33649019|NCT01839487|63058974|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
33649020|NCT01839487|63058975|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
33649021|NCT01839487|63058976|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
33649022|NCT01839487|63058977|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
33649023|NCT01839487|63058978|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
33649024|NCT01839487|63058979|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
33649025|NCT01839487|63058974|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
33649026|NCT01839487|63058975|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
33649027|NCT01839487|63058976|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
33649028|NCT01839487|63058977|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
33649029|NCT01839487|63058978|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
33649030|NCT01839487|63058979|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
33649031|NCT01839487|63058974|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
33649032|NCT01839487|63058975|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
33649033|NCT01839487|63058976|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
33649034|NCT01839487|63058977|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
33649035|NCT01839487|63058978|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
33649036|NCT01839487|63058979|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
33327290|NCT01185353|62703798|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33463930|NCT04035499|62837445|FG000|Overall Study|Withdrawal by Subject|1|||
33649037|NCT01839487|63058974|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
33649038|NCT01839487|63058975|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
33649039|NCT01839487|63058976|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
33649040|NCT01839487|63058977|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
33649041|NCT01839487|63058978|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
33649042|NCT01839487|63058979|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
33649043|NCT01839487|63058974|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
33649044|NCT01839487|63058975|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
33649045|NCT01839487|63058976|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
33649046|NCT01839487|63058977|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
33649047|NCT01839487|63058978|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
33649048|NCT01839487|63058979|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
33649049|NCT01799941|63059006|FG000|Overall Study|Adverse Event|34|||
33649050|NCT01799941|63059006|FG000|Overall Study|Withdrawal by Subject|21|||
33649051|NCT01799941|63059006|FG000|Overall Study|Death|2|||
33649052|NCT01799941|63059006|FG000|Overall Study|Investigator Decision|4|||
33649053|NCT01799941|63059006|FG000|Overall Study|Lack of Efficacy|3|||
33327291|NCT01185353|62703799|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33327292|NCT01185353|62703800|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33327293|NCT01185353|62703801|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33327294|NCT01185353|62703802|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33327295|NCT01185353|62703803|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33649054|NCT01799941|63059006|FG000|Overall Study|Lost to Follow-up|17|||
33649055|NCT01799941|63059006|FG000|Overall Study|Other|15|||
33649056|NCT01799239|63059034|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
33649057|NCT01799239|63059035|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
33649058|NCT01799239|63059034|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
33649059|NCT01799239|63059035|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
33649060|NCT01799239|63059034|FG000|Period 1 (7 Days)|Protocol Violation|0|||
33649061|NCT01799239|63059035|FG001|Period 1 (7 Days)|Protocol Violation|1|||
33649062|NCT01799239|63059034|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
33649063|NCT01799239|63059035|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
33327296|NCT01185353|62703804|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33327297|NCT01185353|62703805|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33327298|NCT01185353|62703806|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
33327299|NCT01185353|62703797|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33327300|NCT01185353|62703798|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33327301|NCT01185353|62703799|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33327302|NCT01185353|62703800|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33327303|NCT01185353|62703801|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33327304|NCT01185353|62703802|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33327305|NCT01185353|62703803|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33649064|NCT01799239|63059034|FG000|Period 2 (7 Days)|Protocol Violation|1|||
33649065|NCT01799239|63059035|FG001|Period 2 (7 Days)|Protocol Violation|0|||
33649066|NCT02999854|63059051|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
33649067|NCT02999854|63059052|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
33649068|NCT02999854|63059051|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
33649069|NCT02999854|63059052|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
33649070|NCT02999854|63059051|FG000|Active Study Phase (up to 18 Months)|Death|7|||
33649071|NCT02999854|63059052|FG001|Active Study Phase (up to 18 Months)|Death|5|||
33649072|NCT02999854|63059051|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
33649073|NCT02999854|63059052|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
33649074|NCT02999854|63059051|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
33649075|NCT02999854|63059052|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
33649076|NCT02999854|63059051|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
33649077|NCT02999854|63059052|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
33327306|NCT01185353|62703804|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33327307|NCT01185353|62703805|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33327308|NCT01185353|62703806|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
33327309|NCT01185353|62703797|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
33327310|NCT01185353|62703798|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
33327311|NCT01185353|62703799|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
33327312|NCT01185353|62703800|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
33327313|NCT01185353|62703801|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
33327314|NCT01185353|62703802|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
33327315|NCT01185353|62703803|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
33327316|NCT01185353|62703804|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
33327317|NCT01185353|62703805|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
33649078|NCT02999854|63059051|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
33649079|NCT02999854|63059052|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
33649080|NCT02999854|63059051|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
33649081|NCT02999854|63059052|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
33649082|NCT04146363|63059185|FG000|Induction Period|Adverse Event|1|||
33327318|NCT01185353|62703806|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
33327319|NCT01185353|62703797|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33327320|NCT01185353|62703798|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33327321|NCT01185353|62703799|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33327322|NCT01185353|62703800|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33327323|NCT01185353|62703801|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33327324|NCT01185353|62703802|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33327325|NCT01185353|62703803|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33327326|NCT01185353|62703804|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
33327327|NCT01185353|62703805|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
33327328|NCT01185353|62703806|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33327329|NCT01185353|62703797|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
33327330|NCT01185353|62703798|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
33327331|NCT01185353|62703799|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
33327332|NCT01185353|62703800|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
33327333|NCT01185353|62703801|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
33327334|NCT01185353|62703802|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
33327335|NCT01185353|62703803|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
33327336|NCT01185353|62703804|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
33327337|NCT01185353|62703805|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
33327338|NCT01185353|62703806|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
33327339|NCT01185353|62703797|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33327340|NCT01185353|62703798|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33327341|NCT01185353|62703799|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33327342|NCT01185353|62703800|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33327343|NCT01185353|62703801|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33327344|NCT01185353|62703802|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33327345|NCT01185353|62703803|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33327346|NCT01185353|62703804|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
33327347|NCT01185353|62703805|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
33327348|NCT01185353|62703806|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33327349|NCT01098240|62703845|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
33327350|NCT01098240|62703846|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
33327351|NCT01098240|62703847|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
33327352|NCT01098240|62703845|FG000|Open-Label Phase|Protocol Violation|4|||
33327353|NCT01098240|62703846|FG001|Open-Label Phase|Protocol Violation|0|||
33327354|NCT01098240|62703847|FG002|Open-Label Phase|Protocol Violation|0|||
33543499|NCT02688530|62934294|FG001|Overall Study|Lost to Follow-up|0|||
33543500|NCT02688530|62934295|FG002|Overall Study|Lost to Follow-up|2|||
33543501|NCT02688530|62934296|FG003|Overall Study|Lost to Follow-up|0|||
33543502|NCT02467270|62934313|FG000|Overall Study|Participants Never Treated|0|||
33543503|NCT02467270|62934314|FG001|Overall Study|Participants Never Treated|1|||
33543504|NCT02467270|62934315|FG002|Overall Study|Participants Never Treated|0|||
33543505|NCT02467270|62934313|FG000|Overall Study|Ongoing|50|||
33543506|NCT02467270|62934314|FG001|Overall Study|Ongoing|41|||
33543507|NCT02467270|62934315|FG002|Overall Study|Ongoing|43|||
33543508|NCT02467270|62934313|FG000|Overall Study|Adverse Event|16|||
33543509|NCT02467270|62934314|FG001|Overall Study|Adverse Event|15|||
33543510|NCT02467270|62934315|FG002|Overall Study|Adverse Event|14|||
33543511|NCT02467270|62934313|FG000|Overall Study|Progressive Disease|7|||
33543512|NCT02467270|62934314|FG001|Overall Study|Progressive Disease|7|||
33543513|NCT02467270|62934315|FG002|Overall Study|Progressive Disease|4|||
33543514|NCT02467270|62934313|FG000|Overall Study|Death|2|||
33543515|NCT02467270|62934314|FG001|Overall Study|Death|0|||
33543516|NCT02467270|62934315|FG002|Overall Study|Death|2|||
33543517|NCT02467270|62934313|FG000|Overall Study|Lack of Efficacy|12|||
33543518|NCT02467270|62934314|FG001|Overall Study|Lack of Efficacy|18|||
33543519|NCT02467270|62934315|FG002|Overall Study|Lack of Efficacy|23|||
33543520|NCT02467270|62934313|FG000|Overall Study|Non-compliance With Study Drug|0|||
33543521|NCT02467270|62934314|FG001|Overall Study|Non-compliance With Study Drug|2|||
33543522|NCT02467270|62934315|FG002|Overall Study|Non-compliance With Study Drug|1|||
33327355|NCT01098240|62703845|FG000|Open-Label Phase|Lost to Follow-up|13|||
33327356|NCT01098240|62703846|FG001|Open-Label Phase|Lost to Follow-up|0|||
33327357|NCT01098240|62703847|FG002|Open-Label Phase|Lost to Follow-up|0|||
33327358|NCT01098240|62703845|FG000|Open-Label Phase|Other|19|||
33327359|NCT01098240|62703846|FG001|Open-Label Phase|Other|0|||
33327360|NCT01098240|62703847|FG002|Open-Label Phase|Other|0|||
33327361|NCT01098240|62703845|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
33543523|NCT02467270|62934313|FG000|Overall Study|Lost to Follow-up|2|||
33543524|NCT02467270|62934314|FG001|Overall Study|Lost to Follow-up|1|||
33649083|NCT04146363|63059186|FG001|Induction Period|Adverse Event|2|||
33543525|NCT02467270|62934315|FG002|Overall Study|Lost to Follow-up|0|||
33327362|NCT01098240|62703846|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
33327363|NCT01098240|62703847|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
33327364|NCT01098240|62703845|FG000|Open-Label Phase|Pregnancy|1|||
33327365|NCT01098240|62703846|FG001|Open-Label Phase|Pregnancy|0|||
33327366|NCT01098240|62703847|FG002|Open-Label Phase|Pregnancy|0|||
33327367|NCT01098240|62703845|FG000|Open-Label Phase|Withdrawal by Subject|9|||
33327368|NCT01098240|62703846|FG001|Open-Label Phase|Withdrawal by Subject|0|||
33327369|NCT01098240|62703847|FG002|Open-Label Phase|Withdrawal by Subject|0|||
33327370|NCT01098240|62703845|FG000|Open-Label Phase|Adverse Event|12|||
33327371|NCT01098240|62703846|FG001|Open-Label Phase|Adverse Event|0|||
33327372|NCT01098240|62703847|FG002|Open-Label Phase|Adverse Event|0|||
33327373|NCT01098240|62703845|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
33327374|NCT01098240|62703846|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
33327375|NCT01098240|62703847|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
33327376|NCT01098240|62703845|FG000|Double-Blind Phase|Protocol Violation|0|||
33327377|NCT01098240|62703846|FG001|Double-Blind Phase|Protocol Violation|2|||
33327378|NCT01098240|62703847|FG002|Double-Blind Phase|Protocol Violation|4|||
33327379|NCT01098240|62703845|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33327380|NCT01098240|62703846|FG001|Double-Blind Phase|Lost to Follow-up|2|||
33327381|NCT01098240|62703847|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33327382|NCT01098240|62703845|FG000|Double-Blind Phase|Other|0|||
33327383|NCT01098240|62703846|FG001|Double-Blind Phase|Other|2|||
33327384|NCT01098240|62703847|FG002|Double-Blind Phase|Other|2|||
33327385|NCT01098240|62703845|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
33327386|NCT01098240|62703846|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
33327387|NCT01098240|62703847|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
33327388|NCT01098240|62703845|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
33649084|NCT04146363|63059187|FG002|Induction Period|Adverse Event|0|||
33649085|NCT04146363|63059188|FG003|Induction Period|Adverse Event|0|||
33649086|NCT04146363|63059189|FG004|Induction Period|Adverse Event|0|||
33649087|NCT04146363|63059190|FG005|Induction Period|Adverse Event|0|||
33649088|NCT04146363|63059191|FG006|Induction Period|Adverse Event|0|||
33649089|NCT04146363|63059192|FG007|Induction Period|Adverse Event|0|||
33649090|NCT04146363|63059193|FG008|Induction Period|Adverse Event|0|||
33649091|NCT04146363|63059194|FG009|Induction Period|Adverse Event|0|||
33649092|NCT04146363|63059195|FG010|Induction Period|Adverse Event|0|||
33649093|NCT04146363|63059185|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
33649094|NCT04146363|63059186|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
33649095|NCT04146363|63059187|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
33649096|NCT04146363|63059188|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
33649097|NCT04146363|63059189|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
33649098|NCT04146363|63059190|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
33649099|NCT04146363|63059191|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
33649100|NCT04146363|63059192|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
33327389|NCT01098240|62703846|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
33327390|NCT01098240|62703847|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
33327391|NCT01098240|62703845|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
33327392|NCT01098240|62703846|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
33327393|NCT01098240|62703847|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
33327394|NCT01098240|62703845|FG000|Double-Blind Phase|Adverse Event|0|||
33327395|NCT01098240|62703846|FG001|Double-Blind Phase|Adverse Event|3|||
33327396|NCT01098240|62703847|FG002|Double-Blind Phase|Adverse Event|3|||
33327397|NCT01098162|62703854|FG000|Overall Study|Adverse Event|37|||
33327398|NCT01098162|62703854|FG000|Overall Study|Lack of Efficacy|4|||
33327399|NCT01098162|62703854|FG000|Overall Study|Wish of Patient|7|||
33327400|NCT01098162|62703854|FG000|Overall Study|Lost to Follow-up|9|||
33327401|NCT01098162|62703854|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
33327402|NCT01098162|62703854|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
33649101|NCT04146363|63059193|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
33649102|NCT04146363|63059194|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
33649103|NCT04146363|63059195|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
33327403|NCT01098162|62703854|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
33327404|NCT01098162|62703854|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
33327405|NCT01098162|62703854|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
33327406|NCT01098162|62703854|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
33327407|NCT01098162|62703854|FG000|Overall Study|Other Reason|1|||
33327408|NCT01098162|62703854|FG000|Overall Study|Reason Unknown|26|||
33327409|NCT01097694|62703860|FG000|Overall Study|Adverse Event|5|||
33327410|NCT01097694|62703861|FG001|Overall Study|Adverse Event|0|||
33327411|NCT01097694|62703860|FG000|Overall Study|Lost to Follow-up|0|||
33649104|NCT04146363|63059185|FG000|Induction Period|Lack of Efficacy|7|||
33649105|NCT04146363|63059186|FG001|Induction Period|Lack of Efficacy|2|||
33649106|NCT04146363|63059187|FG002|Induction Period|Lack of Efficacy|0|||
33649107|NCT04146363|63059188|FG003|Induction Period|Lack of Efficacy|0|||
33327412|NCT01097694|62703861|FG001|Overall Study|Lost to Follow-up|3|||
33327413|NCT01097694|62703860|FG000|Overall Study|Withdrawal by Subject|3|||
33327414|NCT01097694|62703861|FG001|Overall Study|Withdrawal by Subject|1|||
33327415|NCT01102140|62703869|FG000|Overall Study|Lost to Follow-up|1|||
33327416|NCT01102140|62703870|FG001|Overall Study|Lost to Follow-up|0|||
33649108|NCT04146363|63059189|FG004|Induction Period|Lack of Efficacy|0|||
33649109|NCT04146363|63059190|FG005|Induction Period|Lack of Efficacy|0|||
33649110|NCT04146363|63059191|FG006|Induction Period|Lack of Efficacy|0|||
33649111|NCT04146363|63059192|FG007|Induction Period|Lack of Efficacy|0|||
33649112|NCT04146363|63059193|FG008|Induction Period|Lack of Efficacy|0|||
33327417|NCT01102140|62703869|FG000|Overall Study|Investigator terminated study|2|||
33327418|NCT01102140|62703870|FG001|Overall Study|Investigator terminated study|2|||
33327419|NCT00874549|62703882|FG000|Overall Study|Adverse Event|0|||
33327420|NCT00874549|62703883|FG001|Overall Study|Adverse Event|0|||
33327421|NCT00874549|62703884|FG002|Overall Study|Adverse Event|1|||
33327422|NCT00874549|62703885|FG003|Overall Study|Adverse Event|0|||
33327423|NCT00874549|62703882|FG000|Overall Study|Protocol Violation|1|||
33327424|NCT00874549|62703883|FG001|Overall Study|Protocol Violation|0|||
33327425|NCT00874549|62703884|FG002|Overall Study|Protocol Violation|2|||
33327426|NCT00874549|62703885|FG003|Overall Study|Protocol Violation|1|||
33327427|NCT00874549|62703882|FG000|Overall Study|Lost to Follow-up|0|||
33327428|NCT00874549|62703883|FG001|Overall Study|Lost to Follow-up|0|||
33327429|NCT00874549|62703884|FG002|Overall Study|Lost to Follow-up|1|||
33327430|NCT00874549|62703885|FG003|Overall Study|Lost to Follow-up|0|||
33327431|NCT00874549|62703882|FG000|Overall Study|Withdrawal by Subject|0|||
33327432|NCT00874549|62703883|FG001|Overall Study|Withdrawal by Subject|1|||
33327433|NCT00874549|62703884|FG002|Overall Study|Withdrawal by Subject|0|||
33327434|NCT00874549|62703885|FG003|Overall Study|Withdrawal by Subject|1|||
33327435|NCT01155479|62703900|FG000|Part I|Adverse Event|13|||
33327436|NCT01155479|62703901|FG001|Part I|Adverse Event|8|||
33327437|NCT01155479|62703902|FG002|Part I|Adverse Event|18|||
33327438|NCT01155479|62703903|FG003|Part I|Adverse Event|7|||
33327439|NCT01155479|62703904|FG004|Part I|Adverse Event|6|||
33327440|NCT01155479|62703900|FG000|Part I|Administrative|2|||
33327441|NCT01155479|62703901|FG001|Part I|Administrative|2|||
33327442|NCT01155479|62703902|FG002|Part I|Administrative|2|||
33327443|NCT01155479|62703903|FG003|Part I|Administrative|0|||
33327444|NCT01155479|62703904|FG004|Part I|Administrative|0|||
33327445|NCT01155479|62703900|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
33327446|NCT01155479|62703901|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
33327447|NCT01155479|62703902|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
33327448|NCT01155479|62703903|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
33327449|NCT01155479|62703904|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
33327450|NCT01155479|62703900|FG000|Part I|Withdrawal by Subject|11|||
33327451|NCT01155479|62703901|FG001|Part I|Withdrawal by Subject|13|||
33327452|NCT01155479|62703902|FG002|Part I|Withdrawal by Subject|8|||
33327453|NCT01155479|62703903|FG003|Part I|Withdrawal by Subject|8|||
33327454|NCT01155479|62703904|FG004|Part I|Withdrawal by Subject|9|||
33327455|NCT01155479|62703900|FG000|Part I|Lost to Follow-up|0|||
33327456|NCT01155479|62703901|FG001|Part I|Lost to Follow-up|0|||
33327457|NCT01155479|62703902|FG002|Part I|Lost to Follow-up|1|||
33327458|NCT01155479|62703903|FG003|Part I|Lost to Follow-up|1|||
33327459|NCT01155479|62703904|FG004|Part I|Lost to Follow-up|0|||
33327460|NCT01155479|62703900|FG000|Part I|Treatment Failure|3|||
33327461|NCT01155479|62703901|FG001|Part I|Treatment Failure|0|||
33327462|NCT01155479|62703902|FG002|Part I|Treatment Failure|3|||
33327463|NCT01155479|62703903|FG003|Part I|Treatment Failure|1|||
33327464|NCT01155479|62703904|FG004|Part I|Treatment Failure|2|||
33327465|NCT01155479|62703900|FG000|Part I|Did Not Receive Treatment|4|||
33327466|NCT01155479|62703901|FG001|Part I|Did Not Receive Treatment|2|||
33327467|NCT01155479|62703902|FG002|Part I|Did Not Receive Treatment|2|||
33327468|NCT01155479|62703903|FG003|Part I|Did Not Receive Treatment|6|||
33327469|NCT01155479|62703904|FG004|Part I|Did Not Receive Treatment|1|||
33327470|NCT01155479|62703900|FG000|Part I|Non-Compliance with Protocol|2|||
33327471|NCT01155479|62703901|FG001|Part I|Non-Compliance with Protocol|1|||
33327472|NCT01155479|62703902|FG002|Part I|Non-Compliance with Protocol|3|||
33327473|NCT01155479|62703903|FG003|Part I|Non-Compliance with Protocol|3|||
33327474|NCT01155479|62703904|FG004|Part I|Non-Compliance with Protocol|2|||
33327475|NCT01155479|62703900|FG000|Part II|Adverse Event|7|||
33327476|NCT01155479|62703901|FG001|Part II|Adverse Event|6|||
33327477|NCT01155479|62703902|FG002|Part II|Adverse Event|8|||
33327478|NCT01155479|62703903|FG003|Part II|Adverse Event|3|||
33327479|NCT01155479|62703904|FG004|Part II|Adverse Event|4|||
33327480|NCT01155479|62703900|FG000|Part II|Administrative|43|||
33327481|NCT01155479|62703901|FG001|Part II|Administrative|49|||
33543526|NCT02467270|62934313|FG000|Overall Study|Pregnancy|0|||
33327482|NCT01155479|62703902|FG002|Part II|Administrative|36|||
33327483|NCT01155479|62703903|FG003|Part II|Administrative|38|||
33327484|NCT01155479|62703904|FG004|Part II|Administrative|46|||
33327485|NCT01155479|62703900|FG000|Part II|Withdrawal by Subject|8|||
33327486|NCT01155479|62703901|FG001|Part II|Withdrawal by Subject|4|||
33327487|NCT01155479|62703902|FG002|Part II|Withdrawal by Subject|12|||
33327488|NCT01155479|62703903|FG003|Part II|Withdrawal by Subject|7|||
33327489|NCT01155479|62703904|FG004|Part II|Withdrawal by Subject|3|||
33327490|NCT01155479|62703900|FG000|Part II|Lost to Follow-up|1|||
33327491|NCT01155479|62703901|FG001|Part II|Lost to Follow-up|0|||
33327492|NCT01155479|62703902|FG002|Part II|Lost to Follow-up|0|||
33327493|NCT01155479|62703903|FG003|Part II|Lost to Follow-up|0|||
33327494|NCT01155479|62703904|FG004|Part II|Lost to Follow-up|1|||
33327495|NCT01155479|62703900|FG000|Part II|Treatment Failure|0|||
33327496|NCT01155479|62703901|FG001|Part II|Treatment Failure|1|||
33327497|NCT01155479|62703902|FG002|Part II|Treatment Failure|2|||
33327498|NCT01155479|62703903|FG003|Part II|Treatment Failure|0|||
33327499|NCT01155479|62703904|FG004|Part II|Treatment Failure|1|||
33327500|NCT01155479|62703900|FG000|Part II|Non-Compliance with Protocol|0|||
33327501|NCT01155479|62703901|FG001|Part II|Non-Compliance with Protocol|1|||
33327502|NCT01155479|62703902|FG002|Part II|Non-Compliance with Protocol|0|||
33327503|NCT01155479|62703903|FG003|Part II|Non-Compliance with Protocol|2|||
33327504|NCT01155479|62703904|FG004|Part II|Non-Compliance with Protocol|0|||
33327505|NCT01155323|62703932|FG000|First Intervention|exclusion criteria|1|||
33463931|NCT03915067|62837452|FG000|Overall Study|Adverse Event|0|||
33463932|NCT03915067|62837453|FG001|Overall Study|Adverse Event|0|||
33649113|NCT04146363|63059194|FG009|Induction Period|Lack of Efficacy|0|||
33649114|NCT04146363|63059195|FG010|Induction Period|Lack of Efficacy|0|||
33649115|NCT04146363|63059185|FG000|Induction Period|Lost to Follow-up|1|||
33649116|NCT04146363|63059186|FG001|Induction Period|Lost to Follow-up|4|||
33649117|NCT04146363|63059187|FG002|Induction Period|Lost to Follow-up|0|||
33649118|NCT04146363|63059188|FG003|Induction Period|Lost to Follow-up|0|||
33649119|NCT04146363|63059189|FG004|Induction Period|Lost to Follow-up|0|||
33649120|NCT04146363|63059190|FG005|Induction Period|Lost to Follow-up|0|||
33649121|NCT04146363|63059191|FG006|Induction Period|Lost to Follow-up|0|||
33649122|NCT04146363|63059192|FG007|Induction Period|Lost to Follow-up|0|||
33649123|NCT04146363|63059193|FG008|Induction Period|Lost to Follow-up|0|||
33649124|NCT04146363|63059194|FG009|Induction Period|Lost to Follow-up|0|||
33649125|NCT04146363|63059195|FG010|Induction Period|Lost to Follow-up|0|||
33649126|NCT04146363|63059185|FG000|Induction Period|Positive quantiferon test|0|||
33649127|NCT04146363|63059186|FG001|Induction Period|Positive quantiferon test|1|||
33649128|NCT04146363|63059187|FG002|Induction Period|Positive quantiferon test|0|||
33649129|NCT04146363|63059188|FG003|Induction Period|Positive quantiferon test|0|||
33649130|NCT04146363|63059189|FG004|Induction Period|Positive quantiferon test|0|||
33649131|NCT04146363|63059190|FG005|Induction Period|Positive quantiferon test|0|||
33649132|NCT04146363|63059191|FG006|Induction Period|Positive quantiferon test|0|||
33649133|NCT04146363|63059192|FG007|Induction Period|Positive quantiferon test|0|||
33649134|NCT04146363|63059193|FG008|Induction Period|Positive quantiferon test|0|||
33649135|NCT04146363|63059194|FG009|Induction Period|Positive quantiferon test|0|||
33463933|NCT03915067|62837454|FG002|Overall Study|Adverse Event|1|||
33463934|NCT03915067|62837452|FG000|Overall Study|Withdrawal by Subject|4|||
33463935|NCT03915067|62837453|FG001|Overall Study|Withdrawal by Subject|3|||
33463936|NCT03915067|62837454|FG002|Overall Study|Withdrawal by Subject|0|||
33463937|NCT03915067|62837452|FG000|Overall Study|Lost to Follow-up|3|||
33463938|NCT03915067|62837453|FG001|Overall Study|Lost to Follow-up|2|||
33463939|NCT03915067|62837454|FG002|Overall Study|Lost to Follow-up|0|||
33463940|NCT03915067|62837452|FG000|Overall Study|Protocol Deviation|0|||
33463941|NCT03915067|62837453|FG001|Overall Study|Protocol Deviation|0|||
33463942|NCT03915067|62837454|FG002|Overall Study|Protocol Deviation|1|||
33463943|NCT03915067|62837452|FG000|Overall Study|Covid-19 Related Issues|2|||
33543527|NCT02467270|62934314|FG001|Overall Study|Pregnancy|1|||
33649136|NCT04146363|63059195|FG010|Induction Period|Positive quantiferon test|0|||
33649137|NCT04146363|63059185|FG000|Induction Period|Protocol Deviation|5|||
33649138|NCT04146363|63059186|FG001|Induction Period|Protocol Deviation|6|||
33649139|NCT04146363|63059187|FG002|Induction Period|Protocol Deviation|0|||
33649140|NCT04146363|63059188|FG003|Induction Period|Protocol Deviation|0|||
33649141|NCT04146363|63059189|FG004|Induction Period|Protocol Deviation|0|||
33649142|NCT04146363|63059190|FG005|Induction Period|Protocol Deviation|0|||
33649143|NCT04146363|63059191|FG006|Induction Period|Protocol Deviation|0|||
33649144|NCT04146363|63059192|FG007|Induction Period|Protocol Deviation|0|||
33327506|NCT01155323|62703933|FG001|First Intervention|exclusion criteria|1|||
33327507|NCT01155323|62703932|FG000|Second Intervention|Lost to Follow-up|1|||
33327508|NCT01155323|62703933|FG001|Second Intervention|Lost to Follow-up|1|||
33327509|NCT01155167|62703941|FG000|Overall Study|Insufficient ultrasound data|2|||
33463944|NCT03915067|62837453|FG001|Overall Study|Covid-19 Related Issues|4|||
33649145|NCT04146363|63059193|FG008|Induction Period|Protocol Deviation|0|||
33327510|NCT01155167|62703942|FG001|Overall Study|Insufficient ultrasound data|0|||
33649146|NCT04146363|63059194|FG009|Induction Period|Protocol Deviation|0|||
33649147|NCT04146363|63059195|FG010|Induction Period|Protocol Deviation|0|||
33649148|NCT04146363|63059185|FG000|Induction Period|Withdrawal by Subject|6|||
33649149|NCT04146363|63059186|FG001|Induction Period|Withdrawal by Subject|3|||
33649150|NCT04146363|63059187|FG002|Induction Period|Withdrawal by Subject|0|||
33649151|NCT04146363|63059188|FG003|Induction Period|Withdrawal by Subject|0|||
33649152|NCT04146363|63059189|FG004|Induction Period|Withdrawal by Subject|0|||
33649153|NCT04146363|63059190|FG005|Induction Period|Withdrawal by Subject|0|||
33649154|NCT04146363|63059191|FG006|Induction Period|Withdrawal by Subject|0|||
33649155|NCT04146363|63059192|FG007|Induction Period|Withdrawal by Subject|0|||
33649156|NCT04146363|63059193|FG008|Induction Period|Withdrawal by Subject|0|||
33649157|NCT04146363|63059194|FG009|Induction Period|Withdrawal by Subject|0|||
33649158|NCT04146363|63059195|FG010|Induction Period|Withdrawal by Subject|0|||
33649159|NCT04146363|63059185|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
33649160|NCT04146363|63059186|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
33649161|NCT04146363|63059187|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
33327511|NCT01155167|62703941|FG000|Overall Study|Access site changed to femoral artery|1|||
33327512|NCT01155167|62703942|FG001|Overall Study|Access site changed to femoral artery|0|||
33327513|NCT01106586|62703950|FG000|Overall Study|Adverse Event|9|||
33649162|NCT04146363|63059188|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
33649163|NCT04146363|63059189|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
33649164|NCT04146363|63059190|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
33649165|NCT04146363|63059191|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
33649166|NCT04146363|63059192|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
33649167|NCT04146363|63059193|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
33649168|NCT04146363|63059194|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
33649169|NCT04146363|63059195|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
33649170|NCT04146363|63059185|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33327514|NCT01106586|62703951|FG001|Overall Study|Adverse Event|15|||
33327515|NCT01106586|62703950|FG000|Overall Study|Death|1|||
33327516|NCT01106586|62703951|FG001|Overall Study|Death|3|||
33327517|NCT01106586|62703950|FG000|Overall Study|Pregnancy|2|||
33327518|NCT01106586|62703951|FG001|Overall Study|Pregnancy|2|||
33327519|NCT01106586|62703950|FG000|Overall Study|Lack of Efficacy|1|||
33463945|NCT03915067|62837454|FG002|Overall Study|Covid-19 Related Issues|4|||
33463946|NCT03915067|62837452|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
33463947|NCT03915067|62837453|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
33463948|NCT03915067|62837454|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
33463949|NCT03654404|62837462|FG000|Overall Study|Death|1|||
33463950|NCT03654404|62837462|FG000|Overall Study|Lost to Follow-up|2|||
33463951|NCT03654404|62837462|FG000|Overall Study|Withdrawal by Subject|5|||
33463952|NCT03447314|62837527|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
33463953|NCT03447314|62837528|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
33463954|NCT03447314|62837529|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
33543528|NCT02467270|62934315|FG002|Overall Study|Pregnancy|0|||
33543529|NCT02467270|62934313|FG000|Overall Study|Physician Decision|0|||
33543530|NCT02467270|62934314|FG001|Overall Study|Physician Decision|4|||
33543531|NCT02467270|62934315|FG002|Overall Study|Physician Decision|1|||
33543532|NCT02467270|62934313|FG000|Overall Study|Withdrawal by Subject|4|||
33543533|NCT02467270|62934314|FG001|Overall Study|Withdrawal by Subject|3|||
33543534|NCT02467270|62934315|FG002|Overall Study|Withdrawal by Subject|5|||
33649171|NCT04146363|63059186|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33543535|NCT02467270|62934313|FG000|Overall Study|Reason not Specified|1|||
33649172|NCT04146363|63059187|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33649173|NCT04146363|63059188|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33649174|NCT04146363|63059189|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33649175|NCT04146363|63059190|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33649176|NCT04146363|63059191|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33649177|NCT04146363|63059192|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
33649178|NCT04146363|63059193|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33649179|NCT04146363|63059194|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33649180|NCT04146363|63059195|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33651533|NCT01968551|63062952|FG001|Extension Phase|Lost to Follow-up|0|||
33327520|NCT01106586|62703951|FG001|Overall Study|Lack of Efficacy|0|||
33543536|NCT02467270|62934314|FG001|Overall Study|Reason not Specified|2|||
33543537|NCT02467270|62934315|FG002|Overall Study|Reason not Specified|1|||
33649181|NCT04146363|63059185|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33649182|NCT04146363|63059186|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33649183|NCT04146363|63059187|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33649184|NCT04146363|63059188|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33649185|NCT04146363|63059189|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33649186|NCT04146363|63059190|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33649187|NCT04146363|63059191|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
33649188|NCT04146363|63059192|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
33649189|NCT04146363|63059193|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33649190|NCT04146363|63059194|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33649191|NCT04146363|63059195|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33649192|NCT04146363|63059185|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
33649193|NCT04146363|63059186|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
33649194|NCT04146363|63059187|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
33649195|NCT04146363|63059188|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
33649196|NCT04146363|63059189|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
33649197|NCT04146363|63059190|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
33649198|NCT04146363|63059191|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
33649199|NCT04146363|63059192|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
33649200|NCT04146363|63059193|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
33649201|NCT04146363|63059194|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
33327521|NCT01106586|62703950|FG000|Overall Study|Investigator's Discretion|5|||
33327522|NCT01106586|62703951|FG001|Overall Study|Investigator's Discretion|8|||
33327523|NCT01106586|62703950|FG000|Overall Study|Withdrew Consent|18|||
33327524|NCT01106586|62703951|FG001|Overall Study|Withdrew Consent|30|||
33327525|NCT01106586|62703950|FG000|Overall Study|Lost to Follow-up|24|||
33327526|NCT01106586|62703951|FG001|Overall Study|Lost to Follow-up|20|||
33327527|NCT01106586|62703950|FG000|Overall Study|Participant Noncompliance|12|||
33327528|NCT01106586|62703951|FG001|Overall Study|Participant Noncompliance|10|||
33327529|NCT01106586|62703950|FG000|Overall Study|Protocol Violation|1|||
33327530|NCT01106586|62703951|FG001|Overall Study|Protocol Violation|0|||
33327531|NCT01106586|62703950|FG000|Overall Study|Participant Transferred to Another Study|212|||
33327532|NCT01106586|62703951|FG001|Overall Study|Participant Transferred to Another Study|197|||
33649202|NCT04146363|63059195|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
33649203|NCT04146363|63059185|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33649204|NCT04146363|63059186|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33649205|NCT04146363|63059187|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33649206|NCT04146363|63059188|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33327533|NCT01155011|62703959|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
33327534|NCT01155011|62703960|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
33327535|NCT01155011|62703959|FG000|Baseline to 6 Months|investigator decision, moved|4|||
33327536|NCT01155011|62703960|FG001|Baseline to 6 Months|investigator decision, moved|5|||
33327537|NCT01155011|62703959|FG000|Baseline to 6 Months|Death|0|||
33327538|NCT01155011|62703960|FG001|Baseline to 6 Months|Death|1|||
33327539|NCT01155011|62703959|FG000|6 to 12 Months|Withdrawal by Subject|8|||
33327540|NCT01155011|62703960|FG001|6 to 12 Months|Withdrawal by Subject|5|||
33327541|NCT01155011|62703959|FG000|6 to 12 Months|Death|1|||
33327542|NCT01155011|62703960|FG001|6 to 12 Months|Death|5|||
33327543|NCT01106430|62703972|FG000|Overall Study|Adverse Event|8|||
33463955|NCT03447314|62837530|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
33463956|NCT03447314|62837531|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
33463957|NCT03447314|62837532|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
33649207|NCT04146363|63059189|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
33649208|NCT04146363|63059190|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
33651534|NCT01968551|63062953|FG002|Extension Phase|Lost to Follow-up|1|||
33327544|NCT01106430|62703973|FG001|Overall Study|Adverse Event|10|||
33327545|NCT01106430|62703972|FG000|Overall Study|Lack of Efficacy|2|||
33327546|NCT01106430|62703973|FG001|Overall Study|Lack of Efficacy|13|||
33463958|NCT03447314|62837533|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
33463959|NCT03447314|62837534|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33463960|NCT03447314|62837535|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33463961|NCT03447314|62837536|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33543538|NCT05083559|62934325|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
33327547|NCT01106430|62703972|FG000|Overall Study|Lost to Follow-up|5|||
33327548|NCT01106430|62703973|FG001|Overall Study|Lost to Follow-up|1|||
33327549|NCT01106430|62703972|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
33327550|NCT01106430|62703973|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
33327551|NCT01106430|62703972|FG000|Overall Study|Moved Out Of State|0|||
33327552|NCT01106430|62703973|FG001|Overall Study|Moved Out Of State|1|||
33327553|NCT01106430|62703972|FG000|Overall Study|Refused To Take Medication|0|||
33327554|NCT01106430|62703973|FG001|Overall Study|Refused To Take Medication|1|||
33327555|NCT01106430|62703972|FG000|Overall Study|Noncompliance|0|||
33327556|NCT01106430|62703973|FG001|Overall Study|Noncompliance|1|||
33327557|NCT01106430|62703972|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
33327558|NCT01106430|62703973|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
33327559|NCT01106430|62703972|FG000|Overall Study|Previous Use Of Marijuana|1|||
33327560|NCT01106430|62703973|FG001|Overall Study|Previous Use Of Marijuana|0|||
33327561|NCT01106430|62703972|FG000|Overall Study|Protocol Violation|7|||
33327562|NCT01106430|62703973|FG001|Overall Study|Protocol Violation|2|||
33327563|NCT01106430|62703972|FG000|Overall Study|Withdrawal by Subject|8|||
33327564|NCT01106430|62703973|FG001|Overall Study|Withdrawal by Subject|4|||
33327565|NCT01154231|62703979|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
33327566|NCT01154231|62703979|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
33463962|NCT03447314|62837537|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
33463963|NCT03447314|62837538|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
33463964|NCT03447314|62837539|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33463965|NCT03447314|62837540|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33463966|NCT03447314|62837541|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33463967|NCT03447314|62837542|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33543539|NCT05083559|62934326|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
33543540|NCT05083559|62934325|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
33543541|NCT05083559|62934326|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
33543542|NCT05083559|62934325|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
33543543|NCT05083559|62934326|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
33543544|NCT03037307|62934332|FG000|Period 1|Did Not Meet Study Criteria|0|||
33543545|NCT03037307|62934333|FG001|Period 1|Did Not Meet Study Criteria|0|||
33543546|NCT03037307|62934334|FG002|Period 1|Did Not Meet Study Criteria|0|||
33543547|NCT03037307|62934335|FG003|Period 1|Did Not Meet Study Criteria|1|||
33543548|NCT03037307|62934336|FG004|Period 1|Did Not Meet Study Criteria|0|||
33543549|NCT03037307|62934337|FG005|Period 1|Did Not Meet Study Criteria|0|||
33543550|NCT02538094|62934346|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
33543551|NCT02538094|62934347|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
33543552|NCT02538094|62934346|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
33543553|NCT02538094|62934347|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
33543554|NCT02686034|62934355|FG000|Run-In Period 1|Eligibility|12|||
33543555|NCT02686034|62934356|FG001|Run-In Period 1|Eligibility|10|||
33543556|NCT02686034|62934355|FG000|Run-In Period 1|Withdrawal by Subject|4|||
33543557|NCT02686034|62934356|FG001|Run-In Period 1|Withdrawal by Subject|3|||
33463968|NCT03447314|62837543|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33463969|NCT03447314|62837544|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33463970|NCT03447314|62837527|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
33463971|NCT03447314|62837528|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33463972|NCT03447314|62837529|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
33463973|NCT03447314|62837530|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33543558|NCT02686034|62934355|FG000|Run-In Period 1|Lost to Follow-up|4|||
33543559|NCT02686034|62934356|FG001|Run-In Period 1|Lost to Follow-up|4|||
33543560|NCT02686034|62934355|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
33327567|NCT01154153|62703985|FG000|Overall Study|Poor compliance to protocol|2|||
33327568|NCT01154153|62703986|FG001|Overall Study|Poor compliance to protocol|0|||
33327569|NCT01154153|62703985|FG000|Overall Study|Unable to use labs|2|||
33327570|NCT01154153|62703986|FG001|Overall Study|Unable to use labs|3|||
33327571|NCT01154153|62703985|FG000|Overall Study|Withdrew consent|1|||
33649209|NCT04146363|63059191|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
33649210|NCT04146363|63059192|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
33649211|NCT04146363|63059193|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33649212|NCT04146363|63059194|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33649213|NCT04146363|63059195|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33649214|NCT04146363|63059185|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33649215|NCT04146363|63059186|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33649216|NCT04146363|63059187|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
33649217|NCT04146363|63059188|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33649218|NCT04146363|63059189|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33649219|NCT04146363|63059190|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
33649220|NCT04146363|63059191|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
33649221|NCT04146363|63059192|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
33327572|NCT01154153|62703986|FG001|Overall Study|Withdrew consent|0|||
33327573|NCT00874237|62703992|FG000|Overall Study|Physician Decision|0|||
33327574|NCT00874237|62703993|FG001|Overall Study|Physician Decision|1|||
33327575|NCT00874237|62703994|FG002|Overall Study|Physician Decision|0|||
33327576|NCT00874237|62703995|FG003|Overall Study|Physician Decision|0|||
33327577|NCT00874237|62703996|FG004|Overall Study|Physician Decision|0|||
33327578|NCT00874237|62703997|FG005|Overall Study|Physician Decision|0|||
33327579|NCT00874237|62703992|FG000|Overall Study|Withdrawal by Subject|0|||
33327580|NCT00874237|62703993|FG001|Overall Study|Withdrawal by Subject|0|||
33327581|NCT00874237|62703994|FG002|Overall Study|Withdrawal by Subject|1|||
33327582|NCT00874237|62703995|FG003|Overall Study|Withdrawal by Subject|0|||
33327583|NCT00874237|62703996|FG004|Overall Study|Withdrawal by Subject|0|||
33327584|NCT00874237|62703997|FG005|Overall Study|Withdrawal by Subject|0|||
33327585|NCT01153841|62704009|FG000|Overall Study|Adverse Event|1|||
33327586|NCT01153841|62704010|FG001|Overall Study|Adverse Event|0|||
33327587|NCT01153841|62704009|FG000|Overall Study|Withdrawal by Subject|1|||
33327588|NCT01153841|62704010|FG001|Overall Study|Withdrawal by Subject|0|||
33327589|NCT01153841|62704009|FG000|Overall Study|Protocol Violation|2|||
33327590|NCT01153841|62704010|FG001|Overall Study|Protocol Violation|0|||
33327591|NCT01153841|62704009|FG000|Overall Study|Lost to Follow-up|2|||
33327592|NCT01153841|62704010|FG001|Overall Study|Lost to Follow-up|0|||
33649222|NCT04146363|63059193|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33649223|NCT04146363|63059194|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33649224|NCT04146363|63059195|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33649225|NCT04146363|63059185|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
33649226|NCT04146363|63059186|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
33649227|NCT04146363|63059187|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
33649228|NCT04146363|63059188|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
33649229|NCT04146363|63059189|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
33649230|NCT04146363|63059190|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
33649231|NCT04146363|63059191|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
33649232|NCT04146363|63059192|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
33327593|NCT01153763|62704016|FG000|Overall Study|Study Closed|16|||
33463974|NCT03447314|62837531|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33327594|NCT01153763|62704016|FG000|Overall Study|Lost to Follow-up|1|||
33327595|NCT01153763|62704016|FG000|Overall Study|Physician Decision|2|||
33327596|NCT01153763|62704016|FG000|Overall Study|Withdrawal by Subject|2|||
33327597|NCT00871741|62704022|FG000|Overall Study|Premature study termination|9|||
33649233|NCT04146363|63059193|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
33649234|NCT04146363|63059194|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
33649235|NCT04146363|63059195|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
33649236|NCT04146363|63059185|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33649237|NCT04146363|63059186|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33649238|NCT04146363|63059187|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33649239|NCT04146363|63059188|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33649240|NCT04146363|63059189|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33649241|NCT04146363|63059190|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33649242|NCT04146363|63059191|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33649243|NCT04146363|63059192|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33649244|NCT04146363|63059193|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
33649245|NCT04146363|63059194|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
33649246|NCT04146363|63059195|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
33463975|NCT03447314|62837532|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
33463976|NCT03447314|62837533|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
33463977|NCT03447314|62837534|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33463978|NCT03447314|62837535|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33463979|NCT03447314|62837536|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33463980|NCT03447314|62837537|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33463981|NCT03447314|62837538|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33463982|NCT03447314|62837539|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33463983|NCT03447314|62837540|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33463984|NCT03447314|62837541|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33463985|NCT03447314|62837542|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33463986|NCT03447314|62837543|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33463987|NCT03447314|62837544|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33463988|NCT03447314|62837527|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33463989|NCT03447314|62837528|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33463990|NCT03447314|62837529|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
33463991|NCT03447314|62837530|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33463992|NCT03447314|62837531|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33463993|NCT03447314|62837532|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33463994|NCT03447314|62837533|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33327598|NCT00871741|62704023|FG001|Overall Study|Premature study termination|7|||
33327599|NCT01152437|62704032|FG000|Overall Study|Other Adverse Event|8|||
33327600|NCT01152437|62704033|FG001|Overall Study|Other Adverse Event|1|||
33327601|NCT01152437|62704034|FG002|Overall Study|Other Adverse Event|7|||
33327602|NCT01152437|62704032|FG000|Overall Study|Not treated|0|||
33327603|NCT01152437|62704033|FG001|Overall Study|Not treated|1|||
33543561|NCT02686034|62934356|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
33463995|NCT03447314|62837534|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33463996|NCT03447314|62837535|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33463997|NCT03447314|62837536|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33463998|NCT03447314|62837537|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33543562|NCT02686034|62934355|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
33543563|NCT02686034|62934356|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
33649247|NCT04146363|63059185|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33327604|NCT01152437|62704034|FG002|Overall Study|Not treated|2|||
33327605|NCT01152437|62704032|FG000|Overall Study|Progressive disease|27|||
33327606|NCT01152437|62704033|FG001|Overall Study|Progressive disease|13|||
33327607|NCT01152437|62704034|FG002|Overall Study|Progressive disease|32|||
33327608|NCT01152437|62704032|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
33327609|NCT01152437|62704033|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
33327610|NCT01152437|62704034|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
33327611|NCT01151579|62704046|FG000|Overall Study|Physician Decision|3|||
33327612|NCT01151579|62704047|FG001|Overall Study|Physician Decision|1|||
33327613|NCT01151579|62704046|FG000|Overall Study|Withdrawal by Subject|3|||
33327614|NCT01151579|62704047|FG001|Overall Study|Withdrawal by Subject|2|||
33327615|NCT01151579|62704046|FG000|Overall Study|Not meet inclusion criteria|6|||
33327616|NCT01151579|62704047|FG001|Overall Study|Not meet inclusion criteria|4|||
33327617|NCT01097616|62704056|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
33327618|NCT01097616|62704057|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
33327619|NCT01097616|62704058|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
33327620|NCT01097616|62704059|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33327621|NCT01097616|62704060|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33327622|NCT01097616|62704061|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33327623|NCT01097616|62704062|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33327624|NCT01097616|62704063|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33327625|NCT01097616|62704056|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
33327626|NCT01097616|62704057|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
33327627|NCT01097616|62704058|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
33327628|NCT01097616|62704059|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33327629|NCT01097616|62704060|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33327630|NCT01097616|62704061|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33327631|NCT01097616|62704062|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33327632|NCT01097616|62704063|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33327633|NCT01097616|62704056|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
33327634|NCT01097616|62704057|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
33327635|NCT01097616|62704058|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
33327636|NCT01097616|62704059|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33327637|NCT01097616|62704060|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33327638|NCT01097616|62704061|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33327639|NCT01097616|62704062|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33327640|NCT01097616|62704063|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33327641|NCT01097616|62704056|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
33327642|NCT01097616|62704057|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
33327643|NCT01097616|62704058|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33327644|NCT01097616|62704059|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33327645|NCT01097616|62704060|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33327646|NCT01097616|62704061|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33327647|NCT01097616|62704062|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33327648|NCT01097616|62704063|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33327649|NCT01097616|62704056|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
33327650|NCT01097616|62704057|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
33327651|NCT01097616|62704058|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
33327652|NCT01097616|62704059|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33327653|NCT01097616|62704060|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33327654|NCT01097616|62704061|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33327655|NCT01097616|62704062|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33327656|NCT01097616|62704063|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33327657|NCT01097616|62704056|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
33327658|NCT01097616|62704057|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
33327659|NCT01097616|62704058|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
33463999|NCT03447314|62837538|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33464000|NCT03447314|62837539|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33464001|NCT03447314|62837540|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33464002|NCT03447314|62837541|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33464003|NCT03447314|62837542|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33464004|NCT03447314|62837543|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33464005|NCT03447314|62837544|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33543564|NCT02686034|62934355|FG000|Randomized Controlled Period 2|Adverse Event|0|||
33543565|NCT02686034|62934356|FG001|Randomized Controlled Period 2|Adverse Event|2|||
33543566|NCT02686034|62934355|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
33327660|NCT01097616|62704059|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
33327661|NCT01097616|62704060|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
33327662|NCT01097616|62704061|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
33327663|NCT01097616|62704062|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
33327664|NCT01097616|62704063|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
33327665|NCT01097616|62704056|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
33327666|NCT01097616|62704057|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
33327667|NCT01097616|62704058|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33327668|NCT01097616|62704059|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33327669|NCT01097616|62704060|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33327670|NCT01097616|62704061|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33327671|NCT01097616|62704062|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33327672|NCT01097616|62704063|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33327673|NCT01097616|62704056|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33327674|NCT01097616|62704057|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33327675|NCT01097616|62704058|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
33327676|NCT01097616|62704059|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33327677|NCT01097616|62704060|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33327678|NCT01097616|62704061|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33327679|NCT01097616|62704062|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33327680|NCT01097616|62704063|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33327681|NCT01097616|62704056|FG000|Optional DB EXT Phase|Adverse Event|0|||
33327682|NCT01097616|62704057|FG001|Optional DB EXT Phase|Adverse Event|7|||
33327683|NCT01097616|62704058|FG002|Optional DB EXT Phase|Adverse Event|2|||
33327684|NCT01097616|62704059|FG003|Optional DB EXT Phase|Adverse Event|0|||
33327685|NCT01097616|62704060|FG004|Optional DB EXT Phase|Adverse Event|0|||
33327686|NCT01097616|62704061|FG005|Optional DB EXT Phase|Adverse Event|0|||
33327687|NCT01097616|62704062|FG006|Optional DB EXT Phase|Adverse Event|0|||
33327688|NCT01097616|62704063|FG007|Optional DB EXT Phase|Adverse Event|0|||
33327689|NCT01097616|62704056|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
33327690|NCT01097616|62704057|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
33327691|NCT01097616|62704058|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
33327692|NCT01097616|62704059|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
33327693|NCT01097616|62704060|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
33327694|NCT01097616|62704061|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
33327695|NCT01097616|62704062|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
33327696|NCT01097616|62704063|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
33327697|NCT01097616|62704056|FG000|Optional DB EXT Phase|Protocol Violation|0|||
33327698|NCT01097616|62704057|FG001|Optional DB EXT Phase|Protocol Violation|2|||
33327699|NCT01097616|62704058|FG002|Optional DB EXT Phase|Protocol Violation|3|||
33327700|NCT01097616|62704059|FG003|Optional DB EXT Phase|Protocol Violation|0|||
33327701|NCT01097616|62704060|FG004|Optional DB EXT Phase|Protocol Violation|0|||
33327702|NCT01097616|62704061|FG005|Optional DB EXT Phase|Protocol Violation|0|||
33327703|NCT01097616|62704062|FG006|Optional DB EXT Phase|Protocol Violation|0|||
33327704|NCT01097616|62704063|FG007|Optional DB EXT Phase|Protocol Violation|0|||
33327705|NCT01097616|62704056|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
33327706|NCT01097616|62704057|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
33327707|NCT01097616|62704058|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
33327708|NCT01097616|62704059|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
33649248|NCT04146363|63059186|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33649249|NCT04146363|63059187|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33327709|NCT01097616|62704060|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
33327710|NCT01097616|62704061|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
33327711|NCT01097616|62704062|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
33327712|NCT01097616|62704063|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
33327713|NCT01097616|62704056|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
33327714|NCT01097616|62704057|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
33327715|NCT01097616|62704058|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
33327716|NCT01097616|62704059|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
33327717|NCT01097616|62704060|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
33327718|NCT01097616|62704061|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
33327719|NCT01097616|62704062|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
33327720|NCT01097616|62704063|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
33327721|NCT01097616|62704056|FG000|Optional DB EXT Phase|Physician Decision|1|||
33327722|NCT01097616|62704057|FG001|Optional DB EXT Phase|Physician Decision|0|||
33327723|NCT01097616|62704058|FG002|Optional DB EXT Phase|Physician Decision|0|||
33327724|NCT01097616|62704059|FG003|Optional DB EXT Phase|Physician Decision|0|||
33327725|NCT01097616|62704060|FG004|Optional DB EXT Phase|Physician Decision|0|||
33327726|NCT01097616|62704061|FG005|Optional DB EXT Phase|Physician Decision|0|||
33327727|NCT01097616|62704062|FG006|Optional DB EXT Phase|Physician Decision|0|||
33327728|NCT01097616|62704063|FG007|Optional DB EXT Phase|Physician Decision|0|||
33327729|NCT01097616|62704056|FG000|DB RO Phase|Adverse Event|0|||
33327730|NCT01097616|62704057|FG001|DB RO Phase|Adverse Event|0|||
33327731|NCT01097616|62704058|FG002|DB RO Phase|Adverse Event|0|||
33327732|NCT01097616|62704059|FG003|DB RO Phase|Adverse Event|0|||
33327733|NCT01097616|62704060|FG004|DB RO Phase|Adverse Event|0|||
33327734|NCT01097616|62704061|FG005|DB RO Phase|Adverse Event|0|||
33327735|NCT01097616|62704062|FG006|DB RO Phase|Adverse Event|1|||
33327736|NCT01097616|62704063|FG007|DB RO Phase|Adverse Event|0|||
33327737|NCT01097616|62704056|FG000|DB RO Phase|Withdrawal by Subject|0|||
33327738|NCT01097616|62704057|FG001|DB RO Phase|Withdrawal by Subject|0|||
33327739|NCT01097616|62704058|FG002|DB RO Phase|Withdrawal by Subject|0|||
33327740|NCT01097616|62704059|FG003|DB RO Phase|Withdrawal by Subject|0|||
33327741|NCT01097616|62704060|FG004|DB RO Phase|Withdrawal by Subject|0|||
33327742|NCT01097616|62704061|FG005|DB RO Phase|Withdrawal by Subject|1|||
33327743|NCT01097616|62704062|FG006|DB RO Phase|Withdrawal by Subject|0|||
33327744|NCT01097616|62704063|FG007|DB RO Phase|Withdrawal by Subject|0|||
33327745|NCT01097616|62704056|FG000|DB RO Phase|Lost to Follow-up|0|||
33327746|NCT01097616|62704057|FG001|DB RO Phase|Lost to Follow-up|0|||
33327747|NCT01097616|62704058|FG002|DB RO Phase|Lost to Follow-up|0|||
33327748|NCT01097616|62704059|FG003|DB RO Phase|Lost to Follow-up|1|||
33327749|NCT01097616|62704060|FG004|DB RO Phase|Lost to Follow-up|1|||
33327750|NCT01097616|62704061|FG005|DB RO Phase|Lost to Follow-up|0|||
33327751|NCT01097616|62704062|FG006|DB RO Phase|Lost to Follow-up|0|||
33327752|NCT01097616|62704063|FG007|DB RO Phase|Lost to Follow-up|1|||
33327753|NCT01097616|62704056|FG000|DB RO Phase|Not Treated in RO|0|||
33327754|NCT01097616|62704057|FG001|DB RO Phase|Not Treated in RO|0|||
33327755|NCT01097616|62704058|FG002|DB RO Phase|Not Treated in RO|0|||
33327756|NCT01097616|62704059|FG003|DB RO Phase|Not Treated in RO|0|||
33327757|NCT01097616|62704060|FG004|DB RO Phase|Not Treated in RO|0|||
33327758|NCT01097616|62704061|FG005|DB RO Phase|Not Treated in RO|1|||
33327759|NCT01097616|62704062|FG006|DB RO Phase|Not Treated in RO|0|||
33327760|NCT01097616|62704063|FG007|DB RO Phase|Not Treated in RO|0|||
33327761|NCT00871429|62704089|FG000|Overall Study|Lost to Follow-up|6|||
33327762|NCT00871429|62704089|FG000|Overall Study|Withdrawal by Subject|17|||
33327763|NCT00871429|62704089|FG000|Overall Study|Questionnaire not completed|1|||
33327764|NCT01151345|62704097|FG000|First Intervention Period|Protocol Violation|0|||
33327765|NCT01151345|62704098|FG001|First Intervention Period|Protocol Violation|1|||
33327766|NCT00593827|62704106|FG000|Overall Study|On Active Treatment/Pending|0|||
33327767|NCT00593827|62704107|FG001|Overall Study|On Active Treatment/Pending|2|||
33327768|NCT01150097|62704116|FG000|Months 24 to 36 Post-transplantation|Death|2|||
33327769|NCT01150097|62704117|FG001|Months 24 to 36 Post-transplantation|Death|0|||
33327770|NCT01150097|62704118|FG002|Months 24 to 36 Post-transplantation|Death|0|||
33327771|NCT01150097|62704116|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
33327772|NCT01150097|62704117|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
33327773|NCT01150097|62704118|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
33327774|NCT01150097|62704116|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
33327775|NCT01150097|62704117|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
33327776|NCT01150097|62704118|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
33327777|NCT01150097|62704116|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
33327778|NCT01150097|62704117|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
33327779|NCT01150097|62704118|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
33327780|NCT01150097|62704116|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
33327781|NCT01150097|62704117|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
33327782|NCT01150097|62704118|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
33327783|NCT01150097|62704116|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
33327784|NCT01150097|62704117|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
33327785|NCT01150097|62704118|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
33327786|NCT01150097|62704116|FG000|Months 24 to 48 Post-transplantation|Death|2|||
33327787|NCT01150097|62704117|FG001|Months 24 to 48 Post-transplantation|Death|0|||
33327788|NCT01150097|62704118|FG002|Months 24 to 48 Post-transplantation|Death|0|||
33327789|NCT01149863|62704128|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
33327790|NCT01149473|62704134|FG000|First Intervention|Adverse Event|1|||
33327791|NCT01149473|62704135|FG001|First Intervention|Adverse Event|1|||
33327792|NCT01149473|62704134|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
33327793|NCT01149473|62704135|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
33327794|NCT00872989|62704143|FG000|Overall Study|Adverse Event|7|||
33543567|NCT02686034|62934356|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
33649250|NCT04146363|63059188|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33649251|NCT04146363|63059189|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33649252|NCT04146363|63059190|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33649253|NCT04146363|63059191|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33649254|NCT04146363|63059192|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33649255|NCT04146363|63059193|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
33649256|NCT04146363|63059194|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
33649257|NCT04146363|63059195|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33649258|NCT04146363|63059185|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
33649259|NCT04146363|63059186|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
33649260|NCT04146363|63059187|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
33649261|NCT04146363|63059188|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
33649262|NCT04146363|63059189|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
33649263|NCT04146363|63059190|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
33649264|NCT04146363|63059191|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
33649265|NCT04146363|63059192|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
33649266|NCT04146363|63059193|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
33649267|NCT04146363|63059194|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
33649268|NCT04146363|63059195|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
33649269|NCT04146363|63059185|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33649270|NCT04146363|63059186|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33649271|NCT04146363|63059187|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33649272|NCT04146363|63059188|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33649273|NCT04146363|63059189|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33649274|NCT04146363|63059190|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33649275|NCT04146363|63059191|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33649276|NCT04146363|63059192|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33649277|NCT04146363|63059193|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
33649278|NCT04146363|63059194|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
33649279|NCT04146363|63059195|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
33649280|NCT04146363|63059185|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
33649281|NCT04146363|63059186|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
33649282|NCT04146363|63059187|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
33649283|NCT04146363|63059188|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
33649284|NCT04146363|63059189|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
33649285|NCT04146363|63059190|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
33649286|NCT04146363|63059191|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
33649287|NCT04146363|63059192|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
33649288|NCT04146363|63059193|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
33649289|NCT04146363|63059194|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
33649290|NCT04146363|63059195|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
33649291|NCT04146363|63059185|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33649292|NCT04146363|63059186|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33649293|NCT04146363|63059187|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33649294|NCT04146363|63059188|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33327795|NCT00872989|62704144|FG001|Overall Study|Adverse Event|15|||
33327796|NCT00872989|62704143|FG000|Overall Study|Withdrawal by Subject|8|||
33327797|NCT00872989|62704144|FG001|Overall Study|Withdrawal by Subject|5|||
33649295|NCT04146363|63059189|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33649296|NCT04146363|63059190|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33649297|NCT04146363|63059191|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33649298|NCT04146363|63059192|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33649299|NCT04146363|63059193|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33649300|NCT04146363|63059194|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
33649301|NCT04146363|63059195|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33649302|NCT01838941|63059220|FG000|Overall Study|Adverse Event|1|||
33649303|NCT01838941|63059220|FG000|Overall Study|Withdrawal by Subject|1|||
33649304|NCT01773109|63059225|FG000|Overall Study|Symptomatic Progression|2|||
33649305|NCT01773109|63059225|FG000|Overall Study|Death|1|||
33649306|NCT01772719|63059229|FG000|Overall Study|Withdrawal by Subject|3|||
33649307|NCT01772719|63059229|FG000|Overall Study|Adverse Event|2|||
33649308|NCT01772719|63059229|FG000|Overall Study|Protocol Violation|1|||
33649309|NCT01772719|63059229|FG000|Overall Study|Lost to Follow-up|1|||
33649310|NCT01798927|63059236|FG000|Overall Study|Withdrawal by Subject|1|||
33649311|NCT01276288|63059305|FG000|Overall Study|Adverse Event|1|||
33649312|NCT01276288|63059306|FG001|Overall Study|Adverse Event|1|||
33649313|NCT01276288|63059307|FG002|Overall Study|Adverse Event|0|||
33649314|NCT01276288|63059308|FG003|Overall Study|Adverse Event|0|||
33649315|NCT01276288|63059305|FG000|Overall Study|not treated|1|||
33649316|NCT01276288|63059306|FG001|Overall Study|not treated|0|||
33649317|NCT01276288|63059307|FG002|Overall Study|not treated|0|||
33649318|NCT01276288|63059308|FG003|Overall Study|not treated|0|||
33649319|NCT02702271|63059332|FG000|Overall Study|Death|36|||
33649320|NCT02702271|63059333|FG001|Overall Study|Death|7|||
33649321|NCT02702271|63059332|FG000|Overall Study|Lost to Follow-up|12|||
33649322|NCT02702271|63059333|FG001|Overall Study|Lost to Follow-up|0|||
33649323|NCT02702271|63059332|FG000|Overall Study|Withdrawal by Subject|8|||
33649324|NCT02702271|63059333|FG001|Overall Study|Withdrawal by Subject|1|||
33649325|NCT02702271|63059332|FG000|Overall Study|Physician Decision|2|||
33649326|NCT02702271|63059333|FG001|Overall Study|Physician Decision|0|||
33649327|NCT02702271|63059332|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
33649328|NCT02702271|63059333|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
33649329|NCT01276054|63059418|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
33649330|NCT01276054|63059419|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
33649331|NCT01798849|63059428|FG000|Overall Study|Physician Decision|0|||
33649332|NCT01798849|63059429|FG001|Overall Study|Physician Decision|0|||
33649333|NCT01798849|63059430|FG002|Overall Study|Physician Decision|1|||
33649334|NCT01797835|63059510|FG000|Overall Study|Lost to Follow-up|31|||
33649335|NCT01797835|63059511|FG001|Overall Study|Lost to Follow-up|27|||
33649336|NCT01275430|63059517|FG000|Overall Study|Adverse Event|1|||
33649337|NCT01275430|63059517|FG000|Overall Study|No Contrast Injection|6|||
33649338|NCT01275430|63059517|FG000|Overall Study|Device Malfunction|1|||
33649339|NCT01275430|63059517|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
33649340|NCT01838551|63059522|FG000|Overall Study|Adverse Event|16|||
33649341|NCT01838551|63059522|FG000|Overall Study|Death|1|||
33649342|NCT01838551|63059522|FG000|Overall Study|Lack of Efficacy|10|||
33649343|NCT01838551|63059522|FG000|Overall Study|Physician Decision|4|||
33649344|NCT01838551|63059522|FG000|Overall Study|Withdrawal by Subject|10|||
33649345|NCT01838551|63059522|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
33649346|NCT01797445|63059528|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
33649347|NCT01797445|63059529|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
33649348|NCT01797445|63059528|FG000|Double-Blind Phase|Adverse Event|3|||
33327798|NCT00872989|62704143|FG000|Overall Study|Progression/relapse|47|||
33327799|NCT00872989|62704144|FG001|Overall Study|Progression/relapse|35|||
33327800|NCT00872989|62704143|FG000|Overall Study|Not protocol specified|3|||
33327801|NCT00872989|62704144|FG001|Overall Study|Not protocol specified|8|||
33327802|NCT01148771|62704158|FG000|Washout Period|Withdrawal by Subject|0|||
33327803|NCT01148771|62704159|FG001|Washout Period|Withdrawal by Subject|1|||
33327804|NCT01148693|62704171|FG000|Overall Study|Attempts for cannulation were failed|13|||
33327805|NCT01148693|62704172|FG001|Overall Study|Attempts for cannulation were failed|10|||
33327806|NCT00872599|62704178|FG000|Second Washout Period|Adverse Event|1|||
33327807|NCT00872599|62704179|FG001|Second Washout Period|Adverse Event|1|||
33327808|NCT01148537|62704188|FG000|Overall Study|Withdrawal by Subject|1|||
33327809|NCT01148537|62704189|FG001|Overall Study|Withdrawal by Subject|0|||
33327810|NCT01148537|62704190|FG002|Overall Study|Withdrawal by Subject|2|||
33327811|NCT01148537|62704188|FG000|Overall Study|Adverse Event|2|||
33327812|NCT01148537|62704189|FG001|Overall Study|Adverse Event|0|||
33649349|NCT01797445|63059529|FG001|Double-Blind Phase|Adverse Event|0|||
33649350|NCT01797445|63059528|FG000|Double-Blind Phase|Death|5|||
33327813|NCT01148537|62704190|FG002|Overall Study|Adverse Event|1|||
33649351|NCT01797445|63059529|FG001|Double-Blind Phase|Death|4|||
33649352|NCT01797445|63059528|FG000|Double-Blind Phase|Pregnancy|0|||
33649353|NCT01797445|63059529|FG001|Double-Blind Phase|Pregnancy|1|||
33649354|NCT01797445|63059528|FG000|Double-Blind Phase|Lack of Efficacy|1|||
33327814|NCT01148459|62704201|FG000|Overall Study|Serious Adverse Event|5|||
33327815|NCT01148459|62704202|FG001|Overall Study|Serious Adverse Event|4|||
33327816|NCT01148459|62704201|FG000|Overall Study|Withdrawal by Subject|1|||
33327817|NCT01148459|62704202|FG001|Overall Study|Withdrawal by Subject|0|||
33327818|NCT01148459|62704201|FG000|Overall Study|Migrated/moved from study area|3|||
33327819|NCT01148459|62704202|FG001|Overall Study|Migrated/moved from study area|6|||
33327820|NCT01148459|62704201|FG000|Overall Study|Lost to Follow-up|2|||
33327821|NCT01148459|62704202|FG001|Overall Study|Lost to Follow-up|0|||
33327822|NCT01148459|62704201|FG000|Overall Study|Refusal|1|||
33327823|NCT01148459|62704202|FG001|Overall Study|Refusal|0|||
33327824|NCT01148459|62704201|FG000|Overall Study|Failure to comply with study procedures|0|||
33327825|NCT01148459|62704202|FG001|Overall Study|Failure to comply with study procedures|1|||
33327826|NCT00872521|62704211|FG000|Completed PAD Induction|Patient choice|0|||
33327827|NCT00872521|62704212|FG001|Completed PAD Induction|Patient choice|1|||
33327828|NCT00872521|62704213|FG002|Completed PAD Induction|Patient choice|0|||
33327829|NCT00872521|62704211|FG000|Completed PAD Induction|Disease progression|0|||
33327830|NCT00872521|62704212|FG001|Completed PAD Induction|Disease progression|2|||
33327831|NCT00872521|62704213|FG002|Completed PAD Induction|Disease progression|0|||
33327832|NCT00872521|62704211|FG000|Completed PAD Induction|Adverse Event|4|||
33327833|NCT00872521|62704212|FG001|Completed PAD Induction|Adverse Event|0|||
33327834|NCT00872521|62704213|FG002|Completed PAD Induction|Adverse Event|0|||
33327835|NCT00872521|62704211|FG000|Completed PAD Induction|Death|1|||
33327836|NCT00872521|62704212|FG001|Completed PAD Induction|Death|1|||
33327837|NCT00872521|62704213|FG002|Completed PAD Induction|Death|0|||
33327838|NCT00872521|62704211|FG000|Primary Endpoint Analysis|Other|1|||
33327839|NCT00872521|62704212|FG001|Primary Endpoint Analysis|Other|2|||
33327840|NCT00872521|62704213|FG002|Primary Endpoint Analysis|Other|0|||
33327841|NCT00872521|62704211|FG000|Primary Endpoint Analysis|Patient choice|0|||
33327842|NCT00872521|62704212|FG001|Primary Endpoint Analysis|Patient choice|1|||
33327843|NCT00872521|62704213|FG002|Primary Endpoint Analysis|Patient choice|0|||
33327844|NCT00872521|62704211|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
33327845|NCT00872521|62704212|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
33327846|NCT00872521|62704213|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
33327847|NCT00872521|62704211|FG000|Primary Endpoint Analysis|Patient response missing|0|||
33327848|NCT00872521|62704212|FG001|Primary Endpoint Analysis|Patient response missing|0|||
33327849|NCT00872521|62704213|FG002|Primary Endpoint Analysis|Patient response missing|1|||
33327850|NCT00872521|62704211|FG000|Completed 3-month Follow up|Other|0|||
33649355|NCT01797445|63059529|FG001|Double-Blind Phase|Lack of Efficacy|2|||
33649356|NCT01797445|63059528|FG000|Double-Blind Phase|Investigator's Discretion|15|||
33649357|NCT01797445|63059529|FG001|Double-Blind Phase|Investigator's Discretion|17|||
33649358|NCT01797445|63059528|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
33649359|NCT01797445|63059529|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
33649360|NCT01797445|63059528|FG000|Double-Blind Phase|Protocol Violation|0|||
33327851|NCT00872521|62704212|FG001|Completed 3-month Follow up|Other|2|||
33327852|NCT00872521|62704213|FG002|Completed 3-month Follow up|Other|0|||
33327853|NCT00872521|62704211|FG000|Completed 3-month Follow up|Physician Decision|0|||
33327854|NCT00872521|62704212|FG001|Completed 3-month Follow up|Physician Decision|1|||
33327855|NCT00872521|62704213|FG002|Completed 3-month Follow up|Physician Decision|0|||
33327856|NCT00872521|62704211|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
33327857|NCT00872521|62704212|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
33327858|NCT00872521|62704213|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
33327859|NCT01148225|62704232|FG000|Overall Study|Other|185|||
33327860|NCT01190891|62704241|FG000|Overall Study|Protocol Violation|1|||
33327861|NCT01190891|62704242|FG001|Overall Study|Protocol Violation|0|||
33327862|NCT01190891|62704241|FG000|Overall Study|Withdrawal by Subject|5|||
33327863|NCT01190891|62704242|FG001|Overall Study|Withdrawal by Subject|0|||
33327864|NCT00871975|62704248|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
33327865|NCT00871975|62704248|FG000|Overall Study|Catheters could not be inserted|1|||
33327866|NCT00871975|62704248|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
33327867|NCT00871975|62704248|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
33327868|NCT01190813|62704254|FG000|Overall Study|Lost to Follow-up|1|||
33327869|NCT01190813|62704255|FG001|Overall Study|Lost to Follow-up|2|||
33327870|NCT01190813|62704254|FG000|Overall Study|Withdrawal by Subject|2|||
33327871|NCT01190813|62704255|FG001|Overall Study|Withdrawal by Subject|1|||
33327872|NCT01190813|62704254|FG000|Overall Study|Refused study treatment after randomized|1|||
33327873|NCT01190813|62704255|FG001|Overall Study|Refused study treatment after randomized|0|||
33327874|NCT01190813|62704254|FG000|Overall Study|Adverse Event|0|||
33327875|NCT01190813|62704255|FG001|Overall Study|Adverse Event|1|||
33327876|NCT00870727|62704277|FG000|Overall Study|Lost to Follow-up|0|||
33327877|NCT00870727|62704278|FG001|Overall Study|Lost to Follow-up|1|||
33327878|NCT00870727|62704277|FG000|Overall Study|Lack of Efficacy|1|||
33327879|NCT00870727|62704278|FG001|Overall Study|Lack of Efficacy|3|||
33327880|NCT00870727|62704277|FG000|Overall Study|Adverse Event|0|||
33327881|NCT00870727|62704278|FG001|Overall Study|Adverse Event|1|||
33327882|NCT01147055|62704284|FG000|First Intervention Period|Lost to Follow-up|1|||
33327883|NCT01147055|62704285|FG001|First Intervention Period|Lost to Follow-up|0|||
33327884|NCT01146665|62704293|FG000|Overall Study|Withdrawal by Subject|10|||
33327885|NCT01146665|62704294|FG001|Overall Study|Withdrawal by Subject|16|||
33327886|NCT01145885|62704309|FG000|Overall Study|Progressive Disease|7|||
33327887|NCT01190267|62704321|FG000|Overall Study|Adverse Event|10|||
33327888|NCT01190267|62704322|FG001|Overall Study|Adverse Event|0|||
33327889|NCT01190267|62704321|FG000|Overall Study|Treatment Failure|8|||
33327890|NCT01190267|62704322|FG001|Overall Study|Treatment Failure|2|||
33327891|NCT01190267|62704321|FG000|Overall Study|Lost to Follow-up|2|||
33327892|NCT01190267|62704322|FG001|Overall Study|Lost to Follow-up|0|||
33327893|NCT01190267|62704321|FG000|Overall Study|Withdrawal by Subject|13|||
33327894|NCT01190267|62704322|FG001|Overall Study|Withdrawal by Subject|1|||
33327895|NCT01190267|62704321|FG000|Overall Study|Protocol Violation|8|||
33327896|NCT01190267|62704322|FG001|Overall Study|Protocol Violation|1|||
33327897|NCT00869089|62704328|FG000|Overall Study|Lost to Follow-up|1|||
33327898|NCT00869089|62704328|FG000|Overall Study|Withdrawal by Subject|1|||
33327899|NCT00869089|62704328|FG000|Overall Study|Screen Fail|1|||
33327900|NCT01190189|62704332|FG000|Overall Study|Lost to Follow-up|4|||
33327901|NCT01190189|62704332|FG000|Overall Study|Withdrawal by Subject|1|||
33327902|NCT01190189|62704332|FG000|Overall Study|Migrated/moved from study area|1|||
33327903|NCT00871117|62704338|FG000|Overall Study|Lost to Follow-up|5|||
33649361|NCT01797445|63059529|FG001|Double-Blind Phase|Protocol Violation|1|||
33649362|NCT01797445|63059528|FG000|Double-Blind Phase|Withdrew Consent|20|||
33327904|NCT00871117|62704339|FG001|Overall Study|Lost to Follow-up|6|||
33327905|NCT00871117|62704338|FG000|Overall Study|Other|0|||
33327906|NCT00871117|62704339|FG001|Overall Study|Other|4|||
33327907|NCT00870103|62704346|FG000|Overall Study|Physician Decision|2|||
33327908|NCT00870103|62704346|FG000|Overall Study|Lost to Follow-up|2|||
33327909|NCT01145417|62704365|FG000|Overall Study|Death|1|||
33327910|NCT01145417|62704366|FG001|Overall Study|Death|0|||
33327911|NCT01145417|62704365|FG000|Overall Study|Lost to Follow-up|2|||
33327912|NCT01145417|62704366|FG001|Overall Study|Lost to Follow-up|1|||
33327913|NCT01145417|62704365|FG000|Overall Study|Withdrawal by Subject|1|||
33649363|NCT01797445|63059529|FG001|Double-Blind Phase|Withdrew Consent|35|||
33649364|NCT01797445|63059528|FG000|Double-Blind Phase|Lost to Follow-up|34|||
33649365|NCT01797445|63059529|FG001|Double-Blind Phase|Lost to Follow-up|26|||
33649366|NCT01797445|63059528|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
33649367|NCT01797445|63059529|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
33649368|NCT01611259|63059537|FG000|Overall Study|Physician Decision|1|||
33327914|NCT01145417|62704366|FG001|Overall Study|Withdrawal by Subject|2|||
33327915|NCT01145417|62704365|FG000|Overall Study|Pregnancy|1|||
33327916|NCT01145417|62704366|FG001|Overall Study|Pregnancy|0|||
33327917|NCT01145417|62704365|FG000|Overall Study|Adverse Event|0|||
33649369|NCT01611259|63059537|FG000|Overall Study|Lack of Efficacy|2|||
33649370|NCT01611259|63059537|FG000|Overall Study|Adverse Event|4|||
33649371|NCT01611259|63059537|FG000|Overall Study|Withdrawal by Subject|7|||
33649372|NCT01795495|63059544|FG000|Overall Study|Protocol Violation|1|||
33649373|NCT01795495|63059545|FG001|Overall Study|Protocol Violation|0|||
33649374|NCT01795495|63059546|FG002|Overall Study|Protocol Violation|1|||
33649375|NCT01795495|63059544|FG000|Overall Study|Physician Decision|0|||
33649376|NCT01795495|63059545|FG001|Overall Study|Physician Decision|0|||
33649377|NCT01795495|63059546|FG002|Overall Study|Physician Decision|1|||
33327918|NCT01145417|62704366|FG001|Overall Study|Adverse Event|1|||
33327919|NCT01145417|62704365|FG000|Overall Study|Study terminated by sponsor|35|||
33327920|NCT01145417|62704366|FG001|Overall Study|Study terminated by sponsor|43|||
33543568|NCT02686034|62934355|FG000|Open Label Period 3|Lost to Follow-up|0|||
33543569|NCT02686034|62934356|FG001|Open Label Period 3|Lost to Follow-up|1|||
33543570|NCT02685488|62934364|FG000|Overall Study|Withdrawal by Subject|0|||
33327921|NCT01145417|62704365|FG000|Overall Study|Other|1|||
33327922|NCT01145417|62704366|FG001|Overall Study|Other|0|||
33327923|NCT01144715|62704374|FG000|Overall Study|Lost to Follow-up|2|||
33327924|NCT01144715|62704375|FG001|Overall Study|Lost to Follow-up|1|||
33327925|NCT01144715|62704374|FG000|Overall Study|Withdrawal by Subject|2|||
33327926|NCT01144715|62704375|FG001|Overall Study|Withdrawal by Subject|1|||
33327927|NCT01144715|62704374|FG000|Overall Study|Adverse Event|0|||
33327928|NCT01144715|62704375|FG001|Overall Study|Adverse Event|1|||
33327929|NCT01189487|62704381|FG000|Overall Study|Lack of Efficacy|2|||
33649378|NCT01794949|63059556|FG000|Overall Study|Lost to Follow-up|1|||
33649379|NCT01794949|63059557|FG001|Overall Study|Lost to Follow-up|0|||
33649380|NCT01770379|63059566|FG000|Overall Study|Technical issues|1|||
33649381|NCT01770379|63059567|FG001|Overall Study|Technical issues|0|||
33649382|NCT01770379|63059568|FG002|Overall Study|Technical issues|0|||
33327930|NCT01189487|62704381|FG000|Overall Study|Adverse Event|1|||
33327931|NCT01106352|62704390|FG000|Overall Study|Subjects untreated|0|||
33327932|NCT01106352|62704391|FG001|Overall Study|Subjects untreated|0|||
33327933|NCT01106352|62704392|FG002|Overall Study|Subjects untreated|0|||
33327934|NCT01106352|62704393|FG003|Overall Study|Subjects untreated|3|||
33327935|NCT01106352|62704394|FG004|Overall Study|Subjects untreated|4|||
33327936|NCT01106352|62704390|FG000|Overall Study|Sponsor Decision|1|||
33327937|NCT01106352|62704391|FG001|Overall Study|Sponsor Decision|0|||
33327938|NCT01106352|62704392|FG002|Overall Study|Sponsor Decision|0|||
33327939|NCT01106352|62704393|FG003|Overall Study|Sponsor Decision|0|||
33327940|NCT01106352|62704394|FG004|Overall Study|Sponsor Decision|0|||
33327941|NCT01106352|62704390|FG000|Overall Study|Too ill to come in for the visit|0|||
33327942|NCT01106352|62704391|FG001|Overall Study|Too ill to come in for the visit|0|||
33327943|NCT01106352|62704392|FG002|Overall Study|Too ill to come in for the visit|1|||
33327944|NCT01106352|62704393|FG003|Overall Study|Too ill to come in for the visit|0|||
33327945|NCT01106352|62704394|FG004|Overall Study|Too ill to come in for the visit|0|||
33327946|NCT01106352|62704390|FG000|Overall Study|Lost to Follow-up|0|||
33327947|NCT01106352|62704391|FG001|Overall Study|Lost to Follow-up|0|||
33327948|NCT01106352|62704392|FG002|Overall Study|Lost to Follow-up|0|||
33327949|NCT01106352|62704393|FG003|Overall Study|Lost to Follow-up|0|||
33327950|NCT01106352|62704394|FG004|Overall Study|Lost to Follow-up|1|||
33327951|NCT01106352|62704390|FG000|Overall Study|Death|0|||
33327952|NCT01106352|62704391|FG001|Overall Study|Death|0|||
33327953|NCT01106352|62704392|FG002|Overall Study|Death|1|||
33327954|NCT01106352|62704393|FG003|Overall Study|Death|3|||
33327955|NCT01106352|62704394|FG004|Overall Study|Death|1|||
33327956|NCT01106352|62704390|FG000|Overall Study|Disease progression|0|||
33327957|NCT01106352|62704391|FG001|Overall Study|Disease progression|0|||
33327958|NCT01106352|62704392|FG002|Overall Study|Disease progression|0|||
33327959|NCT01106352|62704393|FG003|Overall Study|Disease progression|1|||
33327960|NCT01106352|62704394|FG004|Overall Study|Disease progression|0|||
33327961|NCT01106352|62704390|FG000|Overall Study|Withdrawal by Subject|0|||
33327962|NCT01106352|62704391|FG001|Overall Study|Withdrawal by Subject|0|||
33327963|NCT01106352|62704392|FG002|Overall Study|Withdrawal by Subject|0|||
33327964|NCT01106352|62704393|FG003|Overall Study|Withdrawal by Subject|3|||
33327965|NCT01106352|62704394|FG004|Overall Study|Withdrawal by Subject|2|||
33327966|NCT01106352|62704390|FG000|Overall Study|Went on hospice|0|||
33327967|NCT01106352|62704391|FG001|Overall Study|Went on hospice|0|||
33327968|NCT01106352|62704392|FG002|Overall Study|Went on hospice|0|||
33327969|NCT01106352|62704393|FG003|Overall Study|Went on hospice|1|||
33327970|NCT01106352|62704394|FG004|Overall Study|Went on hospice|0|||
33327971|NCT01106352|62704390|FG000|Overall Study|Subject entered hospice|0|||
33327972|NCT01106352|62704391|FG001|Overall Study|Subject entered hospice|0|||
33327973|NCT01106352|62704392|FG002|Overall Study|Subject entered hospice|0|||
33327974|NCT01106352|62704393|FG003|Overall Study|Subject entered hospice|1|||
33327975|NCT01106352|62704394|FG004|Overall Study|Subject entered hospice|0|||
33327976|NCT01106352|62704390|FG000|Overall Study|Home hospice since July 2013|0|||
33327977|NCT01106352|62704391|FG001|Overall Study|Home hospice since July 2013|0|||
33327978|NCT01106352|62704392|FG002|Overall Study|Home hospice since July 2013|0|||
33327979|NCT01106352|62704393|FG003|Overall Study|Home hospice since July 2013|1|||
33327980|NCT01106352|62704394|FG004|Overall Study|Home hospice since July 2013|0|||
33327981|NCT01144403|62704410|FG000|Overall Study|Lost to Follow-up|3|||
33327982|NCT01144403|62704410|FG000|Overall Study|Death|1|||
33327983|NCT01144403|62704410|FG000|Overall Study|Adverse Event|1|||
33327984|NCT01143389|62704417|FG000|Overall Study|Lost to Follow-up|26|||
33327985|NCT01143389|62704418|FG001|Overall Study|Lost to Follow-up|25|||
33327986|NCT00868231|62704424|FG000|Treatment Period 1|Adverse Event|0|||
33327987|NCT00868231|62704425|FG001|Treatment Period 1|Adverse Event|0|||
33327988|NCT00868231|62704426|FG002|Treatment Period 1|Adverse Event|0|||
33327989|NCT00868231|62704427|FG003|Treatment Period 1|Adverse Event|0|||
33327990|NCT00868231|62704428|FG004|Treatment Period 1|Adverse Event|1|||
33327991|NCT00868231|62704429|FG005|Treatment Period 1|Adverse Event|0|||
33327992|NCT00868231|62704424|FG000|Treatment Period 2|Adverse Event|1|||
33327993|NCT00868231|62704425|FG001|Treatment Period 2|Adverse Event|0|||
33327994|NCT00868231|62704426|FG002|Treatment Period 2|Adverse Event|0|||
33327995|NCT00868231|62704427|FG003|Treatment Period 2|Adverse Event|0|||
33327996|NCT00868231|62704428|FG004|Treatment Period 2|Adverse Event|0|||
33327997|NCT00868231|62704429|FG005|Treatment Period 2|Adverse Event|0|||
33327998|NCT00868231|62704424|FG000|Treatment Period 3|Adverse Event|0|||
33543571|NCT02685488|62934365|FG001|Overall Study|Withdrawal by Subject|1|||
33327999|NCT00868231|62704425|FG001|Treatment Period 3|Adverse Event|0|||
33328000|NCT00868231|62704426|FG002|Treatment Period 3|Adverse Event|1|||
33328001|NCT00868231|62704427|FG003|Treatment Period 3|Adverse Event|0|||
33328002|NCT00868231|62704428|FG004|Treatment Period 3|Adverse Event|0|||
33328003|NCT00868231|62704429|FG005|Treatment Period 3|Adverse Event|0|||
33543572|NCT02533570|62934374|FG000|Overall Study|Adverse Event|0|||
33328004|NCT01143077|62704440|FG000|Overall Study|Lack of Efficacy|0|||
33328005|NCT01143077|62704441|FG001|Overall Study|Lack of Efficacy|2|||
33328006|NCT01143077|62704442|FG002|Overall Study|Lack of Efficacy|1|||
33328007|NCT01143077|62704440|FG000|Overall Study|Adverse Event|5|||
33328008|NCT01143077|62704441|FG001|Overall Study|Adverse Event|6|||
33328009|NCT01143077|62704442|FG002|Overall Study|Adverse Event|5|||
33328010|NCT01143077|62704440|FG000|Overall Study|Lost to Follow-up|2|||
33328011|NCT01143077|62704441|FG001|Overall Study|Lost to Follow-up|3|||
33328012|NCT01143077|62704442|FG002|Overall Study|Lost to Follow-up|4|||
33328013|NCT01143077|62704440|FG000|Overall Study|Protocol Violation|2|||
33328014|NCT01143077|62704441|FG001|Overall Study|Protocol Violation|0|||
33328015|NCT01143077|62704442|FG002|Overall Study|Protocol Violation|0|||
33328016|NCT01143077|62704440|FG000|Overall Study|Withdrawal by Subject|4|||
33328017|NCT01143077|62704441|FG001|Overall Study|Withdrawal by Subject|3|||
33328018|NCT01143077|62704442|FG002|Overall Study|Withdrawal by Subject|3|||
33328019|NCT01143077|62704440|FG000|Overall Study|Non-compliance with study drug|0|||
33328020|NCT01143077|62704441|FG001|Overall Study|Non-compliance with study drug|1|||
33328021|NCT01143077|62704442|FG002|Overall Study|Non-compliance with study drug|1|||
33328022|NCT01143077|62704440|FG000|Overall Study|Administrative|1|||
33328023|NCT01143077|62704441|FG001|Overall Study|Administrative|0|||
33328024|NCT01143077|62704442|FG002|Overall Study|Administrative|0|||
33328025|NCT01143077|62704440|FG000|Overall Study|Principal Investigator Decision|2|||
33328026|NCT01143077|62704441|FG001|Overall Study|Principal Investigator Decision|0|||
33328027|NCT01143077|62704442|FG002|Overall Study|Principal Investigator Decision|1|||
33328028|NCT01096446|62704452|FG000|Overall Study|Death|1|||
33328029|NCT01096446|62704453|FG001|Overall Study|Death|0|||
33328030|NCT01096446|62704452|FG000|Overall Study|Protocol Violation|2|||
33328031|NCT01096446|62704453|FG001|Overall Study|Protocol Violation|0|||
33328032|NCT00864721|62704458|FG000|Overall Study|Patient request|11|||
33328033|NCT00864721|62704458|FG000|Overall Study|Hospitalized|1|||
33328034|NCT00864721|62704458|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
33328035|NCT00864721|62704458|FG000|Overall Study|Adverse Event|21|||
33328036|NCT01095666|62704465|FG000|Overall Study|Lack of Efficacy|0|||
33328037|NCT01095666|62704466|FG001|Overall Study|Lack of Efficacy|0|||
33328038|NCT01095666|62704467|FG002|Overall Study|Lack of Efficacy|1|||
33543573|NCT02533570|62934375|FG001|Overall Study|Adverse Event|1|||
33543574|NCT02533570|62934376|FG002|Overall Study|Adverse Event|1|||
33649383|NCT01770379|63059566|FG000|Overall Study|Withdrawal by Subject|7|||
33649384|NCT01770379|63059567|FG001|Overall Study|Withdrawal by Subject|10|||
33649385|NCT01770379|63059568|FG002|Overall Study|Withdrawal by Subject|7|||
33649386|NCT01770379|63059566|FG000|Overall Study|study terminated by sponsor|22|||
33649387|NCT01770379|63059567|FG001|Overall Study|study terminated by sponsor|23|||
33649388|NCT01770379|63059568|FG002|Overall Study|study terminated by sponsor|22|||
33649389|NCT01770379|63059566|FG000|Overall Study|Protocol Violation|0|||
33649390|NCT01770379|63059567|FG001|Overall Study|Protocol Violation|1|||
33649391|NCT01770379|63059568|FG002|Overall Study|Protocol Violation|1|||
33649392|NCT01770379|63059566|FG000|Overall Study|Physician Decision|0|||
33649393|NCT01770379|63059567|FG001|Overall Study|Physician Decision|1|||
33649394|NCT01770379|63059568|FG002|Overall Study|Physician Decision|2|||
33649395|NCT01770379|63059566|FG000|Overall Study|Lost to Follow-up|0|||
33649396|NCT01770379|63059567|FG001|Overall Study|Lost to Follow-up|0|||
33649397|NCT01770379|63059568|FG002|Overall Study|Lost to Follow-up|2|||
33649398|NCT01770379|63059566|FG000|Overall Study|Lack of Efficacy|8|||
33649399|NCT01770379|63059567|FG001|Overall Study|Lack of Efficacy|6|||
33649400|NCT01770379|63059568|FG002|Overall Study|Lack of Efficacy|6|||
33649401|NCT01770379|63059566|FG000|Overall Study|Adverse Event|1|||
33649402|NCT01770379|63059567|FG001|Overall Study|Adverse Event|3|||
33649403|NCT01770379|63059568|FG002|Overall Study|Adverse Event|2|||
33649404|NCT01986881|63059581|FG000|Overall Study|Death|228|||
33649405|NCT01986881|63059582|FG001|Overall Study|Death|233|||
33649406|NCT01986881|63059583|FG002|Overall Study|Death|247|||
33328039|NCT01095666|62704465|FG000|Overall Study|Adverse Event|2|||
33328040|NCT01095666|62704466|FG001|Overall Study|Adverse Event|1|||
33328041|NCT01095666|62704467|FG002|Overall Study|Adverse Event|3|||
33328042|NCT01095666|62704465|FG000|Overall Study|Lost to Follow-up|2|||
33328043|NCT01095666|62704466|FG001|Overall Study|Lost to Follow-up|2|||
33543575|NCT03036839|62934387|FG000|Overall Study|Adverse Event|0|||
33649407|NCT01986881|63059581|FG000|Overall Study|Lost to Follow-up|51|||
33649408|NCT01986881|63059582|FG001|Overall Study|Lost to Follow-up|44|||
33649409|NCT01986881|63059583|FG002|Overall Study|Lost to Follow-up|55|||
33649410|NCT01986881|63059581|FG000|Overall Study|Physician Decision|7|||
33649411|NCT01986881|63059582|FG001|Overall Study|Physician Decision|4|||
33649412|NCT01986881|63059583|FG002|Overall Study|Physician Decision|6|||
33649413|NCT01986881|63059581|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
33649414|NCT01986881|63059582|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
33649415|NCT01986881|63059583|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
33649416|NCT01986881|63059581|FG000|Overall Study|Withdrawal by Subject|41|||
33649417|NCT01986881|63059582|FG001|Overall Study|Withdrawal by Subject|60|||
33649418|NCT01986881|63059583|FG002|Overall Study|Withdrawal by Subject|45|||
33649419|NCT01986881|63059581|FG000|Overall Study|Subject Moved|0|||
33649420|NCT01986881|63059582|FG001|Overall Study|Subject Moved|1|||
33649421|NCT01986881|63059583|FG002|Overall Study|Subject Moved|0|||
33649422|NCT01986881|63059581|FG000|Overall Study|Other|1|||
33649423|NCT01986881|63059582|FG001|Overall Study|Other|2|||
33649424|NCT01986881|63059583|FG002|Overall Study|Other|2|||
33649425|NCT01609543|63059614|FG000|Overall Study|Disease Progression|28|||
33649426|NCT01609543|63059614|FG000|Overall Study|Adverse Event|5|||
33649427|NCT01609543|63059614|FG000|Overall Study|Withdrawal by Subject|1|||
33649428|NCT01609543|63059614|FG000|Overall Study|Protocol Violation|1|||
33649429|NCT01609543|63059614|FG000|Overall Study|Death|7|||
33649430|NCT02003183|63059621|FG000|Overall Study|Lost to Follow-up|0|||
33649431|NCT02003183|63059622|FG001|Overall Study|Lost to Follow-up|2|||
33649432|NCT01986647|63059632|FG000|Overall Study|Lost to Follow-up|4|||
33649433|NCT01986647|63059633|FG001|Overall Study|Lost to Follow-up|1|||
33649434|NCT01986647|63059634|FG002|Overall Study|Lost to Follow-up|4|||
33649435|NCT01986647|63059635|FG003|Overall Study|Lost to Follow-up|4|||
33649436|NCT01986647|63059632|FG000|Overall Study|Withdrawal by Subject|1|||
33649437|NCT01986647|63059633|FG001|Overall Study|Withdrawal by Subject|3|||
33649438|NCT01986647|63059634|FG002|Overall Study|Withdrawal by Subject|2|||
33649439|NCT01986647|63059635|FG003|Overall Study|Withdrawal by Subject|3|||
33649440|NCT01986647|63059632|FG000|Overall Study|Health|5|||
33649441|NCT01986647|63059633|FG001|Overall Study|Health|3|||
33649442|NCT01986647|63059634|FG002|Overall Study|Health|6|||
33649443|NCT01986647|63059635|FG003|Overall Study|Health|4|||
33649444|NCT02002091|63059651|FG000|Screening|Lost to Follow-up|10|||
33649445|NCT02002091|63059652|FG001|Screening|Lost to Follow-up|12|||
33649446|NCT02002091|63059651|FG000|Screening|Death|3|||
33649447|NCT02002091|63059652|FG001|Screening|Death|2|||
33649448|NCT01985321|63059689|FG000|Overall Study|Protocol Violation|4|||
33649449|NCT01985321|63059690|FG001|Overall Study|Protocol Violation|3|||
33649450|NCT01985321|63059689|FG000|Overall Study|Withdrawal by Subject|1|||
33649451|NCT01985321|63059690|FG001|Overall Study|Withdrawal by Subject|0|||
33649452|NCT01985321|63059689|FG000|Overall Study|Lost to Follow-up|5|||
33649453|NCT01985321|63059690|FG001|Overall Study|Lost to Follow-up|2|||
33649454|NCT01985321|63059689|FG000|Overall Study|Subject treated wrong type of sore|1|||
33649455|NCT01985321|63059690|FG001|Overall Study|Subject treated wrong type of sore|0|||
33649456|NCT02000921|63059699|FG000|Overall Study|Withdrawal by Subject|3|||
33649457|NCT02000921|63059700|FG001|Overall Study|Withdrawal by Subject|10|||
33649458|NCT02000921|63059701|FG002|Overall Study|Withdrawal by Subject|5|||
33649459|NCT02000921|63059699|FG000|Overall Study|Lost to Follow-up|2|||
33649460|NCT02000921|63059700|FG001|Overall Study|Lost to Follow-up|4|||
33649461|NCT02000921|63059701|FG002|Overall Study|Lost to Follow-up|5|||
33649462|NCT02000921|63059699|FG000|Overall Study|Physician Decision|0|||
33649463|NCT02000921|63059700|FG001|Overall Study|Physician Decision|2|||
33649464|NCT02000921|63059701|FG002|Overall Study|Physician Decision|0|||
33649465|NCT01836523|63059747|FG000|Overall Study|Adverse Event|15|||
33649466|NCT01836523|63059748|FG001|Overall Study|Adverse Event|41|||
33649467|NCT01836523|63059749|FG002|Overall Study|Adverse Event|49|||
33649468|NCT01836523|63059750|FG003|Overall Study|Adverse Event|14|||
33649469|NCT01836523|63059747|FG000|Overall Study|Protocol Violation|6|||
33649470|NCT01836523|63059748|FG001|Overall Study|Protocol Violation|3|||
33649471|NCT01836523|63059749|FG002|Overall Study|Protocol Violation|2|||
33649472|NCT01836523|63059750|FG003|Overall Study|Protocol Violation|4|||
33649473|NCT01836523|63059747|FG000|Overall Study|Met Withdrawal Criteria|13|||
33649474|NCT01836523|63059748|FG001|Overall Study|Met Withdrawal Criteria|13|||
33649475|NCT01836523|63059749|FG002|Overall Study|Met Withdrawal Criteria|21|||
33649476|NCT01836523|63059750|FG003|Overall Study|Met Withdrawal Criteria|27|||
33649477|NCT01836523|63059747|FG000|Overall Study|Unclassified|17|||
33543576|NCT03036839|62934388|FG001|Overall Study|Adverse Event|0|||
33649478|NCT01836523|63059748|FG001|Overall Study|Unclassified|28|||
33649479|NCT01836523|63059749|FG002|Overall Study|Unclassified|19|||
33649480|NCT01836523|63059750|FG003|Overall Study|Unclassified|29|||
33649481|NCT01275196|63059762|FG000|Overall Study|Adverse Event|3|||
33649482|NCT01275196|63059763|FG001|Overall Study|Adverse Event|5|||
33649483|NCT01275196|63059762|FG000|Overall Study|Withdrawal by Subject|4|||
33649484|NCT01275196|63059763|FG001|Overall Study|Withdrawal by Subject|5|||
33649485|NCT01275196|63059762|FG000|Overall Study|Lost to Follow-up|1|||
33649486|NCT01275196|63059763|FG001|Overall Study|Lost to Follow-up|0|||
33649487|NCT01275196|63059762|FG000|Overall Study|Disease Progression|6|||
33649488|NCT01275196|63059763|FG001|Overall Study|Disease Progression|5|||
33649489|NCT01275196|63059762|FG000|Overall Study|Protocol Violation|1|||
33649490|NCT01275196|63059763|FG001|Overall Study|Protocol Violation|0|||
33649491|NCT01275196|63059762|FG000|Overall Study|Suboptimal response/treatment failure|5|||
33649492|NCT01275196|63059763|FG001|Overall Study|Suboptimal response/treatment failure|6|||
33649493|NCT01984697|63059776|FG000|Overall Study|Adverse Event|0|||
33649494|NCT01984697|63059777|FG001|Overall Study|Adverse Event|0|||
33649495|NCT01984697|63059778|FG002|Overall Study|Adverse Event|2|||
33649496|NCT01984697|63059779|FG003|Overall Study|Adverse Event|0|||
33649497|NCT01984697|63059780|FG004|Overall Study|Adverse Event|0|||
33649498|NCT01984697|63059776|FG000|Overall Study|Lost to Follow-up|14|||
33649499|NCT01984697|63059777|FG001|Overall Study|Lost to Follow-up|5|||
33649500|NCT01984697|63059778|FG002|Overall Study|Lost to Follow-up|10|||
33649501|NCT01984697|63059779|FG003|Overall Study|Lost to Follow-up|6|||
33649502|NCT01984697|63059780|FG004|Overall Study|Lost to Follow-up|21|||
33649503|NCT01984697|63059776|FG000|Overall Study|Physician Decision|3|||
33649504|NCT01984697|63059777|FG001|Overall Study|Physician Decision|0|||
33649505|NCT01984697|63059778|FG002|Overall Study|Physician Decision|0|||
33649506|NCT01984697|63059779|FG003|Overall Study|Physician Decision|1|||
33649507|NCT01984697|63059780|FG004|Overall Study|Physician Decision|0|||
33649508|NCT01984697|63059776|FG000|Overall Study|Protocol Violation|8|||
33649509|NCT01984697|63059777|FG001|Overall Study|Protocol Violation|5|||
33649510|NCT01984697|63059778|FG002|Overall Study|Protocol Violation|3|||
33649511|NCT01984697|63059779|FG003|Overall Study|Protocol Violation|2|||
33649512|NCT01984697|63059780|FG004|Overall Study|Protocol Violation|0|||
33649513|NCT01984697|63059776|FG000|Overall Study|Withdrawal by Subject|15|||
33649514|NCT01984697|63059777|FG001|Overall Study|Withdrawal by Subject|21|||
33649515|NCT01984697|63059778|FG002|Overall Study|Withdrawal by Subject|13|||
33649516|NCT01984697|63059779|FG003|Overall Study|Withdrawal by Subject|11|||
33649517|NCT01984697|63059780|FG004|Overall Study|Withdrawal by Subject|13|||
33649518|NCT01984697|63059776|FG000|Overall Study|Missed last follow-up visit|1|||
33649519|NCT01984697|63059777|FG001|Overall Study|Missed last follow-up visit|0|||
33649520|NCT01984697|63059778|FG002|Overall Study|Missed last follow-up visit|0|||
33649521|NCT01984697|63059779|FG003|Overall Study|Missed last follow-up visit|0|||
33649522|NCT01984697|63059780|FG004|Overall Study|Missed last follow-up visit|0|||
33649523|NCT01984697|63059776|FG000|Overall Study|Death|0|||
33649524|NCT01984697|63059777|FG001|Overall Study|Death|0|||
33649525|NCT01984697|63059778|FG002|Overall Study|Death|0|||
33649526|NCT01984697|63059779|FG003|Overall Study|Death|1|||
33649527|NCT01984697|63059780|FG004|Overall Study|Death|0|||
33649528|NCT01984697|63059776|FG000|Overall Study|Pregnancy|2|||
33649529|NCT01984697|63059777|FG001|Overall Study|Pregnancy|0|||
33649530|NCT01984697|63059778|FG002|Overall Study|Pregnancy|1|||
33649531|NCT01984697|63059779|FG003|Overall Study|Pregnancy|0|||
33649532|NCT01984697|63059780|FG004|Overall Study|Pregnancy|1|||
33649533|NCT02000531|63059794|FG000|Overall Study|Lost to Follow-up|1|||
33649534|NCT02000531|63059795|FG001|Overall Study|Lost to Follow-up|0|||
33649535|NCT02000531|63059794|FG000|Overall Study|Discontinued due to data cut-off|3|||
33649536|NCT02000531|63059795|FG001|Overall Study|Discontinued due to data cut-off|8|||
33649537|NCT01609231|63059803|FG000|Overall Study|Adverse Event|1|||
33649538|NCT01609231|63059804|FG001|Overall Study|Adverse Event|3|||
33649539|NCT01609231|63059803|FG000|Overall Study|Physician Decision|1|||
33649540|NCT01609231|63059804|FG001|Overall Study|Physician Decision|0|||
33649541|NCT01609231|63059803|FG000|Overall Study|Withdrawal by Subject|1|||
33649542|NCT01609231|63059804|FG001|Overall Study|Withdrawal by Subject|0|||
33649543|NCT01793935|63059812|FG000|Overall Study|Pregnancy|1|||
33649544|NCT01793935|63059813|FG001|Overall Study|Pregnancy|0|||
33649545|NCT01793935|63059812|FG000|Overall Study|Protocol Violation|2|||
33649546|NCT01793935|63059813|FG001|Overall Study|Protocol Violation|1|||
33649547|NCT01793935|63059812|FG000|Overall Study|Adverse Event|2|||
33649548|NCT01793935|63059813|FG001|Overall Study|Adverse Event|0|||
33649549|NCT01793935|63059812|FG000|Overall Study|Patient did not take study medication|1|||
33649550|NCT01793935|63059813|FG001|Overall Study|Patient did not take study medication|1|||
33649551|NCT01793935|63059812|FG000|Overall Study|Lost to Follow-up|0|||
33649552|NCT01793935|63059813|FG001|Overall Study|Lost to Follow-up|1|||
33464006|NCT03447314|62837527|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33649553|NCT02092025|63059819|FG000|Overall Study|Case Report Forms Uncollected|44|||
33649554|NCT02092025|63059819|FG000|Overall Study|Protocol Deviation|24|||
33649555|NCT01769443|63059825|FG000|Overall Study|Study closure|1|||
33649556|NCT01769443|63059826|FG001|Overall Study|Study closure|0|||
33649557|NCT01768117|63059833|FG000|Overall Study|Lost to Follow-up|1|||
33649558|NCT01768117|63059833|FG000|Overall Study|Withdrawal by Subject|2|||
33649559|NCT01768117|63059833|FG000|Overall Study|Protocol Violation|3|||
33649560|NCT01767493|63059837|FG000|Overall Study|screen failures|3|||
33649561|NCT01274182|63059844|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
33649562|NCT01274182|63059845|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33649563|NCT01274182|63059846|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
33649564|NCT01274182|63059844|FG000|Overall Study|Adverse Event|4|||
33649565|NCT01274182|63059845|FG001|Overall Study|Adverse Event|5|||
33649566|NCT01274182|63059846|FG002|Overall Study|Adverse Event|3|||
33649567|NCT01274182|63059844|FG000|Overall Study|Withdrawal by Subject|5|||
33649568|NCT01274182|63059845|FG001|Overall Study|Withdrawal by Subject|5|||
33649569|NCT01274182|63059846|FG002|Overall Study|Withdrawal by Subject|3|||
33649570|NCT01274182|63059844|FG000|Overall Study|Lost to Follow-up|2|||
33649571|NCT01274182|63059845|FG001|Overall Study|Lost to Follow-up|3|||
33649572|NCT01274182|63059846|FG002|Overall Study|Lost to Follow-up|1|||
33649573|NCT01274182|63059844|FG000|Overall Study|Protocol Violation|3|||
33649574|NCT01274182|63059845|FG001|Overall Study|Protocol Violation|2|||
33649575|NCT01274182|63059846|FG002|Overall Study|Protocol Violation|0|||
33649576|NCT01274182|63059844|FG000|Overall Study|Death|1|||
33649577|NCT01274182|63059845|FG001|Overall Study|Death|0|||
33649578|NCT01274182|63059846|FG002|Overall Study|Death|1|||
33464007|NCT03447314|62837528|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464008|NCT03447314|62837529|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
33464009|NCT03447314|62837530|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464010|NCT03447314|62837531|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464011|NCT03447314|62837532|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464012|NCT03447314|62837533|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464013|NCT03447314|62837534|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464014|NCT03447314|62837535|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464015|NCT03447314|62837536|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464016|NCT03447314|62837537|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464017|NCT03447314|62837538|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464018|NCT03447314|62837539|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464019|NCT03447314|62837540|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464020|NCT03447314|62837541|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464021|NCT03447314|62837542|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464022|NCT03447314|62837543|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464023|NCT03447314|62837544|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33464024|NCT03447314|62837527|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464025|NCT03447314|62837528|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464026|NCT03447314|62837529|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464027|NCT03447314|62837530|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464028|NCT03447314|62837531|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464029|NCT03447314|62837532|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464030|NCT03447314|62837533|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464031|NCT03447314|62837534|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464032|NCT03447314|62837535|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464033|NCT03447314|62837536|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464034|NCT03447314|62837537|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
33464035|NCT03447314|62837538|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464036|NCT03447314|62837539|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464037|NCT03447314|62837540|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464038|NCT03447314|62837541|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464039|NCT03447314|62837542|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464040|NCT03447314|62837543|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464041|NCT03447314|62837544|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33464042|NCT03447314|62837527|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33464043|NCT03447314|62837528|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33464044|NCT03447314|62837529|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33464045|NCT03447314|62837530|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
33464046|NCT03447314|62837531|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33464047|NCT03447314|62837532|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
33543577|NCT03036839|62934389|FG002|Overall Study|Adverse Event|1|||
33543578|NCT03036839|62934387|FG000|Overall Study|Death|3|||
33543579|NCT03036839|62934388|FG001|Overall Study|Death|0|||
33649579|NCT01984229|63059860|FG000|Safety Follow-up Period|Adverse Event|1|||
33649580|NCT01984229|63059861|FG001|Safety Follow-up Period|Adverse Event|1|||
33649581|NCT01984229|63059860|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
33649582|NCT01984229|63059861|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
33649583|NCT01835899|63059876|FG000|Overall Study|Adverse Event|0|||
33649584|NCT01835899|63059877|FG001|Overall Study|Adverse Event|0|||
33649585|NCT01835899|63059878|FG002|Overall Study|Adverse Event|1|||
33649586|NCT01835899|63059876|FG000|Overall Study|Other than stated above|0|||
33649587|NCT01835899|63059877|FG001|Overall Study|Other than stated above|1|||
33649588|NCT01835899|63059878|FG002|Overall Study|Other than stated above|0|||
33328044|NCT01095666|62704467|FG002|Overall Study|Lost to Follow-up|0|||
33649589|NCT01766401|63059890|FG000|Overall Study|Adverse Event|7|||
33649590|NCT01766401|63059891|FG001|Overall Study|Adverse Event|22|||
33649591|NCT01766401|63059890|FG000|Overall Study|Lack of Efficacy|1|||
33649592|NCT01766401|63059891|FG001|Overall Study|Lack of Efficacy|2|||
33649593|NCT01766401|63059890|FG000|Overall Study|Protocol Violation|3|||
33649594|NCT01766401|63059891|FG001|Overall Study|Protocol Violation|8|||
33649595|NCT01766401|63059890|FG000|Overall Study|Withdrawal by Subject|15|||
33649596|NCT01766401|63059891|FG001|Overall Study|Withdrawal by Subject|12|||
33649597|NCT01766401|63059890|FG000|Overall Study|Lost to Follow-up|10|||
33649598|NCT01766401|63059891|FG001|Overall Study|Lost to Follow-up|11|||
33649599|NCT01766401|63059890|FG000|Overall Study|Pregnancy|1|||
33649600|NCT01766401|63059891|FG001|Overall Study|Pregnancy|1|||
33649601|NCT01272934|63059899|FG000|Overall Study|Adverse Event|0|||
33649602|NCT01272934|63059900|FG001|Overall Study|Adverse Event|1|||
33649603|NCT01272934|63059899|FG000|Overall Study|Abnormal Laboratory Value|0|||
33649604|NCT01272934|63059900|FG001|Overall Study|Abnormal Laboratory Value|1|||
33649605|NCT01983683|63059918|FG000|Overall Study|Withdrawal by Subject|14|||
33649606|NCT01983683|63059919|FG001|Overall Study|Withdrawal by Subject|18|||
33649607|NCT01983683|63059918|FG000|Overall Study|Death|11|||
33649608|NCT01983683|63059919|FG001|Overall Study|Death|15|||
33649609|NCT01983683|63059918|FG000|Overall Study|Physician Decision|8|||
33649610|NCT01983683|63059919|FG001|Overall Study|Physician Decision|9|||
33649611|NCT01983683|63059918|FG000|Overall Study|Lost to Follow-up|4|||
33649612|NCT01983683|63059919|FG001|Overall Study|Lost to Follow-up|8|||
33649613|NCT01983683|63059918|FG000|Overall Study|Sponsor Decision|1|||
33649614|NCT01983683|63059919|FG001|Overall Study|Sponsor Decision|1|||
33649615|NCT01998893|63059925|FG000|Overall Study|Adverse Event|2|||
33649616|NCT01998893|63059925|FG000|Overall Study|Death|1|||
33649617|NCT01998893|63059925|FG000|Overall Study|Lost to Follow-up|8|||
33649618|NCT01998893|63059925|FG000|Overall Study|Physician Decision|2|||
33649619|NCT01998893|63059925|FG000|Overall Study|Protocol Violation|2|||
33649620|NCT01998893|63059925|FG000|Overall Study|Withdrawal by Subject|1|||
33649621|NCT01998893|63059925|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
33649622|NCT01791985|63059929|FG000|Overall Study|Adverse Event|7|||
33649623|NCT01791985|63059929|FG000|Overall Study|Withdrawal by Subject|1|||
33649624|NCT01998737|63059936|FG000|Overall Study|Corrupted database|23|||
33649625|NCT01998737|63059937|FG001|Overall Study|Corrupted database|0|||
33649626|NCT01791517|63059946|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
33649627|NCT01791517|63059947|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
33649628|NCT01791517|63059948|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
33649629|NCT01791517|63059949|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
33649630|NCT01791517|63059950|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
33649631|NCT01791517|63059951|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
33649632|NCT01791517|63059952|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
33649633|NCT01791517|63059953|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
33649634|NCT01791517|63059954|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
33649635|NCT01791517|63059955|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
33649636|NCT01791517|63059956|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
33649637|NCT01791517|63059957|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
33649638|NCT01791517|63059946|FG000|Phase I: Period 1|Adverse Event|0|||
33649639|NCT01791517|63059947|FG001|Phase I: Period 1|Adverse Event|0|||
33649640|NCT01791517|63059948|FG002|Phase I: Period 1|Adverse Event|1|||
33649641|NCT01791517|63059949|FG003|Phase I: Period 1|Adverse Event|1|||
33649642|NCT01791517|63059950|FG004|Phase I: Period 1|Adverse Event|0|||
33649643|NCT01791517|63059951|FG005|Phase I: Period 1|Adverse Event|0|||
33649644|NCT01791517|63059952|FG006|Phase I: Period 1|Adverse Event|0|||
33649645|NCT01791517|63059953|FG007|Phase I: Period 1|Adverse Event|0|||
33649646|NCT01791517|63059954|FG008|Phase I: Period 1|Adverse Event|0|||
33649647|NCT01791517|63059955|FG009|Phase I: Period 1|Adverse Event|0|||
33328045|NCT01095666|62704465|FG000|Overall Study|Withdrawal by Subject|6|||
33649648|NCT01791517|63059956|FG010|Phase I: Period 1|Adverse Event|0|||
33649649|NCT01791517|63059957|FG011|Phase I: Period 1|Adverse Event|0|||
33649650|NCT01791517|63059946|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
33649651|NCT01791517|63059947|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33649652|NCT01791517|63059948|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33649653|NCT01791517|63059949|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33649654|NCT01791517|63059950|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33649655|NCT01791517|63059951|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33649656|NCT01791517|63059952|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33649657|NCT01791517|63059953|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33649658|NCT01791517|63059954|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33649659|NCT01791517|63059955|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33649660|NCT01791517|63059956|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33649661|NCT01791517|63059957|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33649662|NCT01791517|63059946|FG000|Phase I: Period 1|Protocol Violation|0|||
33649663|NCT01791517|63059947|FG001|Phase I: Period 1|Protocol Violation|1|||
33649664|NCT01791517|63059948|FG002|Phase I: Period 1|Protocol Violation|0|||
33649665|NCT01791517|63059949|FG003|Phase I: Period 1|Protocol Violation|0|||
33649666|NCT01791517|63059950|FG004|Phase I: Period 1|Protocol Violation|0|||
33649667|NCT01791517|63059951|FG005|Phase I: Period 1|Protocol Violation|0|||
33649668|NCT01791517|63059952|FG006|Phase I: Period 1|Protocol Violation|0|||
33649669|NCT01791517|63059953|FG007|Phase I: Period 1|Protocol Violation|0|||
33649670|NCT01791517|63059954|FG008|Phase I: Period 1|Protocol Violation|0|||
33649671|NCT01791517|63059955|FG009|Phase I: Period 1|Protocol Violation|0|||
33649672|NCT01791517|63059956|FG010|Phase I: Period 1|Protocol Violation|0|||
33649673|NCT01791517|63059957|FG011|Phase I: Period 1|Protocol Violation|0|||
33649674|NCT01791517|63059946|FG000|Phase I: Period 1|Lost to Follow-up|0|||
33649675|NCT01791517|63059947|FG001|Phase I: Period 1|Lost to Follow-up|0|||
33649676|NCT01791517|63059948|FG002|Phase I: Period 1|Lost to Follow-up|0|||
33649677|NCT01791517|63059949|FG003|Phase I: Period 1|Lost to Follow-up|1|||
33649678|NCT01791517|63059950|FG004|Phase I: Period 1|Lost to Follow-up|0|||
33649679|NCT01791517|63059951|FG005|Phase I: Period 1|Lost to Follow-up|0|||
33649680|NCT01791517|63059952|FG006|Phase I: Period 1|Lost to Follow-up|1|||
33649681|NCT01791517|63059953|FG007|Phase I: Period 1|Lost to Follow-up|0|||
33649682|NCT01791517|63059954|FG008|Phase I: Period 1|Lost to Follow-up|1|||
33649683|NCT01791517|63059955|FG009|Phase I: Period 1|Lost to Follow-up|1|||
33649684|NCT01791517|63059956|FG010|Phase I: Period 1|Lost to Follow-up|0|||
33649685|NCT01791517|63059957|FG011|Phase I: Period 1|Lost to Follow-up|0|||
33649686|NCT01791517|63059946|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
33649687|NCT01791517|63059947|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
33649688|NCT01791517|63059948|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
33649689|NCT01791517|63059949|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
33649690|NCT01791517|63059950|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
33649691|NCT01791517|63059951|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
33543580|NCT03036839|62934389|FG002|Overall Study|Death|3|||
33649692|NCT01791517|63059952|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
33649693|NCT01791517|63059953|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
33649694|NCT01791517|63059954|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
33649695|NCT01791517|63059955|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
33649696|NCT01791517|63059956|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
33649697|NCT01791517|63059957|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
33649698|NCT01791517|63059946|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
33649699|NCT01791517|63059947|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33649700|NCT01791517|63059948|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33649701|NCT01791517|63059949|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33649702|NCT01791517|63059950|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33649703|NCT01791517|63059951|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33649704|NCT01791517|63059952|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33649705|NCT01791517|63059953|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33649706|NCT01791517|63059954|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33649707|NCT01791517|63059955|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33649708|NCT01791517|63059956|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33649709|NCT01791517|63059957|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33649710|NCT01791517|63059946|FG000|Phase I: Period 2|Protocol Violation|0|||
33649711|NCT01791517|63059947|FG001|Phase I: Period 2|Protocol Violation|0|||
33649712|NCT01791517|63059948|FG002|Phase I: Period 2|Protocol Violation|0|||
33649713|NCT01791517|63059949|FG003|Phase I: Period 2|Protocol Violation|1|||
33649714|NCT01791517|63059950|FG004|Phase I: Period 2|Protocol Violation|0|||
33649715|NCT01791517|63059951|FG005|Phase I: Period 2|Protocol Violation|0|||
33649716|NCT01791517|63059952|FG006|Phase I: Period 2|Protocol Violation|0|||
33649717|NCT01791517|63059953|FG007|Phase I: Period 2|Protocol Violation|0|||
33649718|NCT01791517|63059954|FG008|Phase I: Period 2|Protocol Violation|0|||
33649719|NCT01791517|63059955|FG009|Phase I: Period 2|Protocol Violation|0|||
33649720|NCT01791517|63059956|FG010|Phase I: Period 2|Protocol Violation|0|||
33649721|NCT01791517|63059957|FG011|Phase I: Period 2|Protocol Violation|0|||
33649722|NCT01791517|63059946|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
33649723|NCT01791517|63059947|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
33464048|NCT03447314|62837533|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33649724|NCT01791517|63059948|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
33649725|NCT01791517|63059949|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
33649726|NCT01791517|63059950|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
33649727|NCT01791517|63059951|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
33649728|NCT01791517|63059952|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
33464049|NCT03447314|62837534|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33649729|NCT01791517|63059953|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
33649730|NCT01791517|63059954|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
33649731|NCT01791517|63059955|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
33649732|NCT01791517|63059956|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
33649733|NCT01791517|63059957|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
33649734|NCT01791517|63059946|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33649735|NCT01791517|63059947|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33649736|NCT01791517|63059948|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33649737|NCT01791517|63059949|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33649738|NCT01791517|63059950|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33649739|NCT01791517|63059951|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33649740|NCT01791517|63059952|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33649741|NCT01791517|63059953|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33649742|NCT01791517|63059954|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33649743|NCT01791517|63059955|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33649744|NCT01791517|63059956|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
33649745|NCT01791517|63059957|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33649746|NCT01791517|63059946|FG000|Phase I: Period 2|Lens Discomfort|0|||
33649747|NCT01791517|63059947|FG001|Phase I: Period 2|Lens Discomfort|0|||
33649748|NCT01791517|63059948|FG002|Phase I: Period 2|Lens Discomfort|0|||
33649749|NCT01791517|63059949|FG003|Phase I: Period 2|Lens Discomfort|0|||
33649750|NCT01791517|63059950|FG004|Phase I: Period 2|Lens Discomfort|0|||
33649751|NCT01791517|63059951|FG005|Phase I: Period 2|Lens Discomfort|1|||
33649752|NCT01791517|63059952|FG006|Phase I: Period 2|Lens Discomfort|0|||
33649753|NCT01791517|63059953|FG007|Phase I: Period 2|Lens Discomfort|0|||
33649754|NCT01791517|63059954|FG008|Phase I: Period 2|Lens Discomfort|0|||
33649755|NCT01791517|63059955|FG009|Phase I: Period 2|Lens Discomfort|0|||
33649756|NCT01791517|63059956|FG010|Phase I: Period 2|Lens Discomfort|0|||
33649757|NCT01791517|63059957|FG011|Phase I: Period 2|Lens Discomfort|0|||
33649758|NCT01791517|63059946|FG000|Phase I: Period 2|Lost to Follow-up|0|||
33649759|NCT01791517|63059947|FG001|Phase I: Period 2|Lost to Follow-up|3|||
33649760|NCT01791517|63059948|FG002|Phase I: Period 2|Lost to Follow-up|2|||
33649761|NCT01791517|63059949|FG003|Phase I: Period 2|Lost to Follow-up|0|||
33649762|NCT01791517|63059950|FG004|Phase I: Period 2|Lost to Follow-up|0|||
33649763|NCT01791517|63059951|FG005|Phase I: Period 2|Lost to Follow-up|0|||
33649764|NCT01791517|63059952|FG006|Phase I: Period 2|Lost to Follow-up|0|||
33464050|NCT03447314|62837535|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33464051|NCT03447314|62837536|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33464052|NCT03447314|62837537|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33464053|NCT03447314|62837538|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33464054|NCT03447314|62837539|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33464055|NCT03447314|62837540|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33464056|NCT03447314|62837541|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33464057|NCT03447314|62837542|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33464058|NCT03447314|62837543|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33464059|NCT03447314|62837544|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33464060|NCT03423121|62837587|FG000|Overall Study|Lost to Follow-up|2|||
33464061|NCT03423121|62837588|FG001|Overall Study|Lost to Follow-up|6|||
33464062|NCT03423121|62837587|FG000|Overall Study|Adverse Event|1|||
33464063|NCT03423121|62837588|FG001|Overall Study|Adverse Event|0|||
33464064|NCT03335475|62837596|FG000|Overall Study|Did not wear accelerometer|4|||
33464065|NCT03335475|62837597|FG001|Overall Study|Did not wear accelerometer|0|||
33464066|NCT03335475|62837596|FG000|Overall Study|Withdrawal by Subject|0|||
33464067|NCT03335475|62837597|FG001|Overall Study|Withdrawal by Subject|1|||
33464068|NCT03252756|62837605|FG000|Overall Study|Protocol Violation|2|||
33464069|NCT03252756|62837606|FG001|Overall Study|Protocol Violation|4|||
33464070|NCT03252756|62837605|FG000|Overall Study|COVID-19 Pandemic|1|||
33464071|NCT03252756|62837606|FG001|Overall Study|COVID-19 Pandemic|1|||
33464072|NCT03252756|62837605|FG000|Overall Study|Study Drug Expiration|0|||
33464073|NCT03252756|62837606|FG001|Overall Study|Study Drug Expiration|1|||
33464074|NCT03164356|62837618|FG000|Overall Study|Lost to Follow-up|1|||
33464075|NCT03164356|62837619|FG001|Overall Study|Lost to Follow-up|1|||
33464076|NCT03164356|62837620|FG002|Overall Study|Lost to Follow-up|2|||
33464077|NCT03164356|62837621|FG003|Overall Study|Lost to Follow-up|1|||
33464078|NCT03164356|62837618|FG000|Overall Study|Physician Decision|0|||
33464079|NCT03164356|62837619|FG001|Overall Study|Physician Decision|0|||
33464080|NCT03164356|62837620|FG002|Overall Study|Physician Decision|3|||
33649765|NCT01791517|63059953|FG007|Phase I: Period 2|Lost to Follow-up|0|||
33649766|NCT01791517|63059954|FG008|Phase I: Period 2|Lost to Follow-up|0|||
33649767|NCT01791517|63059955|FG009|Phase I: Period 2|Lost to Follow-up|0|||
33649768|NCT01791517|63059956|FG010|Phase I: Period 2|Lost to Follow-up|0|||
33649769|NCT01791517|63059957|FG011|Phase I: Period 2|Lost to Follow-up|0|||
33649770|NCT01791517|63059946|FG000|Phase I: Period 3|Lens Discomfort|0|||
33649771|NCT01791517|63059947|FG001|Phase I: Period 3|Lens Discomfort|0|||
33649772|NCT01791517|63059948|FG002|Phase I: Period 3|Lens Discomfort|0|||
33649773|NCT01791517|63059949|FG003|Phase I: Period 3|Lens Discomfort|0|||
33649774|NCT01791517|63059950|FG004|Phase I: Period 3|Lens Discomfort|0|||
33649775|NCT01791517|63059951|FG005|Phase I: Period 3|Lens Discomfort|0|||
33649776|NCT01791517|63059952|FG006|Phase I: Period 3|Lens Discomfort|0|||
33649777|NCT01791517|63059953|FG007|Phase I: Period 3|Lens Discomfort|0|||
33649778|NCT01791517|63059954|FG008|Phase I: Period 3|Lens Discomfort|0|||
33649779|NCT01791517|63059955|FG009|Phase I: Period 3|Lens Discomfort|0|||
33649780|NCT01791517|63059956|FG010|Phase I: Period 3|Lens Discomfort|0|||
33649781|NCT01791517|63059957|FG011|Phase I: Period 3|Lens Discomfort|1|||
33649782|NCT01791517|63059946|FG000|Phase I: Period 3|Lost to Follow-up|0|||
33649783|NCT01791517|63059947|FG001|Phase I: Period 3|Lost to Follow-up|1|||
33649784|NCT01791517|63059948|FG002|Phase I: Period 3|Lost to Follow-up|0|||
33649785|NCT01791517|63059949|FG003|Phase I: Period 3|Lost to Follow-up|0|||
33649786|NCT01791517|63059950|FG004|Phase I: Period 3|Lost to Follow-up|1|||
33649787|NCT01791517|63059951|FG005|Phase I: Period 3|Lost to Follow-up|0|||
33649788|NCT01791517|63059952|FG006|Phase I: Period 3|Lost to Follow-up|0|||
33649789|NCT01791517|63059953|FG007|Phase I: Period 3|Lost to Follow-up|0|||
33649790|NCT01791517|63059954|FG008|Phase I: Period 3|Lost to Follow-up|0|||
33649791|NCT01791517|63059955|FG009|Phase I: Period 3|Lost to Follow-up|0|||
33649792|NCT01791517|63059956|FG010|Phase I: Period 3|Lost to Follow-up|0|||
33649793|NCT01791517|63059957|FG011|Phase I: Period 3|Lost to Follow-up|0|||
33649794|NCT01791517|63059946|FG000|Phase I: Period 3|Adverse Event|0|||
33464081|NCT03164356|62837621|FG003|Overall Study|Physician Decision|0|||
33464082|NCT03164356|62837618|FG000|Overall Study|Protocol Violation|2|||
33464083|NCT03164356|62837619|FG001|Overall Study|Protocol Violation|1|||
33464084|NCT03164356|62837620|FG002|Overall Study|Protocol Violation|0|||
33464085|NCT03164356|62837621|FG003|Overall Study|Protocol Violation|0|||
33464086|NCT03164356|62837618|FG000|Overall Study|Withdrawal by Subject|1|||
33464087|NCT03164356|62837619|FG001|Overall Study|Withdrawal by Subject|0|||
33464088|NCT03164356|62837620|FG002|Overall Study|Withdrawal by Subject|0|||
33464089|NCT03164356|62837621|FG003|Overall Study|Withdrawal by Subject|0|||
33464090|NCT03164356|62837618|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
33464091|NCT03164356|62837619|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
33464092|NCT03164356|62837620|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
33464093|NCT03164356|62837621|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
33464094|NCT03164356|62837618|FG000|Overall Study|Subject Incarcerated|0|||
33464095|NCT03164356|62837619|FG001|Overall Study|Subject Incarcerated|1|||
33464096|NCT03164356|62837620|FG002|Overall Study|Subject Incarcerated|0|||
33464097|NCT03164356|62837621|FG003|Overall Study|Subject Incarcerated|0|||
33464098|NCT03164356|62837618|FG000|Overall Study|Prosthetist unable to participate|0|||
33464099|NCT03164356|62837619|FG001|Overall Study|Prosthetist unable to participate|2|||
33464100|NCT03164356|62837620|FG002|Overall Study|Prosthetist unable to participate|1|||
33543581|NCT03036839|62934387|FG000|Overall Study|Withdrew Consent|0|||
33649795|NCT01791517|63059947|FG001|Phase I: Period 3|Adverse Event|0|||
33649796|NCT01791517|63059948|FG002|Phase I: Period 3|Adverse Event|0|||
33649797|NCT01791517|63059949|FG003|Phase I: Period 3|Adverse Event|1|||
33649798|NCT01791517|63059950|FG004|Phase I: Period 3|Adverse Event|0|||
33649799|NCT01791517|63059951|FG005|Phase I: Period 3|Adverse Event|0|||
33649800|NCT01791517|63059952|FG006|Phase I: Period 3|Adverse Event|0|||
33464101|NCT03164356|62837621|FG003|Overall Study|Prosthetist unable to participate|0|||
33464102|NCT02577406|62837652|FG000|Randomized Period|Death|1|||
33649801|NCT01791517|63059953|FG007|Phase I: Period 3|Adverse Event|0|||
33649802|NCT01791517|63059954|FG008|Phase I: Period 3|Adverse Event|0|||
33649803|NCT01791517|63059955|FG009|Phase I: Period 3|Adverse Event|0|||
33649804|NCT01791517|63059956|FG010|Phase I: Period 3|Adverse Event|0|||
33649805|NCT01791517|63059957|FG011|Phase I: Period 3|Adverse Event|0|||
33649806|NCT01791517|63059946|FG000|Phase II|Lost to Follow-up|1|||
33649807|NCT01791517|63059947|FG001|Phase II|Lost to Follow-up|0|||
33649808|NCT01791517|63059948|FG002|Phase II|Lost to Follow-up|1|||
33649809|NCT01791517|63059949|FG003|Phase II|Lost to Follow-up|0|||
33649810|NCT01791517|63059950|FG004|Phase II|Lost to Follow-up|1|||
33649811|NCT01791517|63059951|FG005|Phase II|Lost to Follow-up|2|||
33649812|NCT01791517|63059952|FG006|Phase II|Lost to Follow-up|0|||
33649813|NCT01791517|63059953|FG007|Phase II|Lost to Follow-up|1|||
33649814|NCT01791517|63059954|FG008|Phase II|Lost to Follow-up|1|||
33649815|NCT01791517|63059955|FG009|Phase II|Lost to Follow-up|1|||
33649816|NCT01791517|63059956|FG010|Phase II|Lost to Follow-up|0|||
33649817|NCT01791517|63059957|FG011|Phase II|Lost to Follow-up|0|||
33649818|NCT01791517|63059946|FG000|Phase II|Withdrawal by Subject|1|||
33649819|NCT01791517|63059947|FG001|Phase II|Withdrawal by Subject|0|||
33649820|NCT01791517|63059948|FG002|Phase II|Withdrawal by Subject|0|||
33649821|NCT01791517|63059949|FG003|Phase II|Withdrawal by Subject|0|||
33649822|NCT01791517|63059950|FG004|Phase II|Withdrawal by Subject|0|||
33649823|NCT01791517|63059951|FG005|Phase II|Withdrawal by Subject|2|||
33649824|NCT01791517|63059952|FG006|Phase II|Withdrawal by Subject|0|||
33649825|NCT01791517|63059953|FG007|Phase II|Withdrawal by Subject|1|||
33649826|NCT01791517|63059954|FG008|Phase II|Withdrawal by Subject|0|||
33649827|NCT01791517|63059955|FG009|Phase II|Withdrawal by Subject|0|||
33649828|NCT01791517|63059956|FG010|Phase II|Withdrawal by Subject|1|||
33649829|NCT01791517|63059957|FG011|Phase II|Withdrawal by Subject|0|||
33649830|NCT01791517|63059946|FG000|Phase II|Lack of Efficacy|0|||
33649831|NCT01791517|63059947|FG001|Phase II|Lack of Efficacy|0|||
33649832|NCT01791517|63059948|FG002|Phase II|Lack of Efficacy|0|||
33649833|NCT01791517|63059949|FG003|Phase II|Lack of Efficacy|0|||
33649834|NCT01791517|63059950|FG004|Phase II|Lack of Efficacy|1|||
33649835|NCT01791517|63059951|FG005|Phase II|Lack of Efficacy|0|||
33649836|NCT01791517|63059952|FG006|Phase II|Lack of Efficacy|0|||
33649837|NCT01791517|63059953|FG007|Phase II|Lack of Efficacy|0|||
33649838|NCT01791517|63059954|FG008|Phase II|Lack of Efficacy|0|||
33649839|NCT01791517|63059955|FG009|Phase II|Lack of Efficacy|0|||
33649840|NCT01791517|63059956|FG010|Phase II|Lack of Efficacy|0|||
33649841|NCT01791517|63059957|FG011|Phase II|Lack of Efficacy|0|||
33649842|NCT01791517|63059946|FG000|Phase II|Adverse Event|0|||
33649843|NCT01791517|63059947|FG001|Phase II|Adverse Event|0|||
33649844|NCT01791517|63059948|FG002|Phase II|Adverse Event|0|||
33649845|NCT01791517|63059949|FG003|Phase II|Adverse Event|0|||
33649846|NCT01791517|63059950|FG004|Phase II|Adverse Event|0|||
33649847|NCT01791517|63059951|FG005|Phase II|Adverse Event|0|||
33649848|NCT01791517|63059952|FG006|Phase II|Adverse Event|2|||
33649849|NCT01791517|63059953|FG007|Phase II|Adverse Event|1|||
33649850|NCT01791517|63059954|FG008|Phase II|Adverse Event|0|||
33649851|NCT01791517|63059955|FG009|Phase II|Adverse Event|1|||
33649852|NCT01791517|63059956|FG010|Phase II|Adverse Event|0|||
33649853|NCT01791517|63059957|FG011|Phase II|Adverse Event|0|||
33649854|NCT01791517|63059946|FG000|Phase II|Lens Handling Difficulties|0|||
33649855|NCT01791517|63059947|FG001|Phase II|Lens Handling Difficulties|0|||
33649856|NCT01791517|63059948|FG002|Phase II|Lens Handling Difficulties|0|||
33649857|NCT01791517|63059949|FG003|Phase II|Lens Handling Difficulties|0|||
33649858|NCT01791517|63059950|FG004|Phase II|Lens Handling Difficulties|0|||
33543582|NCT03036839|62934388|FG001|Overall Study|Withdrew Consent|0|||
33543583|NCT03036839|62934389|FG002|Overall Study|Withdrew Consent|1|||
33543584|NCT01286207|62934400|FG000|Overall Study|Adverse Event|27|||
33543585|NCT01286207|62934401|FG001|Overall Study|Adverse Event|41|||
33543586|NCT01286207|62934402|FG002|Overall Study|Adverse Event|8|||
33543587|NCT01286207|62934400|FG000|Overall Study|Lost to Follow-up|49|||
33543588|NCT01286207|62934401|FG001|Overall Study|Lost to Follow-up|43|||
33543589|NCT01286207|62934402|FG002|Overall Study|Lost to Follow-up|20|||
33543590|NCT01286207|62934400|FG000|Overall Study|Withdrawal by Subject|93|||
33543591|NCT01286207|62934401|FG001|Overall Study|Withdrawal by Subject|79|||
33543592|NCT01286207|62934402|FG002|Overall Study|Withdrawal by Subject|41|||
33543593|NCT01286207|62934400|FG000|Overall Study|Lack of Response|92|||
33543594|NCT01286207|62934401|FG001|Overall Study|Lack of Response|38|||
33543595|NCT01286207|62934402|FG002|Overall Study|Lack of Response|8|||
33543596|NCT01286207|62934400|FG000|Overall Study|Other|37|||
33543597|NCT01286207|62934401|FG001|Overall Study|Other|47|||
33543598|NCT01286207|62934402|FG002|Overall Study|Other|13|||
33543599|NCT00968201|62934439|FG000|Base Study - (Period II)|Adverse Event|8|||
33543600|NCT00968201|62934440|FG001|Base Study - (Period II)|Adverse Event|0|||
33543601|NCT00968201|62934441|FG002|Base Study - (Period II)|Adverse Event|16|||
33543602|NCT00968201|62934439|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
33543603|NCT00968201|62934440|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
33543604|NCT00968201|62934441|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
33543605|NCT00968201|62934439|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
33543606|NCT00968201|62934440|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
33543607|NCT00968201|62934441|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
33543608|NCT00968201|62934439|FG000|Base Study - (Period II)|Protocol Violation|12|||
33543609|NCT00968201|62934440|FG001|Base Study - (Period II)|Protocol Violation|0|||
33649859|NCT01791517|63059951|FG005|Phase II|Lens Handling Difficulties|0|||
33649860|NCT01791517|63059952|FG006|Phase II|Lens Handling Difficulties|0|||
33649861|NCT01791517|63059953|FG007|Phase II|Lens Handling Difficulties|0|||
33649862|NCT01791517|63059954|FG008|Phase II|Lens Handling Difficulties|1|||
33649863|NCT01791517|63059955|FG009|Phase II|Lens Handling Difficulties|0|||
33649864|NCT01791517|63059956|FG010|Phase II|Lens Handling Difficulties|0|||
33649865|NCT01791517|63059957|FG011|Phase II|Lens Handling Difficulties|0|||
33649866|NCT01791517|63059946|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
33649867|NCT01791517|63059947|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
33649868|NCT01791517|63059948|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
33649869|NCT01791517|63059949|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
33649870|NCT01791517|63059950|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
33649871|NCT01791517|63059951|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
33649872|NCT01791517|63059952|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
33649873|NCT01791517|63059953|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
33649874|NCT01791517|63059954|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
33649875|NCT01791517|63059955|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
33649876|NCT01791517|63059956|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
33649877|NCT01791517|63059957|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
33649878|NCT01791517|63059946|FG000|Phase II|Pre-Existing Ocular Issue|0|||
33649879|NCT01791517|63059947|FG001|Phase II|Pre-Existing Ocular Issue|0|||
33649880|NCT01791517|63059948|FG002|Phase II|Pre-Existing Ocular Issue|0|||
33649881|NCT01791517|63059949|FG003|Phase II|Pre-Existing Ocular Issue|0|||
33649882|NCT01791517|63059950|FG004|Phase II|Pre-Existing Ocular Issue|0|||
33649883|NCT01791517|63059951|FG005|Phase II|Pre-Existing Ocular Issue|0|||
33649884|NCT01791517|63059952|FG006|Phase II|Pre-Existing Ocular Issue|0|||
33649885|NCT01791517|63059953|FG007|Phase II|Pre-Existing Ocular Issue|0|||
33649886|NCT01791517|63059954|FG008|Phase II|Pre-Existing Ocular Issue|0|||
33649887|NCT01791517|63059955|FG009|Phase II|Pre-Existing Ocular Issue|0|||
33649888|NCT01791517|63059956|FG010|Phase II|Pre-Existing Ocular Issue|0|||
33649889|NCT01791517|63059957|FG011|Phase II|Pre-Existing Ocular Issue|1|||
33649890|NCT01998581|63059977|FG000|Overall Study|Refused repeat treatment|20|||
33649891|NCT01998581|63059978|FG001|Overall Study|Refused repeat treatment|4|||
33649892|NCT01998581|63059977|FG000|Overall Study|Protocol Violation|1|||
33649893|NCT01998581|63059978|FG001|Overall Study|Protocol Violation|0|||
33649894|NCT01998581|63059977|FG000|Overall Study|Withdrawal by Subject|8|||
33649895|NCT01998581|63059978|FG001|Overall Study|Withdrawal by Subject|1|||
33649896|NCT01998581|63059977|FG000|Overall Study|Lost to Follow-up|12|||
33649897|NCT01998581|63059978|FG001|Overall Study|Lost to Follow-up|4|||
33649898|NCT01998581|63059977|FG000|Overall Study|Adverse Event|1|||
33649899|NCT01998581|63059978|FG001|Overall Study|Adverse Event|1|||
33649900|NCT01998581|63059977|FG000|Overall Study|Other reasons|3|||
33649901|NCT01998581|63059978|FG001|Overall Study|Other reasons|2|||
33649902|NCT01998581|63059977|FG000|Overall Study|Randomized but withdrew before treatment|1|||
33649903|NCT01998581|63059978|FG001|Overall Study|Randomized but withdrew before treatment|0|||
33649904|NCT01983293|63059987|FG000|Overall Study|Withdrawal by Subject|29|||
33649905|NCT01983293|63059988|FG001|Overall Study|Withdrawal by Subject|15|||
33649906|NCT01983293|63059987|FG000|Overall Study|Missing 12-month visit|3|||
33649907|NCT01983293|63059988|FG001|Overall Study|Missing 12-month visit|3|||
33649908|NCT01983293|63059987|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
33649909|NCT01983293|63059988|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
33649910|NCT01791205|63059996|FG000|Phase II|Lack of Efficacy|6|||
33649911|NCT01791205|63059997|FG001|Phase II|Lack of Efficacy|0|||
33649912|NCT01791205|63059996|FG000|Phase II|Adverse Event|2|||
33649913|NCT01791205|63059997|FG001|Phase II|Adverse Event|0|||
33649914|NCT01791205|63059996|FG000|Phase II|Safety|1|||
33649915|NCT01791205|63059997|FG001|Phase II|Safety|0|||
33649916|NCT01791205|63059996|FG000|Phase II|Lost to Follow-up|1|||
33649917|NCT01791205|63059997|FG001|Phase II|Lost to Follow-up|0|||
33649918|NCT01791205|63059996|FG000|Phase II|Remission of disease|1|||
33649919|NCT01791205|63059997|FG001|Phase II|Remission of disease|0|||
33649920|NCT01791205|63059996|FG000|Phase II|Physician's decision|1|||
33649921|NCT01791205|63059997|FG001|Phase II|Physician's decision|0|||
33464103|NCT02577406|62837653|FG001|Randomized Period|Death|0|||
33649922|NCT01272232|63060006|FG000|Weeks 0-56|Adverse Event|39|||
33649923|NCT01272232|63060007|FG001|Weeks 0-56|Adverse Event|18|||
33649924|NCT01272232|63060008|FG002|Weeks 0-56|Adverse Event|7|||
33649925|NCT01272232|63060006|FG000|Weeks 0-56|Lack of Efficacy|0|||
33649926|NCT01272232|63060007|FG001|Weeks 0-56|Lack of Efficacy|0|||
33649927|NCT01272232|63060008|FG002|Weeks 0-56|Lack of Efficacy|3|||
33649928|NCT01272232|63060006|FG000|Weeks 0-56|Protocol Violation|12|||
33649929|NCT01272232|63060007|FG001|Weeks 0-56|Protocol Violation|8|||
33649930|NCT01272232|63060008|FG002|Weeks 0-56|Protocol Violation|13|||
33464104|NCT02577406|62837652|FG000|Randomized Period|Other reasons|0|||
33649931|NCT01272232|63060006|FG000|Weeks 0-56|Withdrawal criteria|32|||
33649932|NCT01272232|63060007|FG001|Weeks 0-56|Withdrawal criteria|14|||
33649933|NCT01272232|63060008|FG002|Weeks 0-56|Withdrawal criteria|37|||
33649934|NCT01272232|63060006|FG000|Weeks 0-56|Unclassified|16|||
33649935|NCT01272232|63060007|FG001|Weeks 0-56|Unclassified|7|||
33649936|NCT01272232|63060008|FG002|Weeks 0-56|Unclassified|12|||
33649937|NCT01272232|63060006|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
33649938|NCT01272232|63060007|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
33649939|NCT01272232|63060008|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
33649940|NCT01272232|63060006|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
33649941|NCT01272232|63060007|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
33649942|NCT01272232|63060008|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
33649943|NCT01272232|63060006|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
33649944|NCT01272232|63060007|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
33649945|NCT01272232|63060008|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
33649946|NCT01272232|63060006|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
33649947|NCT01272232|63060007|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
33649948|NCT01272232|63060008|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
33649949|NCT01272232|63060006|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
33649950|NCT01272232|63060007|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
33649951|NCT01272232|63060008|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
33649952|NCT01791127|63060016|FG000|Overall Study|Death|356|||
33649953|NCT01791127|63060016|FG000|Overall Study|Patient has withdrawn from study|293|||
33649954|NCT01791127|63060016|FG000|Overall Study|Lost to Follow-up|42|||
33649955|NCT01791127|63060016|FG000|Overall Study|All Siello leads are explanted|31|||
33649956|NCT01791127|63060016|FG000|Overall Study|Completion of 30 day safety registry|1|||
33649957|NCT01791127|63060016|FG000|Overall Study|Study terminated for EP Passion|749|||
33649958|NCT01997333|63060047|FG000|Randomization and Treatment|Disease Progression|70|||
33649959|NCT01997333|63060048|FG001|Randomization and Treatment|Disease Progression|159|||
33649960|NCT01997333|63060047|FG000|Randomization and Treatment|Adverse Event|10|||
33649961|NCT01997333|63060048|FG001|Randomization and Treatment|Adverse Event|32|||
33649962|NCT01997333|63060047|FG000|Randomization and Treatment|Physician Decision|0|||
33649963|NCT01997333|63060048|FG001|Randomization and Treatment|Physician Decision|4|||
33649964|NCT01997333|63060047|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
33649965|NCT01997333|63060048|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
33649966|NCT01997333|63060047|FG000|Randomization and Treatment|Did not receive treatment|17|||
33649967|NCT01997333|63060048|FG001|Randomization and Treatment|Did not receive treatment|5|||
33649968|NCT01997333|63060047|FG000|Survival Follow up|Withdrawal by Subject|15|||
33649969|NCT01997333|63060048|FG001|Survival Follow up|Withdrawal by Subject|6|||
33649970|NCT01997333|63060047|FG000|Survival Follow up|Lost to Follow-up|0|||
33649971|NCT01997333|63060048|FG001|Survival Follow up|Lost to Follow-up|6|||
33649972|NCT01997333|63060047|FG000|Survival Follow up|Various|1|||
33649973|NCT01997333|63060048|FG001|Survival Follow up|Various|2|||
33649974|NCT01982435|63060112|FG000|Overall Study|Adverse Event|1|||
33649975|NCT01982435|63060113|FG001|Overall Study|Adverse Event|0|||
33649976|NCT01620983|63060153|FG000|Overall Study|Lost to Follow-up|8|||
33649977|NCT01620983|63060154|FG001|Overall Study|Lost to Follow-up|4|||
33328046|NCT01095666|62704466|FG001|Overall Study|Withdrawal by Subject|6|||
33328047|NCT01095666|62704467|FG002|Overall Study|Withdrawal by Subject|1|||
33328048|NCT01095666|62704465|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
33328049|NCT01095666|62704466|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
33328050|NCT01095666|62704467|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
33328051|NCT01100658|62704475|FG000|Overall Study|Withdrawal by Subject|1|||
33328052|NCT01100502|62704481|FG000|Overall Study|Withdrawal by Subject|18|||
33328053|NCT01100502|62704482|FG001|Overall Study|Withdrawal by Subject|25|||
33328054|NCT01100502|62704481|FG000|Overall Study|Lost to Follow-up|13|||
33328055|NCT01100502|62704482|FG001|Overall Study|Lost to Follow-up|28|||
33328056|NCT01100502|62704481|FG000|Overall Study|Site request to end participation in study|0|||
33328057|NCT01100502|62704482|FG001|Overall Study|Site request to end participation in study|1|||
33328058|NCT01100502|62704481|FG000|Overall Study|Death|45|||
33328059|NCT01100502|62704482|FG001|Overall Study|Death|40|||
33328060|NCT01094886|62704488|FG000|Overall Study|Adverse Event|2|||
33328061|NCT01094886|62704488|FG000|Overall Study|Withdrawal by Subject|5|||
33328062|NCT01094808|62704495|FG000|Overall Study|Withdrawal by Subject|1|||
33328063|NCT01094808|62704496|FG001|Overall Study|Withdrawal by Subject|1|||
33328064|NCT01094808|62704497|FG002|Overall Study|Withdrawal by Subject|0|||
33543610|NCT00968201|62934441|FG002|Base Study - (Period II)|Protocol Violation|12|||
33543611|NCT00968201|62934439|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
33649978|NCT01620983|63060155|FG002|Overall Study|Lost to Follow-up|9|||
33649979|NCT01620983|63060153|FG000|Overall Study|Withdrawal by Subject|6|||
33649980|NCT01620983|63060154|FG001|Overall Study|Withdrawal by Subject|8|||
33649981|NCT01620983|63060155|FG002|Overall Study|Withdrawal by Subject|1|||
33649982|NCT01620983|63060153|FG000|Overall Study|Death|2|||
33649983|NCT01620983|63060154|FG001|Overall Study|Death|0|||
33328065|NCT00864253|62704507|FG000|Overall Study|Adverse Event|56|||
33328066|NCT00864253|62704508|FG001|Overall Study|Adverse Event|11|||
33328067|NCT00864253|62704507|FG000|Overall Study|Unrelated Adverse Event|3|||
33328068|NCT00864253|62704508|FG001|Overall Study|Unrelated Adverse Event|1|||
33328069|NCT00864253|62704507|FG000|Overall Study|Physician Decision|11|||
33328070|NCT00864253|62704508|FG001|Overall Study|Physician Decision|15|||
33328071|NCT00864253|62704507|FG000|Overall Study|Protocol Violation|0|||
33328072|NCT00864253|62704508|FG001|Overall Study|Protocol Violation|2|||
33328073|NCT00864253|62704507|FG000|Overall Study|Lost to Follow-up|1|||
33328074|NCT00864253|62704508|FG001|Overall Study|Lost to Follow-up|1|||
33328075|NCT00864253|62704507|FG000|Overall Study|Withdrawal by Subject|18|||
33464105|NCT02577406|62837653|FG001|Randomized Period|Other reasons|20|||
33464106|NCT02577406|62837652|FG000|Treatment Period|Transition to commercially available treatment|1|||
33464107|NCT02577406|62837653|FG001|Treatment Period|Transition to commercially available treatment|0|||
33649984|NCT01620983|63060155|FG002|Overall Study|Death|0|||
33649985|NCT01620983|63060153|FG000|Overall Study|Physician Decision|3|||
33649986|NCT01620983|63060154|FG001|Overall Study|Physician Decision|10|||
33649987|NCT01620983|63060155|FG002|Overall Study|Physician Decision|5|||
33649988|NCT01996709|63060165|FG000|Overall Study|Withdrawal by Subject|1|||
33649989|NCT01996709|63060166|FG001|Overall Study|Withdrawal by Subject|0|||
33649990|NCT01996709|63060165|FG000|Overall Study|Lost to Follow-up|3|||
33649991|NCT01996709|63060166|FG001|Overall Study|Lost to Follow-up|0|||
33649992|NCT01996709|63060165|FG000|Overall Study|Subject Non-Compliant|1|||
33649993|NCT01996709|63060166|FG001|Overall Study|Subject Non-Compliant|0|||
33649994|NCT01996709|63060165|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
33649995|NCT01996709|63060166|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
33649996|NCT01996319|63060191|FG000|Overall Study|Protocol Violation|1|||
33649997|NCT01996319|63060192|FG001|Overall Study|Protocol Violation|0|||
33649998|NCT01996319|63060191|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
33649999|NCT01996319|63060192|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
33650000|NCT01996319|63060191|FG000|Overall Study|Adverse Event|2|||
33650001|NCT01996319|63060192|FG001|Overall Study|Adverse Event|2|||
33650002|NCT01279486|63060198|FG000|Overall Study|Lost to Follow-up|1|||
33650003|NCT01279954|63060204|FG000|Overall Study|Lack of Efficacy|3|||
33543612|NCT00968201|62934440|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
33543613|NCT00968201|62934441|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
33543614|NCT00968201|62934439|FG000|Base Study - (Period II)|Site Error|0|||
33543615|NCT00968201|62934440|FG001|Base Study - (Period II)|Site Error|0|||
33650004|NCT01279954|63060205|FG001|Overall Study|Lack of Efficacy|4|||
33650005|NCT01278862|63060216|FG000|Overall Study|Lost to Follow-up|1|||
33650006|NCT01278862|63060217|FG001|Overall Study|Lost to Follow-up|1|||
33650007|NCT01278394|63060232|FG000|Overall Study|Lost to Follow-up|1|||
33650008|NCT01981187|63060236|FG000|Overall Study|Participant/guardian decision|2|||
33650009|NCT01981187|63060236|FG000|Overall Study|Physician Decision|1|||
33650010|NCT01981187|63060236|FG000|Overall Study|Disease progression|2|||
33650011|NCT01981187|63060236|FG000|Overall Study|Adverse Event|7|||
33650012|NCT01278160|63060242|FG000|Overall Study|Adverse Event|1|||
33650013|NCT01278160|63060243|FG001|Overall Study|Adverse Event|1|||
33650014|NCT01278160|63060242|FG000|Overall Study|Lost to Follow-up|0|||
33650015|NCT01278160|63060243|FG001|Overall Study|Lost to Follow-up|1|||
33650016|NCT01278160|63060242|FG000|Overall Study|Withdrawal by Subject|3|||
33650017|NCT01278160|63060243|FG001|Overall Study|Withdrawal by Subject|2|||
33650018|NCT01278160|63060242|FG000|Overall Study|Unclassified|1|||
33328076|NCT00864253|62704508|FG001|Overall Study|Withdrawal by Subject|18|||
33328077|NCT00864253|62704507|FG000|Overall Study|Death|1|||
33464108|NCT02577406|62837652|FG000|Treatment Period|Progressive disease|47|||
33464109|NCT02577406|62837653|FG001|Treatment Period|Progressive disease|36|||
33464110|NCT02577406|62837652|FG000|Treatment Period|Death|36|||
33464111|NCT02577406|62837653|FG001|Treatment Period|Death|23|||
33464112|NCT02577406|62837652|FG000|Treatment Period|Other reasons|3|||
33464113|NCT02577406|62837653|FG001|Treatment Period|Other reasons|37|||
33464114|NCT02577406|62837652|FG000|Treatment Period|Withdrawal by Subject|10|||
33464115|NCT02577406|62837653|FG001|Treatment Period|Withdrawal by Subject|24|||
33464116|NCT02577406|62837652|FG000|Treatment Period|Adverse Event|17|||
33543616|NCT00968201|62934441|FG002|Base Study - (Period II)|Site Error|1|||
33543617|NCT00968201|62934439|FG000|Extension Study - (Period III)|Adverse Event|0|||
33650019|NCT01278160|63060243|FG001|Overall Study|Unclassified|2|||
33650020|NCT01996241|63060251|FG000|Overall Study|Lost to Follow-up|252|||
33650021|NCT01996241|63060252|FG001|Overall Study|Lost to Follow-up|235|||
33650022|NCT02091869|63060262|FG000|Overall Study|Withdrawal by Subject|0|||
33650023|NCT02091869|63060263|FG001|Overall Study|Withdrawal by Subject|3|||
33650024|NCT01981109|63060278|FG000|Overall Study|Death|36|||
33650025|NCT01981109|63060278|FG000|Overall Study|Withdrawal by Subject|40|||
33650026|NCT01981109|63060278|FG000|Overall Study|Lost to Follow-up|9|||
33650027|NCT01981109|63060278|FG000|Overall Study|No Discontinuation Documentation|37|||
33464117|NCT02577406|62837653|FG001|Treatment Period|Adverse Event|12|||
33650028|NCT01981109|63060278|FG000|Overall Study|Study Termination|100|||
33464118|NCT02577406|62837652|FG000|Treatment Period|Disease relapse|27|||
33650029|NCT01981109|63060278|FG000|Overall Study|No data available|2|||
33650030|NCT00248794|63060286|FG000|Overall Study|Lost to Follow-up|6|||
33650031|NCT00248794|63060287|FG001|Overall Study|Lost to Follow-up|8|||
33650032|NCT00248794|63060288|FG002|Overall Study|Lost to Follow-up|3|||
33650033|NCT01995539|63060302|FG000|Overall Study|Screening Failure|1|||
33650034|NCT01995539|63060302|FG000|Overall Study|Withdrawal by Investigator|15|||
33650035|NCT01995539|63060302|FG000|Overall Study|Withdrawal by Subject|11|||
33650036|NCT01995539|63060302|FG000|Overall Study|Lost to Follow-up|5|||
33650037|NCT01995539|63060302|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
33650038|NCT01835587|63060310|FG000|Overall Study|Disease Recurrence or Relapse|0|||
33650039|NCT01835587|63060311|FG001|Overall Study|Disease Recurrence or Relapse|3|||
33650040|NCT01835587|63060312|FG002|Overall Study|Disease Recurrence or Relapse|0|||
33650041|NCT01835587|63060313|FG003|Overall Study|Disease Recurrence or Relapse|3|||
33650042|NCT01835587|63060310|FG000|Overall Study|Withdrawal by Subject|2|||
33650043|NCT01835587|63060311|FG001|Overall Study|Withdrawal by Subject|0|||
33650044|NCT01835587|63060312|FG002|Overall Study|Withdrawal by Subject|0|||
33650045|NCT01835587|63060313|FG003|Overall Study|Withdrawal by Subject|3|||
33650046|NCT01835587|63060310|FG000|Overall Study|Adverse Event|0|||
33650047|NCT01835587|63060311|FG001|Overall Study|Adverse Event|0|||
33650048|NCT01835587|63060312|FG002|Overall Study|Adverse Event|2|||
33650049|NCT01835587|63060313|FG003|Overall Study|Adverse Event|2|||
33650050|NCT01835587|63060310|FG000|Overall Study|Death|0|||
33650051|NCT01835587|63060311|FG001|Overall Study|Death|0|||
33650052|NCT01835587|63060312|FG002|Overall Study|Death|0|||
33650053|NCT01835587|63060313|FG003|Overall Study|Death|1|||
33650054|NCT01835587|63060310|FG000|Overall Study|Miscellaneous|0|||
33650055|NCT01835587|63060311|FG001|Overall Study|Miscellaneous|1|||
33650056|NCT01835587|63060312|FG002|Overall Study|Miscellaneous|0|||
33650057|NCT01835587|63060313|FG003|Overall Study|Miscellaneous|0|||
33650058|NCT01736917|63060330|FG000|Overall Study|Adverse Event|1|||
33650059|NCT01736917|63060330|FG000|Overall Study|Protocol Violation|10|||
33650060|NCT01277302|63060339|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
33650061|NCT01277302|63060340|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
33650062|NCT01277302|63060341|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
33650063|NCT01277302|63060339|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
33650064|NCT01277302|63060340|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
33650065|NCT01277302|63060341|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
33650066|NCT01277302|63060339|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
33650067|NCT01277302|63060340|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
33650068|NCT01277302|63060341|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
33650069|NCT01277302|63060339|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
33650070|NCT01277302|63060340|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
33650071|NCT01277302|63060341|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
33650072|NCT01277302|63060339|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
33650073|NCT01277302|63060340|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
33650074|NCT01277302|63060341|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
33650075|NCT01277302|63060339|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
33650076|NCT01277302|63060340|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
33650077|NCT01277302|63060341|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
33650078|NCT01277302|63060339|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
33650079|NCT01277302|63060340|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
33650080|NCT01277302|63060341|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
33650081|NCT01277302|63060339|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
33650082|NCT01277302|63060340|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
33650083|NCT01277302|63060341|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
33650084|NCT01277302|63060339|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
33650085|NCT01277302|63060340|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
33650086|NCT01277302|63060341|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
33650087|NCT01980875|63060352|FG000|Overall Study|Withdrew Consent|1|||
33650088|NCT01980875|63060353|FG001|Overall Study|Withdrew Consent|1|||
33650089|NCT01980875|63060354|FG002|Overall Study|Withdrew Consent|1|||
33650090|NCT01980875|63060352|FG000|Overall Study|Study Terminated by Sponsor|7|||
33650091|NCT01980875|63060353|FG001|Overall Study|Study Terminated by Sponsor|24|||
33650092|NCT01980875|63060354|FG002|Overall Study|Study Terminated by Sponsor|22|||
33650093|NCT01980875|63060352|FG000|Overall Study|Lost to Follow-up|0|||
33650094|NCT01980875|63060353|FG001|Overall Study|Lost to Follow-up|0|||
33650095|NCT01980875|63060354|FG002|Overall Study|Lost to Follow-up|1|||
33650096|NCT01995461|63060362|FG000|Overall Study|Death|1|||
33650097|NCT01995461|63060362|FG000|Overall Study|Lost to Follow-up|2|||
33650098|NCT01995461|63060362|FG000|Overall Study|Withdrawal by Subject|2|||
33650099|NCT01980095|63060368|FG000|Overall Study|Lost to Follow-up|6|||
33650100|NCT01980095|63060369|FG001|Overall Study|Lost to Follow-up|7|||
33650101|NCT01980095|63060368|FG000|Overall Study|Withdrawal by Subject|2|||
33650102|NCT01980095|63060369|FG001|Overall Study|Withdrawal by Subject|3|||
33650103|NCT01980095|63060368|FG000|Overall Study|Poor compliance|5|||
33650104|NCT01980095|63060369|FG001|Overall Study|Poor compliance|0|||
33650105|NCT01980095|63060368|FG000|Overall Study|Safety issue|0|||
33650106|NCT01980095|63060369|FG001|Overall Study|Safety issue|1|||
33650107|NCT01980095|63060368|FG000|Overall Study|Study drug discontinued|1|||
33650108|NCT01980095|63060369|FG001|Overall Study|Study drug discontinued|0|||
33650109|NCT01980095|63060368|FG000|Overall Study|Randomized by mistake|1|||
33650110|NCT01980095|63060369|FG001|Overall Study|Randomized by mistake|0|||
33650111|NCT01980017|63060379|FG000|Overall Study|Lost to Follow-up|30|||
33650112|NCT01980017|63060380|FG001|Overall Study|Lost to Follow-up|21|||
33650113|NCT01980017|63060379|FG000|Overall Study|Death|0|||
33650114|NCT01980017|63060380|FG001|Overall Study|Death|1|||
33650115|NCT01978145|63060389|FG000|Treatment Period 1|Adverse Event|1|||
33650116|NCT01978145|63060390|FG001|Treatment Period 1|Adverse Event|9|||
33650117|NCT01978145|63060389|FG000|Treatment Period 1|Physician Decision|1|||
33650118|NCT01978145|63060390|FG001|Treatment Period 1|Physician Decision|0|||
33650119|NCT01978145|63060389|FG000|Treatment Period 1|Withdrawal by Subject|5|||
33650120|NCT01978145|63060390|FG001|Treatment Period 1|Withdrawal by Subject|4|||
33650121|NCT01978145|63060389|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
33650122|NCT01978145|63060390|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
33650123|NCT01978145|63060389|FG000|Washout Period 1|Adverse Event|0|||
33650124|NCT01978145|63060390|FG001|Washout Period 1|Adverse Event|1|||
33650125|NCT01978145|63060389|FG000|Washout Period 1|Withdrawal by Subject|1|||
33650126|NCT01978145|63060390|FG001|Washout Period 1|Withdrawal by Subject|1|||
33650127|NCT01978145|63060389|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
33650128|NCT01978145|63060390|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
33650129|NCT01978145|63060389|FG000|Treatment Period 2|Adverse Event|3|||
33650130|NCT01978145|63060390|FG001|Treatment Period 2|Adverse Event|3|||
33650131|NCT01978145|63060389|FG000|Treatment Period 2|Protocol Violation|0|||
33650132|NCT01978145|63060390|FG001|Treatment Period 2|Protocol Violation|1|||
33650133|NCT01978145|63060389|FG000|Treatment Period 2|Lost to Follow-up|1|||
33650134|NCT01978145|63060390|FG001|Treatment Period 2|Lost to Follow-up|1|||
33650135|NCT01978145|63060389|FG000|Treatment Period 2|Withdrawal by Subject|7|||
33650136|NCT01978145|63060390|FG001|Treatment Period 2|Withdrawal by Subject|4|||
33650137|NCT01978145|63060389|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
33650138|NCT01978145|63060390|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
33650139|NCT01967537|63060396|FG000|Overall Study|Withdrawal by Subject|52|||
33650140|NCT01967537|63060396|FG000|Overall Study|Refuse treatment|2|||
33650141|NCT01967537|63060396|FG000|Overall Study|Lost to Follow-up|6|||
33650142|NCT01967225|63060404|FG000|Overall Study|Adverse Event|3|||
33650143|NCT01967225|63060405|FG001|Overall Study|Adverse Event|1|||
33650144|NCT01967225|63060404|FG000|Overall Study|Withdrawal by Subject|2|||
33650145|NCT01967225|63060405|FG001|Overall Study|Withdrawal by Subject|1|||
33650146|NCT01967225|63060404|FG000|Overall Study|Lack of Efficacy|1|||
33650147|NCT01967225|63060405|FG001|Overall Study|Lack of Efficacy|1|||
33650148|NCT01967225|63060404|FG000|Overall Study|Switching to other therapy|2|||
33650149|NCT01967225|63060405|FG001|Overall Study|Switching to other therapy|0|||
33650150|NCT01967225|63060404|FG000|Overall Study|Protocol driven decision point|1|||
33650151|NCT01967225|63060405|FG001|Overall Study|Protocol driven decision point|0|||
33650152|NCT01967225|63060404|FG000|Overall Study|Logistical difficulties|1|||
33650153|NCT01967225|63060405|FG001|Overall Study|Logistical difficulties|0|||
33650154|NCT01967225|63060404|FG000|Overall Study|Protocol Violation|2|||
33650155|NCT01967225|63060405|FG001|Overall Study|Protocol Violation|0|||
33650156|NCT01967147|63060415|FG000|Overall Study|Adverse Event|5|||
33650157|NCT01967147|63060416|FG001|Overall Study|Adverse Event|2|||
33543618|NCT00968201|62934440|FG001|Extension Study - (Period III)|Adverse Event|5|||
33543619|NCT00968201|62934441|FG002|Extension Study - (Period III)|Adverse Event|22|||
33543620|NCT00968201|62934439|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
33543621|NCT00968201|62934440|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
33543622|NCT00968201|62934441|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
33543623|NCT00968201|62934439|FG000|Extension Study - (Period III)|Protocol Violation|0|||
33543624|NCT00968201|62934440|FG001|Extension Study - (Period III)|Protocol Violation|17|||
33543625|NCT00968201|62934441|FG002|Extension Study - (Period III)|Protocol Violation|14|||
33650158|NCT01967147|63060415|FG000|Overall Study|Lack of Efficacy|1|||
33650159|NCT01967147|63060416|FG001|Overall Study|Lack of Efficacy|4|||
33650160|NCT01967147|63060415|FG000|Overall Study|Lost to Follow-up|1|||
33650161|NCT01967147|63060416|FG001|Overall Study|Lost to Follow-up|2|||
33650162|NCT01967147|63060415|FG000|Overall Study|Withdrawal by Subject|2|||
33650163|NCT01967147|63060416|FG001|Overall Study|Withdrawal by Subject|4|||
33650164|NCT01967147|63060415|FG000|Overall Study|Non-compliance with Study Drug|0|||
33543626|NCT00968201|62934439|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
33650165|NCT01967147|63060416|FG001|Overall Study|Non-compliance with Study Drug|3|||
33650166|NCT01967147|63060415|FG000|Overall Study|Other|4|||
33650167|NCT01967147|63060416|FG001|Overall Study|Other|5|||
33650168|NCT01967069|63060425|FG000|Overall Study|Adverse Event|2|||
33650169|NCT01967069|63060426|FG001|Overall Study|Adverse Event|2|||
33650170|NCT01967069|63060425|FG000|Overall Study|Lost to Follow-up|5|||
33650171|NCT01967069|63060426|FG001|Overall Study|Lost to Follow-up|2|||
33650172|NCT01967069|63060425|FG000|Overall Study|Withdrawal by Subject|1|||
33650173|NCT01967069|63060426|FG001|Overall Study|Withdrawal by Subject|3|||
33650174|NCT01967069|63060425|FG000|Overall Study|Lack of Efficacy|0|||
33650175|NCT01967069|63060426|FG001|Overall Study|Lack of Efficacy|1|||
33650176|NCT01790503|63060443|FG000|Overall Study|Adverse Event|1|||
33650177|NCT01790503|63060444|FG001|Overall Study|Adverse Event|0|||
33650178|NCT01790503|63060445|FG002|Overall Study|Adverse Event|0|||
33650179|NCT01790503|63060446|FG003|Overall Study|Adverse Event|0|||
33650180|NCT01790503|63060447|FG004|Overall Study|Adverse Event|0|||
33650181|NCT01790503|63060448|FG005|Overall Study|Adverse Event|2|||
33650182|NCT01790503|63060449|FG006|Overall Study|Adverse Event|0|||
33650183|NCT01790503|63060450|FG007|Overall Study|Adverse Event|0|||
33650184|NCT01790503|63060451|FG008|Overall Study|Adverse Event|2|||
33650185|NCT01790503|63060452|FG009|Overall Study|Adverse Event|4|||
33650186|NCT01790503|63060453|FG010|Overall Study|Adverse Event|7|||
33650187|NCT01790503|63060443|FG000|Overall Study|Withdrawal by Subject|0|||
33650188|NCT01790503|63060444|FG001|Overall Study|Withdrawal by Subject|0|||
33650189|NCT01790503|63060445|FG002|Overall Study|Withdrawal by Subject|1|||
33650190|NCT01790503|63060446|FG003|Overall Study|Withdrawal by Subject|1|||
33650191|NCT01790503|63060447|FG004|Overall Study|Withdrawal by Subject|1|||
33650192|NCT01790503|63060448|FG005|Overall Study|Withdrawal by Subject|2|||
33650193|NCT01790503|63060449|FG006|Overall Study|Withdrawal by Subject|1|||
33650194|NCT01790503|63060450|FG007|Overall Study|Withdrawal by Subject|0|||
33650195|NCT01790503|63060451|FG008|Overall Study|Withdrawal by Subject|0|||
33650196|NCT01790503|63060452|FG009|Overall Study|Withdrawal by Subject|0|||
33650197|NCT01790503|63060453|FG010|Overall Study|Withdrawal by Subject|1|||
33650198|NCT01790503|63060443|FG000|Overall Study|Disease progression|2|||
33650199|NCT01790503|63060444|FG001|Overall Study|Disease progression|1|||
33650200|NCT01790503|63060445|FG002|Overall Study|Disease progression|0|||
33650201|NCT01790503|63060446|FG003|Overall Study|Disease progression|1|||
33650202|NCT01790503|63060447|FG004|Overall Study|Disease progression|2|||
33650203|NCT01790503|63060448|FG005|Overall Study|Disease progression|1|||
33650204|NCT01790503|63060449|FG006|Overall Study|Disease progression|0|||
33650205|NCT01790503|63060450|FG007|Overall Study|Disease progression|1|||
33650206|NCT01790503|63060451|FG008|Overall Study|Disease progression|0|||
33650207|NCT01790503|63060452|FG009|Overall Study|Disease progression|17|||
33650208|NCT01790503|63060453|FG010|Overall Study|Disease progression|7|||
33650209|NCT01790503|63060443|FG000|Overall Study|Protocol Violation|0|||
33650210|NCT01790503|63060444|FG001|Overall Study|Protocol Violation|0|||
33650211|NCT01790503|63060445|FG002|Overall Study|Protocol Violation|0|||
33650212|NCT01790503|63060446|FG003|Overall Study|Protocol Violation|0|||
33650213|NCT01790503|63060447|FG004|Overall Study|Protocol Violation|0|||
33650214|NCT01790503|63060448|FG005|Overall Study|Protocol Violation|0|||
33650215|NCT01790503|63060449|FG006|Overall Study|Protocol Violation|0|||
33650216|NCT01790503|63060450|FG007|Overall Study|Protocol Violation|0|||
33650217|NCT01790503|63060451|FG008|Overall Study|Protocol Violation|0|||
33650218|NCT01790503|63060452|FG009|Overall Study|Protocol Violation|1|||
33650219|NCT01790503|63060453|FG010|Overall Study|Protocol Violation|0|||
33650220|NCT01790503|63060443|FG000|Overall Study|Physician Decision|0|||
33650221|NCT01790503|63060444|FG001|Overall Study|Physician Decision|0|||
33650222|NCT01790503|63060445|FG002|Overall Study|Physician Decision|0|||
33650223|NCT01790503|63060446|FG003|Overall Study|Physician Decision|0|||
33650224|NCT01790503|63060447|FG004|Overall Study|Physician Decision|0|||
33650225|NCT01790503|63060448|FG005|Overall Study|Physician Decision|0|||
33650226|NCT01790503|63060449|FG006|Overall Study|Physician Decision|0|||
33650227|NCT01790503|63060450|FG007|Overall Study|Physician Decision|0|||
33650228|NCT01790503|63060451|FG008|Overall Study|Physician Decision|0|||
33650229|NCT01790503|63060452|FG009|Overall Study|Physician Decision|1|||
33650230|NCT01790503|63060453|FG010|Overall Study|Physician Decision|1|||
33650231|NCT01790503|63060443|FG000|Overall Study|Death|0|||
33650232|NCT01790503|63060444|FG001|Overall Study|Death|0|||
33650233|NCT01790503|63060445|FG002|Overall Study|Death|0|||
33650234|NCT01790503|63060446|FG003|Overall Study|Death|0|||
33650235|NCT01790503|63060447|FG004|Overall Study|Death|0|||
33650236|NCT01790503|63060448|FG005|Overall Study|Death|0|||
33650237|NCT01790503|63060449|FG006|Overall Study|Death|0|||
33650238|NCT01790503|63060450|FG007|Overall Study|Death|0|||
33650239|NCT01790503|63060451|FG008|Overall Study|Death|0|||
33650240|NCT01790503|63060452|FG009|Overall Study|Death|1|||
33650241|NCT01790503|63060453|FG010|Overall Study|Death|0|||
33650242|NCT01790503|63060443|FG000|Overall Study|Non Compliance|0|||
33650243|NCT01790503|63060444|FG001|Overall Study|Non Compliance|0|||
33650244|NCT01790503|63060445|FG002|Overall Study|Non Compliance|0|||
33650245|NCT01790503|63060446|FG003|Overall Study|Non Compliance|0|||
33650246|NCT01790503|63060447|FG004|Overall Study|Non Compliance|1|||
33650247|NCT01790503|63060448|FG005|Overall Study|Non Compliance|0|||
33650248|NCT01790503|63060449|FG006|Overall Study|Non Compliance|0|||
33650249|NCT01790503|63060450|FG007|Overall Study|Non Compliance|0|||
33650250|NCT01790503|63060451|FG008|Overall Study|Non Compliance|0|||
33650251|NCT01790503|63060452|FG009|Overall Study|Non Compliance|0|||
33650252|NCT01790503|63060453|FG010|Overall Study|Non Compliance|0|||
33650253|NCT01790503|63060443|FG000|Overall Study|Other|0|||
33650254|NCT01790503|63060444|FG001|Overall Study|Other|0|||
33650255|NCT01790503|63060445|FG002|Overall Study|Other|0|||
33650256|NCT01790503|63060446|FG003|Overall Study|Other|0|||
33650257|NCT01790503|63060447|FG004|Overall Study|Other|1|||
33650258|NCT01790503|63060448|FG005|Overall Study|Other|0|||
33650259|NCT01790503|63060449|FG006|Overall Study|Other|0|||
33650260|NCT01790503|63060450|FG007|Overall Study|Other|0|||
33650261|NCT01790503|63060451|FG008|Overall Study|Other|1|||
33650262|NCT01790503|63060452|FG009|Overall Study|Other|2|||
33650263|NCT01790503|63060453|FG010|Overall Study|Other|0|||
33650264|NCT01790113|63060492|FG000|Overall Study|Adverse Event|2|||
33650265|NCT01790113|63060493|FG001|Overall Study|Adverse Event|7|||
33650266|NCT01790113|63060492|FG000|Overall Study|Study ended due to FDA clearance|1|||
33650267|NCT01790113|63060493|FG001|Overall Study|Study ended due to FDA clearance|68|||
33650268|NCT01789567|63060499|FG000|Overall Study|Death|6|||
33650269|NCT01765543|63060503|FG000|Overall Study|Death|1|||
33650270|NCT01765543|63060503|FG000|Overall Study|Withdrawal by Subject|2|||
33650271|NCT01765153|63060513|FG000|Training Phase 1|Format of intervention differed|1|||
33650272|NCT01765153|63060514|FG001|Training Phase 1|Format of intervention differed|0|||
33650273|NCT01765153|63060513|FG000|Training Phase 1|Poor participation in intervention|0|||
33650274|NCT01765153|63060514|FG001|Training Phase 1|Poor participation in intervention|1|||
33650275|NCT01765153|63060513|FG000|Rest Phase 1|Withdrawal by Subject|0|||
33650276|NCT01765153|63060514|FG001|Rest Phase 1|Withdrawal by Subject|1|||
33650277|NCT01765153|63060513|FG000|Training Phase 2|Withdrawal by Subject|0|||
33650278|NCT01765153|63060514|FG001|Training Phase 2|Withdrawal by Subject|1|||
33650279|NCT01765153|63060513|FG000|Rest Phase 2|Lost to Follow-up|2|||
33650280|NCT01765153|63060514|FG001|Rest Phase 2|Lost to Follow-up|1|||
33650281|NCT00248170|63060526|FG000|Overall Study|Withdrawal by Subject|71|||
33650282|NCT00248170|63060527|FG001|Overall Study|Withdrawal by Subject|79|||
33650283|NCT00248170|63060526|FG000|Overall Study|Protocol Violation|35|||
33650284|NCT00248170|63060527|FG001|Overall Study|Protocol Violation|30|||
33650285|NCT00248170|63060526|FG000|Overall Study|Lost to Follow-up|28|||
33650286|NCT00248170|63060527|FG001|Overall Study|Lost to Follow-up|35|||
33650287|NCT00248170|63060526|FG000|Overall Study|Disease progression|196|||
33650288|NCT00248170|63060527|FG001|Overall Study|Disease progression|216|||
33650289|NCT00248170|63060526|FG000|Overall Study|Death|28|||
33650290|NCT00248170|63060527|FG001|Overall Study|Death|47|||
33650291|NCT00248170|63060526|FG000|Overall Study|Adverse Event|311|||
33650292|NCT00248170|63060527|FG001|Overall Study|Adverse Event|296|||
33650293|NCT00248170|63060526|FG000|Overall Study|Administrative problems|22|||
33650294|NCT00248170|63060527|FG001|Overall Study|Administrative problems|25|||
33650295|NCT00248170|63060526|FG000|Overall Study|Abnormal test procedure(s) result|49|||
33650296|NCT00248170|63060527|FG001|Overall Study|Abnormal test procedure(s) result|61|||
33650297|NCT00248170|63060526|FG000|Overall Study|Abnormal laboratory values|4|||
33650298|NCT00248170|63060527|FG001|Overall Study|Abnormal laboratory values|0|||
33650299|NCT00248170|63060526|FG000|Overall Study|Protocol deviation|17|||
33650300|NCT00248170|63060527|FG001|Overall Study|Protocol deviation|19|||
33650301|NCT01764997|63060538|FG000|Run-in Period|Adverse Event|15|||
33650302|NCT01764997|63060539|FG001|Run-in Period|Adverse Event|0|||
33650303|NCT01764997|63060540|FG002|Run-in Period|Adverse Event|0|||
33650304|NCT01764997|63060541|FG003|Run-in Period|Adverse Event|0|||
33650305|NCT01764997|63060542|FG004|Run-in Period|Adverse Event|0|||
33650306|NCT01764997|63060538|FG000|Run-in Period|Lack of Efficacy|5|||
33650307|NCT01764997|63060539|FG001|Run-in Period|Lack of Efficacy|0|||
33650308|NCT01764997|63060540|FG002|Run-in Period|Lack of Efficacy|0|||
33328078|NCT00864253|62704508|FG001|Overall Study|Death|0|||
33328079|NCT00864253|62704507|FG000|Overall Study|Ongoing|2|||
33464119|NCT02577406|62837653|FG001|Treatment Period|Disease relapse|1|||
33650309|NCT01764997|63060541|FG003|Run-in Period|Lack of Efficacy|0|||
33650310|NCT01764997|63060542|FG004|Run-in Period|Lack of Efficacy|0|||
33650311|NCT01764997|63060538|FG000|Run-in Period|Poor compliance to protocol|1|||
33650312|NCT01764997|63060539|FG001|Run-in Period|Poor compliance to protocol|0|||
33650313|NCT01764997|63060540|FG002|Run-in Period|Poor compliance to protocol|0|||
33650314|NCT01764997|63060541|FG003|Run-in Period|Poor compliance to protocol|0|||
33650315|NCT01764997|63060542|FG004|Run-in Period|Poor compliance to protocol|0|||
33650316|NCT01764997|63060538|FG000|Run-in Period|Other than specified above|17|||
33650317|NCT01764997|63060539|FG001|Run-in Period|Other than specified above|0|||
33650318|NCT01764997|63060540|FG002|Run-in Period|Other than specified above|0|||
33650319|NCT01764997|63060541|FG003|Run-in Period|Other than specified above|0|||
33650320|NCT01764997|63060542|FG004|Run-in Period|Other than specified above|0|||
33328080|NCT00864253|62704508|FG001|Overall Study|Ongoing|3|||
33650321|NCT01764997|63060538|FG000|Study Drug Treatment Period|Adverse Event|0|||
33650322|NCT01764997|63060539|FG001|Study Drug Treatment Period|Adverse Event|1|||
33650323|NCT01764997|63060540|FG002|Study Drug Treatment Period|Adverse Event|0|||
33650324|NCT01764997|63060541|FG003|Study Drug Treatment Period|Adverse Event|0|||
33650325|NCT01764997|63060542|FG004|Study Drug Treatment Period|Adverse Event|24|||
33650326|NCT01764997|63060538|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
33650327|NCT01764997|63060539|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
33650328|NCT01764997|63060540|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
33650329|NCT01764997|63060541|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
33650330|NCT01764997|63060542|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
33650331|NCT01764997|63060538|FG000|Study Drug Treatment Period|Other than specified above|0|||
33650332|NCT01764997|63060539|FG001|Study Drug Treatment Period|Other than specified above|0|||
33650333|NCT01764997|63060540|FG002|Study Drug Treatment Period|Other than specified above|0|||
33650334|NCT01764997|63060541|FG003|Study Drug Treatment Period|Other than specified above|0|||
33650335|NCT01764997|63060542|FG004|Study Drug Treatment Period|Other than specified above|10|||
33650336|NCT01276756|63060554|FG000|Overall Study|Lost to Follow-up|2|||
33650337|NCT01276756|63060555|FG001|Overall Study|Lost to Follow-up|0|||
33650338|NCT01276756|63060554|FG000|Overall Study|Adverse Event|3|||
33650339|NCT01276756|63060555|FG001|Overall Study|Adverse Event|2|||
33650340|NCT00246376|63060566|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
33650341|NCT00246376|63060567|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
33650342|NCT00246376|63060568|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
33650343|NCT00246376|63060569|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
33650344|NCT00246376|63060570|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
33650345|NCT00246376|63060566|FG000|Overall Study|Adverse Event|2|||
33650346|NCT00246376|63060567|FG001|Overall Study|Adverse Event|3|||
33650347|NCT00246376|63060568|FG002|Overall Study|Adverse Event|1|||
33650348|NCT00246376|63060569|FG003|Overall Study|Adverse Event|3|||
33650349|NCT00246376|63060570|FG004|Overall Study|Adverse Event|1|||
33650350|NCT00246376|63060566|FG000|Overall Study|Lost to Follow-up|2|||
33650351|NCT00246376|63060567|FG001|Overall Study|Lost to Follow-up|11|||
33650352|NCT00246376|63060568|FG002|Overall Study|Lost to Follow-up|11|||
33650353|NCT00246376|63060569|FG003|Overall Study|Lost to Follow-up|16|||
33650354|NCT00246376|63060570|FG004|Overall Study|Lost to Follow-up|13|||
33650355|NCT01764841|63060628|FG000|Overall Study|Logistical Difficulties|0|||
33650356|NCT01764841|63060629|FG001|Overall Study|Logistical Difficulties|1|||
33650357|NCT01764841|63060630|FG002|Overall Study|Logistical Difficulties|0|||
33650358|NCT01764841|63060631|FG003|Overall Study|Logistical Difficulties|0|||
33650359|NCT01764841|63060628|FG000|Overall Study|Death|3|||
33650360|NCT01764841|63060629|FG001|Overall Study|Death|0|||
33650361|NCT01764841|63060630|FG002|Overall Study|Death|1|||
33650362|NCT01764841|63060631|FG003|Overall Study|Death|4|||
33650363|NCT01764841|63060628|FG000|Overall Study|No Follow Up|1|||
33650364|NCT01764841|63060629|FG001|Overall Study|No Follow Up|0|||
33650365|NCT01764841|63060630|FG002|Overall Study|No Follow Up|1|||
33650366|NCT01764841|63060631|FG003|Overall Study|No Follow Up|0|||
33650367|NCT01764841|63060628|FG000|Overall Study|Protocol Violation|0|||
33650368|NCT01764841|63060629|FG001|Overall Study|Protocol Violation|1|||
33650369|NCT01764841|63060630|FG002|Overall Study|Protocol Violation|0|||
33650370|NCT01764841|63060631|FG003|Overall Study|Protocol Violation|0|||
33650371|NCT01764841|63060628|FG000|Overall Study|Withdrawal by Subject|16|||
33650372|NCT01764841|63060629|FG001|Overall Study|Withdrawal by Subject|24|||
33650373|NCT01764841|63060630|FG002|Overall Study|Withdrawal by Subject|11|||
33650374|NCT01764841|63060631|FG003|Overall Study|Withdrawal by Subject|15|||
33650375|NCT01764841|63060628|FG000|Overall Study|Lost to Follow-up|3|||
33650376|NCT01764841|63060629|FG001|Overall Study|Lost to Follow-up|0|||
33650377|NCT01764841|63060630|FG002|Overall Study|Lost to Follow-up|1|||
33650378|NCT01764841|63060631|FG003|Overall Study|Lost to Follow-up|0|||
33650379|NCT00245050|63060643|FG000|Overall Study|Adverse Event|3|||
33650380|NCT00245050|63060644|FG001|Overall Study|Adverse Event|2|||
33650381|NCT00243412|63060682|FG000|Overall Study|Death|0|||
33650382|NCT00243412|63060683|FG001|Overall Study|Death|1|||
33650383|NCT00243412|63060682|FG000|Overall Study|Adverse Event|4|||
33650384|NCT00243412|63060683|FG001|Overall Study|Adverse Event|2|||
33650385|NCT00243412|63060682|FG000|Overall Study|Lost to Follow-up|0|||
33650386|NCT00243412|63060683|FG001|Overall Study|Lost to Follow-up|1|||
33650387|NCT00243412|63060682|FG000|Overall Study|Physician Decision|1|||
33650388|NCT00243412|63060683|FG001|Overall Study|Physician Decision|1|||
33650389|NCT00243412|63060682|FG000|Overall Study|Withdrawal by Subject|4|||
33650390|NCT00243412|63060683|FG001|Overall Study|Withdrawal by Subject|5|||
33650391|NCT00243412|63060682|FG000|Overall Study|Other|1|||
33650392|NCT00243412|63060683|FG001|Overall Study|Other|1|||
33650393|NCT03805750|63060698|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
33650394|NCT03805750|63060699|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
33650395|NCT03804268|63060707|FG000|Overall Study|Adverse Event|2|||
33650396|NCT03804268|63060708|FG001|Overall Study|Adverse Event|2|||
33650397|NCT03804268|63060707|FG000|Overall Study|Withdrawal by Subject|2|||
33650398|NCT03804268|63060708|FG001|Overall Study|Withdrawal by Subject|0|||
33650399|NCT03804268|63060707|FG000|Overall Study|Lost to Follow-up|1|||
33650400|NCT03804268|63060708|FG001|Overall Study|Lost to Follow-up|0|||
33650401|NCT03804268|63060707|FG000|Overall Study|Physician Decision|2|||
33650402|NCT03804268|63060708|FG001|Overall Study|Physician Decision|0|||
33650403|NCT00243022|63060733|FG000|Overall Study|Withdrawal by Subject|1|||
33650404|NCT00243022|63060734|FG001|Overall Study|Withdrawal by Subject|0|||
33650405|NCT00243022|63060733|FG000|Overall Study|Death|1|||
33650406|NCT00243022|63060734|FG001|Overall Study|Death|0|||
33650407|NCT00243022|63060733|FG000|Overall Study|Difficult Travel Distance|0|||
33650408|NCT00243022|63060734|FG001|Overall Study|Difficult Travel Distance|1|||
33650409|NCT01736683|63060819|FG000|Overall Study|Disease Relapse|0|||
33650410|NCT01736683|63060820|FG001|Overall Study|Disease Relapse|0|||
33650411|NCT01736683|63060821|FG002|Overall Study|Disease Relapse|2|||
33650412|NCT01736683|63060822|FG003|Overall Study|Disease Relapse|1|||
33650413|NCT01736683|63060823|FG004|Overall Study|Disease Relapse|0|||
33650414|NCT01736683|63060819|FG000|Overall Study|Adverse Event|0|||
33650415|NCT01736683|63060820|FG001|Overall Study|Adverse Event|2|||
33650416|NCT01736683|63060821|FG002|Overall Study|Adverse Event|2|||
33650417|NCT01736683|63060822|FG003|Overall Study|Adverse Event|3|||
33650418|NCT01736683|63060823|FG004|Overall Study|Adverse Event|2|||
33650419|NCT01736683|63060819|FG000|Overall Study|Withdrawal by Subject|0|||
33650420|NCT01736683|63060820|FG001|Overall Study|Withdrawal by Subject|0|||
33650421|NCT01736683|63060821|FG002|Overall Study|Withdrawal by Subject|3|||
33650422|NCT01736683|63060822|FG003|Overall Study|Withdrawal by Subject|1|||
33650423|NCT01736683|63060823|FG004|Overall Study|Withdrawal by Subject|1|||
33650424|NCT01736683|63060819|FG000|Overall Study|Lack of Therapeutic Effect|7|||
33650425|NCT01736683|63060820|FG001|Overall Study|Lack of Therapeutic Effect|4|||
33650426|NCT01736683|63060821|FG002|Overall Study|Lack of Therapeutic Effect|13|||
33650427|NCT01736683|63060822|FG003|Overall Study|Lack of Therapeutic Effect|20|||
33650428|NCT01736683|63060823|FG004|Overall Study|Lack of Therapeutic Effect|1|||
33650429|NCT01736683|63060819|FG000|Overall Study|Progressive Disease|0|||
33650430|NCT01736683|63060820|FG001|Overall Study|Progressive Disease|0|||
33650431|NCT01736683|63060821|FG002|Overall Study|Progressive Disease|0|||
33650432|NCT01736683|63060822|FG003|Overall Study|Progressive Disease|1|||
33650433|NCT01736683|63060823|FG004|Overall Study|Progressive Disease|0|||
33650434|NCT01736683|63060819|FG000|Overall Study|Other|0|||
33650435|NCT01736683|63060820|FG001|Overall Study|Other|0|||
33650436|NCT01736683|63060821|FG002|Overall Study|Other|1|||
33650437|NCT01736683|63060822|FG003|Overall Study|Other|9|||
33650438|NCT01736683|63060823|FG004|Overall Study|Other|1|||
33650439|NCT01788943|63060839|FG000|Overall Study|Withdrawal by Subject|1|||
33650440|NCT01788943|63060840|FG001|Overall Study|Withdrawal by Subject|0|||
33650441|NCT01788163|63060867|FG000|Overall Study|Other|53|||
33650442|NCT01788163|63060868|FG001|Overall Study|Other|0|||
33650443|NCT01788163|63060869|FG002|Overall Study|Other|0|||
33650444|NCT01788163|63060870|FG003|Overall Study|Other|0|||
33650445|NCT01788163|63060871|FG004|Overall Study|Other|0|||
33650446|NCT01788163|63060872|FG005|Overall Study|Other|7|||
33650447|NCT01788163|63060873|FG006|Overall Study|Other|1|||
33650448|NCT01788163|63060874|FG007|Overall Study|Other|48|||
33650449|NCT01788163|63060875|FG008|Overall Study|Other|15|||
33650450|NCT01788163|63060867|FG000|Overall Study|Withdrawal by Subject|2|||
33650451|NCT01788163|63060868|FG001|Overall Study|Withdrawal by Subject|0|||
33650452|NCT01788163|63060869|FG002|Overall Study|Withdrawal by Subject|0|||
33650453|NCT01788163|63060870|FG003|Overall Study|Withdrawal by Subject|0|||
33650454|NCT01788163|63060871|FG004|Overall Study|Withdrawal by Subject|0|||
33650455|NCT01788163|63060872|FG005|Overall Study|Withdrawal by Subject|0|||
33650456|NCT01788163|63060873|FG006|Overall Study|Withdrawal by Subject|0|||
33650457|NCT01788163|63060874|FG007|Overall Study|Withdrawal by Subject|0|||
33650458|NCT01788163|63060875|FG008|Overall Study|Withdrawal by Subject|1|||
33650459|NCT01787461|63061011|FG000|Overall Study|Adverse Event|4|||
33650460|NCT01787461|63061012|FG001|Overall Study|Adverse Event|3|||
33650461|NCT01787461|63061011|FG000|Overall Study|Lost to Follow-up|3|||
33650462|NCT01787461|63061012|FG001|Overall Study|Lost to Follow-up|2|||
33650463|NCT01787461|63061011|FG000|Overall Study|No longer met eligibility criteria|1|||
33650464|NCT01787461|63061012|FG001|Overall Study|No longer met eligibility criteria|0|||
33650465|NCT01787461|63061011|FG000|Overall Study|Withdrawal by Subject|3|||
33650466|NCT01787461|63061012|FG001|Overall Study|Withdrawal by Subject|4|||
33650467|NCT01787461|63061011|FG000|Overall Study|Protocol Violation|3|||
33650468|NCT01787461|63061012|FG001|Overall Study|Protocol Violation|0|||
33650469|NCT01786993|63061037|FG000|Overall Study|Death|6|||
33650470|NCT01786993|63061038|FG001|Overall Study|Death|7|||
33650471|NCT01786993|63061037|FG000|Overall Study|Withdrawal by Subject|3|||
33650472|NCT01786993|63061038|FG001|Overall Study|Withdrawal by Subject|2|||
33650473|NCT01786993|63061037|FG000|Overall Study|Lost to Follow-up|0|||
33650474|NCT01786993|63061038|FG001|Overall Study|Lost to Follow-up|1|||
33650475|NCT01786993|63061037|FG000|Overall Study|Subject Non-Compliance|1|||
33650476|NCT01786993|63061038|FG001|Overall Study|Subject Non-Compliance|0|||
33650477|NCT01786993|63061037|FG000|Overall Study|System Explant|1|||
33650478|NCT01786993|63061038|FG001|Overall Study|System Explant|0|||
33650479|NCT01786993|63061037|FG000|Overall Study|Hospice Admission|1|||
33650480|NCT01786993|63061038|FG001|Overall Study|Hospice Admission|0|||
33650481|NCT01966445|63061063|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
33650482|NCT01966445|63061064|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
33650483|NCT01966445|63061065|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
33650484|NCT01966445|63061066|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
33650485|NCT01966445|63061067|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
33650486|NCT01966445|63061068|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
33650487|NCT01966445|63061069|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
33650488|NCT01966445|63061063|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
33650489|NCT01966445|63061064|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
33650490|NCT01966445|63061065|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
33650491|NCT01966445|63061066|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
33650492|NCT01966445|63061067|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
33650493|NCT01966445|63061068|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
33650494|NCT01966445|63061069|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
33650495|NCT01966445|63061063|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
33650496|NCT01966445|63061064|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
33650497|NCT01966445|63061065|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
33650498|NCT01966445|63061066|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
33650499|NCT01966445|63061067|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
33650500|NCT01966445|63061068|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
33650501|NCT01966445|63061069|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
33650502|NCT01966445|63061063|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
33650503|NCT01966445|63061064|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
33650504|NCT01966445|63061065|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
33650505|NCT01966445|63061066|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
33650506|NCT01966445|63061067|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
33650507|NCT01966445|63061068|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
33650508|NCT01966445|63061069|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
33650509|NCT01966445|63061063|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
33650510|NCT01966445|63061064|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
33650511|NCT01966445|63061065|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
33650512|NCT01966445|63061066|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
33650513|NCT01966445|63061067|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
33650514|NCT01966445|63061068|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
33650515|NCT01966445|63061069|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
33650516|NCT01763905|63061089|FG000|Overall Study|Withdrawal by Subject|1|||
33650517|NCT01763905|63061090|FG001|Overall Study|Withdrawal by Subject|1|||
33650518|NCT01763905|63061091|FG002|Overall Study|Withdrawal by Subject|0|||
33650519|NCT01763905|63061092|FG003|Overall Study|Withdrawal by Subject|1|||
33650520|NCT01763905|63061089|FG000|Overall Study|Decision by sponsor|5|||
33650521|NCT01763905|63061090|FG001|Overall Study|Decision by sponsor|0|||
33650522|NCT01763905|63061091|FG002|Overall Study|Decision by sponsor|8|||
33650523|NCT01763905|63061092|FG003|Overall Study|Decision by sponsor|0|||
33650524|NCT01763905|63061089|FG000|Overall Study|Lost to Follow-up|0|||
33650525|NCT01763905|63061090|FG001|Overall Study|Lost to Follow-up|0|||
33650526|NCT01763905|63061091|FG002|Overall Study|Lost to Follow-up|1|||
33650527|NCT01763905|63061092|FG003|Overall Study|Lost to Follow-up|0|||
33650528|NCT02091167|63061104|FG000|Overall Study|Lost to Follow-up|0|||
33650529|NCT02091167|63061105|FG001|Overall Study|Lost to Follow-up|2|||
33650530|NCT02091089|63061111|FG000|Overall Study|Lost to Follow-up|2|||
33650531|NCT01763203|63061126|FG000|Overall Study|Death|4|||
33650532|NCT01763203|63061127|FG001|Overall Study|Death|7|||
33650533|NCT01763203|63061126|FG000|Overall Study|Lost to Follow-up|12|||
33650534|NCT01763203|63061127|FG001|Overall Study|Lost to Follow-up|12|||
33650535|NCT01763203|63061126|FG000|Overall Study|Withdrawal by Subject|8|||
33650536|NCT01763203|63061127|FG001|Overall Study|Withdrawal by Subject|12|||
33650537|NCT01763203|63061126|FG000|Overall Study|Moved out of study region|7|||
33650538|NCT01763203|63061127|FG001|Overall Study|Moved out of study region|10|||
33650539|NCT01763203|63061126|FG000|Overall Study|Physician Decision|2|||
33650540|NCT01763203|63061127|FG001|Overall Study|Physician Decision|1|||
33650541|NCT01763047|63061144|FG000|Period 1|Test Article Not Available|4|||
33650542|NCT01763047|63061145|FG001|Period 1|Test Article Not Available|1|||
33650543|NCT01763047|63061144|FG000|Period 1|Protocol Violation|4|||
33650544|NCT01763047|63061145|FG001|Period 1|Protocol Violation|4|||
33650545|NCT01763047|63061144|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
33650546|NCT01763047|63061145|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
33650547|NCT01763047|63061144|FG000|Period 1|Adverse Event|0|||
33650548|NCT01763047|63061145|FG001|Period 1|Adverse Event|1|||
33650549|NCT01763047|63061144|FG000|Period 1|Unsatisfactory Visual Response|0|||
33650550|NCT01763047|63061145|FG001|Period 1|Unsatisfactory Visual Response|3|||
33650551|NCT01763047|63061144|FG000|Period 1|Lens Power Not Available|0|||
33650552|NCT01763047|63061145|FG001|Period 1|Lens Power Not Available|1|||
33650553|NCT01763047|63061144|FG000|Period 1|Study Site office Closed|0|||
33650554|NCT01763047|63061145|FG001|Period 1|Study Site office Closed|1|||
33650555|NCT01763047|63061144|FG000|Period 2|Lens Discomfort|1|||
33650556|NCT01763047|63061145|FG001|Period 2|Lens Discomfort|0|||
33650557|NCT01763047|63061144|FG000|Period 2|No longer meets Eligibility Criteria|1|||
33650558|NCT01763047|63061145|FG001|Period 2|No longer meets Eligibility Criteria|0|||
33650559|NCT01763047|63061144|FG000|Period 2|Study Site office Closed|1|||
33650560|NCT01763047|63061145|FG001|Period 2|Study Site office Closed|1|||
33650561|NCT01763047|63061144|FG000|Period 2|Unsatisfactory Visual Response|1|||
33650562|NCT01763047|63061145|FG001|Period 2|Unsatisfactory Visual Response|1|||
33650563|NCT01763047|63061144|FG000|Period 2|Protocol Violation|0|||
33650564|NCT01763047|63061145|FG001|Period 2|Protocol Violation|2|||
33650565|NCT01763047|63061144|FG000|Period 2|Unsatisfactory lens Fitting|0|||
33650566|NCT01763047|63061145|FG001|Period 2|Unsatisfactory lens Fitting|1|||
33650567|NCT01977677|63061157|FG000|Overall Study|Unrelated Adverse Event|0|||
33650568|NCT01977677|63061158|FG001|Overall Study|Unrelated Adverse Event|0|||
33650569|NCT01977677|63061159|FG002|Overall Study|Unrelated Adverse Event|1|||
33650570|NCT01762345|63061167|FG000|Overall Study|Adverse Event|5|||
33650571|NCT01762345|63061167|FG000|Overall Study|Protocol Violation|2|||
33650572|NCT02090855|63061172|FG000|Overall Study|no evaluable Standard of Truth results|2|||
33650573|NCT01761565|63061179|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
33650574|NCT01619579|63061189|FG000|Overall Study|Withdrawal by Subject|0|||
33650575|NCT01619579|63061190|FG001|Overall Study|Withdrawal by Subject|3|||
33650576|NCT01736215|63061196|FG000|Overall Study|Early termination of erythropoietin use|1|||
33650577|NCT01736215|63061196|FG000|Overall Study|Adverse Event|4|||
33650578|NCT01736215|63061196|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
33650579|NCT01736215|63061196|FG000|Overall Study|Insufficient data to perform analysis|8|||
33650580|NCT01786603|63061202|FG000|Overall Study|Death|5|||
33650581|NCT01786603|63061203|FG001|Overall Study|Death|1|||
33650582|NCT01786603|63061202|FG000|Overall Study|Adverse Event|6|||
33650583|NCT01786603|63061203|FG001|Overall Study|Adverse Event|2|||
33650584|NCT01786603|63061202|FG000|Overall Study|Physician decision to withdraw|6|||
33650585|NCT01786603|63061203|FG001|Overall Study|Physician decision to withdraw|7|||
33650586|NCT01786603|63061202|FG000|Overall Study|Lost to Follow-up|1|||
33650587|NCT01786603|63061203|FG001|Overall Study|Lost to Follow-up|2|||
33650588|NCT01619423|63061226|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
33650589|NCT01619423|63061227|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
33650590|NCT01619423|63061228|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
33650591|NCT01619423|63061229|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
33650592|NCT01735279|63061242|FG000|Overall Study|Lost to Follow-up|11|||
33650593|NCT01735279|63061243|FG001|Overall Study|Lost to Follow-up|8|||
33650594|NCT01759381|63061251|FG000|Overall Study|Death|1|||
33650595|NCT01759381|63061252|FG001|Overall Study|Death|0|||
33650596|NCT01758523|63061271|FG000|Overall Study|Adverse Event|2|||
33650597|NCT01758523|63061272|FG001|Overall Study|Adverse Event|1|||
33650598|NCT01758523|63061271|FG000|Overall Study|Lack of Efficacy|4|||
33328081|NCT00864253|62704507|FG000|Overall Study|Untreated|7|||
33650599|NCT01758523|63061272|FG001|Overall Study|Lack of Efficacy|2|||
33650600|NCT01758523|63061271|FG000|Overall Study|Lost to Follow-up|3|||
33650601|NCT01758523|63061272|FG001|Overall Study|Lost to Follow-up|4|||
33650602|NCT01758523|63061271|FG000|Overall Study|Withdrawal by Subject|12|||
33650603|NCT01758523|63061272|FG001|Overall Study|Withdrawal by Subject|7|||
33650604|NCT01758289|63061295|FG000|Overall Study|Premature Study Termination|44|||
33650605|NCT01758289|63061295|FG000|Overall Study|Adverse Event|9|||
33650606|NCT01757821|63061319|FG000|Overall Study|Adverse Event|1|||
33650607|NCT01735201|63061348|FG000|Overall Study|Adverse Event|1|||
33328082|NCT00864253|62704508|FG001|Overall Study|Untreated|7|||
33543627|NCT00968201|62934440|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
33650608|NCT01735201|63061349|FG001|Overall Study|Adverse Event|1|||
33650609|NCT01735201|63061350|FG002|Overall Study|Adverse Event|0|||
33650610|NCT01735201|63061351|FG003|Overall Study|Adverse Event|1|||
33650611|NCT01735201|63061352|FG004|Overall Study|Adverse Event|1|||
33650612|NCT01735201|63061353|FG005|Overall Study|Adverse Event|3|||
33650613|NCT01735201|63061354|FG006|Overall Study|Adverse Event|2|||
33650614|NCT01735201|63061355|FG007|Overall Study|Adverse Event|1|||
33650615|NCT01735201|63061348|FG000|Overall Study|Personal Reasons|1|||
33650616|NCT01735201|63061349|FG001|Overall Study|Personal Reasons|0|||
33650617|NCT01735201|63061350|FG002|Overall Study|Personal Reasons|0|||
33650618|NCT01735201|63061351|FG003|Overall Study|Personal Reasons|0|||
33650619|NCT01735201|63061352|FG004|Overall Study|Personal Reasons|0|||
33650620|NCT01735201|63061353|FG005|Overall Study|Personal Reasons|0|||
33650621|NCT01735201|63061354|FG006|Overall Study|Personal Reasons|0|||
33650622|NCT01735201|63061355|FG007|Overall Study|Personal Reasons|0|||
33650623|NCT01735201|63061348|FG000|Overall Study|Protocol Violation|1|||
33650624|NCT01735201|63061349|FG001|Overall Study|Protocol Violation|0|||
33650625|NCT01735201|63061350|FG002|Overall Study|Protocol Violation|0|||
33650626|NCT01735201|63061351|FG003|Overall Study|Protocol Violation|0|||
33650627|NCT01735201|63061352|FG004|Overall Study|Protocol Violation|0|||
33650628|NCT01735201|63061353|FG005|Overall Study|Protocol Violation|0|||
33650629|NCT01735201|63061354|FG006|Overall Study|Protocol Violation|0|||
33650630|NCT01735201|63061355|FG007|Overall Study|Protocol Violation|0|||
33650631|NCT01735201|63061348|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33650632|NCT01735201|63061349|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33650633|NCT01735201|63061350|FG002|Overall Study|Other Miscellaneous Reasons|0|||
33650634|NCT01735201|63061351|FG003|Overall Study|Other Miscellaneous Reasons|1|||
33650635|NCT01735201|63061352|FG004|Overall Study|Other Miscellaneous Reasons|0|||
33650636|NCT01735201|63061353|FG005|Overall Study|Other Miscellaneous Reasons|2|||
33650637|NCT01735201|63061354|FG006|Overall Study|Other Miscellaneous Reasons|1|||
33650638|NCT01735201|63061355|FG007|Overall Study|Other Miscellaneous Reasons|1|||
33650639|NCT01734811|63061375|FG000|Overall Study|Lost to Follow-up|2|||
33650640|NCT01734811|63061376|FG001|Overall Study|Lost to Follow-up|3|||
33650641|NCT01734811|63061375|FG000|Overall Study|Withdrawal by Subject|2|||
33650642|NCT01734811|63061376|FG001|Overall Study|Withdrawal by Subject|0|||
33650643|NCT01757275|63061384|FG000|Overall Study|Lost to Follow-up|1|||
33650644|NCT01757275|63061385|FG001|Overall Study|Lost to Follow-up|2|||
33650645|NCT01757275|63061384|FG000|Overall Study|Adverse Event|3|||
33650646|NCT01757275|63061385|FG001|Overall Study|Adverse Event|3|||
33650647|NCT01757275|63061384|FG000|Overall Study|Withdrawal by Subject|2|||
33650648|NCT01757275|63061385|FG001|Overall Study|Withdrawal by Subject|4|||
33650649|NCT01757275|63061384|FG000|Overall Study|Not treated|3|||
33650650|NCT01757275|63061385|FG001|Overall Study|Not treated|4|||
33650651|NCT01757197|63061400|FG000|Overall Study|Death|2|||
33650652|NCT01784965|63061424|FG000|Overall Study|Withdrawal by Subject|6|||
33650653|NCT01784965|63061425|FG001|Overall Study|Withdrawal by Subject|3|||
33650654|NCT01784965|63061424|FG000|Overall Study|Adverse Event|0|||
33650655|NCT01784965|63061425|FG001|Overall Study|Adverse Event|8|||
33650656|NCT01784419|63061433|FG000|Overall Study|Adverse Event|3|||
33650657|NCT01784029|63061440|FG000|Overall Study|Lost to Follow-up|19|||
33650658|NCT01784029|63061441|FG001|Overall Study|Lost to Follow-up|20|||
33650659|NCT01784029|63061442|FG002|Overall Study|Lost to Follow-up|22|||
33650660|NCT01733329|63061464|FG000|Overall Study|Protocol Violation|1|||
33650661|NCT01733329|63061465|FG001|Overall Study|Protocol Violation|1|||
33650662|NCT01733329|63061464|FG000|Overall Study|Uterine artery injury|1|||
33650663|NCT01733329|63061465|FG001|Overall Study|Uterine artery injury|0|||
33650664|NCT01783483|63061473|FG000|Overall Study|Death|3|||
33650665|NCT01783483|63061474|FG001|Overall Study|Death|3|||
33650666|NCT01783483|63061473|FG000|Overall Study|Lost to Follow-up|14|||
33650667|NCT01783483|63061474|FG001|Overall Study|Lost to Follow-up|10|||
33650668|NCT01783483|63061473|FG000|Overall Study|Withdrawal by Subject|2|||
33650669|NCT01783483|63061474|FG001|Overall Study|Withdrawal by Subject|1|||
33650670|NCT01783483|63061473|FG000|Overall Study|Physician Decision|1|||
33650671|NCT01783483|63061474|FG001|Overall Study|Physician Decision|1|||
33650672|NCT01607593|63061493|FG000|Overall Study|Adverse Event|15|||
33650673|NCT01607593|63061493|FG000|Overall Study|Lack of Efficacy|16|||
33464120|NCT02577406|62837652|FG000|Treatment Period|HSCT|6|||
33464121|NCT02577406|62837653|FG001|Treatment Period|HSCT|2|||
33464122|NCT02577406|62837652|FG000|Treatment Period|Lost to Follow-up|0|||
33650674|NCT01607593|63061493|FG000|Overall Study|Lost to Follow-up|25|||
33650675|NCT01607593|63061493|FG000|Overall Study|Continuation|33|||
33650676|NCT01607593|63061493|FG000|Overall Study|Other|4|||
33650677|NCT01755637|63061506|FG000|Period 1|Adverse Event|0|||
33650678|NCT01755637|63061507|FG001|Period 1|Adverse Event|1|||
33650679|NCT01732549|63061525|FG000|Overall Study|Adverse Event|13|||
33650680|NCT01732549|63061526|FG001|Overall Study|Adverse Event|3|||
33650681|NCT01732549|63061525|FG000|Overall Study|Consent withdrawn|13|||
33650682|NCT01732549|63061526|FG001|Overall Study|Consent withdrawn|6|||
33650683|NCT01732549|63061525|FG000|Overall Study|Disease progression|37|||
33650684|NCT01732549|63061526|FG001|Overall Study|Disease progression|50|||
33650685|NCT01732549|63061525|FG000|Overall Study|Other|8|||
33650686|NCT01732549|63061526|FG001|Overall Study|Other|14|||
33650687|NCT01755091|63061545|FG000|Overall Study|Withdrawal by Subject|6|||
33650688|NCT01755091|63061546|FG001|Overall Study|Withdrawal by Subject|1|||
33650689|NCT01755091|63061547|FG002|Overall Study|Withdrawal by Subject|3|||
33650690|NCT01755091|63061545|FG000|Overall Study|Adverse Event|1|||
33650691|NCT01755091|63061546|FG001|Overall Study|Adverse Event|1|||
33650692|NCT01755091|63061547|FG002|Overall Study|Adverse Event|1|||
33650693|NCT01755091|63061545|FG000|Overall Study|Lost to Follow-up|1|||
33650694|NCT01755091|63061546|FG001|Overall Study|Lost to Follow-up|0|||
33650695|NCT01755091|63061547|FG002|Overall Study|Lost to Follow-up|1|||
33650696|NCT01755091|63061545|FG000|Overall Study|Physician Decision|1|||
33650697|NCT01755091|63061546|FG001|Overall Study|Physician Decision|1|||
33650698|NCT01755091|63061547|FG002|Overall Study|Physician Decision|2|||
33650699|NCT01754467|63061580|FG000|Overall Study|Lost to Follow-up|1|||
33650700|NCT01753999|63061584|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
33650701|NCT01753999|63061585|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
33650702|NCT01753999|63061584|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
33650703|NCT01753999|63061585|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
33650704|NCT01753999|63061584|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
33650705|NCT01753999|63061585|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
33650706|NCT01753999|63061584|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
33650707|NCT01753999|63061585|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
33650708|NCT01753999|63061584|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
33650709|NCT01753999|63061585|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
33650710|NCT01753999|63061584|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
33464123|NCT02577406|62837653|FG001|Treatment Period|Lost to Follow-up|1|||
33464124|NCT02577406|62837652|FG000|Treatment Period|Protocol Violation|0|||
33464125|NCT02577406|62837653|FG001|Treatment Period|Protocol Violation|1|||
33464126|NCT01925131|62837678|FG000|Overall Study|Death|0|||
33464127|NCT01925131|62837679|FG001|Overall Study|Death|0|||
33464128|NCT01925131|62837680|FG002|Overall Study|Death|1|||
33464129|NCT01925131|62837681|FG003|Overall Study|Death|0|||
33464130|NCT01925131|62837682|FG004|Overall Study|Death|0|||
33464131|NCT01925131|62837683|FG005|Overall Study|Death|0|||
33464132|NCT01925131|62837678|FG000|Overall Study|Progression/Relapse|1|||
33464133|NCT01925131|62837679|FG001|Overall Study|Progression/Relapse|1|||
33464134|NCT01925131|62837680|FG002|Overall Study|Progression/Relapse|4|||
33464135|NCT01925131|62837681|FG003|Overall Study|Progression/Relapse|0|||
33464136|NCT01925131|62837682|FG004|Overall Study|Progression/Relapse|0|||
33464137|NCT01925131|62837683|FG005|Overall Study|Progression/Relapse|1|||
33464138|NCT01925131|62837678|FG000|Overall Study|Patient Refusal|1|||
33464139|NCT01925131|62837679|FG001|Overall Study|Patient Refusal|0|||
33464140|NCT01925131|62837680|FG002|Overall Study|Patient Refusal|0|||
33650711|NCT01753999|63061585|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
33650712|NCT01783015|63061605|FG000|Blinded Treatment|Adverse Event|0|||
33650713|NCT01783015|63061606|FG001|Blinded Treatment|Adverse Event|1|||
33650714|NCT01783015|63061607|FG002|Blinded Treatment|Adverse Event|0|||
33650715|NCT01783015|63061605|FG000|Blinded Treatment|Protocol Violation|0|||
33650716|NCT01783015|63061606|FG001|Blinded Treatment|Protocol Violation|1|||
33650717|NCT01783015|63061607|FG002|Blinded Treatment|Protocol Violation|0|||
33650718|NCT01783015|63061605|FG000|Blinded Treatment|Withdrawal by Subject|0|||
33650719|NCT01783015|63061606|FG001|Blinded Treatment|Withdrawal by Subject|1|||
33650720|NCT01783015|63061607|FG002|Blinded Treatment|Withdrawal by Subject|0|||
33650721|NCT01783015|63061605|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
33650722|NCT01783015|63061606|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
33650723|NCT01783015|63061607|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
33650724|NCT01783015|63061605|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
33650725|NCT01783015|63061606|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
33650726|NCT01783015|63061607|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
33650727|NCT01782859|63061617|FG000|Overall Study|Protocol Violation|6|||
33650728|NCT01782859|63061618|FG001|Overall Study|Protocol Violation|6|||
33650729|NCT01782859|63061617|FG000|Overall Study|Withdrawal by Subject|0|||
33464141|NCT01925131|62837681|FG003|Overall Study|Patient Refusal|0|||
33543628|NCT00968201|62934441|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
33543629|NCT00968201|62934439|FG000|Extension Study - (Period III)|Patient Relocated|0|||
33543630|NCT00968201|62934440|FG001|Extension Study - (Period III)|Patient Relocated|1|||
33543631|NCT00968201|62934441|FG002|Extension Study - (Period III)|Patient Relocated|1|||
33543632|NCT00968201|62934439|FG000|Extension Study - (Period III)|Noncompliance|0|||
33543633|NCT00968201|62934440|FG001|Extension Study - (Period III)|Noncompliance|0|||
33543634|NCT00968201|62934441|FG002|Extension Study - (Period III)|Noncompliance|3|||
33543635|NCT00968201|62934439|FG000|Extension Study - (Period III)|Other|0|||
33543636|NCT00968201|62934440|FG001|Extension Study - (Period III)|Other|0|||
33543637|NCT00968201|62934441|FG002|Extension Study - (Period III)|Other|2|||
33464142|NCT01925131|62837682|FG004|Overall Study|Patient Refusal|0|||
33464143|NCT01925131|62837683|FG005|Overall Study|Patient Refusal|0|||
33464144|NCT01925131|62837678|FG000|Overall Study|Adverse Event|0|||
33464145|NCT01925131|62837679|FG001|Overall Study|Adverse Event|0|||
33543638|NCT00968201|62934439|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
33650730|NCT01782859|63061618|FG001|Overall Study|Withdrawal by Subject|1|||
33464146|NCT01925131|62837680|FG002|Overall Study|Adverse Event|2|||
33650731|NCT01782469|63061625|FG000|Overall Study|Lost to Follow-up|1|||
33464147|NCT01925131|62837681|FG003|Overall Study|Adverse Event|0|||
33464148|NCT01925131|62837682|FG004|Overall Study|Adverse Event|1|||
33543639|NCT00968201|62934440|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
33650732|NCT01782313|63061629|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
33650733|NCT01782313|63061629|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
33650734|NCT01782313|63061629|FG000|Treated Cycle 3|Progressive Disease|21|||
33650735|NCT01782313|63061629|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
33650736|NCT01782313|63061629|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
33650737|NCT01782313|63061629|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
33650738|NCT01782313|63061629|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
33650739|NCT01782313|63061629|FG000|Survival Follow up|Lost to Follow-up|1|||
33650740|NCT01781611|63061652|FG000|Overall Study|Adverse Event|4|||
33650741|NCT01781611|63061653|FG001|Overall Study|Adverse Event|0|||
33650742|NCT01781299|63061670|FG000|Overall Study|Withdrawal by Subject|0|||
33650743|NCT01781299|63061671|FG001|Overall Study|Withdrawal by Subject|1|||
33650744|NCT01732471|63061677|FG000|Overall Study|Withdrawal by Subject|1|||
33650745|NCT01780987|63061696|FG000|Overall Study|Adverse Event|0|||
33650746|NCT01780987|63061697|FG001|Overall Study|Adverse Event|4|||
33650747|NCT01780987|63061696|FG000|Overall Study|Withdrawal by Subject|2|||
33650748|NCT01780987|63061697|FG001|Overall Study|Withdrawal by Subject|0|||
33650749|NCT01780987|63061696|FG000|Overall Study|Request of Changing Hospital|0|||
33650750|NCT01780987|63061697|FG001|Overall Study|Request of Changing Hospital|1|||
33650751|NCT01780987|63061696|FG000|Overall Study|Changing Residence|1|||
33543640|NCT00968201|62934441|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
33543641|NCT00943397|62934452|FG000|Overall Study|Adverse Event|0|||
33543642|NCT00943397|62934453|FG001|Overall Study|Adverse Event|6|||
33543643|NCT00943397|62934452|FG000|Overall Study|Lost to Follow-up|0|||
33543644|NCT00943397|62934453|FG001|Overall Study|Lost to Follow-up|4|||
33543645|NCT00943397|62934452|FG000|Overall Study|Protocol Violation|2|||
33543646|NCT00943397|62934453|FG001|Overall Study|Protocol Violation|5|||
33543647|NCT00943397|62934452|FG000|Overall Study|Withdrawal by Subject|1|||
33543648|NCT00943397|62934453|FG001|Overall Study|Withdrawal by Subject|1|||
33543649|NCT00943397|62934452|FG000|Overall Study|Site terminated and other|12|||
33543650|NCT00943397|62934453|FG001|Overall Study|Site terminated and other|56|||
33543651|NCT00702845|62934461|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
33543652|NCT00702845|62934462|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
33543653|NCT00702845|62934461|FG000|Overall Study|Too high ovarian response|5|||
33543654|NCT00702845|62934462|FG001|Overall Study|Too high ovarian response|1|||
33543655|NCT00702845|62934461|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
33543656|NCT00702845|62934462|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
33543657|NCT00702845|62934461|FG000|Overall Study|Insufficient ovarian response|1|||
33543658|NCT00702845|62934462|FG001|Overall Study|Insufficient ovarian response|0|||
33543659|NCT00702845|62934461|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
33543660|NCT00702845|62934462|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
33543661|NCT00702845|62934461|FG000|Overall Study|No or abnormal fertilization|4|||
33543662|NCT00702845|62934462|FG001|Overall Study|No or abnormal fertilization|2|||
33543663|NCT00702845|62934461|FG000|Overall Study|Patient's decision|2|||
33543664|NCT00702845|62934462|FG001|Overall Study|Patient's decision|1|||
33543665|NCT00702845|62934461|FG000|Overall Study|Not randomized|0|||
33543666|NCT00702845|62934462|FG001|Overall Study|Not randomized|1|||
33543667|NCT01302847|62934476|FG000|Overall Study|Ongoing|0|||
33543668|NCT01302847|62934477|FG001|Overall Study|Ongoing|0|||
33543669|NCT01302847|62934478|FG002|Overall Study|Ongoing|0|||
33543670|NCT01302847|62934479|FG003|Overall Study|Ongoing|0|||
33543671|NCT01302847|62934480|FG004|Overall Study|Ongoing|0|||
33543672|NCT01302847|62934481|FG005|Overall Study|Ongoing|27|||
33543673|NCT01302847|62934482|FG006|Overall Study|Ongoing|22|||
33543674|NCT01302847|62934483|FG007|Overall Study|Ongoing|17|||
33543675|NCT01302847|62934476|FG000|Overall Study|Death|0|||
33543676|NCT01302847|62934477|FG001|Overall Study|Death|1|||
33543677|NCT01302847|62934478|FG002|Overall Study|Death|0|||
33543678|NCT01302847|62934479|FG003|Overall Study|Death|0|||
33543679|NCT01302847|62934480|FG004|Overall Study|Death|0|||
33543680|NCT01302847|62934481|FG005|Overall Study|Death|1|||
33543681|NCT01302847|62934482|FG006|Overall Study|Death|1|||
33543682|NCT01302847|62934483|FG007|Overall Study|Death|0|||
33543683|NCT01302847|62934476|FG000|Overall Study|Pregnancy|2|||
33543684|NCT01302847|62934477|FG001|Overall Study|Pregnancy|0|||
33543685|NCT01302847|62934478|FG002|Overall Study|Pregnancy|0|||
33543686|NCT01302847|62934479|FG003|Overall Study|Pregnancy|0|||
33543687|NCT01302847|62934480|FG004|Overall Study|Pregnancy|0|||
33543688|NCT01302847|62934481|FG005|Overall Study|Pregnancy|0|||
33543689|NCT01302847|62934482|FG006|Overall Study|Pregnancy|0|||
33543690|NCT01302847|62934483|FG007|Overall Study|Pregnancy|0|||
33650752|NCT01780987|63061697|FG001|Overall Study|Changing Residence|0|||
33650753|NCT01780987|63061696|FG000|Overall Study|Not Receiving any Study Medication|0|||
33543691|NCT01302847|62934476|FG000|Overall Study|Virologic failure|0|||
33543692|NCT01302847|62934477|FG001|Overall Study|Virologic failure|2|||
33543693|NCT01302847|62934478|FG002|Overall Study|Virologic failure|2|||
33543694|NCT01302847|62934479|FG003|Overall Study|Virologic failure|0|||
33543695|NCT01302847|62934480|FG004|Overall Study|Virologic failure|1|||
33543696|NCT01302847|62934481|FG005|Overall Study|Virologic failure|1|||
33543697|NCT01302847|62934482|FG006|Overall Study|Virologic failure|0|||
33543698|NCT01302847|62934483|FG007|Overall Study|Virologic failure|2|||
33543699|NCT01302847|62934476|FG000|Overall Study|Severe debilitation, unable to continue|0|||
33543700|NCT01302847|62934477|FG001|Overall Study|Severe debilitation, unable to continue|0|||
33543701|NCT01302847|62934478|FG002|Overall Study|Severe debilitation, unable to continue|0|||
33543702|NCT01302847|62934479|FG003|Overall Study|Severe debilitation, unable to continue|0|||
33543703|NCT01302847|62934480|FG004|Overall Study|Severe debilitation, unable to continue|0|||
33543704|NCT01302847|62934481|FG005|Overall Study|Severe debilitation, unable to continue|1|||
33543705|NCT01302847|62934482|FG006|Overall Study|Severe debilitation, unable to continue|1|||
33543706|NCT01302847|62934483|FG007|Overall Study|Severe debilitation, unable to continue|0|||
33543707|NCT01302847|62934476|FG000|Overall Study|Not able to get to clinic|1|||
33543708|NCT01302847|62934477|FG001|Overall Study|Not able to get to clinic|1|||
33543709|NCT01302847|62934478|FG002|Overall Study|Not able to get to clinic|0|||
33650754|NCT01780987|63061697|FG001|Overall Study|Not Receiving any Study Medication|1|||
33650755|NCT01730053|63061786|FG000|Overall Study|Participant moved|0|||
33650756|NCT01730053|63061787|FG001|Overall Study|Participant moved|0|||
33650757|NCT01730053|63061788|FG002|Overall Study|Participant moved|1|||
33650758|NCT01730053|63061789|FG003|Overall Study|Participant moved|0|||
33650759|NCT01730053|63061790|FG004|Overall Study|Participant moved|0|||
33650760|NCT01730053|63061791|FG005|Overall Study|Participant moved|0|||
33650761|NCT01730053|63061786|FG000|Overall Study|Physician Decision|0|||
33650762|NCT01730053|63061787|FG001|Overall Study|Physician Decision|0|||
33650763|NCT01730053|63061788|FG002|Overall Study|Physician Decision|0|||
33650764|NCT01730053|63061789|FG003|Overall Study|Physician Decision|1|||
33650765|NCT01730053|63061790|FG004|Overall Study|Physician Decision|0|||
33650766|NCT01730053|63061791|FG005|Overall Study|Physician Decision|0|||
33650767|NCT01730053|63061786|FG000|Overall Study|Adverse Event|2|||
33650768|NCT01730053|63061787|FG001|Overall Study|Adverse Event|6|||
33650769|NCT01730053|63061788|FG002|Overall Study|Adverse Event|3|||
33650770|NCT01730053|63061789|FG003|Overall Study|Adverse Event|3|||
33650771|NCT01730053|63061790|FG004|Overall Study|Adverse Event|2|||
33650772|NCT01730053|63061791|FG005|Overall Study|Adverse Event|2|||
33650773|NCT01730053|63061786|FG000|Overall Study|Poor compliance to protocol|1|||
33650774|NCT01730053|63061787|FG001|Overall Study|Poor compliance to protocol|2|||
33650775|NCT01730053|63061788|FG002|Overall Study|Poor compliance to protocol|2|||
33650776|NCT01730053|63061789|FG003|Overall Study|Poor compliance to protocol|0|||
33650777|NCT01730053|63061790|FG004|Overall Study|Poor compliance to protocol|0|||
33650778|NCT01730053|63061791|FG005|Overall Study|Poor compliance to protocol|2|||
33650779|NCT01730053|63061786|FG000|Overall Study|Other than specified|2|||
33650780|NCT01730053|63061787|FG001|Overall Study|Other than specified|6|||
33650781|NCT01730053|63061788|FG002|Overall Study|Other than specified|5|||
33650782|NCT01730053|63061789|FG003|Overall Study|Other than specified|4|||
33650783|NCT01730053|63061790|FG004|Overall Study|Other than specified|7|||
33650784|NCT01730053|63061791|FG005|Overall Study|Other than specified|9|||
33650785|NCT01752985|63061826|FG000|Treatment Period|Subject request to discontinue treatment|1|||
33650786|NCT01752985|63061827|FG001|Treatment Period|Subject request to discontinue treatment|0|||
33650787|NCT01752985|63061828|FG002|Treatment Period|Subject request to discontinue treatment|1|||
33650788|NCT01752985|63061826|FG000|Treatment Period|Subject no longer meets study criteria|0|||
33650789|NCT01752985|63061827|FG001|Treatment Period|Subject no longer meets study criteria|1|||
33650790|NCT01752985|63061828|FG002|Treatment Period|Subject no longer meets study criteria|1|||
33650791|NCT01752985|63061826|FG000|Treatment Period|Adverse Event|2|||
33650792|NCT01752985|63061827|FG001|Treatment Period|Adverse Event|1|||
33464149|NCT01925131|62837683|FG005|Overall Study|Adverse Event|3|||
33464150|NCT01925131|62837678|FG000|Overall Study|Other - Not Protocol Specified|3|||
33464151|NCT01925131|62837679|FG001|Overall Study|Other - Not Protocol Specified|1|||
33464152|NCT01925131|62837680|FG002|Overall Study|Other - Not Protocol Specified|2|||
33464153|NCT01925131|62837681|FG003|Overall Study|Other - Not Protocol Specified|5|||
33464154|NCT01925131|62837682|FG004|Overall Study|Other - Not Protocol Specified|10|||
33464155|NCT01925131|62837683|FG005|Overall Study|Other - Not Protocol Specified|6|||
33464156|NCT01809691|62837701|FG000|Overall Study|Currently on Treatment|192|||
33464157|NCT01809691|62837702|FG001|Overall Study|Currently on Treatment|100|||
33464158|NCT01809691|62837701|FG000|Overall Study|No Protocol Treatment|10|||
33464159|NCT01809691|62837702|FG001|Overall Study|No Protocol Treatment|11|||
33464160|NCT01809691|62837701|FG000|Overall Study|Adverse Event|80|||
33464161|NCT01809691|62837702|FG001|Overall Study|Adverse Event|21|||
33464162|NCT01809691|62837701|FG000|Overall Study|Disease Progression|226|||
33650793|NCT01752985|63061828|FG002|Treatment Period|Adverse Event|2|||
33650794|NCT01752985|63061826|FG000|Treatment Period|Withdrawal by Subject|1|||
33650795|NCT01752985|63061827|FG001|Treatment Period|Withdrawal by Subject|1|||
33650796|NCT01752985|63061828|FG002|Treatment Period|Withdrawal by Subject|0|||
33650797|NCT01752985|63061826|FG000|Treatment Period|Lost to Follow-up|0|||
33650798|NCT01752985|63061827|FG001|Treatment Period|Lost to Follow-up|0|||
33650799|NCT01752985|63061828|FG002|Treatment Period|Lost to Follow-up|1|||
33650800|NCT01751113|63061836|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
33650801|NCT01751113|63061837|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
33650802|NCT01751113|63061838|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
33650803|NCT01751113|63061839|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
33650804|NCT01751113|63061840|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
33650805|NCT01751113|63061841|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
33650806|NCT01751113|63061836|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
33650807|NCT01751113|63061837|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
33650808|NCT01751113|63061838|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
33650809|NCT01751113|63061839|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
33650810|NCT01751113|63061840|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
33650811|NCT01751113|63061841|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
33650812|NCT01750879|63061852|FG000|Overall Study|Adverse Event|8|||
33650813|NCT01750879|63061853|FG001|Overall Study|Adverse Event|0|||
33650814|NCT01750879|63061852|FG000|Overall Study|Lack of Efficacy|1|||
33650815|NCT01750879|63061853|FG001|Overall Study|Lack of Efficacy|0|||
33650816|NCT01750879|63061852|FG000|Overall Study|Withdrawal by Subject|1|||
33650817|NCT01750879|63061853|FG001|Overall Study|Withdrawal by Subject|0|||
33650818|NCT01750879|63061852|FG000|Overall Study|Did not complete per protocol|0|||
33650819|NCT01750879|63061853|FG001|Overall Study|Did not complete per protocol|3|||
33650820|NCT01719380|63061879|FG000|Overall Study|Adverse Event|0|||
33650821|NCT01719380|63061880|FG001|Overall Study|Adverse Event|0|||
33650822|NCT01719380|63061881|FG002|Overall Study|Adverse Event|1|||
33650823|NCT01719380|63061882|FG003|Overall Study|Adverse Event|2|||
33650824|NCT01719380|63061883|FG004|Overall Study|Adverse Event|0|||
33650825|NCT01719380|63061884|FG005|Overall Study|Adverse Event|1|||
33650826|NCT01719380|63061885|FG006|Overall Study|Adverse Event|0|||
33650827|NCT01719380|63061886|FG007|Overall Study|Adverse Event|1|||
33650828|NCT01719380|63061887|FG008|Overall Study|Adverse Event|4|||
33650829|NCT01719380|63061888|FG009|Overall Study|Adverse Event|3|||
33650830|NCT01719380|63061879|FG000|Overall Study|Death|0|||
33650831|NCT01719380|63061880|FG001|Overall Study|Death|1|||
33650832|NCT01719380|63061881|FG002|Overall Study|Death|0|||
33328083|NCT01094730|62704516|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
33328084|NCT01094730|62704517|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
33328085|NCT01094730|62704516|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
33328086|NCT01094730|62704517|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
33650833|NCT01719380|63061882|FG003|Overall Study|Death|0|||
33650834|NCT01719380|63061883|FG004|Overall Study|Death|0|||
33543710|NCT01302847|62934479|FG003|Overall Study|Not able to get to clinic|0|||
33543711|NCT01302847|62934480|FG004|Overall Study|Not able to get to clinic|0|||
33543712|NCT01302847|62934481|FG005|Overall Study|Not able to get to clinic|0|||
33543713|NCT01302847|62934482|FG006|Overall Study|Not able to get to clinic|0|||
33543714|NCT01302847|62934483|FG007|Overall Study|Not able to get to clinic|0|||
33543715|NCT01302847|62934476|FG000|Overall Study|Site closing|2|||
33543716|NCT01302847|62934477|FG001|Overall Study|Site closing|2|||
33543717|NCT01302847|62934478|FG002|Overall Study|Site closing|0|||
33543718|NCT01302847|62934479|FG003|Overall Study|Site closing|0|||
33543719|NCT01302847|62934480|FG004|Overall Study|Site closing|0|||
33543720|NCT01302847|62934481|FG005|Overall Study|Site closing|0|||
33543721|NCT01302847|62934482|FG006|Overall Study|Site closing|0|||
33543722|NCT01302847|62934483|FG007|Overall Study|Site closing|0|||
33543723|NCT01302847|62934476|FG000|Overall Study|Withdrawal by Subject|1|||
33543724|NCT01302847|62934477|FG001|Overall Study|Withdrawal by Subject|0|||
33543725|NCT01302847|62934478|FG002|Overall Study|Withdrawal by Subject|0|||
33543726|NCT01302847|62934479|FG003|Overall Study|Withdrawal by Subject|0|||
33543727|NCT01302847|62934480|FG004|Overall Study|Withdrawal by Subject|1|||
33543728|NCT01302847|62934481|FG005|Overall Study|Withdrawal by Subject|0|||
33650835|NCT01719380|63061884|FG005|Overall Study|Death|0|||
33650836|NCT01719380|63061885|FG006|Overall Study|Death|0|||
33650837|NCT01719380|63061886|FG007|Overall Study|Death|0|||
33650838|NCT01719380|63061887|FG008|Overall Study|Death|3|||
33650839|NCT01719380|63061888|FG009|Overall Study|Death|3|||
33650840|NCT01719380|63061879|FG000|Overall Study|Participant/Guardian Decision|0|||
33543729|NCT01302847|62934482|FG006|Overall Study|Withdrawal by Subject|0|||
33650841|NCT01719380|63061880|FG001|Overall Study|Participant/Guardian Decision|0|||
33650842|NCT01719380|63061881|FG002|Overall Study|Participant/Guardian Decision|1|||
33650843|NCT01719380|63061882|FG003|Overall Study|Participant/Guardian Decision|0|||
33650844|NCT01719380|63061883|FG004|Overall Study|Participant/Guardian Decision|0|||
33650845|NCT01719380|63061884|FG005|Overall Study|Participant/Guardian Decision|0|||
33650846|NCT01719380|63061885|FG006|Overall Study|Participant/Guardian Decision|0|||
33650847|NCT01719380|63061886|FG007|Overall Study|Participant/Guardian Decision|0|||
33650848|NCT01719380|63061887|FG008|Overall Study|Participant/Guardian Decision|2|||
33650849|NCT01719380|63061888|FG009|Overall Study|Participant/Guardian Decision|2|||
33650850|NCT01719380|63061879|FG000|Overall Study|Physician Decision|0|||
33650851|NCT01719380|63061880|FG001|Overall Study|Physician Decision|0|||
33650852|NCT01719380|63061881|FG002|Overall Study|Physician Decision|2|||
33650853|NCT01719380|63061882|FG003|Overall Study|Physician Decision|0|||
33650854|NCT01719380|63061883|FG004|Overall Study|Physician Decision|0|||
33650855|NCT01719380|63061884|FG005|Overall Study|Physician Decision|0|||
33650856|NCT01719380|63061885|FG006|Overall Study|Physician Decision|0|||
33650857|NCT01719380|63061886|FG007|Overall Study|Physician Decision|0|||
33650858|NCT01719380|63061887|FG008|Overall Study|Physician Decision|1|||
33650859|NCT01719380|63061888|FG009|Overall Study|Physician Decision|1|||
33650860|NCT01719380|63061879|FG000|Overall Study|Lack of Efficacy|2|||
33650861|NCT01719380|63061880|FG001|Overall Study|Lack of Efficacy|6|||
33650862|NCT01719380|63061881|FG002|Overall Study|Lack of Efficacy|5|||
33650863|NCT01719380|63061882|FG003|Overall Study|Lack of Efficacy|6|||
33650864|NCT01719380|63061883|FG004|Overall Study|Lack of Efficacy|3|||
33650865|NCT01719380|63061884|FG005|Overall Study|Lack of Efficacy|7|||
33650866|NCT01719380|63061885|FG006|Overall Study|Lack of Efficacy|10|||
33650867|NCT01719380|63061886|FG007|Overall Study|Lack of Efficacy|6|||
33650868|NCT01719380|63061887|FG008|Overall Study|Lack of Efficacy|39|||
33650869|NCT01719380|63061888|FG009|Overall Study|Lack of Efficacy|42|||
33650870|NCT01719380|63061879|FG000|Overall Study|Progressive Disease|0|||
33650871|NCT01719380|63061880|FG001|Overall Study|Progressive Disease|0|||
33650872|NCT01719380|63061881|FG002|Overall Study|Progressive Disease|0|||
33650873|NCT01719380|63061882|FG003|Overall Study|Progressive Disease|0|||
33650874|NCT01719380|63061883|FG004|Overall Study|Progressive Disease|0|||
33650875|NCT01719380|63061884|FG005|Overall Study|Progressive Disease|0|||
33650876|NCT01719380|63061885|FG006|Overall Study|Progressive Disease|0|||
33650877|NCT01719380|63061886|FG007|Overall Study|Progressive Disease|0|||
33650878|NCT01719380|63061887|FG008|Overall Study|Progressive Disease|1|||
33650879|NCT01719380|63061888|FG009|Overall Study|Progressive Disease|0|||
33650880|NCT01743560|63061938|FG000|Overall Study|Disease progression|26|||
33650881|NCT01743560|63061938|FG000|Overall Study|Adverse Event|8|||
33650882|NCT01743560|63061938|FG000|Overall Study|Death|3|||
33650883|NCT01743560|63061938|FG000|Overall Study|Withdrawal by Subject|2|||
33650884|NCT01743560|63061938|FG000|Overall Study|Protocol Violation|1|||
33650885|NCT01743560|63061938|FG000|Overall Study|>1 dose of study drug|3|||
33650886|NCT01743092|63061968|FG000|Overall Study|Lost to Follow-up|14|||
33650887|NCT01743092|63061969|FG001|Overall Study|Lost to Follow-up|15|||
33650888|NCT01780831|63062002|FG000|Overall Study|Withdrawal by Subject|0|||
33650889|NCT01780831|63062003|FG001|Overall Study|Withdrawal by Subject|0|||
33650890|NCT01780831|63062004|FG002|Overall Study|Withdrawal by Subject|4|||
33650891|NCT01780831|63062005|FG003|Overall Study|Withdrawal by Subject|0|||
33650892|NCT01780831|63062002|FG000|Overall Study|Lost to Follow-up|0|||
33650893|NCT01780831|63062003|FG001|Overall Study|Lost to Follow-up|0|||
33650894|NCT01780831|63062004|FG002|Overall Study|Lost to Follow-up|0|||
33650895|NCT01780831|63062005|FG003|Overall Study|Lost to Follow-up|1|||
33650896|NCT01778023|63062064|FG000|Overall Study|Withdrawal by Subject|0|||
33650897|NCT01778023|63062065|FG001|Overall Study|Withdrawal by Subject|3|||
33650898|NCT01753297|63062073|FG000|Overall Study|Lost to Follow-up|7|||
33650899|NCT01753297|63062074|FG001|Overall Study|Lost to Follow-up|2|||
33650900|NCT01753297|63062073|FG000|Overall Study|Withdrawal by Subject|26|||
33650901|NCT01753297|63062074|FG001|Overall Study|Withdrawal by Subject|23|||
33650902|NCT01753297|63062073|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
33650903|NCT01753297|63062074|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
33650904|NCT01753297|63062073|FG000|Overall Study|Death|0|||
33650905|NCT01753297|63062074|FG001|Overall Study|Death|2|||
33650906|NCT01753297|63062073|FG000|Overall Study|Did not attend end of study visit|7|||
33650907|NCT01753297|63062074|FG001|Overall Study|Did not attend end of study visit|8|||
33650908|NCT01777321|63062084|FG000|Overall Study|Withdrawal by Subject|0|||
33650909|NCT01777321|63062085|FG001|Overall Study|Withdrawal by Subject|1|||
33650910|NCT01729819|63062093|FG000|Overall Study|Adverse Event|2|||
33650911|NCT01729819|63062094|FG001|Overall Study|Adverse Event|4|||
33650912|NCT01729819|63062093|FG000|Overall Study|Lack of Efficacy|1|||
33650913|NCT01729819|63062094|FG001|Overall Study|Lack of Efficacy|0|||
33650914|NCT01729819|63062093|FG000|Overall Study|Lost to Follow-up|2|||
33650915|NCT01729819|63062094|FG001|Overall Study|Lost to Follow-up|0|||
33650916|NCT01729819|63062093|FG000|Overall Study|Other reason|1|||
33650917|NCT01729819|63062094|FG001|Overall Study|Other reason|0|||
33650918|NCT01729819|63062093|FG000|Overall Study|Protocol Violation|0|||
33650919|NCT01729819|63062094|FG001|Overall Study|Protocol Violation|1|||
33650920|NCT01729819|63062093|FG000|Overall Study|Withdrawal by Subject|0|||
33650921|NCT01729819|63062094|FG001|Overall Study|Withdrawal by Subject|2|||
33650922|NCT01776541|63062105|FG000|Overall Study|Administrative Reason|6|||
33650923|NCT01776541|63062106|FG001|Overall Study|Administrative Reason|2|||
33650924|NCT01776541|63062105|FG000|Overall Study|Death|4|||
33650925|NCT01776541|63062106|FG001|Overall Study|Death|0|||
33650926|NCT01776541|63062105|FG000|Overall Study|Lost to Follow-up|27|||
33650927|NCT01776541|63062106|FG001|Overall Study|Lost to Follow-up|48|||
33650928|NCT01776541|63062105|FG000|Overall Study|Unclassified|5|||
33650929|NCT01776541|63062106|FG001|Overall Study|Unclassified|4|||
33650930|NCT01776541|63062105|FG000|Overall Study|Protocol Violation|2|||
33650931|NCT01776541|63062106|FG001|Overall Study|Protocol Violation|1|||
33650932|NCT01776541|63062105|FG000|Overall Study|Withdrawal by Subject|12|||
33650933|NCT01776541|63062106|FG001|Overall Study|Withdrawal by Subject|20|||
33650934|NCT01742078|63062135|FG000|Overall Study|Withdrawal by Subject|0|||
33464163|NCT01809691|62837702|FG001|Overall Study|Disease Progression|372|||
33464164|NCT01809691|62837701|FG000|Overall Study|Death|26|||
33464165|NCT01809691|62837702|FG001|Overall Study|Death|13|||
33464166|NCT01809691|62837701|FG000|Overall Study|Participant Refusal|70|||
33543730|NCT01302847|62934483|FG007|Overall Study|Withdrawal by Subject|1|||
33543731|NCT01302847|62934476|FG000|Overall Study|Not willing to adhere to requirements|5|||
33543732|NCT01302847|62934477|FG001|Overall Study|Not willing to adhere to requirements|0|||
33543733|NCT01302847|62934478|FG002|Overall Study|Not willing to adhere to requirements|0|||
33464167|NCT01809691|62837702|FG001|Overall Study|Participant Refusal|72|||
33464168|NCT01809691|62837701|FG000|Overall Study|Other, Not Specified|34|||
33464169|NCT01809691|62837702|FG001|Overall Study|Other, Not Specified|52|||
33464170|NCT01698918|62837708|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
33464171|NCT01698918|62837708|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
33464172|NCT01698918|62837708|FG000|First Line Treatment (Core+Extension)|Death|2|||
33464173|NCT01698918|62837708|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
33464174|NCT01698918|62837708|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
33464175|NCT01698918|62837708|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
33464176|NCT01698918|62837708|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
33464177|NCT01698918|62837708|FG000|Second Line Treatment (Core+Extension)|Death|1|||
33464178|NCT01698918|62837708|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
33464179|NCT01698918|62837708|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
33464180|NCT01574274|62837723|FG000|Overall Study|Ineligible|0|||
33464181|NCT01574274|62837724|FG001|Overall Study|Ineligible|1|||
33464182|NCT01574274|62837723|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
33464183|NCT01574274|62837724|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
33464184|NCT01574274|62837723|FG000|Overall Study|Ph+ B-ALL|3|||
33464185|NCT01574274|62837724|FG001|Overall Study|Ph+ B-ALL|4|||
33464186|NCT01574274|62837723|FG000|Overall Study|Induction Death|2|||
33464187|NCT01574274|62837724|FG001|Overall Study|Induction Death|0|||
33464188|NCT01574274|62837723|FG000|Overall Study|Induction Failure|4|||
33543734|NCT01302847|62934479|FG003|Overall Study|Not willing to adhere to requirements|1|||
33543735|NCT01302847|62934480|FG004|Overall Study|Not willing to adhere to requirements|0|||
33543736|NCT01302847|62934481|FG005|Overall Study|Not willing to adhere to requirements|0|||
33543737|NCT01302847|62934482|FG006|Overall Study|Not willing to adhere to requirements|0|||
33543738|NCT01302847|62934483|FG007|Overall Study|Not willing to adhere to requirements|2|||
33543739|NCT01302847|62934476|FG000|Overall Study|Site unable to contact participant|2|||
33543740|NCT01302847|62934477|FG001|Overall Study|Site unable to contact participant|1|||
33543741|NCT01302847|62934478|FG002|Overall Study|Site unable to contact participant|0|||
33543742|NCT01302847|62934479|FG003|Overall Study|Site unable to contact participant|0|||
33650935|NCT01742078|63062136|FG001|Overall Study|Withdrawal by Subject|0|||
33464189|NCT01574274|62837724|FG001|Overall Study|Induction Failure|1|||
33464190|NCT01574274|62837723|FG000|Overall Study|Adverse Event|16|||
33464191|NCT01574274|62837724|FG001|Overall Study|Adverse Event|13|||
33464192|NCT01574274|62837723|FG000|Overall Study|Remission Death|1|||
33464193|NCT01574274|62837724|FG001|Overall Study|Remission Death|0|||
33650936|NCT01742078|63062137|FG002|Overall Study|Withdrawal by Subject|0|||
33464194|NCT01574274|62837723|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
33543743|NCT01302847|62934480|FG004|Overall Study|Site unable to contact participant|0|||
33543744|NCT01302847|62934481|FG005|Overall Study|Site unable to contact participant|0|||
33650937|NCT01742078|63062138|FG003|Overall Study|Withdrawal by Subject|1|||
33650938|NCT01742078|63062139|FG004|Overall Study|Withdrawal by Subject|0|||
33650939|NCT01742078|63062140|FG005|Overall Study|Withdrawal by Subject|0|||
33464195|NCT01574274|62837724|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
33464196|NCT01574274|62837723|FG000|Overall Study|Other, unknown|3|||
33464197|NCT01574274|62837724|FG001|Overall Study|Other, unknown|2|||
33464198|NCT01208974|62837730|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
33464199|NCT01208974|62837731|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
33650940|NCT01742078|63062141|FG006|Overall Study|Withdrawal by Subject|0|||
33464200|NCT01208974|62837732|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
33650941|NCT01742078|63062142|FG007|Overall Study|Withdrawal by Subject|0|||
33650942|NCT01742078|63062143|FG008|Overall Study|Withdrawal by Subject|0|||
33650943|NCT01741688|63062165|FG000|Overall Study|Lack of insurance coverage|2|||
33650944|NCT01741688|63062165|FG000|Overall Study|Withdrawal by Subject|1|||
33650945|NCT01709084|63062172|FG000|Overall Study|Lost to Follow-up|4|||
33650946|NCT01709084|63062173|FG001|Overall Study|Lost to Follow-up|7|||
33650947|NCT01709084|63062172|FG000|Overall Study|Withdrawal by Subject|2|||
33650948|NCT01709084|63062173|FG001|Overall Study|Withdrawal by Subject|2|||
33650949|NCT01709084|63062172|FG000|Overall Study|Adverse Event|5|||
33650950|NCT01709084|63062173|FG001|Overall Study|Adverse Event|0|||
33650951|NCT01709084|63062172|FG000|Overall Study|Other|5|||
33650952|NCT01709084|63062173|FG001|Overall Study|Other|3|||
33650953|NCT01709084|63062172|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
33650954|NCT01709084|63062173|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
33650955|NCT01709084|63062172|FG000|Overall Study|Not Treated|0|||
33650956|NCT01709084|63062173|FG001|Overall Study|Not Treated|2|||
33650957|NCT01776307|63062182|FG000|Overall Study|Not dosed|0|||
33650958|NCT01776307|63062183|FG001|Overall Study|Not dosed|0|||
33650959|NCT01776307|63062184|FG002|Overall Study|Not dosed|1|||
33650960|NCT01729039|63062215|FG000|Overall Study|disqualified|2|||
33650961|NCT01729039|63062216|FG001|Overall Study|disqualified|5|||
33650962|NCT01729039|63062215|FG000|Overall Study|Withdrawal by Subject|8|||
33650963|NCT01729039|63062216|FG001|Overall Study|Withdrawal by Subject|7|||
33650964|NCT01775995|63062227|FG000|Overall Study|Lost to Follow-up|1|||
33650965|NCT01775995|63062228|FG001|Overall Study|Lost to Follow-up|1|||
33650966|NCT01741532|63062236|FG000|Overall Study|Adverse Event|4|||
33650967|NCT01741532|63062237|FG001|Overall Study|Adverse Event|0|||
33650968|NCT01741532|63062236|FG000|Overall Study|Withdrawal by Subject|1|||
33650969|NCT01741532|63062237|FG001|Overall Study|Withdrawal by Subject|1|||
33650970|NCT01741532|63062236|FG000|Overall Study|Protocol Violation|0|||
33650971|NCT01741532|63062237|FG001|Overall Study|Protocol Violation|1|||
33650972|NCT01741532|63062236|FG000|Overall Study|Worsening of the disease|3|||
33650973|NCT01741532|63062237|FG001|Overall Study|Worsening of the disease|1|||
33650974|NCT01741532|63062236|FG000|Overall Study|Sponsor decision|1|||
33650975|NCT01741532|63062237|FG001|Overall Study|Sponsor decision|0|||
33650976|NCT01741532|63062236|FG000|Overall Study|Medical event|1|||
33650977|NCT01741532|63062237|FG001|Overall Study|Medical event|0|||
33650978|NCT01719224|63062247|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
33650979|NCT01719224|63062248|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
33650980|NCT01717976|63062259|FG000|Overall Study|Protocol Violation|0|||
33650981|NCT01717976|63062260|FG001|Overall Study|Protocol Violation|1|||
33650982|NCT01740440|63062266|FG000|Overall Study|Lost to Follow-up|3|||
33650983|NCT01740128|63062273|FG000|Overall Study|Pregnancy|0|||
33650984|NCT01740128|63062274|FG001|Overall Study|Pregnancy|1|||
33650985|NCT01740128|63062273|FG000|Overall Study|Protocol Violation|1|||
33650986|NCT01740128|63062274|FG001|Overall Study|Protocol Violation|2|||
33650987|NCT01740128|63062273|FG000|Overall Study|Lost to Follow-up|2|||
33650988|NCT01740128|63062274|FG001|Overall Study|Lost to Follow-up|2|||
33650989|NCT01740128|63062273|FG000|Overall Study|Withdrawal by Subject|1|||
33650990|NCT01740128|63062274|FG001|Overall Study|Withdrawal by Subject|0|||
33650991|NCT01740128|63062273|FG000|Overall Study|Insufficient protocol compliance|2|||
33650992|NCT01740128|63062274|FG001|Overall Study|Insufficient protocol compliance|2|||
33650993|NCT01976741|63062290|FG000|Overall Study|Withdrawal by Subject|1|||
33650994|NCT01976741|63062291|FG001|Overall Study|Withdrawal by Subject|0|||
33650995|NCT01976741|63062292|FG002|Overall Study|Withdrawal by Subject|1|||
33650996|NCT01976741|63062293|FG003|Overall Study|Withdrawal by Subject|1|||
33650997|NCT01976741|63062294|FG004|Overall Study|Withdrawal by Subject|0|||
33328087|NCT01094730|62704516|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
33543745|NCT01302847|62934482|FG006|Overall Study|Site unable to contact participant|2|||
33328088|NCT01094730|62704517|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
33543746|NCT01302847|62934483|FG007|Overall Study|Site unable to contact participant|0|||
33543747|NCT03039569|62934512|FG000|Overall Study|Lost to Follow-up|5|||
33543748|NCT03039569|62934513|FG001|Overall Study|Lost to Follow-up|4|||
33543749|NCT01272037|62934522|FG000|Overall Study|Death|30|||
33543750|NCT01272037|62934523|FG001|Overall Study|Death|30|||
33543751|NCT01272037|62934522|FG000|Overall Study|Adverse Event|12|||
33543752|NCT01272037|62934523|FG001|Overall Study|Adverse Event|7|||
33543753|NCT01272037|62934522|FG000|Overall Study|Withdrawal by Subject|158|||
33543754|NCT01272037|62934523|FG001|Overall Study|Withdrawal by Subject|83|||
33543755|NCT01272037|62934522|FG000|Overall Study|Disease progression|85|||
33543756|NCT01272037|62934523|FG001|Overall Study|Disease progression|125|||
33543757|NCT01272037|62934522|FG000|Overall Study|Other reason|49|||
33543758|NCT01272037|62934523|FG001|Overall Study|Other reason|45|||
33543759|NCT01272037|62934522|FG000|Overall Study|Delinquent data|6|||
33543760|NCT01272037|62934523|FG001|Overall Study|Delinquent data|4|||
33650998|NCT01976741|63062295|FG005|Overall Study|Withdrawal by Subject|0|||
33328089|NCT01094730|62704516|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
33543761|NCT01272037|62934522|FG000|Overall Study|Reason under review|107|||
33543762|NCT01272037|62934523|FG001|Overall Study|Reason under review|136|||
33543763|NCT01272037|62934522|FG000|Overall Study|On treatment|173|||
33543764|NCT01272037|62934523|FG001|Overall Study|On treatment|185|||
33543765|NCT02738775|62934535|FG000|Overall Study|Withdrawal by Subject|0|||
33464201|NCT01208974|62837733|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
33650999|NCT01976741|63062296|FG006|Overall Study|Withdrawal by Subject|1|||
33651000|NCT01976741|63062297|FG007|Overall Study|Withdrawal by Subject|4|||
33328090|NCT01094730|62704517|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
33328091|NCT01094730|62704516|FG000|Period 2 (14 Days)|Protocol Violation|2|||
33328092|NCT01094730|62704517|FG001|Period 2 (14 Days)|Protocol Violation|0|||
33543766|NCT02738775|62934536|FG001|Overall Study|Withdrawal by Subject|1|||
33543767|NCT02738775|62934537|FG002|Overall Study|Withdrawal by Subject|0|||
33543768|NCT02738775|62934538|FG003|Overall Study|Withdrawal by Subject|0|||
33543769|NCT02738775|62934539|FG004|Overall Study|Withdrawal by Subject|0|||
33543770|NCT02738775|62934540|FG005|Overall Study|Withdrawal by Subject|0|||
33543771|NCT02738775|62934535|FG000|Overall Study|Adverse Event|0|||
33543772|NCT02738775|62934536|FG001|Overall Study|Adverse Event|0|||
33543773|NCT02738775|62934537|FG002|Overall Study|Adverse Event|0|||
33543774|NCT02738775|62934538|FG003|Overall Study|Adverse Event|1|||
33543775|NCT02738775|62934539|FG004|Overall Study|Adverse Event|0|||
33543776|NCT02738775|62934540|FG005|Overall Study|Adverse Event|0|||
33543777|NCT02738775|62934535|FG000|Overall Study|Pregnancy|0|||
33543778|NCT02738775|62934536|FG001|Overall Study|Pregnancy|1|||
33543779|NCT02738775|62934537|FG002|Overall Study|Pregnancy|0|||
33543780|NCT02738775|62934538|FG003|Overall Study|Pregnancy|0|||
33543781|NCT02738775|62934539|FG004|Overall Study|Pregnancy|0|||
33543782|NCT02738775|62934540|FG005|Overall Study|Pregnancy|0|||
33543783|NCT02738775|62934535|FG000|Overall Study|Missing|0|||
33543784|NCT02738775|62934536|FG001|Overall Study|Missing|0|||
33543785|NCT02738775|62934537|FG002|Overall Study|Missing|0|||
33543786|NCT02738775|62934538|FG003|Overall Study|Missing|0|||
33543787|NCT02738775|62934539|FG004|Overall Study|Missing|0|||
33543788|NCT02738775|62934540|FG005|Overall Study|Missing|1|||
33543789|NCT02314923|62934577|FG000|Overall Study|Death|0|||
33543790|NCT02314923|62934578|FG001|Overall Study|Death|0|||
33543791|NCT02314923|62934579|FG002|Overall Study|Death|0|||
33543792|NCT02314923|62934580|FG003|Overall Study|Death|1|||
33543793|NCT02314923|62934581|FG004|Overall Study|Death|0|||
33543794|NCT02314923|62934582|FG005|Overall Study|Death|0|||
33543795|NCT02314923|62934583|FG006|Overall Study|Death|0|||
33543796|NCT02314923|62934584|FG007|Overall Study|Death|0|||
33543797|NCT02314923|62934585|FG008|Overall Study|Death|0|||
33543798|NCT02314923|62934586|FG009|Overall Study|Death|0|||
33543799|NCT02314923|62934577|FG000|Overall Study|Lost to Follow-up|2|||
33543800|NCT02314923|62934578|FG001|Overall Study|Lost to Follow-up|3|||
33543801|NCT02314923|62934579|FG002|Overall Study|Lost to Follow-up|1|||
33543802|NCT02314923|62934580|FG003|Overall Study|Lost to Follow-up|0|||
33543803|NCT02314923|62934581|FG004|Overall Study|Lost to Follow-up|0|||
33543804|NCT02314923|62934582|FG005|Overall Study|Lost to Follow-up|0|||
33651001|NCT01976741|63062298|FG008|Overall Study|Withdrawal by Subject|0|||
33328093|NCT01094730|62704516|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
33543805|NCT02314923|62934583|FG006|Overall Study|Lost to Follow-up|3|||
33543806|NCT02314923|62934584|FG007|Overall Study|Lost to Follow-up|4|||
33543807|NCT02314923|62934585|FG008|Overall Study|Lost to Follow-up|2|||
33543808|NCT02314923|62934586|FG009|Overall Study|Lost to Follow-up|0|||
33543809|NCT02314923|62934577|FG000|Overall Study|Withdrawal by Subject|0|||
33543810|NCT02314923|62934578|FG001|Overall Study|Withdrawal by Subject|0|||
33543811|NCT02314923|62934579|FG002|Overall Study|Withdrawal by Subject|1|||
33464202|NCT01208974|62837730|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
33464203|NCT01208974|62837731|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
33464204|NCT01208974|62837732|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
33464205|NCT01208974|62837733|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
33464206|NCT01208974|62837730|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
33464207|NCT01208974|62837731|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
33651002|NCT01976741|63062299|FG009|Overall Study|Withdrawal by Subject|0|||
33651003|NCT01976741|63062290|FG000|Overall Study|Adverse Event|0|||
33651004|NCT01976741|63062291|FG001|Overall Study|Adverse Event|0|||
33651005|NCT01976741|63062292|FG002|Overall Study|Adverse Event|2|||
33651006|NCT01976741|63062293|FG003|Overall Study|Adverse Event|0|||
33651007|NCT01976741|63062294|FG004|Overall Study|Adverse Event|0|||
33651008|NCT01976741|63062295|FG005|Overall Study|Adverse Event|0|||
33651009|NCT01976741|63062296|FG006|Overall Study|Adverse Event|3|||
33651010|NCT01976741|63062297|FG007|Overall Study|Adverse Event|8|||
33651011|NCT01976741|63062298|FG008|Overall Study|Adverse Event|1|||
33651012|NCT01976741|63062299|FG009|Overall Study|Adverse Event|4|||
33651013|NCT01727713|63062333|FG000|Overall Study|Lost to Follow-up|5|||
33651014|NCT01727713|63062333|FG000|Overall Study|Adverse Event|10|||
33651015|NCT01727713|63062333|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
33651016|NCT01727713|63062333|FG000|Overall Study|Withdrawal by Subject|13|||
33651017|NCT01727713|63062333|FG000|Overall Study|Protocol Deviation|2|||
33651018|NCT01965431|63062337|FG000|Overall Study|Adverse Event|0|||
33651019|NCT01965431|63062338|FG001|Overall Study|Adverse Event|1|||
33651020|NCT01965431|63062339|FG002|Overall Study|Adverse Event|0|||
33651021|NCT01965431|63062340|FG003|Overall Study|Adverse Event|0|||
33651022|NCT01965431|63062341|FG004|Overall Study|Adverse Event|0|||
33651023|NCT01965431|63062342|FG005|Overall Study|Adverse Event|0|||
33651024|NCT01965431|63062337|FG000|Overall Study|Other than stated above|6|||
33651025|NCT01965431|63062338|FG001|Overall Study|Other than stated above|5|||
33651026|NCT01965431|63062339|FG002|Overall Study|Other than stated above|6|||
33651027|NCT01965431|63062340|FG003|Overall Study|Other than stated above|6|||
33651028|NCT01965431|63062341|FG004|Overall Study|Other than stated above|6|||
33651029|NCT01965431|63062342|FG005|Overall Study|Other than stated above|6|||
33651030|NCT01976663|63062352|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
33464208|NCT01208974|62837732|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
33464209|NCT01208974|62837733|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
33543812|NCT02314923|62934580|FG003|Overall Study|Withdrawal by Subject|0|||
33543813|NCT02314923|62934581|FG004|Overall Study|Withdrawal by Subject|1|||
33543814|NCT02314923|62934582|FG005|Overall Study|Withdrawal by Subject|0|||
33651031|NCT01976663|63062352|FG000|Overall Study|Personal Reasons|6|||
33651032|NCT01976663|63062352|FG000|Overall Study|Withdrawal by Subject|4|||
33651033|NCT01976663|63062352|FG000|Overall Study|Screen Failure|3|||
33651034|NCT01976663|63062352|FG000|Overall Study|Adverse Event|2|||
33651035|NCT01976663|63062352|FG000|Overall Study|Lost to Follow-up|3|||
33464210|NCT00840177|62837743|FG000|Overall Study|Adverse Event|5|||
33464211|NCT00840177|62837744|FG001|Overall Study|Adverse Event|1|||
33464212|NCT00840177|62837745|FG002|Overall Study|Adverse Event|1|||
33464213|NCT00840177|62837743|FG000|Overall Study|Refusal unrelated to adverse events|1|||
33464214|NCT00840177|62837744|FG001|Overall Study|Refusal unrelated to adverse events|0|||
33464215|NCT00840177|62837745|FG002|Overall Study|Refusal unrelated to adverse events|1|||
33464216|NCT00840177|62837743|FG000|Overall Study|Progression/relapse|2|||
33464217|NCT00840177|62837744|FG001|Overall Study|Progression/relapse|0|||
33464218|NCT00840177|62837745|FG002|Overall Study|Progression/relapse|0|||
33464219|NCT00840177|62837743|FG000|Overall Study|Death|4|||
33464220|NCT00840177|62837744|FG001|Overall Study|Death|5|||
33464221|NCT00840177|62837745|FG002|Overall Study|Death|5|||
33464222|NCT00840177|62837743|FG000|Overall Study|not protocol specified|6|||
33464223|NCT00840177|62837744|FG001|Overall Study|not protocol specified|3|||
33464224|NCT00840177|62837745|FG002|Overall Study|not protocol specified|0|||
33543815|NCT02314923|62934583|FG006|Overall Study|Withdrawal by Subject|1|||
33543816|NCT02314923|62934584|FG007|Overall Study|Withdrawal by Subject|0|||
33543817|NCT02314923|62934585|FG008|Overall Study|Withdrawal by Subject|0|||
33543818|NCT02314923|62934586|FG009|Overall Study|Withdrawal by Subject|0|||
33543819|NCT02314923|62934577|FG000|Overall Study|Physician Decision|0|||
33543820|NCT02314923|62934578|FG001|Overall Study|Physician Decision|1|||
33543821|NCT02314923|62934579|FG002|Overall Study|Physician Decision|0|||
33464225|NCT00840177|62837743|FG000|Overall Study|Ineligible|0|||
33464226|NCT00840177|62837744|FG001|Overall Study|Ineligible|0|||
33464227|NCT00840177|62837745|FG002|Overall Study|Ineligible|3|||
33464228|NCT00840177|62837743|FG000|Overall Study|Did not start treatment|0|||
33464229|NCT00840177|62837744|FG001|Overall Study|Did not start treatment|0|||
33464230|NCT00840177|62837745|FG002|Overall Study|Did not start treatment|1|||
33543822|NCT02314923|62934580|FG003|Overall Study|Physician Decision|0|||
33543823|NCT02314923|62934581|FG004|Overall Study|Physician Decision|0|||
33464231|NCT01347580|62837755|FG000|Overall Study|Withdrawal by Subject|13|||
33543824|NCT02314923|62934582|FG005|Overall Study|Physician Decision|0|||
33543825|NCT02314923|62934583|FG006|Overall Study|Physician Decision|0|||
33543826|NCT02314923|62934584|FG007|Overall Study|Physician Decision|0|||
33543827|NCT02314923|62934585|FG008|Overall Study|Physician Decision|0|||
33543828|NCT02314923|62934586|FG009|Overall Study|Physician Decision|0|||
33543829|NCT02314923|62934577|FG000|Overall Study|Participant unavailable|0|||
33543830|NCT02314923|62934578|FG001|Overall Study|Participant unavailable|0|||
33543831|NCT02314923|62934579|FG002|Overall Study|Participant unavailable|0|||
33543832|NCT02314923|62934580|FG003|Overall Study|Participant unavailable|0|||
33543833|NCT02314923|62934581|FG004|Overall Study|Participant unavailable|0|||
33543834|NCT02314923|62934582|FG005|Overall Study|Participant unavailable|1|||
33543835|NCT02314923|62934583|FG006|Overall Study|Participant unavailable|0|||
33543836|NCT02314923|62934584|FG007|Overall Study|Participant unavailable|0|||
33543837|NCT02314923|62934585|FG008|Overall Study|Participant unavailable|0|||
33543838|NCT02314923|62934586|FG009|Overall Study|Participant unavailable|0|||
33543839|NCT02314923|62934577|FG000|Overall Study|Screen failure|0|||
33543840|NCT02314923|62934578|FG001|Overall Study|Screen failure|0|||
33543841|NCT02314923|62934579|FG002|Overall Study|Screen failure|0|||
33543842|NCT02314923|62934580|FG003|Overall Study|Screen failure|0|||
33543843|NCT02314923|62934581|FG004|Overall Study|Screen failure|0|||
33464232|NCT01347580|62837756|FG001|Overall Study|Withdrawal by Subject|23|||
33464233|NCT01347580|62837755|FG000|Overall Study|Death|30|||
33464234|NCT01347580|62837756|FG001|Overall Study|Death|19|||
33464235|NCT01347580|62837755|FG000|Overall Study|Protocol Violation|10|||
33464236|NCT01347580|62837756|FG001|Overall Study|Protocol Violation|7|||
33464237|NCT01347580|62837755|FG000|Overall Study|Lost to Follow-up|3|||
33464238|NCT01347580|62837756|FG001|Overall Study|Lost to Follow-up|1|||
33464239|NCT01347580|62837755|FG000|Overall Study|Had other reason|9|||
33464240|NCT01347580|62837756|FG001|Overall Study|Had other reason|6|||
33464241|NCT00398411|62837764|FG000|Overall Study|Death|0|||
33464242|NCT00398411|62837765|FG001|Overall Study|Death|1|||
33543844|NCT02314923|62934582|FG005|Overall Study|Screen failure|0|||
33543845|NCT02314923|62934583|FG006|Overall Study|Screen failure|1|||
33543846|NCT02314923|62934584|FG007|Overall Study|Screen failure|0|||
33543847|NCT02314923|62934585|FG008|Overall Study|Screen failure|0|||
33328094|NCT01094730|62704517|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
33328095|NCT01094730|62704516|FG000|Period 2 (14 Days)|Adverse Event|0|||
33328096|NCT01094730|62704517|FG001|Period 2 (14 Days)|Adverse Event|1|||
33464243|NCT03352414|62837773|FG000|Overall Study|Ineligible by operative criteria|12|||
33464244|NCT03352414|62837774|FG001|Overall Study|Ineligible by operative criteria|10|||
33464245|NCT00364793|62837786|FG000|Overall Study|Adverse Event|2|||
33651036|NCT01775137|63062360|FG000|Overall Study|Death|1|||
33651037|NCT01775137|63062360|FG000|Overall Study|Protocol deviation|2|||
33651038|NCT01775137|63062360|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33651039|NCT01775137|63062360|FG000|Overall Study|Adverse Event|1|||
33651040|NCT01775137|63062360|FG000|Overall Study|Withdrawal by participants|5|||
33651041|NCT01976507|63062367|FG000|Overall Study|Adverse Event|6|||
33651042|NCT01976507|63062367|FG000|Overall Study|ablation not done, drug not given|1|||
33651043|NCT01964963|63062371|FG000|Overall Study|Case Report Forms Uncollected|888|||
33651044|NCT01964963|63062371|FG000|Overall Study|Protocol Deviation|50|||
33651045|NCT01964963|63062371|FG000|Overall Study|Data Reliability was not Assured|5|||
33651046|NCT01964105|63062378|FG000|Overall Study|Lost to Follow-up|2|||
33651047|NCT01964105|63062379|FG001|Overall Study|Lost to Follow-up|13|||
33464246|NCT00364793|62837787|FG001|Overall Study|Adverse Event|0|||
33464247|NCT00364793|62837788|FG002|Overall Study|Adverse Event|0|||
33464248|NCT00364793|62837789|FG003|Overall Study|Adverse Event|0|||
33464249|NCT00364793|62837786|FG000|Overall Study|Death|1|||
33464250|NCT00364793|62837787|FG001|Overall Study|Death|0|||
33464251|NCT00364793|62837788|FG002|Overall Study|Death|1|||
33464252|NCT00364793|62837789|FG003|Overall Study|Death|0|||
33464253|NCT00364793|62837786|FG000|Overall Study|Lack of Efficacy|3|||
33464254|NCT00364793|62837787|FG001|Overall Study|Lack of Efficacy|3|||
33464255|NCT00364793|62837788|FG002|Overall Study|Lack of Efficacy|1|||
33464256|NCT00364793|62837789|FG003|Overall Study|Lack of Efficacy|1|||
33464257|NCT00364793|62837786|FG000|Overall Study|Lost to Follow-up|1|||
33464258|NCT00364793|62837787|FG001|Overall Study|Lost to Follow-up|0|||
33464259|NCT00364793|62837788|FG002|Overall Study|Lost to Follow-up|2|||
33464260|NCT00364793|62837789|FG003|Overall Study|Lost to Follow-up|0|||
33464261|NCT00364793|62837786|FG000|Overall Study|Poor or non-compliance|1|||
33464262|NCT00364793|62837787|FG001|Overall Study|Poor or non-compliance|1|||
33464263|NCT00364793|62837788|FG002|Overall Study|Poor or non-compliance|0|||
33464264|NCT00364793|62837789|FG003|Overall Study|Poor or non-compliance|1|||
33464265|NCT00364793|62837786|FG000|Overall Study|No longer meets criteria|0|||
33464266|NCT00364793|62837787|FG001|Overall Study|No longer meets criteria|0|||
33464267|NCT00364793|62837788|FG002|Overall Study|No longer meets criteria|0|||
33464268|NCT00364793|62837789|FG003|Overall Study|No longer meets criteria|1|||
33464269|NCT00364793|62837786|FG000|Overall Study|Withdrawal by Subject|0|||
33464270|NCT00364793|62837787|FG001|Overall Study|Withdrawal by Subject|1|||
33464271|NCT00364793|62837788|FG002|Overall Study|Withdrawal by Subject|0|||
33464272|NCT00364793|62837789|FG003|Overall Study|Withdrawal by Subject|0|||
33464273|NCT03351478|62837805|FG000|Overall Study|At the subject's own request|11|||
33464274|NCT03351478|62837806|FG001|Overall Study|At the subject's own request|12|||
33464275|NCT03351478|62837807|FG002|Overall Study|At the subject's own request|5|||
33464276|NCT03351478|62837805|FG000|Overall Study|Adverse Event|1|||
33464277|NCT03351478|62837806|FG001|Overall Study|Adverse Event|2|||
33464278|NCT03351478|62837807|FG002|Overall Study|Adverse Event|1|||
33464279|NCT03351478|62837805|FG000|Overall Study|Poor compliance to protocol|1|||
33464280|NCT03351478|62837806|FG001|Overall Study|Poor compliance to protocol|0|||
33464281|NCT03351478|62837807|FG002|Overall Study|Poor compliance to protocol|0|||
33464282|NCT03351478|62837805|FG000|Overall Study|Reason not Specified|1|||
33464283|NCT03351478|62837806|FG001|Overall Study|Reason not Specified|3|||
33651048|NCT01964105|63062380|FG002|Overall Study|Lost to Follow-up|0|||
33651049|NCT01974323|63062390|FG000|Overall Study|Other Reasons|25|||
33651050|NCT01974323|63062391|FG001|Overall Study|Other Reasons|28|||
33651051|NCT01974323|63062390|FG000|Overall Study|Protocol Violation|2|||
33464284|NCT03351478|62837807|FG002|Overall Study|Reason not Specified|0|||
33464285|NCT03351478|62837805|FG000|Overall Study|Lost to Follow-up|0|||
33464286|NCT03351478|62837806|FG001|Overall Study|Lost to Follow-up|0|||
33464287|NCT03351478|62837807|FG002|Overall Study|Lost to Follow-up|1|||
33651052|NCT01974323|63062391|FG001|Overall Study|Protocol Violation|2|||
33651053|NCT01974323|63062390|FG000|Overall Study|Personal Reasons|15|||
33464288|NCT00363545|62837817|FG000|Overall Study|Serious Adverse Event|0|||
33464289|NCT00363545|62837818|FG001|Overall Study|Serious Adverse Event|1|||
33464290|NCT00363545|62837817|FG000|Overall Study|Withdrawal by Subject|12|||
33464291|NCT00363545|62837818|FG001|Overall Study|Withdrawal by Subject|15|||
33464292|NCT00363545|62837817|FG000|Overall Study|Migrated/moved from study area|3|||
33464293|NCT00363545|62837818|FG001|Overall Study|Migrated/moved from study area|6|||
33464294|NCT00363545|62837817|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
33464295|NCT00363545|62837818|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
33651054|NCT01974323|63062391|FG001|Overall Study|Personal Reasons|19|||
33543848|NCT02314923|62934586|FG009|Overall Study|Screen failure|0|||
33543849|NCT02314923|62934577|FG000|Overall Study|Participant relocation|1|||
33543850|NCT02314923|62934578|FG001|Overall Study|Participant relocation|0|||
33543851|NCT02314923|62934579|FG002|Overall Study|Participant relocation|0|||
33543852|NCT02314923|62934580|FG003|Overall Study|Participant relocation|0|||
33543853|NCT02314923|62934581|FG004|Overall Study|Participant relocation|0|||
33543854|NCT02314923|62934582|FG005|Overall Study|Participant relocation|0|||
33543855|NCT02314923|62934583|FG006|Overall Study|Participant relocation|0|||
33543856|NCT02314923|62934584|FG007|Overall Study|Participant relocation|1|||
33543857|NCT02314923|62934585|FG008|Overall Study|Participant relocation|0|||
33543858|NCT02314923|62934586|FG009|Overall Study|Participant relocation|0|||
33543859|NCT03023137|62934611|FG000|Overall Study|Multiple pregnancy|2|||
33543860|NCT03023137|62934612|FG001|Overall Study|Multiple pregnancy|4|||
33543861|NCT03023137|62934611|FG000|Overall Study|Lost to Follow-up|1|||
33543862|NCT03023137|62934612|FG001|Overall Study|Lost to Follow-up|1|||
33543863|NCT03023137|62934611|FG000|Overall Study|Protocol Violation|0|||
33543864|NCT03023137|62934612|FG001|Overall Study|Protocol Violation|4|||
33543865|NCT03023137|62934611|FG000|Overall Study|Lost the baby in a car accident|1|||
33543866|NCT03023137|62934612|FG001|Overall Study|Lost the baby in a car accident|0|||
33543867|NCT03049813|62934623|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
33543868|NCT03049813|62934624|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
33543869|NCT03049813|62934625|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
33543870|NCT03049813|62934626|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
33543871|NCT03049813|62934623|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
33464296|NCT00363545|62837817|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
33464297|NCT00363545|62837818|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
33464298|NCT00363545|62837817|FG000|Overall Study|Others|1|||
33464299|NCT00363545|62837818|FG001|Overall Study|Others|0|||
33464300|NCT03351244|62837827|FG000|Overall Study|Adverse Event|7|||
33464301|NCT03351244|62837828|FG001|Overall Study|Adverse Event|11|||
33464302|NCT03351244|62837829|FG002|Overall Study|Adverse Event|12|||
33464303|NCT03351244|62837827|FG000|Overall Study|Investigator's decision|0|||
33464304|NCT03351244|62837828|FG001|Overall Study|Investigator's decision|0|||
33464305|NCT03351244|62837829|FG002|Overall Study|Investigator's decision|2|||
33464306|NCT03351244|62837827|FG000|Overall Study|System error|0|||
33464307|NCT03351244|62837828|FG001|Overall Study|System error|0|||
33464308|NCT03351244|62837829|FG002|Overall Study|System error|2|||
33464309|NCT03351244|62837827|FG000|Overall Study|COVID-19 restrictions|3|||
33464310|NCT03351244|62837828|FG001|Overall Study|COVID-19 restrictions|0|||
33464311|NCT03351244|62837829|FG002|Overall Study|COVID-19 restrictions|1|||
33464312|NCT03351244|62837827|FG000|Overall Study|Non-compliance|2|||
33464313|NCT03351244|62837828|FG001|Overall Study|Non-compliance|5|||
33464314|NCT03351244|62837829|FG002|Overall Study|Non-compliance|0|||
33464315|NCT03351244|62837827|FG000|Overall Study|Withdrawal by Subject|11|||
33464316|NCT03351244|62837828|FG001|Overall Study|Withdrawal by Subject|16|||
33543872|NCT03049813|62934624|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
33543873|NCT03049813|62934625|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
33464317|NCT03351244|62837829|FG002|Overall Study|Withdrawal by Subject|13|||
33543874|NCT03049813|62934626|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
33543875|NCT03049813|62934623|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
33464318|NCT03351244|62837827|FG000|Overall Study|Lost to Follow-up|2|||
33464319|NCT03351244|62837828|FG001|Overall Study|Lost to Follow-up|6|||
33464320|NCT03351244|62837829|FG002|Overall Study|Lost to Follow-up|4|||
33543876|NCT03049813|62934624|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
33328097|NCT01094730|62704516|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
33464321|NCT03351244|62837827|FG000|Overall Study|Protocol Violation|2|||
33464322|NCT03351244|62837828|FG001|Overall Study|Protocol Violation|2|||
33464323|NCT03351244|62837829|FG002|Overall Study|Protocol Violation|0|||
33543877|NCT03049813|62934625|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
33543878|NCT03049813|62934626|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
33464324|NCT03386032|62837842|FG000|Overall Study|Lack of Efficacy|6|||
33464325|NCT03386032|62837843|FG001|Overall Study|Lack of Efficacy|2|||
33464326|NCT03386032|62837844|FG002|Overall Study|Lack of Efficacy|0|||
33464327|NCT03386032|62837842|FG000|Overall Study|Adverse Event|2|||
33543879|NCT03049813|62934623|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
33543880|NCT03049813|62934624|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
33543881|NCT03049813|62934625|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
33543882|NCT03049813|62934626|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
33543883|NCT03022981|62934637|FG000|Overall Study|Adverse Event|0|||
33543884|NCT03022981|62934638|FG001|Overall Study|Adverse Event|1|||
33543885|NCT03022981|62934639|FG002|Overall Study|Adverse Event|0|||
33543886|NCT03022981|62934637|FG000|Overall Study|Investigator's Discretion|0|||
33464328|NCT03386032|62837843|FG001|Overall Study|Adverse Event|2|||
33543887|NCT03022981|62934638|FG001|Overall Study|Investigator's Discretion|1|||
33543888|NCT03022981|62934639|FG002|Overall Study|Investigator's Discretion|2|||
33543889|NCT03022981|62934637|FG000|Overall Study|Lost to Follow-up|6|||
33543890|NCT03022981|62934638|FG001|Overall Study|Lost to Follow-up|2|||
33543891|NCT03022981|62934639|FG002|Overall Study|Lost to Follow-up|1|||
33543892|NCT03022981|62934637|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33543893|NCT03022981|62934638|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33651055|NCT01974323|63062390|FG000|Overall Study|Lost to Follow-up|45|||
33651056|NCT01974323|63062391|FG001|Overall Study|Lost to Follow-up|40|||
33651057|NCT01974323|63062390|FG000|Overall Study|Pregnancy|2|||
33651058|NCT01974323|63062391|FG001|Overall Study|Pregnancy|1|||
33651059|NCT01974323|63062390|FG000|Overall Study|Lack of Efficacy|1|||
33651060|NCT01974323|63062391|FG001|Overall Study|Lack of Efficacy|1|||
33651061|NCT01974323|63062390|FG000|Overall Study|Adverse Event|2|||
33651062|NCT01974323|63062391|FG001|Overall Study|Adverse Event|2|||
33651063|NCT01963403|63062399|FG000|Overall Study|Lost to Follow-up|2|||
33651064|NCT01963403|63062400|FG001|Overall Study|Lost to Follow-up|3|||
33651065|NCT01963403|63062399|FG000|Overall Study|Implant removal|0|||
33651066|NCT01963403|63062400|FG001|Overall Study|Implant removal|1|||
33651067|NCT01973387|63062410|FG000|Overall Study|Adverse Event|14|||
33651068|NCT01973387|63062411|FG001|Overall Study|Adverse Event|4|||
33651069|NCT01973387|63062410|FG000|Overall Study|Withdrawal by Subject|7|||
33651070|NCT01973387|63062411|FG001|Overall Study|Withdrawal by Subject|4|||
33651071|NCT01973387|63062410|FG000|Overall Study|Study terminated by sponsor|63|||
33651072|NCT01973387|63062411|FG001|Overall Study|Study terminated by sponsor|0|||
33651073|NCT01973387|63062410|FG000|Overall Study|Progressive disease or relapse|16|||
33651074|NCT01973387|63062411|FG001|Overall Study|Progressive disease or relapse|5|||
33651075|NCT01973387|63062410|FG000|Overall Study|Death|4|||
33651076|NCT01973387|63062411|FG001|Overall Study|Death|3|||
33651077|NCT01973387|63062410|FG000|Overall Study|Randomized, not treated|2|||
33651078|NCT01973387|63062411|FG001|Overall Study|Randomized, not treated|2|||
33651079|NCT01973231|63062419|FG000|Overall Study|Protocol Violation|1|||
33651080|NCT01973231|63062420|FG001|Overall Study|Protocol Violation|1|||
33651081|NCT01973231|63062419|FG000|Overall Study|Lost to Follow-up|1|||
33651082|NCT01973231|63062420|FG001|Overall Study|Lost to Follow-up|1|||
33651083|NCT01973231|63062419|FG000|Overall Study|unclassified|2|||
33651084|NCT01973231|63062420|FG001|Overall Study|unclassified|1|||
33651085|NCT01973231|63062419|FG000|Overall Study|Withdrawal by Subject|7|||
33651086|NCT01973231|63062420|FG001|Overall Study|Withdrawal by Subject|9|||
33464329|NCT03386032|62837844|FG002|Overall Study|Adverse Event|0|||
33464330|NCT03386032|62837842|FG000|Overall Study|Withdrawal by Subject|1|||
33464331|NCT03386032|62837843|FG001|Overall Study|Withdrawal by Subject|0|||
33543894|NCT03022981|62934639|FG002|Overall Study|Non-Compliance With Study Drug|2|||
33651087|NCT01961687|63062426|FG000|Overall Study|Lost to Follow-up|19|||
33651088|NCT01961687|63062426|FG000|Overall Study|Re-operation|17|||
33651089|NCT01961687|63062426|FG000|Overall Study|Death|7|||
33651090|NCT01961687|63062426|FG000|Overall Study|Withdrawal by Subject|6|||
33651091|NCT01961687|63062426|FG000|Overall Study|Adverse Event|6|||
33464332|NCT03386032|62837844|FG002|Overall Study|Withdrawal by Subject|0|||
33464333|NCT03386032|62837842|FG000|Overall Study|Lost to Follow-up|9|||
33464334|NCT03386032|62837843|FG001|Overall Study|Lost to Follow-up|3|||
33464335|NCT03386032|62837844|FG002|Overall Study|Lost to Follow-up|0|||
33464336|NCT00077610|62837855|FG000|Overall Study|Adverse Event|9|||
33464337|NCT00077610|62837856|FG001|Overall Study|Adverse Event|7|||
33464338|NCT00077610|62837857|FG002|Overall Study|Adverse Event|1|||
33328098|NCT01094730|62704517|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
33328099|NCT00864097|62704532|FG000|Overall Study|Death|0|||
33464339|NCT00077610|62837855|FG000|Overall Study|Lost to Follow-up|0|||
33464340|NCT00077610|62837856|FG001|Overall Study|Lost to Follow-up|1|||
33464341|NCT00077610|62837857|FG002|Overall Study|Lost to Follow-up|2|||
33464342|NCT00077610|62837855|FG000|Overall Study|Withdrawal by Subject|4|||
33464343|NCT00077610|62837856|FG001|Overall Study|Withdrawal by Subject|10|||
33464344|NCT00077610|62837857|FG002|Overall Study|Withdrawal by Subject|6|||
33464345|NCT00077610|62837855|FG000|Overall Study|Death|17|||
33464346|NCT00077610|62837856|FG001|Overall Study|Death|13|||
33464347|NCT00077610|62837857|FG002|Overall Study|Death|13|||
33464348|NCT00077610|62837855|FG000|Overall Study|Renal transplant|12|||
33464349|NCT00077610|62837856|FG001|Overall Study|Renal transplant|15|||
33464350|NCT00077610|62837857|FG002|Overall Study|Renal transplant|11|||
33464351|NCT00077610|62837855|FG000|Overall Study|Withdrew from dialysis care|5|||
33464352|NCT00077610|62837856|FG001|Overall Study|Withdrew from dialysis care|0|||
33464353|NCT00077610|62837857|FG002|Overall Study|Withdrew from dialysis care|3|||
33543895|NCT03022981|62934637|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
33543896|NCT03022981|62934638|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
33464354|NCT00077610|62837855|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33328100|NCT00864097|62704533|FG001|Overall Study|Death|1|||
33328101|NCT00864097|62704534|FG002|Overall Study|Death|0|||
33328102|NCT00864097|62704535|FG003|Overall Study|Death|0|||
33464355|NCT00077610|62837856|FG001|Overall Study|Insufficient Therapeutic Response|0|||
33464356|NCT00077610|62837857|FG002|Overall Study|Insufficient Therapeutic Response|0|||
33543897|NCT03022981|62934639|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
33464357|NCT00077610|62837855|FG000|Overall Study|Multiple blood transfusions|0|||
33464358|NCT00077610|62837856|FG001|Overall Study|Multiple blood transfusions|0|||
33543898|NCT03377699|62934659|FG000|Overall Study|Withdrawal by Subject|2|||
33543899|NCT03377699|62934660|FG001|Overall Study|Withdrawal by Subject|9|||
33328103|NCT00864097|62704532|FG000|Overall Study|Adverse Event|6|||
33328104|NCT00864097|62704533|FG001|Overall Study|Adverse Event|8|||
33328105|NCT00864097|62704534|FG002|Overall Study|Adverse Event|11|||
33328106|NCT00864097|62704535|FG003|Overall Study|Adverse Event|9|||
33328107|NCT00864097|62704532|FG000|Overall Study|Lack of Efficacy|9|||
33328108|NCT00864097|62704533|FG001|Overall Study|Lack of Efficacy|3|||
33328109|NCT00864097|62704534|FG002|Overall Study|Lack of Efficacy|7|||
33464359|NCT00077610|62837857|FG002|Overall Study|Multiple blood transfusions|1|||
33464360|NCT00077610|62837855|FG000|Overall Study|Principal Investigator's decision|1|||
33464361|NCT00077610|62837856|FG001|Overall Study|Principal Investigator's decision|0|||
33543900|NCT03377699|62934659|FG000|Overall Study|Lost to Follow-up|1|||
33543901|NCT03377699|62934660|FG001|Overall Study|Lost to Follow-up|1|||
33651092|NCT01961687|63062426|FG000|Overall Study|Moved to area without study site|2|||
33651093|NCT01961687|63062426|FG000|Overall Study|Sponsor decision|2|||
33651094|NCT01961687|63062426|FG000|Overall Study|Physician Decision|1|||
33464362|NCT00077610|62837857|FG002|Overall Study|Principal Investigator's decision|1|||
33464363|NCT00077610|62837855|FG000|Overall Study|Worsening of health condition|1|||
33328110|NCT00864097|62704535|FG003|Overall Study|Lack of Efficacy|2|||
33328111|NCT00864097|62704532|FG000|Overall Study|Lost to Follow-up|0|||
33328112|NCT00864097|62704533|FG001|Overall Study|Lost to Follow-up|1|||
33328113|NCT00864097|62704534|FG002|Overall Study|Lost to Follow-up|0|||
33328114|NCT00864097|62704535|FG003|Overall Study|Lost to Follow-up|1|||
33328115|NCT00864097|62704532|FG000|Overall Study|Withdrawal by Subject|15|||
33328116|NCT00864097|62704533|FG001|Overall Study|Withdrawal by Subject|11|||
33328117|NCT00864097|62704534|FG002|Overall Study|Withdrawal by Subject|11|||
33328118|NCT00864097|62704535|FG003|Overall Study|Withdrawal by Subject|12|||
33328119|NCT00864097|62704532|FG000|Overall Study|Protocol Violation|2|||
33464364|NCT00077610|62837856|FG001|Overall Study|Worsening of health condition|1|||
33464365|NCT00077610|62837857|FG002|Overall Study|Worsening of health condition|0|||
33464366|NCT00077610|62837855|FG000|Overall Study|Given Epogen in hospital|1|||
33464367|NCT00077610|62837856|FG001|Overall Study|Given Epogen in hospital|0|||
33464368|NCT00077610|62837857|FG002|Overall Study|Given Epogen in hospital|0|||
33464369|NCT00077610|62837855|FG000|Overall Study|Transferred to other unit|0|||
33464370|NCT00077610|62837856|FG001|Overall Study|Transferred to other unit|0|||
33464371|NCT00077610|62837857|FG002|Overall Study|Transferred to other unit|1|||
33543902|NCT03377699|62934659|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
33543903|NCT03377699|62934660|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
33543904|NCT03377699|62934659|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
33543905|NCT03377699|62934660|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
33464372|NCT00077610|62837855|FG000|Overall Study|Transferred to nursing home|0|||
33464373|NCT00077610|62837856|FG001|Overall Study|Transferred to nursing home|0|||
33464374|NCT00077610|62837857|FG002|Overall Study|Transferred to nursing home|1|||
33464375|NCT00077610|62837855|FG000|Overall Study|Transfer to satellite unit|1|||
33464376|NCT00077610|62837856|FG001|Overall Study|Transfer to satellite unit|0|||
33464377|NCT00077610|62837857|FG002|Overall Study|Transfer to satellite unit|0|||
33464378|NCT00077610|62837855|FG000|Overall Study|Transfer to other center for surgery|1|||
33464379|NCT00077610|62837856|FG001|Overall Study|Transfer to other center for surgery|0|||
33464380|NCT00077610|62837857|FG002|Overall Study|Transfer to other center for surgery|0|||
33464381|NCT00077610|62837855|FG000|Overall Study|Change in dialysis modality|1|||
33464382|NCT00077610|62837856|FG001|Overall Study|Change in dialysis modality|0|||
33464383|NCT00077610|62837857|FG002|Overall Study|Change in dialysis modality|0|||
33464384|NCT00077610|62837855|FG000|Overall Study|Relocation|0|||
33464385|NCT00077610|62837856|FG001|Overall Study|Relocation|8|||
33464386|NCT00077610|62837857|FG002|Overall Study|Relocation|5|||
33464387|NCT00077610|62837855|FG000|Overall Study|Financial issues|0|||
33464388|NCT00077610|62837856|FG001|Overall Study|Financial issues|1|||
33464389|NCT00077610|62837857|FG002|Overall Study|Financial issues|0|||
33464390|NCT00077610|62837855|FG000|Overall Study|Sponsors decision to withdraw|0|||
33543906|NCT03377699|62934659|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
33543907|NCT03377699|62934660|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
33543908|NCT03377699|62934659|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
33543909|NCT03377699|62934660|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
33543910|NCT01314443|62934672|FG000|Overall Study|Withdrawal by Subject|2|||
33543911|NCT01314443|62934673|FG001|Overall Study|Withdrawal by Subject|1|||
33543912|NCT01314443|62934674|FG002|Overall Study|Withdrawal by Subject|1|||
33543913|NCT01314443|62934675|FG003|Overall Study|Withdrawal by Subject|1|||
33543914|NCT01314443|62934672|FG000|Overall Study|Protocol Violation|2|||
33651095|NCT01961687|63062426|FG000|Overall Study|Unable to meet follow-up requirements|1|||
33651096|NCT01961609|63062488|FG000|Initiation|Missing|3|||
33651097|NCT01961609|63062489|FG001|Initiation|Missing|2|||
33651098|NCT01961609|63062490|FG002|Initiation|Missing|0|||
33651099|NCT01961609|63062491|FG003|Initiation|Missing|0|||
33651100|NCT01961609|63062488|FG000|Initiation|Protocol deviation|1|||
33651101|NCT01961609|63062489|FG001|Initiation|Protocol deviation|0|||
33651102|NCT01961609|63062490|FG002|Initiation|Protocol deviation|0|||
33651103|NCT01961609|63062491|FG003|Initiation|Protocol deviation|0|||
33543915|NCT01314443|62934673|FG001|Overall Study|Protocol Violation|2|||
33464391|NCT00077610|62837856|FG001|Overall Study|Sponsors decision to withdraw|0|||
33464392|NCT00077610|62837857|FG002|Overall Study|Sponsors decision to withdraw|1|||
33464393|NCT03385564|62837874|FG000|Overall Study|Adverse Event|0|||
33464394|NCT03385564|62837875|FG001|Overall Study|Adverse Event|0|||
33651104|NCT01961609|63062488|FG000|Initiation|Death|0|||
33651105|NCT01961609|63062489|FG001|Initiation|Death|1|||
33651106|NCT01961609|63062490|FG002|Initiation|Death|0|||
33328120|NCT00864097|62704533|FG001|Overall Study|Protocol Violation|1|||
33328121|NCT00864097|62704534|FG002|Overall Study|Protocol Violation|0|||
33328122|NCT00864097|62704535|FG003|Overall Study|Protocol Violation|1|||
33328123|NCT00864097|62704532|FG000|Overall Study|Terminated by sponsor|105|||
33464395|NCT03385564|62837876|FG002|Overall Study|Adverse Event|3|||
33464396|NCT03385564|62837877|FG003|Overall Study|Adverse Event|3|||
33464397|NCT03385564|62837874|FG000|Overall Study|Other than listed|0|||
33464398|NCT03385564|62837875|FG001|Overall Study|Other than listed|0|||
33464399|NCT03385564|62837876|FG002|Overall Study|Other than listed|0|||
33464400|NCT03385564|62837877|FG003|Overall Study|Other than listed|5|||
33464401|NCT03385564|62837874|FG000|Overall Study|Withdrawal by Subject|0|||
33464402|NCT03385564|62837875|FG001|Overall Study|Withdrawal by Subject|1|||
33464403|NCT03385564|62837876|FG002|Overall Study|Withdrawal by Subject|1|||
33328124|NCT00864097|62704533|FG001|Overall Study|Terminated by sponsor|112|||
33328125|NCT00864097|62704534|FG002|Overall Study|Terminated by sponsor|102|||
33651107|NCT01961609|63062491|FG003|Initiation|Death|0|||
33328126|NCT00864097|62704535|FG003|Overall Study|Terminated by sponsor|99|||
33328127|NCT00864097|62704532|FG000|Overall Study|Randomized but not treated|2|||
33328128|NCT00864097|62704533|FG001|Overall Study|Randomized but not treated|0|||
33328129|NCT00864097|62704534|FG002|Overall Study|Randomized but not treated|1|||
33543916|NCT01314443|62934674|FG002|Overall Study|Protocol Violation|1|||
33543917|NCT01314443|62934675|FG003|Overall Study|Protocol Violation|1|||
33543918|NCT02923921|62934687|FG000|Overall Study|Sponsor Decision|39|||
33543919|NCT02923921|62934688|FG001|Overall Study|Sponsor Decision|38|||
33543920|NCT02923921|62934687|FG000|Overall Study|Lost to Follow-up|1|||
33464404|NCT03385564|62837877|FG003|Overall Study|Withdrawal by Subject|0|||
33464405|NCT03385564|62837874|FG000|Overall Study|Lack of Efficacy|0|||
33464406|NCT03385564|62837875|FG001|Overall Study|Lack of Efficacy|0|||
33464407|NCT03385564|62837876|FG002|Overall Study|Lack of Efficacy|0|||
33464408|NCT03385564|62837877|FG003|Overall Study|Lack of Efficacy|1|||
33464409|NCT03385564|62837874|FG000|Overall Study|Death|0|||
33543921|NCT02923921|62934688|FG001|Overall Study|Lost to Follow-up|0|||
33464410|NCT03385564|62837875|FG001|Overall Study|Death|0|||
33543922|NCT02923921|62934687|FG000|Overall Study|Withdrawal by Subject|6|||
33543923|NCT02923921|62934688|FG001|Overall Study|Withdrawal by Subject|13|||
33543924|NCT02923921|62934687|FG000|Overall Study|Unknown, Not Collected|7|||
33543925|NCT02923921|62934688|FG001|Overall Study|Unknown, Not Collected|6|||
33328130|NCT00864097|62704535|FG003|Overall Study|Randomized but not treated|0|||
33328131|NCT00864097|62704532|FG000|Overall Study|Other|0|||
33328132|NCT00864097|62704533|FG001|Overall Study|Other|0|||
33328133|NCT00864097|62704534|FG002|Overall Study|Other|0|||
33328134|NCT00864097|62704535|FG003|Overall Study|Other|1|||
33328135|NCT01183013|62704552|FG000|Overall Study|Adverse Event|6|||
33328136|NCT01183013|62704553|FG001|Overall Study|Adverse Event|8|||
33328137|NCT01183013|62704554|FG002|Overall Study|Adverse Event|5|||
33328138|NCT01183013|62704555|FG003|Overall Study|Adverse Event|5|||
33328139|NCT01183013|62704556|FG004|Overall Study|Adverse Event|10|||
33328140|NCT01183013|62704557|FG005|Overall Study|Adverse Event|10|||
33328141|NCT01183013|62704558|FG006|Overall Study|Adverse Event|6|||
33328142|NCT01183013|62704552|FG000|Overall Study|Lack of Efficacy|3|||
33328143|NCT01183013|62704553|FG001|Overall Study|Lack of Efficacy|2|||
33328144|NCT01183013|62704554|FG002|Overall Study|Lack of Efficacy|1|||
33328145|NCT01183013|62704555|FG003|Overall Study|Lack of Efficacy|2|||
33328146|NCT01183013|62704556|FG004|Overall Study|Lack of Efficacy|1|||
33328147|NCT01183013|62704557|FG005|Overall Study|Lack of Efficacy|2|||
33328148|NCT01183013|62704558|FG006|Overall Study|Lack of Efficacy|0|||
33328149|NCT01183013|62704552|FG000|Overall Study|Protocol Violation|5|||
33328150|NCT01183013|62704553|FG001|Overall Study|Protocol Violation|2|||
33328151|NCT01183013|62704554|FG002|Overall Study|Protocol Violation|4|||
33328152|NCT01183013|62704555|FG003|Overall Study|Protocol Violation|0|||
33328153|NCT01183013|62704556|FG004|Overall Study|Protocol Violation|4|||
33328154|NCT01183013|62704557|FG005|Overall Study|Protocol Violation|3|||
33328155|NCT01183013|62704558|FG006|Overall Study|Protocol Violation|3|||
33328156|NCT01183013|62704552|FG000|Overall Study|Lost to Follow-up|7|||
33328157|NCT01183013|62704553|FG001|Overall Study|Lost to Follow-up|3|||
33328158|NCT01183013|62704554|FG002|Overall Study|Lost to Follow-up|4|||
33328159|NCT01183013|62704555|FG003|Overall Study|Lost to Follow-up|3|||
33328160|NCT01183013|62704556|FG004|Overall Study|Lost to Follow-up|2|||
33328161|NCT01183013|62704557|FG005|Overall Study|Lost to Follow-up|6|||
33328162|NCT01183013|62704558|FG006|Overall Study|Lost to Follow-up|5|||
33328163|NCT01183013|62704552|FG000|Overall Study|Withdrawal by Subject|9|||
33328164|NCT01183013|62704553|FG001|Overall Study|Withdrawal by Subject|13|||
33328165|NCT01183013|62704554|FG002|Overall Study|Withdrawal by Subject|10|||
33328166|NCT01183013|62704555|FG003|Overall Study|Withdrawal by Subject|8|||
33328167|NCT01183013|62704556|FG004|Overall Study|Withdrawal by Subject|7|||
33328168|NCT01183013|62704557|FG005|Overall Study|Withdrawal by Subject|9|||
33328169|NCT01183013|62704558|FG006|Overall Study|Withdrawal by Subject|10|||
33328170|NCT01183013|62704552|FG000|Overall Study|Reasons other than stated above|15|||
33328171|NCT01183013|62704553|FG001|Overall Study|Reasons other than stated above|11|||
33328172|NCT01183013|62704554|FG002|Overall Study|Reasons other than stated above|17|||
33328173|NCT01183013|62704555|FG003|Overall Study|Reasons other than stated above|12|||
33328174|NCT01183013|62704556|FG004|Overall Study|Reasons other than stated above|12|||
33328175|NCT01183013|62704557|FG005|Overall Study|Reasons other than stated above|15|||
33328176|NCT01183013|62704558|FG006|Overall Study|Reasons other than stated above|13|||
33328177|NCT01141283|62704582|FG000|Overall Study|Adverse Event|56|||
33328178|NCT01141283|62704582|FG000|Overall Study|Lost to Follow-up|4|||
33328179|NCT01141283|62704582|FG000|Overall Study|Withdrawal by Subject|14|||
33328180|NCT01141283|62704582|FG000|Overall Study|Administrative|4|||
33328181|NCT01141283|62704582|FG000|Overall Study|Lack of Efficacy|10|||
33328182|NCT00863707|62704588|FG000|Overall Study|Randomized, but drug not received|4|||
33328183|NCT00863707|62704589|FG001|Overall Study|Randomized, but drug not received|3|||
33328184|NCT01094184|62704597|FG000|Overall Study|Death|35|||
33328185|NCT01094184|62704598|FG001|Overall Study|Death|11|||
33328186|NCT01134731|62704607|FG000|Overall Study|Adverse Event|3|||
33328187|NCT01134731|62704608|FG001|Overall Study|Adverse Event|2|||
33328188|NCT01134731|62704609|FG002|Overall Study|Adverse Event|1|||
33328189|NCT01134731|62704607|FG000|Overall Study|Physician Decision|2|||
33328190|NCT01134731|62704608|FG001|Overall Study|Physician Decision|2|||
33328191|NCT01134731|62704609|FG002|Overall Study|Physician Decision|2|||
33328192|NCT01134731|62704607|FG000|Overall Study|Lack of Efficacy|0|||
33328193|NCT01134731|62704608|FG001|Overall Study|Lack of Efficacy|0|||
33328194|NCT01134731|62704609|FG002|Overall Study|Lack of Efficacy|1|||
33328195|NCT01134731|62704607|FG000|Overall Study|Withdrawal by Subject|3|||
33328196|NCT01134731|62704608|FG001|Overall Study|Withdrawal by Subject|3|||
33328197|NCT01134731|62704609|FG002|Overall Study|Withdrawal by Subject|1|||
33328198|NCT01134731|62704607|FG000|Overall Study|Lost to Follow-up|5|||
33328199|NCT01134731|62704608|FG001|Overall Study|Lost to Follow-up|4|||
33328200|NCT01134731|62704609|FG002|Overall Study|Lost to Follow-up|3|||
33328201|NCT01141205|62704620|FG000|Overall Study|Physician Decision|1|||
33328202|NCT01141205|62704621|FG001|Overall Study|Physician Decision|1|||
33328203|NCT01141205|62704620|FG000|Overall Study|Lost to Follow-up|1|||
33328204|NCT01141205|62704621|FG001|Overall Study|Lost to Follow-up|0|||
33651108|NCT01961609|63062488|FG000|Initiation|Administrative problems|1|||
33328205|NCT01141205|62704620|FG000|Overall Study|Withdrawal by Subject|1|||
33651109|NCT01961609|63062489|FG001|Initiation|Administrative problems|0|||
33328206|NCT01141205|62704621|FG001|Overall Study|Withdrawal by Subject|1|||
33328207|NCT01140503|62704631|FG000|Overall Study|Withdrawal by Subject|1|||
33328208|NCT00863317|62704637|FG000|Overall Study|Lost to Follow-up|8|||
33328209|NCT00863317|62704638|FG001|Overall Study|Lost to Follow-up|9|||
33328210|NCT01200368|62704647|FG000|Infant Series|Adverse Event|2|||
33328211|NCT01200368|62704648|FG001|Infant Series|Adverse Event|2|||
33328212|NCT01200368|62704649|FG002|Infant Series|Adverse Event|3|||
33328213|NCT01200368|62704647|FG000|Infant Series|Withdrawal by Subject|0|||
33328214|NCT01200368|62704648|FG001|Infant Series|Withdrawal by Subject|2|||
33328215|NCT01200368|62704649|FG002|Infant Series|Withdrawal by Subject|2|||
33464411|NCT03385564|62837876|FG002|Overall Study|Death|1|||
33464412|NCT03385564|62837877|FG003|Overall Study|Death|0|||
33651110|NCT01961609|63062490|FG002|Initiation|Administrative problems|0|||
33651111|NCT01961609|63062491|FG003|Initiation|Administrative problems|0|||
33651112|NCT01961609|63062488|FG000|Initiation|Withdrawal by Subject|1|||
33651113|NCT01961609|63062489|FG001|Initiation|Withdrawal by Subject|2|||
33651114|NCT01961609|63062490|FG002|Initiation|Withdrawal by Subject|0|||
33464413|NCT00066222|62837887|FG000|Overall Study|No protocol treatment received|1|||
33651115|NCT01961609|63062491|FG003|Initiation|Withdrawal by Subject|0|||
33651116|NCT01961609|63062488|FG000|Initiation|Lack of Efficacy|2|||
33651117|NCT01961609|63062489|FG001|Initiation|Lack of Efficacy|1|||
33651118|NCT01961609|63062490|FG002|Initiation|Lack of Efficacy|0|||
33651119|NCT01961609|63062491|FG003|Initiation|Lack of Efficacy|0|||
33651120|NCT01961609|63062488|FG000|Initiation|Abnormal lab values|0|||
33651121|NCT01961609|63062489|FG001|Initiation|Abnormal lab values|1|||
33651122|NCT01961609|63062490|FG002|Initiation|Abnormal lab values|0|||
33651123|NCT01961609|63062491|FG003|Initiation|Abnormal lab values|0|||
33651124|NCT01961609|63062488|FG000|Initiation|Adverse Event|3|||
33464414|NCT00397943|62837896|FG000|Overall Study|Unspecified reasons|12|||
33464415|NCT00397943|62837897|FG001|Overall Study|Unspecified reasons|9|||
33543926|NCT03039023|62934699|FG000|Overall Study|Withdrawal by Subject|1|||
33543927|NCT03039023|62934700|FG001|Overall Study|Withdrawal by Subject|0|||
33543928|NCT03039023|62934701|FG002|Overall Study|Withdrawal by Subject|1|||
33543929|NCT03039023|62934702|FG003|Overall Study|Withdrawal by Subject|1|||
33543930|NCT03039023|62934703|FG004|Overall Study|Withdrawal by Subject|0|||
33543931|NCT03039023|62934699|FG000|Overall Study|Physician Decision|0|||
33543932|NCT03039023|62934700|FG001|Overall Study|Physician Decision|0|||
33543933|NCT03039023|62934701|FG002|Overall Study|Physician Decision|0|||
33543934|NCT03039023|62934702|FG003|Overall Study|Physician Decision|1|||
33543935|NCT03039023|62934703|FG004|Overall Study|Physician Decision|0|||
33543936|NCT03022045|62934717|FG000|Overall Study|Adverse Event|0|||
33543937|NCT03022045|62934718|FG001|Overall Study|Adverse Event|1|||
33543938|NCT03022045|62934717|FG000|Overall Study|Withdrawal by Subject|1|||
33543939|NCT03022045|62934718|FG001|Overall Study|Withdrawal by Subject|1|||
33651125|NCT01961609|63062489|FG001|Initiation|Adverse Event|5|||
33651126|NCT01961609|63062490|FG002|Initiation|Adverse Event|0|||
33464416|NCT00397943|62837898|FG002|Overall Study|Unspecified reasons|0|||
33464417|NCT00397943|62837899|FG003|Overall Study|Unspecified reasons|0|||
33464418|NCT00397943|62837900|FG004|Overall Study|Unspecified reasons|0|||
33464419|NCT00066066|62837915|FG000|Overall Study|Lost to Follow-up|6|||
33464420|NCT00066066|62837916|FG001|Overall Study|Lost to Follow-up|4|||
33464421|NCT00066066|62837917|FG002|Overall Study|Lost to Follow-up|7|||
33464422|NCT00066066|62837918|FG003|Overall Study|Lost to Follow-up|4|||
33464423|NCT00066066|62837919|FG004|Overall Study|Lost to Follow-up|3|||
33464424|NCT00066066|62837920|FG005|Overall Study|Lost to Follow-up|5|||
33464425|NCT00363467|62837934|FG000|Overall Study|Physician Decision|1|||
33464426|NCT00397631|62837940|FG000|Overall Study|Adverse Event|5|||
33464427|NCT00397631|62837941|FG001|Overall Study|Adverse Event|6|||
33464428|NCT00397631|62837940|FG000|Overall Study|Lack of Efficacy|7|||
33464429|NCT00397631|62837941|FG001|Overall Study|Lack of Efficacy|10|||
33464430|NCT00397631|62837940|FG000|Overall Study|Lost to Follow-up|8|||
33464431|NCT00397631|62837941|FG001|Overall Study|Lost to Follow-up|9|||
33464432|NCT00397631|62837940|FG000|Overall Study|Physician Decision|2|||
33464433|NCT00397631|62837941|FG001|Overall Study|Physician Decision|0|||
33464434|NCT00397631|62837940|FG000|Overall Study|Protocol Violation|0|||
33464435|NCT00397631|62837941|FG001|Overall Study|Protocol Violation|1|||
33464436|NCT00397631|62837940|FG000|Overall Study|Withdrawal by Subject|7|||
33464437|NCT00397631|62837941|FG001|Overall Study|Withdrawal by Subject|14|||
33464438|NCT00397631|62837940|FG000|Overall Study|protocol discontinuation criteria|1|||
33464439|NCT00397631|62837941|FG001|Overall Study|protocol discontinuation criteria|4|||
33464440|NCT00077376|62837947|FG000|Overall Study|Adverse Event|8|||
33464441|NCT00077376|62837947|FG000|Overall Study|Withdrawal by Subject|2|||
33464442|NCT00077376|62837947|FG000|Overall Study|Death|1|||
33464443|NCT00077376|62837947|FG000|Overall Study|Physician Decision|1|||
33464444|NCT00077376|62837947|FG000|Overall Study|Alternative therapy|5|||
33464445|NCT00077376|62837947|FG000|Overall Study|Complicating disease|1|||
33464446|NCT00077376|62837947|FG000|Overall Study|Still on treatment|1|||
33464447|NCT00077376|62837947|FG000|Overall Study|Symptomatic deterioration|1|||
33543940|NCT03037619|62934730|FG000|Overall Study|Lost to Follow-up|0|||
33543941|NCT03037619|62934731|FG001|Overall Study|Lost to Follow-up|1|||
33651127|NCT01961609|63062491|FG003|Initiation|Adverse Event|0|||
33651128|NCT01961609|63062488|FG000|Initiation|Randomized but not treated|1|||
33464448|NCT00077376|62837947|FG000|Overall Study|Surgery|1|||
33543942|NCT04771013|62934739|FG000|Overall Study|Withdrawal by Subject|2|||
33464449|NCT00077376|62837947|FG000|Overall Study|Insurance ran out|1|||
33464450|NCT00363311|62837953|FG000|Overall Study|Adverse Event|6|||
33464451|NCT00363311|62837954|FG001|Overall Study|Adverse Event|4|||
33464452|NCT00363311|62837953|FG000|Overall Study|Lost to Follow-up|3|||
33464453|NCT00363311|62837954|FG001|Overall Study|Lost to Follow-up|0|||
33464454|NCT00363311|62837953|FG000|Overall Study|Protocol Violation|1|||
33464455|NCT00363311|62837954|FG001|Overall Study|Protocol Violation|2|||
33328216|NCT01200368|62704647|FG000|Infant Series|Did not meet entrance criteria|0|||
33328217|NCT01200368|62704648|FG001|Infant Series|Did not meet entrance criteria|1|||
33328218|NCT01200368|62704649|FG002|Infant Series|Did not meet entrance criteria|0|||
33328219|NCT01200368|62704647|FG000|Infant Series|Randomized, not vaccinated|0|||
33328220|NCT01200368|62704648|FG001|Infant Series|Randomized, not vaccinated|1|||
33328221|NCT01200368|62704649|FG002|Infant Series|Randomized, not vaccinated|1|||
33328222|NCT01200368|62704647|FG000|Infant Series|Other|1|||
33464456|NCT00363311|62837953|FG000|Overall Study|Withdrawal by Subject|12|||
33464457|NCT00363311|62837954|FG001|Overall Study|Withdrawal by Subject|6|||
33464458|NCT00363311|62837953|FG000|Overall Study|Physician Decision|1|||
33464459|NCT00363311|62837954|FG001|Overall Study|Physician Decision|1|||
33464460|NCT00363311|62837953|FG000|Overall Study|Sponsor Terminated Study|2|||
33464461|NCT00363311|62837954|FG001|Overall Study|Sponsor Terminated Study|2|||
33464462|NCT00363311|62837953|FG000|Overall Study|Disease Progression|46|||
33464463|NCT00363311|62837954|FG001|Overall Study|Disease Progression|26|||
33464464|NCT00363311|62837953|FG000|Overall Study|Non-Compliance|1|||
33464465|NCT00363311|62837954|FG001|Overall Study|Non-Compliance|1|||
33464466|NCT00363311|62837953|FG000|Overall Study|Participant Refused Biopsy|1|||
33464467|NCT00363311|62837954|FG001|Overall Study|Participant Refused Biopsy|0|||
33464468|NCT00363311|62837953|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
33464469|NCT00363311|62837954|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
33464470|NCT00363311|62837953|FG000|Overall Study|Participant Opted for Treatment|1|||
33464471|NCT00363311|62837954|FG001|Overall Study|Participant Opted for Treatment|0|||
33464472|NCT00363311|62837953|FG000|Overall Study|Participant Moved to Another Country|1|||
33464473|NCT00363311|62837954|FG001|Overall Study|Participant Moved to Another Country|0|||
33464474|NCT00363311|62837953|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
33328223|NCT01200368|62704648|FG001|Infant Series|Other|0|||
33328224|NCT01200368|62704649|FG002|Infant Series|Other|0|||
33328225|NCT01200368|62704647|FG000|After Infant Series|Adverse Event|6|||
33328226|NCT01200368|62704648|FG001|After Infant Series|Adverse Event|6|||
33328227|NCT01200368|62704649|FG002|After Infant Series|Adverse Event|3|||
33464475|NCT00363311|62837954|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
33464476|NCT00363311|62837953|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
33464477|NCT00363311|62837954|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
33464478|NCT00363311|62837953|FG000|Overall Study|Participant Moved to Louisiana|0|||
33464479|NCT00363311|62837954|FG001|Overall Study|Participant Moved to Louisiana|1|||
33328228|NCT01200368|62704647|FG000|After Infant Series|Withdrawal by Subject|10|||
33464480|NCT00362609|62837962|FG000|Overall Study|Withdrawal by Subject|0|||
33464481|NCT00362609|62837963|FG001|Overall Study|Withdrawal by Subject|1|||
33464482|NCT00362609|62837962|FG000|Overall Study|Protocol Violation|0|||
33464483|NCT00362609|62837963|FG001|Overall Study|Protocol Violation|1|||
33464484|NCT00362375|62837971|FG000|Overall Study|Lost to Follow-up|40|||
33464485|NCT00362375|62837972|FG001|Overall Study|Lost to Follow-up|35|||
33464486|NCT00362297|62837980|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
33464487|NCT00362297|62837981|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
33651129|NCT01961609|63062489|FG001|Initiation|Randomized but not treated|1|||
33651130|NCT01961609|63062490|FG002|Initiation|Randomized but not treated|0|||
33464488|NCT00065442|62837989|FG000|Overall Study|Lost to Follow-up|1|||
33651131|NCT01961609|63062491|FG003|Initiation|Randomized but not treated|0|||
33464489|NCT00065442|62837990|FG001|Overall Study|Lost to Follow-up|1|||
33464490|NCT00065442|62837989|FG000|Overall Study|Death|121|||
33464491|NCT00065442|62837990|FG001|Overall Study|Death|210|||
33464492|NCT00065442|62837989|FG000|Overall Study|Withdrawal by Subject|3|||
33464493|NCT00065442|62837990|FG001|Overall Study|Withdrawal by Subject|9|||
33464494|NCT00090402|62837999|FG000|Overall Study|Death|1|||
33464495|NCT00090402|62838000|FG001|Overall Study|Death|1|||
33464496|NCT00090402|62838001|FG002|Overall Study|Death|0|||
33464497|NCT00090402|62837999|FG000|Overall Study|subject moved|0|||
33464498|NCT00090402|62838000|FG001|Overall Study|subject moved|1|||
33464499|NCT00090402|62838001|FG002|Overall Study|subject moved|0|||
33464500|NCT00090402|62837999|FG000|Overall Study|stopped taking study medication|1|||
33464501|NCT00090402|62838000|FG001|Overall Study|stopped taking study medication|0|||
33464502|NCT00090402|62838001|FG002|Overall Study|stopped taking study medication|1|||
33464503|NCT00361283|62838012|FG000|Overall Study|Lost to Follow-up|27|||
33464504|NCT00077064|62838018|FG000|Overall Study|Adverse Event|0|||
33464505|NCT00077064|62838019|FG001|Overall Study|Adverse Event|4|||
33464506|NCT00077064|62838018|FG000|Overall Study|Patient refusal|0|||
33651535|NCT01707992|63062968|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
33464507|NCT00077064|62838019|FG001|Overall Study|Patient refusal|2|||
33464508|NCT00396383|62838026|FG000|Overall Study|Death|2|||
33464509|NCT00396383|62838026|FG000|Overall Study|Lost to Follow-up|1|||
33328229|NCT01200368|62704648|FG001|After Infant Series|Withdrawal by Subject|8|||
33328230|NCT01200368|62704649|FG002|After Infant Series|Withdrawal by Subject|4|||
33464510|NCT00395447|62838032|FG000|Overall Study|Death|37|||
33464511|NCT00395447|62838033|FG001|Overall Study|Death|32|||
33464512|NCT00395447|62838032|FG000|Overall Study|Lost to Follow-up|52|||
33464513|NCT00395447|62838033|FG001|Overall Study|Lost to Follow-up|43|||
33464514|NCT00395447|62838032|FG000|Overall Study|Withdrawal by Subject|24|||
33464515|NCT00395447|62838033|FG001|Overall Study|Withdrawal by Subject|19|||
33464516|NCT00395447|62838032|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
33464517|NCT00395447|62838033|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
33464518|NCT03404674|62838045|FG000|Overall Study|Inability to Attend Future Visits|0|||
33464519|NCT03404674|62838046|FG001|Overall Study|Inability to Attend Future Visits|1|||
33464520|NCT03404674|62838047|FG002|Overall Study|Inability to Attend Future Visits|1|||
33651132|NCT01961609|63062488|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
33328231|NCT01200368|62704647|FG000|After Infant Series|Lost to Follow-up|1|||
33651133|NCT01961609|63062489|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
33651134|NCT01961609|63062490|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
33464521|NCT03404674|62838048|FG003|Overall Study|Inability to Attend Future Visits|0|||
33464522|NCT03404674|62838049|FG004|Overall Study|Inability to Attend Future Visits|0|||
33464523|NCT03404674|62838050|FG005|Overall Study|Inability to Attend Future Visits|0|||
33464524|NCT03404674|62838045|FG000|Overall Study|Behavioral Problems|0|||
33464525|NCT03404674|62838046|FG001|Overall Study|Behavioral Problems|0|||
33464526|NCT03404674|62838047|FG002|Overall Study|Behavioral Problems|1|||
33464527|NCT03404674|62838048|FG003|Overall Study|Behavioral Problems|0|||
33464528|NCT03404674|62838049|FG004|Overall Study|Behavioral Problems|0|||
33464529|NCT03404674|62838050|FG005|Overall Study|Behavioral Problems|0|||
33464530|NCT03404674|62838045|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
33464531|NCT03404674|62838046|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
33464532|NCT03404674|62838047|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
33464533|NCT03404674|62838048|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
33464534|NCT03404674|62838049|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
33464535|NCT03404674|62838050|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
33464536|NCT00064662|62838067|FG000|Overall Study|Death|1|||
33464537|NCT00064662|62838068|FG001|Overall Study|Death|1|||
33464538|NCT00064662|62838067|FG000|Overall Study|Lost to Follow-up|57|||
33464539|NCT00064662|62838068|FG001|Overall Study|Lost to Follow-up|44|||
33464540|NCT00064662|62838067|FG000|Overall Study|Withdrawal by Subject|14|||
33464541|NCT00064662|62838068|FG001|Overall Study|Withdrawal by Subject|14|||
33464542|NCT00064662|62838067|FG000|Overall Study|Administratively withdrawn|2|||
33464543|NCT00064662|62838068|FG001|Overall Study|Administratively withdrawn|2|||
33464544|NCT03404518|62838076|FG000|Overall Study|Lost to Follow-up|28|||
33464545|NCT03404518|62838077|FG001|Overall Study|Lost to Follow-up|30|||
33464546|NCT03404518|62838076|FG000|Overall Study|Protocol Violation|13|||
33464547|NCT03404518|62838077|FG001|Overall Study|Protocol Violation|6|||
33464548|NCT03404206|62838086|FG000|Overall Study|Withdrawal by Subject|1|||
33464549|NCT03404206|62838087|FG001|Overall Study|Withdrawal by Subject|1|||
33464550|NCT03404206|62838088|FG002|Overall Study|Withdrawal by Subject|0|||
33464551|NCT03404206|62838086|FG000|Overall Study|Lost to Follow-up|3|||
33464552|NCT03404206|62838087|FG001|Overall Study|Lost to Follow-up|1|||
33464553|NCT03404206|62838088|FG002|Overall Study|Lost to Follow-up|0|||
33464554|NCT03403426|62838096|FG000|Overall Study|Death|1|||
33464555|NCT03403426|62838096|FG000|Overall Study|Lost to Follow-up|2|||
33464556|NCT00394901|62838104|FG000|Baseline Phase|Protocol Violation|0|||
33464557|NCT00394901|62838105|FG001|Baseline Phase|Protocol Violation|0|||
33464558|NCT00394901|62838106|FG002|Baseline Phase|Protocol Violation|1|||
33464559|NCT00394901|62838107|FG003|Baseline Phase|Protocol Violation|0|||
33464560|NCT00394901|62838104|FG000|Double-blind Phase|Adverse Event|5|||
33464561|NCT00394901|62838105|FG001|Double-blind Phase|Adverse Event|7|||
33464562|NCT00394901|62838106|FG002|Double-blind Phase|Adverse Event|16|||
33464563|NCT00394901|62838107|FG003|Double-blind Phase|Adverse Event|20|||
33464564|NCT00394901|62838104|FG000|Double-blind Phase|Lack of Efficacy|6|||
33651135|NCT01961609|63062491|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
33651136|NCT01961609|63062488|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
33464565|NCT00394901|62838105|FG001|Double-blind Phase|Lack of Efficacy|4|||
33464566|NCT00394901|62838106|FG002|Double-blind Phase|Lack of Efficacy|1|||
33464567|NCT00394901|62838107|FG003|Double-blind Phase|Lack of Efficacy|3|||
33328232|NCT01200368|62704648|FG001|After Infant Series|Lost to Follow-up|0|||
33328233|NCT01200368|62704649|FG002|After Infant Series|Lost to Follow-up|0|||
33328234|NCT01200368|62704647|FG000|After Infant Series|Other|1|||
33328235|NCT01200368|62704648|FG001|After Infant Series|Other|2|||
33328236|NCT01200368|62704649|FG002|After Infant Series|Other|2|||
33328237|NCT01200368|62704647|FG000|Toddler Dose|Adverse Event|0|||
33328238|NCT01200368|62704648|FG001|Toddler Dose|Adverse Event|3|||
33651137|NCT01961609|63062489|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
33651138|NCT01961609|63062490|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
33464568|NCT00394901|62838104|FG000|Double-blind Phase|Withdrawal by Subject|2|||
33464569|NCT00394901|62838105|FG001|Double-blind Phase|Withdrawal by Subject|0|||
33464570|NCT00394901|62838106|FG002|Double-blind Phase|Withdrawal by Subject|0|||
33464571|NCT00394901|62838107|FG003|Double-blind Phase|Withdrawal by Subject|0|||
33464572|NCT00394901|62838104|FG000|Double-blind Phase|Lost to Follow-up|0|||
33464573|NCT00394901|62838105|FG001|Double-blind Phase|Lost to Follow-up|0|||
33464574|NCT00394901|62838106|FG002|Double-blind Phase|Lost to Follow-up|0|||
33464575|NCT00394901|62838107|FG003|Double-blind Phase|Lost to Follow-up|1|||
33464576|NCT00394901|62838104|FG000|Double-blind Phase|Protocol Violation|0|||
33464577|NCT00394901|62838105|FG001|Double-blind Phase|Protocol Violation|0|||
33464578|NCT00394901|62838106|FG002|Double-blind Phase|Protocol Violation|0|||
33464579|NCT00394901|62838107|FG003|Double-blind Phase|Protocol Violation|1|||
33464580|NCT00394901|62838104|FG000|Double-blind Phase|Death|1|||
33328239|NCT01200368|62704649|FG002|Toddler Dose|Adverse Event|1|||
33328240|NCT01079130|62704670|FG000|Overall Study|Adverse Event|1|||
33328241|NCT01079130|62704671|FG001|Overall Study|Adverse Event|1|||
33464581|NCT00394901|62838105|FG001|Double-blind Phase|Death|0|||
33464582|NCT00394901|62838106|FG002|Double-blind Phase|Death|0|||
33464583|NCT00394901|62838107|FG003|Double-blind Phase|Death|0|||
33464584|NCT00394901|62838104|FG000|Double-blind Phase|Subject's Personal Reason|1|||
33651139|NCT01961609|63062491|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
33651140|NCT01961609|63062488|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
33651141|NCT01961609|63062489|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
33651142|NCT01961609|63062490|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
33651143|NCT01961609|63062491|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
33651144|NCT01961609|63062488|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
33651145|NCT01961609|63062489|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
33651146|NCT01961609|63062490|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
33651147|NCT01961609|63062491|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
33651148|NCT01961609|63062488|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
33651149|NCT01961609|63062489|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
33651150|NCT01961609|63062490|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
33464585|NCT00394901|62838105|FG001|Double-blind Phase|Subject's Personal Reason|0|||
33464586|NCT00394901|62838106|FG002|Double-blind Phase|Subject's Personal Reason|0|||
33543943|NCT04771013|62934740|FG001|Overall Study|Withdrawal by Subject|0|||
33543944|NCT04771013|62934739|FG000|Overall Study|Death|0|||
33543945|NCT04771013|62934740|FG001|Overall Study|Death|5|||
33543946|NCT04771013|62934739|FG000|Overall Study|Referred to another hospital before day 20|0|||
33543947|NCT04771013|62934740|FG001|Overall Study|Referred to another hospital before day 20|1|||
33543948|NCT03021265|62934746|FG000|Overall Study|Adverse Event|29|||
33328242|NCT01079130|62704672|FG002|Overall Study|Adverse Event|0|||
33651151|NCT01961609|63062491|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
33328243|NCT01079130|62704673|FG003|Overall Study|Adverse Event|1|||
33464587|NCT00394901|62838107|FG003|Double-blind Phase|Subject's Personal Reason|1|||
33464588|NCT00394901|62838104|FG000|Double-blind Phase|Lack of Compliance|0|||
33464589|NCT00394901|62838105|FG001|Double-blind Phase|Lack of Compliance|3|||
33464590|NCT00394901|62838106|FG002|Double-blind Phase|Lack of Compliance|0|||
33464591|NCT00394901|62838107|FG003|Double-blind Phase|Lack of Compliance|0|||
33464592|NCT00394901|62838104|FG000|Double-blind Phase|Entry into another study was found|0|||
33464593|NCT00394901|62838105|FG001|Double-blind Phase|Entry into another study was found|0|||
33464594|NCT00394901|62838106|FG002|Double-blind Phase|Entry into another study was found|1|||
33543949|NCT03021265|62934746|FG000|Overall Study|Lack of Efficacy|3|||
33328244|NCT01079130|62704674|FG004|Overall Study|Adverse Event|5|||
33464595|NCT00394901|62838107|FG003|Double-blind Phase|Entry into another study was found|0|||
33464596|NCT00394901|62838104|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
33464597|NCT00394901|62838105|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
33464598|NCT00394901|62838106|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
33464599|NCT00394901|62838107|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
33651152|NCT01961609|63062488|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
33651153|NCT01961609|63062489|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
33651154|NCT01961609|63062490|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
33651155|NCT01961609|63062491|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
33464600|NCT03349060|62838123|FG000|Overall Study|Adverse Event|9|||
33464601|NCT03349060|62838124|FG001|Overall Study|Adverse Event|9|||
33464602|NCT03349060|62838125|FG002|Overall Study|Adverse Event|7|||
33464603|NCT03349060|62838123|FG000|Overall Study|Lack of Efficacy|1|||
33464604|NCT03349060|62838124|FG001|Overall Study|Lack of Efficacy|0|||
33464605|NCT03349060|62838125|FG002|Overall Study|Lack of Efficacy|2|||
33464606|NCT03349060|62838123|FG000|Overall Study|Lost to Follow-up|2|||
33464607|NCT03349060|62838124|FG001|Overall Study|Lost to Follow-up|1|||
33464608|NCT03349060|62838125|FG002|Overall Study|Lost to Follow-up|1|||
33464609|NCT03349060|62838123|FG000|Overall Study|Protocol Violation|2|||
33464610|NCT03349060|62838124|FG001|Overall Study|Protocol Violation|2|||
33464611|NCT03349060|62838125|FG002|Overall Study|Protocol Violation|1|||
33464612|NCT03349060|62838123|FG000|Overall Study|Withdrawal by Subject|5|||
33464613|NCT03349060|62838124|FG001|Overall Study|Withdrawal by Subject|3|||
33464614|NCT03349060|62838125|FG002|Overall Study|Withdrawal by Subject|4|||
33464615|NCT03349060|62838123|FG000|Overall Study|Medication error,no linked adverse event|0|||
33464616|NCT03349060|62838124|FG001|Overall Study|Medication error,no linked adverse event|0|||
33464617|NCT03349060|62838125|FG002|Overall Study|Medication error,no linked adverse event|1|||
33464618|NCT03349060|62838123|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
33464619|NCT03349060|62838124|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
33464620|NCT03349060|62838125|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
33464621|NCT03349060|62838123|FG000|Overall Study|Other|2|||
33464622|NCT03349060|62838124|FG001|Overall Study|Other|1|||
33464623|NCT03349060|62838125|FG002|Overall Study|Other|0|||
33464624|NCT03348904|62838136|FG000|Overall Study|Administrative reason by the sponsor|0|||
33464625|NCT03348904|62838137|FG001|Overall Study|Administrative reason by the sponsor|1|||
33464626|NCT03348904|62838138|FG002|Overall Study|Administrative reason by the sponsor|0|||
33464627|NCT00359021|62838148|FG000|Overall Study|Adverse Event|26|||
33464628|NCT00359021|62838149|FG001|Overall Study|Adverse Event|8|||
33464629|NCT00359021|62838148|FG000|Overall Study|Subject Non-Compliant|1|||
33464630|NCT00359021|62838149|FG001|Overall Study|Subject Non-Compliant|2|||
33464631|NCT00359021|62838148|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
33464632|NCT00359021|62838149|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
33651156|NCT01961609|63062488|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
33328245|NCT01079130|62704675|FG005|Overall Study|Adverse Event|1|||
33464633|NCT00359021|62838148|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
33464634|NCT00359021|62838149|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
33464635|NCT00359021|62838148|FG000|Overall Study|Withdrawal by Subject|2|||
33464636|NCT00359021|62838149|FG001|Overall Study|Withdrawal by Subject|9|||
33651157|NCT01961609|63062489|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
33464637|NCT00359021|62838148|FG000|Overall Study|Lost to Follow-up|1|||
33464638|NCT00359021|62838149|FG001|Overall Study|Lost to Follow-up|0|||
33464639|NCT00359021|62838148|FG000|Overall Study|Other|4|||
33464640|NCT00359021|62838149|FG001|Overall Study|Other|1|||
33464641|NCT00359021|62838148|FG000|Overall Study|Pregnancy|1|||
33464642|NCT00359021|62838149|FG001|Overall Study|Pregnancy|0|||
33464643|NCT00360269|62838159|FG000|Overall Study|Lost to Follow-up|7|||
33464644|NCT00360269|62838160|FG001|Overall Study|Lost to Follow-up|9|||
33464645|NCT00360269|62838159|FG000|Overall Study|Physician Decision|1|||
33464646|NCT00360269|62838160|FG001|Overall Study|Physician Decision|2|||
33543950|NCT03021265|62934746|FG000|Overall Study|Improved|17|||
33543951|NCT03021265|62934746|FG000|Overall Study|Lost to Follow-up|67|||
33543952|NCT03021265|62934746|FG000|Overall Study|No reason given|2|||
33543953|NCT03021265|62934746|FG000|Overall Study|No visit since the first visit|4|||
33328246|NCT01079130|62704670|FG000|Overall Study|Administrative problems|1|||
33328247|NCT01079130|62704671|FG001|Overall Study|Administrative problems|3|||
33328248|NCT01079130|62704672|FG002|Overall Study|Administrative problems|0|||
33328249|NCT01079130|62704673|FG003|Overall Study|Administrative problems|0|||
33328250|NCT01079130|62704674|FG004|Overall Study|Administrative problems|0|||
33328251|NCT01079130|62704675|FG005|Overall Study|Administrative problems|1|||
33328252|NCT01079130|62704670|FG000|Overall Study|Withdrawal by Subject|0|||
33328253|NCT01079130|62704671|FG001|Overall Study|Withdrawal by Subject|1|||
33328254|NCT01079130|62704672|FG002|Overall Study|Withdrawal by Subject|0|||
33328255|NCT01079130|62704673|FG003|Overall Study|Withdrawal by Subject|0|||
33328256|NCT01079130|62704674|FG004|Overall Study|Withdrawal by Subject|1|||
33328257|NCT01079130|62704675|FG005|Overall Study|Withdrawal by Subject|3|||
33328258|NCT01079130|62704670|FG000|Overall Study|Protocol deviation|0|||
33328259|NCT01079130|62704671|FG001|Overall Study|Protocol deviation|2|||
33328260|NCT01079130|62704672|FG002|Overall Study|Protocol deviation|1|||
33328261|NCT01079130|62704673|FG003|Overall Study|Protocol deviation|2|||
33328262|NCT01079130|62704674|FG004|Overall Study|Protocol deviation|0|||
33328263|NCT01079130|62704675|FG005|Overall Study|Protocol deviation|0|||
33328264|NCT01079130|62704670|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33328265|NCT01079130|62704671|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33328266|NCT01079130|62704672|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33328267|NCT01079130|62704673|FG003|Overall Study|Abnormal test procedure result(s)|0|||
33328268|NCT01079130|62704674|FG004|Overall Study|Abnormal test procedure result(s)|1|||
33328269|NCT01079130|62704675|FG005|Overall Study|Abnormal test procedure result(s)|0|||
33328270|NCT01079130|62704670|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33328271|NCT01079130|62704671|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33328272|NCT01079130|62704672|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33328273|NCT01079130|62704673|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
33328274|NCT01079130|62704674|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
33464647|NCT00360269|62838159|FG000|Overall Study|Adverse Event|1|||
33464648|NCT00360269|62838160|FG001|Overall Study|Adverse Event|0|||
33464649|NCT00360269|62838159|FG000|Overall Study|Withdrawal by Subject|1|||
33464650|NCT00360269|62838160|FG001|Overall Study|Withdrawal by Subject|1|||
33464651|NCT00076752|62838166|FG000|Overall Study|Death|2|||
33464652|NCT00076752|62838166|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
33464653|NCT03384940|62838174|FG000|Overall Study|Progressive disease|36|||
33464654|NCT03384940|62838175|FG001|Overall Study|Progressive disease|11|||
33464655|NCT03384940|62838176|FG002|Overall Study|Progressive disease|13|||
33464656|NCT03384940|62838174|FG000|Overall Study|Clinical progression|4|||
33464657|NCT03384940|62838175|FG001|Overall Study|Clinical progression|0|||
33464658|NCT03384940|62838176|FG002|Overall Study|Clinical progression|3|||
33464659|NCT03384940|62838174|FG000|Overall Study|Adverse Event|7|||
33464660|NCT03384940|62838175|FG001|Overall Study|Adverse Event|1|||
33464661|NCT03384940|62838176|FG002|Overall Study|Adverse Event|1|||
33464662|NCT03384940|62838174|FG000|Overall Study|Withdrawal by Subject|3|||
33464663|NCT03384940|62838175|FG001|Overall Study|Withdrawal by Subject|1|||
33464664|NCT03384940|62838176|FG002|Overall Study|Withdrawal by Subject|0|||
33464665|NCT03384940|62838174|FG000|Overall Study|Physician Decision|1|||
33464666|NCT03384940|62838175|FG001|Overall Study|Physician Decision|1|||
33464667|NCT03384940|62838176|FG002|Overall Study|Physician Decision|0|||
33464668|NCT03384940|62838174|FG000|Overall Study|Death|2|||
33464669|NCT03384940|62838175|FG001|Overall Study|Death|1|||
33464670|NCT03384940|62838176|FG002|Overall Study|Death|0|||
33464671|NCT03384940|62838174|FG000|Overall Study|Other|0|||
33464672|NCT03384940|62838175|FG001|Overall Study|Other|0|||
33464673|NCT03384940|62838176|FG002|Overall Study|Other|1|||
33464674|NCT00075582|62838186|FG000|Overall Study|Adverse Event|3|||
33464675|NCT00075582|62838187|FG001|Overall Study|Adverse Event|1|||
33464676|NCT00075582|62838186|FG000|Overall Study|Lack of Efficacy|4|||
33464677|NCT00075582|62838187|FG001|Overall Study|Lack of Efficacy|8|||
33464678|NCT00075582|62838186|FG000|Overall Study|Physician Decision|5|||
33464679|NCT00075582|62838187|FG001|Overall Study|Physician Decision|8|||
33464680|NCT00075582|62838186|FG000|Overall Study|Withdrawal by Subject|2|||
33464681|NCT00075582|62838187|FG001|Overall Study|Withdrawal by Subject|2|||
33464682|NCT00075582|62838186|FG000|Overall Study|Ineligible for study|36|||
33464683|NCT00075582|62838187|FG001|Overall Study|Ineligible for study|16|||
33464684|NCT00063258|62838199|FG000|Overall Study|Physician Decision|2|||
33464685|NCT00063258|62838200|FG001|Overall Study|Physician Decision|0|||
33464686|NCT00063258|62838199|FG000|Overall Study|Lack of Efficacy|2|||
33464687|NCT00063258|62838200|FG001|Overall Study|Lack of Efficacy|0|||
33464688|NCT00088530|62838208|FG000|Overall Study|Progressive/Relapsed Disease|28|||
33464689|NCT00088530|62838209|FG001|Overall Study|Progressive/Relapsed Disease|39|||
33464690|NCT00088530|62838208|FG000|Overall Study|Adverse Event|15|||
33464691|NCT00088530|62838209|FG001|Overall Study|Adverse Event|9|||
33651158|NCT01961609|63062490|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
33651159|NCT01961609|63062491|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
33651160|NCT01961609|63062488|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
33328275|NCT01079130|62704675|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
33464692|NCT00088530|62838208|FG000|Overall Study|Withdrawal by Subject|2|||
33464693|NCT00088530|62838209|FG001|Overall Study|Withdrawal by Subject|5|||
33464694|NCT00088530|62838208|FG000|Overall Study|Lost to Follow-up|2|||
33464695|NCT00088530|62838209|FG001|Overall Study|Lost to Follow-up|0|||
33464696|NCT00088530|62838208|FG000|Overall Study|Physician Decision|2|||
33543954|NCT04611789|62934753|FG000|Overall Study|Lost to Follow-up|1|||
33543955|NCT04611789|62934754|FG001|Overall Study|Lost to Follow-up|0|||
33464697|NCT00088530|62838209|FG001|Overall Study|Physician Decision|0|||
33464698|NCT00088530|62838208|FG000|Overall Study|Sponsor decision|0|||
33543956|NCT04611789|62934755|FG002|Overall Study|Lost to Follow-up|0|||
33328276|NCT01079130|62704670|FG000|Overall Study|Lost to Follow-up|0|||
33328277|NCT01079130|62704671|FG001|Overall Study|Lost to Follow-up|0|||
33464699|NCT00088530|62838209|FG001|Overall Study|Sponsor decision|1|||
33464700|NCT00088530|62838208|FG000|Overall Study|Patient never treated|1|||
33464701|NCT00088530|62838209|FG001|Overall Study|Patient never treated|0|||
33464702|NCT00359801|62838217|FG000|Overall Study|Lost to Follow-up|72|||
33464703|NCT00359801|62838218|FG001|Overall Study|Lost to Follow-up|58|||
33464704|NCT00359801|62838217|FG000|Overall Study|Withdrawal by Subject|143|||
33464705|NCT00359801|62838218|FG001|Overall Study|Withdrawal by Subject|96|||
33464706|NCT00359801|62838217|FG000|Overall Study|Other|66|||
33464707|NCT00359801|62838218|FG001|Overall Study|Other|46|||
33651161|NCT01961609|63062489|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
33464708|NCT00359801|62838217|FG000|Overall Study|Final Status Unknown: missing data|7|||
33464709|NCT00359801|62838218|FG001|Overall Study|Final Status Unknown: missing data|4|||
33464710|NCT00359801|62838217|FG000|Overall Study|Sponsor Decision|17|||
33464711|NCT00359801|62838218|FG001|Overall Study|Sponsor Decision|16|||
33464712|NCT00045032|62838227|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
33464713|NCT00045032|62838228|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
33464714|NCT00045032|62838229|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
33464715|NCT00045032|62838227|FG000|Overall Study|Death|22|||
33464716|NCT00045032|62838228|FG001|Overall Study|Death|24|||
33651162|NCT01961609|63062490|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
33651163|NCT01961609|63062491|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
33651164|NCT01961609|63062488|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
33651165|NCT01961609|63062489|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
33651166|NCT01961609|63062490|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
33543957|NCT03561597|62934771|FG000|Overall Study|Lost to Follow-up|20|||
33543958|NCT03034967|62934794|FG000|Overall Study|Withdrawal by Subject|9|||
33651167|NCT01961609|63062491|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
33651168|NCT01961609|63062488|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
33651169|NCT01961609|63062489|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
33651170|NCT01961609|63062490|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
33651171|NCT01961609|63062491|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
33651172|NCT01961609|63062488|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
33651173|NCT01961609|63062489|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
33651174|NCT01961609|63062490|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
33651175|NCT01961609|63062491|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
33651176|NCT01961609|63062488|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
33543959|NCT03034967|62934795|FG001|Overall Study|Withdrawal by Subject|2|||
33651177|NCT01961609|63062489|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
33651178|NCT01961609|63062490|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
33651179|NCT01961609|63062491|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
33651180|NCT01774981|63062600|FG000|Overall Study|Adverse Event|0|||
33651181|NCT01774981|63062601|FG001|Overall Study|Adverse Event|0|||
33651182|NCT01774981|63062602|FG002|Overall Study|Adverse Event|0|||
33651183|NCT01774981|63062603|FG003|Overall Study|Adverse Event|0|||
33328278|NCT01079130|62704672|FG002|Overall Study|Lost to Follow-up|0|||
33328279|NCT01079130|62704673|FG003|Overall Study|Lost to Follow-up|0|||
33328280|NCT01079130|62704674|FG004|Overall Study|Lost to Follow-up|1|||
33328281|NCT01079130|62704675|FG005|Overall Study|Lost to Follow-up|0|||
33651184|NCT01774981|63062604|FG004|Overall Study|Adverse Event|0|||
33651185|NCT01774981|63062605|FG005|Overall Study|Adverse Event|1|||
33328282|NCT01078974|62704689|FG000|Overall Study|Adverse Event|3|||
33328283|NCT00869557|62704695|FG000|Randomized Phase|Lost to Follow-up|2|||
33328284|NCT00869557|62704696|FG001|Randomized Phase|Lost to Follow-up|1|||
33651186|NCT01774981|63062606|FG006|Overall Study|Adverse Event|0|||
33651187|NCT01774981|63062607|FG007|Overall Study|Adverse Event|0|||
33328285|NCT00869557|62704695|FG000|Randomized Phase|Investigator's Discretion|1|||
33328286|NCT00869557|62704696|FG001|Randomized Phase|Investigator's Discretion|0|||
33328287|NCT00869557|62704695|FG000|Randomized Phase|Withdrew Consent|0|||
33328288|NCT00869557|62704696|FG001|Randomized Phase|Withdrew Consent|1|||
33328289|NCT00869557|62704695|FG000|Extension Phase|Adverse Event|2|||
33651188|NCT01774981|63062600|FG000|Overall Study|Withdrawal by Subject|0|||
33328290|NCT00869557|62704696|FG001|Extension Phase|Adverse Event|2|||
33651189|NCT01774981|63062601|FG001|Overall Study|Withdrawal by Subject|0|||
33328291|NCT00869557|62704695|FG000|Extension Phase|Lack of Efficacy|1|||
33328292|NCT00869557|62704696|FG001|Extension Phase|Lack of Efficacy|0|||
33651190|NCT01774981|63062602|FG002|Overall Study|Withdrawal by Subject|0|||
33328293|NCT00869557|62704695|FG000|Extension Phase|Lost to Follow-up|3|||
33651191|NCT01774981|63062603|FG003|Overall Study|Withdrawal by Subject|0|||
33464717|NCT00045032|62838229|FG002|Overall Study|Death|17|||
33464718|NCT00045032|62838227|FG000|Overall Study|Insufficient Therapeutic Response|542|||
33464719|NCT00045032|62838228|FG001|Overall Study|Insufficient Therapeutic Response|437|||
33651192|NCT01774981|63062604|FG004|Overall Study|Withdrawal by Subject|0|||
33651193|NCT01774981|63062605|FG005|Overall Study|Withdrawal by Subject|0|||
33651194|NCT01774981|63062606|FG006|Overall Study|Withdrawal by Subject|0|||
33651195|NCT01774981|63062607|FG007|Overall Study|Withdrawal by Subject|1|||
33651196|NCT01774981|63062600|FG000|Overall Study|Death|0|||
33651197|NCT01774981|63062601|FG001|Overall Study|Death|0|||
33651198|NCT01774981|63062602|FG002|Overall Study|Death|0|||
33651199|NCT01774981|63062603|FG003|Overall Study|Death|0|||
33651200|NCT01774981|63062604|FG004|Overall Study|Death|1|||
33651201|NCT01774981|63062605|FG005|Overall Study|Death|0|||
33651202|NCT01774981|63062606|FG006|Overall Study|Death|0|||
33651203|NCT01774981|63062607|FG007|Overall Study|Death|0|||
33651204|NCT01972841|63062636|FG000|Overall Study|Randomized but Never Received Treatment|2|||
33328294|NCT00869557|62704696|FG001|Extension Phase|Lost to Follow-up|1|||
33651205|NCT01972841|63062637|FG001|Overall Study|Randomized but Never Received Treatment|5|||
33651206|NCT01972841|63062638|FG002|Overall Study|Randomized but Never Received Treatment|4|||
33464720|NCT00045032|62838229|FG002|Overall Study|Insufficient Therapeutic Response|445|||
33328295|NCT00869557|62704695|FG000|Extension Phase|Investigator's Discretion|2|||
33328296|NCT00869557|62704696|FG001|Extension Phase|Investigator's Discretion|0|||
33464721|NCT00045032|62838227|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
33464722|NCT00045032|62838228|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
33464723|NCT00045032|62838229|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
33464724|NCT00045032|62838227|FG000|Overall Study|Other Protocol Violation|2|||
33464725|NCT00045032|62838228|FG001|Overall Study|Other Protocol Violation|0|||
33464726|NCT00045032|62838229|FG002|Overall Study|Other Protocol Violation|1|||
33464727|NCT00045032|62838227|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
33464728|NCT00045032|62838228|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
33464729|NCT00045032|62838229|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
33464730|NCT00045032|62838227|FG000|Overall Study|Failure to Return|57|||
33464731|NCT00045032|62838228|FG001|Overall Study|Failure to Return|62|||
33464732|NCT00045032|62838229|FG002|Overall Study|Failure to Return|61|||
33464733|NCT00045032|62838227|FG000|Overall Study|Other|93|||
33464734|NCT00045032|62838228|FG001|Overall Study|Other|84|||
33464735|NCT00045032|62838229|FG002|Overall Study|Other|105|||
33464736|NCT00356915|62838242|FG000|Overall Study|Non compliance|1|||
33464737|NCT00356915|62838243|FG001|Overall Study|Non compliance|2|||
33464738|NCT00356915|62838244|FG002|Overall Study|Non compliance|1|||
33464739|NCT00356915|62838242|FG000|Overall Study|Protocol Violation|2|||
33543960|NCT03034967|62934796|FG002|Overall Study|Withdrawal by Subject|6|||
33543961|NCT03034967|62934797|FG003|Overall Study|Withdrawal by Subject|6|||
33543962|NCT03034967|62934798|FG004|Overall Study|Withdrawal by Subject|9|||
33543963|NCT03034967|62934799|FG005|Overall Study|Withdrawal by Subject|2|||
33543964|NCT03034967|62934794|FG000|Overall Study|Physician Decision|1|||
33543965|NCT03034967|62934795|FG001|Overall Study|Physician Decision|0|||
33543966|NCT03034967|62934796|FG002|Overall Study|Physician Decision|1|||
33543967|NCT03034967|62934797|FG003|Overall Study|Physician Decision|1|||
33543968|NCT03034967|62934798|FG004|Overall Study|Physician Decision|1|||
33543969|NCT03034967|62934799|FG005|Overall Study|Physician Decision|0|||
33543970|NCT03034967|62934794|FG000|Overall Study|Lost to Follow-up|0|||
33543971|NCT03034967|62934795|FG001|Overall Study|Lost to Follow-up|0|||
33543972|NCT03034967|62934796|FG002|Overall Study|Lost to Follow-up|0|||
33464740|NCT00356915|62838243|FG001|Overall Study|Protocol Violation|3|||
33464741|NCT00356915|62838244|FG002|Overall Study|Protocol Violation|2|||
33464742|NCT00356915|62838242|FG000|Overall Study|Withdrawal by Subject|14|||
33543973|NCT03034967|62934797|FG003|Overall Study|Lost to Follow-up|1|||
33464743|NCT00356915|62838243|FG001|Overall Study|Withdrawal by Subject|14|||
33543974|NCT03034967|62934798|FG004|Overall Study|Lost to Follow-up|0|||
33543975|NCT03034967|62934799|FG005|Overall Study|Lost to Follow-up|2|||
33651207|NCT01972841|63062639|FG003|Overall Study|Randomized but Never Received Treatment|2|||
33651208|NCT01972841|63062640|FG004|Overall Study|Randomized but Never Received Treatment|6|||
33651209|NCT01972841|63062641|FG005|Overall Study|Randomized but Never Received Treatment|13|||
33651210|NCT01972841|63062636|FG000|Overall Study|Adverse Event|13|||
33651211|NCT01972841|63062637|FG001|Overall Study|Adverse Event|8|||
33651212|NCT01972841|63062638|FG002|Overall Study|Adverse Event|12|||
33651213|NCT01972841|63062639|FG003|Overall Study|Adverse Event|9|||
33464744|NCT00356915|62838244|FG002|Overall Study|Withdrawal by Subject|10|||
33464745|NCT00356915|62838242|FG000|Overall Study|Lack of Efficacy|0|||
33651214|NCT01972841|63062640|FG004|Overall Study|Adverse Event|21|||
33651215|NCT01972841|63062641|FG005|Overall Study|Adverse Event|26|||
33651216|NCT01972841|63062636|FG000|Overall Study|Lack of Efficacy|1|||
33651217|NCT01972841|63062637|FG001|Overall Study|Lack of Efficacy|0|||
33328297|NCT00869557|62704695|FG000|Extension Phase|Withdrew Consent|2|||
33464746|NCT00356915|62838243|FG001|Overall Study|Lack of Efficacy|0|||
33651218|NCT01972841|63062638|FG002|Overall Study|Lack of Efficacy|0|||
33651219|NCT01972841|63062639|FG003|Overall Study|Lack of Efficacy|2|||
33651220|NCT01972841|63062640|FG004|Overall Study|Lack of Efficacy|4|||
33651221|NCT01972841|63062641|FG005|Overall Study|Lack of Efficacy|1|||
33651222|NCT01972841|63062636|FG000|Overall Study|Lost to Follow-up|4|||
33651223|NCT01972841|63062637|FG001|Overall Study|Lost to Follow-up|2|||
33651224|NCT01972841|63062638|FG002|Overall Study|Lost to Follow-up|4|||
33651225|NCT01972841|63062639|FG003|Overall Study|Lost to Follow-up|2|||
33651226|NCT01972841|63062640|FG004|Overall Study|Lost to Follow-up|9|||
33651227|NCT01972841|63062641|FG005|Overall Study|Lost to Follow-up|3|||
33651228|NCT01972841|63062636|FG000|Overall Study|Protocol Violation|2|||
33651229|NCT01972841|63062637|FG001|Overall Study|Protocol Violation|2|||
33651230|NCT01972841|63062638|FG002|Overall Study|Protocol Violation|3|||
33651231|NCT01972841|63062639|FG003|Overall Study|Protocol Violation|5|||
33651232|NCT01972841|63062640|FG004|Overall Study|Protocol Violation|9|||
33651233|NCT01972841|63062641|FG005|Overall Study|Protocol Violation|4|||
33651234|NCT01972841|63062636|FG000|Overall Study|Withdrawal by participants|21|||
33651235|NCT01972841|63062637|FG001|Overall Study|Withdrawal by participants|27|||
33464747|NCT00356915|62838244|FG002|Overall Study|Lack of Efficacy|3|||
33651236|NCT01972841|63062638|FG002|Overall Study|Withdrawal by participants|23|||
33651237|NCT01972841|63062639|FG003|Overall Study|Withdrawal by participants|16|||
33328298|NCT00869557|62704696|FG001|Extension Phase|Withdrew Consent|0|||
33464748|NCT00356915|62838242|FG000|Overall Study|Lost to Follow-up|27|||
33651536|NCT01707992|63062969|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
33651537|NCT01707992|63062970|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
33464906|NCT02952586|62838391|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
33464907|NCT02952586|62838392|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
33464908|NCT02952586|62838391|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
33464909|NCT02952586|62838392|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
33464910|NCT02952586|62838391|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
33464911|NCT02952586|62838392|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
33544263|NCT03010501|62935109|FG003|Study Week 1|Withdrawal by Subject|2|||
33544264|NCT03010501|62935110|FG004|Study Week 1|Withdrawal by Subject|0|||
33544265|NCT03010501|62935111|FG005|Study Week 1|Withdrawal by Subject|0|||
33544266|NCT03010501|62935106|FG000|Study Week 3|Withdrawal by Subject|0|||
33544267|NCT03010501|62935107|FG001|Study Week 3|Withdrawal by Subject|0|||
33464912|NCT02952586|62838391|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
33464913|NCT02952586|62838392|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
33464914|NCT02952586|62838391|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
33464915|NCT02952586|62838392|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
33464916|NCT02952586|62838391|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
33464917|NCT02952586|62838392|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
33464918|NCT02952586|62838391|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
33464919|NCT02952586|62838392|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
33544268|NCT03010501|62935108|FG002|Study Week 3|Withdrawal by Subject|0|||
33544269|NCT03010501|62935109|FG003|Study Week 3|Withdrawal by Subject|1|||
33544270|NCT03010501|62935110|FG004|Study Week 3|Withdrawal by Subject|0|||
33544271|NCT03010501|62935111|FG005|Study Week 3|Withdrawal by Subject|0|||
33544272|NCT03002623|62935121|FG000|Overall Study|Lost to Follow-up|1|||
33544273|NCT03002623|62935122|FG001|Overall Study|Lost to Follow-up|0|||
33544274|NCT03002623|62935121|FG000|Overall Study|Physician Decision|1|||
33544275|NCT03002623|62935122|FG001|Overall Study|Physician Decision|1|||
33544276|NCT03010423|62935130|FG000|Overall Study|Study termination|8|||
33544277|NCT03002311|62935136|FG000|Overall Study|Lost to Follow-up|13|||
33544278|NCT03002311|62935137|FG001|Overall Study|Lost to Follow-up|26|||
33544279|NCT03002311|62935136|FG000|Overall Study|Referral provider called to schedule app|3|||
33544280|NCT03002311|62935137|FG001|Overall Study|Referral provider called to schedule app|3|||
33544281|NCT03002311|62935136|FG000|Overall Study|Physician Decision|3|||
33544282|NCT03002311|62935137|FG001|Overall Study|Physician Decision|1|||
33544283|NCT03002077|62935143|FG000|Overall Study|Non-compliance with Study Drug|4|||
33544284|NCT03002077|62935143|FG000|Overall Study|Non-compliance w/Background ADT|1|||
33544285|NCT03002077|62935143|FG000|Overall Study|Study Terminated by Sponsor|257|||
33544286|NCT03002077|62935143|FG000|Overall Study|Site Terminated by Sponsor|5|||
33544287|NCT03002077|62935143|FG000|Overall Study|Miscellaneous Reasons|10|||
33544288|NCT03002077|62935143|FG000|Overall Study|Adverse Event|23|||
33544289|NCT03002077|62935143|FG000|Overall Study|Lack of Efficacy|20|||
33544290|NCT03002077|62935143|FG000|Overall Study|Withdrawal by Subject|72|||
33544291|NCT03002077|62935143|FG000|Overall Study|Lost to Follow-up|21|||
33544292|NCT03002077|62935143|FG000|Overall Study|Pregnancy|4|||
33544293|NCT03002077|62935143|FG000|Overall Study|Protocol Violation|21|||
33544294|NCT03008005|62935150|FG000|Overall Study|Physician Decision|1|||
33544295|NCT03008005|62935151|FG001|Overall Study|Physician Decision|0|||
33544296|NCT03008005|62935152|FG002|Overall Study|Physician Decision|0|||
33544297|NCT03008005|62935150|FG000|Overall Study|Withdrawal by Subject|1|||
33544298|NCT03008005|62935151|FG001|Overall Study|Withdrawal by Subject|0|||
33544299|NCT03008005|62935152|FG002|Overall Study|Withdrawal by Subject|0|||
33544300|NCT03008005|62935150|FG000|Overall Study|Ineligible|0|||
33544301|NCT03008005|62935151|FG001|Overall Study|Ineligible|1|||
33544302|NCT03008005|62935152|FG002|Overall Study|Ineligible|0|||
33544303|NCT02440425|62935169|FG000|Overall Study|Death likely due to disease progression|1|||
33544304|NCT02440425|62935169|FG000|Overall Study|Withdrawal by Subject|2|||
33544305|NCT02440425|62935169|FG000|Overall Study|Adverse Event|1|||
33544306|NCT02440425|62935169|FG000|Overall Study|Adverse Event/Ineligible|1|||
33544307|NCT03001219|62935184|FG000|Proof of Concept|Study Termination by Sponsor|0|||
33651538|NCT01707992|63062971|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
33544308|NCT03001219|62935185|FG001|Proof of Concept|Study Termination by Sponsor|1|||
33544309|NCT03001219|62935184|FG000|Proof of Concept|Withdrawal by Subject|0|||
33544310|NCT03001219|62935185|FG001|Proof of Concept|Withdrawal by Subject|4|||
33544311|NCT03001219|62935184|FG000|Proof of Concept|Protocol Deviation|0|||
33544312|NCT03001219|62935185|FG001|Proof of Concept|Protocol Deviation|1|||
33544313|NCT03001219|62935184|FG000|Proof of Concept|Adverse Event|1|||
33544314|NCT03001219|62935185|FG001|Proof of Concept|Adverse Event|1|||
33544315|NCT03001219|62935184|FG000|Proof of Concept|Physician Decision|1|||
33544316|NCT03001219|62935185|FG001|Proof of Concept|Physician Decision|0|||
33544317|NCT03001219|62935184|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
33544318|NCT03001219|62935185|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
33544319|NCT03001219|62935184|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
33544320|NCT03001219|62935185|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
33544321|NCT03001219|62935184|FG000|Extension Period Analysis|Physician Decision|0|||
33464920|NCT02952586|62838391|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
33544322|NCT03001219|62935185|FG001|Extension Period Analysis|Physician Decision|1|||
33544323|NCT03001219|62935184|FG000|Extension Period Analysis|Adverse Event|1|||
33544324|NCT03001219|62935185|FG001|Extension Period Analysis|Adverse Event|1|||
33544325|NCT03001219|62935184|FG000|Extension Period Analysis|Protocol Deviation|0|||
33544326|NCT03001219|62935185|FG001|Extension Period Analysis|Protocol Deviation|1|||
33544327|NCT03001219|62935184|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
33544328|NCT03001219|62935185|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
33544329|NCT03000673|62935200|FG000|Overall Study|Withdrawal by Subject|1|||
33544330|NCT03000673|62935201|FG001|Overall Study|Withdrawal by Subject|0|||
33544331|NCT03000673|62935202|FG002|Overall Study|Withdrawal by Subject|0|||
33544332|NCT03000673|62935203|FG003|Overall Study|Withdrawal by Subject|0|||
33544333|NCT02912455|62935216|FG000|Overall Study|Withdrawal by Subject|0|||
33544334|NCT02912455|62935217|FG001|Overall Study|Withdrawal by Subject|1|||
33544335|NCT02912455|62935216|FG000|Overall Study|Lack of Efficacy|0|||
33544336|NCT02912455|62935217|FG001|Overall Study|Lack of Efficacy|1|||
33544337|NCT02912455|62935216|FG000|Overall Study|Lost to Follow-up|2|||
33544338|NCT02912455|62935217|FG001|Overall Study|Lost to Follow-up|1|||
33544339|NCT04524507|62935225|FG000|Overall Study|Lost to Follow-up|2|||
33544340|NCT04524507|62935226|FG001|Overall Study|Lost to Follow-up|4|||
33544341|NCT04524507|62935225|FG000|Overall Study|Withdrawal by Subject|2|||
33544342|NCT04524507|62935226|FG001|Overall Study|Withdrawal by Subject|9|||
33544343|NCT04524507|62935225|FG000|Overall Study|Death|2|||
33544344|NCT04524507|62935226|FG001|Overall Study|Death|10|||
33544345|NCT02999191|62935235|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
33544346|NCT02999191|62935236|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
33544347|NCT02999191|62935237|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
33544348|NCT02531698|62935247|FG000|Overall Study|Adverse Event|2|||
33544349|NCT02531698|62935248|FG001|Overall Study|Adverse Event|1|||
33544350|NCT02531698|62935247|FG000|Overall Study|Withdrawal by Subject|6|||
33544351|NCT02531698|62935248|FG001|Overall Study|Withdrawal by Subject|1|||
33544352|NCT02531698|62935247|FG000|Overall Study|Protocol Violation|2|||
33544353|NCT02531698|62935248|FG001|Overall Study|Protocol Violation|0|||
33544354|NCT02531698|62935247|FG000|Overall Study|Lost to Follow-up|1|||
33544355|NCT02531698|62935248|FG001|Overall Study|Lost to Follow-up|0|||
33544356|NCT02998021|62935265|FG000|Overall Study|Withdrawal by Subject|3|||
33544357|NCT02998021|62935266|FG001|Overall Study|Withdrawal by Subject|1|||
33544358|NCT02998021|62935265|FG000|Overall Study|unsafe home|0|||
33544359|NCT02998021|62935266|FG001|Overall Study|unsafe home|1|||
33544360|NCT03034577|62935280|FG000|Overall Study|Withdrawal by Subject|6|||
33544361|NCT03034577|62935281|FG001|Overall Study|Withdrawal by Subject|9|||
33544362|NCT03034577|62935280|FG000|Overall Study|Lost to Follow-up|25|||
33464921|NCT02952586|62838392|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
33464922|NCT02952586|62838391|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
33464923|NCT02952586|62838392|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
33464924|NCT02952586|62838391|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
33464925|NCT02952586|62838392|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
33464926|NCT02952586|62838391|FG000|CRT for Cisplatin (63 Days)|Death|3|||
33464927|NCT02952586|62838392|FG001|CRT for Cisplatin (63 Days)|Death|8|||
33464928|NCT02952586|62838391|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
33464929|NCT02952586|62838392|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
33464930|NCT02952586|62838391|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
33464931|NCT02952586|62838392|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
33464932|NCT02952586|62838391|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
33464933|NCT02952586|62838392|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
33464934|NCT02952586|62838391|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
33464935|NCT02952586|62838392|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
33464936|NCT02952586|62838391|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
33544363|NCT03034577|62935281|FG001|Overall Study|Lost to Follow-up|26|||
33544364|NCT01659736|62935291|FG000|Treatment Period|Adverse Event|1|||
33544365|NCT01659736|62935292|FG001|Treatment Period|Adverse Event|1|||
33544366|NCT01659736|62935291|FG000|Treatment Period|Protocol Violation|3|||
33544367|NCT01659736|62935292|FG001|Treatment Period|Protocol Violation|1|||
33544368|NCT01659736|62935291|FG000|Treatment Period|Withdrawal by Subject|1|||
33544369|NCT01659736|62935292|FG001|Treatment Period|Withdrawal by Subject|0|||
33544370|NCT01659736|62935291|FG000|3-month Follow-up|Lost to Follow-up|0|||
33544371|NCT01659736|62935292|FG001|3-month Follow-up|Lost to Follow-up|1|||
33544372|NCT02997163|62935304|FG000|Overall Study|Adverse Event|1|||
33544373|NCT02997163|62935305|FG001|Overall Study|Adverse Event|0|||
33544374|NCT02997163|62935306|FG002|Overall Study|Adverse Event|0|||
33544375|NCT02997163|62935307|FG003|Overall Study|Adverse Event|1|||
33544376|NCT00458536|62935317|FG000|Overall Study|Disease progression prior to treatment|7|||
33544377|NCT00458536|62935317|FG000|Overall Study|Unable to make vaccine|3|||
33544378|NCT00458536|62935317|FG000|Overall Study|No measurable disease after surgery|2|||
33544379|NCT00458536|62935317|FG000|Overall Study|Did not have renal cell carcinoma|2|||
33544380|NCT00458536|62935317|FG000|Overall Study|Patient did not have surgery|1|||
33544381|NCT00458536|62935317|FG000|Overall Study|Ineligible due to toxicity|1|||
33544382|NCT00458536|62935317|FG000|Overall Study|Withdrawal by Subject|1|||
33544383|NCT00458536|62935317|FG000|Overall Study|Progressive disease during treatment|2|||
33544384|NCT02526550|62935321|FG000|Overall Study|Lost to Follow-up|1|||
33544385|NCT03030989|62935336|FG000|Overall Study|Fever|2|||
33544386|NCT03030989|62935337|FG001|Overall Study|Fever|2|||
33544387|NCT03030989|62935336|FG000|Overall Study|Rash|2|||
33544388|NCT03030989|62935337|FG001|Overall Study|Rash|1|||
33544389|NCT03030989|62935336|FG000|Overall Study|Fatigue/Overwhelmed|1|||
33544390|NCT03030989|62935337|FG001|Overall Study|Fatigue/Overwhelmed|5|||
33544391|NCT03030989|62935336|FG000|Overall Study|Positive Blood Cultures|2|||
33544392|NCT03030989|62935337|FG001|Overall Study|Positive Blood Cultures|1|||
33544393|NCT03030989|62935336|FG000|Overall Study|Line Removed|0|||
33544394|NCT03030989|62935337|FG001|Overall Study|Line Removed|2|||
33544395|NCT03030989|62935336|FG000|Overall Study|No longer interested|5|||
33544396|NCT03030989|62935337|FG001|Overall Study|No longer interested|3|||
33544397|NCT03030599|62935343|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
33544398|NCT03030599|62935344|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
33544399|NCT03030599|62935345|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
33544400|NCT03030599|62935343|FG000|Open Label Treatment and Titration|Other|1|||
33544401|NCT03030599|62935344|FG001|Open Label Treatment and Titration|Other|0|||
33544402|NCT03030599|62935345|FG002|Open Label Treatment and Titration|Other|0|||
33544403|NCT03030599|62935343|FG000|Open Label Treatment and Titration|Physician Decision|3|||
33544404|NCT03030599|62935344|FG001|Open Label Treatment and Titration|Physician Decision|0|||
33544405|NCT03030599|62935345|FG002|Open Label Treatment and Titration|Physician Decision|0|||
33544406|NCT03030599|62935343|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
33544407|NCT03030599|62935344|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
33544408|NCT03030599|62935345|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
33544409|NCT03030599|62935343|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
33544410|NCT03030599|62935344|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
33544411|NCT03030599|62935345|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
33544412|NCT03030599|62935343|FG000|Open Label Treatment and Titration|Adverse Event|18|||
33544413|NCT03030599|62935344|FG001|Open Label Treatment and Titration|Adverse Event|0|||
33544414|NCT03030599|62935345|FG002|Open Label Treatment and Titration|Adverse Event|0|||
33464937|NCT02952586|62838392|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
33464938|NCT02952586|62838391|FG000|CRT for Cisplatin (63 Days)|Other|1|||
33464939|NCT02952586|62838392|FG001|CRT for Cisplatin (63 Days)|Other|1|||
33544415|NCT03030599|62935343|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
33544416|NCT03030599|62935344|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
33544417|NCT03030599|62935345|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
33464940|NCT02952586|62838391|FG000|CRT for IMRT (63 Days)|Death|5|||
33464941|NCT02952586|62838392|FG001|CRT for IMRT (63 Days)|Death|8|||
33464942|NCT02952586|62838391|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
33544418|NCT03030599|62935343|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
33544419|NCT03030599|62935344|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
33544420|NCT03030599|62935345|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
33544421|NCT03030599|62935343|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
33544422|NCT03030599|62935344|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
33464943|NCT02952586|62838392|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
33464944|NCT02952586|62838391|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
33464945|NCT02952586|62838392|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
33464946|NCT02952586|62838391|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
33544423|NCT03030599|62935345|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
33544424|NCT03030599|62935343|FG000|Stable Dose|Protocol deviation|3|||
33544425|NCT03030599|62935344|FG001|Stable Dose|Protocol deviation|0|||
33544426|NCT03030599|62935345|FG002|Stable Dose|Protocol deviation|0|||
33544427|NCT03030599|62935343|FG000|Stable Dose|Adverse Event|1|||
33544428|NCT03030599|62935344|FG001|Stable Dose|Adverse Event|0|||
33544429|NCT03030599|62935345|FG002|Stable Dose|Adverse Event|0|||
33544430|NCT03030599|62935343|FG000|Stable Dose|Lost to Follow-up|1|||
33544431|NCT03030599|62935344|FG001|Stable Dose|Lost to Follow-up|0|||
33544432|NCT03030599|62935345|FG002|Stable Dose|Lost to Follow-up|0|||
33544433|NCT03030599|62935343|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
33544434|NCT03030599|62935344|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
33544435|NCT03030599|62935345|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
33544436|NCT03030599|62935343|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
33544437|NCT03030599|62935344|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
33544438|NCT03030599|62935345|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
33544439|NCT03030599|62935343|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
33544440|NCT03030599|62935344|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
33544441|NCT03030599|62935345|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
33544442|NCT03030599|62935343|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
33544443|NCT03030599|62935344|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
33544444|NCT03030599|62935345|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
33544445|NCT03030599|62935343|FG000|Open-label Extension|Adverse Event|3|||
33544446|NCT03030599|62935344|FG001|Open-label Extension|Adverse Event|0|||
33544447|NCT03030599|62935345|FG002|Open-label Extension|Adverse Event|0|||
33544448|NCT03030599|62935343|FG000|Open-label Extension|Lost to Follow-up|2|||
33544449|NCT03030599|62935344|FG001|Open-label Extension|Lost to Follow-up|0|||
33544450|NCT03030599|62935345|FG002|Open-label Extension|Lost to Follow-up|0|||
33544451|NCT03030599|62935343|FG000|Open-label Extension|Lack of Efficacy|1|||
33544452|NCT03030599|62935344|FG001|Open-label Extension|Lack of Efficacy|0|||
33544453|NCT03030599|62935345|FG002|Open-label Extension|Lack of Efficacy|0|||
33544454|NCT03030599|62935343|FG000|Open-label Extension|Other Reason|1|||
33464947|NCT02952586|62838392|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
33464948|NCT02952586|62838391|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
33464949|NCT02952586|62838392|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
33544455|NCT03030599|62935344|FG001|Open-label Extension|Other Reason|0|||
33544456|NCT03030599|62935345|FG002|Open-label Extension|Other Reason|0|||
33544457|NCT03031847|62935355|FG000|Overall Study|Death|1|||
33544458|NCT03031847|62935356|FG001|Overall Study|Death|1|||
33544459|NCT03031847|62935357|FG002|Overall Study|Death|2|||
33544460|NCT03031847|62935358|FG003|Overall Study|Death|3|||
33544461|NCT03031847|62935355|FG000|Overall Study|Lost to Follow-up|1|||
33544462|NCT03031847|62935356|FG001|Overall Study|Lost to Follow-up|1|||
33544463|NCT03031847|62935357|FG002|Overall Study|Lost to Follow-up|2|||
33544464|NCT03031847|62935358|FG003|Overall Study|Lost to Follow-up|3|||
33544465|NCT03028415|62935370|FG000|Overall Study|Lost to Follow-up|6|||
33544466|NCT03028415|62935371|FG001|Overall Study|Lost to Follow-up|3|||
33544467|NCT03028415|62935370|FG000|Overall Study|Withdrawal by Subject|1|||
33544468|NCT03028415|62935371|FG001|Overall Study|Withdrawal by Subject|0|||
33544469|NCT03028415|62935370|FG000|Overall Study|Discontinued due to COVID-19|1|||
33544470|NCT03028415|62935371|FG001|Overall Study|Discontinued due to COVID-19|0|||
33544471|NCT02692040|62935395|FG000|Overall Study|Protocol Violation|0|||
33544472|NCT02692040|62935396|FG001|Overall Study|Protocol Violation|0|||
33464950|NCT02952586|62838391|FG000|CRT for IMRT (63 Days)|Other|1|||
33464951|NCT02952586|62838392|FG001|CRT for IMRT (63 Days)|Other|0|||
33464952|NCT02952586|62838391|FG000|Maintenance Phase (12 Months)|Death|17|||
33464953|NCT02952586|62838392|FG001|Maintenance Phase (12 Months)|Death|11|||
33464954|NCT02952586|62838391|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
33464955|NCT02952586|62838392|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
33544473|NCT02692040|62935397|FG002|Overall Study|Protocol Violation|0|||
33544474|NCT02692040|62935398|FG003|Overall Study|Protocol Violation|0|||
33544475|NCT02692040|62935399|FG004|Overall Study|Protocol Violation|0|||
33464956|NCT02952586|62838391|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
33464957|NCT02952586|62838392|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
33464958|NCT02952586|62838391|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
33464959|NCT02952586|62838392|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
33464960|NCT02952586|62838391|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
33464961|NCT02952586|62838392|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
33464962|NCT02952586|62838391|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
33464963|NCT02952586|62838392|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
33464964|NCT02952586|62838391|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
33464965|NCT02952586|62838392|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
33464966|NCT02952586|62838391|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
33464967|NCT02952586|62838392|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
33464968|NCT02952586|62838391|FG000|Maintenance Phase (12 Months)|Other|2|||
33464969|NCT02952586|62838392|FG001|Maintenance Phase (12 Months)|Other|1|||
33464970|NCT02952586|62838391|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
33464971|NCT02952586|62838392|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
33544476|NCT02692040|62935400|FG005|Overall Study|Protocol Violation|0|||
33544477|NCT02692040|62935401|FG006|Overall Study|Protocol Violation|0|||
33544478|NCT02692040|62935402|FG007|Overall Study|Protocol Violation|0|||
33544479|NCT02692040|62935403|FG008|Overall Study|Protocol Violation|0|||
33544480|NCT02692040|62935404|FG009|Overall Study|Protocol Violation|0|||
33544481|NCT02692040|62935405|FG010|Overall Study|Protocol Violation|0|||
33464972|NCT02952586|62838391|FG000|Follow-Up Phase (90 Days)|Death|12|||
33464973|NCT02952586|62838392|FG001|Follow-Up Phase (90 Days)|Death|10|||
33464974|NCT02952586|62838391|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
33328321|NCT01134263|62704712|FG000|Overall Study|Withdrawal by Subject|8|||
33328322|NCT01134263|62704713|FG001|Overall Study|Withdrawal by Subject|6|||
33464975|NCT02952586|62838392|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
33464976|NCT02952586|62838391|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
33544482|NCT02692040|62935406|FG011|Overall Study|Protocol Violation|0|||
33544483|NCT02692040|62935407|FG012|Overall Study|Protocol Violation|1|||
33544484|NCT02692040|62935408|FG013|Overall Study|Protocol Violation|0|||
33544485|NCT02692040|62935409|FG014|Overall Study|Protocol Violation|0|||
33544486|NCT02692040|62935410|FG015|Overall Study|Protocol Violation|0|||
33544487|NCT02692040|62935411|FG016|Overall Study|Protocol Violation|0|||
33544488|NCT02692040|62935395|FG000|Overall Study|Adverse Event|0|||
33544489|NCT02692040|62935396|FG001|Overall Study|Adverse Event|0|||
33544490|NCT02692040|62935397|FG002|Overall Study|Adverse Event|0|||
33544491|NCT02692040|62935398|FG003|Overall Study|Adverse Event|0|||
33544492|NCT02692040|62935399|FG004|Overall Study|Adverse Event|0|||
33544493|NCT02692040|62935400|FG005|Overall Study|Adverse Event|0|||
33544494|NCT02692040|62935401|FG006|Overall Study|Adverse Event|0|||
33464977|NCT02952586|62838392|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
33464978|NCT02952586|62838391|FG000|Follow-Up Phase (90 Days)|Other|7|||
33464979|NCT02952586|62838392|FG001|Follow-Up Phase (90 Days)|Other|5|||
33464980|NCT02952586|62838391|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
33464981|NCT02952586|62838392|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
33464982|NCT02952586|62838391|FG000|LT Follow-up (up to 45 Months)|Death|51|||
33464983|NCT02952586|62838392|FG001|LT Follow-up (up to 45 Months)|Death|31|||
33464984|NCT02952586|62838391|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
33464985|NCT02952586|62838392|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
33464986|NCT02952586|62838391|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
33464987|NCT02952586|62838392|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
33544495|NCT02692040|62935402|FG007|Overall Study|Adverse Event|0|||
33544496|NCT02692040|62935403|FG008|Overall Study|Adverse Event|0|||
33544497|NCT02692040|62935404|FG009|Overall Study|Adverse Event|0|||
33544498|NCT02692040|62935405|FG010|Overall Study|Adverse Event|0|||
33544499|NCT02692040|62935406|FG011|Overall Study|Adverse Event|0|||
33651539|NCT01707992|63062972|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
33651540|NCT01707992|63062973|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
33651541|NCT01707992|63062968|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
33651542|NCT01707992|63062969|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
33328323|NCT01134263|62704714|FG002|Overall Study|Withdrawal by Subject|16|||
33328324|NCT01134263|62704715|FG003|Overall Study|Withdrawal by Subject|7|||
33328325|NCT01134263|62704716|FG004|Overall Study|Withdrawal by Subject|5|||
33328326|NCT01134263|62704712|FG000|Overall Study|Enrolled, but not treated|1|||
33328327|NCT01134263|62704713|FG001|Overall Study|Enrolled, but not treated|1|||
33328328|NCT01134263|62704714|FG002|Overall Study|Enrolled, but not treated|0|||
33328329|NCT01134263|62704715|FG003|Overall Study|Enrolled, but not treated|1|||
33328330|NCT01134263|62704716|FG004|Overall Study|Enrolled, but not treated|0|||
33328331|NCT01199822|62704737|FG000|Overall Study|Investigator discontinued therapy|0|||
33328332|NCT01199822|62704738|FG001|Overall Study|Investigator discontinued therapy|1|||
33464988|NCT02952586|62838391|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
33464989|NCT02952586|62838392|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
33464990|NCT03384316|62838401|FG000|Overall Study|Screen failure|0|||
33464991|NCT03384316|62838402|FG001|Overall Study|Screen failure|1|||
33464992|NCT03403192|62838414|FG000|Overall Study|Lost to Follow-up|1|||
33464993|NCT03403192|62838415|FG001|Overall Study|Lost to Follow-up|2|||
33464994|NCT03403192|62838416|FG002|Overall Study|Lost to Follow-up|0|||
33544500|NCT02692040|62935407|FG012|Overall Study|Adverse Event|0|||
33544501|NCT02692040|62935408|FG013|Overall Study|Adverse Event|3|||
33544502|NCT02692040|62935409|FG014|Overall Study|Adverse Event|1|||
33544503|NCT02692040|62935410|FG015|Overall Study|Adverse Event|1|||
33544504|NCT02692040|62935411|FG016|Overall Study|Adverse Event|0|||
33544505|NCT03029819|62935490|FG000|Overall Study|Lost to Follow-up|3|||
33544506|NCT03029819|62935491|FG001|Overall Study|Lost to Follow-up|5|||
33544507|NCT03029819|62935490|FG000|Overall Study|Removed due to disruptive behavior|0|||
33544508|NCT03029819|62935491|FG001|Overall Study|Removed due to disruptive behavior|1|||
33544509|NCT02678390|62935502|FG000|AE (1 Day)|Withdrawal by Subject|0|||
33544510|NCT02678390|62935503|FG001|AE (1 Day)|Withdrawal by Subject|1|||
33464995|NCT03403192|62838417|FG003|Overall Study|Lost to Follow-up|0|||
33464996|NCT03403192|62838414|FG000|Overall Study|Unable to respond|0|||
33464997|NCT03403192|62838415|FG001|Overall Study|Unable to respond|1|||
33464998|NCT03403192|62838416|FG002|Overall Study|Unable to respond|0|||
33464999|NCT03403192|62838417|FG003|Overall Study|Unable to respond|0|||
33544511|NCT03027557|62935512|FG000|Overall Study|Adverse Event|1|||
33544512|NCT03027557|62935513|FG001|Overall Study|Adverse Event|0|||
33544513|NCT03027557|62935514|FG002|Overall Study|Adverse Event|0|||
33544514|NCT03029585|62935524|FG000|Overall Study|Death|1|||
33544515|NCT03029585|62935525|FG001|Overall Study|Death|1|||
33544516|NCT03029585|62935524|FG000|Overall Study|Withdrawal by Subject|1|||
33544517|NCT03029585|62935525|FG001|Overall Study|Withdrawal by Subject|0|||
33544518|NCT02678000|62935536|FG000|PART 2|Adverse Event|0|||
33544519|NCT02678000|62935537|FG001|PART 2|Adverse Event|0|||
33544520|NCT02678000|62935538|FG002|PART 2|Adverse Event|2|||
33544521|NCT02678000|62935539|FG003|PART 2|Adverse Event|1|||
33328333|NCT01199822|62704739|FG002|Overall Study|Investigator discontinued therapy|0|||
33328334|NCT01096056|62704756|FG000|Overall Study|Lost to Follow-up|0|||
33328335|NCT01096056|62704757|FG001|Overall Study|Lost to Follow-up|1|||
33328336|NCT00866359|62704765|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
33328337|NCT00866359|62704766|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
33328338|NCT00866359|62704767|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
33328339|NCT00866359|62704768|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
33328340|NCT00866359|62704765|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
33328341|NCT00866359|62704766|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
33328342|NCT00866359|62704767|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
33328343|NCT00866359|62704768|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
33328344|NCT00866359|62704765|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
33328345|NCT00866359|62704766|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
33328346|NCT00866359|62704767|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
33328347|NCT00866359|62704768|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
33328348|NCT00866359|62704765|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
33328349|NCT00866359|62704766|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
33328350|NCT00866359|62704767|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
33328351|NCT00866359|62704768|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
33328352|NCT00866359|62704765|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
33328353|NCT00866359|62704766|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
33328354|NCT00866359|62704767|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
33328355|NCT00866359|62704768|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
33328356|NCT00866359|62704765|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
33328357|NCT00866359|62704766|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
33328358|NCT00866359|62704767|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
33328359|NCT00866359|62704768|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
33328360|NCT01199198|62704797|FG000|Overall Study|Adverse Event|3|||
33328361|NCT01199198|62704798|FG001|Overall Study|Adverse Event|0|||
33328362|NCT01199198|62704797|FG000|Overall Study|Lost to Follow-up|1|||
33328363|NCT01199198|62704798|FG001|Overall Study|Lost to Follow-up|5|||
33328364|NCT01199198|62704797|FG000|Overall Study|Withdrawal by Subject|1|||
33328365|NCT01199198|62704798|FG001|Overall Study|Withdrawal by Subject|2|||
33328366|NCT01199198|62704797|FG000|Overall Study|ICU Transfer|1|||
33328367|NCT01199198|62704798|FG001|Overall Study|ICU Transfer|2|||
33328368|NCT01199198|62704797|FG000|Overall Study|Hospice-care transfer|1|||
33328369|NCT01199198|62704798|FG001|Overall Study|Hospice-care transfer|2|||
33328370|NCT01095978|62704804|FG000|Overall Study|Did not take Klacid SR|2|||
33328371|NCT01095978|62704804|FG000|Overall Study|Adverse Event|1|||
33328372|NCT01134107|62704812|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
33328373|NCT01134107|62704813|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
33328374|NCT01134107|62704812|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
33465000|NCT03403192|62838414|FG000|Overall Study|Incomplete|3|||
33465001|NCT03403192|62838415|FG001|Overall Study|Incomplete|1|||
33465002|NCT03403192|62838416|FG002|Overall Study|Incomplete|3|||
33465003|NCT03403192|62838417|FG003|Overall Study|Incomplete|6|||
33465004|NCT00356525|62838431|FG000|Overall Study|Progressive Disease|8|||
33465005|NCT00356525|62838432|FG001|Overall Study|Progressive Disease|5|||
33465006|NCT00356525|62838433|FG002|Overall Study|Progressive Disease|4|||
33465007|NCT00356525|62838434|FG003|Overall Study|Progressive Disease|2|||
33544522|NCT02678000|62935540|FG004|PART 2|Adverse Event|0|||
33544523|NCT02678000|62935536|FG000|PART 2|Withdrawal by Subject|0|||
33544524|NCT02678000|62935537|FG001|PART 2|Withdrawal by Subject|0|||
33465008|NCT00356525|62838431|FG000|Overall Study|Adverse Event|1|||
33465009|NCT00356525|62838432|FG001|Overall Study|Adverse Event|3|||
33465010|NCT00356525|62838433|FG002|Overall Study|Adverse Event|1|||
33465011|NCT00356525|62838434|FG003|Overall Study|Adverse Event|1|||
33465012|NCT00356525|62838431|FG000|Overall Study|Lost to Follow-up|1|||
33465013|NCT00356525|62838432|FG001|Overall Study|Lost to Follow-up|0|||
33651543|NCT01707992|63062970|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
33651544|NCT01707992|63062971|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
33465014|NCT00356525|62838433|FG002|Overall Study|Lost to Follow-up|0|||
33465015|NCT00356525|62838434|FG003|Overall Study|Lost to Follow-up|0|||
33465016|NCT00356525|62838431|FG000|Overall Study|Physician Decision|2|||
33465017|NCT00356525|62838432|FG001|Overall Study|Physician Decision|2|||
33465018|NCT00356525|62838433|FG002|Overall Study|Physician Decision|2|||
33465019|NCT00356525|62838434|FG003|Overall Study|Physician Decision|1|||
33465020|NCT00356525|62838431|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
33465021|NCT00356525|62838432|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
33465022|NCT00356525|62838433|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
33465023|NCT00356525|62838434|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
33465024|NCT00356525|62838431|FG000|Overall Study|Withdrawal by Subject|1|||
33465025|NCT00356525|62838432|FG001|Overall Study|Withdrawal by Subject|1|||
33465026|NCT00356525|62838433|FG002|Overall Study|Withdrawal by Subject|0|||
33465027|NCT00356525|62838434|FG003|Overall Study|Withdrawal by Subject|3|||
33465028|NCT00356525|62838431|FG000|Overall Study|Death|0|||
33465029|NCT00356525|62838432|FG001|Overall Study|Death|0|||
33465030|NCT00356525|62838433|FG002|Overall Study|Death|0|||
33465031|NCT00356525|62838434|FG003|Overall Study|Death|1|||
33465032|NCT00356525|62838431|FG000|Overall Study|Sponsor Decision|0|||
33465033|NCT00356525|62838432|FG001|Overall Study|Sponsor Decision|0|||
33465034|NCT00356525|62838433|FG002|Overall Study|Sponsor Decision|0|||
33465035|NCT00356525|62838434|FG003|Overall Study|Sponsor Decision|1|||
33544525|NCT02678000|62935538|FG002|PART 2|Withdrawal by Subject|1|||
33544526|NCT02678000|62935539|FG003|PART 2|Withdrawal by Subject|0|||
33544527|NCT02678000|62935540|FG004|PART 2|Withdrawal by Subject|0|||
33544528|NCT02691572|62935567|FG000|Overall Study|Withdrawal by Subject|1|||
33544529|NCT02691572|62935568|FG001|Overall Study|Withdrawal by Subject|0|||
33544530|NCT02691572|62935567|FG000|Overall Study|Protocol Violation|0|||
33544531|NCT02691572|62935568|FG001|Overall Study|Protocol Violation|1|||
33544532|NCT02677844|62935576|FG000|Period 3|Withdrawal by Subject|0|||
33544533|NCT02677844|62935577|FG001|Period 3|Withdrawal by Subject|0|||
33544534|NCT02677844|62935578|FG002|Period 3|Withdrawal by Subject|0|||
33544535|NCT02677844|62935579|FG003|Period 3|Withdrawal by Subject|1|||
33544536|NCT02677844|62935580|FG004|Period 3|Withdrawal by Subject|0|||
33544537|NCT02677844|62935581|FG005|Period 3|Withdrawal by Subject|0|||
33544538|NCT02677844|62935582|FG006|Period 3|Withdrawal by Subject|0|||
33544539|NCT02691494|62935604|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
33544540|NCT02691494|62935605|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
33544541|NCT02691494|62935606|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
33544542|NCT02691494|62935604|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
33544543|NCT02691494|62935605|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
33544544|NCT02691494|62935606|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
33544545|NCT02691494|62935604|FG000|Post-Treatment Follow-Up Period|Other|2|||
33544546|NCT02691494|62935605|FG001|Post-Treatment Follow-Up Period|Other|1|||
33544547|NCT02691494|62935606|FG002|Post-Treatment Follow-Up Period|Other|1|||
33544548|NCT02691494|62935604|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
33544549|NCT02691494|62935605|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
33544550|NCT02691494|62935606|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
33544551|NCT02691494|62935604|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
33544552|NCT02691494|62935605|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
33544553|NCT02691494|62935606|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
33544554|NCT02677220|62935614|FG000|Overall Study|Adverse Event|1|||
33544555|NCT02682602|62935621|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
33544556|NCT02682602|62935622|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
33465036|NCT00356369|62838446|FG000|Active Phase|Withdrawal by Subject|2|||
33544557|NCT02682602|62935621|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
33544558|NCT02682602|62935622|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
33544559|NCT02681510|62935632|FG000|Overall Study|Withdrawal by Subject|1|||
33544560|NCT02681510|62935632|FG000|Overall Study|Lost to Follow-up|9|||
33465037|NCT00356369|62838447|FG001|Active Phase|Withdrawal by Subject|1|||
33465038|NCT03383614|62838457|FG000|Overall Study|Withdrawal by Subject|0|||
33544561|NCT02690714|62935636|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
33544562|NCT02690714|62935636|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
33544563|NCT01898793|62935651|FG000|Overall Study|Death|2|||
33544564|NCT01898793|62935652|FG001|Overall Study|Death|1|||
33544565|NCT01898793|62935653|FG002|Overall Study|Death|4|||
33544566|NCT01898793|62935654|FG003|Overall Study|Death|0|||
33544567|NCT01898793|62935655|FG004|Overall Study|Death|0|||
33544568|NCT01898793|62935656|FG005|Overall Study|Death|0|||
33544569|NCT01898793|62935657|FG006|Overall Study|Death|0|||
33544570|NCT01791543|62935676|FG000|Overall Study|Lost to Follow-up|1|||
33544571|NCT01791543|62935676|FG000|Overall Study|Adverse Event|1|||
33544572|NCT02925455|62935683|FG000|Overall Study|Withdrawal by Subject|2|||
33544573|NCT02925455|62935684|FG001|Overall Study|Withdrawal by Subject|0|||
33544574|NCT03033069|62935694|FG000|Overall Study|Adverse Event|6|||
33544575|NCT03033069|62935695|FG001|Overall Study|Adverse Event|7|||
33544576|NCT03033069|62935696|FG002|Overall Study|Adverse Event|4|||
33544577|NCT03033069|62935697|FG003|Overall Study|Adverse Event|6|||
33544578|NCT03033069|62935694|FG000|Overall Study|Lack of Efficacy|0|||
33544579|NCT03033069|62935695|FG001|Overall Study|Lack of Efficacy|0|||
33544580|NCT03033069|62935696|FG002|Overall Study|Lack of Efficacy|1|||
33544581|NCT03033069|62935697|FG003|Overall Study|Lack of Efficacy|0|||
33544582|NCT03033069|62935694|FG000|Overall Study|Lost to Follow-up|6|||
33544583|NCT03033069|62935695|FG001|Overall Study|Lost to Follow-up|5|||
33544584|NCT03033069|62935696|FG002|Overall Study|Lost to Follow-up|5|||
33544585|NCT03033069|62935697|FG003|Overall Study|Lost to Follow-up|6|||
33544586|NCT03033069|62935694|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33544587|NCT03033069|62935695|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33544588|NCT03033069|62935696|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33465039|NCT03383614|62838458|FG001|Overall Study|Withdrawal by Subject|1|||
33465040|NCT03383614|62838459|FG002|Overall Study|Withdrawal by Subject|0|||
33465041|NCT03383614|62838460|FG003|Overall Study|Withdrawal by Subject|0|||
33465042|NCT03403036|62838475|FG000|Overall Study|Lack of Efficacy|5|||
33465043|NCT00356135|62838482|FG000|Overall Study|Protocol Violation|1|||
33465044|NCT00356135|62838483|FG001|Overall Study|Protocol Violation|0|||
33465045|NCT00356135|62838484|FG002|Overall Study|Protocol Violation|0|||
33465046|NCT00356135|62838482|FG000|Overall Study|Adverse Event|1|||
33465047|NCT00356135|62838483|FG001|Overall Study|Adverse Event|0|||
33465048|NCT00356135|62838484|FG002|Overall Study|Adverse Event|0|||
33465049|NCT00356135|62838482|FG000|Overall Study|Lost to Follow-up|0|||
33465050|NCT00356135|62838483|FG001|Overall Study|Lost to Follow-up|0|||
33465051|NCT00356135|62838484|FG002|Overall Study|Lost to Follow-up|1|||
33465052|NCT00356135|62838482|FG000|Overall Study|Physician Decision|1|||
33465053|NCT00356135|62838483|FG001|Overall Study|Physician Decision|1|||
33465054|NCT00356135|62838484|FG002|Overall Study|Physician Decision|1|||
33465055|NCT00356135|62838482|FG000|Overall Study|Subject non-compliance|1|||
33465056|NCT00356135|62838483|FG001|Overall Study|Subject non-compliance|1|||
33465057|NCT00356135|62838484|FG002|Overall Study|Subject non-compliance|3|||
33465058|NCT03383146|62838496|FG000|Overall Study|Screen Failure|1|||
33465059|NCT03383146|62838497|FG001|Overall Study|Screen Failure|0|||
33465060|NCT03383146|62838496|FG000|Overall Study|Adverse Event|6|||
33328375|NCT01134107|62704813|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
33328376|NCT01134107|62704812|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
33465061|NCT03383146|62838497|FG001|Overall Study|Adverse Event|18|||
33465062|NCT03383146|62838496|FG000|Overall Study|Lack of Efficacy|0|||
33465063|NCT03383146|62838497|FG001|Overall Study|Lack of Efficacy|3|||
33465064|NCT03383146|62838496|FG000|Overall Study|Withdrawal by Subject|20|||
33465065|NCT03383146|62838497|FG001|Overall Study|Withdrawal by Subject|36|||
33465066|NCT03383146|62838496|FG000|Overall Study|Lost to Follow-up|5|||
33465067|NCT03383146|62838497|FG001|Overall Study|Lost to Follow-up|15|||
33465068|NCT03383146|62838496|FG000|Overall Study|Death|0|||
33465069|NCT03383146|62838497|FG001|Overall Study|Death|2|||
33465070|NCT03383146|62838496|FG000|Overall Study|Physician Decision|0|||
33544589|NCT03033069|62935697|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33544590|NCT03033069|62935694|FG000|Overall Study|Protocol Deviation|0|||
33544591|NCT03033069|62935695|FG001|Overall Study|Protocol Deviation|1|||
33544592|NCT03033069|62935696|FG002|Overall Study|Protocol Deviation|0|||
33544593|NCT03033069|62935697|FG003|Overall Study|Protocol Deviation|0|||
33544594|NCT03033069|62935694|FG000|Overall Study|Withdrawal by Subject|10|||
33544595|NCT03033069|62935695|FG001|Overall Study|Withdrawal by Subject|10|||
33544596|NCT03033069|62935696|FG002|Overall Study|Withdrawal by Subject|11|||
33544597|NCT03033069|62935697|FG003|Overall Study|Withdrawal by Subject|6|||
33544598|NCT03033069|62935694|FG000|Overall Study|Withdrawal By Caregiver|1|||
33465071|NCT03383146|62838497|FG001|Overall Study|Physician Decision|1|||
33465072|NCT03383146|62838496|FG000|Overall Study|Protocol Deviation|1|||
33465073|NCT03383146|62838497|FG001|Overall Study|Protocol Deviation|8|||
33465074|NCT03383146|62838496|FG000|Overall Study|Study Terminated by the Sponsor|48|||
33465075|NCT03383146|62838497|FG001|Overall Study|Study Terminated by the Sponsor|95|||
33465076|NCT03383146|62838496|FG000|Overall Study|Reason not Specified|4|||
33465077|NCT03383146|62838497|FG001|Overall Study|Reason not Specified|6|||
33465078|NCT03616964|62838507|FG000|Overall Study|Adverse Event|15|||
33465079|NCT03616964|62838508|FG001|Overall Study|Adverse Event|10|||
33465080|NCT03616964|62838509|FG002|Overall Study|Adverse Event|16|||
33465081|NCT03616964|62838507|FG000|Overall Study|Death|3|||
33544599|NCT03033069|62935695|FG001|Overall Study|Withdrawal By Caregiver|0|||
33465082|NCT03616964|62838508|FG001|Overall Study|Death|0|||
33465083|NCT03616964|62838509|FG002|Overall Study|Death|4|||
33465084|NCT03616964|62838507|FG000|Overall Study|Lack of Efficacy|4|||
33465085|NCT03616964|62838508|FG001|Overall Study|Lack of Efficacy|8|||
33465086|NCT03616964|62838509|FG002|Overall Study|Lack of Efficacy|8|||
33465087|NCT03616964|62838507|FG000|Overall Study|Lost to Follow-up|2|||
33465088|NCT03616964|62838508|FG001|Overall Study|Lost to Follow-up|1|||
33465089|NCT03616964|62838509|FG002|Overall Study|Lost to Follow-up|3|||
33465090|NCT03616964|62838507|FG000|Overall Study|Withdrawal by Subject|18|||
33465091|NCT03616964|62838508|FG001|Overall Study|Withdrawal by Subject|14|||
33465092|NCT03616964|62838509|FG002|Overall Study|Withdrawal by Subject|21|||
33465093|NCT03616964|62838507|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
33465094|NCT03616964|62838508|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
33465095|NCT03616964|62838509|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
33465096|NCT03616964|62838507|FG000|Overall Study|Sponsor's Decision|1|||
33465097|NCT03616964|62838508|FG001|Overall Study|Sponsor's Decision|0|||
33465098|NCT03616964|62838509|FG002|Overall Study|Sponsor's Decision|0|||
33465099|NCT03616964|62838507|FG000|Overall Study|Physician Decision|0|||
33465100|NCT03616964|62838508|FG001|Overall Study|Physician Decision|2|||
33465101|NCT03616964|62838509|FG002|Overall Study|Physician Decision|0|||
33465102|NCT03616964|62838507|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
33465103|NCT03616964|62838508|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
33465104|NCT03616964|62838509|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
33465105|NCT03616964|62838507|FG000|Overall Study|Protocol Violation|0|||
33465106|NCT03616964|62838508|FG001|Overall Study|Protocol Violation|1|||
33465107|NCT03616964|62838509|FG002|Overall Study|Protocol Violation|0|||
33465108|NCT03616964|62838507|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
33465109|NCT03616964|62838508|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
33465110|NCT03616964|62838509|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
33465111|NCT03616964|62838507|FG000|Overall Study|Randomized but Never Treated|1|||
33544600|NCT03033069|62935696|FG002|Overall Study|Withdrawal By Caregiver|0|||
33544601|NCT03033069|62935697|FG003|Overall Study|Withdrawal By Caregiver|0|||
33544602|NCT03033069|62935694|FG000|Overall Study|Reason not Specified|0|||
33544603|NCT03033069|62935695|FG001|Overall Study|Reason not Specified|1|||
33544604|NCT03033069|62935696|FG002|Overall Study|Reason not Specified|0|||
33544605|NCT03033069|62935697|FG003|Overall Study|Reason not Specified|1|||
33544606|NCT02917265|62935709|FG000|Overall Study|Physician Decision|1|||
33544607|NCT02917265|62935710|FG001|Overall Study|Physician Decision|0|||
33544608|NCT02917265|62935709|FG000|Overall Study|Withdrawal by Subject|1|||
33544609|NCT02917265|62935710|FG001|Overall Study|Withdrawal by Subject|0|||
33544610|NCT02136069|62935720|FG000|Overall Study|UC flare-up|1|||
33544611|NCT02136069|62935721|FG001|Overall Study|UC flare-up|0|||
33544612|NCT02136069|62935720|FG000|Overall Study|Adverse Event|6|||
33544613|NCT02136069|62935721|FG001|Overall Study|Adverse Event|8|||
33544614|NCT02136069|62935720|FG000|Overall Study|Death|0|||
33544615|NCT02136069|62935721|FG001|Overall Study|Death|1|||
33544616|NCT02136069|62935720|FG000|Overall Study|Lack of Efficacy|10|||
33544617|NCT02136069|62935721|FG001|Overall Study|Lack of Efficacy|4|||
33544618|NCT02136069|62935720|FG000|Overall Study|Lost to Follow-up|1|||
33544619|NCT02136069|62935721|FG001|Overall Study|Lost to Follow-up|0|||
33544620|NCT02136069|62935720|FG000|Overall Study|Non-Compliance|1|||
33544621|NCT02136069|62935721|FG001|Overall Study|Non-Compliance|0|||
33544622|NCT02136069|62935720|FG000|Overall Study|Physician Decision|5|||
33544623|NCT02136069|62935721|FG001|Overall Study|Physician Decision|4|||
33544624|NCT02136069|62935720|FG000|Overall Study|Withdrawal by Subject|10|||
33544625|NCT02136069|62935721|FG001|Overall Study|Withdrawal by Subject|11|||
33544626|NCT02917031|62935730|FG000|Overall Study|Reason not specified|7|||
33544627|NCT02917031|62935731|FG001|Overall Study|Reason not specified|5|||
33544628|NCT02917031|62935732|FG002|Overall Study|Reason not specified|6|||
33544629|NCT02917031|62935730|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
33544630|NCT02917031|62935731|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
33544631|NCT02917031|62935732|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
33544632|NCT02917031|62935730|FG000|Overall Study|Withdrawal by Subject|3|||
33465112|NCT03616964|62838508|FG001|Overall Study|Randomized but Never Treated|1|||
33544633|NCT02917031|62935731|FG001|Overall Study|Withdrawal by Subject|3|||
33544634|NCT02917031|62935732|FG002|Overall Study|Withdrawal by Subject|0|||
33544635|NCT02917031|62935730|FG000|Overall Study|Physician Decision|1|||
33544636|NCT02917031|62935731|FG001|Overall Study|Physician Decision|0|||
33544637|NCT02917031|62935732|FG002|Overall Study|Physician Decision|0|||
33465113|NCT03616964|62838509|FG002|Overall Study|Randomized but Never Treated|1|||
33544638|NCT02917031|62935730|FG000|Overall Study|Adverse Event|4|||
33544639|NCT02917031|62935731|FG001|Overall Study|Adverse Event|1|||
33544640|NCT02917031|62935732|FG002|Overall Study|Adverse Event|5|||
33544641|NCT02917031|62935730|FG000|Overall Study|Death|2|||
33544642|NCT02917031|62935731|FG001|Overall Study|Death|3|||
33544643|NCT02917031|62935732|FG002|Overall Study|Death|4|||
33544644|NCT01018563|62935741|FG000|Overall Study|Termination of the study by Sponsor|2|||
33544645|NCT01018563|62935742|FG001|Overall Study|Termination of the study by Sponsor|1|||
33544646|NCT02528188|62935755|FG000|Overall Study|Adverse Event|23|||
33544647|NCT02528188|62935756|FG001|Overall Study|Adverse Event|22|||
33544648|NCT02528188|62935757|FG002|Overall Study|Adverse Event|8|||
33544649|NCT02528188|62935755|FG000|Overall Study|Protocol Violation|4|||
33544650|NCT02528188|62935756|FG001|Overall Study|Protocol Violation|6|||
33544651|NCT02528188|62935757|FG002|Overall Study|Protocol Violation|4|||
33544652|NCT02528188|62935755|FG000|Overall Study|Lack of Efficacy|19|||
33544653|NCT02528188|62935756|FG001|Overall Study|Lack of Efficacy|21|||
33544654|NCT02528188|62935757|FG002|Overall Study|Lack of Efficacy|22|||
33544655|NCT02528188|62935755|FG000|Overall Study|Withdrawal by Subject|97|||
33544656|NCT02528188|62935756|FG001|Overall Study|Withdrawal by Subject|104|||
33544657|NCT02528188|62935757|FG002|Overall Study|Withdrawal by Subject|100|||
33544658|NCT02528188|62935755|FG000|Overall Study|Lost to Follow-up|25|||
33544659|NCT02528188|62935756|FG001|Overall Study|Lost to Follow-up|21|||
33544660|NCT02528188|62935757|FG002|Overall Study|Lost to Follow-up|31|||
33544661|NCT02528188|62935755|FG000|Overall Study|Death|4|||
33544662|NCT02528188|62935756|FG001|Overall Study|Death|4|||
33544663|NCT02528188|62935757|FG002|Overall Study|Death|0|||
33544664|NCT02528188|62935755|FG000|Overall Study|Other|89|||
33544665|NCT02528188|62935756|FG001|Overall Study|Other|91|||
33544666|NCT02528188|62935757|FG002|Overall Study|Other|74|||
33544667|NCT02528188|62935755|FG000|Overall Study|Randomized but not treated|6|||
33544668|NCT02528188|62935756|FG001|Overall Study|Randomized but not treated|7|||
33544669|NCT02528188|62935757|FG002|Overall Study|Randomized but not treated|12|||
33544670|NCT03896165|62935765|FG000|Overall Study|Withdrawal by Subject|2|||
33544671|NCT05361304|62935778|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
33544672|NCT05361304|62935779|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
33544673|NCT05361304|62935778|FG000|Overall Study|COVID-19 Related|1|||
33544674|NCT05361304|62935779|FG001|Overall Study|COVID-19 Related|2|||
33465114|NCT00350519|62838521|FG000|Overall Study|Death|0|||
33465115|NCT00350519|62838522|FG001|Overall Study|Death|1|||
33465116|NCT00350519|62838521|FG000|Overall Study|Physician Decision|0|||
33465117|NCT00350519|62838522|FG001|Overall Study|Physician Decision|1|||
33465118|NCT00350519|62838521|FG000|Overall Study|Protocol Violation|1|||
33465119|NCT00350519|62838522|FG001|Overall Study|Protocol Violation|2|||
33465120|NCT00350519|62838521|FG000|Overall Study|Withdrawal by Subject|3|||
33465121|NCT00350519|62838522|FG001|Overall Study|Withdrawal by Subject|2|||
33465122|NCT03382912|62838530|FG000|Overall Study|Physician Decision|0|||
33465123|NCT03382912|62838531|FG001|Overall Study|Physician Decision|1|||
33465124|NCT03382912|62838530|FG000|Overall Study|Sponsor Decision|6|||
33465125|NCT03382912|62838531|FG001|Overall Study|Sponsor Decision|6|||
33465126|NCT03382912|62838530|FG000|Overall Study|Withdrawal by Subject|0|||
33465127|NCT03382912|62838531|FG001|Overall Study|Withdrawal by Subject|5|||
33465128|NCT00350207|62838540|FG000|Overall Study|Adverse Event|5|||
33465129|NCT00350207|62838541|FG001|Overall Study|Adverse Event|2|||
33465130|NCT00350207|62838542|FG002|Overall Study|Adverse Event|2|||
33465131|NCT00350207|62838540|FG000|Overall Study|Lack of Efficacy|1|||
33544675|NCT05361304|62935778|FG000|Overall Study|Withdrawal by Subject|1|||
33544676|NCT05361304|62935779|FG001|Overall Study|Withdrawal by Subject|0|||
33544677|NCT02269917|62935802|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
33544678|NCT02269917|62935803|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
33544679|NCT02269917|62935804|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
33465132|NCT00350207|62838541|FG001|Overall Study|Lack of Efficacy|0|||
33465133|NCT00350207|62838542|FG002|Overall Study|Lack of Efficacy|2|||
33465134|NCT00350207|62838540|FG000|Overall Study|Lost to Follow-up|1|||
33465135|NCT00350207|62838541|FG001|Overall Study|Lost to Follow-up|0|||
33465136|NCT00350207|62838542|FG002|Overall Study|Lost to Follow-up|1|||
33544680|NCT02269917|62935802|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
33544681|NCT02269917|62935803|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
33544682|NCT02269917|62935804|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
33544683|NCT02269917|62935802|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
33544684|NCT02269917|62935803|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
33544685|NCT02269917|62935804|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
33544686|NCT02269917|62935802|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
33544687|NCT02269917|62935803|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
33544688|NCT02269917|62935804|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
33544689|NCT02269917|62935802|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
33465137|NCT00350207|62838540|FG000|Overall Study|Withdrawal by Subject|0|||
33465138|NCT00350207|62838541|FG001|Overall Study|Withdrawal by Subject|1|||
33465139|NCT00350207|62838542|FG002|Overall Study|Withdrawal by Subject|1|||
33465140|NCT00350207|62838540|FG000|Overall Study|Other|1|||
33465141|NCT00350207|62838541|FG001|Overall Study|Other|3|||
33465142|NCT00350207|62838542|FG002|Overall Study|Other|1|||
33465143|NCT00349973|62838552|FG000|Overall Study|Adverse Event|3|||
33465144|NCT00349973|62838553|FG001|Overall Study|Adverse Event|3|||
33651545|NCT01707992|63062972|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
33651546|NCT01707992|63062973|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
33651547|NCT01707992|63062968|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
33328377|NCT01134107|62704813|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
33328378|NCT01134107|62704812|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
33328379|NCT01134107|62704813|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
33328380|NCT01134107|62704812|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
33328381|NCT01134107|62704813|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
33328382|NCT01134107|62704812|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
33328383|NCT01134107|62704813|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
33328384|NCT01134107|62704812|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
33328385|NCT01134107|62704813|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
33328386|NCT01199042|62704819|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
33465145|NCT00349973|62838552|FG000|Overall Study|Withdrawal by Subject|1|||
33465146|NCT00349973|62838553|FG001|Overall Study|Withdrawal by Subject|0|||
33465147|NCT03187262|62838559|FG000|Induction|Lack of Efficacy|2|||
33465148|NCT03187262|62838559|FG000|Induction|Progressive Disease|4|||
33465149|NCT03187262|62838559|FG000|Consolidation|Progressive Disease|5|||
33465150|NCT03381196|62838565|FG000|Overall Study|Withdrawal by Subject|7|||
33465151|NCT03381196|62838566|FG001|Overall Study|Withdrawal by Subject|7|||
33465152|NCT03381196|62838565|FG000|Overall Study|Other|0|||
33465153|NCT03381196|62838566|FG001|Overall Study|Other|1|||
33465154|NCT03381196|62838565|FG000|Overall Study|Lost to Follow-up|5|||
33544690|NCT02269917|62935803|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
33544691|NCT02269917|62935804|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
33544692|NCT02269917|62935802|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
33544693|NCT02269917|62935803|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
33544694|NCT02269917|62935804|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
33544695|NCT02269917|62935802|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
33544696|NCT02269917|62935803|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
33544697|NCT02269917|62935804|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
33544698|NCT02269917|62935802|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
33544699|NCT02269917|62935803|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
33544700|NCT02269917|62935804|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
33544701|NCT02269917|62935802|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
33651548|NCT01707992|63062969|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
33651549|NCT01707992|63062970|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
33651550|NCT01707992|63062971|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
33651551|NCT01707992|63062972|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
33651552|NCT01707992|63062973|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
33328387|NCT01199042|62704819|FG000|At Home (3 Months)|Lost to Follow-up|1|||
33328388|NCT01198574|62704832|FG000|Overall Study|Resigned from schools|4|||
33465155|NCT03381196|62838566|FG001|Overall Study|Lost to Follow-up|4|||
33651553|NCT01707992|63062968|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
33651554|NCT01707992|63062969|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
33651555|NCT01707992|63062970|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
33651556|NCT01707992|63062971|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
33328389|NCT01198574|62704833|FG001|Overall Study|Resigned from schools|1|||
33328390|NCT01198574|62704834|FG002|Overall Study|Resigned from schools|1|||
33328391|NCT01198574|62704835|FG003|Overall Study|Resigned from schools|4|||
33328392|NCT01198028|62704845|FG000|Overall Study|Adverse Event|5|||
33328393|NCT01198028|62704845|FG000|Overall Study|Death|3|||
33465156|NCT03381196|62838565|FG000|Overall Study|Death|0|||
33465157|NCT03381196|62838566|FG001|Overall Study|Death|1|||
33544702|NCT02269917|62935803|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
33544703|NCT02269917|62935804|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
33544704|NCT02269917|62935802|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
33544705|NCT02269917|62935803|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
33544706|NCT02269917|62935804|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
33544707|NCT02269917|62935802|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
33544708|NCT02269917|62935803|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
33544709|NCT02269917|62935804|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
33544710|NCT02269917|62935802|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
33544711|NCT02269917|62935803|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
33544712|NCT02269917|62935804|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
33544713|NCT02269917|62935802|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
33544714|NCT02269917|62935803|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
33544715|NCT02269917|62935804|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
33544716|NCT02269917|62935802|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
33544717|NCT02269917|62935803|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
33544718|NCT02269917|62935804|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
33544719|NCT02269917|62935802|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
33544720|NCT02269917|62935803|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
33544721|NCT02269917|62935804|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
33544722|NCT02269917|62935802|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
33544723|NCT02269917|62935803|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
33544724|NCT02269917|62935804|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
33544725|NCT02522494|62935815|FG000|Overall Study|Lost to Follow-up|6|||
33544726|NCT02522494|62935816|FG001|Overall Study|Lost to Follow-up|2|||
33544727|NCT02522494|62935815|FG000|Overall Study|Withdrawal by Subject|1|||
33544728|NCT02522494|62935816|FG001|Overall Study|Withdrawal by Subject|0|||
33544729|NCT02522494|62935815|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
33544730|NCT02522494|62935816|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
33544731|NCT02522494|62935815|FG000|Overall Study|Participant did not watch the video|1|||
33544732|NCT02522494|62935816|FG001|Overall Study|Participant did not watch the video|0|||
33544733|NCT02522494|62935815|FG000|Overall Study|Death|0|||
33544734|NCT02522494|62935816|FG001|Overall Study|Death|1|||
33544735|NCT01658020|62935824|FG000|Overall Study|Adverse Event|3|||
33544736|NCT01658020|62935825|FG001|Overall Study|Adverse Event|3|||
33544737|NCT01658020|62935824|FG000|Overall Study|Lost to Follow-up|1|||
33544738|NCT01658020|62935825|FG001|Overall Study|Lost to Follow-up|0|||
33544739|NCT01658020|62935824|FG000|Overall Study|Withdrawal by Subject|4|||
33544740|NCT01658020|62935825|FG001|Overall Study|Withdrawal by Subject|5|||
33544741|NCT01658020|62935824|FG000|Overall Study|Protocol Violation|0|||
33544742|NCT01658020|62935825|FG001|Overall Study|Protocol Violation|1|||
33544743|NCT03389477|62935843|FG000|Step 1|Withdrawal by Subject|1|||
33544744|NCT03389477|62935844|FG001|Step 1|Withdrawal by Subject|0|||
33544745|NCT03389477|62935843|FG000|Step 2|Withdrawal by Subject|1|||
33544746|NCT03389477|62935844|FG001|Step 2|Withdrawal by Subject|2|||
33544747|NCT03389477|62935843|FG000|Step 2|Disease progression|1|||
33544748|NCT03389477|62935844|FG001|Step 2|Disease progression|0|||
33544749|NCT03389477|62935843|FG000|Step 2|Death|0|||
33544750|NCT03389477|62935844|FG001|Step 2|Death|1|||
33544751|NCT03389477|62935843|FG000|Step 2|Poor performance status and nutrition|0|||
33544752|NCT03389477|62935844|FG001|Step 2|Poor performance status and nutrition|1|||
33544753|NCT03389477|62935843|FG000|Step 3|Withdrawal after 3 cycles|0|||
33544754|NCT03389477|62935844|FG001|Step 3|Withdrawal after 3 cycles|1|||
33544755|NCT03389477|62935843|FG000|Step 3|Still receiving active treatment|4|||
33544756|NCT03389477|62935844|FG001|Step 3|Still receiving active treatment|0|||
33544757|NCT03389477|62935843|FG000|Step 3|Progressive disease after 2 cycles|1|||
33544758|NCT03389477|62935844|FG001|Step 3|Progressive disease after 2 cycles|0|||
33544759|NCT02680574|62935854|FG000|Overall Study|Death|137|||
33544760|NCT02680574|62935855|FG001|Overall Study|Death|137|||
33544761|NCT02680574|62935854|FG000|Overall Study|Withdrawal by Subject|17|||
33544762|NCT02680574|62935855|FG001|Overall Study|Withdrawal by Subject|9|||
33544763|NCT02680574|62935854|FG000|Overall Study|Lost to Follow-up|4|||
33544764|NCT02680574|62935855|FG001|Overall Study|Lost to Follow-up|6|||
33544765|NCT02522884|62935861|FG000|Overall Study|Withdrawal by Subject|6|||
33544766|NCT02522884|62935861|FG000|Overall Study|Death|3|||
33544767|NCT02522884|62935861|FG000|Overall Study|Missed 12-month Follow-up|9|||
33544768|NCT02674568|62935878|FG000|Overall Study|Withdrawal by Subject|5|||
33544769|NCT02674568|62935878|FG000|Overall Study|Death|303|||
33544770|NCT02674568|62935878|FG000|Overall Study|Physician Decision|2|||
33544771|NCT02674568|62935878|FG000|Overall Study|Lost to Follow-up|9|||
33544772|NCT02674568|62935878|FG000|Overall Study|Other, Not Specified|20|||
33544773|NCT03022799|62935907|FG000|Overall Study|Adverse Event|0|||
33544774|NCT03022799|62935908|FG001|Overall Study|Adverse Event|0|||
33544775|NCT03022799|62935909|FG002|Overall Study|Adverse Event|0|||
33544776|NCT03022799|62935910|FG003|Overall Study|Adverse Event|0|||
33544777|NCT03022799|62935911|FG004|Overall Study|Adverse Event|0|||
33544778|NCT03022799|62935912|FG005|Overall Study|Adverse Event|0|||
33544779|NCT03022799|62935913|FG006|Overall Study|Adverse Event|0|||
33544780|NCT03022799|62935914|FG007|Overall Study|Adverse Event|0|||
33544781|NCT03022799|62935915|FG008|Overall Study|Adverse Event|0|||
33544782|NCT03022799|62935916|FG009|Overall Study|Adverse Event|1|||
33544783|NCT03022799|62935917|FG010|Overall Study|Adverse Event|1|||
33544784|NCT03022799|62935918|FG011|Overall Study|Adverse Event|0|||
33544785|NCT03022799|62935919|FG012|Overall Study|Adverse Event|0|||
33544786|NCT02674334|62935966|FG000|Overall Study|Lost to Follow-up|5|||
33544787|NCT02674334|62935967|FG001|Overall Study|Lost to Follow-up|3|||
33544788|NCT02674334|62935966|FG000|Overall Study|participant difficulty breathing|1|||
33544789|NCT02674334|62935967|FG001|Overall Study|participant difficulty breathing|0|||
33544790|NCT02674334|62935966|FG000|Overall Study|NIRS not recording|1|||
33544791|NCT02674334|62935967|FG001|Overall Study|NIRS not recording|0|||
33544792|NCT03026075|62935973|FG000|Overall Study|Physician Decision|1|||
33544793|NCT01373918|62935979|FG000|Overall Study|Physician Decision|0|||
33544794|NCT01373918|62935980|FG001|Overall Study|Physician Decision|1|||
33544795|NCT02667626|62935988|FG000|Overall Study|Withdrawal by Subject|0|||
33544796|NCT02667626|62935989|FG001|Overall Study|Withdrawal by Subject|1|||
33544797|NCT02522728|62936000|FG000|Overall Study|Withdrawal by Subject|6|||
33544798|NCT02522728|62936001|FG001|Overall Study|Withdrawal by Subject|6|||
33544799|NCT02522728|62936000|FG000|Overall Study|Death|4|||
33544800|NCT02522728|62936001|FG001|Overall Study|Death|3|||
33544801|NCT02522728|62936000|FG000|Overall Study|Adverse Event|2|||
33544802|NCT02522728|62936001|FG001|Overall Study|Adverse Event|1|||
33544803|NCT02522728|62936000|FG000|Overall Study|Did not receive randomized study device|0|||
33544804|NCT02522728|62936001|FG001|Overall Study|Did not receive randomized study device|1|||
33544805|NCT03025217|62936016|FG000|Overall Study|Pregnancy|1|||
33544806|NCT03025217|62936016|FG000|Overall Study|Lost to Follow-up|1|||
33544807|NCT03025217|62936016|FG000|Overall Study|Not eligible, poor English|2|||
33544808|NCT03023813|62936023|FG000|Overall Study|Lost to Follow-up|1|||
33544809|NCT03023813|62936024|FG001|Overall Study|Lost to Follow-up|2|||
33544810|NCT03023813|62936025|FG002|Overall Study|Lost to Follow-up|0|||
33544811|NCT01365130|62936034|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
33651557|NCT01707992|63062972|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
33544812|NCT01657162|62936040|FG000|Overall Study|Adverse Event|26|||
33544813|NCT01657162|62936041|FG001|Overall Study|Adverse Event|36|||
33544814|NCT01657162|62936040|FG000|Overall Study|Withdrawal by Subject|13|||
33544815|NCT01657162|62936041|FG001|Overall Study|Withdrawal by Subject|13|||
33544816|NCT01657162|62936040|FG000|Overall Study|Continuing Significant Deterioration|9|||
33544817|NCT01657162|62936041|FG001|Overall Study|Continuing Significant Deterioration|3|||
33544818|NCT01657162|62936040|FG000|Overall Study|Refusal of Treatment|4|||
33544819|NCT01657162|62936041|FG001|Overall Study|Refusal of Treatment|6|||
33544820|NCT01657162|62936040|FG000|Overall Study|Lost to Follow-up|3|||
33544821|NCT01657162|62936041|FG001|Overall Study|Lost to Follow-up|4|||
33544822|NCT01657162|62936040|FG000|Overall Study|Death|2|||
33544823|NCT01657162|62936041|FG001|Overall Study|Death|3|||
33544824|NCT01657162|62936040|FG000|Overall Study|Inability to Complete Study Procedures|1|||
33544825|NCT01657162|62936041|FG001|Overall Study|Inability to Complete Study Procedures|7|||
33544826|NCT01657162|62936040|FG000|Overall Study|Protocol Violation|1|||
33544827|NCT01657162|62936041|FG001|Overall Study|Protocol Violation|0|||
33544828|NCT01657162|62936040|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
33544829|NCT01657162|62936041|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
33544830|NCT01657162|62936040|FG000|Overall Study|Other than Specified|0|||
33544831|NCT01657162|62936041|FG001|Overall Study|Other than Specified|2|||
33544832|NCT01373294|62936075|FG000|Overall Study|Adverse Event|1|||
33544833|NCT01373294|62936076|FG001|Overall Study|Adverse Event|0|||
33544834|NCT01656304|62936082|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
33544835|NCT03023423|62936089|FG000|Overall Study|Death|5|||
33544836|NCT03023423|62936090|FG001|Overall Study|Death|12|||
33544837|NCT03023423|62936091|FG002|Overall Study|Death|20|||
33544838|NCT03023423|62936089|FG000|Overall Study|Other|0|||
33544839|NCT03023423|62936090|FG001|Overall Study|Other|2|||
33544840|NCT03023423|62936091|FG002|Overall Study|Other|2|||
33544841|NCT03023423|62936089|FG000|Overall Study|Ongoing|2|||
33544842|NCT03023423|62936090|FG001|Overall Study|Ongoing|32|||
33544843|NCT03023423|62936091|FG002|Overall Study|Ongoing|24|||
33544844|NCT03185741|62936106|FG000|Baseline|Withdrawal by Subject|1|||
33544845|NCT03185741|62936107|FG001|Baseline|Withdrawal by Subject|3|||
33544846|NCT03185741|62936108|FG002|Baseline|Withdrawal by Subject|2|||
33544847|NCT03185741|62936106|FG000|Baseline|Lost to Follow-up|1|||
33544848|NCT03185741|62936107|FG001|Baseline|Lost to Follow-up|2|||
33544849|NCT03185741|62936108|FG002|Baseline|Lost to Follow-up|3|||
33544850|NCT03185741|62936106|FG000|3Month|Death|1|||
33544851|NCT03185741|62936107|FG001|3Month|Death|1|||
33544852|NCT03185741|62936108|FG002|3Month|Death|2|||
33544853|NCT03185741|62936106|FG000|3Month|Withdrawal by Subject|1|||
33544854|NCT03185741|62936107|FG001|3Month|Withdrawal by Subject|5|||
33544855|NCT03185741|62936108|FG002|3Month|Withdrawal by Subject|1|||
33544856|NCT03185741|62936106|FG000|3Month|Lost to Follow-up|7|||
33544857|NCT03185741|62936107|FG001|3Month|Lost to Follow-up|9|||
33544858|NCT03185741|62936108|FG002|3Month|Lost to Follow-up|8|||
33544859|NCT03185741|62936106|FG000|3Month|Unavailable for 3Month|11|||
33544860|NCT03185741|62936107|FG001|3Month|Unavailable for 3Month|10|||
33544861|NCT03185741|62936108|FG002|3Month|Unavailable for 3Month|11|||
33544862|NCT03185741|62936106|FG000|3Month|Protocol Violation|0|||
33544863|NCT03185741|62936107|FG001|3Month|Protocol Violation|0|||
33544864|NCT03185741|62936108|FG002|3Month|Protocol Violation|3|||
33544865|NCT03185741|62936106|FG000|6Month|Death|1|||
33544866|NCT03185741|62936107|FG001|6Month|Death|1|||
33544867|NCT03185741|62936108|FG002|6Month|Death|2|||
33544868|NCT03185741|62936106|FG000|6Month|Withdrawal by Subject|2|||
33544869|NCT03185741|62936107|FG001|6Month|Withdrawal by Subject|3|||
33544870|NCT03185741|62936108|FG002|6Month|Withdrawal by Subject|1|||
33328394|NCT01198028|62704845|FG000|Overall Study|Physician Decision|2|||
33544871|NCT03185741|62936106|FG000|6Month|Lost to Follow-up|16|||
33544872|NCT03185741|62936107|FG001|6Month|Lost to Follow-up|15|||
33544873|NCT03185741|62936108|FG002|6Month|Lost to Follow-up|16|||
33544874|NCT02672852|62936118|FG000|Part A1|Disease Worsening|1|||
33544875|NCT02672852|62936119|FG001|Part A1|Disease Worsening|0|||
33328395|NCT01197950|62704852|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
33328396|NCT01197950|62704853|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
33544876|NCT02672852|62936120|FG002|Part A1|Disease Worsening|0|||
33544877|NCT02672852|62936121|FG003|Part A1|Disease Worsening|0|||
33544878|NCT02672852|62936122|FG004|Part A1|Disease Worsening|0|||
33544879|NCT02672852|62936123|FG005|Part A1|Disease Worsening|0|||
33328397|NCT01197950|62704854|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
33544880|NCT02672852|62936124|FG006|Part A1|Disease Worsening|0|||
33544881|NCT02672852|62936118|FG000|Part A1|Adverse Event|0|||
33544882|NCT02672852|62936119|FG001|Part A1|Adverse Event|1|||
33544883|NCT02672852|62936120|FG002|Part A1|Adverse Event|0|||
33465158|NCT03381196|62838565|FG000|Overall Study|Adverse Event|1|||
33465159|NCT03381196|62838566|FG001|Overall Study|Adverse Event|0|||
33465160|NCT03381196|62838565|FG000|Overall Study|Randomized, not treated|3|||
33465161|NCT03381196|62838566|FG001|Overall Study|Randomized, not treated|6|||
33465162|NCT02950558|62838574|FG000|Overall Study|Lost to Follow-up|2|||
33465163|NCT02950558|62838575|FG001|Overall Study|Lost to Follow-up|0|||
33544884|NCT02672852|62936121|FG003|Part A1|Adverse Event|0|||
33544885|NCT02672852|62936122|FG004|Part A1|Adverse Event|0|||
33465164|NCT03345472|62838582|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
33544886|NCT02672852|62936123|FG005|Part A1|Adverse Event|0|||
33465165|NCT03345472|62838582|FG000|Implant to 3 Months|Physician Decision|1|||
33465166|NCT03345472|62838582|FG000|Implant to 3 Months|Adverse Event|1|||
33465167|NCT03345472|62838582|FG000|3 Months to 12 Months|Physician Decision|3|||
33465168|NCT03345472|62838582|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
33465169|NCT03345472|62838582|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
33465170|NCT03345472|62838582|FG000|3 Months to 12 Months|Adverse Event|1|||
33465171|NCT03345472|62838582|FG000|3 Months to 12 Months|Death|1|||
33465172|NCT00349349|62838589|FG000|Overall Study|Adverse Event|5|||
33465173|NCT00349349|62838590|FG001|Overall Study|Adverse Event|6|||
33465174|NCT00349349|62838591|FG002|Overall Study|Adverse Event|2|||
33465175|NCT00349349|62838589|FG000|Overall Study|Withdrawal by Subject|5|||
33465176|NCT00349349|62838590|FG001|Overall Study|Withdrawal by Subject|2|||
33465177|NCT00349349|62838591|FG002|Overall Study|Withdrawal by Subject|1|||
33465178|NCT00349349|62838589|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
33465179|NCT00349349|62838590|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
33465180|NCT00349349|62838591|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
33465181|NCT00349349|62838589|FG000|Overall Study|Death|13|||
33465182|NCT00349349|62838590|FG001|Overall Study|Death|10|||
33465183|NCT00349349|62838591|FG002|Overall Study|Death|1|||
33465184|NCT00349349|62838589|FG000|Overall Study|Other Treatment Selected|2|||
33465185|NCT00349349|62838590|FG001|Overall Study|Other Treatment Selected|0|||
33465186|NCT00349349|62838591|FG002|Overall Study|Other Treatment Selected|0|||
33465187|NCT00349349|62838589|FG000|Overall Study|Participant Reduced General Condition|0|||
33465188|NCT00349349|62838590|FG001|Overall Study|Participant Reduced General Condition|1|||
33465189|NCT00349349|62838591|FG002|Overall Study|Participant Reduced General Condition|0|||
33465190|NCT00349349|62838589|FG000|Overall Study|Physician Decision|1|||
33465191|NCT00349349|62838590|FG001|Overall Study|Physician Decision|2|||
33465192|NCT00349349|62838591|FG002|Overall Study|Physician Decision|1|||
33465193|NCT00349349|62838589|FG000|Overall Study|No Response|0|||
33465194|NCT00349349|62838590|FG001|Overall Study|No Response|3|||
33465195|NCT00349349|62838591|FG002|Overall Study|No Response|0|||
33465196|NCT00349349|62838589|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
33465197|NCT00349349|62838590|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
33465198|NCT00349349|62838591|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
33465199|NCT02950480|62838603|FG000|Overall Study|Withdrawal by Subject|1|||
33465200|NCT02950480|62838604|FG001|Overall Study|Withdrawal by Subject|0|||
33465201|NCT00348881|62838612|FG000|Overall Study|Lost to Follow-up|12|||
33465202|NCT00348881|62838613|FG001|Overall Study|Lost to Follow-up|6|||
33465203|NCT00348881|62838612|FG000|Overall Study|Withdrawal by Subject|3|||
33465204|NCT00348881|62838613|FG001|Overall Study|Withdrawal by Subject|4|||
33465205|NCT00348881|62838612|FG000|Overall Study|Adverse Event|2|||
33465206|NCT00348881|62838613|FG001|Overall Study|Adverse Event|0|||
33465207|NCT00348881|62838612|FG000|Overall Study|Serious Adverse Event|0|||
33465208|NCT00348881|62838613|FG001|Overall Study|Serious Adverse Event|2|||
33465209|NCT03376516|62838623|FG000|Overall Study|Not treated|1|||
33465210|NCT03376516|62838623|FG000|Overall Study|Consent withdrawn|1|||
33465211|NCT03797144|62838649|FG000|Enrollment|Protocol Violation|4|||
33544887|NCT02672852|62936124|FG006|Part A1|Adverse Event|0|||
33544888|NCT02672852|62936118|FG000|Part A1|Lost to Follow-up|1|||
33544889|NCT02672852|62936119|FG001|Part A1|Lost to Follow-up|2|||
33544890|NCT02672852|62936120|FG002|Part A1|Lost to Follow-up|0|||
33544891|NCT02672852|62936121|FG003|Part A1|Lost to Follow-up|0|||
33544892|NCT02672852|62936122|FG004|Part A1|Lost to Follow-up|0|||
33328398|NCT01092780|62704862|FG000|Washout Period 1|Adverse Event|0|||
33328399|NCT01092780|62704863|FG001|Washout Period 1|Adverse Event|1|||
33328400|NCT01092780|62704864|FG002|Washout Period 1|Adverse Event|0|||
33328401|NCT01092780|62704865|FG003|Washout Period 1|Adverse Event|0|||
33328402|NCT01092780|62704862|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
33328403|NCT01092780|62704863|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
33328404|NCT01092780|62704864|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
33328405|NCT01092780|62704865|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
33328406|NCT01092780|62704862|FG000|Washout Period 2|Adverse Event|0|||
33328407|NCT01092780|62704863|FG001|Washout Period 2|Adverse Event|1|||
33328408|NCT01092780|62704864|FG002|Washout Period 2|Adverse Event|1|||
33328409|NCT01092780|62704865|FG003|Washout Period 2|Adverse Event|0|||
33328410|NCT01092546|62704875|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
33328411|NCT01197794|62704886|FG000|Overall Study|Adverse Event|3|||
33328412|NCT01197794|62704887|FG001|Overall Study|Adverse Event|2|||
33328413|NCT01197794|62704888|FG002|Overall Study|Adverse Event|4|||
33465212|NCT03797144|62838650|FG001|Enrollment|Protocol Violation|1|||
33544893|NCT02672852|62936123|FG005|Part A1|Lost to Follow-up|0|||
33328414|NCT01197794|62704889|FG003|Overall Study|Adverse Event|4|||
33328415|NCT01197794|62704890|FG004|Overall Study|Adverse Event|4|||
33328416|NCT01197794|62704891|FG005|Overall Study|Adverse Event|2|||
33465213|NCT03797144|62838649|FG000|Surgery|Protocol Violation|1|||
33465214|NCT03797144|62838650|FG001|Surgery|Protocol Violation|0|||
33544894|NCT02672852|62936124|FG006|Part A1|Lost to Follow-up|0|||
33544895|NCT02672852|62936118|FG000|Part A1|Withdrawal by Subject|1|||
33465215|NCT03797144|62838649|FG000|3 Month|Early termination cut-off date|2|||
33465216|NCT03797144|62838650|FG001|3 Month|Early termination cut-off date|0|||
33465217|NCT03797144|62838649|FG000|12 Month|Early termination cut-off date|8|||
33465218|NCT03797144|62838650|FG001|12 Month|Early termination cut-off date|9|||
33465219|NCT03797144|62838649|FG000|24 Month|Early termination cut-off date|1|||
33465220|NCT03797144|62838650|FG001|24 Month|Early termination cut-off date|1|||
33465221|NCT00347009|62838657|FG000|Overall Study|Death|1|||
33465222|NCT00347009|62838657|FG000|Overall Study|Adverse Event|6|||
33465223|NCT00347009|62838657|FG000|Overall Study|Withdrawal by Subject|3|||
33465224|NCT00347009|62838657|FG000|Overall Study|Physician Decision|5|||
33465225|NCT00347009|62838657|FG000|Overall Study|Lost to Follow-up|4|||
33465226|NCT00347009|62838657|FG000|Overall Study|Protocol Violation|2|||
33465227|NCT00347009|62838657|FG000|Overall Study|Adverse Laboratory Experience|1|||
33465228|NCT00347009|62838657|FG000|Overall Study|Insufficient Viral Suppression|3|||
33465229|NCT00347009|62838657|FG000|Overall Study|Increased ALT/HBV DNA|1|||
33465230|NCT00347009|62838657|FG000|Overall Study|Serious Adverse Event|1|||
33544896|NCT02672852|62936119|FG001|Part A1|Withdrawal by Subject|1|||
33328417|NCT01197794|62704892|FG006|Overall Study|Adverse Event|3|||
33328418|NCT01197794|62704886|FG000|Overall Study|Protocol Violation|0|||
33328419|NCT01197794|62704887|FG001|Overall Study|Protocol Violation|0|||
33328420|NCT01197794|62704888|FG002|Overall Study|Protocol Violation|0|||
33328421|NCT01197794|62704889|FG003|Overall Study|Protocol Violation|0|||
33328422|NCT01197794|62704890|FG004|Overall Study|Protocol Violation|2|||
33328423|NCT01197794|62704891|FG005|Overall Study|Protocol Violation|0|||
33328424|NCT01197794|62704892|FG006|Overall Study|Protocol Violation|1|||
33328425|NCT01197794|62704886|FG000|Overall Study|Development of study withdrawal criteria|3|||
33328426|NCT01197794|62704887|FG001|Overall Study|Development of study withdrawal criteria|0|||
33328427|NCT01197794|62704888|FG002|Overall Study|Development of study withdrawal criteria|0|||
33328428|NCT01197794|62704889|FG003|Overall Study|Development of study withdrawal criteria|1|||
33328429|NCT01197794|62704890|FG004|Overall Study|Development of study withdrawal criteria|0|||
33328430|NCT01197794|62704891|FG005|Overall Study|Development of study withdrawal criteria|0|||
33328431|NCT01197794|62704892|FG006|Overall Study|Development of study withdrawal criteria|1|||
33328432|NCT01197794|62704886|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
33328433|NCT01197794|62704887|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
33328434|NCT01197794|62704888|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
33328435|NCT01197794|62704889|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
33465231|NCT00346775|62838665|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
33465232|NCT00346775|62838666|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
33465233|NCT00346775|62838665|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
33544897|NCT02672852|62936120|FG002|Part A1|Withdrawal by Subject|0|||
33544898|NCT02672852|62936121|FG003|Part A1|Withdrawal by Subject|0|||
33465234|NCT00346775|62838666|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
33465235|NCT00346775|62838665|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
33465236|NCT00346775|62838666|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
33544899|NCT02672852|62936122|FG004|Part A1|Withdrawal by Subject|0|||
33328436|NCT01197794|62704890|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
33465237|NCT00346697|62838678|FG000|Overall Study|Lost to Follow-up|0|||
33465238|NCT00346697|62838679|FG001|Overall Study|Lost to Follow-up|1|||
33465239|NCT03400852|62838689|FG000|Blinded Treatment Period|Physician Decision|0|||
33465240|NCT03400852|62838690|FG001|Blinded Treatment Period|Physician Decision|1|||
33465241|NCT03400852|62838691|FG002|Blinded Treatment Period|Physician Decision|0|||
33465242|NCT03400852|62838689|FG000|Blinded Treatment Period|Adverse Event|1|||
33465243|NCT03400852|62838690|FG001|Blinded Treatment Period|Adverse Event|1|||
33465244|NCT03400852|62838691|FG002|Blinded Treatment Period|Adverse Event|0|||
33465245|NCT03400852|62838689|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
33465246|NCT03400852|62838690|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
33465247|NCT03400852|62838691|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
33465248|NCT03400852|62838689|FG000|Open Label Period|Physician Decision|0|||
33465249|NCT03400852|62838690|FG001|Open Label Period|Physician Decision|0|||
33465250|NCT03400852|62838691|FG002|Open Label Period|Physician Decision|1|||
33465251|NCT03400852|62838689|FG000|Open Label Period|Study terminated by sponsor|0|||
33465252|NCT03400852|62838690|FG001|Open Label Period|Study terminated by sponsor|0|||
33465253|NCT03400852|62838691|FG002|Open Label Period|Study terminated by sponsor|21|||
33465254|NCT03398356|62838702|FG000|Before Treatment|Lost to Follow-up|1|||
33465255|NCT03398356|62838703|FG001|Before Treatment|Lost to Follow-up|2|||
33465256|NCT03398356|62838704|FG002|Before Treatment|Lost to Follow-up|0|||
33465257|NCT03398356|62838702|FG000|Before Treatment|drug intolerance|2|||
33465258|NCT03398356|62838703|FG001|Before Treatment|drug intolerance|1|||
33465259|NCT03398356|62838704|FG002|Before Treatment|drug intolerance|0|||
33465260|NCT03398356|62838702|FG000|Before Treatment|Withdrawal by Subject|0|||
33465261|NCT03398356|62838703|FG001|Before Treatment|Withdrawal by Subject|5|||
33465262|NCT03398356|62838704|FG002|Before Treatment|Withdrawal by Subject|0|||
33465263|NCT03398356|62838702|FG000|Before Treatment|Physician Decision|0|||
33465264|NCT03398356|62838703|FG001|Before Treatment|Physician Decision|0|||
33465265|NCT03398356|62838704|FG002|Before Treatment|Physician Decision|11|||
33465266|NCT03398356|62838702|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
33465267|NCT03398356|62838703|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
33465268|NCT03398356|62838704|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
33465269|NCT00346151|62838712|FG000|Overall Study|Withdrawal by Subject|3|||
33465270|NCT00130286|62838720|FG000|Overall Study|Withdrawal by Subject|0|||
33465271|NCT00130286|62838721|FG001|Overall Study|Withdrawal by Subject|1|||
33465272|NCT00130286|62838722|FG002|Overall Study|Withdrawal by Subject|2|||
33465273|NCT00130286|62838723|FG003|Overall Study|Withdrawal by Subject|2|||
33465274|NCT00130286|62838720|FG000|Overall Study|Adverse Event|0|||
33465275|NCT00130286|62838721|FG001|Overall Study|Adverse Event|0|||
33544900|NCT02672852|62936123|FG005|Part A1|Withdrawal by Subject|0|||
33544901|NCT02672852|62936124|FG006|Part A1|Withdrawal by Subject|0|||
33544902|NCT02672852|62936118|FG000|Part A2|Disease worsening|0|||
33544903|NCT02672852|62936119|FG001|Part A2|Disease worsening|0|||
33544904|NCT02672852|62936120|FG002|Part A2|Disease worsening|1|||
33544905|NCT02672852|62936121|FG003|Part A2|Disease worsening|0|||
33544906|NCT02672852|62936122|FG004|Part A2|Disease worsening|0|||
33651558|NCT01707992|63062973|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
33651559|NCT01707992|63062968|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
33651560|NCT01707992|63062969|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
33328437|NCT01197794|62704891|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
33328438|NCT01197794|62704892|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
33328439|NCT01197794|62704886|FG000|Overall Study|Withdrawal by Subject|3|||
33328440|NCT01197794|62704887|FG001|Overall Study|Withdrawal by Subject|3|||
33328441|NCT01197794|62704888|FG002|Overall Study|Withdrawal by Subject|4|||
33328442|NCT01197794|62704889|FG003|Overall Study|Withdrawal by Subject|1|||
33328443|NCT01197794|62704890|FG004|Overall Study|Withdrawal by Subject|1|||
33328444|NCT01197794|62704891|FG005|Overall Study|Withdrawal by Subject|5|||
33328445|NCT01197794|62704892|FG006|Overall Study|Withdrawal by Subject|6|||
33328446|NCT01197794|62704886|FG000|Overall Study|Lost to Follow-up|1|||
33328447|NCT01197794|62704887|FG001|Overall Study|Lost to Follow-up|1|||
33328448|NCT01197794|62704888|FG002|Overall Study|Lost to Follow-up|0|||
33328449|NCT01197794|62704889|FG003|Overall Study|Lost to Follow-up|1|||
33328450|NCT01197794|62704890|FG004|Overall Study|Lost to Follow-up|0|||
33328451|NCT01197794|62704891|FG005|Overall Study|Lost to Follow-up|1|||
33328452|NCT01197794|62704892|FG006|Overall Study|Lost to Follow-up|0|||
33465276|NCT00130286|62838722|FG002|Overall Study|Adverse Event|2|||
33465277|NCT00130286|62838723|FG003|Overall Study|Adverse Event|0|||
33465278|NCT00130286|62838720|FG000|Overall Study|Missing lab specimens|0|||
33465279|NCT00130286|62838721|FG001|Overall Study|Missing lab specimens|2|||
33465280|NCT00130286|62838722|FG002|Overall Study|Missing lab specimens|0|||
33465281|NCT00130286|62838723|FG003|Overall Study|Missing lab specimens|0|||
33465282|NCT00346073|62838735|FG000|Overall Study|Serious Adverse Event|2|||
33465283|NCT00346073|62838736|FG001|Overall Study|Serious Adverse Event|0|||
33465284|NCT00346073|62838735|FG000|Overall Study|Lost to Follow-up|39|||
33544907|NCT02672852|62936123|FG005|Part A2|Disease worsening|0|||
33544908|NCT02672852|62936124|FG006|Part A2|Disease worsening|0|||
33465285|NCT00346073|62838736|FG001|Overall Study|Lost to Follow-up|24|||
33465286|NCT03374488|62838744|FG000|Overall Study|Death|13|||
33465287|NCT03374488|62838745|FG001|Overall Study|Death|13|||
33465288|NCT03374488|62838744|FG000|Overall Study|Withdrawal by Subject|3|||
33465289|NCT03374488|62838745|FG001|Overall Study|Withdrawal by Subject|1|||
33465290|NCT03374488|62838744|FG000|Overall Study|Physician Decision|3|||
33465291|NCT03374488|62838745|FG001|Overall Study|Physician Decision|0|||
33465292|NCT00345683|62838754|FG000|Overall Study|Lost to Follow-up|19|||
33544909|NCT02672852|62936118|FG000|Part A2|Adverse Event|0|||
33544910|NCT02672852|62936119|FG001|Part A2|Adverse Event|0|||
33544911|NCT02672852|62936120|FG002|Part A2|Adverse Event|3|||
33328453|NCT01197794|62704886|FG000|Overall Study|Other|1|||
33328454|NCT01197794|62704887|FG001|Overall Study|Other|1|||
33328455|NCT01197794|62704888|FG002|Overall Study|Other|3|||
33328456|NCT01197794|62704889|FG003|Overall Study|Other|0|||
33328457|NCT01197794|62704890|FG004|Overall Study|Other|2|||
33328458|NCT01197794|62704891|FG005|Overall Study|Other|2|||
33328459|NCT01197794|62704892|FG006|Overall Study|Other|4|||
33328460|NCT01078662|62704914|FG000|Overall Study|Death|41|||
33328461|NCT01078662|62704915|FG001|Overall Study|Death|103|||
33328462|NCT01078662|62704916|FG002|Overall Study|Death|18|||
33328463|NCT01078662|62704917|FG003|Overall Study|Death|5|||
33328464|NCT01078662|62704918|FG004|Overall Study|Death|8|||
33328465|NCT01078662|62704914|FG000|Overall Study|Patients reached data cut-off|12|||
33328466|NCT01078662|62704915|FG001|Overall Study|Patients reached data cut-off|53|||
33328467|NCT01078662|62704916|FG002|Overall Study|Patients reached data cut-off|2|||
33328468|NCT01078662|62704917|FG003|Overall Study|Patients reached data cut-off|2|||
33328469|NCT01078662|62704918|FG004|Overall Study|Patients reached data cut-off|3|||
33328470|NCT01078662|62704914|FG000|Overall Study|Withdrawal by Subject|4|||
33328471|NCT01078662|62704915|FG001|Overall Study|Withdrawal by Subject|11|||
33328472|NCT01078662|62704916|FG002|Overall Study|Withdrawal by Subject|1|||
33328473|NCT01078662|62704917|FG003|Overall Study|Withdrawal by Subject|0|||
33328474|NCT01078662|62704918|FG004|Overall Study|Withdrawal by Subject|0|||
33328475|NCT01078662|62704914|FG000|Overall Study|Protocol Violation|0|||
33328476|NCT01078662|62704915|FG001|Overall Study|Protocol Violation|1|||
33328477|NCT01078662|62704916|FG002|Overall Study|Protocol Violation|0|||
33328478|NCT01078662|62704917|FG003|Overall Study|Protocol Violation|0|||
33544912|NCT02672852|62936121|FG003|Part A2|Adverse Event|0|||
33651561|NCT01707992|63062970|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
33651562|NCT01707992|63062971|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
33651563|NCT01707992|63062972|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
33651564|NCT01707992|63062973|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
33328479|NCT01078662|62704918|FG004|Overall Study|Protocol Violation|0|||
33328480|NCT01078662|62704914|FG000|Overall Study|Lost to Follow-up|1|||
33328481|NCT01078662|62704915|FG001|Overall Study|Lost to Follow-up|0|||
33328482|NCT01078662|62704916|FG002|Overall Study|Lost to Follow-up|0|||
33328483|NCT01078662|62704917|FG003|Overall Study|Lost to Follow-up|0|||
33328484|NCT01078662|62704918|FG004|Overall Study|Lost to Follow-up|0|||
33328485|NCT01091454|62704927|FG000|Overall Study|Ineligible|1|||
33328486|NCT01140347|62704933|FG000|Overall Study|Lost to Follow-up|5|||
33465293|NCT00345683|62838755|FG001|Overall Study|Lost to Follow-up|7|||
33544913|NCT02672852|62936122|FG004|Part A2|Adverse Event|0|||
33328487|NCT01140347|62704934|FG001|Overall Study|Lost to Follow-up|6|||
33465294|NCT00345683|62838754|FG000|Overall Study|Other|6|||
33465295|NCT00345683|62838755|FG001|Overall Study|Other|2|||
33544914|NCT02672852|62936123|FG005|Part A2|Adverse Event|0|||
33328488|NCT01140347|62704933|FG000|Overall Study|Withdrawal by Subject|13|||
33328489|NCT01140347|62704934|FG001|Overall Study|Withdrawal by Subject|8|||
33328490|NCT01197560|62704942|FG000|Overall Study|Adverse Event|6|||
33328491|NCT01197560|62704943|FG001|Overall Study|Adverse Event|8|||
33328492|NCT01197560|62704942|FG000|Overall Study|Death|3|||
33328493|NCT01197560|62704943|FG001|Overall Study|Death|5|||
33328494|NCT01197560|62704942|FG000|Overall Study|Withdrawal by Subject|1|||
33328495|NCT01197560|62704943|FG001|Overall Study|Withdrawal by Subject|1|||
33328496|NCT01197560|62704942|FG000|Overall Study|Disease progression|40|||
33328497|NCT01197560|62704943|FG001|Overall Study|Disease progression|35|||
33328498|NCT01197560|62704942|FG000|Overall Study|Miscellaneous|4|||
33328499|NCT01197560|62704943|FG001|Overall Study|Miscellaneous|3|||
33328500|NCT01197560|62704942|FG000|Overall Study|Missing|0|||
33328501|NCT01197560|62704943|FG001|Overall Study|Missing|1|||
33328502|NCT01133405|62704960|FG000|Period 1|Withdrawal by Subject|0|||
33328503|NCT01133405|62704961|FG001|Period 1|Withdrawal by Subject|1|||
33328504|NCT01133405|62704962|FG002|Period 1|Withdrawal by Subject|0|||
33328505|NCT01133405|62704963|FG003|Period 1|Withdrawal by Subject|1|||
33328506|NCT01133405|62704964|FG004|Period 1|Withdrawal by Subject|0|||
33328507|NCT01133405|62704965|FG005|Period 1|Withdrawal by Subject|1|||
33328508|NCT01133405|62704966|FG006|Period 1|Withdrawal by Subject|0|||
33328509|NCT01133405|62704967|FG007|Period 1|Withdrawal by Subject|0|||
33328510|NCT01133405|62704968|FG008|Period 1|Withdrawal by Subject|0|||
33328511|NCT01133405|62704969|FG009|Period 1|Withdrawal by Subject|0|||
33328512|NCT01133405|62704960|FG000|Period 1|Physician Decision|0|||
33328513|NCT01133405|62704961|FG001|Period 1|Physician Decision|0|||
33328514|NCT01133405|62704962|FG002|Period 1|Physician Decision|0|||
33328515|NCT01133405|62704963|FG003|Period 1|Physician Decision|1|||
33328516|NCT01133405|62704964|FG004|Period 1|Physician Decision|0|||
33328517|NCT01133405|62704965|FG005|Period 1|Physician Decision|0|||
33328518|NCT01133405|62704966|FG006|Period 1|Physician Decision|0|||
33328519|NCT01133405|62704967|FG007|Period 1|Physician Decision|0|||
33328520|NCT01133405|62704968|FG008|Period 1|Physician Decision|0|||
33328521|NCT01133405|62704969|FG009|Period 1|Physician Decision|0|||
33328522|NCT01133405|62704960|FG000|Period 1|Discontinued after randomization|1|||
33328523|NCT01133405|62704961|FG001|Period 1|Discontinued after randomization|0|||
33328524|NCT01133405|62704962|FG002|Period 1|Discontinued after randomization|0|||
33328525|NCT01133405|62704963|FG003|Period 1|Discontinued after randomization|0|||
33328526|NCT01133405|62704964|FG004|Period 1|Discontinued after randomization|0|||
33328527|NCT01133405|62704965|FG005|Period 1|Discontinued after randomization|0|||
33328528|NCT01133405|62704966|FG006|Period 1|Discontinued after randomization|1|||
33328529|NCT01133405|62704967|FG007|Period 1|Discontinued after randomization|0|||
33328530|NCT01133405|62704968|FG008|Period 1|Discontinued after randomization|0|||
33328531|NCT01133405|62704969|FG009|Period 1|Discontinued after randomization|0|||
33328532|NCT01133405|62704960|FG000|Period 1|Received drug only in period 2|0|||
33328533|NCT01133405|62704961|FG001|Period 1|Received drug only in period 2|1|||
33328534|NCT01133405|62704962|FG002|Period 1|Received drug only in period 2|0|||
33328535|NCT01133405|62704963|FG003|Period 1|Received drug only in period 2|2|||
33328536|NCT01133405|62704964|FG004|Period 1|Received drug only in period 2|0|||
33328537|NCT01133405|62704965|FG005|Period 1|Received drug only in period 2|1|||
33328538|NCT01133405|62704966|FG006|Period 1|Received drug only in period 2|0|||
33328539|NCT01133405|62704967|FG007|Period 1|Received drug only in period 2|0|||
33328540|NCT01133405|62704968|FG008|Period 1|Received drug only in period 2|0|||
33328541|NCT01133405|62704969|FG009|Period 1|Received drug only in period 2|0|||
33328542|NCT01133405|62704960|FG000|Period 1|Received drug only in period 3|0|||
33328543|NCT01133405|62704961|FG001|Period 1|Received drug only in period 3|1|||
33328544|NCT01133405|62704962|FG002|Period 1|Received drug only in period 3|1|||
33328545|NCT01133405|62704963|FG003|Period 1|Received drug only in period 3|0|||
33328546|NCT01133405|62704964|FG004|Period 1|Received drug only in period 3|0|||
33328547|NCT01133405|62704965|FG005|Period 1|Received drug only in period 3|0|||
33328548|NCT01133405|62704966|FG006|Period 1|Received drug only in period 3|0|||
33328549|NCT01133405|62704967|FG007|Period 1|Received drug only in period 3|0|||
33328550|NCT01133405|62704968|FG008|Period 1|Received drug only in period 3|0|||
33328551|NCT01133405|62704969|FG009|Period 1|Received drug only in period 3|0|||
33328552|NCT01133405|62704960|FG000|Period 2|Adverse Event|0|||
33544915|NCT02672852|62936124|FG006|Part A2|Adverse Event|0|||
33651565|NCT01707992|63062968|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
33328553|NCT01133405|62704961|FG001|Period 2|Adverse Event|0|||
33328554|NCT01133405|62704962|FG002|Period 2|Adverse Event|1|||
33328555|NCT01133405|62704963|FG003|Period 2|Adverse Event|0|||
33328556|NCT01133405|62704964|FG004|Period 2|Adverse Event|0|||
33328557|NCT01133405|62704965|FG005|Period 2|Adverse Event|0|||
33328558|NCT01133405|62704966|FG006|Period 2|Adverse Event|0|||
33328559|NCT01133405|62704967|FG007|Period 2|Adverse Event|0|||
33328560|NCT01133405|62704968|FG008|Period 2|Adverse Event|0|||
33328561|NCT01133405|62704969|FG009|Period 2|Adverse Event|0|||
33328562|NCT01133405|62704960|FG000|Period 2|Withdrawal by Subject|0|||
33328563|NCT01133405|62704961|FG001|Period 2|Withdrawal by Subject|0|||
33544916|NCT02672852|62936118|FG000|Part A2|Lost to Follow-up|0|||
33328564|NCT01133405|62704962|FG002|Period 2|Withdrawal by Subject|0|||
33328565|NCT01133405|62704963|FG003|Period 2|Withdrawal by Subject|1|||
33328566|NCT01133405|62704964|FG004|Period 2|Withdrawal by Subject|0|||
33328567|NCT01133405|62704965|FG005|Period 2|Withdrawal by Subject|1|||
33328568|NCT01133405|62704966|FG006|Period 2|Withdrawal by Subject|0|||
33328569|NCT01133405|62704967|FG007|Period 2|Withdrawal by Subject|0|||
33328570|NCT01133405|62704968|FG008|Period 2|Withdrawal by Subject|0|||
33328571|NCT01133405|62704969|FG009|Period 2|Withdrawal by Subject|0|||
33328572|NCT01133405|62704960|FG000|Period 2|Entry Criteria Not Met|0|||
33465296|NCT03828383|62838763|FG000|Overall Study|Lost to Follow-up|3|||
33544917|NCT02672852|62936119|FG001|Part A2|Lost to Follow-up|0|||
33544918|NCT02672852|62936120|FG002|Part A2|Lost to Follow-up|2|||
33544919|NCT02672852|62936121|FG003|Part A2|Lost to Follow-up|0|||
33544920|NCT02672852|62936122|FG004|Part A2|Lost to Follow-up|0|||
33544921|NCT02672852|62936123|FG005|Part A2|Lost to Follow-up|0|||
33544922|NCT02672852|62936124|FG006|Part A2|Lost to Follow-up|0|||
33544923|NCT02672852|62936118|FG000|Part A2|Withdrawal by Subject|0|||
33544924|NCT02672852|62936119|FG001|Part A2|Withdrawal by Subject|0|||
33544925|NCT02672852|62936120|FG002|Part A2|Withdrawal by Subject|1|||
33544926|NCT02672852|62936121|FG003|Part A2|Withdrawal by Subject|0|||
33544927|NCT02672852|62936122|FG004|Part A2|Withdrawal by Subject|0|||
33544928|NCT02672852|62936123|FG005|Part A2|Withdrawal by Subject|0|||
33544929|NCT02672852|62936124|FG006|Part A2|Withdrawal by Subject|0|||
33544930|NCT02672852|62936118|FG000|Part A2|Other|0|||
33544931|NCT02672852|62936119|FG001|Part A2|Other|0|||
33544932|NCT02672852|62936120|FG002|Part A2|Other|3|||
33544933|NCT02672852|62936121|FG003|Part A2|Other|0|||
33544934|NCT02672852|62936122|FG004|Part A2|Other|0|||
33544935|NCT02672852|62936123|FG005|Part A2|Other|0|||
33544936|NCT02672852|62936124|FG006|Part A2|Other|0|||
33544937|NCT02672852|62936118|FG000|Part A2|Not entered in Part B|0|||
33544938|NCT02672852|62936119|FG001|Part A2|Not entered in Part B|0|||
33544939|NCT02672852|62936120|FG002|Part A2|Not entered in Part B|0|||
33544940|NCT02672852|62936121|FG003|Part A2|Not entered in Part B|4|||
33544941|NCT02672852|62936122|FG004|Part A2|Not entered in Part B|0|||
33544942|NCT02672852|62936123|FG005|Part A2|Not entered in Part B|0|||
33544943|NCT02672852|62936124|FG006|Part A2|Not entered in Part B|0|||
33544944|NCT02672852|62936118|FG000|Part B|Disease worsening|0|||
33544945|NCT02672852|62936119|FG001|Part B|Disease worsening|0|||
33544946|NCT02672852|62936120|FG002|Part B|Disease worsening|0|||
33544947|NCT02672852|62936121|FG003|Part B|Disease worsening|0|||
33544948|NCT02672852|62936122|FG004|Part B|Disease worsening|1|||
33544949|NCT02672852|62936123|FG005|Part B|Disease worsening|0|||
33544950|NCT02672852|62936124|FG006|Part B|Disease worsening|1|||
33544951|NCT02672852|62936118|FG000|Part B|Worsening pre-existing condition|0|||
33544952|NCT02672852|62936119|FG001|Part B|Worsening pre-existing condition|0|||
33544953|NCT02672852|62936120|FG002|Part B|Worsening pre-existing condition|0|||
33544954|NCT02672852|62936121|FG003|Part B|Worsening pre-existing condition|0|||
33544955|NCT02672852|62936122|FG004|Part B|Worsening pre-existing condition|0|||
33544956|NCT02672852|62936123|FG005|Part B|Worsening pre-existing condition|1|||
33544957|NCT02672852|62936124|FG006|Part B|Worsening pre-existing condition|0|||
33544958|NCT02672852|62936118|FG000|Part B|Other adverse event|0|||
33544959|NCT02672852|62936119|FG001|Part B|Other adverse event|0|||
33544960|NCT02672852|62936120|FG002|Part B|Other adverse event|0|||
33328573|NCT01133405|62704961|FG001|Period 2|Entry Criteria Not Met|1|||
33465297|NCT03828383|62838764|FG001|Overall Study|Lost to Follow-up|2|||
33465298|NCT03828383|62838763|FG000|Overall Study|Withdrawal by Subject|4|||
33465299|NCT03828383|62838764|FG001|Overall Study|Withdrawal by Subject|5|||
33465300|NCT00345605|62838770|FG000|Arm 1|Adverse Event|0|||
33465301|NCT00345605|62838771|FG001|Arm 1|Adverse Event|1|||
33465302|NCT00345605|62838770|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
33465303|NCT00345605|62838771|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
33465304|NCT03394924|62838782|FG000|Overall Study|Adverse Event|0|||
33465305|NCT03394924|62838783|FG001|Overall Study|Adverse Event|5|||
33465306|NCT03394924|62838784|FG002|Overall Study|Adverse Event|0|||
33465307|NCT03394924|62838782|FG000|Overall Study|Withdrawal by Subject|2|||
33328574|NCT01133405|62704962|FG002|Period 2|Entry Criteria Not Met|0|||
33328575|NCT01133405|62704963|FG003|Period 2|Entry Criteria Not Met|0|||
33465308|NCT03394924|62838783|FG001|Overall Study|Withdrawal by Subject|0|||
33544961|NCT02672852|62936121|FG003|Part B|Other adverse event|0|||
33544962|NCT02672852|62936122|FG004|Part B|Other adverse event|3|||
33544963|NCT02672852|62936123|FG005|Part B|Other adverse event|5|||
33544964|NCT02672852|62936124|FG006|Part B|Other adverse event|1|||
33544965|NCT02672852|62936118|FG000|Part B|Lost to Follow-up|0|||
33544966|NCT02672852|62936119|FG001|Part B|Lost to Follow-up|0|||
33544967|NCT02672852|62936120|FG002|Part B|Lost to Follow-up|0|||
33544968|NCT02672852|62936121|FG003|Part B|Lost to Follow-up|0|||
33544969|NCT02672852|62936122|FG004|Part B|Lost to Follow-up|3|||
33544970|NCT02672852|62936123|FG005|Part B|Lost to Follow-up|4|||
33544971|NCT02672852|62936124|FG006|Part B|Lost to Follow-up|1|||
33465309|NCT03394924|62838784|FG002|Overall Study|Withdrawal by Subject|0|||
33465310|NCT03394924|62838782|FG000|Overall Study|Lost to Follow-up|0|||
33465311|NCT03394924|62838783|FG001|Overall Study|Lost to Follow-up|1|||
33465312|NCT03394924|62838784|FG002|Overall Study|Lost to Follow-up|0|||
33465313|NCT03394924|62838782|FG000|Overall Study|Did not meet all inclusion criteria|1|||
33465314|NCT03394924|62838783|FG001|Overall Study|Did not meet all inclusion criteria|0|||
33465315|NCT03394924|62838784|FG002|Overall Study|Did not meet all inclusion criteria|0|||
33465316|NCT00345293|62838794|FG000|Overall Study|Unable to access line for sample|1|||
33465317|NCT00345293|62838795|FG001|Overall Study|Unable to access line for sample|0|||
33544972|NCT02672852|62936118|FG000|Part B|Withdrawal by Subject|0|||
33544973|NCT02672852|62936119|FG001|Part B|Withdrawal by Subject|0|||
33544974|NCT02672852|62936120|FG002|Part B|Withdrawal by Subject|0|||
33544975|NCT02672852|62936121|FG003|Part B|Withdrawal by Subject|0|||
33544976|NCT02672852|62936122|FG004|Part B|Withdrawal by Subject|5|||
33544977|NCT02672852|62936123|FG005|Part B|Withdrawal by Subject|0|||
33544978|NCT02672852|62936124|FG006|Part B|Withdrawal by Subject|7|||
33544979|NCT02672852|62936118|FG000|Part B|Other|0|||
33544980|NCT02672852|62936119|FG001|Part B|Other|0|||
33544981|NCT02672852|62936120|FG002|Part B|Other|0|||
33544982|NCT02672852|62936121|FG003|Part B|Other|0|||
33544983|NCT02672852|62936122|FG004|Part B|Other|4|||
33544984|NCT02672852|62936123|FG005|Part B|Other|1|||
33544985|NCT02672852|62936124|FG006|Part B|Other|2|||
33544986|NCT02671760|62936135|FG000|Overall Study|Lost to Follow-up|0|||
33544987|NCT02671760|62936136|FG001|Overall Study|Lost to Follow-up|1|||
33544988|NCT02671760|62936137|FG002|Overall Study|Lost to Follow-up|0|||
33544989|NCT02667236|62936147|FG000|Overall Study|Adverse Event|1|||
33544990|NCT02667236|62936148|FG001|Overall Study|Adverse Event|1|||
33544991|NCT02667236|62936147|FG000|Overall Study|Withdrawal by Subject|2|||
33544992|NCT02667236|62936148|FG001|Overall Study|Withdrawal by Subject|0|||
33544993|NCT01126749|62936158|FG000|Phase 1b|Other|0|||
33544994|NCT01126749|62936159|FG001|Phase 1b|Other|1|||
33544995|NCT01126749|62936160|FG002|Phase 1b|Other|0|||
33544996|NCT01126749|62936161|FG003|Phase 1b|Other|0|||
33544997|NCT01126749|62936158|FG000|Phase 1b|Withdrawal by Subject|0|||
33544998|NCT01126749|62936159|FG001|Phase 1b|Withdrawal by Subject|1|||
33544999|NCT01126749|62936160|FG002|Phase 1b|Withdrawal by Subject|0|||
33545000|NCT01126749|62936161|FG003|Phase 1b|Withdrawal by Subject|0|||
33545001|NCT01126749|62936158|FG000|Phase 1b|Death|3|||
33545002|NCT01126749|62936159|FG001|Phase 1b|Death|4|||
33545003|NCT01126749|62936160|FG002|Phase 1b|Death|0|||
33545004|NCT01126749|62936161|FG003|Phase 1b|Death|0|||
33545005|NCT01126749|62936158|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
33545006|NCT01126749|62936159|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
33545007|NCT01126749|62936160|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
33545008|NCT01126749|62936161|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
33545009|NCT01126749|62936158|FG000|Phase 2|Study Termination by Sponsor|0|||
33465318|NCT00345293|62838794|FG000|Overall Study|Withdrawal by Subject|1|||
33465319|NCT00345293|62838795|FG001|Overall Study|Withdrawal by Subject|0|||
33465320|NCT00355121|62838804|FG000|Overall Study|Did not receive study vaccine|1|||
33545010|NCT01126749|62936159|FG001|Phase 2|Study Termination by Sponsor|0|||
33545011|NCT01126749|62936160|FG002|Phase 2|Study Termination by Sponsor|12|||
33545012|NCT01126749|62936161|FG003|Phase 2|Study Termination by Sponsor|6|||
33545013|NCT01126749|62936158|FG000|Phase 2|Other|0|||
33545014|NCT01126749|62936159|FG001|Phase 2|Other|0|||
33545015|NCT01126749|62936160|FG002|Phase 2|Other|4|||
33545016|NCT01126749|62936161|FG003|Phase 2|Other|2|||
33545017|NCT01126749|62936158|FG000|Phase 2|Withdrawal by Subject|0|||
33545018|NCT01126749|62936159|FG001|Phase 2|Withdrawal by Subject|0|||
33545019|NCT01126749|62936160|FG002|Phase 2|Withdrawal by Subject|0|||
33545020|NCT01126749|62936161|FG003|Phase 2|Withdrawal by Subject|2|||
33545021|NCT01126749|62936158|FG000|Phase 2|Lost to Follow-up|0|||
33545022|NCT01126749|62936159|FG001|Phase 2|Lost to Follow-up|0|||
33651566|NCT01707992|63062969|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
33651567|NCT01707992|63062970|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
33651568|NCT01707992|63062971|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
33651569|NCT01707992|63062972|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
33651570|NCT01707992|63062973|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
33651571|NCT01707992|63062968|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
33651572|NCT01707992|63062969|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
33651573|NCT01707992|63062970|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
33651574|NCT01707992|63062971|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
33651575|NCT01707992|63062972|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
33651576|NCT01707992|63062973|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
33651577|NCT01707992|63062968|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
33651578|NCT01707992|63062969|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
33651579|NCT01707992|63062970|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
33651580|NCT01707992|63062971|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
33651581|NCT01707992|63062972|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
33651582|NCT01707992|63062973|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
33651583|NCT01707992|63062968|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
33651584|NCT01707992|63062969|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
33651585|NCT01707992|63062970|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
33651586|NCT01707992|63062971|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
33651587|NCT01707992|63062972|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
33651588|NCT01707992|63062973|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
33651589|NCT01707992|63062968|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
33651590|NCT01707992|63062969|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
33651591|NCT01707992|63062970|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
33651592|NCT01707992|63062971|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
33651593|NCT01707992|63062972|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
33651594|NCT01707992|63062973|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
33651595|NCT01707992|63062968|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
33651596|NCT01707992|63062969|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
33651597|NCT01707992|63062970|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
33651598|NCT01707992|63062971|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
33651599|NCT01707992|63062972|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
33651600|NCT01707992|63062973|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
33651601|NCT01707992|63062968|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
33651602|NCT01707992|63062969|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
33651603|NCT01707992|63062970|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
33651604|NCT01707992|63062971|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
33651605|NCT01707992|63062972|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
33651606|NCT01707992|63062973|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
33651607|NCT01707992|63062968|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
33651608|NCT01707992|63062969|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
33651609|NCT01707992|63062970|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
33651610|NCT01707992|63062971|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
33651611|NCT01707992|63062972|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
33651612|NCT01707992|63062973|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
33651613|NCT01707992|63062968|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
33651614|NCT01707992|63062969|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
33651615|NCT01707992|63062970|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
33651616|NCT01707992|63062971|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
33651617|NCT01707992|63062972|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
33651618|NCT01707992|63062973|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
33651619|NCT01707992|63062968|FG000|Active Treatment Phase (24 Months)|Death|0|||
33651620|NCT01707992|63062969|FG001|Active Treatment Phase (24 Months)|Death|0|||
33651621|NCT01707992|63062970|FG002|Active Treatment Phase (24 Months)|Death|0|||
33651622|NCT01707992|63062971|FG003|Active Treatment Phase (24 Months)|Death|2|||
33651623|NCT01707992|63062972|FG004|Active Treatment Phase (24 Months)|Death|0|||
33651624|NCT01707992|63062973|FG005|Active Treatment Phase (24 Months)|Death|0|||
33651625|NCT01707992|63062968|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
33651626|NCT01707992|63062969|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
33651627|NCT01707992|63062970|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
33651628|NCT01707992|63062971|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
33651629|NCT01707992|63062972|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
33651630|NCT01707992|63062973|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
33651631|NCT01707992|63062968|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
33651632|NCT01707992|63062969|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
33651633|NCT01707992|63062970|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
33651634|NCT01707992|63062971|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
33651635|NCT01707992|63062972|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
33651636|NCT01707992|63062973|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
33651637|NCT01707992|63062968|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
33651638|NCT01707992|63062969|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
33651639|NCT01707992|63062970|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
33651640|NCT01707992|63062971|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
33651641|NCT01707992|63062972|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
33651642|NCT01707992|63062973|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
33651643|NCT01707992|63062968|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
33651644|NCT01707992|63062969|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
33651645|NCT01707992|63062970|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
33651646|NCT01707992|63062971|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
33651647|NCT01707992|63062972|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
33651648|NCT01707992|63062973|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
33651649|NCT01946165|63062990|FG000|Overall Study|Physician Decision|2|||
33651650|NCT01946165|63062991|FG001|Overall Study|Physician Decision|0|||
33651651|NCT01946165|63062990|FG000|Overall Study|Withdrawal by Subject|0|||
33651652|NCT01946165|63062991|FG001|Overall Study|Withdrawal by Subject|2|||
33651653|NCT01707667|63063000|FG000|Period 1|expulsion of colonic sensor catheter|1|||
33651654|NCT01707667|63063001|FG001|Period 1|expulsion of colonic sensor catheter|0|||
33651655|NCT01959503|63063009|FG000|Overall Study|Death|2|||
33651656|NCT01959503|63063010|FG001|Overall Study|Death|1|||
33651657|NCT01959503|63063009|FG000|Overall Study|Randomized but not treated|1|||
33651658|NCT01959503|63063010|FG001|Overall Study|Randomized but not treated|1|||
33651659|NCT01605799|63063018|FG000|Overall Study|Withdrawal by Subject|2|||
33651660|NCT01605799|63063019|FG001|Overall Study|Withdrawal by Subject|1|||
33651661|NCT01706575|63063025|FG000|Overall Study|Participant Withdrew Consent|4|||
33651662|NCT01706575|63063025|FG000|Overall Study|Lost to Follow-up|2|||
33651663|NCT01706575|63063025|FG000|Overall Study|Started but not Treated|6|||
33651664|NCT01959425|63063031|FG000|Overall Study|Withdrawal by Subject|5|||
33651665|NCT01959425|63063032|FG001|Overall Study|Withdrawal by Subject|4|||
33651666|NCT01959425|63063031|FG000|Overall Study|Lost to Follow-up|1|||
33651667|NCT01959425|63063032|FG001|Overall Study|Lost to Follow-up|0|||
33651668|NCT01959425|63063031|FG000|Overall Study|Discontinued Subjects|6|||
33651669|NCT01959425|63063032|FG001|Overall Study|Discontinued Subjects|4|||
33651670|NCT01725529|63063041|FG000|Overall Study|Adverse Event|1|||
33651671|NCT01725529|63063042|FG001|Overall Study|Adverse Event|0|||
33651672|NCT01725529|63063043|FG002|Overall Study|Adverse Event|0|||
33651673|NCT01725529|63063041|FG000|Overall Study|Lost to Follow-up|2|||
33651674|NCT01725529|63063042|FG001|Overall Study|Lost to Follow-up|1|||
33651675|NCT01725529|63063043|FG002|Overall Study|Lost to Follow-up|1|||
33651676|NCT01725529|63063041|FG000|Overall Study|Protocol Violation|0|||
33651677|NCT01725529|63063042|FG001|Overall Study|Protocol Violation|1|||
33651678|NCT01725529|63063043|FG002|Overall Study|Protocol Violation|1|||
33651679|NCT01725529|63063041|FG000|Overall Study|Withdrawal by Subject|12|||
33545023|NCT01126749|62936160|FG002|Phase 2|Lost to Follow-up|0|||
33651680|NCT01725529|63063042|FG001|Overall Study|Withdrawal by Subject|14|||
33651681|NCT01725529|63063043|FG002|Overall Study|Withdrawal by Subject|8|||
33651682|NCT01605097|63063051|FG000|Overall Study|Protocol Violation|1|||
33651683|NCT01605019|63063058|FG000|Overall Study|pt did not meet transplant endpoint|3|||
33651684|NCT01605019|63063059|FG001|Overall Study|pt did not meet transplant endpoint|0|||
33651685|NCT01705717|63063067|FG000|Overall Study|Adverse Event|2|||
33651686|NCT01705717|63063068|FG001|Overall Study|Adverse Event|2|||
33651687|NCT01705717|63063067|FG000|Overall Study|Lack of Efficacy|0|||
33651688|NCT01705717|63063068|FG001|Overall Study|Lack of Efficacy|1|||
33651689|NCT01705717|63063067|FG000|Overall Study|Other|0|||
33651690|NCT01705717|63063068|FG001|Overall Study|Other|2|||
33651691|NCT01744483|63063076|FG000|Overall Study|Death|9|||
33651692|NCT01744483|63063077|FG001|Overall Study|Death|4|||
33651693|NCT01744483|63063078|FG002|Overall Study|Death|11|||
33545024|NCT01126749|62936161|FG003|Phase 2|Lost to Follow-up|1|||
33545025|NCT01126749|62936158|FG000|Phase 2|Death|0|||
33545026|NCT01126749|62936159|FG001|Phase 2|Death|0|||
33545027|NCT01126749|62936160|FG002|Phase 2|Death|22|||
33545028|NCT01126749|62936161|FG003|Phase 2|Death|22|||
33545029|NCT01126749|62936158|FG000|Phase 2|Adverse Event|0|||
33545030|NCT01126749|62936159|FG001|Phase 2|Adverse Event|0|||
33545031|NCT01126749|62936160|FG002|Phase 2|Adverse Event|0|||
33545032|NCT01126749|62936161|FG003|Phase 2|Adverse Event|1|||
33545033|NCT02521948|62936171|FG000|Overall Study|Adverse Event|2|||
33545034|NCT02521948|62936171|FG000|Overall Study|Death|4|||
33545035|NCT02521948|62936171|FG000|Overall Study|Lost to Follow-up|1|||
33545036|NCT02521948|62936171|FG000|Overall Study|Did not attend one or both follow-ups|6|||
33545037|NCT04446429|62936180|FG000|Overall Study|Lost to Follow-up|6|||
33545038|NCT04446429|62936181|FG001|Overall Study|Lost to Follow-up|0|||
33545039|NCT02832687|62936189|FG000|Overall Study|Adverse Event|0|||
33545040|NCT02832687|62936190|FG001|Overall Study|Adverse Event|2|||
33545041|NCT01656850|62936215|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
33545042|NCT01656850|62936216|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
33545043|NCT03116685|62936228|FG000|Overall Study|Physician Decision|0|||
33545044|NCT03116685|62936229|FG001|Overall Study|Physician Decision|1|||
33545045|NCT02666222|62936249|FG000|Overall Study|Death|2|||
33545046|NCT00739401|62936253|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
33545047|NCT00739401|62936253|FG000|Overall Study|Death|3|||
33545048|NCT00739401|62936253|FG000|Overall Study|Withdrawal by Subject|4|||
33545049|NCT01365052|62936259|FG000|Overall Study|Adverse Event|4|||
33545050|NCT01365052|62936260|FG001|Overall Study|Adverse Event|4|||
33545051|NCT01372748|62936268|FG000|Overall Study|Lost to Follow-up|16|||
33545052|NCT01372748|62936269|FG001|Overall Study|Lost to Follow-up|34|||
33545053|NCT01372748|62936268|FG000|Overall Study|Withdrawal by Subject|7|||
33545054|NCT01372748|62936269|FG001|Overall Study|Withdrawal by Subject|5|||
33545055|NCT02736825|62936277|FG000|Overall Study|Lost to Follow-up|10|||
33545056|NCT02736825|62936278|FG001|Overall Study|Lost to Follow-up|11|||
33545057|NCT02736825|62936277|FG000|Overall Study|Early Termination|0|||
33545058|NCT02736825|62936278|FG001|Overall Study|Early Termination|1|||
33545059|NCT02670122|62936285|FG000|Overall Study|Lost to Follow-up|4|||
33545060|NCT03283371|62936298|FG000|Placebo-controlled|Adverse Event|1|||
33545061|NCT03283371|62936299|FG001|Placebo-controlled|Adverse Event|1|||
33545062|NCT03283371|62936300|FG002|Placebo-controlled|Adverse Event|0|||
33545063|NCT03283371|62936301|FG003|Placebo-controlled|Adverse Event|0|||
33545064|NCT03283371|62936298|FG000|Placebo-controlled|Lack of Efficacy|1|||
33545065|NCT03283371|62936299|FG001|Placebo-controlled|Lack of Efficacy|0|||
33545066|NCT03283371|62936300|FG002|Placebo-controlled|Lack of Efficacy|0|||
33545067|NCT03283371|62936301|FG003|Placebo-controlled|Lack of Efficacy|0|||
33545068|NCT03283371|62936298|FG000|Placebo-controlled|Withdrawal by Subject|1|||
33545069|NCT03283371|62936299|FG001|Placebo-controlled|Withdrawal by Subject|1|||
33545070|NCT03283371|62936300|FG002|Placebo-controlled|Withdrawal by Subject|0|||
33545071|NCT03283371|62936301|FG003|Placebo-controlled|Withdrawal by Subject|0|||
33545072|NCT03283371|62936298|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
33545073|NCT03283371|62936299|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
33545074|NCT03283371|62936300|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
33545075|NCT03283371|62936301|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
33545076|NCT03283371|62936298|FG000|Open-label Phase|Adverse Event|0|||
33545077|NCT03283371|62936299|FG001|Open-label Phase|Adverse Event|0|||
33545078|NCT03283371|62936300|FG002|Open-label Phase|Adverse Event|2|||
33545079|NCT03283371|62936301|FG003|Open-label Phase|Adverse Event|0|||
33545080|NCT03283371|62936298|FG000|Open-label Phase|Withdrawal by Subject|0|||
33545081|NCT03283371|62936299|FG001|Open-label Phase|Withdrawal by Subject|0|||
33545082|NCT03283371|62936300|FG002|Open-label Phase|Withdrawal by Subject|1|||
33545083|NCT03283371|62936301|FG003|Open-label Phase|Withdrawal by Subject|0|||
33545084|NCT03283371|62936298|FG000|Open-label Phase|Other|0|||
33545085|NCT03283371|62936299|FG001|Open-label Phase|Other|0|||
33310143|NCT01287221|62685511|FG000|Overall Study|Adverse Event|3|||
33545086|NCT03283371|62936300|FG002|Open-label Phase|Other|1|||
33545087|NCT03283371|62936301|FG003|Open-label Phase|Other|1|||
33545088|NCT03069417|62936313|FG000|Overall Study|Lost to Follow-up|2|||
33545089|NCT03069417|62936314|FG001|Overall Study|Lost to Follow-up|0|||
33545090|NCT03069417|62936313|FG000|Overall Study|Reason Unknown|4|||
33545091|NCT03069417|62936314|FG001|Overall Study|Reason Unknown|7|||
33545092|NCT04930263|62936323|FG000|Overall Study|Withdrawal by Subject|3|||
33545093|NCT04930263|62936324|FG001|Overall Study|Withdrawal by Subject|5|||
33651694|NCT01744483|63063076|FG000|Overall Study|Lost to Follow-up|8|||
33651695|NCT01744483|63063077|FG001|Overall Study|Lost to Follow-up|9|||
33651696|NCT01744483|63063078|FG002|Overall Study|Lost to Follow-up|11|||
33651697|NCT01744483|63063076|FG000|Overall Study|Protocol Violation|1|||
33651698|NCT01744483|63063077|FG001|Overall Study|Protocol Violation|2|||
33651699|NCT01744483|63063078|FG002|Overall Study|Protocol Violation|1|||
33651700|NCT01744483|63063076|FG000|Overall Study|Withdrawal by Subject|4|||
33651701|NCT01744483|63063077|FG001|Overall Study|Withdrawal by Subject|6|||
33651702|NCT01744483|63063078|FG002|Overall Study|Withdrawal by Subject|2|||
33651703|NCT01744483|63063076|FG000|Overall Study|No ICU Admit|5|||
33651704|NCT01744483|63063077|FG001|Overall Study|No ICU Admit|1|||
33651705|NCT01744483|63063078|FG002|Overall Study|No ICU Admit|2|||
33651706|NCT01744483|63063076|FG000|Overall Study|Routed to OSH|2|||
33545094|NCT02665286|62936333|FG000|Overall Study|Lost to Follow-up|3|||
33545095|NCT02665286|62936334|FG001|Overall Study|Lost to Follow-up|2|||
33545096|NCT02665286|62936335|FG002|Overall Study|Lost to Follow-up|1|||
33545097|NCT02134925|62936345|FG000|Overall Study|Withdrawal by Subject|1|||
33651707|NCT01744483|63063077|FG001|Overall Study|Routed to OSH|0|||
33651708|NCT01744483|63063078|FG002|Overall Study|Routed to OSH|1|||
33328576|NCT01133405|62704964|FG004|Period 2|Entry Criteria Not Met|0|||
33328577|NCT01133405|62704965|FG005|Period 2|Entry Criteria Not Met|0|||
33328578|NCT01133405|62704966|FG006|Period 2|Entry Criteria Not Met|0|||
33328579|NCT01133405|62704967|FG007|Period 2|Entry Criteria Not Met|0|||
33465321|NCT00355121|62838805|FG001|Overall Study|Did not receive study vaccine|0|||
33465322|NCT00355121|62838806|FG002|Overall Study|Did not receive study vaccine|1|||
33465323|NCT00355121|62838804|FG000|Overall Study|Adverse Event|0|||
33465324|NCT00355121|62838805|FG001|Overall Study|Adverse Event|1|||
33328580|NCT01133405|62704968|FG008|Period 2|Entry Criteria Not Met|0|||
33328581|NCT01133405|62704969|FG009|Period 2|Entry Criteria Not Met|0|||
33328582|NCT01133405|62704960|FG000|Period 2|Physician Decision|0|||
33328583|NCT01133405|62704961|FG001|Period 2|Physician Decision|0|||
33328584|NCT01133405|62704962|FG002|Period 2|Physician Decision|0|||
33328585|NCT01133405|62704963|FG003|Period 2|Physician Decision|0|||
33328586|NCT01133405|62704964|FG004|Period 2|Physician Decision|0|||
33328587|NCT01133405|62704965|FG005|Period 2|Physician Decision|1|||
33328588|NCT01133405|62704966|FG006|Period 2|Physician Decision|0|||
33328589|NCT01133405|62704967|FG007|Period 2|Physician Decision|0|||
33328590|NCT01133405|62704968|FG008|Period 2|Physician Decision|0|||
33328591|NCT01133405|62704969|FG009|Period 2|Physician Decision|0|||
33328592|NCT01196078|62705001|FG000|Overall Study|Withdrawal by Subject|3|||
33328593|NCT01196078|62705002|FG001|Overall Study|Withdrawal by Subject|5|||
33328594|NCT01196078|62705001|FG000|Overall Study|Adverse Event|4|||
33328595|NCT01196078|62705002|FG001|Overall Study|Adverse Event|4|||
33328596|NCT01196078|62705001|FG000|Overall Study|Protocol Violation|2|||
33328597|NCT01196078|62705002|FG001|Overall Study|Protocol Violation|1|||
33328598|NCT01196078|62705001|FG000|Overall Study|Lack of Efficacy|17|||
33328599|NCT01196078|62705002|FG001|Overall Study|Lack of Efficacy|23|||
33328600|NCT01196078|62705001|FG000|Overall Study|Lost to Follow-up|1|||
33328601|NCT01196078|62705002|FG001|Overall Study|Lost to Follow-up|0|||
33328602|NCT01196078|62705001|FG000|Overall Study|Death|6|||
33328603|NCT01196078|62705002|FG001|Overall Study|Death|4|||
33328604|NCT01078584|62705008|FG000|Overall Study|Final Status Unknown|1073|||
33328605|NCT01078584|62705008|FG000|Overall Study|Lost to Follow-up|670|||
33328606|NCT01078584|62705008|FG000|Overall Study|Non-serious Adverse Event|577|||
33328607|NCT01078584|62705008|FG000|Overall Study|Withdrawal of Consent|244|||
33328608|NCT01078584|62705008|FG000|Overall Study|Physician Withdrew from Study|90|||
33328609|NCT01078584|62705008|FG000|Overall Study|Non-compliance|67|||
33328610|NCT01078584|62705008|FG000|Overall Study|Blood Pressure Controlled|49|||
33328611|NCT01078584|62705008|FG000|Overall Study|Physician Switched Medication|26|||
33328612|NCT01078584|62705008|FG000|Overall Study|Physician Discontinued Patient|12|||
33328613|NCT01078584|62705008|FG000|Overall Study|Lack of Efficacy|98|||
33328614|NCT01078584|62705008|FG000|Overall Study|Protocol Violation|75|||
33328615|NCT01078584|62705008|FG000|Overall Study|Serious Adverse Event|27|||
33328616|NCT01078584|62705008|FG000|Overall Study|Multiple Reasons|2|||
33328617|NCT01133171|62705028|FG000|Overall Study|Withdrawal by Subject|1|||
33328618|NCT01133171|62705029|FG001|Overall Study|Withdrawal by Subject|2|||
33328619|NCT01133171|62705030|FG002|Overall Study|Withdrawal by Subject|0|||
33465325|NCT00355121|62838806|FG002|Overall Study|Adverse Event|0|||
33651709|NCT01744093|63063088|FG000|Overall Study|Withdrawal by Subject|6|||
33328620|NCT01195844|62705038|FG000|Overall Study|Fecal sample not collected|40|||
33328621|NCT01132547|62705054|FG000|Overall Study|Withdrawal by Subject|3|||
33328622|NCT01132547|62705055|FG001|Overall Study|Withdrawal by Subject|1|||
33328623|NCT01132547|62705054|FG000|Overall Study|Death|1|||
33328624|NCT01132547|62705055|FG001|Overall Study|Death|0|||
33328625|NCT01194830|62705063|FG000|Overall Study|Adverse Event|3|||
33328626|NCT01194830|62705064|FG001|Overall Study|Adverse Event|2|||
33328627|NCT01194830|62705063|FG000|Overall Study|Protocol Violation|5|||
33328628|NCT01194830|62705064|FG001|Overall Study|Protocol Violation|4|||
33651710|NCT01744093|63063089|FG001|Overall Study|Withdrawal by Subject|1|||
33651711|NCT01725451|63063103|FG000|Period 1|Withdrawal by Subject|1|||
33651712|NCT01725451|63063104|FG001|Period 1|Withdrawal by Subject|0|||
33651713|NCT01725451|63063105|FG002|Period 1|Withdrawal by Subject|0|||
33651714|NCT01725451|63063106|FG003|Period 1|Withdrawal by Subject|0|||
33651715|NCT01725451|63063103|FG000|Washout From Period 3|Protocol Violation|0|||
33651716|NCT01725451|63063104|FG001|Washout From Period 3|Protocol Violation|0|||
33651717|NCT01725451|63063105|FG002|Washout From Period 3|Protocol Violation|1|||
33651718|NCT01725451|63063106|FG003|Washout From Period 3|Protocol Violation|0|||
33651719|NCT01725451|63063103|FG000|Washout From Period 3|Adverse Event|0|||
33651720|NCT01725451|63063104|FG001|Washout From Period 3|Adverse Event|1|||
33651721|NCT01725451|63063105|FG002|Washout From Period 3|Adverse Event|0|||
33651722|NCT01725451|63063106|FG003|Washout From Period 3|Adverse Event|0|||
33651723|NCT01725451|63063103|FG000|Period 4|Adverse Event|0|||
33651724|NCT01725451|63063104|FG001|Period 4|Adverse Event|0|||
33651725|NCT01725451|63063105|FG002|Period 4|Adverse Event|1|||
33651726|NCT01725451|63063106|FG003|Period 4|Adverse Event|0|||
33651727|NCT01707290|63063123|FG000|Overall Study|Adverse event (AE)|1|||
33651728|NCT01707290|63063124|FG001|Overall Study|Adverse event (AE)|0|||
33651729|NCT01707290|63063123|FG000|Overall Study|Physician Decision|1|||
33651730|NCT01707290|63063124|FG001|Overall Study|Physician Decision|0|||
33651731|NCT01707290|63063123|FG000|Overall Study|Lost to Follow-up|3|||
33651732|NCT01707290|63063124|FG001|Overall Study|Lost to Follow-up|0|||
33651733|NCT01707290|63063123|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
33651734|NCT01707290|63063124|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
33651735|NCT01707290|63063123|FG000|Overall Study|Commercial drug available|60|||
33651736|NCT01707290|63063124|FG001|Overall Study|Commercial drug available|1|||
33651737|NCT01707290|63063123|FG000|Overall Study|Other unspecified|17|||
33651738|NCT01707290|63063124|FG001|Overall Study|Other unspecified|0|||
33651739|NCT01717040|63063135|FG000|Overall Study|Lost to Follow-up|2|||
33651740|NCT01717040|63063136|FG001|Overall Study|Lost to Follow-up|3|||
33651741|NCT01717040|63063135|FG000|Overall Study|Lack of Efficacy|1|||
33651742|NCT01717040|63063136|FG001|Overall Study|Lack of Efficacy|1|||
33651743|NCT01717040|63063135|FG000|Overall Study|Adverse Event|1|||
33651744|NCT01717040|63063136|FG001|Overall Study|Adverse Event|0|||
33651745|NCT01717040|63063135|FG000|Overall Study|Required Medication Change|0|||
33651746|NCT01717040|63063136|FG001|Overall Study|Required Medication Change|1|||
33651747|NCT01717040|63063135|FG000|Overall Study|New Substance Use Disorder|1|||
33651748|NCT01717040|63063136|FG001|Overall Study|New Substance Use Disorder|0|||
33651749|NCT01743469|63063163|FG000|Active Treatment Phase|Adverse Event|10|||
33651750|NCT01743469|63063164|FG001|Active Treatment Phase|Adverse Event|5|||
33651751|NCT01743469|63063165|FG002|Active Treatment Phase|Adverse Event|8|||
33651752|NCT01743469|63063166|FG003|Active Treatment Phase|Adverse Event|1|||
33651753|NCT01743469|63063163|FG000|Active Treatment Phase|Disease Progression|40|||
33651754|NCT01743469|63063164|FG001|Active Treatment Phase|Disease Progression|47|||
33651755|NCT01743469|63063165|FG002|Active Treatment Phase|Disease Progression|30|||
33651756|NCT01743469|63063166|FG003|Active Treatment Phase|Disease Progression|20|||
33651757|NCT01743469|63063163|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
33651758|NCT01743469|63063164|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
33651759|NCT01743469|63063165|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
33328629|NCT01194830|62705063|FG000|Overall Study|Lost to Follow-up|9|||
33328630|NCT01194830|62705064|FG001|Overall Study|Lost to Follow-up|7|||
33328631|NCT01194830|62705063|FG000|Overall Study|Withdrawal by Subject|2|||
33465326|NCT00355121|62838804|FG000|Overall Study|Protocol Violation|7|||
33465327|NCT00355121|62838805|FG001|Overall Study|Protocol Violation|9|||
33465328|NCT00355121|62838806|FG002|Overall Study|Protocol Violation|1|||
33465329|NCT00355121|62838804|FG000|Overall Study|Lost to Follow-up|4|||
33465330|NCT00355121|62838805|FG001|Overall Study|Lost to Follow-up|7|||
33465331|NCT00355121|62838806|FG002|Overall Study|Lost to Follow-up|1|||
33465332|NCT00355121|62838804|FG000|Overall Study|Withdrawal by Subject|9|||
33465333|NCT00355121|62838805|FG001|Overall Study|Withdrawal by Subject|10|||
33545098|NCT02134925|62936346|FG001|Overall Study|Withdrawal by Subject|0|||
33545099|NCT02134925|62936345|FG000|Overall Study|Cancel|1|||
33465334|NCT00355121|62838806|FG002|Overall Study|Withdrawal by Subject|2|||
33465335|NCT00355121|62838804|FG000|Overall Study|Serious adverse events|0|||
33465336|NCT00355121|62838805|FG001|Overall Study|Serious adverse events|2|||
33545100|NCT02134925|62936346|FG001|Overall Study|Cancel|6|||
33465337|NCT00355121|62838806|FG002|Overall Study|Serious adverse events|0|||
33651760|NCT01743469|63063166|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
33651761|NCT01743469|63063163|FG000|Active Treatment Phase|Missing|1|||
33651762|NCT01743469|63063164|FG001|Active Treatment Phase|Missing|0|||
33651763|NCT01743469|63063165|FG002|Active Treatment Phase|Missing|0|||
33651764|NCT01743469|63063166|FG003|Active Treatment Phase|Missing|0|||
33651765|NCT01743469|63063163|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
33651766|NCT01743469|63063164|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
33651767|NCT01743469|63063165|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
33651768|NCT01743469|63063166|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
33651769|NCT01743469|63063163|FG000|Follow-up Period - Post-Treatment|Death|43|||
33651770|NCT01743469|63063164|FG001|Follow-up Period - Post-Treatment|Death|47|||
33545101|NCT02911519|62936354|FG000|Overall Study|Lost to Follow-up|2|||
33545102|NCT02911519|62936355|FG001|Overall Study|Lost to Follow-up|2|||
33545103|NCT02911519|62936354|FG000|Overall Study|Death|0|||
33545104|NCT02911519|62936355|FG001|Overall Study|Death|2|||
33545105|NCT02911285|62936363|FG000|Overall Study|Lost to Follow-up|8|||
33545106|NCT02911285|62936364|FG001|Overall Study|Lost to Follow-up|5|||
33545107|NCT02911285|62936363|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
33651771|NCT01743469|63063165|FG002|Follow-up Period - Post-Treatment|Death|22|||
33651772|NCT01743469|63063166|FG003|Follow-up Period - Post-Treatment|Death|16|||
33651773|NCT01743469|63063163|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
33651774|NCT01743469|63063164|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
33651775|NCT01743469|63063165|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
33651776|NCT01743469|63063166|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
33328632|NCT01194830|62705064|FG001|Overall Study|Withdrawal by Subject|1|||
33328633|NCT01194830|62705063|FG000|Overall Study|Lack of Efficacy|1|||
33328634|NCT01194830|62705064|FG001|Overall Study|Lack of Efficacy|1|||
33328635|NCT01194830|62705063|FG000|Overall Study|Non-compliance issues|4|||
33328636|NCT01194830|62705064|FG001|Overall Study|Non-compliance issues|4|||
33328637|NCT01194830|62705063|FG000|Overall Study|Other Reason|12|||
33328638|NCT01194830|62705064|FG001|Overall Study|Other Reason|8|||
33328639|NCT01194440|62705070|FG000|Baseline (First Dose)|Reason not specified|4|||
33328640|NCT01194440|62705070|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
33328641|NCT01194440|62705070|FG000|Baseline (First Dose)|Change in therapy|1|||
33328642|NCT01194440|62705070|FG000|Baseline (First Dose)|Adverse Event|1|||
33328643|NCT01194440|62705070|FG000|6-months (2nd Dose)|Change in therapy|4|||
33328644|NCT00951015|62705079|FG000|Randomization Phase 96 Week|Adverse Event|1|||
33328645|NCT00951015|62705080|FG001|Randomization Phase 96 Week|Adverse Event|1|||
33465338|NCT00343889|62838819|FG000|Overall Study|Lost to Follow-up|2|||
33465339|NCT00343889|62838820|FG001|Overall Study|Lost to Follow-up|0|||
33465340|NCT00343889|62838819|FG000|Overall Study|Withdrawal by Subject|0|||
33465341|NCT00343889|62838820|FG001|Overall Study|Withdrawal by Subject|1|||
33465342|NCT00343889|62838819|FG000|Overall Study|Protocol Violation|1|||
33465343|NCT00343889|62838820|FG001|Overall Study|Protocol Violation|0|||
33465344|NCT00354341|62838828|FG000|Overall Study|Adverse Event|1|||
33465345|NCT00354341|62838829|FG001|Overall Study|Adverse Event|0|||
33465346|NCT00354341|62838828|FG000|Overall Study|Death|0|||
33465347|NCT00354341|62838829|FG001|Overall Study|Death|2|||
33465348|NCT00354341|62838828|FG000|Overall Study|Refused treatment|1|||
33465349|NCT00354341|62838829|FG001|Overall Study|Refused treatment|2|||
33465350|NCT00354341|62838828|FG000|Overall Study|Failure to return|0|||
33465351|NCT00354341|62838829|FG001|Overall Study|Failure to return|1|||
33465352|NCT00354341|62838828|FG000|Overall Study|Other|1|||
33465353|NCT00354341|62838829|FG001|Overall Study|Other|2|||
33465354|NCT00354107|62838835|FG000|Overall Study|Adverse Event|2|||
33465355|NCT00354107|62838835|FG000|Overall Study|Physician Decision|2|||
33465356|NCT00354107|62838835|FG000|Overall Study|Withdrawal by Subject|1|||
33465357|NCT00354029|62838841|FG000|Overall Study|Protocol Violation|4|||
33465358|NCT00354029|62838842|FG001|Overall Study|Protocol Violation|2|||
33465359|NCT00353873|62838850|FG000|Overall Study|Protocol Violation|1|||
33465360|NCT00353873|62838851|FG001|Overall Study|Protocol Violation|2|||
33465361|NCT00353873|62838850|FG000|Overall Study|Exacerbation|1|||
33465362|NCT00353873|62838851|FG001|Overall Study|Exacerbation|0|||
33465363|NCT00353873|62838850|FG000|Overall Study|Adverse Event|1|||
33465364|NCT00353873|62838851|FG001|Overall Study|Adverse Event|0|||
33465365|NCT00353873|62838850|FG000|Overall Study|Physician Decision|2|||
33465366|NCT00353873|62838851|FG001|Overall Study|Physician Decision|0|||
33465367|NCT00353873|62838850|FG000|Overall Study|Withdrawal by Subject|1|||
33465368|NCT00353873|62838851|FG001|Overall Study|Withdrawal by Subject|1|||
33465369|NCT03796676|62838860|FG000|Overall Study|Adverse Event|2|||
33465370|NCT03796676|62838861|FG001|Overall Study|Adverse Event|1|||
33465371|NCT03796676|62838862|FG002|Overall Study|Adverse Event|2|||
33465372|NCT03796676|62838860|FG000|Overall Study|Lost to Follow-up|2|||
33465373|NCT03796676|62838861|FG001|Overall Study|Lost to Follow-up|1|||
33465374|NCT03796676|62838862|FG002|Overall Study|Lost to Follow-up|0|||
33465375|NCT03796676|62838860|FG000|Overall Study|Protocol Violation|0|||
33465376|NCT03796676|62838861|FG001|Overall Study|Protocol Violation|0|||
33465377|NCT03796676|62838862|FG002|Overall Study|Protocol Violation|1|||
33465378|NCT03796676|62838860|FG000|Overall Study|Withdrawal by Subject|1|||
33465379|NCT03796676|62838861|FG001|Overall Study|Withdrawal by Subject|1|||
33465380|NCT03796676|62838862|FG002|Overall Study|Withdrawal by Subject|0|||
33465381|NCT03796676|62838860|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
33465382|NCT03796676|62838861|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
33328646|NCT00951015|62705081|FG002|Randomization Phase 96 Week|Adverse Event|2|||
33328647|NCT00951015|62705082|FG003|Randomization Phase 96 Week|Adverse Event|5|||
33328648|NCT00951015|62705083|FG004|Randomization Phase 96 Week|Adverse Event|0|||
33465383|NCT03796676|62838862|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
33465384|NCT03342898|62838876|FG000|Overall Study|Adverse Event|3|||
33651777|NCT01743001|63063178|FG000|Overall Study|Physician Decision|1|||
33651778|NCT01743001|63063179|FG001|Overall Study|Physician Decision|0|||
33651779|NCT01743001|63063178|FG000|Overall Study|Pregnancy|1|||
33651780|NCT01743001|63063179|FG001|Overall Study|Pregnancy|0|||
33651781|NCT01743001|63063178|FG000|Overall Study|Death|1|||
33651782|NCT01743001|63063179|FG001|Overall Study|Death|0|||
33651783|NCT01704079|63063198|FG000|Overall Study|Withdrawal by Subject|5|||
33651784|NCT01704079|63063199|FG001|Overall Study|Withdrawal by Subject|7|||
33651785|NCT01704079|63063198|FG000|Overall Study|Lost to Follow-up|2|||
33651786|NCT01704079|63063199|FG001|Overall Study|Lost to Follow-up|5|||
33328649|NCT00951015|62705079|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
33465385|NCT03342898|62838877|FG001|Overall Study|Adverse Event|1|||
33465386|NCT03342898|62838878|FG002|Overall Study|Adverse Event|0|||
33465387|NCT03342898|62838876|FG000|Overall Study|Lost to Follow-up|44|||
33465388|NCT03342898|62838877|FG001|Overall Study|Lost to Follow-up|40|||
33465389|NCT03342898|62838878|FG002|Overall Study|Lost to Follow-up|42|||
33465390|NCT03342898|62838876|FG000|Overall Study|Withdrawal of Consent|5|||
33465391|NCT03342898|62838877|FG001|Overall Study|Withdrawal of Consent|9|||
33465392|NCT03342898|62838878|FG002|Overall Study|Withdrawal of Consent|11|||
33465393|NCT03342898|62838876|FG000|Overall Study|Death|0|||
33465394|NCT03342898|62838877|FG001|Overall Study|Death|1|||
33465395|NCT03342898|62838878|FG002|Overall Study|Death|1|||
33465396|NCT03342898|62838876|FG000|Overall Study|Reason not Specified|2|||
33465397|NCT03342898|62838877|FG001|Overall Study|Reason not Specified|2|||
33465398|NCT03342898|62838878|FG002|Overall Study|Reason not Specified|0|||
33465399|NCT00339833|62838888|FG000|Overall Study|Withdrawal by Subject|1|||
33651787|NCT01704079|63063198|FG000|Overall Study|Adverse Event|4|||
33328650|NCT00951015|62705080|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
33328651|NCT00951015|62705081|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
33328652|NCT00951015|62705082|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
33328653|NCT00951015|62705083|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
33328654|NCT00951015|62705079|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
33328655|NCT00951015|62705080|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
33328656|NCT00951015|62705081|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
33328657|NCT00951015|62705082|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
33328658|NCT00951015|62705083|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
33328659|NCT00951015|62705079|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
33328660|NCT00951015|62705080|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
33328661|NCT00951015|62705081|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
33328662|NCT00951015|62705082|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
33328663|NCT00951015|62705083|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
33328664|NCT00951015|62705079|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
33328665|NCT00951015|62705080|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
33328666|NCT00951015|62705081|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
33328667|NCT00951015|62705082|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
33328668|NCT00951015|62705083|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
33328669|NCT00951015|62705079|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
33328670|NCT00951015|62705080|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
33328671|NCT00951015|62705081|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
33328672|NCT00951015|62705082|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
33328673|NCT00951015|62705083|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
33328674|NCT00951015|62705079|FG000|Open-label Phase|Adverse Event|0|||
33328675|NCT00951015|62705080|FG001|Open-label Phase|Adverse Event|0|||
33328676|NCT00951015|62705081|FG002|Open-label Phase|Adverse Event|0|||
33328677|NCT00951015|62705082|FG003|Open-label Phase|Adverse Event|0|||
33328678|NCT00951015|62705083|FG004|Open-label Phase|Adverse Event|3|||
33328679|NCT00951015|62705079|FG000|Open-label Phase|Lack of Efficacy|0|||
33328680|NCT00951015|62705080|FG001|Open-label Phase|Lack of Efficacy|0|||
33328681|NCT00951015|62705081|FG002|Open-label Phase|Lack of Efficacy|0|||
33328682|NCT00951015|62705082|FG003|Open-label Phase|Lack of Efficacy|0|||
33328683|NCT00951015|62705083|FG004|Open-label Phase|Lack of Efficacy|1|||
33328684|NCT00951015|62705079|FG000|Open-label Phase|Protocol Violation|0|||
33328685|NCT00951015|62705080|FG001|Open-label Phase|Protocol Violation|0|||
33328686|NCT00951015|62705081|FG002|Open-label Phase|Protocol Violation|0|||
33465400|NCT00339833|62838889|FG001|Overall Study|Withdrawal by Subject|2|||
33465401|NCT00339833|62838888|FG000|Overall Study|toothache|0|||
33465402|NCT00339833|62838889|FG001|Overall Study|toothache|1|||
33465403|NCT00339833|62838888|FG000|Overall Study|indigestion|0|||
33465404|NCT00339833|62838889|FG001|Overall Study|indigestion|1|||
33651788|NCT01704079|63063199|FG001|Overall Study|Adverse Event|7|||
33328687|NCT00951015|62705082|FG003|Open-label Phase|Protocol Violation|0|||
33328688|NCT00951015|62705083|FG004|Open-label Phase|Protocol Violation|12|||
33328689|NCT00951015|62705079|FG000|Open-label Phase|Lost to Follow-up|0|||
33328690|NCT00951015|62705080|FG001|Open-label Phase|Lost to Follow-up|0|||
33328691|NCT00951015|62705081|FG002|Open-label Phase|Lost to Follow-up|0|||
33465405|NCT00339833|62838888|FG000|Overall Study|Chest pain|0|||
33328692|NCT00951015|62705082|FG003|Open-label Phase|Lost to Follow-up|0|||
33328693|NCT00951015|62705083|FG004|Open-label Phase|Lost to Follow-up|12|||
33328694|NCT00951015|62705079|FG000|Open-label Phase|Withdrawal by Subject|0|||
33328695|NCT00951015|62705080|FG001|Open-label Phase|Withdrawal by Subject|0|||
33328696|NCT00951015|62705081|FG002|Open-label Phase|Withdrawal by Subject|0|||
33465406|NCT00339833|62838889|FG001|Overall Study|Chest pain|1|||
33545108|NCT02911285|62936364|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
33545109|NCT02910739|62936376|FG000|Overall Study|Adverse Event|1|||
33545110|NCT02910739|62936377|FG001|Overall Study|Adverse Event|0|||
33545111|NCT02910739|62936378|FG002|Overall Study|Adverse Event|0|||
33545112|NCT02910739|62936379|FG003|Overall Study|Adverse Event|0|||
33545113|NCT01069939|62936387|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
33545114|NCT01069939|62936388|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
33545115|NCT01069939|62936387|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
33545116|NCT01069939|62936388|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
33545117|NCT01069939|62936387|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
33545118|NCT01069939|62936388|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
33545119|NCT01069939|62936387|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
33545120|NCT01069939|62936388|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
33545121|NCT01069939|62936387|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
33545122|NCT01069939|62936388|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
33545123|NCT01069939|62936387|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
33545124|NCT01069939|62936388|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
33545125|NCT01069939|62936387|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
33545126|NCT01069939|62936388|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
33545127|NCT01069939|62936387|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
33545128|NCT01069939|62936388|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
33545129|NCT01069939|62936387|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
33545130|NCT01069939|62936388|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
33545131|NCT01069939|62936387|FG000|Randomised and Included in the Analyses|Removal|1|||
33545132|NCT01069939|62936388|FG001|Randomised and Included in the Analyses|Removal|0|||
33651789|NCT01704079|63063198|FG000|Overall Study|Protocol Violation|1|||
33651790|NCT01704079|63063199|FG001|Overall Study|Protocol Violation|0|||
33651791|NCT01704079|63063198|FG000|Overall Study|Subject noncompliance|2|||
33651792|NCT01704079|63063199|FG001|Overall Study|Subject noncompliance|3|||
33651793|NCT01704079|63063198|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
33651794|NCT01704079|63063199|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
33651795|NCT01703845|63063207|FG000|Overall Study|Adverse Event|1|||
33651796|NCT01703845|63063208|FG001|Overall Study|Adverse Event|0|||
33651797|NCT01703845|63063207|FG000|Overall Study|Protocol Violation|1|||
33545133|NCT01069705|62936394|FG000|Overall Study|Adverse Event|1|||
33545134|NCT01069705|62936394|FG000|Overall Study|Withdrawal by Subject|2|||
33545135|NCT01069627|62936398|FG000|Overall Study|Disease progression|7|||
33545136|NCT01069627|62936398|FG000|Overall Study|Adverse Event|12|||
33545137|NCT01069627|62936398|FG000|Overall Study|Protocol Violation|1|||
33545138|NCT02422797|62936404|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
33545139|NCT02422797|62936405|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
33545140|NCT02422797|62936404|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
33545141|NCT02422797|62936405|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
33651798|NCT01703845|63063208|FG001|Overall Study|Protocol Violation|0|||
33651799|NCT01703845|63063207|FG000|Overall Study|other than stated above|1|||
33651800|NCT01703845|63063208|FG001|Overall Study|other than stated above|0|||
33651801|NCT01724359|63063216|FG000|Overall Study|Adverse Event|10|||
33465407|NCT00339833|62838888|FG000|Overall Study|minor infection|0|||
33465408|NCT00339833|62838889|FG001|Overall Study|minor infection|1|||
33465409|NCT00339833|62838888|FG000|Overall Study|Poor venous access|2|||
33465410|NCT00339833|62838889|FG001|Overall Study|Poor venous access|2|||
33465411|NCT00339833|62838888|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
33465412|NCT00339833|62838889|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
33465413|NCT00339833|62838888|FG000|Overall Study|Error in data records|1|||
33465414|NCT00339833|62838889|FG001|Overall Study|Error in data records|0|||
33465415|NCT03793556|62838897|FG000|Overall Study|Withdrawal by Subject|12|||
33465416|NCT03793556|62838898|FG001|Overall Study|Withdrawal by Subject|1|||
33545142|NCT02422797|62936404|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
33651802|NCT01724359|63063216|FG000|Overall Study|Death|1|||
33328697|NCT00951015|62705082|FG003|Open-label Phase|Withdrawal by Subject|0|||
33465417|NCT03793556|62838897|FG000|Overall Study|Lost to Follow-up|1|||
33545143|NCT02422797|62936405|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
33545144|NCT02422797|62936404|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
33651803|NCT01724359|63063216|FG000|Overall Study|Other|20|||
33328698|NCT00951015|62705083|FG004|Open-label Phase|Withdrawal by Subject|14|||
33545145|NCT02422797|62936405|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
33545146|NCT02422797|62936404|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
33545147|NCT02422797|62936405|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
33545148|NCT02422797|62936404|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
33545149|NCT02422797|62936405|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
33545150|NCT02422797|62936404|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
33545151|NCT02422797|62936405|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
33545152|NCT02422797|62936404|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
33545153|NCT02422797|62936405|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
33545154|NCT02422797|62936404|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
33545155|NCT02422797|62936405|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
33545156|NCT02422797|62936404|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
33545157|NCT02422797|62936405|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
33545158|NCT02422797|62936404|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
33545159|NCT02422797|62936405|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
33545160|NCT02422797|62936404|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
33545161|NCT02422797|62936405|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
33545162|NCT02422797|62936404|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
33651804|NCT01703221|63063225|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
33328699|NCT00951015|62705079|FG000|Open-label Phase|Physician Decision|0|||
33465418|NCT03793556|62838898|FG001|Overall Study|Lost to Follow-up|1|||
33465419|NCT03392194|62838909|FG000|Overall Study|Withdrawal by Subject|1|||
33465420|NCT03392194|62838910|FG001|Overall Study|Withdrawal by Subject|2|||
33465421|NCT03392194|62838909|FG000|Overall Study|Conflicts with personal schedule|1|||
33465422|NCT03392194|62838910|FG001|Overall Study|Conflicts with personal schedule|0|||
33465423|NCT03828617|62838920|FG000|Overall Study|Lost to Follow-up|22|||
33465424|NCT03828617|62838921|FG001|Overall Study|Lost to Follow-up|12|||
33465425|NCT03828617|62838922|FG002|Overall Study|Lost to Follow-up|23|||
33465426|NCT03828617|62838923|FG003|Overall Study|Lost to Follow-up|7|||
33465427|NCT03828617|62838920|FG000|Overall Study|No longer met eligibility criteria|0|||
33465428|NCT03828617|62838921|FG001|Overall Study|No longer met eligibility criteria|1|||
33465429|NCT03828617|62838922|FG002|Overall Study|No longer met eligibility criteria|1|||
33465430|NCT03828617|62838923|FG003|Overall Study|No longer met eligibility criteria|3|||
33465431|NCT03828617|62838920|FG000|Overall Study|Protocol Violation|0|||
33465432|NCT03828617|62838921|FG001|Overall Study|Protocol Violation|2|||
33465433|NCT03828617|62838922|FG002|Overall Study|Protocol Violation|0|||
33465434|NCT03828617|62838923|FG003|Overall Study|Protocol Violation|0|||
33465435|NCT03828617|62838920|FG000|Overall Study|Withdrawal by Subject|2|||
33465436|NCT03828617|62838921|FG001|Overall Study|Withdrawal by Subject|0|||
33465437|NCT03828617|62838922|FG002|Overall Study|Withdrawal by Subject|2|||
33465438|NCT03828617|62838923|FG003|Overall Study|Withdrawal by Subject|0|||
33465439|NCT03391960|62838932|FG000|Overall Study|Protocol Violation|0|||
33465440|NCT03391960|62838933|FG001|Overall Study|Protocol Violation||||
33465441|NCT03390166|62838959|FG000|Overall Study|Death|0|||
33465442|NCT03390166|62838960|FG001|Overall Study|Death|1|||
33465443|NCT03390166|62838959|FG000|Overall Study|Lost to Follow-up|6|||
33465444|NCT03390166|62838960|FG001|Overall Study|Lost to Follow-up|4|||
33465445|NCT03390166|62838959|FG000|Overall Study|Physician Decision|2|||
33465446|NCT03390166|62838960|FG001|Overall Study|Physician Decision|1|||
33465447|NCT03390166|62838959|FG000|Overall Study|Move from study area|3|||
33465448|NCT03390166|62838960|FG001|Overall Study|Move from study area|2|||
33465449|NCT03390166|62838959|FG000|Overall Study|To militarycamp for conscript|1|||
33465450|NCT03390166|62838960|FG001|Overall Study|To militarycamp for conscript|0|||
33545163|NCT02422797|62936405|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
33545164|NCT02422797|62936404|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
33545165|NCT02422797|62936405|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
33328700|NCT00951015|62705080|FG001|Open-label Phase|Physician Decision|0|||
33328701|NCT00951015|62705081|FG002|Open-label Phase|Physician Decision|0|||
33328702|NCT00951015|62705082|FG003|Open-label Phase|Physician Decision|0|||
33328703|NCT00951015|62705083|FG004|Open-label Phase|Physician Decision|8|||
33328704|NCT01139021|62705112|FG000|Overall Study|Adverse Event|0|||
33328705|NCT01139021|62705113|FG001|Overall Study|Adverse Event|0|||
33328706|NCT01139021|62705114|FG002|Overall Study|Adverse Event|0|||
33328707|NCT01139021|62705115|FG003|Overall Study|Adverse Event|0|||
33465451|NCT03390166|62838959|FG000|Overall Study|To drug therapy course|0|||
33465452|NCT03390166|62838960|FG001|Overall Study|To drug therapy course|1|||
33465453|NCT03390166|62838959|FG000|Overall Study|Move to work oversea|0|||
33465454|NCT03390166|62838960|FG001|Overall Study|Move to work oversea|1|||
33465455|NCT03828539|62838968|FG000|Overall Study|Adverse Event|3|||
33465456|NCT03828539|62838969|FG001|Overall Study|Adverse Event|12|||
33465457|NCT03828539|62838968|FG000|Overall Study|Patient's/guardian's decision|3|||
33328708|NCT01139021|62705116|FG004|Overall Study|Adverse Event|1|||
33651805|NCT01703221|63063226|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
33651806|NCT01703221|63063227|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
33651807|NCT01703221|63063225|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
33651808|NCT01703221|63063226|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
33651809|NCT01703221|63063227|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
33651810|NCT01703221|63063225|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
33651811|NCT01703221|63063226|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33651812|NCT01703221|63063227|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33651813|NCT01703221|63063225|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
33651814|NCT01703221|63063226|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
33651815|NCT01703221|63063227|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
33651816|NCT01703221|63063225|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33651817|NCT01703221|63063226|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33651818|NCT01703221|63063227|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
33651819|NCT01703221|63063225|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
33651820|NCT01703221|63063226|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
33651821|NCT01703221|63063227|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
33651822|NCT01703221|63063225|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
33651823|NCT01703221|63063226|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
33651824|NCT01703221|63063227|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
33651825|NCT01703221|63063225|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
33651826|NCT01703221|63063226|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
33651827|NCT01703221|63063227|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
33651828|NCT01722877|63063241|FG000|Overall Study|Death|1|||
33651829|NCT01722877|63063241|FG000|Overall Study|Lost to Follow-up|1|||
33651830|NCT01703065|63063286|FG000|Overall Study|Lack of Efficacy|1|||
33651831|NCT01703065|63063287|FG001|Overall Study|Lack of Efficacy|0|||
33651832|NCT01702987|63063300|FG000|Overall Study|Withdrawal by Subject|1|||
33651833|NCT01702987|63063301|FG001|Overall Study|Withdrawal by Subject|0|||
33651834|NCT01702519|63063322|FG000|Washout Period|Lost to Follow-up|1|||
33651835|NCT01702519|63063323|FG001|Washout Period|Lost to Follow-up|0|||
33651836|NCT01702519|63063322|FG000|Washout Period|Withdrawal by Subject|0|||
33651837|NCT01702519|63063323|FG001|Washout Period|Withdrawal by Subject|2|||
33651838|NCT01739803|63063335|FG000|Overall Study|Lost to Follow-up|9|||
33651839|NCT01739803|63063336|FG001|Overall Study|Lost to Follow-up|6|||
33651840|NCT01739335|63063348|FG000|Overall Study|Lost to Follow-up|7|||
33651841|NCT01739335|63063349|FG001|Overall Study|Lost to Follow-up|4|||
33651842|NCT01739335|63063348|FG000|Overall Study|Ineligible patient randomized|0|||
33651843|NCT01739335|63063349|FG001|Overall Study|Ineligible patient randomized|1|||
33651844|NCT01702363|63063374|FG000|Overall Study|Adverse Event|14|||
33651845|NCT01702363|63063374|FG000|Overall Study|Lack of Efficacy|4|||
33651846|NCT01702363|63063374|FG000|Overall Study|Withdrawal by Subject|2|||
33651847|NCT01722097|63063381|FG000|Overall Study|Patient sheets not returned|6|||
33651848|NCT01722097|63063382|FG001|Overall Study|Patient sheets not returned|5|||
33651849|NCT01701973|63063397|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
33651850|NCT01701973|63063398|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
33651851|NCT01701973|63063399|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
33651852|NCT01701973|63063400|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
33651853|NCT01701973|63063401|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
33651854|NCT01701973|63063402|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
33651855|NCT01701973|63063403|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
33651856|NCT01701973|63063404|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
33545166|NCT03021551|62936421|FG000|Overall Study|Equipment Issues|2|||
33545167|NCT03021551|62936421|FG000|Overall Study|Protocol Violation|1|||
33545168|NCT01585025|62936428|FG000|Overall Study|Withdrawal by Subject|0|||
33545169|NCT01585025|62936429|FG001|Overall Study|Withdrawal by Subject|3|||
33545170|NCT01585025|62936430|FG002|Overall Study|Withdrawal by Subject|4|||
33545171|NCT01068769|62936438|FG000|Overall Study|Ineligible|1|||
33545172|NCT05114564|62936457|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
33651857|NCT01721317|63063455|FG000|Overall Study|Study Closed / Terminated|2|||
33651858|NCT01721317|63063456|FG001|Overall Study|Study Closed / Terminated|2|||
33651859|NCT01721317|63063455|FG000|Overall Study|Physician Decision|0|||
33545173|NCT05114564|62936458|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
33651860|NCT01721317|63063456|FG001|Overall Study|Physician Decision|1|||
33651861|NCT01721317|63063455|FG000|Overall Study|Withdrawal by Subject|0|||
33651862|NCT01721317|63063456|FG001|Overall Study|Withdrawal by Subject|1|||
33651863|NCT01701193|63063466|FG000|Overall Study|Withdrawal by Subject|2|||
33651864|NCT01701193|63063467|FG001|Overall Study|Withdrawal by Subject|2|||
33651865|NCT01701193|63063468|FG002|Overall Study|Withdrawal by Subject|1|||
33651866|NCT01701193|63063469|FG003|Overall Study|Withdrawal by Subject|2|||
33651867|NCT01701193|63063466|FG000|Overall Study|Adverse Event|1|||
33651868|NCT01701193|63063467|FG001|Overall Study|Adverse Event|0|||
33651869|NCT01701193|63063468|FG002|Overall Study|Adverse Event|0|||
33651870|NCT01701193|63063469|FG003|Overall Study|Adverse Event|0|||
33651871|NCT01959347|63063517|FG000|Overall Study|Protocol Violation|9|||
33651872|NCT01959347|63063518|FG001|Overall Study|Protocol Violation|7|||
33545174|NCT05114564|62936457|FG000|First Intervention|Adverse Event|0|||
33545175|NCT05114564|62936458|FG001|First Intervention|Adverse Event|1|||
33545176|NCT04706416|62936466|FG000|Overall Study|Lost to Follow-up|2|||
33545177|NCT04706416|62936467|FG001|Overall Study|Lost to Follow-up|0|||
33545178|NCT04683926|62936480|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
33545179|NCT04683926|62936481|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
33545180|NCT04683926|62936482|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
33545181|NCT04683926|62936483|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
33545182|NCT04343755|62936495|FG000|Overall Study|Death|11|||
33545183|NCT04343755|62936495|FG000|Overall Study|Screen Failure|1|||
33545184|NCT04285346|62936499|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
33545185|NCT04285346|62936500|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
33545186|NCT04285346|62936499|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
33545187|NCT04285346|62936500|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33545188|NCT04285346|62936499|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
33545189|NCT04285346|62936500|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
33545190|NCT04148287|62936515|FG000|Overall Study|Death|2|||
33545191|NCT03772613|62936543|FG000|Overall Study|Lost to Follow-up|0|||
33545192|NCT03772613|62936544|FG001|Overall Study|Lost to Follow-up|1|||
33545193|NCT03772613|62936545|FG002|Overall Study|Lost to Follow-up|1|||
33545194|NCT03739437|62936555|FG000|Overall Study|Lost to Follow-up|2|||
33545195|NCT03739437|62936556|FG001|Overall Study|Lost to Follow-up|5|||
33545196|NCT03730194|62936564|FG000|First Stage Treatment|Withdrawal by Subject|1|||
33465458|NCT03828539|62838969|FG001|Overall Study|Patient's/guardian's decision|5|||
33465459|NCT03828539|62838968|FG000|Overall Study|Lost to Follow-up|4|||
33465460|NCT03828539|62838969|FG001|Overall Study|Lost to Follow-up|2|||
33465461|NCT03828539|62838968|FG000|Overall Study|Protocol Violation|3|||
33465462|NCT03828539|62838969|FG001|Overall Study|Protocol Violation|2|||
33465463|NCT03828539|62838968|FG000|Overall Study|Withdrawal of informed consent|2|||
33465464|NCT03828539|62838969|FG001|Overall Study|Withdrawal of informed consent|1|||
33465465|NCT03828539|62838968|FG000|Overall Study|New therapy for study indication|1|||
33465466|NCT03828539|62838969|FG001|Overall Study|New therapy for study indication|0|||
33465467|NCT03336502|62838977|FG000|Overall Study|Physician Decision|0|||
33465468|NCT03336502|62838978|FG001|Overall Study|Physician Decision|1|||
33465469|NCT03336502|62838977|FG000|Overall Study|Prohibited Drugs|1|||
33465470|NCT03336502|62838978|FG001|Overall Study|Prohibited Drugs|1|||
33465471|NCT03336502|62838977|FG000|Overall Study|Death|1|||
33465472|NCT03336502|62838978|FG001|Overall Study|Death|2|||
33465473|NCT03336502|62838977|FG000|Overall Study|Adverse Event|2|||
33465474|NCT03336502|62838978|FG001|Overall Study|Adverse Event|5|||
33465475|NCT00338741|62838986|FG000|Overall Study|Lost to Follow-up|2|||
33465476|NCT00338741|62838987|FG001|Overall Study|Lost to Follow-up|0|||
33465477|NCT03370510|62838995|FG000|Overall Study|COVID-19|2|||
33465478|NCT03370510|62838996|FG001|Overall Study|COVID-19|0|||
33465479|NCT00351611|62839004|FG000|Overall Study|Adverse Event|11|||
33465480|NCT00351611|62839005|FG001|Overall Study|Adverse Event|3|||
33465481|NCT00351611|62839004|FG000|Overall Study|Death|1|||
33465482|NCT00351611|62839005|FG001|Overall Study|Death|0|||
33465483|NCT00351611|62839004|FG000|Overall Study|Lost to Follow-up|1|||
33465484|NCT00351611|62839005|FG001|Overall Study|Lost to Follow-up|0|||
33465485|NCT00351611|62839004|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
33465486|NCT00351611|62839005|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
33465487|NCT00351611|62839004|FG000|Overall Study|Other|1|||
33465488|NCT00351611|62839005|FG001|Overall Study|Other|0|||
33465489|NCT00351611|62839004|FG000|Overall Study|Protocol Violation|0|||
33545197|NCT03730194|62936565|FG001|First Stage Treatment|Withdrawal by Subject|1|||
33545198|NCT03730194|62936566|FG002|First Stage Treatment|Withdrawal by Subject|0|||
33545199|NCT03730194|62936567|FG003|First Stage Treatment|Withdrawal by Subject|0|||
33545200|NCT03730194|62936568|FG004|First Stage Treatment|Withdrawal by Subject|0|||
33545201|NCT03730194|62936569|FG005|First Stage Treatment|Withdrawal by Subject|0|||
33465490|NCT00351611|62839005|FG001|Overall Study|Protocol Violation|2|||
33465491|NCT00351533|62839013|FG000|Overall Study|Extubated before first BAL|1|||
33465492|NCT00351533|62839014|FG001|Overall Study|Extubated before first BAL|0|||
33465493|NCT00351533|62839013|FG000|Overall Study|Lost to Follow-up|1|||
33465494|NCT00351533|62839014|FG001|Overall Study|Lost to Follow-up|3|||
33465495|NCT00351533|62839013|FG000|Overall Study|Physician Decision|0|||
33465496|NCT00351533|62839014|FG001|Overall Study|Physician Decision|1|||
33545202|NCT03730194|62936564|FG000|First Stage Treatment|Protocol Violation|3|||
33545203|NCT03730194|62936565|FG001|First Stage Treatment|Protocol Violation|3|||
33545204|NCT03730194|62936566|FG002|First Stage Treatment|Protocol Violation|0|||
33545205|NCT03730194|62936567|FG003|First Stage Treatment|Protocol Violation|0|||
33651873|NCT01959035|63063544|FG000|Overall Study|Adverse Event|5|||
33651874|NCT01959035|63063544|FG000|Overall Study|Withdrawal by Subject|4|||
33465497|NCT00351533|62839013|FG000|Overall Study|Withdrawal by Subject|0|||
33465498|NCT00351533|62839014|FG001|Overall Study|Withdrawal by Subject|1|||
33465499|NCT00351377|62839020|FG000|Overall Study|Adverse Event|5|||
33465500|NCT00351377|62839020|FG000|Overall Study|Death|1|||
33465501|NCT00351377|62839020|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33465502|NCT00337727|62839026|FG000|Overall Study|Adverse Event|5|||
33465503|NCT00337727|62839027|FG001|Overall Study|Adverse Event|3|||
33465504|NCT00337727|62839026|FG000|Overall Study|Lost to Follow-up|5|||
33545206|NCT03730194|62936568|FG004|First Stage Treatment|Protocol Violation|0|||
33545207|NCT03730194|62936569|FG005|First Stage Treatment|Protocol Violation|0|||
33545208|NCT03701555|62936612|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
33545209|NCT03701555|62936613|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
33545210|NCT03701555|62936614|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
33545211|NCT03701555|62936615|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
33545212|NCT03701555|62936616|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
33545213|NCT03701555|62936617|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
33545214|NCT03701555|62936618|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
33545215|NCT03701555|62936619|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
33545216|NCT03701555|62936620|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
33545217|NCT03701555|62936621|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
33545218|NCT03701555|62936622|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
33545219|NCT03701555|62936623|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
33328709|NCT01139021|62705117|FG005|Overall Study|Adverse Event|0|||
33328710|NCT01139021|62705112|FG000|Overall Study|Lost to Follow-up|0|||
33328711|NCT01139021|62705113|FG001|Overall Study|Lost to Follow-up|0|||
33328712|NCT01139021|62705114|FG002|Overall Study|Lost to Follow-up|0|||
33328713|NCT01139021|62705115|FG003|Overall Study|Lost to Follow-up|0|||
33328714|NCT01139021|62705116|FG004|Overall Study|Lost to Follow-up|2|||
33328715|NCT01139021|62705117|FG005|Overall Study|Lost to Follow-up|0|||
33328716|NCT01139021|62705112|FG000|Overall Study|Protocol Violation|1|||
33328717|NCT01139021|62705113|FG001|Overall Study|Protocol Violation|0|||
33328718|NCT01139021|62705114|FG002|Overall Study|Protocol Violation|0|||
33328719|NCT01139021|62705115|FG003|Overall Study|Protocol Violation|0|||
33328720|NCT01139021|62705116|FG004|Overall Study|Protocol Violation|2|||
33545220|NCT03701555|62936624|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
33545221|NCT03701555|62936625|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
33545222|NCT03701555|62936626|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
33545223|NCT03701555|62936627|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
33545224|NCT03701555|62936628|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
33545225|NCT03701555|62936629|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
33545226|NCT03701555|62936630|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
33545227|NCT03701555|62936631|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
33545228|NCT03701555|62936632|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
33545229|NCT03701555|62936633|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
33545230|NCT03701555|62936634|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
33545231|NCT03701555|62936635|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
33545232|NCT03701555|62936636|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
33545233|NCT03701555|62936637|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
33545234|NCT03701555|62936638|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
33328721|NCT01139021|62705117|FG005|Overall Study|Protocol Violation|0|||
33328722|NCT01139021|62705112|FG000|Overall Study|Withdrawal by Subject|0|||
33328723|NCT01139021|62705113|FG001|Overall Study|Withdrawal by Subject|0|||
33328724|NCT01139021|62705114|FG002|Overall Study|Withdrawal by Subject|0|||
33328725|NCT01139021|62705115|FG003|Overall Study|Withdrawal by Subject|1|||
33328726|NCT01139021|62705116|FG004|Overall Study|Withdrawal by Subject|4|||
33328727|NCT01139021|62705117|FG005|Overall Study|Withdrawal by Subject|0|||
33545235|NCT03701555|62936639|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
33545236|NCT03701555|62936640|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
33545237|NCT03701555|62936641|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
33545238|NCT03701555|62936642|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
33545239|NCT03701555|62936643|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
33328728|NCT01193660|62705135|FG000|Overall Study|Withdrawal by Subject|2|||
33328729|NCT01193660|62705136|FG001|Overall Study|Withdrawal by Subject|3|||
33328730|NCT01193660|62705137|FG002|Overall Study|Withdrawal by Subject|1|||
33328731|NCT01193660|62705135|FG000|Overall Study|Death|1|||
33328732|NCT01193660|62705136|FG001|Overall Study|Death|0|||
33328733|NCT01193660|62705137|FG002|Overall Study|Death|0|||
33465505|NCT00337727|62839027|FG001|Overall Study|Lost to Follow-up|4|||
33465506|NCT00337727|62839026|FG000|Overall Study|Physician Decision|1|||
33465507|NCT00337727|62839027|FG001|Overall Study|Physician Decision|0|||
33328734|NCT01193660|62705135|FG000|Overall Study|Physician Decision|1|||
33465508|NCT00337727|62839026|FG000|Overall Study|Protocol Violation|4|||
33545240|NCT03701555|62936644|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
33545241|NCT03701555|62936645|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
33545242|NCT03701555|62936646|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
33545243|NCT03701555|62936647|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
33545244|NCT03701555|62936612|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
33651875|NCT01959035|63063544|FG000|Overall Study|Lost to Follow-up|1|||
33651876|NCT01959035|63063544|FG000|Overall Study|Other (no primary reason given)|1|||
33651877|NCT01700959|63063554|FG000|Overall Study|Adverse Event|0|||
33651878|NCT01700959|63063555|FG001|Overall Study|Adverse Event|1|||
33651879|NCT01700959|63063556|FG002|Overall Study|Adverse Event|1|||
33651880|NCT01700959|63063557|FG003|Overall Study|Adverse Event|2|||
33651881|NCT01700959|63063558|FG004|Overall Study|Adverse Event|0|||
33651882|NCT01700959|63063559|FG005|Overall Study|Adverse Event|2|||
33651883|NCT01700959|63063554|FG000|Overall Study|Withdrawal by Subject|15|||
33651884|NCT01700959|63063555|FG001|Overall Study|Withdrawal by Subject|9|||
33651885|NCT01700959|63063556|FG002|Overall Study|Withdrawal by Subject|12|||
33651886|NCT01700959|63063557|FG003|Overall Study|Withdrawal by Subject|11|||
33651887|NCT01700959|63063558|FG004|Overall Study|Withdrawal by Subject|8|||
33651888|NCT01700959|63063559|FG005|Overall Study|Withdrawal by Subject|12|||
33651889|NCT01700959|63063554|FG000|Overall Study|Ineligible|2|||
33651890|NCT01700959|63063555|FG001|Overall Study|Ineligible|1|||
33651891|NCT01700959|63063556|FG002|Overall Study|Ineligible|2|||
33651892|NCT01700959|63063557|FG003|Overall Study|Ineligible|0|||
33651893|NCT01700959|63063558|FG004|Overall Study|Ineligible|0|||
33651894|NCT01700959|63063559|FG005|Overall Study|Ineligible|1|||
33651895|NCT01700959|63063554|FG000|Overall Study|Noncompliant|9|||
33651896|NCT01700959|63063555|FG001|Overall Study|Noncompliant|9|||
33651897|NCT01700959|63063556|FG002|Overall Study|Noncompliant|17|||
33651898|NCT01700959|63063557|FG003|Overall Study|Noncompliant|18|||
33651899|NCT01700959|63063558|FG004|Overall Study|Noncompliant|15|||
33651900|NCT01700959|63063559|FG005|Overall Study|Noncompliant|9|||
33651901|NCT01700959|63063554|FG000|Overall Study|Side effects|1|||
33651902|NCT01700959|63063555|FG001|Overall Study|Side effects|4|||
33651903|NCT01700959|63063556|FG002|Overall Study|Side effects|8|||
33651904|NCT01700959|63063557|FG003|Overall Study|Side effects|4|||
33651905|NCT01700959|63063558|FG004|Overall Study|Side effects|4|||
33651906|NCT01700959|63063559|FG005|Overall Study|Side effects|1|||
33651907|NCT01738477|63063581|FG000|Overall Study|Lost to Follow-up|1|||
33651908|NCT01738477|63063582|FG001|Overall Study|Lost to Follow-up|4|||
33651909|NCT01737931|63063598|FG000|Overall Study|Withdrawal by Subject|0|||
33651910|NCT01737931|63063599|FG001|Overall Study|Withdrawal by Subject|1|||
33651911|NCT01737931|63063600|FG002|Overall Study|Withdrawal by Subject|1|||
33651912|NCT01737931|63063598|FG000|Overall Study|Physician Decision|0|||
33651913|NCT01737931|63063599|FG001|Overall Study|Physician Decision|1|||
33651914|NCT01737931|63063600|FG002|Overall Study|Physician Decision|0|||
33545245|NCT03701555|62936613|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
33545246|NCT03701555|62936614|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
33545247|NCT03701555|62936615|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
33545248|NCT03701555|62936616|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
33545249|NCT03701555|62936617|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
33545250|NCT03701555|62936618|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
33545251|NCT03701555|62936619|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
33545252|NCT03701555|62936620|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
33545253|NCT03701555|62936621|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
33545254|NCT03701555|62936622|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
33545255|NCT03701555|62936623|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
33545256|NCT03701555|62936624|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
33545257|NCT03701555|62936625|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
33545258|NCT03701555|62936626|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
33545259|NCT03701555|62936627|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
33545260|NCT03701555|62936628|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
33545261|NCT03701555|62936629|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
33545262|NCT03701555|62936630|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
33545263|NCT03701555|62936631|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
33545264|NCT03701555|62936632|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
33545265|NCT03701555|62936633|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
33545266|NCT03701555|62936634|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
33651915|NCT01958489|63063606|FG000|Period 2|Adverse Event|0|||
33651916|NCT01958489|63063607|FG001|Period 2|Adverse Event|1|||
33651917|NCT01721161|63063620|FG000|Overall Study|Adverse Event|2|||
33651918|NCT01721161|63063621|FG001|Overall Study|Adverse Event|3|||
33651919|NCT01721161|63063620|FG000|Overall Study|Lost to Follow-up|1|||
33651920|NCT01721161|63063621|FG001|Overall Study|Lost to Follow-up|2|||
33651921|NCT01721161|63063620|FG000|Overall Study|Withdrawal by Subject|1|||
33545267|NCT03701555|62936635|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
33545268|NCT03701555|62936636|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
33545269|NCT03701555|62936637|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
33545270|NCT03701555|62936638|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
33651922|NCT01721161|63063621|FG001|Overall Study|Withdrawal by Subject|1|||
33651923|NCT01721161|63063620|FG000|Overall Study|Other|0|||
33651924|NCT01721161|63063621|FG001|Overall Study|Other|1|||
33651925|NCT01699867|63063628|FG000|Overall Study|Screening Failure|3|||
33651926|NCT01699789|63063647|FG000|Overall Study|Withdrawal by Subject|18|||
33651927|NCT01699789|63063648|FG001|Overall Study|Withdrawal by Subject|23|||
33651928|NCT01699789|63063647|FG000|Overall Study|Death|1|||
33651929|NCT01699789|63063648|FG001|Overall Study|Death|2|||
33651930|NCT01699789|63063647|FG000|Overall Study|Lost to Follow-up|83|||
33651931|NCT01699789|63063648|FG001|Overall Study|Lost to Follow-up|101|||
33651932|NCT01944839|63063671|FG000|Overall Study|Physician Decision|2|||
33651933|NCT01944839|63063672|FG001|Overall Study|Physician Decision|2|||
33651934|NCT01944839|63063671|FG000|Overall Study|Protocol Violation|0|||
33651935|NCT01944839|63063672|FG001|Overall Study|Protocol Violation|1|||
33651936|NCT01944839|63063671|FG000|Overall Study|Adverse Event|10|||
33651937|NCT01944839|63063672|FG001|Overall Study|Adverse Event|5|||
33651938|NCT01944839|63063671|FG000|Overall Study|Withdrawal by Subject|9|||
33651939|NCT01944839|63063672|FG001|Overall Study|Withdrawal by Subject|17|||
33651940|NCT01944839|63063671|FG000|Overall Study|Lost to Follow-up|1|||
33651941|NCT01944839|63063672|FG001|Overall Study|Lost to Follow-up|0|||
33651942|NCT01944839|63063671|FG000|Overall Study|Subject non-compliance|0|||
33651943|NCT01944839|63063672|FG001|Overall Study|Subject non-compliance|3|||
33328735|NCT01193660|62705136|FG001|Overall Study|Physician Decision|0|||
33328736|NCT01193660|62705137|FG002|Overall Study|Physician Decision|1|||
33545271|NCT03701555|62936639|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
33651944|NCT01944059|63063687|FG000|Overall Study|Lost to Follow-up|1|||
33651945|NCT01944059|63063687|FG000|Overall Study|Physician Decision|3|||
33651946|NCT01944059|63063687|FG000|Overall Study|Withdrawal by Subject|1|||
33651947|NCT01944059|63063687|FG000|Overall Study|Adverse Event|2|||
33651948|NCT01720225|63063694|FG000|Overall Study|Withdrawal by Subject|0|||
33651949|NCT01720225|63063695|FG001|Overall Study|Withdrawal by Subject|1|||
33651950|NCT01720225|63063694|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
33651951|NCT01720225|63063695|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
33651952|NCT01943591|63063703|FG000|Overall Study|Lost to Follow-up|3|||
33651953|NCT01943591|63063704|FG001|Overall Study|Lost to Follow-up|4|||
33651954|NCT01943591|63063703|FG000|Overall Study|Death|2|||
33651955|NCT01943591|63063704|FG001|Overall Study|Death|7|||
33651956|NCT01699087|63063710|FG000|Overall Study|Lost to Follow-up|7|||
33545272|NCT03701555|62936640|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
33545273|NCT03701555|62936641|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
33545274|NCT03701555|62936642|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
33545275|NCT03701555|62936643|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
33545276|NCT03701555|62936644|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
33545277|NCT03701555|62936645|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
33545278|NCT03701555|62936646|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
33545279|NCT03701555|62936647|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
33545280|NCT03701555|62936612|FG000|Part 2 (Day 1)|Other|0|||
33545281|NCT03701555|62936613|FG001|Part 2 (Day 1)|Other|0|||
33545282|NCT03701555|62936614|FG002|Part 2 (Day 1)|Other|0|||
33545283|NCT03701555|62936615|FG003|Part 2 (Day 1)|Other|0|||
33651957|NCT01699087|63063710|FG000|Overall Study|Screen failure (prior to treatment)|15|||
33651958|NCT01699087|63063710|FG000|Overall Study|Unable to make future visits|2|||
33651959|NCT01943435|63063718|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
33651960|NCT01943435|63063719|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
33651961|NCT01943435|63063720|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
33651962|NCT01943435|63063718|FG000|Intervention Period|Withdrawal by Subject|3|||
33651963|NCT01943435|63063719|FG001|Intervention Period|Withdrawal by Subject|3|||
33651964|NCT01943435|63063720|FG002|Intervention Period|Withdrawal by Subject|4|||
33651965|NCT01943435|63063718|FG000|2 Month Follow up|Lost to Follow-up|2|||
33651966|NCT01943435|63063719|FG001|2 Month Follow up|Lost to Follow-up|3|||
33651967|NCT01943435|63063720|FG002|2 Month Follow up|Lost to Follow-up|0|||
33651968|NCT01943435|63063718|FG000|6 Month Follow up|Lost to Follow-up|12|||
33651969|NCT01943435|63063719|FG001|6 Month Follow up|Lost to Follow-up|7|||
33545284|NCT03701555|62936616|FG004|Part 2 (Day 1)|Other|0|||
33651970|NCT01943435|63063720|FG002|6 Month Follow up|Lost to Follow-up|15|||
33651971|NCT01942733|63063738|FG000|Overall Study|Lost to Follow-up|1|||
33545285|NCT03701555|62936617|FG005|Part 2 (Day 1)|Other|0|||
33545286|NCT03701555|62936618|FG006|Part 2 (Day 1)|Other|0|||
33651972|NCT01942733|63063738|FG000|Overall Study|Non-compliance with IMP|1|||
33651973|NCT01942733|63063738|FG000|Overall Study|Administrative|1|||
33651974|NCT01957865|63063754|FG000|Overall Study|Found HIV negative|0|||
33545287|NCT03701555|62936619|FG007|Part 2 (Day 1)|Other|0|||
33545288|NCT03701555|62936620|FG008|Part 2 (Day 1)|Other|0|||
33651975|NCT01957865|63063755|FG001|Overall Study|Found HIV negative|0|||
33651976|NCT01957865|63063756|FG002|Overall Study|Found HIV negative|1|||
33651977|NCT01957865|63063754|FG000|Overall Study|Lost to Follow-up|0|||
33651978|NCT01957865|63063755|FG001|Overall Study|Lost to Follow-up|2|||
33651979|NCT01957865|63063756|FG002|Overall Study|Lost to Follow-up|2|||
33465509|NCT00337727|62839027|FG001|Overall Study|Protocol Violation|0|||
33465510|NCT00337727|62839026|FG000|Overall Study|Withdrawal by Subject|3|||
33465511|NCT00337727|62839027|FG001|Overall Study|Withdrawal by Subject|5|||
33465512|NCT00324233|62839035|FG000|First Period|unable to insert catheter|1|||
33465513|NCT00324233|62839036|FG001|First Period|unable to insert catheter|0|||
33465514|NCT00324233|62839035|FG000|Second Period|unable to insert catheter|1|||
33465515|NCT00324233|62839036|FG001|Second Period|unable to insert catheter|1|||
33465516|NCT00324233|62839035|FG000|Second Period|Protocol Violation|4|||
33465517|NCT00324233|62839036|FG001|Second Period|Protocol Violation|6|||
33465518|NCT03335566|62839044|FG000|Overall Study|Adverse Event|0|||
33465519|NCT03335566|62839045|FG001|Overall Study|Adverse Event|1|||
33465520|NCT03335566|62839044|FG000|Overall Study|Lost to Follow-up|1|||
33465521|NCT03335566|62839045|FG001|Overall Study|Lost to Follow-up|0|||
33545289|NCT03701555|62936621|FG009|Part 2 (Day 1)|Other|0|||
33545290|NCT03701555|62936622|FG010|Part 2 (Day 1)|Other|3|||
33545291|NCT03701555|62936623|FG011|Part 2 (Day 1)|Other|1|||
33545292|NCT03701555|62936624|FG012|Part 2 (Day 1)|Other|0|||
33545293|NCT03701555|62936625|FG013|Part 2 (Day 1)|Other|1|||
33545294|NCT03701555|62936626|FG014|Part 2 (Day 1)|Other|0|||
33545295|NCT03701555|62936627|FG015|Part 2 (Day 1)|Other|2|||
33545296|NCT03701555|62936628|FG016|Part 2 (Day 1)|Other|2|||
33545297|NCT03701555|62936629|FG017|Part 2 (Day 1)|Other|0|||
33545298|NCT03701555|62936630|FG018|Part 2 (Day 1)|Other|0|||
33545299|NCT03701555|62936631|FG019|Part 2 (Day 1)|Other|0|||
33545300|NCT03701555|62936632|FG020|Part 2 (Day 1)|Other|0|||
33545301|NCT03701555|62936633|FG021|Part 2 (Day 1)|Other|0|||
33545302|NCT03701555|62936634|FG022|Part 2 (Day 1)|Other|0|||
33545303|NCT03701555|62936635|FG023|Part 2 (Day 1)|Other|0|||
33651980|NCT01957787|63063765|FG000|Overall Study|Death|18|||
33651981|NCT01957787|63063765|FG000|Overall Study|Lost to Follow-up|3|||
33651982|NCT01957787|63063765|FG000|Overall Study|Withdrawal by Subject|3|||
33651983|NCT01957787|63063765|FG000|Overall Study|Entered Hospice or Similar Program|2|||
33651984|NCT01957787|63063765|FG000|Overall Study|Index Tumor(s) Resected|2|||
33651985|NCT01957787|63063765|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
33651986|NCT01957787|63063765|FG000|Overall Study|Local therapy, not cryoablation|6|||
33651987|NCT01698775|63063771|FG000|Phase A|Adverse Event|2|||
33651988|NCT01698775|63063772|FG001|Phase A|Adverse Event|1|||
33651989|NCT01698775|63063771|FG000|Phase A|Death|1|||
33651990|NCT01698775|63063772|FG001|Phase A|Death|1|||
33651991|NCT01698775|63063771|FG000|Phase A|Lack of Efficacy|1|||
33651992|NCT01698775|63063772|FG001|Phase A|Lack of Efficacy|0|||
33651993|NCT01698775|63063771|FG000|Phase A|Lost to Follow-up|1|||
33651994|NCT01698775|63063772|FG001|Phase A|Lost to Follow-up|2|||
33651995|NCT01698775|63063771|FG000|Phase A|Protocol Violation|1|||
33651996|NCT01698775|63063772|FG001|Phase A|Protocol Violation|0|||
33651997|NCT01698775|63063771|FG000|Phase A|Withdrawal by Subject|3|||
33651998|NCT01698775|63063772|FG001|Phase A|Withdrawal by Subject|4|||
33651999|NCT01698775|63063771|FG000|Phase A|Kidney [transplant]|0|||
33652000|NCT01698775|63063772|FG001|Phase A|Kidney [transplant]|1|||
33465522|NCT03335566|62839044|FG000|Overall Study|Technical Problems|1|||
33465523|NCT03335566|62839045|FG001|Overall Study|Technical Problems|0|||
33465524|NCT03335566|62839044|FG000|Overall Study|Protocol Violation|1|||
33465525|NCT03335566|62839045|FG001|Overall Study|Protocol Violation|0|||
33465526|NCT03335566|62839044|FG000|Overall Study|Other than specified above|1|||
33465527|NCT03335566|62839045|FG001|Overall Study|Other than specified above|2|||
33465528|NCT03369418|62839053|FG000|Overall Study|Withdrawal by Subject|3|||
33545304|NCT03701555|62936636|FG024|Part 2 (Day 1)|Other|0|||
33545305|NCT03701555|62936637|FG025|Part 2 (Day 1)|Other|0|||
33545306|NCT03701555|62936638|FG026|Part 2 (Day 1)|Other|0|||
33545307|NCT03701555|62936639|FG027|Part 2 (Day 1)|Other|0|||
33545308|NCT03701555|62936640|FG028|Part 2 (Day 1)|Other|0|||
33545309|NCT03701555|62936641|FG029|Part 2 (Day 1)|Other|0|||
33545310|NCT03701555|62936642|FG030|Part 2 (Day 1)|Other|0|||
33652001|NCT01698775|63063771|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
33652002|NCT01698775|63063772|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
33652003|NCT01698775|63063771|FG000|Phase B|Adverse Event|6|||
33652004|NCT01698775|63063772|FG001|Phase B|Adverse Event|3|||
33652005|NCT01698775|63063771|FG000|Phase B|Death|0|||
33652006|NCT01698775|63063772|FG001|Phase B|Death|1|||
33652007|NCT01698775|63063771|FG000|Phase B|Lack of Efficacy|0|||
33652008|NCT01698775|63063772|FG001|Phase B|Lack of Efficacy|1|||
33652009|NCT01698775|63063771|FG000|Phase B|Lost to Follow-up|0|||
33652010|NCT01698775|63063772|FG001|Phase B|Lost to Follow-up|1|||
33652011|NCT01698775|63063771|FG000|Phase B|Physician Decision|1|||
33652012|NCT01698775|63063772|FG001|Phase B|Physician Decision|1|||
33652013|NCT01698775|63063771|FG000|Phase B|Protocol Violation|1|||
33652014|NCT01698775|63063772|FG001|Phase B|Protocol Violation|1|||
33652015|NCT01698775|63063771|FG000|Phase B|Withdrawal by Subject|6|||
33652016|NCT01698775|63063772|FG001|Phase B|Withdrawal by Subject|2|||
33652017|NCT01941095|63063782|FG000|Overall Study|Insufficient therapeutic response|13|||
33652018|NCT01941095|63063782|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
33652019|NCT01941095|63063782|FG000|Overall Study|Adverse Event|11|||
33652020|NCT01941095|63063782|FG000|Overall Study|Physician Decision|3|||
33652021|NCT01941095|63063782|FG000|Overall Study|Withdrawal by Subject|17|||
33652022|NCT01941095|63063782|FG000|Overall Study|Lost to Follow-up|10|||
33652023|NCT01957709|63063797|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
33652024|NCT01957553|63063814|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
33652025|NCT01957553|63063815|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
33652026|NCT01957553|63063814|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
33652027|NCT01957553|63063815|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
33652028|NCT01957553|63063814|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
33652029|NCT01957553|63063815|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
33652030|NCT01957553|63063814|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
33652031|NCT01957553|63063815|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
33652032|NCT01957553|63063814|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
33652033|NCT01957553|63063815|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
33652034|NCT01957553|63063814|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
33652035|NCT01957553|63063815|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
33545311|NCT03701555|62936643|FG031|Part 2 (Day 1)|Other|0|||
33545312|NCT03701555|62936644|FG032|Part 2 (Day 1)|Other|0|||
33545313|NCT03701555|62936645|FG033|Part 2 (Day 1)|Other|0|||
33545314|NCT03701555|62936646|FG034|Part 2 (Day 1)|Other|0|||
33545315|NCT03701555|62936647|FG035|Part 2 (Day 1)|Other|0|||
33545316|NCT03701555|62936612|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
33545317|NCT03701555|62936613|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
33545318|NCT03701555|62936614|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
33545319|NCT03701555|62936615|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
33545320|NCT03701555|62936616|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
33545321|NCT03701555|62936617|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
33545322|NCT03701555|62936618|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
33545323|NCT03701555|62936619|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
33545324|NCT03701555|62936620|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
33545325|NCT03701555|62936621|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
33545326|NCT03701555|62936622|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
33545327|NCT03701555|62936623|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
33545328|NCT03701555|62936624|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
33545329|NCT03701555|62936625|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
33545330|NCT03701555|62936626|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
33545331|NCT03701555|62936627|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
33545332|NCT03701555|62936628|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
33652036|NCT01957553|63063814|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
33652037|NCT01957553|63063815|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
33652038|NCT01957553|63063814|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
33652039|NCT01957553|63063815|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
33652040|NCT01957553|63063814|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
33652041|NCT01957553|63063815|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
33652042|NCT01957475|63063840|FG000|Test Period 1|Withdrawal by Subject|1|||
33328737|NCT01076166|62705145|FG000|Overall Study|Adverse Event|3|||
33328738|NCT01076166|62705145|FG000|Overall Study|Symptoms improved/resolved|6|||
33328739|NCT01193582|62705156|FG000|Vaccination Series|Withdrawal by Subject|11|||
33328740|NCT01193582|62705157|FG001|Vaccination Series|Withdrawal by Subject|13|||
33545333|NCT03701555|62936629|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
33545334|NCT03701555|62936630|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
33545335|NCT03701555|62936631|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
33545336|NCT03701555|62936632|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
33545337|NCT03701555|62936633|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
33545338|NCT03701555|62936634|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
33545339|NCT03701555|62936635|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
33652043|NCT01957475|63063841|FG001|Test Period 1|Withdrawal by Subject|0|||
33545340|NCT03701555|62936636|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
33545341|NCT03701555|62936637|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
33545342|NCT03701555|62936638|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
33545343|NCT03701555|62936639|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
33545344|NCT03701555|62936640|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
33545345|NCT03701555|62936641|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
33545346|NCT03701555|62936642|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
33545347|NCT03701555|62936643|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
33545348|NCT03701555|62936644|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
33545349|NCT03701555|62936645|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
33545350|NCT03701555|62936646|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
33545351|NCT03701555|62936647|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
33545352|NCT03701555|62936612|FG000|Part 3 (Day 1)|Subject Decision|0|||
33545353|NCT03701555|62936613|FG001|Part 3 (Day 1)|Subject Decision|0|||
33545354|NCT03701555|62936614|FG002|Part 3 (Day 1)|Subject Decision|0|||
33545355|NCT03701555|62936615|FG003|Part 3 (Day 1)|Subject Decision|0|||
33545356|NCT03701555|62936616|FG004|Part 3 (Day 1)|Subject Decision|0|||
33545357|NCT03701555|62936617|FG005|Part 3 (Day 1)|Subject Decision|0|||
33545358|NCT03701555|62936618|FG006|Part 3 (Day 1)|Subject Decision|0|||
33545359|NCT03701555|62936619|FG007|Part 3 (Day 1)|Subject Decision|0|||
33545360|NCT03701555|62936620|FG008|Part 3 (Day 1)|Subject Decision|0|||
33545361|NCT03701555|62936621|FG009|Part 3 (Day 1)|Subject Decision|0|||
33545362|NCT03701555|62936622|FG010|Part 3 (Day 1)|Subject Decision|0|||
33545363|NCT03701555|62936623|FG011|Part 3 (Day 1)|Subject Decision|0|||
33545364|NCT03701555|62936624|FG012|Part 3 (Day 1)|Subject Decision|0|||
33545365|NCT03701555|62936625|FG013|Part 3 (Day 1)|Subject Decision|0|||
33545366|NCT03701555|62936626|FG014|Part 3 (Day 1)|Subject Decision|0|||
33545367|NCT03701555|62936627|FG015|Part 3 (Day 1)|Subject Decision|0|||
33545368|NCT03701555|62936628|FG016|Part 3 (Day 1)|Subject Decision|0|||
33545369|NCT03701555|62936629|FG017|Part 3 (Day 1)|Subject Decision|0|||
33545370|NCT03701555|62936630|FG018|Part 3 (Day 1)|Subject Decision|0|||
33545371|NCT03701555|62936631|FG019|Part 3 (Day 1)|Subject Decision|0|||
33545372|NCT03701555|62936632|FG020|Part 3 (Day 1)|Subject Decision|0|||
33545373|NCT03701555|62936633|FG021|Part 3 (Day 1)|Subject Decision|0|||
33545374|NCT03701555|62936634|FG022|Part 3 (Day 1)|Subject Decision|0|||
33545375|NCT03701555|62936635|FG023|Part 3 (Day 1)|Subject Decision|0|||
33545376|NCT03701555|62936636|FG024|Part 3 (Day 1)|Subject Decision|0|||
33545377|NCT03701555|62936637|FG025|Part 3 (Day 1)|Subject Decision|0|||
33545378|NCT03701555|62936638|FG026|Part 3 (Day 1)|Subject Decision|1|||
33545379|NCT03701555|62936639|FG027|Part 3 (Day 1)|Subject Decision|0|||
33545380|NCT03701555|62936640|FG028|Part 3 (Day 1)|Subject Decision|0|||
33545381|NCT03701555|62936641|FG029|Part 3 (Day 1)|Subject Decision|0|||
33545382|NCT03701555|62936642|FG030|Part 3 (Day 1)|Subject Decision|0|||
33545383|NCT03701555|62936643|FG031|Part 3 (Day 1)|Subject Decision|2|||
33545384|NCT03701555|62936644|FG032|Part 3 (Day 1)|Subject Decision|1|||
33545385|NCT03701555|62936645|FG033|Part 3 (Day 1)|Subject Decision|1|||
33545386|NCT03701555|62936646|FG034|Part 3 (Day 1)|Subject Decision|0|||
33545387|NCT03701555|62936647|FG035|Part 3 (Day 1)|Subject Decision|0|||
33545388|NCT03701555|62936612|FG000|Part 3 (Day 1)|Other|0|||
33545389|NCT03701555|62936613|FG001|Part 3 (Day 1)|Other|0|||
33545390|NCT03701555|62936614|FG002|Part 3 (Day 1)|Other|0|||
33545391|NCT03701555|62936615|FG003|Part 3 (Day 1)|Other|0|||
33545392|NCT03701555|62936616|FG004|Part 3 (Day 1)|Other|0|||
33545393|NCT03701555|62936617|FG005|Part 3 (Day 1)|Other|0|||
33545394|NCT03701555|62936618|FG006|Part 3 (Day 1)|Other|0|||
33545395|NCT03701555|62936619|FG007|Part 3 (Day 1)|Other|0|||
33545396|NCT03701555|62936620|FG008|Part 3 (Day 1)|Other|0|||
33545397|NCT03701555|62936621|FG009|Part 3 (Day 1)|Other|0|||
33545398|NCT03701555|62936622|FG010|Part 3 (Day 1)|Other|0|||
33545399|NCT03701555|62936623|FG011|Part 3 (Day 1)|Other|0|||
33545400|NCT03701555|62936624|FG012|Part 3 (Day 1)|Other|0|||
33545401|NCT03701555|62936625|FG013|Part 3 (Day 1)|Other|0|||
33545402|NCT03701555|62936626|FG014|Part 3 (Day 1)|Other|0|||
33545403|NCT03701555|62936627|FG015|Part 3 (Day 1)|Other|0|||
33545404|NCT03701555|62936628|FG016|Part 3 (Day 1)|Other|0|||
33545405|NCT03701555|62936629|FG017|Part 3 (Day 1)|Other|0|||
33545406|NCT03701555|62936630|FG018|Part 3 (Day 1)|Other|0|||
33652044|NCT01957475|63063840|FG000|Test Period 1|Other|1|||
33545407|NCT03701555|62936631|FG019|Part 3 (Day 1)|Other|0|||
33545408|NCT03701555|62936632|FG020|Part 3 (Day 1)|Other|0|||
33545409|NCT03701555|62936633|FG021|Part 3 (Day 1)|Other|0|||
33545410|NCT03701555|62936634|FG022|Part 3 (Day 1)|Other|0|||
33545411|NCT03701555|62936635|FG023|Part 3 (Day 1)|Other|0|||
33545412|NCT03701555|62936636|FG024|Part 3 (Day 1)|Other|1|||
33545413|NCT03701555|62936637|FG025|Part 3 (Day 1)|Other|1|||
33545414|NCT03701555|62936638|FG026|Part 3 (Day 1)|Other|0|||
33545415|NCT03701555|62936639|FG027|Part 3 (Day 1)|Other|0|||
33545416|NCT03701555|62936640|FG028|Part 3 (Day 1)|Other|0|||
33545417|NCT03701555|62936641|FG029|Part 3 (Day 1)|Other|1|||
33545418|NCT03701555|62936642|FG030|Part 3 (Day 1)|Other|1|||
33545419|NCT03701555|62936643|FG031|Part 3 (Day 1)|Other|0|||
33545420|NCT03701555|62936644|FG032|Part 3 (Day 1)|Other|1|||
33545421|NCT03701555|62936645|FG033|Part 3 (Day 1)|Other|1|||
33652045|NCT01957475|63063841|FG001|Test Period 1|Other|0|||
33652046|NCT01957475|63063840|FG000|Test Period 1|Lack of Efficacy|0|||
33652047|NCT01957475|63063841|FG001|Test Period 1|Lack of Efficacy|1|||
33652048|NCT01957475|63063840|FG000|Test Period 2|Adverse Event|1|||
33652049|NCT01957475|63063841|FG001|Test Period 2|Adverse Event|0|||
33652050|NCT01940939|63063849|FG000|Overall Study|Withdrawal by Subject|2|||
33652051|NCT01940939|63063850|FG001|Overall Study|Withdrawal by Subject|8|||
33652052|NCT01957397|63063856|FG000|Test Period 1|sudden leakage/small bag|1|||
33652053|NCT01957397|63063857|FG001|Test Period 1|sudden leakage/small bag|1|||
33652054|NCT01957397|63063856|FG000|Test Period 1|Withdrawal by Subject|1|||
33652055|NCT01957397|63063857|FG001|Test Period 1|Withdrawal by Subject|0|||
33652056|NCT01957397|63063856|FG000|Test Period 2|Adverse Event|0|||
33652057|NCT01957397|63063857|FG001|Test Period 2|Adverse Event|1|||
33652058|NCT01957397|63063856|FG000|Test Period 3|Adverse Event|1|||
33652059|NCT01957397|63063857|FG001|Test Period 3|Adverse Event|2|||
33652060|NCT01957397|63063856|FG000|Test Period 3|the adhesive did not work|1|||
33652061|NCT01957397|63063857|FG001|Test Period 3|the adhesive did not work|0|||
33652062|NCT01940705|63063871|FG000|Overall Study|Lost to Follow-up|1|||
33652063|NCT01940705|63063872|FG001|Overall Study|Lost to Follow-up|3|||
33652064|NCT01940705|63063873|FG002|Overall Study|Lost to Follow-up|2|||
33652065|NCT01940705|63063874|FG003|Overall Study|Lost to Follow-up|2|||
33652066|NCT01940705|63063871|FG000|Overall Study|Withdrawal by Subject|2|||
33652067|NCT01940705|63063872|FG001|Overall Study|Withdrawal by Subject|2|||
33652068|NCT01940705|63063873|FG002|Overall Study|Withdrawal by Subject|3|||
33652069|NCT01940705|63063874|FG003|Overall Study|Withdrawal by Subject|2|||
33652070|NCT01940705|63063871|FG000|Overall Study|Intervention not given|0|||
33652071|NCT01940705|63063872|FG001|Overall Study|Intervention not given|3|||
33652072|NCT01940705|63063873|FG002|Overall Study|Intervention not given|3|||
33652073|NCT01940705|63063874|FG003|Overall Study|Intervention not given|0|||
33652074|NCT01940705|63063871|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
33652075|NCT01940705|63063872|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
33652076|NCT01940705|63063873|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
33652077|NCT01940705|63063874|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
33652078|NCT01957163|63063899|FG000|Overall Study|Adverse Event|5|||
33652079|NCT01957163|63063900|FG001|Overall Study|Adverse Event|2|||
33652080|NCT01957163|63063901|FG002|Overall Study|Adverse Event|4|||
33652081|NCT01957163|63063899|FG000|Overall Study|Lack of Efficacy|5|||
33652082|NCT01957163|63063900|FG001|Overall Study|Lack of Efficacy|4|||
33652083|NCT01957163|63063901|FG002|Overall Study|Lack of Efficacy|9|||
33545422|NCT03701555|62936646|FG034|Part 3 (Day 1)|Other|0|||
33545423|NCT03701555|62936647|FG035|Part 3 (Day 1)|Other|0|||
33545424|NCT02484443|62936781|FG000|Overall Study|Lack of Efficacy|28|||
33545425|NCT02484443|62936781|FG000|Overall Study|Physician Decision|2|||
33545426|NCT02484443|62936781|FG000|Overall Study|Ineligible|2|||
33545427|NCT02306161|62936787|FG000|Overall Study|Death|1|||
33545428|NCT02306161|62936788|FG001|Overall Study|Death|3|||
33545429|NCT02306161|62936787|FG000|Overall Study|Lack of Efficacy|20|||
33545430|NCT02306161|62936788|FG001|Overall Study|Lack of Efficacy|43|||
33545431|NCT02306161|62936787|FG000|Overall Study|Physician Decision|30|||
33545432|NCT02306161|62936788|FG001|Overall Study|Physician Decision|18|||
33545433|NCT02306161|62936787|FG000|Overall Study|Withdrawal by Subject|4|||
33545434|NCT02306161|62936788|FG001|Overall Study|Withdrawal by Subject|0|||
33545435|NCT02306161|62936787|FG000|Overall Study|Ineligible|9|||
33545436|NCT02306161|62936788|FG001|Overall Study|Ineligible|5|||
33545437|NCT02178098|62936796|FG000|Overall Study|Withdrawal by Subject|0|||
33545438|NCT02178098|62936797|FG001|Overall Study|Withdrawal by Subject|6|||
33545439|NCT02178098|62936796|FG000|Overall Study|Adverse Event|1|||
33545440|NCT02178098|62936797|FG001|Overall Study|Adverse Event|2|||
33545441|NCT02178098|62936796|FG000|Overall Study|Protocol Violation|1|||
33545442|NCT02178098|62936797|FG001|Overall Study|Protocol Violation|1|||
33545443|NCT02178098|62936796|FG000|Overall Study|Lost to Follow-up|0|||
33545444|NCT02178098|62936797|FG001|Overall Study|Lost to Follow-up|1|||
33545445|NCT02178098|62936796|FG000|Overall Study|Sponsor Request|1|||
33545446|NCT02178098|62936797|FG001|Overall Study|Sponsor Request|0|||
33545447|NCT02178098|62936796|FG000|Overall Study|Other|2|||
33545448|NCT02178098|62936797|FG001|Overall Study|Other|2|||
33545449|NCT01915498|62936823|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33545450|NCT01915498|62936824|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33545451|NCT01915498|62936825|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33545452|NCT01915498|62936826|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
33545453|NCT01915498|62936827|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
33652084|NCT01957163|63063899|FG000|Overall Study|Protocol Violation|1|||
33545454|NCT01915498|62936828|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33652085|NCT01957163|63063900|FG001|Overall Study|Protocol Violation|2|||
33652086|NCT01957163|63063901|FG002|Overall Study|Protocol Violation|0|||
33652087|NCT01957163|63063899|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
33545455|NCT01915498|62936829|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33545456|NCT01915498|62936830|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33545457|NCT01915498|62936831|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33545458|NCT01915498|62936832|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
33545459|NCT01915498|62936833|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33545460|NCT01915498|62936834|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33545461|NCT01915498|62936835|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
33545462|NCT01915498|62936836|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
33545463|NCT01915498|62936837|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
33545464|NCT01915498|62936838|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
33545465|NCT01915498|62936839|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
33545466|NCT01915498|62936840|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
33545467|NCT01915498|62936841|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33545468|NCT01915498|62936823|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
33545469|NCT01915498|62936824|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
33545470|NCT01915498|62936825|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
33545471|NCT01915498|62936826|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
33545472|NCT01915498|62936827|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
33545473|NCT01915498|62936828|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
33545474|NCT01915498|62936829|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
33545475|NCT01915498|62936830|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
33545476|NCT01915498|62936831|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
33545477|NCT01915498|62936832|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
33545478|NCT01915498|62936833|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
33545479|NCT01915498|62936834|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
33545480|NCT01915498|62936835|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
33545481|NCT01915498|62936836|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
33652088|NCT01957163|63063900|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
33652089|NCT01957163|63063901|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
33652090|NCT01957163|63063899|FG000|Overall Study|Lost to Follow-up|0|||
33652091|NCT01957163|63063900|FG001|Overall Study|Lost to Follow-up|1|||
33652092|NCT01957163|63063901|FG002|Overall Study|Lost to Follow-up|0|||
33652093|NCT01957163|63063899|FG000|Overall Study|Withdrawal by Subject|4|||
33545482|NCT01915498|62936837|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
33545483|NCT01915498|62936838|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
33545484|NCT01915498|62936839|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
33545485|NCT01915498|62936840|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
33652094|NCT01957163|63063900|FG001|Overall Study|Withdrawal by Subject|2|||
33652095|NCT01957163|63063901|FG002|Overall Study|Withdrawal by Subject|4|||
33652096|NCT01939223|63063955|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
33652097|NCT01939223|63063956|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
33652098|NCT01939223|63063955|FG000|Overall Study|Disease recurrence (radiological)|1|||
33652099|NCT01939223|63063956|FG001|Overall Study|Disease recurrence (radiological)|3|||
33652100|NCT01939223|63063955|FG000|Overall Study|Study stopped by Sponsor|5|||
33652101|NCT01939223|63063956|FG001|Overall Study|Study stopped by Sponsor|7|||
33652102|NCT01939223|63063955|FG000|Overall Study|Withdrawal by Subject|6|||
33652103|NCT01939223|63063956|FG001|Overall Study|Withdrawal by Subject|0|||
33652104|NCT01954745|63064001|FG000|Overall Study|Radiological Progression|11|||
33545486|NCT01915498|62936841|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
33545487|NCT01915498|62936823|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
33545488|NCT01915498|62936824|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
33545489|NCT01915498|62936825|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
33545490|NCT01915498|62936826|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
33545491|NCT01915498|62936827|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
33545492|NCT01915498|62936828|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
33545493|NCT01915498|62936829|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
33545494|NCT01915498|62936830|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
33545495|NCT01915498|62936831|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
33545496|NCT01915498|62936832|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
33652105|NCT01954745|63064001|FG000|Overall Study|Clinical Progression|5|||
33652106|NCT01954745|63064001|FG000|Overall Study|Adverse Event|2|||
33652107|NCT01954745|63064001|FG000|Overall Study|Death|1|||
33652108|NCT01954121|63064016|FG000|Overall Study|Lack of Efficacy|94|||
33652109|NCT01954121|63064017|FG001|Overall Study|Lack of Efficacy|41|||
33545497|NCT01915498|62936833|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
33545498|NCT01915498|62936834|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
33545499|NCT01915498|62936835|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
33545500|NCT01915498|62936836|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
33545501|NCT01915498|62936837|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
33545502|NCT01915498|62936838|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
33545503|NCT01915498|62936839|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
33545504|NCT01915498|62936840|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
33545505|NCT01915498|62936841|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
33545506|NCT01915498|62936823|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545507|NCT01915498|62936824|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33652110|NCT01954121|63064016|FG000|Overall Study|Protocol Violation|0|||
33652111|NCT01954121|63064017|FG001|Overall Study|Protocol Violation|2|||
33545508|NCT01915498|62936825|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545509|NCT01915498|62936826|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545510|NCT01915498|62936827|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545511|NCT01915498|62936828|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545512|NCT01915498|62936829|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545513|NCT01915498|62936830|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545514|NCT01915498|62936831|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545515|NCT01915498|62936832|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545516|NCT01915498|62936833|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
33545517|NCT01915498|62936834|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545518|NCT01915498|62936835|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545519|NCT01915498|62936836|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545520|NCT01915498|62936837|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545521|NCT01915498|62936838|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545522|NCT01915498|62936839|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545523|NCT01915498|62936840|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545524|NCT01915498|62936841|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33545525|NCT01915498|62936823|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
33545526|NCT01915498|62936824|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
33545527|NCT01915498|62936825|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
33545528|NCT01915498|62936826|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
33545529|NCT01915498|62936827|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
33545530|NCT01915498|62936828|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
33545531|NCT01915498|62936829|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
33545532|NCT01915498|62936830|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
33545533|NCT01915498|62936831|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
33545534|NCT01915498|62936832|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
33545535|NCT01915498|62936833|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
33545536|NCT01915498|62936834|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
33545537|NCT01915498|62936835|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
33545538|NCT01915498|62936836|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
33545539|NCT01915498|62936837|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
33545540|NCT01915498|62936838|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
33545541|NCT01915498|62936839|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
33545542|NCT01915498|62936840|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
33545543|NCT01915498|62936841|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
33545544|NCT01915498|62936823|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33545545|NCT01915498|62936824|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33652112|NCT01954121|63064016|FG000|Overall Study|Lost to Follow-up|5|||
33652113|NCT01954121|63064017|FG001|Overall Study|Lost to Follow-up|6|||
33652114|NCT01954121|63064016|FG000|Overall Study|Withdrawal by Subject|18|||
33652115|NCT01954121|63064017|FG001|Overall Study|Withdrawal by Subject|12|||
33652116|NCT01954121|63064016|FG000|Overall Study|Pregnancy|1|||
33652117|NCT01954121|63064017|FG001|Overall Study|Pregnancy|1|||
33652118|NCT01954121|63064016|FG000|Overall Study|AE, serious fatal|1|||
33545546|NCT01915498|62936825|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33545547|NCT01915498|62936826|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33545548|NCT01915498|62936827|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
33652119|NCT01954121|63064017|FG001|Overall Study|AE, serious fatal|0|||
33652120|NCT01954121|63064016|FG000|Overall Study|AE, non-serious non-fatal|5|||
33545549|NCT01915498|62936828|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33545550|NCT01915498|62936829|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33652121|NCT01954121|63064017|FG001|Overall Study|AE, non-serious non-fatal|22|||
33652122|NCT01954121|63064016|FG000|Overall Study|SAE, non-fatal|1|||
33652123|NCT01954121|63064017|FG001|Overall Study|SAE, non-fatal|4|||
33652124|NCT01954121|63064016|FG000|Overall Study|Non-compliant with study procedures|1|||
33652125|NCT01954121|63064017|FG001|Overall Study|Non-compliant with study procedures|0|||
33652126|NCT01954121|63064016|FG000|Overall Study|Non-compliant patient|1|||
33652127|NCT01954121|63064017|FG001|Overall Study|Non-compliant patient|1|||
33652128|NCT01954121|63064016|FG000|Overall Study|Subject did not follow instructions|0|||
33652129|NCT01954121|63064017|FG001|Overall Study|Subject did not follow instructions|2|||
33652130|NCT01952015|63064052|FG000|Induction|Protocol Violation|1|||
33652131|NCT01952015|63064052|FG000|Maintenance|Adverse Event|2|||
33652132|NCT01952015|63064052|FG000|Treatment Period 3|Physician Decision|9|||
33652133|NCT01951703|63064085|FG000|First Intervention|Withdrawal by Subject|1|||
33652134|NCT01951703|63064086|FG001|First Intervention|Withdrawal by Subject|0|||
33652135|NCT01951703|63064085|FG000|First Intervention|Subject was not compliant|1|||
33652136|NCT01951703|63064086|FG001|First Intervention|Subject was not compliant|1|||
33652137|NCT01951703|63064085|FG000|First Intervention|Physician Decision|1|||
33652138|NCT01951703|63064086|FG001|First Intervention|Physician Decision|0|||
33652139|NCT01951703|63064085|FG000|Second Intervention|Protocol Violation|0|||
33652140|NCT01951703|63064086|FG001|Second Intervention|Protocol Violation|1|||
33652141|NCT01951703|63064085|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
33652142|NCT01951703|63064086|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
33652143|NCT01937351|63064112|FG000|Overall Study|Withdrawal by Subject|4|||
33652144|NCT01937351|63064113|FG001|Overall Study|Withdrawal by Subject|2|||
33652145|NCT01937351|63064112|FG000|Overall Study|Death|1|||
33652146|NCT01937351|63064113|FG001|Overall Study|Death|0|||
33652147|NCT01937351|63064112|FG000|Overall Study|Not treated w device, per protocol fail|4|||
33652148|NCT01937351|63064113|FG001|Overall Study|Not treated w device, per protocol fail|0|||
33652149|NCT01737697|63064146|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33652150|NCT01737697|63064147|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
33652151|NCT01737697|63064148|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33652152|NCT01737697|63064149|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
33652153|NCT01737697|63064150|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
33652154|NCT01737697|63064151|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33652155|NCT01737697|63064152|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33652156|NCT01737697|63064153|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33545551|NCT01915498|62936830|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33545552|NCT01915498|62936831|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33545553|NCT01915498|62936832|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
33545554|NCT01915498|62936833|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33545555|NCT01915498|62936834|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33545556|NCT01915498|62936835|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33545557|NCT01915498|62936836|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33545558|NCT01915498|62936837|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33545559|NCT01915498|62936838|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33545560|NCT01915498|62936839|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33545561|NCT01915498|62936840|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33545562|NCT01915498|62936841|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33545563|NCT01915498|62936823|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33545564|NCT01915498|62936824|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
33545565|NCT01915498|62936825|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
33545566|NCT01915498|62936826|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33545567|NCT01915498|62936827|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33545568|NCT01915498|62936828|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33545569|NCT01915498|62936829|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33545570|NCT01915498|62936830|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
33545571|NCT01915498|62936831|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
33652157|NCT01737697|63064154|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33652158|NCT01737697|63064155|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33652159|NCT01737697|63064156|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33652160|NCT01737697|63064157|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33652161|NCT01737697|63064158|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33652162|NCT01737697|63064159|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33652163|NCT01737697|63064160|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33652164|NCT01737697|63064146|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
33652165|NCT01737697|63064147|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
33652166|NCT01737697|63064148|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
33328741|NCT01193582|62705158|FG002|Vaccination Series|Withdrawal by Subject|8|||
33328742|NCT01193582|62705159|FG003|Vaccination Series|Withdrawal by Subject|3|||
33545572|NCT01915498|62936832|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
33545573|NCT01915498|62936833|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33652167|NCT01737697|63064149|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33328743|NCT01193582|62705156|FG000|12 Month Follow-up|Death|0|||
33328744|NCT01193582|62705157|FG001|12 Month Follow-up|Death|0|||
33545574|NCT01915498|62936834|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
33545575|NCT01915498|62936835|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33545576|NCT01915498|62936836|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
33545577|NCT01915498|62936837|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33545578|NCT01915498|62936838|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
33545579|NCT01915498|62936839|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
33545580|NCT01915498|62936840|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
33545581|NCT01915498|62936841|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33545582|NCT01915498|62936823|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
33545583|NCT01915498|62936824|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
33652168|NCT01737697|63064150|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33652169|NCT01737697|63064151|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33652170|NCT01737697|63064152|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33652171|NCT01737697|63064153|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33652172|NCT01737697|63064154|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33652173|NCT01737697|63064155|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33652174|NCT01737697|63064156|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33652175|NCT01737697|63064157|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33652176|NCT01737697|63064158|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33652177|NCT01737697|63064159|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33652178|NCT01737697|63064160|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33652179|NCT01737697|63064146|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
33652180|NCT01737697|63064147|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
33652181|NCT01737697|63064148|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
33652182|NCT01737697|63064149|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
33652183|NCT01737697|63064150|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
33652184|NCT01737697|63064151|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
33652185|NCT01737697|63064152|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
33652186|NCT01737697|63064153|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
33652187|NCT01737697|63064154|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
33652188|NCT01737697|63064155|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
33652189|NCT01737697|63064156|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
33652190|NCT01737697|63064157|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
33652191|NCT01737697|63064158|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
33652192|NCT01737697|63064159|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
33652193|NCT01737697|63064160|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
33652194|NCT01737697|63064146|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33652195|NCT01737697|63064147|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
33652196|NCT01737697|63064148|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33652197|NCT01737697|63064149|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33652198|NCT01737697|63064150|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33652199|NCT01737697|63064151|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33652200|NCT01737697|63064152|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33652201|NCT01737697|63064153|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33652202|NCT01737697|63064154|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33652203|NCT01737697|63064155|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33652204|NCT01737697|63064156|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33545584|NCT01915498|62936825|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33545585|NCT01915498|62936826|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
33545586|NCT01915498|62936827|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33545587|NCT01915498|62936828|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33545588|NCT01915498|62936829|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
33465529|NCT03369418|62839054|FG001|Overall Study|Withdrawal by Subject|3|||
33465530|NCT03334630|62839062|FG000|Overall Study|Withdrawal by Subject|7|||
33465531|NCT03334630|62839063|FG001|Overall Study|Withdrawal by Subject|7|||
33465532|NCT03334630|62839062|FG000|Overall Study|Lost to Follow-up|3|||
33465533|NCT03334630|62839063|FG001|Overall Study|Lost to Follow-up|1|||
33465534|NCT03334630|62839062|FG000|Overall Study|Adverse Event|0|||
33465535|NCT03334630|62839063|FG001|Overall Study|Adverse Event|1|||
33328745|NCT01193582|62705158|FG002|12 Month Follow-up|Death|1|||
33465536|NCT03334630|62839062|FG000|Overall Study|Physician Decision|1|||
33465537|NCT03334630|62839063|FG001|Overall Study|Physician Decision|1|||
33465538|NCT03334630|62839062|FG000|Overall Study|Enrollment closed|2|||
33328746|NCT01193582|62705159|FG003|12 Month Follow-up|Death|0|||
33465539|NCT03334630|62839063|FG001|Overall Study|Enrollment closed|1|||
33545589|NCT01915498|62936830|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33545590|NCT01915498|62936831|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33545591|NCT01915498|62936832|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33545592|NCT01915498|62936833|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
33545593|NCT01915498|62936834|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33545594|NCT01915498|62936835|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
33545595|NCT01915498|62936836|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
33545596|NCT01915498|62936837|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
33545597|NCT01915498|62936838|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
33545598|NCT01915498|62936839|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
33545599|NCT01915498|62936840|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
33545600|NCT01915498|62936841|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33545601|NCT01915498|62936823|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33545602|NCT01915498|62936824|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33545603|NCT01915498|62936825|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33545604|NCT01915498|62936826|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33545605|NCT01915498|62936827|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33545606|NCT01915498|62936828|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33545607|NCT01915498|62936829|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33545608|NCT01915498|62936830|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33545609|NCT01915498|62936831|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33545610|NCT01915498|62936832|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33545611|NCT01915498|62936833|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
33545612|NCT01915498|62936834|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33545613|NCT01915498|62936835|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33545614|NCT01915498|62936836|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
33545615|NCT01915498|62936837|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33545616|NCT01915498|62936838|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33545617|NCT01915498|62936839|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
33545618|NCT01915498|62936840|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
33545619|NCT01915498|62936841|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33545620|NCT01915498|62936823|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
33545621|NCT01915498|62936824|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
33545622|NCT01915498|62936825|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
33545623|NCT01915498|62936826|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
33545624|NCT01915498|62936827|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
33545625|NCT01915498|62936828|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
33545626|NCT01915498|62936829|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
33545627|NCT01915498|62936830|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
33545628|NCT01915498|62936831|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
33545629|NCT01915498|62936832|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
33545630|NCT01915498|62936833|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
33545631|NCT01915498|62936834|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
33545632|NCT01915498|62936835|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
33545633|NCT01915498|62936836|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
33545634|NCT01915498|62936837|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
33545635|NCT01915498|62936838|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
33545636|NCT01915498|62936839|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
33545637|NCT01915498|62936840|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2|||
33545638|NCT01915498|62936841|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
33545639|NCT01915498|62936823|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33545640|NCT01915498|62936824|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33545641|NCT01915498|62936825|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33545642|NCT01915498|62936826|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33652205|NCT01737697|63064157|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33652206|NCT01737697|63064158|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33652207|NCT01737697|63064159|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33652208|NCT01737697|63064160|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33652209|NCT01737697|63064146|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33545643|NCT01915498|62936827|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33545644|NCT01915498|62936828|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
33545645|NCT01915498|62936829|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33545646|NCT01915498|62936830|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33545647|NCT01915498|62936831|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33545648|NCT01915498|62936832|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
33545649|NCT01915498|62936833|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33545650|NCT01915498|62936834|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33545651|NCT01915498|62936835|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33545652|NCT01915498|62936836|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
33545653|NCT01915498|62936837|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
33545654|NCT01915498|62936838|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
33545655|NCT01915498|62936839|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
33545656|NCT01915498|62936840|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
33545657|NCT01915498|62936841|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33545658|NCT01915498|62936823|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545659|NCT01915498|62936824|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545660|NCT01915498|62936825|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545661|NCT01915498|62936826|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545662|NCT01915498|62936827|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545663|NCT01915498|62936828|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545664|NCT01915498|62936829|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545665|NCT01915498|62936830|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545666|NCT01915498|62936831|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545667|NCT01915498|62936832|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545668|NCT01915498|62936833|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545669|NCT01915498|62936834|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545670|NCT01915498|62936835|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545671|NCT01915498|62936836|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545672|NCT01915498|62936837|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545673|NCT01915498|62936838|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545674|NCT01915498|62936839|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545675|NCT01915498|62936840|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
33545676|NCT01915498|62936841|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2|||
33545677|NCT01798004|62936933|FG000|Overall Study|Death|2|||
33545678|NCT01798004|62936933|FG000|Overall Study|Lack of Efficacy|8|||
33545679|NCT01798004|62936933|FG000|Overall Study|Physician Decision|25|||
33545680|NCT01798004|62936933|FG000|Overall Study|Withdrawal by Subject|4|||
33545681|NCT01798004|62936933|FG000|Overall Study|Ineligible|4|||
33545682|NCT01798004|62936933|FG000|Overall Study|Patient/parent refusal|7|||
33545683|NCT01798004|62936933|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
33545684|NCT01798004|62936933|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
33545685|NCT01630434|62936939|FG000|Overall Study|Donor lungs turned down|1|||
33545686|NCT01630434|62936940|FG001|Overall Study|Donor lungs turned down|0|||
33545687|NCT01630434|62936939|FG000|Overall Study|Protocol Violation|9|||
33545688|NCT01630434|62936940|FG001|Overall Study|Protocol Violation|4|||
33545689|NCT01630434|62936939|FG000|Overall Study|Death|20|||
33545690|NCT01630434|62936940|FG001|Overall Study|Death|26|||
33545691|NCT01256398|62936950|FG000|Overall Study|Withdrawal by Subject|1|||
33545692|NCT01175356|62936956|FG000|Overall Study|Death|1|||
33545693|NCT01175356|62936956|FG000|Overall Study|Lack of Efficacy|12|||
33545694|NCT01175356|62936956|FG000|Overall Study|Lost to Follow-up|1|||
33545695|NCT01175356|62936956|FG000|Overall Study|Physician Decision|23|||
33545696|NCT01175356|62936956|FG000|Overall Study|Ineligible|1|||
33545697|NCT01175356|62936956|FG000|Overall Study|Treatment Slot Not Available|18|||
33545698|NCT01175356|62936956|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
33545699|NCT01175356|62936956|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
33545700|NCT01175356|62936956|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
33545701|NCT01175356|62936956|FG000|Overall Study|Inadequate stem cell for transplant|1|||
33545702|NCT01175356|62936956|FG000|Overall Study|Initiation other tx prior to completion|9|||
33545703|NCT01151423|62936962|FG000|Overall Study|Study terminated by Sponsor|9|||
33545704|NCT01151423|62936963|FG001|Overall Study|Study terminated by Sponsor|10|||
33545705|NCT01151423|62936962|FG000|Overall Study|Protocol Violation|0|||
33545706|NCT01151423|62936963|FG001|Overall Study|Protocol Violation|1|||
33545707|NCT01151423|62936962|FG000|Overall Study|Physician Decision|1|||
33545708|NCT01151423|62936963|FG001|Overall Study|Physician Decision|1|||
33652210|NCT01737697|63064147|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33652211|NCT01737697|63064148|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33652212|NCT01737697|63064149|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33545709|NCT01151423|62936962|FG000|Overall Study|Pregnancy|0|||
33545710|NCT01151423|62936963|FG001|Overall Study|Pregnancy|1|||
33545711|NCT01151423|62936962|FG000|Overall Study|Death|0|||
33545712|NCT01151423|62936963|FG001|Overall Study|Death|1|||
33545713|NCT01151423|62936962|FG000|Overall Study|Adverse Event|3|||
33545714|NCT01151423|62936963|FG001|Overall Study|Adverse Event|0|||
33545715|NCT01151423|62936962|FG000|Overall Study|Withdrawal by Subject|1|||
33545716|NCT01151423|62936963|FG001|Overall Study|Withdrawal by Subject|3|||
33545717|NCT01151423|62936962|FG000|Overall Study|Lost to Follow-up|1|||
33545718|NCT01151423|62936963|FG001|Overall Study|Lost to Follow-up|0|||
33545719|NCT01151423|62936962|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
33545720|NCT01151423|62936963|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
33545721|NCT01151423|62936962|FG000|Overall Study|Participated in other clinical trial|1|||
33545722|NCT01151423|62936963|FG001|Overall Study|Participated in other clinical trial|0|||
33545723|NCT00565617|62936978|FG000|Overall Study|Withdrawal by Subject|1|||
33545724|NCT00453154|62936985|FG000|Double BIind Maintenance|Adverse Event|0|||
33545725|NCT00453154|62936986|FG001|Double BIind Maintenance|Adverse Event|0|||
33545726|NCT00453154|62936987|FG002|Double BIind Maintenance|Adverse Event|3|||
33545727|NCT00453154|62936988|FG003|Double BIind Maintenance|Adverse Event|12|||
33545728|NCT00453154|62936985|FG000|Double BIind Maintenance|Death|0|||
33545729|NCT00453154|62936986|FG001|Double BIind Maintenance|Death|0|||
33545730|NCT00453154|62936987|FG002|Double BIind Maintenance|Death|2|||
33545731|NCT00453154|62936988|FG003|Double BIind Maintenance|Death|1|||
33545732|NCT00453154|62936985|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
33545733|NCT00453154|62936986|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
33545734|NCT00453154|62936987|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
33545735|NCT00453154|62936988|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
33545736|NCT00453154|62936985|FG000|Double BIind Maintenance|Progression|0|||
33545737|NCT00453154|62936986|FG001|Double BIind Maintenance|Progression|0|||
33545738|NCT00453154|62936987|FG002|Double BIind Maintenance|Progression|29|||
33545739|NCT00453154|62936988|FG003|Double BIind Maintenance|Progression|26|||
33545740|NCT00453154|62936985|FG000|Double BIind Maintenance|Medical Issues|0|||
33545741|NCT00453154|62936986|FG001|Double BIind Maintenance|Medical Issues|0|||
33545742|NCT00453154|62936987|FG002|Double BIind Maintenance|Medical Issues|3|||
33545743|NCT00453154|62936988|FG003|Double BIind Maintenance|Medical Issues|1|||
33545744|NCT00453154|62936985|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
33545745|NCT00453154|62936986|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
33545746|NCT00453154|62936987|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
33545747|NCT00453154|62936988|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
33545748|NCT00334815|62936999|FG000|Overall Study|Adverse Event|3|||
33545749|NCT00334815|62937000|FG001|Overall Study|Adverse Event|2|||
33545750|NCT00334815|62936999|FG000|Overall Study|Death|0|||
33545751|NCT00334815|62937000|FG001|Overall Study|Death|2|||
33545752|NCT00334815|62936999|FG000|Overall Study|Progression|1|||
33545753|NCT00334815|62937000|FG001|Overall Study|Progression|0|||
33545754|NCT00334815|62936999|FG000|Overall Study|ineligible|1|||
33545755|NCT00334815|62937000|FG001|Overall Study|ineligible|1|||
33545756|NCT00334815|62936999|FG000|Overall Study|patient refused treatment|0|||
33545757|NCT00334815|62937000|FG001|Overall Study|patient refused treatment|1|||
33545758|NCT00334815|62936999|FG000|Overall Study|Physician Decision|2|||
33545759|NCT00334815|62937000|FG001|Overall Study|Physician Decision|4|||
33545760|NCT00258960|62937008|FG000|Overall Study|Death|2|||
33545761|NCT00258960|62937008|FG000|Overall Study|Disease Progression|7|||
33545762|NCT00258960|62937008|FG000|Overall Study|Adverse Event|4|||
33545763|NCT00258960|62937008|FG000|Overall Study|Physician Decision|1|||
33545764|NCT00258960|62937008|FG000|Overall Study|Withdrawal by Subject|1|||
33545765|NCT00258960|62937008|FG000|Overall Study|Mistake|2|||
33545766|NCT00121992|62937014|FG000|Overall Study|Treatment not received|2|||
33545767|NCT00121992|62937015|FG001|Overall Study|Treatment not received|11|||
33545768|NCT00070564|62937027|FG000|Overall Study|Progression|2|||
33545769|NCT00070564|62937028|FG001|Overall Study|Progression|4|||
33545770|NCT00070564|62937029|FG002|Overall Study|Progression|7|||
33545771|NCT00070564|62937030|FG003|Overall Study|Progression|7|||
33545772|NCT00070564|62937031|FG004|Overall Study|Progression|1|||
33545773|NCT00070564|62937032|FG005|Overall Study|Progression|0|||
33545774|NCT00070564|62937027|FG000|Overall Study|Delinquent|1|||
33545775|NCT00070564|62937028|FG001|Overall Study|Delinquent|4|||
33545776|NCT00070564|62937029|FG002|Overall Study|Delinquent|2|||
33545777|NCT00070564|62937030|FG003|Overall Study|Delinquent|0|||
33545778|NCT00070564|62937031|FG004|Overall Study|Delinquent|0|||
33545779|NCT00070564|62937032|FG005|Overall Study|Delinquent|0|||
33545780|NCT00070564|62937027|FG000|Overall Study|Adverse Event|150|||
33545781|NCT00070564|62937028|FG001|Overall Study|Adverse Event|142|||
33545782|NCT00070564|62937029|FG002|Overall Study|Adverse Event|120|||
33545783|NCT00070564|62937030|FG003|Overall Study|Adverse Event|108|||
33545784|NCT00070564|62937031|FG004|Overall Study|Adverse Event|63|||
33545785|NCT00070564|62937032|FG005|Overall Study|Adverse Event|36|||
33545786|NCT00070564|62937027|FG000|Overall Study|Death|4|||
33545787|NCT00070564|62937028|FG001|Overall Study|Death|1|||
33545788|NCT00070564|62937029|FG002|Overall Study|Death|5|||
33545789|NCT00070564|62937030|FG003|Overall Study|Death|3|||
33545790|NCT00070564|62937031|FG004|Overall Study|Death|0|||
33545791|NCT00070564|62937032|FG005|Overall Study|Death|1|||
33545792|NCT00070564|62937027|FG000|Overall Study|Other, not protocol specified|17|||
33545793|NCT00070564|62937028|FG001|Overall Study|Other, not protocol specified|15|||
33545794|NCT00070564|62937029|FG002|Overall Study|Other, not protocol specified|14|||
33545795|NCT00070564|62937030|FG003|Overall Study|Other, not protocol specified|19|||
33545796|NCT00070564|62937031|FG004|Overall Study|Other, not protocol specified|6|||
33545797|NCT00070564|62937032|FG005|Overall Study|Other, not protocol specified|7|||
33545798|NCT00070564|62937027|FG000|Overall Study|Withdrawal by Subject|26|||
33545799|NCT00070564|62937028|FG001|Overall Study|Withdrawal by Subject|37|||
33545800|NCT00070564|62937029|FG002|Overall Study|Withdrawal by Subject|23|||
33545801|NCT00070564|62937030|FG003|Overall Study|Withdrawal by Subject|30|||
33545802|NCT00070564|62937031|FG004|Overall Study|Withdrawal by Subject|8|||
33545803|NCT00070564|62937032|FG005|Overall Study|Withdrawal by Subject|8|||
33545804|NCT00070564|62937027|FG000|Overall Study|Not reported|0|||
33545805|NCT00070564|62937028|FG001|Overall Study|Not reported|0|||
33545806|NCT00070564|62937029|FG002|Overall Study|Not reported|0|||
33545807|NCT00070564|62937030|FG003|Overall Study|Not reported|0|||
33545808|NCT00070564|62937031|FG004|Overall Study|Not reported|1|||
33545809|NCT00070564|62937032|FG005|Overall Study|Not reported|0|||
33545810|NCT02738151|62937058|FG000|Overall Study|Randomized but not treated|4|||
33545811|NCT02738151|62937059|FG001|Overall Study|Randomized but not treated|1|||
33545812|NCT02738151|62937058|FG000|Overall Study|Adverse Event|4|||
33545813|NCT02738151|62937059|FG001|Overall Study|Adverse Event|5|||
33545814|NCT02738151|62937058|FG000|Overall Study|Hypoglycemia|0|||
33545815|NCT02738151|62937059|FG001|Overall Study|Hypoglycemia|1|||
33545816|NCT02738151|62937058|FG000|Overall Study|Poor Compliance to Protocol|4|||
33545817|NCT02738151|62937059|FG001|Overall Study|Poor Compliance to Protocol|3|||
33545818|NCT02738151|62937058|FG000|Overall Study|Other than specified above|11|||
33545819|NCT02738151|62937059|FG001|Overall Study|Other than specified above|21|||
33545820|NCT02993731|62937067|FG000|Overall Study|Study Termination|101|||
33545821|NCT02993731|62937068|FG001|Overall Study|Study Termination|105|||
33545822|NCT02915159|62937086|FG000|Overall Study|Participant no longer meets criteria|2|||
33545823|NCT02915159|62937087|FG001|Overall Study|Participant no longer meets criteria|0|||
33545824|NCT02915159|62937086|FG000|Overall Study|poor/non-compliance|1|||
33545825|NCT02915159|62937087|FG001|Overall Study|poor/non-compliance|0|||
33545826|NCT02915159|62937086|FG000|Overall Study|Participant withdrew consent|5|||
33545827|NCT02915159|62937087|FG001|Overall Study|Participant withdrew consent|1|||
33545828|NCT02915159|62937086|FG000|Overall Study|Request to discontinue treatment|1|||
33465540|NCT03334630|62839062|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
33465541|NCT03334630|62839063|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
33545829|NCT02915159|62937087|FG001|Overall Study|Request to discontinue treatment|2|||
33545830|NCT02915159|62937086|FG000|Overall Study|Adverse Event|2|||
33545831|NCT02915159|62937087|FG001|Overall Study|Adverse Event|2|||
33545832|NCT02915159|62937086|FG000|Overall Study|Lack of Efficacy|0|||
33465542|NCT03334630|62839062|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
33465543|NCT03334630|62839063|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
33465544|NCT03368170|62839071|FG000|Overall Study|Adverse Event|2|||
33465545|NCT03368170|62839072|FG001|Overall Study|Adverse Event|1|||
33465546|NCT00324155|62839080|FG000|Enrolled and Randomized|No longer met study criteria|3|||
33465547|NCT00324155|62839081|FG001|Enrolled and Randomized|No longer met study criteria|0|||
33465548|NCT00324155|62839080|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
33545833|NCT02915159|62937087|FG001|Overall Study|Lack of Efficacy|3|||
33545834|NCT02924051|62937099|FG000|Overall Study|Withdrawal by Subject|1|||
33545835|NCT02924051|62937100|FG001|Overall Study|Withdrawal by Subject|9|||
33545836|NCT02923427|62937114|FG000|Overall Study|convert to laparatomy|2|||
33545837|NCT02923427|62937115|FG001|Overall Study|convert to laparatomy|2|||
33545838|NCT02923427|62937114|FG000|Overall Study|destaturation|1|||
33545839|NCT02923427|62937115|FG001|Overall Study|destaturation|0|||
33545840|NCT02923427|62937114|FG000|Overall Study|can not replace LMA|1|||
33545841|NCT02923427|62937115|FG001|Overall Study|can not replace LMA|0|||
33652213|NCT01737697|63064150|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
33652214|NCT01737697|63064151|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33545842|NCT02669264|62937128|FG000|Overall Study|Death|5|||
33545843|NCT02669264|62937129|FG001|Overall Study|Death|5|||
33545844|NCT02669264|62937130|FG002|Overall Study|Death|3|||
33465549|NCT00324155|62839081|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
33465550|NCT00324155|62839080|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
33465551|NCT00324155|62839081|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
33545845|NCT02669264|62937131|FG003|Overall Study|Death|3|||
33545846|NCT02669264|62937132|FG004|Overall Study|Death|3|||
33545847|NCT02669264|62937133|FG005|Overall Study|Death|6|||
33545848|NCT02669264|62937134|FG006|Overall Study|Death|3|||
33545849|NCT02669264|62937128|FG000|Overall Study|Withdrawal by Subject|0|||
33545850|NCT02669264|62937129|FG001|Overall Study|Withdrawal by Subject|1|||
33545851|NCT02669264|62937130|FG002|Overall Study|Withdrawal by Subject|0|||
33545852|NCT02669264|62937131|FG003|Overall Study|Withdrawal by Subject|0|||
33545853|NCT02669264|62937132|FG004|Overall Study|Withdrawal by Subject|1|||
33545854|NCT02669264|62937133|FG005|Overall Study|Withdrawal by Subject|0|||
33545855|NCT02669264|62937134|FG006|Overall Study|Withdrawal by Subject|0|||
33545856|NCT02669264|62937128|FG000|Overall Study|Lost to Follow-up|0|||
33545857|NCT02669264|62937129|FG001|Overall Study|Lost to Follow-up|0|||
33545858|NCT02669264|62937130|FG002|Overall Study|Lost to Follow-up|0|||
33545859|NCT02669264|62937131|FG003|Overall Study|Lost to Follow-up|0|||
33545860|NCT02669264|62937132|FG004|Overall Study|Lost to Follow-up|1|||
33545861|NCT02669264|62937133|FG005|Overall Study|Lost to Follow-up|0|||
33545862|NCT02669264|62937134|FG006|Overall Study|Lost to Follow-up|0|||
33545863|NCT02669264|62937128|FG000|Overall Study|Miscellaneous|0|||
33545864|NCT02669264|62937129|FG001|Overall Study|Miscellaneous|0|||
33545865|NCT02669264|62937130|FG002|Overall Study|Miscellaneous|0|||
33545866|NCT02669264|62937131|FG003|Overall Study|Miscellaneous|0|||
33545867|NCT02669264|62937132|FG004|Overall Study|Miscellaneous|0|||
33545868|NCT02669264|62937133|FG005|Overall Study|Miscellaneous|0|||
33545869|NCT02669264|62937134|FG006|Overall Study|Miscellaneous|2|||
33545870|NCT02521870|62937160|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33465552|NCT00324155|62839080|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
33465553|NCT00324155|62839081|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
33465554|NCT00324155|62839080|FG000|Received Treatment in Induction Phase|Death|8|||
33465555|NCT00324155|62839081|FG001|Received Treatment in Induction Phase|Death|15|||
33465556|NCT00324155|62839080|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
33465557|NCT00324155|62839081|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
33465558|NCT00324155|62839080|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
33465559|NCT00324155|62839081|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
33465560|NCT00324155|62839080|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
33545871|NCT02521870|62937161|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
33545872|NCT02521870|62937162|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33545873|NCT02521870|62937163|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33545874|NCT02521870|62937164|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33545875|NCT02521870|62937165|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33465561|NCT00324155|62839081|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
33545876|NCT02521870|62937166|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33545877|NCT02521870|62937167|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33545878|NCT02521870|62937168|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33545879|NCT02521870|62937169|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33545880|NCT02521870|62937170|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33545881|NCT02521870|62937171|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33545882|NCT02521870|62937160|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
33545883|NCT02521870|62937161|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
33545884|NCT02521870|62937162|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
33545885|NCT02521870|62937163|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
33545886|NCT02521870|62937164|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
33545887|NCT02521870|62937165|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
33545888|NCT02521870|62937166|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
33465562|NCT00324155|62839080|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
33465563|NCT00324155|62839081|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
33465564|NCT00324155|62839080|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
33465565|NCT00324155|62839081|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
33545889|NCT02521870|62937167|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
33545890|NCT02521870|62937168|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
33545891|NCT02521870|62937169|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
33545892|NCT02521870|62937170|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
33545893|NCT02521870|62937171|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
33545894|NCT02521870|62937160|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
33545895|NCT02521870|62937161|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
33545896|NCT02521870|62937162|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
33545897|NCT02521870|62937163|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
33545898|NCT02521870|62937164|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
33545899|NCT02521870|62937165|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
33465566|NCT00324155|62839080|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
33465567|NCT00324155|62839081|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
33465568|NCT00324155|62839080|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
33465569|NCT00324155|62839081|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
33465570|NCT00324155|62839080|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
33465571|NCT00324155|62839081|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
33465572|NCT00324155|62839080|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
33465573|NCT00324155|62839081|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
33465574|NCT00324155|62839080|FG000|Follow-up Phase|On-going participants still on drug|11|||
33465575|NCT00324155|62839081|FG001|Follow-up Phase|On-going participants still on drug|6|||
33465576|NCT03334396|62839108|FG000|Overall Study|Adverse Event|1|||
33465577|NCT03334396|62839109|FG001|Overall Study|Adverse Event|0|||
33465578|NCT03334396|62839110|FG002|Overall Study|Adverse Event|1|||
33465579|NCT03334396|62839111|FG003|Overall Study|Adverse Event|0|||
33465580|NCT03334396|62839112|FG004|Overall Study|Adverse Event|0|||
33465581|NCT03334396|62839113|FG005|Overall Study|Adverse Event|0|||
33465582|NCT03334396|62839114|FG006|Overall Study|Adverse Event|0|||
33465583|NCT03334396|62839115|FG007|Overall Study|Adverse Event|0|||
33465584|NCT03334396|62839108|FG000|Overall Study|Lack of Efficacy|10|||
33465585|NCT03334396|62839109|FG001|Overall Study|Lack of Efficacy|4|||
33465586|NCT03334396|62839110|FG002|Overall Study|Lack of Efficacy|1|||
33465587|NCT03334396|62839111|FG003|Overall Study|Lack of Efficacy|3|||
33465588|NCT03334396|62839112|FG004|Overall Study|Lack of Efficacy|1|||
33465589|NCT03334396|62839113|FG005|Overall Study|Lack of Efficacy|0|||
33465590|NCT03334396|62839114|FG006|Overall Study|Lack of Efficacy|0|||
33465591|NCT03334396|62839115|FG007|Overall Study|Lack of Efficacy|1|||
33465592|NCT03334396|62839108|FG000|Overall Study|Lost to Follow-up|0|||
33465593|NCT03334396|62839109|FG001|Overall Study|Lost to Follow-up|0|||
33465594|NCT03334396|62839110|FG002|Overall Study|Lost to Follow-up|1|||
33465595|NCT03334396|62839111|FG003|Overall Study|Lost to Follow-up|0|||
33465596|NCT03334396|62839112|FG004|Overall Study|Lost to Follow-up|0|||
33465597|NCT03334396|62839113|FG005|Overall Study|Lost to Follow-up|0|||
33465598|NCT03334396|62839114|FG006|Overall Study|Lost to Follow-up|1|||
33465599|NCT03334396|62839115|FG007|Overall Study|Lost to Follow-up|0|||
33465600|NCT03334396|62839108|FG000|Overall Study|Physician Decision|1|||
33465601|NCT03334396|62839109|FG001|Overall Study|Physician Decision|0|||
33465602|NCT03334396|62839110|FG002|Overall Study|Physician Decision|0|||
33465603|NCT03334396|62839111|FG003|Overall Study|Physician Decision|0|||
33465604|NCT03334396|62839112|FG004|Overall Study|Physician Decision|0|||
33545900|NCT02521870|62937166|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
33465605|NCT03334396|62839113|FG005|Overall Study|Physician Decision|0|||
33465606|NCT03334396|62839114|FG006|Overall Study|Physician Decision|0|||
33465607|NCT03334396|62839115|FG007|Overall Study|Physician Decision|0|||
33465608|NCT03334396|62839108|FG000|Overall Study|Withdrawal by Subject|10|||
33545901|NCT02521870|62937167|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
33465609|NCT03334396|62839109|FG001|Overall Study|Withdrawal by Subject|5|||
33465610|NCT03334396|62839110|FG002|Overall Study|Withdrawal by Subject|7|||
33465611|NCT03334396|62839111|FG003|Overall Study|Withdrawal by Subject|2|||
33465612|NCT03334396|62839112|FG004|Overall Study|Withdrawal by Subject|2|||
33465613|NCT03334396|62839113|FG005|Overall Study|Withdrawal by Subject|1|||
33465614|NCT03334396|62839114|FG006|Overall Study|Withdrawal by Subject|2|||
33465615|NCT03334396|62839115|FG007|Overall Study|Withdrawal by Subject|0|||
33465616|NCT03334396|62839108|FG000|Overall Study|Pregnancy|0|||
33465617|NCT03334396|62839109|FG001|Overall Study|Pregnancy|1|||
33465618|NCT03334396|62839110|FG002|Overall Study|Pregnancy|0|||
33465619|NCT03334396|62839111|FG003|Overall Study|Pregnancy|0|||
33465620|NCT03334396|62839112|FG004|Overall Study|Pregnancy|0|||
33465621|NCT03334396|62839113|FG005|Overall Study|Pregnancy|0|||
33465622|NCT03334396|62839114|FG006|Overall Study|Pregnancy|0|||
33465623|NCT03334396|62839115|FG007|Overall Study|Pregnancy|0|||
33465624|NCT03334396|62839108|FG000|Overall Study|Ineligible|0|||
33465625|NCT03334396|62839109|FG001|Overall Study|Ineligible|1|||
33465626|NCT03334396|62839110|FG002|Overall Study|Ineligible|0|||
33465627|NCT03334396|62839111|FG003|Overall Study|Ineligible|0|||
33465628|NCT03334396|62839112|FG004|Overall Study|Ineligible|0|||
33465629|NCT03334396|62839113|FG005|Overall Study|Ineligible|0|||
33465630|NCT03334396|62839114|FG006|Overall Study|Ineligible|0|||
33465631|NCT03334396|62839115|FG007|Overall Study|Ineligible|0|||
33465632|NCT03334396|62839108|FG000|Overall Study|Started New Job|1|||
33465633|NCT03334396|62839109|FG001|Overall Study|Started New Job|0|||
33465634|NCT03334396|62839110|FG002|Overall Study|Started New Job|0|||
33465635|NCT03334396|62839111|FG003|Overall Study|Started New Job|0|||
33545902|NCT02521870|62937168|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
33545903|NCT02521870|62937169|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
33545904|NCT02521870|62937170|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
33545905|NCT02521870|62937171|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
33545906|NCT02521870|62937160|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
33545907|NCT02521870|62937161|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
33545908|NCT02521870|62937162|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
33545909|NCT02521870|62937163|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
33545910|NCT02521870|62937164|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
33545911|NCT02521870|62937165|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
33545912|NCT02521870|62937166|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
33545913|NCT02521870|62937167|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
33545914|NCT02521870|62937168|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
33545915|NCT02521870|62937169|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
33465636|NCT03334396|62839112|FG004|Overall Study|Started New Job|0|||
33465637|NCT03334396|62839113|FG005|Overall Study|Started New Job|0|||
33465638|NCT03334396|62839114|FG006|Overall Study|Started New Job|0|||
33465639|NCT03334396|62839115|FG007|Overall Study|Started New Job|0|||
33465640|NCT03338998|62839134|FG000|Treatment Period|Withdrawal by Subject|1|||
33465641|NCT03338998|62839135|FG001|Treatment Period|Withdrawal by Subject|1|||
33465642|NCT03338998|62839134|FG000|Treatment Period|Adverse Event|0|||
33545916|NCT02521870|62937170|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
33545917|NCT02521870|62937171|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
33545918|NCT02521870|62937160|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
33545919|NCT02521870|62937161|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
33545920|NCT02521870|62937162|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
33545921|NCT02521870|62937163|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
33545922|NCT02521870|62937164|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
33545923|NCT02521870|62937165|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
33545924|NCT02521870|62937166|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
33545925|NCT02521870|62937167|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
33545926|NCT02521870|62937168|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
33545927|NCT02521870|62937169|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
33545928|NCT02521870|62937170|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
33545929|NCT02521870|62937171|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
33545930|NCT02521870|62937160|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
33545931|NCT02521870|62937161|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
33545932|NCT02521870|62937162|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
33545933|NCT02521870|62937163|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
33465643|NCT03338998|62839135|FG001|Treatment Period|Adverse Event|2|||
33465644|NCT03338998|62839134|FG000|Treatment Period|Protocol deviation|1|||
33465645|NCT03338998|62839135|FG001|Treatment Period|Protocol deviation|0|||
33545934|NCT02521870|62937164|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
33545935|NCT02521870|62937165|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
33465646|NCT03338998|62839134|FG000|Treatment Period|Physician Decision|2|||
33465647|NCT03338998|62839135|FG001|Treatment Period|Physician Decision|0|||
33465648|NCT03338998|62839134|FG000|Treatment Period|Subject failed swallow test|4|||
33465649|NCT03338998|62839135|FG001|Treatment Period|Subject failed swallow test|0|||
33465650|NCT03338998|62839134|FG000|Safety Follow-Up Period|Adverse Event|0|||
33465651|NCT03338998|62839135|FG001|Safety Follow-Up Period|Adverse Event|1|||
33465652|NCT03338998|62839134|FG000|Safety Follow-Up Period|Protocol deviation|1|||
33465653|NCT03338998|62839135|FG001|Safety Follow-Up Period|Protocol deviation|0|||
33465654|NCT03338998|62839134|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
33465655|NCT03338998|62839135|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
33465656|NCT03338296|62839144|FG000|Overall Study|Adverse Event|0|||
33465657|NCT03338296|62839145|FG001|Overall Study|Adverse Event|1|||
33465658|NCT03338296|62839144|FG000|Overall Study|Withdrawal by Subject|14|||
33465659|NCT03338296|62839145|FG001|Overall Study|Withdrawal by Subject|13|||
33465660|NCT03338296|62839144|FG000|Overall Study|Lost to Follow-up|10|||
33465661|NCT03338296|62839145|FG001|Overall Study|Lost to Follow-up|10|||
33465662|NCT03338296|62839144|FG000|Overall Study|Study Terminated by Sponsor|77|||
33465663|NCT03338296|62839145|FG001|Overall Study|Study Terminated by Sponsor|76|||
33465664|NCT03338296|62839144|FG000|Overall Study|Other|2|||
33465665|NCT03338296|62839145|FG001|Overall Study|Other|7|||
33465666|NCT03338296|62839144|FG000|Overall Study|Missing|0|||
33465667|NCT03338296|62839145|FG001|Overall Study|Missing|1|||
33545936|NCT02521870|62937166|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
33545937|NCT02521870|62937167|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
33545938|NCT02521870|62937168|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
33545939|NCT02521870|62937169|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
33545940|NCT02521870|62937170|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
33545941|NCT02521870|62937171|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
33545942|NCT02521870|62937160|FG000|Phase 2: Dose Expansion|Death|0|||
33545943|NCT02521870|62937161|FG001|Phase 2: Dose Expansion|Death|0|||
33545944|NCT02521870|62937162|FG002|Phase 2: Dose Expansion|Death|0|||
33545945|NCT02521870|62937163|FG003|Phase 2: Dose Expansion|Death|0|||
33545946|NCT02521870|62937164|FG004|Phase 2: Dose Expansion|Death|1|||
33545947|NCT02521870|62937165|FG005|Phase 2: Dose Expansion|Death|1|||
33545948|NCT02521870|62937166|FG006|Phase 2: Dose Expansion|Death|3|||
33465668|NCT03338062|62839153|FG000|Overall Study|Alternative Therapy|1|||
33465669|NCT03338062|62839154|FG001|Overall Study|Alternative Therapy|0|||
33465670|NCT03364192|62839161|FG000|Overall Study|Ineligible|10|||
33545949|NCT02521870|62937167|FG007|Phase 2: Dose Expansion|Death|1|||
33545950|NCT02521870|62937168|FG008|Phase 2: Dose Expansion|Death|1|||
33465671|NCT03364192|62839161|FG000|Overall Study|Withdrawal by Subject|5|||
33465672|NCT03364192|62839161|FG000|Overall Study|Lost to Follow-up|1|||
33465673|NCT03783962|62839168|FG000|Overall Study|Lost to Follow-up|3|||
33465674|NCT03783962|62839169|FG001|Overall Study|Lost to Follow-up|6|||
33465675|NCT03783962|62839168|FG000|Overall Study|Protocol Violation|0|||
33465676|NCT03783962|62839169|FG001|Overall Study|Protocol Violation|1|||
33465677|NCT03361228|62839177|FG000|Overall Study|Other|1|||
33465678|NCT03361228|62839178|FG001|Overall Study|Other|1|||
33465679|NCT03361228|62839177|FG000|Overall Study|Death|3|||
33465680|NCT03361228|62839178|FG001|Overall Study|Death|0|||
33465681|NCT03359590|62839184|FG000|First Intervention|Withdrawal by Subject|1|||
33465682|NCT03359590|62839185|FG001|First Intervention|Withdrawal by Subject|1|||
33465683|NCT03359590|62839184|FG000|First Intervention|Protocol Violation|0|||
33465684|NCT03359590|62839185|FG001|First Intervention|Protocol Violation|1|||
33465685|NCT05085964|62839193|FG000|Overall Study|Premature termination of study|21|||
33465686|NCT05085964|62839194|FG001|Overall Study|Premature termination of study|0|||
33465687|NCT02891200|62839203|FG000|Overall Study|Lost to Follow-up|31|||
33465688|NCT02891200|62839204|FG001|Overall Study|Lost to Follow-up|36|||
33465689|NCT02891200|62839203|FG000|Overall Study|Death|10|||
33465690|NCT02891200|62839204|FG001|Overall Study|Death|9|||
33465691|NCT02891200|62839203|FG000|Overall Study|Withdrawal by Subject|1|||
33465692|NCT02891200|62839204|FG001|Overall Study|Withdrawal by Subject|4|||
33465693|NCT02946580|62839212|FG000|Overall Study|Withdrawal by Subject|1|||
33465694|NCT02946580|62839213|FG001|Overall Study|Withdrawal by Subject|2|||
33465695|NCT02946580|62839212|FG000|Overall Study|Adverse Event|0|||
33465696|NCT02946580|62839213|FG001|Overall Study|Adverse Event|2|||
33465697|NCT02946580|62839212|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
33465698|NCT02946580|62839213|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
33545951|NCT02521870|62937169|FG009|Phase 2: Dose Expansion|Death|5|||
33545952|NCT02521870|62937170|FG010|Phase 2: Dose Expansion|Death|2|||
33545953|NCT02521870|62937171|FG011|Phase 2: Dose Expansion|Death|2|||
33545954|NCT02521870|62937160|FG000|Phase 2: Dose Expansion|Other|0|||
33545955|NCT02521870|62937161|FG001|Phase 2: Dose Expansion|Other|0|||
33545956|NCT02521870|62937162|FG002|Phase 2: Dose Expansion|Other|0|||
33545957|NCT02521870|62937163|FG003|Phase 2: Dose Expansion|Other|0|||
33545958|NCT02521870|62937164|FG004|Phase 2: Dose Expansion|Other|10|||
33545959|NCT02521870|62937165|FG005|Phase 2: Dose Expansion|Other|3|||
33545960|NCT02521870|62937166|FG006|Phase 2: Dose Expansion|Other|2|||
33545961|NCT02521870|62937167|FG007|Phase 2: Dose Expansion|Other|0|||
33545962|NCT02521870|62937168|FG008|Phase 2: Dose Expansion|Other|10|||
33545963|NCT02521870|62937169|FG009|Phase 2: Dose Expansion|Other|5|||
33545964|NCT02521870|62937170|FG010|Phase 2: Dose Expansion|Other|1|||
33545965|NCT02521870|62937171|FG011|Phase 2: Dose Expansion|Other|7|||
33545966|NCT02521870|62937160|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33545967|NCT02521870|62937161|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33545968|NCT02521870|62937162|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33545969|NCT02521870|62937163|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33545970|NCT02521870|62937164|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
33545971|NCT02521870|62937165|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33545972|NCT02521870|62937166|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33545973|NCT02521870|62937167|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33545974|NCT02521870|62937168|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33545975|NCT02521870|62937169|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33545976|NCT02521870|62937170|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33545977|NCT02521870|62937171|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33545978|NCT02521870|62937160|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33545979|NCT02521870|62937161|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33545980|NCT02521870|62937162|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33545981|NCT02521870|62937163|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33545982|NCT02521870|62937164|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
33545983|NCT02521870|62937165|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33545984|NCT02521870|62937166|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33545985|NCT02521870|62937167|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33545986|NCT02521870|62937168|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33465699|NCT00323609|62839221|FG000|Overall Study|Death|16|||
33465700|NCT00323609|62839222|FG001|Overall Study|Death|21|||
33465701|NCT00323609|62839223|FG002|Overall Study|Death|0|||
33465702|NCT00323609|62839224|FG003|Overall Study|Death|0|||
33465703|NCT00323609|62839221|FG000|Overall Study|Lost to Follow-up|9|||
33465704|NCT00323609|62839222|FG001|Overall Study|Lost to Follow-up|10|||
33545987|NCT02521870|62937169|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33545988|NCT02521870|62937170|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33465705|NCT00323609|62839223|FG002|Overall Study|Lost to Follow-up|0|||
33545989|NCT02521870|62937171|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33545990|NCT02923349|62937208|FG000|Overall Study|Other|1|||
33545991|NCT02923349|62937209|FG001|Overall Study|Other|2|||
33545992|NCT02923349|62937210|FG002|Overall Study|Other|4|||
33465706|NCT00323609|62839224|FG003|Overall Study|Lost to Follow-up|0|||
33465707|NCT00323609|62839221|FG000|Overall Study|Physician Decision|2|||
33465708|NCT00323609|62839222|FG001|Overall Study|Physician Decision|0|||
33465709|NCT00323609|62839223|FG002|Overall Study|Physician Decision|0|||
33545993|NCT02923349|62937211|FG003|Overall Study|Other|1|||
33545994|NCT02923349|62937212|FG004|Overall Study|Other|3|||
33545995|NCT02923349|62937213|FG005|Overall Study|Other|0|||
33545996|NCT02923349|62937214|FG006|Overall Study|Other|1|||
33545997|NCT02923349|62937208|FG000|Overall Study|Withdrawal by Subject|2|||
33545998|NCT02923349|62937209|FG001|Overall Study|Withdrawal by Subject|2|||
33545999|NCT02923349|62937210|FG002|Overall Study|Withdrawal by Subject|8|||
33546000|NCT02923349|62937211|FG003|Overall Study|Withdrawal by Subject|10|||
33546001|NCT02923349|62937212|FG004|Overall Study|Withdrawal by Subject|12|||
33546002|NCT02923349|62937213|FG005|Overall Study|Withdrawal by Subject|3|||
33546003|NCT02923349|62937214|FG006|Overall Study|Withdrawal by Subject|0|||
33546004|NCT02923349|62937208|FG000|Overall Study|Physician Decision|0|||
33465710|NCT00323609|62839224|FG003|Overall Study|Physician Decision|1|||
33465711|NCT00323609|62839221|FG000|Overall Study|Withdrawal by Subject|11|||
33465712|NCT00323609|62839222|FG001|Overall Study|Withdrawal by Subject|23|||
33465713|NCT00323609|62839223|FG002|Overall Study|Withdrawal by Subject|4|||
33546005|NCT02923349|62937209|FG001|Overall Study|Physician Decision|0|||
33546006|NCT02923349|62937210|FG002|Overall Study|Physician Decision|0|||
33546007|NCT02923349|62937211|FG003|Overall Study|Physician Decision|1|||
33546008|NCT02923349|62937212|FG004|Overall Study|Physician Decision|1|||
33328747|NCT01193582|62705156|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
33328748|NCT01193582|62705157|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
33328749|NCT01193582|62705158|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
33328750|NCT01193582|62705159|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
33328751|NCT00945477|62705171|FG000|Overall Study|Adverse Event|3|||
33328752|NCT00945477|62705171|FG000|Overall Study|Lack of Efficacy|2|||
33328753|NCT00945477|62705171|FG000|Overall Study|Withdrawal by Subject|1|||
33328754|NCT01076088|62705182|FG000|Overall Study|Adverse Event|1|||
33328755|NCT01076088|62705183|FG001|Overall Study|Adverse Event|6|||
33328756|NCT01076088|62705184|FG002|Overall Study|Adverse Event|3|||
33465714|NCT00323609|62839224|FG003|Overall Study|Withdrawal by Subject|4|||
33328757|NCT01076088|62705185|FG003|Overall Study|Adverse Event|2|||
33328758|NCT01076088|62705186|FG004|Overall Study|Adverse Event|3|||
33546009|NCT02923349|62937213|FG005|Overall Study|Physician Decision|0|||
33546010|NCT02923349|62937214|FG006|Overall Study|Physician Decision|2|||
33546011|NCT02923349|62937208|FG000|Overall Study|Lost to Follow-up|0|||
33546012|NCT02923349|62937209|FG001|Overall Study|Lost to Follow-up|0|||
33546013|NCT02923349|62937210|FG002|Overall Study|Lost to Follow-up|3|||
33465715|NCT00323609|62839221|FG000|Overall Study|Other non-VCF-related medical condition|3|||
33465716|NCT00323609|62839222|FG001|Overall Study|Other non-VCF-related medical condition|2|||
33465717|NCT00323609|62839223|FG002|Overall Study|Other non-VCF-related medical condition|0|||
33465718|NCT00323609|62839224|FG003|Overall Study|Other non-VCF-related medical condition|0|||
33465719|NCT00323609|62839221|FG000|Overall Study|Sponsor discontinued trial|29|||
33465720|NCT00323609|62839222|FG001|Overall Study|Sponsor discontinued trial|29|||
33465721|NCT00323609|62839223|FG002|Overall Study|Sponsor discontinued trial|0|||
33465722|NCT00323609|62839224|FG003|Overall Study|Sponsor discontinued trial|0|||
33465723|NCT00323609|62839221|FG000|Overall Study|Unrelenting or severe back pain|1|||
33465724|NCT00323609|62839222|FG001|Overall Study|Unrelenting or severe back pain|1|||
33465725|NCT00323609|62839223|FG002|Overall Study|Unrelenting or severe back pain|0|||
33465726|NCT00323609|62839224|FG003|Overall Study|Unrelenting or severe back pain|0|||
33465727|NCT00323609|62839221|FG000|Overall Study|Logistical withdrawal|9|||
33465728|NCT00323609|62839222|FG001|Overall Study|Logistical withdrawal|5|||
33465729|NCT00323609|62839223|FG002|Overall Study|Logistical withdrawal|0|||
33465730|NCT00323609|62839224|FG003|Overall Study|Logistical withdrawal|1|||
33465731|NCT00323609|62839221|FG000|Overall Study|Other reason|11|||
33465732|NCT00323609|62839222|FG001|Overall Study|Other reason|8|||
33465733|NCT00323609|62839223|FG002|Overall Study|Other reason|4|||
33465734|NCT00323609|62839224|FG003|Overall Study|Other reason|9|||
33465735|NCT04598152|62839230|FG000|Overall Study|Lost to Follow-up|0|||
33465736|NCT04598152|62839231|FG001|Overall Study|Lost to Follow-up|1|||
33465737|NCT00323297|62839239|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
33546014|NCT02923349|62937211|FG003|Overall Study|Lost to Follow-up|0|||
33546015|NCT02923349|62937212|FG004|Overall Study|Lost to Follow-up|1|||
33546016|NCT02923349|62937213|FG005|Overall Study|Lost to Follow-up|1|||
33546017|NCT02923349|62937214|FG006|Overall Study|Lost to Follow-up|0|||
33546018|NCT02923349|62937208|FG000|Overall Study|Death|1|||
33546019|NCT02923349|62937209|FG001|Overall Study|Death|0|||
33546020|NCT02923349|62937210|FG002|Overall Study|Death|2|||
33546021|NCT02923349|62937211|FG003|Overall Study|Death|4|||
33546022|NCT02923349|62937212|FG004|Overall Study|Death|2|||
33546023|NCT02923349|62937213|FG005|Overall Study|Death|3|||
33546024|NCT02923349|62937214|FG006|Overall Study|Death|0|||
33546025|NCT02521792|62937230|FG000|Overall Study|Study Terminated|6|||
33546026|NCT03020615|62937237|FG000|Overall Study|Physician Decision|3|||
33546027|NCT03020615|62937238|FG001|Overall Study|Physician Decision|1|||
33465738|NCT00323297|62839240|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
33465739|NCT00323297|62839239|FG000|Part A (Double Blind Randomized)|Death|0|||
33465740|NCT00323297|62839240|FG001|Part A (Double Blind Randomized)|Death|1|||
33465741|NCT00323297|62839239|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
33546028|NCT03020615|62937239|FG002|Overall Study|Physician Decision|2|||
33546029|NCT03020615|62937237|FG000|Overall Study|Parent/guardian/patient choice|3|||
33546030|NCT03020615|62937238|FG001|Overall Study|Parent/guardian/patient choice|0|||
33546031|NCT03020615|62937239|FG002|Overall Study|Parent/guardian/patient choice|4|||
33546032|NCT03020615|62937237|FG000|Overall Study|Screen failure|0|||
33465742|NCT00323297|62839240|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
33465743|NCT00323297|62839239|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
33465744|NCT00323297|62839240|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
33465745|NCT00323297|62839239|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
33465746|NCT00323297|62839240|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
33465747|NCT00323297|62839239|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
33465748|NCT00323297|62839240|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
33465749|NCT00323297|62839239|FG000|Part B (Open-label)|Death|0|||
33465750|NCT00323297|62839240|FG001|Part B (Open-label)|Death|1|||
33465751|NCT00323297|62839239|FG000|Part B (Open-label)|Reason unspecified|0|||
33465752|NCT00323297|62839240|FG001|Part B (Open-label)|Reason unspecified|1|||
33465753|NCT00323297|62839239|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
33465754|NCT00323297|62839240|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
33465755|NCT00323297|62839239|FG000|Part B (Open-label)|Lack of Efficacy|3|||
33465756|NCT00323297|62839240|FG001|Part B (Open-label)|Lack of Efficacy|1|||
33465757|NCT00323297|62839239|FG000|Part B (Open-label)|Adverse Event|5|||
33546033|NCT03020615|62937238|FG001|Overall Study|Screen failure|0|||
33546034|NCT03020615|62937239|FG002|Overall Study|Screen failure|1|||
33546035|NCT03020615|62937237|FG000|Overall Study|Death|1|||
33546036|NCT03020615|62937238|FG001|Overall Study|Death|0|||
33465758|NCT00323297|62839240|FG001|Part B (Open-label)|Adverse Event|5|||
33465759|NCT00323297|62839239|FG000|Part B (Open-label)|Protocol Violation|0|||
33465760|NCT00323297|62839240|FG001|Part B (Open-label)|Protocol Violation|1|||
33546037|NCT03020615|62937239|FG002|Overall Study|Death|0|||
33546038|NCT03020615|62937237|FG000|Overall Study|Lost to Follow-up|0|||
33546039|NCT03020615|62937238|FG001|Overall Study|Lost to Follow-up|1|||
33546040|NCT03020615|62937239|FG002|Overall Study|Lost to Follow-up|0|||
33546041|NCT03020069|62937252|FG000|Overall Study|Lost to Follow-up|0|||
33465761|NCT00323063|62839248|FG000|Overall Study|Adverse Event|1|||
33465762|NCT00323063|62839249|FG001|Overall Study|Adverse Event|0|||
33465763|NCT00323063|62839248|FG000|Overall Study|brain mets discovered prior to treatment|1|||
33546042|NCT03020069|62937253|FG001|Overall Study|Lost to Follow-up|1|||
33546043|NCT03693170|62937259|FG000|Overall Study|Disease Progression|48|||
33546044|NCT03693170|62937259|FG000|Overall Study|Adverse Event|16|||
33546045|NCT03693170|62937259|FG000|Overall Study|Physician Decision|6|||
33546046|NCT03693170|62937259|FG000|Overall Study|Protocol Violation|2|||
33546047|NCT03693170|62937259|FG000|Overall Study|Death|1|||
33546048|NCT03693170|62937259|FG000|Overall Study|Non compliance with study drug|1|||
33546049|NCT03693170|62937259|FG000|Overall Study|Withdrawal by Subject|1|||
33546050|NCT03021005|62937266|FG000|Overall Study|Lost to Follow-up|39|||
33546051|NCT03021005|62937267|FG001|Overall Study|Lost to Follow-up|26|||
33546052|NCT02914457|62937273|FG000|Overall Study|Withdrawal by Subject|1|||
33546053|NCT02914457|62937273|FG000|Overall Study|Physician Decision|1|||
33546054|NCT02914457|62937273|FG000|Overall Study|No veins available for lead placement|1|||
33546055|NCT02914457|62937273|FG000|Overall Study|Electrical instability of patient|1|||
33546056|NCT02914457|62937273|FG000|Overall Study|ECG acquisition error due to sweating|1|||
33546057|NCT02914457|62937273|FG000|Overall Study|Protocol Violation|1|||
33546058|NCT02665052|62937281|FG000|Overall Study|Lost to Follow-up|1|||
33546059|NCT02665052|62937282|FG001|Overall Study|Lost to Follow-up|0|||
33546060|NCT02665052|62937283|FG002|Overall Study|Lost to Follow-up|0|||
33546061|NCT02665052|62937284|FG003|Overall Study|Lost to Follow-up|0|||
33546062|NCT02665052|62937281|FG000|Overall Study|Withdrawal by Subject|1|||
33546063|NCT02665052|62937282|FG001|Overall Study|Withdrawal by Subject|1|||
33546064|NCT02665052|62937283|FG002|Overall Study|Withdrawal by Subject|0|||
33546065|NCT02665052|62937284|FG003|Overall Study|Withdrawal by Subject|5|||
33546066|NCT02665052|62937281|FG000|Overall Study|Adverse Event|1|||
33546067|NCT02665052|62937282|FG001|Overall Study|Adverse Event|1|||
33546068|NCT02665052|62937283|FG002|Overall Study|Adverse Event|0|||
33546069|NCT02665052|62937284|FG003|Overall Study|Adverse Event|0|||
33546070|NCT03019289|62937304|FG000|Overall Study|Adverse Event|1|||
33546071|NCT03019289|62937305|FG001|Overall Study|Adverse Event|0|||
33546072|NCT03019289|62937306|FG002|Overall Study|Adverse Event|0|||
33546073|NCT03019289|62937307|FG003|Overall Study|Adverse Event|0|||
33546074|NCT03019289|62937308|FG004|Overall Study|Adverse Event|0|||
33546075|NCT03019289|62937309|FG005|Overall Study|Adverse Event|0|||
33546076|NCT03019289|62937310|FG006|Overall Study|Adverse Event|0|||
33546077|NCT03019289|62937311|FG007|Overall Study|Adverse Event|0|||
33546078|NCT03019289|62937312|FG008|Overall Study|Adverse Event|1|||
33465764|NCT00323063|62839249|FG001|Overall Study|brain mets discovered prior to treatment|0|||
33465765|NCT00322049|62839259|FG000|Overall Study|Moved out of area|0|||
33465766|NCT00322049|62839260|FG001|Overall Study|Moved out of area|0|||
33465767|NCT00322049|62839261|FG002|Overall Study|Moved out of area|0|||
33465768|NCT00322049|62839262|FG003|Overall Study|Moved out of area|1|||
33465769|NCT00322049|62839259|FG000|Overall Study|Infected with Dengue during study|0|||
33465770|NCT00322049|62839260|FG001|Overall Study|Infected with Dengue during study|1|||
33465771|NCT00322049|62839261|FG002|Overall Study|Infected with Dengue during study|0|||
33465772|NCT00322049|62839262|FG003|Overall Study|Infected with Dengue during study|0|||
33546079|NCT03019289|62937304|FG000|Overall Study|Other|1|||
33465773|NCT00321893|62839283|FG000|Overall Study|Non-Compliance/Refusal|16|||
33465774|NCT00321893|62839284|FG001|Overall Study|Non-Compliance/Refusal|10|||
33546080|NCT03019289|62937305|FG001|Overall Study|Other|0|||
33546081|NCT03019289|62937306|FG002|Overall Study|Other|0|||
33546082|NCT03019289|62937307|FG003|Overall Study|Other|0|||
33546083|NCT03019289|62937308|FG004|Overall Study|Other|0|||
33546084|NCT03019289|62937309|FG005|Overall Study|Other|0|||
33546085|NCT03019289|62937310|FG006|Overall Study|Other|0|||
33546086|NCT03019289|62937311|FG007|Overall Study|Other|0|||
33465775|NCT00321893|62839283|FG000|Overall Study|Lost to Follow-up|2|||
33546087|NCT03019289|62937312|FG008|Overall Study|Other|0|||
33465776|NCT00321893|62839284|FG001|Overall Study|Lost to Follow-up|1|||
33465777|NCT00321893|62839283|FG000|Overall Study|Adverse Event|6|||
33465778|NCT00321893|62839284|FG001|Overall Study|Adverse Event|3|||
33465779|NCT00371345|62839292|FG000|Overall Study|Disease Progression|21|||
33465780|NCT00371345|62839293|FG001|Overall Study|Disease Progression|35|||
33465781|NCT00371345|62839292|FG000|Overall Study|Study Drug Toxicity|1|||
33465782|NCT00371345|62839293|FG001|Overall Study|Study Drug Toxicity|7|||
33465783|NCT00371345|62839292|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
33465784|NCT00371345|62839293|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
33465785|NCT00371345|62839292|FG000|Overall Study|Participant Request|1|||
33465786|NCT00371345|62839293|FG001|Overall Study|Participant Request|1|||
33465787|NCT00371345|62839292|FG000|Overall Study|Participant Withdrew Consent|0|||
33465788|NCT00371345|62839293|FG001|Overall Study|Participant Withdrew Consent|1|||
33465789|NCT00321737|62839316|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
33465790|NCT00321737|62839317|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
33465791|NCT00321737|62839318|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
33465792|NCT00321737|62839316|FG000|Overall Study|Adverse Event|11|||
33465793|NCT00321737|62839317|FG001|Overall Study|Adverse Event|3|||
33465794|NCT00321737|62839318|FG002|Overall Study|Adverse Event|6|||
33465795|NCT00321737|62839316|FG000|Overall Study|Lost to Follow-up|5|||
33465796|NCT00321737|62839317|FG001|Overall Study|Lost to Follow-up|5|||
33465797|NCT00321737|62839318|FG002|Overall Study|Lost to Follow-up|6|||
33465798|NCT00321737|62839316|FG000|Overall Study|Withdrawal by Subject|19|||
33465799|NCT00321737|62839317|FG001|Overall Study|Withdrawal by Subject|12|||
33465800|NCT00321737|62839318|FG002|Overall Study|Withdrawal by Subject|17|||
33465801|NCT00321737|62839316|FG000|Overall Study|Protocol Violation|0|||
33465802|NCT00321737|62839317|FG001|Overall Study|Protocol Violation|0|||
33465803|NCT00321737|62839318|FG002|Overall Study|Protocol Violation|1|||
33465804|NCT00321737|62839316|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
33465805|NCT00321737|62839317|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
33465806|NCT00321737|62839318|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
33465807|NCT00321737|62839316|FG000|Overall Study|Possible Barrett's Esophagus|2|||
33465808|NCT00321737|62839317|FG001|Overall Study|Possible Barrett's Esophagus|1|||
33465809|NCT00321737|62839318|FG002|Overall Study|Possible Barrett's Esophagus|1|||
33465810|NCT00321737|62839316|FG000|Overall Study|Therapeutic Failure|6|||
33465811|NCT00321737|62839317|FG001|Overall Study|Therapeutic Failure|0|||
33465812|NCT00321737|62839318|FG002|Overall Study|Therapeutic Failure|2|||
33465813|NCT00321737|62839316|FG000|Overall Study|Pregnancy|0|||
33465814|NCT00321737|62839317|FG001|Overall Study|Pregnancy|2|||
33465815|NCT00321737|62839318|FG002|Overall Study|Pregnancy|0|||
33465816|NCT00321737|62839316|FG000|Overall Study|Noncompliance|2|||
33465817|NCT00321737|62839317|FG001|Overall Study|Noncompliance|0|||
33465818|NCT00321737|62839318|FG002|Overall Study|Noncompliance|0|||
33465819|NCT00321737|62839316|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
33465820|NCT00321737|62839317|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
33465821|NCT00321737|62839318|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
33465822|NCT00320801|62839328|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
33465823|NCT00320801|62839329|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
33465824|NCT00320801|62839330|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
33465825|NCT00320801|62839331|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
33465826|NCT00320801|62839328|FG000|Open-label Run-in Period|Adverse Event|33|||
33465827|NCT00320801|62839329|FG001|Open-label Run-in Period|Adverse Event|0|||
33465828|NCT00320801|62839330|FG002|Open-label Run-in Period|Adverse Event|0|||
33465829|NCT00320801|62839331|FG003|Open-label Run-in Period|Adverse Event|0|||
33465830|NCT00320801|62839328|FG000|Open-label Run-in Period|Administrative|10|||
33465831|NCT00320801|62839329|FG001|Open-label Run-in Period|Administrative|0|||
33465832|NCT00320801|62839330|FG002|Open-label Run-in Period|Administrative|0|||
33465833|NCT00320801|62839331|FG003|Open-label Run-in Period|Administrative|0|||
33465834|NCT00320801|62839328|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
33465835|NCT00320801|62839329|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
33465836|NCT00320801|62839330|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
33465837|NCT00320801|62839331|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
33465838|NCT00320801|62839328|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
33465839|NCT00320801|62839329|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
33465840|NCT00320801|62839330|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
33465841|NCT00320801|62839331|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
33465842|NCT00320801|62839328|FG000|Open-label Run-in Period|Did not qualify|1|||
33465843|NCT00320801|62839329|FG001|Open-label Run-in Period|Did not qualify|0|||
33465844|NCT00320801|62839330|FG002|Open-label Run-in Period|Did not qualify|0|||
33465845|NCT00320801|62839331|FG003|Open-label Run-in Period|Did not qualify|0|||
33465846|NCT00320801|62839328|FG000|Double-blind Phase|Withdrawal by Subject|0|||
33465847|NCT00320801|62839329|FG001|Double-blind Phase|Withdrawal by Subject|0|||
33465848|NCT00320801|62839330|FG002|Double-blind Phase|Withdrawal by Subject|1|||
33465849|NCT00320801|62839331|FG003|Double-blind Phase|Withdrawal by Subject|0|||
33465850|NCT00320801|62839328|FG000|Double-blind Phase|Adverse Event|0|||
33465851|NCT00320801|62839329|FG001|Double-blind Phase|Adverse Event|2|||
33465852|NCT00320801|62839330|FG002|Double-blind Phase|Adverse Event|8|||
33465853|NCT00320801|62839331|FG003|Double-blind Phase|Adverse Event|0|||
33465854|NCT00320801|62839328|FG000|Double-blind Phase|Administrative|0|||
33465855|NCT00320801|62839329|FG001|Double-blind Phase|Administrative|0|||
33465856|NCT00320801|62839330|FG002|Double-blind Phase|Administrative|4|||
33465857|NCT00320801|62839331|FG003|Double-blind Phase|Administrative|0|||
33465858|NCT00320801|62839328|FG000|Double-blind Phase|Lack of Efficacy|0|||
33465859|NCT00320801|62839329|FG001|Double-blind Phase|Lack of Efficacy|9|||
33465860|NCT00320801|62839330|FG002|Double-blind Phase|Lack of Efficacy|1|||
33465861|NCT00320801|62839331|FG003|Double-blind Phase|Lack of Efficacy|0|||
33465862|NCT00320801|62839328|FG000|Extension Phase|Withdrawal by Subject|0|||
33465863|NCT00320801|62839329|FG001|Extension Phase|Withdrawal by Subject|0|||
33465864|NCT00320801|62839330|FG002|Extension Phase|Withdrawal by Subject|0|||
33465865|NCT00320801|62839331|FG003|Extension Phase|Withdrawal by Subject|6|||
33465866|NCT00320801|62839328|FG000|Extension Phase|Adverse Event|0|||
33465867|NCT00320801|62839329|FG001|Extension Phase|Adverse Event|0|||
33465868|NCT00320801|62839330|FG002|Extension Phase|Adverse Event|0|||
33465869|NCT00320801|62839331|FG003|Extension Phase|Adverse Event|8|||
33465870|NCT00320801|62839328|FG000|Extension Phase|Administrative|0|||
33465871|NCT00320801|62839329|FG001|Extension Phase|Administrative|0|||
33465872|NCT00320801|62839330|FG002|Extension Phase|Administrative|0|||
33465873|NCT00320801|62839331|FG003|Extension Phase|Administrative|29|||
33465874|NCT00320801|62839328|FG000|Extension Phase|Lack of Efficacy|0|||
33465875|NCT00320801|62839329|FG001|Extension Phase|Lack of Efficacy|0|||
33465876|NCT00320801|62839330|FG002|Extension Phase|Lack of Efficacy|0|||
33465877|NCT00320801|62839331|FG003|Extension Phase|Lack of Efficacy|2|||
33465878|NCT00320801|62839328|FG000|Extension Phase|Lost to Follow-up|0|||
33465879|NCT00320801|62839329|FG001|Extension Phase|Lost to Follow-up|0|||
33465880|NCT00320801|62839330|FG002|Extension Phase|Lost to Follow-up|0|||
33465881|NCT00320801|62839331|FG003|Extension Phase|Lost to Follow-up|3|||
33465882|NCT00320489|62839343|FG000|Overall Study|Adverse Event|26|||
33465883|NCT00320489|62839344|FG001|Overall Study|Adverse Event|25|||
33465884|NCT00320489|62839343|FG000|Overall Study|Clinical Relapse|26|||
33465885|NCT00320489|62839344|FG001|Overall Study|Clinical Relapse|20|||
33465886|NCT00320489|62839343|FG000|Overall Study|Death|0|||
33465887|NCT00320489|62839344|FG001|Overall Study|Death|2|||
33465888|NCT00320489|62839343|FG000|Overall Study|Entry Criteria Exclusion|2|||
33465889|NCT00320489|62839344|FG001|Overall Study|Entry Criteria Exclusion|4|||
33465890|NCT00320489|62839343|FG000|Overall Study|Lack of Efficacy|16|||
33465891|NCT00320489|62839344|FG001|Overall Study|Lack of Efficacy|7|||
33465892|NCT00320489|62839343|FG000|Overall Study|Lost to Follow-up|21|||
33465893|NCT00320489|62839344|FG001|Overall Study|Lost to Follow-up|22|||
33465894|NCT00320489|62839343|FG000|Overall Study|Physician Decision|8|||
33465895|NCT00320489|62839344|FG001|Overall Study|Physician Decision|8|||
33465896|NCT00320489|62839343|FG000|Overall Study|Protocol Violation|4|||
33465897|NCT00320489|62839344|FG001|Overall Study|Protocol Violation|4|||
33465898|NCT00320489|62839343|FG000|Overall Study|Sponsor Decision|3|||
33465899|NCT00320489|62839344|FG001|Overall Study|Sponsor Decision|3|||
33465900|NCT00320489|62839343|FG000|Overall Study|Withdrawal by Subject|39|||
33465901|NCT00320489|62839344|FG001|Overall Study|Withdrawal by Subject|41|||
33465902|NCT03928028|62839353|FG000|Overall Study|Physician Decision|9|||
33465903|NCT03928028|62839354|FG001|Overall Study|Physician Decision|6|||
33465904|NCT03928028|62839355|FG002|Overall Study|Physician Decision|3|||
33465905|NCT03928028|62839353|FG000|Overall Study|Withdrawal by Subject|12|||
33465906|NCT03928028|62839354|FG001|Overall Study|Withdrawal by Subject|3|||
33465907|NCT03928028|62839355|FG002|Overall Study|Withdrawal by Subject|3|||
33465908|NCT00320411|62839363|FG000|Overall Study|No investigational product admin.|4|||
33465909|NCT00320255|62839373|FG000|Overall Study|Lack of Efficacy|1|||
33465910|NCT00320255|62839374|FG001|Overall Study|Lack of Efficacy|0|||
33465911|NCT00320255|62839375|FG002|Overall Study|Lack of Efficacy|0|||
33465912|NCT00320255|62839376|FG003|Overall Study|Lack of Efficacy|0|||
33465913|NCT00320255|62839377|FG004|Overall Study|Lack of Efficacy|0|||
33465914|NCT00320255|62839378|FG005|Overall Study|Lack of Efficacy|0|||
33465915|NCT00320255|62839373|FG000|Overall Study|Adverse Event|5|||
33465916|NCT00320255|62839374|FG001|Overall Study|Adverse Event|2|||
33465917|NCT00320255|62839375|FG002|Overall Study|Adverse Event|3|||
33465918|NCT00320255|62839376|FG003|Overall Study|Adverse Event|2|||
33465919|NCT00320255|62839377|FG004|Overall Study|Adverse Event|0|||
33465920|NCT00320255|62839378|FG005|Overall Study|Adverse Event|0|||
33465921|NCT00320255|62839373|FG000|Overall Study|Withdrawal by Subject|1|||
33465922|NCT00320255|62839374|FG001|Overall Study|Withdrawal by Subject|2|||
33465923|NCT00320255|62839375|FG002|Overall Study|Withdrawal by Subject|2|||
33465924|NCT00320255|62839376|FG003|Overall Study|Withdrawal by Subject|4|||
33465925|NCT00320255|62839377|FG004|Overall Study|Withdrawal by Subject|0|||
33465926|NCT00320255|62839378|FG005|Overall Study|Withdrawal by Subject|0|||
33465927|NCT00320255|62839373|FG000|Overall Study|Poor compliance/noncompliance|1|||
33465928|NCT00320255|62839374|FG001|Overall Study|Poor compliance/noncompliance|1|||
33465929|NCT00320255|62839375|FG002|Overall Study|Poor compliance/noncompliance|0|||
33465930|NCT00320255|62839376|FG003|Overall Study|Poor compliance/noncompliance|1|||
33465931|NCT00320255|62839377|FG004|Overall Study|Poor compliance/noncompliance|0|||
33465932|NCT00320255|62839378|FG005|Overall Study|Poor compliance/noncompliance|0|||
33465933|NCT00320255|62839373|FG000|Overall Study|No longer meets study criteria|0|||
33465934|NCT00320255|62839374|FG001|Overall Study|No longer meets study criteria|0|||
33465935|NCT00320255|62839375|FG002|Overall Study|No longer meets study criteria|0|||
33465936|NCT00320255|62839376|FG003|Overall Study|No longer meets study criteria|1|||
33465937|NCT00320255|62839377|FG004|Overall Study|No longer meets study criteria|0|||
33465938|NCT00320255|62839378|FG005|Overall Study|No longer meets study criteria|0|||
33465939|NCT00320255|62839373|FG000|Overall Study|Other|3|||
33465940|NCT00320255|62839374|FG001|Overall Study|Other|2|||
33465941|NCT00320255|62839375|FG002|Overall Study|Other|1|||
33465942|NCT00320255|62839376|FG003|Overall Study|Other|0|||
33465943|NCT00320255|62839377|FG004|Overall Study|Other|0|||
33465944|NCT00320255|62839378|FG005|Overall Study|Other|0|||
33465945|NCT00370331|62839395|FG000|Overall Study|Adverse Event|4|||
33465946|NCT00370331|62839396|FG001|Overall Study|Adverse Event|13|||
33465947|NCT00370331|62839395|FG000|Overall Study|Withdrawal by Subject|2|||
33465948|NCT00370331|62839396|FG001|Overall Study|Withdrawal by Subject|4|||
33465949|NCT00370331|62839395|FG000|Overall Study|Lost to Follow-up|0|||
33465950|NCT00370331|62839396|FG001|Overall Study|Lost to Follow-up|3|||
33465951|NCT00370331|62839395|FG000|Overall Study|Lack of Efficacy|0|||
33465952|NCT00370331|62839396|FG001|Overall Study|Lack of Efficacy|1|||
33465953|NCT00370331|62839395|FG000|Overall Study|Non-compliance|0|||
33465954|NCT00370331|62839396|FG001|Overall Study|Non-compliance|1|||
33465955|NCT00370331|62839395|FG000|Overall Study|Protocol Violation|1|||
33465956|NCT00370331|62839396|FG001|Overall Study|Protocol Violation|1|||
33465957|NCT02962960|62839405|FG000|Overall Study|Withdrawal by Subject|1|||
33465958|NCT02962960|62839406|FG001|Overall Study|Withdrawal by Subject|1|||
33465959|NCT02962960|62839407|FG002|Overall Study|Withdrawal by Subject|0|||
33465960|NCT02962960|62839405|FG000|Overall Study|Adverse Event|1|||
33465961|NCT02962960|62839406|FG001|Overall Study|Adverse Event|1|||
33328759|NCT01076088|62705187|FG005|Overall Study|Adverse Event|3|||
33328760|NCT01076088|62705182|FG000|Overall Study|Lost to Follow-up|1|||
33328761|NCT01076088|62705183|FG001|Overall Study|Lost to Follow-up|1|||
33328762|NCT01076088|62705184|FG002|Overall Study|Lost to Follow-up|0|||
33328763|NCT01076088|62705185|FG003|Overall Study|Lost to Follow-up|1|||
33328764|NCT01076088|62705186|FG004|Overall Study|Lost to Follow-up|1|||
33328765|NCT01076088|62705187|FG005|Overall Study|Lost to Follow-up|2|||
33328766|NCT01076088|62705182|FG000|Overall Study|Non-compliance with study drug|0|||
33328767|NCT01076088|62705183|FG001|Overall Study|Non-compliance with study drug|0|||
33328768|NCT01076088|62705184|FG002|Overall Study|Non-compliance with study drug|0|||
33328769|NCT01076088|62705185|FG003|Overall Study|Non-compliance with study drug|1|||
33328770|NCT01076088|62705186|FG004|Overall Study|Non-compliance with study drug|0|||
33328771|NCT01076088|62705187|FG005|Overall Study|Non-compliance with study drug|0|||
33465962|NCT02962960|62839407|FG002|Overall Study|Adverse Event|0|||
33465963|NCT02962960|62839405|FG000|Overall Study|Protocol Violation|1|||
33465964|NCT02962960|62839406|FG001|Overall Study|Protocol Violation|0|||
33465965|NCT02962960|62839407|FG002|Overall Study|Protocol Violation|0|||
33465966|NCT00369941|62839419|FG000|Overall Study|Never Treated|1|||
33465967|NCT00369941|62839420|FG001|Overall Study|Never Treated|2|||
33465968|NCT00369941|62839419|FG000|Overall Study|Adverse Event|14|||
33465969|NCT00369941|62839420|FG001|Overall Study|Adverse Event|28|||
33465970|NCT00369941|62839419|FG000|Overall Study|Lack of Efficacy|6|||
33465971|NCT00369941|62839420|FG001|Overall Study|Lack of Efficacy|10|||
33465972|NCT00369941|62839419|FG000|Overall Study|Lost to Follow-up|12|||
33465973|NCT00369941|62839420|FG001|Overall Study|Lost to Follow-up|22|||
33465974|NCT00369941|62839419|FG000|Overall Study|Protocol Violation|5|||
33465975|NCT00369941|62839420|FG001|Overall Study|Protocol Violation|3|||
33465976|NCT00369941|62839419|FG000|Overall Study|Withdrawal by Subject|5|||
33465977|NCT00369941|62839420|FG001|Overall Study|Withdrawal by Subject|18|||
33465978|NCT00369941|62839419|FG000|Overall Study|Pregnancy|4|||
33465979|NCT00369941|62839420|FG001|Overall Study|Pregnancy|2|||
33465980|NCT00369941|62839419|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
33465981|NCT00369941|62839420|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
33465982|NCT00369941|62839419|FG000|Overall Study|Moved|11|||
33465983|NCT00369941|62839420|FG001|Overall Study|Moved|5|||
33328772|NCT01076088|62705182|FG000|Overall Study|Physician Decision|1|||
33328773|NCT01076088|62705183|FG001|Overall Study|Physician Decision|3|||
33465984|NCT00369941|62839419|FG000|Overall Study|Treatment with Prohibited Medication|3|||
33465985|NCT00369941|62839420|FG001|Overall Study|Treatment with Prohibited Medication|1|||
33465986|NCT00369941|62839419|FG000|Overall Study|Employment Interfered with Study Visits|1|||
33465987|NCT00369941|62839420|FG001|Overall Study|Employment Interfered with Study Visits|0|||
33465988|NCT00369941|62839419|FG000|Overall Study|Study Site Terminated|2|||
33465989|NCT00369941|62839420|FG001|Overall Study|Study Site Terminated|0|||
33465990|NCT00369941|62839419|FG000|Overall Study|Miscellaneous|3|||
33465991|NCT00369941|62839420|FG001|Overall Study|Miscellaneous|3|||
33465992|NCT00319553|62839429|FG000|Overall Study|Protocol Violation|1|||
33465993|NCT00319553|62839430|FG001|Overall Study|Protocol Violation|2|||
33465994|NCT00319553|62839429|FG000|Overall Study|Lost to Follow-up|2|||
33465995|NCT00319553|62839430|FG001|Overall Study|Lost to Follow-up|1|||
33546088|NCT02520388|62937335|FG000|Overall Study|Physician Decision|1|||
33546089|NCT02520388|62937336|FG001|Overall Study|Physician Decision|0|||
33465996|NCT00319553|62839429|FG000|Overall Study|Withdrawal by Subject|1|||
33465997|NCT00319553|62839430|FG001|Overall Study|Withdrawal by Subject|1|||
33310144|NCT01287221|62685512|FG001|Overall Study|Adverse Event|3|||
33310145|NCT01287221|62685511|FG000|Overall Study|Withdrawal by Subject|0|||
33310146|NCT01287221|62685512|FG001|Overall Study|Withdrawal by Subject|1|||
33310147|NCT01168401|62685529|FG000|Overall Study|Lost to Follow-up|1|||
33310148|NCT01168401|62685530|FG001|Overall Study|Lost to Follow-up|1|||
33310149|NCT01168401|62685531|FG002|Overall Study|Lost to Follow-up|2|||
33310150|NCT01168401|62685532|FG003|Overall Study|Lost to Follow-up|1|||
33310151|NCT01168401|62685533|FG004|Overall Study|Lost to Follow-up|0|||
33310152|NCT01168401|62685534|FG005|Overall Study|Lost to Follow-up|0|||
33310153|NCT01168401|62685535|FG006|Overall Study|Lost to Follow-up|0|||
33310154|NCT01168401|62685536|FG007|Overall Study|Lost to Follow-up|0|||
33310155|NCT01168401|62685537|FG008|Overall Study|Lost to Follow-up|0|||
33310156|NCT01168401|62685538|FG009|Overall Study|Lost to Follow-up|0|||
33465998|NCT00369785|62839438|FG000|Overall Study|Physician Decision|3|||
33465999|NCT00369785|62839439|FG001|Overall Study|Physician Decision|2|||
33466000|NCT00369785|62839438|FG000|Overall Study|Death|1|||
33466001|NCT00369785|62839439|FG001|Overall Study|Death|2|||
33466002|NCT00369785|62839438|FG000|Overall Study|Withdrawal by Subject|7|||
33466003|NCT00369785|62839439|FG001|Overall Study|Withdrawal by Subject|6|||
33466004|NCT00369785|62839438|FG000|Overall Study|Toxicity|6|||
33466005|NCT00369785|62839439|FG001|Overall Study|Toxicity|4|||
33466006|NCT00369785|62839438|FG000|Overall Study|Never started|0|||
33466007|NCT00369785|62839439|FG001|Overall Study|Never started|2|||
33466008|NCT00369785|62839438|FG000|Overall Study|Progression|4|||
33466009|NCT00369785|62839439|FG001|Overall Study|Progression|4|||
33466010|NCT00369785|62839438|FG000|Overall Study|Multiple reasons|6|||
33466011|NCT00369785|62839439|FG001|Overall Study|Multiple reasons|5|||
33466012|NCT00369707|62839445|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
33466013|NCT00369707|62839445|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
33466014|NCT00369707|62839445|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
33466015|NCT00369707|62839445|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
33466016|NCT00369707|62839445|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
33466017|NCT00369707|62839445|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
33466018|NCT00369707|62839445|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
33466019|NCT00369707|62839445|FG000|Follow up for 2 Years After Treatment|Death|1|||
33466020|NCT00369707|62839445|FG000|Follow up for 2 Years After Treatment|Other|2|||
33466021|NCT02943460|62839452|FG000|Blinded Study Phase|Adverse Event|3|||
33466022|NCT02943460|62839453|FG001|Blinded Study Phase|Adverse Event|0|||
33466023|NCT02943460|62839454|FG002|Blinded Study Phase|Adverse Event|0|||
33466024|NCT02943460|62839452|FG000|Blinded Study Phase|Withdrew Consent|0|||
33466025|NCT02943460|62839453|FG001|Blinded Study Phase|Withdrew Consent|1|||
33466026|NCT02943460|62839454|FG002|Blinded Study Phase|Withdrew Consent|0|||
33466027|NCT02943460|62839452|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
33466028|NCT02943460|62839453|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
33466029|NCT02943460|62839454|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
33466030|NCT02943460|62839452|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
33466031|NCT02943460|62839453|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
33466032|NCT02943460|62839454|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
33466033|NCT02943460|62839452|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
33466034|NCT02943460|62839453|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
33466035|NCT02943460|62839454|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
33466036|NCT03768206|62839465|FG000|Overall Study|Lost to Follow-up|2|||
33466037|NCT03768206|62839466|FG001|Overall Study|Lost to Follow-up|1|||
33466038|NCT03768206|62839465|FG000|Overall Study|Withdrawal by Subject|0|||
33466039|NCT03768206|62839466|FG001|Overall Study|Withdrawal by Subject|1|||
33466040|NCT03767894|62839473|FG000|Overall Study|Withdrawal by Subject|1|||
33466041|NCT03766646|62839479|FG000|Overall Study|Withdrawal by Subject|1|||
33466042|NCT03766646|62839480|FG001|Overall Study|Withdrawal by Subject|0|||
33466043|NCT03766646|62839479|FG000|Overall Study|Protocol Violation|0|||
33466044|NCT03766646|62839480|FG001|Overall Study|Protocol Violation|3|||
33466045|NCT03765164|62839488|FG000|Pre-intervention|Withdrawal by Subject|5|||
33466046|NCT03765164|62839489|FG001|Pre-intervention|Withdrawal by Subject|6|||
33466047|NCT00369629|62839495|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
33466048|NCT00369629|62839496|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
33466049|NCT00369629|62839497|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
33466050|NCT00369629|62839498|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
33466051|NCT00369629|62839495|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
33466052|NCT00369629|62839496|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
33466053|NCT00369629|62839497|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
33466054|NCT00369629|62839498|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
33466055|NCT00369629|62839495|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
33466056|NCT00369629|62839496|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
33466057|NCT00369629|62839497|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
33466058|NCT00369629|62839498|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
33466059|NCT00369629|62839495|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
33466060|NCT00369629|62839496|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
33466061|NCT00369629|62839497|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
33466062|NCT00369629|62839498|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
33466063|NCT00369629|62839495|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
33466064|NCT00369629|62839496|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
33466065|NCT00369629|62839497|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
33466066|NCT00369629|62839498|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
33466067|NCT00369629|62839495|FG000|Completed 4 More Cycles|Progressive disease|2|||
33466068|NCT00369629|62839496|FG001|Completed 4 More Cycles|Progressive disease|1|||
33466069|NCT00369629|62839497|FG002|Completed 4 More Cycles|Progressive disease|2|||
33466070|NCT00369629|62839498|FG003|Completed 4 More Cycles|Progressive disease|0|||
33466071|NCT00369629|62839495|FG000|Follow up for 1 Year|Death|2|||
33466072|NCT00369629|62839496|FG001|Follow up for 1 Year|Death|1|||
33466073|NCT00369629|62839497|FG002|Follow up for 1 Year|Death|1|||
33466074|NCT00369629|62839498|FG003|Follow up for 1 Year|Death|0|||
33466075|NCT00369629|62839495|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
33466076|NCT00369629|62839496|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
33466077|NCT00369629|62839497|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
33466078|NCT00369629|62839498|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
33466079|NCT00369629|62839495|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
33466080|NCT00369629|62839496|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
33466081|NCT00369629|62839497|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
33466082|NCT00369629|62839498|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
33466083|NCT02469064|62839510|FG000|Overall Study|Request not to receive intervention.|1|||
33466084|NCT02469064|62839511|FG001|Overall Study|Request not to receive intervention.|3|||
33466085|NCT02446912|62839520|FG000|Overall Study|Adverse Event|3|||
33466086|NCT02446912|62839521|FG001|Overall Study|Adverse Event|13|||
33466087|NCT02446912|62839522|FG002|Overall Study|Adverse Event|5|||
33466088|NCT02446912|62839520|FG000|Overall Study|Condition under investigation worsened|0|||
33466089|NCT02446912|62839521|FG001|Overall Study|Condition under investigation worsened|1|||
33466090|NCT02446912|62839522|FG002|Overall Study|Condition under investigation worsened|1|||
33466091|NCT02446912|62839520|FG000|Overall Study|Study-specific withdrawal criteria|1|||
33466092|NCT02446912|62839521|FG001|Overall Study|Study-specific withdrawal criteria|0|||
33466093|NCT02446912|62839522|FG002|Overall Study|Study-specific withdrawal criteria|0|||
33466094|NCT02446912|62839520|FG000|Overall Study|Lack of Efficacy|1|||
33466095|NCT02446912|62839521|FG001|Overall Study|Lack of Efficacy|4|||
33466096|NCT02446912|62839522|FG002|Overall Study|Lack of Efficacy|7|||
33466097|NCT02446912|62839520|FG000|Overall Study|Lost to Follow-up|0|||
33466098|NCT02446912|62839521|FG001|Overall Study|Lost to Follow-up|0|||
33466099|NCT02446912|62839522|FG002|Overall Study|Lost to Follow-up|2|||
33466100|NCT02446912|62839520|FG000|Overall Study|Severe non-compliance to protocol|1|||
33466101|NCT02446912|62839521|FG001|Overall Study|Severe non-compliance to protocol|0|||
33466102|NCT02446912|62839522|FG002|Overall Study|Severe non-compliance to protocol|1|||
33466103|NCT02446912|62839520|FG000|Overall Study|Withdrawal by Subject|10|||
33466104|NCT02446912|62839521|FG001|Overall Study|Withdrawal by Subject|15|||
33466105|NCT02446912|62839522|FG002|Overall Study|Withdrawal by Subject|15|||
33466106|NCT02446912|62839520|FG000|Overall Study|Miscellaneous|2|||
33466107|NCT02446912|62839521|FG001|Overall Study|Miscellaneous|2|||
33466108|NCT02446912|62839522|FG002|Overall Study|Miscellaneous|4|||
33466109|NCT00736840|62839530|FG000|Overall Study|Lost to Follow-up|13|||
33466110|NCT00318461|62839539|FG000|Double-Blind, 6 Months|Adverse Event|11|||
33466111|NCT00318461|62839540|FG001|Double-Blind, 6 Months|Adverse Event|23|||
33466112|NCT00318461|62839541|FG002|Double-Blind, 6 Months|Adverse Event|29|||
33466113|NCT00318461|62839542|FG003|Double-Blind, 6 Months|Adverse Event|2|||
33466114|NCT00318461|62839543|FG004|Double-Blind, 6 Months|Adverse Event|8|||
33466115|NCT00318461|62839539|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
33466116|NCT00318461|62839540|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
33466117|NCT00318461|62839541|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
33466118|NCT00318461|62839542|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
33466119|NCT00318461|62839543|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
33546090|NCT02520388|62937335|FG000|Overall Study|Subject or parent/guardian request|0|||
33546091|NCT02520388|62937336|FG001|Overall Study|Subject or parent/guardian request|6|||
33546092|NCT02520388|62937335|FG000|Overall Study|Adverse Event|1|||
33546093|NCT02520388|62937336|FG001|Overall Study|Adverse Event|4|||
33546094|NCT02520388|62937335|FG000|Overall Study|Lost to Follow-up|3|||
33546095|NCT02520388|62937336|FG001|Overall Study|Lost to Follow-up|2|||
33546096|NCT02520388|62937335|FG000|Overall Study|Other (reason not defined)|4|||
33546097|NCT02520388|62937336|FG001|Overall Study|Other (reason not defined)|4|||
33546098|NCT02924129|62937344|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
33546099|NCT02924129|62937345|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
33546100|NCT02924129|62937344|FG000|Overall Study|Withdrawal by Subject|2|||
33546101|NCT02924129|62937345|FG001|Overall Study|Withdrawal by Subject|2|||
33546102|NCT02924129|62937344|FG000|Overall Study|Physician Decision|1|||
33546103|NCT02924129|62937345|FG001|Overall Study|Physician Decision|0|||
33546104|NCT02924129|62937344|FG000|Overall Study|Missed Visit|0|||
33546105|NCT02924129|62937345|FG001|Overall Study|Missed Visit|1|||
33546106|NCT02668640|62937351|FG000|Overall Study|Lost to Follow-up|13|||
33546107|NCT02668640|62937351|FG000|Overall Study|Other, not specified|1|||
33546108|NCT03014453|62937355|FG000|Overall Study|Lost to Follow-up|12|||
33546109|NCT03014453|62937355|FG000|Overall Study|Discontinued GER|3|||
33652215|NCT01737697|63064152|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33652216|NCT01737697|63064153|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33466120|NCT00318461|62839539|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
33546110|NCT03014453|62937355|FG000|Overall Study|Excluded|19|||
33546111|NCT03014453|62937355|FG000|Overall Study|Refused to take part in|37|||
33546112|NCT02664272|62937359|FG000|Overall Study|Fluoroscopic images not made available|2|||
33466121|NCT00318461|62839540|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
33466122|NCT00318461|62839541|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
33466123|NCT00318461|62839542|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
33466124|NCT00318461|62839543|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
33466125|NCT00318461|62839539|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
33466126|NCT00318461|62839540|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
33466127|NCT00318461|62839541|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
33466128|NCT00318461|62839542|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
33466129|NCT00318461|62839543|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
33466130|NCT00318461|62839539|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
33466131|NCT00318461|62839540|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
33466132|NCT00318461|62839541|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
33466133|NCT00318461|62839542|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
33466134|NCT00318461|62839543|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
33466135|NCT00318461|62839539|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
33466136|NCT00318461|62839540|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
33466137|NCT00318461|62839541|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
33466138|NCT00318461|62839542|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
33466139|NCT00318461|62839543|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
33466140|NCT00318461|62839539|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
33466141|NCT00318461|62839540|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
33466142|NCT00318461|62839541|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
33466143|NCT00318461|62839542|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
33466144|NCT00318461|62839543|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
33466145|NCT00318461|62839539|FG000|Double-Blind, 6 Months|Move|0|||
33466146|NCT00318461|62839540|FG001|Double-Blind, 6 Months|Move|1|||
33466147|NCT00318461|62839541|FG002|Double-Blind, 6 Months|Move|0|||
33466148|NCT00318461|62839542|FG003|Double-Blind, 6 Months|Move|0|||
33466149|NCT00318461|62839543|FG004|Double-Blind, 6 Months|Move|0|||
33466150|NCT00318461|62839539|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
33466151|NCT00318461|62839540|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
33466152|NCT00318461|62839541|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
33466153|NCT00318461|62839542|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
33466154|NCT00318461|62839543|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
33466155|NCT00318461|62839539|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
33466156|NCT00318461|62839540|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
33466157|NCT00318461|62839541|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
33466158|NCT00318461|62839542|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
33466159|NCT00318461|62839543|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
33466160|NCT00318461|62839539|FG000|Double-Blind, 6 Months|Work commitment|0|||
33466161|NCT00318461|62839540|FG001|Double-Blind, 6 Months|Work commitment|0|||
33466162|NCT00318461|62839541|FG002|Double-Blind, 6 Months|Work commitment|0|||
33466163|NCT00318461|62839542|FG003|Double-Blind, 6 Months|Work commitment|0|||
33466164|NCT00318461|62839543|FG004|Double-Blind, 6 Months|Work commitment|1|||
33466165|NCT00318461|62839539|FG000|Double-Blind, 6 Months|Investigator decision|0|||
33466166|NCT00318461|62839540|FG001|Double-Blind, 6 Months|Investigator decision|0|||
33328774|NCT01076088|62705184|FG002|Overall Study|Physician Decision|0|||
33328775|NCT01076088|62705185|FG003|Overall Study|Physician Decision|1|||
33328776|NCT01076088|62705186|FG004|Overall Study|Physician Decision|1|||
33328777|NCT01076088|62705187|FG005|Overall Study|Physician Decision|0|||
33328778|NCT01076088|62705182|FG000|Overall Study|Withdrawal by Subject|8|||
33328779|NCT01076088|62705183|FG001|Overall Study|Withdrawal by Subject|8|||
33328780|NCT01076088|62705184|FG002|Overall Study|Withdrawal by Subject|14|||
33328781|NCT01076088|62705185|FG003|Overall Study|Withdrawal by Subject|10|||
33466167|NCT00318461|62839541|FG002|Double-Blind, 6 Months|Investigator decision|0|||
33328782|NCT01076088|62705186|FG004|Overall Study|Withdrawal by Subject|11|||
33328783|NCT01076088|62705187|FG005|Overall Study|Withdrawal by Subject|17|||
33466168|NCT00318461|62839542|FG003|Double-Blind, 6 Months|Investigator decision|0|||
33466169|NCT00318461|62839543|FG004|Double-Blind, 6 Months|Investigator decision|1|||
33466170|NCT00318461|62839539|FG000|Double-Blind, 6 Months|Lack of time|1|||
33466171|NCT00318461|62839540|FG001|Double-Blind, 6 Months|Lack of time|0|||
33466172|NCT00318461|62839541|FG002|Double-Blind, 6 Months|Lack of time|0|||
33466173|NCT00318461|62839542|FG003|Double-Blind, 6 Months|Lack of time|0|||
33466174|NCT00318461|62839543|FG004|Double-Blind, 6 Months|Lack of time|0|||
33466175|NCT00318461|62839539|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
33466176|NCT00318461|62839540|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
33466177|NCT00318461|62839541|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
33466178|NCT00318461|62839542|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
33466179|NCT00318461|62839543|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
33466180|NCT00318461|62839539|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
33466181|NCT00318461|62839540|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
33466182|NCT00318461|62839541|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
33466183|NCT00318461|62839542|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
33466184|NCT00318461|62839543|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
33466185|NCT00318461|62839539|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
33466186|NCT00318461|62839540|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
33466187|NCT00318461|62839541|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
33466188|NCT00318461|62839542|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
33466189|NCT00318461|62839543|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
33466190|NCT00318461|62839539|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
33466191|NCT00318461|62839540|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
33466192|NCT00318461|62839541|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
33466193|NCT00318461|62839542|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
33466194|NCT00318461|62839543|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
33466195|NCT00318461|62839539|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
33466196|NCT00318461|62839540|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
33466197|NCT00318461|62839541|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
33466198|NCT00318461|62839542|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
33466199|NCT00318461|62839543|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
33466200|NCT00318461|62839539|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
33466201|NCT00318461|62839540|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
33466202|NCT00318461|62839541|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
33466203|NCT00318461|62839542|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
33466204|NCT00318461|62839543|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
33466205|NCT00318461|62839539|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
33466206|NCT00318461|62839540|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
33466207|NCT00318461|62839541|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
33466208|NCT00318461|62839542|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
33466209|NCT00318461|62839543|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
33466210|NCT00318461|62839539|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
33466211|NCT00318461|62839540|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
33466212|NCT00318461|62839541|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
33466213|NCT00318461|62839542|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
33466214|NCT00318461|62839543|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
33466215|NCT03764072|62839570|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
33466216|NCT03764072|62839571|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
33466217|NCT03764072|62839572|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
33466218|NCT03764072|62839573|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
33466219|NCT03764072|62839574|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
33546113|NCT02663882|62937365|FG000|Overall Study|Lost to Follow-up|4|||
33546114|NCT02663882|62937366|FG001|Overall Study|Lost to Follow-up|2|||
33546115|NCT03011333|62937379|FG000|Overall Study|Lost to Follow-up|0|||
33328784|NCT01076088|62705182|FG000|Overall Study|Other protocol specified criteria|0|||
33328785|NCT01076088|62705183|FG001|Overall Study|Other protocol specified criteria|0|||
33328786|NCT01076088|62705184|FG002|Overall Study|Other protocol specified criteria|0|||
33328787|NCT01076088|62705185|FG003|Overall Study|Other protocol specified criteria|0|||
33328788|NCT01076088|62705186|FG004|Overall Study|Other protocol specified criteria|0|||
33328789|NCT01076088|62705187|FG005|Overall Study|Other protocol specified criteria|1|||
33328790|NCT01193348|62705202|FG000|Screening Period|Screen Failure|5|||
33328791|NCT01193348|62705202|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
33328792|NCT01193348|62705202|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
33328793|NCT01193348|62705202|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
33546116|NCT03011333|62937380|FG001|Overall Study|Lost to Follow-up|1|||
33546117|NCT03011333|62937381|FG002|Overall Study|Lost to Follow-up|0|||
33328794|NCT01193348|62705202|FG000|Extension Treatment Period|Physician Decision|1|||
33466220|NCT03764072|62839575|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
33466221|NCT03764072|62839570|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
33466222|NCT03764072|62839571|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
33466223|NCT03764072|62839572|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
33466224|NCT03764072|62839573|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
33466225|NCT03764072|62839574|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
33466226|NCT03764072|62839575|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
33466227|NCT03764072|62839570|FG000|Overall Study|Lost to Follow-up|0|||
33466228|NCT03764072|62839571|FG001|Overall Study|Lost to Follow-up|0|||
33466229|NCT03764072|62839572|FG002|Overall Study|Lost to Follow-up|0|||
33466230|NCT03764072|62839573|FG003|Overall Study|Lost to Follow-up|0|||
33466231|NCT03764072|62839574|FG004|Overall Study|Lost to Follow-up|1|||
33466232|NCT03764072|62839575|FG005|Overall Study|Lost to Follow-up|0|||
33466233|NCT03333928|62839597|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
33466234|NCT03333928|62839598|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
33466235|NCT03333928|62839599|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
33466236|NCT03333928|62839597|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
33466237|NCT03333928|62839598|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
33466238|NCT03333928|62839599|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
33466239|NCT03333928|62839597|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
33466240|NCT03333928|62839598|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
33466241|NCT03333928|62839599|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
33466242|NCT03333928|62839597|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
33466243|NCT03333928|62839598|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
33466244|NCT03333928|62839599|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
33466245|NCT03333928|62839597|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
33466246|NCT03333928|62839598|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
33466247|NCT03333928|62839599|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
33466248|NCT03333928|62839597|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
33466249|NCT03333928|62839598|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
33466250|NCT03333928|62839599|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
33466251|NCT03333928|62839597|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
33466252|NCT03333928|62839598|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
33466253|NCT03333928|62839599|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
33466254|NCT03333928|62839597|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
33466255|NCT03333928|62839598|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
33466256|NCT03333928|62839599|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
33466257|NCT02945410|62839621|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
33466258|NCT02945410|62839622|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
33466259|NCT02945410|62839623|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
33466260|NCT02945410|62839624|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
33466261|NCT02945410|62839625|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
33466262|NCT02945410|62839626|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
33466263|NCT02945410|62839621|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
33466264|NCT02945410|62839622|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
33466265|NCT02945410|62839623|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
33466266|NCT02945410|62839624|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
33466267|NCT02945410|62839625|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
33466268|NCT02945410|62839626|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
33466269|NCT02945410|62839621|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
33466270|NCT02945410|62839622|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
33466271|NCT02945410|62839623|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
33466272|NCT02945410|62839624|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
33466273|NCT02945410|62839625|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
33466274|NCT02945410|62839626|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
33466275|NCT02945254|62839636|FG000|Overall Study|Lost to Follow-up|1|||
33466276|NCT02945254|62839637|FG001|Overall Study|Lost to Follow-up|0|||
33466277|NCT02945254|62839636|FG000|Overall Study|Withdrawal by Subject|1|||
33466278|NCT02945254|62839637|FG001|Overall Study|Withdrawal by Subject|0|||
33466279|NCT02943070|62839655|FG000|Overall Study|Physician Decision|1|||
33466280|NCT02943070|62839655|FG000|Overall Study|Adverse Event|2|||
33466281|NCT02943070|62839655|FG000|Overall Study|Death|2|||
33466282|NCT02943070|62839655|FG000|Overall Study|Withdrawal by Subject|3|||
33466283|NCT02943070|62839655|FG000|Overall Study|Lost to Follow-up|4|||
33466284|NCT02943070|62839655|FG000|Overall Study|Retreatment or TURP|13|||
33466285|NCT02943070|62839655|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
33466286|NCT03332212|62839679|FG000|Overall Study|Not treated|0|||
33466287|NCT03332212|62839680|FG001|Overall Study|Not treated|1|||
33466288|NCT03332212|62839681|FG002|Overall Study|Not treated|0|||
33466289|NCT03332212|62839682|FG003|Overall Study|Not treated|0|||
33466290|NCT03332212|62839679|FG000|Overall Study|Adverse Event|0|||
33466291|NCT03332212|62839680|FG001|Overall Study|Adverse Event|0|||
33466292|NCT03332212|62839681|FG002|Overall Study|Adverse Event|0|||
33466293|NCT03332212|62839682|FG003|Overall Study|Adverse Event|1|||
33466294|NCT03332212|62839679|FG000|Overall Study|worsening of disease under study|1|||
33466295|NCT03332212|62839680|FG001|Overall Study|worsening of disease under study|1|||
33466296|NCT03332212|62839681|FG002|Overall Study|worsening of disease under study|0|||
33466297|NCT03332212|62839682|FG003|Overall Study|worsening of disease under study|0|||
33466298|NCT03331666|62839692|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
33466299|NCT03331666|62839693|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
33466300|NCT03331042|62839703|FG000|Overall Study|Protocol Violation|1|||
33466301|NCT03331042|62839704|FG001|Overall Study|Protocol Violation|0|||
33466302|NCT03331042|62839705|FG002|Overall Study|Protocol Violation|0|||
33466303|NCT03331042|62839706|FG003|Overall Study|Protocol Violation|0|||
33466304|NCT03331042|62839703|FG000|Overall Study|Physician Decision|0|||
33466305|NCT03331042|62839704|FG001|Overall Study|Physician Decision|0|||
33466306|NCT03331042|62839705|FG002|Overall Study|Physician Decision|1|||
33466307|NCT03331042|62839706|FG003|Overall Study|Physician Decision|0|||
33466308|NCT03331042|62839703|FG000|Overall Study|Lost to Follow-up|0|||
33466309|NCT03331042|62839704|FG001|Overall Study|Lost to Follow-up|0|||
33466310|NCT03331042|62839705|FG002|Overall Study|Lost to Follow-up|0|||
33466311|NCT03331042|62839706|FG003|Overall Study|Lost to Follow-up|1|||
33466312|NCT03762668|62839724|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
33466313|NCT03762668|62839725|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
33546118|NCT03011333|62937382|FG003|Overall Study|Lost to Follow-up|1|||
33546119|NCT03011333|62937383|FG004|Overall Study|Lost to Follow-up|4|||
33546120|NCT03011333|62937384|FG005|Overall Study|Lost to Follow-up|4|||
33546121|NCT03011333|62937385|FG006|Overall Study|Lost to Follow-up|5|||
33546122|NCT03011099|62937403|FG000|Overall Study|Withdrawal by Subject|0|||
33466314|NCT03762200|62839731|FG000|Overall Study|Death|2|||
33466315|NCT03711370|62839737|FG000|Overall Study|Lost to Follow-up|16|||
33466316|NCT03711370|62839738|FG001|Overall Study|Lost to Follow-up|10|||
33466317|NCT03711370|62839737|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
33466318|NCT03711370|62839738|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
33466319|NCT03329404|62839754|FG000|Overall Study|The study was suspended.|1|||
33466320|NCT03329404|62839755|FG001|Overall Study|The study was suspended.|4|||
33466321|NCT03478930|62839763|FG000|Overall Study|Adverse Event|0|||
33546123|NCT03011099|62937404|FG001|Overall Study|Withdrawal by Subject|2|||
33466322|NCT03478930|62839764|FG001|Overall Study|Adverse Event|1|||
33466323|NCT03478930|62839763|FG000|Overall Study|Lack of Efficacy|3|||
33466324|NCT03478930|62839764|FG001|Overall Study|Lack of Efficacy|3|||
33466325|NCT03478930|62839763|FG000|Overall Study|Withdrawal by Subject|6|||
33466326|NCT03478930|62839764|FG001|Overall Study|Withdrawal by Subject|5|||
33466327|NCT03038438|62839770|FG000|Overall Study|Death|3|||
33466328|NCT03038438|62839770|FG000|Overall Study|Lost to Follow-up|8|||
33466329|NCT03038438|62839770|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
33466330|NCT03038438|62839770|FG000|Overall Study|Withdrawal by Subject|5|||
33466331|NCT03038438|62839770|FG000|Overall Study|No 36-Month Follow-Up|18|||
33466332|NCT03523000|62839774|FG000|Overall Study|Withdrawal by Subject|3|||
33466333|NCT03523000|62839775|FG001|Overall Study|Withdrawal by Subject|0|||
33466334|NCT03523000|62839774|FG000|Overall Study|Unsuccessful trial|2|||
33466335|NCT03523000|62839775|FG001|Overall Study|Unsuccessful trial|0|||
33466336|NCT03327220|62839786|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
33466337|NCT03327220|62839787|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
33466338|NCT03327220|62839786|FG000|Overall Study|Investigator Decision|2|||
33466339|NCT03327220|62839787|FG001|Overall Study|Investigator Decision|0|||
33466340|NCT03327220|62839786|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
33466341|NCT03327220|62839787|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
33466342|NCT03327220|62839786|FG000|Overall Study|Fungal infection|1|||
33466343|NCT03327220|62839787|FG001|Overall Study|Fungal infection|0|||
33466344|NCT03327220|62839786|FG000|Overall Study|Discharged to Rehabilitation|0|||
33466345|NCT03327220|62839787|FG001|Overall Study|Discharged to Rehabilitation|1|||
33466346|NCT03327220|62839786|FG000|Overall Study|Missing|1|||
33466347|NCT03327220|62839787|FG001|Overall Study|Missing|0|||
33466348|NCT00318149|62839799|FG000|Overall Study|Adverse Event|0|||
33466349|NCT00318149|62839800|FG001|Overall Study|Adverse Event|0|||
33466350|NCT00318149|62839801|FG002|Overall Study|Adverse Event|0|||
33466351|NCT00318149|62839802|FG003|Overall Study|Adverse Event|0|||
33466352|NCT00318149|62839803|FG004|Overall Study|Adverse Event|0|||
33466353|NCT00318149|62839804|FG005|Overall Study|Adverse Event|2|||
33466354|NCT00317603|62839820|FG000|Overall Study|Progressive Disease|3|||
33466355|NCT03326518|62839827|FG000|Overall Study|Protocol Violation|1|||
33466356|NCT03326518|62839828|FG001|Overall Study|Protocol Violation|0|||
33466357|NCT03326518|62839829|FG002|Overall Study|Protocol Violation|0|||
33466358|NCT03326518|62839827|FG000|Overall Study|Withdrawal by Subject|1|||
33466359|NCT03326518|62839828|FG001|Overall Study|Withdrawal by Subject|0|||
33466360|NCT03326518|62839829|FG002|Overall Study|Withdrawal by Subject|0|||
33466361|NCT03326518|62839827|FG000|Overall Study|Lost to Follow-up|1|||
33466362|NCT03326518|62839828|FG001|Overall Study|Lost to Follow-up|0|||
33466363|NCT03326518|62839829|FG002|Overall Study|Lost to Follow-up|1|||
33466364|NCT00317369|62839840|FG000|Overall Study|Adverse Event|2|||
33466365|NCT00317369|62839841|FG001|Overall Study|Adverse Event|1|||
33466366|NCT00317369|62839842|FG002|Overall Study|Adverse Event|0|||
33466367|NCT00317369|62839840|FG000|Overall Study|Lack of Efficacy|0|||
33466368|NCT00317369|62839841|FG001|Overall Study|Lack of Efficacy|1|||
33466369|NCT00317369|62839842|FG002|Overall Study|Lack of Efficacy|1|||
33466370|NCT00317369|62839840|FG000|Overall Study|Withdrawal by Subject|0|||
33466371|NCT00317369|62839841|FG001|Overall Study|Withdrawal by Subject|0|||
33466372|NCT00317369|62839842|FG002|Overall Study|Withdrawal by Subject|1|||
33466373|NCT03325894|62839852|FG000|Overall Study|Adverse Event|2|||
33466374|NCT03325894|62839853|FG001|Overall Study|Adverse Event|3|||
33466375|NCT03325894|62839852|FG000|Overall Study|Protocol Violation|1|||
33466376|NCT03325894|62839853|FG001|Overall Study|Protocol Violation|2|||
33466377|NCT03325894|62839852|FG000|Overall Study|Withdrawal by Subject|10|||
33652217|NCT01737697|63064154|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33466378|NCT03325894|62839853|FG001|Overall Study|Withdrawal by Subject|6|||
33466379|NCT03325894|62839852|FG000|Overall Study|Lost to Follow-up|4|||
33466380|NCT03325894|62839853|FG001|Overall Study|Lost to Follow-up|9|||
33466381|NCT03325894|62839852|FG000|Overall Study|Lack of Efficacy|8|||
33546124|NCT03013985|62937414|FG000|Overall Study|Protocol Violation|2|||
33466382|NCT03325894|62839853|FG001|Overall Study|Lack of Efficacy|14|||
33466383|NCT03325894|62839852|FG000|Overall Study|Study Terminated by Sponsor|38|||
33466384|NCT03325894|62839853|FG001|Overall Study|Study Terminated by Sponsor|43|||
33466385|NCT03325894|62839852|FG000|Overall Study|Other (Not received Treatment)|1|||
33466386|NCT03325894|62839853|FG001|Overall Study|Other (Not received Treatment)|0|||
33466387|NCT01239368|62839872|FG000|Overall Study|Principal investigator discretion|1|||
33466388|NCT01239368|62839873|FG001|Overall Study|Principal investigator discretion|0|||
33466389|NCT01239368|62839874|FG002|Overall Study|Principal investigator discretion|0|||
33466390|NCT01239368|62839875|FG003|Overall Study|Principal investigator discretion|0|||
33466391|NCT01239368|62839876|FG004|Overall Study|Principal investigator discretion|1|||
33466392|NCT01239368|62839877|FG005|Overall Study|Principal investigator discretion|2|||
33466393|NCT01239368|62839878|FG006|Overall Study|Principal investigator discretion|0|||
33466394|NCT01239368|62839879|FG007|Overall Study|Principal investigator discretion|0|||
33466395|NCT01239368|62839880|FG008|Overall Study|Principal investigator discretion|0|||
33466396|NCT01239368|62839881|FG009|Overall Study|Principal investigator discretion|1|||
33466397|NCT01239368|62839872|FG000|Overall Study|Disease progression on study|1|||
33466398|NCT01239368|62839873|FG001|Overall Study|Disease progression on study|1|||
33466399|NCT01239368|62839874|FG002|Overall Study|Disease progression on study|1|||
33466400|NCT01239368|62839875|FG003|Overall Study|Disease progression on study|1|||
33466401|NCT01239368|62839876|FG004|Overall Study|Disease progression on study|4|||
33466402|NCT01239368|62839877|FG005|Overall Study|Disease progression on study|2|||
33466403|NCT01239368|62839878|FG006|Overall Study|Disease progression on study|5|||
33466404|NCT01239368|62839879|FG007|Overall Study|Disease progression on study|0|||
33466405|NCT01239368|62839880|FG008|Overall Study|Disease progression on study|0|||
33466406|NCT01239368|62839881|FG009|Overall Study|Disease progression on study|2|||
33466407|NCT01239368|62839872|FG000|Overall Study|Refused further treatment|0|||
33466408|NCT01239368|62839873|FG001|Overall Study|Refused further treatment|0|||
33466409|NCT01239368|62839874|FG002|Overall Study|Refused further treatment|0|||
33466410|NCT01239368|62839875|FG003|Overall Study|Refused further treatment|0|||
33466411|NCT01239368|62839876|FG004|Overall Study|Refused further treatment|0|||
33466412|NCT01239368|62839877|FG005|Overall Study|Refused further treatment|0|||
33546125|NCT03013985|62937415|FG001|Overall Study|Protocol Violation|2|||
33546126|NCT03013985|62937414|FG000|Overall Study|Withdrawal by Subject|14|||
33546127|NCT03013985|62937415|FG001|Overall Study|Withdrawal by Subject|17|||
33546128|NCT03016403|62937425|FG000|Baseline|Death|5|||
33546129|NCT03016403|62937426|FG001|Baseline|Death|8|||
33546130|NCT03016403|62937427|FG002|Baseline|Death|1|||
33546131|NCT03016403|62937428|FG003|Baseline|Death|0|||
33546132|NCT03016403|62937425|FG000|Baseline|Withdrawal by Subject|2|||
33546133|NCT03016403|62937426|FG001|Baseline|Withdrawal by Subject|8|||
33546134|NCT03016403|62937427|FG002|Baseline|Withdrawal by Subject|4|||
33546135|NCT03016403|62937428|FG003|Baseline|Withdrawal by Subject|10|||
33546136|NCT03016403|62937425|FG000|Baseline|Lost to Follow-up|9|||
33546137|NCT03016403|62937426|FG001|Baseline|Lost to Follow-up|11|||
33546138|NCT03016403|62937427|FG002|Baseline|Lost to Follow-up|6|||
33546139|NCT03016403|62937428|FG003|Baseline|Lost to Follow-up|24|||
33546140|NCT03016403|62937425|FG000|6-week Follow-up|Death|1|||
33546141|NCT03016403|62937426|FG001|6-week Follow-up|Death|4|||
33546142|NCT03016403|62937427|FG002|6-week Follow-up|Death|0|||
33546143|NCT03016403|62937428|FG003|6-week Follow-up|Death|0|||
33546144|NCT03016403|62937425|FG000|6-week Follow-up|Lost to Follow-up|2|||
33546145|NCT03016403|62937426|FG001|6-week Follow-up|Lost to Follow-up|7|||
33546146|NCT03016403|62937427|FG002|6-week Follow-up|Lost to Follow-up|4|||
33546147|NCT03016403|62937428|FG003|6-week Follow-up|Lost to Follow-up|8|||
33546148|NCT03016403|62937425|FG000|6-week Follow-up|Withdrawal by Subject|0|||
33546149|NCT03016403|62937426|FG001|6-week Follow-up|Withdrawal by Subject|2|||
33546150|NCT03016403|62937427|FG002|6-week Follow-up|Withdrawal by Subject|0|||
33546151|NCT03016403|62937428|FG003|6-week Follow-up|Withdrawal by Subject|1|||
33546152|NCT03016403|62937425|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
33546153|NCT03016403|62937426|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
33546154|NCT03016403|62937427|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
33546155|NCT03016403|62937428|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
33466413|NCT01239368|62839878|FG006|Overall Study|Refused further treatment|0|||
33466414|NCT01239368|62839879|FG007|Overall Study|Refused further treatment|0|||
33546156|NCT03016403|62937425|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
33546157|NCT03016403|62937426|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
33546158|NCT03016403|62937427|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
33546159|NCT03016403|62937428|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
33546160|NCT03016403|62937425|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
33546161|NCT03016403|62937426|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
33546162|NCT03016403|62937427|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
33546163|NCT03016403|62937428|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
33546164|NCT02520310|62937440|FG000|At 6 Months Clinical Follow-up|Death|1|||
33546165|NCT02520310|62937440|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
33546166|NCT02520310|62937440|FG000|AT 3 Year Clinical Follow-up|Death|2|||
33546167|NCT02520310|62937440|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
33546168|NCT02520310|62937440|FG000|AT 4 Year Clinical Follow-up|Death|1|||
33546169|NCT02520310|62937440|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
33546170|NCT02662556|62937446|FG000|Overall Study|Adverse Event|4|||
33546171|NCT02662556|62937446|FG000|Overall Study|Lack of Efficacy|4|||
33546172|NCT02516098|62937453|FG000|Period 1|Protocol Violation|1|||
33546173|NCT02516098|62937454|FG001|Period 1|Protocol Violation|0|||
33546174|NCT02516098|62937453|FG000|Washout After Period 1|Adverse Event|0|||
33546175|NCT02516098|62937454|FG001|Washout After Period 1|Adverse Event|1|||
33546176|NCT02516098|62937453|FG000|Period 2|Withdrawal by Subject|0|||
33546177|NCT02516098|62937454|FG001|Period 2|Withdrawal by Subject|1|||
33546178|NCT01364428|62937462|FG000|Overall Study|Adverse Event|1|||
33546179|NCT01364428|62937463|FG001|Overall Study|Adverse Event|2|||
33546180|NCT01364428|62937462|FG000|Overall Study|Protocol Violation|2|||
33546181|NCT01364428|62937463|FG001|Overall Study|Protocol Violation|0|||
33546182|NCT01364428|62937462|FG000|Overall Study|Withdrawal Criteria|14|||
33546183|NCT01364428|62937463|FG001|Overall Study|Withdrawal Criteria|10|||
33546184|NCT01364428|62937462|FG000|Overall Study|Other|3|||
33546185|NCT01364428|62937463|FG001|Overall Study|Other|3|||
33546186|NCT02515942|62937472|FG000|Overall Study|Adverse Event|5|||
33546187|NCT02515942|62937473|FG001|Overall Study|Adverse Event|0|||
33546188|NCT02515942|62937474|FG002|Overall Study|Adverse Event|0|||
33546189|NCT02515942|62937472|FG000|Overall Study|Death|0|||
33546190|NCT02515942|62937473|FG001|Overall Study|Death|0|||
33652218|NCT01737697|63064155|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33652219|NCT01737697|63064156|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33652220|NCT01737697|63064157|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33652221|NCT01737697|63064158|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33652222|NCT01737697|63064159|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33652223|NCT01737697|63064160|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33652224|NCT01737697|63064146|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33652225|NCT01737697|63064147|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
33652226|NCT01737697|63064148|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
33652227|NCT01737697|63064149|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
33652228|NCT01737697|63064150|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
33652229|NCT01737697|63064151|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33546191|NCT02515942|62937474|FG002|Overall Study|Death|1|||
33546192|NCT02515942|62937472|FG000|Overall Study|Lack of Efficacy|0|||
33546193|NCT02515942|62937473|FG001|Overall Study|Lack of Efficacy|0|||
33546194|NCT02515942|62937474|FG002|Overall Study|Lack of Efficacy|1|||
33546195|NCT02515942|62937472|FG000|Overall Study|Lost to Follow-up|2|||
33546196|NCT02515942|62937473|FG001|Overall Study|Lost to Follow-up|0|||
33546197|NCT02515942|62937474|FG002|Overall Study|Lost to Follow-up|0|||
33546198|NCT02515942|62937472|FG000|Overall Study|Withdrawal by Subject|0|||
33546199|NCT02515942|62937473|FG001|Overall Study|Withdrawal by Subject|3|||
33546200|NCT02515942|62937474|FG002|Overall Study|Withdrawal by Subject|2|||
33546201|NCT02991859|62937501|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33652230|NCT01737697|63064152|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33546202|NCT02991859|62937502|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
33546203|NCT02991859|62937503|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33546204|NCT02991859|62937504|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33546205|NCT02991859|62937505|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
33546206|NCT02991859|62937506|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33546207|NCT02991859|62937507|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33546208|NCT02991859|62937508|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33652231|NCT01737697|63064153|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33652232|NCT01737697|63064154|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33652233|NCT01737697|63064155|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33652234|NCT01737697|63064156|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33652235|NCT01737697|63064157|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33652236|NCT01737697|63064158|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33652237|NCT01737697|63064159|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33652238|NCT01737697|63064160|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33546209|NCT02991859|62937509|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33546210|NCT02991859|62937510|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33546211|NCT02991859|62937511|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33546212|NCT02991859|62937512|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33546213|NCT02991859|62937513|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33546214|NCT02991859|62937514|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33652239|NCT01737697|63064146|FG000|Subacute Phase|Adverse Event|0|||
33652240|NCT01737697|63064147|FG001|Subacute Phase|Adverse Event|0|||
33546215|NCT02991859|62937515|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33546216|NCT02991859|62937516|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33546217|NCT02991859|62937517|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33546218|NCT02991859|62937501|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33546219|NCT02991859|62937502|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33546220|NCT02991859|62937503|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33546221|NCT02991859|62937504|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33546222|NCT02991859|62937505|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33652241|NCT01737697|63064148|FG002|Subacute Phase|Adverse Event|0|||
33652242|NCT01737697|63064149|FG003|Subacute Phase|Adverse Event|0|||
33652243|NCT01737697|63064150|FG004|Subacute Phase|Adverse Event|0|||
33652244|NCT01737697|63064151|FG005|Subacute Phase|Adverse Event|1|||
33652245|NCT01737697|63064152|FG006|Subacute Phase|Adverse Event|1|||
33652246|NCT01737697|63064153|FG007|Subacute Phase|Adverse Event|1|||
33546223|NCT02991859|62937506|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33546224|NCT02991859|62937507|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33546225|NCT02991859|62937508|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33546226|NCT02991859|62937509|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33546227|NCT02991859|62937510|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33546228|NCT02991859|62937511|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33546229|NCT02991859|62937512|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33546230|NCT02991859|62937513|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
33546231|NCT02991859|62937514|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
33546232|NCT02991859|62937515|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33652247|NCT01737697|63064154|FG008|Subacute Phase|Adverse Event|1|||
33652248|NCT01737697|63064155|FG009|Subacute Phase|Adverse Event|1|||
33652249|NCT01737697|63064156|FG010|Subacute Phase|Adverse Event|4|||
33652250|NCT01737697|63064157|FG011|Subacute Phase|Adverse Event|1|||
33652251|NCT01737697|63064158|FG012|Subacute Phase|Adverse Event|1|||
33652252|NCT01737697|63064159|FG013|Subacute Phase|Adverse Event|0|||
33652253|NCT01737697|63064160|FG014|Subacute Phase|Adverse Event|0|||
33652254|NCT01737697|63064146|FG000|Subacute Phase|Withdrawal by Subject|0|||
33652255|NCT01737697|63064147|FG001|Subacute Phase|Withdrawal by Subject|0|||
33652256|NCT01737697|63064148|FG002|Subacute Phase|Withdrawal by Subject|0|||
33652257|NCT01737697|63064149|FG003|Subacute Phase|Withdrawal by Subject|0|||
33652258|NCT01737697|63064150|FG004|Subacute Phase|Withdrawal by Subject|0|||
33652259|NCT01737697|63064151|FG005|Subacute Phase|Withdrawal by Subject|1|||
33652260|NCT01737697|63064152|FG006|Subacute Phase|Withdrawal by Subject|0|||
33652261|NCT01737697|63064153|FG007|Subacute Phase|Withdrawal by Subject|2|||
33652262|NCT01737697|63064154|FG008|Subacute Phase|Withdrawal by Subject|0|||
33652263|NCT01737697|63064155|FG009|Subacute Phase|Withdrawal by Subject|1|||
33652264|NCT01737697|63064156|FG010|Subacute Phase|Withdrawal by Subject|0|||
33652265|NCT01737697|63064157|FG011|Subacute Phase|Withdrawal by Subject|1|||
33652266|NCT01737697|63064158|FG012|Subacute Phase|Withdrawal by Subject|1|||
33652267|NCT01737697|63064159|FG013|Subacute Phase|Withdrawal by Subject|1|||
33652268|NCT01737697|63064160|FG014|Subacute Phase|Withdrawal by Subject|0|||
33652269|NCT01737697|63064146|FG000|Subacute Phase|Lost to Follow-up|0|||
33652270|NCT01737697|63064147|FG001|Subacute Phase|Lost to Follow-up|0|||
33328795|NCT01193348|62705202|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
33652271|NCT01737697|63064148|FG002|Subacute Phase|Lost to Follow-up|0|||
33652272|NCT01737697|63064149|FG003|Subacute Phase|Lost to Follow-up|0|||
33652273|NCT01737697|63064150|FG004|Subacute Phase|Lost to Follow-up|0|||
33652274|NCT01737697|63064151|FG005|Subacute Phase|Lost to Follow-up|0|||
33652275|NCT01737697|63064152|FG006|Subacute Phase|Lost to Follow-up|0|||
33652276|NCT01737697|63064153|FG007|Subacute Phase|Lost to Follow-up|0|||
33546233|NCT02991859|62937516|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33546234|NCT02991859|62937517|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33546235|NCT02991859|62937501|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33546236|NCT02991859|62937502|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33652277|NCT01737697|63064154|FG008|Subacute Phase|Lost to Follow-up|0|||
33652278|NCT01737697|63064155|FG009|Subacute Phase|Lost to Follow-up|0|||
33546237|NCT02991859|62937503|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33546238|NCT02991859|62937504|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33546239|NCT02991859|62937505|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33546240|NCT02991859|62937506|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
33546241|NCT02991859|62937507|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33546242|NCT02991859|62937508|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33546243|NCT02991859|62937509|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33546244|NCT02991859|62937510|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33546245|NCT02991859|62937511|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33546246|NCT02991859|62937512|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33546247|NCT02991859|62937513|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33546248|NCT02991859|62937514|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33546249|NCT02991859|62937515|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33546250|NCT02991859|62937516|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33546251|NCT02991859|62937517|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33546252|NCT02991859|62937501|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546253|NCT02991859|62937502|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546254|NCT02991859|62937503|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546255|NCT02991859|62937504|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546256|NCT02991859|62937505|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546257|NCT02991859|62937506|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546258|NCT02991859|62937507|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546259|NCT02991859|62937508|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546260|NCT02991859|62937509|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546261|NCT02991859|62937510|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
33546262|NCT02991859|62937511|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546263|NCT02991859|62937512|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546264|NCT02991859|62937513|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546265|NCT02991859|62937514|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546266|NCT02991859|62937515|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546267|NCT02991859|62937516|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546268|NCT02991859|62937517|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33546269|NCT02991859|62937501|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33546270|NCT02991859|62937502|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33546271|NCT02991859|62937503|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33546272|NCT02991859|62937504|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33546273|NCT02991859|62937505|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33546274|NCT02991859|62937506|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33546275|NCT02991859|62937507|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33546276|NCT02991859|62937508|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33546277|NCT02991859|62937509|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
33546278|NCT02991859|62937510|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33546279|NCT02991859|62937511|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33546280|NCT02991859|62937512|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33546281|NCT02991859|62937513|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33328796|NCT00945321|62705211|FG000|Period 1|Adverse Event|0|||
33328797|NCT00945321|62705212|FG001|Period 1|Adverse Event|0|||
33546282|NCT02991859|62937514|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33546283|NCT02991859|62937515|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33546284|NCT02991859|62937516|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33546285|NCT02991859|62937517|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33652279|NCT01737697|63064156|FG010|Subacute Phase|Lost to Follow-up|0|||
33652280|NCT01737697|63064157|FG011|Subacute Phase|Lost to Follow-up|0|||
33652281|NCT01737697|63064158|FG012|Subacute Phase|Lost to Follow-up|0|||
33652282|NCT01737697|63064159|FG013|Subacute Phase|Lost to Follow-up|0|||
33652283|NCT01737697|63064160|FG014|Subacute Phase|Lost to Follow-up|1|||
33546286|NCT03016325|62937600|FG000|Treatment Period|Participant withdrew consent|0|||
33546287|NCT03016325|62937601|FG001|Treatment Period|Participant withdrew consent|1|||
33652284|NCT01737697|63064146|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
33652285|NCT01737697|63064147|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
33328798|NCT00945321|62705213|FG002|Period 1|Adverse Event|0|||
33546288|NCT03016325|62937602|FG002|Treatment Period|Participant withdrew consent|0|||
33546289|NCT03016325|62937603|FG003|Treatment Period|Participant withdrew consent|0|||
33546290|NCT03016325|62937604|FG004|Treatment Period|Participant withdrew consent|0|||
33546291|NCT03016325|62937605|FG005|Treatment Period|Participant withdrew consent|0|||
33546292|NCT03016325|62937606|FG006|Treatment Period|Participant withdrew consent|0|||
33546293|NCT03016325|62937607|FG007|Treatment Period|Participant withdrew consent|0|||
33546294|NCT03016325|62937600|FG000|Treatment Period|Death|0|||
33546295|NCT03016325|62937601|FG001|Treatment Period|Death|0|||
33546296|NCT03016325|62937602|FG002|Treatment Period|Death|0|||
33546297|NCT03016325|62937603|FG003|Treatment Period|Death|0|||
33546298|NCT03016325|62937604|FG004|Treatment Period|Death|2|||
33546299|NCT03016325|62937605|FG005|Treatment Period|Death|0|||
33546300|NCT03016325|62937606|FG006|Treatment Period|Death|0|||
33546301|NCT03016325|62937607|FG007|Treatment Period|Death|0|||
33546302|NCT03016325|62937600|FG000|Treatment Period|Participant refuses assessments|0|||
33546303|NCT03016325|62937601|FG001|Treatment Period|Participant refuses assessments|0|||
33546304|NCT03016325|62937602|FG002|Treatment Period|Participant refuses assessments|1|||
33546305|NCT03016325|62937603|FG003|Treatment Period|Participant refuses assessments|0|||
33546306|NCT03016325|62937604|FG004|Treatment Period|Participant refuses assessments|0|||
33546307|NCT03016325|62937605|FG005|Treatment Period|Participant refuses assessments|0|||
33546308|NCT03016325|62937606|FG006|Treatment Period|Participant refuses assessments|0|||
33546309|NCT03016325|62937607|FG007|Treatment Period|Participant refuses assessments|0|||
33546310|NCT03016325|62937600|FG000|32-Day Follow-Up Period|Death|2|||
33546311|NCT03016325|62937601|FG001|32-Day Follow-Up Period|Death|0|||
33546312|NCT03016325|62937602|FG002|32-Day Follow-Up Period|Death|5|||
33546313|NCT03016325|62937603|FG003|32-Day Follow-Up Period|Death|6|||
33546314|NCT03016325|62937604|FG004|32-Day Follow-Up Period|Death|3|||
33546315|NCT03016325|62937605|FG005|32-Day Follow-Up Period|Death|0|||
33546316|NCT03016325|62937606|FG006|32-Day Follow-Up Period|Death|0|||
33546317|NCT03016325|62937607|FG007|32-Day Follow-Up Period|Death|0|||
33546318|NCT03016325|62937600|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
33546319|NCT03016325|62937601|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
33546320|NCT03016325|62937602|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
33546321|NCT03016325|62937603|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
33546322|NCT03016325|62937604|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
33546323|NCT03016325|62937605|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
33546324|NCT03016325|62937606|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
33546325|NCT03016325|62937607|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
33546326|NCT03016325|62937600|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
33546327|NCT03016325|62937601|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
33546328|NCT03016325|62937602|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
33546329|NCT03016325|62937603|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
33546330|NCT03016325|62937604|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
33546331|NCT03016325|62937605|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
33546332|NCT03016325|62937606|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
33546333|NCT03016325|62937607|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
33546334|NCT03016325|62937600|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
33546335|NCT03016325|62937601|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
33546336|NCT03016325|62937602|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
33546337|NCT03016325|62937603|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
33546338|NCT03016325|62937604|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
33546339|NCT03016325|62937605|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
33546340|NCT03016325|62937606|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
33546341|NCT03016325|62937607|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
33546342|NCT03016325|62937600|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
33546343|NCT03016325|62937601|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
33652286|NCT01737697|63064148|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
33652287|NCT01737697|63064149|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
33652288|NCT01737697|63064150|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
33546344|NCT03016325|62937602|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
33546345|NCT03016325|62937603|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
33546346|NCT03016325|62937604|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
33546347|NCT03016325|62937605|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
33546348|NCT03016325|62937606|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
33546349|NCT03016325|62937607|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
33546350|NCT03016325|62937600|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
33652289|NCT01737697|63064151|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
33546351|NCT03016325|62937601|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
33546352|NCT03016325|62937602|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
33546353|NCT03016325|62937603|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
33652290|NCT01737697|63064152|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
33546354|NCT03016325|62937604|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
33546355|NCT03016325|62937605|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
33546356|NCT03016325|62937606|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
33546357|NCT03016325|62937607|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
33546358|NCT03016325|62937600|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
33546359|NCT03016325|62937601|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
33546360|NCT03016325|62937602|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
33546361|NCT03016325|62937603|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
33652291|NCT01737697|63064153|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
33652292|NCT01737697|63064154|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
33546362|NCT03016325|62937604|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
33546363|NCT03016325|62937605|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
33546364|NCT03016325|62937606|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
33546365|NCT03016325|62937607|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
33546366|NCT03016325|62937600|FG000|182-Day Follow-Up Period|Death|3|||
33546367|NCT03016325|62937601|FG001|182-Day Follow-Up Period|Death|3|||
33546368|NCT03016325|62937602|FG002|182-Day Follow-Up Period|Death|11|||
33546369|NCT03016325|62937603|FG003|182-Day Follow-Up Period|Death|12|||
33546370|NCT03016325|62937604|FG004|182-Day Follow-Up Period|Death|9|||
33546371|NCT03016325|62937605|FG005|182-Day Follow-Up Period|Death|0|||
33546372|NCT03016325|62937606|FG006|182-Day Follow-Up Period|Death|0|||
33546373|NCT03016325|62937607|FG007|182-Day Follow-Up Period|Death|1|||
33546374|NCT03016325|62937600|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
33546375|NCT03016325|62937601|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
33546376|NCT03016325|62937602|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
33546377|NCT03016325|62937603|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
33546378|NCT03016325|62937604|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
33546379|NCT03016325|62937605|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
33546380|NCT03016325|62937606|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
33546381|NCT03016325|62937607|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
33546382|NCT03016325|62937600|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
33546383|NCT03016325|62937601|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
33546384|NCT03016325|62937602|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
33546385|NCT03016325|62937603|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
33546386|NCT03016325|62937604|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
33652293|NCT01737697|63064155|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
33652294|NCT01737697|63064156|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
33652295|NCT01737697|63064157|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
33652296|NCT01737697|63064158|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
33652297|NCT01737697|63064159|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
33652298|NCT01737697|63064160|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
33652299|NCT01737697|63064146|FG000|Subacute Phase|Protocol Violation|0|||
33652300|NCT01737697|63064147|FG001|Subacute Phase|Protocol Violation|0|||
33652301|NCT01737697|63064148|FG002|Subacute Phase|Protocol Violation|0|||
33652302|NCT01737697|63064149|FG003|Subacute Phase|Protocol Violation|0|||
33652303|NCT01737697|63064150|FG004|Subacute Phase|Protocol Violation|0|||
33652304|NCT01737697|63064151|FG005|Subacute Phase|Protocol Violation|1|||
33652305|NCT01737697|63064152|FG006|Subacute Phase|Protocol Violation|0|||
33652306|NCT01737697|63064153|FG007|Subacute Phase|Protocol Violation|0|||
33546387|NCT03016325|62937605|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
33546388|NCT03016325|62937606|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
33546389|NCT03016325|62937607|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
33652307|NCT01737697|63064154|FG008|Subacute Phase|Protocol Violation|0|||
33652308|NCT01737697|63064155|FG009|Subacute Phase|Protocol Violation|0|||
33652309|NCT01737697|63064156|FG010|Subacute Phase|Protocol Violation|1|||
33652310|NCT01737697|63064157|FG011|Subacute Phase|Protocol Violation|0|||
33652311|NCT01737697|63064158|FG012|Subacute Phase|Protocol Violation|0|||
33652312|NCT01737697|63064159|FG013|Subacute Phase|Protocol Violation|0|||
33652313|NCT01737697|63064160|FG014|Subacute Phase|Protocol Violation|0|||
33652314|NCT01737697|63064146|FG000|Subacute Phase|Physician Decision|0|||
33652315|NCT01737697|63064147|FG001|Subacute Phase|Physician Decision|0|||
33652316|NCT01737697|63064148|FG002|Subacute Phase|Physician Decision|0|||
33652317|NCT01737697|63064149|FG003|Subacute Phase|Physician Decision|0|||
33652318|NCT01737697|63064150|FG004|Subacute Phase|Physician Decision|0|||
33652319|NCT01737697|63064151|FG005|Subacute Phase|Physician Decision|0|||
33652320|NCT01737697|63064152|FG006|Subacute Phase|Physician Decision|0|||
33652321|NCT01737697|63064153|FG007|Subacute Phase|Physician Decision|0|||
33652322|NCT01737697|63064154|FG008|Subacute Phase|Physician Decision|1|||
33652323|NCT01737697|63064155|FG009|Subacute Phase|Physician Decision|0|||
33652324|NCT01737697|63064156|FG010|Subacute Phase|Physician Decision|0|||
33652325|NCT01737697|63064157|FG011|Subacute Phase|Physician Decision|0|||
33652326|NCT01737697|63064158|FG012|Subacute Phase|Physician Decision|0|||
33652327|NCT01737697|63064159|FG013|Subacute Phase|Physician Decision|0|||
33652328|NCT01737697|63064160|FG014|Subacute Phase|Physician Decision|0|||
33652329|NCT01737697|63064146|FG000|Subacute Phase|Death|0|||
33652330|NCT01737697|63064147|FG001|Subacute Phase|Death|0|||
33652331|NCT01737697|63064148|FG002|Subacute Phase|Death|0|||
33652332|NCT01737697|63064149|FG003|Subacute Phase|Death|0|||
33546390|NCT03016325|62937600|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
33546391|NCT03016325|62937601|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
33546392|NCT03016325|62937602|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
33546393|NCT03016325|62937603|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
33546394|NCT03016325|62937604|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
33546395|NCT03016325|62937605|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
33546396|NCT03016325|62937606|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
33546397|NCT03016325|62937607|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
33546398|NCT03016325|62937600|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
33546399|NCT03016325|62937601|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
33546400|NCT03016325|62937602|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
33546401|NCT03016325|62937603|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
33546402|NCT03016325|62937604|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
33546403|NCT03016325|62937605|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
33546404|NCT03016325|62937606|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
33546405|NCT03016325|62937607|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
33546406|NCT03016325|62937600|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
33546407|NCT03016325|62937601|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
33546408|NCT03016325|62937602|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
33546409|NCT03016325|62937603|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
33546410|NCT03016325|62937604|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
33546411|NCT03016325|62937605|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
33546412|NCT03016325|62937606|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
33546413|NCT03016325|62937607|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
33652333|NCT01737697|63064150|FG004|Subacute Phase|Death|0|||
33652334|NCT01737697|63064151|FG005|Subacute Phase|Death|0|||
33652335|NCT01737697|63064152|FG006|Subacute Phase|Death|0|||
33652336|NCT01737697|63064153|FG007|Subacute Phase|Death|0|||
33652337|NCT01737697|63064154|FG008|Subacute Phase|Death|0|||
33652338|NCT01737697|63064155|FG009|Subacute Phase|Death|0|||
33652339|NCT01737697|63064156|FG010|Subacute Phase|Death|1|||
33652340|NCT01737697|63064157|FG011|Subacute Phase|Death|0|||
33652341|NCT01737697|63064158|FG012|Subacute Phase|Death|0|||
33652342|NCT01737697|63064159|FG013|Subacute Phase|Death|0|||
33652343|NCT01737697|63064160|FG014|Subacute Phase|Death|0|||
33652344|NCT01682863|63064316|FG000|Overall Study|Subject/guardian decision|19|||
33546414|NCT03016325|62937600|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
33546415|NCT03016325|62937601|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
33546416|NCT03016325|62937602|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
33546417|NCT03016325|62937603|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
33546418|NCT03016325|62937604|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
33546419|NCT03016325|62937605|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
33546420|NCT03016325|62937606|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
33546421|NCT03016325|62937607|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
33546422|NCT03016325|62937600|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
33546423|NCT03016325|62937601|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
33546424|NCT03016325|62937602|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
33546425|NCT03016325|62937603|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
33546426|NCT03016325|62937604|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
33546427|NCT03016325|62937605|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
33546428|NCT03016325|62937606|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
33546429|NCT03016325|62937607|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
33546430|NCT02988115|62937630|FG000|Overall Study|Adverse Event|6|||
33546431|NCT02988115|62937631|FG001|Overall Study|Adverse Event|1|||
33546432|NCT02988115|62937630|FG000|Overall Study|Sponsor Decision|5|||
33546433|NCT02988115|62937631|FG001|Overall Study|Sponsor Decision|2|||
33546434|NCT02988115|62937630|FG000|Overall Study|Withdrawal by Subject|1|||
33546435|NCT02988115|62937631|FG001|Overall Study|Withdrawal by Subject|1|||
33652345|NCT01682863|63064317|FG001|Overall Study|Subject/guardian decision|12|||
33652346|NCT01682863|63064318|FG002|Overall Study|Subject/guardian decision|10|||
33328799|NCT00945321|62705214|FG003|Period 1|Adverse Event|0|||
33546436|NCT02988115|62937630|FG000|Overall Study|Withdrawn by Mistake|1|||
33546437|NCT02988115|62937631|FG001|Overall Study|Withdrawn by Mistake|0|||
33652347|NCT01682863|63064316|FG000|Overall Study|Lost to Follow-up|5|||
33652348|NCT01682863|63064317|FG001|Overall Study|Lost to Follow-up|1|||
33652349|NCT01682863|63064318|FG002|Overall Study|Lost to Follow-up|6|||
33546438|NCT02988115|62937630|FG000|Overall Study|Lost to Follow-up|1|||
33546439|NCT02988115|62937631|FG001|Overall Study|Lost to Follow-up|0|||
33546440|NCT02921425|62937637|FG000|Overall Study|Protocol Violation|9|||
33546441|NCT03008915|62937641|FG000|Treatment 1|Withdrawal by Subject|0|||
33546442|NCT03008915|62937642|FG001|Treatment 1|Withdrawal by Subject|1|||
33546443|NCT02920957|62937653|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
33546444|NCT02920957|62937654|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
33546445|NCT02920957|62937653|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
33546446|NCT02920957|62937654|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
33546447|NCT02920957|62937653|FG000|First Intervention : 1 Month|Adverse Event|1|||
33546448|NCT02920957|62937654|FG001|First Intervention : 1 Month|Adverse Event|0|||
33546449|NCT02920957|62937653|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
33546450|NCT02920957|62937654|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
33546451|NCT03006887|62937671|FG000|Overall Study|Adverse Event|1|||
33546452|NCT02514772|62937677|FG000|Overall Study|Adverse Event|1|||
33546453|NCT02514772|62937678|FG001|Overall Study|Adverse Event|0|||
33546454|NCT02514772|62937677|FG000|Overall Study|Death|0|||
33546455|NCT02514772|62937678|FG001|Overall Study|Death|1|||
33546456|NCT02514772|62937677|FG000|Overall Study|Withdrawal by Subject|2|||
33546457|NCT02514772|62937678|FG001|Overall Study|Withdrawal by Subject|1|||
33546458|NCT03000179|62937686|FG000|Overall Study|Lost to Follow-up|2|||
33546459|NCT02920177|62937692|FG000|Overall Study|Withdrawal by Subject|1|||
33546460|NCT02920177|62937693|FG001|Overall Study|Withdrawal by Subject|1|||
33546461|NCT02920177|62937692|FG000|Overall Study|Physician Decision|1|||
33546462|NCT02920177|62937693|FG001|Overall Study|Physician Decision|0|||
33546463|NCT02920177|62937692|FG000|Overall Study|Lost to Follow-up|0|||
33546464|NCT02920177|62937693|FG001|Overall Study|Lost to Follow-up|1|||
33546465|NCT03006341|62937703|FG000|Overall Study|Not linked in the EMR|25069|||
33546466|NCT03006341|62937704|FG001|Overall Study|Not linked in the EMR|67505|||
33546467|NCT03006341|62937705|FG002|Overall Study|Not linked in the EMR|30993|||
33546468|NCT03006341|62937706|FG003|Overall Study|Not linked in the EMR|10685|||
33546469|NCT03935594|62937714|FG000|Overall Study|Physician Decision|3|||
33546470|NCT02512042|62937722|FG000|Overall Study|Adverse Event|0|||
33546471|NCT02512042|62937723|FG001|Overall Study|Adverse Event|4|||
33546472|NCT02512042|62937722|FG000|Overall Study|Withdrawal by Subject|6|||
33546473|NCT02512042|62937723|FG001|Overall Study|Withdrawal by Subject|6|||
33546474|NCT02512042|62937722|FG000|Overall Study|Non-compliance with study drug|1|||
33546475|NCT02512042|62937723|FG001|Overall Study|Non-compliance with study drug|2|||
33546476|NCT02512042|62937722|FG000|Overall Study|Lost to Follow-up|5|||
33546477|NCT02512042|62937723|FG001|Overall Study|Lost to Follow-up|2|||
33546478|NCT02512042|62937722|FG000|Overall Study|Other|11|||
33546479|NCT02512042|62937723|FG001|Overall Study|Other|11|||
33546480|NCT02911025|62937729|FG000|Overall Study|Lost to Follow-up|3|||
33546481|NCT02919475|62937738|FG000|Overall Study|Adverse Event|3|||
33546482|NCT02919475|62937739|FG001|Overall Study|Adverse Event|3|||
33546483|NCT02919475|62937740|FG002|Overall Study|Adverse Event|3|||
33546484|NCT02919475|62937741|FG003|Overall Study|Adverse Event|9|||
33546485|NCT02919475|62937742|FG004|Overall Study|Adverse Event|2|||
33546486|NCT02919475|62937738|FG000|Overall Study|Death|0|||
33546487|NCT02919475|62937739|FG001|Overall Study|Death|1|||
33546488|NCT02919475|62937740|FG002|Overall Study|Death|0|||
33546489|NCT02919475|62937741|FG003|Overall Study|Death|0|||
33546490|NCT02919475|62937742|FG004|Overall Study|Death|0|||
33546491|NCT02919475|62937738|FG000|Overall Study|Lost to Follow-up|0|||
33546492|NCT02919475|62937739|FG001|Overall Study|Lost to Follow-up|0|||
33546493|NCT02919475|62937740|FG002|Overall Study|Lost to Follow-up|0|||
33546494|NCT02919475|62937741|FG003|Overall Study|Lost to Follow-up|1|||
33546495|NCT02919475|62937742|FG004|Overall Study|Lost to Follow-up|0|||
33546496|NCT02919475|62937738|FG000|Overall Study|Withdrawal by Subject|2|||
33546497|NCT02919475|62937739|FG001|Overall Study|Withdrawal by Subject|3|||
33546498|NCT02919475|62937740|FG002|Overall Study|Withdrawal by Subject|1|||
33546499|NCT02919475|62937741|FG003|Overall Study|Withdrawal by Subject|2|||
33652350|NCT01682863|63064316|FG000|Overall Study|Death|1|||
33652351|NCT01682863|63064317|FG001|Overall Study|Death|3|||
33546500|NCT02919475|62937742|FG004|Overall Study|Withdrawal by Subject|2|||
33546501|NCT02919475|62937738|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
33546502|NCT02919475|62937739|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
33546503|NCT02919475|62937740|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
33546504|NCT02919475|62937741|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
33546505|NCT02919475|62937742|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33546506|NCT01066897|62937756|FG000|Overall Study|Withdrawal by Subject|1|||
33546507|NCT01066897|62937757|FG001|Overall Study|Withdrawal by Subject|0|||
33652352|NCT01682863|63064318|FG002|Overall Study|Death|4|||
33652353|NCT01682863|63064316|FG000|Overall Study|Protocol deviation|1|||
33546508|NCT01066897|62937756|FG000|Overall Study|stopped study after developing the flu.|1|||
33546509|NCT01066897|62937757|FG001|Overall Study|stopped study after developing the flu.|0|||
33546510|NCT02985541|62937764|FG000|Overall Study|Withdrawal by Subject|33|||
33546511|NCT02985541|62937764|FG000|Overall Study|Lost to Follow-up|26|||
33546512|NCT02985541|62937764|FG000|Overall Study|Adverse Event|27|||
33546513|NCT02985541|62937764|FG000|Overall Study|Physician Decision|2|||
33546514|NCT02985541|62937764|FG000|Overall Study|Pregnancy|2|||
33546515|NCT02985541|62937764|FG000|Overall Study|Wish for pregnancy|44|||
33546516|NCT02985541|62937764|FG000|Overall Study|Other reason|5|||
33546517|NCT02985541|62937764|FG000|Overall Study|Not valid for analysis|2|||
33546518|NCT02910037|62937777|FG000|Overall Study|Withdrawal by Subject|4|||
33546519|NCT02910037|62937777|FG000|Overall Study|Lost to Follow-up|6|||
33546520|NCT02511184|62937812|FG000|Overall Study|Death|1|||
33546521|NCT02511184|62937813|FG001|Overall Study|Death|0|||
33546522|NCT02511184|62937812|FG000|Overall Study|Lost to Follow-up|0|||
33546523|NCT02511184|62937813|FG001|Overall Study|Lost to Follow-up|1|||
33546524|NCT02511184|62937812|FG000|Overall Study|Study terminated by sponsor|1|||
33546525|NCT02511184|62937813|FG001|Overall Study|Study terminated by sponsor|5|||
33546526|NCT02511184|62937812|FG000|Overall Study|Withdrawal by Subject|0|||
33546527|NCT02511184|62937813|FG001|Overall Study|Withdrawal by Subject|1|||
33546528|NCT02984995|62937822|FG000|Overall Study|Required stem cell transplant|13|||
33546529|NCT02984995|62937823|FG001|Overall Study|Required stem cell transplant|2|||
33546530|NCT02984995|62937822|FG000|Overall Study|Progressive disease|11|||
33546531|NCT02984995|62937823|FG001|Overall Study|Progressive disease|1|||
33546532|NCT02984995|62937822|FG000|Overall Study|Adverse Event|1|||
33546533|NCT02984995|62937823|FG001|Overall Study|Adverse Event|0|||
33546534|NCT02984683|62937847|FG000|Overall Study|Adverse Event|3|||
33546535|NCT02984683|62937848|FG001|Overall Study|Adverse Event|3|||
33652354|NCT01682863|63064317|FG001|Overall Study|Protocol deviation|0|||
33652355|NCT01682863|63064318|FG002|Overall Study|Protocol deviation|1|||
33652356|NCT01682863|63064316|FG000|Overall Study|Technical problems|1|||
33652357|NCT01682863|63064317|FG001|Overall Study|Technical problems|0|||
33652358|NCT01682863|63064318|FG002|Overall Study|Technical problems|0|||
33652359|NCT01682863|63064316|FG000|Overall Study|Adverse Event|0|||
33652360|NCT01682863|63064317|FG001|Overall Study|Adverse Event|1|||
33652361|NCT01682863|63064318|FG002|Overall Study|Adverse Event|2|||
33652362|NCT01682863|63064316|FG000|Overall Study|Physician Decision|0|||
33652363|NCT01682863|63064317|FG001|Overall Study|Physician Decision|0|||
33652364|NCT01682863|63064318|FG002|Overall Study|Physician Decision|1|||
33652365|NCT01951625|63064331|FG000|Treatment Period|Protocol Violation|2|||
33652366|NCT01951625|63064332|FG001|Treatment Period|Protocol Violation|0|||
33652367|NCT01951625|63064333|FG002|Treatment Period|Protocol Violation|1|||
33652368|NCT01951625|63064334|FG003|Treatment Period|Protocol Violation|3|||
33652369|NCT01951625|63064335|FG004|Treatment Period|Protocol Violation|2|||
33652370|NCT01951625|63064331|FG000|Treatment Period|Physician Decision|0|||
33652371|NCT01951625|63064332|FG001|Treatment Period|Physician Decision|0|||
33652372|NCT01951625|63064333|FG002|Treatment Period|Physician Decision|0|||
33652373|NCT01951625|63064334|FG003|Treatment Period|Physician Decision|0|||
33652374|NCT01951625|63064335|FG004|Treatment Period|Physician Decision|1|||
33652375|NCT01951625|63064331|FG000|Treatment Period|Protocol driven decision point|0|||
33652376|NCT01951625|63064332|FG001|Treatment Period|Protocol driven decision point|5|||
33652377|NCT01951625|63064333|FG002|Treatment Period|Protocol driven decision point|0|||
33652378|NCT01951625|63064334|FG003|Treatment Period|Protocol driven decision point|2|||
33652379|NCT01951625|63064335|FG004|Treatment Period|Protocol driven decision point|1|||
33652380|NCT01951625|63064331|FG000|Treatment Period|Non compliance with study drug|1|||
33652381|NCT01951625|63064332|FG001|Treatment Period|Non compliance with study drug|2|||
33652382|NCT01951625|63064333|FG002|Treatment Period|Non compliance with study drug|2|||
33652383|NCT01951625|63064334|FG003|Treatment Period|Non compliance with study drug|0|||
33652384|NCT01951625|63064335|FG004|Treatment Period|Non compliance with study drug|0|||
33652385|NCT01951625|63064331|FG000|Treatment Period|Death|3|||
33652386|NCT01951625|63064332|FG001|Treatment Period|Death|2|||
33652387|NCT01951625|63064333|FG002|Treatment Period|Death|2|||
33652388|NCT01951625|63064334|FG003|Treatment Period|Death|1|||
33466415|NCT01239368|62839880|FG008|Overall Study|Refused further treatment|0|||
33466416|NCT01239368|62839881|FG009|Overall Study|Refused further treatment|1|||
33466417|NCT01239368|62839872|FG000|Overall Study|Death|0|||
33466418|NCT01239368|62839873|FG001|Overall Study|Death|0|||
33466419|NCT01239368|62839874|FG002|Overall Study|Death|0|||
33466420|NCT01239368|62839875|FG003|Overall Study|Death|0|||
33466421|NCT01239368|62839876|FG004|Overall Study|Death|0|||
33466422|NCT01239368|62839877|FG005|Overall Study|Death|0|||
33466423|NCT01239368|62839878|FG006|Overall Study|Death|1|||
33466424|NCT01239368|62839879|FG007|Overall Study|Death|0|||
33466425|NCT01239368|62839880|FG008|Overall Study|Death|0|||
33466426|NCT01239368|62839881|FG009|Overall Study|Death|0|||
33466427|NCT00369161|62839929|FG000|Overall Study|Adverse Event|15|||
33546536|NCT02984683|62937847|FG000|Overall Study|Withdrawal by Subject|1|||
33546537|NCT02984683|62937848|FG001|Overall Study|Withdrawal by Subject|0|||
33652389|NCT01951625|63064335|FG004|Treatment Period|Death|2|||
33652390|NCT01951625|63064331|FG000|Treatment Period|Adverse Event|7|||
33466428|NCT00369161|62839930|FG001|Overall Study|Adverse Event|13|||
33466429|NCT00369161|62839929|FG000|Overall Study|Abnormal laboratory value|0|||
33652391|NCT01951625|63064332|FG001|Treatment Period|Adverse Event|10|||
33652392|NCT01951625|63064333|FG002|Treatment Period|Adverse Event|9|||
33652393|NCT01951625|63064334|FG003|Treatment Period|Adverse Event|8|||
33652394|NCT01951625|63064335|FG004|Treatment Period|Adverse Event|8|||
33652395|NCT01951625|63064331|FG000|Treatment Period|Withdrawal by Subject|5|||
33652396|NCT01951625|63064332|FG001|Treatment Period|Withdrawal by Subject|2|||
33652397|NCT01951625|63064333|FG002|Treatment Period|Withdrawal by Subject|1|||
33652398|NCT01951625|63064334|FG003|Treatment Period|Withdrawal by Subject|7|||
33652399|NCT01951625|63064335|FG004|Treatment Period|Withdrawal by Subject|3|||
33652400|NCT01951625|63064331|FG000|Treatment Period|Lost to Follow-up|1|||
33652401|NCT01951625|63064332|FG001|Treatment Period|Lost to Follow-up|0|||
33652402|NCT01951625|63064333|FG002|Treatment Period|Lost to Follow-up|0|||
33652403|NCT01951625|63064334|FG003|Treatment Period|Lost to Follow-up|1|||
33652404|NCT01951625|63064335|FG004|Treatment Period|Lost to Follow-up|0|||
33652405|NCT01951625|63064331|FG000|Follow Up Period|Non-compliance with study drug|1|||
33652406|NCT01951625|63064332|FG001|Follow Up Period|Non-compliance with study drug|0|||
33652407|NCT01951625|63064333|FG002|Follow Up Period|Non-compliance with study drug|0|||
33652408|NCT01951625|63064334|FG003|Follow Up Period|Non-compliance with study drug|0|||
33652409|NCT01951625|63064335|FG004|Follow Up Period|Non-compliance with study drug|0|||
33652410|NCT01951625|63064331|FG000|Follow Up Period|Death|1|||
33652411|NCT01951625|63064332|FG001|Follow Up Period|Death|3|||
33652412|NCT01951625|63064333|FG002|Follow Up Period|Death|2|||
33652413|NCT01951625|63064334|FG003|Follow Up Period|Death|2|||
33652414|NCT01951625|63064335|FG004|Follow Up Period|Death|1|||
33652415|NCT01951625|63064331|FG000|Follow Up Period|Logistical difficulties|1|||
33652416|NCT01951625|63064332|FG001|Follow Up Period|Logistical difficulties|2|||
33652417|NCT01951625|63064333|FG002|Follow Up Period|Logistical difficulties|0|||
33652418|NCT01951625|63064334|FG003|Follow Up Period|Logistical difficulties|0|||
33652419|NCT01951625|63064335|FG004|Follow Up Period|Logistical difficulties|0|||
33652420|NCT01951625|63064331|FG000|Follow Up Period|Adverse Event|0|||
33652421|NCT01951625|63064332|FG001|Follow Up Period|Adverse Event|3|||
33652422|NCT01951625|63064333|FG002|Follow Up Period|Adverse Event|2|||
33652423|NCT01951625|63064334|FG003|Follow Up Period|Adverse Event|3|||
33652424|NCT01951625|63064335|FG004|Follow Up Period|Adverse Event|5|||
33652425|NCT01951625|63064331|FG000|Follow Up Period|Withdrawal by Subject|4|||
33652426|NCT01951625|63064332|FG001|Follow Up Period|Withdrawal by Subject|1|||
33652427|NCT01951625|63064333|FG002|Follow Up Period|Withdrawal by Subject|0|||
33652428|NCT01951625|63064334|FG003|Follow Up Period|Withdrawal by Subject|5|||
33652429|NCT01951625|63064335|FG004|Follow Up Period|Withdrawal by Subject|3|||
33652430|NCT01951625|63064331|FG000|Follow Up Period|Lost to Follow-up|1|||
33652431|NCT01951625|63064332|FG001|Follow Up Period|Lost to Follow-up|0|||
33652432|NCT01951625|63064333|FG002|Follow Up Period|Lost to Follow-up|0|||
33466430|NCT00369161|62839930|FG001|Overall Study|Abnormal laboratory value|1|||
33466431|NCT00369161|62839929|FG000|Overall Study|Lack of Efficacy|3|||
33466432|NCT00369161|62839930|FG001|Overall Study|Lack of Efficacy|1|||
33466433|NCT00369161|62839929|FG000|Overall Study|Protocol Violation|0|||
33466434|NCT00369161|62839930|FG001|Overall Study|Protocol Violation|2|||
33466435|NCT00369161|62839929|FG000|Overall Study|Withdrawal by Subject|2|||
33466436|NCT00369161|62839930|FG001|Overall Study|Withdrawal by Subject|3|||
33466437|NCT00369161|62839929|FG000|Overall Study|Death|1|||
33466438|NCT00369161|62839930|FG001|Overall Study|Death|2|||
33466439|NCT00369161|62839929|FG000|Overall Study|Graft loss|4|||
33466440|NCT00369161|62839930|FG001|Overall Study|Graft loss|0|||
33466441|NCT00369161|62839929|FG000|Overall Study|Administrative Problem|2|||
33466442|NCT00369161|62839930|FG001|Overall Study|Administrative Problem|2|||
33466443|NCT00337571|62839940|FG000|Overall Study|Lack of Efficacy|3|||
33466444|NCT00337571|62839941|FG001|Overall Study|Lack of Efficacy|0|||
33466445|NCT00337571|62839942|FG002|Overall Study|Lack of Efficacy|0|||
33466446|NCT00337571|62839943|FG003|Overall Study|Lack of Efficacy|0|||
33466447|NCT00337571|62839940|FG000|Overall Study|Adverse Event|4|||
33466448|NCT00337571|62839941|FG001|Overall Study|Adverse Event|5|||
33466449|NCT00337571|62839942|FG002|Overall Study|Adverse Event|8|||
33466450|NCT00337571|62839943|FG003|Overall Study|Adverse Event|4|||
33546538|NCT02984683|62937847|FG000|Overall Study|Disease progression|7|||
33546539|NCT02984683|62937848|FG001|Overall Study|Disease progression|9|||
33546540|NCT02909101|62937856|FG000|Overall Study|Lost to Follow-up|1|||
33546541|NCT02909101|62937857|FG001|Overall Study|Lost to Follow-up|1|||
33546542|NCT03004469|62937866|FG000|Overall Study|Adverse Event|6|||
33546543|NCT03004469|62937867|FG001|Overall Study|Adverse Event|4|||
33546544|NCT03004469|62937868|FG002|Overall Study|Adverse Event|6|||
33652433|NCT01951625|63064334|FG003|Follow Up Period|Lost to Follow-up|1|||
33652434|NCT01951625|63064335|FG004|Follow Up Period|Lost to Follow-up|1|||
33652435|NCT04400890|63064350|FG000|Overall Study|Withdrawal by Subject|3|||
33310157|NCT01168401|62685539|FG010|Overall Study|Lost to Follow-up|0|||
33466451|NCT00337571|62839940|FG000|Overall Study|Withdrawal by Subject|2|||
33466452|NCT00337571|62839941|FG001|Overall Study|Withdrawal by Subject|2|||
33546545|NCT03004469|62937866|FG000|Overall Study|Lack of Efficacy|1|||
33546546|NCT03004469|62937867|FG001|Overall Study|Lack of Efficacy|0|||
33546547|NCT03004469|62937868|FG002|Overall Study|Lack of Efficacy|1|||
33546548|NCT03004469|62937866|FG000|Overall Study|Lost to Follow-up|23|||
33546549|NCT03004469|62937867|FG001|Overall Study|Lost to Follow-up|14|||
33546550|NCT03004469|62937868|FG002|Overall Study|Lost to Follow-up|6|||
33546551|NCT03004469|62937866|FG000|Overall Study|Non-Compliance with Study Drug|2|||
33546552|NCT03004469|62937867|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33546553|NCT03004469|62937868|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33652436|NCT04400890|63064351|FG001|Overall Study|Withdrawal by Subject|2|||
33652437|NCT01936649|63064357|FG000|Overall Study|Withdrawal by Subject|4|||
33652438|NCT01936649|63064357|FG000|Overall Study|Physician Decision|2|||
33652439|NCT01936649|63064357|FG000|Overall Study|Protocol Violation|2|||
33652440|NCT01936649|63064357|FG000|Overall Study|Other than specified above|5|||
33546554|NCT03004469|62937866|FG000|Overall Study|Protocol Violation|0|||
33546555|NCT03004469|62937867|FG001|Overall Study|Protocol Violation|0|||
33546556|NCT03004469|62937868|FG002|Overall Study|Protocol Violation|1|||
33546557|NCT03004469|62937866|FG000|Overall Study|Withdrawal by Subject|29|||
33546558|NCT03004469|62937867|FG001|Overall Study|Withdrawal by Subject|27|||
33546559|NCT03004469|62937868|FG002|Overall Study|Withdrawal by Subject|10|||
33546560|NCT03004469|62937866|FG000|Overall Study|Other unspecified reason|0|||
33546561|NCT03004469|62937867|FG001|Overall Study|Other unspecified reason|4|||
33546562|NCT03004469|62937868|FG002|Overall Study|Other unspecified reason|1|||
33546563|NCT02910713|62937877|FG000|Overall Study|Protocol Violation|2|||
33546564|NCT02910713|62937877|FG000|Overall Study|Subject Choice|4|||
33546565|NCT02910713|62937877|FG000|Overall Study|Received One Application|10|||
33546566|NCT02910713|62937877|FG000|Overall Study|Received Neither Application|18|||
33546567|NCT02910713|62937877|FG000|Overall Study|Enrollment cap|7|||
33546568|NCT02910713|62937877|FG000|Overall Study|Investigator Discretion|1|||
33546569|NCT02998541|62937885|FG000|Overall Study|Adverse Event|4|||
33546570|NCT02998541|62937886|FG001|Overall Study|Adverse Event|5|||
33546571|NCT02998541|62937887|FG002|Overall Study|Adverse Event|1|||
33546572|NCT02998541|62937885|FG000|Overall Study|Protocol Violation|1|||
33546573|NCT02998541|62937886|FG001|Overall Study|Protocol Violation|0|||
33546574|NCT02998541|62937887|FG002|Overall Study|Protocol Violation|0|||
33546575|NCT02998541|62937885|FG000|Overall Study|Withdrawal by Subject|3|||
33652441|NCT01720069|63064364|FG000|Overall Study|Could not use e-diary correctly|0|||
33652442|NCT01720069|63064365|FG001|Overall Study|Could not use e-diary correctly|1|||
33652443|NCT01720069|63064366|FG002|Overall Study|Could not use e-diary correctly|1|||
33546576|NCT02998541|62937886|FG001|Overall Study|Withdrawal by Subject|1|||
33652444|NCT01720069|63064364|FG000|Overall Study|Randomised without baseline values|0|||
33652445|NCT01720069|63064365|FG001|Overall Study|Randomised without baseline values|0|||
33546577|NCT02998541|62937887|FG002|Overall Study|Withdrawal by Subject|0|||
33546578|NCT02998541|62937885|FG000|Overall Study|Lost to Follow-up|0|||
33652446|NCT01720069|63064366|FG002|Overall Study|Randomised without baseline values|1|||
33546579|NCT02998541|62937886|FG001|Overall Study|Lost to Follow-up|3|||
33546580|NCT02998541|62937887|FG002|Overall Study|Lost to Follow-up|1|||
33546581|NCT02998541|62937885|FG000|Overall Study|Physician Decision|0|||
33546582|NCT02998541|62937886|FG001|Overall Study|Physician Decision|0|||
33546583|NCT02998541|62937887|FG002|Overall Study|Physician Decision|3|||
33652447|NCT01720069|63064364|FG000|Overall Study|Adverse Event|0|||
33652448|NCT01720069|63064365|FG001|Overall Study|Adverse Event|0|||
33652449|NCT01720069|63064366|FG002|Overall Study|Adverse Event|1|||
33652450|NCT01720069|63064364|FG000|Overall Study|Lack of Efficacy|0|||
33652451|NCT01720069|63064365|FG001|Overall Study|Lack of Efficacy|4|||
33652452|NCT01720069|63064366|FG002|Overall Study|Lack of Efficacy|0|||
33652453|NCT01720069|63064364|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
33652454|NCT01720069|63064365|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
33652455|NCT01720069|63064366|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
33652456|NCT01720069|63064364|FG000|Overall Study|Withdrawal by Subject|0|||
33652457|NCT01720069|63064365|FG001|Overall Study|Withdrawal by Subject|2|||
33652458|NCT01720069|63064366|FG002|Overall Study|Withdrawal by Subject|1|||
33652459|NCT01720069|63064364|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
33652460|NCT01720069|63064365|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
33652461|NCT01720069|63064366|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
33652462|NCT01720069|63064364|FG000|Overall Study|Non-compliance on using e-diary|0|||
33652463|NCT01720069|63064365|FG001|Overall Study|Non-compliance on using e-diary|0|||
33652464|NCT01720069|63064366|FG002|Overall Study|Non-compliance on using e-diary|1|||
33652465|NCT01720069|63064364|FG000|Overall Study|Lost to Follow-up|0|||
33652466|NCT01720069|63064365|FG001|Overall Study|Lost to Follow-up|0|||
33652467|NCT01720069|63064366|FG002|Overall Study|Lost to Follow-up|1|||
33652468|NCT01719757|63064412|FG000|Overall Study|Adverse Event|38|||
33652469|NCT01719757|63064412|FG000|Overall Study|Withdrawal by Subject|15|||
33652470|NCT01719757|63064412|FG000|Overall Study|Lost to Follow-up|20|||
33652471|NCT01719757|63064412|FG000|Overall Study|Protocol Violation|1|||
33652472|NCT01719757|63064412|FG000|Overall Study|well controlled pain|27|||
33652473|NCT01718509|63064420|FG000|Overall Study|Lost to Follow-up|18|||
33652474|NCT01718509|63064421|FG001|Overall Study|Lost to Follow-up|15|||
33652475|NCT01718509|63064420|FG000|Overall Study|Withdrawal by Subject|7|||
33652476|NCT01718509|63064421|FG001|Overall Study|Withdrawal by Subject|13|||
33652477|NCT01718509|63064420|FG000|Overall Study|Adverse Event|5|||
33652478|NCT01718509|63064421|FG001|Overall Study|Adverse Event|7|||
33652479|NCT01718509|63064420|FG000|Overall Study|Other|13|||
33652480|NCT01718509|63064421|FG001|Overall Study|Other|11|||
33652481|NCT01718509|63064420|FG000|Overall Study|Protocol Violation|4|||
33652482|NCT01718509|63064421|FG001|Overall Study|Protocol Violation|2|||
33652483|NCT01718509|63064420|FG000|Overall Study|Lack of Efficacy|1|||
33652484|NCT01718509|63064421|FG001|Overall Study|Lack of Efficacy|0|||
33652485|NCT01857934|63064427|FG000|Overall Study|Relapse or progression|2|||
33652486|NCT01857934|63064427|FG000|Overall Study|Unacceptable toxicity|3|||
33652487|NCT01857934|63064427|FG000|Overall Study|Unwillingness or inability to comply|2|||
33652488|NCT01857934|63064427|FG000|Overall Study|Physician Decision|3|||
33652489|NCT01604941|63064468|FG000|Overall Study|Adverse Event|1|||
33652490|NCT01604941|63064469|FG001|Overall Study|Adverse Event|2|||
33652491|NCT01604941|63064470|FG002|Overall Study|Adverse Event|0|||
33652492|NCT01604941|63064471|FG003|Overall Study|Adverse Event|0|||
33652493|NCT01604941|63064472|FG004|Overall Study|Adverse Event|1|||
33466453|NCT00337571|62839942|FG002|Overall Study|Withdrawal by Subject|1|||
33466454|NCT00337571|62839943|FG003|Overall Study|Withdrawal by Subject|0|||
33466455|NCT00337571|62839940|FG000|Overall Study|Lost to Follow-up|3|||
33466456|NCT00337571|62839941|FG001|Overall Study|Lost to Follow-up|1|||
33466457|NCT00337571|62839942|FG002|Overall Study|Lost to Follow-up|0|||
33466458|NCT00337571|62839943|FG003|Overall Study|Lost to Follow-up|1|||
33466459|NCT00337571|62839940|FG000|Overall Study|Poor/noncompliance|1|||
33466460|NCT00337571|62839941|FG001|Overall Study|Poor/noncompliance|1|||
33466461|NCT00337571|62839942|FG002|Overall Study|Poor/noncompliance|1|||
33466462|NCT00337571|62839943|FG003|Overall Study|Poor/noncompliance|1|||
33466463|NCT00337571|62839940|FG000|Overall Study|No longer met study criteria|1|||
33466464|NCT00337571|62839941|FG001|Overall Study|No longer met study criteria|0|||
33466465|NCT00337571|62839942|FG002|Overall Study|No longer met study criteria|0|||
33466466|NCT00337571|62839943|FG003|Overall Study|No longer met study criteria|0|||
33466467|NCT00337571|62839940|FG000|Overall Study|High Potassium level|0|||
33546584|NCT02998541|62937885|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33546585|NCT02998541|62937886|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33652494|NCT01604941|63064473|FG005|Overall Study|Adverse Event|5|||
33652495|NCT01604941|63064468|FG000|Overall Study|Non-compliance|1|||
33652496|NCT01604941|63064469|FG001|Overall Study|Non-compliance|0|||
33652497|NCT01604941|63064470|FG002|Overall Study|Non-compliance|0|||
33652498|NCT01604941|63064471|FG003|Overall Study|Non-compliance|0|||
33652499|NCT01604941|63064472|FG004|Overall Study|Non-compliance|0|||
33652500|NCT01604941|63064473|FG005|Overall Study|Non-compliance|0|||
33652501|NCT01604941|63064468|FG000|Overall Study|Participant Decision|0|||
33652502|NCT01604941|63064469|FG001|Overall Study|Participant Decision|0|||
33652503|NCT01604941|63064470|FG002|Overall Study|Participant Decision|0|||
33652504|NCT01604941|63064471|FG003|Overall Study|Participant Decision|0|||
33652505|NCT01604941|63064472|FG004|Overall Study|Participant Decision|0|||
33652506|NCT01604941|63064473|FG005|Overall Study|Participant Decision|2|||
33652507|NCT01604941|63064468|FG000|Overall Study|Early Study Termination|9|||
33652508|NCT01604941|63064469|FG001|Overall Study|Early Study Termination|2|||
33652509|NCT01604941|63064470|FG002|Overall Study|Early Study Termination|3|||
33652510|NCT01604941|63064471|FG003|Overall Study|Early Study Termination|3|||
33652511|NCT01604941|63064472|FG004|Overall Study|Early Study Termination|0|||
33652512|NCT01604941|63064473|FG005|Overall Study|Early Study Termination|0|||
33652513|NCT01604785|63064481|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
33652514|NCT01604785|63064482|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
33652515|NCT01681849|63064491|FG000|Overall Study|Protocol Violation|2|||
33546586|NCT02998541|62937887|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
33546587|NCT02998151|62937895|FG000|Overall Study|Withdrawal by Subject|3|||
33546588|NCT02998151|62937895|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
33546589|NCT02998151|62937895|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
33546590|NCT01066819|62937926|FG000|Overall Study|Adverse Event|18|||
33546591|NCT01066819|62937927|FG001|Overall Study|Adverse Event|1|||
33546592|NCT01066819|62937928|FG002|Overall Study|Adverse Event|6|||
33546593|NCT01066819|62937929|FG003|Overall Study|Adverse Event|0|||
33546594|NCT01066819|62937930|FG004|Overall Study|Adverse Event|0|||
33546595|NCT01066819|62937931|FG005|Overall Study|Adverse Event|0|||
33546596|NCT01066819|62937926|FG000|Overall Study|Death|5|||
33546597|NCT01066819|62937927|FG001|Overall Study|Death|0|||
33546598|NCT01066819|62937928|FG002|Overall Study|Death|1|||
33546599|NCT01066819|62937929|FG003|Overall Study|Death|0|||
33546600|NCT01066819|62937930|FG004|Overall Study|Death|0|||
33546601|NCT01066819|62937931|FG005|Overall Study|Death|0|||
33546602|NCT01066819|62937926|FG000|Overall Study|Lack of Efficacy|22|||
33546603|NCT01066819|62937927|FG001|Overall Study|Lack of Efficacy|1|||
33546604|NCT01066819|62937928|FG002|Overall Study|Lack of Efficacy|2|||
33546605|NCT01066819|62937929|FG003|Overall Study|Lack of Efficacy|1|||
33546606|NCT01066819|62937930|FG004|Overall Study|Lack of Efficacy|0|||
33546607|NCT01066819|62937931|FG005|Overall Study|Lack of Efficacy|0|||
33546608|NCT01066819|62937926|FG000|Overall Study|Physician Decision|6|||
33546609|NCT01066819|62937927|FG001|Overall Study|Physician Decision|2|||
33546610|NCT01066819|62937928|FG002|Overall Study|Physician Decision|3|||
33546611|NCT01066819|62937929|FG003|Overall Study|Physician Decision|0|||
33546612|NCT01066819|62937930|FG004|Overall Study|Physician Decision|0|||
33546613|NCT01066819|62937931|FG005|Overall Study|Physician Decision|0|||
33546614|NCT01066819|62937926|FG000|Overall Study|Protocol Violation|12|||
33546615|NCT01066819|62937927|FG001|Overall Study|Protocol Violation|6|||
33546616|NCT01066819|62937928|FG002|Overall Study|Protocol Violation|0|||
33546617|NCT01066819|62937929|FG003|Overall Study|Protocol Violation|0|||
33546618|NCT01066819|62937930|FG004|Overall Study|Protocol Violation|0|||
33546619|NCT01066819|62937931|FG005|Overall Study|Protocol Violation|0|||
33546620|NCT01066819|62937926|FG000|Overall Study|Withdrawal by Subject|29|||
33546621|NCT01066819|62937927|FG001|Overall Study|Withdrawal by Subject|11|||
33546622|NCT01066819|62937928|FG002|Overall Study|Withdrawal by Subject|6|||
33546623|NCT01066819|62937929|FG003|Overall Study|Withdrawal by Subject|0|||
33546624|NCT01066819|62937930|FG004|Overall Study|Withdrawal by Subject|0|||
33652516|NCT01681849|63064492|FG001|Overall Study|Protocol Violation|0|||
33652517|NCT01681849|63064493|FG002|Overall Study|Protocol Violation|0|||
33546625|NCT01066819|62937931|FG005|Overall Study|Withdrawal by Subject|0|||
33546626|NCT01066819|62937926|FG000|Overall Study|Administrative|6|||
33546627|NCT01066819|62937927|FG001|Overall Study|Administrative|4|||
33546628|NCT01066819|62937928|FG002|Overall Study|Administrative|2|||
33546629|NCT01066819|62937929|FG003|Overall Study|Administrative|0|||
33546630|NCT01066819|62937930|FG004|Overall Study|Administrative|0|||
33546631|NCT01066819|62937931|FG005|Overall Study|Administrative|0|||
33546632|NCT01066819|62937926|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
33546633|NCT01066819|62937927|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
33546634|NCT01066819|62937928|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
33546635|NCT01066819|62937929|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
33546636|NCT01066819|62937930|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
33546637|NCT01066819|62937931|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
33546638|NCT01066819|62937926|FG000|Overall Study|Early termination|2|||
33546639|NCT01066819|62937927|FG001|Overall Study|Early termination|0|||
33546640|NCT01066819|62937928|FG002|Overall Study|Early termination|0|||
33546641|NCT01066819|62937929|FG003|Overall Study|Early termination|0|||
33546642|NCT01066819|62937930|FG004|Overall Study|Early termination|0|||
33546643|NCT01066819|62937931|FG005|Overall Study|Early termination|0|||
33546644|NCT01066819|62937926|FG000|Overall Study|Failed to return|298|||
33546645|NCT01066819|62937927|FG001|Overall Study|Failed to return|107|||
33546646|NCT01066819|62937928|FG002|Overall Study|Failed to return|68|||
33546647|NCT01066819|62937929|FG003|Overall Study|Failed to return|7|||
33546648|NCT01066819|62937930|FG004|Overall Study|Failed to return|2|||
33546649|NCT01066819|62937931|FG005|Overall Study|Failed to return|3|||
33546650|NCT01066819|62937926|FG000|Overall Study|Lab test not done|9|||
33546651|NCT01066819|62937927|FG001|Overall Study|Lab test not done|0|||
33546652|NCT01066819|62937928|FG002|Overall Study|Lab test not done|2|||
33546653|NCT01066819|62937929|FG003|Overall Study|Lab test not done|1|||
33546654|NCT01066819|62937930|FG004|Overall Study|Lab test not done|0|||
33546655|NCT01066819|62937931|FG005|Overall Study|Lab test not done|0|||
33546656|NCT01066819|62937926|FG000|Overall Study|Miscellaneous|28|||
33546657|NCT01066819|62937927|FG001|Overall Study|Miscellaneous|10|||
33546658|NCT01066819|62937928|FG002|Overall Study|Miscellaneous|18|||
33546659|NCT01066819|62937929|FG003|Overall Study|Miscellaneous|1|||
33546660|NCT01066819|62937930|FG004|Overall Study|Miscellaneous|0|||
33546661|NCT01066819|62937931|FG005|Overall Study|Miscellaneous|0|||
33546662|NCT01066819|62937926|FG000|Overall Study|Non responders|123|||
33546663|NCT01066819|62937927|FG001|Overall Study|Non responders|2|||
33652518|NCT01681849|63064491|FG000|Overall Study|Withdrawal by Subject|3|||
33652519|NCT01681849|63064492|FG001|Overall Study|Withdrawal by Subject|5|||
33652520|NCT01681849|63064493|FG002|Overall Study|Withdrawal by Subject|33|||
33652521|NCT01681849|63064491|FG000|Overall Study|Lost to Follow-up|3|||
33652522|NCT01681849|63064492|FG001|Overall Study|Lost to Follow-up|2|||
33652523|NCT01681849|63064493|FG002|Overall Study|Lost to Follow-up|6|||
33652524|NCT01681771|63064502|FG000|Overall Study|Lost to Follow-up|4|||
33652525|NCT01681771|63064503|FG001|Overall Study|Lost to Follow-up|2|||
33652526|NCT04250350|63064509|FG000|Overall Study|Withdrawal by Subject|13|||
33652527|NCT04250350|63064509|FG000|Overall Study|Lost to Follow-up|8|||
33652528|NCT04250350|63064509|FG000|Overall Study|Adverse Event|5|||
33652529|NCT04250350|63064509|FG000|Overall Study|Lack of Efficacy|4|||
33652530|NCT04250350|63064509|FG000|Overall Study|Physician Decision|1|||
33652531|NCT04250350|63064509|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
33652532|NCT01718353|63064540|FG000|Overall Study|Lost to Follow-up|0|||
33652533|NCT01718353|63064541|FG001|Overall Study|Lost to Follow-up|1|||
33652534|NCT01718353|63064540|FG000|Overall Study|Principal Investigator's Decision|10|||
33652535|NCT01718353|63064541|FG001|Overall Study|Principal Investigator's Decision|4|||
33652536|NCT01718353|63064540|FG000|Overall Study|Randomized but not treated|2|||
33652537|NCT01718353|63064541|FG001|Overall Study|Randomized but not treated|0|||
33652538|NCT01716715|63064551|FG000|Overall Study|Never Treated|2|||
33652539|NCT01716715|63064552|FG001|Overall Study|Never Treated|4|||
33652540|NCT01697449|63064560|FG000|Overall Study|Disease progression|47|||
33652541|NCT01697449|63064560|FG000|Overall Study|Adverse Event|7|||
33652542|NCT01697449|63064560|FG000|Overall Study|Lost to Follow-up|5|||
33652543|NCT01697449|63064560|FG000|Overall Study|Withdrawal by Subject|2|||
33652544|NCT01697449|63064560|FG000|Overall Study|Physician Decision|1|||
33652545|NCT01697449|63064560|FG000|Overall Study|Death|2|||
33652546|NCT01697449|63064560|FG000|Overall Study|Other|1|||
33652547|NCT01697449|63064560|FG000|Overall Study|Missing|25|||
33652548|NCT01696981|63064569|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
33652549|NCT01696981|63064570|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
33652550|NCT01696981|63064569|FG000|Overall Study|Died Before Randomization|3|||
33652551|NCT01696981|63064570|FG001|Overall Study|Died Before Randomization|8|||
33328800|NCT00945321|62705215|FG004|Period 1|Adverse Event|1|||
33652552|NCT01696981|63064569|FG000|Overall Study|Died Before ASU (Control)|278|||
33328801|NCT00945321|62705216|FG005|Period 1|Adverse Event|0|||
33652553|NCT01696981|63064570|FG001|Overall Study|Died Before ASU (Control)|0|||
33652554|NCT01696981|63064569|FG000|Overall Study|Refused ASU (Control)|920|||
33652555|NCT01696981|63064570|FG001|Overall Study|Refused ASU (Control)|0|||
33652556|NCT01696981|63064569|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
33652557|NCT01696981|63064570|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
33652558|NCT01696279|63064576|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
33546664|NCT01066819|62937928|FG002|Overall Study|Non responders|7|||
33546665|NCT01066819|62937929|FG003|Overall Study|Non responders|2|||
33546666|NCT01066819|62937930|FG004|Overall Study|Non responders|0|||
33546667|NCT01066819|62937931|FG005|Overall Study|Non responders|1|||
33652559|NCT01696279|63064577|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
33652560|NCT01696279|63064578|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
33652561|NCT01696279|63064579|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
33546668|NCT01066819|62937926|FG000|Overall Study|Not categorised|9|||
33546669|NCT01066819|62937927|FG001|Overall Study|Not categorised|2|||
33652562|NCT01696279|63064576|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
33652563|NCT01696279|63064577|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
33652564|NCT01696279|63064578|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
33652565|NCT01696279|63064579|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
33652566|NCT01696279|63064576|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
33652567|NCT01696279|63064577|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
33652568|NCT01696279|63064578|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
33652569|NCT01696279|63064579|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
33652570|NCT01696279|63064576|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
33652571|NCT01696279|63064577|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
33652572|NCT01696279|63064578|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
33652573|NCT01696279|63064579|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
33546670|NCT01066819|62937928|FG002|Overall Study|Not categorised|6|||
33546671|NCT01066819|62937929|FG003|Overall Study|Not categorised|1|||
33546672|NCT01066819|62937930|FG004|Overall Study|Not categorised|0|||
33546673|NCT01066819|62937931|FG005|Overall Study|Not categorised|0|||
33546674|NCT01066819|62937926|FG000|Overall Study|Relapse|16|||
33546675|NCT01066819|62937927|FG001|Overall Study|Relapse|4|||
33546676|NCT01066819|62937928|FG002|Overall Study|Relapse|3|||
33546677|NCT01066819|62937929|FG003|Overall Study|Relapse|0|||
33652574|NCT01696279|63064576|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
33652575|NCT01696279|63064577|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
33652576|NCT01696279|63064578|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
33652577|NCT01696279|63064579|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
33652578|NCT01696279|63064576|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
33652579|NCT01696279|63064577|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
33652580|NCT01696279|63064578|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
33652581|NCT01696279|63064579|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
33652582|NCT01696279|63064576|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
33652583|NCT01696279|63064577|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
33652584|NCT01696279|63064578|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
33652585|NCT01696279|63064579|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
33652586|NCT01696279|63064576|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
33652587|NCT01696279|63064577|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
33652588|NCT01696279|63064578|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
33652589|NCT01696279|63064579|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
33652590|NCT01696279|63064576|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
33652591|NCT01696279|63064577|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
33652592|NCT01696279|63064578|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
33652593|NCT01696279|63064579|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
33652594|NCT01696279|63064576|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
33652595|NCT01696279|63064577|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
33652596|NCT01696279|63064578|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
33652597|NCT01696279|63064579|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
33652598|NCT01696279|63064576|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
33652599|NCT01696279|63064577|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
33652600|NCT01696279|63064578|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
33652601|NCT01696279|63064579|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
33652602|NCT01681069|63064590|FG000|Overall Study|Withdrawal by Subject|4|||
33652603|NCT01681069|63064591|FG001|Overall Study|Withdrawal by Subject|5|||
33652604|NCT01681069|63064590|FG000|Overall Study|Protocol Violation|1|||
33652605|NCT01681069|63064591|FG001|Overall Study|Protocol Violation|1|||
33652606|NCT01681069|63064590|FG000|Overall Study|Adverse Event|0|||
33652607|NCT01681069|63064591|FG001|Overall Study|Adverse Event|1|||
33652608|NCT01716559|63064597|FG000|Overall Study|Adverse Event|11|||
33652609|NCT01716559|63064597|FG000|Overall Study|Death|21|||
33652610|NCT01716559|63064597|FG000|Overall Study|Withdrawal by Subject|4|||
33652611|NCT01716559|63064597|FG000|Overall Study|Other withdrawal reason|75|||
33652612|NCT01936181|63064603|FG000|Randomised, Double-blind|Adverse Event|27|||
33652613|NCT01936181|63064604|FG001|Randomised, Double-blind|Adverse Event|21|||
33652614|NCT01936181|63064605|FG002|Randomised, Double-blind|Adverse Event|0|||
33652615|NCT01936181|63064606|FG003|Randomised, Double-blind|Adverse Event|0|||
33652616|NCT01936181|63064603|FG000|Randomised, Double-blind|Protocol Violation|1|||
33652617|NCT01936181|63064604|FG001|Randomised, Double-blind|Protocol Violation|5|||
33652618|NCT01936181|63064605|FG002|Randomised, Double-blind|Protocol Violation|0|||
33652619|NCT01936181|63064606|FG003|Randomised, Double-blind|Protocol Violation|0|||
33652620|NCT01936181|63064603|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
33652621|NCT01936181|63064604|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
33652622|NCT01936181|63064605|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
33652623|NCT01936181|63064606|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
33652624|NCT01936181|63064603|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
33652625|NCT01936181|63064604|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
33652626|NCT01936181|63064605|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
33652627|NCT01936181|63064606|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
33652628|NCT01936181|63064603|FG000|Randomised, Double-blind|Pregnancy|0|||
33652629|NCT01936181|63064604|FG001|Randomised, Double-blind|Pregnancy|1|||
33652630|NCT01936181|63064605|FG002|Randomised, Double-blind|Pregnancy|0|||
33546678|NCT01066819|62937930|FG004|Overall Study|Relapse|0|||
33652631|NCT01936181|63064606|FG003|Randomised, Double-blind|Pregnancy|0|||
33652632|NCT01936181|63064603|FG000|Randomised, Double-blind|Physician Decision|4|||
33652633|NCT01936181|63064604|FG001|Randomised, Double-blind|Physician Decision|4|||
33652634|NCT01936181|63064605|FG002|Randomised, Double-blind|Physician Decision|0|||
33652635|NCT01936181|63064606|FG003|Randomised, Double-blind|Physician Decision|0|||
33652636|NCT01936181|63064603|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
33652637|NCT01936181|63064604|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
33652638|NCT01936181|63064605|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
33652639|NCT01936181|63064606|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
33652640|NCT01936181|63064603|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
33652641|NCT01936181|63064604|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
33652642|NCT01936181|63064605|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
33652643|NCT01936181|63064606|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
33652644|NCT01936181|63064603|FG000|Transition-extension|Adverse Event|3|||
33652645|NCT01936181|63064604|FG001|Transition-extension|Adverse Event|0|||
33652646|NCT01936181|63064605|FG002|Transition-extension|Adverse Event|3|||
33652647|NCT01936181|63064606|FG003|Transition-extension|Adverse Event|1|||
33652648|NCT01936181|63064603|FG000|Transition-extension|Lost to Follow-up|3|||
33652649|NCT01936181|63064604|FG001|Transition-extension|Lost to Follow-up|0|||
33652650|NCT01936181|63064605|FG002|Transition-extension|Lost to Follow-up|1|||
33652651|NCT01936181|63064606|FG003|Transition-extension|Lost to Follow-up|2|||
33652652|NCT01936181|63064603|FG000|Transition-extension|Physician Decision|2|||
33652653|NCT01936181|63064604|FG001|Transition-extension|Physician Decision|0|||
33652654|NCT01936181|63064605|FG002|Transition-extension|Physician Decision|0|||
33652655|NCT01936181|63064606|FG003|Transition-extension|Physician Decision|1|||
33652656|NCT01936181|63064603|FG000|Transition-extension|Withdrawal by Subject|7|||
33652657|NCT01936181|63064604|FG001|Transition-extension|Withdrawal by Subject|0|||
33652658|NCT01936181|63064605|FG002|Transition-extension|Withdrawal by Subject|2|||
33652659|NCT01936181|63064606|FG003|Transition-extension|Withdrawal by Subject|1|||
33652660|NCT01696045|63064619|FG000|Overall Study|Study drug toxicity|1|||
33652661|NCT01696045|63064620|FG001|Overall Study|Study drug toxicity|5|||
33652662|NCT01696045|63064619|FG000|Overall Study|Disease progression|2|||
33652663|NCT01696045|63064620|FG001|Overall Study|Disease progression|2|||
33652664|NCT01716169|63064626|FG000|Overall Study|Adverse Event|1|||
33652665|NCT01716169|63064626|FG000|Overall Study|Lost to Follow-up|1|||
33652666|NCT01716169|63064626|FG000|Overall Study|Withdrawal by Subject|1|||
33652667|NCT01716169|63064626|FG000|Overall Study|inconsistent dressing application|1|||
33652668|NCT01935947|63064635|FG000|Overall Study|Adverse Event|0|||
33652669|NCT01935947|63064636|FG001|Overall Study|Adverse Event|2|||
33652670|NCT01935947|63064637|FG002|Overall Study|Adverse Event|0|||
33652671|NCT01935947|63064635|FG000|Overall Study|Diease Progression|2|||
33652672|NCT01935947|63064636|FG001|Overall Study|Diease Progression|2|||
33652673|NCT01935947|63064637|FG002|Overall Study|Diease Progression|2|||
33328802|NCT00945321|62705211|FG000|Period 4|Lost to Follow-up|0|||
33652674|NCT01935947|63064635|FG000|Overall Study|Death|1|||
33652675|NCT01935947|63064636|FG001|Overall Study|Death|0|||
33652676|NCT01935947|63064637|FG002|Overall Study|Death|0|||
33652677|NCT01618019|63064650|FG000|Overall Study|Withdrawal by Subject|14|||
33652678|NCT01618019|63064651|FG001|Overall Study|Withdrawal by Subject|14|||
33652679|NCT01593787|63064660|FG000|Overall Study|Adverse Event|1|||
33652680|NCT01593787|63064661|FG001|Overall Study|Adverse Event|0|||
33652681|NCT01593787|63064662|FG002|Overall Study|Adverse Event|0|||
33652682|NCT01951157|63064675|FG000|Overall Study|Progressive Disease|12|||
33328803|NCT00945321|62705212|FG001|Period 4|Lost to Follow-up|0|||
33466468|NCT00337571|62839941|FG001|Overall Study|High Potassium level|0|||
33466469|NCT00337571|62839942|FG002|Overall Study|High Potassium level|0|||
33466470|NCT00337571|62839943|FG003|Overall Study|High Potassium level|1|||
33466471|NCT00368927|62839955|FG000|Overall Study|Lost to Follow-up|2|||
33466472|NCT00368927|62839956|FG001|Overall Study|Lost to Follow-up|0|||
33466473|NCT00368927|62839955|FG000|Overall Study|Adverse Event|1|||
33466474|NCT00368927|62839956|FG001|Overall Study|Adverse Event|1|||
33466475|NCT00368927|62839955|FG000|Overall Study|Withdrawal by Subject|1|||
33466476|NCT00368927|62839956|FG001|Overall Study|Withdrawal by Subject|2|||
33466477|NCT00368927|62839955|FG000|Overall Study|Physician Decision|1|||
33466478|NCT00368927|62839956|FG001|Overall Study|Physician Decision|0|||
33466479|NCT00316589|62839979|FG000|Overall Study|Withdrawal by Subject|0|||
33466480|NCT00316589|62839980|FG001|Overall Study|Withdrawal by Subject|5|||
33466481|NCT00316589|62839981|FG002|Overall Study|Withdrawal by Subject|0|||
33466482|NCT00316589|62839982|FG003|Overall Study|Withdrawal by Subject|1|||
33328804|NCT00945321|62705213|FG002|Period 4|Lost to Follow-up|0|||
33328805|NCT00945321|62705214|FG003|Period 4|Lost to Follow-up|0|||
33328806|NCT00945321|62705215|FG004|Period 4|Lost to Follow-up|0|||
33328807|NCT00945321|62705216|FG005|Period 4|Lost to Follow-up|1|||
33328808|NCT00945243|62705234|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
33328809|NCT01192412|62705240|FG000|Overall Study|Lost to Follow-up|2|||
33328810|NCT01192412|62705241|FG001|Overall Study|Lost to Follow-up|1|||
33328811|NCT01192412|62705240|FG000|Overall Study|Withdrawal by Subject|2|||
33466483|NCT00316589|62839979|FG000|Overall Study|Subject unwilling/unable to comply|0|||
33466484|NCT00316589|62839980|FG001|Overall Study|Subject unwilling/unable to comply|6|||
33466485|NCT00316589|62839981|FG002|Overall Study|Subject unwilling/unable to comply|0|||
33466486|NCT00316589|62839982|FG003|Overall Study|Subject unwilling/unable to comply|2|||
33466487|NCT00316589|62839979|FG000|Overall Study|Adverse Event|1|||
33466488|NCT00316589|62839980|FG001|Overall Study|Adverse Event|0|||
33466489|NCT00316589|62839981|FG002|Overall Study|Adverse Event|0|||
33466490|NCT00316589|62839982|FG003|Overall Study|Adverse Event|1|||
33466491|NCT00316589|62839979|FG000|Overall Study|Physician Decision|0|||
33466492|NCT00316589|62839980|FG001|Overall Study|Physician Decision|1|||
33466493|NCT00316589|62839981|FG002|Overall Study|Physician Decision|0|||
33466494|NCT00316589|62839982|FG003|Overall Study|Physician Decision|0|||
33466495|NCT00316589|62839979|FG000|Overall Study|Other reason|0|||
33466496|NCT00316589|62839980|FG001|Overall Study|Other reason|12|||
33466497|NCT00316589|62839981|FG002|Overall Study|Other reason|1|||
33466498|NCT00316589|62839982|FG003|Overall Study|Other reason|1|||
33466499|NCT00316277|62839996|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
33466500|NCT00316277|62839997|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
33466501|NCT00316277|62839996|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
33652683|NCT01951157|63064676|FG001|Overall Study|Progressive Disease|13|||
33652684|NCT01951157|63064677|FG002|Overall Study|Progressive Disease|10|||
33652685|NCT01951157|63064675|FG000|Overall Study|Treatment-unrelated AE|1|||
33652686|NCT01951157|63064676|FG001|Overall Study|Treatment-unrelated AE|0|||
33652687|NCT01951157|63064677|FG002|Overall Study|Treatment-unrelated AE|3|||
33652688|NCT01951157|63064675|FG000|Overall Study|Study Termination|0|||
33652689|NCT01951157|63064676|FG001|Overall Study|Study Termination|0|||
33652690|NCT01951157|63064677|FG002|Overall Study|Study Termination|1|||
33652691|NCT01951157|63064675|FG000|Overall Study|Physician Decision|5|||
33652692|NCT01951157|63064676|FG001|Overall Study|Physician Decision|3|||
33652693|NCT01951157|63064677|FG002|Overall Study|Physician Decision|2|||
33652694|NCT01951157|63064675|FG000|Overall Study|Non-treatmentrelated death|2|||
33652695|NCT01951157|63064676|FG001|Overall Study|Non-treatmentrelated death|2|||
33652696|NCT01951157|63064677|FG002|Overall Study|Non-treatmentrelated death|2|||
33652697|NCT01951157|63064675|FG000|Overall Study|No treated|0|||
33652698|NCT01951157|63064676|FG001|Overall Study|No treated|1|||
33652699|NCT01951157|63064677|FG002|Overall Study|No treated|0|||
33652700|NCT01951157|63064675|FG000|Overall Study|Treatment-related AE|2|||
33652701|NCT01951157|63064676|FG001|Overall Study|Treatment-related AE|0|||
33466502|NCT00316277|62839997|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
33466503|NCT00316277|62839996|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
33466504|NCT00316277|62839997|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
33466505|NCT00316277|62839996|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
33466506|NCT00316277|62839997|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
33466507|NCT00316277|62839996|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
33466508|NCT00316277|62839997|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
33466509|NCT00368849|62840011|FG000|Overall Study|Withdrawal by Subject|0|||
33466510|NCT00368849|62840012|FG001|Overall Study|Withdrawal by Subject|1|||
33466511|NCT00368849|62840011|FG000|Overall Study|Physician Decision|0|||
33466512|NCT00368849|62840012|FG001|Overall Study|Physician Decision|1|||
33652702|NCT01951157|63064677|FG002|Overall Study|Treatment-related AE|4|||
33652703|NCT01951157|63064675|FG000|Overall Study|Consent withdrawn by subject|0|||
33328812|NCT01192412|62705241|FG001|Overall Study|Withdrawal by Subject|1|||
33328813|NCT01192178|62705249|FG000|Overall Study|Withdrawal by Subject|6|||
33652704|NCT01951157|63064676|FG001|Overall Study|Consent withdrawn by subject|1|||
33652705|NCT01951157|63064677|FG002|Overall Study|Consent withdrawn by subject|3|||
33652706|NCT01951157|63064675|FG000|Overall Study|Treatment-related death|0|||
33652707|NCT01951157|63064676|FG001|Overall Study|Treatment-related death|2|||
33652708|NCT01951157|63064677|FG002|Overall Study|Treatment-related death|0|||
33466513|NCT00316199|62840019|FG000|Overall Study|Adverse Event|2|||
33466514|NCT00316199|62840019|FG000|Overall Study|Death|8|||
33466515|NCT00316199|62840019|FG000|Overall Study|Lost to Follow-up|2|||
33466516|NCT00316121|62840025|FG000|Overall Study|Death|1|||
33466517|NCT00316121|62840026|FG001|Overall Study|Death|0|||
33466518|NCT00316121|62840025|FG000|Overall Study|Lost to Follow-up|14|||
33466519|NCT00316121|62840026|FG001|Overall Study|Lost to Follow-up|8|||
33652709|NCT01363349|63064688|FG000|Overall Study|Adverse Event|6|||
33652710|NCT01363349|63064689|FG001|Overall Study|Adverse Event|7|||
33652711|NCT01363349|63064688|FG000|Overall Study|Lack of Efficacy|3|||
33652712|NCT01363349|63064689|FG001|Overall Study|Lack of Efficacy|10|||
33652713|NCT01363349|63064688|FG000|Overall Study|Non compliance/Protocol deviations|2|||
33652714|NCT01363349|63064689|FG001|Overall Study|Non compliance/Protocol deviations|2|||
33652715|NCT01363349|63064688|FG000|Overall Study|Withdrawal by Subject|14|||
33652716|NCT01363349|63064689|FG001|Overall Study|Withdrawal by Subject|6|||
33652717|NCT01363349|63064688|FG000|Overall Study|Lost to Follow-up|5|||
33652718|NCT01363349|63064689|FG001|Overall Study|Lost to Follow-up|6|||
33652719|NCT01363349|63064688|FG000|Overall Study|Not reported|36|||
33652720|NCT01363349|63064689|FG001|Overall Study|Not reported|37|||
33652721|NCT01363349|63064688|FG000|Overall Study|missing|1|||
33652722|NCT01363349|63064689|FG001|Overall Study|missing|2|||
33652723|NCT01933919|63064780|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
33652724|NCT01933919|63064781|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
33652725|NCT01933919|63064780|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
33652726|NCT01933919|63064781|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
33652727|NCT01933919|63064780|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
33652728|NCT01933919|63064781|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
33652729|NCT01933919|63064780|FG000|Open-label Long-term Phase|Adverse Event|2|||
33652730|NCT01933919|63064781|FG001|Open-label Long-term Phase|Adverse Event|0|||
33652731|NCT01933919|63064780|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
33652732|NCT01933919|63064781|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
33652733|NCT01933919|63064780|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
33652734|NCT01933919|63064781|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
33652735|NCT01933919|63064780|FG000|Open-label Long-term Phase|Other|1|||
33652736|NCT01933919|63064781|FG001|Open-label Long-term Phase|Other|2|||
33652737|NCT01933217|63064810|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
33652738|NCT01933217|63064811|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
33652739|NCT01933217|63064810|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
33652740|NCT01933217|63064811|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
33652741|NCT01932437|63064821|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
33652742|NCT01932437|63064822|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
33652743|NCT01932437|63064823|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
33652744|NCT01932437|63064824|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
33652745|NCT01932437|63064825|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
33652746|NCT01932437|63064826|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
33652747|NCT01949051|63064847|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
33652748|NCT01949051|63064848|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
33652749|NCT01949051|63064849|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
33652750|NCT01949051|63064850|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
33652751|NCT01949051|63064851|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
33652752|NCT01949051|63064852|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
33652753|NCT01949051|63064847|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
33652754|NCT01949051|63064848|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33652755|NCT01949051|63064849|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33652756|NCT01949051|63064850|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33652757|NCT01949051|63064851|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33652758|NCT01949051|63064852|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33652759|NCT01949051|63064847|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
33652760|NCT01949051|63064848|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
33652761|NCT01949051|63064849|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
33466520|NCT00316121|62840025|FG000|Overall Study|Withdrawal by Subject|2|||
33652762|NCT01949051|63064850|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
33466521|NCT00316121|62840026|FG001|Overall Study|Withdrawal by Subject|0|||
33466522|NCT00316121|62840025|FG000|Overall Study|Reason is missing|1|||
33546679|NCT01066819|62937931|FG005|Overall Study|Relapse|0|||
33652763|NCT01949051|63064851|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
33652764|NCT01949051|63064852|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
33652765|NCT01949051|63064847|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
33466523|NCT00316121|62840026|FG001|Overall Study|Reason is missing|0|||
33652766|NCT01949051|63064848|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
33466524|NCT00316121|62840025|FG000|Overall Study|Subject relocated|1|||
33466525|NCT00316121|62840026|FG001|Overall Study|Subject relocated|1|||
33466526|NCT00316121|62840025|FG000|Overall Study|Subject refused to return|1|||
33652767|NCT01949051|63064849|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
33652768|NCT01949051|63064850|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
33652769|NCT01949051|63064851|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
33652770|NCT01949051|63064852|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
33652771|NCT01949051|63064847|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
33652772|NCT01949051|63064848|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
33652773|NCT01949051|63064849|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
33652774|NCT01949051|63064850|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
33652775|NCT01949051|63064851|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
33652776|NCT01949051|63064852|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
33652777|NCT01948427|63064865|FG000|Overall Study|Serious Adverse Event|3|||
33652778|NCT01948427|63064866|FG001|Overall Study|Serious Adverse Event|0|||
33652779|NCT01948427|63064867|FG002|Overall Study|Serious Adverse Event|0|||
33652780|NCT01948427|63064868|FG003|Overall Study|Serious Adverse Event|0|||
33652781|NCT01948427|63064869|FG004|Overall Study|Serious Adverse Event|1|||
33652782|NCT01948427|63064865|FG000|Overall Study|Investigator Request|0|||
33652783|NCT01948427|63064866|FG001|Overall Study|Investigator Request|8|||
33652784|NCT01948427|63064867|FG002|Overall Study|Investigator Request|0|||
33652785|NCT01948427|63064868|FG003|Overall Study|Investigator Request|0|||
33652786|NCT01948427|63064869|FG004|Overall Study|Investigator Request|6|||
33652787|NCT01948427|63064865|FG000|Overall Study|Lost to Follow-up|1|||
33652788|NCT01948427|63064866|FG001|Overall Study|Lost to Follow-up|0|||
33652789|NCT01948427|63064867|FG002|Overall Study|Lost to Follow-up|0|||
33652790|NCT01948427|63064868|FG003|Overall Study|Lost to Follow-up|0|||
33652791|NCT01948427|63064869|FG004|Overall Study|Lost to Follow-up|4|||
33652792|NCT01948427|63064865|FG000|Overall Study|Withdrawal by Subject|2|||
33328814|NCT01192178|62705250|FG001|Overall Study|Withdrawal by Subject|10|||
33466527|NCT00316121|62840026|FG001|Overall Study|Subject refused to return|0|||
33466528|NCT00316121|62840025|FG000|Overall Study|Subject no show for visit x 3|1|||
33466529|NCT00316121|62840026|FG001|Overall Study|Subject no show for visit x 3|0|||
33328815|NCT01192178|62705249|FG000|Overall Study|Protocol Violation|10|||
33466530|NCT00316121|62840025|FG000|Overall Study|Subject did not have 24 month visit|1|||
33652793|NCT01948427|63064866|FG001|Overall Study|Withdrawal by Subject|0|||
33652794|NCT01948427|63064867|FG002|Overall Study|Withdrawal by Subject|0|||
33652795|NCT01948427|63064868|FG003|Overall Study|Withdrawal by Subject|0|||
33466531|NCT00316121|62840026|FG001|Overall Study|Subject did not have 24 month visit|0|||
33466532|NCT00337103|62840045|FG000|Overall Study|Progressive Disease|414|||
33466533|NCT00337103|62840046|FG001|Overall Study|Progressive Disease|410|||
33466534|NCT00337103|62840045|FG000|Overall Study|Adverse Event|45|||
33466535|NCT00337103|62840046|FG001|Overall Study|Adverse Event|59|||
33466536|NCT00337103|62840045|FG000|Overall Study|Subject Choice|34|||
33466537|NCT00337103|62840046|FG001|Overall Study|Subject Choice|27|||
33466538|NCT00337103|62840045|FG000|Overall Study|Clinical Progression|27|||
33466539|NCT00337103|62840046|FG001|Overall Study|Clinical Progression|24|||
33466540|NCT00337103|62840045|FG000|Overall Study|Physician Decision|15|||
33466541|NCT00337103|62840046|FG001|Overall Study|Physician Decision|14|||
33466542|NCT00337103|62840045|FG000|Overall Study|Withdrawal by Subject|8|||
33466543|NCT00337103|62840046|FG001|Overall Study|Withdrawal by Subject|5|||
33466544|NCT00337103|62840045|FG000|Overall Study|Other|5|||
33466545|NCT00337103|62840046|FG001|Overall Study|Other|6|||
33546680|NCT01066819|62937926|FG000|Overall Study|Results not available|1|||
33546681|NCT01066819|62937927|FG001|Overall Study|Results not available|0|||
33546682|NCT01066819|62937928|FG002|Overall Study|Results not available|0|||
33546683|NCT01066819|62937929|FG003|Overall Study|Results not available|0|||
33546684|NCT01066819|62937930|FG004|Overall Study|Results not available|0|||
33546685|NCT01066819|62937931|FG005|Overall Study|Results not available|0|||
33546686|NCT01066819|62937926|FG000|Overall Study|Screen failure|1|||
33546687|NCT01066819|62937927|FG001|Overall Study|Screen failure|0|||
33546688|NCT01066819|62937928|FG002|Overall Study|Screen failure|0|||
33546689|NCT01066819|62937929|FG003|Overall Study|Screen failure|0|||
33546690|NCT01066819|62937930|FG004|Overall Study|Screen failure|0|||
33546691|NCT01066819|62937931|FG005|Overall Study|Screen failure|0|||
33466546|NCT00337103|62840045|FG000|Overall Study|Entry Criteria Not Met|4|||
33466547|NCT00337103|62840046|FG001|Overall Study|Entry Criteria Not Met|1|||
33466548|NCT00337103|62840045|FG000|Overall Study|Lost to Follow-up|1|||
33466549|NCT00337103|62840046|FG001|Overall Study|Lost to Follow-up|2|||
33466550|NCT00337103|62840045|FG000|Overall Study|Death|1|||
33466551|NCT00337103|62840046|FG001|Overall Study|Death|0|||
33546692|NCT01066819|62937926|FG000|Overall Study|Spontaneous cure|1|||
33546693|NCT01066819|62937927|FG001|Overall Study|Spontaneous cure|0|||
33546694|NCT01066819|62937928|FG002|Overall Study|Spontaneous cure|0|||
33546695|NCT01066819|62937929|FG003|Overall Study|Spontaneous cure|0|||
33546696|NCT01066819|62937930|FG004|Overall Study|Spontaneous cure|0|||
33546697|NCT01066819|62937931|FG005|Overall Study|Spontaneous cure|0|||
33546698|NCT01066819|62937926|FG000|Overall Study|Treatment never started|85|||
33546699|NCT01066819|62937927|FG001|Overall Study|Treatment never started|19|||
33546700|NCT01066819|62937928|FG002|Overall Study|Treatment never started|19|||
33546701|NCT01066819|62937929|FG003|Overall Study|Treatment never started|3|||
33546702|NCT01066819|62937930|FG004|Overall Study|Treatment never started|2|||
33546703|NCT01066819|62937931|FG005|Overall Study|Treatment never started|2|||
33546704|NCT01066819|62937926|FG000|Overall Study|Treatment stopped|12|||
33546705|NCT01066819|62937927|FG001|Overall Study|Treatment stopped|1|||
33546706|NCT01066819|62937928|FG002|Overall Study|Treatment stopped|2|||
33546707|NCT01066819|62937929|FG003|Overall Study|Treatment stopped|1|||
33546708|NCT01066819|62937930|FG004|Overall Study|Treatment stopped|0|||
33546709|NCT01066819|62937931|FG005|Overall Study|Treatment stopped|0|||
33546710|NCT01066819|62937926|FG000|Overall Study|Other|5|||
33546711|NCT01066819|62937927|FG001|Overall Study|Other|1|||
33546712|NCT01066819|62937928|FG002|Overall Study|Other|1|||
33546713|NCT01066819|62937929|FG003|Overall Study|Other|0|||
33546714|NCT01066819|62937930|FG004|Overall Study|Other|0|||
33546715|NCT01066819|62937931|FG005|Overall Study|Other|0|||
33546716|NCT04056299|62937945|FG000|Overall Study|Sponsor discontinued study|3|||
33546717|NCT04056299|62937946|FG001|Overall Study|Sponsor discontinued study|3|||
33546718|NCT04057937|62937954|FG000|Placebo-controlled Phase|Adverse Event|3|||
33546719|NCT04057937|62937955|FG001|Placebo-controlled Phase|Adverse Event|0|||
33546720|NCT04057937|62937954|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
33546721|NCT04057937|62937955|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
33546722|NCT04057937|62937954|FG000|Active-treatment Phase|Pregnancy|0|||
33546723|NCT04057937|62937955|FG001|Active-treatment Phase|Pregnancy|1|||
33546724|NCT04057937|62937954|FG000|Active-treatment Phase|Physician Decision|0|||
33546725|NCT04057937|62937955|FG001|Active-treatment Phase|Physician Decision|1|||
33546726|NCT01069523|62937964|FG000|Overall Study|Withdrawal by Subject|4|||
33546727|NCT01069523|62937965|FG001|Overall Study|Withdrawal by Subject|7|||
33546728|NCT01069289|62937975|FG000|Overall Study|Withdrawal by Subject|15|||
33546729|NCT01069289|62937976|FG001|Overall Study|Withdrawal by Subject|26|||
33546730|NCT01069289|62937975|FG000|Overall Study|Adverse Event|21|||
33546731|NCT01069289|62937976|FG001|Overall Study|Adverse Event|28|||
33546732|NCT01069289|62937975|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33546733|NCT01069289|62937976|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33546734|NCT01069289|62937975|FG000|Overall Study|Severe non-compliance to protocol|3|||
33546735|NCT01069289|62937976|FG001|Overall Study|Severe non-compliance to protocol|2|||
33546736|NCT01069289|62937975|FG000|Overall Study|Due to deteriorating health condition|1|||
33546737|NCT01069289|62937976|FG001|Overall Study|Due to deteriorating health condition|0|||
33546738|NCT02510794|62937995|FG000|Overall Study|Adverse Event|0|||
33546739|NCT02510794|62937996|FG001|Overall Study|Adverse Event|1|||
33546740|NCT02510794|62937997|FG002|Overall Study|Adverse Event|0|||
33546741|NCT02510794|62937998|FG003|Overall Study|Adverse Event|0|||
33546742|NCT02510794|62937995|FG000|Overall Study|Death|1|||
33546743|NCT02510794|62937996|FG001|Overall Study|Death|2|||
33546744|NCT02510794|62937997|FG002|Overall Study|Death|1|||
33546745|NCT02510794|62937998|FG003|Overall Study|Death|1|||
33546746|NCT02510794|62937995|FG000|Overall Study|Lack of Efficacy|3|||
33546747|NCT02510794|62937996|FG001|Overall Study|Lack of Efficacy|1|||
33546748|NCT02510794|62937997|FG002|Overall Study|Lack of Efficacy|1|||
33546749|NCT02510794|62937998|FG003|Overall Study|Lack of Efficacy|0|||
33328816|NCT01192178|62705250|FG001|Overall Study|Protocol Violation|3|||
33546750|NCT02510794|62937995|FG000|Overall Study|Participant moved out of the area|0|||
33546751|NCT02510794|62937996|FG001|Overall Study|Participant moved out of the area|0|||
33546752|NCT02510794|62937997|FG002|Overall Study|Participant moved out of the area|0|||
33546753|NCT02510794|62937998|FG003|Overall Study|Participant moved out of the area|1|||
33546754|NCT02510794|62937995|FG000|Overall Study|Physician Decision|3|||
33546755|NCT02510794|62937996|FG001|Overall Study|Physician Decision|0|||
33546756|NCT02510794|62937997|FG002|Overall Study|Physician Decision|0|||
33546757|NCT02510794|62937998|FG003|Overall Study|Physician Decision|0|||
33546758|NCT02510794|62937995|FG000|Overall Study|Protocol Violation|0|||
33546759|NCT02510794|62937996|FG001|Overall Study|Protocol Violation|0|||
33546760|NCT02510794|62937997|FG002|Overall Study|Protocol Violation|1|||
33546761|NCT02510794|62937998|FG003|Overall Study|Protocol Violation|0|||
33546762|NCT02510794|62937995|FG000|Overall Study|Withdrawal by Subject|1|||
33546763|NCT02510794|62937996|FG001|Overall Study|Withdrawal by Subject|2|||
33546764|NCT02510794|62937997|FG002|Overall Study|Withdrawal by Subject|4|||
33546765|NCT02510794|62937998|FG003|Overall Study|Withdrawal by Subject|3|||
33652796|NCT01948427|63064869|FG004|Overall Study|Withdrawal by Subject|1|||
33652797|NCT01948427|63064865|FG000|Overall Study|Other, Not Specified|1|||
33652798|NCT01948427|63064866|FG001|Overall Study|Other, Not Specified|9|||
33652799|NCT01948427|63064867|FG002|Overall Study|Other, Not Specified|0|||
33652800|NCT01948427|63064868|FG003|Overall Study|Other, Not Specified|0|||
33652801|NCT01948427|63064869|FG004|Overall Study|Other, Not Specified|2|||
33652802|NCT01948193|63064886|FG000|Overall Study|Serious event|2|||
33652803|NCT01948193|63064886|FG000|Overall Study|Lost to Follow-up|7|||
33652804|NCT01694485|63064896|FG000|Overall Study|Withdrawal by Subject|20|||
33652805|NCT01694485|63064897|FG001|Overall Study|Withdrawal by Subject|6|||
33652806|NCT01694485|63064898|FG002|Overall Study|Withdrawal by Subject|7|||
33466552|NCT00415532|62840055|FG000|Treatment Period|Adverse Event|2|||
33466553|NCT00415532|62840056|FG001|Treatment Period|Adverse Event|3|||
33466554|NCT00415532|62840055|FG000|Treatment Period|Death|2|||
33466555|NCT00415532|62840056|FG001|Treatment Period|Death|1|||
33328817|NCT01192178|62705249|FG000|Overall Study|Physician Decision|2|||
33328818|NCT01192178|62705250|FG001|Overall Study|Physician Decision|4|||
33328819|NCT01192178|62705249|FG000|Overall Study|Lost to Follow-up|3|||
33328820|NCT01192178|62705250|FG001|Overall Study|Lost to Follow-up|3|||
33328821|NCT01192178|62705249|FG000|Overall Study|Adverse Event|2|||
33466556|NCT00415532|62840055|FG000|Treatment Period|Lost to Follow-up|1|||
33466557|NCT00415532|62840056|FG001|Treatment Period|Lost to Follow-up|1|||
33466558|NCT00415532|62840055|FG000|Treatment Period|Protocol Violation|1|||
33466559|NCT00415532|62840056|FG001|Treatment Period|Protocol Violation|0|||
33466560|NCT00415532|62840055|FG000|Treatment Period|Withdrawal by Subject|6|||
33466561|NCT00415532|62840056|FG001|Treatment Period|Withdrawal by Subject|6|||
33466562|NCT00415532|62840055|FG000|Treatment Period|Other|2|||
33466563|NCT00415532|62840056|FG001|Treatment Period|Other|2|||
33466564|NCT00415532|62840055|FG000|Treatment Period|Ineligibility determined|1|||
33466565|NCT00415532|62840056|FG001|Treatment Period|Ineligibility determined|1|||
33466566|NCT00415532|62840055|FG000|Treatment Period|Noncompliance|1|||
33466567|NCT00415532|62840056|FG001|Treatment Period|Noncompliance|1|||
33466568|NCT00415532|62840055|FG000|Treatment Period|Requirement for alternative therapy|1|||
33466569|NCT00415532|62840056|FG001|Treatment Period|Requirement for alternative therapy|0|||
33466570|NCT00415532|62840055|FG000|Safety Follow Up Period|Adverse Event|1|||
33466571|NCT00415532|62840056|FG001|Safety Follow Up Period|Adverse Event|3|||
33466572|NCT00415532|62840055|FG000|Safety Follow Up Period|Death|3|||
33466573|NCT00415532|62840056|FG001|Safety Follow Up Period|Death|0|||
33466574|NCT00415532|62840055|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
33466575|NCT00415532|62840056|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
33466576|NCT00415532|62840055|FG000|Safety Follow Up Period|Other|1|||
33466577|NCT00415532|62840056|FG001|Safety Follow Up Period|Other|4|||
33466578|NCT00415532|62840055|FG000|Safety Follow Up Period|Ineligibility determined|1|||
33466579|NCT00415532|62840056|FG001|Safety Follow Up Period|Ineligibility determined|1|||
33466580|NCT00415532|62840055|FG000|Safety Follow Up Period|Noncompliance|1|||
33466581|NCT00415532|62840056|FG001|Safety Follow Up Period|Noncompliance|0|||
33466582|NCT00415532|62840055|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
33466583|NCT00415532|62840056|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
33652807|NCT01694485|63064899|FG003|Overall Study|Withdrawal by Subject|25|||
33328822|NCT01192178|62705250|FG001|Overall Study|Adverse Event|1|||
33546766|NCT02510014|62938023|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
33546767|NCT02510014|62938024|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
33546768|NCT02510014|62938023|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
33546769|NCT02510014|62938024|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
33546770|NCT02510014|62938023|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
33546771|NCT02510014|62938024|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
33546772|NCT02510014|62938023|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
33546773|NCT02510014|62938024|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
33546774|NCT02510014|62938023|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
33546775|NCT02510014|62938024|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
33546776|NCT02510014|62938023|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
33546777|NCT02510014|62938024|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
33546778|NCT02510014|62938023|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
33546779|NCT02510014|62938024|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
33546780|NCT02510014|62938023|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
33546781|NCT02510014|62938024|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
33546782|NCT02510014|62938023|FG000|Treatment Period|Adverse Event|11|||
33546783|NCT02510014|62938024|FG001|Treatment Period|Adverse Event|4|||
33546784|NCT02510014|62938023|FG000|Treatment Period|Withdrawal symptoms|3|||
33546785|NCT02510014|62938024|FG001|Treatment Period|Withdrawal symptoms|0|||
33546786|NCT02510014|62938023|FG000|Treatment Period|Lost to Follow-up|80|||
33546787|NCT02510014|62938024|FG001|Treatment Period|Lost to Follow-up|19|||
33546788|NCT02510014|62938023|FG000|Treatment Period|Physician Decision|5|||
33546789|NCT02510014|62938024|FG001|Treatment Period|Physician Decision|0|||
33546790|NCT02510014|62938023|FG000|Treatment Period|Withdrawal by Subject|67|||
33546791|NCT02510014|62938024|FG001|Treatment Period|Withdrawal by Subject|24|||
33546792|NCT02510014|62938023|FG000|Treatment Period|Withdrawn by the investigator|7|||
33652808|NCT01694485|63064900|FG004|Overall Study|Withdrawal by Subject|18|||
33652809|NCT01694485|63064896|FG000|Overall Study|Sponsor Decision|3|||
33466584|NCT00315731|62840062|FG000|Overall Study|Lost to Follow-up|1|||
33466585|NCT00315731|62840062|FG000|Overall Study|Death|5|||
33466586|NCT00062868|62840089|FG000|Dose Level 1|Death|2|||
33466587|NCT00062868|62840090|FG001|Dose Level 1|Death|0|||
33466588|NCT00062868|62840091|FG002|Dose Level 1|Death|0|||
33466589|NCT00062868|62840092|FG003|Dose Level 1|Death|2|||
33466590|NCT00062868|62840093|FG004|Dose Level 1|Death|0|||
33466591|NCT00062868|62840094|FG005|Dose Level 1|Death|0|||
33466592|NCT00062868|62840095|FG006|Dose Level 1|Death|3|||
33466593|NCT00062868|62840096|FG007|Dose Level 1|Death|0|||
33466594|NCT00062868|62840097|FG008|Dose Level 1|Death|0|||
33466595|NCT00062868|62840098|FG009|Dose Level 1|Death|0|||
33466596|NCT00062868|62840099|FG010|Dose Level 1|Death|0|||
33466597|NCT00062868|62840100|FG011|Dose Level 1|Death|0|||
33466598|NCT00062868|62840101|FG012|Dose Level 1|Death|0|||
33546793|NCT02510014|62938024|FG001|Treatment Period|Withdrawn by the investigator|1|||
33546794|NCT02510014|62938023|FG000|Treatment Period|Protocol Violation|4|||
33546795|NCT02510014|62938024|FG001|Treatment Period|Protocol Violation|4|||
33466599|NCT00062868|62840102|FG013|Dose Level 1|Death|0|||
33466600|NCT00062868|62840103|FG014|Dose Level 1|Death|0|||
33546796|NCT02510014|62938023|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
33546797|NCT02510014|62938024|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
33466601|NCT00062868|62840104|FG015|Dose Level 1|Death|0|||
33466602|NCT00062868|62840105|FG016|Dose Level 1|Death|0|||
33466603|NCT00062868|62840106|FG017|Dose Level 1|Death|0|||
33466604|NCT00062868|62840107|FG018|Dose Level 1|Death|7|||
33466605|NCT00062868|62840108|FG019|Dose Level 1|Death|0|||
33466606|NCT00062868|62840109|FG020|Dose Level 1|Death|1|||
33466607|NCT00062868|62840089|FG000|Dose Level 1|Lost to Follow-up|0|||
33466608|NCT00062868|62840090|FG001|Dose Level 1|Lost to Follow-up|0|||
33466609|NCT00062868|62840091|FG002|Dose Level 1|Lost to Follow-up|0|||
33466610|NCT00062868|62840092|FG003|Dose Level 1|Lost to Follow-up|0|||
33546798|NCT02509312|62938032|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
33546799|NCT02509312|62938033|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
33546800|NCT02509312|62938032|FG000|Overall Study|Obstetrician refusal|0|||
33546801|NCT02509312|62938033|FG001|Overall Study|Obstetrician refusal|1|||
33546802|NCT02509312|62938032|FG000|Overall Study|Patient elected for TOLAC|1|||
33546803|NCT02509312|62938033|FG001|Overall Study|Patient elected for TOLAC|0|||
33466611|NCT00062868|62840093|FG004|Dose Level 1|Lost to Follow-up|0|||
33466612|NCT00062868|62840094|FG005|Dose Level 1|Lost to Follow-up|0|||
33546804|NCT02509312|62938032|FG000|Overall Study|Cesarean deemed stat|1|||
33546805|NCT02509312|62938033|FG001|Overall Study|Cesarean deemed stat|0|||
33546806|NCT02509312|62938032|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
33546807|NCT02509312|62938033|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
33546808|NCT02509156|62938043|FG000|Randomized Phase|Death|1|||
33546809|NCT02509156|62938044|FG001|Randomized Phase|Death|0|||
33546810|NCT02509156|62938043|FG000|Randomized Phase|Withdrawal by Subject|1|||
33546811|NCT02509156|62938044|FG001|Randomized Phase|Withdrawal by Subject|1|||
33546812|NCT01654666|62938053|FG000|Overall Study|Protocol Violation|7|||
33546813|NCT01654666|62938054|FG001|Overall Study|Protocol Violation|4|||
33546814|NCT01654666|62938055|FG002|Overall Study|Protocol Violation|8|||
33546815|NCT01654666|62938053|FG000|Overall Study|Lost to Follow-up|4|||
33546816|NCT01654666|62938054|FG001|Overall Study|Lost to Follow-up|5|||
33546817|NCT01654666|62938055|FG002|Overall Study|Lost to Follow-up|5|||
33546818|NCT01654666|62938053|FG000|Overall Study|Withdrawal by Subject|4|||
33546819|NCT01654666|62938054|FG001|Overall Study|Withdrawal by Subject|4|||
33546820|NCT01654666|62938055|FG002|Overall Study|Withdrawal by Subject|1|||
33546821|NCT02519842|62938065|FG000|Base Study: Cycle 1|Screening Failure|1|||
33546822|NCT02519842|62938066|FG001|Base Study: Cycle 1|Screening Failure|1|||
33546823|NCT02519842|62938067|FG002|Base Study: Cycle 1|Screening Failure|0|||
33546824|NCT02519842|62938065|FG000|Base Study: Cycle 1|Adverse Event|1|||
33546825|NCT02519842|62938066|FG001|Base Study: Cycle 1|Adverse Event|0|||
33546826|NCT02519842|62938067|FG002|Base Study: Cycle 1|Adverse Event|0|||
33546827|NCT02519842|62938065|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
33546828|NCT02519842|62938066|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
33546829|NCT02519842|62938067|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
33546830|NCT02519842|62938065|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
33546831|NCT02519842|62938066|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
33546832|NCT02519842|62938067|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
33546833|NCT02519842|62938065|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
33546834|NCT02519842|62938066|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
33546835|NCT02519842|62938067|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
33546836|NCT02519842|62938065|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
33546837|NCT02519842|62938066|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
33546838|NCT02519842|62938067|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
33546839|NCT02519842|62938065|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
33546840|NCT02519842|62938066|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
33546841|NCT02519842|62938067|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
33546842|NCT02519842|62938065|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
33546843|NCT02519842|62938066|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
33546844|NCT02519842|62938067|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
33546845|NCT02519842|62938065|FG000|Optional Extension: Cycles 2-6|Death|0|||
33546846|NCT02519842|62938066|FG001|Optional Extension: Cycles 2-6|Death|0|||
33546847|NCT02519842|62938067|FG002|Optional Extension: Cycles 2-6|Death|1|||
33466613|NCT00062868|62840095|FG006|Dose Level 1|Lost to Follow-up|0|||
33466614|NCT00062868|62840096|FG007|Dose Level 1|Lost to Follow-up|0|||
33466615|NCT00062868|62840097|FG008|Dose Level 1|Lost to Follow-up|0|||
33466616|NCT00062868|62840098|FG009|Dose Level 1|Lost to Follow-up|0|||
33466617|NCT00062868|62840099|FG010|Dose Level 1|Lost to Follow-up|0|||
33466618|NCT00062868|62840100|FG011|Dose Level 1|Lost to Follow-up|0|||
33546848|NCT02519842|62938065|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
33546849|NCT02519842|62938066|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
33652810|NCT01694485|63064897|FG001|Overall Study|Sponsor Decision|0|||
33652811|NCT01694485|63064898|FG002|Overall Study|Sponsor Decision|0|||
33652812|NCT01694485|63064899|FG003|Overall Study|Sponsor Decision|2|||
33652813|NCT01694485|63064900|FG004|Overall Study|Sponsor Decision|0|||
33652814|NCT01694485|63064896|FG000|Overall Study|Lost to Follow-up|9|||
33652815|NCT01694485|63064897|FG001|Overall Study|Lost to Follow-up|1|||
33652816|NCT01694485|63064898|FG002|Overall Study|Lost to Follow-up|6|||
33652817|NCT01694485|63064899|FG003|Overall Study|Lost to Follow-up|10|||
33652818|NCT01694485|63064900|FG004|Overall Study|Lost to Follow-up|7|||
33652819|NCT01694485|63064896|FG000|Overall Study|Death|1|||
33652820|NCT01694485|63064897|FG001|Overall Study|Death|0|||
33652821|NCT01694485|63064898|FG002|Overall Study|Death|0|||
33652822|NCT01694485|63064899|FG003|Overall Study|Death|1|||
33652823|NCT01694485|63064900|FG004|Overall Study|Death|0|||
33652824|NCT01931735|63064921|FG000|Randomized Phase|Lost to Follow-up|2|||
33652825|NCT01931735|63064922|FG001|Randomized Phase|Lost to Follow-up|2|||
33652826|NCT01931735|63064923|FG002|Randomized Phase|Lost to Follow-up|5|||
33652827|NCT01931735|63064924|FG003|Randomized Phase|Lost to Follow-up|0|||
33652828|NCT01931735|63064921|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
33652829|NCT01931735|63064922|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
33652830|NCT01931735|63064923|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
33652831|NCT01931735|63064924|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
33652832|NCT01931735|63064921|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
33652833|NCT01931735|63064922|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
33652834|NCT01931735|63064923|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
33652835|NCT01931735|63064924|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
33652836|NCT01930799|63064934|FG000|Overall Study|Withdrawal by Subject|3|||
33652837|NCT01930799|63064934|FG000|Overall Study|Lost to Follow-up|5|||
33652838|NCT01947491|63064942|FG000|Overall Study|Lost to Follow-up|5|||
33652839|NCT01947491|63064943|FG001|Overall Study|Lost to Follow-up|3|||
33652840|NCT01947491|63064944|FG002|Overall Study|Lost to Follow-up|1|||
33652841|NCT01947491|63064945|FG003|Overall Study|Lost to Follow-up|2|||
33652842|NCT01947491|63064942|FG000|Overall Study|Lack of Efficacy|1|||
33652843|NCT01947491|63064943|FG001|Overall Study|Lack of Efficacy|0|||
33652844|NCT01947491|63064944|FG002|Overall Study|Lack of Efficacy|0|||
33652845|NCT01947491|63064945|FG003|Overall Study|Lack of Efficacy|1|||
33652846|NCT01947491|63064942|FG000|Overall Study|Protocol Violation|1|||
33652847|NCT01947491|63064943|FG001|Overall Study|Protocol Violation|0|||
33652848|NCT01947491|63064944|FG002|Overall Study|Protocol Violation|0|||
33652849|NCT01947491|63064945|FG003|Overall Study|Protocol Violation|0|||
33466619|NCT00062868|62840101|FG012|Dose Level 1|Lost to Follow-up|1|||
33466620|NCT00062868|62840102|FG013|Dose Level 1|Lost to Follow-up|0|||
33466621|NCT00062868|62840103|FG014|Dose Level 1|Lost to Follow-up|0|||
33466622|NCT00062868|62840104|FG015|Dose Level 1|Lost to Follow-up|0|||
33466623|NCT00062868|62840105|FG016|Dose Level 1|Lost to Follow-up|0|||
33466624|NCT00062868|62840106|FG017|Dose Level 1|Lost to Follow-up|0|||
33466625|NCT00062868|62840107|FG018|Dose Level 1|Lost to Follow-up|2|||
33466626|NCT00062868|62840108|FG019|Dose Level 1|Lost to Follow-up|0|||
33466627|NCT00062868|62840109|FG020|Dose Level 1|Lost to Follow-up|1|||
33466628|NCT00062868|62840089|FG000|Dose Level 2|Death|0|||
33466629|NCT00062868|62840090|FG001|Dose Level 2|Death|3|||
33466630|NCT00062868|62840091|FG002|Dose Level 2|Death|0|||
33466631|NCT00062868|62840092|FG003|Dose Level 2|Death|0|||
33466632|NCT00062868|62840093|FG004|Dose Level 2|Death|2|||
33466633|NCT00062868|62840094|FG005|Dose Level 2|Death|0|||
33546850|NCT02519842|62938067|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
33546851|NCT02519842|62938065|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
33546852|NCT02519842|62938066|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
33546853|NCT02519842|62938067|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
33546854|NCT02519842|62938065|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
33546855|NCT02519842|62938066|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
33546856|NCT02519842|62938067|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
33546857|NCT02519842|62938065|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
33652850|NCT01947491|63064942|FG000|Overall Study|Withdrawal by Subject|1|||
33652851|NCT01947491|63064943|FG001|Overall Study|Withdrawal by Subject|1|||
33652852|NCT01947491|63064944|FG002|Overall Study|Withdrawal by Subject|1|||
33652853|NCT01947491|63064945|FG003|Overall Study|Withdrawal by Subject|0|||
33652854|NCT01947491|63064942|FG000|Overall Study|Worsening of condition|0|||
33652855|NCT01947491|63064943|FG001|Overall Study|Worsening of condition|1|||
33652856|NCT01947491|63064944|FG002|Overall Study|Worsening of condition|0|||
33466634|NCT00062868|62840095|FG006|Dose Level 2|Death|0|||
33546858|NCT02519842|62938066|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
33546859|NCT02519842|62938067|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
33546860|NCT02509078|62938077|FG000|Overall Study|Protocol Violation|1|||
33546861|NCT02509078|62938078|FG001|Overall Study|Protocol Violation|1|||
33546862|NCT02993783|62938088|FG000|Overall Study|Reason not Specified|6|||
33546863|NCT02993783|62938089|FG001|Overall Study|Reason not Specified|9|||
33546864|NCT02993471|62938095|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
33328823|NCT01192178|62705249|FG000|Overall Study|Lack of Efficacy|1|||
33328824|NCT01192178|62705250|FG001|Overall Study|Lack of Efficacy|2|||
33466635|NCT00062868|62840096|FG007|Dose Level 2|Death|0|||
33466636|NCT00062868|62840097|FG008|Dose Level 2|Death|0|||
33466637|NCT00062868|62840098|FG009|Dose Level 2|Death|0|||
33466638|NCT00062868|62840099|FG010|Dose Level 2|Death|1|||
33466639|NCT00062868|62840100|FG011|Dose Level 2|Death|0|||
33466640|NCT00062868|62840101|FG012|Dose Level 2|Death|0|||
33466641|NCT00062868|62840102|FG013|Dose Level 2|Death|0|||
33466642|NCT00062868|62840103|FG014|Dose Level 2|Death|0|||
33466643|NCT00062868|62840104|FG015|Dose Level 2|Death|0|||
33652857|NCT01947491|63064945|FG003|Overall Study|Worsening of condition|0|||
33466644|NCT00062868|62840105|FG016|Dose Level 2|Death|2|||
33652858|NCT01947491|63064942|FG000|Overall Study|Adverse Event|0|||
33466645|NCT00062868|62840106|FG017|Dose Level 2|Death|0|||
33328825|NCT01192100|62705258|FG000|Overall Study|Withdrawal by Subject|0|||
33546865|NCT02993471|62938095|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
33546866|NCT02988713|62938117|FG000|Overall Study|Withdrawal by Subject|1|||
33652859|NCT01947491|63064943|FG001|Overall Study|Adverse Event|1|||
33652860|NCT01947491|63064944|FG002|Overall Study|Adverse Event|0|||
33466646|NCT00062868|62840107|FG018|Dose Level 2|Death|0|||
33466647|NCT00062868|62840108|FG019|Dose Level 2|Death|0|||
33466648|NCT00062868|62840109|FG020|Dose Level 2|Death|0|||
33466649|NCT00062868|62840089|FG000|Dose Level 2|Lost to Follow-up|0|||
33466650|NCT00062868|62840090|FG001|Dose Level 2|Lost to Follow-up|0|||
33466651|NCT00062868|62840091|FG002|Dose Level 2|Lost to Follow-up|0|||
33466652|NCT00062868|62840092|FG003|Dose Level 2|Lost to Follow-up|0|||
33466653|NCT00062868|62840093|FG004|Dose Level 2|Lost to Follow-up|0|||
33466654|NCT00062868|62840094|FG005|Dose Level 2|Lost to Follow-up|0|||
33466655|NCT00062868|62840095|FG006|Dose Level 2|Lost to Follow-up|0|||
33466656|NCT00062868|62840096|FG007|Dose Level 2|Lost to Follow-up|0|||
33466657|NCT00062868|62840097|FG008|Dose Level 2|Lost to Follow-up|0|||
33466658|NCT00062868|62840098|FG009|Dose Level 2|Lost to Follow-up|0|||
33466659|NCT00062868|62840099|FG010|Dose Level 2|Lost to Follow-up|0|||
33466660|NCT00062868|62840100|FG011|Dose Level 2|Lost to Follow-up|0|||
33466661|NCT00062868|62840101|FG012|Dose Level 2|Lost to Follow-up|0|||
33466662|NCT00062868|62840102|FG013|Dose Level 2|Lost to Follow-up|1|||
33466663|NCT00062868|62840103|FG014|Dose Level 2|Lost to Follow-up|0|||
33466664|NCT00062868|62840104|FG015|Dose Level 2|Lost to Follow-up|0|||
33466665|NCT00062868|62840105|FG016|Dose Level 2|Lost to Follow-up|1|||
33466666|NCT00062868|62840106|FG017|Dose Level 2|Lost to Follow-up|0|||
33466667|NCT00062868|62840107|FG018|Dose Level 2|Lost to Follow-up|0|||
33466668|NCT00062868|62840108|FG019|Dose Level 2|Lost to Follow-up|0|||
33466669|NCT00062868|62840109|FG020|Dose Level 2|Lost to Follow-up|0|||
33466670|NCT00062868|62840089|FG000|Dose Level 3|Death|0|||
33466671|NCT00062868|62840090|FG001|Dose Level 3|Death|0|||
33466672|NCT00062868|62840091|FG002|Dose Level 3|Death|0|||
33466673|NCT00062868|62840092|FG003|Dose Level 3|Death|0|||
33466674|NCT00062868|62840093|FG004|Dose Level 3|Death|0|||
33466675|NCT00062868|62840094|FG005|Dose Level 3|Death|0|||
33466676|NCT00062868|62840095|FG006|Dose Level 3|Death|0|||
33466677|NCT00062868|62840096|FG007|Dose Level 3|Death|0|||
33466678|NCT00062868|62840097|FG008|Dose Level 3|Death|0|||
33466679|NCT00062868|62840098|FG009|Dose Level 3|Death|0|||
33466680|NCT00062868|62840099|FG010|Dose Level 3|Death|0|||
33466681|NCT00062868|62840100|FG011|Dose Level 3|Death|1|||
33466682|NCT00062868|62840101|FG012|Dose Level 3|Death|0|||
33466683|NCT00062868|62840102|FG013|Dose Level 3|Death|0|||
33466684|NCT00062868|62840103|FG014|Dose Level 3|Death|0|||
33466685|NCT00062868|62840104|FG015|Dose Level 3|Death|0|||
33466686|NCT00062868|62840105|FG016|Dose Level 3|Death|0|||
33466687|NCT00062868|62840106|FG017|Dose Level 3|Death|1|||
33466688|NCT00062868|62840107|FG018|Dose Level 3|Death|0|||
33466689|NCT00062868|62840108|FG019|Dose Level 3|Death|0|||
33466690|NCT00062868|62840109|FG020|Dose Level 3|Death|0|||
33466691|NCT00062868|62840089|FG000|Dose Level 3|Lost to Follow-up|0|||
33466692|NCT00062868|62840090|FG001|Dose Level 3|Lost to Follow-up|0|||
33466693|NCT00062868|62840091|FG002|Dose Level 3|Lost to Follow-up|0|||
33466694|NCT00062868|62840092|FG003|Dose Level 3|Lost to Follow-up|0|||
33466695|NCT00062868|62840093|FG004|Dose Level 3|Lost to Follow-up|0|||
33466696|NCT00062868|62840094|FG005|Dose Level 3|Lost to Follow-up|0|||
33466697|NCT00062868|62840095|FG006|Dose Level 3|Lost to Follow-up|0|||
33466698|NCT00062868|62840096|FG007|Dose Level 3|Lost to Follow-up|0|||
33466699|NCT00062868|62840097|FG008|Dose Level 3|Lost to Follow-up|0|||
33466700|NCT00062868|62840098|FG009|Dose Level 3|Lost to Follow-up|0|||
33466701|NCT00062868|62840099|FG010|Dose Level 3|Lost to Follow-up|0|||
33466702|NCT00062868|62840100|FG011|Dose Level 3|Lost to Follow-up|0|||
33466703|NCT00062868|62840101|FG012|Dose Level 3|Lost to Follow-up|0|||
33466704|NCT00062868|62840102|FG013|Dose Level 3|Lost to Follow-up|0|||
33466705|NCT00062868|62840103|FG014|Dose Level 3|Lost to Follow-up|1|||
33466706|NCT00062868|62840104|FG015|Dose Level 3|Lost to Follow-up|0|||
33466707|NCT00062868|62840105|FG016|Dose Level 3|Lost to Follow-up|0|||
33580902|NCT01454934|62978057|FG000|Overall Study|Clinical progression|28|||
33652861|NCT01947491|63064945|FG003|Overall Study|Adverse Event|2|||
33466708|NCT00062868|62840106|FG017|Dose Level 3|Lost to Follow-up|0|||
33466709|NCT00062868|62840107|FG018|Dose Level 3|Lost to Follow-up|0|||
33466710|NCT00062868|62840108|FG019|Dose Level 3|Lost to Follow-up|0|||
33466711|NCT00062868|62840109|FG020|Dose Level 3|Lost to Follow-up|0|||
33466712|NCT00062868|62840089|FG000|Dose Level 3|Withdrew|0|||
33466713|NCT00062868|62840090|FG001|Dose Level 3|Withdrew|0|||
33466714|NCT00062868|62840091|FG002|Dose Level 3|Withdrew|2|||
33466715|NCT00062868|62840092|FG003|Dose Level 3|Withdrew|0|||
33466716|NCT00062868|62840093|FG004|Dose Level 3|Withdrew|0|||
33466717|NCT00062868|62840094|FG005|Dose Level 3|Withdrew|0|||
33466718|NCT00062868|62840095|FG006|Dose Level 3|Withdrew|0|||
33466719|NCT00062868|62840096|FG007|Dose Level 3|Withdrew|0|||
33466720|NCT00062868|62840097|FG008|Dose Level 3|Withdrew|0|||
33466721|NCT00062868|62840098|FG009|Dose Level 3|Withdrew|0|||
33466722|NCT00062868|62840099|FG010|Dose Level 3|Withdrew|0|||
33466723|NCT00062868|62840100|FG011|Dose Level 3|Withdrew|0|||
33466724|NCT00062868|62840101|FG012|Dose Level 3|Withdrew|0|||
33466725|NCT00062868|62840102|FG013|Dose Level 3|Withdrew|0|||
33466726|NCT00062868|62840103|FG014|Dose Level 3|Withdrew|0|||
33466727|NCT00062868|62840104|FG015|Dose Level 3|Withdrew|0|||
33466728|NCT00062868|62840105|FG016|Dose Level 3|Withdrew|0|||
33466729|NCT00062868|62840106|FG017|Dose Level 3|Withdrew|0|||
33466730|NCT00062868|62840107|FG018|Dose Level 3|Withdrew|0|||
33466731|NCT00062868|62840108|FG019|Dose Level 3|Withdrew|0|||
33466732|NCT00062868|62840109|FG020|Dose Level 3|Withdrew|0|||
33466733|NCT00075504|62840155|FG000|Overall Study|Withdrawal by Subject|9|||
33466734|NCT00075504|62840156|FG001|Overall Study|Withdrawal by Subject|7|||
33466735|NCT00062166|62840162|FG000|Overall Study|Withdrawal by Subject|6|||
33466736|NCT00087438|62840167|FG000|Overall Study|Ineligible / No protocol treatment|4|||
33466737|NCT00321464|62840175|FG000|Overall Study|Death|169|||
33466738|NCT00321464|62840176|FG001|Overall Study|Death|174|||
33466739|NCT00321464|62840175|FG000|Overall Study|Disease progression|124|||
33466740|NCT00321464|62840176|FG001|Overall Study|Disease progression|124|||
33466741|NCT00321464|62840175|FG000|Overall Study|Withdrawal by Subject|117|||
33466742|NCT00321464|62840176|FG001|Overall Study|Withdrawal by Subject|118|||
33466743|NCT00321464|62840175|FG000|Overall Study|Participant request|57|||
33466744|NCT00321464|62840176|FG001|Overall Study|Participant request|61|||
33466745|NCT00321464|62840175|FG000|Overall Study|Adverse Event|43|||
33466746|NCT00321464|62840176|FG001|Overall Study|Adverse Event|28|||
33466747|NCT00321464|62840175|FG000|Overall Study|Physician Decision|15|||
33466748|NCT00321464|62840176|FG001|Overall Study|Physician Decision|14|||
33466749|NCT00321464|62840175|FG000|Overall Study|Noncompliance|4|||
33466750|NCT00321464|62840176|FG001|Overall Study|Noncompliance|10|||
33546867|NCT02988713|62938117|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
33546868|NCT01068743|62938121|FG000|Period 3|Adverse Event|0|||
33546869|NCT01068743|62938122|FG001|Period 3|Adverse Event|1|||
33546870|NCT01068743|62938123|FG002|Period 3|Adverse Event|0|||
33546871|NCT01068743|62938124|FG003|Period 3|Adverse Event|0|||
33546872|NCT02992691|62938137|FG000|Overall Study|Adverse Event|2|||
33546873|NCT02992691|62938137|FG000|Overall Study|Withdrawal by Subject|1|||
33546874|NCT02921087|62938154|FG000|Overall Study|Withdrawal by Subject|0|||
33546875|NCT02921087|62938155|FG001|Overall Study|Withdrawal by Subject|1|||
33546876|NCT02907619|62938174|FG000|Overall Study|Study terminated by sponsor|18|||
33546877|NCT02907619|62938175|FG001|Overall Study|Study terminated by sponsor|18|||
33546878|NCT02907619|62938176|FG002|Overall Study|Study terminated by sponsor|19|||
33546879|NCT02907619|62938174|FG000|Overall Study|Death|0|||
33546880|NCT02907619|62938175|FG001|Overall Study|Death|0|||
33546881|NCT02907619|62938176|FG002|Overall Study|Death|1|||
33546882|NCT02907619|62938174|FG000|Overall Study|Withdrawal by Subject|1|||
33546883|NCT02907619|62938175|FG001|Overall Study|Withdrawal by Subject|1|||
33546884|NCT02907619|62938176|FG002|Overall Study|Withdrawal by Subject|0|||
33546885|NCT02907619|62938174|FG000|Overall Study|Other|0|||
33546886|NCT02907619|62938175|FG001|Overall Study|Other|1|||
33546887|NCT02907619|62938176|FG002|Overall Study|Other|0|||
33546888|NCT02986373|62938186|FG000|Overall Study|Adverse Event|4|||
33466751|NCT00321464|62840175|FG000|Overall Study|Lost to Follow-up|7|||
33466752|NCT00321464|62840176|FG001|Overall Study|Lost to Follow-up|8|||
33466753|NCT00321464|62840175|FG000|Overall Study|Protocol deviation|0|||
33466754|NCT00321464|62840176|FG001|Overall Study|Protocol deviation|2|||
33466755|NCT00321464|62840175|FG000|Overall Study|Ineligibility determined|2|||
33466756|NCT00321464|62840176|FG001|Overall Study|Ineligibility determined|1|||
33466757|NCT00321464|62840175|FG000|Overall Study|Other|21|||
33466758|NCT00321464|62840176|FG001|Overall Study|Other|18|||
33466759|NCT02889796|62840186|FG000|Overall Study|Withdrew Consent|18|||
33466760|NCT02889796|62840187|FG001|Overall Study|Withdrew Consent|29|||
33466761|NCT02889796|62840188|FG002|Overall Study|Withdrew Consent|20|||
33466762|NCT02889796|62840189|FG003|Overall Study|Withdrew Consent|1|||
33466763|NCT02889796|62840190|FG004|Overall Study|Withdrew Consent|2|||
33466764|NCT02889796|62840191|FG005|Overall Study|Withdrew Consent|35|||
33466765|NCT02889796|62840186|FG000|Overall Study|Investigator's Discretion|10|||
33466766|NCT02889796|62840187|FG001|Overall Study|Investigator's Discretion|9|||
33466767|NCT02889796|62840188|FG002|Overall Study|Investigator's Discretion|10|||
33466768|NCT02889796|62840189|FG003|Overall Study|Investigator's Discretion|3|||
33546889|NCT02986373|62938186|FG000|Overall Study|Lost to Follow-up|1|||
33466769|NCT02889796|62840190|FG004|Overall Study|Investigator's Discretion|0|||
33466770|NCT02889796|62840191|FG005|Overall Study|Investigator's Discretion|15|||
33466771|NCT02889796|62840186|FG000|Overall Study|Adverse Event|17|||
33466772|NCT02889796|62840187|FG001|Overall Study|Adverse Event|8|||
33466773|NCT02889796|62840188|FG002|Overall Study|Adverse Event|8|||
33546890|NCT02986373|62938186|FG000|Overall Study|Withdrawal by Subject|10|||
33546891|NCT02986373|62938186|FG000|Overall Study|Other|24|||
33546892|NCT02986139|62938192|FG000|Overall Study|Sponsor Decision|1|||
33466774|NCT02889796|62840189|FG003|Overall Study|Adverse Event|4|||
33466775|NCT02889796|62840190|FG004|Overall Study|Adverse Event|1|||
33466776|NCT02889796|62840191|FG005|Overall Study|Adverse Event|7|||
33466777|NCT02889796|62840186|FG000|Overall Study|Lost to Follow-up|5|||
33466778|NCT02889796|62840187|FG001|Overall Study|Lost to Follow-up|7|||
33466779|NCT02889796|62840188|FG002|Overall Study|Lost to Follow-up|2|||
33466780|NCT02889796|62840189|FG003|Overall Study|Lost to Follow-up|0|||
33466781|NCT02889796|62840190|FG004|Overall Study|Lost to Follow-up|2|||
33466782|NCT02889796|62840191|FG005|Overall Study|Lost to Follow-up|6|||
33466783|NCT02889796|62840186|FG000|Overall Study|Protocol Violation|0|||
33466784|NCT02889796|62840187|FG001|Overall Study|Protocol Violation|1|||
33546893|NCT02986139|62938193|FG001|Overall Study|Sponsor Decision|2|||
33546894|NCT02986139|62938192|FG000|Overall Study|Withdrawal by Subject|0|||
33546895|NCT02986139|62938193|FG001|Overall Study|Withdrawal by Subject|1|||
33546896|NCT02986139|62938192|FG000|Overall Study|Lost to Follow-up|0|||
33546897|NCT02986139|62938193|FG001|Overall Study|Lost to Follow-up|1|||
33546898|NCT02989805|62938205|FG000|Overall Study|invalid consent|6|||
33546899|NCT02989805|62938206|FG001|Overall Study|invalid consent|4|||
33546900|NCT02907463|62938212|FG000|Overall Study|Lost to Follow-up|17|||
33546901|NCT02907463|62938212|FG000|Overall Study|Death|10|||
33546902|NCT02907463|62938212|FG000|Overall Study|Withdrawal by Subject|4|||
33466785|NCT02889796|62840188|FG002|Overall Study|Protocol Violation|3|||
33466786|NCT02889796|62840189|FG003|Overall Study|Protocol Violation|0|||
33466787|NCT02889796|62840190|FG004|Overall Study|Protocol Violation|0|||
33466788|NCT02889796|62840191|FG005|Overall Study|Protocol Violation|4|||
33466789|NCT02889796|62840186|FG000|Overall Study|Non-compliance With Study Drug|0|||
33466790|NCT02889796|62840187|FG001|Overall Study|Non-compliance With Study Drug|2|||
33466791|NCT02889796|62840188|FG002|Overall Study|Non-compliance With Study Drug|0|||
33466792|NCT02889796|62840189|FG003|Overall Study|Non-compliance With Study Drug|0|||
33466793|NCT02889796|62840190|FG004|Overall Study|Non-compliance With Study Drug|1|||
33466794|NCT02889796|62840191|FG005|Overall Study|Non-compliance With Study Drug|2|||
33466795|NCT02889796|62840186|FG000|Overall Study|Death|1|||
33466796|NCT02889796|62840187|FG001|Overall Study|Death|1|||
33466797|NCT02889796|62840188|FG002|Overall Study|Death|0|||
33466798|NCT02889796|62840189|FG003|Overall Study|Death|1|||
33466799|NCT02889796|62840190|FG004|Overall Study|Death|0|||
33466800|NCT02889796|62840191|FG005|Overall Study|Death|1|||
33466801|NCT02889796|62840186|FG000|Overall Study|Pregnancy|0|||
33466802|NCT02889796|62840187|FG001|Overall Study|Pregnancy|1|||
33466803|NCT02889796|62840188|FG002|Overall Study|Pregnancy|1|||
33466804|NCT02889796|62840189|FG003|Overall Study|Pregnancy|0|||
33466805|NCT02889796|62840190|FG004|Overall Study|Pregnancy|0|||
33466806|NCT02889796|62840191|FG005|Overall Study|Pregnancy|0|||
33466807|NCT02889796|62840186|FG000|Overall Study|Randomized but not Dosed|2|||
33466808|NCT02889796|62840187|FG001|Overall Study|Randomized but not Dosed|0|||
33466809|NCT02889796|62840188|FG002|Overall Study|Randomized but not Dosed|0|||
33466810|NCT02889796|62840189|FG003|Overall Study|Randomized but not Dosed|0|||
33466811|NCT02889796|62840190|FG004|Overall Study|Randomized but not Dosed|0|||
33546903|NCT02907463|62938212|FG000|Overall Study|MIS Approach was not used|2|||
33546904|NCT02907463|62938212|FG000|Overall Study|Not Implanted with Study Device|2|||
33546905|NCT02907463|62938212|FG000|Overall Study|Device Explanted|1|||
33546906|NCT02907463|62938212|FG000|Overall Study|Missing Exit Form|1|||
33546907|NCT02906917|62938226|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
33546908|NCT02906917|62938227|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
33546909|NCT02906917|62938226|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
33546910|NCT02906917|62938227|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
33546911|NCT02906917|62938226|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
33546912|NCT02906917|62938227|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
33546913|NCT02906917|62938226|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
33546914|NCT02906917|62938227|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
33546915|NCT02906917|62938226|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
33546916|NCT02906917|62938227|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
33546917|NCT02906917|62938226|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
33546918|NCT02906917|62938227|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
33466812|NCT02889796|62840191|FG005|Overall Study|Randomized but not Dosed|2|||
33546919|NCT02906917|62938226|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
33546920|NCT02906917|62938227|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
33466813|NCT02889562|62840216|FG000|Overall Study|Physician Decision|0|||
33466814|NCT02889562|62840217|FG001|Overall Study|Physician Decision|1|||
33466815|NCT02889562|62840216|FG000|Overall Study|Withdrawal by Subject|0|||
33466816|NCT02889562|62840217|FG001|Overall Study|Withdrawal by Subject|1|||
33466817|NCT03323164|62840225|FG000|Overall Study|Poor quality imaging/scans|2|||
33466818|NCT03323164|62840226|FG001|Overall Study|Poor quality imaging/scans|2|||
33466819|NCT03323086|62840238|FG000|Overall Study|Lost to Follow-up|3|||
33466820|NCT03323086|62840239|FG001|Overall Study|Lost to Follow-up|2|||
33546921|NCT02906917|62938226|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
33546922|NCT02906917|62938227|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
33546923|NCT02982187|62938235|FG000|Overall Study|Withdrawal by Subject|0|||
33546924|NCT02982187|62938236|FG001|Overall Study|Withdrawal by Subject|0|||
33546925|NCT02982187|62938237|FG002|Overall Study|Withdrawal by Subject|0|||
33546926|NCT02982187|62938238|FG003|Overall Study|Withdrawal by Subject|0|||
33546927|NCT02982187|62938239|FG004|Overall Study|Withdrawal by Subject|0|||
33546928|NCT02982187|62938240|FG005|Overall Study|Withdrawal by Subject|0|||
33546929|NCT02982187|62938241|FG006|Overall Study|Withdrawal by Subject|1|||
33546930|NCT02982187|62938242|FG007|Overall Study|Withdrawal by Subject|0|||
33546931|NCT02981953|62938252|FG000|Overall Study|Death|9|||
33546932|NCT02981953|62938252|FG000|Overall Study|Withdrawal by Subject|1|||
33546933|NCT02981953|62938252|FG000|Overall Study|Withdrawal to non-compliance|1|||
33546934|NCT01066585|62938268|FG000|Overall Study|Protocol Violation|1|||
33546935|NCT01066585|62938269|FG001|Overall Study|Protocol Violation|0|||
33546936|NCT01066585|62938268|FG000|Overall Study|Withdrawal by Subject|0|||
33546937|NCT01066585|62938269|FG001|Overall Study|Withdrawal by Subject|3|||
33546938|NCT02980783|62938275|FG000|Overall Study|Lost to Follow-up|1|||
33546939|NCT02980705|62938281|FG000|Overall Study|Adverse Event|0|||
33546940|NCT02980705|62938282|FG001|Overall Study|Adverse Event|1|||
33546941|NCT02980705|62938281|FG000|Overall Study|Withdrawal by Subject|6|||
33546942|NCT02980705|62938282|FG001|Overall Study|Withdrawal by Subject|9|||
33546943|NCT02980705|62938281|FG000|Overall Study|withdrew participation|0|||
33546944|NCT02980705|62938282|FG001|Overall Study|withdrew participation|1|||
33466821|NCT02888080|62840247|FG000|Overall Study|Subject / Guardian decision|1|||
33466822|NCT02888080|62840248|FG001|Overall Study|Subject / Guardian decision|3|||
33466823|NCT02888080|62840247|FG000|Overall Study|New Therapy for study indication|1|||
33466824|NCT02888080|62840248|FG001|Overall Study|New Therapy for study indication|0|||
33466825|NCT02888080|62840247|FG000|Overall Study|Lack of Efficacy|0|||
33466826|NCT02888080|62840248|FG001|Overall Study|Lack of Efficacy|1|||
33466827|NCT02888080|62840247|FG000|Overall Study|Adverse Event|0|||
33546945|NCT02980705|62938281|FG000|Overall Study|Lost to Follow-up|2|||
33546946|NCT02980705|62938282|FG001|Overall Study|Lost to Follow-up|0|||
33546947|NCT02989649|62938289|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
33546948|NCT02989649|62938289|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
33546949|NCT02989649|62938289|FG000|Overall Study|Lost For Observation During Study|3|||
33546950|NCT02989649|62938289|FG000|Overall Study|Reason Not Specified|13|||
33546951|NCT02905435|62938293|FG000|Overall Study|Death|2|||
33546952|NCT02905435|62938293|FG000|Overall Study|Physician Decision|1|||
33546953|NCT02905435|62938293|FG000|Overall Study|Lost to Follow-up|4|||
33546954|NCT02978833|62938300|FG000|Overall Study|Study terminated|1|||
33546955|NCT02978833|62938301|FG001|Overall Study|Study terminated|1|||
33546956|NCT01067339|62938310|FG000|Overall Study|Withdrawal by Subject|6|||
33546957|NCT01067339|62938311|FG001|Overall Study|Withdrawal by Subject|5|||
33546958|NCT02573259|62938324|FG000|Overall Study|Death|1|||
33546959|NCT02573259|62938325|FG001|Overall Study|Death|6|||
33546960|NCT02573259|62938326|FG002|Overall Study|Death|5|||
33546961|NCT02573259|62938327|FG003|Overall Study|Death|6|||
33546962|NCT02573259|62938328|FG004|Overall Study|Death|9|||
33546963|NCT02573259|62938329|FG005|Overall Study|Death|32|||
33546964|NCT02573259|62938330|FG006|Overall Study|Death|21|||
33466828|NCT02888080|62840248|FG001|Overall Study|Adverse Event|1|||
33546965|NCT02573259|62938324|FG000|Overall Study|Lost to Follow-up|0|||
33546966|NCT02573259|62938325|FG001|Overall Study|Lost to Follow-up|0|||
33546967|NCT02573259|62938326|FG002|Overall Study|Lost to Follow-up|0|||
33546968|NCT02573259|62938327|FG003|Overall Study|Lost to Follow-up|0|||
33546969|NCT02573259|62938328|FG004|Overall Study|Lost to Follow-up|0|||
33466829|NCT03322462|62840254|FG000|Overall Study|Technical difficulties|2|||
33466830|NCT03322462|62840254|FG000|Overall Study|Other|1|||
33466831|NCT00086580|62840262|FG000|Treatment Period|Disease progression|9|||
33466832|NCT00086580|62840263|FG001|Treatment Period|Disease progression|8|||
33466833|NCT00086580|62840262|FG000|Treatment Period|Unable to comply with protocol|3|||
33466834|NCT00086580|62840263|FG001|Treatment Period|Unable to comply with protocol|1|||
33466835|NCT00086580|62840262|FG000|Treatment Period|Withdrawal by Subject|7|||
33466836|NCT00086580|62840263|FG001|Treatment Period|Withdrawal by Subject|8|||
33466837|NCT00086580|62840262|FG000|Treatment Period|Physician Decision|13|||
33466838|NCT00086580|62840263|FG001|Treatment Period|Physician Decision|7|||
33466839|NCT00086580|62840262|FG000|Treatment Period|AE - not treatment related|7|||
33466840|NCT00086580|62840263|FG001|Treatment Period|AE - not treatment related|7|||
33466841|NCT00086580|62840262|FG000|Treatment Period|Toxicity - treatment related|15|||
33466842|NCT00086580|62840263|FG001|Treatment Period|Toxicity - treatment related|15|||
33466843|NCT00086580|62840262|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
33466844|NCT00086580|62840263|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
33466845|NCT00086580|62840262|FG000|Treatment Period|Death|5|||
33466846|NCT00086580|62840263|FG001|Treatment Period|Death|7|||
33466847|NCT00086580|62840262|FG000|Treatment Period|Other|5|||
33466848|NCT00086580|62840263|FG001|Treatment Period|Other|3|||
33466849|NCT00086580|62840262|FG000|Follow-up Period|Disease progression|72|||
33466850|NCT00086580|62840263|FG001|Follow-up Period|Disease progression|99|||
33466851|NCT00086580|62840262|FG000|Follow-up Period|Unable to comply with protocol|5|||
33466852|NCT00086580|62840263|FG001|Follow-up Period|Unable to comply with protocol|0|||
33466853|NCT00086580|62840262|FG000|Follow-up Period|Withdrawal by Subject|6|||
33466854|NCT00086580|62840263|FG001|Follow-up Period|Withdrawal by Subject|6|||
33466855|NCT00086580|62840262|FG000|Follow-up Period|Physician Decision|0|||
33466856|NCT00086580|62840263|FG001|Follow-up Period|Physician Decision|1|||
33466857|NCT00086580|62840262|FG000|Follow-up Period|AE - not related|1|||
33466858|NCT00086580|62840263|FG001|Follow-up Period|AE - not related|0|||
33466859|NCT00086580|62840262|FG000|Follow-up Period|Death|13|||
33466860|NCT00086580|62840263|FG001|Follow-up Period|Death|7|||
33466861|NCT00086580|62840262|FG000|Follow-up Period|Other|7|||
33466862|NCT00086580|62840263|FG001|Follow-up Period|Other|6|||
33466863|NCT00086580|62840262|FG000|Observation Period|Unable to comply with protocol|1|||
33546970|NCT02573259|62938329|FG005|Overall Study|Lost to Follow-up|2|||
33466864|NCT00086580|62840263|FG001|Observation Period|Unable to comply with protocol|1|||
33466865|NCT00086580|62840262|FG000|Observation Period|Withdrawal by Subject|4|||
33546971|NCT02573259|62938330|FG006|Overall Study|Lost to Follow-up|1|||
33546972|NCT02573259|62938324|FG000|Overall Study|Participant refused further follow-up|0|||
33546973|NCT02573259|62938325|FG001|Overall Study|Participant refused further follow-up|2|||
33466866|NCT00086580|62840263|FG001|Observation Period|Withdrawal by Subject|2|||
33546974|NCT02573259|62938326|FG002|Overall Study|Participant refused further follow-up|1|||
33546975|NCT02573259|62938327|FG003|Overall Study|Participant refused further follow-up|0|||
33546976|NCT02573259|62938328|FG004|Overall Study|Participant refused further follow-up|3|||
33546977|NCT02573259|62938329|FG005|Overall Study|Participant refused further follow-up|20|||
33546978|NCT02573259|62938330|FG006|Overall Study|Participant refused further follow-up|7|||
33546979|NCT02573259|62938324|FG000|Overall Study|Other|0|||
33546980|NCT02573259|62938325|FG001|Overall Study|Other|0|||
33466867|NCT00086580|62840262|FG000|Observation Period|Death|33|||
33466868|NCT00086580|62840263|FG001|Observation Period|Death|55|||
33466869|NCT00086580|62840262|FG000|Observation Period|Other|8|||
33466870|NCT00086580|62840263|FG001|Observation Period|Other|7|||
33466871|NCT00086502|62840271|FG000|Overall Study|Adverse Event|11|||
33466872|NCT00086502|62840272|FG001|Overall Study|Adverse Event|2|||
33466873|NCT00086502|62840271|FG000|Overall Study|Lack of Efficacy|0|||
33546981|NCT02573259|62938326|FG002|Overall Study|Other|0|||
33546982|NCT02573259|62938327|FG003|Overall Study|Other|0|||
33466874|NCT00086502|62840272|FG001|Overall Study|Lack of Efficacy|2|||
33466875|NCT00086502|62840271|FG000|Overall Study|Lost to Follow-up|3|||
33466876|NCT00086502|62840272|FG001|Overall Study|Lost to Follow-up|1|||
33466877|NCT00086502|62840271|FG000|Overall Study|Physician Decision|1|||
33466878|NCT00086502|62840272|FG001|Overall Study|Physician Decision|1|||
33466879|NCT00086502|62840271|FG000|Overall Study|Pregnancy|0|||
33466880|NCT00086502|62840272|FG001|Overall Study|Pregnancy|1|||
33466881|NCT00086502|62840271|FG000|Overall Study|Protocol Violation|3|||
33466882|NCT00086502|62840272|FG001|Overall Study|Protocol Violation|3|||
33466883|NCT00086502|62840271|FG000|Overall Study|Withdrawal by Subject|5|||
33466884|NCT00086502|62840272|FG001|Overall Study|Withdrawal by Subject|6|||
33466885|NCT00086502|62840271|FG000|Overall Study|Patient Moved|1|||
33466886|NCT00086502|62840272|FG001|Overall Study|Patient Moved|1|||
33466887|NCT00086502|62840271|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
33466888|NCT00086502|62840272|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
33466889|NCT00086502|62840271|FG000|Overall Study|Patient Accidentally Unblinded|1|||
33466890|NCT00086502|62840272|FG001|Overall Study|Patient Accidentally Unblinded|0|||
33466891|NCT03826667|62840278|FG000|Overall Study|Protocol deviation|21|||
33466892|NCT03636542|62840290|FG000|Overall Study|Lost to Follow-up|1|||
33466893|NCT03636542|62840291|FG001|Overall Study|Lost to Follow-up|1|||
33466894|NCT03636542|62840290|FG000|Overall Study|Physician Decision|0|||
33466895|NCT03636542|62840291|FG001|Overall Study|Physician Decision|1|||
33546983|NCT02573259|62938328|FG004|Overall Study|Other|1|||
33546984|NCT02573259|62938329|FG005|Overall Study|Other|4|||
33328826|NCT01192100|62705259|FG001|Overall Study|Withdrawal by Subject|0|||
33466896|NCT03636542|62840290|FG000|Overall Study|Withdrawal by Subject|1|||
33466897|NCT03636542|62840291|FG001|Overall Study|Withdrawal by Subject|0|||
33466898|NCT03305770|62840299|FG000|Overall Study|Physician Decision - prior to dispense|0|||
33546985|NCT02573259|62938330|FG006|Overall Study|Other|5|||
33546986|NCT02977507|62938367|FG000|Overall Study|Protocol Deviation|1|||
33546987|NCT02977507|62938368|FG001|Overall Study|Protocol Deviation|0|||
33546988|NCT02977507|62938367|FG000|Overall Study|Lost to Follow-up|1|||
33546989|NCT02977507|62938368|FG001|Overall Study|Lost to Follow-up|0|||
33546990|NCT02976103|62938377|FG000|Overall Study|Withdrawal by Subject|1|||
33546991|NCT02976103|62938378|FG001|Overall Study|Withdrawal by Subject|0|||
33546992|NCT02976103|62938377|FG000|Overall Study|Lost to Follow-up|12|||
33546993|NCT02976103|62938378|FG001|Overall Study|Lost to Follow-up|8|||
33546994|NCT01066039|62938385|FG000|Overall Study|Adverse Event|6|||
33546995|NCT01066039|62938385|FG000|Overall Study|Withdrawal by Subject|17|||
33546996|NCT01066039|62938385|FG000|Overall Study|Protocol Violation|2|||
33546997|NCT01066039|62938385|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
33546998|NCT01066039|62938385|FG000|Overall Study|Investigator's Request|1|||
33546999|NCT01066039|62938385|FG000|Overall Study|Dropout due to Insulin Administration|1|||
33547000|NCT01066039|62938385|FG000|Overall Study|Additional Antihypertensive Required|4|||
33547001|NCT01066039|62938385|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
33547002|NCT01066039|62938385|FG000|Overall Study|Failure to Control Blood Pressure|1|||
33547003|NCT01066039|62938385|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
33547004|NCT02919995|62938395|FG000|Overall Study|Adverse Event|0|||
33547005|NCT02919995|62938396|FG001|Overall Study|Adverse Event|0|||
33547006|NCT02919995|62938397|FG002|Overall Study|Adverse Event|0|||
33547007|NCT02919995|62938398|FG003|Overall Study|Adverse Event|0|||
33547008|NCT02919995|62938399|FG004|Overall Study|Adverse Event|0|||
33547009|NCT02919995|62938400|FG005|Overall Study|Adverse Event|1|||
33547010|NCT02919761|62938408|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
33547011|NCT02919761|62938409|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
33547012|NCT02919761|62938410|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
33547013|NCT02919761|62938408|FG000|Part 1: Open Label|Adverse Event|1|||
33547014|NCT02919761|62938409|FG001|Part 1: Open Label|Adverse Event|0|||
33547015|NCT02919761|62938410|FG002|Part 1: Open Label|Adverse Event|0|||
33547016|NCT02919761|62938408|FG000|Part 1: Open Label|Lost to Follow-up|1|||
33547017|NCT02919761|62938409|FG001|Part 1: Open Label|Lost to Follow-up|0|||
33652862|NCT01715857|63064955|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
33652863|NCT01692301|63064961|FG000|Overall Study|Adverse Event|15|||
33652864|NCT01692301|63064962|FG001|Overall Study|Adverse Event|12|||
33547018|NCT02919761|62938410|FG002|Part 1: Open Label|Lost to Follow-up|0|||
33547019|NCT02919761|62938408|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
33547020|NCT02919761|62938409|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
33547021|NCT02919761|62938410|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
33547022|NCT02919761|62938408|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
33547023|NCT02919761|62938409|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
33652865|NCT01692301|63064961|FG000|Overall Study|Death|1|||
33466899|NCT03305770|62840300|FG001|Overall Study|Physician Decision - prior to dispense|1|||
33466900|NCT03305770|62840299|FG000|Overall Study|Subject moved|1|||
33466901|NCT03305770|62840300|FG001|Overall Study|Subject moved|0|||
33652866|NCT01692301|63064962|FG001|Overall Study|Death|2|||
33547024|NCT02919761|62938410|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
33547025|NCT02919761|62938408|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
33547026|NCT02919761|62938409|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
33547027|NCT02919761|62938410|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
33547028|NCT02919761|62938408|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
33547029|NCT02919761|62938409|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
33547030|NCT02919761|62938410|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
33547031|NCT02919761|62938408|FG000|Part 1: Open Label|Termination by Sponsor|1|||
33547032|NCT02919761|62938409|FG001|Part 1: Open Label|Termination by Sponsor|0|||
33547033|NCT02919761|62938410|FG002|Part 1: Open Label|Termination by Sponsor|0|||
33547034|NCT02919761|62938408|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
33547035|NCT02919761|62938409|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
33547036|NCT02919761|62938410|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
33547037|NCT02919761|62938408|FG000|Part 2: Double-blind|Adverse Event|0|||
33547038|NCT02919761|62938409|FG001|Part 2: Double-blind|Adverse Event|1|||
33547039|NCT02919761|62938410|FG002|Part 2: Double-blind|Adverse Event|0|||
33547040|NCT02919761|62938408|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
33547041|NCT02919761|62938409|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
33547042|NCT02919761|62938410|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
33547043|NCT02919761|62938408|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
33547044|NCT02919761|62938409|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
33547045|NCT02919761|62938410|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
33547046|NCT02919761|62938408|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
33547047|NCT02919761|62938409|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
33547048|NCT02919761|62938410|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
33547049|NCT02919761|62938408|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
33547050|NCT02919761|62938409|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
33547051|NCT02919761|62938410|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
33547052|NCT02919761|62938408|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
33547053|NCT02919761|62938409|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
33547054|NCT02919761|62938410|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
33547055|NCT02919761|62938408|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
33547056|NCT02919761|62938409|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
33547057|NCT02919761|62938410|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
33547058|NCT02910167|62938421|FG000|Overall Study|Adverse Event|1|||
33547059|NCT02910167|62938421|FG000|Overall Study|Lost to Follow-up|18|||
33547060|NCT01067105|62938425|FG000|Overall Study|Adverse Event|14|||
33547061|NCT01067105|62938425|FG000|Overall Study|Protocol Violation|48|||
33547062|NCT01067105|62938425|FG000|Overall Study|Withdrawal by Subject|36|||
33547063|NCT01067105|62938425|FG000|Overall Study|Lost to Follow-up|6|||
33547064|NCT01067105|62938425|FG000|Overall Study|Physician Decision|6|||
33547065|NCT01067105|62938425|FG000|Overall Study|Other|31|||
33547066|NCT02910089|62938435|FG000|Overall Study|Lost insurance eligibility|22|||
33547067|NCT02910089|62938436|FG001|Overall Study|Lost insurance eligibility|16|||
33547068|NCT02985515|62938444|FG000|Olfaction Testing|Lost to Follow-up|0|||
33547069|NCT02985515|62938445|FG001|Olfaction Testing|Lost to Follow-up|5|||
33547070|NCT02985515|62938444|FG000|Olfaction Testing|Protocol Violation|0|||
33547071|NCT02985515|62938445|FG001|Olfaction Testing|Protocol Violation|3|||
33547072|NCT02910011|62938458|FG000|Overall Study|Physician Decision|2|||
33547073|NCT02908841|62938466|FG000|Overall Study|Physician Decision|4|||
33547074|NCT02908841|62938467|FG001|Overall Study|Physician Decision|0|||
33547075|NCT02909153|62938478|FG000|Overall Study|Withdrawal by Subject|0|||
33547076|NCT02909153|62938479|FG001|Overall Study|Withdrawal by Subject|1|||
33547077|NCT02909153|62938480|FG002|Overall Study|Withdrawal by Subject|0|||
33547078|NCT02909153|62938481|FG003|Overall Study|Withdrawal by Subject|0|||
33547079|NCT02909153|62938482|FG004|Overall Study|Withdrawal by Subject|0|||
33547080|NCT02908529|62938494|FG000|Overall Study|Lost to Follow-up|0|||
33547081|NCT02908529|62938495|FG001|Overall Study|Lost to Follow-up|2|||
33547082|NCT02984267|62938505|FG000|Overall Study|Protocol Violation|1|||
33547083|NCT02984267|62938506|FG001|Overall Study|Protocol Violation|0|||
33547084|NCT02984267|62938505|FG000|Overall Study|Withdrawal by Subject|0|||
33547085|NCT02984267|62938506|FG001|Overall Study|Withdrawal by Subject|1|||
33547086|NCT02675751|62938512|FG000|Overall Study|Lost to Follow-up|16|||
33547087|NCT02974855|62938529|FG000|Overall Study|Adverse Event|0|||
33547088|NCT02974855|62938530|FG001|Overall Study|Adverse Event|1|||
33547089|NCT02974855|62938531|FG002|Overall Study|Adverse Event|0|||
33547090|NCT02974855|62938532|FG003|Overall Study|Adverse Event|1|||
33547091|NCT00455403|62938557|FG000|Overall Study|Lost to Follow-up|2|||
33547092|NCT00455403|62938558|FG001|Overall Study|Lost to Follow-up|1|||
33547093|NCT00455403|62938557|FG000|Overall Study|Withdrawal by Subject|1|||
33547094|NCT00455403|62938558|FG001|Overall Study|Withdrawal by Subject|3|||
33652867|NCT01692301|63064961|FG000|Overall Study|Lack of Efficacy|0|||
33652868|NCT01692301|63064962|FG001|Overall Study|Lack of Efficacy|5|||
33652869|NCT01692301|63064961|FG000|Overall Study|Non-compliance with study treatment|1|||
33547095|NCT00455403|62938557|FG000|Overall Study|Protocol Violation|0|||
33547096|NCT00455403|62938558|FG001|Overall Study|Protocol Violation|2|||
33547097|NCT02979613|62938566|FG000|Double-Blind Phase|Withdrew Consent|2|||
33547098|NCT02979613|62938567|FG001|Double-Blind Phase|Withdrew Consent|4|||
33547099|NCT02979613|62938566|FG000|Double-Blind Phase|Pregnancy|2|||
33547100|NCT02979613|62938567|FG001|Double-Blind Phase|Pregnancy|2|||
33547101|NCT02979613|62938566|FG000|Double-Blind Phase|Adverse Event|2|||
33547102|NCT02979613|62938567|FG001|Double-Blind Phase|Adverse Event|0|||
33547103|NCT02979613|62938566|FG000|Double-Blind Phase|Lost to Follow-up|1|||
33547104|NCT02979613|62938567|FG001|Double-Blind Phase|Lost to Follow-up|1|||
33547105|NCT02979613|62938566|FG000|Double-Blind Phase|Protocol Violation|1|||
33547106|NCT02979613|62938567|FG001|Double-Blind Phase|Protocol Violation|1|||
33547107|NCT02979613|62938566|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
33547108|NCT02979613|62938567|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
33547109|NCT02979613|62938566|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
33547110|NCT02979613|62938567|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
33547111|NCT02979613|62938566|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
33547112|NCT02979613|62938567|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
33547113|NCT02979613|62938566|FG000|Open-Label Extension (OLE) Phase|Death|0|||
33547114|NCT02979613|62938567|FG001|Open-Label Extension (OLE) Phase|Death|1|||
33547115|NCT02979613|62938566|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
33547116|NCT02979613|62938567|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
33547117|NCT01064167|62938577|FG000|Overall Study|Protocol Violation|14|||
33547118|NCT01064167|62938578|FG001|Overall Study|Protocol Violation|15|||
33547119|NCT02974543|62938586|FG000|Overall Study|Withdrawal by Subject|1|||
33547120|NCT02974543|62938587|FG001|Overall Study|Withdrawal by Subject|0|||
33547121|NCT01064947|62938601|FG000|Overall Study|negative culture|41|||
33547122|NCT02974153|62938612|FG000|Overall Study|Adverse Event|6|||
33547123|NCT02974153|62938613|FG001|Overall Study|Adverse Event|0|||
33547124|NCT02974153|62938614|FG002|Overall Study|Adverse Event|1|||
33547125|NCT02974153|62938612|FG000|Overall Study|Lack of Efficacy|6|||
33547126|NCT02974153|62938613|FG001|Overall Study|Lack of Efficacy|5|||
33547127|NCT02974153|62938614|FG002|Overall Study|Lack of Efficacy|10|||
33466902|NCT00086190|62840311|FG000|Overall Study|Adverse Event|6|||
33466903|NCT00086190|62840312|FG001|Overall Study|Adverse Event|2|||
33466904|NCT00086190|62840313|FG002|Overall Study|Adverse Event|2|||
33466905|NCT00086190|62840311|FG000|Overall Study|Withdrawal by Subject|0|||
33466906|NCT00086190|62840312|FG001|Overall Study|Withdrawal by Subject|2|||
33466907|NCT00086190|62840313|FG002|Overall Study|Withdrawal by Subject|2|||
33466908|NCT00086190|62840311|FG000|Overall Study|Protocol Violation|1|||
33466909|NCT00086190|62840312|FG001|Overall Study|Protocol Violation|0|||
33466910|NCT00086190|62840313|FG002|Overall Study|Protocol Violation|0|||
33466911|NCT00086190|62840311|FG000|Overall Study|Moved|1|||
33466912|NCT00086190|62840312|FG001|Overall Study|Moved|0|||
33466913|NCT00086190|62840313|FG002|Overall Study|Moved|0|||
33547128|NCT02974153|62938612|FG000|Overall Study|Lost to Follow-up|9|||
33547129|NCT02974153|62938613|FG001|Overall Study|Lost to Follow-up|10|||
33547130|NCT02974153|62938614|FG002|Overall Study|Lost to Follow-up|17|||
33547131|NCT02974153|62938612|FG000|Overall Study|Physician Decision|0|||
33547132|NCT02974153|62938613|FG001|Overall Study|Physician Decision|2|||
33547133|NCT02974153|62938614|FG002|Overall Study|Physician Decision|1|||
33547134|NCT02974153|62938612|FG000|Overall Study|Withdrawal by Subject|9|||
33547135|NCT02974153|62938613|FG001|Overall Study|Withdrawal by Subject|16|||
33547136|NCT02974153|62938614|FG002|Overall Study|Withdrawal by Subject|11|||
33547137|NCT02974153|62938612|FG000|Overall Study|Study Burden|8|||
33547138|NCT02974153|62938613|FG001|Overall Study|Study Burden|7|||
33547139|NCT02974153|62938614|FG002|Overall Study|Study Burden|3|||
33547140|NCT02974153|62938612|FG000|Overall Study|Other|14|||
33547141|NCT02974153|62938613|FG001|Overall Study|Other|8|||
33547142|NCT02974153|62938614|FG002|Overall Study|Other|7|||
33547143|NCT02508532|62938629|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33547144|NCT02508532|62938630|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33547145|NCT02508532|62938631|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33547146|NCT02508532|62938632|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33547147|NCT02508532|62938633|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33547148|NCT02508532|62938634|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33547149|NCT02508532|62938635|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
33547150|NCT02508532|62938636|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33547151|NCT02508532|62938637|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33547152|NCT02508532|62938629|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
33547153|NCT02508532|62938630|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
33547154|NCT02508532|62938631|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
33466914|NCT00086190|62840311|FG000|Overall Study|Worsening depression|0|||
33466915|NCT00086190|62840312|FG001|Overall Study|Worsening depression|0|||
33466916|NCT00086190|62840313|FG002|Overall Study|Worsening depression|2|||
33466917|NCT03320824|62840323|FG000|Overall Study|Withdrawal by Subject|8|||
33466918|NCT03320824|62840324|FG001|Overall Study|Withdrawal by Subject|1|||
33547155|NCT02508532|62938632|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
33547156|NCT02508532|62938633|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
33547157|NCT02508532|62938634|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
33547158|NCT02508532|62938635|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
33547159|NCT02508532|62938636|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
33466919|NCT03320824|62840323|FG000|Overall Study|Lost to Follow-up|10|||
33547160|NCT02508532|62938637|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
33547161|NCT02508532|62938629|FG000|Part 2 - Treatment|Disease Progression|0|||
33466920|NCT03320824|62840324|FG001|Overall Study|Lost to Follow-up|1|||
33466921|NCT03320824|62840323|FG000|Overall Study|moved out of state|0|||
33466922|NCT03320824|62840324|FG001|Overall Study|moved out of state|1|||
33466923|NCT03320824|62840323|FG000|Overall Study|could not complete final visit|0|||
33466924|NCT03320824|62840324|FG001|Overall Study|could not complete final visit|1|||
33466925|NCT03275350|62840336|FG000|Overall Study|Lost to Follow-up|4|||
33466926|NCT03275350|62840337|FG001|Overall Study|Lost to Follow-up|6|||
33466927|NCT03275350|62840336|FG000|Overall Study|Death|2|||
33466928|NCT03275350|62840337|FG001|Overall Study|Death|1|||
33466929|NCT03275350|62840336|FG000|Overall Study|Physician Decision|1|||
33466930|NCT03275350|62840337|FG001|Overall Study|Physician Decision|0|||
33466931|NCT03275350|62840336|FG000|Overall Study|Incarcerated|1|||
33466932|NCT03275350|62840337|FG001|Overall Study|Incarcerated|1|||
33466933|NCT03319732|62840344|FG000|Overall Study|Adverse Event|40|||
33466934|NCT03319732|62840344|FG000|Overall Study|Withdrawal by Subject|50|||
33466935|NCT03319732|62840344|FG000|Overall Study|MS relapse|10|||
33466936|NCT03319732|62840344|FG000|Overall Study|reason not specified|5|||
33466937|NCT03304522|62840351|FG000|Overall Study|Adverse Event|0|||
33466938|NCT03304522|62840352|FG001|Overall Study|Adverse Event|4|||
33466939|NCT03304522|62840351|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
33466940|NCT03304522|62840352|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
33466941|NCT03304522|62840351|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
33466942|NCT03304522|62840352|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
33466943|NCT03304522|62840351|FG000|Overall Study|Other|0|||
33466944|NCT03304522|62840352|FG001|Overall Study|Other|1|||
33466945|NCT03315286|62840360|FG000|Overall Study|Lost to Follow-up|0|||
33466946|NCT03315286|62840361|FG001|Overall Study|Lost to Follow-up|3|||
33466947|NCT03315286|62840360|FG000|Overall Study|Withdrawal by Subject|1|||
33466948|NCT03315286|62840361|FG001|Overall Study|Withdrawal by Subject|0|||
33466949|NCT03315286|62840360|FG000|Overall Study|Protocol Violation|0|||
33466950|NCT03315286|62840361|FG001|Overall Study|Protocol Violation|1|||
33466951|NCT03273946|62840367|FG000|Overall Study|Withdrawal by Subject|5|||
33466952|NCT03273946|62840367|FG000|Overall Study|Unwillingness of the guardian|1|||
33466953|NCT03273946|62840367|FG000|Overall Study|Participant refused to use the drug|2|||
33466954|NCT03273946|62840367|FG000|Overall Study|Participant relative refused to use drug|1|||
33547162|NCT02508532|62938630|FG001|Part 2 - Treatment|Disease Progression|0|||
33547163|NCT02508532|62938631|FG002|Part 2 - Treatment|Disease Progression|0|||
33547164|NCT02508532|62938632|FG003|Part 2 - Treatment|Disease Progression|0|||
33547165|NCT02508532|62938633|FG004|Part 2 - Treatment|Disease Progression|0|||
33547166|NCT02508532|62938634|FG005|Part 2 - Treatment|Disease Progression|0|||
33547167|NCT02508532|62938635|FG006|Part 2 - Treatment|Disease Progression|0|||
33547168|NCT02508532|62938636|FG007|Part 2 - Treatment|Disease Progression|0|||
33547169|NCT02508532|62938637|FG008|Part 2 - Treatment|Disease Progression|118|||
33547170|NCT02508532|62938629|FG000|Part 2 - Treatment|Adverse Event|0|||
33547171|NCT02508532|62938630|FG001|Part 2 - Treatment|Adverse Event|0|||
33547172|NCT02508532|62938631|FG002|Part 2 - Treatment|Adverse Event|0|||
33547173|NCT02508532|62938632|FG003|Part 2 - Treatment|Adverse Event|0|||
33547174|NCT02508532|62938633|FG004|Part 2 - Treatment|Adverse Event|0|||
33547175|NCT02508532|62938634|FG005|Part 2 - Treatment|Adverse Event|0|||
33547176|NCT02508532|62938635|FG006|Part 2 - Treatment|Adverse Event|0|||
33547177|NCT02508532|62938636|FG007|Part 2 - Treatment|Adverse Event|0|||
33547178|NCT02508532|62938637|FG008|Part 2 - Treatment|Adverse Event|49|||
33547179|NCT02508532|62938629|FG000|Part 2 - Treatment|Physician Decision|0|||
33547180|NCT02508532|62938630|FG001|Part 2 - Treatment|Physician Decision|0|||
33547181|NCT02508532|62938631|FG002|Part 2 - Treatment|Physician Decision|0|||
33547182|NCT02508532|62938632|FG003|Part 2 - Treatment|Physician Decision|0|||
33547183|NCT02508532|62938633|FG004|Part 2 - Treatment|Physician Decision|0|||
33547184|NCT02508532|62938634|FG005|Part 2 - Treatment|Physician Decision|0|||
33547185|NCT02508532|62938635|FG006|Part 2 - Treatment|Physician Decision|0|||
33547186|NCT02508532|62938636|FG007|Part 2 - Treatment|Physician Decision|0|||
33547187|NCT02508532|62938637|FG008|Part 2 - Treatment|Physician Decision|12|||
33547188|NCT02508532|62938629|FG000|Part 2 - Treatment|Administrative|0|||
33466955|NCT00314951|62840373|FG000|Treatment|Didn't meet criteria for mITT population|16|||
33466956|NCT00314951|62840374|FG001|Treatment|Didn't meet criteria for mITT population|11|||
33466957|NCT00314951|62840373|FG000|Follow-up|mITT failure|44|||
33466958|NCT00314951|62840374|FG001|Follow-up|mITT failure|34|||
33466959|NCT00085644|62840382|FG000|Double-Blind Period|Adverse Event|5|||
33466960|NCT00085644|62840383|FG001|Double-Blind Period|Adverse Event|2|||
33466961|NCT00085644|62840384|FG002|Double-Blind Period|Adverse Event|0|||
33466962|NCT00085644|62840382|FG000|Double-Blind Period|Withdrawal by Subject|3|||
33466963|NCT00085644|62840383|FG001|Double-Blind Period|Withdrawal by Subject|0|||
33466964|NCT00085644|62840384|FG002|Double-Blind Period|Withdrawal by Subject|0|||
33466965|NCT00085644|62840382|FG000|Double-Blind Period|Lost to Follow-up|2|||
33466966|NCT00085644|62840383|FG001|Double-Blind Period|Lost to Follow-up|1|||
33466967|NCT00085644|62840384|FG002|Double-Blind Period|Lost to Follow-up|0|||
33466968|NCT00085644|62840382|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
33466969|NCT00085644|62840383|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
33466970|NCT00085644|62840384|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
33466971|NCT00085644|62840382|FG000|Double-Blind Period|Contemplating pregnancy|1|||
33466972|NCT00085644|62840383|FG001|Double-Blind Period|Contemplating pregnancy|0|||
33466973|NCT00085644|62840384|FG002|Double-Blind Period|Contemplating pregnancy|0|||
33466974|NCT00085644|62840382|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
33466975|NCT00085644|62840383|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
33466976|NCT00085644|62840384|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
33466977|NCT00085644|62840382|FG000|Open-Label Period|Adverse Event|0|||
33466978|NCT00085644|62840383|FG001|Open-Label Period|Adverse Event|0|||
33466979|NCT00085644|62840384|FG002|Open-Label Period|Adverse Event|38|||
33466980|NCT00085644|62840382|FG000|Open-Label Period|Withdrawal by Subject|0|||
33466981|NCT00085644|62840383|FG001|Open-Label Period|Withdrawal by Subject|0|||
33466982|NCT00085644|62840384|FG002|Open-Label Period|Withdrawal by Subject|29|||
33466983|NCT00085644|62840382|FG000|Open-Label Period|Lost to Follow-up|0|||
33466984|NCT00085644|62840383|FG001|Open-Label Period|Lost to Follow-up|0|||
33466985|NCT00085644|62840384|FG002|Open-Label Period|Lost to Follow-up|13|||
33466986|NCT00085644|62840382|FG000|Open-Label Period|Lack of Efficacy|0|||
33466987|NCT00085644|62840383|FG001|Open-Label Period|Lack of Efficacy|0|||
33466988|NCT00085644|62840384|FG002|Open-Label Period|Lack of Efficacy|15|||
33466989|NCT00085644|62840382|FG000|Open-Label Period|Pregnancy|0|||
33466990|NCT00085644|62840383|FG001|Open-Label Period|Pregnancy|0|||
33466991|NCT00085644|62840384|FG002|Open-Label Period|Pregnancy|3|||
33466992|NCT00085644|62840382|FG000|Open-Label Period|Contemplating pregnancy|0|||
33466993|NCT00085644|62840383|FG001|Open-Label Period|Contemplating pregnancy|0|||
33466994|NCT00085644|62840384|FG002|Open-Label Period|Contemplating pregnancy|3|||
33466995|NCT00085644|62840382|FG000|Open-Label Period|Protocol Violation|0|||
33466996|NCT00085644|62840383|FG001|Open-Label Period|Protocol Violation|0|||
33466997|NCT00085644|62840384|FG002|Open-Label Period|Protocol Violation|4|||
33466998|NCT00085644|62840382|FG000|Open-Label Period|Personal reason|0|||
33466999|NCT00085644|62840383|FG001|Open-Label Period|Personal reason|0|||
33467000|NCT00085644|62840384|FG002|Open-Label Period|Personal reason|4|||
33467001|NCT03315208|62840393|FG000|Overall Study|Lost to Follow-up|11|||
33467002|NCT03315208|62840394|FG001|Overall Study|Lost to Follow-up|6|||
33467003|NCT03315208|62840393|FG000|Overall Study|Withdrawal by Subject|2|||
33467004|NCT03315208|62840394|FG001|Overall Study|Withdrawal by Subject|0|||
33467005|NCT00314795|62840401|FG000|Overall Study|Adverse Event|8|||
33467006|NCT00314795|62840401|FG000|Overall Study|Death|4|||
33467007|NCT00314795|62840401|FG000|Overall Study|Reason not Specified|3|||
33467008|NCT00314795|62840401|FG000|Overall Study|Renal Transplant|3|||
33467009|NCT00314795|62840401|FG000|Overall Study|Participants Withdrew Consent|2|||
33467010|NCT00314327|62840405|FG000|Overall Study|Withdrawal by Subject|1|||
33467011|NCT00336479|62840413|FG000|Overall Study|Adverse Event|8|||
33467012|NCT00336479|62840414|FG001|Overall Study|Adverse Event|11|||
33467013|NCT00336479|62840415|FG002|Overall Study|Adverse Event|18|||
33467014|NCT00336479|62840416|FG003|Overall Study|Adverse Event|4|||
33467015|NCT00336479|62840413|FG000|Overall Study|Noncompliant|1|||
33467016|NCT00336479|62840414|FG001|Overall Study|Noncompliant|7|||
33467017|NCT00336479|62840415|FG002|Overall Study|Noncompliant|3|||
33467018|NCT00336479|62840416|FG003|Overall Study|Noncompliant|0|||
33467019|NCT00336479|62840413|FG000|Overall Study|Physician Decision|2|||
33467020|NCT00336479|62840414|FG001|Overall Study|Physician Decision|3|||
33547189|NCT02508532|62938630|FG001|Part 2 - Treatment|Administrative|0|||
33652870|NCT01692301|63064962|FG001|Overall Study|Non-compliance with study treatment|2|||
33652871|NCT01692301|63064961|FG000|Overall Study|Protocol deviation|9|||
33467021|NCT00336479|62840415|FG002|Overall Study|Physician Decision|1|||
33467022|NCT00336479|62840416|FG003|Overall Study|Physician Decision|0|||
33652872|NCT01692301|63064962|FG001|Overall Study|Protocol deviation|2|||
33652873|NCT01692301|63064961|FG000|Overall Study|Patient/guardian decision|16|||
33652874|NCT01692301|63064962|FG001|Overall Study|Patient/guardian decision|15|||
33467023|NCT00336479|62840413|FG000|Overall Study|Lost to Follow-up|3|||
33467024|NCT00336479|62840414|FG001|Overall Study|Lost to Follow-up|2|||
33467025|NCT00336479|62840415|FG002|Overall Study|Lost to Follow-up|0|||
33467026|NCT00336479|62840416|FG003|Overall Study|Lost to Follow-up|0|||
33547190|NCT02508532|62938631|FG002|Part 2 - Treatment|Administrative|0|||
33467027|NCT00336479|62840413|FG000|Overall Study|Withdrawal by Subject|3|||
33467028|NCT00336479|62840414|FG001|Overall Study|Withdrawal by Subject|2|||
33467029|NCT00336479|62840415|FG002|Overall Study|Withdrawal by Subject|3|||
33467030|NCT00336479|62840416|FG003|Overall Study|Withdrawal by Subject|0|||
33467031|NCT00336479|62840413|FG000|Overall Study|Other|0|||
33467032|NCT00336479|62840414|FG001|Overall Study|Other|0|||
33467033|NCT00336479|62840415|FG002|Overall Study|Other|1|||
33467034|NCT00336479|62840416|FG003|Overall Study|Other|0|||
33467035|NCT00336479|62840413|FG000|Overall Study|Virologic Stopping Rule|20|||
33467036|NCT00336479|62840414|FG001|Overall Study|Virologic Stopping Rule|0|||
33467037|NCT00336479|62840415|FG002|Overall Study|Virologic Stopping Rule|0|||
33652875|NCT01692301|63064961|FG000|Overall Study|Technical problems|0|||
33652876|NCT01692301|63064962|FG001|Overall Study|Technical problems|1|||
33652877|NCT01692301|63064961|FG000|Overall Study|Physician Decision|2|||
33652878|NCT01692301|63064962|FG001|Overall Study|Physician Decision|2|||
33652879|NCT01692301|63064961|FG000|Overall Study|Lost to Follow-up|1|||
33467038|NCT00336479|62840416|FG003|Overall Study|Virologic Stopping Rule|0|||
33467039|NCT00314249|62840429|FG000|Overall Study|Adverse Event|73|||
33467040|NCT00314249|62840430|FG001|Overall Study|Adverse Event|94|||
33467041|NCT00314249|62840429|FG000|Overall Study|Lack of Efficacy|33|||
33467042|NCT00314249|62840430|FG001|Overall Study|Lack of Efficacy|24|||
33467043|NCT00314249|62840429|FG000|Overall Study|Withdrawal by Subject|21|||
33467044|NCT00314249|62840430|FG001|Overall Study|Withdrawal by Subject|28|||
33467045|NCT00314249|62840429|FG000|Overall Study|Lost to Follow-up|15|||
33467046|NCT00314249|62840430|FG001|Overall Study|Lost to Follow-up|9|||
33467047|NCT00314249|62840429|FG000|Overall Study|Physician Decision|1|||
33467048|NCT00314249|62840430|FG001|Overall Study|Physician Decision|1|||
33467049|NCT00314249|62840429|FG000|Overall Study|Withdrawn for other reasons|4|||
33467050|NCT00314249|62840430|FG001|Overall Study|Withdrawn for other reasons|1|||
33467051|NCT00314249|62840429|FG000|Overall Study|Non-Compliant|5|||
33467052|NCT00314249|62840430|FG001|Overall Study|Non-Compliant|6|||
33467053|NCT03315130|62840439|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
33467054|NCT03315130|62840440|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
33467055|NCT03315130|62840441|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
33467056|NCT03315130|62840442|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
33467057|NCT03315130|62840439|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
33467058|NCT03315130|62840440|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
33467059|NCT03315130|62840441|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
33467060|NCT03315130|62840442|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
33467061|NCT03315130|62840439|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
33467062|NCT03315130|62840440|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
33467063|NCT03315130|62840441|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
33467064|NCT03315130|62840442|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
33467065|NCT03315130|62840439|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
33467066|NCT03315130|62840440|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
33467067|NCT03315130|62840441|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
33467068|NCT03315130|62840442|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
33467069|NCT03315130|62840439|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
33467070|NCT03315130|62840440|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
33467071|NCT03315130|62840441|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
33467072|NCT03315130|62840442|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
33467073|NCT03315130|62840439|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
33467074|NCT03315130|62840440|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
33467075|NCT03315130|62840441|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
33467076|NCT03315130|62840442|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
33467077|NCT03273166|62840462|FG000|Overall Study|Withdrawn prior to Completion|31|||
33467078|NCT03314662|62840470|FG000|Overall Study|Withdrawal by Subject|1|||
33467079|NCT03314662|62840471|FG001|Overall Study|Withdrawal by Subject|1|||
33467080|NCT03314662|62840472|FG002|Overall Study|Withdrawal by Subject|1|||
33467081|NCT03314662|62840470|FG000|Overall Study|Lost to Follow-up|5|||
33467082|NCT03314662|62840471|FG001|Overall Study|Lost to Follow-up|4|||
33467083|NCT03314662|62840472|FG002|Overall Study|Lost to Follow-up|4|||
33467084|NCT03314662|62840470|FG000|Overall Study|Death|2|||
33467085|NCT03314662|62840471|FG001|Overall Study|Death|0|||
33467086|NCT03314662|62840472|FG002|Overall Study|Death|0|||
33467087|NCT03271528|62840490|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
33467088|NCT03271528|62840491|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
33467089|NCT03271528|62840490|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
33467090|NCT03271528|62840491|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
33652880|NCT01692301|63064962|FG001|Overall Study|Lost to Follow-up|1|||
33652881|NCT01592773|63064968|FG000|Overall Study|Study Terminated by Sponsor|582|||
33467091|NCT03271528|62840490|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
33467092|NCT03271528|62840491|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
33467093|NCT03271528|62840490|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
33652882|NCT01592773|63064968|FG000|Overall Study|Withdrawal by Subject|35|||
33652883|NCT01592773|63064968|FG000|Overall Study|Lost to Follow-up|19|||
33652884|NCT01592773|63064968|FG000|Overall Study|Adverse Event|17|||
33547191|NCT02508532|62938632|FG003|Part 2 - Treatment|Administrative|0|||
33547192|NCT02508532|62938633|FG004|Part 2 - Treatment|Administrative|0|||
33547193|NCT02508532|62938634|FG005|Part 2 - Treatment|Administrative|0|||
33547194|NCT02508532|62938635|FG006|Part 2 - Treatment|Administrative|0|||
33652885|NCT01592773|63064968|FG000|Overall Study|Lack of Efficacy|9|||
33652886|NCT01592773|63064968|FG000|Overall Study|Protocol Violation|2|||
33652887|NCT01592773|63064968|FG000|Overall Study|Inclusion/exclusion not meet|1|||
33328827|NCT01192100|62705260|FG002|Overall Study|Withdrawal by Subject|0|||
33328828|NCT01192100|62705261|FG003|Overall Study|Withdrawal by Subject|0|||
33328829|NCT01192100|62705262|FG004|Overall Study|Withdrawal by Subject|1|||
33328830|NCT01192100|62705263|FG005|Overall Study|Withdrawal by Subject|0|||
33328831|NCT01192100|62705258|FG000|Overall Study|Protocol Violation|0|||
33328832|NCT01192100|62705259|FG001|Overall Study|Protocol Violation|0|||
33328833|NCT01192100|62705260|FG002|Overall Study|Protocol Violation|0|||
33328834|NCT01192100|62705261|FG003|Overall Study|Protocol Violation|1|||
33328835|NCT01192100|62705262|FG004|Overall Study|Protocol Violation|0|||
33328836|NCT01192100|62705263|FG005|Overall Study|Protocol Violation|0|||
33328837|NCT00869401|62705276|FG000|Overall Study|Withdrawal by Subject|0|||
33328838|NCT00869401|62705277|FG001|Overall Study|Withdrawal by Subject|0|||
33328839|NCT00869401|62705278|FG002|Overall Study|Withdrawal by Subject|0|||
33328840|NCT00869401|62705279|FG003|Overall Study|Withdrawal by Subject|5|||
33328841|NCT00869401|62705280|FG004|Overall Study|Withdrawal by Subject|3|||
33328842|NCT01076010|62705295|FG000|Overall Study|Death|15|||
33328843|NCT01076010|62705296|FG001|Overall Study|Death|1|||
33328844|NCT01076010|62705297|FG002|Overall Study|Death|0|||
33328845|NCT01076010|62705295|FG000|Overall Study|Adverse Event|7|||
33328846|NCT01076010|62705296|FG001|Overall Study|Adverse Event|2|||
33328847|NCT01076010|62705297|FG002|Overall Study|Adverse Event|0|||
33328848|NCT01076010|62705295|FG000|Overall Study|Progressive disease|90|||
33328849|NCT01076010|62705296|FG001|Overall Study|Progressive disease|30|||
33328850|NCT01076010|62705297|FG002|Overall Study|Progressive disease|1|||
33328851|NCT01076010|62705295|FG000|Overall Study|Lack of Efficacy|4|||
33328852|NCT01076010|62705296|FG001|Overall Study|Lack of Efficacy|0|||
33328853|NCT01076010|62705297|FG002|Overall Study|Lack of Efficacy|0|||
33328854|NCT01076010|62705295|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
33328855|NCT01076010|62705296|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
33328856|NCT01076010|62705297|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
33328857|NCT01076010|62705295|FG000|Overall Study|Significant Surgical Procedure|0|||
33328858|NCT01076010|62705296|FG001|Overall Study|Significant Surgical Procedure|1|||
33328859|NCT01076010|62705297|FG002|Overall Study|Significant Surgical Procedure|0|||
33328860|NCT01076010|62705295|FG000|Overall Study|Protocol Violation|0|||
33328861|NCT01076010|62705296|FG001|Overall Study|Protocol Violation|1|||
33328862|NCT01076010|62705297|FG002|Overall Study|Protocol Violation|0|||
33328863|NCT01076010|62705295|FG000|Overall Study|Noncompliance|1|||
33328864|NCT01076010|62705296|FG001|Overall Study|Noncompliance|1|||
33328865|NCT01076010|62705297|FG002|Overall Study|Noncompliance|0|||
33328866|NCT01076010|62705295|FG000|Overall Study|Withdrawal by Subject|3|||
33328867|NCT01076010|62705296|FG001|Overall Study|Withdrawal by Subject|0|||
33328868|NCT01076010|62705297|FG002|Overall Study|Withdrawal by Subject|1|||
33328869|NCT01076010|62705295|FG000|Overall Study|Other|5|||
33328870|NCT01076010|62705296|FG001|Overall Study|Other|2|||
33328871|NCT01076010|62705297|FG002|Overall Study|Other|0|||
33328872|NCT01075152|62705307|FG000|Overall Study|Withdrawal by Subject|1|||
33328873|NCT01075152|62705308|FG001|Overall Study|Withdrawal by Subject|0|||
33328874|NCT01078116|62705316|FG000|Overall Study|Lost to Follow-up|17|||
33328875|NCT01078116|62705316|FG000|Overall Study|Adverse Event|5|||
33328876|NCT01078116|62705316|FG000|Overall Study|Withdrawal by Subject|8|||
33328877|NCT01078116|62705316|FG000|Overall Study|Lack of effectiveness|15|||
33328878|NCT01078116|62705316|FG000|Overall Study|Case report form not completed|3|||
33328879|NCT00950859|62705322|FG000|Overall Study|Adverse Event|3|||
33652888|NCT01592773|63064968|FG000|Overall Study|Other Reason|1|||
33328880|NCT00950859|62705323|FG001|Overall Study|Adverse Event|3|||
33328881|NCT00950859|62705322|FG000|Overall Study|Insufficient Viral Load Response|12|||
33328882|NCT00950859|62705323|FG001|Overall Study|Insufficient Viral Load Response|3|||
33328883|NCT00950859|62705322|FG000|Overall Study|Protocol Violation|1|||
33328884|NCT00950859|62705323|FG001|Overall Study|Protocol Violation|1|||
33328885|NCT00950859|62705322|FG000|Overall Study|Lost to Follow-up|0|||
33328886|NCT00950859|62705323|FG001|Overall Study|Lost to Follow-up|3|||
33328887|NCT00862849|62705329|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
33328888|NCT00862849|62705330|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
33328889|NCT00862849|62705331|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
33328890|NCT00862849|62705332|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
33328891|NCT00862849|62705333|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
33328892|NCT00862849|62705334|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
33328893|NCT00862849|62705329|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
33328894|NCT00862849|62705330|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
33328895|NCT00862849|62705331|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
33467094|NCT03271528|62840491|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
33467095|NCT03271528|62840490|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
33467096|NCT03271528|62840491|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
33467097|NCT03271528|62840490|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
33467098|NCT03271528|62840491|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
33467099|NCT03271528|62840490|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
33467100|NCT03271528|62840491|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
33467101|NCT03301714|62840500|FG000|Overall Study|Lost to Follow-up|10|||
33467102|NCT03301714|62840501|FG001|Overall Study|Lost to Follow-up|4|||
33467103|NCT03301714|62840502|FG002|Overall Study|Lost to Follow-up|4|||
33467104|NCT03301714|62840500|FG000|Overall Study|Did not receive allocated intervention|0|||
33467105|NCT03301714|62840501|FG001|Overall Study|Did not receive allocated intervention|2|||
33467106|NCT03301714|62840502|FG002|Overall Study|Did not receive allocated intervention|3|||
33467107|NCT03299686|62840515|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
33467108|NCT03299686|62840516|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
33467109|NCT03299686|62840515|FG000|Treatment Epoch|Physician Decision|1|||
33467110|NCT03299686|62840516|FG001|Treatment Epoch|Physician Decision|0|||
33467111|NCT03299686|62840515|FG000|Treatment Epoch|Adverse Event|8|||
33467112|NCT03299686|62840516|FG001|Treatment Epoch|Adverse Event|4|||
33547195|NCT02508532|62938636|FG007|Part 2 - Treatment|Administrative|0|||
33547196|NCT02508532|62938637|FG008|Part 2 - Treatment|Administrative|3|||
33547197|NCT02508532|62938629|FG000|Part 2 - Treatment|Sponsor Decision|0|||
33547198|NCT02508532|62938630|FG001|Part 2 - Treatment|Sponsor Decision|0|||
33547199|NCT02508532|62938631|FG002|Part 2 - Treatment|Sponsor Decision|0|||
33547200|NCT02508532|62938632|FG003|Part 2 - Treatment|Sponsor Decision|0|||
33547201|NCT02508532|62938633|FG004|Part 2 - Treatment|Sponsor Decision|0|||
33547202|NCT02508532|62938634|FG005|Part 2 - Treatment|Sponsor Decision|0|||
33547203|NCT02508532|62938635|FG006|Part 2 - Treatment|Sponsor Decision|0|||
33547204|NCT02508532|62938636|FG007|Part 2 - Treatment|Sponsor Decision|0|||
33547205|NCT02508532|62938637|FG008|Part 2 - Treatment|Sponsor Decision|28|||
33547206|NCT02508532|62938629|FG000|Part 2 - Treatment|Death|0|||
33547207|NCT02508532|62938630|FG001|Part 2 - Treatment|Death|0|||
33547208|NCT02508532|62938631|FG002|Part 2 - Treatment|Death|0|||
33547209|NCT02508532|62938632|FG003|Part 2 - Treatment|Death|0|||
33547210|NCT02508532|62938633|FG004|Part 2 - Treatment|Death|0|||
33547211|NCT02508532|62938634|FG005|Part 2 - Treatment|Death|0|||
33547212|NCT02508532|62938635|FG006|Part 2 - Treatment|Death|0|||
33547213|NCT02508532|62938636|FG007|Part 2 - Treatment|Death|0|||
33547214|NCT02508532|62938637|FG008|Part 2 - Treatment|Death|1|||
33547215|NCT02508532|62938629|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
33547216|NCT02508532|62938630|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
33547217|NCT02508532|62938631|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
33547218|NCT02508532|62938632|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
33547219|NCT02508532|62938633|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
33547220|NCT02508532|62938634|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
33467113|NCT03299686|62840515|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
33467114|NCT03299686|62840516|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
33467115|NCT03462758|62840524|FG000|Overall Study|Chose no or other method of contraception|20|||
33467116|NCT03462758|62840525|FG001|Overall Study|Chose no or other method of contraception|23|||
33467117|NCT03462758|62840524|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
33467118|NCT03462758|62840525|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
33467119|NCT03462758|62840524|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
33467120|NCT03462758|62840525|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
33467121|NCT03462758|62840524|FG000|Overall Study|Medical contraindication|2|||
33467122|NCT03462758|62840525|FG001|Overall Study|Medical contraindication|2|||
33547221|NCT02508532|62938635|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
33467123|NCT03462758|62840524|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
33467124|NCT03462758|62840525|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
33467125|NCT00075270|62840533|FG000|Overall Study|Withdrawal by Subject|28|||
33467126|NCT00075270|62840534|FG001|Overall Study|Withdrawal by Subject|21|||
33467127|NCT00075270|62840533|FG000|Overall Study|Lost to Follow-up|25|||
33467128|NCT00075270|62840534|FG001|Overall Study|Lost to Follow-up|28|||
33467129|NCT00075270|62840533|FG000|Overall Study|Protocol Violation|0|||
33547222|NCT02508532|62938636|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
33547223|NCT02508532|62938637|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
33547224|NCT02508532|62938629|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
33547225|NCT02508532|62938630|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
33547226|NCT02508532|62938631|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
33547227|NCT02508532|62938632|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
33547228|NCT02508532|62938633|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
33547229|NCT02508532|62938634|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
33547230|NCT02508532|62938635|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
33547231|NCT02508532|62938636|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
33547232|NCT02508532|62938637|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
33547233|NCT02508532|62938629|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
33547234|NCT02508532|62938630|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
33547235|NCT02508532|62938631|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
33547236|NCT02508532|62938632|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
33547237|NCT02508532|62938633|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
33547238|NCT02508532|62938634|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
33547239|NCT02508532|62938635|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
33547240|NCT02508532|62938636|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
33547241|NCT02508532|62938637|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
33547242|NCT02508532|62938629|FG000|Part 1 and Part 2 End of Study|Death|0|||
33547243|NCT02508532|62938630|FG001|Part 1 and Part 2 End of Study|Death|4|||
33547244|NCT02508532|62938631|FG002|Part 1 and Part 2 End of Study|Death|2|||
33547245|NCT02508532|62938632|FG003|Part 1 and Part 2 End of Study|Death|4|||
33547246|NCT02508532|62938633|FG004|Part 1 and Part 2 End of Study|Death|3|||
33547247|NCT02508532|62938634|FG005|Part 1 and Part 2 End of Study|Death|0|||
33547248|NCT02508532|62938635|FG006|Part 1 and Part 2 End of Study|Death|0|||
33547249|NCT02508532|62938636|FG007|Part 1 and Part 2 End of Study|Death|1|||
33547250|NCT02508532|62938637|FG008|Part 1 and Part 2 End of Study|Death|111|||
33547251|NCT02508532|62938629|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
33547252|NCT02508532|62938630|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
33547253|NCT02508532|62938631|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
33547254|NCT02508532|62938632|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
33547255|NCT02508532|62938633|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
33547256|NCT02508532|62938634|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
33547257|NCT02508532|62938635|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
33547258|NCT02508532|62938636|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
33547259|NCT02508532|62938637|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
33547260|NCT02508532|62938629|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33547261|NCT02508532|62938630|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33547262|NCT02508532|62938631|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33467130|NCT00075270|62840534|FG001|Overall Study|Protocol Violation|2|||
33467131|NCT00075270|62840533|FG000|Overall Study|Death|198|||
33467132|NCT00075270|62840534|FG001|Overall Study|Death|215|||
33547263|NCT02508532|62938632|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33547264|NCT02508532|62938633|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33547265|NCT02508532|62938634|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33547266|NCT02508532|62938635|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33547267|NCT02508532|62938636|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33547268|NCT02508532|62938637|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
33652889|NCT01930175|63064975|FG000|Core Study|Lost to Follow-up|0|||
33652890|NCT01930175|63064976|FG001|Core Study|Lost to Follow-up|1|||
33652891|NCT01930175|63064977|FG002|Core Study|Lost to Follow-up|0|||
33652892|NCT01930175|63064975|FG000|Core Study|Adverse Event|0|||
33652893|NCT01930175|63064976|FG001|Core Study|Adverse Event|0|||
33652894|NCT01930175|63064977|FG002|Core Study|Adverse Event|1|||
33652895|NCT01592695|63064988|FG000|Overall Study|Lost to Follow-up|8|||
33652896|NCT01592695|63064989|FG001|Overall Study|Lost to Follow-up|4|||
33652897|NCT01929863|63064995|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
33652898|NCT01929863|63064996|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
33652899|NCT01929863|63064995|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
33652900|NCT01929863|63064996|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
33652901|NCT01929863|63064995|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
33652902|NCT01929863|63064996|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
33652903|NCT01918085|63065009|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
33652904|NCT01918085|63065010|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
33652905|NCT01714687|63065020|FG000|Overall Study|Withdrawal by Subject|1|||
33652906|NCT01714687|63065021|FG001|Overall Study|Withdrawal by Subject|0|||
33652907|NCT01714687|63065020|FG000|Overall Study|Lost to Follow-up|2|||
33652908|NCT01714687|63065021|FG001|Overall Study|Lost to Follow-up|4|||
33652909|NCT01714609|63065031|FG000|Overall Study|Protocol Violation|1|||
33652910|NCT01714609|63065032|FG001|Overall Study|Protocol Violation|0|||
33652911|NCT01929707|63065038|FG000|Intervention Period 1|Lost to Follow-up|0|||
33652912|NCT01929707|63065039|FG001|Intervention Period 1|Lost to Follow-up|0|||
33652913|NCT01929707|63065040|FG002|Intervention Period 1|Lost to Follow-up|0|||
33652914|NCT01929707|63065041|FG003|Intervention Period 1|Lost to Follow-up|1|||
33652915|NCT01929707|63065042|FG004|Intervention Period 1|Lost to Follow-up|0|||
33547269|NCT02508532|62938629|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
33547270|NCT02508532|62938630|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
33547271|NCT02508532|62938631|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
33547272|NCT02508532|62938632|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
33547273|NCT02508532|62938633|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
33547274|NCT02508532|62938634|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
33547275|NCT02508532|62938635|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
33547276|NCT02508532|62938636|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
33547277|NCT02508532|62938637|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
33547278|NCT02508532|62938629|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33652916|NCT01929707|63065043|FG005|Intervention Period 1|Lost to Follow-up|0|||
33652917|NCT01929707|63065044|FG006|Intervention Period 1|Lost to Follow-up|0|||
33652918|NCT01929707|63065045|FG007|Intervention Period 1|Lost to Follow-up|0|||
33652919|NCT01929707|63065038|FG000|Intervention Period 1|Withdrawal by Subject|0|||
33652920|NCT01929707|63065039|FG001|Intervention Period 1|Withdrawal by Subject|0|||
33328896|NCT00862849|62705332|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
33328897|NCT00862849|62705333|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
33328898|NCT00862849|62705334|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
33467133|NCT00075270|62840533|FG000|Overall Study|Other/Unknown|9|||
33467134|NCT00075270|62840534|FG001|Overall Study|Other/Unknown|5|||
33467135|NCT00075270|62840533|FG000|Overall Study|Missing|26|||
33467136|NCT00075270|62840534|FG001|Overall Study|Missing|13|||
33467137|NCT00074958|62840541|FG000|Overall Study|Adverse Event|1|||
33467138|NCT03298984|62840549|FG000|Overall Study|Physician Decision|1|||
33467139|NCT03298984|62840550|FG001|Overall Study|Physician Decision|0|||
33467140|NCT03298984|62840551|FG002|Overall Study|Physician Decision|0|||
33467141|NCT03298984|62840552|FG003|Overall Study|Physician Decision|6|||
33467142|NCT03298984|62840549|FG000|Overall Study|Lack of Efficacy|0|||
33467143|NCT03298984|62840550|FG001|Overall Study|Lack of Efficacy|1|||
33467144|NCT03298984|62840551|FG002|Overall Study|Lack of Efficacy|1|||
33467145|NCT03298984|62840552|FG003|Overall Study|Lack of Efficacy|4|||
33467146|NCT03298984|62840549|FG000|Overall Study|Relapsed disease (following remission)|0|||
33467147|NCT03298984|62840550|FG001|Overall Study|Relapsed disease (following remission)|0|||
33467148|NCT03298984|62840551|FG002|Overall Study|Relapsed disease (following remission)|1|||
33467149|NCT03298984|62840552|FG003|Overall Study|Relapsed disease (following remission)|1|||
33652921|NCT01929707|63065040|FG002|Intervention Period 1|Withdrawal by Subject|0|||
33547279|NCT02508532|62938630|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33547280|NCT02508532|62938631|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33547281|NCT02508532|62938632|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33547282|NCT02508532|62938633|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33547283|NCT02508532|62938634|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33547284|NCT02508532|62938635|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33547285|NCT02508532|62938636|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33547286|NCT02508532|62938637|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
33547287|NCT02508532|62938629|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
33547288|NCT02508532|62938630|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
33547289|NCT02508532|62938631|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
33547290|NCT02508532|62938632|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
33547291|NCT02508532|62938633|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
33547292|NCT02508532|62938634|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
33547293|NCT02508532|62938635|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
33547294|NCT02508532|62938636|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
33547295|NCT02508532|62938637|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
33547296|NCT02918071|62938666|FG000|Overall Study|Withdrawal by Subject|2|||
33547297|NCT02918071|62938666|FG000|Overall Study|Lost to Follow-up|1|||
33547298|NCT02507752|62938670|FG000|Overall Study|Adverse Event|1|||
33547299|NCT02507752|62938670|FG000|Overall Study|Protocol Violation|6|||
33547300|NCT02507752|62938670|FG000|Overall Study|Lost to Follow-up|7|||
33547301|NCT02507752|62938670|FG000|Overall Study|Infusion reaction at first infusion|1|||
33547302|NCT02507752|62938670|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
33547303|NCT02507752|62938670|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
33547304|NCT02506816|62938674|FG000|Overall Study|Adverse Event|3|||
33547305|NCT02506036|62938680|FG000|First Intervention (4-6 Weeks)|Death|1|||
33547306|NCT02506036|62938681|FG001|First Intervention (4-6 Weeks)|Death|0|||
33547307|NCT02506036|62938680|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
33547308|NCT02506036|62938681|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
33547309|NCT02506036|62938680|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
33547310|NCT02506036|62938681|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
33547311|NCT01063855|62938689|FG000|Overall Study|Adverse Event|4|||
33547312|NCT01063855|62938690|FG001|Overall Study|Adverse Event|4|||
33547313|NCT01063855|62938689|FG000|Overall Study|Death|0|||
33547314|NCT01063855|62938690|FG001|Overall Study|Death|1|||
33547315|NCT01063855|62938689|FG000|Overall Study|Lost to Follow-up|8|||
33547316|NCT01063855|62938690|FG001|Overall Study|Lost to Follow-up|4|||
33547317|NCT01063855|62938689|FG000|Overall Study|Pregnancy|1|||
33547318|NCT01063855|62938690|FG001|Overall Study|Pregnancy|0|||
33547319|NCT01063855|62938689|FG000|Overall Study|Lack of Efficacy|0|||
33547320|NCT01063855|62938690|FG001|Overall Study|Lack of Efficacy|1|||
33547321|NCT01063855|62938689|FG000|Overall Study|Withdrawal by Subject|11|||
33547322|NCT01063855|62938690|FG001|Overall Study|Withdrawal by Subject|8|||
33547323|NCT01063855|62938689|FG000|Overall Study|Reason not specified|13|||
33547324|NCT01063855|62938690|FG001|Overall Study|Reason not specified|11|||
33547325|NCT01063153|62938702|FG000|Overall Study|Found Ineligible During Screening|2|||
33652922|NCT01929707|63065041|FG003|Intervention Period 1|Withdrawal by Subject|2|||
33652923|NCT01929707|63065042|FG004|Intervention Period 1|Withdrawal by Subject|0|||
33652924|NCT01929707|63065043|FG005|Intervention Period 1|Withdrawal by Subject|0|||
33652925|NCT01929707|63065044|FG006|Intervention Period 1|Withdrawal by Subject|0|||
33652926|NCT01929707|63065045|FG007|Intervention Period 1|Withdrawal by Subject|0|||
33652927|NCT01929707|63065038|FG000|Intervention Period 2|Withdrawal by Subject|0|||
33652928|NCT01929707|63065039|FG001|Intervention Period 2|Withdrawal by Subject|0|||
33328899|NCT01090050|62705344|FG000|Overall Study|Lost to Follow-up|0|||
33328900|NCT01090050|62705345|FG001|Overall Study|Lost to Follow-up|1|||
33328901|NCT01090050|62705344|FG000|Overall Study|Lack of Efficacy|1|||
33328902|NCT01090050|62705345|FG001|Overall Study|Lack of Efficacy|5|||
33328903|NCT01090050|62705344|FG000|Overall Study|Physician Decision|0|||
33328904|NCT01090050|62705345|FG001|Overall Study|Physician Decision|1|||
33328905|NCT00944229|62705355|FG000|Overall Study|Withdrawal by Subject|11|||
33328906|NCT00944229|62705355|FG000|Overall Study|Physician Decision|14|||
33328907|NCT01077960|62705359|FG000|Overall Study|Adverse Event|6|||
33328908|NCT01077960|62705359|FG000|Overall Study|Protocol Violation|3|||
33328909|NCT01077960|62705359|FG000|Overall Study|Lost to Follow-up|5|||
33328910|NCT01077960|62705359|FG000|Overall Study|Subject decision|1|||
33328911|NCT01077960|62705359|FG000|Overall Study|Reason unspecified|1|||
33328912|NCT00944697|62705365|FG000|Overall Study|Withdrawal by Subject|1|||
33328913|NCT00944697|62705366|FG001|Overall Study|Withdrawal by Subject|1|||
33328914|NCT00944697|62705365|FG000|Overall Study|Adverse Event|0|||
33328915|NCT00944697|62705366|FG001|Overall Study|Adverse Event|3|||
33328916|NCT00944697|62705365|FG000|Overall Study|Administrative|1|||
33652929|NCT01929707|63065040|FG002|Intervention Period 2|Withdrawal by Subject|0|||
33547326|NCT01063153|62938703|FG001|Overall Study|Found Ineligible During Screening|0|||
33547327|NCT01063153|62938702|FG000|Overall Study|Lost to Follow-up|0|||
33547328|NCT01063153|62938703|FG001|Overall Study|Lost to Follow-up|7|||
33547329|NCT01063153|62938702|FG000|Overall Study|Withdrawal by Subject|0|||
33652930|NCT01929707|63065041|FG003|Intervention Period 2|Withdrawal by Subject|0|||
33652931|NCT01929707|63065042|FG004|Intervention Period 2|Withdrawal by Subject|0|||
33652932|NCT01929707|63065043|FG005|Intervention Period 2|Withdrawal by Subject|2|||
33652933|NCT01929707|63065044|FG006|Intervention Period 2|Withdrawal by Subject|0|||
33652934|NCT01929707|63065045|FG007|Intervention Period 2|Withdrawal by Subject|0|||
33652935|NCT01714063|63065066|FG000|Overall Study|Equipment malfunction|2|||
33652936|NCT01929395|63065077|FG000|Overall Study|Did not complete - non-related toxicity|1|||
33328917|NCT00944697|62705366|FG001|Overall Study|Administrative|1|||
33328918|NCT01077804|62705372|FG000|Overall Study|Unreachable|102|||
33328919|NCT01077804|62705372|FG000|Overall Study|Refused to continue|79|||
33328920|NCT01077804|62705372|FG000|Overall Study|Other|18|||
33328921|NCT01075074|62705396|FG000|Overall Study|Surgeon changed to open incisional case|1|||
33328922|NCT01075074|62705397|FG001|Overall Study|Surgeon changed to open incisional case|2|||
33328923|NCT01075074|62705398|FG002|Overall Study|Surgeon changed to open incisional case|2|||
33328924|NCT00866281|62705412|FG000|Overall Study|Adverse Event|1|||
33467150|NCT03298984|62840549|FG000|Overall Study|Adverse Event|0|||
33467151|NCT03298984|62840550|FG001|Overall Study|Adverse Event|0|||
33467152|NCT03298984|62840551|FG002|Overall Study|Adverse Event|0|||
33467153|NCT03298984|62840552|FG003|Overall Study|Adverse Event|1|||
33547330|NCT01063153|62938703|FG001|Overall Study|Withdrawal by Subject|1|||
33547331|NCT01063153|62938702|FG000|Overall Study|Physician Decision|0|||
33547332|NCT01063153|62938703|FG001|Overall Study|Physician Decision|4|||
33547333|NCT01062841|62938715|FG000|Overall Study|Indwelling Device Removed|41|||
33547334|NCT01062841|62938716|FG001|Overall Study|Indwelling Device Removed|48|||
33547335|NCT01062841|62938715|FG000|Overall Study|Death|3|||
33547336|NCT01062841|62938716|FG001|Overall Study|Death|5|||
33547337|NCT01062841|62938715|FG000|Overall Study|Withdrawal by Subject|2|||
33547338|NCT01062841|62938716|FG001|Overall Study|Withdrawal by Subject|0|||
33547339|NCT01062841|62938715|FG000|Overall Study|Withdrawal by Study|3|||
33547340|NCT01062841|62938716|FG001|Overall Study|Withdrawal by Study|0|||
33547341|NCT02505334|62938724|FG000|Main Treatment Period|Adverse Event|3|||
33652937|NCT01929395|63065078|FG001|Overall Study|Did not complete - non-related toxicity|0|||
33652938|NCT01929395|63065079|FG002|Overall Study|Did not complete - non-related toxicity|0|||
33652939|NCT01929395|63065077|FG000|Overall Study|Withdrawal by Subject|0|||
33652940|NCT01929395|63065078|FG001|Overall Study|Withdrawal by Subject|1|||
33652941|NCT01929395|63065079|FG002|Overall Study|Withdrawal by Subject|0|||
33652942|NCT01929395|63065077|FG000|Overall Study|Screen Fail|0|||
33652943|NCT01929395|63065078|FG001|Overall Study|Screen Fail|0|||
33652944|NCT01929395|63065079|FG002|Overall Study|Screen Fail|1|||
33652945|NCT01713283|63065091|FG000|Overall Study|Lack of Efficacy|10|||
33652946|NCT01713283|63065092|FG001|Overall Study|Lack of Efficacy|2|||
33652947|NCT01713283|63065091|FG000|Overall Study|Lost to Follow-up|1|||
33652948|NCT01713283|63065092|FG001|Overall Study|Lost to Follow-up|1|||
33547342|NCT02505334|62938725|FG001|Main Treatment Period|Adverse Event|3|||
33652949|NCT01592383|63065102|FG000|Overall Study|Adverse Event|1|||
33652950|NCT01691521|63065110|FG000|Overall Study|Adverse Event|4|||
33652951|NCT01691521|63065111|FG001|Overall Study|Adverse Event|0|||
33652952|NCT01691521|63065112|FG002|Overall Study|Adverse Event|1|||
33652953|NCT01691521|63065110|FG000|Overall Study|Lack of Efficacy|1|||
33652954|NCT01691521|63065111|FG001|Overall Study|Lack of Efficacy|1|||
33652955|NCT01691521|63065112|FG002|Overall Study|Lack of Efficacy|2|||
33652956|NCT01691521|63065110|FG000|Overall Study|Protocol Violation|0|||
33652957|NCT01691521|63065111|FG001|Overall Study|Protocol Violation|3|||
33547343|NCT02505334|62938724|FG000|Main Treatment Period|Lack of Efficacy|7|||
33547344|NCT02505334|62938725|FG001|Main Treatment Period|Lack of Efficacy|17|||
33547345|NCT02505334|62938724|FG000|Main Treatment Period|Protocol Violation|0|||
33547346|NCT02505334|62938725|FG001|Main Treatment Period|Protocol Violation|1|||
33547347|NCT02505334|62938724|FG000|Main Treatment Period|Withdrawal by Subject|1|||
33652958|NCT01691521|63065112|FG002|Overall Study|Protocol Violation|0|||
33652959|NCT01691521|63065110|FG000|Overall Study|Lost to Follow-up|0|||
33652960|NCT01691521|63065111|FG001|Overall Study|Lost to Follow-up|2|||
33652961|NCT01691521|63065112|FG002|Overall Study|Lost to Follow-up|2|||
33652962|NCT01691521|63065110|FG000|Overall Study|Physician Decision|2|||
33652963|NCT01691521|63065111|FG001|Overall Study|Physician Decision|1|||
33652964|NCT01691521|63065112|FG002|Overall Study|Physician Decision|0|||
33652965|NCT01691521|63065110|FG000|Overall Study|Withdrawal by Subject|5|||
33652966|NCT01691521|63065111|FG001|Overall Study|Withdrawal by Subject|9|||
33652967|NCT01691521|63065112|FG002|Overall Study|Withdrawal by Subject|4|||
33652968|NCT01929317|63065123|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
33652969|NCT01929317|63065124|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
33652970|NCT01929317|63065123|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
33652971|NCT01929317|63065124|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
33652972|NCT01929317|63065123|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
33467154|NCT03298984|62840549|FG000|Overall Study|Death|0|||
33467155|NCT03298984|62840550|FG001|Overall Study|Death|0|||
33467156|NCT03298984|62840551|FG002|Overall Study|Death|0|||
33467157|NCT03298984|62840552|FG003|Overall Study|Death|2|||
33467158|NCT03298984|62840549|FG000|Overall Study|Insurance Company Decision|0|||
33467159|NCT03298984|62840550|FG001|Overall Study|Insurance Company Decision|0|||
33467160|NCT03298984|62840551|FG002|Overall Study|Insurance Company Decision|0|||
33467161|NCT03298984|62840552|FG003|Overall Study|Insurance Company Decision|1|||
33652973|NCT01929317|63065124|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
33467162|NCT02940574|62840565|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
33467163|NCT02940574|62840566|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
33652974|NCT01929317|63065123|FG000|Long-term Phase|Adverse Event|5|||
33652975|NCT01929317|63065124|FG001|Long-term Phase|Adverse Event|1|||
33652976|NCT01929317|63065123|FG000|Long-term Phase|Physician Decision|3|||
33652977|NCT01929317|63065124|FG001|Long-term Phase|Physician Decision|0|||
33547348|NCT02505334|62938725|FG001|Main Treatment Period|Withdrawal by Subject|8|||
33547349|NCT02505334|62938724|FG000|Main Treatment Period|Unclassified|4|||
33547350|NCT02505334|62938725|FG001|Main Treatment Period|Unclassified|10|||
33652978|NCT01929317|63065123|FG000|Long-term Phase|Withdrawal by Subject|4|||
33652979|NCT01929317|63065124|FG001|Long-term Phase|Withdrawal by Subject|0|||
33652980|NCT01929317|63065123|FG000|Long-term Phase|Protocol Violation|1|||
33652981|NCT01929317|63065124|FG001|Long-term Phase|Protocol Violation|0|||
33652982|NCT01929317|63065123|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
33652983|NCT01929317|63065124|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
33652984|NCT01929317|63065123|FG000|Long-term Phase|Study Closed/Terminated|5|||
33652985|NCT01929317|63065124|FG001|Long-term Phase|Study Closed/Terminated|3|||
33652986|NCT01711879|63065138|FG000|Overall Study|Death|1|||
33652987|NCT01711879|63065139|FG001|Overall Study|Death|0|||
33652988|NCT01689649|63065162|FG000|Overall Study|Lack of Efficacy|3|||
33652989|NCT01689649|63065162|FG000|Overall Study|Non-compliance|11|||
33652990|NCT01689649|63065162|FG000|Overall Study|Protocol Violation|3|||
33652991|NCT01689649|63065162|FG000|Overall Study|Lost to Follow-up|5|||
33652992|NCT01929083|63065166|FG000|Intervention 1|Lost to Follow-up|2|||
33652993|NCT01929083|63065167|FG001|Intervention 1|Lost to Follow-up|0|||
33652994|NCT01929083|63065166|FG000|Intervention 1|Nonadherent to study medications|1|||
33328925|NCT00866281|62705413|FG001|Overall Study|Adverse Event|0|||
33547351|NCT02505334|62938724|FG000|Extension Treatment Period|Adverse Event|5|||
33547352|NCT02505334|62938725|FG001|Extension Treatment Period|Adverse Event|0|||
33547353|NCT02505334|62938724|FG000|Extension Treatment Period|Lack of Efficacy|4|||
33547354|NCT02505334|62938725|FG001|Extension Treatment Period|Lack of Efficacy|0|||
33547355|NCT02505334|62938724|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
33547356|NCT02505334|62938725|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
33547357|NCT02505334|62938724|FG000|Extension Treatment Period|Unclassified|3|||
33547358|NCT02505334|62938725|FG001|Extension Treatment Period|Unclassified|0|||
33547359|NCT01062061|62938731|FG000|Overall Study|Enrolled more than once|2|||
33547360|NCT01062061|62938731|FG000|Overall Study|Investigated before study start|13|||
33547361|NCT01062061|62938731|FG000|Overall Study|Outside chief indications|10|||
33547362|NCT01062061|62938731|FG000|Overall Study|Failed to meet inclusion criteria|2|||
33547363|NCT02504320|62938743|FG000|Treatment Period 1|Positive Drug Screen|0|||
33547364|NCT02504320|62938744|FG001|Treatment Period 1|Positive Drug Screen|0|||
33547365|NCT02504320|62938745|FG002|Treatment Period 1|Positive Drug Screen|1|||
33547366|NCT02504320|62938746|FG003|Treatment Period 1|Positive Drug Screen|0|||
33547367|NCT02504320|62938743|FG000|Treatment Period 2|Positive Drug Screen|0|||
33547368|NCT02504320|62938744|FG001|Treatment Period 2|Positive Drug Screen|1|||
33547369|NCT02504320|62938745|FG002|Treatment Period 2|Positive Drug Screen|0|||
33547370|NCT02504320|62938746|FG003|Treatment Period 2|Positive Drug Screen|0|||
33547371|NCT02504320|62938743|FG000|Treatment Period 3|Positive Drug Screen|0|||
33547372|NCT02504320|62938744|FG001|Treatment Period 3|Positive Drug Screen|0|||
33547373|NCT02504320|62938745|FG002|Treatment Period 3|Positive Drug Screen|0|||
33547374|NCT02504320|62938746|FG003|Treatment Period 3|Positive Drug Screen|1|||
33547375|NCT02504320|62938743|FG000|Treatment Period 3|Adverse Event|0|||
33547376|NCT02504320|62938744|FG001|Treatment Period 3|Adverse Event|0|||
33547377|NCT02504320|62938745|FG002|Treatment Period 3|Adverse Event|1|||
33547378|NCT02504320|62938746|FG003|Treatment Period 3|Adverse Event|0|||
33547379|NCT01061671|62938758|FG000|Overall Study|Withdrawal by Subject|16|||
33547380|NCT01061671|62938759|FG001|Overall Study|Withdrawal by Subject|20|||
33547381|NCT01061671|62938758|FG000|Overall Study|Lost to Follow-up|3|||
33652995|NCT01929083|63065167|FG001|Intervention 1|Nonadherent to study medications|0|||
33652996|NCT01929083|63065166|FG000|Intervention 2|Adverse Event|0|||
33328926|NCT00866281|62705412|FG000|Overall Study|Withdrawal by participants|3|||
33467164|NCT02940574|62840565|FG000|1-year Follow-up|Lost to Follow-up|3|||
33467165|NCT02940574|62840566|FG001|1-year Follow-up|Lost to Follow-up|4|||
33467166|NCT03606512|62840578|FG000|Overall Study|Lost to Follow-up|0|||
33467167|NCT03606512|62840579|FG001|Overall Study|Lost to Follow-up|1|||
33467168|NCT03606512|62840578|FG000|Overall Study|'moved from study area|0|||
33467169|NCT03606512|62840579|FG001|Overall Study|'moved from study area|1|||
33467170|NCT03760250|62840601|FG000|Overall Study|Withdrawal by Subject|1|||
33467171|NCT03760250|62840601|FG000|Overall Study|Physician Decision|1|||
33467172|NCT03757988|62840605|FG000|Overall Study|Withdrawal by Subject|1|||
33467173|NCT00313781|62840612|FG000|Before Crossover|Death|22|||
33467174|NCT00313781|62840613|FG001|Before Crossover|Death|8|||
33328927|NCT00866281|62705413|FG001|Overall Study|Withdrawal by participants|0|||
33328928|NCT00866281|62705412|FG000|Overall Study|Disease progression|3|||
33328929|NCT00866281|62705413|FG001|Overall Study|Disease progression|11|||
33328930|NCT00866281|62705412|FG000|Overall Study|New cancer therapy|0|||
33328931|NCT00866281|62705413|FG001|Overall Study|New cancer therapy|4|||
33328932|NCT01077258|62705422|FG000|Overall Study|Lost to Follow-up|1390|||
33328933|NCT01077258|62705422|FG000|Overall Study|Adverse drug reaction|218|||
33328934|NCT01077258|62705422|FG000|Overall Study|Lack of Efficacy|663|||
33328935|NCT01077258|62705422|FG000|Overall Study|Clinical remission|37|||
33328936|NCT01077258|62705422|FG000|Overall Study|Other reasons|260|||
33328937|NCT00943917|62705450|FG000|Stage I|Adverse Event|1|||
33467175|NCT00313781|62840614|FG002|Before Crossover|Death|0|||
33547382|NCT01061671|62938759|FG001|Overall Study|Lost to Follow-up|5|||
33547383|NCT01061671|62938758|FG000|Overall Study|Death|28|||
33547384|NCT01061671|62938759|FG001|Overall Study|Death|30|||
33547385|NCT00709995|62938767|FG000|Overall Study|Adverse Event|4|||
33547386|NCT00709995|62938768|FG001|Overall Study|Adverse Event|2|||
33547387|NCT00709995|62938767|FG000|Overall Study|Withdrawal by Subject|1|||
33547388|NCT00709995|62938768|FG001|Overall Study|Withdrawal by Subject|3|||
33547389|NCT02503540|62938777|FG000|Overall Study|Death|2|||
33547390|NCT02503540|62938777|FG000|Overall Study|Withdrawal by Subject|1|||
33652997|NCT01929083|63065167|FG001|Intervention 2|Adverse Event|1|||
33652998|NCT01689337|63065173|FG000|Overall Study|Study Discontinuation|1|||
33652999|NCT01688635|63065179|FG000|Washout 1|Withdrawal by Subject|1|||
33653000|NCT01688635|63065180|FG001|Washout 1|Withdrawal by Subject|0|||
33653001|NCT01688635|63065179|FG000|Washout 1|Adverse Event|0|||
33653002|NCT01688635|63065180|FG001|Washout 1|Adverse Event|1|||
33653003|NCT01688635|63065179|FG000|Washout 1|Physician Decision|0|||
33653004|NCT01688635|63065180|FG001|Washout 1|Physician Decision|1|||
33653005|NCT01688635|63065179|FG000|Washout 2|Physician Decision|1|||
33653006|NCT01688635|63065180|FG001|Washout 2|Physician Decision|0|||
33653007|NCT01688635|63065179|FG000|Washout 2|Withdrawal by Subject|1|||
33653008|NCT01688635|63065180|FG001|Washout 2|Withdrawal by Subject|0|||
33653009|NCT01688635|63065179|FG000|Washout 2|Sponsor Decision|1|||
33653010|NCT01688635|63065180|FG001|Washout 2|Sponsor Decision|2|||
33653011|NCT01688635|63065179|FG000|Washout 3|Withdrawal by Subject|1|||
33653012|NCT01688635|63065180|FG001|Washout 3|Withdrawal by Subject|0|||
33653013|NCT01591681|63065187|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
33653014|NCT01591681|63065187|FG000|Overall Study|Failed to use system during run-in|1|||
33653015|NCT01711645|63065202|FG000|Overall Study|Withdrawal by Subject|8|||
33653016|NCT01711645|63065202|FG000|Overall Study|Lost to Follow-up|6|||
33653017|NCT01711645|63065202|FG000|Overall Study|Physician Decision|5|||
33653018|NCT01590433|63065217|FG000|Overall Study|Lost to Follow-up|20|||
33653019|NCT01590433|63065218|FG001|Overall Study|Lost to Follow-up|8|||
33653020|NCT01590433|63065217|FG000|Overall Study|Withdrawal by Subject|21|||
33653021|NCT01590433|63065218|FG001|Overall Study|Withdrawal by Subject|11|||
33653022|NCT01590433|63065217|FG000|Overall Study|Adverse Event|11|||
33653023|NCT01590433|63065218|FG001|Overall Study|Adverse Event|3|||
33653024|NCT01928927|63065235|FG000|Overall Study|Lost to Follow-up|1|||
33653025|NCT01928927|63065236|FG001|Overall Study|Lost to Follow-up|0|||
33653026|NCT01928927|63065235|FG000|Overall Study|Withdrawal by Subject|1|||
33653027|NCT01928927|63065236|FG001|Overall Study|Withdrawal by Subject|1|||
33653028|NCT01710709|63065257|FG000|Overall Study|Lost to Follow-up|29|||
33653029|NCT01710709|63065257|FG000|Overall Study|Adverse Event|48|||
33653030|NCT01710709|63065257|FG000|Overall Study|Participant met withdrawal criteria|33|||
33653031|NCT01710709|63065257|FG000|Overall Study|Participant withdrawn by investigator|2|||
33653032|NCT01710709|63065257|FG000|Overall Study|Withdrawal by Subject|53|||
33653033|NCT01710709|63065257|FG000|Overall Study|Protocol Violation|5|||
33653034|NCT01710709|63065257|FG000|Overall Study|Lack of Efficacy|3|||
33653035|NCT01617629|63065262|FG000|Overall Study|Death|2|||
33653036|NCT01617629|63065262|FG000|Overall Study|Investigator's Clinical Judgement|1|||
33653037|NCT01617629|63065262|FG000|Overall Study|Reason Not Specified|1|||
33653038|NCT01617629|63065262|FG000|Overall Study|Participant Withdrew Consent|2|||
33653039|NCT01686373|63065277|FG000|Overall Study|Lost to Follow-up|3|||
33653040|NCT01686373|63065278|FG001|Overall Study|Lost to Follow-up|0|||
33653041|NCT01686373|63065277|FG000|Overall Study|Withdrawal by Subject|0|||
33653042|NCT01686373|63065278|FG001|Overall Study|Withdrawal by Subject|1|||
33653043|NCT01686373|63065277|FG000|Overall Study|Adverse Event|0|||
33653044|NCT01686373|63065278|FG001|Overall Study|Adverse Event|1|||
33653045|NCT01709695|63065286|FG000|Overall Study|Withdrawal by Subject|1|||
33653046|NCT01709695|63065287|FG001|Overall Study|Withdrawal by Subject|1|||
33653047|NCT01685983|63065297|FG000|Overall Study|Adverse Event|7|||
33328938|NCT00943917|62705451|FG001|Stage I|Adverse Event|2|||
33547391|NCT02502526|62938784|FG000|Overall Study|Lost to Follow-up|2|||
33547392|NCT02502526|62938785|FG001|Overall Study|Lost to Follow-up|2|||
33653048|NCT01685983|63065297|FG000|Overall Study|Death|1|||
33653049|NCT01685983|63065297|FG000|Overall Study|Withdrawal by Subject|19|||
33653050|NCT01685983|63065297|FG000|Overall Study|Protocol Violation|2|||
33653051|NCT01685983|63065297|FG000|Overall Study|Physician Decision|13|||
33653052|NCT01685983|63065297|FG000|Overall Study|Other|7|||
33653053|NCT01685983|63065297|FG000|Overall Study|Progressive Disease|32|||
33653054|NCT01685983|63065297|FG000|Overall Study|Noncompliance with Study Drug|1|||
33653055|NCT01685437|63065309|FG000|Overall Study|Withdrawal by Subject|22|||
33653056|NCT01685437|63065309|FG000|Overall Study|Lost to Follow-up|3|||
33547393|NCT02502526|62938786|FG002|Overall Study|Lost to Follow-up|3|||
33653057|NCT01685437|63065309|FG000|Overall Study|Adverse Event|1|||
33653058|NCT01685437|63065309|FG000|Overall Study|Protocol Violation|4|||
33653059|NCT01685437|63065309|FG000|Overall Study|Unable to make visits due to work|1|||
33653060|NCT01685203|63065349|FG000|Overall Study|Lost to Follow-up|3|||
33653061|NCT01685203|63065350|FG001|Overall Study|Lost to Follow-up|3|||
33653062|NCT01685203|63065351|FG002|Overall Study|Lost to Follow-up|0|||
33547394|NCT02502526|62938784|FG000|Overall Study|Withdrawal by Subject|0|||
33547395|NCT02502526|62938785|FG001|Overall Study|Withdrawal by Subject|1|||
33547396|NCT02502526|62938786|FG002|Overall Study|Withdrawal by Subject|1|||
33547397|NCT02502526|62938784|FG000|Overall Study|Disqualified due to cataract grading|0|||
33547398|NCT02502526|62938785|FG001|Overall Study|Disqualified due to cataract grading|0|||
33547399|NCT02502526|62938786|FG002|Overall Study|Disqualified due to cataract grading|1|||
33547400|NCT02502526|62938784|FG000|Overall Study|Enrollment suspension|4|||
33547401|NCT02502526|62938785|FG001|Overall Study|Enrollment suspension|1|||
33547402|NCT02502526|62938786|FG002|Overall Study|Enrollment suspension|1|||
33547403|NCT02972515|62938795|FG000|Overall Study|Lost to Follow-up|78|||
33547404|NCT02972359|62938799|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
33547405|NCT02972359|62938799|FG000|Overall Study|Lack of Efficacy|1|||
33547406|NCT02972359|62938799|FG000|Overall Study|Adverse Event|4|||
33547407|NCT02972359|62938799|FG000|Overall Study|Death|1|||
33547408|NCT02972359|62938799|FG000|Overall Study|Withdrawal by Subject|30|||
33547409|NCT02972359|62938799|FG000|Overall Study|Protocol Violation|1|||
33547410|NCT02972359|62938799|FG000|Overall Study|Lost to Follow-up|26|||
33547411|NCT02972359|62938799|FG000|Overall Study|Other reasons|5|||
33547412|NCT02972359|62938799|FG000|Overall Study|Missing|1|||
33547413|NCT01060111|62938806|FG000|Overall Study|Adverse Event|9|||
33547414|NCT01060111|62938807|FG001|Overall Study|Adverse Event|5|||
33547415|NCT01060111|62938808|FG002|Overall Study|Adverse Event|18|||
33547416|NCT01060111|62938806|FG000|Overall Study|Lack of Efficacy|2|||
33547417|NCT01060111|62938807|FG001|Overall Study|Lack of Efficacy|1|||
33547418|NCT01060111|62938808|FG002|Overall Study|Lack of Efficacy|0|||
33547419|NCT01060111|62938806|FG000|Overall Study|Inappropriate participant|5|||
33547420|NCT01060111|62938807|FG001|Overall Study|Inappropriate participant|4|||
33547421|NCT01060111|62938808|FG002|Overall Study|Inappropriate participant|5|||
33547422|NCT01060111|62938806|FG000|Overall Study|Participants' evasion for hospital visit|0|||
33547423|NCT01060111|62938807|FG001|Overall Study|Participants' evasion for hospital visit|3|||
33547424|NCT01060111|62938808|FG002|Overall Study|Participants' evasion for hospital visit|2|||
33547425|NCT01060111|62938806|FG000|Overall Study|Participants' non-cooperation|8|||
33653063|NCT01685203|63065352|FG003|Overall Study|Lost to Follow-up|1|||
33467176|NCT00313781|62840612|FG000|Before Crossover|Lost to Follow-up|0|||
33467177|NCT00313781|62840613|FG001|Before Crossover|Lost to Follow-up|3|||
33467178|NCT00313781|62840614|FG002|Before Crossover|Lost to Follow-up|0|||
33467179|NCT00313781|62840612|FG000|Before Crossover|Withdrawal by Subject|3|||
33467180|NCT00313781|62840613|FG001|Before Crossover|Withdrawal by Subject|1|||
33547426|NCT01060111|62938807|FG001|Overall Study|Participants' non-cooperation|6|||
33547427|NCT01060111|62938808|FG002|Overall Study|Participants' non-cooperation|6|||
33547428|NCT01060111|62938806|FG000|Overall Study|Adverse event and insufficient effect|0|||
33547429|NCT01060111|62938807|FG001|Overall Study|Adverse event and insufficient effect|1|||
33547430|NCT01060111|62938808|FG002|Overall Study|Adverse event and insufficient effect|0|||
33547431|NCT01060111|62938806|FG000|Overall Study|Participants' non-cooperation|1|||
33547432|NCT01060111|62938807|FG001|Overall Study|Participants' non-cooperation|0|||
33547433|NCT01060111|62938808|FG002|Overall Study|Participants' non-cooperation|0|||
33547434|NCT01060111|62938806|FG000|Overall Study|Other|2|||
33467181|NCT00313781|62840614|FG002|Before Crossover|Withdrawal by Subject|0|||
33467182|NCT00313781|62840612|FG000|Before Crossover|Other|45|||
33467183|NCT00313781|62840613|FG001|Before Crossover|Other|30|||
33467184|NCT00313781|62840614|FG002|Before Crossover|Other|0|||
33467185|NCT00313781|62840612|FG000|Before Crossover|Crossover|0|||
33467186|NCT00313781|62840613|FG001|Before Crossover|Crossover|37|||
33467187|NCT00313781|62840614|FG002|Before Crossover|Crossover|0|||
33467188|NCT00313781|62840612|FG000|Before Crossover|Randomized, not treated|5|||
33467189|NCT00313781|62840613|FG001|Before Crossover|Randomized, not treated|0|||
33467190|NCT00313781|62840614|FG002|Before Crossover|Randomized, not treated|0|||
33467191|NCT00313781|62840612|FG000|After Crossover|Death|0|||
33467192|NCT00313781|62840613|FG001|After Crossover|Death|0|||
33467193|NCT00313781|62840614|FG002|After Crossover|Death|6|||
33467194|NCT00313781|62840612|FG000|After Crossover|Withdrawal by Subject|0|||
33547435|NCT01060111|62938807|FG001|Overall Study|Other|3|||
33653064|NCT01685203|63065353|FG004|Overall Study|Lost to Follow-up|0|||
33467195|NCT00313781|62840613|FG001|After Crossover|Withdrawal by Subject|0|||
33467196|NCT00313781|62840614|FG002|After Crossover|Withdrawal by Subject|3|||
33467197|NCT00313781|62840612|FG000|After Crossover|Other|0|||
33467198|NCT00313781|62840613|FG001|After Crossover|Other|0|||
33467199|NCT00313781|62840614|FG002|After Crossover|Other|18|||
33467200|NCT00368537|62840625|FG000|Randomization|No study drug dosed|13|||
33467201|NCT00368537|62840626|FG001|Randomization|No study drug dosed|6|||
33467202|NCT00368537|62840625|FG000|Baseline Participants|Lost to Follow-up|16|||
33547436|NCT01060111|62938808|FG002|Overall Study|Other|4|||
33547437|NCT02969863|62938819|FG000|Overall Study|Physician Decision|1|||
33467203|NCT00368537|62840626|FG001|Baseline Participants|Lost to Follow-up|17|||
33467204|NCT00368537|62840625|FG000|Baseline Participants|Withdrawal by Subject|6|||
33547438|NCT02969863|62938820|FG001|Overall Study|Physician Decision|0|||
33547439|NCT02969863|62938821|FG002|Overall Study|Physician Decision|0|||
33547440|NCT02969863|62938822|FG003|Overall Study|Physician Decision|0|||
33467205|NCT00368537|62840626|FG001|Baseline Participants|Withdrawal by Subject|4|||
33467206|NCT00368537|62840625|FG000|Baseline Participants|Death|1|||
33467207|NCT00368537|62840626|FG001|Baseline Participants|Death|2|||
33467208|NCT00368537|62840625|FG000|Baseline Participants|No susceptibility|1|||
33547441|NCT02969863|62938823|FG004|Overall Study|Physician Decision|0|||
33467209|NCT00368537|62840626|FG001|Baseline Participants|No susceptibility|0|||
33467210|NCT00368537|62840625|FG000|Baseline Participants|Patient uncompliant|0|||
33467211|NCT00368537|62840626|FG001|Baseline Participants|Patient uncompliant|1|||
33467212|NCT00313703|62840636|FG000|Overall Study|Lost to Follow-up|11|||
33547442|NCT02969863|62938824|FG005|Overall Study|Physician Decision|0|||
33653065|NCT01685203|63065354|FG005|Overall Study|Lost to Follow-up|0|||
33653066|NCT01685203|63065355|FG006|Overall Study|Lost to Follow-up|0|||
33467213|NCT00313703|62840637|FG001|Overall Study|Lost to Follow-up|2|||
33467214|NCT00313703|62840638|FG002|Overall Study|Lost to Follow-up|5|||
33547443|NCT02969707|62938840|FG000|Overall Study|Adverse Event|1|||
33467215|NCT00313703|62840639|FG003|Overall Study|Lost to Follow-up|12|||
33467216|NCT00313313|62840652|FG000|Overall Study|Lack of Efficacy|14|||
33467217|NCT00313313|62840653|FG001|Overall Study|Lack of Efficacy|9|||
33467218|NCT00313313|62840654|FG002|Overall Study|Lack of Efficacy|20|||
33547444|NCT02969707|62938841|FG001|Overall Study|Adverse Event|2|||
33547445|NCT02969707|62938840|FG000|Overall Study|Lost to Follow-up|3|||
33547446|NCT02969707|62938841|FG001|Overall Study|Lost to Follow-up|0|||
33547447|NCT02969707|62938840|FG000|Overall Study|Physician Decision|0|||
33547448|NCT02969707|62938841|FG001|Overall Study|Physician Decision|1|||
33547449|NCT02969707|62938840|FG000|Overall Study|Protocol Violation|1|||
33547450|NCT02969707|62938841|FG001|Overall Study|Protocol Violation|1|||
33547451|NCT02969707|62938840|FG000|Overall Study|Withdrawal by Subject|3|||
33547452|NCT02969707|62938841|FG001|Overall Study|Withdrawal by Subject|4|||
33547453|NCT02967055|62938852|FG000|Overall Study|Excluded|40|||
33547454|NCT02967055|62938852|FG000|Overall Study|Screen fail|3|||
33547455|NCT02967055|62938852|FG000|Overall Study|Lost to Follow-up|2|||
33547456|NCT02967055|62938852|FG000|Overall Study|Stopped due to side effects|3|||
33547457|NCT02967055|62938852|FG000|Overall Study|Stopped due to drug cost|1|||
33547458|NCT02904265|62938858|FG000|Overall Study|Physician Decision|1|||
33547459|NCT02904265|62938859|FG001|Overall Study|Physician Decision|2|||
33547460|NCT03461211|62938867|FG000|Overall Study|Adverse Event|1|||
33547461|NCT03461211|62938868|FG001|Overall Study|Adverse Event|1|||
33547462|NCT03461211|62938867|FG000|Overall Study|Lack of Efficacy|0|||
33547463|NCT03461211|62938868|FG001|Overall Study|Lack of Efficacy|1|||
33547464|NCT02967679|62938876|FG000|Overall Study|Adverse Event|1|||
33547465|NCT02966509|62938886|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
33547466|NCT02966509|62938887|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
33547467|NCT02966509|62938886|FG000|Baseline Satisfaction Survey|Death|0|||
33547468|NCT02966509|62938887|FG001|Baseline Satisfaction Survey|Death|1|||
33653067|NCT01685203|63065349|FG000|Overall Study|Adverse Event|0|||
33653068|NCT01685203|63065350|FG001|Overall Study|Adverse Event|0|||
33653069|NCT01685203|63065351|FG002|Overall Study|Adverse Event|0|||
33653070|NCT01685203|63065352|FG003|Overall Study|Adverse Event|0|||
33653071|NCT01685203|63065353|FG004|Overall Study|Adverse Event|0|||
33653072|NCT01685203|63065354|FG005|Overall Study|Adverse Event|2|||
33653073|NCT01685203|63065355|FG006|Overall Study|Adverse Event|0|||
33653074|NCT01685203|63065349|FG000|Overall Study|Adverse event and withdrew consent|1|||
33653075|NCT01685203|63065350|FG001|Overall Study|Adverse event and withdrew consent|0|||
33653076|NCT01685203|63065351|FG002|Overall Study|Adverse event and withdrew consent|0|||
33653077|NCT01685203|63065352|FG003|Overall Study|Adverse event and withdrew consent|0|||
33653078|NCT01685203|63065353|FG004|Overall Study|Adverse event and withdrew consent|0|||
33467219|NCT00313313|62840652|FG000|Overall Study|Withdrawal of consent by subject|18|||
33467220|NCT00313313|62840653|FG001|Overall Study|Withdrawal of consent by subject|17|||
33467221|NCT00313313|62840654|FG002|Overall Study|Withdrawal of consent by subject|31|||
33467222|NCT00313313|62840652|FG000|Overall Study|Lost to Follow-up|10|||
33467223|NCT00313313|62840653|FG001|Overall Study|Lost to Follow-up|7|||
33467224|NCT00313313|62840654|FG002|Overall Study|Lost to Follow-up|9|||
33467225|NCT00313313|62840652|FG000|Overall Study|Adverse Event|15|||
33467226|NCT00313313|62840653|FG001|Overall Study|Adverse Event|16|||
33467227|NCT00313313|62840654|FG002|Overall Study|Adverse Event|12|||
33467228|NCT00313313|62840652|FG000|Overall Study|Physician Decision|2|||
33467229|NCT00313313|62840653|FG001|Overall Study|Physician Decision|6|||
33467230|NCT00313313|62840654|FG002|Overall Study|Physician Decision|4|||
33467231|NCT00313313|62840652|FG000|Overall Study|Poor/Noncompliance|3|||
33467232|NCT00313313|62840653|FG001|Overall Study|Poor/Noncompliance|6|||
33467233|NCT00313313|62840654|FG002|Overall Study|Poor/Noncompliance|2|||
33467234|NCT00313313|62840652|FG000|Overall Study|Pregnancy|1|||
33467235|NCT00313313|62840653|FG001|Overall Study|Pregnancy|2|||
33547469|NCT02966509|62938886|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
33547470|NCT02966509|62938887|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
33653079|NCT01685203|63065354|FG005|Overall Study|Adverse event and withdrew consent|0|||
33653080|NCT01685203|63065355|FG006|Overall Study|Adverse event and withdrew consent|0|||
33653081|NCT01685203|63065349|FG000|Overall Study|Patient's decision|0|||
33653082|NCT01685203|63065350|FG001|Overall Study|Patient's decision|0|||
33467236|NCT00313313|62840654|FG002|Overall Study|Pregnancy|0|||
33467237|NCT00313313|62840652|FG000|Overall Study|Death|0|||
33467238|NCT00313313|62840653|FG001|Overall Study|Death|0|||
33547471|NCT02966509|62938886|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
33547472|NCT02966509|62938887|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
33653083|NCT01685203|63065351|FG002|Overall Study|Patient's decision|0|||
33467239|NCT00313313|62840654|FG002|Overall Study|Death|2|||
33467240|NCT00313313|62840652|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
33547473|NCT02966509|62938886|FG000|6 Month Satisfaction Decision Survey|Death|22|||
33653084|NCT01685203|63065352|FG003|Overall Study|Patient's decision|0|||
33653085|NCT01685203|63065353|FG004|Overall Study|Patient's decision|0|||
33653086|NCT01685203|63065354|FG005|Overall Study|Patient's decision|1|||
33467241|NCT00313313|62840653|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
33467242|NCT00313313|62840654|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
33467243|NCT00312845|62840664|FG000|Overall Study|Adverse Event|19|||
33467244|NCT00312845|62840665|FG001|Overall Study|Adverse Event|5|||
33467245|NCT00312845|62840664|FG000|Overall Study|Death|2|||
33467246|NCT00312845|62840665|FG001|Overall Study|Death|2|||
33467247|NCT00312845|62840664|FG000|Overall Study|Withdrawal by Subject|14|||
33467248|NCT00312845|62840665|FG001|Overall Study|Withdrawal by Subject|6|||
33467249|NCT00312845|62840664|FG000|Overall Study|Disease Progression|56|||
33467250|NCT00312845|62840665|FG001|Overall Study|Disease Progression|77|||
33467251|NCT00312845|62840664|FG000|Overall Study|Lost to Follow-up|2|||
33467252|NCT00312845|62840665|FG001|Overall Study|Lost to Follow-up|0|||
33467253|NCT00312845|62840664|FG000|Overall Study|Other|6|||
33467254|NCT00312845|62840665|FG001|Overall Study|Other|5|||
33467255|NCT00368069|62840673|FG000|Overall Study|Adverse Event|5|||
33467256|NCT00368069|62840674|FG001|Overall Study|Adverse Event|2|||
33467257|NCT00368069|62840673|FG000|Overall Study|Lack of Efficacy|0|||
33467258|NCT00368069|62840674|FG001|Overall Study|Lack of Efficacy|1|||
33467259|NCT00368069|62840673|FG000|Overall Study|Lost to Follow-up|1|||
33467260|NCT00368069|62840674|FG001|Overall Study|Lost to Follow-up|0|||
33653087|NCT01685203|63065355|FG006|Overall Study|Patient's decision|0|||
33653088|NCT01928771|63065374|FG000|Overall Study|Adverse Event|6|||
33547474|NCT02966509|62938887|FG001|6 Month Satisfaction Decision Survey|Death|25|||
33547475|NCT02966509|62938886|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
33547476|NCT02966509|62938887|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
33467261|NCT00368069|62840673|FG000|Overall Study|Protocol Violation|0|||
33467262|NCT00368069|62840674|FG001|Overall Study|Protocol Violation|2|||
33467263|NCT00368069|62840673|FG000|Overall Study|Withdrawal of Consent|2|||
33467264|NCT00368069|62840674|FG001|Overall Study|Withdrawal of Consent|1|||
33467265|NCT00368069|62840673|FG000|Overall Study|no blood sampling possible|0|||
33467266|NCT00368069|62840674|FG001|Overall Study|no blood sampling possible|1|||
33653089|NCT01928771|63065375|FG001|Overall Study|Adverse Event|5|||
33653090|NCT01928771|63065376|FG002|Overall Study|Adverse Event|1|||
33653091|NCT01928771|63065374|FG000|Overall Study|Death|2|||
33653092|NCT01928771|63065375|FG001|Overall Study|Death|2|||
33653093|NCT01928771|63065376|FG002|Overall Study|Death|2|||
33653094|NCT01928771|63065374|FG000|Overall Study|Lost to Follow-up|5|||
33653095|NCT01928771|63065375|FG001|Overall Study|Lost to Follow-up|6|||
33653096|NCT01928771|63065376|FG002|Overall Study|Lost to Follow-up|3|||
33653097|NCT01928771|63065374|FG000|Overall Study|Withdrawal by Subject|20|||
33653098|NCT01928771|63065375|FG001|Overall Study|Withdrawal by Subject|15|||
33653099|NCT01928771|63065376|FG002|Overall Study|Withdrawal by Subject|17|||
33653100|NCT01928771|63065374|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
33653101|NCT01928771|63065375|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
33653102|NCT01928771|63065376|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
33653103|NCT01928771|63065374|FG000|Overall Study|Other Reasons|9|||
33653104|NCT01928771|63065375|FG001|Overall Study|Other Reasons|9|||
33653105|NCT01928771|63065376|FG002|Overall Study|Other Reasons|14|||
33653106|NCT01928771|63065374|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
33653107|NCT01928771|63065375|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
33467267|NCT00367991|62840682|FG000|Overall Study|Withdrawal by Subject|1|||
33467268|NCT00367991|62840683|FG001|Overall Study|Withdrawal by Subject|1|||
33467269|NCT00367991|62840682|FG000|Overall Study|Adverse Event|1|||
33467270|NCT00367991|62840683|FG001|Overall Study|Adverse Event|1|||
33467271|NCT00367835|62840691|FG000|Overall Study|Adverse Event|14|||
33547477|NCT02966509|62938886|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
33547478|NCT02966509|62938887|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
33547479|NCT02966509|62938886|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
33653108|NCT01928771|63065376|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
33653109|NCT01589653|63065386|FG000|Overall Study|Protocol Violation|3|||
33653110|NCT01589653|63065387|FG001|Overall Study|Protocol Violation|1|||
33653111|NCT01589653|63065386|FG000|Overall Study|Withdrawal criteria|4|||
33653112|NCT01589653|63065387|FG001|Overall Study|Withdrawal criteria|7|||
33653113|NCT01589653|63065386|FG000|Overall Study|Unclassified|0|||
33467272|NCT00367835|62840692|FG001|Overall Study|Adverse Event|1|||
33467273|NCT00367835|62840691|FG000|Overall Study|Protocol Violation|1|||
33467274|NCT00367835|62840692|FG001|Overall Study|Protocol Violation|7|||
33547480|NCT02966509|62938887|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
33653114|NCT01589653|63065387|FG001|Overall Study|Unclassified|3|||
33653115|NCT01928615|63065393|FG000|Overall Study|Study Terminated by Sponsor|2|||
33467275|NCT00367835|62840691|FG000|Overall Study|Withdrawal by Subject|7|||
33467276|NCT00367835|62840692|FG001|Overall Study|Withdrawal by Subject|6|||
33653116|NCT01589497|63065402|FG000|Overall Study|Withdrawal by Subject|0|||
33547481|NCT02966509|62938886|FG000|6 Month Satisfaction Survey|Death|36|||
33547482|NCT02966509|62938887|FG001|6 Month Satisfaction Survey|Death|33|||
33547483|NCT02966509|62938886|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
33547484|NCT02966509|62938887|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
33547485|NCT02966509|62938886|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
33547486|NCT02966509|62938887|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
33547487|NCT02966509|62938886|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
33547488|NCT02966509|62938887|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
33547489|NCT02966509|62938886|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
33547490|NCT02966509|62938887|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
33547491|NCT02966509|62938886|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
33547492|NCT02966509|62938887|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
33547493|NCT02966353|62938893|FG000|Overall Study|Withdrawal by Subject|7|||
33547494|NCT02966353|62938893|FG000|Overall Study|Adverse Event|4|||
33547495|NCT02966353|62938893|FG000|Overall Study|Death|4|||
33547496|NCT02966353|62938893|FG000|Overall Study|Physician Decision|3|||
33547497|NCT02966353|62938893|FG000|Overall Study|Progressive disease|2|||
33547498|NCT02966353|62938893|FG000|Overall Study|Protocol deviation|2|||
33547499|NCT02965573|62938926|FG000|Overall Study|Lack of Efficacy|1|||
33547500|NCT02965573|62938927|FG001|Overall Study|Lack of Efficacy|0|||
33547501|NCT02964325|62938935|FG000|Overall Study|Lost to Follow-up|3|||
33547502|NCT02964325|62938936|FG001|Overall Study|Lost to Follow-up|3|||
33547503|NCT02964325|62938935|FG000|Overall Study|Physician Decision|5|||
33547504|NCT02964325|62938936|FG001|Overall Study|Physician Decision|4|||
33547505|NCT02964325|62938935|FG000|Overall Study|Death|1|||
33547506|NCT02964325|62938936|FG001|Overall Study|Death|3|||
33547507|NCT02964325|62938935|FG000|Overall Study|Withdrawal by Subject|2|||
33547508|NCT02964325|62938936|FG001|Overall Study|Withdrawal by Subject|1|||
33547509|NCT02964325|62938935|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
33547510|NCT02964325|62938936|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
33547511|NCT02964247|62938944|FG000|Overall Study|Lost to Follow-up|2|||
33547512|NCT02964247|62938945|FG001|Overall Study|Lost to Follow-up|0|||
33547513|NCT02964247|62938944|FG000|Overall Study|Withdrawal by Subject|1|||
33547514|NCT02964247|62938945|FG001|Overall Study|Withdrawal by Subject|2|||
33547515|NCT03654729|62938954|FG000|Overall Study|Death|9|||
33547516|NCT03654729|62938955|FG001|Overall Study|Death|9|||
33547517|NCT03654729|62938956|FG002|Overall Study|Death|16|||
33547518|NCT03654729|62938954|FG000|Overall Study|Withdrawal by Subject|8|||
33547519|NCT03654729|62938955|FG001|Overall Study|Withdrawal by Subject|6|||
33547520|NCT03654729|62938956|FG002|Overall Study|Withdrawal by Subject|4|||
33547521|NCT03654729|62938954|FG000|Overall Study|Study terminated by Sponsor|3|||
33547522|NCT03654729|62938955|FG001|Overall Study|Study terminated by Sponsor|5|||
33547523|NCT03654729|62938956|FG002|Overall Study|Study terminated by Sponsor|4|||
33653117|NCT01589497|63065403|FG001|Overall Study|Withdrawal by Subject|1|||
33653118|NCT01589497|63065404|FG002|Overall Study|Withdrawal by Subject|0|||
33653119|NCT01589497|63065405|FG003|Overall Study|Withdrawal by Subject|1|||
33653120|NCT01589497|63065402|FG000|Overall Study|Death|1|||
33653121|NCT01589497|63065403|FG001|Overall Study|Death|0|||
33653122|NCT01589497|63065404|FG002|Overall Study|Death|0|||
33328939|NCT00943917|62705452|FG002|Stage I|Adverse Event|2|||
33467277|NCT00367835|62840691|FG000|Overall Study|Lost to Follow-up|1|||
33467278|NCT00367835|62840692|FG001|Overall Study|Lost to Follow-up|4|||
33467279|NCT00367835|62840691|FG000|Overall Study|Lack of Efficacy|3|||
33467280|NCT00367835|62840692|FG001|Overall Study|Lack of Efficacy|12|||
33467281|NCT00367835|62840691|FG000|Overall Study|Subject in juvenile detention center|1|||
33467282|NCT00367835|62840692|FG001|Overall Study|Subject in juvenile detention center|0|||
33467283|NCT00367835|62840691|FG000|Overall Study|refused blood collection|1|||
33467284|NCT00367835|62840692|FG001|Overall Study|refused blood collection|0|||
33467285|NCT00367835|62840691|FG000|Overall Study|Did not respond to calls|1|||
33467286|NCT00367835|62840692|FG001|Overall Study|Did not respond to calls|0|||
33467287|NCT00367835|62840691|FG000|Overall Study|History of lead poisoning|0|||
33467288|NCT00367835|62840692|FG001|Overall Study|History of lead poisoning|1|||
33467289|NCT03267940|62840704|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
33467290|NCT03267940|62840705|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
33547524|NCT03654729|62938954|FG000|Overall Study|Not reported|2|||
33547525|NCT03654729|62938955|FG001|Overall Study|Not reported|4|||
33547526|NCT03654729|62938956|FG002|Overall Study|Not reported|5|||
33547527|NCT03654729|62938954|FG000|Overall Study|Progressive disease|3|||
33547528|NCT03654729|62938955|FG001|Overall Study|Progressive disease|0|||
33547529|NCT03654729|62938956|FG002|Overall Study|Progressive disease|0|||
33547530|NCT03654729|62938954|FG000|Overall Study|Lost to Follow-up|2|||
33547531|NCT03654729|62938955|FG001|Overall Study|Lost to Follow-up|0|||
33547532|NCT03654729|62938956|FG002|Overall Study|Lost to Follow-up|0|||
33547533|NCT03654729|62938954|FG000|Overall Study|Physician Decision|2|||
33547534|NCT03654729|62938955|FG001|Overall Study|Physician Decision|0|||
33653123|NCT01589497|63065405|FG003|Overall Study|Death|0|||
33653124|NCT01589497|63065402|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
33653125|NCT01589497|63065403|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
33653126|NCT01589497|63065404|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
33653127|NCT01589497|63065405|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
33653128|NCT01928381|63065420|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
33653129|NCT01928381|63065421|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
33653130|NCT01928381|63065422|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
33653131|NCT01928381|63065423|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
33653132|NCT01928381|63065424|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
33653133|NCT01928381|63065425|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
33653134|NCT01928381|63065426|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
33653135|NCT01928381|63065420|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
33653136|NCT01928381|63065421|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
33653137|NCT01928381|63065422|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
33653138|NCT01928381|63065423|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
33653139|NCT01928381|63065424|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
33653140|NCT01928381|63065425|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
33653141|NCT01928381|63065426|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
33653142|NCT01928381|63065420|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
33653143|NCT01928381|63065421|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
33653144|NCT01928381|63065422|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
33653145|NCT01928381|63065423|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
33653146|NCT01928381|63065424|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
33653147|NCT01928381|63065425|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
33653148|NCT01928381|63065426|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
33653149|NCT01928381|63065420|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
33653150|NCT01928381|63065421|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
33653151|NCT01928381|63065422|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
33653152|NCT01928381|63065423|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
33653153|NCT01928381|63065424|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
33653154|NCT01928381|63065425|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
33653155|NCT01928381|63065426|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
33653156|NCT01928381|63065420|FG000|Part 1 - Pain Training|Protocol Violation|1|||
33653157|NCT01928381|63065421|FG001|Part 1 - Pain Training|Protocol Violation|0|||
33653158|NCT01928381|63065422|FG002|Part 1 - Pain Training|Protocol Violation|0|||
33653159|NCT01928381|63065423|FG003|Part 1 - Pain Training|Protocol Violation|0|||
33653160|NCT01928381|63065424|FG004|Part 1 - Pain Training|Protocol Violation|0|||
33653161|NCT01928381|63065425|FG005|Part 1 - Pain Training|Protocol Violation|0|||
33328940|NCT00943917|62705453|FG003|Stage I|Adverse Event|0|||
33653162|NCT01928381|63065426|FG006|Part 1 - Pain Training|Protocol Violation|0|||
33653163|NCT01928381|63065420|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
33653164|NCT01928381|63065421|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
33653165|NCT01928381|63065422|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
33653166|NCT01928381|63065423|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
33653167|NCT01928381|63065424|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
33653168|NCT01928381|63065425|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
33653169|NCT01928381|63065426|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
33653170|NCT01928381|63065420|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
33653171|NCT01928381|63065421|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
33653172|NCT01928381|63065422|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
33653173|NCT01928381|63065423|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
33653174|NCT01928381|63065424|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
33653175|NCT01928381|63065425|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
33653176|NCT01928381|63065426|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
33653177|NCT01928381|63065420|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
33653178|NCT01928381|63065421|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
33653179|NCT01928381|63065422|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
33653180|NCT01928381|63065423|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
33653181|NCT01928381|63065424|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
33653182|NCT01928381|63065425|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
33653183|NCT01928381|63065426|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
33653184|NCT01928381|63065420|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
33653185|NCT01928381|63065421|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
33653186|NCT01928381|63065422|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
33653187|NCT01928381|63065423|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
33653188|NCT01928381|63065424|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
33653189|NCT01928381|63065425|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
33653190|NCT01928381|63065426|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
33653191|NCT01928381|63065420|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
33653192|NCT01928381|63065421|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
33653193|NCT01928381|63065422|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
33653194|NCT01928381|63065423|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
33653195|NCT01928381|63065424|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
33653196|NCT01928381|63065425|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
33653197|NCT01928381|63065426|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
33653198|NCT01928381|63065420|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
33653199|NCT01928381|63065421|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
33653200|NCT01928381|63065422|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
33653201|NCT01928381|63065423|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
33653202|NCT01928381|63065424|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
33653203|NCT01928381|63065425|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
33653204|NCT01928381|63065426|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
33653205|NCT01928381|63065420|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
33653206|NCT01928381|63065421|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
33653207|NCT01928381|63065422|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
33547535|NCT03654729|62938956|FG002|Overall Study|Physician Decision|0|||
33547536|NCT03654729|62938954|FG000|Overall Study|Protocol Violation|1|||
33547537|NCT03654729|62938955|FG001|Overall Study|Protocol Violation|1|||
33547538|NCT03654729|62938956|FG002|Overall Study|Protocol Violation|0|||
33547539|NCT03654729|62938954|FG000|Overall Study|Non-compliance with study drug|0|||
33547540|NCT03654729|62938955|FG001|Overall Study|Non-compliance with study drug|1|||
33547541|NCT03654729|62938956|FG002|Overall Study|Non-compliance with study drug|0|||
33547542|NCT03654729|62938954|FG000|Overall Study|Site terminated by Sponsor|1|||
33547543|NCT03654729|62938955|FG001|Overall Study|Site terminated by Sponsor|0|||
33547544|NCT03654729|62938956|FG002|Overall Study|Site terminated by Sponsor|0|||
33547545|NCT01377987|62938964|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
33547546|NCT01377987|62938965|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
33547547|NCT02898259|62938976|FG000|Overall Study|Adverse Event|0|||
33547548|NCT02898259|62938977|FG001|Overall Study|Adverse Event|0|||
33547549|NCT02898259|62938978|FG002|Overall Study|Adverse Event|1|||
33547550|NCT02898259|62938979|FG003|Overall Study|Adverse Event|0|||
33547551|NCT02898259|62938980|FG004|Overall Study|Adverse Event|0|||
33547552|NCT02898259|62938976|FG000|Overall Study|Lack of Efficacy|1|||
33547553|NCT02898259|62938977|FG001|Overall Study|Lack of Efficacy|1|||
33547554|NCT02898259|62938978|FG002|Overall Study|Lack of Efficacy|3|||
33547555|NCT02898259|62938979|FG003|Overall Study|Lack of Efficacy|0|||
33547556|NCT02898259|62938980|FG004|Overall Study|Lack of Efficacy|0|||
33547557|NCT02898259|62938976|FG000|Overall Study|Lost to Follow-up|0|||
33547558|NCT02898259|62938977|FG001|Overall Study|Lost to Follow-up|0|||
33547559|NCT02898259|62938978|FG002|Overall Study|Lost to Follow-up|1|||
33547560|NCT02898259|62938979|FG003|Overall Study|Lost to Follow-up|0|||
33547561|NCT02898259|62938980|FG004|Overall Study|Lost to Follow-up|0|||
33547562|NCT02898259|62938976|FG000|Overall Study|Transformation before study began|0|||
33547563|NCT02898259|62938977|FG001|Overall Study|Transformation before study began|0|||
33547564|NCT02898259|62938978|FG002|Overall Study|Transformation before study began|0|||
33547565|NCT02898259|62938979|FG003|Overall Study|Transformation before study began|1|||
33547566|NCT02898259|62938980|FG004|Overall Study|Transformation before study began|0|||
33547567|NCT02963935|62938995|FG000|Overall Study|Adverse Event|12|||
33547568|NCT02963935|62938996|FG001|Overall Study|Adverse Event|6|||
33547569|NCT02963935|62938995|FG000|Overall Study|Protocol Violation|2|||
33547570|NCT02963935|62938996|FG001|Overall Study|Protocol Violation|1|||
33547571|NCT02963935|62938995|FG000|Overall Study|Lack of Efficacy|0|||
33547572|NCT02963935|62938996|FG001|Overall Study|Lack of Efficacy|2|||
33547573|NCT02963935|62938995|FG000|Overall Study|Lost to Follow-up|1|||
33547574|NCT02963935|62938996|FG001|Overall Study|Lost to Follow-up|6|||
33547575|NCT02963935|62938995|FG000|Overall Study|Unclassified|13|||
33547576|NCT02963935|62938996|FG001|Overall Study|Unclassified|22|||
33547577|NCT02963701|62939004|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
33547578|NCT02963701|62939005|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
33547579|NCT01345591|62939011|FG000|Overall Study|Lost to Follow-up|1|||
33547580|NCT02961751|62939020|FG000|Overall Study|Lost to Follow-up|11|||
33467291|NCT03267940|62840706|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
33467292|NCT03267940|62840707|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
33467293|NCT03267940|62840708|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
33467294|NCT03267940|62840709|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
33467295|NCT03267940|62840704|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
33467296|NCT03267940|62840705|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
33467297|NCT03267940|62840706|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
33467298|NCT03267940|62840707|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
33467299|NCT03267940|62840708|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
33467300|NCT03267940|62840709|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
33467301|NCT03267940|62840704|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
33467302|NCT03267940|62840705|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
33467303|NCT03267940|62840706|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
33467304|NCT03267940|62840707|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
33467305|NCT03267940|62840708|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
33467306|NCT03267940|62840709|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
33467307|NCT03267940|62840704|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
33467308|NCT03267940|62840705|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
33467309|NCT03267940|62840706|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
33467310|NCT03267940|62840707|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
33467311|NCT03267940|62840708|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
33467312|NCT03267940|62840709|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
33467313|NCT03267940|62840704|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
33328941|NCT00943917|62705454|FG004|Stage I|Adverse Event|0|||
33328942|NCT00943917|62705455|FG005|Stage I|Adverse Event|0|||
33328943|NCT00943917|62705456|FG006|Stage I|Adverse Event|0|||
33328944|NCT00943917|62705457|FG007|Stage I|Adverse Event|0|||
33328945|NCT00943917|62705458|FG008|Stage I|Adverse Event|0|||
33328946|NCT00943917|62705459|FG009|Stage I|Adverse Event|0|||
33467314|NCT03267940|62840705|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
33467315|NCT03267940|62840706|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
33467316|NCT03267940|62840707|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
33467317|NCT03267940|62840708|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
33467318|NCT03267940|62840709|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
33467319|NCT03267940|62840704|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
33467320|NCT03267940|62840705|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
33547581|NCT02961751|62939020|FG000|Overall Study|Physician Decision|2|||
33547582|NCT02961751|62939020|FG000|Overall Study|Not Eligible at Enrollment|1|||
33547583|NCT02961751|62939020|FG000|Overall Study|Protocol Violation|1|||
33547584|NCT02963311|62939024|FG000|Overall Study|Withdrawal by Subject|1|||
33653208|NCT01928381|63065423|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
33653209|NCT01928381|63065424|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
33653210|NCT01928381|63065425|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
33328947|NCT00943917|62705460|FG010|Stage I|Adverse Event|0|||
33328948|NCT00943917|62705461|FG011|Stage I|Adverse Event|0|||
33328949|NCT00943917|62705462|FG012|Stage I|Adverse Event|0|||
33328950|NCT00943917|62705463|FG013|Stage I|Adverse Event|0|||
33467321|NCT03267940|62840706|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
33467322|NCT03267940|62840707|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
33467323|NCT03267940|62840708|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
33467324|NCT03267940|62840709|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
33467325|NCT03267940|62840704|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
33467326|NCT03267940|62840705|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
33467327|NCT03267940|62840706|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
33467328|NCT03267940|62840707|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
33467329|NCT03267940|62840708|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
33467330|NCT03267940|62840709|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
33467331|NCT03267940|62840704|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
33467332|NCT03267940|62840705|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
33467333|NCT03267940|62840706|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
33467334|NCT03267940|62840707|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
33467335|NCT03267940|62840708|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
33467336|NCT03267940|62840709|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
33467337|NCT03267940|62840704|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
33467338|NCT03267940|62840705|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
33467339|NCT03267940|62840706|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
33467340|NCT03267940|62840707|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
33467341|NCT03267940|62840708|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
33467342|NCT03267940|62840709|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
33467343|NCT03296566|62840729|FG000|Overall Study|Lost to Follow-up|19|||
33467344|NCT03296566|62840730|FG001|Overall Study|Lost to Follow-up|46|||
33467345|NCT03296566|62840729|FG000|Overall Study|Withdrawal by Subject|0|||
33467346|NCT03296566|62840730|FG001|Overall Study|Withdrawal by Subject|3|||
33467347|NCT03755882|62840736|FG000|Period 1|Protocol Violation|1|||
33467348|NCT03755882|62840737|FG001|Period 1|Protocol Violation|0|||
33467349|NCT03755882|62840736|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
33467350|NCT03755882|62840737|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
33467351|NCT00312377|62840745|FG000|Overall Study|Death|403|||
33467352|NCT00312377|62840746|FG001|Overall Study|Death|418|||
33467353|NCT00312377|62840745|FG000|Overall Study|Withdrawal by Subject|23|||
33467354|NCT00312377|62840746|FG001|Overall Study|Withdrawal by Subject|30|||
33467355|NCT00312377|62840745|FG000|Overall Study|Lost to Follow-up|9|||
33547585|NCT02963311|62939024|FG000|Overall Study|Screen Failure|4|||
33547586|NCT02962765|62939028|FG000|Overall Study|Protocol Violation|9|||
33547587|NCT02962765|62939028|FG000|Overall Study|Withdrawal by Subject|3|||
33547588|NCT02962765|62939028|FG000|Overall Study|Lost to Follow-up|1|||
33547589|NCT02962765|62939028|FG000|Overall Study|Death|1|||
33547590|NCT02962765|62939028|FG000|Overall Study|Limited access to study medication|3|||
33547591|NCT00965757|62939041|FG000|Double-blind Phase|Progression of concomitant disease|1|||
33547592|NCT00965757|62939042|FG001|Double-blind Phase|Progression of concomitant disease|2|||
33547593|NCT00965757|62939043|FG002|Double-blind Phase|Progression of concomitant disease|0|||
33547594|NCT00965757|62939044|FG003|Double-blind Phase|Progression of concomitant disease|0|||
33547595|NCT00965757|62939041|FG000|Double-blind Phase|Adverse drug reaction|2|||
33547596|NCT00965757|62939042|FG001|Double-blind Phase|Adverse drug reaction|1|||
33653211|NCT01928381|63065426|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
33653212|NCT01928381|63065420|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
33653213|NCT01928381|63065421|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
33653214|NCT01928381|63065422|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
33547597|NCT00965757|62939043|FG002|Double-blind Phase|Adverse drug reaction|0|||
33547598|NCT00965757|62939044|FG003|Double-blind Phase|Adverse drug reaction|0|||
33653215|NCT01928381|63065423|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
33653216|NCT01928381|63065424|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
33653217|NCT01928381|63065425|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
33467356|NCT00312377|62840746|FG001|Overall Study|Lost to Follow-up|12|||
33467357|NCT00312377|62840745|FG000|Overall Study|Non-compliance|0|||
33467358|NCT00312377|62840746|FG001|Overall Study|Non-compliance|2|||
33467359|NCT00312377|62840745|FG000|Overall Study|Randomised but never received treatment|6|||
33547599|NCT00965757|62939041|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
33547600|NCT00965757|62939042|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
33547601|NCT00965757|62939043|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
33547602|NCT00965757|62939044|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
33547603|NCT00965757|62939041|FG000|Double-blind Phase|Lack of Efficacy|7|||
33547604|NCT00965757|62939042|FG001|Double-blind Phase|Lack of Efficacy|11|||
33547605|NCT00965757|62939043|FG002|Double-blind Phase|Lack of Efficacy|0|||
33547606|NCT00965757|62939044|FG003|Double-blind Phase|Lack of Efficacy|0|||
33547607|NCT00965757|62939041|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
33547608|NCT00965757|62939042|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
33547609|NCT00965757|62939043|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
33547610|NCT00965757|62939044|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
33547611|NCT00965757|62939041|FG000|Double-blind Phase|Lost to Follow-up|0|||
33547612|NCT00965757|62939042|FG001|Double-blind Phase|Lost to Follow-up|1|||
33547613|NCT00965757|62939043|FG002|Double-blind Phase|Lost to Follow-up|0|||
33547614|NCT00965757|62939044|FG003|Double-blind Phase|Lost to Follow-up|0|||
33547615|NCT00965757|62939041|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
33547616|NCT00965757|62939042|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
33547617|NCT00965757|62939043|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
33547618|NCT00965757|62939044|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
33547619|NCT00965757|62939041|FG000|Double-blind Phase|Other|1|||
33547620|NCT00965757|62939042|FG001|Double-blind Phase|Other|0|||
33547621|NCT00965757|62939043|FG002|Double-blind Phase|Other|0|||
33547622|NCT00965757|62939044|FG003|Double-blind Phase|Other|0|||
33547623|NCT00965757|62939041|FG000|Extension Phase|Progression of concomitant disease|0|||
33547624|NCT00965757|62939042|FG001|Extension Phase|Progression of concomitant disease|0|||
33547625|NCT00965757|62939043|FG002|Extension Phase|Progression of concomitant disease|4|||
33547626|NCT00965757|62939044|FG003|Extension Phase|Progression of concomitant disease|2|||
33547627|NCT00965757|62939041|FG000|Extension Phase|Adverse drug reaction|0|||
33547628|NCT00965757|62939042|FG001|Extension Phase|Adverse drug reaction|0|||
33547629|NCT00965757|62939043|FG002|Extension Phase|Adverse drug reaction|6|||
33547630|NCT00965757|62939044|FG003|Extension Phase|Adverse drug reaction|3|||
33547631|NCT00965757|62939041|FG000|Extension Phase|Abnormal Laboratory Value|0|||
33547632|NCT00965757|62939042|FG001|Extension Phase|Abnormal Laboratory Value|0|||
33547633|NCT00965757|62939043|FG002|Extension Phase|Abnormal Laboratory Value|6|||
33547634|NCT00965757|62939044|FG003|Extension Phase|Abnormal Laboratory Value|1|||
33547635|NCT00965757|62939041|FG000|Extension Phase|Lack of Efficacy|0|||
33547636|NCT00965757|62939042|FG001|Extension Phase|Lack of Efficacy|0|||
33547637|NCT00965757|62939043|FG002|Extension Phase|Lack of Efficacy|8|||
33547638|NCT00965757|62939044|FG003|Extension Phase|Lack of Efficacy|12|||
33547639|NCT00965757|62939041|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
33547640|NCT00965757|62939042|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
33547641|NCT00965757|62939043|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
33547642|NCT00965757|62939044|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
33547643|NCT00965757|62939041|FG000|Extension Phase|Lost to Follow-up|0|||
33547644|NCT00965757|62939042|FG001|Extension Phase|Lost to Follow-up|0|||
33653218|NCT01928381|63065426|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
33653219|NCT01928381|63065420|FG000|Washout First Intervention|Protocol Violation|0|||
33653220|NCT01928381|63065421|FG001|Washout First Intervention|Protocol Violation|0|||
33653221|NCT01928381|63065422|FG002|Washout First Intervention|Protocol Violation|0|||
33653222|NCT01928381|63065423|FG003|Washout First Intervention|Protocol Violation|0|||
33653223|NCT01928381|63065424|FG004|Washout First Intervention|Protocol Violation|1|||
33653224|NCT01928381|63065425|FG005|Washout First Intervention|Protocol Violation|0|||
33653225|NCT01928381|63065426|FG006|Washout First Intervention|Protocol Violation|0|||
33653226|NCT01928381|63065420|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
33653227|NCT01928381|63065421|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
33653228|NCT01928381|63065422|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
33653229|NCT01928381|63065423|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
33653230|NCT01928381|63065424|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
33653231|NCT01928381|63065425|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
33653232|NCT01928381|63065426|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
33653233|NCT01928381|63065420|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
33653234|NCT01928381|63065421|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
33653235|NCT01928381|63065422|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
33653236|NCT01928381|63065423|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
33653237|NCT01928381|63065424|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
33547645|NCT00965757|62939043|FG002|Extension Phase|Lost to Follow-up|0|||
33547646|NCT00965757|62939044|FG003|Extension Phase|Lost to Follow-up|1|||
33547647|NCT00965757|62939041|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
33653238|NCT01928381|63065425|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
33547648|NCT00965757|62939042|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
33547649|NCT00965757|62939043|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
33547650|NCT00965757|62939044|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
33653239|NCT01928381|63065426|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
33653240|NCT01928225|63065438|FG000|Overall Study|Pregnancy|1|||
33653241|NCT01928225|63065439|FG001|Overall Study|Pregnancy|0|||
33653242|NCT01928225|63065438|FG000|Overall Study|basaloid cervical cancer|1|||
33653243|NCT01928225|63065439|FG001|Overall Study|basaloid cervical cancer|0|||
33547651|NCT00965757|62939041|FG000|Extension Phase|Protocol Violation|0|||
33547652|NCT00965757|62939042|FG001|Extension Phase|Protocol Violation|0|||
33547653|NCT00965757|62939043|FG002|Extension Phase|Protocol Violation|0|||
33547654|NCT00965757|62939044|FG003|Extension Phase|Protocol Violation|1|||
33547655|NCT00965757|62939041|FG000|Extension Phase|Other|0|||
33547656|NCT00965757|62939042|FG001|Extension Phase|Other|0|||
33547657|NCT00965757|62939043|FG002|Extension Phase|Other|2|||
33547658|NCT00965757|62939044|FG003|Extension Phase|Other|1|||
33547659|NCT03072459|62939052|FG000|Overall Study|Device revised/removed|1|||
33547660|NCT03072459|62939052|FG000|Overall Study|Subject not able to return|1|||
33547661|NCT01067521|62939058|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
33547662|NCT01067521|62939059|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
33547663|NCT01067521|62939058|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
33547664|NCT01067521|62939059|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
33547665|NCT01067521|62939058|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
33547666|NCT01067521|62939059|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
33547667|NCT01067521|62939058|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
33547668|NCT01067521|62939059|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
33547669|NCT01067521|62939058|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
33547670|NCT01067521|62939059|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
33547671|NCT01067521|62939058|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
33547672|NCT01067521|62939059|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
33547673|NCT01067521|62939058|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
33547674|NCT01067521|62939059|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
33547675|NCT01067521|62939058|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
33547676|NCT01067521|62939059|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
33547677|NCT01067521|62939058|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
33547678|NCT01067521|62939059|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
33547679|NCT01067521|62939058|FG000|Open-Label Period|Death|3|||
33547680|NCT01067521|62939059|FG001|Open-Label Period|Death|1|||
33547681|NCT01067521|62939058|FG000|Open-Label Period|Adverse Event|30|||
33547682|NCT01067521|62939059|FG001|Open-Label Period|Adverse Event|28|||
33547683|NCT01067521|62939058|FG000|Open-Label Period|Withdrawal by Subject|160|||
33547684|NCT01067521|62939059|FG001|Open-Label Period|Withdrawal by Subject|88|||
33547685|NCT01067521|62939058|FG000|Open-Label Period|Physician Decision|13|||
33547686|NCT01067521|62939059|FG001|Open-Label Period|Physician Decision|11|||
33547687|NCT01067521|62939058|FG000|Open-Label Period|Non-compliance with study drug|5|||
33547688|NCT01067521|62939059|FG001|Open-Label Period|Non-compliance with study drug|0|||
33547689|NCT01067521|62939058|FG000|Open-Label Period|Protocol Violation|3|||
33547690|NCT01067521|62939059|FG001|Open-Label Period|Protocol Violation|0|||
33547691|NCT01067521|62939058|FG000|Open-Label Period|Pregnancy|14|||
33547692|NCT01067521|62939059|FG001|Open-Label Period|Pregnancy|8|||
33547693|NCT01067521|62939058|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
33547694|NCT01067521|62939059|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
33547695|NCT01067521|62939058|FG000|Open-Label Period|Lost to Follow-up|21|||
33547696|NCT01067521|62939059|FG001|Open-Label Period|Lost to Follow-up|20|||
33547697|NCT02735577|62939070|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
33547698|NCT02735577|62939070|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
33547699|NCT01345123|62939077|FG000|Overall Study|participants no longer with health plan|79|||
33547700|NCT01345123|62939078|FG001|Overall Study|participants no longer with health plan|85|||
33547701|NCT01345123|62939079|FG002|Overall Study|participants no longer with health plan|88|||
33653244|NCT01928225|63065438|FG000|Overall Study|Lost to Follow-up|1|||
33653245|NCT01928225|63065439|FG001|Overall Study|Lost to Follow-up|3|||
33653246|NCT01927757|63065446|FG000|Overall Study|Withdrawal by Subject|14|||
33653247|NCT01927757|63065446|FG000|Overall Study|Lost to Follow-up|2|||
33653248|NCT01927757|63065446|FG000|Overall Study|Decision by Sponsor|2|||
33653249|NCT01927757|63065446|FG000|Overall Study|Other|1|||
33547702|NCT02735421|62939088|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
33547703|NCT02735421|62939088|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
33547704|NCT02735421|62939088|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
33547705|NCT02735421|62939088|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
33547706|NCT02735421|62939088|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
33547707|NCT02735421|62939088|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
33653250|NCT01927757|63065446|FG000|Overall Study|Ethical Reasons|4|||
33653251|NCT01927367|63065456|FG000|Overall Study|Withdrawal by Subject|7|||
33653252|NCT01927367|63065457|FG001|Overall Study|Withdrawal by Subject|4|||
33653253|NCT01927367|63065456|FG000|Overall Study|No baseline data|0|||
33547708|NCT02735421|62939088|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
33547709|NCT02983799|62939105|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
33547710|NCT02983799|62939106|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
33547711|NCT02983799|62939107|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
33547712|NCT02983799|62939108|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
33547713|NCT02983799|62939109|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
33547714|NCT02983799|62939105|FG000|Overall Study|Death|20|||
33547715|NCT02983799|62939106|FG001|Overall Study|Death|5|||
33547716|NCT02983799|62939107|FG002|Overall Study|Death|23|||
33547717|NCT02983799|62939108|FG003|Overall Study|Death|47|||
33547718|NCT02983799|62939109|FG004|Overall Study|Death|7|||
33547719|NCT02983799|62939105|FG000|Overall Study|Withdrawal by Subject|1|||
33547720|NCT02983799|62939106|FG001|Overall Study|Withdrawal by Subject|0|||
33547721|NCT02983799|62939107|FG002|Overall Study|Withdrawal by Subject|3|||
33547722|NCT02983799|62939108|FG003|Overall Study|Withdrawal by Subject|4|||
33547723|NCT02983799|62939109|FG004|Overall Study|Withdrawal by Subject|1|||
33547724|NCT02983799|62939105|FG000|Overall Study|Protocol Violation|0|||
33547725|NCT02983799|62939106|FG001|Overall Study|Protocol Violation|1|||
33547726|NCT02983799|62939107|FG002|Overall Study|Protocol Violation|0|||
33547727|NCT02983799|62939108|FG003|Overall Study|Protocol Violation|0|||
33547728|NCT02983799|62939109|FG004|Overall Study|Protocol Violation|1|||
33547729|NCT02983799|62939105|FG000|Overall Study|Lost to Follow-up|1|||
33547730|NCT02983799|62939106|FG001|Overall Study|Lost to Follow-up|0|||
33547731|NCT02983799|62939107|FG002|Overall Study|Lost to Follow-up|1|||
33547732|NCT02983799|62939108|FG003|Overall Study|Lost to Follow-up|0|||
33547733|NCT02983799|62939109|FG004|Overall Study|Lost to Follow-up|0|||
33547734|NCT02186847|62939127|FG000|Overall Study|Protocol Violation|3|||
33547735|NCT02186847|62939128|FG001|Overall Study|Protocol Violation|0|||
33547736|NCT01066871|62939138|FG000|Overall Study|Lost to Follow-up|0|||
33547737|NCT01066871|62939139|FG001|Overall Study|Lost to Follow-up|2|||
33547738|NCT01066871|62939140|FG002|Overall Study|Lost to Follow-up|2|||
33547739|NCT01066871|62939141|FG003|Overall Study|Lost to Follow-up|0|||
33547740|NCT01066871|62939138|FG000|Overall Study|Protocol Violation|1|||
33547741|NCT01066871|62939139|FG001|Overall Study|Protocol Violation|0|||
33547742|NCT01066871|62939140|FG002|Overall Study|Protocol Violation|3|||
33547743|NCT01066871|62939141|FG003|Overall Study|Protocol Violation|2|||
33547744|NCT01066871|62939138|FG000|Overall Study|Lack of Efficacy|0|||
33547745|NCT01066871|62939139|FG001|Overall Study|Lack of Efficacy|0|||
33547746|NCT01066871|62939140|FG002|Overall Study|Lack of Efficacy|0|||
33547747|NCT01066871|62939141|FG003|Overall Study|Lack of Efficacy|1|||
33547748|NCT01066871|62939138|FG000|Overall Study|Withdrawal by Subject|3|||
33547749|NCT01066871|62939139|FG001|Overall Study|Withdrawal by Subject|1|||
33547750|NCT01066871|62939140|FG002|Overall Study|Withdrawal by Subject|0|||
33547751|NCT01066871|62939141|FG003|Overall Study|Withdrawal by Subject|0|||
33547752|NCT01066871|62939138|FG000|Overall Study|Other|0|||
33547753|NCT01066871|62939139|FG001|Overall Study|Other|2|||
33547754|NCT01066871|62939140|FG002|Overall Study|Other|1|||
33547755|NCT01066871|62939141|FG003|Overall Study|Other|2|||
33547756|NCT02982863|62939161|FG000|Overall Study|Not eligible patients|809|||
33547757|NCT02982863|62939162|FG001|Overall Study|Not eligible patients|4261|||
33547758|NCT02982863|62939163|FG002|Overall Study|Not eligible patients|1852|||
33547759|NCT02982863|62939164|FG003|Overall Study|Not eligible patients|1400|||
33547760|NCT02982863|62939165|FG004|Overall Study|Not eligible patients|492|||
33547761|NCT04343651|62939208|FG000|Overall Study|Physician Decision|2|||
33547762|NCT04343651|62939209|FG001|Overall Study|Physician Decision|1|||
33547763|NCT04343651|62939208|FG000|Overall Study|Lost to Follow-up|2|||
33547764|NCT04343651|62939209|FG001|Overall Study|Lost to Follow-up|1|||
33547765|NCT04343651|62939208|FG000|Overall Study|Protocol Violation|4|||
33547766|NCT04343651|62939209|FG001|Overall Study|Protocol Violation|6|||
33547767|NCT04343651|62939208|FG000|Overall Study|Missing|3|||
33547768|NCT04343651|62939209|FG001|Overall Study|Missing|9|||
33547769|NCT04343651|62939208|FG000|Overall Study|Withdrawal by Subject|0|||
33547770|NCT04343651|62939209|FG001|Overall Study|Withdrawal by Subject|4|||
33547771|NCT04343651|62939208|FG000|Overall Study|Death|0|||
33547772|NCT04343651|62939209|FG001|Overall Study|Death|1|||
33547773|NCT04343651|62939208|FG000|Overall Study|Did not start treatment|1|||
33547774|NCT04343651|62939209|FG001|Overall Study|Did not start treatment|1|||
33547775|NCT04343651|62939208|FG000|Overall Study|Patient did not complete visits 3-6|0|||
33547776|NCT04343651|62939209|FG001|Overall Study|Patient did not complete visits 3-6|1|||
33547777|NCT02906579|62939217|FG000|Overall Study|Adverse Event|1|||
33547778|NCT02906579|62939217|FG000|Overall Study|Physician Decision|1|||
33547779|NCT01328535|62939237|FG000|Overall Study|Ineligible|1|||
33547780|NCT02905331|62939245|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
33547781|NCT02905331|62939246|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
33547782|NCT02905331|62939247|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
33547783|NCT02905331|62939245|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
33547784|NCT02905331|62939246|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
33547785|NCT02905331|62939247|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
33547786|NCT02905331|62939245|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
33547787|NCT02905331|62939246|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
33547788|NCT02905331|62939247|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
33547789|NCT02905331|62939245|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
33547790|NCT02905331|62939246|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
33547791|NCT02905331|62939247|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
33547792|NCT02905331|62939245|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
33547793|NCT02905331|62939246|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
33547794|NCT02905331|62939247|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
33547795|NCT02979197|62939258|FG000|Overall Study|Adverse Event|4|||
33547796|NCT02979197|62939259|FG001|Overall Study|Adverse Event|2|||
33547797|NCT02979197|62939260|FG002|Overall Study|Adverse Event|0|||
33547798|NCT02979197|62939258|FG000|Overall Study|Protocol Violation|0|||
33547799|NCT02979197|62939259|FG001|Overall Study|Protocol Violation|1|||
33547800|NCT02979197|62939260|FG002|Overall Study|Protocol Violation|0|||
33547801|NCT02979197|62939258|FG000|Overall Study|Subject unable to commit to study dates|0|||
33547802|NCT02979197|62939259|FG001|Overall Study|Subject unable to commit to study dates|1|||
33547803|NCT02979197|62939260|FG002|Overall Study|Subject unable to commit to study dates|0|||
33547804|NCT02982239|62939270|FG000|Overall Study|Lost to Follow-up|3|||
33547805|NCT02982239|62939271|FG001|Overall Study|Lost to Follow-up|2|||
33547806|NCT01066793|62939284|FG000|Overall Study|Death|4|||
33547807|NCT01066793|62939285|FG001|Overall Study|Death|1|||
33547808|NCT01066793|62939286|FG002|Overall Study|Death|1|||
33547809|NCT01066793|62939287|FG003|Overall Study|Death|0|||
33547810|NCT01066793|62939288|FG004|Overall Study|Death|0|||
33547811|NCT01066793|62939289|FG005|Overall Study|Death|0|||
33547812|NCT01066793|62939284|FG000|Overall Study|Lack of Efficacy|2|||
33547813|NCT01066793|62939285|FG001|Overall Study|Lack of Efficacy|1|||
33547814|NCT01066793|62939286|FG002|Overall Study|Lack of Efficacy|0|||
33547815|NCT01066793|62939287|FG003|Overall Study|Lack of Efficacy|0|||
33547816|NCT01066793|62939288|FG004|Overall Study|Lack of Efficacy|0|||
33547817|NCT01066793|62939289|FG005|Overall Study|Lack of Efficacy|0|||
33547818|NCT01066793|62939284|FG000|Overall Study|Lost to Follow-up|180|||
33547819|NCT01066793|62939285|FG001|Overall Study|Lost to Follow-up|39|||
33547820|NCT01066793|62939286|FG002|Overall Study|Lost to Follow-up|82|||
33547821|NCT01066793|62939287|FG003|Overall Study|Lost to Follow-up|16|||
33547822|NCT01066793|62939288|FG004|Overall Study|Lost to Follow-up|0|||
33547823|NCT01066793|62939289|FG005|Overall Study|Lost to Follow-up|1|||
33547824|NCT01066793|62939284|FG000|Overall Study|Physician Decision|3|||
33547825|NCT01066793|62939285|FG001|Overall Study|Physician Decision|0|||
33547826|NCT01066793|62939286|FG002|Overall Study|Physician Decision|0|||
33547827|NCT01066793|62939287|FG003|Overall Study|Physician Decision|0|||
33547828|NCT01066793|62939288|FG004|Overall Study|Physician Decision|0|||
33547829|NCT01066793|62939289|FG005|Overall Study|Physician Decision|0|||
33547830|NCT01066793|62939284|FG000|Overall Study|Protocol Violation|3|||
33547831|NCT01066793|62939285|FG001|Overall Study|Protocol Violation|2|||
33547832|NCT01066793|62939286|FG002|Overall Study|Protocol Violation|2|||
33547833|NCT01066793|62939287|FG003|Overall Study|Protocol Violation|0|||
33547834|NCT01066793|62939288|FG004|Overall Study|Protocol Violation|0|||
33547835|NCT01066793|62939289|FG005|Overall Study|Protocol Violation|0|||
33547836|NCT01066793|62939284|FG000|Overall Study|Withdrawal by Subject|7|||
33547837|NCT01066793|62939285|FG001|Overall Study|Withdrawal by Subject|4|||
33547838|NCT01066793|62939286|FG002|Overall Study|Withdrawal by Subject|1|||
33547839|NCT01066793|62939287|FG003|Overall Study|Withdrawal by Subject|0|||
33547840|NCT01066793|62939288|FG004|Overall Study|Withdrawal by Subject|0|||
33547841|NCT01066793|62939289|FG005|Overall Study|Withdrawal by Subject|0|||
33547842|NCT01066793|62939284|FG000|Overall Study|Early Termination|3|||
33547843|NCT01066793|62939285|FG001|Overall Study|Early Termination|0|||
33547844|NCT01066793|62939286|FG002|Overall Study|Early Termination|0|||
33547845|NCT01066793|62939287|FG003|Overall Study|Early Termination|0|||
33547846|NCT01066793|62939288|FG004|Overall Study|Early Termination|0|||
33547847|NCT01066793|62939289|FG005|Overall Study|Early Termination|0|||
33547848|NCT01066793|62939284|FG000|Overall Study|Lab test not done|7|||
33547849|NCT01066793|62939285|FG001|Overall Study|Lab test not done|0|||
33547850|NCT01066793|62939286|FG002|Overall Study|Lab test not done|0|||
33547851|NCT01066793|62939287|FG003|Overall Study|Lab test not done|1|||
33547852|NCT01066793|62939288|FG004|Overall Study|Lab test not done|0|||
33547853|NCT01066793|62939289|FG005|Overall Study|Lab test not done|0|||
33547854|NCT01066793|62939284|FG000|Overall Study|Miscellaneous|4|||
33547855|NCT01066793|62939285|FG001|Overall Study|Miscellaneous|5|||
33547856|NCT01066793|62939286|FG002|Overall Study|Miscellaneous|6|||
33547857|NCT01066793|62939287|FG003|Overall Study|Miscellaneous|0|||
33547858|NCT01066793|62939288|FG004|Overall Study|Miscellaneous|0|||
33547859|NCT01066793|62939289|FG005|Overall Study|Miscellaneous|0|||
33547860|NCT01066793|62939284|FG000|Overall Study|Non-responders|104|||
33547861|NCT01066793|62939285|FG001|Overall Study|Non-responders|5|||
33547862|NCT01066793|62939286|FG002|Overall Study|Non-responders|11|||
33547863|NCT01066793|62939287|FG003|Overall Study|Non-responders|25|||
33547864|NCT01066793|62939288|FG004|Overall Study|Non-responders|0|||
33547865|NCT01066793|62939289|FG005|Overall Study|Non-responders|0|||
33547866|NCT01066793|62939284|FG000|Overall Study|Other|15|||
33547867|NCT01066793|62939285|FG001|Overall Study|Other|5|||
33547868|NCT01066793|62939286|FG002|Overall Study|Other|6|||
33547869|NCT01066793|62939287|FG003|Overall Study|Other|2|||
33547870|NCT01066793|62939288|FG004|Overall Study|Other|0|||
33547871|NCT01066793|62939289|FG005|Overall Study|Other|0|||
33547872|NCT01066793|62939284|FG000|Overall Study|Relapse|20|||
33547873|NCT01066793|62939285|FG001|Overall Study|Relapse|8|||
33547874|NCT01066793|62939286|FG002|Overall Study|Relapse|2|||
33547875|NCT01066793|62939287|FG003|Overall Study|Relapse|3|||
33547876|NCT01066793|62939288|FG004|Overall Study|Relapse|0|||
33547877|NCT01066793|62939289|FG005|Overall Study|Relapse|0|||
33547878|NCT01066793|62939284|FG000|Overall Study|Result Not Available|1|||
33547879|NCT01066793|62939285|FG001|Overall Study|Result Not Available|0|||
33547880|NCT01066793|62939286|FG002|Overall Study|Result Not Available|0|||
33547881|NCT01066793|62939287|FG003|Overall Study|Result Not Available|0|||
33547882|NCT01066793|62939288|FG004|Overall Study|Result Not Available|0|||
33547883|NCT01066793|62939289|FG005|Overall Study|Result Not Available|0|||
33547884|NCT01066793|62939284|FG000|Overall Study|Treatment Interrupted|1|||
33547885|NCT01066793|62939285|FG001|Overall Study|Treatment Interrupted|1|||
33653254|NCT01927367|63065457|FG001|Overall Study|No baseline data|1|||
33653255|NCT01913639|63065463|FG000|Overall Study|Not Eligible|3|||
33653256|NCT01913483|63065469|FG000|Overall Study|Withdrawal by Subject|1|||
33653257|NCT01913483|63065470|FG001|Overall Study|Withdrawal by Subject|2|||
33653258|NCT01913483|63065469|FG000|Overall Study|Lost to Follow-up|6|||
33653259|NCT01913483|63065470|FG001|Overall Study|Lost to Follow-up|3|||
33653260|NCT01913483|63065469|FG000|Overall Study|Death|14|||
33328951|NCT00943917|62705464|FG014|Stage I|Adverse Event|0|||
33547886|NCT01066793|62939286|FG002|Overall Study|Treatment Interrupted|0|||
33547887|NCT01066793|62939287|FG003|Overall Study|Treatment Interrupted|0|||
33547888|NCT01066793|62939288|FG004|Overall Study|Treatment Interrupted|0|||
33547889|NCT01066793|62939289|FG005|Overall Study|Treatment Interrupted|0|||
33547890|NCT01066793|62939284|FG000|Overall Study|Treatment Never Started|18|||
33547891|NCT01066793|62939285|FG001|Overall Study|Treatment Never Started|5|||
33547892|NCT01066793|62939286|FG002|Overall Study|Treatment Never Started|4|||
33547893|NCT01066793|62939287|FG003|Overall Study|Treatment Never Started|1|||
33328952|NCT00943917|62705450|FG000|Stage I|Lost to Follow-up|0|||
33547894|NCT01066793|62939288|FG004|Overall Study|Treatment Never Started|0|||
33653261|NCT01913483|63065470|FG001|Overall Study|Death|17|||
33653262|NCT01913405|63065476|FG000|Overall Study|Withdrawal by Subject|1|||
33547895|NCT01066793|62939289|FG005|Overall Study|Treatment Never Started|0|||
33547896|NCT01066793|62939284|FG000|Overall Study|Treatment Stopped|2|||
33547897|NCT01066793|62939285|FG001|Overall Study|Treatment Stopped|1|||
33547898|NCT01066793|62939286|FG002|Overall Study|Treatment Stopped|0|||
33547899|NCT01066793|62939287|FG003|Overall Study|Treatment Stopped|1|||
33547900|NCT01066793|62939288|FG004|Overall Study|Treatment Stopped|0|||
33547901|NCT01066793|62939289|FG005|Overall Study|Treatment Stopped|0|||
33547902|NCT03985293|62939310|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
33547903|NCT03985293|62939311|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
33547904|NCT03985293|62939312|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
33547905|NCT03985293|62939313|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
33547906|NCT03985293|62939314|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
33653263|NCT01913405|63065476|FG000|Overall Study|Adverse Event|1|||
33653264|NCT01927055|63065496|FG000|Open-label|Adverse Event|6|||
33547907|NCT03985293|62939315|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
33547908|NCT03985293|62939310|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
33547909|NCT03985293|62939311|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
33547910|NCT03985293|62939312|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
33547911|NCT03985293|62939313|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
33547912|NCT03985293|62939314|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
33547913|NCT03985293|62939315|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
33547914|NCT03985293|62939310|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
33547915|NCT03985293|62939311|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
33547916|NCT03985293|62939312|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
33547917|NCT03985293|62939313|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
33547918|NCT03985293|62939314|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
33547919|NCT03985293|62939315|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
33547920|NCT03985293|62939310|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
33547921|NCT03985293|62939311|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
33547922|NCT03985293|62939312|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
33547923|NCT03985293|62939313|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
33547924|NCT03985293|62939314|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
33547925|NCT03985293|62939315|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
33547926|NCT03985293|62939310|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
33547927|NCT03985293|62939311|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
33547928|NCT03985293|62939312|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
33547929|NCT03985293|62939313|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
33547930|NCT03985293|62939314|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
33547931|NCT03985293|62939315|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
33547932|NCT03985293|62939310|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
33547933|NCT03985293|62939311|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
33547934|NCT03985293|62939312|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
33547935|NCT03985293|62939313|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
33653265|NCT01927055|63065497|FG001|Open-label|Adverse Event|0|||
33653266|NCT01927055|63065498|FG002|Open-label|Adverse Event|0|||
33653267|NCT01927055|63065496|FG000|Open-label|Withdrawal by Subject|1|||
33653268|NCT01927055|63065497|FG001|Open-label|Withdrawal by Subject|0|||
33653269|NCT01927055|63065498|FG002|Open-label|Withdrawal by Subject|0|||
33653270|NCT01927055|63065496|FG000|Open-label|Study Stopped|4|||
33547936|NCT03985293|62939314|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
33547937|NCT03985293|62939315|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
33653271|NCT01927055|63065497|FG001|Open-label|Study Stopped|0|||
33653272|NCT01927055|63065498|FG002|Open-label|Study Stopped|0|||
33547938|NCT03985293|62939310|FG000|FOLLOW-UP|Lost to Follow-up|0|||
33547939|NCT03985293|62939311|FG001|FOLLOW-UP|Lost to Follow-up|0|||
33547940|NCT03985293|62939312|FG002|FOLLOW-UP|Lost to Follow-up|1|||
33547941|NCT03985293|62939313|FG003|FOLLOW-UP|Lost to Follow-up|0|||
33547942|NCT03985293|62939314|FG004|FOLLOW-UP|Lost to Follow-up|0|||
33547943|NCT03985293|62939315|FG005|FOLLOW-UP|Lost to Follow-up|0|||
33547944|NCT03654755|62939332|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
33547945|NCT03654755|62939333|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
33547946|NCT03654755|62939334|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
33547947|NCT03654755|62939332|FG000|Overall Study|Withdrawal by Subject|2|||
33547948|NCT03654755|62939333|FG001|Overall Study|Withdrawal by Subject|4|||
33547949|NCT03654755|62939334|FG002|Overall Study|Withdrawal by Subject|8|||
33547950|NCT03654755|62939332|FG000|Overall Study|Lost to Follow-up|1|||
33653273|NCT01927055|63065496|FG000|Open-label|Supine Hypertension|4|||
33653274|NCT01927055|63065497|FG001|Open-label|Supine Hypertension|0|||
33653275|NCT01927055|63065498|FG002|Open-label|Supine Hypertension|0|||
33547951|NCT03654755|62939333|FG001|Overall Study|Lost to Follow-up|3|||
33547952|NCT03654755|62939334|FG002|Overall Study|Lost to Follow-up|7|||
33547953|NCT03654755|62939332|FG000|Overall Study|Physician Decision|0|||
33547954|NCT03654755|62939333|FG001|Overall Study|Physician Decision|1|||
33547955|NCT03654755|62939334|FG002|Overall Study|Physician Decision|0|||
33653276|NCT01927055|63065496|FG000|Open-label|Difficulty attending study visits|1|||
33653277|NCT01927055|63065497|FG001|Open-label|Difficulty attending study visits|0|||
33547956|NCT03654755|62939332|FG000|Overall Study|Adverse Event|0|||
33547957|NCT03654755|62939333|FG001|Overall Study|Adverse Event|0|||
33547958|NCT03654755|62939334|FG002|Overall Study|Adverse Event|4|||
33547959|NCT03654755|62939332|FG000|Overall Study|Lack of Efficacy|0|||
33547960|NCT03654755|62939333|FG001|Overall Study|Lack of Efficacy|0|||
33547961|NCT03654755|62939334|FG002|Overall Study|Lack of Efficacy|1|||
33547962|NCT02980601|62939344|FG000|Overall Study|Lost to Follow-up|2|||
33547963|NCT02980601|62939345|FG001|Overall Study|Lost to Follow-up|2|||
33547964|NCT02980601|62939344|FG000|Overall Study|Death|0|||
33547965|NCT02980601|62939345|FG001|Overall Study|Death|1|||
33547966|NCT02980601|62939344|FG000|Overall Study|Graft loss|1|||
33547967|NCT02980601|62939345|FG001|Overall Study|Graft loss|0|||
33547968|NCT02980601|62939344|FG000|Overall Study|Failed to sign consent|2|||
33547969|NCT02980601|62939345|FG001|Overall Study|Failed to sign consent|0|||
33547970|NCT02980523|62939356|FG000|Overall Study|Lost to Follow-up|1|||
33547971|NCT02980523|62939357|FG001|Overall Study|Lost to Follow-up|4|||
33547972|NCT02980523|62939358|FG002|Overall Study|Lost to Follow-up|1|||
33547973|NCT02980523|62939359|FG003|Overall Study|Lost to Follow-up|2|||
33547974|NCT02980523|62939360|FG004|Overall Study|Lost to Follow-up|1|||
33547975|NCT02980523|62939356|FG000|Overall Study|Excluded from analysis|1|||
33547976|NCT02980523|62939357|FG001|Overall Study|Excluded from analysis|3|||
33547977|NCT02980523|62939358|FG002|Overall Study|Excluded from analysis|1|||
33547978|NCT02980523|62939359|FG003|Overall Study|Excluded from analysis|1|||
33547979|NCT02980523|62939360|FG004|Overall Study|Excluded from analysis|1|||
33547980|NCT02980523|62939356|FG000|Overall Study|Lack of Efficacy|1|||
33547981|NCT02980523|62939357|FG001|Overall Study|Lack of Efficacy|4|||
33547982|NCT02980523|62939358|FG002|Overall Study|Lack of Efficacy|4|||
33547983|NCT02980523|62939359|FG003|Overall Study|Lack of Efficacy|5|||
33547984|NCT02980523|62939360|FG004|Overall Study|Lack of Efficacy|8|||
33547985|NCT02980523|62939356|FG000|Overall Study|Did not receive intervention|0|||
33547986|NCT02980523|62939357|FG001|Overall Study|Did not receive intervention|0|||
33547987|NCT02980523|62939358|FG002|Overall Study|Did not receive intervention|0|||
33547988|NCT02980523|62939359|FG003|Overall Study|Did not receive intervention|1|||
33547989|NCT02980523|62939360|FG004|Overall Study|Did not receive intervention|0|||
33547990|NCT02980133|62939379|FG000|Overall Study|Other than specified|1|||
33547991|NCT02980133|62939380|FG001|Overall Study|Other than specified|1|||
33547992|NCT02980133|62939381|FG002|Overall Study|Other than specified|2|||
33547993|NCT02980133|62939382|FG003|Overall Study|Other than specified|2|||
33547994|NCT02980133|62939379|FG000|Overall Study|Lost to Follow-up|0|||
33547995|NCT02980133|62939380|FG001|Overall Study|Lost to Follow-up|0|||
33547996|NCT02980133|62939381|FG002|Overall Study|Lost to Follow-up|1|||
33547997|NCT02980133|62939382|FG003|Overall Study|Lost to Follow-up|3|||
33547998|NCT02980133|62939379|FG000|Overall Study|Protocol Violation|0|||
33547999|NCT02980133|62939380|FG001|Overall Study|Protocol Violation|1|||
33548000|NCT02980133|62939381|FG002|Overall Study|Protocol Violation|0|||
33548001|NCT02980133|62939382|FG003|Overall Study|Protocol Violation|0|||
33548002|NCT02980133|62939379|FG000|Overall Study|Withdrawal by parent/guardian|6|||
33548003|NCT02980133|62939380|FG001|Overall Study|Withdrawal by parent/guardian|3|||
33548004|NCT02980133|62939381|FG002|Overall Study|Withdrawal by parent/guardian|3|||
33548005|NCT02980133|62939382|FG003|Overall Study|Withdrawal by parent/guardian|1|||
33548006|NCT02980133|62939379|FG000|Overall Study|Withdrawal by Subject|0|||
33548007|NCT02980133|62939380|FG001|Overall Study|Withdrawal by Subject|0|||
33548008|NCT02980133|62939381|FG002|Overall Study|Withdrawal by Subject|1|||
33548009|NCT02980133|62939382|FG003|Overall Study|Withdrawal by Subject|0|||
33548010|NCT02979431|62939399|FG000|Overall Study|Parent/guardian withdrew consent|2|||
33548011|NCT02979431|62939400|FG001|Overall Study|Parent/guardian withdrew consent|1|||
33548012|NCT02979431|62939401|FG002|Overall Study|Parent/guardian withdrew consent|1|||
33548013|NCT02979431|62939402|FG003|Overall Study|Parent/guardian withdrew consent|1|||
33548014|NCT02979431|62939399|FG000|Overall Study|Randomized but received no study drug|1|||
33548015|NCT02979431|62939400|FG001|Overall Study|Randomized but received no study drug|1|||
33548016|NCT02979431|62939401|FG002|Overall Study|Randomized but received no study drug|0|||
33548017|NCT02979431|62939402|FG003|Overall Study|Randomized but received no study drug|0|||
33548018|NCT02979431|62939399|FG000|Overall Study|Adverse Event|0|||
33548019|NCT02979431|62939400|FG001|Overall Study|Adverse Event|0|||
33548020|NCT02979431|62939401|FG002|Overall Study|Adverse Event|1|||
33548021|NCT02979431|62939402|FG003|Overall Study|Adverse Event|0|||
33548022|NCT02979431|62939399|FG000|Overall Study|Subject left country after Day14|1|||
33548023|NCT02979431|62939400|FG001|Overall Study|Subject left country after Day14|0|||
33548024|NCT02979431|62939401|FG002|Overall Study|Subject left country after Day14|0|||
33548025|NCT02979431|62939402|FG003|Overall Study|Subject left country after Day14|0|||
33548026|NCT02978417|62939414|FG000|Overall Study|Lost to Follow-up|2|||
33548027|NCT02978417|62939415|FG001|Overall Study|Lost to Follow-up|2|||
33548028|NCT02733627|62939438|FG000|Overall Study|Adverse Event|0|||
33548029|NCT02733627|62939439|FG001|Overall Study|Adverse Event|1|||
33548030|NCT02733627|62939440|FG002|Overall Study|Adverse Event|1|||
33548031|NCT02733627|62939441|FG003|Overall Study|Adverse Event|0|||
33653278|NCT01927055|63065498|FG002|Open-label|Difficulty attending study visits|0|||
33653279|NCT01927055|63065496|FG000|Double-Blind|Adverse Event|0|||
33653280|NCT01927055|63065497|FG001|Double-Blind|Adverse Event|1|||
33653281|NCT01927055|63065498|FG002|Double-Blind|Adverse Event|1|||
33653282|NCT01927055|63065496|FG000|Double-Blind|Protocol Violation|0|||
33653283|NCT01927055|63065497|FG001|Double-Blind|Protocol Violation|0|||
33653284|NCT01927055|63065498|FG002|Double-Blind|Protocol Violation|1|||
33653285|NCT01927055|63065496|FG000|Double-Blind|Withdrawal by Subject|0|||
33653286|NCT01927055|63065497|FG001|Double-Blind|Withdrawal by Subject|2|||
33653287|NCT01927055|63065498|FG002|Double-Blind|Withdrawal by Subject|3|||
33653288|NCT01927055|63065496|FG000|Double-Blind|Study Stopped|0|||
33653289|NCT01927055|63065497|FG001|Double-Blind|Study Stopped|7|||
33653290|NCT01927055|63065498|FG002|Double-Blind|Study Stopped|7|||
33653291|NCT01927055|63065496|FG000|Double-Blind|Supine Hypertension|0|||
33653292|NCT01927055|63065497|FG001|Double-Blind|Supine Hypertension|0|||
33653293|NCT01927055|63065498|FG002|Double-Blind|Supine Hypertension|1|||
33653294|NCT01927055|63065496|FG000|Double-Blind|Extended Vacation|0|||
33653295|NCT01927055|63065497|FG001|Double-Blind|Extended Vacation|1|||
33653296|NCT01927055|63065498|FG002|Double-Blind|Extended Vacation|0|||
33653297|NCT01913327|63065507|FG000|Overall Study|Withdrawal by Subject|0|||
33653298|NCT01913327|63065508|FG001|Overall Study|Withdrawal by Subject|1|||
33653299|NCT01926509|63065518|FG000|Overall Study|vital sign met discontinuation criteria|1|||
33548032|NCT02733627|62939438|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
33548033|NCT02733627|62939439|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
33548034|NCT02733627|62939440|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
33548035|NCT02733627|62939441|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
33548036|NCT02958865|62939458|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33653300|NCT01926509|63065519|FG001|Overall Study|vital sign met discontinuation criteria|0|||
33653301|NCT01926509|63065520|FG002|Overall Study|vital sign met discontinuation criteria|0|||
33653302|NCT01926509|63065521|FG003|Overall Study|vital sign met discontinuation criteria|0|||
33467360|NCT00312377|62840746|FG001|Overall Study|Randomised but never received treatment|6|||
33467361|NCT00312377|62840745|FG000|Overall Study|Discontinue treatment survival follow up|202|||
33467362|NCT00312377|62840746|FG001|Overall Study|Discontinue treatment survival follow up|200|||
33467363|NCT00312377|62840745|FG000|Overall Study|Site ended participation in study|1|||
33467364|NCT00312377|62840746|FG001|Overall Study|Site ended participation in study|0|||
33467365|NCT03295318|62840755|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
33467366|NCT03295318|62840756|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
33467367|NCT03295318|62840757|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
33467368|NCT03295318|62840755|FG000|Overall Study|Death|1|||
33467369|NCT03295318|62840756|FG001|Overall Study|Death|1|||
33467370|NCT03295318|62840757|FG002|Overall Study|Death|1|||
33467371|NCT03295318|62840755|FG000|Overall Study|Protocol Violation|4|||
33467372|NCT03295318|62840756|FG001|Overall Study|Protocol Violation|3|||
33467373|NCT03295318|62840757|FG002|Overall Study|Protocol Violation|3|||
33467374|NCT03295318|62840755|FG000|Overall Study|Withdrawal by Subject|0|||
33467375|NCT03295318|62840756|FG001|Overall Study|Withdrawal by Subject|0|||
33467376|NCT03295318|62840757|FG002|Overall Study|Withdrawal by Subject|1|||
33328953|NCT00943917|62705451|FG001|Stage I|Lost to Follow-up|0|||
33328954|NCT00943917|62705452|FG002|Stage I|Lost to Follow-up|1|||
33328955|NCT00943917|62705453|FG003|Stage I|Lost to Follow-up|0|||
33328956|NCT00943917|62705454|FG004|Stage I|Lost to Follow-up|0|||
33328957|NCT00943917|62705455|FG005|Stage I|Lost to Follow-up|0|||
33328958|NCT00943917|62705456|FG006|Stage I|Lost to Follow-up|0|||
33328959|NCT00943917|62705457|FG007|Stage I|Lost to Follow-up|0|||
33467377|NCT03295318|62840755|FG000|Overall Study|Subject discontinued due to travel|0|||
33467378|NCT03295318|62840756|FG001|Overall Study|Subject discontinued due to travel|1|||
33467379|NCT03295318|62840757|FG002|Overall Study|Subject discontinued due to travel|0|||
33467380|NCT03311230|62840787|FG000|Overall Study|Withdrawal by Subject|1|||
33467381|NCT03311230|62840788|FG001|Overall Study|Withdrawal by Subject|4|||
33328960|NCT00943917|62705458|FG008|Stage I|Lost to Follow-up|0|||
33467382|NCT03311230|62840789|FG002|Overall Study|Withdrawal by Subject|2|||
33328961|NCT00943917|62705459|FG009|Stage I|Lost to Follow-up|0|||
33328962|NCT00943917|62705460|FG010|Stage I|Lost to Follow-up|0|||
33328963|NCT00943917|62705461|FG011|Stage I|Lost to Follow-up|0|||
33653303|NCT01926119|63065531|FG000|Overall Study|Withdrawal by Subject|1|||
33653304|NCT01912781|63065537|FG000|Overall Study|Withdrawal by Subject|2|||
33653305|NCT01912781|63065538|FG001|Overall Study|Withdrawal by Subject|0|||
33653306|NCT01925417|63065545|FG000|Overall Study|Withdrawal by Subject|2|||
33653307|NCT01925417|63065545|FG000|Overall Study|Death|1|||
33653308|NCT01911845|63065550|FG000|Overall Study|Adverse Event|2|||
33653309|NCT01911845|63065550|FG000|Overall Study|Lost to Follow-up|1|||
33653310|NCT01911845|63065550|FG000|Overall Study|Other (not specified)|3|||
33653311|NCT01925183|63065558|FG000|Overall Study|Adverse Event|1|||
33653312|NCT01925183|63065559|FG001|Overall Study|Adverse Event|0|||
33653313|NCT01910519|63065567|FG000|Overall Study|Withdrawal by Subject|2|||
33548037|NCT02958865|62939459|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
33548038|NCT02958865|62939460|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33548039|NCT02958865|62939461|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
33548040|NCT02958865|62939462|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
33548041|NCT02958865|62939463|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
33548042|NCT02958865|62939464|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
33548043|NCT02958865|62939465|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33548044|NCT02958865|62939466|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33548045|NCT02958865|62939467|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33548046|NCT02958865|62939468|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33548047|NCT02958865|62939469|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33548048|NCT02958865|62939470|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33548049|NCT02958865|62939471|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33548050|NCT02958865|62939472|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33653314|NCT01910519|63065568|FG001|Overall Study|Withdrawal by Subject|0|||
33653315|NCT01910519|63065567|FG000|Overall Study|Adverse Event|2|||
33653316|NCT01910519|63065568|FG001|Overall Study|Adverse Event|0|||
33653317|NCT01910441|63065576|FG000|Overall Study|Sponsor decision|0|||
33653318|NCT01910441|63065577|FG001|Overall Study|Sponsor decision|2|||
33653319|NCT01910441|63065576|FG000|Overall Study|Lost to Follow-up|6|||
33653320|NCT01910441|63065577|FG001|Overall Study|Lost to Follow-up|5|||
33653321|NCT01910441|63065576|FG000|Overall Study|Withdrawal by Subject|0|||
33653322|NCT01910441|63065577|FG001|Overall Study|Withdrawal by Subject|1|||
33653323|NCT01910441|63065576|FG000|Overall Study|Non-compliance|0|||
33653324|NCT01910441|63065577|FG001|Overall Study|Non-compliance|1|||
33653325|NCT01910441|63065576|FG000|Overall Study|Adverse Event|1|||
33653326|NCT01910441|63065577|FG001|Overall Study|Adverse Event|0|||
33653327|NCT01910441|63065576|FG000|Overall Study|Physician Decision|0|||
33653328|NCT01910441|63065577|FG001|Overall Study|Physician Decision|1|||
33653329|NCT01923467|63065583|FG000|Overall Study|Lost to Follow-up|62|||
33653330|NCT01923467|63065583|FG000|Overall Study|Subject non-interest|479|||
33653331|NCT01910129|63065589|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
33653332|NCT01910129|63065590|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
33653333|NCT01910129|63065591|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
33653334|NCT01910129|63065589|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
33653335|NCT01910129|63065590|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
33653336|NCT01910129|63065591|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
33653337|NCT01909973|63065611|FG000|Overall Study|Lost to Follow-up|1|||
33653338|NCT01909973|63065612|FG001|Overall Study|Lost to Follow-up|0|||
33653339|NCT01617005|63065618|FG000|Overall Study|Pregnancy|1|||
33653340|NCT01617005|63065618|FG000|Overall Study|Lack of motivation for treatment|1|||
33653341|NCT01925339|63065624|FG000|Overall Study|Adverse Event|2|||
33653342|NCT01925339|63065625|FG001|Overall Study|Adverse Event|0|||
33653343|NCT01908803|63065633|FG000|Overall Study|Adverse Event|1|||
33653344|NCT01908803|63065634|FG001|Overall Study|Adverse Event|0|||
33653345|NCT01908803|63065633|FG000|Overall Study|Physician Decision|0|||
33653346|NCT01908803|63065634|FG001|Overall Study|Physician Decision|1|||
33653347|NCT01908803|63065633|FG000|Overall Study|Withdrawal by Subject|1|||
33653348|NCT01908803|63065634|FG001|Overall Study|Withdrawal by Subject|0|||
33653349|NCT01908803|63065633|FG000|Overall Study|Randomization Error|1|||
33653350|NCT01908803|63065634|FG001|Overall Study|Randomization Error|0|||
33653351|NCT01908803|63065633|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
33653352|NCT01908803|63065634|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
33653353|NCT01908101|63065641|FG000|Overall Study|Physician Decision|1|||
33653354|NCT01908101|63065641|FG000|Overall Study|Withdrawal by Subject|1|||
33653355|NCT01908101|63065641|FG000|Overall Study|Incorrect Diagnosis|2|||
33653356|NCT01908101|63065641|FG000|Overall Study|Incorrect Starting Dose|1|||
33653357|NCT01908101|63065641|FG000|Overall Study|Did not complete the first cycle|4|||
33653358|NCT01923389|63065647|FG000|Overall Study|Protocol Violation|1|||
33328964|NCT00943917|62705462|FG012|Stage I|Lost to Follow-up|0|||
33653359|NCT01923389|63065648|FG001|Overall Study|Protocol Violation|0|||
33653360|NCT01907087|63065655|FG000|Overall Study|Withdrawal by Subject|1|||
33328965|NCT00943917|62705463|FG013|Stage I|Lost to Follow-up|0|||
33653361|NCT01616771|63065659|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
33653362|NCT01589185|63065673|FG000|Overall Study|Death|1|||
33548051|NCT02958865|62939473|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33548052|NCT02958865|62939458|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
33548053|NCT02958865|62939459|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
33548054|NCT02958865|62939460|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
33548055|NCT02958865|62939461|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
33548056|NCT02958865|62939462|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
33548057|NCT02958865|62939463|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
33548058|NCT02958865|62939464|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
33548059|NCT02958865|62939465|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
33548060|NCT02958865|62939466|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
33548061|NCT02958865|62939467|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
33548062|NCT02958865|62939468|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
33548063|NCT02958865|62939469|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
33548064|NCT02958865|62939470|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
33653363|NCT01589185|63065674|FG001|Overall Study|Death|2|||
33653364|NCT01589185|63065675|FG002|Overall Study|Death|2|||
33653365|NCT01589185|63065676|FG003|Overall Study|Death|0|||
33653366|NCT01589185|63065677|FG004|Overall Study|Death|1|||
33653367|NCT01589185|63065673|FG000|Overall Study|Lost to Follow-up|1|||
33653368|NCT01589185|63065674|FG001|Overall Study|Lost to Follow-up|0|||
33653369|NCT01589185|63065675|FG002|Overall Study|Lost to Follow-up|2|||
33653370|NCT01589185|63065676|FG003|Overall Study|Lost to Follow-up|3|||
33653371|NCT01589185|63065677|FG004|Overall Study|Lost to Follow-up|0|||
33653372|NCT01588951|63065693|FG000|Overall Study|Ineligible in retrospect|0|||
33653373|NCT01588951|63065694|FG001|Overall Study|Ineligible in retrospect|0|||
33653374|NCT01588951|63065695|FG002|Overall Study|Ineligible in retrospect|1|||
33653375|NCT01709383|63065705|FG000|Overall Study|Lost to Follow-up|1|||
33653376|NCT01709383|63065706|FG001|Overall Study|Lost to Follow-up|0|||
33653377|NCT01588405|63065714|FG000|Overall Study|Adverse Event|1|||
33653378|NCT01588405|63065714|FG000|Overall Study|Clinical Worsening|1|||
33653379|NCT01923311|63065723|FG000|Overall Study|Pregnancy|1|||
33653380|NCT01923311|63065724|FG001|Overall Study|Pregnancy|0|||
33653381|NCT01923311|63065723|FG000|Overall Study|Investigator's Discretion|1|||
33548065|NCT02958865|62939471|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
33548066|NCT02958865|62939472|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
33548067|NCT02958865|62939473|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
33548068|NCT02958865|62939458|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
33548069|NCT02958865|62939459|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
33548070|NCT02958865|62939460|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33548071|NCT02958865|62939461|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33548072|NCT02958865|62939462|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33548073|NCT02958865|62939463|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33548074|NCT02958865|62939464|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33548075|NCT02958865|62939465|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33548076|NCT02958865|62939466|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33548077|NCT02958865|62939467|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33548078|NCT02958865|62939468|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33548079|NCT02958865|62939469|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33548080|NCT02958865|62939470|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33548081|NCT02958865|62939471|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33548082|NCT02958865|62939472|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33548083|NCT02958865|62939473|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33548084|NCT02958865|62939458|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
33548085|NCT02958865|62939459|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33548086|NCT02958865|62939460|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
33548087|NCT02958865|62939461|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
33548088|NCT02958865|62939462|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
33548089|NCT02958865|62939463|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
33548090|NCT02958865|62939464|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
33548091|NCT02958865|62939465|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33548092|NCT02958865|62939466|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33653382|NCT01923311|63065724|FG001|Overall Study|Investigator's Discretion|0|||
33653383|NCT01923311|63065723|FG000|Overall Study|Non-Compliance with Study Drug|2|||
33653384|NCT01923311|63065724|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33653385|NCT01923311|63065723|FG000|Overall Study|Withdrew Consent|1|||
33653386|NCT01923311|63065724|FG001|Overall Study|Withdrew Consent|0|||
33548093|NCT02958865|62939467|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33653387|NCT01923311|63065723|FG000|Overall Study|Study Terminated by Sponsor|12|||
33653388|NCT01923311|63065724|FG001|Overall Study|Study Terminated by Sponsor|0|||
33653389|NCT01603615|63065731|FG000|Overall Study|Did not Receive Treatment|7|||
33548094|NCT02958865|62939468|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33653390|NCT01603615|63065731|FG000|Overall Study|Lost to Follow-up|9|||
33653391|NCT01603615|63065731|FG000|Overall Study|Personal Reasons|17|||
33548095|NCT02958865|62939469|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33548096|NCT02958865|62939470|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33548097|NCT02958865|62939471|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33548098|NCT02958865|62939472|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33548099|NCT02958865|62939473|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33548100|NCT02958865|62939458|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33548101|NCT02958865|62939459|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33548102|NCT02958865|62939460|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33548103|NCT02958865|62939461|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
33548104|NCT02958865|62939462|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33548105|NCT02958865|62939463|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33548106|NCT02958865|62939464|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
33548107|NCT02958865|62939465|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33548108|NCT02958865|62939466|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33548109|NCT02958865|62939467|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33548110|NCT02958865|62939468|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33548111|NCT02958865|62939469|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33653392|NCT01603615|63065731|FG000|Overall Study|Other Miscellaneous|1|||
33653393|NCT01685047|63065735|FG000|Overall Study|Withdrawal by Subject|20|||
33653394|NCT01685047|63065735|FG000|Overall Study|Death|26|||
33653395|NCT01685047|63065735|FG000|Overall Study|Lost to Follow-up|8|||
33328966|NCT00943917|62705464|FG014|Stage I|Lost to Follow-up|0|||
33653396|NCT01685047|63065735|FG000|Overall Study|Physician Decision|25|||
33467383|NCT03311230|62840790|FG003|Overall Study|Withdrawal by Subject|7|||
33467384|NCT03311230|62840787|FG000|Overall Study|Unrelated injury|0|||
33467385|NCT03311230|62840788|FG001|Overall Study|Unrelated injury|1|||
33467386|NCT03311230|62840789|FG002|Overall Study|Unrelated injury|0|||
33467387|NCT03311230|62840790|FG003|Overall Study|Unrelated injury|0|||
33467388|NCT00312221|62840803|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
33467389|NCT00312221|62840804|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
33467390|NCT00312221|62840805|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
33467391|NCT00312221|62840806|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
33467392|NCT00312221|62840803|FG000|Open-label Run-in Period|Adverse Event|74|||
33467393|NCT00312221|62840804|FG001|Open-label Run-in Period|Adverse Event|0|||
33467394|NCT00312221|62840805|FG002|Open-label Run-in Period|Adverse Event|0|||
33653397|NCT01685047|63065735|FG000|Overall Study|Adverse Event|5|||
33653398|NCT01685047|63065735|FG000|Overall Study|patient withdrawn by sponsor|1|||
33653399|NCT01905683|63065739|FG000|Overall Study|Protocol Violation|1|||
33467395|NCT00312221|62840806|FG003|Open-label Run-in Period|Adverse Event|0|||
33653400|NCT01905683|63065739|FG000|Overall Study|Re-injection criteria not met; others|13|||
33653401|NCT01905683|63065739|FG000|Overall Study|Physician Decision|1|||
33653402|NCT01905683|63065739|FG000|Overall Study|Lack of Efficacy|8|||
33653403|NCT01905683|63065739|FG000|Overall Study|Withdrawal by Subject|20|||
33653404|NCT01905683|63065739|FG000|Overall Study|Adverse Event|4|||
33653405|NCT01905683|63065739|FG000|Overall Study|Lost to Follow-up|4|||
33653406|NCT01921829|63065745|FG000|Overall Study|Withdrawal by Subject|0|||
33653407|NCT01921829|63065746|FG001|Overall Study|Withdrawal by Subject|1|||
33653408|NCT01904903|63065752|FG000|Overall Study|Withdrawal by Subject|1|||
33653409|NCT01921517|63065758|FG000|Overall Study|Lost to Follow-up|5|||
33653410|NCT01921517|63065759|FG001|Overall Study|Lost to Follow-up|0|||
33653411|NCT01921517|63065758|FG000|Overall Study|Newly diagnosed health concern|2|||
33653412|NCT01921517|63065759|FG001|Overall Study|Newly diagnosed health concern|0|||
33653413|NCT01921517|63065758|FG000|Overall Study|Physician Decision|0|||
33653414|NCT01921517|63065759|FG001|Overall Study|Physician Decision|2|||
33653415|NCT01921517|63065758|FG000|Overall Study|Withdrawal by Subject|7|||
33653416|NCT01921517|63065759|FG001|Overall Study|Withdrawal by Subject|3|||
33467396|NCT00312221|62840803|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
33328967|NCT00943917|62705450|FG000|Stage I|hyperglycemia|0|||
33328968|NCT00943917|62705451|FG001|Stage I|hyperglycemia|0|||
33328969|NCT00943917|62705452|FG002|Stage I|hyperglycemia|1|||
33328970|NCT00943917|62705453|FG003|Stage I|hyperglycemia|0|||
33328971|NCT00943917|62705454|FG004|Stage I|hyperglycemia|0|||
33328972|NCT00943917|62705455|FG005|Stage I|hyperglycemia|0|||
33328973|NCT00943917|62705456|FG006|Stage I|hyperglycemia|0|||
33328974|NCT00943917|62705457|FG007|Stage I|hyperglycemia|0|||
33328975|NCT00943917|62705458|FG008|Stage I|hyperglycemia|0|||
33328976|NCT00943917|62705459|FG009|Stage I|hyperglycemia|0|||
33467397|NCT00312221|62840804|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
33467398|NCT00312221|62840805|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
33467399|NCT00312221|62840806|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
33467400|NCT00312221|62840803|FG000|Open-label Run-in Period|Administrative|42|||
33467401|NCT00312221|62840804|FG001|Open-label Run-in Period|Administrative|0|||
33467402|NCT00312221|62840805|FG002|Open-label Run-in Period|Administrative|0|||
33467403|NCT00312221|62840806|FG003|Open-label Run-in Period|Administrative|0|||
33467404|NCT00312221|62840803|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
33467405|NCT00312221|62840804|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
33467406|NCT00312221|62840805|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
33467407|NCT00312221|62840806|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
33467408|NCT00312221|62840803|FG000|Open-label Run-in Period|Did not qualify|5|||
33467409|NCT00312221|62840804|FG001|Open-label Run-in Period|Did not qualify|0|||
33467410|NCT00312221|62840805|FG002|Open-label Run-in Period|Did not qualify|0|||
33467411|NCT00312221|62840806|FG003|Open-label Run-in Period|Did not qualify|0|||
33467412|NCT00312221|62840803|FG000|Double-blind Phase|Withdrawal by Subject|0|||
33467413|NCT00312221|62840804|FG001|Double-blind Phase|Withdrawal by Subject|6|||
33467414|NCT00312221|62840805|FG002|Double-blind Phase|Withdrawal by Subject|8|||
33467415|NCT00312221|62840806|FG003|Double-blind Phase|Withdrawal by Subject|7|||
33467416|NCT00312221|62840803|FG000|Double-blind Phase|Adverse Event|0|||
33467417|NCT00312221|62840804|FG001|Double-blind Phase|Adverse Event|10|||
33467418|NCT00312221|62840805|FG002|Double-blind Phase|Adverse Event|19|||
33467419|NCT00312221|62840806|FG003|Double-blind Phase|Adverse Event|18|||
33467420|NCT00312221|62840803|FG000|Double-blind Phase|Lost to Follow-up|0|||
33467421|NCT00312221|62840804|FG001|Double-blind Phase|Lost to Follow-up|0|||
33467422|NCT00312221|62840805|FG002|Double-blind Phase|Lost to Follow-up|2|||
33467423|NCT00312221|62840806|FG003|Double-blind Phase|Lost to Follow-up|2|||
33467424|NCT00312221|62840803|FG000|Double-blind Phase|Administrative|0|||
33467425|NCT00312221|62840804|FG001|Double-blind Phase|Administrative|26|||
33467426|NCT00312221|62840805|FG002|Double-blind Phase|Administrative|37|||
33467427|NCT00312221|62840806|FG003|Double-blind Phase|Administrative|33|||
33467428|NCT00312221|62840803|FG000|Double-blind Phase|Lack of Efficacy|0|||
33467429|NCT00312221|62840804|FG001|Double-blind Phase|Lack of Efficacy|17|||
33467430|NCT00312221|62840805|FG002|Double-blind Phase|Lack of Efficacy|6|||
33467431|NCT00312221|62840806|FG003|Double-blind Phase|Lack of Efficacy|10|||
33467432|NCT03294538|62840830|FG000|Overall Study|Adverse Event|0|||
33467433|NCT03294538|62840831|FG001|Overall Study|Adverse Event|1|||
33467434|NCT03294538|62840832|FG002|Overall Study|Adverse Event|1|||
33467435|NCT03294538|62840830|FG000|Overall Study|Lost to Follow-up|1|||
33467436|NCT03294538|62840831|FG001|Overall Study|Lost to Follow-up|0|||
33467437|NCT03294538|62840832|FG002|Overall Study|Lost to Follow-up|0|||
33467438|NCT03294538|62840830|FG000|Overall Study|Outside of Visit Window|4|||
33467439|NCT03294538|62840831|FG001|Overall Study|Outside of Visit Window|4|||
33467440|NCT03294538|62840832|FG002|Overall Study|Outside of Visit Window|1|||
33467441|NCT03265600|62840842|FG000|Overall Study|Lost to Follow-up|17|||
33467442|NCT03265600|62840843|FG001|Overall Study|Lost to Follow-up|5|||
33467443|NCT03265600|62840842|FG000|Overall Study|Withdrawal by Subject|4|||
33467444|NCT03265600|62840843|FG001|Overall Study|Withdrawal by Subject|2|||
33467445|NCT03265600|62840842|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
33467446|NCT03265600|62840843|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
33467447|NCT00335153|62840849|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
33467448|NCT00335153|62840849|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
33467449|NCT00335153|62840849|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
33467450|NCT00335153|62840849|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
33467451|NCT00335153|62840849|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
33467452|NCT00335153|62840849|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
33467453|NCT00335153|62840849|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
33467454|NCT00335153|62840849|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
33467455|NCT00335153|62840849|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
33467456|NCT00335153|62840849|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
33548112|NCT02958865|62939470|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33548113|NCT02958865|62939471|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33548114|NCT02958865|62939472|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33548115|NCT02958865|62939473|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33548116|NCT02958865|62939458|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33548117|NCT02958865|62939459|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33548118|NCT02958865|62939460|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
33548119|NCT02958865|62939461|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33548120|NCT02958865|62939462|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33548121|NCT02958865|62939463|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33548122|NCT02958865|62939464|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33548123|NCT02958865|62939465|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33548124|NCT02958865|62939466|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33467457|NCT03265132|62840855|FG000|Overall Study|Adverse Event|0|||
33467458|NCT03265132|62840856|FG001|Overall Study|Adverse Event|1|||
33653417|NCT01921517|63065758|FG000|Overall Study|Subject missed final imaging|1|||
33653418|NCT01921517|63065759|FG001|Overall Study|Subject missed final imaging|4|||
33467459|NCT03265132|62840855|FG000|Overall Study|Lack of Efficacy|0|||
33467460|NCT03265132|62840856|FG001|Overall Study|Lack of Efficacy|2|||
33467461|NCT03265132|62840855|FG000|Overall Study|Progressive disease|0|||
33467462|NCT03265132|62840856|FG001|Overall Study|Progressive disease|2|||
33467463|NCT03265132|62840855|FG000|Overall Study|Withdrawal by Subject|0|||
33467464|NCT03265132|62840856|FG001|Overall Study|Withdrawal by Subject|1|||
33467465|NCT02939950|62840866|FG000|Overall Study|Lost to Follow-up|13|||
33467466|NCT02939950|62840867|FG001|Overall Study|Lost to Follow-up|16|||
33467467|NCT02939950|62840866|FG000|Overall Study|Positive slit lamp findings|0|||
33467468|NCT02939950|62840867|FG001|Overall Study|Positive slit lamp findings|1|||
33467469|NCT02939950|62840866|FG000|Overall Study|Chalazion upper lid|0|||
33467470|NCT02939950|62840867|FG001|Overall Study|Chalazion upper lid|1|||
33467471|NCT02939950|62840866|FG000|Overall Study|Lack of motivation|0|||
33467472|NCT02939950|62840867|FG001|Overall Study|Lack of motivation|2|||
33467473|NCT02939950|62840866|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
33467474|NCT02939950|62840867|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
33467475|NCT02939950|62840866|FG000|Overall Study|Military orders|1|||
33467476|NCT02939950|62840867|FG001|Overall Study|Military orders|0|||
33467477|NCT02939950|62840866|FG000|Overall Study|Participant Relocated|5|||
33467478|NCT02939950|62840867|FG001|Overall Study|Participant Relocated|3|||
33467479|NCT02939950|62840866|FG000|Overall Study|Study related symptoms|8|||
33467480|NCT02939950|62840867|FG001|Overall Study|Study related symptoms|8|||
33467481|NCT02939950|62840866|FG000|Overall Study|Unacceptable lens movement|2|||
33467482|NCT02939950|62840867|FG001|Overall Study|Unacceptable lens movement|0|||
33467483|NCT02939950|62840866|FG000|Overall Study|Protocol Violation|6|||
33467484|NCT02939950|62840867|FG001|Overall Study|Protocol Violation|3|||
33467485|NCT02939950|62840866|FG000|Overall Study|Physician Decision|2|||
33467486|NCT02939950|62840867|FG001|Overall Study|Physician Decision|0|||
33467487|NCT02939950|62840866|FG000|Overall Study|Pregnancy|6|||
33467488|NCT02939950|62840867|FG001|Overall Study|Pregnancy|7|||
33467489|NCT02939950|62840866|FG000|Overall Study|Withdrawal by Subject|12|||
33467490|NCT02939950|62840867|FG001|Overall Study|Withdrawal by Subject|28|||
33467491|NCT02939950|62840866|FG000|Overall Study|Adverse Event|7|||
33467492|NCT02939950|62840867|FG001|Overall Study|Adverse Event|3|||
33467493|NCT02939950|62840866|FG000|Overall Study|Randomized, not dispensed|1|||
33467494|NCT02939950|62840867|FG001|Overall Study|Randomized, not dispensed|0|||
33467495|NCT02939950|62840866|FG000|Overall Study|Ineligible at Baseline|2|||
33467496|NCT02939950|62840867|FG001|Overall Study|Ineligible at Baseline|8|||
33467497|NCT03753542|62840875|FG000|Overall Study|Lost to Follow-up|9|||
33467498|NCT03753542|62840876|FG001|Overall Study|Lost to Follow-up|14|||
33467499|NCT03292588|62840884|FG000|Overall Study|Death|1|||
33467500|NCT03292588|62840885|FG001|Overall Study|Death|0|||
33467501|NCT03292588|62840884|FG000|Overall Study|Lost to Follow-up|12|||
33467502|NCT03292588|62840885|FG001|Overall Study|Lost to Follow-up|16|||
33467503|NCT03292588|62840884|FG000|Overall Study|Physician Decision|0|||
33467504|NCT03292588|62840885|FG001|Overall Study|Physician Decision|1|||
33467505|NCT03292588|62840884|FG000|Overall Study|Withdrawal by Subject|4|||
33467506|NCT03292588|62840885|FG001|Overall Study|Withdrawal by Subject|4|||
33467507|NCT03292588|62840884|FG000|Overall Study|Move out of town|1|||
33467508|NCT03292588|62840885|FG001|Overall Study|Move out of town|0|||
33467509|NCT03292588|62840884|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
33467510|NCT03292588|62840885|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
33467511|NCT03752528|62840893|FG000|Part A|Lost to Follow-up|1|||
33467512|NCT03752528|62840893|FG000|Part A|Protocol Violation|1|||
33467513|NCT03752528|62840893|FG000|Part B|Protocol Violation|1|||
33467514|NCT03752528|62840893|FG000|Part B|Study terminated by sponsor|3|||
33467515|NCT00334295|62840900|FG000|Overall Study|Patients received fewer than 3 injection|5|||
33467516|NCT03292432|62840906|FG000|Overall Study|Lost to Follow-up|11|||
33467517|NCT03292432|62840907|FG001|Overall Study|Lost to Follow-up|8|||
33467518|NCT03292432|62840906|FG000|Overall Study|Death|2|||
33467519|NCT03292432|62840907|FG001|Overall Study|Death|1|||
33467520|NCT03292432|62840906|FG000|Overall Study|Withdrawal by Subject|1|||
33467521|NCT03292432|62840907|FG001|Overall Study|Withdrawal by Subject|2|||
33467522|NCT03292432|62840906|FG000|Overall Study|Site closed before any data collected|1|||
33467523|NCT03292432|62840907|FG001|Overall Study|Site closed before any data collected|0|||
33467524|NCT03291808|62840913|FG000|Overall Study|Lost to Follow-up|6|||
33467525|NCT03291808|62840913|FG000|Overall Study|Research burden|4|||
33467526|NCT03263806|62840919|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
33467527|NCT03263806|62840920|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
33467528|NCT03263806|62840919|FG000|Overall Study|Withdrawal by Subject|0|||
33467529|NCT03263806|62840920|FG001|Overall Study|Withdrawal by Subject|1|||
33467530|NCT03263806|62840919|FG000|Overall Study|Study Termination|5|||
33467531|NCT03263806|62840920|FG001|Overall Study|Study Termination|6|||
33467532|NCT03751280|62840928|FG000|Overall Study|Adverse Event|0|||
33653419|NCT01921205|63065767|FG000|Overall Study|Adverse Event|12|||
33467533|NCT03751280|62840929|FG001|Overall Study|Adverse Event|1|||
33467534|NCT03751280|62840928|FG000|Overall Study|Lost to Follow-up|3|||
33467535|NCT03751280|62840929|FG001|Overall Study|Lost to Follow-up|5|||
33467536|NCT03751280|62840928|FG000|Overall Study|Physician Decision|0|||
33467537|NCT03751280|62840929|FG001|Overall Study|Physician Decision|2|||
33467538|NCT03751280|62840928|FG000|Overall Study|Protocol Violation|0|||
33467539|NCT03751280|62840929|FG001|Overall Study|Protocol Violation|2|||
33467540|NCT03751280|62840928|FG000|Overall Study|Withdrawal by Subject|5|||
33467541|NCT03751280|62840929|FG001|Overall Study|Withdrawal by Subject|2|||
33467542|NCT00311363|62840939|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
33467543|NCT00311363|62840940|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
33467544|NCT00311363|62840941|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
33467545|NCT00311363|62840939|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
33467546|NCT00311363|62840940|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
33467547|NCT00311363|62840941|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
33467548|NCT00311363|62840939|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
33467549|NCT00311363|62840940|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
33467550|NCT00311363|62840941|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
33467551|NCT00311363|62840939|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
33467552|NCT00311363|62840940|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
33467553|NCT00311363|62840941|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
33467554|NCT00311363|62840939|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
33467555|NCT00311363|62840940|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
33467556|NCT00311363|62840941|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
33467557|NCT00311363|62840939|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
33467558|NCT00311363|62840940|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
33467559|NCT00311363|62840941|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
33467560|NCT00311363|62840939|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
33467561|NCT00311363|62840940|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
33467562|NCT00311363|62840941|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
33467563|NCT00311363|62840939|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
33467564|NCT00311363|62840940|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
33467565|NCT00311363|62840941|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
33467566|NCT00311363|62840939|FG000|24-Week Single-Blind Treatment Period|Death|1|||
33467567|NCT00311363|62840940|FG001|24-Week Single-Blind Treatment Period|Death|0|||
33467568|NCT00311363|62840941|FG002|24-Week Single-Blind Treatment Period|Death|0|||
33467569|NCT00311363|62840939|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
33467570|NCT00311363|62840940|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
33467571|NCT00311363|62840941|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
33467572|NCT00311363|62840939|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
33467573|NCT00311363|62840940|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
33467574|NCT00311363|62840941|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
33467575|NCT00311363|62840939|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
33467576|NCT00311363|62840940|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
33467577|NCT00311363|62840941|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
33467578|NCT00311363|62840939|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
33467579|NCT00311363|62840940|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
33467580|NCT00311363|62840941|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
33467581|NCT00311363|62840939|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
33328977|NCT00943917|62705460|FG010|Stage I|hyperglycemia|0|||
33328978|NCT00943917|62705461|FG011|Stage I|hyperglycemia|0|||
33328979|NCT00943917|62705462|FG012|Stage I|hyperglycemia|0|||
33328980|NCT00943917|62705463|FG013|Stage I|hyperglycemia|0|||
33328981|NCT00943917|62705464|FG014|Stage I|hyperglycemia|0|||
33328982|NCT00943917|62705450|FG000|Stage I|A1C elevation|1|||
33328983|NCT00943917|62705451|FG001|Stage I|A1C elevation|0|||
33328984|NCT00943917|62705452|FG002|Stage I|A1C elevation|0|||
33328985|NCT00943917|62705453|FG003|Stage I|A1C elevation|0|||
33328986|NCT00943917|62705454|FG004|Stage I|A1C elevation|0|||
33328987|NCT00943917|62705455|FG005|Stage I|A1C elevation|0|||
33467582|NCT00311363|62840940|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
33467583|NCT00311363|62840941|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
33467584|NCT00311363|62840939|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
33467585|NCT00311363|62840940|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
33467586|NCT00311363|62840941|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
33467587|NCT00333983|62840954|FG000|Overall Study|Lost to Follow-up|2|||
33467588|NCT00333983|62840955|FG001|Overall Study|Lost to Follow-up|1|||
33467589|NCT00333983|62840956|FG002|Overall Study|Lost to Follow-up|0|||
33467590|NCT00333983|62840954|FG000|Overall Study|Adverse Event|1|||
33467591|NCT00333983|62840955|FG001|Overall Study|Adverse Event|1|||
33467592|NCT00333983|62840956|FG002|Overall Study|Adverse Event|1|||
33467593|NCT00333983|62840954|FG000|Overall Study|Withdrawal by Subject|0|||
33467594|NCT00333983|62840955|FG001|Overall Study|Withdrawal by Subject|3|||
33467595|NCT00333983|62840956|FG002|Overall Study|Withdrawal by Subject|1|||
33467596|NCT03262012|62840968|FG000|Overall Study|Withdrawal by Subject|15|||
33467597|NCT03262012|62840969|FG001|Overall Study|Withdrawal by Subject|13|||
33467598|NCT03262012|62840970|FG002|Overall Study|Withdrawal by Subject|8|||
33467599|NCT03262012|62840971|FG003|Overall Study|Withdrawal by Subject|7|||
33467600|NCT03262012|62840968|FG000|Overall Study|Adverse Event|10|||
33467601|NCT03262012|62840969|FG001|Overall Study|Adverse Event|12|||
33467602|NCT03262012|62840970|FG002|Overall Study|Adverse Event|4|||
33467603|NCT03262012|62840971|FG003|Overall Study|Adverse Event|6|||
33467604|NCT03262012|62840968|FG000|Overall Study|Physician Decision|2|||
33467605|NCT03262012|62840969|FG001|Overall Study|Physician Decision|5|||
33467606|NCT03262012|62840970|FG002|Overall Study|Physician Decision|1|||
33467607|NCT03262012|62840971|FG003|Overall Study|Physician Decision|0|||
33467608|NCT03262012|62840968|FG000|Overall Study|Lack of Efficacy|0|||
33467609|NCT03262012|62840969|FG001|Overall Study|Lack of Efficacy|5|||
33467610|NCT03262012|62840970|FG002|Overall Study|Lack of Efficacy|1|||
33467611|NCT03262012|62840971|FG003|Overall Study|Lack of Efficacy|2|||
33467612|NCT03262012|62840968|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
33467613|NCT03262012|62840969|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
33467614|NCT03262012|62840970|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
33467615|NCT03262012|62840971|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
33467616|NCT03288142|62840983|FG000|Overall Study|Lost to Follow-up|22|||
33467617|NCT03288142|62840984|FG001|Overall Study|Lost to Follow-up|15|||
33467618|NCT00310817|62840996|FG000|Overall Study|AE or Death|3|||
33467619|NCT00310817|62840997|FG001|Overall Study|AE or Death|1|||
33467620|NCT00310817|62840998|FG002|Overall Study|AE or Death|0|||
33467621|NCT00310817|62840999|FG003|Overall Study|AE or Death|0|||
33467622|NCT00310817|62840996|FG000|Overall Study|Withdrawal by Subject|1|||
33467623|NCT00310817|62840997|FG001|Overall Study|Withdrawal by Subject|4|||
33467624|NCT00310817|62840998|FG002|Overall Study|Withdrawal by Subject|6|||
33467625|NCT00310817|62840999|FG003|Overall Study|Withdrawal by Subject|7|||
33467626|NCT00310817|62840996|FG000|Overall Study|Lost to Follow-up|2|||
33467627|NCT00310817|62840997|FG001|Overall Study|Lost to Follow-up|1|||
33467628|NCT00310817|62840998|FG002|Overall Study|Lost to Follow-up|0|||
33467629|NCT00310817|62840999|FG003|Overall Study|Lost to Follow-up|0|||
33467630|NCT00310817|62840996|FG000|Overall Study|Inappropriate Enrollment|1|||
33467631|NCT00310817|62840997|FG001|Overall Study|Inappropriate Enrollment|0|||
33467632|NCT00310817|62840998|FG002|Overall Study|Inappropriate Enrollment|1|||
33467633|NCT00310817|62840999|FG003|Overall Study|Inappropriate Enrollment|0|||
33467634|NCT00310817|62840996|FG000|Overall Study|Protocol Violation|1|||
33467635|NCT00310817|62840997|FG001|Overall Study|Protocol Violation|1|||
33467636|NCT00310817|62840998|FG002|Overall Study|Protocol Violation|1|||
33467637|NCT00310817|62840999|FG003|Overall Study|Protocol Violation|1|||
33467638|NCT00310817|62840996|FG000|Overall Study|Unable to classify|3|||
33548125|NCT02958865|62939467|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33548126|NCT02958865|62939468|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33548127|NCT02958865|62939469|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33548128|NCT02958865|62939470|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33548129|NCT02958865|62939471|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33548130|NCT02958865|62939472|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33467639|NCT00310817|62840997|FG001|Overall Study|Unable to classify|1|||
33467640|NCT00310817|62840998|FG002|Overall Study|Unable to classify|0|||
33467641|NCT00310817|62840999|FG003|Overall Study|Unable to classify|0|||
33467642|NCT02940886|62841044|FG000|Overall Study|Adverse Event|7|||
33467643|NCT02940886|62841045|FG001|Overall Study|Adverse Event|3|||
33467644|NCT02940886|62841044|FG000|Overall Study|Protocol Violation|0|||
33653420|NCT01921205|63065768|FG001|Overall Study|Adverse Event|7|||
33467645|NCT02940886|62841045|FG001|Overall Study|Protocol Violation|2|||
33467646|NCT02940886|62841044|FG000|Overall Study|Withdrawal by Subject|28|||
33467647|NCT02940886|62841045|FG001|Overall Study|Withdrawal by Subject|20|||
33467648|NCT02940886|62841044|FG000|Overall Study|Death|1|||
33467649|NCT02940886|62841045|FG001|Overall Study|Death|0|||
33467650|NCT02940886|62841044|FG000|Overall Study|Lack of Efficacy|1|||
33467651|NCT02940886|62841045|FG001|Overall Study|Lack of Efficacy|0|||
33467652|NCT02940886|62841044|FG000|Overall Study|Lost to Follow-up|49|||
33467653|NCT02940886|62841045|FG001|Overall Study|Lost to Follow-up|21|||
33467654|NCT02940886|62841044|FG000|Overall Study|Physician Decision|9|||
33467655|NCT02940886|62841045|FG001|Overall Study|Physician Decision|4|||
33467656|NCT02940886|62841044|FG000|Overall Study|Sponsor decision|0|||
33467657|NCT02940886|62841045|FG001|Overall Study|Sponsor decision|1|||
33467658|NCT02940886|62841044|FG000|Overall Study|No treatment|7|||
33467659|NCT02940886|62841045|FG001|Overall Study|No treatment|2|||
33467660|NCT02940886|62841044|FG000|Overall Study|Enrolment error|0|||
33467661|NCT02940886|62841045|FG001|Overall Study|Enrolment error|1|||
33467662|NCT03285958|62841055|FG000|Overall Study|Lost to Follow-up|1|||
33467663|NCT03285958|62841056|FG001|Overall Study|Lost to Follow-up|1|||
33467664|NCT03285958|62841055|FG000|Overall Study|Withdrawal by Subject|1|||
33467665|NCT03285958|62841056|FG001|Overall Study|Withdrawal by Subject|0|||
33467666|NCT03285958|62841055|FG000|Overall Study|Not able to attend required orientation|3|||
33467667|NCT03285958|62841056|FG001|Overall Study|Not able to attend required orientation|0|||
33467668|NCT03285646|62841065|FG000|Overall Study|Adverse Event|1|||
33467669|NCT03285646|62841066|FG001|Overall Study|Adverse Event|0|||
33467670|NCT03285646|62841065|FG000|Overall Study|Withdrawal by Subject|10|||
33467671|NCT03285646|62841066|FG001|Overall Study|Withdrawal by Subject|2|||
33467672|NCT03285646|62841065|FG000|Overall Study|Lost to Follow-up|2|||
33467673|NCT03285646|62841066|FG001|Overall Study|Lost to Follow-up|1|||
33467674|NCT03285646|62841065|FG000|Overall Study|Investigator/Sponsor Decision|0|||
33467675|NCT03285646|62841066|FG001|Overall Study|Investigator/Sponsor Decision|1|||
33467676|NCT03309202|62841077|FG000|Overall Study|Lost to Follow-up|1|||
33467677|NCT03309202|62841078|FG001|Overall Study|Lost to Follow-up|0|||
33467678|NCT03309202|62841079|FG002|Overall Study|Lost to Follow-up|0|||
33467679|NCT03309202|62841080|FG003|Overall Study|Lost to Follow-up|0|||
33467680|NCT00074490|62841095|FG000|Overall Study|Progressive malignancy|0|||
33467681|NCT00074490|62841096|FG001|Overall Study|Progressive malignancy|7|||
33467682|NCT00074490|62841097|FG002|Overall Study|Progressive malignancy|0|||
33467683|NCT00074490|62841098|FG003|Overall Study|Progressive malignancy|0|||
33467684|NCT00074490|62841099|FG004|Overall Study|Progressive malignancy|3|||
33467685|NCT00074490|62841100|FG005|Overall Study|Progressive malignancy|0|||
33467686|NCT03285490|62841115|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
33467687|NCT03285490|62841116|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
33467688|NCT03285490|62841115|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
33467689|NCT03285490|62841116|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
33467690|NCT02939716|62841123|FG000|Overall Study|scanner failure|0|||
33467691|NCT02939716|62841124|FG001|Overall Study|scanner failure|0|||
33467692|NCT02939716|62841125|FG002|Overall Study|scanner failure|0|||
33467693|NCT02939716|62841126|FG003|Overall Study|scanner failure|1|||
33467694|NCT02939716|62841127|FG004|Overall Study|scanner failure|1|||
33467695|NCT02939716|62841128|FG005|Overall Study|scanner failure|1|||
33467696|NCT00367133|62841157|FG000|2 Years|Death|20|||
33467697|NCT00367133|62841158|FG001|2 Years|Death|12|||
33467698|NCT00367133|62841159|FG002|2 Years|Death|12|||
33467699|NCT00367133|62841157|FG000|2 Years|Dropped|34|||
33467700|NCT00367133|62841158|FG001|2 Years|Dropped|19|||
33467701|NCT00367133|62841159|FG002|2 Years|Dropped|33|||
33467702|NCT00367133|62841157|FG000|2 Years|Missed visit|4|||
33467703|NCT00367133|62841158|FG001|2 Years|Missed visit|5|||
33467704|NCT00367133|62841159|FG002|2 Years|Missed visit|4|||
33467705|NCT00367055|62841169|FG000|Overall Study|Adverse Event|6|||
33548131|NCT02958865|62939473|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33548132|NCT02958865|62939458|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
33548133|NCT02958865|62939459|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
33548134|NCT02958865|62939460|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
33467706|NCT00367055|62841170|FG001|Overall Study|Adverse Event|3|||
33467707|NCT00367055|62841169|FG000|Overall Study|Patient's Willing|3|||
33467708|NCT00367055|62841170|FG001|Overall Study|Patient's Willing|2|||
33467709|NCT00367055|62841169|FG000|Overall Study|Lack of Efficacy|1|||
33467710|NCT00367055|62841170|FG001|Overall Study|Lack of Efficacy|2|||
33467711|NCT00367055|62841169|FG000|Overall Study|Lost to Follow-up|1|||
33467712|NCT00367055|62841170|FG001|Overall Study|Lost to Follow-up|1|||
33467713|NCT00367055|62841169|FG000|Overall Study|Protocol Violation|0|||
33467714|NCT00367055|62841170|FG001|Overall Study|Protocol Violation|1|||
33467715|NCT00367055|62841169|FG000|Overall Study|Stopping Criterion Met|0|||
33467716|NCT00367055|62841170|FG001|Overall Study|Stopping Criterion Met|1|||
33467717|NCT00367055|62841169|FG000|Overall Study|Participant Living too Far from Hospital|0|||
33467718|NCT00367055|62841170|FG001|Overall Study|Participant Living too Far from Hospital|1|||
33467719|NCT00057330|62841178|FG000|Overall Study|Adverse Event|9|||
33467720|NCT00057330|62841179|FG001|Overall Study|Adverse Event|12|||
33467721|NCT00057330|62841178|FG000|Overall Study|Death|1|||
33467722|NCT00057330|62841179|FG001|Overall Study|Death|0|||
33467723|NCT00057330|62841178|FG000|Overall Study|Protocol Violation|1|||
33467724|NCT00057330|62841179|FG001|Overall Study|Protocol Violation|1|||
33548135|NCT02958865|62939461|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33548136|NCT02958865|62939462|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33548137|NCT02958865|62939463|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33467725|NCT00057330|62841178|FG000|Overall Study|Withdrawal by Subject|115|||
33467726|NCT00057330|62841179|FG001|Overall Study|Withdrawal by Subject|84|||
33467727|NCT00057330|62841178|FG000|Overall Study|Lost to Follow-up|745|||
33467728|NCT00057330|62841179|FG001|Overall Study|Lost to Follow-up|617|||
33467729|NCT00057330|62841178|FG000|Overall Study|Physician Decision|1|||
33467730|NCT00057330|62841179|FG001|Overall Study|Physician Decision|0|||
33548138|NCT02958865|62939464|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33548139|NCT02958865|62939465|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33548140|NCT02958865|62939466|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33548141|NCT02958865|62939467|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33548142|NCT02958865|62939468|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33548143|NCT02958865|62939469|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33548144|NCT02958865|62939470|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33548145|NCT02958865|62939471|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33548146|NCT02958865|62939472|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33548147|NCT02958865|62939473|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33548148|NCT02958865|62939458|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
33548149|NCT02958865|62939459|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
33548150|NCT02958865|62939460|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
33548151|NCT02958865|62939461|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
33548152|NCT02958865|62939462|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
33548153|NCT02958865|62939463|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
33548154|NCT02958865|62939464|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
33548155|NCT02958865|62939465|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
33548156|NCT02958865|62939466|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
33548157|NCT02958865|62939467|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
33548158|NCT02958865|62939468|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
33548159|NCT02958865|62939469|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
33548160|NCT02958865|62939470|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
33548161|NCT02958865|62939471|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
33548162|NCT02958865|62939472|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
33548163|NCT02958865|62939473|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
33548164|NCT02958865|62939458|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33548165|NCT02958865|62939459|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33548166|NCT02958865|62939460|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33548167|NCT02958865|62939461|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33548168|NCT02958865|62939462|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
33548169|NCT02958865|62939463|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33548170|NCT02958865|62939464|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33548171|NCT02958865|62939465|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33548172|NCT02958865|62939466|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33548173|NCT02958865|62939467|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33548174|NCT02958865|62939468|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33548175|NCT02958865|62939469|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33548176|NCT02958865|62939470|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33548177|NCT02958865|62939471|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33548178|NCT02958865|62939472|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33548179|NCT02958865|62939473|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33548180|NCT02958865|62939458|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33548181|NCT02958865|62939459|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33548182|NCT02958865|62939460|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33548183|NCT02958865|62939461|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33548184|NCT02958865|62939462|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33548185|NCT02958865|62939463|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33467731|NCT00057330|62841178|FG000|Overall Study|Other|260|||
33467732|NCT00057330|62841179|FG001|Overall Study|Other|206|||
33467733|NCT03283696|62841187|FG000|Overall Study|Physician Decision|5|||
33548186|NCT02958865|62939464|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33548187|NCT02958865|62939465|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
33548188|NCT02958865|62939466|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
33548189|NCT02958865|62939467|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
33467734|NCT03283696|62841188|FG001|Overall Study|Physician Decision|6|||
33467735|NCT03283696|62841187|FG000|Overall Study|Withdrawal by Subject|2|||
33467736|NCT03283696|62841188|FG001|Overall Study|Withdrawal by Subject|0|||
33467737|NCT02939560|62841194|FG000|Overall Study|Withdrawal by Subject|2|||
33467738|NCT02939560|62841194|FG000|Overall Study|Protocol Violation|1|||
33467739|NCT03748706|62841198|FG000|Overall Study|Lost to Follow-up|1|||
33467740|NCT03747302|62841204|FG000|Overall Study|Withdrawal by Subject|1|||
33467741|NCT03747302|62841205|FG001|Overall Study|Withdrawal by Subject|2|||
33467742|NCT00056862|62841215|FG000|Overall Study|Protocol Violation|1|||
33548190|NCT02958865|62939468|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33653421|NCT01921205|63065767|FG000|Overall Study|Lack of Efficacy|1|||
33467743|NCT00056862|62841216|FG001|Overall Study|Protocol Violation|0|||
33467744|NCT00056316|62841224|FG000|Overall Study|Withdrawal by Subject|2|||
33467745|NCT00056316|62841225|FG001|Overall Study|Withdrawal by Subject|2|||
33467746|NCT00056316|62841224|FG000|Overall Study|Death/NH placement of pt|1|||
33467747|NCT00056316|62841225|FG001|Overall Study|Death/NH placement of pt|1|||
33467748|NCT03308968|62841234|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
33467749|NCT03308968|62841235|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
33467750|NCT03308968|62841236|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
33467751|NCT03308968|62841234|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
33467752|NCT03308968|62841235|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
33467753|NCT03308968|62841236|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
33467754|NCT03308968|62841234|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
33467755|NCT03308968|62841235|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
33467756|NCT03308968|62841236|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
33467757|NCT03308968|62841234|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
33467758|NCT03308968|62841235|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
33467759|NCT03308968|62841236|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
33467760|NCT03308968|62841234|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
33467761|NCT03308968|62841235|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
33467762|NCT03308968|62841236|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
33467763|NCT03308968|62841234|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
33467764|NCT03308968|62841235|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
33467765|NCT03308968|62841236|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
33467766|NCT03308968|62841234|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
33467767|NCT03308968|62841235|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
33467768|NCT03308968|62841236|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
33467769|NCT03308968|62841234|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
33467770|NCT03308968|62841235|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
33467771|NCT03308968|62841236|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
33467772|NCT03308968|62841234|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
33467773|NCT03308968|62841235|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
33467774|NCT03308968|62841236|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
33467775|NCT03308968|62841234|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
33467776|NCT03308968|62841235|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
33467777|NCT03308968|62841236|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
33467778|NCT03308968|62841234|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
33467779|NCT03308968|62841235|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
33467780|NCT03308968|62841236|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
33467781|NCT03308968|62841234|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
33467782|NCT03308968|62841235|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
33467783|NCT03308968|62841236|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
33467784|NCT03308968|62841234|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
33467785|NCT03308968|62841235|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
33467786|NCT03308968|62841236|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
33467787|NCT03308968|62841234|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
33467788|NCT03308968|62841235|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
33467789|NCT03308968|62841236|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
33467790|NCT02940730|62841249|FG000|Intervention 2|Physician Decision|7|||
33467791|NCT02940730|62841250|FG001|Intervention 2|Physician Decision|0|||
33467792|NCT03741062|62841258|FG000|Overall Study|Protocol Violation|1|||
33467793|NCT03741062|62841259|FG001|Overall Study|Protocol Violation|0|||
33467794|NCT03281668|62841265|FG000|Overall Study|Physician Decision|1|||
33467795|NCT03281668|62841265|FG000|Overall Study|scheduling conflict, family circumstance|2|||
33467796|NCT03281668|62841265|FG000|Overall Study|Withdrawal by Subject|4|||
33467797|NCT03281668|62841265|FG000|Overall Study|Lost to Follow-up|1|||
33467798|NCT03307252|62841280|FG000|Part 2, Period 1|Treatment not received|0|||
33467799|NCT03307252|62841281|FG001|Part 2, Period 1|Treatment not received|0|||
33467800|NCT03307252|62841282|FG002|Part 2, Period 1|Treatment not received|0|||
33467801|NCT03307252|62841283|FG003|Part 2, Period 1|Treatment not received|0|||
33548191|NCT02958865|62939469|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
33467802|NCT03307252|62841284|FG004|Part 2, Period 1|Treatment not received|0|||
33467803|NCT03307252|62841285|FG005|Part 2, Period 1|Treatment not received|1|||
33467804|NCT03307252|62841286|FG006|Part 2, Period 1|Treatment not received|0|||
33467805|NCT03307252|62841287|FG007|Part 2, Period 1|Treatment not received|0|||
33467806|NCT03307252|62841288|FG008|Part 2, Period 1|Treatment not received|0|||
33467807|NCT03307252|62841289|FG009|Part 2, Period 1|Treatment not received|0|||
33467808|NCT03307252|62841290|FG010|Part 2, Period 1|Treatment not received|0|||
33467809|NCT03307252|62841280|FG000|Part 2, Period 3|Other than listed|0|||
33467810|NCT03307252|62841281|FG001|Part 2, Period 3|Other than listed|0|||
33467811|NCT03307252|62841282|FG002|Part 2, Period 3|Other than listed|0|||
33467812|NCT03307252|62841283|FG003|Part 2, Period 3|Other than listed|0|||
33467813|NCT03307252|62841284|FG004|Part 2, Period 3|Other than listed|1|||
33467814|NCT03307252|62841285|FG005|Part 2, Period 3|Other than listed|0|||
33467815|NCT03307252|62841286|FG006|Part 2, Period 3|Other than listed|0|||
33467816|NCT03307252|62841287|FG007|Part 2, Period 3|Other than listed|0|||
33467817|NCT03307252|62841288|FG008|Part 2, Period 3|Other than listed|0|||
33467818|NCT03307252|62841289|FG009|Part 2, Period 3|Other than listed|0|||
33467819|NCT03307252|62841290|FG010|Part 2, Period 3|Other than listed|0|||
33467820|NCT03307252|62841280|FG000|Part 2, Period 4|Other than listed|0|||
33467821|NCT03307252|62841281|FG001|Part 2, Period 4|Other than listed|0|||
33548192|NCT02958865|62939470|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
33548193|NCT02958865|62939471|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
33548194|NCT02958865|62939472|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
33548195|NCT02958865|62939473|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
33467822|NCT03307252|62841282|FG002|Part 2, Period 4|Other than listed|0|||
33467823|NCT03307252|62841283|FG003|Part 2, Period 4|Other than listed|0|||
33467824|NCT03307252|62841284|FG004|Part 2, Period 4|Other than listed|0|||
33467825|NCT03307252|62841285|FG005|Part 2, Period 4|Other than listed|0|||
33467826|NCT03307252|62841286|FG006|Part 2, Period 4|Other than listed|1|||
33467827|NCT03307252|62841287|FG007|Part 2, Period 4|Other than listed|0|||
33467828|NCT03307252|62841288|FG008|Part 2, Period 4|Other than listed|0|||
33467829|NCT03307252|62841289|FG009|Part 2, Period 4|Other than listed|0|||
33467830|NCT03307252|62841290|FG010|Part 2, Period 4|Other than listed|0|||
33467831|NCT03307252|62841280|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33467832|NCT03307252|62841281|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33467833|NCT03307252|62841282|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33467834|NCT03307252|62841283|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33467835|NCT03307252|62841284|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33467836|NCT03307252|62841285|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33467837|NCT03307252|62841286|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33467838|NCT03307252|62841287|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33467839|NCT03307252|62841288|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33467840|NCT03307252|62841289|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33467841|NCT03307252|62841290|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
33467842|NCT03307174|62841308|FG000|Overall Study|Unplanned ICU Administrion|5|||
33467843|NCT03307174|62841309|FG001|Overall Study|Unplanned ICU Administrion|3|||
33467844|NCT03307174|62841308|FG000|Overall Study|Aborted Surgery|1|||
33467845|NCT03307174|62841309|FG001|Overall Study|Aborted Surgery|2|||
33467846|NCT03307174|62841308|FG000|Overall Study|Hypotension|6|||
33548196|NCT02958865|62939458|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33548197|NCT02958865|62939459|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33653422|NCT01921205|63065768|FG001|Overall Study|Lack of Efficacy|0|||
33653423|NCT01921205|63065767|FG000|Overall Study|Protocol Violation|1|||
33653424|NCT01921205|63065768|FG001|Overall Study|Protocol Violation|3|||
33653425|NCT01921205|63065767|FG000|Overall Study|Lost to Follow-up|1|||
33653426|NCT01921205|63065768|FG001|Overall Study|Lost to Follow-up|1|||
33467847|NCT03307174|62841309|FG001|Overall Study|Hypotension|0|||
33467848|NCT03307174|62841308|FG000|Overall Study|Nonfunctional epidural|1|||
33548198|NCT02958865|62939460|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33548199|NCT02958865|62939461|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33548200|NCT02958865|62939462|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33548201|NCT02958865|62939463|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33548202|NCT02958865|62939464|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33653427|NCT01921205|63065767|FG000|Overall Study|Withdrawal by Subject|6|||
33653428|NCT01921205|63065768|FG001|Overall Study|Withdrawal by Subject|5|||
33548203|NCT02958865|62939465|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33653429|NCT01921205|63065767|FG000|Overall Study|Use Of Prohibited Medication|0|||
33467849|NCT03307174|62841309|FG001|Overall Study|Nonfunctional epidural|1|||
33467850|NCT03307174|62841308|FG000|Overall Study|Planned epidural removal|1|||
33467851|NCT03307174|62841309|FG001|Overall Study|Planned epidural removal|0|||
33467852|NCT03307174|62841308|FG000|Overall Study|Intrathecal catheter placement|0|||
33328988|NCT00943917|62705456|FG006|Stage I|A1C elevation|0|||
33328989|NCT00943917|62705457|FG007|Stage I|A1C elevation|0|||
33328990|NCT00943917|62705458|FG008|Stage I|A1C elevation|0|||
33328991|NCT00943917|62705459|FG009|Stage I|A1C elevation|0|||
33328992|NCT00943917|62705460|FG010|Stage I|A1C elevation|0|||
33328993|NCT00943917|62705461|FG011|Stage I|A1C elevation|0|||
33328994|NCT00943917|62705462|FG012|Stage I|A1C elevation|0|||
33328995|NCT00943917|62705463|FG013|Stage I|A1C elevation|0|||
33328996|NCT00943917|62705464|FG014|Stage I|A1C elevation|0|||
33328997|NCT00943917|62705450|FG000|Stage I|Withdrawal by Subject|2|||
33328998|NCT00943917|62705451|FG001|Stage I|Withdrawal by Subject|1|||
33328999|NCT00943917|62705452|FG002|Stage I|Withdrawal by Subject|2|||
33329000|NCT00943917|62705453|FG003|Stage I|Withdrawal by Subject|0|||
33329001|NCT00943917|62705454|FG004|Stage I|Withdrawal by Subject|0|||
33329002|NCT00943917|62705455|FG005|Stage I|Withdrawal by Subject|0|||
33329003|NCT00943917|62705456|FG006|Stage I|Withdrawal by Subject|0|||
33329004|NCT00943917|62705457|FG007|Stage I|Withdrawal by Subject|0|||
33329005|NCT00943917|62705458|FG008|Stage I|Withdrawal by Subject|0|||
33329006|NCT00943917|62705459|FG009|Stage I|Withdrawal by Subject|0|||
33329007|NCT00943917|62705460|FG010|Stage I|Withdrawal by Subject|0|||
33329008|NCT00943917|62705461|FG011|Stage I|Withdrawal by Subject|0|||
33329009|NCT00943917|62705462|FG012|Stage I|Withdrawal by Subject|0|||
33329010|NCT00943917|62705463|FG013|Stage I|Withdrawal by Subject|0|||
33329011|NCT00943917|62705464|FG014|Stage I|Withdrawal by Subject|0|||
33329012|NCT00943917|62705450|FG000|Stage II|Adverse Event|0|||
33329013|NCT00943917|62705451|FG001|Stage II|Adverse Event|0|||
33329014|NCT00943917|62705452|FG002|Stage II|Adverse Event|0|||
33329015|NCT00943917|62705453|FG003|Stage II|Adverse Event|0|||
33329016|NCT00943917|62705454|FG004|Stage II|Adverse Event|0|||
33329017|NCT00943917|62705455|FG005|Stage II|Adverse Event|1|||
33329018|NCT00943917|62705456|FG006|Stage II|Adverse Event|3|||
33329019|NCT00943917|62705457|FG007|Stage II|Adverse Event|0|||
33329020|NCT00943917|62705458|FG008|Stage II|Adverse Event|1|||
33329021|NCT00943917|62705459|FG009|Stage II|Adverse Event|0|||
33329022|NCT00943917|62705460|FG010|Stage II|Adverse Event|0|||
33329023|NCT00943917|62705461|FG011|Stage II|Adverse Event|0|||
33329024|NCT00943917|62705462|FG012|Stage II|Adverse Event|0|||
33329025|NCT00943917|62705463|FG013|Stage II|Adverse Event|0|||
33329026|NCT00943917|62705464|FG014|Stage II|Adverse Event|0|||
33329027|NCT00943917|62705450|FG000|Stage II|Withdrawal by Subject|0|||
33329028|NCT00943917|62705451|FG001|Stage II|Withdrawal by Subject|0|||
33329029|NCT00943917|62705452|FG002|Stage II|Withdrawal by Subject|0|||
33329030|NCT00943917|62705453|FG003|Stage II|Withdrawal by Subject|0|||
33329031|NCT00943917|62705454|FG004|Stage II|Withdrawal by Subject|0|||
33329032|NCT00943917|62705455|FG005|Stage II|Withdrawal by Subject|1|||
33329033|NCT00943917|62705456|FG006|Stage II|Withdrawal by Subject|0|||
33329034|NCT00943917|62705457|FG007|Stage II|Withdrawal by Subject|0|||
33329035|NCT00943917|62705458|FG008|Stage II|Withdrawal by Subject|0|||
33329036|NCT00943917|62705459|FG009|Stage II|Withdrawal by Subject|0|||
33329037|NCT00943917|62705460|FG010|Stage II|Withdrawal by Subject|0|||
33329038|NCT00943917|62705461|FG011|Stage II|Withdrawal by Subject|0|||
33329039|NCT00943917|62705462|FG012|Stage II|Withdrawal by Subject|0|||
33329040|NCT00943917|62705463|FG013|Stage II|Withdrawal by Subject|0|||
33329041|NCT00943917|62705464|FG014|Stage II|Withdrawal by Subject|0|||
33329042|NCT00943917|62705450|FG000|Stage II|Pregnancy|0|||
33467853|NCT03307174|62841309|FG001|Overall Study|Intrathecal catheter placement|1|||
33467854|NCT03258814|62841317|FG000|Overall Study|Early Termination|4|||
33329043|NCT00943917|62705451|FG001|Stage II|Pregnancy|0|||
33329044|NCT00943917|62705452|FG002|Stage II|Pregnancy|0|||
33329045|NCT00943917|62705453|FG003|Stage II|Pregnancy|0|||
33329046|NCT00943917|62705454|FG004|Stage II|Pregnancy|0|||
33329047|NCT00943917|62705455|FG005|Stage II|Pregnancy|1|||
33329048|NCT00943917|62705456|FG006|Stage II|Pregnancy|0|||
33329049|NCT00943917|62705457|FG007|Stage II|Pregnancy|0|||
33329050|NCT00943917|62705458|FG008|Stage II|Pregnancy|0|||
33329051|NCT00943917|62705459|FG009|Stage II|Pregnancy|0|||
33329052|NCT00943917|62705460|FG010|Stage II|Pregnancy|0|||
33329053|NCT00943917|62705461|FG011|Stage II|Pregnancy|0|||
33329054|NCT00943917|62705462|FG012|Stage II|Pregnancy|0|||
33329055|NCT00943917|62705463|FG013|Stage II|Pregnancy|0|||
33329056|NCT00943917|62705464|FG014|Stage II|Pregnancy|0|||
33329057|NCT00943917|62705450|FG000|Stage II Continuation|Adverse Event|0|||
33329058|NCT00943917|62705451|FG001|Stage II Continuation|Adverse Event|0|||
33329059|NCT00943917|62705452|FG002|Stage II Continuation|Adverse Event|0|||
33329060|NCT00943917|62705453|FG003|Stage II Continuation|Adverse Event|0|||
33329061|NCT00943917|62705454|FG004|Stage II Continuation|Adverse Event|0|||
33329062|NCT00943917|62705455|FG005|Stage II Continuation|Adverse Event|0|||
33329063|NCT00943917|62705456|FG006|Stage II Continuation|Adverse Event|0|||
33329064|NCT00943917|62705457|FG007|Stage II Continuation|Adverse Event|0|||
33329065|NCT00943917|62705458|FG008|Stage II Continuation|Adverse Event|0|||
33329066|NCT00943917|62705459|FG009|Stage II Continuation|Adverse Event|0|||
33329067|NCT00943917|62705460|FG010|Stage II Continuation|Adverse Event|0|||
33329068|NCT00943917|62705461|FG011|Stage II Continuation|Adverse Event|1|||
33329069|NCT00943917|62705462|FG012|Stage II Continuation|Adverse Event|2|||
33329070|NCT00943917|62705463|FG013|Stage II Continuation|Adverse Event|1|||
33329071|NCT00943917|62705464|FG014|Stage II Continuation|Adverse Event|1|||
33329072|NCT00943917|62705450|FG000|Stage II Continuation|Withdrawal by Subject|0|||
33329073|NCT00943917|62705451|FG001|Stage II Continuation|Withdrawal by Subject|0|||
33329074|NCT00943917|62705452|FG002|Stage II Continuation|Withdrawal by Subject|0|||
33329075|NCT00943917|62705453|FG003|Stage II Continuation|Withdrawal by Subject|0|||
33329076|NCT00943917|62705454|FG004|Stage II Continuation|Withdrawal by Subject|0|||
33329077|NCT00943917|62705455|FG005|Stage II Continuation|Withdrawal by Subject|0|||
33329078|NCT00943917|62705456|FG006|Stage II Continuation|Withdrawal by Subject|0|||
33329079|NCT00943917|62705457|FG007|Stage II Continuation|Withdrawal by Subject|0|||
33329080|NCT00943917|62705458|FG008|Stage II Continuation|Withdrawal by Subject|0|||
33329081|NCT00943917|62705459|FG009|Stage II Continuation|Withdrawal by Subject|0|||
33329082|NCT00943917|62705460|FG010|Stage II Continuation|Withdrawal by Subject|0|||
33329083|NCT00943917|62705461|FG011|Stage II Continuation|Withdrawal by Subject|0|||
33329084|NCT00943917|62705462|FG012|Stage II Continuation|Withdrawal by Subject|0|||
33329085|NCT00943917|62705463|FG013|Stage II Continuation|Withdrawal by Subject|1|||
33329086|NCT00943917|62705464|FG014|Stage II Continuation|Withdrawal by Subject|3|||
33329087|NCT00943917|62705450|FG000|Stage II Continuation|Protocol Violation|0|||
33329088|NCT00943917|62705451|FG001|Stage II Continuation|Protocol Violation|0|||
33329089|NCT00943917|62705452|FG002|Stage II Continuation|Protocol Violation|0|||
33329090|NCT00943917|62705453|FG003|Stage II Continuation|Protocol Violation|0|||
33329091|NCT00943917|62705454|FG004|Stage II Continuation|Protocol Violation|0|||
33329092|NCT00943917|62705455|FG005|Stage II Continuation|Protocol Violation|0|||
33329093|NCT00943917|62705456|FG006|Stage II Continuation|Protocol Violation|0|||
33329094|NCT00943917|62705457|FG007|Stage II Continuation|Protocol Violation|0|||
33329095|NCT00943917|62705458|FG008|Stage II Continuation|Protocol Violation|0|||
33329096|NCT00943917|62705459|FG009|Stage II Continuation|Protocol Violation|1|||
33329097|NCT00943917|62705460|FG010|Stage II Continuation|Protocol Violation|0|||
33329098|NCT00943917|62705461|FG011|Stage II Continuation|Protocol Violation|1|||
33329099|NCT00943917|62705462|FG012|Stage II Continuation|Protocol Violation|0|||
33329100|NCT00943917|62705463|FG013|Stage II Continuation|Protocol Violation|0|||
33329101|NCT00943917|62705464|FG014|Stage II Continuation|Protocol Violation|0|||
33329102|NCT00943917|62705450|FG000|Stage II Continuation|hypoglycemia|0|||
33329103|NCT00943917|62705451|FG001|Stage II Continuation|hypoglycemia|0|||
33329104|NCT00943917|62705452|FG002|Stage II Continuation|hypoglycemia|0|||
33329105|NCT00943917|62705453|FG003|Stage II Continuation|hypoglycemia|0|||
33329106|NCT00943917|62705454|FG004|Stage II Continuation|hypoglycemia|0|||
33329107|NCT00943917|62705455|FG005|Stage II Continuation|hypoglycemia|0|||
33329108|NCT00943917|62705456|FG006|Stage II Continuation|hypoglycemia|0|||
33329109|NCT00943917|62705457|FG007|Stage II Continuation|hypoglycemia|0|||
33329110|NCT00943917|62705458|FG008|Stage II Continuation|hypoglycemia|0|||
33329111|NCT00943917|62705459|FG009|Stage II Continuation|hypoglycemia|0|||
33329112|NCT00943917|62705460|FG010|Stage II Continuation|hypoglycemia|0|||
33329113|NCT00943917|62705461|FG011|Stage II Continuation|hypoglycemia|0|||
33329114|NCT00943917|62705462|FG012|Stage II Continuation|hypoglycemia|1|||
33329115|NCT00943917|62705463|FG013|Stage II Continuation|hypoglycemia|0|||
33467855|NCT03258814|62841318|FG001|Overall Study|Early Termination|3|||
33467856|NCT03258814|62841319|FG002|Overall Study|Early Termination|10|||
33467857|NCT03257410|62841328|FG000|Overall Study|Adverse Event|2|||
33467858|NCT03257410|62841329|FG001|Overall Study|Adverse Event|3|||
33467859|NCT03257410|62841328|FG000|Overall Study|Protocol Violation|1|||
33467860|NCT03257410|62841329|FG001|Overall Study|Protocol Violation|2|||
33467861|NCT03257410|62841328|FG000|Overall Study|Lost to Follow-up|1|||
33329116|NCT00943917|62705464|FG014|Stage II Continuation|hypoglycemia|0|||
33329117|NCT00943917|62705450|FG000|Stage II Continuation|A1C elevation|0|||
33329118|NCT00943917|62705451|FG001|Stage II Continuation|A1C elevation|0|||
33329119|NCT00943917|62705452|FG002|Stage II Continuation|A1C elevation|0|||
33329120|NCT00943917|62705453|FG003|Stage II Continuation|A1C elevation|0|||
33329121|NCT00943917|62705454|FG004|Stage II Continuation|A1C elevation|0|||
33329122|NCT00943917|62705455|FG005|Stage II Continuation|A1C elevation|0|||
33329123|NCT00943917|62705456|FG006|Stage II Continuation|A1C elevation|0|||
33329124|NCT00943917|62705457|FG007|Stage II Continuation|A1C elevation|0|||
33329125|NCT00943917|62705458|FG008|Stage II Continuation|A1C elevation|0|||
33329126|NCT00943917|62705459|FG009|Stage II Continuation|A1C elevation|0|||
33329127|NCT00943917|62705460|FG010|Stage II Continuation|A1C elevation|0|||
33329128|NCT00943917|62705461|FG011|Stage II Continuation|A1C elevation|0|||
33653430|NCT01921205|63065768|FG001|Overall Study|Use Of Prohibited Medication|1|||
33653431|NCT01921205|63065767|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
33653432|NCT01921205|63065768|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
33653433|NCT01921205|63065767|FG000|Overall Study|Non Compliance Of The Parent|0|||
33653434|NCT01921205|63065768|FG001|Overall Study|Non Compliance Of The Parent|1|||
33653435|NCT01921205|63065767|FG000|Overall Study|Non Compliance Of Child|0|||
33653436|NCT01921205|63065768|FG001|Overall Study|Non Compliance Of Child|1|||
33653437|NCT01920893|63065776|FG000|Overall Study|Adverse Event|5|||
33653438|NCT01920893|63065777|FG001|Overall Study|Adverse Event|2|||
33653439|NCT01920893|63065776|FG000|Overall Study|Lack of Efficacy|2|||
33653440|NCT01920893|63065777|FG001|Overall Study|Lack of Efficacy|0|||
33653441|NCT01709305|63065784|FG000|Phase 1|Clinical Adverse Event|80|||
33653442|NCT01709305|63065785|FG001|Phase 1|Clinical Adverse Event|0|||
33653443|NCT01709305|63065786|FG002|Phase 1|Clinical Adverse Event|0|||
33653444|NCT01709305|63065787|FG003|Phase 1|Clinical Adverse Event|0|||
33329129|NCT00943917|62705462|FG012|Stage II Continuation|A1C elevation|0|||
33329130|NCT00943917|62705463|FG013|Stage II Continuation|A1C elevation|1|||
33329131|NCT00943917|62705464|FG014|Stage II Continuation|A1C elevation|0|||
33329132|NCT01077024|62705499|FG000|Overall Study|Lost to Follow-up|20|||
33329133|NCT01077024|62705500|FG001|Overall Study|Lost to Follow-up|14|||
33329134|NCT01077024|62705499|FG000|Overall Study|Withdrawal by Subject|0|||
33329135|NCT01077024|62705500|FG001|Overall Study|Withdrawal by Subject|2|||
33329136|NCT01077024|62705499|FG000|Overall Study|Incarcerated|7|||
33329137|NCT01077024|62705500|FG001|Overall Study|Incarcerated|8|||
33329138|NCT01077024|62705499|FG000|Overall Study|Other|4|||
33329139|NCT01077024|62705500|FG001|Overall Study|Other|4|||
33329140|NCT01089582|62705506|FG000|Overall Study|Death|2|||
33329141|NCT01089582|62705506|FG000|Overall Study|Adverse Event|15|||
33329142|NCT01089582|62705506|FG000|Overall Study|Lost to Follow-up|8|||
33329143|NCT01089582|62705506|FG000|Overall Study|Other|4|||
33329144|NCT01089582|62705506|FG000|Overall Study|Withdrawal by Subject|1|||
33329145|NCT00862459|62705513|FG000|Overall Study|Lost to Follow-up|1|||
33329146|NCT00862459|62705514|FG001|Overall Study|Lost to Follow-up|2|||
33329147|NCT00862459|62705515|FG002|Overall Study|Lost to Follow-up|2|||
33329148|NCT00862459|62705513|FG000|Overall Study|Protocol Violation|1|||
33329149|NCT00862459|62705514|FG001|Overall Study|Protocol Violation|0|||
33329150|NCT00862459|62705515|FG002|Overall Study|Protocol Violation|0|||
33329151|NCT00862459|62705513|FG000|Overall Study|Withdrawal by Subject|1|||
33329152|NCT00862459|62705514|FG001|Overall Study|Withdrawal by Subject|1|||
33329153|NCT00862459|62705515|FG002|Overall Study|Withdrawal by Subject|3|||
33329154|NCT00862459|62705513|FG000|Overall Study|Adverse Event|0|||
33329155|NCT00862459|62705514|FG001|Overall Study|Adverse Event|1|||
33329156|NCT00862459|62705515|FG002|Overall Study|Adverse Event|0|||
33329157|NCT00862459|62705513|FG000|Overall Study|Personal reasons|1|||
33329158|NCT00862459|62705514|FG001|Overall Study|Personal reasons|0|||
33329159|NCT00862459|62705515|FG002|Overall Study|Personal reasons|0|||
33329160|NCT00862459|62705513|FG000|Overall Study|Operation|1|||
33329161|NCT00862459|62705514|FG001|Overall Study|Operation|1|||
33329162|NCT00862459|62705515|FG002|Overall Study|Operation|0|||
33329163|NCT00862459|62705513|FG000|Overall Study|Intravenous (IV) site problems|1|||
33329164|NCT00862459|62705514|FG001|Overall Study|Intravenous (IV) site problems|0|||
33329165|NCT00862459|62705515|FG002|Overall Study|Intravenous (IV) site problems|1|||
33329166|NCT00862459|62705513|FG000|Overall Study|Unable to hold still for imaging|0|||
33329167|NCT00862459|62705514|FG001|Overall Study|Unable to hold still for imaging|1|||
33329168|NCT00862459|62705515|FG002|Overall Study|Unable to hold still for imaging|0|||
33329169|NCT00862459|62705513|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
33329170|NCT00862459|62705514|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
33467862|NCT03257410|62841329|FG001|Overall Study|Lost to Follow-up|0|||
33467863|NCT03257410|62841328|FG000|Overall Study|Withdrawal by Subject|1|||
33329171|NCT00862459|62705515|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
33329172|NCT00862459|62705513|FG000|Overall Study|Administrative problems|0|||
33329173|NCT00862459|62705514|FG001|Overall Study|Administrative problems|1|||
33329174|NCT00862459|62705515|FG002|Overall Study|Administrative problems|0|||
33467864|NCT03257410|62841329|FG001|Overall Study|Withdrawal by Subject|2|||
33329175|NCT00580047|62705527|FG000|Overall Study|Lost to Follow-up|1|||
33329176|NCT00580047|62705528|FG001|Overall Study|Lost to Follow-up|1|||
33329177|NCT00580047|62705529|FG002|Overall Study|Lost to Follow-up|0|||
33329178|NCT00580047|62705527|FG000|Overall Study|Withdrawal by Subject|1|||
33329179|NCT00580047|62705528|FG001|Overall Study|Withdrawal by Subject|1|||
33329180|NCT00580047|62705529|FG002|Overall Study|Withdrawal by Subject|2|||
33329181|NCT00580047|62705527|FG000|Overall Study|Withdrawal by Subject|1|||
33329182|NCT00580047|62705528|FG001|Overall Study|Withdrawal by Subject|0|||
33329183|NCT00580047|62705529|FG002|Overall Study|Withdrawal by Subject|0|||
33329184|NCT01074450|62705542|FG000|First Intervention|Emesis in Dosing Interval|0|||
33329185|NCT01074450|62705543|FG001|First Intervention|Emesis in Dosing Interval|2|||
33329186|NCT01074450|62705542|FG000|Second Intervention|Protocol Violation|1|||
33329187|NCT01074450|62705543|FG001|Second Intervention|Protocol Violation|0|||
33329188|NCT01074450|62705542|FG000|Second Intervention|Physician Decision|0|||
33329189|NCT01074450|62705543|FG001|Second Intervention|Physician Decision|1|||
33329190|NCT00943761|62705551|FG000|Overall Study|Lost to Follow-up|2|||
33329191|NCT00943761|62705552|FG001|Overall Study|Lost to Follow-up|0|||
33329192|NCT00943761|62705551|FG000|Overall Study|Withdrawal by Subject|2|||
33329193|NCT00943761|62705552|FG001|Overall Study|Withdrawal by Subject|1|||
33329194|NCT00949533|62705560|FG000|Overall Study|Lost to Follow-up|0|||
33329195|NCT00949533|62705561|FG001|Overall Study|Lost to Follow-up|1|||
33329196|NCT00866047|62705567|FG000|Treatment Period|Progressive disease|13|||
33329197|NCT00866047|62705567|FG000|Treatment Period|Adverse Event|16|||
33329198|NCT00866047|62705567|FG000|Treatment Period|Physician Decision|14|||
33329199|NCT00866047|62705567|FG000|Treatment Period|Withdrawal by Subject|5|||
33329200|NCT00866047|62705567|FG000|Follow-up Period|Lost to Follow-up|5|||
33329201|NCT00869323|62705571|FG000|Maintenance Therapy|concurrent illness|1|||
33329202|NCT01192022|62705579|FG000|Overall Study|Withdrawal of Consent|3|||
33329203|NCT01192022|62705580|FG001|Overall Study|Withdrawal of Consent|1|||
33329204|NCT01192022|62705581|FG002|Overall Study|Withdrawal of Consent|0|||
33329205|NCT01192022|62705582|FG003|Overall Study|Withdrawal of Consent|0|||
33329206|NCT01192022|62705583|FG004|Overall Study|Withdrawal of Consent|0|||
33329207|NCT01192022|62705579|FG000|Overall Study|Lost to Follow-up|4|||
33329208|NCT01192022|62705580|FG001|Overall Study|Lost to Follow-up|2|||
33329209|NCT01192022|62705581|FG002|Overall Study|Lost to Follow-up|1|||
33329210|NCT01192022|62705582|FG003|Overall Study|Lost to Follow-up|1|||
33329211|NCT01192022|62705583|FG004|Overall Study|Lost to Follow-up|0|||
33329212|NCT01192022|62705579|FG000|Overall Study|Adverse Event|1|||
33329213|NCT01192022|62705580|FG001|Overall Study|Adverse Event|0|||
33329214|NCT01192022|62705581|FG002|Overall Study|Adverse Event|0|||
33329215|NCT01192022|62705582|FG003|Overall Study|Adverse Event|0|||
33329216|NCT01192022|62705583|FG004|Overall Study|Adverse Event|0|||
33329217|NCT01192022|62705579|FG000|Overall Study|Fatal Adverse Event|4|||
33329218|NCT01192022|62705580|FG001|Overall Study|Fatal Adverse Event|6|||
33329219|NCT01192022|62705581|FG002|Overall Study|Fatal Adverse Event|0|||
33329220|NCT01192022|62705582|FG003|Overall Study|Fatal Adverse Event|0|||
33329221|NCT01192022|62705583|FG004|Overall Study|Fatal Adverse Event|1|||
33329222|NCT01192022|62705579|FG000|Overall Study|Physician withdrew-patient hardship|1|||
33329223|NCT01192022|62705580|FG001|Overall Study|Physician withdrew-patient hardship|0|||
33329224|NCT01192022|62705581|FG002|Overall Study|Physician withdrew-patient hardship|0|||
33329225|NCT01192022|62705582|FG003|Overall Study|Physician withdrew-patient hardship|0|||
33329226|NCT01192022|62705583|FG004|Overall Study|Physician withdrew-patient hardship|0|||
33329227|NCT01192022|62705579|FG000|Overall Study|Patient too sick from chemotherapy|0|||
33329228|NCT01192022|62705580|FG001|Overall Study|Patient too sick from chemotherapy|1|||
33329229|NCT01192022|62705581|FG002|Overall Study|Patient too sick from chemotherapy|0|||
33329230|NCT01192022|62705582|FG003|Overall Study|Patient too sick from chemotherapy|0|||
33329231|NCT01192022|62705583|FG004|Overall Study|Patient too sick from chemotherapy|0|||
33329232|NCT01192022|62705579|FG000|Overall Study|Patient needed surgery|0|||
33329233|NCT01192022|62705580|FG001|Overall Study|Patient needed surgery|1|||
33329234|NCT01192022|62705581|FG002|Overall Study|Patient needed surgery|0|||
33329235|NCT01192022|62705582|FG003|Overall Study|Patient needed surgery|0|||
33467865|NCT03257410|62841328|FG000|Overall Study|Physician Decision|1|||
33329236|NCT01192022|62705583|FG004|Overall Study|Patient needed surgery|0|||
33467866|NCT03257410|62841329|FG001|Overall Study|Physician Decision|1|||
33548204|NCT02958865|62939466|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
33329237|NCT01192022|62705579|FG000|Overall Study|Parents did not allow all follow up|0|||
33329238|NCT01192022|62705580|FG001|Overall Study|Parents did not allow all follow up|0|||
33329239|NCT01192022|62705581|FG002|Overall Study|Parents did not allow all follow up|0|||
33329240|NCT01192022|62705582|FG003|Overall Study|Parents did not allow all follow up|1|||
33329241|NCT01192022|62705583|FG004|Overall Study|Parents did not allow all follow up|0|||
33329242|NCT01191944|62705596|FG000|Overall Study|Adverse Event|11|||
33329243|NCT01191944|62705597|FG001|Overall Study|Adverse Event|12|||
33329244|NCT01191944|62705596|FG000|Overall Study|Protocol Violation|1|||
33329245|NCT01191944|62705597|FG001|Overall Study|Protocol Violation|2|||
33329246|NCT01191944|62705596|FG000|Overall Study|Withdrawal by Subject|4|||
33329247|NCT01191944|62705597|FG001|Overall Study|Withdrawal by Subject|2|||
33467867|NCT03257410|62841328|FG000|Overall Study|Renal transplantation|2|||
33467868|NCT03257410|62841329|FG001|Overall Study|Renal transplantation|0|||
33653445|NCT01709305|63065788|FG004|Phase 1|Clinical Adverse Event|0|||
33653446|NCT01709305|63065784|FG000|Phase 1|Death|2|||
33653447|NCT01709305|63065785|FG001|Phase 1|Death|0|||
33653448|NCT01709305|63065786|FG002|Phase 1|Death|0|||
33653449|NCT01709305|63065787|FG003|Phase 1|Death|0|||
33653450|NCT01709305|63065788|FG004|Phase 1|Death|0|||
33653451|NCT01709305|63065784|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
33653452|NCT01709305|63065785|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
33653453|NCT01709305|63065786|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
33653454|NCT01709305|63065787|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
33653455|NCT01709305|63065788|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
33653456|NCT01709305|63065784|FG000|Phase 1|Laboratory Adverse Event|16|||
33653457|NCT01709305|63065785|FG001|Phase 1|Laboratory Adverse Event|0|||
33653458|NCT01709305|63065786|FG002|Phase 1|Laboratory Adverse Event|0|||
33653459|NCT01709305|63065787|FG003|Phase 1|Laboratory Adverse Event|0|||
33653460|NCT01709305|63065788|FG004|Phase 1|Laboratory Adverse Event|0|||
33653461|NCT01709305|63065784|FG000|Phase 1|Lost to Follow-up|147|||
33653462|NCT01709305|63065785|FG001|Phase 1|Lost to Follow-up|0|||
33653463|NCT01709305|63065786|FG002|Phase 1|Lost to Follow-up|0|||
33653464|NCT01709305|63065787|FG003|Phase 1|Lost to Follow-up|0|||
33653465|NCT01709305|63065788|FG004|Phase 1|Lost to Follow-up|0|||
33653466|NCT01709305|63065784|FG000|Phase 1|Travel, moving, etc.|30|||
33653467|NCT01709305|63065785|FG001|Phase 1|Travel, moving, etc.|0|||
33653468|NCT01709305|63065786|FG002|Phase 1|Travel, moving, etc.|0|||
33653469|NCT01709305|63065787|FG003|Phase 1|Travel, moving, etc.|0|||
33653470|NCT01709305|63065788|FG004|Phase 1|Travel, moving, etc.|0|||
33653471|NCT01709305|63065784|FG000|Phase 1|Physician Decision|13|||
33653472|NCT01709305|63065785|FG001|Phase 1|Physician Decision|0|||
33653473|NCT01709305|63065786|FG002|Phase 1|Physician Decision|0|||
33653474|NCT01709305|63065787|FG003|Phase 1|Physician Decision|0|||
33653475|NCT01709305|63065788|FG004|Phase 1|Physician Decision|0|||
33653476|NCT01709305|63065784|FG000|Phase 1|Protocol Violation|118|||
33653477|NCT01709305|63065785|FG001|Phase 1|Protocol Violation|0|||
33653478|NCT01709305|63065786|FG002|Phase 1|Protocol Violation|0|||
33653479|NCT01709305|63065787|FG003|Phase 1|Protocol Violation|0|||
33653480|NCT01709305|63065788|FG004|Phase 1|Protocol Violation|0|||
33653481|NCT01709305|63065784|FG000|Phase 1|Withdrawal by Subject|218|||
33653482|NCT01709305|63065785|FG001|Phase 1|Withdrawal by Subject|0|||
33653483|NCT01709305|63065786|FG002|Phase 1|Withdrawal by Subject|0|||
33653484|NCT01709305|63065787|FG003|Phase 1|Withdrawal by Subject|0|||
33653485|NCT01709305|63065788|FG004|Phase 1|Withdrawal by Subject|0|||
33653486|NCT01709305|63065784|FG000|Phase 2|Clinical Adverse Event|0|||
33653487|NCT01709305|63065785|FG001|Phase 2|Clinical Adverse Event|10|||
33653488|NCT01709305|63065786|FG002|Phase 2|Clinical Adverse Event|10|||
33653489|NCT01709305|63065787|FG003|Phase 2|Clinical Adverse Event|6|||
33653490|NCT01709305|63065788|FG004|Phase 2|Clinical Adverse Event|11|||
33653491|NCT01709305|63065784|FG000|Phase 2|Death|0|||
33653492|NCT01709305|63065785|FG001|Phase 2|Death|0|||
33653493|NCT01709305|63065786|FG002|Phase 2|Death|1|||
33653494|NCT01709305|63065787|FG003|Phase 2|Death|0|||
33653495|NCT01709305|63065788|FG004|Phase 2|Death|0|||
33653496|NCT01709305|63065784|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
33653497|NCT01709305|63065785|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
33467869|NCT03257410|62841328|FG000|Overall Study|Switch to peritoneal dialysis|1|||
33467870|NCT03257410|62841329|FG001|Overall Study|Switch to peritoneal dialysis|0|||
33467871|NCT03257410|62841328|FG000|Overall Study|Death|3|||
33467872|NCT03257410|62841329|FG001|Overall Study|Death|2|||
33467873|NCT03257410|62841328|FG000|Overall Study|Change to another dialysis center|2|||
33467874|NCT03257410|62841329|FG001|Overall Study|Change to another dialysis center|2|||
33467875|NCT03257410|62841328|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
33467876|NCT03257410|62841329|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
33329248|NCT01191944|62705596|FG000|Overall Study|Other|1|||
33653498|NCT01709305|63065786|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
33653499|NCT01709305|63065787|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
33653500|NCT01709305|63065788|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
33653501|NCT01709305|63065784|FG000|Phase 2|Laboratory Adverse Event|0|||
33653502|NCT01709305|63065785|FG001|Phase 2|Laboratory Adverse Event|1|||
33653503|NCT01709305|63065786|FG002|Phase 2|Laboratory Adverse Event|0|||
33653504|NCT01709305|63065787|FG003|Phase 2|Laboratory Adverse Event|1|||
33653505|NCT01709305|63065788|FG004|Phase 2|Laboratory Adverse Event|1|||
33653506|NCT01709305|63065784|FG000|Phase 2|Lost to Follow-up|0|||
33653507|NCT01709305|63065785|FG001|Phase 2|Lost to Follow-up|10|||
33653508|NCT01709305|63065786|FG002|Phase 2|Lost to Follow-up|6|||
33653509|NCT01709305|63065787|FG003|Phase 2|Lost to Follow-up|9|||
33329249|NCT01191944|62705597|FG001|Overall Study|Other|3|||
33329250|NCT01191788|62705605|FG000|Overall Study|Lost to Follow-up|21|||
33329251|NCT01191788|62705606|FG001|Overall Study|Lost to Follow-up|22|||
33329252|NCT00940875|62705615|FG000|Treatment Phase|Adverse Event|9|||
33329253|NCT00940875|62705616|FG001|Treatment Phase|Adverse Event|3|||
33329254|NCT00940875|62705615|FG000|Treatment Phase|Death|3|||
33329255|NCT00940875|62705616|FG001|Treatment Phase|Death|5|||
33329256|NCT00940875|62705615|FG000|Treatment Phase|Lack of Efficacy|1|||
33329257|NCT00940875|62705616|FG001|Treatment Phase|Lack of Efficacy|0|||
33329258|NCT00940875|62705615|FG000|Treatment Phase|Withdrawal by Subject|3|||
33329259|NCT00940875|62705616|FG001|Treatment Phase|Withdrawal by Subject|0|||
33329260|NCT00940875|62705615|FG000|Treatment Phase|Disease progression|9|||
33329261|NCT00940875|62705616|FG001|Treatment Phase|Disease progression|11|||
33329262|NCT00940875|62705615|FG000|Treatment Phase|Physician Decision|1|||
33329263|NCT00940875|62705616|FG001|Treatment Phase|Physician Decision|0|||
33329264|NCT00940875|62705615|FG000|Post-Study Treatment|Death|0|||
33329265|NCT00940875|62705616|FG001|Post-Study Treatment|Death|1|||
33329266|NCT00940875|62705615|FG000|Post-Study Treatment|Disease Progression|0|||
33329267|NCT00940875|62705616|FG001|Post-Study Treatment|Disease Progression|2|||
33329268|NCT00940485|62705625|FG000|Overall Study|HBeAb positive at Baseline|3|||
33329269|NCT00940485|62705626|FG001|Overall Study|HBeAb positive at Baseline|2|||
33329270|NCT00940485|62705625|FG000|Overall Study|Lost to Follow-up|2|||
33329271|NCT00940485|62705626|FG001|Overall Study|Lost to Follow-up|3|||
33329272|NCT00940485|62705625|FG000|Overall Study|Adverse Event|8|||
33329273|NCT00940485|62705626|FG001|Overall Study|Adverse Event|0|||
33329274|NCT00940485|62705625|FG000|Overall Study|Withdrawal by Subject|1|||
33329275|NCT00940485|62705626|FG001|Overall Study|Withdrawal by Subject|1|||
33329276|NCT00940485|62705625|FG000|Overall Study|Others|1|||
33329277|NCT00940485|62705626|FG001|Overall Study|Others|1|||
33329278|NCT00943605|62705634|FG000|Overall Study|Study termination|30|||
33329279|NCT00943605|62705635|FG001|Overall Study|Study termination|30|||
33329280|NCT01132313|62705653|FG000|Overall Study|Lack of Efficacy|1|||
33329281|NCT01132313|62705654|FG001|Overall Study|Lack of Efficacy|0|||
33329282|NCT01132313|62705655|FG002|Overall Study|Lack of Efficacy|0|||
33329283|NCT01132313|62705656|FG003|Overall Study|Lack of Efficacy|0|||
33329284|NCT01132313|62705657|FG004|Overall Study|Lack of Efficacy|0|||
33329285|NCT01132313|62705658|FG005|Overall Study|Lack of Efficacy|0|||
33329286|NCT01132313|62705659|FG006|Overall Study|Lack of Efficacy|0|||
33329287|NCT01132313|62705660|FG007|Overall Study|Lack of Efficacy|3|||
33329288|NCT01132313|62705661|FG008|Overall Study|Lack of Efficacy|14|||
33329289|NCT01132313|62705662|FG009|Overall Study|Lack of Efficacy|16|||
33329290|NCT01132313|62705663|FG010|Overall Study|Lack of Efficacy|0|||
33329291|NCT01132313|62705664|FG011|Overall Study|Lack of Efficacy|0|||
33329292|NCT01132313|62705653|FG000|Overall Study|Not treated|2|||
33329293|NCT01132313|62705654|FG001|Overall Study|Not treated|0|||
33329294|NCT01132313|62705655|FG002|Overall Study|Not treated|0|||
33329295|NCT01132313|62705656|FG003|Overall Study|Not treated|0|||
33329296|NCT01132313|62705657|FG004|Overall Study|Not treated|2|||
33329297|NCT01132313|62705658|FG005|Overall Study|Not treated|1|||
33329298|NCT01132313|62705659|FG006|Overall Study|Not treated|3|||
33329299|NCT01132313|62705660|FG007|Overall Study|Not treated|0|||
33329300|NCT01132313|62705661|FG008|Overall Study|Not treated|0|||
33329301|NCT01132313|62705662|FG009|Overall Study|Not treated|0|||
33329302|NCT01132313|62705663|FG010|Overall Study|Not treated|0|||
33329303|NCT01132313|62705664|FG011|Overall Study|Not treated|0|||
33548205|NCT02958865|62939467|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
33548206|NCT02958865|62939468|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33548207|NCT02958865|62939469|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
33548208|NCT02958865|62939470|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33548209|NCT02958865|62939471|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
33548210|NCT02958865|62939472|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33548211|NCT02958865|62939473|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
33548212|NCT02958865|62939458|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33548213|NCT02958865|62939459|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33329304|NCT01132313|62705653|FG000|Overall Study|Adverse Event|0|||
33329305|NCT01132313|62705654|FG001|Overall Study|Adverse Event|0|||
33329306|NCT01132313|62705655|FG002|Overall Study|Adverse Event|4|||
33329307|NCT01132313|62705656|FG003|Overall Study|Adverse Event|10|||
33329308|NCT01132313|62705657|FG004|Overall Study|Adverse Event|19|||
33329309|NCT01132313|62705658|FG005|Overall Study|Adverse Event|6|||
33329310|NCT01132313|62705659|FG006|Overall Study|Adverse Event|5|||
33329311|NCT01132313|62705660|FG007|Overall Study|Adverse Event|3|||
33329312|NCT01132313|62705661|FG008|Overall Study|Adverse Event|7|||
33329313|NCT01132313|62705662|FG009|Overall Study|Adverse Event|2|||
33329314|NCT01132313|62705663|FG010|Overall Study|Adverse Event|0|||
33329315|NCT01132313|62705664|FG011|Overall Study|Adverse Event|0|||
33329316|NCT01132313|62705653|FG000|Overall Study|Protocol Violation|0|||
33329317|NCT01132313|62705654|FG001|Overall Study|Protocol Violation|0|||
33329318|NCT01132313|62705655|FG002|Overall Study|Protocol Violation|0|||
33329319|NCT01132313|62705656|FG003|Overall Study|Protocol Violation|1|||
33329320|NCT01132313|62705657|FG004|Overall Study|Protocol Violation|0|||
33329321|NCT01132313|62705658|FG005|Overall Study|Protocol Violation|0|||
33329322|NCT01132313|62705659|FG006|Overall Study|Protocol Violation|0|||
33329323|NCT01132313|62705660|FG007|Overall Study|Protocol Violation|0|||
33329324|NCT01132313|62705661|FG008|Overall Study|Protocol Violation|0|||
33329325|NCT01132313|62705662|FG009|Overall Study|Protocol Violation|0|||
33329326|NCT01132313|62705663|FG010|Overall Study|Protocol Violation|0|||
33329327|NCT01132313|62705664|FG011|Overall Study|Protocol Violation|0|||
33329328|NCT01132313|62705653|FG000|Overall Study|Lost to Follow-up|0|||
33329329|NCT01132313|62705654|FG001|Overall Study|Lost to Follow-up|0|||
33329330|NCT01132313|62705655|FG002|Overall Study|Lost to Follow-up|1|||
33329331|NCT01132313|62705656|FG003|Overall Study|Lost to Follow-up|0|||
33329332|NCT01132313|62705657|FG004|Overall Study|Lost to Follow-up|0|||
33329333|NCT01132313|62705658|FG005|Overall Study|Lost to Follow-up|0|||
33653510|NCT01709305|63065788|FG004|Phase 2|Lost to Follow-up|5|||
33329334|NCT01132313|62705659|FG006|Overall Study|Lost to Follow-up|0|||
33329335|NCT01132313|62705660|FG007|Overall Study|Lost to Follow-up|1|||
33329336|NCT01132313|62705661|FG008|Overall Study|Lost to Follow-up|0|||
33467877|NCT03257410|62841328|FG000|Overall Study|Miscellaneous|2|||
33467878|NCT03257410|62841329|FG001|Overall Study|Miscellaneous|2|||
33467879|NCT03257410|62841328|FG000|Overall Study|Other|0|||
33467880|NCT03257410|62841329|FG001|Overall Study|Other|1|||
33467881|NCT00056160|62841337|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
33653511|NCT01709305|63065784|FG000|Phase 2|Travel, moving, etc.|0|||
33653512|NCT01709305|63065785|FG001|Phase 2|Travel, moving, etc.|2|||
33653513|NCT01709305|63065786|FG002|Phase 2|Travel, moving, etc.|3|||
33653514|NCT01709305|63065787|FG003|Phase 2|Travel, moving, etc.|3|||
33653515|NCT01709305|63065788|FG004|Phase 2|Travel, moving, etc.|5|||
33653516|NCT01709305|63065784|FG000|Phase 2|Physician Decision|0|||
33653517|NCT01709305|63065785|FG001|Phase 2|Physician Decision|2|||
33653518|NCT01709305|63065786|FG002|Phase 2|Physician Decision|0|||
33653519|NCT01709305|63065787|FG003|Phase 2|Physician Decision|1|||
33653520|NCT01709305|63065788|FG004|Phase 2|Physician Decision|2|||
33467882|NCT00056160|62841338|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
33467883|NCT00056160|62841337|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
33467884|NCT00056160|62841338|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
33329337|NCT01132313|62705662|FG009|Overall Study|Lost to Follow-up|0|||
33329338|NCT01132313|62705663|FG010|Overall Study|Lost to Follow-up|0|||
33329339|NCT01132313|62705664|FG011|Overall Study|Lost to Follow-up|0|||
33467885|NCT00056160|62841337|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
33467886|NCT00056160|62841338|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
33548214|NCT02958865|62939460|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33548215|NCT02958865|62939461|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33653521|NCT01709305|63065784|FG000|Phase 2|Protocol Violation|0|||
33329340|NCT01132313|62705653|FG000|Overall Study|Withdrawal by Subject|0|||
33329341|NCT01132313|62705654|FG001|Overall Study|Withdrawal by Subject|0|||
33329342|NCT01132313|62705655|FG002|Overall Study|Withdrawal by Subject|3|||
33329343|NCT01132313|62705656|FG003|Overall Study|Withdrawal by Subject|3|||
33329344|NCT01132313|62705657|FG004|Overall Study|Withdrawal by Subject|6|||
33329345|NCT01132313|62705658|FG005|Overall Study|Withdrawal by Subject|0|||
33329346|NCT01132313|62705659|FG006|Overall Study|Withdrawal by Subject|1|||
33329347|NCT01132313|62705660|FG007|Overall Study|Withdrawal by Subject|0|||
33329348|NCT01132313|62705661|FG008|Overall Study|Withdrawal by Subject|0|||
33329349|NCT01132313|62705662|FG009|Overall Study|Withdrawal by Subject|2|||
33329350|NCT01132313|62705663|FG010|Overall Study|Withdrawal by Subject|0|||
33329351|NCT01132313|62705664|FG011|Overall Study|Withdrawal by Subject|0|||
33329352|NCT01132313|62705653|FG000|Overall Study|Lack of antiviral response|0|||
33329353|NCT01132313|62705654|FG001|Overall Study|Lack of antiviral response|0|||
33329354|NCT01132313|62705655|FG002|Overall Study|Lack of antiviral response|12|||
33329355|NCT01132313|62705656|FG003|Overall Study|Lack of antiviral response|18|||
33329356|NCT01132313|62705657|FG004|Overall Study|Lack of antiviral response|18|||
33329357|NCT01132313|62705658|FG005|Overall Study|Lack of antiviral response|18|||
33329358|NCT01132313|62705659|FG006|Overall Study|Lack of antiviral response|21|||
33329359|NCT01132313|62705660|FG007|Overall Study|Lack of antiviral response|0|||
33329360|NCT01132313|62705661|FG008|Overall Study|Lack of antiviral response|0|||
33329361|NCT01132313|62705662|FG009|Overall Study|Lack of antiviral response|0|||
33329362|NCT01132313|62705663|FG010|Overall Study|Lack of antiviral response|1|||
33329363|NCT01132313|62705664|FG011|Overall Study|Lack of antiviral response|0|||
33329364|NCT01132313|62705653|FG000|Overall Study|Other reason not defined above|0|||
33329365|NCT01132313|62705654|FG001|Overall Study|Other reason not defined above|0|||
33329366|NCT01132313|62705655|FG002|Overall Study|Other reason not defined above|0|||
33329367|NCT01132313|62705656|FG003|Overall Study|Other reason not defined above|0|||
33329368|NCT01132313|62705657|FG004|Overall Study|Other reason not defined above|0|||
33329369|NCT01132313|62705658|FG005|Overall Study|Other reason not defined above|0|||
33329370|NCT01132313|62705659|FG006|Overall Study|Other reason not defined above|0|||
33329371|NCT01132313|62705660|FG007|Overall Study|Other reason not defined above|1|||
33329372|NCT01132313|62705661|FG008|Overall Study|Other reason not defined above|0|||
33329373|NCT01132313|62705662|FG009|Overall Study|Other reason not defined above|0|||
33329374|NCT01132313|62705663|FG010|Overall Study|Other reason not defined above|0|||
33329375|NCT01132313|62705664|FG011|Overall Study|Other reason not defined above|0|||
33329376|NCT00861757|62705699|FG000|Overall Study|Adverse Event|1|||
33329377|NCT00861757|62705700|FG001|Overall Study|Adverse Event|5|||
33329378|NCT00861757|62705701|FG002|Overall Study|Adverse Event|7|||
33329379|NCT00861757|62705702|FG003|Overall Study|Adverse Event|2|||
33329380|NCT00861757|62705699|FG000|Overall Study|Entry Criteria Not Met|1|||
33329381|NCT00861757|62705700|FG001|Overall Study|Entry Criteria Not Met|2|||
33329382|NCT00861757|62705701|FG002|Overall Study|Entry Criteria Not Met|1|||
33329383|NCT00861757|62705702|FG003|Overall Study|Entry Criteria Not Met|1|||
33329384|NCT00861757|62705699|FG000|Overall Study|Lack of Efficacy|3|||
33329385|NCT00861757|62705700|FG001|Overall Study|Lack of Efficacy|1|||
33329386|NCT00861757|62705701|FG002|Overall Study|Lack of Efficacy|0|||
33329387|NCT00861757|62705702|FG003|Overall Study|Lack of Efficacy|1|||
33329388|NCT00861757|62705699|FG000|Overall Study|Lost to Follow-up|1|||
33329389|NCT00861757|62705700|FG001|Overall Study|Lost to Follow-up|0|||
33329390|NCT00861757|62705701|FG002|Overall Study|Lost to Follow-up|1|||
33329391|NCT00861757|62705702|FG003|Overall Study|Lost to Follow-up|1|||
33548216|NCT02958865|62939462|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33548217|NCT02958865|62939463|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33548218|NCT02958865|62939464|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33548219|NCT02958865|62939465|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33653522|NCT01709305|63065785|FG001|Phase 2|Protocol Violation|19|||
33329392|NCT00861757|62705699|FG000|Overall Study|Physician Decision|0|||
33329393|NCT00861757|62705700|FG001|Overall Study|Physician Decision|0|||
33329394|NCT00861757|62705701|FG002|Overall Study|Physician Decision|0|||
33329395|NCT00861757|62705702|FG003|Overall Study|Physician Decision|1|||
33329396|NCT00861757|62705699|FG000|Overall Study|Protocol Violation|2|||
33329397|NCT00861757|62705700|FG001|Overall Study|Protocol Violation|2|||
33329398|NCT00861757|62705701|FG002|Overall Study|Protocol Violation|4|||
33329399|NCT00861757|62705702|FG003|Overall Study|Protocol Violation|1|||
33329400|NCT00861757|62705699|FG000|Overall Study|Withdrawal by Subject|1|||
33329401|NCT00861757|62705700|FG001|Overall Study|Withdrawal by Subject|5|||
33329402|NCT00861757|62705701|FG002|Overall Study|Withdrawal by Subject|5|||
33329403|NCT00861757|62705702|FG003|Overall Study|Withdrawal by Subject|2|||
33329404|NCT01131455|62705719|FG000|Overall Study|Death of PI|6|||
33329405|NCT01131455|62705720|FG001|Overall Study|Death of PI|4|||
33329406|NCT01131455|62705721|FG002|Overall Study|Death of PI|0|||
33653523|NCT01709305|63065786|FG002|Phase 2|Protocol Violation|19|||
33653524|NCT01709305|63065787|FG003|Phase 2|Protocol Violation|13|||
33653525|NCT01709305|63065788|FG004|Phase 2|Protocol Violation|9|||
33653526|NCT01709305|63065784|FG000|Phase 2|Withdrawal by Subject|0|||
33653527|NCT01709305|63065785|FG001|Phase 2|Withdrawal by Subject|8|||
33653528|NCT01709305|63065786|FG002|Phase 2|Withdrawal by Subject|6|||
33653529|NCT01709305|63065787|FG003|Phase 2|Withdrawal by Subject|15|||
33653530|NCT01709305|63065788|FG004|Phase 2|Withdrawal by Subject|12|||
33653531|NCT01684423|63065808|FG000|Overall Study|Withdrawal by Subject|0|||
33653532|NCT01684423|63065809|FG001|Overall Study|Withdrawal by Subject|0|||
33653533|NCT01684423|63065810|FG002|Overall Study|Withdrawal by Subject|1|||
33653534|NCT01684423|63065811|FG003|Overall Study|Withdrawal by Subject|0|||
33653535|NCT01684423|63065812|FG004|Overall Study|Withdrawal by Subject|0|||
33653536|NCT01709227|63065828|FG000|Overall Study|Physician Decision|1|||
33653537|NCT01709227|63065829|FG001|Overall Study|Physician Decision|0|||
33653538|NCT01709227|63065828|FG000|Overall Study|Pleural Peritoneal communication|0|||
33329407|NCT01138007|62705732|FG000|Overall Study|Adverse Event|4|||
33467887|NCT00056160|62841337|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
33467888|NCT00056160|62841338|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
33467889|NCT00056160|62841337|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
33467890|NCT00056160|62841338|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
33467891|NCT00056160|62841337|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
33467892|NCT00056160|62841338|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
33653539|NCT01709227|63065829|FG001|Overall Study|Pleural Peritoneal communication|9|||
33653540|NCT01684033|63065836|FG000|Period 1, First 30 Days|Adverse Event|1|||
33329408|NCT01138007|62705733|FG001|Overall Study|Adverse Event|12|||
33329409|NCT01138007|62705734|FG002|Overall Study|Adverse Event|9|||
33329410|NCT01138007|62705732|FG000|Overall Study|Lack of Efficacy|2|||
33329411|NCT01138007|62705733|FG001|Overall Study|Lack of Efficacy|0|||
33329412|NCT01138007|62705734|FG002|Overall Study|Lack of Efficacy|6|||
33329413|NCT01138007|62705732|FG000|Overall Study|Protocol Violation|2|||
33329414|NCT01138007|62705733|FG001|Overall Study|Protocol Violation|3|||
33329415|NCT01138007|62705734|FG002|Overall Study|Protocol Violation|2|||
33329416|NCT01138007|62705732|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
33329417|NCT01138007|62705733|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
33329418|NCT01138007|62705734|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
33329419|NCT01138007|62705732|FG000|Overall Study|Lost to Follow-up|3|||
33329420|NCT01138007|62705733|FG001|Overall Study|Lost to Follow-up|3|||
33329421|NCT01138007|62705734|FG002|Overall Study|Lost to Follow-up|5|||
33329422|NCT01138007|62705732|FG000|Overall Study|Physician Decision|0|||
33329423|NCT01138007|62705733|FG001|Overall Study|Physician Decision|5|||
33329424|NCT01138007|62705734|FG002|Overall Study|Physician Decision|3|||
33329425|NCT01138007|62705732|FG000|Overall Study|Withdrawal by Subject|5|||
33329426|NCT01138007|62705733|FG001|Overall Study|Withdrawal by Subject|6|||
33329427|NCT01138007|62705734|FG002|Overall Study|Withdrawal by Subject|15|||
33329428|NCT00865345|62705744|FG000|Overall Study|Withdrawal by Subject|2|||
33329429|NCT01131299|62705748|FG000|Overall Study|Withdrawal by Subject|4|||
33329430|NCT01131299|62705749|FG001|Overall Study|Withdrawal by Subject|7|||
33329431|NCT01130831|62705754|FG000|Overall Study|Withdrawal by Subject|7|||
33329432|NCT01130831|62705754|FG000|Overall Study|Death|4|||
33329433|NCT01130831|62705754|FG000|Overall Study|Information was missing|3|||
33329434|NCT01130597|62705770|FG000|Overall Study|Protocol-specified (High K+)|1|||
33329435|NCT01130597|62705770|FG000|Overall Study|Adverse Event|4|||
33329436|NCT01130597|62705770|FG000|Overall Study|Death|1|||
33329437|NCT01130597|62705770|FG000|Overall Study|Protocol Violation|1|||
33329438|NCT00939003|62705776|FG000|Double-blind Treatment Period|Adverse Event|1|||
33329439|NCT00939003|62705777|FG001|Double-blind Treatment Period|Adverse Event|1|||
33329440|NCT00939003|62705776|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
33329441|NCT00939003|62705777|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
33329442|NCT00939003|62705776|FG000|Double-blind Treatment Period|Pregnancy|0|||
33329443|NCT00939003|62705777|FG001|Double-blind Treatment Period|Pregnancy|1|||
33329444|NCT00939003|62705776|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
33329445|NCT00939003|62705777|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
33329446|NCT00939003|62705776|FG000|Open-label Treatment Period|Adverse Event|4|||
33329447|NCT00939003|62705777|FG001|Open-label Treatment Period|Adverse Event|8|||
33329448|NCT00939003|62705776|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
33329449|NCT00939003|62705777|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
33329450|NCT00939003|62705776|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
33329451|NCT00939003|62705777|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
33329452|NCT00939003|62705776|FG000|Open-label Treatment Period|Pregnancy|1|||
33329453|NCT00939003|62705777|FG001|Open-label Treatment Period|Pregnancy|1|||
33329454|NCT00939003|62705776|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
33329455|NCT00939003|62705777|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
33329456|NCT00939003|62705776|FG000|Open-label Treatment Period|Site Closure|3|||
33329457|NCT00939003|62705777|FG001|Open-label Treatment Period|Site Closure|4|||
33329458|NCT01188668|62705786|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
33329459|NCT01188668|62705786|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
33329460|NCT01188668|62705786|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
33329461|NCT01130051|62705793|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
33329462|NCT01130051|62705794|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
33329463|NCT01130051|62705793|FG000|Washout Period of 14 Days|Protocol Violation|1|||
33329464|NCT01130051|62705794|FG001|Washout Period of 14 Days|Protocol Violation|1|||
33329465|NCT00865189|62705802|FG000|Overall Study|Other|1|||
33329466|NCT00865189|62705803|FG001|Overall Study|Other|2|||
33329467|NCT00865189|62705802|FG000|Overall Study|Death|4|||
33329468|NCT00865189|62705803|FG001|Overall Study|Death|11|||
33329469|NCT00865189|62705802|FG000|Overall Study|Lost to Follow-up|6|||
33329470|NCT00865189|62705803|FG001|Overall Study|Lost to Follow-up|6|||
33329471|NCT00865189|62705802|FG000|Overall Study|Withdrawal by Subject|1|||
33329472|NCT00865189|62705803|FG001|Overall Study|Withdrawal by Subject|0|||
33329473|NCT01182194|62705811|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
33329474|NCT01182194|62705812|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
33329475|NCT01181726|62705820|FG000|First Intervention|Adverse Event|1|||
33329476|NCT01181726|62705821|FG001|First Intervention|Adverse Event|0|||
33329477|NCT01137071|62705827|FG000|Overall Study|Disease Progression|11|||
33329478|NCT01137071|62705827|FG000|Overall Study|Withdrawal by Subject|2|||
33329479|NCT01137071|62705827|FG000|Overall Study|Wrongly Included|1|||
33329480|NCT00860743|62705842|FG000|Overall Study|Withdrawal by Subject|3|||
33329481|NCT00860743|62705843|FG001|Overall Study|Withdrawal by Subject|0|||
33329482|NCT01186796|62705851|FG000|Overall Study|Adverse Event|3|||
33329483|NCT01186796|62705852|FG001|Overall Study|Adverse Event|0|||
33329484|NCT01186796|62705851|FG000|Overall Study|Withdrawal by Subject|1|||
33329485|NCT01186796|62705852|FG001|Overall Study|Withdrawal by Subject|1|||
33329486|NCT01186796|62705851|FG000|Overall Study|Protocol Violation|0|||
33329487|NCT01186796|62705852|FG001|Overall Study|Protocol Violation|1|||
33329488|NCT01136915|62705860|FG000|Overall Study|Lost to Follow-up|2|||
33329489|NCT01136915|62705861|FG001|Overall Study|Lost to Follow-up|0|||
33329490|NCT01136915|62705860|FG000|Overall Study|Exclusion criterion met|0|||
33329491|NCT01136915|62705861|FG001|Overall Study|Exclusion criterion met|1|||
33329492|NCT00940017|62705869|FG000|Overall Study|did not meet entrance criteria|3|||
33329493|NCT00940017|62705869|FG000|Overall Study|Adverse Event|1|||
33329494|NCT01129583|62705875|FG000|Overall Study|Death|1|||
33329495|NCT01129583|62705876|FG001|Overall Study|Death|0|||
33329496|NCT01129583|62705875|FG000|Overall Study|Lost to Follow-up|1|||
33329497|NCT01129583|62705876|FG001|Overall Study|Lost to Follow-up|1|||
33329498|NCT01129583|62705875|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
33329499|NCT01129583|62705876|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
33329500|NCT01186328|62705882|FG000|Overall Study|Death|1|||
33329501|NCT01186328|62705883|FG001|Overall Study|Death|0|||
33329502|NCT01186328|62705884|FG002|Overall Study|Death|0|||
33329503|NCT00848497|62705891|FG000|Overall Study|Screen failure|2|||
33329504|NCT00848497|62705892|FG001|Overall Study|Screen failure|0|||
33329505|NCT00848497|62705891|FG000|Overall Study|Withdrawal by Subject|0|||
33329506|NCT00848497|62705892|FG001|Overall Study|Withdrawal by Subject|1|||
33329507|NCT00857623|62705902|FG000|Overall Study|Adverse Event|5|||
33329508|NCT00857623|62705903|FG001|Overall Study|Adverse Event|2|||
33329509|NCT00857623|62705902|FG000|Overall Study|Study-specific discontinuation criteria|5|||
33329510|NCT00857623|62705903|FG001|Overall Study|Study-specific discontinuation criteria|3|||
33329511|NCT00857623|62705902|FG000|Overall Study|Withdrawal by Subject|2|||
33329512|NCT00857623|62705903|FG001|Overall Study|Withdrawal by Subject|1|||
33329513|NCT00857623|62705902|FG000|Overall Study|Lack of Efficacy|1|||
33329514|NCT00857623|62705903|FG001|Overall Study|Lack of Efficacy|1|||
33329515|NCT00857623|62705902|FG000|Overall Study|Severe non-compliance to protocol|1|||
33329516|NCT00857623|62705903|FG001|Overall Study|Severe non-compliance to protocol|1|||
33329517|NCT00857623|62705902|FG000|Overall Study|Intake of prohibited medication|0|||
33329518|NCT00857623|62705903|FG001|Overall Study|Intake of prohibited medication|1|||
33329519|NCT00857623|62705902|FG000|Overall Study|Positive for HEP C|0|||
33329520|NCT00857623|62705903|FG001|Overall Study|Positive for HEP C|1|||
33329521|NCT01185782|62705911|FG000|Overall Study|Adverse Event|0|||
33329522|NCT01185782|62705912|FG001|Overall Study|Adverse Event|1|||
33329523|NCT01185782|62705911|FG000|Overall Study|Protocol Violation|1|||
33329524|NCT01185782|62705912|FG001|Overall Study|Protocol Violation|0|||
33329525|NCT01185782|62705911|FG000|Overall Study|Poor Response to Treatment|3|||
33329526|NCT01185782|62705912|FG001|Overall Study|Poor Response to Treatment|1|||
33329527|NCT01185782|62705911|FG000|Overall Study|Other|2|||
33329528|NCT01185782|62705912|FG001|Overall Study|Other|5|||
33329529|NCT01185782|62705911|FG000|Overall Study|Randomized but not treated|0|||
33329530|NCT01185782|62705912|FG001|Overall Study|Randomized but not treated|4|||
33329531|NCT01129115|62705922|FG000|Overall Study|Adverse Event|1|||
33467893|NCT00056160|62841337|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
33467894|NCT00056160|62841338|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
33329532|NCT01129115|62705923|FG001|Overall Study|Adverse Event|2|||
33329533|NCT01129115|62705924|FG002|Overall Study|Adverse Event|3|||
33329534|NCT01129115|62705925|FG003|Overall Study|Adverse Event|3|||
33329535|NCT01129115|62705922|FG000|Overall Study|Withdrawal by Subject|1|||
33329536|NCT01129115|62705923|FG001|Overall Study|Withdrawal by Subject|3|||
33329537|NCT01129115|62705924|FG002|Overall Study|Withdrawal by Subject|1|||
33329538|NCT01129115|62705925|FG003|Overall Study|Withdrawal by Subject|4|||
33329539|NCT01129115|62705922|FG000|Overall Study|Protocol Violation|0|||
33329540|NCT01129115|62705923|FG001|Overall Study|Protocol Violation|2|||
33653541|NCT01684033|63065837|FG001|Period 1, First 30 Days|Adverse Event|1|||
33653542|NCT01684033|63065836|FG000|Period 1, First 30 Days|Noncompliance|1|||
33653543|NCT01684033|63065837|FG001|Period 1, First 30 Days|Noncompliance|0|||
33329541|NCT01129115|62705924|FG002|Overall Study|Protocol Violation|2|||
33329542|NCT01129115|62705925|FG003|Overall Study|Protocol Violation|2|||
33329543|NCT01185704|62705937|FG000|Overall Study|Randomized but not treated|3|||
33329544|NCT01185704|62705938|FG001|Overall Study|Randomized but not treated|3|||
33329545|NCT01185704|62705937|FG000|Overall Study|Lack of ovarian response|5|||
33329546|NCT01185704|62705938|FG001|Overall Study|Lack of ovarian response|1|||
33329547|NCT01185704|62705937|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
33329548|NCT01185704|62705938|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
33329549|NCT01185704|62705937|FG000|Overall Study|Ectopic pregnancy|0|||
33329550|NCT01185704|62705938|FG001|Overall Study|Ectopic pregnancy|1|||
33329551|NCT01128959|62705944|FG000|Lead in Period|Adverse Event|3|||
33329552|NCT01128959|62705944|FG000|Treatment Period|Adverse Event|3|||
33329553|NCT01128959|62705944|FG000|Treatment Period|Withdrawal by Subject|1|||
33329554|NCT00859573|62705952|FG000|Overall Study|Withdrawal by Subject|4|||
33329555|NCT00859573|62705953|FG001|Overall Study|Withdrawal by Subject|1|||
33329556|NCT00859573|62705952|FG000|Overall Study|Physician Decision|1|||
33329557|NCT00859573|62705953|FG001|Overall Study|Physician Decision|1|||
33329558|NCT01136291|62705961|FG000|Overall Study|Lost to Follow-up|1|||
33329559|NCT01136291|62705962|FG001|Overall Study|Lost to Follow-up|1|||
33329560|NCT01185548|62705968|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
33329561|NCT01128569|62705981|FG000|Washout Period 1|Adverse Event|0|||
33329562|NCT01128569|62705982|FG001|Washout Period 1|Adverse Event|0|||
33329563|NCT01128569|62705983|FG002|Washout Period 1|Adverse Event|1|||
33329564|NCT01128569|62705984|FG003|Washout Period 1|Adverse Event|0|||
33329565|NCT01128569|62705985|FG004|Washout Period 1|Adverse Event|0|||
33329566|NCT01128569|62705986|FG005|Washout Period 1|Adverse Event|0|||
33329567|NCT01128569|62705981|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33329568|NCT01128569|62705982|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33329569|NCT01128569|62705983|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33329570|NCT01128569|62705984|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33329571|NCT01128569|62705985|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33329572|NCT01128569|62705986|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33329573|NCT01128413|62705996|FG000|Overall Study|Withdrawal by Subject|1|||
33329574|NCT01128413|62705997|FG001|Overall Study|Withdrawal by Subject|0|||
33329575|NCT01128413|62705996|FG000|Overall Study|NICOM Monitor Problems|2|||
33329576|NCT01128413|62705997|FG001|Overall Study|NICOM Monitor Problems|1|||
33329577|NCT01128413|62705996|FG000|Overall Study|Pt made DNR|1|||
33329578|NCT01128413|62705997|FG001|Overall Study|Pt made DNR|0|||
33329579|NCT01185080|62706006|FG000|Overall Study|Adverse Event|1|||
33329580|NCT01185080|62706007|FG001|Overall Study|Adverse Event|1|||
33329581|NCT01185080|62706008|FG002|Overall Study|Adverse Event|0|||
33329582|NCT01185080|62706006|FG000|Overall Study|Personal reasons|0|||
33329583|NCT01185080|62706007|FG001|Overall Study|Personal reasons|0|||
33329584|NCT01185080|62706008|FG002|Overall Study|Personal reasons|1|||
33329585|NCT01128179|62706018|FG000|Overall Study|Death|1|||
33329586|NCT01128179|62706019|FG001|Overall Study|Death|0|||
33329587|NCT01128179|62706018|FG000|Overall Study|Protocol Violation|1|||
33329588|NCT01128179|62706019|FG001|Overall Study|Protocol Violation|0|||
33329589|NCT01181102|62706027|FG000|Overall Study|Adverse Event|28|||
33329590|NCT01181102|62706028|FG001|Overall Study|Adverse Event|26|||
33329591|NCT01181102|62706027|FG000|Overall Study|Lack of Efficacy|3|||
33329592|NCT01181102|62706028|FG001|Overall Study|Lack of Efficacy|1|||
33329593|NCT01181102|62706027|FG000|Overall Study|Lost to Follow-up|2|||
33329594|NCT01181102|62706028|FG001|Overall Study|Lost to Follow-up|0|||
33329595|NCT01181102|62706027|FG000|Overall Study|Physician Decision|3|||
33329596|NCT01181102|62706028|FG001|Overall Study|Physician Decision|1|||
33329597|NCT01181102|62706027|FG000|Overall Study|Protocol Violation|5|||
33329598|NCT01181102|62706028|FG001|Overall Study|Protocol Violation|6|||
33329599|NCT01181102|62706027|FG000|Overall Study|Withdrawal by Subject|10|||
33329600|NCT01181102|62706028|FG001|Overall Study|Withdrawal by Subject|12|||
33329601|NCT00858637|62706036|FG000|Active Comparison Phase|Adverse Event|14|||
33653544|NCT01684033|63065836|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
33653545|NCT01684033|63065837|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
33653546|NCT01684033|63065836|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
33329602|NCT00858637|62706037|FG001|Active Comparison Phase|Adverse Event|0|||
33329603|NCT00858637|62706038|FG002|Active Comparison Phase|Adverse Event|0|||
33329604|NCT00858637|62706039|FG003|Active Comparison Phase|Adverse Event|9|||
33329605|NCT00858637|62706040|FG004|Active Comparison Phase|Adverse Event|0|||
33329606|NCT00858637|62706041|FG005|Active Comparison Phase|Adverse Event|0|||
33329607|NCT00858637|62706036|FG000|Active Comparison Phase|Death|1|||
33329608|NCT00858637|62706037|FG001|Active Comparison Phase|Death|0|||
33329609|NCT00858637|62706038|FG002|Active Comparison Phase|Death|0|||
33329610|NCT00858637|62706039|FG003|Active Comparison Phase|Death|1|||
33653547|NCT01684033|63065837|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
33329611|NCT00858637|62706040|FG004|Active Comparison Phase|Death|0|||
33548220|NCT02958865|62939466|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33548221|NCT02958865|62939467|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
33548222|NCT02958865|62939468|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33548223|NCT02958865|62939469|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33548224|NCT02958865|62939470|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33548225|NCT02958865|62939471|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33548226|NCT02958865|62939472|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33548227|NCT02958865|62939473|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
33548228|NCT02958865|62939458|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33548229|NCT02958865|62939459|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33548230|NCT02958865|62939460|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33548231|NCT02958865|62939461|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33548232|NCT02958865|62939462|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33548233|NCT02958865|62939463|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33548234|NCT02958865|62939464|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33548235|NCT02958865|62939465|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33548236|NCT02958865|62939466|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33548237|NCT02958865|62939467|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33548238|NCT02958865|62939468|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33548239|NCT02958865|62939469|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
33548240|NCT02958865|62939470|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
33548241|NCT02958865|62939471|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
33653548|NCT01684033|63065836|FG000|Period 2, Second 30 Days|Adverse Event|1|||
33329612|NCT00858637|62706041|FG005|Active Comparison Phase|Death|0|||
33329613|NCT00858637|62706036|FG000|Active Comparison Phase|Physician Decision|1|||
33329614|NCT00858637|62706037|FG001|Active Comparison Phase|Physician Decision|0|||
33467895|NCT00056160|62841337|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
33329615|NCT00858637|62706038|FG002|Active Comparison Phase|Physician Decision|0|||
33329616|NCT00858637|62706039|FG003|Active Comparison Phase|Physician Decision|1|||
33467896|NCT00056160|62841338|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
33467897|NCT00056160|62841337|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
33467898|NCT00056160|62841338|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
33467899|NCT00056160|62841337|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
33467900|NCT00056160|62841338|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
33467901|NCT00056160|62841337|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
33329617|NCT00858637|62706040|FG004|Active Comparison Phase|Physician Decision|0|||
33329618|NCT00858637|62706041|FG005|Active Comparison Phase|Physician Decision|0|||
33329619|NCT00858637|62706036|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
33329620|NCT00858637|62706037|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
33329621|NCT00858637|62706038|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
33329622|NCT00858637|62706039|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
33329623|NCT00858637|62706040|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
33329624|NCT00858637|62706041|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
33548242|NCT02958865|62939472|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
33548243|NCT02958865|62939473|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
33548244|NCT02958865|62939458|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
33548245|NCT02958865|62939459|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
33548246|NCT02958865|62939460|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
33548247|NCT02958865|62939461|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
33548248|NCT02958865|62939462|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
33548249|NCT02958865|62939463|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
33548250|NCT02958865|62939464|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
33548251|NCT02958865|62939465|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
33548252|NCT02958865|62939466|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
33548253|NCT02958865|62939467|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
33548254|NCT02958865|62939468|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
33548255|NCT02958865|62939469|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
33548256|NCT02958865|62939470|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
33548257|NCT02958865|62939471|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
33548258|NCT02958865|62939472|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
33548259|NCT02958865|62939473|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
33548260|NCT02958865|62939458|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33548261|NCT02958865|62939459|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33548262|NCT02958865|62939460|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33548263|NCT02958865|62939461|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33548264|NCT02958865|62939462|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33653549|NCT01684033|63065837|FG001|Period 2, Second 30 Days|Adverse Event|0|||
33653550|NCT01903811|63065878|FG000|Overall Study|No measurable disease|1|||
33548265|NCT02958865|62939463|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33548266|NCT02958865|62939464|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33548267|NCT02958865|62939465|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33548268|NCT02958865|62939466|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33548269|NCT02958865|62939467|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33548270|NCT02958865|62939468|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33548271|NCT02958865|62939469|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33548272|NCT02958865|62939470|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33548273|NCT02958865|62939471|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
33548274|NCT02958865|62939472|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33548275|NCT02958865|62939473|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33329625|NCT00858637|62706036|FG000|Active Comparison Phase|Other Reasons|1|||
33329626|NCT00858637|62706037|FG001|Active Comparison Phase|Other Reasons|0|||
33329627|NCT00858637|62706038|FG002|Active Comparison Phase|Other Reasons|0|||
33329628|NCT00858637|62706039|FG003|Active Comparison Phase|Other Reasons|1|||
33329629|NCT00858637|62706040|FG004|Active Comparison Phase|Other Reasons|0|||
33329630|NCT00858637|62706041|FG005|Active Comparison Phase|Other Reasons|0|||
33329631|NCT00858637|62706036|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
33329632|NCT00858637|62706037|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
33329633|NCT00858637|62706038|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
33329634|NCT00858637|62706039|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
33329635|NCT00858637|62706040|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
33653551|NCT01903811|63065879|FG001|Overall Study|No measurable disease|1|||
33653552|NCT01903811|63065878|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
33329636|NCT00858637|62706041|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
33548276|NCT02958865|62939458|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33548277|NCT02958865|62939459|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33329637|NCT00858637|62706036|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
33329638|NCT00858637|62706037|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
33329639|NCT00858637|62706038|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
33329640|NCT00858637|62706039|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
33329641|NCT00858637|62706040|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
33329642|NCT00858637|62706041|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
33329643|NCT00858403|62706051|FG000|Overall Study|Withdrawal by Subject|1|||
33329644|NCT00858403|62706051|FG000|Overall Study|Death|3|||
33329645|NCT00858403|62706051|FG000|Overall Study|Disease Progression|1|||
33329646|NCT00858247|62706057|FG000|Baseline Assessment|Withdrawal by Subject|1|||
33329647|NCT00858247|62706058|FG001|Baseline Assessment|Withdrawal by Subject|1|||
33329648|NCT00858247|62706057|FG000|Baseline Assessment|Poor IV access|1|||
33329649|NCT00858247|62706058|FG001|Baseline Assessment|Poor IV access|0|||
33329650|NCT00858247|62706057|FG000|Baseline Assessment|Protocol Violation|0|||
33329651|NCT00858247|62706058|FG001|Baseline Assessment|Protocol Violation|1|||
33329652|NCT00858247|62706057|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
33329653|NCT00858247|62706058|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
33329654|NCT00838435|62706064|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
33329655|NCT00838435|62706064|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
33329656|NCT00838435|62706064|FG000|Part 2 (7 Years)|Adverse Event|2|||
33329657|NCT00838435|62706064|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
33329658|NCT00838435|62706064|FG000|Part 2 (7 Years)|Physician Decision|1|||
33329659|NCT00838435|62706064|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
33329660|NCT00838435|62706064|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
33329661|NCT00838201|62706073|FG000|Overall Study|Investigator decision, or other reasons|2|||
33329662|NCT00838201|62706074|FG001|Overall Study|Investigator decision, or other reasons|3|||
33329663|NCT00838201|62706073|FG000|Overall Study|Noncompliance|0|||
33329664|NCT00838201|62706074|FG001|Overall Study|Noncompliance|1|||
33329665|NCT00838201|62706073|FG000|Overall Study|Administrative decision|1|||
33329666|NCT00838201|62706074|FG001|Overall Study|Administrative decision|2|||
33329667|NCT00838201|62706073|FG000|Overall Study|Disease progression|3|||
33329668|NCT00838201|62706074|FG001|Overall Study|Disease progression|3|||
33329669|NCT00838201|62706073|FG000|Overall Study|Consent withdrawn|16|||
33329670|NCT00838201|62706074|FG001|Overall Study|Consent withdrawn|19|||
33329671|NCT00838201|62706073|FG000|Overall Study|Lost to Follow-up|4|||
33329672|NCT00838201|62706074|FG001|Overall Study|Lost to Follow-up|3|||
33329673|NCT00838201|62706073|FG000|Overall Study|Adverse Event|5|||
33329674|NCT00838201|62706074|FG001|Overall Study|Adverse Event|9|||
33329675|NCT00838201|62706073|FG000|Overall Study|Death|11|||
33329676|NCT00838201|62706074|FG001|Overall Study|Death|13|||
33329677|NCT00837967|62706080|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
33329678|NCT00837967|62706081|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
33653553|NCT01903811|63065879|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
33653554|NCT01903811|63065878|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
33653555|NCT01903811|63065879|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
33653556|NCT01903811|63065878|FG000|Overall Study|Withdrawal by Subject|0|||
33653557|NCT01903811|63065879|FG001|Overall Study|Withdrawal by Subject|1|||
33653558|NCT01709149|63065896|FG000|Open-label Lead-in Phase|Adverse Event|109|||
33653559|NCT01709149|63065897|FG001|Open-label Lead-in Phase|Adverse Event|0|||
33653560|NCT01709149|63065898|FG002|Open-label Lead-in Phase|Adverse Event|0|||
33653561|NCT01709149|63065896|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
33653562|NCT01709149|63065897|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
33653563|NCT01709149|63065898|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
33653564|NCT01709149|63065896|FG000|Open-label Lead-in Phase|Death|1|||
33653565|NCT01709149|63065897|FG001|Open-label Lead-in Phase|Death|0|||
33653566|NCT01709149|63065898|FG002|Open-label Lead-in Phase|Death|0|||
33653567|NCT01709149|63065896|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
33653568|NCT01709149|63065897|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
33329679|NCT02756806|62706087|FG000|Overall Study|Study terminated early|5|||
33329680|NCT00942357|62706093|FG000|Overall Study|Ineligible|37|||
33329681|NCT00942357|62706094|FG001|Overall Study|Ineligible|40|||
33329682|NCT00939783|62706100|FG000|Overall Study|Death|6|||
33329683|NCT00939783|62706100|FG000|Overall Study|Adverse Event|39|||
33329684|NCT00939783|62706100|FG000|Overall Study|Study Terminated by Sponsor|498|||
33329685|NCT00939783|62706100|FG000|Overall Study|Withdrawal by Subject|78|||
33653569|NCT01709149|63065898|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
33329686|NCT00939783|62706100|FG000|Overall Study|Other|16|||
33653570|NCT01709149|63065896|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
33653571|NCT01709149|63065897|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
33653572|NCT01709149|63065898|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
33653573|NCT01709149|63065896|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33329687|NCT00939783|62706100|FG000|Overall Study|Lost to Follow-up|8|||
33329688|NCT00939783|62706100|FG000|Overall Study|Protocol Violation|3|||
33329689|NCT00939783|62706100|FG000|Overall Study|Enrolled but not treated|1|||
33467902|NCT00056160|62841338|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
33467903|NCT00056160|62841337|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
33467904|NCT00056160|62841338|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
33467905|NCT00056160|62841337|FG000|Final Follow-up|Transferred into expanded access study.|3|||
33467906|NCT00056160|62841338|FG001|Final Follow-up|Transferred into expanded access study.|0|||
33467907|NCT00056160|62841337|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
33467908|NCT00056160|62841338|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
33467909|NCT00056160|62841337|FG000|Final Follow-up|Adverse Event|1|||
33329690|NCT00939627|62706106|FG000|Overall Study|Disease Progression|16|||
33329691|NCT00939627|62706107|FG001|Overall Study|Disease Progression|12|||
33329692|NCT00939627|62706108|FG002|Overall Study|Disease Progression|0|||
33329693|NCT00939627|62706106|FG000|Overall Study|Adverse Event|6|||
33329694|NCT00939627|62706107|FG001|Overall Study|Adverse Event|7|||
33329695|NCT00939627|62706108|FG002|Overall Study|Adverse Event|0|||
33329696|NCT00939627|62706106|FG000|Overall Study|Death|0|||
33329697|NCT00939627|62706107|FG001|Overall Study|Death|2|||
33329698|NCT00939627|62706108|FG002|Overall Study|Death|0|||
33329699|NCT00939627|62706106|FG000|Overall Study|Withdrawal by Subject|2|||
33329700|NCT00939627|62706107|FG001|Overall Study|Withdrawal by Subject|4|||
33329701|NCT00939627|62706108|FG002|Overall Study|Withdrawal by Subject|0|||
33329702|NCT00939627|62706106|FG000|Overall Study|Other complicating disease|1|||
33329703|NCT00939627|62706107|FG001|Overall Study|Other complicating disease|1|||
33329704|NCT00939627|62706108|FG002|Overall Study|Other complicating disease|0|||
33329705|NCT00939627|62706106|FG000|Overall Study|Not compliant|2|||
33329706|NCT00939627|62706107|FG001|Overall Study|Not compliant|0|||
33329707|NCT00939627|62706108|FG002|Overall Study|Not compliant|0|||
33329708|NCT00939627|62706106|FG000|Overall Study|No off-tx reason given|0|||
33329709|NCT00939627|62706107|FG001|Overall Study|No off-tx reason given|2|||
33329710|NCT00939627|62706108|FG002|Overall Study|No off-tx reason given|0|||
33329711|NCT00937833|62706116|FG000|Overall Study|Protocol Violation|1|||
33329712|NCT00937833|62706117|FG001|Overall Study|Protocol Violation|2|||
33329713|NCT00937833|62706116|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
33329714|NCT00937833|62706117|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
33329715|NCT00937833|62706116|FG000|Overall Study|Lost to Follow-up|10|||
33329716|NCT00937833|62706117|FG001|Overall Study|Lost to Follow-up|8|||
33329717|NCT00937833|62706116|FG000|Overall Study|Withdrawal by Subject|4|||
33329718|NCT00937833|62706117|FG001|Overall Study|Withdrawal by Subject|6|||
33329719|NCT01135511|62706132|FG000|Overall Study|Adverse Event|0|||
33329720|NCT01135511|62706133|FG001|Overall Study|Adverse Event|1|||
33329721|NCT01135511|62706134|FG002|Overall Study|Adverse Event|2|||
33329722|NCT01135511|62706135|FG003|Overall Study|Adverse Event|0|||
33329723|NCT01135511|62706136|FG004|Overall Study|Adverse Event|0|||
33467910|NCT00056160|62841338|FG001|Final Follow-up|Adverse Event|0|||
33467911|NCT00061932|62841346|FG000|Overall Study|Withdrawal by Subject|13|||
33467912|NCT00061932|62841347|FG001|Overall Study|Withdrawal by Subject|4|||
33467913|NCT03280264|62841354|FG000|Overall Study|Adverse Event|1|||
33467914|NCT03280264|62841354|FG000|Overall Study|Physician Decision|1|||
33467915|NCT03280264|62841354|FG000|Overall Study|Withdrawal by Subject|1|||
33467916|NCT00060840|62841361|FG000|Overall Study|Change in surgical plan|2|||
33467917|NCT00060840|62841362|FG001|Overall Study|Change in surgical plan|6|||
33467918|NCT00060840|62841361|FG000|Overall Study|Death|0|||
33467919|NCT00060840|62841362|FG001|Overall Study|Death|1|||
33467920|NCT00060840|62841361|FG000|Overall Study|Withdrawal by Subject|0|||
33467921|NCT00060840|62841362|FG001|Overall Study|Withdrawal by Subject|1|||
33467922|NCT00060840|62841361|FG000|Overall Study|Subinvestigator unavailable|0|||
33467923|NCT00060840|62841362|FG001|Overall Study|Subinvestigator unavailable|1|||
33467924|NCT00060840|62841361|FG000|Overall Study|Physician Decision|1|||
33467925|NCT00060840|62841362|FG001|Overall Study|Physician Decision|0|||
33467926|NCT00060840|62841361|FG000|Overall Study|Other|1|||
33467927|NCT00060840|62841362|FG001|Overall Study|Other|0|||
33467928|NCT03280108|62841370|FG000|Overall Study|Lost to Follow-up|2|||
33467929|NCT03280108|62841371|FG001|Overall Study|Lost to Follow-up|0|||
33467930|NCT00059202|62841384|FG000|Overall Study|Withdrawal by Subject|5|||
33467931|NCT00059202|62841385|FG001|Overall Study|Withdrawal by Subject|9|||
33653574|NCT01709149|63065897|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
33329724|NCT01135511|62706137|FG005|Overall Study|Adverse Event|1|||
33329725|NCT01135511|62706138|FG006|Overall Study|Adverse Event|0|||
33329726|NCT01135511|62706139|FG007|Overall Study|Adverse Event|1|||
33467932|NCT00059202|62841384|FG000|Overall Study|Protocol Violation|1|||
33467933|NCT00059202|62841385|FG001|Overall Study|Protocol Violation|3|||
33329727|NCT01135511|62706140|FG008|Overall Study|Adverse Event|0|||
33329728|NCT01135511|62706132|FG000|Overall Study|Lack of Efficacy|0|||
33329729|NCT01135511|62706133|FG001|Overall Study|Lack of Efficacy|1|||
33329730|NCT01135511|62706134|FG002|Overall Study|Lack of Efficacy|1|||
33329731|NCT01135511|62706135|FG003|Overall Study|Lack of Efficacy|2|||
33329732|NCT01135511|62706136|FG004|Overall Study|Lack of Efficacy|0|||
33329733|NCT01135511|62706137|FG005|Overall Study|Lack of Efficacy|0|||
33329734|NCT01135511|62706138|FG006|Overall Study|Lack of Efficacy|0|||
33329735|NCT01135511|62706139|FG007|Overall Study|Lack of Efficacy|0|||
33329736|NCT01135511|62706140|FG008|Overall Study|Lack of Efficacy|0|||
33329737|NCT01135511|62706132|FG000|Overall Study|Protocol Violation|0|||
33329738|NCT01135511|62706133|FG001|Overall Study|Protocol Violation|0|||
33329739|NCT01135511|62706134|FG002|Overall Study|Protocol Violation|3|||
33329740|NCT01135511|62706135|FG003|Overall Study|Protocol Violation|0|||
33329741|NCT01135511|62706136|FG004|Overall Study|Protocol Violation|0|||
33329742|NCT01135511|62706137|FG005|Overall Study|Protocol Violation|0|||
33329743|NCT01135511|62706138|FG006|Overall Study|Protocol Violation|0|||
33329744|NCT01135511|62706139|FG007|Overall Study|Protocol Violation|0|||
33329745|NCT01135511|62706140|FG008|Overall Study|Protocol Violation|0|||
33329746|NCT01135511|62706132|FG000|Overall Study|Pregnancy|0|||
33329747|NCT01135511|62706133|FG001|Overall Study|Pregnancy|0|||
33329748|NCT01135511|62706134|FG002|Overall Study|Pregnancy|0|||
33329749|NCT01135511|62706135|FG003|Overall Study|Pregnancy|1|||
33329750|NCT01135511|62706136|FG004|Overall Study|Pregnancy|0|||
33329751|NCT01135511|62706137|FG005|Overall Study|Pregnancy|0|||
33329752|NCT01135511|62706138|FG006|Overall Study|Pregnancy|0|||
33329753|NCT01135511|62706139|FG007|Overall Study|Pregnancy|0|||
33329754|NCT01135511|62706140|FG008|Overall Study|Pregnancy|0|||
33329755|NCT01135511|62706132|FG000|Overall Study|could not visit the clinic|0|||
33329756|NCT01135511|62706133|FG001|Overall Study|could not visit the clinic|1|||
33329757|NCT01135511|62706134|FG002|Overall Study|could not visit the clinic|2|||
33329758|NCT01135511|62706135|FG003|Overall Study|could not visit the clinic|0|||
33329759|NCT01135511|62706136|FG004|Overall Study|could not visit the clinic|0|||
33329760|NCT01135511|62706137|FG005|Overall Study|could not visit the clinic|0|||
33329761|NCT01135511|62706138|FG006|Overall Study|could not visit the clinic|0|||
33329762|NCT01135511|62706139|FG007|Overall Study|could not visit the clinic|0|||
33329763|NCT01135511|62706140|FG008|Overall Study|could not visit the clinic|0|||
33329764|NCT01135511|62706132|FG000|Overall Study|noncompliance with study drug taken|0|||
33329765|NCT01135511|62706133|FG001|Overall Study|noncompliance with study drug taken|0|||
33329766|NCT01135511|62706134|FG002|Overall Study|noncompliance with study drug taken|0|||
33329767|NCT01135511|62706135|FG003|Overall Study|noncompliance with study drug taken|0|||
33329768|NCT01135511|62706136|FG004|Overall Study|noncompliance with study drug taken|1|||
33329769|NCT01135511|62706137|FG005|Overall Study|noncompliance with study drug taken|0|||
33329770|NCT01135511|62706138|FG006|Overall Study|noncompliance with study drug taken|0|||
33329771|NCT01135511|62706139|FG007|Overall Study|noncompliance with study drug taken|0|||
33329772|NCT01135511|62706140|FG008|Overall Study|noncompliance with study drug taken|0|||
33329773|NCT01135511|62706132|FG000|Overall Study|Withdrawal by Subject|0|||
33467934|NCT00059202|62841384|FG000|Overall Study|drug toxicity|0|||
33329774|NCT01135511|62706133|FG001|Overall Study|Withdrawal by Subject|0|||
33329775|NCT01135511|62706134|FG002|Overall Study|Withdrawal by Subject|0|||
33329776|NCT01135511|62706135|FG003|Overall Study|Withdrawal by Subject|0|||
33329777|NCT01135511|62706136|FG004|Overall Study|Withdrawal by Subject|0|||
33329778|NCT01135511|62706137|FG005|Overall Study|Withdrawal by Subject|0|||
33329779|NCT01135511|62706138|FG006|Overall Study|Withdrawal by Subject|1|||
33329780|NCT01135511|62706139|FG007|Overall Study|Withdrawal by Subject|0|||
33329781|NCT01135511|62706140|FG008|Overall Study|Withdrawal by Subject|1|||
33329782|NCT01184846|62706169|FG000|Overall Study|Adverse Event|2|||
33329783|NCT01184846|62706169|FG000|Overall Study|Insufficient response|1|||
33329784|NCT01180400|62706177|FG000|Overall Study|Withdrawal by Subject|5|||
33329785|NCT01180400|62706178|FG001|Overall Study|Withdrawal by Subject|6|||
33329786|NCT01180400|62706177|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33329787|NCT01180400|62706178|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
33329788|NCT01180400|62706177|FG000|Overall Study|Adverse Event|12|||
33329789|NCT01180400|62706178|FG001|Overall Study|Adverse Event|10|||
33329790|NCT01180400|62706177|FG000|Overall Study|Severe non-compliance to protocol|1|||
33329791|NCT01180400|62706178|FG001|Overall Study|Severe non-compliance to protocol|2|||
33329792|NCT01180400|62706177|FG000|Overall Study|Condition under investigation worsened|2|||
33548278|NCT02958865|62939460|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33548279|NCT02958865|62939461|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33329793|NCT01180400|62706178|FG001|Overall Study|Condition under investigation worsened|1|||
33329794|NCT01180400|62706177|FG000|Overall Study|Lack of Efficacy|2|||
33329795|NCT01180400|62706178|FG001|Overall Study|Lack of Efficacy|0|||
33329796|NCT01180400|62706177|FG000|Overall Study|Study-specific withdrawal criteria|1|||
33329797|NCT01180400|62706178|FG001|Overall Study|Study-specific withdrawal criteria|2|||
33329798|NCT01180400|62706177|FG000|Overall Study|Lost to Follow-up|2|||
33329799|NCT01180400|62706178|FG001|Overall Study|Lost to Follow-up|3|||
33329800|NCT01180400|62706177|FG000|Overall Study|Other|0|||
33329801|NCT01180400|62706178|FG001|Overall Study|Other|1|||
33329802|NCT01180244|62706186|FG000|Overall Study|Lack of Efficacy|0|||
33329803|NCT01180244|62706187|FG001|Overall Study|Lack of Efficacy|7|||
33329804|NCT01180244|62706186|FG000|Overall Study|Physician Decision|3|||
33329805|NCT01180244|62706187|FG001|Overall Study|Physician Decision|0|||
33329806|NCT01180244|62706186|FG000|Overall Study|Adverse Event|1|||
33329807|NCT01180244|62706187|FG001|Overall Study|Adverse Event|0|||
33329808|NCT01180244|62706186|FG000|Overall Study|Withdrawal by Subject|0|||
33329809|NCT01180244|62706187|FG001|Overall Study|Withdrawal by Subject|1|||
33329810|NCT01180244|62706186|FG000|Overall Study|Protocol Violation|1|||
33329811|NCT01180244|62706187|FG001|Overall Study|Protocol Violation|0|||
33329812|NCT01180244|62706186|FG000|Overall Study|Lost to Follow-up|1|||
33329813|NCT01180244|62706187|FG001|Overall Study|Lost to Follow-up|0|||
33329814|NCT01191086|62706193|FG000|Overall Study|Adverse Event|20|||
33329815|NCT01191086|62706193|FG000|Overall Study|Lack of Efficacy|10|||
33329816|NCT01191086|62706193|FG000|Overall Study|Lost to Follow-up|4|||
33329817|NCT01191086|62706193|FG000|Overall Study|Physician Decision|2|||
33329818|NCT01191086|62706193|FG000|Overall Study|Withdrawal by Subject|24|||
33329819|NCT01191086|62706193|FG000|Overall Study|Discontinuation criterion met|1|||
33329820|NCT01191086|62706193|FG000|Overall Study|Other|1|||
33329821|NCT01088412|62706200|FG000|Overall Study|Adverse Event|38|||
33329822|NCT01088412|62706201|FG001|Overall Study|Adverse Event|0|||
33329823|NCT01088412|62706202|FG002|Overall Study|Adverse Event|0|||
33329824|NCT01088412|62706200|FG000|Overall Study|Death|42|||
33329825|NCT01088412|62706201|FG001|Overall Study|Death|6|||
33329826|NCT01088412|62706202|FG002|Overall Study|Death|0|||
33329827|NCT01088412|62706200|FG000|Overall Study|Other Reason per Case Report Form|2089|||
33329828|NCT01088412|62706201|FG001|Overall Study|Other Reason per Case Report Form|103|||
33329829|NCT01088412|62706202|FG002|Overall Study|Other Reason per Case Report Form|9|||
33329830|NCT01088412|62706200|FG000|Overall Study|Withdrawal by Subject|1761|||
33329831|NCT01088412|62706201|FG001|Overall Study|Withdrawal by Subject|25|||
33329832|NCT01088412|62706202|FG002|Overall Study|Withdrawal by Subject|1|||
33329833|NCT01088412|62706200|FG000|Overall Study|Received Another GH Product|79|||
33329834|NCT01088412|62706201|FG001|Overall Study|Received Another GH Product|0|||
33329835|NCT01088412|62706202|FG002|Overall Study|Received Another GH Product|0|||
33329836|NCT01088412|62706200|FG000|Overall Study|Participant Moved|601|||
33329837|NCT01088412|62706201|FG001|Overall Study|Participant Moved|21|||
33329838|NCT01088412|62706202|FG002|Overall Study|Participant Moved|2|||
33329839|NCT01088412|62706200|FG000|Overall Study|Physician Decision|1041|||
33548280|NCT02958865|62939462|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33653575|NCT01709149|63065898|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
33329840|NCT01088412|62706201|FG001|Overall Study|Physician Decision|8|||
33329841|NCT01088412|62706202|FG002|Overall Study|Physician Decision|4|||
33329842|NCT01088412|62706200|FG000|Overall Study|Sponsor Decision|4467|||
33329843|NCT01088412|62706201|FG001|Overall Study|Sponsor Decision|79|||
33329844|NCT01088412|62706202|FG002|Overall Study|Sponsor Decision|23|||
33329845|NCT01088412|62706200|FG000|Overall Study|Third Party Required to Change Brand|487|||
33329846|NCT01088412|62706201|FG001|Overall Study|Third Party Required to Change Brand|0|||
33329847|NCT01088412|62706202|FG002|Overall Study|Third Party Required to Change Brand|0|||
33329848|NCT01088412|62706200|FG000|Overall Study|Lost to Follow-up|3052|||
33329849|NCT01088412|62706201|FG001|Overall Study|Lost to Follow-up|130|||
33329850|NCT01088412|62706202|FG002|Overall Study|Lost to Follow-up|11|||
33329851|NCT01088412|62706200|FG000|Overall Study|Study Summary Not Completed|4360|||
33329852|NCT01088412|62706201|FG001|Overall Study|Study Summary Not Completed|64|||
33329853|NCT01088412|62706202|FG002|Overall Study|Study Summary Not Completed|22|||
33329854|NCT01086384|62706215|FG000|2-week Run-in Period|Adverse Event|1|||
33329855|NCT01086384|62706216|FG001|2-week Run-in Period|Adverse Event|0|||
33329856|NCT01086384|62706217|FG002|2-week Run-in Period|Adverse Event|0|||
33329857|NCT01086384|62706215|FG000|2-week Run-in Period|Protocol Violation|1|||
33329858|NCT01086384|62706216|FG001|2-week Run-in Period|Protocol Violation|0|||
33329859|NCT01086384|62706217|FG002|2-week Run-in Period|Protocol Violation|0|||
33329860|NCT01086384|62706215|FG000|2-week Run-in Period|Lost to Follow-up|1|||
33329861|NCT01086384|62706216|FG001|2-week Run-in Period|Lost to Follow-up|0|||
33329862|NCT01086384|62706217|FG002|2-week Run-in Period|Lost to Follow-up|0|||
33329863|NCT01086384|62706215|FG000|2-week Run-in Period|Physician Decision|6|||
33329864|NCT01086384|62706216|FG001|2-week Run-in Period|Physician Decision|0|||
33329865|NCT01086384|62706217|FG002|2-week Run-in Period|Physician Decision|0|||
33329866|NCT01086384|62706215|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
33329867|NCT01086384|62706216|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
33329868|NCT01086384|62706217|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
33329869|NCT01086384|62706215|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
33329870|NCT01086384|62706216|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
33329871|NCT01086384|62706217|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
33329872|NCT01086384|62706215|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
33329873|NCT01086384|62706216|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
33329874|NCT01086384|62706217|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
33329875|NCT01086384|62706215|FG000|2-week Run-in Period|Randomized in Error|1|||
33329876|NCT01086384|62706216|FG001|2-week Run-in Period|Randomized in Error|0|||
33329877|NCT01086384|62706217|FG002|2-week Run-in Period|Randomized in Error|0|||
33329878|NCT01086384|62706215|FG000|Treatment Period|Withdrawal by Subject|0|||
33329879|NCT01086384|62706216|FG001|Treatment Period|Withdrawal by Subject|53|||
33329880|NCT01086384|62706217|FG002|Treatment Period|Withdrawal by Subject|55|||
33329881|NCT01086384|62706215|FG000|Treatment Period|Protocol Violation|0|||
33329882|NCT01086384|62706216|FG001|Treatment Period|Protocol Violation|26|||
33329883|NCT01086384|62706217|FG002|Treatment Period|Protocol Violation|17|||
33329884|NCT01086384|62706215|FG000|Treatment Period|Lack of Efficacy|0|||
33329885|NCT01086384|62706216|FG001|Treatment Period|Lack of Efficacy|22|||
33329886|NCT01086384|62706217|FG002|Treatment Period|Lack of Efficacy|13|||
33329887|NCT01086384|62706215|FG000|Treatment Period|Adverse Event|0|||
33329888|NCT01086384|62706216|FG001|Treatment Period|Adverse Event|19|||
33329889|NCT01086384|62706217|FG002|Treatment Period|Adverse Event|15|||
33329890|NCT01086384|62706215|FG000|Treatment Period|Lost to Follow-up|0|||
33329891|NCT01086384|62706216|FG001|Treatment Period|Lost to Follow-up|11|||
33329892|NCT01086384|62706217|FG002|Treatment Period|Lost to Follow-up|9|||
33329893|NCT01086384|62706215|FG000|Treatment Period|Physician Decision|0|||
33329894|NCT01086384|62706216|FG001|Treatment Period|Physician Decision|9|||
33329895|NCT01086384|62706217|FG002|Treatment Period|Physician Decision|6|||
33329896|NCT01086384|62706215|FG000|Treatment Period|Study Closed/Terminated|0|||
33329897|NCT01086384|62706216|FG001|Treatment Period|Study Closed/Terminated|7|||
33329898|NCT01086384|62706217|FG002|Treatment Period|Study Closed/Terminated|8|||
33329899|NCT01086384|62706215|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
33329900|NCT01086384|62706216|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
33329901|NCT01086384|62706217|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
33329902|NCT01086384|62706215|FG000|Treatment Period|Received Treatment in Error|0|||
33467935|NCT00059202|62841385|FG001|Overall Study|drug toxicity|3|||
33329903|NCT01086384|62706216|FG001|Treatment Period|Received Treatment in Error|1|||
33329904|NCT01086384|62706217|FG002|Treatment Period|Received Treatment in Error|0|||
33329905|NCT01127633|62706238|FG000|Overall Study|Adverse Event|74|||
33467936|NCT03278626|62841394|FG000|Overall Study|Death|2|||
33467937|NCT03278626|62841394|FG000|Overall Study|Toxicity|1|||
33467938|NCT03278626|62841394|FG000|Overall Study|Disease Progression|2|||
33329906|NCT01127633|62706239|FG001|Overall Study|Adverse Event|73|||
33467939|NCT03277846|62841400|FG000|Overall Study|Inpatient stay too brief|12|||
33467940|NCT03277846|62841401|FG001|Overall Study|Inpatient stay too brief|11|||
33653576|NCT01709149|63065896|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
33329907|NCT01127633|62706238|FG000|Overall Study|Death|40|||
33329908|NCT01127633|62706239|FG001|Overall Study|Death|43|||
33329909|NCT01127633|62706238|FG000|Overall Study|Lost to Follow-up|4|||
33329910|NCT01127633|62706239|FG001|Overall Study|Lost to Follow-up|0|||
33329911|NCT01127633|62706238|FG000|Overall Study|Parent/Caregiver Decision|246|||
33329912|NCT01127633|62706239|FG001|Overall Study|Parent/Caregiver Decision|228|||
33329913|NCT01127633|62706238|FG000|Overall Study|Physician Decision|60|||
33329914|NCT01127633|62706239|FG001|Overall Study|Physician Decision|45|||
33329915|NCT01127633|62706238|FG000|Overall Study|Withdrawal by Subject|57|||
33329916|NCT01127633|62706239|FG001|Overall Study|Withdrawal by Subject|72|||
33329917|NCT01127633|62706238|FG000|Overall Study|Sponsor Decision|163|||
33329918|NCT01127633|62706239|FG001|Overall Study|Sponsor Decision|195|||
33329919|NCT01127633|62706238|FG000|Overall Study|Protocol Violation|8|||
33329920|NCT01127633|62706239|FG001|Overall Study|Protocol Violation|16|||
33329921|NCT01127633|62706238|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
33329922|NCT01127633|62706239|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
33329923|NCT01127633|62706238|FG000|Overall Study|Not treated|1|||
33548281|NCT02958865|62939463|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33548282|NCT02958865|62939464|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33548283|NCT02958865|62939465|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33548284|NCT02958865|62939466|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33548285|NCT02958865|62939467|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33548286|NCT02958865|62939468|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33548287|NCT02958865|62939469|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33548288|NCT02958865|62939470|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33548289|NCT02958865|62939471|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
33548290|NCT02958865|62939472|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33548291|NCT02958865|62939473|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33653577|NCT01709149|63065897|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
33329924|NCT01127633|62706239|FG001|Overall Study|Not treated|0|||
33329925|NCT01122173|62706245|FG000|Overall Study|Lost to Follow-up|3|||
33329926|NCT01122173|62706245|FG000|Overall Study|Withdrawal by Subject|3|||
33329927|NCT01122173|62706245|FG000|Overall Study|Left study for other reasons|3|||
33329928|NCT01127165|62706252|FG000|Overall Study|Adverse Event|2|||
33329929|NCT01127165|62706253|FG001|Overall Study|Adverse Event|2|||
33329930|NCT01127165|62706252|FG000|Overall Study|Lack of Efficacy|10|||
33329931|NCT01127165|62706253|FG001|Overall Study|Lack of Efficacy|8|||
33329932|NCT01127165|62706252|FG000|Overall Study|Lost to Follow-up|3|||
33329933|NCT01127165|62706253|FG001|Overall Study|Lost to Follow-up|5|||
33329934|NCT01127165|62706252|FG000|Overall Study|Withdrawal by Subject|1|||
33329935|NCT01127165|62706253|FG001|Overall Study|Withdrawal by Subject|3|||
33329936|NCT01127165|62706252|FG000|Overall Study|Protocol Violation|0|||
33329937|NCT01127165|62706253|FG001|Overall Study|Protocol Violation|1|||
33329938|NCT01126619|62706259|FG000|Overall Study|Not eligible for the study|2|||
33329939|NCT01126619|62706259|FG000|Overall Study|Investigator decision|4|||
33329940|NCT01126619|62706259|FG000|Overall Study|Serious adverse event|1|||
33329941|NCT01126619|62706259|FG000|Overall Study|Withdrawal by Subject|9|||
33329942|NCT01126619|62706259|FG000|Overall Study|Non-compliance|1|||
33329943|NCT00941733|62706267|FG000|Overall Study|Death|24|||
33467941|NCT00073008|62841409|FG000|Overall Study|Missing|6|||
33467942|NCT00073008|62841410|FG001|Overall Study|Missing|6|||
33467943|NCT00073008|62841409|FG000|Overall Study|Withdrawal by Subject|2|||
33467944|NCT00073008|62841410|FG001|Overall Study|Withdrawal by Subject|2|||
33467945|NCT00073008|62841409|FG000|Overall Study|Lost to Follow-up|1|||
33467946|NCT00073008|62841410|FG001|Overall Study|Lost to Follow-up|3|||
33467947|NCT00073008|62841409|FG000|Overall Study|Death|46|||
33467948|NCT00073008|62841410|FG001|Overall Study|Death|47|||
33467949|NCT00073008|62841409|FG000|Overall Study|"Other selected on Case Report Form"|7|||
33329944|NCT00941733|62706268|FG001|Overall Study|Death|10|||
33467950|NCT00073008|62841410|FG001|Overall Study|"Other selected on Case Report Form"|5|||
33467951|NCT00058422|62841416|FG000|Overall Study|Not treated|2|||
33467952|NCT00072384|62841420|FG000|Overall Study|Physician Decision|1|||
33329945|NCT00941733|62706267|FG000|Overall Study|Withdrawal by Subject|14|||
33329946|NCT00941733|62706268|FG001|Overall Study|Withdrawal by Subject|6|||
33329947|NCT00941733|62706267|FG000|Overall Study|Adverse Event|20|||
33329948|NCT00941733|62706268|FG001|Overall Study|Adverse Event|4|||
33329949|NCT00941733|62706267|FG000|Overall Study|Lost to Follow-up|1|||
33329950|NCT00941733|62706268|FG001|Overall Study|Lost to Follow-up|2|||
33329951|NCT00941733|62706267|FG000|Overall Study|Protocol Violation|15|||
33329952|NCT00941733|62706268|FG001|Overall Study|Protocol Violation|6|||
33329953|NCT00941655|62706276|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
33329954|NCT00941655|62706277|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
33329955|NCT00941655|62706276|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
33329956|NCT00941655|62706277|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
33329957|NCT00941655|62706276|FG000|Overall Study|progressed while on chemo|0|||
33329958|NCT00941655|62706277|FG001|Overall Study|progressed while on chemo|2|||
33329959|NCT00941655|62706276|FG000|Overall Study|refused further treatment|0|||
33329960|NCT00941655|62706277|FG001|Overall Study|refused further treatment|1|||
33329961|NCT00941655|62706276|FG000|Overall Study|withdrew consent|0|||
33329962|NCT00941655|62706277|FG001|Overall Study|withdrew consent|1|||
33329963|NCT00941655|62706276|FG000|Overall Study|non-compliant|0|||
33329964|NCT00941655|62706277|FG001|Overall Study|non-compliant|1|||
33329965|NCT00939393|62706286|FG000|Overall Study|Withdrawal by Subject|1|||
33329966|NCT00939393|62706287|FG001|Overall Study|Withdrawal by Subject|0|||
33329967|NCT00939393|62706286|FG000|Overall Study|Lost to Follow-up|3|||
33329968|NCT00939393|62706287|FG001|Overall Study|Lost to Follow-up|0|||
33329969|NCT00936117|62706304|FG000|Overall Study|Adverse Event|7|||
33329970|NCT00936117|62706304|FG000|Overall Study|Unable to continue oral medication|3|||
33329971|NCT04088500|62706309|FG000|Overall Study|Reason unknown|1|||
33329972|NCT04088500|62706309|FG000|Overall Study|Participant withdrew consent|1|||
33329973|NCT04088500|62706309|FG000|Overall Study|Disease progression|3|||
33329974|NCT01082874|62706317|FG000|Overall Study|Lost to Follow-up|10|||
33329975|NCT01082874|62706318|FG001|Overall Study|Lost to Follow-up|10|||
33329976|NCT01082874|62706319|FG002|Overall Study|Lost to Follow-up|6|||
33329977|NCT01082874|62706320|FG003|Overall Study|Lost to Follow-up|10|||
33329978|NCT01082874|62706317|FG000|Overall Study|Withdrawal by Subject|1|||
33329979|NCT01082874|62706318|FG001|Overall Study|Withdrawal by Subject|2|||
33329980|NCT01082874|62706319|FG002|Overall Study|Withdrawal by Subject|5|||
33329981|NCT01082874|62706320|FG003|Overall Study|Withdrawal by Subject|3|||
33329982|NCT00933543|62706332|FG000|Overall Study|Adverse Event|2|||
33329983|NCT00933543|62706333|FG001|Overall Study|Adverse Event|1|||
33329984|NCT00933543|62706332|FG000|Overall Study|Lost to Follow-up|0|||
33329985|NCT00933543|62706333|FG001|Overall Study|Lost to Follow-up|1|||
33329986|NCT00933543|62706332|FG000|Overall Study|Withdrawal by Subject|0|||
33329987|NCT00933543|62706333|FG001|Overall Study|Withdrawal by Subject|1|||
33329988|NCT00933543|62706332|FG000|Overall Study|Lack of Efficacy|0|||
33329989|NCT00933543|62706333|FG001|Overall Study|Lack of Efficacy|3|||
33329990|NCT00933543|62706332|FG000|Overall Study|Other|1|||
33329991|NCT00933543|62706333|FG001|Overall Study|Other|1|||
33329992|NCT01082328|62706339|FG000|Overall Study|Adverse Event|1|||
33329993|NCT01079988|62706348|FG000|Overall Study|Lost to Follow-up|0|||
33329994|NCT01079988|62706349|FG001|Overall Study|Lost to Follow-up|0|||
33329995|NCT01079988|62706350|FG002|Overall Study|Lost to Follow-up|0|||
33329996|NCT01079988|62706351|FG003|Overall Study|Lost to Follow-up|1|||
33329997|NCT01079988|62706352|FG004|Overall Study|Lost to Follow-up|0|||
33329998|NCT01079988|62706348|FG000|Overall Study|Lack of Efficacy|1|||
33329999|NCT01079988|62706349|FG001|Overall Study|Lack of Efficacy|0|||
33330000|NCT01079988|62706350|FG002|Overall Study|Lack of Efficacy|0|||
33330001|NCT01079988|62706351|FG003|Overall Study|Lack of Efficacy|0|||
33330002|NCT01079988|62706352|FG004|Overall Study|Lack of Efficacy|0|||
33330003|NCT01079988|62706348|FG000|Overall Study|Other|0|||
33330004|NCT01079988|62706349|FG001|Overall Study|Other|0|||
33330005|NCT01079988|62706350|FG002|Overall Study|Other|0|||
33330006|NCT01079988|62706351|FG003|Overall Study|Other|2|||
33330007|NCT01079988|62706352|FG004|Overall Study|Other|1|||
33330008|NCT01074216|62706364|FG000|Overall Study|Physician Decision|1|||
33330009|NCT01074216|62706364|FG000|Overall Study|Not Treated|12|||
33330010|NCT01079832|62706368|FG000|Overall Study|Withdrawal by Subject|1|||
33330011|NCT01072344|62706374|FG000|Overall Study|Relasped-reached end point|7|||
33330012|NCT01072344|62706375|FG001|Overall Study|Relasped-reached end point|12|||
33330013|NCT01072344|62706374|FG000|Overall Study|Protocol Violation|1|||
33330014|NCT01072344|62706375|FG001|Overall Study|Protocol Violation|2|||
33330015|NCT01072344|62706374|FG000|Overall Study|Lost to Follow-up|3|||
33330016|NCT01072344|62706375|FG001|Overall Study|Lost to Follow-up|4|||
33330017|NCT01071954|62706381|FG000|Overall Study|Noncompliance|4|||
33330018|NCT01071954|62706381|FG000|Overall Study|Adverse Event|1|||
33330019|NCT01071954|62706381|FG000|Overall Study|Withdrawal by Subject|11|||
33653578|NCT01709149|63065898|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
33330020|NCT01071954|62706381|FG000|Overall Study|Requirement for Alternative Therapy|5|||
33330021|NCT01071954|62706381|FG000|Overall Study|Administrative Decision|5|||
33330022|NCT01071954|62706381|FG000|Overall Study|Protocol Specified Criteria|1|||
33330023|NCT00837811|62706388|FG000|Overall Study|Adverse Event|4|||
33330024|NCT00837811|62706389|FG001|Overall Study|Adverse Event|6|||
33330025|NCT00837811|62706390|FG002|Overall Study|Adverse Event|0|||
33330026|NCT00837811|62706388|FG000|Overall Study|Death|1|||
33330027|NCT00837811|62706389|FG001|Overall Study|Death|1|||
33330028|NCT00837811|62706390|FG002|Overall Study|Death|0|||
33330029|NCT00837811|62706388|FG000|Overall Study|Lack of Efficacy|0|||
33330030|NCT00837811|62706389|FG001|Overall Study|Lack of Efficacy|11|||
33330031|NCT00837811|62706390|FG002|Overall Study|Lack of Efficacy|0|||
33330032|NCT00837811|62706388|FG000|Overall Study|Lost to Follow-up|1|||
33330033|NCT00837811|62706389|FG001|Overall Study|Lost to Follow-up|3|||
33330034|NCT00837811|62706390|FG002|Overall Study|Lost to Follow-up|0|||
33330035|NCT00837811|62706388|FG000|Overall Study|Physician Decision|0|||
33330036|NCT00837811|62706389|FG001|Overall Study|Physician Decision|2|||
33330037|NCT00837811|62706390|FG002|Overall Study|Physician Decision|1|||
33330038|NCT00837811|62706388|FG000|Overall Study|Withdrawal by Subject|1|||
33330039|NCT00837811|62706389|FG001|Overall Study|Withdrawal by Subject|9|||
33330040|NCT00837811|62706390|FG002|Overall Study|Withdrawal by Subject|0|||
33330041|NCT00837811|62706388|FG000|Overall Study|Sponsor Decision|0|||
33330042|NCT00837811|62706389|FG001|Overall Study|Sponsor Decision|2|||
33330043|NCT00837811|62706390|FG002|Overall Study|Sponsor Decision|0|||
33330044|NCT00857389|62706407|FG000|Overall Study|Did not proceed to transplant|2|||
33330045|NCT01071798|62706411|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
33330046|NCT01071798|62706411|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
33330047|NCT01071798|62706411|FG000|Participants Who Received One Cycle|Patient requirement|20|||
33330048|NCT01071798|62706411|FG000|Participants Who Received One Cycle|Death|5|||
33330049|NCT01071798|62706411|FG000|Participants Who Received One Cycle|Change of therapy|6|||
33330050|NCT01071798|62706411|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
33330051|NCT01071798|62706411|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
33330052|NCT01071798|62706411|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
33330053|NCT01071798|62706411|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
33330054|NCT01071798|62706411|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
33330055|NCT00857311|62706429|FG000|Overall Study|Lost to Follow-up|1|||
33330056|NCT00857311|62706430|FG001|Overall Study|Lost to Follow-up|0|||
33330057|NCT00857311|62706431|FG002|Overall Study|Lost to Follow-up|0|||
33330058|NCT00857311|62706432|FG003|Overall Study|Lost to Follow-up|0|||
33330059|NCT00857233|62706438|FG000|Overall Study|Adverse Event|24|||
33330060|NCT00857233|62706438|FG000|Overall Study|Lack of Efficacy|1|||
33330061|NCT00857233|62706438|FG000|Overall Study|Non-compliance|1|||
33330062|NCT00857233|62706438|FG000|Overall Study|Withdrawal of Consent|9|||
33330063|NCT00857233|62706438|FG000|Overall Study|Lost to Follow-up|4|||
33330064|NCT00857233|62706438|FG000|Overall Study|Nursing Home Placement|14|||
33330065|NCT00857233|62706438|FG000|Overall Study|Other Reasons|2|||
33330066|NCT00856999|62706442|FG000|Overall Study|Withdrawal by Subject|5|||
33330067|NCT01071252|62706452|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
33330068|NCT01071252|62706453|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
33330069|NCT01071252|62706454|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
33330070|NCT01071252|62706455|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
33330071|NCT01071252|62706456|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
33330072|NCT01071252|62706452|FG000|Overall Study|Withdrawal by Subject|8|||
33330073|NCT01071252|62706453|FG001|Overall Study|Withdrawal by Subject|2|||
33330074|NCT01071252|62706454|FG002|Overall Study|Withdrawal by Subject|1|||
33330075|NCT01071252|62706455|FG003|Overall Study|Withdrawal by Subject|2|||
33330076|NCT01071252|62706456|FG004|Overall Study|Withdrawal by Subject|3|||
33330077|NCT01071252|62706452|FG000|Overall Study|administrative problems|1|||
33330078|NCT01071252|62706453|FG001|Overall Study|administrative problems|1|||
33330079|NCT01071252|62706454|FG002|Overall Study|administrative problems|0|||
33330080|NCT01071252|62706455|FG003|Overall Study|administrative problems|2|||
33330081|NCT01071252|62706456|FG004|Overall Study|administrative problems|1|||
33330082|NCT01071252|62706452|FG000|Overall Study|Lost to Follow-up|1|||
33330083|NCT01071252|62706453|FG001|Overall Study|Lost to Follow-up|0|||
33467953|NCT00072384|62841420|FG000|Overall Study|Ineligible|8|||
33467954|NCT00054132|62841426|FG000|Overall Study|Not Treated|1|||
33467955|NCT00071760|62841431|FG000|Overall Study|Adverse Event|3|||
33467956|NCT00071760|62841431|FG000|Overall Study|Lost to Follow-up|4|||
33467957|NCT00071760|62841431|FG000|Overall Study|Protocol Violation|1|||
33467958|NCT00071760|62841431|FG000|Overall Study|Withdrawal by Subject|3|||
33467959|NCT00071760|62841431|FG000|Overall Study|Insufficient Viral Load Response|3|||
33467960|NCT00071760|62841431|FG000|Overall Study|Pulmonary Tuberculosis|1|||
33653579|NCT01709149|63065896|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
33330084|NCT01071252|62706454|FG002|Overall Study|Lost to Follow-up|1|||
33330085|NCT01071252|62706455|FG003|Overall Study|Lost to Follow-up|2|||
33330086|NCT01071252|62706456|FG004|Overall Study|Lost to Follow-up|0|||
33330087|NCT01071252|62706452|FG000|Overall Study|Adverse Event|1|||
33330088|NCT01071252|62706453|FG001|Overall Study|Adverse Event|1|||
33467961|NCT00071760|62841431|FG000|Overall Study|Unavailability of RTV|8|||
33653580|NCT01709149|63065897|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
33330089|NCT01071252|62706454|FG002|Overall Study|Adverse Event|0|||
33330090|NCT01071252|62706455|FG003|Overall Study|Adverse Event|1|||
33330091|NCT01071252|62706456|FG004|Overall Study|Adverse Event|0|||
33330092|NCT01071252|62706452|FG000|Overall Study|Death|0|||
33330093|NCT01071252|62706453|FG001|Overall Study|Death|0|||
33330094|NCT01071252|62706454|FG002|Overall Study|Death|0|||
33330095|NCT01071252|62706455|FG003|Overall Study|Death|0|||
33330096|NCT01071252|62706456|FG004|Overall Study|Death|1|||
33330097|NCT00856843|62706470|FG000|Overall Study|Withdrawal by Subject|1|||
33330098|NCT00856843|62706471|FG001|Overall Study|Withdrawal by Subject|5|||
33330099|NCT00856843|62706470|FG000|Overall Study|Lack of Efficacy|1|||
33330100|NCT00856843|62706471|FG001|Overall Study|Lack of Efficacy|0|||
33330101|NCT00856609|62706479|FG000|Overall Study|Adverse Event|1|||
33330102|NCT00856609|62706480|FG001|Overall Study|Adverse Event|0|||
33330103|NCT01071096|62706486|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
33330104|NCT01071096|62706487|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
33330105|NCT00856375|62706506|FG000|Overall Study|Other|0|||
33330106|NCT00856375|62706507|FG001|Overall Study|Other|1|||
33330107|NCT00856375|62706506|FG000|Overall Study|Death|32|||
33330108|NCT00856375|62706507|FG001|Overall Study|Death|30|||
33330109|NCT00856375|62706506|FG000|Overall Study|Sponsor Terminated Study|7|||
33330110|NCT00856375|62706507|FG001|Overall Study|Sponsor Terminated Study|7|||
33330111|NCT00856375|62706506|FG000|Overall Study|Withdrawal by Subject|2|||
33330112|NCT00856375|62706507|FG001|Overall Study|Withdrawal by Subject|1|||
33330113|NCT00856375|62706506|FG000|Overall Study|Lost to Follow-up|1|||
33330114|NCT00856375|62706507|FG001|Overall Study|Lost to Follow-up|2|||
33330115|NCT01070784|62706515|FG000|Overall Study|Withdrawal by Subject|6|||
33330116|NCT01070784|62706516|FG001|Overall Study|Withdrawal by Subject|9|||
33330117|NCT01070784|62706515|FG000|Overall Study|Adverse Event|14|||
33330118|NCT01070784|62706516|FG001|Overall Study|Adverse Event|9|||
33330119|NCT00837577|62706524|FG000|Double-blind Period|Clinical Adverse Event|1|||
33330120|NCT00837577|62706525|FG001|Double-blind Period|Clinical Adverse Event|0|||
33330121|NCT00837577|62706524|FG000|Double-blind Period|Withdrawal by Subject|1|||
33330122|NCT00837577|62706525|FG001|Double-blind Period|Withdrawal by Subject|0|||
33330123|NCT00837577|62706524|FG000|Open-label Period|Clinical Adverse Event|2|||
33330124|NCT00837577|62706525|FG001|Open-label Period|Clinical Adverse Event|2|||
33330125|NCT00837577|62706524|FG000|Open-label Period|Laboratory Adverse Event|0|||
33330126|NCT00837577|62706525|FG001|Open-label Period|Laboratory Adverse Event|1|||
33330127|NCT00837577|62706524|FG000|Open-label Period|Lack of Efficacy|4|||
33330128|NCT00837577|62706525|FG001|Open-label Period|Lack of Efficacy|3|||
33330129|NCT00837577|62706524|FG000|Open-label Period|Withdrawal by Subject|1|||
33330130|NCT00837577|62706525|FG001|Open-label Period|Withdrawal by Subject|2|||
33330131|NCT00837577|62706524|FG000|Open-label Period|Other Reason|1|||
33330132|NCT00837577|62706525|FG001|Open-label Period|Other Reason|1|||
33330133|NCT01070550|62706538|FG000|Overall Study|Adverse Event|43|||
33330134|NCT01070550|62706539|FG001|Overall Study|Adverse Event|1|||
33330135|NCT01070550|62706540|FG002|Overall Study|Adverse Event|3|||
33330136|NCT01070550|62706541|FG003|Overall Study|Adverse Event|0|||
33330137|NCT01070550|62706542|FG004|Overall Study|Adverse Event|0|||
33330138|NCT01070550|62706543|FG005|Overall Study|Adverse Event|0|||
33330139|NCT01070550|62706538|FG000|Overall Study|Death|20|||
33330140|NCT01070550|62706539|FG001|Overall Study|Death|4|||
33330141|NCT01070550|62706540|FG002|Overall Study|Death|3|||
33330142|NCT01070550|62706541|FG003|Overall Study|Death|0|||
33330143|NCT01070550|62706542|FG004|Overall Study|Death|0|||
33330144|NCT01070550|62706543|FG005|Overall Study|Death|0|||
33330145|NCT01070550|62706538|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
33330146|NCT01070550|62706539|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
33330147|NCT01070550|62706540|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
33330148|NCT01070550|62706541|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
33330149|NCT01070550|62706542|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
33467962|NCT00071760|62841431|FG000|Overall Study|Relocation|1|||
33467963|NCT00071760|62841431|FG000|Overall Study|Investigator's Recommendation (Rec.)|4|||
33467964|NCT00071760|62841431|FG000|Overall Study|Study Team Rec./Resistance|1|||
33467965|NCT00071760|62841431|FG000|Overall Study|Ongoing|25|||
33467966|NCT00053898|62841443|FG000|Overall Study|No follow-up data from any source|9|||
33467967|NCT00053898|62841444|FG001|Overall Study|No follow-up data from any source|12|||
33467968|NCT00053898|62841443|FG000|Overall Study|Follow-up from telephone contact only|5|||
33548292|NCT02958865|62939458|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33548293|NCT02958865|62939459|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33548294|NCT02958865|62939460|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33548295|NCT02958865|62939461|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33653581|NCT01709149|63065898|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
33653582|NCT01709149|63065896|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
33653583|NCT01709149|63065897|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
33653584|NCT01709149|63065898|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
33653585|NCT01709149|63065896|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33653586|NCT01709149|63065897|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
33653587|NCT01709149|63065898|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33653588|NCT01568593|63065907|FG000|Overall Study|Lack of Efficacy|4|||
33653589|NCT01568593|63065908|FG001|Overall Study|Lack of Efficacy|1|||
33653590|NCT01568593|63065907|FG000|Overall Study|Adverse Event|3|||
33653591|NCT01568593|63065908|FG001|Overall Study|Adverse Event|2|||
33653592|NCT01683565|63065916|FG000|Overall Study|Lost to Follow-up|2|||
33653593|NCT01683565|63065917|FG001|Overall Study|Lost to Follow-up|0|||
33653594|NCT01683565|63065916|FG000|Overall Study|Discontinued Intervention|1|||
33653595|NCT01683565|63065917|FG001|Overall Study|Discontinued Intervention|1|||
33653596|NCT01903031|63065941|FG000|Overall Study|Not Able to Attend Clinic|1|||
33653597|NCT01903031|63065942|FG001|Overall Study|Not Able to Attend Clinic|1|||
33653598|NCT01903031|63065943|FG002|Overall Study|Not Able to Attend Clinic|0|||
33653599|NCT01903031|63065941|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
33653600|NCT01903031|63065942|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
33653601|NCT01903031|63065943|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
33653602|NCT01903031|63065941|FG000|Overall Study|Adverse Event|0|||
33653603|NCT01903031|63065942|FG001|Overall Study|Adverse Event|1|||
33653604|NCT01903031|63065943|FG002|Overall Study|Adverse Event|0|||
33653605|NCT01903031|63065941|FG000|Overall Study|Withdrawal by Subject|0|||
33653606|NCT01903031|63065942|FG001|Overall Study|Withdrawal by Subject|1|||
33653607|NCT01903031|63065943|FG002|Overall Study|Withdrawal by Subject|1|||
33653608|NCT01903031|63065941|FG000|Overall Study|Protocol Violation|0|||
33653609|NCT01903031|63065942|FG001|Overall Study|Protocol Violation|0|||
33653610|NCT01903031|63065943|FG002|Overall Study|Protocol Violation|2|||
33653611|NCT01903031|63065941|FG000|Overall Study|Lost to Follow-up|0|||
33653612|NCT01903031|63065942|FG001|Overall Study|Lost to Follow-up|0|||
33653613|NCT01903031|63065943|FG002|Overall Study|Lost to Follow-up|1|||
33653614|NCT01903031|63065941|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
33467969|NCT00053898|62841444|FG001|Overall Study|Follow-up from telephone contact only|1|||
33330150|NCT01070550|62706543|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
33330151|NCT01070550|62706538|FG000|Overall Study|Early termination|3|||
33330152|NCT01070550|62706539|FG001|Overall Study|Early termination|0|||
33330153|NCT01070550|62706540|FG002|Overall Study|Early termination|0|||
33330154|NCT01070550|62706541|FG003|Overall Study|Early termination|0|||
33330155|NCT01070550|62706542|FG004|Overall Study|Early termination|0|||
33330156|NCT01070550|62706543|FG005|Overall Study|Early termination|0|||
33330157|NCT01070550|62706538|FG000|Overall Study|Failed to return|450|||
33330158|NCT01070550|62706539|FG001|Overall Study|Failed to return|33|||
33330159|NCT01070550|62706540|FG002|Overall Study|Failed to return|144|||
33330160|NCT01070550|62706541|FG003|Overall Study|Failed to return|40|||
33330161|NCT01070550|62706542|FG004|Overall Study|Failed to return|1|||
33330162|NCT01070550|62706543|FG005|Overall Study|Failed to return|2|||
33330163|NCT01070550|62706538|FG000|Overall Study|Incomplete treatment|2|||
33330164|NCT01070550|62706539|FG001|Overall Study|Incomplete treatment|0|||
33330165|NCT01070550|62706540|FG002|Overall Study|Incomplete treatment|0|||
33330166|NCT01070550|62706541|FG003|Overall Study|Incomplete treatment|0|||
33330167|NCT01070550|62706542|FG004|Overall Study|Incomplete treatment|0|||
33330168|NCT01070550|62706543|FG005|Overall Study|Incomplete treatment|0|||
33330169|NCT01070550|62706538|FG000|Overall Study|Lab test not done|22|||
33330170|NCT01070550|62706539|FG001|Overall Study|Lab test not done|3|||
33330171|NCT01070550|62706540|FG002|Overall Study|Lab test not done|4|||
33330172|NCT01070550|62706541|FG003|Overall Study|Lab test not done|1|||
33330173|NCT01070550|62706542|FG004|Overall Study|Lab test not done|0|||
33330174|NCT01070550|62706543|FG005|Overall Study|Lab test not done|1|||
33330175|NCT01070550|62706538|FG000|Overall Study|Lack of Efficacy|65|||
33330176|NCT01070550|62706539|FG001|Overall Study|Lack of Efficacy|1|||
33330177|NCT01070550|62706540|FG002|Overall Study|Lack of Efficacy|5|||
33330178|NCT01070550|62706541|FG003|Overall Study|Lack of Efficacy|5|||
33330179|NCT01070550|62706542|FG004|Overall Study|Lack of Efficacy|0|||
33330180|NCT01070550|62706543|FG005|Overall Study|Lack of Efficacy|1|||
33330181|NCT01070550|62706538|FG000|Overall Study|Miscellaneous|12|||
33330182|NCT01070550|62706539|FG001|Overall Study|Miscellaneous|2|||
33330183|NCT01070550|62706540|FG002|Overall Study|Miscellaneous|3|||
33330184|NCT01070550|62706541|FG003|Overall Study|Miscellaneous|1|||
33330185|NCT01070550|62706542|FG004|Overall Study|Miscellaneous|0|||
33330186|NCT01070550|62706543|FG005|Overall Study|Miscellaneous|0|||
33330187|NCT01070550|62706538|FG000|Overall Study|New treatment started|3|||
33330188|NCT01070550|62706539|FG001|Overall Study|New treatment started|1|||
33330189|NCT01070550|62706540|FG002|Overall Study|New treatment started|0|||
33330190|NCT01070550|62706541|FG003|Overall Study|New treatment started|2|||
33330191|NCT01070550|62706542|FG004|Overall Study|New treatment started|0|||
33330192|NCT01070550|62706543|FG005|Overall Study|New treatment started|0|||
33330193|NCT01070550|62706538|FG000|Overall Study|Non-responders|493|||
33330194|NCT01070550|62706539|FG001|Overall Study|Non-responders|4|||
33330195|NCT01070550|62706540|FG002|Overall Study|Non-responders|21|||
33330196|NCT01070550|62706541|FG003|Overall Study|Non-responders|20|||
33330197|NCT01070550|62706542|FG004|Overall Study|Non-responders|0|||
33330198|NCT01070550|62706543|FG005|Overall Study|Non-responders|2|||
33330199|NCT01070550|62706538|FG000|Overall Study|Not categorized|33|||
33330200|NCT01070550|62706539|FG001|Overall Study|Not categorized|2|||
33330201|NCT01070550|62706540|FG002|Overall Study|Not categorized|6|||
33330202|NCT01070550|62706541|FG003|Overall Study|Not categorized|1|||
33330203|NCT01070550|62706542|FG004|Overall Study|Not categorized|0|||
33330204|NCT01070550|62706543|FG005|Overall Study|Not categorized|1|||
33330205|NCT01070550|62706538|FG000|Overall Study|Protocol Violation|15|||
33330206|NCT01070550|62706539|FG001|Overall Study|Protocol Violation|1|||
33330207|NCT01070550|62706540|FG002|Overall Study|Protocol Violation|1|||
33330208|NCT01070550|62706541|FG003|Overall Study|Protocol Violation|1|||
33330209|NCT01070550|62706542|FG004|Overall Study|Protocol Violation|0|||
33330210|NCT01070550|62706543|FG005|Overall Study|Protocol Violation|0|||
33330211|NCT01070550|62706538|FG000|Overall Study|Relapse|44|||
33330212|NCT01070550|62706539|FG001|Overall Study|Relapse|5|||
33330213|NCT01070550|62706540|FG002|Overall Study|Relapse|14|||
33467970|NCT03256552|62841480|FG000|Overall Study|Protocol Violation|1|||
33330214|NCT01070550|62706541|FG003|Overall Study|Relapse|4|||
33330215|NCT01070550|62706542|FG004|Overall Study|Relapse|0|||
33330216|NCT01070550|62706543|FG005|Overall Study|Relapse|0|||
33330217|NCT01070550|62706538|FG000|Overall Study|Result not available|3|||
33330218|NCT01070550|62706539|FG001|Overall Study|Result not available|1|||
33467971|NCT03256552|62841480|FG000|Overall Study|Physician Decision|1|||
33467972|NCT03256552|62841480|FG000|Overall Study|Adverse Event|1|||
33330219|NCT01070550|62706540|FG002|Overall Study|Result not available|3|||
33330220|NCT01070550|62706541|FG003|Overall Study|Result not available|0|||
33330221|NCT01070550|62706542|FG004|Overall Study|Result not available|0|||
33330222|NCT01070550|62706543|FG005|Overall Study|Result not available|0|||
33330223|NCT01070550|62706538|FG000|Overall Study|Screen failure|1|||
33330224|NCT01070550|62706539|FG001|Overall Study|Screen failure|0|||
33330225|NCT01070550|62706540|FG002|Overall Study|Screen failure|0|||
33330226|NCT01070550|62706541|FG003|Overall Study|Screen failure|0|||
33330227|NCT01070550|62706542|FG004|Overall Study|Screen failure|0|||
33330228|NCT01070550|62706543|FG005|Overall Study|Screen failure|0|||
33330229|NCT01070550|62706538|FG000|Overall Study|Sponsor decision|1|||
33330230|NCT01070550|62706539|FG001|Overall Study|Sponsor decision|0|||
33330231|NCT01070550|62706540|FG002|Overall Study|Sponsor decision|0|||
33330232|NCT01070550|62706541|FG003|Overall Study|Sponsor decision|0|||
33330233|NCT01070550|62706542|FG004|Overall Study|Sponsor decision|0|||
33330234|NCT01070550|62706543|FG005|Overall Study|Sponsor decision|0|||
33330235|NCT01070550|62706538|FG000|Overall Study|Treatment duration shortened|1|||
33330236|NCT01070550|62706539|FG001|Overall Study|Treatment duration shortened|0|||
33330237|NCT01070550|62706540|FG002|Overall Study|Treatment duration shortened|0|||
33548296|NCT02958865|62939462|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33548297|NCT02958865|62939463|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33548298|NCT02958865|62939464|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33653615|NCT01903031|63065942|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
33653616|NCT01903031|63065943|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
33330238|NCT01070550|62706541|FG003|Overall Study|Treatment duration shortened|0|||
33330239|NCT01070550|62706542|FG004|Overall Study|Treatment duration shortened|0|||
33653617|NCT01616693|63065975|FG000|Evaluated for Safety|Physician Decision|1|||
33330240|NCT01070550|62706543|FG005|Overall Study|Treatment duration shortened|0|||
33330241|NCT01070550|62706538|FG000|Overall Study|Treatment interrupted|7|||
33330242|NCT01070550|62706539|FG001|Overall Study|Treatment interrupted|0|||
33330243|NCT01070550|62706540|FG002|Overall Study|Treatment interrupted|1|||
33330244|NCT01070550|62706541|FG003|Overall Study|Treatment interrupted|1|||
33330245|NCT01070550|62706542|FG004|Overall Study|Treatment interrupted|0|||
33330246|NCT01070550|62706543|FG005|Overall Study|Treatment interrupted|0|||
33330247|NCT01070550|62706538|FG000|Overall Study|Treatment not started|14|||
33330248|NCT01070550|62706539|FG001|Overall Study|Treatment not started|2|||
33330249|NCT01070550|62706540|FG002|Overall Study|Treatment not started|4|||
33330250|NCT01070550|62706541|FG003|Overall Study|Treatment not started|0|||
33330251|NCT01070550|62706542|FG004|Overall Study|Treatment not started|0|||
33330252|NCT01070550|62706543|FG005|Overall Study|Treatment not started|0|||
33330253|NCT01070550|62706538|FG000|Overall Study|Treatment restarted|0|||
33330254|NCT01070550|62706539|FG001|Overall Study|Treatment restarted|1|||
33330255|NCT01070550|62706540|FG002|Overall Study|Treatment restarted|0|||
33330256|NCT01070550|62706541|FG003|Overall Study|Treatment restarted|0|||
33330257|NCT01070550|62706542|FG004|Overall Study|Treatment restarted|0|||
33330258|NCT01070550|62706543|FG005|Overall Study|Treatment restarted|0|||
33330259|NCT01070550|62706538|FG000|Overall Study|Treatment stopped|3|||
33330260|NCT01070550|62706539|FG001|Overall Study|Treatment stopped|0|||
33330261|NCT01070550|62706540|FG002|Overall Study|Treatment stopped|0|||
33330262|NCT01070550|62706541|FG003|Overall Study|Treatment stopped|0|||
33330263|NCT01070550|62706542|FG004|Overall Study|Treatment stopped|0|||
33330264|NCT01070550|62706543|FG005|Overall Study|Treatment stopped|0|||
33330265|NCT01070550|62706538|FG000|Overall Study|Treatment unavailable|1|||
33330266|NCT01070550|62706539|FG001|Overall Study|Treatment unavailable|0|||
33330267|NCT01070550|62706540|FG002|Overall Study|Treatment unavailable|0|||
33330268|NCT01070550|62706541|FG003|Overall Study|Treatment unavailable|0|||
33330269|NCT01070550|62706542|FG004|Overall Study|Treatment unavailable|0|||
33330270|NCT01070550|62706543|FG005|Overall Study|Treatment unavailable|0|||
33330271|NCT01070550|62706538|FG000|Overall Study|Treatment was stopped early|7|||
33330272|NCT01070550|62706539|FG001|Overall Study|Treatment was stopped early|0|||
33330273|NCT01070550|62706540|FG002|Overall Study|Treatment was stopped early|0|||
33330274|NCT01070550|62706541|FG003|Overall Study|Treatment was stopped early|0|||
33330275|NCT01070550|62706542|FG004|Overall Study|Treatment was stopped early|0|||
33330276|NCT01070550|62706543|FG005|Overall Study|Treatment was stopped early|0|||
33330277|NCT01070550|62706538|FG000|Overall Study|Other|5|||
33330278|NCT01070550|62706539|FG001|Overall Study|Other|0|||
33330279|NCT01070550|62706540|FG002|Overall Study|Other|0|||
33330280|NCT01070550|62706541|FG003|Overall Study|Other|1|||
33330281|NCT01070550|62706542|FG004|Overall Study|Other|0|||
33330282|NCT01070550|62706543|FG005|Overall Study|Other|0|||
33330283|NCT01070550|62706538|FG000|Overall Study|Withdrawal by Subject|35|||
33330284|NCT01070550|62706539|FG001|Overall Study|Withdrawal by Subject|0|||
33330285|NCT01070550|62706540|FG002|Overall Study|Withdrawal by Subject|3|||
33330286|NCT01070550|62706541|FG003|Overall Study|Withdrawal by Subject|0|||
33330287|NCT01070550|62706542|FG004|Overall Study|Withdrawal by Subject|0|||
33330288|NCT01070550|62706543|FG005|Overall Study|Withdrawal by Subject|0|||
33330289|NCT00848107|62706558|FG000|Overall Study|Lost to Follow-up|2|||
33330290|NCT00848107|62706558|FG000|Overall Study|Withdrawal by Subject|8|||
33330291|NCT00848107|62706558|FG000|Overall Study|Adverse Event|9|||
33330292|NCT00848107|62706558|FG000|Overall Study|Death|1|||
33330293|NCT00848107|62706558|FG000|Overall Study|Pregnancy|1|||
33330294|NCT00856297|62706567|FG000|Overall Study|Unable to classify|2|||
33330295|NCT00856297|62706568|FG001|Overall Study|Unable to classify|0|||
33330296|NCT00856297|62706569|FG002|Overall Study|Unable to classify|0|||
33330297|NCT00856297|62706570|FG003|Overall Study|Unable to classify|0|||
33330298|NCT00856297|62706571|FG004|Overall Study|Unable to classify|0|||
33330299|NCT01046136|62706590|FG000|Overall Study|Withdrawal by Subject|0|||
33330300|NCT01046136|62706591|FG001|Overall Study|Withdrawal by Subject|4|||
33330301|NCT01046136|62706590|FG000|Overall Study|Physician Decision|1|||
33330302|NCT01046136|62706591|FG001|Overall Study|Physician Decision|1|||
33330303|NCT01046136|62706590|FG000|Overall Study|Lost to Follow-up|3|||
33330304|NCT01046136|62706591|FG001|Overall Study|Lost to Follow-up|3|||
33330305|NCT01070394|62706599|FG000|Overall Study|Adverse Event|6|||
33467973|NCT03256552|62841480|FG000|Overall Study|Withdrawal by Subject|2|||
33467974|NCT00071058|62841490|FG000|Overall Study|brain tumor-removed from study|1|||
33467975|NCT00053352|62841497|FG000|Overall Study|Lost to Follow-up|0|||
33467976|NCT00053352|62841498|FG001|Overall Study|Lost to Follow-up|1|||
33467977|NCT00053352|62841497|FG000|Overall Study|Physician Decision|11|||
33467978|NCT00053352|62841498|FG001|Overall Study|Physician Decision|1|||
33467979|NCT00053352|62841497|FG000|Overall Study|Withdrawal by Subject|1|||
33330306|NCT01070394|62706599|FG000|Overall Study|Withdrawal by Subject|1|||
33330307|NCT00836953|62706605|FG000|Overall Study|Withdrawal by Subject|1|||
33330308|NCT00836953|62706605|FG000|Overall Study|Lost to Follow-up|1|||
33330309|NCT01070316|62706609|FG000|Extension Phase|Lack of Efficacy|3|||
33330310|NCT01070316|62706609|FG000|Extension Phase|Withdrawal by Subject|1|||
33330311|NCT01126541|62706616|FG000|Overall Study|Adverse Event|0|||
33330312|NCT01126541|62706617|FG001|Overall Study|Adverse Event|2|||
33330313|NCT01126541|62706618|FG002|Overall Study|Adverse Event|4|||
33330314|NCT01126541|62706616|FG000|Overall Study|Death|0|||
33330315|NCT01126541|62706617|FG001|Overall Study|Death|1|||
33330316|NCT01126541|62706618|FG002|Overall Study|Death|0|||
33330317|NCT01126541|62706616|FG000|Overall Study|Lack of Efficacy|6|||
33330318|NCT01126541|62706617|FG001|Overall Study|Lack of Efficacy|1|||
33330319|NCT01126541|62706618|FG002|Overall Study|Lack of Efficacy|11|||
33330320|NCT01126541|62706616|FG000|Overall Study|Lost to Follow-up|1|||
33330321|NCT01126541|62706617|FG001|Overall Study|Lost to Follow-up|2|||
33330322|NCT01126541|62706618|FG002|Overall Study|Lost to Follow-up|2|||
33330323|NCT01126541|62706616|FG000|Overall Study|Withdrawal by Subject|2|||
33330324|NCT01126541|62706617|FG001|Overall Study|Withdrawal by Subject|5|||
33330325|NCT01126541|62706618|FG002|Overall Study|Withdrawal by Subject|6|||
33330326|NCT01126541|62706616|FG000|Overall Study|Protocol Violation|0|||
33330327|NCT01126541|62706617|FG001|Overall Study|Protocol Violation|0|||
33330328|NCT01126541|62706618|FG002|Overall Study|Protocol Violation|1|||
33330329|NCT01126541|62706616|FG000|Overall Study|Administrative reason or other|1|||
33330330|NCT01126541|62706617|FG001|Overall Study|Administrative reason or other|1|||
33330331|NCT01126541|62706618|FG002|Overall Study|Administrative reason or other|2|||
33330332|NCT00836875|62706630|FG000|Overall Study|Death|3|||
33330333|NCT00836875|62706631|FG001|Overall Study|Death|2|||
33330334|NCT00836875|62706630|FG000|Overall Study|Withdrawal by Subject|0|||
33330335|NCT00836875|62706631|FG001|Overall Study|Withdrawal by Subject|1|||
33330336|NCT01125917|62706637|FG000|Overall Study|Adverse Event|43|||
33330337|NCT01125917|62706637|FG000|Overall Study|Lost to Follow-up|23|||
33330338|NCT01125917|62706637|FG000|Overall Study|Withdrawal by Subject|31|||
33330339|NCT01125917|62706637|FG000|Overall Study|Administrative|223|||
33330340|NCT01125917|62706637|FG000|Overall Study|Lack of Efficacy|19|||
33330341|NCT00847561|62706643|FG000|Overall Study|Withdrawal by Subject|4|||
33330342|NCT00847561|62706644|FG001|Overall Study|Withdrawal by Subject|3|||
33330343|NCT00847561|62706643|FG000|Overall Study|Unable to schedule|9|||
33330344|NCT00847561|62706644|FG001|Overall Study|Unable to schedule|1|||
33330345|NCT01121549|62706650|FG000|Overall Study|Adverse Event|10|||
33330346|NCT01121549|62706650|FG000|Overall Study|Lack of Efficacy|11|||
33330347|NCT01121549|62706650|FG000|Overall Study|Lost to Follow-up|12|||
33330348|NCT01121549|62706650|FG000|Overall Study|Did not meet entrance criteria|9|||
33330349|NCT01121549|62706650|FG000|Overall Study|Study terminated by sponsor|197|||
33330350|NCT01121549|62706650|FG000|Overall Study|Pregnancy|1|||
33330351|NCT01121549|62706650|FG000|Overall Study|Protocol Violation|33|||
33330352|NCT01121549|62706650|FG000|Overall Study|Withdrawal by Subject|16|||
33330353|NCT01121549|62706650|FG000|Overall Study|Other|58|||
33330354|NCT00847405|62706656|FG000|First Intervention|Adverse Event|0|||
33330355|NCT00847405|62706657|FG001|First Intervention|Adverse Event|1|||
33330356|NCT00847405|62706656|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
33330357|NCT00847405|62706657|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
33330358|NCT00836095|62706663|FG000|Overall Study|Physician Decision|0|||
33330359|NCT00836095|62706664|FG001|Overall Study|Physician Decision|3|||
33467980|NCT00053352|62841498|FG001|Overall Study|Withdrawal by Subject|0|||
33467981|NCT00053352|62841497|FG000|Overall Study|Ineligible|8|||
33330360|NCT00835237|62706681|FG000|Overall Study|Lost to Follow-up|4|||
33330361|NCT00835237|62706682|FG001|Overall Study|Lost to Follow-up|0|||
33330362|NCT00835237|62706681|FG000|Overall Study|Withdrawal by Subject|2|||
33330363|NCT00835237|62706682|FG001|Overall Study|Withdrawal by Subject|0|||
33330364|NCT01072500|62706690|FG000|Overall Study|Death|2|||
33330365|NCT01072500|62706691|FG001|Overall Study|Death|2|||
33467982|NCT00053352|62841498|FG001|Overall Study|Ineligible|8|||
33330366|NCT01072500|62706690|FG000|Overall Study|Lost to Follow-up|5|||
33330367|NCT01072500|62706691|FG001|Overall Study|Lost to Follow-up|2|||
33330368|NCT01072500|62706690|FG000|Overall Study|Withdrawal by Subject|17|||
33330369|NCT01072500|62706691|FG001|Overall Study|Withdrawal by Subject|10|||
33467983|NCT00053352|62841497|FG000|Overall Study|Disease at new site|1|||
33330370|NCT00847015|62706699|FG000|Overall Study|Withdrawal by Subject|1|||
33330371|NCT00847015|62706699|FG000|Overall Study|declined any surgery|1|||
33467984|NCT00053352|62841498|FG001|Overall Study|Disease at new site|0|||
33330372|NCT00847015|62706699|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
33330373|NCT00855595|62706705|FG000|Overall Study|Withdrawal by Subject|1|||
33330374|NCT00855595|62706706|FG001|Overall Study|Withdrawal by Subject|2|||
33330375|NCT00855595|62706705|FG000|Overall Study|Lost to Follow-up|3|||
33330376|NCT00855595|62706706|FG001|Overall Study|Lost to Follow-up|3|||
33330377|NCT00855595|62706705|FG000|Overall Study|Adverse Event|1|||
33330378|NCT00855595|62706706|FG001|Overall Study|Adverse Event|1|||
33330379|NCT00855595|62706705|FG000|Overall Study|patient moved out of state|1|||
33330380|NCT00855595|62706706|FG001|Overall Study|patient moved out of state|0|||
33330381|NCT00855595|62706705|FG000|Overall Study|patient left country|0|||
33330382|NCT00855595|62706706|FG001|Overall Study|patient left country|1|||
33330383|NCT00855439|62706714|FG000|Overall Study|Withdrawal by Subject|2|||
33330384|NCT00855439|62706715|FG001|Overall Study|Withdrawal by Subject|0|||
33330385|NCT00855439|62706714|FG000|Overall Study|Pregnancy|1|||
33330386|NCT00855439|62706715|FG001|Overall Study|Pregnancy|0|||
33330387|NCT01064856|62706723|FG000|Double-blind (DB) Period|Adverse Event|1|||
33330388|NCT01064856|62706724|FG001|Double-blind (DB) Period|Adverse Event|0|||
33330389|NCT01064856|62706725|FG002|Double-blind (DB) Period|Adverse Event|0|||
33330390|NCT01064856|62706726|FG003|Double-blind (DB) Period|Adverse Event|0|||
33330391|NCT01064856|62706723|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
33330392|NCT01064856|62706724|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
33330393|NCT01064856|62706725|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
33330394|NCT01064856|62706726|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
33330395|NCT01064856|62706723|FG000|Open-label (OL) Period|Adverse Event|0|||
33330396|NCT01064856|62706724|FG001|Open-label (OL) Period|Adverse Event|0|||
33330397|NCT01064856|62706725|FG002|Open-label (OL) Period|Adverse Event|12|||
33330398|NCT01064856|62706726|FG003|Open-label (OL) Period|Adverse Event|6|||
33330399|NCT01064856|62706723|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
33330400|NCT01064856|62706724|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
33330401|NCT01064856|62706725|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
33330402|NCT01064856|62706726|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
33330403|NCT01064856|62706723|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
33330404|NCT01064856|62706724|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
33330405|NCT01064856|62706725|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
33330406|NCT01064856|62706726|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
33330407|NCT01064856|62706723|FG000|Open-label (OL) Period|Other|0|||
33330408|NCT01064856|62706724|FG001|Open-label (OL) Period|Other|0|||
33330409|NCT01064856|62706725|FG002|Open-label (OL) Period|Other|7|||
33330410|NCT01064856|62706726|FG003|Open-label (OL) Period|Other|7|||
33330411|NCT00846391|62706736|FG000|Overall Study|Physician Decision|0|||
33330412|NCT00846391|62706737|FG001|Overall Study|Physician Decision|0|||
33330413|NCT00846391|62706738|FG002|Overall Study|Physician Decision|1|||
33330414|NCT00846391|62706736|FG000|Overall Study|Study Terminated by Sponsor|1|||
33330415|NCT00846391|62706737|FG001|Overall Study|Study Terminated by Sponsor|2|||
33330416|NCT00846391|62706738|FG002|Overall Study|Study Terminated by Sponsor|2|||
33330417|NCT01042392|62706748|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
33330418|NCT01042392|62706749|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
33330419|NCT01042392|62706750|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
33330420|NCT01042392|62706751|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
33330421|NCT01042392|62706748|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
33330422|NCT01042392|62706749|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
33330423|NCT01042392|62706750|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
33330424|NCT01042392|62706751|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
33330425|NCT01042392|62706748|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
33330426|NCT01042392|62706749|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
33330427|NCT01042392|62706750|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
33330428|NCT01042392|62706751|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
33330429|NCT01042392|62706748|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
33467985|NCT03245398|62841507|FG000|Overall Study|Travelled to another island|1|||
33548299|NCT02958865|62939465|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33330430|NCT01042392|62706749|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
33330431|NCT01042392|62706750|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
33330432|NCT01042392|62706751|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
33548300|NCT02958865|62939466|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33330433|NCT01042392|62706748|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
33330434|NCT01042392|62706749|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
33330435|NCT01042392|62706750|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
33330436|NCT01042392|62706751|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
33330437|NCT01042392|62706748|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
33330438|NCT01042392|62706749|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
33330439|NCT01042392|62706750|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
33330440|NCT01042392|62706751|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
33330441|NCT01042392|62706748|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
33330442|NCT01042392|62706749|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
33330443|NCT01042392|62706750|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
33330444|NCT01042392|62706751|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
33330445|NCT01042392|62706748|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
33330446|NCT01042392|62706749|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
33330447|NCT01042392|62706750|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
33330448|NCT01042392|62706751|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
33330449|NCT01042392|62706748|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
33330450|NCT01042392|62706749|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
33330451|NCT01042392|62706750|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
33330452|NCT01042392|62706751|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
33330453|NCT01064310|62706765|FG000|Period 1|Adverse Event|7|||
33330454|NCT01064310|62706766|FG001|Period 1|Adverse Event|10|||
33330455|NCT01064310|62706767|FG002|Period 1|Adverse Event|0|||
33330456|NCT01064310|62706765|FG000|Period 1|Physician Decision|1|||
33330457|NCT01064310|62706766|FG001|Period 1|Physician Decision|0|||
33330458|NCT01064310|62706767|FG002|Period 1|Physician Decision|0|||
33330459|NCT01064310|62706765|FG000|Period 1|Withdrawal by Subject|2|||
33330460|NCT01064310|62706766|FG001|Period 1|Withdrawal by Subject|2|||
33330461|NCT01064310|62706767|FG002|Period 1|Withdrawal by Subject|0|||
33330462|NCT01064310|62706765|FG000|Period 1|Lack of Efficacy|3|||
33330463|NCT01064310|62706766|FG001|Period 1|Lack of Efficacy|5|||
33330464|NCT01064310|62706767|FG002|Period 1|Lack of Efficacy|0|||
33330465|NCT01064310|62706765|FG000|Period 1|Entered Open-label Period|1|||
33330466|NCT01064310|62706766|FG001|Period 1|Entered Open-label Period|1|||
33330467|NCT01064310|62706767|FG002|Period 1|Entered Open-label Period|0|||
33330468|NCT01064310|62706765|FG000|Period 2|Adverse Event|2|||
33330469|NCT01064310|62706766|FG001|Period 2|Adverse Event|1|||
33330470|NCT01064310|62706767|FG002|Period 2|Adverse Event|0|||
33330471|NCT01064310|62706765|FG000|Period 2|Physician Decision|0|||
33330472|NCT01064310|62706766|FG001|Period 2|Physician Decision|1|||
33330473|NCT01064310|62706767|FG002|Period 2|Physician Decision|0|||
33330474|NCT01064310|62706765|FG000|Period 2|Entered Open-label Period|1|||
33330475|NCT01064310|62706766|FG001|Period 2|Entered Open-label Period|0|||
33330476|NCT01064310|62706767|FG002|Period 2|Entered Open-label Period|0|||
33330477|NCT01064310|62706765|FG000|Period 2|Lack of Efficacy|1|||
33330478|NCT01064310|62706766|FG001|Period 2|Lack of Efficacy|4|||
33330479|NCT01064310|62706767|FG002|Period 2|Lack of Efficacy|0|||
33330480|NCT01064310|62706765|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
33330481|NCT01064310|62706766|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
33330482|NCT01064310|62706767|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
33330483|NCT01064310|62706765|FG000|Open Label Pazopinib|Adverse Event|0|||
33330484|NCT01064310|62706766|FG001|Open Label Pazopinib|Adverse Event|0|||
33330485|NCT01064310|62706767|FG002|Open Label Pazopinib|Adverse Event|12|||
33330486|NCT01064310|62706765|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
33330487|NCT01064310|62706766|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
33330488|NCT01064310|62706767|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
33330489|NCT01064310|62706765|FG000|Open Label Pazopinib|Physician Decision|0|||
33330490|NCT01064310|62706766|FG001|Open Label Pazopinib|Physician Decision|0|||
33330491|NCT01064310|62706767|FG002|Open Label Pazopinib|Physician Decision|20|||
33330492|NCT01037244|62706780|FG000|Overall Study|Adverse Event|3|||
33330493|NCT01037244|62706781|FG001|Overall Study|Adverse Event|2|||
33330494|NCT01037244|62706782|FG002|Overall Study|Adverse Event|6|||
33330495|NCT01037244|62706783|FG003|Overall Study|Adverse Event|3|||
33330496|NCT01037244|62706780|FG000|Overall Study|Lack of Efficacy|1|||
33330497|NCT01037244|62706781|FG001|Overall Study|Lack of Efficacy|1|||
33330498|NCT01037244|62706782|FG002|Overall Study|Lack of Efficacy|0|||
33548301|NCT02958865|62939467|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
33330499|NCT01037244|62706783|FG003|Overall Study|Lack of Efficacy|1|||
33330500|NCT01037244|62706780|FG000|Overall Study|Lost to Follow-up|3|||
33330501|NCT01037244|62706781|FG001|Overall Study|Lost to Follow-up|3|||
33330502|NCT01037244|62706782|FG002|Overall Study|Lost to Follow-up|4|||
33330503|NCT01037244|62706783|FG003|Overall Study|Lost to Follow-up|4|||
33330504|NCT01037244|62706780|FG000|Overall Study|Withdrawal by Subject|1|||
33330505|NCT01037244|62706781|FG001|Overall Study|Withdrawal by Subject|5|||
33330506|NCT01037244|62706782|FG002|Overall Study|Withdrawal by Subject|3|||
33330507|NCT01037244|62706783|FG003|Overall Study|Withdrawal by Subject|5|||
33330508|NCT01037244|62706780|FG000|Overall Study|Partner Withdrew Consent|2|||
33330509|NCT01037244|62706781|FG001|Overall Study|Partner Withdrew Consent|1|||
33330510|NCT01037244|62706782|FG002|Overall Study|Partner Withdrew Consent|0|||
33330511|NCT01037244|62706783|FG003|Overall Study|Partner Withdrew Consent|0|||
33330512|NCT01037244|62706780|FG000|Overall Study|Various|3|||
33330513|NCT01037244|62706781|FG001|Overall Study|Various|2|||
33330514|NCT01037244|62706782|FG002|Overall Study|Various|1|||
33330515|NCT01037244|62706783|FG003|Overall Study|Various|1|||
33330516|NCT00833989|62706797|FG000|Overall Study|Physician Decision|0|||
33330517|NCT00833989|62706798|FG001|Overall Study|Physician Decision|0|||
33330518|NCT00833989|62706799|FG002|Overall Study|Physician Decision|0|||
33330519|NCT00833989|62706800|FG003|Overall Study|Physician Decision|1|||
33330520|NCT00833989|62706797|FG000|Overall Study|Withdrawal by Subject|3|||
33330521|NCT00833989|62706798|FG001|Overall Study|Withdrawal by Subject|0|||
33330522|NCT00833989|62706799|FG002|Overall Study|Withdrawal by Subject|1|||
33330523|NCT00833989|62706800|FG003|Overall Study|Withdrawal by Subject|1|||
33330524|NCT01037088|62706813|FG000|Overall Study|Withdrawal by Subject|3|||
33330525|NCT01042236|62706822|FG000|Treatment Period 1|Adverse Event|0|||
33330526|NCT01042236|62706823|FG001|Treatment Period 1|Adverse Event|1|||
33330527|NCT01042236|62706824|FG002|Treatment Period 1|Adverse Event|0|||
33330528|NCT01042236|62706825|FG003|Treatment Period 1|Adverse Event|0|||
33330529|NCT01042236|62706826|FG004|Treatment Period 1|Adverse Event|1|||
33330530|NCT01042236|62706827|FG005|Treatment Period 1|Adverse Event|0|||
33330531|NCT01042236|62706822|FG000|Treatment Period 3|Adverse Event|0|||
33330532|NCT01042236|62706823|FG001|Treatment Period 3|Adverse Event|0|||
33330533|NCT01042236|62706824|FG002|Treatment Period 3|Adverse Event|0|||
33330534|NCT01042236|62706825|FG003|Treatment Period 3|Adverse Event|1|||
33548302|NCT02958865|62939468|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33330535|NCT01042236|62706826|FG004|Treatment Period 3|Adverse Event|0|||
33330536|NCT01042236|62706827|FG005|Treatment Period 3|Adverse Event|0|||
33330537|NCT01042236|62706822|FG000|Treatment Period 3|Protocol Violation|0|||
33330538|NCT01042236|62706823|FG001|Treatment Period 3|Protocol Violation|0|||
33330539|NCT01042236|62706824|FG002|Treatment Period 3|Protocol Violation|0|||
33330540|NCT01042236|62706825|FG003|Treatment Period 3|Protocol Violation|1|||
33330541|NCT01042236|62706826|FG004|Treatment Period 3|Protocol Violation|0|||
33330542|NCT01042236|62706827|FG005|Treatment Period 3|Protocol Violation|0|||
33330543|NCT00592501|62706835|FG000|Overall Study|Withdrawal by Subject|1|||
33330544|NCT00592501|62706835|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
33330545|NCT01040832|62706841|FG000|Overall Study|Adverse Event|4|||
33330546|NCT01040832|62706842|FG001|Overall Study|Adverse Event|5|||
33330547|NCT01040832|62706841|FG000|Overall Study|Death|4|||
33330548|NCT01040832|62706842|FG001|Overall Study|Death|6|||
33330549|NCT01040832|62706841|FG000|Overall Study|Withdrawal by Subject|2|||
33330550|NCT01040832|62706842|FG001|Overall Study|Withdrawal by Subject|3|||
33330551|NCT01040832|62706841|FG000|Overall Study|Progressive disease|32|||
33330552|NCT01040832|62706842|FG001|Overall Study|Progressive disease|17|||
33330553|NCT01040832|62706841|FG000|Overall Study|Symptomatic deterioration|2|||
33330554|NCT01040832|62706842|FG001|Overall Study|Symptomatic deterioration|5|||
33330555|NCT01040832|62706841|FG000|Overall Study|Other|2|||
33330556|NCT01040832|62706842|FG001|Overall Study|Other|1|||
33330557|NCT00854581|62706848|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
33330558|NCT00854581|62706848|FG000|Induction (Up to Day 21)|Death|1|||
33330559|NCT00854581|62706848|FG000|Induction (Up to Day 21)|Physician Decision|1|||
33330560|NCT00854581|62706848|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
33330561|NCT00833911|62706857|FG000|Titration|Adverse Event|18|||
33330562|NCT00833911|62706857|FG000|Titration|Withdrawal by Subject|3|||
33330563|NCT00833911|62706857|FG000|Maintenance Phase I|Adverse Event|73|||
33330564|NCT00833911|62706857|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
33330565|NCT00833911|62706857|FG000|Maintenance Phase I|Physician Decision|10|||
33330566|NCT00833911|62706857|FG000|Maintenance Phase I|Lack of Efficacy|4|||
33330567|NCT00833911|62706857|FG000|Maintenance Phase II|Adverse Event|6|||
33330568|NCT00833911|62706857|FG000|Maintenance Phase II|Physician Decision|2|||
33330569|NCT00833911|62706857|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
33330570|NCT00833911|62706857|FG000|Maintenance Phase II|Lack of Efficacy|1|||
33330571|NCT01125293|62706871|FG000|Overall Study|Disease Progression|1|||
33330572|NCT01125293|62706872|FG001|Overall Study|Disease Progression|3|||
33330573|NCT01125293|62706873|FG002|Overall Study|Disease Progression|4|||
33330574|NCT01125293|62706874|FG003|Overall Study|Disease Progression|3|||
33330575|NCT01125293|62706875|FG004|Overall Study|Disease Progression|5|||
33330576|NCT01125293|62706876|FG005|Overall Study|Disease Progression|12|||
33330577|NCT01125293|62706871|FG000|Overall Study|Adverse Event|1|||
33330578|NCT01125293|62706872|FG001|Overall Study|Adverse Event|0|||
33330579|NCT01125293|62706873|FG002|Overall Study|Adverse Event|0|||
33330580|NCT01125293|62706874|FG003|Overall Study|Adverse Event|0|||
33330581|NCT01125293|62706875|FG004|Overall Study|Adverse Event|2|||
33330582|NCT01125293|62706876|FG005|Overall Study|Adverse Event|8|||
33330583|NCT01125293|62706871|FG000|Overall Study|Symptomatic Deterioration|1|||
33330584|NCT01125293|62706872|FG001|Overall Study|Symptomatic Deterioration|0|||
33330585|NCT01125293|62706873|FG002|Overall Study|Symptomatic Deterioration|0|||
33330586|NCT01125293|62706874|FG003|Overall Study|Symptomatic Deterioration|0|||
33330587|NCT01125293|62706875|FG004|Overall Study|Symptomatic Deterioration|0|||
33330588|NCT01125293|62706876|FG005|Overall Study|Symptomatic Deterioration|0|||
33330589|NCT01125293|62706871|FG000|Overall Study|Death|0|||
33330590|NCT01125293|62706872|FG001|Overall Study|Death|0|||
33330591|NCT01125293|62706873|FG002|Overall Study|Death|0|||
33330592|NCT01125293|62706874|FG003|Overall Study|Death|0|||
33330593|NCT01125293|62706875|FG004|Overall Study|Death|1|||
33330594|NCT01125293|62706876|FG005|Overall Study|Death|0|||
33330595|NCT01125293|62706871|FG000|Overall Study|Withdrawal by Subject|0|||
33330596|NCT01125293|62706872|FG001|Overall Study|Withdrawal by Subject|0|||
33330597|NCT01125293|62706873|FG002|Overall Study|Withdrawal by Subject|0|||
33330598|NCT01125293|62706874|FG003|Overall Study|Withdrawal by Subject|0|||
33330599|NCT01125293|62706875|FG004|Overall Study|Withdrawal by Subject|2|||
33330600|NCT01125293|62706876|FG005|Overall Study|Withdrawal by Subject|1|||
33330601|NCT01125293|62706871|FG000|Overall Study|Physician Decision|0|||
33330602|NCT01125293|62706872|FG001|Overall Study|Physician Decision|0|||
33330603|NCT01125293|62706873|FG002|Overall Study|Physician Decision|0|||
33330604|NCT01125293|62706874|FG003|Overall Study|Physician Decision|0|||
33330605|NCT01125293|62706875|FG004|Overall Study|Physician Decision|0|||
33330606|NCT01125293|62706876|FG005|Overall Study|Physician Decision|2|||
33330607|NCT01121393|62706895|FG000|Overall Study|Progressive disease|201|||
33330608|NCT01121393|62706896|FG001|Overall Study|Progressive disease|20|||
33330609|NCT01121393|62706895|FG000|Overall Study|Other Adverse events|24|||
33330610|NCT01121393|62706896|FG001|Overall Study|Other Adverse events|45|||
33330611|NCT01121393|62706895|FG000|Overall Study|Non-compliant with protocol|0|||
33330612|NCT01121393|62706896|FG001|Overall Study|Non-compliant with protocol|3|||
33330613|NCT01121393|62706895|FG000|Overall Study|Lost to Follow-up|1|||
33330614|NCT01121393|62706896|FG001|Overall Study|Lost to Follow-up|0|||
33330615|NCT01121393|62706895|FG000|Overall Study|Refused cont. medication|7|||
33330616|NCT01121393|62706896|FG001|Overall Study|Refused cont. medication|7|||
33330617|NCT01121393|62706895|FG000|Overall Study|Not treated|3|||
33330618|NCT01121393|62706896|FG001|Overall Study|Not treated|9|||
33330619|NCT01121393|62706895|FG000|Overall Study|Other than listed|6|||
33330620|NCT01121393|62706896|FG001|Overall Study|Other than listed|0|||
33330621|NCT00937521|62706947|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
33330622|NCT00937521|62706948|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
33330623|NCT00937521|62706949|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
33330624|NCT00937521|62706950|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
33330625|NCT00937521|62706951|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
33330626|NCT00937521|62706952|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
33330627|NCT00937521|62706953|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
33330628|NCT00937521|62706954|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
33330629|NCT00937521|62706947|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
33330630|NCT00937521|62706948|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
33330631|NCT00937521|62706949|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
33330632|NCT00937521|62706950|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
33330633|NCT00937521|62706951|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
33330634|NCT00937521|62706952|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
33330635|NCT00937521|62706953|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
33330636|NCT00937521|62706954|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
33330637|NCT00937521|62706947|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
33330638|NCT00937521|62706948|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
33330639|NCT00937521|62706949|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
33330640|NCT00937521|62706950|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
33330641|NCT00937521|62706951|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
33330642|NCT00937521|62706952|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
33330643|NCT00937521|62706953|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
33330644|NCT00937521|62706954|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
33330645|NCT00937521|62706947|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
33330646|NCT00937521|62706948|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
33330647|NCT00937521|62706949|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
33330648|NCT00937521|62706950|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
33330649|NCT00937521|62706951|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
33330650|NCT00937521|62706952|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
33330651|NCT00937521|62706953|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
33330652|NCT00937521|62706954|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
33548303|NCT02958865|62939469|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33548304|NCT02958865|62939470|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33548305|NCT02958865|62939471|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33548306|NCT02958865|62939472|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33548307|NCT02958865|62939473|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33548308|NCT02958553|62939525|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
33548309|NCT02958553|62939525|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
33548310|NCT02501902|62939538|FG000|Overall Study|Subject Refused Further Follow-up|0|||
33548311|NCT02501902|62939539|FG001|Overall Study|Subject Refused Further Follow-up|0|||
33548312|NCT02501902|62939540|FG002|Overall Study|Subject Refused Further Follow-up|0|||
33548313|NCT02501902|62939541|FG003|Overall Study|Subject Refused Further Follow-up|0|||
33548314|NCT02501902|62939542|FG004|Overall Study|Subject Refused Further Follow-up|0|||
33548315|NCT02501902|62939543|FG005|Overall Study|Subject Refused Further Follow-up|0|||
33548316|NCT02501902|62939544|FG006|Overall Study|Subject Refused Further Follow-up|0|||
33653618|NCT01616693|63065976|FG001|Evaluated for Safety|Physician Decision|0|||
33330653|NCT00937521|62706947|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
33653619|NCT01616693|63065977|FG002|Evaluated for Safety|Physician Decision|1|||
33653620|NCT01616693|63065978|FG003|Evaluated for Safety|Physician Decision|0|||
33653621|NCT01616693|63065975|FG000|Received Both Vaccines|Adverse Event|2|||
33653622|NCT01616693|63065976|FG001|Received Both Vaccines|Adverse Event|0|||
33653623|NCT01616693|63065977|FG002|Received Both Vaccines|Adverse Event|0|||
33653624|NCT01616693|63065978|FG003|Received Both Vaccines|Adverse Event|0|||
33653625|NCT01616693|63065975|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
33653626|NCT01616693|63065976|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
33653627|NCT01616693|63065977|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
33653628|NCT01616693|63065978|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
33330654|NCT00937521|62706948|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
33330655|NCT00937521|62706949|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
33330656|NCT00937521|62706950|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
33330657|NCT00937521|62706951|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
33467986|NCT03245398|62841508|FG001|Overall Study|Travelled to another island|0|||
33330658|NCT00937521|62706952|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
33467987|NCT03244618|62841518|FG000|Overall Study|Lost to Follow-up|3|||
33467988|NCT03244618|62841519|FG001|Overall Study|Lost to Follow-up|4|||
33467989|NCT03244618|62841518|FG000|Overall Study|Protocol Violation|4|||
33467990|NCT03244618|62841519|FG001|Overall Study|Protocol Violation|3|||
33467991|NCT03244618|62841518|FG000|Overall Study|Withdrawal by Subject|0|||
33467992|NCT03244618|62841519|FG001|Overall Study|Withdrawal by Subject|2|||
33467993|NCT00052962|62841527|FG000|Overall Study|Not evaluable|0|||
33467994|NCT00052962|62841528|FG001|Overall Study|Not evaluable|2|||
33467995|NCT00052962|62841527|FG000|Overall Study|Not randomized/not evaluable|1|||
33467996|NCT00052962|62841528|FG001|Overall Study|Not randomized/not evaluable|0|||
33330659|NCT00937521|62706953|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
33330660|NCT00937521|62706954|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
33330661|NCT00937521|62706947|FG000|Booster Phase|Adverse Event|0|||
33330662|NCT00937521|62706948|FG001|Booster Phase|Adverse Event|0|||
33330663|NCT00937521|62706949|FG002|Booster Phase|Adverse Event|0|||
33330664|NCT00937521|62706950|FG003|Booster Phase|Adverse Event|0|||
33330665|NCT00937521|62706951|FG004|Booster Phase|Adverse Event|0|||
33330666|NCT00937521|62706952|FG005|Booster Phase|Adverse Event|0|||
33330667|NCT00937521|62706953|FG006|Booster Phase|Adverse Event|1|||
33330668|NCT00937521|62706954|FG007|Booster Phase|Adverse Event|0|||
33330669|NCT00937521|62706947|FG000|Booster Phase|Withdrawal by Subject|1|||
33330670|NCT00937521|62706948|FG001|Booster Phase|Withdrawal by Subject|0|||
33330671|NCT00937521|62706949|FG002|Booster Phase|Withdrawal by Subject|0|||
33330672|NCT00937521|62706950|FG003|Booster Phase|Withdrawal by Subject|1|||
33330673|NCT00937521|62706951|FG004|Booster Phase|Withdrawal by Subject|0|||
33330674|NCT00937521|62706952|FG005|Booster Phase|Withdrawal by Subject|0|||
33330675|NCT00937521|62706953|FG006|Booster Phase|Withdrawal by Subject|0|||
33330676|NCT00937521|62706954|FG007|Booster Phase|Withdrawal by Subject|2|||
33330677|NCT00937521|62706947|FG000|Booster Phase|Lost to Follow-up|2|||
33330678|NCT00937521|62706948|FG001|Booster Phase|Lost to Follow-up|2|||
33330679|NCT00937521|62706949|FG002|Booster Phase|Lost to Follow-up|4|||
33330680|NCT00937521|62706950|FG003|Booster Phase|Lost to Follow-up|2|||
33330681|NCT00937521|62706951|FG004|Booster Phase|Lost to Follow-up|4|||
33330682|NCT00937521|62706952|FG005|Booster Phase|Lost to Follow-up|4|||
33330683|NCT00937521|62706953|FG006|Booster Phase|Lost to Follow-up|3|||
33330684|NCT00937521|62706954|FG007|Booster Phase|Lost to Follow-up|0|||
33330685|NCT00937521|62706947|FG000|Booster Phase|Administrative Reason|0|||
33330686|NCT00937521|62706948|FG001|Booster Phase|Administrative Reason|0|||
33330687|NCT00937521|62706949|FG002|Booster Phase|Administrative Reason|1|||
33330688|NCT00937521|62706950|FG003|Booster Phase|Administrative Reason|0|||
33330689|NCT00937521|62706951|FG004|Booster Phase|Administrative Reason|1|||
33330690|NCT00937521|62706952|FG005|Booster Phase|Administrative Reason|1|||
33330691|NCT00937521|62706953|FG006|Booster Phase|Administrative Reason|0|||
33330692|NCT00937521|62706954|FG007|Booster Phase|Administrative Reason|0|||
33330693|NCT00937521|62706947|FG000|Booster Phase|Protocol Deviation|0|||
33330694|NCT00937521|62706948|FG001|Booster Phase|Protocol Deviation|0|||
33653629|NCT01616693|63065975|FG000|Received Both Vaccines|Lost to Follow-up|4|||
33330695|NCT00937521|62706949|FG002|Booster Phase|Protocol Deviation|0|||
33330696|NCT00937521|62706950|FG003|Booster Phase|Protocol Deviation|0|||
33330697|NCT00937521|62706951|FG004|Booster Phase|Protocol Deviation|0|||
33330698|NCT00937521|62706952|FG005|Booster Phase|Protocol Deviation|0|||
33330699|NCT00937521|62706953|FG006|Booster Phase|Protocol Deviation|1|||
33330700|NCT00937521|62706954|FG007|Booster Phase|Protocol Deviation|0|||
33330701|NCT00935883|62706989|FG000|Treatment Period|Physician Decision|1|||
33330702|NCT00935883|62706990|FG001|Treatment Period|Physician Decision|0|||
33330703|NCT00935883|62706989|FG000|Treatment Period|Withdrawal by Subject|0|||
33330704|NCT00935883|62706990|FG001|Treatment Period|Withdrawal by Subject|2|||
33330705|NCT00936975|62706996|FG000|Overall Study|Withdrawal by Subject|1|||
33330706|NCT00936975|62706996|FG000|Overall Study|Disease progression|3|||
33330707|NCT00936975|62706996|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
33330708|NCT00936897|62707003|FG000|Overall Study|Withdrawal by Subject|9|||
33330709|NCT00936897|62707004|FG001|Overall Study|Withdrawal by Subject|19|||
33330710|NCT00936897|62707003|FG000|Overall Study|Adverse Event|4|||
33548317|NCT02501902|62939545|FG007|Overall Study|Subject Refused Further Follow-up|1|||
33548318|NCT02501902|62939538|FG000|Overall Study|Study Terminated by Sponsor|0|||
33548319|NCT02501902|62939539|FG001|Overall Study|Study Terminated by Sponsor|3|||
33548320|NCT02501902|62939540|FG002|Overall Study|Study Terminated by Sponsor|0|||
33548321|NCT02501902|62939541|FG003|Overall Study|Study Terminated by Sponsor|1|||
33548322|NCT02501902|62939542|FG004|Overall Study|Study Terminated by Sponsor|1|||
33548323|NCT02501902|62939543|FG005|Overall Study|Study Terminated by Sponsor|0|||
33548324|NCT02501902|62939544|FG006|Overall Study|Study Terminated by Sponsor|2|||
33548325|NCT02501902|62939545|FG007|Overall Study|Study Terminated by Sponsor|4|||
33330711|NCT00936897|62707004|FG001|Overall Study|Adverse Event|13|||
33548326|NCT02501902|62939538|FG000|Overall Study|Death|3|||
33548327|NCT02501902|62939539|FG001|Overall Study|Death|4|||
33548328|NCT02501902|62939540|FG002|Overall Study|Death|4|||
33548329|NCT02501902|62939541|FG003|Overall Study|Death|10|||
33548330|NCT02501902|62939542|FG004|Overall Study|Death|10|||
33548331|NCT02501902|62939543|FG005|Overall Study|Death|11|||
33330712|NCT00936897|62707003|FG000|Overall Study|Other|3|||
33330713|NCT00936897|62707004|FG001|Overall Study|Other|9|||
33330714|NCT00936897|62707003|FG000|Overall Study|Lost to Follow-up|1|||
33330715|NCT00936897|62707004|FG001|Overall Study|Lost to Follow-up|10|||
33330716|NCT00936897|62707003|FG000|Overall Study|Administrative Decision|1|||
33330717|NCT00936897|62707004|FG001|Overall Study|Administrative Decision|2|||
33330718|NCT00936897|62707003|FG000|Overall Study|Protocol Violation|1|||
33330719|NCT00936897|62707004|FG001|Overall Study|Protocol Violation|1|||
33330720|NCT00936897|62707003|FG000|Overall Study|Ineligibility Determined|0|||
33330721|NCT00936897|62707004|FG001|Overall Study|Ineligibility Determined|3|||
33330722|NCT00936897|62707003|FG000|Overall Study|Noncompliance|0|||
33330723|NCT00936897|62707004|FG001|Overall Study|Noncompliance|2|||
33330724|NCT00936897|62707003|FG000|Overall Study|Death|0|||
33330725|NCT00936897|62707004|FG001|Overall Study|Death|1|||
33330726|NCT01120691|62707013|FG000|Overall Study|Adverse Event|59|||
33330727|NCT01120691|62707014|FG001|Overall Study|Adverse Event|67|||
33330728|NCT01120691|62707015|FG002|Overall Study|Adverse Event|47|||
33330729|NCT01120691|62707013|FG000|Overall Study|Subject withdrew consent|33|||
33330730|NCT01120691|62707014|FG001|Overall Study|Subject withdrew consent|50|||
33330731|NCT01120691|62707015|FG002|Overall Study|Subject withdrew consent|44|||
33330732|NCT01120691|62707013|FG000|Overall Study|Death|21|||
33330733|NCT01120691|62707014|FG001|Overall Study|Death|22|||
33330734|NCT01120691|62707015|FG002|Overall Study|Death|24|||
33330735|NCT01120691|62707013|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
33330736|NCT01120691|62707014|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
33330737|NCT01120691|62707015|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
33330738|NCT01120691|62707013|FG000|Overall Study|Administrative problems|15|||
33330739|NCT01120691|62707014|FG001|Overall Study|Administrative problems|8|||
33330740|NCT01120691|62707015|FG002|Overall Study|Administrative problems|9|||
33330741|NCT01120691|62707013|FG000|Overall Study|Protocol deviation|13|||
33330742|NCT01120691|62707014|FG001|Overall Study|Protocol deviation|12|||
33330743|NCT01120691|62707015|FG002|Overall Study|Protocol deviation|12|||
33330744|NCT01120691|62707013|FG000|Overall Study|Lost to Follow-up|5|||
33330745|NCT01120691|62707014|FG001|Overall Study|Lost to Follow-up|6|||
33330746|NCT01120691|62707015|FG002|Overall Study|Lost to Follow-up|4|||
33330747|NCT01120691|62707013|FG000|Overall Study|Abnormal test procedure result(s)|3|||
33330748|NCT01120691|62707014|FG001|Overall Study|Abnormal test procedure result(s)|2|||
33330749|NCT01120691|62707015|FG002|Overall Study|Abnormal test procedure result(s)|1|||
33330750|NCT01120691|62707013|FG000|Overall Study|Patient's inability to use the device|3|||
33330751|NCT01120691|62707014|FG001|Overall Study|Patient's inability to use the device|1|||
33330752|NCT01120691|62707015|FG002|Overall Study|Patient's inability to use the device|0|||
33330753|NCT01120691|62707013|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33467997|NCT00051636|62841536|FG000|Period 1 - Core|Adverse Event|2|||
33467998|NCT00051636|62841537|FG001|Period 1 - Core|Adverse Event|2|||
33467999|NCT00051636|62841536|FG000|Period 1 - Core|Protocol Violation|1|||
33468000|NCT00051636|62841537|FG001|Period 1 - Core|Protocol Violation|0|||
33468001|NCT00051636|62841536|FG000|Period 1 - Core|Withdrawal by Subject|1|||
33468002|NCT00051636|62841537|FG001|Period 1 - Core|Withdrawal by Subject|2|||
33468003|NCT00051636|62841536|FG000|Period 1 - Core|Lost to Follow-up|0|||
33548332|NCT02501902|62939544|FG006|Overall Study|Death|7|||
33548333|NCT02501902|62939545|FG007|Overall Study|Death|15|||
33548334|NCT01955109|62939570|FG000|Overall Study|Adverse Event|2|||
33548335|NCT01955109|62939571|FG001|Overall Study|Adverse Event|0|||
33548336|NCT01955109|62939570|FG000|Overall Study|Participant unwilling to continue|35|||
33548337|NCT01955109|62939571|FG001|Overall Study|Participant unwilling to continue|7|||
33548338|NCT01955109|62939570|FG000|Overall Study|Physician Decision|2|||
33548339|NCT01955109|62939571|FG001|Overall Study|Physician Decision|0|||
33653630|NCT01616693|63065976|FG001|Received Both Vaccines|Lost to Follow-up|3|||
33330754|NCT01120691|62707014|FG001|Overall Study|Abnormal laboratory value(s)|3|||
33468004|NCT00051636|62841537|FG001|Period 1 - Core|Lost to Follow-up|2|||
33468005|NCT00051636|62841536|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
33468006|NCT00051636|62841537|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
33548340|NCT01955109|62939570|FG000|Overall Study|Lost to Follow-up|3|||
33330755|NCT01120691|62707015|FG002|Overall Study|Abnormal laboratory value(s)|4|||
33330756|NCT00935493|62707039|FG000|Overall Study|Lost to Follow-up|1|||
33330757|NCT00935493|62707040|FG001|Overall Study|Lost to Follow-up|1|||
33330758|NCT00935493|62707041|FG002|Overall Study|Lost to Follow-up|1|||
33330759|NCT00935493|62707039|FG000|Overall Study|Treatment Discontinued|0|||
33330760|NCT00935493|62707040|FG001|Overall Study|Treatment Discontinued|1|||
33330761|NCT00935493|62707041|FG002|Overall Study|Treatment Discontinued|0|||
33330762|NCT03856996|62707051|FG000|Overall Study|Withdrawal by Subject|1|||
33330763|NCT03856996|62707052|FG001|Overall Study|Withdrawal by Subject|0|||
33468007|NCT00051636|62841536|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
33548341|NCT01955109|62939571|FG001|Overall Study|Lost to Follow-up|1|||
33653631|NCT01616693|63065977|FG002|Received Both Vaccines|Lost to Follow-up|4|||
33653632|NCT01616693|63065978|FG003|Received Both Vaccines|Lost to Follow-up|4|||
33653633|NCT01616693|63065975|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
33653634|NCT01616693|63065976|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
33653635|NCT01616693|63065977|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
33653636|NCT01616693|63065978|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
33653637|NCT01616459|63066085|FG000|Overall Study|Adverse Event|1|||
33653638|NCT01616459|63066086|FG001|Overall Study|Adverse Event|1|||
33653639|NCT01616459|63066087|FG002|Overall Study|Adverse Event|2|||
33653640|NCT01616459|63066088|FG003|Overall Study|Adverse Event|0|||
33653641|NCT01616459|63066085|FG000|Overall Study|Lost to Follow-up|1|||
33653642|NCT01616459|63066086|FG001|Overall Study|Lost to Follow-up|11|||
33653643|NCT01616459|63066087|FG002|Overall Study|Lost to Follow-up|3|||
33653644|NCT01616459|63066088|FG003|Overall Study|Lost to Follow-up|2|||
33653645|NCT01616459|63066085|FG000|Overall Study|Protocol Violation|0|||
33653646|NCT01616459|63066086|FG001|Overall Study|Protocol Violation|0|||
33653647|NCT01616459|63066087|FG002|Overall Study|Protocol Violation|0|||
33548342|NCT01955109|62939570|FG000|Overall Study|Non-compliance|3|||
33548343|NCT01955109|62939571|FG001|Overall Study|Non-compliance|1|||
33653648|NCT01616459|63066088|FG003|Overall Study|Protocol Violation|2|||
33653649|NCT01616459|63066085|FG000|Overall Study|Withdrawal by Subject|2|||
33653650|NCT01616459|63066086|FG001|Overall Study|Withdrawal by Subject|4|||
33653651|NCT01616459|63066087|FG002|Overall Study|Withdrawal by Subject|4|||
33653652|NCT01616459|63066088|FG003|Overall Study|Withdrawal by Subject|4|||
33653653|NCT01616459|63066085|FG000|Overall Study|Other reason|0|||
33653654|NCT01616459|63066086|FG001|Overall Study|Other reason|1|||
33468008|NCT00051636|62841537|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
33468009|NCT00051636|62841536|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
33468010|NCT00051636|62841537|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
33468011|NCT00051636|62841536|FG000|Period 2- Extended Observation Period|Death|4|||
33468012|NCT00051636|62841537|FG001|Period 2- Extended Observation Period|Death|5|||
33468013|NCT00051636|62841536|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
33468014|NCT00051636|62841537|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
33468015|NCT03255382|62841545|FG000|Overall Study|Adverse Event|3|||
33468016|NCT03255382|62841546|FG001|Overall Study|Adverse Event|0|||
33468017|NCT03255382|62841545|FG000|Overall Study|Lost to Follow-up|2|||
33468018|NCT03255382|62841546|FG001|Overall Study|Lost to Follow-up|0|||
33468019|NCT03255382|62841545|FG000|Overall Study|Withdrawal by Subject|2|||
33468020|NCT03255382|62841546|FG001|Overall Study|Withdrawal by Subject|0|||
33468021|NCT03255382|62841545|FG000|Overall Study|Other|6|||
33468022|NCT03255382|62841546|FG001|Overall Study|Other|0|||
33468023|NCT03254602|62841553|FG000|Overall Study|Lost to Follow-up|4|||
33468024|NCT00038142|62841559|FG000|Overall Study|Ineligible|1|||
33468025|NCT00038142|62841560|FG001|Overall Study|Ineligible|0|||
33468026|NCT00038142|62841559|FG000|Overall Study|Progressive Disease|11|||
33468027|NCT00038142|62841560|FG001|Overall Study|Progressive Disease|7|||
33468028|NCT00038142|62841559|FG000|Overall Study|Death|1|||
33468029|NCT00038142|62841560|FG001|Overall Study|Death|0|||
33548344|NCT02500732|62939579|FG000|Overall Study|Physician Decision|0|||
33548345|NCT02500732|62939580|FG001|Overall Study|Physician Decision|1|||
33548346|NCT02518048|62939586|FG000|Overall Study|Withdrawal by Subject|1|||
33548347|NCT02499952|62939591|FG000|Overall Study|Lost to Follow-up|1|||
33548348|NCT02499952|62939591|FG000|Overall Study|Death|9|||
33548349|NCT02499406|62939595|FG000|Overall Study|missed 3 treatment sessions|4|||
33548350|NCT02499172|62939603|FG000|Overall Study|Financial reason|0|||
33548351|NCT02499172|62939604|FG001|Overall Study|Financial reason|0|||
33548352|NCT02499172|62939605|FG002|Overall Study|Financial reason|523|||
33548353|NCT02499172|62939606|FG003|Overall Study|Financial reason|436|||
33548354|NCT02499172|62939603|FG000|Overall Study|Lost to Follow-up|65|||
33548355|NCT02499172|62939604|FG001|Overall Study|Lost to Follow-up|64|||
33653655|NCT01616459|63066087|FG002|Overall Study|Other reason|1|||
33653656|NCT01616459|63066088|FG003|Overall Study|Other reason|0|||
33653657|NCT01919801|63066105|FG000|Overall Study|Withdrawal by Subject|1|||
33653658|NCT01919801|63066106|FG001|Overall Study|Withdrawal by Subject|0|||
33468030|NCT00038142|62841559|FG000|Overall Study|Adverse Event|1|||
33468031|NCT00038142|62841560|FG001|Overall Study|Adverse Event|0|||
33548356|NCT02499172|62939605|FG002|Overall Study|Lost to Follow-up|0|||
33653659|NCT01919801|63066105|FG000|Overall Study|Physician Decision|0|||
33468032|NCT00038142|62841559|FG000|Overall Study|Unknown Reason|8|||
33468033|NCT00038142|62841560|FG001|Overall Study|Unknown Reason|0|||
33468034|NCT00366899|62841568|FG000|Infant Series|Withdrawal by Subject|4|||
33548357|NCT02499172|62939606|FG003|Overall Study|Lost to Follow-up|0|||
33548358|NCT02498392|62939618|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
33653660|NCT01919801|63066106|FG001|Overall Study|Physician Decision|1|||
33653661|NCT01919801|63066105|FG000|Overall Study|Lost to Follow-up|0|||
33653662|NCT01919801|63066106|FG001|Overall Study|Lost to Follow-up|1|||
33330764|NCT03856996|62707051|FG000|Overall Study|Lost to Follow-up|0|||
33330765|NCT03856996|62707052|FG001|Overall Study|Lost to Follow-up|1|||
33330766|NCT03856996|62707051|FG000|Overall Study|Adverse Event|1|||
33330767|NCT03856996|62707052|FG001|Overall Study|Adverse Event|1|||
33330768|NCT03856996|62707051|FG000|Overall Study|Other|1|||
33330769|NCT03856996|62707052|FG001|Overall Study|Other|0|||
33330770|NCT00935259|62707058|FG000|Period 1|Administrative (scheduling conflict)|1|||
33330771|NCT00935259|62707059|FG001|Period 1|Administrative (scheduling conflict)|1|||
33330772|NCT01120379|62707076|FG000|One Year Timepoint|Withdrawal by Subject|41|||
33330773|NCT01120379|62707076|FG000|One Year Timepoint|Lost to Follow-up|115|||
33330774|NCT01120379|62707076|FG000|One Year Timepoint|Death|108|||
33330775|NCT01120379|62707076|FG000|One Year Timepoint|Physician Decision|9|||
33330776|NCT01120379|62707076|FG000|One Year Timepoint|Any other reason for early termination|5|||
33330777|NCT01120379|62707076|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
33330778|NCT01120379|62707076|FG000|Two Year Timepoint|Lost to Follow-up|87|||
33330779|NCT01120379|62707076|FG000|Two Year Timepoint|Death|123|||
33330780|NCT01120379|62707076|FG000|Two Year Timepoint|Physician Decision|12|||
33330781|NCT01120379|62707076|FG000|Two Year Timepoint|Any other reason for early termination|4|||
33330782|NCT01120379|62707076|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
33330783|NCT01120379|62707076|FG000|Three Year Timepoint|Lost to Follow-up|43|||
33330784|NCT01120379|62707076|FG000|Three Year Timepoint|Death|120|||
33330785|NCT01120379|62707076|FG000|Three Year Timepoint|Physician Decision|9|||
33330786|NCT01120379|62707076|FG000|Three Year Timepoint|Any other reason for early termination|17|||
33653663|NCT01919801|63066105|FG000|Overall Study|Other|0|||
33653664|NCT01919801|63066106|FG001|Overall Study|Other|1|||
33653665|NCT01919723|63066114|FG000|Overall Study|Blood Samples Hemolyzed|2|||
33653666|NCT01919723|63066115|FG001|Overall Study|Blood Samples Hemolyzed|2|||
33653667|NCT01919489|63066123|FG000|Overall Study|Rejected the need of injections|4|||
33653668|NCT01919489|63066124|FG001|Overall Study|Rejected the need of injections|7|||
33653669|NCT01919489|63066123|FG000|Overall Study|Adverse Event|10|||
33653670|NCT01919489|63066124|FG001|Overall Study|Adverse Event|0|||
33653671|NCT01919489|63066123|FG000|Overall Study|Hospital readmission|2|||
33653672|NCT01919489|63066124|FG001|Overall Study|Hospital readmission|9|||
33330787|NCT01120379|62707076|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
33330788|NCT01120379|62707076|FG000|Four Year Timepoint|Lost to Follow-up|10|||
33330789|NCT01120379|62707076|FG000|Four Year Timepoint|Death|131|||
33330790|NCT01120379|62707076|FG000|Four Year Timepoint|Physician Decision|5|||
33330791|NCT01120379|62707076|FG000|Four Year Timepoint|Any other reason for early termination|217|||
33330792|NCT01120067|62707082|FG000|Overall Study|Lost to Follow-up|3|||
33330793|NCT01120067|62707083|FG001|Overall Study|Lost to Follow-up|1|||
33330794|NCT01120067|62707082|FG000|Overall Study|fail to engage >3 sessions|2|||
33330795|NCT01120067|62707083|FG001|Overall Study|fail to engage >3 sessions|0|||
33330796|NCT01124045|62707091|FG000|Overall Study|Lost to Follow-up|0|||
33653673|NCT01919489|63066123|FG000|Overall Study|Death|2|||
33653674|NCT01919489|63066124|FG001|Overall Study|Death|1|||
33330797|NCT01124045|62707092|FG001|Overall Study|Lost to Follow-up|1|||
33330798|NCT01124045|62707091|FG000|Overall Study|Physician Decision|0|||
33330799|NCT01124045|62707092|FG001|Overall Study|Physician Decision|2|||
33330800|NCT01123889|62707100|FG000|Overall Study|Lost to Follow-up|3|||
33330801|NCT01123889|62707101|FG001|Overall Study|Lost to Follow-up|1|||
33330802|NCT00934947|62707109|FG000|Overall Study|Adverse Event|0|||
33330803|NCT00934947|62707110|FG001|Overall Study|Adverse Event|2|||
33330804|NCT01123655|62707120|FG000|Overall Study|Medication for RA had to be changed|1|||
33330805|NCT01123655|62707121|FG001|Overall Study|Medication for RA had to be changed|0|||
33330806|NCT01123655|62707122|FG002|Overall Study|Medication for RA had to be changed|0|||
33330807|NCT01123655|62707120|FG000|Overall Study|new illness|0|||
33330808|NCT01123655|62707121|FG001|Overall Study|new illness|1|||
33330809|NCT01123655|62707122|FG002|Overall Study|new illness|0|||
33330810|NCT01123655|62707120|FG000|Overall Study|began prohibitive drug|0|||
33330811|NCT01123655|62707121|FG001|Overall Study|began prohibitive drug|0|||
33330812|NCT01123655|62707122|FG002|Overall Study|began prohibitive drug|1|||
33330813|NCT00934791|62707130|FG000|Overall Study|Withdrawal by Subject|1|||
33330814|NCT00934791|62707131|FG001|Overall Study|Withdrawal by Subject|0|||
33330815|NCT01119443|62707139|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
33330816|NCT01119443|62707140|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
33330817|NCT01111019|62707149|FG000|Overall Study|Withdrew Prematurely|2|||
33330818|NCT01111019|62707149|FG000|Overall Study|Other|1|||
33330819|NCT01119287|62707168|FG000|Overall Study|Patient Decision, not related to AE|0|||
33330820|NCT01119287|62707169|FG001|Overall Study|Patient Decision, not related to AE|0|||
33330821|NCT01119287|62707170|FG002|Overall Study|Patient Decision, not related to AE|2|||
33330822|NCT01119287|62707171|FG003|Overall Study|Patient Decision, not related to AE|2|||
33330823|NCT01119287|62707172|FG004|Overall Study|Patient Decision, not related to AE|1|||
33330824|NCT01119287|62707173|FG005|Overall Study|Patient Decision, not related to AE|0|||
33330825|NCT01110707|62707187|FG000|Overall Study|Protocol Violation|0|||
33330826|NCT01110707|62707188|FG001|Overall Study|Protocol Violation|3|||
33330827|NCT01119131|62707198|FG000|Overall Study|Adverse Event|1|||
33330828|NCT01119131|62707199|FG001|Overall Study|Adverse Event|1|||
33330829|NCT01119131|62707200|FG002|Overall Study|Adverse Event|1|||
33330830|NCT01119131|62707198|FG000|Overall Study|Non-Compliance|1|||
33330831|NCT01119131|62707199|FG001|Overall Study|Non-Compliance|0|||
33330832|NCT01119131|62707200|FG002|Overall Study|Non-Compliance|4|||
33330833|NCT01119131|62707198|FG000|Overall Study|Physician Decision|0|||
33330834|NCT01119131|62707199|FG001|Overall Study|Physician Decision|0|||
33330835|NCT01119131|62707200|FG002|Overall Study|Physician Decision|1|||
33330836|NCT01118975|62707210|FG000|Overall Study|Adverse Event|0|||
33330837|NCT01118975|62707211|FG001|Overall Study|Adverse Event|1|||
33330838|NCT01110239|62707221|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
33330839|NCT01110239|62707222|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
33330840|NCT01110239|62707223|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
33330841|NCT01110239|62707224|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
33330842|NCT01110239|62707221|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
33330843|NCT01110239|62707222|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
33330844|NCT01110239|62707223|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
33330845|NCT01110239|62707224|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
33330846|NCT01118663|62707237|FG000|Overall Study|Adverse Event|2|||
33330847|NCT01118663|62707238|FG001|Overall Study|Adverse Event|1|||
33330848|NCT01118663|62707237|FG000|Overall Study|Withdrawal by Subject|0|||
33330849|NCT01118663|62707238|FG001|Overall Study|Withdrawal by Subject|1|||
33330850|NCT01118351|62707244|FG000|Overall Study|Adverse Event|3|||
33330851|NCT01118351|62707244|FG000|Overall Study|Withdrawal by Subject|1|||
33330852|NCT01110005|62707250|FG000|Overall Study|ineligible|1|||
33330853|NCT01110005|62707251|FG001|Overall Study|ineligible|2|||
33330854|NCT01110005|62707250|FG000|Overall Study|missing consent|3|||
33330855|NCT01110005|62707251|FG001|Overall Study|missing consent|2|||
33330856|NCT01110005|62707250|FG000|Overall Study|Withdrawal by Subject|0|||
33330857|NCT01110005|62707251|FG001|Overall Study|Withdrawal by Subject|1|||
33330858|NCT01118117|62707274|FG000|Overall Study|Death|8|||
33330859|NCT01118117|62707275|FG001|Overall Study|Death|0|||
33330860|NCT01118117|62707274|FG000|Overall Study|Lost to Follow-up|6|||
33330861|NCT01118117|62707275|FG001|Overall Study|Lost to Follow-up|0|||
33330862|NCT01118117|62707274|FG000|Overall Study|Missed 12 Month Visit|7|||
33330863|NCT01118117|62707275|FG001|Overall Study|Missed 12 Month Visit|0|||
33468035|NCT00366899|62841569|FG001|Infant Series|Withdrawal by Subject|7|||
33468036|NCT00366899|62841568|FG000|Infant Series|Protocol Violation|2|||
33468037|NCT00366899|62841569|FG001|Infant Series|Protocol Violation|1|||
33468038|NCT00366899|62841568|FG000|Infant Series|Failed to return|1|||
33468039|NCT00366899|62841569|FG001|Infant Series|Failed to return|1|||
33468040|NCT00366899|62841568|FG000|Infant Series|Lost to Follow-up|0|||
33468041|NCT00366899|62841569|FG001|Infant Series|Lost to Follow-up|2|||
33653675|NCT01919489|63066123|FG000|Overall Study|Lost to Follow-up|38|||
33330864|NCT01109849|62707283|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
33330865|NCT01109849|62707284|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
33330866|NCT01109849|62707285|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
33330867|NCT01109849|62707286|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
33330868|NCT01109849|62707287|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
33330869|NCT01109849|62707283|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
33330870|NCT01109849|62707284|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
33330871|NCT01109849|62707285|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
33330872|NCT01109849|62707286|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
33468042|NCT00366899|62841568|FG000|Infant Series|Adverse Event|0|||
33653676|NCT01919489|63066124|FG001|Overall Study|Lost to Follow-up|27|||
33330873|NCT01109849|62707287|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
33330874|NCT01109849|62707283|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
33330875|NCT01109849|62707284|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
33330876|NCT01109849|62707285|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
33330877|NCT01109849|62707286|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
33330878|NCT01109849|62707287|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
33330879|NCT01109849|62707283|FG000|Initial Randomization: ADHD Treatment|move away|2|||
33330880|NCT01109849|62707284|FG001|Initial Randomization: ADHD Treatment|move away|7|||
33330881|NCT01109849|62707285|FG002|Initial Randomization: ADHD Treatment|move away|0|||
33330882|NCT01109849|62707286|FG003|Initial Randomization: ADHD Treatment|move away|0|||
33330883|NCT01109849|62707287|FG004|Initial Randomization: ADHD Treatment|move away|0|||
33330884|NCT01109849|62707283|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
33330885|NCT01109849|62707284|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
33330886|NCT01109849|62707285|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
33330887|NCT01109849|62707286|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
33330888|NCT01109849|62707287|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
33330889|NCT01109849|62707283|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
33330890|NCT01109849|62707284|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
33330891|NCT01109849|62707285|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
33330892|NCT01109849|62707286|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
33330893|NCT01109849|62707287|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
33330894|NCT01061736|62707317|FG000|Overall Study|Dose regimen not selected|0|||
33330895|NCT01061736|62707318|FG001|Overall Study|Dose regimen not selected|0|||
33330896|NCT01061736|62707319|FG002|Overall Study|Dose regimen not selected|0|||
33330897|NCT01061736|62707320|FG003|Overall Study|Dose regimen not selected|0|||
33330898|NCT01061736|62707321|FG004|Overall Study|Dose regimen not selected|0|||
33330899|NCT01061736|62707322|FG005|Overall Study|Dose regimen not selected|0|||
33330900|NCT01061736|62707323|FG006|Overall Study|Dose regimen not selected|79|||
33330901|NCT01061736|62707324|FG007|Overall Study|Dose regimen not selected|0|||
33330902|NCT01061736|62707325|FG008|Overall Study|Dose regimen not selected|0|||
33330903|NCT01061736|62707326|FG009|Overall Study|Dose regimen not selected|0|||
33330904|NCT01061736|62707317|FG000|Overall Study|Adverse Event|13|||
33330905|NCT01061736|62707318|FG001|Overall Study|Adverse Event|1|||
33330906|NCT01061736|62707319|FG002|Overall Study|Adverse Event|3|||
33653677|NCT01919411|63066132|FG000|Overall Study|Lost to Follow-up|2|||
33653678|NCT01919411|63066133|FG001|Overall Study|Lost to Follow-up|4|||
33653679|NCT01919411|63066132|FG000|Overall Study|Physician Decision|1|||
33653680|NCT01919411|63066133|FG001|Overall Study|Physician Decision|0|||
33653681|NCT01919411|63066132|FG000|Overall Study|Protocol Violation|2|||
33653682|NCT01919411|63066133|FG001|Overall Study|Protocol Violation|1|||
33653683|NCT01901393|63066141|FG000|Overall Study|Adverse Event|1|||
33653684|NCT01901393|63066142|FG001|Overall Study|Adverse Event|0|||
33653685|NCT01890707|63066150|FG000|Overall Study|Lost to Follow-up|1|||
33653686|NCT01890707|63066151|FG001|Overall Study|Lost to Follow-up|1|||
33653687|NCT01900691|63066157|FG000|Overall Study|Death|7|||
33653688|NCT01900691|63066157|FG000|Overall Study|Lost to Follow-up|4|||
33653689|NCT01900691|63066157|FG000|Overall Study|Study Device Not Placed|3|||
33653690|NCT01900691|63066157|FG000|Overall Study|Non study stent placed|2|||
33653691|NCT01900691|63066157|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
33653692|NCT01900691|63066157|FG000|Overall Study|Complete stent migration through digestive tract|1|||
33653693|NCT01890473|63066164|FG000|Overall Study|Lost to Follow-up|1|||
33653694|NCT01890473|63066165|FG001|Overall Study|Lost to Follow-up|0|||
33653695|NCT01890473|63066164|FG000|Overall Study|Poor/non-compliance|1|||
33653696|NCT01890473|63066165|FG001|Overall Study|Poor/non-compliance|0|||
33653697|NCT01889069|63066175|FG000|Overall Study|Death|18|||
33330907|NCT01061736|62707320|FG003|Overall Study|Adverse Event|2|||
33330908|NCT01061736|62707321|FG004|Overall Study|Adverse Event|4|||
33653698|NCT01889069|63066175|FG000|Overall Study|Progression of Disease|14|||
33653699|NCT01889069|63066175|FG000|Overall Study|Lost to Follow-up|6|||
33653700|NCT01889069|63066175|FG000|Overall Study|Other|4|||
33330909|NCT01061736|62707322|FG005|Overall Study|Adverse Event|1|||
33330910|NCT01061736|62707323|FG006|Overall Study|Adverse Event|4|||
33330911|NCT01061736|62707324|FG007|Overall Study|Adverse Event|63|||
33330912|NCT01061736|62707325|FG008|Overall Study|Adverse Event|67|||
33330913|NCT01061736|62707326|FG009|Overall Study|Adverse Event|34|||
33330914|NCT01061736|62707317|FG000|Overall Study|Lack of Efficacy|0|||
33330915|NCT01061736|62707318|FG001|Overall Study|Lack of Efficacy|2|||
33330916|NCT01061736|62707319|FG002|Overall Study|Lack of Efficacy|1|||
33330917|NCT01061736|62707320|FG003|Overall Study|Lack of Efficacy|1|||
33330918|NCT01061736|62707321|FG004|Overall Study|Lack of Efficacy|1|||
33330919|NCT01061736|62707322|FG005|Overall Study|Lack of Efficacy|2|||
33330920|NCT01061736|62707323|FG006|Overall Study|Lack of Efficacy|1|||
33330921|NCT01061736|62707324|FG007|Overall Study|Lack of Efficacy|9|||
33330922|NCT01061736|62707325|FG008|Overall Study|Lack of Efficacy|9|||
33330923|NCT01061736|62707326|FG009|Overall Study|Lack of Efficacy|10|||
33330924|NCT01061736|62707317|FG000|Overall Study|Poor compliance to protocol|0|||
33330925|NCT01061736|62707318|FG001|Overall Study|Poor compliance to protocol|0|||
33330926|NCT01061736|62707319|FG002|Overall Study|Poor compliance to protocol|0|||
33330927|NCT01061736|62707320|FG003|Overall Study|Poor compliance to protocol|0|||
33330928|NCT01061736|62707321|FG004|Overall Study|Poor compliance to protocol|0|||
33330929|NCT01061736|62707322|FG005|Overall Study|Poor compliance to protocol|0|||
33330930|NCT01061736|62707323|FG006|Overall Study|Poor compliance to protocol|0|||
33330931|NCT01061736|62707324|FG007|Overall Study|Poor compliance to protocol|2|||
33330932|NCT01061736|62707325|FG008|Overall Study|Poor compliance to protocol|5|||
33330933|NCT01061736|62707326|FG009|Overall Study|Poor compliance to protocol|9|||
33653701|NCT01889069|63066175|FG000|Overall Study|Consent Withdrawal|3|||
33653702|NCT02533180|63066187|FG000|Overall Study|Death|0|||
33653703|NCT02533180|63066188|FG001|Overall Study|Death|2|||
33653704|NCT02533180|63066187|FG000|Overall Study|Lost to Follow-up|0|||
33653705|NCT02533180|63066188|FG001|Overall Study|Lost to Follow-up|1|||
33653706|NCT02533180|63066187|FG000|Overall Study|Physician Decision|0|||
33653707|NCT02533180|63066188|FG001|Overall Study|Physician Decision|1|||
33653708|NCT02533180|63066187|FG000|Overall Study|Withdrawal by Subject|2|||
33653709|NCT02533180|63066188|FG001|Overall Study|Withdrawal by Subject|5|||
33330934|NCT01061736|62707317|FG000|Overall Study|Not treated|0|||
33330935|NCT01061736|62707318|FG001|Overall Study|Not treated|0|||
33330936|NCT01061736|62707319|FG002|Overall Study|Not treated|0|||
33330937|NCT01061736|62707320|FG003|Overall Study|Not treated|0|||
33330938|NCT01061736|62707321|FG004|Overall Study|Not treated|1|||
33330939|NCT01061736|62707322|FG005|Overall Study|Not treated|0|||
33653710|NCT02533180|63066187|FG000|Overall Study|Screen Failure|37|||
33653711|NCT02533180|63066188|FG001|Overall Study|Screen Failure|0|||
33330940|NCT01061736|62707323|FG006|Overall Study|Not treated|0|||
33330941|NCT01061736|62707324|FG007|Overall Study|Not treated|2|||
33330942|NCT01061736|62707325|FG008|Overall Study|Not treated|1|||
33330943|NCT01061736|62707326|FG009|Overall Study|Not treated|0|||
33330944|NCT01061736|62707317|FG000|Overall Study|Other than specified above|0|||
33330945|NCT01061736|62707318|FG001|Overall Study|Other than specified above|1|||
33330946|NCT01061736|62707319|FG002|Overall Study|Other than specified above|2|||
33330947|NCT01061736|62707320|FG003|Overall Study|Other than specified above|0|||
33330948|NCT01061736|62707321|FG004|Overall Study|Other than specified above|1|||
33330949|NCT01061736|62707322|FG005|Overall Study|Other than specified above|0|||
33330950|NCT01061736|62707323|FG006|Overall Study|Other than specified above|0|||
33330951|NCT01061736|62707324|FG007|Overall Study|Other than specified above|18|||
33330952|NCT01061736|62707325|FG008|Overall Study|Other than specified above|15|||
33330953|NCT01061736|62707326|FG009|Overall Study|Other than specified above|21|||
33330954|NCT01117337|62707353|FG000|Overall Study|Lost to Follow-up|4|||
33330955|NCT01117337|62707354|FG001|Overall Study|Lost to Follow-up|0|||
33330956|NCT01108523|62707364|FG000|Overall Study|Protocol Violation|4|||
33330957|NCT01035606|62707371|FG000|Overall Study|change in health, job demands,family|3|||
33330958|NCT01035606|62707372|FG001|Overall Study|change in health, job demands,family|3|||
33330959|NCT01035606|62707373|FG002|Overall Study|change in health, job demands,family|4|||
33330960|NCT01117181|62707383|FG000|Overall Study|Lost to Follow-up|1|||
33330961|NCT01117181|62707384|FG001|Overall Study|Lost to Follow-up|0|||
33330962|NCT01117181|62707383|FG000|Overall Study|Withdrawal by Subject|0|||
33330963|NCT01117181|62707384|FG001|Overall Study|Withdrawal by Subject|2|||
33330964|NCT01040130|62707392|FG000|Overall Study|Adverse Event|1|||
33330965|NCT01040130|62707393|FG001|Overall Study|Adverse Event|1|||
33330966|NCT01040130|62707394|FG002|Overall Study|Adverse Event|0|||
33330967|NCT01040130|62707395|FG003|Overall Study|Adverse Event|5|||
33330968|NCT01040130|62707396|FG004|Overall Study|Adverse Event|0|||
33330969|NCT01040130|62707397|FG005|Overall Study|Adverse Event|3|||
33330970|NCT01040130|62707392|FG000|Overall Study|Protocol Violation|0|||
33330971|NCT01040130|62707393|FG001|Overall Study|Protocol Violation|0|||
33330972|NCT01040130|62707394|FG002|Overall Study|Protocol Violation|2|||
33330973|NCT01040130|62707395|FG003|Overall Study|Protocol Violation|0|||
33330974|NCT01040130|62707396|FG004|Overall Study|Protocol Violation|0|||
33330975|NCT01040130|62707397|FG005|Overall Study|Protocol Violation|0|||
33330976|NCT01040130|62707392|FG000|Overall Study|Withdrawal by Subject|0|||
33330977|NCT01040130|62707393|FG001|Overall Study|Withdrawal by Subject|2|||
33330978|NCT01040130|62707394|FG002|Overall Study|Withdrawal by Subject|0|||
33330979|NCT01040130|62707395|FG003|Overall Study|Withdrawal by Subject|0|||
33330980|NCT01040130|62707396|FG004|Overall Study|Withdrawal by Subject|0|||
33330981|NCT01040130|62707397|FG005|Overall Study|Withdrawal by Subject|1|||
33330982|NCT01040130|62707392|FG000|Overall Study|Other reasons not listed above|2|||
33468043|NCT00366899|62841569|FG001|Infant Series|Adverse Event|1|||
33468044|NCT00366899|62841568|FG000|Infant Series|Physician Decision|1|||
33468045|NCT00366899|62841569|FG001|Infant Series|Physician Decision|0|||
33468046|NCT00366899|62841568|FG000|Infant Series|Randomized but not consented|1|||
33330983|NCT01040130|62707393|FG001|Overall Study|Other reasons not listed above|0|||
33330984|NCT01040130|62707394|FG002|Overall Study|Other reasons not listed above|0|||
33330985|NCT01040130|62707395|FG003|Overall Study|Other reasons not listed above|0|||
33468047|NCT00366899|62841569|FG001|Infant Series|Randomized but not consented|0|||
33653712|NCT02533180|63066187|FG000|Overall Study|Protocol Deviation|0|||
33653713|NCT02533180|63066188|FG001|Overall Study|Protocol Deviation|1|||
33653714|NCT02533180|63066187|FG000|Overall Study|Non-compliance|0|||
33653715|NCT02533180|63066188|FG001|Overall Study|Non-compliance|1|||
33653716|NCT01739348|63066226|FG000|Part I (Base Study)|Adverse Event|41|||
33653717|NCT01739348|63066227|FG001|Part I (Base Study)|Adverse Event|52|||
33653718|NCT01739348|63066228|FG002|Part I (Base Study)|Adverse Event|8|||
33330986|NCT01040130|62707396|FG004|Overall Study|Other reasons not listed above|0|||
33330987|NCT01040130|62707397|FG005|Overall Study|Other reasons not listed above|0|||
33330988|NCT00932451|62707407|FG000|Overall Study|Withdrawal by Subject|69|||
33330989|NCT00932451|62707407|FG000|Overall Study|Lost to Follow-up|22|||
33330990|NCT00932451|62707407|FG000|Overall Study|Death|726|||
33330991|NCT00932451|62707407|FG000|Overall Study|Other reasons|5|||
33330992|NCT01108055|62707415|FG000|Overall Study|Ineligible|11|||
33330993|NCT01108055|62707415|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
33330994|NCT01107899|62707422|FG000|Overall Study|Physician Decision|5|||
33330995|NCT01107899|62707423|FG001|Overall Study|Physician Decision|0|||
33330996|NCT01107899|62707424|FG002|Overall Study|Physician Decision|3|||
33330997|NCT01107899|62707422|FG000|Overall Study|Withdrawal by Subject|0|||
33330998|NCT01107899|62707423|FG001|Overall Study|Withdrawal by Subject|0|||
33330999|NCT01107899|62707424|FG002|Overall Study|Withdrawal by Subject|1|||
33331000|NCT01115933|62707435|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
33331001|NCT01107743|62707492|FG000|Overall Study|Protocol Violation|46|||
33331002|NCT01059864|62707541|FG000|Open-Label Run-In Phase|Adverse Event|7|||
33331003|NCT01059864|62707542|FG001|Open-Label Run-In Phase|Adverse Event|0|||
33331004|NCT01059864|62707543|FG002|Open-Label Run-In Phase|Adverse Event|0|||
33331005|NCT01059864|62707541|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
33331006|NCT01059864|62707542|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
33331007|NCT01059864|62707543|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
33331008|NCT01059864|62707541|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
33331009|NCT01059864|62707542|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
33331010|NCT01059864|62707543|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
33331011|NCT01059864|62707541|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
33331012|NCT01059864|62707542|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
33331013|NCT01059864|62707543|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
33331014|NCT01059864|62707541|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
33331015|NCT01059864|62707542|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
33331016|NCT01059864|62707543|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
33468048|NCT00366899|62841568|FG000|After Infant Series|Lost to Follow-up|4|||
33468049|NCT00366899|62841569|FG001|After Infant Series|Lost to Follow-up|3|||
33468050|NCT00366899|62841568|FG000|After Infant Series|Withdrawal by Subject|1|||
33653719|NCT01739348|63066229|FG003|Part I (Base Study)|Adverse Event|33|||
33653720|NCT01739348|63066226|FG000|Part I (Base Study)|Death|10|||
33653721|NCT01739348|63066227|FG001|Part I (Base Study)|Death|7|||
33653722|NCT01739348|63066228|FG002|Part I (Base Study)|Death|2|||
33653723|NCT01739348|63066229|FG003|Part I (Base Study)|Death|8|||
33468051|NCT00366899|62841569|FG001|After Infant Series|Withdrawal by Subject|4|||
33653724|NCT01739348|63066226|FG000|Part I (Base Study)|Lack of Efficacy|3|||
33653725|NCT01739348|63066227|FG001|Part I (Base Study)|Lack of Efficacy|8|||
33653726|NCT01739348|63066228|FG002|Part I (Base Study)|Lack of Efficacy|0|||
33653727|NCT01739348|63066229|FG003|Part I (Base Study)|Lack of Efficacy|7|||
33653728|NCT01739348|63066226|FG000|Part I (Base Study)|Lost to Follow-up|4|||
33653729|NCT01739348|63066227|FG001|Part I (Base Study)|Lost to Follow-up|2|||
33331017|NCT01059864|62707541|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
33468052|NCT00366899|62841568|FG000|After Infant Series|Adverse Event|1|||
33468053|NCT00366899|62841569|FG001|After Infant Series|Adverse Event|2|||
33468054|NCT00366899|62841568|FG000|After Infant Series|Protocol Violation|1|||
33653730|NCT01739348|63066228|FG002|Part I (Base Study)|Lost to Follow-up|4|||
33653731|NCT01739348|63066229|FG003|Part I (Base Study)|Lost to Follow-up|4|||
33653732|NCT01739348|63066226|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
33653733|NCT01739348|63066227|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
33331018|NCT01059864|62707542|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
33331019|NCT01059864|62707543|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
33331020|NCT01035138|62707553|FG000|Overall Study|Adverse Event|4|||
33331021|NCT01035138|62707554|FG001|Overall Study|Adverse Event|0|||
33653734|NCT01739348|63066228|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
33468055|NCT00366899|62841569|FG001|After Infant Series|Protocol Violation|0|||
33468056|NCT00366899|62841568|FG000|Toddler Dose|Withdrawal by Subject|1|||
33468057|NCT00366899|62841569|FG001|Toddler Dose|Withdrawal by Subject|1|||
33468058|NCT00366899|62841568|FG000|Toddler Dose|Protocol Violation|1|||
33468059|NCT00366899|62841569|FG001|Toddler Dose|Protocol Violation|0|||
33468060|NCT03254134|62841603|FG000|Overall Study|Not eligible patients|599|||
33468061|NCT03254134|62841604|FG001|Overall Study|Not eligible patients|3630|||
33468062|NCT00037830|62841613|FG000|Overall Study|Adverse Event|2|||
33468063|NCT00037830|62841614|FG001|Overall Study|Adverse Event|0|||
33468064|NCT00037830|62841615|FG002|Overall Study|Adverse Event|0|||
33468065|NCT00037830|62841613|FG000|Overall Study|Withdrawal by Subject|4|||
33548359|NCT02498392|62939619|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
33548360|NCT02498392|62939618|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
33548361|NCT02498392|62939619|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
33548362|NCT02498392|62939618|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
33548363|NCT02498392|62939619|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
33468066|NCT00037830|62841614|FG001|Overall Study|Withdrawal by Subject|5|||
33468067|NCT00037830|62841615|FG002|Overall Study|Withdrawal by Subject|1|||
33548364|NCT02498392|62939618|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
33548365|NCT02498392|62939619|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
33468068|NCT00037830|62841613|FG000|Overall Study|Protocol Violation|2|||
33548366|NCT02498392|62939618|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
33548367|NCT02498392|62939619|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
33548368|NCT02498392|62939618|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
33468069|NCT00037830|62841614|FG001|Overall Study|Protocol Violation|2|||
33468070|NCT00037830|62841615|FG002|Overall Study|Protocol Violation|0|||
33331022|NCT01035138|62707555|FG002|Overall Study|Adverse Event|2|||
33331023|NCT01035138|62707553|FG000|Overall Study|Caregiver Decision|2|||
33331024|NCT01035138|62707554|FG001|Overall Study|Caregiver Decision|0|||
33331025|NCT01035138|62707555|FG002|Overall Study|Caregiver Decision|1|||
33331026|NCT01035138|62707553|FG000|Overall Study|Withdrawal by Subject|1|||
33331027|NCT01035138|62707554|FG001|Overall Study|Withdrawal by Subject|0|||
33331028|NCT01035138|62707555|FG002|Overall Study|Withdrawal by Subject|0|||
33331029|NCT01035138|62707553|FG000|Overall Study|Physician Decision|0|||
33331030|NCT01035138|62707554|FG001|Overall Study|Physician Decision|0|||
33331031|NCT01035138|62707555|FG002|Overall Study|Physician Decision|1|||
33331032|NCT01035138|62707553|FG000|Overall Study|Sponsor Decision|66|||
33331033|NCT01035138|62707554|FG001|Overall Study|Sponsor Decision|60|||
33331034|NCT01035138|62707555|FG002|Overall Study|Sponsor Decision|42|||
33331035|NCT01035138|62707553|FG000|Overall Study|Lost to Follow-up|0|||
33331036|NCT01035138|62707554|FG001|Overall Study|Lost to Follow-up|0|||
33331037|NCT01035138|62707555|FG002|Overall Study|Lost to Follow-up|1|||
33331038|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
33331039|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
33331040|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
33468071|NCT00037830|62841613|FG000|Overall Study|Unrelated Medical Problem|2|||
33468072|NCT00037830|62841614|FG001|Overall Study|Unrelated Medical Problem|0|||
33468073|NCT00037830|62841615|FG002|Overall Study|Unrelated Medical Problem|0|||
33331041|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
33331042|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
33331043|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
33331044|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
33331045|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
33331046|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
33331047|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
33331048|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
33331049|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
33331050|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
33331051|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
33331052|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
33331053|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
33331054|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Program Termination|3|||
33331055|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Program Termination|0|||
33331056|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Program Termination|1|||
33331057|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Program Termination|1|||
33331058|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
33331059|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
33331060|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
33331061|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
33331062|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
33331063|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
33331064|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
33331065|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
33468074|NCT03242434|62841625|FG000|Overall Study|Death|0|||
33468075|NCT03242434|62841626|FG001|Overall Study|Death|2|||
33468076|NCT02939014|62841635|FG000|Overall Study|Lost to Follow-up|1|||
33331066|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
33331067|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
33331068|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
33331069|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
33331070|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
33331071|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
33468077|NCT02939014|62841636|FG001|Overall Study|Lost to Follow-up|0|||
33331072|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
33331073|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
33331074|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
33331075|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
33331076|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
33331077|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
33331078|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
33331079|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
33331080|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
33331081|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
33331082|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
33331083|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
33331084|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
33331085|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
33331086|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
33331087|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
33331088|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
33331089|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
33331090|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
33331091|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
33331092|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
33331093|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
33331094|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
33331095|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
33331096|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
33331097|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
33331098|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
33331099|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
33331100|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
33331101|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
33331102|NCT03739840|62707569|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
33331103|NCT03739840|62707570|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
33331104|NCT03739840|62707571|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
33331105|NCT03739840|62707572|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
33331106|NCT03739840|62707569|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
33331107|NCT03739840|62707570|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
33331108|NCT03739840|62707571|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
33331109|NCT03739840|62707572|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
33331110|NCT03739840|62707569|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
33331111|NCT03739840|62707570|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
33331112|NCT03739840|62707571|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
33331113|NCT03739840|62707572|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
33331114|NCT03739840|62707569|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
33468078|NCT02939014|62841635|FG000|Overall Study|Death|4|||
33468079|NCT02939014|62841636|FG001|Overall Study|Death|3|||
33468080|NCT00051558|62841645|FG000|Overall Study|Adverse Event|30|||
33468081|NCT00051558|62841646|FG001|Overall Study|Adverse Event|18|||
33468082|NCT00051558|62841645|FG000|Overall Study|Withdrawal by Subject|29|||
33331115|NCT03739840|62707570|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
33331116|NCT03739840|62707571|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
33331117|NCT03739840|62707572|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
33331118|NCT03739840|62707569|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
33331119|NCT03739840|62707570|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
33331120|NCT03739840|62707571|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
33331121|NCT03739840|62707572|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
33331122|NCT03739840|62707569|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
33331123|NCT03739840|62707570|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
33331124|NCT03739840|62707571|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
33331125|NCT03739840|62707572|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
33331126|NCT03739840|62707569|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
33331127|NCT03739840|62707570|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
33331128|NCT03739840|62707571|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
33331129|NCT03739840|62707572|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
33331130|NCT03739840|62707569|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
33331131|NCT03739840|62707570|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
33331132|NCT03739840|62707571|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
33331133|NCT03739840|62707572|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
33331134|NCT03739840|62707569|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
33331135|NCT03739840|62707570|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
33331136|NCT03739840|62707571|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
33331137|NCT03739840|62707572|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
33331138|NCT01035060|62707596|FG000|Overall Study|Lost to Follow-up|0|||
33331139|NCT01035060|62707597|FG001|Overall Study|Lost to Follow-up|7|||
33331140|NCT01035060|62707596|FG000|Overall Study|Did not quality after 2nd screening|14|||
33548369|NCT02498392|62939619|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
33548370|NCT03205605|62939627|FG000|Overall Study|Withdrawal by Subject|1|||
33548371|NCT02498236|62939645|FG000|Overall Study|Did not show for testing|1|||
33548372|NCT02498236|62939646|FG001|Overall Study|Did not show for testing|0|||
33548373|NCT02498236|62939647|FG002|Overall Study|Did not show for testing|0|||
33548374|NCT02498236|62939648|FG003|Overall Study|Did not show for testing|0|||
33548375|NCT02498236|62939649|FG004|Overall Study|Did not show for testing|0|||
33548376|NCT02498236|62939650|FG005|Overall Study|Did not show for testing|0|||
33548377|NCT02498236|62939651|FG006|Overall Study|Did not show for testing|0|||
33548378|NCT02498236|62939652|FG007|Overall Study|Did not show for testing|1|||
33548379|NCT02498236|62939645|FG000|Overall Study|Equipment failure|0|||
33548380|NCT02498236|62939646|FG001|Overall Study|Equipment failure|0|||
33548381|NCT02498236|62939647|FG002|Overall Study|Equipment failure|0|||
33548382|NCT02498236|62939648|FG003|Overall Study|Equipment failure|0|||
33548383|NCT02498236|62939649|FG004|Overall Study|Equipment failure|0|||
33548384|NCT02498236|62939650|FG005|Overall Study|Equipment failure|0|||
33548385|NCT02498236|62939651|FG006|Overall Study|Equipment failure|1|||
33548386|NCT02498236|62939652|FG007|Overall Study|Equipment failure|0|||
33548387|NCT02498236|62939645|FG000|Overall Study|Withdrawal by Subject|0|||
33653735|NCT01739348|63066229|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
33548388|NCT02498236|62939646|FG001|Overall Study|Withdrawal by Subject|0|||
33548389|NCT02498236|62939647|FG002|Overall Study|Withdrawal by Subject|0|||
33548390|NCT02498236|62939648|FG003|Overall Study|Withdrawal by Subject|0|||
33653736|NCT01739348|63066226|FG000|Part I (Base Study)|Physician Decision|10|||
33653737|NCT01739348|63066227|FG001|Part I (Base Study)|Physician Decision|7|||
33653738|NCT01739348|63066228|FG002|Part I (Base Study)|Physician Decision|1|||
33653739|NCT01739348|63066229|FG003|Part I (Base Study)|Physician Decision|4|||
33331141|NCT01035060|62707597|FG001|Overall Study|Did not quality after 2nd screening|1|||
33548391|NCT02498236|62939649|FG004|Overall Study|Withdrawal by Subject|1|||
33548392|NCT02498236|62939650|FG005|Overall Study|Withdrawal by Subject|0|||
33331142|NCT01035060|62707596|FG000|Overall Study|Withdrawal by Subject|8|||
33331143|NCT01035060|62707597|FG001|Overall Study|Withdrawal by Subject|6|||
33331144|NCT01035060|62707596|FG000|Overall Study|Physician Decision|2|||
33331145|NCT01035060|62707597|FG001|Overall Study|Physician Decision|0|||
33331146|NCT01039428|62707605|FG000|Overall Study|Protocol Violation|1|||
33331147|NCT01039428|62707606|FG001|Overall Study|Protocol Violation|0|||
33331148|NCT01039428|62707605|FG000|Overall Study|Withdrawal by Subject|1|||
33331149|NCT01039428|62707606|FG001|Overall Study|Withdrawal by Subject|0|||
33331150|NCT01034358|62707612|FG000|Overall Study|Withdrawal by Subject|1|||
33331151|NCT01034358|62707612|FG000|Overall Study|Protocol Violation|1|||
33331152|NCT01033734|62707620|FG000|Overall Study|Withdrawal by Subject|1|||
33331153|NCT01115855|62707635|FG000|Overall Study|Adverse Event|16|||
33331154|NCT01115855|62707636|FG001|Overall Study|Adverse Event|18|||
33331155|NCT01115855|62707635|FG000|Overall Study|Death|6|||
33331156|NCT01115855|62707636|FG001|Overall Study|Death|5|||
33331157|NCT01115855|62707635|FG000|Overall Study|Lab Abnormality|1|||
33331158|NCT01115855|62707636|FG001|Overall Study|Lab Abnormality|1|||
33331159|NCT01115855|62707635|FG000|Overall Study|Protocol Violation|0|||
33331160|NCT01115855|62707636|FG001|Overall Study|Protocol Violation|1|||
33331161|NCT01115855|62707635|FG000|Overall Study|Withdrawal by Subject|5|||
33468083|NCT00051558|62841646|FG001|Overall Study|Withdrawal by Subject|42|||
33468084|NCT00051558|62841645|FG000|Overall Study|Death|9|||
33653740|NCT01739348|63066226|FG000|Part I (Base Study)|Protocol Violation|2|||
33653741|NCT01739348|63066227|FG001|Part I (Base Study)|Protocol Violation|0|||
33331162|NCT01115855|62707636|FG001|Overall Study|Withdrawal by Subject|5|||
33331163|NCT01115855|62707635|FG000|Overall Study|Other|8|||
33331164|NCT01115855|62707636|FG001|Overall Study|Other|6|||
33331165|NCT01115309|62707646|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
33331166|NCT01115309|62707646|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
33331167|NCT01115309|62707646|FG000|Long-term Follow-up|Lost to Follow-up|6|||
33331168|NCT03638128|62707654|FG000|Overall Study|Withdrawal by Subject|1|||
33331169|NCT03638128|62707655|FG001|Overall Study|Withdrawal by Subject|7|||
33331170|NCT03638128|62707656|FG002|Overall Study|Withdrawal by Subject|6|||
33331171|NCT03638128|62707654|FG000|Overall Study|Sponsor Decision|15|||
33331172|NCT03638128|62707655|FG001|Overall Study|Sponsor Decision|12|||
33331173|NCT03638128|62707656|FG002|Overall Study|Sponsor Decision|19|||
33331174|NCT03638128|62707654|FG000|Overall Study|Lost to Follow-up|0|||
33331175|NCT03638128|62707655|FG001|Overall Study|Lost to Follow-up|0|||
33331176|NCT03638128|62707656|FG002|Overall Study|Lost to Follow-up|1|||
33331177|NCT01059630|62707669|FG000|Overall Study|Death|100|||
33331178|NCT01059630|62707670|FG001|Overall Study|Death|84|||
33331179|NCT01059630|62707669|FG000|Overall Study|Lost to Follow-up|4|||
33331180|NCT01059630|62707670|FG001|Overall Study|Lost to Follow-up|1|||
33331181|NCT01059630|62707669|FG000|Overall Study|Physician Decision|2|||
33331182|NCT01059630|62707670|FG001|Overall Study|Physician Decision|4|||
33331183|NCT01059630|62707669|FG000|Overall Study|Withdrawal by Subject|21|||
33331184|NCT01059630|62707670|FG001|Overall Study|Withdrawal by Subject|14|||
33331185|NCT00932373|62707687|FG000|Overall Study|Progressive disease|3|||
33331186|NCT00932373|62707688|FG001|Overall Study|Progressive disease|1|||
33331187|NCT00932373|62707689|FG002|Overall Study|Progressive disease|0|||
33331188|NCT00932373|62707690|FG003|Overall Study|Progressive disease|0|||
33331189|NCT00932373|62707691|FG004|Overall Study|Progressive disease|10|||
33331190|NCT00932373|62707692|FG005|Overall Study|Progressive disease|1|||
33331191|NCT00932373|62707693|FG006|Overall Study|Progressive disease|0|||
33331192|NCT00932373|62707694|FG007|Overall Study|Progressive disease|2|||
33331193|NCT00932373|62707695|FG008|Overall Study|Progressive disease|1|||
33331194|NCT00932373|62707696|FG009|Overall Study|Progressive disease|9|||
33331195|NCT00932373|62707697|FG010|Overall Study|Progressive disease|2|||
33331196|NCT00932373|62707687|FG000|Overall Study|Adverse Event|0|||
33331197|NCT00932373|62707688|FG001|Overall Study|Adverse Event|0|||
33331198|NCT00932373|62707689|FG002|Overall Study|Adverse Event|0|||
33331199|NCT00932373|62707690|FG003|Overall Study|Adverse Event|0|||
33331200|NCT00932373|62707691|FG004|Overall Study|Adverse Event|2|||
33331201|NCT00932373|62707692|FG005|Overall Study|Adverse Event|1|||
33331202|NCT00932373|62707693|FG006|Overall Study|Adverse Event|0|||
33331203|NCT00932373|62707694|FG007|Overall Study|Adverse Event|1|||
33331204|NCT00932373|62707695|FG008|Overall Study|Adverse Event|0|||
33331205|NCT00932373|62707696|FG009|Overall Study|Adverse Event|2|||
33331206|NCT00932373|62707697|FG010|Overall Study|Adverse Event|1|||
33331207|NCT00932373|62707687|FG000|Overall Study|Physician Decision|0|||
33331208|NCT00932373|62707688|FG001|Overall Study|Physician Decision|0|||
33331209|NCT00932373|62707689|FG002|Overall Study|Physician Decision|1|||
33331210|NCT00932373|62707690|FG003|Overall Study|Physician Decision|0|||
33331211|NCT00932373|62707691|FG004|Overall Study|Physician Decision|2|||
33331212|NCT00932373|62707692|FG005|Overall Study|Physician Decision|0|||
33331213|NCT00932373|62707693|FG006|Overall Study|Physician Decision|0|||
33331214|NCT00932373|62707694|FG007|Overall Study|Physician Decision|0|||
33331215|NCT00932373|62707695|FG008|Overall Study|Physician Decision|0|||
33331216|NCT00932373|62707696|FG009|Overall Study|Physician Decision|1|||
33331217|NCT00932373|62707697|FG010|Overall Study|Physician Decision|0|||
33331218|NCT00932373|62707687|FG000|Overall Study|Dose limiting toxicity|0|||
33331219|NCT00932373|62707688|FG001|Overall Study|Dose limiting toxicity|0|||
33331220|NCT00932373|62707689|FG002|Overall Study|Dose limiting toxicity|0|||
33331221|NCT00932373|62707690|FG003|Overall Study|Dose limiting toxicity|0|||
33331222|NCT00932373|62707691|FG004|Overall Study|Dose limiting toxicity|0|||
33331223|NCT00932373|62707692|FG005|Overall Study|Dose limiting toxicity|1|||
33331224|NCT00932373|62707693|FG006|Overall Study|Dose limiting toxicity|0|||
33331225|NCT00932373|62707694|FG007|Overall Study|Dose limiting toxicity|0|||
33331226|NCT00932373|62707695|FG008|Overall Study|Dose limiting toxicity|0|||
33331227|NCT00932373|62707696|FG009|Overall Study|Dose limiting toxicity|0|||
33331228|NCT00932373|62707697|FG010|Overall Study|Dose limiting toxicity|0|||
33331229|NCT00932373|62707687|FG000|Overall Study|Withdrawal by Subject|0|||
33331230|NCT00932373|62707688|FG001|Overall Study|Withdrawal by Subject|0|||
33331231|NCT00932373|62707689|FG002|Overall Study|Withdrawal by Subject|0|||
33331232|NCT00932373|62707690|FG003|Overall Study|Withdrawal by Subject|0|||
33331233|NCT00932373|62707691|FG004|Overall Study|Withdrawal by Subject|0|||
33331234|NCT00932373|62707692|FG005|Overall Study|Withdrawal by Subject|0|||
33331235|NCT00932373|62707693|FG006|Overall Study|Withdrawal by Subject|0|||
33331236|NCT00932373|62707694|FG007|Overall Study|Withdrawal by Subject|0|||
33331237|NCT00932373|62707695|FG008|Overall Study|Withdrawal by Subject|1|||
33331238|NCT00932373|62707696|FG009|Overall Study|Withdrawal by Subject|0|||
33331239|NCT00932373|62707697|FG010|Overall Study|Withdrawal by Subject|0|||
33331240|NCT00932373|62707687|FG000|Overall Study|Clinical progression|0|||
33331241|NCT00932373|62707688|FG001|Overall Study|Clinical progression|0|||
33331242|NCT00932373|62707689|FG002|Overall Study|Clinical progression|0|||
33331243|NCT00932373|62707690|FG003|Overall Study|Clinical progression|0|||
33331244|NCT00932373|62707691|FG004|Overall Study|Clinical progression|0|||
33331245|NCT00932373|62707692|FG005|Overall Study|Clinical progression|0|||
33331246|NCT00932373|62707693|FG006|Overall Study|Clinical progression|1|||
33331247|NCT00932373|62707694|FG007|Overall Study|Clinical progression|0|||
33331248|NCT00932373|62707695|FG008|Overall Study|Clinical progression|0|||
33331249|NCT00932373|62707696|FG009|Overall Study|Clinical progression|0|||
33331250|NCT00932373|62707697|FG010|Overall Study|Clinical progression|0|||
33331251|NCT00932373|62707687|FG000|Overall Study|Lack of Efficacy|0|||
33331252|NCT00932373|62707688|FG001|Overall Study|Lack of Efficacy|0|||
33331253|NCT00932373|62707689|FG002|Overall Study|Lack of Efficacy|0|||
33331254|NCT00932373|62707690|FG003|Overall Study|Lack of Efficacy|0|||
33331255|NCT00932373|62707691|FG004|Overall Study|Lack of Efficacy|0|||
33331256|NCT00932373|62707692|FG005|Overall Study|Lack of Efficacy|0|||
33331257|NCT00932373|62707693|FG006|Overall Study|Lack of Efficacy|0|||
33331258|NCT00932373|62707694|FG007|Overall Study|Lack of Efficacy|0|||
33331259|NCT00932373|62707695|FG008|Overall Study|Lack of Efficacy|0|||
33331260|NCT00932373|62707696|FG009|Overall Study|Lack of Efficacy|1|||
33331261|NCT00932373|62707697|FG010|Overall Study|Lack of Efficacy|0|||
33331262|NCT01055496|62707731|FG000|Overall Study|Withdrawal by Subject|2|||
33331263|NCT01055496|62707732|FG001|Overall Study|Withdrawal by Subject|4|||
33331264|NCT01055496|62707731|FG000|Overall Study|Death|13|||
33331265|NCT01055496|62707732|FG001|Overall Study|Death|23|||
33331266|NCT01055496|62707731|FG000|Overall Study|Lost to Follow-up|0|||
33331267|NCT01055496|62707732|FG001|Overall Study|Lost to Follow-up|2|||
33331268|NCT01055496|62707731|FG000|Overall Study|Other - Unspecified|0|||
33331269|NCT01055496|62707732|FG001|Overall Study|Other - Unspecified|1|||
33331270|NCT01055262|62707759|FG000|Overall Study|Adverse Event|5|||
33331271|NCT01055262|62707759|FG000|Overall Study|Protocol Violation|3|||
33331272|NCT01055262|62707759|FG000|Overall Study|Uncooperativeness|1|||
33331273|NCT01052844|62707765|FG000|Overall Study|Adverse Event|0|||
33331274|NCT01052844|62707766|FG001|Overall Study|Adverse Event|1|||
33331275|NCT01049412|62707774|FG000|Period I|Withdrawal by Subject|4|||
33331276|NCT01049412|62707775|FG001|Period I|Withdrawal by Subject|6|||
33331277|NCT01049412|62707774|FG000|Period I|Lost to Follow-up|2|||
33331278|NCT01049412|62707775|FG001|Period I|Lost to Follow-up|2|||
33331279|NCT01049412|62707774|FG000|Period I|Physician Decision|0|||
33331280|NCT01049412|62707775|FG001|Period I|Physician Decision|3|||
33331281|NCT01049412|62707774|FG000|Period I|Protocol Violation|1|||
33331282|NCT01049412|62707775|FG001|Period I|Protocol Violation|2|||
33331283|NCT01049412|62707774|FG000|Period I|Adverse Event|1|||
33331284|NCT01049412|62707775|FG001|Period I|Adverse Event|0|||
33331285|NCT01049412|62707774|FG000|Period II|Withdrawal by Subject|2|||
33331286|NCT01049412|62707775|FG001|Period II|Withdrawal by Subject|3|||
33331287|NCT01049412|62707774|FG000|Period II|Adverse Event|1|||
33331288|NCT01049412|62707775|FG001|Period II|Adverse Event|0|||
33331289|NCT01049412|62707774|FG000|Period II|Lost to Follow-up|1|||
33331290|NCT01049412|62707775|FG001|Period II|Lost to Follow-up|0|||
33331291|NCT00934089|62707785|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
33331292|NCT00934089|62707786|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
33331293|NCT00934089|62707785|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
33331294|NCT00934089|62707786|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
33331295|NCT01032174|62707794|FG000|Overall Study|Adverse Event|0|||
33331296|NCT01032174|62707795|FG001|Overall Study|Adverse Event|1|||
33331297|NCT00933933|62707806|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
33331298|NCT00933933|62707807|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
33331299|NCT00933933|62707808|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
33331300|NCT00933933|62707806|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
33331301|NCT00933933|62707807|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
33331302|NCT00933933|62707808|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
33331303|NCT01032018|62707826|FG000|Overall Study|Lost to Follow-up|6|||
33331304|NCT01032018|62707827|FG001|Overall Study|Lost to Follow-up|5|||
33331305|NCT01032018|62707826|FG000|Overall Study|Death|0|||
33331306|NCT01032018|62707827|FG001|Overall Study|Death|1|||
33331307|NCT01031706|62707835|FG000|Overall Study|Adverse Event|1|||
33331308|NCT01031706|62707836|FG001|Overall Study|Adverse Event|0|||
33331309|NCT01031706|62707835|FG000|Overall Study|Withdrawal by Subject|1|||
33331310|NCT01031706|62707836|FG001|Overall Study|Withdrawal by Subject|1|||
33331311|NCT00927069|62707844|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
33331312|NCT00927069|62707845|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
33331313|NCT00927069|62707846|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
33331314|NCT00927069|62707847|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
33331315|NCT00927069|62707844|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
33331316|NCT00927069|62707845|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
33331317|NCT00927069|62707846|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
33331318|NCT00927069|62707847|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
33331319|NCT00927069|62707844|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
33331320|NCT00927069|62707845|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
33331321|NCT00927069|62707846|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
33468085|NCT00051558|62841646|FG001|Overall Study|Death|15|||
33468086|NCT00051558|62841645|FG000|Overall Study|Lost to Follow-up|4|||
33331322|NCT00927069|62707847|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
33331323|NCT00927069|62707844|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
33331324|NCT00927069|62707845|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
33331325|NCT00927069|62707846|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
33331326|NCT00927069|62707847|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
33468087|NCT00051558|62841646|FG001|Overall Study|Lost to Follow-up|13|||
33331327|NCT00927069|62707844|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
33331328|NCT00927069|62707845|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
33331329|NCT00927069|62707846|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
33331330|NCT00927069|62707847|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
33331331|NCT01031628|62707861|FG000|Overall Study|Study terminated early|0|||
33331332|NCT01031628|62707862|FG001|Overall Study|Study terminated early|1|||
33331333|NCT01031628|62707863|FG002|Overall Study|Study terminated early|3|||
33331334|NCT01031628|62707864|FG003|Overall Study|Study terminated early|0|||
33331335|NCT01031004|62707876|FG000|Overall Study|Protocol Violation|0|||
33331336|NCT01031004|62707877|FG001|Overall Study|Protocol Violation|1|||
33331337|NCT01031004|62707876|FG000|Overall Study|Lost to Follow-up|1|||
33331338|NCT01031004|62707877|FG001|Overall Study|Lost to Follow-up|0|||
33331339|NCT00931515|62707885|FG000|Overall Study|Lost to Follow-up|2|||
33331340|NCT00931515|62707886|FG001|Overall Study|Lost to Follow-up|5|||
33331341|NCT01028352|62707892|FG000|Overall Study|Ineligible due to baseline average pain|5|||
33331342|NCT01028352|62707892|FG000|Overall Study|Withdrawal by Subject|1|||
33331343|NCT00929643|62707909|FG000|Overall Study|Protocol Violation|2|||
33331344|NCT00926367|62707915|FG000|Overall Study|Withdrawal by Subject|0|||
33331345|NCT00926367|62707916|FG001|Overall Study|Withdrawal by Subject|1|||
33331346|NCT00926367|62707915|FG000|Overall Study|Lost to Follow-up|1|||
33331347|NCT00926367|62707916|FG001|Overall Study|Lost to Follow-up|0|||
33331348|NCT00926367|62707915|FG000|Overall Study|Skin Irritation|1|||
33331349|NCT00926367|62707916|FG001|Overall Study|Skin Irritation|2|||
33331350|NCT01114529|62707927|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
33331351|NCT01114529|62707928|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
33331352|NCT01114529|62707929|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
33331353|NCT01114529|62707927|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
33331354|NCT01114529|62707928|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
33331355|NCT01114529|62707929|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
33331356|NCT01114529|62707927|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
33331357|NCT01114529|62707928|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
33331358|NCT01114529|62707929|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
33331359|NCT01114529|62707927|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
33331360|NCT01114529|62707928|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
33331361|NCT01114529|62707929|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
33331362|NCT01114529|62707927|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
33331363|NCT01114529|62707928|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
33331364|NCT01114529|62707929|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
33331365|NCT01114529|62707927|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
33331366|NCT01114529|62707928|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
33331367|NCT01114529|62707929|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
33331368|NCT01114529|62707927|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
33331369|NCT01114529|62707928|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
33331370|NCT01114529|62707929|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
33331371|NCT01114529|62707927|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
33331372|NCT01114529|62707928|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
33331373|NCT01114529|62707929|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
33331374|NCT01114529|62707927|FG000|Completed Study Medication at Month 24|Death|2|||
33331375|NCT01114529|62707928|FG001|Completed Study Medication at Month 24|Death|1|||
33331376|NCT01114529|62707929|FG002|Completed Study Medication at Month 24|Death|2|||
33331377|NCT01114529|62707927|FG000|Completed Study Medication at Month 24|Graft loss|0|||
33331378|NCT01114529|62707928|FG001|Completed Study Medication at Month 24|Graft loss|2|||
33331379|NCT01114529|62707929|FG002|Completed Study Medication at Month 24|Graft loss|0|||
33331380|NCT01114529|62707927|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
33331381|NCT01114529|62707928|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
33331382|NCT01114529|62707929|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
33331383|NCT01114529|62707927|FG000|Completed Study Medication at Month 24|Missing|2|||
33331384|NCT01114529|62707928|FG001|Completed Study Medication at Month 24|Missing|0|||
33331385|NCT01114529|62707929|FG002|Completed Study Medication at Month 24|Missing|0|||
33331386|NCT01114529|62707927|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
33331387|NCT01114529|62707928|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
33331388|NCT01114529|62707929|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
33331389|NCT01114529|62707927|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
33331390|NCT01114529|62707928|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
33331391|NCT01114529|62707929|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
33331392|NCT01114529|62707927|FG000|Completed Study Phase at Month 24|Death|8|||
33331393|NCT01114529|62707928|FG001|Completed Study Phase at Month 24|Death|5|||
33331394|NCT01114529|62707929|FG002|Completed Study Phase at Month 24|Death|4|||
33331395|NCT01114529|62707927|FG000|Completed Study Phase at Month 24|Other|2|||
33331396|NCT01114529|62707928|FG001|Completed Study Phase at Month 24|Other|0|||
33331397|NCT01114529|62707929|FG002|Completed Study Phase at Month 24|Other|0|||
33331398|NCT01114529|62707927|FG000|Completed Study Phase at Month 24|Missing|2|||
33331399|NCT01114529|62707928|FG001|Completed Study Phase at Month 24|Missing|0|||
33331400|NCT01114529|62707929|FG002|Completed Study Phase at Month 24|Missing|0|||
33331401|NCT00926289|62707941|FG000|Overall Study|Adverse Event|9|||
33331402|NCT00926289|62707942|FG001|Overall Study|Adverse Event|11|||
33331403|NCT00926289|62707941|FG000|Overall Study|Protocol Violation|8|||
33331404|NCT00926289|62707942|FG001|Overall Study|Protocol Violation|12|||
33331405|NCT00926289|62707941|FG000|Overall Study|Lost to Follow-up|3|||
33331406|NCT00926289|62707942|FG001|Overall Study|Lost to Follow-up|6|||
33331407|NCT00926289|62707941|FG000|Overall Study|Withdrawal by Subject|4|||
33331408|NCT00926289|62707942|FG001|Overall Study|Withdrawal by Subject|4|||
33331409|NCT00926289|62707941|FG000|Overall Study|Other|1|||
33331410|NCT00926289|62707942|FG001|Overall Study|Other|3|||
33331411|NCT03208036|62707967|FG000|Baseline Assessment|Withdrawal by Subject|1|||
33331412|NCT03208036|62707968|FG001|Baseline Assessment|Withdrawal by Subject|1|||
33331413|NCT03208036|62707967|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
33331414|NCT03208036|62707968|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
33331415|NCT03208036|62707967|FG000|Intervention|Withdrawal by Subject|3|||
33331416|NCT03208036|62707968|FG001|Intervention|Withdrawal by Subject|2|||
33331417|NCT03208036|62707967|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
33468088|NCT00051558|62841645|FG000|Overall Study|Protocol Violation|3|||
33468089|NCT00051558|62841646|FG001|Overall Study|Protocol Violation|4|||
33331418|NCT03208036|62707968|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
33331419|NCT00926211|62707974|FG000|Overall Study|Lost to Follow-up|1|||
33468090|NCT00051558|62841645|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
33468091|NCT00051558|62841646|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
33468092|NCT00051558|62841645|FG000|Overall Study|Sponsor Decision|6|||
33468093|NCT00051558|62841646|FG001|Overall Study|Sponsor Decision|1|||
33468094|NCT00051558|62841645|FG000|Overall Study|Other|2|||
33468095|NCT00051558|62841646|FG001|Overall Study|Other|1|||
33468096|NCT00051558|62841645|FG000|Overall Study|Significant Lab Value|2|||
33468097|NCT00051558|62841646|FG001|Overall Study|Significant Lab Value|0|||
33468098|NCT00051558|62841645|FG000|Overall Study|Physician Decision|5|||
33468099|NCT00051558|62841646|FG001|Overall Study|Physician Decision|0|||
33548393|NCT02498236|62939651|FG006|Overall Study|Withdrawal by Subject|0|||
33548394|NCT02498236|62939652|FG007|Overall Study|Withdrawal by Subject|0|||
33548395|NCT02496676|62939675|FG000|Phase 1 - Period 1|Adverse Event|0|||
33548396|NCT02496676|62939676|FG001|Phase 1 - Period 1|Adverse Event|1|||
33548397|NCT02496676|62939675|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
33548398|NCT02496676|62939676|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
33548399|NCT02517268|62939692|FG000|Overall Study|Withdrawal by Subject|1|||
33653742|NCT01739348|63066228|FG002|Part I (Base Study)|Protocol Violation|1|||
33331420|NCT01114373|62707979|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
33331421|NCT01114373|62707980|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
33331422|NCT01114373|62707979|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
33331423|NCT01114373|62707980|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
33331424|NCT01114373|62707979|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
33331425|NCT01114373|62707980|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
33331426|NCT01114373|62707979|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
33468100|NCT03251482|62841657|FG000|Overall Study|Withdrawal by Subject|0|||
33468101|NCT03251482|62841658|FG001|Overall Study|Withdrawal by Subject|1|||
33331427|NCT01114373|62707980|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
33468102|NCT03251482|62841659|FG002|Overall Study|Withdrawal by Subject|0|||
33468103|NCT03251482|62841660|FG003|Overall Study|Withdrawal by Subject|0|||
33548400|NCT02517268|62939693|FG001|Overall Study|Withdrawal by Subject|0|||
33548401|NCT01160211|62939702|FG000|Overall Study|ongoing|90|||
33548402|NCT01160211|62939703|FG001|Overall Study|ongoing|75|||
33653743|NCT01739348|63066229|FG003|Part I (Base Study)|Protocol Violation|2|||
33468104|NCT03251482|62841661|FG004|Overall Study|Withdrawal by Subject|0|||
33468105|NCT03249454|62841673|FG000|Overall Study|Withdrawal by Subject|0|||
33468106|NCT03249454|62841674|FG001|Overall Study|Withdrawal by Subject|0|||
33468107|NCT03249454|62841675|FG002|Overall Study|Withdrawal by Subject|0|||
33468108|NCT03249454|62841676|FG003|Overall Study|Withdrawal by Subject|0|||
33468109|NCT03249454|62841677|FG004|Overall Study|Withdrawal by Subject|0|||
33468110|NCT03249454|62841678|FG005|Overall Study|Withdrawal by Subject|0|||
33331428|NCT00925899|62707992|FG000|Part 1|Death|1|||
33331429|NCT00925899|62707993|FG001|Part 1|Death|2|||
33331430|NCT00925899|62707992|FG000|Part 1|Withdrawal by Subject|10|||
33331431|NCT00925899|62707993|FG001|Part 1|Withdrawal by Subject|9|||
33331432|NCT01114217|62708002|FG000|Overall Study|Adverse Event|5|||
33331433|NCT01114217|62708003|FG001|Overall Study|Adverse Event|3|||
33331434|NCT01114217|62708002|FG000|Overall Study|Lost to Follow-up|17|||
33331435|NCT01114217|62708003|FG001|Overall Study|Lost to Follow-up|33|||
33331436|NCT01114217|62708002|FG000|Overall Study|Withdrawal by Subject|21|||
33331437|NCT01114217|62708003|FG001|Overall Study|Withdrawal by Subject|28|||
33331438|NCT01114217|62708002|FG000|Overall Study|Other-Clerical Error|3|||
33331439|NCT01114217|62708003|FG001|Overall Study|Other-Clerical Error|0|||
33331440|NCT01114217|62708002|FG000|Overall Study|Other-Early termination|6|||
33331441|NCT01114217|62708003|FG001|Overall Study|Other-Early termination|10|||
33331442|NCT01114217|62708002|FG000|Overall Study|Other-Procedure|1|||
33331443|NCT01114217|62708003|FG001|Overall Study|Other-Procedure|1|||
33331444|NCT01114217|62708002|FG000|Overall Study|Other-Pregnancy|2|||
33331445|NCT01114217|62708003|FG001|Overall Study|Other-Pregnancy|4|||
33331446|NCT01114217|62708002|FG000|Overall Study|Other-Protocol Violation|1|||
33331447|NCT01114217|62708003|FG001|Overall Study|Other-Protocol Violation|3|||
33331448|NCT01114217|62708002|FG000|Overall Study|Other-Lack of Efficacy|1|||
33331449|NCT01114217|62708003|FG001|Overall Study|Other-Lack of Efficacy|0|||
33331450|NCT01114217|62708002|FG000|Overall Study|Other-Non Compliance|2|||
33331451|NCT01114217|62708003|FG001|Overall Study|Other-Non Compliance|0|||
33331452|NCT01114217|62708002|FG000|Overall Study|Other-Physician Decision|1|||
33331453|NCT01114217|62708003|FG001|Overall Study|Other-Physician Decision|1|||
33331454|NCT01114217|62708002|FG000|Overall Study|Other-Sponsor Decision|10|||
33331455|NCT01114217|62708003|FG001|Overall Study|Other-Sponsor Decision|12|||
33331456|NCT01114217|62708002|FG000|Overall Study|Other-Study Termination|0|||
33331457|NCT01114217|62708003|FG001|Overall Study|Other-Study Termination|1|||
33331458|NCT01114217|62708002|FG000|Overall Study|Other-Study Withdrawn|1|||
33331459|NCT01114217|62708003|FG001|Overall Study|Other-Study Withdrawn|1|||
33331460|NCT01114217|62708002|FG000|Overall Study|Other-Site Stopped Communicating|2|||
33468111|NCT03249454|62841679|FG006|Overall Study|Withdrawal by Subject|0|||
33468112|NCT03249454|62841680|FG007|Overall Study|Withdrawal by Subject|0|||
33331461|NCT01114217|62708003|FG001|Overall Study|Other-Site Stopped Communicating|0|||
33331462|NCT01114217|62708002|FG000|Overall Study|Other-Lost to Follow-up|1|||
33331463|NCT01114217|62708003|FG001|Overall Study|Other-Lost to Follow-up|0|||
33331464|NCT01114217|62708002|FG000|Overall Study|Other-Withdrawal by Subject|1|||
33468113|NCT03249454|62841681|FG008|Overall Study|Withdrawal by Subject|0|||
33548403|NCT01160211|62939704|FG002|Overall Study|ongoing|79|||
33331465|NCT01114217|62708003|FG001|Overall Study|Other-Withdrawal by Subject|1|||
33468114|NCT03249454|62841682|FG009|Overall Study|Withdrawal by Subject|1|||
33468115|NCT03249454|62841683|FG010|Overall Study|Withdrawal by Subject|1|||
33468116|NCT03732248|62841696|FG000|Overall Study|Withdrawal by Subject|1|||
33468117|NCT03732248|62841697|FG001|Overall Study|Withdrawal by Subject|0|||
33468118|NCT00310037|62841705|FG000|Overall Study|Adverse Event|7|||
33468119|NCT00310037|62841706|FG001|Overall Study|Adverse Event|14|||
33468120|NCT00310037|62841705|FG000|Overall Study|Withdrawal by Subject|4|||
33468121|NCT00310037|62841706|FG001|Overall Study|Withdrawal by Subject|3|||
33468122|NCT00310037|62841705|FG000|Overall Study|Progression|6|||
33468123|NCT00310037|62841706|FG001|Overall Study|Progression|0|||
33468124|NCT00310037|62841705|FG000|Overall Study|Non-protocol treatment|1|||
33468125|NCT00310037|62841706|FG001|Overall Study|Non-protocol treatment|0|||
33468126|NCT00309959|62841712|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
33468127|NCT03238924|62841723|FG000|Overall Study|Withdrawal by Subject|2|||
33468128|NCT03238924|62841724|FG001|Overall Study|Withdrawal by Subject|2|||
33468129|NCT03247816|62841730|FG000|Overall Study|Adverse Event|12|||
33468130|NCT03247816|62841730|FG000|Overall Study|Physician Decision|3|||
33468131|NCT03247816|62841730|FG000|Overall Study|Lack of Efficacy|1|||
33331466|NCT01030536|62708012|FG000|Overall Study|Withdrawal by Subject|0|||
33331467|NCT01030536|62708013|FG001|Overall Study|Withdrawal by Subject|0|||
33331468|NCT01030536|62708014|FG002|Overall Study|Withdrawal by Subject|1|||
33331469|NCT01030536|62708015|FG003|Overall Study|Withdrawal by Subject|0|||
33331470|NCT01030536|62708016|FG004|Overall Study|Withdrawal by Subject|0|||
33331471|NCT01030536|62708012|FG000|Overall Study|undefined|1|||
33331472|NCT01030536|62708013|FG001|Overall Study|undefined|0|||
33331473|NCT01030536|62708014|FG002|Overall Study|undefined|1|||
33331474|NCT01030536|62708015|FG003|Overall Study|undefined|1|||
33331475|NCT01030536|62708016|FG004|Overall Study|undefined|0|||
33331476|NCT01030536|62708012|FG000|Overall Study|Adverse Event|0|||
33331477|NCT01030536|62708013|FG001|Overall Study|Adverse Event|3|||
33331478|NCT01030536|62708014|FG002|Overall Study|Adverse Event|1|||
33331479|NCT01030536|62708015|FG003|Overall Study|Adverse Event|0|||
33331480|NCT01030536|62708016|FG004|Overall Study|Adverse Event|1|||
33331481|NCT01030536|62708012|FG000|Overall Study|Progressive disease|6|||
33331482|NCT01030536|62708013|FG001|Overall Study|Progressive disease|2|||
33331483|NCT01030536|62708014|FG002|Overall Study|Progressive disease|3|||
33331484|NCT01030536|62708015|FG003|Overall Study|Progressive disease|2|||
33331485|NCT01030536|62708016|FG004|Overall Study|Progressive disease|0|||
33331486|NCT01030536|62708012|FG000|Overall Study|Death|0|||
33331487|NCT01030536|62708013|FG001|Overall Study|Death|1|||
33331488|NCT01030536|62708014|FG002|Overall Study|Death|0|||
33331489|NCT01030536|62708015|FG003|Overall Study|Death|0|||
33331490|NCT01030536|62708016|FG004|Overall Study|Death|0|||
33331491|NCT01030458|62708034|FG000|Overall Study|Lost to Follow-up|9|||
33331492|NCT01030458|62708035|FG001|Overall Study|Lost to Follow-up|10|||
33331493|NCT01030458|62708034|FG000|Overall Study|Withdrawal by Subject|2|||
33468132|NCT03247816|62841730|FG000|Overall Study|Lost to Follow-up|10|||
33331494|NCT01030458|62708035|FG001|Overall Study|Withdrawal by Subject|3|||
33331495|NCT01030458|62708034|FG000|Overall Study|Logistical reasons|9|||
33331496|NCT01030458|62708035|FG001|Overall Study|Logistical reasons|5|||
33331497|NCT01030458|62708034|FG000|Overall Study|Moved or changed job|6|||
33331498|NCT01030458|62708035|FG001|Overall Study|Moved or changed job|13|||
33331499|NCT01030458|62708034|FG000|Overall Study|Side effect of medication|1|||
33548404|NCT01160211|62939702|FG000|Overall Study|Withdrawal by Subject|3|||
33548405|NCT01160211|62939703|FG001|Overall Study|Withdrawal by Subject|5|||
33468133|NCT03247816|62841730|FG000|Overall Study|Missing Feraccru stop date|3|||
33468134|NCT00333359|62841748|FG000|Overall Study|Adverse Event|29|||
33468135|NCT00333359|62841749|FG001|Overall Study|Adverse Event|35|||
33468136|NCT00333359|62841748|FG000|Overall Study|Withdrawal by Subject|19|||
33468137|NCT00333359|62841749|FG001|Overall Study|Withdrawal by Subject|37|||
33468138|NCT00333359|62841748|FG000|Overall Study|Physician Decision|2|||
33468139|NCT00333359|62841749|FG001|Overall Study|Physician Decision|2|||
33468140|NCT00333359|62841748|FG000|Overall Study|Protocol Non-compliance|2|||
33468141|NCT00333359|62841749|FG001|Overall Study|Protocol Non-compliance|8|||
33468142|NCT00333359|62841748|FG000|Overall Study|Lost to Follow-up|15|||
33468143|NCT00333359|62841749|FG001|Overall Study|Lost to Follow-up|25|||
33468144|NCT00333359|62841748|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
33468145|NCT00333359|62841749|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
33468146|NCT00333359|62841748|FG000|Overall Study|Treatment Failure|3|||
33468147|NCT00333359|62841749|FG001|Overall Study|Treatment Failure|8|||
33468148|NCT00333359|62841748|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
33468149|NCT00333359|62841749|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
33331500|NCT01030458|62708035|FG001|Overall Study|Side effect of medication|1|||
33331501|NCT00930969|62708041|FG000|Overall Study|Death|5|||
33468150|NCT03246724|62841761|FG000|Overall Study|Withdrawal by Subject|5|||
33468151|NCT03246724|62841762|FG001|Overall Study|Withdrawal by Subject|2|||
33468152|NCT03246724|62841763|FG002|Overall Study|Withdrawal by Subject|4|||
33468153|NCT03246724|62841764|FG003|Overall Study|Withdrawal by Subject|2|||
33468154|NCT03246724|62841761|FG000|Overall Study|Ineligible on day of surgery|7|||
33468155|NCT03246724|62841762|FG001|Overall Study|Ineligible on day of surgery|2|||
33468156|NCT03246724|62841763|FG002|Overall Study|Ineligible on day of surgery|0|||
33468157|NCT03246724|62841764|FG003|Overall Study|Ineligible on day of surgery|3|||
33468158|NCT03246724|62841761|FG000|Overall Study|Study completed before surgical date|2|||
33468159|NCT03246724|62841762|FG001|Overall Study|Study completed before surgical date|1|||
33468160|NCT03246724|62841763|FG002|Overall Study|Study completed before surgical date|8|||
33468161|NCT03246724|62841764|FG003|Overall Study|Study completed before surgical date|1|||
33468162|NCT03246724|62841761|FG000|Overall Study|Transferred to other arm|0|||
33468163|NCT03246724|62841762|FG001|Overall Study|Transferred to other arm|0|||
33468164|NCT03246724|62841763|FG002|Overall Study|Transferred to other arm|1|||
33468165|NCT03246724|62841764|FG003|Overall Study|Transferred to other arm|0|||
33468166|NCT03246724|62841761|FG000|Overall Study|Unable to obtain medication timely|0|||
33468167|NCT03246724|62841762|FG001|Overall Study|Unable to obtain medication timely|2|||
33468168|NCT03246724|62841763|FG002|Overall Study|Unable to obtain medication timely|2|||
33331502|NCT00930969|62708041|FG000|Overall Study|Lost to Follow-up|1|||
33331503|NCT00930969|62708041|FG000|Overall Study|Physician Decision|13|||
33331504|NCT00930969|62708041|FG000|Overall Study|Withdrawal by Subject|19|||
33331505|NCT01114139|62708047|FG000|Overall Study|Adverse Event|3|||
33331506|NCT01114139|62708048|FG001|Overall Study|Adverse Event|2|||
33331507|NCT01114139|62708047|FG000|Overall Study|Lost to Follow-up|15|||
33331508|NCT01114139|62708048|FG001|Overall Study|Lost to Follow-up|3|||
33331509|NCT01114139|62708047|FG000|Overall Study|Withdrawal by Subject|17|||
33468169|NCT03246724|62841764|FG003|Overall Study|Unable to obtain medication timely|1|||
33468170|NCT03246724|62841761|FG000|Overall Study|Re-consented to participate|0|||
33468171|NCT03246724|62841762|FG001|Overall Study|Re-consented to participate|0|||
33548406|NCT01160211|62939704|FG002|Overall Study|Withdrawal by Subject|3|||
33548407|NCT01160211|62939702|FG000|Overall Study|Physician Decision|2|||
33548408|NCT01160211|62939703|FG001|Overall Study|Physician Decision|0|||
33331510|NCT01114139|62708048|FG001|Overall Study|Withdrawal by Subject|6|||
33331511|NCT01114139|62708047|FG000|Overall Study|Other-Missed 1 visit|1|||
33468172|NCT03246724|62841763|FG002|Overall Study|Re-consented to participate|0|||
33548409|NCT01160211|62939704|FG002|Overall Study|Physician Decision|0|||
33468173|NCT03246724|62841764|FG003|Overall Study|Re-consented to participate|1|||
33468174|NCT03246646|62841776|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
33468175|NCT03246646|62841777|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
33468176|NCT03246646|62841776|FG000|Overall Study|Withdrawal by Subject|3|||
33468177|NCT03246646|62841777|FG001|Overall Study|Withdrawal by Subject|0|||
33468178|NCT03246646|62841776|FG000|Overall Study|Lost to Follow-up|7|||
33468179|NCT03246646|62841777|FG001|Overall Study|Lost to Follow-up|0|||
33468180|NCT01347112|62841785|FG000|Overall Study|Withdrawal by Subject|1|||
33468181|NCT01347112|62841786|FG001|Overall Study|Withdrawal by Subject|7|||
33331512|NCT01114139|62708048|FG001|Overall Study|Other-Missed 1 visit|0|||
33331513|NCT01114139|62708047|FG000|Overall Study|Other-Protocol Violation|1|||
33331514|NCT01114139|62708048|FG001|Overall Study|Other-Protocol Violation|0|||
33331515|NCT01114139|62708047|FG000|Overall Study|Other-Out of window for study drug dose|1|||
33331516|NCT01114139|62708048|FG001|Overall Study|Other-Out of window for study drug dose|0|||
33331517|NCT01114139|62708047|FG000|Overall Study|Other-Participant falsified records|0|||
33331518|NCT01114139|62708048|FG001|Overall Study|Other-Participant falsified records|1|||
33331519|NCT01114139|62708047|FG000|Overall Study|Other-Participant went on hospice|0|||
33548410|NCT01160211|62939702|FG000|Overall Study|Lost to Follow-up|4|||
33548411|NCT01160211|62939703|FG001|Overall Study|Lost to Follow-up|7|||
33548412|NCT01160211|62939704|FG002|Overall Study|Lost to Follow-up|5|||
33548413|NCT01064687|62939717|FG000|Overall Study|Adverse Event|9|||
33548414|NCT01064687|62939718|FG001|Overall Study|Adverse Event|4|||
33548415|NCT01064687|62939719|FG002|Overall Study|Adverse Event|10|||
33548416|NCT01064687|62939720|FG003|Overall Study|Adverse Event|3|||
33653744|NCT01739348|63066226|FG000|Part I (Base Study)|Screen Failure|2|||
33653745|NCT01739348|63066227|FG001|Part I (Base Study)|Screen Failure|0|||
33653746|NCT01739348|63066228|FG002|Part I (Base Study)|Screen Failure|0|||
33653747|NCT01739348|63066229|FG003|Part I (Base Study)|Screen Failure|0|||
33653748|NCT01739348|63066226|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
33331520|NCT01114139|62708048|FG001|Overall Study|Other-Participant went on hospice|1|||
33331521|NCT01114139|62708047|FG000|Overall Study|Other-Physician changed treatment|1|||
33331522|NCT01114139|62708048|FG001|Overall Study|Other-Physician changed treatment|0|||
33331523|NCT01114139|62708047|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
33331524|NCT01114139|62708048|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
33331525|NCT01027884|62708056|FG000|Overall Study|Adverse Event|2|||
33331526|NCT01027884|62708057|FG001|Overall Study|Adverse Event|1|||
33331527|NCT01027884|62708056|FG000|Overall Study|Protocol Violation|1|||
33331528|NCT01027884|62708057|FG001|Overall Study|Protocol Violation|0|||
33331529|NCT01027884|62708056|FG000|Overall Study|Non-compliance|1|||
33331530|NCT01027884|62708057|FG001|Overall Study|Non-compliance|1|||
33331531|NCT01027884|62708056|FG000|Overall Study|Withdrawal by Subject|0|||
33331532|NCT01027884|62708057|FG001|Overall Study|Withdrawal by Subject|1|||
33331533|NCT01027884|62708056|FG000|Overall Study|Lost to Follow-up|0|||
33331534|NCT01027884|62708057|FG001|Overall Study|Lost to Follow-up|1|||
33331535|NCT01027884|62708056|FG000|Overall Study|Spinal fixation surgery|0|||
33331536|NCT01027884|62708057|FG001|Overall Study|Spinal fixation surgery|3|||
33331537|NCT03387514|62708065|FG000|Overall Study|Withdrawal by Subject|2|||
33331538|NCT03387514|62708065|FG000|Overall Study|Physician Decision|1|||
33468182|NCT01347112|62841785|FG000|Overall Study|Lost to Follow-up|3|||
33468183|NCT01347112|62841786|FG001|Overall Study|Lost to Follow-up|5|||
33468184|NCT00308711|62841796|FG000|Overall Study|Withdrawal by Subject|1|||
33468185|NCT00308711|62841797|FG001|Overall Study|Withdrawal by Subject|0|||
33468186|NCT00308711|62841798|FG002|Overall Study|Withdrawal by Subject|1|||
33468187|NCT00308711|62841796|FG000|Overall Study|Protocol Violation|0|||
33468188|NCT00308711|62841797|FG001|Overall Study|Protocol Violation|1|||
33468189|NCT00308711|62841798|FG002|Overall Study|Protocol Violation|1|||
33468190|NCT00308711|62841796|FG000|Overall Study|Lost to Follow-up|0|||
33468191|NCT00308711|62841797|FG001|Overall Study|Lost to Follow-up|1|||
33548417|NCT01064687|62939717|FG000|Overall Study|Death|1|||
33653749|NCT01739348|63066227|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
33331539|NCT03387514|62708065|FG000|Overall Study|Lost to Follow-up|2|||
33331540|NCT01113749|62708080|FG000|Overall Study|Lost to Follow-up|1|||
33331541|NCT01113749|62708081|FG001|Overall Study|Lost to Follow-up|2|||
33331542|NCT01022580|62708089|FG000|Overall Study|Death|18|||
33331543|NCT01022580|62708090|FG001|Overall Study|Death|22|||
33331544|NCT01107353|62708104|FG000|Overall Study|Positive Drug Screen|1|||
33331545|NCT01107353|62708105|FG001|Overall Study|Positive Drug Screen|0|||
33331546|NCT01107197|62708113|FG000|Overall Study|Death|12|||
33331547|NCT01107197|62708114|FG001|Overall Study|Death|10|||
33331548|NCT01107197|62708113|FG000|Overall Study|Lost to Follow-up|5|||
33331549|NCT01107197|62708114|FG001|Overall Study|Lost to Follow-up|8|||
33331550|NCT01107197|62708113|FG000|Overall Study|Withdrawal by Subject|3|||
33331551|NCT01107197|62708114|FG001|Overall Study|Withdrawal by Subject|5|||
33331552|NCT01112579|62708131|FG000|Overall Study|Missed Visit|1|||
33331553|NCT01112579|62708132|FG001|Overall Study|Missed Visit|1|||
33331554|NCT01112579|62708131|FG000|Overall Study|Death|0|||
33331555|NCT01112579|62708132|FG001|Overall Study|Death|2|||
33331556|NCT01112267|62708140|FG000|Overall Study|Adverse Event|24|||
33331557|NCT01112267|62708141|FG001|Overall Study|Adverse Event|6|||
33331558|NCT01112267|62708140|FG000|Overall Study|Withdrawal by Subject|3|||
33331559|NCT01112267|62708141|FG001|Overall Study|Withdrawal by Subject|5|||
33331560|NCT01112267|62708140|FG000|Overall Study|Protocol Violation|5|||
33331561|NCT01112267|62708141|FG001|Overall Study|Protocol Violation|3|||
33331562|NCT01112267|62708140|FG000|Overall Study|Participants not compliant|1|||
33331563|NCT01112267|62708141|FG001|Overall Study|Participants not compliant|2|||
33331564|NCT01112267|62708140|FG000|Overall Study|Participants not receive any study drug|1|||
33331565|NCT01112267|62708141|FG001|Overall Study|Participants not receive any study drug|2|||
33331566|NCT00925587|62708149|FG000|Overall Study|Protocol Specified Criteria|6|||
33331567|NCT00925587|62708150|FG001|Overall Study|Protocol Specified Criteria|6|||
33331568|NCT00925587|62708149|FG000|Overall Study|Physician Decision|4|||
33331569|NCT00925587|62708150|FG001|Overall Study|Physician Decision|1|||
33331570|NCT00925587|62708149|FG000|Overall Study|Protocol Violation|6|||
33331571|NCT00925587|62708150|FG001|Overall Study|Protocol Violation|4|||
33331572|NCT00925587|62708149|FG000|Overall Study|Withdrawal by Subject|9|||
33331573|NCT00925587|62708150|FG001|Overall Study|Withdrawal by Subject|6|||
33331574|NCT00925587|62708149|FG000|Overall Study|Death|5|||
33331575|NCT00925587|62708150|FG001|Overall Study|Death|5|||
33331576|NCT00925587|62708149|FG000|Overall Study|Adverse Event|6|||
33331577|NCT00925587|62708150|FG001|Overall Study|Adverse Event|2|||
33331578|NCT00925587|62708149|FG000|Overall Study|Lost to Follow-up|0|||
33331579|NCT00925587|62708150|FG001|Overall Study|Lost to Follow-up|1|||
33548418|NCT01064687|62939718|FG001|Overall Study|Death|1|||
33331580|NCT00928707|62708162|FG000|Overall Study|Protocol Violation|1|||
33331581|NCT00928707|62708163|FG001|Overall Study|Protocol Violation|0|||
33331582|NCT00930813|62708171|FG000|Overall Study|Death|4|||
33331583|NCT00930813|62708172|FG001|Overall Study|Death|5|||
33331584|NCT00930813|62708171|FG000|Overall Study|Withdrawal by Subject|2|||
33331585|NCT00930813|62708172|FG001|Overall Study|Withdrawal by Subject|5|||
33548419|NCT01064687|62939719|FG002|Overall Study|Death|0|||
33331586|NCT00930813|62708171|FG000|Overall Study|Lost to Follow-up|2|||
33331587|NCT00930813|62708172|FG001|Overall Study|Lost to Follow-up|4|||
33331588|NCT00930579|62708180|FG000|Overall Study|Withdrawal by Subject|1|||
33331589|NCT00930579|62708180|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
33331590|NCT00925353|62708184|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
33548420|NCT01064687|62939720|FG003|Overall Study|Death|0|||
33548421|NCT01064687|62939717|FG000|Overall Study|Entry Criteria Not Met|3|||
33548422|NCT01064687|62939718|FG001|Overall Study|Entry Criteria Not Met|0|||
33331591|NCT01106651|62708208|FG000|Overall Study|Adverse Event|17|||
33331592|NCT01106651|62708209|FG001|Overall Study|Adverse Event|9|||
33331593|NCT01106651|62708210|FG002|Overall Study|Adverse Event|23|||
33331594|NCT01106651|62708208|FG000|Overall Study|Lost to Follow-up|8|||
33331595|NCT01106651|62708209|FG001|Overall Study|Lost to Follow-up|2|||
33548423|NCT01064687|62939719|FG002|Overall Study|Entry Criteria Not Met|0|||
33331596|NCT01106651|62708210|FG002|Overall Study|Lost to Follow-up|6|||
33331597|NCT01106651|62708208|FG000|Overall Study|Physician Decision|4|||
33331598|NCT01106651|62708209|FG001|Overall Study|Physician Decision|3|||
33331599|NCT01106651|62708210|FG002|Overall Study|Physician Decision|1|||
33331600|NCT01106651|62708208|FG000|Overall Study|Protocol Violation|1|||
33331601|NCT01106651|62708209|FG001|Overall Study|Protocol Violation|2|||
33331602|NCT01106651|62708210|FG002|Overall Study|Protocol Violation|1|||
33331603|NCT01106651|62708208|FG000|Overall Study|Withdrawal by Subject|14|||
33331604|NCT01106651|62708209|FG001|Overall Study|Withdrawal by Subject|7|||
33331605|NCT01106651|62708210|FG002|Overall Study|Withdrawal by Subject|4|||
33331606|NCT01106651|62708208|FG000|Overall Study|Noncompliance with study drug|1|||
33331607|NCT01106651|62708209|FG001|Overall Study|Noncompliance with study drug|0|||
33331608|NCT01106651|62708210|FG002|Overall Study|Noncompliance with study drug|2|||
33331609|NCT01106651|62708208|FG000|Overall Study|Other|34|||
33331610|NCT01106651|62708209|FG001|Overall Study|Other|31|||
33331611|NCT01106651|62708210|FG002|Overall Study|Other|21|||
33331612|NCT01106651|62708208|FG000|Overall Study|Death|0|||
33331613|NCT01106651|62708209|FG001|Overall Study|Death|3|||
33331614|NCT01106651|62708210|FG002|Overall Study|Death|0|||
33331615|NCT01027650|62708229|FG000|Overall Study|Personal Reasons|0|||
33331616|NCT01027650|62708230|FG001|Overall Study|Personal Reasons|0|||
33331617|NCT01027650|62708231|FG002|Overall Study|Personal Reasons|0|||
33331618|NCT01027650|62708232|FG003|Overall Study|Personal Reasons|0|||
33331619|NCT01027650|62708233|FG004|Overall Study|Personal Reasons|2|||
33331620|NCT01027650|62708234|FG005|Overall Study|Personal Reasons|1|||
33331621|NCT01027650|62708235|FG006|Overall Study|Personal Reasons|0|||
33331622|NCT01027650|62708236|FG007|Overall Study|Personal Reasons|0|||
33331623|NCT01027650|62708229|FG000|Overall Study|Lost to Follow-up|0|||
33331624|NCT01027650|62708230|FG001|Overall Study|Lost to Follow-up|0|||
33331625|NCT01027650|62708231|FG002|Overall Study|Lost to Follow-up|0|||
33331626|NCT01027650|62708232|FG003|Overall Study|Lost to Follow-up|0|||
33331627|NCT01027650|62708233|FG004|Overall Study|Lost to Follow-up|0|||
33331628|NCT01027650|62708234|FG005|Overall Study|Lost to Follow-up|0|||
33331629|NCT01027650|62708235|FG006|Overall Study|Lost to Follow-up|1|||
33331630|NCT01027650|62708236|FG007|Overall Study|Lost to Follow-up|0|||
33331631|NCT01027650|62708229|FG000|Overall Study|Lack of Efficacy|0|||
33331632|NCT01027650|62708230|FG001|Overall Study|Lack of Efficacy|0|||
33331633|NCT01027650|62708231|FG002|Overall Study|Lack of Efficacy|0|||
33331634|NCT01027650|62708232|FG003|Overall Study|Lack of Efficacy|0|||
33331635|NCT01027650|62708233|FG004|Overall Study|Lack of Efficacy|0|||
33331636|NCT01027650|62708234|FG005|Overall Study|Lack of Efficacy|1|||
33331637|NCT01027650|62708235|FG006|Overall Study|Lack of Efficacy|0|||
33331638|NCT01027650|62708236|FG007|Overall Study|Lack of Efficacy|0|||
33331639|NCT01106027|62708254|FG000|Overall Study|Lost graft early, discontinued|1|||
33331640|NCT00927927|62708273|FG000|Overall Study|Withdrawal by Subject|0|||
33331641|NCT00927927|62708274|FG001|Overall Study|Withdrawal by Subject|0|||
33331642|NCT00927927|62708275|FG002|Overall Study|Withdrawal by Subject|0|||
33331643|NCT00927927|62708276|FG003|Overall Study|Withdrawal by Subject|0|||
33331644|NCT00927927|62708277|FG004|Overall Study|Withdrawal by Subject|0|||
33331645|NCT00927927|62708278|FG005|Overall Study|Withdrawal by Subject|0|||
33331646|NCT00927927|62708279|FG006|Overall Study|Withdrawal by Subject|0|||
33331647|NCT00927927|62708280|FG007|Overall Study|Withdrawal by Subject|2|||
33331648|NCT00927927|62708281|FG008|Overall Study|Withdrawal by Subject|0|||
33331649|NCT00927927|62708282|FG009|Overall Study|Withdrawal by Subject|0|||
33331650|NCT00927927|62708283|FG010|Overall Study|Withdrawal by Subject|0|||
33331651|NCT00927927|62708284|FG011|Overall Study|Withdrawal by Subject|2|||
33331652|NCT00927927|62708285|FG012|Overall Study|Withdrawal by Subject|0|||
33331653|NCT00927927|62708286|FG013|Overall Study|Withdrawal by Subject|0|||
33331654|NCT00927927|62708287|FG014|Overall Study|Withdrawal by Subject|0|||
33331655|NCT01027416|62708321|FG000|Overall Study|Withdrawal by Subject|0|||
33331656|NCT01027416|62708322|FG001|Overall Study|Withdrawal by Subject|1|||
33331657|NCT01027416|62708321|FG000|Overall Study|Physician Decision|1|||
33331658|NCT01027416|62708322|FG001|Overall Study|Physician Decision|4|||
33331659|NCT00923559|62708330|FG000|Overall Study|Lost to Follow-up|2|||
33331660|NCT00923559|62708331|FG001|Overall Study|Lost to Follow-up|3|||
33331661|NCT01015638|62708341|FG000|Overall Study|Withdrawal by Subject|1|||
33331662|NCT01015638|62708342|FG001|Overall Study|Withdrawal by Subject|0|||
33331663|NCT01022502|62708348|FG000|Overall Study|Adverse Event|1|||
33331664|NCT01022502|62708348|FG000|Overall Study|employment related reasons|1|||
33331665|NCT01022502|62708348|FG000|Overall Study|Withdrawal by Subject|1|||
33331666|NCT01105091|62708356|FG000|Overall Study|Death|2|||
33331667|NCT01105091|62708357|FG001|Overall Study|Death|0|||
33331668|NCT00924729|62708367|FG000|Overall Study|insufficient volume for analysis|1|||
33331669|NCT00924729|62708368|FG001|Overall Study|insufficient volume for analysis|0|||
33331670|NCT00924729|62708367|FG000|Overall Study|Protocol Violation|1|||
33331671|NCT00924729|62708368|FG001|Overall Study|Protocol Violation|0|||
33331672|NCT01099709|62708376|FG000|Period 1|Withdrawal by Subject|0|||
33331673|NCT01099709|62708377|FG001|Period 1|Withdrawal by Subject|1|||
33331674|NCT01099709|62708376|FG000|Period 1|Positive cotinine test|0|||
33468192|NCT00308711|62841798|FG002|Overall Study|Lost to Follow-up|0|||
33468193|NCT00308711|62841796|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
33468194|NCT00308711|62841797|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
33468195|NCT00308711|62841798|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
33468196|NCT00308711|62841796|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
33468197|NCT00308711|62841797|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
33468198|NCT00308711|62841798|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
33468199|NCT00308555|62841808|FG000|Overall Study|Withdrawal by Subject|1|||
33468200|NCT00308555|62841809|FG001|Overall Study|Withdrawal by Subject|0|||
33468201|NCT00308555|62841808|FG000|Overall Study|Physician Decision|2|||
33468202|NCT00308555|62841809|FG001|Overall Study|Physician Decision|0|||
33468203|NCT00050778|62841818|FG000|Overall Study|Adverse Event|13|||
33468204|NCT00050778|62841819|FG001|Overall Study|Adverse Event|3|||
33468205|NCT00050778|62841820|FG002|Overall Study|Adverse Event|2|||
33468206|NCT00050778|62841818|FG000|Overall Study|Death|0|||
33468207|NCT00050778|62841819|FG001|Overall Study|Death|1|||
33468208|NCT00050778|62841820|FG002|Overall Study|Death|1|||
33468209|NCT00050778|62841818|FG000|Overall Study|Lack of Efficacy|16|||
33468210|NCT00050778|62841819|FG001|Overall Study|Lack of Efficacy|2|||
33468211|NCT00050778|62841820|FG002|Overall Study|Lack of Efficacy|2|||
33468212|NCT00050778|62841818|FG000|Overall Study|Lost to Follow-up|0|||
33468213|NCT00050778|62841819|FG001|Overall Study|Lost to Follow-up|2|||
33468214|NCT00050778|62841820|FG002|Overall Study|Lost to Follow-up|4|||
33468215|NCT00050778|62841818|FG000|Overall Study|Physician Decision|3|||
33468216|NCT00050778|62841819|FG001|Overall Study|Physician Decision|0|||
33468217|NCT00050778|62841820|FG002|Overall Study|Physician Decision|2|||
33468218|NCT00050778|62841818|FG000|Overall Study|Protocol Violation|2|||
33468219|NCT00050778|62841819|FG001|Overall Study|Protocol Violation|0|||
33468220|NCT00050778|62841820|FG002|Overall Study|Protocol Violation|1|||
33468221|NCT00050778|62841818|FG000|Overall Study|Withdrawal by Subject|6|||
33468222|NCT00050778|62841819|FG001|Overall Study|Withdrawal by Subject|8|||
33468223|NCT00050778|62841820|FG002|Overall Study|Withdrawal by Subject|4|||
33468224|NCT00050778|62841818|FG000|Overall Study|Randomized but not treated|4|||
33468225|NCT00050778|62841819|FG001|Overall Study|Randomized but not treated|5|||
33468226|NCT00050778|62841820|FG002|Overall Study|Randomized but not treated|2|||
33468227|NCT00050778|62841818|FG000|Overall Study|Familial and personal reasons|1|||
33468228|NCT00050778|62841819|FG001|Overall Study|Familial and personal reasons|0|||
33468229|NCT00050778|62841820|FG002|Overall Study|Familial and personal reasons|0|||
33468230|NCT00050622|62841830|FG000|Overall Study|Adverse Event|1|||
33468231|NCT00308087|62841856|FG000|Overall Study|Progressive Disease|19|||
33468232|NCT00308087|62841857|FG001|Overall Study|Progressive Disease|21|||
33548424|NCT01064687|62939720|FG003|Overall Study|Entry Criteria Not Met|0|||
33548425|NCT01064687|62939717|FG000|Overall Study|Lack of Efficacy|1|||
33548426|NCT01064687|62939718|FG001|Overall Study|Lack of Efficacy|0|||
33548427|NCT01064687|62939719|FG002|Overall Study|Lack of Efficacy|2|||
33548428|NCT01064687|62939720|FG003|Overall Study|Lack of Efficacy|3|||
33331675|NCT01099709|62708377|FG001|Period 1|Positive cotinine test|1|||
33548429|NCT01064687|62939717|FG000|Overall Study|Lost to Follow-up|7|||
33331676|NCT01099709|62708376|FG000|Period 1|Adverse Event|1|||
33468233|NCT00308087|62841856|FG000|Overall Study|Study Closure|11|||
33468234|NCT00308087|62841857|FG001|Overall Study|Study Closure|12|||
33468235|NCT00308087|62841856|FG000|Overall Study|Withdrawal by Subject|2|||
33468236|NCT00308087|62841857|FG001|Overall Study|Withdrawal by Subject|1|||
33468237|NCT00308087|62841856|FG000|Overall Study|Other|4|||
33468238|NCT00308087|62841857|FG001|Overall Study|Other|3|||
33468239|NCT00307931|62841863|FG000|Overall Study|Adverse Event|1|||
33468240|NCT02796170|62841869|FG000|Overall Study|Lost to Follow-up|3|||
33653750|NCT01739348|63066228|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
33331677|NCT01099709|62708377|FG001|Period 1|Adverse Event|0|||
33331678|NCT01099397|62708384|FG000|Overall Study|Lost to Follow-up|4|||
33331679|NCT01099397|62708384|FG000|Overall Study|Protocol Violation|4|||
33331680|NCT01099397|62708384|FG000|Overall Study|Withdrawal by Subject|5|||
33331681|NCT01022424|62708389|FG000|Overall Study|Adverse Event|1|||
33331682|NCT01022424|62708389|FG000|Overall Study|Physician Decision|1|||
33331683|NCT01022424|62708389|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
33331684|NCT01098851|62708399|FG000|Overall Study|Equipment failure|1|||
33331685|NCT01098851|62708400|FG001|Overall Study|Equipment failure|0|||
33331686|NCT01026948|62708406|FG000|Overall Study|Physician Decision|8|||
33331687|NCT01104779|62708414|FG000|Overall Study|Protocol Violation|1|||
33331688|NCT01104779|62708415|FG001|Overall Study|Protocol Violation|2|||
33331689|NCT01104779|62708416|FG002|Overall Study|Protocol Violation|2|||
33331690|NCT01104779|62708414|FG000|Overall Study|Lack of Efficacy|26|||
33331691|NCT01104779|62708415|FG001|Overall Study|Lack of Efficacy|12|||
33331692|NCT01104779|62708416|FG002|Overall Study|Lack of Efficacy|13|||
33331693|NCT01104779|62708414|FG000|Overall Study|Adverse Event|13|||
33331694|NCT01104779|62708415|FG001|Overall Study|Adverse Event|14|||
33331695|NCT01104779|62708416|FG002|Overall Study|Adverse Event|13|||
33331696|NCT01104779|62708414|FG000|Overall Study|Did not meet inc/exc criteria|1|||
33331697|NCT01104779|62708415|FG001|Overall Study|Did not meet inc/exc criteria|1|||
33331698|NCT01104779|62708416|FG002|Overall Study|Did not meet inc/exc criteria|1|||
33331699|NCT01104779|62708414|FG000|Overall Study|Other reasons|0|||
33331700|NCT01104779|62708415|FG001|Overall Study|Other reasons|1|||
33331701|NCT01104779|62708416|FG002|Overall Study|Other reasons|0|||
33331702|NCT01104779|62708414|FG000|Overall Study|Lost to Follow-up|2|||
33331703|NCT01104779|62708415|FG001|Overall Study|Lost to Follow-up|0|||
33653751|NCT01739348|63066229|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
33653752|NCT01739348|63066226|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
33653753|NCT01739348|63066227|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
33653754|NCT01739348|63066228|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
33653755|NCT01739348|63066229|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
33653756|NCT01739348|63066226|FG000|Part I (Base Study)|Participant Moved|4|||
33653757|NCT01739348|63066227|FG001|Part I (Base Study)|Participant Moved|3|||
33653758|NCT01739348|63066228|FG002|Part I (Base Study)|Participant Moved|1|||
33653759|NCT01739348|63066229|FG003|Part I (Base Study)|Participant Moved|7|||
33653760|NCT01739348|63066226|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
33653761|NCT01739348|63066227|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
33653762|NCT01739348|63066228|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
33653763|NCT01739348|63066229|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
33653764|NCT01739348|63066226|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
33653765|NCT01739348|63066227|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
33653766|NCT01739348|63066228|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
33653767|NCT01739348|63066229|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
33653768|NCT01739348|63066226|FG000|Part II (Extension Study)|Adverse Event|10|||
33653769|NCT01739348|63066227|FG001|Part II (Extension Study)|Adverse Event|11|||
33331704|NCT01104779|62708416|FG002|Overall Study|Lost to Follow-up|1|||
33331705|NCT01104779|62708414|FG000|Overall Study|Withdrawal by Subject|16|||
33331706|NCT01104779|62708415|FG001|Overall Study|Withdrawal by Subject|25|||
33331707|NCT01104779|62708416|FG002|Overall Study|Withdrawal by Subject|32|||
33468241|NCT02796170|62841870|FG001|Overall Study|Lost to Follow-up|0|||
33468242|NCT00049842|62841878|FG000|Treatment Phase|Adverse Event|47|||
33468243|NCT00049842|62841879|FG001|Treatment Phase|Adverse Event|12|||
33468244|NCT00049842|62841878|FG000|Treatment Phase|Withdrawal by Subject|35|||
33653770|NCT01739348|63066228|FG002|Part II (Extension Study)|Adverse Event|7|||
33653771|NCT01739348|63066229|FG003|Part II (Extension Study)|Adverse Event|26|||
33653772|NCT01739348|63066226|FG000|Part II (Extension Study)|Death|3|||
33468245|NCT00049842|62841879|FG001|Treatment Phase|Withdrawal by Subject|46|||
33468246|NCT00049842|62841878|FG000|Treatment Phase|Non-compliance with protocol|7|||
33468247|NCT00049842|62841879|FG001|Treatment Phase|Non-compliance with protocol|8|||
33468248|NCT00049842|62841878|FG000|Treatment Phase|Lost to Follow-up|4|||
33468249|NCT00049842|62841879|FG001|Treatment Phase|Lost to Follow-up|8|||
33468250|NCT00049842|62841878|FG000|Treatment Phase|Administrative|0|||
33548430|NCT01064687|62939718|FG001|Overall Study|Lost to Follow-up|10|||
33331708|NCT00918957|62708426|FG000|Overall Study|Adverse Event|2|||
33331709|NCT00918957|62708427|FG001|Overall Study|Adverse Event|0|||
33331710|NCT00918957|62708426|FG000|Overall Study|Withdrawal by Subject|1|||
33331711|NCT00918957|62708427|FG001|Overall Study|Withdrawal by Subject|0|||
33331712|NCT01022268|62708435|FG000|Overall Study|Withdrawal by Subject|1|||
33331713|NCT01022268|62708436|FG001|Overall Study|Withdrawal by Subject|0|||
33331714|NCT01022268|62708435|FG000|Overall Study|Withdrawal by Subject|1|||
33331715|NCT01022268|62708436|FG001|Overall Study|Withdrawal by Subject|0|||
33331716|NCT01015560|62708442|FG000|Overall Study|Adverse Event|1|||
33331717|NCT01015560|62708442|FG000|Overall Study|Not protocol specified|1|||
33331718|NCT01015560|62708442|FG000|Overall Study|Withdrawal by Subject|1|||
33331719|NCT00918879|62708448|FG000|Overall Study|Withdrawal by Subject|4|||
33331720|NCT00918879|62708449|FG001|Overall Study|Withdrawal by Subject|4|||
33331721|NCT00918879|62708448|FG000|Overall Study|Lost to Follow-up|1|||
33331722|NCT00918879|62708449|FG001|Overall Study|Lost to Follow-up|1|||
33331723|NCT00918879|62708448|FG000|Overall Study|Severe non-compliance to protocol|1|||
33331724|NCT00918879|62708449|FG001|Overall Study|Severe non-compliance to protocol|1|||
33331725|NCT01026792|62708455|FG000|Overall Study|Protocol Violation|1|||
33331726|NCT01026324|62708462|FG000|Follow up/Survival|Withdrawal by Subject|1|||
33331727|NCT01026324|62708463|FG001|Follow up/Survival|Withdrawal by Subject|0|||
33331728|NCT01026324|62708464|FG002|Follow up/Survival|Withdrawal by Subject|0|||
33331729|NCT01098539|62708475|FG000|Overall Study|Adverse Event|26|||
33331730|NCT01098539|62708476|FG001|Overall Study|Adverse Event|26|||
33331731|NCT01098539|62708475|FG000|Overall Study|Protocol Violation|1|||
33331732|NCT01098539|62708476|FG001|Overall Study|Protocol Violation|4|||
33331733|NCT01098539|62708475|FG000|Overall Study|Noncompliance|3|||
33331734|NCT01098539|62708476|FG001|Overall Study|Noncompliance|5|||
33331735|NCT01098539|62708475|FG000|Overall Study|Lost to Follow-up|4|||
33331736|NCT01098539|62708476|FG001|Overall Study|Lost to Follow-up|4|||
33331737|NCT01098539|62708475|FG000|Overall Study|Withdrawal by Subject|12|||
33331738|NCT01098539|62708476|FG001|Overall Study|Withdrawal by Subject|26|||
33331739|NCT01098539|62708475|FG000|Overall Study|Physician Decision|5|||
33331740|NCT01098539|62708476|FG001|Overall Study|Physician Decision|3|||
33331741|NCT01098461|62708486|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
33331742|NCT01098461|62708487|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
33331743|NCT01098461|62708488|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
33331744|NCT01098461|62708489|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
33331745|NCT01098461|62708486|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
33331746|NCT01098461|62708487|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
33331747|NCT01098461|62708488|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
33331748|NCT01098461|62708489|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
33331749|NCT01098461|62708486|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
33331750|NCT01098461|62708487|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
33331751|NCT01098461|62708488|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
33331752|NCT01098461|62708489|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
33331753|NCT01098461|62708486|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
33331754|NCT01098461|62708487|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
33331755|NCT01098461|62708488|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
33331756|NCT01098461|62708489|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
33331757|NCT01098461|62708486|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
33331758|NCT01098461|62708487|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
33653773|NCT01739348|63066227|FG001|Part II (Extension Study)|Death|3|||
33331759|NCT01098461|62708488|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
33331760|NCT01098461|62708489|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
33331761|NCT01098461|62708486|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
33331762|NCT01098461|62708487|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
33653774|NCT01739348|63066228|FG002|Part II (Extension Study)|Death|2|||
33653775|NCT01739348|63066229|FG003|Part II (Extension Study)|Death|6|||
33331763|NCT01098461|62708488|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
33331764|NCT01098461|62708489|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
33331765|NCT01098461|62708486|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
33468251|NCT00049842|62841879|FG001|Treatment Phase|Administrative|3|||
33468252|NCT00049842|62841878|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
33468253|NCT00049842|62841879|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
33468254|NCT00049842|62841878|FG000|Follow-up Phase|Adverse Event|6|||
33468255|NCT00049842|62841879|FG001|Follow-up Phase|Adverse Event|1|||
33468256|NCT00049842|62841878|FG000|Follow-up Phase|Other|1|||
33468257|NCT00049842|62841879|FG001|Follow-up Phase|Other|4|||
33468258|NCT00307151|62841889|FG000|Overall Study|Death|4|||
33468259|NCT00307151|62841890|FG001|Overall Study|Death|3|||
33468260|NCT00307151|62841891|FG002|Overall Study|Death|10|||
33468261|NCT00307151|62841892|FG003|Overall Study|Death|3|||
33468262|NCT00307151|62841889|FG000|Overall Study|Severe debilitation, unable to continue|1|||
33468263|NCT00307151|62841890|FG001|Overall Study|Severe debilitation, unable to continue|0|||
33468264|NCT00307151|62841891|FG002|Overall Study|Severe debilitation, unable to continue|0|||
33468265|NCT00307151|62841892|FG003|Overall Study|Severe debilitation, unable to continue|0|||
33468266|NCT00307151|62841889|FG000|Overall Study|Subject unable to get to clinic|1|||
33468267|NCT00307151|62841890|FG001|Overall Study|Subject unable to get to clinic|0|||
33468268|NCT00307151|62841891|FG002|Overall Study|Subject unable to get to clinic|6|||
33468269|NCT00307151|62841892|FG003|Overall Study|Subject unable to get to clinic|2|||
33468270|NCT00307151|62841889|FG000|Overall Study|Withdrew consent|0|||
33468271|NCT00307151|62841890|FG001|Overall Study|Withdrew consent|1|||
33468272|NCT00307151|62841891|FG002|Overall Study|Withdrew consent|1|||
33468273|NCT00307151|62841892|FG003|Overall Study|Withdrew consent|3|||
33468274|NCT00307151|62841889|FG000|Overall Study|Not willing to adhere to study reqs|2|||
33468275|NCT00307151|62841890|FG001|Overall Study|Not willing to adhere to study reqs|0|||
33468276|NCT00307151|62841891|FG002|Overall Study|Not willing to adhere to study reqs|2|||
33468277|NCT00307151|62841892|FG003|Overall Study|Not willing to adhere to study reqs|2|||
33468278|NCT00307151|62841889|FG000|Overall Study|Clinic unable to contact subject|3|||
33468279|NCT00307151|62841890|FG001|Overall Study|Clinic unable to contact subject|3|||
33468280|NCT00307151|62841891|FG002|Overall Study|Clinic unable to contact subject|1|||
33468281|NCT00307151|62841892|FG003|Overall Study|Clinic unable to contact subject|1|||
33468282|NCT02654132|62841904|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
33468283|NCT02654132|62841905|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
33468284|NCT02654132|62841904|FG000|Treatment Period|Disease progression|43|||
33468285|NCT02654132|62841905|FG001|Treatment Period|Disease progression|38|||
33468286|NCT02654132|62841904|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
33468287|NCT02654132|62841905|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
33468288|NCT02654132|62841904|FG000|Treatment Period|Other reasons|4|||
33468289|NCT02654132|62841905|FG001|Treatment Period|Other reasons|2|||
33468290|NCT02654132|62841904|FG000|Treatment Period|Study drug toxicity|2|||
33468291|NCT02654132|62841905|FG001|Treatment Period|Study drug toxicity|2|||
33468292|NCT02654132|62841904|FG000|Treatment Period|Withdrawal by Subject|2|||
33468293|NCT02654132|62841905|FG001|Treatment Period|Withdrawal by Subject|1|||
33468294|NCT02654132|62841904|FG000|Treatment Period|Maximum Clinical Benefit|0|||
33468295|NCT02654132|62841905|FG001|Treatment Period|Maximum Clinical Benefit|2|||
33468296|NCT02654132|62841904|FG000|Treatment Period|Participant request to discontinue|2|||
33468297|NCT02654132|62841905|FG001|Treatment Period|Participant request to discontinue|0|||
33468298|NCT02654132|62841904|FG000|Treatment Period|Administrative reasons by sponsor|0|||
33468299|NCT02654132|62841905|FG001|Treatment Period|Administrative reasons by sponsor|1|||
33468300|NCT02654132|62841904|FG000|Treatment Period|Death|1|||
33468301|NCT02654132|62841905|FG001|Treatment Period|Death|0|||
33468302|NCT03241342|62841914|FG000|Overall Study|Adverse Event|5|||
33468303|NCT03241342|62841915|FG001|Overall Study|Adverse Event|8|||
33468304|NCT03241342|62841916|FG002|Overall Study|Adverse Event|4|||
33468305|NCT03241342|62841914|FG000|Overall Study|Lack of Efficacy|0|||
33468306|NCT03241342|62841915|FG001|Overall Study|Lack of Efficacy|0|||
33468307|NCT03241342|62841916|FG002|Overall Study|Lack of Efficacy|1|||
33468308|NCT03241342|62841914|FG000|Overall Study|noncompliance with study drug|2|||
33468309|NCT03241342|62841915|FG001|Overall Study|noncompliance with study drug|1|||
33468310|NCT03241342|62841916|FG002|Overall Study|noncompliance with study drug|1|||
33331766|NCT01098461|62708487|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
33331767|NCT01098461|62708488|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
33331768|NCT01098461|62708489|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
33331769|NCT01098305|62708502|FG000|Overall Study|Lost to Follow-up|31|||
33331770|NCT01098305|62708503|FG001|Overall Study|Lost to Follow-up|33|||
33331771|NCT00833833|62708515|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
33331772|NCT00833833|62708516|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
33331773|NCT00833833|62708517|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
33331774|NCT00833833|62708518|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
33331775|NCT00833833|62708519|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
33331776|NCT00833833|62708520|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
33331777|NCT00833833|62708515|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
33331778|NCT00833833|62708516|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
33331779|NCT00833833|62708517|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
33331780|NCT00833833|62708518|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
33331781|NCT00833833|62708519|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
33331782|NCT00833833|62708520|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
33331783|NCT00833833|62708515|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
33331784|NCT00833833|62708516|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
33331785|NCT00833833|62708517|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
33331786|NCT00833833|62708518|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
33468311|NCT03241342|62841914|FG000|Overall Study|sponsor decision|0|||
33468312|NCT03241342|62841915|FG001|Overall Study|sponsor decision|1|||
33468313|NCT03241342|62841916|FG002|Overall Study|sponsor decision|2|||
33468314|NCT03241342|62841914|FG000|Overall Study|not reported|15|||
33468315|NCT03241342|62841915|FG001|Overall Study|not reported|21|||
33468316|NCT03241342|62841916|FG002|Overall Study|not reported|19|||
33468317|NCT00306995|62841931|FG000|Study Part I|Withdrawal by Subject|0|||
33468318|NCT00306995|62841932|FG001|Study Part I|Withdrawal by Subject|0|||
33468319|NCT00306995|62841933|FG002|Study Part I|Withdrawal by Subject|0|||
33468320|NCT00306995|62841934|FG003|Study Part I|Withdrawal by Subject|0|||
33468321|NCT00306995|62841935|FG004|Study Part I|Withdrawal by Subject|0|||
33468322|NCT00306995|62841936|FG005|Study Part I|Withdrawal by Subject|0|||
33468323|NCT00306995|62841937|FG006|Study Part I|Withdrawal by Subject|1|||
33468324|NCT00306995|62841931|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
33468325|NCT00306995|62841932|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
33468326|NCT00306995|62841933|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
33468327|NCT00306995|62841934|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
33468328|NCT00306995|62841935|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
33468329|NCT00306995|62841936|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
33468330|NCT00306995|62841937|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
33468331|NCT00121108|62841984|FG000|Overall Study|Lost to Follow-up|10|||
33468332|NCT00121108|62841985|FG001|Overall Study|Lost to Follow-up|22|||
33468333|NCT00121108|62841984|FG000|Overall Study|Withdrawal by Subject|106|||
33468334|NCT00121108|62841985|FG001|Overall Study|Withdrawal by Subject|195|||
33468335|NCT00121108|62841984|FG000|Overall Study|Death|5|||
33468336|NCT00121108|62841985|FG001|Overall Study|Death|8|||
33468337|NCT02387996|62841992|FG000|Overall Study|Disease Progression|167|||
33468338|NCT02387996|62841992|FG000|Overall Study|Study Drug Toxicity|31|||
33468339|NCT02387996|62841992|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
33468340|NCT02387996|62841992|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
33468341|NCT02387996|62841992|FG000|Overall Study|Subject Withdrew Consent|5|||
33468342|NCT02387996|62841992|FG000|Overall Study|Lost to Follow-up|1|||
33468343|NCT02387996|62841992|FG000|Overall Study|Poor/Non-Compliance|1|||
33468344|NCT02387996|62841992|FG000|Overall Study|Other Reasons|5|||
33468345|NCT02387996|62841992|FG000|Overall Study|Death|1|||
33468346|NCT03212326|62841996|FG000|Overall Study|Physician Decision|4|||
33468347|NCT03229486|62842035|FG000|Overall Study|Protocol Violation|0|||
33468348|NCT03229486|62842036|FG001|Overall Study|Protocol Violation|1|||
33468349|NCT01779050|62842044|FG000|Overall Study|Withdrawal by Subject|1|||
33468350|NCT01779050|62842045|FG001|Overall Study|Withdrawal by Subject|0|||
33468351|NCT00306527|62842055|FG000|Overall Study|Lost to Follow-up|3|||
33468352|NCT00306527|62842056|FG001|Overall Study|Lost to Follow-up|4|||
33468353|NCT00306527|62842057|FG002|Overall Study|Lost to Follow-up|3|||
33468354|NCT00306527|62842058|FG003|Overall Study|Lost to Follow-up|0|||
33468355|NCT00306527|62842055|FG000|Overall Study|Withdrawal by Subject|2|||
33468356|NCT00306527|62842056|FG001|Overall Study|Withdrawal by Subject|3|||
33331787|NCT00833833|62708519|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
33331788|NCT00833833|62708520|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
33331789|NCT00833833|62708515|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
33331790|NCT00833833|62708516|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
33468357|NCT00306527|62842057|FG002|Overall Study|Withdrawal by Subject|0|||
33468358|NCT00306527|62842058|FG003|Overall Study|Withdrawal by Subject|3|||
33468359|NCT00306527|62842055|FG000|Overall Study|Adverse Event|0|||
33468360|NCT00306527|62842056|FG001|Overall Study|Adverse Event|0|||
33468361|NCT00306527|62842057|FG002|Overall Study|Adverse Event|1|||
33468362|NCT00306527|62842058|FG003|Overall Study|Adverse Event|1|||
33468363|NCT00306527|62842055|FG000|Overall Study|Death|1|||
33468364|NCT00306527|62842056|FG001|Overall Study|Death|0|||
33468365|NCT00306527|62842057|FG002|Overall Study|Death|1|||
33468366|NCT00306527|62842058|FG003|Overall Study|Death|2|||
33468367|NCT00306293|62842072|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
33468368|NCT00306293|62842073|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
33468369|NCT00306293|62842072|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
33468370|NCT00306293|62842073|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
33468371|NCT00306293|62842072|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
33468372|NCT00306293|62842073|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
33468373|NCT00306293|62842072|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
33468374|NCT00306293|62842073|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
33468375|NCT00306293|62842072|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
33468376|NCT00306293|62842073|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
33468377|NCT00306293|62842072|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
33468378|NCT00306293|62842073|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
33468379|NCT00306293|62842072|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
33468380|NCT00306293|62842073|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
33548431|NCT01064687|62939719|FG002|Overall Study|Lost to Follow-up|13|||
33548432|NCT01064687|62939720|FG003|Overall Study|Lost to Follow-up|5|||
33548433|NCT01064687|62939717|FG000|Overall Study|Physician Decision|2|||
33653776|NCT01739348|63066226|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
33653777|NCT01739348|63066227|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
33653778|NCT01739348|63066228|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
33653779|NCT01739348|63066229|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
33653780|NCT01739348|63066226|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
33653781|NCT01739348|63066227|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
33653782|NCT01739348|63066228|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
33653783|NCT01739348|63066229|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
33653784|NCT01739348|63066226|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
33653785|NCT01739348|63066227|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
33653786|NCT01739348|63066228|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
33653787|NCT01739348|63066229|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
33653788|NCT01739348|63066226|FG000|Part II (Extension Study)|Physician Decision|7|||
33653789|NCT01739348|63066227|FG001|Part II (Extension Study)|Physician Decision|11|||
33653790|NCT01739348|63066228|FG002|Part II (Extension Study)|Physician Decision|6|||
33653791|NCT01739348|63066229|FG003|Part II (Extension Study)|Physician Decision|12|||
33653792|NCT01739348|63066226|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
33653793|NCT01739348|63066227|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
33653794|NCT01739348|63066228|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
33653795|NCT01739348|63066229|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
33653796|NCT01739348|63066226|FG000|Part II (Extension Study)|Participant Moved|3|||
33653797|NCT01739348|63066227|FG001|Part II (Extension Study)|Participant Moved|3|||
33653798|NCT01739348|63066228|FG002|Part II (Extension Study)|Participant Moved|0|||
33653799|NCT01739348|63066229|FG003|Part II (Extension Study)|Participant Moved|3|||
33653800|NCT01739348|63066226|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
33653801|NCT01739348|63066227|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
33653802|NCT01739348|63066228|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
33331791|NCT00833833|62708517|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
33331792|NCT00833833|62708518|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
33468381|NCT00306293|62842072|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
33468382|NCT00306293|62842073|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
33468383|NCT00294671|62842083|FG000|Overall Study|Lack of Efficacy|11|||
33468384|NCT00294671|62842084|FG001|Overall Study|Lack of Efficacy|23|||
33468385|NCT00294671|62842083|FG000|Overall Study|Liver transplant|7|||
33548434|NCT01064687|62939718|FG001|Overall Study|Physician Decision|2|||
33548435|NCT01064687|62939719|FG002|Overall Study|Physician Decision|0|||
33548436|NCT01064687|62939720|FG003|Overall Study|Physician Decision|0|||
33548437|NCT01064687|62939717|FG000|Overall Study|Protocol Violation|1|||
33548438|NCT01064687|62939718|FG001|Overall Study|Protocol Violation|1|||
33653803|NCT01739348|63066229|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
33653804|NCT01739348|63066226|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
33653805|NCT01739348|63066227|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
33653806|NCT01739348|63066228|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
33653807|NCT01739348|63066229|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
33548439|NCT01064687|62939719|FG002|Overall Study|Protocol Violation|0|||
33548440|NCT01064687|62939720|FG003|Overall Study|Protocol Violation|1|||
33468386|NCT00294671|62842084|FG001|Overall Study|Liver transplant|9|||
33468387|NCT00294671|62842083|FG000|Overall Study|Drug related adverse event (AE)|4|||
33468388|NCT00294671|62842084|FG001|Overall Study|Drug related adverse event (AE)|2|||
33468389|NCT00294671|62842083|FG000|Overall Study|Non-drug related AE|3|||
33468390|NCT00294671|62842084|FG001|Overall Study|Non-drug related AE|2|||
33468391|NCT00294671|62842083|FG000|Overall Study|Lost to Follow-up|1|||
33468392|NCT00294671|62842084|FG001|Overall Study|Lost to Follow-up|3|||
33468393|NCT00294671|62842083|FG000|Overall Study|Non-compliance|1|||
33468394|NCT00294671|62842084|FG001|Overall Study|Non-compliance|0|||
33653808|NCT01738646|63066261|FG000|Overall Study|Still Receiving Treatment|2|||
33548441|NCT01064687|62939717|FG000|Overall Study|Sponsor Decision|0|||
33548442|NCT01064687|62939718|FG001|Overall Study|Sponsor Decision|0|||
33548443|NCT01064687|62939719|FG002|Overall Study|Sponsor Decision|3|||
33548444|NCT01064687|62939720|FG003|Overall Study|Sponsor Decision|0|||
33548445|NCT01064687|62939717|FG000|Overall Study|Withdrawal by Subject|9|||
33548446|NCT01064687|62939718|FG001|Overall Study|Withdrawal by Subject|7|||
33548447|NCT01064687|62939719|FG002|Overall Study|Withdrawal by Subject|12|||
33548448|NCT01064687|62939720|FG003|Overall Study|Withdrawal by Subject|5|||
33548449|NCT01064687|62939717|FG000|Overall Study|Treatment Noncompliance|1|||
33548450|NCT01064687|62939718|FG001|Overall Study|Treatment Noncompliance|1|||
33548451|NCT01064687|62939719|FG002|Overall Study|Treatment Noncompliance|1|||
33548452|NCT01064687|62939720|FG003|Overall Study|Treatment Noncompliance|0|||
33548453|NCT02493946|62939744|FG000|DB Period|Withdrawal by Subject|8|||
33548454|NCT02493946|62939745|FG001|DB Period|Withdrawal by Subject|5|||
33548455|NCT02493946|62939746|FG002|DB Period|Withdrawal by Subject|0|||
33548456|NCT02493946|62939744|FG000|Open Label Period|Withdrawal by Subject|0|||
33548457|NCT02493946|62939745|FG001|Open Label Period|Withdrawal by Subject|0|||
33548458|NCT02493946|62939746|FG002|Open Label Period|Withdrawal by Subject|74|||
33548459|NCT02493946|62939744|FG000|Open Label Period|Adverse Event|0|||
33548460|NCT02493946|62939745|FG001|Open Label Period|Adverse Event|0|||
33548461|NCT02493946|62939746|FG002|Open Label Period|Adverse Event|4|||
33548462|NCT02493946|62939744|FG000|Open Label Period|Lost to Follow-up|0|||
33548463|NCT02493946|62939745|FG001|Open Label Period|Lost to Follow-up|0|||
33548464|NCT02493946|62939746|FG002|Open Label Period|Lost to Follow-up|1|||
33548465|NCT02493946|62939744|FG000|Open Label Period|Investigator decision, non-compliance|0|||
33548466|NCT02493946|62939745|FG001|Open Label Period|Investigator decision, non-compliance|0|||
33653809|NCT01716104|63066268|FG000|Overall Study|Do not meet inclusion criteria|6|||
33653810|NCT01716104|63066269|FG001|Overall Study|Do not meet inclusion criteria|7|||
33653811|NCT04426695|63066349|FG000|Overall Study|Death|2|||
33468395|NCT00294671|62842083|FG000|Overall Study|Death|0|||
33468396|NCT00294671|62842084|FG001|Overall Study|Death|1|||
33468397|NCT01495598|62842090|FG000|Overall Study|Death during follow up period|2|||
33468398|NCT01495598|62842090|FG000|Overall Study|Death on study|1|||
33468399|NCT01495598|62842090|FG000|Overall Study|Lost to Follow-up|3|||
33468400|NCT01495598|62842090|FG000|Overall Study|Physician Decision|8|||
33468401|NCT02937454|62842121|FG000|Overall Study|Adverse Event|0|||
33468402|NCT02937454|62842122|FG001|Overall Study|Adverse Event|1|||
33468403|NCT02937454|62842121|FG000|Overall Study|Death|98|||
33468404|NCT02937454|62842122|FG001|Overall Study|Death|95|||
33468405|NCT02937454|62842121|FG000|Overall Study|Lost to Follow-up|1|||
33468406|NCT02937454|62842122|FG001|Overall Study|Lost to Follow-up|1|||
33468407|NCT02937454|62842121|FG000|Overall Study|Physician Decision|0|||
33468408|NCT02937454|62842122|FG001|Overall Study|Physician Decision|1|||
33468409|NCT02937454|62842121|FG000|Overall Study|Protocol Violation|6|||
33468410|NCT02937454|62842122|FG001|Overall Study|Protocol Violation|10|||
33468411|NCT02937454|62842121|FG000|Overall Study|Withdrawal by Subject|27|||
33468412|NCT02937454|62842122|FG001|Overall Study|Withdrawal by Subject|15|||
33468413|NCT02937454|62842121|FG000|Overall Study|Other|8|||
33468414|NCT02937454|62842122|FG001|Overall Study|Other|5|||
33468415|NCT03211858|62842141|FG000|Overall Study|Adverse Event|8|||
33468416|NCT03211858|62842142|FG001|Overall Study|Adverse Event|6|||
33468417|NCT03211858|62842141|FG000|Overall Study|Lack of Efficacy|0|||
33468418|NCT03211858|62842142|FG001|Overall Study|Lack of Efficacy|4|||
33468419|NCT03211858|62842141|FG000|Overall Study|Poor compliance to protocol|6|||
33468420|NCT03211858|62842142|FG001|Overall Study|Poor compliance to protocol|2|||
33468421|NCT03211858|62842141|FG000|Overall Study|Non-serious Hypoglycemia|1|||
33468422|NCT03211858|62842142|FG001|Overall Study|Non-serious Hypoglycemia|0|||
33468423|NCT03211858|62842141|FG000|Overall Study|Other than specified above|22|||
33548467|NCT02493946|62939746|FG002|Open Label Period|Investigator decision, non-compliance|2|||
33548468|NCT02493946|62939744|FG000|Open Label Period|Investigator decision, non-availability|0|||
33653812|NCT04426695|63066350|FG001|Overall Study|Death|0|||
33468424|NCT03211858|62842142|FG001|Overall Study|Other than specified above|21|||
33468425|NCT03211156|62842154|FG000|Overall Study|Withdrawal by Subject|0|||
33468426|NCT03211156|62842155|FG001|Overall Study|Withdrawal by Subject|2|||
33468427|NCT03211156|62842154|FG000|Overall Study|Lost to Follow-up|1|||
33548469|NCT02493946|62939745|FG001|Open Label Period|Investigator decision, non-availability|0|||
33548470|NCT02493946|62939746|FG002|Open Label Period|Investigator decision, non-availability|1|||
33548471|NCT02493946|62939744|FG000|Open Label Period|Pregnancy|0|||
33468428|NCT03211156|62842155|FG001|Overall Study|Lost to Follow-up|1|||
33468429|NCT03211156|62842154|FG000|Overall Study|Adverse Event|1|||
33468430|NCT03211156|62842155|FG001|Overall Study|Adverse Event|0|||
33548472|NCT02493946|62939745|FG001|Open Label Period|Pregnancy|0|||
33548473|NCT02493946|62939746|FG002|Open Label Period|Pregnancy|3|||
33548474|NCT02493946|62939744|FG000|Open Label Period|Site error|0|||
33548475|NCT02493946|62939745|FG001|Open Label Period|Site error|0|||
33548476|NCT02493946|62939746|FG002|Open Label Period|Site error|1|||
33548477|NCT01064531|62939756|FG000|Overall Study|Lost to Follow-up|0|||
33548478|NCT01064531|62939757|FG001|Overall Study|Lost to Follow-up|2|||
33548479|NCT01064531|62939756|FG000|Overall Study|Physician Decision|0|||
33548480|NCT01064531|62939757|FG001|Overall Study|Physician Decision|1|||
33548481|NCT01064531|62939756|FG000|Overall Study|Withdrawal by Subject|2|||
33548482|NCT01064531|62939757|FG001|Overall Study|Withdrawal by Subject|2|||
33548483|NCT01064531|62939756|FG000|Overall Study|Revision due to femoral stem loosening|1|||
33548484|NCT01064531|62939757|FG001|Overall Study|Revision due to femoral stem loosening|0|||
33548485|NCT01064531|62939756|FG000|Overall Study|Revision due to dislocation|0|||
33548486|NCT01064531|62939757|FG001|Overall Study|Revision due to dislocation|1|||
33548487|NCT01064531|62939756|FG000|Overall Study|Death|0|||
33548488|NCT01064531|62939757|FG001|Overall Study|Death|1|||
33548489|NCT02220855|62939763|FG000|Overall Study|Adverse Event|8|||
33548490|NCT02220855|62939763|FG000|Overall Study|Disease Progression|5|||
33548491|NCT02220855|62939763|FG000|Overall Study|Withdrawal by Subject|1|||
33548492|NCT02918279|62939769|FG000|Overall Study|Lost to Follow-up|3|||
33548493|NCT02918279|62939770|FG001|Overall Study|Lost to Follow-up|6|||
33548494|NCT02918279|62939769|FG000|Overall Study|Withdrawal by Subject|5|||
33653813|NCT04426695|63066351|FG002|Overall Study|Death|1|||
33653814|NCT04426695|63066352|FG003|Overall Study|Death|27|||
33331793|NCT00833833|62708519|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
33468431|NCT04472494|62842163|FG000|Pre-treatment|Other reasons|2|||
33468432|NCT04472494|62842164|FG001|Pre-treatment|Other reasons|0|||
33468433|NCT04472494|62842163|FG000|Treatment|Death|5|||
33468434|NCT04472494|62842164|FG001|Treatment|Death|2|||
33468435|NCT04472494|62842163|FG000|Treatment|Hospital discharge|1|||
33468436|NCT04472494|62842164|FG001|Treatment|Hospital discharge|1|||
33468437|NCT04419506|62842174|FG000|Overall Study|Adverse Event|0|||
33468438|NCT04419506|62842175|FG001|Overall Study|Adverse Event|10|||
33468439|NCT04419506|62842176|FG002|Overall Study|Adverse Event|0|||
33468440|NCT04419506|62842177|FG003|Overall Study|Adverse Event|3|||
33468441|NCT04419506|62842174|FG000|Overall Study|Withdrawal by Subject|0|||
33468442|NCT04419506|62842175|FG001|Overall Study|Withdrawal by Subject|0|||
33468443|NCT04419506|62842176|FG002|Overall Study|Withdrawal by Subject|0|||
33468444|NCT04419506|62842177|FG003|Overall Study|Withdrawal by Subject|1|||
33468445|NCT04419506|62842174|FG000|Overall Study|poor-compliance|0|||
33468446|NCT04419506|62842175|FG001|Overall Study|poor-compliance|0|||
33468447|NCT04419506|62842176|FG002|Overall Study|poor-compliance|0|||
33468448|NCT04419506|62842177|FG003|Overall Study|poor-compliance|1|||
33468449|NCT03236506|62842190|FG000|Overall Study|Death|1|||
33468450|NCT03236506|62842191|FG001|Overall Study|Death|1|||
33468451|NCT03236506|62842192|FG002|Overall Study|Death|1|||
33468452|NCT03236506|62842190|FG000|Overall Study|Withdrawal by Subject|3|||
33468453|NCT03236506|62842191|FG001|Overall Study|Withdrawal by Subject|3|||
33468454|NCT03236506|62842192|FG002|Overall Study|Withdrawal by Subject|4|||
33548495|NCT02918279|62939770|FG001|Overall Study|Withdrawal by Subject|15|||
33653815|NCT04426695|63066353|FG004|Overall Study|Death|25|||
33653816|NCT04426695|63066354|FG005|Overall Study|Death|21|||
33331794|NCT00833833|62708520|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
33468455|NCT03236506|62842190|FG000|Overall Study|Did not initiate treatment|2|||
33468456|NCT03236506|62842191|FG001|Overall Study|Did not initiate treatment|1|||
33468457|NCT03236506|62842192|FG002|Overall Study|Did not initiate treatment|2|||
33468458|NCT03227692|62842211|FG000|Overall Study|Protocol Violation|1|||
33468459|NCT03227692|62842212|FG001|Overall Study|Protocol Violation|1|||
33468460|NCT03227692|62842211|FG000|Overall Study|Lost to Follow-up|4|||
33468461|NCT03227692|62842212|FG001|Overall Study|Lost to Follow-up|2|||
33548496|NCT02918279|62939769|FG000|Overall Study|Withdrawal by parent/guardian|2|||
33548497|NCT02918279|62939770|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33548498|NCT02918279|62939769|FG000|Overall Study|Other|3|||
33548499|NCT02918279|62939770|FG001|Overall Study|Other|1|||
33653817|NCT04426695|63066355|FG006|Overall Study|Death|42|||
33331795|NCT00833833|62708515|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
33331796|NCT00833833|62708516|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33468462|NCT03227692|62842211|FG000|Overall Study|Adverse Event|0|||
33468463|NCT03227692|62842212|FG001|Overall Study|Adverse Event|2|||
33653818|NCT04426695|63066356|FG007|Overall Study|Death|23|||
33653819|NCT04426695|63066357|FG008|Overall Study|Death|37|||
33653820|NCT04426695|63066358|FG009|Overall Study|Death|14|||
33653821|NCT04426695|63066359|FG010|Overall Study|Death|8|||
33653822|NCT04426695|63066360|FG011|Overall Study|Death|7|||
33653823|NCT04426695|63066361|FG012|Overall Study|Death|13|||
33653824|NCT04426695|63066362|FG013|Overall Study|Death|25|||
33653825|NCT04426695|63066363|FG014|Overall Study|Death|19|||
33653826|NCT04426695|63066364|FG015|Overall Study|Death|7|||
33653827|NCT04426695|63066365|FG016|Overall Study|Death|8|||
33653828|NCT04426695|63066366|FG017|Overall Study|Death|4|||
33653829|NCT04426695|63066349|FG000|Overall Study|Lost to Follow-up|2|||
33653830|NCT04426695|63066350|FG001|Overall Study|Lost to Follow-up|4|||
33653831|NCT04426695|63066351|FG002|Overall Study|Lost to Follow-up|1|||
33653832|NCT04426695|63066352|FG003|Overall Study|Lost to Follow-up|19|||
33653833|NCT04426695|63066353|FG004|Overall Study|Lost to Follow-up|10|||
33653834|NCT04426695|63066354|FG005|Overall Study|Lost to Follow-up|14|||
33653835|NCT04426695|63066355|FG006|Overall Study|Lost to Follow-up|5|||
33653836|NCT04426695|63066356|FG007|Overall Study|Lost to Follow-up|14|||
33653837|NCT04426695|63066357|FG008|Overall Study|Lost to Follow-up|10|||
33653838|NCT04426695|63066358|FG009|Overall Study|Lost to Follow-up|11|||
33653839|NCT04426695|63066359|FG010|Overall Study|Lost to Follow-up|12|||
33653840|NCT04426695|63066360|FG011|Overall Study|Lost to Follow-up|6|||
33653841|NCT04426695|63066361|FG012|Overall Study|Lost to Follow-up|2|||
33653842|NCT04426695|63066362|FG013|Overall Study|Lost to Follow-up|2|||
33653843|NCT04426695|63066363|FG014|Overall Study|Lost to Follow-up|2|||
33653844|NCT04426695|63066364|FG015|Overall Study|Lost to Follow-up|0|||
33653845|NCT04426695|63066365|FG016|Overall Study|Lost to Follow-up|0|||
33653846|NCT04426695|63066366|FG017|Overall Study|Lost to Follow-up|0|||
33653847|NCT04426695|63066349|FG000|Overall Study|Participant Decision|1|||
33653848|NCT04426695|63066350|FG001|Overall Study|Participant Decision|2|||
33468464|NCT03210220|62842220|FG000|Overall Study|Physician Decision|1|||
33468465|NCT03210220|62842221|FG001|Overall Study|Physician Decision|0|||
33468466|NCT03209518|62842227|FG000|Overall Study|Case Report Forms Uncollected|1|||
33468467|NCT03209518|62842227|FG000|Overall Study|Protocol Deviation|1|||
33468468|NCT03725852|62842233|FG000|Overall Study|Death|1|||
33468469|NCT03725852|62842234|FG001|Overall Study|Death|0|||
33468470|NCT03725852|62842233|FG000|Overall Study|Withdrawal by Subject|1|||
33468471|NCT03725852|62842234|FG001|Overall Study|Withdrawal by Subject|0|||
33468472|NCT03725852|62842233|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
33653849|NCT04426695|63066351|FG002|Overall Study|Participant Decision|2|||
33653850|NCT04426695|63066352|FG003|Overall Study|Participant Decision|12|||
33653851|NCT04426695|63066353|FG004|Overall Study|Participant Decision|18|||
33653852|NCT04426695|63066354|FG005|Overall Study|Participant Decision|22|||
33653853|NCT04426695|63066355|FG006|Overall Study|Participant Decision|13|||
33653854|NCT04426695|63066356|FG007|Overall Study|Participant Decision|13|||
33653855|NCT04426695|63066357|FG008|Overall Study|Participant Decision|10|||
33653856|NCT04426695|63066358|FG009|Overall Study|Participant Decision|15|||
33653857|NCT04426695|63066359|FG010|Overall Study|Participant Decision|16|||
33653858|NCT04426695|63066360|FG011|Overall Study|Participant Decision|17|||
33653859|NCT04426695|63066361|FG012|Overall Study|Participant Decision|2|||
33653860|NCT04426695|63066362|FG013|Overall Study|Participant Decision|1|||
33653861|NCT04426695|63066363|FG014|Overall Study|Participant Decision|2|||
33653862|NCT04426695|63066364|FG015|Overall Study|Participant Decision|0|||
33653863|NCT04426695|63066365|FG016|Overall Study|Participant Decision|0|||
33653864|NCT04426695|63066366|FG017|Overall Study|Participant Decision|0|||
33653865|NCT04426695|63066349|FG000|Overall Study|Adverse Event|0|||
33653866|NCT04426695|63066350|FG001|Overall Study|Adverse Event|0|||
33653867|NCT04426695|63066351|FG002|Overall Study|Adverse Event|0|||
33653868|NCT04426695|63066352|FG003|Overall Study|Adverse Event|0|||
33653869|NCT04426695|63066353|FG004|Overall Study|Adverse Event|0|||
33653870|NCT04426695|63066354|FG005|Overall Study|Adverse Event|0|||
33468473|NCT03725852|62842234|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
33468474|NCT00304031|62842243|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
33468475|NCT00304031|62842244|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
33468476|NCT00304031|62842245|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
33468477|NCT00304031|62842243|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
33468478|NCT00304031|62842244|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
33468479|NCT00304031|62842245|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
33468480|NCT00304031|62842243|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
33468481|NCT00304031|62842244|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
33468482|NCT00304031|62842245|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
33468483|NCT00304031|62842243|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
33468484|NCT00304031|62842244|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
33468485|NCT00304031|62842245|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
33468486|NCT00304031|62842243|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
33468487|NCT00304031|62842244|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
33468488|NCT00304031|62842245|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
33468489|NCT00304031|62842243|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
33468490|NCT00304031|62842244|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
33468491|NCT00304031|62842245|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
33468492|NCT00304031|62842243|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
33468493|NCT00304031|62842244|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
33468494|NCT00304031|62842245|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
33468495|NCT00304031|62842243|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
33468496|NCT00304031|62842244|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
33468497|NCT00304031|62842245|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
33468498|NCT00304031|62842243|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
33468499|NCT00304031|62842244|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
33468500|NCT00304031|62842245|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
33468501|NCT00332189|62842260|FG000|Overall Study|Adverse Event|3|||
33468502|NCT00332189|62842260|FG000|Overall Study|Uncooperative/Noncompliant|3|||
33468503|NCT00332189|62842260|FG000|Overall Study|Withdrawal by Subject|9|||
33468504|NCT00332189|62842260|FG000|Overall Study|Lack of Efficacy|4|||
33468505|NCT00332189|62842260|FG000|Overall Study|Moved out of country|2|||
33468506|NCT00331799|62842265|FG000|Overall Study|Withdrawal by Subject|2|||
33468507|NCT00331799|62842265|FG000|Overall Study|Sedation|1|||
33468508|NCT00303719|62842271|FG000|Overall Study|Not evaluable, prior therapies|0|||
33468509|NCT00303719|62842272|FG001|Overall Study|Not evaluable, prior therapies|30|||
33468510|NCT00303719|62842271|FG000|Overall Study|Lost to Follow-up|0|||
33468511|NCT00303719|62842272|FG001|Overall Study|Lost to Follow-up|7|||
33468512|NCT00331409|62842279|FG000|Overall Study|Lack of Efficacy|4|||
33468513|NCT00303485|62842285|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
33468514|NCT00303485|62842286|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
33468515|NCT00303485|62842285|FG000|Overall Study|Failure to return|0|||
33468516|NCT00303485|62842286|FG001|Overall Study|Failure to return|1|||
33468517|NCT00303485|62842285|FG000|Overall Study|Withdrawal by Subject|1|||
33468518|NCT00303485|62842286|FG001|Overall Study|Withdrawal by Subject|0|||
33468519|NCT03235726|62842300|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33468520|NCT03235726|62842301|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33468521|NCT03235726|62842302|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33468522|NCT03235726|62842303|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33468523|NCT03235726|62842304|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
33468524|NCT03235726|62842305|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33468525|NCT03235726|62842306|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33468526|NCT03235726|62842307|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33468527|NCT03235726|62842308|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33468528|NCT03235726|62842309|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33468529|NCT03235726|62842300|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33468530|NCT03235726|62842301|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33468531|NCT03235726|62842302|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33468532|NCT03235726|62842303|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33468533|NCT03235726|62842304|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
33468534|NCT03235726|62842305|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33468535|NCT03235726|62842306|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33468536|NCT03235726|62842307|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33468537|NCT03235726|62842308|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33468538|NCT03235726|62842309|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33468539|NCT00303953|62842344|FG000|Overall Study|Ineligible|1|||
33468540|NCT00303953|62842344|FG000|Overall Study|Death|1|||
33468541|NCT00303953|62842344|FG000|Overall Study|Adverse Event|4|||
33468542|NCT00303953|62842344|FG000|Overall Study|Lack of Efficacy|12|||
33468543|NCT00303953|62842344|FG000|Overall Study|Physician Decision|1|||
33468544|NCT02935894|62842348|FG000|Overall Study|Subject dismissed|1|||
33468545|NCT03224182|62842354|FG000|Overall Study|Study Drug Not Instilled|6|||
33468546|NCT03224182|62842355|FG001|Overall Study|Study Drug Not Instilled|1|||
33468547|NCT03224182|62842354|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
33468548|NCT03224182|62842355|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
33468549|NCT03224182|62842354|FG000|Overall Study|Withdrew of Consent|4|||
33468550|NCT03224182|62842355|FG001|Overall Study|Withdrew of Consent|2|||
33468551|NCT03224182|62842354|FG000|Overall Study|Investigator Decision|3|||
33468552|NCT03224182|62842355|FG001|Overall Study|Investigator Decision|1|||
33468553|NCT03224182|62842354|FG000|Overall Study|Sponsor Decision|26|||
33468554|NCT03224182|62842355|FG001|Overall Study|Sponsor Decision|12|||
33468555|NCT03224182|62842354|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
33468556|NCT03224182|62842355|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
33468557|NCT03224182|62842354|FG000|Overall Study|Lost to Follow-up|1|||
33468558|NCT03224182|62842355|FG001|Overall Study|Lost to Follow-up|0|||
33548500|NCT02956837|62939780|FG000|Overall Study|Serious Adverse Events|0|||
33548501|NCT02956837|62939781|FG001|Overall Study|Serious Adverse Events|1|||
33548502|NCT02956837|62939782|FG002|Overall Study|Serious Adverse Events|0|||
33548503|NCT02956837|62939783|FG003|Overall Study|Serious Adverse Events|0|||
33548504|NCT02956837|62939780|FG000|Overall Study|Withdrawal by Subject|0|||
33548505|NCT02956837|62939781|FG001|Overall Study|Withdrawal by Subject|1|||
33548506|NCT02956837|62939782|FG002|Overall Study|Withdrawal by Subject|0|||
33548507|NCT02956837|62939783|FG003|Overall Study|Withdrawal by Subject|3|||
33548508|NCT02956837|62939780|FG000|Overall Study|Lost to Follow-up|0|||
33548509|NCT02956837|62939781|FG001|Overall Study|Lost to Follow-up|1|||
33548510|NCT02956837|62939782|FG002|Overall Study|Lost to Follow-up|2|||
33548511|NCT02956837|62939783|FG003|Overall Study|Lost to Follow-up|0|||
33548512|NCT01063595|62939796|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
33548513|NCT01063595|62939797|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
33548514|NCT01063595|62939796|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
33548515|NCT01063595|62939797|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
33548516|NCT01063595|62939796|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
33548517|NCT01063595|62939797|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
33548518|NCT01063595|62939796|FG000|First Intervention|Adverse Event|1|||
33548519|NCT01063595|62939797|FG001|First Intervention|Adverse Event|4|||
33548520|NCT01063595|62939796|FG000|First Intervention|Withdrawal by Subject|1|||
33548521|NCT01063595|62939797|FG001|First Intervention|Withdrawal by Subject|0|||
33548522|NCT01063595|62939796|FG000|First Intervention|Reason not Specified|0|||
33548523|NCT01063595|62939797|FG001|First Intervention|Reason not Specified|1|||
33468559|NCT03224182|62842354|FG000|Overall Study|Participant Had Recurrence|11|||
33468560|NCT03224182|62842355|FG001|Overall Study|Participant Had Recurrence|5|||
33468561|NCT03224182|62842354|FG000|Overall Study|Death|0|||
33468562|NCT03224182|62842355|FG001|Overall Study|Death|1|||
33468563|NCT03224182|62842354|FG000|Overall Study|Reason not Specified|3|||
33468564|NCT03224182|62842355|FG001|Overall Study|Reason not Specified|3|||
33468565|NCT03224182|62842354|FG000|Overall Study|Other|1|||
33468566|NCT03224182|62842355|FG001|Overall Study|Other|0|||
33468567|NCT02935192|62842363|FG000|Overall Study|Withdrawal by Subject|8|||
33468568|NCT02935192|62842364|FG001|Overall Study|Withdrawal by Subject|4|||
33468569|NCT03722264|62842370|FG000|Overall Study|Physician Decision|3|||
33468570|NCT03722030|62842378|FG000|Overall Study|Withdrawal by Subject|1|||
33468571|NCT03722030|62842379|FG001|Overall Study|Withdrawal by Subject|0|||
33653871|NCT04426695|63066355|FG006|Overall Study|Adverse Event|0|||
33653872|NCT04426695|63066356|FG007|Overall Study|Adverse Event|1|||
33468572|NCT03221842|62842386|FG000|Period 1 (Open-label)|Adverse Event|4|||
33468573|NCT03221842|62842387|FG001|Period 1 (Open-label)|Adverse Event|0|||
33468574|NCT03221842|62842386|FG000|Period 1 (Open-label)|Physician Decision|2|||
33468575|NCT03221842|62842387|FG001|Period 1 (Open-label)|Physician Decision|0|||
33468576|NCT03221842|62842386|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
33468577|NCT03221842|62842387|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
33468578|NCT03221842|62842386|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
33468579|NCT03221842|62842387|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
33468580|NCT03221842|62842386|FG000|Period 1 (Open-label)|Other|2|||
33548524|NCT01063283|62939805|FG000|Cycle 1|Adverse Event|2|||
33548525|NCT01063283|62939806|FG001|Cycle 1|Adverse Event|0|||
33548526|NCT01063283|62939807|FG002|Cycle 1|Adverse Event|0|||
33548527|NCT01063283|62939805|FG000|Cycle 1|Technical failure in data collection|1|||
33548528|NCT01063283|62939806|FG001|Cycle 1|Technical failure in data collection|0|||
33548529|NCT01063283|62939807|FG002|Cycle 1|Technical failure in data collection|0|||
33548530|NCT01062971|62939815|FG000|Overall Study|Protocol Violation|1|||
33548531|NCT01062971|62939816|FG001|Overall Study|Protocol Violation|3|||
33548532|NCT01062971|62939815|FG000|Overall Study|Lost to Follow-up|3|||
33548533|NCT01062971|62939816|FG001|Overall Study|Lost to Follow-up|4|||
33548534|NCT01348165|62939829|FG000|Overall Study|Adverse Event|0|||
33468581|NCT03221842|62842387|FG001|Period 1 (Open-label)|Other|0|||
33468582|NCT03221842|62842386|FG000|Period 2 (Randomized, Blinded)|Death|0|||
33468583|NCT03221842|62842387|FG001|Period 2 (Randomized, Blinded)|Death|1|||
33468584|NCT03221842|62842386|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
33468585|NCT03221842|62842387|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
33468586|NCT03364738|62842397|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
33468587|NCT03364738|62842397|FG000|Overall Study|Withdrawal by Subject|1|||
33468588|NCT03364738|62842397|FG000|Overall Study|Adverse Event|1|||
33468589|NCT00303329|62842404|FG000|Overall Study|Adverse Event|7|||
33468590|NCT00303329|62842405|FG001|Overall Study|Adverse Event|14|||
33468591|NCT00303329|62842404|FG000|Overall Study|Abnormal Laboratory Values|0|||
33468592|NCT00303329|62842405|FG001|Overall Study|Abnormal Laboratory Values|1|||
33468593|NCT00303329|62842404|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
33548535|NCT01348165|62939830|FG001|Overall Study|Adverse Event|0|||
33548536|NCT01348165|62939831|FG002|Overall Study|Adverse Event|0|||
33548537|NCT01348165|62939832|FG003|Overall Study|Adverse Event|0|||
33548538|NCT01348165|62939833|FG004|Overall Study|Adverse Event|0|||
33548539|NCT01348165|62939834|FG005|Overall Study|Adverse Event|0|||
33548540|NCT01348165|62939835|FG006|Overall Study|Adverse Event|1|||
33653873|NCT04426695|63066357|FG008|Overall Study|Adverse Event|0|||
33653874|NCT04426695|63066358|FG009|Overall Study|Adverse Event|0|||
33331797|NCT00833833|62708517|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
33331798|NCT00833833|62708518|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33331799|NCT00833833|62708519|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33331800|NCT00833833|62708520|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33331801|NCT00833833|62708515|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
33331802|NCT00833833|62708516|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
33331803|NCT00833833|62708517|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
33331804|NCT00833833|62708518|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
33331805|NCT00833833|62708519|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
33331806|NCT00833833|62708520|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
33331807|NCT00833833|62708515|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
33331808|NCT00833833|62708516|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
33331809|NCT00833833|62708517|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
33468594|NCT00303329|62842405|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33468595|NCT00303329|62842404|FG000|Overall Study|Condition no longer requires study drug|0|||
33468596|NCT00303329|62842405|FG001|Overall Study|Condition no longer requires study drug|8|||
33468597|NCT00303329|62842404|FG000|Overall Study|Protocol Violation|3|||
33468598|NCT00303329|62842405|FG001|Overall Study|Protocol Violation|0|||
33468599|NCT00303329|62842404|FG000|Overall Study|Withdrawal by Subject|9|||
33468600|NCT00303329|62842405|FG001|Overall Study|Withdrawal by Subject|15|||
33468601|NCT00303329|62842404|FG000|Overall Study|Lost to Follow-up|0|||
33468602|NCT00303329|62842405|FG001|Overall Study|Lost to Follow-up|1|||
33468603|NCT00303329|62842404|FG000|Overall Study|Administrative problems|1|||
33468604|NCT00303329|62842405|FG001|Overall Study|Administrative problems|0|||
33468605|NCT00303329|62842404|FG000|Overall Study|Death|2|||
33468606|NCT00303329|62842405|FG001|Overall Study|Death|12|||
33468607|NCT00303329|62842404|FG000|Overall Study|Stopped at end of core|3|||
33468608|NCT00303329|62842405|FG001|Overall Study|Stopped at end of core|9|||
33468609|NCT00303329|62842404|FG000|Overall Study|Stopped at end of extension 1|1|||
33468610|NCT00303329|62842405|FG001|Overall Study|Stopped at end of extension 1|0|||
33468611|NCT00329849|62842413|FG000|Overall Study|Withdrawal by Subject|6|||
33468612|NCT00329849|62842414|FG001|Overall Study|Withdrawal by Subject|4|||
33468613|NCT02934178|62842426|FG000|Received Vaccination 2|Death|0|||
33468614|NCT02934178|62842427|FG001|Received Vaccination 2|Death|1|||
33468615|NCT02934178|62842426|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
33468616|NCT02934178|62842427|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
33468617|NCT00329303|62842436|FG000|Overall Study|Lack of Efficacy|1|||
33468618|NCT00329303|62842437|FG001|Overall Study|Lack of Efficacy|0|||
33548541|NCT02493868|62939855|FG000|Induction Phase: DE Participants|Adverse Event|22|||
33331810|NCT00833833|62708518|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
33468619|NCT00329303|62842436|FG000|Overall Study|Decision of the sponsor|0|||
33468620|NCT00329303|62842437|FG001|Overall Study|Decision of the sponsor|1|||
33468621|NCT00329303|62842436|FG000|Overall Study|Patient no longer available|1|||
33468622|NCT00329303|62842437|FG001|Overall Study|Patient no longer available|0|||
33548542|NCT02493868|62939856|FG001|Induction Phase: DE Participants|Adverse Event|0|||
33653875|NCT04426695|63066359|FG010|Overall Study|Adverse Event|1|||
33548543|NCT02493868|62939855|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
33548544|NCT02493868|62939856|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
33331811|NCT00833833|62708519|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
33331812|NCT00833833|62708520|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
33331813|NCT00833833|62708515|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
33331814|NCT00833833|62708516|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
33331815|NCT00833833|62708517|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
33331816|NCT00833833|62708518|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
33331817|NCT00833833|62708519|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
33331818|NCT00833833|62708520|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
33331819|NCT00833833|62708515|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
33331820|NCT00833833|62708516|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
33331821|NCT00833833|62708517|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
33331822|NCT00833833|62708518|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
33331823|NCT00833833|62708519|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
33331824|NCT00833833|62708520|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
33331825|NCT00833833|62708515|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33331826|NCT00833833|62708516|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33331827|NCT00833833|62708517|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33653876|NCT04426695|63066360|FG011|Overall Study|Adverse Event|1|||
33331828|NCT00833833|62708518|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33331829|NCT00833833|62708519|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
33331830|NCT00833833|62708520|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
33653877|NCT04426695|63066361|FG012|Overall Study|Adverse Event|0|||
33331831|NCT00833833|62708515|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
33331832|NCT00833833|62708516|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
33331833|NCT00833833|62708517|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
33331834|NCT00833833|62708518|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
33331835|NCT00833833|62708519|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
33331836|NCT00833833|62708520|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
33331837|NCT00833833|62708515|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
33331838|NCT00833833|62708516|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
33331839|NCT00833833|62708517|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
33331840|NCT00833833|62708518|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
33331841|NCT00833833|62708519|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
33331842|NCT00833833|62708520|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
33331843|NCT00833833|62708515|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
33331844|NCT00833833|62708516|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
33331845|NCT00833833|62708517|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
33331846|NCT00833833|62708518|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
33331847|NCT00833833|62708519|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
33331848|NCT00833833|62708520|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
33331849|NCT01098071|62708540|FG000|Overall Study|Surgery (adenoidectomy)|2|||
33331850|NCT01098071|62708540|FG000|Overall Study|Lost to Follow-up|13|||
33331851|NCT01097057|62708544|FG000|Overall Study|Physician Decision|3|||
33331852|NCT01022112|62708553|FG000|Overall Study|Adverse Event|1|||
33331853|NCT01022112|62708554|FG001|Overall Study|Adverse Event|2|||
33331854|NCT01022112|62708555|FG002|Overall Study|Adverse Event|0|||
33331855|NCT01022112|62708556|FG003|Overall Study|Adverse Event|1|||
33331856|NCT01022112|62708557|FG004|Overall Study|Adverse Event|0|||
33468623|NCT00329303|62842436|FG000|Overall Study|Patient relocated|0|||
33653878|NCT04426695|63066362|FG013|Overall Study|Adverse Event|0|||
33653879|NCT04426695|63066363|FG014|Overall Study|Adverse Event|0|||
33331857|NCT01022112|62708553|FG000|Overall Study|Lack of Efficacy|1|||
33468624|NCT00329303|62842437|FG001|Overall Study|Patient relocated|1|||
33653880|NCT04426695|63066364|FG015|Overall Study|Adverse Event|0|||
33653881|NCT04426695|63066365|FG016|Overall Study|Adverse Event|0|||
33331858|NCT01022112|62708554|FG001|Overall Study|Lack of Efficacy|0|||
33331859|NCT01022112|62708555|FG002|Overall Study|Lack of Efficacy|0|||
33331860|NCT01022112|62708556|FG003|Overall Study|Lack of Efficacy|0|||
33331861|NCT01022112|62708557|FG004|Overall Study|Lack of Efficacy|1|||
33653882|NCT04426695|63066366|FG017|Overall Study|Adverse Event|0|||
33468625|NCT03216850|62842444|FG000|Overall Study|Pre-analytical error|6|||
33468626|NCT00302159|62842448|FG000|Overall Study|pt declined before treatment started|1|||
33468627|NCT00302159|62842448|FG000|Overall Study|pt started Avastin|1|||
33468628|NCT00302081|62842456|FG000|Overall Study|Adverse Event|6|||
33468629|NCT00302081|62842457|FG001|Overall Study|Adverse Event|5|||
33468630|NCT00302081|62842458|FG002|Overall Study|Adverse Event|4|||
33468631|NCT00302081|62842456|FG000|Overall Study|Lost to Follow-up|21|||
33468632|NCT00302081|62842457|FG001|Overall Study|Lost to Follow-up|18|||
33468633|NCT00302081|62842458|FG002|Overall Study|Lost to Follow-up|28|||
33468634|NCT00302081|62842456|FG000|Overall Study|Withdrawal by Subject|8|||
33468635|NCT00302081|62842457|FG001|Overall Study|Withdrawal by Subject|12|||
33468636|NCT00302081|62842458|FG002|Overall Study|Withdrawal by Subject|8|||
33468637|NCT00302081|62842456|FG000|Overall Study|Protocol Violation|5|||
33468638|NCT00302081|62842457|FG001|Overall Study|Protocol Violation|1|||
33468639|NCT00302081|62842458|FG002|Overall Study|Protocol Violation|2|||
33468640|NCT00302081|62842456|FG000|Overall Study|Lack of Efficacy|1|||
33468641|NCT00302081|62842457|FG001|Overall Study|Lack of Efficacy|0|||
33468642|NCT00302081|62842458|FG002|Overall Study|Lack of Efficacy|5|||
33468643|NCT00302081|62842456|FG000|Overall Study|Death|2|||
33468644|NCT00302081|62842457|FG001|Overall Study|Death|1|||
33468645|NCT00302081|62842458|FG002|Overall Study|Death|0|||
33468646|NCT00302081|62842456|FG000|Overall Study|Other|13|||
33468647|NCT00302081|62842457|FG001|Overall Study|Other|6|||
33468648|NCT00302081|62842458|FG002|Overall Study|Other|5|||
33468649|NCT00302003|62842466|FG000|Overall Study|Lack of Efficacy|62|||
33468650|NCT00302003|62842466|FG000|Overall Study|Lost to Follow-up|1|||
33468651|NCT00302003|62842466|FG000|Overall Study|Physician Decision|2|||
33468652|NCT00302003|62842466|FG000|Overall Study|Withdrawal by Subject|5|||
33468653|NCT00302003|62842466|FG000|Overall Study|Ineligible|9|||
33468654|NCT00302003|62842466|FG000|Overall Study|Protocol Violation|1|||
33468655|NCT00036270|62842472|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
33468656|NCT00036270|62842473|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
33468657|NCT00036270|62842472|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
33468658|NCT00036270|62842473|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
33468659|NCT00036270|62842472|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
33468660|NCT00036270|62842473|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
33468661|NCT00036270|62842472|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
33468662|NCT00036270|62842473|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
33468663|NCT00036270|62842472|FG000|Study Treatment to 5 Year Report|Other|277|||
33468664|NCT00036270|62842473|FG001|Study Treatment to 5 Year Report|Other|288|||
33468665|NCT00036270|62842472|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
33468666|NCT00036270|62842473|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
33468667|NCT00036270|62842472|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
33468668|NCT00036270|62842473|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
33468669|NCT00036270|62842472|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
33468670|NCT00036270|62842473|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
33468671|NCT00036270|62842472|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
33468672|NCT00036270|62842473|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
33468673|NCT00036270|62842472|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
33468674|NCT00036270|62842473|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
33468675|NCT00036270|62842472|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
33653883|NCT04426695|63066349|FG000|Overall Study|Sponsor Request|0|||
33331862|NCT01022112|62708553|FG000|Overall Study|Physician Decision|0|||
33331863|NCT01022112|62708554|FG001|Overall Study|Physician Decision|0|||
33331864|NCT01022112|62708555|FG002|Overall Study|Physician Decision|1|||
33331865|NCT01022112|62708556|FG003|Overall Study|Physician Decision|0|||
33331866|NCT01022112|62708557|FG004|Overall Study|Physician Decision|1|||
33331867|NCT01022112|62708553|FG000|Overall Study|Withdrawal by Subject|0|||
33331868|NCT01022112|62708554|FG001|Overall Study|Withdrawal by Subject|1|||
33331869|NCT01022112|62708555|FG002|Overall Study|Withdrawal by Subject|2|||
33331870|NCT01022112|62708556|FG003|Overall Study|Withdrawal by Subject|2|||
33331871|NCT01022112|62708557|FG004|Overall Study|Withdrawal by Subject|1|||
33331872|NCT01022112|62708553|FG000|Overall Study|Fasting plasma glucose level increased|1|||
33468676|NCT00036270|62842473|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
33468677|NCT00301067|62842479|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
33468678|NCT00301067|62842480|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
33468679|NCT00301067|62842481|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
33468680|NCT00301067|62842482|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
33468681|NCT00301067|62842479|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
33468682|NCT00301067|62842480|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
33468683|NCT00301067|62842481|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
33468684|NCT00301067|62842482|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
33468685|NCT00301067|62842479|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
33468686|NCT00301067|62842480|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
33468687|NCT00301067|62842481|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
33468688|NCT00301067|62842482|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
33468689|NCT00301067|62842479|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
33468690|NCT00301067|62842480|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
33468691|NCT00301067|62842481|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
33468692|NCT00301067|62842482|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
33468693|NCT00301067|62842479|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
33548545|NCT02493868|62939855|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
33548546|NCT02493868|62939856|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
33548547|NCT02493868|62939855|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
33468694|NCT00301067|62842480|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
33468695|NCT00301067|62842481|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
33468696|NCT00301067|62842482|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
33468697|NCT00301067|62842479|FG000|Follow up Until Death|Alive at last data cut point|1|||
33468698|NCT00301067|62842480|FG001|Follow up Until Death|Alive at last data cut point|0|||
33468699|NCT00301067|62842481|FG002|Follow up Until Death|Alive at last data cut point|0|||
33468700|NCT00301067|62842482|FG003|Follow up Until Death|Alive at last data cut point|1|||
33468701|NCT00007020|62842493|FG000|Overall Study|Death|16|||
33468702|NCT00007020|62842493|FG000|Overall Study|Lost to Follow-up|13|||
33468703|NCT00007020|62842493|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
33468704|NCT00007020|62842493|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
33468705|NCT00007020|62842493|FG000|Overall Study|Pt cared for by outside physician|4|||
33468706|NCT00007020|62842493|FG000|Overall Study|No evidence of treatment|6|||
33468707|NCT00300755|62842502|FG000|Overall Study|Adverse Event|1|||
33468708|NCT00300755|62842503|FG001|Overall Study|Adverse Event|2|||
33468709|NCT00300755|62842504|FG002|Overall Study|Adverse Event|1|||
33468710|NCT00300755|62842502|FG000|Overall Study|Withdrawal by Subject|0|||
33468711|NCT00300755|62842503|FG001|Overall Study|Withdrawal by Subject|2|||
33468712|NCT00300755|62842504|FG002|Overall Study|Withdrawal by Subject|0|||
33468713|NCT00300755|62842502|FG000|Overall Study|Protocol Violation|0|||
33468714|NCT00300755|62842503|FG001|Overall Study|Protocol Violation|0|||
33468715|NCT00300755|62842504|FG002|Overall Study|Protocol Violation|1|||
33468716|NCT00033540|62842512|FG000|Overall Study|Adverse Event|14|||
33468717|NCT00033540|62842512|FG000|Overall Study|Death|1|||
33468718|NCT00033540|62842512|FG000|Overall Study|Progression|26|||
33468719|NCT00033540|62842512|FG000|Overall Study|Withdrawal by Subject|6|||
33468720|NCT00033540|62842512|FG000|Overall Study|Other|5|||
33548548|NCT02493868|62939856|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
33548549|NCT02493868|62939855|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
33548550|NCT02493868|62939856|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
33653884|NCT04426695|63066350|FG001|Overall Study|Sponsor Request|0|||
33653885|NCT04426695|63066351|FG002|Overall Study|Sponsor Request|0|||
33653886|NCT04426695|63066352|FG003|Overall Study|Sponsor Request|0|||
33653887|NCT04426695|63066353|FG004|Overall Study|Sponsor Request|0|||
33653888|NCT04426695|63066354|FG005|Overall Study|Sponsor Request|0|||
33653889|NCT04426695|63066355|FG006|Overall Study|Sponsor Request|1|||
33653890|NCT04426695|63066356|FG007|Overall Study|Sponsor Request|0|||
33653891|NCT04426695|63066357|FG008|Overall Study|Sponsor Request|0|||
33653892|NCT04426695|63066358|FG009|Overall Study|Sponsor Request|0|||
33331873|NCT01022112|62708554|FG001|Overall Study|Fasting plasma glucose level increased|0|||
33331874|NCT01022112|62708555|FG002|Overall Study|Fasting plasma glucose level increased|0|||
33468721|NCT00033540|62842512|FG000|Overall Study|Ineligible|3|||
33468722|NCT00033540|62842512|FG000|Overall Study|Never received treatment|2|||
33468723|NCT00300365|62842519|FG000|Overall Study|Lost to Follow-up|1|||
33468724|NCT00300365|62842520|FG001|Overall Study|Lost to Follow-up|0|||
33468725|NCT00300365|62842519|FG000|Overall Study|Physician Decision|2|||
33468726|NCT00300365|62842520|FG001|Overall Study|Physician Decision|0|||
33468727|NCT00300365|62842519|FG000|Overall Study|Withdrawal by Subject|1|||
33468728|NCT00300365|62842520|FG001|Overall Study|Withdrawal by Subject|0|||
33468729|NCT00300365|62842519|FG000|Overall Study|Adverse Event|0|||
33468730|NCT00300365|62842520|FG001|Overall Study|Adverse Event|2|||
33468731|NCT00048048|62842535|FG000|Core Treatment|Withdrawal by Subject|0|||
33468732|NCT00048048|62842536|FG001|Core Treatment|Withdrawal by Subject|0|||
33468733|NCT00048048|62842537|FG002|Core Treatment|Withdrawal by Subject|1|||
33468734|NCT00048048|62842538|FG003|Core Treatment|Withdrawal by Subject|0|||
33468735|NCT00048048|62842539|FG004|Core Treatment|Withdrawal by Subject|0|||
33468736|NCT00048048|62842540|FG005|Core Treatment|Withdrawal by Subject|0|||
33468737|NCT00048048|62842541|FG006|Core Treatment|Withdrawal by Subject|0|||
33468738|NCT00048048|62842542|FG007|Core Treatment|Withdrawal by Subject|0|||
33468739|NCT00048048|62842543|FG008|Core Treatment|Withdrawal by Subject|0|||
33468740|NCT00048048|62842544|FG009|Core Treatment|Withdrawal by Subject|0|||
33653893|NCT04426695|63066359|FG010|Overall Study|Sponsor Request|0|||
33653894|NCT04426695|63066360|FG011|Overall Study|Sponsor Request|0|||
33331875|NCT01022112|62708556|FG003|Overall Study|Fasting plasma glucose level increased|0|||
33331876|NCT01022112|62708557|FG004|Overall Study|Fasting plasma glucose level increased|7|||
33331877|NCT01096667|62708574|FG000|Overall Study|Lost to Follow-up|1|||
33331878|NCT01096667|62708575|FG001|Overall Study|Lost to Follow-up|1|||
33331879|NCT01096667|62708576|FG002|Overall Study|Lost to Follow-up|1|||
33331880|NCT01096667|62708577|FG003|Overall Study|Lost to Follow-up|0|||
33331881|NCT01096667|62708578|FG004|Overall Study|Lost to Follow-up|0|||
33331882|NCT01096667|62708574|FG000|Overall Study|Withdrawal by Subject|1|||
33331883|NCT01096667|62708575|FG001|Overall Study|Withdrawal by Subject|0|||
33331884|NCT01096667|62708576|FG002|Overall Study|Withdrawal by Subject|0|||
33331885|NCT01096667|62708577|FG003|Overall Study|Withdrawal by Subject|1|||
33331886|NCT01096667|62708578|FG004|Overall Study|Withdrawal by Subject|0|||
33331887|NCT01096667|62708574|FG000|Overall Study|Reason not available|0|||
33331888|NCT01096667|62708575|FG001|Overall Study|Reason not available|1|||
33331889|NCT01096667|62708576|FG002|Overall Study|Reason not available|1|||
33331890|NCT01096667|62708577|FG003|Overall Study|Reason not available|1|||
33331891|NCT01096667|62708578|FG004|Overall Study|Reason not available|0|||
33331892|NCT01096667|62708574|FG000|Overall Study|Protocol Violation|0|||
33331893|NCT01096667|62708575|FG001|Overall Study|Protocol Violation|0|||
33331894|NCT01096667|62708576|FG002|Overall Study|Protocol Violation|0|||
33331895|NCT01096667|62708577|FG003|Overall Study|Protocol Violation|1|||
33331896|NCT01096667|62708578|FG004|Overall Study|Protocol Violation|0|||
33331897|NCT01096667|62708574|FG000|Overall Study|Not treated|1|||
33331898|NCT01096667|62708575|FG001|Overall Study|Not treated|0|||
33331899|NCT01096667|62708576|FG002|Overall Study|Not treated|0|||
33331900|NCT01096667|62708577|FG003|Overall Study|Not treated|0|||
33331901|NCT01096667|62708578|FG004|Overall Study|Not treated|0|||
33331902|NCT01014624|62708593|FG000|Overall Study|Adverse Event|0|||
33331903|NCT01014624|62708594|FG001|Overall Study|Adverse Event|1|||
33331904|NCT01014624|62708593|FG000|Overall Study|Protocol Violation|1|||
33468741|NCT00048048|62842545|FG010|Core Treatment|Withdrawal by Subject|0|||
33468742|NCT00048048|62842546|FG011|Core Treatment|Withdrawal by Subject|0|||
33468743|NCT00048048|62842535|FG000|Core Treatment|Adverse Event|0|||
33468744|NCT00048048|62842536|FG001|Core Treatment|Adverse Event|0|||
33653895|NCT04426695|63066361|FG012|Overall Study|Sponsor Request|0|||
33653896|NCT04426695|63066362|FG013|Overall Study|Sponsor Request|0|||
33653897|NCT04426695|63066363|FG014|Overall Study|Sponsor Request|0|||
33653898|NCT04426695|63066364|FG015|Overall Study|Sponsor Request|0|||
33653899|NCT04426695|63066365|FG016|Overall Study|Sponsor Request|0|||
33653900|NCT04426695|63066366|FG017|Overall Study|Sponsor Request|0|||
33653901|NCT04426695|63066349|FG000|Overall Study|Physician Decision|0|||
33653902|NCT04426695|63066350|FG001|Overall Study|Physician Decision|0|||
33653903|NCT04426695|63066351|FG002|Overall Study|Physician Decision|0|||
33653904|NCT04426695|63066352|FG003|Overall Study|Physician Decision|0|||
33653905|NCT04426695|63066353|FG004|Overall Study|Physician Decision|0|||
33653906|NCT04426695|63066354|FG005|Overall Study|Physician Decision|0|||
33653907|NCT04426695|63066355|FG006|Overall Study|Physician Decision|0|||
33653908|NCT04426695|63066356|FG007|Overall Study|Physician Decision|0|||
33653909|NCT04426695|63066357|FG008|Overall Study|Physician Decision|0|||
33653910|NCT04426695|63066358|FG009|Overall Study|Physician Decision|1|||
33653911|NCT04426695|63066359|FG010|Overall Study|Physician Decision|0|||
33653912|NCT04426695|63066360|FG011|Overall Study|Physician Decision|0|||
33653913|NCT04426695|63066361|FG012|Overall Study|Physician Decision|1|||
33653914|NCT04426695|63066362|FG013|Overall Study|Physician Decision|0|||
33653915|NCT04426695|63066363|FG014|Overall Study|Physician Decision|0|||
33653916|NCT04426695|63066364|FG015|Overall Study|Physician Decision|0|||
33653917|NCT04426695|63066365|FG016|Overall Study|Physician Decision|0|||
33653918|NCT04426695|63066366|FG017|Overall Study|Physician Decision|0|||
33653919|NCT04426695|63066349|FG000|Overall Study|Randomized but Never Treated|3|||
33653920|NCT04426695|63066350|FG001|Overall Study|Randomized but Never Treated|1|||
33653921|NCT04426695|63066351|FG002|Overall Study|Randomized but Never Treated|0|||
33653922|NCT04426695|63066352|FG003|Overall Study|Randomized but Never Treated|4|||
33653923|NCT04426695|63066353|FG004|Overall Study|Randomized but Never Treated|5|||
33653924|NCT04426695|63066354|FG005|Overall Study|Randomized but Never Treated|5|||
33653925|NCT04426695|63066355|FG006|Overall Study|Randomized but Never Treated|4|||
33653926|NCT04426695|63066356|FG007|Overall Study|Randomized but Never Treated|6|||
33653927|NCT04426695|63066357|FG008|Overall Study|Randomized but Never Treated|6|||
33653928|NCT04426695|63066358|FG009|Overall Study|Randomized but Never Treated|3|||
33653929|NCT04426695|63066359|FG010|Overall Study|Randomized but Never Treated|3|||
33653930|NCT04426695|63066360|FG011|Overall Study|Randomized but Never Treated|6|||
33653931|NCT04426695|63066361|FG012|Overall Study|Randomized but Never Treated|1|||
33653932|NCT04426695|63066362|FG013|Overall Study|Randomized but Never Treated|2|||
33653933|NCT04426695|63066363|FG014|Overall Study|Randomized but Never Treated|0|||
33653934|NCT04426695|63066364|FG015|Overall Study|Randomized but Never Treated|0|||
33331905|NCT01014624|62708594|FG001|Overall Study|Protocol Violation|0|||
33331906|NCT01014624|62708593|FG000|Overall Study|Withdrawal by Subject|1|||
33331907|NCT01014624|62708594|FG001|Overall Study|Withdrawal by Subject|0|||
33331908|NCT01021878|62708604|FG000|Overall Study|Lost to Follow-up|4|||
33331909|NCT01021878|62708605|FG001|Overall Study|Lost to Follow-up|3|||
33331910|NCT01021878|62708604|FG000|Overall Study|Death|0|||
33331911|NCT01021878|62708605|FG001|Overall Study|Death|1|||
33331912|NCT01021878|62708604|FG000|Overall Study|Adverse Event|6|||
33331913|NCT01021878|62708605|FG001|Overall Study|Adverse Event|5|||
33331914|NCT01021878|62708604|FG000|Overall Study|Transplantation|6|||
33331915|NCT01021878|62708605|FG001|Overall Study|Transplantation|1|||
33331916|NCT00854113|62708625|FG000|Overall Study|Adverse Event|0|||
33331917|NCT00854113|62708626|FG001|Overall Study|Adverse Event|0|||
33331918|NCT00854113|62708627|FG002|Overall Study|Adverse Event|0|||
33331919|NCT00854113|62708628|FG003|Overall Study|Adverse Event|0|||
33331920|NCT00854113|62708629|FG004|Overall Study|Adverse Event|0|||
33331921|NCT00854113|62708630|FG005|Overall Study|Adverse Event|0|||
33331922|NCT00854113|62708631|FG006|Overall Study|Adverse Event|0|||
33331923|NCT00854113|62708632|FG007|Overall Study|Adverse Event|2|||
33331924|NCT00854113|62708633|FG008|Overall Study|Adverse Event|0|||
33331925|NCT00854113|62708634|FG009|Overall Study|Adverse Event|0|||
33331926|NCT00854113|62708635|FG010|Overall Study|Adverse Event|0|||
33331927|NCT00854113|62708625|FG000|Overall Study|Withdrawal by Subject|0|||
33331928|NCT00854113|62708626|FG001|Overall Study|Withdrawal by Subject|0|||
33331929|NCT00854113|62708627|FG002|Overall Study|Withdrawal by Subject|0|||
33331930|NCT00854113|62708628|FG003|Overall Study|Withdrawal by Subject|0|||
33331931|NCT00854113|62708629|FG004|Overall Study|Withdrawal by Subject|0|||
33331932|NCT00854113|62708630|FG005|Overall Study|Withdrawal by Subject|0|||
33331933|NCT00854113|62708631|FG006|Overall Study|Withdrawal by Subject|0|||
33331934|NCT00854113|62708632|FG007|Overall Study|Withdrawal by Subject|1|||
33331935|NCT00854113|62708633|FG008|Overall Study|Withdrawal by Subject|1|||
33331936|NCT00854113|62708634|FG009|Overall Study|Withdrawal by Subject|0|||
33331937|NCT00854113|62708635|FG010|Overall Study|Withdrawal by Subject|0|||
33331938|NCT00845845|62708661|FG000|Overall Study|Lost to Follow-up|0|||
33331939|NCT00845845|62708662|FG001|Overall Study|Lost to Follow-up|4|||
33331940|NCT01104701|62708672|FG000|Overall Study|Withdrawal by Subject|0|||
33331941|NCT01104701|62708673|FG001|Overall Study|Withdrawal by Subject|1|||
33331942|NCT01104701|62708674|FG002|Overall Study|Withdrawal by Subject|2|||
33331943|NCT01104701|62708675|FG003|Overall Study|Withdrawal by Subject|1|||
33331944|NCT01104701|62708672|FG000|Overall Study|Adverse Event|0|||
33331945|NCT01104701|62708673|FG001|Overall Study|Adverse Event|0|||
33331946|NCT01104701|62708674|FG002|Overall Study|Adverse Event|0|||
33331947|NCT01104701|62708675|FG003|Overall Study|Adverse Event|1|||
33331948|NCT01104701|62708672|FG000|Overall Study|Physician Decision|0|||
33331949|NCT01104701|62708673|FG001|Overall Study|Physician Decision|2|||
33331950|NCT01104701|62708674|FG002|Overall Study|Physician Decision|0|||
33331951|NCT01104701|62708675|FG003|Overall Study|Physician Decision|0|||
33331952|NCT00833755|62708689|FG000|Overall Study|Physician Decision|4|||
33331953|NCT00833755|62708690|FG001|Overall Study|Physician Decision|4|||
33331954|NCT00833755|62708691|FG002|Overall Study|Physician Decision|2|||
33331955|NCT00833755|62708692|FG003|Overall Study|Physician Decision|6|||
33331956|NCT00833755|62708689|FG000|Overall Study|Subject had scheduling issues|0|||
33331957|NCT00833755|62708690|FG001|Overall Study|Subject had scheduling issues|1|||
33331958|NCT00833755|62708691|FG002|Overall Study|Subject had scheduling issues|0|||
33331959|NCT00833755|62708692|FG003|Overall Study|Subject had scheduling issues|0|||
33331960|NCT01021332|62708703|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
33331961|NCT01021332|62708703|FG000|Overall Study|Adverse Event|43|||
33331962|NCT01021332|62708703|FG000|Overall Study|Lack of Efficacy|19|||
33331963|NCT01021332|62708703|FG000|Overall Study|Withdrawal of Consent|23|||
33331964|NCT01021332|62708703|FG000|Overall Study|Lost to Follow-up|4|||
33331965|NCT01021332|62708703|FG000|Overall Study|Protocol Violation|9|||
33331966|NCT01021332|62708703|FG000|Overall Study|Miscellaneous|3|||
33331967|NCT00923091|62708717|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
33331968|NCT00923091|62708718|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
33331969|NCT00923091|62708719|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
33331970|NCT00923091|62708720|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
33331971|NCT00923091|62708721|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
33331972|NCT00923091|62708722|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
33331973|NCT00923091|62708723|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
33331974|NCT00923091|62708724|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
33331975|NCT00923091|62708725|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
33331976|NCT00923091|62708726|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
33331977|NCT00923091|62708727|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
33331978|NCT00923091|62708728|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
33331979|NCT00923091|62708729|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
33331980|NCT00923091|62708717|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
33331981|NCT00923091|62708718|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
33331982|NCT00923091|62708719|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
33331983|NCT00923091|62708720|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
33331984|NCT00923091|62708721|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
33331985|NCT00923091|62708722|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
33331986|NCT00923091|62708723|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
33331987|NCT00923091|62708724|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
33331988|NCT00923091|62708725|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
33331989|NCT00923091|62708726|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
33331990|NCT00923091|62708727|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
33331991|NCT00923091|62708728|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
33331992|NCT00923091|62708729|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
33331993|NCT00923091|62708717|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
33331994|NCT00923091|62708718|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
33331995|NCT00923091|62708719|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
33331996|NCT00923091|62708720|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
33331997|NCT00923091|62708721|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
33331998|NCT00923091|62708722|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
33331999|NCT00923091|62708723|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
33332000|NCT00923091|62708724|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
33332001|NCT00923091|62708725|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
33332002|NCT00923091|62708726|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
33332003|NCT00923091|62708727|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
33332004|NCT00923091|62708728|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
33332005|NCT00923091|62708729|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
33332006|NCT00923091|62708717|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33332007|NCT00923091|62708718|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33332008|NCT00923091|62708719|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33332009|NCT00923091|62708720|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33332010|NCT00923091|62708721|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33332011|NCT00923091|62708722|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
33332012|NCT00923091|62708723|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33332013|NCT00923091|62708724|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33332014|NCT00923091|62708725|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33332015|NCT00923091|62708726|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33332016|NCT00923091|62708727|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33332017|NCT00923091|62708728|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33332018|NCT00923091|62708729|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33332019|NCT00923091|62708717|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33332020|NCT00923091|62708718|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
33332021|NCT00923091|62708719|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33332022|NCT00923091|62708720|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
33332023|NCT00923091|62708721|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33332024|NCT00923091|62708722|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
33332025|NCT00923091|62708723|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33332026|NCT00923091|62708724|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33332027|NCT00923091|62708725|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33332028|NCT00923091|62708726|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33332029|NCT00923091|62708727|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33332030|NCT00923091|62708728|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33332031|NCT00923091|62708729|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33332032|NCT00923091|62708717|FG000|Period III (Single-Blind)|Adverse Event|5|||
33332033|NCT00923091|62708718|FG001|Period III (Single-Blind)|Adverse Event|0|||
33332034|NCT00923091|62708719|FG002|Period III (Single-Blind)|Adverse Event|0|||
33332035|NCT00923091|62708720|FG003|Period III (Single-Blind)|Adverse Event|0|||
33332036|NCT00923091|62708721|FG004|Period III (Single-Blind)|Adverse Event|0|||
33332037|NCT00923091|62708722|FG005|Period III (Single-Blind)|Adverse Event|0|||
33332038|NCT00923091|62708723|FG006|Period III (Single-Blind)|Adverse Event|0|||
33332039|NCT00923091|62708724|FG007|Period III (Single-Blind)|Adverse Event|0|||
33332040|NCT00923091|62708725|FG008|Period III (Single-Blind)|Adverse Event|0|||
33332041|NCT00923091|62708726|FG009|Period III (Single-Blind)|Adverse Event|0|||
33332042|NCT00923091|62708727|FG010|Period III (Single-Blind)|Adverse Event|0|||
33332043|NCT00923091|62708728|FG011|Period III (Single-Blind)|Adverse Event|0|||
33332044|NCT00923091|62708729|FG012|Period III (Single-Blind)|Adverse Event|0|||
33332045|NCT00923091|62708717|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
33332046|NCT00923091|62708718|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
33332047|NCT00923091|62708719|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
33332048|NCT00923091|62708720|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
33332049|NCT00923091|62708721|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
33332050|NCT00923091|62708722|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
33332051|NCT00923091|62708723|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
33332052|NCT00923091|62708724|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
33332053|NCT00923091|62708725|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
33332054|NCT00923091|62708726|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
33332055|NCT00923091|62708727|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
33332056|NCT00923091|62708728|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
33548551|NCT02493868|62939855|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
33548552|NCT02493868|62939856|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
33332057|NCT00923091|62708729|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
33332058|NCT00923091|62708717|FG000|Period III (Single-Blind)|Protocol Violation|3|||
33332059|NCT00923091|62708718|FG001|Period III (Single-Blind)|Protocol Violation|0|||
33332060|NCT00923091|62708719|FG002|Period III (Single-Blind)|Protocol Violation|0|||
33332061|NCT00923091|62708720|FG003|Period III (Single-Blind)|Protocol Violation|0|||
33332062|NCT00923091|62708721|FG004|Period III (Single-Blind)|Protocol Violation|0|||
33332063|NCT00923091|62708722|FG005|Period III (Single-Blind)|Protocol Violation|0|||
33468745|NCT00048048|62842537|FG002|Core Treatment|Adverse Event|0|||
33468746|NCT00048048|62842538|FG003|Core Treatment|Adverse Event|0|||
33468747|NCT00048048|62842539|FG004|Core Treatment|Adverse Event|0|||
33468748|NCT00048048|62842540|FG005|Core Treatment|Adverse Event|0|||
33468749|NCT00048048|62842541|FG006|Core Treatment|Adverse Event|0|||
33468750|NCT00048048|62842542|FG007|Core Treatment|Adverse Event|1|||
33468751|NCT00048048|62842543|FG008|Core Treatment|Adverse Event|0|||
33468752|NCT00048048|62842544|FG009|Core Treatment|Adverse Event|0|||
33332064|NCT00923091|62708723|FG006|Period III (Single-Blind)|Protocol Violation|0|||
33332065|NCT00923091|62708724|FG007|Period III (Single-Blind)|Protocol Violation|0|||
33468753|NCT00048048|62842545|FG010|Core Treatment|Adverse Event|0|||
33332066|NCT00923091|62708725|FG008|Period III (Single-Blind)|Protocol Violation|0|||
33332067|NCT00923091|62708726|FG009|Period III (Single-Blind)|Protocol Violation|0|||
33332068|NCT00923091|62708727|FG010|Period III (Single-Blind)|Protocol Violation|0|||
33332069|NCT00923091|62708728|FG011|Period III (Single-Blind)|Protocol Violation|0|||
33332070|NCT00923091|62708729|FG012|Period III (Single-Blind)|Protocol Violation|0|||
33332071|NCT00923091|62708717|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
33332072|NCT00923091|62708718|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
33332073|NCT00923091|62708719|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
33332074|NCT00923091|62708720|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
33332075|NCT00923091|62708721|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
33332076|NCT00923091|62708722|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
33332077|NCT00923091|62708723|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
33332078|NCT00923091|62708724|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
33332079|NCT00923091|62708725|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
33332080|NCT00923091|62708726|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
33332081|NCT00923091|62708727|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
33332082|NCT00923091|62708728|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
33332083|NCT00923091|62708729|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
33332084|NCT00923091|62708717|FG000|Period IV (Double-Blind)|Adverse Event|2|||
33332085|NCT00923091|62708718|FG001|Period IV (Double-Blind)|Adverse Event|0|||
33332086|NCT00923091|62708719|FG002|Period IV (Double-Blind)|Adverse Event|0|||
33332087|NCT00923091|62708720|FG003|Period IV (Double-Blind)|Adverse Event|0|||
33332088|NCT00923091|62708721|FG004|Period IV (Double-Blind)|Adverse Event|0|||
33332089|NCT00923091|62708722|FG005|Period IV (Double-Blind)|Adverse Event|0|||
33332090|NCT00923091|62708723|FG006|Period IV (Double-Blind)|Adverse Event|0|||
33332091|NCT00923091|62708724|FG007|Period IV (Double-Blind)|Adverse Event|0|||
33332092|NCT00923091|62708725|FG008|Period IV (Double-Blind)|Adverse Event|0|||
33332093|NCT00923091|62708726|FG009|Period IV (Double-Blind)|Adverse Event|0|||
33332094|NCT00923091|62708727|FG010|Period IV (Double-Blind)|Adverse Event|0|||
33332095|NCT00923091|62708728|FG011|Period IV (Double-Blind)|Adverse Event|0|||
33332096|NCT00923091|62708729|FG012|Period IV (Double-Blind)|Adverse Event|0|||
33332097|NCT00923091|62708717|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33332098|NCT00923091|62708718|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
33332099|NCT00923091|62708719|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33332100|NCT00923091|62708720|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33332101|NCT00923091|62708721|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33332102|NCT00923091|62708722|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33332103|NCT00923091|62708723|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33332104|NCT00923091|62708724|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33332105|NCT00923091|62708725|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33332106|NCT00923091|62708726|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33332107|NCT00923091|62708727|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33332108|NCT00923091|62708728|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33332109|NCT00923091|62708729|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33332110|NCT00923091|62708717|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
33332111|NCT00923091|62708718|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
33332112|NCT00923091|62708719|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
33332113|NCT00923091|62708720|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
33332114|NCT00923091|62708721|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
33332115|NCT00923091|62708722|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
33332116|NCT00923091|62708723|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
33332117|NCT00923091|62708724|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
33332118|NCT00923091|62708725|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
33332119|NCT00923091|62708726|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
33468754|NCT00048048|62842546|FG011|Core Treatment|Adverse Event|0|||
33653935|NCT04426695|63066365|FG016|Overall Study|Randomized but Never Treated|0|||
33653936|NCT04426695|63066366|FG017|Overall Study|Randomized but Never Treated|0|||
33653937|NCT01838200|63066443|FG000|Overall Study|Adverse Event|0|||
33332120|NCT00923091|62708727|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
33332121|NCT00923091|62708728|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
33332122|NCT00923091|62708729|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
33332123|NCT00923091|62708717|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
33332124|NCT00923091|62708718|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
33332125|NCT00923091|62708719|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
33332126|NCT00923091|62708720|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
33332127|NCT00923091|62708721|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
33332128|NCT00923091|62708722|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
33332129|NCT00923091|62708723|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
33332130|NCT00923091|62708724|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
33332131|NCT00923091|62708725|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
33332132|NCT00923091|62708726|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
33332133|NCT00923091|62708727|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
33653938|NCT01838200|63066444|FG001|Overall Study|Adverse Event|2|||
33653939|NCT01838200|63066443|FG000|Overall Study|Progressive disease|3|||
33653940|NCT01838200|63066444|FG001|Overall Study|Progressive disease|0|||
33653941|NCT03219034|63066487|FG000|Overall Study|Lost to Follow-up|9|||
33653942|NCT03219034|63066488|FG001|Overall Study|Lost to Follow-up|13|||
33653943|NCT03219034|63066487|FG000|Overall Study|Additional dental work needed|1|||
33653944|NCT03219034|63066488|FG001|Overall Study|Additional dental work needed|0|||
33653945|NCT03219034|63066487|FG000|Overall Study|UPPP Surgery|1|||
33653946|NCT03219034|63066488|FG001|Overall Study|UPPP Surgery|0|||
33653947|NCT03219034|63066487|FG000|Overall Study|Dental sensitivity|0|||
33653948|NCT03219034|63066488|FG001|Overall Study|Dental sensitivity|1|||
33653949|NCT03219034|63066487|FG000|Overall Study|Death in family|0|||
33653950|NCT03219034|63066488|FG001|Overall Study|Death in family|1|||
33653951|NCT01706198|63066512|FG000|Overall Study|Adverse Event|12|||
33653952|NCT01706198|63066513|FG001|Overall Study|Adverse Event|15|||
33653953|NCT01706198|63066512|FG000|Overall Study|Protocol Violation|7|||
33653954|NCT01706198|63066513|FG001|Overall Study|Protocol Violation|5|||
33332134|NCT00923091|62708728|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
33332135|NCT00923091|62708729|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
33332136|NCT00923091|62708717|FG000|Period V (Double -Blind)|Protocol Violation|0|||
33332137|NCT00923091|62708718|FG001|Period V (Double -Blind)|Protocol Violation|0|||
33332138|NCT00923091|62708719|FG002|Period V (Double -Blind)|Protocol Violation|0|||
33332139|NCT00923091|62708720|FG003|Period V (Double -Blind)|Protocol Violation|0|||
33332140|NCT00923091|62708721|FG004|Period V (Double -Blind)|Protocol Violation|0|||
33332141|NCT00923091|62708722|FG005|Period V (Double -Blind)|Protocol Violation|0|||
33332142|NCT00923091|62708723|FG006|Period V (Double -Blind)|Protocol Violation|0|||
33332143|NCT00923091|62708724|FG007|Period V (Double -Blind)|Protocol Violation|0|||
33332144|NCT00923091|62708725|FG008|Period V (Double -Blind)|Protocol Violation|0|||
33332145|NCT00923091|62708726|FG009|Period V (Double -Blind)|Protocol Violation|0|||
33332146|NCT00923091|62708727|FG010|Period V (Double -Blind)|Protocol Violation|0|||
33332147|NCT00923091|62708728|FG011|Period V (Double -Blind)|Protocol Violation|0|||
33332148|NCT00923091|62708729|FG012|Period V (Double -Blind)|Protocol Violation|1|||
33332149|NCT00923091|62708717|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
33332150|NCT00923091|62708718|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
33332151|NCT00923091|62708719|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
33332152|NCT00923091|62708720|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
33332153|NCT00923091|62708721|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
33332154|NCT00923091|62708722|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
33332155|NCT00923091|62708723|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
33332156|NCT00923091|62708724|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
33332157|NCT00923091|62708725|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
33332158|NCT00923091|62708726|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
33332159|NCT00923091|62708727|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
33332160|NCT00923091|62708728|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
33332161|NCT00923091|62708729|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
33332162|NCT00923091|62708717|FG000|Period VI (Open-Label)|Adverse Event|17|||
33332163|NCT00923091|62708718|FG001|Period VI (Open-Label)|Adverse Event|0|||
33332164|NCT00923091|62708719|FG002|Period VI (Open-Label)|Adverse Event|4|||
33332165|NCT00923091|62708720|FG003|Period VI (Open-Label)|Adverse Event|1|||
33332166|NCT00923091|62708721|FG004|Period VI (Open-Label)|Adverse Event|1|||
33332167|NCT00923091|62708722|FG005|Period VI (Open-Label)|Adverse Event|0|||
33332168|NCT00923091|62708723|FG006|Period VI (Open-Label)|Adverse Event|0|||
33332169|NCT00923091|62708724|FG007|Period VI (Open-Label)|Adverse Event|0|||
33653955|NCT01706198|63066512|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
33653956|NCT01706198|63066513|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
33653957|NCT01706198|63066512|FG000|Overall Study|Lost to Follow-up|97|||
33332170|NCT00923091|62708725|FG008|Period VI (Open-Label)|Adverse Event|0|||
33332171|NCT00923091|62708726|FG009|Period VI (Open-Label)|Adverse Event|0|||
33332172|NCT00923091|62708727|FG010|Period VI (Open-Label)|Adverse Event|0|||
33332173|NCT00923091|62708728|FG011|Period VI (Open-Label)|Adverse Event|0|||
33653958|NCT01706198|63066513|FG001|Overall Study|Lost to Follow-up|93|||
33653959|NCT01706198|63066512|FG000|Overall Study|Physician Decision|23|||
33653960|NCT01706198|63066513|FG001|Overall Study|Physician Decision|37|||
33332174|NCT00923091|62708729|FG012|Period VI (Open-Label)|Adverse Event|0|||
33332175|NCT00923091|62708717|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
33332176|NCT00923091|62708718|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
33332177|NCT00923091|62708719|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
33332178|NCT00923091|62708720|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
33332179|NCT00923091|62708721|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
33332180|NCT00923091|62708722|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
33332181|NCT00923091|62708723|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
33332182|NCT00923091|62708724|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
33332183|NCT00923091|62708725|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
33332184|NCT00923091|62708726|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
33332185|NCT00923091|62708727|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
33332186|NCT00923091|62708728|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
33332187|NCT00923091|62708729|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
33332188|NCT00923091|62708717|FG000|Period VI (Open-Label)|Protocol Violation|6|||
33332189|NCT00923091|62708718|FG001|Period VI (Open-Label)|Protocol Violation|1|||
33332190|NCT00923091|62708719|FG002|Period VI (Open-Label)|Protocol Violation|3|||
33332191|NCT00923091|62708720|FG003|Period VI (Open-Label)|Protocol Violation|1|||
33332192|NCT00923091|62708721|FG004|Period VI (Open-Label)|Protocol Violation|4|||
33332193|NCT00923091|62708722|FG005|Period VI (Open-Label)|Protocol Violation|0|||
33332194|NCT00923091|62708723|FG006|Period VI (Open-Label)|Protocol Violation|0|||
33332195|NCT00923091|62708724|FG007|Period VI (Open-Label)|Protocol Violation|0|||
33332196|NCT00923091|62708725|FG008|Period VI (Open-Label)|Protocol Violation|0|||
33332197|NCT00923091|62708726|FG009|Period VI (Open-Label)|Protocol Violation|0|||
33332198|NCT00923091|62708727|FG010|Period VI (Open-Label)|Protocol Violation|0|||
33332199|NCT00923091|62708728|FG011|Period VI (Open-Label)|Protocol Violation|0|||
33332200|NCT00923091|62708729|FG012|Period VI (Open-Label)|Protocol Violation|0|||
33332201|NCT00923091|62708717|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
33332202|NCT00923091|62708718|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
33332203|NCT00923091|62708719|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
33332204|NCT00923091|62708720|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
33332205|NCT00923091|62708721|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
33332206|NCT00923091|62708722|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
33332207|NCT00923091|62708723|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
33332208|NCT00923091|62708724|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
33332209|NCT00923091|62708725|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
33332210|NCT00923091|62708726|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
33332211|NCT00923091|62708727|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
33332212|NCT00923091|62708728|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
33332213|NCT00923091|62708729|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
33332214|NCT00923091|62708717|FG000|Period VI (Open-Label)|Other Reason|0|||
33332215|NCT00923091|62708718|FG001|Period VI (Open-Label)|Other Reason|0|||
33332216|NCT00923091|62708719|FG002|Period VI (Open-Label)|Other Reason|0|||
33332217|NCT00923091|62708720|FG003|Period VI (Open-Label)|Other Reason|1|||
33332218|NCT00923091|62708721|FG004|Period VI (Open-Label)|Other Reason|1|||
33332219|NCT00923091|62708722|FG005|Period VI (Open-Label)|Other Reason|0|||
33332220|NCT00923091|62708723|FG006|Period VI (Open-Label)|Other Reason|0|||
33332221|NCT00923091|62708724|FG007|Period VI (Open-Label)|Other Reason|0|||
33332222|NCT00923091|62708725|FG008|Period VI (Open-Label)|Other Reason|0|||
33332223|NCT00923091|62708726|FG009|Period VI (Open-Label)|Other Reason|0|||
33332224|NCT00923091|62708727|FG010|Period VI (Open-Label)|Other Reason|0|||
33332225|NCT00923091|62708728|FG011|Period VI (Open-Label)|Other Reason|0|||
33332226|NCT00923091|62708729|FG012|Period VI (Open-Label)|Other Reason|0|||
33332227|NCT00853957|62708756|FG000|Overall Study|Adverse Event|9|||
33332228|NCT00853957|62708757|FG001|Overall Study|Adverse Event|3|||
33332229|NCT00853957|62708756|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33332230|NCT00853957|62708757|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33332231|NCT00853957|62708756|FG000|Overall Study|Subject withdrew consent|4|||
33332232|NCT00853957|62708757|FG001|Overall Study|Subject withdrew consent|5|||
33332233|NCT00853957|62708756|FG000|Overall Study|Lost to Follow-up|1|||
33332234|NCT00853957|62708757|FG001|Overall Study|Lost to Follow-up|6|||
33332235|NCT00853957|62708756|FG000|Overall Study|Protocol deviation|0|||
33332236|NCT00853957|62708757|FG001|Overall Study|Protocol deviation|3|||
33332237|NCT01021020|62708763|FG000|Period I|Protocol Violation|1|||
33332238|NCT01021020|62708763|FG000|Period I|Withdrawal by Subject|1|||
33332239|NCT01021020|62708763|FG000|14 Day Washout Period A|Physician Decision|1|||
33332240|NCT00833053|62708777|FG000|Overall Study|Adverse Event|4|||
33332241|NCT00833053|62708778|FG001|Overall Study|Adverse Event|0|||
33332242|NCT00833053|62708777|FG000|Overall Study|Treatment Failure|3|||
33332243|NCT00833053|62708778|FG001|Overall Study|Treatment Failure|1|||
33332244|NCT00833053|62708777|FG000|Overall Study|Withdrawal by Subject|0|||
33332245|NCT00833053|62708778|FG001|Overall Study|Withdrawal by Subject|1|||
33332246|NCT00833053|62708777|FG000|Overall Study|Protocol Violation|2|||
33332247|NCT00833053|62708778|FG001|Overall Study|Protocol Violation|1|||
33332248|NCT00832975|62708784|FG000|Overall Study|Lost to Follow-up|7|||
33332249|NCT00832975|62708784|FG000|Overall Study|Protocol Violation|6|||
33332250|NCT00832975|62708784|FG000|Overall Study|Death|5|||
33332251|NCT00832975|62708784|FG000|Overall Study|Physician Decision|4|||
33332252|NCT00832975|62708784|FG000|Overall Study|Withdrawal by Subject|3|||
33332253|NCT00832975|62708784|FG000|Overall Study|Other reasons|14|||
33332254|NCT01020786|62708788|FG000|Induction Period|Entry Criteria Not Met|2|||
33332255|NCT01020786|62708788|FG000|Induction Period|Adverse Event|10|||
33332256|NCT01020786|62708788|FG000|Induction Period|Progressive Disease|31|||
33332257|NCT01020786|62708788|FG000|Induction Period|Investigator Decision|3|||
33332258|NCT01020786|62708788|FG000|Induction Period|Withdrawal by Subject|3|||
33332259|NCT01020786|62708788|FG000|Maintenance Period|Adverse Event|8|||
33332260|NCT01020786|62708788|FG000|Maintenance Period|Progressive Disease|43|||
33332261|NCT01020786|62708788|FG000|Maintenance Period|Withdrawal by Subject|8|||
33332262|NCT01020786|62708788|FG000|Maintenance Period|Sponsor Decision|1|||
33332263|NCT00918645|62708793|FG000|Overall Study|Withdrawal by Subject|1|||
33332264|NCT00922935|62708800|FG000|Overall Study|Protocol Violation|0|||
33332265|NCT00922935|62708801|FG001|Overall Study|Protocol Violation|3|||
33332266|NCT00922935|62708802|FG002|Overall Study|Protocol Violation|0|||
33332267|NCT00922935|62708800|FG000|Overall Study|Physician Decision|1|||
33332268|NCT00922935|62708801|FG001|Overall Study|Physician Decision|1|||
33332269|NCT00922935|62708802|FG002|Overall Study|Physician Decision|0|||
33332270|NCT00922935|62708800|FG000|Overall Study|Lost to Follow-up|0|||
33332271|NCT00922935|62708801|FG001|Overall Study|Lost to Follow-up|1|||
33332272|NCT00922935|62708802|FG002|Overall Study|Lost to Follow-up|0|||
33332273|NCT01020474|62708812|FG000|Overall Study|Adverse Event|4|||
33332274|NCT01020474|62708813|FG001|Overall Study|Adverse Event|4|||
33332275|NCT01020474|62708812|FG000|Overall Study|Protocol Violation|0|||
33332276|NCT01020474|62708813|FG001|Overall Study|Protocol Violation|2|||
33332277|NCT01020474|62708812|FG000|Overall Study|Withdrawal by Subject|5|||
33332278|NCT01020474|62708813|FG001|Overall Study|Withdrawal by Subject|7|||
33548553|NCT02493868|62939855|FG000|Induction Phase: DE Participants|Other|8|||
33332279|NCT01020474|62708812|FG000|Overall Study|Other Reasons|1|||
33332280|NCT01020474|62708813|FG001|Overall Study|Other Reasons|1|||
33332281|NCT01020474|62708812|FG000|Overall Study|Insufficient Clinical Response|0|||
33332282|NCT01020474|62708813|FG001|Overall Study|Insufficient Clinical Response|3|||
33332283|NCT00922779|62708819|FG000|Overall Study|Adverse Event|67|||
33332284|NCT00922779|62708819|FG000|Overall Study|Pregnancy|7|||
33332285|NCT00922779|62708819|FG000|Overall Study|Withdrawal by Subject|308|||
33332286|NCT00922779|62708819|FG000|Overall Study|Lost to Follow-up|44|||
33332287|NCT00922779|62708819|FG000|Overall Study|Other|27|||
33332288|NCT00922779|62708819|FG000|Overall Study|Missing|1874|||
33332289|NCT00924651|62708825|FG000|Overall Study|Chemo started too soon|2|||
33332290|NCT00924651|62708826|FG001|Overall Study|Chemo started too soon|3|||
33332291|NCT00924651|62708825|FG000|Overall Study|No Reason|3|||
33332292|NCT00924651|62708826|FG001|Overall Study|No Reason|7|||
33332293|NCT00924651|62708825|FG000|Overall Study|Overwhelmed|6|||
33332294|NCT00924651|62708826|FG001|Overall Study|Overwhelmed|6|||
33332295|NCT00924651|62708825|FG000|Overall Study|Noncompliant|1|||
33332296|NCT00924651|62708826|FG001|Overall Study|Noncompliant|4|||
33332297|NCT00924651|62708825|FG000|Overall Study|Medical|1|||
33332298|NCT00924651|62708826|FG001|Overall Study|Medical|3|||
33332299|NCT00924651|62708825|FG000|Overall Study|Changed Mind|10|||
33332300|NCT00924651|62708826|FG001|Overall Study|Changed Mind|1|||
33332301|NCT00924651|62708825|FG000|Overall Study|Incomplete Form|2|||
33332302|NCT00924651|62708826|FG001|Overall Study|Incomplete Form|1|||
33332303|NCT00922623|62708832|FG000|Overall Study|Other|4|||
33332304|NCT00922623|62708832|FG000|Overall Study|Lost to Follow-up|1|||
33332305|NCT01025232|62708840|FG000|Overall Study|Study drug no longer available|3|||
33332306|NCT01025232|62708841|FG001|Overall Study|Study drug no longer available|6|||
33332307|NCT01025154|62708847|FG000|Overall Study|Lost to Follow-up|1|||
33332308|NCT01025154|62708847|FG000|Overall Study|Withdrawal by Subject|1|||
33332309|NCT00832819|62708854|FG000|Overall Study|Adverse Event|0|||
33332310|NCT00832819|62708855|FG001|Overall Study|Adverse Event|1|||
33332311|NCT00832819|62708856|FG002|Overall Study|Adverse Event|0|||
33332312|NCT00832819|62708854|FG000|Overall Study|Protocol Violation|0|||
33332313|NCT00832819|62708855|FG001|Overall Study|Protocol Violation|0|||
33332314|NCT00832819|62708856|FG002|Overall Study|Protocol Violation|1|||
33332315|NCT00853723|62708865|FG000|Overall Study|Adverse Event|3|||
33332316|NCT00853723|62708866|FG001|Overall Study|Adverse Event|4|||
33332317|NCT00853723|62708867|FG002|Overall Study|Adverse Event|1|||
33332318|NCT00853723|62708865|FG000|Overall Study|Withdrawal by Subject|2|||
33332319|NCT00853723|62708866|FG001|Overall Study|Withdrawal by Subject|1|||
33332320|NCT00853723|62708867|FG002|Overall Study|Withdrawal by Subject|0|||
33332321|NCT00853723|62708865|FG000|Overall Study|Protocol Violation|1|||
33332322|NCT00853723|62708866|FG001|Overall Study|Protocol Violation|2|||
33332323|NCT00853723|62708867|FG002|Overall Study|Protocol Violation|1|||
33332324|NCT01104545|62708881|FG000|Overall Study|Adverse Event|0|||
33332325|NCT01104545|62708882|FG001|Overall Study|Adverse Event|1|||
33332326|NCT01104545|62708883|FG002|Overall Study|Adverse Event|2|||
33332327|NCT00918255|62708931|FG000|Overall Study|Adverse Event|1|||
33332328|NCT00918255|62708932|FG001|Overall Study|Adverse Event|0|||
33332329|NCT00918255|62708933|FG002|Overall Study|Adverse Event|0|||
33332330|NCT00918255|62708931|FG000|Overall Study|Withdrawal by Subject|1|||
33332331|NCT00918255|62708932|FG001|Overall Study|Withdrawal by Subject|0|||
33332332|NCT00918255|62708933|FG002|Overall Study|Withdrawal by Subject|2|||
33332333|NCT00918255|62708931|FG000|Overall Study|Lack of Efficacy|1|||
33332334|NCT00918255|62708932|FG001|Overall Study|Lack of Efficacy|0|||
33332335|NCT00918255|62708933|FG002|Overall Study|Lack of Efficacy|0|||
33332336|NCT00918255|62708931|FG000|Overall Study|Lost to Follow-up|1|||
33468755|NCT00048048|62842535|FG000|Extension Year 1|Early withdrawals|0|||
33468756|NCT00048048|62842536|FG001|Extension Year 1|Early withdrawals|0|||
33468757|NCT00048048|62842537|FG002|Extension Year 1|Early withdrawals|0|||
33653961|NCT01706198|63066512|FG000|Overall Study|Withdrawal by Subject|23|||
33332337|NCT00918255|62708932|FG001|Overall Study|Lost to Follow-up|0|||
33332338|NCT00918255|62708933|FG002|Overall Study|Lost to Follow-up|2|||
33332339|NCT00918255|62708931|FG000|Overall Study|Exceeded allowed number of interventions|0|||
33332340|NCT00918255|62708932|FG001|Overall Study|Exceeded allowed number of interventions|0|||
33332341|NCT00918255|62708933|FG002|Overall Study|Exceeded allowed number of interventions|1|||
33332342|NCT00918255|62708931|FG000|Overall Study|Non-compliance|1|||
33332343|NCT00918255|62708932|FG001|Overall Study|Non-compliance|0|||
33332344|NCT00918255|62708933|FG002|Overall Study|Non-compliance|0|||
33332345|NCT00918255|62708931|FG000|Overall Study|Investigator discretion|1|||
33332346|NCT00918255|62708932|FG001|Overall Study|Investigator discretion|0|||
33332347|NCT00918255|62708933|FG002|Overall Study|Investigator discretion|0|||
33332348|NCT01096589|62708945|FG000|Overall Study|Adverse Event|2|||
33332349|NCT01096589|62708946|FG001|Overall Study|Adverse Event|1|||
33332350|NCT01096589|62708947|FG002|Overall Study|Adverse Event|2|||
33332351|NCT01096589|62708948|FG003|Overall Study|Adverse Event|1|||
33332352|NCT01096589|62708945|FG000|Overall Study|Withdrawal by Subject|2|||
33332353|NCT01096589|62708946|FG001|Overall Study|Withdrawal by Subject|1|||
33332354|NCT01096589|62708947|FG002|Overall Study|Withdrawal by Subject|1|||
33332355|NCT01096589|62708948|FG003|Overall Study|Withdrawal by Subject|1|||
33332356|NCT01096589|62708945|FG000|Overall Study|Compliance with protocol|0|||
33332357|NCT01096589|62708946|FG001|Overall Study|Compliance with protocol|0|||
33332358|NCT01096589|62708947|FG002|Overall Study|Compliance with protocol|1|||
33332359|NCT01096589|62708948|FG003|Overall Study|Compliance with protocol|0|||
33332360|NCT01096589|62708945|FG000|Overall Study|found treatment exhausting|0|||
33332361|NCT01096589|62708946|FG001|Overall Study|found treatment exhausting|0|||
33332362|NCT01096589|62708947|FG002|Overall Study|found treatment exhausting|0|||
33332363|NCT01096589|62708948|FG003|Overall Study|found treatment exhausting|1|||
33332364|NCT00845065|62708964|FG000|Overall Study|Adverse Event|3|||
33332365|NCT00845065|62708965|FG001|Overall Study|Adverse Event|23|||
33332366|NCT00845065|62708964|FG000|Overall Study|Lack of Efficacy|43|||
33332367|NCT00845065|62708965|FG001|Overall Study|Lack of Efficacy|21|||
33332368|NCT00845065|62708964|FG000|Overall Study|Non-Medical Reasons|1|||
33332369|NCT00845065|62708965|FG001|Overall Study|Non-Medical Reasons|11|||
33332370|NCT00832585|62708971|FG000|Overall Study|Withdrawal by Subject|1|||
33332371|NCT00832585|62708971|FG000|Overall Study|Lost to Follow-up|1|||
33332372|NCT00918567|62708977|FG000|Overall Study|Lack of Efficacy|3|||
33332373|NCT00918567|62708978|FG001|Overall Study|Lack of Efficacy|1|||
33548554|NCT02493868|62939856|FG001|Induction Phase: DE Participants|Other|0|||
33548555|NCT02493868|62939855|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
33332374|NCT00918567|62708977|FG000|Overall Study|Withdrawal by Subject|1|||
33332375|NCT00918567|62708978|FG001|Overall Study|Withdrawal by Subject|1|||
33332376|NCT00918567|62708977|FG000|Overall Study|Adverse Event|1|||
33332377|NCT00918567|62708978|FG001|Overall Study|Adverse Event|0|||
33332378|NCT01024920|62708986|FG000|Overall Study|Progressive disease|47|||
33332379|NCT01024920|62708987|FG001|Overall Study|Progressive disease|25|||
33332380|NCT01024920|62708986|FG000|Overall Study|Adverse Event|8|||
33332381|NCT01024920|62708987|FG001|Overall Study|Adverse Event|4|||
33332382|NCT01024920|62708986|FG000|Overall Study|Lost to Follow-up|0|||
33332383|NCT01024920|62708987|FG001|Overall Study|Lost to Follow-up|1|||
33332384|NCT01024920|62708986|FG000|Overall Study|Patient refusal to continue|4|||
33332385|NCT01024920|62708987|FG001|Overall Study|Patient refusal to continue|0|||
33332386|NCT01024920|62708986|FG000|Overall Study|Other than listed|5|||
33332387|NCT01024920|62708987|FG001|Overall Study|Other than listed|1|||
33332388|NCT01024920|62708986|FG000|Overall Study|Not treated|3|||
33332389|NCT01024920|62708987|FG001|Overall Study|Not treated|0|||
33332390|NCT01024920|62708986|FG000|Overall Study|Protocol Violation|0|||
33332391|NCT01024920|62708987|FG001|Overall Study|Protocol Violation|1|||
33332392|NCT00832117|62708995|FG000|Overall Study|Death|1|||
33332393|NCT00832117|62708995|FG000|Overall Study|Disease Progression|11|||
33332394|NCT01104311|62709004|FG000|Overall Study|Withdrawal by Subject|6|||
33332395|NCT01104311|62709005|FG001|Overall Study|Withdrawal by Subject|6|||
33332396|NCT01104311|62709004|FG000|Overall Study|Protocol Violation|0|||
33332397|NCT01104311|62709005|FG001|Overall Study|Protocol Violation|1|||
33332398|NCT01104311|62709004|FG000|Overall Study|Physician Decision|2|||
33332399|NCT01104311|62709005|FG001|Overall Study|Physician Decision|2|||
33332400|NCT01104311|62709004|FG000|Overall Study|low compliance|1|||
33332401|NCT01104311|62709005|FG001|Overall Study|low compliance|1|||
33332402|NCT01104311|62709004|FG000|Overall Study|Adverse Event|1|||
33332403|NCT01104311|62709005|FG001|Overall Study|Adverse Event|2|||
33332404|NCT00831493|62709015|FG000|Overall Study|Intractable nausea and vomiting|1|||
33332405|NCT00853567|62709022|FG000|Overall Study|Study prematurely terminated|71|||
33332406|NCT00853489|62709032|FG000|Overall Study|Lost to Follow-up|5|||
33332407|NCT00853489|62709033|FG001|Overall Study|Lost to Follow-up|2|||
33332408|NCT01019694|62709042|FG000|Overall Study|Adverse Event|12|||
33332409|NCT01019694|62709043|FG001|Overall Study|Adverse Event|16|||
33332410|NCT01019694|62709044|FG002|Overall Study|Adverse Event|19|||
33332411|NCT01019694|62709042|FG000|Overall Study|Protocol Violation|2|||
33332412|NCT01019694|62709043|FG001|Overall Study|Protocol Violation|6|||
33332413|NCT01019694|62709044|FG002|Overall Study|Protocol Violation|4|||
33332414|NCT01019694|62709042|FG000|Overall Study|Lost to Follow-up|5|||
33332415|NCT01019694|62709043|FG001|Overall Study|Lost to Follow-up|3|||
33332416|NCT01019694|62709044|FG002|Overall Study|Lost to Follow-up|3|||
33332417|NCT01019694|62709042|FG000|Overall Study|Withdrawal by Subject|4|||
33332418|NCT01019694|62709043|FG001|Overall Study|Withdrawal by Subject|6|||
33332419|NCT01019694|62709044|FG002|Overall Study|Withdrawal by Subject|12|||
33332420|NCT01019694|62709042|FG000|Overall Study|Not treated|0|||
33332421|NCT01019694|62709043|FG001|Overall Study|Not treated|2|||
33332422|NCT01019694|62709044|FG002|Overall Study|Not treated|3|||
33332423|NCT01019694|62709042|FG000|Overall Study|Other reason (not specified)|1|||
33332424|NCT01019694|62709043|FG001|Overall Study|Other reason (not specified)|5|||
33332425|NCT01019694|62709044|FG002|Overall Study|Other reason (not specified)|6|||
33332426|NCT00831415|62709052|FG000|Overall Study|Adverse Event|14|||
33332427|NCT00831415|62709052|FG000|Overall Study|Failed to return|3|||
33332428|NCT00831415|62709052|FG000|Overall Study|Physician Decision|6|||
33332429|NCT00831415|62709052|FG000|Overall Study|Lost to Follow-up|9|||
33332430|NCT00831415|62709052|FG000|Overall Study|Protocol Violation|3|||
33332431|NCT00831415|62709052|FG000|Overall Study|Withdrawal by Subject|35|||
33332432|NCT00831415|62709052|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
33468758|NCT00048048|62842538|FG003|Extension Year 1|Early withdrawals|0|||
33468759|NCT00048048|62842539|FG004|Extension Year 1|Early withdrawals|0|||
33468760|NCT00048048|62842540|FG005|Extension Year 1|Early withdrawals|0|||
33332433|NCT00831415|62709052|FG000|Overall Study|Death|1|||
33332434|NCT01095653|62709059|FG000|Overall Study|Lack of Efficacy|3|||
33332435|NCT01095653|62709060|FG001|Overall Study|Lack of Efficacy|0|||
33332436|NCT01095653|62709061|FG002|Overall Study|Lack of Efficacy|0|||
33332437|NCT01095653|62709059|FG000|Overall Study|Adverse Event|1|||
33332438|NCT01095653|62709060|FG001|Overall Study|Adverse Event|4|||
33332439|NCT01095653|62709061|FG002|Overall Study|Adverse Event|4|||
33332440|NCT01095653|62709059|FG000|Overall Study|Lost to Follow-up|1|||
33332441|NCT01095653|62709060|FG001|Overall Study|Lost to Follow-up|0|||
33332442|NCT01095653|62709061|FG002|Overall Study|Lost to Follow-up|4|||
33332443|NCT01095653|62709059|FG000|Overall Study|Withdrawal by Subject|4|||
33332444|NCT01095653|62709060|FG001|Overall Study|Withdrawal by Subject|5|||
33332445|NCT01095653|62709061|FG002|Overall Study|Withdrawal by Subject|3|||
33332446|NCT01095653|62709059|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
33332447|NCT01095653|62709060|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
33332448|NCT01095653|62709061|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
33332449|NCT00920907|62709071|FG000|Induction Period|Adverse Event|0|||
33332450|NCT00920907|62709072|FG001|Induction Period|Adverse Event|2|||
33332451|NCT00920907|62709071|FG000|Induction Period|Death|1|||
33332452|NCT00920907|62709072|FG001|Induction Period|Death|1|||
33332453|NCT00920907|62709071|FG000|Induction Period|Disease Progression|12|||
33332454|NCT00920907|62709072|FG001|Induction Period|Disease Progression|11|||
33332455|NCT00920907|62709071|FG000|Induction Period|Study Drug Toxicity|8|||
33468761|NCT00048048|62842541|FG006|Extension Year 1|Early withdrawals|0|||
33468762|NCT00048048|62842542|FG007|Extension Year 1|Early withdrawals|0|||
33468763|NCT00048048|62842543|FG008|Extension Year 1|Early withdrawals|0|||
33332456|NCT00920907|62709072|FG001|Induction Period|Study Drug Toxicity|6|||
33332457|NCT00920907|62709071|FG000|Induction Period|No longer meets study criteria|0|||
33332458|NCT00920907|62709072|FG001|Induction Period|No longer meets study criteria|1|||
33332459|NCT00920907|62709071|FG000|Induction Period|Withdrawal by Subject|1|||
33332460|NCT00920907|62709072|FG001|Induction Period|Withdrawal by Subject|1|||
33332461|NCT00920907|62709071|FG000|Maintenance Period|Disease Progression|3|||
33332462|NCT00920907|62709072|FG001|Maintenance Period|Disease Progression|7|||
33332463|NCT00920907|62709071|FG000|Maintenance Period|Administrative (study closure)|7|||
33332464|NCT00920907|62709072|FG001|Maintenance Period|Administrative (study closure)|2|||
33332465|NCT00920907|62709071|FG000|Maintenance Period|Study Drug Toxicity|0|||
33332466|NCT00920907|62709072|FG001|Maintenance Period|Study Drug Toxicity|2|||
33332467|NCT00920907|62709071|FG000|Maintenance Period|Death|1|||
33332468|NCT00920907|62709072|FG001|Maintenance Period|Death|1|||
33332469|NCT00920907|62709071|FG000|Maintenance Period|Withdrawal by Subject|1|||
33332470|NCT00920907|62709072|FG001|Maintenance Period|Withdrawal by Subject|0|||
33332471|NCT00920907|62709071|FG000|Maintenance Period|Adverse Event|0|||
33332472|NCT00920907|62709072|FG001|Maintenance Period|Adverse Event|1|||
33332473|NCT01103141|62709082|FG000|Overall Study|Death|0|||
33332474|NCT01103141|62709083|FG001|Overall Study|Death|1|||
33332475|NCT01103141|62709082|FG000|Overall Study|Lost to Follow-up|2|||
33332476|NCT01103141|62709083|FG001|Overall Study|Lost to Follow-up|1|||
33332477|NCT00844831|62709089|FG000|Overall Study|Withdrawal by Subject|4|||
33332478|NCT00844831|62709089|FG000|Overall Study|Adverse Event|1|||
33332479|NCT00844831|62709089|FG000|Overall Study|Physician Decision|1|||
33332480|NCT00920829|62709101|FG000|Allocation|No post randomization data|3|||
33332481|NCT00920829|62709102|FG001|Allocation|No post randomization data|1|||
33332482|NCT00920829|62709103|FG002|Allocation|No post randomization data|0|||
33332483|NCT00920829|62709104|FG003|Allocation|No post randomization data|2|||
33332484|NCT00920829|62709101|FG000|Available for Analysis|Withdrawal by Subject|6|||
33332485|NCT00920829|62709102|FG001|Available for Analysis|Withdrawal by Subject|6|||
33332486|NCT00920829|62709103|FG002|Available for Analysis|Withdrawal by Subject|6|||
33332487|NCT00920829|62709104|FG003|Available for Analysis|Withdrawal by Subject|10|||
33332488|NCT00920829|62709101|FG000|Available for Analysis|Required Medical Treatment|0|||
33332489|NCT00920829|62709102|FG001|Available for Analysis|Required Medical Treatment|1|||
33332490|NCT00920829|62709103|FG002|Available for Analysis|Required Medical Treatment|2|||
33332491|NCT00920829|62709104|FG003|Available for Analysis|Required Medical Treatment|0|||
33332492|NCT00920829|62709101|FG000|Available for Analysis|Adverse Event|1|||
33332493|NCT00920829|62709102|FG001|Available for Analysis|Adverse Event|2|||
33332494|NCT00920829|62709103|FG002|Available for Analysis|Adverse Event|1|||
33332495|NCT00920829|62709104|FG003|Available for Analysis|Adverse Event|0|||
33332496|NCT00920829|62709101|FG000|Available for Analysis|Death|1|||
33332497|NCT00920829|62709102|FG001|Available for Analysis|Death|0|||
33332498|NCT00920829|62709103|FG002|Available for Analysis|Death|0|||
33332499|NCT00920829|62709104|FG003|Available for Analysis|Death|0|||
33332500|NCT00920829|62709101|FG000|Available for Analysis|Protocol Violation|0|||
33332501|NCT00920829|62709102|FG001|Available for Analysis|Protocol Violation|0|||
33332502|NCT00920829|62709103|FG002|Available for Analysis|Protocol Violation|1|||
33332503|NCT00920829|62709104|FG003|Available for Analysis|Protocol Violation|0|||
33332504|NCT00920829|62709101|FG000|Available for Analysis|Required more treatment|0|||
33332505|NCT00920829|62709102|FG001|Available for Analysis|Required more treatment|2|||
33332506|NCT00920829|62709103|FG002|Available for Analysis|Required more treatment|0|||
33332507|NCT00920829|62709104|FG003|Available for Analysis|Required more treatment|1|||
33332508|NCT00831181|62709114|FG000|Overall Study|Adverse Event|12|||
33332509|NCT01023672|62709119|FG000|Overall Study|Worsening disease|2|||
33332510|NCT01023672|62709119|FG000|Overall Study|Death|1|||
33332511|NCT01094171|62709123|FG000|Overall Study|Lost to Follow-up|2|||
33332512|NCT01094171|62709123|FG000|Overall Study|Informed consent withdrawal|4|||
33332513|NCT01094171|62709123|FG000|Overall Study|Migration from the study area|3|||
33332514|NCT01094171|62709123|FG000|Overall Study|Other|1|||
33332515|NCT01093625|62709129|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
33332516|NCT01093625|62709130|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
33332517|NCT01093625|62709129|FG000|2-Week Visit|Withdrawal by Subject|1|||
33332518|NCT01093625|62709130|FG001|2-Week Visit|Withdrawal by Subject|0|||
33332519|NCT01093625|62709129|FG000|1-Month Visit|Lost to Follow-up|2|||
33332520|NCT01093625|62709130|FG001|1-Month Visit|Lost to Follow-up|0|||
33332521|NCT01093625|62709129|FG000|3-Month Visit|Lost to Follow-up|2|||
33332522|NCT01093625|62709130|FG001|3-Month Visit|Lost to Follow-up|0|||
33332523|NCT01093625|62709129|FG000|6-Month Visit|Withdrawal by Subject|6|||
33332524|NCT01093625|62709130|FG001|6-Month Visit|Withdrawal by Subject|7|||
33332525|NCT01093625|62709129|FG000|6-Month Visit|Lost to Follow-up|2|||
33332526|NCT01093625|62709130|FG001|6-Month Visit|Lost to Follow-up|2|||
33332527|NCT01093625|62709129|FG000|1-Year Visit|Lost to Follow-up|5|||
33332528|NCT01093625|62709130|FG001|1-Year Visit|Lost to Follow-up|3|||
33332529|NCT01023516|62709138|FG000|Overall Study|Voluntary discontinuation|7|||
33332530|NCT01023516|62709139|FG001|Overall Study|Voluntary discontinuation|5|||
33332531|NCT01023516|62709138|FG000|Overall Study|Adverse Event|9|||
33332532|NCT01023516|62709139|FG001|Overall Study|Adverse Event|6|||
33332533|NCT01023516|62709138|FG000|Overall Study|Safety reason|0|||
33332534|NCT01023516|62709139|FG001|Overall Study|Safety reason|3|||
33332535|NCT01023516|62709138|FG000|Overall Study|Study-specific criteria|4|||
33332536|NCT01023516|62709139|FG001|Overall Study|Study-specific criteria|2|||
33332537|NCT01023516|62709138|FG000|Overall Study|Incorrect enrolment|4|||
33332538|NCT01023516|62709139|FG001|Overall Study|Incorrect enrolment|2|||
33332539|NCT00844753|62709149|FG000|Overall Study|Lack of Efficacy|1|||
33332540|NCT00844753|62709150|FG001|Overall Study|Lack of Efficacy|0|||
33332541|NCT00844753|62709151|FG002|Overall Study|Lack of Efficacy|2|||
33332542|NCT00844753|62709152|FG003|Overall Study|Lack of Efficacy|2|||
33332543|NCT00844753|62709149|FG000|Overall Study|Adverse Event|3|||
33332544|NCT00844753|62709150|FG001|Overall Study|Adverse Event|2|||
33332545|NCT00844753|62709151|FG002|Overall Study|Adverse Event|5|||
33332546|NCT00844753|62709152|FG003|Overall Study|Adverse Event|5|||
33332547|NCT00844753|62709149|FG000|Overall Study|Lost to Follow-up|1|||
33332548|NCT00844753|62709150|FG001|Overall Study|Lost to Follow-up|1|||
33332549|NCT00844753|62709151|FG002|Overall Study|Lost to Follow-up|0|||
33332550|NCT00844753|62709152|FG003|Overall Study|Lost to Follow-up|1|||
33332551|NCT00844753|62709149|FG000|Overall Study|could not swallow medication|2|||
33332552|NCT00844753|62709150|FG001|Overall Study|could not swallow medication|0|||
33332553|NCT00844753|62709151|FG002|Overall Study|could not swallow medication|0|||
33332554|NCT00844753|62709152|FG003|Overall Study|could not swallow medication|0|||
33332555|NCT00844753|62709149|FG000|Overall Study|Withdrawal by Subject|1|||
33332556|NCT00844753|62709150|FG001|Overall Study|Withdrawal by Subject|0|||
33332557|NCT00844753|62709151|FG002|Overall Study|Withdrawal by Subject|0|||
33332558|NCT00844753|62709152|FG003|Overall Study|Withdrawal by Subject|3|||
33332559|NCT00830947|62709162|FG000|Overall Study|Lost to Follow-up|4|||
33332560|NCT00830947|62709163|FG001|Overall Study|Lost to Follow-up|4|||
33332561|NCT01018992|62709171|FG000|Overall Study|Adverse Event|8|||
33332562|NCT01018992|62709172|FG001|Overall Study|Adverse Event|3|||
33332563|NCT01018992|62709171|FG000|Overall Study|Withdrawal by Subject|3|||
33332564|NCT01018992|62709172|FG001|Overall Study|Withdrawal by Subject|8|||
33332565|NCT01018992|62709171|FG000|Overall Study|Protocol Violation|0|||
33332566|NCT01018992|62709172|FG001|Overall Study|Protocol Violation|4|||
33332567|NCT01018992|62709171|FG000|Overall Study|Lost to Follow-up|5|||
33332568|NCT01018992|62709172|FG001|Overall Study|Lost to Follow-up|1|||
33332569|NCT00917553|62709180|FG000|Overall Study|Lost to Follow-up|2|||
33332570|NCT00917553|62709181|FG001|Overall Study|Lost to Follow-up|1|||
33332571|NCT01018680|62709189|FG000|Overall Study|Adverse Event|23|||
33332572|NCT01018680|62709190|FG001|Overall Study|Adverse Event|40|||
33332573|NCT01018680|62709189|FG000|Overall Study|Withdrawal by Subject|10|||
33332574|NCT01018680|62709190|FG001|Overall Study|Withdrawal by Subject|10|||
33332575|NCT01018680|62709189|FG000|Overall Study|Protocol Violation|5|||
33332576|NCT01018680|62709190|FG001|Overall Study|Protocol Violation|8|||
33332577|NCT01018680|62709189|FG000|Overall Study|Sponsor Decision|6|||
33332578|NCT01018680|62709190|FG001|Overall Study|Sponsor Decision|7|||
33332579|NCT01018680|62709189|FG000|Overall Study|Lack of Efficacy|8|||
33332580|NCT01018680|62709190|FG001|Overall Study|Lack of Efficacy|2|||
33468764|NCT00048048|62842544|FG009|Extension Year 1|Early withdrawals|2|||
33468765|NCT00048048|62842545|FG010|Extension Year 1|Early withdrawals|2|||
33332581|NCT01018680|62709189|FG000|Overall Study|Lost to Follow-up|5|||
33332582|NCT01018680|62709190|FG001|Overall Study|Lost to Follow-up|3|||
33468766|NCT00048048|62842546|FG011|Extension Year 1|Early withdrawals|4|||
33332583|NCT01018680|62709189|FG000|Overall Study|Entry Criteria Not Met|1|||
33332584|NCT01018680|62709190|FG001|Overall Study|Entry Criteria Not Met|4|||
33332585|NCT01018680|62709189|FG000|Overall Study|Physician Decision|3|||
33332586|NCT01018680|62709190|FG001|Overall Study|Physician Decision|1|||
33332587|NCT01012440|62709196|FG000|Overall Study|Withdrawal by Subject|2|||
33332588|NCT00916929|62709202|FG000|Overall Study|Lost to Follow-up|1|||
33332589|NCT00916929|62709203|FG001|Overall Study|Lost to Follow-up|3|||
33332590|NCT00916929|62709202|FG000|Overall Study|Death|5|||
33332591|NCT00916929|62709203|FG001|Overall Study|Death|10|||
33332592|NCT00916929|62709202|FG000|Overall Study|Withdrawal by Subject|1|||
33332593|NCT00916929|62709203|FG001|Overall Study|Withdrawal by Subject|5|||
33332594|NCT00916929|62709202|FG000|Overall Study|Left ventricular epicardial lead|1|||
33332595|NCT00916929|62709203|FG001|Overall Study|Left ventricular epicardial lead|2|||
33332596|NCT00916929|62709202|FG000|Overall Study|Transferred to hospice care|1|||
33332597|NCT00916929|62709203|FG001|Overall Study|Transferred to hospice care|1|||
33332598|NCT00916929|62709202|FG000|Overall Study|System explant|1|||
33332599|NCT00916929|62709203|FG001|Overall Study|System explant|0|||
33332600|NCT00916929|62709202|FG000|Overall Study|Moved to another state|0|||
33332601|NCT00916929|62709203|FG001|Overall Study|Moved to another state|1|||
33332602|NCT00916929|62709202|FG000|Overall Study|Device unable to process impedance data|0|||
33332603|NCT00916929|62709203|FG001|Overall Study|Device unable to process impedance data|7|||
33332604|NCT00844597|62709217|FG000|Overall Study|Adverse Event|0|||
33332605|NCT00844597|62709218|FG001|Overall Study|Adverse Event|0|||
33332606|NCT00844597|62709219|FG002|Overall Study|Adverse Event|0|||
33332607|NCT00844597|62709220|FG003|Overall Study|Adverse Event|1|||
33332608|NCT00844597|62709221|FG004|Overall Study|Adverse Event|0|||
33332609|NCT00844597|62709222|FG005|Overall Study|Adverse Event|0|||
33332610|NCT01017120|62709240|FG000|Overall Study|Adverse Event|9|||
33332611|NCT01017120|62709241|FG001|Overall Study|Adverse Event|0|||
33332612|NCT01017120|62709240|FG000|Overall Study|Lost to Follow-up|13|||
33332613|NCT01017120|62709241|FG001|Overall Study|Lost to Follow-up|11|||
33332614|NCT01017120|62709240|FG000|Overall Study|Lack of Efficacy|1|||
33332615|NCT01017120|62709241|FG001|Overall Study|Lack of Efficacy|0|||
33332616|NCT01017120|62709240|FG000|Overall Study|Withdrawal by Subject|39|||
33332617|NCT01017120|62709241|FG001|Overall Study|Withdrawal by Subject|21|||
33332618|NCT01017120|62709240|FG000|Overall Study|Pregnancy|1|||
33332619|NCT01017120|62709241|FG001|Overall Study|Pregnancy|1|||
33332620|NCT01017120|62709240|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
33332621|NCT01017120|62709241|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
33332622|NCT01017120|62709240|FG000|Overall Study|Relocated Out of Town|0|||
33332623|NCT01017120|62709241|FG001|Overall Study|Relocated Out of Town|2|||
33332624|NCT01017120|62709240|FG000|Overall Study|Protocol Violation|1|||
33332625|NCT01017120|62709241|FG001|Overall Study|Protocol Violation|0|||
33332626|NCT01017120|62709240|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
33332627|NCT01017120|62709241|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
33332628|NCT01016964|62709249|FG000|Overall Study|Lost to Follow-up|3|||
33332629|NCT01016964|62709250|FG001|Overall Study|Lost to Follow-up|3|||
33332630|NCT02996110|62709261|FG000|Pre-Treatment|Other Reasons|0|||
33332631|NCT02996110|62709262|FG001|Pre-Treatment|Other Reasons|1|||
33332632|NCT02996110|62709263|FG002|Pre-Treatment|Other Reasons|0|||
33332633|NCT02996110|62709264|FG003|Pre-Treatment|Other Reasons|0|||
33332634|NCT02996110|62709265|FG004|Pre-Treatment|Other Reasons|1|||
33332635|NCT02996110|62709261|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
33332636|NCT02996110|62709262|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
33332637|NCT02996110|62709263|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
33332638|NCT02996110|62709264|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
33332639|NCT02996110|62709265|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
33332640|NCT02996110|62709261|FG000|Track 1|Disease Progression|15|||
33332641|NCT02996110|62709262|FG001|Track 1|Disease Progression|17|||
33332642|NCT02996110|62709263|FG002|Track 1|Disease Progression|0|||
33332643|NCT02996110|62709264|FG003|Track 1|Disease Progression|0|||
33332644|NCT02996110|62709265|FG004|Track 1|Disease Progression|0|||
33332645|NCT02996110|62709261|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
33332646|NCT02996110|62709262|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
33332647|NCT02996110|62709263|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
33332648|NCT02996110|62709264|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
33332649|NCT02996110|62709265|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
33332650|NCT02996110|62709261|FG000|Track 1|Study Drug Toxicity|5|||
33332651|NCT02996110|62709262|FG001|Track 1|Study Drug Toxicity|3|||
33332652|NCT02996110|62709263|FG002|Track 1|Study Drug Toxicity|0|||
33332653|NCT02996110|62709264|FG003|Track 1|Study Drug Toxicity|0|||
33332654|NCT02996110|62709265|FG004|Track 1|Study Drug Toxicity|0|||
33332655|NCT02996110|62709261|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
33332656|NCT02996110|62709262|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
33332657|NCT02996110|62709263|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
33332658|NCT02996110|62709264|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
33332659|NCT02996110|62709265|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
33332660|NCT02996110|62709261|FG000|Track 1|Administrative Reason by Sponsor|0|||
33332661|NCT02996110|62709262|FG001|Track 1|Administrative Reason by Sponsor|1|||
33332662|NCT02996110|62709263|FG002|Track 1|Administrative Reason by Sponsor|0|||
33332663|NCT02996110|62709264|FG003|Track 1|Administrative Reason by Sponsor|0|||
33332664|NCT02996110|62709265|FG004|Track 1|Administrative Reason by Sponsor|0|||
33332665|NCT02996110|62709261|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
33332666|NCT02996110|62709262|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
33332667|NCT02996110|62709263|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
33332668|NCT02996110|62709264|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
33332669|NCT02996110|62709265|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
33332670|NCT02996110|62709261|FG000|Track 2|Disease Progression|33|||
33332671|NCT02996110|62709262|FG001|Track 2|Disease Progression|26|||
33332672|NCT02996110|62709263|FG002|Track 2|Disease Progression|19|||
33332673|NCT02996110|62709264|FG003|Track 2|Disease Progression|16|||
33332674|NCT02996110|62709265|FG004|Track 2|Disease Progression|15|||
33332675|NCT02996110|62709261|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
33332676|NCT02996110|62709262|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
33332677|NCT02996110|62709263|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
33332678|NCT02996110|62709264|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
33332679|NCT02996110|62709265|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
33332680|NCT02996110|62709261|FG000|Track 2|Death|0|||
33332681|NCT02996110|62709262|FG001|Track 2|Death|0|||
33332682|NCT02996110|62709263|FG002|Track 2|Death|1|||
33332683|NCT02996110|62709264|FG003|Track 2|Death|0|||
33332684|NCT02996110|62709265|FG004|Track 2|Death|1|||
33332685|NCT02996110|62709261|FG000|Track 2|Study Drug Toxicity|4|||
33332686|NCT02996110|62709262|FG001|Track 2|Study Drug Toxicity|1|||
33332687|NCT02996110|62709263|FG002|Track 2|Study Drug Toxicity|4|||
33332688|NCT02996110|62709264|FG003|Track 2|Study Drug Toxicity|1|||
33332689|NCT02996110|62709265|FG004|Track 2|Study Drug Toxicity|0|||
33332690|NCT02996110|62709261|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
33332691|NCT02996110|62709262|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
33332692|NCT02996110|62709263|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
33332693|NCT02996110|62709264|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
33332694|NCT02996110|62709265|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
33332695|NCT02996110|62709261|FG000|Track 2|Participant Withdrew Consent|1|||
33332696|NCT02996110|62709262|FG001|Track 2|Participant Withdrew Consent|2|||
33332697|NCT02996110|62709263|FG002|Track 2|Participant Withdrew Consent|3|||
33332698|NCT02996110|62709264|FG003|Track 2|Participant Withdrew Consent|1|||
33332699|NCT02996110|62709265|FG004|Track 2|Participant Withdrew Consent|1|||
33332700|NCT02996110|62709261|FG000|Track 2|Other Reasons|0|||
33332701|NCT02996110|62709262|FG001|Track 2|Other Reasons|0|||
33332702|NCT02996110|62709263|FG002|Track 2|Other Reasons|1|||
33332703|NCT02996110|62709264|FG003|Track 2|Other Reasons|0|||
33332704|NCT02996110|62709265|FG004|Track 2|Other Reasons|1|||
33332705|NCT00916617|62709283|FG000|Overall Study|Adverse Event|3|||
33332706|NCT00916617|62709284|FG001|Overall Study|Adverse Event|2|||
33332707|NCT00916617|62709285|FG002|Overall Study|Adverse Event|6|||
33332708|NCT00916617|62709286|FG003|Overall Study|Adverse Event|3|||
33332709|NCT00916617|62709283|FG000|Overall Study|Withdrawal by Subject|3|||
33332710|NCT00916617|62709284|FG001|Overall Study|Withdrawal by Subject|2|||
33332711|NCT00916617|62709285|FG002|Overall Study|Withdrawal by Subject|0|||
33332712|NCT00916617|62709286|FG003|Overall Study|Withdrawal by Subject|1|||
33332713|NCT00916617|62709283|FG000|Overall Study|Caregiver Request|3|||
33332714|NCT00916617|62709284|FG001|Overall Study|Caregiver Request|2|||
33332715|NCT00916617|62709285|FG002|Overall Study|Caregiver Request|1|||
33332716|NCT00916617|62709286|FG003|Overall Study|Caregiver Request|0|||
33332717|NCT00916617|62709283|FG000|Overall Study|Physician Decision|1|||
33332718|NCT00916617|62709284|FG001|Overall Study|Physician Decision|1|||
33332719|NCT00916617|62709285|FG002|Overall Study|Physician Decision|0|||
33332720|NCT00916617|62709286|FG003|Overall Study|Physician Decision|0|||
33332721|NCT00916617|62709283|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
33332722|NCT00916617|62709284|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
33332723|NCT00916617|62709285|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
33332724|NCT00916617|62709286|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
33332725|NCT00916617|62709283|FG000|Overall Study|Lost to Follow-up|2|||
33332726|NCT00916617|62709284|FG001|Overall Study|Lost to Follow-up|1|||
33332727|NCT00916617|62709285|FG002|Overall Study|Lost to Follow-up|0|||
33332728|NCT00916617|62709286|FG003|Overall Study|Lost to Follow-up|0|||
33332729|NCT00916617|62709283|FG000|Overall Study|Lack of Efficacy|1|||
33332730|NCT00916617|62709284|FG001|Overall Study|Lack of Efficacy|0|||
33332731|NCT00916617|62709285|FG002|Overall Study|Lack of Efficacy|0|||
33332732|NCT00916617|62709286|FG003|Overall Study|Lack of Efficacy|0|||
33332733|NCT00916617|62709283|FG000|Overall Study|Other|2|||
33332734|NCT00916617|62709284|FG001|Overall Study|Other|0|||
33332735|NCT00916617|62709285|FG002|Overall Study|Other|0|||
33332736|NCT00916617|62709286|FG003|Overall Study|Other|2|||
33332737|NCT01103063|62709298|FG000|Overall Study|Adverse Event|3|||
33332738|NCT01103063|62709299|FG001|Overall Study|Adverse Event|1|||
33332739|NCT01103063|62709298|FG000|Overall Study|Lost to Follow-up|68|||
33332740|NCT01103063|62709299|FG001|Overall Study|Lost to Follow-up|51|||
33332741|NCT01103063|62709298|FG000|Overall Study|Withdrawal by Subject|60|||
33332742|NCT01103063|62709299|FG001|Overall Study|Withdrawal by Subject|15|||
33332743|NCT01103063|62709298|FG000|Overall Study|Other|16|||
33332744|NCT01103063|62709299|FG001|Overall Study|Other|11|||
33332745|NCT01103063|62709298|FG000|Overall Study|Protocol Violation|1|||
33332746|NCT01103063|62709299|FG001|Overall Study|Protocol Violation|0|||
33332747|NCT01103063|62709298|FG000|Overall Study|Study terminated by Sponsor|326|||
33332748|NCT01103063|62709299|FG001|Overall Study|Study terminated by Sponsor|342|||
33332749|NCT01103063|62709298|FG000|Overall Study|Death|3|||
33332750|NCT01103063|62709299|FG001|Overall Study|Death|1|||
33332751|NCT01091675|62709307|FG000|Overall Study|Adverse Event|7|||
33332752|NCT01091675|62709307|FG000|Overall Study|Lack of Efficacy|27|||
33332753|NCT01091519|62709313|FG000|Overall Study|Adverse Event|12|||
33332754|NCT01091519|62709314|FG001|Overall Study|Adverse Event|16|||
33332755|NCT01091519|62709313|FG000|Overall Study|Death|1|||
33332756|NCT01091519|62709314|FG001|Overall Study|Death|0|||
33332757|NCT01091519|62709313|FG000|Overall Study|Lack of Efficacy|16|||
33332758|NCT01091519|62709314|FG001|Overall Study|Lack of Efficacy|19|||
33332759|NCT01091519|62709313|FG000|Overall Study|Lost to Follow-up|14|||
33332760|NCT01091519|62709314|FG001|Overall Study|Lost to Follow-up|24|||
33332761|NCT01091519|62709313|FG000|Overall Study|Withdrawal by Subject|2|||
33332762|NCT01091519|62709314|FG001|Overall Study|Withdrawal by Subject|2|||
33332763|NCT01091519|62709313|FG000|Overall Study|Other|6|||
33332764|NCT01091519|62709314|FG001|Overall Study|Other|8|||
33332765|NCT01091519|62709313|FG000|Overall Study|Randomized not treated|4|||
33332766|NCT01091519|62709314|FG001|Overall Study|Randomized not treated|4|||
33332767|NCT01011738|62709323|FG000|Overall Study|Death|12|||
33332768|NCT01011738|62709324|FG001|Overall Study|Death|3|||
33332769|NCT01011738|62709325|FG002|Overall Study|Death|0|||
33332770|NCT01011738|62709323|FG000|Overall Study|Unknown reasons|312|||
33332771|NCT01011738|62709324|FG001|Overall Study|Unknown reasons|291|||
33332772|NCT01011738|62709325|FG002|Overall Study|Unknown reasons|17|||
33332773|NCT00918333|62709336|FG000|Overall Study|Drug not taken per protocol|1|||
33332774|NCT00918333|62709337|FG001|Overall Study|Drug not taken per protocol|0|||
33332775|NCT00918333|62709336|FG000|Overall Study|Inadequate amount of drugs provided|1|||
33332776|NCT00918333|62709337|FG001|Overall Study|Inadequate amount of drugs provided|4|||
33332777|NCT00918333|62709336|FG000|Overall Study|Ineligible|1|||
33332778|NCT00918333|62709337|FG001|Overall Study|Ineligible|0|||
33332779|NCT00918333|62709336|FG000|Overall Study|Withdrawal by Subject|0|||
33332780|NCT00918333|62709337|FG001|Overall Study|Withdrawal by Subject|1|||
33332781|NCT01091363|62709348|FG000|Overall Study|Withdrawal by Subject|11|||
33332782|NCT01091363|62709349|FG001|Overall Study|Withdrawal by Subject|15|||
33332783|NCT01091363|62709348|FG000|Overall Study|Lost to Follow-up|2|||
33332784|NCT01091363|62709349|FG001|Overall Study|Lost to Follow-up|2|||
33332785|NCT01090973|62709355|FG000|Overall Study|Disease progression|1|||
33332786|NCT01090739|62709359|FG000|Enrollment|Withdrawal by Subject|24|||
33332787|NCT01090739|62709359|FG000|Enrollment|Protocol Violation|14|||
33332788|NCT01090739|62709359|FG000|Enrollment|Lost to Follow-up|5|||
33332789|NCT01090739|62709359|FG000|Enrollment|Physician Decision|5|||
33332790|NCT01090739|62709359|FG000|Enrollment|Sponsor termination of site|4|||
33332791|NCT01090739|62709359|FG000|Enrollment|Study implant limit reached|2|||
33332792|NCT01090739|62709359|FG000|Enrollment|Adverse Event|1|||
33332793|NCT01090739|62709359|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
33332794|NCT01090739|62709359|FG000|12 Month Follow-up|Lost to Follow-up|1|||
33332795|NCT01090739|62709359|FG000|12 Month Follow-up|Physician Decision|1|||
33332796|NCT01090739|62709359|FG000|12 Month Follow-up|Death|1|||
33332797|NCT01090739|62709359|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
33332798|NCT01090739|62709359|FG000|24 Month Follow-up|Lost to Follow-up|1|||
33332799|NCT01090739|62709359|FG000|24 Month Follow-up|Death|1|||
33332800|NCT01090739|62709359|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
33332801|NCT01090739|62709359|FG000|36 Month Follow-up|Visit still pending|17|||
33332802|NCT00916383|62709377|FG000|Overall Study|Adverse Event|1|||
33332803|NCT00916383|62709377|FG000|Overall Study|Death|1|||
33332804|NCT00916383|62709377|FG000|Overall Study|Protocol Violation|1|||
33332805|NCT00916305|62709387|FG000|Overall Study|Lost to Follow-up|21|||
33332806|NCT00916305|62709388|FG001|Overall Study|Lost to Follow-up|27|||
33332807|NCT00916305|62709387|FG000|Overall Study|Withdrawal by Subject|0|||
33332808|NCT00916305|62709388|FG001|Overall Study|Withdrawal by Subject|1|||
33332809|NCT00916149|62709397|FG000|Overall Study|Lost to Follow-up|3|||
33332810|NCT00916149|62709398|FG001|Overall Study|Lost to Follow-up|2|||
33332811|NCT00916149|62709399|FG002|Overall Study|Lost to Follow-up|0|||
33332812|NCT00916149|62709397|FG000|Overall Study|Unable to place scalp EEG leads|1|||
33332813|NCT00916149|62709398|FG001|Overall Study|Unable to place scalp EEG leads|0|||
33332814|NCT00916149|62709399|FG002|Overall Study|Unable to place scalp EEG leads|0|||
33332815|NCT01090427|62709409|FG000|After Controlled Period|Death|0|||
33332816|NCT01090427|62709410|FG001|After Controlled Period|Death|0|||
33332817|NCT01090427|62709411|FG002|After Controlled Period|Death|0|||
33332818|NCT01090427|62709412|FG003|After Controlled Period|Death|0|||
33332819|NCT01090427|62709413|FG004|After Controlled Period|Death|0|||
33332820|NCT01090427|62709414|FG005|After Controlled Period|Death|1|||
33332821|NCT01090427|62709415|FG006|After Controlled Period|Death|0|||
33332822|NCT01090427|62709409|FG000|After Controlled Period|Lack of Efficacy|0|||
33332823|NCT01090427|62709410|FG001|After Controlled Period|Lack of Efficacy|0|||
33332824|NCT01090427|62709411|FG002|After Controlled Period|Lack of Efficacy|0|||
33332825|NCT01090427|62709412|FG003|After Controlled Period|Lack of Efficacy|0|||
33332826|NCT01090427|62709413|FG004|After Controlled Period|Lack of Efficacy|0|||
33332827|NCT01090427|62709414|FG005|After Controlled Period|Lack of Efficacy|3|||
33332828|NCT01090427|62709415|FG006|After Controlled Period|Lack of Efficacy|2|||
33332829|NCT01090427|62709409|FG000|After Controlled Period|Adverse Event|0|||
33332830|NCT01090427|62709410|FG001|After Controlled Period|Adverse Event|0|||
33332831|NCT01090427|62709411|FG002|After Controlled Period|Adverse Event|0|||
33332832|NCT01090427|62709412|FG003|After Controlled Period|Adverse Event|2|||
33332833|NCT01090427|62709413|FG004|After Controlled Period|Adverse Event|0|||
33332834|NCT01090427|62709414|FG005|After Controlled Period|Adverse Event|1|||
33332835|NCT01090427|62709415|FG006|After Controlled Period|Adverse Event|0|||
33332836|NCT01016262|62709439|FG000|Double-blind Phase|Adverse Event|0|||
33332837|NCT01016262|62709440|FG001|Double-blind Phase|Adverse Event|0|||
33332838|NCT01016262|62709441|FG002|Double-blind Phase|Adverse Event|1|||
33332839|NCT01016262|62709442|FG003|Double-blind Phase|Adverse Event|0|||
33332840|NCT01016262|62709443|FG004|Double-blind Phase|Adverse Event|0|||
33332841|NCT01016262|62709444|FG005|Double-blind Phase|Adverse Event|0|||
33332842|NCT01016262|62709439|FG000|Double-blind Phase|Lack of Efficacy|1|||
33332843|NCT01016262|62709440|FG001|Double-blind Phase|Lack of Efficacy|0|||
33332844|NCT01016262|62709441|FG002|Double-blind Phase|Lack of Efficacy|5|||
33332845|NCT01016262|62709442|FG003|Double-blind Phase|Lack of Efficacy|0|||
33332846|NCT01016262|62709443|FG004|Double-blind Phase|Lack of Efficacy|0|||
33332847|NCT01016262|62709444|FG005|Double-blind Phase|Lack of Efficacy|0|||
33332848|NCT01016262|62709439|FG000|Double-blind Phase|Disease Progression|0|||
33332849|NCT01016262|62709440|FG001|Double-blind Phase|Disease Progression|1|||
33332850|NCT01016262|62709441|FG002|Double-blind Phase|Disease Progression|2|||
33332851|NCT01016262|62709442|FG003|Double-blind Phase|Disease Progression|0|||
33332852|NCT01016262|62709443|FG004|Double-blind Phase|Disease Progression|0|||
33332853|NCT01016262|62709444|FG005|Double-blind Phase|Disease Progression|0|||
33332854|NCT01016262|62709439|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
33332855|NCT01016262|62709440|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
33332856|NCT01016262|62709441|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
33332857|NCT01016262|62709442|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
33332858|NCT01016262|62709443|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
33332859|NCT01016262|62709444|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
33332860|NCT01016262|62709439|FG000|Open-Label Phase|Adverse Event|0|||
33332861|NCT01016262|62709440|FG001|Open-Label Phase|Adverse Event|0|||
33332862|NCT01016262|62709441|FG002|Open-Label Phase|Adverse Event|0|||
33332863|NCT01016262|62709442|FG003|Open-Label Phase|Adverse Event|1|||
33332864|NCT01016262|62709443|FG004|Open-Label Phase|Adverse Event|0|||
33332865|NCT01016262|62709444|FG005|Open-Label Phase|Adverse Event|0|||
33332866|NCT01016262|62709439|FG000|Open-Label Phase|Lost to Follow-up|0|||
33332867|NCT01016262|62709440|FG001|Open-Label Phase|Lost to Follow-up|0|||
33332868|NCT01016262|62709441|FG002|Open-Label Phase|Lost to Follow-up|0|||
33332869|NCT01016262|62709442|FG003|Open-Label Phase|Lost to Follow-up|0|||
33332870|NCT01016262|62709443|FG004|Open-Label Phase|Lost to Follow-up|1|||
33332871|NCT01016262|62709444|FG005|Open-Label Phase|Lost to Follow-up|0|||
33332872|NCT01016262|62709439|FG000|Open-Label Phase|Lack of Efficacy|0|||
33332873|NCT01016262|62709440|FG001|Open-Label Phase|Lack of Efficacy|0|||
33332874|NCT01016262|62709441|FG002|Open-Label Phase|Lack of Efficacy|0|||
33332875|NCT01016262|62709442|FG003|Open-Label Phase|Lack of Efficacy|1|||
33332876|NCT01016262|62709443|FG004|Open-Label Phase|Lack of Efficacy|0|||
33332877|NCT01016262|62709444|FG005|Open-Label Phase|Lack of Efficacy|0|||
33332878|NCT01016262|62709439|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
33332879|NCT01016262|62709440|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
33332880|NCT01016262|62709441|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
33332881|NCT01016262|62709442|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
33332882|NCT01016262|62709443|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
33332883|NCT01016262|62709444|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
33332884|NCT01001910|62709455|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
33332885|NCT01009554|62709461|FG000|Overall Study|Adverse Event|1|||
33332886|NCT01009554|62709462|FG001|Overall Study|Adverse Event|1|||
33332887|NCT01009554|62709461|FG000|Overall Study|Withdrawal by Subject|1|||
33332888|NCT01009554|62709462|FG001|Overall Study|Withdrawal by Subject|3|||
33332889|NCT01009554|62709461|FG000|Overall Study|Noncompliant with Study Product|0|||
33332890|NCT01009554|62709462|FG001|Overall Study|Noncompliant with Study Product|3|||
33332891|NCT01006590|62709470|FG000|Overall Study|Adverse Event|2|||
33332892|NCT01006590|62709471|FG001|Overall Study|Adverse Event|3|||
33332893|NCT01006590|62709470|FG000|Overall Study|Death|1|||
33332894|NCT01006590|62709471|FG001|Overall Study|Death|1|||
33332895|NCT01006590|62709470|FG000|Overall Study|Lost to Follow-up|1|||
33332896|NCT01006590|62709471|FG001|Overall Study|Lost to Follow-up|1|||
33332897|NCT01006590|62709470|FG000|Overall Study|Protocol Violation|1|||
33332898|NCT01006590|62709471|FG001|Overall Study|Protocol Violation|0|||
33332899|NCT01006590|62709470|FG000|Overall Study|Withdrawal by Subject|4|||
33332900|NCT01006590|62709471|FG001|Overall Study|Withdrawal by Subject|2|||
33332901|NCT01006590|62709470|FG000|Overall Study|Study specific discontinuation criteria|16|||
33332902|NCT01006590|62709471|FG001|Overall Study|Study specific discontinuation criteria|23|||
33332903|NCT01006590|62709470|FG000|Overall Study|Other|3|||
33332904|NCT01006590|62709471|FG001|Overall Study|Other|2|||
33332905|NCT01001832|62709479|FG000|Short-term Period|Adverse Event|2|||
33332906|NCT01001832|62709480|FG001|Short-term Period|Adverse Event|3|||
33332907|NCT01001832|62709479|FG000|Long-term Period|Adverse Event|2|||
33332908|NCT01001832|62709480|FG001|Long-term Period|Adverse Event|1|||
33332909|NCT01001832|62709479|FG000|Long-term Period|Withdrawal by Subject|1|||
33332910|NCT01001832|62709480|FG001|Long-term Period|Withdrawal by Subject|0|||
33332911|NCT01001832|62709479|FG000|Long-term Period|Lack of Efficacy|0|||
33332912|NCT01001832|62709480|FG001|Long-term Period|Lack of Efficacy|2|||
33332913|NCT01001832|62709479|FG000|Long-term Period|Other|1|||
33332914|NCT01001832|62709480|FG001|Long-term Period|Other|2|||
33332915|NCT01001832|62709479|FG000|Follow-up Period|Withdrawal by Subject|1|||
33332916|NCT01001832|62709480|FG001|Follow-up Period|Withdrawal by Subject|0|||
33332917|NCT01001832|62709479|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
33332918|NCT01001832|62709480|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
33332919|NCT01001832|62709479|FG000|Follow-up Period|Other|2|||
33332920|NCT01001832|62709480|FG001|Follow-up Period|Other|1|||
33332921|NCT01001598|62709489|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
33332922|NCT01001598|62709489|FG000|Overall Study|Adverse Event|1|||
33332923|NCT01006356|62709493|FG000|Overall Study|Adverse Event|6|||
33332924|NCT01006356|62709493|FG000|Overall Study|Physician Decision|1|||
33332925|NCT01006356|62709493|FG000|Overall Study|Paticipants did not cooperate|6|||
33332926|NCT01006356|62709493|FG000|Overall Study|Withdrawal by Subject|1|||
33332927|NCT01006356|62709493|FG000|Overall Study|Choice by participants|2|||
33332928|NCT01006356|62709493|FG000|Overall Study|Protocol Violation|3|||
33332929|NCT01006356|62709493|FG000|Overall Study|Other|23|||
33332930|NCT01089725|62709502|FG000|Overall Study|Adverse Event|1|||
33332931|NCT01089725|62709503|FG001|Overall Study|Adverse Event|1|||
33332932|NCT01089725|62709504|FG002|Overall Study|Adverse Event|0|||
33332933|NCT01089725|62709505|FG003|Overall Study|Adverse Event|0|||
33332934|NCT01089725|62709506|FG004|Overall Study|Adverse Event|2|||
33332935|NCT01089725|62709502|FG000|Overall Study|Lack of Efficacy|4|||
33332936|NCT01089725|62709503|FG001|Overall Study|Lack of Efficacy|3|||
33332937|NCT01089725|62709504|FG002|Overall Study|Lack of Efficacy|1|||
33332938|NCT01089725|62709505|FG003|Overall Study|Lack of Efficacy|0|||
33332939|NCT01089725|62709506|FG004|Overall Study|Lack of Efficacy|4|||
33332940|NCT01089725|62709502|FG000|Overall Study|Lost to Follow-up|2|||
33332941|NCT01089725|62709503|FG001|Overall Study|Lost to Follow-up|2|||
33332942|NCT01089725|62709504|FG002|Overall Study|Lost to Follow-up|0|||
33332943|NCT01089725|62709505|FG003|Overall Study|Lost to Follow-up|3|||
33332944|NCT01089725|62709506|FG004|Overall Study|Lost to Follow-up|0|||
33332945|NCT01089725|62709502|FG000|Overall Study|Protocol Violation|0|||
33332946|NCT01089725|62709503|FG001|Overall Study|Protocol Violation|0|||
33332947|NCT01089725|62709504|FG002|Overall Study|Protocol Violation|1|||
33332948|NCT01089725|62709505|FG003|Overall Study|Protocol Violation|1|||
33332949|NCT01089725|62709506|FG004|Overall Study|Protocol Violation|0|||
33332950|NCT01089725|62709502|FG000|Overall Study|Withdrawal by Subject|5|||
33332951|NCT01089725|62709503|FG001|Overall Study|Withdrawal by Subject|5|||
33332952|NCT01089725|62709504|FG002|Overall Study|Withdrawal by Subject|4|||
33468767|NCT00048048|62842535|FG000|Extension Year 2|Early withdrawals|0|||
33468768|NCT00048048|62842536|FG001|Extension Year 2|Early withdrawals|0|||
33332953|NCT01089725|62709505|FG003|Overall Study|Withdrawal by Subject|5|||
33332954|NCT01089725|62709506|FG004|Overall Study|Withdrawal by Subject|4|||
33332955|NCT01089725|62709502|FG000|Overall Study|Study Terminated by Sponsor|51|||
33332956|NCT01089725|62709503|FG001|Overall Study|Study Terminated by Sponsor|56|||
33332957|NCT01089725|62709504|FG002|Overall Study|Study Terminated by Sponsor|53|||
33332958|NCT01089725|62709505|FG003|Overall Study|Study Terminated by Sponsor|68|||
33332959|NCT01089725|62709506|FG004|Overall Study|Study Terminated by Sponsor|68|||
33332960|NCT01089725|62709502|FG000|Overall Study|Randomized, but not treated|0|||
33332961|NCT01089725|62709503|FG001|Overall Study|Randomized, but not treated|1|||
33332962|NCT01089725|62709504|FG002|Overall Study|Randomized, but not treated|2|||
33332963|NCT01089725|62709505|FG003|Overall Study|Randomized, but not treated|1|||
33332964|NCT01089725|62709506|FG004|Overall Study|Randomized, but not treated|2|||
33332965|NCT01089725|62709502|FG000|Overall Study|Other|3|||
33332966|NCT01089725|62709503|FG001|Overall Study|Other|0|||
33332967|NCT01089725|62709504|FG002|Overall Study|Other|0|||
33332968|NCT01089725|62709505|FG003|Overall Study|Other|1|||
33332969|NCT01089725|62709506|FG004|Overall Study|Other|0|||
33332970|NCT01101191|62709522|FG000|Period 1|Withdrawal by Subject|1|||
33332971|NCT01101191|62709523|FG001|Period 1|Withdrawal by Subject|0|||
33332972|NCT01101191|62709522|FG000|Period 1|Adverse Event|1|||
33332973|NCT01101191|62709523|FG001|Period 1|Adverse Event|2|||
33332974|NCT01178762|62709530|FG000|Overall Study|Lost to Follow-up|15|||
33332975|NCT01178294|62709534|FG000|Overall Study|Adverse Event|4|||
33332976|NCT01178294|62709534|FG000|Overall Study|Lost to Follow-up|2|||
33332977|NCT01178294|62709534|FG000|Overall Study|Lack of Efficacy|1|||
33332978|NCT01178294|62709534|FG000|Overall Study|Death|1|||
33332979|NCT01178294|62709534|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
33332980|NCT01178294|62709534|FG000|Overall Study|Subject status is terminal|1|||
33332981|NCT01178294|62709534|FG000|Overall Study|Completion status could not be verified|1|||
33332982|NCT01178138|62709538|FG000|Overall Study|Lost to Follow-up|8|||
33332983|NCT01178138|62709538|FG000|Overall Study|Withdrawal by Subject|7|||
33332984|NCT01178138|62709538|FG000|Overall Study|Physician Decision|8|||
33332985|NCT01177670|62709547|FG000|Overall Study|Study Terminated|115|||
33332986|NCT01177670|62709547|FG000|Overall Study|Physician Decision|50|||
33332987|NCT01177670|62709547|FG000|Overall Study|Withdrawal by Subject|4|||
33332988|NCT01190228|62709554|FG000|Overall Study|Protocol Violation|4|||
33332989|NCT01190228|62709555|FG001|Overall Study|Protocol Violation|0|||
33332990|NCT01190228|62709556|FG002|Overall Study|Protocol Violation|0|||
33332991|NCT01190228|62709554|FG000|Overall Study|Withdrawal by Subject|1|||
33332992|NCT01190228|62709555|FG001|Overall Study|Withdrawal by Subject|0|||
33332993|NCT01190228|62709556|FG002|Overall Study|Withdrawal by Subject|0|||
33332994|NCT01009086|62709569|FG000|Overall Study|Lack of Efficacy|16|||
33332995|NCT01009086|62709570|FG001|Overall Study|Lack of Efficacy|15|||
33332996|NCT01009086|62709571|FG002|Overall Study|Lack of Efficacy|9|||
33332997|NCT01009086|62709569|FG000|Overall Study|Lost to Follow-up|4|||
33332998|NCT01009086|62709570|FG001|Overall Study|Lost to Follow-up|5|||
33332999|NCT01009086|62709571|FG002|Overall Study|Lost to Follow-up|3|||
33333000|NCT01009086|62709569|FG000|Overall Study|Adverse Event|12|||
33333001|NCT01009086|62709570|FG001|Overall Study|Adverse Event|11|||
33333002|NCT01009086|62709571|FG002|Overall Study|Adverse Event|8|||
33333003|NCT01009086|62709569|FG000|Overall Study|Withdrawal by Subject|9|||
33333004|NCT01009086|62709570|FG001|Overall Study|Withdrawal by Subject|11|||
33333005|NCT01009086|62709571|FG002|Overall Study|Withdrawal by Subject|13|||
33333006|NCT01009086|62709569|FG000|Overall Study|Other|3|||
33333007|NCT01009086|62709570|FG001|Overall Study|Other|5|||
33333008|NCT01009086|62709571|FG002|Overall Study|Other|1|||
33333009|NCT01190150|62709586|FG000|First Treatment|Withdrawal by Subject|1|||
33333010|NCT01190150|62709587|FG001|First Treatment|Withdrawal by Subject|0|||
33333011|NCT01190150|62709586|FG000|Washout|Withdrawal by Subject|0|||
33333012|NCT01190150|62709587|FG001|Washout|Withdrawal by Subject|1|||
33333013|NCT01190150|62709586|FG000|Washout|Difficulty in adherence|0|||
33333014|NCT01190150|62709587|FG001|Washout|Difficulty in adherence|1|||
33333015|NCT01001520|62709593|FG000|Medication Period 1|Withdrawal by Subject|2|||
33333016|NCT01001520|62709594|FG001|Medication Period 1|Withdrawal by Subject|2|||
33333017|NCT01001520|62709593|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
33333018|NCT01001520|62709594|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
33333019|NCT01001520|62709593|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
33333020|NCT01001520|62709594|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
33333021|NCT01001520|62709593|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
33333022|NCT01001520|62709594|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
33333023|NCT01001520|62709593|FG000|Washout Period|Withdrawal by Subject|2|||
33653962|NCT01706198|63066513|FG001|Overall Study|Withdrawal by Subject|31|||
33333024|NCT01001520|62709594|FG001|Washout Period|Withdrawal by Subject|1|||
33653963|NCT01705730|63066519|FG000|Overall Study|Lack of Efficacy|1|||
33653964|NCT01705730|63066519|FG000|Overall Study|Adverse Event|3|||
33653965|NCT01705730|63066519|FG000|Overall Study|Lost to Follow-up|1|||
33333025|NCT01001520|62709593|FG000|Medication Period 2|Withdrawal by Subject|0|||
33333026|NCT01001520|62709594|FG001|Medication Period 2|Withdrawal by Subject|3|||
33333027|NCT01189604|62709618|FG000|Overall Study|Impossible to visit|0|||
33333028|NCT01189604|62709619|FG001|Overall Study|Impossible to visit|0|||
33333029|NCT01189604|62709620|FG002|Overall Study|Impossible to visit|0|||
33333030|NCT01189604|62709621|FG003|Overall Study|Impossible to visit|0|||
33333031|NCT01189604|62709622|FG004|Overall Study|Impossible to visit|0|||
33333032|NCT01189604|62709623|FG005|Overall Study|Impossible to visit|1|||
33333033|NCT01189604|62709624|FG006|Overall Study|Impossible to visit|0|||
33333034|NCT01189604|62709618|FG000|Overall Study|Adverse Event|0|||
33468769|NCT00048048|62842537|FG002|Extension Year 2|Early withdrawals|0|||
33468770|NCT00048048|62842538|FG003|Extension Year 2|Early withdrawals|0|||
33468771|NCT00048048|62842539|FG004|Extension Year 2|Early withdrawals|0|||
33548556|NCT02493868|62939856|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
33333035|NCT01189604|62709619|FG001|Overall Study|Adverse Event|1|||
33333036|NCT01189604|62709620|FG002|Overall Study|Adverse Event|0|||
33333037|NCT01189604|62709621|FG003|Overall Study|Adverse Event|0|||
33333038|NCT01189604|62709622|FG004|Overall Study|Adverse Event|2|||
33333039|NCT01189604|62709623|FG005|Overall Study|Adverse Event|0|||
33468772|NCT00048048|62842540|FG005|Extension Year 2|Early withdrawals|0|||
33548557|NCT02493868|62939855|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
33548558|NCT02493868|62939856|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
33548559|NCT02493868|62939855|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
33548560|NCT02493868|62939856|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
33548561|NCT02493868|62939855|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
33548562|NCT02493868|62939856|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
33548563|NCT02493868|62939855|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
33548564|NCT02493868|62939856|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
33548565|NCT02493868|62939855|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
33548566|NCT02493868|62939856|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
33548567|NCT02493868|62939855|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
33548568|NCT02493868|62939856|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
33548569|NCT02493868|62939855|FG000|Optimization Phase: DE+TE Participants|Other|10|||
33548570|NCT02493868|62939856|FG001|Optimization Phase: DE+TE Participants|Other|2|||
33333040|NCT01189604|62709624|FG006|Overall Study|Adverse Event|1|||
33333041|NCT01189604|62709618|FG000|Overall Study|Withdrawal by Subject|1|||
33333042|NCT01189604|62709619|FG001|Overall Study|Withdrawal by Subject|0|||
33333043|NCT01189604|62709620|FG002|Overall Study|Withdrawal by Subject|0|||
33333044|NCT01189604|62709621|FG003|Overall Study|Withdrawal by Subject|0|||
33333045|NCT01189604|62709622|FG004|Overall Study|Withdrawal by Subject|0|||
33333046|NCT01189604|62709623|FG005|Overall Study|Withdrawal by Subject|0|||
33333047|NCT01189604|62709624|FG006|Overall Study|Withdrawal by Subject|0|||
33333048|NCT01008696|62709642|FG000|Overall Study|Participant's evasion of hospital visit|5|||
33333049|NCT01008696|62709643|FG001|Overall Study|Participant's evasion of hospital visit|4|||
33333050|NCT01008696|62709642|FG000|Overall Study|Withdrawal by Subject|2|||
33333051|NCT01008696|62709643|FG001|Overall Study|Withdrawal by Subject|4|||
33333052|NCT01008696|62709642|FG000|Overall Study|Physician Decision|5|||
33333053|NCT01008696|62709643|FG001|Overall Study|Physician Decision|1|||
33333054|NCT01008696|62709642|FG000|Overall Study|Adverse Event|1|||
33333055|NCT01008696|62709643|FG001|Overall Study|Adverse Event|0|||
33333056|NCT01008696|62709642|FG000|Overall Study|Participants' non-cooperation|2|||
33333057|NCT01008696|62709643|FG001|Overall Study|Participants' non-cooperation|3|||
33333058|NCT01008696|62709642|FG000|Overall Study|Other|2|||
33333059|NCT01008696|62709643|FG001|Overall Study|Other|3|||
33333060|NCT01008696|62709642|FG000|Overall Study|Other|0|||
33333061|NCT01008696|62709643|FG001|Overall Study|Other|2|||
33333062|NCT01176968|62709662|FG000|Overall Study|Adverse Event|10|||
33333063|NCT01176968|62709663|FG001|Overall Study|Adverse Event|11|||
33333064|NCT01176968|62709662|FG000|Overall Study|Death|2|||
33333065|NCT01176968|62709663|FG001|Overall Study|Death|3|||
33333066|NCT01176968|62709662|FG000|Overall Study|Lack of Efficacy|0|||
33333067|NCT01176968|62709663|FG001|Overall Study|Lack of Efficacy|1|||
33333068|NCT01176968|62709662|FG000|Overall Study|Lost to Follow-up|16|||
33333069|NCT01176968|62709663|FG001|Overall Study|Lost to Follow-up|14|||
33333070|NCT01176968|62709662|FG000|Overall Study|Withdrawal by Subject|48|||
33333071|NCT01176968|62709663|FG001|Overall Study|Withdrawal by Subject|48|||
33548571|NCT02493868|62939855|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
33333072|NCT01176968|62709662|FG000|Overall Study|Protocol Violation|2|||
33333073|NCT01176968|62709663|FG001|Overall Study|Protocol Violation|1|||
33333074|NCT01176968|62709662|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
33333075|NCT01176968|62709663|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
33333076|NCT01176968|62709662|FG000|Overall Study|Study terminated by sponsor|0|||
33333077|NCT01176968|62709663|FG001|Overall Study|Study terminated by sponsor|1|||
33333078|NCT01176968|62709662|FG000|Overall Study|Reason not defined|5|||
33333079|NCT01176968|62709663|FG001|Overall Study|Reason not defined|3|||
33333080|NCT01006122|62709674|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
33333081|NCT01006122|62709675|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
33333082|NCT01006122|62709674|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
33333083|NCT01006122|62709675|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
33333084|NCT01006122|62709674|FG000|First Double-blind Intervention Period|Pregnancy|0|||
33333085|NCT01006122|62709675|FG001|First Double-blind Intervention Period|Pregnancy|1|||
33333086|NCT01006122|62709674|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
33333087|NCT01006122|62709675|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
33333088|NCT01006122|62709674|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
33333089|NCT01006122|62709675|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
33333090|NCT01006122|62709674|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
33333091|NCT01006122|62709675|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
33333092|NCT01006122|62709674|FG000|First Double-blind Intervention Period|Other|3|||
33333093|NCT01006122|62709675|FG001|First Double-blind Intervention Period|Other|0|||
33333094|NCT01006122|62709674|FG000|First Double-blind Intervention Period|Adverse Event|0|||
33333095|NCT01006122|62709675|FG001|First Double-blind Intervention Period|Adverse Event|4|||
33333096|NCT01006122|62709674|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
33333097|NCT01006122|62709675|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
33333098|NCT01006122|62709674|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
33333099|NCT01006122|62709675|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
33333100|NCT01006122|62709674|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
33333101|NCT01006122|62709675|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
33333102|NCT01006122|62709674|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
33333103|NCT01006122|62709675|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
33333104|NCT01006122|62709674|FG000|Second Double-blind Intervention Period|Death|0|||
33333105|NCT01006122|62709675|FG001|Second Double-blind Intervention Period|Death|1|||
33333106|NCT01005966|62709681|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
33333107|NCT01005966|62709682|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
33333108|NCT01005966|62709683|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
33333109|NCT01005966|62709684|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
33333110|NCT01005966|62709685|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
33333111|NCT01005966|62709681|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
33333112|NCT01005966|62709682|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
33333113|NCT01005966|62709683|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
33333114|NCT01005966|62709684|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
33333115|NCT01005966|62709685|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
33333116|NCT01005966|62709681|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
33333117|NCT01005966|62709682|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
33333118|NCT01005966|62709683|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
33333119|NCT01005966|62709684|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
33333120|NCT01005966|62709685|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
33333121|NCT01005966|62709681|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
33333122|NCT01005966|62709682|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
33333123|NCT01005966|62709683|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
33468773|NCT00048048|62842541|FG006|Extension Year 2|Early withdrawals|0|||
33468774|NCT00048048|62842542|FG007|Extension Year 2|Early withdrawals|0|||
33468775|NCT00048048|62842543|FG008|Extension Year 2|Early withdrawals|0|||
33333124|NCT01005966|62709684|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
33333125|NCT01005966|62709685|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
33333126|NCT01005966|62709681|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33333127|NCT01005966|62709682|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33468776|NCT00048048|62842544|FG009|Extension Year 2|Early withdrawals|0|||
33333128|NCT01005966|62709683|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33333129|NCT01005966|62709684|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
33333130|NCT01005966|62709685|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33333131|NCT01005966|62709681|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33333132|NCT01005966|62709682|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33333133|NCT01005966|62709683|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
33333134|NCT01005966|62709684|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33333135|NCT01005966|62709685|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33333136|NCT01005966|62709681|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
33333137|NCT01005966|62709682|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
33333138|NCT01005966|62709683|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
33333139|NCT01005966|62709684|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
33333140|NCT01005966|62709685|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
33333141|NCT01005966|62709681|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
33333142|NCT01005966|62709682|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
33333143|NCT01005966|62709683|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
33333144|NCT01005966|62709684|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
33333145|NCT01005966|62709685|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
33333146|NCT01005966|62709681|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
33333147|NCT01005966|62709682|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
33333148|NCT01005966|62709683|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
33333149|NCT01005966|62709684|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
33333150|NCT01005966|62709685|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
33333151|NCT01005732|62709711|FG000|Overall Study|Lost to Follow-up|10|||
33333152|NCT01005732|62709711|FG000|Overall Study|Death|1|||
33333153|NCT00603382|62709725|FG000|Overall Study|Adverse Event|0|||
33333154|NCT00603382|62709726|FG001|Overall Study|Adverse Event|1|||
33333155|NCT00603382|62709727|FG002|Overall Study|Adverse Event|1|||
33333156|NCT00603382|62709728|FG003|Overall Study|Adverse Event|2|||
33333157|NCT00603382|62709729|FG004|Overall Study|Adverse Event|1|||
33333158|NCT00603382|62709730|FG005|Overall Study|Adverse Event|2|||
33333159|NCT00603382|62709725|FG000|Overall Study|Lack of Efficacy|14|||
33333160|NCT00603382|62709726|FG001|Overall Study|Lack of Efficacy|9|||
33333161|NCT00603382|62709727|FG002|Overall Study|Lack of Efficacy|3|||
33333162|NCT00603382|62709728|FG003|Overall Study|Lack of Efficacy|6|||
33333163|NCT00603382|62709729|FG004|Overall Study|Lack of Efficacy|6|||
33333164|NCT00603382|62709730|FG005|Overall Study|Lack of Efficacy|11|||
33333165|NCT00603382|62709725|FG000|Overall Study|Protocol Violation|1|||
33333166|NCT00603382|62709726|FG001|Overall Study|Protocol Violation|0|||
33333167|NCT00603382|62709727|FG002|Overall Study|Protocol Violation|1|||
33333168|NCT00603382|62709728|FG003|Overall Study|Protocol Violation|2|||
33333169|NCT00603382|62709729|FG004|Overall Study|Protocol Violation|1|||
33333170|NCT00603382|62709730|FG005|Overall Study|Protocol Violation|0|||
33333171|NCT00603382|62709725|FG000|Overall Study|Lost to Follow-up|0|||
33333172|NCT00603382|62709726|FG001|Overall Study|Lost to Follow-up|1|||
33333173|NCT00603382|62709727|FG002|Overall Study|Lost to Follow-up|1|||
33333174|NCT00603382|62709728|FG003|Overall Study|Lost to Follow-up|1|||
33333175|NCT00603382|62709729|FG004|Overall Study|Lost to Follow-up|0|||
33333176|NCT00603382|62709730|FG005|Overall Study|Lost to Follow-up|1|||
33333177|NCT00603382|62709725|FG000|Overall Study|Physician Decision|0|||
33333178|NCT00603382|62709726|FG001|Overall Study|Physician Decision|0|||
33333179|NCT00603382|62709727|FG002|Overall Study|Physician Decision|2|||
33333180|NCT00603382|62709728|FG003|Overall Study|Physician Decision|0|||
33333181|NCT00603382|62709729|FG004|Overall Study|Physician Decision|1|||
33333182|NCT00603382|62709730|FG005|Overall Study|Physician Decision|3|||
33333183|NCT00603382|62709725|FG000|Overall Study|Withdrawal by Subject|3|||
33333184|NCT00603382|62709726|FG001|Overall Study|Withdrawal by Subject|3|||
33333185|NCT00603382|62709727|FG002|Overall Study|Withdrawal by Subject|1|||
33333186|NCT00603382|62709728|FG003|Overall Study|Withdrawal by Subject|1|||
33333187|NCT00603382|62709729|FG004|Overall Study|Withdrawal by Subject|0|||
33333188|NCT00603382|62709730|FG005|Overall Study|Withdrawal by Subject|1|||
33333189|NCT01176266|62709744|FG000|Overall Study|Death|6|||
33333190|NCT01176266|62709744|FG000|Overall Study|Withdrawal by Subject|3|||
33333191|NCT01182428|62709754|FG000|Overall Study|Physician Decision|1|||
33333192|NCT01182428|62709755|FG001|Overall Study|Physician Decision|0|||
33333193|NCT01182428|62709754|FG000|Overall Study|Lost to Follow-up|9|||
33333194|NCT01182428|62709755|FG001|Overall Study|Lost to Follow-up|1|||
33333195|NCT01182428|62709754|FG000|Overall Study|Withdrawal by Subject|1|||
33333196|NCT01182428|62709755|FG001|Overall Study|Withdrawal by Subject|0|||
33333197|NCT00603304|62709763|FG000|Overall Study|Lost to Follow-up|5|||
33333198|NCT00603304|62709764|FG001|Overall Study|Lost to Follow-up|7|||
33333199|NCT00603304|62709763|FG000|Overall Study|Withdrawal by Subject|8|||
33333200|NCT00603304|62709764|FG001|Overall Study|Withdrawal by Subject|5|||
33333201|NCT00603304|62709763|FG000|Overall Study|Protocol Violation|1|||
33333202|NCT00603304|62709764|FG001|Overall Study|Protocol Violation|0|||
33333203|NCT00603304|62709763|FG000|Overall Study|Adverse Event|4|||
33333204|NCT00603304|62709764|FG001|Overall Study|Adverse Event|2|||
33333205|NCT00603304|62709763|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
33333206|NCT00603304|62709764|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
33333207|NCT00603304|62709763|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
33333208|NCT00603304|62709764|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
33333209|NCT00603304|62709763|FG000|Overall Study|Exclusionary Medication|2|||
33333210|NCT00603304|62709764|FG001|Overall Study|Exclusionary Medication|3|||
33333211|NCT00603304|62709763|FG000|Overall Study|Non-Compliant|0|||
33333212|NCT00603304|62709764|FG001|Overall Study|Non-Compliant|1|||
33333213|NCT00603304|62709763|FG000|Overall Study|Moved Away|0|||
33333214|NCT00603304|62709764|FG001|Overall Study|Moved Away|2|||
33333215|NCT00603304|62709763|FG000|Overall Study|Other|2|||
33333216|NCT00603304|62709764|FG001|Overall Study|Other|0|||
33333217|NCT00603304|62709763|FG000|Overall Study|Patient Decision|2|||
33333218|NCT00603304|62709764|FG001|Overall Study|Patient Decision|0|||
33333219|NCT01176032|62709774|FG000|Overall Study|Adverse Event|1|||
33333220|NCT01176032|62709775|FG001|Overall Study|Adverse Event|0|||
33333221|NCT01176032|62709774|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33333222|NCT01176032|62709775|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33333223|NCT01176032|62709774|FG000|Overall Study|Protocol Violation|1|||
33333224|NCT01176032|62709775|FG001|Overall Study|Protocol Violation|0|||
33333225|NCT01176032|62709774|FG000|Overall Study|Informed consent withdrawn|3|||
33333226|NCT01176032|62709775|FG001|Overall Study|Informed consent withdrawn|0|||
33333227|NCT01176032|62709774|FG000|Overall Study|Other|1|||
33333228|NCT01176032|62709775|FG001|Overall Study|Other|0|||
33333229|NCT01008618|62709786|FG000|Period 1 (Titration Period)|Physician Decision|2|||
33333230|NCT01008618|62709787|FG001|Period 1 (Titration Period)|Physician Decision|0|||
33333231|NCT01008618|62709788|FG002|Period 1 (Titration Period)|Physician Decision|0|||
33333232|NCT01008618|62709786|FG000|Period 1 (Titration Period)|Adverse Event|33|||
33333233|NCT01008618|62709787|FG001|Period 1 (Titration Period)|Adverse Event|0|||
33333234|NCT01008618|62709788|FG002|Period 1 (Titration Period)|Adverse Event|0|||
33333235|NCT01008618|62709786|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
33333236|NCT01008618|62709787|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
33333237|NCT01008618|62709788|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
33333238|NCT01008618|62709786|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
33333239|NCT01008618|62709787|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
33333240|NCT01008618|62709788|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
33333241|NCT01008618|62709786|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
33333242|NCT01008618|62709787|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
33333243|NCT01008618|62709788|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
33333244|NCT01008618|62709786|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
33333245|NCT01008618|62709787|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
33333246|NCT01008618|62709788|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
33333247|NCT01008618|62709786|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
33333248|NCT01008618|62709787|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
33333249|NCT01008618|62709788|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
33333250|NCT01008618|62709786|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
33333251|NCT01008618|62709787|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
33333252|NCT01008618|62709788|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
33333253|NCT01008618|62709786|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
33333254|NCT01008618|62709787|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
33333255|NCT01008618|62709788|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
33333256|NCT01008618|62709786|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
33333257|NCT01008618|62709787|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
33333258|NCT01008618|62709788|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
33333259|NCT01008618|62709786|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
33333260|NCT01008618|62709787|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
33333261|NCT01008618|62709788|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
33333262|NCT01008618|62709786|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
33333263|NCT01008618|62709787|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
33333264|NCT01008618|62709788|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
33333265|NCT01001208|62709799|FG000|Overall Study|Adverse Event|10|||
33333266|NCT01001208|62709800|FG001|Overall Study|Adverse Event|5|||
33333267|NCT01001208|62709799|FG000|Overall Study|Lost to Follow-up|5|||
33333268|NCT01001208|62709800|FG001|Overall Study|Lost to Follow-up|9|||
33333269|NCT01001208|62709799|FG000|Overall Study|Physician Decision|1|||
33333270|NCT01001208|62709800|FG001|Overall Study|Physician Decision|0|||
33333271|NCT01001208|62709799|FG000|Overall Study|Withdrawal by Subject|4|||
33333272|NCT01001208|62709800|FG001|Overall Study|Withdrawal by Subject|5|||
33333273|NCT01001208|62709799|FG000|Overall Study|Ineligibility Determined|4|||
33333274|NCT01001208|62709800|FG001|Overall Study|Ineligibility Determined|2|||
33333275|NCT01001208|62709799|FG000|Overall Study|Noncompliance|4|||
33333276|NCT01001208|62709800|FG001|Overall Study|Noncompliance|7|||
33333277|NCT01001208|62709799|FG000|Overall Study|Disease Progression|0|||
33333278|NCT01001208|62709800|FG001|Overall Study|Disease Progression|3|||
33333279|NCT01001208|62709799|FG000|Overall Study|Other|0|||
33333280|NCT01001208|62709800|FG001|Overall Study|Other|2|||
33333281|NCT01000974|62709809|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
33333282|NCT01000974|62709810|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
33333283|NCT01000974|62709811|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
33333284|NCT01000974|62709809|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
33333285|NCT01000974|62709810|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
33333286|NCT01000974|62709811|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
33333287|NCT01000974|62709809|FG000|Primary Vaccination Phase|Protocol Violation|40|||
33333288|NCT01000974|62709810|FG001|Primary Vaccination Phase|Protocol Violation|3|||
33333289|NCT01000974|62709811|FG002|Primary Vaccination Phase|Protocol Violation|2|||
33333290|NCT01000974|62709809|FG000|Primary Vaccination Phase|Adverse Event|14|||
33333291|NCT01000974|62709810|FG001|Primary Vaccination Phase|Adverse Event|2|||
33333292|NCT01000974|62709811|FG002|Primary Vaccination Phase|Adverse Event|2|||
33333293|NCT01000974|62709809|FG000|Primary Vaccination Phase|Other|4|||
33333294|NCT01000974|62709810|FG001|Primary Vaccination Phase|Other|9|||
33333295|NCT01000974|62709811|FG002|Primary Vaccination Phase|Other|12|||
33333296|NCT01000974|62709809|FG000|Booster Vaccination Phase|Protocol Violation|0|||
33333297|NCT01000974|62709810|FG001|Booster Vaccination Phase|Protocol Violation|0|||
33333298|NCT01000974|62709811|FG002|Booster Vaccination Phase|Protocol Violation|2|||
33333299|NCT01000974|62709809|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
33333300|NCT01000974|62709810|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
33333301|NCT01000974|62709811|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
33333302|NCT01000974|62709809|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
33333303|NCT01000974|62709810|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
33333304|NCT01000974|62709811|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
33333305|NCT01000974|62709809|FG000|Booster Vaccination Phase|Other|24|||
33333306|NCT01000974|62709810|FG001|Booster Vaccination Phase|Other|6|||
33333307|NCT01000974|62709811|FG002|Booster Vaccination Phase|Other|4|||
33333308|NCT01193842|62709827|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
33333309|NCT01193842|62709828|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
33333310|NCT01193842|62709829|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
33333311|NCT01193842|62709830|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
33333312|NCT01193842|62709831|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
33333313|NCT01193842|62709827|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
33333314|NCT01193842|62709828|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
33333315|NCT01193842|62709829|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
33333316|NCT01193842|62709830|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
33333317|NCT01193842|62709831|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
33333318|NCT01193842|62709827|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
33333319|NCT01193842|62709828|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
33333320|NCT01193842|62709829|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
33333321|NCT01193842|62709830|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
33333322|NCT01193842|62709831|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
33333323|NCT01193842|62709827|FG000|Phase II: Randomized Groups|Death|0|||
33333324|NCT01193842|62709828|FG001|Phase II: Randomized Groups|Death|0|||
33333325|NCT01193842|62709829|FG002|Phase II: Randomized Groups|Death|0|||
33333326|NCT01193842|62709830|FG003|Phase II: Randomized Groups|Death|1|||
33333327|NCT01193842|62709831|FG004|Phase II: Randomized Groups|Death|1|||
33333328|NCT01193842|62709827|FG000|Phase II: Randomized Groups|Adverse Event|0|||
33333329|NCT01193842|62709828|FG001|Phase II: Randomized Groups|Adverse Event|0|||
33333330|NCT01193842|62709829|FG002|Phase II: Randomized Groups|Adverse Event|0|||
33333331|NCT01193842|62709830|FG003|Phase II: Randomized Groups|Adverse Event|5|||
33333332|NCT01193842|62709831|FG004|Phase II: Randomized Groups|Adverse Event|3|||
33333333|NCT01193842|62709827|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
33333334|NCT01193842|62709828|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
33333335|NCT01193842|62709829|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
33333336|NCT01193842|62709830|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
33333337|NCT01193842|62709831|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
33333338|NCT01193842|62709827|FG000|Phase II: Randomized Groups|Ineligible|0|||
33333339|NCT01193842|62709828|FG001|Phase II: Randomized Groups|Ineligible|0|||
33333340|NCT01193842|62709829|FG002|Phase II: Randomized Groups|Ineligible|0|||
33333341|NCT01193842|62709830|FG003|Phase II: Randomized Groups|Ineligible|0|||
33333342|NCT01193842|62709831|FG004|Phase II: Randomized Groups|Ineligible|1|||
33333343|NCT01193842|62709827|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
33333344|NCT01193842|62709828|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
33333345|NCT01193842|62709829|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
33333346|NCT01193842|62709830|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
33333347|NCT01193842|62709831|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
33333348|NCT01004406|62709850|FG000|Overall Study|Withdrawal by Subject|2|||
33333349|NCT01004406|62709851|FG001|Overall Study|Withdrawal by Subject|0|||
33333350|NCT01004406|62709850|FG000|Overall Study|Lost to Follow-up|1|||
33333351|NCT01004406|62709851|FG001|Overall Study|Lost to Follow-up|0|||
33333352|NCT01182350|62709866|FG000|Overall Study|Adverse Event|5|||
33333353|NCT01182350|62709867|FG001|Overall Study|Adverse Event|0|||
33333354|NCT01182350|62709868|FG002|Overall Study|Adverse Event|0|||
33333355|NCT01182350|62709869|FG003|Overall Study|Adverse Event|0|||
33333356|NCT01182350|62709870|FG004|Overall Study|Adverse Event|0|||
33333357|NCT01182350|62709866|FG000|Overall Study|Disease Progression|15|||
33333358|NCT01182350|62709867|FG001|Overall Study|Disease Progression|12|||
33333359|NCT01182350|62709868|FG002|Overall Study|Disease Progression|0|||
33333360|NCT01182350|62709869|FG003|Overall Study|Disease Progression|1|||
33333361|NCT01182350|62709870|FG004|Overall Study|Disease Progression|0|||
33333362|NCT01182350|62709866|FG000|Overall Study|Death|0|||
33333363|NCT01182350|62709867|FG001|Overall Study|Death|1|||
33333364|NCT01182350|62709868|FG002|Overall Study|Death|1|||
33333365|NCT01182350|62709869|FG003|Overall Study|Death|0|||
33333366|NCT01182350|62709870|FG004|Overall Study|Death|0|||
33333367|NCT01182350|62709866|FG000|Overall Study|Withdrawal by Subject|3|||
33333368|NCT01182350|62709867|FG001|Overall Study|Withdrawal by Subject|1|||
33333369|NCT01182350|62709868|FG002|Overall Study|Withdrawal by Subject|0|||
33333370|NCT01182350|62709869|FG003|Overall Study|Withdrawal by Subject|1|||
33333371|NCT01182350|62709870|FG004|Overall Study|Withdrawal by Subject|0|||
33333372|NCT01182350|62709866|FG000|Overall Study|Alternative Therapy|2|||
33333373|NCT01182350|62709867|FG001|Overall Study|Alternative Therapy|0|||
33333374|NCT01182350|62709868|FG002|Overall Study|Alternative Therapy|1|||
33333375|NCT01182350|62709869|FG003|Overall Study|Alternative Therapy|0|||
33333376|NCT01182350|62709870|FG004|Overall Study|Alternative Therapy|0|||
33333377|NCT01182350|62709866|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
33333378|NCT01182350|62709867|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
33333379|NCT01182350|62709868|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
33333380|NCT01182350|62709869|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
33333381|NCT01182350|62709870|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
33333382|NCT01182350|62709866|FG000|Overall Study|Unevaluable for Biopsy|0|||
33333383|NCT01182350|62709867|FG001|Overall Study|Unevaluable for Biopsy|0|||
33333384|NCT01182350|62709868|FG002|Overall Study|Unevaluable for Biopsy|0|||
33333385|NCT01182350|62709869|FG003|Overall Study|Unevaluable for Biopsy|0|||
33333386|NCT01182350|62709870|FG004|Overall Study|Unevaluable for Biopsy|3|||
33333387|NCT01163474|62709886|FG000|Overall Study|Withdrawal by Subject|1|||
33333388|NCT01163474|62709886|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
33333389|NCT01163474|62709886|FG000|Overall Study|Lost to Follow-up|3|||
33333390|NCT00603538|62709896|FG000|Overall Study|Adverse Event|0|||
33333391|NCT00603538|62709897|FG001|Overall Study|Adverse Event|4|||
33333392|NCT00603538|62709898|FG002|Overall Study|Adverse Event|2|||
33333393|NCT00603538|62709896|FG000|Overall Study|Objective progression or relapse|3|||
33333394|NCT00603538|62709897|FG001|Overall Study|Objective progression or relapse|0|||
33333395|NCT00603538|62709898|FG002|Overall Study|Objective progression or relapse|0|||
33333396|NCT01163318|62709909|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
33333397|NCT01163318|62709909|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
33333398|NCT01163318|62709909|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
33333399|NCT01163318|62709909|FG000|Overall Study|Participants Without Case Report Form|7|||
33333400|NCT01163318|62709909|FG000|Overall Study|Multiple Reasons Per Participant|224|||
33333401|NCT01162304|62709913|FG000|Overall Study|Beck scale to high|11|||
33333402|NCT04515394|62709919|FG000|Overall Study|Participant did not receive treatment|1|||
33333403|NCT01175018|62709925|FG000|Overall Study|Adverse Event|3|||
33333404|NCT01175018|62709926|FG001|Overall Study|Adverse Event|1|||
33333405|NCT01174784|62709934|FG000|Overall Study|Screen fails|4|||
33333406|NCT01174550|62709941|FG000|Overall Study|Death|75|||
33333407|NCT01174550|62709942|FG001|Overall Study|Death|74|||
33333408|NCT01174550|62709941|FG000|Overall Study|Lost to Follow-up|652|||
33333409|NCT01174550|62709942|FG001|Overall Study|Lost to Follow-up|510|||
33333410|NCT01174550|62709941|FG000|Overall Study|Withdrawal by Subject|543|||
33333411|NCT01174550|62709942|FG001|Overall Study|Withdrawal by Subject|289|||
33333412|NCT01008150|62709952|FG000|Overall Study|did not receive study drug|1|||
33333413|NCT01008150|62709953|FG001|Overall Study|did not receive study drug|1|||
33333414|NCT01008150|62709954|FG002|Overall Study|did not receive study drug|1|||
33333415|NCT01008150|62709955|FG003|Overall Study|did not receive study drug|0|||
33333416|NCT01007916|62709966|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
33333417|NCT01007916|62709967|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
33333418|NCT01007916|62709966|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
33333419|NCT01007916|62709967|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
33333420|NCT01007838|62709977|FG000|Overall Study|Withdrawal by Subject|1|||
33333421|NCT01007838|62709978|FG001|Overall Study|Withdrawal by Subject|0|||
33333422|NCT01007838|62709979|FG002|Overall Study|Withdrawal by Subject|0|||
33333423|NCT01007838|62709980|FG003|Overall Study|Withdrawal by Subject|0|||
33333424|NCT01007838|62709977|FG000|Overall Study|Physician Decision|1|||
33333425|NCT01007838|62709978|FG001|Overall Study|Physician Decision|0|||
33333426|NCT01007838|62709979|FG002|Overall Study|Physician Decision|0|||
33333427|NCT01007838|62709980|FG003|Overall Study|Physician Decision|0|||
33333428|NCT01007838|62709977|FG000|Overall Study|Started home haemodialysis|1|||
33333429|NCT01007838|62709978|FG001|Overall Study|Started home haemodialysis|0|||
33333430|NCT01007838|62709979|FG002|Overall Study|Started home haemodialysis|0|||
33333431|NCT01007838|62709980|FG003|Overall Study|Started home haemodialysis|0|||
33333432|NCT01007448|62709992|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
33333433|NCT01007448|62709993|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
33333434|NCT01007448|62709992|FG000|Overall Study|Staph Skin Infection Flare|1|||
33333435|NCT01007448|62709993|FG001|Overall Study|Staph Skin Infection Flare|0|||
33333436|NCT01007448|62709992|FG000|Overall Study|Participant Leaving the Country|1|||
33333437|NCT01007448|62709993|FG001|Overall Study|Participant Leaving the Country|0|||
33333438|NCT01007448|62709992|FG000|Overall Study|Participant Given Prohibited Medication|1|||
33333439|NCT01007448|62709993|FG001|Overall Study|Participant Given Prohibited Medication|0|||
33333440|NCT01007448|62709992|FG000|Overall Study|Progressive Disease|1|||
33333441|NCT01007448|62709993|FG001|Overall Study|Progressive Disease|2|||
33333442|NCT01007448|62709992|FG000|Overall Study|Lack of Efficacy|2|||
33333443|NCT01007448|62709993|FG001|Overall Study|Lack of Efficacy|0|||
33333444|NCT01007448|62709992|FG000|Overall Study|Withdrawal by Subject|2|||
33333445|NCT01007448|62709993|FG001|Overall Study|Withdrawal by Subject|3|||
33333446|NCT01007448|62709992|FG000|Overall Study|Adverse Event|1|||
33333447|NCT01007448|62709993|FG001|Overall Study|Adverse Event|4|||
33333448|NCT03538756|62709999|FG000|Long-Term Follow-up|Adverse Event|0|||
33333449|NCT03538756|62710000|FG001|Long-Term Follow-up|Adverse Event|0|||
33333450|NCT03538756|62710001|FG002|Long-Term Follow-up|Adverse Event|6|||
33333451|NCT03538756|62709999|FG000|Long-Term Follow-up|Death|0|||
33333452|NCT03538756|62710000|FG001|Long-Term Follow-up|Death|0|||
33333453|NCT03538756|62710001|FG002|Long-Term Follow-up|Death|1|||
33333454|NCT03538756|62709999|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
33333455|NCT03538756|62710000|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
33468777|NCT00048048|62842545|FG010|Extension Year 2|Early withdrawals|4|||
33333456|NCT03538756|62710001|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
33333457|NCT03538756|62709999|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
33333458|NCT03538756|62710000|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
33333459|NCT03538756|62710001|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
33468778|NCT00048048|62842546|FG011|Extension Year 2|Early withdrawals|2|||
33468779|NCT00300053|62842576|FG000|Overall Study|Patient/Caregiver Preference|2|||
33468780|NCT00300053|62842577|FG001|Overall Study|Patient/Caregiver Preference|2|||
33333460|NCT03538756|62709999|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
33333461|NCT03538756|62710000|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
33333462|NCT03538756|62710001|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
33333463|NCT01004250|62710011|FG000|Induction Therapy Period|Adverse Event|10|||
33333464|NCT01004250|62710011|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
33333465|NCT01004250|62710011|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
33333466|NCT01004250|62710011|FG000|Induction Therapy Period|Physician Decision|2|||
33333467|NCT01004250|62710011|FG000|Maintenance Therapy Period|Adverse Event|15|||
33468781|NCT00300053|62842578|FG002|Overall Study|Patient/Caregiver Preference|3|||
33333468|NCT01004250|62710011|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
33333469|NCT01004250|62710011|FG000|Maintenance Therapy Period|Protocol Violation|1|||
33333470|NCT01004250|62710011|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
33333471|NCT01004250|62710011|FG000|Maintenance Therapy Period|Physician Decision|4|||
33333472|NCT01004250|62710011|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
33333473|NCT01004172|62710019|FG000|Overall Study|Progressive Disease in CNS Only|16|||
33333474|NCT01004172|62710019|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
33333475|NCT01004172|62710019|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
33333476|NCT01004172|62710019|FG000|Overall Study|Adverse Event|1|||
33333477|NCT01004172|62710019|FG000|Overall Study|Physician Decision|1|||
33333478|NCT01004172|62710019|FG000|Overall Study|Symptomatic Deterioration|2|||
33333479|NCT01161524|62710026|FG000|Core Study (23 Weeks)|Adverse Event|3|||
33333480|NCT01161524|62710027|FG001|Core Study (23 Weeks)|Adverse Event|0|||
33333481|NCT01161524|62710028|FG002|Core Study (23 Weeks)|Adverse Event|0|||
33333482|NCT01161524|62710026|FG000|Core Study (23 Weeks)|Other|1|||
33333483|NCT01161524|62710027|FG001|Core Study (23 Weeks)|Other|0|||
33333484|NCT01161524|62710028|FG002|Core Study (23 Weeks)|Other|0|||
33333485|NCT01161524|62710026|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
33333486|NCT01161524|62710027|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
33333487|NCT01161524|62710028|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
33333488|NCT01161524|62710026|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
33333489|NCT01161524|62710027|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
33333490|NCT01161524|62710028|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
33333491|NCT01161524|62710026|FG000|Core Study (23 Weeks)|Subject Choice|3|||
33333492|NCT01161524|62710027|FG001|Core Study (23 Weeks)|Subject Choice|2|||
33333493|NCT01161524|62710028|FG002|Core Study (23 Weeks)|Subject Choice|0|||
33333494|NCT01161524|62710026|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
33333495|NCT01161524|62710027|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
33333496|NCT01161524|62710028|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
33333497|NCT01161524|62710026|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
33333498|NCT01161524|62710027|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
33333499|NCT01161524|62710028|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
33333500|NCT01161524|62710026|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
33333501|NCT01161524|62710027|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
33333502|NCT01161524|62710028|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
33333503|NCT01161524|62710026|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
33548572|NCT02493868|62939856|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
33548573|NCT02493868|62939855|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
33548574|NCT02493868|62939856|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
33333504|NCT01161524|62710027|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
33333505|NCT01161524|62710028|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
33333506|NCT01161524|62710026|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
33333507|NCT01161524|62710027|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
33333508|NCT01161524|62710028|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
33333509|NCT01000506|62710041|FG000|Overall Study|Adverse Event|6|||
33333510|NCT01000506|62710042|FG001|Overall Study|Adverse Event|5|||
33333511|NCT01000506|62710043|FG002|Overall Study|Adverse Event|8|||
33333512|NCT01000506|62710044|FG003|Overall Study|Adverse Event|9|||
33333513|NCT01000506|62710041|FG000|Overall Study|Lack of Efficacy|8|||
33333514|NCT01000506|62710042|FG001|Overall Study|Lack of Efficacy|6|||
33333515|NCT01000506|62710043|FG002|Overall Study|Lack of Efficacy|4|||
33333516|NCT01000506|62710044|FG003|Overall Study|Lack of Efficacy|4|||
33333517|NCT01000506|62710041|FG000|Overall Study|Protocol Violation|1|||
33333518|NCT01000506|62710042|FG001|Overall Study|Protocol Violation|1|||
33333519|NCT01000506|62710043|FG002|Overall Study|Protocol Violation|0|||
33333520|NCT01000506|62710044|FG003|Overall Study|Protocol Violation|0|||
33333521|NCT01000506|62710041|FG000|Overall Study|Lost to Follow-up|1|||
33333522|NCT01000506|62710042|FG001|Overall Study|Lost to Follow-up|1|||
33333523|NCT01000506|62710043|FG002|Overall Study|Lost to Follow-up|4|||
33548575|NCT02493868|62939855|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
33548576|NCT02493868|62939856|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
33333524|NCT01000506|62710044|FG003|Overall Study|Lost to Follow-up|0|||
33333525|NCT01000506|62710041|FG000|Overall Study|Physician Decision|1|||
33333526|NCT01000506|62710042|FG001|Overall Study|Physician Decision|3|||
33468782|NCT00300053|62842576|FG000|Overall Study|Death|0|||
33468783|NCT00300053|62842577|FG001|Overall Study|Death|0|||
33333527|NCT01000506|62710043|FG002|Overall Study|Physician Decision|3|||
33333528|NCT01000506|62710044|FG003|Overall Study|Physician Decision|3|||
33333529|NCT01000506|62710041|FG000|Overall Study|Withdrawal by Subject|11|||
33333530|NCT01000506|62710042|FG001|Overall Study|Withdrawal by Subject|8|||
33333531|NCT01000506|62710043|FG002|Overall Study|Withdrawal by Subject|2|||
33333532|NCT01000506|62710044|FG003|Overall Study|Withdrawal by Subject|7|||
33468784|NCT00300053|62842578|FG002|Overall Study|Death|3|||
33333533|NCT01174238|62710054|FG000|Overall Study|Lost to Follow-up|2|||
33333534|NCT01174160|62710063|FG000|Overall Study|Adverse Event|1|||
33333535|NCT01174160|62710064|FG001|Overall Study|Adverse Event|0|||
33333536|NCT01174160|62710063|FG000|Overall Study|Lost to Follow-up|1|||
33333537|NCT01174160|62710064|FG001|Overall Study|Lost to Follow-up|0|||
33333538|NCT01174160|62710063|FG000|Overall Study|Physician Decision|1|||
33333539|NCT01174160|62710064|FG001|Overall Study|Physician Decision|0|||
33333540|NCT01174160|62710063|FG000|Overall Study|Protocol Violation|4|||
33333541|NCT01174160|62710064|FG001|Overall Study|Protocol Violation|6|||
33333542|NCT01174160|62710063|FG000|Overall Study|Withdrawal by Subject|1|||
33333543|NCT01174160|62710064|FG001|Overall Study|Withdrawal by Subject|0|||
33333544|NCT01161446|62710072|FG000|Overall Study|Lost to Follow-up|18|||
33333545|NCT01161446|62710073|FG001|Overall Study|Lost to Follow-up|14|||
33333546|NCT01161446|62710072|FG000|Overall Study|Withdrawal by Subject|0|||
33333547|NCT01161446|62710073|FG001|Overall Study|Withdrawal by Subject|1|||
33333548|NCT01174004|62710081|FG000|Overall Study|Adverse Event|2|||
33333549|NCT01174004|62710082|FG001|Overall Study|Adverse Event|10|||
33333550|NCT01174004|62710081|FG000|Overall Study|Withdrawal by Subject|2|||
33333551|NCT01174004|62710082|FG001|Overall Study|Withdrawal by Subject|3|||
33333552|NCT01174004|62710081|FG000|Overall Study|At Discretion of Sponsor|2|||
33333553|NCT01174004|62710082|FG001|Overall Study|At Discretion of Sponsor|2|||
33333554|NCT01174004|62710081|FG000|Overall Study|Protocol Violation|0|||
33333555|NCT01174004|62710082|FG001|Overall Study|Protocol Violation|1|||
33333556|NCT01174004|62710081|FG000|Overall Study|Physician Decision|1|||
33333557|NCT01174004|62710082|FG001|Overall Study|Physician Decision|0|||
33333558|NCT01173692|62710090|FG000|Overall Study|Adverse Event|1|||
33333559|NCT01173692|62710091|FG001|Overall Study|Adverse Event|2|||
33333560|NCT01173692|62710090|FG000|Overall Study|Withdrawal by Subject|1|||
33333561|NCT01173692|62710091|FG001|Overall Study|Withdrawal by Subject|3|||
33333562|NCT01101035|62710099|FG000|Overall Study|Adverse Event|191|||
33333563|NCT01101035|62710100|FG001|Overall Study|Adverse Event|172|||
33333564|NCT01101035|62710099|FG000|Overall Study|Major Protocol Deviation|52|||
33333565|NCT01101035|62710100|FG001|Overall Study|Major Protocol Deviation|46|||
33333566|NCT01101035|62710099|FG000|Overall Study|Lost to Follow-up|226|||
33333567|NCT01101035|62710100|FG001|Overall Study|Lost to Follow-up|223|||
33333568|NCT01101035|62710099|FG000|Overall Study|Voluntary Withdrawal|595|||
33333569|NCT01101035|62710100|FG001|Overall Study|Voluntary Withdrawal|587|||
33333570|NCT01101035|62710099|FG000|Overall Study|Reason not Specified|333|||
33333571|NCT01101035|62710100|FG001|Overall Study|Reason not Specified|363|||
33333572|NCT01100567|62710108|FG000|Overall Study|Withdrawal by Subject|5|||
33333573|NCT01100567|62710109|FG001|Overall Study|Withdrawal by Subject|8|||
33333574|NCT01100567|62710108|FG000|Overall Study|Early Hospital Discharge|6|||
33333575|NCT01100567|62710109|FG001|Overall Study|Early Hospital Discharge|4|||
33333576|NCT01100567|62710108|FG000|Overall Study|Lost to Follow-up|1|||
33333577|NCT01100567|62710109|FG001|Overall Study|Lost to Follow-up|2|||
33333578|NCT01100567|62710108|FG000|Overall Study|Physician Decision|0|||
33333579|NCT01100567|62710109|FG001|Overall Study|Physician Decision|1|||
33333580|NCT01100567|62710108|FG000|Overall Study|Deemed ineligible after consent|0|||
33333581|NCT01100567|62710109|FG001|Overall Study|Deemed ineligible after consent|1|||
33333582|NCT01160822|62710122|FG000|Overall Study|Adverse Event|0|||
33333583|NCT01160822|62710123|FG001|Overall Study|Adverse Event|0|||
33333584|NCT01160822|62710124|FG002|Overall Study|Adverse Event|0|||
33333585|NCT01160822|62710125|FG003|Overall Study|Adverse Event|0|||
33333586|NCT01160822|62710126|FG004|Overall Study|Adverse Event|1|||
33333587|NCT01160822|62710127|FG005|Overall Study|Adverse Event|2|||
33333588|NCT01160822|62710128|FG006|Overall Study|Adverse Event|5|||
33333589|NCT01160822|62710122|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33333590|NCT01160822|62710123|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33333591|NCT01160822|62710124|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33333592|NCT01160822|62710125|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
33333593|NCT01160822|62710126|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
33333594|NCT01160822|62710127|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
33333595|NCT01160822|62710128|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
33333596|NCT01160822|62710122|FG000|Overall Study|Withdrawal by Subject|0|||
33333597|NCT01160822|62710123|FG001|Overall Study|Withdrawal by Subject|0|||
33333598|NCT01160822|62710124|FG002|Overall Study|Withdrawal by Subject|0|||
33333599|NCT01160822|62710125|FG003|Overall Study|Withdrawal by Subject|0|||
33468785|NCT00300053|62842576|FG000|Overall Study|Lost to Follow-up|0|||
33333600|NCT01160822|62710126|FG004|Overall Study|Withdrawal by Subject|0|||
33333601|NCT01160822|62710127|FG005|Overall Study|Withdrawal by Subject|0|||
33333602|NCT01160822|62710128|FG006|Overall Study|Withdrawal by Subject|1|||
33333603|NCT01160822|62710122|FG000|Overall Study|Lost to Follow-up|0|||
33333604|NCT01160822|62710123|FG001|Overall Study|Lost to Follow-up|0|||
33333605|NCT01160822|62710124|FG002|Overall Study|Lost to Follow-up|0|||
33333606|NCT01160822|62710125|FG003|Overall Study|Lost to Follow-up|0|||
33333607|NCT01160822|62710126|FG004|Overall Study|Lost to Follow-up|1|||
33333608|NCT01160822|62710127|FG005|Overall Study|Lost to Follow-up|0|||
33468786|NCT00300053|62842577|FG001|Overall Study|Lost to Follow-up|1|||
33333609|NCT01160822|62710128|FG006|Overall Study|Lost to Follow-up|0|||
33333610|NCT01160822|62710122|FG000|Overall Study|Administrative problems|0|||
33333611|NCT01160822|62710123|FG001|Overall Study|Administrative problems|0|||
33333612|NCT01160822|62710124|FG002|Overall Study|Administrative problems|0|||
33333613|NCT01160822|62710125|FG003|Overall Study|Administrative problems|0|||
33333614|NCT01160822|62710126|FG004|Overall Study|Administrative problems|1|||
33333615|NCT01160822|62710127|FG005|Overall Study|Administrative problems|0|||
33333616|NCT01160822|62710128|FG006|Overall Study|Administrative problems|0|||
33333617|NCT01160822|62710122|FG000|Overall Study|Protocol deviation|0|||
33333618|NCT01160822|62710123|FG001|Overall Study|Protocol deviation|0|||
33333619|NCT01160822|62710124|FG002|Overall Study|Protocol deviation|0|||
33333620|NCT01160822|62710125|FG003|Overall Study|Protocol deviation|0|||
33333621|NCT01160822|62710126|FG004|Overall Study|Protocol deviation|2|||
33333622|NCT01160822|62710127|FG005|Overall Study|Protocol deviation|0|||
33333623|NCT01160822|62710128|FG006|Overall Study|Protocol deviation|0|||
33333624|NCT01006980|62710147|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
33333625|NCT01006980|62710148|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
33333626|NCT01006980|62710147|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
33333627|NCT01006980|62710148|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
33333628|NCT01006980|62710147|FG000|Vemurafenib and Dacarbazine|Death|13|||
33333629|NCT01006980|62710148|FG001|Vemurafenib and Dacarbazine|Death|12|||
33333630|NCT01006980|62710147|FG000|Vemurafenib and Dacarbazine|Progression|257|||
33333631|NCT01006980|62710148|FG001|Vemurafenib and Dacarbazine|Progression|218|||
33333632|NCT01006980|62710147|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
33333633|NCT01006980|62710148|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
33333634|NCT01006980|62710147|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
33333635|NCT01006980|62710148|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
33333636|NCT01006980|62710147|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
33333637|NCT01006980|62710148|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
33333638|NCT01006980|62710147|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
33333639|NCT01006980|62710148|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
33333640|NCT01006980|62710147|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
33333641|NCT01006980|62710148|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
33333642|NCT01006980|62710147|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
33333643|NCT01006980|62710148|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
33333644|NCT01006980|62710147|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
33333645|NCT01006980|62710148|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
33333646|NCT01006980|62710147|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
33333647|NCT01006980|62710148|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
33333648|NCT01006980|62710147|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
33333649|NCT01006980|62710148|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
33333650|NCT00887926|62710159|FG000|Overall Study|Withdrawal by Subject|0|||
33333651|NCT00887926|62710160|FG001|Overall Study|Withdrawal by Subject|1|||
33333652|NCT00887926|62710161|FG002|Overall Study|Withdrawal by Subject|0|||
33333653|NCT00887926|62710162|FG003|Overall Study|Withdrawal by Subject|0|||
33333654|NCT00998400|62710180|FG000|Overall Study|Lack of interest/motivation|1|||
33333655|NCT00998400|62710181|FG001|Overall Study|Lack of interest/motivation|2|||
33333656|NCT00998400|62710180|FG000|Overall Study|Logistical problems|1|||
33333657|NCT00998400|62710181|FG001|Overall Study|Logistical problems|0|||
33333658|NCT00997386|62710188|FG000|Overall Study|Death|7|||
33468787|NCT00300053|62842578|FG002|Overall Study|Lost to Follow-up|0|||
33333659|NCT00996996|62710192|FG000|Overall Study|Progressive Disease|10|||
33333660|NCT00996996|62710192|FG000|Overall Study|Non-compliance|8|||
33333661|NCT00996996|62710192|FG000|Overall Study|Lost to Follow-up|9|||
33333662|NCT00996996|62710192|FG000|Overall Study|Death|5|||
33333663|NCT00996996|62710192|FG000|Overall Study|Did Not Receive Study Medications|1|||
33333664|NCT00996918|62710201|FG000|Overall Study|Lack of Efficacy|1|||
33468788|NCT00299975|62842590|FG000|Overall Study|Adverse Event|1|||
33468789|NCT00299975|62842591|FG001|Overall Study|Adverse Event|0|||
33468790|NCT00299975|62842592|FG002|Overall Study|Adverse Event|2|||
33333665|NCT00996918|62710202|FG001|Overall Study|Lack of Efficacy|1|||
33333666|NCT00996918|62710203|FG002|Overall Study|Lack of Efficacy|2|||
33333667|NCT00996918|62710204|FG003|Overall Study|Lack of Efficacy|2|||
33333668|NCT00996918|62710205|FG004|Overall Study|Lack of Efficacy|0|||
33333669|NCT00996918|62710201|FG000|Overall Study|Adverse Event|2|||
33333670|NCT00996918|62710202|FG001|Overall Study|Adverse Event|5|||
33333671|NCT00996918|62710203|FG002|Overall Study|Adverse Event|2|||
33333672|NCT00996918|62710204|FG003|Overall Study|Adverse Event|6|||
33333673|NCT00996918|62710205|FG004|Overall Study|Adverse Event|0|||
33333674|NCT00996918|62710201|FG000|Overall Study|Withdrawal by Subject|1|||
33333675|NCT00996918|62710202|FG001|Overall Study|Withdrawal by Subject|4|||
33333676|NCT00996918|62710203|FG002|Overall Study|Withdrawal by Subject|3|||
33333677|NCT00996918|62710204|FG003|Overall Study|Withdrawal by Subject|3|||
33333678|NCT00996918|62710205|FG004|Overall Study|Withdrawal by Subject|2|||
33333679|NCT00996918|62710201|FG000|Overall Study|Physician Decision|1|||
33333680|NCT00996918|62710202|FG001|Overall Study|Physician Decision|0|||
33333681|NCT00996918|62710203|FG002|Overall Study|Physician Decision|0|||
33333682|NCT00996918|62710204|FG003|Overall Study|Physician Decision|0|||
33333683|NCT00996918|62710205|FG004|Overall Study|Physician Decision|0|||
33333684|NCT00996918|62710201|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
33333685|NCT00996918|62710202|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
33333686|NCT00996918|62710203|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
33333687|NCT00996918|62710204|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
33333688|NCT00996918|62710205|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
33333689|NCT00996918|62710201|FG000|Overall Study|Loss of Caregiver|0|||
33333690|NCT00996918|62710202|FG001|Overall Study|Loss of Caregiver|1|||
33333691|NCT00996918|62710203|FG002|Overall Study|Loss of Caregiver|0|||
33333692|NCT00996918|62710204|FG003|Overall Study|Loss of Caregiver|0|||
33333693|NCT00996918|62710205|FG004|Overall Study|Loss of Caregiver|0|||
33333694|NCT00996918|62710201|FG000|Overall Study|Other|3|||
33333695|NCT00996918|62710202|FG001|Overall Study|Other|1|||
33548577|NCT02493868|62939855|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
33548578|NCT02493868|62939856|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
33548579|NCT02493868|62939855|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
33548580|NCT02493868|62939856|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
33548581|NCT02493868|62939855|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
33548582|NCT02493868|62939856|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
33548583|NCT02493868|62939855|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
33548584|NCT02493868|62939856|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
33548585|NCT02493868|62939855|FG000|Follow-up Phase|Lost to Follow-up|1|||
33548586|NCT02493868|62939856|FG001|Follow-up Phase|Lost to Follow-up|0|||
33548587|NCT02493868|62939855|FG000|Follow-up Phase|Withdrawal by Subject|3|||
33548588|NCT02493868|62939856|FG001|Follow-up Phase|Withdrawal by Subject|0|||
33548589|NCT02493868|62939855|FG000|Follow-up Phase|Investigator Decision|5|||
33548590|NCT02493868|62939856|FG001|Follow-up Phase|Investigator Decision|1|||
33548591|NCT02493868|62939855|FG000|Follow-up Phase|Other|2|||
33548592|NCT02493868|62939856|FG001|Follow-up Phase|Other|1|||
33548593|NCT02516410|62939870|FG000|Overall Study|Adverse Event|0|||
33548594|NCT02516410|62939871|FG001|Overall Study|Adverse Event|1|||
33548595|NCT02516410|62939870|FG000|Overall Study|Withdrawal by Subject|0|||
33548596|NCT02516410|62939871|FG001|Overall Study|Withdrawal by Subject|1|||
33548597|NCT02493712|62939881|FG000|Overall Study|Withdrawal by Subject|1|||
33548598|NCT02493712|62939882|FG001|Overall Study|Withdrawal by Subject|0|||
33548599|NCT02493712|62939883|FG002|Overall Study|Withdrawal by Subject|2|||
33548600|NCT02493712|62939881|FG000|Overall Study|Protocol Violation|0|||
33548601|NCT02493712|62939882|FG001|Overall Study|Protocol Violation|0|||
33548602|NCT02493712|62939883|FG002|Overall Study|Protocol Violation|1|||
33548603|NCT02493712|62939881|FG000|Overall Study|Lost to Follow-up|1|||
33548604|NCT02493712|62939882|FG001|Overall Study|Lost to Follow-up|0|||
33548605|NCT02493712|62939883|FG002|Overall Study|Lost to Follow-up|0|||
33548606|NCT02493712|62939881|FG000|Overall Study|Physician Decision|0|||
33548607|NCT02493712|62939882|FG001|Overall Study|Physician Decision|1|||
33333696|NCT00996918|62710203|FG002|Overall Study|Other|0|||
33333697|NCT00996918|62710204|FG003|Overall Study|Other|0|||
33333698|NCT00996918|62710205|FG004|Overall Study|Other|0|||
33333699|NCT01160744|62710221|FG000|Overall Study|Withdrawal by Subject|11|||
33333700|NCT01160744|62710222|FG001|Overall Study|Withdrawal by Subject|5|||
33333701|NCT01160744|62710223|FG002|Overall Study|Withdrawal by Subject|6|||
33468791|NCT00299975|62842590|FG000|Overall Study|Pregnancy|0|||
33548608|NCT02493712|62939883|FG002|Overall Study|Physician Decision|0|||
33548609|NCT02493712|62939881|FG000|Overall Study|Lack of Efficacy|0|||
33548610|NCT02493712|62939882|FG001|Overall Study|Lack of Efficacy|5|||
33548611|NCT02493712|62939883|FG002|Overall Study|Lack of Efficacy|3|||
33333702|NCT01160744|62710224|FG003|Overall Study|Withdrawal by Subject|4|||
33333703|NCT01160744|62710221|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
33333704|NCT01160744|62710222|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
33333705|NCT01160744|62710223|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
33333706|NCT01160744|62710224|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
33333707|NCT01160354|62710239|FG000|Overall Study|Death|0|||
33333708|NCT01160354|62710240|FG001|Overall Study|Death|1|||
33333709|NCT01160354|62710241|FG002|Overall Study|Death|1|||
33333710|NCT01160198|62710252|FG000|Overall Study|Withdrawal by Subject|2|||
33333711|NCT01160198|62710253|FG001|Overall Study|Withdrawal by Subject|1|||
33333712|NCT01160198|62710254|FG002|Overall Study|Withdrawal by Subject|0|||
33333713|NCT01160198|62710252|FG000|Overall Study|Adverse Event|0|||
33333714|NCT01160198|62710253|FG001|Overall Study|Adverse Event|1|||
33333715|NCT01160198|62710254|FG002|Overall Study|Adverse Event|0|||
33333716|NCT01160198|62710252|FG000|Overall Study|Lost to Follow-up|0|||
33333717|NCT01160198|62710253|FG001|Overall Study|Lost to Follow-up|1|||
33333718|NCT01160198|62710254|FG002|Overall Study|Lost to Follow-up|0|||
33333719|NCT01160198|62710252|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
33333720|NCT01160198|62710253|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
33333721|NCT01160198|62710254|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
33333722|NCT01159574|62710262|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
33333723|NCT01159574|62710262|FG000|Treatment Phase|Adverse Event|3|||
33333724|NCT01159574|62710262|FG000|Treatment Phase|Death|6|||
33333725|NCT01159574|62710262|FG000|Treatment Phase|Physician Decision|2|||
33333726|NCT01159574|62710262|FG000|Treatment Phase|Withdrawal by Subject|7|||
33333727|NCT01159574|62710262|FG000|Treatment Phase|still on treatment|2|||
33333728|NCT01159574|62710262|FG000|Follow Up Phase|Lost to Follow-up|2|||
33333729|NCT01159574|62710262|FG000|Follow Up Phase|still being followed for overall surviva|18|||
33333730|NCT01158950|62710266|FG000|1st Intervention (1 Day)|Physician Decision|1|||
33333731|NCT01158950|62710267|FG001|1st Intervention (1 Day)|Physician Decision|2|||
33333732|NCT01172288|62710274|FG000|Overall Study|Adverse Event|1|||
33333733|NCT01172288|62710275|FG001|Overall Study|Adverse Event|0|||
33333734|NCT01172288|62710274|FG000|Overall Study|Protocol Violation|0|||
33333735|NCT01172288|62710275|FG001|Overall Study|Protocol Violation|1|||
33468792|NCT00299975|62842591|FG001|Overall Study|Pregnancy|0|||
33468793|NCT00299975|62842592|FG002|Overall Study|Pregnancy|1|||
33468794|NCT00299975|62842590|FG000|Overall Study|Lack of Efficacy|1|||
33468795|NCT00299975|62842591|FG001|Overall Study|Lack of Efficacy|0|||
33468796|NCT00299975|62842592|FG002|Overall Study|Lack of Efficacy|1|||
33468797|NCT00299975|62842590|FG000|Overall Study|Lost to Follow-up|1|||
33468798|NCT00299975|62842591|FG001|Overall Study|Lost to Follow-up|0|||
33468799|NCT00299975|62842592|FG002|Overall Study|Lost to Follow-up|0|||
33468800|NCT00299975|62842590|FG000|Overall Study|Withdrawal by Subject|0|||
33468801|NCT00299975|62842591|FG001|Overall Study|Withdrawal by Subject|1|||
33468802|NCT00299975|62842592|FG002|Overall Study|Withdrawal by Subject|3|||
33468803|NCT00299975|62842590|FG000|Overall Study|Physician Decision|0|||
33468804|NCT00299975|62842591|FG001|Overall Study|Physician Decision|0|||
33468805|NCT00299975|62842592|FG002|Overall Study|Physician Decision|1|||
33468806|NCT00004980|62842602|FG000|Overall Study|Withdrawal by Subject|1|||
33548612|NCT02516332|62939894|FG000|Overall Study|Withdrawal by Subject|2|||
33333736|NCT00996840|62710286|FG000|Overall Study|Adverse Event|0|||
33468807|NCT00004980|62842603|FG001|Overall Study|Withdrawal by Subject|0|||
33333737|NCT00996840|62710287|FG001|Overall Study|Adverse Event|1|||
33333738|NCT00996840|62710288|FG002|Overall Study|Adverse Event|0|||
33333739|NCT00996840|62710289|FG003|Overall Study|Adverse Event|0|||
33468808|NCT00004980|62842602|FG000|Overall Study|memory difficulties|1|||
33333740|NCT00996840|62710290|FG004|Overall Study|Adverse Event|0|||
33653966|NCT01705730|63066519|FG000|Overall Study|Reason not Specified|4|||
33653967|NCT01705652|63066525|FG000|Overall Study|Adverse Event|1|||
33653968|NCT01705652|63066526|FG001|Overall Study|Adverse Event|0|||
33653969|NCT01705652|63066525|FG000|Overall Study|Withdrawal by Subject|1|||
33653970|NCT01705652|63066526|FG001|Overall Study|Withdrawal by Subject|2|||
33653971|NCT01705652|63066525|FG000|Overall Study|non-compliance|1|||
33653972|NCT01705652|63066526|FG001|Overall Study|non-compliance|1|||
33653973|NCT01705574|63066554|FG000|Double-Blind Phase|Lost to Follow-up|12|||
33653974|NCT01705574|63066555|FG001|Double-Blind Phase|Lost to Follow-up|16|||
33653975|NCT01705574|63066556|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33653976|NCT01705574|63066557|FG003|Double-Blind Phase|Lost to Follow-up|0|||
33653977|NCT01705574|63066554|FG000|Double-Blind Phase|Adverse Event|3|||
33653978|NCT01705574|63066555|FG001|Double-Blind Phase|Adverse Event|10|||
33653979|NCT01705574|63066556|FG002|Double-Blind Phase|Adverse Event|0|||
33653980|NCT01705574|63066557|FG003|Double-Blind Phase|Adverse Event|0|||
33653981|NCT01705574|63066554|FG000|Double-Blind Phase|Withdrew Consent|8|||
33653982|NCT01705574|63066555|FG001|Double-Blind Phase|Withdrew Consent|5|||
33653983|NCT01705574|63066556|FG002|Double-Blind Phase|Withdrew Consent|0|||
33653984|NCT01705574|63066557|FG003|Double-Blind Phase|Withdrew Consent|0|||
33653985|NCT01705574|63066554|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
33653986|NCT01705574|63066555|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
33653987|NCT01705574|63066556|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
33653988|NCT01705574|63066557|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
33653989|NCT01705574|63066554|FG000|Double-Blind Phase|Pregnancy|1|||
33653990|NCT01705574|63066555|FG001|Double-Blind Phase|Pregnancy|1|||
33653991|NCT01705574|63066556|FG002|Double-Blind Phase|Pregnancy|0|||
33653992|NCT01705574|63066557|FG003|Double-Blind Phase|Pregnancy|0|||
33653993|NCT01705574|63066554|FG000|Double-Blind Phase|Protocol Violation|1|||
33653994|NCT01705574|63066555|FG001|Double-Blind Phase|Protocol Violation|0|||
33653995|NCT01705574|63066556|FG002|Double-Blind Phase|Protocol Violation|0|||
33653996|NCT01705574|63066557|FG003|Double-Blind Phase|Protocol Violation|0|||
33653997|NCT01705574|63066554|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
33653998|NCT01705574|63066555|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
33653999|NCT01705574|63066556|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
33654000|NCT01705574|63066557|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
33654001|NCT01705574|63066554|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
33654002|NCT01705574|63066555|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
33654003|NCT01705574|63066556|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
33654004|NCT01705574|63066557|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
33654005|NCT01705574|63066554|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
33654006|NCT01705574|63066555|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
33654007|NCT01705574|63066556|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
33654008|NCT01705574|63066557|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
33654009|NCT01705574|63066554|FG000|Open-Label Extension Phase|Adverse Event|3|||
33654010|NCT01705574|63066555|FG001|Open-Label Extension Phase|Adverse Event|0|||
33654011|NCT01705574|63066556|FG002|Open-Label Extension Phase|Adverse Event|0|||
33654012|NCT01705574|63066557|FG003|Open-Label Extension Phase|Adverse Event|1|||
33654013|NCT01705574|63066554|FG000|Open-Label Extension Phase|Death|2|||
33654014|NCT01705574|63066555|FG001|Open-Label Extension Phase|Death|0|||
33333741|NCT00996840|62710286|FG000|Overall Study|Physician Decision|0|||
33654015|NCT01705574|63066556|FG002|Open-Label Extension Phase|Death|1|||
33654016|NCT01705574|63066557|FG003|Open-Label Extension Phase|Death|0|||
33654017|NCT01705574|63066554|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
33654018|NCT01705574|63066555|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
33654019|NCT01705574|63066556|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
33654020|NCT01705574|63066557|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
33654021|NCT01705574|63066554|FG000|Open-Label Extension Phase|Physician Decision|0|||
33654022|NCT01705574|63066555|FG001|Open-Label Extension Phase|Physician Decision|0|||
33654023|NCT01705574|63066556|FG002|Open-Label Extension Phase|Physician Decision|2|||
33654024|NCT01705574|63066557|FG003|Open-Label Extension Phase|Physician Decision|0|||
33654025|NCT01705574|63066554|FG000|Open-Label Extension Phase|Pregnancy|0|||
33654026|NCT01705574|63066555|FG001|Open-Label Extension Phase|Pregnancy|0|||
33654027|NCT01705574|63066556|FG002|Open-Label Extension Phase|Pregnancy|1|||
33654028|NCT01705574|63066557|FG003|Open-Label Extension Phase|Pregnancy|1|||
33333742|NCT00996840|62710287|FG001|Overall Study|Physician Decision|0|||
33654029|NCT01737710|63066578|FG000|Overall Study|Lost to Follow-up|0|||
33654030|NCT01737710|63066579|FG001|Overall Study|Lost to Follow-up|2|||
33654031|NCT01737710|63066580|FG002|Overall Study|Lost to Follow-up|2|||
33654032|NCT01737710|63066581|FG003|Overall Study|Lost to Follow-up|0|||
33654033|NCT01737710|63066582|FG004|Overall Study|Lost to Follow-up|0|||
33654034|NCT01737710|63066578|FG000|Overall Study|Withdrawal by Subject|1|||
33654035|NCT01737710|63066579|FG001|Overall Study|Withdrawal by Subject|1|||
33654036|NCT01737710|63066580|FG002|Overall Study|Withdrawal by Subject|1|||
33654037|NCT01737710|63066581|FG003|Overall Study|Withdrawal by Subject|0|||
33333743|NCT00996840|62710288|FG002|Overall Study|Physician Decision|1|||
33333744|NCT00996840|62710289|FG003|Overall Study|Physician Decision|1|||
33333745|NCT00996840|62710290|FG004|Overall Study|Physician Decision|2|||
33333746|NCT00996840|62710286|FG000|Overall Study|Withdrawal by Subject|1|||
33333747|NCT00996840|62710287|FG001|Overall Study|Withdrawal by Subject|1|||
33333748|NCT00996840|62710288|FG002|Overall Study|Withdrawal by Subject|0|||
33333749|NCT00996840|62710289|FG003|Overall Study|Withdrawal by Subject|0|||
33333750|NCT00996840|62710290|FG004|Overall Study|Withdrawal by Subject|0|||
33333751|NCT00998946|62710306|FG000|Overall Study|Lost to Follow-up|1|||
33333752|NCT00998946|62710306|FG000|Overall Study|Withdrawal by Subject|1|||
33333753|NCT00998946|62710306|FG000|Overall Study|Death|2|||
33333754|NCT00998946|62710306|FG000|Overall Study|Reason Unspecified|3|||
33333755|NCT00998946|62710306|FG000|Overall Study|Enrolled but not Dosed|2|||
33333756|NCT01158404|62710318|FG000|Overall Study|Withdrawal by Subject|0|||
33333757|NCT01158404|62710319|FG001|Overall Study|Withdrawal by Subject|1|||
33333758|NCT01158404|62710320|FG002|Overall Study|Withdrawal by Subject|0|||
33333759|NCT01158404|62710321|FG003|Overall Study|Withdrawal by Subject|0|||
33333760|NCT01158404|62710322|FG004|Overall Study|Withdrawal by Subject|3|||
33333761|NCT01158404|62710323|FG005|Overall Study|Withdrawal by Subject|1|||
33333762|NCT01158404|62710324|FG006|Overall Study|Withdrawal by Subject|0|||
33333763|NCT01158404|62710325|FG007|Overall Study|Withdrawal by Subject|1|||
33333764|NCT01158404|62710318|FG000|Overall Study|Physician Decision|0|||
33333765|NCT01158404|62710319|FG001|Overall Study|Physician Decision|0|||
33333766|NCT01158404|62710320|FG002|Overall Study|Physician Decision|0|||
33333767|NCT01158404|62710321|FG003|Overall Study|Physician Decision|0|||
33333768|NCT01158404|62710322|FG004|Overall Study|Physician Decision|0|||
33333769|NCT01158404|62710323|FG005|Overall Study|Physician Decision|0|||
33333770|NCT01158404|62710324|FG006|Overall Study|Physician Decision|0|||
33333771|NCT01158404|62710325|FG007|Overall Study|Physician Decision|1|||
33333772|NCT01158404|62710318|FG000|Overall Study|Progressive Disease|0|||
33333773|NCT01158404|62710319|FG001|Overall Study|Progressive Disease|0|||
33333774|NCT01158404|62710320|FG002|Overall Study|Progressive Disease|0|||
33333775|NCT01158404|62710321|FG003|Overall Study|Progressive Disease|0|||
33333776|NCT01158404|62710322|FG004|Overall Study|Progressive Disease|0|||
33333777|NCT01158404|62710323|FG005|Overall Study|Progressive Disease|0|||
33333778|NCT01158404|62710324|FG006|Overall Study|Progressive Disease|1|||
33333779|NCT01158404|62710325|FG007|Overall Study|Progressive Disease|0|||
33333780|NCT00998790|62710345|FG000|Overall Study|Withdrawal by Subject|21|||
33333781|NCT01001988|62710349|FG000|Overall Study|Protocol Violation|84|||
33333782|NCT01001988|62710349|FG000|Overall Study|Withdrawal by Subject|18|||
33333783|NCT01001988|62710349|FG000|Overall Study|Lost to Follow-up|15|||
33333784|NCT00996606|62710353|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
33333785|NCT00996606|62710353|FG000|Overall Study|Insufficient Therapeutic Response|2|||
33333786|NCT00996606|62710353|FG000|Overall Study|Protocol Violation|1|||
33333787|NCT00996606|62710353|FG000|Overall Study|Withdrawal by Subject|3|||
33333788|NCT00995436|62710360|FG000|Overall Study|Withdrawal by Subject|2|||
33333789|NCT00995436|62710361|FG001|Overall Study|Withdrawal by Subject|5|||
33333790|NCT00995436|62710362|FG002|Overall Study|Withdrawal by Subject|0|||
33333791|NCT00994890|62710373|FG000|Overall Study|Adverse Event|13|||
33333792|NCT00994890|62710374|FG001|Overall Study|Adverse Event|9|||
33333793|NCT00994890|62710375|FG002|Overall Study|Adverse Event|11|||
33333794|NCT00994890|62710373|FG000|Overall Study|Lack of Efficacy|0|||
33333795|NCT00994890|62710374|FG001|Overall Study|Lack of Efficacy|0|||
33333796|NCT00994890|62710375|FG002|Overall Study|Lack of Efficacy|1|||
33333797|NCT00994890|62710373|FG000|Overall Study|Lost to Follow-up|6|||
33333798|NCT00994890|62710374|FG001|Overall Study|Lost to Follow-up|1|||
33333799|NCT00994890|62710375|FG002|Overall Study|Lost to Follow-up|3|||
33333800|NCT00994890|62710373|FG000|Overall Study|No longer willing to participate|8|||
33333801|NCT00994890|62710374|FG001|Overall Study|No longer willing to participate|5|||
33333802|NCT00994890|62710375|FG002|Overall Study|No longer willing to participate|13|||
33333803|NCT00994890|62710373|FG000|Overall Study|Protocol Violation|2|||
33333804|NCT00994890|62710374|FG001|Overall Study|Protocol Violation|4|||
33333805|NCT00994890|62710375|FG002|Overall Study|Protocol Violation|0|||
33333806|NCT00994890|62710373|FG000|Overall Study|Study terminated by sponsor|199|||
33333807|NCT00994890|62710374|FG001|Overall Study|Study terminated by sponsor|201|||
33333808|NCT00994890|62710375|FG002|Overall Study|Study terminated by sponsor|197|||
33333809|NCT00994890|62710373|FG000|Overall Study|Randomized, but not treated|1|||
33333810|NCT00994890|62710374|FG001|Overall Study|Randomized, but not treated|0|||
33333811|NCT00994890|62710375|FG002|Overall Study|Randomized, but not treated|0|||
33333812|NCT00994890|62710373|FG000|Overall Study|Other|2|||
33333813|NCT00994890|62710374|FG001|Overall Study|Other|2|||
33333814|NCT00994890|62710375|FG002|Overall Study|Other|1|||
33333815|NCT00994422|62710385|FG000|Overall Study|Lost to Follow-up|7|||
33333816|NCT00994422|62710386|FG001|Overall Study|Lost to Follow-up|1|||
33333817|NCT01171976|62710397|FG000|Overall Study|Protocol Violation|0|||
33333818|NCT01171976|62710398|FG001|Overall Study|Protocol Violation|0|||
33333819|NCT01171976|62710399|FG002|Overall Study|Protocol Violation|1|||
33333820|NCT01171976|62710397|FG000|Overall Study|Death|2|||
33333821|NCT01171976|62710398|FG001|Overall Study|Death|4|||
33333822|NCT01171976|62710399|FG002|Overall Study|Death|1|||
33333823|NCT01171976|62710397|FG000|Overall Study|Lost to Follow-up|4|||
33333824|NCT01171976|62710398|FG001|Overall Study|Lost to Follow-up|0|||
33333825|NCT01171976|62710399|FG002|Overall Study|Lost to Follow-up|2|||
33333826|NCT01171976|62710397|FG000|Overall Study|Withdrawal by Subject|1|||
33333827|NCT01171976|62710398|FG001|Overall Study|Withdrawal by Subject|5|||
33333828|NCT01171976|62710399|FG002|Overall Study|Withdrawal by Subject|6|||
33333829|NCT01171976|62710397|FG000|Overall Study|Abnormal test result|1|||
33333830|NCT01171976|62710398|FG001|Overall Study|Abnormal test result|0|||
33333831|NCT01171976|62710399|FG002|Overall Study|Abnormal test result|0|||
33333832|NCT01171976|62710397|FG000|Overall Study|Adverse Event|6|||
33333833|NCT01171976|62710398|FG001|Overall Study|Adverse Event|2|||
33333834|NCT01171976|62710399|FG002|Overall Study|Adverse Event|5|||
33333835|NCT00996216|62710407|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
33333836|NCT00996216|62710407|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
33333837|NCT00996216|62710407|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
33333838|NCT00830869|62710424|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
33333839|NCT00830869|62710425|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
33333840|NCT00830869|62710426|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
33333841|NCT00830869|62710427|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
33333842|NCT00830869|62710428|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
33333843|NCT00830869|62710429|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
33333844|NCT00830869|62710430|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
33333845|NCT00830869|62710431|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
33333846|NCT00830869|62710432|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
33333847|NCT00830869|62710433|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
33333848|NCT00830869|62710434|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
33333849|NCT00830869|62710435|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
33468809|NCT00004980|62842603|FG001|Overall Study|memory difficulties|1|||
33333850|NCT00830869|62710424|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
33333851|NCT00830869|62710425|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
33333852|NCT00830869|62710426|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
33333853|NCT00830869|62710427|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
33333854|NCT00830869|62710428|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
33333855|NCT00830869|62710429|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
33333856|NCT00830869|62710430|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
33333857|NCT00830869|62710431|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
33333858|NCT00830869|62710432|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
33333859|NCT00830869|62710433|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
33333860|NCT00830869|62710434|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
33333861|NCT00830869|62710435|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
33333862|NCT00830869|62710424|FG000|Period 1: Part 1|Adverse Event|0|||
33333863|NCT00830869|62710425|FG001|Period 1: Part 1|Adverse Event|0|||
33333864|NCT00830869|62710426|FG002|Period 1: Part 1|Adverse Event|0|||
33333865|NCT00830869|62710427|FG003|Period 1: Part 1|Adverse Event|0|||
33333866|NCT00830869|62710428|FG004|Period 1: Part 1|Adverse Event|0|||
33333867|NCT00830869|62710429|FG005|Period 1: Part 1|Adverse Event|1|||
33333868|NCT00830869|62710430|FG006|Period 1: Part 1|Adverse Event|1|||
33333869|NCT00830869|62710431|FG007|Period 1: Part 1|Adverse Event|0|||
33333870|NCT00830869|62710432|FG008|Period 1: Part 1|Adverse Event|0|||
33333871|NCT00830869|62710433|FG009|Period 1: Part 1|Adverse Event|0|||
33333872|NCT00830869|62710434|FG010|Period 1: Part 1|Adverse Event|0|||
33333873|NCT00830869|62710435|FG011|Period 1: Part 1|Adverse Event|0|||
33333874|NCT00830869|62710424|FG000|Period 1: Part 1|Progressive disease|1|||
33333875|NCT00830869|62710425|FG001|Period 1: Part 1|Progressive disease|0|||
33333876|NCT00830869|62710426|FG002|Period 1: Part 1|Progressive disease|1|||
33333877|NCT00830869|62710427|FG003|Period 1: Part 1|Progressive disease|6|||
33333878|NCT00830869|62710428|FG004|Period 1: Part 1|Progressive disease|4|||
33333879|NCT00830869|62710429|FG005|Period 1: Part 1|Progressive disease|4|||
33333880|NCT00830869|62710430|FG006|Period 1: Part 1|Progressive disease|1|||
33333881|NCT00830869|62710431|FG007|Period 1: Part 1|Progressive disease|0|||
33333882|NCT00830869|62710432|FG008|Period 1: Part 1|Progressive disease|0|||
33333883|NCT00830869|62710433|FG009|Period 1: Part 1|Progressive disease|0|||
33333884|NCT00830869|62710434|FG010|Period 1: Part 1|Progressive disease|0|||
33333885|NCT00830869|62710435|FG011|Period 1: Part 1|Progressive disease|0|||
33333886|NCT00830869|62710424|FG000|Period 2: Part 2|Protocol Violation|0|||
33333887|NCT00830869|62710425|FG001|Period 2: Part 2|Protocol Violation|0|||
33333888|NCT00830869|62710426|FG002|Period 2: Part 2|Protocol Violation|0|||
33333889|NCT00830869|62710427|FG003|Period 2: Part 2|Protocol Violation|0|||
33333890|NCT00830869|62710428|FG004|Period 2: Part 2|Protocol Violation|0|||
33333891|NCT00830869|62710429|FG005|Period 2: Part 2|Protocol Violation|0|||
33333892|NCT00830869|62710430|FG006|Period 2: Part 2|Protocol Violation|0|||
33333893|NCT00830869|62710431|FG007|Period 2: Part 2|Protocol Violation|1|||
33333894|NCT00830869|62710432|FG008|Period 2: Part 2|Protocol Violation|0|||
33333895|NCT00830869|62710433|FG009|Period 2: Part 2|Protocol Violation|1|||
33333896|NCT00830869|62710434|FG010|Period 2: Part 2|Protocol Violation|0|||
33333897|NCT00830869|62710435|FG011|Period 2: Part 2|Protocol Violation|0|||
33333898|NCT00830869|62710424|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
33333899|NCT00830869|62710425|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
33333900|NCT00830869|62710426|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
33333901|NCT00830869|62710427|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
33333902|NCT00830869|62710428|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
33333903|NCT00830869|62710429|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
33333904|NCT00830869|62710430|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
33333905|NCT00830869|62710431|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
33333906|NCT00830869|62710432|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
33333907|NCT00830869|62710433|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
33333908|NCT00830869|62710434|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
33333909|NCT00830869|62710435|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
33333910|NCT00830869|62710424|FG000|Period 2: Part 2|Adverse Event|0|||
33333911|NCT00830869|62710425|FG001|Period 2: Part 2|Adverse Event|0|||
33333912|NCT00830869|62710426|FG002|Period 2: Part 2|Adverse Event|0|||
33333913|NCT00830869|62710427|FG003|Period 2: Part 2|Adverse Event|0|||
33333914|NCT00830869|62710428|FG004|Period 2: Part 2|Adverse Event|0|||
33333915|NCT00830869|62710429|FG005|Period 2: Part 2|Adverse Event|0|||
33333916|NCT00830869|62710430|FG006|Period 2: Part 2|Adverse Event|0|||
33333917|NCT00830869|62710431|FG007|Period 2: Part 2|Adverse Event|4|||
33333918|NCT00830869|62710432|FG008|Period 2: Part 2|Adverse Event|3|||
33333919|NCT00830869|62710433|FG009|Period 2: Part 2|Adverse Event|2|||
33333920|NCT00830869|62710434|FG010|Period 2: Part 2|Adverse Event|2|||
33654038|NCT01737710|63066582|FG004|Overall Study|Withdrawal by Subject|0|||
33333921|NCT00830869|62710435|FG011|Period 2: Part 2|Adverse Event|0|||
33333922|NCT00830869|62710424|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
33333923|NCT00830869|62710425|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
33333924|NCT00830869|62710426|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
33333925|NCT00830869|62710427|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
33333926|NCT00830869|62710428|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
33333927|NCT00830869|62710429|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
33333928|NCT00830869|62710430|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
33333929|NCT00830869|62710431|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
33333930|NCT00830869|62710432|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
33333931|NCT00830869|62710433|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
33333932|NCT00830869|62710434|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
33333933|NCT00830869|62710435|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
33333934|NCT00830869|62710424|FG000|Period 2: Part 2|Progressive disease|0|||
33333935|NCT00830869|62710425|FG001|Period 2: Part 2|Progressive disease|0|||
33333936|NCT00830869|62710426|FG002|Period 2: Part 2|Progressive disease|0|||
33333937|NCT00830869|62710427|FG003|Period 2: Part 2|Progressive disease|0|||
33333938|NCT00830869|62710428|FG004|Period 2: Part 2|Progressive disease|0|||
33333939|NCT00830869|62710429|FG005|Period 2: Part 2|Progressive disease|0|||
33333940|NCT00830869|62710430|FG006|Period 2: Part 2|Progressive disease|0|||
33333941|NCT00830869|62710431|FG007|Period 2: Part 2|Progressive disease|14|||
33333942|NCT00830869|62710432|FG008|Period 2: Part 2|Progressive disease|11|||
33333943|NCT00830869|62710433|FG009|Period 2: Part 2|Progressive disease|12|||
33333944|NCT00830869|62710434|FG010|Period 2: Part 2|Progressive disease|8|||
33333945|NCT00830869|62710435|FG011|Period 2: Part 2|Progressive disease|15|||
33333946|NCT00830869|62710424|FG000|Period 2: Part 2|Other|0|||
33333947|NCT00830869|62710425|FG001|Period 2: Part 2|Other|0|||
33333948|NCT00830869|62710426|FG002|Period 2: Part 2|Other|0|||
33333949|NCT00830869|62710427|FG003|Period 2: Part 2|Other|0|||
33333950|NCT00830869|62710428|FG004|Period 2: Part 2|Other|0|||
33333951|NCT00830869|62710429|FG005|Period 2: Part 2|Other|0|||
33333952|NCT00830869|62710430|FG006|Period 2: Part 2|Other|0|||
33333953|NCT00830869|62710431|FG007|Period 2: Part 2|Other|0|||
33333954|NCT00830869|62710432|FG008|Period 2: Part 2|Other|0|||
33333955|NCT00830869|62710433|FG009|Period 2: Part 2|Other|1|||
33333956|NCT00830869|62710434|FG010|Period 2: Part 2|Other|0|||
33333957|NCT00830869|62710435|FG011|Period 2: Part 2|Other|0|||
33333958|NCT00844519|62710464|FG000|Overall Study|Withdrawal by Subject|1|||
33333959|NCT00844519|62710465|FG001|Overall Study|Withdrawal by Subject|1|||
33333960|NCT00844519|62710464|FG000|Overall Study|Adverse Event|1|||
33333961|NCT00844519|62710465|FG001|Overall Study|Adverse Event|0|||
33333962|NCT01171820|62710473|FG000|Overall Study|Death|3|||
33333963|NCT01171820|62710474|FG001|Overall Study|Death|3|||
33333964|NCT01171820|62710473|FG000|Overall Study|Lost to Follow-up|0|||
33333965|NCT01171820|62710474|FG001|Overall Study|Lost to Follow-up|1|||
33333966|NCT01171820|62710473|FG000|Overall Study|Withdrawal by Subject|2|||
33333967|NCT01171820|62710474|FG001|Overall Study|Withdrawal by Subject|0|||
33333968|NCT01171820|62710473|FG000|Overall Study|Physician Decision|0|||
33333969|NCT01171820|62710474|FG001|Overall Study|Physician Decision|1|||
33333970|NCT01171820|62710473|FG000|Overall Study|1-Year Missed Visit|1|||
33333971|NCT01171820|62710474|FG001|Overall Study|1-Year Missed Visit|1|||
33333972|NCT00994110|62710482|FG000|Overall Study|Withdrawal by Subject|9|||
33333973|NCT00994110|62710483|FG001|Overall Study|Withdrawal by Subject|9|||
33333974|NCT00994110|62710482|FG000|Overall Study|Not Treated|4|||
33333975|NCT00994110|62710483|FG001|Overall Study|Not Treated|8|||
33333976|NCT00994110|62710482|FG000|Overall Study|Adverse Event|1|||
33333977|NCT00994110|62710483|FG001|Overall Study|Adverse Event|0|||
33333978|NCT00994110|62710482|FG000|Overall Study|Patient not resected|41|||
33333979|NCT00994110|62710483|FG001|Overall Study|Patient not resected|52|||
33333980|NCT00994110|62710482|FG000|Overall Study|Pt not eligible|10|||
33333981|NCT00994110|62710483|FG001|Overall Study|Pt not eligible|5|||
33333982|NCT00993954|62710491|FG000|Overall Study|Protocol Violation|21|||
33333983|NCT00993954|62710492|FG001|Overall Study|Protocol Violation|2|||
33333984|NCT01157234|62710500|FG000|Overall Study|Withdrawal by Subject|1|||
33333985|NCT01157234|62710501|FG001|Overall Study|Withdrawal by Subject|0|||
33333986|NCT00991302|62710516|FG000|Overall Study|Death|0|||
33333987|NCT00991302|62710517|FG001|Overall Study|Death|1|||
33333988|NCT00991302|62710516|FG000|Overall Study|Lost to Follow-up|14|||
33333989|NCT00991302|62710517|FG001|Overall Study|Lost to Follow-up|12|||
33333990|NCT00995670|62710526|FG000|Overall Study|Failed arterial cannulation|1|||
33333991|NCT00995670|62710527|FG001|Overall Study|Failed arterial cannulation|0|||
33333992|NCT00995670|62710528|FG002|Overall Study|Failed arterial cannulation|3|||
33333993|NCT00601354|62710538|FG000|Overall Study|Lost to Follow-up|4|||
33333994|NCT00601354|62710539|FG001|Overall Study|Lost to Follow-up|5|||
33333995|NCT00853099|62710548|FG000|Double-blind Period|Adverse Event|7|||
33333996|NCT00853099|62710549|FG001|Double-blind Period|Adverse Event|9|||
33333997|NCT00853099|62710550|FG002|Double-blind Period|Adverse Event|13|||
33333998|NCT00853099|62710551|FG003|Double-blind Period|Adverse Event|0|||
33333999|NCT00853099|62710548|FG000|Double-blind Period|Withdrawal by Subject|2|||
33334000|NCT00853099|62710549|FG001|Double-blind Period|Withdrawal by Subject|3|||
33334001|NCT00853099|62710550|FG002|Double-blind Period|Withdrawal by Subject|0|||
33334002|NCT00853099|62710551|FG003|Double-blind Period|Withdrawal by Subject|0|||
33334003|NCT00853099|62710548|FG000|Double-blind Period|Lack of Efficacy|14|||
33334004|NCT00853099|62710549|FG001|Double-blind Period|Lack of Efficacy|17|||
33334005|NCT00853099|62710550|FG002|Double-blind Period|Lack of Efficacy|16|||
33334006|NCT00853099|62710551|FG003|Double-blind Period|Lack of Efficacy|0|||
33334007|NCT00853099|62710548|FG000|Double-blind Period|Other|0|||
33334008|NCT00853099|62710549|FG001|Double-blind Period|Other|0|||
33334009|NCT00853099|62710550|FG002|Double-blind Period|Other|1|||
33334010|NCT00853099|62710551|FG003|Double-blind Period|Other|0|||
33334011|NCT00853099|62710548|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
33334012|NCT00853099|62710549|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
33334013|NCT00853099|62710550|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
33334014|NCT00853099|62710551|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
33334015|NCT00853099|62710548|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
33334016|NCT00853099|62710549|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
33334017|NCT00853099|62710550|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
33334018|NCT00853099|62710551|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
33334019|NCT00853099|62710548|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
33334020|NCT00853099|62710549|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
33334021|NCT00853099|62710550|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
33334022|NCT00853099|62710551|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
33334023|NCT00853099|62710548|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
33334024|NCT00853099|62710549|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
33334025|NCT00853099|62710550|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
33334026|NCT00853099|62710551|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
33334027|NCT00853099|62710548|FG000|Double-blind + Open-label Periods|Other|0|||
33334028|NCT00853099|62710549|FG001|Double-blind + Open-label Periods|Other|0|||
33468810|NCT00004980|62842602|FG000|Overall Study|Physician Decision|0|||
33468811|NCT00004980|62842603|FG001|Overall Study|Physician Decision|1|||
33468812|NCT00326963|62842609|FG000|Overall Study|Adverse Event|2|||
33468813|NCT00326963|62842609|FG000|Overall Study|Injection site reaction|1|||
33468814|NCT00326963|62842609|FG000|Overall Study|Death|1|||
33334029|NCT00853099|62710550|FG002|Double-blind + Open-label Periods|Other|0|||
33334030|NCT00853099|62710551|FG003|Double-blind + Open-label Periods|Other|6|||
33334031|NCT00992784|62710564|FG000|Overall Study|Adverse Event|2|||
33334032|NCT00992784|62710565|FG001|Overall Study|Adverse Event|1|||
33334033|NCT00992784|62710566|FG002|Overall Study|Adverse Event|0|||
33334034|NCT00992784|62710564|FG000|Overall Study|Withdrawal by Subject|1|||
33334035|NCT00992784|62710565|FG001|Overall Study|Withdrawal by Subject|1|||
33334036|NCT00992784|62710566|FG002|Overall Study|Withdrawal by Subject|1|||
33334037|NCT00830167|62710576|FG000|Overall Study|Lack of Efficacy|26|||
33334038|NCT00830167|62710577|FG001|Overall Study|Lack of Efficacy|10|||
33334039|NCT00830167|62710576|FG000|Overall Study|Adverse Event|8|||
33334040|NCT00830167|62710577|FG001|Overall Study|Adverse Event|24|||
33334041|NCT00830167|62710576|FG000|Overall Study|Not meeting entrance criteria|2|||
33334042|NCT00830167|62710577|FG001|Overall Study|Not meeting entrance criteria|5|||
33334043|NCT00830167|62710576|FG000|Overall Study|Withdrawal by Subject|2|||
33334044|NCT00830167|62710577|FG001|Overall Study|Withdrawal by Subject|0|||
33334045|NCT00830167|62710576|FG000|Overall Study|Lost to Follow-up|0|||
33334046|NCT00830167|62710577|FG001|Overall Study|Lost to Follow-up|1|||
33334047|NCT00830167|62710576|FG000|Overall Study|Protocol Violation|0|||
33334048|NCT00830167|62710577|FG001|Overall Study|Protocol Violation|1|||
33334049|NCT00830167|62710576|FG000|Overall Study|Other|2|||
33334050|NCT00830167|62710577|FG001|Overall Study|Other|2|||
33334051|NCT00992394|62710585|FG000|Overall Study|Lack of Efficacy|6|||
33334052|NCT00992394|62710586|FG001|Overall Study|Lack of Efficacy|3|||
33334053|NCT00992394|62710585|FG000|Overall Study|Adverse Event|4|||
33334054|NCT00992394|62710586|FG001|Overall Study|Adverse Event|5|||
33334055|NCT00992394|62710585|FG000|Overall Study|Withdrawal by Subject|8|||
33334056|NCT00992394|62710586|FG001|Overall Study|Withdrawal by Subject|2|||
33468815|NCT00326963|62842609|FG000|Overall Study|Failure to return|10|||
33334057|NCT00992394|62710585|FG000|Overall Study|Physician Decision|1|||
33334058|NCT00992394|62710586|FG001|Overall Study|Physician Decision|0|||
33334059|NCT00992394|62710585|FG000|Overall Study|Protocol Violation|2|||
33334060|NCT00992394|62710586|FG001|Overall Study|Protocol Violation|4|||
33334061|NCT00992394|62710585|FG000|Overall Study|Lost to Follow-up|2|||
33334062|NCT00992394|62710586|FG001|Overall Study|Lost to Follow-up|0|||
33334063|NCT00992394|62710585|FG000|Overall Study|Other event|1|||
33334064|NCT00992394|62710586|FG001|Overall Study|Other event|0|||
33334065|NCT00829933|62710596|FG000|Overall Study|Adverse Event|2|||
33334066|NCT00829933|62710597|FG001|Overall Study|Adverse Event|3|||
33334067|NCT00829933|62710598|FG002|Overall Study|Adverse Event|2|||
33334068|NCT00829933|62710599|FG003|Overall Study|Adverse Event|1|||
33334069|NCT00829933|62710596|FG000|Overall Study|Death|0|||
33334070|NCT00829933|62710597|FG001|Overall Study|Death|0|||
33334071|NCT00829933|62710598|FG002|Overall Study|Death|1|||
33334072|NCT00829933|62710599|FG003|Overall Study|Death|1|||
33334073|NCT00829933|62710596|FG000|Overall Study|Lack of Efficacy|0|||
33334074|NCT00829933|62710597|FG001|Overall Study|Lack of Efficacy|1|||
33334075|NCT00829933|62710598|FG002|Overall Study|Lack of Efficacy|0|||
33334076|NCT00829933|62710599|FG003|Overall Study|Lack of Efficacy|0|||
33334077|NCT00829933|62710596|FG000|Overall Study|Physician Decision|5|||
33334078|NCT00829933|62710597|FG001|Overall Study|Physician Decision|7|||
33334079|NCT00829933|62710598|FG002|Overall Study|Physician Decision|8|||
33334080|NCT00829933|62710599|FG003|Overall Study|Physician Decision|1|||
33334081|NCT00829933|62710596|FG000|Overall Study|Pregnancy|0|||
33334082|NCT00829933|62710597|FG001|Overall Study|Pregnancy|0|||
33334083|NCT00829933|62710598|FG002|Overall Study|Pregnancy|0|||
33334084|NCT00829933|62710599|FG003|Overall Study|Pregnancy|2|||
33334085|NCT00829933|62710596|FG000|Overall Study|Protocol Violation|2|||
33334086|NCT00829933|62710597|FG001|Overall Study|Protocol Violation|1|||
33334087|NCT00829933|62710598|FG002|Overall Study|Protocol Violation|0|||
33334088|NCT00829933|62710599|FG003|Overall Study|Protocol Violation|0|||
33334089|NCT00829933|62710596|FG000|Overall Study|withdrew before treatment started|5|||
33334090|NCT00829933|62710597|FG001|Overall Study|withdrew before treatment started|1|||
33334091|NCT00829933|62710598|FG002|Overall Study|withdrew before treatment started|2|||
33334092|NCT00829933|62710599|FG003|Overall Study|withdrew before treatment started|9|||
33334093|NCT01170962|62710612|FG000|Treatment Period|Lack of Efficacy|96|||
33334094|NCT01170962|62710613|FG001|Treatment Period|Lack of Efficacy|91|||
33334095|NCT01170962|62710614|FG002|Treatment Period|Lack of Efficacy|7|||
33334096|NCT01170962|62710612|FG000|Treatment Period|Adverse Event|11|||
33334097|NCT01170962|62710613|FG001|Treatment Period|Adverse Event|12|||
33334098|NCT01170962|62710614|FG002|Treatment Period|Adverse Event|3|||
33334099|NCT01170962|62710612|FG000|Treatment Period|Withdrawal by Subject|2|||
33334100|NCT01170962|62710613|FG001|Treatment Period|Withdrawal by Subject|1|||
33334101|NCT01170962|62710614|FG002|Treatment Period|Withdrawal by Subject|0|||
33334102|NCT01170962|62710612|FG000|Treatment Period|Lost to Follow-up|1|||
33334103|NCT01170962|62710613|FG001|Treatment Period|Lost to Follow-up|1|||
33334104|NCT01170962|62710614|FG002|Treatment Period|Lost to Follow-up|1|||
33334105|NCT01170962|62710612|FG000|Treatment Period|Participant no longer meets criteria|0|||
33334106|NCT01170962|62710613|FG001|Treatment Period|Participant no longer meets criteria|1|||
33334107|NCT01170962|62710614|FG002|Treatment Period|Participant no longer meets criteria|0|||
33334108|NCT01170962|62710612|FG000|Treatment Period|Request to discontinue treatment|7|||
33334109|NCT01170962|62710613|FG001|Treatment Period|Request to discontinue treatment|3|||
33468816|NCT00326963|62842609|FG000|Overall Study|Withdrawal by Subject|10|||
33548613|NCT02516332|62939895|FG001|Overall Study|Withdrawal by Subject|1|||
33548614|NCT02516332|62939896|FG002|Overall Study|Withdrawal by Subject|2|||
33334110|NCT01170962|62710614|FG002|Treatment Period|Request to discontinue treatment|1|||
33334111|NCT01170962|62710612|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
33334112|NCT01170962|62710613|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
33334113|NCT01170962|62710614|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
33334114|NCT01170962|62710612|FG000|Follow up Period|Withdrawal by Subject|14|||
33334115|NCT01170962|62710613|FG001|Follow up Period|Withdrawal by Subject|10|||
33334116|NCT01170962|62710614|FG002|Follow up Period|Withdrawal by Subject|2|||
33334117|NCT01170962|62710612|FG000|Follow up Period|Lost to Follow-up|13|||
33334118|NCT01170962|62710613|FG001|Follow up Period|Lost to Follow-up|8|||
33334119|NCT01170962|62710614|FG002|Follow up Period|Lost to Follow-up|1|||
33334120|NCT01170962|62710612|FG000|Follow up Period|Death|2|||
33334121|NCT01170962|62710613|FG001|Follow up Period|Death|2|||
33334122|NCT01170962|62710614|FG002|Follow up Period|Death|0|||
33334123|NCT01170962|62710612|FG000|Follow up Period|Others|10|||
33334124|NCT01170962|62710613|FG001|Follow up Period|Others|7|||
33334125|NCT01170962|62710614|FG002|Follow up Period|Others|3|||
33334126|NCT00843193|62710633|FG000|Overall Study|Adverse Event|2|||
33334127|NCT00843193|62710634|FG001|Overall Study|Adverse Event|4|||
33334128|NCT00843193|62710633|FG000|Overall Study|Lack of Efficacy|1|||
33334129|NCT00843193|62710634|FG001|Overall Study|Lack of Efficacy|1|||
33334130|NCT00843193|62710633|FG000|Overall Study|Protocol Violation|1|||
33334131|NCT00843193|62710634|FG001|Overall Study|Protocol Violation|2|||
33334132|NCT00843193|62710633|FG000|Overall Study|Lost to Follow-up|1|||
33334133|NCT00843193|62710634|FG001|Overall Study|Lost to Follow-up|0|||
33334134|NCT00843193|62710633|FG000|Overall Study|Physician Decision|0|||
33334135|NCT00843193|62710634|FG001|Overall Study|Physician Decision|1|||
33334136|NCT00843193|62710633|FG000|Overall Study|Withdrawal by Subject|3|||
33334137|NCT00843193|62710634|FG001|Overall Study|Withdrawal by Subject|3|||
33334138|NCT00829621|62710643|FG000|Overall Study|Death|1|||
33334139|NCT00829621|62710644|FG001|Overall Study|Death|0|||
33334140|NCT00829621|62710643|FG000|Overall Study|Lost to Follow-up|3|||
33334141|NCT00829621|62710644|FG001|Overall Study|Lost to Follow-up|4|||
33334142|NCT01157078|62710652|FG000|Overall Study|Withdrawal by Subject|12|||
33334143|NCT01157078|62710653|FG001|Overall Study|Withdrawal by Subject|14|||
33334144|NCT01157078|62710652|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33334145|NCT01157078|62710653|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33334146|NCT01157078|62710652|FG000|Overall Study|Adverse Event|6|||
33334147|NCT01157078|62710653|FG001|Overall Study|Adverse Event|6|||
33334148|NCT01157078|62710652|FG000|Overall Study|Severe non-compliance to protocol|2|||
33334149|NCT01157078|62710653|FG001|Overall Study|Severe non-compliance to protocol|4|||
33334150|NCT01157078|62710652|FG000|Overall Study|Condition under investigation worsened|0|||
33334151|NCT01157078|62710653|FG001|Overall Study|Condition under investigation worsened|1|||
33334152|NCT01157078|62710652|FG000|Overall Study|Lack of Efficacy|2|||
33334153|NCT01157078|62710653|FG001|Overall Study|Lack of Efficacy|0|||
33334154|NCT01157078|62710652|FG000|Overall Study|Study-specific withdrawal criteria|2|||
33334155|NCT01157078|62710653|FG001|Overall Study|Study-specific withdrawal criteria|2|||
33334156|NCT01157078|62710652|FG000|Overall Study|Lost to Follow-up|7|||
33334157|NCT01157078|62710653|FG001|Overall Study|Lost to Follow-up|5|||
33334158|NCT01157078|62710652|FG000|Overall Study|Other|2|||
33334159|NCT01157078|62710653|FG001|Overall Study|Other|4|||
33334160|NCT00591721|62710661|FG000|Overall Study|Withdrawal by Subject|10|||
33334161|NCT00591721|62710662|FG001|Overall Study|Withdrawal by Subject|10|||
33334162|NCT00591721|62710661|FG000|Overall Study|Lost to Follow-up|1|||
33334163|NCT00591721|62710662|FG001|Overall Study|Lost to Follow-up|4|||
33334164|NCT00591721|62710661|FG000|Overall Study|Intervention not received|10|||
33334165|NCT00591721|62710662|FG001|Overall Study|Intervention not received|8|||
33334166|NCT01156844|62710672|FG000|Overall Study|Adverse Event|0|||
33334167|NCT01156844|62710673|FG001|Overall Study|Adverse Event|0|||
33334168|NCT01156844|62710674|FG002|Overall Study|Adverse Event|1|||
33334169|NCT01156844|62710675|FG003|Overall Study|Adverse Event|1|||
33334170|NCT01156844|62710672|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33334171|NCT01156844|62710673|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33468817|NCT00326963|62842609|FG000|Overall Study|Refused treatment / did not cooperate|5|||
33334172|NCT01156844|62710674|FG002|Overall Study|Abnormal test procedure result(s)|2|||
33334173|NCT01156844|62710675|FG003|Overall Study|Abnormal test procedure result(s)|2|||
33334174|NCT01156844|62710672|FG000|Overall Study|Withdrawal by Subject|0|||
33334175|NCT01156844|62710673|FG001|Overall Study|Withdrawal by Subject|0|||
33334176|NCT01156844|62710674|FG002|Overall Study|Withdrawal by Subject|2|||
33334177|NCT01156844|62710675|FG003|Overall Study|Withdrawal by Subject|2|||
33334178|NCT01156844|62710672|FG000|Overall Study|Lost to Follow-up|0|||
33334179|NCT01156844|62710673|FG001|Overall Study|Lost to Follow-up|0|||
33334180|NCT01156844|62710674|FG002|Overall Study|Lost to Follow-up|1|||
33334181|NCT01156844|62710675|FG003|Overall Study|Lost to Follow-up|0|||
33334182|NCT01156844|62710672|FG000|Overall Study|Administrative problems|0|||
33334183|NCT01156844|62710673|FG001|Overall Study|Administrative problems|1|||
33334184|NCT01156844|62710674|FG002|Overall Study|Administrative problems|0|||
33334185|NCT01156844|62710675|FG003|Overall Study|Administrative problems|1|||
33334186|NCT01156844|62710672|FG000|Overall Study|Protocol deviation|2|||
33334187|NCT01156844|62710673|FG001|Overall Study|Protocol deviation|0|||
33334188|NCT01156844|62710674|FG002|Overall Study|Protocol deviation|0|||
33334189|NCT01156844|62710675|FG003|Overall Study|Protocol deviation|0|||
33334190|NCT00853021|62710688|FG000|Overall Study|Adverse Event|2|||
33334191|NCT00853021|62710688|FG000|Overall Study|Withdrawal by Subject|2|||
33334192|NCT00853021|62710688|FG000|Overall Study|Death|1|||
33334193|NCT01156532|62710692|FG000|Overall Study|Family Reasons|1|||
33334194|NCT01156532|62710692|FG000|Overall Study|Lost to Follow-up|1|||
33334195|NCT00843115|62710696|FG000|Overall Study|Death|4|||
33334196|NCT00843115|62710696|FG000|Overall Study|Adverse Event|30|||
33334197|NCT00843115|62710696|FG000|Overall Study|Lost to Follow-up|4|||
33334198|NCT00843115|62710696|FG000|Overall Study|Withdrawal by Subject|17|||
33334199|NCT00843115|62710696|FG000|Overall Study|Family wanted meds stopped|1|||
33334200|NCT00843115|62710696|FG000|Overall Study|Family does not want continuation|1|||
33334201|NCT00843115|62710696|FG000|Overall Study|Patient forgot to take meds|1|||
33334202|NCT00843115|62710696|FG000|Overall Study|Does not meet entrance criteria|1|||
33334203|NCT00843115|62710696|FG000|Overall Study|Physician Decision|1|||
33334204|NCT00843115|62710696|FG000|Overall Study|Family discontinued meds|1|||
33334205|NCT00843115|62710696|FG000|Overall Study|patient took for 2 days then stopped|1|||
33334206|NCT00843115|62710696|FG000|Overall Study|patient never took the medication|1|||
33334207|NCT00843115|62710696|FG000|Overall Study|hospitalized due to deterioration|1|||
33334208|NCT00843115|62710696|FG000|Overall Study|week 12 not done|1|||
33334209|NCT00843115|62710696|FG000|Overall Study|Syndrome De Glissement|1|||
33334210|NCT01156376|62710703|FG000|Overall Study|Adverse Event|1|||
33334211|NCT01156376|62710704|FG001|Overall Study|Adverse Event|0|||
33334212|NCT01156376|62710705|FG002|Overall Study|Adverse Event|1|||
33334213|NCT01156376|62710703|FG000|Overall Study|Withdrawal by Subject|0|||
33334214|NCT01156376|62710704|FG001|Overall Study|Withdrawal by Subject|0|||
33334215|NCT01156376|62710705|FG002|Overall Study|Withdrawal by Subject|3|||
33334216|NCT00829387|62710715|FG000|Overall Study|Withdrawal by Subject|2|||
33334217|NCT00829387|62710716|FG001|Overall Study|Withdrawal by Subject|3|||
33334218|NCT00829387|62710715|FG000|Overall Study|Disqualified by PI|1|||
33334219|NCT00829387|62710716|FG001|Overall Study|Disqualified by PI|0|||
33334220|NCT01156142|62710724|FG000|Overall Study|Withdrawal by Subject|8|||
33334221|NCT01156142|62710725|FG001|Overall Study|Withdrawal by Subject|6|||
33334222|NCT01156142|62710724|FG000|Overall Study|Ineligible|0|||
33334223|NCT01156142|62710725|FG001|Overall Study|Ineligible|1|||
33334224|NCT00842257|62710731|FG000|Overall Study|Adverse Event|1|||
33334225|NCT00852475|62710737|FG000|Overall Study|Lost to Follow-up|3|||
33334226|NCT00852475|62710738|FG001|Overall Study|Lost to Follow-up|4|||
33334227|NCT01155284|62710748|FG000|Overall Study|Withdrawal by Subject|4|||
33334228|NCT01155284|62710749|FG001|Overall Study|Withdrawal by Subject|3|||
33334229|NCT01155284|62710748|FG000|Overall Study|Lost to Follow-up|1|||
33334230|NCT01155284|62710749|FG001|Overall Study|Lost to Follow-up|2|||
33334231|NCT01155284|62710748|FG000|Overall Study|Physician Decision|1|||
33334232|NCT01155284|62710749|FG001|Overall Study|Physician Decision|0|||
33334233|NCT01155284|62710748|FG000|Overall Study|Adverse Event|1|||
33334234|NCT01155284|62710749|FG001|Overall Study|Adverse Event|0|||
33334235|NCT00852397|62710760|FG000|Overall Study|Adverse Event|4|||
33334236|NCT00852397|62710761|FG001|Overall Study|Adverse Event|6|||
33334237|NCT00852397|62710762|FG002|Overall Study|Adverse Event|4|||
33334238|NCT00852397|62710760|FG000|Overall Study|Death|0|||
33334239|NCT00852397|62710761|FG001|Overall Study|Death|0|||
33334240|NCT00852397|62710762|FG002|Overall Study|Death|1|||
33334241|NCT00852397|62710760|FG000|Overall Study|Withdrawal by Subject|4|||
33334242|NCT00852397|62710761|FG001|Overall Study|Withdrawal by Subject|1|||
33334243|NCT00852397|62710762|FG002|Overall Study|Withdrawal by Subject|2|||
33334244|NCT00852397|62710760|FG000|Overall Study|Study terminated by sponsor|2|||
33334245|NCT00852397|62710761|FG001|Overall Study|Study terminated by sponsor|1|||
33334246|NCT00852397|62710762|FG002|Overall Study|Study terminated by sponsor|6|||
33334247|NCT00852397|62710760|FG000|Overall Study|Difficulty in study site visit|1|||
33334248|NCT00852397|62710761|FG001|Overall Study|Difficulty in study site visit|0|||
33334249|NCT00852397|62710762|FG002|Overall Study|Difficulty in study site visit|0|||
33334250|NCT00852397|62710760|FG000|Overall Study|Protocol Violation|0|||
33334251|NCT00852397|62710761|FG001|Overall Study|Protocol Violation|0|||
33334252|NCT00852397|62710762|FG002|Overall Study|Protocol Violation|1|||
33334253|NCT00841321|62710772|FG000|Overall Study|Lost to Follow-up|1|||
33334254|NCT00841321|62710773|FG001|Overall Study|Lost to Follow-up|1|||
33334255|NCT00841321|62710772|FG000|Overall Study|Adverse Event|0|||
33334256|NCT00841321|62710773|FG001|Overall Study|Adverse Event|2|||
33334257|NCT00986232|62710785|FG000|Overall Study|Adverse Event|1|||
33334258|NCT00986232|62710786|FG001|Overall Study|Adverse Event|2|||
33334259|NCT00986232|62710787|FG002|Overall Study|Adverse Event|3|||
33334260|NCT00986232|62710788|FG003|Overall Study|Adverse Event|0|||
33334261|NCT00986232|62710785|FG000|Overall Study|Lost to Follow-up|19|||
33334262|NCT00986232|62710786|FG001|Overall Study|Lost to Follow-up|12|||
33334263|NCT00986232|62710787|FG002|Overall Study|Lost to Follow-up|12|||
33334264|NCT00986232|62710788|FG003|Overall Study|Lost to Follow-up|7|||
33334265|NCT00986232|62710785|FG000|Overall Study|Protocol Violation|2|||
33334266|NCT00986232|62710786|FG001|Overall Study|Protocol Violation|3|||
33334267|NCT00986232|62710787|FG002|Overall Study|Protocol Violation|0|||
33334268|NCT00986232|62710788|FG003|Overall Study|Protocol Violation|1|||
33334269|NCT00986232|62710785|FG000|Overall Study|Withdrawal by Subject|13|||
33334270|NCT00986232|62710786|FG001|Overall Study|Withdrawal by Subject|16|||
33334271|NCT00986232|62710787|FG002|Overall Study|Withdrawal by Subject|12|||
33334272|NCT00986232|62710788|FG003|Overall Study|Withdrawal by Subject|3|||
33334273|NCT00986232|62710785|FG000|Overall Study|Missed one or more bleeds|13|||
33334274|NCT00986232|62710786|FG001|Overall Study|Missed one or more bleeds|10|||
33334275|NCT00986232|62710787|FG002|Overall Study|Missed one or more bleeds|6|||
33334276|NCT00986232|62710788|FG003|Overall Study|Missed one or more bleeds|7|||
33334277|NCT00986232|62710785|FG000|Overall Study|Incomplete safety follow-up|3|||
33334278|NCT00986232|62710786|FG001|Overall Study|Incomplete safety follow-up|7|||
33334279|NCT00986232|62710787|FG002|Overall Study|Incomplete safety follow-up|2|||
33334280|NCT00986232|62710788|FG003|Overall Study|Incomplete safety follow-up|2|||
33334281|NCT00852241|62710804|FG000|Overall Study|Physician Decision|18|||
33334282|NCT01169636|62710813|FG000|Overall Study|Adverse Event|0|||
33334283|NCT01169636|62710814|FG001|Overall Study|Adverse Event|0|||
33334284|NCT01169636|62710815|FG002|Overall Study|Adverse Event|1|||
33334285|NCT01169636|62710816|FG003|Overall Study|Adverse Event|1|||
33334286|NCT01169636|62710817|FG004|Overall Study|Adverse Event|0|||
33334287|NCT01169636|62710813|FG000|Overall Study|Screen failure|0|||
33334288|NCT01169636|62710814|FG001|Overall Study|Screen failure|0|||
33334289|NCT01169636|62710815|FG002|Overall Study|Screen failure|2|||
33334290|NCT01169636|62710816|FG003|Overall Study|Screen failure|0|||
33334291|NCT01169636|62710817|FG004|Overall Study|Screen failure|0|||
33334292|NCT01169636|62710813|FG000|Overall Study|Withdrawal by Subject|0|||
33334293|NCT01169636|62710814|FG001|Overall Study|Withdrawal by Subject|0|||
33334294|NCT01169636|62710815|FG002|Overall Study|Withdrawal by Subject|0|||
33334295|NCT01169636|62710816|FG003|Overall Study|Withdrawal by Subject|0|||
33334296|NCT01169636|62710817|FG004|Overall Study|Withdrawal by Subject|3|||
33334297|NCT01169558|62710827|FG000|Overall Study|Disease progression|98|||
33334298|NCT01169558|62710827|FG000|Overall Study|Adverse Event|25|||
33334299|NCT01169558|62710827|FG000|Overall Study|Withdrawal of Consent|8|||
33334300|NCT01169558|62710827|FG000|Overall Study|Medical Decision|7|||
33334301|NCT01169558|62710827|FG000|Overall Study|Stable Disease|4|||
33334302|NCT01169558|62710827|FG000|Overall Study|Lost to Follow-up|4|||
33334303|NCT01169558|62710827|FG000|Overall Study|Need for Surgery|4|||
33334304|NCT01169558|62710827|FG000|Overall Study|Non-compliance|2|||
33334305|NCT01169558|62710827|FG000|Overall Study|Protocol Violation|2|||
33334306|NCT01169558|62710827|FG000|Overall Study|Partial response|2|||
33334307|NCT00840463|62710833|FG000|Overall Study|Adverse Event|1|||
33334308|NCT00840463|62710834|FG001|Overall Study|Adverse Event|0|||
33334309|NCT01155050|62710844|FG000|Overall Study|Lost to Follow-up|15|||
33334310|NCT01155050|62710845|FG001|Overall Study|Lost to Follow-up|20|||
33334311|NCT01155050|62710846|FG002|Overall Study|Lost to Follow-up|19|||
33334312|NCT01155050|62710847|FG003|Overall Study|Lost to Follow-up|22|||
33334313|NCT01168856|62710859|FG000|Overall Study|Lost to Follow-up|4|||
33334314|NCT01168856|62710860|FG001|Overall Study|Lost to Follow-up|34|||
33334315|NCT01168856|62710859|FG000|Overall Study|Withdrawal by Subject|6|||
33334316|NCT01168856|62710860|FG001|Overall Study|Withdrawal by Subject|8|||
33334317|NCT01168856|62710859|FG000|Overall Study|Physician Decision|2|||
33334318|NCT01168856|62710860|FG001|Overall Study|Physician Decision|1|||
33334319|NCT01168856|62710859|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
33334320|NCT01168856|62710860|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
33334321|NCT01168856|62710859|FG000|Overall Study|Participant received anti-HCV treatment|1|||
33334322|NCT01168856|62710860|FG001|Overall Study|Participant received anti-HCV treatment|0|||
33334323|NCT01168856|62710859|FG000|Overall Study|Death|0|||
33334324|NCT01168856|62710860|FG001|Overall Study|Death|2|||
33334325|NCT01168856|62710859|FG000|Overall Study|Other|1|||
33334326|NCT01168856|62710860|FG001|Overall Study|Other|291|||
33334327|NCT01168856|62710859|FG000|Overall Study|Protocol Violation|4|||
33334328|NCT01168856|62710860|FG001|Overall Study|Protocol Violation|6|||
33334329|NCT00828451|62710871|FG000|Overall Study|Death|2|||
33334330|NCT00828451|62710871|FG000|Overall Study|Lack of intravenous line|7|||
33334331|NCT00828451|62710871|FG000|Overall Study|Withdrawal by Subject|1|||
33334332|NCT00828451|62710871|FG000|Overall Study|Deterioration in clinical status|1|||
33334333|NCT00839917|62710877|FG000|Overall Study|Lost to Follow-up|1|||
33334334|NCT00839917|62710878|FG001|Overall Study|Lost to Follow-up|0|||
33334335|NCT00839917|62710877|FG000|Overall Study|Did not receive vaccine|0|||
33334336|NCT00839917|62710878|FG001|Overall Study|Did not receive vaccine|1|||
33334337|NCT00839527|62710887|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
33334338|NCT00839527|62710888|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
33334339|NCT00839527|62710889|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
33334340|NCT00839527|62710887|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
33334341|NCT00839527|62710888|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
33334342|NCT00839527|62710889|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
33334343|NCT00839527|62710887|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
33334344|NCT00839527|62710888|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
33334345|NCT00839527|62710889|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
33334346|NCT00839527|62710887|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
33334347|NCT00839527|62710888|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
33334348|NCT00839527|62710889|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
33334349|NCT00839527|62710887|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
33334350|NCT00839527|62710888|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
33334351|NCT00839527|62710889|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
33334352|NCT00839527|62710887|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
33334353|NCT00839527|62710888|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
33334354|NCT00839527|62710889|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
33334355|NCT00839527|62710887|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
33334356|NCT00839527|62710888|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
33334357|NCT00839527|62710889|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
33334358|NCT00839527|62710887|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
33334359|NCT00839527|62710888|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
33334360|NCT00839527|62710889|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
33334361|NCT00839527|62710887|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
33334362|NCT00839527|62710888|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
33334363|NCT00839527|62710889|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
33334364|NCT00839527|62710887|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
33334365|NCT00839527|62710888|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
33334366|NCT00839527|62710889|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
33334367|NCT00839527|62710887|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
33334368|NCT00839527|62710888|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
33334369|NCT00839527|62710889|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
33334370|NCT00839527|62710887|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
33334371|NCT00839527|62710888|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
33334372|NCT00839527|62710889|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
33334373|NCT00839527|62710887|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
33334374|NCT00839527|62710888|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
33334375|NCT00839527|62710889|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
33334376|NCT00839527|62710887|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
33334377|NCT00839527|62710888|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
33334378|NCT00839527|62710889|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
33334379|NCT00839527|62710887|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
33334380|NCT00839527|62710888|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
33334381|NCT00839527|62710889|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
33334382|NCT00839527|62710887|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
33334383|NCT00839527|62710888|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
33334384|NCT00839527|62710889|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
33334385|NCT00839527|62710887|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
33334386|NCT00839527|62710888|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
33334387|NCT00839527|62710889|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
33334388|NCT00839527|62710887|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
33334389|NCT00839527|62710888|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
33334390|NCT00839527|62710889|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
33334391|NCT00839527|62710887|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
33334392|NCT00839527|62710888|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
33334393|NCT00839527|62710889|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
33334394|NCT00839527|62710887|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
33334395|NCT00839527|62710888|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
33334396|NCT00839527|62710889|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
33334397|NCT00839527|62710887|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
33334398|NCT00839527|62710888|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
33334399|NCT00839527|62710889|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
33334400|NCT00839527|62710887|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
33334401|NCT00839527|62710888|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
33334402|NCT00839527|62710889|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
33334403|NCT00839527|62710887|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
33334404|NCT00839527|62710888|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
33334405|NCT00839527|62710889|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
33334406|NCT00839527|62710887|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
33334407|NCT00839527|62710888|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
33334408|NCT00839527|62710889|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
33334409|NCT00600886|62710901|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
33334410|NCT00600886|62710902|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
33334411|NCT00600886|62710901|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
33334412|NCT00600886|62710902|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
33334413|NCT00600886|62710901|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
33334414|NCT00600886|62710902|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
33334415|NCT00600886|62710901|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
33334416|NCT00600886|62710902|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
33334417|NCT00600886|62710901|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
33334418|NCT00600886|62710902|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
33334419|NCT00600886|62710901|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
33334420|NCT00600886|62710902|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
33334421|NCT00600886|62710901|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
33334422|NCT00600886|62710902|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
33334423|NCT00600886|62710901|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
33334424|NCT00600886|62710902|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
33334425|NCT00600886|62710901|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
33334426|NCT00600886|62710902|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
33334427|NCT00600886|62710901|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
33334428|NCT00600886|62710902|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
33334429|NCT00600886|62710901|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
33334430|NCT00600886|62710902|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
33334431|NCT00600886|62710901|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
33334432|NCT00600886|62710902|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
33334433|NCT00600886|62710901|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
33334434|NCT00600886|62710902|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
33334435|NCT00600886|62710901|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
33334436|NCT00600886|62710902|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
33334437|NCT00600886|62710901|FG000|Extension - Same Treatment (FAS)|Death|1|||
33334438|NCT00600886|62710902|FG001|Extension - Same Treatment (FAS)|Death|1|||
33334439|NCT00600886|62710901|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
33334440|NCT00600886|62710902|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
33334441|NCT00600886|62710901|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
33334442|NCT00600886|62710902|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
33334443|NCT00600886|62710901|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
33334444|NCT00600886|62710902|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
33334445|NCT00600886|62710901|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
33334446|NCT00600886|62710902|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
33334447|NCT00600886|62710901|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
33334448|NCT00600886|62710902|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
33334449|NCT00600886|62710901|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
33334450|NCT00600886|62710902|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
33334451|NCT00600886|62710901|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
33334452|NCT00600886|62710902|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
33334453|NCT00600886|62710901|FG000|Extension - After Crossover (CAS)|Death|1|||
33334454|NCT00600886|62710902|FG001|Extension - After Crossover (CAS)|Death|0|||
33334455|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
33334456|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
33334457|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
33334458|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
33334459|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
33334460|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
33334461|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
33334462|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
33334463|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
33334464|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
33334465|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
33334466|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
33334467|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
33334468|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
33334469|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
33334470|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
33334471|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
33334472|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
33334473|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
33334474|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
33334475|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
33334476|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
33334477|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
33334478|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
33334479|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
33334480|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
33334481|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
33334482|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
33334483|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
33334484|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
33334485|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
33334486|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
33334487|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
33334488|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
33334489|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
33334490|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
33334491|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
33334492|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
33334493|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
33334494|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
33334495|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
33334496|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
33334497|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
33334498|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
33334499|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
33334500|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
33334501|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
33334502|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
33334503|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
33334504|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
33334505|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
33334506|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
33334507|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Site closed|0|||
33334508|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Site closed|0|||
33334509|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Site closed|1|||
33334510|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Site closed|0|||
33334511|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
33334512|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
33334513|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
33334514|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
33334515|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
33334516|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
33334517|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
33334518|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
33334519|NCT00838903|62710926|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
33334520|NCT00838903|62710927|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
33334521|NCT00838903|62710928|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
33334522|NCT00838903|62710929|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
33334523|NCT00838903|62710926|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
33334524|NCT00838903|62710927|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
33334525|NCT00838903|62710928|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
33334526|NCT00838903|62710929|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
33334527|NCT00838903|62710926|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
33334528|NCT00838903|62710927|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
33334529|NCT00838903|62710928|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
33334530|NCT00838903|62710929|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
33334531|NCT00838903|62710926|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
33334532|NCT00838903|62710927|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
33334533|NCT00838903|62710928|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
33334534|NCT00838903|62710929|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
33334535|NCT00838903|62710926|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
33334536|NCT00838903|62710927|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
33334537|NCT00838903|62710928|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
33334538|NCT00838903|62710929|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
33334539|NCT00838903|62710926|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
33334540|NCT00838903|62710927|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
33334541|NCT00838903|62710928|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
33334542|NCT00838903|62710929|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
33334543|NCT00838903|62710926|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
33334544|NCT00838903|62710927|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
33334545|NCT00838903|62710928|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
33334546|NCT00838903|62710929|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
33334547|NCT00838903|62710926|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
33334548|NCT00838903|62710927|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
33334549|NCT00838903|62710928|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
33334550|NCT00838903|62710929|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
33334551|NCT00838903|62710926|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
33334552|NCT00838903|62710927|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
33334553|NCT00838903|62710928|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
33334554|NCT00838903|62710929|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
33334555|NCT00838903|62710926|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
33334556|NCT00838903|62710927|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
33334557|NCT00838903|62710928|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
33334558|NCT00838903|62710929|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
33334559|NCT00838903|62710926|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
33334560|NCT00838903|62710927|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
33334561|NCT00838903|62710928|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
33334562|NCT00838903|62710929|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
33334563|NCT00838903|62710926|FG000|Follow-up Period (8 Weeks)|Missing|1|||
33334564|NCT00838903|62710927|FG001|Follow-up Period (8 Weeks)|Missing|2|||
33334565|NCT00838903|62710928|FG002|Follow-up Period (8 Weeks)|Missing|1|||
33334566|NCT00838903|62710929|FG003|Follow-up Period (8 Weeks)|Missing|1|||
33334567|NCT00828139|62710943|FG000|Overall Study|Adverse Event|8|||
33334568|NCT00828139|62710944|FG001|Overall Study|Adverse Event|1|||
33334569|NCT00828139|62710945|FG002|Overall Study|Adverse Event|10|||
33334570|NCT00828139|62710946|FG003|Overall Study|Adverse Event|5|||
33334571|NCT00828139|62710943|FG000|Overall Study|Death|2|||
33334572|NCT00828139|62710944|FG001|Overall Study|Death|1|||
33334573|NCT00828139|62710945|FG002|Overall Study|Death|0|||
33334574|NCT00828139|62710946|FG003|Overall Study|Death|2|||
33334575|NCT00828139|62710943|FG000|Overall Study|Refusal unrelated to toxicity|3|||
33334576|NCT00828139|62710944|FG001|Overall Study|Refusal unrelated to toxicity|4|||
33334577|NCT00828139|62710945|FG002|Overall Study|Refusal unrelated to toxicity|5|||
33334578|NCT00828139|62710946|FG003|Overall Study|Refusal unrelated to toxicity|3|||
33334579|NCT00828139|62710943|FG000|Overall Study|Disease Progression|24|||
33334580|NCT00828139|62710944|FG001|Overall Study|Disease Progression|33|||
33334581|NCT00828139|62710945|FG002|Overall Study|Disease Progression|35|||
33334582|NCT00828139|62710946|FG003|Overall Study|Disease Progression|39|||
33334583|NCT00828139|62710943|FG000|Overall Study|Other|4|||
33334584|NCT00828139|62710944|FG001|Overall Study|Other|2|||
33334585|NCT00828139|62710945|FG002|Overall Study|Other|5|||
33334586|NCT00828139|62710946|FG003|Overall Study|Other|2|||
33334587|NCT00838513|62710956|FG000|Screening Period|Screen Failure|3|||
33334588|NCT00838513|62710956|FG000|Extension Treatment Period|Death|1|||
33334589|NCT00838513|62710956|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
33334590|NCT00600106|62710962|FG000|Overall Study|Withdrawal by Subject|1|||
33334591|NCT00600106|62710963|FG001|Overall Study|Withdrawal by Subject|1|||
33334592|NCT00850993|62710973|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
33334593|NCT00850993|62710974|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
33468818|NCT00326963|62842609|FG000|Overall Study|Violation of selection criteria at entry|2|||
33468819|NCT00326963|62842609|FG000|Overall Study|Other protocol violation|1|||
33334594|NCT00850993|62710975|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
33334595|NCT00850993|62710976|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
33334596|NCT00818779|62710988|FG000|Overall Study|Protocol Violation|1|||
33334597|NCT00818779|62710989|FG001|Overall Study|Protocol Violation|0|||
33334598|NCT00818779|62710988|FG000|Overall Study|Lost to Follow-up|1|||
33334599|NCT00818779|62710989|FG001|Overall Study|Lost to Follow-up|0|||
33334600|NCT00818779|62710988|FG000|Overall Study|Adverse Event|4|||
33334601|NCT00818779|62710989|FG001|Overall Study|Adverse Event|1|||
33334602|NCT00850759|62710999|FG000|Overall Study|Lost to Follow-up|7|||
33334603|NCT00850759|62711000|FG001|Overall Study|Lost to Follow-up|5|||
33334604|NCT00850759|62711001|FG002|Overall Study|Lost to Follow-up|5|||
33334605|NCT00850759|62711002|FG003|Overall Study|Lost to Follow-up|3|||
33334606|NCT00827827|62711014|FG000|Overall Study|Lost to Follow-up|3|||
33334607|NCT00827827|62711015|FG001|Overall Study|Lost to Follow-up|0|||
33334608|NCT00827827|62711014|FG000|Overall Study|Fall at home- hospitalization|1|||
33334609|NCT00827827|62711015|FG001|Overall Study|Fall at home- hospitalization|0|||
33334610|NCT00827827|62711014|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
33334611|NCT00827827|62711015|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
33334612|NCT00827827|62711014|FG000|Overall Study|Gout|1|||
33334613|NCT00827827|62711015|FG001|Overall Study|Gout|0|||
33334614|NCT00827827|62711014|FG000|Overall Study|Transportation issues|1|||
33334615|NCT00827827|62711015|FG001|Overall Study|Transportation issues|0|||
33334616|NCT00827827|62711014|FG000|Overall Study|Burned with water at home|1|||
33334617|NCT00827827|62711015|FG001|Overall Study|Burned with water at home|0|||
33334618|NCT00600028|62711024|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
33334619|NCT00600028|62711025|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
33334620|NCT00600028|62711024|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
33334621|NCT00600028|62711025|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
33334622|NCT00600028|62711024|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
33334623|NCT00600028|62711025|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
33334624|NCT03542266|62711034|FG000|Treatment Phase|Withdrawal by Subject|1|||
33334625|NCT03542266|62711034|FG000|Treatment Phase|Adverse Event|1|||
33334626|NCT03542266|62711034|FG000|Treatment Phase|PD|1|||
33334627|NCT00818623|62711046|FG000|Overall Study|Adverse Event|1|||
33334628|NCT00818623|62711047|FG001|Overall Study|Adverse Event|0|||
33334629|NCT00818623|62711048|FG002|Overall Study|Adverse Event|1|||
33334630|NCT00818623|62711049|FG003|Overall Study|Adverse Event|0|||
33334631|NCT00818623|62711050|FG004|Overall Study|Adverse Event|0|||
33334632|NCT00818623|62711051|FG005|Overall Study|Adverse Event|1|||
33334633|NCT00818623|62711052|FG006|Overall Study|Adverse Event|0|||
33334634|NCT00818623|62711053|FG007|Overall Study|Adverse Event|0|||
33334635|NCT00818623|62711046|FG000|Overall Study|Bad prostate specific antigen response|0|||
33334636|NCT00818623|62711047|FG001|Overall Study|Bad prostate specific antigen response|3|||
33334637|NCT00818623|62711048|FG002|Overall Study|Bad prostate specific antigen response|2|||
33334638|NCT00818623|62711049|FG003|Overall Study|Bad prostate specific antigen response|5|||
33334639|NCT00818623|62711050|FG004|Overall Study|Bad prostate specific antigen response|0|||
33334640|NCT00818623|62711051|FG005|Overall Study|Bad prostate specific antigen response|1|||
33334641|NCT00818623|62711052|FG006|Overall Study|Bad prostate specific antigen response|0|||
33334642|NCT00818623|62711053|FG007|Overall Study|Bad prostate specific antigen response|0|||
33334643|NCT00818623|62711046|FG000|Overall Study|Withdrawal by Subject|0|||
33334644|NCT00818623|62711047|FG001|Overall Study|Withdrawal by Subject|1|||
33334645|NCT00818623|62711048|FG002|Overall Study|Withdrawal by Subject|1|||
33334646|NCT00818623|62711049|FG003|Overall Study|Withdrawal by Subject|0|||
33334647|NCT00818623|62711050|FG004|Overall Study|Withdrawal by Subject|0|||
33334648|NCT00818623|62711051|FG005|Overall Study|Withdrawal by Subject|1|||
33334649|NCT00818623|62711052|FG006|Overall Study|Withdrawal by Subject|1|||
33334650|NCT00818623|62711053|FG007|Overall Study|Withdrawal by Subject|1|||
33334651|NCT00818623|62711046|FG000|Overall Study|Protocol Violation|1|||
33334652|NCT00818623|62711047|FG001|Overall Study|Protocol Violation|0|||
33334653|NCT00818623|62711048|FG002|Overall Study|Protocol Violation|0|||
33334654|NCT00818623|62711049|FG003|Overall Study|Protocol Violation|0|||
33334655|NCT00818623|62711050|FG004|Overall Study|Protocol Violation|1|||
33334656|NCT00818623|62711051|FG005|Overall Study|Protocol Violation|0|||
33334657|NCT00818623|62711052|FG006|Overall Study|Protocol Violation|1|||
33334658|NCT00818623|62711053|FG007|Overall Study|Protocol Violation|0|||
33334659|NCT00818623|62711046|FG000|Overall Study|Need of additional treatment|0|||
33334660|NCT00818623|62711047|FG001|Overall Study|Need of additional treatment|0|||
33334661|NCT00818623|62711048|FG002|Overall Study|Need of additional treatment|0|||
33334662|NCT00818623|62711049|FG003|Overall Study|Need of additional treatment|0|||
33334663|NCT00818623|62711050|FG004|Overall Study|Need of additional treatment|1|||
33334664|NCT00818623|62711051|FG005|Overall Study|Need of additional treatment|0|||
33334665|NCT00818623|62711052|FG006|Overall Study|Need of additional treatment|0|||
33334666|NCT00818623|62711053|FG007|Overall Study|Need of additional treatment|0|||
33334667|NCT00818623|62711046|FG000|Overall Study|Lack of trial drug at site|0|||
33334668|NCT00818623|62711047|FG001|Overall Study|Lack of trial drug at site|0|||
33334669|NCT00818623|62711048|FG002|Overall Study|Lack of trial drug at site|0|||
33334670|NCT00818623|62711049|FG003|Overall Study|Lack of trial drug at site|0|||
33334671|NCT00818623|62711050|FG004|Overall Study|Lack of trial drug at site|2|||
33334672|NCT00818623|62711051|FG005|Overall Study|Lack of trial drug at site|0|||
33334673|NCT00818623|62711052|FG006|Overall Study|Lack of trial drug at site|1|||
33334674|NCT00818623|62711053|FG007|Overall Study|Lack of trial drug at site|0|||
33334675|NCT00818623|62711046|FG000|Overall Study|Disease progression|0|||
33334676|NCT00818623|62711047|FG001|Overall Study|Disease progression|0|||
33334677|NCT00818623|62711048|FG002|Overall Study|Disease progression|0|||
33334678|NCT00818623|62711049|FG003|Overall Study|Disease progression|0|||
33334679|NCT00818623|62711050|FG004|Overall Study|Disease progression|0|||
33334680|NCT00818623|62711051|FG005|Overall Study|Disease progression|0|||
33334681|NCT00818623|62711052|FG006|Overall Study|Disease progression|1|||
33334682|NCT00818623|62711053|FG007|Overall Study|Disease progression|0|||
33334683|NCT00827359|62711071|FG000|Overall Study|Progressive Diseas|19|||
33334684|NCT00827359|62711071|FG000|Overall Study|Unacceptable Toxicity|5|||
33334685|NCT00827359|62711071|FG000|Overall Study|Ineligible|1|||
33334686|NCT00818389|62711077|FG000|Overall Study|Death|1|||
33334687|NCT00818389|62711078|FG001|Overall Study|Death|3|||
33334688|NCT00818389|62711077|FG000|Overall Study|ALS Disease Progression|1|||
33334689|NCT00818389|62711078|FG001|Overall Study|ALS Disease Progression|0|||
33334690|NCT00818389|62711077|FG000|Overall Study|Withdrawal by Subject|2|||
33334691|NCT00818389|62711078|FG001|Overall Study|Withdrawal by Subject|2|||
33334692|NCT00818389|62711077|FG000|Overall Study|Adverse Event|0|||
33334693|NCT00818389|62711078|FG001|Overall Study|Adverse Event|1|||
33334694|NCT00850135|62711084|FG000|Overall Study|Physician Decision|1|||
33334695|NCT01154816|62711102|FG000|Overall Study|Withdrawal by Subject|1|||
33334696|NCT01154816|62711103|FG001|Overall Study|Withdrawal by Subject|0|||
33334697|NCT01154816|62711104|FG002|Overall Study|Withdrawal by Subject|0|||
33334698|NCT01154816|62711105|FG003|Overall Study|Withdrawal by Subject|1|||
33334699|NCT01154816|62711106|FG004|Overall Study|Withdrawal by Subject|0|||
33334700|NCT01154816|62711107|FG005|Overall Study|Withdrawal by Subject|0|||
33334701|NCT01154816|62711108|FG006|Overall Study|Withdrawal by Subject|0|||
33334702|NCT01154816|62711109|FG007|Overall Study|Withdrawal by Subject|0|||
33334703|NCT01154816|62711110|FG008|Overall Study|Withdrawal by Subject|1|||
33334704|NCT01154816|62711111|FG009|Overall Study|Withdrawal by Subject|3|||
33334705|NCT01154816|62711112|FG010|Overall Study|Withdrawal by Subject|0|||
33334706|NCT01154816|62711113|FG011|Overall Study|Withdrawal by Subject|0|||
33334707|NCT01154816|62711102|FG000|Overall Study|Progressive Disease|13|||
33334708|NCT01154816|62711103|FG001|Overall Study|Progressive Disease|8|||
33334709|NCT01154816|62711104|FG002|Overall Study|Progressive Disease|9|||
33334710|NCT01154816|62711105|FG003|Overall Study|Progressive Disease|9|||
33334711|NCT01154816|62711106|FG004|Overall Study|Progressive Disease|8|||
33334712|NCT01154816|62711107|FG005|Overall Study|Progressive Disease|8|||
33334713|NCT01154816|62711108|FG006|Overall Study|Progressive Disease|5|||
33334714|NCT01154816|62711109|FG007|Overall Study|Progressive Disease|6|||
33334715|NCT01154816|62711110|FG008|Overall Study|Progressive Disease|8|||
33334716|NCT01154816|62711111|FG009|Overall Study|Progressive Disease|6|||
33334717|NCT01154816|62711112|FG010|Overall Study|Progressive Disease|10|||
33334718|NCT01154816|62711113|FG011|Overall Study|Progressive Disease|3|||
33334719|NCT01154816|62711102|FG000|Overall Study|Physician Decision|1|||
33334720|NCT01154816|62711103|FG001|Overall Study|Physician Decision|0|||
33334721|NCT01154816|62711104|FG002|Overall Study|Physician Decision|1|||
33334722|NCT01154816|62711105|FG003|Overall Study|Physician Decision|0|||
33334723|NCT01154816|62711106|FG004|Overall Study|Physician Decision|2|||
33334724|NCT01154816|62711107|FG005|Overall Study|Physician Decision|0|||
33334725|NCT01154816|62711108|FG006|Overall Study|Physician Decision|0|||
33334726|NCT01154816|62711109|FG007|Overall Study|Physician Decision|0|||
33334727|NCT01154816|62711110|FG008|Overall Study|Physician Decision|0|||
33548615|NCT02483572|62939906|FG000|Overall Study|Withdrawal by Subject|1|||
33548616|NCT02483572|62939907|FG001|Overall Study|Withdrawal by Subject|0|||
33334728|NCT01154816|62711111|FG009|Overall Study|Physician Decision|1|||
33334729|NCT01154816|62711112|FG010|Overall Study|Physician Decision|1|||
33334730|NCT01154816|62711113|FG011|Overall Study|Physician Decision|1|||
33334731|NCT01154816|62711102|FG000|Overall Study|Adverse Event|5|||
33334732|NCT01154816|62711103|FG001|Overall Study|Adverse Event|2|||
33334733|NCT01154816|62711104|FG002|Overall Study|Adverse Event|0|||
33334734|NCT01154816|62711105|FG003|Overall Study|Adverse Event|0|||
33334735|NCT01154816|62711106|FG004|Overall Study|Adverse Event|0|||
33334736|NCT01154816|62711107|FG005|Overall Study|Adverse Event|0|||
33334737|NCT01154816|62711108|FG006|Overall Study|Adverse Event|1|||
33334738|NCT01154816|62711109|FG007|Overall Study|Adverse Event|1|||
33334739|NCT01154816|62711110|FG008|Overall Study|Adverse Event|0|||
33334740|NCT01154816|62711111|FG009|Overall Study|Adverse Event|0|||
33334741|NCT01154816|62711112|FG010|Overall Study|Adverse Event|0|||
33334742|NCT01154816|62711113|FG011|Overall Study|Adverse Event|0|||
33334743|NCT00849901|62711159|FG000|Acute Treatment Phase|Adverse Event|9|||
33334744|NCT00849901|62711160|FG001|Acute Treatment Phase|Adverse Event|1|||
33334745|NCT00849901|62711161|FG002|Acute Treatment Phase|Adverse Event|3|||
33334746|NCT00849901|62711159|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
33334747|NCT00849901|62711160|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
33334748|NCT00849901|62711161|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
33334749|NCT00849901|62711159|FG000|Acute Treatment Phase|Protocol Violation|0|||
33334750|NCT00849901|62711160|FG001|Acute Treatment Phase|Protocol Violation|2|||
33334751|NCT00849901|62711161|FG002|Acute Treatment Phase|Protocol Violation|1|||
33334752|NCT00849901|62711159|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
33334753|NCT00849901|62711160|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
33334754|NCT00849901|62711161|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
33334755|NCT00849901|62711159|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
33334756|NCT00849901|62711160|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
33334757|NCT00849901|62711161|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
33334758|NCT00849901|62711159|FG000|Acute Treatment Phase|Physician Decision|1|||
33334759|NCT00849901|62711160|FG001|Acute Treatment Phase|Physician Decision|1|||
33334760|NCT00849901|62711161|FG002|Acute Treatment Phase|Physician Decision|1|||
33334761|NCT00849901|62711159|FG000|Acute Treatment Phase|Sponsor Decision|1|||
33334762|NCT00849901|62711160|FG001|Acute Treatment Phase|Sponsor Decision|0|||
33334763|NCT00849901|62711161|FG002|Acute Treatment Phase|Sponsor Decision|0|||
33334764|NCT00849901|62711159|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
33334765|NCT00849901|62711160|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
33334766|NCT00849901|62711161|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
33334767|NCT00849901|62711159|FG000|Extension Phase|Adverse Event|2|||
33334768|NCT00849901|62711160|FG001|Extension Phase|Adverse Event|8|||
33334769|NCT00849901|62711161|FG002|Extension Phase|Adverse Event|4|||
33334770|NCT00849901|62711159|FG000|Extension Phase|Lost to Follow-up|3|||
33334771|NCT00849901|62711160|FG001|Extension Phase|Lost to Follow-up|0|||
33334772|NCT00849901|62711161|FG002|Extension Phase|Lost to Follow-up|1|||
33334773|NCT00849901|62711159|FG000|Extension Phase|Protocol Violation|2|||
33334774|NCT00849901|62711160|FG001|Extension Phase|Protocol Violation|2|||
33334775|NCT00849901|62711161|FG002|Extension Phase|Protocol Violation|4|||
33334776|NCT00849901|62711159|FG000|Extension Phase|Withdrawal by Subject|7|||
33334777|NCT00849901|62711160|FG001|Extension Phase|Withdrawal by Subject|6|||
33334778|NCT00849901|62711161|FG002|Extension Phase|Withdrawal by Subject|3|||
33334779|NCT00849901|62711159|FG000|Extension Phase|Parent or Caregiver Decision|10|||
33334780|NCT00849901|62711160|FG001|Extension Phase|Parent or Caregiver Decision|4|||
33334781|NCT00849901|62711161|FG002|Extension Phase|Parent or Caregiver Decision|4|||
33334782|NCT00849901|62711159|FG000|Extension Phase|Physician Decision|1|||
33334783|NCT00849901|62711160|FG001|Extension Phase|Physician Decision|2|||
33334784|NCT00849901|62711161|FG002|Extension Phase|Physician Decision|0|||
33334785|NCT00849901|62711159|FG000|Extension Phase|Lack of Efficacy|2|||
33334786|NCT00849901|62711160|FG001|Extension Phase|Lack of Efficacy|4|||
33334787|NCT00849901|62711161|FG002|Extension Phase|Lack of Efficacy|1|||
33334788|NCT01168232|62711175|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
33334789|NCT01168232|62711175|FG000|Overall Study|Ineligible- Wrong cell type|6|||
33334790|NCT01168232|62711175|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
33334791|NCT00817531|62711179|FG000|Overall Study|Adverse Event|1|||
33334792|NCT00817531|62711179|FG000|Overall Study|Lack of Efficacy|1|||
33334793|NCT00817063|62711185|FG000|Overall Study|Adverse Event|32|||
33334794|NCT00817063|62711186|FG001|Overall Study|Adverse Event|13|||
33468820|NCT00326963|62842609|FG000|Overall Study|Administrative / other|1|||
33468821|NCT00326885|62842614|FG000|Overall Study|Adverse Event|1|||
33334795|NCT00817063|62711185|FG000|Overall Study|Death|1|||
33334796|NCT00817063|62711186|FG001|Overall Study|Death|1|||
33334797|NCT00817063|62711185|FG000|Overall Study|Lack of Efficacy|33|||
33334798|NCT00817063|62711186|FG001|Overall Study|Lack of Efficacy|86|||
33334799|NCT00817063|62711185|FG000|Overall Study|Failure to Return|13|||
33334800|NCT00817063|62711186|FG001|Overall Study|Failure to Return|12|||
33334801|NCT00817063|62711185|FG000|Overall Study|Violation of Selection at Entry|7|||
33334802|NCT00817063|62711186|FG001|Overall Study|Violation of Selection at Entry|4|||
33334803|NCT00817063|62711185|FG000|Overall Study|Protocol Violation|3|||
33334804|NCT00817063|62711186|FG001|Overall Study|Protocol Violation|8|||
33468822|NCT00326885|62842614|FG000|Overall Study|Withdrawal by Subject|3|||
33334805|NCT00817063|62711185|FG000|Overall Study|Withdrawal by Subject|17|||
33334806|NCT00817063|62711186|FG001|Overall Study|Withdrawal by Subject|37|||
33334807|NCT00817063|62711185|FG000|Overall Study|Early Improvement|19|||
33334808|NCT00817063|62711186|FG001|Overall Study|Early Improvement|4|||
33334809|NCT00817063|62711185|FG000|Overall Study|Administrative|10|||
33334810|NCT00817063|62711186|FG001|Overall Study|Administrative|4|||
33334811|NCT00817063|62711185|FG000|Overall Study|Abnormality of Laboratory Test|2|||
33334812|NCT00817063|62711186|FG001|Overall Study|Abnormality of Laboratory Test|1|||
33334813|NCT01167140|62711192|FG000|Overall Study|Withdrawal by Subject|1|||
33334814|NCT01166750|62711198|FG000|Overall Study|Lost to Follow-up|1|||
33654039|NCT01737710|63066578|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
33654040|NCT01737710|63066579|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
33654041|NCT01737710|63066580|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
33654042|NCT01737710|63066581|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
33654043|NCT01737710|63066582|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
33654044|NCT01682876|63066597|FG000|Overall Study|Administrative reason|4|||
33654045|NCT01682876|63066598|FG001|Overall Study|Administrative reason|4|||
33654046|NCT01682876|63066599|FG002|Overall Study|Administrative reason|0|||
33654047|NCT01682876|63066600|FG003|Overall Study|Administrative reason|3|||
33654048|NCT01682876|63066597|FG000|Overall Study|Adverse Event|0|||
33654049|NCT01682876|63066598|FG001|Overall Study|Adverse Event|0|||
33654050|NCT01682876|63066599|FG002|Overall Study|Adverse Event|0|||
33654051|NCT01682876|63066600|FG003|Overall Study|Adverse Event|1|||
33654052|NCT01682876|63066597|FG000|Overall Study|Lost to Follow-up|11|||
33654053|NCT01682876|63066598|FG001|Overall Study|Lost to Follow-up|15|||
33654054|NCT01682876|63066599|FG002|Overall Study|Lost to Follow-up|9|||
33654055|NCT01682876|63066600|FG003|Overall Study|Lost to Follow-up|11|||
33654056|NCT01682876|63066597|FG000|Overall Study|Protocol Violation|1|||
33654057|NCT01682876|63066598|FG001|Overall Study|Protocol Violation|1|||
33654058|NCT01682876|63066599|FG002|Overall Study|Protocol Violation|1|||
33654059|NCT01682876|63066600|FG003|Overall Study|Protocol Violation|1|||
33654060|NCT01682876|63066597|FG000|Overall Study|Withdrawal by Subject|4|||
33654061|NCT01682876|63066598|FG001|Overall Study|Withdrawal by Subject|0|||
33654062|NCT01682876|63066599|FG002|Overall Study|Withdrawal by Subject|0|||
33654063|NCT01682876|63066600|FG003|Overall Study|Withdrawal by Subject|2|||
33654064|NCT01682876|63066597|FG000|Overall Study|Other|1|||
33654065|NCT01682876|63066598|FG001|Overall Study|Other|0|||
33654066|NCT01682876|63066599|FG002|Overall Study|Other|1|||
33654067|NCT01682876|63066600|FG003|Overall Study|Other|1|||
33654068|NCT01682720|63066617|FG000|Overall Study|Randomized but Not Treated|0|||
33654069|NCT01682720|63066618|FG001|Overall Study|Randomized but Not Treated|1|||
33654070|NCT01682720|63066619|FG002|Overall Study|Randomized but Not Treated|1|||
33654071|NCT01682720|63066620|FG003|Overall Study|Randomized but Not Treated|0|||
33654072|NCT01682720|63066617|FG000|Overall Study|Terminated by Sponsor|83|||
33654073|NCT01682720|63066618|FG001|Overall Study|Terminated by Sponsor|0|||
33654074|NCT01682720|63066619|FG002|Overall Study|Terminated by Sponsor|0|||
33654075|NCT01682720|63066620|FG003|Overall Study|Terminated by Sponsor|0|||
33654076|NCT01682720|63066617|FG000|Overall Study|Efficacy Failure|0|||
33654077|NCT01682720|63066618|FG001|Overall Study|Efficacy Failure|3|||
33654078|NCT01682720|63066619|FG002|Overall Study|Efficacy Failure|3|||
33654079|NCT01682720|63066620|FG003|Overall Study|Efficacy Failure|30|||
33654080|NCT01682720|63066617|FG000|Overall Study|Lost to Follow-up|1|||
33654081|NCT01682720|63066618|FG001|Overall Study|Lost to Follow-up|1|||
33654082|NCT01682720|63066619|FG002|Overall Study|Lost to Follow-up|0|||
33654083|NCT01682720|63066620|FG003|Overall Study|Lost to Follow-up|6|||
33654084|NCT01682720|63066617|FG000|Overall Study|Subject Withdrew Consent|0|||
33654085|NCT01682720|63066618|FG001|Overall Study|Subject Withdrew Consent|0|||
33654086|NCT01682720|63066619|FG002|Overall Study|Subject Withdrew Consent|2|||
33654087|NCT01682720|63066620|FG003|Overall Study|Subject Withdrew Consent|2|||
33654088|NCT01682720|63066617|FG000|Overall Study|Adverse Event|1|||
33654089|NCT01682720|63066618|FG001|Overall Study|Adverse Event|0|||
33654090|NCT01682720|63066619|FG002|Overall Study|Adverse Event|1|||
33654091|NCT01682720|63066620|FG003|Overall Study|Adverse Event|1|||
33334815|NCT01166750|62711199|FG001|Overall Study|Lost to Follow-up|0|||
33654092|NCT01714544|63066639|FG000|Overall Study|Lost to Follow-up|1|||
33654093|NCT01714544|63066639|FG000|Overall Study|Physician Decision|1|||
33654094|NCT01714544|63066639|FG000|Overall Study|Withdrawal by Subject|1|||
33654095|NCT01703858|63066646|FG000|Overall Study|Withdrawal by Subject|0|||
33654096|NCT01703858|63066647|FG001|Overall Study|Withdrawal by Subject|1|||
33654097|NCT01703858|63066648|FG002|Overall Study|Withdrawal by Subject|0|||
33654098|NCT01714310|63066664|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
33654099|NCT01714310|63066665|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
33654100|NCT01714310|63066666|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
33654101|NCT01714310|63066664|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
33334816|NCT00826267|62711208|FG000|Overall Study|Other Adverse Event|1|||
33334817|NCT00826267|62711209|FG001|Overall Study|Other Adverse Event|0|||
33334818|NCT00826267|62711210|FG002|Overall Study|Other Adverse Event|0|||
33334819|NCT00986154|62711221|FG000|Overall Study|Death|136|||
33334820|NCT00986154|62711222|FG001|Overall Study|Death|127|||
33334821|NCT00986154|62711221|FG000|Overall Study|Lost to Follow-up|7|||
33334822|NCT00986154|62711222|FG001|Overall Study|Lost to Follow-up|4|||
33334823|NCT00986154|62711221|FG000|Overall Study|Withdrawal by Subject|32|||
33334824|NCT00986154|62711222|FG001|Overall Study|Withdrawal by Subject|33|||
33334825|NCT00986154|62711221|FG000|Overall Study|investigator/subject decide not continue|6|||
33334826|NCT00986154|62711222|FG001|Overall Study|investigator/subject decide not continue|3|||
33334827|NCT00986154|62711221|FG000|Overall Study|never received study drug|25|||
33334828|NCT00986154|62711222|FG001|Overall Study|never received study drug|27|||
33334829|NCT00848965|62711228|FG000|Overall Study|Adverse Event|1|||
33334830|NCT00848965|62711228|FG000|Overall Study|Withdrawal by Subject|1|||
33334831|NCT01154036|62711247|FG000|Phase I|Physician Decision|0|||
33334832|NCT01154036|62711248|FG001|Phase I|Physician Decision|1|||
33334833|NCT01154036|62711249|FG002|Phase I|Physician Decision|0|||
33334834|NCT01154036|62711250|FG003|Phase I|Physician Decision|0|||
33334835|NCT01154036|62711251|FG004|Phase I|Physician Decision|0|||
33334836|NCT01154036|62711252|FG005|Phase I|Physician Decision|0|||
33334837|NCT01154036|62711253|FG006|Phase I|Physician Decision|0|||
33334838|NCT01154036|62711254|FG007|Phase I|Physician Decision|0|||
33334839|NCT01154036|62711247|FG000|Phase I|Lost to Follow-up|0|||
33334840|NCT01154036|62711248|FG001|Phase I|Lost to Follow-up|3|||
33334841|NCT01154036|62711249|FG002|Phase I|Lost to Follow-up|6|||
33334842|NCT01154036|62711250|FG003|Phase I|Lost to Follow-up|0|||
33334843|NCT01154036|62711251|FG004|Phase I|Lost to Follow-up|0|||
33334844|NCT01154036|62711252|FG005|Phase I|Lost to Follow-up|0|||
33334845|NCT01154036|62711253|FG006|Phase I|Lost to Follow-up|0|||
33334846|NCT01154036|62711254|FG007|Phase I|Lost to Follow-up|0|||
33334847|NCT01154036|62711247|FG000|Phase I|Protocol Violation|0|||
33334848|NCT01154036|62711248|FG001|Phase I|Protocol Violation|3|||
33334849|NCT01154036|62711249|FG002|Phase I|Protocol Violation|9|||
33334850|NCT01154036|62711250|FG003|Phase I|Protocol Violation|0|||
33334851|NCT01154036|62711251|FG004|Phase I|Protocol Violation|0|||
33334852|NCT01154036|62711252|FG005|Phase I|Protocol Violation|0|||
33334853|NCT01154036|62711253|FG006|Phase I|Protocol Violation|0|||
33334854|NCT01154036|62711254|FG007|Phase I|Protocol Violation|0|||
33334855|NCT01154036|62711247|FG000|Phase I|Withdrawal by Subject|2|||
33334856|NCT01154036|62711248|FG001|Phase I|Withdrawal by Subject|10|||
33334857|NCT01154036|62711249|FG002|Phase I|Withdrawal by Subject|29|||
33334858|NCT01154036|62711250|FG003|Phase I|Withdrawal by Subject|0|||
33334859|NCT01154036|62711251|FG004|Phase I|Withdrawal by Subject|0|||
33334860|NCT01154036|62711252|FG005|Phase I|Withdrawal by Subject|0|||
33334861|NCT01154036|62711253|FG006|Phase I|Withdrawal by Subject|0|||
33334862|NCT01154036|62711254|FG007|Phase I|Withdrawal by Subject|0|||
33334863|NCT01154036|62711247|FG000|Phase I|Adverse Event|1|||
33334864|NCT01154036|62711248|FG001|Phase I|Adverse Event|11|||
33334865|NCT01154036|62711249|FG002|Phase I|Adverse Event|12|||
33334866|NCT01154036|62711250|FG003|Phase I|Adverse Event|0|||
33334867|NCT01154036|62711251|FG004|Phase I|Adverse Event|0|||
33334868|NCT01154036|62711252|FG005|Phase I|Adverse Event|0|||
33334869|NCT01154036|62711253|FG006|Phase I|Adverse Event|0|||
33334870|NCT01154036|62711254|FG007|Phase I|Adverse Event|0|||
33334871|NCT01154036|62711247|FG000|Phase II|Adverse Event|0|||
33334872|NCT01154036|62711248|FG001|Phase II|Adverse Event|0|||
33334873|NCT01154036|62711249|FG002|Phase II|Adverse Event|0|||
33334874|NCT01154036|62711250|FG003|Phase II|Adverse Event|0|||
33334875|NCT01154036|62711251|FG004|Phase II|Adverse Event|1|||
33334876|NCT01154036|62711252|FG005|Phase II|Adverse Event|1|||
33468823|NCT00326885|62842614|FG000|Overall Study|Physician Decision|1|||
33654102|NCT01714310|63066665|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
33334877|NCT01154036|62711253|FG006|Phase II|Adverse Event|1|||
33334878|NCT01154036|62711254|FG007|Phase II|Adverse Event|1|||
33334879|NCT01154036|62711247|FG000|Phase II|Physician Decision|0|||
33334880|NCT01154036|62711248|FG001|Phase II|Physician Decision|0|||
33334881|NCT01154036|62711249|FG002|Phase II|Physician Decision|0|||
33334882|NCT01154036|62711250|FG003|Phase II|Physician Decision|0|||
33334883|NCT01154036|62711251|FG004|Phase II|Physician Decision|0|||
33334884|NCT01154036|62711252|FG005|Phase II|Physician Decision|0|||
33334885|NCT01154036|62711253|FG006|Phase II|Physician Decision|1|||
33334886|NCT01154036|62711254|FG007|Phase II|Physician Decision|0|||
33334887|NCT01154036|62711247|FG000|Phase II|Lost to Follow-up|0|||
33334888|NCT01154036|62711248|FG001|Phase II|Lost to Follow-up|0|||
33334889|NCT01154036|62711249|FG002|Phase II|Lost to Follow-up|0|||
33334890|NCT01154036|62711250|FG003|Phase II|Lost to Follow-up|1|||
33334891|NCT01154036|62711251|FG004|Phase II|Lost to Follow-up|2|||
33334892|NCT01154036|62711252|FG005|Phase II|Lost to Follow-up|0|||
33334893|NCT01154036|62711253|FG006|Phase II|Lost to Follow-up|2|||
33334894|NCT01154036|62711254|FG007|Phase II|Lost to Follow-up|1|||
33334895|NCT01154036|62711247|FG000|Phase II|Protocol Violation|0|||
33334896|NCT01154036|62711248|FG001|Phase II|Protocol Violation|0|||
33334897|NCT01154036|62711249|FG002|Phase II|Protocol Violation|0|||
33334898|NCT01154036|62711250|FG003|Phase II|Protocol Violation|0|||
33334899|NCT01154036|62711251|FG004|Phase II|Protocol Violation|1|||
33334900|NCT01154036|62711252|FG005|Phase II|Protocol Violation|2|||
33334901|NCT01154036|62711253|FG006|Phase II|Protocol Violation|0|||
33334902|NCT01154036|62711254|FG007|Phase II|Protocol Violation|0|||
33334903|NCT01154036|62711247|FG000|Phase II|Withdrawal by Subject|0|||
33334904|NCT01154036|62711248|FG001|Phase II|Withdrawal by Subject|0|||
33334905|NCT01154036|62711249|FG002|Phase II|Withdrawal by Subject|0|||
33334906|NCT01154036|62711250|FG003|Phase II|Withdrawal by Subject|0|||
33334907|NCT01154036|62711251|FG004|Phase II|Withdrawal by Subject|4|||
33334908|NCT01154036|62711252|FG005|Phase II|Withdrawal by Subject|2|||
33334909|NCT01154036|62711253|FG006|Phase II|Withdrawal by Subject|5|||
33334910|NCT01154036|62711254|FG007|Phase II|Withdrawal by Subject|4|||
33334911|NCT00816595|62711276|FG000|Overall Study|Withdrawal by Subject|2|||
33334912|NCT00816595|62711277|FG001|Overall Study|Withdrawal by Subject|0|||
33334913|NCT01166438|62711287|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
33334914|NCT01166438|62711288|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
33334915|NCT01166438|62711287|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
33334916|NCT01166438|62711288|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
33334917|NCT01166438|62711287|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
33334918|NCT01166438|62711288|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
33334919|NCT01166438|62711287|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
33334920|NCT01166438|62711288|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
33334921|NCT01166438|62711287|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
33334922|NCT01166438|62711288|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
33334923|NCT01166438|62711287|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
33334924|NCT01166438|62711288|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
33334925|NCT01153958|62711297|FG000|Overall Study|Study Terminated|36|||
33334926|NCT01153958|62711298|FG001|Overall Study|Study Terminated|32|||
33334927|NCT00599638|62711308|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
33334928|NCT00599638|62711309|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
33334929|NCT00599638|62711310|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
33334930|NCT00599638|62711311|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
33334931|NCT00599638|62711308|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
33334932|NCT00599638|62711309|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
33334933|NCT00599638|62711310|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
33334934|NCT00599638|62711311|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
33334935|NCT00599638|62711308|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
33334936|NCT00599638|62711309|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
33334937|NCT00599638|62711310|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
33334938|NCT00599638|62711311|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
33334939|NCT00599638|62711308|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
33334940|NCT00599638|62711309|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
33334941|NCT00599638|62711310|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
33334942|NCT00599638|62711311|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
33548617|NCT02483572|62939906|FG000|Overall Study|Lost to Follow-up|1|||
33334943|NCT00599638|62711308|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
33334944|NCT00599638|62711309|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
33334945|NCT00599638|62711310|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
33334946|NCT00599638|62711311|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
33334947|NCT00599638|62711308|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
33334948|NCT00599638|62711309|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
33334949|NCT00599638|62711310|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
33334950|NCT00599638|62711311|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
33334951|NCT00599638|62711308|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
33334952|NCT00599638|62711309|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
33334953|NCT00599638|62711310|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
33334954|NCT00599638|62711311|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
33334955|NCT00599638|62711308|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
33334956|NCT00599638|62711309|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
33334957|NCT00599638|62711310|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
33334958|NCT00599638|62711311|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
33334959|NCT00599638|62711308|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
33334960|NCT00599638|62711309|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
33334961|NCT00599638|62711310|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
33334962|NCT00599638|62711311|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
33334963|NCT01166282|62711321|FG000|Open-label Period|Adverse Event|0|||
33334964|NCT01166282|62711322|FG001|Open-label Period|Adverse Event|0|||
33334965|NCT01166282|62711323|FG002|Open-label Period|Adverse Event|6|||
33334966|NCT01166282|62711321|FG000|Open-label Period|Withdrawal by Subject|0|||
33334967|NCT01166282|62711322|FG001|Open-label Period|Withdrawal by Subject|0|||
33334968|NCT01166282|62711323|FG002|Open-label Period|Withdrawal by Subject|4|||
33334969|NCT01166282|62711321|FG000|Open-label Period|Lack of Efficacy|0|||
33334970|NCT01166282|62711322|FG001|Open-label Period|Lack of Efficacy|0|||
33334971|NCT01166282|62711323|FG002|Open-label Period|Lack of Efficacy|2|||
33334972|NCT01166282|62711321|FG000|Open-label Period|Remission|0|||
33334973|NCT01166282|62711322|FG001|Open-label Period|Remission|0|||
33334974|NCT01166282|62711323|FG002|Open-label Period|Remission|4|||
33334975|NCT01166282|62711321|FG000|Open-label Period|Irregular Compliance|0|||
33334976|NCT01166282|62711322|FG001|Open-label Period|Irregular Compliance|0|||
33334977|NCT01166282|62711323|FG002|Open-label Period|Irregular Compliance|1|||
33334978|NCT01153724|62711331|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33334979|NCT01153724|62711331|FG000|Treatment Period 2|Adverse Event|1|||
33334980|NCT01153724|62711331|FG000|Treatment Period 2|Other reason not defined above|1|||
33334981|NCT01152788|62711339|FG000|Overall Study|Withdrawal by Subject|0|||
33334982|NCT01152788|62711340|FG001|Overall Study|Withdrawal by Subject|3|||
33548618|NCT02483572|62939907|FG001|Overall Study|Lost to Follow-up|0|||
33548619|NCT02483572|62939906|FG000|Overall Study|Physician Decision|0|||
33548620|NCT02483572|62939907|FG001|Overall Study|Physician Decision|1|||
33548621|NCT01062425|62939915|FG000|Overall Study|Protocol Violation|3|||
33548622|NCT01062425|62939916|FG001|Overall Study|Protocol Violation|6|||
33548623|NCT01060553|62939922|FG000|Overall Study|Lost to Follow-up|3|||
33548624|NCT01060553|62939923|FG001|Overall Study|Lost to Follow-up|5|||
33548625|NCT01060553|62939922|FG000|Overall Study|Withdrawal by Subject|5|||
33548626|NCT01060553|62939923|FG001|Overall Study|Withdrawal by Subject|5|||
33548627|NCT01060553|62939922|FG000|Overall Study|Lack of Efficacy|1|||
33548628|NCT01060553|62939923|FG001|Overall Study|Lack of Efficacy|0|||
33548629|NCT02491684|62939930|FG000|Treatment Phase|Adverse Event|2|||
33468824|NCT00326885|62842614|FG000|Overall Study|Hospice withdrew consent|2|||
33468825|NCT00326495|62842619|FG000|Overall Study|Switched to alternative treatment|1|||
33548630|NCT02491684|62939931|FG001|Treatment Phase|Adverse Event|2|||
33548631|NCT02491684|62939930|FG000|Treatment Phase|Incorrect randomisation|1|||
33548632|NCT02491684|62939931|FG001|Treatment Phase|Incorrect randomisation|0|||
33468826|NCT00326495|62842619|FG000|Overall Study|Disease progression before treatment|1|||
33468827|NCT00326495|62842619|FG000|Overall Study|Refused further treatment|2|||
33468828|NCT00326495|62842619|FG000|Overall Study|Subject off study before assessment|1|||
33468829|NCT00326417|62842625|FG000|Overall Study|Withdrawal by Subject|0|||
33468830|NCT00326417|62842626|FG001|Overall Study|Withdrawal by Subject|0|||
33468831|NCT00326417|62842627|FG002|Overall Study|Withdrawal by Subject|1|||
33468832|NCT00326417|62842628|FG003|Overall Study|Withdrawal by Subject|0|||
33548633|NCT02491684|62939930|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
33334983|NCT01152788|62711339|FG000|Overall Study|No treatment|0|||
33334984|NCT01152788|62711340|FG001|Overall Study|No treatment|1|||
33334985|NCT01165424|62711346|FG000|Overall Study|Clinical adverse experiences|1|||
33334986|NCT01165424|62711346|FG000|Overall Study|Laboratory adverse experiences|1|||
33468833|NCT00326417|62842625|FG000|Overall Study|Arm Closed|7|||
33548634|NCT02491684|62939931|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
33548635|NCT01061723|62939943|FG000|Overall Study|Adverse Event|0|||
33548636|NCT01061723|62939944|FG001|Overall Study|Adverse Event|2|||
33548637|NCT01061723|62939945|FG002|Overall Study|Adverse Event|5|||
33548638|NCT01061723|62939946|FG003|Overall Study|Adverse Event|5|||
33548639|NCT01061723|62939947|FG004|Overall Study|Adverse Event|2|||
33548640|NCT01061723|62939948|FG005|Overall Study|Adverse Event|6|||
33548641|NCT01061723|62939943|FG000|Overall Study|Lack of Efficacy|2|||
33548642|NCT01061723|62939944|FG001|Overall Study|Lack of Efficacy|3|||
33548643|NCT01061723|62939945|FG002|Overall Study|Lack of Efficacy|4|||
33548644|NCT01061723|62939946|FG003|Overall Study|Lack of Efficacy|2|||
33548645|NCT01061723|62939947|FG004|Overall Study|Lack of Efficacy|1|||
33548646|NCT01061723|62939948|FG005|Overall Study|Lack of Efficacy|1|||
33548647|NCT01061723|62939943|FG000|Overall Study|Randomized but not treated|0|||
33548648|NCT01061723|62939944|FG001|Overall Study|Randomized but not treated|0|||
33548649|NCT01061723|62939945|FG002|Overall Study|Randomized but not treated|0|||
33548650|NCT01061723|62939946|FG003|Overall Study|Randomized but not treated|0|||
33548651|NCT01061723|62939947|FG004|Overall Study|Randomized but not treated|0|||
33548652|NCT01061723|62939948|FG005|Overall Study|Randomized but not treated|1|||
33548653|NCT01061723|62939943|FG000|Overall Study|Other than specified above|2|||
33548654|NCT01061723|62939944|FG001|Overall Study|Other than specified above|1|||
33548655|NCT01061723|62939945|FG002|Overall Study|Other than specified above|1|||
33548656|NCT01061723|62939946|FG003|Overall Study|Other than specified above|1|||
33548657|NCT01061723|62939947|FG004|Overall Study|Other than specified above|0|||
33548658|NCT01061723|62939948|FG005|Overall Study|Other than specified above|1|||
33548659|NCT01061567|62939967|FG000|Overall Study|Adverse Event|32|||
33548660|NCT01061567|62939967|FG000|Overall Study|Death|2|||
33548661|NCT01061567|62939967|FG000|Overall Study|Lack of Efficacy|3|||
33548662|NCT01061567|62939967|FG000|Overall Study|Lost to Follow-up|24|||
33548663|NCT01061567|62939967|FG000|Overall Study|Protocol Violation|1|||
33548664|NCT01061567|62939967|FG000|Overall Study|Withdrawal by Subject|11|||
33548665|NCT01061567|62939967|FG000|Overall Study|Other reason than stated above|3|||
33548666|NCT01061333|62939971|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
33548667|NCT01061333|62939972|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
33548668|NCT02489968|62939985|FG000|Open-label Treatment Period|Adverse Event|14|||
33548669|NCT02489968|62939986|FG001|Open-label Treatment Period|Adverse Event|7|||
33548670|NCT02489968|62939987|FG002|Open-label Treatment Period|Adverse Event|0|||
33548671|NCT02489968|62939988|FG003|Open-label Treatment Period|Adverse Event|0|||
33548672|NCT02489968|62939989|FG004|Open-label Treatment Period|Adverse Event|0|||
33548673|NCT02489968|62939990|FG005|Open-label Treatment Period|Adverse Event|0|||
33548674|NCT02489968|62939985|FG000|Open-label Treatment Period|Protocol Violation|2|||
33548675|NCT02489968|62939986|FG001|Open-label Treatment Period|Protocol Violation|2|||
33548676|NCT02489968|62939987|FG002|Open-label Treatment Period|Protocol Violation|0|||
33548677|NCT02489968|62939988|FG003|Open-label Treatment Period|Protocol Violation|0|||
33548678|NCT02489968|62939989|FG004|Open-label Treatment Period|Protocol Violation|0|||
33548679|NCT02489968|62939990|FG005|Open-label Treatment Period|Protocol Violation|0|||
33548680|NCT02489968|62939985|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
33548681|NCT02489968|62939986|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
33548682|NCT02489968|62939987|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
33548683|NCT02489968|62939988|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
33548684|NCT02489968|62939989|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
33548685|NCT02489968|62939990|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
33548686|NCT02489968|62939985|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
33548687|NCT02489968|62939986|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
33548688|NCT02489968|62939987|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
33654103|NCT01714310|63066666|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
33654104|NCT01714310|63066664|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
33468834|NCT00326417|62842626|FG001|Overall Study|Arm Closed|0|||
33468835|NCT00326417|62842627|FG002|Overall Study|Arm Closed|0|||
33468836|NCT00326417|62842628|FG003|Overall Study|Arm Closed|3|||
33468837|NCT00326417|62842625|FG000|Overall Study|Death|7|||
33468838|NCT00326417|62842626|FG001|Overall Study|Death|0|||
33468839|NCT00326417|62842627|FG002|Overall Study|Death|0|||
33468840|NCT00326417|62842628|FG003|Overall Study|Death|0|||
33468841|NCT03825341|62842638|FG000|Overall Study|Withdrawal by Subject|0|||
33468842|NCT03825341|62842639|FG001|Overall Study|Withdrawal by Subject|1|||
33468843|NCT00297479|62842650|FG000|Overall Study|Lost to Follow-up|37|||
33468844|NCT00297479|62842651|FG001|Overall Study|Lost to Follow-up|54|||
33548689|NCT02489968|62939988|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
33548690|NCT02489968|62939989|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
33654105|NCT01714310|63066665|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
33468845|NCT00297479|62842652|FG002|Overall Study|Lost to Follow-up|51|||
33468846|NCT00688870|62842662|FG000|Infant Series|Parent or legal guardian request|4|||
33548691|NCT02489968|62939990|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
33548692|NCT02489968|62939985|FG000|Open-label Treatment Period|Other than specified above|204|||
33548693|NCT02489968|62939986|FG001|Open-label Treatment Period|Other than specified above|189|||
33548694|NCT02489968|62939987|FG002|Open-label Treatment Period|Other than specified above|0|||
33334987|NCT01165424|62711346|FG000|Overall Study|Did not meet entry criteria|1|||
33334988|NCT01165424|62711346|FG000|Overall Study|Participant moved (relocated)|1|||
33334989|NCT01152554|62711352|FG000|Overall Study|Withdrawal by Subject|73|||
33334990|NCT01152554|62711353|FG001|Overall Study|Withdrawal by Subject|28|||
33334991|NCT01152554|62711352|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
33334992|NCT01152554|62711353|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
33334993|NCT01152554|62711352|FG000|Overall Study|Adverse Event|67|||
33334994|NCT01152554|62711353|FG001|Overall Study|Adverse Event|14|||
33334995|NCT01152554|62711352|FG000|Overall Study|Severe non-compliance to protocol|36|||
33334996|NCT01152554|62711353|FG001|Overall Study|Severe non-compliance to protocol|14|||
33334997|NCT01152554|62711352|FG000|Overall Study|Condition under investigation worsened|5|||
33334998|NCT01152554|62711353|FG001|Overall Study|Condition under investigation worsened|2|||
33334999|NCT01152554|62711352|FG000|Overall Study|Lack of Efficacy|20|||
33335000|NCT01152554|62711353|FG001|Overall Study|Lack of Efficacy|3|||
33335001|NCT01152554|62711352|FG000|Overall Study|Study-specific withdrawal criteria|17|||
33335002|NCT01152554|62711353|FG001|Overall Study|Study-specific withdrawal criteria|8|||
33335003|NCT01152554|62711352|FG000|Overall Study|Lost to Follow-up|87|||
33335004|NCT01152554|62711353|FG001|Overall Study|Lost to Follow-up|32|||
33335005|NCT01152554|62711352|FG000|Overall Study|Other|28|||
33335006|NCT01152554|62711353|FG001|Overall Study|Other|8|||
33335007|NCT01152554|62711352|FG000|Overall Study|Death|1|||
33335008|NCT01152554|62711353|FG001|Overall Study|Death|1|||
33335009|NCT00598702|62711367|FG000|Overall Study|Other|0|||
33335010|NCT00598702|62711368|FG001|Overall Study|Other|2|||
33335011|NCT00598702|62711369|FG002|Overall Study|Other|0|||
33335012|NCT00598702|62711370|FG003|Overall Study|Other|0|||
33335013|NCT00598702|62711371|FG004|Overall Study|Other|0|||
33335014|NCT00598702|62711372|FG005|Overall Study|Other|1|||
33335015|NCT00598702|62711373|FG006|Overall Study|Other|0|||
33335016|NCT00598702|62711374|FG007|Overall Study|Other|0|||
33335017|NCT00598702|62711367|FG000|Overall Study|Early discharge from hospital|0|||
33335018|NCT00598702|62711368|FG001|Overall Study|Early discharge from hospital|0|||
33335019|NCT00598702|62711369|FG002|Overall Study|Early discharge from hospital|2|||
33335020|NCT00598702|62711370|FG003|Overall Study|Early discharge from hospital|5|||
33335021|NCT00598702|62711371|FG004|Overall Study|Early discharge from hospital|0|||
33335022|NCT00598702|62711372|FG005|Overall Study|Early discharge from hospital|10|||
33335023|NCT00598702|62711373|FG006|Overall Study|Early discharge from hospital|1|||
33335024|NCT00598702|62711374|FG007|Overall Study|Early discharge from hospital|0|||
33335025|NCT00598702|62711367|FG000|Overall Study|Adverse Event|0|||
33335026|NCT00598702|62711368|FG001|Overall Study|Adverse Event|0|||
33335027|NCT00598702|62711369|FG002|Overall Study|Adverse Event|0|||
33335028|NCT00598702|62711370|FG003|Overall Study|Adverse Event|1|||
33335029|NCT00598702|62711371|FG004|Overall Study|Adverse Event|0|||
33335030|NCT00598702|62711372|FG005|Overall Study|Adverse Event|0|||
33335031|NCT00598702|62711373|FG006|Overall Study|Adverse Event|0|||
33335032|NCT00598702|62711374|FG007|Overall Study|Adverse Event|0|||
33335033|NCT00598702|62711367|FG000|Overall Study|Withdrawal by Subject|0|||
33335034|NCT00598702|62711368|FG001|Overall Study|Withdrawal by Subject|0|||
33335035|NCT00598702|62711369|FG002|Overall Study|Withdrawal by Subject|0|||
33335036|NCT00598702|62711370|FG003|Overall Study|Withdrawal by Subject|1|||
33335037|NCT00598702|62711371|FG004|Overall Study|Withdrawal by Subject|1|||
33335038|NCT00598702|62711372|FG005|Overall Study|Withdrawal by Subject|0|||
33335039|NCT00598702|62711373|FG006|Overall Study|Withdrawal by Subject|0|||
33335040|NCT00598702|62711374|FG007|Overall Study|Withdrawal by Subject|0|||
33335041|NCT00598702|62711367|FG000|Overall Study|Physician Decision|0|||
33335042|NCT00598702|62711368|FG001|Overall Study|Physician Decision|0|||
33335043|NCT00598702|62711369|FG002|Overall Study|Physician Decision|0|||
33335044|NCT00598702|62711370|FG003|Overall Study|Physician Decision|0|||
33335045|NCT00598702|62711371|FG004|Overall Study|Physician Decision|1|||
33335046|NCT00598702|62711372|FG005|Overall Study|Physician Decision|0|||
33335047|NCT00598702|62711373|FG006|Overall Study|Physician Decision|0|||
33335048|NCT00598702|62711374|FG007|Overall Study|Physician Decision|0|||
33335049|NCT00598702|62711367|FG000|Overall Study|Dose limiting toxicity|0|||
33335050|NCT00598702|62711368|FG001|Overall Study|Dose limiting toxicity|0|||
33335051|NCT00598702|62711369|FG002|Overall Study|Dose limiting toxicity|0|||
33335052|NCT00598702|62711370|FG003|Overall Study|Dose limiting toxicity|1|||
33335053|NCT00598702|62711371|FG004|Overall Study|Dose limiting toxicity|1|||
33335054|NCT00598702|62711372|FG005|Overall Study|Dose limiting toxicity|1|||
33335055|NCT00598702|62711373|FG006|Overall Study|Dose limiting toxicity|0|||
33335056|NCT00598702|62711374|FG007|Overall Study|Dose limiting toxicity|0|||
33335057|NCT01148810|62711394|FG000|Overall Study|Adverse Event|0|||
33335058|NCT01148810|62711395|FG001|Overall Study|Adverse Event|2|||
33335059|NCT01148810|62711394|FG000|Overall Study|Lack of Efficacy|0|||
33335060|NCT01148810|62711395|FG001|Overall Study|Lack of Efficacy|1|||
33335061|NCT01148810|62711394|FG000|Overall Study|Withdrawal by Subject|0|||
33335062|NCT01148810|62711395|FG001|Overall Study|Withdrawal by Subject|2|||
33335063|NCT01148810|62711394|FG000|Overall Study|Protocol Violation|1|||
33335064|NCT01148810|62711395|FG001|Overall Study|Protocol Violation|0|||
33335065|NCT01151618|62711402|FG000|Overall Study|Adverse Event|2|||
33335066|NCT01151618|62711402|FG000|Overall Study|Withdrawal by Subject|7|||
33335067|NCT01164956|62711406|FG000|Overall Study|Side Effects|1|||
33335068|NCT01164956|62711407|FG001|Overall Study|Side Effects|0|||
33335069|NCT01164956|62711408|FG002|Overall Study|Side Effects|1|||
33335070|NCT01164722|62711418|FG000|Overall Study|Adverse Event|0|||
33335071|NCT01164722|62711419|FG001|Overall Study|Adverse Event|1|||
33335072|NCT01164722|62711418|FG000|Overall Study|Withdrawal by Subject|3|||
33335073|NCT01164722|62711419|FG001|Overall Study|Withdrawal by Subject|4|||
33335074|NCT01164722|62711418|FG000|Overall Study|Lost to Follow-up|3|||
33335075|NCT01164722|62711419|FG001|Overall Study|Lost to Follow-up|6|||
33335076|NCT01164722|62711418|FG000|Overall Study|met protocol criteria for non-treatment|11|||
33335077|NCT01164722|62711419|FG001|Overall Study|met protocol criteria for non-treatment|1|||
33335078|NCT01164722|62711418|FG000|Overall Study|enrolled on other study, concomitant med|1|||
33335079|NCT01164722|62711419|FG001|Overall Study|enrolled on other study, concomitant med|3|||
33335080|NCT01151540|62711425|FG000|Overall Study|Other|2|||
33335081|NCT01151540|62711425|FG000|Overall Study|Adverse event, non-fatal|4|||
33335082|NCT01151540|62711425|FG000|Overall Study|Withdrawal by Subject|7|||
33335083|NCT01163786|62711429|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
33468847|NCT00688870|62842663|FG001|Infant Series|Parent or legal guardian request|0|||
33468848|NCT00297167|62842673|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
33654106|NCT01714310|63066666|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
33654107|NCT01714310|63066664|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
33335084|NCT01163786|62711429|FG000|Treatment With Bortezomib|Adverse Event|2|||
33335085|NCT01163786|62711429|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
33335086|NCT00984282|62711435|FG000|Double Blind Treatment|Adverse Event|40|||
33335087|NCT00984282|62711436|FG001|Double Blind Treatment|Adverse Event|6|||
33335088|NCT00984282|62711435|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
33335089|NCT00984282|62711436|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
33335090|NCT00984282|62711435|FG000|Double Blind Treatment|Physician Decision|1|||
33335091|NCT00984282|62711436|FG001|Double Blind Treatment|Physician Decision|2|||
33335092|NCT00984282|62711435|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
33335093|NCT00984282|62711436|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
33335094|NCT00984282|62711435|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
33335095|NCT00984282|62711436|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
33335096|NCT00984282|62711435|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
33335097|NCT00984282|62711436|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
33335098|NCT00984282|62711435|FG000|Double Blind Treatment|Lost to Follow-up|3|||
33335099|NCT00984282|62711436|FG001|Double Blind Treatment|Lost to Follow-up|0|||
33335100|NCT00984282|62711435|FG000|Double Blind Treatment|Death|8|||
33335101|NCT00984282|62711436|FG001|Double Blind Treatment|Death|4|||
33335102|NCT00984282|62711435|FG000|Double Blind Treatment|Not treated|0|||
33335103|NCT00984282|62711436|FG001|Double Blind Treatment|Not treated|1|||
33335104|NCT00984282|62711435|FG000|Double Blind Treatment|Switched to commercial drug|6|||
33335105|NCT00984282|62711436|FG001|Double Blind Treatment|Switched to commercial drug|1|||
33335106|NCT00984282|62711435|FG000|Double Blind Treatment|protocol driven decision point|1|||
33335107|NCT00984282|62711436|FG001|Double Blind Treatment|protocol driven decision point|1|||
33335108|NCT00984282|62711435|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
33335109|NCT00984282|62711436|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
33335110|NCT00984282|62711435|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
33335111|NCT00984282|62711436|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
33335112|NCT00984282|62711435|FG000|Open-label Treatment|Adverse Event|20|||
33335113|NCT00984282|62711436|FG001|Open-label Treatment|Adverse Event|30|||
33335114|NCT00984282|62711435|FG000|Open-label Treatment|Withdrawal by Subject|6|||
33335115|NCT00984282|62711436|FG001|Open-label Treatment|Withdrawal by Subject|21|||
33335116|NCT00984282|62711435|FG000|Open-label Treatment|Death|7|||
33335117|NCT00984282|62711436|FG001|Open-label Treatment|Death|15|||
33335118|NCT00984282|62711435|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
33335119|NCT00984282|62711436|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
33335120|NCT00984282|62711435|FG000|Open-label Treatment|Lost to Follow-up|1|||
33335121|NCT00984282|62711436|FG001|Open-label Treatment|Lost to Follow-up|1|||
33335122|NCT00984282|62711435|FG000|Open-label Treatment|Patient convenience|1|||
33335123|NCT00984282|62711436|FG001|Open-label Treatment|Patient convenience|0|||
33335124|NCT00984282|62711435|FG000|Open-label Treatment|Non-compliant with study medication|1|||
33335125|NCT00984282|62711436|FG001|Open-label Treatment|Non-compliant with study medication|0|||
33335126|NCT00984282|62711435|FG000|Open-label Treatment|Target lesion removed|0|||
33335127|NCT00984282|62711436|FG001|Open-label Treatment|Target lesion removed|1|||
33335128|NCT00984282|62711435|FG000|Open-label Treatment|Protocol driven decision point|1|||
33335129|NCT00984282|62711436|FG001|Open-label Treatment|Protocol driven decision point|1|||
33335130|NCT00984282|62711435|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
33335131|NCT00984282|62711436|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
33335132|NCT00984282|62711435|FG000|Open-label Treatment|Switched to commercial drug|6|||
33335133|NCT00984282|62711436|FG001|Open-label Treatment|Switched to commercial drug|7|||
33335134|NCT00984282|62711435|FG000|Open-label Treatment|Physician Decision|1|||
33335135|NCT00984282|62711436|FG001|Open-label Treatment|Physician Decision|0|||
33335136|NCT00984282|62711435|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
33335137|NCT00984282|62711436|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
33335138|NCT00984282|62711435|FG000|Long Term Follow-up|Death|27|||
33335139|NCT00984282|62711436|FG001|Long Term Follow-up|Death|68|||
33335140|NCT00984282|62711435|FG000|Long Term Follow-up|Lost to Follow-up|3|||
33335141|NCT00984282|62711436|FG001|Long Term Follow-up|Lost to Follow-up|6|||
33335142|NCT00984282|62711435|FG000|Long Term Follow-up|Protocol driven decision point|25|||
33335143|NCT00984282|62711436|FG001|Long Term Follow-up|Protocol driven decision point|26|||
33335144|NCT00984282|62711435|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
33335145|NCT00984282|62711436|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
33335146|NCT00984282|62711435|FG000|Long Term Follow-up|Switched to commercial drug|4|||
33335147|NCT00984282|62711436|FG001|Long Term Follow-up|Switched to commercial drug|2|||
33335148|NCT00984282|62711435|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
33335149|NCT00984282|62711436|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
33335150|NCT01147874|62711444|FG000|Overall Study|Adverse Event|5|||
33335151|NCT01147874|62711444|FG000|Overall Study|Investigator's Request|1|||
33335152|NCT01147874|62711444|FG000|Overall Study|Lost to Follow-up|25|||
33335153|NCT01147874|62711444|FG000|Overall Study|Other|5|||
33335154|NCT01147874|62711444|FG000|Overall Study|Protocol Violation|5|||
33335155|NCT01147874|62711444|FG000|Overall Study|Sponsor's Decision|2|||
33654108|NCT01714310|63066665|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
33335156|NCT01147874|62711444|FG000|Overall Study|Withdrawal by Subject|24|||
33335157|NCT01147640|62711450|FG000|Overall Study|Adverse Event|2|||
33335158|NCT01147640|62711451|FG001|Overall Study|Adverse Event|0|||
33654109|NCT01714310|63066666|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
33654110|NCT01713998|63066687|FG000|Overall Study|Lost to Follow-up|2|||
33335159|NCT01147640|62711450|FG000|Overall Study|Physician Decision|1|||
33335160|NCT01147640|62711451|FG001|Overall Study|Physician Decision|0|||
33335161|NCT01147640|62711450|FG000|Overall Study|Withdrawal by Subject|1|||
33335162|NCT01147640|62711451|FG001|Overall Study|Withdrawal by Subject|0|||
33335163|NCT01147640|62711450|FG000|Overall Study|Lost to Follow-up|0|||
33335164|NCT01147640|62711451|FG001|Overall Study|Lost to Follow-up|1|||
33335165|NCT01147640|62711450|FG000|Overall Study|Didn't meet eligibility criteria|1|||
33335166|NCT01147640|62711451|FG001|Overall Study|Didn't meet eligibility criteria|0|||
33468849|NCT00297167|62842674|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
33468850|NCT00297167|62842675|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
33468851|NCT00297167|62842673|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
33468852|NCT00297167|62842674|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
33468853|NCT00297167|62842675|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
33468854|NCT03216226|62842684|FG000|Overall Study|Adverse Event|3|||
33468855|NCT03216226|62842685|FG001|Overall Study|Adverse Event|0|||
33468856|NCT03216226|62842684|FG000|Overall Study|Protocol Violation|1|||
33468857|NCT03216226|62842685|FG001|Overall Study|Protocol Violation|3|||
33468858|NCT03216226|62842684|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
33468859|NCT03216226|62842685|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
33468860|NCT03216226|62842684|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
33468861|NCT03216226|62842685|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
33468862|NCT03216226|62842684|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
33468863|NCT03216226|62842685|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
33468864|NCT03215758|62842693|FG000|Overall Study|Technical Problems|1|||
33468865|NCT03215758|62842694|FG001|Overall Study|Technical Problems|0|||
33468866|NCT03215758|62842693|FG000|Overall Study|Protocol deviation|0|||
33468867|NCT03215758|62842694|FG001|Overall Study|Protocol deviation|1|||
33468868|NCT03215758|62842693|FG000|Overall Study|Physician Decision|0|||
33468869|NCT03215758|62842694|FG001|Overall Study|Physician Decision|1|||
33468870|NCT03215758|62842693|FG000|Overall Study|Death|0|||
33468871|NCT03215758|62842694|FG001|Overall Study|Death|1|||
33468872|NCT03215758|62842693|FG000|Overall Study|Adverse Event|1|||
33468873|NCT03215758|62842694|FG001|Overall Study|Adverse Event|2|||
33468874|NCT03215758|62842693|FG000|Overall Study|Subject/Guardian Decision|3|||
33468875|NCT03215758|62842694|FG001|Overall Study|Subject/Guardian Decision|3|||
33468876|NCT00290771|62842702|FG000|Overall Study|Disease progression|95|||
33468877|NCT00290771|62842703|FG001|Overall Study|Disease progression|73|||
33468878|NCT00290771|62842702|FG000|Overall Study|Death|11|||
33468879|NCT00290771|62842703|FG001|Overall Study|Death|10|||
33468880|NCT00290771|62842702|FG000|Overall Study|Adverse Event|12|||
33468881|NCT00290771|62842703|FG001|Overall Study|Adverse Event|6|||
33468882|NCT00290771|62842702|FG000|Overall Study|Withdrawal by Subject|5|||
33468883|NCT00290771|62842703|FG001|Overall Study|Withdrawal by Subject|6|||
33468884|NCT00290771|62842702|FG000|Overall Study|Administrative problems|2|||
33468885|NCT00290771|62842703|FG001|Overall Study|Administrative problems|1|||
33468886|NCT00290771|62842702|FG000|Overall Study|Protocol Violation|2|||
33468887|NCT00290771|62842703|FG001|Overall Study|Protocol Violation|0|||
33468888|NCT00290771|62842702|FG000|Overall Study|Lost to Follow-up|0|||
33468889|NCT00290771|62842703|FG001|Overall Study|Lost to Follow-up|1|||
33468890|NCT00274625|62842712|FG000|Overall Study|Lost to Follow-up|46|||
33468891|NCT00274625|62842713|FG001|Overall Study|Lost to Follow-up|54|||
33468892|NCT00274625|62842712|FG000|Overall Study|Excluded from analysis|14|||
33468893|NCT00274625|62842713|FG001|Overall Study|Excluded from analysis|8|||
33468894|NCT00290693|62842719|FG000|Overall Study|Withdrawal by Subject|2|||
33468895|NCT03214666|62842730|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
33468896|NCT03214666|62842731|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
33468897|NCT03214666|62842732|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
33468898|NCT03214666|62842733|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
33468899|NCT03214666|62842734|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
33468900|NCT03214666|62842735|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
33468901|NCT00274469|62842752|FG000|Overall Study|Death|63|||
33468902|NCT00274469|62842753|FG001|Overall Study|Death|74|||
33468903|NCT00274469|62842752|FG000|Overall Study|Did not consent to OS follow-up|16|||
33468904|NCT00274469|62842753|FG001|Overall Study|Did not consent to OS follow-up|19|||
33468905|NCT03214588|62842762|FG000|Overall Study|Adverse Event|1|||
33468906|NCT03214588|62842763|FG001|Overall Study|Adverse Event|0|||
33468907|NCT03214588|62842764|FG002|Overall Study|Adverse Event|2|||
33654111|NCT01713998|63066688|FG001|Overall Study|Lost to Follow-up|0|||
33654112|NCT01713998|63066689|FG002|Overall Study|Lost to Follow-up|2|||
33654113|NCT01713998|63066687|FG000|Overall Study|Withdrawal by Subject|1|||
33468908|NCT03214588|62842762|FG000|Overall Study|Reason Not Specified|0|||
33468909|NCT03214588|62842763|FG001|Overall Study|Reason Not Specified|1|||
33468910|NCT03214588|62842764|FG002|Overall Study|Reason Not Specified|0|||
33468911|NCT03166618|62842774|FG000|Overall Study|Study was Terminated|0|||
33335167|NCT01121900|62711457|FG000|First Intervention Period|Adverse Event|1|||
33335168|NCT01121900|62711458|FG001|First Intervention Period|Adverse Event|1|||
33335169|NCT01121900|62711457|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
33335170|NCT01121900|62711458|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33335171|NCT01121666|62711466|FG000|Overall Study|Protocol Violation|29|||
33335172|NCT01121666|62711467|FG001|Overall Study|Protocol Violation|10|||
33335173|NCT00984126|62711477|FG000|Overall Study|Protocol Violation|0|||
33335174|NCT00984126|62711478|FG001|Overall Study|Protocol Violation|0|||
33335175|NCT00984126|62711479|FG002|Overall Study|Protocol Violation|1|||
33335176|NCT00984126|62711480|FG003|Overall Study|Protocol Violation|2|||
33335177|NCT00984126|62711477|FG000|Overall Study|Adverse Event|0|||
33335178|NCT00984126|62711478|FG001|Overall Study|Adverse Event|0|||
33335179|NCT00984126|62711479|FG002|Overall Study|Adverse Event|0|||
33335180|NCT00984126|62711480|FG003|Overall Study|Adverse Event|2|||
33335181|NCT00984126|62711477|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
33335182|NCT00984126|62711478|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
33335183|NCT00984126|62711479|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
33335184|NCT00984126|62711480|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
33335185|NCT00984126|62711477|FG000|Overall Study|Withdrawal criteria|0|||
33335186|NCT00984126|62711478|FG001|Overall Study|Withdrawal criteria|1|||
33335187|NCT00984126|62711479|FG002|Overall Study|Withdrawal criteria|3|||
33335188|NCT00984126|62711480|FG003|Overall Study|Withdrawal criteria|9|||
33335189|NCT00979602|62711501|FG000|Overall Study|Serious Adverse Event|5|||
33335190|NCT00979602|62711502|FG001|Overall Study|Serious Adverse Event|3|||
33335191|NCT00979602|62711501|FG000|Overall Study|Protocol Violation|3|||
33335192|NCT00979602|62711502|FG001|Overall Study|Protocol Violation|0|||
33335193|NCT00979602|62711501|FG000|Overall Study|Withdrawal by Subject|31|||
33335194|NCT00979602|62711502|FG001|Overall Study|Withdrawal by Subject|25|||
33335195|NCT00979602|62711501|FG000|Overall Study|Lost to Follow-up|100|||
33335196|NCT00979602|62711502|FG001|Overall Study|Lost to Follow-up|96|||
33335197|NCT00979602|62711501|FG000|Overall Study|Migrated/moved from study area|3|||
33335198|NCT00979602|62711502|FG001|Overall Study|Migrated/moved from study area|6|||
33335199|NCT00979602|62711501|FG000|Overall Study|Others|3|||
33335200|NCT00979602|62711502|FG001|Overall Study|Others|3|||
33335201|NCT00816361|62711527|FG000|Overall Study|Withdrawal by Subject|0|||
33335202|NCT00816361|62711528|FG001|Overall Study|Withdrawal by Subject|0|||
33335203|NCT00816361|62711529|FG002|Overall Study|Withdrawal by Subject|0|||
33335204|NCT00816361|62711530|FG003|Overall Study|Withdrawal by Subject|0|||
33335205|NCT00816361|62711531|FG004|Overall Study|Withdrawal by Subject|1|||
33335206|NCT00816361|62711532|FG005|Overall Study|Withdrawal by Subject|2|||
33335207|NCT00816361|62711533|FG006|Overall Study|Withdrawal by Subject|0|||
33335208|NCT00816361|62711534|FG007|Overall Study|Withdrawal by Subject|2|||
33335209|NCT00816361|62711535|FG008|Overall Study|Withdrawal by Subject|1|||
33335210|NCT00816361|62711527|FG000|Overall Study|Death|4|||
33335211|NCT00816361|62711528|FG001|Overall Study|Death|3|||
33335212|NCT00816361|62711529|FG002|Overall Study|Death|3|||
33335213|NCT00816361|62711530|FG003|Overall Study|Death|3|||
33335214|NCT00816361|62711531|FG004|Overall Study|Death|1|||
33335215|NCT00816361|62711532|FG005|Overall Study|Death|1|||
33335216|NCT00816361|62711533|FG006|Overall Study|Death|3|||
33335217|NCT00816361|62711534|FG007|Overall Study|Death|7|||
33335218|NCT00816361|62711535|FG008|Overall Study|Death|8|||
33335219|NCT00816361|62711527|FG000|Overall Study|Other|0|||
33335220|NCT00816361|62711528|FG001|Overall Study|Other|0|||
33335221|NCT00816361|62711529|FG002|Overall Study|Other|0|||
33335222|NCT00816361|62711530|FG003|Overall Study|Other|0|||
33335223|NCT00816361|62711531|FG004|Overall Study|Other|0|||
33335224|NCT00816361|62711532|FG005|Overall Study|Other|0|||
33335225|NCT00816361|62711533|FG006|Overall Study|Other|0|||
33335226|NCT00816361|62711534|FG007|Overall Study|Other|0|||
33335227|NCT00816361|62711535|FG008|Overall Study|Other|1|||
33335228|NCT00826111|62711558|FG000|Overall Study|Lost to Follow-up|0|||
33335229|NCT00826111|62711559|FG001|Overall Study|Lost to Follow-up|1|||
33335230|NCT00826111|62711558|FG000|Overall Study|Protocol Violation|1|||
33335231|NCT00826111|62711559|FG001|Overall Study|Protocol Violation|0|||
33335232|NCT00826111|62711558|FG000|Overall Study|Withdrawal by Subject|5|||
33335233|NCT00826111|62711559|FG001|Overall Study|Withdrawal by Subject|0|||
33335234|NCT00826111|62711558|FG000|Overall Study|Physician Decision|1|||
33335235|NCT00826111|62711559|FG001|Overall Study|Physician Decision|1|||
33335236|NCT00982644|62711570|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
33335237|NCT00982644|62711571|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
33335238|NCT00982644|62711570|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
33335239|NCT00982644|62711571|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
33335240|NCT00982644|62711570|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
33335241|NCT00982644|62711571|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
33335242|NCT00982644|62711570|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
33335243|NCT00982644|62711571|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
33335244|NCT00982644|62711570|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
33335245|NCT00982644|62711571|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
33335246|NCT00982644|62711570|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
33335247|NCT00982644|62711571|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
33335248|NCT00982644|62711570|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
33335249|NCT00982644|62711571|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
33335250|NCT00982644|62711570|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
33335251|NCT00982644|62711571|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
33335252|NCT00982644|62711570|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
33335253|NCT00982644|62711571|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
33335254|NCT00982644|62711570|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
33335255|NCT00982644|62711571|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
33335256|NCT00815659|62711577|FG000|Overall Study|Adverse Event|9|||
33335257|NCT00815659|62711577|FG000|Overall Study|Withdrawal by Subject|9|||
33335258|NCT00815659|62711577|FG000|Overall Study|Lost to Follow-up|4|||
33335259|NCT00815659|62711577|FG000|Overall Study|Protocol Violation|1|||
33335260|NCT00825175|62711583|FG000|Overall Study|Withdrawal by Subject|0|||
33335261|NCT00825175|62711584|FG001|Overall Study|Withdrawal by Subject|5|||
33335262|NCT00824473|62711592|FG000|Overall Study|Adverse Event|4|||
33335263|NCT00824473|62711593|FG001|Overall Study|Adverse Event|5|||
33335264|NCT00824473|62711592|FG000|Overall Study|Lack of Efficacy|2|||
33335265|NCT00824473|62711593|FG001|Overall Study|Lack of Efficacy|2|||
33335266|NCT00824473|62711592|FG000|Overall Study|Protocol Violation|2|||
33335267|NCT00824473|62711593|FG001|Overall Study|Protocol Violation|0|||
33335268|NCT00824473|62711592|FG000|Overall Study|Non-Compliance|4|||
33335269|NCT00824473|62711593|FG001|Overall Study|Non-Compliance|2|||
33335270|NCT00824473|62711592|FG000|Overall Study|Withdrawal by Subject|2|||
33335271|NCT00824473|62711593|FG001|Overall Study|Withdrawal by Subject|3|||
33335272|NCT00824473|62711592|FG000|Overall Study|Other|1|||
33335273|NCT00824473|62711593|FG001|Overall Study|Other|1|||
33335274|NCT00815191|62711605|FG000|Overall Study|Protocol Violation|1|||
33335275|NCT00815191|62711606|FG001|Overall Study|Protocol Violation|1|||
33335276|NCT00812929|62711612|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
33335277|NCT00812929|62711613|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
33335278|NCT00812929|62711614|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
33335279|NCT00812929|62711615|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
33335280|NCT00812929|62711616|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
33335281|NCT00812929|62711617|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
33335282|NCT00812929|62711618|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
33335283|NCT00812929|62711619|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
33335284|NCT00812929|62711620|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
33335285|NCT00812929|62711621|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
33335286|NCT00812929|62711612|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
33335287|NCT00812929|62711613|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
33335288|NCT00812929|62711614|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
33335289|NCT00812929|62711615|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
33335290|NCT00812929|62711616|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
33335291|NCT00812929|62711617|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
33335292|NCT00812929|62711618|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
33335293|NCT00812929|62711619|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
33335294|NCT00812929|62711620|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
33654114|NCT01713998|63066688|FG001|Overall Study|Withdrawal by Subject|0|||
33335295|NCT00812929|62711621|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
33335296|NCT00812929|62711612|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
33335297|NCT00812929|62711613|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
33335298|NCT00812929|62711614|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
33335299|NCT00812929|62711615|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
33335300|NCT00812929|62711616|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
33335301|NCT00812929|62711617|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
33335302|NCT00812929|62711618|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
33335303|NCT00812929|62711619|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
33335304|NCT00812929|62711620|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
33335305|NCT00812929|62711621|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
33335306|NCT00824161|62711638|FG000|Overall Study|Withdrawal by Subject|1|||
33335307|NCT00824161|62711638|FG000|Overall Study|Screen Failure|1|||
33335308|NCT00979134|62711647|FG000|Overall Study|Disease progression|18|||
33335309|NCT00979134|62711648|FG001|Overall Study|Disease progression|2|||
33335310|NCT00979134|62711649|FG002|Overall Study|Disease progression|5|||
33335311|NCT00979134|62711647|FG000|Overall Study|Adverse Event|0|||
33335312|NCT00979134|62711648|FG001|Overall Study|Adverse Event|0|||
33335313|NCT00979134|62711649|FG002|Overall Study|Adverse Event|2|||
33335314|NCT00979134|62711647|FG000|Overall Study|Withdrawal by Subject|1|||
33335315|NCT00979134|62711648|FG001|Overall Study|Withdrawal by Subject|1|||
33335316|NCT00979134|62711649|FG002|Overall Study|Withdrawal by Subject|2|||
33335317|NCT00979134|62711647|FG000|Overall Study|Lost to Follow-up|2|||
33335318|NCT00979134|62711648|FG001|Overall Study|Lost to Follow-up|2|||
33335319|NCT00979134|62711649|FG002|Overall Study|Lost to Follow-up|0|||
33335320|NCT00979134|62711647|FG000|Overall Study|Death|4|||
33335321|NCT00979134|62711648|FG001|Overall Study|Death|0|||
33335322|NCT00979134|62711649|FG002|Overall Study|Death|26|||
33335323|NCT00979134|62711647|FG000|Overall Study|Other|8|||
33335324|NCT00979134|62711648|FG001|Overall Study|Other|1|||
33335325|NCT00979134|62711649|FG002|Overall Study|Other|5|||
33335326|NCT00824005|62711664|FG000|Overall Study|Death|0|||
33335327|NCT00824005|62711665|FG001|Overall Study|Death|1|||
33335328|NCT00824005|62711664|FG000|Overall Study|Lost to Follow-up|0|||
33335329|NCT00824005|62711665|FG001|Overall Study|Lost to Follow-up|1|||
33335330|NCT00814879|62711673|FG000|By Week 24|Cancer Diagnosis|1|||
33335331|NCT00814879|62711674|FG001|By Week 24|Cancer Diagnosis|0|||
33335332|NCT00814879|62711673|FG000|By Week 24|Incarceration|0|||
33335333|NCT00814879|62711674|FG001|By Week 24|Incarceration|1|||
33335334|NCT00814879|62711673|FG000|By Week 48|Lost to Follow-up|2|||
33335335|NCT00814879|62711674|FG001|By Week 48|Lost to Follow-up|2|||
33335336|NCT00814879|62711673|FG000|By Week 48|Death|0|||
33335337|NCT00814879|62711674|FG001|By Week 48|Death|1|||
33335338|NCT03347422|62711683|FG000|Part A (26 Weeks)|Adverse Event|3|||
33335339|NCT03347422|62711684|FG001|Part A (26 Weeks)|Adverse Event|0|||
33335340|NCT03347422|62711683|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
33335341|NCT03347422|62711684|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
33335342|NCT03347422|62711683|FG000|Part B (149 Weeks)|Adverse Event|0|||
33335343|NCT03347422|62711684|FG001|Part B (149 Weeks)|Adverse Event|1|||
33335344|NCT03347422|62711683|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
33335345|NCT03347422|62711684|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
33335346|NCT03347422|62711683|FG000|Part B (149 Weeks)|Other|1|||
33335347|NCT03347422|62711684|FG001|Part B (149 Weeks)|Other|0|||
33335348|NCT00814801|62711700|FG000|Overall Study|Adverse Event|15|||
33335349|NCT00814801|62711701|FG001|Overall Study|Adverse Event|16|||
33335350|NCT00814801|62711702|FG002|Overall Study|Adverse Event|19|||
33335351|NCT00814801|62711700|FG000|Overall Study|Withdrawal by Subject|9|||
33335352|NCT00814801|62711701|FG001|Overall Study|Withdrawal by Subject|11|||
33335353|NCT00814801|62711702|FG002|Overall Study|Withdrawal by Subject|14|||
33335354|NCT00814801|62711700|FG000|Overall Study|Inappropriate as a subject|1|||
33468912|NCT03166618|62842775|FG001|Overall Study|Study was Terminated|1|||
33468913|NCT03162796|62842792|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
33335355|NCT00814801|62711701|FG001|Overall Study|Inappropriate as a subject|1|||
33335356|NCT00814801|62711702|FG002|Overall Study|Inappropriate as a subject|1|||
33335357|NCT00814801|62711700|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
33335358|NCT00814801|62711701|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
33335359|NCT00814801|62711702|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
33335360|NCT00814801|62711700|FG000|Overall Study|Missing or change of caregiver|6|||
33335361|NCT00814801|62711701|FG001|Overall Study|Missing or change of caregiver|2|||
33335362|NCT00814801|62711702|FG002|Overall Study|Missing or change of caregiver|4|||
33335363|NCT00814801|62711700|FG000|Overall Study|Non-compliance|0|||
33335364|NCT00814801|62711701|FG001|Overall Study|Non-compliance|1|||
33335365|NCT00814801|62711702|FG002|Overall Study|Non-compliance|1|||
33335366|NCT00814801|62711700|FG000|Overall Study|Other|2|||
33335367|NCT00814801|62711701|FG001|Overall Study|Other|6|||
33335368|NCT00814801|62711702|FG002|Overall Study|Other|4|||
33335369|NCT00823615|62711710|FG000|Period 2|Lost to Follow-up|2|||
33335370|NCT00823615|62711711|FG001|Period 2|Lost to Follow-up|0|||
33335371|NCT00823615|62711710|FG000|Period 2|Time/Job Conflict|1|||
33335372|NCT00823615|62711711|FG001|Period 2|Time/Job Conflict|2|||
33335373|NCT00812461|62711719|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
33335374|NCT00812461|62711720|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
33335375|NCT00812461|62711719|FG000|All Treated Patients|Adverse Event|8|||
33335376|NCT00812461|62711720|FG001|All Treated Patients|Adverse Event|15|||
33335377|NCT00812461|62711719|FG000|All Treated Patients|Lack of Efficacy|13|||
33335378|NCT00812461|62711720|FG001|All Treated Patients|Lack of Efficacy|7|||
33335379|NCT00812461|62711719|FG000|All Treated Patients|Non-compliance|6|||
33335380|NCT00812461|62711720|FG001|All Treated Patients|Non-compliance|9|||
33335381|NCT00812461|62711719|FG000|All Treated Patients|Protocol Violation|36|||
33335382|NCT00812461|62711720|FG001|All Treated Patients|Protocol Violation|27|||
33335383|NCT00812461|62711719|FG000|All Treated Patients|Withdrawal by Subject|45|||
33335384|NCT00812461|62711720|FG001|All Treated Patients|Withdrawal by Subject|54|||
33335385|NCT00812461|62711719|FG000|All Treated Patients|Lost to Follow-up|11|||
33335386|NCT00812461|62711720|FG001|All Treated Patients|Lost to Follow-up|14|||
33335387|NCT00812461|62711719|FG000|All Treated Patients|Other Reason|13|||
33335388|NCT00812461|62711720|FG001|All Treated Patients|Other Reason|21|||
33335389|NCT00599326|62711726|FG000|Overall Study|Lost to Follow-up|1|||
33335390|NCT00599326|62711726|FG000|Overall Study|Noncompliant|1|||
33335391|NCT00978432|62711733|FG000|Overall Study|Withdrawal by Subject|0|||
33335392|NCT00978432|62711734|FG001|Overall Study|Withdrawal by Subject|0|||
33335393|NCT00978432|62711735|FG002|Overall Study|Withdrawal by Subject|1|||
33335394|NCT00978432|62711733|FG000|Overall Study|Lack of Efficacy|1|||
33335395|NCT00978432|62711734|FG001|Overall Study|Lack of Efficacy|1|||
33335396|NCT00978432|62711735|FG002|Overall Study|Lack of Efficacy|3|||
33335397|NCT00978432|62711733|FG000|Overall Study|Adverse Event|2|||
33335398|NCT00978432|62711734|FG001|Overall Study|Adverse Event|0|||
33335399|NCT00978432|62711735|FG002|Overall Study|Adverse Event|1|||
33335400|NCT00975780|62711745|FG000|Follow Up|Death|88|||
33335401|NCT00975780|62711746|FG001|Follow Up|Death|122|||
33335402|NCT00975780|62711745|FG000|Follow Up|Facility Withdrawal|7|||
33335403|NCT00975780|62711746|FG001|Follow Up|Facility Withdrawal|23|||
33335404|NCT00975780|62711745|FG000|Follow Up|Discharged from Facility|7|||
33335405|NCT00975780|62711746|FG001|Follow Up|Discharged from Facility|12|||
33335406|NCT00814489|62711755|FG000|Overall Study|Other|2|||
33335407|NCT00814489|62711756|FG001|Overall Study|Other|0|||
33335408|NCT00814489|62711757|FG002|Overall Study|Other|1|||
33335409|NCT00814333|62711769|FG000|Enrollment|Lost to Follow-up|1|||
33335410|NCT00814333|62711770|FG001|Enrollment|Lost to Follow-up|0|||
33335411|NCT01147250|62711778|FG000|Overall Study|Lost to Follow-up|14|||
33335412|NCT01147250|62711779|FG001|Overall Study|Lost to Follow-up|11|||
33335413|NCT01147250|62711778|FG000|Overall Study|Withdrawal by Subject|83|||
33335414|NCT01147250|62711779|FG001|Overall Study|Withdrawal by Subject|88|||
33335415|NCT01147250|62711778|FG000|Overall Study|Site termination by sponsor|13|||
33335416|NCT01147250|62711779|FG001|Overall Study|Site termination by sponsor|5|||
33335417|NCT01147250|62711778|FG000|Overall Study|Other than specified|0|||
33335418|NCT01147250|62711779|FG001|Overall Study|Other than specified|1|||
33335419|NCT00813943|62711788|FG000|Overall Study|Ongoing at cut-off date|5|||
33335420|NCT00813943|62711789|FG001|Overall Study|Ongoing at cut-off date|5|||
33335421|NCT00813943|62711790|FG002|Overall Study|Ongoing at cut-off date|3|||
33335422|NCT00821509|62711802|FG000|Overall Study|Withdrawal by Subject|12|||
33335423|NCT00821509|62711803|FG001|Overall Study|Withdrawal by Subject|11|||
33335424|NCT00821509|62711804|FG002|Overall Study|Withdrawal by Subject|34|||
33335425|NCT00821431|62711814|FG000|Overall Study|Adverse Event|6|||
33335426|NCT00821431|62711815|FG001|Overall Study|Adverse Event|3|||
33335427|NCT00821431|62711814|FG000|Overall Study|Withdrawal by Subject|5|||
33335428|NCT00821431|62711815|FG001|Overall Study|Withdrawal by Subject|0|||
33335429|NCT00821431|62711814|FG000|Overall Study|Lost to Follow-up|1|||
33335430|NCT00821431|62711815|FG001|Overall Study|Lost to Follow-up|0|||
33335431|NCT00821431|62711814|FG000|Overall Study|Protocol Violation|3|||
33335432|NCT00821431|62711815|FG001|Overall Study|Protocol Violation|1|||
33335433|NCT00821431|62711814|FG000|Overall Study|Physician Decision|0|||
33335434|NCT00821431|62711815|FG001|Overall Study|Physician Decision|1|||
33335435|NCT03982368|62711824|FG000|Overall Study|Adverse Event|6|||
33335436|NCT03982368|62711825|FG001|Overall Study|Adverse Event|4|||
33335437|NCT03982368|62711826|FG002|Overall Study|Adverse Event|3|||
33335438|NCT03982368|62711824|FG000|Overall Study|Lost to Follow-up|2|||
33335439|NCT03982368|62711825|FG001|Overall Study|Lost to Follow-up|1|||
33335440|NCT03982368|62711826|FG002|Overall Study|Lost to Follow-up|0|||
33335441|NCT03982368|62711824|FG000|Overall Study|Withdrawal by Subject|1|||
33335442|NCT03982368|62711825|FG001|Overall Study|Withdrawal by Subject|2|||
33335443|NCT03982368|62711826|FG002|Overall Study|Withdrawal by Subject|0|||
33335444|NCT03982368|62711824|FG000|Overall Study|unknow|4|||
33335445|NCT03982368|62711825|FG001|Overall Study|unknow|0|||
33335446|NCT03982368|62711826|FG002|Overall Study|unknow|2|||
33335447|NCT00813865|62711837|FG000|Overall Study|Failure to Respond|3|||
33335448|NCT00813865|62711837|FG000|Overall Study|Lost to Follow-up|3|||
33335449|NCT00813865|62711837|FG000|Overall Study|Withdrawal by Subject|1|||
33335450|NCT01147172|62711841|FG000|Overall Study|Withdrawal by Subject|2|||
33335451|NCT01147172|62711841|FG000|Overall Study|Lost to Follow-up|2|||
33335452|NCT01120964|62711849|FG000|Overall Study|Did not receive full treatment|1|||
33335453|NCT01120964|62711850|FG001|Overall Study|Did not receive full treatment|0|||
33335454|NCT01146860|62711858|FG000|Overall Study|Withdrawal by Subject|0|||
33335455|NCT01146860|62711859|FG001|Overall Study|Withdrawal by Subject|1|||
33335456|NCT00591565|62711865|FG000|Overall Study|lost follow up, withdrawn|5|||
33335457|NCT01146782|62711869|FG000|Screening Cohort|Screen Failure|187|||
33335458|NCT01146782|62711869|FG000|Screening Cohort|Lost to Follow-up|4|||
33335459|NCT01146782|62711869|FG000|Screening Cohort|Physician Decision|1|||
33335460|NCT01146782|62711869|FG000|Screening Cohort|Withdrawal by Subject|29|||
33335461|NCT01146782|62711869|FG000|Safety Cohort|Screen Failure|61|||
33335462|NCT01146782|62711869|FG000|Safety Cohort|Withdrawal by Subject|4|||
33335463|NCT01146782|62711869|FG000|Safety Cohort|Control AHI <5|4|||
33335464|NCT01146782|62711869|FG000|Safety Cohort|TST <4 hrs|14|||
33335465|NCT01146782|62711869|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
33335466|NCT01146782|62711869|FG000|Primary Endpoint Cohort|Physician Decision|1|||
33335467|NCT00978120|62711878|FG000|Overall Study|Death|0|||
33335468|NCT00978120|62711879|FG001|Overall Study|Death|0|||
33335469|NCT00978120|62711880|FG002|Overall Study|Death|0|||
33335470|NCT00978120|62711881|FG003|Overall Study|Death|1|||
33335471|NCT00978120|62711878|FG000|Overall Study|Lost to Follow-up|0|||
33335472|NCT00978120|62711879|FG001|Overall Study|Lost to Follow-up|0|||
33335473|NCT00978120|62711880|FG002|Overall Study|Lost to Follow-up|3|||
33335474|NCT00978120|62711881|FG003|Overall Study|Lost to Follow-up|0|||
33335475|NCT00978120|62711878|FG000|Overall Study|Withdrawal by Subject|2|||
33335476|NCT00978120|62711879|FG001|Overall Study|Withdrawal by Subject|0|||
33335477|NCT00978120|62711880|FG002|Overall Study|Withdrawal by Subject|0|||
33335478|NCT00978120|62711881|FG003|Overall Study|Withdrawal by Subject|0|||
33335479|NCT00978120|62711878|FG000|Overall Study|Moved out of state|0|||
33335480|NCT00978120|62711879|FG001|Overall Study|Moved out of state|0|||
33335481|NCT00978120|62711880|FG002|Overall Study|Moved out of state|0|||
33335482|NCT00978120|62711881|FG003|Overall Study|Moved out of state|1|||
33335483|NCT00978042|62711897|FG000|Initial Treatment Period|Treated in Error|0|||
33335484|NCT00978042|62711898|FG001|Initial Treatment Period|Treated in Error|3|||
33335485|NCT00978042|62711897|FG000|Initial Treatment Period|Ineligibility|1|||
33335486|NCT00978042|62711898|FG001|Initial Treatment Period|Ineligibility|0|||
33335487|NCT00978042|62711897|FG000|Initial Treatment Period|Lost to Follow-up|21|||
33335488|NCT00978042|62711898|FG001|Initial Treatment Period|Lost to Follow-up|3|||
33335489|NCT00978042|62711897|FG000|Initial Treatment Period|Adverse Event|2|||
33335490|NCT00978042|62711898|FG001|Initial Treatment Period|Adverse Event|0|||
33335491|NCT00978042|62711897|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
33335492|NCT00978042|62711898|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
33335493|NCT00978042|62711897|FG000|Initial Treatment Period|Consent withdrawn|22|||
33335494|NCT00978042|62711898|FG001|Initial Treatment Period|Consent withdrawn|9|||
33335495|NCT00978042|62711897|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
33335496|NCT00978042|62711898|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
33335497|NCT01133678|62711906|FG000|Overall Study|Death|1|||
33335498|NCT01133678|62711907|FG001|Overall Study|Death|1|||
33335499|NCT01133522|62711923|FG000|Overall Study|Withdrawal by Subject|0|||
33335500|NCT01133522|62711924|FG001|Overall Study|Withdrawal by Subject|1|||
33335501|NCT01133522|62711925|FG002|Overall Study|Withdrawal by Subject|0|||
33335502|NCT01133522|62711926|FG003|Overall Study|Withdrawal by Subject|1|||
33335503|NCT01133522|62711927|FG004|Overall Study|Withdrawal by Subject|0|||
33335504|NCT01133522|62711928|FG005|Overall Study|Withdrawal by Subject|0|||
33335505|NCT01133522|62711929|FG006|Overall Study|Withdrawal by Subject|0|||
33335506|NCT01133522|62711930|FG007|Overall Study|Withdrawal by Subject|0|||
33335507|NCT01133522|62711931|FG008|Overall Study|Withdrawal by Subject|0|||
33335508|NCT01133522|62711932|FG009|Overall Study|Withdrawal by Subject|0|||
33335509|NCT01133522|62711923|FG000|Overall Study|Physician Decision|0|||
33335510|NCT01133522|62711924|FG001|Overall Study|Physician Decision|0|||
33335511|NCT01133522|62711925|FG002|Overall Study|Physician Decision|0|||
33335512|NCT01133522|62711926|FG003|Overall Study|Physician Decision|0|||
33335513|NCT01133522|62711927|FG004|Overall Study|Physician Decision|1|||
33335514|NCT01133522|62711928|FG005|Overall Study|Physician Decision|0|||
33335515|NCT01133522|62711929|FG006|Overall Study|Physician Decision|0|||
33335516|NCT01133522|62711930|FG007|Overall Study|Physician Decision|0|||
33335517|NCT01133522|62711931|FG008|Overall Study|Physician Decision|0|||
33335518|NCT01133522|62711932|FG009|Overall Study|Physician Decision|0|||
33335519|NCT01133288|62711961|FG000|Eligibility Assessment|met exclusion criteria|5|||
33335520|NCT01133288|62711961|FG000|Intervention Allocation|study terminated|2|||
33335521|NCT00883090|62711969|FG000|Overall Study|Sponsor's decision|1|||
33335522|NCT00883090|62711969|FG000|Overall Study|Withdrawal by Subject|1|||
33335523|NCT01132820|62711973|FG000|Overall Study|Ineligible: wrong cell type|1|||
33335524|NCT01132820|62711973|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
33335525|NCT01132820|62711973|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
33335526|NCT01132820|62711973|FG000|Overall Study|Never treated|1|||
33335527|NCT01132820|62711973|FG000|Overall Study|Inadequate data|1|||
33335528|NCT00885352|62711992|FG000|Overall Study|Adverse Event|2|||
33335529|NCT00885352|62711993|FG001|Overall Study|Adverse Event|3|||
33335530|NCT00885352|62711992|FG000|Overall Study|Lost to Follow-up|2|||
33335531|NCT00885352|62711993|FG001|Overall Study|Lost to Follow-up|2|||
33335532|NCT00885352|62711992|FG000|Overall Study|Physician Decision|0|||
33335533|NCT00885352|62711993|FG001|Overall Study|Physician Decision|3|||
33335534|NCT00885352|62711992|FG000|Overall Study|Protocol Violation|0|||
33335535|NCT00885352|62711993|FG001|Overall Study|Protocol Violation|2|||
33335536|NCT00885352|62711992|FG000|Overall Study|Withdrawal by Subject|1|||
33335537|NCT00885352|62711993|FG001|Overall Study|Withdrawal by Subject|5|||
33335538|NCT00885352|62711992|FG000|Overall Study|Contradiction to study medication|0|||
33335539|NCT00885352|62711993|FG001|Overall Study|Contradiction to study medication|2|||
33335540|NCT00885352|62711992|FG000|Overall Study|Excluded medication|2|||
33335541|NCT00885352|62711993|FG001|Overall Study|Excluded medication|2|||
33335542|NCT00885352|62711992|FG000|Overall Study|Lab abnormalities|1|||
33335543|NCT00885352|62711993|FG001|Overall Study|Lab abnormalities|1|||
33335544|NCT00885118|62712004|FG000|Overall Study|Adverse Event|1|||
33335545|NCT00885118|62712005|FG001|Overall Study|Adverse Event|0|||
33335546|NCT00885118|62712006|FG002|Overall Study|Adverse Event|0|||
33335547|NCT00885118|62712007|FG003|Overall Study|Adverse Event|0|||
33335548|NCT00885118|62712008|FG004|Overall Study|Adverse Event|0|||
33335549|NCT00885118|62712004|FG000|Overall Study|Withdrawal by Subject|0|||
33335550|NCT00885118|62712005|FG001|Overall Study|Withdrawal by Subject|0|||
33335551|NCT00885118|62712006|FG002|Overall Study|Withdrawal by Subject|0|||
33335552|NCT00885118|62712007|FG003|Overall Study|Withdrawal by Subject|0|||
33335553|NCT00885118|62712008|FG004|Overall Study|Withdrawal by Subject|1|||
33335554|NCT00885118|62712004|FG000|Overall Study|Other reason not defined above|0|||
33335555|NCT00885118|62712005|FG001|Overall Study|Other reason not defined above|0|||
33335556|NCT00885118|62712006|FG002|Overall Study|Other reason not defined above|1|||
33335557|NCT00885118|62712007|FG003|Overall Study|Other reason not defined above|0|||
33335558|NCT00885118|62712008|FG004|Overall Study|Other reason not defined above|0|||
33335559|NCT00880906|62712026|FG000|Overall Study|Lost to Follow-up|0|||
33335560|NCT00880906|62712027|FG001|Overall Study|Lost to Follow-up|1|||
33468914|NCT03162796|62842793|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
33468915|NCT03162796|62842794|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
33468916|NCT03162796|62842792|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
33468917|NCT03162796|62842793|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
33335561|NCT00880906|62712026|FG000|Overall Study|Did not meet criteria following patholog|12|||
33335562|NCT00880906|62712027|FG001|Overall Study|Did not meet criteria following patholog|6|||
33335563|NCT00882310|62712033|FG000|Overall Study|Screen Failure|10|||
33335564|NCT00882310|62712033|FG000|Overall Study|Never received treatment|1|||
33335565|NCT00882310|62712033|FG000|Overall Study|Death|6|||
33468918|NCT03162796|62842794|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
33335566|NCT00882310|62712033|FG000|Overall Study|Progression of disease|4|||
33335567|NCT00882310|62712033|FG000|Overall Study|Adverse Event|1|||
33335568|NCT00884650|62712039|FG000|Overall Study|Did not return complete pain diaries|7|||
33335569|NCT00884650|62712040|FG001|Overall Study|Did not return complete pain diaries|7|||
33335570|NCT00884650|62712039|FG000|Overall Study|Admitted Post-Op|1|||
33335571|NCT00884650|62712040|FG001|Overall Study|Admitted Post-Op|0|||
33335572|NCT00884650|62712039|FG000|Overall Study|Femoral Stress Fracture|1|||
33335573|NCT00884650|62712040|FG001|Overall Study|Femoral Stress Fracture|0|||
33335574|NCT00884650|62712039|FG000|Overall Study|Pain Pump Complication|0|||
33335575|NCT00884650|62712040|FG001|Overall Study|Pain Pump Complication|1|||
33335576|NCT00881608|62712052|FG000|Overall Study|Study prematurely terminated|11|||
33335577|NCT01088399|62712067|FG000|Overall Study|Adverse Event|211|||
33335578|NCT01088399|62712068|FG001|Overall Study|Adverse Event|16|||
33335579|NCT01088399|62712069|FG002|Overall Study|Adverse Event|0|||
33335580|NCT01088399|62712067|FG000|Overall Study|Death|204|||
33335581|NCT01088399|62712068|FG001|Overall Study|Death|45|||
33335582|NCT01088399|62712069|FG002|Overall Study|Death|0|||
33335583|NCT01088399|62712067|FG000|Overall Study|Lack of Efficacy|298|||
33335584|NCT01088399|62712068|FG001|Overall Study|Lack of Efficacy|7|||
33335585|NCT01088399|62712069|FG002|Overall Study|Lack of Efficacy|5|||
33335586|NCT01088399|62712067|FG000|Overall Study|Lost to Follow-up|1070|||
33335587|NCT01088399|62712068|FG001|Overall Study|Lost to Follow-up|278|||
33335588|NCT01088399|62712069|FG002|Overall Study|Lost to Follow-up|58|||
33335589|NCT01088399|62712067|FG000|Overall Study|Physician Decision|531|||
33335590|NCT01088399|62712068|FG001|Overall Study|Physician Decision|88|||
33335591|NCT01088399|62712069|FG002|Overall Study|Physician Decision|16|||
33335592|NCT01088399|62712067|FG000|Overall Study|Withdrawal by Subject|544|||
33335593|NCT01088399|62712068|FG001|Overall Study|Withdrawal by Subject|195|||
33335594|NCT01088399|62712069|FG002|Overall Study|Withdrawal by Subject|33|||
33335595|NCT01088399|62712067|FG000|Overall Study|Change to or start of somatropin therapy|234|||
33335596|NCT01088399|62712068|FG001|Overall Study|Change to or start of somatropin therapy|17|||
33335597|NCT01088399|62712069|FG002|Overall Study|Change to or start of somatropin therapy|12|||
33335598|NCT01088399|62712067|FG000|Overall Study|Sponsor decision|1573|||
33335599|NCT01088399|62712068|FG001|Overall Study|Sponsor decision|298|||
33335600|NCT01088399|62712069|FG002|Overall Study|Sponsor decision|7|||
33335601|NCT01088399|62712067|FG000|Overall Study|Protocol Violation|10|||
33335602|NCT01088399|62712068|FG001|Overall Study|Protocol Violation|1|||
33335603|NCT01088399|62712069|FG002|Overall Study|Protocol Violation|0|||
33335604|NCT01088399|62712067|FG000|Overall Study|Enrollment criteria not met|48|||
33335605|NCT01088399|62712068|FG001|Overall Study|Enrollment criteria not met|119|||
33335606|NCT01088399|62712069|FG002|Overall Study|Enrollment criteria not met|70|||
33335607|NCT01088399|62712067|FG000|Overall Study|Study summary visit not completed|2398|||
33335608|NCT01088399|62712068|FG001|Overall Study|Study summary visit not completed|283|||
33335609|NCT01088399|62712069|FG002|Overall Study|Study summary visit not completed|80|||
33335610|NCT00598078|62712077|FG000|Period 2 (Day 2)|Adverse Event|1|||
33335611|NCT00598078|62712078|FG001|Period 2 (Day 2)|Adverse Event|0|||
33335612|NCT01079195|62712086|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
33335613|NCT01079195|62712086|FG000|Overall Study|No Documentation Available|437|||
33335614|NCT01079195|62712086|FG000|Overall Study|Adverse Event|157|||
33335615|NCT01079195|62712086|FG000|Overall Study|Reason Unknown|39|||
33335616|NCT01079195|62712086|FG000|Overall Study|Withdrawal by Subject|18|||
33335617|NCT01079195|62712086|FG000|Overall Study|Financial Reasons|15|||
33335618|NCT01079195|62712086|FG000|Overall Study|Lack of Effectiveness|12|||
33335619|NCT01079195|62712086|FG000|Overall Study|Physician Decision|4|||
33335620|NCT01079195|62712086|FG000|Overall Study|Improved Status of Participant|4|||
33335621|NCT01079195|62712086|FG000|Overall Study|No Follow-up Documentation Available|4|||
33335622|NCT01079195|62712086|FG000|Overall Study|Non-compliance|2|||
33335623|NCT00883558|62712090|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
33335624|NCT00883558|62712091|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
33335625|NCT00883558|62712092|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
33468919|NCT03162796|62842792|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
33468920|NCT03162796|62842793|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
33335626|NCT00883558|62712090|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
33335627|NCT00883558|62712091|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
33335628|NCT00883558|62712092|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
33335629|NCT00883558|62712090|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
33335630|NCT00883558|62712091|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
33335631|NCT00883558|62712092|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
33335632|NCT00883558|62712090|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
33468921|NCT03162796|62842794|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
33335633|NCT00883558|62712091|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
33335634|NCT00883558|62712092|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
33335635|NCT00883558|62712090|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
33335636|NCT00883558|62712091|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
33335637|NCT00883558|62712092|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
33335638|NCT00880750|62712100|FG000|First Intervention|Adverse Event|1|||
33335639|NCT00880750|62712101|FG001|First Intervention|Adverse Event|0|||
33335640|NCT00880750|62712100|FG000|First Intervention|Unable to collect urine|4|||
33335641|NCT00880750|62712101|FG001|First Intervention|Unable to collect urine|0|||
33335642|NCT00880750|62712100|FG000|First Intervention|Non-compliance with meals|0|||
33335643|NCT00880750|62712101|FG001|First Intervention|Non-compliance with meals|1|||
33335644|NCT00880750|62712100|FG000|First Intervention|Withdrawal by Subject|2|||
33335645|NCT00880750|62712101|FG001|First Intervention|Withdrawal by Subject|0|||
33335646|NCT00880750|62712100|FG000|First Intervention|Lost to Follow-up|2|||
33335647|NCT00880750|62712101|FG001|First Intervention|Lost to Follow-up|0|||
33335648|NCT00880750|62712100|FG000|Second Intervention|Withdrawal by Subject|2|||
33335649|NCT00880750|62712101|FG001|Second Intervention|Withdrawal by Subject|2|||
33335650|NCT00880750|62712100|FG000|Second Intervention|Protocol Violation|1|||
33335651|NCT00880750|62712101|FG001|Second Intervention|Protocol Violation|0|||
33335652|NCT00880750|62712100|FG000|Second Intervention|Unable to collect urine|1|||
33335653|NCT00880750|62712101|FG001|Second Intervention|Unable to collect urine|0|||
33335654|NCT00597766|62712110|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
33335655|NCT00597766|62712111|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
33335656|NCT00597766|62712112|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
33335657|NCT00597766|62712110|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
33335658|NCT00597766|62712111|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
33335659|NCT00597766|62712112|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
33335660|NCT00979992|62712120|FG000|Overall Study|Ineligible - inadequate pathology|1|||
33335661|NCT00979992|62712120|FG000|Overall Study|Ineligible - wrong cell type|2|||
33335662|NCT00979992|62712120|FG000|Overall Study|Refused - Never Treated|2|||
33335663|NCT01079741|62712129|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
33335664|NCT01079741|62712130|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
33335665|NCT01079741|62712131|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
33335666|NCT01079741|62712132|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
33335667|NCT01079741|62712133|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
33335668|NCT01079741|62712129|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
33335669|NCT01079741|62712130|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
33335670|NCT01079741|62712131|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
33335671|NCT01079741|62712132|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
33335672|NCT01079741|62712133|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
33335673|NCT01079663|62712147|FG000|Overall Study|Adverse Event|0|||
33335674|NCT01079663|62712148|FG001|Overall Study|Adverse Event|2|||
33335675|NCT01079663|62712147|FG000|Overall Study|Protocol Violation|0|||
33335676|NCT01079663|62712148|FG001|Overall Study|Protocol Violation|2|||
33548695|NCT02489968|62939988|FG003|Open-label Treatment Period|Other than specified above|0|||
33548696|NCT02489968|62939989|FG004|Open-label Treatment Period|Other than specified above|0|||
33548697|NCT02489968|62939990|FG005|Open-label Treatment Period|Other than specified above|0|||
33335677|NCT00879814|62712158|FG000|Overall Study|Adverse Event|0|||
33335678|NCT00879814|62712159|FG001|Overall Study|Adverse Event|1|||
33335679|NCT00879814|62712160|FG002|Overall Study|Adverse Event|0|||
33335680|NCT00879814|62712161|FG003|Overall Study|Adverse Event|0|||
33335681|NCT00879814|62712158|FG000|Overall Study|Lost to Follow-up|1|||
33468922|NCT03162796|62842792|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
33468923|NCT03162796|62842793|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
33468924|NCT03162796|62842794|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
33468925|NCT03162796|62842792|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
33468926|NCT03162796|62842793|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
33468927|NCT03162796|62842794|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
33468928|NCT03162796|62842792|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
33468929|NCT03162796|62842793|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
33468930|NCT03162796|62842794|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
33468931|NCT03162796|62842792|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
33468932|NCT03162796|62842793|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
33468933|NCT03162796|62842794|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
33468934|NCT03162796|62842792|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
33468935|NCT03162796|62842793|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
33468936|NCT03162796|62842794|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
33468937|NCT03162796|62842792|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
33468938|NCT03162796|62842793|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
33468939|NCT03162796|62842794|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
33468940|NCT03162796|62842792|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
33468941|NCT03162796|62842793|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
33468942|NCT03162796|62842794|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
33468943|NCT03162796|62842792|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
33468944|NCT03162796|62842793|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
33468945|NCT03162796|62842794|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
33468946|NCT03162328|62842807|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
33468947|NCT03162328|62842808|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
33468948|NCT03162328|62842809|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
33468949|NCT03162328|62842807|FG000|Screening Period|Withdrawal by Subject|1|||
33468950|NCT03162328|62842808|FG001|Screening Period|Withdrawal by Subject|0|||
33468951|NCT03162328|62842809|FG002|Screening Period|Withdrawal by Subject|0|||
33468952|NCT03162328|62842807|FG000|Study Period|Withdrawal by Subject|0|||
33468953|NCT03162328|62842808|FG001|Study Period|Withdrawal by Subject|0|||
33468954|NCT03162328|62842809|FG002|Study Period|Withdrawal by Subject|1|||
33468955|NCT00272987|62842823|FG000|Overall Study|Adverse Event|1|||
33468956|NCT00272987|62842824|FG001|Overall Study|Adverse Event|0|||
33468957|NCT00272987|62842825|FG002|Overall Study|Adverse Event|0|||
33468958|NCT00272987|62842823|FG000|Overall Study|Lost to Follow-up|3|||
33468959|NCT00272987|62842824|FG001|Overall Study|Lost to Follow-up|1|||
33468960|NCT00272987|62842825|FG002|Overall Study|Lost to Follow-up|1|||
33468961|NCT00272987|62842823|FG000|Overall Study|Withdrawal by Subject|1|||
33468962|NCT00272987|62842824|FG001|Overall Study|Withdrawal by Subject|0|||
33468963|NCT00272987|62842825|FG002|Overall Study|Withdrawal by Subject|3|||
33468964|NCT00272987|62842823|FG000|Overall Study|Sponsor Terminated study|0|||
33468965|NCT00272987|62842824|FG001|Overall Study|Sponsor Terminated study|1|||
33468966|NCT00272987|62842825|FG002|Overall Study|Sponsor Terminated study|1|||
33468967|NCT00272987|62842823|FG000|Overall Study|Disease progression|1|||
33468968|NCT00272987|62842824|FG001|Overall Study|Disease progression|1|||
33468969|NCT00272987|62842825|FG002|Overall Study|Disease progression|2|||
33468970|NCT00272987|62842823|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
33468971|NCT00272987|62842824|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
33468972|NCT00272987|62842825|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
33468973|NCT00272987|62842823|FG000|Overall Study|Death|1|||
33468974|NCT00272987|62842824|FG001|Overall Study|Death|0|||
33468975|NCT00272987|62842825|FG002|Overall Study|Death|0|||
33468976|NCT01730950|62842835|FG000|Overall Study|Protocol Violation|6|||
33468977|NCT01730950|62842836|FG001|Overall Study|Protocol Violation|6|||
33335682|NCT00879814|62712159|FG001|Overall Study|Lost to Follow-up|0|||
33335683|NCT00879814|62712160|FG002|Overall Study|Lost to Follow-up|0|||
33335684|NCT00879814|62712161|FG003|Overall Study|Lost to Follow-up|2|||
33335685|NCT00879814|62712158|FG000|Overall Study|Participant Failed to Return|0|||
33335686|NCT00879814|62712159|FG001|Overall Study|Participant Failed to Return|0|||
33335687|NCT00879814|62712160|FG002|Overall Study|Participant Failed to Return|0|||
33335688|NCT00879814|62712161|FG003|Overall Study|Participant Failed to Return|1|||
33335689|NCT00879814|62712158|FG000|Overall Study|Withdrawal by Subject|3|||
33335690|NCT00879814|62712159|FG001|Overall Study|Withdrawal by Subject|1|||
33335691|NCT00879814|62712160|FG002|Overall Study|Withdrawal by Subject|1|||
33335692|NCT00879814|62712161|FG003|Overall Study|Withdrawal by Subject|2|||
33335693|NCT00879814|62712158|FG000|Overall Study|Physician Decision|0|||
33335694|NCT00879814|62712159|FG001|Overall Study|Physician Decision|0|||
33335695|NCT00879814|62712160|FG002|Overall Study|Physician Decision|1|||
33335696|NCT00879814|62712161|FG003|Overall Study|Physician Decision|0|||
33335697|NCT00879814|62712158|FG000|Overall Study|Other|0|||
33335698|NCT00879814|62712159|FG001|Overall Study|Other|0|||
33335699|NCT00879814|62712160|FG002|Overall Study|Other|1|||
33335700|NCT00879814|62712161|FG003|Overall Study|Other|0|||
33335701|NCT01132664|62712176|FG000|Phase lb|Adverse Event|0|||
33335702|NCT01132664|62712177|FG001|Phase lb|Adverse Event|1|||
33335703|NCT01132664|62712178|FG002|Phase lb|Adverse Event|0|||
33335704|NCT01132664|62712179|FG003|Phase lb|Adverse Event|0|||
33335705|NCT01132664|62712180|FG004|Phase lb|Adverse Event|0|||
33335706|NCT01132664|62712176|FG000|Phase lb|Withdrawal by Subject|1|||
33335707|NCT01132664|62712177|FG001|Phase lb|Withdrawal by Subject|2|||
33335708|NCT01132664|62712178|FG002|Phase lb|Withdrawal by Subject|0|||
33335709|NCT01132664|62712179|FG003|Phase lb|Withdrawal by Subject|0|||
33654115|NCT01713998|63066689|FG002|Overall Study|Withdrawal by Subject|0|||
33654116|NCT01681628|63066699|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
33335710|NCT01132664|62712180|FG004|Phase lb|Withdrawal by Subject|0|||
33335711|NCT01132664|62712176|FG000|Phase lb|Disease Progression|4|||
33468978|NCT00271505|62842843|FG000|Overall Study|Screen Failure|3|||
33335712|NCT01132664|62712177|FG001|Phase lb|Disease Progression|9|||
33335713|NCT01132664|62712178|FG002|Phase lb|Disease Progression|0|||
33335714|NCT01132664|62712179|FG003|Phase lb|Disease Progression|0|||
33335715|NCT01132664|62712180|FG004|Phase lb|Disease Progression|0|||
33335716|NCT01132664|62712176|FG000|Phase ll|Death|0|||
33335717|NCT01132664|62712177|FG001|Phase ll|Death|0|||
33335718|NCT01132664|62712178|FG002|Phase ll|Death|2|||
33335719|NCT01132664|62712179|FG003|Phase ll|Death|0|||
33335720|NCT01132664|62712180|FG004|Phase ll|Death|0|||
33335721|NCT01132664|62712176|FG000|Phase ll|Adverse Event|0|||
33335722|NCT01132664|62712177|FG001|Phase ll|Adverse Event|0|||
33335723|NCT01132664|62712178|FG002|Phase ll|Adverse Event|10|||
33335724|NCT01132664|62712179|FG003|Phase ll|Adverse Event|0|||
33335725|NCT01132664|62712180|FG004|Phase ll|Adverse Event|0|||
33335726|NCT01132664|62712176|FG000|Phase ll|Withdrawal by Subject|0|||
33335727|NCT01132664|62712177|FG001|Phase ll|Withdrawal by Subject|0|||
33335728|NCT01132664|62712178|FG002|Phase ll|Withdrawal by Subject|3|||
33335729|NCT01132664|62712179|FG003|Phase ll|Withdrawal by Subject|0|||
33335730|NCT01132664|62712180|FG004|Phase ll|Withdrawal by Subject|0|||
33335731|NCT01132664|62712176|FG000|Phase ll|Disease progression|0|||
33335732|NCT01132664|62712177|FG001|Phase ll|Disease progression|0|||
33335733|NCT01132664|62712178|FG002|Phase ll|Disease progression|35|||
33335734|NCT01132664|62712179|FG003|Phase ll|Disease progression|0|||
33335735|NCT01132664|62712180|FG004|Phase ll|Disease progression|0|||
33335736|NCT01132664|62712176|FG000|BM Cohort|Disease progression|0|||
33468979|NCT00271505|62842843|FG000|Overall Study|Adverse Event|1|||
33468980|NCT00271505|62842843|FG000|Overall Study|Death|1|||
33468981|NCT01642186|62842851|FG000|Overall Study|Death|0|||
33468982|NCT01642186|62842852|FG001|Overall Study|Death|2|||
33468983|NCT01642186|62842853|FG002|Overall Study|Death|2|||
33468984|NCT01642186|62842851|FG000|Overall Study|Lost to Follow-up|0|||
33468985|NCT01642186|62842852|FG001|Overall Study|Lost to Follow-up|0|||
33468986|NCT01642186|62842853|FG002|Overall Study|Lost to Follow-up|1|||
33468987|NCT00423514|62842863|FG000|Overall Study|Ineligible|1|||
33468988|NCT00423514|62842864|FG001|Overall Study|Ineligible|0|||
33468989|NCT00289991|62842872|FG000|Overall Study|Death|35|||
33468990|NCT00289991|62842873|FG001|Overall Study|Death|38|||
33468991|NCT00289991|62842872|FG000|Overall Study|Adverse Event|15|||
33468992|NCT00289991|62842873|FG001|Overall Study|Adverse Event|13|||
33468993|NCT00289991|62842872|FG000|Overall Study|Failure of prophylaxis|1|||
33468994|NCT00289991|62842873|FG001|Overall Study|Failure of prophylaxis|1|||
33468995|NCT00289991|62842872|FG000|Overall Study|Fungal breakthrough infection|0|||
33468996|NCT00289991|62842873|FG001|Overall Study|Fungal breakthrough infection|1|||
33468997|NCT00289991|62842872|FG000|Overall Study|Lost to Follow-up|0|||
33468998|NCT00289991|62842873|FG001|Overall Study|Lost to Follow-up|1|||
33468999|NCT00289991|62842872|FG000|Overall Study|Withdrawal by Subject|2|||
33469000|NCT00289991|62842873|FG001|Overall Study|Withdrawal by Subject|12|||
33469001|NCT00289991|62842872|FG000|Overall Study|Other|5|||
33469002|NCT00289991|62842873|FG001|Overall Study|Other|14|||
33469003|NCT00289913|62842884|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33469004|NCT00289913|62842885|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
33469005|NCT00289913|62842886|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33469006|NCT00289913|62842887|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33469007|NCT00289913|62842888|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33469008|NCT00289913|62842884|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
33469009|NCT00289913|62842885|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
33469010|NCT00289913|62842886|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
33469011|NCT00289913|62842887|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
33469012|NCT00289913|62842888|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
33469013|NCT00289913|62842884|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
33469014|NCT00289913|62842885|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
33469015|NCT00289913|62842886|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
33469016|NCT00289913|62842887|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
33469017|NCT00289913|62842888|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
33469018|NCT00289913|62842884|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
33469019|NCT00289913|62842885|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
33469020|NCT00289913|62842886|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
33469021|NCT00289913|62842887|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
33469022|NCT00289913|62842888|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
33469023|NCT00289913|62842884|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33654117|NCT01681628|63066700|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
33469024|NCT00289913|62842885|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33654118|NCT01681628|63066699|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
33335737|NCT01132664|62712177|FG001|BM Cohort|Disease progression|0|||
33335738|NCT01132664|62712178|FG002|BM Cohort|Disease progression|0|||
33335739|NCT01132664|62712179|FG003|BM Cohort|Disease progression|3|||
33335740|NCT01132664|62712180|FG004|BM Cohort|Disease progression|4|||
33335741|NCT01132664|62712176|FG000|BM Cohort|Adverse Event|0|||
33335742|NCT01132664|62712177|FG001|BM Cohort|Adverse Event|0|||
33335743|NCT01132664|62712178|FG002|BM Cohort|Adverse Event|0|||
33335744|NCT01132664|62712179|FG003|BM Cohort|Adverse Event|0|||
33335745|NCT01132664|62712180|FG004|BM Cohort|Adverse Event|1|||
33335746|NCT01132664|62712176|FG000|BM Cohort|Withdrawal by Subject|0|||
33335747|NCT01132664|62712177|FG001|BM Cohort|Withdrawal by Subject|0|||
33335748|NCT01132664|62712178|FG002|BM Cohort|Withdrawal by Subject|0|||
33335749|NCT01132664|62712179|FG003|BM Cohort|Withdrawal by Subject|0|||
33335750|NCT01132664|62712180|FG004|BM Cohort|Withdrawal by Subject|1|||
33335751|NCT00591409|62712202|FG000|Overall Study|Not Treated|0|||
33335752|NCT00591409|62712203|FG001|Overall Study|Not Treated|0|||
33335753|NCT00591409|62712204|FG002|Overall Study|Not Treated|0|||
33335754|NCT00591409|62712205|FG003|Overall Study|Not Treated|0|||
33335755|NCT00591409|62712206|FG004|Overall Study|Not Treated|1|||
33335756|NCT00591409|62712207|FG005|Overall Study|Not Treated|0|||
33335757|NCT00591409|62712208|FG006|Overall Study|Not Treated|0|||
33335758|NCT00591409|62712209|FG007|Overall Study|Not Treated|0|||
33335759|NCT00591409|62712210|FG008|Overall Study|Not Treated|0|||
33335760|NCT00591409|62712211|FG009|Overall Study|Not Treated|1|||
33335761|NCT01078805|62712233|FG000|Overall Study|Clinically significant abnormal lab|5|||
33469025|NCT00289913|62842886|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33469026|NCT00289913|62842887|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
33469027|NCT00289913|62842888|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33469028|NCT00289913|62842884|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
33469029|NCT00289913|62842885|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
33469030|NCT00289913|62842886|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
33469031|NCT00289913|62842887|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
33469032|NCT00289913|62842888|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
33469033|NCT00289913|62842884|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
33548698|NCT02489968|62939985|FG000|Double-blind Treatment Period|Adverse Event|0|||
33548699|NCT02489968|62939986|FG001|Double-blind Treatment Period|Adverse Event|0|||
33548700|NCT02489968|62939987|FG002|Double-blind Treatment Period|Adverse Event|2|||
33469034|NCT00289913|62842885|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
33548701|NCT02489968|62939988|FG003|Double-blind Treatment Period|Adverse Event|6|||
33548702|NCT02489968|62939989|FG004|Double-blind Treatment Period|Adverse Event|4|||
33548703|NCT02489968|62939990|FG005|Double-blind Treatment Period|Adverse Event|5|||
33548704|NCT02489968|62939985|FG000|Double-blind Treatment Period|Protocol Violation|0|||
33548705|NCT02489968|62939986|FG001|Double-blind Treatment Period|Protocol Violation|0|||
33548706|NCT02489968|62939987|FG002|Double-blind Treatment Period|Protocol Violation|0|||
33548707|NCT02489968|62939988|FG003|Double-blind Treatment Period|Protocol Violation|0|||
33548708|NCT02489968|62939989|FG004|Double-blind Treatment Period|Protocol Violation|1|||
33548709|NCT02489968|62939990|FG005|Double-blind Treatment Period|Protocol Violation|1|||
33548710|NCT02489968|62939985|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
33548711|NCT02489968|62939986|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
33548712|NCT02489968|62939987|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33548713|NCT02489968|62939988|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
33548714|NCT02489968|62939989|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
33548715|NCT02489968|62939990|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
33548716|NCT02489968|62939985|FG000|Double-blind Treatment Period|Other than specified above|0|||
33548717|NCT02489968|62939986|FG001|Double-blind Treatment Period|Other than specified above|0|||
33548718|NCT02489968|62939987|FG002|Double-blind Treatment Period|Other than specified above|0|||
33548719|NCT02489968|62939988|FG003|Double-blind Treatment Period|Other than specified above|0|||
33548720|NCT02489968|62939989|FG004|Double-blind Treatment Period|Other than specified above|1|||
33548721|NCT02489968|62939990|FG005|Double-blind Treatment Period|Other than specified above|0|||
33548722|NCT02483416|62940004|FG000|Overall Study|Other reason|0|||
33548723|NCT02483416|62940005|FG001|Overall Study|Other reason|1|||
33548724|NCT02483416|62940004|FG000|Overall Study|Treatment stop|3|||
33548725|NCT02483416|62940005|FG001|Overall Study|Treatment stop|0|||
33548726|NCT01061177|62940012|FG000|Overall Study|Adverse Event|117|||
33548727|NCT01061177|62940012|FG000|Overall Study|Withdrawal by Subject|27|||
33548728|NCT01061177|62940012|FG000|Overall Study|Disease progression|17|||
33548729|NCT01061177|62940012|FG000|Overall Study|Protocol Violation|11|||
33548730|NCT01061177|62940012|FG000|Overall Study|Lost to Follow-up|9|||
33548731|NCT01061177|62940012|FG000|Overall Study|New cancer therapy|9|||
33548732|NCT01061177|62940012|FG000|Overall Study|Abnormal laboratory values|6|||
33335762|NCT01078805|62712233|FG000|Overall Study|Death|134|||
33335763|NCT01078805|62712233|FG000|Overall Study|Lost to Follow-up|676|||
33335764|NCT01078805|62712233|FG000|Overall Study|Physician Decision|169|||
33335765|NCT01078805|62712233|FG000|Overall Study|Serious adverse event|26|||
33335766|NCT01078805|62712233|FG000|Overall Study|Sponsor decision|46|||
33335767|NCT01078805|62712233|FG000|Overall Study|Withdrawal by Subject|739|||
33335768|NCT01078805|62712233|FG000|Overall Study|Other|173|||
33335769|NCT01078805|62712233|FG000|Overall Study|Didn't take study drug|82|||
33335770|NCT00820027|62712241|FG000|Overall Study|Adverse Event|15|||
33548733|NCT01061177|62940012|FG000|Overall Study|Abnormal test procedure results|4|||
33654119|NCT01681628|63066700|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
33654120|NCT01681628|63066699|FG000|19 Months Follow-up|Death|1|||
33654121|NCT01681628|63066700|FG001|19 Months Follow-up|Death|0|||
33654122|NCT01681628|63066699|FG000|19 Months Follow-up|Lost to Follow-up|61|||
33654123|NCT01681628|63066700|FG001|19 Months Follow-up|Lost to Follow-up|43|||
33654124|NCT00016354|63066722|FG000|Overall Study|Lack of Efficacy|0|||
33654125|NCT00016354|63066723|FG001|Overall Study|Lack of Efficacy|0|||
33654126|NCT00016354|63066724|FG002|Overall Study|Lack of Efficacy|0|||
33654127|NCT00016354|63066725|FG003|Overall Study|Lack of Efficacy|0|||
33654128|NCT00016354|63066726|FG004|Overall Study|Lack of Efficacy|0|||
33654129|NCT00016354|63066727|FG005|Overall Study|Lack of Efficacy|0|||
33654130|NCT00016354|63066728|FG006|Overall Study|Lack of Efficacy|0|||
33654131|NCT00016354|63066729|FG007|Overall Study|Lack of Efficacy|1|||
33654132|NCT01681472|63066737|FG000|Overall Study|Adverse Event|0|||
33654133|NCT01681472|63066738|FG001|Overall Study|Adverse Event|1|||
33654134|NCT01681472|63066739|FG002|Overall Study|Adverse Event|0|||
33654135|NCT01681472|63066740|FG003|Overall Study|Adverse Event|0|||
33654136|NCT01049308|63066769|FG000|Pill Counts|Withdrawal by Subject|83|||
33654137|NCT01713686|63066776|FG000|Overall Study|Lost to Follow-up|9|||
33654138|NCT01713686|63066776|FG000|Overall Study|Withdrawal by Subject|6|||
33654139|NCT01047436|63066782|FG000|Overall Study|Protocol Violation|1|||
33654140|NCT01047436|63066783|FG001|Overall Study|Protocol Violation|0|||
33654141|NCT01681004|63066791|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
33654142|NCT01681004|63066792|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
33654143|NCT01681004|63066791|FG000|Study Completion|Lost to Follow-up|8|||
33654144|NCT01681004|63066792|FG001|Study Completion|Lost to Follow-up|3|||
33654145|NCT01681004|63066791|FG000|Study Completion|Physician Decision|1|||
33654146|NCT01681004|63066792|FG001|Study Completion|Physician Decision|3|||
33654147|NCT01681004|63066791|FG000|Study Completion|Site Termination|2|||
33654148|NCT01681004|63066792|FG001|Study Completion|Site Termination|1|||
33654149|NCT01681004|63066791|FG000|Study Completion|Death|1|||
33654150|NCT01681004|63066792|FG001|Study Completion|Death|1|||
33654151|NCT01046110|63066804|FG000|Overall Study|Adverse Event|9|||
33654152|NCT01046110|63066805|FG001|Overall Study|Adverse Event|2|||
33654153|NCT01046110|63066804|FG000|Overall Study|Lack of Efficacy|0|||
33654154|NCT01046110|63066805|FG001|Overall Study|Lack of Efficacy|1|||
33654155|NCT01046110|63066804|FG000|Overall Study|Protocol Violation|7|||
33654156|NCT01046110|63066805|FG001|Overall Study|Protocol Violation|12|||
33654157|NCT01046110|63066804|FG000|Overall Study|Withdrawal Criteria|3|||
33654158|NCT01046110|63066805|FG001|Overall Study|Withdrawal Criteria|5|||
33654159|NCT01046110|63066804|FG000|Overall Study|Unclassified|36|||
33654160|NCT01046110|63066805|FG001|Overall Study|Unclassified|35|||
33654161|NCT01713530|63066813|FG000|Overall Study|Adverse Event|0|||
33654162|NCT01713530|63066814|FG001|Overall Study|Adverse Event|5|||
33654163|NCT01713530|63066813|FG000|Overall Study|Withdrawal criteria|21|||
33654164|NCT01713530|63066814|FG001|Overall Study|Withdrawal criteria|12|||
33654165|NCT01713530|63066813|FG000|Overall Study|Unclassified|4|||
33654166|NCT01713530|63066814|FG001|Overall Study|Unclassified|2|||
33654167|NCT01045798|63066822|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
33654168|NCT01045798|63066823|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
33654169|NCT01045798|63066822|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
33654170|NCT01045798|63066823|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
33654171|NCT01045798|63066822|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
33654172|NCT01045798|63066823|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
33654173|NCT01045798|63066822|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
33654174|NCT01045798|63066823|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
33654175|NCT01712984|63066836|FG000|Overall Study|Adverse Event|0|||
33654176|NCT01712984|63066837|FG001|Overall Study|Adverse Event|0|||
33654177|NCT01712984|63066838|FG002|Overall Study|Adverse Event|1|||
33654178|NCT01712984|63066836|FG000|Overall Study|Protocol Violation|2|||
33654179|NCT01712984|63066837|FG001|Overall Study|Protocol Violation|0|||
33654180|NCT01712984|63066838|FG002|Overall Study|Protocol Violation|1|||
33654181|NCT01712984|63066836|FG000|Overall Study|Lost to Follow-up|8|||
33654182|NCT01712984|63066837|FG001|Overall Study|Lost to Follow-up|10|||
33654183|NCT01712984|63066838|FG002|Overall Study|Lost to Follow-up|1|||
33654184|NCT01712984|63066836|FG000|Overall Study|Withdrawal by Subject|6|||
33654185|NCT01712984|63066837|FG001|Overall Study|Withdrawal by Subject|6|||
33654186|NCT01712984|63066838|FG002|Overall Study|Withdrawal by Subject|7|||
33654187|NCT01042678|63066849|FG000|Overall Study|Physician Decision|1|||
33654188|NCT01042678|63066850|FG001|Overall Study|Physician Decision|0|||
33654189|NCT01042678|63066851|FG002|Overall Study|Physician Decision|0|||
33654190|NCT01042678|63066852|FG003|Overall Study|Physician Decision|0|||
33654191|NCT01042678|63066853|FG004|Overall Study|Physician Decision|0|||
33654192|NCT01042678|63066854|FG005|Overall Study|Physician Decision|0|||
33654193|NCT01042600|63066864|FG000|Overall Study|Ineligible|1|||
33654194|NCT01042600|63066865|FG001|Overall Study|Ineligible|0|||
33335771|NCT00820027|62712242|FG001|Overall Study|Adverse Event|8|||
33335772|NCT00820027|62712243|FG002|Overall Study|Adverse Event|10|||
33335773|NCT00820027|62712244|FG003|Overall Study|Adverse Event|5|||
33335774|NCT00820027|62712241|FG000|Overall Study|Lack of Efficacy|2|||
33335775|NCT00820027|62712242|FG001|Overall Study|Lack of Efficacy|1|||
33335776|NCT00820027|62712243|FG002|Overall Study|Lack of Efficacy|2|||
33335777|NCT00820027|62712244|FG003|Overall Study|Lack of Efficacy|2|||
33335778|NCT00820027|62712241|FG000|Overall Study|Physician Decision|0|||
33335779|NCT00820027|62712242|FG001|Overall Study|Physician Decision|1|||
33335780|NCT00820027|62712243|FG002|Overall Study|Physician Decision|1|||
33335781|NCT00820027|62712244|FG003|Overall Study|Physician Decision|0|||
33335782|NCT00820027|62712241|FG000|Overall Study|Protocol Violation|3|||
33335783|NCT00820027|62712242|FG001|Overall Study|Protocol Violation|0|||
33335784|NCT00820027|62712243|FG002|Overall Study|Protocol Violation|4|||
33335785|NCT00820027|62712244|FG003|Overall Study|Protocol Violation|0|||
33335786|NCT00820027|62712241|FG000|Overall Study|Withdrawal by Subject|6|||
33335787|NCT00820027|62712242|FG001|Overall Study|Withdrawal by Subject|4|||
33335788|NCT00820027|62712243|FG002|Overall Study|Withdrawal by Subject|4|||
33335789|NCT00820027|62712244|FG003|Overall Study|Withdrawal by Subject|6|||
33335790|NCT01076153|62712255|FG000|Overall Study|Symptoms improved/resolved|10|||
33335791|NCT01076153|62712255|FG000|Overall Study|Adverse Event|1|||
33335792|NCT01076075|62712265|FG000|Overall Study|Adverse Event|3|||
33335793|NCT01076075|62712266|FG001|Overall Study|Adverse Event|9|||
33335794|NCT01076075|62712265|FG000|Overall Study|Lack of Efficacy|5|||
33335795|NCT01076075|62712266|FG001|Overall Study|Lack of Efficacy|4|||
33335796|NCT01076075|62712265|FG000|Overall Study|Lost to Follow-up|6|||
33335797|NCT01076075|62712266|FG001|Overall Study|Lost to Follow-up|5|||
33335798|NCT01076075|62712265|FG000|Overall Study|other|19|||
33335799|NCT01076075|62712266|FG001|Overall Study|other|9|||
33335800|NCT01076075|62712265|FG000|Overall Study|Protocol Violation|0|||
33335801|NCT01076075|62712266|FG001|Overall Study|Protocol Violation|1|||
33335802|NCT01076075|62712265|FG000|Overall Study|Withdrawal by Subject|8|||
33335803|NCT01076075|62712266|FG001|Overall Study|Withdrawal by Subject|19|||
33335804|NCT01075763|62712277|FG000|Overall Study|Lost to Follow-up|2|||
33335805|NCT01075763|62712278|FG001|Overall Study|Lost to Follow-up|1|||
33335806|NCT01075763|62712277|FG000|Overall Study|Lack of Efficacy|0|||
33335807|NCT01075763|62712278|FG001|Overall Study|Lack of Efficacy|1|||
33335808|NCT01075763|62712277|FG000|Overall Study|Withdrawal by Subject|2|||
33335809|NCT01075763|62712278|FG001|Overall Study|Withdrawal by Subject|2|||
33335810|NCT00881530|62712290|FG000|Overall Study|Adverse Event|5|||
33335811|NCT00881530|62712291|FG001|Overall Study|Adverse Event|1|||
33335812|NCT00881530|62712292|FG002|Overall Study|Adverse Event|1|||
33335813|NCT00881530|62712293|FG003|Overall Study|Adverse Event|4|||
33335814|NCT00881530|62712294|FG004|Overall Study|Adverse Event|10|||
33335815|NCT00881530|62712295|FG005|Overall Study|Adverse Event|2|||
33335816|NCT00881530|62712290|FG000|Overall Study|Lack of Efficacy|1|||
33335817|NCT00881530|62712291|FG001|Overall Study|Lack of Efficacy|0|||
33335818|NCT00881530|62712292|FG002|Overall Study|Lack of Efficacy|0|||
33335819|NCT00881530|62712293|FG003|Overall Study|Lack of Efficacy|0|||
33335820|NCT00881530|62712294|FG004|Overall Study|Lack of Efficacy|1|||
33335821|NCT00881530|62712295|FG005|Overall Study|Lack of Efficacy|1|||
33335822|NCT00881530|62712290|FG000|Overall Study|Not compliant with the protocol|0|||
33335823|NCT00881530|62712291|FG001|Overall Study|Not compliant with the protocol|0|||
33335824|NCT00881530|62712292|FG002|Overall Study|Not compliant with the protocol|0|||
33335825|NCT00881530|62712293|FG003|Overall Study|Not compliant with the protocol|0|||
33335826|NCT00881530|62712294|FG004|Overall Study|Not compliant with the protocol|2|||
33335827|NCT00881530|62712295|FG005|Overall Study|Not compliant with the protocol|0|||
33335828|NCT00881530|62712290|FG000|Overall Study|Lost to Follow-up|0|||
33335829|NCT00881530|62712291|FG001|Overall Study|Lost to Follow-up|1|||
33548734|NCT01061177|62940012|FG000|Overall Study|Administratie problems|4|||
33335830|NCT00881530|62712292|FG002|Overall Study|Lost to Follow-up|1|||
33335831|NCT00881530|62712293|FG003|Overall Study|Lost to Follow-up|3|||
33335832|NCT00881530|62712294|FG004|Overall Study|Lost to Follow-up|1|||
33335833|NCT00881530|62712295|FG005|Overall Study|Lost to Follow-up|0|||
33335834|NCT00881530|62712290|FG000|Overall Study|Refused to continue medication|7|||
33335835|NCT00881530|62712291|FG001|Overall Study|Refused to continue medication|2|||
33335836|NCT00881530|62712292|FG002|Overall Study|Refused to continue medication|1|||
33335837|NCT00881530|62712293|FG003|Overall Study|Refused to continue medication|2|||
33335838|NCT00881530|62712294|FG004|Overall Study|Refused to continue medication|0|||
33469035|NCT00289913|62842886|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
33469036|NCT00289913|62842887|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
33335839|NCT00881530|62712295|FG005|Overall Study|Refused to continue medication|0|||
33469037|NCT00289913|62842888|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
33335840|NCT00881530|62712290|FG000|Overall Study|Other reason not defined above|1|||
33335841|NCT00881530|62712291|FG001|Overall Study|Other reason not defined above|1|||
33335842|NCT00881530|62712292|FG002|Overall Study|Other reason not defined above|2|||
33335843|NCT00881530|62712293|FG003|Overall Study|Other reason not defined above|0|||
33335844|NCT00881530|62712294|FG004|Overall Study|Other reason not defined above|0|||
33335845|NCT00881530|62712295|FG005|Overall Study|Other reason not defined above|2|||
33335846|NCT01075685|62712311|FG000|Overall Study|Protocol Violation|9|||
33335847|NCT01075685|62712312|FG001|Overall Study|Protocol Violation|1|||
33335848|NCT01075685|62712311|FG000|Overall Study|Withdrawal by Subject|20|||
33335849|NCT01075685|62712312|FG001|Overall Study|Withdrawal by Subject|5|||
33335850|NCT01075685|62712311|FG000|Overall Study|Lost to Follow-up|563|||
33335851|NCT01075685|62712312|FG001|Overall Study|Lost to Follow-up|220|||
33335852|NCT01075217|62712320|FG000|Overall Study|Adverse Event|1|||
33335853|NCT01075217|62712321|FG001|Overall Study|Adverse Event|1|||
33335854|NCT01075217|62712320|FG000|Overall Study|Physician Decision|1|||
33335855|NCT01075217|62712321|FG001|Overall Study|Physician Decision|0|||
33335856|NCT01078571|62712335|FG000|Overall Study|Adverse Event|36|||
33335857|NCT01078571|62712335|FG000|Overall Study|Lack of effectiveness|36|||
33335858|NCT01078571|62712335|FG000|Overall Study|Reason not reported|21|||
33335859|NCT01078571|62712335|FG000|Overall Study|Withdrawal by Subject|12|||
33335860|NCT01078571|62712335|FG000|Overall Study|Lost to Follow-up|8|||
33335861|NCT01078571|62712335|FG000|Overall Study|Protocol Violation|2|||
33335862|NCT00977106|62712346|FG000|Overall Study|Adverse Event|5|||
33335863|NCT00977106|62712347|FG001|Overall Study|Adverse Event|6|||
33335864|NCT00977106|62712346|FG000|Overall Study|Withdrawal by Subject|2|||
33335865|NCT00977106|62712347|FG001|Overall Study|Withdrawal by Subject|2|||
33335866|NCT00977106|62712346|FG000|Overall Study|Lack of Efficacy|2|||
33335867|NCT00977106|62712347|FG001|Overall Study|Lack of Efficacy|2|||
33335868|NCT00977106|62712346|FG000|Overall Study|Protocol Violation|0|||
33335869|NCT00977106|62712347|FG001|Overall Study|Protocol Violation|1|||
33335870|NCT00977106|62712346|FG000|Overall Study|Other|1|||
33335871|NCT00977106|62712347|FG001|Overall Study|Other|0|||
33335872|NCT01077713|62712357|FG000|Overall Study|Withdrawal by Subject|1|||
33335873|NCT01077713|62712358|FG001|Overall Study|Withdrawal by Subject|2|||
33335874|NCT01077713|62712357|FG000|Overall Study|Progressive Disease (PD)|0|||
33335875|NCT01077713|62712358|FG001|Overall Study|Progressive Disease (PD)|1|||
33335876|NCT01077713|62712357|FG000|Overall Study|Death|28|||
33335877|NCT01077713|62712358|FG001|Overall Study|Death|29|||
33335878|NCT01077713|62712357|FG000|Overall Study|Lost to Follow-up|1|||
33335879|NCT01077713|62712358|FG001|Overall Study|Lost to Follow-up|1|||
33335880|NCT01077713|62712357|FG000|Overall Study|Adverse Event|2|||
33335881|NCT01077713|62712358|FG001|Overall Study|Adverse Event|1|||
33335882|NCT01077713|62712357|FG000|Overall Study|Other|4|||
33335883|NCT01077713|62712358|FG001|Overall Study|Other|2|||
33335884|NCT00813709|62712367|FG000|Double Blind Period|Adverse Event|4|||
33335885|NCT00813709|62712368|FG001|Double Blind Period|Adverse Event|1|||
33335886|NCT00813709|62712369|FG002|Double Blind Period|Adverse Event|4|||
33335887|NCT00813709|62712370|FG003|Double Blind Period|Adverse Event|0|||
33335888|NCT00813709|62712371|FG004|Double Blind Period|Adverse Event|0|||
33335889|NCT00813709|62712372|FG005|Double Blind Period|Adverse Event|0|||
33335890|NCT00813709|62712367|FG000|Double Blind Period|Lost to Follow-up|3|||
33335891|NCT00813709|62712368|FG001|Double Blind Period|Lost to Follow-up|2|||
33335892|NCT00813709|62712369|FG002|Double Blind Period|Lost to Follow-up|2|||
33335893|NCT00813709|62712370|FG003|Double Blind Period|Lost to Follow-up|0|||
33335894|NCT00813709|62712371|FG004|Double Blind Period|Lost to Follow-up|0|||
33335895|NCT00813709|62712372|FG005|Double Blind Period|Lost to Follow-up|0|||
33335896|NCT00813709|62712367|FG000|Double Blind Period|Switched to open label phase|9|||
33335897|NCT00813709|62712368|FG001|Double Blind Period|Switched to open label phase|26|||
33335898|NCT00813709|62712369|FG002|Double Blind Period|Switched to open label phase|18|||
33335899|NCT00813709|62712370|FG003|Double Blind Period|Switched to open label phase|0|||
33335900|NCT00813709|62712371|FG004|Double Blind Period|Switched to open label phase|0|||
33335901|NCT00813709|62712372|FG005|Double Blind Period|Switched to open label phase|0|||
33335902|NCT00813709|62712367|FG000|Double Blind Period|Randomized but not treated|1|||
33335903|NCT00813709|62712368|FG001|Double Blind Period|Randomized but not treated|3|||
33335904|NCT00813709|62712369|FG002|Double Blind Period|Randomized but not treated|1|||
33335905|NCT00813709|62712370|FG003|Double Blind Period|Randomized but not treated|0|||
33335906|NCT00813709|62712371|FG004|Double Blind Period|Randomized but not treated|0|||
33335907|NCT00813709|62712372|FG005|Double Blind Period|Randomized but not treated|0|||
33335908|NCT00813709|62712367|FG000|Double Blind Period|Other|14|||
33335909|NCT00813709|62712368|FG001|Double Blind Period|Other|9|||
33335910|NCT00813709|62712369|FG002|Double Blind Period|Other|6|||
33335911|NCT00813709|62712370|FG003|Double Blind Period|Other|0|||
33335912|NCT00813709|62712371|FG004|Double Blind Period|Other|0|||
33335913|NCT00813709|62712372|FG005|Double Blind Period|Other|0|||
33335914|NCT00813709|62712367|FG000|Open Label Period|Adverse Event|0|||
33335915|NCT00813709|62712368|FG001|Open Label Period|Adverse Event|0|||
33335916|NCT00813709|62712369|FG002|Open Label Period|Adverse Event|0|||
33335917|NCT00813709|62712370|FG003|Open Label Period|Adverse Event|5|||
33335918|NCT00813709|62712371|FG004|Open Label Period|Adverse Event|4|||
33335919|NCT00813709|62712372|FG005|Open Label Period|Adverse Event|3|||
33335920|NCT00813709|62712367|FG000|Open Label Period|Lack of Efficacy|0|||
33335921|NCT00813709|62712368|FG001|Open Label Period|Lack of Efficacy|0|||
33335922|NCT00813709|62712369|FG002|Open Label Period|Lack of Efficacy|0|||
33335923|NCT00813709|62712370|FG003|Open Label Period|Lack of Efficacy|3|||
33335924|NCT00813709|62712371|FG004|Open Label Period|Lack of Efficacy|1|||
33335925|NCT00813709|62712372|FG005|Open Label Period|Lack of Efficacy|1|||
33335926|NCT00813709|62712367|FG000|Open Label Period|Randomized but not treated|0|||
33335927|NCT00813709|62712368|FG001|Open Label Period|Randomized but not treated|0|||
33335928|NCT00813709|62712369|FG002|Open Label Period|Randomized but not treated|0|||
33335929|NCT00813709|62712370|FG003|Open Label Period|Randomized but not treated|1|||
33335930|NCT00813709|62712371|FG004|Open Label Period|Randomized but not treated|0|||
33335931|NCT00813709|62712372|FG005|Open Label Period|Randomized but not treated|1|||
33335932|NCT00813709|62712367|FG000|Open Label Period|Other|0|||
33335933|NCT00813709|62712368|FG001|Open Label Period|Other|0|||
33335934|NCT00813709|62712369|FG002|Open Label Period|Other|0|||
33335935|NCT00813709|62712370|FG003|Open Label Period|Other|11|||
33335936|NCT00813709|62712371|FG004|Open Label Period|Other|5|||
33335937|NCT00813709|62712372|FG005|Open Label Period|Other|6|||
33335938|NCT01077323|62712404|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
33335939|NCT01077323|62712405|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
33335940|NCT01077323|62712406|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
33335941|NCT01077323|62712404|FG000|Overall Study|Dispensing of drug in baseline period|0|||
33335942|NCT01077323|62712405|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
33335943|NCT01077323|62712406|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
33335944|NCT01077323|62712404|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
33335945|NCT01077323|62712405|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
33335946|NCT01077323|62712406|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
33335947|NCT00976950|62712414|FG000|Overall Study|Adverse Event|3|||
33335948|NCT00976950|62712414|FG000|Overall Study|Events with no relationship to Aptivus|3|||
33335949|NCT00976716|62712418|FG000|Overall Study|Adverse Event|1|||
33335950|NCT00819247|62712426|FG000|Overall Study|Adverse Event|0|||
33335951|NCT00819247|62712427|FG001|Overall Study|Adverse Event|5|||
33335952|NCT00819247|62712428|FG002|Overall Study|Adverse Event|3|||
33335953|NCT00819247|62712426|FG000|Overall Study|Insufficient testosterone response|5|||
33335954|NCT00819247|62712427|FG001|Overall Study|Insufficient testosterone response|8|||
33335955|NCT00819247|62712428|FG002|Overall Study|Insufficient testosterone response|10|||
33335956|NCT00819247|62712426|FG000|Overall Study|Withdrawal by Subject|1|||
33335957|NCT00819247|62712427|FG001|Overall Study|Withdrawal by Subject|0|||
33335958|NCT00819247|62712428|FG002|Overall Study|Withdrawal by Subject|0|||
33335959|NCT00819247|62712426|FG000|Overall Study|Protocol Violation|1|||
33335960|NCT00819247|62712427|FG001|Overall Study|Protocol Violation|0|||
33335961|NCT00819247|62712428|FG002|Overall Study|Protocol Violation|1|||
33335962|NCT00819247|62712426|FG000|Overall Study|Mistakenly withdrawn|0|||
33335963|NCT00819247|62712427|FG001|Overall Study|Mistakenly withdrawn|1|||
33335964|NCT00819247|62712428|FG002|Overall Study|Mistakenly withdrawn|0|||
33335965|NCT00819247|62712426|FG000|Overall Study|Bad prostate-specific antigen response|3|||
33335966|NCT00819247|62712427|FG001|Overall Study|Bad prostate-specific antigen response|2|||
33335967|NCT00819247|62712428|FG002|Overall Study|Bad prostate-specific antigen response|0|||
33335968|NCT00819247|62712426|FG000|Overall Study|Other|1|||
33335969|NCT00819247|62712427|FG001|Overall Study|Other|0|||
33335970|NCT00819247|62712428|FG002|Overall Study|Other|0|||
33335971|NCT00973674|62712438|FG000|Overall Study|Protocol Violation|2|||
33335972|NCT00973674|62712439|FG001|Overall Study|Protocol Violation|0|||
33335973|NCT00819091|62712448|FG000|Overall Study|Adverse Event|3|||
33335974|NCT00819091|62712449|FG001|Overall Study|Adverse Event|5|||
33335975|NCT00819091|62712448|FG000|Overall Study|Protocol Violation|0|||
33335976|NCT00819091|62712449|FG001|Overall Study|Protocol Violation|1|||
33335977|NCT00819091|62712448|FG000|Overall Study|Lost to Follow-up|2|||
33335978|NCT00819091|62712449|FG001|Overall Study|Lost to Follow-up|0|||
33335979|NCT00819091|62712448|FG000|Overall Study|Withdrawal by Subject|1|||
33335980|NCT00819091|62712449|FG001|Overall Study|Withdrawal by Subject|2|||
33335981|NCT00819091|62712448|FG000|Overall Study|Other|1|||
33335982|NCT00819091|62712449|FG001|Overall Study|Other|2|||
33335983|NCT00973362|62712457|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
33335984|NCT00973362|62712458|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
33335985|NCT00973362|62712457|FG000|Baseline Evaluation|No colposcopy visit|62|||
33335986|NCT00973362|62712458|FG001|Baseline Evaluation|No colposcopy visit|0|||
33335987|NCT00973362|62712457|FG000|Baseline Evaluation|Inevaluable|686|||
33335988|NCT00973362|62712458|FG001|Baseline Evaluation|Inevaluable|223|||
33335989|NCT00973362|62712457|FG000|3-Year Follow-up|Lost to Follow-up|17|||
33335990|NCT00973362|62712458|FG001|3-Year Follow-up|Lost to Follow-up|0|||
33335991|NCT00819013|62712471|FG000|Overall Study|Not meeting continuing study eligibility|2|||
33335992|NCT00819013|62712472|FG001|Overall Study|Not meeting continuing study eligibility|1|||
33335993|NCT00819013|62712473|FG002|Overall Study|Not meeting continuing study eligibility|2|||
33335994|NCT00819013|62712474|FG003|Overall Study|Not meeting continuing study eligibility|1|||
33335995|NCT00819013|62712471|FG000|Overall Study|Adverse Event|0|||
33335996|NCT00819013|62712472|FG001|Overall Study|Adverse Event|0|||
33335997|NCT00819013|62712473|FG002|Overall Study|Adverse Event|1|||
33335998|NCT00819013|62712474|FG003|Overall Study|Adverse Event|0|||
33335999|NCT00819013|62712471|FG000|Overall Study|Withdrawal by Subject|1|||
33336000|NCT00819013|62712472|FG001|Overall Study|Withdrawal by Subject|0|||
33336001|NCT00819013|62712473|FG002|Overall Study|Withdrawal by Subject|1|||
33336002|NCT00819013|62712474|FG003|Overall Study|Withdrawal by Subject|0|||
33336003|NCT00819013|62712471|FG000|Overall Study|Lost to Follow-up|0|||
33336004|NCT00819013|62712472|FG001|Overall Study|Lost to Follow-up|0|||
33336005|NCT00819013|62712473|FG002|Overall Study|Lost to Follow-up|1|||
33336006|NCT00819013|62712474|FG003|Overall Study|Lost to Follow-up|2|||
33336007|NCT00819013|62712471|FG000|Overall Study|Death|0|||
33336008|NCT00819013|62712472|FG001|Overall Study|Death|0|||
33336009|NCT00819013|62712473|FG002|Overall Study|Death|0|||
33336010|NCT00819013|62712474|FG003|Overall Study|Death|1|||
33336011|NCT00976560|62712486|FG000|Overall Study|Adverse Event|5|||
33336012|NCT00976560|62712487|FG001|Overall Study|Adverse Event|5|||
33336013|NCT00976560|62712486|FG000|Overall Study|Lack of Efficacy|3|||
33336014|NCT00976560|62712487|FG001|Overall Study|Lack of Efficacy|5|||
33336015|NCT00976560|62712486|FG000|Overall Study|Protocol Violation|1|||
33336016|NCT00976560|62712487|FG001|Overall Study|Protocol Violation|0|||
33336017|NCT00976560|62712486|FG000|Overall Study|Lost to Follow-up|1|||
33336018|NCT00976560|62712487|FG001|Overall Study|Lost to Follow-up|0|||
33336019|NCT00976560|62712486|FG000|Overall Study|Physician Decision|2|||
33336020|NCT00976560|62712487|FG001|Overall Study|Physician Decision|0|||
33336021|NCT00976560|62712486|FG000|Overall Study|Withdrawal by Subject|2|||
33336022|NCT00976560|62712487|FG001|Overall Study|Withdrawal by Subject|3|||
33336023|NCT00976482|62712493|FG000|Overall Study|Death|208|||
33336024|NCT00976482|62712493|FG000|Overall Study|Withdrawal by Subject|45|||
33336025|NCT00976482|62712493|FG000|Overall Study|Center terminated|1|||
33336026|NCT00976482|62712493|FG000|Overall Study|Protocol Violation|5|||
33336027|NCT00975156|62712499|FG000|Overall Study|Protocol Violation|0|||
33336028|NCT00975156|62712500|FG001|Overall Study|Protocol Violation|1|||
33336029|NCT00810043|62712512|FG000|Overall Study|Withdrawal by Subject|1|||
33336030|NCT00810043|62712513|FG001|Overall Study|Withdrawal by Subject|0|||
33336031|NCT00810043|62712514|FG002|Overall Study|Withdrawal by Subject|2|||
33336032|NCT00810043|62712512|FG000|Overall Study|Lost to Follow-up|1|||
33336033|NCT00810043|62712513|FG001|Overall Study|Lost to Follow-up|0|||
33336034|NCT00810043|62712514|FG002|Overall Study|Lost to Follow-up|0|||
33336035|NCT00810043|62712512|FG000|Overall Study|Physician Decision|0|||
33336036|NCT00810043|62712513|FG001|Overall Study|Physician Decision|0|||
33336037|NCT00810043|62712514|FG002|Overall Study|Physician Decision|2|||
33336038|NCT00810043|62712512|FG000|Overall Study|Death|2|||
33336039|NCT00810043|62712513|FG001|Overall Study|Death|0|||
33336040|NCT00810043|62712514|FG002|Overall Study|Death|0|||
33336041|NCT00810043|62712512|FG000|Overall Study|Unrelated medical problem|0|||
33336042|NCT00810043|62712513|FG001|Overall Study|Unrelated medical problem|1|||
33336043|NCT00810043|62712514|FG002|Overall Study|Unrelated medical problem|0|||
33336044|NCT00810043|62712512|FG000|Overall Study|Non-medical problem|0|||
33336045|NCT00810043|62712513|FG001|Overall Study|Non-medical problem|0|||
33336046|NCT00810043|62712514|FG002|Overall Study|Non-medical problem|1|||
33336047|NCT00810043|62712512|FG000|Overall Study|No longer met enrollment criteria|0|||
33336048|NCT00810043|62712513|FG001|Overall Study|No longer met enrollment criteria|0|||
33336049|NCT00810043|62712514|FG002|Overall Study|No longer met enrollment criteria|3|||
33336050|NCT01120184|62712526|FG000|Overall Study|Adverse Event|0|||
33336051|NCT01120184|62712527|FG001|Overall Study|Adverse Event|1|||
33336052|NCT01120184|62712528|FG002|Overall Study|Adverse Event|0|||
33336053|NCT01120184|62712526|FG000|Overall Study|Lost to Follow-up|13|||
33336054|NCT01120184|62712527|FG001|Overall Study|Lost to Follow-up|13|||
33336055|NCT01120184|62712528|FG002|Overall Study|Lost to Follow-up|11|||
33336056|NCT01120184|62712526|FG000|Overall Study|Physician Decision|9|||
33336057|NCT01120184|62712527|FG001|Overall Study|Physician Decision|1|||
33336058|NCT01120184|62712528|FG002|Overall Study|Physician Decision|3|||
33336059|NCT01120184|62712526|FG000|Overall Study|Reason not Specified|8|||
33336060|NCT01120184|62712527|FG001|Overall Study|Reason not Specified|3|||
33336061|NCT01120184|62712528|FG002|Overall Study|Reason not Specified|12|||
33336062|NCT01120184|62712526|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
33336063|NCT01120184|62712527|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
33336064|NCT01120184|62712528|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
33336065|NCT01120184|62712526|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
33336066|NCT01120184|62712527|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
33336067|NCT01120184|62712528|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
33336068|NCT01120184|62712526|FG000|Overall Study|Death|170|||
33336069|NCT01120184|62712527|FG001|Overall Study|Death|176|||
33336070|NCT01120184|62712528|FG002|Overall Study|Death|169|||
33336071|NCT01120028|62712540|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
33336072|NCT01120028|62712541|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
33336073|NCT01120028|62712542|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
33336074|NCT01120028|62712543|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
33336075|NCT01120028|62712540|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
33336076|NCT01120028|62712541|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
33336077|NCT01120028|62712542|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
33336078|NCT01120028|62712543|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
33336079|NCT00878800|62712559|FG000|Overall Study|Adverse Event|0|||
33336080|NCT00878800|62712560|FG001|Overall Study|Adverse Event|0|||
33336081|NCT00878800|62712561|FG002|Overall Study|Adverse Event|2|||
33336082|NCT00878800|62712562|FG003|Overall Study|Adverse Event|0|||
33336083|NCT00878800|62712563|FG004|Overall Study|Adverse Event|1|||
33336084|NCT00878800|62712559|FG000|Overall Study|Progressive disease|1|||
33336085|NCT00878800|62712560|FG001|Overall Study|Progressive disease|5|||
33336086|NCT00878800|62712561|FG002|Overall Study|Progressive disease|6|||
33336087|NCT00878800|62712562|FG003|Overall Study|Progressive disease|5|||
33336088|NCT00878800|62712563|FG004|Overall Study|Progressive disease|13|||
33336089|NCT00878800|62712559|FG000|Overall Study|Withdrew consent|1|||
33336090|NCT00878800|62712560|FG001|Overall Study|Withdrew consent|1|||
33336091|NCT00878800|62712561|FG002|Overall Study|Withdrew consent|0|||
33336092|NCT00878800|62712562|FG003|Overall Study|Withdrew consent|1|||
33336093|NCT00878800|62712563|FG004|Overall Study|Withdrew consent|1|||
33336094|NCT00878800|62712559|FG000|Overall Study|Death|0|||
33336095|NCT00878800|62712560|FG001|Overall Study|Death|0|||
33336096|NCT00878800|62712561|FG002|Overall Study|Death|1|||
33336097|NCT00878800|62712562|FG003|Overall Study|Death|0|||
33336098|NCT00878800|62712563|FG004|Overall Study|Death|0|||
33336099|NCT00878800|62712559|FG000|Overall Study|Other|1|||
33336100|NCT00878800|62712560|FG001|Overall Study|Other|1|||
33336101|NCT00878800|62712561|FG002|Overall Study|Other|0|||
33336102|NCT00878800|62712562|FG003|Overall Study|Other|0|||
33336103|NCT00878800|62712563|FG004|Overall Study|Other|1|||
33336104|NCT01119950|62712574|FG000|Overall Study|Adverse Event|25|||
33336105|NCT01119950|62712574|FG000|Overall Study|Withdrawal by Subject|9|||
33336106|NCT01119950|62712574|FG000|Overall Study|Protocol Violation|5|||
33336107|NCT01119950|62712574|FG000|Overall Study|Lost to Follow-up|4|||
33336108|NCT01119950|62712574|FG000|Overall Study|Administrative|2|||
33336109|NCT01119950|62712574|FG000|Overall Study|Abnormal lab value|1|||
33336110|NCT01119950|62712574|FG000|Overall Study|Death|1|||
33336111|NCT01145222|62712604|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
33336112|NCT01145222|62712605|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
33336113|NCT01145222|62712606|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
33336114|NCT01145222|62712607|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
33336115|NCT01145222|62712604|FG000|Overall Study|Poor bowel preparation|0|||
33336116|NCT01145222|62712605|FG001|Overall Study|Poor bowel preparation|0|||
33336117|NCT01145222|62712606|FG002|Overall Study|Poor bowel preparation|0|||
33336118|NCT01145222|62712607|FG003|Overall Study|Poor bowel preparation|1|||
33336119|NCT01145066|62712620|FG000|Overall Study|To resume NSAIDs|2|||
33336120|NCT01145066|62712621|FG001|Overall Study|To resume NSAIDs|2|||
33336121|NCT01145066|62712622|FG002|Overall Study|To resume NSAIDs|1|||
33336122|NCT01145066|62712620|FG000|Overall Study|Non-related surgery|0|||
33336123|NCT01145066|62712621|FG001|Overall Study|Non-related surgery|0|||
33336124|NCT01145066|62712622|FG002|Overall Study|Non-related surgery|1|||
33336125|NCT01145066|62712620|FG000|Overall Study|Withdrawal by Subject|0|||
33336126|NCT01145066|62712621|FG001|Overall Study|Withdrawal by Subject|0|||
33548735|NCT01061177|62940012|FG000|Overall Study|Death|4|||
33548736|NCT02481934|62940016|FG000|Overall Study|Death|2|||
33654195|NCT01041976|63066874|FG000|Overall Study|Withdrawal by Subject|3|||
33654196|NCT01041976|63066875|FG001|Overall Study|Withdrawal by Subject|0|||
33654197|NCT01041976|63066874|FG000|Overall Study|Incarceration|2|||
33654198|NCT01041976|63066875|FG001|Overall Study|Incarceration|0|||
33336127|NCT01145066|62712622|FG002|Overall Study|Withdrawal by Subject|2|||
33336128|NCT01145066|62712620|FG000|Overall Study|To start new med|1|||
33336129|NCT01145066|62712621|FG001|Overall Study|To start new med|0|||
33336130|NCT01145066|62712622|FG002|Overall Study|To start new med|0|||
33336131|NCT01145066|62712620|FG000|Overall Study|problems swallowing capsule|1|||
33336132|NCT01145066|62712621|FG001|Overall Study|problems swallowing capsule|0|||
33336133|NCT01145066|62712622|FG002|Overall Study|problems swallowing capsule|0|||
33336134|NCT01145066|62712620|FG000|Overall Study|Abdominal discomfort|0|||
33336135|NCT01145066|62712621|FG001|Overall Study|Abdominal discomfort|1|||
33336136|NCT01145066|62712622|FG002|Overall Study|Abdominal discomfort|0|||
33336137|NCT01145066|62712620|FG000|Overall Study|Low platelet count|0|||
33336138|NCT01145066|62712621|FG001|Overall Study|Low platelet count|1|||
33654199|NCT01041976|63066874|FG000|Overall Study|Death|0|||
33336139|NCT01145066|62712622|FG002|Overall Study|Low platelet count|0|||
33336140|NCT01132118|62712632|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
33336141|NCT01132118|62712633|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
33336142|NCT01132118|62712632|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
33336143|NCT01132118|62712633|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
33336144|NCT01132118|62712632|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
33336145|NCT01132118|62712633|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
33336146|NCT00972816|62712647|FG000|Overall Study|Adverse Event|0|||
33336147|NCT00972816|62712648|FG001|Overall Study|Adverse Event|0|||
33336148|NCT00972816|62712649|FG002|Overall Study|Adverse Event|1|||
33336149|NCT00972816|62712650|FG003|Overall Study|Adverse Event|0|||
33336150|NCT00972816|62712651|FG004|Overall Study|Adverse Event|0|||
33336151|NCT00972816|62712652|FG005|Overall Study|Adverse Event|0|||
33336152|NCT00972816|62712653|FG006|Overall Study|Adverse Event|0|||
33336153|NCT00972816|62712654|FG007|Overall Study|Adverse Event|0|||
33336154|NCT00972816|62712647|FG000|Overall Study|Withdrawal by Subject|4|||
33336155|NCT00972816|62712648|FG001|Overall Study|Withdrawal by Subject|2|||
33336156|NCT00972816|62712649|FG002|Overall Study|Withdrawal by Subject|1|||
33336157|NCT00972816|62712650|FG003|Overall Study|Withdrawal by Subject|3|||
33336158|NCT00972816|62712651|FG004|Overall Study|Withdrawal by Subject|0|||
33336159|NCT00972816|62712652|FG005|Overall Study|Withdrawal by Subject|1|||
33336160|NCT00972816|62712653|FG006|Overall Study|Withdrawal by Subject|1|||
33336161|NCT00972816|62712654|FG007|Overall Study|Withdrawal by Subject|2|||
33336162|NCT00972816|62712647|FG000|Overall Study|Lost to Follow-up|11|||
33336163|NCT00972816|62712648|FG001|Overall Study|Lost to Follow-up|9|||
33336164|NCT00972816|62712649|FG002|Overall Study|Lost to Follow-up|7|||
33336165|NCT00972816|62712650|FG003|Overall Study|Lost to Follow-up|5|||
33336166|NCT00972816|62712651|FG004|Overall Study|Lost to Follow-up|11|||
33336167|NCT00972816|62712652|FG005|Overall Study|Lost to Follow-up|10|||
33336168|NCT00972816|62712653|FG006|Overall Study|Lost to Follow-up|7|||
33336169|NCT00972816|62712654|FG007|Overall Study|Lost to Follow-up|7|||
33336170|NCT00972816|62712647|FG000|Overall Study|Inappropriate enrolment|0|||
33336171|NCT00972816|62712648|FG001|Overall Study|Inappropriate enrolment|0|||
33336172|NCT00972816|62712649|FG002|Overall Study|Inappropriate enrolment|0|||
33336173|NCT00972816|62712650|FG003|Overall Study|Inappropriate enrolment|0|||
33336174|NCT00972816|62712651|FG004|Overall Study|Inappropriate enrolment|0|||
33336175|NCT00972816|62712652|FG005|Overall Study|Inappropriate enrolment|0|||
33336176|NCT00972816|62712653|FG006|Overall Study|Inappropriate enrolment|2|||
33336177|NCT00972816|62712654|FG007|Overall Study|Inappropriate enrolment|0|||
33336178|NCT00972816|62712647|FG000|Overall Study|Unable to classify|2|||
33336179|NCT00972816|62712648|FG001|Overall Study|Unable to classify|0|||
33336180|NCT00972816|62712649|FG002|Overall Study|Unable to classify|0|||
33336181|NCT00972816|62712650|FG003|Overall Study|Unable to classify|0|||
33336182|NCT00972816|62712651|FG004|Overall Study|Unable to classify|1|||
33336183|NCT00972816|62712652|FG005|Overall Study|Unable to classify|0|||
33336184|NCT00972816|62712653|FG006|Overall Study|Unable to classify|0|||
33336185|NCT00972816|62712654|FG007|Overall Study|Unable to classify|0|||
33336186|NCT00969618|62712672|FG000|Overall Study|Adverse Event|29|||
33336187|NCT00969618|62712672|FG000|Overall Study|Entry Criteria Not Met|3|||
33336188|NCT00969618|62712672|FG000|Overall Study|Lack of Efficacy|2|||
33336189|NCT00969618|62712672|FG000|Overall Study|Lost to Follow-up|7|||
33336190|NCT00969618|62712672|FG000|Overall Study|Physician Decision|1|||
33336191|NCT00969618|62712672|FG000|Overall Study|Protocol Violation|9|||
33336192|NCT00969618|62712672|FG000|Overall Study|Withdrawal by Subject|27|||
33336193|NCT00969540|62712678|FG000|Overall Study|Lost to Follow-up|1|||
33336194|NCT00969540|62712679|FG001|Overall Study|Lost to Follow-up|1|||
33336195|NCT00975000|62712699|FG000|Overall Study|Other|1|||
33336196|NCT00975000|62712700|FG001|Overall Study|Other|0|||
33336197|NCT00975000|62712699|FG000|Overall Study|Adverse Event|1|||
33336198|NCT00975000|62712700|FG001|Overall Study|Adverse Event|1|||
33336199|NCT00975000|62712699|FG000|Overall Study|Withdrawal by Subject|2|||
33336200|NCT00975000|62712700|FG001|Overall Study|Withdrawal by Subject|2|||
33336201|NCT00975000|62712699|FG000|Overall Study|Lost to Follow-up|0|||
33548737|NCT02973425|62940022|FG000|Overall Study|Lost to Follow-up|49|||
33336202|NCT00975000|62712700|FG001|Overall Study|Lost to Follow-up|1|||
33336203|NCT00975000|62712699|FG000|Overall Study|Protocol-specified Criteria|1|||
33336204|NCT00975000|62712700|FG001|Overall Study|Protocol-specified Criteria|0|||
33336205|NCT00975000|62712699|FG000|Overall Study|Non-compliance|0|||
33336206|NCT00975000|62712700|FG001|Overall Study|Non-compliance|1|||
33336207|NCT00974922|62712706|FG000|Overall Study|study terminated|24|||
33336208|NCT00972504|62712710|FG000|Overall Study|Adverse Event|2|||
33336209|NCT00972504|62712710|FG000|Overall Study|Investigator discretion|1|||
33336210|NCT00969228|62712722|FG000|Overall Study|Adverse Event|1|||
33336211|NCT00969228|62712723|FG001|Overall Study|Adverse Event|0|||
33336212|NCT00969228|62712722|FG000|Overall Study|Withdrawal by Subject|4|||
33336213|NCT00969228|62712723|FG001|Overall Study|Withdrawal by Subject|0|||
33336214|NCT00969228|62712722|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
33336215|NCT00969228|62712723|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
33336216|NCT00969150|62712731|FG000|Overall Study|Adverse Event|4|||
33336217|NCT00969150|62712732|FG001|Overall Study|Adverse Event|14|||
33336218|NCT00969150|62712731|FG000|Overall Study|Lack of Efficacy|1|||
33336219|NCT00969150|62712732|FG001|Overall Study|Lack of Efficacy|1|||
33336220|NCT00969150|62712731|FG000|Overall Study|Protocol Violation|9|||
33336221|NCT00969150|62712732|FG001|Overall Study|Protocol Violation|12|||
33336222|NCT00969150|62712731|FG000|Overall Study|Withdrawal by Subject|13|||
33336223|NCT00969150|62712732|FG001|Overall Study|Withdrawal by Subject|9|||
33336224|NCT00969150|62712731|FG000|Overall Study|Lost to Follow-up|5|||
33336225|NCT00969150|62712732|FG001|Overall Study|Lost to Follow-up|4|||
33336226|NCT00969150|62712731|FG000|Overall Study|Other reasons|1|||
33336227|NCT00969150|62712732|FG001|Overall Study|Other reasons|0|||
33336228|NCT00974220|62712740|FG000|Treatment Period 1|Adverse Event|2|||
33336229|NCT00974220|62712741|FG001|Treatment Period 1|Adverse Event|1|||
33336230|NCT00974220|62712740|FG000|Treatment Period 1|noncompliant subjects|0|||
33336231|NCT00974220|62712741|FG001|Treatment Period 1|noncompliant subjects|1|||
33336232|NCT00971178|62712750|FG000|Overall Study|Lost to Follow-up|2|||
33336233|NCT00971178|62712751|FG001|Overall Study|Lost to Follow-up|2|||
33336234|NCT00971178|62712752|FG002|Overall Study|Lost to Follow-up|2|||
33336235|NCT03670602|62712762|FG000|Overall Study|Lost to Follow-up|1|||
33336236|NCT03670602|62712763|FG001|Overall Study|Lost to Follow-up|0|||
33336237|NCT03670602|62712762|FG000|Overall Study|Withdrawal by Subject|0|||
33336238|NCT03670602|62712763|FG001|Overall Study|Withdrawal by Subject|3|||
33336239|NCT00968526|62712771|FG000|Overall Study|Adverse Event|2|||
33336240|NCT00968526|62712772|FG001|Overall Study|Adverse Event|0|||
33336241|NCT00968526|62712771|FG000|Overall Study|Migrated/moved from study area|1|||
33336242|NCT00968526|62712772|FG001|Overall Study|Migrated/moved from study area|0|||
33336243|NCT03664674|62712789|FG000|Overall Study|Adverse Event|1|||
33336244|NCT03664674|62712790|FG001|Overall Study|Adverse Event|1|||
33336245|NCT03664674|62712789|FG000|Overall Study|Physician Decision|0|||
33336246|NCT03664674|62712790|FG001|Overall Study|Physician Decision|1|||
33336247|NCT03664674|62712789|FG000|Overall Study|Withdrawal by Subject|2|||
33336248|NCT03664674|62712790|FG001|Overall Study|Withdrawal by Subject|0|||
33336249|NCT00967668|62712801|FG000|Overall Study|Withdrawal by Subject|13|||
33336250|NCT00967668|62712802|FG001|Overall Study|Withdrawal by Subject|8|||
33336251|NCT00967668|62712803|FG002|Overall Study|Withdrawal by Subject|8|||
33336252|NCT00967668|62712801|FG000|Overall Study|Death|0|||
33336253|NCT00967668|62712802|FG001|Overall Study|Death|2|||
33336254|NCT00967668|62712803|FG002|Overall Study|Death|4|||
33336255|NCT00967668|62712801|FG000|Overall Study|Removed due to behavior|1|||
33336256|NCT00967668|62712802|FG001|Overall Study|Removed due to behavior|1|||
33336257|NCT00967668|62712803|FG002|Overall Study|Removed due to behavior|2|||
33336258|NCT00967668|62712801|FG000|Overall Study|Refused Year 2|11|||
33336259|NCT00967668|62712802|FG001|Overall Study|Refused Year 2|6|||
33336260|NCT00967668|62712803|FG002|Overall Study|Refused Year 2|4|||
33336261|NCT00967668|62712801|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
33336262|NCT00967668|62712802|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
33336263|NCT00967668|62712803|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
33336264|NCT00967668|62712801|FG000|Overall Study|Lost to Follow-up|15|||
33336265|NCT00967668|62712802|FG001|Overall Study|Lost to Follow-up|9|||
33336266|NCT00967668|62712803|FG002|Overall Study|Lost to Follow-up|16|||
33548738|NCT02973425|62940023|FG001|Overall Study|Lost to Follow-up|53|||
33548739|NCT02489500|62940032|FG000|Overall Study|Death|1|||
33336267|NCT00967668|62712801|FG000|Overall Study|Refused 12-mo assessment|3|||
33336268|NCT00967668|62712802|FG001|Overall Study|Refused 12-mo assessment|1|||
33336269|NCT00967668|62712803|FG002|Overall Study|Refused 12-mo assessment|9|||
33336270|NCT00967668|62712801|FG000|Overall Study|Pregnancy|1|||
33336271|NCT00967668|62712802|FG001|Overall Study|Pregnancy|0|||
33336272|NCT00967668|62712803|FG002|Overall Study|Pregnancy|0|||
33336273|NCT00970944|62712816|FG000|Overall Study|Death|1|||
33336274|NCT00970944|62712817|FG001|Overall Study|Death|0|||
33336275|NCT00970944|62712816|FG000|Overall Study|Physician Decision|0|||
33336276|NCT00970944|62712817|FG001|Overall Study|Physician Decision|2|||
33336277|NCT04839289|62712826|FG000|Overall Study|Withdrawal by Subject|1|||
33336278|NCT04839289|62712827|FG001|Overall Study|Withdrawal by Subject|0|||
33336279|NCT04440813|62712835|FG000|Overall Study|Lost to Follow-up|5|||
33336280|NCT04440813|62712836|FG001|Overall Study|Lost to Follow-up|5|||
33336281|NCT04233073|62712850|FG000|Overall Study|Death|5|||
33336282|NCT04120116|62712858|FG000|Overall Study|Lost to Follow-up|0|||
33336283|NCT04120116|62712859|FG001|Overall Study|Lost to Follow-up|1|||
33336284|NCT04120116|62712860|FG002|Overall Study|Lost to Follow-up|0|||
33336285|NCT04120116|62712861|FG003|Overall Study|Lost to Follow-up|2|||
33336286|NCT04120116|62712858|FG000|Overall Study|Withdrawal by Subject|1|||
33336287|NCT04120116|62712859|FG001|Overall Study|Withdrawal by Subject|0|||
33336288|NCT04120116|62712860|FG002|Overall Study|Withdrawal by Subject|1|||
33336289|NCT04120116|62712861|FG003|Overall Study|Withdrawal by Subject|1|||
33336290|NCT04120116|62712858|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
33336291|NCT04120116|62712859|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
33336292|NCT04120116|62712860|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
33336293|NCT04120116|62712861|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
33336294|NCT03657810|62712884|FG000|Overall Study|Adverse Event|0|||
33336295|NCT03657810|62712885|FG001|Overall Study|Adverse Event|1|||
33336296|NCT03657810|62712886|FG002|Overall Study|Adverse Event|0|||
33336297|NCT03657810|62712884|FG000|Overall Study|Lack of Efficacy|4|||
33336298|NCT03657810|62712885|FG001|Overall Study|Lack of Efficacy|1|||
33336299|NCT03657810|62712886|FG002|Overall Study|Lack of Efficacy|3|||
33336300|NCT03657810|62712884|FG000|Overall Study|Protocol Violation|1|||
33336301|NCT03657810|62712885|FG001|Overall Study|Protocol Violation|0|||
33336302|NCT03657810|62712886|FG002|Overall Study|Protocol Violation|0|||
33336303|NCT03657810|62712884|FG000|Overall Study|Lost to Follow-up|0|||
33336304|NCT03657810|62712885|FG001|Overall Study|Lost to Follow-up|1|||
33336305|NCT03657810|62712886|FG002|Overall Study|Lost to Follow-up|0|||
33336306|NCT03657810|62712884|FG000|Overall Study|Not provided|0|||
33336307|NCT03657810|62712885|FG001|Overall Study|Not provided|1|||
33336308|NCT03657810|62712886|FG002|Overall Study|Not provided|0|||
33469038|NCT00289913|62842884|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
33469039|NCT00289913|62842885|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
33469040|NCT00289913|62842886|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
33469041|NCT00289913|62842887|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
33469042|NCT00289913|62842888|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
33469043|NCT00289913|62842884|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
33469044|NCT00289913|62842885|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
33469045|NCT00289913|62842886|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
33469046|NCT00289913|62842887|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
33469047|NCT00289913|62842888|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
33469048|NCT00289913|62842884|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33469049|NCT00289913|62842885|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33469050|NCT00289913|62842886|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
33469051|NCT00289913|62842887|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33469052|NCT00289913|62842888|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33469053|NCT00289913|62842884|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
33469054|NCT00289913|62842885|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
33469055|NCT00289913|62842886|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
33469056|NCT00289913|62842887|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
33469057|NCT00289913|62842888|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
33469058|NCT00289913|62842884|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
33469059|NCT00289913|62842885|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
33469060|NCT00289913|62842886|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
33469061|NCT00289913|62842887|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
33469062|NCT00289913|62842888|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
33469063|NCT00289913|62842884|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
33469064|NCT00289913|62842885|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
33469065|NCT00289913|62842886|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
33469066|NCT00289913|62842887|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
33469067|NCT00289913|62842888|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
33654200|NCT01041976|63066875|FG001|Overall Study|Death|4|||
33654201|NCT01712516|63066901|FG000|Overall Study|Technical problems|0|||
33654202|NCT01712516|63066902|FG001|Overall Study|Technical problems|0|||
33336309|NCT03370341|62712908|FG000|Overall Study|Lost to Follow-up|0|||
33336310|NCT03370341|62712909|FG001|Overall Study|Lost to Follow-up|1|||
33654203|NCT01712516|63066903|FG002|Overall Study|Technical problems|0|||
33654204|NCT01712516|63066904|FG003|Overall Study|Technical problems|2|||
33654205|NCT01712516|63066901|FG000|Overall Study|Lost to Follow-up|0|||
33654206|NCT01712516|63066902|FG001|Overall Study|Lost to Follow-up|0|||
33654207|NCT01712516|63066903|FG002|Overall Study|Lost to Follow-up|2|||
33654208|NCT01712516|63066904|FG003|Overall Study|Lost to Follow-up|1|||
33654209|NCT01712516|63066901|FG000|Overall Study|Death|0|||
33654210|NCT01712516|63066902|FG001|Overall Study|Death|1|||
33654211|NCT01712516|63066903|FG002|Overall Study|Death|0|||
33654212|NCT01712516|63066904|FG003|Overall Study|Death|0|||
33654213|NCT01712516|63066901|FG000|Overall Study|Protocol deviation|1|||
33654214|NCT01712516|63066902|FG001|Overall Study|Protocol deviation|0|||
33654215|NCT01712516|63066903|FG002|Overall Study|Protocol deviation|1|||
33654216|NCT01712516|63066904|FG003|Overall Study|Protocol deviation|0|||
33654217|NCT01712516|63066901|FG000|Overall Study|Physician Decision|2|||
33654218|NCT01712516|63066902|FG001|Overall Study|Physician Decision|0|||
33654219|NCT01712516|63066903|FG002|Overall Study|Physician Decision|0|||
33336331|NCT02544074|62712993|FG000|Overall Study|Withdrawal by Subject|0|||
33469068|NCT00289913|62842884|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
33469069|NCT00289913|62842885|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33469070|NCT00289913|62842886|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
33469071|NCT00289913|62842887|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33469072|NCT00289913|62842888|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33469073|NCT00289913|62842884|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
33469074|NCT00289913|62842885|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
33469075|NCT00289913|62842886|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
33469076|NCT00289913|62842887|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
33469077|NCT00289913|62842888|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
33469078|NCT00289913|62842884|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
33469079|NCT00289913|62842885|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
33469080|NCT00289913|62842886|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
33469081|NCT00289913|62842887|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
33469082|NCT00289913|62842888|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
33469083|NCT00289913|62842884|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
33469084|NCT00289913|62842885|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
33469085|NCT00289913|62842886|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
33469086|NCT00289913|62842887|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
33469087|NCT00289913|62842888|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
33469088|NCT00289913|62842884|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
33469089|NCT00289913|62842885|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
33469090|NCT00289913|62842886|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
33469091|NCT00289913|62842887|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
33469092|NCT00289913|62842888|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
33469093|NCT00289913|62842884|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
33469094|NCT00289913|62842885|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
33469095|NCT00289913|62842886|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
33469096|NCT00289913|62842887|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
33469097|NCT00289913|62842888|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
33469098|NCT00289913|62842884|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
33469099|NCT00289913|62842885|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
33469100|NCT00289913|62842886|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
33469101|NCT00289913|62842887|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
33469102|NCT00289913|62842888|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
33469103|NCT00289913|62842884|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
33469104|NCT00289913|62842885|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
33469105|NCT00289913|62842886|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
33469106|NCT00289913|62842887|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
33469107|NCT00289913|62842888|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
33469108|NCT00289913|62842884|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
33469109|NCT00289913|62842885|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
33469110|NCT00289913|62842886|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
33469111|NCT00289913|62842887|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
33654220|NCT01712516|63066904|FG003|Overall Study|Physician Decision|1|||
33654221|NCT01712516|63066901|FG000|Overall Study|Withdrawal by Subject|3|||
33336332|NCT02544074|62712994|FG001|Overall Study|Withdrawal by Subject|1|||
33336333|NCT02544074|62712995|FG002|Overall Study|Withdrawal by Subject|0|||
33336334|NCT02544074|62712996|FG003|Overall Study|Withdrawal by Subject|0|||
33336335|NCT02544074|62712997|FG004|Overall Study|Withdrawal by Subject|0|||
33336336|NCT02544074|62712998|FG005|Overall Study|Withdrawal by Subject|0|||
33336337|NCT02544074|62712999|FG006|Overall Study|Withdrawal by Subject|0|||
33336338|NCT02544074|62713000|FG007|Overall Study|Withdrawal by Subject|0|||
33336339|NCT02544074|62713001|FG008|Overall Study|Withdrawal by Subject|0|||
33336340|NCT02544074|62713002|FG009|Overall Study|Withdrawal by Subject|0|||
33336341|NCT02544074|62713003|FG010|Overall Study|Withdrawal by Subject|0|||
33336342|NCT02544074|62713004|FG011|Overall Study|Withdrawal by Subject|0|||
33336343|NCT02544074|62713005|FG012|Overall Study|Withdrawal by Subject|0|||
33336344|NCT02544074|62713006|FG013|Overall Study|Withdrawal by Subject|0|||
33336345|NCT02544074|62713007|FG014|Overall Study|Withdrawal by Subject|0|||
33336346|NCT02544074|62713008|FG015|Overall Study|Withdrawal by Subject|0|||
33336347|NCT02544074|62713009|FG016|Overall Study|Withdrawal by Subject|0|||
33336348|NCT02544074|62713010|FG017|Overall Study|Withdrawal by Subject|0|||
33336349|NCT02544074|62713011|FG018|Overall Study|Withdrawal by Subject|0|||
33336350|NCT02544074|62713012|FG019|Overall Study|Withdrawal by Subject|0|||
33336351|NCT02544074|62713013|FG020|Overall Study|Withdrawal by Subject|0|||
33336352|NCT02544074|62712993|FG000|Overall Study|Tablet error|0|||
33336353|NCT02544074|62712994|FG001|Overall Study|Tablet error|0|||
33336354|NCT02544074|62712995|FG002|Overall Study|Tablet error|0|||
33336355|NCT02544074|62712996|FG003|Overall Study|Tablet error|0|||
33336356|NCT02544074|62712997|FG004|Overall Study|Tablet error|0|||
33336357|NCT02544074|62712998|FG005|Overall Study|Tablet error|1|||
33336358|NCT02544074|62712999|FG006|Overall Study|Tablet error|0|||
33336359|NCT02544074|62713000|FG007|Overall Study|Tablet error|0|||
33336360|NCT02544074|62713001|FG008|Overall Study|Tablet error|0|||
33336361|NCT02544074|62713002|FG009|Overall Study|Tablet error|1|||
33336362|NCT02544074|62713003|FG010|Overall Study|Tablet error|0|||
33336363|NCT02544074|62713004|FG011|Overall Study|Tablet error|0|||
33336364|NCT02544074|62713005|FG012|Overall Study|Tablet error|0|||
33336365|NCT02544074|62713006|FG013|Overall Study|Tablet error|0|||
33336366|NCT02544074|62713007|FG014|Overall Study|Tablet error|0|||
33336367|NCT02544074|62713008|FG015|Overall Study|Tablet error|0|||
33336368|NCT02544074|62713009|FG016|Overall Study|Tablet error|0|||
33336369|NCT02544074|62713010|FG017|Overall Study|Tablet error|0|||
33336370|NCT02544074|62713011|FG018|Overall Study|Tablet error|0|||
33336371|NCT02544074|62713012|FG019|Overall Study|Tablet error|0|||
33336372|NCT02544074|62713013|FG020|Overall Study|Tablet error|0|||
33336373|NCT02502799|62713051|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
33336374|NCT02502799|62713052|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
33336375|NCT02502799|62713053|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
33336376|NCT02502799|62713054|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
33336377|NCT02502799|62713051|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
33336378|NCT02502799|62713052|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
33336379|NCT02502799|62713053|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
33336380|NCT02502799|62713054|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
33336381|NCT02502799|62713051|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
33336382|NCT02502799|62713052|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
33336383|NCT02502799|62713053|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
33336384|NCT02502799|62713054|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
33336385|NCT02502799|62713051|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
33336386|NCT02502799|62713052|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
33336387|NCT02502799|62713053|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
33336388|NCT02502799|62713054|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
33336389|NCT02502799|62713051|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
33336390|NCT02502799|62713052|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
33336391|NCT02502799|62713053|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
33336392|NCT02502799|62713054|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
33336393|NCT02086448|62713067|FG000|Overall Study|Withdrawal by Subject|1|||
33336394|NCT02086448|62713068|FG001|Overall Study|Withdrawal by Subject|0|||
33336395|NCT02086448|62713069|FG002|Overall Study|Withdrawal by Subject|0|||
33336396|NCT02086448|62713070|FG003|Overall Study|Withdrawal by Subject|2|||
33654222|NCT01712516|63066902|FG001|Overall Study|Withdrawal by Subject|9|||
33654223|NCT01712516|63066903|FG002|Overall Study|Withdrawal by Subject|3|||
33654224|NCT01712516|63066904|FG003|Overall Study|Withdrawal by Subject|9|||
33654225|NCT01703000|63066914|FG000|Overall Study|Death|1|||
33336397|NCT01993836|62713083|FG000|Overall Study|Surgery Cancelled|3|||
33336398|NCT01993836|62713084|FG001|Overall Study|Surgery Cancelled|0|||
33336399|NCT01993836|62713085|FG002|Overall Study|Surgery Cancelled|0|||
33336400|NCT01993836|62713083|FG000|Overall Study|Physician Decision|2|||
33336401|NCT01993836|62713084|FG001|Overall Study|Physician Decision|1|||
33336402|NCT01993836|62713085|FG002|Overall Study|Physician Decision|0|||
33336403|NCT01993836|62713083|FG000|Overall Study|Death|0|||
33336404|NCT01993836|62713084|FG001|Overall Study|Death|2|||
33654226|NCT01040728|63066918|FG000|Overall Study|Adverse Event|4|||
33336405|NCT01993836|62713085|FG002|Overall Study|Death|0|||
33336406|NCT01993836|62713083|FG000|Overall Study|Withdrawal by Subject|12|||
33336407|NCT01993836|62713084|FG001|Overall Study|Withdrawal by Subject|10|||
33336408|NCT01993836|62713085|FG002|Overall Study|Withdrawal by Subject|5|||
33336409|NCT00753545|62713100|FG000|Overall Study|Death|98|||
33336410|NCT00753545|62713101|FG001|Overall Study|Death|112|||
33336411|NCT00753545|62713100|FG000|Overall Study|Lost to Follow-up|2|||
33336412|NCT00753545|62713101|FG001|Overall Study|Lost to Follow-up|3|||
33336413|NCT00753545|62713100|FG000|Overall Study|Protocol Violation|1|||
33336414|NCT00753545|62713101|FG001|Overall Study|Protocol Violation|0|||
33336415|NCT00753545|62713100|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
33336416|NCT00753545|62713101|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
33336417|NCT00278915|62713116|FG000|Overall Study|Lack of Efficacy|1|||
33336418|NCT00970632|62713123|FG000|Overall Study|Adverse Event|2|||
33336419|NCT00970632|62713124|FG001|Overall Study|Adverse Event|2|||
33336420|NCT00970632|62713125|FG002|Overall Study|Adverse Event|1|||
33336421|NCT00970632|62713123|FG000|Overall Study|Lack of Efficacy|3|||
33336422|NCT00970632|62713124|FG001|Overall Study|Lack of Efficacy|0|||
33336423|NCT00970632|62713125|FG002|Overall Study|Lack of Efficacy|0|||
33336424|NCT00970632|62713123|FG000|Overall Study|Lost to Follow-up|3|||
33336425|NCT00970632|62713124|FG001|Overall Study|Lost to Follow-up|0|||
33336426|NCT00970632|62713125|FG002|Overall Study|Lost to Follow-up|2|||
33336427|NCT00970632|62713123|FG000|Overall Study|Protocol Violation|8|||
33336428|NCT00970632|62713124|FG001|Overall Study|Protocol Violation|5|||
33336429|NCT00970632|62713125|FG002|Overall Study|Protocol Violation|8|||
33336430|NCT00970632|62713123|FG000|Overall Study|Withdrawal by Subject|7|||
33336431|NCT00970632|62713124|FG001|Overall Study|Withdrawal by Subject|6|||
33336432|NCT00970632|62713125|FG002|Overall Study|Withdrawal by Subject|4|||
33336433|NCT00970632|62713123|FG000|Overall Study|Entry criteria not met|0|||
33336434|NCT00970632|62713124|FG001|Overall Study|Entry criteria not met|2|||
33336435|NCT00970632|62713125|FG002|Overall Study|Entry criteria not met|2|||
33336436|NCT00970632|62713123|FG000|Overall Study|Sponsor decision|1|||
33336437|NCT00970632|62713124|FG001|Overall Study|Sponsor decision|0|||
33336438|NCT00970632|62713125|FG002|Overall Study|Sponsor decision|1|||
33336439|NCT01144364|62713135|FG000|Induction Phase|Disease progression|14|||
33336440|NCT01144364|62713136|FG001|Induction Phase|Disease progression|0|||
33336441|NCT01144364|62713137|FG002|Induction Phase|Disease progression|0|||
33336442|NCT01144364|62713135|FG000|Induction Phase|Adverse Event|9|||
33336443|NCT01144364|62713136|FG001|Induction Phase|Adverse Event|0|||
33336444|NCT01144364|62713137|FG002|Induction Phase|Adverse Event|0|||
33336445|NCT01144364|62713135|FG000|Induction Phase|Death|1|||
33336446|NCT01144364|62713136|FG001|Induction Phase|Death|0|||
33336447|NCT01144364|62713137|FG002|Induction Phase|Death|0|||
33336448|NCT01144364|62713135|FG000|Induction Phase|Withdrawal by Subject|1|||
33336449|NCT01144364|62713136|FG001|Induction Phase|Withdrawal by Subject|0|||
33336450|NCT01144364|62713137|FG002|Induction Phase|Withdrawal by Subject|0|||
33336451|NCT01144364|62713135|FG000|Induction Phase|Lost to Follow-up|2|||
33336452|NCT01144364|62713136|FG001|Induction Phase|Lost to Follow-up|0|||
33336453|NCT01144364|62713137|FG002|Induction Phase|Lost to Follow-up|0|||
33336454|NCT01144364|62713135|FG000|Induction Phase|Physician Decision|1|||
33336455|NCT01144364|62713136|FG001|Induction Phase|Physician Decision|0|||
33336456|NCT01144364|62713137|FG002|Induction Phase|Physician Decision|0|||
33336457|NCT01144364|62713135|FG000|Induction Phase|Stable disease|2|||
33336458|NCT01144364|62713136|FG001|Induction Phase|Stable disease|0|||
33336459|NCT01144364|62713137|FG002|Induction Phase|Stable disease|0|||
33336460|NCT01144364|62713135|FG000|Induction Phase|Secondary neoplasia|1|||
33336461|NCT01144364|62713136|FG001|Induction Phase|Secondary neoplasia|0|||
33336462|NCT01144364|62713137|FG002|Induction Phase|Secondary neoplasia|0|||
33336463|NCT01144364|62713135|FG000|Induction Phase|Protocol Violation|1|||
33336464|NCT01144364|62713136|FG001|Induction Phase|Protocol Violation|0|||
33336465|NCT01144364|62713137|FG002|Induction Phase|Protocol Violation|0|||
33336466|NCT01144364|62713135|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
33336467|NCT01144364|62713136|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
33654227|NCT01040728|63066919|FG001|Overall Study|Adverse Event|8|||
33336468|NCT01144364|62713137|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
33336469|NCT01144364|62713135|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
33336470|NCT01144364|62713136|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
33336471|NCT01144364|62713137|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
33336472|NCT01144364|62713135|FG000|Follow-Up/Maintenance Phase|Death|0|||
33336473|NCT01144364|62713136|FG001|Follow-Up/Maintenance Phase|Death|2|||
33336474|NCT01144364|62713137|FG002|Follow-Up/Maintenance Phase|Death|0|||
33336475|NCT01144364|62713135|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
33336476|NCT01144364|62713136|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
33336477|NCT01144364|62713137|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
33336478|NCT01144364|62713135|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
33336479|NCT01144364|62713136|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
33336480|NCT01144364|62713137|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
33336481|NCT01144364|62713135|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
33336482|NCT01144364|62713136|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
33336483|NCT01144364|62713137|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
33336484|NCT01144364|62713135|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
33336485|NCT01144364|62713136|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
33336486|NCT01144364|62713137|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
33336487|NCT01119248|62713147|FG000|Overall Study|Physician Decision|5|||
33336488|NCT01131494|62713152|FG000|Overall Study|Withdrawal by Subject|2|||
33336489|NCT01131260|62713159|FG000|Overall Study|Randomization error|5|||
33336490|NCT01131260|62713160|FG001|Overall Study|Randomization error|1|||
33336491|NCT01131260|62713159|FG000|Overall Study|Declined to continue participation|8|||
33336492|NCT01131260|62713160|FG001|Overall Study|Declined to continue participation|13|||
33336493|NCT01131260|62713159|FG000|Overall Study|Physician Decision|22|||
33336494|NCT01131260|62713160|FG001|Overall Study|Physician Decision|24|||
33336495|NCT01131260|62713159|FG000|Overall Study|Technical problems|7|||
33336496|NCT01131260|62713160|FG001|Overall Study|Technical problems|6|||
33336497|NCT01131260|62713159|FG000|Overall Study|Staff error|2|||
33336498|NCT01131260|62713160|FG001|Overall Study|Staff error|1|||
33336499|NCT01131260|62713159|FG000|Overall Study|Ineligible|0|||
33336500|NCT01131260|62713160|FG001|Overall Study|Ineligible|2|||
33336501|NCT00965094|62713170|FG000|Overall Study|Adverse Event|5|||
33336502|NCT00965094|62713171|FG001|Overall Study|Adverse Event|0|||
33336503|NCT00965094|62713170|FG000|Overall Study|Lost to Follow-up|0|||
33336504|NCT00965094|62713171|FG001|Overall Study|Lost to Follow-up|1|||
33336505|NCT01131182|62713180|FG000|Overall Study|Withdrawal by Subject|1|||
33336506|NCT01131182|62713181|FG001|Overall Study|Withdrawal by Subject|1|||
33336507|NCT01131182|62713180|FG000|Overall Study|Lost to Follow-up|14|||
33336508|NCT01131182|62713181|FG001|Overall Study|Lost to Follow-up|15|||
33336509|NCT01131182|62713180|FG000|Overall Study|Other Reason|1|||
33336510|NCT01131182|62713181|FG001|Overall Study|Other Reason|0|||
33336511|NCT00964860|62713189|FG000|Overall Study|Withdrawal by Subject|0|||
33336512|NCT00964860|62713190|FG001|Overall Study|Withdrawal by Subject|1|||
33336513|NCT01131104|62713196|FG000|Overall Study|Withdrawal by Subject|3|||
33336514|NCT01131104|62713196|FG000|Overall Study|Physician Decision|4|||
33336515|NCT01131104|62713196|FG000|Overall Study|Information Not Available|5|||
33336516|NCT01131104|62713196|FG000|Overall Study|No Information on Index Date of Onset|1|||
33336517|NCT01118780|62713202|FG000|Overall Study|Adverse Event|15|||
33336518|NCT01118780|62713203|FG001|Overall Study|Adverse Event|15|||
33336519|NCT01118780|62713202|FG000|Overall Study|Death|1|||
33336520|NCT01118780|62713203|FG001|Overall Study|Death|0|||
33336521|NCT01118780|62713202|FG000|Overall Study|Lack of Efficacy|2|||
33336522|NCT01118780|62713203|FG001|Overall Study|Lack of Efficacy|6|||
33336523|NCT01118780|62713202|FG000|Overall Study|Physician Decision|2|||
33336524|NCT01118780|62713203|FG001|Overall Study|Physician Decision|0|||
33336525|NCT01118780|62713202|FG000|Overall Study|Protocol Violation|3|||
33336526|NCT01118780|62713203|FG001|Overall Study|Protocol Violation|6|||
33336527|NCT01118780|62713202|FG000|Overall Study|Withdrawal by Subject|13|||
33336528|NCT01118780|62713203|FG001|Overall Study|Withdrawal by Subject|8|||
33336529|NCT00964782|62713214|FG000|Overall Study|Lost to Follow-up|1|||
33336530|NCT00964782|62713215|FG001|Overall Study|Lost to Follow-up|0|||
33336531|NCT00966654|62713223|FG000|Overall Study|Study was terminated,PI left institution|12|||
33336532|NCT03262116|62713235|FG000|Overall Study|Physician Decision|0|||
33469112|NCT00289913|62842888|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
33469113|NCT00289913|62842884|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
33336533|NCT03262116|62713236|FG001|Overall Study|Physician Decision|2|||
33336534|NCT03262116|62713237|FG002|Overall Study|Physician Decision|1|||
33336535|NCT03262116|62713238|FG003|Overall Study|Physician Decision|1|||
33336536|NCT03262116|62713239|FG004|Overall Study|Physician Decision|1|||
33336537|NCT03262116|62713240|FG005|Overall Study|Physician Decision|2|||
33336538|NCT01130168|62713248|FG000|Period 1|Withdrawal by Subject|0|||
33336539|NCT01130168|62713249|FG001|Period 1|Withdrawal by Subject|1|||
33336540|NCT01130168|62713250|FG002|Period 1|Withdrawal by Subject|0|||
33336541|NCT01130168|62713251|FG003|Period 1|Withdrawal by Subject|1|||
33336542|NCT01130168|62713252|FG004|Period 1|Withdrawal by Subject|0|||
33336543|NCT01130168|62713253|FG005|Period 1|Withdrawal by Subject|0|||
33336544|NCT01130168|62713248|FG000|Period 1|Discontinued For Other Reason|0|||
33336545|NCT01130168|62713249|FG001|Period 1|Discontinued For Other Reason|0|||
33336546|NCT01130168|62713250|FG002|Period 1|Discontinued For Other Reason|1|||
33336547|NCT01130168|62713251|FG003|Period 1|Discontinued For Other Reason|1|||
33336548|NCT01130168|62713252|FG004|Period 1|Discontinued For Other Reason|0|||
33336549|NCT01130168|62713253|FG005|Period 1|Discontinued For Other Reason|0|||
33336550|NCT01130168|62713248|FG000|Period 1|Adverse Event|0|||
33336551|NCT01130168|62713249|FG001|Period 1|Adverse Event|0|||
33336552|NCT01130168|62713250|FG002|Period 1|Adverse Event|0|||
33336553|NCT01130168|62713251|FG003|Period 1|Adverse Event|1|||
33336554|NCT01130168|62713252|FG004|Period 1|Adverse Event|0|||
33336555|NCT01130168|62713253|FG005|Period 1|Adverse Event|0|||
33336556|NCT01144052|62713264|FG000|Overall Study|Withdrawal by Subject|1|||
33336557|NCT01144052|62713265|FG001|Overall Study|Withdrawal by Subject|1|||
33336558|NCT01143896|62713275|FG000|Overall Study|Did not complete Baseline Interview|5|||
33336559|NCT01143896|62713276|FG001|Overall Study|Did not complete Baseline Interview|4|||
33336560|NCT01143896|62713275|FG000|Overall Study|Lost to Follow-up|18|||
33336561|NCT01143896|62713276|FG001|Overall Study|Lost to Follow-up|13|||
33336562|NCT01143896|62713275|FG000|Overall Study|Withdrawal by Subject|13|||
33336563|NCT01143896|62713276|FG001|Overall Study|Withdrawal by Subject|5|||
33336564|NCT01143896|62713275|FG000|Overall Study|Death|6|||
33336565|NCT01143896|62713276|FG001|Overall Study|Death|3|||
33336566|NCT01118312|62713285|FG000|Overall Study|Lost to Follow-up|33|||
33336567|NCT01118312|62713286|FG001|Overall Study|Lost to Follow-up|32|||
33336568|NCT01118312|62713285|FG000|Overall Study|Withdrawal by Subject|1|||
33336569|NCT01118312|62713286|FG001|Overall Study|Withdrawal by Subject|3|||
33336570|NCT01117766|62713292|FG000|First Intervention|Adverse Event|0|||
33336571|NCT01117766|62713293|FG001|First Intervention|Adverse Event|1|||
33336572|NCT01117766|62713292|FG000|First Intervention|Protocol Violation|1|||
33336573|NCT01117766|62713293|FG001|First Intervention|Protocol Violation|0|||
33336574|NCT01117766|62713292|FG000|Washout Period|Protocol Violation|0|||
33336575|NCT01117766|62713293|FG001|Washout Period|Protocol Violation|2|||
33336576|NCT01117766|62713292|FG000|Second Intervention|Lost to Follow-up|1|||
33336577|NCT01117766|62713293|FG001|Second Intervention|Lost to Follow-up|0|||
33336578|NCT01117766|62713292|FG000|Second Intervention|Other|1|||
33336579|NCT01117766|62713293|FG001|Second Intervention|Other|2|||
33336580|NCT01117766|62713292|FG000|Second Intervention|Adverse Event|0|||
33336581|NCT01117766|62713293|FG001|Second Intervention|Adverse Event|2|||
33336582|NCT01117766|62713292|FG000|Second Intervention|Withdrawal by Subject|0|||
33336583|NCT01117766|62713293|FG001|Second Intervention|Withdrawal by Subject|1|||
33336584|NCT01117454|62713301|FG000|Overall Study|Pregnancy|0|||
33336585|NCT01117454|62713302|FG001|Overall Study|Pregnancy|1|||
33336586|NCT01116440|62713310|FG000|Treatment|Withdrawal by Subject|2|||
33336587|NCT01116440|62713311|FG001|Treatment|Withdrawal by Subject|2|||
33336588|NCT01116440|62713310|FG000|Treatment|Lost to Follow-up|1|||
33336589|NCT01116440|62713311|FG001|Treatment|Lost to Follow-up|1|||
33336590|NCT01116440|62713310|FG000|Treatment|Protocol Violation|0|||
33336591|NCT01116440|62713311|FG001|Treatment|Protocol Violation|2|||
33336592|NCT01116440|62713310|FG000|Treatment|Lack of Efficacy|0|||
33336593|NCT01116440|62713311|FG001|Treatment|Lack of Efficacy|1|||
33336594|NCT01116440|62713310|FG000|Treatment|Adverse Event|0|||
33336595|NCT01116440|62713311|FG001|Treatment|Adverse Event|1|||
33336596|NCT01116440|62713310|FG000|Withdrawal|Withdrawal by Subject|0|||
33336597|NCT01116440|62713311|FG001|Withdrawal|Withdrawal by Subject|1|||
33336598|NCT01116440|62713310|FG000|Withdrawal|Lost to Follow-up|0|||
33336599|NCT01116440|62713311|FG001|Withdrawal|Lost to Follow-up|1|||
33336600|NCT01116440|62713310|FG000|Follow-up|Lost to Follow-up|0|||
33336601|NCT01116440|62713311|FG001|Follow-up|Lost to Follow-up|1|||
33336602|NCT01116440|62713310|FG000|Follow-up|Withdrawal by Subject|0|||
33336603|NCT01116440|62713311|FG001|Follow-up|Withdrawal by Subject|1|||
33336604|NCT01129622|62713319|FG000|Overall Study|Withdrawal by Subject|2|||
33336605|NCT01128842|62713324|FG000|Overall Study|Adverse Event|1|||
33336606|NCT01128842|62713324|FG000|Overall Study|Disease Progression|6|||
33336607|NCT03624036|62713333|FG000|Overall Study|Still on Study|5|||
33336608|NCT03624036|62713334|FG001|Overall Study|Still on Study|1|||
33548740|NCT02489500|62940033|FG001|Overall Study|Death|1|||
33336609|NCT03624036|62713335|FG002|Overall Study|Still on Study|3|||
33548741|NCT02732847|62940041|FG000|Overall Study|some filled early|42|||
33654228|NCT01040728|63066920|FG002|Overall Study|Adverse Event|0|||
33336610|NCT03624036|62713336|FG003|Overall Study|Still on Study|3|||
33336611|NCT03624036|62713333|FG000|Overall Study|Death|1|||
33336612|NCT03624036|62713334|FG001|Overall Study|Death|2|||
33336613|NCT03624036|62713335|FG002|Overall Study|Death|0|||
33336614|NCT03624036|62713336|FG003|Overall Study|Death|0|||
33336615|NCT03624036|62713333|FG000|Overall Study|Enrolled but Never Treated|1|||
33336616|NCT03624036|62713334|FG001|Overall Study|Enrolled but Never Treated|0|||
33336617|NCT03624036|62713335|FG002|Overall Study|Enrolled but Never Treated|0|||
33336618|NCT03624036|62713336|FG003|Overall Study|Enrolled but Never Treated|0|||
33336619|NCT01143038|62713346|FG000|Overall Study|Withdrawal by Subject|4|||
33336620|NCT01143038|62713346|FG000|Overall Study|Requirement for alternative therapy|5|||
33336621|NCT01143038|62713346|FG000|Overall Study|Adverse Event|3|||
33548742|NCT02732847|62940042|FG001|Overall Study|some filled early|42|||
33336622|NCT01143038|62713346|FG000|Overall Study|Lost to Follow-up|2|||
33336623|NCT01143038|62713346|FG000|Overall Study|Protocol Deviation|1|||
33336624|NCT01143038|62713346|FG000|Overall Study|Death|1|||
33336625|NCT00966264|62713352|FG000|Overall Study|Lost to Follow-up|4|||
33336626|NCT00966264|62713353|FG001|Overall Study|Lost to Follow-up|3|||
33336627|NCT00915525|62713361|FG000|Overall Study|Protocol Violation|9|||
33336628|NCT00915525|62713362|FG001|Overall Study|Protocol Violation|4|||
33336629|NCT00915525|62713361|FG000|Overall Study|Withdrawal by Subject|59|||
33336630|NCT00915525|62713362|FG001|Overall Study|Withdrawal by Subject|21|||
33336631|NCT00915525|62713361|FG000|Overall Study|Lost to Follow-up|27|||
33336632|NCT00915525|62713362|FG001|Overall Study|Lost to Follow-up|16|||
33336633|NCT00915525|62713361|FG000|Overall Study|Pregnancy|2|||
33336634|NCT00915525|62713362|FG001|Overall Study|Pregnancy|0|||
33336635|NCT00915525|62713361|FG000|Overall Study|Lack of Efficacy|15|||
33336636|NCT00915525|62713362|FG001|Overall Study|Lack of Efficacy|32|||
33336637|NCT00915525|62713361|FG000|Overall Study|Adverse Event|29|||
33336638|NCT00915525|62713362|FG001|Overall Study|Adverse Event|13|||
33336639|NCT00915525|62713361|FG000|Overall Study|Missing|12|||
33336640|NCT00915525|62713362|FG001|Overall Study|Missing|1|||
33336641|NCT00915525|62713361|FG000|Overall Study|Other Reason|35|||
33336642|NCT00915525|62713362|FG001|Overall Study|Other Reason|12|||
33336643|NCT00915525|62713361|FG000|Overall Study|Site Closed|27|||
33336644|NCT00915525|62713362|FG001|Overall Study|Site Closed|9|||
33336645|NCT00915525|62713361|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
33336646|NCT00915525|62713362|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
33336647|NCT00915525|62713361|FG000|Overall Study|Study Burden|28|||
33336648|NCT00915525|62713362|FG001|Overall Study|Study Burden|12|||
33336649|NCT00915525|62713361|FG000|Overall Study|Non-Compliance|3|||
33336650|NCT00915525|62713362|FG001|Overall Study|Non-Compliance|1|||
33336651|NCT00915525|62713361|FG000|Overall Study|Patient Moved|15|||
33336652|NCT00915525|62713362|FG001|Overall Study|Patient Moved|9|||
33336653|NCT01074047|62713390|FG000|Treatment Phase|Adverse Event|89|||
33336654|NCT01074047|62713391|FG001|Treatment Phase|Adverse Event|66|||
33336655|NCT01074047|62713390|FG000|Treatment Phase|Disease Progression|16|||
33336656|NCT01074047|62713391|FG001|Treatment Phase|Disease Progression|21|||
33336657|NCT01074047|62713390|FG000|Treatment Phase|Withdrawal by Subject|27|||
33336658|NCT01074047|62713391|FG001|Treatment Phase|Withdrawal by Subject|48|||
33336659|NCT01074047|62713390|FG000|Treatment Phase|Death|53|||
33336660|NCT01074047|62713391|FG001|Treatment Phase|Death|58|||
33336661|NCT01074047|62713390|FG000|Treatment Phase|Lost to Follow-up|0|||
33336662|NCT01074047|62713391|FG001|Treatment Phase|Lost to Follow-up|1|||
33336663|NCT01074047|62713390|FG000|Treatment Phase|Protocol Violation|0|||
33336664|NCT01074047|62713391|FG001|Treatment Phase|Protocol Violation|1|||
33336665|NCT01074047|62713390|FG000|Treatment Phase|Miscellaneous|32|||
33336666|NCT01074047|62713391|FG001|Treatment Phase|Miscellaneous|39|||
33336667|NCT01074047|62713390|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
33336668|NCT01074047|62713391|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
33336669|NCT01074047|62713390|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
33336670|NCT01074047|62713391|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
33336671|NCT01074047|62713390|FG000|Survival Follow-Up Phase|Death|116|||
33336672|NCT01074047|62713391|FG001|Survival Follow-Up Phase|Death|124|||
33336673|NCT01074047|62713390|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
33336674|NCT01074047|62713391|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
33336675|NCT01074047|62713390|FG000|Extension Phase|Physician Decision|1|||
33336676|NCT01074047|62713391|FG001|Extension Phase|Physician Decision|0|||
33548743|NCT02489344|62940048|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
33548744|NCT02489344|62940048|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
33548745|NCT02489344|62940048|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
33548746|NCT02489344|62940048|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
33548747|NCT02488330|62940052|FG000|Overall Study|Adverse Event|1|||
33548748|NCT02488330|62940052|FG000|Overall Study|Physician Decision|2|||
33548749|NCT02488330|62940052|FG000|Overall Study|Death|2|||
33336677|NCT01074047|62713390|FG000|Extension Phase|Adverse Event|5|||
33336678|NCT01074047|62713391|FG001|Extension Phase|Adverse Event|0|||
33336679|NCT01074047|62713390|FG000|Extension Phase|Disease Progression|9|||
33336680|NCT01074047|62713391|FG001|Extension Phase|Disease Progression|0|||
33336681|NCT01074047|62713390|FG000|Extension Phase|Withdrawal by Subject|2|||
33336682|NCT01074047|62713391|FG001|Extension Phase|Withdrawal by Subject|0|||
33336683|NCT01074047|62713390|FG000|Extension Phase|Death|5|||
33336684|NCT01074047|62713391|FG001|Extension Phase|Death|0|||
33336685|NCT01142726|62713407|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
33336686|NCT01142726|62713408|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
33336687|NCT01142726|62713409|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
33336688|NCT01142726|62713407|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
33336689|NCT01142726|62713408|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
33336690|NCT01142726|62713409|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
33336691|NCT01142726|62713407|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
33336692|NCT01142726|62713408|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
33336693|NCT01142726|62713409|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
33336694|NCT01142726|62713407|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
33336695|NCT01142726|62713408|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
33336696|NCT01142726|62713409|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
33336697|NCT01142726|62713407|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
33336698|NCT01142726|62713408|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
33336699|NCT01142726|62713409|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
33336700|NCT01142726|62713407|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
33336701|NCT01142726|62713408|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
33336702|NCT01142726|62713409|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
33336703|NCT01142726|62713407|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
33336704|NCT01142726|62713408|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
33336705|NCT01142726|62713409|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
33336706|NCT01142726|62713407|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
33336707|NCT01142726|62713408|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
33336708|NCT01142726|62713409|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
33336709|NCT01142726|62713407|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
33336710|NCT01142726|62713408|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
33336711|NCT01142726|62713409|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
33336712|NCT01142726|62713407|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
33336713|NCT01142726|62713408|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
33336714|NCT01142726|62713409|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
33336715|NCT01142726|62713407|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
33336716|NCT01142726|62713408|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
33336717|NCT01142726|62713409|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
33336718|NCT01142726|62713407|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
33336719|NCT01142726|62713408|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
33336720|NCT01142726|62713409|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
33336721|NCT01142726|62713407|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
33336722|NCT01142726|62713408|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
33469114|NCT00289913|62842885|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
33469115|NCT00289913|62842886|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
33654229|NCT01040728|63066921|FG003|Overall Study|Adverse Event|4|||
33654230|NCT01040728|63066918|FG000|Overall Study|Withdrawal by Subject|0|||
33654231|NCT01040728|63066919|FG001|Overall Study|Withdrawal by Subject|1|||
33654232|NCT01040728|63066920|FG002|Overall Study|Withdrawal by Subject|1|||
33654233|NCT01040728|63066921|FG003|Overall Study|Withdrawal by Subject|0|||
33654234|NCT01040728|63066918|FG000|Overall Study|Protocol Violation|0|||
33654235|NCT01040728|63066919|FG001|Overall Study|Protocol Violation|0|||
33654236|NCT01040728|63066920|FG002|Overall Study|Protocol Violation|0|||
33654237|NCT01040728|63066921|FG003|Overall Study|Protocol Violation|1|||
33654238|NCT01040728|63066918|FG000|Overall Study|Lack of Efficacy|0|||
33654239|NCT01040728|63066919|FG001|Overall Study|Lack of Efficacy|1|||
33654240|NCT01040728|63066920|FG002|Overall Study|Lack of Efficacy|0|||
33654241|NCT01040728|63066921|FG003|Overall Study|Lack of Efficacy|1|||
33654242|NCT01040728|63066918|FG000|Overall Study|Other reasons not listed above|0|||
33654243|NCT01040728|63066919|FG001|Overall Study|Other reasons not listed above|1|||
33654244|NCT01040728|63066920|FG002|Overall Study|Other reasons not listed above|0|||
33654245|NCT01040728|63066921|FG003|Overall Study|Other reasons not listed above|0|||
33654246|NCT01593020|63066939|FG000|Overall Study|Adverse Event|1|||
33654247|NCT01593020|63066940|FG001|Overall Study|Adverse Event|1|||
33654248|NCT01593020|63066939|FG000|Overall Study|Death|0|||
33654249|NCT01593020|63066940|FG001|Overall Study|Death|1|||
33654250|NCT01593020|63066939|FG000|Overall Study|Ineligible|1|||
33654251|NCT01593020|63066940|FG001|Overall Study|Ineligible|0|||
33654252|NCT01040260|63066948|FG000|Overall Study|Withdrawal by Subject|12|||
33654253|NCT01040260|63066949|FG001|Overall Study|Withdrawal by Subject|6|||
33654254|NCT01040260|63066948|FG000|Overall Study|Lost to Follow-up|3|||
33654255|NCT01040260|63066949|FG001|Overall Study|Lost to Follow-up|5|||
33336723|NCT01142726|62713409|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
33336724|NCT01142726|62713407|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
33336725|NCT01142726|62713408|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
33336726|NCT01142726|62713409|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
33336727|NCT01142726|62713407|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
33336728|NCT01142726|62713408|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
33336729|NCT01142726|62713409|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
33336730|NCT01142726|62713407|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
33336731|NCT01142726|62713408|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
33336732|NCT01142726|62713409|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
33336733|NCT01073267|62713425|FG000|Overall Study|Disease Progression|3|||
33654256|NCT01712438|63066955|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
33654257|NCT01712438|63066955|FG000|Overall Study|Ongoing ITI treatment|6|||
33654258|NCT01712438|63066955|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
33654259|NCT01712438|63066955|FG000|Overall Study|Prematurely Discontinued|25|||
33654260|NCT01712204|63066966|FG000|Overall Study|Adverse Event|3|||
33654261|NCT01712204|63066967|FG001|Overall Study|Adverse Event|1|||
33654262|NCT01712204|63066966|FG000|Overall Study|Withdrawal by Subject|3|||
33654263|NCT01712204|63066967|FG001|Overall Study|Withdrawal by Subject|3|||
33654264|NCT01712204|63066966|FG000|Overall Study|Lost to Follow-up|1|||
33654265|NCT01712204|63066967|FG001|Overall Study|Lost to Follow-up|0|||
33654266|NCT01712204|63066966|FG000|Overall Study|Protocol Violation|1|||
33654267|NCT01712204|63066967|FG001|Overall Study|Protocol Violation|1|||
33654268|NCT01592864|63066975|FG000|Overall Study|Withdrawal by Subject|0|||
33654269|NCT01592864|63066976|FG001|Overall Study|Withdrawal by Subject|1|||
33654270|NCT01592786|63066982|FG000|Overall Study|Adverse Event|60|||
33654271|NCT01592786|63066982|FG000|Overall Study|Lack of Efficacy|19|||
33654272|NCT01592786|63066982|FG000|Overall Study|Protocol Violation|14|||
33654273|NCT01592786|63066982|FG000|Overall Study|Withdrawal by Subject|23|||
33654274|NCT01592786|63066982|FG000|Overall Study|Lost to Follow-up|19|||
33654275|NCT01592786|63066982|FG000|Overall Study|Other|3|||
33654276|NCT01711736|63066988|FG000|Overall Study|Lost to Follow-up|4|||
33654277|NCT01711736|63066989|FG001|Overall Study|Lost to Follow-up|1|||
33654278|NCT01711736|63066988|FG000|Overall Study|Withdrawal by Subject|6|||
33654279|NCT01711736|63066989|FG001|Overall Study|Withdrawal by Subject|6|||
33654280|NCT01711736|63066988|FG000|Overall Study|Migrated/moved from study area|2|||
33654281|NCT01711736|63066989|FG001|Overall Study|Migrated/moved from study area|1|||
33654282|NCT01592708|63066998|FG000|Overall Study|Protocol Violation|3|||
33654283|NCT01592708|63066999|FG001|Overall Study|Protocol Violation|0|||
33654284|NCT01042522|63067010|FG000|Overall Study|Adverse Event|1|||
33654285|NCT01042522|63067011|FG001|Overall Study|Adverse Event|2|||
33654286|NCT01042522|63067010|FG000|Overall Study|Disease Progression|5|||
33654287|NCT01042522|63067011|FG001|Overall Study|Disease Progression|0|||
33654288|NCT01042522|63067010|FG000|Overall Study|Death|1|||
33654289|NCT01042522|63067011|FG001|Overall Study|Death|0|||
33654290|NCT01042522|63067010|FG000|Overall Study|Patient Refused|0|||
33654291|NCT01042522|63067011|FG001|Overall Study|Patient Refused|3|||
33654292|NCT01042522|63067010|FG000|Overall Study|Withdrawal by Subject|1|||
33654293|NCT01042522|63067011|FG001|Overall Study|Withdrawal by Subject|1|||
33654294|NCT01702844|63067017|FG000|Overall Study|Adverse Event|9|||
33654295|NCT01702844|63067017|FG000|Overall Study|Death|1|||
33654296|NCT01702844|63067017|FG000|Overall Study|Withdrawal by Subject|3|||
33654297|NCT01702844|63067017|FG000|Overall Study|Physician Decision|6|||
33654298|NCT01702532|63067023|FG000|Overall Study|Adverse Event|0|||
33654299|NCT01702532|63067024|FG001|Overall Study|Adverse Event|1|||
33654300|NCT01702454|63067033|FG000|Overall Study|Consent withdrawal|0|||
33654301|NCT01702454|63067034|FG001|Overall Study|Consent withdrawal|1|||
33654302|NCT01702454|63067033|FG000|Overall Study|Migrated/moved from study area|0|||
33654303|NCT01702454|63067034|FG001|Overall Study|Migrated/moved from study area|1|||
33654304|NCT01702454|63067033|FG000|Overall Study|Lost to Follow-up|3|||
33654305|NCT01702454|63067034|FG001|Overall Study|Lost to Follow-up|6|||
33654306|NCT01702298|63067047|FG000|Overall Study|Withdrawal by Subject|1|||
33654307|NCT01701362|63067053|FG000|Overall Study|Adverse events not related to study drug|1|||
33336734|NCT01142336|62713431|FG000|Overall Study|Adverse Event|1|||
33654308|NCT01701362|63067054|FG001|Overall Study|Adverse events not related to study drug|6|||
33654309|NCT01701362|63067053|FG000|Overall Study|Adverse events related to study drug|12|||
33654310|NCT01701362|63067054|FG001|Overall Study|Adverse events related to study drug|10|||
33654311|NCT01701362|63067053|FG000|Overall Study|Protocol Violation|5|||
33654312|NCT01701362|63067054|FG001|Overall Study|Protocol Violation|3|||
33654313|NCT01701362|63067053|FG000|Overall Study|No longer willing to participate|8|||
33654314|NCT01701362|63067054|FG001|Overall Study|No longer willing to participate|14|||
33654315|NCT01701362|63067053|FG000|Overall Study|Lost to Follow-up|6|||
33654316|NCT01701362|63067054|FG001|Overall Study|Lost to Follow-up|9|||
33654317|NCT01701362|63067053|FG000|Overall Study|Insufficient clinical response|6|||
33654318|NCT01701362|63067054|FG001|Overall Study|Insufficient clinical response|6|||
33654319|NCT01701362|63067053|FG000|Overall Study|Death|0|||
33336735|NCT01142336|62713432|FG001|Overall Study|Adverse Event|1|||
33336736|NCT01142336|62713431|FG000|Overall Study|Lost to Follow-up|0|||
33336737|NCT01142336|62713432|FG001|Overall Study|Lost to Follow-up|1|||
33336738|NCT00915681|62713441|FG000|Overall Study|Screening failures|46|||
33336739|NCT01128296|62713445|FG000|Overall Study|Physician Decision|0|||
33336740|NCT01128296|62713446|FG001|Overall Study|Physician Decision|0|||
33336741|NCT01128296|62713447|FG002|Overall Study|Physician Decision|0|||
33336742|NCT01128296|62713448|FG003|Overall Study|Physician Decision|0|||
33336743|NCT01128296|62713449|FG004|Overall Study|Physician Decision|0|||
33336744|NCT01128296|62713450|FG005|Overall Study|Physician Decision|3|||
33336745|NCT01128296|62713445|FG000|Overall Study|Withdrawal by Subject|0|||
33336746|NCT01128296|62713446|FG001|Overall Study|Withdrawal by Subject|0|||
33336747|NCT01128296|62713447|FG002|Overall Study|Withdrawal by Subject|0|||
33469116|NCT00289913|62842887|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
33469117|NCT00289913|62842888|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
33336748|NCT01128296|62713448|FG003|Overall Study|Withdrawal by Subject|0|||
33336749|NCT01128296|62713449|FG004|Overall Study|Withdrawal by Subject|0|||
33469118|NCT00289913|62842884|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33469119|NCT00289913|62842885|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
33469120|NCT00289913|62842886|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33548750|NCT02488330|62940052|FG000|Overall Study|Disease Progression|3|||
33548751|NCT02488330|62940052|FG000|Overall Study|Study Termination by Sponsor|4|||
33548752|NCT02481310|62940059|FG000|Follow up|Still in follow up|0|||
33548753|NCT02481310|62940060|FG001|Follow up|Still in follow up|3|||
33548754|NCT02481310|62940061|FG002|Follow up|Still in follow up|0|||
33548755|NCT02480764|62940068|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
33548756|NCT02480764|62940069|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
33548757|NCT02480764|62940070|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
33548758|NCT02480764|62940068|FG000|Overall Study|Major Protocol Deviation|1|||
33548759|NCT02480764|62940069|FG001|Overall Study|Major Protocol Deviation|4|||
33469121|NCT00289913|62842887|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33469122|NCT00289913|62842888|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33469123|NCT00289913|62842884|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
33469124|NCT00289913|62842885|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
33654320|NCT01701362|63067054|FG001|Overall Study|Death|1|||
33469125|NCT00289913|62842886|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
33469126|NCT00289913|62842887|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
33469127|NCT00289913|62842888|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
33469128|NCT00289913|62842884|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
33469129|NCT00289913|62842885|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
33469130|NCT00289913|62842886|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
33469131|NCT00289913|62842887|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
33469132|NCT00289913|62842888|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
33469133|NCT00289913|62842884|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33469134|NCT00289913|62842885|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33469135|NCT00289913|62842886|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33469136|NCT00289913|62842887|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33469137|NCT00289913|62842888|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
33469138|NCT00289913|62842884|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
33469139|NCT00289913|62842885|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
33469140|NCT00289913|62842886|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
33548760|NCT02480764|62940070|FG002|Overall Study|Major Protocol Deviation|3|||
33548761|NCT02480764|62940068|FG000|Overall Study|Lost to Follow-up|0|||
33548762|NCT02480764|62940069|FG001|Overall Study|Lost to Follow-up|1|||
33548763|NCT02480764|62940070|FG002|Overall Study|Lost to Follow-up|2|||
33654321|NCT01701362|63067053|FG000|Overall Study|Randomized but not treated|1|||
33336750|NCT01128296|62713450|FG005|Overall Study|Withdrawal by Subject|2|||
33336751|NCT01115738|62713464|FG000|Overall Study|Death|1|||
33336752|NCT01115738|62713465|FG001|Overall Study|Death|0|||
33469141|NCT00289913|62842887|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
33469142|NCT00289913|62842888|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
33469143|NCT00289913|62842884|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
33469144|NCT00289913|62842885|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
33469145|NCT00289913|62842886|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
33469146|NCT00289913|62842887|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
33469147|NCT00289913|62842888|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
33469148|NCT00289913|62842884|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
33469149|NCT00289913|62842885|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
33469150|NCT00289913|62842886|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
33469151|NCT00289913|62842887|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
33469152|NCT00289913|62842888|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
33469153|NCT00289913|62842884|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
33469154|NCT00289913|62842885|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
33469155|NCT00289913|62842886|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
33469156|NCT00289913|62842887|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
33469157|NCT00289913|62842888|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
33469158|NCT00289289|62842906|FG000|Overall Study|Withdrawal by Subject|5|||
33469159|NCT00289289|62842907|FG001|Overall Study|Withdrawal by Subject|3|||
33469160|NCT00289289|62842908|FG002|Overall Study|Withdrawal by Subject|15|||
33469161|NCT00289289|62842906|FG000|Overall Study|Lost to Follow-up|1|||
33469162|NCT00289289|62842907|FG001|Overall Study|Lost to Follow-up|0|||
33469163|NCT00289289|62842908|FG002|Overall Study|Lost to Follow-up|1|||
33469164|NCT00289289|62842906|FG000|Overall Study|Death|4|||
33469165|NCT00289289|62842907|FG001|Overall Study|Death|2|||
33469166|NCT00289289|62842908|FG002|Overall Study|Death|5|||
33469167|NCT00289289|62842906|FG000|Overall Study|No implant attempted|0|||
33469168|NCT00289289|62842907|FG001|Overall Study|No implant attempted|0|||
33469169|NCT00289289|62842908|FG002|Overall Study|No implant attempted|1|||
33469170|NCT00289289|62842906|FG000|Overall Study|Physician Decision|1|||
33469171|NCT00289289|62842907|FG001|Overall Study|Physician Decision|0|||
33469172|NCT00289289|62842908|FG002|Overall Study|Physician Decision|6|||
33336753|NCT01115738|62713466|FG002|Overall Study|Death|0|||
33336754|NCT01115738|62713464|FG000|Overall Study|Lost to Follow-up|0|||
33336755|NCT01115738|62713465|FG001|Overall Study|Lost to Follow-up|0|||
33336756|NCT01115738|62713466|FG002|Overall Study|Lost to Follow-up|1|||
33469173|NCT00289289|62842906|FG000|Overall Study|Non-study device implanted|2|||
33469174|NCT00289289|62842907|FG001|Overall Study|Non-study device implanted|1|||
33469175|NCT00289289|62842908|FG002|Overall Study|Non-study device implanted|3|||
33469176|NCT00289289|62842906|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
33469177|NCT00289289|62842907|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
33469178|NCT00289289|62842908|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
33469179|NCT00289289|62842906|FG000|Overall Study|Other Exit Reason|6|||
33469180|NCT00289289|62842907|FG001|Overall Study|Other Exit Reason|4|||
33469181|NCT00289289|62842908|FG002|Overall Study|Other Exit Reason|12|||
33469182|NCT00270257|62842917|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
33469183|NCT00270257|62842918|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
33469184|NCT00269633|62842928|FG000|Overall Study|Withdrawal by Subject|1|||
33469185|NCT00269633|62842929|FG001|Overall Study|Withdrawal by Subject|0|||
33469186|NCT00269477|62842939|FG000|Overall Study|Protocol Violation|5|||
33469187|NCT00269477|62842940|FG001|Overall Study|Protocol Violation|5|||
33469188|NCT00269477|62842941|FG002|Overall Study|Protocol Violation|1|||
33469189|NCT00269477|62842942|FG003|Overall Study|Protocol Violation|0|||
33469190|NCT00269477|62842939|FG000|Overall Study|Missed post-vaccination blood draw|0|||
33469191|NCT00269477|62842940|FG001|Overall Study|Missed post-vaccination blood draw|1|||
33469192|NCT00269477|62842941|FG002|Overall Study|Missed post-vaccination blood draw|0|||
33469193|NCT00269477|62842942|FG003|Overall Study|Missed post-vaccination blood draw|0|||
33469194|NCT00269399|62842954|FG000|Overall Study|Lack of Efficacy|27|||
33469195|NCT00269399|62842955|FG001|Overall Study|Lack of Efficacy|10|||
33469196|NCT00269399|62842954|FG000|Overall Study|Adverse Event|10|||
33469197|NCT00269399|62842955|FG001|Overall Study|Adverse Event|4|||
33469198|NCT00269399|62842954|FG000|Overall Study|Withdrawal by Subject|2|||
33469199|NCT00269399|62842955|FG001|Overall Study|Withdrawal by Subject|5|||
33336757|NCT01115738|62713464|FG000|Overall Study|Physician Decision|18|||
33336758|NCT01115738|62713465|FG001|Overall Study|Physician Decision|15|||
33336759|NCT01115738|62713466|FG002|Overall Study|Physician Decision|17|||
33469200|NCT00269399|62842954|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
33469201|NCT00269399|62842955|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
33548764|NCT02480764|62940068|FG000|Overall Study|Voluntary Withdrawal|6|||
33336760|NCT01115738|62713464|FG000|Overall Study|Withdrawal by Subject|6|||
33336761|NCT01115738|62713465|FG001|Overall Study|Withdrawal by Subject|6|||
33336762|NCT01115738|62713466|FG002|Overall Study|Withdrawal by Subject|9|||
33336763|NCT01141478|62713484|FG000|Overall Study|Withdrawal by Subject|1|||
33336764|NCT01141478|62713485|FG001|Overall Study|Withdrawal by Subject|1|||
33336765|NCT01114880|62713493|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
33336766|NCT01114880|62713494|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
33336767|NCT01114880|62713493|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
33336768|NCT01114880|62713494|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
33336769|NCT01114880|62713493|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
33336770|NCT01114880|62713494|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
33336771|NCT01114880|62713493|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
33336772|NCT01114880|62713494|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
33336773|NCT01114880|62713493|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
33336774|NCT01114880|62713494|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
33336775|NCT01114880|62713493|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
33336776|NCT01114880|62713494|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
33336777|NCT01114724|62713502|FG000|Overall Study|Death|8|||
33336778|NCT01114724|62713502|FG000|Overall Study|Lost to Follow-up|1|||
33336779|NCT01114724|62713502|FG000|Overall Study|Withdrawal by Subject|1|||
33336780|NCT00964392|62713509|FG000|Overall Study|Withdrawal by Subject|4|||
33336781|NCT00964392|62713510|FG001|Overall Study|Withdrawal by Subject|6|||
33336782|NCT00964392|62713509|FG000|Overall Study|Lost to Follow-up|4|||
33336783|NCT00964392|62713510|FG001|Overall Study|Lost to Follow-up|10|||
33336784|NCT00964392|62713509|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
33336785|NCT00964392|62713510|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
33336786|NCT00964392|62713509|FG000|Overall Study|Not completed|44|||
33336787|NCT00964392|62713510|FG001|Overall Study|Not completed|168|||
33336788|NCT00914589|62713519|FG000|Overall Study|Adverse Event|1|||
33336789|NCT00914589|62713520|FG001|Overall Study|Adverse Event|0|||
33336790|NCT00914589|62713521|FG002|Overall Study|Adverse Event|1|||
33336791|NCT00914589|62713519|FG000|Overall Study|Protocol Violation|8|||
33336792|NCT00914589|62713520|FG001|Overall Study|Protocol Violation|6|||
33336793|NCT00914589|62713521|FG002|Overall Study|Protocol Violation|3|||
33336794|NCT00914589|62713519|FG000|Overall Study|unclassified|16|||
33336795|NCT00914589|62713520|FG001|Overall Study|unclassified|9|||
33336796|NCT00914589|62713521|FG002|Overall Study|unclassified|7|||
33336797|NCT00914589|62713519|FG000|Overall Study|Death|0|||
33336798|NCT00914589|62713520|FG001|Overall Study|Death|1|||
33336799|NCT00914589|62713521|FG002|Overall Study|Death|1|||
33336800|NCT00912405|62713529|FG000|Overall Study|Lost to Follow-up|5|||
33336801|NCT00878722|62713541|FG000|Overall Study|Progressive disease|3|||
33336802|NCT00878722|62713542|FG001|Overall Study|Progressive disease|3|||
33336803|NCT00878722|62713543|FG002|Overall Study|Progressive disease|3|||
33336804|NCT00878722|62713544|FG003|Overall Study|Progressive disease|7|||
33336805|NCT00878722|62713545|FG004|Overall Study|Progressive disease|7|||
33336806|NCT00878722|62713546|FG005|Overall Study|Progressive disease|1|||
33336807|NCT00878722|62713547|FG006|Overall Study|Progressive disease|4|||
33336808|NCT00878722|62713548|FG007|Overall Study|Progressive disease|3|||
33336809|NCT00878722|62713541|FG000|Overall Study|Death|0|||
33336810|NCT00878722|62713542|FG001|Overall Study|Death|0|||
33336811|NCT00878722|62713543|FG002|Overall Study|Death|0|||
33336812|NCT00878722|62713544|FG003|Overall Study|Death|1|||
33336813|NCT00878722|62713545|FG004|Overall Study|Death|0|||
33336814|NCT00878722|62713546|FG005|Overall Study|Death|1|||
33336815|NCT00878722|62713547|FG006|Overall Study|Death|0|||
33336816|NCT00878722|62713548|FG007|Overall Study|Death|2|||
33336817|NCT00878722|62713541|FG000|Overall Study|Adverse Event|0|||
33336818|NCT00878722|62713542|FG001|Overall Study|Adverse Event|0|||
33336819|NCT00878722|62713543|FG002|Overall Study|Adverse Event|0|||
33336820|NCT00878722|62713544|FG003|Overall Study|Adverse Event|0|||
33336821|NCT00878722|62713545|FG004|Overall Study|Adverse Event|0|||
33336822|NCT00878722|62713546|FG005|Overall Study|Adverse Event|0|||
33548765|NCT02480764|62940069|FG001|Overall Study|Voluntary Withdrawal|5|||
33336823|NCT00878722|62713547|FG006|Overall Study|Adverse Event|2|||
33336824|NCT00878722|62713548|FG007|Overall Study|Adverse Event|0|||
33336825|NCT00878722|62713541|FG000|Overall Study|Withdrawal by Subject|0|||
33336826|NCT00878722|62713542|FG001|Overall Study|Withdrawal by Subject|0|||
33336827|NCT00878722|62713543|FG002|Overall Study|Withdrawal by Subject|0|||
33336828|NCT00878722|62713544|FG003|Overall Study|Withdrawal by Subject|0|||
33336829|NCT00878722|62713545|FG004|Overall Study|Withdrawal by Subject|0|||
33336830|NCT00878722|62713546|FG005|Overall Study|Withdrawal by Subject|0|||
33336831|NCT00878722|62713547|FG006|Overall Study|Withdrawal by Subject|0|||
33336832|NCT00878722|62713548|FG007|Overall Study|Withdrawal by Subject|2|||
33336833|NCT00878722|62713541|FG000|Overall Study|Relapse|0|||
33336834|NCT00878722|62713542|FG001|Overall Study|Relapse|0|||
33336835|NCT00878722|62713543|FG002|Overall Study|Relapse|0|||
33336836|NCT00878722|62713544|FG003|Overall Study|Relapse|1|||
33336837|NCT00878722|62713545|FG004|Overall Study|Relapse|0|||
33336838|NCT00878722|62713546|FG005|Overall Study|Relapse|0|||
33336839|NCT00878722|62713547|FG006|Overall Study|Relapse|0|||
33336840|NCT00878722|62713548|FG007|Overall Study|Relapse|0|||
33336841|NCT00964158|62713576|FG000|Overall Study|Lost to Follow-up|0|||
33336842|NCT00964158|62713577|FG001|Overall Study|Lost to Follow-up|1|||
33336843|NCT00964158|62713578|FG002|Overall Study|Lost to Follow-up|2|||
33336844|NCT00964158|62713576|FG000|Overall Study|Withdrawal by Subject|0|||
33336845|NCT00964158|62713577|FG001|Overall Study|Withdrawal by Subject|0|||
33336846|NCT00964158|62713578|FG002|Overall Study|Withdrawal by Subject|6|||
33336847|NCT00961350|62713591|FG000|Overall Study|Adverse Event|18|||
33336848|NCT00961350|62713592|FG001|Overall Study|Adverse Event|33|||
33469202|NCT00269399|62842954|FG000|Overall Study|Other|0|||
33469203|NCT00269399|62842955|FG001|Overall Study|Other|4|||
33469204|NCT00269399|62842954|FG000|Overall Study|Development of exclusion criteria|0|||
33469205|NCT00269399|62842955|FG001|Overall Study|Development of exclusion criteria|1|||
33469206|NCT00269087|62842961|FG000|Overall Study|Adverse Event|20|||
33469207|NCT00269087|62842961|FG000|Overall Study|Withdrawal by Subject|1|||
33469208|NCT00269087|62842961|FG000|Overall Study|Exacerbation of COPD|13|||
33469209|NCT00289133|62842967|FG000|Overall Study|Non-study device implanted|12|||
33469210|NCT00289133|62842968|FG001|Overall Study|Non-study device implanted|0|||
33469211|NCT00289133|62842967|FG000|Overall Study|Protocol Violation|32|||
33469212|NCT00289133|62842968|FG001|Overall Study|Protocol Violation|38|||
33469213|NCT00289133|62842967|FG000|Overall Study|Withdrawal by Subject|9|||
33336849|NCT00961350|62713591|FG000|Overall Study|Withdrawal by Subject|10|||
33336850|NCT00961350|62713592|FG001|Overall Study|Withdrawal by Subject|10|||
33336851|NCT00961350|62713591|FG000|Overall Study|Lost to Follow-up|3|||
33336852|NCT00961350|62713592|FG001|Overall Study|Lost to Follow-up|3|||
33336853|NCT00961350|62713591|FG000|Overall Study|Misc|16|||
33336854|NCT00961350|62713592|FG001|Overall Study|Misc|21|||
33336855|NCT00963924|62713600|FG000|Overall Study|Adverse Event|1|||
33336856|NCT00963924|62713601|FG001|Overall Study|Adverse Event|0|||
33336857|NCT00963924|62713600|FG000|Overall Study|Withdrawal by Subject|0|||
33336858|NCT00963924|62713601|FG001|Overall Study|Withdrawal by Subject|1|||
33336859|NCT00963924|62713600|FG000|Overall Study|Changed antipsychotic|0|||
33336860|NCT00963924|62713601|FG001|Overall Study|Changed antipsychotic|1|||
33336861|NCT00963924|62713600|FG000|Overall Study|Lost to Follow-up|0|||
33336862|NCT00963924|62713601|FG001|Overall Study|Lost to Follow-up|1|||
33336863|NCT03265665|62713611|FG000|24-week Data Collection|Withdrawal by Subject|2|||
33336864|NCT03265665|62713612|FG001|24-week Data Collection|Withdrawal by Subject|2|||
33336865|NCT03265665|62713611|FG000|24-week Data Collection|Lost to Follow-up|4|||
33336866|NCT03265665|62713612|FG001|24-week Data Collection|Lost to Follow-up|5|||
33336867|NCT03265665|62713611|FG000|36-week Data Collection|Lost to Follow-up|6|||
33336868|NCT03265665|62713612|FG001|36-week Data Collection|Lost to Follow-up|8|||
33336869|NCT01114646|62713622|FG000|Overall Study|Withdrawal by Subject|3|||
33336870|NCT01114646|62713623|FG001|Overall Study|Withdrawal by Subject|2|||
33336871|NCT00965562|62713632|FG000|Overall Study|Lost to Follow-up|1|||
33336872|NCT00965562|62713633|FG001|Overall Study|Lost to Follow-up|2|||
33336873|NCT00965562|62713634|FG002|Overall Study|Lost to Follow-up|3|||
33336874|NCT00965562|62713632|FG000|Overall Study|Withdrawal by Subject|2|||
33336875|NCT00965562|62713633|FG001|Overall Study|Withdrawal by Subject|2|||
33336876|NCT00965562|62713634|FG002|Overall Study|Withdrawal by Subject|0|||
33336877|NCT00912093|62713648|FG000|The Controlled Phase|Death|0|||
33336878|NCT00912093|62713649|FG001|The Controlled Phase|Death|1|||
33336879|NCT00912093|62713650|FG002|The Controlled Phase|Death|0|||
33336880|NCT00912093|62713651|FG003|The Controlled Phase|Death|0|||
33336881|NCT00912093|62713652|FG004|The Controlled Phase|Death|0|||
33336882|NCT00912093|62713648|FG000|The Controlled Phase|Medical Condition|0|||
33336883|NCT00912093|62713649|FG001|The Controlled Phase|Medical Condition|1|||
33336884|NCT00912093|62713650|FG002|The Controlled Phase|Medical Condition|0|||
33336885|NCT00912093|62713651|FG003|The Controlled Phase|Medical Condition|0|||
33336886|NCT00912093|62713652|FG004|The Controlled Phase|Medical Condition|0|||
33336887|NCT00912093|62713648|FG000|The Controlled Phase|Lost to Follow-up|0|||
33336888|NCT00912093|62713649|FG001|The Controlled Phase|Lost to Follow-up|0|||
33336889|NCT00912093|62713650|FG002|The Controlled Phase|Lost to Follow-up|0|||
33336890|NCT00912093|62713651|FG003|The Controlled Phase|Lost to Follow-up|0|||
33336891|NCT00912093|62713652|FG004|The Controlled Phase|Lost to Follow-up|1|||
33336892|NCT00965484|62713660|FG000|Overall Study|Protocol Violation|1|||
33336893|NCT00965484|62713660|FG000|Overall Study|Withdrawal by Subject|1|||
33336894|NCT00961116|62713664|FG000|Washout Period of 7 Days|Adverse Event|1|||
33336895|NCT00961116|62713665|FG001|Washout Period of 7 Days|Adverse Event|1|||
33336896|NCT00961116|62713664|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
33336897|NCT00961116|62713665|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33336898|NCT00961116|62713664|FG000|Washout Period of 7 Days|Protocol Violation|0|||
33336899|NCT00961116|62713665|FG001|Washout Period of 7 Days|Protocol Violation|1|||
33336900|NCT00912015|62713676|FG000|Overall Study|Lack of Efficacy|1|||
33336901|NCT00912015|62713677|FG001|Overall Study|Lack of Efficacy|0|||
33336902|NCT00912015|62713678|FG002|Overall Study|Lack of Efficacy|0|||
33336903|NCT00912015|62713679|FG003|Overall Study|Lack of Efficacy|0|||
33336904|NCT00912015|62713676|FG000|Overall Study|Withdrawal by Subject|8|||
33336905|NCT00912015|62713677|FG001|Overall Study|Withdrawal by Subject|8|||
33336906|NCT00912015|62713678|FG002|Overall Study|Withdrawal by Subject|3|||
33336907|NCT00912015|62713679|FG003|Overall Study|Withdrawal by Subject|0|||
33336908|NCT00912015|62713676|FG000|Overall Study|Protocol Violation|1|||
33336909|NCT00912015|62713677|FG001|Overall Study|Protocol Violation|0|||
33336910|NCT00912015|62713678|FG002|Overall Study|Protocol Violation|0|||
33336911|NCT00912015|62713679|FG003|Overall Study|Protocol Violation|1|||
33336912|NCT00912015|62713676|FG000|Overall Study|Adverse Event|6|||
33336913|NCT00912015|62713677|FG001|Overall Study|Adverse Event|0|||
33336914|NCT00912015|62713678|FG002|Overall Study|Adverse Event|0|||
33336915|NCT00912015|62713679|FG003|Overall Study|Adverse Event|1|||
33336916|NCT00960804|62713692|FG000|Overall Study|Adverse Event|1|||
33336917|NCT00960804|62713693|FG001|Overall Study|Adverse Event|0|||
33336918|NCT00960804|62713694|FG002|Overall Study|Adverse Event|0|||
33336919|NCT00960804|62713692|FG000|Overall Study|Withdrawal by Subject|1|||
33336920|NCT00960804|62713693|FG001|Overall Study|Withdrawal by Subject|0|||
33336921|NCT00960804|62713694|FG002|Overall Study|Withdrawal by Subject|0|||
33336922|NCT00960804|62713692|FG000|Overall Study|Study terminated by the sponsor|5|||
33336923|NCT00960804|62713693|FG001|Overall Study|Study terminated by the sponsor|4|||
33336924|NCT00960804|62713694|FG002|Overall Study|Study terminated by the sponsor|10|||
33336925|NCT01126580|62713705|FG000|Overall Study|Adverse Event|14|||
33336926|NCT01126580|62713706|FG001|Overall Study|Adverse Event|8|||
33336927|NCT01126580|62713707|FG002|Overall Study|Adverse Event|12|||
33336928|NCT01126580|62713705|FG000|Overall Study|Withdrawal by Subject|11|||
33336929|NCT01126580|62713706|FG001|Overall Study|Withdrawal by Subject|19|||
33336930|NCT01126580|62713707|FG002|Overall Study|Withdrawal by Subject|14|||
33336931|NCT01126580|62713705|FG000|Overall Study|Sponsor Decision|5|||
33336932|NCT01126580|62713706|FG001|Overall Study|Sponsor Decision|4|||
33336933|NCT01126580|62713707|FG002|Overall Study|Sponsor Decision|7|||
33336934|NCT01126580|62713705|FG000|Overall Study|Physician Decision|1|||
33336935|NCT01126580|62713706|FG001|Overall Study|Physician Decision|1|||
33336936|NCT01126580|62713707|FG002|Overall Study|Physician Decision|2|||
33336937|NCT01126580|62713705|FG000|Overall Study|Entry Criteria Not Met|1|||
33336938|NCT01126580|62713706|FG001|Overall Study|Entry Criteria Not Met|1|||
33336939|NCT01126580|62713707|FG002|Overall Study|Entry Criteria Not Met|2|||
33336940|NCT01126580|62713705|FG000|Overall Study|Lack of Efficacy|2|||
33336941|NCT01126580|62713706|FG001|Overall Study|Lack of Efficacy|3|||
33336942|NCT01126580|62713707|FG002|Overall Study|Lack of Efficacy|4|||
33336943|NCT01126580|62713705|FG000|Overall Study|Protocol Violation|0|||
33336944|NCT01126580|62713706|FG001|Overall Study|Protocol Violation|1|||
33336945|NCT01126580|62713707|FG002|Overall Study|Protocol Violation|2|||
33336946|NCT01126580|62713705|FG000|Overall Study|Lost to Follow-up|15|||
33336947|NCT01126580|62713706|FG001|Overall Study|Lost to Follow-up|13|||
33336948|NCT01126580|62713707|FG002|Overall Study|Lost to Follow-up|9|||
33336949|NCT01126580|62713705|FG000|Overall Study|Treatment Non-compliance|0|||
33336950|NCT01126580|62713706|FG001|Overall Study|Treatment Non-compliance|2|||
33336951|NCT01126580|62713707|FG002|Overall Study|Treatment Non-compliance|3|||
33336952|NCT00911157|62713718|FG000|Overall Study|Adverse Event|4|||
33336953|NCT00911157|62713719|FG001|Overall Study|Adverse Event|1|||
33336954|NCT00911157|62713718|FG000|Overall Study|Withdrawal by Subject|1|||
33336955|NCT00911157|62713719|FG001|Overall Study|Withdrawal by Subject|1|||
33336956|NCT00911157|62713718|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
33336957|NCT00911157|62713719|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
33336958|NCT00911157|62713718|FG000|Overall Study|Need to treat for lung cancer|1|||
33336959|NCT00911157|62713719|FG001|Overall Study|Need to treat for lung cancer|0|||
33336960|NCT00960570|62713725|FG000|21 Day Washout Period|Adverse Event|1|||
33336961|NCT00960570|62713725|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
33336962|NCT00960570|62713725|FG000|1 Day Period Between Dosing|Adverse Event|2|||
33336963|NCT00960570|62713725|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
33336964|NCT01126424|62713738|FG000|Overall Study|Adverse Event|0|||
33336965|NCT01126424|62713739|FG001|Overall Study|Adverse Event|0|||
33336966|NCT01126424|62713740|FG002|Overall Study|Adverse Event|0|||
33336967|NCT01126424|62713741|FG003|Overall Study|Adverse Event|0|||
33336968|NCT01126424|62713742|FG004|Overall Study|Adverse Event|1|||
33336969|NCT01126424|62713743|FG005|Overall Study|Adverse Event|0|||
33336970|NCT01126424|62713738|FG000|Overall Study|Withdrawal by Subject|0|||
33336971|NCT01126424|62713739|FG001|Overall Study|Withdrawal by Subject|0|||
33336972|NCT01126424|62713740|FG002|Overall Study|Withdrawal by Subject|1|||
33336973|NCT01126424|62713741|FG003|Overall Study|Withdrawal by Subject|3|||
33336974|NCT01126424|62713742|FG004|Overall Study|Withdrawal by Subject|1|||
33336975|NCT01126424|62713743|FG005|Overall Study|Withdrawal by Subject|0|||
33336976|NCT01126268|62713751|FG000|Overall Study|Adverse Event|1|||
33336977|NCT00879658|62713762|FG000|Overall Study|Abnormal laboratory value(s)|3|||
33336978|NCT00879658|62713763|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33336979|NCT00879658|62713764|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33336980|NCT00879658|62713765|FG003|Overall Study|Abnormal laboratory value(s)|1|||
33336981|NCT00879658|62713766|FG004|Overall Study|Abnormal laboratory value(s)|0|||
33336982|NCT00879658|62713767|FG005|Overall Study|Abnormal laboratory value(s)|0|||
33336983|NCT00879658|62713768|FG006|Overall Study|Abnormal laboratory value(s)|0|||
33336984|NCT00879658|62713762|FG000|Overall Study|Administrative problems|2|||
33336985|NCT00879658|62713763|FG001|Overall Study|Administrative problems|1|||
33336986|NCT00879658|62713764|FG002|Overall Study|Administrative problems|0|||
33336987|NCT00879658|62713765|FG003|Overall Study|Administrative problems|1|||
33336988|NCT00879658|62713766|FG004|Overall Study|Administrative problems|0|||
33336989|NCT00879658|62713767|FG005|Overall Study|Administrative problems|0|||
33336990|NCT00879658|62713768|FG006|Overall Study|Administrative problems|0|||
33336991|NCT00879658|62713762|FG000|Overall Study|Adverse Event|6|||
33336992|NCT00879658|62713763|FG001|Overall Study|Adverse Event|4|||
33336993|NCT00879658|62713764|FG002|Overall Study|Adverse Event|3|||
33336994|NCT00879658|62713765|FG003|Overall Study|Adverse Event|1|||
33336995|NCT00879658|62713766|FG004|Overall Study|Adverse Event|2|||
33336996|NCT00879658|62713767|FG005|Overall Study|Adverse Event|0|||
33336997|NCT00879658|62713768|FG006|Overall Study|Adverse Event|0|||
33336998|NCT00879658|62713762|FG000|Overall Study|Protocol Violation|1|||
33336999|NCT00879658|62713763|FG001|Overall Study|Protocol Violation|0|||
33337000|NCT00879658|62713764|FG002|Overall Study|Protocol Violation|0|||
33337001|NCT00879658|62713765|FG003|Overall Study|Protocol Violation|0|||
33337002|NCT00879658|62713766|FG004|Overall Study|Protocol Violation|0|||
33337003|NCT00879658|62713767|FG005|Overall Study|Protocol Violation|0|||
33337004|NCT00879658|62713768|FG006|Overall Study|Protocol Violation|0|||
33337005|NCT00879658|62713762|FG000|Overall Study|Withdrawal by Subject|3|||
33337006|NCT00879658|62713763|FG001|Overall Study|Withdrawal by Subject|0|||
33337007|NCT00879658|62713764|FG002|Overall Study|Withdrawal by Subject|2|||
33337008|NCT00879658|62713765|FG003|Overall Study|Withdrawal by Subject|0|||
33337009|NCT00879658|62713766|FG004|Overall Study|Withdrawal by Subject|0|||
33337010|NCT00879658|62713767|FG005|Overall Study|Withdrawal by Subject|1|||
33337011|NCT00879658|62713768|FG006|Overall Study|Withdrawal by Subject|0|||
33337012|NCT00879658|62713762|FG000|Overall Study|Lack of Efficacy|0|||
33469214|NCT00289133|62842968|FG001|Overall Study|Withdrawal by Subject|10|||
33469215|NCT00289133|62842967|FG000|Overall Study|Death|5|||
33469216|NCT00289133|62842968|FG001|Overall Study|Death|10|||
33469217|NCT00289133|62842967|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
33469218|NCT00289133|62842968|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
33469219|NCT00289133|62842967|FG000|Overall Study|Physician Decision|41|||
33337013|NCT00879658|62713763|FG001|Overall Study|Lack of Efficacy|0|||
33337014|NCT00879658|62713764|FG002|Overall Study|Lack of Efficacy|2|||
33337015|NCT00879658|62713765|FG003|Overall Study|Lack of Efficacy|0|||
33337016|NCT00879658|62713766|FG004|Overall Study|Lack of Efficacy|0|||
33337017|NCT00879658|62713767|FG005|Overall Study|Lack of Efficacy|0|||
33337018|NCT00879658|62713768|FG006|Overall Study|Lack of Efficacy|0|||
33337019|NCT00879658|62713762|FG000|Overall Study|misrandomized (never received study med)|0|||
33337020|NCT00879658|62713763|FG001|Overall Study|misrandomized (never received study med)|0|||
33337021|NCT00879658|62713764|FG002|Overall Study|misrandomized (never received study med)|0|||
33337022|NCT00879658|62713765|FG003|Overall Study|misrandomized (never received study med)|1|||
33337023|NCT00879658|62713766|FG004|Overall Study|misrandomized (never received study med)|0|||
33337024|NCT00879658|62713767|FG005|Overall Study|misrandomized (never received study med)|0|||
33337025|NCT00879658|62713768|FG006|Overall Study|misrandomized (never received study med)|0|||
33337026|NCT00959946|62713798|FG000|Overall Study|Adverse Event|0|||
33337027|NCT00959946|62713799|FG001|Overall Study|Adverse Event|0|||
33337028|NCT00959946|62713800|FG002|Overall Study|Adverse Event|2|||
33337029|NCT00959946|62713801|FG003|Overall Study|Adverse Event|1|||
33337030|NCT00959946|62713802|FG004|Overall Study|Adverse Event|0|||
33337031|NCT00959946|62713803|FG005|Overall Study|Adverse Event|1|||
33337032|NCT00959946|62713804|FG006|Overall Study|Adverse Event|0|||
33337033|NCT00959946|62713805|FG007|Overall Study|Adverse Event|0|||
33337034|NCT00959946|62713798|FG000|Overall Study|Death|0|||
33337035|NCT00959946|62713799|FG001|Overall Study|Death|0|||
33337036|NCT00959946|62713800|FG002|Overall Study|Death|0|||
33337037|NCT00959946|62713801|FG003|Overall Study|Death|0|||
33337038|NCT00959946|62713802|FG004|Overall Study|Death|0|||
33337039|NCT00959946|62713803|FG005|Overall Study|Death|1|||
33337040|NCT00959946|62713804|FG006|Overall Study|Death|0|||
33337041|NCT00959946|62713805|FG007|Overall Study|Death|0|||
33337042|NCT00959946|62713798|FG000|Overall Study|Disease Progression|2|||
33337043|NCT00959946|62713799|FG001|Overall Study|Disease Progression|4|||
33337044|NCT00959946|62713800|FG002|Overall Study|Disease Progression|2|||
33337045|NCT00959946|62713801|FG003|Overall Study|Disease Progression|4|||
33337046|NCT00959946|62713802|FG004|Overall Study|Disease Progression|4|||
33337047|NCT00959946|62713803|FG005|Overall Study|Disease Progression|6|||
33337048|NCT00959946|62713804|FG006|Overall Study|Disease Progression|2|||
33337049|NCT00959946|62713805|FG007|Overall Study|Disease Progression|2|||
33337050|NCT00959946|62713798|FG000|Overall Study|Withdrawal by Subject|0|||
33337051|NCT00959946|62713799|FG001|Overall Study|Withdrawal by Subject|0|||
33337052|NCT00959946|62713800|FG002|Overall Study|Withdrawal by Subject|0|||
33337053|NCT00959946|62713801|FG003|Overall Study|Withdrawal by Subject|0|||
33337054|NCT00959946|62713802|FG004|Overall Study|Withdrawal by Subject|0|||
33337055|NCT00959946|62713803|FG005|Overall Study|Withdrawal by Subject|1|||
33337056|NCT00959946|62713804|FG006|Overall Study|Withdrawal by Subject|0|||
33337057|NCT00959946|62713805|FG007|Overall Study|Withdrawal by Subject|0|||
33337058|NCT00911937|62713830|FG000|Overall Study|Death|1|||
33469220|NCT00289133|62842968|FG001|Overall Study|Physician Decision|45|||
33469221|NCT00289133|62842967|FG000|Overall Study|Revision|8|||
33469222|NCT00289133|62842968|FG001|Overall Study|Revision|6|||
33337059|NCT00911937|62713831|FG001|Overall Study|Death|0|||
33337060|NCT00911937|62713830|FG000|Overall Study|Lost to Follow-up|8|||
33337061|NCT00911937|62713831|FG001|Overall Study|Lost to Follow-up|5|||
33337062|NCT00911937|62713830|FG000|Overall Study|Withdrawal by Subject|10|||
33469223|NCT00289133|62842967|FG000|Overall Study|Lost to Follow-up|92|||
33337063|NCT00911937|62713831|FG001|Overall Study|Withdrawal by Subject|7|||
33337064|NCT00911937|62713830|FG000|Overall Study|Withdrawn due to pregnancy|1|||
33337065|NCT00911937|62713831|FG001|Overall Study|Withdrawn due to pregnancy|0|||
33337066|NCT00911937|62713830|FG000|Overall Study|Adverse Event|11|||
33469224|NCT00289133|62842968|FG001|Overall Study|Lost to Follow-up|115|||
33469225|NCT00288587|62842980|FG000|Overall Study|Death|4|||
33337067|NCT00911937|62713831|FG001|Overall Study|Adverse Event|25|||
33337068|NCT00911937|62713830|FG000|Overall Study|Lack of Efficacy|11|||
33337069|NCT00911937|62713831|FG001|Overall Study|Lack of Efficacy|6|||
33469226|NCT00288587|62842981|FG001|Overall Study|Death|4|||
33337070|NCT00911937|62713830|FG000|Overall Study|Did not meet inclusion criteria|9|||
33337071|NCT00911937|62713831|FG001|Overall Study|Did not meet inclusion criteria|11|||
33337072|NCT00911937|62713830|FG000|Overall Study|Protocol Violation|14|||
33337073|NCT00911937|62713831|FG001|Overall Study|Protocol Violation|23|||
33337074|NCT00911937|62713830|FG000|Overall Study|Randomized but not treated|13|||
33337075|NCT00911937|62713831|FG001|Overall Study|Randomized but not treated|13|||
33337076|NCT00911937|62713830|FG000|Overall Study|Other|9|||
33337077|NCT00911937|62713831|FG001|Overall Study|Other|5|||
33337078|NCT00880048|62713840|FG000|Overall Study|Adverse Event|2|||
33337079|NCT00880048|62713841|FG001|Overall Study|Adverse Event|3|||
33337080|NCT00880048|62713842|FG002|Overall Study|Adverse Event|5|||
33337081|NCT00880048|62713840|FG000|Overall Study|Lack of Efficacy|1|||
33337082|NCT00880048|62713841|FG001|Overall Study|Lack of Efficacy|2|||
33337083|NCT00880048|62713842|FG002|Overall Study|Lack of Efficacy|2|||
33337084|NCT00880048|62713840|FG000|Overall Study|Protocol Violation|4|||
33337085|NCT00880048|62713841|FG001|Overall Study|Protocol Violation|6|||
33337086|NCT00880048|62713842|FG002|Overall Study|Protocol Violation|5|||
33337087|NCT00880048|62713840|FG000|Overall Study|Lost to Follow-up|6|||
33337088|NCT00880048|62713841|FG001|Overall Study|Lost to Follow-up|6|||
33337089|NCT00880048|62713842|FG002|Overall Study|Lost to Follow-up|5|||
33337090|NCT00880048|62713840|FG000|Overall Study|Physician Decision|1|||
33337091|NCT00880048|62713841|FG001|Overall Study|Physician Decision|1|||
33337092|NCT00880048|62713842|FG002|Overall Study|Physician Decision|7|||
33337093|NCT00880048|62713840|FG000|Overall Study|Withdrawal by Subject|5|||
33337094|NCT00880048|62713841|FG001|Overall Study|Withdrawal by Subject|8|||
33337095|NCT00880048|62713842|FG002|Overall Study|Withdrawal by Subject|5|||
33337096|NCT00880048|62713840|FG000|Overall Study|Study closed/terminated|9|||
33337097|NCT00880048|62713841|FG001|Overall Study|Study closed/terminated|7|||
33337098|NCT00880048|62713842|FG002|Overall Study|Study closed/terminated|6|||
33337099|NCT00962208|62713852|FG000|Overall Study|Could not achieve good vision|9|||
33337100|NCT00962208|62713853|FG001|Overall Study|Could not achieve good vision|0|||
33337101|NCT00962208|62713852|FG000|Overall Study|Contraindicated to continue study|5|||
33337102|NCT00962208|62713853|FG001|Overall Study|Contraindicated to continue study|1|||
33337103|NCT00962208|62713852|FG000|Overall Study|Lost to Follow-up|0|||
33337104|NCT00962208|62713853|FG001|Overall Study|Lost to Follow-up|9|||
33337105|NCT01076543|62713865|FG000|Overall Study|Withdrawal by Subject|2|||
33337106|NCT01076543|62713866|FG001|Overall Study|Withdrawal by Subject|0|||
33337107|NCT01076543|62713867|FG002|Overall Study|Withdrawal by Subject|0|||
33337108|NCT01076543|62713868|FG003|Overall Study|Withdrawal by Subject|0|||
33337109|NCT01076543|62713869|FG004|Overall Study|Withdrawal by Subject|0|||
33337110|NCT01076543|62713870|FG005|Overall Study|Withdrawal by Subject|0|||
33337111|NCT01072877|62713890|FG000|Overall Study|Lost to Follow-up|1|||
33337112|NCT01072877|62713891|FG001|Overall Study|Lost to Follow-up|1|||
33337113|NCT01072877|62713892|FG002|Overall Study|Lost to Follow-up|0|||
33337114|NCT01072877|62713893|FG003|Overall Study|Lost to Follow-up|2|||
33337115|NCT01072877|62713894|FG004|Overall Study|Lost to Follow-up|0|||
33469227|NCT00288587|62842980|FG000|Overall Study|Transplant|0|||
33469228|NCT00288587|62842981|FG001|Overall Study|Transplant|3|||
33469229|NCT00288587|62842980|FG000|Overall Study|Adverse Event|0|||
33469230|NCT00288587|62842981|FG001|Overall Study|Adverse Event|1|||
33469231|NCT00288587|62842980|FG000|Overall Study|Physician Decision|0|||
33469232|NCT00288587|62842981|FG001|Overall Study|Physician Decision|2|||
33469233|NCT00288587|62842980|FG000|Overall Study|Severe Aortic Stenosis|1|||
33469234|NCT00288587|62842981|FG001|Overall Study|Severe Aortic Stenosis|0|||
33469235|NCT00268463|62842989|FG000|Overall Study|study terminated due to low accrual|10|||
33469236|NCT00268463|62842990|FG001|Overall Study|study terminated due to low accrual|12|||
33469237|NCT00288509|62842996|FG000|Treatment Cycle 1|Adverse Event|1|||
33469238|NCT00288509|62842996|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
33469239|NCT00288509|62842996|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
33469240|NCT00288509|62842996|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
33469241|NCT00288509|62842996|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
33469242|NCT00288509|62842996|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
33469243|NCT00288509|62842996|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
33337116|NCT00961896|62713911|FG000|Overall Study|Abnormal laboratory value|0|||
33337117|NCT00961896|62713912|FG001|Overall Study|Abnormal laboratory value|0|||
33469244|NCT00288509|62842996|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
33337118|NCT00961896|62713913|FG002|Overall Study|Abnormal laboratory value|1|||
33337119|NCT00957528|62713927|FG000|Overall Study|Protocol Violation|0|||
33469245|NCT00288509|62842996|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
33469246|NCT00288509|62842996|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
33469247|NCT00288509|62842996|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
33469248|NCT00288509|62842996|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
33469249|NCT00288509|62842996|FG000|Treatment Cycle 4|Physician Decision|4|||
33469250|NCT00288509|62842996|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
33469251|NCT00266825|62843002|FG000|Completed Follow-Up|Lost to Follow-up|14|||
33337120|NCT00957528|62713928|FG001|Overall Study|Protocol Violation|1|||
33337121|NCT00957528|62713929|FG002|Overall Study|Protocol Violation|0|||
33337122|NCT00957528|62713927|FG000|Overall Study|Withdrawal by Subject|0|||
33337123|NCT00957528|62713928|FG001|Overall Study|Withdrawal by Subject|0|||
33337124|NCT00957528|62713929|FG002|Overall Study|Withdrawal by Subject|1|||
33337125|NCT00958776|62713939|FG000|Overall Study|Adverse Event|0|||
33337126|NCT00958776|62713940|FG001|Overall Study|Adverse Event|1|||
33337127|NCT00958776|62713939|FG000|Overall Study|Physician Decision|1|||
33337128|NCT00958776|62713940|FG001|Overall Study|Physician Decision|0|||
33337129|NCT00958776|62713939|FG000|Overall Study|Lost to Follow-up|2|||
33337130|NCT00958776|62713940|FG001|Overall Study|Lost to Follow-up|6|||
33337131|NCT00958776|62713939|FG000|Overall Study|Withdrawal by Subject|7|||
33337132|NCT00958776|62713940|FG001|Overall Study|Withdrawal by Subject|16|||
33337133|NCT00958776|62713939|FG000|Overall Study|Protocol Violation|1|||
33337134|NCT00958776|62713940|FG001|Overall Study|Protocol Violation|1|||
33337135|NCT00958776|62713939|FG000|Overall Study|Death|2|||
33337136|NCT00958776|62713940|FG001|Overall Study|Death|1|||
33337137|NCT00958776|62713939|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
33337138|NCT00958776|62713940|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
33337139|NCT00958776|62713939|FG000|Overall Study|Missing|1|||
33337140|NCT00958776|62713940|FG001|Overall Study|Missing|1|||
33337141|NCT00596830|62713949|FG000|Overall Study|Death|258|||
33337142|NCT00596830|62713950|FG001|Overall Study|Death|247|||
33337143|NCT00596830|62713949|FG000|Overall Study|Lost to Follow-up|7|||
33337144|NCT00596830|62713950|FG001|Overall Study|Lost to Follow-up|11|||
33337145|NCT00596830|62713949|FG000|Overall Study|Withdrawal by Subject|22|||
33337146|NCT00596830|62713950|FG001|Overall Study|Withdrawal by Subject|12|||
33337147|NCT00596830|62713949|FG000|Overall Study|Study terminated by sponsor|51|||
33337148|NCT00596830|62713950|FG001|Overall Study|Study terminated by sponsor|62|||
33337149|NCT00596830|62713949|FG000|Overall Study|Follow-up was discontinued|1|||
33337150|NCT00596830|62713950|FG001|Overall Study|Follow-up was discontinued|0|||
33337151|NCT00596830|62713949|FG000|Overall Study|Randomized but not treated|3|||
33337152|NCT00596830|62713950|FG001|Overall Study|Randomized but not treated|7|||
33337153|NCT00957372|62713959|FG000|PART I|Lost to Follow-up|0|||
33337154|NCT00957372|62713960|FG001|PART I|Lost to Follow-up|0|||
33337155|NCT00957372|62713961|FG002|PART I|Lost to Follow-up|1|||
33337156|NCT00957372|62713962|FG003|PART I|Lost to Follow-up|0|||
33337157|NCT00957372|62713959|FG000|PART II|Withdrawal by Subject|0|||
33337158|NCT00957372|62713960|FG001|PART II|Withdrawal by Subject|0|||
33337159|NCT00957372|62713961|FG002|PART II|Withdrawal by Subject|0|||
33337160|NCT00957372|62713962|FG003|PART II|Withdrawal by Subject|8|||
33337161|NCT00957372|62713959|FG000|PART II|Physician Decision|0|||
33337162|NCT00957372|62713960|FG001|PART II|Physician Decision|0|||
33337163|NCT00957372|62713961|FG002|PART II|Physician Decision|0|||
33337164|NCT00957372|62713962|FG003|PART II|Physician Decision|1|||
33337165|NCT00957372|62713959|FG000|PART II|Pregnancy|0|||
33337166|NCT00957372|62713960|FG001|PART II|Pregnancy|0|||
33337167|NCT00957372|62713961|FG002|PART II|Pregnancy|0|||
33337168|NCT00957372|62713962|FG003|PART II|Pregnancy|1|||
33337169|NCT00957372|62713959|FG000|PART II|Not Know|0|||
33337170|NCT00957372|62713960|FG001|PART II|Not Know|0|||
33337171|NCT00957372|62713961|FG002|PART II|Not Know|0|||
33337172|NCT00957372|62713962|FG003|PART II|Not Know|20|||
33337173|NCT00957372|62713959|FG000|PART II|Adverse Event|0|||
33337174|NCT00957372|62713960|FG001|PART II|Adverse Event|0|||
33337175|NCT00957372|62713961|FG002|PART II|Adverse Event|0|||
33337176|NCT00957372|62713962|FG003|PART II|Adverse Event|10|||
33337177|NCT00957372|62713959|FG000|PART II|Patient non-compliance|0|||
33469252|NCT00266825|62843003|FG001|Completed Follow-Up|Lost to Follow-up|19|||
33469253|NCT00266825|62843002|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
33469254|NCT00266825|62843003|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
33469255|NCT00265889|62843011|FG000|Overall Study|Physician Decision|1|||
33469256|NCT00265889|62843011|FG000|Overall Study|Protocol Violation|1|||
33469257|NCT00265889|62843011|FG000|Overall Study|Insurance denied the request|3|||
33469258|NCT03209362|62843017|FG000|Overall Study|Adverse Event|0|||
33469259|NCT03209362|62843018|FG001|Overall Study|Adverse Event|1|||
33469260|NCT03209362|62843017|FG000|Overall Study|Lost to Follow-up|0|||
33469261|NCT03209362|62843018|FG001|Overall Study|Lost to Follow-up|1|||
33337178|NCT00957372|62713960|FG001|PART II|Patient non-compliance|0|||
33337179|NCT00957372|62713961|FG002|PART II|Patient non-compliance|0|||
33337180|NCT00957372|62713962|FG003|PART II|Patient non-compliance|4|||
33337181|NCT00952848|62713978|FG000|Overall Study|Withdrawal by Subject|4|||
33337182|NCT00952614|62713982|FG000|Overall Study|Death|3|||
33469262|NCT03209362|62843017|FG000|Overall Study|Withdrawal by Subject|2|||
33469263|NCT03209362|62843018|FG001|Overall Study|Withdrawal by Subject|0|||
33469264|NCT03209362|62843017|FG000|Overall Study|Other|0|||
33337183|NCT00952614|62713982|FG000|Overall Study|Lost to Follow-up|3|||
33337184|NCT00952614|62713982|FG000|Overall Study|other reason|1|||
33337185|NCT00911859|62713990|FG000|Treatment Period|Adverse Event|3|||
33337186|NCT00911859|62713991|FG001|Treatment Period|Adverse Event|3|||
33337187|NCT00911859|62713992|FG002|Treatment Period|Adverse Event|7|||
33337188|NCT00911859|62713990|FG000|Treatment Period|Death|1|||
33337189|NCT00911859|62713991|FG001|Treatment Period|Death|3|||
33337190|NCT00911859|62713992|FG002|Treatment Period|Death|5|||
33337191|NCT00911859|62713990|FG000|Treatment Period|Lack of Efficacy|1|||
33337192|NCT00911859|62713991|FG001|Treatment Period|Lack of Efficacy|7|||
33337193|NCT00911859|62713992|FG002|Treatment Period|Lack of Efficacy|5|||
33469265|NCT03209362|62843018|FG001|Overall Study|Other|1|||
33469266|NCT02932462|62843026|FG000|Overall Study|Adverse Event|1|||
33469267|NCT02932462|62843027|FG001|Overall Study|Adverse Event|2|||
33469268|NCT02932462|62843026|FG000|Overall Study|Lost to Follow-up|4|||
33469269|NCT02932462|62843027|FG001|Overall Study|Lost to Follow-up|1|||
33469270|NCT02932462|62843026|FG000|Overall Study|Protocol Violation|0|||
33469271|NCT02932462|62843027|FG001|Overall Study|Protocol Violation|5|||
33469272|NCT02932462|62843026|FG000|Overall Study|Withdrawal by Subject|1|||
33469273|NCT02932462|62843027|FG001|Overall Study|Withdrawal by Subject|4|||
33469274|NCT02932462|62843026|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33469275|NCT02932462|62843027|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33469276|NCT02932462|62843026|FG000|Overall Study|Progressive Disease|1|||
33469277|NCT02932462|62843027|FG001|Overall Study|Progressive Disease|0|||
33469278|NCT03206788|62843035|FG000|Overall Study|Withdrawal by Subject|0|||
33469279|NCT03206788|62843036|FG001|Overall Study|Withdrawal by Subject|1|||
33469280|NCT03206788|62843035|FG000|Overall Study|Adverse Event|0|||
33469281|NCT03206788|62843036|FG001|Overall Study|Adverse Event|1|||
33469282|NCT03206788|62843035|FG000|Overall Study|Physician Decision|0|||
33469283|NCT03206788|62843036|FG001|Overall Study|Physician Decision|1|||
33469284|NCT03205150|62843045|FG000|Overall Study|Protocol deviation|1|||
33469285|NCT03205150|62843046|FG001|Overall Study|Protocol deviation|3|||
33469286|NCT03205150|62843047|FG002|Overall Study|Protocol deviation|0|||
33469287|NCT03205150|62843045|FG000|Overall Study|Patient/guardian decision|0|||
33469288|NCT03205150|62843046|FG001|Overall Study|Patient/guardian decision|3|||
33469289|NCT03205150|62843047|FG002|Overall Study|Patient/guardian decision|0|||
33469290|NCT03205150|62843045|FG000|Overall Study|Adverse Event|1|||
33469291|NCT03205150|62843046|FG001|Overall Study|Adverse Event|1|||
33469292|NCT03205150|62843047|FG002|Overall Study|Adverse Event|1|||
33469293|NCT03205150|62843045|FG000|Overall Study|Lost to Follow-up|0|||
33469294|NCT03205150|62843046|FG001|Overall Study|Lost to Follow-up|0|||
33469295|NCT03205150|62843047|FG002|Overall Study|Lost to Follow-up|1|||
33469296|NCT02932306|62843058|FG000|Overall Study|Withdrawal by Subject|16|||
33469297|NCT02932306|62843059|FG001|Overall Study|Withdrawal by Subject|25|||
33469298|NCT02932306|62843058|FG000|Overall Study|Adverse Event|3|||
33469299|NCT02932306|62843059|FG001|Overall Study|Adverse Event|0|||
33469300|NCT02932306|62843058|FG000|Overall Study|Pregnancy|2|||
33469301|NCT02932306|62843059|FG001|Overall Study|Pregnancy|0|||
33469302|NCT02932306|62843058|FG000|Overall Study|Protocol Violation|1|||
33469303|NCT02932306|62843059|FG001|Overall Study|Protocol Violation|1|||
33469304|NCT02932306|62843058|FG000|Overall Study|Noncompliance with Study Drug|1|||
33469305|NCT02932306|62843059|FG001|Overall Study|Noncompliance with Study Drug|1|||
33469306|NCT02932306|62843058|FG000|Overall Study|Lost to Follow-up|36|||
33469307|NCT02932306|62843059|FG001|Overall Study|Lost to Follow-up|40|||
33469308|NCT02932306|62843058|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
33469309|NCT02932306|62843059|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
33469310|NCT02932306|62843058|FG000|Overall Study|Lack of Efficacy|0|||
33469311|NCT02932306|62843059|FG001|Overall Study|Lack of Efficacy|2|||
33469312|NCT02932306|62843058|FG000|Overall Study|Worsening condition|2|||
33469313|NCT02932306|62843059|FG001|Overall Study|Worsening condition|0|||
33469314|NCT02932306|62843058|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
33469315|NCT02932306|62843059|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
33469316|NCT02932228|62843067|FG000|Overall Study|Death|8|||
33469317|NCT02932228|62843068|FG001|Overall Study|Death|23|||
33469318|NCT02932228|62843067|FG000|Overall Study|not eligible upon chart review|2|||
33469319|NCT02932228|62843068|FG001|Overall Study|not eligible upon chart review|5|||
33469320|NCT02931838|62843082|FG000|Overall Study|Reason not provided by investigator|1|||
33469321|NCT02931838|62843083|FG001|Overall Study|Reason not provided by investigator|0|||
33469322|NCT02931838|62843084|FG002|Overall Study|Reason not provided by investigator|1|||
33469323|NCT02931838|62843085|FG003|Overall Study|Reason not provided by investigator|0|||
33469324|NCT02931838|62843086|FG004|Overall Study|Reason not provided by investigator|0|||
33469325|NCT02931838|62843087|FG005|Overall Study|Reason not provided by investigator|0|||
33469326|NCT02931838|62843082|FG000|Overall Study|Poor/non-compliance|0|||
33469327|NCT02931838|62843083|FG001|Overall Study|Poor/non-compliance|0|||
33469328|NCT02931838|62843084|FG002|Overall Study|Poor/non-compliance|1|||
33337194|NCT00911859|62713990|FG000|Treatment Period|Physician Decision|3|||
33469329|NCT02931838|62843085|FG003|Overall Study|Poor/non-compliance|0|||
33469330|NCT02931838|62843086|FG004|Overall Study|Poor/non-compliance|0|||
33469331|NCT02931838|62843087|FG005|Overall Study|Poor/non-compliance|0|||
33337195|NCT00911859|62713991|FG001|Treatment Period|Physician Decision|3|||
33469332|NCT02931838|62843082|FG000|Overall Study|Lack of Efficacy|5|||
33469333|NCT02931838|62843083|FG001|Overall Study|Lack of Efficacy|4|||
33337196|NCT00911859|62713992|FG002|Treatment Period|Physician Decision|3|||
33337197|NCT00911859|62713990|FG000|Treatment Period|Withdrawal by Subject|0|||
33337198|NCT00911859|62713991|FG001|Treatment Period|Withdrawal by Subject|4|||
33337199|NCT00911859|62713992|FG002|Treatment Period|Withdrawal by Subject|5|||
33337200|NCT00911859|62713990|FG000|Treatment Period|Did not receive study treatment|0|||
33337201|NCT00911859|62713991|FG001|Treatment Period|Did not receive study treatment|1|||
33337202|NCT00911859|62713992|FG002|Treatment Period|Did not receive study treatment|0|||
33337203|NCT00911859|62713990|FG000|Maintainance Period|Lack of Efficacy|0|||
33337204|NCT00911859|62713991|FG001|Maintainance Period|Lack of Efficacy|0|||
33337205|NCT00911859|62713992|FG002|Maintainance Period|Lack of Efficacy|9|||
33337206|NCT00911859|62713990|FG000|Maintainance Period|Physician Decision|0|||
33337207|NCT00911859|62713991|FG001|Maintainance Period|Physician Decision|0|||
33337208|NCT00911859|62713992|FG002|Maintainance Period|Physician Decision|9|||
33337209|NCT00911859|62713990|FG000|Maintainance Period|Withdrawal by Subject|0|||
33337210|NCT00911859|62713991|FG001|Maintainance Period|Withdrawal by Subject|0|||
33337211|NCT00911859|62713992|FG002|Maintainance Period|Withdrawal by Subject|3|||
33337212|NCT00911859|62713990|FG000|Follow-up Period|Death|5|||
33337213|NCT00911859|62713991|FG001|Follow-up Period|Death|8|||
33337214|NCT00911859|62713992|FG002|Follow-up Period|Death|10|||
33337215|NCT00911859|62713990|FG000|Follow-up Period|Lost to Follow-up|1|||
33337216|NCT00911859|62713991|FG001|Follow-up Period|Lost to Follow-up|1|||
33337217|NCT00911859|62713992|FG002|Follow-up Period|Lost to Follow-up|0|||
33337218|NCT00911859|62713990|FG000|Follow-up Period|Withdrawal by Subject|0|||
33337219|NCT00911859|62713991|FG001|Follow-up Period|Withdrawal by Subject|4|||
33337220|NCT00911859|62713992|FG002|Follow-up Period|Withdrawal by Subject|4|||
33337221|NCT00911859|62713990|FG000|Follow-up Period|Study terminated by sponsor|5|||
33469334|NCT02931838|62843084|FG002|Overall Study|Lack of Efficacy|0|||
33337222|NCT00911859|62713991|FG001|Follow-up Period|Study terminated by sponsor|33|||
33337223|NCT00911859|62713992|FG002|Follow-up Period|Study terminated by sponsor|27|||
33337224|NCT00956592|62714002|FG000|Overall Study|Protocol Violation|1|||
33337225|NCT00956592|62714003|FG001|Overall Study|Protocol Violation|3|||
33337226|NCT02725593|62714013|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
33337227|NCT02725593|62714014|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
33337228|NCT02725593|62714013|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
33337229|NCT02725593|62714014|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
33337230|NCT02725593|62714013|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
33337231|NCT02725593|62714014|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
33337232|NCT02725593|62714013|FG000|Long Term Extension|Withdrawal by Subject|1|||
33337233|NCT02725593|62714014|FG001|Long Term Extension|Withdrawal by Subject|3|||
33337234|NCT00911625|62714022|FG000|Overall Study|Lost to Follow-up|7|||
33337235|NCT00911625|62714023|FG001|Overall Study|Lost to Follow-up|0|||
33337236|NCT00596752|62714031|FG000|Overall Study|Other Reason|44|||
33337237|NCT00596752|62714032|FG001|Overall Study|Other Reason|49|||
33337238|NCT00596752|62714031|FG000|Overall Study|Adverse Event|34|||
33337239|NCT00596752|62714032|FG001|Overall Study|Adverse Event|34|||
33337240|NCT00596752|62714031|FG000|Overall Study|Lost to Follow-up|22|||
33337241|NCT00596752|62714032|FG001|Overall Study|Lost to Follow-up|38|||
33337242|NCT00596752|62714031|FG000|Overall Study|Withdrawal by Subject|12|||
33337243|NCT00596752|62714032|FG001|Overall Study|Withdrawal by Subject|9|||
33337244|NCT00596752|62714031|FG000|Overall Study|Unsatisfactory Compliance|9|||
33337245|NCT00596752|62714032|FG001|Overall Study|Unsatisfactory Compliance|6|||
33337246|NCT00596752|62714031|FG000|Overall Study|Lack of Efficacy|4|||
33337247|NCT00596752|62714032|FG001|Overall Study|Lack of Efficacy|7|||
33337248|NCT00596752|62714031|FG000|Overall Study|Protocol Violation|1|||
33337249|NCT00596752|62714032|FG001|Overall Study|Protocol Violation|0|||
33337250|NCT00958074|62714040|FG000|Overall Study|Withdrawal by Subject|0|||
33337251|NCT00958074|62714041|FG001|Overall Study|Withdrawal by Subject|1|||
33337252|NCT00809965|62714050|FG000|Overall Study|Death|194|||
33337253|NCT00809965|62714051|FG001|Overall Study|Death|147|||
33337254|NCT00809965|62714052|FG002|Overall Study|Death|196|||
33337255|NCT00809965|62714050|FG000|Overall Study|Lost to Follow-up|17|||
33337256|NCT00809965|62714051|FG001|Overall Study|Lost to Follow-up|10|||
33337257|NCT00809965|62714052|FG002|Overall Study|Lost to Follow-up|18|||
33337258|NCT00809965|62714050|FG000|Overall Study|Withdrawal by Subject|405|||
33337259|NCT00809965|62714051|FG001|Overall Study|Withdrawal by Subject|448|||
33337260|NCT00809965|62714052|FG002|Overall Study|Withdrawal by Subject|441|||
33337261|NCT00809965|62714050|FG000|Overall Study|Other Reason|167|||
33337262|NCT00809965|62714051|FG001|Overall Study|Other Reason|170|||
33337263|NCT00809965|62714052|FG002|Overall Study|Other Reason|189|||
33337264|NCT00597376|62714062|FG000|Overall Study|Withdrawal by Subject|4|||
33337265|NCT00597376|62714063|FG001|Overall Study|Withdrawal by Subject|3|||
33337266|NCT00597376|62714062|FG000|Overall Study|Adverse Event|4|||
33337267|NCT00597376|62714063|FG001|Overall Study|Adverse Event|1|||
33337268|NCT00910689|62714099|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
33337269|NCT00910689|62714100|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
33337270|NCT00910689|62714101|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
33337271|NCT00910689|62714102|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
33337272|NCT00910689|62714099|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
33469335|NCT02931838|62843085|FG003|Overall Study|Lack of Efficacy|0|||
33469336|NCT02931838|62843086|FG004|Overall Study|Lack of Efficacy|0|||
33469337|NCT02931838|62843087|FG005|Overall Study|Lack of Efficacy|1|||
33469338|NCT02931838|62843082|FG000|Overall Study|Lost to Follow-up|1|||
33469339|NCT02931838|62843083|FG001|Overall Study|Lost to Follow-up|0|||
33548766|NCT02480764|62940070|FG002|Overall Study|Voluntary Withdrawal|10|||
33548767|NCT02480764|62940068|FG000|Overall Study|Lack of Efficacy|0|||
33469340|NCT02931838|62843084|FG002|Overall Study|Lost to Follow-up|1|||
33469341|NCT02931838|62843085|FG003|Overall Study|Lost to Follow-up|1|||
33337273|NCT00910689|62714100|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
33337274|NCT00910689|62714101|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
33337275|NCT00910689|62714102|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
33337276|NCT00910689|62714099|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
33337277|NCT00910689|62714100|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
33337278|NCT00910689|62714101|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
33469342|NCT02931838|62843086|FG004|Overall Study|Lost to Follow-up|2|||
33469343|NCT02931838|62843087|FG005|Overall Study|Lost to Follow-up|0|||
33469344|NCT02931838|62843082|FG000|Overall Study|Subject request to discontinue treatment|4|||
33469345|NCT02931838|62843083|FG001|Overall Study|Subject request to discontinue treatment|3|||
33337279|NCT00910689|62714102|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
33337280|NCT00910689|62714099|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
33337281|NCT00910689|62714100|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
33337282|NCT00910689|62714101|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
33337283|NCT00910689|62714102|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
33469346|NCT02931838|62843084|FG002|Overall Study|Subject request to discontinue treatment|3|||
33337284|NCT00910689|62714099|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
33337285|NCT00910689|62714100|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
33337286|NCT00910689|62714101|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
33337287|NCT00910689|62714102|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
33337288|NCT00910689|62714099|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
33337289|NCT00910689|62714100|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
33337290|NCT00910689|62714101|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
33337291|NCT00910689|62714102|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
33337292|NCT00910689|62714099|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
33337293|NCT00910689|62714100|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
33337294|NCT00910689|62714101|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
33337295|NCT00910689|62714102|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
33337296|NCT00910689|62714099|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
33337297|NCT00910689|62714100|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
33337298|NCT00910689|62714101|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
33337299|NCT00910689|62714102|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
33337300|NCT00910689|62714099|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
33337301|NCT00910689|62714100|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
33337302|NCT00910689|62714101|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
33337303|NCT00910689|62714102|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
33337304|NCT00910689|62714099|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
33337305|NCT00910689|62714100|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
33337306|NCT00910689|62714101|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
33337307|NCT00910689|62714102|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
33337308|NCT00910689|62714099|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
33337309|NCT00910689|62714100|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
33337310|NCT00910689|62714101|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
33337311|NCT00910689|62714102|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
33337312|NCT00910689|62714099|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
33337313|NCT00910689|62714100|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
33337314|NCT00910689|62714101|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
33337315|NCT00910689|62714102|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
33337316|NCT00910689|62714099|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
33337317|NCT00910689|62714100|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
33337318|NCT00910689|62714101|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
33337319|NCT00910689|62714102|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
33337320|NCT00910689|62714099|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
33337321|NCT00910689|62714100|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
33337322|NCT00910689|62714101|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
33337323|NCT00910689|62714102|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
33337324|NCT00910689|62714099|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
33337325|NCT00910689|62714100|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
33337326|NCT00910689|62714101|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
33337327|NCT00910689|62714102|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
33337328|NCT00910689|62714099|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
33337329|NCT00910689|62714100|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
33337330|NCT00910689|62714101|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
33337331|NCT00910689|62714102|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
33337332|NCT00910689|62714099|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
33337333|NCT00910689|62714100|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
33337334|NCT00910689|62714101|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
33337335|NCT00910689|62714102|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
33337336|NCT00910689|62714099|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
33337337|NCT00910689|62714100|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
33337338|NCT00910689|62714101|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
33337339|NCT00910689|62714102|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
33337340|NCT00910689|62714099|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
33337341|NCT00910689|62714100|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
33337342|NCT00910689|62714101|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
33337343|NCT00910689|62714102|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
33337344|NCT00910689|62714099|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
33337345|NCT00910689|62714100|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
33337346|NCT00910689|62714101|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
33337347|NCT00910689|62714102|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
33548768|NCT02480764|62940069|FG001|Overall Study|Lack of Efficacy|3|||
33337348|NCT00910689|62714099|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
33337349|NCT00910689|62714100|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
33337350|NCT00910689|62714101|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
33337351|NCT00910689|62714102|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
33337352|NCT00807001|62714117|FG000|Overall Study|Non-compliance|0|||
33337353|NCT00807001|62714118|FG001|Overall Study|Non-compliance|1|||
33337354|NCT00807001|62714119|FG002|Overall Study|Non-compliance|0|||
33337355|NCT00807001|62714120|FG003|Overall Study|Non-compliance|0|||
33337356|NCT00807001|62714121|FG004|Overall Study|Non-compliance|0|||
33337357|NCT00809341|62714135|FG000|Overall Study|Physician Decision|0|||
33337358|NCT00809341|62714136|FG001|Overall Study|Physician Decision|1|||
33337359|NCT01125800|62714147|FG000|Phase I|Protocol Violation|0|||
33337360|NCT01125800|62714148|FG001|Phase I|Protocol Violation|3|||
33337361|NCT01125800|62714149|FG002|Phase I|Protocol Violation|1|||
33337362|NCT01125800|62714150|FG003|Phase I|Protocol Violation|1|||
33337363|NCT01125800|62714151|FG004|Phase I|Protocol Violation|0|||
33337364|NCT01125800|62714147|FG000|Phase I|Adverse Event|2|||
33337365|NCT01125800|62714148|FG001|Phase I|Adverse Event|2|||
33337366|NCT01125800|62714149|FG002|Phase I|Adverse Event|1|||
33337367|NCT01125800|62714150|FG003|Phase I|Adverse Event|7|||
33337368|NCT01125800|62714151|FG004|Phase I|Adverse Event|0|||
33337369|NCT01125800|62714147|FG000|Phase I|Administrative problems|1|||
33337370|NCT01125800|62714148|FG001|Phase I|Administrative problems|0|||
33337371|NCT01125800|62714149|FG002|Phase I|Administrative problems|0|||
33337372|NCT01125800|62714150|FG003|Phase I|Administrative problems|0|||
33337373|NCT01125800|62714151|FG004|Phase I|Administrative problems|0|||
33337374|NCT01125800|62714147|FG000|Phase I|Withdrawal by Subject|0|||
33337375|NCT01125800|62714148|FG001|Phase I|Withdrawal by Subject|0|||
33337376|NCT01125800|62714149|FG002|Phase I|Withdrawal by Subject|1|||
33337377|NCT01125800|62714150|FG003|Phase I|Withdrawal by Subject|0|||
33337378|NCT01125800|62714151|FG004|Phase I|Withdrawal by Subject|0|||
33337379|NCT01125800|62714147|FG000|Phase I|Disease progression|5|||
33337380|NCT01125800|62714148|FG001|Phase I|Disease progression|4|||
33337381|NCT01125800|62714149|FG002|Phase I|Disease progression|1|||
33337382|NCT01125800|62714150|FG003|Phase I|Disease progression|3|||
33337383|NCT01125800|62714151|FG004|Phase I|Disease progression|0|||
33337384|NCT01125800|62714147|FG000|Phase II|Protocol Violation|0|||
33337385|NCT01125800|62714148|FG001|Phase II|Protocol Violation|0|||
33337386|NCT01125800|62714149|FG002|Phase II|Protocol Violation|0|||
33337387|NCT01125800|62714150|FG003|Phase II|Protocol Violation|0|||
33337388|NCT01125800|62714151|FG004|Phase II|Protocol Violation|1|||
33337389|NCT01125800|62714147|FG000|Phase II|Adverse Event|0|||
33337390|NCT01125800|62714148|FG001|Phase II|Adverse Event|0|||
33337391|NCT01125800|62714149|FG002|Phase II|Adverse Event|0|||
33337392|NCT01125800|62714150|FG003|Phase II|Adverse Event|0|||
33337393|NCT01125800|62714151|FG004|Phase II|Adverse Event|2|||
33337394|NCT01125800|62714147|FG000|Phase II|Disease progression|0|||
33337395|NCT01125800|62714148|FG001|Phase II|Disease progression|0|||
33337396|NCT01125800|62714149|FG002|Phase II|Disease progression|0|||
33337397|NCT01125800|62714150|FG003|Phase II|Disease progression|1|||
33469347|NCT02931838|62843085|FG003|Overall Study|Subject request to discontinue treatment|0|||
33469348|NCT02931838|62843086|FG004|Overall Study|Subject request to discontinue treatment|1|||
33469349|NCT02931838|62843087|FG005|Overall Study|Subject request to discontinue treatment|0|||
33469350|NCT02931838|62843082|FG000|Overall Study|Withdrawal by Subject|1|||
33469351|NCT02931838|62843083|FG001|Overall Study|Withdrawal by Subject|2|||
33469352|NCT02931838|62843084|FG002|Overall Study|Withdrawal by Subject|0|||
33469353|NCT02931838|62843085|FG003|Overall Study|Withdrawal by Subject|1|||
33469354|NCT02931838|62843086|FG004|Overall Study|Withdrawal by Subject|0|||
33469355|NCT02931838|62843087|FG005|Overall Study|Withdrawal by Subject|0|||
33469356|NCT02931838|62843082|FG000|Overall Study|Adverse Event|2|||
33469357|NCT02931838|62843083|FG001|Overall Study|Adverse Event|1|||
33337398|NCT01125800|62714151|FG004|Phase II|Disease progression|8|||
33337399|NCT01125722|62714168|FG000|Overall Study|Withdrawal by Subject|2|||
33337400|NCT01125722|62714169|FG001|Overall Study|Withdrawal by Subject|1|||
33337401|NCT01125722|62714168|FG000|Overall Study|Lost to Follow-up|1|||
33337402|NCT01125722|62714169|FG001|Overall Study|Lost to Follow-up|0|||
33337403|NCT00811135|62714175|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
33469358|NCT02931838|62843084|FG002|Overall Study|Adverse Event|2|||
33469359|NCT02931838|62843085|FG003|Overall Study|Adverse Event|1|||
33337404|NCT00811135|62714175|FG000|Overall Study|Death|3|||
33337405|NCT00811135|62714175|FG000|Overall Study|Protocol Violation|2|||
33337406|NCT00811135|62714175|FG000|Overall Study|Violation of Selection Criteria|1|||
33337407|NCT00811135|62714175|FG000|Overall Study|Refused Treatment|1|||
33469360|NCT02931838|62843086|FG004|Overall Study|Adverse Event|3|||
33337408|NCT00811135|62714175|FG000|Overall Study|Withdrawal by Subject|3|||
33337409|NCT00811135|62714175|FG000|Overall Study|Administrative/Other Unspecified|11|||
33337410|NCT00811135|62714175|FG000|Overall Study|Ongoing|59|||
33337411|NCT00811057|62714182|FG000|Overall Study|Protocol Violation|5|||
33337412|NCT00811057|62714183|FG001|Overall Study|Protocol Violation|10|||
33337413|NCT00811057|62714184|FG002|Overall Study|Protocol Violation|10|||
33337414|NCT00879970|62714195|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
33337415|NCT00879970|62714196|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
33469361|NCT02931838|62843087|FG005|Overall Study|Adverse Event|1|||
33469362|NCT03201562|62843109|FG000|Overall Study|Physician Decision|0|||
33469363|NCT03201562|62843110|FG001|Overall Study|Physician Decision|0|||
33469364|NCT03201562|62843111|FG002|Overall Study|Physician Decision|1|||
33469365|NCT03201562|62843109|FG000|Overall Study|Adverse Event|0|||
33469366|NCT03201562|62843110|FG001|Overall Study|Adverse Event|0|||
33469367|NCT03201562|62843111|FG002|Overall Study|Adverse Event|1|||
33469368|NCT03201562|62843109|FG000|Overall Study|Lost to Follow-up|0|||
33469369|NCT03201562|62843110|FG001|Overall Study|Lost to Follow-up|1|||
33469370|NCT03201562|62843111|FG002|Overall Study|Lost to Follow-up|2|||
33469371|NCT03200860|62843121|FG000|Overall Study|Withdrawal by Subject|1|||
33469372|NCT03200860|62843122|FG001|Overall Study|Withdrawal by Subject|0|||
33469373|NCT03198754|62843130|FG000|Overall Study|Withdrawal by Subject|5|||
33469374|NCT03198754|62843131|FG001|Overall Study|Withdrawal by Subject|4|||
33469375|NCT03198754|62843130|FG000|Overall Study|Lost to Follow-up|4|||
33469376|NCT03198754|62843131|FG001|Overall Study|Lost to Follow-up|3|||
33469377|NCT03198754|62843130|FG000|Overall Study|Ineligible|2|||
33469378|NCT03198754|62843131|FG001|Overall Study|Ineligible|1|||
33469379|NCT03198520|62843137|FG000|Overall Study|Physician Decision|2|||
33469380|NCT03198520|62843137|FG000|Overall Study|Protocol Violation|2|||
33469381|NCT03198520|62843137|FG000|Overall Study|Withdrawal by Subject|1|||
33469382|NCT03198520|62843137|FG000|Overall Study|Study Ended|1|||
33469383|NCT03194464|62843149|FG000|Overall Study|data not usable|2|||
33469384|NCT03192904|62843157|FG000|Overall Study|Physician Decision|3|||
33469385|NCT03192904|62843158|FG001|Overall Study|Physician Decision|1|||
33469386|NCT03192904|62843157|FG000|Overall Study|Lost to Follow-up|0|||
33469387|NCT03192904|62843158|FG001|Overall Study|Lost to Follow-up|1|||
33469388|NCT03188536|62843164|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
33469389|NCT03188536|62843164|FG000|Overall Study|Not participated/met inclusion criteria|1|||
33469390|NCT03187756|62843168|FG000|Overall Study|Termination of study|4|||
33469391|NCT03187132|62843174|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
33469392|NCT03187132|62843175|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
33469393|NCT03187132|62843174|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
33469394|NCT03187132|62843175|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
33469395|NCT03187132|62843174|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
33469396|NCT03187132|62843175|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
33548769|NCT02480764|62940070|FG002|Overall Study|Lack of Efficacy|3|||
33548770|NCT02480764|62940068|FG000|Overall Study|Reason not Specified|0|||
33548771|NCT02480764|62940069|FG001|Overall Study|Reason not Specified|1|||
33548772|NCT02480764|62940070|FG002|Overall Study|Reason not Specified|0|||
33548773|NCT02487472|62940078|FG000|Overall Study|Did not complete telephonic interviews|9|||
33548774|NCT02487472|62940078|FG000|Overall Study|Other|2|||
33548775|NCT02451670|62940086|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
33548776|NCT02451670|62940087|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
33548777|NCT02486692|62940095|FG000|Overall Study|did not login for randomization|4|||
33548778|NCT02486692|62940096|FG001|Overall Study|did not login for randomization|7|||
33548779|NCT01060007|62940113|FG000|Overall Study|Withdrawal by Subject|1|||
33548780|NCT01060007|62940113|FG000|Overall Study|Inevaluable for response at surgery|3|||
33548781|NCT02971163|62940122|FG000|Overall Study|Lost to Follow-up|4|||
33548782|NCT02971163|62940123|FG001|Overall Study|Lost to Follow-up|2|||
33548783|NCT02971007|62940132|FG000|Overall Study|Adverse Event|1|||
33548784|NCT02971007|62940133|FG001|Overall Study|Adverse Event|0|||
33548785|NCT02971007|62940134|FG002|Overall Study|Adverse Event|0|||
33548786|NCT02971007|62940132|FG000|Overall Study|Lost to Follow-up|0|||
33548787|NCT02971007|62940133|FG001|Overall Study|Lost to Follow-up|1|||
33548788|NCT02971007|62940134|FG002|Overall Study|Lost to Follow-up|1|||
33548789|NCT02971007|62940132|FG000|Overall Study|Withdrawal by Subject|0|||
33548790|NCT02971007|62940133|FG001|Overall Study|Withdrawal by Subject|1|||
33548791|NCT02971007|62940134|FG002|Overall Study|Withdrawal by Subject|0|||
33548792|NCT02971007|62940132|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
33548793|NCT02971007|62940133|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
33548794|NCT02971007|62940134|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
33548795|NCT02971007|62940132|FG000|Overall Study|Patient discontinued study drug|0|||
33548796|NCT02971007|62940133|FG001|Overall Study|Patient discontinued study drug|1|||
33548797|NCT02971007|62940134|FG002|Overall Study|Patient discontinued study drug|0|||
33548798|NCT03881553|62940145|FG000|Overall Study|Discharged prior to participation|1|||
33548799|NCT03881553|62940146|FG001|Overall Study|Discharged prior to participation|1|||
33469397|NCT03187132|62843174|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
33469398|NCT03187132|62843175|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
33469399|NCT03187132|62843174|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
33548800|NCT03881553|62940147|FG002|Overall Study|Discharged prior to participation|0|||
33548801|NCT03881553|62940145|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
33580903|NCT01454934|62978058|FG001|Overall Study|Clinical progression|25|||
33469400|NCT03187132|62843175|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
33469401|NCT03187132|62843174|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
33469402|NCT03187132|62843175|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
33469403|NCT03187132|62843174|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
33469404|NCT03187132|62843175|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
33469405|NCT03187132|62843174|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
33469406|NCT03187132|62843175|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
33469407|NCT03187132|62843174|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
33469408|NCT03187132|62843175|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
33469409|NCT03187132|62843174|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
33469410|NCT03187132|62843175|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
33469411|NCT03187132|62843174|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
33469412|NCT03187132|62843175|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
33469413|NCT03184558|62843181|FG000|Overall Study|Withdrawal by Subject|2|||
33469414|NCT03184558|62843181|FG000|Overall Study|Death|16|||
33469415|NCT03184558|62843181|FG000|Overall Study|Lost to Follow-up|2|||
33469416|NCT03184558|62843181|FG000|Overall Study|Other|9|||
33469417|NCT03183778|62843185|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
33469418|NCT03182686|62843191|FG000|Overall Study|Lost to Follow-up|2|||
33469419|NCT03182686|62843192|FG001|Overall Study|Lost to Follow-up|0|||
33469420|NCT03182686|62843191|FG000|Overall Study|Adverse Event|2|||
33469421|NCT03182686|62843192|FG001|Overall Study|Adverse Event|0|||
33469422|NCT03182686|62843191|FG000|Overall Study|Withdrawal by Subject|3|||
33469423|NCT03182686|62843192|FG001|Overall Study|Withdrawal by Subject|0|||
33469424|NCT03181594|62843198|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
33469425|NCT03181594|62843198|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
33469426|NCT03181594|62843198|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
33469427|NCT03181594|62843198|FG000|Initial Study Protocol (12-month FU)|Death|1|||
33469428|NCT03181594|62843198|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
33469429|NCT03181594|62843198|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
33469430|NCT03180736|62843204|FG000|Overall Study|Adverse Event|3|||
33469431|NCT03180736|62843205|FG001|Overall Study|Adverse Event|4|||
33469432|NCT03180736|62843204|FG000|Overall Study|Death|10|||
33469433|NCT03180736|62843205|FG001|Overall Study|Death|7|||
33469434|NCT03180736|62843204|FG000|Overall Study|Withdrawal by Subject|5|||
33469435|NCT03180736|62843205|FG001|Overall Study|Withdrawal by Subject|12|||
33469436|NCT03180736|62843204|FG000|Overall Study|Lost to Follow-up|1|||
33469437|NCT03180736|62843205|FG001|Overall Study|Lost to Follow-up|0|||
33469438|NCT03180736|62843204|FG000|Overall Study|Lack of Efficacy|66|||
33469439|NCT03180736|62843205|FG001|Overall Study|Lack of Efficacy|87|||
33469440|NCT03180736|62843204|FG000|Overall Study|Physician Decision|4|||
33469441|NCT03180736|62843205|FG001|Overall Study|Physician Decision|7|||
33469442|NCT03180736|62843204|FG000|Overall Study|randomized but not treated|2|||
33469443|NCT03180736|62843205|FG001|Overall Study|randomized but not treated|3|||
33469444|NCT03178942|62843218|FG000|Overall Study|Withdrawal by Subject|2|||
33469445|NCT03178942|62843219|FG001|Overall Study|Withdrawal by Subject|0|||
33337416|NCT00879970|62714197|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
33337417|NCT00879970|62714198|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
33337418|NCT00879970|62714199|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
33337419|NCT00879970|62714195|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
33469446|NCT03178942|62843218|FG000|Overall Study|Lost to Follow-up|1|||
33469447|NCT03178942|62843219|FG001|Overall Study|Lost to Follow-up|2|||
33469448|NCT03175198|62843225|FG000|Overall Study|Adverse Event|480|||
33469449|NCT03175198|62843225|FG000|Overall Study|No actual visit|120|||
33469450|NCT03175198|62843225|FG000|Overall Study|Registration rule not followed|4|||
33469451|NCT03175198|62843225|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
33469452|NCT03175198|62843225|FG000|Overall Study|Other personal reason|509|||
33469453|NCT03175198|62843225|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
33469454|NCT03175198|62843225|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
33469455|NCT03175198|62843225|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
33469456|NCT03175198|62843225|FG000|Overall Study|To conduct invasive treatment of operation|53|||
33469457|NCT03175198|62843225|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
33469458|NCT03175120|62843231|FG000|Overall Study|Adverse Event|2|||
33469459|NCT03175120|62843232|FG001|Overall Study|Adverse Event|2|||
33469460|NCT03175120|62843231|FG000|Overall Study|Protocol Violation|5|||
33469461|NCT03175120|62843232|FG001|Overall Study|Protocol Violation|2|||
33469462|NCT03175120|62843231|FG000|Overall Study|Lost to Follow-up|1|||
33469463|NCT03175120|62843232|FG001|Overall Study|Lost to Follow-up|0|||
33469464|NCT03175120|62843231|FG000|Overall Study|Withdrawal by Subject|2|||
33469465|NCT03175120|62843232|FG001|Overall Study|Withdrawal by Subject|5|||
33469466|NCT03175120|62843231|FG000|Overall Study|Other|2|||
33469467|NCT03175120|62843232|FG001|Overall Study|Other|3|||
33337420|NCT00879970|62714196|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
33337421|NCT00879970|62714197|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
33337422|NCT00879970|62714198|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
33469468|NCT03172702|62843238|FG000|Overall Study|Adverse Event|9|||
33337423|NCT00879970|62714199|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
33337424|NCT00879970|62714195|FG000|Period 1 TZD Randomization|Death|2|||
33337425|NCT00879970|62714196|FG001|Period 1 TZD Randomization|Death|1|||
33337426|NCT00879970|62714197|FG002|Period 1 TZD Randomization|Death|0|||
33337427|NCT00879970|62714198|FG003|Period 1 TZD Randomization|Death|0|||
33337428|NCT00879970|62714199|FG004|Period 1 TZD Randomization|Death|0|||
33337429|NCT00879970|62714195|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
33337430|NCT00879970|62714196|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
33337431|NCT00879970|62714197|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
33337432|NCT00879970|62714198|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
33337433|NCT00879970|62714199|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
33337434|NCT00879970|62714195|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
33337435|NCT00879970|62714196|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
33337436|NCT00879970|62714197|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
33337437|NCT00879970|62714198|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
33337438|NCT00879970|62714199|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
33337439|NCT00879970|62714195|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
33337440|NCT00879970|62714196|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
33337441|NCT00879970|62714197|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
33337442|NCT00879970|62714198|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
33337443|NCT00879970|62714199|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
33337444|NCT00879970|62714195|FG000|Period 2 Vitamin D Randomization|Death|0|||
33337445|NCT00879970|62714196|FG001|Period 2 Vitamin D Randomization|Death|0|||
33337446|NCT00879970|62714197|FG002|Period 2 Vitamin D Randomization|Death|0|||
33337447|NCT00879970|62714198|FG003|Period 2 Vitamin D Randomization|Death|2|||
33337448|NCT00879970|62714199|FG004|Period 2 Vitamin D Randomization|Death|0|||
33337449|NCT00808639|62714217|FG000|Overall Study|Disease progression before surgery.|1|||
33337450|NCT00810901|62714223|FG000|Overall Study|Lost to Follow-up|88|||
33469469|NCT03172702|62843238|FG000|Overall Study|Death|2|||
33469470|NCT03172702|62843238|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
33469471|NCT03172702|62843238|FG000|Overall Study|Withdrawal by Subject|5|||
33469472|NCT03172702|62843238|FG000|Overall Study|Other|2|||
33469473|NCT02795182|62843247|FG000|Overall Study|Death|5|||
33469474|NCT02795182|62843248|FG001|Overall Study|Death|4|||
33469475|NCT02795182|62843249|FG002|Overall Study|Death|4|||
33469476|NCT02795182|62843250|FG003|Overall Study|Death|18|||
33469477|NCT02795182|62843247|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
33469478|NCT02795182|62843248|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
33469479|NCT02795182|62843249|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
33469480|NCT02795182|62843250|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
33469481|NCT02795182|62843247|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
33469482|NCT02795182|62843248|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
33469483|NCT02795182|62843249|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
33469484|NCT02795182|62843250|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
33469485|NCT02795182|62843247|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
33469486|NCT02795182|62843248|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
33469487|NCT02795182|62843249|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
33469488|NCT02795182|62843250|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
33469489|NCT02795182|62843247|FG000|Overall Study|Withdrawal by Subject|4|||
33469490|NCT02795182|62843248|FG001|Overall Study|Withdrawal by Subject|0|||
33469491|NCT02795182|62843249|FG002|Overall Study|Withdrawal by Subject|0|||
33469492|NCT02795182|62843250|FG003|Overall Study|Withdrawal by Subject|3|||
33469493|NCT02795182|62843247|FG000|Overall Study|Lost to Follow-up|0|||
33469494|NCT02795182|62843248|FG001|Overall Study|Lost to Follow-up|0|||
33469495|NCT02795182|62843249|FG002|Overall Study|Lost to Follow-up|1|||
33469496|NCT02795182|62843250|FG003|Overall Study|Lost to Follow-up|1|||
33469497|NCT02795182|62843247|FG000|Overall Study|Roll Over to Long Term Extension|3|||
33469498|NCT02795182|62843248|FG001|Overall Study|Roll Over to Long Term Extension|3|||
33469499|NCT02795182|62843249|FG002|Overall Study|Roll Over to Long Term Extension|2|||
33469500|NCT02795182|62843250|FG003|Overall Study|Roll Over to Long Term Extension|5|||
33469501|NCT02795182|62843247|FG000|Overall Study|Progressive Disease|0|||
33337451|NCT00810901|62714224|FG001|Overall Study|Lost to Follow-up|58|||
33337452|NCT00910299|62714232|FG000|Overall Study|Withdrawal by Subject|16|||
33337453|NCT00910299|62714233|FG001|Overall Study|Withdrawal by Subject|13|||
33337454|NCT00910299|62714232|FG000|Overall Study|Sponsor Decision|58|||
33337455|NCT00910299|62714233|FG001|Overall Study|Sponsor Decision|60|||
33469502|NCT02795182|62843248|FG001|Overall Study|Progressive Disease|1|||
33337456|NCT00910299|62714232|FG000|Overall Study|Didn't receive any study drug|2|||
33337457|NCT00910299|62714233|FG001|Overall Study|Didn't receive any study drug|1|||
33337458|NCT00595504|62714241|FG000|Overall Study|Withdrawal by Subject|1|||
33337459|NCT00595504|62714242|FG001|Overall Study|Withdrawal by Subject|3|||
33337460|NCT00595504|62714241|FG000|Overall Study|Physician Decision|1|||
33337461|NCT00595504|62714242|FG001|Overall Study|Physician Decision|0|||
33337462|NCT00808483|62714250|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
33337463|NCT00808483|62714251|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
33337464|NCT00808483|62714250|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
33337465|NCT00808483|62714251|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
33337466|NCT00808483|62714250|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
33337467|NCT00808483|62714251|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
33337468|NCT00810511|62714266|FG000|Overall Study|Protocol Violation|0|||
33337469|NCT00810511|62714267|FG001|Overall Study|Protocol Violation|1|||
33337470|NCT00810511|62714266|FG000|Overall Study|Lack of Efficacy|9|||
33337471|NCT00810511|62714267|FG001|Overall Study|Lack of Efficacy|1|||
33337472|NCT00810511|62714266|FG000|Overall Study|death in the family|0|||
33337473|NCT00810511|62714267|FG001|Overall Study|death in the family|1|||
33337474|NCT00810511|62714266|FG000|Overall Study|Lost to Follow-up|1|||
33337475|NCT00810511|62714267|FG001|Overall Study|Lost to Follow-up|0|||
33337476|NCT00810511|62714266|FG000|Overall Study|deposits on contact lens|0|||
33337477|NCT00810511|62714267|FG001|Overall Study|deposits on contact lens|1|||
33337478|NCT00596362|62714273|FG000|Overall Study|Progressive Disease|1|||
33337479|NCT00907803|62714280|FG000|Overall Study|Withdrawal of consent - long commute|1|||
33337480|NCT00907803|62714281|FG001|Overall Study|Withdrawal of consent - long commute|0|||
33337481|NCT00907803|62714282|FG002|Overall Study|Withdrawal of consent - long commute|0|||
33337482|NCT00907803|62714280|FG000|Overall Study|Adverse Event|2|||
33337483|NCT00907803|62714281|FG001|Overall Study|Adverse Event|0|||
33337484|NCT00907803|62714282|FG002|Overall Study|Adverse Event|0|||
33337485|NCT00907803|62714280|FG000|Overall Study|Withdrawal by Subject|0|||
33337486|NCT00907803|62714281|FG001|Overall Study|Withdrawal by Subject|1|||
33337487|NCT00907803|62714282|FG002|Overall Study|Withdrawal by Subject|0|||
33337488|NCT00907803|62714280|FG000|Overall Study|Lost to Follow-up|0|||
33337489|NCT00907803|62714281|FG001|Overall Study|Lost to Follow-up|1|||
33337490|NCT00907803|62714282|FG002|Overall Study|Lost to Follow-up|0|||
33337491|NCT00907803|62714280|FG000|Overall Study|Protocol Violation|0|||
33337492|NCT00907803|62714281|FG001|Overall Study|Protocol Violation|1|||
33337493|NCT00907803|62714282|FG002|Overall Study|Protocol Violation|0|||
33337494|NCT00808249|62714294|FG000|Overall Study|Adverse Event|4|||
33337495|NCT00808249|62714295|FG001|Overall Study|Adverse Event|7|||
33337496|NCT00808249|62714296|FG002|Overall Study|Adverse Event|10|||
33337497|NCT00808249|62714297|FG003|Overall Study|Adverse Event|6|||
33337498|NCT00808249|62714294|FG000|Overall Study|Lost to Follow-up|2|||
33337499|NCT00808249|62714295|FG001|Overall Study|Lost to Follow-up|3|||
33337500|NCT00808249|62714296|FG002|Overall Study|Lost to Follow-up|3|||
33337501|NCT00808249|62714297|FG003|Overall Study|Lost to Follow-up|5|||
33337502|NCT00808249|62714294|FG000|Overall Study|Withdrawal by Subject|4|||
33337503|NCT00808249|62714295|FG001|Overall Study|Withdrawal by Subject|0|||
33337504|NCT00808249|62714296|FG002|Overall Study|Withdrawal by Subject|2|||
33337505|NCT00808249|62714297|FG003|Overall Study|Withdrawal by Subject|4|||
33337506|NCT00808249|62714294|FG000|Overall Study|Protocol Violation|3|||
33337507|NCT00808249|62714295|FG001|Overall Study|Protocol Violation|3|||
33337508|NCT00808249|62714296|FG002|Overall Study|Protocol Violation|3|||
33337509|NCT00808249|62714297|FG003|Overall Study|Protocol Violation|0|||
33337510|NCT00808249|62714294|FG000|Overall Study|Lack of Efficacy|1|||
33337511|NCT00808249|62714295|FG001|Overall Study|Lack of Efficacy|1|||
33337512|NCT00808249|62714296|FG002|Overall Study|Lack of Efficacy|0|||
33337513|NCT00808249|62714297|FG003|Overall Study|Lack of Efficacy|0|||
33337514|NCT00808249|62714294|FG000|Overall Study|study specific discontinuation criteria|1|||
33337515|NCT00808249|62714295|FG001|Overall Study|study specific discontinuation criteria|0|||
33337516|NCT00808249|62714296|FG002|Overall Study|study specific discontinuation criteria|1|||
33337517|NCT00808249|62714297|FG003|Overall Study|study specific discontinuation criteria|0|||
33337518|NCT00808249|62714294|FG000|Overall Study|All other reasons|2|||
33337519|NCT00808249|62714295|FG001|Overall Study|All other reasons|1|||
33337520|NCT00808249|62714296|FG002|Overall Study|All other reasons|3|||
33337521|NCT00808249|62714297|FG003|Overall Study|All other reasons|1|||
33337522|NCT00908895|62714309|FG000|Overall Study|Lost to Follow-up|1|||
33337523|NCT00908895|62714310|FG001|Overall Study|Lost to Follow-up|3|||
33337524|NCT00908895|62714309|FG000|Overall Study|algodystrophy|2|||
33337525|NCT00908895|62714310|FG001|Overall Study|algodystrophy|2|||
33337526|NCT00908895|62714309|FG000|Overall Study|Adverse Event|1|||
33337527|NCT00908895|62714310|FG001|Overall Study|Adverse Event|1|||
33337528|NCT00591253|62714319|FG000|Overall Study|Adverse Event|3|||
33337529|NCT00591253|62714320|FG001|Overall Study|Adverse Event|3|||
33337530|NCT00591253|62714321|FG002|Overall Study|Adverse Event|1|||
33337531|NCT00591253|62714319|FG000|Overall Study|Protocol Violation|2|||
33337532|NCT00591253|62714320|FG001|Overall Study|Protocol Violation|2|||
33337533|NCT00591253|62714321|FG002|Overall Study|Protocol Violation|2|||
33337534|NCT00591253|62714319|FG000|Overall Study|Lost to Follow-up|2|||
33337535|NCT00591253|62714320|FG001|Overall Study|Lost to Follow-up|4|||
33337536|NCT00591253|62714321|FG002|Overall Study|Lost to Follow-up|0|||
33337537|NCT00591253|62714319|FG000|Overall Study|Withdrawal by Subject|1|||
33337538|NCT00591253|62714320|FG001|Overall Study|Withdrawal by Subject|7|||
33337539|NCT00591253|62714321|FG002|Overall Study|Withdrawal by Subject|6|||
33337540|NCT00591253|62714319|FG000|Overall Study|Lack of Efficacy|1|||
33337541|NCT00591253|62714320|FG001|Overall Study|Lack of Efficacy|0|||
33337542|NCT00591253|62714321|FG002|Overall Study|Lack of Efficacy|3|||
33337543|NCT00591253|62714319|FG000|Overall Study|Other|5|||
33337544|NCT00591253|62714320|FG001|Overall Study|Other|5|||
33337545|NCT00591253|62714321|FG002|Overall Study|Other|3|||
33337546|NCT00908583|62714329|FG000|Phase 1|Withdrawal by Subject|1|||
33337547|NCT00908583|62714329|FG000|Phase 1|Adverse Event|4|||
33337548|NCT00908583|62714329|FG000|Phase 2|Physician Decision|1|||
33337549|NCT00908583|62714329|FG000|Phase 2|Adverse Event|1|||
33337550|NCT00908583|62714329|FG000|Phase 3|Adverse Event|2|||
33337551|NCT00908583|62714329|FG000|Phase 4|Adverse Event|1|||
33337552|NCT00908583|62714329|FG000|Phase 4|Physician Decision|1|||
33337553|NCT00908583|62714329|FG000|Phase 5|Adverse Event|3|||
33337554|NCT00909363|62714350|FG000|Overall Study|Withdrawal by Subject|1|||
33337555|NCT00909363|62714351|FG001|Overall Study|Withdrawal by Subject|0|||
33337556|NCT00909363|62714352|FG002|Overall Study|Withdrawal by Subject|0|||
33337557|NCT00909363|62714350|FG000|Overall Study|Lack of Efficacy|1|||
33337558|NCT00909363|62714351|FG001|Overall Study|Lack of Efficacy|0|||
33337559|NCT00909363|62714352|FG002|Overall Study|Lack of Efficacy|0|||
33337560|NCT00810355|62714366|FG000|Overall Study|Lost to Follow-up|13|||
33337561|NCT00810355|62714367|FG001|Overall Study|Lost to Follow-up|17|||
33337562|NCT00810355|62714368|FG002|Overall Study|Lost to Follow-up|11|||
33337563|NCT00810355|62714366|FG000|Overall Study|Withdrawal by Subject|1|||
33337564|NCT00810355|62714367|FG001|Overall Study|Withdrawal by Subject|0|||
33337565|NCT00810355|62714368|FG002|Overall Study|Withdrawal by Subject|0|||
33548802|NCT03881553|62940146|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
33548803|NCT03881553|62940147|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
33548804|NCT02970929|62940155|FG000|Overall Study|Adverse Event|18|||
33548805|NCT02970929|62940155|FG000|Overall Study|Lack of Efficacy|8|||
33548806|NCT02970929|62940155|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
33548807|NCT02970929|62940155|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
33548808|NCT02970929|62940155|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
33548809|NCT02970929|62940155|FG000|Overall Study|LOST TO FOLLOWUP|6|||
33337566|NCT00908349|62714376|FG000|Overall Study|Adverse Event|10|||
33337567|NCT00908349|62714376|FG000|Overall Study|Withdrawal by Subject|9|||
33337568|NCT00908349|62714376|FG000|Overall Study|Physician Decision|5|||
33337569|NCT00908349|62714376|FG000|Overall Study|Lost to Follow-up|5|||
33337570|NCT00908349|62714376|FG000|Overall Study|Various|6|||
33337571|NCT01125566|62714382|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
33337572|NCT01125566|62714383|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
33337573|NCT01125566|62714384|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
33337574|NCT01125566|62714382|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
33337575|NCT01125566|62714383|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
33337576|NCT01125566|62714384|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
33337577|NCT01125566|62714382|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
33337578|NCT01125566|62714383|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
33337579|NCT01125566|62714384|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
33337580|NCT01125566|62714382|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
33337581|NCT01125566|62714383|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
33337582|NCT01125566|62714384|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
33337583|NCT01125566|62714382|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
33337584|NCT01125566|62714383|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
33337585|NCT01125566|62714384|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
33337586|NCT01125566|62714382|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
33337587|NCT01125566|62714383|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
33337588|NCT01125566|62714384|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
33337589|NCT01125566|62714382|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
33337590|NCT01125566|62714383|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
33337591|NCT01125566|62714384|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
33337592|NCT01125566|62714382|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
33337593|NCT01125566|62714383|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
33337594|NCT01125566|62714384|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
33337595|NCT01125566|62714382|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
33337596|NCT01125566|62714383|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
33337597|NCT01125566|62714384|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
33337598|NCT01125566|62714382|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
33337599|NCT01125566|62714383|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
33337600|NCT01125566|62714384|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
33337601|NCT01125566|62714382|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
33337602|NCT01125566|62714383|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
33337603|NCT01125566|62714384|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
33337604|NCT01125566|62714382|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
33337605|NCT01125566|62714383|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
33337606|NCT01125566|62714384|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
33337607|NCT00810277|62714391|FG000|Overall Study|Adverse Event|1|||
33337608|NCT00595582|62714395|FG000|Overall Study|Pilot study that PI terminated|2|||
33337609|NCT00595582|62714395|FG000|Overall Study|Lost to Follow-up|1|||
33337610|NCT00595582|62714395|FG000|Overall Study|Adverse Event|2|||
33337611|NCT00595582|62714395|FG000|Overall Study|Physician Decision|5|||
33337612|NCT00808015|62714399|FG000|Overall Study|Death|1|||
33337613|NCT00808015|62714399|FG000|Overall Study|Lack of Efficacy|58|||
33337614|NCT00808015|62714399|FG000|Overall Study|Lost to Follow-up|76|||
33337615|NCT00808015|62714399|FG000|Overall Study|Participants not willing to participate|158|||
33337616|NCT00808015|62714399|FG000|Overall Study|Adverse Event|22|||
33337617|NCT00808015|62714399|FG000|Overall Study|Other|25|||
33337618|NCT00808015|62714399|FG000|Overall Study|Enrolled but not treated|4|||
33337619|NCT00810199|62714405|FG000|Overall Study|Adverse Event|24|||
33337620|NCT00810199|62714406|FG001|Overall Study|Adverse Event|26|||
33337621|NCT00810199|62714405|FG000|Overall Study|Death|4|||
33337622|NCT00810199|62714406|FG001|Overall Study|Death|6|||
33337623|NCT00810199|62714405|FG000|Overall Study|Withdrew consent|9|||
33337624|NCT00810199|62714406|FG001|Overall Study|Withdrew consent|12|||
33337625|NCT00810199|62714405|FG000|Overall Study|Insufficient therapeutic response|5|||
33337626|NCT00810199|62714406|FG001|Overall Study|Insufficient therapeutic response|14|||
33337627|NCT00810199|62714405|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
33337628|NCT00810199|62714406|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
33337629|NCT00810199|62714405|FG000|Overall Study|Administrative/Other|5|||
33337630|NCT00810199|62714406|FG001|Overall Study|Administrative/Other|6|||
33337631|NCT00810199|62714405|FG000|Overall Study|Protocol Violation|2|||
33337632|NCT00810199|62714406|FG001|Overall Study|Protocol Violation|6|||
33337633|NCT00810199|62714405|FG000|Overall Study|Failure to return|1|||
33337634|NCT00810199|62714406|FG001|Overall Study|Failure to return|4|||
33337635|NCT00810199|62714405|FG000|Overall Study|Did not receive study drug|2|||
33337636|NCT00810199|62714406|FG001|Overall Study|Did not receive study drug|1|||
33337637|NCT00877006|62714420|FG000|Treatment Period|Death|2|||
33337638|NCT00877006|62714421|FG001|Treatment Period|Death|1|||
33337639|NCT00877006|62714420|FG000|Treatment Period|Adverse Event|10|||
33337640|NCT00877006|62714421|FG001|Treatment Period|Adverse Event|3|||
33337641|NCT00877006|62714420|FG000|Treatment Period|Withdrawal by Subject|2|||
33337642|NCT00877006|62714421|FG001|Treatment Period|Withdrawal by Subject|3|||
33337643|NCT00877006|62714420|FG000|Treatment Period|Protocol Violation|1|||
33469503|NCT02795182|62843249|FG002|Overall Study|Progressive Disease|0|||
33469504|NCT02795182|62843250|FG003|Overall Study|Progressive Disease|4|||
33469505|NCT02795182|62843247|FG000|Overall Study|Physician Decision|0|||
33337644|NCT00877006|62714421|FG001|Treatment Period|Protocol Violation|0|||
33337645|NCT00877006|62714420|FG000|Treatment Period|Lost to Follow-up|0|||
33337646|NCT00877006|62714421|FG001|Treatment Period|Lost to Follow-up|1|||
33337647|NCT00877006|62714420|FG000|Treatment Period|Disease Progression|1|||
33337648|NCT00877006|62714421|FG001|Treatment Period|Disease Progression|2|||
33337649|NCT00877006|62714420|FG000|Treatment Period|Started New Treatment Regimen|2|||
33337650|NCT00877006|62714421|FG001|Treatment Period|Started New Treatment Regimen|5|||
33337651|NCT00877006|62714420|FG000|Treatment Period|Other|4|||
33337652|NCT00877006|62714421|FG001|Treatment Period|Other|4|||
33337653|NCT00877006|62714420|FG000|Treatment Period|Randomized but Not Treated|3|||
33337654|NCT00877006|62714421|FG001|Treatment Period|Randomized but Not Treated|8|||
33337655|NCT00877006|62714420|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
33337656|NCT00877006|62714421|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
33337657|NCT00877006|62714420|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
33337658|NCT00877006|62714421|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
33337659|NCT00877006|62714420|FG000|Long-Term Follow-up Period|Death|26|||
33337660|NCT00877006|62714421|FG001|Long-Term Follow-up Period|Death|18|||
33337661|NCT00877006|62714420|FG000|Long-Term Follow-up Period|Other|7|||
33337662|NCT00877006|62714421|FG001|Long-Term Follow-up Period|Other|9|||
33337663|NCT00876928|62714431|FG000|Overall Study|Lost to Follow-up|2|||
33337664|NCT00876928|62714432|FG001|Overall Study|Lost to Follow-up|5|||
33337665|NCT00876928|62714431|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
33337666|NCT00876928|62714432|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
33337667|NCT00807937|62714442|FG000|Overall Study|Adverse Event|12|||
33337668|NCT00807937|62714443|FG001|Overall Study|Adverse Event|12|||
33337669|NCT00807937|62714444|FG002|Overall Study|Adverse Event|5|||
33337670|NCT00807937|62714445|FG003|Overall Study|Adverse Event|4|||
33337671|NCT00807937|62714442|FG000|Overall Study|Protocol Violation|4|||
33337672|NCT00807937|62714443|FG001|Overall Study|Protocol Violation|5|||
33337673|NCT00807937|62714444|FG002|Overall Study|Protocol Violation|3|||
33337674|NCT00807937|62714445|FG003|Overall Study|Protocol Violation|3|||
33337675|NCT00807937|62714442|FG000|Overall Study|Withdrawal by Subject|5|||
33337676|NCT00807937|62714443|FG001|Overall Study|Withdrawal by Subject|4|||
33337677|NCT00807937|62714444|FG002|Overall Study|Withdrawal by Subject|1|||
33337678|NCT00807937|62714445|FG003|Overall Study|Withdrawal by Subject|4|||
33337679|NCT00807937|62714442|FG000|Overall Study|Lost to Follow-up|4|||
33337680|NCT00807937|62714443|FG001|Overall Study|Lost to Follow-up|0|||
33337681|NCT00807937|62714444|FG002|Overall Study|Lost to Follow-up|2|||
33337682|NCT00807937|62714445|FG003|Overall Study|Lost to Follow-up|1|||
33337683|NCT00807937|62714442|FG000|Overall Study|Lack of Efficacy|0|||
33337684|NCT00807937|62714443|FG001|Overall Study|Lack of Efficacy|0|||
33337685|NCT00807937|62714444|FG002|Overall Study|Lack of Efficacy|1|||
33337686|NCT00807937|62714445|FG003|Overall Study|Lack of Efficacy|2|||
33337687|NCT00807937|62714442|FG000|Overall Study|Intake of prohibited medicine|0|||
33337688|NCT00807937|62714443|FG001|Overall Study|Intake of prohibited medicine|0|||
33337689|NCT00807937|62714444|FG002|Overall Study|Intake of prohibited medicine|2|||
33337690|NCT00807937|62714445|FG003|Overall Study|Intake of prohibited medicine|0|||
33337691|NCT00807937|62714442|FG000|Overall Study|All other reasons (not provided)|2|||
33337692|NCT00807937|62714443|FG001|Overall Study|All other reasons (not provided)|4|||
33337693|NCT00807937|62714444|FG002|Overall Study|All other reasons (not provided)|0|||
33469506|NCT02795182|62843248|FG001|Overall Study|Physician Decision|0|||
33469507|NCT02795182|62843249|FG002|Overall Study|Physician Decision|0|||
33469508|NCT02795182|62843250|FG003|Overall Study|Physician Decision|1|||
33469509|NCT03167242|62843279|FG000|Overall Study|Patient/Guardian Decision|0|||
33469510|NCT03167242|62843280|FG001|Overall Study|Patient/Guardian Decision|1|||
33469511|NCT03167242|62843281|FG002|Overall Study|Patient/Guardian Decision|2|||
33469512|NCT03167242|62843282|FG003|Overall Study|Patient/Guardian Decision|1|||
33469513|NCT03167242|62843283|FG004|Overall Study|Patient/Guardian Decision|1|||
33548810|NCT02970929|62940155|FG000|Overall Study|MOVED OUT OF STATE|1|||
33654322|NCT01701362|63067054|FG001|Overall Study|Randomized but not treated|2|||
33654323|NCT01701362|63067053|FG000|Overall Study|Reasons other than those mentioned above|3|||
33654324|NCT01701362|63067054|FG001|Overall Study|Reasons other than those mentioned above|5|||
33654325|NCT01710800|63067083|FG000|Overall Study|Withdrawal by Subject|21|||
33654326|NCT01710800|63067083|FG000|Overall Study|Protocol Violation|1|||
33654327|NCT01710020|63067089|FG000|Period 1|Protocol Violation|1|||
33654328|NCT01700348|63067095|FG000|Overall Study|Withdrawal by Subject|22|||
33654329|NCT01700348|63067095|FG000|Overall Study|Lost to Follow-up|1|||
33654330|NCT01700192|63067103|FG000|Overall Study|Adverse Event|73|||
33337694|NCT00807937|62714445|FG003|Overall Study|All other reasons (not provided)|1|||
33337695|NCT00906945|62714460|FG000|Overall Study|Found to be not eligible|0|||
33337696|NCT00906945|62714461|FG001|Overall Study|Found to be not eligible|0|||
33337697|NCT00906945|62714462|FG002|Overall Study|Found to be not eligible|0|||
33337698|NCT00906945|62714463|FG003|Overall Study|Found to be not eligible|1|||
33337699|NCT00906945|62714464|FG004|Overall Study|Found to be not eligible|1|||
33337700|NCT00906945|62714465|FG005|Overall Study|Found to be not eligible|1|||
33337701|NCT00906945|62714460|FG000|Overall Study|Physician Decision|0|||
33469514|NCT03167242|62843284|FG005|Overall Study|Patient/Guardian Decision|1|||
33337702|NCT00906945|62714461|FG001|Overall Study|Physician Decision|0|||
33337703|NCT00906945|62714462|FG002|Overall Study|Physician Decision|0|||
33337704|NCT00906945|62714463|FG003|Overall Study|Physician Decision|0|||
33337705|NCT00906945|62714464|FG004|Overall Study|Physician Decision|0|||
33337706|NCT00906945|62714465|FG005|Overall Study|Physician Decision|1|||
33337707|NCT00807235|62714483|FG000|Overall Study|Adverse Event|1|||
33337708|NCT00807235|62714484|FG001|Overall Study|Adverse Event|0|||
33337709|NCT00876694|62714492|FG000|Overall Study|Adverse Event|10|||
33337710|NCT00876694|62714493|FG001|Overall Study|Adverse Event|7|||
33337711|NCT00876694|62714492|FG000|Overall Study|Subject withdrew consent|6|||
33337712|NCT00876694|62714493|FG001|Overall Study|Subject withdrew consent|4|||
33337713|NCT00876694|62714492|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33337714|NCT00876694|62714493|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33337715|NCT00876694|62714492|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33337716|NCT00876694|62714493|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33337717|NCT00876694|62714492|FG000|Overall Study|Administrative problems|1|||
33337718|NCT00876694|62714493|FG001|Overall Study|Administrative problems|1|||
33337719|NCT00876694|62714492|FG000|Overall Study|Death|1|||
33337720|NCT00876694|62714493|FG001|Overall Study|Death|0|||
33337721|NCT00805441|62714501|FG000|Overall Study|Adverse Event|5|||
33337722|NCT00805441|62714502|FG001|Overall Study|Adverse Event|2|||
33337723|NCT00805441|62714501|FG000|Overall Study|Lack of Efficacy|0|||
33337724|NCT00805441|62714502|FG001|Overall Study|Lack of Efficacy|2|||
33337725|NCT00805441|62714501|FG000|Overall Study|Protocol Violation|4|||
33337726|NCT00805441|62714502|FG001|Overall Study|Protocol Violation|8|||
33337727|NCT00805441|62714501|FG000|Overall Study|Lost to Follow-up|10|||
33337728|NCT00805441|62714502|FG001|Overall Study|Lost to Follow-up|13|||
33337729|NCT00805441|62714501|FG000|Overall Study|Withdrawal by Subject|15|||
33337730|NCT00805441|62714502|FG001|Overall Study|Withdrawal by Subject|9|||
33337731|NCT00805441|62714501|FG000|Overall Study|Physician Decision|0|||
33337732|NCT00805441|62714502|FG001|Overall Study|Physician Decision|1|||
33337733|NCT00805441|62714501|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
33337734|NCT00805441|62714502|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
33337735|NCT00590317|62714510|FG000|Overall Study|Lack of Efficacy|1|||
33337736|NCT00590317|62714511|FG001|Overall Study|Lack of Efficacy|5|||
33337737|NCT01139762|62714520|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
33337738|NCT01139762|62714521|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
33337739|NCT01139762|62714522|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
33337740|NCT01139762|62714520|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
33337741|NCT01139762|62714521|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
33337742|NCT01139762|62714522|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
33337743|NCT01139762|62714520|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
33337744|NCT01139762|62714521|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
33337745|NCT01139762|62714522|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
33337746|NCT01139762|62714520|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
33337747|NCT01139762|62714521|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
33337748|NCT01139762|62714522|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
33337749|NCT01139762|62714520|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
33337750|NCT01139762|62714521|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
33337751|NCT01139762|62714522|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
33337752|NCT01139762|62714520|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
33337753|NCT01139762|62714521|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
33337754|NCT01139762|62714522|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
33337755|NCT01139762|62714520|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
33337756|NCT01139762|62714521|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
33337757|NCT01139762|62714522|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
33337758|NCT01139762|62714520|FG000|Double-Blind Randomized Active Treatment|Death|0|||
33337759|NCT01139762|62714521|FG001|Double-Blind Randomized Active Treatment|Death|1|||
33337760|NCT01139762|62714522|FG002|Double-Blind Randomized Active Treatment|Death|1|||
33337761|NCT01139762|62714520|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
33337762|NCT01139762|62714521|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
33337763|NCT01139762|62714522|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
33337764|NCT01139762|62714520|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
33337765|NCT01139762|62714521|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
33337766|NCT01139762|62714522|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
33337767|NCT01139762|62714520|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
33337768|NCT01139762|62714521|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
33337769|NCT01139762|62714522|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
33337770|NCT01139762|62714520|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
33337771|NCT01139762|62714521|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
33337772|NCT01139762|62714522|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
33337773|NCT01139762|62714520|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
33337774|NCT01139762|62714521|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
33337775|NCT01139762|62714522|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
33337776|NCT01139762|62714520|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
33337777|NCT01139762|62714521|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
33337778|NCT01139762|62714522|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
33337779|NCT01139762|62714520|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
33337780|NCT01139762|62714521|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
33337781|NCT01139762|62714522|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
33337782|NCT00805285|62714529|FG000|Overall Study|Lack of Efficacy|1|||
33337783|NCT01139450|62714536|FG000|Overall Study|Withdrawal by Subject|7|||
33337784|NCT01139450|62714537|FG001|Overall Study|Withdrawal by Subject|10|||
33337785|NCT01139450|62714538|FG002|Overall Study|Withdrawal by Subject|13|||
33337786|NCT01139450|62714536|FG000|Overall Study|Lack of Efficacy|3|||
33337787|NCT01139450|62714537|FG001|Overall Study|Lack of Efficacy|1|||
33337788|NCT01139450|62714538|FG002|Overall Study|Lack of Efficacy|8|||
33337789|NCT01139450|62714536|FG000|Overall Study|Protocol Violation|6|||
33337790|NCT01139450|62714537|FG001|Overall Study|Protocol Violation|5|||
33337791|NCT01139450|62714538|FG002|Overall Study|Protocol Violation|2|||
33337792|NCT01139450|62714536|FG000|Overall Study|Lost to Follow-up|9|||
33337793|NCT01139450|62714537|FG001|Overall Study|Lost to Follow-up|7|||
33337794|NCT01139450|62714538|FG002|Overall Study|Lost to Follow-up|11|||
33337795|NCT01139450|62714536|FG000|Overall Study|Administrative|0|||
33337796|NCT01139450|62714537|FG001|Overall Study|Administrative|0|||
33337797|NCT01139450|62714538|FG002|Overall Study|Administrative|1|||
33337798|NCT01139450|62714536|FG000|Overall Study|Adverse Event|2|||
33337799|NCT01139450|62714537|FG001|Overall Study|Adverse Event|2|||
33337800|NCT01139450|62714538|FG002|Overall Study|Adverse Event|3|||
33337801|NCT00805207|62714555|FG000|Overall Study|Protocol Violation|0|||
33337802|NCT00805207|62714556|FG001|Overall Study|Protocol Violation|0|||
33337803|NCT00805207|62714557|FG002|Overall Study|Protocol Violation|1|||
33337804|NCT00805207|62714558|FG003|Overall Study|Protocol Violation|0|||
33337805|NCT00805207|62714559|FG004|Overall Study|Protocol Violation|0|||
33337806|NCT00805207|62714560|FG005|Overall Study|Protocol Violation|0|||
33337807|NCT00805207|62714561|FG006|Overall Study|Protocol Violation|0|||
33337808|NCT00805207|62714562|FG007|Overall Study|Protocol Violation|0|||
33337809|NCT00805207|62714563|FG008|Overall Study|Protocol Violation|0|||
33337810|NCT00805207|62714555|FG000|Overall Study|Physician Decision|0|||
33337811|NCT00805207|62714556|FG001|Overall Study|Physician Decision|1|||
33469515|NCT03167242|62843285|FG006|Overall Study|Patient/Guardian Decision|0|||
33469516|NCT03167242|62843286|FG007|Overall Study|Patient/Guardian Decision|0|||
33469517|NCT03167242|62843287|FG008|Overall Study|Patient/Guardian Decision|0|||
33469518|NCT03167242|62843288|FG009|Overall Study|Patient/Guardian Decision|0|||
33469519|NCT03167242|62843289|FG010|Overall Study|Patient/Guardian Decision|1|||
33469520|NCT03167242|62843290|FG011|Overall Study|Patient/Guardian Decision|0|||
33469521|NCT03167242|62843279|FG000|Overall Study|Lost to Follow-up|0|||
33469522|NCT03167242|62843280|FG001|Overall Study|Lost to Follow-up|0|||
33469523|NCT03167242|62843281|FG002|Overall Study|Lost to Follow-up|1|||
33469524|NCT03167242|62843282|FG003|Overall Study|Lost to Follow-up|0|||
33469525|NCT03167242|62843283|FG004|Overall Study|Lost to Follow-up|0|||
33469526|NCT03167242|62843284|FG005|Overall Study|Lost to Follow-up|1|||
33469527|NCT03167242|62843285|FG006|Overall Study|Lost to Follow-up|2|||
33469528|NCT03167242|62843286|FG007|Overall Study|Lost to Follow-up|1|||
33469529|NCT03167242|62843287|FG008|Overall Study|Lost to Follow-up|0|||
33469530|NCT03167242|62843288|FG009|Overall Study|Lost to Follow-up|0|||
33469531|NCT03167242|62843289|FG010|Overall Study|Lost to Follow-up|1|||
33469532|NCT03167242|62843290|FG011|Overall Study|Lost to Follow-up|1|||
33337812|NCT00805207|62714557|FG002|Overall Study|Physician Decision|0|||
33337813|NCT00805207|62714558|FG003|Overall Study|Physician Decision|0|||
33337814|NCT00805207|62714559|FG004|Overall Study|Physician Decision|0|||
33337815|NCT00805207|62714560|FG005|Overall Study|Physician Decision|1|||
33337816|NCT00805207|62714561|FG006|Overall Study|Physician Decision|0|||
33337817|NCT00805207|62714562|FG007|Overall Study|Physician Decision|0|||
33337818|NCT00805207|62714563|FG008|Overall Study|Physician Decision|0|||
33337819|NCT00805207|62714555|FG000|Overall Study|Withdrawal by Subject|0|||
33337820|NCT00805207|62714556|FG001|Overall Study|Withdrawal by Subject|1|||
33337821|NCT00805207|62714557|FG002|Overall Study|Withdrawal by Subject|0|||
33337822|NCT00805207|62714558|FG003|Overall Study|Withdrawal by Subject|0|||
33337823|NCT00805207|62714559|FG004|Overall Study|Withdrawal by Subject|1|||
33469533|NCT03167242|62843279|FG000|Overall Study|Reason not provided|0|||
33337824|NCT00805207|62714560|FG005|Overall Study|Withdrawal by Subject|2|||
33469534|NCT03167242|62843280|FG001|Overall Study|Reason not provided|0|||
33469535|NCT03167242|62843281|FG002|Overall Study|Reason not provided|0|||
33469536|NCT03167242|62843282|FG003|Overall Study|Reason not provided|0|||
33469537|NCT03167242|62843283|FG004|Overall Study|Reason not provided|0|||
33337825|NCT00805207|62714561|FG006|Overall Study|Withdrawal by Subject|0|||
33337826|NCT00805207|62714562|FG007|Overall Study|Withdrawal by Subject|0|||
33337827|NCT00805207|62714563|FG008|Overall Study|Withdrawal by Subject|0|||
33337828|NCT00805675|62714590|FG000|Overall Study|Adverse Event|0|||
33337829|NCT00805675|62714591|FG001|Overall Study|Adverse Event|0|||
33337830|NCT00805675|62714592|FG002|Overall Study|Adverse Event|1|||
33337831|NCT00589303|62714606|FG000|Overall Study|Withdrawal by Subject|2|||
33337832|NCT00589303|62714607|FG001|Overall Study|Withdrawal by Subject|1|||
33337833|NCT00952380|62714618|FG000|Overall Study|Other|0|||
33337834|NCT00952380|62714619|FG001|Overall Study|Other|0|||
33337835|NCT00952380|62714620|FG002|Overall Study|Other|0|||
33337836|NCT00952380|62714621|FG003|Overall Study|Other|0|||
33337837|NCT00952380|62714622|FG004|Overall Study|Other|1|||
33337838|NCT00952380|62714618|FG000|Overall Study|Withdrawal by Subject|0|||
33337839|NCT00952380|62714619|FG001|Overall Study|Withdrawal by Subject|0|||
33337840|NCT00952380|62714620|FG002|Overall Study|Withdrawal by Subject|1|||
33337841|NCT00952380|62714621|FG003|Overall Study|Withdrawal by Subject|0|||
33337842|NCT00952380|62714622|FG004|Overall Study|Withdrawal by Subject|2|||
33337843|NCT00952380|62714618|FG000|Overall Study|Adverse Event|0|||
33337844|NCT00952380|62714619|FG001|Overall Study|Adverse Event|1|||
33337845|NCT00952380|62714620|FG002|Overall Study|Adverse Event|0|||
33337846|NCT00952380|62714621|FG003|Overall Study|Adverse Event|0|||
33337847|NCT00952380|62714622|FG004|Overall Study|Adverse Event|3|||
33337848|NCT00952380|62714618|FG000|Overall Study|Physician Decision|0|||
33337849|NCT00952380|62714619|FG001|Overall Study|Physician Decision|0|||
33337850|NCT00952380|62714620|FG002|Overall Study|Physician Decision|1|||
33337851|NCT00952380|62714621|FG003|Overall Study|Physician Decision|2|||
33337852|NCT00952380|62714622|FG004|Overall Study|Physician Decision|0|||
33337853|NCT00952380|62714618|FG000|Overall Study|Non-compliant to protocol|0|||
33337854|NCT00952380|62714619|FG001|Overall Study|Non-compliant to protocol|0|||
33337855|NCT00952380|62714620|FG002|Overall Study|Non-compliant to protocol|0|||
33337856|NCT00952380|62714621|FG003|Overall Study|Non-compliant to protocol|1|||
33337857|NCT00952380|62714622|FG004|Overall Study|Non-compliant to protocol|0|||
33337858|NCT00803179|62714639|FG000|Overall Study|Lost to Follow-up|3|||
33337859|NCT00804193|62714646|FG000|Overall Study|Lack of baseline fungus|32|||
33337860|NCT00804193|62714647|FG001|Overall Study|Lack of baseline fungus|31|||
33337861|NCT00804193|62714648|FG002|Overall Study|Lack of baseline fungus|19|||
33337862|NCT00804193|62714646|FG000|Overall Study|Adverse Event|0|||
33337863|NCT00804193|62714647|FG001|Overall Study|Adverse Event|0|||
33337864|NCT00804193|62714648|FG002|Overall Study|Adverse Event|2|||
33337865|NCT00804193|62714646|FG000|Overall Study|Lack of Efficacy|1|||
33337866|NCT00804193|62714647|FG001|Overall Study|Lack of Efficacy|1|||
33337867|NCT00804193|62714648|FG002|Overall Study|Lack of Efficacy|3|||
33337868|NCT00804193|62714646|FG000|Overall Study|Protocol Violation|0|||
33337869|NCT00804193|62714647|FG001|Overall Study|Protocol Violation|8|||
33337870|NCT00804193|62714648|FG002|Overall Study|Protocol Violation|2|||
33337871|NCT00804193|62714646|FG000|Overall Study|Lost to Follow-up|3|||
33337872|NCT00804193|62714647|FG001|Overall Study|Lost to Follow-up|3|||
33337873|NCT00804193|62714648|FG002|Overall Study|Lost to Follow-up|4|||
33337874|NCT00804193|62714646|FG000|Overall Study|Withdrawal by Subject|3|||
33337875|NCT00804193|62714647|FG001|Overall Study|Withdrawal by Subject|1|||
33337876|NCT00804193|62714648|FG002|Overall Study|Withdrawal by Subject|2|||
33337877|NCT00957996|62714658|FG000|Overall Study|Death|4|||
33337878|NCT00957996|62714659|FG001|Overall Study|Death|10|||
33337879|NCT00957996|62714658|FG000|Overall Study|Lost to Follow-up|4|||
33337880|NCT00957996|62714659|FG001|Overall Study|Lost to Follow-up|7|||
33337881|NCT00957996|62714658|FG000|Overall Study|Withdrawal by Subject|9|||
33337882|NCT00957996|62714659|FG001|Overall Study|Withdrawal by Subject|2|||
33337883|NCT00957996|62714658|FG000|Overall Study|Adverse Event|2|||
33337884|NCT00957996|62714659|FG001|Overall Study|Adverse Event|1|||
33337885|NCT00957996|62714658|FG000|Overall Study|Physician Decision|1|||
33337886|NCT00957996|62714659|FG001|Overall Study|Physician Decision|1|||
33337887|NCT00957996|62714658|FG000|Overall Study|Influenza-related complication|0|||
33337888|NCT00957996|62714659|FG001|Overall Study|Influenza-related complication|1|||
33337889|NCT00957996|62714658|FG000|Overall Study|Missing|1|||
33337890|NCT00957996|62714659|FG001|Overall Study|Missing|0|||
33337891|NCT00957996|62714658|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
33337892|NCT00957996|62714659|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
33337893|NCT00589693|62714669|FG000|Overall Study|randomized in error|12|||
33337894|NCT00589693|62714670|FG001|Overall Study|randomized in error|6|||
33337895|NCT00589693|62714669|FG000|Overall Study|Adverse Event|4|||
33337896|NCT00589693|62714670|FG001|Overall Study|Adverse Event|4|||
33337897|NCT00589693|62714669|FG000|Overall Study|Death|26|||
33337898|NCT00589693|62714670|FG001|Overall Study|Death|16|||
33337899|NCT00589693|62714669|FG000|Overall Study|Lack of Efficacy|0|||
33337900|NCT00589693|62714670|FG001|Overall Study|Lack of Efficacy|1|||
33337901|NCT00589693|62714669|FG000|Overall Study|Lost to Follow-up|1|||
33337902|NCT00589693|62714670|FG001|Overall Study|Lost to Follow-up|0|||
33337903|NCT00589693|62714669|FG000|Overall Study|Physician Decision|0|||
33337904|NCT00589693|62714670|FG001|Overall Study|Physician Decision|1|||
33337905|NCT00589693|62714669|FG000|Overall Study|Protocol Violation|1|||
33337906|NCT00589693|62714670|FG001|Overall Study|Protocol Violation|1|||
33337907|NCT00803101|62714678|FG000|Overall Study|Death / Serious Adverse Event|4|||
33337908|NCT00803101|62714679|FG001|Overall Study|Death / Serious Adverse Event|6|||
33337909|NCT00803101|62714678|FG000|Overall Study|Withdrawal by Subject|6|||
33337910|NCT00803101|62714679|FG001|Overall Study|Withdrawal by Subject|4|||
33337911|NCT00803101|62714678|FG000|Overall Study|Lost to Follow-up|2|||
33337912|NCT00803101|62714679|FG001|Overall Study|Lost to Follow-up|2|||
33337913|NCT00803101|62714678|FG000|Overall Study|Protocol Violation|1|||
33337914|NCT00803101|62714679|FG001|Overall Study|Protocol Violation|7|||
33337915|NCT00803101|62714678|FG000|Overall Study|Surgery finished outside protocol window|1|||
33337916|NCT00803101|62714679|FG001|Overall Study|Surgery finished outside protocol window|1|||
33337917|NCT00803101|62714678|FG000|Overall Study|Patient died outside SAE report period|1|||
33337918|NCT00803101|62714679|FG001|Overall Study|Patient died outside SAE report period|0|||
33337919|NCT00803101|62714678|FG000|Overall Study|Patient did not attend scheduled visit|2|||
33337920|NCT00803101|62714679|FG001|Overall Study|Patient did not attend scheduled visit|1|||
33337921|NCT00803101|62714678|FG000|Overall Study|Patient did not have surgery|1|||
33337922|NCT00803101|62714679|FG001|Overall Study|Patient did not have surgery|1|||
33337923|NCT00801229|62714687|FG000|Signed Consent|Withdrawal by Subject|2|||
33337924|NCT00801229|62714688|FG001|Signed Consent|Withdrawal by Subject|2|||
33337925|NCT00801229|62714687|FG000|Signed Consent|Found Ineligible|1|||
33337926|NCT00801229|62714688|FG001|Signed Consent|Found Ineligible|1|||
33337927|NCT00801229|62714687|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
33337928|NCT00801229|62714688|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
33337929|NCT00801229|62714687|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
33337930|NCT00801229|62714688|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
33337931|NCT00801229|62714687|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
33337932|NCT00801229|62714688|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
33337933|NCT00801229|62714687|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
33337934|NCT00801229|62714688|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
33337935|NCT00801229|62714687|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
33337936|NCT00801229|62714688|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
33337937|NCT00801229|62714687|FG000|Received Study Drug/Placebo|Adverse Event|1|||
33654331|NCT01700192|63067104|FG001|Overall Study|Adverse Event|18|||
33654332|NCT01700192|63067103|FG000|Overall Study|Lack of Efficacy|1|||
33654333|NCT01700192|63067104|FG001|Overall Study|Lack of Efficacy|0|||
33337938|NCT00801229|62714688|FG001|Received Study Drug/Placebo|Adverse Event|1|||
33337939|NCT00948246|62714694|FG000|Overall Study|Lost to Follow-up|11|||
33337940|NCT00948246|62714694|FG000|Overall Study|Adverse Event|11|||
33337941|NCT00948246|62714694|FG000|Overall Study|Death|1|||
33337942|NCT00948246|62714694|FG000|Overall Study|Withdrawal by Subject|1|||
33337943|NCT00800683|62714700|FG000|Overall Study|Adverse Event|11|||
33337944|NCT00800683|62714701|FG001|Overall Study|Adverse Event|8|||
33337945|NCT00800683|62714700|FG000|Overall Study|Lost to Follow-up|3|||
33337946|NCT00800683|62714701|FG001|Overall Study|Lost to Follow-up|1|||
33337947|NCT00800683|62714700|FG000|Overall Study|Withdrawal by Subject|1|||
33337948|NCT00800683|62714701|FG001|Overall Study|Withdrawal by Subject|7|||
33337949|NCT00800683|62714700|FG000|Overall Study|Lack of Efficacy|1|||
33337950|NCT00800683|62714701|FG001|Overall Study|Lack of Efficacy|1|||
33337951|NCT00800683|62714700|FG000|Overall Study|Other|1|||
33337952|NCT00800683|62714701|FG001|Overall Study|Other|2|||
33337953|NCT01124864|62714713|FG000|Overall Study|Follow up phase competed as per protocol|18|||
33337954|NCT01124864|62714714|FG001|Overall Study|Follow up phase competed as per protocol|22|||
33337955|NCT01124864|62714715|FG002|Overall Study|Follow up phase competed as per protocol|24|||
33337956|NCT01124864|62714716|FG003|Overall Study|Follow up phase competed as per protocol|18|||
33337957|NCT01124864|62714717|FG004|Overall Study|Follow up phase competed as per protocol|26|||
33337958|NCT01124864|62714718|FG005|Overall Study|Follow up phase competed as per protocol|2|||
33337959|NCT01124864|62714713|FG000|Overall Study|Death|6|||
33337960|NCT01124864|62714714|FG001|Overall Study|Death|9|||
33337961|NCT01124864|62714715|FG002|Overall Study|Death|6|||
33337962|NCT01124864|62714716|FG003|Overall Study|Death|2|||
33337963|NCT01124864|62714717|FG004|Overall Study|Death|1|||
33337964|NCT01124864|62714718|FG005|Overall Study|Death|0|||
33337965|NCT01124864|62714713|FG000|Overall Study|Withdrawal by Subject|2|||
33337966|NCT01124864|62714714|FG001|Overall Study|Withdrawal by Subject|3|||
33337967|NCT01124864|62714715|FG002|Overall Study|Withdrawal by Subject|4|||
33337968|NCT01124864|62714716|FG003|Overall Study|Withdrawal by Subject|0|||
33337969|NCT01124864|62714717|FG004|Overall Study|Withdrawal by Subject|2|||
33337970|NCT01124864|62714718|FG005|Overall Study|Withdrawal by Subject|1|||
33337971|NCT01124864|62714713|FG000|Overall Study|Lost to Follow-up|1|||
33654334|NCT01700192|63067103|FG000|Overall Study|Lost to Follow-up|42|||
33654335|NCT01700192|63067104|FG001|Overall Study|Lost to Follow-up|29|||
33337972|NCT01124864|62714714|FG001|Overall Study|Lost to Follow-up|1|||
33337973|NCT01124864|62714715|FG002|Overall Study|Lost to Follow-up|0|||
33337974|NCT01124864|62714716|FG003|Overall Study|Lost to Follow-up|1|||
33337975|NCT01124864|62714717|FG004|Overall Study|Lost to Follow-up|0|||
33337976|NCT01124864|62714718|FG005|Overall Study|Lost to Follow-up|0|||
33337977|NCT01124864|62714713|FG000|Overall Study|Protocol Violation|1|||
33337978|NCT01124864|62714714|FG001|Overall Study|Protocol Violation|0|||
33337979|NCT01124864|62714715|FG002|Overall Study|Protocol Violation|0|||
33337980|NCT01124864|62714716|FG003|Overall Study|Protocol Violation|0|||
33337981|NCT01124864|62714717|FG004|Overall Study|Protocol Violation|1|||
33337982|NCT01124864|62714718|FG005|Overall Study|Protocol Violation|0|||
33337983|NCT01113710|62714734|FG000|Overall Study|Adverse Event|64|||
33337984|NCT01113710|62714734|FG000|Overall Study|Lack of Efficacy|41|||
33337985|NCT01113710|62714734|FG000|Overall Study|No Information Available|40|||
33337986|NCT01113710|62714734|FG000|Overall Study|Withdrawal by Subject|28|||
33337987|NCT01113710|62714734|FG000|Overall Study|Lost to Follow-up|20|||
33337988|NCT01113710|62714734|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
33337989|NCT01113710|62714734|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
33337990|NCT01113710|62714734|FG000|Overall Study|Lack of Patient's Compliance|8|||
33337991|NCT01113710|62714734|FG000|Overall Study|Other|7|||
33337992|NCT01113710|62714734|FG000|Overall Study|Adverse Event/Other|5|||
33337993|NCT01113710|62714734|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
33337994|NCT01113710|62714734|FG000|Overall Study|Lack of Efficacy/Other|4|||
33337995|NCT01113710|62714734|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
33337996|NCT01113710|62714734|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
33337997|NCT01113710|62714734|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
33337998|NCT01113710|62714734|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
33337999|NCT01113710|62714734|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
33338000|NCT01113710|62714734|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
33338001|NCT01113710|62714734|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
33338002|NCT01113710|62714734|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
33338003|NCT01113710|62714734|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
33338004|NCT01113710|62714734|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
33469538|NCT03167242|62843284|FG005|Overall Study|Reason not provided|0|||
33469539|NCT03167242|62843285|FG006|Overall Study|Reason not provided|0|||
33469540|NCT03167242|62843286|FG007|Overall Study|Reason not provided|0|||
33469541|NCT03167242|62843287|FG008|Overall Study|Reason not provided|1|||
33469542|NCT03167242|62843288|FG009|Overall Study|Reason not provided|0|||
33469543|NCT03167242|62843289|FG010|Overall Study|Reason not provided|0|||
33469544|NCT03167242|62843290|FG011|Overall Study|Reason not provided|0|||
33469545|NCT03286426|62843326|FG000|Overall Study|Physician Decision|3|||
33469546|NCT02882152|62843345|FG000|Overall Study|Lost to Follow-up|1|||
33469547|NCT02882152|62843346|FG001|Overall Study|Lost to Follow-up|0|||
33469548|NCT00286091|62843354|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
33469549|NCT00286091|62843355|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
33469550|NCT00286091|62843354|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
33469551|NCT00286091|62843355|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
33469552|NCT00286091|62843354|FG000|Double-blind Treatment Phase|Death|58|||
33469553|NCT00286091|62843355|FG001|Double-blind Treatment Phase|Death|65|||
33469554|NCT00286091|62843354|FG000|Double-blind Treatment Phase|Adverse Event|28|||
33469555|NCT00286091|62843355|FG001|Double-blind Treatment Phase|Adverse Event|40|||
33469556|NCT00286091|62843354|FG000|Double-blind Treatment Phase|Disease Progression|22|||
33469557|NCT00286091|62843355|FG001|Double-blind Treatment Phase|Disease Progression|35|||
33469558|NCT00286091|62843354|FG000|Double-blind Treatment Phase|Other|25|||
33469559|NCT00286091|62843355|FG001|Double-blind Treatment Phase|Other|33|||
33469560|NCT00286091|62843354|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
33469561|NCT00286091|62843355|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
33469562|NCT00286091|62843354|FG000|Double-blind Treatment Phase|Noncompliance|8|||
33469563|NCT00286091|62843355|FG001|Double-blind Treatment Phase|Noncompliance|8|||
33469564|NCT00286091|62843354|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
33469565|NCT00286091|62843355|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
33469566|NCT00286091|62843354|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
33469567|NCT00286091|62843355|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
33469568|NCT00286091|62843354|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
33469569|NCT00286091|62843355|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
33338005|NCT01113710|62714734|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
33338006|NCT01113710|62714734|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
33469570|NCT00286091|62843354|FG000|Open-label Treatment Phase|Physician Decision|24|||
33338007|NCT01113710|62714734|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
33338008|NCT01124162|62714740|FG000|First Intervention|Adverse Event|2|||
33338009|NCT01124162|62714741|FG001|First Intervention|Adverse Event|0|||
33338010|NCT01124162|62714740|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
33469571|NCT00286091|62843355|FG001|Open-label Treatment Phase|Physician Decision|21|||
33469572|NCT00286091|62843354|FG000|Open-label Treatment Phase|Adverse Event|5|||
33469573|NCT00286091|62843355|FG001|Open-label Treatment Phase|Adverse Event|16|||
33469574|NCT00286091|62843354|FG000|Open-label Treatment Phase|Other|11|||
33469575|NCT00286091|62843355|FG001|Open-label Treatment Phase|Other|11|||
33469576|NCT00286091|62843354|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
33469577|NCT00286091|62843355|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
33469578|NCT00286091|62843354|FG000|Open-label Treatment Phase|Death|10|||
33469579|NCT00286091|62843355|FG001|Open-label Treatment Phase|Death|7|||
33469580|NCT00286091|62843354|FG000|Open-label Treatment Phase|Disease Progression|9|||
33469581|NCT00286091|62843355|FG001|Open-label Treatment Phase|Disease Progression|3|||
33469582|NCT00286091|62843354|FG000|Open-label Treatment Phase|Noncompliance|3|||
33469583|NCT00286091|62843355|FG001|Open-label Treatment Phase|Noncompliance|1|||
33469584|NCT00286091|62843354|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
33469585|NCT00286091|62843355|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
33469586|NCT00286091|62843354|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
33469587|NCT00286091|62843355|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
33469588|NCT00286091|62843354|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
33469589|NCT00286091|62843355|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
33469590|NCT00285857|62843363|FG000|Overall Study|Withdrawal by Subject|2|||
33469591|NCT00285857|62843363|FG000|Overall Study|Inadequate initial breast cytology|1|||
33469592|NCT00285857|62843363|FG000|Overall Study|Adverse Event|1|||
33469593|NCT00284141|62843372|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
33469594|NCT00284141|62843372|FG000|Overall Study|Adverse Event|19|||
33469595|NCT00284141|62843372|FG000|Overall Study|Participant's request|9|||
33469596|NCT00284141|62843372|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
33469597|NCT00284141|62843372|FG000|Overall Study|Clinical deterioration / death|2|||
33469598|NCT00284141|62843372|FG000|Overall Study|General decline|1|||
33469599|NCT00284141|62843372|FG000|Overall Study|Pneumonia|1|||
33469600|NCT00284141|62843372|FG000|Overall Study|Did not take study medication|2|||
33469601|NCT00284141|62843372|FG000|Overall Study|Ongoing treatment|2|||
33469602|NCT00265343|62843380|FG000|Overall Study|Adverse Event|10|||
33469603|NCT00265343|62843381|FG001|Overall Study|Adverse Event|7|||
33469604|NCT00265343|62843380|FG000|Overall Study|Withdrawal by Subject|3|||
33469605|NCT00265343|62843381|FG001|Overall Study|Withdrawal by Subject|9|||
33469606|NCT00265343|62843380|FG000|Overall Study|Other|8|||
33469607|NCT00265343|62843381|FG001|Overall Study|Other|3|||
33469608|NCT00283595|62843389|FG000|Overall Study|Withdrawal by Subject|1|||
33469609|NCT00283595|62843390|FG001|Overall Study|Withdrawal by Subject|2|||
33469610|NCT00265109|62843396|FG000|Overall Study|Withdrawal by Subject|5|||
33469611|NCT00265109|62843396|FG000|Overall Study|Adverse Event|1|||
33469612|NCT03235024|62843403|FG000|Overall Study|Adverse Event|2|||
33469613|NCT03235024|62843404|FG001|Overall Study|Adverse Event|2|||
33469614|NCT03235024|62843403|FG000|Overall Study|Death|1|||
33469615|NCT03235024|62843404|FG001|Overall Study|Death|0|||
33469616|NCT03235024|62843403|FG000|Overall Study|Lost to Follow-up|2|||
33469617|NCT03235024|62843404|FG001|Overall Study|Lost to Follow-up|5|||
33469618|NCT03235024|62843403|FG000|Overall Study|Protocol Violation|1|||
33469619|NCT03235024|62843404|FG001|Overall Study|Protocol Violation|0|||
33469620|NCT03235024|62843403|FG000|Overall Study|Withdrawal by Subject|0|||
33469621|NCT03235024|62843404|FG001|Overall Study|Withdrawal by Subject|3|||
33469622|NCT03233308|62843410|FG000|Overall Study|Adverse Event|1|||
33338011|NCT01124162|62714741|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
33338012|NCT00906399|62714750|FG000|Year 1|Randomized But Not Treated|0|||
33338013|NCT00906399|62714751|FG001|Year 1|Randomized But Not Treated|1|||
33338014|NCT00906399|62714752|FG002|Year 1|Randomized But Not Treated|3|||
33338015|NCT00906399|62714753|FG003|Year 1|Randomized But Not Treated|0|||
33338016|NCT00906399|62714754|FG004|Year 1|Randomized But Not Treated|0|||
33338017|NCT00906399|62714755|FG005|Year 1|Randomized But Not Treated|0|||
33469623|NCT03233308|62843410|FG000|Overall Study|Protocol Violation|1|||
33469624|NCT00283439|62843425|FG000|Overall Study|Adverse Event|0|||
33469625|NCT00283439|62843426|FG001|Overall Study|Adverse Event|0|||
33469626|NCT00283439|62843427|FG002|Overall Study|Adverse Event|0|||
33469627|NCT00283439|62843428|FG003|Overall Study|Adverse Event|1|||
33469628|NCT00283439|62843425|FG000|Overall Study|Death|0|||
33469629|NCT00283439|62843426|FG001|Overall Study|Death|0|||
33469630|NCT00283439|62843427|FG002|Overall Study|Death|1|||
33469631|NCT00283439|62843428|FG003|Overall Study|Death|0|||
33338018|NCT00906399|62714756|FG006|Year 1|Randomized But Not Treated|0|||
33338019|NCT00906399|62714750|FG000|Year 1|Adverse Event|4|||
33469632|NCT00283439|62843425|FG000|Overall Study|Disease progression|0|||
33338020|NCT00906399|62714751|FG001|Year 1|Adverse Event|22|||
33469633|NCT00283439|62843426|FG001|Overall Study|Disease progression|1|||
33469634|NCT00283439|62843427|FG002|Overall Study|Disease progression|0|||
33469635|NCT00283439|62843428|FG003|Overall Study|Disease progression|0|||
33469636|NCT00283439|62843425|FG000|Overall Study|Requirement for alternative therapy|1|||
33469637|NCT00283439|62843426|FG001|Overall Study|Requirement for alternative therapy|2|||
33469638|NCT00283439|62843427|FG002|Overall Study|Requirement for alternative therapy|5|||
33338021|NCT00906399|62714752|FG002|Year 1|Adverse Event|24|||
33338022|NCT00906399|62714753|FG003|Year 1|Adverse Event|0|||
33338023|NCT00906399|62714754|FG004|Year 1|Adverse Event|0|||
33338024|NCT00906399|62714755|FG005|Year 1|Adverse Event|0|||
33338025|NCT00906399|62714756|FG006|Year 1|Adverse Event|0|||
33338026|NCT00906399|62714750|FG000|Year 1|Lost to Follow-up|4|||
33338027|NCT00906399|62714751|FG001|Year 1|Lost to Follow-up|4|||
33338028|NCT00906399|62714752|FG002|Year 1|Lost to Follow-up|2|||
33338029|NCT00906399|62714753|FG003|Year 1|Lost to Follow-up|0|||
33338030|NCT00906399|62714754|FG004|Year 1|Lost to Follow-up|0|||
33338031|NCT00906399|62714755|FG005|Year 1|Lost to Follow-up|0|||
33338032|NCT00906399|62714756|FG006|Year 1|Lost to Follow-up|0|||
33338033|NCT00906399|62714750|FG000|Year 1|Withdrawal by Subject|30|||
33338034|NCT00906399|62714751|FG001|Year 1|Withdrawal by Subject|32|||
33338035|NCT00906399|62714752|FG002|Year 1|Withdrawal by Subject|36|||
33338036|NCT00906399|62714753|FG003|Year 1|Withdrawal by Subject|0|||
33338037|NCT00906399|62714754|FG004|Year 1|Withdrawal by Subject|0|||
33338038|NCT00906399|62714755|FG005|Year 1|Withdrawal by Subject|0|||
33338039|NCT00906399|62714756|FG006|Year 1|Withdrawal by Subject|0|||
33338040|NCT00906399|62714750|FG000|Year 1|Physician Decision|0|||
33338041|NCT00906399|62714751|FG001|Year 1|Physician Decision|1|||
33338042|NCT00906399|62714752|FG002|Year 1|Physician Decision|3|||
33338043|NCT00906399|62714753|FG003|Year 1|Physician Decision|0|||
33338044|NCT00906399|62714754|FG004|Year 1|Physician Decision|0|||
33338045|NCT00906399|62714755|FG005|Year 1|Physician Decision|0|||
33338046|NCT00906399|62714756|FG006|Year 1|Physician Decision|0|||
33338047|NCT00906399|62714750|FG000|Year 1|Death|2|||
33338048|NCT00906399|62714751|FG001|Year 1|Death|1|||
33338049|NCT00906399|62714752|FG002|Year 1|Death|1|||
33338050|NCT00906399|62714753|FG003|Year 1|Death|0|||
33338051|NCT00906399|62714754|FG004|Year 1|Death|0|||
33338052|NCT00906399|62714755|FG005|Year 1|Death|0|||
33338053|NCT00906399|62714756|FG006|Year 1|Death|0|||
33338054|NCT00906399|62714750|FG000|Year 1|Other|4|||
33338055|NCT00906399|62714751|FG001|Year 1|Other|2|||
33338056|NCT00906399|62714752|FG002|Year 1|Other|7|||
33338057|NCT00906399|62714753|FG003|Year 1|Other|0|||
33338058|NCT00906399|62714754|FG004|Year 1|Other|0|||
33338059|NCT00906399|62714755|FG005|Year 1|Other|0|||
33338060|NCT00906399|62714756|FG006|Year 1|Other|0|||
33338061|NCT00906399|62714750|FG000|Year 2|Adverse Event|0|||
33338062|NCT00906399|62714751|FG001|Year 2|Adverse Event|0|||
33338063|NCT00906399|62714752|FG002|Year 2|Adverse Event|0|||
33338064|NCT00906399|62714753|FG003|Year 2|Adverse Event|9|||
33338065|NCT00906399|62714754|FG004|Year 2|Adverse Event|8|||
33338066|NCT00906399|62714755|FG005|Year 2|Adverse Event|11|||
33338067|NCT00906399|62714756|FG006|Year 2|Adverse Event|6|||
33338068|NCT00906399|62714750|FG000|Year 2|Lost to Follow-up|0|||
33338069|NCT00906399|62714751|FG001|Year 2|Lost to Follow-up|0|||
33338070|NCT00906399|62714752|FG002|Year 2|Lost to Follow-up|0|||
33338071|NCT00906399|62714753|FG003|Year 2|Lost to Follow-up|1|||
33338072|NCT00906399|62714754|FG004|Year 2|Lost to Follow-up|4|||
33338073|NCT00906399|62714755|FG005|Year 2|Lost to Follow-up|2|||
33338074|NCT00906399|62714756|FG006|Year 2|Lost to Follow-up|4|||
33338075|NCT00906399|62714750|FG000|Year 2|Withdrawal by Subject|0|||
33338076|NCT00906399|62714751|FG001|Year 2|Withdrawal by Subject|0|||
33338077|NCT00906399|62714752|FG002|Year 2|Withdrawal by Subject|0|||
33338078|NCT00906399|62714753|FG003|Year 2|Withdrawal by Subject|17|||
33338079|NCT00906399|62714754|FG004|Year 2|Withdrawal by Subject|18|||
33338080|NCT00906399|62714755|FG005|Year 2|Withdrawal by Subject|27|||
33338081|NCT00906399|62714756|FG006|Year 2|Withdrawal by Subject|13|||
33338082|NCT00906399|62714750|FG000|Year 2|Physician Decision|0|||
33338083|NCT00906399|62714751|FG001|Year 2|Physician Decision|0|||
33338084|NCT00906399|62714752|FG002|Year 2|Physician Decision|0|||
33338085|NCT00906399|62714753|FG003|Year 2|Physician Decision|0|||
33338086|NCT00906399|62714754|FG004|Year 2|Physician Decision|2|||
33338087|NCT00906399|62714755|FG005|Year 2|Physician Decision|6|||
33338088|NCT00906399|62714756|FG006|Year 2|Physician Decision|3|||
33338089|NCT00906399|62714750|FG000|Year 2|Death|0|||
33338090|NCT00906399|62714751|FG001|Year 2|Death|0|||
33338091|NCT00906399|62714752|FG002|Year 2|Death|0|||
33338092|NCT00906399|62714753|FG003|Year 2|Death|1|||
33338093|NCT00906399|62714754|FG004|Year 2|Death|0|||
33338094|NCT00906399|62714755|FG005|Year 2|Death|0|||
33338095|NCT00906399|62714756|FG006|Year 2|Death|3|||
33338096|NCT00906399|62714750|FG000|Year 2|Other|0|||
33338097|NCT00906399|62714751|FG001|Year 2|Other|0|||
33338098|NCT00906399|62714752|FG002|Year 2|Other|0|||
33338099|NCT00906399|62714753|FG003|Year 2|Other|2|||
33338100|NCT00906399|62714754|FG004|Year 2|Other|3|||
33338101|NCT00906399|62714755|FG005|Year 2|Other|1|||
33338102|NCT00906399|62714756|FG006|Year 2|Other|0|||
33338103|NCT01111838|62714768|FG000|Overall Study|Patient Ineligible|2|||
33338104|NCT01111838|62714768|FG000|Overall Study|Not Treated|3|||
33338105|NCT01111838|62714768|FG000|Overall Study|Clinical deterioration|1|||
33338106|NCT01111838|62714768|FG000|Overall Study|Other Complicating Disease|1|||
33338107|NCT00947856|62714774|FG000|Treatment Period|Progressive Disease|33|||
33338108|NCT00947856|62714775|FG001|Treatment Period|Progressive Disease|12|||
33338109|NCT00947856|62714774|FG000|Treatment Period|Adverse Event|15|||
33338110|NCT00947856|62714775|FG001|Treatment Period|Adverse Event|9|||
33338111|NCT00947856|62714774|FG000|Treatment Period|Physician Decision|14|||
33338112|NCT00947856|62714775|FG001|Treatment Period|Physician Decision|6|||
33338113|NCT00947856|62714774|FG000|Treatment Period|Study Stopped by Sponsor|4|||
33338114|NCT00947856|62714775|FG001|Treatment Period|Study Stopped by Sponsor|4|||
33338115|NCT00947856|62714774|FG000|Treatment Period|Withdrawal by Subject|12|||
33338116|NCT00947856|62714775|FG001|Treatment Period|Withdrawal by Subject|1|||
33338117|NCT00947856|62714774|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
33338118|NCT00947856|62714775|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
33338119|NCT00947856|62714774|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
33338120|NCT00947856|62714775|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
33338121|NCT00947856|62714774|FG000|Follow-up Period|Lost to Follow-up|7|||
33338122|NCT00947856|62714775|FG001|Follow-up Period|Lost to Follow-up|0|||
33338123|NCT00947856|62714774|FG000|Follow-up Period|Patient unavailable for site visits|1|||
33338124|NCT00947856|62714775|FG001|Follow-up Period|Patient unavailable for site visits|0|||
33338125|NCT00947856|62714774|FG000|Follow-up Period|Withdrawal by Subject|1|||
33338126|NCT00947856|62714775|FG001|Follow-up Period|Withdrawal by Subject|0|||
33338127|NCT00947544|62714790|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
33338128|NCT00947544|62714791|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
33338129|NCT00907335|62714803|FG000|Overall Study|Withdrawal by Subject|2|||
33338130|NCT00907335|62714804|FG001|Overall Study|Withdrawal by Subject|0|||
33338131|NCT00907335|62714803|FG000|Overall Study|Adverse Event|4|||
33338132|NCT00907335|62714804|FG001|Overall Study|Adverse Event|1|||
33338133|NCT00907335|62714803|FG000|Overall Study|Lost to Follow-up|2|||
33338134|NCT00907335|62714804|FG001|Overall Study|Lost to Follow-up|0|||
33338135|NCT00947154|62714810|FG000|Overall Study|Lost to Follow-up|1|||
33338136|NCT01124006|62714818|FG000|Overall Study|Withdrawal by Subject|2|||
33338137|NCT01124006|62714819|FG001|Overall Study|Withdrawal by Subject|2|||
33338138|NCT01124006|62714820|FG002|Overall Study|Withdrawal by Subject|0|||
33338139|NCT01124006|62714818|FG000|Overall Study|Lost to Follow-up|1|||
33338140|NCT01124006|62714819|FG001|Overall Study|Lost to Follow-up|0|||
33338141|NCT01124006|62714820|FG002|Overall Study|Lost to Follow-up|1|||
33338142|NCT01124006|62714818|FG000|Overall Study|Other|0|||
33338143|NCT01124006|62714819|FG001|Overall Study|Other|0|||
33338144|NCT01124006|62714820|FG002|Overall Study|Other|1|||
33338145|NCT00952068|62714828|FG000|Overall Study|Adverse Event|3|||
33338146|NCT00952068|62714828|FG000|Overall Study|Withdrawal by Subject|4|||
33338147|NCT01123850|62714832|FG000|Overall Study|Slow enrollment|45|||
33338148|NCT01123382|62714838|FG000|Overall Study|Withdrawal by Subject|1|||
33338149|NCT01123382|62714839|FG001|Overall Study|Withdrawal by Subject|4|||
33338150|NCT01123382|62714838|FG000|Overall Study|Lost to Follow-up|1|||
33338151|NCT01123382|62714839|FG001|Overall Study|Lost to Follow-up|2|||
33338152|NCT00951912|62714848|FG000|Overall Study|Lack of Efficacy|1|||
33338153|NCT00951912|62714849|FG001|Overall Study|Lack of Efficacy|0|||
33338154|NCT00951912|62714850|FG002|Overall Study|Lack of Efficacy|0|||
33338155|NCT00951912|62714848|FG000|Overall Study|Adverse Event|0|||
33338156|NCT00951912|62714849|FG001|Overall Study|Adverse Event|1|||
33338157|NCT00951912|62714850|FG002|Overall Study|Adverse Event|1|||
33338158|NCT00951912|62714848|FG000|Overall Study|Lost to Follow-up|2|||
33338159|NCT00951912|62714849|FG001|Overall Study|Lost to Follow-up|2|||
33338160|NCT00951912|62714850|FG002|Overall Study|Lost to Follow-up|0|||
33338161|NCT00951912|62714848|FG000|Overall Study|Physician Decision|1|||
33338162|NCT00951912|62714849|FG001|Overall Study|Physician Decision|0|||
33338163|NCT00951912|62714850|FG002|Overall Study|Physician Decision|1|||
33469639|NCT00283439|62843428|FG003|Overall Study|Requirement for alternative therapy|2|||
33469640|NCT00283439|62843425|FG000|Overall Study|Stem cell transplant|6|||
33469641|NCT00283439|62843426|FG001|Overall Study|Stem cell transplant|6|||
33469642|NCT00283439|62843427|FG002|Overall Study|Stem cell transplant|4|||
33469643|NCT00283439|62843428|FG003|Overall Study|Stem cell transplant|3|||
33469644|NCT00283439|62843425|FG000|Overall Study|Treatment discontinued|0|||
33469645|NCT00283439|62843426|FG001|Overall Study|Treatment discontinued|2|||
33338164|NCT00951912|62714848|FG000|Overall Study|Withdrawal by Subject|1|||
33338165|NCT00951912|62714849|FG001|Overall Study|Withdrawal by Subject|1|||
33338166|NCT00951912|62714850|FG002|Overall Study|Withdrawal by Subject|0|||
33338167|NCT00951912|62714848|FG000|Overall Study|Other:Depression|1|||
33338168|NCT00951912|62714849|FG001|Overall Study|Other:Depression|0|||
33338169|NCT00951912|62714850|FG002|Overall Study|Other:Depression|0|||
33338170|NCT00951912|62714848|FG000|Overall Study|Other: Colon cancer|1|||
33338171|NCT00951912|62714849|FG001|Overall Study|Other: Colon cancer|0|||
33338172|NCT00951912|62714850|FG002|Overall Study|Other: Colon cancer|0|||
33338173|NCT00951912|62714848|FG000|Overall Study|Other: Stroke|0|||
33338174|NCT00951912|62714849|FG001|Overall Study|Other: Stroke|1|||
33338175|NCT00951912|62714850|FG002|Overall Study|Other: Stroke|0|||
33338176|NCT01123148|62714858|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
33338177|NCT01123148|62714858|FG000|Overall Study|Didn't meet milestone criteria|1|||
33338178|NCT01123070|62714866|FG000|Part B Double Blind Period|Protocol Violation|0|||
33338179|NCT01123070|62714867|FG001|Part B Double Blind Period|Protocol Violation|0|||
33338180|NCT01123070|62714868|FG002|Part B Double Blind Period|Protocol Violation|0|||
33338181|NCT01123070|62714869|FG003|Part B Double Blind Period|Protocol Violation|1|||
33338182|NCT01123070|62714866|FG000|Part B Double Blind Period|Adverse Event|0|||
33338183|NCT01123070|62714867|FG001|Part B Double Blind Period|Adverse Event|0|||
33338184|NCT01123070|62714868|FG002|Part B Double Blind Period|Adverse Event|2|||
33338185|NCT01123070|62714869|FG003|Part B Double Blind Period|Adverse Event|0|||
33338186|NCT01123070|62714866|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
33338187|NCT01123070|62714867|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
33338188|NCT01123070|62714868|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
33338189|NCT01123070|62714869|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
33338190|NCT01122680|62714880|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
33338191|NCT01122680|62714881|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
33338192|NCT01122680|62714882|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
33338193|NCT01122680|62714883|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
33338194|NCT01122680|62714880|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
33338195|NCT01122680|62714881|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
33338196|NCT01122680|62714882|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
33338197|NCT01122680|62714883|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
33338198|NCT01122680|62714880|FG000|Period 1 (4 Weeks)|Other|1|||
33338199|NCT01122680|62714881|FG001|Period 1 (4 Weeks)|Other|1|||
33338200|NCT01122680|62714882|FG002|Period 1 (4 Weeks)|Other|0|||
33338201|NCT01122680|62714883|FG003|Period 1 (4 Weeks)|Other|0|||
33338202|NCT01122680|62714880|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
33338203|NCT01122680|62714881|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
33338204|NCT01122680|62714882|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
33338205|NCT01122680|62714883|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
33338206|NCT01122680|62714880|FG000|Period 2 (4 Weeks)|Other|1|||
33338207|NCT01122680|62714881|FG001|Period 2 (4 Weeks)|Other|0|||
33338208|NCT01122680|62714882|FG002|Period 2 (4 Weeks)|Other|0|||
33338209|NCT01122680|62714883|FG003|Period 2 (4 Weeks)|Other|0|||
33338210|NCT01122680|62714880|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
33338211|NCT01122680|62714881|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
33338212|NCT01122680|62714882|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
33338213|NCT01122680|62714883|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
33338214|NCT01122680|62714880|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
33338215|NCT01122680|62714881|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
33338216|NCT01122680|62714882|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
33338217|NCT01122680|62714883|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
33338218|NCT00946998|62714895|FG000|Overall Study|Exited prior to first outcome assessment|5|||
33338219|NCT00946998|62714896|FG001|Overall Study|Exited prior to first outcome assessment|3|||
33338220|NCT01138826|62714902|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
33338221|NCT01138826|62714903|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
33338222|NCT01138826|62714904|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
33338223|NCT01138826|62714905|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
33338224|NCT01138826|62714906|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
33338225|NCT01138826|62714907|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
33338226|NCT00906087|62714915|FG000|Initial Washout|Withdrawal by Subject|1|||
33338227|NCT00906087|62714915|FG000|Initial Washout|Physician Decision|1|||
33338228|NCT00907257|62714924|FG000|Overall Study|Adverse Event|0|||
33338229|NCT00907257|62714925|FG001|Overall Study|Adverse Event|4|||
33338230|NCT00907257|62714924|FG000|Overall Study|Protocol Violation|1|||
33338231|NCT00907257|62714925|FG001|Overall Study|Protocol Violation|2|||
33338232|NCT00907257|62714924|FG000|Overall Study|Lost to Follow-up|3|||
33338233|NCT00907257|62714925|FG001|Overall Study|Lost to Follow-up|3|||
33338234|NCT00907257|62714924|FG000|Overall Study|Withdrawal by Subject|1|||
33338235|NCT00907257|62714925|FG001|Overall Study|Withdrawal by Subject|2|||
33338236|NCT00907257|62714924|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
33338237|NCT00907257|62714925|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
33338238|NCT00907257|62714924|FG000|Overall Study|Moved|1|||
33338239|NCT00907257|62714925|FG001|Overall Study|Moved|0|||
33338240|NCT00907257|62714924|FG000|Overall Study|Personal Reasons|6|||
33338241|NCT00907257|62714925|FG001|Overall Study|Personal Reasons|1|||
33338242|NCT01138046|62714931|FG000|Overall Study|Withdrawal due to death|6|||
33338243|NCT00876460|62714943|FG000|Combination Therapy Phase|Progressive disease|2|||
33338244|NCT00876460|62714944|FG001|Combination Therapy Phase|Progressive disease|3|||
33338245|NCT00876460|62714945|FG002|Combination Therapy Phase|Progressive disease|3|||
33338246|NCT00876460|62714946|FG003|Combination Therapy Phase|Progressive disease|3|||
33338247|NCT00876460|62714947|FG004|Combination Therapy Phase|Progressive disease|3|||
33338248|NCT00876460|62714948|FG005|Combination Therapy Phase|Progressive disease|1|||
33338249|NCT00876460|62714949|FG006|Combination Therapy Phase|Progressive disease|1|||
33338250|NCT00876460|62714950|FG007|Combination Therapy Phase|Progressive disease|1|||
33338251|NCT00876460|62714943|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
33338252|NCT00876460|62714944|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
33338253|NCT00876460|62714945|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
33338254|NCT00876460|62714946|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
33338255|NCT00876460|62714947|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
33338256|NCT00876460|62714948|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
33338257|NCT00876460|62714949|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
33338258|NCT00876460|62714950|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
33338259|NCT00876460|62714943|FG000|Combination Therapy Phase|Adverse Event|0|||
33338260|NCT00876460|62714944|FG001|Combination Therapy Phase|Adverse Event|2|||
33338261|NCT00876460|62714945|FG002|Combination Therapy Phase|Adverse Event|0|||
33338262|NCT00876460|62714946|FG003|Combination Therapy Phase|Adverse Event|2|||
33338263|NCT00876460|62714947|FG004|Combination Therapy Phase|Adverse Event|2|||
33338264|NCT00876460|62714948|FG005|Combination Therapy Phase|Adverse Event|0|||
33338265|NCT00876460|62714949|FG006|Combination Therapy Phase|Adverse Event|3|||
33338266|NCT00876460|62714950|FG007|Combination Therapy Phase|Adverse Event|2|||
33338267|NCT00876460|62714943|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
33338268|NCT00876460|62714944|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
33338269|NCT00876460|62714945|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
33338270|NCT00876460|62714946|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
33338271|NCT00876460|62714947|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
33338272|NCT00876460|62714948|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
33338273|NCT00876460|62714949|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
33338274|NCT00876460|62714950|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
33338275|NCT00876460|62714943|FG000|Combination Therapy Phase|Other reason not defined above|0|||
33338276|NCT00876460|62714944|FG001|Combination Therapy Phase|Other reason not defined above|0|||
33338277|NCT00876460|62714945|FG002|Combination Therapy Phase|Other reason not defined above|0|||
33338278|NCT00876460|62714946|FG003|Combination Therapy Phase|Other reason not defined above|0|||
33338279|NCT00876460|62714947|FG004|Combination Therapy Phase|Other reason not defined above|0|||
33338280|NCT00876460|62714948|FG005|Combination Therapy Phase|Other reason not defined above|0|||
33338281|NCT00876460|62714949|FG006|Combination Therapy Phase|Other reason not defined above|1|||
33338282|NCT00876460|62714950|FG007|Combination Therapy Phase|Other reason not defined above|2|||
33338283|NCT00876460|62714943|FG000|Combination Therapy Phase|Not treated|0|||
33338284|NCT00876460|62714944|FG001|Combination Therapy Phase|Not treated|0|||
33338285|NCT00876460|62714945|FG002|Combination Therapy Phase|Not treated|0|||
33338286|NCT00876460|62714946|FG003|Combination Therapy Phase|Not treated|0|||
33338287|NCT00876460|62714947|FG004|Combination Therapy Phase|Not treated|0|||
33338288|NCT00876460|62714948|FG005|Combination Therapy Phase|Not treated|0|||
33338289|NCT00876460|62714949|FG006|Combination Therapy Phase|Not treated|1|||
33338290|NCT00876460|62714950|FG007|Combination Therapy Phase|Not treated|0|||
33338291|NCT00876460|62714943|FG000|Mono Therapy Phase|Progressive disease|0|||
33338292|NCT00876460|62714944|FG001|Mono Therapy Phase|Progressive disease|0|||
33338293|NCT00876460|62714945|FG002|Mono Therapy Phase|Progressive disease|0|||
33338294|NCT00876460|62714946|FG003|Mono Therapy Phase|Progressive disease|0|||
33338295|NCT00876460|62714947|FG004|Mono Therapy Phase|Progressive disease|2|||
33338296|NCT00876460|62714948|FG005|Mono Therapy Phase|Progressive disease|0|||
33338297|NCT00876460|62714949|FG006|Mono Therapy Phase|Progressive disease|1|||
33338298|NCT00876460|62714950|FG007|Mono Therapy Phase|Progressive disease|3|||
33338299|NCT00876460|62714943|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
33338300|NCT00876460|62714944|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
33338301|NCT00876460|62714945|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
33338302|NCT00876460|62714946|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
33338303|NCT00876460|62714947|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
33338304|NCT00876460|62714948|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
33338305|NCT00876460|62714949|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
33338306|NCT00876460|62714950|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
33338307|NCT00876460|62714943|FG000|Mono Therapy Phase|Adverse Event|0|||
33338308|NCT00876460|62714944|FG001|Mono Therapy Phase|Adverse Event|0|||
33338309|NCT00876460|62714945|FG002|Mono Therapy Phase|Adverse Event|0|||
33338310|NCT00876460|62714946|FG003|Mono Therapy Phase|Adverse Event|1|||
33338311|NCT00876460|62714947|FG004|Mono Therapy Phase|Adverse Event|0|||
33338312|NCT00876460|62714948|FG005|Mono Therapy Phase|Adverse Event|0|||
33338313|NCT00876460|62714949|FG006|Mono Therapy Phase|Adverse Event|0|||
33338314|NCT00876460|62714950|FG007|Mono Therapy Phase|Adverse Event|0|||
33338315|NCT00908115|62714980|FG000|Overall Study|Other|14|||
33338316|NCT01137812|62714986|FG000|Overall Study|Adverse Event|21|||
33338317|NCT01137812|62714987|FG001|Overall Study|Adverse Event|14|||
33338318|NCT01137812|62714986|FG000|Overall Study|Lost to Follow-up|6|||
33338319|NCT01137812|62714987|FG001|Overall Study|Lost to Follow-up|8|||
33338320|NCT01137812|62714986|FG000|Overall Study|Physician Decision|25|||
33338321|NCT01137812|62714987|FG001|Overall Study|Physician Decision|17|||
33469646|NCT00283439|62843427|FG002|Overall Study|Treatment discontinued|1|||
33338322|NCT01137812|62714986|FG000|Overall Study|Protocol Violation|5|||
33338323|NCT01137812|62714987|FG001|Overall Study|Protocol Violation|4|||
33338324|NCT01137812|62714986|FG000|Overall Study|Withdrawal by Subject|5|||
33338325|NCT01137812|62714987|FG001|Overall Study|Withdrawal by Subject|13|||
33338326|NCT01137812|62714986|FG000|Overall Study|Death|2|||
33338327|NCT01137812|62714987|FG001|Overall Study|Death|0|||
33338328|NCT01137812|62714986|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
33338329|NCT01137812|62714987|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
33338330|NCT01137812|62714986|FG000|Overall Study|Other|19|||
33338331|NCT01137812|62714987|FG001|Overall Study|Other|27|||
33338332|NCT01137578|62714993|FG000|Overall Study|Participant requested to Discontinue|3|||
33338333|NCT01137578|62714994|FG001|Overall Study|Participant requested to Discontinue|0|||
33338334|NCT01137578|62714995|FG002|Overall Study|Participant requested to Discontinue|0|||
33338335|NCT01137578|62714993|FG000|Overall Study|Withdrawal by Subject|1|||
33338336|NCT01137578|62714994|FG001|Overall Study|Withdrawal by Subject|0|||
33338337|NCT01137578|62714995|FG002|Overall Study|Withdrawal by Subject|0|||
33338338|NCT01137578|62714993|FG000|Overall Study|Other|12|||
33338339|NCT01137578|62714994|FG001|Overall Study|Other|2|||
33338340|NCT01137578|62714995|FG002|Overall Study|Other|6|||
33338341|NCT00946920|62715025|FG000|Overall Study|Withdrawal by Subject|28|||
33338342|NCT00946920|62715026|FG001|Overall Study|Withdrawal by Subject|15|||
33338343|NCT00946920|62715025|FG000|Overall Study|Lost to Follow-up|2|||
33338344|NCT00946920|62715026|FG001|Overall Study|Lost to Follow-up|2|||
33338345|NCT00946920|62715025|FG000|Overall Study|Physician Decision|5|||
33338346|NCT00946920|62715026|FG001|Overall Study|Physician Decision|2|||
33338347|NCT00946920|62715025|FG000|Overall Study|Adverse Event|41|||
33338348|NCT00946920|62715026|FG001|Overall Study|Adverse Event|14|||
33338349|NCT00946920|62715025|FG000|Overall Study|Protocol Violation|16|||
33469647|NCT00283439|62843428|FG003|Overall Study|Treatment discontinued|3|||
33469648|NCT00283439|62843425|FG000|Overall Study|Other|1|||
33469649|NCT00283439|62843426|FG001|Overall Study|Other|0|||
33469650|NCT00283439|62843427|FG002|Overall Study|Other|0|||
33469651|NCT00283439|62843428|FG003|Overall Study|Other|0|||
33469652|NCT03233230|62843442|FG000|Overall Study|Adverse Event|6|||
33469653|NCT03233230|62843443|FG001|Overall Study|Adverse Event|3|||
33548811|NCT02970929|62940155|FG000|Overall Study|Withdrawal by Subject|16|||
33548812|NCT02970305|62940172|FG000|Overall Study|Adverse Event|10|||
33548813|NCT02970305|62940173|FG001|Overall Study|Adverse Event|6|||
33548814|NCT02970305|62940172|FG000|Overall Study|Lack of Efficacy|1|||
33469654|NCT03233230|62843444|FG002|Overall Study|Adverse Event|6|||
33469655|NCT03233230|62843445|FG003|Overall Study|Adverse Event|3|||
33469656|NCT03233230|62843442|FG000|Overall Study|Protocol Violation|1|||
33469657|NCT03233230|62843443|FG001|Overall Study|Protocol Violation|2|||
33469658|NCT03233230|62843444|FG002|Overall Study|Protocol Violation|1|||
33469659|NCT03233230|62843445|FG003|Overall Study|Protocol Violation|1|||
33469660|NCT03233230|62843442|FG000|Overall Study|Lack of Efficacy|1|||
33469661|NCT03233230|62843443|FG001|Overall Study|Lack of Efficacy|0|||
33469662|NCT03233230|62843444|FG002|Overall Study|Lack of Efficacy|0|||
33654336|NCT01700192|63067103|FG000|Overall Study|Noncompliance with study drug|0|||
33654337|NCT01700192|63067104|FG001|Overall Study|Noncompliance with study drug|5|||
33338350|NCT00946920|62715026|FG001|Overall Study|Protocol Violation|8|||
33338351|NCT00946920|62715025|FG000|Overall Study|Miscellaneous reasons|18|||
33338352|NCT00946920|62715026|FG001|Overall Study|Miscellaneous reasons|3|||
33338353|NCT00946530|62715036|FG000|Overall Study|Withdrawal by Subject|0|||
33338354|NCT00946530|62715037|FG001|Overall Study|Withdrawal by Subject|3|||
33338355|NCT00946530|62715038|FG002|Overall Study|Withdrawal by Subject|0|||
33338356|NCT00946530|62715039|FG003|Overall Study|Withdrawal by Subject|3|||
33338357|NCT00946530|62715036|FG000|Overall Study|Physician Decision|1|||
33338358|NCT00946530|62715037|FG001|Overall Study|Physician Decision|1|||
33338359|NCT00946530|62715038|FG002|Overall Study|Physician Decision|1|||
33338360|NCT00946530|62715039|FG003|Overall Study|Physician Decision|1|||
33338361|NCT00946296|62715055|FG000|Overall Study|Physician Decision|3|||
33469663|NCT03233230|62843445|FG003|Overall Study|Lack of Efficacy|0|||
33469664|NCT03233230|62843442|FG000|Overall Study|Other|5|||
33469665|NCT03233230|62843443|FG001|Overall Study|Other|5|||
33469666|NCT03233230|62843444|FG002|Overall Study|Other|5|||
33338362|NCT00946296|62715056|FG001|Overall Study|Physician Decision|0|||
33338363|NCT00945906|62715062|FG000|Overall Study|Withdrawal by Subject|1|||
33338364|NCT00945906|62715062|FG000|Overall Study|Did not want to return for last visit|2|||
33338365|NCT00945906|62715062|FG000|Overall Study|Unable to return for last visit|2|||
33338366|NCT00945906|62715062|FG000|Overall Study|Moved to another country|2|||
33469667|NCT03233230|62843445|FG003|Overall Study|Other|3|||
33469668|NCT03233230|62843442|FG000|Overall Study|Withdrawal by Subject|2|||
33469669|NCT03233230|62843443|FG001|Overall Study|Withdrawal by Subject|2|||
33469670|NCT03233230|62843444|FG002|Overall Study|Withdrawal by Subject|0|||
33548815|NCT02970305|62940173|FG001|Overall Study|Lack of Efficacy|1|||
33469671|NCT03233230|62843445|FG003|Overall Study|Withdrawal by Subject|1|||
33469672|NCT03233230|62843442|FG000|Overall Study|Lost to Follow-up|0|||
33580904|NCT01454934|62978057|FG000|Overall Study|Other|6|||
33338367|NCT00594646|62715066|FG000|Overall Study|Withdrawal by Subject|1|||
33338368|NCT00594646|62715066|FG000|Overall Study|Lost to Follow-up|15|||
33338369|NCT01111604|62715074|FG000|Overall Study|Lost to Follow-up|0|||
33338370|NCT01111604|62715075|FG001|Overall Study|Lost to Follow-up|0|||
33338371|NCT01111604|62715076|FG002|Overall Study|Lost to Follow-up|1|||
33338372|NCT01111604|62715074|FG000|Overall Study|Withdrew Consent|3|||
33338373|NCT01111604|62715075|FG001|Overall Study|Withdrew Consent|0|||
33338374|NCT01111604|62715076|FG002|Overall Study|Withdrew Consent|2|||
33338375|NCT01111604|62715074|FG000|Overall Study|Withdrawal by Subject|2|||
33338376|NCT01111604|62715075|FG001|Overall Study|Withdrawal by Subject|0|||
33338377|NCT01111604|62715076|FG002|Overall Study|Withdrawal by Subject|0|||
33338378|NCT01111604|62715074|FG000|Overall Study|Death|1|||
33338379|NCT01111604|62715075|FG001|Overall Study|Death|0|||
33338380|NCT01111604|62715076|FG002|Overall Study|Death|0|||
33338381|NCT01111604|62715074|FG000|Overall Study|Met Exclusion Criteria|2|||
33338382|NCT01111604|62715075|FG001|Overall Study|Met Exclusion Criteria|0|||
33338383|NCT01111604|62715076|FG002|Overall Study|Met Exclusion Criteria|0|||
33338384|NCT00950742|62715104|FG000|Overall Study|Other Adverse Event|1|||
33338385|NCT00950742|62715105|FG001|Overall Study|Other Adverse Event|0|||
33338386|NCT00950742|62715104|FG000|Overall Study|Withdrawal by Subject|3|||
33338387|NCT00950742|62715105|FG001|Overall Study|Withdrawal by Subject|0|||
33338388|NCT00950742|62715104|FG000|Overall Study|Progressive Disease|6|||
33338389|NCT00950742|62715105|FG001|Overall Study|Progressive Disease|2|||
33338390|NCT00950742|62715104|FG000|Overall Study|Dose limiting toxicity|6|||
33338391|NCT00950742|62715105|FG001|Overall Study|Dose limiting toxicity|0|||
33338392|NCT00955110|62715115|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
33338393|NCT00955110|62715115|FG000|Treatment Phase|Adverse Event|2|||
33338394|NCT00955110|62715115|FG000|Treatment Phase|Administrative reasons|2|||
33338395|NCT00955110|62715115|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
33338396|NCT00955110|62715115|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
33338397|NCT00950664|62715129|FG000|First Intervention|Lost to Follow-up|1|||
33338398|NCT00950664|62715130|FG001|First Intervention|Lost to Follow-up|3|||
33338399|NCT00950664|62715129|FG000|First Intervention|Withdrawal by Subject|2|||
33338400|NCT00950664|62715130|FG001|First Intervention|Withdrawal by Subject|2|||
33338401|NCT01111526|62715136|FG000|Overall Study|GVHD Disease Progression|0|||
33338402|NCT01111526|62715137|FG001|Overall Study|GVHD Disease Progression|1|||
33338403|NCT01111526|62715138|FG002|Overall Study|GVHD Disease Progression|2|||
33338404|NCT01111292|62715144|FG000|Treatment|Physician Decision|1|||
33338405|NCT01111292|62715145|FG001|Treatment|Physician Decision|1|||
33338406|NCT00944658|62715153|FG000|Treatment 12 Weeks|Adverse Event|0|||
33338407|NCT00944658|62715154|FG001|Treatment 12 Weeks|Adverse Event|2|||
33338408|NCT01110200|62715162|FG000|Overall Study|Adverse Event|28|||
33338409|NCT01110200|62715163|FG001|Overall Study|Adverse Event|28|||
33338410|NCT01110200|62715162|FG000|Overall Study|Withdrawal by Subject|25|||
33338411|NCT01110200|62715163|FG001|Overall Study|Withdrawal by Subject|32|||
33338412|NCT01110200|62715162|FG000|Overall Study|Lack of Efficacy|16|||
33338413|NCT01110200|62715163|FG001|Overall Study|Lack of Efficacy|25|||
33338414|NCT01110200|62715162|FG000|Overall Study|Protocol Violation|14|||
33338415|NCT01110200|62715163|FG001|Overall Study|Protocol Violation|12|||
33338416|NCT01110200|62715162|FG000|Overall Study|Physician Decision|13|||
33338417|NCT01110200|62715163|FG001|Overall Study|Physician Decision|17|||
33338418|NCT01110200|62715162|FG000|Overall Study|Lost to Follow-up|10|||
33338419|NCT01110200|62715163|FG001|Overall Study|Lost to Follow-up|7|||
33338420|NCT01108796|62715173|FG000|Overall Study|Adverse Event|0|||
33338421|NCT01108796|62715174|FG001|Overall Study|Adverse Event|1|||
33338422|NCT01108796|62715173|FG000|Overall Study|Lost to Follow-up|7|||
33338423|NCT01108796|62715174|FG001|Overall Study|Lost to Follow-up|6|||
33338424|NCT01108718|62715184|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
33338425|NCT01108718|62715185|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
33338426|NCT01137110|62715192|FG000|Overall Study|Protocol Violation|1|||
33338427|NCT01137110|62715193|FG001|Overall Study|Protocol Violation|0|||
33338428|NCT01136954|62715201|FG000|Overall Study|Adverse Event|3|||
33338429|NCT01136954|62715202|FG001|Overall Study|Adverse Event|2|||
33338430|NCT01136954|62715201|FG000|Overall Study|Withdrawal by Subject|6|||
33338431|NCT01136954|62715202|FG001|Overall Study|Withdrawal by Subject|2|||
33469673|NCT03233230|62843443|FG001|Overall Study|Lost to Follow-up|3|||
33469674|NCT03233230|62843444|FG002|Overall Study|Lost to Follow-up|0|||
33338432|NCT01136954|62715201|FG000|Overall Study|Lack of Efficacy|14|||
33338433|NCT01136954|62715202|FG001|Overall Study|Lack of Efficacy|13|||
33338434|NCT01136954|62715201|FG000|Overall Study|Physician Decision|0|||
33338435|NCT01136954|62715202|FG001|Overall Study|Physician Decision|1|||
33338436|NCT01136954|62715201|FG000|Overall Study|Other|1|||
33338437|NCT01136954|62715202|FG001|Overall Study|Other|3|||
33338438|NCT01136876|62715211|FG000|Overall Study|Lost to Follow-up|0|||
33338439|NCT01136876|62715212|FG001|Overall Study|Lost to Follow-up|1|||
33338440|NCT01136876|62715211|FG000|Overall Study|Physician Decision|3|||
33469675|NCT03233230|62843445|FG003|Overall Study|Lost to Follow-up|0|||
33469676|NCT00283049|62843458|FG000|Overall Study|Adverse Event|6|||
33338441|NCT01136876|62715212|FG001|Overall Study|Physician Decision|5|||
33338442|NCT01136876|62715211|FG000|Overall Study|Missing NGAL measurement|2|||
33338443|NCT01136876|62715212|FG001|Overall Study|Missing NGAL measurement|5|||
33338444|NCT01105130|62715223|FG000|Overall Study|Withdrawal by Subject|4|||
33338445|NCT01105130|62715224|FG001|Overall Study|Withdrawal by Subject|6|||
33338446|NCT01105130|62715225|FG002|Overall Study|Withdrawal by Subject|2|||
33338447|NCT01105130|62715223|FG000|Overall Study|Never Started|2|||
33338448|NCT01105130|62715224|FG001|Overall Study|Never Started|2|||
33338449|NCT01105130|62715225|FG002|Overall Study|Never Started|4|||
33338450|NCT01105130|62715223|FG000|Overall Study|Toxicity|1|||
33338451|NCT01105130|62715224|FG001|Overall Study|Toxicity|3|||
33338452|NCT01105130|62715225|FG002|Overall Study|Toxicity|2|||
33338453|NCT01105130|62715223|FG000|Overall Study|Multiple Reasons|3|||
33338454|NCT01105130|62715224|FG001|Overall Study|Multiple Reasons|0|||
33338455|NCT01105130|62715225|FG002|Overall Study|Multiple Reasons|2|||
33338456|NCT01108094|62715237|FG000|Overall Study|Adverse Event|2|||
33338457|NCT01108094|62715238|FG001|Overall Study|Adverse Event|0|||
33338458|NCT01108094|62715239|FG002|Overall Study|Adverse Event|0|||
33338459|NCT01108094|62715240|FG003|Overall Study|Adverse Event|0|||
33338460|NCT01108094|62715237|FG000|Overall Study|Withdrawal by Subject|1|||
33338461|NCT01108094|62715238|FG001|Overall Study|Withdrawal by Subject|0|||
33338462|NCT01108094|62715239|FG002|Overall Study|Withdrawal by Subject|0|||
33338463|NCT01108094|62715240|FG003|Overall Study|Withdrawal by Subject|0|||
33338464|NCT00954174|62715257|FG000|Overall Study|Adverse Event|28|||
33338465|NCT00954174|62715258|FG001|Overall Study|Adverse Event|23|||
33338466|NCT00954174|62715259|FG002|Overall Study|Adverse Event|4|||
33338467|NCT00954174|62715260|FG003|Overall Study|Adverse Event|9|||
33338468|NCT00954174|62715257|FG000|Overall Study|Death|4|||
33338469|NCT00954174|62715258|FG001|Overall Study|Death|2|||
33338470|NCT00954174|62715259|FG002|Overall Study|Death|0|||
33338471|NCT00954174|62715260|FG003|Overall Study|Death|0|||
33338472|NCT00954174|62715257|FG000|Overall Study|Lack of Efficacy|32|||
33338473|NCT00954174|62715258|FG001|Overall Study|Lack of Efficacy|22|||
33338474|NCT00954174|62715259|FG002|Overall Study|Lack of Efficacy|8|||
33338475|NCT00954174|62715260|FG003|Overall Study|Lack of Efficacy|6|||
33338476|NCT00954174|62715257|FG000|Overall Study|Withdrawal by Subject|14|||
33338477|NCT00954174|62715258|FG001|Overall Study|Withdrawal by Subject|10|||
33338478|NCT00954174|62715259|FG002|Overall Study|Withdrawal by Subject|4|||
33338479|NCT00954174|62715260|FG003|Overall Study|Withdrawal by Subject|3|||
33338480|NCT00954174|62715257|FG000|Overall Study|Medical Reason|4|||
33338481|NCT00954174|62715258|FG001|Overall Study|Medical Reason|2|||
33338482|NCT00954174|62715259|FG002|Overall Study|Medical Reason|1|||
33338483|NCT00954174|62715260|FG003|Overall Study|Medical Reason|0|||
33338484|NCT00954174|62715257|FG000|Overall Study|Ineligible|40|||
33338485|NCT00954174|62715258|FG001|Overall Study|Ineligible|47|||
33338486|NCT00954174|62715259|FG002|Overall Study|Ineligible|7|||
33338487|NCT00954174|62715260|FG003|Overall Study|Ineligible|4|||
33338488|NCT00954174|62715257|FG000|Overall Study|Never Treated|4|||
33338489|NCT00954174|62715258|FG001|Overall Study|Never Treated|17|||
33338490|NCT00954174|62715259|FG002|Overall Study|Never Treated|0|||
33338491|NCT00954174|62715260|FG003|Overall Study|Never Treated|3|||
33338492|NCT01136408|62715276|FG000|Overall Study|Adverse Event|4|||
33338493|NCT01136408|62715277|FG001|Overall Study|Adverse Event|8|||
33338494|NCT01136408|62715278|FG002|Overall Study|Adverse Event|4|||
33338495|NCT01136408|62715276|FG000|Overall Study|Protocol Violation|1|||
33338496|NCT01136408|62715277|FG001|Overall Study|Protocol Violation|1|||
33338497|NCT01136408|62715278|FG002|Overall Study|Protocol Violation|1|||
33338498|NCT01136174|62715294|FG000|Overall Study|Adverse Event|0|||
33338499|NCT01136174|62715295|FG001|Overall Study|Adverse Event|0|||
33338500|NCT01136174|62715296|FG002|Overall Study|Adverse Event|0|||
33469677|NCT00283049|62843459|FG001|Overall Study|Adverse Event|1|||
33469678|NCT00283049|62843460|FG002|Overall Study|Adverse Event|4|||
33548816|NCT02970305|62940172|FG000|Overall Study|Noncompliance with study drug|2|||
33338501|NCT01136174|62715297|FG003|Overall Study|Adverse Event|4|||
33338502|NCT01135394|62715316|FG000|Screening|Lost to Follow-up|2|||
33338503|NCT01135394|62715316|FG000|Screening|Withdrawal by Subject|10|||
33338504|NCT01135394|62715316|FG000|Screening|Screening failure|16|||
33338505|NCT01135394|62715316|FG000|Screening|Physician Decision|5|||
33338506|NCT01135394|62715316|FG000|Baseline Assessment|Withdrawal by Subject|9|||
33338507|NCT01135394|62715316|FG000|Baseline Assessment|Physician Decision|3|||
33338508|NCT01135394|62715316|FG000|Baseline Assessment|Lost to Follow-up|2|||
33338509|NCT01135394|62715316|FG000|Baseline Assessment|Adverse Event|1|||
33338510|NCT01135394|62715316|FG000|Study Treatment|Withdrawal by Subject|1|||
33338511|NCT01135394|62715316|FG000|Study Treatment|Physician Decision|1|||
33338512|NCT01135394|62715316|FG000|Study Treatment|Adverse Event|2|||
33338513|NCT00949884|62715323|FG000|Overall Study|Adverse Event|14|||
33338514|NCT00949884|62715324|FG001|Overall Study|Adverse Event|3|||
33338515|NCT00949884|62715325|FG002|Overall Study|Adverse Event|12|||
33338516|NCT00949884|62715323|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
33338517|NCT00949884|62715324|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
33338518|NCT00949884|62715325|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
33338519|NCT00949884|62715323|FG000|Overall Study|Lost to Follow-up|7|||
33338520|NCT00949884|62715324|FG001|Overall Study|Lost to Follow-up|5|||
33338521|NCT00949884|62715325|FG002|Overall Study|Lost to Follow-up|5|||
33338522|NCT00949884|62715323|FG000|Overall Study|Physician Decision|5|||
33338523|NCT00949884|62715324|FG001|Overall Study|Physician Decision|0|||
33338524|NCT00949884|62715325|FG002|Overall Study|Physician Decision|6|||
33338525|NCT00949884|62715323|FG000|Overall Study|Treatment non-compliance|5|||
33338526|NCT00949884|62715324|FG001|Overall Study|Treatment non-compliance|0|||
33338527|NCT00949884|62715325|FG002|Overall Study|Treatment non-compliance|8|||
33338528|NCT00949884|62715323|FG000|Overall Study|Withdrawal by Subject|13|||
33338529|NCT00949884|62715324|FG001|Overall Study|Withdrawal by Subject|4|||
33338530|NCT00949884|62715325|FG002|Overall Study|Withdrawal by Subject|16|||
33338531|NCT00949884|62715323|FG000|Overall Study|Lack of Efficacy|4|||
33338532|NCT00949884|62715324|FG001|Overall Study|Lack of Efficacy|2|||
33338533|NCT00949884|62715325|FG002|Overall Study|Lack of Efficacy|7|||
33338534|NCT00949884|62715323|FG000|Overall Study|Study terminated by sponsor|0|||
33338535|NCT00949884|62715324|FG001|Overall Study|Study terminated by sponsor|0|||
33338536|NCT00949884|62715325|FG002|Overall Study|Study terminated by sponsor|1|||
33338537|NCT00949650|62715336|FG000|Overall Study|Progressive disease|188|||
33338538|NCT00949650|62715337|FG001|Overall Study|Progressive disease|19|||
33338539|NCT00949650|62715336|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
33338540|NCT00949650|62715337|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
33338541|NCT00949650|62715336|FG000|Overall Study|Other Adverse Event (AE)|28|||
33338542|NCT00949650|62715337|FG001|Overall Study|Other Adverse Event (AE)|17|||
33338543|NCT00949650|62715336|FG000|Overall Study|Protocol Violation|1|||
33338544|NCT00949650|62715337|FG001|Overall Study|Protocol Violation|4|||
33338545|NCT00949650|62715336|FG000|Overall Study|Refusal to continue medication|7|||
33338546|NCT00949650|62715337|FG001|Overall Study|Refusal to continue medication|11|||
33338547|NCT00949650|62715336|FG000|Overall Study|Not treated|1|||
33338548|NCT00949650|62715337|FG001|Overall Study|Not treated|4|||
33338549|NCT00949650|62715336|FG000|Overall Study|Other not specified above|5|||
33338550|NCT00949650|62715337|FG001|Overall Study|Other not specified above|0|||
33338551|NCT00908037|62715354|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33338552|NCT00908037|62715355|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33338553|NCT00908037|62715356|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33338554|NCT00908037|62715357|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33338555|NCT00908037|62715358|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
33338556|NCT00908037|62715359|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33338557|NCT00908037|62715360|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
33338558|NCT00908037|62715361|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33338559|NCT00908037|62715362|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
33338560|NCT00908037|62715363|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33338561|NCT00908037|62715364|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33338562|NCT00908037|62715365|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33338563|NCT00908037|62715354|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33338564|NCT00908037|62715355|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33338565|NCT00908037|62715356|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33338566|NCT00908037|62715357|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33338567|NCT00908037|62715358|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
33338568|NCT00908037|62715359|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33338569|NCT00908037|62715360|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33338570|NCT00908037|62715361|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33338571|NCT00908037|62715362|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
33338572|NCT00908037|62715363|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33338573|NCT00908037|62715364|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33338574|NCT00908037|62715365|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33338575|NCT00908037|62715354|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33338576|NCT00908037|62715355|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33338577|NCT00908037|62715356|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33338578|NCT00908037|62715357|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
33338579|NCT00908037|62715358|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33338580|NCT00908037|62715359|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33338581|NCT00908037|62715360|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
33338582|NCT00908037|62715361|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33338583|NCT00908037|62715362|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33338584|NCT00908037|62715363|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33338585|NCT00908037|62715364|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33469679|NCT00283049|62843458|FG000|Overall Study|Protocol Violation|3|||
33469680|NCT00283049|62843459|FG001|Overall Study|Protocol Violation|0|||
33338586|NCT00908037|62715365|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33338587|NCT00908037|62715354|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33338588|NCT00908037|62715355|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33338589|NCT00908037|62715356|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33338590|NCT00908037|62715357|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33338591|NCT00908037|62715358|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33338592|NCT00908037|62715359|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33338593|NCT00908037|62715360|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33338594|NCT00908037|62715361|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33338595|NCT00908037|62715362|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33338596|NCT00908037|62715363|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33338597|NCT00908037|62715364|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33338598|NCT00908037|62715365|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
33338599|NCT00908037|62715354|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33338600|NCT00908037|62715355|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33338601|NCT00908037|62715356|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33338602|NCT00908037|62715357|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33338603|NCT00908037|62715358|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33338604|NCT00908037|62715359|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33338605|NCT00908037|62715360|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33338606|NCT00908037|62715361|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33338607|NCT00908037|62715362|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33338608|NCT00908037|62715363|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
33338609|NCT00908037|62715364|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33338610|NCT00908037|62715365|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
33338611|NCT00908037|62715354|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33338612|NCT00908037|62715355|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33338613|NCT00908037|62715356|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33338614|NCT00908037|62715357|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33338615|NCT00908037|62715358|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33338616|NCT00908037|62715359|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33338617|NCT00908037|62715360|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33338618|NCT00908037|62715361|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33338619|NCT00908037|62715362|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33338620|NCT00908037|62715363|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
33338621|NCT00908037|62715364|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33338622|NCT00908037|62715365|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33338623|NCT00908037|62715354|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33338624|NCT00908037|62715355|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33338625|NCT00908037|62715356|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33338626|NCT00908037|62715357|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33338627|NCT00908037|62715358|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33338628|NCT00908037|62715359|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33338629|NCT00908037|62715360|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33338630|NCT00908037|62715361|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33338631|NCT00908037|62715362|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33338632|NCT00908037|62715363|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33338633|NCT00908037|62715364|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
33338634|NCT00908037|62715365|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33338635|NCT00908037|62715354|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33338636|NCT00908037|62715355|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33338637|NCT00908037|62715356|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33338638|NCT00908037|62715357|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33338639|NCT00908037|62715358|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33338640|NCT00908037|62715359|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33338641|NCT00908037|62715360|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33338642|NCT00908037|62715361|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33338643|NCT00908037|62715362|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33338644|NCT00908037|62715363|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
33338645|NCT00908037|62715364|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33338646|NCT00908037|62715365|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33338647|NCT00908037|62715354|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33338648|NCT00908037|62715355|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33338649|NCT00908037|62715356|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33338650|NCT00908037|62715357|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33338651|NCT00908037|62715358|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33338652|NCT00908037|62715359|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33338653|NCT00908037|62715360|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33338654|NCT00908037|62715361|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33338655|NCT00908037|62715362|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33338656|NCT00908037|62715363|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33338657|NCT00908037|62715364|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
33338658|NCT00908037|62715365|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33338659|NCT00904215|62715417|FG000|Overall Study|Adverse Event|25|||
33338660|NCT00904215|62715417|FG000|Overall Study|Protocol Violation|10|||
33338661|NCT00904215|62715417|FG000|Overall Study|Lost to Follow-up|63|||
33338662|NCT00904215|62715417|FG000|Overall Study|Withdrawal by Subject|9|||
33338663|NCT00904215|62715417|FG000|Overall Study|Other|28|||
33338664|NCT00905307|62715427|FG000|Overall Study|Switched to Open Label Rescue|7|||
33338665|NCT00905307|62715428|FG001|Overall Study|Switched to Open Label Rescue|17|||
33338666|NCT00905307|62715429|FG002|Overall Study|Switched to Open Label Rescue|11|||
33338667|NCT00905307|62715430|FG003|Overall Study|Switched to Open Label Rescue|11|||
33338668|NCT00905307|62715431|FG004|Overall Study|Switched to Open Label Rescue|4|||
33338669|NCT00905307|62715432|FG005|Overall Study|Switched to Open Label Rescue|15|||
33338670|NCT00905307|62715427|FG000|Overall Study|Lost to Follow-up|0|||
33338671|NCT00905307|62715428|FG001|Overall Study|Lost to Follow-up|0|||
33338672|NCT00905307|62715429|FG002|Overall Study|Lost to Follow-up|0|||
33338673|NCT00905307|62715430|FG003|Overall Study|Lost to Follow-up|0|||
33338674|NCT00905307|62715431|FG004|Overall Study|Lost to Follow-up|1|||
33338675|NCT00905307|62715432|FG005|Overall Study|Lost to Follow-up|1|||
33338676|NCT00905307|62715427|FG000|Overall Study|Adverse Event|3|||
33338677|NCT00905307|62715428|FG001|Overall Study|Adverse Event|4|||
33338678|NCT00905307|62715429|FG002|Overall Study|Adverse Event|5|||
33338679|NCT00905307|62715430|FG003|Overall Study|Adverse Event|11|||
33338680|NCT00905307|62715431|FG004|Overall Study|Adverse Event|3|||
33338681|NCT00905307|62715432|FG005|Overall Study|Adverse Event|5|||
33338682|NCT00905307|62715427|FG000|Overall Study|Withdrawal by Subject|5|||
33338683|NCT00905307|62715428|FG001|Overall Study|Withdrawal by Subject|13|||
33338684|NCT00905307|62715429|FG002|Overall Study|Withdrawal by Subject|15|||
33338685|NCT00905307|62715430|FG003|Overall Study|Withdrawal by Subject|11|||
33338686|NCT00905307|62715431|FG004|Overall Study|Withdrawal by Subject|4|||
33338687|NCT00905307|62715432|FG005|Overall Study|Withdrawal by Subject|13|||
33338688|NCT00905307|62715427|FG000|Overall Study|Protocol Violation|1|||
33338689|NCT00905307|62715428|FG001|Overall Study|Protocol Violation|0|||
33338690|NCT00905307|62715429|FG002|Overall Study|Protocol Violation|1|||
33338691|NCT00905307|62715430|FG003|Overall Study|Protocol Violation|0|||
33338692|NCT00905307|62715431|FG004|Overall Study|Protocol Violation|0|||
33338693|NCT00905307|62715432|FG005|Overall Study|Protocol Violation|0|||
33338694|NCT00905307|62715427|FG000|Overall Study|Lack of Efficacy|6|||
33338695|NCT00905307|62715428|FG001|Overall Study|Lack of Efficacy|3|||
33338696|NCT00905307|62715429|FG002|Overall Study|Lack of Efficacy|5|||
33338697|NCT00905307|62715430|FG003|Overall Study|Lack of Efficacy|4|||
33338698|NCT00905307|62715431|FG004|Overall Study|Lack of Efficacy|4|||
33469681|NCT00283049|62843460|FG002|Overall Study|Protocol Violation|3|||
33469682|NCT00283049|62843458|FG000|Overall Study|Death|1|||
33338699|NCT00905307|62715432|FG005|Overall Study|Lack of Efficacy|8|||
33338700|NCT00907881|62715459|FG000|Overall Study|Lost to Follow-up|59|||
33338701|NCT00907881|62715459|FG000|Overall Study|Noncompliance|5|||
33338702|NCT00907881|62715459|FG000|Overall Study|Withdrawal by Subject|5|||
33338703|NCT00907881|62715459|FG000|Overall Study|Protocol Violation|1|||
33469683|NCT00283049|62843459|FG001|Overall Study|Death|1|||
33469684|NCT00283049|62843460|FG002|Overall Study|Death|1|||
33469685|NCT00283049|62843458|FG000|Overall Study|Lack of Efficacy|0|||
33469686|NCT00283049|62843459|FG001|Overall Study|Lack of Efficacy|1|||
33469687|NCT00283049|62843460|FG002|Overall Study|Lack of Efficacy|1|||
33548817|NCT02970305|62940173|FG001|Overall Study|Noncompliance with study drug|4|||
33548818|NCT02970305|62940172|FG000|Overall Study|Protocol Violation|2|||
33338704|NCT00907881|62715459|FG000|Overall Study|Missing discontinuation information|15|||
33338705|NCT00904917|62715467|FG000|Overall Study|Lost to Follow-up|2|||
33338706|NCT00904917|62715468|FG001|Overall Study|Lost to Follow-up|2|||
33338707|NCT00904917|62715469|FG002|Overall Study|Lost to Follow-up|2|||
33338708|NCT00904917|62715470|FG003|Overall Study|Lost to Follow-up|2|||
33338709|NCT00904839|62715485|FG000|Overall Study|Adverse Event|0|||
33338710|NCT00904839|62715486|FG001|Overall Study|Adverse Event|5|||
33338711|NCT00904839|62715487|FG002|Overall Study|Adverse Event|4|||
33469688|NCT00283049|62843458|FG000|Overall Study|Lost to Follow-up|4|||
33338712|NCT00904839|62715485|FG000|Overall Study|Protocol Violation|0|||
33338713|NCT00904839|62715486|FG001|Overall Study|Protocol Violation|1|||
33338714|NCT00904839|62715487|FG002|Overall Study|Protocol Violation|1|||
33338715|NCT00904839|62715485|FG000|Overall Study|Lost to Follow-up|0|||
33338716|NCT00904839|62715486|FG001|Overall Study|Lost to Follow-up|1|||
33338717|NCT00904839|62715487|FG002|Overall Study|Lost to Follow-up|2|||
33338718|NCT00904839|62715485|FG000|Overall Study|Withdrawal by Subject|0|||
33338719|NCT00904839|62715486|FG001|Overall Study|Withdrawal by Subject|2|||
33338720|NCT00904839|62715487|FG002|Overall Study|Withdrawal by Subject|0|||
33338721|NCT00904839|62715485|FG000|Overall Study|Not treated|1|||
33338722|NCT00904839|62715486|FG001|Overall Study|Not treated|0|||
33338723|NCT00904839|62715487|FG002|Overall Study|Not treated|1|||
33338724|NCT00904839|62715485|FG000|Overall Study|Other than above|0|||
33338725|NCT00904839|62715486|FG001|Overall Study|Other than above|9|||
33338726|NCT00904839|62715487|FG002|Overall Study|Other than above|7|||
33338727|NCT00903357|62715498|FG000|First Intervention|Withdrawal by Subject|5|||
33338728|NCT00903357|62715499|FG001|First Intervention|Withdrawal by Subject|3|||
33654338|NCT01700192|63067103|FG000|Overall Study|Physician Decision|2|||
33654339|NCT01700192|63067104|FG001|Overall Study|Physician Decision|3|||
33654340|NCT01700192|63067103|FG000|Overall Study|Pregnancy|1|||
33654341|NCT01700192|63067104|FG001|Overall Study|Pregnancy|4|||
33654342|NCT01700192|63067103|FG000|Overall Study|Progressive disease|1|||
33654343|NCT01700192|63067104|FG001|Overall Study|Progressive disease|0|||
33654344|NCT01700192|63067103|FG000|Overall Study|Protocol Violation|3|||
33654345|NCT01700192|63067104|FG001|Overall Study|Protocol Violation|4|||
33654346|NCT01700192|63067103|FG000|Overall Study|Technical problems|0|||
33654347|NCT01700192|63067104|FG001|Overall Study|Technical problems|1|||
33654348|NCT01700192|63067103|FG000|Overall Study|Withdrawal by Subject|56|||
33654349|NCT01700192|63067104|FG001|Overall Study|Withdrawal by Subject|64|||
33654350|NCT01700192|63067103|FG000|Overall Study|Never received study drug|1|||
33654351|NCT01700192|63067104|FG001|Overall Study|Never received study drug|0|||
33654352|NCT01709864|63067121|FG000|Overall Study|Physician Decision|0|||
33654353|NCT01709864|63067122|FG001|Overall Study|Physician Decision|1|||
33654354|NCT01709864|63067121|FG000|Overall Study|subject/guardian decision|5|||
33654355|NCT01709864|63067122|FG001|Overall Study|subject/guardian decision|6|||
33654356|NCT01709864|63067121|FG000|Overall Study|Lost to Follow-up|1|||
33654357|NCT01709864|63067122|FG001|Overall Study|Lost to Follow-up|0|||
33654358|NCT01709864|63067121|FG000|Overall Study|non-compliance with study treatment|1|||
33654359|NCT01709864|63067122|FG001|Overall Study|non-compliance with study treatment|1|||
33654360|NCT01709864|63067121|FG000|Overall Study|Adverse Event|0|||
33654361|NCT01709864|63067122|FG001|Overall Study|Adverse Event|2|||
33654362|NCT01709864|63067121|FG000|Overall Study|Death|0|||
33654363|NCT01709864|63067122|FG001|Overall Study|Death|1|||
33654364|NCT01709708|63067130|FG000|Overall Study|Protocol Violation|1|||
33654365|NCT01709708|63067131|FG001|Overall Study|Protocol Violation|2|||
33654366|NCT01709318|63067154|FG000|Overall Study|Adverse Event|3|||
33654367|NCT01709318|63067155|FG001|Overall Study|Adverse Event|4|||
33654368|NCT01709318|63067156|FG002|Overall Study|Adverse Event|2|||
33654369|NCT01709318|63067157|FG003|Overall Study|Adverse Event|2|||
33654370|NCT01709318|63067158|FG004|Overall Study|Adverse Event|0|||
33654371|NCT01709318|63067159|FG005|Overall Study|Adverse Event|1|||
33654372|NCT01709318|63067160|FG006|Overall Study|Adverse Event|2|||
33654373|NCT01709318|63067154|FG000|Overall Study|Lost to Follow-up|2|||
33654374|NCT01709318|63067155|FG001|Overall Study|Lost to Follow-up|0|||
33654375|NCT01709318|63067156|FG002|Overall Study|Lost to Follow-up|0|||
33654376|NCT01709318|63067157|FG003|Overall Study|Lost to Follow-up|0|||
33654377|NCT01709318|63067158|FG004|Overall Study|Lost to Follow-up|1|||
33654378|NCT01709318|63067159|FG005|Overall Study|Lost to Follow-up|1|||
33654379|NCT01709318|63067160|FG006|Overall Study|Lost to Follow-up|1|||
33654380|NCT01709318|63067154|FG000|Overall Study|Non-compliance with Study Drug|0|||
33654381|NCT01709318|63067155|FG001|Overall Study|Non-compliance with Study Drug|2|||
33654382|NCT01709318|63067156|FG002|Overall Study|Non-compliance with Study Drug|1|||
33654383|NCT01709318|63067157|FG003|Overall Study|Non-compliance with Study Drug|1|||
33654384|NCT01709318|63067158|FG004|Overall Study|Non-compliance with Study Drug|0|||
33654385|NCT01709318|63067159|FG005|Overall Study|Non-compliance with Study Drug|0|||
33654386|NCT01709318|63067160|FG006|Overall Study|Non-compliance with Study Drug|2|||
33654387|NCT01709318|63067154|FG000|Overall Study|Physician Decision|0|||
33654388|NCT01709318|63067155|FG001|Overall Study|Physician Decision|0|||
33654389|NCT01709318|63067156|FG002|Overall Study|Physician Decision|0|||
33654390|NCT01709318|63067157|FG003|Overall Study|Physician Decision|0|||
33654391|NCT01709318|63067158|FG004|Overall Study|Physician Decision|0|||
33654392|NCT01709318|63067159|FG005|Overall Study|Physician Decision|0|||
33338729|NCT00903357|62715498|FG000|First Intervention|Flu|0|||
33338730|NCT00903357|62715499|FG001|First Intervention|Flu|1|||
33338731|NCT00903357|62715498|FG000|Wash Out Period of 2 Weeks|Flu|0|||
33338732|NCT00903357|62715499|FG001|Wash Out Period of 2 Weeks|Flu|1|||
33654393|NCT01709318|63067160|FG006|Overall Study|Physician Decision|1|||
33338733|NCT00903357|62715498|FG000|Second Intervention|Lost to Follow-up|1|||
33654394|NCT01709318|63067154|FG000|Overall Study|Pregnancy|0|||
33654395|NCT01709318|63067155|FG001|Overall Study|Pregnancy|0|||
33338734|NCT00903357|62715499|FG001|Second Intervention|Lost to Follow-up|0|||
33338735|NCT00904371|62715509|FG000|Overall Study|Adverse Event|2|||
33338736|NCT00904371|62715509|FG000|Overall Study|Lost to Follow-up|4|||
33338737|NCT00904371|62715509|FG000|Overall Study|Discontinued at target blood pressure|2|||
33338738|NCT00904371|62715509|FG000|Overall Study|Continued with Tritace|1|||
33338739|NCT01104662|62715521|FG000|Overall Study|Adverse Event|2|||
33338740|NCT01104662|62715522|FG001|Overall Study|Adverse Event|2|||
33338741|NCT01104662|62715523|FG002|Overall Study|Adverse Event|0|||
33338742|NCT01104662|62715524|FG003|Overall Study|Adverse Event|1|||
33338743|NCT01104662|62715525|FG004|Overall Study|Adverse Event|1|||
33338744|NCT01104662|62715526|FG005|Overall Study|Adverse Event|1|||
33338745|NCT01104662|62715527|FG006|Overall Study|Adverse Event|0|||
33338746|NCT01104662|62715528|FG007|Overall Study|Adverse Event|0|||
33338747|NCT01104662|62715521|FG000|Overall Study|Clinical Failure|1|||
33338748|NCT01104662|62715522|FG001|Overall Study|Clinical Failure|0|||
33338749|NCT01104662|62715523|FG002|Overall Study|Clinical Failure|0|||
33338750|NCT01104662|62715524|FG003|Overall Study|Clinical Failure|0|||
33338751|NCT01104662|62715525|FG004|Overall Study|Clinical Failure|0|||
33338752|NCT01104662|62715526|FG005|Overall Study|Clinical Failure|1|||
33338753|NCT01104662|62715527|FG006|Overall Study|Clinical Failure|0|||
33338754|NCT01104662|62715528|FG007|Overall Study|Clinical Failure|0|||
33338755|NCT01104662|62715521|FG000|Overall Study|Participant left investigator's care|1|||
33338756|NCT01104662|62715522|FG001|Overall Study|Participant left investigator's care|1|||
33338757|NCT01104662|62715523|FG002|Overall Study|Participant left investigator's care|0|||
33338758|NCT01104662|62715524|FG003|Overall Study|Participant left investigator's care|0|||
33338759|NCT01104662|62715525|FG004|Overall Study|Participant left investigator's care|0|||
33338760|NCT01104662|62715526|FG005|Overall Study|Participant left investigator's care|0|||
33338761|NCT01104662|62715527|FG006|Overall Study|Participant left investigator's care|0|||
33338762|NCT01104662|62715528|FG007|Overall Study|Participant left investigator's care|0|||
33338763|NCT01104662|62715521|FG000|Overall Study|Reason not specified|3|||
33338764|NCT01104662|62715522|FG001|Overall Study|Reason not specified|3|||
33338765|NCT01104662|62715523|FG002|Overall Study|Reason not specified|0|||
33338766|NCT01104662|62715524|FG003|Overall Study|Reason not specified|0|||
33338767|NCT01104662|62715525|FG004|Overall Study|Reason not specified|0|||
33338768|NCT01104662|62715526|FG005|Overall Study|Reason not specified|1|||
33338769|NCT01104662|62715527|FG006|Overall Study|Reason not specified|0|||
33338770|NCT01104662|62715528|FG007|Overall Study|Reason not specified|0|||
33338771|NCT01104662|62715521|FG000|Overall Study|Randomized but not treated|3|||
33338772|NCT01104662|62715522|FG001|Overall Study|Randomized but not treated|4|||
33338773|NCT01104662|62715523|FG002|Overall Study|Randomized but not treated|1|||
33338774|NCT01104662|62715524|FG003|Overall Study|Randomized but not treated|0|||
33338775|NCT01104662|62715525|FG004|Overall Study|Randomized but not treated|0|||
33338776|NCT01104662|62715526|FG005|Overall Study|Randomized but not treated|1|||
33338777|NCT01104662|62715527|FG006|Overall Study|Randomized but not treated|0|||
33338778|NCT01104662|62715528|FG007|Overall Study|Randomized but not treated|0|||
33338779|NCT01104584|62715547|FG000|Overall Study|Study drug never administered|21|||
33338780|NCT01104584|62715547|FG000|Overall Study|Study prematurely discontinued|2|||
33338781|NCT01103960|62715571|FG000|Overall Study|Adverse Event|2|||
33338782|NCT01103960|62715572|FG001|Overall Study|Adverse Event|1|||
33338783|NCT01103960|62715571|FG000|Overall Study|Withdrawal by Subject|2|||
33338784|NCT01103960|62715572|FG001|Overall Study|Withdrawal by Subject|1|||
33338785|NCT01103960|62715571|FG000|Overall Study|Other|1|||
33338786|NCT01103960|62715572|FG001|Overall Study|Other|0|||
33338787|NCT01107392|62715580|FG000|Overall Study|Adverse Event|2|||
33338788|NCT01107392|62715581|FG001|Overall Study|Adverse Event|0|||
33338789|NCT01107392|62715580|FG000|Overall Study|Personal Reasons|2|||
33338790|NCT01107392|62715581|FG001|Overall Study|Personal Reasons|3|||
33338791|NCT01107392|62715580|FG000|Overall Study|Administrative decision|1|||
33338792|NCT01107392|62715581|FG001|Overall Study|Administrative decision|0|||
33338793|NCT01106846|62715589|FG000|Overall Study|Change in surgical procedure|0|||
33338794|NCT01106846|62715590|FG001|Overall Study|Change in surgical procedure|1|||
33338795|NCT00902577|62715596|FG000|Overall Study|Withdrawal by Subject|6|||
33338796|NCT00902577|62715596|FG000|Overall Study|FMISO production failure|2|||
33338797|NCT01106690|62715631|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
33338798|NCT01106690|62715632|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
33338799|NCT01106690|62715633|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
33338800|NCT01106690|62715631|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
33338801|NCT01106690|62715632|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
33338802|NCT01106690|62715633|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
33338803|NCT01106690|62715631|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
33338804|NCT01106690|62715632|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
33338805|NCT01106690|62715633|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
33338806|NCT01106690|62715631|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
33338807|NCT01106690|62715632|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
33338808|NCT01106690|62715633|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
33338809|NCT01106690|62715631|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
33338810|NCT01106690|62715632|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
33338811|NCT01106690|62715633|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
33338812|NCT01106690|62715631|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33338813|NCT01106690|62715632|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
33338814|NCT01106690|62715633|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33338815|NCT01106690|62715631|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
33338816|NCT01106690|62715632|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
33338817|NCT01106690|62715633|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
33338818|NCT01106690|62715631|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
33338819|NCT01106690|62715632|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
33338820|NCT01106690|62715633|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
33338821|NCT01106690|62715631|FG000|Core Period: Baseline to Week 26|Other|10|||
33338822|NCT01106690|62715632|FG001|Core Period: Baseline to Week 26|Other|2|||
33338823|NCT01106690|62715633|FG002|Core Period: Baseline to Week 26|Other|6|||
33338824|NCT01106690|62715631|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
33338825|NCT01106690|62715632|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
33338826|NCT01106690|62715633|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
33338827|NCT01106690|62715631|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33338828|NCT01106690|62715632|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
33338829|NCT01106690|62715633|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
33338830|NCT01106690|62715631|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33338831|NCT01106690|62715632|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
33338832|NCT01106690|62715633|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
33338833|NCT01106690|62715631|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
33338834|NCT01106690|62715632|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
33338835|NCT01106690|62715633|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
33338836|NCT01106690|62715631|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
33338837|NCT01106690|62715632|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
33338838|NCT01106690|62715633|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
33338839|NCT01106690|62715631|FG000|Extension Period: Week 26 to Week 52|Other|8|||
33338840|NCT01106690|62715632|FG001|Extension Period: Week 26 to Week 52|Other|3|||
33338841|NCT01106690|62715633|FG002|Extension Period: Week 26 to Week 52|Other|4|||
33338842|NCT01106690|62715631|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
33338843|NCT01106690|62715632|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33338844|NCT01106690|62715633|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33338845|NCT01103180|62715663|FG000|Overall Study|Withdrawal by Subject|8|||
33338846|NCT01103180|62715664|FG001|Overall Study|Withdrawal by Subject|13|||
33338847|NCT01103180|62715663|FG000|Overall Study|Lost to Follow-up|13|||
33338848|NCT01103180|62715664|FG001|Overall Study|Lost to Follow-up|7|||
33338849|NCT01103180|62715663|FG000|Overall Study|Physician Decision|1|||
33338850|NCT01103180|62715664|FG001|Overall Study|Physician Decision|0|||
33338851|NCT01103180|62715663|FG000|Overall Study|Protocol Violation|0|||
33338852|NCT01103180|62715664|FG001|Overall Study|Protocol Violation|1|||
33338853|NCT00944034|62715682|FG000|Overall Study|Inappropriate enrollment|0|||
33338854|NCT00944034|62715683|FG001|Overall Study|Inappropriate enrollment|1|||
33338855|NCT00944034|62715684|FG002|Overall Study|Inappropriate enrollment|0|||
33338856|NCT00944034|62715685|FG003|Overall Study|Inappropriate enrollment|1|||
33338857|NCT00944034|62715686|FG004|Overall Study|Inappropriate enrollment|2|||
33338858|NCT00944034|62715687|FG005|Overall Study|Inappropriate enrollment|1|||
33469689|NCT00283049|62843459|FG001|Overall Study|Lost to Follow-up|2|||
33469690|NCT00283049|62843460|FG002|Overall Study|Lost to Follow-up|5|||
33338859|NCT00944034|62715688|FG006|Overall Study|Inappropriate enrollment|0|||
33338860|NCT00944034|62715689|FG007|Overall Study|Inappropriate enrollment|0|||
33338861|NCT00944034|62715690|FG008|Overall Study|Inappropriate enrollment|1|||
33338862|NCT00944034|62715691|FG009|Overall Study|Inappropriate enrollment|1|||
33469691|NCT00283049|62843458|FG000|Overall Study|Withdrawal by Subject|26|||
33338863|NCT00944034|62715692|FG010|Overall Study|Inappropriate enrollment|0|||
33338864|NCT00944034|62715693|FG011|Overall Study|Inappropriate enrollment|0|||
33338865|NCT00944034|62715682|FG000|Overall Study|Withdrawal by Subject|3|||
33338866|NCT00944034|62715683|FG001|Overall Study|Withdrawal by Subject|2|||
33338867|NCT00944034|62715684|FG002|Overall Study|Withdrawal by Subject|6|||
33338868|NCT00944034|62715685|FG003|Overall Study|Withdrawal by Subject|2|||
33338869|NCT00944034|62715686|FG004|Overall Study|Withdrawal by Subject|5|||
33338870|NCT00944034|62715687|FG005|Overall Study|Withdrawal by Subject|8|||
33338871|NCT00944034|62715688|FG006|Overall Study|Withdrawal by Subject|2|||
33338872|NCT00944034|62715689|FG007|Overall Study|Withdrawal by Subject|2|||
33338873|NCT00944034|62715690|FG008|Overall Study|Withdrawal by Subject|3|||
33338874|NCT00944034|62715691|FG009|Overall Study|Withdrawal by Subject|4|||
33338875|NCT00944034|62715692|FG010|Overall Study|Withdrawal by Subject|0|||
33338876|NCT00944034|62715693|FG011|Overall Study|Withdrawal by Subject|4|||
33338877|NCT00944034|62715682|FG000|Overall Study|Lost to Follow-up|0|||
33338878|NCT00944034|62715683|FG001|Overall Study|Lost to Follow-up|4|||
33338879|NCT00944034|62715684|FG002|Overall Study|Lost to Follow-up|2|||
33338880|NCT00944034|62715685|FG003|Overall Study|Lost to Follow-up|0|||
33338881|NCT00944034|62715686|FG004|Overall Study|Lost to Follow-up|5|||
33338882|NCT00944034|62715687|FG005|Overall Study|Lost to Follow-up|7|||
33338883|NCT00944034|62715688|FG006|Overall Study|Lost to Follow-up|0|||
33338884|NCT00944034|62715689|FG007|Overall Study|Lost to Follow-up|1|||
33338885|NCT00944034|62715690|FG008|Overall Study|Lost to Follow-up|5|||
33338886|NCT00944034|62715691|FG009|Overall Study|Lost to Follow-up|1|||
33338887|NCT00944034|62715692|FG010|Overall Study|Lost to Follow-up|1|||
33338888|NCT00944034|62715693|FG011|Overall Study|Lost to Follow-up|0|||
33338889|NCT00944034|62715682|FG000|Overall Study|Death|0|||
33338890|NCT00944034|62715683|FG001|Overall Study|Death|0|||
33338891|NCT00944034|62715684|FG002|Overall Study|Death|1|||
33338892|NCT00944034|62715685|FG003|Overall Study|Death|0|||
33338893|NCT00944034|62715686|FG004|Overall Study|Death|0|||
33338894|NCT00944034|62715687|FG005|Overall Study|Death|0|||
33338895|NCT00944034|62715688|FG006|Overall Study|Death|0|||
33338896|NCT00944034|62715689|FG007|Overall Study|Death|0|||
33338897|NCT00944034|62715690|FG008|Overall Study|Death|0|||
33338898|NCT00944034|62715691|FG009|Overall Study|Death|0|||
33469692|NCT00283049|62843459|FG001|Overall Study|Withdrawal by Subject|24|||
33469693|NCT00283049|62843460|FG002|Overall Study|Withdrawal by Subject|19|||
33469694|NCT00283049|62843458|FG000|Overall Study|Discontinuation of Study|18|||
33469695|NCT00283049|62843459|FG001|Overall Study|Discontinuation of Study|16|||
33469696|NCT00283049|62843460|FG002|Overall Study|Discontinuation of Study|20|||
33469697|NCT00283049|62843458|FG000|Overall Study|No longer requires study treatment|0|||
33469698|NCT00283049|62843459|FG001|Overall Study|No longer requires study treatment|0|||
33469699|NCT00283049|62843460|FG002|Overall Study|No longer requires study treatment|1|||
33469700|NCT00264875|62843468|FG000|Overall Study|Adverse Event|6|||
33469701|NCT00264875|62843468|FG000|Overall Study|Lost to Follow-up|6|||
33469702|NCT00264875|62843468|FG000|Overall Study|Protocol Violation|11|||
33469703|NCT00264875|62843468|FG000|Overall Study|Withdrawal by Subject|7|||
33469704|NCT03152110|62843472|FG000|Overall Study|Withdrawal by Subject|3|||
33469705|NCT03151408|62843479|FG000|Overall Study|Adverse Event|24|||
33469706|NCT03151408|62843480|FG001|Overall Study|Adverse Event|23|||
33469707|NCT03151408|62843479|FG000|Overall Study|Death|46|||
33469708|NCT03151408|62843480|FG001|Overall Study|Death|26|||
33469709|NCT03151408|62843479|FG000|Overall Study|Physician Decision|13|||
33469710|NCT03151408|62843480|FG001|Overall Study|Physician Decision|19|||
33469711|NCT03151408|62843479|FG000|Overall Study|Withdrawal by Subject|16|||
33469712|NCT03151408|62843480|FG001|Overall Study|Withdrawal by Subject|20|||
33338899|NCT00944034|62715692|FG010|Overall Study|Death|0|||
33338900|NCT00944034|62715693|FG011|Overall Study|Death|0|||
33338901|NCT00944034|62715682|FG000|Overall Study|Protocol Violation|2|||
33338902|NCT00944034|62715683|FG001|Overall Study|Protocol Violation|0|||
33338903|NCT00944034|62715684|FG002|Overall Study|Protocol Violation|0|||
33338904|NCT00944034|62715685|FG003|Overall Study|Protocol Violation|1|||
33469713|NCT03151408|62843479|FG000|Overall Study|Progressive disease|45|||
33469714|NCT03151408|62843480|FG001|Overall Study|Progressive disease|61|||
33469715|NCT03151408|62843479|FG000|Overall Study|non-compliance by patient|1|||
33338905|NCT00944034|62715686|FG004|Overall Study|Protocol Violation|2|||
33338906|NCT00944034|62715687|FG005|Overall Study|Protocol Violation|3|||
33469716|NCT03151408|62843480|FG001|Overall Study|non-compliance by patient|0|||
33469717|NCT03151408|62843479|FG000|Overall Study|other reasons|56|||
33469718|NCT03151408|62843480|FG001|Overall Study|other reasons|52|||
33469719|NCT03151408|62843479|FG000|Overall Study|randomized and not treated|2|||
33469720|NCT03151408|62843480|FG001|Overall Study|randomized and not treated|2|||
33338907|NCT00944034|62715688|FG006|Overall Study|Protocol Violation|0|||
33338908|NCT00944034|62715689|FG007|Overall Study|Protocol Violation|1|||
33338909|NCT00944034|62715690|FG008|Overall Study|Protocol Violation|1|||
33469721|NCT00546754|62843488|FG000|Overall Study|Serious Adverse Event|1|||
33469722|NCT00546754|62843489|FG001|Overall Study|Serious Adverse Event|1|||
33469723|NCT00546754|62843488|FG000|Overall Study|Adverse Event|11|||
33469724|NCT00546754|62843489|FG001|Overall Study|Adverse Event|16|||
33469725|NCT00546754|62843488|FG000|Overall Study|Lack of Efficacy|1|||
33469726|NCT00546754|62843489|FG001|Overall Study|Lack of Efficacy|1|||
33469727|NCT00546754|62843488|FG000|Overall Study|Lost to Follow-up|9|||
33469728|NCT00546754|62843489|FG001|Overall Study|Lost to Follow-up|15|||
33469729|NCT00546754|62843488|FG000|Overall Study|Protocol Violation|3|||
33469730|NCT00546754|62843489|FG001|Overall Study|Protocol Violation|0|||
33469731|NCT00546754|62843488|FG000|Overall Study|Withdrawal by Subject|6|||
33469732|NCT00546754|62843489|FG001|Overall Study|Withdrawal by Subject|7|||
33469733|NCT00546754|62843488|FG000|Overall Study|Dyspnea|1|||
33469734|NCT00546754|62843489|FG001|Overall Study|Dyspnea|0|||
33469735|NCT00546754|62843488|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
33469736|NCT00546754|62843489|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
33469737|NCT00546754|62843488|FG000|Overall Study|Hip Replacement|1|||
33469738|NCT00546754|62843489|FG001|Overall Study|Hip Replacement|0|||
33469739|NCT00546754|62843488|FG000|Overall Study|Suicide|1|||
33469740|NCT00546754|62843489|FG001|Overall Study|Suicide|0|||
33469741|NCT00546754|62843488|FG000|Overall Study|Missing Cooperation|1|||
33469742|NCT00546754|62843489|FG001|Overall Study|Missing Cooperation|0|||
33469743|NCT00546754|62843488|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
33469744|NCT00546754|62843489|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
33469745|NCT00546754|62843488|FG000|Overall Study|Patient's Decision|0|||
33469746|NCT00546754|62843489|FG001|Overall Study|Patient's Decision|1|||
33469747|NCT00546754|62843488|FG000|Overall Study|Missing|14|||
33654396|NCT01709318|63067156|FG002|Overall Study|Pregnancy|0|||
33654397|NCT01709318|63067157|FG003|Overall Study|Pregnancy|0|||
33654398|NCT01709318|63067158|FG004|Overall Study|Pregnancy|1|||
33654399|NCT01709318|63067159|FG005|Overall Study|Pregnancy|0|||
33469748|NCT00546754|62843489|FG001|Overall Study|Missing|7|||
33469749|NCT00282347|62843497|FG000|Treatment Period|Death|2|||
33469750|NCT00282347|62843498|FG001|Treatment Period|Death|0|||
33469751|NCT00282347|62843497|FG000|Treatment Period|Lost to Follow-up|2|||
33469752|NCT00282347|62843498|FG001|Treatment Period|Lost to Follow-up|5|||
33469753|NCT00282347|62843497|FG000|Treatment Period|Withdrawal by Subject|1|||
33338910|NCT00944034|62715691|FG009|Overall Study|Protocol Violation|4|||
33469754|NCT00282347|62843498|FG001|Treatment Period|Withdrawal by Subject|3|||
33469755|NCT00282347|62843497|FG000|Treatment Period|Physician Decision|0|||
33469756|NCT00282347|62843498|FG001|Treatment Period|Physician Decision|1|||
33469757|NCT00282347|62843497|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
33654400|NCT01709318|63067160|FG006|Overall Study|Pregnancy|0|||
33338911|NCT00944034|62715692|FG010|Overall Study|Protocol Violation|0|||
33338912|NCT00944034|62715693|FG011|Overall Study|Protocol Violation|0|||
33338913|NCT00944034|62715682|FG000|Overall Study|Unable to classify|0|||
33338914|NCT00944034|62715683|FG001|Overall Study|Unable to classify|0|||
33338915|NCT00944034|62715684|FG002|Overall Study|Unable to classify|0|||
33338916|NCT00944034|62715685|FG003|Overall Study|Unable to classify|0|||
33338917|NCT00944034|62715686|FG004|Overall Study|Unable to classify|0|||
33338918|NCT00944034|62715687|FG005|Overall Study|Unable to classify|1|||
33338919|NCT00944034|62715688|FG006|Overall Study|Unable to classify|1|||
33338920|NCT00944034|62715689|FG007|Overall Study|Unable to classify|1|||
33338921|NCT00944034|62715690|FG008|Overall Study|Unable to classify|0|||
33338922|NCT00944034|62715691|FG009|Overall Study|Unable to classify|0|||
33338923|NCT00944034|62715692|FG010|Overall Study|Unable to classify|0|||
33338924|NCT00944034|62715693|FG011|Overall Study|Unable to classify|0|||
33654401|NCT01709318|63067154|FG000|Overall Study|Protocol Violation|0|||
33654402|NCT01709318|63067155|FG001|Overall Study|Protocol Violation|0|||
33338925|NCT00944034|62715682|FG000|Overall Study|Administrative reason|0|||
33338926|NCT00944034|62715683|FG001|Overall Study|Administrative reason|0|||
33338927|NCT00944034|62715684|FG002|Overall Study|Administrative reason|0|||
33338928|NCT00944034|62715685|FG003|Overall Study|Administrative reason|0|||
33338929|NCT00944034|62715686|FG004|Overall Study|Administrative reason|0|||
33338930|NCT00944034|62715687|FG005|Overall Study|Administrative reason|0|||
33338931|NCT00944034|62715688|FG006|Overall Study|Administrative reason|1|||
33338932|NCT00944034|62715689|FG007|Overall Study|Administrative reason|0|||
33338933|NCT00944034|62715690|FG008|Overall Study|Administrative reason|0|||
33338934|NCT00944034|62715691|FG009|Overall Study|Administrative reason|0|||
33338935|NCT00944034|62715692|FG010|Overall Study|Administrative reason|0|||
33338936|NCT00944034|62715693|FG011|Overall Study|Administrative reason|0|||
33338937|NCT01106534|62715736|FG000|Overall Study|Withdrawal by Subject|18|||
33338938|NCT01106534|62715736|FG000|Overall Study|Lost to Follow-up|2|||
33338939|NCT01106534|62715736|FG000|Overall Study|Death|16|||
33338940|NCT01106534|62715736|FG000|Overall Study|Physician Decision|1|||
33338941|NCT00941304|62715746|FG000|Overall Study|Lost to Follow-up|1|||
33338942|NCT00941304|62715747|FG001|Overall Study|Lost to Follow-up|0|||
33338943|NCT00941304|62715748|FG002|Overall Study|Lost to Follow-up|0|||
33338944|NCT00941304|62715749|FG003|Overall Study|Lost to Follow-up|0|||
33338945|NCT00941304|62715750|FG004|Overall Study|Lost to Follow-up|0|||
33338946|NCT00941070|62715762|FG000|Overall Study|Patient non-compliant|1|||
33338947|NCT01098812|62715771|FG000|Overall Study|Death|2|||
33338948|NCT01098812|62715772|FG001|Overall Study|Death|0|||
33338949|NCT01098812|62715773|FG002|Overall Study|Death|1|||
33338950|NCT01098812|62715771|FG000|Overall Study|Lost to Follow-up|0|||
33338951|NCT01098812|62715772|FG001|Overall Study|Lost to Follow-up|1|||
33338952|NCT01098812|62715773|FG002|Overall Study|Lost to Follow-up|0|||
33338953|NCT00903201|62715783|FG000|Overall Study|Adverse Event|1|||
33338954|NCT00903201|62715784|FG001|Overall Study|Adverse Event|4|||
33338955|NCT00903201|62715785|FG002|Overall Study|Adverse Event|0|||
33338956|NCT00903201|62715783|FG000|Overall Study|Protocol Violation|2|||
33338957|NCT00903201|62715784|FG001|Overall Study|Protocol Violation|1|||
33338958|NCT00903201|62715785|FG002|Overall Study|Protocol Violation|0|||
33338959|NCT00903201|62715783|FG000|Overall Study|Lost to Follow-up|0|||
33338960|NCT00903201|62715784|FG001|Overall Study|Lost to Follow-up|1|||
33338961|NCT00903201|62715785|FG002|Overall Study|Lost to Follow-up|0|||
33338962|NCT00903201|62715783|FG000|Overall Study|Physician Decision|1|||
33338963|NCT00903201|62715784|FG001|Overall Study|Physician Decision|0|||
33338964|NCT00903201|62715785|FG002|Overall Study|Physician Decision|1|||
33338965|NCT00903201|62715783|FG000|Overall Study|Withdrawal by Subject|1|||
33338966|NCT00903201|62715784|FG001|Overall Study|Withdrawal by Subject|0|||
33338967|NCT00903201|62715785|FG002|Overall Study|Withdrawal by Subject|1|||
33338968|NCT00902265|62715795|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
33469758|NCT00282347|62843498|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
33338969|NCT00902265|62715795|FG000|Overall Study|Adverse Event|2|||
33338970|NCT00902265|62715795|FG000|Overall Study|Lack of Efficacy|2|||
33338971|NCT00902265|62715795|FG000|Overall Study|Protocol Violation|1|||
33338972|NCT00943722|62715813|FG000|Base Study|Adverse Event|0|||
33338973|NCT00943722|62715814|FG001|Base Study|Adverse Event|0|||
33338974|NCT00943722|62715815|FG002|Base Study|Adverse Event|0|||
33338975|NCT00943722|62715816|FG003|Base Study|Adverse Event|1|||
33338976|NCT00943722|62715817|FG004|Base Study|Adverse Event|0|||
33338977|NCT00943722|62715818|FG005|Base Study|Adverse Event|0|||
33469759|NCT00282347|62843497|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
33338978|NCT00943722|62715819|FG006|Base Study|Adverse Event|0|||
33338979|NCT00943722|62715813|FG000|Base Study|Lost to Follow-up|12|||
33338980|NCT00943722|62715814|FG001|Base Study|Lost to Follow-up|8|||
33338981|NCT00943722|62715815|FG002|Base Study|Lost to Follow-up|10|||
33338982|NCT00943722|62715816|FG003|Base Study|Lost to Follow-up|8|||
33338983|NCT00943722|62715817|FG004|Base Study|Lost to Follow-up|11|||
33338984|NCT00943722|62715818|FG005|Base Study|Lost to Follow-up|0|||
33338985|NCT00943722|62715819|FG006|Base Study|Lost to Follow-up|0|||
33338986|NCT00943722|62715813|FG000|Base Study|Physician Decision|1|||
33338987|NCT00943722|62715814|FG001|Base Study|Physician Decision|0|||
33338988|NCT00943722|62715815|FG002|Base Study|Physician Decision|0|||
33338989|NCT00943722|62715816|FG003|Base Study|Physician Decision|0|||
33338990|NCT00943722|62715817|FG004|Base Study|Physician Decision|1|||
33338991|NCT00943722|62715818|FG005|Base Study|Physician Decision|0|||
33338992|NCT00943722|62715819|FG006|Base Study|Physician Decision|0|||
33338993|NCT00943722|62715813|FG000|Base Study|Pregnancy|0|||
33338994|NCT00943722|62715814|FG001|Base Study|Pregnancy|0|||
33338995|NCT00943722|62715815|FG002|Base Study|Pregnancy|1|||
33338996|NCT00943722|62715816|FG003|Base Study|Pregnancy|0|||
33338997|NCT00943722|62715817|FG004|Base Study|Pregnancy|2|||
33338998|NCT00943722|62715818|FG005|Base Study|Pregnancy|0|||
33338999|NCT00943722|62715819|FG006|Base Study|Pregnancy|0|||
33339000|NCT00943722|62715813|FG000|Base Study|Protocol Violation|0|||
33339001|NCT00943722|62715814|FG001|Base Study|Protocol Violation|1|||
33339002|NCT00943722|62715815|FG002|Base Study|Protocol Violation|0|||
33339003|NCT00943722|62715816|FG003|Base Study|Protocol Violation|0|||
33339004|NCT00943722|62715817|FG004|Base Study|Protocol Violation|2|||
33339005|NCT00943722|62715818|FG005|Base Study|Protocol Violation|0|||
33339006|NCT00943722|62715819|FG006|Base Study|Protocol Violation|0|||
33339007|NCT00943722|62715813|FG000|Base Study|Withdrawal by Subject|12|||
33339008|NCT00943722|62715814|FG001|Base Study|Withdrawal by Subject|13|||
33339009|NCT00943722|62715815|FG002|Base Study|Withdrawal by Subject|2|||
33339010|NCT00943722|62715816|FG003|Base Study|Withdrawal by Subject|13|||
33339011|NCT00943722|62715817|FG004|Base Study|Withdrawal by Subject|8|||
33339012|NCT00943722|62715818|FG005|Base Study|Withdrawal by Subject|0|||
33339013|NCT00943722|62715819|FG006|Base Study|Withdrawal by Subject|0|||
33339014|NCT00943722|62715813|FG000|Base Study|Month 12 visit not completed|0|||
33339015|NCT00943722|62715814|FG001|Base Study|Month 12 visit not completed|0|||
33339016|NCT00943722|62715815|FG002|Base Study|Month 12 visit not completed|0|||
33339017|NCT00943722|62715816|FG003|Base Study|Month 12 visit not completed|0|||
33339018|NCT00943722|62715817|FG004|Base Study|Month 12 visit not completed|2|||
33339019|NCT00943722|62715818|FG005|Base Study|Month 12 visit not completed|0|||
33339020|NCT00943722|62715819|FG006|Base Study|Month 12 visit not completed|0|||
33339021|NCT00943722|62715813|FG000|First Extension Study: EXT 1|Adverse Event|0|||
33339022|NCT00943722|62715814|FG001|First Extension Study: EXT 1|Adverse Event|0|||
33339023|NCT00943722|62715815|FG002|First Extension Study: EXT 1|Adverse Event|0|||
33339024|NCT00943722|62715816|FG003|First Extension Study: EXT 1|Adverse Event|0|||
33339025|NCT00943722|62715817|FG004|First Extension Study: EXT 1|Adverse Event|0|||
33339026|NCT00943722|62715818|FG005|First Extension Study: EXT 1|Adverse Event|1|||
33339027|NCT00943722|62715819|FG006|First Extension Study: EXT 1|Adverse Event|0|||
33339028|NCT00943722|62715813|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
33339029|NCT00943722|62715814|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
33339030|NCT00943722|62715815|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
33339031|NCT00943722|62715816|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
33339032|NCT00943722|62715817|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
33469760|NCT00282347|62843498|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
33469761|NCT00282347|62843497|FG000|Safety Follow-up Period|Physician Decision|1|||
33469762|NCT00282347|62843498|FG001|Safety Follow-up Period|Physician Decision|1|||
33469763|NCT00282347|62843497|FG000|Safety Follow-up Period|Protocol Deviation|0|||
33469764|NCT00282347|62843498|FG001|Safety Follow-up Period|Protocol Deviation|2|||
33469765|NCT00282347|62843497|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
33469766|NCT00282347|62843498|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
33469767|NCT00282347|62843497|FG000|B Cell Follow-up Period|Physician Decision|1|||
33469768|NCT00282347|62843498|FG001|B Cell Follow-up Period|Physician Decision|0|||
33469769|NCT00282347|62843497|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
33548819|NCT02970305|62940173|FG001|Overall Study|Protocol Violation|2|||
33339033|NCT00943722|62715818|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
33339034|NCT00943722|62715819|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
33339035|NCT00943722|62715813|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
33339036|NCT00943722|62715814|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
33339037|NCT00943722|62715815|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
33339038|NCT00943722|62715816|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
33339039|NCT00943722|62715817|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
33339040|NCT00943722|62715818|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
33339041|NCT00943722|62715819|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
33339042|NCT00943722|62715813|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
33339043|NCT00943722|62715814|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
33339044|NCT00943722|62715815|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
33339045|NCT00943722|62715816|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
33339046|NCT00943722|62715817|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
33339047|NCT00943722|62715818|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
33339048|NCT00943722|62715819|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
33339049|NCT00943722|62715813|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
33339050|NCT00943722|62715814|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
33339051|NCT00943722|62715815|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
33339052|NCT00943722|62715816|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
33469770|NCT00282347|62843498|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
33469771|NCT00405964|62843508|FG000|Overall Study|Treatment Failure|17|||
33469772|NCT00405964|62843509|FG001|Overall Study|Treatment Failure|45|||
33469773|NCT00405964|62843508|FG000|Overall Study|Adverse Event|7|||
33469774|NCT00405964|62843509|FG001|Overall Study|Adverse Event|16|||
33469775|NCT00405964|62843508|FG000|Overall Study|Lost to Follow-up|5|||
33469776|NCT00405964|62843509|FG001|Overall Study|Lost to Follow-up|5|||
33469777|NCT00405964|62843508|FG000|Overall Study|Withdrawal by Subject|19|||
33469778|NCT00405964|62843509|FG001|Overall Study|Withdrawal by Subject|23|||
33469779|NCT00405964|62843508|FG000|Overall Study|Protocol Violation|11|||
33469780|NCT00405964|62843509|FG001|Overall Study|Protocol Violation|6|||
33469781|NCT00264797|62843517|FG000|Overall Study|Withdrawal by Subject|11|||
33339053|NCT00943722|62715817|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
33339054|NCT00943722|62715818|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
33339055|NCT00943722|62715819|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
33339056|NCT00943722|62715813|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
33339057|NCT00943722|62715814|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
33339058|NCT00943722|62715815|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
33339059|NCT00943722|62715816|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
33339060|NCT00943722|62715817|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
33339061|NCT00943722|62715818|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
33339062|NCT00943722|62715819|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
33339063|NCT00943722|62715813|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
33339064|NCT00943722|62715814|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
33339065|NCT00943722|62715815|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
33339066|NCT00943722|62715816|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
33339067|NCT00943722|62715817|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
33339068|NCT00943722|62715818|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
33339069|NCT00943722|62715819|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
33339070|NCT00943722|62715813|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
33339071|NCT00943722|62715814|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
33339072|NCT00943722|62715815|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
33339073|NCT00943722|62715816|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
33339074|NCT00943722|62715817|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
33339075|NCT00943722|62715818|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
33339076|NCT00943722|62715819|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
33339077|NCT00943722|62715813|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
33339078|NCT00943722|62715814|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
33339079|NCT00943722|62715815|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
33339080|NCT00943722|62715816|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
33339081|NCT00943722|62715817|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
33339082|NCT00943722|62715818|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
33339083|NCT00943722|62715819|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
33339084|NCT00901485|62715842|FG000|Overall Study|Lack of Efficacy|0|||
33339085|NCT00901485|62715843|FG001|Overall Study|Lack of Efficacy|2|||
33339086|NCT00901485|62715842|FG000|Overall Study|Withdrawal by Subject|1|||
33339087|NCT00901485|62715843|FG001|Overall Study|Withdrawal by Subject|2|||
33339088|NCT00896337|62715849|FG000|Overall Study|Death|7|||
33339089|NCT00896337|62715849|FG000|Overall Study|Withdrawal by Subject|7|||
33339090|NCT00896337|62715849|FG000|Overall Study|Lost to Follow-up|11|||
33339091|NCT00953706|62715860|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
33339092|NCT00953706|62715861|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
33339093|NCT00953706|62715862|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
33339094|NCT00953706|62715863|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
33339095|NCT00953706|62715860|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
33339096|NCT00953706|62715861|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
33339097|NCT00953706|62715862|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
33469782|NCT00264797|62843518|FG001|Overall Study|Withdrawal by Subject|11|||
33469783|NCT00264797|62843517|FG000|Overall Study|Lost to Follow-up|9|||
33339098|NCT00953706|62715863|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
33339099|NCT00953706|62715860|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
33339100|NCT00953706|62715861|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
33469784|NCT00264797|62843518|FG001|Overall Study|Lost to Follow-up|17|||
33469785|NCT00264797|62843517|FG000|Overall Study|Moved from area|3|||
33469786|NCT00264797|62843518|FG001|Overall Study|Moved from area|1|||
33548820|NCT02970305|62940172|FG000|Overall Study|Withdrawal by Subject|12|||
33548821|NCT02970305|62940173|FG001|Overall Study|Withdrawal by Subject|11|||
33548822|NCT02970305|62940172|FG000|Overall Study|Not further specified|1|||
33339101|NCT00953706|62715862|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
33339102|NCT00953706|62715863|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
33339103|NCT00953706|62715860|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
33339104|NCT00953706|62715861|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
33339105|NCT00953706|62715862|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
33339106|NCT00953706|62715863|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
33339107|NCT00953706|62715860|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
33339108|NCT00953706|62715861|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
33339109|NCT00953706|62715862|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
33339110|NCT00953706|62715863|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
33339111|NCT00953706|62715860|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
33339112|NCT00953706|62715861|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
33339113|NCT00953706|62715862|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
33339114|NCT00953706|62715863|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
33339115|NCT00953706|62715860|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
33339116|NCT00953706|62715861|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
33339117|NCT00953706|62715862|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
33339118|NCT00953706|62715863|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
33339119|NCT00953706|62715860|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
33469787|NCT00264797|62843517|FG000|Overall Study|Practical Problems|2|||
33469788|NCT00264797|62843518|FG001|Overall Study|Practical Problems|3|||
33654403|NCT01709318|63067156|FG002|Overall Study|Protocol Violation|0|||
33469789|NCT00264797|62843517|FG000|Overall Study|Incarceration|4|||
33469790|NCT00264797|62843518|FG001|Overall Study|Incarceration|5|||
33469791|NCT00264797|62843517|FG000|Overall Study|Pressure/advice from Outsiders|1|||
33469792|NCT00264797|62843518|FG001|Overall Study|Pressure/advice from Outsiders|1|||
33469793|NCT00264797|62843517|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
33469794|NCT00264797|62843518|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
33469795|NCT00264797|62843517|FG000|Overall Study|Other|3|||
33469796|NCT00264797|62843518|FG001|Overall Study|Other|4|||
33469797|NCT03148756|62843526|FG000|Overall Study|Study Terminated|0|||
33469798|NCT03148756|62843527|FG001|Overall Study|Study Terminated|1|||
33469799|NCT00282113|62843536|FG000|Overall Study|Removed at parents request|1|||
33469800|NCT00282113|62843537|FG001|Overall Study|Removed at parents request|0|||
33469801|NCT00282113|62843538|FG002|Overall Study|Removed at parents request|0|||
33548823|NCT02970305|62940173|FG001|Overall Study|Not further specified|2|||
33469802|NCT00281957|62843548|FG000|Overall Study|Adverse Event|7|||
33548824|NCT02970305|62940172|FG000|Overall Study|Lost to Follow-up|1|||
33548825|NCT02970305|62940173|FG001|Overall Study|Lost to Follow-up|2|||
33548826|NCT02022033|62940192|FG000|Overall Study|Physician Decision|1|||
33548827|NCT03505671|62940198|FG000|Overall Study|Withdrawal by Subject|2|||
33548828|NCT03505671|62940199|FG001|Overall Study|Withdrawal by Subject|1|||
33548829|NCT03505671|62940198|FG000|Overall Study|Lost to Follow-up|1|||
33548830|NCT03505671|62940199|FG001|Overall Study|Lost to Follow-up|0|||
33548831|NCT01103349|62940220|FG000|Overall Study|Adverse Event|8|||
33548832|NCT01103349|62940221|FG001|Overall Study|Adverse Event|5|||
33548833|NCT01103349|62940222|FG002|Overall Study|Adverse Event|3|||
33548834|NCT01103349|62940220|FG000|Overall Study|Consent withdrawn|1|||
33548835|NCT01103349|62940221|FG001|Overall Study|Consent withdrawn|0|||
33548836|NCT01103349|62940222|FG002|Overall Study|Consent withdrawn|0|||
33654404|NCT01709318|63067157|FG003|Overall Study|Protocol Violation|0|||
33654405|NCT01709318|63067158|FG004|Overall Study|Protocol Violation|2|||
33654406|NCT01709318|63067159|FG005|Overall Study|Protocol Violation|0|||
33654407|NCT01709318|63067160|FG006|Overall Study|Protocol Violation|1|||
33469803|NCT00281957|62843549|FG001|Overall Study|Adverse Event|2|||
33469804|NCT00281957|62843548|FG000|Overall Study|Death|1|||
33469805|NCT00281957|62843549|FG001|Overall Study|Death|0|||
33469806|NCT00281957|62843548|FG000|Overall Study|Progression/relapse|47|||
33548837|NCT01103349|62940220|FG000|Overall Study|Incorrectly included in the trial|1|||
33548838|NCT01103349|62940221|FG001|Overall Study|Incorrectly included in the trial|0|||
33339120|NCT00953706|62715861|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
33339121|NCT00953706|62715862|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
33339122|NCT00953706|62715863|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
33339123|NCT00953706|62715860|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
33339124|NCT00953706|62715861|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
33339125|NCT00953706|62715862|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
33339126|NCT00953706|62715863|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
33339127|NCT00953706|62715860|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
33339128|NCT00953706|62715861|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
33339129|NCT00953706|62715862|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
33339130|NCT00953706|62715863|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
33339131|NCT00953706|62715860|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
33339132|NCT00953706|62715861|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
33339133|NCT00953706|62715862|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
33339134|NCT00953706|62715863|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
33339135|NCT00940992|62715876|FG000|Overall Study|Adverse Event|2|||
33339136|NCT00940992|62715877|FG001|Overall Study|Adverse Event|0|||
33339137|NCT00940992|62715878|FG002|Overall Study|Adverse Event|1|||
33339138|NCT00940992|62715876|FG000|Overall Study|subject request|2|||
33339139|NCT00940992|62715877|FG001|Overall Study|subject request|1|||
33339140|NCT00940992|62715878|FG002|Overall Study|subject request|0|||
33339141|NCT00940992|62715876|FG000|Overall Study|Lost to Follow-up|0|||
33339142|NCT00940992|62715877|FG001|Overall Study|Lost to Follow-up|1|||
33339143|NCT00940992|62715878|FG002|Overall Study|Lost to Follow-up|1|||
33339144|NCT00938964|62715888|FG000|Overall Study|Death|3|||
33339145|NCT00938964|62715889|FG001|Overall Study|Death|3|||
33339146|NCT00938964|62715888|FG000|Overall Study|Lost to Follow-up|2|||
33339147|NCT00938964|62715889|FG001|Overall Study|Lost to Follow-up|3|||
33339148|NCT00938964|62715888|FG000|Overall Study|Withdrawal by Subject|22|||
33339149|NCT00938964|62715889|FG001|Overall Study|Withdrawal by Subject|18|||
33339150|NCT00938964|62715888|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
33339151|NCT00938964|62715889|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
33339152|NCT00938886|62715897|FG000|Overall Study|Death|0|||
33339153|NCT00938886|62715898|FG001|Overall Study|Death|1|||
33339154|NCT00938886|62715897|FG000|Overall Study|Withdrawal by Subject|4|||
33339155|NCT00938886|62715898|FG001|Overall Study|Withdrawal by Subject|7|||
33339156|NCT00938886|62715897|FG000|Overall Study|Lost to Follow-up|3|||
33339157|NCT00938886|62715898|FG001|Overall Study|Lost to Follow-up|2|||
33339158|NCT00942708|62715904|FG000|Overall Study|Withdrawal by Subject|1|||
33339159|NCT00937950|62715909|FG000|Overall Study|Withdrawal by Subject|23|||
33339160|NCT00937950|62715909|FG000|Overall Study|Migrated/moved from study area|27|||
33339161|NCT00937950|62715909|FG000|Overall Study|Lost to Follow-up|144|||
33339162|NCT00937950|62715909|FG000|Overall Study|Missing confirmed|4|||
33339163|NCT00937950|62715909|FG000|Overall Study|Other|18|||
33339164|NCT00942162|62715916|FG000|Overall Study|Death|45|||
33339165|NCT00942162|62715917|FG001|Overall Study|Death|35|||
33339166|NCT00942162|62715918|FG002|Overall Study|Death|0|||
33339167|NCT00942162|62715916|FG000|Overall Study|Withdrawal by Subject|7|||
33339168|NCT00942162|62715917|FG001|Overall Study|Withdrawal by Subject|2|||
33339169|NCT00942162|62715918|FG002|Overall Study|Withdrawal by Subject|0|||
33339170|NCT00942162|62715916|FG000|Overall Study|Lost to Follow-up|4|||
33339171|NCT00942162|62715917|FG001|Overall Study|Lost to Follow-up|0|||
33339172|NCT00942162|62715918|FG002|Overall Study|Lost to Follow-up|0|||
33339173|NCT00942162|62715916|FG000|Overall Study|Other|14|||
33339174|NCT00942162|62715917|FG001|Overall Study|Other|13|||
33339175|NCT00942162|62715918|FG002|Overall Study|Other|2|||
33339176|NCT00942084|62715928|FG000|Overall Study|Death|2|||
33339177|NCT00941928|62715932|FG000|Overall Study|Withdrawal by Subject|1|||
33339178|NCT00941928|62715932|FG000|Overall Study|Disease Progression|1|||
33339179|NCT00937560|62715936|FG000|Initial Treatment|Death|6|||
33339180|NCT00937560|62715936|FG000|Initial Treatment|Withdraw consent|3|||
33339181|NCT00937560|62715936|FG000|Initial Treatment|Adverse Event|1|||
33339182|NCT00937560|62715936|FG000|Initial Treatment|Lost to Follow-up|1|||
33339183|NCT00937560|62715936|FG000|Initial Treatment|No end of study page|10|||
33339184|NCT00937560|62715936|FG000|Maintenance Treatment|Death|12|||
33339185|NCT00937560|62715936|FG000|Maintenance Treatment|Withdraw consent|5|||
33339186|NCT00937560|62715936|FG000|Maintenance Treatment|According to protocol|1|||
33339187|NCT00594568|62715943|FG000|Initial Treatment|Adverse Event|51|||
33339188|NCT00594568|62715944|FG001|Initial Treatment|Adverse Event|121|||
33339189|NCT00594568|62715945|FG002|Initial Treatment|Adverse Event|144|||
33339190|NCT00594568|62715943|FG000|Initial Treatment|Death|6|||
33339191|NCT00594568|62715944|FG001|Initial Treatment|Death|11|||
33339192|NCT00594568|62715945|FG002|Initial Treatment|Death|15|||
33339193|NCT00594568|62715943|FG000|Initial Treatment|Lost to Follow-up|4|||
33339194|NCT00594568|62715944|FG001|Initial Treatment|Lost to Follow-up|1|||
33339195|NCT00594568|62715945|FG002|Initial Treatment|Lost to Follow-up|4|||
33339196|NCT00594568|62715943|FG000|Initial Treatment|Physician Decision|3|||
33339197|NCT00594568|62715944|FG001|Initial Treatment|Physician Decision|2|||
33339198|NCT00594568|62715945|FG002|Initial Treatment|Physician Decision|4|||
33339199|NCT00594568|62715943|FG000|Initial Treatment|Protocol Violation|2|||
33339200|NCT00594568|62715944|FG001|Initial Treatment|Protocol Violation|2|||
33339201|NCT00594568|62715945|FG002|Initial Treatment|Protocol Violation|5|||
33339202|NCT00594568|62715943|FG000|Initial Treatment|Withdrawal by Subject|25|||
33339203|NCT00594568|62715944|FG001|Initial Treatment|Withdrawal by Subject|31|||
33339204|NCT00594568|62715945|FG002|Initial Treatment|Withdrawal by Subject|46|||
33654408|NCT01709318|63067154|FG000|Overall Study|Technical Problems|1|||
33654409|NCT01709318|63067155|FG001|Overall Study|Technical Problems|0|||
33654410|NCT01709318|63067156|FG002|Overall Study|Technical Problems|0|||
33654411|NCT01709318|63067157|FG003|Overall Study|Technical Problems|0|||
33654412|NCT01709318|63067158|FG004|Overall Study|Technical Problems|0|||
33654413|NCT01709318|63067159|FG005|Overall Study|Technical Problems|0|||
33654414|NCT01709318|63067160|FG006|Overall Study|Technical Problems|0|||
33339205|NCT00594568|62715943|FG000|Initial Treatment|Sponsor decision|193|||
33339206|NCT00594568|62715944|FG001|Initial Treatment|Sponsor decision|142|||
33339207|NCT00594568|62715945|FG002|Initial Treatment|Sponsor decision|147|||
33339208|NCT00594568|62715943|FG000|Initial Treatment|Caregiver decision|21|||
33339209|NCT00594568|62715944|FG001|Initial Treatment|Caregiver decision|36|||
33339210|NCT00594568|62715945|FG002|Initial Treatment|Caregiver decision|36|||
33339211|NCT00594568|62715943|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
33339212|NCT00594568|62715944|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
33339213|NCT00594568|62715945|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
33339214|NCT00594568|62715943|FG000|Initial Treatment|Entry criteria exclusion|0|||
33339215|NCT00594568|62715944|FG001|Initial Treatment|Entry criteria exclusion|1|||
33339216|NCT00594568|62715945|FG002|Initial Treatment|Entry criteria exclusion|1|||
33339217|NCT00594568|62715943|FG000|Delayed Start|Death|0|||
33339218|NCT00594568|62715944|FG001|Delayed Start|Death|0|||
33339219|NCT00594568|62715945|FG002|Delayed Start|Death|1|||
33339220|NCT00594568|62715943|FG000|Delayed Start|Adverse Event|12|||
33339221|NCT00594568|62715944|FG001|Delayed Start|Adverse Event|2|||
33339222|NCT00594568|62715945|FG002|Delayed Start|Adverse Event|2|||
33339223|NCT00594568|62715943|FG000|Delayed Start|Withdrawal by Subject|4|||
33339224|NCT00594568|62715944|FG001|Delayed Start|Withdrawal by Subject|3|||
33339225|NCT00594568|62715945|FG002|Delayed Start|Withdrawal by Subject|0|||
33339226|NCT00594568|62715943|FG000|Delayed Start|Physician Decision|0|||
33339227|NCT00594568|62715944|FG001|Delayed Start|Physician Decision|0|||
33339228|NCT00594568|62715945|FG002|Delayed Start|Physician Decision|1|||
33339229|NCT00594568|62715943|FG000|Delayed Start|Lost to Follow-up|0|||
33339230|NCT00594568|62715944|FG001|Delayed Start|Lost to Follow-up|0|||
33339231|NCT00594568|62715945|FG002|Delayed Start|Lost to Follow-up|1|||
33339232|NCT00594568|62715943|FG000|Delayed Start|Caregiver Decision|5|||
33339233|NCT00594568|62715944|FG001|Delayed Start|Caregiver Decision|6|||
33339234|NCT00594568|62715945|FG002|Delayed Start|Caregiver Decision|2|||
33339235|NCT00594568|62715943|FG000|Delayed Start|Sponsor Decision|77|||
33339236|NCT00594568|62715944|FG001|Delayed Start|Sponsor Decision|66|||
33339237|NCT00594568|62715945|FG002|Delayed Start|Sponsor Decision|59|||
33339238|NCT00594568|62715943|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
33339239|NCT00594568|62715944|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
33339240|NCT00594568|62715945|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
33339241|NCT00594568|62715943|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
33339242|NCT00594568|62715944|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
33548839|NCT01103349|62940222|FG002|Overall Study|Incorrectly included in the trial|0|||
33548840|NCT01103349|62940220|FG000|Overall Study|Withdrawal by Subject|1|||
33654415|NCT01709318|63067154|FG000|Overall Study|Withdrawal by Subject|3|||
33339243|NCT00594568|62715945|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
33339244|NCT00594568|62715943|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
33339245|NCT00594568|62715944|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
33339246|NCT00594568|62715945|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
33339247|NCT00594568|62715943|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
33339248|NCT00594568|62715944|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
33654416|NCT01709318|63067155|FG001|Overall Study|Withdrawal by Subject|0|||
33654417|NCT01709318|63067156|FG002|Overall Study|Withdrawal by Subject|3|||
33339249|NCT00594568|62715945|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
33339250|NCT00594568|62715943|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
33339251|NCT00594568|62715944|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
33339252|NCT00594568|62715945|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
33339253|NCT00594568|62715943|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
33339254|NCT00594568|62715944|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
33548841|NCT01103349|62940221|FG001|Overall Study|Withdrawal by Subject|1|||
33339255|NCT00594568|62715945|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
33339256|NCT00875056|62715973|FG000|Overall Study|Adverse Event|6|||
33654418|NCT01709318|63067157|FG003|Overall Study|Withdrawal by Subject|3|||
33339257|NCT00875056|62715974|FG001|Overall Study|Adverse Event|1|||
33339258|NCT00875056|62715975|FG002|Overall Study|Adverse Event|2|||
33339259|NCT00875056|62715973|FG000|Overall Study|Progressive Disease|14|||
33339260|NCT00875056|62715974|FG001|Overall Study|Progressive Disease|8|||
33339261|NCT00875056|62715975|FG002|Overall Study|Progressive Disease|3|||
33339262|NCT00875056|62715973|FG000|Overall Study|Withdrawal by Subject|3|||
33339263|NCT00875056|62715974|FG001|Overall Study|Withdrawal by Subject|0|||
33339264|NCT00875056|62715975|FG002|Overall Study|Withdrawal by Subject|1|||
33339265|NCT00940602|62715985|FG000|Overall Study|Administrative problems|1|||
33339266|NCT00940602|62715986|FG001|Overall Study|Administrative problems|1|||
33339267|NCT00940602|62715985|FG000|Overall Study|Patient/guardian decision|13|||
33339268|NCT00940602|62715986|FG001|Overall Study|Patient/guardian decision|28|||
33339269|NCT00940602|62715985|FG000|Overall Study|Physician Decision|8|||
33339270|NCT00940602|62715986|FG001|Overall Study|Physician Decision|5|||
33339271|NCT00940602|62715985|FG000|Overall Study|Pregnancy|1|||
33339272|NCT00940602|62715986|FG001|Overall Study|Pregnancy|0|||
33339273|NCT00940602|62715985|FG000|Overall Study|Protocol Deviation (untreated)|1|||
33339274|NCT00940602|62715986|FG001|Overall Study|Protocol Deviation (untreated)|0|||
33339275|NCT00940602|62715985|FG000|Overall Study|Disease progression|8|||
33339276|NCT00940602|62715986|FG001|Overall Study|Disease progression|2|||
33339277|NCT00940602|62715985|FG000|Overall Study|Death|38|||
33339278|NCT00940602|62715986|FG001|Overall Study|Death|19|||
33339279|NCT00940602|62715985|FG000|Overall Study|Lost to Follow-up|3|||
33339280|NCT00940602|62715986|FG001|Overall Study|Lost to Follow-up|1|||
33339281|NCT00940602|62715985|FG000|Overall Study|Patient withdrew consent|26|||
33339282|NCT00940602|62715986|FG001|Overall Study|Patient withdrew consent|13|||
33339283|NCT00940602|62715985|FG000|Overall Study|Adverse Event|7|||
33339284|NCT00940602|62715986|FG001|Overall Study|Adverse Event|2|||
33339285|NCT00940602|62715985|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
33339286|NCT00940602|62715986|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
33339287|NCT00875524|62715995|FG000|Overall Study|Serious adverse event|0|||
33339288|NCT00875524|62715996|FG001|Overall Study|Serious adverse event|1|||
33339289|NCT00875524|62715995|FG000|Overall Study|Protocol Violation|4|||
33339290|NCT00875524|62715996|FG001|Overall Study|Protocol Violation|0|||
33339291|NCT00875524|62715995|FG000|Overall Study|Lost to Follow-up|1|||
33339292|NCT00875524|62715996|FG001|Overall Study|Lost to Follow-up|0|||
33339293|NCT00875524|62715995|FG000|Overall Study|Withdrawal by Subject|3|||
33339294|NCT00875524|62715996|FG001|Overall Study|Withdrawal by Subject|5|||
33339295|NCT01094288|62716010|FG000|Overall Study|Adverse Event|0|||
33339296|NCT01094288|62716011|FG001|Overall Study|Adverse Event|3|||
33339297|NCT01094288|62716012|FG002|Overall Study|Adverse Event|1|||
33339298|NCT01094288|62716013|FG003|Overall Study|Adverse Event|1|||
33339299|NCT01094288|62716014|FG004|Overall Study|Adverse Event|0|||
33339300|NCT01094288|62716015|FG005|Overall Study|Adverse Event|0|||
33339301|NCT01094288|62716016|FG006|Overall Study|Adverse Event|0|||
33339302|NCT01094288|62716017|FG007|Overall Study|Adverse Event|0|||
33339303|NCT01094288|62716010|FG000|Overall Study|Withdrawal by Subject|0|||
33339304|NCT01094288|62716011|FG001|Overall Study|Withdrawal by Subject|1|||
33339305|NCT01094288|62716012|FG002|Overall Study|Withdrawal by Subject|2|||
33339306|NCT01094288|62716013|FG003|Overall Study|Withdrawal by Subject|0|||
33339307|NCT01094288|62716014|FG004|Overall Study|Withdrawal by Subject|0|||
33339308|NCT01094288|62716015|FG005|Overall Study|Withdrawal by Subject|0|||
33339309|NCT01094288|62716016|FG006|Overall Study|Withdrawal by Subject|0|||
33339310|NCT01094288|62716017|FG007|Overall Study|Withdrawal by Subject|2|||
33339311|NCT01094288|62716010|FG000|Overall Study|Initiation of Alternative Therapy|0|||
33339312|NCT01094288|62716011|FG001|Overall Study|Initiation of Alternative Therapy|0|||
33339313|NCT01094288|62716012|FG002|Overall Study|Initiation of Alternative Therapy|1|||
33339314|NCT01094288|62716013|FG003|Overall Study|Initiation of Alternative Therapy|0|||
33339315|NCT01094288|62716014|FG004|Overall Study|Initiation of Alternative Therapy|0|||
33339316|NCT01094288|62716015|FG005|Overall Study|Initiation of Alternative Therapy|0|||
33339317|NCT01094288|62716016|FG006|Overall Study|Initiation of Alternative Therapy|0|||
33339318|NCT01094288|62716017|FG007|Overall Study|Initiation of Alternative Therapy|0|||
33339319|NCT01094288|62716010|FG000|Overall Study|Reason not Specified|2|||
33339320|NCT01094288|62716011|FG001|Overall Study|Reason not Specified|3|||
33339321|NCT01094288|62716012|FG002|Overall Study|Reason not Specified|0|||
33339322|NCT01094288|62716013|FG003|Overall Study|Reason not Specified|1|||
33339323|NCT01094288|62716014|FG004|Overall Study|Reason not Specified|0|||
33339324|NCT01094288|62716015|FG005|Overall Study|Reason not Specified|0|||
33339325|NCT01094288|62716016|FG006|Overall Study|Reason not Specified|0|||
33339326|NCT01094288|62716017|FG007|Overall Study|Reason not Specified|0|||
33339327|NCT01094288|62716010|FG000|Overall Study|Ongoing Participants|0|||
33339328|NCT01094288|62716011|FG001|Overall Study|Ongoing Participants|3|||
33339329|NCT01094288|62716012|FG002|Overall Study|Ongoing Participants|0|||
33339330|NCT01094288|62716013|FG003|Overall Study|Ongoing Participants|0|||
33339331|NCT01094288|62716014|FG004|Overall Study|Ongoing Participants|0|||
33339332|NCT01094288|62716015|FG005|Overall Study|Ongoing Participants|0|||
33339333|NCT01094288|62716016|FG006|Overall Study|Ongoing Participants|0|||
33339334|NCT01094288|62716017|FG007|Overall Study|Ongoing Participants|0|||
33339335|NCT00874120|62716041|FG000|First Intervention|Adverse Event|0|||
33339336|NCT00874120|62716042|FG001|First Intervention|Adverse Event|1|||
33339337|NCT00874120|62716041|FG000|First Intervention|Withdrawal by Subject|2|||
33339338|NCT00874120|62716042|FG001|First Intervention|Withdrawal by Subject|0|||
33339339|NCT00874120|62716041|FG000|First Intervention|Lost to Follow-up|0|||
33339340|NCT00874120|62716042|FG001|First Intervention|Lost to Follow-up|1|||
33339341|NCT00874120|62716041|FG000|First Intervention|Protocol Violation|3|||
33339342|NCT00874120|62716042|FG001|First Intervention|Protocol Violation|0|||
33339343|NCT00874120|62716041|FG000|First Intervention|positive drug test|1|||
33339344|NCT00874120|62716042|FG001|First Intervention|positive drug test|0|||
33339345|NCT00874120|62716041|FG000|Second Intervention|Withdrawal by Subject|1|||
33339346|NCT00874120|62716042|FG001|Second Intervention|Withdrawal by Subject|0|||
33339347|NCT00874120|62716041|FG000|Second Intervention|Protocol Violation|1|||
33339348|NCT00874120|62716042|FG001|Second Intervention|Protocol Violation|0|||
33339349|NCT00939822|62716050|FG000|Overall Study|Lost to Follow-up|1|||
33339350|NCT00939822|62716051|FG001|Overall Study|Lost to Follow-up|0|||
33339351|NCT00939822|62716050|FG000|Overall Study|withdrew from study due to busy schedule|1|||
33339352|NCT00939822|62716051|FG001|Overall Study|withdrew from study due to busy schedule|1|||
33339353|NCT00939822|62716050|FG000|Overall Study|Mental health issues|0|||
33339354|NCT00939822|62716051|FG001|Overall Study|Mental health issues|2|||
33339355|NCT00939510|62716057|FG000|Overall Study|Withdrawal by Subject|1|||
33339356|NCT01098266|62716063|FG000|Overall Study|Physician Decision|1|||
33339357|NCT01098266|62716064|FG001|Overall Study|Physician Decision|0|||
33339358|NCT01098266|62716063|FG000|Overall Study|Death|3|||
33339359|NCT01098266|62716064|FG001|Overall Study|Death|2|||
33339360|NCT01098266|62716063|FG000|Overall Study|Withdrawal by Subject|3|||
33339361|NCT01098266|62716064|FG001|Overall Study|Withdrawal by Subject|5|||
33339362|NCT00935532|62716072|FG000|Overall Study|Adverse Event|11|||
33339363|NCT00935532|62716073|FG001|Overall Study|Adverse Event|6|||
33339364|NCT00935532|62716072|FG000|Overall Study|Death|1|||
33339365|NCT00935532|62716073|FG001|Overall Study|Death|0|||
33339366|NCT00935532|62716072|FG000|Overall Study|Lost to Follow-up|1|||
33339367|NCT00935532|62716073|FG001|Overall Study|Lost to Follow-up|0|||
33339368|NCT00935532|62716072|FG000|Overall Study|Physician Decision|1|||
33339369|NCT00935532|62716073|FG001|Overall Study|Physician Decision|2|||
33339370|NCT00935532|62716072|FG000|Overall Study|Protocol Violation|2|||
33548842|NCT01103349|62940222|FG002|Overall Study|Withdrawal by Subject|0|||
33548843|NCT01103349|62940220|FG000|Overall Study|did not want to take trial medication|0|||
33654419|NCT01709318|63067158|FG004|Overall Study|Withdrawal by Subject|0|||
33339371|NCT00935532|62716073|FG001|Overall Study|Protocol Violation|1|||
33339372|NCT00935532|62716072|FG000|Overall Study|Subject Decision|2|||
33339373|NCT00935532|62716073|FG001|Overall Study|Subject Decision|1|||
33339374|NCT00935532|62716072|FG000|Overall Study|Sponsor Decision|0|||
33339375|NCT00935532|62716073|FG001|Overall Study|Sponsor Decision|1|||
33339376|NCT00935532|62716072|FG000|Overall Study|Loss Glucose Control|4|||
33339377|NCT00935532|62716073|FG001|Overall Study|Loss Glucose Control|0|||
33339378|NCT01093586|62716079|FG000|Overall Study|Failed to engraft|3|||
33339379|NCT00937404|62716083|FG000|Overall Study|Protocol Violation|1|||
33339380|NCT00937404|62716083|FG000|Overall Study|Withdrawal by Subject|1|||
33339381|NCT01098110|62716090|FG000|Overall Study|Withdrawal by Subject|14|||
33339382|NCT01098110|62716091|FG001|Overall Study|Withdrawal by Subject|24|||
33339383|NCT01098110|62716092|FG002|Overall Study|Withdrawal by Subject|19|||
33339384|NCT01098110|62716090|FG000|Overall Study|Adverse Event|30|||
33339385|NCT01098110|62716091|FG001|Overall Study|Adverse Event|32|||
33339386|NCT01098110|62716092|FG002|Overall Study|Adverse Event|43|||
33339387|NCT01098110|62716090|FG000|Overall Study|Lack of Efficacy|13|||
33339388|NCT01098110|62716091|FG001|Overall Study|Lack of Efficacy|9|||
33339389|NCT01098110|62716092|FG002|Overall Study|Lack of Efficacy|27|||
33339390|NCT01098110|62716090|FG000|Overall Study|Other|4|||
33339391|NCT01098110|62716091|FG001|Overall Study|Other|7|||
33339392|NCT01098110|62716092|FG002|Overall Study|Other|5|||
33339393|NCT01098110|62716090|FG000|Overall Study|Untreated|1|||
33339394|NCT01098110|62716091|FG001|Overall Study|Untreated|1|||
33339395|NCT01098110|62716092|FG002|Overall Study|Untreated|0|||
33339396|NCT01092728|62716102|FG000|Overall Study|Withdrawal by Subject|2|||
33339397|NCT01092728|62716103|FG001|Overall Study|Withdrawal by Subject|0|||
33339398|NCT01092728|62716102|FG000|Overall Study|Adverse Event|0|||
33339399|NCT01092728|62716103|FG001|Overall Study|Adverse Event|1|||
33339400|NCT01092728|62716102|FG000|Overall Study|Disease Progression|1|||
33339401|NCT01092728|62716103|FG001|Overall Study|Disease Progression|13|||
33339402|NCT01092728|62716102|FG000|Overall Study|Prohibited Concomitant Medications|1|||
33339403|NCT01092728|62716103|FG001|Overall Study|Prohibited Concomitant Medications|0|||
33339404|NCT01096550|62716111|FG000|Overall Study|discontinued site|10|||
33339405|NCT01096550|62716112|FG001|Overall Study|discontinued site|11|||
33339406|NCT01096550|62716111|FG000|Overall Study|non-regular treatment track at clinic|1|||
33339407|NCT01096550|62716112|FG001|Overall Study|non-regular treatment track at clinic|1|||
33339408|NCT01096550|62716111|FG000|Overall Study|clinic readmission|1|||
33339409|NCT01096550|62716112|FG001|Overall Study|clinic readmission|1|||
33339410|NCT01096550|62716111|FG000|Overall Study|Withdrawal by Subject|0|||
33339411|NCT01096550|62716112|FG001|Overall Study|Withdrawal by Subject|1|||
33339412|NCT01096550|62716111|FG000|Overall Study|non-African American participant|13|||
33339413|NCT01096550|62716112|FG001|Overall Study|non-African American participant|6|||
33339414|NCT01096550|62716111|FG000|Overall Study|Lost to Follow-up|12|||
33339415|NCT01096550|62716112|FG001|Overall Study|Lost to Follow-up|9|||
33339416|NCT01101542|62716118|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
33339417|NCT01101542|62716118|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
33339418|NCT01101542|62716118|FG000|Year 4 Surveillance Period|Other|287|||
33339419|NCT01101542|62716118|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
33339420|NCT01101542|62716118|FG000|Year 5 Surveillance Period|Pregnancy|1|||
33339421|NCT01101542|62716118|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
33339422|NCT01101542|62716118|FG000|Year 6 Surveillance Period|Pregnancy|1|||
33339423|NCT01101542|62716118|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
33339424|NCT00937326|62716127|FG000|Overall Study|Adverse Event|0|||
33339425|NCT00937326|62716128|FG001|Overall Study|Adverse Event|3|||
33339426|NCT00937326|62716129|FG002|Overall Study|Adverse Event|1|||
33339427|NCT00937326|62716130|FG003|Overall Study|Adverse Event|1|||
33339428|NCT00937326|62716131|FG004|Overall Study|Adverse Event|2|||
33339429|NCT00937326|62716127|FG000|Overall Study|Death|0|||
33339430|NCT00937326|62716128|FG001|Overall Study|Death|0|||
33339431|NCT00937326|62716129|FG002|Overall Study|Death|1|||
33339432|NCT00937326|62716130|FG003|Overall Study|Death|0|||
33339433|NCT00937326|62716131|FG004|Overall Study|Death|0|||
33339434|NCT00937326|62716127|FG000|Overall Study|Withdrawal by Subject|3|||
33339435|NCT00937326|62716128|FG001|Overall Study|Withdrawal by Subject|4|||
33339436|NCT00937326|62716129|FG002|Overall Study|Withdrawal by Subject|1|||
33339437|NCT00937326|62716130|FG003|Overall Study|Withdrawal by Subject|4|||
33339438|NCT00937326|62716131|FG004|Overall Study|Withdrawal by Subject|3|||
33339439|NCT00937326|62716127|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
33339440|NCT00937326|62716128|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
33339441|NCT00937326|62716129|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
33339442|NCT00937326|62716130|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
33339443|NCT00937326|62716131|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
33339444|NCT00873730|62716150|FG000|Overall Study|Protocol Deviation|5|||
33339445|NCT00873730|62716151|FG001|Overall Study|Protocol Deviation|2|||
33339446|NCT00873730|62716150|FG000|Overall Study|Adverse Event|0|||
33339447|NCT00873730|62716151|FG001|Overall Study|Adverse Event|2|||
33339448|NCT00873730|62716150|FG000|Overall Study|Withdrawal by Subject|0|||
33339449|NCT00873730|62716151|FG001|Overall Study|Withdrawal by Subject|1|||
33339450|NCT00873730|62716150|FG000|Overall Study|Sponsor decision|1|||
33339451|NCT00873730|62716151|FG001|Overall Study|Sponsor decision|0|||
33339452|NCT00874432|62716161|FG000|Overall Study|Withdrawal by Subject|1|||
33339453|NCT00874432|62716162|FG001|Overall Study|Withdrawal by Subject|0|||
33339454|NCT00874432|62716163|FG002|Overall Study|Withdrawal by Subject|0|||
33339455|NCT00874432|62716164|FG003|Overall Study|Withdrawal by Subject|0|||
33339456|NCT00874432|62716161|FG000|Overall Study|Physician Decision|1|||
33339457|NCT00874432|62716162|FG001|Overall Study|Physician Decision|0|||
33339458|NCT00874432|62716163|FG002|Overall Study|Physician Decision|0|||
33339459|NCT00874432|62716164|FG003|Overall Study|Physician Decision|0|||
33339460|NCT00874432|62716161|FG000|Overall Study|Other|1|||
33339461|NCT00874432|62716162|FG001|Overall Study|Other|2|||
33339462|NCT00874432|62716163|FG002|Overall Study|Other|8|||
33339463|NCT00874432|62716164|FG003|Overall Study|Other|3|||
33339464|NCT00935220|62716176|FG000|Overall Study|Adverse Event|1|||
33339465|NCT00935220|62716176|FG000|Overall Study|Other reason (not specified)|1|||
33339466|NCT00874276|62716182|FG000|Overall Study|Withdrawal by Subject|1|||
33339467|NCT00874276|62716183|FG001|Overall Study|Withdrawal by Subject|1|||
33339468|NCT00594958|62716194|FG000|Overall Study|Withdrawal by Subject|1|||
33339469|NCT00594958|62716195|FG001|Overall Study|Withdrawal by Subject|0|||
33339470|NCT00594958|62716196|FG002|Overall Study|Withdrawal by Subject|1|||
33339471|NCT00594958|62716194|FG000|Overall Study|Adverse Event|4|||
33339472|NCT00594958|62716195|FG001|Overall Study|Adverse Event|1|||
33339473|NCT00594958|62716196|FG002|Overall Study|Adverse Event|2|||
33339474|NCT00594958|62716194|FG000|Overall Study|Pregnancy|0|||
33339475|NCT00594958|62716195|FG001|Overall Study|Pregnancy|2|||
33339476|NCT00594958|62716196|FG002|Overall Study|Pregnancy|0|||
33339477|NCT00594958|62716194|FG000|Overall Study|Protocol Violation|1|||
33339478|NCT00594958|62716195|FG001|Overall Study|Protocol Violation|0|||
33339479|NCT00594958|62716196|FG002|Overall Study|Protocol Violation|2|||
33339480|NCT00594958|62716194|FG000|Overall Study|Lost to Follow-up|5|||
33339481|NCT00594958|62716195|FG001|Overall Study|Lost to Follow-up|0|||
33339482|NCT00594958|62716196|FG002|Overall Study|Lost to Follow-up|3|||
33339483|NCT00594958|62716194|FG000|Overall Study|administrative|3|||
33339484|NCT00594958|62716195|FG001|Overall Study|administrative|0|||
33339485|NCT00594958|62716196|FG002|Overall Study|administrative|2|||
33339486|NCT00594880|62716206|FG000|Overall Study|Withdrawal by Subject|1|||
33339487|NCT00594880|62716207|FG001|Overall Study|Withdrawal by Subject|1|||
33339488|NCT00594880|62716206|FG000|Overall Study|Lost to Follow-up|1|||
33339489|NCT00594880|62716207|FG001|Overall Study|Lost to Follow-up|0|||
33339490|NCT00871858|62716219|FG000|Overall Study|Protocol Violation|3|||
33339491|NCT00871858|62716220|FG001|Overall Study|Protocol Violation|4|||
33339492|NCT00871858|62716219|FG000|Overall Study|Adverse Event|1|||
33339493|NCT00871858|62716220|FG001|Overall Study|Adverse Event|1|||
33339494|NCT00871858|62716219|FG000|Overall Study|Withdrawal by Subject|1|||
33339495|NCT00871858|62716220|FG001|Overall Study|Withdrawal by Subject|1|||
33339496|NCT00871858|62716219|FG000|Overall Study|Lost to Follow-up|0|||
33339497|NCT00871858|62716220|FG001|Overall Study|Lost to Follow-up|1|||
33339498|NCT00871780|62716226|FG000|Overall Study|Enrolled But Not Treated|6|||
33339499|NCT00871780|62716226|FG000|Overall Study|Withdrawal by Subject|9|||
33339500|NCT00871780|62716226|FG000|Overall Study|Adverse Event|6|||
33339501|NCT00871780|62716226|FG000|Overall Study|Voluntary Discontinuation|4|||
33339502|NCT00871780|62716226|FG000|Overall Study|Death|1|||
33339503|NCT00871780|62716226|FG000|Overall Study|Physician Decision|1|||
33339504|NCT00594178|62716233|FG000|Overall Study|Physician Decision|5|||
33339505|NCT00933270|62716237|FG000|Overall Study|Withdrawal by Subject|26|||
33339506|NCT00933270|62716237|FG000|Overall Study|Insufficient Follow-up|10|||
33339507|NCT00933270|62716237|FG000|Overall Study|Lost to Follow-up|14|||
33339508|NCT00933270|62716237|FG000|Overall Study|Adverse Event|1|||
33339509|NCT00933270|62716237|FG000|Overall Study|Missed Visit|2|||
33339510|NCT00933270|62716237|FG000|Overall Study|Death|24|||
33339511|NCT00933270|62716237|FG000|Overall Study|Moved or would not return|10|||
33339512|NCT00936858|62716242|FG000|Overall Study|Death|3|||
33339513|NCT00936858|62716242|FG000|Overall Study|Progression|29|||
33339514|NCT00936858|62716242|FG000|Overall Study|Withdrawal by Subject|5|||
33339515|NCT00936858|62716242|FG000|Overall Study|Adverse Event|1|||
33339516|NCT00936858|62716242|FG000|Overall Study|Physician Decision|7|||
33339517|NCT00936858|62716242|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
33339518|NCT00936858|62716242|FG000|Overall Study|Lost to Follow-up|1|||
33339519|NCT00872170|62716249|FG000|Overall Study|Adverse Event|1|||
33339520|NCT00872170|62716250|FG001|Overall Study|Adverse Event|0|||
33339521|NCT00936702|62716255|FG000|Overall Study|Disease progression|34|||
33339522|NCT00936702|62716255|FG000|Overall Study|Adverse Event|8|||
33339523|NCT00936702|62716255|FG000|Overall Study|Withdrawal by Subject|2|||
33339524|NCT00936702|62716255|FG000|Overall Study|Alternative Treatment|1|||
33548844|NCT01103349|62940221|FG001|Overall Study|did not want to take trial medication|1|||
33339525|NCT00936702|62716255|FG000|Overall Study|Other|1|||
33339526|NCT00594100|62716259|FG000|Procedure|Technical Failure|9|||
33339527|NCT00594100|62716259|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
33339528|NCT00594100|62716259|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
33339529|NCT00594100|62716259|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
33339530|NCT01092182|62716266|FG000|Overall Study|Death|0|||
33339531|NCT01092182|62716267|FG001|Overall Study|Death|5|||
33469807|NCT00281957|62843549|FG001|Overall Study|Progression/relapse|35|||
33339532|NCT01092182|62716268|FG002|Overall Study|Death|3|||
33339533|NCT01092182|62716266|FG000|Overall Study|participant safety|1|||
33339534|NCT01092182|62716267|FG001|Overall Study|participant safety|2|||
33339535|NCT01092182|62716268|FG002|Overall Study|participant safety|0|||
33339536|NCT01092182|62716266|FG000|Overall Study|Physician Decision|0|||
33339537|NCT01092182|62716267|FG001|Overall Study|Physician Decision|6|||
33469808|NCT00281957|62843548|FG000|Overall Study|Not protocol specified|8|||
33339538|NCT01092182|62716268|FG002|Overall Study|Physician Decision|0|||
33339539|NCT01092182|62716266|FG000|Overall Study|Did not meet criteria|0|||
33339540|NCT01092182|62716267|FG001|Overall Study|Did not meet criteria|0|||
33339541|NCT01092182|62716268|FG002|Overall Study|Did not meet criteria|25|||
33339542|NCT01092182|62716266|FG000|Overall Study|Non-compliance|0|||
33339543|NCT01092182|62716267|FG001|Overall Study|Non-compliance|3|||
33339544|NCT01092182|62716268|FG002|Overall Study|Non-compliance|0|||
33339545|NCT01092182|62716266|FG000|Overall Study|Participant refused follow-up|0|||
33339546|NCT01092182|62716267|FG001|Overall Study|Participant refused follow-up|2|||
33339547|NCT01092182|62716268|FG002|Overall Study|Participant refused follow-up|0|||
33339548|NCT00932646|62716276|FG000|Overall Study|Adverse Event|2|||
33339549|NCT00932646|62716277|FG001|Overall Study|Adverse Event|1|||
33339550|NCT00932646|62716278|FG002|Overall Study|Adverse Event|1|||
33339551|NCT00932646|62716279|FG003|Overall Study|Adverse Event|1|||
33339552|NCT00932646|62716276|FG000|Overall Study|Lost to Follow-up|2|||
33339553|NCT00932646|62716277|FG001|Overall Study|Lost to Follow-up|1|||
33339554|NCT00932646|62716278|FG002|Overall Study|Lost to Follow-up|0|||
33339555|NCT00932646|62716279|FG003|Overall Study|Lost to Follow-up|0|||
33339556|NCT00932646|62716276|FG000|Overall Study|Withdrawal by Subject|1|||
33339557|NCT00932646|62716277|FG001|Overall Study|Withdrawal by Subject|1|||
33339558|NCT00932646|62716278|FG002|Overall Study|Withdrawal by Subject|3|||
33339559|NCT00932646|62716279|FG003|Overall Study|Withdrawal by Subject|0|||
33339560|NCT00871234|62716293|FG000|Overall Study|Adverse Event|2|||
33339561|NCT00871234|62716293|FG000|Overall Study|Lost to Follow-up|3|||
33339562|NCT01091246|62716300|FG000|Overall Study|Lost to Follow-up|23|||
33339563|NCT01091246|62716301|FG001|Overall Study|Lost to Follow-up|11|||
33339564|NCT01091246|62716302|FG002|Overall Study|Lost to Follow-up|7|||
33339565|NCT01091246|62716300|FG000|Overall Study|Adverse Event|1|||
33339566|NCT01091246|62716301|FG001|Overall Study|Adverse Event|0|||
33339567|NCT01091246|62716302|FG002|Overall Study|Adverse Event|1|||
33339568|NCT01091246|62716300|FG000|Overall Study|Withdrawal by Subject|9|||
33339569|NCT01091246|62716301|FG001|Overall Study|Withdrawal by Subject|5|||
33339570|NCT01091246|62716302|FG002|Overall Study|Withdrawal by Subject|4|||
33339571|NCT01091246|62716300|FG000|Overall Study|Subject not dosed|2|||
33339572|NCT01091246|62716301|FG001|Overall Study|Subject not dosed|0|||
33339573|NCT01091246|62716302|FG002|Overall Study|Subject not dosed|1|||
33339574|NCT01097330|62716314|FG000|Overall Study|Study terminated early|7|||
33339575|NCT01097330|62716315|FG001|Overall Study|Study terminated early|5|||
33469809|NCT00281957|62843549|FG001|Overall Study|Not protocol specified|1|||
33469810|NCT00281957|62843548|FG000|Overall Study|Not eligible|1|||
33469811|NCT00281957|62843549|FG001|Overall Study|Not eligible|2|||
33469812|NCT00281957|62843548|FG000|Overall Study|Did not start treatment|3|||
33469813|NCT00281957|62843549|FG001|Overall Study|Did not start treatment|1|||
33469814|NCT00281957|62843548|FG000|Overall Study|Refusal unrelated to adverse events|0|||
33469815|NCT00281957|62843549|FG001|Overall Study|Refusal unrelated to adverse events|1|||
33469816|NCT00281099|62843559|FG000|Overall Study|Death|46|||
33469817|NCT00281099|62843560|FG001|Overall Study|Death|57|||
33469818|NCT00281099|62843559|FG000|Overall Study|Lost to Follow-up|10|||
33469819|NCT00281099|62843560|FG001|Overall Study|Lost to Follow-up|19|||
33469820|NCT00281099|62843559|FG000|Overall Study|Withdrawal by Subject|65|||
33469821|NCT00281099|62843560|FG001|Overall Study|Withdrawal by Subject|70|||
33469822|NCT00281099|62843559|FG000|Overall Study|Physician Decision|79|||
33469823|NCT00281099|62843560|FG001|Overall Study|Physician Decision|72|||
33469824|NCT00281099|62843559|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
33469825|NCT00281099|62843560|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
33469826|NCT00262925|62843567|FG000|Overall Study|Lack of Efficacy|3|||
33469827|NCT00262925|62843567|FG000|Overall Study|Adverse Event|4|||
33654420|NCT01709318|63067159|FG005|Overall Study|Withdrawal by Subject|2|||
33654421|NCT01709318|63067160|FG006|Overall Study|Withdrawal by Subject|4|||
33654422|NCT01709318|63067154|FG000|Overall Study|Other Protocol Specified Criteria|0|||
33654423|NCT01709318|63067155|FG001|Overall Study|Other Protocol Specified Criteria|1|||
33654424|NCT01709318|63067156|FG002|Overall Study|Other Protocol Specified Criteria|0|||
33339576|NCT00934440|62716321|FG000|Overall Study|Lost to Follow-up|1|||
33339577|NCT00934362|62716328|FG000|Overall Study|Adverse Event|1|||
33339578|NCT00934362|62716329|FG001|Overall Study|Adverse Event|0|||
33339579|NCT00934128|62716337|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
33339580|NCT00934128|62716338|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
33339581|NCT00934128|62716337|FG000|First Intervention (2 Hours)|Adverse Event|4|||
33339582|NCT00934128|62716338|FG001|First Intervention (2 Hours)|Adverse Event|1|||
33339583|NCT00934128|62716337|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
33469828|NCT00262925|62843567|FG000|Overall Study|Death|2|||
33469829|NCT00262925|62843567|FG000|Overall Study|alternative therapy|1|||
33469830|NCT00262925|62843567|FG000|Overall Study|Other|1|||
33580905|NCT01454934|62978058|FG001|Overall Study|Other|17|||
33580906|NCT01454934|62978057|FG000|Overall Study|Adverse Event|28|||
33339584|NCT00934128|62716338|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
33339585|NCT00934128|62716337|FG000|Washout Period (1 Hour)|Patient preference|1|||
33339586|NCT00934128|62716338|FG001|Washout Period (1 Hour)|Patient preference|3|||
33339587|NCT00934128|62716337|FG000|Washout Period (1 Hour)|Pain|1|||
33339588|NCT00934128|62716338|FG001|Washout Period (1 Hour)|Pain|0|||
33339589|NCT00934128|62716337|FG000|Washout Period (1 Hour)|Too tired|1|||
33339590|NCT00934128|62716338|FG001|Washout Period (1 Hour)|Too tired|0|||
33339591|NCT00934128|62716337|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
33339592|NCT00934128|62716338|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
33339593|NCT00934128|62716337|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
33339594|NCT00934128|62716338|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
33339595|NCT00871000|62716346|FG000|Overall Study|Withdrawal by Subject|1|||
33339596|NCT00871000|62716347|FG001|Overall Study|Withdrawal by Subject|0|||
33339597|NCT01096784|62716355|FG000|Overall Study|Withdrawal by Subject|2|||
33339598|NCT01096784|62716356|FG001|Overall Study|Withdrawal by Subject|1|||
33339599|NCT01096784|62716355|FG000|Overall Study|Adverse Event|11|||
33339600|NCT01096784|62716356|FG001|Overall Study|Adverse Event|9|||
33339601|NCT01096784|62716355|FG000|Overall Study|Protocol Deviation|2|||
33339602|NCT01096784|62716356|FG001|Overall Study|Protocol Deviation|2|||
33339603|NCT01096784|62716355|FG000|Overall Study|Administrative Decision|0|||
33339604|NCT01096784|62716356|FG001|Overall Study|Administrative Decision|1|||
33339605|NCT01096784|62716355|FG000|Overall Study|Other Unspecified|0|||
33339606|NCT01096784|62716356|FG001|Overall Study|Other Unspecified|1|||
33339607|NCT00934050|62716370|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
33339608|NCT00934050|62716371|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
33339609|NCT00934050|62716372|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
33339610|NCT00934050|62716373|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
33339611|NCT00934050|62716374|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
33339612|NCT00934050|62716375|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
33339613|NCT00934050|62716370|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
33339614|NCT00934050|62716371|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
33339615|NCT00934050|62716372|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
33339616|NCT00934050|62716373|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
33339617|NCT00934050|62716374|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
33339618|NCT00934050|62716375|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
33339619|NCT00934050|62716370|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
33339620|NCT00934050|62716371|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
33339621|NCT00934050|62716372|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
33339622|NCT00934050|62716373|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
33339623|NCT00934050|62716374|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
33339624|NCT00934050|62716375|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
33339625|NCT00934050|62716370|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
33339626|NCT00934050|62716371|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
33339627|NCT00934050|62716372|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
33339628|NCT00934050|62716373|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
33339629|NCT00934050|62716374|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
33339630|NCT00934050|62716375|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
33339631|NCT00934050|62716370|FG000|Enrolled After 15 Dec 2009|Death|0|||
33339632|NCT00934050|62716371|FG001|Enrolled After 15 Dec 2009|Death|0|||
33339633|NCT00934050|62716372|FG002|Enrolled After 15 Dec 2009|Death|0|||
33339634|NCT00934050|62716373|FG003|Enrolled After 15 Dec 2009|Death|0|||
33339635|NCT00934050|62716374|FG004|Enrolled After 15 Dec 2009|Death|0|||
33339636|NCT00934050|62716375|FG005|Enrolled After 15 Dec 2009|Death|1|||
33339637|NCT00934050|62716370|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
33339638|NCT00934050|62716371|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
33339639|NCT00934050|62716372|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
33339640|NCT00934050|62716373|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
33339641|NCT00934050|62716374|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
33339642|NCT00934050|62716375|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
33339643|NCT00934050|62716370|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
33339644|NCT00934050|62716371|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
33339645|NCT00934050|62716372|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
33654425|NCT01709318|63067157|FG003|Overall Study|Other Protocol Specified Criteria|0|||
33339646|NCT00934050|62716373|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
33339647|NCT00934050|62716374|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
33339648|NCT00934050|62716375|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
33339649|NCT01091168|62716387|FG000|Overall Study|Progressive disease|250|||
33339650|NCT01091168|62716388|FG001|Overall Study|Progressive disease|234|||
33339651|NCT01091168|62716387|FG000|Overall Study|Adverse Event|21|||
33339652|NCT01091168|62716388|FG001|Overall Study|Adverse Event|24|||
33339653|NCT01091168|62716387|FG000|Overall Study|Lost to Follow-up|0|||
33339654|NCT01091168|62716388|FG001|Overall Study|Lost to Follow-up|1|||
33339655|NCT01091168|62716387|FG000|Overall Study|Physician, patient's decision, other|27|||
33339656|NCT01091168|62716388|FG001|Overall Study|Physician, patient's decision, other|37|||
33339657|NCT00864916|62716396|FG000|Overall Study|Lost to Follow-up|4|||
33339658|NCT00864916|62716397|FG001|Overall Study|Lost to Follow-up|4|||
33339659|NCT00864916|62716396|FG000|Overall Study|Protocol Violation|1|||
33339660|NCT00864916|62716397|FG001|Overall Study|Protocol Violation|0|||
33339661|NCT00864916|62716396|FG000|Overall Study|Withdrawal by Subject|1|||
33339662|NCT00864916|62716397|FG001|Overall Study|Withdrawal by Subject|0|||
33339663|NCT00864682|62716406|FG000|Overall Study|Protocol Violation|2|||
33339664|NCT00864682|62716407|FG001|Overall Study|Protocol Violation|1|||
33339665|NCT00864682|62716408|FG002|Overall Study|Protocol Violation|2|||
33339666|NCT00931944|62716416|FG000|Overall Study|Adverse Event|4|||
33339667|NCT00931944|62716416|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
33339668|NCT00931944|62716416|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
33339669|NCT00931944|62716416|FG000|Overall Study|Death|28|||
33339670|NCT00931944|62716416|FG000|Overall Study|Other|2|||
33339671|NCT00929994|62716420|FG000|Overall Study|Withdrawal by Subject|1|||
33339672|NCT00929994|62716420|FG000|Overall Study|medical issue unrelated to intervention|4|||
33339673|NCT00929994|62716420|FG000|Overall Study|employment|1|||
33339674|NCT01090310|62716431|FG000|Core Study|Adverse Event|2|||
33339675|NCT01090310|62716432|FG001|Core Study|Adverse Event|2|||
33339676|NCT01090310|62716433|FG002|Core Study|Adverse Event|1|||
33339677|NCT01090310|62716434|FG003|Core Study|Adverse Event|1|||
33339678|NCT01090310|62716431|FG000|Core Study|Subject withdrew consent|0|||
33339679|NCT01090310|62716432|FG001|Core Study|Subject withdrew consent|3|||
33339680|NCT01090310|62716433|FG002|Core Study|Subject withdrew consent|1|||
33339681|NCT01090310|62716434|FG003|Core Study|Subject withdrew consent|1|||
33339682|NCT01090310|62716431|FG000|Core Study|Abnormal test procedure result|0|||
33339683|NCT01090310|62716432|FG001|Core Study|Abnormal test procedure result|0|||
33339684|NCT01090310|62716433|FG002|Core Study|Abnormal test procedure result|1|||
33469831|NCT03720470|62843577|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
33469832|NCT03720470|62843578|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
33469833|NCT03720470|62843579|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
33469834|NCT03720470|62843580|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
33469835|NCT03720470|62843581|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
33469836|NCT03720470|62843582|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
33469837|NCT03720470|62843577|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
33469838|NCT03720470|62843578|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
33469839|NCT03720470|62843579|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
33469840|NCT03720470|62843580|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
33469841|NCT03720470|62843581|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
33469842|NCT03720470|62843582|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
33469843|NCT03720470|62843577|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
33469844|NCT03720470|62843578|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
33469845|NCT03720470|62843579|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
33469846|NCT03720470|62843580|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
33469847|NCT03720470|62843581|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
33469848|NCT03720470|62843582|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
33469849|NCT03720470|62843577|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
33469850|NCT03720470|62843578|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
33469851|NCT03720470|62843579|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
33469852|NCT03720470|62843580|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
33469853|NCT03720470|62843581|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
33469854|NCT03720470|62843582|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
33469855|NCT03720470|62843577|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
33469856|NCT03720470|62843578|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
33469857|NCT03720470|62843579|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
33469858|NCT03720470|62843580|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
33469859|NCT03720470|62843581|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
33469860|NCT03720470|62843582|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
33469861|NCT03720470|62843577|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
33469862|NCT03720470|62843578|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
33469863|NCT03720470|62843579|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
33469864|NCT03720470|62843580|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
33339685|NCT01090310|62716434|FG003|Core Study|Abnormal test procedure result|0|||
33339686|NCT01090310|62716431|FG000|Core Study|Administrative reasons|5|||
33339687|NCT01090310|62716432|FG001|Core Study|Administrative reasons|6|||
33339688|NCT01090310|62716433|FG002|Core Study|Administrative reasons|4|||
33339689|NCT01090310|62716434|FG003|Core Study|Administrative reasons|4|||
33339690|NCT01090310|62716431|FG000|Core Study|Protocol deviation|1|||
33339691|NCT01090310|62716432|FG001|Core Study|Protocol deviation|0|||
33339692|NCT01090310|62716433|FG002|Core Study|Protocol deviation|0|||
33339693|NCT01090310|62716434|FG003|Core Study|Protocol deviation|1|||
33339694|NCT01090310|62716431|FG000|Extension Study|Aministrative problems|13|||
33339695|NCT01090310|62716432|FG001|Extension Study|Aministrative problems|15|||
33339696|NCT01090310|62716433|FG002|Extension Study|Aministrative problems|14|||
33339697|NCT01090310|62716434|FG003|Extension Study|Aministrative problems|18|||
33339698|NCT01090310|62716431|FG000|Extension Study|Adverse Event|0|||
33339699|NCT01090310|62716432|FG001|Extension Study|Adverse Event|0|||
33339700|NCT01090310|62716433|FG002|Extension Study|Adverse Event|0|||
33339701|NCT01090310|62716434|FG003|Extension Study|Adverse Event|1|||
33339702|NCT01090310|62716431|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
33339703|NCT01090310|62716432|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
33339704|NCT01090310|62716433|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
33339705|NCT01090310|62716434|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
33339706|NCT01090310|62716431|FG000|Extension Study|Subject withdrew consent|0|||
33339707|NCT01090310|62716432|FG001|Extension Study|Subject withdrew consent|1|||
33339708|NCT01090310|62716433|FG002|Extension Study|Subject withdrew consent|0|||
33339709|NCT01090310|62716434|FG003|Extension Study|Subject withdrew consent|0|||
33339710|NCT01090076|62716446|FG000|Overall Study|Death|1|||
33339711|NCT01090076|62716447|FG001|Overall Study|Death|1|||
33339712|NCT01090076|62716446|FG000|Overall Study|Withdrawal by Subject|0|||
33339713|NCT01090076|62716447|FG001|Overall Study|Withdrawal by Subject|1|||
33339714|NCT00869050|62716455|FG000|Overall Study|Screen Failure|3|||
33339715|NCT00927186|62716461|FG000|12 Months Primary Study|Adverse Event|5|||
33339716|NCT00927186|62716462|FG001|12 Months Primary Study|Adverse Event|2|||
33339717|NCT00927186|62716461|FG000|12 Months Primary Study|Lost to Follow-up|1|||
33339718|NCT00927186|62716462|FG001|12 Months Primary Study|Lost to Follow-up|0|||
33339719|NCT00927186|62716461|FG000|12 Months Primary Study|Protocol Violation|0|||
33339720|NCT00927186|62716462|FG001|12 Months Primary Study|Protocol Violation|1|||
33339721|NCT00927186|62716461|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
33339722|NCT00927186|62716462|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
33339723|NCT00593554|62716473|FG000|Overall Study|Death|1|||
33339724|NCT00593554|62716474|FG001|Overall Study|Death|2|||
33339725|NCT00593554|62716473|FG000|Overall Study|Physician Decision|0|||
33339726|NCT00593554|62716474|FG001|Overall Study|Physician Decision|1|||
33339727|NCT00593554|62716473|FG000|Overall Study|Withdrawal by Subject|1|||
33339728|NCT00593554|62716474|FG001|Overall Study|Withdrawal by Subject|0|||
33339729|NCT00593554|62716473|FG000|Overall Study|Disease Progression|1|||
33339730|NCT00593554|62716474|FG001|Overall Study|Disease Progression|2|||
33339731|NCT01101308|62716480|FG000|Period 1|Adverse Event|2|||
33339732|NCT01101308|62716481|FG001|Period 1|Adverse Event|1|||
33339733|NCT01101308|62716480|FG000|Period 1|Positive for cotinine|1|||
33339734|NCT01101308|62716481|FG001|Period 1|Positive for cotinine|0|||
33339735|NCT00926796|62716490|FG000|Overall Study|Did not receive randomized treatment|4|||
33339736|NCT00926796|62716491|FG001|Overall Study|Did not receive randomized treatment|7|||
33339737|NCT00926796|62716490|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
33339738|NCT00926796|62716491|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
33339739|NCT00926796|62716490|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
33339740|NCT00926796|62716491|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
33339741|NCT00926796|62716490|FG000|Overall Study|Adverse Event|7|||
33339742|NCT00926796|62716491|FG001|Overall Study|Adverse Event|14|||
33339743|NCT00926796|62716490|FG000|Overall Study|Lost to Follow-up|22|||
33339744|NCT00926796|62716491|FG001|Overall Study|Lost to Follow-up|13|||
33339745|NCT00926796|62716490|FG000|Overall Study|Protocol Violation|15|||
33339746|NCT00926796|62716491|FG001|Overall Study|Protocol Violation|11|||
33339747|NCT00926796|62716490|FG000|Overall Study|Withdrawal by Subject|1|||
33339748|NCT00926796|62716491|FG001|Overall Study|Withdrawal by Subject|0|||
33339749|NCT01087736|62716501|FG000|Overall Study|Lost to Follow-up|1|||
33339750|NCT01087736|62716502|FG001|Overall Study|Lost to Follow-up|0|||
33339751|NCT01087736|62716501|FG000|Overall Study|Death|0|||
33339752|NCT01087736|62716502|FG001|Overall Study|Death|1|||
33339753|NCT01087736|62716501|FG000|Overall Study|Withdrawal by Subject|0|||
33339754|NCT01087736|62716502|FG001|Overall Study|Withdrawal by Subject|1|||
33339755|NCT01079936|62716512|FG000|Phase I: MTD|First Remission Status|2|||
33548845|NCT01103349|62940222|FG002|Overall Study|did not want to take trial medication|0|||
33339756|NCT01079936|62716513|FG001|Phase I: MTD|First Remission Status|0|||
33339757|NCT01079936|62716514|FG002|Phase I: MTD|First Remission Status|0|||
33339758|NCT01079936|62716515|FG003|Phase I: MTD|First Remission Status|0|||
33339759|NCT01079936|62716516|FG004|Phase I: MTD|First Remission Status|0|||
33339760|NCT01079936|62716512|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
33339761|NCT01079936|62716513|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
33339762|NCT01079936|62716514|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
33339763|NCT01079936|62716515|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
33339764|NCT01079936|62716516|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
33339765|NCT01079936|62716512|FG000|Phase II|Adverse Event|0|||
33339766|NCT01079936|62716513|FG001|Phase II|Adverse Event|0|||
33339767|NCT01079936|62716514|FG002|Phase II|Adverse Event|1|||
33339768|NCT01079936|62716515|FG003|Phase II|Adverse Event|0|||
33339769|NCT01079936|62716516|FG004|Phase II|Adverse Event|0|||
33339770|NCT01079936|62716512|FG000|Phase II|Insurance Issue|0|||
33339771|NCT01079936|62716513|FG001|Phase II|Insurance Issue|0|||
33339772|NCT01079936|62716514|FG002|Phase II|Insurance Issue|0|||
33339773|NCT01079936|62716515|FG003|Phase II|Insurance Issue|0|||
33339774|NCT01079936|62716516|FG004|Phase II|Insurance Issue|1|||
33339775|NCT00931710|62716529|FG000|Overall Study|Adverse Event|16|||
33339776|NCT00931710|62716530|FG001|Overall Study|Adverse Event|10|||
33339777|NCT00931710|62716529|FG000|Overall Study|Abnormal test procedure results|2|||
33339778|NCT00931710|62716530|FG001|Overall Study|Abnormal test procedure results|0|||
33339779|NCT00931710|62716529|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
33339780|NCT00931710|62716530|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
33339781|NCT00931710|62716529|FG000|Overall Study|Patient withdrew consent|4|||
33339782|NCT00931710|62716530|FG001|Overall Study|Patient withdrew consent|9|||
33339783|NCT00931710|62716529|FG000|Overall Study|Lost to Follow-up|6|||
33339784|NCT00931710|62716530|FG001|Overall Study|Lost to Follow-up|5|||
33339785|NCT00931710|62716529|FG000|Overall Study|Protocol deviation|1|||
33339786|NCT00931710|62716530|FG001|Overall Study|Protocol deviation|2|||
33339787|NCT01100528|62716536|FG000|Overall Study|Death|1|||
33339788|NCT01100528|62716536|FG000|Overall Study|Withdrawal by Subject|2|||
33339789|NCT01079234|62716543|FG000|Main: Week 0 to 26|Adverse Event|5|||
33339790|NCT01079234|62716544|FG001|Main: Week 0 to 26|Adverse Event|4|||
33339791|NCT01079234|62716545|FG002|Main: Week 0 to 26|Adverse Event|1|||
33339792|NCT01079234|62716546|FG003|Main: Week 0 to 26|Adverse Event|0|||
33339793|NCT01079234|62716543|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
33339794|NCT01079234|62716544|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
33339795|NCT01079234|62716545|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
33339796|NCT01079234|62716546|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
33339797|NCT01079234|62716543|FG000|Main: Week 0 to 26|Protocol Violation|6|||
33339798|NCT01079234|62716544|FG001|Main: Week 0 to 26|Protocol Violation|2|||
33339799|NCT01079234|62716545|FG002|Main: Week 0 to 26|Protocol Violation|4|||
33339800|NCT01079234|62716546|FG003|Main: Week 0 to 26|Protocol Violation|0|||
33339801|NCT01079234|62716543|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
33339802|NCT01079234|62716544|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
33339803|NCT01079234|62716545|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
33339804|NCT01079234|62716546|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
33339805|NCT01079234|62716543|FG000|Main: Week 0 to 26|Unclassified|7|||
33339806|NCT01079234|62716544|FG001|Main: Week 0 to 26|Unclassified|13|||
33339807|NCT01079234|62716545|FG002|Main: Week 0 to 26|Unclassified|4|||
33339808|NCT01079234|62716546|FG003|Main: Week 0 to 26|Unclassified|0|||
33339809|NCT01079234|62716543|FG000|Extension: Week 27 to 52|Adverse Event|0|||
33339810|NCT01079234|62716544|FG001|Extension: Week 27 to 52|Adverse Event|0|||
33339811|NCT01079234|62716545|FG002|Extension: Week 27 to 52|Adverse Event|1|||
33339812|NCT01079234|62716546|FG003|Extension: Week 27 to 52|Adverse Event|0|||
33339813|NCT01079234|62716543|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
33339814|NCT01079234|62716544|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
33339815|NCT01079234|62716545|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
33339816|NCT01079234|62716546|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
33339817|NCT01079234|62716543|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
33339818|NCT01079234|62716544|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
33339819|NCT01079234|62716545|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
33339820|NCT01079234|62716546|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
33339821|NCT01079234|62716543|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
33339822|NCT01079234|62716544|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
33339823|NCT01079234|62716545|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
33339824|NCT01079234|62716546|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
33339825|NCT01079234|62716543|FG000|Extension: Week 27 to 52|Unclassified|0|||
33339826|NCT01079234|62716544|FG001|Extension: Week 27 to 52|Unclassified|0|||
33339827|NCT01079234|62716545|FG002|Extension: Week 27 to 52|Unclassified|4|||
33339828|NCT01079234|62716546|FG003|Extension: Week 27 to 52|Unclassified|7|||
33339829|NCT00931632|62716557|FG000|Overall Study|Withdrawal by Subject|2|||
33339830|NCT00931632|62716558|FG001|Overall Study|Withdrawal by Subject|3|||
33339831|NCT00931632|62716557|FG000|Overall Study|Adverse Event|19|||
33339832|NCT00931632|62716558|FG001|Overall Study|Adverse Event|15|||
33339833|NCT01078922|62716564|FG000|Overall Study|Adverse Event|1|||
33339834|NCT00863746|62716571|FG000|Treatment|Not treated|4|||
33339835|NCT00863746|62716572|FG001|Treatment|Not treated|2|||
33339836|NCT00863746|62716571|FG000|Treatment|Adverse Event|41|||
33339837|NCT00863746|62716572|FG001|Treatment|Adverse Event|16|||
33339838|NCT00863746|62716571|FG000|Treatment|non-compliant with study medication|4|||
33339839|NCT00863746|62716572|FG001|Treatment|non-compliant with study medication|0|||
33339840|NCT00863746|62716571|FG000|Treatment|Consent withdrawn|15|||
33339841|NCT00863746|62716572|FG001|Treatment|Consent withdrawn|14|||
33339842|NCT00863746|62716571|FG000|Treatment|Lost to Follow-up|1|||
33339843|NCT00863746|62716572|FG001|Treatment|Lost to Follow-up|0|||
33339844|NCT00863746|62716571|FG000|Treatment|Protocol Violation|5|||
33339845|NCT00863746|62716572|FG001|Treatment|Protocol Violation|3|||
33339846|NCT00863746|62716571|FG000|Treatment|Other|1|||
33339847|NCT00863746|62716572|FG001|Treatment|Other|0|||
33339848|NCT00863746|62716571|FG000|Survival Follow up|Death|244|||
33339849|NCT00863746|62716572|FG001|Survival Follow up|Death|271|||
33339850|NCT00863746|62716571|FG000|Survival Follow up|Lost to Follow-up|2|||
33339851|NCT00863746|62716572|FG001|Survival Follow up|Lost to Follow-up|1|||
33339852|NCT00863746|62716571|FG000|Survival Follow up|Consent Withdrawn|7|||
33339853|NCT00863746|62716572|FG001|Survival Follow up|Consent Withdrawn|8|||
33548846|NCT01103349|62940220|FG000|Overall Study|forgot to take medication|0|||
33548847|NCT01103349|62940221|FG001|Overall Study|forgot to take medication|0|||
33548848|NCT01103349|62940222|FG002|Overall Study|forgot to take medication|1|||
33548849|NCT02959177|62940233|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
33654426|NCT01709318|63067158|FG004|Overall Study|Other Protocol Specified Criteria|0|||
33339854|NCT00926328|62716580|FG000|Overall Study|Lost to Follow-up|12|||
33339855|NCT00926328|62716581|FG001|Overall Study|Lost to Follow-up|14|||
33339856|NCT00863512|62716589|FG000|Overall Study|Adverse Event|2|||
33339857|NCT00863512|62716590|FG001|Overall Study|Adverse Event|0|||
33339858|NCT00863512|62716589|FG000|Overall Study|Withdrawal by Subject|11|||
33339859|NCT00863512|62716590|FG001|Overall Study|Withdrawal by Subject|0|||
33339860|NCT00863512|62716589|FG000|Overall Study|Physician Decision|1|||
33339861|NCT00863512|62716590|FG001|Overall Study|Physician Decision|0|||
33339862|NCT00868192|62716596|FG000|Overall Study|Ineligible|4|||
33654427|NCT01709318|63067159|FG005|Overall Study|Other Protocol Specified Criteria|0|||
33654428|NCT01709318|63067160|FG006|Overall Study|Other Protocol Specified Criteria|0|||
33339866|NCT00930930|62716606|FG000|Overall Study|Death|1|||
33339867|NCT00930930|62716607|FG001|Overall Study|Death|0|||
33339868|NCT00930930|62716606|FG000|Overall Study|Physician Decision|1|||
33339869|NCT00930930|62716607|FG001|Overall Study|Physician Decision|0|||
33339870|NCT00930930|62716606|FG000|Overall Study|Adverse Event|13|||
33339871|NCT00930930|62716607|FG001|Overall Study|Adverse Event|3|||
33339872|NCT00930930|62716606|FG000|Overall Study|Withdrawal by Subject|3|||
33339873|NCT00930930|62716607|FG001|Overall Study|Withdrawal by Subject|1|||
33339874|NCT00930930|62716606|FG000|Overall Study|Disease progression|2|||
33339875|NCT00930930|62716607|FG001|Overall Study|Disease progression|3|||
33339876|NCT00930930|62716606|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
33339877|NCT00930930|62716607|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
33339878|NCT00930930|62716606|FG000|Overall Study|patients not compliant|1|||
33339879|NCT00930930|62716607|FG001|Overall Study|patients not compliant|1|||
33339880|NCT00862654|62716617|FG000|Overall Study|Lack of Efficacy|1|||
33339881|NCT00862654|62716618|FG001|Overall Study|Lack of Efficacy|0|||
33339882|NCT00862654|62716619|FG002|Overall Study|Lack of Efficacy|1|||
33339883|NCT00862654|62716620|FG003|Overall Study|Lack of Efficacy|0|||
33339884|NCT00862654|62716617|FG000|Overall Study|Lost to Follow-up|1|||
33339885|NCT00862654|62716618|FG001|Overall Study|Lost to Follow-up|2|||
33339886|NCT00862654|62716619|FG002|Overall Study|Lost to Follow-up|1|||
33339887|NCT00862654|62716620|FG003|Overall Study|Lost to Follow-up|3|||
33339888|NCT00862654|62716617|FG000|Overall Study|Adverse Event|0|||
33339889|NCT00862654|62716618|FG001|Overall Study|Adverse Event|1|||
33339890|NCT00862654|62716619|FG002|Overall Study|Adverse Event|1|||
33339891|NCT00862654|62716620|FG003|Overall Study|Adverse Event|0|||
33339892|NCT00862654|62716617|FG000|Overall Study|Pregnancy|1|||
33339893|NCT00862654|62716618|FG001|Overall Study|Pregnancy|1|||
33339894|NCT00862654|62716619|FG002|Overall Study|Pregnancy|0|||
33339895|NCT00862654|62716620|FG003|Overall Study|Pregnancy|0|||
33339896|NCT00862654|62716617|FG000|Overall Study|Withdrawal by Subject|2|||
33339897|NCT00862654|62716618|FG001|Overall Study|Withdrawal by Subject|2|||
33339898|NCT00862654|62716619|FG002|Overall Study|Withdrawal by Subject|2|||
33339899|NCT00862654|62716620|FG003|Overall Study|Withdrawal by Subject|3|||
33339900|NCT00862654|62716617|FG000|Overall Study|Subject mistake|0|||
33339901|NCT00862654|62716618|FG001|Overall Study|Subject mistake|1|||
33339902|NCT00862654|62716619|FG002|Overall Study|Subject mistake|0|||
33339903|NCT00862654|62716620|FG003|Overall Study|Subject mistake|0|||
33339904|NCT00862654|62716617|FG000|Overall Study|Familly constraint|0|||
33339905|NCT00862654|62716618|FG001|Overall Study|Familly constraint|1|||
33339906|NCT00862654|62716619|FG002|Overall Study|Familly constraint|0|||
33339907|NCT00862654|62716620|FG003|Overall Study|Familly constraint|0|||
33548850|NCT02959177|62940234|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
33548851|NCT02959177|62940235|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
33548852|NCT02959177|62940233|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
33339908|NCT00862654|62716617|FG000|Overall Study|Never used study drugs|1|||
33339909|NCT00862654|62716618|FG001|Overall Study|Never used study drugs|0|||
33339910|NCT00862654|62716619|FG002|Overall Study|Never used study drugs|0|||
33339911|NCT00862654|62716620|FG003|Overall Study|Never used study drugs|0|||
33339912|NCT00862654|62716617|FG000|Overall Study|Included after end of inclusions|0|||
33339913|NCT00862654|62716618|FG001|Overall Study|Included after end of inclusions|0|||
33339914|NCT00862654|62716619|FG002|Overall Study|Included after end of inclusions|1|||
33339915|NCT00862654|62716620|FG003|Overall Study|Included after end of inclusions|0|||
33339916|NCT00867490|62716630|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
33339917|NCT00867490|62716630|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
33339918|NCT00867490|62716630|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
33339919|NCT00867490|62716630|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
33339920|NCT00867490|62716630|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
33339921|NCT00930774|62716641|FG000|Overall Study|Withdrawal by Subject|1|||
33339922|NCT00930774|62716642|FG001|Overall Study|Withdrawal by Subject|9|||
33339923|NCT00930774|62716643|FG002|Overall Study|Withdrawal by Subject|2|||
33339924|NCT00930774|62716644|FG003|Overall Study|Withdrawal by Subject|0|||
33339925|NCT00867334|62716657|FG000|Overall Study|Withdrawal by Subject|0|||
33339926|NCT00867334|62716658|FG001|Overall Study|Withdrawal by Subject|1|||
33339927|NCT00867334|62716657|FG000|Overall Study|Withdrawal by Subject|1|||
33339928|NCT00867334|62716658|FG001|Overall Study|Withdrawal by Subject|0|||
33339929|NCT00867334|62716657|FG000|Overall Study|Withdrawal by Subject|1|||
33339930|NCT00867334|62716658|FG001|Overall Study|Withdrawal by Subject|0|||
33339931|NCT00925704|62716670|FG000|First Intervention|Withdrew consent|0|||
33339932|NCT00925704|62716671|FG001|First Intervention|Withdrew consent|0|||
33339933|NCT00925704|62716672|FG002|First Intervention|Withdrew consent|0|||
33339934|NCT00925704|62716673|FG003|First Intervention|Withdrew consent|1|||
33339935|NCT00925704|62716674|FG004|First Intervention|Withdrew consent|1|||
33339936|NCT00925704|62716675|FG005|First Intervention|Withdrew consent|0|||
33339937|NCT00925704|62716670|FG000|Second Intervention|Withdrawal by Subject|1|||
33339938|NCT00925704|62716671|FG001|Second Intervention|Withdrawal by Subject|0|||
33339939|NCT00925704|62716672|FG002|Second Intervention|Withdrawal by Subject|0|||
33339940|NCT00925704|62716673|FG003|Second Intervention|Withdrawal by Subject|0|||
33339941|NCT00925704|62716674|FG004|Second Intervention|Withdrawal by Subject|1|||
33339942|NCT00925704|62716675|FG005|Second Intervention|Withdrawal by Subject|0|||
33339943|NCT00925704|62716670|FG000|Third Intervention|Withdrew consent|0|||
33339944|NCT00925704|62716671|FG001|Third Intervention|Withdrew consent|0|||
33339945|NCT00925704|62716672|FG002|Third Intervention|Withdrew consent|0|||
33339946|NCT00925704|62716673|FG003|Third Intervention|Withdrew consent|0|||
33339947|NCT00925704|62716674|FG004|Third Intervention|Withdrew consent|0|||
33339948|NCT00925704|62716675|FG005|Third Intervention|Withdrew consent|1|||
33339949|NCT01076192|62716686|FG000|Overall Study|Other|197|||
33339950|NCT01076036|62716691|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
33339951|NCT01075958|62716695|FG000|Overall Study|Blood sample could not be obtained|44|||
33339952|NCT01096316|62716701|FG000|Overall Study|Lost to Follow-up|15|||
33339953|NCT01096316|62716702|FG001|Overall Study|Lost to Follow-up|9|||
33339954|NCT00925548|62716710|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
33339955|NCT00925548|62716711|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
33339956|NCT00866788|62716722|FG000|Overall Study|Adverse Event|0|||
33339957|NCT00866788|62716723|FG001|Overall Study|Adverse Event|2|||
33339958|NCT00866788|62716724|FG002|Overall Study|Adverse Event|0|||
33339959|NCT00866788|62716725|FG003|Overall Study|Adverse Event|1|||
33339960|NCT00866788|62716722|FG000|Overall Study|Lost to Follow-up|1|||
33339961|NCT00866788|62716723|FG001|Overall Study|Lost to Follow-up|1|||
33339962|NCT00866788|62716724|FG002|Overall Study|Lost to Follow-up|0|||
33339963|NCT00866788|62716725|FG003|Overall Study|Lost to Follow-up|2|||
33339964|NCT00866788|62716722|FG000|Overall Study|Withdrawal by Subject|2|||
33339965|NCT00866788|62716723|FG001|Overall Study|Withdrawal by Subject|1|||
33339966|NCT00866788|62716724|FG002|Overall Study|Withdrawal by Subject|0|||
33339967|NCT00866788|62716725|FG003|Overall Study|Withdrawal by Subject|1|||
33339968|NCT00866788|62716722|FG000|Overall Study|Pregnancy|0|||
33339969|NCT00866788|62716723|FG001|Overall Study|Pregnancy|1|||
33339970|NCT00866788|62716724|FG002|Overall Study|Pregnancy|0|||
33339971|NCT00866788|62716725|FG003|Overall Study|Pregnancy|0|||
33339972|NCT00866788|62716722|FG000|Overall Study|Disease progression|3|||
33339973|NCT00866788|62716723|FG001|Overall Study|Disease progression|1|||
33339974|NCT00866788|62716724|FG002|Overall Study|Disease progression|1|||
33339975|NCT00866788|62716725|FG003|Overall Study|Disease progression|0|||
33339976|NCT00866788|62716722|FG000|Overall Study|Physician Decision|0|||
33339977|NCT00866788|62716723|FG001|Overall Study|Physician Decision|0|||
33339978|NCT00866788|62716724|FG002|Overall Study|Physician Decision|1|||
33339979|NCT00866788|62716725|FG003|Overall Study|Physician Decision|1|||
33339980|NCT00860470|62716740|FG000|Overall Study|Death|6|||
33339981|NCT00860470|62716741|FG001|Overall Study|Death|10|||
33339982|NCT00860470|62716740|FG000|Overall Study|Moved away|8|||
33339983|NCT00860470|62716741|FG001|Overall Study|Moved away|10|||
33339984|NCT00860470|62716740|FG000|Overall Study|Lost to Follow-up|34|||
33339985|NCT00860470|62716741|FG001|Overall Study|Lost to Follow-up|39|||
33339986|NCT00923364|62716747|FG000|Overall Study|Death|3|||
33339987|NCT00923364|62716748|FG001|Overall Study|Death|0|||
33339988|NCT00923364|62716747|FG000|Overall Study|Did not go to transplant|1|||
33339989|NCT00923364|62716748|FG001|Overall Study|Did not go to transplant|0|||
33339990|NCT01096160|62716763|FG000|Overall Study|Adverse Event|0|||
33339991|NCT01096160|62716764|FG001|Overall Study|Adverse Event|0|||
33339992|NCT01096160|62716765|FG002|Overall Study|Adverse Event|1|||
33339993|NCT01096160|62716766|FG003|Overall Study|Adverse Event|0|||
33339994|NCT01096160|62716767|FG004|Overall Study|Adverse Event|0|||
33339995|NCT01096160|62716768|FG005|Overall Study|Adverse Event|0|||
33339996|NCT01096160|62716769|FG006|Overall Study|Adverse Event|0|||
33339997|NCT01096160|62716770|FG007|Overall Study|Adverse Event|0|||
33339998|NCT01096160|62716771|FG008|Overall Study|Adverse Event|0|||
33339999|NCT01096160|62716772|FG009|Overall Study|Adverse Event|1|||
33340000|NCT01096160|62716763|FG000|Overall Study|Met stopping criteria per protocol|0|||
33340001|NCT01096160|62716764|FG001|Overall Study|Met stopping criteria per protocol|0|||
33340002|NCT01096160|62716765|FG002|Overall Study|Met stopping criteria per protocol|0|||
33340003|NCT01096160|62716766|FG003|Overall Study|Met stopping criteria per protocol|0|||
33340004|NCT01096160|62716767|FG004|Overall Study|Met stopping criteria per protocol|1|||
33340005|NCT01096160|62716768|FG005|Overall Study|Met stopping criteria per protocol|0|||
33340006|NCT01096160|62716769|FG006|Overall Study|Met stopping criteria per protocol|2|||
33340007|NCT01096160|62716770|FG007|Overall Study|Met stopping criteria per protocol|0|||
33340008|NCT01096160|62716771|FG008|Overall Study|Met stopping criteria per protocol|2|||
33340009|NCT01096160|62716772|FG009|Overall Study|Met stopping criteria per protocol|0|||
33340010|NCT00860158|62716807|FG000|Overall Study|Study Terminated|1|||
33340011|NCT00929526|62716813|FG000|Overall Study|Withdrawal by Subject|1|||
33340012|NCT00929526|62716814|FG001|Overall Study|Withdrawal by Subject|11|||
33340013|NCT00929526|62716813|FG000|Overall Study|Lost to Follow-up|8|||
33340014|NCT00929526|62716814|FG001|Overall Study|Lost to Follow-up|12|||
33340015|NCT00929526|62716813|FG000|Overall Study|Other|8|||
33340016|NCT00929526|62716814|FG001|Overall Study|Other|6|||
33340017|NCT00859456|62716820|FG000|Overall Study|Adverse Event|3|||
33340018|NCT00859456|62716820|FG000|Overall Study|Progressive disease|2|||
33340019|NCT00859456|62716820|FG000|Overall Study|Non-compliance|3|||
33340020|NCT01075646|62716828|FG000|Overall Study|Lost to Follow-up|4|||
33340021|NCT01075646|62716829|FG001|Overall Study|Lost to Follow-up|3|||
33340022|NCT01075646|62716830|FG002|Overall Study|Lost to Follow-up|1|||
33340023|NCT01075646|62716831|FG003|Overall Study|Lost to Follow-up|2|||
33340024|NCT01075412|62716843|FG000|Overall Study|Withdrawal by Subject|0|||
33340025|NCT01075412|62716844|FG001|Overall Study|Withdrawal by Subject|1|||
33340026|NCT00799903|62716851|FG000|Overall Study|Investigator Site Closed|25|||
33340027|NCT00799903|62716852|FG001|Overall Study|Investigator Site Closed|23|||
33340028|NCT00799903|62716851|FG000|Overall Study|Withdrawal by Subject|179|||
33654429|NCT01699178|63067178|FG000|Overall Study|Adverse Event|1|||
33654430|NCT01699178|63067179|FG001|Overall Study|Adverse Event|5|||
33654431|NCT01699178|63067178|FG000|Overall Study|Lost to Follow-up|1|||
33654432|NCT01699178|63067179|FG001|Overall Study|Lost to Follow-up|6|||
33654433|NCT01699178|63067178|FG000|Overall Study|Non-compliance with Study Drug|3|||
33654434|NCT01699178|63067179|FG001|Overall Study|Non-compliance with Study Drug|1|||
33654435|NCT01699178|63067178|FG000|Overall Study|Physician Decision|1|||
33654436|NCT01699178|63067179|FG001|Overall Study|Physician Decision|0|||
33654437|NCT01699178|63067178|FG000|Overall Study|Withdrawal by Subject|4|||
33654438|NCT01699178|63067179|FG001|Overall Study|Withdrawal by Subject|12|||
33654439|NCT01699178|63067178|FG000|Overall Study|Hematocrit >54%|1|||
33654440|NCT01699178|63067179|FG001|Overall Study|Hematocrit >54%|1|||
33654441|NCT01699178|63067178|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
33654442|NCT01699178|63067179|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
33654443|NCT01699178|63067178|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
33654444|NCT01699178|63067179|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
33340029|NCT00799903|62716852|FG001|Overall Study|Withdrawal by Subject|175|||
33654445|NCT01683409|63067190|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
33654446|NCT01683409|63067191|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
33654447|NCT01683409|63067192|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
33340030|NCT00799903|62716851|FG000|Overall Study|Lost to Follow-up|69|||
33340031|NCT00799903|62716852|FG001|Overall Study|Lost to Follow-up|80|||
33340032|NCT01075256|62716861|FG000|Overall Study|Withdrawal by Subject|1|||
33340033|NCT01075256|62716862|FG001|Overall Study|Withdrawal by Subject|0|||
33340034|NCT01075256|62716863|FG002|Overall Study|Withdrawal by Subject|0|||
33340035|NCT00923130|62716876|FG000|Overall Study|Stopped treatment due to progression|17|||
33340036|NCT00923130|62716876|FG000|Overall Study|Death|1|||
33340037|NCT00923130|62716876|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
33340038|NCT00923130|62716876|FG000|Overall Study|Switched to alternative treatment|2|||
33340039|NCT00923130|62716876|FG000|Overall Study|Refused further treatment|2|||
33340040|NCT03253627|62716882|FG000|Overall Study|Lost to Follow-up|1|||
33340041|NCT03253627|62716883|FG001|Overall Study|Lost to Follow-up|2|||
33340042|NCT03253627|62716882|FG000|Overall Study|Withdrawal by Subject|0|||
33340043|NCT03253627|62716883|FG001|Overall Study|Withdrawal by Subject|2|||
33340044|NCT03253627|62716882|FG000|Overall Study|Inability to complete MRI|1|||
33340045|NCT03253627|62716883|FG001|Overall Study|Inability to complete MRI|0|||
33340046|NCT01075178|62716891|FG000|Subject Matching|eligible but not matched|130|||
33340047|NCT01075178|62716892|FG001|Subject Matching|eligible but not matched|403|||
33340048|NCT01075178|62716891|FG000|Subject Chart Review|died before chart review period|0|||
33340049|NCT01075178|62716892|FG001|Subject Chart Review|died before chart review period|2|||
33340050|NCT01075178|62716891|FG000|Subject Chart Review|no data collected due to site closure|3|||
33340051|NCT01075178|62716892|FG001|Subject Chart Review|no data collected due to site closure|4|||
33340052|NCT01075178|62716891|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
33340053|NCT01075178|62716892|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
33340054|NCT00799825|62716898|FG000|Overall Study|Adverse Event|1|||
33340055|NCT00799825|62716898|FG000|Overall Study|Withdrawal by Subject|6|||
33340056|NCT00799825|62716898|FG000|Overall Study|Lost to Follow-up|38|||
33340057|NCT00799825|62716898|FG000|Overall Study|Pregnancy|3|||
33340058|NCT00799591|62716902|FG000|Overall Study|De-escalation of doses|20|||
33340059|NCT00799591|62716902|FG000|Overall Study|Death|14|||
33340060|NCT00799591|62716902|FG000|Overall Study|Technical failure|12|||
33340061|NCT00799591|62716902|FG000|Overall Study|Resistant germ|11|||
33340062|NCT00799591|62716902|FG000|Overall Study|New infection|4|||
33340063|NCT00799591|62716902|FG000|Overall Study|Resistance germ and technical failure|2|||
33340064|NCT00799591|62716902|FG000|Overall Study|Persistance of fever undetermined origin|1|||
33340065|NCT00799591|62716902|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
33340066|NCT00799591|62716902|FG000|Overall Study|Infectious origin not probable|1|||
33340067|NCT01075100|62716908|FG000|Overall Study|Adverse Event|15|||
33340068|NCT01075100|62716909|FG001|Overall Study|Adverse Event|18|||
33340069|NCT01075100|62716908|FG000|Overall Study|Patient Request|4|||
33340070|NCT01075100|62716909|FG001|Overall Study|Patient Request|4|||
33340071|NCT01075100|62716908|FG000|Overall Study|Investigator Request|2|||
33340072|NCT01075100|62716909|FG001|Overall Study|Investigator Request|1|||
33340073|NCT01075100|62716908|FG000|Overall Study|Disease Progression|25|||
33340074|NCT01075100|62716909|FG001|Overall Study|Disease Progression|29|||
33340075|NCT01075100|62716908|FG000|Overall Study|Other|3|||
33340076|NCT01075100|62716909|FG001|Overall Study|Other|1|||
33340077|NCT00803023|62716921|FG000|Overall Study|Adverse Event|5|||
33340078|NCT00803023|62716922|FG001|Overall Study|Adverse Event|4|||
33340079|NCT00803023|62716923|FG002|Overall Study|Adverse Event|8|||
33340080|NCT00803023|62716924|FG003|Overall Study|Adverse Event|6|||
33340081|NCT00803023|62716921|FG000|Overall Study|Withdrawal by Subject|0|||
33340082|NCT00803023|62716922|FG001|Overall Study|Withdrawal by Subject|2|||
33340083|NCT00803023|62716923|FG002|Overall Study|Withdrawal by Subject|0|||
33340084|NCT00803023|62716924|FG003|Overall Study|Withdrawal by Subject|0|||
33340085|NCT00803023|62716921|FG000|Overall Study|Lost to Follow-up|0|||
33340086|NCT00803023|62716922|FG001|Overall Study|Lost to Follow-up|1|||
33340087|NCT00803023|62716923|FG002|Overall Study|Lost to Follow-up|2|||
33340088|NCT00803023|62716924|FG003|Overall Study|Lost to Follow-up|1|||
33340089|NCT00803023|62716921|FG000|Overall Study|Lack of Efficacy|0|||
33340090|NCT00803023|62716922|FG001|Overall Study|Lack of Efficacy|1|||
33340091|NCT00803023|62716923|FG002|Overall Study|Lack of Efficacy|1|||
33340092|NCT00803023|62716924|FG003|Overall Study|Lack of Efficacy|1|||
33340093|NCT00859222|62716937|FG000|Overall Study|Adverse Event|2|||
33340094|NCT00859222|62716938|FG001|Overall Study|Adverse Event|3|||
33340095|NCT00859222|62716939|FG002|Overall Study|Adverse Event|6|||
33340096|NCT00859222|62716940|FG003|Overall Study|Adverse Event|24|||
33340097|NCT00859222|62716941|FG004|Overall Study|Adverse Event|15|||
33340098|NCT00859222|62716937|FG000|Overall Study|DLT|1|||
33340099|NCT00859222|62716938|FG001|Overall Study|DLT|0|||
33340100|NCT00859222|62716939|FG002|Overall Study|DLT|0|||
33340101|NCT00859222|62716940|FG003|Overall Study|DLT|0|||
33340102|NCT00859222|62716941|FG004|Overall Study|DLT|0|||
33340103|NCT01072448|62716958|FG000|Overall Study|Adverse Event|9|||
33340104|NCT01072448|62716959|FG001|Overall Study|Adverse Event|10|||
33340105|NCT01072448|62716958|FG000|Overall Study|Subject withdrew consent|4|||
33340106|NCT01072448|62716959|FG001|Overall Study|Subject withdrew consent|9|||
33340107|NCT01072448|62716958|FG000|Overall Study|Protocol deviation|3|||
33340108|NCT01072448|62716959|FG001|Overall Study|Protocol deviation|4|||
33340109|NCT01072448|62716958|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33340110|NCT01072448|62716959|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33340111|NCT01072448|62716958|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33340112|NCT01072448|62716959|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33340113|NCT01072448|62716958|FG000|Overall Study|Lost to Follow-up|1|||
33340114|NCT01072448|62716959|FG001|Overall Study|Lost to Follow-up|1|||
33340115|NCT01072448|62716958|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33340116|NCT01072448|62716959|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33340117|NCT01072448|62716958|FG000|Overall Study|Death|0|||
33340118|NCT01072448|62716959|FG001|Overall Study|Death|2|||
33340119|NCT00922974|62716968|FG000|Phase II Component|Protocol Violation|2|||
33340120|NCT00922974|62716969|FG001|Phase II Component|Protocol Violation|0|||
33340121|NCT00922974|62716968|FG000|Phase II Component|Not evaluable for treatment review|5|||
33340122|NCT00922974|62716969|FG001|Phase II Component|Not evaluable for treatment review|0|||
33340123|NCT00922974|62716968|FG000|Phase III Component|Protocol Violation|8|||
33340124|NCT00922974|62716969|FG001|Phase III Component|Protocol Violation|6|||
33340125|NCT00858988|62716979|FG000|Analysis|Lactulose unable to be detected in urine|2|||
33340126|NCT00858988|62716980|FG001|Analysis|Lactulose unable to be detected in urine|1|||
33340127|NCT00858832|62716988|FG000|Overall Study|became ineligible: delivered vaginally|1|||
33340128|NCT00858832|62716989|FG001|Overall Study|became ineligible: delivered vaginally|0|||
33340129|NCT00858832|62716988|FG000|Overall Study|Adverse Event|0|||
33340130|NCT00858832|62716989|FG001|Overall Study|Adverse Event|1|||
33340131|NCT01071512|62716995|FG000|Overall Study|Adverse Event|1|||
33340132|NCT01071512|62716995|FG000|Overall Study|Development of antibodies to drug|2|||
33340133|NCT01071512|62716995|FG000|Overall Study|positive anti-JC virus antibody test|2|||
33340134|NCT00858442|62717001|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
33340135|NCT00858442|62717002|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
33340136|NCT01071278|62717009|FG000|Overall Study|Premature Discontinuation|254|||
33340137|NCT01071278|62717009|FG000|Overall Study|Completion Status Unknown|459|||
33340138|NCT00858208|62717015|FG000|Overall Study|Adverse Event|3|||
33340139|NCT00858208|62717015|FG000|Overall Study|Lost to Follow-up|26|||
33340140|NCT00858208|62717015|FG000|Overall Study|Participant refused|40|||
33340141|NCT00858208|62717015|FG000|Overall Study|Other|10|||
33340142|NCT01071200|62717021|FG000|Overall Study|Lack of ovarian response|1|||
33340143|NCT01071200|62717022|FG001|Overall Study|Lack of ovarian response|1|||
33340144|NCT01071200|62717021|FG000|Overall Study|No fertilization|4|||
33340145|NCT01071200|62717022|FG001|Overall Study|No fertilization|0|||
33340146|NCT01071200|62717021|FG000|Overall Study|No oocytes retrieved|1|||
33340147|NCT01071200|62717022|FG001|Overall Study|No oocytes retrieved|1|||
33340148|NCT01071200|62717021|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
33340149|NCT01071200|62717022|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
33340150|NCT01071200|62717021|FG000|Overall Study|No viable embryos|0|||
33340151|NCT01071200|62717022|FG001|Overall Study|No viable embryos|1|||
33340152|NCT02207569|62717028|FG000|1-Month|Death|6|||
33340153|NCT02207569|62717028|FG000|1-Month|Withdrawal by Subject|2|||
33340154|NCT02207569|62717028|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
33340155|NCT02207569|62717028|FG000|6-Month|Death|8|||
33340156|NCT02207569|62717028|FG000|6-Month|Withdrawal by Subject|2|||
33340157|NCT02207569|62717028|FG000|12-Month|Death|14|||
33340158|NCT02207569|62717028|FG000|12-Month|Withdrawal by Subject|2|||
33340159|NCT02207569|62717028|FG000|24-Month|Death|23|||
33340160|NCT02207569|62717028|FG000|24-Month|Withdrawal by Subject|3|||
33340161|NCT02207569|62717028|FG000|36-Month|Death|23|||
33340162|NCT02207569|62717028|FG000|36-Month|Withdrawal by Subject|4|||
33340163|NCT02207569|62717028|FG000|48-Month|Death|25|||
33340164|NCT02207569|62717028|FG000|48-Month|Withdrawal by Subject|2|||
33340165|NCT02207569|62717028|FG000|48-Month|Lost to Follow-up|4|||
33340166|NCT02207569|62717028|FG000|60-Month|Death|1|||
33340167|NCT02207569|62717028|FG000|60-Month|Lost to Follow-up|1|||
33340168|NCT02207569|62717028|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
33340169|NCT02207569|62717028|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
33340170|NCT01070966|62717032|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
33340171|NCT01070966|62717032|FG000|Participants for Safety Evaluation|Off-label use|9|||
33340172|NCT01070966|62717032|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
33340173|NCT01070966|62717032|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
33340174|NCT01070966|62717032|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
33340175|NCT01070966|62717032|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
33340176|NCT01070966|62717032|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
33548853|NCT02959177|62940234|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
33340177|NCT01070966|62717032|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
33340178|NCT01070888|62717045|FG000|First Intervention (14 Days)|Adverse Event|0|||
33340179|NCT01070888|62717046|FG001|First Intervention (14 Days)|Adverse Event|1|||
33340180|NCT01070888|62717045|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
33340181|NCT01070888|62717046|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
33340182|NCT01070888|62717045|FG000|Washout (14 Days)|Physician Decision|1|||
33340183|NCT01070888|62717046|FG001|Washout (14 Days)|Physician Decision|0|||
33340184|NCT00857896|62717052|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
33340185|NCT00857818|62717059|FG000|Overall Study|Lack of Efficacy|1|||
33340186|NCT00857818|62717060|FG001|Overall Study|Lack of Efficacy|0|||
33340187|NCT00857818|62717059|FG000|Overall Study|Adverse Event|3|||
33340188|NCT00857818|62717060|FG001|Overall Study|Adverse Event|0|||
33340189|NCT00857818|62717059|FG000|Overall Study|Withdrawal by Subject|0|||
33340190|NCT00857818|62717060|FG001|Overall Study|Withdrawal by Subject|4|||
33340191|NCT00857818|62717059|FG000|Overall Study|Sponsor terminated study|6|||
33340192|NCT00857818|62717060|FG001|Overall Study|Sponsor terminated study|4|||
33340193|NCT00857818|62717059|FG000|Overall Study|Investigator decision|1|||
33340194|NCT00857818|62717060|FG001|Overall Study|Investigator decision|0|||
33340195|NCT01074944|62717066|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
33340196|NCT01074944|62717067|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
33340197|NCT01074944|62717068|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
33340198|NCT01074944|62717069|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
33340199|NCT01074944|62717070|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
33340200|NCT01074944|62717066|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
33340201|NCT01074944|62717067|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
33340202|NCT01074944|62717068|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
33340203|NCT01074944|62717069|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
33340204|NCT01074944|62717070|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
33340205|NCT01074944|62717066|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
33340206|NCT01074944|62717067|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
33340207|NCT01074944|62717068|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
33340208|NCT01074944|62717069|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
33340209|NCT01074944|62717070|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
33340210|NCT01074944|62717066|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
33340211|NCT01074944|62717067|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
33340212|NCT01074944|62717068|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
33340213|NCT01074944|62717069|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
33340214|NCT01074944|62717070|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
33340215|NCT01074944|62717066|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
33340216|NCT01074944|62717067|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
33340217|NCT01074944|62717068|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
33340218|NCT01074944|62717069|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
33340219|NCT01074944|62717070|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
33340220|NCT01074944|62717066|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
33340221|NCT01074944|62717067|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
33340222|NCT01074944|62717068|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
33340223|NCT01074944|62717069|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
33340224|NCT01074944|62717070|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
33340225|NCT01074944|62717066|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
33340226|NCT01074944|62717067|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
33340227|NCT01074944|62717068|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
33340228|NCT01074944|62717069|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
33340229|NCT01074944|62717070|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
33340230|NCT01074944|62717066|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
33340231|NCT01074944|62717067|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
33340232|NCT01074944|62717068|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
33340233|NCT01074944|62717069|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
33340234|NCT01074944|62717070|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
33340235|NCT01074944|62717066|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
33340236|NCT01074944|62717067|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
33340237|NCT01074944|62717068|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
33340238|NCT01074944|62717069|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
33340239|NCT01074944|62717070|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
33340240|NCT01074944|62717066|FG000|Long Term Treatment|Adverse Event|0|||
33340241|NCT01074944|62717067|FG001|Long Term Treatment|Adverse Event|0|||
33469865|NCT03720470|62843581|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
33580907|NCT01454934|62978058|FG001|Overall Study|Adverse Event|24|||
33340242|NCT01074944|62717068|FG002|Long Term Treatment|Adverse Event|0|||
33340243|NCT01074944|62717069|FG003|Long Term Treatment|Adverse Event|3|||
33340244|NCT01074944|62717070|FG004|Long Term Treatment|Adverse Event|0|||
33340245|NCT01074944|62717066|FG000|Long Term Treatment|Lost to Follow-up|0|||
33340246|NCT01074944|62717067|FG001|Long Term Treatment|Lost to Follow-up|0|||
33340247|NCT01074944|62717068|FG002|Long Term Treatment|Lost to Follow-up|0|||
33340248|NCT01074944|62717069|FG003|Long Term Treatment|Lost to Follow-up|2|||
33340249|NCT01074944|62717070|FG004|Long Term Treatment|Lost to Follow-up|0|||
33340250|NCT01074944|62717066|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
33340251|NCT01074944|62717067|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
33340252|NCT01074944|62717068|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
33340253|NCT01074944|62717069|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
33340254|NCT01074944|62717070|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
33340255|NCT01074944|62717066|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
33340256|NCT01074944|62717067|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
33340257|NCT01074944|62717068|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
33340258|NCT01074944|62717069|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
33340259|NCT01074944|62717070|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
33340260|NCT01074944|62717066|FG000|Long Term Treatment|Withdrawal by Subject|0|||
33340261|NCT01074944|62717067|FG001|Long Term Treatment|Withdrawal by Subject|0|||
33340262|NCT01074944|62717068|FG002|Long Term Treatment|Withdrawal by Subject|0|||
33340263|NCT01074944|62717069|FG003|Long Term Treatment|Withdrawal by Subject|2|||
33340264|NCT01074944|62717070|FG004|Long Term Treatment|Withdrawal by Subject|0|||
33340265|NCT01074944|62717066|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
33340266|NCT01074944|62717067|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
33340267|NCT01074944|62717068|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
33340268|NCT01074944|62717069|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
33340269|NCT01074944|62717070|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
33340270|NCT01074944|62717066|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
33340271|NCT01074944|62717067|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
33340272|NCT01074944|62717068|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
33340273|NCT01074944|62717069|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
33548854|NCT02959177|62940235|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
33548855|NCT02959177|62940233|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
33548856|NCT02959177|62940234|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
33548857|NCT02959177|62940235|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
33548858|NCT02959177|62940233|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
33654448|NCT01683409|63067193|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
33654449|NCT01683409|63067194|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
33654450|NCT01683409|63067190|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
33340274|NCT01074944|62717070|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
33548859|NCT02959177|62940234|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
33340275|NCT00802945|62717080|FG000|Overall Study|Death|27|||
33340276|NCT00802945|62717081|FG001|Overall Study|Death|23|||
33340277|NCT00802945|62717080|FG000|Overall Study|Terminated by sponsor|8|||
33340278|NCT00802945|62717081|FG001|Overall Study|Terminated by sponsor|12|||
33340279|NCT01074554|62717091|FG000|Overall Study|Adverse Event|3|||
33340280|NCT01074554|62717092|FG001|Overall Study|Adverse Event|3|||
33340281|NCT01074554|62717091|FG000|Overall Study|Lost to Follow-up|0|||
33340282|NCT01074554|62717092|FG001|Overall Study|Lost to Follow-up|1|||
33340283|NCT00857584|62717100|FG000|Overall Study|Lack of Efficacy|1|||
33340284|NCT00857584|62717101|FG001|Overall Study|Lack of Efficacy|2|||
33340285|NCT00857584|62717100|FG000|Overall Study|Adverse Event|2|||
33340286|NCT00857584|62717101|FG001|Overall Study|Adverse Event|2|||
33340287|NCT00857584|62717100|FG000|Overall Study|Physician Decision|1|||
33340288|NCT00857584|62717101|FG001|Overall Study|Physician Decision|1|||
33340289|NCT00798967|62717109|FG000|Overall Study|Adverse Event|2|||
33340290|NCT00798967|62717110|FG001|Overall Study|Adverse Event|3|||
33340291|NCT00798967|62717109|FG000|Overall Study|Withdrawal by Subject|0|||
33340292|NCT00798967|62717110|FG001|Overall Study|Withdrawal by Subject|1|||
33340293|NCT00798967|62717109|FG000|Overall Study|Physician Decision|1|||
33340294|NCT00798967|62717110|FG001|Overall Study|Physician Decision|0|||
33340295|NCT00798967|62717109|FG000|Overall Study|Randomized in error by site|1|||
33340296|NCT00798967|62717110|FG001|Overall Study|Randomized in error by site|0|||
33340297|NCT01074242|62717117|FG000|Overall Study|Case report before date of contract|40|||
33340298|NCT01074242|62717117|FG000|Overall Study|Lost to Follow-up|1|||
33340299|NCT01074242|62717117|FG000|Overall Study|Case report unclear|6|||
33340300|NCT01074242|62717117|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
33340301|NCT01074242|62717117|FG000|Overall Study|Duplicate Case Report Form|5|||
33340302|NCT00798889|62717121|FG000|Overall Study|Adverse Event|53|||
33340303|NCT00798889|62717121|FG000|Overall Study|Protocol Violation|2|||
33340304|NCT00798889|62717121|FG000|Overall Study|Withdrawal by Subject|31|||
33340305|NCT00798889|62717121|FG000|Overall Study|Lost to Follow-up|1|||
33340306|NCT00798889|62717121|FG000|Overall Study|Lack of Efficacy|213|||
33340307|NCT00798889|62717121|FG000|Overall Study|Decision of Sponsor|11|||
33340308|NCT00798889|62717121|FG000|Overall Study|Enrolled, Not treated|3|||
33340309|NCT00796861|62717125|FG000|Overall Study|Withdrawal by Subject|2|||
33340310|NCT00796861|62717125|FG000|Overall Study|Death|2|||
33340311|NCT00802867|62717129|FG000|Overall Study|Lost to Follow-up|6|||
33340312|NCT00802867|62717129|FG000|Overall Study|Protocol Violation|6|||
33340313|NCT00802867|62717129|FG000|Overall Study|Withdrawal by Subject|1|||
33340314|NCT00798655|62717133|FG000|Overall Study|Did not receive at least one dose of pan|2|||
33340315|NCT00796549|62717137|FG000|Overall Study|Adverse Event|11|||
33340316|NCT00796549|62717137|FG000|Overall Study|not entered|149|||
33340317|NCT00796549|62717137|FG000|Overall Study|Other|2|||
33340318|NCT00796549|62717137|FG000|Overall Study|Progressive disease|56|||
33340319|NCT00856492|62717146|FG000|Overall Study|Ineligible or withdrew consent|1|||
33340320|NCT00856492|62717147|FG001|Overall Study|Ineligible or withdrew consent|1|||
33340321|NCT00856492|62717148|FG002|Overall Study|Ineligible or withdrew consent|2|||
33340322|NCT00856180|62717159|FG000|Overall Study|Adverse Event|4|||
33340323|NCT00856180|62717159|FG000|Overall Study|Progressive Disease|16|||
33340324|NCT00900627|62717171|FG000|Overall Study|Condition under investigation worsened|4|||
33340325|NCT00900627|62717172|FG001|Overall Study|Condition under investigation worsened|0|||
33340326|NCT00900627|62717173|FG002|Overall Study|Condition under investigation worsened|5|||
33340327|NCT00900627|62717174|FG003|Overall Study|Condition under investigation worsened|3|||
33340328|NCT00900627|62717175|FG004|Overall Study|Condition under investigation worsened|0|||
33340329|NCT00900627|62717176|FG005|Overall Study|Condition under investigation worsened|0|||
33340330|NCT00900627|62717171|FG000|Overall Study|Withdrawal by Subject|1|||
33340331|NCT00900627|62717172|FG001|Overall Study|Withdrawal by Subject|0|||
33340332|NCT00900627|62717173|FG002|Overall Study|Withdrawal by Subject|1|||
33340333|NCT00900627|62717174|FG003|Overall Study|Withdrawal by Subject|0|||
33340334|NCT00900627|62717175|FG004|Overall Study|Withdrawal by Subject|1|||
33340335|NCT00900627|62717176|FG005|Overall Study|Withdrawal by Subject|2|||
33340336|NCT00900627|62717171|FG000|Overall Study|Adverse Event|1|||
33469866|NCT03720470|62843582|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
33340337|NCT00900627|62717172|FG001|Overall Study|Adverse Event|2|||
33340338|NCT00900627|62717173|FG002|Overall Study|Adverse Event|0|||
33340339|NCT00900627|62717174|FG003|Overall Study|Adverse Event|3|||
33340340|NCT00900627|62717175|FG004|Overall Study|Adverse Event|0|||
33340341|NCT00900627|62717176|FG005|Overall Study|Adverse Event|0|||
33340342|NCT00900627|62717171|FG000|Overall Study|Death|0|||
33340343|NCT00900627|62717172|FG001|Overall Study|Death|0|||
33340344|NCT00900627|62717173|FG002|Overall Study|Death|0|||
33340345|NCT00900627|62717174|FG003|Overall Study|Death|0|||
33340346|NCT00900627|62717175|FG004|Overall Study|Death|28|||
33340347|NCT00900627|62717176|FG005|Overall Study|Death|24|||
33340348|NCT00866320|62717190|FG000|Overall Study|Withdrawal by Subject|4|||
33340349|NCT00866320|62717190|FG000|Overall Study|Death|2|||
33340350|NCT00869518|62717198|FG000|Overall Study|Lost to Follow-up|1|||
33340351|NCT00869518|62717199|FG001|Overall Study|Lost to Follow-up|1|||
33340352|NCT00797563|62717205|FG000|Overall Study|Adverse Event|1|||
33340353|NCT00869440|62717213|FG000|Overall Study|Withdrawal by Subject|1|||
33340354|NCT00869440|62717214|FG001|Overall Study|Withdrawal by Subject|0|||
33340355|NCT00869440|62717215|FG002|Overall Study|Withdrawal by Subject|0|||
33340356|NCT00869440|62717216|FG003|Overall Study|Withdrawal by Subject|0|||
33340357|NCT00869440|62717213|FG000|Overall Study|Physician Decision|1|||
33340358|NCT00869440|62717214|FG001|Overall Study|Physician Decision|1|||
33340359|NCT00869440|62717215|FG002|Overall Study|Physician Decision|0|||
33340360|NCT00869440|62717216|FG003|Overall Study|Physician Decision|0|||
33340361|NCT00895947|62717228|FG000|Overall Study|Adverse Event|3|||
33340362|NCT00895947|62717229|FG001|Overall Study|Adverse Event|4|||
33340363|NCT00895947|62717228|FG000|Overall Study|Lost to Follow-up|3|||
33340364|NCT00895947|62717229|FG001|Overall Study|Lost to Follow-up|4|||
33340365|NCT00895947|62717228|FG000|Overall Study|Protocol Violation|4|||
33340366|NCT00895947|62717229|FG001|Overall Study|Protocol Violation|2|||
33340367|NCT00895947|62717228|FG000|Overall Study|Withdrawal by Subject|2|||
33340368|NCT00895947|62717229|FG001|Overall Study|Withdrawal by Subject|0|||
33340369|NCT00869362|62717237|FG000|Overall Study|Death|0|||
33340370|NCT00869362|62717238|FG001|Overall Study|Death|2|||
33340371|NCT00869362|62717237|FG000|Overall Study|Lost to Follow-up|1|||
33340372|NCT00869362|62717238|FG001|Overall Study|Lost to Follow-up|3|||
33340373|NCT00588445|62717245|FG000|Overall Study|Protocol Violation|1|||
33340374|NCT00588445|62717245|FG000|Overall Study|Withdrawal by Subject|3|||
33340375|NCT00588445|62717245|FG000|Overall Study|Disease Progression|1|||
33340376|NCT00588445|62717245|FG000|Overall Study|Not Treated|10|||
33340377|NCT00796315|62717251|FG000|Overall Study|Protocol Violation|0|||
33340378|NCT00796315|62717252|FG001|Overall Study|Protocol Violation|1|||
33340379|NCT00796315|62717253|FG002|Overall Study|Protocol Violation|0|||
33340380|NCT00855166|62717266|FG000|Overall Study|Adverse Event|0|||
33340381|NCT00855166|62717267|FG001|Overall Study|Adverse Event|2|||
33340382|NCT00855166|62717266|FG000|Overall Study|Death|0|||
33340383|NCT00855166|62717267|FG001|Overall Study|Death|1|||
33340384|NCT00855166|62717266|FG000|Overall Study|Withdrawal by Subject|1|||
33340385|NCT00855166|62717267|FG001|Overall Study|Withdrawal by Subject|4|||
33340386|NCT00855166|62717266|FG000|Overall Study|Poor/non-compliance|2|||
33340387|NCT00855166|62717267|FG001|Overall Study|Poor/non-compliance|0|||
33340388|NCT00855166|62717266|FG000|Overall Study|Administrative reasons by sponsor|1|||
33340389|NCT00855166|62717267|FG001|Overall Study|Administrative reasons by sponsor|0|||
33340390|NCT00855166|62717266|FG000|Overall Study|Subject no longer meets study criteria|1|||
33340391|NCT00855166|62717267|FG001|Overall Study|Subject no longer meets study criteria|1|||
33340392|NCT00587587|62717277|FG000|Overall Study|Lost to Follow-up|6|||
33340393|NCT00587587|62717278|FG001|Overall Study|Lost to Follow-up|1|||
33340394|NCT00854620|62717286|FG000|Overall Study|Adverse Event|1|||
33340395|NCT00793585|62717292|FG000|Overall Study|Adverse Event|1|||
33340396|NCT00793585|62717293|FG001|Overall Study|Adverse Event|1|||
33340397|NCT00793585|62717292|FG000|Overall Study|Protocol Violation|1|||
33340398|NCT00793585|62717293|FG001|Overall Study|Protocol Violation|2|||
33340399|NCT00898443|62717301|FG000|Overall Study|Withdrawal by Subject|1|||
33340400|NCT00898443|62717302|FG001|Overall Study|Withdrawal by Subject|0|||
33340401|NCT00900159|62717310|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
33340402|NCT00900159|62717311|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
33340403|NCT00854308|62717330|FG000|Overall Study|Disease progression|42|||
33340404|NCT00854308|62717331|FG001|Overall Study|Disease progression|50|||
33340405|NCT00854308|62717330|FG000|Overall Study|Adverse Event|8|||
33340406|NCT00854308|62717331|FG001|Overall Study|Adverse Event|3|||
33340407|NCT00854308|62717330|FG000|Overall Study|Death|2|||
33340408|NCT00854308|62717331|FG001|Overall Study|Death|5|||
33340409|NCT00854308|62717330|FG000|Overall Study|Physician Decision|6|||
33340410|NCT00854308|62717331|FG001|Overall Study|Physician Decision|6|||
33340411|NCT00854308|62717330|FG000|Overall Study|Withdrawal by Subject|4|||
33340412|NCT00854308|62717331|FG001|Overall Study|Withdrawal by Subject|2|||
33340413|NCT00854308|62717330|FG000|Overall Study|Sponsor's decision to terminate study|0|||
33340414|NCT00854308|62717331|FG001|Overall Study|Sponsor's decision to terminate study|1|||
33340415|NCT00592852|62717337|FG000|Overall Study|Non-compliance|1|||
33469867|NCT03720470|62843577|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
33580908|NCT01454934|62978057|FG000|Overall Study|Withdrawn consent|2|||
33340416|NCT00592852|62717337|FG000|Overall Study|Adverse Event|3|||
33340417|NCT00592852|62717337|FG000|Overall Study|Found ineligible|1|||
33340418|NCT00592852|62717337|FG000|Overall Study|Withdrawal by Subject|1|||
33340419|NCT00895245|62717341|FG000|Overall Study|Lack of Efficacy|6|||
33340420|NCT00865306|62717347|FG000|Controlled Trial|Lost to Follow-up|1|||
33340421|NCT00865306|62717348|FG001|Controlled Trial|Lost to Follow-up|1|||
33340422|NCT00865306|62717347|FG000|Controlled Trial|Difficulty commuting|2|||
33340423|NCT00865306|62717348|FG001|Controlled Trial|Difficulty commuting|0|||
33340424|NCT00865306|62717347|FG000|Controlled Trial|Improved btw baseline and first session|1|||
33340425|NCT00865306|62717348|FG001|Controlled Trial|Improved btw baseline and first session|0|||
33340426|NCT00865306|62717347|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
33340427|NCT00865306|62717348|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
33340428|NCT00865306|62717347|FG000|Controlled Trial|Withdrawal by Subject|0|||
33340429|NCT00865306|62717348|FG001|Controlled Trial|Withdrawal by Subject|1|||
33340430|NCT00896649|62717354|FG000|Overall Study|Physician Decision|1|||
33340431|NCT00896649|62717354|FG000|Overall Study|Pregnancy|1|||
33340432|NCT00896649|62717354|FG000|Overall Study|missing documentation|1|||
33340433|NCT00896649|62717354|FG000|Overall Study|technical difficulties|2|||
33340434|NCT00796003|62717361|FG000|Overall Study|Disease Progression|2|||
33340435|NCT00796003|62717362|FG001|Overall Study|Disease Progression|13|||
33340436|NCT00796003|62717361|FG000|Overall Study|Adverse Event|1|||
33340437|NCT00796003|62717362|FG001|Overall Study|Adverse Event|7|||
33654451|NCT01683409|63067191|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
33340438|NCT00796003|62717361|FG000|Overall Study|Specified organ function not met|0|||
33654452|NCT01683409|63067192|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
33654453|NCT01683409|63067193|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
33340439|NCT00796003|62717362|FG001|Overall Study|Specified organ function not met|1|||
33340440|NCT00796003|62717361|FG000|Overall Study|Physician Decision|0|||
33340441|NCT00796003|62717362|FG001|Overall Study|Physician Decision|4|||
33340442|NCT00796003|62717361|FG000|Overall Study|Withdrawal by Subject|0|||
33340443|NCT00796003|62717362|FG001|Overall Study|Withdrawal by Subject|1|||
33340444|NCT00796003|62717361|FG000|Overall Study|Other|0|||
33340445|NCT00796003|62717362|FG001|Overall Study|Other|1|||
33340446|NCT00796003|62717361|FG000|Overall Study|Participants Not treated|0|||
33340447|NCT00796003|62717362|FG001|Overall Study|Participants Not treated|2|||
33340448|NCT00895011|62717374|FG000|Overall Study|Withdrawal by Subject|14|||
33340449|NCT00895011|62717375|FG001|Overall Study|Withdrawal by Subject|7|||
33340450|NCT00895011|62717376|FG002|Overall Study|Withdrawal by Subject|2|||
33340451|NCT00895011|62717374|FG000|Overall Study|Lost to Follow-up|5|||
33340452|NCT00895011|62717375|FG001|Overall Study|Lost to Follow-up|4|||
33340453|NCT00895011|62717376|FG002|Overall Study|Lost to Follow-up|1|||
33340454|NCT00895011|62717374|FG000|Overall Study|Protocol Violation|3|||
33340455|NCT00895011|62717375|FG001|Overall Study|Protocol Violation|1|||
33340456|NCT00895011|62717376|FG002|Overall Study|Protocol Violation|3|||
33340457|NCT00895011|62717374|FG000|Overall Study|Adverse Event|1|||
33340458|NCT00895011|62717375|FG001|Overall Study|Adverse Event|2|||
33340459|NCT00895011|62717376|FG002|Overall Study|Adverse Event|2|||
33340460|NCT00895011|62717374|FG000|Overall Study|schedule conflict|1|||
33340461|NCT00895011|62717375|FG001|Overall Study|schedule conflict|0|||
33340462|NCT00895011|62717376|FG002|Overall Study|schedule conflict|0|||
33340463|NCT00899847|62717385|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
33340464|NCT00795535|62717391|FG000|Overall Study|incomplete data and technical problems|20|||
33340465|NCT00853762|62717399|FG000|Overall Study|Premature Termination|16|||
33340466|NCT00853762|62717400|FG001|Overall Study|Premature Termination|15|||
33340467|NCT00853762|62717401|FG002|Overall Study|Premature Termination|14|||
33340468|NCT00853762|62717402|FG003|Overall Study|Premature Termination|21|||
33340469|NCT00853762|62717399|FG000|Overall Study|Protocol Violation|0|||
33340470|NCT00853762|62717400|FG001|Overall Study|Protocol Violation|0|||
33340471|NCT00853762|62717401|FG002|Overall Study|Protocol Violation|0|||
33340472|NCT00853762|62717402|FG003|Overall Study|Protocol Violation|1|||
33340473|NCT00853762|62717399|FG000|Overall Study|Withdrawal by Subject|0|||
33340474|NCT00853762|62717400|FG001|Overall Study|Withdrawal by Subject|0|||
33340475|NCT00853762|62717401|FG002|Overall Study|Withdrawal by Subject|1|||
33340476|NCT00853762|62717402|FG003|Overall Study|Withdrawal by Subject|0|||
33340477|NCT00853762|62717399|FG000|Overall Study|Other|0|||
33340478|NCT00853762|62717400|FG001|Overall Study|Other|2|||
33340479|NCT00853762|62717401|FG002|Overall Study|Other|0|||
33340480|NCT00853762|62717402|FG003|Overall Study|Other|0|||
33340481|NCT00853762|62717399|FG000|Overall Study|Randomised but not Treated|0|||
33340482|NCT00853762|62717400|FG001|Overall Study|Randomised but not Treated|2|||
33340483|NCT00853762|62717401|FG002|Overall Study|Randomised but not Treated|2|||
33340484|NCT00853762|62717402|FG003|Overall Study|Randomised but not Treated|0|||
33340485|NCT00789529|62717414|FG000|Overall Study|Withdrawal by Subject|0|||
33340486|NCT00789529|62717415|FG001|Overall Study|Withdrawal by Subject|1|||
33340487|NCT00789529|62717414|FG000|Overall Study|Other Reason|1|||
33340488|NCT00789529|62717415|FG001|Overall Study|Other Reason|0|||
33340489|NCT00894933|62717421|FG000|Overall Study|Lost to Follow-up|2|||
33340490|NCT00894933|62717421|FG000|Overall Study|Cancelled Procedure|1|||
33340491|NCT00894933|62717421|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
33340492|NCT00792805|62717428|FG000|Overall Study|Adverse Event|12|||
33340493|NCT00792805|62717429|FG001|Overall Study|Adverse Event|10|||
33340494|NCT00792805|62717430|FG002|Overall Study|Adverse Event|10|||
33340495|NCT00792805|62717428|FG000|Overall Study|Subject withdrew consent|5|||
33340496|NCT00792805|62717429|FG001|Overall Study|Subject withdrew consent|6|||
33340497|NCT00792805|62717430|FG002|Overall Study|Subject withdrew consent|5|||
33340498|NCT00792805|62717428|FG000|Overall Study|Administrative problems|2|||
33340499|NCT00792805|62717429|FG001|Overall Study|Administrative problems|0|||
33340500|NCT00792805|62717430|FG002|Overall Study|Administrative problems|4|||
33340501|NCT00792805|62717428|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33340502|NCT00792805|62717429|FG001|Overall Study|Abnormal test procedure result(s)|2|||
33340503|NCT00792805|62717430|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33340504|NCT00792805|62717428|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33340505|NCT00792805|62717429|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
33340506|NCT00792805|62717430|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
33340507|NCT00792805|62717428|FG000|Overall Study|Lost to Follow-up|1|||
33340508|NCT00792805|62717429|FG001|Overall Study|Lost to Follow-up|1|||
33340509|NCT00792805|62717430|FG002|Overall Study|Lost to Follow-up|6|||
33340510|NCT00792805|62717428|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33340511|NCT00792805|62717429|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33340512|NCT00792805|62717430|FG002|Overall Study|Abnormal laboratory value(s)|1|||
33340513|NCT00792805|62717428|FG000|Overall Study|Protocol deviation|0|||
33340514|NCT00792805|62717429|FG001|Overall Study|Protocol deviation|1|||
33340515|NCT00792805|62717430|FG002|Overall Study|Protocol deviation|1|||
33340516|NCT00925002|62717441|FG000|Overall Study|Other|1|||
33340517|NCT00925002|62717442|FG001|Overall Study|Other|4|||
33340518|NCT00925002|62717443|FG002|Overall Study|Other|0|||
33340519|NCT00925002|62717441|FG000|Overall Study|Death|1|||
33340520|NCT00925002|62717442|FG001|Overall Study|Death|1|||
33340521|NCT00925002|62717443|FG002|Overall Study|Death|5|||
33340522|NCT00925002|62717441|FG000|Overall Study|Adverse Event|3|||
33340523|NCT00925002|62717442|FG001|Overall Study|Adverse Event|1|||
33340524|NCT00925002|62717443|FG002|Overall Study|Adverse Event|2|||
33340525|NCT00925002|62717441|FG000|Overall Study|Participant withdrew consent|1|||
33340526|NCT00925002|62717442|FG001|Overall Study|Participant withdrew consent|3|||
33340527|NCT00925002|62717443|FG002|Overall Study|Participant withdrew consent|3|||
33340528|NCT00928746|62717452|FG000|Overall Study|Adverse Event|2|||
33340529|NCT00928746|62717452|FG000|Overall Study|Protocol Violation|1|||
33340530|NCT00928746|62717452|FG000|Overall Study|Withdrawal by Subject|1|||
33340531|NCT00928746|62717452|FG000|Overall Study|Other|2|||
33340532|NCT00922428|62717458|FG000|Overall Study|retrospective/extremely implausible data|2|||
33340533|NCT00922428|62717458|FG000|Overall Study|no medication use or questionable use|13|||
33340534|NCT00894543|62717470|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
33340535|NCT00894543|62717471|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
33340536|NCT00894543|62717470|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
33340537|NCT00894543|62717471|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
33340538|NCT00922272|62717477|FG000|Open-label Phase|Adverse Event|5|||
33340539|NCT00922272|62717478|FG001|Open-label Phase|Adverse Event|0|||
33340540|NCT00922272|62717477|FG000|Open-label Phase|Protocol Violation|1|||
33340541|NCT00922272|62717478|FG001|Open-label Phase|Protocol Violation|0|||
33340542|NCT00922272|62717477|FG000|Open-label Phase|Withdrawal by Subject|11|||
33340543|NCT00922272|62717478|FG001|Open-label Phase|Withdrawal by Subject|0|||
33340544|NCT00922272|62717477|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
33340545|NCT00922272|62717478|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
33340546|NCT00922272|62717477|FG000|Open-label Phase|Withdrawal criteria met|5|||
33340547|NCT00922272|62717478|FG001|Open-label Phase|Withdrawal criteria met|0|||
33340548|NCT00922272|62717477|FG000|Double-blind Phase|Adverse Event|1|||
33340549|NCT00922272|62717478|FG001|Double-blind Phase|Adverse Event|1|||
33340550|NCT00922272|62717477|FG000|Double-blind Phase|Withdrawal by Subject|1|||
33340551|NCT00922272|62717478|FG001|Double-blind Phase|Withdrawal by Subject|1|||
33340552|NCT00922272|62717477|FG000|Double-blind Phase|Lost to Follow-up|2|||
33340553|NCT00922272|62717478|FG001|Double-blind Phase|Lost to Follow-up|1|||
33340554|NCT00922272|62717477|FG000|Double-blind Phase|Withdrawal criteria met|1|||
33340555|NCT00922272|62717478|FG001|Double-blind Phase|Withdrawal criteria met|1|||
33340556|NCT00922272|62717477|FG000|Double-blind Phase|Noncompliance|1|||
33340557|NCT00922272|62717478|FG001|Double-blind Phase|Noncompliance|1|||
33340558|NCT00922272|62717477|FG000|Double-blind Phase|Positive urine drug screen|1|||
33340559|NCT00922272|62717478|FG001|Double-blind Phase|Positive urine drug screen|1|||
33340560|NCT00853372|62717488|FG000|Overall Study|Death|30|||
33340561|NCT00853372|62717489|FG001|Overall Study|Death|26|||
33340562|NCT00853372|62717488|FG000|Overall Study|Lost to Follow-up|1|||
33340563|NCT00853372|62717489|FG001|Overall Study|Lost to Follow-up|2|||
33340564|NCT00853372|62717488|FG000|Overall Study|Full Consent Withdrawn|1|||
33340565|NCT00853372|62717489|FG001|Overall Study|Full Consent Withdrawn|1|||
33340566|NCT00848536|62717497|FG000|Overall Study|Adverse Event|2|||
33340567|NCT00848536|62717498|FG001|Overall Study|Adverse Event|2|||
33340568|NCT00848536|62717497|FG000|Overall Study|Withdrawal by Subject|0|||
33340569|NCT00848536|62717498|FG001|Overall Study|Withdrawal by Subject|1|||
33340570|NCT00848536|62717497|FG000|Overall Study|Protocol Violation|0|||
33340571|NCT00848536|62717498|FG001|Overall Study|Protocol Violation|1|||
33340572|NCT00848536|62717497|FG000|Overall Study|Noncompliance|1|||
33469868|NCT03720470|62843578|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
33340573|NCT00848536|62717498|FG001|Overall Study|Noncompliance|0|||
33340574|NCT00848536|62717497|FG000|Overall Study|Inadequate Control of IOP|1|||
33340575|NCT00848536|62717498|FG001|Overall Study|Inadequate Control of IOP|1|||
33340576|NCT00848536|62717497|FG000|Overall Study|Patient Moved|0|||
33340577|NCT00848536|62717498|FG001|Overall Study|Patient Moved|2|||
33340578|NCT00922116|62717504|FG000|Overall Study|Adverse Event|4|||
33340579|NCT00922116|62717504|FG000|Overall Study|Death|1|||
33340580|NCT00922116|62717504|FG000|Overall Study|Lost to Follow-up|1|||
33340581|NCT00922116|62717504|FG000|Overall Study|Withdrawal by Subject|4|||
33340582|NCT00922116|62717504|FG000|Overall Study|Other|5|||
33340583|NCT00921024|62717510|FG000|Overall Study|Lost to Follow-up|2|||
33340584|NCT00921024|62717511|FG001|Overall Study|Lost to Follow-up|0|||
33340585|NCT00921024|62717510|FG000|Overall Study|Received concomittant therapy|2|||
33340586|NCT00921024|62717511|FG001|Overall Study|Received concomittant therapy|0|||
33340587|NCT00921024|62717510|FG000|Overall Study|Withdrawal by Subject|0|||
33340588|NCT00921024|62717511|FG001|Overall Study|Withdrawal by Subject|3|||
33340589|NCT00928668|62717517|FG000|Overall Study|Adverse Event|1|||
33340590|NCT00928668|62717518|FG001|Overall Study|Adverse Event|0|||
33340591|NCT00928668|62717519|FG002|Overall Study|Adverse Event|0|||
33340592|NCT00928668|62717520|FG003|Overall Study|Adverse Event|0|||
33340593|NCT00928668|62717521|FG004|Overall Study|Adverse Event|0|||
33340594|NCT00928668|62717517|FG000|Overall Study|Protocol Violation|0|||
33340595|NCT00928668|62717518|FG001|Overall Study|Protocol Violation|0|||
33340596|NCT00928668|62717519|FG002|Overall Study|Protocol Violation|0|||
33340597|NCT00928668|62717520|FG003|Overall Study|Protocol Violation|0|||
33340598|NCT00928668|62717521|FG004|Overall Study|Protocol Violation|1|||
33340599|NCT00928668|62717517|FG000|Overall Study|Withdrawal by Subject|0|||
33340600|NCT00928668|62717518|FG001|Overall Study|Withdrawal by Subject|1|||
33340601|NCT00928668|62717519|FG002|Overall Study|Withdrawal by Subject|1|||
33340602|NCT00928668|62717520|FG003|Overall Study|Withdrawal by Subject|0|||
33340603|NCT00928668|62717521|FG004|Overall Study|Withdrawal by Subject|0|||
33340604|NCT00928668|62717517|FG000|Overall Study|Other reasons not listed above|0|||
33340605|NCT00928668|62717518|FG001|Overall Study|Other reasons not listed above|0|||
33340606|NCT00928668|62717519|FG002|Overall Study|Other reasons not listed above|0|||
33340607|NCT00928668|62717520|FG003|Overall Study|Other reasons not listed above|1|||
33340608|NCT00928668|62717521|FG004|Overall Study|Other reasons not listed above|0|||
33340609|NCT00592774|62717543|FG000|Overall Study|Adverse Event|5|||
33340610|NCT00592774|62717544|FG001|Overall Study|Adverse Event|19|||
33340611|NCT00592774|62717545|FG002|Overall Study|Adverse Event|2|||
33340612|NCT00592774|62717546|FG003|Overall Study|Adverse Event|14|||
33340613|NCT00592774|62717547|FG004|Overall Study|Adverse Event|8|||
33340614|NCT00592774|62717543|FG000|Overall Study|Protocol Violation|0|||
33340615|NCT00592774|62717544|FG001|Overall Study|Protocol Violation|1|||
33340616|NCT00592774|62717545|FG002|Overall Study|Protocol Violation|0|||
33340617|NCT00592774|62717546|FG003|Overall Study|Protocol Violation|0|||
33340618|NCT00592774|62717547|FG004|Overall Study|Protocol Violation|1|||
33340619|NCT00592774|62717543|FG000|Overall Study|Withdrawal by Subject|3|||
33340620|NCT00592774|62717544|FG001|Overall Study|Withdrawal by Subject|7|||
33340621|NCT00592774|62717545|FG002|Overall Study|Withdrawal by Subject|0|||
33340622|NCT00592774|62717546|FG003|Overall Study|Withdrawal by Subject|0|||
33340623|NCT00592774|62717547|FG004|Overall Study|Withdrawal by Subject|0|||
33340624|NCT00592774|62717543|FG000|Overall Study|Lack of Efficacy|3|||
33340625|NCT00592774|62717544|FG001|Overall Study|Lack of Efficacy|3|||
33340626|NCT00592774|62717545|FG002|Overall Study|Lack of Efficacy|0|||
33340627|NCT00592774|62717546|FG003|Overall Study|Lack of Efficacy|0|||
33340628|NCT00592774|62717547|FG004|Overall Study|Lack of Efficacy|2|||
33340629|NCT00592774|62717543|FG000|Overall Study|Physician Decision|0|||
33340630|NCT00592774|62717544|FG001|Overall Study|Physician Decision|1|||
33340631|NCT00592774|62717545|FG002|Overall Study|Physician Decision|1|||
33340632|NCT00592774|62717546|FG003|Overall Study|Physician Decision|0|||
33340633|NCT00592774|62717547|FG004|Overall Study|Physician Decision|1|||
33340634|NCT00592774|62717543|FG000|Overall Study|Other|0|||
33340635|NCT00592774|62717544|FG001|Overall Study|Other|1|||
33340636|NCT00592774|62717545|FG002|Overall Study|Other|1|||
33340637|NCT00592774|62717546|FG003|Overall Study|Other|0|||
33340638|NCT00592774|62717547|FG004|Overall Study|Other|2|||
33340639|NCT00837694|62717565|FG000|Overall Study|Lost to Follow-up|2|||
33340640|NCT00837694|62717566|FG001|Overall Study|Lost to Follow-up|0|||
33340641|NCT00837694|62717567|FG002|Overall Study|Lost to Follow-up|2|||
33580909|NCT01454934|62978058|FG001|Overall Study|Withdrawn consent|5|||
33340642|NCT00837694|62717568|FG003|Overall Study|Lost to Follow-up|1|||
33340643|NCT00837694|62717569|FG004|Overall Study|Lost to Follow-up|1|||
33340644|NCT00837694|62717570|FG005|Overall Study|Lost to Follow-up|1|||
33340645|NCT00852202|62717587|FG000|Overall Study|Adverse Event|2|||
33340646|NCT00852202|62717588|FG001|Overall Study|Adverse Event|3|||
33340647|NCT00852202|62717589|FG002|Overall Study|Adverse Event|7|||
33340648|NCT00852202|62717587|FG000|Overall Study|Lack of Efficacy|4|||
33340649|NCT00852202|62717588|FG001|Overall Study|Lack of Efficacy|1|||
33340650|NCT00852202|62717589|FG002|Overall Study|Lack of Efficacy|2|||
33340651|NCT00852202|62717587|FG000|Overall Study|Protocol Violation|2|||
33340652|NCT00852202|62717588|FG001|Overall Study|Protocol Violation|2|||
33340653|NCT00852202|62717589|FG002|Overall Study|Protocol Violation|7|||
33340654|NCT00852202|62717587|FG000|Overall Study|Withdrawal by Subject|3|||
33340655|NCT00852202|62717588|FG001|Overall Study|Withdrawal by Subject|1|||
33340656|NCT00852202|62717589|FG002|Overall Study|Withdrawal by Subject|2|||
33340657|NCT00852202|62717587|FG000|Overall Study|Lost to Follow-up|5|||
33340658|NCT00852202|62717588|FG001|Overall Study|Lost to Follow-up|5|||
33340659|NCT00852202|62717589|FG002|Overall Study|Lost to Follow-up|6|||
33340660|NCT00852202|62717587|FG000|Overall Study|pregnancy,moving away and surgery|1|||
33340661|NCT00852202|62717588|FG001|Overall Study|pregnancy,moving away and surgery|0|||
33340662|NCT00852202|62717589|FG002|Overall Study|pregnancy,moving away and surgery|2|||
33340663|NCT01074008|62717607|FG000|Overall Study|Adverse Event|0|||
33340664|NCT01074008|62717608|FG001|Overall Study|Adverse Event|1|||
33340665|NCT01074008|62717609|FG002|Overall Study|Adverse Event|0|||
33340666|NCT01074008|62717610|FG003|Overall Study|Adverse Event|0|||
33340667|NCT01074008|62717611|FG004|Overall Study|Adverse Event|0|||
33340668|NCT01074008|62717612|FG005|Overall Study|Adverse Event|0|||
33340669|NCT01074008|62717613|FG006|Overall Study|Adverse Event|0|||
33340670|NCT01074008|62717614|FG007|Overall Study|Adverse Event|0|||
33340671|NCT01074008|62717615|FG008|Overall Study|Adverse Event|0|||
33340672|NCT01074008|62717607|FG000|Overall Study|Withdrawal by Subject|1|||
33340673|NCT01074008|62717608|FG001|Overall Study|Withdrawal by Subject|1|||
33340674|NCT01074008|62717609|FG002|Overall Study|Withdrawal by Subject|1|||
33340675|NCT01074008|62717610|FG003|Overall Study|Withdrawal by Subject|0|||
33340676|NCT01074008|62717611|FG004|Overall Study|Withdrawal by Subject|1|||
33340677|NCT01074008|62717612|FG005|Overall Study|Withdrawal by Subject|0|||
33340678|NCT01074008|62717613|FG006|Overall Study|Withdrawal by Subject|0|||
33340679|NCT01074008|62717614|FG007|Overall Study|Withdrawal by Subject|0|||
33340680|NCT01074008|62717615|FG008|Overall Study|Withdrawal by Subject|0|||
33340681|NCT01074008|62717607|FG000|Overall Study|Lost to Follow-up|0|||
33340682|NCT01074008|62717608|FG001|Overall Study|Lost to Follow-up|1|||
33340683|NCT01074008|62717609|FG002|Overall Study|Lost to Follow-up|1|||
33340684|NCT01074008|62717610|FG003|Overall Study|Lost to Follow-up|1|||
33340685|NCT01074008|62717611|FG004|Overall Study|Lost to Follow-up|1|||
33340686|NCT01074008|62717612|FG005|Overall Study|Lost to Follow-up|0|||
33340687|NCT01074008|62717613|FG006|Overall Study|Lost to Follow-up|1|||
33340688|NCT01074008|62717614|FG007|Overall Study|Lost to Follow-up|0|||
33340689|NCT01074008|62717615|FG008|Overall Study|Lost to Follow-up|4|||
33340690|NCT01073930|62717646|FG000|Overall Study|Withdrawal by Subject|3|||
33340691|NCT01073930|62717647|FG001|Overall Study|Withdrawal by Subject|2|||
33340692|NCT01073930|62717646|FG000|Overall Study|Lost to Follow-up|0|||
33340693|NCT01073930|62717647|FG001|Overall Study|Lost to Follow-up|1|||
33340694|NCT01073930|62717646|FG000|Overall Study|Adverse Event|0|||
33340695|NCT01073930|62717647|FG001|Overall Study|Adverse Event|1|||
33340696|NCT01073930|62717646|FG000|Overall Study|Noncompliance with study drug|0|||
33340697|NCT01073930|62717647|FG001|Overall Study|Noncompliance with study drug|1|||
33340698|NCT01073930|62717646|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
33340699|NCT01073930|62717647|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
33340700|NCT01073618|62717653|FG000|Overall Study|Death|208|||
33340701|NCT01073618|62717653|FG000|Overall Study|Adverse Event|19|||
33340702|NCT01073618|62717653|FG000|Overall Study|Other|80|||
33340703|NCT01073462|62717657|FG000|Overall Study|Death|14|||
33340704|NCT01073462|62717657|FG000|Overall Study|Kidney transplant|10|||
33340705|NCT01073462|62717657|FG000|Overall Study|Low parathyroid hormone levels|8|||
33340706|NCT01073462|62717657|FG000|Overall Study|Serious adverse event|2|||
33340707|NCT01073462|62717657|FG000|Overall Study|Lost to Follow-up|7|||
33340708|NCT00789373|62717661|FG000|Induction|Adverse Event|64|||
33340709|NCT00789373|62717662|FG001|Induction|Adverse Event|0|||
33340710|NCT00789373|62717663|FG002|Induction|Adverse Event|0|||
33340711|NCT00789373|62717661|FG000|Induction|Death Due to study disease|24|||
33340712|NCT00789373|62717662|FG001|Induction|Death Due to study disease|0|||
33340713|NCT00789373|62717663|FG002|Induction|Death Due to study disease|0|||
33340714|NCT00789373|62717661|FG000|Induction|Death due to adverse event|19|||
33340715|NCT00789373|62717662|FG001|Induction|Death due to adverse event|0|||
33654454|NCT01683409|63067194|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
33340716|NCT00789373|62717663|FG002|Induction|Death due to adverse event|0|||
33340717|NCT00789373|62717661|FG000|Induction|Death due to toxicity|11|||
33340718|NCT00789373|62717662|FG001|Induction|Death due to toxicity|0|||
33340719|NCT00789373|62717663|FG002|Induction|Death due to toxicity|0|||
33340720|NCT00789373|62717661|FG000|Induction|Death due to procedure|1|||
33340721|NCT00789373|62717662|FG001|Induction|Death due to procedure|0|||
33340722|NCT00789373|62717663|FG002|Induction|Death due to procedure|0|||
33548860|NCT02959177|62940235|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
33340723|NCT00789373|62717661|FG000|Induction|Investigator decision|7|||
33340724|NCT00789373|62717662|FG001|Induction|Investigator decision|0|||
33340725|NCT00789373|62717663|FG002|Induction|Investigator decision|0|||
33340726|NCT00789373|62717661|FG000|Induction|Protocol entry criteria not met|9|||
33340727|NCT00789373|62717662|FG001|Induction|Protocol entry criteria not met|0|||
33340728|NCT00789373|62717663|FG002|Induction|Protocol entry criteria not met|0|||
33340729|NCT00789373|62717661|FG000|Induction|Lost to Follow-up|6|||
33340730|NCT00789373|62717662|FG001|Induction|Lost to Follow-up|0|||
33340731|NCT00789373|62717663|FG002|Induction|Lost to Follow-up|0|||
33340732|NCT00789373|62717661|FG000|Induction|Protocol Violation|1|||
33340733|NCT00789373|62717662|FG001|Induction|Protocol Violation|0|||
33340734|NCT00789373|62717663|FG002|Induction|Protocol Violation|0|||
33340735|NCT00789373|62717661|FG000|Induction|Progressive Disease|220|||
33340736|NCT00789373|62717662|FG001|Induction|Progressive Disease|0|||
33340737|NCT00789373|62717663|FG002|Induction|Progressive Disease|0|||
33340738|NCT00789373|62717661|FG000|Induction|Withdrawal by Subject|37|||
33340739|NCT00789373|62717662|FG001|Induction|Withdrawal by Subject|0|||
33340740|NCT00789373|62717663|FG002|Induction|Withdrawal by Subject|0|||
33340741|NCT00789373|62717661|FG000|Maintenance|Adverse Event|0|||
33340742|NCT00789373|62717662|FG001|Maintenance|Adverse Event|65|||
33340743|NCT00789373|62717663|FG002|Maintenance|Adverse Event|12|||
33340744|NCT00789373|62717661|FG000|Maintenance|Death due to study disease|0|||
33340745|NCT00789373|62717662|FG001|Maintenance|Death due to study disease|3|||
33340746|NCT00789373|62717663|FG002|Maintenance|Death due to study disease|1|||
33340747|NCT00789373|62717661|FG000|Maintenance|Death due to adverse event|0|||
33340748|NCT00789373|62717662|FG001|Maintenance|Death due to adverse event|4|||
33340749|NCT00789373|62717663|FG002|Maintenance|Death due to adverse event|1|||
33340750|NCT00789373|62717661|FG000|Maintenance|Death due to toxicity|0|||
33340751|NCT00789373|62717662|FG001|Maintenance|Death due to toxicity|1|||
33340752|NCT00789373|62717663|FG002|Maintenance|Death due to toxicity|2|||
33340753|NCT00789373|62717661|FG000|Maintenance|Investigator Decision|0|||
33340754|NCT00789373|62717662|FG001|Maintenance|Investigator Decision|4|||
33340755|NCT00789373|62717663|FG002|Maintenance|Investigator Decision|2|||
33340756|NCT00789373|62717661|FG000|Maintenance|Protocol entry criteria not met|0|||
33340757|NCT00789373|62717662|FG001|Maintenance|Protocol entry criteria not met|2|||
33340758|NCT00789373|62717663|FG002|Maintenance|Protocol entry criteria not met|0|||
33340759|NCT00789373|62717661|FG000|Maintenance|Lost to Follow-up|0|||
33340760|NCT00789373|62717662|FG001|Maintenance|Lost to Follow-up|2|||
33340761|NCT00789373|62717663|FG002|Maintenance|Lost to Follow-up|0|||
33340762|NCT00789373|62717661|FG000|Maintenance|Progressive Disease|0|||
33340763|NCT00789373|62717662|FG001|Maintenance|Progressive Disease|253|||
33340764|NCT00789373|62717663|FG002|Maintenance|Progressive Disease|152|||
33340765|NCT00789373|62717661|FG000|Maintenance|Withdrawal by Subject|0|||
33340766|NCT00789373|62717662|FG001|Maintenance|Withdrawal by Subject|21|||
33340767|NCT00789373|62717663|FG002|Maintenance|Withdrawal by Subject|8|||
33340768|NCT00789373|62717661|FG000|Maintenance|Sponsor Decision|0|||
33340769|NCT00789373|62717662|FG001|Maintenance|Sponsor Decision|0|||
33340770|NCT00789373|62717663|FG002|Maintenance|Sponsor Decision|2|||
33340771|NCT00789373|62717661|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
33340772|NCT00789373|62717662|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
33340773|NCT00789373|62717663|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
33340774|NCT00851890|62717678|FG000|Overall Study|Lost to Follow-up|0|||
33340775|NCT00851890|62717679|FG001|Overall Study|Lost to Follow-up|1|||
33340776|NCT00851890|62717680|FG002|Overall Study|Lost to Follow-up|0|||
33340777|NCT00851890|62717681|FG003|Overall Study|Lost to Follow-up|1|||
33340778|NCT00788827|62717691|FG000|Overall Study|Lack of Efficacy|2|||
33340779|NCT00592072|62717697|FG000|Wash Out Period|Lost to Follow-up|1|||
33340780|NCT00592072|62717698|FG001|Wash Out Period|Lost to Follow-up|1|||
33340781|NCT00792571|62717704|FG000|Overall Study|Death|1|||
33340782|NCT00792571|62717704|FG000|Overall Study|Adverse Event|4|||
33340783|NCT00792571|62717704|FG000|Overall Study|Withdrawal by Subject|1|||
33340784|NCT00792571|62717704|FG000|Overall Study|Other|4|||
33340785|NCT01069484|62717710|FG000|Overall Study|Death-in-near-family|1|||
33340786|NCT01069484|62717711|FG001|Overall Study|Death-in-near-family|0|||
33340787|NCT01069484|62717710|FG000|Overall Study|No specific reason|8|||
33340788|NCT01069484|62717711|FG001|Overall Study|No specific reason|2|||
33340789|NCT01069484|62717710|FG000|Overall Study|Illness mother or child|3|||
33340790|NCT01069484|62717711|FG001|Overall Study|Illness mother or child|1|||
33340791|NCT00794365|62717718|FG000|Overall Study|Lost to Follow-up|38|||
33340792|NCT00794365|62717718|FG000|Overall Study|Other|17|||
33340793|NCT00794365|62717718|FG000|Overall Study|Poor Compliance|11|||
33340794|NCT00794365|62717718|FG000|Overall Study|Adverse Event|10|||
33340795|NCT00794365|62717718|FG000|Overall Study|Lack of Efficacy|3|||
33340796|NCT01067144|62717724|FG000|Treatment|Did not receive allocated intervention|4|||
33340797|NCT01067144|62717725|FG001|Treatment|Did not receive allocated intervention|7|||
33340798|NCT01067144|62717724|FG000|Follow-up|Lost to Follow-up|22|||
33340799|NCT01067144|62717725|FG001|Follow-up|Lost to Follow-up|12|||
33340800|NCT01067144|62717724|FG000|Follow-up|Censored owing to second surgery|19|||
33340801|NCT01067144|62717725|FG001|Follow-up|Censored owing to second surgery|28|||
33340802|NCT01067144|62717724|FG000|Follow-up|Withdrawal by Subject|18|||
33340803|NCT01067144|62717725|FG001|Follow-up|Withdrawal by Subject|14|||
33340804|NCT01067144|62717724|FG000|Follow-up|Surgery cancelled|0|||
33340805|NCT01067144|62717725|FG001|Follow-up|Surgery cancelled|1|||
33340806|NCT01067144|62717724|FG000|Follow-up|Death|0|||
33340807|NCT01067144|62717725|FG001|Follow-up|Death|1|||
33340808|NCT01078298|62717733|FG000|Overall Study|Lost to Follow-up|12|||
33340809|NCT01078298|62717734|FG001|Overall Study|Lost to Follow-up|13|||
33340810|NCT01078298|62717733|FG000|Overall Study|Withdrawal by Subject|31|||
33340811|NCT01078298|62717734|FG001|Overall Study|Withdrawal by Subject|33|||
33340812|NCT01078298|62717733|FG000|Overall Study|Protocol Violation|6|||
33340813|NCT01078298|62717734|FG001|Overall Study|Protocol Violation|6|||
33340814|NCT01078298|62717733|FG000|Overall Study|Adverse Event|6|||
33340815|NCT01078298|62717734|FG001|Overall Study|Adverse Event|5|||
33340816|NCT01078298|62717733|FG000|Overall Study|Death|2|||
33340817|NCT01078298|62717734|FG001|Overall Study|Death|0|||
33340818|NCT01078298|62717733|FG000|Overall Study|Did not meet entrance criteria|0|||
33340819|NCT01078298|62717734|FG001|Overall Study|Did not meet entrance criteria|1|||
33340820|NCT01078298|62717733|FG000|Overall Study|Other|24|||
33340821|NCT01078298|62717734|FG001|Overall Study|Other|32|||
33340822|NCT00788593|62717740|FG000|Placebo Run-in Phase|Adverse Event|2|||
33340823|NCT00788593|62717741|FG001|Placebo Run-in Phase|Adverse Event|0|||
33340824|NCT00788593|62717742|FG002|Placebo Run-in Phase|Adverse Event|0|||
33340825|NCT00788593|62717740|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
33340826|NCT00788593|62717741|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
33340827|NCT00788593|62717742|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
33340828|NCT00788593|62717740|FG000|Placebo Run-in Phase|Protocol Violation|2|||
33340829|NCT00788593|62717741|FG001|Placebo Run-in Phase|Protocol Violation|0|||
33340830|NCT00788593|62717742|FG002|Placebo Run-in Phase|Protocol Violation|0|||
33340831|NCT00788593|62717740|FG000|First Intervention Period|Adverse Event|0|||
33340832|NCT00788593|62717741|FG001|First Intervention Period|Adverse Event|1|||
33340833|NCT00788593|62717742|FG002|First Intervention Period|Adverse Event|0|||
33340834|NCT00788593|62717740|FG000|Second Intervention Period|Lost to Follow-up|0|||
33340835|NCT00788593|62717741|FG001|Second Intervention Period|Lost to Follow-up|1|||
33340836|NCT00788593|62717742|FG002|Second Intervention Period|Lost to Follow-up|0|||
33340837|NCT00788593|62717740|FG000|Second Intervention Period|Other|0|||
33340838|NCT00788593|62717741|FG001|Second Intervention Period|Other|0|||
33340839|NCT00788593|62717742|FG002|Second Intervention Period|Other|1|||
33340840|NCT00793819|62717754|FG000|Overall Study|Adverse Event|8|||
33340841|NCT00793819|62717755|FG001|Overall Study|Adverse Event|4|||
33340842|NCT00793819|62717754|FG000|Overall Study|Lack of Efficacy|1|||
33340843|NCT00793819|62717755|FG001|Overall Study|Lack of Efficacy|1|||
33340844|NCT00793819|62717754|FG000|Overall Study|Withdrawal by Subject|4|||
33340845|NCT00793819|62717755|FG001|Overall Study|Withdrawal by Subject|3|||
33340846|NCT00793819|62717754|FG000|Overall Study|Lost to Follow-up|1|||
33340847|NCT00793819|62717755|FG001|Overall Study|Lost to Follow-up|1|||
33340848|NCT00792259|62717764|FG000|Overall Study|Poor Quality Scans|1|||
33340849|NCT00792259|62717765|FG001|Overall Study|Poor Quality Scans|0|||
33340850|NCT00792259|62717766|FG002|Overall Study|Poor Quality Scans|0|||
33340851|NCT00894387|62717776|FG000|Overall Study|Adverse Event|44|||
33340852|NCT00894387|62717777|FG001|Overall Study|Adverse Event|45|||
33340853|NCT00894387|62717776|FG000|Overall Study|Abnormal Laboratory values|2|||
33340854|NCT00894387|62717777|FG001|Overall Study|Abnormal Laboratory values|2|||
33340855|NCT00894387|62717776|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33340856|NCT00894387|62717777|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33340857|NCT00894387|62717776|FG000|Overall Study|Lost to Follow-up|3|||
33340858|NCT00894387|62717777|FG001|Overall Study|Lost to Follow-up|5|||
33340859|NCT00894387|62717776|FG000|Overall Study|Administrative problems|2|||
33340860|NCT00894387|62717777|FG001|Overall Study|Administrative problems|2|||
33340861|NCT00894387|62717776|FG000|Overall Study|Death|77|||
33340862|NCT00894387|62717777|FG001|Overall Study|Death|76|||
33340863|NCT00894387|62717776|FG000|Overall Study|Protocol Deviation|4|||
33340864|NCT00894387|62717777|FG001|Overall Study|Protocol Deviation|0|||
33340865|NCT00894387|62717776|FG000|Overall Study|Patient's request|25|||
33340866|NCT00894387|62717777|FG001|Overall Study|Patient's request|30|||
33340867|NCT00894387|62717776|FG000|Overall Study|Other (Missing)|5|||
33340868|NCT00894387|62717777|FG001|Overall Study|Other (Missing)|3|||
33340869|NCT00894387|62717776|FG000|Overall Study|Mis-randomized|13|||
33340870|NCT00894387|62717777|FG001|Overall Study|Mis-randomized|9|||
33340871|NCT00894387|62717776|FG000|Overall Study|GCP non-compliance|0|||
33340872|NCT00894387|62717777|FG001|Overall Study|GCP non-compliance|2|||
33340873|NCT00928512|62717788|FG000|Overall Study|Adverse Event|4|||
33340874|NCT00928512|62717789|FG001|Overall Study|Adverse Event|3|||
33340875|NCT00928512|62717790|FG002|Overall Study|Adverse Event|2|||
33340876|NCT00928512|62717791|FG003|Overall Study|Adverse Event|8|||
33340877|NCT00928512|62717792|FG004|Overall Study|Adverse Event|6|||
33340878|NCT00928512|62717788|FG000|Overall Study|Lack of Efficacy|2|||
33340879|NCT00928512|62717789|FG001|Overall Study|Lack of Efficacy|0|||
33340880|NCT00928512|62717790|FG002|Overall Study|Lack of Efficacy|4|||
33340881|NCT00928512|62717791|FG003|Overall Study|Lack of Efficacy|7|||
33340882|NCT00928512|62717792|FG004|Overall Study|Lack of Efficacy|3|||
33340883|NCT00928512|62717788|FG000|Overall Study|Protocol Violation|0|||
33340884|NCT00928512|62717789|FG001|Overall Study|Protocol Violation|1|||
33340885|NCT00928512|62717790|FG002|Overall Study|Protocol Violation|0|||
33340886|NCT00928512|62717791|FG003|Overall Study|Protocol Violation|1|||
33340887|NCT00928512|62717792|FG004|Overall Study|Protocol Violation|3|||
33340888|NCT00928512|62717788|FG000|Overall Study|Withdrawal by Subject|3|||
33340889|NCT00928512|62717789|FG001|Overall Study|Withdrawal by Subject|0|||
33340890|NCT00928512|62717790|FG002|Overall Study|Withdrawal by Subject|3|||
33340891|NCT00928512|62717791|FG003|Overall Study|Withdrawal by Subject|4|||
33340892|NCT00928512|62717792|FG004|Overall Study|Withdrawal by Subject|0|||
33340893|NCT00928512|62717788|FG000|Overall Study|Lost to Follow-up|1|||
33340894|NCT00928512|62717789|FG001|Overall Study|Lost to Follow-up|1|||
33340895|NCT00928512|62717790|FG002|Overall Study|Lost to Follow-up|2|||
33340896|NCT00928512|62717791|FG003|Overall Study|Lost to Follow-up|1|||
33340897|NCT00928512|62717792|FG004|Overall Study|Lost to Follow-up|3|||
33340898|NCT00928512|62717788|FG000|Overall Study|Administrative Problems|0|||
33340899|NCT00928512|62717789|FG001|Overall Study|Administrative Problems|1|||
33340900|NCT00928512|62717790|FG002|Overall Study|Administrative Problems|0|||
33340901|NCT00928512|62717791|FG003|Overall Study|Administrative Problems|0|||
33340902|NCT00928512|62717792|FG004|Overall Study|Administrative Problems|0|||
33340903|NCT00787891|62717810|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
33469869|NCT03720470|62843579|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
33469870|NCT03720470|62843580|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
33469871|NCT03720470|62843581|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
33469872|NCT03720470|62843582|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
33469873|NCT03720470|62843577|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
33469874|NCT03720470|62843578|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
33469875|NCT03720470|62843579|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
33469876|NCT03720470|62843580|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
33469877|NCT03720470|62843581|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
33469878|NCT03720470|62843582|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
33469879|NCT03720470|62843577|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
33469880|NCT03720470|62843578|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
33469881|NCT03720470|62843579|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
33469882|NCT03720470|62843580|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
33469883|NCT03720470|62843581|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
33469884|NCT03720470|62843582|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
33469885|NCT03720470|62843577|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
33469886|NCT03720470|62843578|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
33469887|NCT03720470|62843579|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
33469888|NCT03720470|62843580|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
33469889|NCT03720470|62843581|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
33469890|NCT03720470|62843582|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
33469891|NCT03720470|62843577|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
33469892|NCT03720470|62843578|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
33469893|NCT03720470|62843579|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
33469894|NCT03720470|62843580|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
33469895|NCT03720470|62843581|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
33469896|NCT03720470|62843582|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
33469897|NCT03720470|62843577|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
33469898|NCT03720470|62843578|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
33469899|NCT03720470|62843579|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
33469900|NCT03720470|62843580|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
33469901|NCT03720470|62843581|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
33340904|NCT00787891|62717811|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
33340905|NCT00787891|62717810|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
33340906|NCT00787891|62717811|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
33340907|NCT00787891|62717810|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
33340908|NCT00787891|62717811|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
33469902|NCT03720470|62843582|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
33469903|NCT03720470|62843577|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
33340909|NCT00787891|62717810|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
33340910|NCT00787891|62717811|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
33340911|NCT00787891|62717810|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
33340912|NCT00787891|62717811|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
33340913|NCT00787891|62717810|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
33340914|NCT00787891|62717811|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
33340915|NCT00787891|62717810|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
33340916|NCT00787891|62717811|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
33340917|NCT00787891|62717810|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
33340918|NCT00787891|62717811|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
33340919|NCT00787891|62717810|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
33340920|NCT00787891|62717811|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
33340921|NCT00787891|62717810|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
33340922|NCT00787891|62717811|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
33340923|NCT00892437|62717821|FG000|Randomized Phase|Randomized but not treated|6|||
33340924|NCT00892437|62717822|FG001|Randomized Phase|Randomized but not treated|0|||
33340925|NCT00892437|62717821|FG000|Randomized Phase|Adverse Event|2|||
33340926|NCT00892437|62717822|FG001|Randomized Phase|Adverse Event|2|||
33340927|NCT00892437|62717821|FG000|Randomized Phase|Lost to Follow-up|1|||
33340928|NCT00892437|62717822|FG001|Randomized Phase|Lost to Follow-up|3|||
33340929|NCT00892437|62717821|FG000|Randomized Phase|Investigator's Discretion|1|||
33340930|NCT00892437|62717822|FG001|Randomized Phase|Investigator's Discretion|0|||
33340931|NCT00892437|62717821|FG000|Randomized Phase|Withdrew Consent|1|||
33340932|NCT00892437|62717822|FG001|Randomized Phase|Withdrew Consent|0|||
33340933|NCT00892437|62717821|FG000|Open-Label Extension Phase|Adverse Event|4|||
33340934|NCT00892437|62717822|FG001|Open-Label Extension Phase|Adverse Event|2|||
33340935|NCT00892437|62717821|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
33340936|NCT00892437|62717822|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
33340937|NCT00892437|62717821|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
33340938|NCT00892437|62717822|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
33340939|NCT00892437|62717821|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
33340940|NCT00892437|62717822|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
33340941|NCT00892437|62717821|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
33340942|NCT00892437|62717822|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
33340943|NCT00792103|62717829|FG000|Overall Study|Enrolled, not treated|15|||
33340944|NCT00792103|62717829|FG000|Overall Study|Lost to Follow-up|17|||
33340945|NCT00792103|62717829|FG000|Overall Study|Adverse Event|25|||
33340946|NCT00792103|62717829|FG000|Overall Study|Withdrawal by Subject|52|||
33340947|NCT00792103|62717829|FG000|Overall Study|Protocol Violation|10|||
33340948|NCT00792103|62717829|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
33340949|NCT00892281|62717835|FG000|Overall Study|Adverse Event|65|||
33340950|NCT00892281|62717836|FG001|Overall Study|Adverse Event|8|||
33340951|NCT00892281|62717835|FG000|Overall Study|Lost to Follow-up|81|||
33340952|NCT00892281|62717836|FG001|Overall Study|Lost to Follow-up|8|||
33340953|NCT00892281|62717835|FG000|Overall Study|Pregnancy|1|||
33340954|NCT00892281|62717836|FG001|Overall Study|Pregnancy|0|||
33340955|NCT00892281|62717835|FG000|Overall Study|Protocol Violation|7|||
33340956|NCT00892281|62717836|FG001|Overall Study|Protocol Violation|2|||
33340957|NCT00892281|62717835|FG000|Overall Study|Withdrawal by Subject|86|||
33340958|NCT00892281|62717836|FG001|Overall Study|Withdrawal by Subject|14|||
33340959|NCT00892281|62717835|FG000|Overall Study|Subject failed to return for final visit|2|||
33340960|NCT00892281|62717836|FG001|Overall Study|Subject failed to return for final visit|0|||
33340961|NCT00892281|62717835|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
33340962|NCT00892281|62717836|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
33340963|NCT00892281|62717835|FG000|Overall Study|Final visit completed 4 weeks late|0|||
33340964|NCT00892281|62717836|FG001|Overall Study|Final visit completed 4 weeks late|1|||
33340965|NCT00892281|62717835|FG000|Overall Study|Subject completed day after study closed|1|||
33340966|NCT00892281|62717836|FG001|Overall Study|Subject completed day after study closed|0|||
33340967|NCT00892281|62717835|FG000|Overall Study|Family emergency|1|||
33340968|NCT00892281|62717836|FG001|Overall Study|Family emergency|0|||
33340969|NCT00892281|62717835|FG000|Overall Study|Last visit not done - death in family|1|||
33340970|NCT00892281|62717836|FG001|Overall Study|Last visit not done - death in family|0|||
33340971|NCT00892281|62717835|FG000|Overall Study|Did not meet incl/excl criteria|1|||
33340972|NCT00892281|62717836|FG001|Overall Study|Did not meet incl/excl criteria|0|||
33340973|NCT00892281|62717835|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
33340974|NCT00892281|62717836|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
33340975|NCT00892281|62717835|FG000|Overall Study|Unable to redeem the drug voucher|1|||
33340976|NCT00892281|62717836|FG001|Overall Study|Unable to redeem the drug voucher|0|||
33340977|NCT00892281|62717835|FG000|Overall Study|Subject not good candidate for study|1|||
33340978|NCT00892281|62717836|FG001|Overall Study|Subject not good candidate for study|0|||
33340979|NCT00892281|62717835|FG000|Overall Study|Subject did not return for any visits|1|||
33340980|NCT00892281|62717836|FG001|Overall Study|Subject did not return for any visits|0|||
33340981|NCT00892281|62717835|FG000|Overall Study|Subject missed several visits/lost meds|1|||
33340982|NCT00892281|62717836|FG001|Overall Study|Subject missed several visits/lost meds|0|||
33340983|NCT00892281|62717835|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
33340984|NCT00892281|62717836|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
33340985|NCT00892281|62717835|FG000|Overall Study|Scheduled for knee replacement|0|||
33340986|NCT00892281|62717836|FG001|Overall Study|Scheduled for knee replacement|1|||
33340987|NCT00892281|62717835|FG000|Overall Study|PI complained of inadequate compensation|3|||
33340988|NCT00892281|62717836|FG001|Overall Study|PI complained of inadequate compensation|0|||
33340989|NCT00892281|62717835|FG000|Overall Study|Subject lost interest in program|0|||
33340990|NCT00892281|62717836|FG001|Overall Study|Subject lost interest in program|1|||
33340991|NCT00892281|62717835|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
33340992|NCT00892281|62717836|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
33340993|NCT00892281|62717835|FG000|Overall Study|Death in family|1|||
33340994|NCT00892281|62717836|FG001|Overall Study|Death in family|0|||
33340995|NCT00892281|62717835|FG000|Overall Study|Lack of efficacy of study product|2|||
33340996|NCT00892281|62717836|FG001|Overall Study|Lack of efficacy of study product|0|||
33340997|NCT00892281|62717835|FG000|Overall Study|Subject not seen by PI at final visit|1|||
33340998|NCT00892281|62717836|FG001|Overall Study|Subject not seen by PI at final visit|0|||
33340999|NCT00892281|62717835|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
33341000|NCT00892281|62717836|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
33341001|NCT00892281|62717835|FG000|Overall Study|Missed multiple visits|1|||
33341002|NCT00892281|62717836|FG001|Overall Study|Missed multiple visits|0|||
33341003|NCT00892281|62717835|FG000|Overall Study|Missed visits rescheduled out of window|1|||
33341004|NCT00892281|62717836|FG001|Overall Study|Missed visits rescheduled out of window|0|||
33341005|NCT00892281|62717835|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
33341006|NCT00892281|62717836|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
33341007|NCT00892281|62717835|FG000|Overall Study|Subject had history of drug abuse|1|||
33341008|NCT00892281|62717836|FG001|Overall Study|Subject had history of drug abuse|0|||
33341009|NCT00892281|62717835|FG000|Overall Study|Rash on hand|1|||
33341010|NCT00892281|62717836|FG001|Overall Study|Rash on hand|0|||
33341011|NCT00892281|62717835|FG000|Overall Study|Visit 4 date out of window|1|||
33341012|NCT00892281|62717836|FG001|Overall Study|Visit 4 date out of window|0|||
33341013|NCT00784693|62717844|FG000|Overall Study|Lost to Follow-up|0|||
33341014|NCT00784693|62717845|FG001|Overall Study|Lost to Follow-up|1|||
33341015|NCT00784693|62717844|FG000|Overall Study|Lack of Efficacy|1|||
33341016|NCT00784693|62717845|FG001|Overall Study|Lack of Efficacy|1|||
33341017|NCT00784693|62717844|FG000|Overall Study|Withdrawal by Subject|0|||
33341018|NCT00784693|62717845|FG001|Overall Study|Withdrawal by Subject|4|||
33341019|NCT00784693|62717844|FG000|Overall Study|Randomized but not Treated|1|||
33341020|NCT00784693|62717845|FG001|Overall Study|Randomized but not Treated|0|||
33341021|NCT00784693|62717844|FG000|Overall Study|Other|1|||
33341022|NCT00784693|62717845|FG001|Overall Study|Other|0|||
33341023|NCT00893763|62717853|FG000|Overall Study|extubated|110|||
33341024|NCT00893763|62717854|FG001|Overall Study|extubated|110|||
33341025|NCT00892047|62717864|FG000|Overall Study|Adverse Event|2|||
33341026|NCT00892047|62717865|FG001|Overall Study|Adverse Event|2|||
33341027|NCT00892047|62717864|FG000|Overall Study|subject burden|2|||
33341028|NCT00892047|62717865|FG001|Overall Study|subject burden|3|||
33341029|NCT00892047|62717864|FG000|Overall Study|Lack of Efficacy|0|||
33341030|NCT00892047|62717865|FG001|Overall Study|Lack of Efficacy|2|||
33341031|NCT00787267|62717873|FG000|Overall Study|Screen failure/Ineligible|10|||
33341032|NCT00787267|62717873|FG000|Overall Study|No Reason Provided|1|||
33341033|NCT00787267|62717873|FG000|Overall Study|Withdrawal by Subject|1|||
33341034|NCT00928434|62717880|FG000|Overall Study|Adverse Event|14|||
33654455|NCT01683409|63067190|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
33341035|NCT00928434|62717881|FG001|Overall Study|Adverse Event|5|||
33341036|NCT00928434|62717882|FG002|Overall Study|Adverse Event|18|||
33341037|NCT00928434|62717880|FG000|Overall Study|Protocol Violation|5|||
33341038|NCT00928434|62717881|FG001|Overall Study|Protocol Violation|0|||
33341039|NCT00928434|62717882|FG002|Overall Study|Protocol Violation|8|||
33341040|NCT00928434|62717880|FG000|Overall Study|Physician Decision|2|||
33341041|NCT00928434|62717881|FG001|Overall Study|Physician Decision|0|||
33341042|NCT00928434|62717882|FG002|Overall Study|Physician Decision|3|||
33341043|NCT00928434|62717880|FG000|Overall Study|Lost to Follow-up|1|||
33341044|NCT00928434|62717881|FG001|Overall Study|Lost to Follow-up|0|||
33341045|NCT00928434|62717882|FG002|Overall Study|Lost to Follow-up|3|||
33341046|NCT00928434|62717880|FG000|Overall Study|Withdrawal by Subject|5|||
33341047|NCT00928434|62717881|FG001|Overall Study|Withdrawal by Subject|3|||
33341048|NCT00928434|62717882|FG002|Overall Study|Withdrawal by Subject|2|||
33341049|NCT00928434|62717880|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
33341050|NCT00928434|62717881|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
33341051|NCT00928434|62717882|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
33341052|NCT00928434|62717880|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
33341053|NCT00928434|62717881|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
33341054|NCT00928434|62717882|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
33341055|NCT00928434|62717880|FG000|Overall Study|Other (not meeting above criteria)|5|||
33341056|NCT00928434|62717881|FG001|Overall Study|Other (not meeting above criteria)|1|||
33341057|NCT00928434|62717882|FG002|Overall Study|Other (not meeting above criteria)|2|||
33341058|NCT00787189|62717900|FG000|Overall Study|Lost to Follow-up|2|||
33341059|NCT00787189|62717901|FG001|Overall Study|Lost to Follow-up|2|||
33341060|NCT00784459|62717909|FG000|Overall Study|Adverse Event|0|||
33341061|NCT00784459|62717910|FG001|Overall Study|Adverse Event|2|||
33341062|NCT00786799|62717918|FG000|Overall Study|Lost to Follow-up|1|||
33341063|NCT00786799|62717919|FG001|Overall Study|Lost to Follow-up|1|||
33341064|NCT00786565|62717930|FG000|Enrollment Prior to Surgery|Site Closed|3|||
33341065|NCT00786565|62717930|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
33341066|NCT00786565|62717930|FG000|Post Surgery|Abnormal macular pucker|1|||
33341067|NCT00786565|62717930|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
33341068|NCT00784147|62717938|FG000|Overall Study|Lost to Follow-up|2|||
33341069|NCT00784147|62717939|FG001|Overall Study|Lost to Follow-up|4|||
33341070|NCT00784147|62717938|FG000|Overall Study|Withdrawal by Subject|1|||
33341071|NCT00784147|62717939|FG001|Overall Study|Withdrawal by Subject|3|||
33341072|NCT00784147|62717938|FG000|Overall Study|Physician Decision|2|||
33341073|NCT00784147|62717939|FG001|Overall Study|Physician Decision|1|||
33341074|NCT00784147|62717938|FG000|Overall Study|Protocol Violation|1|||
33341075|NCT00784147|62717939|FG001|Overall Study|Protocol Violation|1|||
33341076|NCT00784147|62717938|FG000|Overall Study|Death|2|||
33341077|NCT00784147|62717939|FG001|Overall Study|Death|0|||
33341078|NCT00891813|62717945|FG000|Overall Study|Adverse Event|3|||
33341079|NCT00891813|62717945|FG000|Overall Study|Withdrawal by Subject|1|||
33341080|NCT00891813|62717945|FG000|Overall Study|Patient Noncompliance|6|||
33341081|NCT00891813|62717945|FG000|Overall Study|Protocol Violation|2|||
33341082|NCT00783835|62717962|FG000|Overall Study|Adverse Event|3|||
33341083|NCT00783835|62717962|FG000|Overall Study|Medical Criteria|1|||
33341084|NCT00783835|62717962|FG000|Overall Study|Withdrawal by Subject|2|||
33341085|NCT00783835|62717962|FG000|Overall Study|Lost to Follow-up|1|||
33341086|NCT00783835|62717962|FG000|Overall Study|Participant not Adherent|3|||
33341087|NCT00783289|62717970|FG000|Overall Study|Protocol Violation|0|||
33341088|NCT00783289|62717971|FG001|Overall Study|Protocol Violation|1|||
33341089|NCT00783289|62717972|FG002|Overall Study|Protocol Violation|0|||
33341090|NCT00783289|62717973|FG003|Overall Study|Protocol Violation|0|||
33341091|NCT00847912|62717988|FG000|Overall Study|Protocol Violation|6|||
33341092|NCT00847912|62717989|FG001|Overall Study|Protocol Violation|7|||
33341093|NCT00847912|62717988|FG000|Overall Study|Withdrawal by Subject|3|||
33341094|NCT00847912|62717989|FG001|Overall Study|Withdrawal by Subject|6|||
33341095|NCT00850564|62717996|FG000|Overall Study|Withdrawal by Subject|2|||
33341096|NCT00837148|62718000|FG000|Overall Study|Adverse Event|1|||
33341097|NCT00837148|62718000|FG000|Overall Study|Death|1|||
33341098|NCT00849940|62718004|FG000|Overall Study|Physician Decision|4|||
33341099|NCT00849472|62718008|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
33341100|NCT00849472|62718008|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
33341101|NCT00849472|62718008|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
33341102|NCT00849472|62718008|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
33341103|NCT00849472|62718008|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
33341104|NCT00849472|62718008|FG000|Weekly Paclitaxel|Disease Progression|1|||
33341105|NCT00849472|62718008|FG000|Weekly Paclitaxel|Adverse Event|11|||
33548861|NCT02959177|62940233|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
33548862|NCT02959177|62940234|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
33341106|NCT00849472|62718008|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
33341107|NCT00849472|62718008|FG000|Weekly Paclitaxel|Physician Decision|3|||
33341108|NCT00849472|62718008|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
33341109|NCT00849472|62718008|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
33341110|NCT00849472|62718008|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
33341111|NCT00849472|62718008|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
33341112|NCT00849472|62718008|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
33341113|NCT00849472|62718008|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
33341114|NCT00849472|62718008|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
33341115|NCT00849472|62718008|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
33341116|NCT00782509|62718016|FG000|Overall Study|Adverse Event|20|||
33341117|NCT00782509|62718017|FG001|Overall Study|Adverse Event|10|||
33548863|NCT02959177|62940235|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
33341118|NCT00782509|62718018|FG002|Overall Study|Adverse Event|20|||
33341119|NCT00782509|62718016|FG000|Overall Study|Lost to Follow-up|1|||
33341120|NCT00782509|62718017|FG001|Overall Study|Lost to Follow-up|2|||
33341121|NCT00782509|62718018|FG002|Overall Study|Lost to Follow-up|3|||
33341122|NCT00782509|62718016|FG000|Overall Study|Withdrawal by Subject|3|||
33341123|NCT00782509|62718017|FG001|Overall Study|Withdrawal by Subject|5|||
33341124|NCT00782509|62718018|FG002|Overall Study|Withdrawal by Subject|8|||
33341125|NCT00782509|62718016|FG000|Overall Study|Non compliance with protocol|2|||
33341126|NCT00782509|62718017|FG001|Overall Study|Non compliance with protocol|0|||
33341127|NCT00782509|62718018|FG002|Overall Study|Non compliance with protocol|0|||
33341128|NCT00782509|62718016|FG000|Overall Study|Other reasons not stated above|5|||
33341129|NCT00782509|62718017|FG001|Overall Study|Other reasons not stated above|2|||
33341130|NCT00782509|62718018|FG002|Overall Study|Other reasons not stated above|3|||
33341131|NCT00782509|62718016|FG000|Overall Study|Lack of Efficacy|10|||
33341132|NCT00782509|62718017|FG001|Overall Study|Lack of Efficacy|5|||
33341133|NCT00782509|62718018|FG002|Overall Study|Lack of Efficacy|2|||
33341134|NCT00927810|62718037|FG000|Overall Study|Withdrawal by Subject|0|||
33341135|NCT00927810|62718038|FG001|Overall Study|Withdrawal by Subject|3|||
33341136|NCT00927810|62718039|FG002|Overall Study|Withdrawal by Subject|0|||
33341137|NCT00927810|62718040|FG003|Overall Study|Withdrawal by Subject|1|||
33341138|NCT00927810|62718037|FG000|Overall Study|Lost to Follow-up|0|||
33341139|NCT00927810|62718038|FG001|Overall Study|Lost to Follow-up|2|||
33341140|NCT00927810|62718039|FG002|Overall Study|Lost to Follow-up|1|||
33341141|NCT00927810|62718040|FG003|Overall Study|Lost to Follow-up|1|||
33341142|NCT00927810|62718037|FG000|Overall Study|Death|0|||
33341143|NCT00927810|62718038|FG001|Overall Study|Death|2|||
33341144|NCT00927810|62718039|FG002|Overall Study|Death|0|||
33341145|NCT00927810|62718040|FG003|Overall Study|Death|0|||
33341146|NCT00927810|62718037|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33341147|NCT00927810|62718038|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33341148|NCT00927810|62718039|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33341149|NCT00927810|62718040|FG003|Overall Study|Abnormal laboratory value(s)|0|||
33341150|NCT00848926|62718058|FG000|Treatment Period|Progressive disease|45|||
33341151|NCT00848926|62718058|FG000|Treatment Period|Adverse Event|20|||
33341152|NCT00848926|62718058|FG000|Treatment Period|Physician Decision|12|||
33341153|NCT00848926|62718058|FG000|Treatment Period|Withdrawal by Subject|7|||
33341154|NCT00848926|62718058|FG000|Follow-up Period|Lost to Follow-up|7|||
33341155|NCT00848926|62718058|FG000|Follow-up Period|Withdrawal by Subject|3|||
33341156|NCT00848926|62718058|FG000|Follow-up Period|Other|2|||
33341157|NCT00847132|62718064|FG000|Overall Study|Death|1|||
33341158|NCT00847132|62718065|FG001|Overall Study|Death|1|||
33341159|NCT00918138|62718073|FG000|Overall Study|Subject withdrew consent|1|||
33341160|NCT00918138|62718074|FG001|Overall Study|Subject withdrew consent|1|||
33341161|NCT00918138|62718073|FG000|Overall Study|Death|1|||
33341162|NCT00918138|62718074|FG001|Overall Study|Death|0|||
33341163|NCT00782275|62718080|FG000|Overall Study|Adverse Event|11|||
33341164|NCT00782275|62718080|FG000|Overall Study|Withdrawal by Subject|1|||
33341165|NCT00782275|62718080|FG000|Overall Study|Progressive Disease|21|||
33341166|NCT00782275|62718080|FG000|Overall Study|Physician Decision|4|||
33341167|NCT00782275|62718080|FG000|Overall Study|Not started treatment|1|||
33341168|NCT00782275|62718080|FG000|Overall Study|Other|3|||
33341169|NCT00791557|62718084|FG000|Overall Study|Adverse Event|1|||
33341170|NCT00920790|62718088|FG000|Overall Study|aggravation of general condition|14|||
33341171|NCT00781963|62718094|FG000|Overall Study|Death|3|||
33341172|NCT00781963|62718095|FG001|Overall Study|Death|0|||
33341173|NCT00781963|62718094|FG000|Overall Study|Lost to Follow-up|2|||
33341174|NCT00781963|62718095|FG001|Overall Study|Lost to Follow-up|1|||
33341175|NCT00781963|62718094|FG000|Overall Study|Withdrawal by Subject|3|||
33341176|NCT00781963|62718095|FG001|Overall Study|Withdrawal by Subject|1|||
33548864|NCT02959177|62940233|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
33548865|NCT02959177|62940234|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
33341177|NCT00781963|62718094|FG000|Overall Study|Refused follow-up|9|||
33341178|NCT00781963|62718095|FG001|Overall Study|Refused follow-up|0|||
33341179|NCT00920556|62718101|FG000|Overall Study|Adverse Event|16|||
33341180|NCT00920556|62718101|FG000|Overall Study|Physician Decision|7|||
33341181|NCT00920556|62718101|FG000|Overall Study|Withdrawal by Subject|1|||
33341182|NCT00781885|62718109|FG000|Overall Study|Physician Decision|1|||
33341183|NCT00918684|62718113|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
33341184|NCT00918684|62718113|FG000|Treatment Phase|Lack of Efficacy|6|||
33341185|NCT00918684|62718113|FG000|Treatment Phase|Lost to Follow-up|2|||
33341186|NCT00918684|62718113|FG000|Treatment Phase|Physician Decision|8|||
33341187|NCT00918684|62718113|FG000|Treatment Phase|Protocol Violation|1|||
33341188|NCT00918684|62718113|FG000|Treatment Phase|Withdrawal by Subject|8|||
33341189|NCT00786409|62718117|FG000|Overall Study|Withdrawal by Subject|2|||
33341190|NCT00786409|62718117|FG000|Overall Study|Adverse Event|2|||
33341191|NCT00786409|62718117|FG000|Overall Study|Pregnancy|2|||
33341192|NCT00786409|62718117|FG000|Overall Study|Lost to Follow-up|1|||
33341193|NCT00919854|62718121|FG000|Overall Study|Adverse Event|1|||
33341194|NCT00891735|62718129|FG000|Overall Study|Adverse Event|2|||
33341195|NCT00891735|62718130|FG001|Overall Study|Adverse Event|0|||
33341196|NCT00891735|62718131|FG002|Overall Study|Adverse Event|2|||
33341197|NCT00891735|62718132|FG003|Overall Study|Adverse Event|0|||
33341198|NCT00891735|62718129|FG000|Overall Study|Death|8|||
33341199|NCT00891735|62718130|FG001|Overall Study|Death|5|||
33341200|NCT00891735|62718131|FG002|Overall Study|Death|4|||
33341201|NCT00891735|62718132|FG003|Overall Study|Death|5|||
33341202|NCT00891735|62718129|FG000|Overall Study|Lost to Follow-up|2|||
33341203|NCT00891735|62718130|FG001|Overall Study|Lost to Follow-up|2|||
33341204|NCT00891735|62718131|FG002|Overall Study|Lost to Follow-up|2|||
33654456|NCT01683409|63067191|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
33654457|NCT01683409|63067192|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
33654458|NCT01683409|63067193|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
33654459|NCT01683409|63067194|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
33654460|NCT01683409|63067190|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
33654461|NCT01683409|63067191|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
33654462|NCT01683409|63067192|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
33654463|NCT01683409|63067193|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
33654464|NCT01683409|63067194|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
33654465|NCT01683409|63067190|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
33654466|NCT01683409|63067191|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
33654467|NCT01683409|63067192|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
33654468|NCT01683409|63067193|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
33654469|NCT01683409|63067194|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
33654470|NCT01683409|63067190|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
33654471|NCT01683409|63067191|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
33654472|NCT01683409|63067192|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
33654473|NCT01683409|63067193|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
33654474|NCT01683409|63067194|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
33654475|NCT01683409|63067190|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
33654476|NCT01683409|63067191|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
33654477|NCT01683409|63067192|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
33654478|NCT01683409|63067193|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
33654479|NCT01683409|63067194|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
33654480|NCT01683409|63067190|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
33654481|NCT01683409|63067191|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
33654482|NCT01683409|63067192|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
33654483|NCT01683409|63067193|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
33654484|NCT01683409|63067194|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
33654485|NCT01683409|63067190|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
33654486|NCT01683409|63067191|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
33654487|NCT01683409|63067192|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
33654488|NCT01683409|63067193|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
33654489|NCT01683409|63067194|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
33654490|NCT01683409|63067190|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
33654491|NCT01683409|63067191|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
33654492|NCT01683409|63067192|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
33654493|NCT01683409|63067193|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
33654494|NCT01683409|63067194|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
33654495|NCT01683409|63067190|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
33654496|NCT01683409|63067191|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
33654497|NCT01683409|63067192|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
33654498|NCT01683409|63067193|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
33654499|NCT01683409|63067194|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
33654500|NCT01699022|63067220|FG000|Overall Study|Early discontinuation from the study|3|||
33654501|NCT01683019|63067228|FG000|Overall Study|Withdrawal by Subject|2|||
33654502|NCT01683019|63067229|FG001|Overall Study|Withdrawal by Subject|1|||
33654503|NCT01683019|63067230|FG002|Overall Study|Withdrawal by Subject|4|||
33654504|NCT01709162|63067240|FG000|Overall Study|Disease progression|3|||
33654505|NCT01709162|63067241|FG001|Overall Study|Disease progression|3|||
33654506|NCT01709162|63067240|FG000|Overall Study|Study drug toxicity|2|||
33654507|NCT01709162|63067241|FG001|Overall Study|Study drug toxicity|0|||
33654508|NCT01709162|63067240|FG000|Overall Study|Administrative reason by sponsor|0|||
33341205|NCT00891735|62718132|FG003|Overall Study|Lost to Follow-up|2|||
33654509|NCT01709162|63067241|FG001|Overall Study|Administrative reason by sponsor|1|||
33341206|NCT00891735|62718129|FG000|Overall Study|Physician's decision to withdraw patient|1|||
33341207|NCT00891735|62718130|FG001|Overall Study|Physician's decision to withdraw patient|0|||
33341208|NCT00891735|62718131|FG002|Overall Study|Physician's decision to withdraw patient|0|||
33341209|NCT00891735|62718132|FG003|Overall Study|Physician's decision to withdraw patient|0|||
33341210|NCT00891735|62718129|FG000|Overall Study|Patient's decision to withdraw|4|||
33341211|NCT00891735|62718130|FG001|Overall Study|Patient's decision to withdraw|9|||
33341212|NCT00891735|62718131|FG002|Overall Study|Patient's decision to withdraw|4|||
33341213|NCT00891735|62718132|FG003|Overall Study|Patient's decision to withdraw|8|||
33341214|NCT00891657|62718144|FG000|Overall Study|Withdrawal by Subject|1|||
33341215|NCT00891657|62718145|FG001|Overall Study|Withdrawal by Subject|1|||
33341216|NCT00917124|62718153|FG000|Overall Study|Protocol Violation|4|||
33341217|NCT00917124|62718154|FG001|Overall Study|Protocol Violation|6|||
33341218|NCT00889863|62718160|FG000|Part I: Open Label|Death|1|||
33341219|NCT00889863|62718161|FG001|Part I: Open Label|Death|0|||
33341220|NCT00889863|62718160|FG000|Part I: Open Label|Adverse Event|4|||
33341221|NCT00889863|62718161|FG001|Part I: Open Label|Adverse Event|0|||
33341222|NCT00889863|62718160|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
33341223|NCT00889863|62718161|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
33341224|NCT00889863|62718160|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
33341225|NCT00889863|62718161|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
33341226|NCT00889863|62718160|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
33341227|NCT00889863|62718161|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
33341228|NCT00889863|62718160|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
33341229|NCT00889863|62718161|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
33341230|NCT00889863|62718160|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
33341231|NCT00889863|62718161|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
33341232|NCT00915018|62718171|FG000|Overall Study|Death|75|||
33341233|NCT00915018|62718172|FG001|Overall Study|Death|70|||
33341234|NCT00915018|62718171|FG000|Overall Study|Lost to Follow-up|10|||
33341235|NCT00915018|62718172|FG001|Overall Study|Lost to Follow-up|5|||
33341236|NCT00915018|62718171|FG000|Overall Study|Withdrawal by Subject|38|||
33341237|NCT00915018|62718172|FG001|Overall Study|Withdrawal by Subject|27|||
33341238|NCT00915018|62718171|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
33341239|NCT00915018|62718172|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
33341240|NCT00916578|62718178|FG000|Overall Study|Physician Decision|2|||
33341241|NCT00916578|62718178|FG000|Overall Study|Withdrawal by Subject|3|||
33341242|NCT00916578|62718178|FG000|Overall Study|Insurance Denial|2|||
33341243|NCT00889707|62718184|FG000|Overall Study|Adverse Event|1|||
33341244|NCT00889707|62718185|FG001|Overall Study|Adverse Event|0|||
33341245|NCT00889707|62718184|FG000|Overall Study|Withdrawal by Subject|4|||
33341246|NCT00889707|62718185|FG001|Overall Study|Withdrawal by Subject|3|||
33341247|NCT00889707|62718184|FG000|Overall Study|Lost to Follow-up|0|||
33341248|NCT00889707|62718185|FG001|Overall Study|Lost to Follow-up|2|||
33341249|NCT00889707|62718184|FG000|Overall Study|Lack of Efficacy|2|||
33341250|NCT00889707|62718185|FG001|Overall Study|Lack of Efficacy|5|||
33341251|NCT00914940|62718191|FG000|D0 to D100 Post-transplant|Death|2|||
33341252|NCT00914940|62718191|FG000|D101 to 2 Years Post-transplant|Death|8|||
33341253|NCT00914940|62718191|FG000|2 Years to 5 Years Post-transplant|Death|3|||
33341254|NCT00835978|62718199|FG000|Overall Study|Death|33|||
33341255|NCT00835978|62718200|FG001|Overall Study|Death|40|||
33341256|NCT00835978|62718201|FG002|Overall Study|Death|49|||
33341257|NCT00835978|62718202|FG003|Overall Study|Death|4|||
33341258|NCT00835978|62718199|FG000|Overall Study|Lost to Follow-up|3|||
33341259|NCT00835978|62718200|FG001|Overall Study|Lost to Follow-up|4|||
33341260|NCT00835978|62718201|FG002|Overall Study|Lost to Follow-up|2|||
33341261|NCT00835978|62718202|FG003|Overall Study|Lost to Follow-up|1|||
33341262|NCT00835978|62718199|FG000|Overall Study|Other|5|||
33341263|NCT00835978|62718200|FG001|Overall Study|Other|1|||
33341264|NCT00835978|62718201|FG002|Overall Study|Other|8|||
33341265|NCT00835978|62718202|FG003|Overall Study|Other|0|||
33341266|NCT00835978|62718199|FG000|Overall Study|Objective progression or relapse|2|||
33341267|NCT00835978|62718200|FG001|Overall Study|Objective progression or relapse|0|||
33341268|NCT00835978|62718201|FG002|Overall Study|Objective progression or relapse|1|||
33341269|NCT00835978|62718202|FG003|Overall Study|Objective progression or relapse|0|||
33341270|NCT00835978|62718199|FG000|Overall Study|Adverse Event|1|||
33341271|NCT00835978|62718200|FG001|Overall Study|Adverse Event|0|||
33341272|NCT00835978|62718201|FG002|Overall Study|Adverse Event|1|||
33341273|NCT00835978|62718202|FG003|Overall Study|Adverse Event|0|||
33341274|NCT00835978|62718199|FG000|Overall Study|Withdrawal by Subject|0|||
33341275|NCT00835978|62718200|FG001|Overall Study|Withdrawal by Subject|3|||
33341276|NCT00835978|62718201|FG002|Overall Study|Withdrawal by Subject|0|||
33341277|NCT00835978|62718202|FG003|Overall Study|Withdrawal by Subject|5|||
33341278|NCT00835978|62718199|FG000|Overall Study|Study terminated by sponsor|12|||
33341279|NCT00835978|62718200|FG001|Overall Study|Study terminated by sponsor|8|||
33341280|NCT00835978|62718201|FG002|Overall Study|Study terminated by sponsor|30|||
33341281|NCT00835978|62718202|FG003|Overall Study|Study terminated by sponsor|0|||
33341282|NCT00914628|62718219|FG000|Overall Study|Death|35|||
33341283|NCT00914628|62718220|FG001|Overall Study|Death|17|||
33341284|NCT00914628|62718219|FG000|Overall Study|Medical decision|4|||
33341285|NCT00914628|62718220|FG001|Overall Study|Medical decision|0|||
33341286|NCT00914628|62718219|FG000|Overall Study|Protocol Violation|1|||
33341287|NCT00914628|62718220|FG001|Overall Study|Protocol Violation|0|||
33341288|NCT00914628|62718219|FG000|Overall Study|Lack of Efficacy|1|||
33341289|NCT00914628|62718220|FG001|Overall Study|Lack of Efficacy|0|||
33341290|NCT00914628|62718219|FG000|Overall Study|non-randomized|1|||
33341291|NCT00914628|62718220|FG001|Overall Study|non-randomized|0|||
33341292|NCT00914628|62718219|FG000|Overall Study|Relapse|1|||
33341293|NCT00914628|62718220|FG001|Overall Study|Relapse|2|||
33341294|NCT00914628|62718219|FG000|Overall Study|Study terminated by Sponsor|14|||
33341295|NCT00914628|62718220|FG001|Overall Study|Study terminated by Sponsor|8|||
33341296|NCT00914628|62718219|FG000|Overall Study|Patients who did not receive a single dose|7|||
33341297|NCT00914628|62718220|FG001|Overall Study|Patients who did not receive a single dose|1|||
33341298|NCT01077518|62718232|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
33341299|NCT01077518|62718233|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
33341300|NCT01077518|62718234|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
33341301|NCT01077518|62718232|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
33341302|NCT01077518|62718233|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
33341303|NCT01077518|62718234|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
33341304|NCT01077518|62718232|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
33341305|NCT01077518|62718233|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
33341306|NCT01077518|62718234|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
33341307|NCT01077518|62718232|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
33341308|NCT01077518|62718233|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
33341309|NCT01077518|62718234|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
33341310|NCT01077518|62718232|FG000|Optional Ofa Phase|Physician Decision|0|||
33341311|NCT01077518|62718233|FG001|Optional Ofa Phase|Physician Decision|0|||
33341312|NCT01077518|62718234|FG002|Optional Ofa Phase|Physician Decision|1|||
33341313|NCT01077518|62718232|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
33341314|NCT01077518|62718233|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
33341315|NCT01077518|62718234|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
33341316|NCT01077518|62718232|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
33341317|NCT01077518|62718233|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
33341318|NCT01077518|62718234|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
33341319|NCT00835120|62718243|FG000|Overall Study|Lack of Efficacy|1|||
33341320|NCT00835120|62718243|FG000|Overall Study|Lost to Follow-up|3|||
33341321|NCT00835120|62718243|FG000|Overall Study|Adverse Event|2|||
33341322|NCT00835120|62718243|FG000|Overall Study|Withdrawal by Subject|2|||
33341323|NCT00914316|62718251|FG000|Phase 1|Physician Decision|4|||
33341324|NCT00914316|62718252|FG001|Phase 1|Physician Decision|0|||
33341325|NCT00914316|62718253|FG002|Phase 1|Physician Decision|1|||
33341326|NCT00914316|62718254|FG003|Phase 1|Physician Decision|2|||
33341327|NCT00914316|62718251|FG000|Phase 1|Withdrawal by Subject|0|||
33341328|NCT00914316|62718252|FG001|Phase 1|Withdrawal by Subject|2|||
33341329|NCT00914316|62718253|FG002|Phase 1|Withdrawal by Subject|4|||
33341330|NCT00914316|62718254|FG003|Phase 1|Withdrawal by Subject|0|||
33654510|NCT01709162|63067240|FG000|Overall Study|Other|1|||
33654511|NCT01709162|63067241|FG001|Overall Study|Other|0|||
33654512|NCT01709162|63067240|FG000|Overall Study|Withdrawal by Subject|0|||
33341331|NCT00914316|62718251|FG000|Phase 1|Adverse Event|1|||
33341332|NCT00914316|62718252|FG001|Phase 1|Adverse Event|0|||
33341333|NCT00914316|62718253|FG002|Phase 1|Adverse Event|0|||
33654513|NCT01709162|63067241|FG001|Overall Study|Withdrawal by Subject|1|||
33341334|NCT00914316|62718254|FG003|Phase 1|Adverse Event|0|||
33341335|NCT00914316|62718251|FG000|Phase 2|Withdrawal by Subject|1|||
33341336|NCT00914316|62718252|FG001|Phase 2|Withdrawal by Subject|0|||
33341337|NCT00914316|62718253|FG002|Phase 2|Withdrawal by Subject|1|||
33341338|NCT00914316|62718254|FG003|Phase 2|Withdrawal by Subject|0|||
33341339|NCT00827632|62718266|FG000|Overall Study|Lost to Follow-up|8|||
33341340|NCT00827632|62718267|FG001|Overall Study|Lost to Follow-up|12|||
33341341|NCT00827632|62718266|FG000|Overall Study|Early withdrawal|14|||
33341342|NCT00827632|62718267|FG001|Overall Study|Early withdrawal|11|||
33341343|NCT00827242|62718275|FG000|Overall Study|Withdrawal by Subject|2|||
33341344|NCT00827242|62718276|FG001|Overall Study|Withdrawal by Subject|4|||
33341345|NCT00827242|62718275|FG000|Overall Study|Protocol Violation|1|||
33341346|NCT00827242|62718276|FG001|Overall Study|Protocol Violation|3|||
33341347|NCT00827242|62718275|FG000|Overall Study|Lost to Follow-up|0|||
33341348|NCT00827242|62718276|FG001|Overall Study|Lost to Follow-up|3|||
33341349|NCT00827242|62718275|FG000|Overall Study|Adverse Event Excluding Death|2|||
33341350|NCT00827242|62718276|FG001|Overall Study|Adverse Event Excluding Death|1|||
33341351|NCT00827242|62718275|FG000|Overall Study|Entry Criteria Not Met|4|||
33341352|NCT00827242|62718276|FG001|Overall Study|Entry Criteria Not Met|1|||
33341353|NCT00827242|62718275|FG000|Overall Study|Physician Decision|2|||
33341354|NCT00827242|62718276|FG001|Overall Study|Physician Decision|0|||
33341355|NCT00827242|62718275|FG000|Overall Study|Death|1|||
33341356|NCT00827242|62718276|FG001|Overall Study|Death|0|||
33341357|NCT00827242|62718275|FG000|Overall Study|Lack of Efficacy|1|||
33341358|NCT00827242|62718276|FG001|Overall Study|Lack of Efficacy|0|||
33341359|NCT01077362|62718285|FG000|Overall Study|Lack of Efficacy|13|||
33341360|NCT01077362|62718286|FG001|Overall Study|Lack of Efficacy|8|||
33341361|NCT01077362|62718287|FG002|Overall Study|Lack of Efficacy|10|||
33341362|NCT01077362|62718285|FG000|Overall Study|Lost to Follow-up|1|||
33341363|NCT01077362|62718286|FG001|Overall Study|Lost to Follow-up|0|||
33341364|NCT01077362|62718287|FG002|Overall Study|Lost to Follow-up|3|||
33341365|NCT01077362|62718285|FG000|Overall Study|Adverse Event|12|||
33341366|NCT01077362|62718286|FG001|Overall Study|Adverse Event|7|||
33341367|NCT01077362|62718287|FG002|Overall Study|Adverse Event|4|||
33341368|NCT01077362|62718285|FG000|Overall Study|Withdrawal by Subject|5|||
33341369|NCT01077362|62718286|FG001|Overall Study|Withdrawal by Subject|3|||
33341370|NCT01077362|62718287|FG002|Overall Study|Withdrawal by Subject|5|||
33341371|NCT01077362|62718285|FG000|Overall Study|Other|0|||
33341372|NCT01077362|62718286|FG001|Overall Study|Other|1|||
33341373|NCT01077362|62718287|FG002|Overall Study|Other|2|||
33341374|NCT00846586|62718302|FG000|Overall Study|Adverse Event|20|||
33341375|NCT00846586|62718303|FG001|Overall Study|Adverse Event|10|||
33341376|NCT00846586|62718302|FG000|Overall Study|Subject withdrew consent|8|||
33341377|NCT00846586|62718303|FG001|Overall Study|Subject withdrew consent|10|||
33341378|NCT00846586|62718302|FG000|Overall Study|Administrative problems|5|||
33341379|NCT00846586|62718303|FG001|Overall Study|Administrative problems|4|||
33341380|NCT00846586|62718302|FG000|Overall Study|Death|2|||
33341381|NCT00846586|62718303|FG001|Overall Study|Death|0|||
33341382|NCT00846586|62718302|FG000|Overall Study|Protocol deviation|2|||
33341383|NCT00846586|62718303|FG001|Overall Study|Protocol deviation|6|||
33341384|NCT00846586|62718302|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33341385|NCT00846586|62718303|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33341386|NCT00846586|62718302|FG000|Overall Study|Lost to Follow-up|1|||
33341387|NCT00846586|62718303|FG001|Overall Study|Lost to Follow-up|4|||
33341388|NCT00846586|62718302|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33341389|NCT00846586|62718303|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33341390|NCT00785785|62718311|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
33341391|NCT00785785|62718312|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
33341392|NCT00785785|62718311|FG000|Core Phase up to 36 Months|Adverse Event|31|||
33341393|NCT00785785|62718312|FG001|Core Phase up to 36 Months|Adverse Event|21|||
33341394|NCT00785785|62718311|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
33341395|NCT00785785|62718312|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
33341396|NCT00785785|62718311|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
33341397|NCT00785785|62718312|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
33341398|NCT00785785|62718311|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
33341399|NCT00785785|62718312|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
33341400|NCT00785785|62718311|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
33341401|NCT00785785|62718312|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
33341402|NCT00785785|62718311|FG000|Core Phase up to 36 Months|Administrative problems|3|||
33341403|NCT00785785|62718312|FG001|Core Phase up to 36 Months|Administrative problems|3|||
33341404|NCT00785785|62718311|FG000|Core Phase up to 36 Months|Death|5|||
33341405|NCT00785785|62718312|FG001|Core Phase up to 36 Months|Death|8|||
33341406|NCT00785785|62718311|FG000|Core Phase up to 36 Months|Disease progression|139|||
33341407|NCT00785785|62718312|FG001|Core Phase up to 36 Months|Disease progression|119|||
33341408|NCT00785785|62718311|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
33341409|NCT00785785|62718312|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
33341410|NCT00785785|62718311|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
33341411|NCT00785785|62718312|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
33341412|NCT00785785|62718311|FG000|Optional Extension Phase|Adverse Event|4|||
33341413|NCT00785785|62718312|FG001|Optional Extension Phase|Adverse Event|5|||
33341414|NCT00785785|62718311|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
33341415|NCT00785785|62718312|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
33341416|NCT00785785|62718311|FG000|Optional Extension Phase|Lost to Follow-up|1|||
33341417|NCT00785785|62718312|FG001|Optional Extension Phase|Lost to Follow-up|0|||
33341418|NCT00785785|62718311|FG000|Optional Extension Phase|Administrative problems|2|||
33341419|NCT00785785|62718312|FG001|Optional Extension Phase|Administrative problems|0|||
33341420|NCT00785785|62718311|FG000|Optional Extension Phase|Death|1|||
33341421|NCT00785785|62718312|FG001|Optional Extension Phase|Death|5|||
33341422|NCT00785785|62718311|FG000|Optional Extension Phase|Disease progression|22|||
33341423|NCT00785785|62718312|FG001|Optional Extension Phase|Disease progression|70|||
33341424|NCT00785785|62718311|FG000|Optional Extension Phase|Protocol deviation|0|||
33341425|NCT00785785|62718312|FG001|Optional Extension Phase|Protocol deviation|2|||
33341426|NCT00785785|62718311|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
33341427|NCT00785785|62718312|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
33341428|NCT01077284|62718323|FG000|Overall Study|Adverse Event|2|||
33341429|NCT01077284|62718324|FG001|Overall Study|Adverse Event|0|||
33341430|NCT01077284|62718325|FG002|Overall Study|Adverse Event|1|||
33341431|NCT01077284|62718323|FG000|Overall Study|Lost to Follow-up|1|||
33341432|NCT01077284|62718324|FG001|Overall Study|Lost to Follow-up|2|||
33341433|NCT01077284|62718325|FG002|Overall Study|Lost to Follow-up|0|||
33341434|NCT01077284|62718323|FG000|Overall Study|Withdrawal by Subject|2|||
33341435|NCT01077284|62718324|FG001|Overall Study|Withdrawal by Subject|3|||
33341436|NCT01077284|62718325|FG002|Overall Study|Withdrawal by Subject|1|||
33341437|NCT01077284|62718323|FG000|Overall Study|Other|0|||
33341438|NCT01077284|62718324|FG001|Overall Study|Other|0|||
33341439|NCT01077284|62718325|FG002|Overall Study|Other|1|||
33341440|NCT00826618|62718333|FG000|Overall Study|Withdrawal by Subject|1|||
33341441|NCT01077128|62718337|FG000|Overall Study|Adverse Event|8|||
33341442|NCT01077128|62718337|FG000|Overall Study|Lack of Efficacy|1|||
33341443|NCT01077128|62718337|FG000|Overall Study|Disease exacerbation|1|||
33341444|NCT01077128|62718337|FG000|Overall Study|Adverse event and consent withdrawal|1|||
33341445|NCT01077128|62718337|FG000|Overall Study|Adverse event and disease exacerbation|1|||
33341446|NCT01077128|62718337|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
33341447|NCT01077128|62718337|FG000|Overall Study|Other|54|||
33341448|NCT00826540|62718391|FG000|Overall Study|ineligible|3|||
33341449|NCT00826540|62718391|FG000|Overall Study|Withdrawal by Subject|1|||
33341450|NCT01077050|62718395|FG000|Overall Study|Subjects signed ICF could not be located|1|||
33341451|NCT01077050|62718395|FG000|Overall Study|Screen failure|8|||
33341452|NCT00592384|62718401|FG000|Overall Study|Withdrawal by Subject|5|||
33341453|NCT00592384|62718402|FG001|Overall Study|Withdrawal by Subject|6|||
33341454|NCT00846040|62718411|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
33341455|NCT00846040|62718412|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
33341456|NCT00846040|62718413|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
33341457|NCT00846040|62718411|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
33341458|NCT00846040|62718412|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
33341459|NCT00846040|62718413|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
33341460|NCT00826228|62718422|FG000|Overall Study|Withdrawal by Subject|1|||
33341461|NCT00825994|62718427|FG000|Overall Study|Withdrawal by Subject|2|||
33341462|NCT00825994|62718427|FG000|Overall Study|Lost to Follow-up|1|||
33341463|NCT00825994|62718427|FG000|Overall Study|Protocol Violation|1|||
33341464|NCT00825994|62718427|FG000|Overall Study|Placebo Responder at V2|1|||
33341465|NCT00825916|62718434|FG000|Overall Study|Lost to Follow-up|4|||
33341466|NCT00825916|62718435|FG001|Overall Study|Lost to Follow-up|2|||
33341467|NCT00825916|62718436|FG002|Overall Study|Lost to Follow-up|1|||
33341468|NCT00791479|62718483|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
33341469|NCT00791479|62718484|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
33341470|NCT00791479|62718485|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
33341471|NCT00791479|62718486|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
33341472|NCT00791479|62718487|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
33341473|NCT00791479|62718488|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
33341474|NCT00791479|62718483|FG000|Overall Study|Adverse Event|0|||
33341475|NCT00791479|62718484|FG001|Overall Study|Adverse Event|1|||
33341476|NCT00791479|62718485|FG002|Overall Study|Adverse Event|0|||
33341477|NCT00791479|62718486|FG003|Overall Study|Adverse Event|2|||
33341478|NCT00791479|62718487|FG004|Overall Study|Adverse Event|0|||
33341479|NCT00791479|62718488|FG005|Overall Study|Adverse Event|1|||
33341480|NCT00791479|62718483|FG000|Overall Study|Lost to Follow-up|0|||
33341481|NCT00791479|62718484|FG001|Overall Study|Lost to Follow-up|1|||
33341482|NCT00791479|62718485|FG002|Overall Study|Lost to Follow-up|0|||
33341483|NCT00791479|62718486|FG003|Overall Study|Lost to Follow-up|0|||
33341484|NCT00791479|62718487|FG004|Overall Study|Lost to Follow-up|0|||
33341485|NCT00791479|62718488|FG005|Overall Study|Lost to Follow-up|1|||
33341486|NCT00791479|62718483|FG000|Overall Study|Protocol Violation|2|||
33341487|NCT00791479|62718484|FG001|Overall Study|Protocol Violation|1|||
33341488|NCT00791479|62718485|FG002|Overall Study|Protocol Violation|0|||
33341489|NCT00791479|62718486|FG003|Overall Study|Protocol Violation|1|||
33341490|NCT00791479|62718487|FG004|Overall Study|Protocol Violation|0|||
33341491|NCT00791479|62718488|FG005|Overall Study|Protocol Violation|0|||
33341492|NCT00791479|62718483|FG000|Overall Study|Withdrawal by Subject|0|||
33341493|NCT00791479|62718484|FG001|Overall Study|Withdrawal by Subject|0|||
33341494|NCT00791479|62718485|FG002|Overall Study|Withdrawal by Subject|0|||
33341495|NCT00791479|62718486|FG003|Overall Study|Withdrawal by Subject|1|||
33654514|NCT01698554|63067251|FG000|Overall Study|Adverse Event|2|||
33654515|NCT01698554|63067252|FG001|Overall Study|Adverse Event|5|||
33341496|NCT00791479|62718487|FG004|Overall Study|Withdrawal by Subject|0|||
33341497|NCT00791479|62718488|FG005|Overall Study|Withdrawal by Subject|1|||
33341498|NCT00890097|62718512|FG000|Overall Study|Adverse Event|21|||
33341499|NCT00890097|62718513|FG001|Overall Study|Adverse Event|32|||
33341500|NCT00890097|62718514|FG002|Overall Study|Adverse Event|28|||
33341501|NCT00890097|62718512|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
33341502|NCT00890097|62718513|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
33341503|NCT00890097|62718514|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
33341504|NCT00890097|62718512|FG000|Overall Study|Withdrew Consent|9|||
33341505|NCT00890097|62718513|FG001|Overall Study|Withdrew Consent|6|||
33341506|NCT00890097|62718514|FG002|Overall Study|Withdrew Consent|9|||
33341507|NCT00890097|62718512|FG000|Overall Study|Lost to Follow-up|5|||
33341508|NCT00890097|62718513|FG001|Overall Study|Lost to Follow-up|5|||
33341509|NCT00890097|62718514|FG002|Overall Study|Lost to Follow-up|5|||
33341510|NCT00890097|62718512|FG000|Overall Study|Noncompliance|0|||
33341511|NCT00890097|62718513|FG001|Overall Study|Noncompliance|4|||
33341512|NCT00890097|62718514|FG002|Overall Study|Noncompliance|4|||
33654516|NCT01698554|63067253|FG002|Overall Study|Adverse Event|0|||
33341513|NCT00890097|62718512|FG000|Overall Study|Sponsor Decision|7|||
33341514|NCT00890097|62718513|FG001|Overall Study|Sponsor Decision|11|||
33341515|NCT00890097|62718514|FG002|Overall Study|Sponsor Decision|7|||
33341516|NCT00890097|62718512|FG000|Overall Study|Did not attend final visit|2|||
33341517|NCT00890097|62718513|FG001|Overall Study|Did not attend final visit|3|||
33341518|NCT00890097|62718514|FG002|Overall Study|Did not attend final visit|0|||
33341519|NCT00890097|62718512|FG000|Overall Study|Subject Decision|3|||
33341520|NCT00890097|62718513|FG001|Overall Study|Subject Decision|2|||
33341521|NCT00890097|62718514|FG002|Overall Study|Subject Decision|6|||
33341522|NCT00890097|62718512|FG000|Overall Study|Randomization Error|2|||
33341523|NCT00890097|62718513|FG001|Overall Study|Randomization Error|0|||
33341524|NCT00890097|62718514|FG002|Overall Study|Randomization Error|0|||
33341525|NCT00890097|62718512|FG000|Overall Study|Failed inclusion criteria|3|||
33341526|NCT00890097|62718513|FG001|Overall Study|Failed inclusion criteria|4|||
33341527|NCT00890097|62718514|FG002|Overall Study|Failed inclusion criteria|0|||
33341528|NCT00890097|62718512|FG000|Overall Study|Transportation|0|||
33341529|NCT00890097|62718513|FG001|Overall Study|Transportation|2|||
33341530|NCT00890097|62718514|FG002|Overall Study|Transportation|0|||
33341531|NCT00890097|62718512|FG000|Overall Study|Subject Moved|0|||
33341532|NCT00890097|62718513|FG001|Overall Study|Subject Moved|4|||
33341533|NCT00890097|62718514|FG002|Overall Study|Subject Moved|0|||
33341534|NCT00890097|62718512|FG000|Overall Study|Protocol Deviation|1|||
33341535|NCT00890097|62718513|FG001|Overall Study|Protocol Deviation|1|||
33341536|NCT00890097|62718514|FG002|Overall Study|Protocol Deviation|1|||
33341537|NCT00913458|62718522|FG000|Phase 1|Non-Responder|54|||
33341538|NCT00913458|62718523|FG001|Phase 1|Non-Responder|0|||
33341539|NCT00913458|62718524|FG002|Phase 1|Non-Responder|0|||
33341540|NCT00913458|62718525|FG003|Phase 1|Non-Responder|0|||
33341541|NCT00913458|62718526|FG004|Phase 1|Non-Responder|0|||
33341542|NCT00913458|62718527|FG005|Phase 1|Non-Responder|0|||
33341543|NCT00913458|62718528|FG006|Phase 1|Non-Responder|0|||
33341544|NCT00913458|62718522|FG000|Phase 1|Subject Request|17|||
33341545|NCT00913458|62718523|FG001|Phase 1|Subject Request|0|||
33341546|NCT00913458|62718524|FG002|Phase 1|Subject Request|0|||
33341547|NCT00913458|62718525|FG003|Phase 1|Subject Request|0|||
33341548|NCT00913458|62718526|FG004|Phase 1|Subject Request|0|||
33341549|NCT00913458|62718527|FG005|Phase 1|Subject Request|0|||
33341550|NCT00913458|62718528|FG006|Phase 1|Subject Request|0|||
33341551|NCT00913458|62718522|FG000|Phase 1|Adverse Event|20|||
33341552|NCT00913458|62718523|FG001|Phase 1|Adverse Event|0|||
33341553|NCT00913458|62718524|FG002|Phase 1|Adverse Event|0|||
33341554|NCT00913458|62718525|FG003|Phase 1|Adverse Event|0|||
33341555|NCT00913458|62718526|FG004|Phase 1|Adverse Event|0|||
33341556|NCT00913458|62718527|FG005|Phase 1|Adverse Event|0|||
33341557|NCT00913458|62718528|FG006|Phase 1|Adverse Event|0|||
33341558|NCT00913458|62718522|FG000|Phase 1|Lost to Follow-up|2|||
33341559|NCT00913458|62718523|FG001|Phase 1|Lost to Follow-up|0|||
33341560|NCT00913458|62718524|FG002|Phase 1|Lost to Follow-up|0|||
33341561|NCT00913458|62718525|FG003|Phase 1|Lost to Follow-up|0|||
33341562|NCT00913458|62718526|FG004|Phase 1|Lost to Follow-up|0|||
33341563|NCT00913458|62718527|FG005|Phase 1|Lost to Follow-up|0|||
33341564|NCT00913458|62718528|FG006|Phase 1|Lost to Follow-up|0|||
33341565|NCT00913458|62718522|FG000|Phase 1|Protocol Violation|10|||
33341566|NCT00913458|62718523|FG001|Phase 1|Protocol Violation|0|||
33341567|NCT00913458|62718524|FG002|Phase 1|Protocol Violation|0|||
33341568|NCT00913458|62718525|FG003|Phase 1|Protocol Violation|0|||
33341569|NCT00913458|62718526|FG004|Phase 1|Protocol Violation|0|||
33341570|NCT00913458|62718527|FG005|Phase 1|Protocol Violation|0|||
33341571|NCT00913458|62718528|FG006|Phase 1|Protocol Violation|0|||
33341572|NCT00913458|62718522|FG000|Phase 1|Sponsor|2|||
33341573|NCT00913458|62718523|FG001|Phase 1|Sponsor|0|||
33341574|NCT00913458|62718524|FG002|Phase 1|Sponsor|0|||
33341575|NCT00913458|62718525|FG003|Phase 1|Sponsor|0|||
33341576|NCT00913458|62718526|FG004|Phase 1|Sponsor|0|||
33341577|NCT00913458|62718527|FG005|Phase 1|Sponsor|0|||
33341578|NCT00913458|62718528|FG006|Phase 1|Sponsor|0|||
33341579|NCT00913458|62718522|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
33341580|NCT00913458|62718523|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
33341581|NCT00913458|62718524|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
33341582|NCT00913458|62718525|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
33341583|NCT00913458|62718526|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
33341584|NCT00913458|62718527|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
33341585|NCT00913458|62718528|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
33341586|NCT00913458|62718522|FG000|Phase 2|Non-Responder|0|||
33341587|NCT00913458|62718523|FG001|Phase 2|Non-Responder|5|||
33341588|NCT00913458|62718524|FG002|Phase 2|Non-Responder|7|||
33341589|NCT00913458|62718525|FG003|Phase 2|Non-Responder|12|||
33341590|NCT00913458|62718526|FG004|Phase 2|Non-Responder|0|||
33341591|NCT00913458|62718527|FG005|Phase 2|Non-Responder|0|||
33341592|NCT00913458|62718528|FG006|Phase 2|Non-Responder|0|||
33341593|NCT00913458|62718522|FG000|Phase 2|Subject Request|0|||
33341594|NCT00913458|62718523|FG001|Phase 2|Subject Request|0|||
33341595|NCT00913458|62718524|FG002|Phase 2|Subject Request|1|||
33341596|NCT00913458|62718525|FG003|Phase 2|Subject Request|2|||
33341597|NCT00913458|62718526|FG004|Phase 2|Subject Request|0|||
33341598|NCT00913458|62718527|FG005|Phase 2|Subject Request|0|||
33341599|NCT00913458|62718528|FG006|Phase 2|Subject Request|0|||
33341600|NCT00913458|62718522|FG000|Phase 2|Adverse Event|0|||
33469904|NCT03720470|62843578|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
33469905|NCT03720470|62843579|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
33469906|NCT03720470|62843580|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
33469907|NCT03720470|62843581|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
33469908|NCT03720470|62843582|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
33469909|NCT03720470|62843577|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
33469910|NCT03720470|62843578|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
33469911|NCT03720470|62843579|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
33469912|NCT03720470|62843580|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
33469913|NCT03720470|62843581|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
33469914|NCT03720470|62843582|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
33469915|NCT03720470|62843577|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
33469916|NCT03720470|62843578|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
33469917|NCT03720470|62843579|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
33469918|NCT03720470|62843580|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
33469919|NCT03720470|62843581|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
33469920|NCT03720470|62843582|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
33469921|NCT03720470|62843577|FG000|Treatment Period: Final 4 Weeks|Other|0|||
33469922|NCT03720470|62843578|FG001|Treatment Period: Final 4 Weeks|Other|1|||
33469923|NCT03720470|62843579|FG002|Treatment Period: Final 4 Weeks|Other|0|||
33469924|NCT03720470|62843580|FG003|Treatment Period: Final 4 Weeks|Other|2|||
33469925|NCT03720470|62843581|FG004|Treatment Period: Final 4 Weeks|Other|1|||
33341601|NCT00913458|62718523|FG001|Phase 2|Adverse Event|3|||
33341602|NCT00913458|62718524|FG002|Phase 2|Adverse Event|0|||
33341603|NCT00913458|62718525|FG003|Phase 2|Adverse Event|1|||
33341604|NCT00913458|62718526|FG004|Phase 2|Adverse Event|0|||
33341605|NCT00913458|62718527|FG005|Phase 2|Adverse Event|0|||
33341606|NCT00913458|62718528|FG006|Phase 2|Adverse Event|0|||
33341607|NCT00913458|62718522|FG000|Phase 2|Lost to Follow-up|0|||
33341608|NCT00913458|62718523|FG001|Phase 2|Lost to Follow-up|0|||
33341609|NCT00913458|62718524|FG002|Phase 2|Lost to Follow-up|0|||
33341610|NCT00913458|62718525|FG003|Phase 2|Lost to Follow-up|1|||
33341611|NCT00913458|62718526|FG004|Phase 2|Lost to Follow-up|0|||
33341612|NCT00913458|62718527|FG005|Phase 2|Lost to Follow-up|0|||
33341613|NCT00913458|62718528|FG006|Phase 2|Lost to Follow-up|0|||
33341614|NCT00913458|62718522|FG000|Phase 2|Protocol Violation|0|||
33341615|NCT00913458|62718523|FG001|Phase 2|Protocol Violation|2|||
33341616|NCT00913458|62718524|FG002|Phase 2|Protocol Violation|0|||
33341617|NCT00913458|62718525|FG003|Phase 2|Protocol Violation|0|||
33341618|NCT00913458|62718526|FG004|Phase 2|Protocol Violation|0|||
33341619|NCT00913458|62718527|FG005|Phase 2|Protocol Violation|0|||
33341620|NCT00913458|62718528|FG006|Phase 2|Protocol Violation|0|||
33341621|NCT00913458|62718522|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
33341622|NCT00913458|62718523|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
33341623|NCT00913458|62718524|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
33341624|NCT00913458|62718525|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
33341625|NCT00913458|62718526|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
33341626|NCT00913458|62718527|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
33341627|NCT00913458|62718528|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
33341628|NCT00913458|62718522|FG000|Phase 3|Adverse Event|0|||
33341629|NCT00913458|62718523|FG001|Phase 3|Adverse Event|0|||
33341630|NCT00913458|62718524|FG002|Phase 3|Adverse Event|0|||
33341631|NCT00913458|62718525|FG003|Phase 3|Adverse Event|0|||
33341632|NCT00913458|62718526|FG004|Phase 3|Adverse Event|5|||
33341633|NCT00913458|62718527|FG005|Phase 3|Adverse Event|4|||
33341634|NCT00913458|62718528|FG006|Phase 3|Adverse Event|1|||
33341635|NCT00913458|62718522|FG000|Phase 3|Lost to Follow-up|0|||
33341636|NCT00913458|62718523|FG001|Phase 3|Lost to Follow-up|0|||
33341637|NCT00913458|62718524|FG002|Phase 3|Lost to Follow-up|0|||
33341638|NCT00913458|62718525|FG003|Phase 3|Lost to Follow-up|0|||
33341639|NCT00913458|62718526|FG004|Phase 3|Lost to Follow-up|2|||
33341640|NCT00913458|62718527|FG005|Phase 3|Lost to Follow-up|0|||
33341641|NCT00913458|62718528|FG006|Phase 3|Lost to Follow-up|0|||
33341642|NCT00913458|62718522|FG000|Phase 3|Non-Responder|0|||
33341643|NCT00913458|62718523|FG001|Phase 3|Non-Responder|0|||
33341644|NCT00913458|62718524|FG002|Phase 3|Non-Responder|0|||
33341645|NCT00913458|62718525|FG003|Phase 3|Non-Responder|0|||
33341646|NCT00913458|62718526|FG004|Phase 3|Non-Responder|0|||
33341647|NCT00913458|62718527|FG005|Phase 3|Non-Responder|1|||
33341648|NCT00913458|62718528|FG006|Phase 3|Non-Responder|3|||
33341649|NCT00913458|62718522|FG000|Phase 3|Withdrawal by Subject|0|||
33341650|NCT00913458|62718523|FG001|Phase 3|Withdrawal by Subject|0|||
33341651|NCT00913458|62718524|FG002|Phase 3|Withdrawal by Subject|0|||
33341652|NCT00913458|62718525|FG003|Phase 3|Withdrawal by Subject|0|||
33341653|NCT00913458|62718526|FG004|Phase 3|Withdrawal by Subject|1|||
33341654|NCT00913458|62718527|FG005|Phase 3|Withdrawal by Subject|2|||
33341655|NCT00913458|62718528|FG006|Phase 3|Withdrawal by Subject|0|||
33341656|NCT00913458|62718522|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
33341657|NCT00913458|62718523|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
33654517|NCT01698554|63067254|FG003|Overall Study|Adverse Event|1|||
33654518|NCT01698554|63067251|FG000|Overall Study|Lost to Follow-up|1|||
33654519|NCT01698554|63067252|FG001|Overall Study|Lost to Follow-up|0|||
33654520|NCT01698554|63067253|FG002|Overall Study|Lost to Follow-up|0|||
33654521|NCT01698554|63067254|FG003|Overall Study|Lost to Follow-up|0|||
33654522|NCT01698554|63067251|FG000|Overall Study|Personal Reasons|0|||
33654523|NCT01698554|63067252|FG001|Overall Study|Personal Reasons|5|||
33341658|NCT00913458|62718524|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
33341659|NCT00913458|62718525|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
33654524|NCT01698554|63067253|FG002|Overall Study|Personal Reasons|1|||
33654525|NCT01698554|63067254|FG003|Overall Study|Personal Reasons|1|||
33654526|NCT01698554|63067251|FG000|Overall Study|Protocol Violation|2|||
33654527|NCT01698554|63067252|FG001|Overall Study|Protocol Violation|0|||
33341660|NCT00913458|62718526|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
33341661|NCT00913458|62718527|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
33341662|NCT00913458|62718528|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
33341663|NCT00785707|62718545|FG000|Overall Study|Lost to Follow-up|7|||
33341664|NCT00913380|62718551|FG000|Clinical Outcomes|Lost to Follow-up|6|||
33341665|NCT00913380|62718552|FG001|Clinical Outcomes|Lost to Follow-up|6|||
33341666|NCT00785629|62718562|FG000|Overall Study|Adverse Event|2|||
33341667|NCT00785629|62718563|FG001|Overall Study|Adverse Event|1|||
33341668|NCT00785629|62718564|FG002|Overall Study|Adverse Event|1|||
33341669|NCT00785629|62718565|FG003|Overall Study|Adverse Event|5|||
33341670|NCT00785629|62718562|FG000|Overall Study|Protocol Violation|1|||
33341671|NCT00785629|62718563|FG001|Overall Study|Protocol Violation|2|||
33341672|NCT00785629|62718564|FG002|Overall Study|Protocol Violation|4|||
33341673|NCT00785629|62718565|FG003|Overall Study|Protocol Violation|5|||
33341674|NCT00785629|62718562|FG000|Overall Study|administrative decision|5|||
33341675|NCT00785629|62718563|FG001|Overall Study|administrative decision|1|||
33341676|NCT00785629|62718564|FG002|Overall Study|administrative decision|3|||
33341677|NCT00785629|62718565|FG003|Overall Study|administrative decision|4|||
33341678|NCT00785629|62718562|FG000|Overall Study|Withdrawal by Subject|0|||
33341679|NCT00785629|62718563|FG001|Overall Study|Withdrawal by Subject|1|||
33341680|NCT00785629|62718564|FG002|Overall Study|Withdrawal by Subject|2|||
33341681|NCT00785629|62718565|FG003|Overall Study|Withdrawal by Subject|2|||
33341682|NCT00916344|62718573|FG000|Overall Study|Death|2|||
33341683|NCT00916344|62718573|FG000|Overall Study|ICD upgrade|1|||
33341684|NCT00916344|62718573|FG000|Overall Study|Drop-out|5|||
33341685|NCT00913770|62718580|FG000|Overall Study|Unable to contact|24|||
33341686|NCT00913770|62718581|FG001|Overall Study|Unable to contact|19|||
33341687|NCT00913770|62718582|FG002|Overall Study|Unable to contact|13|||
33341688|NCT00913770|62718580|FG000|Overall Study|Refused|11|||
33341689|NCT00913770|62718581|FG001|Overall Study|Refused|10|||
33341690|NCT00913770|62718582|FG002|Overall Study|Refused|8|||
33341691|NCT00780559|62718592|FG000|Overall Study|Lost to Follow-up|2|||
33341692|NCT00780559|62718593|FG001|Overall Study|Lost to Follow-up|7|||
33341693|NCT00780559|62718592|FG000|Overall Study|Death|1|||
33341694|NCT00780559|62718593|FG001|Overall Study|Death|0|||
33341695|NCT00912912|62718601|FG000|Overall Study|Withdrawal by Subject|1|||
33341696|NCT00912912|62718601|FG000|Overall Study|Disease Progression|3|||
33341697|NCT00889005|62718607|FG000|Overall Study|Lost to Follow-up|4|||
33341698|NCT00889005|62718608|FG001|Overall Study|Lost to Follow-up|2|||
33341699|NCT00889005|62718607|FG000|Overall Study|Withdrawal by Subject|4|||
33341700|NCT00889005|62718608|FG001|Overall Study|Withdrawal by Subject|0|||
33341701|NCT00779857|62718614|FG000|Overall Study|Death|1|||
33341702|NCT00779857|62718614|FG000|Overall Study|Withdrawal by Subject|3|||
33341703|NCT00779857|62718614|FG000|Overall Study|Missed Visit|2|||
33341704|NCT00913692|62718618|FG000|Screening (4 Months)|Physician Decision|3|||
33341705|NCT00913692|62718618|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
33341706|NCT00913692|62718618|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
33341707|NCT00784927|62718625|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
33341708|NCT00784927|62718625|FG000|Overall Study|Protocol Violation|1|||
33341709|NCT00784927|62718625|FG000|Overall Study|Ineligible|1|||
33341710|NCT00779779|62718630|FG000|Overall Study|Adverse Event|1|||
33341711|NCT00779779|62718630|FG000|Overall Study|Protocol Violation|14|||
33341712|NCT00779779|62718630|FG000|Overall Study|Withdrawal by Subject|4|||
33341713|NCT00779779|62718630|FG000|Overall Study|Lost to Follow-up|5|||
33341714|NCT00845728|62718636|FG000|Overall Study|Abnormal laboratory value (s)|2|||
33341715|NCT00845728|62718637|FG001|Overall Study|Abnormal laboratory value (s)|2|||
33341716|NCT00845728|62718636|FG000|Overall Study|Patient's inability to use the device|4|||
33341717|NCT00845728|62718637|FG001|Overall Study|Patient's inability to use the device|6|||
33341718|NCT00845728|62718636|FG000|Overall Study|Abnormal test procedure result (s)|7|||
33341719|NCT00845728|62718637|FG001|Overall Study|Abnormal test procedure result (s)|2|||
33341720|NCT00845728|62718636|FG000|Overall Study|Lost to Follow-up|22|||
33341721|NCT00845728|62718637|FG001|Overall Study|Lost to Follow-up|13|||
33341722|NCT00845728|62718636|FG000|Overall Study|Death|24|||
33341723|NCT00845728|62718637|FG001|Overall Study|Death|26|||
33341724|NCT00845728|62718636|FG000|Overall Study|Administrative Problems|34|||
33341725|NCT00845728|62718637|FG001|Overall Study|Administrative Problems|26|||
33341726|NCT00845728|62718636|FG000|Overall Study|Protocol Violation|36|||
33341727|NCT00845728|62718637|FG001|Overall Study|Protocol Violation|24|||
33341728|NCT00845728|62718636|FG000|Overall Study|Lack of Efficacy|51|||
33341729|NCT00845728|62718637|FG001|Overall Study|Lack of Efficacy|39|||
33341730|NCT00845728|62718636|FG000|Overall Study|Adverse Event|101|||
33341731|NCT00845728|62718637|FG001|Overall Study|Adverse Event|96|||
33341732|NCT00845728|62718636|FG000|Overall Study|Withdrawal by Subject|105|||
33341733|NCT00845728|62718637|FG001|Overall Study|Withdrawal by Subject|108|||
33341734|NCT00779467|62718647|FG000|Overall Study|Lack of Efficacy|11|||
33341735|NCT00779467|62718648|FG001|Overall Study|Lack of Efficacy|2|||
33341736|NCT00779467|62718649|FG002|Overall Study|Lack of Efficacy|6|||
33341737|NCT00779467|62718650|FG003|Overall Study|Lack of Efficacy|11|||
33341738|NCT00779467|62718647|FG000|Overall Study|failed inclusion criteria|3|||
33341739|NCT00779467|62718648|FG001|Overall Study|failed inclusion criteria|3|||
33341740|NCT00779467|62718649|FG002|Overall Study|failed inclusion criteria|1|||
33341741|NCT00779467|62718650|FG003|Overall Study|failed inclusion criteria|2|||
33341742|NCT00779467|62718647|FG000|Overall Study|missing data|1|||
33341743|NCT00779467|62718648|FG001|Overall Study|missing data|0|||
33341744|NCT00779467|62718649|FG002|Overall Study|missing data|1|||
33341745|NCT00779467|62718650|FG003|Overall Study|missing data|4|||
33341746|NCT00779467|62718647|FG000|Overall Study|technical issue|0|||
33341747|NCT00779467|62718648|FG001|Overall Study|technical issue|0|||
33341748|NCT00779467|62718649|FG002|Overall Study|technical issue|2|||
33341749|NCT00779467|62718650|FG003|Overall Study|technical issue|1|||
33341750|NCT00779467|62718647|FG000|Overall Study|unavailable research staff|0|||
33654528|NCT01698554|63067253|FG002|Overall Study|Protocol Violation|1|||
33341751|NCT00779467|62718648|FG001|Overall Study|unavailable research staff|0|||
33341752|NCT00779467|62718649|FG002|Overall Study|unavailable research staff|0|||
33341753|NCT00779467|62718650|FG003|Overall Study|unavailable research staff|1|||
33341754|NCT00778921|62718663|FG000|Overall Study|Adverse Event|9|||
33341755|NCT00778921|62718664|FG001|Overall Study|Adverse Event|10|||
33341756|NCT00778921|62718665|FG002|Overall Study|Adverse Event|14|||
33341757|NCT00778921|62718663|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
33341758|NCT00778921|62718664|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
33341759|NCT00778921|62718665|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
33341760|NCT00778921|62718663|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
33341761|NCT00778921|62718664|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
33341762|NCT00778921|62718665|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
33341763|NCT00778921|62718663|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
33341764|NCT00778921|62718664|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
33341765|NCT00778921|62718665|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
33341766|NCT00778921|62718663|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
33341767|NCT00778921|62718664|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
33341768|NCT00778921|62718665|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
33341769|NCT00778921|62718663|FG000|Overall Study|Patient withdrew request|3|||
33341770|NCT00778921|62718664|FG001|Overall Study|Patient withdrew request|1|||
33341771|NCT00778921|62718665|FG002|Overall Study|Patient withdrew request|6|||
33341772|NCT00778921|62718663|FG000|Overall Study|Lost to Follow-up|0|||
33341773|NCT00778921|62718664|FG001|Overall Study|Lost to Follow-up|2|||
33341774|NCT00778921|62718665|FG002|Overall Study|Lost to Follow-up|1|||
33341775|NCT00778921|62718663|FG000|Overall Study|Administrative Problems|1|||
33341776|NCT00778921|62718664|FG001|Overall Study|Administrative Problems|2|||
33341777|NCT00778921|62718665|FG002|Overall Study|Administrative Problems|0|||
33341778|NCT00778921|62718663|FG000|Overall Study|Protocol Violation|3|||
33341779|NCT00778921|62718664|FG001|Overall Study|Protocol Violation|0|||
33341780|NCT00778921|62718665|FG002|Overall Study|Protocol Violation|2|||
33341781|NCT00778921|62718663|FG000|Overall Study|Not treated|0|||
33341782|NCT00778921|62718664|FG001|Overall Study|Not treated|2|||
33341783|NCT00778921|62718665|FG002|Overall Study|Not treated|2|||
33341784|NCT00915876|62718675|FG000|Overall Study|Adverse Event|0|||
33341785|NCT00915876|62718676|FG001|Overall Study|Adverse Event|1|||
33341786|NCT00587431|62718684|FG000|Overall Study|Adverse Event|1|||
33341787|NCT00587431|62718685|FG001|Overall Study|Adverse Event|0|||
33341788|NCT00587431|62718684|FG000|Overall Study|Withdrawal by Subject|0|||
33341789|NCT00587431|62718685|FG001|Overall Study|Withdrawal by Subject|1|||
33341790|NCT00776659|62718694|FG000|Overall Study|Lost to Follow-up|15|||
33341791|NCT00776659|62718694|FG000|Overall Study|Withdrawal by Subject|10|||
33341792|NCT00776659|62718694|FG000|Overall Study|Study Terminated by Sponsor|1|||
33341793|NCT00825682|62718700|FG000|Overall Study|personal reasons/ inconvenience|13|||
33341794|NCT00825682|62718701|FG001|Overall Study|personal reasons/ inconvenience|5|||
33341795|NCT00833794|62718710|FG000|Open-label Phase|Adverse Event|225|||
33341796|NCT00833794|62718711|FG001|Open-label Phase|Adverse Event|0|||
33341797|NCT00833794|62718710|FG000|Open-label Phase|Lack of Efficacy|28|||
33341798|NCT00833794|62718711|FG001|Open-label Phase|Lack of Efficacy|0|||
33341799|NCT00833794|62718710|FG000|Open-label Phase|Withdrawal by Subject|48|||
33341800|NCT00833794|62718711|FG001|Open-label Phase|Withdrawal by Subject|0|||
33341801|NCT00833794|62718710|FG000|Open-label Phase|Physician Decision|20|||
33341802|NCT00833794|62718711|FG001|Open-label Phase|Physician Decision|0|||
33341803|NCT00833794|62718710|FG000|Open-label Phase|Administrative reason|1|||
33341804|NCT00833794|62718711|FG001|Open-label Phase|Administrative reason|0|||
33341805|NCT00833794|62718710|FG000|Open-label Phase|Protocol Violation|47|||
33341806|NCT00833794|62718711|FG001|Open-label Phase|Protocol Violation|0|||
33341807|NCT00833794|62718710|FG000|Open-label Phase|Did not complete wash-out period|12|||
33341808|NCT00833794|62718711|FG001|Open-label Phase|Did not complete wash-out period|0|||
33341809|NCT00833794|62718710|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
33341810|NCT00833794|62718711|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
33341811|NCT00833794|62718710|FG000|Double-blind Phase|Adverse Event|44|||
33469926|NCT03720470|62843582|FG005|Treatment Period: Final 4 Weeks|Other|0|||
33654529|NCT01698554|63067254|FG003|Overall Study|Protocol Violation|0|||
33341812|NCT00833794|62718711|FG001|Double-blind Phase|Adverse Event|11|||
33341813|NCT00833794|62718710|FG000|Double-blind Phase|Lack of Efficacy|34|||
33341814|NCT00833794|62718711|FG001|Double-blind Phase|Lack of Efficacy|22|||
33341815|NCT00833794|62718710|FG000|Double-blind Phase|Withdrawal by Subject|23|||
33341816|NCT00833794|62718711|FG001|Double-blind Phase|Withdrawal by Subject|6|||
33341817|NCT00833794|62718710|FG000|Double-blind Phase|Physician Decision|4|||
33341818|NCT00833794|62718711|FG001|Double-blind Phase|Physician Decision|7|||
33341819|NCT00833794|62718710|FG000|Double-blind Phase|Administrative reason|1|||
33654530|NCT01698554|63067251|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33341820|NCT00833794|62718711|FG001|Double-blind Phase|Administrative reason|3|||
33341821|NCT00912288|62718721|FG000|Overall Study|Death|0|||
33341822|NCT00912288|62718722|FG001|Overall Study|Death|1|||
33341823|NCT00912288|62718721|FG000|Overall Study|Adverse Event|1|||
33341824|NCT00912288|62718722|FG001|Overall Study|Adverse Event|1|||
33341825|NCT00912288|62718721|FG000|Overall Study|Lost to Follow-up|1|||
33341826|NCT00912288|62718722|FG001|Overall Study|Lost to Follow-up|0|||
33341827|NCT00912288|62718721|FG000|Overall Study|Protocol Violation|1|||
33341828|NCT00912288|62718722|FG001|Overall Study|Protocol Violation|0|||
33341829|NCT00912288|62718721|FG000|Overall Study|Withdrawal by Subject|3|||
33341830|NCT00912288|62718722|FG001|Overall Study|Withdrawal by Subject|3|||
33341831|NCT00912288|62718721|FG000|Overall Study|Study terminated by sponsor|34|||
33341832|NCT00912288|62718722|FG001|Overall Study|Study terminated by sponsor|35|||
33341833|NCT00912288|62718721|FG000|Overall Study|Other|1|||
33341834|NCT00912288|62718722|FG001|Overall Study|Other|0|||
33341835|NCT00778375|62718728|FG000|Overall Study|Ineligible|3|||
33341836|NCT00777829|62718734|FG000|Overall Study|Withdrawal by Subject|0|||
33341837|NCT00777829|62718735|FG001|Overall Study|Withdrawal by Subject|2|||
33341838|NCT00775021|62718743|FG000|First Intervention|Lost to Follow-up|1|||
33341839|NCT00775021|62718744|FG001|First Intervention|Lost to Follow-up|0|||
33341840|NCT00775021|62718743|FG000|Second Intervention|Adverse Event|0|||
33341841|NCT00775021|62718744|FG001|Second Intervention|Adverse Event|1|||
33341842|NCT00777205|62718752|FG000|Overall Study|Lost to Follow-up|25|||
33341843|NCT00777205|62718753|FG001|Overall Study|Lost to Follow-up|9|||
33341844|NCT00777205|62718752|FG000|Overall Study|Withdrawal by Subject|6|||
33341845|NCT00777205|62718753|FG001|Overall Study|Withdrawal by Subject|4|||
33341846|NCT00777205|62718752|FG000|Overall Study|Death|0|||
33341847|NCT00777205|62718753|FG001|Overall Study|Death|2|||
33341848|NCT00777205|62718752|FG000|Overall Study|Protocol Violation|0|||
33341849|NCT00777205|62718753|FG001|Overall Study|Protocol Violation|56|||
33341850|NCT00833638|62718764|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
33341851|NCT00833638|62718765|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
33341852|NCT00833638|62718766|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
33341853|NCT00833638|62718764|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
33341854|NCT00833638|62718765|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
33341855|NCT00833638|62718766|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
33341856|NCT00833638|62718764|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
33341857|NCT00833638|62718765|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
33341858|NCT00833638|62718766|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
33341859|NCT00833638|62718764|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
33341860|NCT00833638|62718765|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
33341861|NCT00833638|62718766|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
33341862|NCT00833638|62718764|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
33341863|NCT00833638|62718765|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
33341864|NCT00833638|62718766|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
33341865|NCT00833638|62718764|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
33341866|NCT00833638|62718765|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
33341867|NCT00833638|62718766|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
33341868|NCT00833638|62718764|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
33341869|NCT00833638|62718765|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
33341870|NCT00833638|62718766|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
33341871|NCT00833638|62718764|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
33341872|NCT00833638|62718765|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
33341873|NCT00833638|62718766|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
33341874|NCT00833638|62718764|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
33341875|NCT00833638|62718765|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
33341876|NCT00833638|62718766|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
33341877|NCT01041404|62718784|FG000|Overall Study|Adverse Event|45|||
33341878|NCT01041404|62718785|FG001|Overall Study|Adverse Event|35|||
33341879|NCT01041404|62718784|FG000|Overall Study|Lack of Efficacy|200|||
33341880|NCT01041404|62718785|FG001|Overall Study|Lack of Efficacy|210|||
33341881|NCT01041404|62718784|FG000|Overall Study|Violation of Selection Criteria|0|||
33341882|NCT01041404|62718785|FG001|Overall Study|Violation of Selection Criteria|1|||
33341883|NCT01041404|62718784|FG000|Overall Study|Protocol Violation|4|||
33341884|NCT01041404|62718785|FG001|Overall Study|Protocol Violation|0|||
33341885|NCT01041404|62718784|FG000|Overall Study|Withdrawal by Subject|29|||
33341886|NCT01041404|62718785|FG001|Overall Study|Withdrawal by Subject|23|||
33341887|NCT01041404|62718784|FG000|Overall Study|Failure to Return|1|||
33341888|NCT01041404|62718785|FG001|Overall Study|Failure to Return|2|||
33341889|NCT01041404|62718784|FG000|Overall Study|Other|11|||
33341890|NCT01041404|62718785|FG001|Overall Study|Other|23|||
33341891|NCT00777049|62718796|FG000|Overall Study|Withdrawal by Subject|1|||
33341892|NCT00777049|62718797|FG001|Overall Study|Withdrawal by Subject|0|||
33341893|NCT00777049|62718796|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
33341894|NCT00777049|62718797|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
33341895|NCT00774787|62718803|FG000|Overall Study|Lost to Follow-up|1|||
33341896|NCT00888927|62718811|FG000|Overall Study|Adverse Event|0|||
33341897|NCT00888927|62718812|FG001|Overall Study|Adverse Event|0|||
33341898|NCT00888927|62718813|FG002|Overall Study|Adverse Event|0|||
33341899|NCT00888927|62718814|FG003|Overall Study|Adverse Event|1|||
33341900|NCT00888927|62718811|FG000|Overall Study|Withdrawal of consent|0|||
33341901|NCT00888927|62718812|FG001|Overall Study|Withdrawal of consent|0|||
33341902|NCT00888927|62718813|FG002|Overall Study|Withdrawal of consent|0|||
33341903|NCT00888927|62718814|FG003|Overall Study|Withdrawal of consent|1|||
33341904|NCT01040780|62718826|FG000|Overall Study|Protocol Violation|1|||
33341905|NCT01040780|62718827|FG001|Overall Study|Protocol Violation|3|||
33341906|NCT00888849|62718838|FG000|Overall Study|Death|4|||
33341907|NCT00888849|62718839|FG001|Overall Study|Death|7|||
33341908|NCT00888849|62718838|FG000|Overall Study|Lost to Follow-up|1|||
33341909|NCT00888849|62718839|FG001|Overall Study|Lost to Follow-up|2|||
33341910|NCT01059812|62718847|FG000|Overall Study|Adverse Event|9|||
33341911|NCT01059812|62718848|FG001|Overall Study|Adverse Event|5|||
33341912|NCT01059812|62718847|FG000|Overall Study|Lack of Efficacy|2|||
33341913|NCT01059812|62718848|FG001|Overall Study|Lack of Efficacy|2|||
33341914|NCT01059812|62718847|FG000|Overall Study|Protocol Violation|3|||
33341915|NCT01059812|62718848|FG001|Overall Study|Protocol Violation|1|||
33341916|NCT01059812|62718847|FG000|Overall Study|Withdrawal Criteria|9|||
33341917|NCT01059812|62718848|FG001|Overall Study|Withdrawal Criteria|4|||
33341918|NCT01059812|62718847|FG000|Overall Study|Unclassified|14|||
33341919|NCT01059812|62718848|FG001|Overall Study|Unclassified|4|||
33341920|NCT00888615|62718854|FG000|Overall Study|No treatment|2|||
33341921|NCT00845650|62718864|FG000|Overall Study|Withdrawal by Subject|0|||
33341922|NCT00845650|62718865|FG001|Overall Study|Withdrawal by Subject|0|||
33341923|NCT00845650|62718866|FG002|Overall Study|Withdrawal by Subject|0|||
33341924|NCT00845650|62718867|FG003|Overall Study|Withdrawal by Subject|0|||
33341925|NCT00845650|62718868|FG004|Overall Study|Withdrawal by Subject|2|||
33341926|NCT00845650|62718869|FG005|Overall Study|Withdrawal by Subject|0|||
33341927|NCT00845650|62718864|FG000|Overall Study|Lost to Follow-up|0|||
33341928|NCT00845650|62718865|FG001|Overall Study|Lost to Follow-up|0|||
33341929|NCT00845650|62718866|FG002|Overall Study|Lost to Follow-up|3|||
33341930|NCT00845650|62718867|FG003|Overall Study|Lost to Follow-up|1|||
33341931|NCT00845650|62718868|FG004|Overall Study|Lost to Follow-up|0|||
33341932|NCT00845650|62718869|FG005|Overall Study|Lost to Follow-up|1|||
33341933|NCT00845650|62718864|FG000|Overall Study|Sponsor hold on dosing|0|||
33341934|NCT00845650|62718865|FG001|Overall Study|Sponsor hold on dosing|0|||
33341935|NCT00845650|62718866|FG002|Overall Study|Sponsor hold on dosing|0|||
33341936|NCT00845650|62718867|FG003|Overall Study|Sponsor hold on dosing|0|||
33341937|NCT00845650|62718868|FG004|Overall Study|Sponsor hold on dosing|1|||
33341938|NCT00845650|62718869|FG005|Overall Study|Sponsor hold on dosing|1|||
33341939|NCT00845650|62718864|FG000|Overall Study|Unable to access IV line|1|||
33341940|NCT00845650|62718865|FG001|Overall Study|Unable to access IV line|0|||
33341941|NCT00845650|62718866|FG002|Overall Study|Unable to access IV line|0|||
33341942|NCT00845650|62718867|FG003|Overall Study|Unable to access IV line|0|||
33341943|NCT00845650|62718868|FG004|Overall Study|Unable to access IV line|0|||
33341944|NCT00845650|62718869|FG005|Overall Study|Unable to access IV line|0|||
33341945|NCT00888381|62718887|FG000|Overall Study|Lost to Follow-up|0|||
33341946|NCT00888381|62718888|FG001|Overall Study|Lost to Follow-up|1|||
33341947|NCT00887913|62718894|FG000|Overall Study|Withdrawal by Subject|6|||
33341948|NCT00833560|62718898|FG000|Overall Study|Toxicity|13|||
33341949|NCT00833560|62718898|FG000|Overall Study|Adverse Event|11|||
33341950|NCT00833560|62718898|FG000|Overall Study|Protocol Violation|6|||
33341951|NCT00833560|62718898|FG000|Overall Study|Lack of Efficacy|4|||
33341952|NCT00833560|62718898|FG000|Overall Study|Death|2|||
33341953|NCT00833560|62718898|FG000|Overall Study|Pregression of other disease|1|||
33341954|NCT00833560|62718898|FG000|Overall Study|Other|5|||
33341955|NCT00887679|62718902|FG000|Overall Study|Withdrawal by Subject|1|||
33341956|NCT00887679|62718902|FG000|Overall Study|Lost to Follow-up|4|||
33341957|NCT00887679|62718902|FG000|Overall Study|Physician Decision|5|||
33341958|NCT00833482|62718909|FG000|Days 11-20|Adverse Event|0|||
33341959|NCT00833482|62718910|FG001|Days 11-20|Adverse Event|2|||
33341960|NCT00833482|62718911|FG002|Days 11-20|Adverse Event|0|||
33341961|NCT00833482|62718912|FG003|Days 11-20|Adverse Event|0|||
33341962|NCT00833482|62718913|FG004|Days 11-20|Adverse Event|0|||
33341963|NCT00833482|62718914|FG005|Days 11-20|Adverse Event|0|||
33341964|NCT00833482|62718909|FG000|Days 11-20|Withdrawal by Subject|0|||
33341965|NCT00833482|62718910|FG001|Days 11-20|Withdrawal by Subject|1|||
33341966|NCT00833482|62718911|FG002|Days 11-20|Withdrawal by Subject|0|||
33341967|NCT00833482|62718912|FG003|Days 11-20|Withdrawal by Subject|0|||
33341968|NCT00833482|62718913|FG004|Days 11-20|Withdrawal by Subject|0|||
33341969|NCT00833482|62718914|FG005|Days 11-20|Withdrawal by Subject|0|||
33341970|NCT00833482|62718909|FG000|Days 21-30|Adverse Event|0|||
33341971|NCT00833482|62718910|FG001|Days 21-30|Adverse Event|0|||
33341972|NCT00833482|62718911|FG002|Days 21-30|Adverse Event|1|||
33341973|NCT00833482|62718912|FG003|Days 21-30|Adverse Event|0|||
33341974|NCT00833482|62718913|FG004|Days 21-30|Adverse Event|0|||
33341975|NCT00833482|62718914|FG005|Days 21-30|Adverse Event|0|||
33341976|NCT00833482|62718909|FG000|Days 21-30|Withdrawal by Subject|0|||
33341977|NCT00833482|62718910|FG001|Days 21-30|Withdrawal by Subject|0|||
33341978|NCT00833482|62718911|FG002|Days 21-30|Withdrawal by Subject|0|||
33341979|NCT00833482|62718912|FG003|Days 21-30|Withdrawal by Subject|0|||
33341980|NCT00833482|62718913|FG004|Days 21-30|Withdrawal by Subject|1|||
33341981|NCT00833482|62718914|FG005|Days 21-30|Withdrawal by Subject|0|||
33341982|NCT00845182|62718939|FG000|Overall Study|Lost to Follow-up|3|||
33341983|NCT00845182|62718940|FG001|Overall Study|Lost to Follow-up|3|||
33341984|NCT00845182|62718941|FG002|Overall Study|Lost to Follow-up|4|||
33341985|NCT00845182|62718939|FG000|Overall Study|Adverse Event|0|||
33341986|NCT00845182|62718940|FG001|Overall Study|Adverse Event|1|||
33341987|NCT00845182|62718941|FG002|Overall Study|Adverse Event|1|||
33341988|NCT00845182|62718939|FG000|Overall Study|Physician Decision|0|||
33341989|NCT00845182|62718940|FG001|Overall Study|Physician Decision|0|||
33341990|NCT00845182|62718941|FG002|Overall Study|Physician Decision|1|||
33341991|NCT00833248|62718955|FG000|Overall Study|Adverse Event|3|||
33341992|NCT00833248|62718956|FG001|Overall Study|Adverse Event|0|||
33341993|NCT00833248|62718955|FG000|Overall Study|Protocol Violation|1|||
33341994|NCT00833248|62718956|FG001|Overall Study|Protocol Violation|2|||
33341995|NCT00833248|62718955|FG000|Overall Study|Withdrawal by Subject|0|||
33341996|NCT00833248|62718956|FG001|Overall Study|Withdrawal by Subject|1|||
33341997|NCT00887289|62718962|FG000|Overall Study|Lack of Efficacy|14|||
33341998|NCT00887289|62718962|FG000|Overall Study|Adverse Event|27|||
33341999|NCT00887289|62718962|FG000|Overall Study|Withdrawal by Subject|26|||
33342000|NCT00887289|62718962|FG000|Overall Study|Lost to Follow-up|8|||
33342001|NCT00887289|62718962|FG000|Overall Study|Other|20|||
33342002|NCT00833092|62718968|FG000|Overall Study|Withdrawal by Subject|2|||
33342003|NCT00833092|62718969|FG001|Overall Study|Withdrawal by Subject|3|||
33342004|NCT00833092|62718968|FG000|Overall Study|Protocol Violation|2|||
33342005|NCT00833092|62718969|FG001|Overall Study|Protocol Violation|1|||
33342006|NCT00833092|62718968|FG000|Overall Study|Diarrhea|0|||
33342007|NCT00833092|62718969|FG001|Overall Study|Diarrhea|2|||
33342008|NCT00833092|62718968|FG000|Overall Study|constipation|0|||
33342009|NCT00833092|62718969|FG001|Overall Study|constipation|1|||
33342010|NCT00823264|62718977|FG000|Overall Study|Protocol Violation|2|||
33342011|NCT00823264|62718978|FG001|Overall Study|Protocol Violation|0|||
33342012|NCT00832780|62718984|FG000|Overall Study|Death|16|||
33342013|NCT00832780|62718984|FG000|Overall Study|Lost to Follow-up|4|||
33342014|NCT00832780|62718984|FG000|Overall Study|no reason given|2|||
33342015|NCT00832780|62718984|FG000|Overall Study|other complicating condition|2|||
33342016|NCT00832780|62718984|FG000|Overall Study|Physician Decision|1|||
33342017|NCT00591838|62718993|FG000|Overall Study|Withdrawal by Subject|0|||
33342018|NCT00591838|62718994|FG001|Overall Study|Withdrawal by Subject|0|||
33342019|NCT00591838|62718995|FG002|Overall Study|Withdrawal by Subject|0|||
33342020|NCT00591838|62718996|FG003|Overall Study|Withdrawal by Subject|1|||
33342021|NCT00591838|62718997|FG004|Overall Study|Withdrawal by Subject|0|||
33342022|NCT00832624|62719010|FG000|Overall Study|Study Terminated|10|||
33342023|NCT00832078|62719014|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
33342024|NCT00832078|62719015|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
33342025|NCT00832078|62719014|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
33342026|NCT00832078|62719015|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
33342027|NCT00822172|62719023|FG000|Overall Study|Adverse Event|10|||
33342028|NCT00822172|62719024|FG001|Overall Study|Adverse Event|12|||
33342029|NCT00822172|62719023|FG000|Overall Study|Death|1|||
33342030|NCT00822172|62719024|FG001|Overall Study|Death|0|||
33342031|NCT00822172|62719023|FG000|Overall Study|Lost to Follow-up|3|||
33342032|NCT00822172|62719024|FG001|Overall Study|Lost to Follow-up|1|||
33342033|NCT00822172|62719023|FG000|Overall Study|Withdrawal by Subject|1|||
33342034|NCT00822172|62719024|FG001|Overall Study|Withdrawal by Subject|4|||
33342035|NCT00822172|62719023|FG000|Overall Study|site closed|0|||
33342036|NCT00822172|62719024|FG001|Overall Study|site closed|1|||
33342037|NCT00822172|62719023|FG000|Overall Study|Other|0|||
33342038|NCT00822172|62719024|FG001|Overall Study|Other|1|||
33342039|NCT00832000|62719030|FG000|Overall Study|Adverse Event|2|||
33342040|NCT00832000|62719031|FG001|Overall Study|Adverse Event|0|||
33342041|NCT00832000|62719030|FG000|Overall Study|Withdrawal by Subject|1|||
33342042|NCT00832000|62719031|FG001|Overall Study|Withdrawal by Subject|0|||
33342043|NCT00832000|62719030|FG000|Overall Study|No calls to IVR in either period|1|||
33342044|NCT00832000|62719031|FG001|Overall Study|No calls to IVR in either period|1|||
33342045|NCT00832000|62719030|FG000|Overall Study|No calls to IVR in period 2|2|||
33342046|NCT00832000|62719031|FG001|Overall Study|No calls to IVR in period 2|0|||
33342047|NCT00911508|62719068|FG000|Overall Study|Lost to Follow-up|27|||
33342048|NCT00911508|62719069|FG001|Overall Study|Lost to Follow-up|18|||
33342049|NCT00911508|62719068|FG000|Overall Study|Withdrawal by Subject|79|||
33342050|NCT00911508|62719069|FG001|Overall Study|Withdrawal by Subject|112|||
33342051|NCT00774397|62719095|FG000|Overall Study|Adverse Event|1|||
33342052|NCT00774397|62719096|FG001|Overall Study|Adverse Event|3|||
33342053|NCT00774397|62719097|FG002|Overall Study|Adverse Event|16|||
33342054|NCT00774397|62719098|FG003|Overall Study|Adverse Event|8|||
33342055|NCT00774397|62719099|FG004|Overall Study|Adverse Event|8|||
33342056|NCT00774397|62719100|FG005|Overall Study|Adverse Event|3|||
33342057|NCT00774397|62719101|FG006|Overall Study|Adverse Event|16|||
33342058|NCT00774397|62719095|FG000|Overall Study|Lack of Efficacy|11|||
33342059|NCT00774397|62719096|FG001|Overall Study|Lack of Efficacy|4|||
33342060|NCT00774397|62719097|FG002|Overall Study|Lack of Efficacy|5|||
33342061|NCT00774397|62719098|FG003|Overall Study|Lack of Efficacy|3|||
33342062|NCT00774397|62719099|FG004|Overall Study|Lack of Efficacy|27|||
33342063|NCT00774397|62719100|FG005|Overall Study|Lack of Efficacy|15|||
33342064|NCT00774397|62719101|FG006|Overall Study|Lack of Efficacy|9|||
33342065|NCT00774397|62719095|FG000|Overall Study|Protocol Violation|0|||
33342066|NCT00774397|62719096|FG001|Overall Study|Protocol Violation|1|||
33342067|NCT00774397|62719097|FG002|Overall Study|Protocol Violation|3|||
33342068|NCT00774397|62719098|FG003|Overall Study|Protocol Violation|1|||
33342069|NCT00774397|62719099|FG004|Overall Study|Protocol Violation|2|||
33342070|NCT00774397|62719100|FG005|Overall Study|Protocol Violation|1|||
33342071|NCT00774397|62719101|FG006|Overall Study|Protocol Violation|0|||
33342072|NCT00774397|62719095|FG000|Overall Study|Lost to Follow-up|0|||
33342073|NCT00774397|62719096|FG001|Overall Study|Lost to Follow-up|1|||
33342074|NCT00774397|62719097|FG002|Overall Study|Lost to Follow-up|1|||
33342075|NCT00774397|62719098|FG003|Overall Study|Lost to Follow-up|1|||
33342076|NCT00774397|62719099|FG004|Overall Study|Lost to Follow-up|0|||
33342077|NCT00774397|62719100|FG005|Overall Study|Lost to Follow-up|1|||
33342078|NCT00774397|62719101|FG006|Overall Study|Lost to Follow-up|0|||
33342079|NCT00774397|62719095|FG000|Overall Study|Refused to continue trial medication|1|||
33342080|NCT00774397|62719096|FG001|Overall Study|Refused to continue trial medication|3|||
33342081|NCT00774397|62719097|FG002|Overall Study|Refused to continue trial medication|2|||
33342082|NCT00774397|62719098|FG003|Overall Study|Refused to continue trial medication|2|||
33342083|NCT00774397|62719099|FG004|Overall Study|Refused to continue trial medication|6|||
33342084|NCT00774397|62719100|FG005|Overall Study|Refused to continue trial medication|2|||
33469927|NCT00262847|62843605|FG000|Overall Study|Disease Progression|309|||
33342085|NCT00774397|62719101|FG006|Overall Study|Refused to continue trial medication|3|||
33342086|NCT00774397|62719095|FG000|Overall Study|Not treated|0|||
33342087|NCT00774397|62719096|FG001|Overall Study|Not treated|0|||
33342088|NCT00774397|62719097|FG002|Overall Study|Not treated|0|||
33342089|NCT00774397|62719098|FG003|Overall Study|Not treated|0|||
33342090|NCT00774397|62719099|FG004|Overall Study|Not treated|1|||
33342091|NCT00774397|62719100|FG005|Overall Study|Not treated|0|||
33342092|NCT00774397|62719101|FG006|Overall Study|Not treated|1|||
33342093|NCT00774397|62719095|FG000|Overall Study|Other than those stated above|1|||
33342094|NCT00774397|62719096|FG001|Overall Study|Other than those stated above|1|||
33342095|NCT00774397|62719097|FG002|Overall Study|Other than those stated above|3|||
33342096|NCT00774397|62719098|FG003|Overall Study|Other than those stated above|2|||
33342097|NCT00774397|62719099|FG004|Overall Study|Other than those stated above|2|||
33342098|NCT00774397|62719100|FG005|Overall Study|Other than those stated above|0|||
33342099|NCT00774397|62719101|FG006|Overall Study|Other than those stated above|1|||
33342100|NCT00909870|62719156|FG000|Overall Study|Adverse Event|13|||
33342101|NCT00909870|62719157|FG001|Overall Study|Adverse Event|7|||
33342102|NCT00909870|62719156|FG000|Overall Study|Protocol Violation|1|||
33342103|NCT00909870|62719157|FG001|Overall Study|Protocol Violation|2|||
33342104|NCT00909870|62719156|FG000|Overall Study|Withdrawal by Subject|5|||
33342105|NCT00909870|62719157|FG001|Overall Study|Withdrawal by Subject|8|||
33342106|NCT00909870|62719156|FG000|Overall Study|Lost to Follow-up|3|||
33342107|NCT00909870|62719157|FG001|Overall Study|Lost to Follow-up|3|||
33342108|NCT00909870|62719156|FG000|Overall Study|Physician Decision|0|||
33342109|NCT00909870|62719157|FG001|Overall Study|Physician Decision|2|||
33342110|NCT00909870|62719156|FG000|Overall Study|Other|1|||
33342111|NCT00909870|62719157|FG001|Overall Study|Other|5|||
33342112|NCT00768469|62719166|FG000|Overall Study|Adverse Event|0|||
33342113|NCT00768469|62719167|FG001|Overall Study|Adverse Event|2|||
33342114|NCT00768469|62719166|FG000|Overall Study|Disease Progression|3|||
33342115|NCT00768469|62719167|FG001|Overall Study|Disease Progression|4|||
33342116|NCT00768469|62719166|FG000|Overall Study|Withdrawal by Subject|0|||
33342117|NCT00768469|62719167|FG001|Overall Study|Withdrawal by Subject|1|||
33342118|NCT00886821|62719188|FG000|Stage 2|Adverse Event|0|||
33342119|NCT00886821|62719189|FG001|Stage 2|Adverse Event|0|||
33342120|NCT00886821|62719190|FG002|Stage 2|Adverse Event|0|||
33342121|NCT00886821|62719191|FG003|Stage 2|Adverse Event|0|||
33342122|NCT00886821|62719192|FG004|Stage 2|Adverse Event|0|||
33342123|NCT00886821|62719193|FG005|Stage 2|Adverse Event|0|||
33342124|NCT00886821|62719194|FG006|Stage 2|Adverse Event|0|||
33342125|NCT00886821|62719195|FG007|Stage 2|Adverse Event|0|||
33342126|NCT00886821|62719196|FG008|Stage 2|Adverse Event|0|||
33342127|NCT00886821|62719197|FG009|Stage 2|Adverse Event|0|||
33342128|NCT00886821|62719198|FG010|Stage 2|Adverse Event|0|||
33342129|NCT00886821|62719199|FG011|Stage 2|Adverse Event|1|||
33342130|NCT00886821|62719200|FG012|Stage 2|Adverse Event|3|||
33342131|NCT00886821|62719201|FG013|Stage 2|Adverse Event|0|||
33342132|NCT00886821|62719188|FG000|Stage 2|Lost to Follow-up|0|||
33342133|NCT00886821|62719189|FG001|Stage 2|Lost to Follow-up|0|||
33342134|NCT00886821|62719190|FG002|Stage 2|Lost to Follow-up|0|||
33342135|NCT00886821|62719191|FG003|Stage 2|Lost to Follow-up|0|||
33342136|NCT00886821|62719192|FG004|Stage 2|Lost to Follow-up|0|||
33342137|NCT00886821|62719193|FG005|Stage 2|Lost to Follow-up|0|||
33342138|NCT00886821|62719194|FG006|Stage 2|Lost to Follow-up|0|||
33342139|NCT00886821|62719195|FG007|Stage 2|Lost to Follow-up|0|||
33342140|NCT00886821|62719196|FG008|Stage 2|Lost to Follow-up|0|||
33342141|NCT00886821|62719197|FG009|Stage 2|Lost to Follow-up|0|||
33342142|NCT00886821|62719198|FG010|Stage 2|Lost to Follow-up|0|||
33342143|NCT00886821|62719199|FG011|Stage 2|Lost to Follow-up|0|||
33342144|NCT00886821|62719200|FG012|Stage 2|Lost to Follow-up|2|||
33342145|NCT00886821|62719201|FG013|Stage 2|Lost to Follow-up|1|||
33342146|NCT00886743|62719245|FG000|Overall Study|Adverse Event|3|||
33342147|NCT00886743|62719245|FG000|Overall Study|Other|1|||
33342148|NCT00886587|62719251|FG000|Overall Study|Adverse Event|2|||
33342149|NCT00886587|62719252|FG001|Overall Study|Adverse Event|1|||
33342150|NCT00886587|62719251|FG000|Overall Study|Protocol Violation|2|||
33342151|NCT00886587|62719252|FG001|Overall Study|Protocol Violation|0|||
33342152|NCT00886587|62719251|FG000|Overall Study|Withdrawal by Subject|0|||
33342153|NCT00886587|62719252|FG001|Overall Study|Withdrawal by Subject|1|||
33342154|NCT00886119|62719258|FG000|Period 1|Did not meet inclusion criteria|1|||
33342155|NCT00886119|62719259|FG001|Period 1|Did not meet inclusion criteria|0|||
33342156|NCT00768079|62719268|FG000|Overall Study|Lost to Follow-up|2|||
33342157|NCT00768079|62719269|FG001|Overall Study|Lost to Follow-up|0|||
33342158|NCT00768079|62719270|FG002|Overall Study|Lost to Follow-up|4|||
33342159|NCT00768079|62719268|FG000|Overall Study|Participant incarcerated|0|||
33342160|NCT00768079|62719269|FG001|Overall Study|Participant incarcerated|1|||
33342161|NCT00768079|62719270|FG002|Overall Study|Participant incarcerated|0|||
33342162|NCT00767455|62719280|FG000|Overall Study|Investigator error|19|||
33342163|NCT00766831|62719286|FG000|Overall Study|Withdrawal by Subject|4|||
33342164|NCT00766831|62719286|FG000|Overall Study|Lost to Follow-up|3|||
33342165|NCT00766831|62719286|FG000|Overall Study|Adverse Event|20|||
33342166|NCT00766831|62719286|FG000|Overall Study|Protocol Violation|15|||
33342167|NCT00766831|62719286|FG000|Overall Study|Physician Decision|5|||
33342168|NCT00766831|62719286|FG000|Overall Study|Withdrawal of consent|26|||
33342169|NCT00766831|62719286|FG000|Overall Study|Non cooperation by participants|14|||
33342170|NCT00766831|62719286|FG000|Overall Study|Other|28|||
33342171|NCT00766675|62719290|FG000|Overall Study|Adverse Event|16|||
33342172|NCT00766675|62719290|FG000|Overall Study|Lost to Follow-up|2|||
33342173|NCT00766675|62719290|FG000|Overall Study|Withdrawal by Subject|11|||
33342174|NCT00766675|62719290|FG000|Overall Study|Protocol Violation|8|||
33342175|NCT00766675|62719290|FG000|Overall Study|Participant took prohibited medication|1|||
33342176|NCT00766675|62719290|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
33342177|NCT00766675|62719290|FG000|Overall Study|Insufficient therapy|1|||
33342178|NCT00766597|62719294|FG000|Overall Study|Unexpected closure of study|4|||
33342179|NCT00766597|62719294|FG000|Overall Study|Without CCR5-tropic virus|5|||
33342180|NCT00910962|62719303|FG000|Overall Study|Adverse Event|5|||
33342181|NCT00910962|62719304|FG001|Overall Study|Adverse Event|20|||
33342182|NCT00910962|62719305|FG002|Overall Study|Adverse Event|17|||
33342183|NCT00910962|62719303|FG000|Overall Study|Protocol Violation|1|||
33342184|NCT00910962|62719304|FG001|Overall Study|Protocol Violation|3|||
33342185|NCT00910962|62719305|FG002|Overall Study|Protocol Violation|3|||
33342186|NCT00910962|62719303|FG000|Overall Study|Lost to Follow-up|0|||
33342187|NCT00910962|62719304|FG001|Overall Study|Lost to Follow-up|3|||
33342188|NCT00910962|62719305|FG002|Overall Study|Lost to Follow-up|1|||
33342189|NCT00910962|62719303|FG000|Overall Study|Physician Decision|0|||
33342190|NCT00910962|62719304|FG001|Overall Study|Physician Decision|6|||
33342191|NCT00910962|62719305|FG002|Overall Study|Physician Decision|6|||
33342192|NCT00910962|62719303|FG000|Overall Study|Withdrawal by Subject|25|||
33342193|NCT00910962|62719304|FG001|Overall Study|Withdrawal by Subject|32|||
33342194|NCT00910962|62719305|FG002|Overall Study|Withdrawal by Subject|32|||
33342195|NCT00910962|62719303|FG000|Overall Study|Reached defined stopping criteria|12|||
33342196|NCT00910962|62719304|FG001|Overall Study|Reached defined stopping criteria|14|||
33342197|NCT00910962|62719305|FG002|Overall Study|Reached defined stopping criteria|17|||
33342198|NCT00773461|62719317|FG000|Overall Study|Adverse Event|1|||
33342199|NCT00773461|62719318|FG001|Overall Study|Adverse Event|3|||
33342200|NCT00773461|62719317|FG000|Overall Study|Withdrawal by Subject|4|||
33342201|NCT00773461|62719318|FG001|Overall Study|Withdrawal by Subject|1|||
33342202|NCT00773383|62719325|FG000|Overall Study|Adverse Event|4|||
33342203|NCT00773383|62719325|FG000|Overall Study|Death|1|||
33342204|NCT00773383|62719325|FG000|Overall Study|Progression of Disease|23|||
33342205|NCT00773383|62719325|FG000|Overall Study|Other|2|||
33342206|NCT00773383|62719325|FG000|Overall Study|No study dose received|1|||
33342207|NCT00757003|62719333|FG000|Overall Study|Death|33|||
33342208|NCT00757003|62719333|FG000|Overall Study|Lost to Follow-up|9|||
33342209|NCT00757003|62719333|FG000|Overall Study|Withdrawal by Subject|4|||
33342210|NCT00757003|62719333|FG000|Overall Study|Surgically explanted|2|||
33342211|NCT00757003|62719333|FG000|Overall Study|Not implanted|1|||
33342212|NCT00766363|62719342|FG000|Overall Study|Withdrawal by Subject|1|||
33342213|NCT00766363|62719343|FG001|Overall Study|Withdrawal by Subject|0|||
33342214|NCT00766363|62719344|FG002|Overall Study|Withdrawal by Subject|0|||
33342215|NCT00766363|62719345|FG003|Overall Study|Withdrawal by Subject|0|||
33342216|NCT00766363|62719342|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
33342217|NCT00766363|62719343|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
33342218|NCT00766363|62719344|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
33342219|NCT00766363|62719345|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
33469928|NCT00262847|62843606|FG001|Overall Study|Disease Progression|274|||
33469929|NCT00262847|62843607|FG002|Overall Study|Disease Progression|195|||
33469930|NCT00262847|62843605|FG000|Overall Study|Patient Refusal|41|||
33469931|NCT00262847|62843606|FG001|Overall Study|Patient Refusal|52|||
33469932|NCT00262847|62843607|FG002|Overall Study|Patient Refusal|47|||
33469933|NCT00262847|62843605|FG000|Overall Study|Adverse Event|74|||
33469934|NCT00262847|62843606|FG001|Overall Study|Adverse Event|88|||
33469935|NCT00262847|62843607|FG002|Overall Study|Adverse Event|108|||
33469936|NCT00262847|62843605|FG000|Overall Study|Death|8|||
33469937|NCT00262847|62843606|FG001|Overall Study|Death|8|||
33469938|NCT00262847|62843607|FG002|Overall Study|Death|11|||
33469939|NCT00262847|62843605|FG000|Overall Study|Concomitant disease|3|||
33469940|NCT00262847|62843606|FG001|Overall Study|Concomitant disease|2|||
33342220|NCT02636946|62719358|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
33342221|NCT02636946|62719359|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
33342222|NCT02636946|62719358|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
33342223|NCT02636946|62719359|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
33342224|NCT02636946|62719358|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
33342225|NCT02636946|62719359|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
33342226|NCT02636946|62719358|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
33469941|NCT00262847|62843607|FG002|Overall Study|Concomitant disease|4|||
33469942|NCT00262847|62843605|FG000|Overall Study|Other Reasons|79|||
33342227|NCT02636946|62719359|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
33342228|NCT02636946|62719358|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
33342229|NCT02636946|62719359|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
33342230|NCT02636946|62719358|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
33342231|NCT02636946|62719359|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
33342232|NCT00766051|62719367|FG000|Overall Study|Withdrawal by Subject|2|||
33342233|NCT00766051|62719368|FG001|Overall Study|Withdrawal by Subject|0|||
33342234|NCT00909792|62719376|FG000|Period 1|Did not meet inclusion criteria|0|||
33342235|NCT00909792|62719377|FG001|Period 1|Did not meet inclusion criteria|1|||
33342236|NCT00909792|62719376|FG000|Period 2|Biomicroscopy|1|||
33342237|NCT00909792|62719377|FG001|Period 2|Biomicroscopy|0|||
33342238|NCT00909792|62719376|FG000|Period 2|Lost to Follow-up|0|||
33342239|NCT00909792|62719377|FG001|Period 2|Lost to Follow-up|1|||
33342240|NCT00765817|62719385|FG000|Overall Study|Adverse Event|13|||
33342241|NCT00765817|62719386|FG001|Overall Study|Adverse Event|1|||
33342242|NCT00765817|62719385|FG000|Overall Study|Death|0|||
33342243|NCT00765817|62719386|FG001|Overall Study|Death|1|||
33342244|NCT00765817|62719385|FG000|Overall Study|Entry criteria not met|2|||
33342245|NCT00765817|62719386|FG001|Overall Study|Entry criteria not met|2|||
33342246|NCT00765817|62719385|FG000|Overall Study|Loss of glucose control|0|||
33342247|NCT00765817|62719386|FG001|Overall Study|Loss of glucose control|2|||
33342248|NCT00765817|62719385|FG000|Overall Study|Lost to Follow-up|1|||
33342249|NCT00765817|62719386|FG001|Overall Study|Lost to Follow-up|3|||
33342250|NCT00765817|62719385|FG000|Overall Study|Physician Decision|2|||
33342251|NCT00765817|62719386|FG001|Overall Study|Physician Decision|1|||
33342252|NCT00765817|62719385|FG000|Overall Study|Protocol Violation|1|||
33342253|NCT00765817|62719386|FG001|Overall Study|Protocol Violation|1|||
33342254|NCT00765817|62719385|FG000|Overall Study|Subject decision|7|||
33342255|NCT00765817|62719386|FG001|Overall Study|Subject decision|11|||
33342256|NCT00772603|62719395|FG000|Overall Study|Withdrawal by Subject|11|||
33342257|NCT00772603|62719396|FG001|Overall Study|Withdrawal by Subject|10|||
33342258|NCT00772603|62719397|FG002|Overall Study|Withdrawal by Subject|6|||
33342259|NCT00772603|62719395|FG000|Overall Study|Adverse Event|37|||
33342260|NCT00772603|62719396|FG001|Overall Study|Adverse Event|18|||
33342261|NCT00772603|62719397|FG002|Overall Study|Adverse Event|10|||
33342262|NCT00772603|62719395|FG000|Overall Study|Subject Non-compliance|1|||
33342263|NCT00772603|62719396|FG001|Overall Study|Subject Non-compliance|6|||
33342264|NCT00772603|62719397|FG002|Overall Study|Subject Non-compliance|4|||
33342265|NCT00772603|62719395|FG000|Overall Study|Protocol Violation|0|||
33342266|NCT00772603|62719396|FG001|Overall Study|Protocol Violation|1|||
33342267|NCT00772603|62719397|FG002|Overall Study|Protocol Violation|1|||
33342268|NCT00772603|62719395|FG000|Overall Study|Lost to Follow-up|1|||
33342269|NCT00772603|62719396|FG001|Overall Study|Lost to Follow-up|5|||
33342270|NCT00772603|62719397|FG002|Overall Study|Lost to Follow-up|2|||
33342271|NCT00772603|62719395|FG000|Overall Study|Physician Decision|0|||
33342272|NCT00772603|62719396|FG001|Overall Study|Physician Decision|0|||
33342273|NCT00772603|62719397|FG002|Overall Study|Physician Decision|1|||
33342274|NCT00772603|62719395|FG000|Overall Study|Other|2|||
33342275|NCT00772603|62719396|FG001|Overall Study|Other|0|||
33342276|NCT00772603|62719397|FG002|Overall Study|Other|2|||
33342277|NCT00772447|62719410|FG000|Overall Study|Withdrawal by Subject|9|||
33342278|NCT00772447|62719411|FG001|Overall Study|Withdrawal by Subject|5|||
33342279|NCT00772447|62719410|FG000|Overall Study|Physician Decision|4|||
33342280|NCT00772447|62719411|FG001|Overall Study|Physician Decision|8|||
33342281|NCT00772447|62719410|FG000|Overall Study|Lost to Follow-up|2|||
33342282|NCT00772447|62719411|FG001|Overall Study|Lost to Follow-up|4|||
33342283|NCT00772447|62719410|FG000|Overall Study|incorrect enrolment|3|||
33342284|NCT00772447|62719411|FG001|Overall Study|incorrect enrolment|4|||
33342285|NCT00772447|62719410|FG000|Overall Study|Protocol Violation|0|||
33342286|NCT00772447|62719411|FG001|Overall Study|Protocol Violation|1|||
33654531|NCT01698554|63067252|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33342287|NCT00772447|62719410|FG000|Overall Study|all others|2|||
33342288|NCT00772447|62719411|FG001|Overall Study|all others|2|||
33342289|NCT00765037|62719418|FG000|Overall Study|Lost to Follow-up|5|||
33342290|NCT00765037|62719418|FG000|Overall Study|Adverse Event|1|||
33342291|NCT00831844|62719432|FG000|Overall Study|Adverse Event|2|||
33342292|NCT00831844|62719433|FG001|Overall Study|Adverse Event|0|||
33342293|NCT00831844|62719434|FG002|Overall Study|Adverse Event|0|||
33342294|NCT00831844|62719435|FG003|Overall Study|Adverse Event|0|||
33342295|NCT00831844|62719436|FG004|Overall Study|Adverse Event|1|||
33342296|NCT00831844|62719437|FG005|Overall Study|Adverse Event|1|||
33342297|NCT00831844|62719438|FG006|Overall Study|Adverse Event|2|||
33342298|NCT00831844|62719439|FG007|Overall Study|Adverse Event|0|||
33342299|NCT00831844|62719440|FG008|Overall Study|Adverse Event|0|||
33342300|NCT00831844|62719441|FG009|Overall Study|Adverse Event|0|||
33342301|NCT00831844|62719432|FG000|Overall Study|Death|0|||
33342302|NCT00831844|62719433|FG001|Overall Study|Death|0|||
33342303|NCT00831844|62719434|FG002|Overall Study|Death|0|||
33342304|NCT00831844|62719435|FG003|Overall Study|Death|1|||
33342305|NCT00831844|62719436|FG004|Overall Study|Death|0|||
33342306|NCT00831844|62719437|FG005|Overall Study|Death|0|||
33342307|NCT00831844|62719438|FG006|Overall Study|Death|0|||
33342308|NCT00831844|62719439|FG007|Overall Study|Death|0|||
33342309|NCT00831844|62719440|FG008|Overall Study|Death|0|||
33342310|NCT00831844|62719441|FG009|Overall Study|Death|0|||
33342311|NCT00831844|62719432|FG000|Overall Study|Lack of Efficacy|8|||
33342312|NCT00831844|62719433|FG001|Overall Study|Lack of Efficacy|10|||
33342313|NCT00831844|62719434|FG002|Overall Study|Lack of Efficacy|15|||
33342314|NCT00831844|62719435|FG003|Overall Study|Lack of Efficacy|8|||
33342315|NCT00831844|62719436|FG004|Overall Study|Lack of Efficacy|11|||
33342316|NCT00831844|62719437|FG005|Overall Study|Lack of Efficacy|17|||
33342317|NCT00831844|62719438|FG006|Overall Study|Lack of Efficacy|8|||
33342318|NCT00831844|62719439|FG007|Overall Study|Lack of Efficacy|9|||
33342319|NCT00831844|62719440|FG008|Overall Study|Lack of Efficacy|7|||
33342320|NCT00831844|62719441|FG009|Overall Study|Lack of Efficacy|0|||
33342321|NCT00831844|62719432|FG000|Overall Study|Physician Decision|0|||
33342322|NCT00831844|62719433|FG001|Overall Study|Physician Decision|1|||
33342323|NCT00831844|62719434|FG002|Overall Study|Physician Decision|3|||
33342324|NCT00831844|62719435|FG003|Overall Study|Physician Decision|1|||
33342325|NCT00831844|62719436|FG004|Overall Study|Physician Decision|1|||
33342326|NCT00831844|62719437|FG005|Overall Study|Physician Decision|1|||
33342327|NCT00831844|62719438|FG006|Overall Study|Physician Decision|0|||
33342328|NCT00831844|62719439|FG007|Overall Study|Physician Decision|0|||
33342329|NCT00831844|62719440|FG008|Overall Study|Physician Decision|1|||
33342330|NCT00831844|62719441|FG009|Overall Study|Physician Decision|0|||
33342331|NCT00831844|62719432|FG000|Overall Study|Withdrawal by Subject|0|||
33342332|NCT00831844|62719433|FG001|Overall Study|Withdrawal by Subject|0|||
33342333|NCT00831844|62719434|FG002|Overall Study|Withdrawal by Subject|1|||
33342334|NCT00831844|62719435|FG003|Overall Study|Withdrawal by Subject|0|||
33342335|NCT00831844|62719436|FG004|Overall Study|Withdrawal by Subject|0|||
33342336|NCT00831844|62719437|FG005|Overall Study|Withdrawal by Subject|0|||
33342337|NCT00831844|62719438|FG006|Overall Study|Withdrawal by Subject|0|||
33342338|NCT00831844|62719439|FG007|Overall Study|Withdrawal by Subject|1|||
33342339|NCT00831844|62719440|FG008|Overall Study|Withdrawal by Subject|1|||
33342340|NCT00831844|62719441|FG009|Overall Study|Withdrawal by Subject|0|||
33342341|NCT00831844|62719432|FG000|Overall Study|Ineligible|0|||
33342342|NCT00831844|62719433|FG001|Overall Study|Ineligible|1|||
33342343|NCT00831844|62719434|FG002|Overall Study|Ineligible|1|||
33342344|NCT00831844|62719435|FG003|Overall Study|Ineligible|0|||
33342345|NCT00831844|62719436|FG004|Overall Study|Ineligible|1|||
33342346|NCT00831844|62719437|FG005|Overall Study|Ineligible|0|||
33342347|NCT00831844|62719438|FG006|Overall Study|Ineligible|0|||
33342348|NCT00831844|62719439|FG007|Overall Study|Ineligible|0|||
33342349|NCT00831844|62719440|FG008|Overall Study|Ineligible|0|||
33342350|NCT00831844|62719441|FG009|Overall Study|Ineligible|0|||
33342351|NCT00764881|62719465|FG000|Overall Study|Adverse Event|5|||
33342352|NCT00764881|62719466|FG001|Overall Study|Adverse Event|1|||
33342353|NCT00764881|62719465|FG000|Overall Study|Withdrawal by Subject|1|||
33342354|NCT00764881|62719466|FG001|Overall Study|Withdrawal by Subject|3|||
33342355|NCT00764881|62719465|FG000|Overall Study|Protocol Violation|2|||
33548866|NCT02959177|62940235|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
33342356|NCT00764881|62719466|FG001|Overall Study|Protocol Violation|2|||
33342357|NCT00764881|62719465|FG000|Overall Study|Lost to Follow-up|2|||
33342358|NCT00764881|62719466|FG001|Overall Study|Lost to Follow-up|0|||
33342359|NCT00764881|62719465|FG000|Overall Study|Noncompliant|1|||
33342360|NCT00764881|62719466|FG001|Overall Study|Noncompliant|0|||
33342361|NCT00764881|62719465|FG000|Overall Study|Accidentally discontinued study drug|1|||
33342362|NCT00764881|62719466|FG001|Overall Study|Accidentally discontinued study drug|0|||
33342363|NCT00764881|62719465|FG000|Overall Study|Wished to become pregnant|1|||
33342364|NCT00764881|62719466|FG001|Overall Study|Wished to become pregnant|0|||
33548867|NCT02959177|62940233|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
33654532|NCT01698554|63067253|FG002|Overall Study|Other Miscellaneous Reasons|0|||
33342365|NCT00764881|62719465|FG000|Overall Study|Carcinoma detected|1|||
33342366|NCT00764881|62719466|FG001|Overall Study|Carcinoma detected|0|||
33342367|NCT00764881|62719465|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
33342368|NCT00764881|62719466|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
33342369|NCT00764881|62719465|FG000|Overall Study|no treatment or no observation|2|||
33342370|NCT00764881|62719466|FG001|Overall Study|no treatment or no observation|2|||
33342371|NCT00844558|62719474|FG000|Overall Study|Withdrawal by Subject|9|||
33342372|NCT00844558|62719475|FG001|Overall Study|Withdrawal by Subject|2|||
33342373|NCT00844558|62719474|FG000|Overall Study|Death|1|||
33654533|NCT01698554|63067254|FG003|Overall Study|Other Miscellaneous Reasons|0|||
33654534|NCT01698320|63067266|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
33654535|NCT01698320|63067267|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
33654536|NCT01698320|63067268|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
33654537|NCT01698320|63067266|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
33654538|NCT01698320|63067267|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
33654539|NCT01698320|63067268|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
33654540|NCT01698320|63067266|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
33654541|NCT01698320|63067267|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
33654542|NCT01698320|63067268|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
33654543|NCT01698320|63067266|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
33654544|NCT01698320|63067267|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
33654545|NCT01698320|63067268|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
33654546|NCT01698320|63067266|FG000|12-Week Double-Blind Period|Adverse Event|0|||
33654547|NCT01698320|63067267|FG001|12-Week Double-Blind Period|Adverse Event|1|||
33654548|NCT01698320|63067268|FG002|12-Week Double-Blind Period|Adverse Event|1|||
33654549|NCT01698320|63067266|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
33654550|NCT01698320|63067267|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
33654551|NCT01698320|63067268|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
33654552|NCT01698320|63067266|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
33654553|NCT01698320|63067267|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
33654554|NCT01698320|63067268|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
33654555|NCT01698320|63067266|FG000|12-Week Double-Blind Period|Pregnancy|0|||
33654556|NCT01698320|63067267|FG001|12-Week Double-Blind Period|Pregnancy|1|||
33654557|NCT01698320|63067268|FG002|12-Week Double-Blind Period|Pregnancy|1|||
33654558|NCT01698320|63067266|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
33654559|NCT01698320|63067267|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
33654560|NCT01698320|63067268|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
33654561|NCT01698320|63067266|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
33654562|NCT01698320|63067267|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
33654563|NCT01698320|63067268|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
33654564|NCT01698320|63067266|FG000|40-Week Open-Label Period|Adverse Event|0|||
33654565|NCT01698320|63067267|FG001|40-Week Open-Label Period|Adverse Event|3|||
33654566|NCT01698320|63067268|FG002|40-Week Open-Label Period|Adverse Event|2|||
33654567|NCT01698320|63067266|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
33654568|NCT01698320|63067267|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
33654569|NCT01698320|63067268|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
33654570|NCT01698320|63067266|FG000|40-Week Open-Label Period|Pregnancy|0|||
33654571|NCT01698320|63067267|FG001|40-Week Open-Label Period|Pregnancy|2|||
33654572|NCT01698320|63067268|FG002|40-Week Open-Label Period|Pregnancy|1|||
33654573|NCT01698320|63067266|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
33654574|NCT01698320|63067267|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
33654575|NCT01698320|63067268|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
33654576|NCT01698320|63067266|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
33654577|NCT01698320|63067267|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
33654578|NCT01698320|63067268|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
33654579|NCT01698008|63067278|FG000|Overall Study|Withdrawal by Subject|1|||
33654580|NCT01698008|63067279|FG001|Overall Study|Withdrawal by Subject|2|||
33654581|NCT01697696|63067295|FG000|Overall Study|Study terminated by sponsor|0|||
33654582|NCT01697696|63067296|FG001|Overall Study|Study terminated by sponsor|3|||
33654583|NCT01697696|63067295|FG000|Overall Study|Protocol deviation|1|||
33654584|NCT01697696|63067296|FG001|Overall Study|Protocol deviation|0|||
33654585|NCT01697696|63067295|FG000|Overall Study|Physician Decision|1|||
33654586|NCT01697696|63067296|FG001|Overall Study|Physician Decision|0|||
33654587|NCT01697696|63067295|FG000|Overall Study|Death|4|||
33654588|NCT01697696|63067296|FG001|Overall Study|Death|2|||
33654589|NCT01697696|63067295|FG000|Overall Study|Lost to Follow-up|10|||
33654590|NCT01697696|63067296|FG001|Overall Study|Lost to Follow-up|7|||
33654591|NCT01697696|63067295|FG000|Overall Study|Subject/guardian decision|31|||
33654592|NCT01697696|63067296|FG001|Overall Study|Subject/guardian decision|35|||
33654593|NCT01569152|63067304|FG000|Phase IIa, Period 1|Early Escape|5|||
33654594|NCT01569152|63067305|FG001|Phase IIa, Period 1|Early Escape|22|||
33654595|NCT01569152|63067306|FG002|Phase IIa, Period 1|Early Escape|0|||
33654596|NCT01569152|63067304|FG000|Phase IIa, Period 1|Adverse Event|4|||
33654597|NCT01569152|63067305|FG001|Phase IIa, Period 1|Adverse Event|0|||
33654598|NCT01569152|63067306|FG002|Phase IIa, Period 1|Adverse Event|0|||
33654599|NCT01569152|63067304|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
33654600|NCT01569152|63067305|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
33654601|NCT01569152|63067306|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
33654602|NCT01569152|63067304|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
33654603|NCT01569152|63067305|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
33342374|NCT00844558|62719475|FG001|Overall Study|Death|0|||
33342375|NCT00844558|62719474|FG000|Overall Study|Protocol Violation|1|||
33342376|NCT00844558|62719475|FG001|Overall Study|Protocol Violation|1|||
33342377|NCT00844558|62719474|FG000|Overall Study|Lost to Follow-up|0|||
33342378|NCT00844558|62719475|FG001|Overall Study|Lost to Follow-up|1|||
33342379|NCT00844558|62719474|FG000|Overall Study|Physician Decision|1|||
33342380|NCT00844558|62719475|FG001|Overall Study|Physician Decision|0|||
33342381|NCT00772369|62719486|FG000|Overall Study|Did not return record release form|1|||
33342382|NCT00821236|62719493|FG000|Overall Study|Lost to Follow-up|3|||
33342383|NCT00756457|62719503|FG000|Overall Study|Lost to Follow-up|1|||
33342384|NCT00756457|62719504|FG001|Overall Study|Lost to Follow-up|2|||
33342385|NCT00844480|62719528|FG000|Overall Study|Withdrawal by Subject|2|||
33342386|NCT00844480|62719529|FG001|Overall Study|Withdrawal by Subject|3|||
33342387|NCT00771901|62719538|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
33342388|NCT00771901|62719539|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
33342389|NCT00771901|62719540|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
33342390|NCT00843856|62719550|FG000|Overall Study|Lost to Follow-up|1|||
33342391|NCT00843856|62719551|FG001|Overall Study|Lost to Follow-up|2|||
33342392|NCT00764491|62719559|FG000|Overall Study|Lost to Follow-up|35|||
33342393|NCT00764491|62719560|FG001|Overall Study|Lost to Follow-up|17|||
33342394|NCT00843778|62719566|FG000|Overall Study|Adverse Event|15|||
33342395|NCT00843778|62719566|FG000|Overall Study|Lack of Efficacy|14|||
33342396|NCT00843778|62719566|FG000|Overall Study|Loss of efficacy|2|||
33342397|NCT00843778|62719566|FG000|Overall Study|Withdrawal by Subject|4|||
33342398|NCT00910728|62719579|FG000|Overall Study|Lack of Efficacy|2|||
33342399|NCT00910728|62719580|FG001|Overall Study|Lack of Efficacy|3|||
33342400|NCT00910728|62719581|FG002|Overall Study|Lack of Efficacy|1|||
33342401|NCT00910728|62719582|FG003|Overall Study|Lack of Efficacy|2|||
33342402|NCT00910728|62719583|FG004|Overall Study|Lack of Efficacy|1|||
33342403|NCT00910728|62719584|FG005|Overall Study|Lack of Efficacy|0|||
33342404|NCT00910728|62719585|FG006|Overall Study|Lack of Efficacy|2|||
33342405|NCT00910728|62719586|FG007|Overall Study|Lack of Efficacy|2|||
33342406|NCT00910728|62719587|FG008|Overall Study|Lack of Efficacy|2|||
33342407|NCT00910728|62719579|FG000|Overall Study|Withdrawal by Subject|0|||
33342408|NCT00910728|62719580|FG001|Overall Study|Withdrawal by Subject|0|||
33342409|NCT00910728|62719581|FG002|Overall Study|Withdrawal by Subject|0|||
33342410|NCT00910728|62719582|FG003|Overall Study|Withdrawal by Subject|0|||
33342411|NCT00910728|62719583|FG004|Overall Study|Withdrawal by Subject|3|||
33342412|NCT00910728|62719584|FG005|Overall Study|Withdrawal by Subject|1|||
33342413|NCT00910728|62719585|FG006|Overall Study|Withdrawal by Subject|2|||
33342414|NCT00910728|62719586|FG007|Overall Study|Withdrawal by Subject|0|||
33342415|NCT00910728|62719587|FG008|Overall Study|Withdrawal by Subject|0|||
33342416|NCT00910728|62719579|FG000|Overall Study|(not specified)|2|||
33342417|NCT00910728|62719580|FG001|Overall Study|(not specified)|0|||
33342418|NCT00910728|62719581|FG002|Overall Study|(not specified)|1|||
33342419|NCT00910728|62719582|FG003|Overall Study|(not specified)|0|||
33342420|NCT00910728|62719583|FG004|Overall Study|(not specified)|1|||
33342421|NCT00910728|62719584|FG005|Overall Study|(not specified)|0|||
33342422|NCT00910728|62719585|FG006|Overall Study|(not specified)|0|||
33342423|NCT00910728|62719586|FG007|Overall Study|(not specified)|0|||
33342424|NCT00910728|62719587|FG008|Overall Study|(not specified)|0|||
33342425|NCT00910728|62719579|FG000|Overall Study|Adverse Event|2|||
33342426|NCT00910728|62719580|FG001|Overall Study|Adverse Event|0|||
33342427|NCT00910728|62719581|FG002|Overall Study|Adverse Event|1|||
33342428|NCT00910728|62719582|FG003|Overall Study|Adverse Event|1|||
33342429|NCT00910728|62719583|FG004|Overall Study|Adverse Event|0|||
33342430|NCT00910728|62719584|FG005|Overall Study|Adverse Event|0|||
33342431|NCT00910728|62719585|FG006|Overall Study|Adverse Event|2|||
33342432|NCT00910728|62719586|FG007|Overall Study|Adverse Event|1|||
33342433|NCT00910728|62719587|FG008|Overall Study|Adverse Event|1|||
33342434|NCT00820222|62719609|FG000|Overall Study|Lost to Follow-up|10|||
33342435|NCT00820222|62719610|FG001|Overall Study|Lost to Follow-up|9|||
33342436|NCT00820222|62719609|FG000|Overall Study|Withdrawal by Subject|19|||
33342437|NCT00820222|62719610|FG001|Overall Study|Withdrawal by Subject|21|||
33548868|NCT02959177|62940234|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
33342438|NCT00820222|62719609|FG000|Overall Study|Physician Decision|93|||
33342439|NCT00820222|62719610|FG001|Overall Study|Physician Decision|88|||
33548869|NCT02959177|62940235|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
33342440|NCT00820222|62719609|FG000|Overall Study|Sponsor Terminated Study|43|||
33342441|NCT00820222|62719610|FG001|Overall Study|Sponsor Terminated Study|65|||
33342442|NCT00820222|62719609|FG000|Overall Study|Unkown|11|||
33342443|NCT00820222|62719610|FG001|Overall Study|Unkown|7|||
33342444|NCT01039688|62719619|FG000|Overall Study|Adverse Event|38|||
33342445|NCT01039688|62719620|FG001|Overall Study|Adverse Event|39|||
33342446|NCT01039688|62719621|FG002|Overall Study|Adverse Event|24|||
33342447|NCT01039688|62719619|FG000|Overall Study|Lack of Efficacy|20|||
33342448|NCT01039688|62719620|FG001|Overall Study|Lack of Efficacy|11|||
33342449|NCT01039688|62719621|FG002|Overall Study|Lack of Efficacy|26|||
33342450|NCT01039688|62719619|FG000|Overall Study|Lost to Follow-up|11|||
33342451|NCT01039688|62719620|FG001|Overall Study|Lost to Follow-up|9|||
33342452|NCT01039688|62719621|FG002|Overall Study|Lost to Follow-up|5|||
33342453|NCT01039688|62719619|FG000|Overall Study|Other|13|||
33342454|NCT01039688|62719620|FG001|Overall Study|Other|25|||
33342455|NCT01039688|62719621|FG002|Overall Study|Other|12|||
33342456|NCT01039688|62719619|FG000|Overall Study|Withdrawal by Subject|23|||
33342457|NCT01039688|62719620|FG001|Overall Study|Withdrawal by Subject|27|||
33469943|NCT00262847|62843606|FG001|Overall Study|Other Reasons|88|||
33469944|NCT00262847|62843607|FG002|Overall Study|Other Reasons|27|||
33469945|NCT00262847|62843605|FG000|Overall Study|Did not receive study treatment|4|||
33469946|NCT00262847|62843606|FG001|Overall Study|Did not receive study treatment|1|||
33469947|NCT00262847|62843607|FG002|Overall Study|Did not receive study treatment|4|||
33469948|NCT00280397|62843618|FG000|Overall Study|Adverse Event|1|||
33469949|NCT00262301|62843627|FG000|Double-blind Phase|Lost to Follow-up|1|||
33469950|NCT00262301|62843628|FG001|Double-blind Phase|Lost to Follow-up|0|||
33469951|NCT00262301|62843629|FG002|Double-blind Phase|Lost to Follow-up|0|||
33469952|NCT00262301|62843627|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
33469953|NCT00262301|62843628|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
33469954|NCT00262301|62843629|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
33469955|NCT00279305|62843639|FG000|Overall Study|Pregnancy|1|||
33469956|NCT00279305|62843640|FG001|Overall Study|Pregnancy|0|||
33469957|NCT00279305|62843639|FG000|Overall Study|Withdrawal by Subject|2|||
33469958|NCT00279305|62843640|FG001|Overall Study|Withdrawal by Subject|0|||
33469959|NCT00279305|62843639|FG000|Overall Study|Dificulting establishing IV|1|||
33469960|NCT00279305|62843640|FG001|Overall Study|Dificulting establishing IV|0|||
33469961|NCT00279305|62843639|FG000|Overall Study|FDA Safety Alert|4|||
33469962|NCT00279305|62843640|FG001|Overall Study|FDA Safety Alert|1|||
33469963|NCT00278993|62843646|FG000|Overall Study|Adverse Event|24|||
33469964|NCT00278993|62843646|FG000|Overall Study|Withdrawal by Subject|5|||
33469965|NCT00278993|62843646|FG000|Overall Study|Progressive Disease|65|||
33469966|NCT00278993|62843646|FG000|Overall Study|Physician Decision|9|||
33469967|NCT00278993|62843646|FG000|Overall Study|Not Otherwise Specified|4|||
33469968|NCT00277355|62843652|FG000|Overall Study|Withdrawal by Subject|3|||
33469969|NCT00277355|62843653|FG001|Overall Study|Withdrawal by Subject|3|||
33469970|NCT00277355|62843652|FG000|Overall Study|Lost to Follow-up|2|||
33469971|NCT00277355|62843653|FG001|Overall Study|Lost to Follow-up|2|||
33469972|NCT00277355|62843652|FG000|Overall Study|Adverse Event|5|||
33469973|NCT00277355|62843653|FG001|Overall Study|Adverse Event|0|||
33469974|NCT00277355|62843652|FG000|Overall Study|Death|3|||
33469975|NCT00277355|62843653|FG001|Overall Study|Death|0|||
33469976|NCT00277355|62843652|FG000|Overall Study|Physician Decision|1|||
33469977|NCT00277355|62843653|FG001|Overall Study|Physician Decision|0|||
33469978|NCT00262223|62843662|FG000|Treatment Phase|Withdrawal by Subject|3|||
33469979|NCT00262223|62843663|FG001|Treatment Phase|Withdrawal by Subject|6|||
33469980|NCT00262223|62843662|FG000|Treatment Phase|Adverse Event|1|||
33469981|NCT00262223|62843663|FG001|Treatment Phase|Adverse Event|2|||
33469982|NCT00262223|62843662|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
33469983|NCT00262223|62843663|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
33469984|NCT00262223|62843662|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
33469985|NCT00262223|62843663|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
33469986|NCT00262223|62843662|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
33469987|NCT00262223|62843663|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
33469988|NCT00276419|62843672|FG000|First Intervention|Adverse Event|1|||
33469989|NCT00276419|62843673|FG001|First Intervention|Adverse Event|0|||
33469990|NCT00276419|62843672|FG000|First Intervention|Withdrawal by Subject|0|||
33469991|NCT00276419|62843673|FG001|First Intervention|Withdrawal by Subject|2|||
33469992|NCT00262067|62843694|FG000|Overall Study|Death|190|||
33469993|NCT00262067|62843695|FG001|Overall Study|Death|89|||
33469994|NCT00262067|62843696|FG002|Overall Study|Death|186|||
33469995|NCT00262067|62843697|FG003|Overall Study|Death|99|||
33469996|NCT00262067|62843694|FG000|Overall Study|Lost to Follow-up|5|||
33469997|NCT00262067|62843695|FG001|Overall Study|Lost to Follow-up|4|||
33469998|NCT00262067|62843696|FG002|Overall Study|Lost to Follow-up|7|||
33469999|NCT00262067|62843697|FG003|Overall Study|Lost to Follow-up|5|||
33342458|NCT01039688|62719621|FG002|Overall Study|Withdrawal by Subject|13|||
33342459|NCT01039688|62719619|FG000|Overall Study|Death|2|||
33470000|NCT00262067|62843694|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
33470001|NCT00262067|62843695|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
33470002|NCT00262067|62843696|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
33342460|NCT01039688|62719620|FG001|Overall Study|Death|0|||
33470003|NCT00262067|62843697|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
33470004|NCT00262067|62843694|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
33470005|NCT00262067|62843695|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
33470006|NCT00262067|62843696|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
33470007|NCT00262067|62843697|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
33470008|NCT00275561|62843709|FG000|Overall Study|Withdrawal by Subject|0|||
33342461|NCT01039688|62719621|FG002|Overall Study|Death|0|||
33342462|NCT02237508|62719642|FG000|Overall Study|Withdrawal by Subject|0|||
33342463|NCT02237508|62719643|FG001|Overall Study|Withdrawal by Subject|2|||
33342464|NCT02237508|62719644|FG002|Overall Study|Withdrawal by Subject|0|||
33342465|NCT02237508|62719645|FG003|Overall Study|Withdrawal by Subject|1|||
33342466|NCT02237508|62719646|FG004|Overall Study|Withdrawal by Subject|0|||
33342467|NCT02237508|62719647|FG005|Overall Study|Withdrawal by Subject|1|||
33342468|NCT02237508|62719648|FG006|Overall Study|Withdrawal by Subject|1|||
33342469|NCT02237508|62719649|FG007|Overall Study|Withdrawal by Subject|0|||
33342470|NCT02237508|62719650|FG008|Overall Study|Withdrawal by Subject|1|||
33342471|NCT02237508|62719651|FG009|Overall Study|Withdrawal by Subject|0|||
33342472|NCT02237508|62719642|FG000|Overall Study|Physician Decision|0|||
33342473|NCT02237508|62719643|FG001|Overall Study|Physician Decision|1|||
33342474|NCT02237508|62719644|FG002|Overall Study|Physician Decision|0|||
33342475|NCT02237508|62719645|FG003|Overall Study|Physician Decision|0|||
33342476|NCT02237508|62719646|FG004|Overall Study|Physician Decision|0|||
33342477|NCT02237508|62719647|FG005|Overall Study|Physician Decision|0|||
33342478|NCT02237508|62719648|FG006|Overall Study|Physician Decision|0|||
33342479|NCT02237508|62719649|FG007|Overall Study|Physician Decision|0|||
33342480|NCT02237508|62719650|FG008|Overall Study|Physician Decision|0|||
33342481|NCT02237508|62719651|FG009|Overall Study|Physician Decision|0|||
33342482|NCT02237508|62719642|FG000|Overall Study|Protocol Violation|0|||
33342483|NCT02237508|62719643|FG001|Overall Study|Protocol Violation|0|||
33342484|NCT02237508|62719644|FG002|Overall Study|Protocol Violation|1|||
33342485|NCT02237508|62719645|FG003|Overall Study|Protocol Violation|0|||
33342486|NCT02237508|62719646|FG004|Overall Study|Protocol Violation|0|||
33342487|NCT02237508|62719647|FG005|Overall Study|Protocol Violation|0|||
33342488|NCT02237508|62719648|FG006|Overall Study|Protocol Violation|0|||
33342489|NCT02237508|62719649|FG007|Overall Study|Protocol Violation|0|||
33342490|NCT02237508|62719650|FG008|Overall Study|Protocol Violation|0|||
33342491|NCT02237508|62719651|FG009|Overall Study|Protocol Violation|0|||
33342492|NCT00909090|62719671|FG000|Overall Study|Lost to Follow-up|17|||
33342493|NCT00909090|62719672|FG001|Overall Study|Lost to Follow-up|17|||
33342494|NCT00909480|62719683|FG000|Overall Study|Adverse Event|5|||
33342495|NCT00909480|62719684|FG001|Overall Study|Adverse Event|3|||
33342496|NCT00909480|62719683|FG000|Overall Study|Protocol Violation|6|||
33342497|NCT00909480|62719684|FG001|Overall Study|Protocol Violation|8|||
33342498|NCT00909480|62719683|FG000|Overall Study|Withdrawal criteria|9|||
33342499|NCT00909480|62719684|FG001|Overall Study|Withdrawal criteria|11|||
33342500|NCT00909480|62719683|FG000|Overall Study|Unclassified|18|||
33342501|NCT00909480|62719684|FG001|Overall Study|Unclassified|19|||
33342502|NCT01058096|62719692|FG000|Double-blind Treatment Phase|Adverse Event|11|||
33342503|NCT01058096|62719693|FG001|Double-blind Treatment Phase|Adverse Event|15|||
33342504|NCT01058096|62719692|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
33342505|NCT01058096|62719693|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
33342506|NCT01058096|62719692|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
33342507|NCT01058096|62719693|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
33342508|NCT01058096|62719692|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
33342509|NCT01058096|62719693|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
33342510|NCT01058096|62719692|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
33342511|NCT01058096|62719693|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
33342512|NCT01058096|62719692|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
33342513|NCT01058096|62719693|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
33342514|NCT01057862|62719701|FG000|Overall Study|Withdrawal by Subject|1|||
33342515|NCT01057862|62719702|FG001|Overall Study|Withdrawal by Subject|2|||
33342516|NCT01038128|62719708|FG000|Overall Study|Lack of Efficacy|1|||
33342517|NCT01038128|62719708|FG000|Overall Study|Lost to Follow-up|1|||
33342518|NCT01038128|62719708|FG000|Overall Study|Withdrawal by Subject|2|||
33342519|NCT00842530|62719729|FG000|Overall Study|Serious adverse event|0|||
33342520|NCT00842530|62719730|FG001|Overall Study|Serious adverse event|6|||
33342521|NCT00842530|62719729|FG000|Overall Study|Other adverse event|6|||
33342522|NCT00842530|62719730|FG001|Overall Study|Other adverse event|1|||
33342523|NCT00842530|62719729|FG000|Overall Study|Protocol Violation|32|||
33342524|NCT00842530|62719730|FG001|Overall Study|Protocol Violation|14|||
33342525|NCT00842530|62719729|FG000|Overall Study|Lost to Follow-up|6|||
33342526|NCT00842530|62719730|FG001|Overall Study|Lost to Follow-up|8|||
33342527|NCT00842530|62719729|FG000|Overall Study|Withdrawal by Subject|73|||
33342528|NCT00842530|62719730|FG001|Overall Study|Withdrawal by Subject|28|||
33342529|NCT00819910|62719741|FG000|Overall Study|Adverse Event|0|||
33342530|NCT00819910|62719742|FG001|Overall Study|Adverse Event|0|||
33342531|NCT00819910|62719743|FG002|Overall Study|Adverse Event|2|||
33342532|NCT00819910|62719744|FG003|Overall Study|Adverse Event|1|||
33342533|NCT00819910|62719741|FG000|Overall Study|Withdrawal by Subject|1|||
33342534|NCT00819910|62719742|FG001|Overall Study|Withdrawal by Subject|1|||
33342535|NCT00819910|62719743|FG002|Overall Study|Withdrawal by Subject|1|||
33342536|NCT00819910|62719744|FG003|Overall Study|Withdrawal by Subject|0|||
33342537|NCT00819910|62719741|FG000|Overall Study|Lost to Follow-up|1|||
33342538|NCT00819910|62719742|FG001|Overall Study|Lost to Follow-up|0|||
33342539|NCT00819910|62719743|FG002|Overall Study|Lost to Follow-up|0|||
33342540|NCT00819910|62719744|FG003|Overall Study|Lost to Follow-up|0|||
33342541|NCT00830518|62719758|FG000|Overall Study|Progressive Disease|18|||
33342542|NCT00830518|62719759|FG001|Overall Study|Progressive Disease|8|||
33342543|NCT00830518|62719758|FG000|Overall Study|Symptomatic Deterioration|4|||
33342544|NCT00830518|62719759|FG001|Overall Study|Symptomatic Deterioration|1|||
33342545|NCT00830518|62719758|FG000|Overall Study|Adverse Event|14|||
33342546|NCT00830518|62719759|FG001|Overall Study|Adverse Event|1|||
33342547|NCT00830518|62719758|FG000|Overall Study|Withdrawal by Patient|2|||
33342548|NCT00830518|62719759|FG001|Overall Study|Withdrawal by Patient|0|||
33342549|NCT00830518|62719758|FG000|Overall Study|Reason not Specified|8|||
33342550|NCT00830518|62719759|FG001|Overall Study|Reason not Specified|1|||
33342551|NCT00908544|62719768|FG000|Overall Study|Withdrawal by Subject|2|||
33342552|NCT00908544|62719769|FG001|Overall Study|Withdrawal by Subject|4|||
33342553|NCT00908544|62719768|FG000|Overall Study|Lack of Efficacy|0|||
33342554|NCT00908544|62719769|FG001|Overall Study|Lack of Efficacy|1|||
33342555|NCT00908544|62719768|FG000|Overall Study|Pregnancy|1|||
33342556|NCT00908544|62719769|FG001|Overall Study|Pregnancy|0|||
33342557|NCT00908544|62719768|FG000|Overall Study|Relocation abroad|1|||
33342558|NCT00908544|62719769|FG001|Overall Study|Relocation abroad|1|||
33342559|NCT00908544|62719768|FG000|Overall Study|Unable to visit sutdy center|1|||
33342560|NCT00908544|62719769|FG001|Overall Study|Unable to visit sutdy center|0|||
33342561|NCT00830440|62719777|FG000|Overall Study|Protocol Violation|1|||
33342562|NCT00830440|62719778|FG001|Overall Study|Protocol Violation|0|||
33342563|NCT00830440|62719777|FG000|Overall Study|Withdrawal by Subject|1|||
33342564|NCT00830440|62719778|FG001|Overall Study|Withdrawal by Subject|0|||
33342565|NCT00830440|62719777|FG000|Overall Study|unsuccessful procedure|4|||
33342566|NCT00830440|62719778|FG001|Overall Study|unsuccessful procedure|0|||
33342567|NCT00830440|62719777|FG000|Overall Study|Adverse Event|2|||
33342568|NCT00830440|62719778|FG001|Overall Study|Adverse Event|0|||
33342569|NCT00908310|62719785|FG000|Overall Study|Death|37|||
33342570|NCT00908310|62719785|FG000|Overall Study|Withdrawal by Subject|7|||
33342571|NCT00908310|62719785|FG000|Overall Study|Lost to Follow-up|7|||
33342572|NCT00908310|62719785|FG000|Overall Study|Screening failure|5|||
33342573|NCT00908310|62719785|FG000|Overall Study|Other reasons|4|||
33342574|NCT00830128|62719789|FG000|Overall Study|Adverse Event|5|||
33342575|NCT00830128|62719789|FG000|Overall Study|Lack of Efficacy|7|||
33342576|NCT00830128|62719789|FG000|Overall Study|Protocol Violation|1|||
33342577|NCT00830128|62719789|FG000|Overall Study|Withdrawal by Subject|2|||
33342578|NCT00830128|62719789|FG000|Overall Study|Family obligation|1|||
33342579|NCT00830128|62719789|FG000|Overall Study|Relocation|1|||
33342580|NCT00830128|62719789|FG000|Overall Study|Work obligation|1|||
33342581|NCT00830128|62719789|FG000|Overall Study|Operating a vehicle|1|||
33342582|NCT00841906|62719795|FG000|Overall Study|Withdrawal by Subject|2|||
33342583|NCT00841906|62719796|FG001|Overall Study|Withdrawal by Subject|0|||
33342584|NCT00771667|62719808|FG000|Induction Phase|Adverse Event|5|||
33342585|NCT00771667|62719809|FG001|Induction Phase|Adverse Event|2|||
33342586|NCT00771667|62719810|FG002|Induction Phase|Adverse Event|4|||
33342587|NCT00771667|62719811|FG003|Induction Phase|Adverse Event|1|||
33342588|NCT00771667|62719812|FG004|Induction Phase|Adverse Event|0|||
33342589|NCT00771667|62719813|FG005|Induction Phase|Adverse Event|0|||
33342590|NCT00771667|62719814|FG006|Induction Phase|Adverse Event|0|||
33342591|NCT00771667|62719815|FG007|Induction Phase|Adverse Event|0|||
33342592|NCT00771667|62719816|FG008|Induction Phase|Adverse Event|0|||
33342593|NCT00771667|62719817|FG009|Induction Phase|Adverse Event|0|||
33342594|NCT00771667|62719808|FG000|Induction Phase|Lack of Efficacy|9|||
33342595|NCT00771667|62719809|FG001|Induction Phase|Lack of Efficacy|2|||
33342596|NCT00771667|62719810|FG002|Induction Phase|Lack of Efficacy|4|||
33342597|NCT00771667|62719811|FG003|Induction Phase|Lack of Efficacy|3|||
33342598|NCT00771667|62719812|FG004|Induction Phase|Lack of Efficacy|0|||
33342599|NCT00771667|62719813|FG005|Induction Phase|Lack of Efficacy|0|||
33342600|NCT00771667|62719814|FG006|Induction Phase|Lack of Efficacy|0|||
33342601|NCT00771667|62719815|FG007|Induction Phase|Lack of Efficacy|0|||
33342602|NCT00771667|62719816|FG008|Induction Phase|Lack of Efficacy|0|||
33470009|NCT00275561|62843710|FG001|Overall Study|Withdrawal by Subject|1|||
33470010|NCT00275561|62843709|FG000|Overall Study|Travel|1|||
33470011|NCT00275561|62843710|FG001|Overall Study|Travel|1|||
33342603|NCT00771667|62719817|FG009|Induction Phase|Lack of Efficacy|0|||
33342604|NCT00771667|62719808|FG000|Induction Phase|Lost to Follow-up|1|||
33342605|NCT00771667|62719809|FG001|Induction Phase|Lost to Follow-up|0|||
33342606|NCT00771667|62719810|FG002|Induction Phase|Lost to Follow-up|1|||
33342607|NCT00771667|62719811|FG003|Induction Phase|Lost to Follow-up|0|||
33342608|NCT00771667|62719812|FG004|Induction Phase|Lost to Follow-up|0|||
33342609|NCT00771667|62719813|FG005|Induction Phase|Lost to Follow-up|0|||
33342610|NCT00771667|62719814|FG006|Induction Phase|Lost to Follow-up|0|||
33342611|NCT00771667|62719815|FG007|Induction Phase|Lost to Follow-up|0|||
33342612|NCT00771667|62719816|FG008|Induction Phase|Lost to Follow-up|0|||
33342613|NCT00771667|62719817|FG009|Induction Phase|Lost to Follow-up|0|||
33342614|NCT00771667|62719808|FG000|Induction Phase|Other|4|||
33342615|NCT00771667|62719809|FG001|Induction Phase|Other|6|||
33342616|NCT00771667|62719810|FG002|Induction Phase|Other|3|||
33342617|NCT00771667|62719811|FG003|Induction Phase|Other|4|||
33342618|NCT00771667|62719812|FG004|Induction Phase|Other|0|||
33342619|NCT00771667|62719813|FG005|Induction Phase|Other|0|||
33342620|NCT00771667|62719814|FG006|Induction Phase|Other|0|||
33342621|NCT00771667|62719815|FG007|Induction Phase|Other|0|||
33342622|NCT00771667|62719816|FG008|Induction Phase|Other|0|||
33342623|NCT00771667|62719817|FG009|Induction Phase|Other|0|||
33342624|NCT00771667|62719808|FG000|Maintenance Phase|Adverse Event|0|||
33342625|NCT00771667|62719809|FG001|Maintenance Phase|Adverse Event|0|||
33342626|NCT00771667|62719810|FG002|Maintenance Phase|Adverse Event|0|||
33342627|NCT00771667|62719811|FG003|Maintenance Phase|Adverse Event|0|||
33342628|NCT00771667|62719812|FG004|Maintenance Phase|Adverse Event|1|||
33342629|NCT00771667|62719813|FG005|Maintenance Phase|Adverse Event|3|||
33342630|NCT00771667|62719814|FG006|Maintenance Phase|Adverse Event|5|||
33342631|NCT00771667|62719815|FG007|Maintenance Phase|Adverse Event|1|||
33342632|NCT00771667|62719816|FG008|Maintenance Phase|Adverse Event|8|||
33342633|NCT00771667|62719817|FG009|Maintenance Phase|Adverse Event|7|||
33342634|NCT00771667|62719808|FG000|Maintenance Phase|Lack of Efficacy|0|||
33342635|NCT00771667|62719809|FG001|Maintenance Phase|Lack of Efficacy|0|||
33342636|NCT00771667|62719810|FG002|Maintenance Phase|Lack of Efficacy|0|||
33342637|NCT00771667|62719811|FG003|Maintenance Phase|Lack of Efficacy|0|||
33342638|NCT00771667|62719812|FG004|Maintenance Phase|Lack of Efficacy|1|||
33342639|NCT00771667|62719813|FG005|Maintenance Phase|Lack of Efficacy|3|||
33342640|NCT00771667|62719814|FG006|Maintenance Phase|Lack of Efficacy|3|||
33342641|NCT00771667|62719815|FG007|Maintenance Phase|Lack of Efficacy|2|||
33342642|NCT00771667|62719816|FG008|Maintenance Phase|Lack of Efficacy|11|||
33342643|NCT00771667|62719817|FG009|Maintenance Phase|Lack of Efficacy|7|||
33342644|NCT00771667|62719808|FG000|Maintenance Phase|Other|0|||
33342645|NCT00771667|62719809|FG001|Maintenance Phase|Other|0|||
33342646|NCT00771667|62719810|FG002|Maintenance Phase|Other|0|||
33342647|NCT00771667|62719811|FG003|Maintenance Phase|Other|0|||
33342648|NCT00771667|62719812|FG004|Maintenance Phase|Other|0|||
33342649|NCT00771667|62719813|FG005|Maintenance Phase|Other|1|||
33342650|NCT00771667|62719814|FG006|Maintenance Phase|Other|2|||
33342651|NCT00771667|62719815|FG007|Maintenance Phase|Other|2|||
33342652|NCT00771667|62719816|FG008|Maintenance Phase|Other|3|||
33342653|NCT00771667|62719817|FG009|Maintenance Phase|Other|3|||
33342654|NCT00770965|62719839|FG000|Safety Set|Withdrawal by Subject|0|||
33342655|NCT00770965|62719840|FG001|Safety Set|Withdrawal by Subject|0|||
33342656|NCT00770965|62719841|FG002|Safety Set|Withdrawal by Subject|0|||
33342657|NCT00770965|62719842|FG003|Safety Set|Withdrawal by Subject|1|||
33342658|NCT00770965|62719839|FG000|Safety Set|Protocol deviation|0|||
33342659|NCT00770965|62719840|FG001|Safety Set|Protocol deviation|0|||
33342660|NCT00770965|62719841|FG002|Safety Set|Protocol deviation|1|||
33342661|NCT00770965|62719842|FG003|Safety Set|Protocol deviation|0|||
33342662|NCT00770965|62719839|FG000|Excluded Set|Administrative problems|14|||
33342663|NCT00770965|62719840|FG001|Excluded Set|Administrative problems|12|||
33342664|NCT00770965|62719841|FG002|Excluded Set|Administrative problems|12|||
33342665|NCT00770965|62719842|FG003|Excluded Set|Administrative problems|10|||
33342666|NCT00770965|62719839|FG000|Excluded Set|Withdrawal by Subject|1|||
33342667|NCT00770965|62719840|FG001|Excluded Set|Withdrawal by Subject|1|||
33342668|NCT00770965|62719841|FG002|Excluded Set|Withdrawal by Subject|2|||
33342669|NCT00770965|62719842|FG003|Excluded Set|Withdrawal by Subject|3|||
33342670|NCT00763555|62719854|FG000|Overall Study|Adverse Event|2|||
33342671|NCT00763555|62719855|FG001|Overall Study|Adverse Event|1|||
33342672|NCT00763555|62719854|FG000|Overall Study|Withdrawal by Subject|2|||
33342673|NCT00763555|62719855|FG001|Overall Study|Withdrawal by Subject|6|||
33342674|NCT00763555|62719854|FG000|Overall Study|Lost to Follow-up|0|||
33342675|NCT00763555|62719855|FG001|Overall Study|Lost to Follow-up|3|||
33342676|NCT00763321|62719864|FG000|Open-label Period|Adverse Event|24|||
33342677|NCT00763321|62719865|FG001|Open-label Period|Adverse Event|0|||
33342678|NCT00763321|62719866|FG002|Open-label Period|Adverse Event|0|||
33342679|NCT00763321|62719864|FG000|Open-label Period|Lost to Follow-up|14|||
33342680|NCT00763321|62719865|FG001|Open-label Period|Lost to Follow-up|0|||
33342681|NCT00763321|62719866|FG002|Open-label Period|Lost to Follow-up|0|||
33342682|NCT00763321|62719864|FG000|Open-label Period|Withdrawal by Subject|7|||
33342683|NCT00763321|62719865|FG001|Open-label Period|Withdrawal by Subject|0|||
33342684|NCT00763321|62719866|FG002|Open-label Period|Withdrawal by Subject|0|||
33342685|NCT00763321|62719864|FG000|Open-label Period|Subject noncompliant|7|||
33342686|NCT00763321|62719865|FG001|Open-label Period|Subject noncompliant|0|||
33342687|NCT00763321|62719866|FG002|Open-label Period|Subject noncompliant|0|||
33342688|NCT00763321|62719864|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
33342689|NCT00763321|62719865|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
33342690|NCT00763321|62719866|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
33342691|NCT00763321|62719864|FG000|Open-label Period|Lack of Efficacy|2|||
33342692|NCT00763321|62719865|FG001|Open-label Period|Lack of Efficacy|0|||
33342693|NCT00763321|62719866|FG002|Open-label Period|Lack of Efficacy|0|||
33342694|NCT00763321|62719864|FG000|Open-label Period|Other|4|||
33342695|NCT00763321|62719865|FG001|Open-label Period|Other|0|||
33342696|NCT00763321|62719866|FG002|Open-label Period|Other|0|||
33342697|NCT00763321|62719864|FG000|Double-blind Period|Lack of Efficacy|0|||
33342698|NCT00763321|62719865|FG001|Double-blind Period|Lack of Efficacy|9|||
33342699|NCT00763321|62719866|FG002|Double-blind Period|Lack of Efficacy|17|||
33342700|NCT00763321|62719864|FG000|Double-blind Period|Adverse Event|0|||
33342701|NCT00763321|62719865|FG001|Double-blind Period|Adverse Event|4|||
33342702|NCT00763321|62719866|FG002|Double-blind Period|Adverse Event|4|||
33342703|NCT00763321|62719864|FG000|Double-blind Period|Lost to Follow-up|0|||
33342704|NCT00763321|62719865|FG001|Double-blind Period|Lost to Follow-up|4|||
33342705|NCT00763321|62719866|FG002|Double-blind Period|Lost to Follow-up|2|||
33342706|NCT00763321|62719864|FG000|Double-blind Period|Withdrawal by Subject|0|||
33342707|NCT00763321|62719865|FG001|Double-blind Period|Withdrawal by Subject|2|||
33342708|NCT00763321|62719866|FG002|Double-blind Period|Withdrawal by Subject|3|||
33342709|NCT00763321|62719864|FG000|Double-blind Period|Other|0|||
33342710|NCT00763321|62719865|FG001|Double-blind Period|Other|2|||
33342711|NCT00763321|62719866|FG002|Double-blind Period|Other|3|||
33342712|NCT00770653|62719875|FG000|Overall Study|Adverse Event|13|||
33342713|NCT00770653|62719876|FG001|Overall Study|Adverse Event|5|||
33342714|NCT00770653|62719875|FG000|Overall Study|Protocol Violation|8|||
33342715|NCT00770653|62719876|FG001|Overall Study|Protocol Violation|6|||
33342716|NCT00770653|62719875|FG000|Overall Study|Withdrawal by Subject|4|||
33342717|NCT00770653|62719876|FG001|Overall Study|Withdrawal by Subject|7|||
33342718|NCT00770653|62719875|FG000|Overall Study|Lack of Compliance|1|||
33342719|NCT00770653|62719876|FG001|Overall Study|Lack of Compliance|4|||
33342720|NCT00770653|62719875|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
33342721|NCT00770653|62719876|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
33342722|NCT00770653|62719875|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
33342723|NCT00770653|62719876|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
33342724|NCT00770653|62719875|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
33342725|NCT00770653|62719876|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
33342726|NCT00770653|62719875|FG000|Overall Study|Lost to Follow-up|1|||
33342727|NCT00770653|62719876|FG001|Overall Study|Lost to Follow-up|2|||
33342728|NCT00770653|62719875|FG000|Overall Study|Physician Decision|1|||
33342729|NCT00770653|62719876|FG001|Overall Study|Physician Decision|0|||
33342730|NCT00819052|62719884|FG000|Overall Study|Adverse Event|0|||
33342731|NCT00819052|62719885|FG001|Overall Study|Adverse Event|5|||
33342732|NCT00819052|62719884|FG000|Overall Study|Protocol Violation|1|||
33342733|NCT00819052|62719885|FG001|Overall Study|Protocol Violation|2|||
33342734|NCT00819052|62719884|FG000|Overall Study|Lost to Follow-up|1|||
33342735|NCT00819052|62719885|FG001|Overall Study|Lost to Follow-up|2|||
33342736|NCT00819052|62719884|FG000|Overall Study|Withdrawal by Subject|1|||
33342737|NCT00819052|62719885|FG001|Overall Study|Withdrawal by Subject|2|||
33342738|NCT00819052|62719884|FG000|Overall Study|Lack of Efficacy|1|||
33342739|NCT00819052|62719885|FG001|Overall Study|Lack of Efficacy|1|||
33342740|NCT00819052|62719884|FG000|Overall Study|Pregnancy|1|||
33342741|NCT00819052|62719885|FG001|Overall Study|Pregnancy|2|||
33342742|NCT00819052|62719884|FG000|Overall Study|Death or events leading to death|1|||
33342743|NCT00819052|62719885|FG001|Overall Study|Death or events leading to death|0|||
33342744|NCT00763009|62719894|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
33342745|NCT00841672|62719901|FG000|Overall Study|Adverse Event|7|||
33342746|NCT00841672|62719902|FG001|Overall Study|Adverse Event|16|||
33342747|NCT00841672|62719901|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33342748|NCT00841672|62719902|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33342749|NCT00841672|62719901|FG000|Overall Study|Subject withdrew consent|2|||
33342750|NCT00841672|62719902|FG001|Overall Study|Subject withdrew consent|4|||
33342751|NCT00841672|62719901|FG000|Overall Study|Lost to Follow-up|1|||
33342752|NCT00841672|62719902|FG001|Overall Study|Lost to Follow-up|1|||
33342753|NCT00841672|62719901|FG000|Overall Study|Administrative problems|9|||
33342754|NCT00841672|62719902|FG001|Overall Study|Administrative problems|9|||
33342755|NCT00841672|62719901|FG000|Overall Study|Misrandomized|1|||
33342756|NCT00841672|62719902|FG001|Overall Study|Misrandomized|0|||
33342757|NCT00841672|62719901|FG000|Overall Study|Protocol Deviation|0|||
33342758|NCT00841672|62719902|FG001|Overall Study|Protocol Deviation|1|||
33342759|NCT00908232|62719908|FG000|Cycle 1 to 4|Death|5|||
33342760|NCT00908232|62719909|FG001|Cycle 1 to 4|Death|0|||
33342761|NCT00908232|62719910|FG002|Cycle 1 to 4|Death|0|||
33342762|NCT00908232|62719911|FG003|Cycle 1 to 4|Death|0|||
33342763|NCT00908232|62719908|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
33342764|NCT00908232|62719909|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
33342765|NCT00908232|62719910|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
33342766|NCT00908232|62719911|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
33342767|NCT00908232|62719908|FG000|Cycle 1 to 4|Progressive Disease|6|||
33342768|NCT00908232|62719909|FG001|Cycle 1 to 4|Progressive Disease|0|||
33342769|NCT00908232|62719910|FG002|Cycle 1 to 4|Progressive Disease|0|||
33342770|NCT00908232|62719911|FG003|Cycle 1 to 4|Progressive Disease|0|||
33342771|NCT00908232|62719908|FG000|Cycle 1 to 4|Adverse Event|12|||
33342772|NCT00908232|62719909|FG001|Cycle 1 to 4|Adverse Event|0|||
33342773|NCT00908232|62719910|FG002|Cycle 1 to 4|Adverse Event|0|||
33342774|NCT00908232|62719911|FG003|Cycle 1 to 4|Adverse Event|0|||
33342775|NCT00908232|62719908|FG000|Cycle 1 to 4|Other|1|||
33342776|NCT00908232|62719909|FG001|Cycle 1 to 4|Other|0|||
33342777|NCT00908232|62719910|FG002|Cycle 1 to 4|Other|0|||
33342778|NCT00908232|62719911|FG003|Cycle 1 to 4|Other|0|||
33342779|NCT00908232|62719908|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
33342780|NCT00908232|62719909|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
33342781|NCT00908232|62719910|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
33342782|NCT00908232|62719911|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
33342783|NCT00908232|62719908|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
33342784|NCT00908232|62719909|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
33342785|NCT00908232|62719910|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
33342786|NCT00908232|62719911|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
33342787|NCT00908232|62719908|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
33342788|NCT00908232|62719909|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
33342789|NCT00908232|62719910|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
33342790|NCT00908232|62719911|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
33342791|NCT00908232|62719908|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
33342792|NCT00908232|62719909|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
33342793|NCT00908232|62719910|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
33342794|NCT00908232|62719911|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
33342795|NCT00908232|62719908|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
33342796|NCT00908232|62719909|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
33342797|NCT00908232|62719910|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
33342798|NCT00908232|62719911|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
33342799|NCT00908232|62719908|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
33342800|NCT00908232|62719909|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
33342801|NCT00908232|62719910|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
33342802|NCT00908232|62719911|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
33342803|NCT00908232|62719908|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
33342804|NCT00908232|62719909|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
33342805|NCT00908232|62719910|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
33342806|NCT00908232|62719911|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
33342807|NCT00908232|62719908|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
33342808|NCT00908232|62719909|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
33342809|NCT00908232|62719910|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
33342810|NCT00908232|62719911|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
33342811|NCT00770341|62719920|FG000|Overall Study|Did not meet eligibility criteria|1|||
33342812|NCT00770341|62719921|FG001|Overall Study|Did not meet eligibility criteria|0|||
33342813|NCT00770341|62719922|FG002|Overall Study|Did not meet eligibility criteria|0|||
33342814|NCT00770341|62719920|FG000|Overall Study|Withdrawal by Subject|0|||
33342815|NCT00770341|62719921|FG001|Overall Study|Withdrawal by Subject|1|||
33342816|NCT00770341|62719922|FG002|Overall Study|Withdrawal by Subject|0|||
33342817|NCT00770341|62719920|FG000|Overall Study|Clinical Adverse Event|3|||
33342818|NCT00770341|62719921|FG001|Overall Study|Clinical Adverse Event|1|||
33342819|NCT00770341|62719922|FG002|Overall Study|Clinical Adverse Event|2|||
33342820|NCT00770341|62719920|FG000|Overall Study|Laboratory adverse event|3|||
33342821|NCT00770341|62719921|FG001|Overall Study|Laboratory adverse event|3|||
33342822|NCT00770341|62719922|FG002|Overall Study|Laboratory adverse event|0|||
33342823|NCT00770341|62719920|FG000|Overall Study|Lack of Efficacy|3|||
33342824|NCT00770341|62719921|FG001|Overall Study|Lack of Efficacy|0|||
33342825|NCT00770341|62719922|FG002|Overall Study|Lack of Efficacy|1|||
33342826|NCT00770341|62719920|FG000|Overall Study|Other|1|||
33342827|NCT00770341|62719921|FG001|Overall Study|Other|0|||
33342828|NCT00770341|62719922|FG002|Overall Study|Other|0|||
33342829|NCT00770341|62719920|FG000|Overall Study|Not treated|1|||
33342830|NCT00770341|62719921|FG001|Overall Study|Not treated|0|||
33342831|NCT00770341|62719922|FG002|Overall Study|Not treated|0|||
33342832|NCT00762463|62719939|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
33342833|NCT00762463|62719940|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
33342834|NCT00762463|62719941|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
33342835|NCT00762463|62719942|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
33342836|NCT00762463|62719939|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
33342837|NCT00762463|62719940|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
33342838|NCT00762463|62719941|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
33342839|NCT00762463|62719942|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
33342840|NCT00762463|62719939|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
33342841|NCT00762463|62719940|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
33342842|NCT00762463|62719941|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
33342843|NCT00762463|62719942|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
33342844|NCT00762463|62719939|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
33342845|NCT00762463|62719940|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
33342846|NCT00762463|62719941|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
33342847|NCT00762463|62719942|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
33342848|NCT00762463|62719939|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
33342849|NCT00762463|62719940|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
33342850|NCT00762463|62719941|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
33342851|NCT00762463|62719942|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
33342852|NCT00762463|62719939|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
33342853|NCT00762463|62719940|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
33342854|NCT00762463|62719941|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
33342855|NCT00762463|62719942|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
33342856|NCT00762463|62719939|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
33342857|NCT00762463|62719940|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
33342858|NCT00762463|62719941|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
33342859|NCT00762463|62719942|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
33342860|NCT00762463|62719939|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
33342861|NCT00762463|62719940|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
33342862|NCT00762463|62719941|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
33342863|NCT00762463|62719942|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
33342864|NCT00762385|62719955|FG000|First Intervention|Lens Issue|1|||
33342865|NCT00762385|62719956|FG001|First Intervention|Lens Issue|1|||
33342866|NCT00762385|62719955|FG000|First Intervention|Lost to Follow-up|0|||
33342867|NCT00762385|62719956|FG001|First Intervention|Lost to Follow-up|2|||
33342868|NCT00762385|62719955|FG000|First Intervention|Ineligible|1|||
33342869|NCT00762385|62719956|FG001|First Intervention|Ineligible|0|||
33342870|NCT00762385|62719955|FG000|First Intervention|Protocol Violation|0|||
33342871|NCT00762385|62719956|FG001|First Intervention|Protocol Violation|1|||
33342872|NCT00762385|62719955|FG000|Second Intervention|Protocol Violation|3|||
33342873|NCT00762385|62719956|FG001|Second Intervention|Protocol Violation|3|||
33342874|NCT00906282|62719965|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
33342875|NCT00906282|62719965|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
33342876|NCT00906282|62719965|FG000|Preoperative Chemotherapy|Progressive disease|6|||
33342877|NCT00906282|62719965|FG000|Preoperative Chemotherapy|Toxicity|1|||
33342878|NCT00762229|62719972|FG000|Overall Study|Lost to Follow-up|1|||
33342879|NCT00762229|62719973|FG001|Overall Study|Lost to Follow-up|1|||
33342880|NCT00762229|62719972|FG000|Overall Study|did not recveive intervention|0|||
33342881|NCT00762229|62719973|FG001|Overall Study|did not recveive intervention|1|||
33342882|NCT00907374|62719981|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
33342883|NCT00907374|62719982|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
33342884|NCT00818662|62719992|FG000|Overall Study|Adverse Event|5|||
33342885|NCT00818662|62719993|FG001|Overall Study|Adverse Event|14|||
33342886|NCT00818662|62719994|FG002|Overall Study|Adverse Event|4|||
33342887|NCT00818662|62719995|FG003|Overall Study|Adverse Event|3|||
33342888|NCT00818662|62719992|FG000|Overall Study|Withdrawal by Subject|5|||
33342889|NCT00818662|62719993|FG001|Overall Study|Withdrawal by Subject|4|||
33342890|NCT00818662|62719994|FG002|Overall Study|Withdrawal by Subject|2|||
33342891|NCT00818662|62719995|FG003|Overall Study|Withdrawal by Subject|2|||
33342892|NCT00818662|62719992|FG000|Overall Study|Death|1|||
33342893|NCT00818662|62719993|FG001|Overall Study|Death|3|||
33342894|NCT00818662|62719994|FG002|Overall Study|Death|0|||
33342895|NCT00818662|62719995|FG003|Overall Study|Death|0|||
33342896|NCT00818662|62719992|FG000|Overall Study|Physician Decision|1|||
33342897|NCT00818662|62719993|FG001|Overall Study|Physician Decision|0|||
33342898|NCT00818662|62719994|FG002|Overall Study|Physician Decision|0|||
33342899|NCT00818662|62719995|FG003|Overall Study|Physician Decision|0|||
33342900|NCT00818662|62719992|FG000|Overall Study|Lost to Follow-up|0|||
33342901|NCT00818662|62719993|FG001|Overall Study|Lost to Follow-up|0|||
33342902|NCT00818662|62719994|FG002|Overall Study|Lost to Follow-up|0|||
33342903|NCT00818662|62719995|FG003|Overall Study|Lost to Follow-up|1|||
33342904|NCT00818662|62719992|FG000|Overall Study|Unwilling or Unable to Participate|4|||
33342905|NCT00818662|62719993|FG001|Overall Study|Unwilling or Unable to Participate|6|||
33470012|NCT00275561|62843709|FG000|Overall Study|Scheduling|1|||
33654604|NCT01569152|63067306|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
33654605|NCT01569152|63067304|FG000|Phase IIa, Period 1|Protocol Violation|0|||
33654606|NCT01569152|63067305|FG001|Phase IIa, Period 1|Protocol Violation|1|||
33342906|NCT00818662|62719994|FG002|Overall Study|Unwilling or Unable to Participate|2|||
33342907|NCT00818662|62719995|FG003|Overall Study|Unwilling or Unable to Participate|4|||
33342908|NCT00818662|62719992|FG000|Overall Study|Protocol Violation|1|||
33342909|NCT00818662|62719993|FG001|Overall Study|Protocol Violation|1|||
33342910|NCT00818662|62719994|FG002|Overall Study|Protocol Violation|0|||
33342911|NCT00818662|62719995|FG003|Overall Study|Protocol Violation|0|||
33342912|NCT00818662|62719992|FG000|Overall Study|Requires a Prohibited Medication|1|||
33342913|NCT00818662|62719993|FG001|Overall Study|Requires a Prohibited Medication|0|||
33342914|NCT00818662|62719994|FG002|Overall Study|Requires a Prohibited Medication|0|||
33342915|NCT00818662|62719995|FG003|Overall Study|Requires a Prohibited Medication|0|||
33342916|NCT00818662|62719992|FG000|Overall Study|Safety Risk|1|||
33342917|NCT00818662|62719993|FG001|Overall Study|Safety Risk|1|||
33342918|NCT00818662|62719994|FG002|Overall Study|Safety Risk|0|||
33342919|NCT00818662|62719995|FG003|Overall Study|Safety Risk|1|||
33342920|NCT00818662|62719992|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
33342921|NCT00818662|62719993|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
33342922|NCT00818662|62719994|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
33342923|NCT00818662|62719995|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
33342924|NCT00818662|62719992|FG000|Overall Study|Participant's health declined|0|||
33342925|NCT00818662|62719993|FG001|Overall Study|Participant's health declined|0|||
33342926|NCT00818662|62719994|FG002|Overall Study|Participant's health declined|0|||
33342927|NCT00818662|62719995|FG003|Overall Study|Participant's health declined|1|||
33342928|NCT00818662|62719992|FG000|Overall Study|Caregiver to pursue other treatment|0|||
33342929|NCT00818662|62719993|FG001|Overall Study|Caregiver to pursue other treatment|1|||
33342930|NCT00818662|62719994|FG002|Overall Study|Caregiver to pursue other treatment|0|||
33470013|NCT00275561|62843710|FG001|Overall Study|Scheduling|2|||
33470014|NCT00275561|62843709|FG000|Overall Study|Family Issues|0|||
33470015|NCT00275561|62843710|FG001|Overall Study|Family Issues|2|||
33470016|NCT00274937|62843720|FG000|Overall Study|Physician Decision|10|||
33470017|NCT00274937|62843720|FG000|Overall Study|Withdrawal by Subject|6|||
33470018|NCT00274937|62843720|FG000|Overall Study|Progressive Disease|4|||
33470019|NCT00251693|62843727|FG000|Overall Study|Adverse Event|17|||
33470020|NCT00251693|62843728|FG001|Overall Study|Adverse Event|9|||
33470021|NCT00251693|62843729|FG002|Overall Study|Adverse Event|9|||
33470022|NCT00251693|62843727|FG000|Overall Study|Protocol Violation|2|||
33470023|NCT00251693|62843728|FG001|Overall Study|Protocol Violation|0|||
33470024|NCT00251693|62843729|FG002|Overall Study|Protocol Violation|2|||
33470025|NCT00251693|62843727|FG000|Overall Study|Lost to Follow-up|12|||
33470026|NCT00251693|62843728|FG001|Overall Study|Lost to Follow-up|7|||
33470027|NCT00251693|62843729|FG002|Overall Study|Lost to Follow-up|8|||
33470028|NCT00251693|62843727|FG000|Overall Study|Withdrawal by Subject|11|||
33470029|NCT00251693|62843728|FG001|Overall Study|Withdrawal by Subject|17|||
33470030|NCT00251693|62843729|FG002|Overall Study|Withdrawal by Subject|14|||
33470031|NCT00251693|62843727|FG000|Overall Study|Lack of Efficacy|0|||
33470032|NCT00251693|62843728|FG001|Overall Study|Lack of Efficacy|1|||
33470033|NCT00251693|62843729|FG002|Overall Study|Lack of Efficacy|0|||
33470034|NCT00251693|62843727|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
33470035|NCT00251693|62843728|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
33470036|NCT00251693|62843729|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
33470037|NCT00251693|62843727|FG000|Overall Study|Noncompliant|0|||
33470038|NCT00251693|62843728|FG001|Overall Study|Noncompliant|0|||
33470039|NCT00251693|62843729|FG002|Overall Study|Noncompliant|2|||
33470040|NCT00251693|62843727|FG000|Overall Study|Possible Barrett's esophagus|3|||
33470041|NCT00251693|62843728|FG001|Overall Study|Possible Barrett's esophagus|5|||
33470042|NCT00251693|62843729|FG002|Overall Study|Possible Barrett's esophagus|2|||
33470043|NCT00251693|62843727|FG000|Overall Study|Subject request/subject unavailable|1|||
33470044|NCT00251693|62843728|FG001|Overall Study|Subject request/subject unavailable|2|||
33470045|NCT00251693|62843729|FG002|Overall Study|Subject request/subject unavailable|0|||
33470046|NCT00251693|62843727|FG000|Overall Study|Abnormal laboratory findings|0|||
33470047|NCT00251693|62843728|FG001|Overall Study|Abnormal laboratory findings|0|||
33470048|NCT00251693|62843729|FG002|Overall Study|Abnormal laboratory findings|1|||
33470049|NCT00250835|62843737|FG000|Overall Study|Withdrawal by Subject|1|||
33470050|NCT03716024|62843747|FG000|Overall Study|Randomized, not Treated|7|||
33470051|NCT03716024|62843748|FG001|Overall Study|Randomized, not Treated|8|||
33470052|NCT03716024|62843747|FG000|Overall Study|Adverse Event|1|||
33470053|NCT03716024|62843748|FG001|Overall Study|Adverse Event|2|||
33470054|NCT03716024|62843747|FG000|Overall Study|Treatment Failure|1|||
33470055|NCT03716024|62843748|FG001|Overall Study|Treatment Failure|0|||
33470056|NCT03716024|62843747|FG000|Overall Study|Lost to Follow-up|2|||
33470057|NCT03716024|62843748|FG001|Overall Study|Lost to Follow-up|6|||
33470058|NCT03716024|62843747|FG000|Overall Study|Withdrawal by Subject|0|||
33470059|NCT03716024|62843748|FG001|Overall Study|Withdrawal by Subject|1|||
33470060|NCT03716024|62843747|FG000|Overall Study|Missing Reason|0|||
33470061|NCT03716024|62843748|FG001|Overall Study|Missing Reason|1|||
33470062|NCT00250679|62843757|FG000|Overall Study|Adverse Event|12|||
33470063|NCT00250679|62843758|FG001|Overall Study|Adverse Event|15|||
33342931|NCT00818662|62719995|FG003|Overall Study|Caregiver to pursue other treatment|0|||
33342932|NCT00818662|62719992|FG000|Overall Study|Moving out of state|0|||
33342933|NCT00818662|62719993|FG001|Overall Study|Moving out of state|0|||
33342934|NCT00818662|62719994|FG002|Overall Study|Moving out of state|0|||
33342935|NCT00818662|62719995|FG003|Overall Study|Moving out of state|1|||
33342936|NCT00818662|62719992|FG000|Overall Study|Declined move to another study site|1|||
33342937|NCT00818662|62719993|FG001|Overall Study|Declined move to another study site|0|||
33342938|NCT00818662|62719994|FG002|Overall Study|Declined move to another study site|0|||
33342939|NCT00818662|62719995|FG003|Overall Study|Declined move to another study site|0|||
33342940|NCT00818662|62719992|FG000|Overall Study|Change in living situation|0|||
33342941|NCT00818662|62719993|FG001|Overall Study|Change in living situation|0|||
33342942|NCT00818662|62719994|FG002|Overall Study|Change in living situation|0|||
33342943|NCT00818662|62719995|FG003|Overall Study|Change in living situation|1|||
33342944|NCT00818662|62719992|FG000|Overall Study|Study partner decision|0|||
33342945|NCT00818662|62719993|FG001|Overall Study|Study partner decision|0|||
33342946|NCT00818662|62719994|FG002|Overall Study|Study partner decision|0|||
33342947|NCT00818662|62719995|FG003|Overall Study|Study partner decision|1|||
33342948|NCT00818662|62719992|FG000|Overall Study|Admitted to long term nursing care|0|||
33342949|NCT00818662|62719993|FG001|Overall Study|Admitted to long term nursing care|1|||
33342950|NCT00818662|62719994|FG002|Overall Study|Admitted to long term nursing care|0|||
33342951|NCT00818662|62719995|FG003|Overall Study|Admitted to long term nursing care|0|||
33342952|NCT00903786|62720006|FG000|Overall Study|Physician Decision|6|||
33342953|NCT00903786|62720006|FG000|Overall Study|Lack of Efficacy|5|||
33342954|NCT00903786|62720006|FG000|Overall Study|Reason other than lack of efficacy|4|||
33342955|NCT00762073|62720015|FG000|Overall Study|Lack of Efficacy|1|||
33342956|NCT00762073|62720016|FG001|Overall Study|Lack of Efficacy|1|||
33342957|NCT00762073|62720017|FG002|Overall Study|Lack of Efficacy|0|||
33342958|NCT00762073|62720018|FG003|Overall Study|Lack of Efficacy|0|||
33342959|NCT00762073|62720015|FG000|Overall Study|Adverse Event|1|||
33342960|NCT00762073|62720016|FG001|Overall Study|Adverse Event|0|||
33342961|NCT00762073|62720017|FG002|Overall Study|Adverse Event|1|||
33342962|NCT00762073|62720018|FG003|Overall Study|Adverse Event|1|||
33342963|NCT00762073|62720015|FG000|Overall Study|Significant Subject Noncompliance|0|||
33342964|NCT00762073|62720016|FG001|Overall Study|Significant Subject Noncompliance|1|||
33342965|NCT00762073|62720017|FG002|Overall Study|Significant Subject Noncompliance|0|||
33342966|NCT00762073|62720018|FG003|Overall Study|Significant Subject Noncompliance|1|||
33342967|NCT00762073|62720015|FG000|Overall Study|Withdrawal by Subject|1|||
33342968|NCT00762073|62720016|FG001|Overall Study|Withdrawal by Subject|2|||
33342969|NCT00762073|62720017|FG002|Overall Study|Withdrawal by Subject|1|||
33342970|NCT00762073|62720018|FG003|Overall Study|Withdrawal by Subject|1|||
33342971|NCT00762073|62720015|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
33342972|NCT00762073|62720016|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
33342973|NCT00762073|62720017|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
33342974|NCT00762073|62720018|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
33342975|NCT00761761|62720037|FG000|Overall Study|Lost to Follow-up|3|||
33342976|NCT00761761|62720038|FG001|Overall Study|Lost to Follow-up|1|||
33342977|NCT00761761|62720037|FG000|Overall Study|Withdrawal by Subject|3|||
33342978|NCT00761761|62720038|FG001|Overall Study|Withdrawal by Subject|0|||
33342979|NCT00761605|62720046|FG000|Overall Study|Adverse Event|26|||
33342980|NCT00761605|62720046|FG000|Overall Study|Death|2|||
33342981|NCT00761605|62720046|FG000|Overall Study|Lack of Efficacy|26|||
33342982|NCT00761605|62720046|FG000|Overall Study|Lost to Follow-up|29|||
33342983|NCT00761605|62720046|FG000|Overall Study|Withdrawal by Subject|37|||
33342984|NCT00761605|62720046|FG000|Overall Study|Other|21|||
33342985|NCT00761527|62720054|FG000|Overall Study|Adverse Event|3|||
33342986|NCT00761527|62720054|FG000|Overall Study|Poor Compliance|8|||
33342987|NCT00761527|62720054|FG000|Overall Study|Lost to Follow-up|9|||
33342988|NCT00761527|62720054|FG000|Overall Study|Unknown reason|2|||
33342989|NCT00770029|62720060|FG000|Overall Study|Lost to Follow-up|2|||
33342990|NCT00770029|62720061|FG001|Overall Study|Lost to Follow-up|0|||
33342991|NCT00770029|62720060|FG000|Overall Study|Withdrawal by Subject|3|||
33342992|NCT00770029|62720061|FG001|Overall Study|Withdrawal by Subject|3|||
33342993|NCT00770029|62720060|FG000|Overall Study|Adverse Event|1|||
33342994|NCT00770029|62720061|FG001|Overall Study|Adverse Event|0|||
33342995|NCT00817414|62720072|FG000|Overall Study|Adverse Event|1|||
33654607|NCT01569152|63067306|FG002|Phase IIa, Period 1|Protocol Violation|0|||
33654608|NCT01569152|63067304|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
33342996|NCT00817414|62720073|FG001|Overall Study|Adverse Event|1|||
33342997|NCT00817414|62720074|FG002|Overall Study|Adverse Event|1|||
33342998|NCT00817414|62720075|FG003|Overall Study|Adverse Event|0|||
33342999|NCT00817414|62720076|FG004|Overall Study|Adverse Event|0|||
33343000|NCT00817414|62720072|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
33343001|NCT00817414|62720073|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
33343002|NCT00817414|62720074|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
33343003|NCT00817414|62720075|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
33343004|NCT00817414|62720076|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
33343005|NCT00817414|62720072|FG000|Overall Study|Withdrawal by Subject|1|||
33343006|NCT00817414|62720073|FG001|Overall Study|Withdrawal by Subject|1|||
33343007|NCT00817414|62720074|FG002|Overall Study|Withdrawal by Subject|0|||
33343008|NCT00817414|62720075|FG003|Overall Study|Withdrawal by Subject|0|||
33343009|NCT00817414|62720076|FG004|Overall Study|Withdrawal by Subject|0|||
33343010|NCT00817414|62720072|FG000|Overall Study|Lost to Follow-up|0|||
33343011|NCT00817414|62720073|FG001|Overall Study|Lost to Follow-up|0|||
33343012|NCT00817414|62720074|FG002|Overall Study|Lost to Follow-up|1|||
33343013|NCT00817414|62720075|FG003|Overall Study|Lost to Follow-up|1|||
33343014|NCT00817414|62720076|FG004|Overall Study|Lost to Follow-up|1|||
33343015|NCT00817414|62720072|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
33343016|NCT00817414|62720073|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
33343017|NCT00817414|62720074|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
33343018|NCT00817414|62720075|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
33343019|NCT00817414|62720076|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
33343020|NCT00817414|62720072|FG000|Overall Study|Protocol Violation|0|||
33343021|NCT00817414|62720073|FG001|Overall Study|Protocol Violation|0|||
33343022|NCT00817414|62720074|FG002|Overall Study|Protocol Violation|0|||
33343023|NCT00817414|62720075|FG003|Overall Study|Protocol Violation|0|||
33343024|NCT00817414|62720076|FG004|Overall Study|Protocol Violation|1|||
33343025|NCT00769561|62720095|FG000|Overall Study|Withdrawal by Subject|2|||
33343026|NCT00769561|62720096|FG001|Overall Study|Withdrawal by Subject|2|||
33343027|NCT00769561|62720095|FG000|Overall Study|Lost to Follow-up|1|||
33343028|NCT00769561|62720096|FG001|Overall Study|Lost to Follow-up|3|||
33343029|NCT00817336|62720104|FG000|Overall Study|Withdrawal by Subject|1|||
33343030|NCT00817336|62720105|FG001|Overall Study|Withdrawal by Subject|1|||
33343031|NCT00761215|62720113|FG000|Overall Study|Randomized but didn't receive drug|1|||
33343032|NCT00761215|62720114|FG001|Overall Study|Randomized but didn't receive drug|1|||
33343033|NCT00761215|62720115|FG002|Overall Study|Randomized but didn't receive drug|2|||
33343034|NCT00761215|62720113|FG000|Overall Study|Lost to Follow-up|6|||
33343035|NCT00761215|62720114|FG001|Overall Study|Lost to Follow-up|3|||
33343036|NCT00761215|62720115|FG002|Overall Study|Lost to Follow-up|6|||
33343037|NCT00761215|62720113|FG000|Overall Study|Withdrawal by Subject|1|||
33343038|NCT00761215|62720114|FG001|Overall Study|Withdrawal by Subject|0|||
33343039|NCT00761215|62720115|FG002|Overall Study|Withdrawal by Subject|0|||
33343040|NCT00761215|62720113|FG000|Overall Study|Bacteremia|1|||
33343041|NCT00761215|62720114|FG001|Overall Study|Bacteremia|0|||
33343042|NCT00761215|62720115|FG002|Overall Study|Bacteremia|0|||
33343043|NCT05101122|62720148|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
33343044|NCT05101122|62720148|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
33343045|NCT05101122|62720148|FG000|AD313 80/5|Withdrawal by Subject|1|||
33343046|NCT05101122|62720148|FG000|AD313 80/10|Physician Decision|1|||
33343047|NCT05038163|62720170|FG000|Stage 1|Did not complete survey|374|||
33343048|NCT05038163|62720171|FG001|Stage 1|Did not complete survey|0|||
33343049|NCT05038163|62720172|FG002|Stage 1|Did not complete survey|0|||
33343050|NCT05038163|62720173|FG003|Stage 1|Did not complete survey|0|||
33343051|NCT05038163|62720174|FG004|Stage 1|Did not complete survey|0|||
33343052|NCT05038163|62720175|FG005|Stage 1|Did not complete survey|0|||
33343053|NCT05038163|62720170|FG000|Stage 2|Did not complete Stage 2 survey|0|||
33343054|NCT05038163|62720171|FG001|Stage 2|Did not complete Stage 2 survey|29|||
33343055|NCT05038163|62720172|FG002|Stage 2|Did not complete Stage 2 survey|30|||
33343056|NCT05038163|62720173|FG003|Stage 2|Did not complete Stage 2 survey|24|||
33343057|NCT05038163|62720174|FG004|Stage 2|Did not complete Stage 2 survey|21|||
33343058|NCT05038163|62720175|FG005|Stage 2|Did not complete Stage 2 survey|100|||
33343059|NCT04516746|62720203|FG000|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|21090|||
33343060|NCT04516746|62720204|FG001|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|10305|||
33343061|NCT04516746|62720203|FG000|Overall Study|Withdrawal by Subject|362|||
33343062|NCT04516746|62720204|FG001|Overall Study|Withdrawal by Subject|408|||
33343063|NCT04516746|62720203|FG000|Overall Study|Lost to Follow-up|157|||
33343064|NCT04516746|62720204|FG001|Overall Study|Lost to Follow-up|86|||
33343065|NCT04516746|62720203|FG000|Overall Study|Protocol deviation|18|||
33654609|NCT01569152|63067305|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
33343066|NCT04516746|62720204|FG001|Overall Study|Protocol deviation|7|||
33343067|NCT04516746|62720203|FG000|Overall Study|Death|8|||
33343068|NCT04516746|62720204|FG001|Overall Study|Death|7|||
33343069|NCT04516746|62720203|FG000|Overall Study|Physician Decision|0|||
33343070|NCT04516746|62720204|FG001|Overall Study|Physician Decision|2|||
33343071|NCT04516746|62720203|FG000|Overall Study|Other|0|||
33343072|NCT04516746|62720204|FG001|Overall Study|Other|1|||
33470064|NCT00250679|62843759|FG002|Overall Study|Adverse Event|16|||
33343073|NCT04413617|62720234|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
33343074|NCT04413617|62720235|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
33343075|NCT04413617|62720236|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
33654610|NCT01569152|63067306|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
33343076|NCT04413617|62720237|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
33343077|NCT04413617|62720238|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
33343078|NCT04413617|62720234|FG000|Overall Study|Protocol Violation|0|||
33343079|NCT04413617|62720235|FG001|Overall Study|Protocol Violation|1|||
33343080|NCT04413617|62720236|FG002|Overall Study|Protocol Violation|0|||
33343081|NCT04413617|62720237|FG003|Overall Study|Protocol Violation|0|||
33343082|NCT04413617|62720238|FG004|Overall Study|Protocol Violation|1|||
33343083|NCT04413617|62720234|FG000|Overall Study|Lack of Efficacy|2|||
33343084|NCT04413617|62720235|FG001|Overall Study|Lack of Efficacy|0|||
33343085|NCT04413617|62720236|FG002|Overall Study|Lack of Efficacy|2|||
33343086|NCT04413617|62720237|FG003|Overall Study|Lack of Efficacy|1|||
33343087|NCT04413617|62720238|FG004|Overall Study|Lack of Efficacy|0|||
33343088|NCT04413617|62720234|FG000|Overall Study|Withdrawal by Subject|3|||
33343089|NCT04413617|62720235|FG001|Overall Study|Withdrawal by Subject|4|||
33343090|NCT04413617|62720236|FG002|Overall Study|Withdrawal by Subject|2|||
33343091|NCT04413617|62720237|FG003|Overall Study|Withdrawal by Subject|5|||
33343092|NCT04413617|62720238|FG004|Overall Study|Withdrawal by Subject|3|||
33343093|NCT04413617|62720234|FG000|Overall Study|Death|1|||
33343094|NCT04413617|62720235|FG001|Overall Study|Death|0|||
33343095|NCT04413617|62720236|FG002|Overall Study|Death|0|||
33343096|NCT04413617|62720237|FG003|Overall Study|Death|0|||
33343097|NCT04413617|62720238|FG004|Overall Study|Death|0|||
33343098|NCT04413617|62720234|FG000|Overall Study|Adverse Event|1|||
33343099|NCT04413617|62720235|FG001|Overall Study|Adverse Event|0|||
33343100|NCT04413617|62720236|FG002|Overall Study|Adverse Event|0|||
33343101|NCT04413617|62720237|FG003|Overall Study|Adverse Event|1|||
33343102|NCT04413617|62720238|FG004|Overall Study|Adverse Event|1|||
33343103|NCT04413617|62720234|FG000|Overall Study|COVID-19|0|||
33343104|NCT04413617|62720235|FG001|Overall Study|COVID-19|1|||
33343105|NCT04413617|62720236|FG002|Overall Study|COVID-19|0|||
33343106|NCT04413617|62720237|FG003|Overall Study|COVID-19|0|||
33343107|NCT04413617|62720238|FG004|Overall Study|COVID-19|0|||
33343108|NCT04055116|62720270|FG000|First Intervention|Physician Decision|2|||
33343109|NCT04055116|62720271|FG001|First Intervention|Physician Decision|7|||
33343110|NCT03512262|62720317|FG000|Overall Study|Adverse Event|8|||
33343111|NCT03512262|62720318|FG001|Overall Study|Adverse Event|3|||
33343112|NCT03512262|62720317|FG000|Overall Study|Death (non-treatment emergent)|1|||
33343113|NCT03512262|62720318|FG001|Overall Study|Death (non-treatment emergent)|0|||
33343114|NCT03512262|62720317|FG000|Overall Study|Withdrawal by Subject|17|||
33343115|NCT03512262|62720318|FG001|Overall Study|Withdrawal by Subject|9|||
33343116|NCT03512262|62720317|FG000|Overall Study|Lost to Follow-up|7|||
33343117|NCT03512262|62720318|FG001|Overall Study|Lost to Follow-up|1|||
33343118|NCT03512262|62720317|FG000|Overall Study|Other than Specified|2|||
33343119|NCT03512262|62720318|FG001|Overall Study|Other than Specified|2|||
33343120|NCT03499600|62720326|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
33343121|NCT03499600|62720327|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
33343122|NCT03007979|62720341|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
33343123|NCT02960893|62720347|FG000|Randomization Phase (8-week)|Adverse Event|5|||
33343124|NCT02960893|62720348|FG001|Randomization Phase (8-week)|Adverse Event|0|||
33343125|NCT02960893|62720347|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
33343126|NCT02960893|62720348|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
33343127|NCT02960893|62720347|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
33343128|NCT02960893|62720348|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
33343129|NCT02960893|62720347|FG000|Extension Phase (48-week)|Adverse Event|2|||
33343130|NCT02960893|62720348|FG001|Extension Phase (48-week)|Adverse Event|3|||
33343131|NCT02960893|62720347|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
33343132|NCT02960893|62720348|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
33343133|NCT02960893|62720347|FG000|Extension Phase (48-week)|Other Reason|2|||
33343134|NCT02960893|62720348|FG001|Extension Phase (48-week)|Other Reason|1|||
33343135|NCT02960893|62720347|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
33343136|NCT02960893|62720348|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
33343137|NCT02960893|62720347|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
33654611|NCT01569152|63067304|FG000|Safety Extension, Period 3|Adverse Event|0|||
33343138|NCT02960893|62720348|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
33343139|NCT02867813|62720363|FG000|Overall Study|Withdrawal by Subject|57|||
33343140|NCT02867813|62720364|FG001|Overall Study|Withdrawal by Subject|56|||
33343141|NCT02867813|62720363|FG000|Overall Study|Decision by Sponsor|7|||
33343142|NCT02867813|62720364|FG001|Overall Study|Decision by Sponsor|7|||
33343143|NCT02867813|62720363|FG000|Overall Study|Lost to Follow-up|91|||
33343144|NCT02867813|62720364|FG001|Overall Study|Lost to Follow-up|78|||
33343145|NCT02867813|62720363|FG000|Overall Study|Missing|2|||
33343146|NCT02867813|62720364|FG001|Overall Study|Missing|1|||
33343147|NCT02867813|62720363|FG000|Overall Study|Death|294|||
33343148|NCT02867813|62720364|FG001|Overall Study|Death|268|||
33343149|NCT02278055|62720376|FG000|Overall Study|Adverse Event|1|||
33343150|NCT02278055|62720376|FG000|Overall Study|Lost to Follow-up|1|||
33343151|NCT02278055|62720376|FG000|Overall Study|Withdrawal by Subject|2|||
33343152|NCT02278055|62720376|FG000|Overall Study|Progressive Disease|4|||
33343153|NCT02231879|62720382|FG000|Overall Study|Adverse Event|2|||
33343154|NCT02231879|62720383|FG001|Overall Study|Adverse Event|1|||
33343155|NCT02231879|62720382|FG000|Overall Study|Lack of Efficacy|0|||
33343156|NCT02231879|62720383|FG001|Overall Study|Lack of Efficacy|1|||
33343157|NCT01833806|62720404|FG000|Overall Study|Alternative treatment|2|||
33343158|NCT01833806|62720404|FG000|Overall Study|Death|5|||
33343159|NCT01833806|62720404|FG000|Overall Study|Physician Decision|1|||
33343160|NCT01833806|62720404|FG000|Overall Study|Lost to Follow-up|1|||
33343161|NCT01712490|62720410|FG000|Overall Study|Ongoing|601|||
33343162|NCT01712490|62720411|FG001|Overall Study|Ongoing|586|||
33343163|NCT01712490|62720410|FG000|Overall Study|Other|11|||
33343164|NCT01712490|62720411|FG001|Overall Study|Other|11|||
33343165|NCT01712490|62720410|FG000|Overall Study|Withdrawal by Subject|36|||
33343166|NCT01712490|62720411|FG001|Overall Study|Withdrawal by Subject|44|||
33343167|NCT01712490|62720410|FG000|Overall Study|Lost to Follow-up|16|||
33343168|NCT01712490|62720411|FG001|Overall Study|Lost to Follow-up|29|||
33343169|NCT01439802|62720417|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
33343170|NCT01439802|62720417|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
33343171|NCT00816556|62720428|FG000|Overall Study|Adverse Event|1|||
33343172|NCT00816556|62720429|FG001|Overall Study|Adverse Event|1|||
33343173|NCT00816556|62720430|FG002|Overall Study|Adverse Event|1|||
33343174|NCT00816556|62720428|FG000|Overall Study|Withdrawal by Subject|1|||
33343175|NCT00816556|62720429|FG001|Overall Study|Withdrawal by Subject|1|||
33343176|NCT00816556|62720430|FG002|Overall Study|Withdrawal by Subject|1|||
33343177|NCT00816556|62720428|FG000|Overall Study|Lost to Follow-up|0|||
33343178|NCT00816556|62720429|FG001|Overall Study|Lost to Follow-up|0|||
33343179|NCT00816556|62720430|FG002|Overall Study|Lost to Follow-up|1|||
33343180|NCT00760747|62720440|FG000|Study Period II|Adverse Event|3|||
33343181|NCT00760747|62720441|FG001|Study Period II|Adverse Event|4|||
33343182|NCT00760747|62720440|FG000|Study Period II|Lack of Efficacy|0|||
33343183|NCT00760747|62720441|FG001|Study Period II|Lack of Efficacy|6|||
33343184|NCT00760747|62720440|FG000|Study Period II|Parent/Caregiver Decision|3|||
33343185|NCT00760747|62720441|FG001|Study Period II|Parent/Caregiver Decision|0|||
33343186|NCT00760747|62720440|FG000|Study Period II|Protocol Violation|6|||
33343187|NCT00760747|62720441|FG001|Study Period II|Protocol Violation|3|||
33343188|NCT00760747|62720440|FG000|Study Period II|Withdrawal by Subject|1|||
33343189|NCT00760747|62720441|FG001|Study Period II|Withdrawal by Subject|0|||
33343190|NCT00760747|62720440|FG000|Study Period II|No drug administered|0|||
33343191|NCT00760747|62720441|FG001|Study Period II|No drug administered|1|||
33343192|NCT00760747|62720440|FG000|Study Period III|Adverse Event|1|||
33343193|NCT00760747|62720441|FG001|Study Period III|Adverse Event|0|||
33654612|NCT01569152|63067305|FG001|Safety Extension, Period 3|Adverse Event|0|||
33654613|NCT01569152|63067306|FG002|Safety Extension, Period 3|Adverse Event|4|||
33654614|NCT01569152|63067304|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
33654615|NCT01569152|63067305|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
33654616|NCT01569152|63067306|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
33654617|NCT01569152|63067304|FG000|Safety Extension, Period 3|Physician Decision|0|||
33654618|NCT01569152|63067305|FG001|Safety Extension, Period 3|Physician Decision|0|||
33654619|NCT01569152|63067306|FG002|Safety Extension, Period 3|Physician Decision|2|||
33654620|NCT01569152|63067304|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
33654621|NCT01569152|63067305|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
33654622|NCT01569152|63067306|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
33654623|NCT01569074|63067331|FG000|Overall Study|Study stopped|6|||
33654624|NCT01569074|63067332|FG001|Overall Study|Study stopped|6|||
33654625|NCT01569074|63067333|FG002|Overall Study|Study stopped|8|||
33654626|NCT01569074|63067334|FG003|Overall Study|Study stopped|7|||
33654627|NCT01569074|63067335|FG004|Overall Study|Study stopped|7|||
33654628|NCT01569074|63067331|FG000|Overall Study|Study-specific discontinuation criteria|0|||
33343194|NCT00760747|62720440|FG000|Study Period III|Lack of Efficacy|1|||
33343195|NCT00760747|62720441|FG001|Study Period III|Lack of Efficacy|0|||
33343196|NCT00760747|62720440|FG000|Study Period III|Parent/Caregiver Decision|0|||
33470065|NCT00250679|62843757|FG000|Overall Study|Protocol Violation|2|||
33654629|NCT01569074|63067332|FG001|Overall Study|Study-specific discontinuation criteria|1|||
33343197|NCT00760747|62720441|FG001|Study Period III|Parent/Caregiver Decision|1|||
33343198|NCT00760747|62720440|FG000|Study Period III|Protocol Violation|1|||
33343199|NCT00760747|62720441|FG001|Study Period III|Protocol Violation|1|||
33343200|NCT00760747|62720440|FG000|Study Period III|Physician Decision|0|||
33343201|NCT00760747|62720441|FG001|Study Period III|Physician Decision|1|||
33343202|NCT00760669|62720447|FG000|Overall Study|Not assessed for overall improvement|18|||
33343203|NCT00760669|62720447|FG000|Overall Study|Participants missing efficacy assessment|6|||
33343204|NCT00760669|62720447|FG000|Overall Study|Participants with overlapping cases|1|||
33343205|NCT00760669|62720447|FG000|Overall Study|Took drug before entering in contract|5|||
33343206|NCT00769483|62720457|FG000|Overall Study|Withdrawal by Subject|0|||
33654630|NCT01569074|63067333|FG002|Overall Study|Study-specific discontinuation criteria|0|||
33654631|NCT01569074|63067334|FG003|Overall Study|Study-specific discontinuation criteria|0|||
33654632|NCT01569074|63067335|FG004|Overall Study|Study-specific discontinuation criteria|0|||
33654633|NCT01569074|63067331|FG000|Overall Study|Severe non-compliance to protocol|0|||
33654634|NCT01569074|63067332|FG001|Overall Study|Severe non-compliance to protocol|0|||
33654635|NCT01569074|63067333|FG002|Overall Study|Severe non-compliance to protocol|1|||
33654636|NCT01569074|63067334|FG003|Overall Study|Severe non-compliance to protocol|0|||
33654637|NCT01569074|63067335|FG004|Overall Study|Severe non-compliance to protocol|0|||
33654638|NCT01569074|63067331|FG000|Overall Study|eg change in circumstances|0|||
33654639|NCT01569074|63067332|FG001|Overall Study|eg change in circumstances|2|||
33343207|NCT00769483|62720458|FG001|Overall Study|Withdrawal by Subject|1|||
33343208|NCT00769483|62720459|FG002|Overall Study|Withdrawal by Subject|0|||
33343209|NCT00769483|62720460|FG003|Overall Study|Withdrawal by Subject|0|||
33343210|NCT00769483|62720461|FG004|Overall Study|Withdrawal by Subject|1|||
33343211|NCT00769483|62720462|FG005|Overall Study|Withdrawal by Subject|0|||
33343212|NCT00760513|62720480|FG000|Overall Study|Withdrawal by Subject|5|||
33343213|NCT00760513|62720481|FG001|Overall Study|Withdrawal by Subject|7|||
33343214|NCT00907296|62720499|FG000|Overall Study|Ineligibility Determined|1|||
33343215|NCT00907296|62720500|FG001|Overall Study|Ineligibility Determined|0|||
33343216|NCT00907296|62720501|FG002|Overall Study|Ineligibility Determined|0|||
33343217|NCT00907296|62720502|FG003|Overall Study|Ineligibility Determined|1|||
33343218|NCT00907296|62720503|FG004|Overall Study|Ineligibility Determined|0|||
33343219|NCT00907296|62720504|FG005|Overall Study|Ineligibility Determined|0|||
33343220|NCT00907296|62720505|FG006|Overall Study|Ineligibility Determined|0|||
33343221|NCT00907296|62720506|FG007|Overall Study|Ineligibility Determined|1|||
33343222|NCT00907296|62720507|FG008|Overall Study|Ineligibility Determined|0|||
33343223|NCT00907296|62720508|FG009|Overall Study|Ineligibility Determined|0|||
33343224|NCT00907296|62720499|FG000|Overall Study|Protocol Deviation|0|||
33343225|NCT00907296|62720500|FG001|Overall Study|Protocol Deviation|1|||
33343226|NCT00907296|62720501|FG002|Overall Study|Protocol Deviation|0|||
33343227|NCT00907296|62720502|FG003|Overall Study|Protocol Deviation|0|||
33343228|NCT00907296|62720503|FG004|Overall Study|Protocol Deviation|0|||
33343229|NCT00907296|62720504|FG005|Overall Study|Protocol Deviation|0|||
33343230|NCT00907296|62720505|FG006|Overall Study|Protocol Deviation|0|||
33343231|NCT00907296|62720506|FG007|Overall Study|Protocol Deviation|0|||
33343232|NCT00907296|62720507|FG008|Overall Study|Protocol Deviation|0|||
33343233|NCT00907296|62720508|FG009|Overall Study|Protocol Deviation|0|||
33343234|NCT00907296|62720499|FG000|Overall Study|Noncompliance|1|||
33343235|NCT00907296|62720500|FG001|Overall Study|Noncompliance|1|||
33343236|NCT00907296|62720501|FG002|Overall Study|Noncompliance|1|||
33343237|NCT00907296|62720502|FG003|Overall Study|Noncompliance|0|||
33343238|NCT00907296|62720503|FG004|Overall Study|Noncompliance|0|||
33343239|NCT00907296|62720504|FG005|Overall Study|Noncompliance|1|||
33343240|NCT00907296|62720505|FG006|Overall Study|Noncompliance|0|||
33343241|NCT00907296|62720506|FG007|Overall Study|Noncompliance|2|||
33343242|NCT00907296|62720507|FG008|Overall Study|Noncompliance|0|||
33343243|NCT00907296|62720508|FG009|Overall Study|Noncompliance|0|||
33343244|NCT00907296|62720499|FG000|Overall Study|Adverse Event|2|||
33343245|NCT00907296|62720500|FG001|Overall Study|Adverse Event|0|||
33343246|NCT00907296|62720501|FG002|Overall Study|Adverse Event|0|||
33343247|NCT00907296|62720502|FG003|Overall Study|Adverse Event|0|||
33343248|NCT00907296|62720503|FG004|Overall Study|Adverse Event|0|||
33343249|NCT00907296|62720504|FG005|Overall Study|Adverse Event|0|||
33343250|NCT00907296|62720505|FG006|Overall Study|Adverse Event|1|||
33343251|NCT00907296|62720506|FG007|Overall Study|Adverse Event|0|||
33343252|NCT00907296|62720507|FG008|Overall Study|Adverse Event|0|||
33343253|NCT00907296|62720508|FG009|Overall Study|Adverse Event|1|||
33343254|NCT00907296|62720499|FG000|Overall Study|Withdrawal by Subject|7|||
33654640|NCT01569074|63067333|FG002|Overall Study|eg change in circumstances|0|||
33343255|NCT00907296|62720500|FG001|Overall Study|Withdrawal by Subject|2|||
33343256|NCT00907296|62720501|FG002|Overall Study|Withdrawal by Subject|1|||
33343257|NCT00907296|62720502|FG003|Overall Study|Withdrawal by Subject|1|||
33343258|NCT00907296|62720503|FG004|Overall Study|Withdrawal by Subject|1|||
33343259|NCT00907296|62720504|FG005|Overall Study|Withdrawal by Subject|5|||
33343260|NCT00907296|62720505|FG006|Overall Study|Withdrawal by Subject|3|||
33343261|NCT00907296|62720506|FG007|Overall Study|Withdrawal by Subject|2|||
33343262|NCT00907296|62720507|FG008|Overall Study|Withdrawal by Subject|4|||
33654641|NCT01569074|63067334|FG003|Overall Study|eg change in circumstances|1|||
33343263|NCT00907296|62720508|FG009|Overall Study|Withdrawal by Subject|2|||
33343264|NCT00907296|62720499|FG000|Overall Study|Lost to Follow-up|9|||
33343265|NCT00907296|62720500|FG001|Overall Study|Lost to Follow-up|1|||
33343266|NCT00907296|62720501|FG002|Overall Study|Lost to Follow-up|0|||
33343267|NCT00907296|62720502|FG003|Overall Study|Lost to Follow-up|2|||
33343268|NCT00907296|62720503|FG004|Overall Study|Lost to Follow-up|0|||
33343269|NCT00907296|62720504|FG005|Overall Study|Lost to Follow-up|3|||
33343270|NCT00907296|62720505|FG006|Overall Study|Lost to Follow-up|2|||
33343271|NCT00907296|62720506|FG007|Overall Study|Lost to Follow-up|2|||
33343272|NCT00907296|62720507|FG008|Overall Study|Lost to Follow-up|0|||
33343273|NCT00907296|62720508|FG009|Overall Study|Lost to Follow-up|4|||
33343274|NCT00816400|62720539|FG000|Overall Study|Death|2|||
33343275|NCT00816400|62720540|FG001|Overall Study|Death|3|||
33343276|NCT00816400|62720541|FG002|Overall Study|Death|3|||
33343277|NCT00816400|62720542|FG003|Overall Study|Death|3|||
33343278|NCT00816400|62720543|FG004|Overall Study|Death|2|||
33343279|NCT00816400|62720544|FG005|Overall Study|Death|3|||
33343280|NCT00816400|62720545|FG006|Overall Study|Death|2|||
33343281|NCT00816400|62720546|FG007|Overall Study|Death|5|||
33343282|NCT00816400|62720547|FG008|Overall Study|Death|6|||
33343283|NCT00816400|62720539|FG000|Overall Study|In hospice care at the end of the study|0|||
33548870|NCT04706403|62940252|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
33548871|NCT04706403|62940253|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
33548872|NCT04706403|62940254|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
33548873|NCT04706403|62940255|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
33548874|NCT04706403|62940256|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
33548875|NCT02983617|62940270|FG000|Overall Study|Adverse Event|0|||
33343284|NCT00816400|62720540|FG001|Overall Study|In hospice care at the end of the study|0|||
33343285|NCT00816400|62720541|FG002|Overall Study|In hospice care at the end of the study|2|||
33343286|NCT00816400|62720542|FG003|Overall Study|In hospice care at the end of the study|0|||
33343287|NCT00816400|62720543|FG004|Overall Study|In hospice care at the end of the study|0|||
33343288|NCT00816400|62720544|FG005|Overall Study|In hospice care at the end of the study|0|||
33343289|NCT00816400|62720545|FG006|Overall Study|In hospice care at the end of the study|0|||
33343290|NCT00816400|62720546|FG007|Overall Study|In hospice care at the end of the study|0|||
33343291|NCT00816400|62720547|FG008|Overall Study|In hospice care at the end of the study|0|||
33343292|NCT00906204|62720570|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
33343293|NCT00906204|62720571|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
33343294|NCT00906204|62720570|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
33343295|NCT00906204|62720571|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
33343296|NCT00906204|62720570|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
33343297|NCT00906204|62720571|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
33343298|NCT00906204|62720570|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
33343299|NCT00906204|62720571|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
33343300|NCT00906204|62720570|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
33343301|NCT00906204|62720571|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
33343302|NCT00905424|62720608|FG000|Overall Study|Lost to Follow-up|3|||
33343303|NCT00905424|62720609|FG001|Overall Study|Lost to Follow-up|3|||
33343304|NCT00905424|62720608|FG000|Overall Study|Withdrawal by Subject|1|||
33343305|NCT00905424|62720609|FG001|Overall Study|Withdrawal by Subject|2|||
33343306|NCT00905424|62720608|FG000|Overall Study|Adverse Event|4|||
33343307|NCT00905424|62720609|FG001|Overall Study|Adverse Event|2|||
33343308|NCT00905424|62720608|FG000|Overall Study|Non-compliance with study medication|2|||
33343309|NCT00905424|62720609|FG001|Overall Study|Non-compliance with study medication|0|||
33343310|NCT00905424|62720608|FG000|Overall Study|Sponsor decision|1|||
33343311|NCT00905424|62720609|FG001|Overall Study|Sponsor decision|0|||
33343312|NCT00905424|62720608|FG000|Overall Study|Positive urine drug screen|0|||
33343313|NCT00905424|62720609|FG001|Overall Study|Positive urine drug screen|1|||
33343314|NCT00905424|62720608|FG000|Overall Study|Non-adherence to visit schedule|0|||
33343315|NCT00905424|62720609|FG001|Overall Study|Non-adherence to visit schedule|1|||
33343316|NCT00816166|62720619|FG000|Overall Study|Lost to Follow-up|6|||
33343317|NCT00816166|62720620|FG001|Overall Study|Lost to Follow-up|10|||
33343318|NCT00816166|62720619|FG000|Overall Study|Death|4|||
33343319|NCT00816166|62720620|FG001|Overall Study|Death|2|||
33343320|NCT00815308|62720626|FG000|Overall Study|Adverse Event|4|||
33470066|NCT00250679|62843758|FG001|Overall Study|Protocol Violation|4|||
33470067|NCT00250679|62843759|FG002|Overall Study|Protocol Violation|3|||
33470068|NCT00250679|62843757|FG000|Overall Study|Withdrawal by Subject|15|||
33470069|NCT00250679|62843758|FG001|Overall Study|Withdrawal by Subject|18|||
33470070|NCT00250679|62843759|FG002|Overall Study|Withdrawal by Subject|15|||
33470071|NCT00250679|62843757|FG000|Overall Study|Lost to Follow-up|3|||
33470072|NCT00250679|62843758|FG001|Overall Study|Lost to Follow-up|4|||
33470073|NCT00250679|62843759|FG002|Overall Study|Lost to Follow-up|2|||
33470074|NCT00250679|62843757|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
33470075|NCT00250679|62843758|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
33343321|NCT00815308|62720626|FG000|Overall Study|Withdrawal by Subject|0|||
33343322|NCT00815308|62720626|FG000|Overall Study|Protocol Violation|6|||
33343323|NCT01039376|62720632|FG000|Overall Study|Lost to Follow-up|5|||
33343324|NCT01039376|62720633|FG001|Overall Study|Lost to Follow-up|12|||
33343325|NCT01039376|62720632|FG000|Overall Study|Physician Decision|15|||
33343326|NCT01039376|62720633|FG001|Overall Study|Physician Decision|10|||
33343327|NCT01039376|62720632|FG000|Overall Study|Withdrawal by Subject|20|||
33343328|NCT01039376|62720633|FG001|Overall Study|Withdrawal by Subject|32|||
33343329|NCT01039376|62720632|FG000|Overall Study|Study terminated by Sponsor|90|||
33343330|NCT01039376|62720633|FG001|Overall Study|Study terminated by Sponsor|72|||
33343331|NCT00905034|62720640|FG000|Overall Study|Withdrawal by Subject|1|||
33343332|NCT00828568|62720647|FG000|Randomized|Withdrawal by Subject|1|||
33343333|NCT00828568|62720648|FG001|Randomized|Withdrawal by Subject|0|||
33343334|NCT00828568|62720649|FG002|Randomized|Withdrawal by Subject|2|||
33343335|NCT00828568|62720647|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
33343336|NCT00828568|62720648|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
33343337|NCT00828568|62720649|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
33343338|NCT00828568|62720647|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
33343339|NCT00828568|62720648|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
33343340|NCT00828568|62720649|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
33343341|NCT00828568|62720647|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
33343342|NCT00828568|62720648|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
33343343|NCT00828568|62720649|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
33343344|NCT00828568|62720647|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
33343345|NCT00828568|62720648|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
33343346|NCT00828568|62720649|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
33343347|NCT01038752|62720660|FG000|Overall Study|Tumor Progression|2|||
33343348|NCT01038752|62720661|FG001|Overall Study|Tumor Progression|2|||
33343349|NCT01038752|62720660|FG000|Overall Study|Lost to Follow-up|3|||
33343350|NCT01038752|62720661|FG001|Overall Study|Lost to Follow-up|3|||
33343351|NCT00903630|62720670|FG000|Phase 2|Adverse Event|0|||
33343352|NCT00903630|62720671|FG001|Phase 2|Adverse Event|0|||
33343353|NCT00903630|62720672|FG002|Phase 2|Adverse Event|1|||
33343354|NCT01037114|62720682|FG000|Year 20|Others|1|||
33343355|NCT00840970|62720686|FG000|Overall Study|Adverse Event|0|||
33343356|NCT00840970|62720687|FG001|Overall Study|Adverse Event|0|||
33343357|NCT00840970|62720688|FG002|Overall Study|Adverse Event|1|||
33343358|NCT01054820|62720698|FG000|Overall Study|Withdrawal by Subject|2|||
33343359|NCT00840658|62720706|FG000|Overall Study|Death|2|||
33343360|NCT00840658|62720707|FG001|Overall Study|Death|2|||
33343361|NCT00840658|62720708|FG002|Overall Study|Death|3|||
33343362|NCT00840658|62720709|FG003|Overall Study|Death|3|||
33343363|NCT00840658|62720706|FG000|Overall Study|Lost to Follow-up|3|||
33343364|NCT00840658|62720707|FG001|Overall Study|Lost to Follow-up|1|||
33343365|NCT00840658|62720708|FG002|Overall Study|Lost to Follow-up|2|||
33343366|NCT00840658|62720709|FG003|Overall Study|Lost to Follow-up|1|||
33343367|NCT01036724|62720725|FG000|Overall Study|Adverse Event|1|||
33343368|NCT01036724|62720726|FG001|Overall Study|Adverse Event|2|||
33343369|NCT01036724|62720725|FG000|Overall Study|Lack of Efficacy|1|||
33343370|NCT01036724|62720726|FG001|Overall Study|Lack of Efficacy|1|||
33343371|NCT01036724|62720725|FG000|Overall Study|Protocol Violation|4|||
33343372|NCT01036724|62720726|FG001|Overall Study|Protocol Violation|5|||
33470076|NCT00250679|62843759|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
33470077|NCT00250679|62843757|FG000|Overall Study|Lack of Efficacy|0|||
33470078|NCT00250679|62843758|FG001|Overall Study|Lack of Efficacy|1|||
33470079|NCT00250679|62843759|FG002|Overall Study|Lack of Efficacy|3|||
33470080|NCT00250679|62843757|FG000|Overall Study|Technical Holter issues|1|||
33470081|NCT00250679|62843758|FG001|Overall Study|Technical Holter issues|0|||
33470082|NCT00250679|62843759|FG002|Overall Study|Technical Holter issues|2|||
33470083|NCT00250679|62843757|FG000|Overall Study|Moved|1|||
33470084|NCT00250679|62843758|FG001|Overall Study|Moved|1|||
33470085|NCT00250679|62843759|FG002|Overall Study|Moved|0|||
33470086|NCT00250679|62843757|FG000|Overall Study|Non-compliance|1|||
33470087|NCT00250679|62843758|FG001|Overall Study|Non-compliance|1|||
33470088|NCT00250679|62843759|FG002|Overall Study|Non-compliance|0|||
33470089|NCT00250679|62843757|FG000|Overall Study|various single events: hip surgery,diary|3|||
33470090|NCT00250679|62843758|FG001|Overall Study|various single events: hip surgery,diary|1|||
33343373|NCT01052714|62720734|FG000|Overall Study|Adverse Event|6|||
33343374|NCT01052714|62720735|FG001|Overall Study|Adverse Event|3|||
33343375|NCT01052714|62720736|FG002|Overall Study|Adverse Event|0|||
33470091|NCT00250679|62843759|FG002|Overall Study|various single events: hip surgery,diary|1|||
33470092|NCT00261833|62843769|FG000|Overall Study|Death|1|||
33470093|NCT00261833|62843770|FG001|Overall Study|Death|3|||
33654642|NCT01569074|63067335|FG004|Overall Study|eg change in circumstances|1|||
33654643|NCT01569074|63067331|FG000|Overall Study|Adverse Event|1|||
33343376|NCT01052714|62720734|FG000|Overall Study|Death|1|||
33343377|NCT01052714|62720735|FG001|Overall Study|Death|2|||
33343378|NCT01052714|62720736|FG002|Overall Study|Death|0|||
33343379|NCT01052714|62720734|FG000|Overall Study|Lost to Follow-up|2|||
33343380|NCT01052714|62720735|FG001|Overall Study|Lost to Follow-up|3|||
33343381|NCT01052714|62720736|FG002|Overall Study|Lost to Follow-up|0|||
33343382|NCT01052714|62720734|FG000|Overall Study|Physician Decision|9|||
33343383|NCT01052714|62720735|FG001|Overall Study|Physician Decision|9|||
33470094|NCT00261833|62843769|FG000|Overall Study|Adverse Event|1|||
33654644|NCT01569074|63067332|FG001|Overall Study|Adverse Event|0|||
33343384|NCT01052714|62720736|FG002|Overall Study|Physician Decision|1|||
33343385|NCT01052714|62720734|FG000|Overall Study|Withdrawal by Subject|7|||
33343386|NCT01052714|62720735|FG001|Overall Study|Withdrawal by Subject|12|||
33343387|NCT01052714|62720736|FG002|Overall Study|Withdrawal by Subject|1|||
33343388|NCT01052480|62720753|FG000|Overall Study|Lost to Follow-up|3|||
33343389|NCT01052480|62720754|FG001|Overall Study|Lost to Follow-up|3|||
33343390|NCT01052480|62720753|FG000|Overall Study|Protocol Violation|1|||
33343391|NCT01052480|62720754|FG001|Overall Study|Protocol Violation|0|||
33343392|NCT01052480|62720753|FG000|Overall Study|Withdrawal by Subject|3|||
33343393|NCT01052480|62720754|FG001|Overall Study|Withdrawal by Subject|7|||
33343394|NCT01052480|62720753|FG000|Overall Study|Physician Decision|0|||
33343395|NCT01052480|62720754|FG001|Overall Study|Physician Decision|2|||
33343396|NCT01052480|62720753|FG000|Overall Study|Death|1|||
33343397|NCT01052480|62720754|FG001|Overall Study|Death|5|||
33343398|NCT00904722|62720760|FG000|Overall Study|Physician Decision|1|||
33343399|NCT01029782|62720766|FG000|Overall Study|Lost to Follow-up|2|||
33343400|NCT01029782|62720767|FG001|Overall Study|Lost to Follow-up|2|||
33343401|NCT01029782|62720766|FG000|Overall Study|Diagnosis changed|1|||
33343402|NCT01029782|62720767|FG001|Overall Study|Diagnosis changed|1|||
33343403|NCT01029782|62720766|FG000|Overall Study|Adverse Event|0|||
33343404|NCT01029782|62720767|FG001|Overall Study|Adverse Event|1|||
33343405|NCT01029782|62720766|FG000|Overall Study|Physician Decision|0|||
33343406|NCT01029782|62720767|FG001|Overall Study|Physician Decision|1|||
33343407|NCT01029782|62720766|FG000|Overall Study|Protocol Violation|0|||
33343408|NCT01029782|62720767|FG001|Overall Study|Protocol Violation|2|||
33343409|NCT01029782|62720766|FG000|Overall Study|Withdrawal by Subject|0|||
33343410|NCT01029782|62720767|FG001|Overall Study|Withdrawal by Subject|1|||
33343411|NCT01029704|62720782|FG000|Overall Study|Adverse Event|0|||
33343412|NCT01029704|62720783|FG001|Overall Study|Adverse Event|0|||
33343413|NCT01029704|62720784|FG002|Overall Study|Adverse Event|0|||
33343414|NCT01029704|62720785|FG003|Overall Study|Adverse Event|0|||
33343415|NCT01029704|62720786|FG004|Overall Study|Adverse Event|0|||
33343416|NCT01029704|62720787|FG005|Overall Study|Adverse Event|0|||
33343417|NCT01029704|62720788|FG006|Overall Study|Adverse Event|1|||
33343418|NCT01029704|62720789|FG007|Overall Study|Adverse Event|1|||
33343419|NCT01029704|62720790|FG008|Overall Study|Adverse Event|0|||
33343420|NCT01029704|62720782|FG000|Overall Study|Withdrawal by Subject|0|||
33343421|NCT01029704|62720783|FG001|Overall Study|Withdrawal by Subject|0|||
33343422|NCT01029704|62720784|FG002|Overall Study|Withdrawal by Subject|0|||
33343423|NCT01029704|62720785|FG003|Overall Study|Withdrawal by Subject|0|||
33343424|NCT01029704|62720786|FG004|Overall Study|Withdrawal by Subject|2|||
33343425|NCT01029704|62720787|FG005|Overall Study|Withdrawal by Subject|1|||
33343426|NCT01029704|62720788|FG006|Overall Study|Withdrawal by Subject|1|||
33343427|NCT01029704|62720789|FG007|Overall Study|Withdrawal by Subject|1|||
33470095|NCT00261833|62843770|FG001|Overall Study|Adverse Event|4|||
33343428|NCT01029704|62720790|FG008|Overall Study|Withdrawal by Subject|0|||
33343429|NCT01029704|62720782|FG000|Overall Study|Lost to Follow-up|0|||
33343430|NCT01029704|62720783|FG001|Overall Study|Lost to Follow-up|0|||
33343431|NCT01029704|62720784|FG002|Overall Study|Lost to Follow-up|0|||
33343432|NCT01029704|62720785|FG003|Overall Study|Lost to Follow-up|0|||
33343433|NCT01029704|62720786|FG004|Overall Study|Lost to Follow-up|0|||
33343434|NCT01029704|62720787|FG005|Overall Study|Lost to Follow-up|0|||
33343435|NCT01029704|62720788|FG006|Overall Study|Lost to Follow-up|1|||
33343436|NCT01029704|62720789|FG007|Overall Study|Lost to Follow-up|1|||
33343437|NCT01029704|62720790|FG008|Overall Study|Lost to Follow-up|1|||
33343438|NCT01029704|62720782|FG000|Overall Study|Lack of Efficacy|0|||
33343439|NCT01029704|62720783|FG001|Overall Study|Lack of Efficacy|0|||
33343440|NCT01029704|62720784|FG002|Overall Study|Lack of Efficacy|0|||
33343441|NCT01029704|62720785|FG003|Overall Study|Lack of Efficacy|0|||
33343442|NCT01029704|62720786|FG004|Overall Study|Lack of Efficacy|2|||
33343443|NCT01029704|62720787|FG005|Overall Study|Lack of Efficacy|3|||
33343444|NCT01029704|62720788|FG006|Overall Study|Lack of Efficacy|1|||
33343445|NCT01029704|62720789|FG007|Overall Study|Lack of Efficacy|2|||
33343446|NCT01029704|62720790|FG008|Overall Study|Lack of Efficacy|0|||
33343447|NCT01029704|62720782|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
33343448|NCT01029704|62720783|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
33343449|NCT01029704|62720784|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
33343450|NCT01029704|62720785|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
33343451|NCT01029704|62720786|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
33343452|NCT01029704|62720787|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
33343453|NCT01029704|62720788|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
33343454|NCT01029704|62720789|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
33343455|NCT01029704|62720790|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
33343456|NCT00840034|62720812|FG000|Acute Treatment Phase|Adverse Event|6|||
33343457|NCT00840034|62720813|FG001|Acute Treatment Phase|Adverse Event|8|||
33343458|NCT00840034|62720812|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
33343459|NCT00840034|62720813|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
33343460|NCT00840034|62720812|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
33343461|NCT00840034|62720813|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
33343462|NCT00840034|62720812|FG000|Acute Treatment Phase|Physician Decision|0|||
33343463|NCT00840034|62720813|FG001|Acute Treatment Phase|Physician Decision|1|||
33343464|NCT00840034|62720812|FG000|Acute Treatment Phase|Protocol Violation|2|||
33343465|NCT00840034|62720813|FG001|Acute Treatment Phase|Protocol Violation|4|||
33343466|NCT00840034|62720812|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
33343467|NCT00840034|62720813|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
33343468|NCT00840034|62720812|FG000|Taper Phase|Adverse Event|1|||
33343469|NCT00840034|62720813|FG001|Taper Phase|Adverse Event|0|||
33343470|NCT00840034|62720812|FG000|Taper Phase|Lost to Follow-up|1|||
33343471|NCT00840034|62720813|FG001|Taper Phase|Lost to Follow-up|1|||
33343472|NCT00840034|62720812|FG000|Taper Phase|Withdrawal by Subject|1|||
33343473|NCT00840034|62720813|FG001|Taper Phase|Withdrawal by Subject|1|||
33343474|NCT00813904|62720821|FG000|Overall Study|Death|1|||
33343475|NCT00839956|62720825|FG000|Overall Study|Adverse Event|2|||
33343476|NCT00839956|62720825|FG000|Overall Study|Lack of Efficacy|6|||
33343477|NCT00839956|62720825|FG000|Overall Study|Physician Decision|1|||
33343478|NCT00839956|62720825|FG000|Overall Study|Withdrawal by Subject|3|||
33343479|NCT00839800|62720831|FG000|Overall Study|Adverse Event|8|||
33343480|NCT00839800|62720832|FG001|Overall Study|Adverse Event|12|||
33343481|NCT00839800|62720831|FG000|Overall Study|Lost to Follow-up|31|||
33343482|NCT00839800|62720832|FG001|Overall Study|Lost to Follow-up|26|||
33343483|NCT00839800|62720831|FG000|Overall Study|Withdrawal by Subject|28|||
33343484|NCT00839800|62720832|FG001|Overall Study|Withdrawal by Subject|34|||
33343485|NCT00839800|62720831|FG000|Overall Study|Incorrect Enrolment|3|||
33343486|NCT00839800|62720832|FG001|Overall Study|Incorrect Enrolment|3|||
33343487|NCT00839800|62720831|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
33343488|NCT00839800|62720832|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
33343489|NCT00839800|62720831|FG000|Overall Study|Safety Reasons|2|||
33343490|NCT00839800|62720832|FG001|Overall Study|Safety Reasons|1|||
33343491|NCT00839800|62720831|FG000|Overall Study|Other|8|||
33343492|NCT00839800|62720832|FG001|Overall Study|Other|14|||
33343493|NCT00839800|62720831|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
33343494|NCT00839800|62720832|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
33343495|NCT00753415|62720866|FG000|Part A|Disease progression|1|||
33343496|NCT00753415|62720867|FG001|Part A|Disease progression|0|||
33343497|NCT00753415|62720868|FG002|Part A|Disease progression|1|||
33343498|NCT00753415|62720869|FG003|Part A|Disease progression|2|||
33343499|NCT00753415|62720870|FG004|Part A|Disease progression|0|||
33343500|NCT00753415|62720871|FG005|Part A|Disease progression|0|||
33343501|NCT00753415|62720872|FG006|Part A|Disease progression|0|||
33343502|NCT00753415|62720873|FG007|Part A|Disease progression|0|||
33343503|NCT00753415|62720874|FG008|Part A|Disease progression|0|||
33343504|NCT00753415|62720875|FG009|Part A|Disease progression|0|||
33343505|NCT00753415|62720866|FG000|Part A|Withdrawal by Subject|0|||
33343506|NCT00753415|62720867|FG001|Part A|Withdrawal by Subject|0|||
33343507|NCT00753415|62720868|FG002|Part A|Withdrawal by Subject|1|||
33343508|NCT00753415|62720869|FG003|Part A|Withdrawal by Subject|0|||
33470096|NCT00261833|62843769|FG000|Overall Study|Withdrawal by Subject|5|||
33343509|NCT00753415|62720870|FG004|Part A|Withdrawal by Subject|0|||
33343510|NCT00753415|62720871|FG005|Part A|Withdrawal by Subject|0|||
33343511|NCT00753415|62720872|FG006|Part A|Withdrawal by Subject|0|||
33470097|NCT00261833|62843770|FG001|Overall Study|Withdrawal by Subject|7|||
33343512|NCT00753415|62720873|FG007|Part A|Withdrawal by Subject|0|||
33343513|NCT00753415|62720874|FG008|Part A|Withdrawal by Subject|0|||
33343514|NCT00753415|62720875|FG009|Part A|Withdrawal by Subject|0|||
33343515|NCT00753415|62720866|FG000|Part B|Lost to Follow-up|0|||
33343516|NCT00753415|62720867|FG001|Part B|Lost to Follow-up|0|||
33343517|NCT00753415|62720868|FG002|Part B|Lost to Follow-up|0|||
33343518|NCT00753415|62720869|FG003|Part B|Lost to Follow-up|0|||
33343519|NCT00753415|62720870|FG004|Part B|Lost to Follow-up|0|||
33343520|NCT00753415|62720871|FG005|Part B|Lost to Follow-up|0|||
33343521|NCT00753415|62720872|FG006|Part B|Lost to Follow-up|0|||
33343522|NCT00753415|62720873|FG007|Part B|Lost to Follow-up|1|||
33343523|NCT00753415|62720874|FG008|Part B|Lost to Follow-up|1|||
33343524|NCT00753415|62720875|FG009|Part B|Lost to Follow-up|0|||
33343525|NCT00753415|62720866|FG000|Part B|Disease progression|0|||
33343526|NCT00753415|62720867|FG001|Part B|Disease progression|0|||
33343527|NCT00753415|62720868|FG002|Part B|Disease progression|0|||
33343528|NCT00753415|62720869|FG003|Part B|Disease progression|0|||
33343529|NCT00753415|62720870|FG004|Part B|Disease progression|0|||
33343530|NCT00753415|62720871|FG005|Part B|Disease progression|0|||
33343531|NCT00753415|62720872|FG006|Part B|Disease progression|0|||
33548876|NCT02983617|62940271|FG001|Overall Study|Adverse Event|7|||
33654645|NCT01569074|63067333|FG002|Overall Study|Adverse Event|3|||
33654646|NCT01569074|63067334|FG003|Overall Study|Adverse Event|0|||
33654647|NCT01569074|63067335|FG004|Overall Study|Adverse Event|0|||
33654648|NCT01604408|63067353|FG000|Treatment Period 1|Protocol Violation|0|||
33654649|NCT01604408|63067354|FG001|Treatment Period 1|Protocol Violation|1|||
33654650|NCT01604408|63067353|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33654651|NCT01604408|63067354|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33654652|NCT01604408|63067353|FG000|Treatment Period 2|Protocol Violation|1|||
33654653|NCT01604408|63067354|FG001|Treatment Period 2|Protocol Violation|0|||
33654654|NCT01604408|63067353|FG000|Treatment Period 2|Adverse Event|0|||
33654655|NCT01604408|63067354|FG001|Treatment Period 2|Adverse Event|1|||
33654656|NCT01604408|63067353|FG000|Treatment Period 3|Protocol Violation|1|||
33654657|NCT01604408|63067354|FG001|Treatment Period 3|Protocol Violation|1|||
33654658|NCT01604408|63067353|FG000|Treatment Period 3|Adverse Event|0|||
33654659|NCT01604408|63067354|FG001|Treatment Period 3|Adverse Event|3|||
33654660|NCT01604408|63067353|FG000|Treatment Period 3|Withdrawal by Subject|3|||
33654661|NCT01604408|63067354|FG001|Treatment Period 3|Withdrawal by Subject|1|||
33654662|NCT01604408|63067353|FG000|Treatment Period 3|Sponsor Decision|1|||
33654663|NCT01604408|63067354|FG001|Treatment Period 3|Sponsor Decision|0|||
33654664|NCT01604408|63067353|FG000|Treatment Period 4|Death|1|||
33654665|NCT01604408|63067354|FG001|Treatment Period 4|Death|0|||
33654666|NCT01604408|63067353|FG000|Treatment Period 4|Withdrawal by Subject|2|||
33654667|NCT01604408|63067354|FG001|Treatment Period 4|Withdrawal by Subject|1|||
33654668|NCT01604408|63067353|FG000|Treatment Period 4|Adverse Event|0|||
33654669|NCT01604408|63067354|FG001|Treatment Period 4|Adverse Event|1|||
33654670|NCT01604408|63067353|FG000|Treatment Period 5|Adverse Event|4|||
33654671|NCT01604408|63067354|FG001|Treatment Period 5|Adverse Event|0|||
33654672|NCT01604408|63067353|FG000|Treatment Period 6|Lost to Follow-up|0|||
33654673|NCT01604408|63067354|FG001|Treatment Period 6|Lost to Follow-up|1|||
33654674|NCT01604408|63067353|FG000|Treatment Period 6|Adverse Event|2|||
33654675|NCT01604408|63067354|FG001|Treatment Period 6|Adverse Event|0|||
33654676|NCT01604408|63067353|FG000|Treatment Period 6|Sponsor decision|0|||
33654677|NCT01604408|63067354|FG001|Treatment Period 6|Sponsor decision|1|||
33654678|NCT01604408|63067353|FG000|Observation Period|Adverse Event|1|||
33654679|NCT01604408|63067354|FG001|Observation Period|Adverse Event|1|||
33654680|NCT01604408|63067353|FG000|Observation Period|Withdrawal by Subject|0|||
33654681|NCT01604408|63067354|FG001|Observation Period|Withdrawal by Subject|2|||
33654682|NCT01567826|63067362|FG000|Overall Study|Lost to Follow-up|3|||
33654683|NCT01567826|63067363|FG001|Overall Study|Lost to Follow-up|2|||
33654684|NCT01697462|63067371|FG000|Overall Study|Disease Progression|1|||
33654685|NCT01697462|63067371|FG000|Overall Study|Adverse Event|6|||
33654686|NCT01697462|63067371|FG000|Overall Study|Lost to Follow-up|21|||
33343532|NCT00753415|62720873|FG007|Part B|Disease progression|0|||
33343533|NCT00753415|62720874|FG008|Part B|Disease progression|2|||
33343534|NCT00753415|62720875|FG009|Part B|Disease progression|1|||
33343535|NCT00754741|62720902|FG000|Overall Study|Died or disenrolled|57|||
33343536|NCT00754741|62720903|FG001|Overall Study|Died or disenrolled|69|||
33470098|NCT00261833|62843769|FG000|Overall Study|Protocol Violation|0|||
33470099|NCT00261833|62843770|FG001|Overall Study|Protocol Violation|1|||
33470100|NCT00261833|62843769|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
33470101|NCT00261833|62843770|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
33654687|NCT01697462|63067371|FG000|Overall Study|Withdrawal by Subject|12|||
33654688|NCT01697462|63067371|FG000|Overall Study|Investigator Decision|21|||
33654689|NCT01697462|63067371|FG000|Overall Study|Death|1|||
33654690|NCT01697462|63067371|FG000|Overall Study|Other|10|||
33654691|NCT01697462|63067371|FG000|Overall Study|Missing|5|||
33343537|NCT00754741|62720904|FG002|Overall Study|Died or disenrolled|54|||
33343538|NCT00752791|62720912|FG000|Overall Study|Adverse Event|7|||
33343539|NCT00752791|62720912|FG000|Overall Study|Withdrawal by Subject|1|||
33343540|NCT00752791|62720912|FG000|Overall Study|Physician Decision|1|||
33343541|NCT00752791|62720912|FG000|Overall Study|Death|1|||
33343542|NCT00752791|62720912|FG000|Overall Study|Renal transplant|3|||
33343543|NCT00752791|62720912|FG000|Overall Study|Switched to hemodialysis|2|||
33343544|NCT00752791|62720912|FG000|Overall Study|Protocol deviation|1|||
33343545|NCT00902304|62720923|FG000|Overall Study|Adverse Event|4|||
33343546|NCT00902304|62720924|FG001|Overall Study|Adverse Event|10|||
33343547|NCT00902304|62720925|FG002|Overall Study|Adverse Event|25|||
33343548|NCT00902304|62720923|FG000|Overall Study|Investigator discretion|3|||
33343549|NCT00902304|62720924|FG001|Overall Study|Investigator discretion|5|||
33343550|NCT00902304|62720925|FG002|Overall Study|Investigator discretion|13|||
33343551|NCT00902304|62720923|FG000|Overall Study|Lost to Follow-up|7|||
33343552|NCT00902304|62720924|FG001|Overall Study|Lost to Follow-up|7|||
33343553|NCT00902304|62720925|FG002|Overall Study|Lost to Follow-up|7|||
33343554|NCT00902304|62720923|FG000|Overall Study|Protocol Violation|9|||
33343555|NCT00902304|62720924|FG001|Overall Study|Protocol Violation|18|||
33343556|NCT00902304|62720925|FG002|Overall Study|Protocol Violation|20|||
33343557|NCT00902304|62720923|FG000|Overall Study|Withdrawal by Subject|32|||
33343558|NCT00902304|62720924|FG001|Overall Study|Withdrawal by Subject|22|||
33343559|NCT00902304|62720925|FG002|Overall Study|Withdrawal by Subject|43|||
33343560|NCT00902304|62720923|FG000|Overall Study|includes pregnancy|3|||
33343561|NCT00902304|62720924|FG001|Overall Study|includes pregnancy|9|||
33470102|NCT00261833|62843769|FG000|Overall Study|Lung transplantation|1|||
33470103|NCT00261833|62843770|FG001|Overall Study|Lung transplantation|1|||
33470104|NCT00261833|62843769|FG000|Overall Study|Missing reason|1|||
33470105|NCT00261833|62843770|FG001|Overall Study|Missing reason|0|||
33470106|NCT00261833|62843769|FG000|Overall Study|Not interested in being participant|0|||
33470107|NCT00261833|62843770|FG001|Overall Study|Not interested in being participant|1|||
33470108|NCT03713684|62843781|FG000|Overall Study|Adverse Event|1|||
33470109|NCT03713684|62843782|FG001|Overall Study|Adverse Event|3|||
33470110|NCT03713684|62843783|FG002|Overall Study|Adverse Event|1|||
33470111|NCT03713684|62843784|FG003|Overall Study|Adverse Event|0|||
33343562|NCT00902304|62720925|FG002|Overall Study|includes pregnancy|2|||
33343563|NCT00759109|62720936|FG000|Overall Study|Adverse Event|17|||
33343564|NCT00759109|62720937|FG001|Overall Study|Adverse Event|12|||
33343565|NCT00759109|62720936|FG000|Overall Study|Inability to comply|1|||
33343566|NCT00759109|62720937|FG001|Overall Study|Inability to comply|1|||
33343567|NCT00759109|62720936|FG000|Overall Study|Withdrawal by Subject|9|||
33343568|NCT00759109|62720937|FG001|Overall Study|Withdrawal by Subject|5|||
33343569|NCT00759109|62720936|FG000|Overall Study|Death|4|||
33343570|NCT00759109|62720937|FG001|Overall Study|Death|3|||
33343571|NCT00759109|62720936|FG000|Overall Study|Lost to Follow-up|4|||
33343572|NCT00759109|62720937|FG001|Overall Study|Lost to Follow-up|6|||
33343573|NCT00759109|62720936|FG000|Overall Study|Started new therapy|2|||
33343574|NCT00759109|62720937|FG001|Overall Study|Started new therapy|6|||
33343575|NCT00759109|62720936|FG000|Overall Study|HCV RNA negative|1|||
33343576|NCT00759109|62720937|FG001|Overall Study|HCV RNA negative|0|||
33343577|NCT00759109|62720936|FG000|Overall Study|Participant moved to a different city|0|||
33343578|NCT00759109|62720937|FG001|Overall Study|Participant moved to a different city|1|||
33343579|NCT00759109|62720936|FG000|Overall Study|Participant had a liver transplant|0|||
33343580|NCT00759109|62720937|FG001|Overall Study|Participant had a liver transplant|1|||
33343581|NCT00759109|62720936|FG000|Overall Study|Lost during study|1|||
33343582|NCT00759109|62720937|FG001|Overall Study|Lost during study|0|||
33343583|NCT00759031|62720945|FG000|First Intervention (1 Day)|Physician Decision|1|||
33343584|NCT00759031|62720946|FG001|First Intervention (1 Day)|Physician Decision|0|||
33343585|NCT00759031|62720945|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
33343586|NCT00759031|62720946|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
33343587|NCT00759031|62720945|FG000|First Intervention (1 Day)|Screening failure|1|||
33343588|NCT00759031|62720946|FG001|First Intervention (1 Day)|Screening failure|0|||
33343589|NCT00758485|62720954|FG000|Overall Study|Lost to Follow-up|0|||
33654692|NCT01696994|63067377|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
33654693|NCT01696994|63067378|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
33343590|NCT00758485|62720955|FG001|Overall Study|Lost to Follow-up|1|||
33343591|NCT00758485|62720954|FG000|Overall Study|Not Treated|1|||
33343592|NCT00758485|62720955|FG001|Overall Study|Not Treated|2|||
33343593|NCT00757783|62720964|FG000|Overall Study|Adverse Event|0|||
33343594|NCT00757783|62720965|FG001|Overall Study|Adverse Event|2|||
33343595|NCT00757783|62720964|FG000|Overall Study|Lost to Follow-up|1|||
33343596|NCT00757783|62720965|FG001|Overall Study|Lost to Follow-up|1|||
33343597|NCT00757783|62720964|FG000|Overall Study|Protocol Violation|1|||
33343598|NCT00757783|62720965|FG001|Overall Study|Protocol Violation|0|||
33343599|NCT00757783|62720964|FG000|Overall Study|Withdrawal by Subject|2|||
33343600|NCT00757783|62720965|FG001|Overall Study|Withdrawal by Subject|1|||
33343601|NCT00757783|62720964|FG000|Overall Study|Other|1|||
33343602|NCT00757783|62720965|FG001|Overall Study|Other|2|||
33343603|NCT00757705|62720971|FG000|Overall Study|Adverse Event|19|||
33343604|NCT00757705|62720971|FG000|Overall Study|Lost to Follow-up|16|||
33343605|NCT00757705|62720971|FG000|Overall Study|Withdrawal by Subject|25|||
33343606|NCT00757705|62720971|FG000|Overall Study|Insufficient Response|26|||
33343607|NCT00757705|62720971|FG000|Overall Study|Ineligible to continue|8|||
33343608|NCT00757705|62720971|FG000|Overall Study|Non-compliant|9|||
33343609|NCT00757705|62720971|FG000|Overall Study|Other|18|||
33343610|NCT00757627|62720975|FG000|Overall Study|Adverse Event|15|||
33343611|NCT00757627|62720975|FG000|Overall Study|Lack of Efficacy|10|||
33343612|NCT00757627|62720975|FG000|Overall Study|Lost to Follow-up|28|||
33343613|NCT00757627|62720975|FG000|Overall Study|Withdrawal by Subject|27|||
33343614|NCT00757627|62720975|FG000|Overall Study|Other|1|||
33343615|NCT01023308|62720986|FG000|Overall Study|Abnormal test proceedure results|3|||
33343616|NCT01023308|62720987|FG001|Overall Study|Abnormal test proceedure results|8|||
33343617|NCT01023308|62720986|FG000|Overall Study|Administrative problems|2|||
33343618|NCT01023308|62720987|FG001|Overall Study|Administrative problems|1|||
33343619|NCT01023308|62720986|FG000|Overall Study|Adverse Event|130|||
33343620|NCT01023308|62720987|FG001|Overall Study|Adverse Event|66|||
33343621|NCT01023308|62720986|FG000|Overall Study|Death|21|||
33343622|NCT01023308|62720987|FG001|Overall Study|Death|17|||
33343623|NCT01023308|62720986|FG000|Overall Study|Disease progression|82|||
33343624|NCT01023308|62720987|FG001|Overall Study|Disease progression|153|||
33343625|NCT01023308|62720986|FG000|Overall Study|New Cancer therapy|4|||
33343626|NCT01023308|62720987|FG001|Overall Study|New Cancer therapy|7|||
33343627|NCT01023308|62720986|FG000|Overall Study|Protocol Violation|3|||
33343628|NCT01023308|62720987|FG001|Overall Study|Protocol Violation|4|||
33343629|NCT01023308|62720986|FG000|Overall Study|Untreated|5|||
33343630|NCT01023308|62720987|FG001|Overall Study|Untreated|5|||
33343631|NCT01023308|62720986|FG000|Overall Study|Lost to Follow-up|1|||
33343632|NCT01023308|62720987|FG001|Overall Study|Lost to Follow-up|0|||
33343633|NCT01023308|62720986|FG000|Overall Study|Withdrawal by Subject|34|||
33343634|NCT01023308|62720987|FG001|Overall Study|Withdrawal by Subject|18|||
33343635|NCT01022996|62720993|FG000|Overall Study|Adverse Event|14|||
33343636|NCT01022996|62720993|FG000|Overall Study|Withdrawal by Subject|3|||
33343637|NCT01022996|62720993|FG000|Overall Study|Lost to Follow-up|1|||
33343638|NCT01022996|62720993|FG000|Overall Study|Administrative problems|6|||
33343639|NCT01022996|62720993|FG000|Overall Study|Disease Progression|32|||
33343640|NCT01022996|62720993|FG000|Overall Study|Protocol Violation|1|||
33343641|NCT00757237|62720999|FG000|Overall Study|Lost to Follow-up|0|||
33343642|NCT00757237|62721000|FG001|Overall Study|Lost to Follow-up|1|||
33343643|NCT00757237|62720999|FG000|Overall Study|Protocol Violation|0|||
33343644|NCT00757237|62721000|FG001|Overall Study|Protocol Violation|2|||
33343645|NCT00757237|62720999|FG000|Overall Study|Physician Decision|2|||
33343646|NCT00757237|62721000|FG001|Overall Study|Physician Decision|3|||
33343647|NCT00757237|62720999|FG000|Overall Study|Withdrawal by Subject|8|||
33343648|NCT00757237|62721000|FG001|Overall Study|Withdrawal by Subject|12|||
33343649|NCT00757237|62720999|FG000|Overall Study|Safety or Tolerability|3|||
33343650|NCT00757237|62721000|FG001|Overall Study|Safety or Tolerability|5|||
33343651|NCT00757237|62720999|FG000|Overall Study|Other|0|||
33343652|NCT00757237|62721000|FG001|Overall Study|Other|2|||
33343653|NCT01029392|62721008|FG000|Overall Study|Withdrawal by Subject|18|||
33343654|NCT01029392|62721009|FG001|Overall Study|Withdrawal by Subject|11|||
33343655|NCT01029392|62721008|FG000|Overall Study|Physician Decision|2|||
33343656|NCT01029392|62721009|FG001|Overall Study|Physician Decision|0|||
33343657|NCT00903006|62721021|FG000|Overall Study|Withdrawal by Subject|2|||
33343658|NCT00903006|62721022|FG001|Overall Study|Withdrawal by Subject|0|||
33343659|NCT00903006|62721023|FG002|Overall Study|Withdrawal by Subject|0|||
33343660|NCT00903006|62721024|FG003|Overall Study|Withdrawal by Subject|0|||
33343661|NCT00903006|62721021|FG000|Overall Study|Progressive Disease|0|||
33343662|NCT00903006|62721022|FG001|Overall Study|Progressive Disease|3|||
33654694|NCT01696994|63067377|FG000|Overall Study|Died Before Randomization|1|||
33343663|NCT00903006|62721023|FG002|Overall Study|Progressive Disease|1|||
33343664|NCT00903006|62721024|FG003|Overall Study|Progressive Disease|0|||
33343665|NCT00839332|62721037|FG000|Phase 1|Disease Progression|38|||
33343666|NCT00839332|62721038|FG001|Phase 1|Disease Progression|0|||
33343667|NCT00839332|62721039|FG002|Phase 1|Disease Progression|0|||
33343668|NCT00839332|62721037|FG000|Phase 1|Adverse Event|6|||
33343669|NCT00839332|62721038|FG001|Phase 1|Adverse Event|0|||
33343670|NCT00839332|62721039|FG002|Phase 1|Adverse Event|0|||
33343671|NCT00839332|62721037|FG000|Phase 1|Withdrawal by Subject|4|||
33343672|NCT00839332|62721038|FG001|Phase 1|Withdrawal by Subject|0|||
33343673|NCT00839332|62721039|FG002|Phase 1|Withdrawal by Subject|0|||
33343674|NCT00839332|62721037|FG000|Phase 1|Physician Decision|2|||
33343675|NCT00839332|62721038|FG001|Phase 1|Physician Decision|0|||
33343676|NCT00839332|62721039|FG002|Phase 1|Physician Decision|0|||
33343677|NCT00839332|62721037|FG000|Phase 2|Protocol Violation|0|||
33343678|NCT00839332|62721038|FG001|Phase 2|Protocol Violation|1|||
33343679|NCT00839332|62721039|FG002|Phase 2|Protocol Violation|0|||
33343680|NCT00839332|62721037|FG000|Phase 2|Disease Progression|0|||
33343681|NCT00839332|62721038|FG001|Phase 2|Disease Progression|46|||
33343682|NCT00839332|62721039|FG002|Phase 2|Disease Progression|21|||
33343683|NCT00839332|62721037|FG000|Phase 2|Adverse Event|0|||
33343684|NCT00839332|62721038|FG001|Phase 2|Adverse Event|8|||
33343685|NCT00839332|62721039|FG002|Phase 2|Adverse Event|6|||
33343686|NCT00839332|62721037|FG000|Phase 2|Death|0|||
33343687|NCT00839332|62721038|FG001|Phase 2|Death|4|||
33343688|NCT00839332|62721039|FG002|Phase 2|Death|2|||
33343689|NCT00839332|62721037|FG000|Phase 2|Withdrawal by Subject|0|||
33343690|NCT00839332|62721038|FG001|Phase 2|Withdrawal by Subject|5|||
33343691|NCT00839332|62721039|FG002|Phase 2|Withdrawal by Subject|8|||
33343692|NCT00839332|62721037|FG000|Phase 2|Physician Decision|0|||
33343693|NCT00839332|62721038|FG001|Phase 2|Physician Decision|4|||
33343694|NCT00839332|62721039|FG002|Phase 2|Physician Decision|1|||
33343695|NCT00839332|62721037|FG000|Phase 2|Lost to Follow-up|0|||
33343696|NCT00839332|62721038|FG001|Phase 2|Lost to Follow-up|0|||
33343697|NCT00839332|62721039|FG002|Phase 2|Lost to Follow-up|1|||
33343698|NCT00902850|62721050|FG000|Overall Study|Physician Decision|2|||
33343699|NCT00902850|62721051|FG001|Overall Study|Physician Decision|2|||
33343700|NCT00902538|62721060|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
33343701|NCT00902538|62721061|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
33343702|NCT00902538|62721062|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
33343703|NCT00902538|62721063|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
33343704|NCT00902538|62721064|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
33343705|NCT00902538|62721065|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
33343706|NCT00902538|62721060|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
33343707|NCT00902538|62721061|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
33343708|NCT00902538|62721062|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
33343709|NCT00902538|62721063|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
33343710|NCT00902538|62721064|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
33343711|NCT00902538|62721065|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
33343712|NCT00902538|62721060|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
33343713|NCT00902538|62721061|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
33343714|NCT00902538|62721062|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
33343715|NCT00902538|62721063|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
33343716|NCT00902538|62721064|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
33343717|NCT00902538|62721065|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
33343718|NCT00902538|62721060|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
33343719|NCT00902538|62721061|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
33343720|NCT00902538|62721062|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
33343721|NCT00902538|62721063|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
33343722|NCT00902538|62721064|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
33343723|NCT00902538|62721065|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
33343724|NCT00902538|62721060|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
33343725|NCT00902538|62721061|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
33343726|NCT00902538|62721062|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
33343727|NCT00902538|62721063|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
33343728|NCT00902538|62721064|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
33343729|NCT00902538|62721065|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
33343730|NCT00902538|62721060|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
33343731|NCT00902538|62721061|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
33343732|NCT00902538|62721062|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
33343733|NCT00902538|62721063|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
33343734|NCT00902538|62721064|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
33343735|NCT00902538|62721065|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
33343736|NCT00902538|62721060|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
33343737|NCT00902538|62721061|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
33343738|NCT00902538|62721062|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
33343739|NCT00902538|62721063|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
33343740|NCT00902538|62721064|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
33343741|NCT00902538|62721065|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
33343742|NCT00902538|62721060|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
33343743|NCT00902538|62721061|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
33343744|NCT00902538|62721062|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
33343745|NCT00902538|62721063|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
33343746|NCT00902538|62721064|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
33343747|NCT00902538|62721065|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
33343748|NCT00902538|62721060|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
33343749|NCT00902538|62721061|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
33343750|NCT00902538|62721062|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
33343751|NCT00902538|62721063|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
33343752|NCT00902538|62721064|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
33343753|NCT00902538|62721065|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
33343754|NCT00902538|62721060|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
33343755|NCT00902538|62721061|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
33343756|NCT00902538|62721062|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
33343757|NCT00902538|62721063|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
33343758|NCT00902538|62721064|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
33343759|NCT00902538|62721065|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
33343760|NCT00902538|62721060|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
33343761|NCT00902538|62721061|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
33343762|NCT00902538|62721062|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
33343763|NCT00902538|62721063|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
33343764|NCT00902538|62721064|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
33343765|NCT00902538|62721065|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
33343766|NCT00902538|62721060|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
33343767|NCT00902538|62721061|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
33343768|NCT00902538|62721062|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
33343769|NCT00902538|62721063|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
33343770|NCT00902538|62721064|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
33343771|NCT00902538|62721065|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
33343772|NCT00902538|62721060|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
33343773|NCT00902538|62721061|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
33343774|NCT00902538|62721062|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
33343775|NCT00902538|62721063|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
33654695|NCT01696994|63067378|FG001|Overall Study|Died Before Randomization|2|||
33654696|NCT01696994|63067377|FG000|Overall Study|Died Before ASU (Control)|73|||
33343776|NCT00902538|62721064|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
33343777|NCT00902538|62721065|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
33343778|NCT00902538|62721060|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
33343779|NCT00902538|62721061|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
33343780|NCT00902538|62721062|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
33343781|NCT00902538|62721063|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
33343782|NCT00902538|62721064|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
33343783|NCT00902538|62721065|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
33343784|NCT00902538|62721060|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
33343785|NCT00902538|62721061|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
33343786|NCT00902538|62721062|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
33343787|NCT00902538|62721063|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
33343788|NCT00902538|62721064|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
33343789|NCT00902538|62721065|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
33343790|NCT00902538|62721060|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
33343791|NCT00902538|62721061|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
33343792|NCT00902538|62721062|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
33343793|NCT00902538|62721063|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
33343794|NCT00902538|62721064|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
33343795|NCT00902538|62721065|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
33343796|NCT00902538|62721060|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
33343797|NCT00902538|62721061|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
33343798|NCT00902538|62721062|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
33343799|NCT00902538|62721063|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
33343800|NCT00902538|62721064|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
33343801|NCT00902538|62721065|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
33343802|NCT01036022|62721087|FG000|Overall Study|Adverse Event|1|||
33654697|NCT01696994|63067378|FG001|Overall Study|Died Before ASU (Control)|0|||
33654698|NCT01696994|63067377|FG000|Overall Study|No Ovaries at Baseline|4807|||
33654699|NCT01696994|63067378|FG001|Overall Study|No Ovaries at Baseline|4851|||
33654700|NCT01696994|63067377|FG000|Overall Study|Refused ASU (Control)|311|||
33654701|NCT01696994|63067378|FG001|Overall Study|Refused ASU (Control)|0|||
33654702|NCT01696994|63067377|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
33343803|NCT01036022|62721088|FG001|Overall Study|Adverse Event|3|||
33343804|NCT01036022|62721089|FG002|Overall Study|Adverse Event|2|||
33343805|NCT01036022|62721090|FG003|Overall Study|Adverse Event|1|||
33343806|NCT01036022|62721091|FG004|Overall Study|Adverse Event|0|||
33343807|NCT01036022|62721092|FG005|Overall Study|Adverse Event|2|||
33343808|NCT01036022|62721087|FG000|Overall Study|Lack of Efficacy|1|||
33343809|NCT01036022|62721088|FG001|Overall Study|Lack of Efficacy|1|||
33343810|NCT01036022|62721089|FG002|Overall Study|Lack of Efficacy|1|||
33343811|NCT01036022|62721090|FG003|Overall Study|Lack of Efficacy|0|||
33343812|NCT01036022|62721091|FG004|Overall Study|Lack of Efficacy|1|||
33343813|NCT01036022|62721092|FG005|Overall Study|Lack of Efficacy|1|||
33343814|NCT01036022|62721087|FG000|Overall Study|Physician Decision|0|||
33343815|NCT01036022|62721088|FG001|Overall Study|Physician Decision|0|||
33343816|NCT01036022|62721089|FG002|Overall Study|Physician Decision|1|||
33343817|NCT01036022|62721090|FG003|Overall Study|Physician Decision|0|||
33343818|NCT01036022|62721091|FG004|Overall Study|Physician Decision|0|||
33343819|NCT01036022|62721092|FG005|Overall Study|Physician Decision|0|||
33343820|NCT01036022|62721087|FG000|Overall Study|Withdrawal by Subject|0|||
33343821|NCT01036022|62721088|FG001|Overall Study|Withdrawal by Subject|0|||
33343822|NCT01036022|62721089|FG002|Overall Study|Withdrawal by Subject|0|||
33343823|NCT01036022|62721090|FG003|Overall Study|Withdrawal by Subject|1|||
33343824|NCT01036022|62721091|FG004|Overall Study|Withdrawal by Subject|2|||
33343825|NCT01036022|62721092|FG005|Overall Study|Withdrawal by Subject|0|||
33343826|NCT00752557|62721117|FG000|Overall Study|Withdrawal by Subject|4|||
33343827|NCT00752557|62721118|FG001|Overall Study|Withdrawal by Subject|3|||
33343828|NCT00752557|62721119|FG002|Overall Study|Withdrawal by Subject|3|||
33343829|NCT00752557|62721117|FG000|Overall Study|Unspecified resaons|0|||
33343830|NCT00752557|62721118|FG001|Overall Study|Unspecified resaons|2|||
33343831|NCT00752557|62721119|FG002|Overall Study|Unspecified resaons|2|||
33343832|NCT00752557|62721117|FG000|Overall Study|Lost to Follow-up|1|||
33343833|NCT00752557|62721118|FG001|Overall Study|Lost to Follow-up|0|||
33343834|NCT00752557|62721119|FG002|Overall Study|Lost to Follow-up|1|||
33343835|NCT00747643|62721131|FG000|Overall Study|Withdrawal by Subject|36|||
33343836|NCT00747643|62721132|FG001|Overall Study|Withdrawal by Subject|27|||
33343837|NCT01022762|62721140|FG000|Overall Study|Adverse Event|3|||
33343838|NCT01022762|62721141|FG001|Overall Study|Adverse Event|1|||
33343839|NCT01022762|62721140|FG000|Overall Study|Lack of Efficacy|0|||
33343840|NCT01022762|62721141|FG001|Overall Study|Lack of Efficacy|1|||
33343841|NCT01022762|62721140|FG000|Overall Study|Protocol Violation|7|||
33343842|NCT01022762|62721141|FG001|Overall Study|Protocol Violation|6|||
33343843|NCT01022762|62721140|FG000|Overall Study|Unclassified|12|||
33343844|NCT01022762|62721141|FG001|Overall Study|Unclassified|20|||
33343845|NCT01028378|62721147|FG000|Overall Study|Lost to Follow-up|12|||
33343846|NCT01028378|62721147|FG000|Overall Study|Withdrawal by Subject|1|||
33343847|NCT01028378|62721147|FG000|Overall Study|Adminstrative Reasons|4|||
33343848|NCT00747565|62721153|FG000|Overall Study|Withdrawal by Subject|10|||
33343849|NCT00747565|62721154|FG001|Overall Study|Withdrawal by Subject|6|||
33343850|NCT00747565|62721153|FG000|Overall Study|Lost to Follow-up|4|||
33343851|NCT00747565|62721154|FG001|Overall Study|Lost to Follow-up|1|||
33343852|NCT01028300|62721160|FG000|Overall Study|Study Terminated|4|||
33343853|NCT00752089|62721164|FG000|Overall Study|Adverse Event|1|||
33343854|NCT00752089|62721164|FG000|Overall Study|Protocol Deviation|2|||
33343855|NCT00752089|62721164|FG000|Overall Study|Could not attend visit 9|1|||
33343856|NCT00752089|62721164|FG000|Overall Study|Not capable of wearing partial denture|1|||
33343857|NCT00752089|62721164|FG000|Overall Study|Cannot continue the study|1|||
33343858|NCT00751933|62721175|FG000|Overall Study|Withdrawal by Subject|0|||
33343859|NCT00751933|62721176|FG001|Overall Study|Withdrawal by Subject|1|||
33343860|NCT00751933|62721177|FG002|Overall Study|Withdrawal by Subject|0|||
33343861|NCT00751933|62721178|FG003|Overall Study|Withdrawal by Subject|0|||
33343862|NCT00751933|62721175|FG000|Overall Study|Physician Decision|0|||
33343863|NCT00751933|62721176|FG001|Overall Study|Physician Decision|0|||
33548877|NCT02983617|62940270|FG000|Overall Study|Death|0|||
33548878|NCT02983617|62940271|FG001|Overall Study|Death|1|||
33548879|NCT02983617|62940270|FG000|Overall Study|Investigator's Discretion|0|||
33548880|NCT02983617|62940271|FG001|Overall Study|Investigator's Discretion|1|||
33343864|NCT00751933|62721177|FG002|Overall Study|Physician Decision|1|||
33343865|NCT00751933|62721178|FG003|Overall Study|Physician Decision|1|||
33343866|NCT00751621|62721182|FG000|Overall Study|Adverse Event|1|||
33343867|NCT00751621|62721182|FG000|Overall Study|Withdrawal by Subject|1|||
33343868|NCT00751621|62721182|FG000|Overall Study|Subject moved to another country|1|||
33343869|NCT00751621|62721182|FG000|Overall Study|Poor adherence to asthma treatment|1|||
33343870|NCT01028222|62721190|FG000|Overall Study|Protocol deviation|1|||
33343871|NCT01028222|62721191|FG001|Overall Study|Protocol deviation|0|||
33343872|NCT01028222|62721190|FG000|Overall Study|Disease progression|33|||
33343873|NCT01028222|62721191|FG001|Overall Study|Disease progression|9|||
33343874|NCT01028222|62721190|FG000|Overall Study|Administrative problems|1|||
33343875|NCT01028222|62721191|FG001|Overall Study|Administrative problems|1|||
33343876|NCT01028222|62721190|FG000|Overall Study|Lost to Follow-up|0|||
33343877|NCT01028222|62721191|FG001|Overall Study|Lost to Follow-up|1|||
33548881|NCT02873689|62940279|FG000|Overall Study|Lack of Efficacy|1|||
33343878|NCT01028222|62721190|FG000|Overall Study|Withdrawal by Subject|1|||
33343879|NCT01028222|62721191|FG001|Overall Study|Withdrawal by Subject|0|||
33343880|NCT01028222|62721190|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
33343881|NCT01028222|62721191|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
33343882|NCT01028222|62721190|FG000|Overall Study|Adverse Event|2|||
33343883|NCT01028222|62721191|FG001|Overall Study|Adverse Event|0|||
33343884|NCT00586495|62721198|FG000|Treatment Period|Adverse Event|11|||
33343885|NCT00586495|62721198|FG000|Treatment Period|Death|1|||
33343886|NCT00586495|62721198|FG000|Treatment Period|Protocol Violation|1|||
33343887|NCT00586495|62721198|FG000|Treatment Period|Withdrawal by Subject|1|||
33343888|NCT00586495|62721198|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
33343889|NCT00586495|62721198|FG000|Treatment Period|Switch to commercial drug|10|||
33343890|NCT00586495|62721198|FG000|Follow-up|Death|40|||
33343891|NCT00586495|62721198|FG000|Follow-up|Lost to Follow-up|1|||
33343892|NCT00586495|62721198|FG000|Follow-up|Withdrawal by Subject|4|||
33343893|NCT00586495|62721198|FG000|Follow-up|Protocol driven decision point|37|||
33343894|NCT00586495|62721198|FG000|Follow-up|Switch to commercial drug|10|||
33343895|NCT01027754|62721204|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
33343896|NCT01027754|62721205|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
33343897|NCT01027754|62721204|FG000|Overall Study|Withdrawal by Subject|0|||
33343898|NCT01027754|62721205|FG001|Overall Study|Withdrawal by Subject|5|||
33343899|NCT01034540|62721217|FG000|Overall Study|Adverse Event|0|||
33343900|NCT01034540|62721218|FG001|Overall Study|Adverse Event|1|||
33343901|NCT00774930|62721228|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
33343902|NCT00774930|62721229|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
33343903|NCT00774930|62721228|FG000|DB Phase|Adverse Event|1|||
33343904|NCT00774930|62721229|FG001|DB Phase|Adverse Event|2|||
33343905|NCT00774930|62721228|FG000|DB Phase|Subject Decision|1|||
33343906|NCT00774930|62721229|FG001|DB Phase|Subject Decision|5|||
33343907|NCT00774930|62721228|FG000|DB Phase|Sponsor Decision|0|||
33343908|NCT00774930|62721229|FG001|DB Phase|Sponsor Decision|1|||
33343909|NCT00774930|62721228|FG000|DB Phase|Disease Progression|1|||
33343910|NCT00774930|62721229|FG001|DB Phase|Disease Progression|1|||
33343911|NCT00774930|62721228|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
33343912|NCT00774930|62721229|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
33343913|NCT00774930|62721228|FG000|IOL Phase|Adverse Event|1|||
33343914|NCT00774930|62721229|FG001|IOL Phase|Adverse Event|1|||
33343915|NCT00774930|62721228|FG000|IOL Phase|Subject Decision|4|||
33343916|NCT00774930|62721229|FG001|IOL Phase|Subject Decision|3|||
33343917|NCT00774930|62721228|FG000|IOL Phase|Physician Decision|3|||
33343918|NCT00774930|62721229|FG001|IOL Phase|Physician Decision|2|||
33343919|NCT00774930|62721228|FG000|IOL Phase|Sponsor Decision|1|||
33343920|NCT00774930|62721229|FG001|IOL Phase|Sponsor Decision|0|||
33343921|NCT00774930|62721228|FG000|IOL Phase|Disease Progression|2|||
33343922|NCT00774930|62721229|FG001|IOL Phase|Disease Progression|1|||
33343923|NCT00774930|62721228|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
33343924|NCT00774930|62721229|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
33343925|NCT00774930|62721228|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
33343926|NCT00774930|62721229|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
33343927|NCT00774930|62721228|FG000|IOL Phase|Other|1|||
33343928|NCT00774930|62721229|FG001|IOL Phase|Other|0|||
33343929|NCT00774930|62721228|FG000|IOL Phase|Brain radiation|0|||
33343930|NCT00774930|62721229|FG001|IOL Phase|Brain radiation|1|||
33343931|NCT00774930|62721228|FG000|LTOLE Phase|Adverse Event|7|||
33343932|NCT00774930|62721229|FG001|LTOLE Phase|Adverse Event|3|||
33343933|NCT00774930|62721228|FG000|LTOLE Phase|Subject decision|0|||
33343934|NCT00774930|62721229|FG001|LTOLE Phase|Subject decision|5|||
33343935|NCT00774930|62721228|FG000|LTOLE Phase|Physician Decision|4|||
33343936|NCT00774930|62721229|FG001|LTOLE Phase|Physician Decision|1|||
33343937|NCT00774930|62721228|FG000|LTOLE Phase|Sponsor decision|2|||
33343938|NCT00774930|62721229|FG001|LTOLE Phase|Sponsor decision|1|||
33343939|NCT00774930|62721228|FG000|LTOLE Phase|Disease Progression|2|||
33343940|NCT00774930|62721229|FG001|LTOLE Phase|Disease Progression|5|||
33343941|NCT00774930|62721228|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
33343942|NCT00774930|62721229|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
33343943|NCT00774930|62721228|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
33343944|NCT00774930|62721229|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
33343945|NCT01027364|62721250|FG000|Overall Study|Adverse Event|1|||
33343946|NCT01027364|62721251|FG001|Overall Study|Adverse Event|0|||
33343947|NCT01027364|62721252|FG002|Overall Study|Adverse Event|1|||
33343948|NCT01027364|62721253|FG003|Overall Study|Adverse Event|0|||
33343949|NCT01027364|62721250|FG000|Overall Study|Lost to Follow-up|1|||
33343950|NCT01027364|62721251|FG001|Overall Study|Lost to Follow-up|0|||
33343951|NCT01027364|62721252|FG002|Overall Study|Lost to Follow-up|0|||
33343952|NCT01027364|62721253|FG003|Overall Study|Lost to Follow-up|0|||
33343953|NCT01027364|62721250|FG000|Overall Study|Protocol Violation|1|||
33343954|NCT01027364|62721251|FG001|Overall Study|Protocol Violation|0|||
33343955|NCT01027364|62721252|FG002|Overall Study|Protocol Violation|0|||
33343956|NCT01027364|62721253|FG003|Overall Study|Protocol Violation|1|||
33343957|NCT01027364|62721250|FG000|Overall Study|Withdrawal by Subject|1|||
33343958|NCT01027364|62721251|FG001|Overall Study|Withdrawal by Subject|2|||
33343959|NCT01027364|62721252|FG002|Overall Study|Withdrawal by Subject|0|||
33343960|NCT01027364|62721253|FG003|Overall Study|Withdrawal by Subject|0|||
33343961|NCT01027286|62721281|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
33343962|NCT01027286|62721282|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
33343963|NCT01027286|62721281|FG000|Overall Study|Lost to Follow-up|0|||
33343964|NCT01027286|62721282|FG001|Overall Study|Lost to Follow-up|1|||
33343965|NCT01026974|62721292|FG000|Overall Study|Withdrawal by Subject|0|||
33343966|NCT01026974|62721293|FG001|Overall Study|Withdrawal by Subject|1|||
33343967|NCT01026974|62721294|FG002|Overall Study|Withdrawal by Subject|7|||
33343968|NCT01026974|62721295|FG003|Overall Study|Withdrawal by Subject|2|||
33343969|NCT01026974|62721292|FG000|Overall Study|Lost to Follow-up|1|||
33343970|NCT01026974|62721293|FG001|Overall Study|Lost to Follow-up|1|||
33343971|NCT01026974|62721294|FG002|Overall Study|Lost to Follow-up|4|||
33343972|NCT01026974|62721295|FG003|Overall Study|Lost to Follow-up|0|||
33343973|NCT01026974|62721292|FG000|Overall Study|Adverse Event|0|||
33343974|NCT01026974|62721293|FG001|Overall Study|Adverse Event|0|||
33343975|NCT01026974|62721294|FG002|Overall Study|Adverse Event|0|||
33343976|NCT01026974|62721295|FG003|Overall Study|Adverse Event|1|||
33343977|NCT01026974|62721292|FG000|Overall Study|Inappropriate enrollment|0|||
33343978|NCT01026974|62721293|FG001|Overall Study|Inappropriate enrollment|0|||
33343979|NCT01026974|62721294|FG002|Overall Study|Inappropriate enrollment|1|||
33343980|NCT01026974|62721295|FG003|Overall Study|Inappropriate enrollment|0|||
33343981|NCT00897390|62721310|FG000|Overall Study|Adverse Event|2|||
33343982|NCT00897390|62721310|FG000|Overall Study|No Longer Met Study Criteria|1|||
33343983|NCT00897390|62721310|FG000|Overall Study|Personal Reasons|1|||
33343984|NCT00897390|62721310|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
33343985|NCT01034462|62721323|FG000|Overall Study|Adverse Event|7|||
33343986|NCT01034462|62721324|FG001|Overall Study|Adverse Event|17|||
33343987|NCT01034462|62721323|FG000|Overall Study|Lack of Efficacy|4|||
33343988|NCT01034462|62721324|FG001|Overall Study|Lack of Efficacy|4|||
33343989|NCT01034462|62721323|FG000|Overall Study|Protocol Violation|10|||
33343990|NCT01034462|62721324|FG001|Overall Study|Protocol Violation|7|||
33343991|NCT01034462|62721323|FG000|Overall Study|Withdrawal by Subject|9|||
33343992|NCT01034462|62721324|FG001|Overall Study|Withdrawal by Subject|8|||
33343993|NCT01034462|62721323|FG000|Overall Study|Lost to Follow-up|14|||
33343994|NCT01034462|62721324|FG001|Overall Study|Lost to Follow-up|16|||
33343995|NCT01034462|62721323|FG000|Overall Study|Other reasons|1|||
33343996|NCT01034462|62721324|FG001|Overall Study|Other reasons|2|||
33343997|NCT01033448|62721332|FG000|Overall Study|Withdrawal by Subject|4|||
33343998|NCT01033448|62721332|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
33343999|NCT01033448|62721332|FG000|Overall Study|Lost to Follow-up|3|||
33344000|NCT01033448|62721332|FG000|Overall Study|Withdrew due to other reasons|3|||
33344001|NCT01033448|62721332|FG000|Overall Study|Unknown disposition|1|||
33344002|NCT00746941|62721342|FG000|Overall Study|Death|2|||
33344003|NCT00746941|62721343|FG001|Overall Study|Death|0|||
33344004|NCT00746941|62721344|FG002|Overall Study|Death|0|||
33344005|NCT00746941|62721345|FG003|Overall Study|Death|6|||
33344006|NCT00746941|62721342|FG000|Overall Study|Physician Decision|0|||
33344007|NCT00746941|62721343|FG001|Overall Study|Physician Decision|0|||
33344008|NCT00746941|62721344|FG002|Overall Study|Physician Decision|2|||
33344009|NCT00746941|62721345|FG003|Overall Study|Physician Decision|0|||
33344010|NCT00746941|62721342|FG000|Overall Study|Withdrawal by Subject|3|||
33344011|NCT00746941|62721343|FG001|Overall Study|Withdrawal by Subject|0|||
33344012|NCT00746941|62721344|FG002|Overall Study|Withdrawal by Subject|0|||
33344013|NCT00746941|62721345|FG003|Overall Study|Withdrawal by Subject|2|||
33344014|NCT00746941|62721342|FG000|Overall Study|Other, reason not provided|2|||
33344015|NCT00746941|62721343|FG001|Overall Study|Other, reason not provided|4|||
33344016|NCT00746941|62721344|FG002|Overall Study|Other, reason not provided|0|||
33344017|NCT00746941|62721345|FG003|Overall Study|Other, reason not provided|4|||
33344018|NCT00746941|62721342|FG000|Overall Study|Adverse Event|0|||
33344019|NCT00746941|62721343|FG001|Overall Study|Adverse Event|0|||
33344020|NCT00746941|62721344|FG002|Overall Study|Adverse Event|0|||
33344021|NCT00746941|62721345|FG003|Overall Study|Adverse Event|1|||
33344022|NCT00746785|62721357|FG000|Overall Study|Lost to Follow-up|29|||
33344023|NCT00746785|62721358|FG001|Overall Study|Lost to Follow-up|25|||
33344024|NCT00746785|62721359|FG002|Overall Study|Lost to Follow-up|27|||
33344025|NCT00750919|62721367|FG000|Overall Study|Adverse Event|9|||
33344026|NCT00750919|62721367|FG000|Overall Study|Withdrawal by Subject|1|||
33344027|NCT00750919|62721367|FG000|Overall Study|Lack of Efficacy|8|||
33344028|NCT00750919|62721367|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
33344029|NCT00750919|62721367|FG000|Overall Study|Other|36|||
33344030|NCT00746551|62721373|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
33344031|NCT00746551|62721374|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
33344032|NCT00746551|62721373|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
33344033|NCT00746551|62721374|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
33548882|NCT02873689|62940280|FG001|Overall Study|Lack of Efficacy|0|||
33344034|NCT00746551|62721373|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
33344035|NCT00746551|62721374|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
33344036|NCT00753649|62721382|FG000|Overall Study|Migrated/moved from study area|1|||
33344037|NCT00753649|62721383|FG001|Overall Study|Migrated/moved from study area|0|||
33344038|NCT00753649|62721382|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
33344039|NCT00753649|62721383|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
33344040|NCT00753649|62721382|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
33344041|NCT00753649|62721383|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
33344042|NCT00753649|62721382|FG000|Overall Study|Protocol Violation|2|||
33344043|NCT00753649|62721383|FG001|Overall Study|Protocol Violation|0|||
33344044|NCT00750139|62721393|FG000|Overall Study|Adverse Event|1|||
33344045|NCT00750139|62721394|FG001|Overall Study|Adverse Event|2|||
33344046|NCT00750139|62721395|FG002|Overall Study|Adverse Event|0|||
33344047|NCT00750139|62721396|FG003|Overall Study|Adverse Event|1|||
33344048|NCT00750139|62721393|FG000|Overall Study|Lost to Follow-up|17|||
33344049|NCT00750139|62721394|FG001|Overall Study|Lost to Follow-up|12|||
33344050|NCT00750139|62721395|FG002|Overall Study|Lost to Follow-up|15|||
33344051|NCT00750139|62721396|FG003|Overall Study|Lost to Follow-up|6|||
33344052|NCT00750139|62721393|FG000|Overall Study|Withdrawal by Subject|3|||
33344053|NCT00750139|62721394|FG001|Overall Study|Withdrawal by Subject|2|||
33344054|NCT00750139|62721395|FG002|Overall Study|Withdrawal by Subject|6|||
33344055|NCT00750139|62721396|FG003|Overall Study|Withdrawal by Subject|2|||
33344056|NCT00750139|62721393|FG000|Overall Study|Physician Decision|1|||
33344057|NCT00750139|62721394|FG001|Overall Study|Physician Decision|1|||
33344058|NCT00750139|62721395|FG002|Overall Study|Physician Decision|0|||
33344059|NCT00750139|62721396|FG003|Overall Study|Physician Decision|0|||
33344060|NCT00750139|62721393|FG000|Overall Study|Non-compliance|1|||
33344061|NCT00750139|62721394|FG001|Overall Study|Non-compliance|0|||
33344062|NCT00750139|62721395|FG002|Overall Study|Non-compliance|1|||
33344063|NCT00750139|62721396|FG003|Overall Study|Non-compliance|3|||
33344064|NCT00750139|62721393|FG000|Overall Study|Termination by sponsor|4|||
33344065|NCT00750139|62721394|FG001|Overall Study|Termination by sponsor|0|||
33344066|NCT00750139|62721395|FG002|Overall Study|Termination by sponsor|0|||
33344067|NCT00750139|62721396|FG003|Overall Study|Termination by sponsor|1|||
33344068|NCT00750139|62721393|FG000|Overall Study|Non-specific|62|||
33344069|NCT00750139|62721394|FG001|Overall Study|Non-specific|42|||
33344070|NCT00750139|62721395|FG002|Overall Study|Non-specific|79|||
33344071|NCT00750139|62721396|FG003|Overall Study|Non-specific|33|||
33344072|NCT00750061|62721410|FG000|Overall Study|Adverse Event|2|||
33344073|NCT00750061|62721411|FG001|Overall Study|Adverse Event|0|||
33344074|NCT00750061|62721410|FG000|Overall Study|Withdrawal by Subject|0|||
33344075|NCT00750061|62721411|FG001|Overall Study|Withdrawal by Subject|1|||
33344076|NCT00750061|62721410|FG000|Overall Study|Physician Decision|0|||
33344077|NCT00750061|62721411|FG001|Overall Study|Physician Decision|1|||
33344078|NCT00744757|62721417|FG000|Overall Study|Objective disease progression|7|||
33344079|NCT00744757|62721417|FG000|Overall Study|Physician Decision|5|||
33344080|NCT00744757|62721417|FG000|Overall Study|Withdrawal by Subject|1|||
33344081|NCT00744757|62721417|FG000|Overall Study|Death|6|||
33344082|NCT00744757|62721417|FG000|Overall Study|Adverse Event|2|||
33344083|NCT00745849|62721421|FG000|First Intervention|Withdrawal by Subject|0|||
33344084|NCT00745849|62721422|FG001|First Intervention|Withdrawal by Subject|1|||
33344085|NCT00745849|62721421|FG000|First Intervention|Lost to Follow-up|1|||
33344086|NCT00745849|62721422|FG001|First Intervention|Lost to Follow-up|1|||
33344087|NCT00745849|62721421|FG000|Second Intervention|Lost to Follow-up|2|||
33344088|NCT00745849|62721422|FG001|Second Intervention|Lost to Follow-up|1|||
33344089|NCT00749203|62721439|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
33344090|NCT00749203|62721440|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
33344091|NCT00749203|62721439|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
33344092|NCT00749203|62721440|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
33344093|NCT00749203|62721439|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
33344094|NCT00749203|62721440|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
33344095|NCT00749203|62721439|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
33470112|NCT03713684|62843781|FG000|Overall Study|Poor compliance to protocol|2|||
33344096|NCT00749203|62721440|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
33344097|NCT00749203|62721439|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
33344098|NCT00749203|62721440|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
33344099|NCT00749203|62721439|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
33344100|NCT00749203|62721440|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
33344101|NCT00748969|62721448|FG000|Overall Study|Withdrawal by Subject|1|||
33344102|NCT00748969|62721449|FG001|Overall Study|Withdrawal by Subject|0|||
33344103|NCT00748969|62721448|FG000|Overall Study|Withdrawal by Subject|0|||
33344104|NCT00748969|62721449|FG001|Overall Study|Withdrawal by Subject|1|||
33344105|NCT00745615|62721459|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
33344106|NCT00745615|62721460|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
33344107|NCT00745615|62721461|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
33344108|NCT00745615|62721462|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
33344109|NCT00745615|62721463|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
33344110|NCT00745615|62721464|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
33344111|NCT00745615|62721459|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
33344112|NCT00745615|62721460|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
33344113|NCT00745615|62721461|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
33344114|NCT00745615|62721462|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
33344115|NCT00745615|62721463|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
33344116|NCT00745615|62721464|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
33344117|NCT00745615|62721459|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
33344118|NCT00745615|62721460|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
33344119|NCT00745615|62721461|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
33344120|NCT00745615|62721462|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
33344121|NCT00745615|62721463|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
33344122|NCT00745615|62721464|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
33344123|NCT00745615|62721459|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
33344124|NCT00745615|62721460|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
33344125|NCT00745615|62721461|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
33344126|NCT00745615|62721462|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
33344127|NCT00745615|62721463|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
33344128|NCT00745615|62721464|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
33344129|NCT00745615|62721459|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
33344130|NCT00745615|62721460|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
33344131|NCT00745615|62721461|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
33344132|NCT00745615|62721462|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
33344133|NCT00745615|62721463|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
33344134|NCT00745615|62721464|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
33344135|NCT00745615|62721459|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
33344136|NCT00745615|62721460|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
33344137|NCT00745615|62721461|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
33344138|NCT00745615|62721462|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
33344139|NCT00745615|62721463|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
33344140|NCT00745615|62721464|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
33344141|NCT00745615|62721459|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
33344142|NCT00745615|62721460|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
33344143|NCT00745615|62721461|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
33344144|NCT00745615|62721462|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
33344145|NCT00745615|62721463|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
33344146|NCT00745615|62721464|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
33344147|NCT00745615|62721459|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
33344148|NCT00745615|62721460|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
33344149|NCT00745615|62721461|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
33344150|NCT00745615|62721462|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
33344151|NCT00745615|62721463|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
33344152|NCT00745615|62721464|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
33344153|NCT00745615|62721459|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
33344154|NCT00745615|62721460|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
33344155|NCT00745615|62721461|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
33344156|NCT00745615|62721462|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
33344157|NCT00745615|62721463|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
33344158|NCT00745615|62721464|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
33344159|NCT00745615|62721459|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
33344160|NCT00745615|62721460|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
33344161|NCT00745615|62721461|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
33344162|NCT00745615|62721462|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
33344163|NCT00745615|62721463|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
33344164|NCT00745615|62721464|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
33344165|NCT00745615|62721459|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
33344166|NCT00745615|62721460|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
33344167|NCT00745615|62721461|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
33344168|NCT00745615|62721462|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
33344169|NCT00745615|62721463|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
33344170|NCT00745615|62721464|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
33654703|NCT01696994|63067378|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
33654704|NCT01592240|63067538|FG000|Overall Study|Adverse Event|1|||
33344171|NCT00745615|62721459|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
33344172|NCT00745615|62721460|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
33344173|NCT00745615|62721461|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
33344174|NCT00745615|62721462|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
33344175|NCT00745615|62721463|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
33344176|NCT00745615|62721464|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
33344177|NCT00745615|62721459|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
33344178|NCT00745615|62721460|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
33344179|NCT00745615|62721461|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
33344180|NCT00745615|62721462|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
33344181|NCT00745615|62721463|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
33344182|NCT00745615|62721464|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
33344183|NCT00745615|62721459|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
33344184|NCT00745615|62721460|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
33344185|NCT00745615|62721461|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
33344186|NCT00745615|62721462|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
33344187|NCT00745615|62721463|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
33344188|NCT00745615|62721464|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
33344189|NCT00744523|62721478|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
33344190|NCT00744523|62721479|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
33344191|NCT04517253|62721490|FG000|Overall Study|Adverse Event|1|||
33344192|NCT04517253|62721491|FG001|Overall Study|Adverse Event|0|||
33344193|NCT04517253|62721492|FG002|Overall Study|Adverse Event|0|||
33344194|NCT04517253|62721490|FG000|Overall Study|Death|0|||
33470113|NCT03713684|62843782|FG001|Overall Study|Poor compliance to protocol|1|||
33470114|NCT03713684|62843783|FG002|Overall Study|Poor compliance to protocol|0|||
33470115|NCT03713684|62843784|FG003|Overall Study|Poor compliance to protocol|1|||
33470116|NCT03713684|62843781|FG000|Overall Study|Withdrawal by Subject|14|||
33470117|NCT03713684|62843782|FG001|Overall Study|Withdrawal by Subject|6|||
33470118|NCT03713684|62843783|FG002|Overall Study|Withdrawal by Subject|14|||
33470119|NCT03713684|62843784|FG003|Overall Study|Withdrawal by Subject|16|||
33470120|NCT03713684|62843781|FG000|Overall Study|Other than specified|69|||
33470121|NCT03713684|62843782|FG001|Overall Study|Other than specified|77|||
33470122|NCT03713684|62843783|FG002|Overall Study|Other than specified|73|||
33470123|NCT03713684|62843784|FG003|Overall Study|Other than specified|70|||
33470124|NCT03711266|62843794|FG000|Overall Study|Lost to Follow-up|10|||
33470125|NCT03150862|62843806|FG000|Overall Study|Death|2|||
33470126|NCT03150862|62843807|FG001|Overall Study|Death|7|||
33470127|NCT03150862|62843808|FG002|Overall Study|Death|8|||
33470128|NCT03150862|62843809|FG003|Overall Study|Death|27|||
33470129|NCT03150862|62843810|FG004|Overall Study|Death|4|||
33470130|NCT03150862|62843811|FG005|Overall Study|Death|8|||
33470131|NCT03150862|62843812|FG006|Overall Study|Death|6|||
33470132|NCT03150862|62843813|FG007|Overall Study|Death|21|||
33470133|NCT03150862|62843806|FG000|Overall Study|Withdrawal by Subject|1|||
33470134|NCT03150862|62843807|FG001|Overall Study|Withdrawal by Subject|1|||
33470135|NCT03150862|62843808|FG002|Overall Study|Withdrawal by Subject|0|||
33470136|NCT03150862|62843809|FG003|Overall Study|Withdrawal by Subject|3|||
33470137|NCT03150862|62843810|FG004|Overall Study|Withdrawal by Subject|1|||
33470138|NCT03150862|62843811|FG005|Overall Study|Withdrawal by Subject|1|||
33470139|NCT03150862|62843812|FG006|Overall Study|Withdrawal by Subject|1|||
33470140|NCT03150862|62843813|FG007|Overall Study|Withdrawal by Subject|3|||
33470141|NCT03150862|62843806|FG000|Overall Study|Lost to Follow-up|0|||
33470142|NCT03150862|62843807|FG001|Overall Study|Lost to Follow-up|0|||
33470143|NCT03150862|62843808|FG002|Overall Study|Lost to Follow-up|1|||
33470144|NCT03150862|62843809|FG003|Overall Study|Lost to Follow-up|0|||
33470145|NCT03150862|62843810|FG004|Overall Study|Lost to Follow-up|0|||
33470146|NCT03150862|62843811|FG005|Overall Study|Lost to Follow-up|0|||
33470147|NCT03150862|62843812|FG006|Overall Study|Lost to Follow-up|0|||
33470148|NCT03150862|62843813|FG007|Overall Study|Lost to Follow-up|2|||
33470149|NCT03150862|62843806|FG000|Overall Study|Sponsor's decision|0|||
33470150|NCT03150862|62843807|FG001|Overall Study|Sponsor's decision|0|||
33470151|NCT03150862|62843808|FG002|Overall Study|Sponsor's decision|0|||
33470152|NCT03150862|62843809|FG003|Overall Study|Sponsor's decision|10|||
33548883|NCT02873689|62940279|FG000|Overall Study|Withdrawal by Subject|2|||
33548884|NCT02873689|62940280|FG001|Overall Study|Withdrawal by Subject|2|||
33344195|NCT04517253|62721491|FG001|Overall Study|Death|1|||
33344196|NCT04517253|62721492|FG002|Overall Study|Death|0|||
33470153|NCT03150862|62843810|FG004|Overall Study|Sponsor's decision|3|||
33470154|NCT03150862|62843811|FG005|Overall Study|Sponsor's decision|0|||
33470155|NCT03150862|62843812|FG006|Overall Study|Sponsor's decision|1|||
33470156|NCT03150862|62843813|FG007|Overall Study|Sponsor's decision|1|||
33470157|NCT03150862|62843806|FG000|Overall Study|Change in Methylation status|0|||
33470158|NCT03150862|62843807|FG001|Overall Study|Change in Methylation status|0|||
33548885|NCT02873689|62940279|FG000|Overall Study|Protocol Violation|1|||
33470159|NCT03150862|62843808|FG002|Overall Study|Change in Methylation status|0|||
33470160|NCT03150862|62843809|FG003|Overall Study|Change in Methylation status|0|||
33470161|NCT03150862|62843810|FG004|Overall Study|Change in Methylation status|1|||
33470162|NCT03150862|62843811|FG005|Overall Study|Change in Methylation status|0|||
33470163|NCT03150862|62843812|FG006|Overall Study|Change in Methylation status|0|||
33470164|NCT03150862|62843813|FG007|Overall Study|Change in Methylation status|0|||
33470165|NCT03150862|62843806|FG000|Overall Study|Roll over in to Long Term Extension|0|||
33470166|NCT03150862|62843807|FG001|Overall Study|Roll over in to Long Term Extension|0|||
33470167|NCT03150862|62843808|FG002|Overall Study|Roll over in to Long Term Extension|0|||
33654705|NCT01592240|63067539|FG001|Overall Study|Adverse Event|0|||
33470168|NCT03150862|62843809|FG003|Overall Study|Roll over in to Long Term Extension|0|||
33654706|NCT01592240|63067540|FG002|Overall Study|Adverse Event|0|||
33344197|NCT00744991|62721502|FG000|Overall Study|Progressive Disease|11|||
33344198|NCT00744991|62721502|FG000|Overall Study|Withdrawal by Subject|8|||
33344199|NCT00744991|62721502|FG000|Overall Study|Physician Decision|3|||
33344200|NCT00744991|62721502|FG000|Overall Study|Adverse Event|2|||
33344201|NCT00744991|62721502|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
33344202|NCT00839254|62721526|FG000|Overall Study|Protocol Violation|0|||
33344203|NCT00839254|62721527|FG001|Overall Study|Protocol Violation|1|||
33344204|NCT00839254|62721528|FG002|Overall Study|Protocol Violation|1|||
33344205|NCT00839254|62721529|FG003|Overall Study|Protocol Violation|1|||
33344206|NCT00839254|62721530|FG004|Overall Study|Protocol Violation|0|||
33344207|NCT00839254|62721531|FG005|Overall Study|Protocol Violation|0|||
33344208|NCT00839254|62721532|FG006|Overall Study|Protocol Violation|1|||
33344209|NCT00839254|62721533|FG007|Overall Study|Protocol Violation|2|||
33344210|NCT00839254|62721526|FG000|Overall Study|Physician Decision|0|||
33654707|NCT01592240|63067541|FG003|Overall Study|Adverse Event|1|||
33654708|NCT01592240|63067542|FG004|Overall Study|Adverse Event|1|||
33654709|NCT01592240|63067543|FG005|Overall Study|Adverse Event|0|||
33654710|NCT01592240|63067544|FG006|Overall Study|Adverse Event|0|||
33654711|NCT01592240|63067538|FG000|Overall Study|Death|0|||
33654712|NCT01592240|63067539|FG001|Overall Study|Death|1|||
33654713|NCT01592240|63067540|FG002|Overall Study|Death|0|||
33654714|NCT01592240|63067541|FG003|Overall Study|Death|0|||
33654715|NCT01592240|63067542|FG004|Overall Study|Death|0|||
33344211|NCT00839254|62721527|FG001|Overall Study|Physician Decision|1|||
33344212|NCT00839254|62721528|FG002|Overall Study|Physician Decision|0|||
33344213|NCT00839254|62721529|FG003|Overall Study|Physician Decision|0|||
33344214|NCT00839254|62721530|FG004|Overall Study|Physician Decision|0|||
33344215|NCT00839254|62721531|FG005|Overall Study|Physician Decision|0|||
33344216|NCT00839254|62721532|FG006|Overall Study|Physician Decision|0|||
33344217|NCT00839254|62721533|FG007|Overall Study|Physician Decision|1|||
33344218|NCT00839254|62721526|FG000|Overall Study|Wrong treatment number allocation|0|||
33344219|NCT00839254|62721527|FG001|Overall Study|Wrong treatment number allocation|1|||
33344220|NCT00839254|62721528|FG002|Overall Study|Wrong treatment number allocation|0|||
33344221|NCT00839254|62721529|FG003|Overall Study|Wrong treatment number allocation|0|||
33344222|NCT00839254|62721530|FG004|Overall Study|Wrong treatment number allocation|0|||
33344223|NCT00839254|62721531|FG005|Overall Study|Wrong treatment number allocation|1|||
33344224|NCT00839254|62721532|FG006|Overall Study|Wrong treatment number allocation|0|||
33654716|NCT01592240|63067543|FG005|Overall Study|Death|0|||
33654717|NCT01592240|63067544|FG006|Overall Study|Death|0|||
33344225|NCT00839254|62721533|FG007|Overall Study|Wrong treatment number allocation|0|||
33344226|NCT00839254|62721526|FG000|Overall Study|Adverse Event|12|||
33344227|NCT00839254|62721527|FG001|Overall Study|Adverse Event|6|||
33344228|NCT00839254|62721528|FG002|Overall Study|Adverse Event|3|||
33344229|NCT00839254|62721529|FG003|Overall Study|Adverse Event|5|||
33344230|NCT00839254|62721530|FG004|Overall Study|Adverse Event|2|||
33344231|NCT00839254|62721531|FG005|Overall Study|Adverse Event|1|||
33344232|NCT00839254|62721532|FG006|Overall Study|Adverse Event|0|||
33344233|NCT00839254|62721533|FG007|Overall Study|Adverse Event|1|||
33654718|NCT01592240|63067538|FG000|Overall Study|Lost to Follow-up|1|||
33654719|NCT01592240|63067539|FG001|Overall Study|Lost to Follow-up|3|||
33654720|NCT01592240|63067540|FG002|Overall Study|Lost to Follow-up|1|||
33344234|NCT00839254|62721526|FG000|Overall Study|Withdrawal by Subject|87|||
33470169|NCT03150862|62843810|FG004|Overall Study|Roll over in to Long Term Extension|0|||
33470170|NCT03150862|62843811|FG005|Overall Study|Roll over in to Long Term Extension|0|||
33470171|NCT03150862|62843812|FG006|Overall Study|Roll over in to Long Term Extension|0|||
33470172|NCT03150862|62843813|FG007|Overall Study|Roll over in to Long Term Extension|1|||
33470173|NCT03150862|62843806|FG000|Overall Study|Progressive Disease|0|||
33344235|NCT00839254|62721527|FG001|Overall Study|Withdrawal by Subject|53|||
33344236|NCT00839254|62721528|FG002|Overall Study|Withdrawal by Subject|54|||
33344237|NCT00839254|62721529|FG003|Overall Study|Withdrawal by Subject|32|||
33344238|NCT00839254|62721530|FG004|Overall Study|Withdrawal by Subject|27|||
33344239|NCT00839254|62721531|FG005|Overall Study|Withdrawal by Subject|15|||
33654721|NCT01592240|63067541|FG003|Overall Study|Lost to Follow-up|0|||
33654722|NCT01592240|63067542|FG004|Overall Study|Lost to Follow-up|3|||
33654723|NCT01592240|63067543|FG005|Overall Study|Lost to Follow-up|2|||
33344240|NCT00839254|62721532|FG006|Overall Study|Withdrawal by Subject|22|||
33344241|NCT00839254|62721533|FG007|Overall Study|Withdrawal by Subject|9|||
33344242|NCT00839254|62721526|FG000|Overall Study|Wrong group allocation|0|||
33344243|NCT00839254|62721527|FG001|Overall Study|Wrong group allocation|0|||
33344244|NCT00839254|62721528|FG002|Overall Study|Wrong group allocation|0|||
33344245|NCT00839254|62721529|FG003|Overall Study|Wrong group allocation|0|||
33344246|NCT00839254|62721530|FG004|Overall Study|Wrong group allocation|0|||
33344247|NCT00839254|62721531|FG005|Overall Study|Wrong group allocation|0|||
33344248|NCT00839254|62721532|FG006|Overall Study|Wrong group allocation|1|||
33344249|NCT00839254|62721533|FG007|Overall Study|Wrong group allocation|0|||
33344250|NCT00839254|62721526|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
33344251|NCT00839254|62721527|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
33344252|NCT00839254|62721528|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
33344253|NCT00839254|62721529|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
33344254|NCT00839254|62721530|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
33344255|NCT00839254|62721531|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
33344256|NCT00839254|62721532|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
33344257|NCT00839254|62721533|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
33344258|NCT00839254|62721526|FG000|Overall Study|Withdrawn due to non-compliance|2|||
33344259|NCT00839254|62721527|FG001|Overall Study|Withdrawn due to non-compliance|0|||
33344260|NCT00839254|62721528|FG002|Overall Study|Withdrawn due to non-compliance|0|||
33344261|NCT00839254|62721529|FG003|Overall Study|Withdrawn due to non-compliance|0|||
33344262|NCT00839254|62721530|FG004|Overall Study|Withdrawn due to non-compliance|0|||
33344263|NCT00839254|62721531|FG005|Overall Study|Withdrawn due to non-compliance|0|||
33344264|NCT00839254|62721532|FG006|Overall Study|Withdrawn due to non-compliance|0|||
33344265|NCT00839254|62721533|FG007|Overall Study|Withdrawn due to non-compliance|0|||
33344266|NCT00839254|62721526|FG000|Overall Study|Lost to Follow-up|51|||
33344267|NCT00839254|62721527|FG001|Overall Study|Lost to Follow-up|30|||
33344268|NCT00839254|62721528|FG002|Overall Study|Lost to Follow-up|32|||
33344269|NCT00839254|62721529|FG003|Overall Study|Lost to Follow-up|24|||
33344270|NCT00839254|62721530|FG004|Overall Study|Lost to Follow-up|8|||
33344271|NCT00839254|62721531|FG005|Overall Study|Lost to Follow-up|8|||
33344272|NCT00839254|62721532|FG006|Overall Study|Lost to Follow-up|4|||
33344273|NCT00839254|62721533|FG007|Overall Study|Lost to Follow-up|2|||
33344274|NCT00586339|62721585|FG000|Overall Study|Withdrawal by Subject|1|||
33344275|NCT00586339|62721586|FG001|Overall Study|Withdrawal by Subject|3|||
33344276|NCT00586339|62721587|FG002|Overall Study|Withdrawal by Subject|1|||
33344277|NCT00586339|62721585|FG000|Overall Study|Migrated/moved from study area|3|||
33344278|NCT00586339|62721586|FG001|Overall Study|Migrated/moved from study area|2|||
33344279|NCT00586339|62721587|FG002|Overall Study|Migrated/moved from study area|4|||
33344280|NCT00586339|62721585|FG000|Overall Study|Lost to Follow-up|3|||
33344281|NCT00586339|62721586|FG001|Overall Study|Lost to Follow-up|2|||
33344282|NCT00586339|62721587|FG002|Overall Study|Lost to Follow-up|1|||
33344283|NCT00812968|62721595|FG000|Overall Study|Relapse after erythroid response|6|||
33344284|NCT00812968|62721595|FG000|Overall Study|Disease progression|1|||
33344285|NCT00812968|62721595|FG000|Overall Study|No further treatment required|1|||
33344286|NCT00812968|62721595|FG000|Overall Study|Study closed due to marketing approval|3|||
33344287|NCT00839098|62721604|FG000|Overall Study|Withdrawal by Subject|2|||
33344288|NCT00839098|62721605|FG001|Overall Study|Withdrawal by Subject|1|||
33344289|NCT00839098|62721606|FG002|Overall Study|Withdrawal by Subject|7|||
33344290|NCT00813748|62721616|FG000|Skin Test Substudy|Physician Decision|0|||
33344291|NCT00813748|62721617|FG001|Skin Test Substudy|Physician Decision|1|||
33344292|NCT00813592|62721625|FG000|Overall Study|Disease assessment was not completed per|2|||
33344293|NCT00813358|62721630|FG000|Overall Study|Death|32|||
33344294|NCT00813358|62721630|FG000|Overall Study|Lost to Follow-up|12|||
33344295|NCT00813358|62721630|FG000|Overall Study|other endpoints|5|||
33344296|NCT00813358|62721630|FG000|Overall Study|Withdrawal by Subject|20|||
33344297|NCT00812812|62721636|FG000|Overall Study|Adverse Event|2|||
33344298|NCT00812812|62721637|FG001|Overall Study|Adverse Event|1|||
33344299|NCT00812812|62721636|FG000|Overall Study|Lack of Efficacy|1|||
33344300|NCT00812812|62721637|FG001|Overall Study|Lack of Efficacy|0|||
33344301|NCT00812812|62721636|FG000|Overall Study|Lost to Follow-up|0|||
33344302|NCT00812812|62721637|FG001|Overall Study|Lost to Follow-up|1|||
33344303|NCT00812812|62721636|FG000|Overall Study|Withdrawal by Subject|0|||
33344304|NCT00812812|62721637|FG001|Overall Study|Withdrawal by Subject|2|||
33344305|NCT00810082|62721647|FG000|Overall Study|Lost to Follow-up|0|||
33470174|NCT03150862|62843807|FG001|Overall Study|Progressive Disease|0|||
33470175|NCT03150862|62843808|FG002|Overall Study|Progressive Disease|0|||
33548886|NCT02873689|62940280|FG001|Overall Study|Protocol Violation|0|||
33344306|NCT00810082|62721648|FG001|Overall Study|Lost to Follow-up|4|||
33344307|NCT00748189|62721656|FG000|Overall Study|Death|99|||
33344308|NCT00748189|62721657|FG001|Overall Study|Death|84|||
33344309|NCT00748189|62721656|FG000|Overall Study|Withdrawal by Subject|23|||
33344310|NCT00748189|62721657|FG001|Overall Study|Withdrawal by Subject|29|||
33344311|NCT00748189|62721656|FG000|Overall Study|Physician Decision|16|||
33470176|NCT03150862|62843809|FG003|Overall Study|Progressive Disease|0|||
33344312|NCT00748189|62721657|FG001|Overall Study|Physician Decision|5|||
33344313|NCT00748189|62721656|FG000|Overall Study|Lost to Follow-up|8|||
33344314|NCT00748189|62721657|FG001|Overall Study|Lost to Follow-up|15|||
33344315|NCT00748189|62721656|FG000|Overall Study|Study terminated by Sponsor|70|||
33344316|NCT00748189|62721657|FG001|Overall Study|Study terminated by Sponsor|79|||
33344317|NCT00744055|62721670|FG000|Overall Study|Withdrawal by Subject|6|||
33344318|NCT00744055|62721671|FG001|Overall Study|Withdrawal by Subject|9|||
33344319|NCT00744055|62721670|FG000|Overall Study|Lack of Efficacy|0|||
33344320|NCT00744055|62721671|FG001|Overall Study|Lack of Efficacy|1|||
33344321|NCT00744055|62721670|FG000|Overall Study|Physician Decision|0|||
33344322|NCT00744055|62721671|FG001|Overall Study|Physician Decision|2|||
33344323|NCT00744055|62721670|FG000|Overall Study|Protocol Violation|1|||
33344324|NCT00744055|62721671|FG001|Overall Study|Protocol Violation|1|||
33344325|NCT00744055|62721670|FG000|Overall Study|Lost to Follow-up|0|||
33344326|NCT00744055|62721671|FG001|Overall Study|Lost to Follow-up|1|||
33344327|NCT00748033|62721679|FG000|Overall Study|Adverse Event|0|||
33344328|NCT00748033|62721680|FG001|Overall Study|Adverse Event|1|||
33344329|NCT00735553|62721697|FG000|Overall Study|Study prematurely terminated|77|||
33344330|NCT00740779|62721708|FG000|Overall Study|Adverse Event|4|||
33344331|NCT00740779|62721709|FG001|Overall Study|Adverse Event|6|||
33470177|NCT03150862|62843810|FG004|Overall Study|Progressive Disease|0|||
33470178|NCT03150862|62843811|FG005|Overall Study|Progressive Disease|0|||
33470179|NCT03150862|62843812|FG006|Overall Study|Progressive Disease|0|||
33470180|NCT03150862|62843813|FG007|Overall Study|Progressive Disease|2|||
33470181|NCT00260429|62843842|FG000|Overall Study|failure to follow appointments|1|||
33470182|NCT00260429|62843843|FG001|Overall Study|failure to follow appointments|0|||
33470183|NCT00260429|62843842|FG000|Overall Study|scheduled hand surgery|1|||
33470184|NCT00260429|62843843|FG001|Overall Study|scheduled hand surgery|0|||
33470185|NCT00379288|62843853|FG000|Overall Study|Adverse Event|5|||
33470186|NCT00379288|62843854|FG001|Overall Study|Adverse Event|6|||
33470187|NCT00379288|62843855|FG002|Overall Study|Adverse Event|2|||
33470188|NCT00379288|62843856|FG003|Overall Study|Adverse Event|0|||
33470189|NCT00379288|62843853|FG000|Overall Study|Treatment Failure|0|||
33470190|NCT00379288|62843854|FG001|Overall Study|Treatment Failure|1|||
33470191|NCT00379288|62843855|FG002|Overall Study|Treatment Failure|0|||
33470192|NCT00379288|62843856|FG003|Overall Study|Treatment Failure|1|||
33470193|NCT00379288|62843853|FG000|Overall Study|Lost to Follow-up|3|||
33470194|NCT00379288|62843854|FG001|Overall Study|Lost to Follow-up|3|||
33470195|NCT00379288|62843855|FG002|Overall Study|Lost to Follow-up|2|||
33470196|NCT00379288|62843856|FG003|Overall Study|Lost to Follow-up|0|||
33470197|NCT00379288|62843853|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
33470198|NCT00379288|62843854|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
33470199|NCT00379288|62843855|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
33470200|NCT00379288|62843856|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
33470201|NCT00379288|62843853|FG000|Overall Study|Subject withdrew-related to study drug|1|||
33470202|NCT00379288|62843854|FG001|Overall Study|Subject withdrew-related to study drug|0|||
33470203|NCT00379288|62843855|FG002|Overall Study|Subject withdrew-related to study drug|0|||
33470204|NCT00379288|62843856|FG003|Overall Study|Subject withdrew-related to study drug|1|||
33470205|NCT00379288|62843853|FG000|Overall Study|Noncompliance with protocol|8|||
33470206|NCT00379288|62843854|FG001|Overall Study|Noncompliance with protocol|6|||
33548887|NCT02873689|62940279|FG000|Overall Study|Adverse Event|2|||
33548888|NCT02873689|62940280|FG001|Overall Study|Adverse Event|2|||
33344332|NCT00740779|62721710|FG002|Overall Study|Adverse Event|3|||
33344333|NCT00740779|62721708|FG000|Overall Study|Protocol Violation|1|||
33344334|NCT00740779|62721709|FG001|Overall Study|Protocol Violation|1|||
33344335|NCT00740779|62721710|FG002|Overall Study|Protocol Violation|1|||
33344336|NCT00740779|62721708|FG000|Overall Study|Lack of Efficacy|0|||
33344337|NCT00740779|62721709|FG001|Overall Study|Lack of Efficacy|0|||
33344338|NCT00740779|62721710|FG002|Overall Study|Lack of Efficacy|2|||
33470207|NCT00379288|62843855|FG002|Overall Study|Noncompliance with protocol|2|||
33470208|NCT00379288|62843856|FG003|Overall Study|Noncompliance with protocol|1|||
33470209|NCT00379288|62843853|FG000|Overall Study|Did not meet protocol eligibility|0|||
33470210|NCT00379288|62843854|FG001|Overall Study|Did not meet protocol eligibility|1|||
33470211|NCT00379288|62843855|FG002|Overall Study|Did not meet protocol eligibility|0|||
33470212|NCT00379288|62843856|FG003|Overall Study|Did not meet protocol eligibility|2|||
33470213|NCT00379288|62843853|FG000|Overall Study|Administrative|2|||
33470214|NCT00379288|62843854|FG001|Overall Study|Administrative|2|||
33470215|NCT00379288|62843855|FG002|Overall Study|Administrative|0|||
33470216|NCT00379288|62843856|FG003|Overall Study|Administrative|1|||
33470217|NCT00243503|62843866|FG000|Overall Study|Adverse Event|11|||
33470218|NCT00243503|62843866|FG000|Overall Study|Withdrawal by Subject|1|||
33470219|NCT00243503|62843866|FG000|Overall Study|Lack of Efficacy|44|||
33344339|NCT00740779|62721708|FG000|Overall Study|Withdrawal by Subject|2|||
33470220|NCT00243503|62843866|FG000|Overall Study|Death|1|||
33470221|NCT00243503|62843866|FG000|Overall Study|Other|1|||
33470222|NCT00239837|62843873|FG000|Overall Study|Lost to Follow-up|3|||
33470223|NCT00239837|62843874|FG001|Overall Study|Lost to Follow-up|7|||
33344340|NCT00740779|62721709|FG001|Overall Study|Withdrawal by Subject|4|||
33344341|NCT00740779|62721710|FG002|Overall Study|Withdrawal by Subject|2|||
33344342|NCT00740779|62721708|FG000|Overall Study|Lost to Follow-up|2|||
33344343|NCT00740779|62721709|FG001|Overall Study|Lost to Follow-up|3|||
33344344|NCT00740779|62721710|FG002|Overall Study|Lost to Follow-up|5|||
33344345|NCT00735475|62721720|FG000|Overall Study|Adverse Event|0|||
33344346|NCT00735475|62721721|FG001|Overall Study|Adverse Event|1|||
33344347|NCT00735475|62721720|FG000|Overall Study|Death|1|||
33344348|NCT00735475|62721721|FG001|Overall Study|Death|1|||
33344349|NCT00735475|62721720|FG000|Overall Study|Lost to Follow-up|3|||
33344350|NCT00735475|62721721|FG001|Overall Study|Lost to Follow-up|3|||
33344351|NCT00735475|62721720|FG000|Overall Study|Physician Decision|0|||
33344352|NCT00735475|62721721|FG001|Overall Study|Physician Decision|1|||
33344353|NCT00735475|62721720|FG000|Overall Study|Withdrawal by Subject|4|||
33344354|NCT00735475|62721721|FG001|Overall Study|Withdrawal by Subject|5|||
33344355|NCT01026818|62721730|FG000|Screening Period|Entry Criteria Not Met|105|||
33344356|NCT01026818|62721731|FG001|Screening Period|Entry Criteria Not Met|0|||
33344357|NCT01026818|62721732|FG002|Screening Period|Entry Criteria Not Met|0|||
33344358|NCT01026818|62721733|FG003|Screening Period|Entry Criteria Not Met|0|||
33344359|NCT01026818|62721730|FG000|Screening Period|Withdrawal by Subject|49|||
33344360|NCT01026818|62721731|FG001|Screening Period|Withdrawal by Subject|0|||
33344361|NCT01026818|62721732|FG002|Screening Period|Withdrawal by Subject|0|||
33344362|NCT01026818|62721733|FG003|Screening Period|Withdrawal by Subject|0|||
33344363|NCT01026818|62721730|FG000|Screening Period|Protocol Deviation|3|||
33344364|NCT01026818|62721731|FG001|Screening Period|Protocol Deviation|0|||
33344365|NCT01026818|62721732|FG002|Screening Period|Protocol Deviation|0|||
33344366|NCT01026818|62721733|FG003|Screening Period|Protocol Deviation|0|||
33344367|NCT01026818|62721730|FG000|Screening Period|Adverse Event|2|||
33344368|NCT01026818|62721731|FG001|Screening Period|Adverse Event|0|||
33344369|NCT01026818|62721732|FG002|Screening Period|Adverse Event|0|||
33344370|NCT01026818|62721733|FG003|Screening Period|Adverse Event|0|||
33344371|NCT01026818|62721730|FG000|Screening Period|Physician Decision|1|||
33344372|NCT01026818|62721731|FG001|Screening Period|Physician Decision|0|||
33344373|NCT01026818|62721732|FG002|Screening Period|Physician Decision|0|||
33344374|NCT01026818|62721733|FG003|Screening Period|Physician Decision|0|||
33344375|NCT01026818|62721730|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
33344376|NCT01026818|62721731|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
33344377|NCT01026818|62721732|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
33344378|NCT01026818|62721733|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
33344379|NCT01026818|62721730|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
33344380|NCT01026818|62721731|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
33344381|NCT01026818|62721732|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
33344382|NCT01026818|62721733|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
33344383|NCT01026818|62721730|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
33344384|NCT01026818|62721731|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
33344385|NCT01026818|62721732|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
33344386|NCT01026818|62721733|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
33344387|NCT01026818|62721730|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
33344388|NCT01026818|62721731|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
33344389|NCT01026818|62721732|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
33344390|NCT01026818|62721733|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
33344391|NCT01026818|62721730|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
33344392|NCT01026818|62721731|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
33344393|NCT01026818|62721732|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
33344394|NCT01026818|62721733|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
33344395|NCT01026818|62721730|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
33344396|NCT01026818|62721731|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
33548889|NCT02873689|62940279|FG000|Overall Study|Randomized but not Treated|1|||
33548890|NCT02873689|62940280|FG001|Overall Study|Randomized but not Treated|1|||
33548891|NCT02901431|62940294|FG000|PK Part|Adverse Event|0|||
33548892|NCT02901431|62940295|FG001|PK Part|Adverse Event|1|||
33548893|NCT02901431|62940296|FG002|PK Part|Adverse Event|0|||
33548894|NCT02901431|62940297|FG003|PK Part|Adverse Event|0|||
33548895|NCT02901431|62940298|FG004|PK Part|Adverse Event|0|||
33548896|NCT02901431|62940299|FG005|PK Part|Adverse Event|0|||
33548897|NCT02901431|62940300|FG006|PK Part|Adverse Event|0|||
33548898|NCT02901431|62940301|FG007|PK Part|Adverse Event|0|||
33344397|NCT01026818|62721732|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
33344398|NCT01026818|62721733|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
33344399|NCT01026818|62721730|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
33344400|NCT01026818|62721731|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
33344401|NCT01026818|62721732|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
33548899|NCT02901431|62940302|FG008|PK Part|Adverse Event|0|||
33548900|NCT02901431|62940303|FG009|PK Part|Adverse Event|0|||
33344402|NCT01026818|62721733|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
33344403|NCT01026818|62721730|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
33344404|NCT01026818|62721731|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
33344405|NCT01026818|62721732|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
33344406|NCT01026818|62721733|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
33344407|NCT01026818|62721730|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
33344408|NCT01026818|62721731|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
33344409|NCT01026818|62721732|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
33344410|NCT01026818|62721733|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
33344411|NCT01026818|62721730|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
33344412|NCT01026818|62721731|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
33344413|NCT01026818|62721732|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
33344414|NCT01026818|62721733|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
33344415|NCT01026818|62721730|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
33344416|NCT01026818|62721731|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
33344417|NCT01026818|62721732|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
33344418|NCT01026818|62721733|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
33344419|NCT01026818|62721730|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
33344420|NCT01026818|62721731|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
33344421|NCT01026818|62721732|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
33344422|NCT01026818|62721733|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
33344423|NCT01026818|62721730|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
33344424|NCT01026818|62721731|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
33344425|NCT01026818|62721732|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
33344426|NCT01026818|62721733|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
33344427|NCT01026818|62721730|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
33344428|NCT01026818|62721731|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
33344429|NCT01026818|62721732|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
33344430|NCT01026818|62721733|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
33344431|NCT01026818|62721730|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
33344432|NCT01026818|62721731|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
33344433|NCT01026818|62721732|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
33344434|NCT01026818|62721733|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
33344435|NCT01026818|62721730|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
33344436|NCT01026818|62721731|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
33344437|NCT01026818|62721732|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
33344438|NCT01026818|62721733|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
33344439|NCT01026818|62721730|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
33344440|NCT01026818|62721731|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
33344441|NCT01026818|62721732|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
33654724|NCT01592240|63067544|FG006|Overall Study|Lost to Follow-up|0|||
33654725|NCT01592240|63067538|FG000|Overall Study|Protocol Violation|0|||
33654726|NCT01592240|63067539|FG001|Overall Study|Protocol Violation|0|||
33654727|NCT01592240|63067540|FG002|Overall Study|Protocol Violation|0|||
33654728|NCT01592240|63067541|FG003|Overall Study|Protocol Violation|0|||
33654729|NCT01592240|63067542|FG004|Overall Study|Protocol Violation|0|||
33654730|NCT01592240|63067543|FG005|Overall Study|Protocol Violation|1|||
33654731|NCT01592240|63067544|FG006|Overall Study|Protocol Violation|0|||
33654732|NCT01592240|63067538|FG000|Overall Study|Withdrawal by Subject|0|||
33654733|NCT01592240|63067539|FG001|Overall Study|Withdrawal by Subject|4|||
33654734|NCT01592240|63067540|FG002|Overall Study|Withdrawal by Subject|4|||
33654735|NCT01592240|63067541|FG003|Overall Study|Withdrawal by Subject|1|||
33654736|NCT01592240|63067542|FG004|Overall Study|Withdrawal by Subject|3|||
33654737|NCT01592240|63067543|FG005|Overall Study|Withdrawal by Subject|0|||
33654738|NCT01592240|63067544|FG006|Overall Study|Withdrawal by Subject|2|||
33654739|NCT01592240|63067538|FG000|Overall Study|Other|0|||
33654740|NCT01592240|63067539|FG001|Overall Study|Other|3|||
33344442|NCT01026818|62721733|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
33344443|NCT01026818|62721730|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
33344444|NCT01026818|62721731|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
33344445|NCT01026818|62721732|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
33344446|NCT01026818|62721733|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
33344447|NCT01026818|62721730|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
33654741|NCT01592240|63067540|FG002|Overall Study|Other|1|||
33654742|NCT01592240|63067541|FG003|Overall Study|Other|1|||
33654743|NCT01592240|63067542|FG004|Overall Study|Other|0|||
33344448|NCT01026818|62721731|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
33654744|NCT01592240|63067543|FG005|Overall Study|Other|0|||
33654745|NCT01592240|63067544|FG006|Overall Study|Other|1|||
33654746|NCT01592240|63067538|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
33344449|NCT01026818|62721732|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
33344450|NCT01026818|62721733|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
33344451|NCT00735397|62721745|FG000|Overall Study|Adverse Event|194|||
33344452|NCT00735397|62721745|FG000|Overall Study|Lost to Follow-up|33|||
33344453|NCT00735397|62721745|FG000|Overall Study|Participant choice|252|||
33344454|NCT00735397|62721745|FG000|Overall Study|Inadequate therapeutic effect|202|||
33344455|NCT00735397|62721745|FG000|Overall Study|Administrative/Other|502|||
33344456|NCT00735007|62721752|FG000|Overall Study|Adverse Event|4|||
33344457|NCT00735007|62721752|FG000|Overall Study|Protocol Violation|1|||
33344458|NCT00743509|62721756|FG000|Overall Study|Withdrawal by Subject|2|||
33344459|NCT00734929|62721762|FG000|Overall Study|Lost to Follow-up|1|||
33344460|NCT00734929|62721763|FG001|Overall Study|Lost to Follow-up|2|||
33344461|NCT00734929|62721762|FG000|Overall Study|No intervention/ screen fail|5|||
33344462|NCT00734929|62721763|FG001|Overall Study|No intervention/ screen fail|3|||
33344463|NCT00734851|62721771|FG000|Overall Study|Withdrawal by Subject|2|||
33344464|NCT00734851|62721771|FG000|Overall Study|Lost to Follow-up|1|||
33344465|NCT00734851|62721771|FG000|Overall Study|Physician Decision|18|||
33344466|NCT00734617|62721777|FG000|Overall Study|Adverse Event|4|||
33344467|NCT00734617|62721778|FG001|Overall Study|Adverse Event|7|||
33344468|NCT00734617|62721777|FG000|Overall Study|Withdrawal by Subject|103|||
33344469|NCT00734617|62721778|FG001|Overall Study|Withdrawal by Subject|95|||
33344470|NCT00743431|62721784|FG000|Overall Study|Toxicity|6|||
33344471|NCT00743431|62721784|FG000|Overall Study|Tumor progression|56|||
33344472|NCT00743431|62721784|FG000|Overall Study|Withdrawal by Subject|13|||
33344473|NCT00743431|62721784|FG000|Overall Study|Death|9|||
33344474|NCT00743431|62721784|FG000|Overall Study|Reason for discontinuation not specified|29|||
33344475|NCT00743431|62721784|FG000|Overall Study|No documentation available|13|||
33344476|NCT00734539|62721790|FG000|Main Study|Death|33|||
33344477|NCT00734539|62721791|FG001|Main Study|Death|32|||
33344478|NCT00734539|62721790|FG000|Main Study|Physician Decision|2|||
33344479|NCT00734539|62721791|FG001|Main Study|Physician Decision|0|||
33344480|NCT00734539|62721790|FG000|Main Study|Withdrawal by Subject|1|||
33344481|NCT00734539|62721791|FG001|Main Study|Withdrawal by Subject|3|||
33344482|NCT00734539|62721790|FG000|Main Study|Enrolled in error; ineligible|1|||
33344483|NCT00734539|62721791|FG001|Main Study|Enrolled in error; ineligible|0|||
33344484|NCT00743275|62721802|FG000|Overall Study|Protocol Violation|0|||
33344485|NCT00743275|62721803|FG001|Overall Study|Protocol Violation|1|||
33344486|NCT00734149|62721809|FG000|Overall Study|Withdrawal by Subject|1|||
33344487|NCT00743197|62721817|FG000|Overall Study|Study terminated due to departure of PI.|1|||
33344488|NCT00743197|62721818|FG001|Overall Study|Study terminated due to departure of PI.|2|||
33344489|NCT00734071|62721826|FG000|Overall Study|Adverse Event|4|||
33344490|NCT00734071|62721827|FG001|Overall Study|Adverse Event|3|||
33344491|NCT00734071|62721826|FG000|Overall Study|Lack of Efficacy|3|||
33344492|NCT00734071|62721827|FG001|Overall Study|Lack of Efficacy|1|||
33344493|NCT00734071|62721826|FG000|Overall Study|Noncompliance|2|||
33344494|NCT00734071|62721827|FG001|Overall Study|Noncompliance|2|||
33344495|NCT00734071|62721826|FG000|Overall Study|Protocol Deviations|3|||
33344496|NCT00734071|62721827|FG001|Overall Study|Protocol Deviations|4|||
33344497|NCT00734071|62721826|FG000|Overall Study|Voluntary Withdrawal|9|||
33344498|NCT00734071|62721827|FG001|Overall Study|Voluntary Withdrawal|7|||
33344499|NCT00734071|62721826|FG000|Overall Study|Lost to Follow-up|16|||
33344500|NCT00734071|62721827|FG001|Overall Study|Lost to Follow-up|8|||
33344501|NCT00734071|62721826|FG000|Overall Study|Other|1|||
33344502|NCT00734071|62721827|FG001|Overall Study|Other|2|||
33344503|NCT00739297|62721833|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
33344504|NCT00739297|62721834|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
33344505|NCT00739297|62721835|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
33344506|NCT00739297|62721836|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
33344507|NCT00739297|62721837|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
33344508|NCT00739297|62721838|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
33344509|NCT00739297|62721839|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
33344510|NCT00739297|62721833|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
33344511|NCT00739297|62721834|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
33344512|NCT00739297|62721835|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
33344513|NCT00739297|62721836|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
33344514|NCT00739297|62721837|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
33344515|NCT00739297|62721838|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
33344516|NCT00739297|62721839|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
33344517|NCT00739063|62721855|FG000|Overall Study|Screen failures|8|||
33344518|NCT01026194|62721861|FG000|Period 1：Double Blind Period|Adverse Event|2|||
33344519|NCT01026194|62721862|FG001|Period 1：Double Blind Period|Adverse Event|1|||
33344520|NCT01026194|62721861|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
33344521|NCT01026194|62721862|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
33344522|NCT01026194|62721861|FG000|Period 1：Double Blind Period|Physician Decision|0|||
33344523|NCT01026194|62721862|FG001|Period 1：Double Blind Period|Physician Decision|4|||
33344524|NCT01026194|62721861|FG000|Period 2：Open-label Period|Adverse Event|4|||
33344525|NCT01026194|62721862|FG001|Period 2：Open-label Period|Adverse Event|5|||
33344526|NCT01026194|62721861|FG000|Period 2：Open-label Period|Physician Decision|3|||
33344527|NCT01026194|62721862|FG001|Period 2：Open-label Period|Physician Decision|1|||
33344528|NCT01026194|62721861|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
33344529|NCT01026194|62721862|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
33344530|NCT01033136|62721872|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
33344531|NCT01033136|62721873|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
33344532|NCT00738673|62721883|FG000|Overall Study|Adverse Event|1|||
33344533|NCT00738673|62721884|FG001|Overall Study|Adverse Event|0|||
33344534|NCT00738673|62721883|FG000|Overall Study|Lack of Efficacy|19|||
33344535|NCT00738673|62721884|FG001|Overall Study|Lack of Efficacy|8|||
33548901|NCT02901431|62940304|FG010|PK Part|Adverse Event|0|||
33654747|NCT01592240|63067539|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
33654748|NCT01592240|63067540|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
33654749|NCT01592240|63067541|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
33344536|NCT00738673|62721883|FG000|Overall Study|Protocol Violation|1|||
33344537|NCT00738673|62721884|FG001|Overall Study|Protocol Violation|2|||
33470224|NCT00259649|62843882|FG000|Overall Study|Lost to Follow-up|7|||
33470225|NCT00259649|62843882|FG000|Overall Study|irregular menses|3|||
33470226|NCT03712280|62843890|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
33470227|NCT03712280|62843891|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
33344538|NCT00738673|62721883|FG000|Overall Study|Withdrawal by Subject|3|||
33344539|NCT00738673|62721884|FG001|Overall Study|Withdrawal by Subject|1|||
33344540|NCT00811954|62721893|FG000|Overall Study|Death|10|||
33344541|NCT00811954|62721894|FG001|Overall Study|Death|6|||
33344542|NCT00811954|62721895|FG002|Overall Study|Death|13|||
33344543|NCT00811954|62721893|FG000|Overall Study|Lost to Follow-up|29|||
33344544|NCT00811954|62721894|FG001|Overall Study|Lost to Follow-up|23|||
33344545|NCT00811954|62721895|FG002|Overall Study|Lost to Follow-up|34|||
33344546|NCT00811954|62721893|FG000|Overall Study|Not able to get to clinic|28|||
33344547|NCT00811954|62721894|FG001|Overall Study|Not able to get to clinic|35|||
33344548|NCT00811954|62721895|FG002|Overall Study|Not able to get to clinic|30|||
33344549|NCT00811954|62721893|FG000|Overall Study|Not willing to adhere to requirements|12|||
33344550|NCT00811954|62721894|FG001|Overall Study|Not willing to adhere to requirements|2|||
33344551|NCT00811954|62721895|FG002|Overall Study|Not willing to adhere to requirements|16|||
33344552|NCT00811954|62721893|FG000|Overall Study|Withdraw consent prior study completion|4|||
33344553|NCT00811954|62721894|FG001|Overall Study|Withdraw consent prior study completion|6|||
33344554|NCT00811954|62721895|FG002|Overall Study|Withdraw consent prior study completion|5|||
33344555|NCT00811954|62721893|FG000|Overall Study|Site Closure|4|||
33344556|NCT00811954|62721894|FG001|Overall Study|Site Closure|0|||
33344557|NCT00811954|62721895|FG002|Overall Study|Site Closure|1|||
33344558|NCT00811954|62721893|FG000|Overall Study|Severe Debilitation|2|||
33344559|NCT00811954|62721894|FG001|Overall Study|Severe Debilitation|0|||
33344560|NCT00811954|62721895|FG002|Overall Study|Severe Debilitation|1|||
33344561|NCT00811954|62721893|FG000|Overall Study|Complete Protocol: No follow-up|0|||
33344562|NCT00811954|62721894|FG001|Overall Study|Complete Protocol: No follow-up|0|||
33344563|NCT00811954|62721895|FG002|Overall Study|Complete Protocol: No follow-up|1|||
33344564|NCT01032200|62721905|FG000|Overall Study|Death|1|||
33344565|NCT01032200|62721906|FG001|Overall Study|Death|1|||
33344566|NCT01032200|62721905|FG000|Overall Study|Withdrawal by Subject|1|||
33344567|NCT01032200|62721906|FG001|Overall Study|Withdrawal by Subject|3|||
33344568|NCT01032200|62721905|FG000|Overall Study|Toxicity|0|||
33344569|NCT01032200|62721906|FG001|Overall Study|Toxicity|2|||
33344570|NCT01032200|62721905|FG000|Overall Study|Progression|1|||
33344571|NCT01032200|62721906|FG001|Overall Study|Progression|0|||
33344572|NCT01032200|62721905|FG000|Overall Study|Multiple|1|||
33470228|NCT03712280|62843892|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
33470229|NCT03712280|62843893|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
33470230|NCT03712280|62843890|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
33470231|NCT03712280|62843891|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
33470232|NCT03712280|62843892|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
33470233|NCT03712280|62843893|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
33344573|NCT01032200|62721906|FG001|Overall Study|Multiple|1|||
33344574|NCT00738283|62721912|FG000|Overall Study|Death|1|||
33344575|NCT00738283|62721912|FG000|Overall Study|Transfer to another facility|2|||
33344576|NCT00738283|62721912|FG000|Overall Study|Discharge home prior to end of study|1|||
33344577|NCT00586105|62721925|FG000|Overall Study|Adverse Event|4|||
33344578|NCT00586105|62721925|FG000|Overall Study|Death|2|||
33344579|NCT00586105|62721925|FG000|Overall Study|Protocol Violation|1|||
33344580|NCT00586105|62721925|FG000|Overall Study|Withdrawal by Subject|3|||
33344581|NCT00586105|62721925|FG000|Overall Study|Disease progression|19|||
33344582|NCT00586105|62721925|FG000|Overall Study|Switched to commercial drug|9|||
33344583|NCT00586105|62721925|FG000|Overall Study|Reason not reported|1|||
33344584|NCT00743119|62721929|FG000|Overall Study|unreliable|3|||
33344585|NCT00743119|62721929|FG000|Overall Study|Withdrawal by Subject|1|||
33344586|NCT00733369|62721943|FG000|Overall Study|Lost to Follow-up|2|||
33344587|NCT00733369|62721944|FG001|Overall Study|Lost to Follow-up|1|||
33344588|NCT00733369|62721943|FG000|Overall Study|Adverse Event|4|||
33344589|NCT00733369|62721944|FG001|Overall Study|Adverse Event|4|||
33344590|NCT00733369|62721943|FG000|Overall Study|Protocol Violation|4|||
33344591|NCT00733369|62721944|FG001|Overall Study|Protocol Violation|4|||
33344592|NCT00813124|62721950|FG000|Overall Study|Death|2|||
33344593|NCT00813124|62721950|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
33344594|NCT00813124|62721950|FG000|Overall Study|Withdrawal by Subject|1|||
33344595|NCT00733291|62721956|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
33344596|NCT00733291|62721957|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
33344597|NCT00733291|62721958|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
33344598|NCT00733291|62721959|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
33344599|NCT00732199|62721972|FG000|Overall Study|Withdrawal by Subject|25|||
33344600|NCT00732199|62721973|FG001|Overall Study|Withdrawal by Subject|18|||
33344601|NCT00732199|62721972|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
33344602|NCT00732199|62721973|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
33344603|NCT00807040|62721984|FG000|Overall Study|Death|24|||
33344604|NCT00807040|62721985|FG001|Overall Study|Death|29|||
33344605|NCT00807040|62721984|FG000|Overall Study|Withdrawal by Subject|8|||
33344606|NCT00807040|62721985|FG001|Overall Study|Withdrawal by Subject|6|||
33344607|NCT00807040|62721984|FG000|Overall Study|Lost to Follow-up|4|||
33344608|NCT00807040|62721985|FG001|Overall Study|Lost to Follow-up|6|||
33344609|NCT00811720|62721993|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
33344610|NCT00811720|62721994|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
33344611|NCT00811720|62721993|FG000|All Treated Patients|Adverse Event|20|||
33344612|NCT00811720|62721994|FG001|All Treated Patients|Adverse Event|62|||
33344613|NCT00811720|62721993|FG000|All Treated Patients|Lack of Efficacy|22|||
33344614|NCT00811720|62721994|FG001|All Treated Patients|Lack of Efficacy|18|||
33344615|NCT00811720|62721993|FG000|All Treated Patients|Non-compliance|0|||
33344616|NCT00811720|62721994|FG001|All Treated Patients|Non-compliance|14|||
33344617|NCT00811720|62721993|FG000|All Treated Patients|Protocol Violation|9|||
33344618|NCT00811720|62721994|FG001|All Treated Patients|Protocol Violation|16|||
33344619|NCT00811720|62721993|FG000|All Treated Patients|Withdrawal by Subject|28|||
33344620|NCT00811720|62721994|FG001|All Treated Patients|Withdrawal by Subject|34|||
33344621|NCT00811720|62721993|FG000|All Treated Patients|Lost to Follow-up|10|||
33344622|NCT00811720|62721994|FG001|All Treated Patients|Lost to Follow-up|16|||
33344623|NCT00811720|62721993|FG000|All Treated Patients|Other Reason|7|||
33344624|NCT00811720|62721994|FG001|All Treated Patients|Other Reason|4|||
33344625|NCT04202679|62722002|FG000|Overall Study|Adverse Event|2|||
33344626|NCT04202679|62722003|FG001|Overall Study|Adverse Event|0|||
33344627|NCT04202679|62722002|FG000|Overall Study|Poor compliance to protocol|1|||
33344628|NCT04202679|62722003|FG001|Overall Study|Poor compliance to protocol|0|||
33344629|NCT04202679|62722002|FG000|Overall Study|Withdrawal by Subject|23|||
33344630|NCT04202679|62722003|FG001|Overall Study|Withdrawal by Subject|6|||
33344631|NCT00811642|62722010|FG000|Overall Study|Adverse Event|3|||
33344632|NCT00811642|62722010|FG000|Overall Study|Protocol Violation|1|||
33344633|NCT00811642|62722010|FG000|Overall Study|Death|2|||
33344634|NCT00811642|62722010|FG000|Overall Study|Withdrawal by Subject|7|||
33470234|NCT03712280|62843890|FG000|Overall Study|Adverse Event|0|||
33470235|NCT03712280|62843891|FG001|Overall Study|Adverse Event|0|||
33470236|NCT03712280|62843892|FG002|Overall Study|Adverse Event|1|||
33470237|NCT03712280|62843893|FG003|Overall Study|Adverse Event|0|||
33470238|NCT01345240|62843908|FG000|Overall Study|Adverse Event|3|||
33470239|NCT01345240|62843909|FG001|Overall Study|Adverse Event|5|||
33470240|NCT01345240|62843910|FG002|Overall Study|Adverse Event|4|||
33470241|NCT01345240|62843911|FG003|Overall Study|Adverse Event|2|||
33470242|NCT01345240|62843912|FG004|Overall Study|Adverse Event|1|||
33470243|NCT01345240|62843908|FG000|Overall Study|Lost to Follow-up|8|||
33344635|NCT00811642|62722010|FG000|Overall Study|Cumulative use of antifungal agent|2|||
33470244|NCT01345240|62843909|FG001|Overall Study|Lost to Follow-up|9|||
33470245|NCT01345240|62843910|FG002|Overall Study|Lost to Follow-up|14|||
33470246|NCT01345240|62843911|FG003|Overall Study|Lost to Follow-up|7|||
33470247|NCT01345240|62843912|FG004|Overall Study|Lost to Follow-up|9|||
33344636|NCT00809926|62722016|FG000|Overall Study|Adverse Event|18|||
33344637|NCT00809926|62722017|FG001|Overall Study|Adverse Event|10|||
33344638|NCT00809926|62722016|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
33344639|NCT00809926|62722017|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33344640|NCT00809926|62722016|FG000|Overall Study|Patient withdrew consent|8|||
33344641|NCT00809926|62722017|FG001|Overall Study|Patient withdrew consent|6|||
33344642|NCT00809926|62722016|FG000|Overall Study|Lost to Follow-up|2|||
33470248|NCT03707912|62843944|FG000|Overall Study|Violation of inclusion criteria|1|||
33470249|NCT03707912|62843945|FG001|Overall Study|Violation of inclusion criteria|0|||
33470250|NCT02883244|62843953|FG000|Overall Study|Lost to Follow-up|0|||
33470251|NCT02883244|62843954|FG001|Overall Study|Lost to Follow-up|1|||
33470252|NCT02882854|62843962|FG000|Overall Study|Lost to Follow-up|1|||
33344643|NCT00809926|62722017|FG001|Overall Study|Lost to Follow-up|1|||
33344644|NCT00809926|62722016|FG000|Overall Study|Administrative Problems|0|||
33344645|NCT00809926|62722017|FG001|Overall Study|Administrative Problems|1|||
33344646|NCT00809926|62722016|FG000|Overall Study|Protocol deviation|0|||
33344647|NCT00809926|62722017|FG001|Overall Study|Protocol deviation|2|||
33344648|NCT00590980|62722023|FG000|Overall Study|Did not meet all inclusion criteria|10|||
33344649|NCT00590902|62722027|FG000|Overall Study|Death|1|||
33344650|NCT00590824|62722035|FG000|Overall Study|Disease could not be resected|0|||
33344651|NCT00590824|62722036|FG001|Overall Study|Disease could not be resected|2|||
33344652|NCT00590824|62722037|FG002|Overall Study|Disease could not be resected|1|||
33344653|NCT00590824|62722038|FG003|Overall Study|Disease could not be resected|0|||
33344654|NCT00590824|62722035|FG000|Overall Study|Adverse Event|0|||
33344655|NCT00590824|62722036|FG001|Overall Study|Adverse Event|0|||
33344656|NCT00590824|62722037|FG002|Overall Study|Adverse Event|0|||
33344657|NCT00590824|62722038|FG003|Overall Study|Adverse Event|1|||
33344658|NCT00590590|62722051|FG000|Overall Study|Lack of Efficacy|1|||
33344659|NCT00590590|62722052|FG001|Overall Study|Lack of Efficacy|2|||
33344660|NCT00590590|62722053|FG002|Overall Study|Lack of Efficacy|0|||
33344661|NCT00590590|62722051|FG000|Overall Study|Adverse Event|1|||
33344662|NCT00590590|62722052|FG001|Overall Study|Adverse Event|0|||
33344663|NCT00590590|62722053|FG002|Overall Study|Adverse Event|0|||
33344664|NCT00590590|62722051|FG000|Overall Study|Protocol Violation|0|||
33344665|NCT00590590|62722052|FG001|Overall Study|Protocol Violation|0|||
33344666|NCT00590590|62722053|FG002|Overall Study|Protocol Violation|2|||
33344667|NCT00590590|62722051|FG000|Overall Study|Lost to Follow-up|4|||
33344668|NCT00590590|62722052|FG001|Overall Study|Lost to Follow-up|1|||
33344669|NCT00590590|62722053|FG002|Overall Study|Lost to Follow-up|2|||
33344670|NCT00590590|62722051|FG000|Overall Study|Withdrawal by Subject|0|||
33344671|NCT00590590|62722052|FG001|Overall Study|Withdrawal by Subject|1|||
33344672|NCT00590590|62722053|FG002|Overall Study|Withdrawal by Subject|1|||
33344673|NCT00590590|62722051|FG000|Overall Study|Did not complete due to study closure|1|||
33344674|NCT00590590|62722052|FG001|Overall Study|Did not complete due to study closure|1|||
33344675|NCT00590590|62722053|FG002|Overall Study|Did not complete due to study closure|1|||
33344676|NCT00590590|62722051|FG000|Overall Study|Did not complete study|0|||
33344677|NCT00590590|62722052|FG001|Overall Study|Did not complete study|1|||
33344678|NCT00590590|62722053|FG002|Overall Study|Did not complete study|0|||
33344679|NCT00809614|62722063|FG000|Overall Study|Lack of Efficacy|2|||
33344680|NCT00809614|62722064|FG001|Overall Study|Lack of Efficacy|3|||
33344681|NCT00809614|62722063|FG000|Overall Study|Withdrawal by Subject|1|||
33344682|NCT00809614|62722064|FG001|Overall Study|Withdrawal by Subject|1|||
33344683|NCT00731731|62722073|FG000|Overall Study|Protocol Violation|0|||
33344684|NCT00731731|62722074|FG001|Overall Study|Protocol Violation|0|||
33344685|NCT00731731|62722075|FG002|Overall Study|Protocol Violation|1|||
33344686|NCT00731731|62722073|FG000|Overall Study|Cancel prior to treatment|0|||
33344687|NCT00731731|62722074|FG001|Overall Study|Cancel prior to treatment|0|||
33344688|NCT00731731|62722075|FG002|Overall Study|Cancel prior to treatment|2|||
33344689|NCT00806494|62722088|FG000|Overall Study|Adverse Event|29|||
33344690|NCT00806494|62722088|FG000|Overall Study|Lack of Efficacy|6|||
33344691|NCT00806494|62722088|FG000|Overall Study|Lost to Follow-up|10|||
33470253|NCT02882854|62843963|FG001|Overall Study|Lost to Follow-up|2|||
33470254|NCT02882854|62843962|FG000|Overall Study|Physician Decision|0|||
33470255|NCT02882854|62843963|FG001|Overall Study|Physician Decision|1|||
33470256|NCT03707522|62843973|FG000|Overall Study|Lost to Follow-up|24|||
33470257|NCT03707522|62843974|FG001|Overall Study|Lost to Follow-up|27|||
33470258|NCT03707522|62843975|FG002|Overall Study|Lost to Follow-up|41|||
33470259|NCT03707522|62843976|FG003|Overall Study|Lost to Follow-up|36|||
33470260|NCT03150082|62843986|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
33344692|NCT00806494|62722088|FG000|Overall Study|Other|30|||
33344693|NCT00806494|62722088|FG000|Overall Study|Withdrawal by Subject|5|||
33344694|NCT00806416|62722095|FG000|Period 1 - Part I|Adverse Event|0|||
33344695|NCT00806416|62722096|FG001|Period 1 - Part I|Adverse Event|1|||
33344696|NCT00806416|62722097|FG002|Period 1 - Part I|Adverse Event|0|||
33344697|NCT00806416|62722098|FG003|Period 1 - Part I|Adverse Event|0|||
33470261|NCT03150082|62843987|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
33470262|NCT03142750|62844015|FG000|Overall Study|Lost to Follow-up|4|||
33470263|NCT03142750|62844016|FG001|Overall Study|Lost to Follow-up|1|||
33344698|NCT00806416|62722095|FG000|Period 1 - Part I|Lost to Follow-up|0|||
33344699|NCT00806416|62722096|FG001|Period 1 - Part I|Lost to Follow-up|2|||
33344700|NCT00806416|62722097|FG002|Period 1 - Part I|Lost to Follow-up|0|||
33548902|NCT02901431|62940305|FG011|PK Part|Adverse Event|0|||
33344701|NCT00806416|62722098|FG003|Period 1 - Part I|Lost to Follow-up|0|||
33344702|NCT00806416|62722095|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
33344703|NCT00806416|62722096|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
33344704|NCT00806416|62722097|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
33344705|NCT00806416|62722098|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
33344706|NCT00806416|62722095|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
33344707|NCT00806416|62722096|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
33344708|NCT00806416|62722097|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
33344709|NCT00806416|62722098|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
33344710|NCT02724969|62722108|FG000|Overall Study|Lost to Follow-up|12|||
33344711|NCT02724969|62722109|FG001|Overall Study|Lost to Follow-up|6|||
33344712|NCT02724969|62722108|FG000|Overall Study|Withdrawal by Subject|3|||
33344713|NCT02724969|62722109|FG001|Overall Study|Withdrawal by Subject|3|||
33344714|NCT02724969|62722108|FG000|Overall Study|Infant demise|0|||
33344715|NCT02724969|62722109|FG001|Overall Study|Infant demise|2|||
33344716|NCT00811252|62722118|FG000|Overall Study|Adverse Event|6|||
33344717|NCT00811252|62722119|FG001|Overall Study|Adverse Event|10|||
33344718|NCT00811252|62722120|FG002|Overall Study|Adverse Event|15|||
33344719|NCT00811252|62722118|FG000|Overall Study|Lack of Efficacy|7|||
33344720|NCT00811252|62722119|FG001|Overall Study|Lack of Efficacy|2|||
33344721|NCT00811252|62722120|FG002|Overall Study|Lack of Efficacy|0|||
33344722|NCT00811252|62722118|FG000|Overall Study|Protocol Violation|3|||
33344723|NCT00811252|62722119|FG001|Overall Study|Protocol Violation|3|||
33344724|NCT00811252|62722120|FG002|Overall Study|Protocol Violation|2|||
33344725|NCT00811252|62722118|FG000|Overall Study|Withdrawal of Consent|1|||
33344726|NCT00811252|62722119|FG001|Overall Study|Withdrawal of Consent|2|||
33344727|NCT00811252|62722120|FG002|Overall Study|Withdrawal of Consent|2|||
33344728|NCT00811252|62722118|FG000|Overall Study|Lost to Follow-up|0|||
33344729|NCT00811252|62722119|FG001|Overall Study|Lost to Follow-up|0|||
33344730|NCT00811252|62722120|FG002|Overall Study|Lost to Follow-up|2|||
33344731|NCT00811252|62722118|FG000|Overall Study|Administrative or Other Reasons|0|||
33344732|NCT00811252|62722119|FG001|Overall Study|Administrative or Other Reasons|3|||
33344733|NCT00811252|62722120|FG002|Overall Study|Administrative or Other Reasons|2|||
33344734|NCT00736957|62722137|FG000|Overall Study|Adverse Event|43|||
33344735|NCT00736957|62722137|FG000|Overall Study|Withdrawal by Subject|49|||
33344736|NCT00736957|62722137|FG000|Overall Study|violation of eligibility criteria|2|||
33344737|NCT00736957|62722137|FG000|Overall Study|did not attend hospital appointments|1|||
33344738|NCT00736957|62722137|FG000|Overall Study|not eligible for Treatment Period I|22|||
33344739|NCT00736957|62722137|FG000|Overall Study|Physician Decision|5|||
33344740|NCT00736879|62722145|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
33344741|NCT00736879|62722146|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
33344742|NCT00736879|62722147|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
33344743|NCT00736879|62722148|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
33344744|NCT00736879|62722145|FG000|Double Blind Treatment Period|Adverse Event|0|||
33344745|NCT00736879|62722146|FG001|Double Blind Treatment Period|Adverse Event|1|||
33344746|NCT00736879|62722147|FG002|Double Blind Treatment Period|Adverse Event|1|||
33344747|NCT00736879|62722148|FG003|Double Blind Treatment Period|Adverse Event|0|||
33344748|NCT00736879|62722145|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
33344749|NCT00736879|62722146|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
33344750|NCT00736879|62722147|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
33344751|NCT00736879|62722148|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
33344752|NCT00736879|62722145|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
33344753|NCT00736879|62722146|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
33344754|NCT00736879|62722147|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
33344755|NCT00736879|62722148|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
33344756|NCT00736879|62722145|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
33344757|NCT00736879|62722146|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
33344758|NCT00736879|62722147|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
33344759|NCT00736879|62722148|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
33344760|NCT00736879|62722145|FG000|Double Blind Treatment Period|No longer met criteria|0|||
33344761|NCT00736879|62722146|FG001|Double Blind Treatment Period|No longer met criteria|1|||
33344762|NCT00736879|62722147|FG002|Double Blind Treatment Period|No longer met criteria|0|||
33344763|NCT00736879|62722148|FG003|Double Blind Treatment Period|No longer met criteria|0|||
33344764|NCT00736879|62722145|FG000|Double Blind Treatment Period|non-specified|0|||
33344765|NCT00736879|62722146|FG001|Double Blind Treatment Period|non-specified|1|||
33344766|NCT00736879|62722147|FG002|Double Blind Treatment Period|non-specified|0|||
33344767|NCT00736879|62722148|FG003|Double Blind Treatment Period|non-specified|0|||
33344768|NCT00736879|62722145|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
33344769|NCT00736879|62722146|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
33344770|NCT00736879|62722147|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
33344771|NCT00736879|62722148|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
33344772|NCT00736879|62722145|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
33344773|NCT00736879|62722146|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
33344774|NCT00736879|62722147|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
33344775|NCT00736879|62722148|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
33344776|NCT00806260|62722167|FG000|Period 1 (1 Day)|Adverse Event|0|||
33344777|NCT00806260|62722168|FG001|Period 1 (1 Day)|Adverse Event|0|||
33344778|NCT00806260|62722169|FG002|Period 1 (1 Day)|Adverse Event|0|||
33344779|NCT00806260|62722170|FG003|Period 1 (1 Day)|Adverse Event|0|||
33344780|NCT00806260|62722171|FG004|Period 1 (1 Day)|Adverse Event|3|||
33344781|NCT00806260|62722172|FG005|Period 1 (1 Day)|Adverse Event|0|||
33344782|NCT00806260|62722167|FG000|Period 2|Adverse Event|0|||
33344783|NCT00806260|62722168|FG001|Period 2|Adverse Event|0|||
33344784|NCT00806260|62722169|FG002|Period 2|Adverse Event|0|||
33344785|NCT00806260|62722170|FG003|Period 2|Adverse Event|1|||
33344786|NCT00806260|62722171|FG004|Period 2|Adverse Event|0|||
33344787|NCT00806260|62722172|FG005|Period 2|Adverse Event|0|||
33344788|NCT00806260|62722167|FG000|Period 2|Protocol Violation|1|||
33344789|NCT00806260|62722168|FG001|Period 2|Protocol Violation|0|||
33344790|NCT00806260|62722169|FG002|Period 2|Protocol Violation|1|||
33344791|NCT00806260|62722170|FG003|Period 2|Protocol Violation|0|||
33344792|NCT00806260|62722171|FG004|Period 2|Protocol Violation|0|||
33344793|NCT00806260|62722172|FG005|Period 2|Protocol Violation|0|||
33344794|NCT00806260|62722167|FG000|Period 2|Need to take concomitant medication|1|||
33344795|NCT00806260|62722168|FG001|Period 2|Need to take concomitant medication|0|||
33344796|NCT00806260|62722169|FG002|Period 2|Need to take concomitant medication|0|||
33344797|NCT00806260|62722170|FG003|Period 2|Need to take concomitant medication|0|||
33344798|NCT00806260|62722171|FG004|Period 2|Need to take concomitant medication|0|||
33344799|NCT00806260|62722172|FG005|Period 2|Need to take concomitant medication|0|||
33344800|NCT00806260|62722167|FG000|Period 2|sponsor request|0|||
33470264|NCT03149848|62844026|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
33470265|NCT03149848|62844026|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
33470266|NCT03706040|62844036|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
33470267|NCT03706040|62844037|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
33470268|NCT03706040|62844038|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
33470269|NCT03706040|62844039|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
33470270|NCT03706040|62844040|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
33654750|NCT01592240|63067542|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
33654751|NCT01592240|63067543|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
33654752|NCT01592240|63067544|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
33654753|NCT01591616|63067587|FG000|Overall Study|Withdrawal by Subject|1|||
33654754|NCT01591460|63067743|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
33654755|NCT01591460|63067743|FG000|Overall Study|Futility Rule (Week 12)|7|||
33654756|NCT01591460|63067743|FG000|Overall Study|Futility Rule (Week 24)|3|||
33654757|NCT01591460|63067743|FG000|Overall Study|Rebound or Breakthrough|3|||
33654758|NCT01591460|63067743|FG000|Overall Study|Treatment Discontinued by Error|1|||
33654759|NCT01591460|63067743|FG000|Overall Study|Lost to Follow-up|1|||
33654760|NCT01591460|63067743|FG000|Overall Study|Noncompliance|1|||
33654761|NCT01591460|63067743|FG000|Overall Study|Participant Refusal|3|||
33654762|NCT01591460|63067743|FG000|Overall Study|Withdrawal by Subject|1|||
33654763|NCT01591460|63067743|FG000|Overall Study|Protocol Violation|1|||
33654764|NCT01591382|63067766|FG000|Overall Study|Discharged Prior to Study Completion|2|||
33654765|NCT01591382|63067767|FG001|Overall Study|Discharged Prior to Study Completion|1|||
33654766|NCT01591382|63067766|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
33654767|NCT01591382|63067767|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
33654768|NCT01696214|63067785|FG000|Overall Study|Lost to Follow-up|1|||
33654769|NCT01696214|63067786|FG001|Overall Study|Lost to Follow-up|0|||
33654770|NCT01696214|63067787|FG002|Overall Study|Lost to Follow-up|0|||
33654771|NCT01696214|63067788|FG003|Overall Study|Lost to Follow-up|0|||
33654772|NCT01543087|63067821|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
33654773|NCT01543087|63067822|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
33654774|NCT01543087|63067823|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
33654775|NCT01543087|63067824|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
33654776|NCT01543087|63067825|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
33344801|NCT00806260|62722168|FG001|Period 2|sponsor request|0|||
33344802|NCT00806260|62722169|FG002|Period 2|sponsor request|1|||
33470271|NCT03706040|62844041|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
33470272|NCT03706040|62844042|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
33344803|NCT00806260|62722170|FG003|Period 2|sponsor request|1|||
33344804|NCT00806260|62722171|FG004|Period 2|sponsor request|0|||
33470273|NCT03706040|62844036|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
33654777|NCT01543087|63067826|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
33344805|NCT00806260|62722172|FG005|Period 2|sponsor request|0|||
33344806|NCT00806260|62722167|FG000|Period 3|Protocol Violation|0|||
33344807|NCT00806260|62722168|FG001|Period 3|Protocol Violation|1|||
33344808|NCT00806260|62722169|FG002|Period 3|Protocol Violation|1|||
33344809|NCT00806260|62722170|FG003|Period 3|Protocol Violation|0|||
33344810|NCT00806260|62722171|FG004|Period 3|Protocol Violation|0|||
33344811|NCT00806260|62722172|FG005|Period 3|Protocol Violation|0|||
33344812|NCT00806260|62722167|FG000|Period 3|Pregnancy|1|||
33344813|NCT00806260|62722168|FG001|Period 3|Pregnancy|0|||
33344814|NCT00806260|62722169|FG002|Period 3|Pregnancy|0|||
33344815|NCT00806260|62722170|FG003|Period 3|Pregnancy|0|||
33344816|NCT00806260|62722171|FG004|Period 3|Pregnancy|0|||
33344817|NCT00806260|62722172|FG005|Period 3|Pregnancy|0|||
33344818|NCT00742885|62722186|FG000|Overall Study|Lost to Follow-up|1|||
33344819|NCT00742885|62722187|FG001|Overall Study|Lost to Follow-up|0|||
33344820|NCT00811174|62722196|FG000|Overall Study|Protocol Violation|2|||
33344821|NCT00811174|62722196|FG000|Overall Study|Sponsors Decision|1|||
33344822|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
33344823|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
33344824|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
33344825|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
33344826|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
33344827|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
33344828|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
33344829|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
33344830|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
33344831|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
33470274|NCT03706040|62844037|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
33470275|NCT03706040|62844038|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
33470276|NCT03706040|62844039|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
33470277|NCT03706040|62844040|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
33470278|NCT03706040|62844041|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
33470279|NCT03706040|62844042|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
33470280|NCT03706040|62844036|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
33654778|NCT01543087|63067821|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
33654779|NCT01543087|63067822|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
33654780|NCT01543087|63067823|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
33344832|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
33344833|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
33470281|NCT03706040|62844037|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
33470282|NCT03706040|62844038|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
33654781|NCT01543087|63067824|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
33654782|NCT01543087|63067825|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
33654783|NCT01543087|63067826|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
33654784|NCT01543087|63067821|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
33654785|NCT01543087|63067822|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
33654786|NCT01543087|63067823|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
33654787|NCT01543087|63067824|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
33654788|NCT01543087|63067825|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
33654789|NCT01543087|63067826|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
33654790|NCT01543087|63067821|FG000|Stage 1 (48 Months)|Other than specified|5|||
33654791|NCT01543087|63067822|FG001|Stage 1 (48 Months)|Other than specified|0|||
33654792|NCT01543087|63067823|FG002|Stage 1 (48 Months)|Other than specified|9|||
33654793|NCT01543087|63067824|FG003|Stage 1 (48 Months)|Other than specified|0|||
33344834|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
33344835|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
33344836|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
33344837|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
33344838|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
33470283|NCT03706040|62844039|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
33470284|NCT03706040|62844040|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
33470285|NCT03706040|62844041|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
33470286|NCT03706040|62844042|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
33470287|NCT03706040|62844036|FG000|Period A (Week 0 to Week 16)|Other|2|||
33470288|NCT03706040|62844037|FG001|Period A (Week 0 to Week 16)|Other|0|||
33470289|NCT03706040|62844038|FG002|Period A (Week 0 to Week 16)|Other|2|||
33470290|NCT03706040|62844039|FG003|Period A (Week 0 to Week 16)|Other|0|||
33470291|NCT03706040|62844040|FG004|Period A (Week 0 to Week 16)|Other|0|||
33654794|NCT01543087|63067825|FG004|Stage 1 (48 Months)|Other than specified|0|||
33344839|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
33470292|NCT03706040|62844041|FG005|Period A (Week 0 to Week 16)|Other|0|||
33470293|NCT03706040|62844042|FG006|Period A (Week 0 to Week 16)|Other|0|||
33654795|NCT01543087|63067826|FG005|Stage 1 (48 Months)|Other than specified|0|||
33548903|NCT02901431|62940306|FG012|PK Part|Adverse Event|0|||
33654796|NCT01543087|63067821|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
33654797|NCT01543087|63067822|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
33654798|NCT01543087|63067823|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
33654799|NCT01543087|63067824|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
33654800|NCT01543087|63067825|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
33654801|NCT01543087|63067826|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
33548904|NCT02901431|62940294|FG000|PK Part|Lost to Follow-up|0|||
33548905|NCT02901431|62940295|FG001|PK Part|Lost to Follow-up|0|||
33548906|NCT02901431|62940296|FG002|PK Part|Lost to Follow-up|1|||
33548907|NCT02901431|62940297|FG003|PK Part|Lost to Follow-up|0|||
33548908|NCT02901431|62940298|FG004|PK Part|Lost to Follow-up|0|||
33548909|NCT02901431|62940299|FG005|PK Part|Lost to Follow-up|0|||
33548910|NCT02901431|62940300|FG006|PK Part|Lost to Follow-up|0|||
33548911|NCT02901431|62940301|FG007|PK Part|Lost to Follow-up|0|||
33344840|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
33344841|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
33344842|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
33344843|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
33344844|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
33344845|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
33344846|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
33344847|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
33344848|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
33344849|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
33344850|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
33344851|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
33344852|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
33344853|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
33344854|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
33344855|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
33344856|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
33344857|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
33344858|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
33344859|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
33344860|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
33344861|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
33344862|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
33344863|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
33344864|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
33344865|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
33344866|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
33344867|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
33344868|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
33344869|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
33344870|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
33344871|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
33344872|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
33344873|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
33344874|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
33344875|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
33344876|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
33344877|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
33344878|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
33344879|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
33344880|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
33548912|NCT02901431|62940302|FG008|PK Part|Lost to Follow-up|0|||
33548913|NCT02901431|62940303|FG009|PK Part|Lost to Follow-up|0|||
33548914|NCT02901431|62940304|FG010|PK Part|Lost to Follow-up|0|||
33548915|NCT02901431|62940305|FG011|PK Part|Lost to Follow-up|0|||
33548916|NCT02901431|62940306|FG012|PK Part|Lost to Follow-up|0|||
33548917|NCT02901431|62940294|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
33548918|NCT02901431|62940295|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33548919|NCT02901431|62940296|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33344881|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
33344882|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
33344883|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
33344884|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
33344885|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
33344886|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
33344887|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
33344888|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
33344889|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
33344890|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
33344891|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
33344892|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Change of location|0|||
33344893|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Change of location|0|||
33344894|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Change of location|0|||
33344895|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Change of location|1|||
33344896|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Change of location|0|||
33344897|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
33344898|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
33344899|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
33344900|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
33344901|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
33344902|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
33344903|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
33344904|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
33344905|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
33344906|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
33344907|NCT00730405|62722205|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
33344908|NCT00730405|62722206|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
33344909|NCT00730405|62722207|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
33344910|NCT00730405|62722208|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
33344911|NCT00730405|62722209|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
33344912|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
33344913|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
33344914|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
33344915|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
33344916|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
33344917|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
33344918|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
33344919|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
33344920|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
33344921|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
33344922|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
33344923|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
33344924|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
33344925|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
33344926|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
33344927|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Death|0|||
33344928|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Death|1|||
33344929|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Death|0|||
33344930|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Death|1|||
33344931|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Death|0|||
33344932|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Change of location|1|||
33344933|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Change of location|1|||
33344934|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Change of location|0|||
33344935|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Change of location|1|||
33344936|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Change of location|0|||
33344937|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
33344938|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
33344939|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
33344940|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
33344941|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
33344942|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
33344943|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
33344944|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
33344945|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
33344946|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
33344947|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
33344948|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
33344949|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
33344950|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
33344951|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
33344952|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
33344953|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
33344954|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
33344955|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
33344956|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
33344957|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
33344958|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
33344959|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
33344960|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
33344961|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
33344962|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
33344963|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
33344964|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
33344965|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
33344966|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
33344967|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
33344968|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
33344969|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
33344970|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
33344971|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
33344972|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
33344973|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
33344974|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
33344975|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
33344976|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
33344977|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
33344978|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
33344979|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
33344980|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
33344981|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
33344982|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
33344983|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
33344984|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
33344985|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
33344986|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
33344987|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Missing|0|||
33344988|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Missing|0|||
33344989|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Missing|2|||
33344990|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Missing|0|||
33344991|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Missing|0|||
33344992|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
33344993|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
33344994|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
33344995|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
33344996|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
33344997|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
33344998|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
33344999|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
33345000|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
33345001|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
33345002|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
33345003|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
33345004|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
33345005|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
33345006|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
33345007|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
33345008|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
33345009|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
33345010|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
33345011|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
33345012|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
33345013|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
33345014|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
33345015|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
33345016|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
33345017|NCT00730405|62722205|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
33345018|NCT00730405|62722206|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
33345019|NCT00730405|62722207|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
33345020|NCT00730405|62722208|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
33345021|NCT00730405|62722209|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
33345022|NCT00736723|62722225|FG000|Overall Study|Withdrawal by Subject|4|||
33345023|NCT00736723|62722226|FG001|Overall Study|Withdrawal by Subject|3|||
33345024|NCT00736645|62722236|FG000|Overall Study|Adverse Event|0|||
33345025|NCT00736645|62722237|FG001|Overall Study|Adverse Event|2|||
33345026|NCT00736645|62722238|FG002|Overall Study|Adverse Event|0|||
33345027|NCT00736645|62722239|FG003|Overall Study|Adverse Event|0|||
33345028|NCT00736489|62722249|FG000|Period 1|Lost to Follow-up|1|||
33345029|NCT00736489|62722250|FG001|Period 1|Lost to Follow-up|0|||
33345030|NCT00736489|62722251|FG002|Period 1|Lost to Follow-up|0|||
33345031|NCT00736489|62722252|FG003|Period 1|Lost to Follow-up|0|||
33345032|NCT00736489|62722253|FG004|Period 1|Lost to Follow-up|0|||
33345033|NCT00736489|62722254|FG005|Period 1|Lost to Follow-up|0|||
33345034|NCT00736489|62722249|FG000|Period 1|Withdrawal by Subject|0|||
33345035|NCT00736489|62722250|FG001|Period 1|Withdrawal by Subject|0|||
33345036|NCT00736489|62722251|FG002|Period 1|Withdrawal by Subject|0|||
33345037|NCT00736489|62722252|FG003|Period 1|Withdrawal by Subject|0|||
33345038|NCT00736489|62722253|FG004|Period 1|Withdrawal by Subject|0|||
33345039|NCT00736489|62722254|FG005|Period 1|Withdrawal by Subject|1|||
33345040|NCT00730327|62722286|FG000|Overall Study|Lost to Follow-up|14|||
33345041|NCT00730327|62722287|FG001|Overall Study|Lost to Follow-up|16|||
33345042|NCT00730327|62722286|FG000|Overall Study|Adverse Event|8|||
33345043|NCT00730327|62722287|FG001|Overall Study|Adverse Event|1|||
33345044|NCT00730327|62722286|FG000|Overall Study|Withdrawal by Subject|3|||
33345045|NCT00730327|62722287|FG001|Overall Study|Withdrawal by Subject|13|||
33345046|NCT00730327|62722286|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
33345047|NCT00730327|62722287|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
33345048|NCT00742417|62722302|FG000|Randomized|Withdrawal by legal representative|0|||
33345049|NCT00742417|62722303|FG001|Randomized|Withdrawal by legal representative|1|||
33345050|NCT00742417|62722302|FG000|Randomized|Withdrawal by Subject|1|||
33345051|NCT00742417|62722303|FG001|Randomized|Withdrawal by Subject|0|||
33345052|NCT00742417|62722302|FG000|Randomized|Physician Decision|1|||
33345053|NCT00742417|62722303|FG001|Randomized|Physician Decision|0|||
33345054|NCT00742417|62722302|FG000|Intensive Period|Withdrawal by Subject|1|||
33345055|NCT00742417|62722303|FG001|Intensive Period|Withdrawal by Subject|1|||
33345056|NCT00742417|62722302|FG000|Intensive Period|Adverse Event|2|||
33345057|NCT00742417|62722303|FG001|Intensive Period|Adverse Event|0|||
33345058|NCT00811018|62722311|FG000|Overall Study|Additional Chronic Treatment|31|||
33345059|NCT00811018|62722311|FG000|Overall Study|Adverse Event|79|||
33345060|NCT00811018|62722311|FG000|Overall Study|Death|147|||
33345061|NCT00811018|62722311|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
33345062|NCT00811018|62722311|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
33345063|NCT00811018|62722311|FG000|Overall Study|Investigator Decision|57|||
33345064|NCT00811018|62722311|FG000|Overall Study|Lost to Follow-up|19|||
33345065|NCT00811018|62722311|FG000|Overall Study|Pregnancy|6|||
33345066|NCT00811018|62722311|FG000|Overall Study|Sponsor Decision|450|||
33345067|NCT00811018|62722311|FG000|Overall Study|Withdrawal by Subject|70|||
33345068|NCT00811018|62722311|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
33345069|NCT00811018|62722311|FG000|Overall Study|Other|26|||
33548920|NCT02901431|62940297|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33548921|NCT02901431|62940298|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33345070|NCT00730171|62722320|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
33345071|NCT00730171|62722320|FG000|Overall Study|Adverse Event|193|||
33345072|NCT00730171|62722320|FG000|Overall Study|Protocol Violation|48|||
33654802|NCT01543087|63067821|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
33345073|NCT00730171|62722320|FG000|Overall Study|Withdrawal by Subject|202|||
33345074|NCT00730171|62722320|FG000|Overall Study|Lost to Follow-up|121|||
33345075|NCT00730171|62722320|FG000|Overall Study|Insufficient Therapeutic Response|141|||
33345076|NCT00730171|62722320|FG000|Overall Study|Other|61|||
33345077|NCT00730015|62722331|FG000|Overall Study|Adverse Event|11|||
33345078|NCT00730015|62722332|FG001|Overall Study|Adverse Event|10|||
33345079|NCT00730015|62722333|FG002|Overall Study|Adverse Event|8|||
33548922|NCT02901431|62940299|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33345080|NCT00730015|62722331|FG000|Overall Study|Protocol Violation|2|||
33345081|NCT00730015|62722332|FG001|Overall Study|Protocol Violation|6|||
33345082|NCT00730015|62722333|FG002|Overall Study|Protocol Violation|4|||
33345083|NCT00730015|62722331|FG000|Overall Study|Withdrawal by Subject|12|||
33345084|NCT00730015|62722332|FG001|Overall Study|Withdrawal by Subject|12|||
33345085|NCT00730015|62722333|FG002|Overall Study|Withdrawal by Subject|8|||
33345086|NCT00730015|62722331|FG000|Overall Study|Lost to Follow-up|4|||
33345087|NCT00730015|62722332|FG001|Overall Study|Lost to Follow-up|10|||
33345088|NCT00730015|62722333|FG002|Overall Study|Lost to Follow-up|3|||
33345089|NCT00730015|62722331|FG000|Overall Study|Lack of Efficacy|1|||
33345090|NCT00730015|62722332|FG001|Overall Study|Lack of Efficacy|2|||
33345091|NCT00730015|62722333|FG002|Overall Study|Lack of Efficacy|8|||
33345092|NCT00730015|62722331|FG000|Overall Study|Other Reason|1|||
33345093|NCT00730015|62722332|FG001|Overall Study|Other Reason|0|||
33345094|NCT00730015|62722333|FG002|Overall Study|Other Reason|1|||
33345095|NCT00806026|62722352|FG000|Overall Study|Death|0|||
33345096|NCT00806026|62722353|FG001|Overall Study|Death|0|||
33345097|NCT00806026|62722354|FG002|Overall Study|Death|0|||
33345098|NCT00806026|62722355|FG003|Overall Study|Death|1|||
33345099|NCT00806026|62722356|FG004|Overall Study|Death|0|||
33345100|NCT00806026|62722357|FG005|Overall Study|Death|0|||
33345101|NCT00806026|62722352|FG000|Overall Study|Did not meet entrance criteria|4|||
33345102|NCT00806026|62722353|FG001|Overall Study|Did not meet entrance criteria|1|||
33345103|NCT00806026|62722354|FG002|Overall Study|Did not meet entrance criteria|2|||
33345104|NCT00806026|62722355|FG003|Overall Study|Did not meet entrance criteria|1|||
33345105|NCT00806026|62722356|FG004|Overall Study|Did not meet entrance criteria|0|||
33345106|NCT00806026|62722357|FG005|Overall Study|Did not meet entrance criteria|0|||
33345107|NCT00806026|62722352|FG000|Overall Study|Lack of Efficacy|5|||
33345108|NCT00806026|62722353|FG001|Overall Study|Lack of Efficacy|18|||
33345109|NCT00806026|62722354|FG002|Overall Study|Lack of Efficacy|13|||
33345110|NCT00806026|62722355|FG003|Overall Study|Lack of Efficacy|4|||
33345111|NCT00806026|62722356|FG004|Overall Study|Lack of Efficacy|8|||
33345112|NCT00806026|62722357|FG005|Overall Study|Lack of Efficacy|7|||
33345113|NCT00806026|62722352|FG000|Overall Study|Lost to Follow-up|8|||
33345114|NCT00806026|62722353|FG001|Overall Study|Lost to Follow-up|15|||
33345115|NCT00806026|62722354|FG002|Overall Study|Lost to Follow-up|8|||
33345116|NCT00806026|62722355|FG003|Overall Study|Lost to Follow-up|2|||
33345117|NCT00806026|62722356|FG004|Overall Study|Lost to Follow-up|6|||
33345118|NCT00806026|62722357|FG005|Overall Study|Lost to Follow-up|6|||
33345119|NCT00806026|62722352|FG000|Overall Study|Withdrawal by Subject|14|||
33345120|NCT00806026|62722353|FG001|Overall Study|Withdrawal by Subject|17|||
33345121|NCT00806026|62722354|FG002|Overall Study|Withdrawal by Subject|9|||
33345122|NCT00806026|62722355|FG003|Overall Study|Withdrawal by Subject|2|||
33345123|NCT00806026|62722356|FG004|Overall Study|Withdrawal by Subject|5|||
33345124|NCT00806026|62722357|FG005|Overall Study|Withdrawal by Subject|3|||
33345125|NCT00806026|62722352|FG000|Overall Study|Other|3|||
33345126|NCT00806026|62722353|FG001|Overall Study|Other|6|||
33345127|NCT00806026|62722354|FG002|Overall Study|Other|8|||
33345128|NCT00806026|62722355|FG003|Overall Study|Other|2|||
33345129|NCT00806026|62722356|FG004|Overall Study|Other|0|||
33345130|NCT00806026|62722357|FG005|Overall Study|Other|4|||
33345131|NCT00806026|62722352|FG000|Overall Study|Protocol Violation|6|||
33345132|NCT00806026|62722353|FG001|Overall Study|Protocol Violation|9|||
33345133|NCT00806026|62722354|FG002|Overall Study|Protocol Violation|9|||
33345134|NCT00806026|62722355|FG003|Overall Study|Protocol Violation|0|||
33345135|NCT00806026|62722356|FG004|Overall Study|Protocol Violation|2|||
33345136|NCT00806026|62722357|FG005|Overall Study|Protocol Violation|3|||
33345137|NCT00806026|62722352|FG000|Overall Study|Adverse Event|52|||
33345138|NCT00806026|62722353|FG001|Overall Study|Adverse Event|35|||
33470294|NCT03706040|62844036|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
33470295|NCT03706040|62844037|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
33470296|NCT03706040|62844038|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
33470297|NCT03706040|62844039|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
33470298|NCT03706040|62844040|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
33470299|NCT03706040|62844041|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
33470300|NCT03706040|62844042|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
33470301|NCT03706040|62844036|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
33470302|NCT03706040|62844037|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
33470303|NCT03706040|62844038|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
33470304|NCT03706040|62844039|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
33470305|NCT03706040|62844040|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
33470306|NCT03706040|62844041|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
33470307|NCT03706040|62844042|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
33470308|NCT03706040|62844036|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
33470309|NCT03706040|62844037|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
33470310|NCT03706040|62844038|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
33470311|NCT03706040|62844039|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
33470312|NCT03706040|62844040|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
33470313|NCT03706040|62844041|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
33470314|NCT03706040|62844042|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
33470315|NCT03706040|62844036|FG000|Period B (Week 16 to Week 52)|Other|0|||
33345139|NCT00806026|62722354|FG002|Overall Study|Adverse Event|44|||
33345140|NCT00806026|62722355|FG003|Overall Study|Adverse Event|17|||
33345141|NCT00806026|62722356|FG004|Overall Study|Adverse Event|9|||
33345142|NCT00806026|62722357|FG005|Overall Study|Adverse Event|9|||
33345143|NCT04026165|62722372|FG000|Run-in Placebo Period|Enrollment Error|13|||
33345144|NCT04026165|62722373|FG001|Run-in Placebo Period|Enrollment Error|0|||
33345145|NCT04026165|62722374|FG002|Run-in Placebo Period|Enrollment Error|0|||
33345146|NCT04026165|62722375|FG003|Run-in Placebo Period|Enrollment Error|0|||
33345147|NCT04026165|62722372|FG000|Run-in Placebo Period|Run-in Failure|4|||
33345148|NCT04026165|62722373|FG001|Run-in Placebo Period|Run-in Failure|0|||
33345149|NCT04026165|62722374|FG002|Run-in Placebo Period|Run-in Failure|0|||
33345150|NCT04026165|62722375|FG003|Run-in Placebo Period|Run-in Failure|0|||
33345151|NCT04026165|62722372|FG000|Run-in Placebo Period|Protocol Violation|2|||
33345152|NCT04026165|62722373|FG001|Run-in Placebo Period|Protocol Violation|0|||
33345153|NCT04026165|62722374|FG002|Run-in Placebo Period|Protocol Violation|0|||
33345154|NCT04026165|62722375|FG003|Run-in Placebo Period|Protocol Violation|0|||
33345155|NCT04026165|62722372|FG000|Run-in Placebo Period|Withdrew Consent|2|||
33345156|NCT04026165|62722373|FG001|Run-in Placebo Period|Withdrew Consent|0|||
33345157|NCT04026165|62722374|FG002|Run-in Placebo Period|Withdrew Consent|0|||
33345158|NCT04026165|62722375|FG003|Run-in Placebo Period|Withdrew Consent|0|||
33345159|NCT04026165|62722372|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
33345160|NCT04026165|62722373|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
33345161|NCT04026165|62722374|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
33345162|NCT04026165|62722375|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
33345163|NCT04026165|62722372|FG000|Run-in SEL Period|Run-in Failure|0|||
33345164|NCT04026165|62722373|FG001|Run-in SEL Period|Run-in Failure|26|||
33345165|NCT04026165|62722374|FG002|Run-in SEL Period|Run-in Failure|0|||
33345166|NCT04026165|62722375|FG003|Run-in SEL Period|Run-in Failure|0|||
33345167|NCT04026165|62722372|FG000|Run-in SEL Period|Withdrew Consent|0|||
33345168|NCT04026165|62722373|FG001|Run-in SEL Period|Withdrew Consent|10|||
33345169|NCT04026165|62722374|FG002|Run-in SEL Period|Withdrew Consent|0|||
33345170|NCT04026165|62722375|FG003|Run-in SEL Period|Withdrew Consent|0|||
33345171|NCT04026165|62722372|FG000|Run-in SEL Period|Enrollment Error|0|||
33345172|NCT04026165|62722373|FG001|Run-in SEL Period|Enrollment Error|4|||
33470316|NCT03706040|62844037|FG001|Period B (Week 16 to Week 52)|Other|0|||
33470317|NCT03706040|62844038|FG002|Period B (Week 16 to Week 52)|Other|0|||
33470318|NCT03706040|62844039|FG003|Period B (Week 16 to Week 52)|Other|4|||
33470319|NCT03706040|62844040|FG004|Period B (Week 16 to Week 52)|Other|5|||
33345173|NCT04026165|62722374|FG002|Run-in SEL Period|Enrollment Error|0|||
33345174|NCT04026165|62722375|FG003|Run-in SEL Period|Enrollment Error|0|||
33345175|NCT04026165|62722372|FG000|Run-in SEL Period|Protocol Violation|0|||
33345176|NCT04026165|62722373|FG001|Run-in SEL Period|Protocol Violation|3|||
33345177|NCT04026165|62722374|FG002|Run-in SEL Period|Protocol Violation|0|||
33345178|NCT04026165|62722375|FG003|Run-in SEL Period|Protocol Violation|0|||
33345179|NCT04026165|62722372|FG000|Run-in SEL Period|Investigator's Discretion|0|||
33345180|NCT04026165|62722373|FG001|Run-in SEL Period|Investigator's Discretion|2|||
33345181|NCT04026165|62722374|FG002|Run-in SEL Period|Investigator's Discretion|0|||
33345182|NCT04026165|62722375|FG003|Run-in SEL Period|Investigator's Discretion|0|||
33345183|NCT04026165|62722372|FG000|Run-in SEL Period|Death|0|||
33345184|NCT04026165|62722373|FG001|Run-in SEL Period|Death|1|||
33345185|NCT04026165|62722374|FG002|Run-in SEL Period|Death|0|||
33345186|NCT04026165|62722375|FG003|Run-in SEL Period|Death|0|||
33345187|NCT04026165|62722372|FG000|Randomized Period|Withdrew Consent|0|||
33345188|NCT04026165|62722373|FG001|Randomized Period|Withdrew Consent|0|||
33345189|NCT04026165|62722374|FG002|Randomized Period|Withdrew Consent|5|||
33345190|NCT04026165|62722375|FG003|Randomized Period|Withdrew Consent|8|||
33345191|NCT04026165|62722372|FG000|Randomized Period|Death|0|||
33345192|NCT04026165|62722373|FG001|Randomized Period|Death|0|||
33345193|NCT04026165|62722374|FG002|Randomized Period|Death|5|||
33345194|NCT04026165|62722375|FG003|Randomized Period|Death|7|||
33345195|NCT04026165|62722372|FG000|Randomized Period|Investigator's Discretion|0|||
33345196|NCT04026165|62722373|FG001|Randomized Period|Investigator's Discretion|0|||
33345197|NCT04026165|62722374|FG002|Randomized Period|Investigator's Discretion|2|||
33345198|NCT04026165|62722375|FG003|Randomized Period|Investigator's Discretion|2|||
33345199|NCT04026165|62722372|FG000|Randomized Period|Lost to Follow-up|0|||
33345200|NCT04026165|62722373|FG001|Randomized Period|Lost to Follow-up|0|||
33345201|NCT04026165|62722374|FG002|Randomized Period|Lost to Follow-up|2|||
33345202|NCT04026165|62722375|FG003|Randomized Period|Lost to Follow-up|2|||
33345203|NCT00805792|62722383|FG000|Overall Study|Death|3|||
33345204|NCT00805792|62722383|FG000|Overall Study|Lost to Follow-up|2|||
33345205|NCT00590044|62722389|FG000|Overall Study|Withdrawal by Subject|2|||
33345206|NCT00590044|62722390|FG001|Overall Study|Withdrawal by Subject|2|||
33345207|NCT00590044|62722389|FG000|Overall Study|wrong insulin arm assigned|1|||
33345208|NCT00590044|62722390|FG001|Overall Study|wrong insulin arm assigned|0|||
33345209|NCT00590044|62722389|FG000|Overall Study|Protocol Violation|1|||
33345210|NCT00590044|62722390|FG001|Overall Study|Protocol Violation|0|||
33345211|NCT00805480|62722403|FG000|Overall Study|Withdrawal by Subject|13|||
33345212|NCT00805480|62722404|FG001|Overall Study|Withdrawal by Subject|5|||
33345213|NCT00805480|62722405|FG002|Overall Study|Withdrawal by Subject|11|||
33345214|NCT00805480|62722406|FG003|Overall Study|Withdrawal by Subject|5|||
33345215|NCT00805480|62722403|FG000|Overall Study|Lost to Follow-up|1|||
33345216|NCT00805480|62722404|FG001|Overall Study|Lost to Follow-up|2|||
33345217|NCT00805480|62722405|FG002|Overall Study|Lost to Follow-up|0|||
33345218|NCT00805480|62722406|FG003|Overall Study|Lost to Follow-up|0|||
33345219|NCT00805480|62722403|FG000|Overall Study|Adverse Event|0|||
33345220|NCT00805480|62722404|FG001|Overall Study|Adverse Event|0|||
33345221|NCT00805480|62722405|FG002|Overall Study|Adverse Event|1|||
33345222|NCT00805480|62722406|FG003|Overall Study|Adverse Event|0|||
33345223|NCT00729937|62722422|FG000|Overall Study|Lost to Follow-up|49|||
33345224|NCT00729937|62722423|FG001|Overall Study|Lost to Follow-up|58|||
33345225|NCT00729937|62722424|FG002|Overall Study|Lost to Follow-up|18|||
33345226|NCT00729937|62722425|FG003|Overall Study|Lost to Follow-up|33|||
33345227|NCT00729937|62722426|FG004|Overall Study|Lost to Follow-up|18|||
33345228|NCT00729937|62722427|FG005|Overall Study|Lost to Follow-up|23|||
33345229|NCT00729937|62722422|FG000|Overall Study|Physician Decision|7|||
33345230|NCT00729937|62722423|FG001|Overall Study|Physician Decision|16|||
33345231|NCT00729937|62722424|FG002|Overall Study|Physician Decision|2|||
33345232|NCT00729937|62722425|FG003|Overall Study|Physician Decision|0|||
33345233|NCT00729937|62722426|FG004|Overall Study|Physician Decision|5|||
33345234|NCT00729937|62722427|FG005|Overall Study|Physician Decision|8|||
33345235|NCT00729937|62722422|FG000|Overall Study|Death|1|||
33345236|NCT00729937|62722423|FG001|Overall Study|Death|0|||
33345237|NCT00729937|62722424|FG002|Overall Study|Death|1|||
33345238|NCT00729937|62722425|FG003|Overall Study|Death|0|||
33345239|NCT00729937|62722426|FG004|Overall Study|Death|0|||
33345240|NCT00729937|62722427|FG005|Overall Study|Death|1|||
33345241|NCT00729937|62722422|FG000|Overall Study|Withdrawal by Subject|3|||
33470320|NCT03706040|62844041|FG005|Period B (Week 16 to Week 52)|Other|23|||
33470321|NCT03706040|62844042|FG006|Period B (Week 16 to Week 52)|Other|17|||
33654803|NCT01543087|63067822|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
33345242|NCT00729937|62722423|FG001|Overall Study|Withdrawal by Subject|5|||
33345243|NCT00729937|62722424|FG002|Overall Study|Withdrawal by Subject|6|||
33345244|NCT00729937|62722425|FG003|Overall Study|Withdrawal by Subject|0|||
33345245|NCT00729937|62722426|FG004|Overall Study|Withdrawal by Subject|4|||
33345246|NCT00729937|62722427|FG005|Overall Study|Withdrawal by Subject|2|||
33345247|NCT00729937|62722422|FG000|Overall Study|Randomized but not treated|12|||
33345248|NCT00729937|62722423|FG001|Overall Study|Randomized but not treated|6|||
33470322|NCT03770000|62844063|FG000|Overall Study|Premature discontinuation due to PD|0|||
33345249|NCT00729937|62722424|FG002|Overall Study|Randomized but not treated|1|||
33345250|NCT00729937|62722425|FG003|Overall Study|Randomized but not treated|0|||
33470323|NCT03770000|62844064|FG001|Overall Study|Premature discontinuation due to PD|0|||
33345251|NCT00729937|62722426|FG004|Overall Study|Randomized but not treated|1|||
33345252|NCT00729937|62722427|FG005|Overall Study|Randomized but not treated|3|||
33345253|NCT00729937|62722422|FG000|Overall Study|Did not meet eligibility criteria|2|||
33345254|NCT00729937|62722423|FG001|Overall Study|Did not meet eligibility criteria|1|||
33345255|NCT00729937|62722424|FG002|Overall Study|Did not meet eligibility criteria|0|||
33345256|NCT00729937|62722425|FG003|Overall Study|Did not meet eligibility criteria|0|||
33345257|NCT00729937|62722426|FG004|Overall Study|Did not meet eligibility criteria|0|||
33345258|NCT00729937|62722427|FG005|Overall Study|Did not meet eligibility criteria|0|||
33345259|NCT00729937|62722422|FG000|Overall Study|Incarcerated|0|||
33345260|NCT00729937|62722423|FG001|Overall Study|Incarcerated|2|||
33345261|NCT00729937|62722424|FG002|Overall Study|Incarcerated|1|||
33345262|NCT00729937|62722425|FG003|Overall Study|Incarcerated|1|||
33345263|NCT00729937|62722426|FG004|Overall Study|Incarcerated|0|||
33345264|NCT00729937|62722427|FG005|Overall Study|Incarcerated|0|||
33345265|NCT00729859|62722444|FG000|Overall Study|Adverse Event|0|||
33345266|NCT00729859|62722445|FG001|Overall Study|Adverse Event|1|||
33345267|NCT00729859|62722446|FG002|Overall Study|Adverse Event|0|||
33345268|NCT00729859|62722444|FG000|Overall Study|Withdrawal by Subject|0|||
33345269|NCT00729859|62722445|FG001|Overall Study|Withdrawal by Subject|1|||
33345270|NCT00729859|62722446|FG002|Overall Study|Withdrawal by Subject|0|||
33345271|NCT00810394|62722462|FG000|Overall Study|Withdrawal by Subject|3|||
33345272|NCT00736333|62722466|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
33345273|NCT00736333|62722466|FG000|Overall Study|Data Missing|2|||
33345274|NCT00736333|62722466|FG000|Overall Study|Tumor Progression|75|||
33345275|NCT00736333|62722466|FG000|Overall Study|Toxicity|6|||
33345276|NCT00736333|62722466|FG000|Overall Study|Withdrawal by Subject|10|||
33345277|NCT00736333|62722466|FG000|Overall Study|Death|7|||
33345278|NCT00736333|62722466|FG000|Overall Study|Other|4|||
33345279|NCT00736255|62722472|FG000|Overall Study|Adverse Event|1|||
33345280|NCT00736255|62722473|FG001|Overall Study|Adverse Event|0|||
33345281|NCT00736255|62722472|FG000|Overall Study|Physician Decision|1|||
33345282|NCT00736255|62722473|FG001|Overall Study|Physician Decision|0|||
33345283|NCT00736255|62722472|FG000|Overall Study|Non-compliance|1|||
33345284|NCT00736255|62722473|FG001|Overall Study|Non-compliance|1|||
33345285|NCT03920254|62722482|FG000|Overall Study|Adverse Event|1|||
33345286|NCT03920254|62722483|FG001|Overall Study|Adverse Event|0|||
33345287|NCT03920254|62722484|FG002|Overall Study|Adverse Event|0|||
33345288|NCT03920254|62722482|FG000|Overall Study|Physician Decision|0|||
33345289|NCT03920254|62722483|FG001|Overall Study|Physician Decision|1|||
33345290|NCT03920254|62722484|FG002|Overall Study|Physician Decision|2|||
33345291|NCT03920254|62722482|FG000|Overall Study|Study Terminated By Sponsor|12|||
33470324|NCT03770000|62844065|FG002|Overall Study|Premature discontinuation due to PD|1|||
33470325|NCT03770000|62844066|FG003|Overall Study|Premature discontinuation due to PD|3|||
33470326|NCT03770000|62844067|FG004|Overall Study|Premature discontinuation due to PD|2|||
33470327|NCT03158272|62844086|FG000|Overall Study|Disease progression|3|||
33470328|NCT03158272|62844087|FG001|Overall Study|Disease progression|3|||
33470329|NCT03158272|62844088|FG002|Overall Study|Disease progression|4|||
33654804|NCT01543087|63067823|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
33654805|NCT01543087|63067824|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
33654806|NCT01543087|63067825|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
33654807|NCT01543087|63067826|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
33654808|NCT01543087|63067821|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
33654809|NCT01543087|63067822|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
33654810|NCT01543087|63067823|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
33345292|NCT03920254|62722483|FG001|Overall Study|Study Terminated By Sponsor|17|||
33470330|NCT03158272|62844089|FG003|Overall Study|Disease progression|6|||
33470331|NCT03158272|62844086|FG000|Overall Study|Death|0|||
33470332|NCT03158272|62844087|FG001|Overall Study|Death|0|||
33470333|NCT03158272|62844088|FG002|Overall Study|Death|1|||
33345293|NCT03920254|62722484|FG002|Overall Study|Study Terminated By Sponsor|12|||
33345294|NCT03920254|62722482|FG000|Overall Study|Withdrawal by Subject|0|||
33345295|NCT03920254|62722483|FG001|Overall Study|Withdrawal by Subject|0|||
33470334|NCT03158272|62844089|FG003|Overall Study|Death|0|||
33345296|NCT03920254|62722484|FG002|Overall Study|Withdrawal by Subject|1|||
33345297|NCT00729469|62722494|FG000|Overall Study|Adverse Event|14|||
33345298|NCT00729469|62722495|FG001|Overall Study|Adverse Event|25|||
33345299|NCT00729469|62722494|FG000|Overall Study|Lost to Follow-up|9|||
33345300|NCT00729469|62722495|FG001|Overall Study|Lost to Follow-up|9|||
33345301|NCT00729469|62722494|FG000|Overall Study|Protocol Violation|2|||
33345302|NCT00729469|62722495|FG001|Overall Study|Protocol Violation|1|||
33345303|NCT00729469|62722494|FG000|Overall Study|Withdrawal by Subject|19|||
33345304|NCT00729469|62722495|FG001|Overall Study|Withdrawal by Subject|8|||
33345305|NCT00729469|62722494|FG000|Overall Study|Other-Not mentioned|9|||
33345306|NCT00729469|62722495|FG001|Overall Study|Other-Not mentioned|4|||
33345307|NCT00742183|62722503|FG000|Overall Study|Adverse Event|2|||
33345308|NCT00742183|62722504|FG001|Overall Study|Adverse Event|2|||
33345309|NCT00742183|62722503|FG000|Overall Study|Death|1|||
33345310|NCT00742183|62722504|FG001|Overall Study|Death|0|||
33345311|NCT00742183|62722503|FG000|Overall Study|Physician Decision|0|||
33345312|NCT00742183|62722504|FG001|Overall Study|Physician Decision|2|||
33345313|NCT00742183|62722503|FG000|Overall Study|Lost to Follow-up|4|||
33345314|NCT00742183|62722504|FG001|Overall Study|Lost to Follow-up|4|||
33345315|NCT00742183|62722503|FG000|Overall Study|Required skin-graft|1|||
33345316|NCT00742183|62722504|FG001|Overall Study|Required skin-graft|1|||
33345317|NCT00742183|62722503|FG000|Overall Study|Withdrawal by Subject|1|||
33345318|NCT00742183|62722504|FG001|Overall Study|Withdrawal by Subject|0|||
33345319|NCT00742183|62722503|FG000|Overall Study|Lack of Efficacy|0|||
33345320|NCT00742183|62722504|FG001|Overall Study|Lack of Efficacy|3|||
33345321|NCT00808444|62722512|FG000|Overall Study|Withdrawal by Subject|1|||
33345322|NCT00808444|62722513|FG001|Overall Study|Withdrawal by Subject|0|||
33345323|NCT00808444|62722512|FG000|Overall Study|Lost to Follow-up|0|||
33345324|NCT00808444|62722513|FG001|Overall Study|Lost to Follow-up|1|||
33345325|NCT00742027|62722519|FG000|Overall Study|Disease Progression|76|||
33345326|NCT00742027|62722519|FG000|Overall Study|New Cancer Therapy|19|||
33345327|NCT00742027|62722519|FG000|Overall Study|Withdrawal by Subject|18|||
33345328|NCT00742027|62722519|FG000|Overall Study|Death|7|||
33345329|NCT00742027|62722519|FG000|Overall Study|Lost to Follow-up|4|||
33345330|NCT00742027|62722519|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
33345331|NCT00742027|62722519|FG000|Overall Study|Missing|2|||
33345332|NCT00742027|62722519|FG000|Overall Study|Administrative Problems|1|||
33345333|NCT03996369|62722525|FG000|Overall Study|Protocol deviation|1|||
33345334|NCT03996369|62722526|FG001|Overall Study|Protocol deviation|1|||
33345335|NCT03996369|62722525|FG000|Overall Study|Physician Decision|4|||
33345336|NCT03996369|62722526|FG001|Overall Study|Physician Decision|2|||
33345337|NCT03996369|62722525|FG000|Overall Study|Participant decision|0|||
33345338|NCT03996369|62722526|FG001|Overall Study|Participant decision|1|||
33345339|NCT03996369|62722525|FG000|Overall Study|Lack of Efficacy|4|||
33345340|NCT03996369|62722526|FG001|Overall Study|Lack of Efficacy|0|||
33345341|NCT03996369|62722525|FG000|Overall Study|Adverse Event|9|||
33345342|NCT03996369|62722526|FG001|Overall Study|Adverse Event|0|||
33345343|NCT03996369|62722525|FG000|Overall Study|Withdrawal by Subject|6|||
33345344|NCT03996369|62722526|FG001|Overall Study|Withdrawal by Subject|8|||
33345345|NCT03996369|62722525|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
33345346|NCT03996369|62722526|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
33345347|NCT03996369|62722525|FG000|Overall Study|Lost to Follow-up|0|||
33345348|NCT03996369|62722526|FG001|Overall Study|Lost to Follow-up|1|||
33345349|NCT00808210|62722534|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
33345350|NCT00808210|62722535|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
33345351|NCT00808210|62722534|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
33345352|NCT00808210|62722535|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
33345353|NCT00808210|62722534|FG000|Double-Blind TX Period|Adverse Event|0|||
33345354|NCT00808210|62722535|FG001|Double-Blind TX Period|Adverse Event|1|||
33345355|NCT00808210|62722534|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
33345356|NCT00808210|62722535|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
33345357|NCT00808210|62722534|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
33345358|NCT00808210|62722535|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
33345359|NCT00808210|62722534|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
33345360|NCT00808210|62722535|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
33345361|NCT00736099|62722543|FG000|Overall Study|Adverse Event|61|||
33345362|NCT00736099|62722544|FG001|Overall Study|Adverse Event|18|||
33345363|NCT00736099|62722543|FG000|Overall Study|Protocol Violation|10|||
33345364|NCT00736099|62722544|FG001|Overall Study|Protocol Violation|4|||
33345365|NCT00736099|62722543|FG000|Overall Study|Lost to Follow-up|12|||
33345366|NCT00736099|62722544|FG001|Overall Study|Lost to Follow-up|5|||
33345367|NCT00736099|62722543|FG000|Overall Study|Withdrawal by Subject|42|||
33345368|NCT00736099|62722544|FG001|Overall Study|Withdrawal by Subject|13|||
33345369|NCT00736099|62722543|FG000|Overall Study|Lack of Efficacy|15|||
33345370|NCT00736099|62722544|FG001|Overall Study|Lack of Efficacy|8|||
33345371|NCT00736099|62722543|FG000|Overall Study|Other reason|43|||
33345372|NCT00736099|62722544|FG001|Overall Study|Other reason|10|||
33345373|NCT00735943|62722550|FG000|Overall Study|Lost to Follow-up|1|||
33345374|NCT00735943|62722550|FG000|Overall Study|Adverse Event|1|||
33345375|NCT00735709|62722558|FG000|Overall Study|Adverse Event|2|||
33345376|NCT00735709|62722559|FG001|Overall Study|Adverse Event|3|||
33470335|NCT03158272|62844086|FG000|Overall Study|Other reasons|0|||
33470336|NCT03158272|62844087|FG001|Overall Study|Other reasons|0|||
33470337|NCT03158272|62844088|FG002|Overall Study|Other reasons|1|||
33470338|NCT03158272|62844089|FG003|Overall Study|Other reasons|0|||
33470339|NCT03158272|62844086|FG000|Overall Study|Adverse event unrelated to the drug|0|||
33470340|NCT03158272|62844087|FG001|Overall Study|Adverse event unrelated to the drug|1|||
33470341|NCT03158272|62844088|FG002|Overall Study|Adverse event unrelated to the drug|0|||
33470342|NCT03158272|62844089|FG003|Overall Study|Adverse event unrelated to the drug|0|||
33470343|NCT03705494|62844103|FG000|Overall Study|Lost to Follow-up|2|||
33470344|NCT03705494|62844104|FG001|Overall Study|Lost to Follow-up|1|||
33470345|NCT03705494|62844103|FG000|Overall Study|Withdrawal by Subject|5|||
33470346|NCT03705494|62844104|FG001|Overall Study|Withdrawal by Subject|2|||
33470347|NCT01431508|62844110|FG000|Overall Study|Lack of Efficacy|1|||
33470348|NCT01431508|62844110|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
33470349|NCT00654628|62844114|FG000|6-week Active Treatment Period|Adverse Event|9|||
33470350|NCT00654628|62844114|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
33345377|NCT00735709|62722560|FG002|Overall Study|Adverse Event|1|||
33345378|NCT00735709|62722561|FG003|Overall Study|Adverse Event|5|||
33345379|NCT00735709|62722558|FG000|Overall Study|Lack of Efficacy|8|||
33345380|NCT00735709|62722559|FG001|Overall Study|Lack of Efficacy|4|||
33345381|NCT00735709|62722560|FG002|Overall Study|Lack of Efficacy|2|||
33345382|NCT00735709|62722561|FG003|Overall Study|Lack of Efficacy|3|||
33345383|NCT00735709|62722558|FG000|Overall Study|Noncompliance|0|||
33345384|NCT00735709|62722559|FG001|Overall Study|Noncompliance|0|||
33345385|NCT00735709|62722560|FG002|Overall Study|Noncompliance|1|||
33345386|NCT00735709|62722561|FG003|Overall Study|Noncompliance|0|||
33345387|NCT00735709|62722558|FG000|Overall Study|Protocol deviations|1|||
33345388|NCT00735709|62722559|FG001|Overall Study|Protocol deviations|2|||
33345389|NCT00735709|62722560|FG002|Overall Study|Protocol deviations|1|||
33345390|NCT00735709|62722561|FG003|Overall Study|Protocol deviations|1|||
33470351|NCT00654628|62844114|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
33470352|NCT00654628|62844114|FG000|6-week Active Treatment Period|Out of window period|1|||
33470353|NCT00654628|62844114|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
33654811|NCT01543087|63067824|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
33345391|NCT00735709|62722558|FG000|Overall Study|Voluntary Withdrawal|1|||
33345392|NCT00735709|62722559|FG001|Overall Study|Voluntary Withdrawal|3|||
33345393|NCT00735709|62722560|FG002|Overall Study|Voluntary Withdrawal|5|||
33345394|NCT00735709|62722561|FG003|Overall Study|Voluntary Withdrawal|7|||
33345395|NCT00735709|62722558|FG000|Overall Study|Lost to Follow-up|0|||
33345396|NCT00735709|62722559|FG001|Overall Study|Lost to Follow-up|1|||
33345397|NCT00735709|62722560|FG002|Overall Study|Lost to Follow-up|1|||
33345398|NCT00735709|62722561|FG003|Overall Study|Lost to Follow-up|1|||
33345399|NCT00735709|62722558|FG000|Overall Study|Excluded medication|1|||
33345400|NCT00735709|62722559|FG001|Overall Study|Excluded medication|0|||
33345401|NCT00735709|62722560|FG002|Overall Study|Excluded medication|0|||
33345402|NCT00735709|62722561|FG003|Overall Study|Excluded medication|1|||
33345403|NCT00729157|62722571|FG000|Overall Study|Withdrawal by Subject|1|||
33345404|NCT00728689|62722577|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
33345405|NCT00728689|62722578|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
33345406|NCT00727909|62722586|FG000|Overall Study|Withdrawal by Subject|5|||
33345407|NCT00727909|62722587|FG001|Overall Study|Withdrawal by Subject|11|||
33345408|NCT00727909|62722588|FG002|Overall Study|Withdrawal by Subject|8|||
33345409|NCT00727909|62722589|FG003|Overall Study|Withdrawal by Subject|5|||
33345410|NCT00727909|62722586|FG000|Overall Study|Death|0|||
33345411|NCT00727909|62722587|FG001|Overall Study|Death|0|||
33345412|NCT00727909|62722588|FG002|Overall Study|Death|1|||
33345413|NCT00727909|62722589|FG003|Overall Study|Death|0|||
33470354|NCT00654628|62844114|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
33654812|NCT01543087|63067825|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
33654813|NCT01543087|63067826|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
33654814|NCT01696058|63067864|FG000|Overall Study|Adverse Event|21|||
33345414|NCT00726895|62722593|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
33470355|NCT00536380|62844121|FG000|Overall Study|Adverse Event|0|||
33470356|NCT00536380|62844122|FG001|Overall Study|Adverse Event|2|||
33345415|NCT00726895|62722594|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33345416|NCT00585325|62722603|FG000|Overall Study|Withdrawal by Subject|1|||
33345417|NCT00585325|62722604|FG001|Overall Study|Withdrawal by Subject|1|||
33345418|NCT00726661|62722612|FG000|Overall Study|Lost to Follow-up|36|||
33345419|NCT00726661|62722613|FG001|Overall Study|Lost to Follow-up|11|||
33345420|NCT00726661|62722612|FG000|Overall Study|Withdrawal by Subject|17|||
33345421|NCT00726661|62722613|FG001|Overall Study|Withdrawal by Subject|13|||
33345422|NCT00726661|62722612|FG000|Overall Study|Trial terminated by sponsor|214|||
33345423|NCT00726661|62722613|FG001|Overall Study|Trial terminated by sponsor|187|||
33345424|NCT00726661|62722612|FG000|Overall Study|Death|475|||
33345425|NCT00726661|62722613|FG001|Overall Study|Death|159|||
33345426|NCT00726661|62722612|FG000|Overall Study|Physician Decision|25|||
33345427|NCT00726661|62722613|FG001|Overall Study|Physician Decision|13|||
33345428|NCT00726661|62722612|FG000|Overall Study|Other|47|||
33345429|NCT00726661|62722613|FG001|Overall Study|Other|35|||
33345430|NCT00741091|62722629|FG000|Overall Study|Death|13|||
33345431|NCT00741091|62722629|FG000|Overall Study|Lost to Follow-up|16|||
33345432|NCT00741091|62722629|FG000|Overall Study|Withdrawal by Subject|6|||
33345433|NCT00741091|62722629|FG000|Overall Study|Missed Visit|22|||
33345434|NCT00741013|62722636|FG000|Overall Study|Adverse Event|1|||
33345435|NCT00741013|62722637|FG001|Overall Study|Adverse Event|0|||
33345436|NCT00741013|62722638|FG002|Overall Study|Adverse Event|0|||
33345437|NCT00741013|62722636|FG000|Overall Study|Withdrawal by Subject|0|||
33345438|NCT00741013|62722637|FG001|Overall Study|Withdrawal by Subject|0|||
33345439|NCT00741013|62722638|FG002|Overall Study|Withdrawal by Subject|1|||
33345440|NCT00741013|62722636|FG000|Overall Study|Discovered failed screen after enrolled|0|||
33345441|NCT00741013|62722637|FG001|Overall Study|Discovered failed screen after enrolled|2|||
33345442|NCT00741013|62722638|FG002|Overall Study|Discovered failed screen after enrolled|0|||
33345443|NCT00740857|62722649|FG000|Overall Study|Withdrawal by Subject|1|||
33345444|NCT00740857|62722650|FG001|Overall Study|Withdrawal by Subject|0|||
33345445|NCT00740857|62722651|FG002|Overall Study|Withdrawal by Subject|0|||
33345446|NCT00808132|62722664|FG000|Overall Study|Adverse Event|34|||
33345447|NCT00808132|62722665|FG001|Overall Study|Adverse Event|33|||
33345448|NCT00808132|62722666|FG002|Overall Study|Adverse Event|16|||
33345449|NCT00808132|62722667|FG003|Overall Study|Adverse Event|31|||
33345450|NCT00808132|62722668|FG004|Overall Study|Adverse Event|33|||
33345451|NCT00808132|62722664|FG000|Overall Study|Death|0|||
33345452|NCT00808132|62722665|FG001|Overall Study|Death|0|||
33345453|NCT00808132|62722666|FG002|Overall Study|Death|0|||
33345454|NCT00808132|62722667|FG003|Overall Study|Death|0|||
33345455|NCT00808132|62722668|FG004|Overall Study|Death|1|||
33345456|NCT00808132|62722664|FG000|Overall Study|Physician Decision|0|||
33345457|NCT00808132|62722665|FG001|Overall Study|Physician Decision|1|||
33345458|NCT00808132|62722666|FG002|Overall Study|Physician Decision|0|||
33345459|NCT00808132|62722667|FG003|Overall Study|Physician Decision|0|||
33345460|NCT00808132|62722668|FG004|Overall Study|Physician Decision|0|||
33345461|NCT00808132|62722664|FG000|Overall Study|Lost to Follow-up|8|||
33345462|NCT00808132|62722665|FG001|Overall Study|Lost to Follow-up|10|||
33345463|NCT00808132|62722666|FG002|Overall Study|Lost to Follow-up|11|||
33345464|NCT00808132|62722667|FG003|Overall Study|Lost to Follow-up|8|||
33345465|NCT00808132|62722668|FG004|Overall Study|Lost to Follow-up|9|||
33345466|NCT00808132|62722664|FG000|Overall Study|Protocol Violation|8|||
33345467|NCT00808132|62722665|FG001|Overall Study|Protocol Violation|9|||
33345468|NCT00808132|62722666|FG002|Overall Study|Protocol Violation|4|||
33345469|NCT00808132|62722667|FG003|Overall Study|Protocol Violation|9|||
33345470|NCT00808132|62722668|FG004|Overall Study|Protocol Violation|5|||
33345471|NCT00808132|62722664|FG000|Overall Study|Withdrawal by Subject|27|||
33345472|NCT00808132|62722665|FG001|Overall Study|Withdrawal by Subject|18|||
33345473|NCT00808132|62722666|FG002|Overall Study|Withdrawal by Subject|2|||
33345474|NCT00808132|62722667|FG003|Overall Study|Withdrawal by Subject|7|||
33345475|NCT00808132|62722668|FG004|Overall Study|Withdrawal by Subject|16|||
33345476|NCT00808132|62722664|FG000|Overall Study|Other|6|||
33345477|NCT00808132|62722665|FG001|Overall Study|Other|4|||
33345478|NCT00808132|62722666|FG002|Overall Study|Other|6|||
33345479|NCT00808132|62722667|FG003|Overall Study|Other|2|||
33345480|NCT00808132|62722668|FG004|Overall Study|Other|15|||
33345481|NCT00808132|62722664|FG000|Overall Study|Randomized, but not treated|10|||
33345482|NCT00808132|62722665|FG001|Overall Study|Randomized, but not treated|7|||
33345483|NCT00808132|62722666|FG002|Overall Study|Randomized, but not treated|9|||
33345484|NCT00808132|62722667|FG003|Overall Study|Randomized, but not treated|8|||
33345485|NCT00808132|62722668|FG004|Overall Study|Randomized, but not treated|9|||
33345486|NCT00808132|62722664|FG000|Overall Study|Unsatisfactory response|5|||
33345487|NCT00808132|62722665|FG001|Overall Study|Unsatisfactory response|6|||
33345488|NCT00808132|62722666|FG002|Overall Study|Unsatisfactory response|6|||
33345489|NCT00808132|62722667|FG003|Overall Study|Unsatisfactory response|4|||
33345490|NCT00808132|62722668|FG004|Overall Study|Unsatisfactory response|12|||
33345491|NCT00727441|62722683|FG000|Overall Study|Disease Progression|11|||
33345492|NCT00727441|62722684|FG001|Overall Study|Disease Progression|14|||
33345493|NCT00727441|62722685|FG002|Overall Study|Disease Progression|17|||
33345494|NCT00727441|62722683|FG000|Overall Study|Eligibility|7|||
33345495|NCT00727441|62722684|FG001|Overall Study|Eligibility|5|||
33345496|NCT00727441|62722685|FG002|Overall Study|Eligibility|7|||
33345497|NCT00727441|62722683|FG000|Overall Study|Death|0|||
33345498|NCT00727441|62722684|FG001|Overall Study|Death|1|||
33345499|NCT00727441|62722685|FG002|Overall Study|Death|1|||
33345500|NCT00727441|62722683|FG000|Overall Study|Physician Decision|0|||
33345501|NCT00727441|62722684|FG001|Overall Study|Physician Decision|1|||
33345502|NCT00727441|62722685|FG002|Overall Study|Physician Decision|0|||
33345503|NCT00727441|62722683|FG000|Overall Study|Withdrawal by Subject|0|||
33345504|NCT00727441|62722684|FG001|Overall Study|Withdrawal by Subject|1|||
33345505|NCT00727441|62722685|FG002|Overall Study|Withdrawal by Subject|0|||
33345506|NCT00717769|62722699|FG000|Overall Study|Adverse Event|9|||
33345507|NCT00717769|62722700|FG001|Overall Study|Adverse Event|6|||
33345508|NCT00717769|62722701|FG002|Overall Study|Adverse Event|1|||
33345509|NCT00717769|62722699|FG000|Overall Study|Lack of compliance|0|||
33345510|NCT00717769|62722700|FG001|Overall Study|Lack of compliance|2|||
33345511|NCT00717769|62722701|FG002|Overall Study|Lack of compliance|0|||
33345512|NCT00717769|62722699|FG000|Overall Study|Lost to Follow-up|3|||
33345513|NCT00717769|62722700|FG001|Overall Study|Lost to Follow-up|4|||
33345514|NCT00717769|62722701|FG002|Overall Study|Lost to Follow-up|0|||
33345515|NCT00717769|62722699|FG000|Overall Study|Lack of Efficacy|1|||
33345516|NCT00717769|62722700|FG001|Overall Study|Lack of Efficacy|2|||
33345517|NCT00717769|62722701|FG002|Overall Study|Lack of Efficacy|0|||
33345518|NCT00717769|62722699|FG000|Overall Study|Protocol Violation|0|||
33345519|NCT00717769|62722700|FG001|Overall Study|Protocol Violation|2|||
33345520|NCT00717769|62722701|FG002|Overall Study|Protocol Violation|0|||
33345521|NCT00717769|62722699|FG000|Overall Study|Sponsor decision|1|||
33345522|NCT00717769|62722700|FG001|Overall Study|Sponsor decision|0|||
33345523|NCT00717769|62722701|FG002|Overall Study|Sponsor decision|10|||
33345524|NCT00717769|62722699|FG000|Overall Study|Withdrew consent|2|||
33345525|NCT00717769|62722700|FG001|Overall Study|Withdrew consent|2|||
33345526|NCT00717769|62722701|FG002|Overall Study|Withdrew consent|0|||
33345527|NCT04153929|62722719|FG000|Overall Study|Other than listed|2|||
33345528|NCT04153929|62722720|FG001|Overall Study|Other than listed|2|||
33345529|NCT04153929|62722721|FG002|Overall Study|Other than listed|0|||
33345530|NCT04153929|62722722|FG003|Overall Study|Other than listed|1|||
33345531|NCT04153929|62722723|FG004|Overall Study|Other than listed|0|||
33345532|NCT04153929|62722724|FG005|Overall Study|Other than listed|2|||
33345533|NCT04153929|62722725|FG006|Overall Study|Other than listed|2|||
33345534|NCT04153929|62722726|FG007|Overall Study|Other than listed|1|||
33345535|NCT04153929|62722719|FG000|Overall Study|Lost to Follow-up|2|||
33345536|NCT04153929|62722720|FG001|Overall Study|Lost to Follow-up|1|||
33345537|NCT04153929|62722721|FG002|Overall Study|Lost to Follow-up|0|||
33345538|NCT04153929|62722722|FG003|Overall Study|Lost to Follow-up|1|||
33345539|NCT04153929|62722723|FG004|Overall Study|Lost to Follow-up|1|||
33345540|NCT04153929|62722724|FG005|Overall Study|Lost to Follow-up|0|||
33345541|NCT04153929|62722725|FG006|Overall Study|Lost to Follow-up|0|||
33345542|NCT04153929|62722726|FG007|Overall Study|Lost to Follow-up|0|||
33345543|NCT04153929|62722719|FG000|Overall Study|Withdrawal by Subject|3|||
33345544|NCT04153929|62722720|FG001|Overall Study|Withdrawal by Subject|1|||
33345545|NCT04153929|62722721|FG002|Overall Study|Withdrawal by Subject|0|||
33345546|NCT04153929|62722722|FG003|Overall Study|Withdrawal by Subject|3|||
33345547|NCT04153929|62722723|FG004|Overall Study|Withdrawal by Subject|1|||
33345548|NCT04153929|62722724|FG005|Overall Study|Withdrawal by Subject|0|||
33345549|NCT04153929|62722725|FG006|Overall Study|Withdrawal by Subject|1|||
33345550|NCT04153929|62722726|FG007|Overall Study|Withdrawal by Subject|0|||
33345551|NCT04153929|62722719|FG000|Overall Study|Protocol Violation|0|||
33345552|NCT04153929|62722720|FG001|Overall Study|Protocol Violation|0|||
33345553|NCT04153929|62722721|FG002|Overall Study|Protocol Violation|0|||
33345554|NCT04153929|62722722|FG003|Overall Study|Protocol Violation|0|||
33345555|NCT04153929|62722723|FG004|Overall Study|Protocol Violation|0|||
33345556|NCT04153929|62722724|FG005|Overall Study|Protocol Violation|0|||
33345557|NCT04153929|62722725|FG006|Overall Study|Protocol Violation|1|||
33345558|NCT04153929|62722726|FG007|Overall Study|Protocol Violation|2|||
33345559|NCT04153929|62722719|FG000|Overall Study|Adverse Event|3|||
33345560|NCT04153929|62722720|FG001|Overall Study|Adverse Event|5|||
33345561|NCT04153929|62722721|FG002|Overall Study|Adverse Event|5|||
33345562|NCT04153929|62722722|FG003|Overall Study|Adverse Event|11|||
33345563|NCT04153929|62722723|FG004|Overall Study|Adverse Event|15|||
33345564|NCT04153929|62722724|FG005|Overall Study|Adverse Event|4|||
33345565|NCT04153929|62722725|FG006|Overall Study|Adverse Event|8|||
33345566|NCT04153929|62722726|FG007|Overall Study|Adverse Event|2|||
33345567|NCT04153929|62722719|FG000|Overall Study|Not treated|1|||
33345568|NCT04153929|62722720|FG001|Overall Study|Not treated|0|||
33345569|NCT04153929|62722721|FG002|Overall Study|Not treated|0|||
33345570|NCT04153929|62722722|FG003|Overall Study|Not treated|0|||
33345571|NCT04153929|62722723|FG004|Overall Study|Not treated|0|||
33345572|NCT04153929|62722724|FG005|Overall Study|Not treated|0|||
33345573|NCT04153929|62722725|FG006|Overall Study|Not treated|1|||
33345574|NCT04153929|62722726|FG007|Overall Study|Not treated|0|||
33345575|NCT00591214|62722744|FG000|Overall Study|Physician Decision|7|||
33345576|NCT00591214|62722744|FG000|Overall Study|Withdrawal by Subject|1|||
33345577|NCT00725725|62722751|FG000|Overall Study|Adverse Event|1|||
33345578|NCT00725725|62722752|FG001|Overall Study|Adverse Event|3|||
33345579|NCT00725725|62722753|FG002|Overall Study|Adverse Event|2|||
33345580|NCT00725725|62722751|FG000|Overall Study|Lost to Follow-up|2|||
33345581|NCT00725725|62722752|FG001|Overall Study|Lost to Follow-up|0|||
33345582|NCT00725725|62722753|FG002|Overall Study|Lost to Follow-up|2|||
33345583|NCT00725725|62722751|FG000|Overall Study|Withdrawal by Subject|1|||
33345584|NCT00725725|62722752|FG001|Overall Study|Withdrawal by Subject|0|||
33345585|NCT00725725|62722753|FG002|Overall Study|Withdrawal by Subject|1|||
33345586|NCT00725725|62722751|FG000|Overall Study|Protocol Violation|0|||
33345587|NCT00725725|62722752|FG001|Overall Study|Protocol Violation|1|||
33345588|NCT00725725|62722753|FG002|Overall Study|Protocol Violation|0|||
33345589|NCT00725101|62722761|FG000|Overall Study|Death|3|||
33345590|NCT00725101|62722761|FG000|Overall Study|Lost to Follow-up|353|||
33345591|NCT00725101|62722761|FG000|Overall Study|Protocol Violation|1|||
33345592|NCT00725101|62722761|FG000|Overall Study|Withdrawal by Subject|127|||
33345593|NCT00725101|62722761|FG000|Overall Study|not specified/no reason given|11|||
33345594|NCT00585169|62722765|FG000|Overall Study|Withdrawal by Subject|1|||
33345595|NCT00807742|62722773|FG000|Overall Study|Death|9|||
33345596|NCT00807742|62722774|FG001|Overall Study|Death|2|||
33345597|NCT00807742|62722773|FG000|Overall Study|Withdrawal by Subject|2|||
33345598|NCT00807742|62722774|FG001|Overall Study|Withdrawal by Subject|1|||
33345599|NCT00807742|62722773|FG000|Overall Study|Lost to Follow-up|35|||
33345600|NCT00807742|62722774|FG001|Overall Study|Lost to Follow-up|51|||
33345601|NCT00724945|62722780|FG000|Period 1|non-compliance|1|||
33345602|NCT00724945|62722781|FG001|Period 1|non-compliance|0|||
33345603|NCT00724945|62722780|FG000|Period 1|Adverse Event|1|||
33345604|NCT00724945|62722781|FG001|Period 1|Adverse Event|1|||
33345605|NCT00724945|62722780|FG000|Period 1|Lost to Follow-up|1|||
33345606|NCT00724945|62722781|FG001|Period 1|Lost to Follow-up|0|||
33345607|NCT00724945|62722780|FG000|Period 2|lens comfort issue|3|||
33345608|NCT00724945|62722781|FG001|Period 2|lens comfort issue|0|||
33345609|NCT00724945|62722780|FG000|Period 2|lens physiology issue|1|||
33345610|NCT00724945|62722781|FG001|Period 2|lens physiology issue|0|||
33345611|NCT00803452|62722789|FG000|Overall Study|Adverse Event|0|||
33345612|NCT00803452|62722790|FG001|Overall Study|Adverse Event|2|||
33345613|NCT00803452|62722789|FG000|Overall Study|Lost to Follow-up|0|||
33345614|NCT00803452|62722790|FG001|Overall Study|Lost to Follow-up|3|||
33345615|NCT00589108|62722799|FG000|Overall Study|Lost to Follow-up|1|||
33345616|NCT00589108|62722800|FG001|Overall Study|Lost to Follow-up|1|||
33345617|NCT00589108|62722801|FG002|Overall Study|Lost to Follow-up|1|||
33345618|NCT00589108|62722799|FG000|Overall Study|Death|3|||
33345619|NCT00589108|62722800|FG001|Overall Study|Death|3|||
33345620|NCT00589108|62722801|FG002|Overall Study|Death|4|||
33345621|NCT00717067|62722814|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
33345622|NCT00717067|62722815|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
33345623|NCT00717067|62722816|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
33345624|NCT00717067|62722817|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
33345625|NCT00717067|62722818|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
33345626|NCT00802438|62722840|FG000|Overall Study|Screen Failure|20|||
33345627|NCT00802438|62722840|FG000|Overall Study|Withdrawal by Subject|7|||
33345628|NCT00802438|62722840|FG000|Overall Study|Physician Decision|1|||
33345629|NCT00588952|62722850|FG000|Overall Study|Adverse Event|0|||
33345630|NCT00588952|62722851|FG001|Overall Study|Adverse Event|2|||
33345631|NCT00588952|62722850|FG000|Overall Study|Withdrawal by Subject|3|||
33345632|NCT00588952|62722851|FG001|Overall Study|Withdrawal by Subject|5|||
33345633|NCT01021748|62722866|FG000|Overall Study|Adverse Event|2|||
33345634|NCT01021748|62722867|FG001|Overall Study|Adverse Event|1|||
33345635|NCT01021748|62722868|FG002|Overall Study|Adverse Event|2|||
33345636|NCT01021748|62722869|FG003|Overall Study|Adverse Event|0|||
33345637|NCT01021748|62722870|FG004|Overall Study|Adverse Event|2|||
33345638|NCT01021748|62722871|FG005|Overall Study|Adverse Event|0|||
33345639|NCT01021748|62722872|FG006|Overall Study|Adverse Event|1|||
33345640|NCT01021748|62722873|FG007|Overall Study|Adverse Event|0|||
33470357|NCT00536380|62844123|FG002|Overall Study|Adverse Event|2|||
33470358|NCT00536380|62844121|FG000|Overall Study|Lost to Follow-up|0|||
33470359|NCT00536380|62844122|FG001|Overall Study|Lost to Follow-up|0|||
33345641|NCT01021748|62722874|FG008|Overall Study|Adverse Event|7|||
33345642|NCT01021748|62722866|FG000|Overall Study|Physician Decision|1|||
33345643|NCT01021748|62722867|FG001|Overall Study|Physician Decision|0|||
33345644|NCT01021748|62722868|FG002|Overall Study|Physician Decision|1|||
33345645|NCT01021748|62722869|FG003|Overall Study|Physician Decision|1|||
33345646|NCT01021748|62722870|FG004|Overall Study|Physician Decision|0|||
33345647|NCT01021748|62722871|FG005|Overall Study|Physician Decision|0|||
33345648|NCT01021748|62722872|FG006|Overall Study|Physician Decision|1|||
33345649|NCT01021748|62722873|FG007|Overall Study|Physician Decision|1|||
33345650|NCT01021748|62722874|FG008|Overall Study|Physician Decision|2|||
33345651|NCT01021748|62722866|FG000|Overall Study|Progressive Disease|3|||
33345652|NCT01021748|62722867|FG001|Overall Study|Progressive Disease|3|||
33345653|NCT01021748|62722868|FG002|Overall Study|Progressive Disease|4|||
33345654|NCT01021748|62722869|FG003|Overall Study|Progressive Disease|6|||
33470360|NCT00536380|62844123|FG002|Overall Study|Lost to Follow-up|1|||
33345655|NCT01021748|62722870|FG004|Overall Study|Progressive Disease|7|||
33345656|NCT01021748|62722871|FG005|Overall Study|Progressive Disease|3|||
33345657|NCT01021748|62722872|FG006|Overall Study|Progressive Disease|0|||
33345658|NCT01021748|62722873|FG007|Overall Study|Progressive Disease|5|||
33345659|NCT01021748|62722874|FG008|Overall Study|Progressive Disease|6|||
33345660|NCT01021748|62722866|FG000|Overall Study|Withdrawal by Subject|0|||
33345661|NCT01021748|62722867|FG001|Overall Study|Withdrawal by Subject|0|||
33345662|NCT01021748|62722868|FG002|Overall Study|Withdrawal by Subject|0|||
33345663|NCT01021748|62722869|FG003|Overall Study|Withdrawal by Subject|0|||
33345664|NCT01021748|62722870|FG004|Overall Study|Withdrawal by Subject|0|||
33345665|NCT01021748|62722871|FG005|Overall Study|Withdrawal by Subject|0|||
33345666|NCT01021748|62722872|FG006|Overall Study|Withdrawal by Subject|1|||
33345667|NCT01021748|62722873|FG007|Overall Study|Withdrawal by Subject|0|||
33345668|NCT01021748|62722874|FG008|Overall Study|Withdrawal by Subject|1|||
33345669|NCT01021748|62722866|FG000|Overall Study|Not Treated|0|||
33345670|NCT01021748|62722867|FG001|Overall Study|Not Treated|1|||
33345671|NCT01021748|62722868|FG002|Overall Study|Not Treated|0|||
33345672|NCT01021748|62722869|FG003|Overall Study|Not Treated|0|||
33345673|NCT01021748|62722870|FG004|Overall Study|Not Treated|0|||
33345674|NCT01021748|62722871|FG005|Overall Study|Not Treated|0|||
33345675|NCT01021748|62722872|FG006|Overall Study|Not Treated|0|||
33345676|NCT01021748|62722873|FG007|Overall Study|Not Treated|0|||
33345677|NCT01021748|62722874|FG008|Overall Study|Not Treated|0|||
33345678|NCT00802360|62722898|FG000|Overall Study|Stimulation failure|4|||
33345679|NCT00802360|62722899|FG001|Overall Study|Stimulation failure|0|||
33345680|NCT00802360|62722900|FG002|Overall Study|Stimulation failure|3|||
33345681|NCT00802360|62722901|FG003|Overall Study|Stimulation failure|3|||
33345682|NCT00802360|62722898|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
33345683|NCT00802360|62722899|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
33345684|NCT00802360|62722900|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
33345685|NCT00802360|62722901|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
33345686|NCT00802360|62722898|FG000|Overall Study|Cycle cancelled|0|||
33345687|NCT00802360|62722899|FG001|Overall Study|Cycle cancelled|1|||
33345688|NCT00802360|62722900|FG002|Overall Study|Cycle cancelled|1|||
33345689|NCT00802360|62722901|FG003|Overall Study|Cycle cancelled|1|||
33345690|NCT00802360|62722898|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
33345691|NCT00802360|62722899|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
33470361|NCT00536380|62844121|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
33470362|NCT00536380|62844122|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
33470363|NCT00536380|62844123|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
33470364|NCT00536380|62844121|FG000|Overall Study|Withdrawal related to study drug|7|||
33470365|NCT00536380|62844122|FG001|Overall Study|Withdrawal related to study drug|5|||
33470366|NCT00536380|62844123|FG002|Overall Study|Withdrawal related to study drug|2|||
33470367|NCT00536380|62844121|FG000|Overall Study|Noncompliance with protocol|3|||
33470368|NCT00536380|62844122|FG001|Overall Study|Noncompliance with protocol|2|||
33470369|NCT00536380|62844123|FG002|Overall Study|Noncompliance with protocol|2|||
33470370|NCT00536380|62844121|FG000|Overall Study|Did not meet protocol eligibility|0|||
33470371|NCT00536380|62844122|FG001|Overall Study|Did not meet protocol eligibility|0|||
33470372|NCT00536380|62844123|FG002|Overall Study|Did not meet protocol eligibility|1|||
33345692|NCT00802360|62722900|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
33345693|NCT00802360|62722901|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
33345694|NCT00802360|62722898|FG000|Overall Study|No positive serum pregnancy|17|||
33345695|NCT00802360|62722899|FG001|Overall Study|No positive serum pregnancy|20|||
33345696|NCT00802360|62722900|FG002|Overall Study|No positive serum pregnancy|14|||
33345697|NCT00802360|62722901|FG003|Overall Study|No positive serum pregnancy|10|||
33345698|NCT00802360|62722898|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
33345699|NCT00802360|62722899|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
33345700|NCT00802360|62722900|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
33345701|NCT00802360|62722901|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
33345702|NCT00802360|62722898|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
33345703|NCT00802360|62722899|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
33345704|NCT00802360|62722900|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
33345705|NCT00802360|62722901|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
33548923|NCT02901431|62940300|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33470373|NCT00536380|62844121|FG000|Overall Study|Administrative|0|||
33470374|NCT00536380|62844122|FG001|Overall Study|Administrative|0|||
33548924|NCT02901431|62940301|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33548925|NCT02901431|62940302|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33470375|NCT00536380|62844123|FG002|Overall Study|Administrative|1|||
33548926|NCT02901431|62940303|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33345706|NCT00802360|62722898|FG000|Overall Study|Other|2|||
33345707|NCT00802360|62722899|FG001|Overall Study|Other|3|||
33345708|NCT00802360|62722900|FG002|Overall Study|Other|6|||
33470376|NCT00496834|62844133|FG000|Overall Study|Withdrawal by Subject|4|||
33470377|NCT00496834|62844134|FG001|Overall Study|Withdrawal by Subject|6|||
33548927|NCT02901431|62940304|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33345709|NCT00802360|62722901|FG003|Overall Study|Other|3|||
33345710|NCT01026038|62722916|FG000|Overall Study|Lost to Follow-up|1|||
33345711|NCT01026038|62722917|FG001|Overall Study|Lost to Follow-up|1|||
33345712|NCT01026038|62722918|FG002|Overall Study|Lost to Follow-up|0|||
33345713|NCT00801892|62722937|FG000|Main Study Period|Withdrawal by Subject|0|||
33345714|NCT00801892|62722938|FG001|Main Study Period|Withdrawal by Subject|1|||
33345715|NCT00801892|62722937|FG000|Sham Crossover Period|Lost to Follow-up|0|||
33345716|NCT00801892|62722938|FG001|Sham Crossover Period|Lost to Follow-up|2|||
33345717|NCT02680587|62722952|FG000|Overall Study|Withdrawal by Subject|1|||
33345718|NCT02680587|62722953|FG001|Overall Study|Withdrawal by Subject|0|||
33345719|NCT00589420|62722963|FG000|Overall Study|screen failure|1|||
33345720|NCT01025336|62722972|FG000|Overall Study|Protocol Violation|0|||
33345721|NCT01025336|62722973|FG001|Overall Study|Protocol Violation|0|||
33345722|NCT01025336|62722974|FG002|Overall Study|Protocol Violation|0|||
33345723|NCT01025336|62722975|FG003|Overall Study|Protocol Violation|2|||
33345724|NCT01025336|62722976|FG004|Overall Study|Protocol Violation|0|||
33345725|NCT00796978|62723010|FG000|Overall Study|Cardiac adverse event|5|||
33345726|NCT00796978|62723010|FG000|Overall Study|Adverse Event|4|||
33345727|NCT00796978|62723010|FG000|Overall Study|Withdrawal by Subject|3|||
33345728|NCT00796822|62723016|FG000|Overall Study|Lost to Follow-up|2|||
33345729|NCT00796822|62723017|FG001|Overall Study|Lost to Follow-up|0|||
33345730|NCT00796822|62723016|FG000|Overall Study|Adverse Event|1|||
33345731|NCT00796822|62723017|FG001|Overall Study|Adverse Event|0|||
33345732|NCT01020812|62723023|FG000|Overall Study|Physician Decision|1|||
33345733|NCT01020812|62723023|FG000|Overall Study|Withdrawal by Subject|1|||
33345734|NCT01020812|62723023|FG000|Overall Study|Protocol Violation|1|||
33345735|NCT01032044|62723029|FG000|Overall Study|Protocol Violation|14|||
33345736|NCT01032044|62723030|FG001|Overall Study|Protocol Violation|8|||
33345737|NCT01032044|62723029|FG000|Overall Study|Adverse Event|0|||
33470378|NCT00496834|62844133|FG000|Overall Study|Contraindicated medication administered|0|||
33470379|NCT00496834|62844134|FG001|Overall Study|Contraindicated medication administered|1|||
33345738|NCT01032044|62723030|FG001|Overall Study|Adverse Event|1|||
33345739|NCT01032044|62723029|FG000|Overall Study|Lost to Follow-up|11|||
33345740|NCT01032044|62723030|FG001|Overall Study|Lost to Follow-up|11|||
33345741|NCT01024946|62723036|FG000|Overall Study|Screen Failure|3|||
33345742|NCT01024946|62723036|FG000|Overall Study|Withdrawal by Subject|1|||
33345743|NCT01024946|62723036|FG000|Overall Study|Adverse Event|1|||
33345744|NCT00724867|62723040|FG000|Overall Study|Adverse Event|25|||
33345745|NCT00724867|62723040|FG000|Overall Study|Lack of Efficacy|14|||
33345746|NCT00724867|62723040|FG000|Overall Study|Lost to Follow-up|12|||
33345747|NCT00724867|62723040|FG000|Overall Study|Non-compliance with study drug|6|||
33345748|NCT00724867|62723040|FG000|Overall Study|Physician Decision|17|||
33345749|NCT00724867|62723040|FG000|Overall Study|Protocol Violation|1|||
33345750|NCT00724867|62723040|FG000|Overall Study|Withdrawal by Subject|31|||
33345751|NCT00724867|62723040|FG000|Overall Study|Sponsor decision to end study|14|||
33345752|NCT00724867|62723040|FG000|Overall Study|Subject incarcerated|1|||
33345753|NCT00724867|62723040|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
33345754|NCT00724867|62723040|FG000|Overall Study|Subject moved out of state|1|||
33345755|NCT00724867|62723040|FG000|Overall Study|Elected to exit due to site closure|2|||
33345756|NCT00724711|62723049|FG000|Overall Study|Adverse Event|7|||
33345757|NCT00724711|62723050|FG001|Overall Study|Adverse Event|3|||
33345758|NCT00724711|62723049|FG000|Overall Study|Pregnancy|0|||
33345759|NCT00724711|62723050|FG001|Overall Study|Pregnancy|1|||
33345760|NCT00724711|62723049|FG000|Overall Study|Lack of Efficacy|0|||
33345761|NCT00724711|62723050|FG001|Overall Study|Lack of Efficacy|1|||
33345762|NCT00724711|62723049|FG000|Overall Study|Physician Decision|0|||
33345763|NCT00724711|62723050|FG001|Overall Study|Physician Decision|3|||
33345764|NCT00724711|62723049|FG000|Overall Study|Withdrawal by Subject|5|||
33345765|NCT00724711|62723050|FG001|Overall Study|Withdrawal by Subject|4|||
33345766|NCT00724711|62723049|FG000|Overall Study|Lost to Follow-up|4|||
33345767|NCT00724711|62723050|FG001|Overall Study|Lost to Follow-up|5|||
33345768|NCT00724711|62723049|FG000|Overall Study|Protocol Violation|1|||
33345769|NCT00724711|62723050|FG001|Overall Study|Protocol Violation|0|||
33345770|NCT01024244|62723061|FG000|Overall Study|Adverse Event|1|||
33470380|NCT00496834|62844133|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
33345771|NCT01024244|62723062|FG001|Overall Study|Adverse Event|2|||
33345772|NCT01024244|62723063|FG002|Overall Study|Adverse Event|0|||
33470381|NCT00496834|62844134|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
33470382|NCT00496834|62844133|FG000|Overall Study|Adverse Event|5|||
33345773|NCT01024244|62723064|FG003|Overall Study|Adverse Event|1|||
33345774|NCT01024244|62723065|FG004|Overall Study|Adverse Event|2|||
33345775|NCT01024244|62723061|FG000|Overall Study|Entry Criteria Not Met|0|||
33345776|NCT01024244|62723062|FG001|Overall Study|Entry Criteria Not Met|1|||
33345777|NCT01024244|62723063|FG002|Overall Study|Entry Criteria Not Met|0|||
33345778|NCT01024244|62723064|FG003|Overall Study|Entry Criteria Not Met|0|||
33345779|NCT01024244|62723065|FG004|Overall Study|Entry Criteria Not Met|0|||
33345780|NCT01024244|62723061|FG000|Overall Study|Lack of Efficacy|1|||
33345781|NCT01024244|62723062|FG001|Overall Study|Lack of Efficacy|0|||
33345782|NCT01024244|62723063|FG002|Overall Study|Lack of Efficacy|0|||
33345783|NCT01024244|62723064|FG003|Overall Study|Lack of Efficacy|0|||
33345784|NCT01024244|62723065|FG004|Overall Study|Lack of Efficacy|0|||
33345785|NCT01024244|62723061|FG000|Overall Study|Protocol Violation|1|||
33345786|NCT01024244|62723062|FG001|Overall Study|Protocol Violation|0|||
33345787|NCT01024244|62723063|FG002|Overall Study|Protocol Violation|0|||
33345788|NCT01024244|62723064|FG003|Overall Study|Protocol Violation|0|||
33345789|NCT01024244|62723065|FG004|Overall Study|Protocol Violation|2|||
33345790|NCT01024244|62723061|FG000|Overall Study|Sponsor Decision|14|||
33345791|NCT01024244|62723062|FG001|Overall Study|Sponsor Decision|7|||
33345792|NCT01024244|62723063|FG002|Overall Study|Sponsor Decision|14|||
33345793|NCT01024244|62723064|FG003|Overall Study|Sponsor Decision|12|||
33345794|NCT01024244|62723065|FG004|Overall Study|Sponsor Decision|10|||
33345795|NCT01024244|62723061|FG000|Overall Study|Withdrawal by Subject|0|||
33345796|NCT01024244|62723062|FG001|Overall Study|Withdrawal by Subject|1|||
33345797|NCT01024244|62723063|FG002|Overall Study|Withdrawal by Subject|0|||
33345798|NCT01024244|62723064|FG003|Overall Study|Withdrawal by Subject|0|||
33345799|NCT01024244|62723065|FG004|Overall Study|Withdrawal by Subject|0|||
33345800|NCT00721279|62723079|FG000|Overall Study|Lack of Efficacy|6|||
33345801|NCT00721279|62723080|FG001|Overall Study|Lack of Efficacy|3|||
33345802|NCT00721279|62723079|FG000|Overall Study|Tolerability insufficient|5|||
33345803|NCT00721279|62723080|FG001|Overall Study|Tolerability insufficient|2|||
33345804|NCT00721279|62723079|FG000|Overall Study|Withdrawal by Subject|13|||
33345805|NCT00721279|62723080|FG001|Overall Study|Withdrawal by Subject|3|||
33345806|NCT00721279|62723079|FG000|Overall Study|Other|12|||
33345807|NCT00721279|62723080|FG001|Overall Study|Other|16|||
33345808|NCT01030952|62723089|FG000|Overall Study|Protocol Violation|0|||
33345809|NCT01030952|62723090|FG001|Overall Study|Protocol Violation|1|||
33345810|NCT01030952|62723089|FG000|Overall Study|Informed consent withdrawal|1|||
33345811|NCT01030952|62723090|FG001|Overall Study|Informed consent withdrawal|0|||
33345812|NCT01030952|62723089|FG000|Overall Study|Lost to Follow-up|0|||
33345813|NCT01030952|62723090|FG001|Overall Study|Lost to Follow-up|1|||
33345814|NCT01030952|62723089|FG000|Overall Study|Unexplained|1|||
33345815|NCT01030952|62723090|FG001|Overall Study|Unexplained|1|||
33345816|NCT01030874|62723100|FG000|Overall Study|Withdrawal by Subject|1|||
33345817|NCT01030874|62723101|FG001|Overall Study|Withdrawal by Subject|0|||
33345818|NCT01030874|62723100|FG000|Overall Study|Discharged in first 2 weeks|17|||
33345819|NCT01030874|62723101|FG001|Overall Study|Discharged in first 2 weeks|16|||
33345820|NCT03611751|62723110|FG000|Pre-treatment|Randomized but not treated|1|||
33345821|NCT03611751|62723111|FG001|Pre-treatment|Randomized but not treated|1|||
33345822|NCT03611751|62723112|FG002|Pre-treatment|Randomized but not treated|0|||
33345823|NCT03611751|62723110|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
33345824|NCT03611751|62723111|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
33345825|NCT03611751|62723112|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
33345826|NCT03611751|62723110|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
33345827|NCT03611751|62723111|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
33345828|NCT03611751|62723112|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
33345829|NCT03611751|62723110|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
33345830|NCT03611751|62723111|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
33345831|NCT03611751|62723112|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
33345832|NCT03611751|62723110|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
33345833|NCT03611751|62723111|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
33345834|NCT03611751|62723112|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
33345835|NCT03611751|62723110|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
33345836|NCT03611751|62723111|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
33345837|NCT03611751|62723112|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
33345838|NCT03611751|62723110|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
33345839|NCT03611751|62723111|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
33345840|NCT03611751|62723112|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
33345841|NCT03611751|62723110|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
33345842|NCT03611751|62723111|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
33345843|NCT03611751|62723112|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
33345844|NCT03611751|62723110|FG000|Treatment Week 0 - Week 16|Death|0|||
33654815|NCT01696058|63067865|FG001|Overall Study|Adverse Event|11|||
33345845|NCT03611751|62723111|FG001|Treatment Week 0 - Week 16|Death|0|||
33345846|NCT03611751|62723112|FG002|Treatment Week 0 - Week 16|Death|1|||
33345847|NCT03611751|62723110|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
33345848|NCT03611751|62723111|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
33345849|NCT03611751|62723112|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
33345850|NCT03611751|62723110|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
33345851|NCT03611751|62723111|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
33345852|NCT03611751|62723112|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
33345853|NCT03611751|62723110|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
33345854|NCT03611751|62723111|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
33345855|NCT03611751|62723112|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
33345856|NCT03611751|62723110|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
33345857|NCT03611751|62723111|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
33345858|NCT03611751|62723112|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
33345859|NCT03611751|62723110|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
33345860|NCT03611751|62723111|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
33345861|NCT03611751|62723112|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
33345862|NCT03611751|62723110|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
33345863|NCT03611751|62723111|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
33345864|NCT03611751|62723112|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
33345865|NCT03611751|62723110|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
33345866|NCT03611751|62723111|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
33345867|NCT03611751|62723112|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
33345868|NCT03611751|62723110|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
33345869|NCT03611751|62723111|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
33345870|NCT03611751|62723112|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
33345871|NCT03611751|62723110|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
33345872|NCT03611751|62723111|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
33345873|NCT03611751|62723112|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
33345874|NCT03611751|62723110|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
33345875|NCT03611751|62723111|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
33345876|NCT03611751|62723112|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
33345877|NCT03611751|62723110|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
33345878|NCT03611751|62723111|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
33345879|NCT03611751|62723112|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
33345880|NCT03611751|62723110|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
33345881|NCT03611751|62723111|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
33345882|NCT03611751|62723112|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
33345883|NCT03611751|62723110|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
33345884|NCT03611751|62723111|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
33345885|NCT03611751|62723112|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
33345886|NCT03611751|62723110|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
33345887|NCT03611751|62723111|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
33345888|NCT03611751|62723112|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
33345889|NCT00721123|62723129|FG000|Overall Study|Adverse Event|96|||
33345890|NCT00721123|62723129|FG000|Overall Study|Death|10|||
33345891|NCT00721123|62723129|FG000|Overall Study|Insufficient Therapeutic Response|21|||
33345892|NCT00721123|62723129|FG000|Overall Study|Protocol Violation|1|||
33345893|NCT00721123|62723129|FG000|Overall Study|Refused Treatment|41|||
33345894|NCT00721123|62723129|FG000|Overall Study|Failure to Return|9|||
33345895|NCT00721123|62723129|FG000|Overall Study|Withdrawal by Subject|5|||
33345896|NCT00720499|62723149|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
33345897|NCT00720499|62723150|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
33345898|NCT00720499|62723149|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
33345899|NCT00720499|62723150|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
33345900|NCT00720499|62723149|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
33345901|NCT00720499|62723150|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
33345902|NCT00724243|62723157|FG000|Overall Study|Lack of Efficacy|10|||
33345903|NCT00724243|62723157|FG000|Overall Study|Adverse Event|5|||
33470383|NCT00496834|62844134|FG001|Overall Study|Adverse Event|3|||
33470384|NCT00496834|62844133|FG000|Overall Study|IP administration violation|2|||
33470385|NCT00496834|62844134|FG001|Overall Study|IP administration violation|0|||
33470386|NCT00496834|62844133|FG000|Overall Study|Lost to Follow-up|2|||
33470387|NCT00496834|62844134|FG001|Overall Study|Lost to Follow-up|0|||
33470388|NCT00496834|62844133|FG000|Overall Study|Blood Pressure control failure|2|||
33470389|NCT00496834|62844134|FG001|Overall Study|Blood Pressure control failure|1|||
33470390|NCT05244122|62844142|FG000|Overall Study|Withdrawal by Subject|318|||
33470391|NCT00166504|62844163|FG000|Overall Study|Adverse Event|3|||
33470392|NCT00166504|62844164|FG001|Overall Study|Adverse Event|3|||
33345904|NCT00720343|62723161|FG000|Overall Study|Physician Decision|3|||
33345905|NCT00720343|62723161|FG000|Overall Study|No data|3|||
33345906|NCT00720109|62723167|FG000|Induction Period|Did not meet eligibility criteria|3|||
33345907|NCT00720109|62723168|FG001|Induction Period|Did not meet eligibility criteria|0|||
33345908|NCT00720109|62723169|FG002|Induction Period|Did not meet eligibility criteria|0|||
33345909|NCT00720109|62723167|FG000|Induction Period|Bone Marrow Transplant|2|||
33345910|NCT00720109|62723168|FG001|Induction Period|Bone Marrow Transplant|0|||
33345911|NCT00720109|62723169|FG002|Induction Period|Bone Marrow Transplant|0|||
33345912|NCT00720109|62723167|FG000|Induction Period|Physician Decision|1|||
33470393|NCT00166504|62844163|FG000|Overall Study|Lost to Follow-up|1|||
33345913|NCT00720109|62723168|FG001|Induction Period|Physician Decision|0|||
33345914|NCT00720109|62723169|FG002|Induction Period|Physician Decision|0|||
33345915|NCT00720109|62723167|FG000|Risk Stratification Period|Adverse Event|0|||
33345916|NCT00720109|62723168|FG001|Risk Stratification Period|Adverse Event|1|||
33345917|NCT00720109|62723169|FG002|Risk Stratification Period|Adverse Event|0|||
33345918|NCT00720109|62723167|FG000|Risk Stratification Period|Physician Decision|0|||
33470394|NCT00166504|62844164|FG001|Overall Study|Lost to Follow-up|1|||
33345919|NCT00720109|62723168|FG001|Risk Stratification Period|Physician Decision|2|||
33345920|NCT00720109|62723169|FG002|Risk Stratification Period|Physician Decision|1|||
33345921|NCT00720109|62723167|FG000|Risk Stratification Period|Bone marrow transplant|0|||
33345922|NCT00720109|62723168|FG001|Risk Stratification Period|Bone marrow transplant|9|||
33345923|NCT00720109|62723169|FG002|Risk Stratification Period|Bone marrow transplant|7|||
33345924|NCT00720109|62723167|FG000|Risk Stratification Period|Disease progression or relapse|0|||
33345925|NCT00720109|62723168|FG001|Risk Stratification Period|Disease progression or relapse|2|||
33345926|NCT00720109|62723169|FG002|Risk Stratification Period|Disease progression or relapse|0|||
33345927|NCT00720109|62723167|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
33345928|NCT00720109|62723168|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
33345929|NCT00720109|62723169|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
33345930|NCT01015118|62723180|FG000|Overall Study|Protocol Violation|5|||
33345931|NCT01015118|62723181|FG001|Overall Study|Protocol Violation|6|||
33345932|NCT01015118|62723180|FG000|Overall Study|Withdrawal by Subject|103|||
33345933|NCT01015118|62723181|FG001|Overall Study|Withdrawal by Subject|27|||
33345934|NCT01015118|62723180|FG000|Overall Study|Other Adverse Event (AE)|141|||
33345935|NCT01015118|62723181|FG001|Overall Study|Other Adverse Event (AE)|33|||
33345936|NCT01015118|62723180|FG000|Overall Study|Worsening or AE of underlying disease|5|||
33345937|NCT01015118|62723181|FG001|Overall Study|Worsening or AE of underlying disease|4|||
33345938|NCT01015118|62723180|FG000|Overall Study|Progressive disease|364|||
33345939|NCT01015118|62723181|FG001|Overall Study|Progressive disease|229|||
33345940|NCT01015118|62723180|FG000|Overall Study|Not treated|9|||
33345941|NCT01015118|62723181|FG001|Overall Study|Not treated|5|||
33345942|NCT01015118|62723180|FG000|Overall Study|Other than stated above|42|||
33345943|NCT01015118|62723181|FG001|Overall Study|Other than stated above|23|||
33345944|NCT00800176|62723193|FG000|Overall Study|Adverse Event|2|||
33345945|NCT00800176|62723194|FG001|Overall Study|Adverse Event|1|||
33345946|NCT00800176|62723195|FG002|Overall Study|Adverse Event|0|||
33345947|NCT00800176|62723196|FG003|Overall Study|Adverse Event|2|||
33345948|NCT00800176|62723197|FG004|Overall Study|Adverse Event|1|||
33345949|NCT00800176|62723198|FG005|Overall Study|Adverse Event|1|||
33345950|NCT00800176|62723193|FG000|Overall Study|Refused treatment|3|||
33345951|NCT00800176|62723194|FG001|Overall Study|Refused treatment|2|||
33345952|NCT00800176|62723195|FG002|Overall Study|Refused treatment|0|||
33345953|NCT00800176|62723196|FG003|Overall Study|Refused treatment|0|||
33345954|NCT00800176|62723197|FG004|Overall Study|Refused treatment|1|||
33345955|NCT00800176|62723198|FG005|Overall Study|Refused treatment|4|||
33345956|NCT00800176|62723193|FG000|Overall Study|Failure to return|3|||
33345957|NCT00800176|62723194|FG001|Overall Study|Failure to return|3|||
33345958|NCT00800176|62723195|FG002|Overall Study|Failure to return|0|||
33345959|NCT00800176|62723196|FG003|Overall Study|Failure to return|2|||
33345960|NCT00800176|62723197|FG004|Overall Study|Failure to return|0|||
33345961|NCT00800176|62723198|FG005|Overall Study|Failure to return|0|||
33345962|NCT00800176|62723193|FG000|Overall Study|Other|1|||
33345963|NCT00800176|62723194|FG001|Overall Study|Other|0|||
33345964|NCT00800176|62723195|FG002|Overall Study|Other|0|||
33345965|NCT00800176|62723196|FG003|Overall Study|Other|0|||
33345966|NCT00800176|62723197|FG004|Overall Study|Other|2|||
33345967|NCT00800176|62723198|FG005|Overall Study|Other|0|||
33345968|NCT00715429|62723214|FG000|Overall Study|Did not complete the study diary|0|||
33345969|NCT00715429|62723215|FG001|Overall Study|Did not complete the study diary|1|||
33345970|NCT00715117|62723237|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
33345971|NCT00715117|62723238|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
33345972|NCT00723229|62723251|FG000|First Intervention|Lost to Follow-up|7|||
33345973|NCT00723229|62723252|FG001|First Intervention|Lost to Follow-up|3|||
33345974|NCT01030718|62723267|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
33345975|NCT01030718|62723268|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
33345976|NCT01030718|62723269|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
33345977|NCT01030718|62723267|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
33345978|NCT01030718|62723268|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
33345979|NCT01030718|62723269|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
33345980|NCT01030718|62723267|FG000|Studies CA180-031 and -036 Combined|Death|0|||
33345981|NCT01030718|62723268|FG001|Studies CA180-031 and -036 Combined|Death|1|||
33345982|NCT01030718|62723269|FG002|Studies CA180-031 and -036 Combined|Death|0|||
33345983|NCT01030718|62723267|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
33654816|NCT01696058|63067864|FG000|Overall Study|Lack of Efficacy|2|||
33345984|NCT01030718|62723268|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
33345985|NCT01030718|62723269|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
33345986|NCT01030718|62723267|FG000|Study CA180-036 Only|insufficient effect|1|||
33345987|NCT01030718|62723268|FG001|Study CA180-036 Only|insufficient effect|1|||
33345988|NCT01030718|62723269|FG002|Study CA180-036 Only|insufficient effect|5|||
33345989|NCT01030718|62723267|FG000|Study CA180-036 Only|Adverse Event|2|||
33345990|NCT01030718|62723268|FG001|Study CA180-036 Only|Adverse Event|3|||
33654817|NCT01696058|63067865|FG001|Overall Study|Lack of Efficacy|3|||
33654818|NCT01696058|63067864|FG000|Overall Study|Protocol Violation|9|||
33345991|NCT01030718|62723269|FG002|Study CA180-036 Only|Adverse Event|0|||
33345992|NCT01030718|62723267|FG000|Study CA180-036 Only|Death|0|||
33345993|NCT01030718|62723268|FG001|Study CA180-036 Only|Death|1|||
33345994|NCT01030718|62723269|FG002|Study CA180-036 Only|Death|0|||
33345995|NCT01030718|62723267|FG000|Study CA180-036 Only|Other Reasons|0|||
33345996|NCT01030718|62723268|FG001|Study CA180-036 Only|Other Reasons|2|||
33345997|NCT01030718|62723269|FG002|Study CA180-036 Only|Other Reasons|0|||
33345998|NCT00722761|62723289|FG000|Overall Study|Lost to Follow-up|1|||
33345999|NCT00722761|62723290|FG001|Overall Study|Lost to Follow-up|4|||
33346000|NCT00722761|62723289|FG000|Overall Study|Withdrawal by Subject|5|||
33346001|NCT00722761|62723290|FG001|Overall Study|Withdrawal by Subject|2|||
33346002|NCT00719953|62723296|FG000|Overall Study|Adverse Event|4|||
33346003|NCT01019486|62723303|FG000|Overall Study|Withdrawal by Subject|1|||
33346004|NCT01019486|62723304|FG001|Overall Study|Withdrawal by Subject|1|||
33346005|NCT01019486|62723305|FG002|Overall Study|Withdrawal by Subject|1|||
33346006|NCT02803203|62723314|FG000|Overall Study|Adverse Event|4|||
33346007|NCT02803203|62723314|FG000|Overall Study|Death|4|||
33346008|NCT02803203|62723314|FG000|Overall Study|Progressive disease|29|||
33346009|NCT02803203|62723314|FG000|Overall Study|Withdrawal by Subject|8|||
33346010|NCT02803203|62723314|FG000|Overall Study|Complete resection of target disease|2|||
33346011|NCT02803203|62723314|FG000|Overall Study|Switched to commercial Osi|1|||
33346012|NCT02803203|62723314|FG000|Overall Study|Participant moved away|1|||
33346013|NCT00714493|62723319|FG000|Overall Study|Adverse Event|11|||
33346014|NCT00714493|62723319|FG000|Overall Study|Death|3|||
33346015|NCT00714493|62723319|FG000|Overall Study|Lack of Efficacy|10|||
33346016|NCT00714493|62723319|FG000|Overall Study|Lost to Follow-up|3|||
33346017|NCT00714493|62723319|FG000|Overall Study|Protocol Violation|12|||
33346018|NCT00714493|62723319|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
33346019|NCT00714493|62723319|FG000|Overall Study|OTHER|2|||
33346020|NCT01019252|62723325|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
33346021|NCT01019252|62723326|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
33470395|NCT00166504|62844163|FG000|Overall Study|Withdrawal by Subject|1|||
33470396|NCT00166504|62844164|FG001|Overall Study|Withdrawal by Subject|0|||
33470397|NCT03137992|62844170|FG000|Washout Period 1|Adverse Event|1|||
33470398|NCT03137992|62844171|FG001|Washout Period 1|Adverse Event|1|||
33470399|NCT03137992|62844172|FG002|Washout Period 1|Adverse Event|0|||
33470400|NCT03137992|62844173|FG003|Washout Period 1|Adverse Event|0|||
33470401|NCT03137992|62844174|FG004|Washout Period 1|Adverse Event|0|||
33470402|NCT03137992|62844175|FG005|Washout Period 1|Adverse Event|1|||
33470403|NCT03137992|62844170|FG000|Washout Period 1|Withdrawal by Subject|0|||
33470404|NCT03137992|62844171|FG001|Washout Period 1|Withdrawal by Subject|1|||
33470405|NCT03137992|62844172|FG002|Washout Period 1|Withdrawal by Subject|1|||
33470406|NCT03137992|62844173|FG003|Washout Period 1|Withdrawal by Subject|0|||
33470407|NCT03137992|62844174|FG004|Washout Period 1|Withdrawal by Subject|0|||
33470408|NCT03137992|62844175|FG005|Washout Period 1|Withdrawal by Subject|0|||
33470409|NCT03137992|62844170|FG000|Washout Period 1|Principal Investigator Discretion|0|||
33470410|NCT03137992|62844171|FG001|Washout Period 1|Principal Investigator Discretion|1|||
33470411|NCT03137992|62844172|FG002|Washout Period 1|Principal Investigator Discretion|0|||
33470412|NCT03137992|62844173|FG003|Washout Period 1|Principal Investigator Discretion|0|||
33470413|NCT03137992|62844174|FG004|Washout Period 1|Principal Investigator Discretion|0|||
33470414|NCT03137992|62844175|FG005|Washout Period 1|Principal Investigator Discretion|0|||
33470415|NCT03137992|62844170|FG000|Washout Period 1|COPD Exacerbation|1|||
33470416|NCT03137992|62844171|FG001|Washout Period 1|COPD Exacerbation|1|||
33470417|NCT03137992|62844172|FG002|Washout Period 1|COPD Exacerbation|1|||
33470418|NCT03137992|62844173|FG003|Washout Period 1|COPD Exacerbation|0|||
33470419|NCT03137992|62844174|FG004|Washout Period 1|COPD Exacerbation|1|||
33470420|NCT03137992|62844175|FG005|Washout Period 1|COPD Exacerbation|1|||
33470421|NCT03137992|62844170|FG000|Washout Period 1|Subject Noncompliance|1|||
33470422|NCT03137992|62844171|FG001|Washout Period 1|Subject Noncompliance|0|||
33346022|NCT01019252|62723325|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
33346023|NCT01019252|62723326|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
33470423|NCT03137992|62844172|FG002|Washout Period 1|Subject Noncompliance|0|||
33470424|NCT03137992|62844173|FG003|Washout Period 1|Subject Noncompliance|0|||
33470425|NCT03137992|62844174|FG004|Washout Period 1|Subject Noncompliance|1|||
33470426|NCT03137992|62844175|FG005|Washout Period 1|Subject Noncompliance|0|||
33346024|NCT01019252|62723325|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
33470427|NCT03137992|62844170|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
33470428|NCT03137992|62844171|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
33470429|NCT03137992|62844172|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
33654819|NCT01696058|63067865|FG001|Overall Study|Protocol Violation|3|||
33346025|NCT01019252|62723326|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
33346026|NCT01019252|62723325|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
33346027|NCT01019252|62723326|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
33346028|NCT01013870|62723334|FG000|Overall Study|Lost to Follow-up|1|||
33346029|NCT01013870|62723335|FG001|Overall Study|Lost to Follow-up|3|||
33346030|NCT01013792|62723343|FG000|Overall Study|Study suspended|2|||
33346031|NCT01013792|62723344|FG001|Overall Study|Study suspended|1|||
33346032|NCT01013792|62723343|FG000|Overall Study|Adverse Event|0|||
33346033|NCT01013792|62723344|FG001|Overall Study|Adverse Event|3|||
33346034|NCT01013792|62723343|FG000|Overall Study|Lost to Follow-up|0|||
33346035|NCT01013792|62723344|FG001|Overall Study|Lost to Follow-up|1|||
33346036|NCT01018862|62723353|FG000|Overall Study|Adverse Event|2|||
33346037|NCT01018862|62723354|FG001|Overall Study|Adverse Event|0|||
33346038|NCT01018862|62723355|FG002|Overall Study|Adverse Event|6|||
33346039|NCT01018862|62723353|FG000|Overall Study|Lack of Efficacy|1|||
33346040|NCT01018862|62723354|FG001|Overall Study|Lack of Efficacy|0|||
33346041|NCT01018862|62723355|FG002|Overall Study|Lack of Efficacy|2|||
33346042|NCT01018862|62723353|FG000|Overall Study|Lost to Follow-up|3|||
33346043|NCT01018862|62723354|FG001|Overall Study|Lost to Follow-up|1|||
33346044|NCT01018862|62723355|FG002|Overall Study|Lost to Follow-up|0|||
33346045|NCT01018862|62723353|FG000|Overall Study|Protocol Violation|1|||
33346046|NCT01018862|62723354|FG001|Overall Study|Protocol Violation|3|||
33346047|NCT01018862|62723355|FG002|Overall Study|Protocol Violation|3|||
33346048|NCT01018862|62723353|FG000|Overall Study|Withdrawal by Subject|1|||
33346049|NCT01018862|62723354|FG001|Overall Study|Withdrawal by Subject|2|||
33346050|NCT01018862|62723355|FG002|Overall Study|Withdrawal by Subject|1|||
33346051|NCT01018862|62723353|FG000|Overall Study|administrative problems|5|||
33346052|NCT01018862|62723354|FG001|Overall Study|administrative problems|4|||
33346053|NCT01018862|62723355|FG002|Overall Study|administrative problems|4|||
33346054|NCT01018394|62723365|FG000|Overall Study|Withdrawal by Subject|5|||
33346055|NCT01018394|62723366|FG001|Overall Study|Withdrawal by Subject|5|||
33346056|NCT01018394|62723365|FG000|Overall Study|Lost to Follow-up|4|||
33346057|NCT01018394|62723366|FG001|Overall Study|Lost to Follow-up|3|||
33346058|NCT01017146|62723374|FG000|Overall Study|Adverse Event|11|||
33346059|NCT01017146|62723375|FG001|Overall Study|Adverse Event|1|||
33346060|NCT01017146|62723374|FG000|Overall Study|Lost to Follow-up|14|||
33346061|NCT01017146|62723375|FG001|Overall Study|Lost to Follow-up|14|||
33346062|NCT01017146|62723374|FG000|Overall Study|Noncompliance with Study Product|1|||
33346063|NCT01017146|62723375|FG001|Overall Study|Noncompliance with Study Product|1|||
33346064|NCT01017146|62723374|FG000|Overall Study|Withdrawal by Subject|32|||
33346065|NCT01017146|62723375|FG001|Overall Study|Withdrawal by Subject|16|||
33346066|NCT01017146|62723374|FG000|Overall Study|Relocation|0|||
33346067|NCT01017146|62723375|FG001|Overall Study|Relocation|4|||
33346068|NCT01017146|62723374|FG000|Overall Study|Pregnancy|2|||
33346069|NCT01017146|62723375|FG001|Overall Study|Pregnancy|1|||
33346070|NCT01017146|62723374|FG000|Overall Study|Protocol Violation|2|||
33346071|NCT01017146|62723375|FG001|Overall Study|Protocol Violation|0|||
33346072|NCT01017146|62723374|FG000|Overall Study|Took Excluded Medication|2|||
33346073|NCT01017146|62723375|FG001|Overall Study|Took Excluded Medication|0|||
33346074|NCT01017146|62723374|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
33346075|NCT01017146|62723375|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
33346076|NCT01017146|62723374|FG000|Overall Study|Change in Work Situation|1|||
33346077|NCT01017146|62723375|FG001|Overall Study|Change in Work Situation|0|||
33346078|NCT01010750|62723387|FG000|Second Intervention|Adverse Event|0|||
33346079|NCT01010750|62723388|FG001|Second Intervention|Adverse Event|1|||
33346080|NCT01010750|62723389|FG002|Second Intervention|Adverse Event|0|||
33346081|NCT01010750|62723390|FG003|Second Intervention|Adverse Event|0|||
33346082|NCT01010750|62723391|FG004|Second Intervention|Adverse Event|0|||
33346083|NCT01010750|62723392|FG005|Second Intervention|Adverse Event|0|||
33346084|NCT01012622|62723400|FG000|Overall Study|Withdrawal by Subject|6|||
33346085|NCT01012622|62723400|FG000|Overall Study|Lost to Follow-up|5|||
33346086|NCT01012622|62723400|FG000|Overall Study|Adverse Event|7|||
33346087|NCT01012622|62723400|FG000|Overall Study|non-compliance with the drug|9|||
33346088|NCT01012622|62723400|FG000|Overall Study|Other|1|||
33346089|NCT01012622|62723400|FG000|Overall Study|screening failure|1|||
33346090|NCT01012622|62723400|FG000|Overall Study|withdrawal of consent by a parent|2|||
33346091|NCT00722371|62723411|FG000|Overall Study|Adverse Event|6|||
33346092|NCT00722371|62723412|FG001|Overall Study|Adverse Event|13|||
33346093|NCT00722371|62723413|FG002|Overall Study|Adverse Event|9|||
33346094|NCT00722371|62723414|FG003|Overall Study|Adverse Event|10|||
33346095|NCT00722371|62723415|FG004|Overall Study|Adverse Event|6|||
33346096|NCT00722371|62723416|FG005|Overall Study|Adverse Event|8|||
33346097|NCT00722371|62723417|FG006|Overall Study|Adverse Event|4|||
33346098|NCT00722371|62723411|FG000|Overall Study|Contraindication|0|||
33346099|NCT00722371|62723412|FG001|Overall Study|Contraindication|0|||
33346100|NCT00722371|62723413|FG002|Overall Study|Contraindication|1|||
33346101|NCT00722371|62723414|FG003|Overall Study|Contraindication|0|||
33346102|NCT00722371|62723415|FG004|Overall Study|Contraindication|0|||
33346103|NCT00722371|62723416|FG005|Overall Study|Contraindication|0|||
33346104|NCT00722371|62723417|FG006|Overall Study|Contraindication|0|||
33346105|NCT00722371|62723411|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
33346106|NCT00722371|62723412|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
33346107|NCT00722371|62723413|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
33346108|NCT00722371|62723414|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
33470430|NCT03137992|62844173|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
33470431|NCT03137992|62844174|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
33470432|NCT03137992|62844175|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
33470433|NCT03137992|62844170|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
33470434|NCT03137992|62844171|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
33470435|NCT03137992|62844172|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
33470436|NCT03137992|62844173|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
33470437|NCT03137992|62844174|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
33470438|NCT03137992|62844175|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
33470439|NCT03137992|62844170|FG000|Period 2 (Visit 3)|Adverse Event|0|||
33470440|NCT03137992|62844171|FG001|Period 2 (Visit 3)|Adverse Event|1|||
33470441|NCT03137992|62844172|FG002|Period 2 (Visit 3)|Adverse Event|0|||
33346109|NCT00722371|62723415|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
33346110|NCT00722371|62723416|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
33346111|NCT00722371|62723417|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
33346112|NCT00722371|62723411|FG000|Overall Study|Excluded medication|0|||
33346113|NCT00722371|62723412|FG001|Overall Study|Excluded medication|1|||
33346114|NCT00722371|62723413|FG002|Overall Study|Excluded medication|1|||
33346115|NCT00722371|62723414|FG003|Overall Study|Excluded medication|0|||
33346116|NCT00722371|62723415|FG004|Overall Study|Excluded medication|0|||
33346117|NCT00722371|62723416|FG005|Overall Study|Excluded medication|0|||
33346118|NCT00722371|62723417|FG006|Overall Study|Excluded medication|1|||
33346119|NCT00722371|62723411|FG000|Overall Study|Hyperglycemia|2|||
33346120|NCT00722371|62723412|FG001|Overall Study|Hyperglycemia|6|||
33346121|NCT00722371|62723413|FG002|Overall Study|Hyperglycemia|4|||
33346122|NCT00722371|62723414|FG003|Overall Study|Hyperglycemia|2|||
33346123|NCT00722371|62723415|FG004|Overall Study|Hyperglycemia|5|||
33346124|NCT00722371|62723416|FG005|Overall Study|Hyperglycemia|1|||
33346125|NCT00722371|62723417|FG006|Overall Study|Hyperglycemia|1|||
33346126|NCT00722371|62723411|FG000|Overall Study|Hypoglycemia|1|||
33346127|NCT00722371|62723412|FG001|Overall Study|Hypoglycemia|0|||
33346128|NCT00722371|62723413|FG002|Overall Study|Hypoglycemia|0|||
33346129|NCT00722371|62723414|FG003|Overall Study|Hypoglycemia|0|||
33346130|NCT00722371|62723415|FG004|Overall Study|Hypoglycemia|0|||
33346131|NCT00722371|62723416|FG005|Overall Study|Hypoglycemia|0|||
33346132|NCT00722371|62723417|FG006|Overall Study|Hypoglycemia|0|||
33346133|NCT00722371|62723411|FG000|Overall Study|Lack of Efficacy|4|||
33346134|NCT00722371|62723412|FG001|Overall Study|Lack of Efficacy|6|||
33346135|NCT00722371|62723413|FG002|Overall Study|Lack of Efficacy|6|||
33346136|NCT00722371|62723414|FG003|Overall Study|Lack of Efficacy|6|||
33346137|NCT00722371|62723415|FG004|Overall Study|Lack of Efficacy|2|||
33346138|NCT00722371|62723416|FG005|Overall Study|Lack of Efficacy|3|||
33346139|NCT00722371|62723417|FG006|Overall Study|Lack of Efficacy|0|||
33346140|NCT00722371|62723411|FG000|Overall Study|Lost to Follow-up|11|||
33346141|NCT00722371|62723412|FG001|Overall Study|Lost to Follow-up|14|||
33346142|NCT00722371|62723413|FG002|Overall Study|Lost to Follow-up|21|||
33346143|NCT00722371|62723414|FG003|Overall Study|Lost to Follow-up|13|||
33346144|NCT00722371|62723415|FG004|Overall Study|Lost to Follow-up|8|||
33346145|NCT00722371|62723416|FG005|Overall Study|Lost to Follow-up|16|||
33346146|NCT00722371|62723417|FG006|Overall Study|Lost to Follow-up|13|||
33346147|NCT00722371|62723411|FG000|Overall Study|Physician Decision|5|||
33346148|NCT00722371|62723412|FG001|Overall Study|Physician Decision|2|||
33346149|NCT00722371|62723413|FG002|Overall Study|Physician Decision|2|||
33346150|NCT00722371|62723414|FG003|Overall Study|Physician Decision|5|||
33346151|NCT00722371|62723415|FG004|Overall Study|Physician Decision|2|||
33346152|NCT00722371|62723416|FG005|Overall Study|Physician Decision|3|||
33346153|NCT00722371|62723417|FG006|Overall Study|Physician Decision|4|||
33346154|NCT00722371|62723411|FG000|Overall Study|Pregnancy|1|||
33346155|NCT00722371|62723412|FG001|Overall Study|Pregnancy|1|||
33346156|NCT00722371|62723413|FG002|Overall Study|Pregnancy|0|||
33346157|NCT00722371|62723414|FG003|Overall Study|Pregnancy|0|||
33346158|NCT00722371|62723415|FG004|Overall Study|Pregnancy|0|||
33346159|NCT00722371|62723416|FG005|Overall Study|Pregnancy|1|||
33470442|NCT03137992|62844173|FG003|Period 2 (Visit 3)|Adverse Event|0|||
33470443|NCT03137992|62844174|FG004|Period 2 (Visit 3)|Adverse Event|0|||
33346160|NCT00722371|62723417|FG006|Overall Study|Pregnancy|0|||
33346161|NCT00722371|62723411|FG000|Overall Study|Protocol Violation|6|||
33346162|NCT00722371|62723412|FG001|Overall Study|Protocol Violation|1|||
33346163|NCT00722371|62723413|FG002|Overall Study|Protocol Violation|0|||
33346164|NCT00722371|62723414|FG003|Overall Study|Protocol Violation|1|||
33346165|NCT00722371|62723415|FG004|Overall Study|Protocol Violation|4|||
33346166|NCT00722371|62723416|FG005|Overall Study|Protocol Violation|2|||
33346167|NCT00722371|62723417|FG006|Overall Study|Protocol Violation|1|||
33470444|NCT03137992|62844175|FG005|Period 2 (Visit 3)|Adverse Event|0|||
33346168|NCT00722371|62723411|FG000|Overall Study|Withdrawal by Subject|18|||
33346169|NCT00722371|62723412|FG001|Overall Study|Withdrawal by Subject|27|||
33346170|NCT00722371|62723413|FG002|Overall Study|Withdrawal by Subject|19|||
33346171|NCT00722371|62723414|FG003|Overall Study|Withdrawal by Subject|23|||
33346172|NCT00722371|62723415|FG004|Overall Study|Withdrawal by Subject|19|||
33346173|NCT00722371|62723416|FG005|Overall Study|Withdrawal by Subject|18|||
33346174|NCT00722371|62723417|FG006|Overall Study|Withdrawal by Subject|26|||
33346175|NCT00722137|62723435|FG000|Overall Study|Overt Disease Progression|5|||
33346176|NCT00722137|62723436|FG001|Overall Study|Overt Disease Progression|4|||
33346177|NCT00722137|62723435|FG000|Overall Study|Adverse Event|17|||
33346178|NCT00722137|62723436|FG001|Overall Study|Adverse Event|21|||
33346179|NCT00722137|62723435|FG000|Overall Study|Death|12|||
33346180|NCT00722137|62723436|FG001|Overall Study|Death|7|||
33346181|NCT00722137|62723435|FG000|Overall Study|Withdrawal by Subject|6|||
33346182|NCT00722137|62723436|FG001|Overall Study|Withdrawal by Subject|9|||
33346183|NCT00722137|62723435|FG000|Overall Study|Other Reason Unknown|3|||
33346184|NCT00722137|62723436|FG001|Overall Study|Other Reason Unknown|4|||
33346185|NCT00722137|62723435|FG000|Overall Study|Randomized But Not Treated|2|||
33346186|NCT00722137|62723436|FG001|Overall Study|Randomized But Not Treated|3|||
33346187|NCT00796666|62723450|FG000|Overall Study|Death|2|||
33346188|NCT00796666|62723451|FG001|Overall Study|Death|4|||
33346189|NCT00796666|62723450|FG000|Overall Study|Withdrawal by Subject|2|||
33346190|NCT00796666|62723451|FG001|Overall Study|Withdrawal by Subject|0|||
33346191|NCT00796666|62723450|FG000|Overall Study|Adverse Event|7|||
33346192|NCT00796666|62723451|FG001|Overall Study|Adverse Event|5|||
33346193|NCT00796666|62723450|FG000|Overall Study|Protocol Violation|1|||
33346194|NCT00796666|62723451|FG001|Overall Study|Protocol Violation|0|||
33346195|NCT00796666|62723450|FG000|Overall Study|Other|1|||
33346196|NCT00796666|62723451|FG001|Overall Study|Other|0|||
33346197|NCT00796666|62723450|FG000|Overall Study|Terminated by sponsor|53|||
33346198|NCT00796666|62723451|FG001|Overall Study|Terminated by sponsor|55|||
33346199|NCT00796666|62723450|FG000|Overall Study|Randomized and not treated|1|||
33346200|NCT00796666|62723451|FG001|Overall Study|Randomized and not treated|0|||
33346201|NCT00799708|62723460|FG000|Overall Study|non-compliance|1|||
33346202|NCT00799708|62723461|FG001|Overall Study|non-compliance|0|||
33346203|NCT00799708|62723462|FG002|Overall Study|non-compliance|0|||
33346204|NCT00796510|62723474|FG000|Overall Study|Death|1|||
33346205|NCT00796510|62723475|FG001|Overall Study|Death|0|||
33346206|NCT00796510|62723474|FG000|Overall Study|Study Terminated|2|||
33346207|NCT00796510|62723475|FG001|Overall Study|Study Terminated|0|||
33346208|NCT00588640|62723481|FG000|Overall Study|Physician Decision|1|||
33346209|NCT00588640|62723481|FG000|Overall Study|Ineligible Patient|1|||
33346210|NCT01016912|62723490|FG000|End of Treatment Period|Lack of Efficacy|0|||
33346211|NCT01016912|62723491|FG001|End of Treatment Period|Lack of Efficacy|1|||
33346212|NCT01016912|62723492|FG002|End of Treatment Period|Lack of Efficacy|0|||
33346213|NCT01016912|62723493|FG003|End of Treatment Period|Lack of Efficacy|4|||
33346214|NCT01016912|62723494|FG004|End of Treatment Period|Lack of Efficacy|4|||
33346215|NCT01016912|62723490|FG000|End of Treatment Period|Adverse Event|0|||
33346216|NCT01016912|62723491|FG001|End of Treatment Period|Adverse Event|1|||
33346217|NCT01016912|62723492|FG002|End of Treatment Period|Adverse Event|1|||
33346218|NCT01016912|62723493|FG003|End of Treatment Period|Adverse Event|0|||
33346219|NCT01016912|62723494|FG004|End of Treatment Period|Adverse Event|0|||
33346220|NCT01016912|62723490|FG000|End of Treatment Period|Completed double-blind period only|0|||
33346221|NCT01016912|62723491|FG001|End of Treatment Period|Completed double-blind period only|1|||
33346222|NCT01016912|62723492|FG002|End of Treatment Period|Completed double-blind period only|0|||
33346223|NCT01016912|62723493|FG003|End of Treatment Period|Completed double-blind period only|0|||
33346224|NCT01016912|62723494|FG004|End of Treatment Period|Completed double-blind period only|0|||
33346225|NCT01016912|62723490|FG000|Follow-up Period|Other reason|0|||
33346226|NCT01016912|62723491|FG001|Follow-up Period|Other reason|0|||
33346227|NCT01016912|62723492|FG002|Follow-up Period|Other reason|1|||
33346228|NCT01016912|62723493|FG003|Follow-up Period|Other reason|1|||
33346229|NCT01016912|62723494|FG004|Follow-up Period|Other reason|0|||
33346230|NCT00802672|62723529|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
33346231|NCT00802672|62723530|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
33346232|NCT00802672|62723531|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
33654820|NCT01696058|63067864|FG000|Overall Study|Lost to Follow-up|2|||
33346233|NCT00802672|62723529|FG000|Overall Study|Adverse Event|1|||
33346234|NCT00802672|62723530|FG001|Overall Study|Adverse Event|1|||
33346235|NCT00802672|62723531|FG002|Overall Study|Adverse Event|1|||
33346236|NCT00802672|62723529|FG000|Overall Study|Protocol Violation|2|||
33346237|NCT00802672|62723530|FG001|Overall Study|Protocol Violation|1|||
33346238|NCT00802672|62723531|FG002|Overall Study|Protocol Violation|1|||
33346239|NCT00802672|62723529|FG000|Overall Study|Lost to Follow-up|5|||
33346240|NCT00802672|62723530|FG001|Overall Study|Lost to Follow-up|5|||
33346241|NCT00802672|62723531|FG002|Overall Study|Lost to Follow-up|3|||
33346242|NCT00802672|62723529|FG000|Overall Study|Withdrawal by Subject|1|||
33346243|NCT00802672|62723530|FG001|Overall Study|Withdrawal by Subject|1|||
33346244|NCT00802672|62723531|FG002|Overall Study|Withdrawal by Subject|2|||
33346245|NCT00802672|62723529|FG000|Overall Study|other|3|||
33346246|NCT00802672|62723530|FG001|Overall Study|other|1|||
33346247|NCT00802672|62723531|FG002|Overall Study|other|2|||
33346248|NCT00714415|62723541|FG000|Overall Study|Lack of Efficacy|1|||
33654821|NCT01696058|63067865|FG001|Overall Study|Lost to Follow-up|5|||
33346249|NCT00714415|62723542|FG001|Overall Study|Lack of Efficacy|0|||
33346250|NCT00714415|62723541|FG000|Overall Study|Death|1|||
33346251|NCT00714415|62723542|FG001|Overall Study|Death|0|||
33346252|NCT00714259|62723548|FG000|Overall Study|Death|2|||
33346253|NCT00796120|62723554|FG000|Overall Study|Death|3|||
33346254|NCT00796120|62723555|FG001|Overall Study|Death|0|||
33346255|NCT00796120|62723554|FG000|Overall Study|Adverse Event|11|||
33346256|NCT00796120|62723555|FG001|Overall Study|Adverse Event|6|||
33346257|NCT00796120|62723554|FG000|Overall Study|Progressive disease|22|||
33346258|NCT00796120|62723555|FG001|Overall Study|Progressive disease|13|||
33346259|NCT00796120|62723554|FG000|Overall Study|Participant refusal|3|||
33346260|NCT00796120|62723555|FG001|Overall Study|Participant refusal|4|||
33346261|NCT00796120|62723554|FG000|Overall Study|Other|6|||
33346262|NCT00796120|62723555|FG001|Overall Study|Other|17|||
33346263|NCT00796120|62723554|FG000|Overall Study|Physician Decision|16|||
33346264|NCT00796120|62723555|FG001|Overall Study|Physician Decision|17|||
33346265|NCT00796120|62723554|FG000|Overall Study|Randomized but not treated|0|||
33548928|NCT02901431|62940305|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33548929|NCT02901431|62940306|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33548930|NCT02901431|62940294|FG000|PK Part|Pending dose confirmation|0|||
33548931|NCT02901431|62940295|FG001|PK Part|Pending dose confirmation|1|||
33346266|NCT00796120|62723555|FG001|Overall Study|Randomized but not treated|3|||
33346267|NCT00795886|62723561|FG000|Overall Study|Death|10|||
33346268|NCT00719563|62723568|FG000|Overall Study|Adverse Event|16|||
33346269|NCT00719563|62723569|FG001|Overall Study|Adverse Event|13|||
33346270|NCT00719563|62723568|FG000|Overall Study|Medical condition changed|3|||
33346271|NCT00719563|62723569|FG001|Overall Study|Medical condition changed|5|||
33346272|NCT00719563|62723568|FG000|Overall Study|Lack of Efficacy|3|||
33346273|NCT00719563|62723569|FG001|Overall Study|Lack of Efficacy|7|||
33346274|NCT00719563|62723568|FG000|Overall Study|Personal reasons|6|||
33346275|NCT00719563|62723569|FG001|Overall Study|Personal reasons|7|||
33346276|NCT00719563|62723568|FG000|Overall Study|Unknown reasons|4|||
33346277|NCT00719563|62723569|FG001|Overall Study|Unknown reasons|6|||
33346278|NCT00719563|62723568|FG000|Overall Study|Noncompliant|1|||
33346279|NCT00719563|62723569|FG001|Overall Study|Noncompliant|1|||
33346280|NCT00719563|62723568|FG000|Overall Study|Lost to Follow-up|5|||
33346281|NCT00719563|62723569|FG001|Overall Study|Lost to Follow-up|3|||
33346282|NCT00795184|62723576|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
33346283|NCT00795184|62723577|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
33346284|NCT00718861|62723588|FG000|Overall Study|Withdrawal by Subject|15|||
33346285|NCT00718861|62723589|FG001|Overall Study|Withdrawal by Subject|10|||
33346286|NCT00718861|62723588|FG000|Overall Study|Adverse Event|2|||
33346287|NCT00718861|62723589|FG001|Overall Study|Adverse Event|1|||
33346288|NCT00718861|62723588|FG000|Overall Study|Lost to Follow-up|2|||
33548932|NCT02901431|62940296|FG002|PK Part|Pending dose confirmation|0|||
33548933|NCT02901431|62940297|FG003|PK Part|Pending dose confirmation|0|||
33548934|NCT02901431|62940298|FG004|PK Part|Pending dose confirmation|0|||
33346289|NCT00718861|62723589|FG001|Overall Study|Lost to Follow-up|1|||
33346290|NCT00718861|62723588|FG000|Overall Study|Administrative Problems|1|||
33346291|NCT00718861|62723589|FG001|Overall Study|Administrative Problems|1|||
33346292|NCT00718861|62723588|FG000|Overall Study|Death|1|||
33346293|NCT00718861|62723589|FG001|Overall Study|Death|5|||
33346294|NCT01016600|62723599|FG000|Overall Study|Did not start treatment|1|||
33346295|NCT01016600|62723600|FG001|Overall Study|Did not start treatment|0|||
33346296|NCT01016600|62723601|FG002|Overall Study|Did not start treatment|0|||
33346297|NCT01016600|62723602|FG003|Overall Study|Did not start treatment|0|||
33346298|NCT01016132|62723613|FG000|Overall Study|Discomfort|1|||
33346299|NCT01015820|62723619|FG000|Overall Study|Suboptimal measurements|1|||
33346300|NCT01015820|62723620|FG001|Overall Study|Suboptimal measurements|0|||
33346301|NCT01010204|62723643|FG000|Overall Study|Lost to Follow-up|2|||
33346302|NCT01010204|62723644|FG001|Overall Study|Lost to Follow-up|2|||
33346303|NCT01010204|62723643|FG000|Overall Study|Adverse Event|1|||
33346304|NCT01010204|62723644|FG001|Overall Study|Adverse Event|3|||
33346305|NCT01010204|62723643|FG000|Overall Study|Withdrawal by Subject|2|||
33346306|NCT01010204|62723644|FG001|Overall Study|Withdrawal by Subject|3|||
33346307|NCT01010204|62723643|FG000|Overall Study|psychiatric hospitalization|2|||
33346308|NCT01010204|62723644|FG001|Overall Study|psychiatric hospitalization|1|||
33346309|NCT00718549|62723650|FG000|Induction Phase|Disease Progression|1|||
33346310|NCT00718549|62723651|FG001|Induction Phase|Disease Progression|0|||
33346311|NCT00718549|62723652|FG002|Induction Phase|Disease Progression|0|||
33346312|NCT00718549|62723650|FG000|Induction Phase|Eligibility Criteria Violation|2|||
33346313|NCT00718549|62723651|FG001|Induction Phase|Eligibility Criteria Violation|0|||
33346314|NCT00718549|62723652|FG002|Induction Phase|Eligibility Criteria Violation|0|||
33346315|NCT00718549|62723650|FG000|Induction Phase|Early Termination - No Additional Info|59|||
33548935|NCT02901431|62940299|FG005|PK Part|Pending dose confirmation|0|||
33548936|NCT02901431|62940300|FG006|PK Part|Pending dose confirmation|0|||
33346316|NCT00718549|62723651|FG001|Induction Phase|Early Termination - No Additional Info|0|||
33470445|NCT03137992|62844170|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
33470446|NCT03137992|62844171|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
33470447|NCT03137992|62844172|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
33470448|NCT03137992|62844173|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
33470449|NCT03137992|62844174|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
33470450|NCT03137992|62844175|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
33470451|NCT03137992|62844170|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
33346317|NCT00718549|62723652|FG002|Induction Phase|Early Termination - No Additional Info|0|||
33470452|NCT03137992|62844171|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
33470453|NCT03137992|62844172|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
33470454|NCT03137992|62844173|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
33470455|NCT03137992|62844174|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
33470456|NCT03137992|62844175|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
33346318|NCT00718549|62723650|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
33346319|NCT00718549|62723651|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
33346320|NCT00718549|62723652|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
33346321|NCT00718549|62723650|FG000|Maintenance/ Observation Phase|Death|0|||
33346322|NCT00718549|62723651|FG001|Maintenance/ Observation Phase|Death|1|||
33346323|NCT00718549|62723652|FG002|Maintenance/ Observation Phase|Death|2|||
33346324|NCT00718549|62723650|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
33346325|NCT00718549|62723651|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
33346326|NCT00718549|62723652|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
33346327|NCT00718549|62723650|FG000|Maintenance/ Observation Phase|Progression|0|||
33346328|NCT00718549|62723651|FG001|Maintenance/ Observation Phase|Progression|5|||
33346329|NCT00718549|62723652|FG002|Maintenance/ Observation Phase|Progression|14|||
33346330|NCT00718549|62723650|FG000|Maintenance/ Observation Phase|Relapse|0|||
33346331|NCT00718549|62723651|FG001|Maintenance/ Observation Phase|Relapse|3|||
33346332|NCT00718549|62723652|FG002|Maintenance/ Observation Phase|Relapse|2|||
33470457|NCT03137992|62844170|FG000|Washout Period 2|COPD Exacerbation|1|||
33470458|NCT03137992|62844171|FG001|Washout Period 2|COPD Exacerbation|1|||
33346333|NCT00793624|62723669|FG000|Overall Study|Adverse Event|18|||
33346334|NCT00793624|62723670|FG001|Overall Study|Adverse Event|16|||
33346335|NCT00793624|62723671|FG002|Overall Study|Adverse Event|15|||
33346336|NCT00793624|62723672|FG003|Overall Study|Adverse Event|20|||
33346337|NCT00793624|62723669|FG000|Overall Study|Lost to Follow-up|2|||
33346338|NCT00793624|62723670|FG001|Overall Study|Lost to Follow-up|2|||
33346339|NCT00793624|62723671|FG002|Overall Study|Lost to Follow-up|4|||
33346340|NCT00793624|62723672|FG003|Overall Study|Lost to Follow-up|0|||
33346341|NCT00793624|62723669|FG000|Overall Study|Withdrawal by Subject|20|||
33346342|NCT00793624|62723670|FG001|Overall Study|Withdrawal by Subject|9|||
33346343|NCT00793624|62723671|FG002|Overall Study|Withdrawal by Subject|11|||
33346344|NCT00793624|62723672|FG003|Overall Study|Withdrawal by Subject|14|||
33346345|NCT00793624|62723669|FG000|Overall Study|Lack of Efficacy|9|||
33346346|NCT00793624|62723670|FG001|Overall Study|Lack of Efficacy|2|||
33346347|NCT00793624|62723671|FG002|Overall Study|Lack of Efficacy|1|||
33346348|NCT00793624|62723672|FG003|Overall Study|Lack of Efficacy|3|||
33346349|NCT00793624|62723669|FG000|Overall Study|Non compliance with protocol|2|||
33346350|NCT00793624|62723670|FG001|Overall Study|Non compliance with protocol|3|||
33346351|NCT00793624|62723671|FG002|Overall Study|Non compliance with protocol|2|||
33346352|NCT00793624|62723672|FG003|Overall Study|Non compliance with protocol|3|||
33346353|NCT00793624|62723669|FG000|Overall Study|Other reason not described above|6|||
33346354|NCT00793624|62723670|FG001|Overall Study|Other reason not described above|4|||
33346355|NCT00793624|62723671|FG002|Overall Study|Other reason not described above|6|||
33346356|NCT00793624|62723672|FG003|Overall Study|Other reason not described above|3|||
33346357|NCT00794950|62723690|FG000|BCG Induction|Withdrawal by Subject|2|||
33346358|NCT00794950|62723690|FG000|BCG Induction|ineligible|3|||
33346359|NCT00794950|62723690|FG000|BCG Induction|noncompliant w. BCG|1|||
33346360|NCT00794950|62723690|FG000|BCG Induction|Adverse Event|1|||
33346361|NCT00794950|62723690|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
33346362|NCT00794950|62723690|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
33346363|NCT00794950|62723690|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
33346364|NCT00794950|62723690|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
33346365|NCT00793546|62723697|FG000|Overall Study|Death|3|||
33346366|NCT00793546|62723698|FG001|Overall Study|Death|0|||
33346367|NCT00793546|62723697|FG000|Overall Study|Lost to Follow-up|1|||
33470459|NCT03137992|62844172|FG002|Washout Period 2|COPD Exacerbation|0|||
33470460|NCT03137992|62844173|FG003|Washout Period 2|COPD Exacerbation|0|||
33548937|NCT02901431|62940301|FG007|PK Part|Pending dose confirmation|0|||
33346368|NCT00793546|62723698|FG001|Overall Study|Lost to Follow-up|0|||
33346369|NCT00793546|62723697|FG000|Overall Study|Withdrawal by Subject|1|||
33346370|NCT00793546|62723698|FG001|Overall Study|Withdrawal by Subject|1|||
33346371|NCT00793546|62723697|FG000|Overall Study|Study Terminated by Sponsor|8|||
33346372|NCT00793546|62723698|FG001|Overall Study|Study Terminated by Sponsor|27|||
33346373|NCT00793546|62723697|FG000|Overall Study|Other|1|||
33470461|NCT03137992|62844174|FG004|Washout Period 2|COPD Exacerbation|1|||
33654822|NCT01696058|63067864|FG000|Overall Study|Withdrawal by Subject|4|||
33346374|NCT00793546|62723698|FG001|Overall Study|Other|0|||
33346375|NCT00798694|62723708|FG000|Overall Study|Lost to Follow-up|1|||
33346376|NCT00798694|62723709|FG001|Overall Study|Lost to Follow-up|1|||
33346377|NCT00798694|62723708|FG000|Overall Study|Physician Decision|1|||
33346378|NCT00798694|62723709|FG001|Overall Study|Physician Decision|0|||
33346379|NCT00718315|62723724|FG000|Overall Study|Adverse Event|1|||
33346380|NCT00718315|62723725|FG001|Overall Study|Adverse Event|2|||
33346381|NCT00718315|62723726|FG002|Overall Study|Adverse Event|3|||
33346382|NCT00718315|62723724|FG000|Overall Study|Death|6|||
33346383|NCT00718315|62723725|FG001|Overall Study|Death|6|||
33346384|NCT00718315|62723726|FG002|Overall Study|Death|5|||
33346385|NCT00718315|62723724|FG000|Overall Study|Lost to Follow-up|2|||
33346386|NCT00718315|62723725|FG001|Overall Study|Lost to Follow-up|3|||
33346387|NCT00718315|62723726|FG002|Overall Study|Lost to Follow-up|4|||
33346388|NCT00718315|62723724|FG000|Overall Study|Protocol Violation|5|||
33346389|NCT00718315|62723725|FG001|Overall Study|Protocol Violation|5|||
33346390|NCT00718315|62723726|FG002|Overall Study|Protocol Violation|3|||
33346391|NCT00718315|62723724|FG000|Overall Study|Erlotinib dose decreased|4|||
33346392|NCT00718315|62723725|FG001|Overall Study|Erlotinib dose decreased|3|||
33654823|NCT01696058|63067865|FG001|Overall Study|Withdrawal by Subject|6|||
33654824|NCT01696058|63067864|FG000|Overall Study|Other reason prematurely discontinued|5|||
33654825|NCT01696058|63067865|FG001|Overall Study|Other reason prematurely discontinued|3|||
33654826|NCT01695746|63067871|FG000|Overall Study|Adverse Event|1|||
33654827|NCT01695746|63067871|FG000|Overall Study|Non-compliance by the participant|3|||
33654828|NCT01695746|63067871|FG000|Overall Study|Protocol Violation|5|||
33654829|NCT01695746|63067871|FG000|Overall Study|Participant not willing to participate|3|||
33654830|NCT01694420|63067882|FG000|Overall Study|Lost to Follow-up|3|||
33654831|NCT01675479|63068053|FG000|Overall Study|Lost to Follow-up|11|||
33654832|NCT00089973|63068175|FG000|Overall Study|Adverse Event|3|||
33654833|NCT00089973|63068175|FG000|Overall Study|Withdrawal by Subject|1|||
33654834|NCT00089973|63068175|FG000|Overall Study|Disease progression|45|||
33654835|NCT00089973|63068175|FG000|Overall Study|Death|1|||
33654836|NCT00089661|63068193|FG000|Overall Study|Adverse Event|0|||
33654837|NCT00089661|63068194|FG001|Overall Study|Adverse Event|2|||
33654838|NCT00089661|63068193|FG000|Overall Study|Death|1|||
33654839|NCT00089661|63068194|FG001|Overall Study|Death|0|||
33654840|NCT00089661|63068193|FG000|Overall Study|Lost to Follow-up|0|||
33654841|NCT00089661|63068194|FG001|Overall Study|Lost to Follow-up|3|||
33654842|NCT00089661|63068193|FG000|Overall Study|Withdrawal by Subject|11|||
33654843|NCT00089661|63068194|FG001|Overall Study|Withdrawal by Subject|9|||
33654844|NCT00089661|63068193|FG000|Overall Study|Disease progression|1|||
33654845|NCT00089661|63068194|FG001|Overall Study|Disease progression|3|||
33654846|NCT00089661|63068193|FG000|Overall Study|Ineligibility determined|4|||
33654847|NCT00089661|63068194|FG001|Overall Study|Ineligibility determined|4|||
33654848|NCT00089661|63068193|FG000|Overall Study|Noncompliance|2|||
33654849|NCT00089661|63068194|FG001|Overall Study|Noncompliance|4|||
33654850|NCT00089661|63068193|FG000|Overall Study|Other|2|||
33654851|NCT00089661|63068194|FG001|Overall Study|Other|1|||
33654852|NCT00089583|63068211|FG000|Overall Study|Adverse Event|0|||
33654853|NCT00089583|63068212|FG001|Overall Study|Adverse Event|3|||
33654854|NCT00089583|63068211|FG000|Overall Study|Insufficient Viral Load Response|5|||
33654855|NCT00089583|63068212|FG001|Overall Study|Insufficient Viral Load Response|5|||
33654856|NCT00089583|63068211|FG000|Overall Study|Withdrawal by Subject|0|||
33654857|NCT00089583|63068212|FG001|Overall Study|Withdrawal by Subject|4|||
33654858|NCT00089583|63068211|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
33346393|NCT00718315|62723726|FG002|Overall Study|Erlotinib dose decreased|1|||
33346394|NCT00718315|62723724|FG000|Overall Study|Use of Minocyclin|1|||
33346395|NCT00718315|62723725|FG001|Overall Study|Use of Minocyclin|1|||
33346396|NCT00718315|62723726|FG002|Overall Study|Use of Minocyclin|1|||
33346397|NCT00718315|62723724|FG000|Overall Study|Disease progression|0|||
33346398|NCT00718315|62723725|FG001|Overall Study|Disease progression|1|||
33346399|NCT00718315|62723726|FG002|Overall Study|Disease progression|1|||
33346400|NCT00718315|62723724|FG000|Overall Study|Other|0|||
33346401|NCT00718315|62723725|FG001|Overall Study|Other|0|||
33346402|NCT00718315|62723726|FG002|Overall Study|Other|1|||
33654859|NCT00089583|63068212|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
33654860|NCT00089583|63068211|FG000|Overall Study|Participant Refused Study Medication|0|||
33346403|NCT00718315|62723724|FG000|Overall Study|Use of ATB and Corticoids|0|||
33346404|NCT00718315|62723725|FG001|Overall Study|Use of ATB and Corticoids|1|||
33654861|NCT00089583|63068212|FG001|Overall Study|Participant Refused Study Medication|2|||
33654862|NCT00089583|63068211|FG000|Overall Study|Non-Compliance|0|||
33346405|NCT00718315|62723726|FG002|Overall Study|Use of ATB and Corticoids|2|||
33346406|NCT00798304|62723737|FG000|Overall Study|Adverse Event|0|||
33346407|NCT00798304|62723738|FG001|Overall Study|Adverse Event|1|||
33346408|NCT00798304|62723739|FG002|Overall Study|Adverse Event|1|||
33346409|NCT00798304|62723737|FG000|Overall Study|Discontinuation by Sponsor|14|||
33346410|NCT00798304|62723738|FG001|Overall Study|Discontinuation by Sponsor|21|||
33346411|NCT00798304|62723739|FG002|Overall Study|Discontinuation by Sponsor|9|||
33346412|NCT00718237|62723749|FG000|Overall Study|Adverse Event|1|||
33346413|NCT00718237|62723750|FG001|Overall Study|Adverse Event|3|||
33346414|NCT00718237|62723749|FG000|Overall Study|Lost to Follow-up|2|||
33346415|NCT00718237|62723750|FG001|Overall Study|Lost to Follow-up|2|||
33346416|NCT00718237|62723749|FG000|Overall Study|Physician Decision|1|||
33346417|NCT00718237|62723750|FG001|Overall Study|Physician Decision|0|||
33346418|NCT00718237|62723749|FG000|Overall Study|Withdrawal by Subject|9|||
33346419|NCT00718237|62723750|FG001|Overall Study|Withdrawal by Subject|10|||
33346420|NCT00793780|62723760|FG000|Overall Study|Withdrawal by Subject|2|||
33346421|NCT00793780|62723761|FG001|Overall Study|Withdrawal by Subject|1|||
33346422|NCT02643303|62723776|FG000|Overall Study|Progressive Disease|4|||
33346423|NCT02643303|62723777|FG001|Overall Study|Progressive Disease|4|||
33470462|NCT03137992|62844175|FG005|Washout Period 2|COPD Exacerbation|0|||
33470463|NCT03137992|62844170|FG000|Washout Period 2|Subject Non-compliance|0|||
33470464|NCT03137992|62844171|FG001|Washout Period 2|Subject Non-compliance|1|||
33470465|NCT03137992|62844172|FG002|Washout Period 2|Subject Non-compliance|0|||
33470466|NCT03137992|62844173|FG003|Washout Period 2|Subject Non-compliance|0|||
33470467|NCT03137992|62844174|FG004|Washout Period 2|Subject Non-compliance|0|||
33470468|NCT03137992|62844175|FG005|Washout Period 2|Subject Non-compliance|0|||
33470469|NCT03137992|62844170|FG000|Washout Period 2|Adverse Event|0|||
33470470|NCT03137992|62844171|FG001|Washout Period 2|Adverse Event|0|||
33470471|NCT03137992|62844172|FG002|Washout Period 2|Adverse Event|0|||
33470472|NCT03137992|62844173|FG003|Washout Period 2|Adverse Event|1|||
33470473|NCT03137992|62844174|FG004|Washout Period 2|Adverse Event|1|||
33470474|NCT03137992|62844175|FG005|Washout Period 2|Adverse Event|0|||
33470475|NCT03137992|62844170|FG000|Washout Period 2|Withdrawal by Subject|1|||
33470476|NCT03137992|62844171|FG001|Washout Period 2|Withdrawal by Subject|0|||
33346424|NCT02643303|62723778|FG002|Overall Study|Progressive Disease|1|||
33346425|NCT02643303|62723779|FG003|Overall Study|Progressive Disease|12|||
33346426|NCT02643303|62723780|FG004|Overall Study|Progressive Disease|6|||
33346427|NCT02643303|62723781|FG005|Overall Study|Progressive Disease|4|||
33346428|NCT02643303|62723782|FG006|Overall Study|Progressive Disease|8|||
33346429|NCT02643303|62723783|FG007|Overall Study|Progressive Disease|2|||
33346430|NCT02643303|62723784|FG008|Overall Study|Progressive Disease|6|||
33346431|NCT02643303|62723776|FG000|Overall Study|Adverse Event|0|||
33346432|NCT02643303|62723777|FG001|Overall Study|Adverse Event|1|||
33346433|NCT02643303|62723778|FG002|Overall Study|Adverse Event|0|||
33346434|NCT02643303|62723779|FG003|Overall Study|Adverse Event|0|||
33346435|NCT02643303|62723780|FG004|Overall Study|Adverse Event|1|||
33346436|NCT02643303|62723781|FG005|Overall Study|Adverse Event|0|||
33346437|NCT02643303|62723782|FG006|Overall Study|Adverse Event|0|||
33346438|NCT02643303|62723783|FG007|Overall Study|Adverse Event|0|||
33346439|NCT02643303|62723784|FG008|Overall Study|Adverse Event|0|||
33346440|NCT02643303|62723776|FG000|Overall Study|Withdrawal by Subject|0|||
33470477|NCT03137992|62844172|FG002|Washout Period 2|Withdrawal by Subject|0|||
33470478|NCT03137992|62844173|FG003|Washout Period 2|Withdrawal by Subject|0|||
33470479|NCT03137992|62844174|FG004|Washout Period 2|Withdrawal by Subject|1|||
33470480|NCT03137992|62844175|FG005|Washout Period 2|Withdrawal by Subject|0|||
33470481|NCT03137992|62844170|FG000|Washout Period 2|Sponsor Decision|0|||
33470482|NCT03137992|62844171|FG001|Washout Period 2|Sponsor Decision|0|||
33470483|NCT03137992|62844172|FG002|Washout Period 2|Sponsor Decision|0|||
33470484|NCT03137992|62844173|FG003|Washout Period 2|Sponsor Decision|0|||
33346441|NCT02643303|62723777|FG001|Overall Study|Withdrawal by Subject|0|||
33346442|NCT02643303|62723778|FG002|Overall Study|Withdrawal by Subject|0|||
33346443|NCT02643303|62723779|FG003|Overall Study|Withdrawal by Subject|1|||
33346444|NCT02643303|62723780|FG004|Overall Study|Withdrawal by Subject|0|||
33346445|NCT02643303|62723781|FG005|Overall Study|Withdrawal by Subject|0|||
33470485|NCT03137992|62844174|FG004|Washout Period 2|Sponsor Decision|0|||
33470486|NCT03137992|62844175|FG005|Washout Period 2|Sponsor Decision|1|||
33470487|NCT03137992|62844170|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
33654863|NCT00089583|63068212|FG001|Overall Study|Non-Compliance|4|||
33346446|NCT02643303|62723782|FG006|Overall Study|Withdrawal by Subject|1|||
33346447|NCT02643303|62723783|FG007|Overall Study|Withdrawal by Subject|1|||
33346448|NCT02643303|62723784|FG008|Overall Study|Withdrawal by Subject|1|||
33346449|NCT00790036|62723806|FG000|Overall Study|Abnormal lab values|3|||
33346450|NCT00790036|62723807|FG001|Overall Study|Abnormal lab values|2|||
33346451|NCT00790036|62723806|FG000|Overall Study|Administrative problems|5|||
33346452|NCT00790036|62723807|FG001|Overall Study|Administrative problems|9|||
33346453|NCT00790036|62723806|FG000|Overall Study|Adverse Event|113|||
33346454|NCT00790036|62723807|FG001|Overall Study|Adverse Event|44|||
33346455|NCT00790036|62723806|FG000|Overall Study|Death|1|||
33346456|NCT00790036|62723807|FG001|Overall Study|Death|0|||
33346457|NCT00790036|62723806|FG000|Overall Study|Disease progression|24|||
33346458|NCT00790036|62723807|FG001|Overall Study|Disease progression|48|||
33346459|NCT00790036|62723806|FG000|Overall Study|Lost to Follow-up|1|||
33346460|NCT00790036|62723807|FG001|Overall Study|Lost to Follow-up|2|||
33346461|NCT00790036|62723806|FG000|Overall Study|Protocol Violation|10|||
33346462|NCT00790036|62723807|FG001|Overall Study|Protocol Violation|2|||
33346463|NCT00790036|62723806|FG000|Overall Study|Withdrawal by Subject|18|||
33346464|NCT00790036|62723807|FG001|Overall Study|Withdrawal by Subject|7|||
33346465|NCT00790036|62723806|FG000|Overall Study|Subject/guardian decision|20|||
33346466|NCT00790036|62723807|FG001|Overall Study|Subject/guardian decision|7|||
33346467|NCT00789958|62723814|FG000|Overall Study|Adverse Event|3|||
33346468|NCT00789958|62723814|FG000|Overall Study|Withdrawal by Subject|4|||
33346469|NCT00789958|62723814|FG000|Overall Study|Progression|3|||
33346470|NCT00789958|62723814|FG000|Overall Study|not protocol specified|1|||
33346471|NCT00789958|62723814|FG000|Overall Study|Not eligible/not analyzable|26|||
33346472|NCT00789880|62723826|FG000|Overall Study|Adverse Event|0|||
33346473|NCT00789880|62723827|FG001|Overall Study|Adverse Event|0|||
33346474|NCT00789880|62723828|FG002|Overall Study|Adverse Event|0|||
33346475|NCT00789880|62723829|FG003|Overall Study|Adverse Event|0|||
33346476|NCT00789880|62723830|FG004|Overall Study|Adverse Event|1|||
33346477|NCT00789880|62723831|FG005|Overall Study|Adverse Event|0|||
33346478|NCT00789880|62723826|FG000|Overall Study|Protocol Violation|0|||
33346479|NCT00789880|62723827|FG001|Overall Study|Protocol Violation|1|||
33346480|NCT00789880|62723828|FG002|Overall Study|Protocol Violation|0|||
33346481|NCT00789880|62723829|FG003|Overall Study|Protocol Violation|1|||
33346482|NCT00789880|62723830|FG004|Overall Study|Protocol Violation|0|||
33346483|NCT00789880|62723831|FG005|Overall Study|Protocol Violation|0|||
33346484|NCT00789880|62723826|FG000|Overall Study|Withdrawal by Subject|1|||
33346485|NCT00789880|62723827|FG001|Overall Study|Withdrawal by Subject|0|||
33346486|NCT00789880|62723828|FG002|Overall Study|Withdrawal by Subject|0|||
33346487|NCT00789880|62723829|FG003|Overall Study|Withdrawal by Subject|0|||
33470488|NCT03137992|62844171|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
33470489|NCT03137992|62844172|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
33470490|NCT03137992|62844173|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
33470491|NCT03137992|62844174|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
33346488|NCT00789880|62723830|FG004|Overall Study|Withdrawal by Subject|2|||
33346489|NCT00789880|62723831|FG005|Overall Study|Withdrawal by Subject|0|||
33346490|NCT00792298|62723845|FG000|Treatment Period 1|Adverse Event|0|||
33346491|NCT00792298|62723846|FG001|Treatment Period 1|Adverse Event|1|||
33346492|NCT00792298|62723847|FG002|Treatment Period 1|Adverse Event|0|||
33346493|NCT00792298|62723848|FG003|Treatment Period 1|Adverse Event|1|||
33470492|NCT03137992|62844175|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
33346494|NCT00792298|62723849|FG004|Treatment Period 1|Adverse Event|0|||
33346495|NCT00792298|62723850|FG005|Treatment Period 1|Adverse Event|1|||
33346496|NCT00792298|62723851|FG006|Treatment Period 1|Adverse Event|1|||
33346497|NCT00792298|62723852|FG007|Treatment Period 1|Adverse Event|0|||
33470493|NCT03137992|62844170|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
33470494|NCT03137992|62844171|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
33470495|NCT03137992|62844172|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
33470496|NCT03137992|62844173|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
33470497|NCT03137992|62844174|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
33470498|NCT03137992|62844175|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
33470499|NCT03137992|62844170|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
33470500|NCT03137992|62844171|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
33470501|NCT03137992|62844172|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
33470502|NCT03137992|62844173|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
33470503|NCT03137992|62844174|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
33346498|NCT00792298|62723845|FG000|Treatment Period 1|Lack of Efficacy|0|||
33346499|NCT00792298|62723846|FG001|Treatment Period 1|Lack of Efficacy|0|||
33346500|NCT00792298|62723847|FG002|Treatment Period 1|Lack of Efficacy|1|||
33346501|NCT00792298|62723848|FG003|Treatment Period 1|Lack of Efficacy|0|||
33346502|NCT00792298|62723849|FG004|Treatment Period 1|Lack of Efficacy|0|||
33346503|NCT00792298|62723850|FG005|Treatment Period 1|Lack of Efficacy|0|||
33346504|NCT00792298|62723851|FG006|Treatment Period 1|Lack of Efficacy|0|||
33346505|NCT00792298|62723852|FG007|Treatment Period 1|Lack of Efficacy|0|||
33346506|NCT00792298|62723845|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33346507|NCT00792298|62723846|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33346508|NCT00792298|62723847|FG002|Treatment Period 1|Withdrawal by Subject|1|||
33346509|NCT00792298|62723848|FG003|Treatment Period 1|Withdrawal by Subject|2|||
33346510|NCT00792298|62723849|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33346511|NCT00792298|62723850|FG005|Treatment Period 1|Withdrawal by Subject|2|||
33346512|NCT00792298|62723851|FG006|Treatment Period 1|Withdrawal by Subject|1|||
33346513|NCT00792298|62723852|FG007|Treatment Period 1|Withdrawal by Subject|0|||
33346514|NCT00792298|62723845|FG000|Treatment Period 1|Lost to Follow-up|0|||
33346515|NCT00792298|62723846|FG001|Treatment Period 1|Lost to Follow-up|0|||
33346516|NCT00792298|62723847|FG002|Treatment Period 1|Lost to Follow-up|0|||
33346517|NCT00792298|62723848|FG003|Treatment Period 1|Lost to Follow-up|0|||
33346518|NCT00792298|62723849|FG004|Treatment Period 1|Lost to Follow-up|0|||
33346519|NCT00792298|62723850|FG005|Treatment Period 1|Lost to Follow-up|0|||
33346520|NCT00792298|62723851|FG006|Treatment Period 1|Lost to Follow-up|1|||
33346521|NCT00792298|62723852|FG007|Treatment Period 1|Lost to Follow-up|0|||
33346522|NCT00792298|62723845|FG000|Treatment Period 1|Physician Decision|0|||
33346523|NCT00792298|62723846|FG001|Treatment Period 1|Physician Decision|0|||
33346524|NCT00792298|62723847|FG002|Treatment Period 1|Physician Decision|0|||
33346525|NCT00792298|62723848|FG003|Treatment Period 1|Physician Decision|1|||
33346526|NCT00792298|62723849|FG004|Treatment Period 1|Physician Decision|0|||
33346527|NCT00792298|62723850|FG005|Treatment Period 1|Physician Decision|0|||
33346528|NCT00792298|62723851|FG006|Treatment Period 1|Physician Decision|1|||
33346529|NCT00792298|62723852|FG007|Treatment Period 1|Physician Decision|0|||
33346530|NCT00792298|62723845|FG000|Treatment Period 1|Protocol Violation|0|||
33346531|NCT00792298|62723846|FG001|Treatment Period 1|Protocol Violation|0|||
33346532|NCT00792298|62723847|FG002|Treatment Period 1|Protocol Violation|0|||
33346533|NCT00792298|62723848|FG003|Treatment Period 1|Protocol Violation|0|||
33346534|NCT00792298|62723849|FG004|Treatment Period 1|Protocol Violation|0|||
33346535|NCT00792298|62723850|FG005|Treatment Period 1|Protocol Violation|0|||
33346536|NCT00792298|62723851|FG006|Treatment Period 1|Protocol Violation|0|||
33346537|NCT00792298|62723852|FG007|Treatment Period 1|Protocol Violation|1|||
33346538|NCT00792298|62723845|FG000|Washout|Adverse Event|0|||
33346539|NCT00792298|62723846|FG001|Washout|Adverse Event|0|||
33470504|NCT03137992|62844175|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
33346540|NCT00792298|62723847|FG002|Washout|Adverse Event|0|||
33346541|NCT00792298|62723848|FG003|Washout|Adverse Event|0|||
33346542|NCT00792298|62723849|FG004|Washout|Adverse Event|0|||
33470505|NCT03137992|62844170|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
33346543|NCT00792298|62723850|FG005|Washout|Adverse Event|1|||
33346544|NCT00792298|62723851|FG006|Washout|Adverse Event|0|||
33346545|NCT00792298|62723852|FG007|Washout|Adverse Event|0|||
33346546|NCT00792298|62723845|FG000|Washout|Withdrawal by Subject|0|||
33346547|NCT00792298|62723846|FG001|Washout|Withdrawal by Subject|0|||
33346548|NCT00792298|62723847|FG002|Washout|Withdrawal by Subject|1|||
33346549|NCT00792298|62723848|FG003|Washout|Withdrawal by Subject|0|||
33346550|NCT00792298|62723849|FG004|Washout|Withdrawal by Subject|0|||
33346551|NCT00792298|62723850|FG005|Washout|Withdrawal by Subject|1|||
33346552|NCT00792298|62723851|FG006|Washout|Withdrawal by Subject|0|||
33346553|NCT00792298|62723852|FG007|Washout|Withdrawal by Subject|0|||
33346554|NCT00792298|62723845|FG000|Treatment Period 2|Lack of Efficacy|0|||
33346555|NCT00792298|62723846|FG001|Treatment Period 2|Lack of Efficacy|0|||
33346556|NCT00792298|62723847|FG002|Treatment Period 2|Lack of Efficacy|0|||
33346557|NCT00792298|62723848|FG003|Treatment Period 2|Lack of Efficacy|0|||
33346558|NCT00792298|62723849|FG004|Treatment Period 2|Lack of Efficacy|1|||
33346559|NCT00792298|62723850|FG005|Treatment Period 2|Lack of Efficacy|0|||
33346560|NCT00792298|62723851|FG006|Treatment Period 2|Lack of Efficacy|0|||
33346561|NCT00792298|62723852|FG007|Treatment Period 2|Lack of Efficacy|0|||
33346562|NCT00792298|62723845|FG000|Treatment Period 2|Physician Decision|0|||
33346563|NCT00792298|62723846|FG001|Treatment Period 2|Physician Decision|0|||
33346564|NCT00792298|62723847|FG002|Treatment Period 2|Physician Decision|0|||
33346565|NCT00792298|62723848|FG003|Treatment Period 2|Physician Decision|0|||
33346566|NCT00792298|62723849|FG004|Treatment Period 2|Physician Decision|0|||
33346567|NCT00792298|62723850|FG005|Treatment Period 2|Physician Decision|0|||
33346568|NCT00792298|62723851|FG006|Treatment Period 2|Physician Decision|1|||
33346569|NCT00792298|62723852|FG007|Treatment Period 2|Physician Decision|0|||
33346570|NCT00792298|62723845|FG000|Treatment Period 2|Pregnancy|0|||
33346571|NCT00792298|62723846|FG001|Treatment Period 2|Pregnancy|0|||
33346572|NCT00792298|62723847|FG002|Treatment Period 2|Pregnancy|1|||
33346573|NCT00792298|62723848|FG003|Treatment Period 2|Pregnancy|0|||
33346574|NCT00792298|62723849|FG004|Treatment Period 2|Pregnancy|0|||
33346575|NCT00792298|62723850|FG005|Treatment Period 2|Pregnancy|0|||
33346576|NCT00792298|62723851|FG006|Treatment Period 2|Pregnancy|0|||
33346577|NCT00792298|62723852|FG007|Treatment Period 2|Pregnancy|0|||
33346578|NCT00792298|62723845|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33346579|NCT00792298|62723846|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33346580|NCT00792298|62723847|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33346581|NCT00792298|62723848|FG003|Treatment Period 2|Withdrawal by Subject|2|||
33346582|NCT00792298|62723849|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33346583|NCT00792298|62723850|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33346584|NCT00792298|62723851|FG006|Treatment Period 2|Withdrawal by Subject|0|||
33346585|NCT00792298|62723852|FG007|Treatment Period 2|Withdrawal by Subject|2|||
33346586|NCT00718159|62723876|FG000|Overall Study|Progressive Disease|3|||
33346587|NCT00718159|62723877|FG001|Overall Study|Progressive Disease|3|||
33654864|NCT00089583|63068211|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
33346588|NCT00718159|62723878|FG002|Overall Study|Progressive Disease|2|||
33346589|NCT00718159|62723879|FG003|Overall Study|Progressive Disease|0|||
33346590|NCT00718159|62723880|FG004|Overall Study|Progressive Disease|6|||
33346591|NCT00718159|62723881|FG005|Overall Study|Progressive Disease|0|||
33346592|NCT00718159|62723882|FG006|Overall Study|Progressive Disease|0|||
33346593|NCT00718159|62723876|FG000|Overall Study|Death due to Adverse Event|0|||
33346594|NCT00718159|62723877|FG001|Overall Study|Death due to Adverse Event|0|||
33346595|NCT00718159|62723878|FG002|Overall Study|Death due to Adverse Event|0|||
33346596|NCT00718159|62723879|FG003|Overall Study|Death due to Adverse Event|2|||
33346597|NCT00718159|62723880|FG004|Overall Study|Death due to Adverse Event|2|||
33346598|NCT00718159|62723881|FG005|Overall Study|Death due to Adverse Event|0|||
33346599|NCT00718159|62723882|FG006|Overall Study|Death due to Adverse Event|0|||
33346600|NCT00718159|62723876|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
33346601|NCT00718159|62723877|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
33346602|NCT00718159|62723878|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
33346603|NCT00718159|62723879|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
33346604|NCT00718159|62723880|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
33346605|NCT00718159|62723881|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
33346606|NCT00718159|62723882|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
33346607|NCT00718159|62723876|FG000|Overall Study|Investigator Decision|0|||
33346608|NCT00718159|62723877|FG001|Overall Study|Investigator Decision|0|||
33346609|NCT00718159|62723878|FG002|Overall Study|Investigator Decision|0|||
33346610|NCT00718159|62723879|FG003|Overall Study|Investigator Decision|0|||
33346611|NCT00718159|62723880|FG004|Overall Study|Investigator Decision|0|||
33346612|NCT00718159|62723881|FG005|Overall Study|Investigator Decision|1|||
33346613|NCT00718159|62723882|FG006|Overall Study|Investigator Decision|1|||
33346614|NCT00718081|62723901|FG000|Overall Study|Adverse Event|0|||
33346615|NCT00718081|62723902|FG001|Overall Study|Adverse Event|1|||
33346616|NCT00718081|62723903|FG002|Overall Study|Adverse Event|0|||
33346617|NCT00718081|62723901|FG000|Overall Study|Lack of Efficacy|7|||
33346618|NCT00718081|62723902|FG001|Overall Study|Lack of Efficacy|3|||
33346619|NCT00718081|62723903|FG002|Overall Study|Lack of Efficacy|21|||
33346620|NCT00788710|62723914|FG000|Overall Study|Adverse Event|1|||
33346621|NCT00788710|62723915|FG001|Overall Study|Adverse Event|3|||
33346622|NCT00788710|62723916|FG002|Overall Study|Adverse Event|4|||
33346623|NCT00788710|62723914|FG000|Overall Study|Lack of Efficacy|0|||
33346624|NCT00788710|62723915|FG001|Overall Study|Lack of Efficacy|0|||
33346625|NCT00788710|62723916|FG002|Overall Study|Lack of Efficacy|1|||
33346626|NCT00788710|62723914|FG000|Overall Study|Lost to Follow-up|0|||
33346627|NCT00788710|62723915|FG001|Overall Study|Lost to Follow-up|1|||
33346628|NCT00788710|62723916|FG002|Overall Study|Lost to Follow-up|0|||
33346629|NCT00788710|62723914|FG000|Overall Study|Physician Decision|2|||
33346630|NCT00788710|62723915|FG001|Overall Study|Physician Decision|1|||
33346631|NCT00788710|62723916|FG002|Overall Study|Physician Decision|0|||
33346632|NCT00788710|62723914|FG000|Overall Study|Protocol Violation|0|||
33346633|NCT00788710|62723915|FG001|Overall Study|Protocol Violation|1|||
33346634|NCT00788710|62723916|FG002|Overall Study|Protocol Violation|1|||
33346635|NCT00788710|62723914|FG000|Overall Study|Withdrawal by Subject|2|||
33346636|NCT00788710|62723915|FG001|Overall Study|Withdrawal by Subject|2|||
33346637|NCT00788710|62723916|FG002|Overall Study|Withdrawal by Subject|0|||
33346638|NCT00787930|62723924|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
33346639|NCT00588094|62723934|FG000|Overall Study|Adverse Event|3|||
33346640|NCT00588094|62723934|FG000|Overall Study|Progression of Disease|2|||
33346641|NCT03373383|62723943|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
33346642|NCT03373383|62723944|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
33346643|NCT03373383|62723945|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
33346644|NCT03373383|62723946|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
33346645|NCT03373383|62723947|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
33346646|NCT03373383|62723943|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
33346647|NCT03373383|62723944|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
33346648|NCT03373383|62723945|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
33346649|NCT03373383|62723946|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
33346650|NCT03373383|62723947|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
33346651|NCT03373383|62723943|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
33346652|NCT03373383|62723944|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
33346653|NCT03373383|62723945|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
33346654|NCT03373383|62723946|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
33346655|NCT03373383|62723947|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
33346656|NCT03373383|62723943|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
33346657|NCT03373383|62723944|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
33346658|NCT03373383|62723945|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
33346659|NCT03373383|62723946|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
33346660|NCT03373383|62723947|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
33346661|NCT03373383|62723943|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
33346662|NCT03373383|62723944|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
33346663|NCT03373383|62723945|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
33346664|NCT03373383|62723946|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
33346665|NCT03373383|62723947|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
33346666|NCT03373383|62723943|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
33346667|NCT03373383|62723944|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
33346668|NCT03373383|62723945|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
33346669|NCT03373383|62723946|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
33346670|NCT03373383|62723947|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
33346671|NCT03373383|62723943|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
33346672|NCT03373383|62723944|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
33346673|NCT03373383|62723945|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
33346674|NCT03373383|62723946|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
33346675|NCT03373383|62723947|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
33346676|NCT03373383|62723943|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
33346677|NCT03373383|62723944|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
33346678|NCT03373383|62723945|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
33346679|NCT03373383|62723946|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
33346680|NCT03373383|62723947|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
33346681|NCT03373383|62723943|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
33346682|NCT03373383|62723944|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
33346683|NCT03373383|62723945|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
33346684|NCT03373383|62723946|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
33346685|NCT03373383|62723947|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
33346686|NCT00784654|62723974|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
33346687|NCT00784654|62723975|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
33470506|NCT03137992|62844171|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
33346688|NCT00784654|62723976|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
33470507|NCT03137992|62844172|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
33470508|NCT03137992|62844173|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
33346689|NCT00784654|62723974|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
33346690|NCT00784654|62723975|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
33346691|NCT00784654|62723976|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
33346692|NCT00784654|62723974|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
33346693|NCT00784654|62723975|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
33346694|NCT00784654|62723976|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
33346695|NCT00784654|62723974|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
33346696|NCT00784654|62723975|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
33346697|NCT00784654|62723976|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
33346698|NCT00784654|62723974|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
33346699|NCT00784654|62723975|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
33346700|NCT00784654|62723976|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
33346701|NCT00784654|62723974|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
33346702|NCT00784654|62723975|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
33346703|NCT00784654|62723976|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
33346704|NCT00784654|62723974|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
33346705|NCT00784654|62723975|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
33346706|NCT00784654|62723976|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
33346707|NCT00784654|62723974|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
33346708|NCT00784654|62723975|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
33346709|NCT00784654|62723976|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
33346710|NCT00784654|62723974|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
33346711|NCT00784654|62723975|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
33346712|NCT00784654|62723976|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
33346713|NCT00784654|62723974|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
33346714|NCT00784654|62723975|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
33346715|NCT00784654|62723976|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
33346716|NCT00784654|62723974|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
33346717|NCT00784654|62723975|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
33346718|NCT00784654|62723976|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
33346719|NCT00784654|62723974|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
33346720|NCT00784654|62723975|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
33346721|NCT00784654|62723976|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
33346722|NCT00784654|62723974|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
33346723|NCT00784654|62723975|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
33346724|NCT00784654|62723976|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
33346725|NCT00784654|62723974|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33346726|NCT00784654|62723975|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
33346727|NCT00784654|62723976|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
33346728|NCT00784654|62723974|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
33346729|NCT00784654|62723975|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
33346730|NCT00784654|62723976|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
33346731|NCT00784654|62723974|FG000|Randomized Withdrawal Period|Adverse Event|0|||
33346732|NCT00784654|62723975|FG001|Randomized Withdrawal Period|Adverse Event|1|||
33346733|NCT00784654|62723976|FG002|Randomized Withdrawal Period|Adverse Event|1|||
33346734|NCT00784654|62723974|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
33346735|NCT00784654|62723975|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
33346736|NCT00784654|62723976|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
33346737|NCT00784654|62723974|FG000|Randomized Withdrawal Period|Family reasons|0|||
33346738|NCT00784654|62723975|FG001|Randomized Withdrawal Period|Family reasons|0|||
33346739|NCT00784654|62723976|FG002|Randomized Withdrawal Period|Family reasons|1|||
33346740|NCT00787150|62723990|FG000|Overall Study|Adverse Event|4|||
33346741|NCT00787150|62723991|FG001|Overall Study|Adverse Event|4|||
33346742|NCT00787150|62723992|FG002|Overall Study|Adverse Event|4|||
33346743|NCT00787150|62723990|FG000|Overall Study|Physician Decision|1|||
33346744|NCT00787150|62723991|FG001|Overall Study|Physician Decision|2|||
33346745|NCT00787150|62723992|FG002|Overall Study|Physician Decision|1|||
33346746|NCT00787150|62723990|FG000|Overall Study|Withdrawal by Subject|2|||
33346747|NCT00787150|62723991|FG001|Overall Study|Withdrawal by Subject|1|||
33346748|NCT00787150|62723992|FG002|Overall Study|Withdrawal by Subject|0|||
33346749|NCT00787150|62723990|FG000|Overall Study|Dosing incorrect study durg|2|||
33346750|NCT00787150|62723991|FG001|Overall Study|Dosing incorrect study durg|0|||
33346751|NCT00787150|62723992|FG002|Overall Study|Dosing incorrect study durg|0|||
33346752|NCT00786838|62724002|FG000|Overall Study|Physician Decision|4|||
33346753|NCT00786838|62724002|FG000|Overall Study|Death|4|||
33346754|NCT00786838|62724002|FG000|Overall Study|Adverse Event|6|||
33654865|NCT00089583|63068212|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
33346755|NCT00786838|62724002|FG000|Overall Study|Progressive disease|31|||
33346756|NCT00786838|62724002|FG000|Overall Study|Withdrawal by Subject|4|||
33346757|NCT00785980|62724011|FG000|7 Day Washout Period|Protocol Violation|3|||
33346758|NCT00791518|62724018|FG000|Overall Study|Protocol Violation|93|||
33346759|NCT00785512|62724039|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
33346760|NCT00785512|62724040|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
33346761|NCT00785512|62724039|FG000|Overall Study|Adverse Event|0|||
33346762|NCT00785512|62724040|FG001|Overall Study|Adverse Event|0|||
33346763|NCT00785512|62724039|FG000|Overall Study|Lack of Efficacy|0|||
33346764|NCT00785512|62724040|FG001|Overall Study|Lack of Efficacy|2|||
33346765|NCT00785512|62724039|FG000|Overall Study|Withdrawal by Subject|0|||
33346766|NCT00785512|62724040|FG001|Overall Study|Withdrawal by Subject|1|||
33346767|NCT00785512|62724039|FG000|Overall Study|Lost to Follow-up|3|||
33346768|NCT00785512|62724040|FG001|Overall Study|Lost to Follow-up|0|||
33346769|NCT00785512|62724039|FG000|Overall Study|Precedure Refused|0|||
33346770|NCT00785512|62724040|FG001|Overall Study|Precedure Refused|0|||
33346771|NCT00785512|62724039|FG000|Overall Study|IVRS Programing Error|0|||
33346772|NCT00785512|62724040|FG001|Overall Study|IVRS Programing Error|0|||
33346773|NCT00785512|62724039|FG000|Overall Study|Physician Decision|0|||
33346774|NCT00785512|62724040|FG001|Overall Study|Physician Decision|0|||
33346775|NCT00785512|62724039|FG000|Overall Study|Lack of compliance|0|||
33346776|NCT00785512|62724040|FG001|Overall Study|Lack of compliance|1|||
33346777|NCT00785356|62724050|FG000|Overall Study|Study prematurely terminated|8|||
33346778|NCT00785044|62724058|FG000|Overall Study|Dosed at non-participating sites|152|||
33346779|NCT00785044|62724058|FG000|Overall Study|Death|77|||
33346780|NCT00785044|62724058|FG000|Overall Study|Lost to Follow-up|266|||
33346781|NCT00785044|62724058|FG000|Overall Study|Withdrawal by Subject|1|||
33346782|NCT00784810|62724065|FG000|Overall Study|Adverse Event|32|||
33346783|NCT00784810|62724066|FG001|Overall Study|Adverse Event|20|||
33346784|NCT00784810|62724065|FG000|Overall Study|Lack of Efficacy|14|||
33346785|NCT00784810|62724066|FG001|Overall Study|Lack of Efficacy|11|||
33346786|NCT00784810|62724065|FG000|Overall Study|Withdrawal by Subject|11|||
33346787|NCT00784810|62724066|FG001|Overall Study|Withdrawal by Subject|9|||
33346788|NCT00784810|62724065|FG000|Overall Study|Administrative|5|||
33346789|NCT00784810|62724066|FG001|Overall Study|Administrative|8|||
33346790|NCT00784810|62724065|FG000|Overall Study|Lost to Follow-up|1|||
33346791|NCT00784810|62724066|FG001|Overall Study|Lost to Follow-up|1|||
33346792|NCT00791128|62724072|FG000|Overall Study|Adverse Event|4|||
33346793|NCT00791128|62724072|FG000|Overall Study|Device migration|2|||
33346794|NCT00791128|62724072|FG000|Overall Study|non-compliance by subject|2|||
33346795|NCT00791128|62724072|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
33346796|NCT00776230|62724092|FG000|Overall Study|Lost to Follow-up|2|||
33346797|NCT00776230|62724093|FG001|Overall Study|Lost to Follow-up|1|||
33346798|NCT00776230|62724094|FG002|Overall Study|Lost to Follow-up|5|||
33346799|NCT00776230|62724092|FG000|Overall Study|Not vaccinated at Day 0|1|||
33346800|NCT00776230|62724093|FG001|Overall Study|Not vaccinated at Day 0|0|||
33346801|NCT00776230|62724094|FG002|Overall Study|Not vaccinated at Day 0|0|||
33346802|NCT00776230|62724092|FG000|Overall Study|Withdrawal by Subject|0|||
33346803|NCT00776230|62724093|FG001|Overall Study|Withdrawal by Subject|1|||
33346804|NCT00776230|62724094|FG002|Overall Study|Withdrawal by Subject|0|||
33346805|NCT00776230|62724092|FG000|Overall Study|Subject missed Visit 4|0|||
33346806|NCT00776230|62724093|FG001|Overall Study|Subject missed Visit 4|1|||
33346807|NCT00776230|62724094|FG002|Overall Study|Subject missed Visit 4|0|||
33346808|NCT00775606|62724104|FG000|Overall Study|Study sponsor terminated funding|3|||
33346809|NCT00775606|62724105|FG001|Overall Study|Study sponsor terminated funding|0|||
33346810|NCT02960763|62724124|FG000|Step 1|Withdrawal by Subject|10|||
33346811|NCT02960763|62724125|FG001|Step 1|Withdrawal by Subject|8|||
33346812|NCT02960763|62724126|FG002|Step 1|Withdrawal by Subject|13|||
33346813|NCT02960763|62724127|FG003|Step 1|Withdrawal by Subject|0|||
33346814|NCT02960763|62724128|FG004|Step 1|Withdrawal by Subject|0|||
33346815|NCT02960763|62724124|FG000|Step 1|Lost to Follow-up|7|||
33346816|NCT02960763|62724125|FG001|Step 1|Lost to Follow-up|9|||
33346817|NCT02960763|62724126|FG002|Step 1|Lost to Follow-up|12|||
33346818|NCT02960763|62724127|FG003|Step 1|Lost to Follow-up|0|||
33346819|NCT02960763|62724128|FG004|Step 1|Lost to Follow-up|0|||
33346820|NCT02960763|62724124|FG000|Step 1|Death|1|||
33346821|NCT02960763|62724125|FG001|Step 1|Death|1|||
33346822|NCT02960763|62724126|FG002|Step 1|Death|1|||
33346823|NCT02960763|62724127|FG003|Step 1|Death|0|||
33346824|NCT02960763|62724128|FG004|Step 1|Death|0|||
33346825|NCT02960763|62724124|FG000|Step 1|Investigator discretion|1|||
33346826|NCT02960763|62724125|FG001|Step 1|Investigator discretion|0|||
33346827|NCT02960763|62724126|FG002|Step 1|Investigator discretion|1|||
33346828|NCT02960763|62724127|FG003|Step 1|Investigator discretion|0|||
33346829|NCT02960763|62724128|FG004|Step 1|Investigator discretion|0|||
33346830|NCT02960763|62724124|FG000|Step 1|Other|0|||
33346831|NCT02960763|62724125|FG001|Step 1|Other|0|||
33346832|NCT02960763|62724126|FG002|Step 1|Other|1|||
33346833|NCT02960763|62724127|FG003|Step 1|Other|0|||
33346834|NCT02960763|62724128|FG004|Step 1|Other|0|||
33346835|NCT02960763|62724124|FG000|Step 2|Withdrawal by Subject|0|||
33346836|NCT02960763|62724125|FG001|Step 2|Withdrawal by Subject|0|||
33346837|NCT02960763|62724126|FG002|Step 2|Withdrawal by Subject|0|||
33346838|NCT02960763|62724127|FG003|Step 2|Withdrawal by Subject|7|||
33346839|NCT02960763|62724128|FG004|Step 2|Withdrawal by Subject|3|||
33346840|NCT02960763|62724124|FG000|Step 2|Lost to Follow-up|0|||
33346841|NCT02960763|62724125|FG001|Step 2|Lost to Follow-up|0|||
33346842|NCT02960763|62724126|FG002|Step 2|Lost to Follow-up|0|||
33346843|NCT02960763|62724127|FG003|Step 2|Lost to Follow-up|4|||
33346844|NCT02960763|62724128|FG004|Step 2|Lost to Follow-up|1|||
33548938|NCT02901431|62940302|FG008|PK Part|Pending dose confirmation|0|||
33346845|NCT02960763|62724124|FG000|Step 2|Investigator discretion|0|||
33346846|NCT02960763|62724125|FG001|Step 2|Investigator discretion|0|||
33346847|NCT02960763|62724126|FG002|Step 2|Investigator discretion|0|||
33346848|NCT02960763|62724127|FG003|Step 2|Investigator discretion|0|||
33346849|NCT02960763|62724128|FG004|Step 2|Investigator discretion|1|||
33346850|NCT00775528|62724140|FG000|Overall Study|Protocol Violation|1|||
33346851|NCT00775450|62724149|FG000|Overall Study|Serious Adverse Event|2|||
33346852|NCT00775450|62724150|FG001|Overall Study|Serious Adverse Event|0|||
33346853|NCT00775450|62724151|FG002|Overall Study|Serious Adverse Event|0|||
33346854|NCT00775450|62724152|FG003|Overall Study|Serious Adverse Event|0|||
33346855|NCT00775450|62724153|FG004|Overall Study|Serious Adverse Event|0|||
33346856|NCT00775450|62724149|FG000|Overall Study|Protocol Violation|0|||
33346857|NCT00775450|62724150|FG001|Overall Study|Protocol Violation|0|||
33346858|NCT00775450|62724151|FG002|Overall Study|Protocol Violation|0|||
33346859|NCT00775450|62724152|FG003|Overall Study|Protocol Violation|0|||
33346860|NCT00775450|62724153|FG004|Overall Study|Protocol Violation|1|||
33346861|NCT00775450|62724149|FG000|Overall Study|Withdrawal by Subject|1|||
33346862|NCT00775450|62724150|FG001|Overall Study|Withdrawal by Subject|0|||
33346863|NCT00775450|62724151|FG002|Overall Study|Withdrawal by Subject|0|||
33346864|NCT00775450|62724152|FG003|Overall Study|Withdrawal by Subject|0|||
33346865|NCT00775450|62724153|FG004|Overall Study|Withdrawal by Subject|1|||
33346866|NCT00775138|62724169|FG000|Overall Study|Withdrawal by Subject|0|||
33346867|NCT00775138|62724170|FG001|Overall Study|Withdrawal by Subject|0|||
33346868|NCT00775138|62724171|FG002|Overall Study|Withdrawal by Subject|2|||
33346869|NCT00775138|62724172|FG003|Overall Study|Withdrawal by Subject|2|||
33346870|NCT00775138|62724169|FG000|Overall Study|Adverse Event|0|||
33346871|NCT00775138|62724170|FG001|Overall Study|Adverse Event|0|||
33346872|NCT00775138|62724171|FG002|Overall Study|Adverse Event|1|||
33346873|NCT00775138|62724172|FG003|Overall Study|Adverse Event|0|||
33346874|NCT04605991|62724184|FG000|Overall Study|Adverse Event|5|||
33346875|NCT04605991|62724184|FG000|Overall Study|Lack of Efficacy|1|||
33346876|NCT04605991|62724184|FG000|Overall Study|Lost to Follow-up|8|||
33346877|NCT04605991|62724184|FG000|Overall Study|Physician Decision|4|||
33346878|NCT04605991|62724184|FG000|Overall Study|Withdrawal by Subject|14|||
33346879|NCT04605991|62724184|FG000|Overall Study|Non-compliance with study|1|||
33346880|NCT00783796|62724188|FG000|Overall Study|Did not receive any stent|4|||
33346881|NCT00783796|62724188|FG000|Overall Study|Received non-XIENCE V stent|1|||
33346882|NCT00783796|62724188|FG000|Overall Study|Received commercial XIENCE V stent|1|||
33470509|NCT03137992|62844174|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
33470510|NCT03137992|62844175|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
33470511|NCT03137992|62844170|FG000|Part 2 (Open-label Extension)|Per study team|1|||
33470512|NCT03137992|62844171|FG001|Part 2 (Open-label Extension)|Per study team|0|||
33470513|NCT03137992|62844172|FG002|Part 2 (Open-label Extension)|Per study team|0|||
33470514|NCT03137992|62844173|FG003|Part 2 (Open-label Extension)|Per study team|0|||
33470515|NCT03137992|62844174|FG004|Part 2 (Open-label Extension)|Per study team|0|||
33470516|NCT03137992|62844175|FG005|Part 2 (Open-label Extension)|Per study team|0|||
33470517|NCT03137992|62844170|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
33470518|NCT03137992|62844171|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
33470519|NCT03137992|62844172|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
33470520|NCT03137992|62844173|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
33548939|NCT02901431|62940303|FG009|PK Part|Pending dose confirmation|0|||
33346883|NCT00783718|62724197|FG000|Induction Phase|Adverse Event|4|||
33346884|NCT00783718|62724198|FG001|Induction Phase|Adverse Event|0|||
33346885|NCT00783718|62724199|FG002|Induction Phase|Adverse Event|7|||
33346886|NCT00783718|62724200|FG003|Induction Phase|Adverse Event|0|||
33346887|NCT00783718|62724201|FG004|Induction Phase|Adverse Event|0|||
33346888|NCT00783718|62724202|FG005|Induction Phase|Adverse Event|0|||
33346889|NCT00783718|62724203|FG006|Induction Phase|Adverse Event|0|||
33346890|NCT00783718|62724197|FG000|Induction Phase|Protocol Violation|1|||
33346891|NCT00783718|62724198|FG001|Induction Phase|Protocol Violation|1|||
33346892|NCT00783718|62724199|FG002|Induction Phase|Protocol Violation|6|||
33346893|NCT00783718|62724200|FG003|Induction Phase|Protocol Violation|0|||
33346894|NCT00783718|62724201|FG004|Induction Phase|Protocol Violation|0|||
33346895|NCT00783718|62724202|FG005|Induction Phase|Protocol Violation|0|||
33346896|NCT00783718|62724203|FG006|Induction Phase|Protocol Violation|0|||
33346897|NCT00783718|62724197|FG000|Induction Phase|Lack of Efficacy|5|||
33346898|NCT00783718|62724198|FG001|Induction Phase|Lack of Efficacy|2|||
33346899|NCT00783718|62724199|FG002|Induction Phase|Lack of Efficacy|14|||
33346900|NCT00783718|62724200|FG003|Induction Phase|Lack of Efficacy|0|||
33346901|NCT00783718|62724201|FG004|Induction Phase|Lack of Efficacy|0|||
33346902|NCT00783718|62724202|FG005|Induction Phase|Lack of Efficacy|0|||
33346903|NCT00783718|62724203|FG006|Induction Phase|Lack of Efficacy|0|||
33346904|NCT00783718|62724197|FG000|Induction Phase|Withdrawal by Subject|3|||
33346905|NCT00783718|62724198|FG001|Induction Phase|Withdrawal by Subject|4|||
33346906|NCT00783718|62724199|FG002|Induction Phase|Withdrawal by Subject|8|||
33346907|NCT00783718|62724200|FG003|Induction Phase|Withdrawal by Subject|0|||
33346908|NCT00783718|62724201|FG004|Induction Phase|Withdrawal by Subject|0|||
33346909|NCT00783718|62724202|FG005|Induction Phase|Withdrawal by Subject|0|||
33346910|NCT00783718|62724203|FG006|Induction Phase|Withdrawal by Subject|0|||
33346911|NCT00783718|62724197|FG000|Induction Phase|Lost to Follow-up|1|||
33346912|NCT00783718|62724198|FG001|Induction Phase|Lost to Follow-up|0|||
33346913|NCT00783718|62724199|FG002|Induction Phase|Lost to Follow-up|1|||
33346914|NCT00783718|62724200|FG003|Induction Phase|Lost to Follow-up|0|||
33346915|NCT00783718|62724201|FG004|Induction Phase|Lost to Follow-up|0|||
33346916|NCT00783718|62724202|FG005|Induction Phase|Lost to Follow-up|0|||
33346917|NCT00783718|62724203|FG006|Induction Phase|Lost to Follow-up|0|||
33346918|NCT00783718|62724197|FG000|Maintenance Phase|Adverse Event|12|||
33346919|NCT00783718|62724198|FG001|Maintenance Phase|Adverse Event|0|||
33346920|NCT00783718|62724199|FG002|Maintenance Phase|Adverse Event|0|||
33346921|NCT00783718|62724200|FG003|Maintenance Phase|Adverse Event|15|||
33470521|NCT03137992|62844174|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
33470522|NCT03137992|62844175|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
33470523|NCT03704636|62844183|FG000|Overall Study|Inadequate Venous Flow|3|||
33470524|NCT05096312|62844198|FG000|Overall Study|Lost to Follow-up|2|||
33470525|NCT05096312|62844199|FG001|Overall Study|Lost to Follow-up|4|||
33470526|NCT05096312|62844198|FG000|Overall Study|Adverse Event|1|||
33470527|NCT05096312|62844199|FG001|Overall Study|Adverse Event|0|||
33470528|NCT04908488|62844207|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
33470529|NCT04908488|62844208|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
33470530|NCT04908488|62844207|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
33470531|NCT04908488|62844208|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
33470532|NCT04876274|62844219|FG000|Overall Study|Lost to Follow-up|9|||
33470533|NCT04876274|62844220|FG001|Overall Study|Lost to Follow-up|12|||
33470534|NCT04865354|62844228|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
33470535|NCT04865354|62844229|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
33470536|NCT04865354|62844228|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
33470537|NCT04865354|62844229|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
33470538|NCT04865354|62844228|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
33470539|NCT04865354|62844229|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
33470540|NCT04860518|62844240|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
33470541|NCT04860518|62844241|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
33470542|NCT03110380|62844249|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
33470543|NCT03110380|62844250|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
33470544|NCT03110380|62844251|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
33470545|NCT03110380|62844252|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
33470546|NCT03110380|62844249|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
33470547|NCT03110380|62844250|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
33470548|NCT03110380|62844251|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33470549|NCT03110380|62844252|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33470550|NCT03110380|62844249|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
33470551|NCT03110380|62844250|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
33470552|NCT03110380|62844251|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
33470553|NCT03110380|62844252|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
33470554|NCT03110380|62844249|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
33470555|NCT03110380|62844250|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
33470556|NCT03110380|62844251|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
33470557|NCT03110380|62844252|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
33470558|NCT03110380|62844249|FG000|Double-Blind Treatment Phase|Death|2|||
33470559|NCT03110380|62844250|FG001|Double-Blind Treatment Phase|Death|1|||
33470560|NCT03110380|62844251|FG002|Double-Blind Treatment Phase|Death|0|||
33470561|NCT03110380|62844252|FG003|Double-Blind Treatment Phase|Death|0|||
33470562|NCT03110380|62844249|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
33346922|NCT00783718|62724201|FG004|Maintenance Phase|Adverse Event|7|||
33346923|NCT00783718|62724202|FG005|Maintenance Phase|Adverse Event|6|||
33346924|NCT00783718|62724203|FG006|Maintenance Phase|Adverse Event|16|||
33346925|NCT00783718|62724197|FG000|Maintenance Phase|Protocol Violation|1|||
33346926|NCT00783718|62724198|FG001|Maintenance Phase|Protocol Violation|0|||
33346927|NCT00783718|62724199|FG002|Maintenance Phase|Protocol Violation|0|||
33346928|NCT00783718|62724200|FG003|Maintenance Phase|Protocol Violation|0|||
33346929|NCT00783718|62724201|FG004|Maintenance Phase|Protocol Violation|0|||
33346930|NCT00783718|62724202|FG005|Maintenance Phase|Protocol Violation|0|||
33346931|NCT00783718|62724203|FG006|Maintenance Phase|Protocol Violation|2|||
33346932|NCT00783718|62724197|FG000|Maintenance Phase|Lack of Efficacy|83|||
33346933|NCT00783718|62724198|FG001|Maintenance Phase|Lack of Efficacy|0|||
33346934|NCT00783718|62724199|FG002|Maintenance Phase|Lack of Efficacy|0|||
33346935|NCT00783718|62724200|FG003|Maintenance Phase|Lack of Efficacy|61|||
33346936|NCT00783718|62724201|FG004|Maintenance Phase|Lack of Efficacy|31|||
33346937|NCT00783718|62724202|FG005|Maintenance Phase|Lack of Efficacy|33|||
33346938|NCT00783718|62724203|FG006|Maintenance Phase|Lack of Efficacy|155|||
33346939|NCT00783718|62724197|FG000|Maintenance Phase|Withdrawal by Subject|6|||
33346940|NCT00783718|62724198|FG001|Maintenance Phase|Withdrawal by Subject|0|||
33346941|NCT00783718|62724199|FG002|Maintenance Phase|Withdrawal by Subject|0|||
33346942|NCT00783718|62724200|FG003|Maintenance Phase|Withdrawal by Subject|2|||
33346943|NCT00783718|62724201|FG004|Maintenance Phase|Withdrawal by Subject|5|||
33346944|NCT00783718|62724202|FG005|Maintenance Phase|Withdrawal by Subject|2|||
33346945|NCT00783718|62724203|FG006|Maintenance Phase|Withdrawal by Subject|20|||
33346946|NCT00783718|62724197|FG000|Maintenance Phase|Lost to Follow-up|3|||
33346947|NCT00783718|62724198|FG001|Maintenance Phase|Lost to Follow-up|0|||
33346948|NCT00783718|62724199|FG002|Maintenance Phase|Lost to Follow-up|0|||
33346949|NCT00783718|62724200|FG003|Maintenance Phase|Lost to Follow-up|0|||
33346950|NCT00783718|62724201|FG004|Maintenance Phase|Lost to Follow-up|2|||
33346951|NCT00783718|62724202|FG005|Maintenance Phase|Lost to Follow-up|0|||
33346952|NCT00783718|62724203|FG006|Maintenance Phase|Lost to Follow-up|2|||
33346953|NCT00774748|62724222|FG000|Overall Study|Lost to Follow-up|3|||
33346954|NCT00587860|62724232|FG000|Overall Study|Lost to Follow-up|2|||
33346955|NCT00587860|62724233|FG001|Overall Study|Lost to Follow-up|2|||
33346956|NCT00587860|62724232|FG000|Overall Study|Withdrawal by Subject|3|||
33346957|NCT00587860|62724233|FG001|Overall Study|Withdrawal by Subject|3|||
33346958|NCT00583453|62724241|FG000|Overall Study|discontinued intervention|0|||
33346959|NCT00583453|62724242|FG001|Overall Study|discontinued intervention|2|||
33346960|NCT00583219|62724250|FG000|Phase 2|Withdrawal by Subject|1|||
33346961|NCT01072175|62724270|FG000|Part A (Drug-Drug Interaction)|Death|1|||
33346962|NCT01072175|62724271|FG001|Part A (Drug-Drug Interaction)|Death|0|||
33346963|NCT01072175|62724272|FG002|Part A (Drug-Drug Interaction)|Death|0|||
33346964|NCT01072175|62724273|FG003|Part A (Drug-Drug Interaction)|Death|0|||
33346965|NCT01072175|62724274|FG004|Part A (Drug-Drug Interaction)|Death|0|||
33346966|NCT01072175|62724275|FG005|Part A (Drug-Drug Interaction)|Death|0|||
33346967|NCT01072175|62724276|FG006|Part A (Drug-Drug Interaction)|Death|0|||
33346968|NCT01072175|62724277|FG007|Part A (Drug-Drug Interaction)|Death|0|||
33346969|NCT01072175|62724278|FG008|Part A (Drug-Drug Interaction)|Death|0|||
33346970|NCT01072175|62724279|FG009|Part A (Drug-Drug Interaction)|Death|0|||
33346971|NCT01072175|62724280|FG010|Part A (Drug-Drug Interaction)|Death|0|||
33346972|NCT01072175|62724281|FG011|Part A (Drug-Drug Interaction)|Death|0|||
33346973|NCT01072175|62724282|FG012|Part A (Drug-Drug Interaction)|Death|0|||
33346974|NCT01072175|62724270|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
33346975|NCT01072175|62724271|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33346976|NCT01072175|62724272|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33346977|NCT01072175|62724273|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33346978|NCT01072175|62724274|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33346979|NCT01072175|62724275|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33346980|NCT01072175|62724276|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33346981|NCT01072175|62724277|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33346982|NCT01072175|62724278|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33346983|NCT01072175|62724279|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33346984|NCT01072175|62724280|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33346985|NCT01072175|62724281|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33470563|NCT03110380|62844250|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
33470564|NCT03110380|62844251|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
33346986|NCT01072175|62724282|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33346987|NCT01072175|62724270|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
33346988|NCT01072175|62724271|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33346989|NCT01072175|62724272|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33346990|NCT01072175|62724273|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33470565|NCT03110380|62844252|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
33346991|NCT01072175|62724274|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33346992|NCT01072175|62724275|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33346993|NCT01072175|62724276|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33346994|NCT01072175|62724277|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33346995|NCT01072175|62724278|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33346996|NCT01072175|62724279|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33346997|NCT01072175|62724280|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33346998|NCT01072175|62724281|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33346999|NCT01072175|62724282|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33347000|NCT01072175|62724270|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
33470566|NCT03110380|62844249|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
33470567|NCT03110380|62844250|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
33470568|NCT03110380|62844251|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
33470569|NCT03110380|62844252|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
33470570|NCT03110380|62844249|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
33470571|NCT03110380|62844250|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
33470572|NCT03110380|62844251|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
33470573|NCT03110380|62844252|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
33470574|NCT03110380|62844249|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
33347001|NCT01072175|62724271|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
33347002|NCT01072175|62724272|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
33347003|NCT01072175|62724273|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
33347004|NCT01072175|62724274|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
33347005|NCT01072175|62724275|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
33347006|NCT01072175|62724276|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
33347007|NCT01072175|62724277|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
33347008|NCT01072175|62724278|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
33347009|NCT01072175|62724279|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
33347010|NCT01072175|62724280|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
33347011|NCT01072175|62724281|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
33347012|NCT01072175|62724282|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
33347013|NCT01072175|62724270|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33347014|NCT01072175|62724271|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33347015|NCT01072175|62724272|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
33347016|NCT01072175|62724273|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33347017|NCT01072175|62724274|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
33347018|NCT01072175|62724275|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33470575|NCT03110380|62844250|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
33470576|NCT03110380|62844251|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
33347019|NCT01072175|62724276|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33347020|NCT01072175|62724277|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33347021|NCT01072175|62724278|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33347022|NCT01072175|62724279|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33347023|NCT01072175|62724280|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33347024|NCT01072175|62724281|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33347025|NCT01072175|62724282|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33347026|NCT01072175|62724270|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33347027|NCT01072175|62724271|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
33347028|NCT01072175|62724272|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33347029|NCT01072175|62724273|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
33347030|NCT01072175|62724274|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
33347031|NCT01072175|62724275|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33347032|NCT01072175|62724276|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33347033|NCT01072175|62724277|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33347034|NCT01072175|62724278|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33347035|NCT01072175|62724279|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33347036|NCT01072175|62724280|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33347037|NCT01072175|62724281|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33347038|NCT01072175|62724282|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33347039|NCT01072175|62724270|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33347040|NCT01072175|62724271|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33347041|NCT01072175|62724272|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
33347042|NCT01072175|62724273|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
33347043|NCT01072175|62724274|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
33347044|NCT01072175|62724275|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33347045|NCT01072175|62724276|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33347046|NCT01072175|62724277|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33470577|NCT03110380|62844252|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
33470578|NCT03110380|62844249|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
33470579|NCT03110380|62844250|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
33470580|NCT03110380|62844251|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
33470581|NCT03110380|62844252|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
33347047|NCT01072175|62724278|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33347048|NCT01072175|62724279|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33347049|NCT01072175|62724280|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33347050|NCT01072175|62724281|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33347051|NCT01072175|62724282|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33347052|NCT01072175|62724270|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33347053|NCT01072175|62724271|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
33347054|NCT01072175|62724272|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33347055|NCT01072175|62724273|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
33347056|NCT01072175|62724274|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
33347057|NCT01072175|62724275|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33347058|NCT01072175|62724276|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33347059|NCT01072175|62724277|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33347060|NCT01072175|62724278|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33347061|NCT01072175|62724279|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33347062|NCT01072175|62724280|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33347063|NCT01072175|62724281|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33347064|NCT01072175|62724282|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33347065|NCT01072175|62724270|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
33347066|NCT01072175|62724271|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
33347067|NCT01072175|62724272|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
33347068|NCT01072175|62724273|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
33347069|NCT01072175|62724274|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
33347070|NCT01072175|62724275|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
33347071|NCT01072175|62724276|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
33347072|NCT01072175|62724277|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
33347073|NCT01072175|62724278|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
33347074|NCT01072175|62724279|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
33347075|NCT01072175|62724280|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
33347076|NCT01072175|62724281|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
33347077|NCT01072175|62724282|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
33347078|NCT01072175|62724270|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33347079|NCT01072175|62724271|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33347080|NCT01072175|62724272|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33347081|NCT01072175|62724273|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33347082|NCT01072175|62724274|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33347083|NCT01072175|62724275|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
33347084|NCT01072175|62724276|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
33347085|NCT01072175|62724277|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
33347086|NCT01072175|62724278|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33347087|NCT01072175|62724279|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33347088|NCT01072175|62724280|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33347089|NCT01072175|62724281|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33347090|NCT01072175|62724282|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33347091|NCT01072175|62724270|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33347092|NCT01072175|62724271|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33347093|NCT01072175|62724272|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33347094|NCT01072175|62724273|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33347095|NCT01072175|62724274|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33347096|NCT01072175|62724275|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33347097|NCT01072175|62724276|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
33347098|NCT01072175|62724277|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
33347099|NCT01072175|62724278|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33347100|NCT01072175|62724279|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33347101|NCT01072175|62724280|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33347102|NCT01072175|62724281|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33347103|NCT01072175|62724282|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33347104|NCT01072175|62724270|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33347105|NCT01072175|62724271|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33347106|NCT01072175|62724272|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33347107|NCT01072175|62724273|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33347108|NCT01072175|62724274|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33347109|NCT01072175|62724275|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
33548940|NCT02901431|62940304|FG010|PK Part|Pending dose confirmation|0|||
33548941|NCT02901431|62940305|FG011|PK Part|Pending dose confirmation|0|||
33347110|NCT01072175|62724276|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
33347111|NCT01072175|62724277|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
33347112|NCT01072175|62724278|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33347113|NCT01072175|62724279|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33347114|NCT01072175|62724280|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33347115|NCT01072175|62724281|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33347116|NCT01072175|62724282|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33347117|NCT01072175|62724270|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33347118|NCT01072175|62724271|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33347119|NCT01072175|62724272|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33347120|NCT01072175|62724273|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33347121|NCT01072175|62724274|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33347122|NCT01072175|62724275|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
33347123|NCT01072175|62724276|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
33347124|NCT01072175|62724277|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33347125|NCT01072175|62724278|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33347126|NCT01072175|62724279|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33347127|NCT01072175|62724280|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33347128|NCT01072175|62724281|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33347129|NCT01072175|62724282|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33347130|NCT01072175|62724270|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33347131|NCT01072175|62724271|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33347132|NCT01072175|62724272|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33347133|NCT01072175|62724273|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33347134|NCT01072175|62724274|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33347135|NCT01072175|62724275|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33347136|NCT01072175|62724276|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33347137|NCT01072175|62724277|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33347138|NCT01072175|62724278|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
33347139|NCT01072175|62724279|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33347140|NCT01072175|62724280|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33347141|NCT01072175|62724281|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33347142|NCT01072175|62724282|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33347143|NCT01072175|62724270|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33347144|NCT01072175|62724271|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33347145|NCT01072175|62724272|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33347146|NCT01072175|62724273|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33347147|NCT01072175|62724274|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33347148|NCT01072175|62724275|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33347149|NCT01072175|62724276|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33347150|NCT01072175|62724277|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33347151|NCT01072175|62724278|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
33347152|NCT01072175|62724279|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33347153|NCT01072175|62724280|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33347154|NCT01072175|62724281|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33347155|NCT01072175|62724282|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33347156|NCT01072175|62724270|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33347157|NCT01072175|62724271|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33347158|NCT01072175|62724272|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33347159|NCT01072175|62724273|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33347160|NCT01072175|62724274|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33347161|NCT01072175|62724275|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33347162|NCT01072175|62724276|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33347163|NCT01072175|62724277|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33347164|NCT01072175|62724278|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
33347165|NCT01072175|62724279|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33470582|NCT03110380|62844249|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
33470583|NCT03110380|62844250|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
33347166|NCT01072175|62724280|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33347167|NCT01072175|62724281|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33347168|NCT01072175|62724282|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33470584|NCT03110380|62844251|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
33470585|NCT03110380|62844252|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
33470586|NCT04851314|62844262|FG000|Overall Study|Unable to complete research set-up procedures|0|||
33347169|NCT01072175|62724270|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33347170|NCT01072175|62724271|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33347171|NCT01072175|62724272|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33347172|NCT01072175|62724273|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33347173|NCT01072175|62724274|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33347174|NCT01072175|62724275|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33347175|NCT01072175|62724276|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33347176|NCT01072175|62724277|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33347177|NCT01072175|62724278|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
33347178|NCT01072175|62724279|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33347179|NCT01072175|62724280|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33347180|NCT01072175|62724281|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33347181|NCT01072175|62724282|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33347182|NCT01072175|62724270|FG000|Part D (HPMC Capsules)|Death|0|||
33347183|NCT01072175|62724271|FG001|Part D (HPMC Capsules)|Death|0|||
33347184|NCT01072175|62724272|FG002|Part D (HPMC Capsules)|Death|0|||
33347185|NCT01072175|62724273|FG003|Part D (HPMC Capsules)|Death|0|||
33347186|NCT01072175|62724274|FG004|Part D (HPMC Capsules)|Death|0|||
33347187|NCT01072175|62724275|FG005|Part D (HPMC Capsules)|Death|0|||
33347188|NCT01072175|62724276|FG006|Part D (HPMC Capsules)|Death|0|||
33347189|NCT01072175|62724277|FG007|Part D (HPMC Capsules)|Death|0|||
33347190|NCT01072175|62724278|FG008|Part D (HPMC Capsules)|Death|0|||
33347191|NCT01072175|62724279|FG009|Part D (HPMC Capsules)|Death|10|||
33347192|NCT01072175|62724280|FG010|Part D (HPMC Capsules)|Death|12|||
33347193|NCT01072175|62724281|FG011|Part D (HPMC Capsules)|Death|28|||
33347194|NCT01072175|62724282|FG012|Part D (HPMC Capsules)|Death|26|||
33347195|NCT01072175|62724270|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
33347196|NCT01072175|62724271|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
33347197|NCT01072175|62724272|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
33347198|NCT01072175|62724273|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
33347199|NCT01072175|62724274|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
33347200|NCT01072175|62724275|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
33347201|NCT01072175|62724276|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
33347202|NCT01072175|62724277|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
33347203|NCT01072175|62724278|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
33347204|NCT01072175|62724279|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
33347205|NCT01072175|62724280|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
33347206|NCT01072175|62724281|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
33347207|NCT01072175|62724282|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
33347208|NCT01072175|62724270|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33347209|NCT01072175|62724271|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33347210|NCT01072175|62724272|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33347211|NCT01072175|62724273|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33347212|NCT01072175|62724274|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33347213|NCT01072175|62724275|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33347214|NCT01072175|62724276|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33347215|NCT01072175|62724277|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33347216|NCT01072175|62724278|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33347217|NCT01072175|62724279|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33347218|NCT01072175|62724280|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
33347219|NCT01072175|62724281|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
33347220|NCT01072175|62724282|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
33347221|NCT01072175|62724270|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
33347222|NCT01072175|62724271|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
33347223|NCT01072175|62724272|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
33347224|NCT01072175|62724273|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
33347225|NCT01072175|62724274|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
33347226|NCT01072175|62724275|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
33347227|NCT01072175|62724276|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
33347228|NCT01072175|62724277|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
33347229|NCT01072175|62724278|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
33347230|NCT01072175|62724279|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
33347231|NCT01072175|62724280|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
33347232|NCT01072175|62724281|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
33347233|NCT01072175|62724282|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
33347234|NCT01072175|62724270|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33347235|NCT01072175|62724271|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33347236|NCT01072175|62724272|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33347237|NCT01072175|62724273|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33347238|NCT01072175|62724274|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33347239|NCT01072175|62724275|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33347240|NCT01072175|62724276|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33347241|NCT01072175|62724277|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33347242|NCT01072175|62724278|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33347243|NCT01072175|62724279|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33347244|NCT01072175|62724280|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
33347245|NCT01072175|62724281|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
33347246|NCT01072175|62724282|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33347247|NCT01071317|62724316|FG000|Overall Study|Lost to Follow-up|2|||
33347248|NCT01071317|62724317|FG001|Overall Study|Lost to Follow-up|2|||
33347249|NCT00783094|62724334|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
33347250|NCT00783094|62724335|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
33347251|NCT00783094|62724336|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
33347252|NCT00783094|62724334|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
33347253|NCT00783094|62724335|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
33347254|NCT00783094|62724336|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
33347255|NCT00783094|62724334|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
33347256|NCT00783094|62724335|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
33654866|NCT00089583|63068211|FG000|Overall Study|Participant Management Criteria Met|0|||
33654867|NCT00089583|63068212|FG001|Overall Study|Participant Management Criteria Met|1|||
33654868|NCT00089583|63068211|FG000|Overall Study|Reason Not Provided|0|||
33654869|NCT00089583|63068212|FG001|Overall Study|Reason Not Provided|1|||
33654870|NCT00089583|63068211|FG000|Overall Study|Protocol Violation|0|||
33654871|NCT00089583|63068212|FG001|Overall Study|Protocol Violation|3|||
33654872|NCT00089583|63068211|FG000|Overall Study|Principal Investigator Decision|0|||
33654873|NCT00089583|63068212|FG001|Overall Study|Principal Investigator Decision|10|||
33654874|NCT00089583|63068211|FG000|Overall Study|Start of Disallowed Medication|0|||
33654875|NCT00089583|63068212|FG001|Overall Study|Start of Disallowed Medication|1|||
33654876|NCT00089583|63068211|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
33654877|NCT00089583|63068212|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
33654878|NCT00089583|63068211|FG000|Overall Study|Participant Incarcerated|0|||
33654879|NCT00089583|63068212|FG001|Overall Study|Participant Incarcerated|1|||
33654880|NCT00088881|63068224|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
33654881|NCT00088881|63068224|FG000|Step 1 - R-CHOP|Adverse Event|1|||
33654882|NCT00088881|63068224|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
33654883|NCT00088881|63068224|FG000|Step 1 - R-CHOP|Physician Decision|1|||
33654884|NCT00088881|63068224|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
33654885|NCT00088881|63068224|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
33654886|NCT00088881|63068224|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
33654887|NCT00087555|63068272|FG000|Overall Study|Adverse Event|3|||
33654888|NCT00087555|63068273|FG001|Overall Study|Adverse Event|6|||
33654889|NCT00087555|63068274|FG002|Overall Study|Adverse Event|14|||
33654890|NCT00087555|63068272|FG000|Overall Study|Lost to Follow-up|0|||
33654891|NCT00087555|63068273|FG001|Overall Study|Lost to Follow-up|1|||
33654892|NCT00087555|63068274|FG002|Overall Study|Lost to Follow-up|1|||
33654893|NCT00087555|63068272|FG000|Overall Study|Non - Compliance|1|||
33654894|NCT00087555|63068273|FG001|Overall Study|Non - Compliance|0|||
33654895|NCT00087555|63068274|FG002|Overall Study|Non - Compliance|0|||
33654896|NCT00087555|63068272|FG000|Overall Study|Protocol Violation|0|||
33654897|NCT00087555|63068273|FG001|Overall Study|Protocol Violation|0|||
33654898|NCT00087555|63068274|FG002|Overall Study|Protocol Violation|2|||
33654899|NCT00087555|63068272|FG000|Overall Study|Screen Failure|1|||
33347257|NCT00783094|62724336|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
33347258|NCT00783094|62724334|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
33347259|NCT00783094|62724335|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
33347260|NCT00783094|62724336|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
33347261|NCT00783094|62724334|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
33347262|NCT00783094|62724335|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
33347263|NCT00783094|62724336|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
33347264|NCT00783094|62724334|FG000|Open-Label Extension Period|Adverse Event|12|||
33347265|NCT00783094|62724335|FG001|Open-Label Extension Period|Adverse Event|7|||
33347266|NCT00783094|62724336|FG002|Open-Label Extension Period|Adverse Event|16|||
33654900|NCT00087555|63068273|FG001|Overall Study|Screen Failure|1|||
33654901|NCT00087555|63068274|FG002|Overall Study|Screen Failure|0|||
33654902|NCT00087555|63068272|FG000|Overall Study|Pregnancy|0|||
33654903|NCT00087555|63068273|FG001|Overall Study|Pregnancy|1|||
33654904|NCT00087555|63068274|FG002|Overall Study|Pregnancy|1|||
33347267|NCT00783094|62724334|FG000|Open-Label Extension Period|Death|0|||
33347268|NCT00783094|62724335|FG001|Open-Label Extension Period|Death|0|||
33654905|NCT00087555|63068272|FG000|Overall Study|Withdrawal by Subject|3|||
33654906|NCT00087555|63068273|FG001|Overall Study|Withdrawal by Subject|2|||
33654907|NCT00087555|63068274|FG002|Overall Study|Withdrawal by Subject|1|||
33654908|NCT00087555|63068272|FG000|Overall Study|Lack of Efficacy|2|||
33654909|NCT00087555|63068273|FG001|Overall Study|Lack of Efficacy|0|||
33654910|NCT00087555|63068274|FG002|Overall Study|Lack of Efficacy|1|||
33347269|NCT00783094|62724336|FG002|Open-Label Extension Period|Death|1|||
33347270|NCT00783094|62724334|FG000|Open-Label Extension Period|Protocol Violation|4|||
33347271|NCT00783094|62724335|FG001|Open-Label Extension Period|Protocol Violation|5|||
33347272|NCT00783094|62724336|FG002|Open-Label Extension Period|Protocol Violation|7|||
33347273|NCT00783094|62724334|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
33347274|NCT00783094|62724335|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
33347275|NCT00783094|62724336|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
33347276|NCT00783094|62724334|FG000|Open-Label Extension Period|Physician Decision|4|||
33347277|NCT00783094|62724335|FG001|Open-Label Extension Period|Physician Decision|2|||
33347278|NCT00783094|62724336|FG002|Open-Label Extension Period|Physician Decision|3|||
33347279|NCT00783094|62724334|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
33347280|NCT00783094|62724335|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
33470587|NCT04851314|62844263|FG001|Overall Study|Unable to complete research set-up procedures|2|||
33470588|NCT04851314|62844262|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
33470589|NCT04851314|62844263|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
33470590|NCT04848662|62844271|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
33470591|NCT04848662|62844272|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
33470592|NCT03701516|62844278|FG000|Period 1|Lost to Follow-up|0|||
33470593|NCT03701516|62844279|FG001|Period 1|Lost to Follow-up|1|||
33470594|NCT03701516|62844278|FG000|Period 1|Adverse Event|0|||
33470595|NCT03701516|62844279|FG001|Period 1|Adverse Event|2|||
33470596|NCT03701516|62844278|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
33470597|NCT03701516|62844279|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
33470598|NCT03701516|62844278|FG000|Period 1|Non Compliance to Protocol|2|||
33470599|NCT03701516|62844279|FG001|Period 1|Non Compliance to Protocol|1|||
33470600|NCT03701516|62844278|FG000|Period 1|Withdrawal by Subject|0|||
33470601|NCT03701516|62844279|FG001|Period 1|Withdrawal by Subject|1|||
33470602|NCT03701516|62844278|FG000|Period 2|failed to meet all eligibility creiteria|1|||
33470603|NCT03701516|62844279|FG001|Period 2|failed to meet all eligibility creiteria|0|||
33470604|NCT03701516|62844278|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
33470605|NCT03701516|62844279|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
33654911|NCT00087555|63068272|FG000|Overall Study|Non Compliance|0|||
33347281|NCT00783094|62724336|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
33347282|NCT00790582|62724349|FG000|Overall Study|Death|14|||
33347283|NCT00790582|62724350|FG001|Overall Study|Death|32|||
33347284|NCT00790582|62724349|FG000|Overall Study|Physician Decision|7|||
33347285|NCT00790582|62724350|FG001|Overall Study|Physician Decision|1|||
33347286|NCT00790582|62724349|FG000|Overall Study|Lost to Follow-up|3|||
33347287|NCT00790582|62724350|FG001|Overall Study|Lost to Follow-up|3|||
33347288|NCT00790582|62724349|FG000|Overall Study|Withdrawal by Subject|7|||
33347289|NCT00790582|62724350|FG001|Overall Study|Withdrawal by Subject|51|||
33347290|NCT01048541|62724358|FG000|Overall Study|Withdrawal by Subject|1|||
33347291|NCT01048541|62724359|FG001|Overall Study|Withdrawal by Subject|0|||
33347292|NCT00774046|62724365|FG000|Screening|Not eligible|56|||
33347293|NCT00774046|62724365|FG000|Enrollment|Desired other therapy/refused|28|||
33347294|NCT00774046|62724365|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
33347295|NCT01046903|62724369|FG000|Overall Study|Lost to Follow-up|16|||
33347296|NCT01046903|62724369|FG000|Overall Study|Adverse Event|4|||
33347297|NCT01046903|62724369|FG000|Overall Study|Withdrawal by Subject|3|||
33347298|NCT01046903|62724369|FG000|Overall Study|Other|5|||
33347299|NCT00773968|62724373|FG000|Overall Study|Adverse Event|2|||
33347300|NCT00773968|62724373|FG000|Overall Study|Death|1|||
33347301|NCT00773968|62724373|FG000|Overall Study|Failure to Return|2|||
33347302|NCT00773968|62724373|FG000|Overall Study|Lack of Efficacy|3|||
33347303|NCT00773968|62724373|FG000|Overall Study|Protocol Violation|1|||
33347304|NCT00773968|62724373|FG000|Overall Study|Withdrawal by Subject|11|||
33347305|NCT00773968|62724373|FG000|Overall Study|Screen Failure|17|||
33347306|NCT00773968|62724373|FG000|Overall Study|Other|8|||
33347307|NCT00782626|62724377|FG000|Overall Study|Adverse Event|1|||
33347308|NCT00782626|62724377|FG000|Overall Study|Progressive Disease|5|||
33347309|NCT00782626|62724377|FG000|Overall Study|Other Complicating Disease|1|||
33347310|NCT01071083|62724386|FG000|Overall Study|Adverse Event|1|||
33347311|NCT01071083|62724387|FG001|Overall Study|Adverse Event|0|||
33347312|NCT01071083|62724388|FG002|Overall Study|Adverse Event|1|||
33347313|NCT01071083|62724389|FG003|Overall Study|Adverse Event|0|||
33347314|NCT01071083|62724390|FG004|Overall Study|Adverse Event|1|||
33347315|NCT01071083|62724386|FG000|Overall Study|Withdrawal by Subject|3|||
33347316|NCT01071083|62724387|FG001|Overall Study|Withdrawal by Subject|0|||
33347317|NCT01071083|62724388|FG002|Overall Study|Withdrawal by Subject|2|||
33548942|NCT02901431|62940306|FG012|PK Part|Pending dose confirmation|0|||
33548943|NCT02901431|62940294|FG000|PK Part|8 weeks of treatment ran out|2|||
33347318|NCT01071083|62724389|FG003|Overall Study|Withdrawal by Subject|0|||
33347319|NCT01071083|62724390|FG004|Overall Study|Withdrawal by Subject|3|||
33347320|NCT01071083|62724386|FG000|Overall Study|Physician Decision|1|||
33347321|NCT01071083|62724387|FG001|Overall Study|Physician Decision|0|||
33347322|NCT01071083|62724388|FG002|Overall Study|Physician Decision|0|||
33347323|NCT01071083|62724389|FG003|Overall Study|Physician Decision|1|||
33347324|NCT01071083|62724390|FG004|Overall Study|Physician Decision|1|||
33347325|NCT01071083|62724386|FG000|Overall Study|Early Rescue|1|||
33347326|NCT01071083|62724387|FG001|Overall Study|Early Rescue|0|||
33347327|NCT01071083|62724388|FG002|Overall Study|Early Rescue|0|||
33347328|NCT01071083|62724389|FG003|Overall Study|Early Rescue|0|||
33347329|NCT01071083|62724390|FG004|Overall Study|Early Rescue|1|||
33347330|NCT01071083|62724386|FG000|Overall Study|Subject Moved|0|||
33347331|NCT01071083|62724387|FG001|Overall Study|Subject Moved|1|||
33347332|NCT01071083|62724388|FG002|Overall Study|Subject Moved|0|||
33347333|NCT01071083|62724389|FG003|Overall Study|Subject Moved|0|||
33347334|NCT01071083|62724390|FG004|Overall Study|Subject Moved|0|||
33347335|NCT01071083|62724386|FG000|Overall Study|Images Not Usable (Motion)|0|||
33347336|NCT01071083|62724387|FG001|Overall Study|Images Not Usable (Motion)|1|||
33347337|NCT01071083|62724388|FG002|Overall Study|Images Not Usable (Motion)|0|||
33347338|NCT01071083|62724389|FG003|Overall Study|Images Not Usable (Motion)|0|||
33347339|NCT01071083|62724390|FG004|Overall Study|Images Not Usable (Motion)|0|||
33347340|NCT01071083|62724386|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
33347341|NCT01071083|62724387|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
33347342|NCT01071083|62724388|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
33347343|NCT01071083|62724389|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
33347344|NCT01071083|62724390|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
33347345|NCT01071083|62724386|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
33347346|NCT01071083|62724387|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
33470606|NCT03700892|62844287|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
33470607|NCT03700892|62844288|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
33347347|NCT01071083|62724388|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
33347348|NCT01071083|62724389|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
33347349|NCT01071083|62724390|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
33347350|NCT01071083|62724386|FG000|Overall Study|Subject Refused to Continue|1|||
33347351|NCT01071083|62724387|FG001|Overall Study|Subject Refused to Continue|0|||
33347352|NCT01071083|62724388|FG002|Overall Study|Subject Refused to Continue|0|||
33347353|NCT01071083|62724389|FG003|Overall Study|Subject Refused to Continue|0|||
33654912|NCT00087555|63068273|FG001|Overall Study|Non Compliance|0|||
33347354|NCT01071083|62724390|FG004|Overall Study|Subject Refused to Continue|0|||
33347355|NCT01070771|62724402|FG000|Overall Study|Adverse Event|2|||
33347356|NCT01070771|62724402|FG000|Overall Study|Protocol Violation|1|||
33347357|NCT01070381|62724407|FG000|Period 2, 1 Week of Wear|Handling|0|||
33347358|NCT01070381|62724408|FG001|Period 2, 1 Week of Wear|Handling|1|||
33347359|NCT01070381|62724407|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
33347360|NCT01070381|62724408|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
33347361|NCT01010126|62724429|FG000|Overall Study|Withdrawal by Subject|1|||
33347362|NCT01010126|62724430|FG001|Overall Study|Withdrawal by Subject|0|||
33347363|NCT01010126|62724431|FG002|Overall Study|Withdrawal by Subject|1|||
33347364|NCT01010126|62724432|FG003|Overall Study|Withdrawal by Subject|0|||
33347365|NCT01010126|62724433|FG004|Overall Study|Withdrawal by Subject|3|||
33347366|NCT01010126|62724434|FG005|Overall Study|Withdrawal by Subject|0|||
33347367|NCT01043705|62724451|FG000|Overall Study|Death|28|||
33347368|NCT01043705|62724452|FG001|Overall Study|Death|60|||
33347369|NCT01043705|62724453|FG002|Overall Study|Death|26|||
33347370|NCT01043705|62724451|FG000|Overall Study|Lost to Follow-up|27|||
33347371|NCT01043705|62724452|FG001|Overall Study|Lost to Follow-up|12|||
33347372|NCT01043705|62724453|FG002|Overall Study|Lost to Follow-up|0|||
33347373|NCT01043705|62724451|FG000|Overall Study|Multiple Reasons|4|||
33347374|NCT01043705|62724452|FG001|Overall Study|Multiple Reasons|7|||
33347375|NCT01043705|62724453|FG002|Overall Study|Multiple Reasons|0|||
33347376|NCT01043705|62724451|FG000|Overall Study|Protocol Violation|2|||
33347377|NCT01043705|62724452|FG001|Overall Study|Protocol Violation|1|||
33347378|NCT01043705|62724453|FG002|Overall Study|Protocol Violation|0|||
33347379|NCT01043705|62724451|FG000|Overall Study|Withdrawal by Subject|8|||
33347380|NCT01043705|62724452|FG001|Overall Study|Withdrawal by Subject|6|||
33347381|NCT01043705|62724453|FG002|Overall Study|Withdrawal by Subject|0|||
33347382|NCT01043705|62724451|FG000|Overall Study|Site Closure|8|||
33347383|NCT01043705|62724452|FG001|Overall Study|Site Closure|0|||
33347384|NCT01043705|62724453|FG002|Overall Study|Site Closure|0|||
33347385|NCT01043705|62724451|FG000|Overall Study|Subsequent Procedure|9|||
33347386|NCT01043705|62724452|FG001|Overall Study|Subsequent Procedure|24|||
33347387|NCT01043705|62724453|FG002|Overall Study|Subsequent Procedure|29|||
33347388|NCT01043705|62724451|FG000|Overall Study|Adverse Event|0|||
33347389|NCT01043705|62724452|FG001|Overall Study|Adverse Event|2|||
33470608|NCT03700892|62844289|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
33347390|NCT01043705|62724453|FG002|Overall Study|Adverse Event|0|||
33347391|NCT01043705|62724451|FG000|Overall Study|Screen Fail|21|||
33347392|NCT01043705|62724452|FG001|Overall Study|Screen Fail|0|||
33470609|NCT03700736|62844300|FG000|Overall Study|Pregnancy|1|||
33347393|NCT01043705|62724453|FG002|Overall Study|Screen Fail|0|||
33347394|NCT01043705|62724451|FG000|Overall Study|Other|0|||
33347395|NCT01043705|62724452|FG001|Overall Study|Other|19|||
33347396|NCT01043705|62724453|FG002|Overall Study|Other|25|||
33347397|NCT01070303|62724472|FG000|Overall Study|Adverse Event|39|||
33347398|NCT01070303|62724472|FG000|Overall Study|Withdrawal by Subject|20|||
33347399|NCT01070303|62724472|FG000|Overall Study|Lost to Follow-up|9|||
33347400|NCT01070303|62724472|FG000|Overall Study|Protocol Violation|0|||
33347401|NCT01070303|62724472|FG000|Overall Study|Lack of Efficacy|2|||
33347402|NCT01070303|62724472|FG000|Overall Study|Administrative Reason|1|||
33347403|NCT01070303|62724472|FG000|Overall Study|Other|18|||
33347404|NCT01009814|62724487|FG000|Overall Study|No longer met study criteria|1|||
33347405|NCT01009814|62724488|FG001|Overall Study|No longer met study criteria|1|||
33347406|NCT01009814|62724489|FG002|Overall Study|No longer met study criteria|0|||
33347407|NCT01009814|62724490|FG003|Overall Study|No longer met study criteria|0|||
33347408|NCT01009814|62724491|FG004|Overall Study|No longer met study criteria|0|||
33347409|NCT03824587|62724509|FG000|Run-in Period|Screen Failure|0|||
33347410|NCT03824587|62724510|FG001|Run-in Period|Screen Failure|275|||
33347411|NCT03824587|62724509|FG000|Treatment Period|Adverse Event|4|||
33347412|NCT03824587|62724510|FG001|Treatment Period|Adverse Event|1|||
33347413|NCT03824587|62724509|FG000|Treatment Period|Withdrawal by Subject|0|||
33347414|NCT03824587|62724510|FG001|Treatment Period|Withdrawal by Subject|1|||
33347415|NCT03824587|62724509|FG000|Treatment Period|Kidney Transplant|1|||
33347416|NCT03824587|62724510|FG001|Treatment Period|Kidney Transplant|1|||
33347417|NCT00773734|62724520|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
33347418|NCT00773734|62724521|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
33347419|NCT00773734|62724522|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
33347420|NCT00773734|62724523|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
33347421|NCT00773734|62724524|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
33347422|NCT00773734|62724525|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
33347423|NCT00773734|62724520|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
33347424|NCT00773734|62724521|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
33347425|NCT00773734|62724522|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
33347426|NCT00773734|62724523|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
33347427|NCT00773734|62724524|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
33347428|NCT00773734|62724525|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
33347429|NCT00773734|62724520|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
33347430|NCT00773734|62724521|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
33347431|NCT00773734|62724522|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
33347432|NCT00773734|62724523|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
33347433|NCT00773734|62724524|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
33347434|NCT00773734|62724525|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
33347435|NCT00773734|62724520|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
33347436|NCT00773734|62724521|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
33347437|NCT00773734|62724522|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
33347438|NCT00773734|62724523|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
33347439|NCT00773734|62724524|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
33347440|NCT00773734|62724525|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
33347441|NCT00773734|62724520|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
33347442|NCT00773734|62724521|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
33347443|NCT00773734|62724522|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
33347444|NCT00773734|62724523|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
33347445|NCT00773734|62724524|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
33347446|NCT00773734|62724525|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
33347447|NCT00773734|62724520|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
33347448|NCT00773734|62724521|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
33347449|NCT00773734|62724522|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
33347450|NCT00773734|62724523|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
33347451|NCT00773734|62724524|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
33347452|NCT00773734|62724525|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
33347453|NCT00773734|62724520|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
33347454|NCT00773734|62724521|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
33347455|NCT00773734|62724522|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
33347456|NCT00773734|62724523|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
33347457|NCT00773734|62724524|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
33347458|NCT00773734|62724525|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
33347459|NCT00773734|62724520|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
33347460|NCT00773734|62724521|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
33347461|NCT00773734|62724522|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
33347462|NCT00773734|62724523|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
33347463|NCT00773734|62724524|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
33347464|NCT00773734|62724525|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
33347465|NCT00773734|62724520|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
33347466|NCT00773734|62724521|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
33347467|NCT00773734|62724522|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
33347468|NCT00773734|62724523|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
33347469|NCT00773734|62724524|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
33347470|NCT00773734|62724525|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
33347471|NCT00773734|62724520|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
33347472|NCT00773734|62724521|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
33347473|NCT00773734|62724522|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
33347474|NCT00773734|62724523|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
33347475|NCT00773734|62724524|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
33347476|NCT00773734|62724525|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
33347477|NCT00773734|62724520|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
33347478|NCT00773734|62724521|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
33347479|NCT00773734|62724522|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
33347480|NCT00773734|62724523|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
33347481|NCT00773734|62724524|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
33347482|NCT00773734|62724525|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
33347483|NCT00773734|62724520|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
33347484|NCT00773734|62724521|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
33347485|NCT00773734|62724522|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
33347486|NCT00773734|62724523|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
33347487|NCT00773734|62724524|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
33347488|NCT00773734|62724525|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
33347489|NCT00773734|62724520|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
33347490|NCT00773734|62724521|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
33347491|NCT00773734|62724522|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
33347492|NCT00773734|62724523|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
33347493|NCT00773734|62724524|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
33347494|NCT00773734|62724525|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
33347495|NCT00773734|62724520|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
33347496|NCT00773734|62724521|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
33347497|NCT00773734|62724522|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
33347498|NCT00773734|62724523|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
33347499|NCT00773734|62724524|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
33347500|NCT00773734|62724525|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
33347501|NCT00773734|62724520|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
33347502|NCT00773734|62724521|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
33347503|NCT00773734|62724522|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
33347504|NCT00773734|62724523|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
33347505|NCT00773734|62724524|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
33347506|NCT00773734|62724525|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
33347507|NCT00773734|62724520|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
33347508|NCT00773734|62724521|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
33347509|NCT00773734|62724522|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
33347510|NCT00773734|62724523|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
33347511|NCT00773734|62724524|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
33347512|NCT00773734|62724525|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
33347513|NCT00773734|62724520|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
33347514|NCT00773734|62724521|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
33347515|NCT00773734|62724522|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
33347516|NCT00773734|62724523|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
33347517|NCT00773734|62724524|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
33347518|NCT00773734|62724525|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
33347519|NCT00773734|62724520|FG000|Extension: Active Treatment Week 24-52|Other|0|||
33347520|NCT00773734|62724521|FG001|Extension: Active Treatment Week 24-52|Other|0|||
33347521|NCT00773734|62724522|FG002|Extension: Active Treatment Week 24-52|Other|1|||
33347522|NCT00773734|62724523|FG003|Extension: Active Treatment Week 24-52|Other|2|||
33347523|NCT00773734|62724524|FG004|Extension: Active Treatment Week 24-52|Other|0|||
33347524|NCT00773734|62724525|FG005|Extension: Active Treatment Week 24-52|Other|1|||
33347525|NCT00773734|62724520|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
33347526|NCT00773734|62724521|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
33470610|NCT03700736|62844301|FG001|Overall Study|Pregnancy|1|||
33470611|NCT03700736|62844300|FG000|Overall Study|Withdrawal by Subject|2|||
33470612|NCT03700736|62844301|FG001|Overall Study|Withdrawal by Subject|6|||
33470613|NCT04737278|62844312|FG000|Overall Study|Lost to Follow-up|1|||
33470614|NCT04737278|62844313|FG001|Overall Study|Lost to Follow-up|1|||
33470615|NCT04737278|62844312|FG000|Overall Study|Withdrawal by Subject|1|||
33470616|NCT04737278|62844313|FG001|Overall Study|Withdrawal by Subject|0|||
33470617|NCT04737278|62844312|FG000|Overall Study|Protocol Violation|1|||
33470618|NCT04737278|62844313|FG001|Overall Study|Protocol Violation|1|||
33470619|NCT04737278|62844312|FG000|Overall Study|failure to complete questionnaire|1|||
33470620|NCT04737278|62844313|FG001|Overall Study|failure to complete questionnaire|1|||
33470621|NCT04725500|62844319|FG000|Screening|Screen Failure|26|||
33347527|NCT00773734|62724522|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
33347528|NCT00773734|62724523|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
33347529|NCT00773734|62724524|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
33347530|NCT00773734|62724525|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
33347531|NCT00773734|62724520|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
33347532|NCT00773734|62724521|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
33347533|NCT00773734|62724522|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
33347534|NCT00773734|62724523|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
33347535|NCT00773734|62724524|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
33347536|NCT00773734|62724525|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
33470622|NCT04725500|62844319|FG000|Screening|Withdrawal by Subject|1|||
33470623|NCT04725500|62844319|FG000|2 Week Take Home|Screen Fail|5|||
33470624|NCT04684394|62844325|FG000|Overall Study|Death|1|||
33470625|NCT04684394|62844326|FG001|Overall Study|Death|2|||
33470626|NCT04684394|62844325|FG000|Overall Study|Lost to Follow-up|1|||
33470627|NCT04684394|62844326|FG001|Overall Study|Lost to Follow-up|0|||
33470628|NCT04684394|62844325|FG000|Overall Study|Withdrawal by Subject|2|||
33470629|NCT04684394|62844326|FG001|Overall Study|Withdrawal by Subject|0|||
33347537|NCT00773734|62724520|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
33347538|NCT00773734|62724521|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
33470630|NCT04684394|62844325|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
33470631|NCT04684394|62844326|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
33470632|NCT04674644|62844332|FG000|Overall Study|with missing data|37|||
33470633|NCT04668950|62844339|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
33470634|NCT04668950|62844340|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
33470635|NCT04668950|62844339|FG000|Overall Study|Could not confirm started study medication|15|||
33470636|NCT04668950|62844340|FG001|Overall Study|Could not confirm started study medication|15|||
33470637|NCT04668950|62844339|FG000|Overall Study|Could not confirm baseline status|6|||
33470638|NCT04668950|62844340|FG001|Overall Study|Could not confirm baseline status|2|||
33470639|NCT04668950|62844339|FG000|Overall Study|Drop out and did not start medication|15|||
33470640|NCT04668950|62844340|FG001|Overall Study|Drop out and did not start medication|17|||
33470641|NCT04668950|62844339|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
33470642|NCT04668950|62844340|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
33470643|NCT04668950|62844339|FG000|Overall Study|Other|2|||
33470644|NCT04668950|62844340|FG001|Overall Study|Other|4|||
33470645|NCT03078478|62844348|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
33470646|NCT03078478|62844349|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
33470647|NCT03078478|62844348|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
33470648|NCT03078478|62844349|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
33470649|NCT03078478|62844348|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
33470650|NCT03078478|62844349|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
33470651|NCT03078478|62844348|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
33470652|NCT03078478|62844349|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
33347539|NCT00773734|62724522|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
33347540|NCT00773734|62724523|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
33347541|NCT00773734|62724524|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
33347542|NCT00773734|62724525|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
33347543|NCT00773734|62724520|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
33347544|NCT00773734|62724521|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
33470653|NCT03078478|62844348|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
33470654|NCT03078478|62844349|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
33347545|NCT00773734|62724522|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
33347546|NCT00773734|62724523|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
33347547|NCT00773734|62724524|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
33470655|NCT03078478|62844348|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
33470656|NCT03078478|62844349|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
33470657|NCT03078478|62844348|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
33470658|NCT03078478|62844349|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
33470659|NCT03078478|62844348|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
33470660|NCT03078478|62844349|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
33470661|NCT03539458|62844355|FG000|Overall Study|Death|1|||
33470662|NCT02879578|62844362|FG000|Overall Study|Adverse Event|1|||
33470663|NCT02879578|62844363|FG001|Overall Study|Adverse Event|2|||
33470664|NCT02879578|62844364|FG002|Overall Study|Adverse Event|14|||
33470665|NCT02879578|62844362|FG000|Overall Study|Protocol Violation|0|||
33470666|NCT02879578|62844363|FG001|Overall Study|Protocol Violation|1|||
33470667|NCT02879578|62844364|FG002|Overall Study|Protocol Violation|1|||
33470668|NCT02879578|62844362|FG000|Overall Study|Withdrawal by Subject|8|||
33470669|NCT02879578|62844363|FG001|Overall Study|Withdrawal by Subject|6|||
33470670|NCT02879578|62844364|FG002|Overall Study|Withdrawal by Subject|9|||
33470671|NCT02879578|62844362|FG000|Overall Study|Lost to Follow-up|1|||
33470672|NCT02879578|62844363|FG001|Overall Study|Lost to Follow-up|0|||
33470673|NCT02879578|62844364|FG002|Overall Study|Lost to Follow-up|4|||
33470674|NCT02879578|62844362|FG000|Overall Study|Physician Decision|0|||
33470675|NCT02879578|62844363|FG001|Overall Study|Physician Decision|0|||
33470676|NCT02879578|62844364|FG002|Overall Study|Physician Decision|4|||
33470677|NCT00045942|62844381|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
33470678|NCT00045942|62844382|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33470679|NCT00045942|62844383|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33470680|NCT00045942|62844384|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33470681|NCT00045942|62844385|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33470682|NCT00045942|62844386|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33470683|NCT00045942|62844387|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33470684|NCT00045942|62844388|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33470685|NCT00045942|62844389|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33470686|NCT00045942|62844381|FG000|PKC412A2104 (Core)|Adverse Event|5|||
33470687|NCT00045942|62844382|FG001|PKC412A2104 (Core)|Adverse Event|0|||
33470688|NCT00045942|62844383|FG002|PKC412A2104 (Core)|Adverse Event|0|||
33470689|NCT00045942|62844384|FG003|PKC412A2104 (Core)|Adverse Event|0|||
33470690|NCT00045942|62844385|FG004|PKC412A2104 (Core)|Adverse Event|0|||
33470691|NCT00045942|62844386|FG005|PKC412A2104 (Core)|Adverse Event|0|||
33470692|NCT00045942|62844387|FG006|PKC412A2104 (Core)|Adverse Event|0|||
33347548|NCT00773734|62724525|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
33347549|NCT01009580|62724584|FG000|Overall Study|Adverse Event|4|||
33347550|NCT01009580|62724585|FG001|Overall Study|Adverse Event|4|||
33347551|NCT01009580|62724584|FG000|Overall Study|Lack of Efficacy|0|||
33347552|NCT01009580|62724585|FG001|Overall Study|Lack of Efficacy|1|||
33347553|NCT01009580|62724584|FG000|Overall Study|Protocol Violation|2|||
33347554|NCT01009580|62724585|FG001|Overall Study|Protocol Violation|3|||
33470693|NCT00045942|62844388|FG007|PKC412A2104 (Core)|Adverse Event|0|||
33470694|NCT00045942|62844389|FG008|PKC412A2104 (Core)|Adverse Event|0|||
33470695|NCT00045942|62844381|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
33470696|NCT00045942|62844382|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
33470697|NCT00045942|62844383|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
33470698|NCT00045942|62844384|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
33470699|NCT00045942|62844385|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
33470700|NCT00045942|62844386|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
33470701|NCT00045942|62844387|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
33470702|NCT00045942|62844388|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
33470703|NCT00045942|62844389|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
33654913|NCT00087555|63068274|FG002|Overall Study|Non Compliance|1|||
33654914|NCT00087555|63068272|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
33654915|NCT00087555|63068273|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
33347555|NCT01009580|62724584|FG000|Overall Study|Withdrawal Criteria|4|||
33347556|NCT01009580|62724585|FG001|Overall Study|Withdrawal Criteria|6|||
33347557|NCT01009580|62724584|FG000|Overall Study|Unclassified|17|||
33347558|NCT01009580|62724585|FG001|Overall Study|Unclassified|21|||
33347559|NCT01009346|62724591|FG000|Overall Study|Adverse Event|4|||
33347560|NCT01001702|62724596|FG000|Overall Study|Lost to Follow-up|7|||
33347561|NCT01001702|62724596|FG000|Overall Study|Adverse Event|7|||
33347562|NCT01001702|62724596|FG000|Overall Study|Sponsor Discontinued Study|4|||
33347563|NCT01001702|62724596|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
33347564|NCT01001702|62724596|FG000|Overall Study|Investigator withdrew Subject|10|||
33654916|NCT00087555|63068274|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
33347565|NCT01001702|62724596|FG000|Overall Study|Withdrawal by Subject|19|||
33347566|NCT01001702|62724596|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
33470704|NCT00045942|62844381|FG000|PKC412A2104 (Core)|Death|1|||
33470705|NCT00045942|62844382|FG001|PKC412A2104 (Core)|Death|0|||
33470706|NCT00045942|62844383|FG002|PKC412A2104 (Core)|Death|0|||
33470707|NCT00045942|62844384|FG003|PKC412A2104 (Core)|Death|0|||
33470708|NCT00045942|62844385|FG004|PKC412A2104 (Core)|Death|0|||
33470709|NCT00045942|62844386|FG005|PKC412A2104 (Core)|Death|0|||
33470710|NCT00045942|62844387|FG006|PKC412A2104 (Core)|Death|0|||
33470711|NCT00045942|62844388|FG007|PKC412A2104 (Core)|Death|0|||
33470712|NCT00045942|62844389|FG008|PKC412A2104 (Core)|Death|0|||
33470713|NCT00045942|62844381|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
33470714|NCT00045942|62844382|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
33347567|NCT01070069|62724605|FG000|Overall Study|Death|1|||
33470715|NCT00045942|62844383|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
33470716|NCT00045942|62844384|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
33470717|NCT00045942|62844385|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
33470718|NCT00045942|62844386|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
33470719|NCT00045942|62844387|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
33347568|NCT01070069|62724606|FG001|Overall Study|Death|0|||
33347569|NCT01070069|62724607|FG002|Overall Study|Death|2|||
33347570|NCT01070069|62724608|FG003|Overall Study|Death|0|||
33347571|NCT01070069|62724609|FG004|Overall Study|Death|1|||
33347572|NCT01070069|62724605|FG000|Overall Study|Withdrawal by Subject|1|||
33347573|NCT01070069|62724606|FG001|Overall Study|Withdrawal by Subject|1|||
33347574|NCT01070069|62724607|FG002|Overall Study|Withdrawal by Subject|4|||
33347575|NCT01070069|62724608|FG003|Overall Study|Withdrawal by Subject|0|||
33347576|NCT01070069|62724609|FG004|Overall Study|Withdrawal by Subject|0|||
33347577|NCT01070069|62724605|FG000|Overall Study|Lost to Follow-up|4|||
33347578|NCT01070069|62724606|FG001|Overall Study|Lost to Follow-up|1|||
33347579|NCT01070069|62724607|FG002|Overall Study|Lost to Follow-up|0|||
33347580|NCT01070069|62724608|FG003|Overall Study|Lost to Follow-up|0|||
33347581|NCT01070069|62724609|FG004|Overall Study|Lost to Follow-up|3|||
33347582|NCT01068665|62724626|FG000|Overall Study|Adverse Event|5|||
33347583|NCT01068665|62724627|FG001|Overall Study|Adverse Event|4|||
33347584|NCT01068665|62724626|FG000|Overall Study|Lack of Efficacy|0|||
33347585|NCT01068665|62724627|FG001|Overall Study|Lack of Efficacy|2|||
33347586|NCT01068665|62724626|FG000|Overall Study|Protocol Violation|5|||
33347587|NCT01068665|62724627|FG001|Overall Study|Protocol Violation|2|||
33347588|NCT01068665|62724626|FG000|Overall Study|Withdrawal Criteria|3|||
33347589|NCT01068665|62724627|FG001|Overall Study|Withdrawal Criteria|9|||
33347590|NCT01068665|62724626|FG000|Overall Study|Other|17|||
33347591|NCT01068665|62724627|FG001|Overall Study|Other|12|||
33347592|NCT01001390|62724633|FG000|Overall Study|Failure to wear AFO device|2|||
33347593|NCT01001390|62724634|FG001|Overall Study|Failure to wear AFO device|0|||
33347594|NCT00772954|62724642|FG000|Overall Study|Adverse Event|0|||
33347595|NCT00772954|62724643|FG001|Overall Study|Adverse Event|0|||
33347596|NCT00772954|62724644|FG002|Overall Study|Adverse Event|1|||
33347597|NCT00781768|62724654|FG000|Overall Study|Not transplanted.|0|||
33347598|NCT00781768|62724655|FG001|Overall Study|Not transplanted.|2|||
33347599|NCT01005680|62724663|FG000|Overall Study|Lost to Follow-up|4|||
33347600|NCT01005680|62724664|FG001|Overall Study|Lost to Follow-up|6|||
33347601|NCT01005680|62724663|FG000|Overall Study|Withdrawal by Subject|1|||
33347602|NCT01005680|62724664|FG001|Overall Study|Withdrawal by Subject|4|||
33347603|NCT01005680|62724663|FG000|Overall Study|Physician Decision|1|||
33347604|NCT01005680|62724664|FG001|Overall Study|Physician Decision|1|||
33347605|NCT01005602|62724673|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
33347606|NCT01005602|62724674|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
33347607|NCT01068509|62724690|FG000|Overall Study|Death|0|||
33347608|NCT01068509|62724691|FG001|Overall Study|Death|0|||
33347609|NCT01068509|62724692|FG002|Overall Study|Death|1|||
33347610|NCT01068509|62724690|FG000|Overall Study|Disease Progression|5|||
33347611|NCT01068509|62724691|FG001|Overall Study|Disease Progression|20|||
33347612|NCT01068509|62724692|FG002|Overall Study|Disease Progression|18|||
33347613|NCT01068509|62724690|FG000|Overall Study|Lost to Follow-up|1|||
33347614|NCT01068509|62724691|FG001|Overall Study|Lost to Follow-up|0|||
33347615|NCT01068509|62724692|FG002|Overall Study|Lost to Follow-up|0|||
33347616|NCT01068509|62724690|FG000|Overall Study|Withdrew Consent|0|||
33347617|NCT01068509|62724691|FG001|Overall Study|Withdrew Consent|1|||
33347618|NCT01068509|62724692|FG002|Overall Study|Withdrew Consent|2|||
33347619|NCT01068509|62724690|FG000|Overall Study|Reason Not Specified|0|||
33347620|NCT01068509|62724691|FG001|Overall Study|Reason Not Specified|1|||
33347621|NCT01068509|62724692|FG002|Overall Study|Reason Not Specified|0|||
33347622|NCT01009034|62724699|FG000|Overall Study|Lost to Follow-up|2|||
33347623|NCT01009034|62724699|FG000|Overall Study|Withdrawal by Subject|2|||
33347624|NCT00768430|62724705|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
33347625|NCT00768430|62724706|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
33347626|NCT01064297|62724715|FG000|Overall Study|Lost to Follow-up|791|||
33347627|NCT01064297|62724716|FG001|Overall Study|Lost to Follow-up|48|||
33347628|NCT01064297|62724717|FG002|Overall Study|Lost to Follow-up|133|||
33347629|NCT00781456|62724734|FG000|Overall Study|Adverse Event|3|||
33347630|NCT00781456|62724735|FG001|Overall Study|Adverse Event|3|||
33347631|NCT00781456|62724734|FG000|Overall Study|Withdrawal by Subject|3|||
33347632|NCT00781456|62724735|FG001|Overall Study|Withdrawal by Subject|5|||
33347633|NCT00781456|62724734|FG000|Overall Study|Protocol Violation|4|||
33347634|NCT00781456|62724735|FG001|Overall Study|Protocol Violation|1|||
33347635|NCT00781456|62724734|FG000|Overall Study|Noncompliance With Protocol|1|||
33347636|NCT00781456|62724735|FG001|Overall Study|Noncompliance With Protocol|1|||
33347637|NCT00781456|62724734|FG000|Overall Study|Lost to Follow-up|10|||
33347638|NCT00781456|62724735|FG001|Overall Study|Lost to Follow-up|5|||
33347639|NCT00781456|62724734|FG000|Overall Study|Other Reason, Unknown|0|||
33347640|NCT00781456|62724735|FG001|Overall Study|Other Reason, Unknown|1|||
33347641|NCT00587158|62724743|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
33470720|NCT00045942|62844388|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
33470721|NCT00045942|62844389|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
33470722|NCT00045942|62844381|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
33470723|NCT00045942|62844382|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
33470724|NCT00045942|62844383|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
33470725|NCT00045942|62844384|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
33470726|NCT00045942|62844385|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
33470727|NCT00045942|62844386|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
33470728|NCT00045942|62844387|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
33470729|NCT00045942|62844388|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
33470730|NCT00045942|62844389|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
33470731|NCT00045942|62844381|FG000|PKC412A2104E1|Lack of Efficacy|0|||
33470732|NCT00045942|62844382|FG001|PKC412A2104E1|Lack of Efficacy|11|||
33470733|NCT00045942|62844383|FG002|PKC412A2104E1|Lack of Efficacy|11|||
33470734|NCT00045942|62844384|FG003|PKC412A2104E1|Lack of Efficacy|23|||
33470735|NCT00045942|62844385|FG004|PKC412A2104E1|Lack of Efficacy|17|||
33470736|NCT00045942|62844386|FG005|PKC412A2104E1|Lack of Efficacy|0|||
33470737|NCT00045942|62844387|FG006|PKC412A2104E1|Lack of Efficacy|0|||
33470738|NCT00045942|62844388|FG007|PKC412A2104E1|Lack of Efficacy|0|||
33470739|NCT00045942|62844389|FG008|PKC412A2104E1|Lack of Efficacy|0|||
33470740|NCT00045942|62844381|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
33347642|NCT00587158|62724744|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
33347643|NCT00587158|62724743|FG000|Overall Study|Physician Decision|0|||
33347644|NCT00587158|62724744|FG001|Overall Study|Physician Decision|1|||
33347645|NCT00587158|62724743|FG000|Overall Study|Lost to Follow-up|1|||
33347646|NCT00587158|62724744|FG001|Overall Study|Lost to Follow-up|2|||
33347647|NCT00587158|62724743|FG000|Overall Study|Death|0|||
33470741|NCT00045942|62844382|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
33470742|NCT00045942|62844383|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
33347648|NCT00587158|62724744|FG001|Overall Study|Death|1|||
33347649|NCT00587158|62724743|FG000|Overall Study|Subject did not want to take study med|0|||
33347650|NCT00587158|62724744|FG001|Overall Study|Subject did not want to take study med|1|||
33347651|NCT00582907|62724750|FG000|1st Course|Withdrawal by Subject|1|||
33347652|NCT00582907|62724751|FG001|1st Course|Withdrawal by Subject|0|||
33470743|NCT00045942|62844384|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
33347653|NCT00582907|62724752|FG002|1st Course|Withdrawal by Subject|0|||
33470744|NCT00045942|62844385|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
33470745|NCT00045942|62844386|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
33470746|NCT00045942|62844387|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
33470747|NCT00045942|62844388|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
33470748|NCT00045942|62844389|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
33470749|NCT00045942|62844381|FG000|PKC412A2104E1|Adverse Event|0|||
33470750|NCT00045942|62844382|FG001|PKC412A2104E1|Adverse Event|1|||
33470751|NCT00045942|62844383|FG002|PKC412A2104E1|Adverse Event|1|||
33470752|NCT00045942|62844384|FG003|PKC412A2104E1|Adverse Event|3|||
33470753|NCT00045942|62844385|FG004|PKC412A2104E1|Adverse Event|6|||
33470754|NCT00045942|62844386|FG005|PKC412A2104E1|Adverse Event|0|||
33470755|NCT00045942|62844387|FG006|PKC412A2104E1|Adverse Event|0|||
33470756|NCT00045942|62844388|FG007|PKC412A2104E1|Adverse Event|0|||
33470757|NCT00045942|62844389|FG008|PKC412A2104E1|Adverse Event|0|||
33347654|NCT00582907|62724753|FG003|1st Course|Withdrawal by Subject|0|||
33347655|NCT00582907|62724750|FG000|1st Course|Lost to Follow-up|0|||
33347656|NCT00582907|62724751|FG001|1st Course|Lost to Follow-up|0|||
33548944|NCT02901431|62940295|FG001|PK Part|8 weeks of treatment ran out|0|||
33347657|NCT00582907|62724752|FG002|1st Course|Lost to Follow-up|0|||
33347658|NCT00582907|62724753|FG003|1st Course|Lost to Follow-up|1|||
33347659|NCT00582907|62724750|FG000|2nd Course|Lack of Efficacy|1|||
33347660|NCT00582907|62724751|FG001|2nd Course|Lack of Efficacy|0|||
33347661|NCT00582907|62724752|FG002|2nd Course|Lack of Efficacy|0|||
33347662|NCT00582907|62724753|FG003|2nd Course|Lack of Efficacy|0|||
33347663|NCT01062113|62724762|FG000|Overall Study|Adverse Event|1|||
33347664|NCT01062113|62724763|FG001|Overall Study|Adverse Event|0|||
33347665|NCT01062113|62724764|FG002|Overall Study|Adverse Event|0|||
33347666|NCT01062113|62724762|FG000|Overall Study|Lack of Efficacy|38|||
33347667|NCT01062113|62724763|FG001|Overall Study|Lack of Efficacy|22|||
33347668|NCT01062113|62724764|FG002|Overall Study|Lack of Efficacy|31|||
33347669|NCT01062113|62724762|FG000|Overall Study|Withdrawal by Subject|1|||
33347670|NCT01062113|62724763|FG001|Overall Study|Withdrawal by Subject|0|||
33470758|NCT00045942|62844381|FG000|PKC412A2104E1|Death|0|||
33470759|NCT00045942|62844382|FG001|PKC412A2104E1|Death|4|||
33548945|NCT02901431|62940296|FG002|PK Part|8 weeks of treatment ran out|0|||
33347671|NCT01062113|62724764|FG002|Overall Study|Withdrawal by Subject|0|||
33347672|NCT00772330|62724772|FG000|Overall Study|Lost to Follow-up|3|||
33347673|NCT01038869|62724779|FG000|Overall Study|Withdrawal by Subject|1|||
33470760|NCT00045942|62844383|FG002|PKC412A2104E1|Death|1|||
33470761|NCT00045942|62844384|FG003|PKC412A2104E1|Death|1|||
33470762|NCT00045942|62844385|FG004|PKC412A2104E1|Death|1|||
33347674|NCT01038869|62724779|FG000|Overall Study|Lost to Follow-up|6|||
33347675|NCT01038713|62724790|FG000|Overall Study|Patient to hospice|1|||
33347676|NCT01038713|62724791|FG001|Overall Study|Patient to hospice|1|||
33347677|NCT01038713|62724792|FG002|Overall Study|Patient to hospice|1|||
33347678|NCT01038713|62724790|FG000|Overall Study|Lost to Follow-up|3|||
33347679|NCT01038713|62724791|FG001|Overall Study|Lost to Follow-up|0|||
33347680|NCT01038713|62724792|FG002|Overall Study|Lost to Follow-up|0|||
33347681|NCT01038713|62724790|FG000|Overall Study|Neuroendocrine Tumor|0|||
33347682|NCT01038713|62724791|FG001|Overall Study|Neuroendocrine Tumor|1|||
33347683|NCT01038713|62724792|FG002|Overall Study|Neuroendocrine Tumor|0|||
33347684|NCT01038713|62724790|FG000|Overall Study|died from PEP|0|||
33347685|NCT01038713|62724791|FG001|Overall Study|died from PEP|1|||
33347686|NCT01038713|62724792|FG002|Overall Study|died from PEP|0|||
33347687|NCT01038713|62724790|FG000|Overall Study|Autoimmune Pancreatitis|1|||
33347688|NCT01038713|62724791|FG001|Overall Study|Autoimmune Pancreatitis|0|||
33347689|NCT01038713|62724792|FG002|Overall Study|Autoimmune Pancreatitis|0|||
33347690|NCT00768040|62724802|FG000|Overall Study|Adverse Event|3|||
33347691|NCT00768040|62724803|FG001|Overall Study|Adverse Event|2|||
33347692|NCT00768040|62724802|FG000|Overall Study|Abnormal laboratory value|1|||
33347693|NCT00768040|62724803|FG001|Overall Study|Abnormal laboratory value|1|||
33347694|NCT00767806|62724811|FG000|Overall Study|Adverse Event|30|||
33347695|NCT00767806|62724812|FG001|Overall Study|Adverse Event|11|||
33347696|NCT00767806|62724811|FG000|Overall Study|Withdrawal by Subject|8|||
33548946|NCT02901431|62940297|FG003|PK Part|8 weeks of treatment ran out|0|||
33654917|NCT00087555|63068272|FG000|Overall Study|Patient wanted to go back on Med|1|||
33654918|NCT00087555|63068273|FG001|Overall Study|Patient wanted to go back on Med|0|||
33347697|NCT00767806|62724812|FG001|Overall Study|Withdrawal by Subject|13|||
33347698|NCT00767806|62724811|FG000|Overall Study|Protocol Violation|6|||
33347699|NCT00767806|62724812|FG001|Overall Study|Protocol Violation|5|||
33347700|NCT00767806|62724811|FG000|Overall Study|Lack of Efficacy|1|||
33347701|NCT00767806|62724812|FG001|Overall Study|Lack of Efficacy|9|||
33347702|NCT00767806|62724811|FG000|Overall Study|Physician Decision|4|||
33347703|NCT00767806|62724812|FG001|Overall Study|Physician Decision|3|||
33347704|NCT00767806|62724811|FG000|Overall Study|Lost to Follow-up|1|||
33347705|NCT00767806|62724812|FG001|Overall Study|Lost to Follow-up|4|||
33347706|NCT00767806|62724811|FG000|Overall Study|Entry Criteria Not Met|1|||
33347707|NCT00767806|62724812|FG001|Overall Study|Entry Criteria Not Met|1|||
33347708|NCT00767806|62724811|FG000|Overall Study|Sponsor Decision|0|||
33347709|NCT00767806|62724812|FG001|Overall Study|Sponsor Decision|1|||
33347710|NCT00780910|62724818|FG000|Overall Study|Adverse Event|2|||
33347711|NCT00767104|62724824|FG000|Overall Study|Lost to Follow-up|1|||
33347712|NCT00767104|62724825|FG001|Overall Study|Lost to Follow-up|2|||
33347713|NCT00771472|62724833|FG000|Overall Study|Physician Decision|2|||
33347714|NCT00771472|62724834|FG001|Overall Study|Physician Decision|3|||
33347715|NCT00771472|62724833|FG000|Overall Study|Progressive Disease|3|||
33347716|NCT00771472|62724834|FG001|Overall Study|Progressive Disease|1|||
33347717|NCT00771472|62724833|FG000|Overall Study|Protocol Violation|1|||
33347718|NCT00771472|62724834|FG001|Overall Study|Protocol Violation|0|||
33347719|NCT00771316|62724841|FG000|Overall Study|Adverse Event|0|||
33347720|NCT00771316|62724842|FG001|Overall Study|Adverse Event|1|||
33347721|NCT00771316|62724841|FG000|Overall Study|Patient withdrew consent|1|||
33347722|NCT00771316|62724842|FG001|Overall Study|Patient withdrew consent|0|||
33347723|NCT00771316|62724841|FG000|Overall Study|Discontinued due to early termination|1|||
33347724|NCT00771316|62724842|FG001|Overall Study|Discontinued due to early termination|0|||
33347725|NCT00770770|62724850|FG000|Overall Study|Lost to Follow-up|1|||
33347726|NCT00770770|62724851|FG001|Overall Study|Lost to Follow-up|0|||
33347727|NCT00770770|62724850|FG000|Overall Study|Withdrawal by Subject|1|||
33347728|NCT00770770|62724851|FG001|Overall Study|Withdrawal by Subject|0|||
33347729|NCT00770770|62724850|FG000|Overall Study|Death|0|||
33347730|NCT00770770|62724851|FG001|Overall Study|Death|1|||
33548947|NCT02901431|62940298|FG004|PK Part|8 weeks of treatment ran out|0|||
33654919|NCT00087555|63068274|FG002|Overall Study|Patient wanted to go back on Med|0|||
33347731|NCT00770770|62724850|FG000|Overall Study|Study Terminated|8|||
33347732|NCT00770770|62724851|FG001|Overall Study|Study Terminated|0|||
33347733|NCT00766636|62724859|FG000|Overall Study|Withdrawal by Subject|1|||
33347734|NCT00766636|62724860|FG001|Overall Study|Withdrawal by Subject|1|||
33347735|NCT00766636|62724859|FG000|Overall Study|Incomplete Treatment|0|||
33347736|NCT00766636|62724860|FG001|Overall Study|Incomplete Treatment|1|||
33347737|NCT00766636|62724859|FG000|Overall Study|Adverse Event|1|||
33347738|NCT00766636|62724860|FG001|Overall Study|Adverse Event|0|||
33347739|NCT00766636|62724859|FG000|Overall Study|Disease Progression|1|||
33347740|NCT00766636|62724860|FG001|Overall Study|Disease Progression|0|||
33347741|NCT00770692|62724870|FG000|Overall Study|Withdrawal by Subject|7|||
33347742|NCT00770692|62724871|FG001|Overall Study|Withdrawal by Subject|9|||
33347743|NCT00770692|62724872|FG002|Overall Study|Withdrawal by Subject|9|||
33347744|NCT00770692|62724873|FG003|Overall Study|Withdrawal by Subject|6|||
33347745|NCT00770692|62724870|FG000|Overall Study|Adverse Event|3|||
33347746|NCT00770692|62724871|FG001|Overall Study|Adverse Event|0|||
33347747|NCT00770692|62724872|FG002|Overall Study|Adverse Event|4|||
33347748|NCT00770692|62724873|FG003|Overall Study|Adverse Event|4|||
33347749|NCT00770692|62724870|FG000|Overall Study|Investigator judgment|2|||
33347750|NCT00770692|62724871|FG001|Overall Study|Investigator judgment|0|||
33347751|NCT00770692|62724872|FG002|Overall Study|Investigator judgment|1|||
33347752|NCT00770692|62724873|FG003|Overall Study|Investigator judgment|1|||
33347753|NCT02743819|62724887|FG000|Overall Study|Lack of Efficacy|5|||
33347754|NCT02743819|62724887|FG000|Overall Study|Death|2|||
33347755|NCT02743819|62724887|FG000|Overall Study|Adverse Event|1|||
33347756|NCT01004822|62724899|FG000|Overall Study|Objective progression or relapse|3|||
33347757|NCT01004822|62724900|FG001|Overall Study|Objective progression or relapse|3|||
33347758|NCT01004822|62724901|FG002|Overall Study|Objective progression or relapse|0|||
33347759|NCT01004822|62724902|FG003|Overall Study|Objective progression or relapse|1|||
33347760|NCT01004822|62724903|FG004|Overall Study|Objective progression or relapse|2|||
33347761|NCT01004822|62724904|FG005|Overall Study|Objective progression or relapse|2|||
33347762|NCT01004822|62724905|FG006|Overall Study|Objective progression or relapse|1|||
33347763|NCT01004822|62724906|FG007|Overall Study|Objective progression or relapse|4|||
33347764|NCT01004822|62724899|FG000|Overall Study|Global deterioration of health status|0|||
33347765|NCT01004822|62724900|FG001|Overall Study|Global deterioration of health status|0|||
33347766|NCT01004822|62724901|FG002|Overall Study|Global deterioration of health status|0|||
33347767|NCT01004822|62724902|FG003|Overall Study|Global deterioration of health status|1|||
33347768|NCT01004822|62724903|FG004|Overall Study|Global deterioration of health status|0|||
33347769|NCT01004822|62724904|FG005|Overall Study|Global deterioration of health status|0|||
33347770|NCT01004822|62724905|FG006|Overall Study|Global deterioration of health status|1|||
33347771|NCT01004822|62724906|FG007|Overall Study|Global deterioration of health status|0|||
33347772|NCT01004822|62724899|FG000|Overall Study|No longer willing to continue|0|||
33347773|NCT01004822|62724900|FG001|Overall Study|No longer willing to continue|0|||
33347774|NCT01004822|62724901|FG002|Overall Study|No longer willing to continue|0|||
33347775|NCT01004822|62724902|FG003|Overall Study|No longer willing to continue|1|||
33347776|NCT01004822|62724903|FG004|Overall Study|No longer willing to continue|2|||
33347777|NCT01004822|62724904|FG005|Overall Study|No longer willing to continue|1|||
33347778|NCT01004822|62724905|FG006|Overall Study|No longer willing to continue|1|||
33347779|NCT01004822|62724906|FG007|Overall Study|No longer willing to continue|0|||
33347780|NCT01004822|62724899|FG000|Overall Study|Adverse Event|0|||
33347781|NCT01004822|62724900|FG001|Overall Study|Adverse Event|0|||
33347782|NCT01004822|62724901|FG002|Overall Study|Adverse Event|0|||
33347783|NCT01004822|62724902|FG003|Overall Study|Adverse Event|0|||
33347784|NCT01004822|62724903|FG004|Overall Study|Adverse Event|0|||
33347785|NCT01004822|62724904|FG005|Overall Study|Adverse Event|0|||
33347786|NCT01004822|62724905|FG006|Overall Study|Adverse Event|1|||
33347787|NCT01004822|62724906|FG007|Overall Study|Adverse Event|1|||
33347788|NCT01004822|62724899|FG000|Overall Study|Other|0|||
33347789|NCT01004822|62724900|FG001|Overall Study|Other|0|||
33347790|NCT01004822|62724901|FG002|Overall Study|Other|4|||
33347791|NCT01004822|62724902|FG003|Overall Study|Other|1|||
33347792|NCT01004822|62724903|FG004|Overall Study|Other|0|||
33347793|NCT01004822|62724904|FG005|Overall Study|Other|1|||
33347794|NCT01004822|62724905|FG006|Overall Study|Other|0|||
33347795|NCT01004822|62724906|FG007|Overall Study|Other|0|||
33347796|NCT01001234|62724931|FG000|Overall Study|Withdrawal by Subject|2|||
33347797|NCT01001234|62724932|FG001|Overall Study|Withdrawal by Subject|0|||
33347798|NCT01001234|62724933|FG002|Overall Study|Withdrawal by Subject|3|||
33347799|NCT01001234|62724934|FG003|Overall Study|Withdrawal by Subject|0|||
33347800|NCT01001234|62724935|FG004|Overall Study|Withdrawal by Subject|0|||
33347801|NCT01001234|62724931|FG000|Overall Study|Protocol Violation|34|||
33347802|NCT01001234|62724932|FG001|Overall Study|Protocol Violation|3|||
33347803|NCT01001234|62724933|FG002|Overall Study|Protocol Violation|19|||
33347804|NCT01001234|62724934|FG003|Overall Study|Protocol Violation|18|||
33347805|NCT01001234|62724935|FG004|Overall Study|Protocol Violation|0|||
33347806|NCT01001234|62724931|FG000|Overall Study|Lost to Follow-up|0|||
33347807|NCT01001234|62724932|FG001|Overall Study|Lost to Follow-up|0|||
33347808|NCT01001234|62724933|FG002|Overall Study|Lost to Follow-up|1|||
33347809|NCT01001234|62724934|FG003|Overall Study|Lost to Follow-up|2|||
33347810|NCT01001234|62724935|FG004|Overall Study|Lost to Follow-up|0|||
33347811|NCT01001234|62724931|FG000|Overall Study|Physician Decision|1|||
33347812|NCT01001234|62724932|FG001|Overall Study|Physician Decision|0|||
33347813|NCT01001234|62724933|FG002|Overall Study|Physician Decision|0|||
33347814|NCT01001234|62724934|FG003|Overall Study|Physician Decision|0|||
33347815|NCT01001234|62724935|FG004|Overall Study|Physician Decision|0|||
33347816|NCT01001234|62724931|FG000|Overall Study|Not Treated: Adverse Event|1|||
33347817|NCT01001234|62724932|FG001|Overall Study|Not Treated: Adverse Event|0|||
33347818|NCT01001234|62724933|FG002|Overall Study|Not Treated: Adverse Event|0|||
33347819|NCT01001234|62724934|FG003|Overall Study|Not Treated: Adverse Event|0|||
33347820|NCT01001234|62724935|FG004|Overall Study|Not Treated: Adverse Event|0|||
33347821|NCT01001234|62724931|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
33347822|NCT01001234|62724932|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
33347823|NCT01001234|62724933|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
33347824|NCT01001234|62724934|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
33347825|NCT01001234|62724935|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
33347826|NCT01001234|62724931|FG000|Overall Study|Not Treated: Protocol Violation|3|||
33347827|NCT01001234|62724932|FG001|Overall Study|Not Treated: Protocol Violation|0|||
33347828|NCT01001234|62724933|FG002|Overall Study|Not Treated: Protocol Violation|0|||
33347829|NCT01001234|62724934|FG003|Overall Study|Not Treated: Protocol Violation|0|||
33347830|NCT01001234|62724935|FG004|Overall Study|Not Treated: Protocol Violation|0|||
33347831|NCT01001234|62724931|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
33347832|NCT01001234|62724932|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
33347833|NCT01001234|62724933|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
33347834|NCT01001234|62724934|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
33347835|NCT01001234|62724935|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
33347836|NCT01001234|62724931|FG000|Overall Study|Not Treated: Pregnancy|3|||
33347837|NCT01001234|62724932|FG001|Overall Study|Not Treated: Pregnancy|0|||
33347838|NCT01001234|62724933|FG002|Overall Study|Not Treated: Pregnancy|0|||
33347839|NCT01001234|62724934|FG003|Overall Study|Not Treated: Pregnancy|0|||
33347840|NCT01001234|62724935|FG004|Overall Study|Not Treated: Pregnancy|0|||
33347841|NCT01001234|62724931|FG000|Overall Study|Not Treated: Physician Decision|37|||
33347842|NCT01001234|62724932|FG001|Overall Study|Not Treated: Physician Decision|4|||
33347843|NCT01001234|62724933|FG002|Overall Study|Not Treated: Physician Decision|0|||
33347844|NCT01001234|62724934|FG003|Overall Study|Not Treated: Physician Decision|0|||
33347845|NCT01001234|62724935|FG004|Overall Study|Not Treated: Physician Decision|0|||
33347846|NCT01001234|62724931|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
33347847|NCT01001234|62724932|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
33347848|NCT01001234|62724933|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
33347849|NCT01001234|62724934|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
33347850|NCT01001234|62724935|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
33347851|NCT01004510|62724941|FG000|Overall Study|Adverse Event|1|||
33347852|NCT01004432|62724945|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
33347853|NCT01004432|62724946|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
33347854|NCT01004432|62724947|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
33347855|NCT01004432|62724948|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
33347856|NCT01004432|62724949|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
33347857|NCT01004432|62724945|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
33347858|NCT01004432|62724946|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
33347859|NCT01004432|62724947|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
33347860|NCT01004432|62724948|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
33347861|NCT01004432|62724949|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
33347862|NCT01004432|62724945|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
33347863|NCT01004432|62724946|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
33347864|NCT01004432|62724947|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
33347865|NCT01004432|62724948|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
33347866|NCT01004432|62724949|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
33347867|NCT01004432|62724945|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
33347868|NCT01004432|62724946|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
33347869|NCT01004432|62724947|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
33347870|NCT01004432|62724948|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
33347871|NCT01004432|62724949|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
33347872|NCT01004432|62724945|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
33347873|NCT01004432|62724946|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
33347874|NCT01004432|62724947|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
33347875|NCT01004432|62724948|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
33347876|NCT01004432|62724949|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
33347877|NCT01004432|62724945|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
33347878|NCT01004432|62724946|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
33347879|NCT01004432|62724947|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
33347880|NCT01004432|62724948|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
33347881|NCT01004432|62724949|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
33347882|NCT01004432|62724945|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
33347883|NCT01004432|62724946|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
33347884|NCT01004432|62724947|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
33470763|NCT00045942|62844386|FG005|PKC412A2104E1|Death|0|||
33347885|NCT01004432|62724948|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
33347886|NCT01004432|62724949|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
33347887|NCT01004432|62724945|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
33347888|NCT01004432|62724946|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
33470764|NCT00045942|62844387|FG006|PKC412A2104E1|Death|0|||
33470765|NCT00045942|62844388|FG007|PKC412A2104E1|Death|0|||
33470766|NCT00045942|62844389|FG008|PKC412A2104E1|Death|0|||
33470767|NCT00045942|62844381|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
33470768|NCT00045942|62844382|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
33347889|NCT01004432|62724947|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
33347890|NCT01004432|62724948|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
33347891|NCT01004432|62724949|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
33347892|NCT01004432|62724945|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
33347893|NCT01004432|62724946|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
33347894|NCT01004432|62724947|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
33347895|NCT01004432|62724948|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
33347896|NCT01004432|62724949|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
33347897|NCT01004432|62724945|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
33347898|NCT01004432|62724946|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
33347899|NCT01004432|62724947|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
33347900|NCT01004432|62724948|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
33347901|NCT01004432|62724949|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
33347902|NCT01004432|62724945|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
33347903|NCT01004432|62724946|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
33347904|NCT01004432|62724947|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
33347905|NCT01004432|62724948|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
33347906|NCT01004432|62724949|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
33347907|NCT01004432|62724945|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
33347908|NCT01004432|62724946|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
33347909|NCT01004432|62724947|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
33347910|NCT01004432|62724948|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
33347911|NCT01004432|62724949|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
33347912|NCT01004432|62724945|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
33347913|NCT01004432|62724946|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
33347914|NCT01004432|62724947|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
33347915|NCT01004432|62724948|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
33347916|NCT01004432|62724949|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
33347917|NCT01004432|62724945|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
33347918|NCT01004432|62724946|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
33347919|NCT01004432|62724947|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
33347920|NCT01004432|62724948|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
33347921|NCT01004432|62724949|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
33347922|NCT01004432|62724945|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
33347923|NCT01004432|62724946|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
33347924|NCT01004432|62724947|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
33347925|NCT01004432|62724948|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
33347926|NCT01004432|62724949|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
33347927|NCT01000610|62724963|FG000|Overall Study|Adverse Event|1|||
33347928|NCT01000610|62724963|FG000|Overall Study|Lost to Follow-up|4|||
33347929|NCT01000610|62724963|FG000|Overall Study|Treatment failure|1|||
33347930|NCT01877655|62724969|FG000|Overall Study|Death|57|||
33347931|NCT01877655|62724970|FG001|Overall Study|Death|52|||
33347932|NCT01877655|62724969|FG000|Overall Study|Withdrawal by Subject|18|||
33347933|NCT01877655|62724970|FG001|Overall Study|Withdrawal by Subject|26|||
33347934|NCT01877655|62724969|FG000|Overall Study|Physician Decision|11|||
33347935|NCT01877655|62724970|FG001|Overall Study|Physician Decision|10|||
33347936|NCT01877655|62724969|FG000|Overall Study|Miscellaneous|4|||
33347937|NCT01877655|62724970|FG001|Overall Study|Miscellaneous|4|||
33347938|NCT01877655|62724969|FG000|Overall Study|Randomized but Never Received Drug|8|||
33347939|NCT01877655|62724970|FG001|Overall Study|Randomized but Never Received Drug|5|||
33347940|NCT00586924|62724982|FG000|Overall Study|Adverse event/serious adverse event|0|||
33470769|NCT00045942|62844383|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
33347941|NCT00586924|62724983|FG001|Overall Study|Adverse event/serious adverse event|0|||
33347942|NCT00586924|62724984|FG002|Overall Study|Adverse event/serious adverse event|0|||
33347943|NCT00586924|62724985|FG003|Overall Study|Adverse event/serious adverse event|1|||
33548948|NCT02901431|62940299|FG005|PK Part|8 weeks of treatment ran out|0|||
33347944|NCT00586924|62724986|FG004|Overall Study|Adverse event/serious adverse event|0|||
33470770|NCT00045942|62844384|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
33470771|NCT00045942|62844385|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
33548949|NCT02901431|62940300|FG006|PK Part|8 weeks of treatment ran out|0|||
33347945|NCT00586924|62724987|FG005|Overall Study|Adverse event/serious adverse event|2|||
33347946|NCT00586924|62724982|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
33347947|NCT00586924|62724983|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
33347948|NCT00586924|62724984|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
33347949|NCT00586924|62724985|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
33347950|NCT00586924|62724986|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
33347951|NCT00586924|62724987|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
33347952|NCT00586924|62724982|FG000|Overall Study|Disease progression|0|||
33347953|NCT00586924|62724983|FG001|Overall Study|Disease progression|0|||
33347954|NCT00586924|62724984|FG002|Overall Study|Disease progression|0|||
33347955|NCT00586924|62724985|FG003|Overall Study|Disease progression|1|||
33347956|NCT00586924|62724986|FG004|Overall Study|Disease progression|1|||
33347957|NCT00586924|62724987|FG005|Overall Study|Disease progression|0|||
33347958|NCT00586924|62724982|FG000|Overall Study|Development of neutralizing antibodies|2|||
33347959|NCT00586924|62724983|FG001|Overall Study|Development of neutralizing antibodies|2|||
33347960|NCT00586924|62724984|FG002|Overall Study|Development of neutralizing antibodies|2|||
33347961|NCT00586924|62724985|FG003|Overall Study|Development of neutralizing antibodies|0|||
33347962|NCT00586924|62724986|FG004|Overall Study|Development of neutralizing antibodies|0|||
33347963|NCT00586924|62724987|FG005|Overall Study|Development of neutralizing antibodies|22|||
33347964|NCT00586924|62724982|FG000|Overall Study|Complete response|0|||
33347965|NCT00586924|62724983|FG001|Overall Study|Complete response|1|||
33347966|NCT00586924|62724984|FG002|Overall Study|Complete response|0|||
33347967|NCT00586924|62724985|FG003|Overall Study|Complete response|0|||
33347968|NCT00586924|62724986|FG004|Overall Study|Complete response|2|||
33347969|NCT00586924|62724987|FG005|Overall Study|Complete response|2|||
33347970|NCT00586924|62724982|FG000|Overall Study|Other|1|||
33347971|NCT00586924|62724983|FG001|Overall Study|Other|0|||
33347972|NCT00586924|62724984|FG002|Overall Study|Other|1|||
33347973|NCT00586924|62724985|FG003|Overall Study|Other|1|||
33347974|NCT00586924|62724986|FG004|Overall Study|Other|1|||
33347975|NCT00586924|62724987|FG005|Overall Study|Other|6|||
33347976|NCT01000376|62725003|FG000|Cycle 1 Day 1|Adverse Event|1|||
33347977|NCT01000376|62725004|FG001|Cycle 1 Day 1|Adverse Event|0|||
33347978|NCT01000376|62725003|FG000|Cycle 1 Day 1|Progressive Disease|1|||
33347979|NCT01000376|62725004|FG001|Cycle 1 Day 1|Progressive Disease|0|||
33347980|NCT01038635|62725019|FG000|Overall Study|Disease Progression|2|||
33347981|NCT01038635|62725020|FG001|Overall Study|Disease Progression|0|||
33347982|NCT01038635|62725021|FG002|Overall Study|Disease Progression|0|||
33347983|NCT01038635|62725022|FG003|Overall Study|Disease Progression|0|||
33347984|NCT01038635|62725023|FG004|Overall Study|Disease Progression|0|||
33347985|NCT01038635|62725024|FG005|Overall Study|Disease Progression|0|||
33347986|NCT01038635|62725025|FG006|Overall Study|Disease Progression|1|||
33347987|NCT01038635|62725026|FG007|Overall Study|Disease Progression|4|||
33347988|NCT01038635|62725027|FG008|Overall Study|Disease Progression|0|||
33347989|NCT01038635|62725019|FG000|Overall Study|Death|0|||
33347990|NCT01038635|62725020|FG001|Overall Study|Death|0|||
33347991|NCT01038635|62725021|FG002|Overall Study|Death|0|||
33347992|NCT01038635|62725022|FG003|Overall Study|Death|0|||
33347993|NCT01038635|62725023|FG004|Overall Study|Death|1|||
33347994|NCT01038635|62725024|FG005|Overall Study|Death|0|||
33347995|NCT01038635|62725025|FG006|Overall Study|Death|1|||
33347996|NCT01038635|62725026|FG007|Overall Study|Death|1|||
33347997|NCT01038635|62725027|FG008|Overall Study|Death|2|||
33347998|NCT01000064|62725048|FG000|Overall Study|Withdrawal by Subject|1|||
33347999|NCT01000064|62725049|FG001|Overall Study|Withdrawal by Subject|1|||
33348000|NCT00766090|62725060|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33348001|NCT00766090|62725061|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33348002|NCT00766090|62725062|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33348003|NCT00766090|62725063|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33348004|NCT00766090|62725064|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33348005|NCT00766090|62725065|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33348006|NCT00766090|62725066|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33348007|NCT00766090|62725067|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33348008|NCT00766090|62725068|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
33348009|NCT00766090|62725069|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33348010|NCT00766090|62725070|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33348011|NCT00766090|62725071|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33348012|NCT00766090|62725060|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
33348013|NCT00766090|62725061|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33348014|NCT00766090|62725062|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33348015|NCT00766090|62725063|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33348016|NCT00766090|62725064|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33348017|NCT00766090|62725065|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33348018|NCT00766090|62725066|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33348019|NCT00766090|62725067|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33348020|NCT00766090|62725068|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33348021|NCT00766090|62725069|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33348022|NCT00766090|62725070|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33348023|NCT00766090|62725071|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33348024|NCT00766090|62725060|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
33348025|NCT00766090|62725061|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33348026|NCT00766090|62725062|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33348027|NCT00766090|62725063|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
33348028|NCT00766090|62725064|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33348029|NCT00766090|62725065|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33348030|NCT00766090|62725066|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33348031|NCT00766090|62725067|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33348032|NCT00766090|62725068|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33348033|NCT00766090|62725069|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33348034|NCT00766090|62725070|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33348035|NCT00766090|62725071|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33348036|NCT00766090|62725060|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
33348037|NCT00766090|62725061|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
33348038|NCT00766090|62725062|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
33348039|NCT00766090|62725063|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
33348040|NCT00766090|62725064|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
33348041|NCT00766090|62725065|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
33348042|NCT00766090|62725066|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
33348043|NCT00766090|62725067|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
33348044|NCT00766090|62725068|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
33470772|NCT00045942|62844386|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
33470773|NCT00045942|62844387|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
33348045|NCT00766090|62725069|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
33348046|NCT00766090|62725070|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
33348047|NCT00766090|62725071|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
33348048|NCT00766090|62725060|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33348049|NCT00766090|62725061|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33348050|NCT00766090|62725062|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33348051|NCT00766090|62725063|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33348052|NCT00766090|62725064|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
33348053|NCT00766090|62725065|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33348054|NCT00766090|62725066|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33348055|NCT00766090|62725067|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33348056|NCT00766090|62725068|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33348057|NCT00766090|62725069|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33348058|NCT00766090|62725070|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33348059|NCT00766090|62725071|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33348060|NCT00766090|62725060|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33348061|NCT00766090|62725061|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33348062|NCT00766090|62725062|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
33348063|NCT00766090|62725063|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33348064|NCT00766090|62725064|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33348065|NCT00766090|62725065|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33348066|NCT00766090|62725066|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33348067|NCT00766090|62725067|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33348068|NCT00766090|62725068|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33348069|NCT00766090|62725069|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33348070|NCT00766090|62725070|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33348071|NCT00766090|62725071|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33348072|NCT00766090|62725060|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
33348073|NCT00766090|62725061|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
33348074|NCT00766090|62725062|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
33348075|NCT00766090|62725063|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
33470774|NCT00045942|62844388|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
33470775|NCT00045942|62844389|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
33470776|NCT00045942|62844381|FG000|PKC412A2104E2|Lost to Follow-up|0|||
33470777|NCT00045942|62844382|FG001|PKC412A2104E2|Lost to Follow-up|0|||
33654920|NCT00086619|63068297|FG000|Overall Study|Withdrawal by Subject|6|||
33348076|NCT00766090|62725064|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
33348077|NCT00766090|62725065|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
33348078|NCT00766090|62725066|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
33348079|NCT00766090|62725067|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
33348080|NCT00766090|62725068|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
33470778|NCT00045942|62844383|FG002|PKC412A2104E2|Lost to Follow-up|0|||
33348081|NCT00766090|62725069|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
33348082|NCT00766090|62725070|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
33348083|NCT00766090|62725071|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
33348084|NCT00766090|62725060|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33348085|NCT00766090|62725061|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33348086|NCT00766090|62725062|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33348087|NCT00766090|62725063|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33348088|NCT00766090|62725064|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33348089|NCT00766090|62725065|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
33348090|NCT00766090|62725066|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33348091|NCT00766090|62725067|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33348092|NCT00766090|62725068|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33348093|NCT00766090|62725069|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33348094|NCT00766090|62725070|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33470779|NCT00045942|62844384|FG003|PKC412A2104E2|Lost to Follow-up|0|||
33470780|NCT00045942|62844385|FG004|PKC412A2104E2|Lost to Follow-up|0|||
33470781|NCT00045942|62844386|FG005|PKC412A2104E2|Lost to Follow-up|0|||
33470782|NCT00045942|62844387|FG006|PKC412A2104E2|Lost to Follow-up|0|||
33348095|NCT00766090|62725071|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33348096|NCT00766090|62725060|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33348097|NCT00766090|62725061|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
33348098|NCT00766090|62725062|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33348099|NCT00766090|62725063|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
33348100|NCT00766090|62725064|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33348101|NCT00766090|62725065|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33348102|NCT00766090|62725066|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33348103|NCT00766090|62725067|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33470783|NCT00045942|62844388|FG007|PKC412A2104E2|Lost to Follow-up|3|||
33470784|NCT00045942|62844389|FG008|PKC412A2104E2|Lost to Follow-up|0|||
33470785|NCT00045942|62844381|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
33470786|NCT00045942|62844382|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
33470787|NCT00045942|62844383|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
33470788|NCT00045942|62844384|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
33470789|NCT00045942|62844385|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
33470790|NCT00045942|62844386|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
33470791|NCT00045942|62844387|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
33470792|NCT00045942|62844388|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
33470793|NCT00045942|62844389|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
33470794|NCT00045942|62844381|FG000|PKC412A2104E2|Lack of Efficacy|0|||
33470795|NCT00045942|62844382|FG001|PKC412A2104E2|Lack of Efficacy|0|||
33470796|NCT00045942|62844383|FG002|PKC412A2104E2|Lack of Efficacy|0|||
33470797|NCT00045942|62844384|FG003|PKC412A2104E2|Lack of Efficacy|0|||
33470798|NCT00045942|62844385|FG004|PKC412A2104E2|Lack of Efficacy|0|||
33470799|NCT00045942|62844386|FG005|PKC412A2104E2|Lack of Efficacy|3|||
33470800|NCT00045942|62844387|FG006|PKC412A2104E2|Lack of Efficacy|2|||
33470801|NCT00045942|62844388|FG007|PKC412A2104E2|Lack of Efficacy|2|||
33470802|NCT00045942|62844389|FG008|PKC412A2104E2|Lack of Efficacy|6|||
33470803|NCT00045942|62844381|FG000|PKC412A2104E2|Adverse Event|0|||
33470804|NCT00045942|62844382|FG001|PKC412A2104E2|Adverse Event|0|||
33470805|NCT00045942|62844383|FG002|PKC412A2104E2|Adverse Event|0|||
33470806|NCT00045942|62844384|FG003|PKC412A2104E2|Adverse Event|0|||
33470807|NCT00045942|62844385|FG004|PKC412A2104E2|Adverse Event|0|||
33470808|NCT00045942|62844386|FG005|PKC412A2104E2|Adverse Event|4|||
33470809|NCT00045942|62844387|FG006|PKC412A2104E2|Adverse Event|3|||
33470810|NCT00045942|62844388|FG007|PKC412A2104E2|Adverse Event|1|||
33470811|NCT00045942|62844389|FG008|PKC412A2104E2|Adverse Event|0|||
33470812|NCT00045942|62844381|FG000|PKC412A2104E2|Death|0|||
33470813|NCT00045942|62844382|FG001|PKC412A2104E2|Death|0|||
33470814|NCT00045942|62844383|FG002|PKC412A2104E2|Death|0|||
33470815|NCT00045942|62844384|FG003|PKC412A2104E2|Death|0|||
33470816|NCT00045942|62844385|FG004|PKC412A2104E2|Death|0|||
33470817|NCT00045942|62844386|FG005|PKC412A2104E2|Death|1|||
33470818|NCT00045942|62844387|FG006|PKC412A2104E2|Death|2|||
33470819|NCT00045942|62844388|FG007|PKC412A2104E2|Death|0|||
33654921|NCT00086619|63068298|FG001|Overall Study|Withdrawal by Subject|6|||
33348104|NCT00766090|62725068|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33348105|NCT00766090|62725069|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33348106|NCT00766090|62725070|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33470820|NCT00045942|62844389|FG008|PKC412A2104E2|Death|0|||
33470821|NCT04386616|62844416|FG000|Overall Study|Death|22|||
33470822|NCT04386616|62844417|FG001|Overall Study|Death|22|||
33470823|NCT04386616|62844418|FG002|Overall Study|Death|21|||
33470824|NCT04386616|62844416|FG000|Overall Study|Lost to Follow-up|5|||
33470825|NCT04386616|62844417|FG001|Overall Study|Lost to Follow-up|8|||
33470826|NCT04386616|62844418|FG002|Overall Study|Lost to Follow-up|6|||
33470827|NCT04386616|62844416|FG000|Overall Study|Withdrawal by Subject|2|||
33470828|NCT04386616|62844417|FG001|Overall Study|Withdrawal by Subject|4|||
33470829|NCT04386616|62844418|FG002|Overall Study|Withdrawal by Subject|1|||
33470830|NCT04386616|62844416|FG000|Overall Study|Adverse Event|1|||
33348107|NCT00766090|62725071|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
33348108|NCT00766090|62725060|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33348109|NCT00766090|62725061|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33348110|NCT00766090|62725062|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33348111|NCT00766090|62725063|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33348112|NCT00766090|62725064|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
33348113|NCT00766090|62725065|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33348114|NCT00766090|62725066|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33348115|NCT00766090|62725067|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33348116|NCT00766090|62725068|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33348117|NCT00766090|62725069|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33348118|NCT00766090|62725070|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33348119|NCT00766090|62725071|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33348120|NCT00580801|62725088|FG000|Overall Study|Physician Decision|1|||
33348121|NCT00580801|62725089|FG001|Overall Study|Physician Decision|0|||
33348122|NCT00580801|62725090|FG002|Overall Study|Physician Decision|0|||
33348123|NCT00580801|62725088|FG000|Overall Study|Adverse Event|2|||
33348124|NCT00580801|62725089|FG001|Overall Study|Adverse Event|0|||
33348125|NCT00580801|62725090|FG002|Overall Study|Adverse Event|0|||
33348126|NCT00580801|62725088|FG000|Overall Study|Lost to Follow-up|2|||
33348127|NCT00580801|62725089|FG001|Overall Study|Lost to Follow-up|0|||
33348128|NCT00580801|62725090|FG002|Overall Study|Lost to Follow-up|0|||
33348129|NCT00580801|62725088|FG000|Overall Study|Reached a virologic endpoint|0|||
33348130|NCT00580801|62725089|FG001|Overall Study|Reached a virologic endpoint|1|||
33348131|NCT00580801|62725090|FG002|Overall Study|Reached a virologic endpoint|2|||
33348132|NCT00580801|62725088|FG000|Overall Study|Participant non-compliant|0|||
33348133|NCT00580801|62725089|FG001|Overall Study|Participant non-compliant|0|||
33348134|NCT00580801|62725090|FG002|Overall Study|Participant non-compliant|1|||
33348135|NCT00580801|62725088|FG000|Overall Study|Travel|1|||
33348136|NCT00580801|62725089|FG001|Overall Study|Travel|0|||
33348137|NCT00580801|62725090|FG002|Overall Study|Travel|0|||
33348138|NCT01059539|62725098|FG000|Overall Study|Adverse Event|66|||
33348139|NCT01059539|62725098|FG000|Overall Study|Insufficient Therapeutic Response|26|||
33348140|NCT01059539|62725098|FG000|Overall Study|Protocol Violation|55|||
33348141|NCT01059539|62725098|FG000|Overall Study|Withdrawal of Consent|80|||
33348142|NCT01059539|62725098|FG000|Overall Study|Lost to Follow-up|42|||
33348143|NCT01059539|62725098|FG000|Overall Study|Reason Not Specified|2|||
33348144|NCT00999908|62725102|FG000|Treatment Period 1|Subject withdrew consent|2|||
33348145|NCT00999908|62725103|FG001|Treatment Period 1|Subject withdrew consent|0|||
33348146|NCT00999908|62725104|FG002|Treatment Period 1|Subject withdrew consent|0|||
33348147|NCT00999908|62725102|FG000|Treatment Period 2|Protocol Violation|1|||
33348148|NCT00999908|62725103|FG001|Treatment Period 2|Protocol Violation|0|||
33348149|NCT00999908|62725104|FG002|Treatment Period 2|Protocol Violation|0|||
33348150|NCT00580723|62725112|FG000|Overall Study|Did not want to participate in extension|3|||
33348151|NCT00580723|62725112|FG000|Overall Study|Lost to Follow-up|5|||
33348152|NCT00999596|62725116|FG000|Overall Study|Statistical population not required|101|||
33348153|NCT04676867|62725125|FG000|Overall Study|Screen failure|0|||
33470831|NCT04386616|62844417|FG001|Overall Study|Adverse Event|1|||
33470832|NCT04386616|62844418|FG002|Overall Study|Adverse Event|0|||
33470833|NCT00045708|62844438|FG000|Phase 1|early progressive disease|0|||
33348154|NCT04676867|62725126|FG001|Overall Study|Screen failure|0|||
33348155|NCT04676867|62725127|FG002|Overall Study|Screen failure|6|||
33348156|NCT04676867|62725128|FG003|Overall Study|Screen failure|2|||
33348157|NCT04676867|62725125|FG000|Overall Study|Death|0|||
33348158|NCT04676867|62725126|FG001|Overall Study|Death|0|||
33548950|NCT02901431|62940301|FG007|PK Part|8 weeks of treatment ran out|0|||
33348159|NCT04676867|62725127|FG002|Overall Study|Death|1|||
33348160|NCT04676867|62725128|FG003|Overall Study|Death|0|||
33348161|NCT04676867|62725125|FG000|Overall Study|Withdrawal by Subject|2|||
33348162|NCT04676867|62725126|FG001|Overall Study|Withdrawal by Subject|2|||
33470834|NCT00045708|62844439|FG001|Phase 1|early progressive disease|1|||
33548951|NCT02901431|62940302|FG008|PK Part|8 weeks of treatment ran out|0|||
33470835|NCT00045708|62844440|FG002|Phase 1|early progressive disease|0|||
33470836|NCT00045630|62844457|FG000|Overall Study|Adverse Event|1|||
33470837|NCT00045630|62844457|FG000|Overall Study|Refusal unrelated to adverse event|1|||
33470838|NCT00045630|62844457|FG000|Overall Study|Progression/relapse|1|||
33470839|NCT00045630|62844457|FG000|Overall Study|Death|1|||
33470840|NCT00045630|62844457|FG000|Overall Study|Ineligible|2|||
33348163|NCT04676867|62725127|FG002|Overall Study|Withdrawal by Subject|4|||
33348164|NCT04676867|62725128|FG003|Overall Study|Withdrawal by Subject|4|||
33470841|NCT00003702|62844463|FG000|Overall Study|Ineligible cell types|2|||
33470842|NCT00003702|62844464|FG001|Overall Study|Ineligible cell types|2|||
33470843|NCT00003702|62844463|FG000|Overall Study|Did not meet criteria for persistence|8|||
33470844|NCT00003702|62844464|FG001|Overall Study|Did not meet criteria for persistence|5|||
33470845|NCT00003702|62844463|FG000|Overall Study|WHO score > 6|2|||
33470846|NCT00003702|62844464|FG001|Overall Study|WHO score > 6|1|||
33470847|NCT00003702|62844463|FG000|Overall Study|Inadequate documentation of disease|1|||
33470848|NCT00003702|62844464|FG001|Overall Study|Inadequate documentation of disease|3|||
33470849|NCT00031590|62844471|FG000|Overall Study|Adverse Event|1|||
33470850|NCT00031590|62844471|FG000|Overall Study|Withdrawal by parents|2|||
33654922|NCT00086619|63068297|FG000|Overall Study|Adverse Event|8|||
33654923|NCT00086619|63068298|FG001|Overall Study|Adverse Event|10|||
33654924|NCT00086619|63068297|FG000|Overall Study|Protocol Violation|1|||
33654925|NCT00086619|63068298|FG001|Overall Study|Protocol Violation|1|||
33348165|NCT04676867|62725125|FG000|Overall Study|Lost to Follow-up|1|||
33348166|NCT04676867|62725126|FG001|Overall Study|Lost to Follow-up|0|||
33348167|NCT04676867|62725127|FG002|Overall Study|Lost to Follow-up|0|||
33348168|NCT04676867|62725128|FG003|Overall Study|Lost to Follow-up|0|||
33348169|NCT00770224|62725138|FG000|Step 1: Induction|Adverse Event|3|||
33348170|NCT00770224|62725139|FG001|Step 1: Induction|Adverse Event|0|||
33348171|NCT00770224|62725138|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
33348172|NCT00770224|62725139|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
33348173|NCT00770224|62725138|FG000|Step 1: Induction|Other reason not protocol specified|2|||
33348174|NCT00770224|62725139|FG001|Step 1: Induction|Other reason not protocol specified|0|||
33348175|NCT00770224|62725138|FG000|Step 1: Induction|Ineligible|2|||
33348176|NCT00770224|62725139|FG001|Step 1: Induction|Ineligible|0|||
33348177|NCT00770224|62725138|FG000|Step 1: Induction|No protocol treatment given|1|||
33348178|NCT00770224|62725139|FG001|Step 1: Induction|No protocol treatment given|0|||
33348179|NCT00770224|62725138|FG000|Step 2: Maintenance|Adverse Event|0|||
33348180|NCT00770224|62725139|FG001|Step 2: Maintenance|Adverse Event|10|||
33348181|NCT00770224|62725138|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
33348182|NCT00770224|62725139|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
33348183|NCT00770224|62725138|FG000|Step 2: Maintenance|Progression/relapse|0|||
33348184|NCT00770224|62725139|FG001|Step 2: Maintenance|Progression/relapse|1|||
33348185|NCT00770224|62725138|FG000|Step 2: Maintenance|Death|0|||
33348186|NCT00770224|62725139|FG001|Step 2: Maintenance|Death|2|||
33348187|NCT00770224|62725138|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
33348188|NCT00770224|62725139|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
33348189|NCT00770224|62725138|FG000|Step 2: Maintenance|Ineligible|0|||
33348190|NCT00770224|62725139|FG001|Step 2: Maintenance|Ineligible|2|||
33348191|NCT02399215|62725146|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
33654926|NCT00085917|63068311|FG000|Overall Study|Adverse Event|4|||
33654927|NCT00085917|63068312|FG001|Overall Study|Adverse Event|3|||
33654928|NCT00084747|63068318|FG000|Overall Study|Relapsed|8|||
33654929|NCT00084747|63068318|FG000|Overall Study|Death|3|||
33654930|NCT00084747|63068318|FG000|Overall Study|Withdrawal by Subject|2|||
33654931|NCT00081159|63068353|FG000|Overall Study|Withdrawal by Subject|0|||
33654932|NCT00081159|63068354|FG001|Overall Study|Withdrawal by Subject|3|||
33654933|NCT00081159|63068353|FG000|Overall Study|Myelosuppression prior to treatment|0|||
33654934|NCT00081159|63068354|FG001|Overall Study|Myelosuppression prior to treatment|1|||
33654935|NCT00081159|63068353|FG000|Overall Study|Lost to Follow-up|2|||
33654936|NCT00081159|63068354|FG001|Overall Study|Lost to Follow-up|1|||
33654937|NCT00080223|63068369|FG000|Overall Study|Adverse Event|23|||
33654938|NCT00080223|63068369|FG000|Overall Study|Death|21|||
33654939|NCT00080223|63068369|FG000|Overall Study|Withdrawal by Subject|13|||
33348192|NCT02399215|62725146|FG000|Overall Study|Withdrawal by Subject|1|||
33470851|NCT00239681|62844478|FG000|Overall Study|Adverse Event|100|||
33348193|NCT01057589|62725150|FG000|Overall Study|Disease Progression|35|||
33348194|NCT01057589|62725150|FG000|Overall Study|Adverse Event|10|||
33348195|NCT01057589|62725150|FG000|Overall Study|Physician Decision|8|||
33348196|NCT01057589|62725150|FG000|Overall Study|Withdrawal by Subject|3|||
33654940|NCT00080223|63068369|FG000|Overall Study|Lung Transplantation|9|||
33654941|NCT00080223|63068369|FG000|Overall Study|Non-compliance With Study Treatment|7|||
33654942|NCT00080223|63068369|FG000|Overall Study|Participant unwilling to continue|2|||
33654943|NCT00080223|63068369|FG000|Overall Study|Physician Decision|1|||
33654944|NCT01899053|63068980|FG000|Overall Study|Progressive Disease|4|||
33470852|NCT00239681|62844479|FG001|Overall Study|Adverse Event|99|||
33348197|NCT01057589|62725150|FG000|Overall Study|Sponsor Decision|1|||
33348198|NCT01057589|62725150|FG000|Overall Study|Death|8|||
33348199|NCT01057589|62725150|FG000|Overall Study|Lost to Follow-up|1|||
33348200|NCT01716117|62725156|FG000|Overall Study|Death|5|||
33348201|NCT01716117|62725157|FG001|Overall Study|Death|2|||
33348202|NCT01716117|62725156|FG000|Overall Study|Withdrawal by Subject|2|||
33348203|NCT01716117|62725157|FG001|Overall Study|Withdrawal by Subject|0|||
33348204|NCT00579553|62725173|FG000|Overall Study|Lost to Follow-up|16|||
33348205|NCT00579553|62725174|FG001|Overall Study|Lost to Follow-up|13|||
33348206|NCT01650831|62725180|FG000|Overall Study|Screen failure|1|||
33348207|NCT00581893|62725188|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
33348208|NCT00581893|62725189|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
33348209|NCT00770146|62725197|FG000|Treatment Period|Withdrawal by Subject|6|||
33348210|NCT00770146|62725198|FG001|Treatment Period|Withdrawal by Subject|13|||
33348211|NCT00770146|62725197|FG000|Treatment Period|Adverse Event|2|||
33348212|NCT00770146|62725198|FG001|Treatment Period|Adverse Event|26|||
33348213|NCT00770146|62725197|FG000|Treatment Period|Other|1|||
33348214|NCT00770146|62725198|FG001|Treatment Period|Other|5|||
33348215|NCT00770146|62725197|FG000|Treatment Period|Protocol non-compliance|0|||
33348216|NCT00770146|62725198|FG001|Treatment Period|Protocol non-compliance|1|||
33348217|NCT00770146|62725197|FG000|Follow-up Period|Withdrawal by Subject|7|||
33348218|NCT00770146|62725198|FG001|Follow-up Period|Withdrawal by Subject|13|||
33348219|NCT00770146|62725197|FG000|Follow-up Period|Adverse Event|0|||
33348220|NCT00770146|62725198|FG001|Follow-up Period|Adverse Event|2|||
33348221|NCT00770146|62725197|FG000|Follow-up Period|Other|4|||
33348222|NCT00770146|62725198|FG001|Follow-up Period|Other|5|||
33348223|NCT01056341|62725209|FG000|Overall Study|Treatment Intolerance|0|||
33348224|NCT01056341|62725210|FG001|Overall Study|Treatment Intolerance|2|||
33348225|NCT01056341|62725211|FG002|Overall Study|Treatment Intolerance|0|||
33348226|NCT01056341|62725212|FG003|Overall Study|Treatment Intolerance|2|||
33348227|NCT01056341|62725213|FG004|Overall Study|Treatment Intolerance|0|||
33348228|NCT01056341|62725209|FG000|Overall Study|Lack of Efficacy|32|||
33348229|NCT01056341|62725210|FG001|Overall Study|Lack of Efficacy|30|||
33348230|NCT01056341|62725211|FG002|Overall Study|Lack of Efficacy|7|||
33348231|NCT01056341|62725212|FG003|Overall Study|Lack of Efficacy|25|||
33348232|NCT01056341|62725213|FG004|Overall Study|Lack of Efficacy|9|||
33348233|NCT01056341|62725209|FG000|Overall Study|Other reasons|4|||
33348234|NCT01056341|62725210|FG001|Overall Study|Other reasons|4|||
33348235|NCT01056341|62725211|FG002|Overall Study|Other reasons|8|||
33348236|NCT01056341|62725212|FG003|Overall Study|Other reasons|9|||
33348237|NCT01056341|62725213|FG004|Overall Study|Other reasons|5|||
33348238|NCT00999518|62725236|FG000|Overall Study|Adverse Event|1|||
33348239|NCT00999518|62725237|FG001|Overall Study|Adverse Event|6|||
33348240|NCT00999518|62725238|FG002|Overall Study|Adverse Event|3|||
33348241|NCT00999518|62725239|FG003|Overall Study|Adverse Event|1|||
33348242|NCT00999518|62725240|FG004|Overall Study|Adverse Event|2|||
33348243|NCT00999518|62725236|FG000|Overall Study|Lack of Efficacy|2|||
33348244|NCT00999518|62725237|FG001|Overall Study|Lack of Efficacy|0|||
33348245|NCT00999518|62725238|FG002|Overall Study|Lack of Efficacy|0|||
33348246|NCT00999518|62725239|FG003|Overall Study|Lack of Efficacy|2|||
33348247|NCT00999518|62725240|FG004|Overall Study|Lack of Efficacy|2|||
33348248|NCT00999518|62725236|FG000|Overall Study|Lost to Follow-up|0|||
33348249|NCT00999518|62725237|FG001|Overall Study|Lost to Follow-up|0|||
33348250|NCT00999518|62725238|FG002|Overall Study|Lost to Follow-up|0|||
33348251|NCT00999518|62725239|FG003|Overall Study|Lost to Follow-up|4|||
33348252|NCT00999518|62725240|FG004|Overall Study|Lost to Follow-up|1|||
33348253|NCT00999518|62725236|FG000|Overall Study|Did not meet entrance criteria|0|||
33348254|NCT00999518|62725237|FG001|Overall Study|Did not meet entrance criteria|0|||
33348255|NCT00999518|62725238|FG002|Overall Study|Did not meet entrance criteria|0|||
33348256|NCT00999518|62725239|FG003|Overall Study|Did not meet entrance criteria|0|||
33348257|NCT00999518|62725240|FG004|Overall Study|Did not meet entrance criteria|1|||
33348258|NCT00999518|62725236|FG000|Overall Study|Study terminated by sponsor|10|||
33348259|NCT00999518|62725237|FG001|Overall Study|Study terminated by sponsor|6|||
33348260|NCT00999518|62725238|FG002|Overall Study|Study terminated by sponsor|5|||
33348261|NCT00999518|62725239|FG003|Overall Study|Study terminated by sponsor|5|||
33348262|NCT00999518|62725240|FG004|Overall Study|Study terminated by sponsor|9|||
33654945|NCT01899053|63068981|FG001|Overall Study|Progressive Disease|0|||
33348263|NCT00999518|62725236|FG000|Overall Study|Pregnancy|0|||
33348264|NCT00999518|62725237|FG001|Overall Study|Pregnancy|0|||
33348265|NCT00999518|62725238|FG002|Overall Study|Pregnancy|1|||
33348266|NCT00999518|62725239|FG003|Overall Study|Pregnancy|0|||
33348267|NCT00999518|62725240|FG004|Overall Study|Pregnancy|0|||
33348268|NCT00999518|62725236|FG000|Overall Study|Protocol Violation|0|||
33348269|NCT00999518|62725237|FG001|Overall Study|Protocol Violation|1|||
33348270|NCT00999518|62725238|FG002|Overall Study|Protocol Violation|0|||
33348271|NCT00999518|62725239|FG003|Overall Study|Protocol Violation|0|||
33348272|NCT00999518|62725240|FG004|Overall Study|Protocol Violation|2|||
33348273|NCT00999518|62725236|FG000|Overall Study|Withdrawal by Subject|5|||
33654946|NCT01899053|63068982|FG002|Overall Study|Progressive Disease|3|||
33654947|NCT01899053|63068983|FG003|Overall Study|Progressive Disease|0|||
33348274|NCT00999518|62725237|FG001|Overall Study|Withdrawal by Subject|4|||
33348275|NCT00999518|62725238|FG002|Overall Study|Withdrawal by Subject|10|||
33348276|NCT00999518|62725239|FG003|Overall Study|Withdrawal by Subject|6|||
33348277|NCT00999518|62725240|FG004|Overall Study|Withdrawal by Subject|1|||
33348278|NCT00999518|62725236|FG000|Overall Study|Other|5|||
33348279|NCT00999518|62725237|FG001|Overall Study|Other|7|||
33348280|NCT00999518|62725238|FG002|Overall Study|Other|1|||
33348281|NCT00999518|62725239|FG003|Overall Study|Other|4|||
33348282|NCT00999518|62725240|FG004|Overall Study|Other|5|||
33348283|NCT00999518|62725236|FG000|Overall Study|Randomized but not Treated|1|||
33348284|NCT00999518|62725237|FG001|Overall Study|Randomized but not Treated|1|||
33348285|NCT00999518|62725238|FG002|Overall Study|Randomized but not Treated|2|||
33348286|NCT00999518|62725239|FG003|Overall Study|Randomized but not Treated|0|||
33348287|NCT00999518|62725240|FG004|Overall Study|Randomized but not Treated|1|||
33348288|NCT01056263|62725256|FG000|Overall Study|Adverse Event|12|||
33348289|NCT01056263|62725256|FG000|Overall Study|Death|1|||
33348290|NCT01056263|62725256|FG000|Overall Study|Withdrawal by Subject|1|||
33348291|NCT01056263|62725256|FG000|Overall Study|Lack of Efficacy|29|||
33348292|NCT01056263|62725256|FG000|Overall Study|Progressive disease|2|||
33348293|NCT01056263|62725256|FG000|Overall Study|Neoplasm progression|1|||
33348294|NCT01056263|62725256|FG000|Overall Study|Objective progression or relapse|1|||
33348295|NCT01056263|62725256|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
33348296|NCT01056107|62725264|FG000|Overall Study|Withdrawal by Subject|0|||
33348297|NCT01056107|62725265|FG001|Overall Study|Withdrawal by Subject|1|||
33348298|NCT01056107|62725266|FG002|Overall Study|Withdrawal by Subject|3|||
33348299|NCT01056107|62725267|FG003|Overall Study|Withdrawal by Subject|0|||
33348300|NCT01003886|62725277|FG000|Overall Study|Lack of Efficacy|5|||
33348301|NCT01003886|62725277|FG000|Overall Study|Lost to Follow-up|169|||
33348302|NCT01003886|62725277|FG000|Overall Study|Withdrawal by Subject|39|||
33348303|NCT01003886|62725277|FG000|Overall Study|Other|14|||
33348304|NCT01003886|62725277|FG000|Overall Study|Adverse Event|3|||
33348305|NCT01003184|62725283|FG000|Overall Study|Adverse Event|12|||
33348306|NCT01003184|62725284|FG001|Overall Study|Adverse Event|5|||
33348307|NCT01003184|62725283|FG000|Overall Study|Lost to Follow-up|1|||
33348308|NCT01003184|62725284|FG001|Overall Study|Lost to Follow-up|0|||
33348309|NCT01003184|62725283|FG000|Overall Study|Loss of glucose control|1|||
33348310|NCT01003184|62725284|FG001|Overall Study|Loss of glucose control|1|||
33348311|NCT01003184|62725283|FG000|Overall Study|Protocol Violation|3|||
33348312|NCT01003184|62725284|FG001|Overall Study|Protocol Violation|0|||
33348313|NCT01003184|62725283|FG000|Overall Study|Withdrawal by Subject|1|||
33348314|NCT01003184|62725284|FG001|Overall Study|Withdrawal by Subject|6|||
33348315|NCT01003184|62725283|FG000|Overall Study|Physician Decision|1|||
33348316|NCT01003184|62725284|FG001|Overall Study|Physician Decision|0|||
33348317|NCT01029353|62725294|FG000|Overall Study|Lost to Follow-up|4|||
33348318|NCT01029353|62725295|FG001|Overall Study|Lost to Follow-up|5|||
33348319|NCT01029353|62725296|FG002|Overall Study|Lost to Follow-up|5|||
33348320|NCT01029353|62725297|FG003|Overall Study|Lost to Follow-up|4|||
33348321|NCT01029353|62725294|FG000|Overall Study|Consent Withdrawn|2|||
33348322|NCT01029353|62725295|FG001|Overall Study|Consent Withdrawn|0|||
33348323|NCT01029353|62725296|FG002|Overall Study|Consent Withdrawn|0|||
33348324|NCT01029353|62725297|FG003|Overall Study|Consent Withdrawn|0|||
33348325|NCT01029353|62725294|FG000|Overall Study|Primary Outcome Indeterminate|1|||
33348326|NCT01029353|62725295|FG001|Overall Study|Primary Outcome Indeterminate|3|||
33348327|NCT01029353|62725296|FG002|Overall Study|Primary Outcome Indeterminate|2|||
33348328|NCT01029353|62725297|FG003|Overall Study|Primary Outcome Indeterminate|0|||
33348329|NCT01008410|62725309|FG000|Overall Study|Adverse Event|13|||
33348330|NCT01008410|62725310|FG001|Overall Study|Adverse Event|7|||
33348331|NCT01008410|62725309|FG000|Overall Study|Withdrawal by Subject|6|||
33348332|NCT01008410|62725310|FG001|Overall Study|Withdrawal by Subject|2|||
33348333|NCT01008410|62725309|FG000|Overall Study|Lost to Follow-up|1|||
33654948|NCT01899053|63068984|FG004|Overall Study|Progressive Disease|3|||
33348334|NCT01008410|62725310|FG001|Overall Study|Lost to Follow-up|0|||
33348335|NCT01008410|62725309|FG000|Overall Study|Noncompliance|1|||
33348336|NCT01008410|62725310|FG001|Overall Study|Noncompliance|0|||
33348337|NCT01008410|62725309|FG000|Overall Study|Low Cortisol|2|||
33348338|NCT01008410|62725310|FG001|Overall Study|Low Cortisol|0|||
33348339|NCT01008410|62725309|FG000|Overall Study|Lack of Efficacy|2|||
33348340|NCT01008410|62725310|FG001|Overall Study|Lack of Efficacy|6|||
33470853|NCT00239681|62844478|FG000|Overall Study|Withdrawal by Subject|458|||
33470854|NCT00239681|62844479|FG001|Overall Study|Withdrawal by Subject|489|||
33470855|NCT00239681|62844478|FG000|Overall Study|Lost to Follow-up|28|||
33470856|NCT00239681|62844479|FG001|Overall Study|Lost to Follow-up|22|||
33470857|NCT00239681|62844478|FG000|Overall Study|Protocol Violation|4|||
33470858|NCT00239681|62844479|FG001|Overall Study|Protocol Violation|4|||
33470859|NCT00239681|62844478|FG000|Overall Study|Physician Decision|13|||
33470860|NCT00239681|62844479|FG001|Overall Study|Physician Decision|17|||
33470861|NCT00239681|62844478|FG000|Overall Study|No information chacked on CaseReportForm|90|||
33470862|NCT00239681|62844479|FG001|Overall Study|No information chacked on CaseReportForm|84|||
33348341|NCT01008410|62725309|FG000|Overall Study|Met Exclusion Criterion|0|||
33348342|NCT01008410|62725310|FG001|Overall Study|Met Exclusion Criterion|1|||
33348343|NCT01023269|62725316|FG000|Overall Study|early termination of the study|2|||
33348344|NCT01023269|62725317|FG001|Overall Study|early termination of the study|0|||
33348345|NCT01007942|62725349|FG000|Overall Study|Adverse Event|29|||
33348346|NCT01007942|62725350|FG001|Overall Study|Adverse Event|14|||
33348347|NCT01007942|62725349|FG000|Overall Study|Abnormal test procedure|0|||
33348348|NCT01007942|62725350|FG001|Overall Study|Abnormal test procedure|1|||
33348349|NCT01007942|62725349|FG000|Overall Study|Disease progression|217|||
33348350|NCT01007942|62725350|FG001|Overall Study|Disease progression|242|||
33348351|NCT01007942|62725349|FG000|Overall Study|New cancer therapy|5|||
33348352|NCT01007942|62725350|FG001|Overall Study|New cancer therapy|1|||
33348353|NCT01007942|62725349|FG000|Overall Study|Protocol Violation|1|||
33348354|NCT01007942|62725350|FG001|Overall Study|Protocol Violation|1|||
33348355|NCT01007942|62725349|FG000|Overall Study|Withdrawal by Subject|19|||
33348356|NCT01007942|62725350|FG001|Overall Study|Withdrawal by Subject|14|||
33348357|NCT01007942|62725349|FG000|Overall Study|Lost to Follow-up|1|||
33348358|NCT01007942|62725350|FG001|Overall Study|Lost to Follow-up|0|||
33348359|NCT01007942|62725349|FG000|Overall Study|Administrative problems|2|||
33348360|NCT01007942|62725350|FG001|Overall Study|Administrative problems|0|||
33348361|NCT01007942|62725349|FG000|Overall Study|Death|3|||
33348362|NCT01007942|62725350|FG001|Overall Study|Death|2|||
33348363|NCT01007942|62725349|FG000|Overall Study|Patients untreated|4|||
33348364|NCT01007942|62725350|FG001|Overall Study|Patients untreated|3|||
33348365|NCT01023035|62725363|FG000|Treatment Period|Adverse Event|27|||
33348366|NCT01023035|62725364|FG001|Treatment Period|Adverse Event|32|||
33348367|NCT01023035|62725365|FG002|Treatment Period|Adverse Event|50|||
33348368|NCT01023035|62725363|FG000|Treatment Period|Non-Medical Reasons|19|||
33348369|NCT01023035|62725364|FG001|Treatment Period|Non-Medical Reasons|22|||
33348370|NCT01023035|62725365|FG002|Treatment Period|Non-Medical Reasons|44|||
33348371|NCT01023035|62725363|FG000|Treatment Period|Treatment Failure|26|||
33348372|NCT01023035|62725364|FG001|Treatment Period|Treatment Failure|31|||
33348373|NCT01023035|62725365|FG002|Treatment Period|Treatment Failure|24|||
33348374|NCT01023035|62725363|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
33348375|NCT01023035|62725364|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
33348376|NCT01023035|62725365|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
33348377|NCT01023035|62725363|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
33348378|NCT01023035|62725364|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
33348379|NCT01023035|62725365|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
33348380|NCT01028651|62725375|FG000|Overall Study|Death|2|||
33348381|NCT01028651|62725375|FG000|Overall Study|Adverse Event|1|||
33348382|NCT01028027|62725383|FG000|Overall Study|Lost to Follow-up|4|||
33348383|NCT01028027|62725384|FG001|Overall Study|Lost to Follow-up|1|||
33348384|NCT01028027|62725383|FG000|Overall Study|Withdrawal by Subject|5|||
33348385|NCT01028027|62725384|FG001|Overall Study|Withdrawal by Subject|3|||
33348386|NCT01028027|62725383|FG000|Overall Study|Adverse Event|4|||
33348387|NCT01028027|62725384|FG001|Overall Study|Adverse Event|7|||
33348388|NCT01028027|62725383|FG000|Overall Study|Protocol Violation|3|||
33348389|NCT01028027|62725384|FG001|Overall Study|Protocol Violation|1|||
33348390|NCT01028027|62725383|FG000|Overall Study|Lack of Efficacy|0|||
33348391|NCT01028027|62725384|FG001|Overall Study|Lack of Efficacy|1|||
33348392|NCT01007552|62725390|FG000|Overall Study|Withdrawal by Subject|1|||
33470863|NCT02878330|62844487|FG000|Overall Study|Death|3|||
33470864|NCT02878330|62844488|FG001|Overall Study|Death|2|||
33348393|NCT01007396|62725394|FG000|Overall Study|Lost to Follow-up|47|||
33470865|NCT02878330|62844487|FG000|Overall Study|Lost to Follow-up|11|||
33470866|NCT02878330|62844488|FG001|Overall Study|Lost to Follow-up|26|||
33470867|NCT02878330|62844487|FG000|Overall Study|Withdrawal by Subject|11|||
33470868|NCT02878330|62844488|FG001|Overall Study|Withdrawal by Subject|21|||
33470869|NCT02878330|62844487|FG000|Overall Study|Other|4|||
33470870|NCT02878330|62844488|FG001|Overall Study|Other|7|||
33470871|NCT00238433|62844495|FG000|Overall Study|Screen failure|1|||
33470872|NCT00238433|62844495|FG000|Overall Study|Lost to Follow-up|1|||
33470873|NCT00238433|62844495|FG000|Overall Study|Death|1|||
33470874|NCT00045162|62844502|FG000|Overall Study|Ineligible|12|||
33470875|NCT00045162|62844503|FG001|Overall Study|Ineligible|8|||
33470876|NCT00045162|62844502|FG000|Overall Study|Not treated|7|||
33470877|NCT00045162|62844503|FG001|Overall Study|Not treated|2|||
33470878|NCT00045162|62844502|FG000|Overall Study|Adverse Event|55|||
33470879|NCT00045162|62844503|FG001|Overall Study|Adverse Event|50|||
33470880|NCT00045162|62844502|FG000|Overall Study|Lack of Efficacy|32|||
33470881|NCT00045162|62844503|FG001|Overall Study|Lack of Efficacy|29|||
33470882|NCT00045162|62844502|FG000|Overall Study|Death|10|||
33470883|NCT00045162|62844503|FG001|Overall Study|Death|10|||
33470884|NCT00045162|62844502|FG000|Overall Study|Withdrawal by Subject|5|||
33470885|NCT00045162|62844503|FG001|Overall Study|Withdrawal by Subject|3|||
33470886|NCT00045162|62844502|FG000|Overall Study|Other|21|||
33470887|NCT00045162|62844503|FG001|Overall Study|Other|16|||
33470888|NCT02748616|62844509|FG000|Overall Study|Lost to Follow-up|1|||
33470889|NCT02748616|62844509|FG000|Overall Study|Withdrawal by Subject|2|||
33470890|NCT02748616|62844509|FG000|Overall Study|Physician Decision|2|||
33470891|NCT02748616|62844509|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
33470892|NCT00238121|62844515|FG000|Overall Study|Withdrawal by Subject|1|||
33470893|NCT00238121|62844516|FG001|Overall Study|Withdrawal by Subject|1|||
33470894|NCT00238121|62844515|FG000|Overall Study|Adverse Event|2|||
33470895|NCT00238121|62844516|FG001|Overall Study|Adverse Event|1|||
33470896|NCT03139552|62844521|FG000|Overall Study|unable to attend tasting due to schedule|3|||
33470897|NCT03804918|62844532|FG000|Overall Study|Participant did not use the app|1|||
33470898|NCT03139240|62844540|FG000|Overall Study|Lost to Follow-up|0|||
33470899|NCT03139240|62844541|FG001|Overall Study|Lost to Follow-up|1|||
33470900|NCT03139240|62844542|FG002|Overall Study|Lost to Follow-up|1|||
33470901|NCT03139240|62844543|FG003|Overall Study|Lost to Follow-up|0|||
33470902|NCT00237809|62844555|FG000|Overall Study|Lost to Follow-up|11|||
33470903|NCT00237809|62844556|FG001|Overall Study|Lost to Follow-up|10|||
33470904|NCT00237809|62844557|FG002|Overall Study|Lost to Follow-up|9|||
33470905|NCT00237809|62844558|FG003|Overall Study|Lost to Follow-up|9|||
33470906|NCT00003498|62844568|FG000|Overall Study|Not evaluable.|4|||
33470907|NCT00003492|62844572|FG000|Overall Study|Not evaluable|6|||
33470908|NCT03136198|62844578|FG000|Overall Study|Withdrawal by Subject|0|||
33470909|NCT03136198|62844579|FG001|Overall Study|Withdrawal by Subject|1|||
33470910|NCT00042666|62844585|FG000|Overall Study|Adverse Event|2|||
33470911|NCT00042666|62844585|FG000|Overall Study|Death|4|||
33470912|NCT00042666|62844585|FG000|Overall Study|Protocol Violation|1|||
33470913|NCT00042666|62844585|FG000|Overall Study|Participant/Physician Perception|1|||
33470914|NCT00042666|62844585|FG000|Overall Study|Progressive Disease|41|||
33470915|NCT00042666|62844585|FG000|Overall Study|Other|1|||
33470916|NCT00042666|62844585|FG000|Overall Study|Other|4|||
33470917|NCT00042432|62844592|FG000|Overall Study|Adverse Event|4|||
33470918|NCT00042432|62844593|FG001|Overall Study|Adverse Event|1|||
33470919|NCT00042432|62844592|FG000|Overall Study|Withdrawal by Subject|1|||
33470920|NCT00042432|62844593|FG001|Overall Study|Withdrawal by Subject|3|||
33470921|NCT00042432|62844592|FG000|Overall Study|Death|0|||
33470922|NCT00042432|62844593|FG001|Overall Study|Death|2|||
33470923|NCT00042432|62844592|FG000|Overall Study|Ineligibility determined|1|||
33470924|NCT00042432|62844593|FG001|Overall Study|Ineligibility determined|0|||
33470925|NCT00042432|62844592|FG000|Overall Study|Initiation of maintenance dialysis|1|||
33470926|NCT00042432|62844593|FG001|Overall Study|Initiation of maintenance dialysis|1|||
33470927|NCT00042432|62844592|FG000|Overall Study|Other|2|||
33470928|NCT00042432|62844593|FG001|Overall Study|Other|0|||
33470929|NCT00003474|62844599|FG000|Overall Study|Not Evaluable|14|||
33470930|NCT01542736|62844603|FG000|Overall Study|Death|1|||
33470931|NCT01346410|62844607|FG000|Overall Study|Death|1|||
33470932|NCT00003456|62844611|FG000|Overall Study|Not evaluable|8|||
33470933|NCT02719522|62844615|FG000|Overall Study|Implant Failure|4|||
33470934|NCT02719522|62844615|FG000|Overall Study|Death|2|||
33470935|NCT02719522|62844615|FG000|Overall Study|Lost to Follow-up|5|||
33470936|NCT00237185|62844621|FG000|Core|Adverse Event|3|||
33470937|NCT00237185|62844622|FG001|Core|Adverse Event|4|||
33470938|NCT00237185|62844621|FG000|Core|Abnormal laboratory value|0|||
33470939|NCT00237185|62844622|FG001|Core|Abnormal laboratory value|4|||
33470940|NCT00237185|62844621|FG000|Core|Abnormal test procedure results|1|||
33470941|NCT00237185|62844622|FG001|Core|Abnormal test procedure results|0|||
33470942|NCT00237185|62844621|FG000|Core|Lack of Efficacy|30|||
33470943|NCT00237185|62844622|FG001|Core|Lack of Efficacy|23|||
33470944|NCT00237185|62844621|FG000|Core|Protocol Violation|1|||
33470945|NCT00237185|62844622|FG001|Core|Protocol Violation|1|||
33470946|NCT00237185|62844621|FG000|Core|Withdrawal by Subject|4|||
33470947|NCT00237185|62844622|FG001|Core|Withdrawal by Subject|4|||
33470948|NCT00237185|62844621|FG000|Core|Administrative problems|0|||
33470949|NCT00237185|62844622|FG001|Core|Administrative problems|1|||
33470950|NCT00237185|62844621|FG000|Core|Death|4|||
33470951|NCT00237185|62844622|FG001|Core|Death|0|||
33348394|NCT00998738|62725398|FG000|Overall Study|Uknown|1|||
33348395|NCT00997334|62725402|FG000|Overall Study|still on therapy|12|||
33348396|NCT00997334|62725402|FG000|Overall Study|Adverse Event|3|||
33348397|NCT00997334|62725402|FG000|Overall Study|Patient non-compliance|1|||
33348398|NCT00997334|62725402|FG000|Overall Study|Withdrawal by Subject|3|||
33348399|NCT00997334|62725402|FG000|Overall Study|Death|2|||
33348400|NCT00997334|62725402|FG000|Overall Study|Urgent Palliative Care|2|||
33348401|NCT00997334|62725402|FG000|Overall Study|No lesion amenable|1|||
33348402|NCT00997334|62725402|FG000|Overall Study|Ineligible|1|||
33348403|NCT00996944|62725408|FG000|Double-blind Treatment Period|Adverse Event|2|||
33348404|NCT00996944|62725409|FG001|Double-blind Treatment Period|Adverse Event|1|||
33348405|NCT00996944|62725408|FG000|Double-blind Treatment Period|Protocol Violation|1|||
33348406|NCT00996944|62725409|FG001|Double-blind Treatment Period|Protocol Violation|0|||
33348407|NCT00996944|62725408|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
33348408|NCT00996944|62725409|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
33348409|NCT00996944|62725408|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
33348410|NCT00996944|62725409|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
33348411|NCT00996944|62725408|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
33348412|NCT00996944|62725409|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
33348413|NCT01002482|62725419|FG000|Overall Study|Withdrawal by Subject|14|||
33348414|NCT01002482|62725420|FG001|Overall Study|Withdrawal by Subject|21|||
33348415|NCT01002482|62725419|FG000|Overall Study|Included twice|1|||
33348416|NCT01002482|62725420|FG001|Overall Study|Included twice|0|||
33348417|NCT01027949|62725426|FG000|Overall Study|Death|174|||
33348418|NCT01027949|62725426|FG000|Overall Study|Progressive Disease|163|||
33348419|NCT01027949|62725426|FG000|Overall Study|Adverse Event|172|||
33348420|NCT01027949|62725426|FG000|Overall Study|Withdrawal by Subject|113|||
33348421|NCT01027949|62725426|FG000|Overall Study|Lost to Follow-up|17|||
33348422|NCT01027949|62725426|FG000|Overall Study|Protocol Violation|13|||
33348423|NCT01027949|62725426|FG000|Overall Study|PI Decision|8|||
33348424|NCT01027949|62725426|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
33348425|NCT01027949|62725426|FG000|Overall Study|Non-compliance with Study Procedures|7|||
33348426|NCT01027949|62725426|FG000|Overall Study|Lung Transplant|5|||
33348427|NCT01027949|62725426|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
33348428|NCT01027949|62725426|FG000|Overall Study|Use of Excluded Medication|2|||
33348429|NCT01027949|62725426|FG000|Overall Study|Patient Self-discontinuation|1|||
33348430|NCT01027949|62725426|FG000|Overall Study|Pregnancy|1|||
33348431|NCT01027949|62725426|FG000|Overall Study|Surgery|1|||
33348432|NCT01038323|62725433|FG000|Overall Study|Withdrawal by Subject|3|||
33348433|NCT01038323|62725434|FG001|Overall Study|Withdrawal by Subject|2|||
33348434|NCT01038323|62725435|FG002|Overall Study|Withdrawal by Subject|4|||
33348435|NCT01027871|62725446|FG000|Overall Study|Physician Decision|1|||
33348436|NCT01027871|62725447|FG001|Overall Study|Physician Decision|5|||
33348437|NCT01027871|62725448|FG002|Overall Study|Physician Decision|0|||
33348438|NCT01027871|62725446|FG000|Overall Study|Protocol Violation|0|||
33348439|NCT01027871|62725447|FG001|Overall Study|Protocol Violation|2|||
33348440|NCT01027871|62725448|FG002|Overall Study|Protocol Violation|2|||
33348441|NCT01027871|62725446|FG000|Overall Study|Withdrawal by Subject|1|||
33348442|NCT01027871|62725447|FG001|Overall Study|Withdrawal by Subject|2|||
33348443|NCT01027871|62725448|FG002|Overall Study|Withdrawal by Subject|2|||
33348444|NCT01027871|62725446|FG000|Overall Study|Adverse Event|0|||
33348445|NCT01027871|62725447|FG001|Overall Study|Adverse Event|2|||
33348446|NCT01027871|62725448|FG002|Overall Study|Adverse Event|2|||
33348447|NCT01027871|62725446|FG000|Overall Study|Sponsor Decision|0|||
33470952|NCT00237185|62844621|FG000|Core|Determined ineligible post randomization|1|||
33348448|NCT01027871|62725447|FG001|Overall Study|Sponsor Decision|2|||
33348449|NCT01027871|62725448|FG002|Overall Study|Sponsor Decision|0|||
33348450|NCT01027871|62725446|FG000|Overall Study|Discontinued Prior to Treatment|0|||
33348451|NCT01027871|62725447|FG001|Overall Study|Discontinued Prior to Treatment|0|||
33348452|NCT01027871|62725448|FG002|Overall Study|Discontinued Prior to Treatment|1|||
33348453|NCT01021553|62725464|FG000|Overall Study|Adverse Event|1|||
33348454|NCT01021553|62725465|FG001|Overall Study|Adverse Event|0|||
33348455|NCT01021553|62725466|FG002|Overall Study|Adverse Event|0|||
33348456|NCT01021553|62725464|FG000|Overall Study|Lack of Efficacy|2|||
33470953|NCT00237185|62844622|FG001|Core|Determined ineligible post randomization|0|||
33348457|NCT01021553|62725465|FG001|Overall Study|Lack of Efficacy|2|||
33348458|NCT01021553|62725466|FG002|Overall Study|Lack of Efficacy|0|||
33470954|NCT00237185|62844621|FG000|Extension|Adverse Event|1|||
33470955|NCT00237185|62844622|FG001|Extension|Adverse Event|0|||
33470956|NCT00237185|62844621|FG000|Extension|Abnormal laboratory value|0|||
33348459|NCT01021553|62725464|FG000|Overall Study|Protocol Violation|0|||
33348460|NCT01021553|62725465|FG001|Overall Study|Protocol Violation|2|||
33348461|NCT01021553|62725466|FG002|Overall Study|Protocol Violation|2|||
33470957|NCT00237185|62844622|FG001|Extension|Abnormal laboratory value|1|||
33470958|NCT00237185|62844621|FG000|Extension|Lack of Efficacy|9|||
33348462|NCT01021553|62725464|FG000|Overall Study|Lost to Follow-up|0|||
33348463|NCT01021553|62725465|FG001|Overall Study|Lost to Follow-up|0|||
33348464|NCT01021553|62725466|FG002|Overall Study|Lost to Follow-up|1|||
33348465|NCT01021553|62725464|FG000|Overall Study|Withdrawal by Subject|1|||
33348466|NCT01021553|62725465|FG001|Overall Study|Withdrawal by Subject|1|||
33348467|NCT01021553|62725466|FG002|Overall Study|Withdrawal by Subject|0|||
33348468|NCT01026389|62725481|FG000|Overall Study|Withdrawal by Subject|1|||
33348469|NCT01026389|62725482|FG001|Overall Study|Withdrawal by Subject|3|||
33348470|NCT01026389|62725481|FG000|Overall Study|change of treatment, patient moved|4|||
33348471|NCT01026389|62725482|FG001|Overall Study|change of treatment, patient moved|2|||
33348472|NCT01006616|62725492|FG000|Period 1 (6 Months)|Adverse Event|10|||
33348473|NCT01006616|62725493|FG001|Period 1 (6 Months)|Adverse Event|31|||
33470959|NCT00237185|62844622|FG001|Extension|Lack of Efficacy|14|||
33470960|NCT00237185|62844621|FG000|Extension|Condition no longer required study drug|0|||
33470961|NCT00237185|62844622|FG001|Extension|Condition no longer required study drug|1|||
33470962|NCT00237185|62844621|FG000|Extension|Withdrawal by Subject|3|||
33470963|NCT00237185|62844622|FG001|Extension|Withdrawal by Subject|2|||
33470964|NCT00237185|62844621|FG000|Extension|Lost to Follow-up|1|||
33348474|NCT01006616|62725494|FG002|Period 1 (6 Months)|Adverse Event|37|||
33348475|NCT01006616|62725495|FG003|Period 1 (6 Months)|Adverse Event|9|||
33348476|NCT01006616|62725492|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
33348477|NCT01006616|62725493|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
33348478|NCT01006616|62725494|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
33348479|NCT01006616|62725495|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
33348480|NCT01006616|62725492|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
33348481|NCT01006616|62725493|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
33348482|NCT01006616|62725494|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
33348483|NCT01006616|62725495|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
33348484|NCT01006616|62725492|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
33348485|NCT01006616|62725493|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
33348486|NCT01006616|62725494|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
33348487|NCT01006616|62725495|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
33348488|NCT01006616|62725492|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
33348489|NCT01006616|62725493|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
33348490|NCT01006616|62725494|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
33348491|NCT01006616|62725495|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
33348492|NCT01006616|62725492|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
33348493|NCT01006616|62725493|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
33348494|NCT01006616|62725494|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
33348495|NCT01006616|62725495|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
33348496|NCT01006616|62725492|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
33348497|NCT01006616|62725493|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
33348498|NCT01006616|62725494|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
33348499|NCT01006616|62725495|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
33348500|NCT01006616|62725492|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
33348501|NCT01006616|62725493|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
33348502|NCT01006616|62725494|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
33348503|NCT01006616|62725495|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
33348504|NCT01006616|62725492|FG000|Period 1 (6 Months)|Not Treated|0|||
33470965|NCT00237185|62844622|FG001|Extension|Lost to Follow-up|0|||
33470966|NCT00237185|62844621|FG000|Extension|Administrative problems|1|||
33470967|NCT00237185|62844622|FG001|Extension|Administrative problems|0|||
33470968|NCT00237185|62844621|FG000|Extension|Death|1|||
33470969|NCT00237185|62844622|FG001|Extension|Death|1|||
33548952|NCT02901431|62940303|FG009|PK Part|8 weeks of treatment ran out|0|||
33548953|NCT02901431|62940304|FG010|PK Part|8 weeks of treatment ran out|0|||
33548954|NCT02901431|62940305|FG011|PK Part|8 weeks of treatment ran out|0|||
33548955|NCT02901431|62940306|FG012|PK Part|8 weeks of treatment ran out|0|||
33548956|NCT02901431|62940294|FG000|PK Part|Stopped treatment after 8 weeks|1|||
33348505|NCT01006616|62725493|FG001|Period 1 (6 Months)|Not Treated|0|||
33348506|NCT01006616|62725494|FG002|Period 1 (6 Months)|Not Treated|1|||
33348507|NCT01006616|62725495|FG003|Period 1 (6 Months)|Not Treated|1|||
33348508|NCT01006616|62725492|FG000|Period 2 (18 Months)|Adverse Event|6|||
33348509|NCT01006616|62725493|FG001|Period 2 (18 Months)|Adverse Event|6|||
33470970|NCT00003222|62844630|FG000|Overall Study|Physician Decision|0|||
33470971|NCT00003222|62844631|FG001|Overall Study|Physician Decision|1|||
33470972|NCT02877082|62844637|FG000|Overall Study|Trial was closed early|5|||
33470973|NCT02875834|62844645|FG000|Open-label Phase|Withdrawal by Subject|3|||
33470974|NCT02875834|62844646|FG001|Open-label Phase|Withdrawal by Subject|0|||
33548957|NCT02901431|62940295|FG001|PK Part|Stopped treatment after 8 weeks|0|||
33348510|NCT01006616|62725494|FG002|Period 2 (18 Months)|Adverse Event|6|||
33348511|NCT01006616|62725495|FG003|Period 2 (18 Months)|Adverse Event|4|||
33348512|NCT01006616|62725492|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
33348513|NCT01006616|62725493|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
33348514|NCT01006616|62725494|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
33348515|NCT01006616|62725495|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
33348516|NCT01006616|62725492|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
33348517|NCT01006616|62725493|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
33348518|NCT01006616|62725494|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
33348519|NCT01006616|62725495|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
33348520|NCT01006616|62725492|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
33348521|NCT01006616|62725493|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
33348522|NCT01006616|62725494|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
33348523|NCT01006616|62725495|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
33348524|NCT01006616|62725492|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
33348525|NCT01006616|62725493|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
33348526|NCT01006616|62725494|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
33348527|NCT01006616|62725495|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
33348528|NCT01006616|62725492|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
33348529|NCT01006616|62725493|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
33348530|NCT01006616|62725494|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
33348531|NCT01006616|62725495|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
33348532|NCT01006616|62725492|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
33348533|NCT01006616|62725493|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
33348534|NCT01006616|62725494|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
33348535|NCT01006616|62725495|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
33348536|NCT01006616|62725492|FG000|Period 2 (18 Months)|Study Terminated|63|||
33348537|NCT01006616|62725493|FG001|Period 2 (18 Months)|Study Terminated|46|||
33348538|NCT01006616|62725494|FG002|Period 2 (18 Months)|Study Terminated|44|||
33348539|NCT01006616|62725495|FG003|Period 2 (18 Months)|Study Terminated|70|||
33348540|NCT00996632|62725507|FG000|Overall Study|Physician Decision|0|||
33348541|NCT00996632|62725508|FG001|Overall Study|Physician Decision|0|||
33348542|NCT01025843|62725524|FG000|Washout 4|Withdrawal by Subject|0|||
33348543|NCT01025843|62725525|FG001|Washout 4|Withdrawal by Subject|0|||
33348544|NCT01025843|62725526|FG002|Washout 4|Withdrawal by Subject|1|||
33348545|NCT01025843|62725527|FG003|Washout 4|Withdrawal by Subject|1|||
33348546|NCT01025843|62725528|FG004|Washout 4|Withdrawal by Subject|0|||
33348547|NCT01025843|62725529|FG005|Washout 4|Withdrawal by Subject|0|||
33348548|NCT01025843|62725530|FG006|Washout 4|Withdrawal by Subject|0|||
33348549|NCT01025843|62725531|FG007|Washout 4|Withdrawal by Subject|0|||
33348550|NCT01025843|62725532|FG008|Washout 4|Withdrawal by Subject|0|||
33348551|NCT01025843|62725533|FG009|Washout 4|Withdrawal by Subject|0|||
33348552|NCT01036763|62725561|FG000|Overall Study|Adverse Event|25|||
33348553|NCT01036763|62725561|FG000|Overall Study|Lost to Follow-up|28|||
33348554|NCT01036763|62725561|FG000|Overall Study|Other reason (not specified)|40|||
33348555|NCT01021007|62725567|FG000|Overall Study|Lost to Follow-up|1|||
33348556|NCT01021007|62725568|FG001|Overall Study|Lost to Follow-up|1|||
33348557|NCT01021007|62725567|FG000|Overall Study|Adverse Event|1|||
33348558|NCT01021007|62725568|FG001|Overall Study|Adverse Event|3|||
33348559|NCT01020773|62725576|FG000|Overall Study|Withdrawal by Subject|4|||
33348560|NCT01020773|62725577|FG001|Overall Study|Withdrawal by Subject|3|||
33348561|NCT01020305|62725583|FG000|Overall Study|Adverse Event|2|||
33348562|NCT01036529|62725589|FG000|Overall Study|Adverse Event|0|||
33348563|NCT01036529|62725590|FG001|Overall Study|Adverse Event|1|||
33348564|NCT01036529|62725589|FG000|Overall Study|Lost to Follow-up|0|||
33348565|NCT01036529|62725590|FG001|Overall Study|Lost to Follow-up|1|||
33348566|NCT01036529|62725589|FG000|Overall Study|Physician Decision|1|||
33348567|NCT01036529|62725590|FG001|Overall Study|Physician Decision|0|||
33470975|NCT02875834|62844647|FG002|Open-label Phase|Withdrawal by Subject|0|||
33470976|NCT02875834|62844648|FG003|Open-label Phase|Withdrawal by Subject|0|||
33654949|NCT01899053|63068985|FG005|Overall Study|Progressive Disease|1|||
33348568|NCT01036529|62725589|FG000|Overall Study|Withdrawal by Subject|1|||
33470977|NCT02875834|62844645|FG000|Open-label Phase|(Not collected)|4|||
33470978|NCT02875834|62844646|FG001|Open-label Phase|(Not collected)|0|||
33348569|NCT01036529|62725590|FG001|Overall Study|Withdrawal by Subject|1|||
33348570|NCT01036529|62725589|FG000|Overall Study|Sponsor study termination|11|||
33470979|NCT02875834|62844647|FG002|Open-label Phase|(Not collected)|0|||
33348571|NCT01036529|62725590|FG001|Overall Study|Sponsor study termination|12|||
33348572|NCT01024751|62725598|FG000|Enrolled Participants|Ineligible at baseline|3|||
33470980|NCT02875834|62844648|FG003|Open-label Phase|(Not collected)|0|||
33348573|NCT01024751|62725599|FG001|Enrolled Participants|Ineligible at baseline|4|||
33348574|NCT01024751|62725598|FG000|Eligible Participants|Withdrawal by Subject|0|||
33470981|NCT02875834|62844645|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
33654950|NCT01899053|63068986|FG006|Overall Study|Progressive Disease|1|||
33470982|NCT02875834|62844646|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
33470983|NCT02875834|62844647|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
33470984|NCT02875834|62844648|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
33470985|NCT02875834|62844645|FG000|Randomized Treatment Phase|Protocol Violation|0|||
33470986|NCT02875834|62844646|FG001|Randomized Treatment Phase|Protocol Violation|2|||
33470987|NCT02875834|62844647|FG002|Randomized Treatment Phase|Protocol Violation|0|||
33470988|NCT02875834|62844648|FG003|Randomized Treatment Phase|Protocol Violation|0|||
33470989|NCT02875834|62844645|FG000|Randomized Treatment Phase|(Not collected)|0|||
33470990|NCT02875834|62844646|FG001|Randomized Treatment Phase|(Not collected)|9|||
33470991|NCT02875834|62844647|FG002|Randomized Treatment Phase|(Not collected)|10|||
33470992|NCT02875834|62844648|FG003|Randomized Treatment Phase|(Not collected)|9|||
33470993|NCT02875366|62844660|FG000|Overall Study|Adverse Event|0|||
33470994|NCT02875366|62844661|FG001|Overall Study|Adverse Event|2|||
33548958|NCT02901431|62940296|FG002|PK Part|Stopped treatment after 8 weeks|1|||
33548959|NCT02901431|62940297|FG003|PK Part|Stopped treatment after 8 weeks|0|||
33348575|NCT01024751|62725599|FG001|Eligible Participants|Withdrawal by Subject|1|||
33348576|NCT01024751|62725598|FG000|Eligible Participants|Lost to Follow-up|0|||
33348577|NCT01024751|62725599|FG001|Eligible Participants|Lost to Follow-up|1|||
33348578|NCT01024751|62725598|FG000|Eligible Participants|Ineligible|0|||
33348579|NCT01024751|62725599|FG001|Eligible Participants|Ineligible|1|||
33348580|NCT01019369|62725607|FG000|Overall Study|Lost to Follow-up|10|||
33348581|NCT01019369|62725608|FG001|Overall Study|Lost to Follow-up|6|||
33348582|NCT01019369|62725607|FG000|Overall Study|Withdrawal by Subject|0|||
33348583|NCT01019369|62725608|FG001|Overall Study|Withdrawal by Subject|1|||
33348584|NCT01019135|62725618|FG000|Overall Study|Did not receive allocated intervention|12|||
33348585|NCT01019135|62725619|FG001|Overall Study|Did not receive allocated intervention|6|||
33348586|NCT01019135|62725620|FG002|Overall Study|Did not receive allocated intervention|25|||
33348587|NCT01019135|62725618|FG000|Overall Study|Did not attend CR|8|||
33348588|NCT01019135|62725619|FG001|Overall Study|Did not attend CR|13|||
33348589|NCT01019135|62725620|FG002|Overall Study|Did not attend CR|6|||
33348590|NCT01018979|62725630|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
33348591|NCT01018979|62725631|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
33348592|NCT01018979|62725630|FG000|Overall Study|Not received at least one dose|0|||
33348593|NCT01018979|62725631|FG001|Overall Study|Not received at least one dose|1|||
33348594|NCT01572493|62725649|FG000|Overall Study|Physician Decision|1|||
33348595|NCT01572493|62725650|FG001|Overall Study|Physician Decision|0|||
33348596|NCT01572493|62725651|FG002|Overall Study|Physician Decision|0|||
33348597|NCT01572493|62725652|FG003|Overall Study|Physician Decision|0|||
33348598|NCT01572493|62725653|FG004|Overall Study|Physician Decision|0|||
33348599|NCT01572493|62725654|FG005|Overall Study|Physician Decision|0|||
33348600|NCT01572493|62725655|FG006|Overall Study|Physician Decision|0|||
33348601|NCT01572493|62725656|FG007|Overall Study|Physician Decision|0|||
33348602|NCT01572493|62725657|FG008|Overall Study|Physician Decision|0|||
33348603|NCT01572493|62725649|FG000|Overall Study|Switched to alternative treatment|0|||
33348604|NCT01572493|62725650|FG001|Overall Study|Switched to alternative treatment|1|||
33348605|NCT01572493|62725651|FG002|Overall Study|Switched to alternative treatment|2|||
33348606|NCT01572493|62725652|FG003|Overall Study|Switched to alternative treatment|1|||
33348607|NCT01572493|62725653|FG004|Overall Study|Switched to alternative treatment|2|||
33348608|NCT01572493|62725654|FG005|Overall Study|Switched to alternative treatment|0|||
33348609|NCT01572493|62725655|FG006|Overall Study|Switched to alternative treatment|2|||
33348610|NCT01572493|62725656|FG007|Overall Study|Switched to alternative treatment|0|||
33348611|NCT01572493|62725657|FG008|Overall Study|Switched to alternative treatment|2|||
33348612|NCT01572493|62725649|FG000|Overall Study|Death|0|||
33348613|NCT01572493|62725650|FG001|Overall Study|Death|0|||
33348614|NCT01572493|62725651|FG002|Overall Study|Death|0|||
33348615|NCT01572493|62725652|FG003|Overall Study|Death|1|||
33348616|NCT01572493|62725653|FG004|Overall Study|Death|0|||
33348617|NCT01572493|62725654|FG005|Overall Study|Death|1|||
33348618|NCT01572493|62725655|FG006|Overall Study|Death|0|||
33348619|NCT01572493|62725656|FG007|Overall Study|Death|0|||
33348620|NCT01572493|62725657|FG008|Overall Study|Death|0|||
33348621|NCT01572493|62725649|FG000|Overall Study|Adverse Event|0|||
33348622|NCT01572493|62725650|FG001|Overall Study|Adverse Event|0|||
33348623|NCT01572493|62725651|FG002|Overall Study|Adverse Event|0|||
33348624|NCT01572493|62725652|FG003|Overall Study|Adverse Event|0|||
33348625|NCT01572493|62725653|FG004|Overall Study|Adverse Event|0|||
33348626|NCT01572493|62725654|FG005|Overall Study|Adverse Event|0|||
33348627|NCT01572493|62725655|FG006|Overall Study|Adverse Event|1|||
33470995|NCT02875366|62844660|FG000|Overall Study|Noncompliance|0|||
33348628|NCT01572493|62725656|FG007|Overall Study|Adverse Event|0|||
33348629|NCT01572493|62725657|FG008|Overall Study|Adverse Event|0|||
33348630|NCT01018511|62725684|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
33348631|NCT01018511|62725685|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
33348632|NCT01018511|62725686|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
33348633|NCT01018511|62725687|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
33348634|NCT01018511|62725684|FG000|Overall Study|Adverse Event|5|||
33348635|NCT01018511|62725685|FG001|Overall Study|Adverse Event|9|||
33348636|NCT01018511|62725686|FG002|Overall Study|Adverse Event|13|||
33348637|NCT01018511|62725687|FG003|Overall Study|Adverse Event|10|||
33348638|NCT01018511|62725684|FG000|Overall Study|Lack of Efficacy|4|||
33348639|NCT01018511|62725685|FG001|Overall Study|Lack of Efficacy|1|||
33348640|NCT01018511|62725686|FG002|Overall Study|Lack of Efficacy|1|||
33348641|NCT01018511|62725687|FG003|Overall Study|Lack of Efficacy|2|||
33348642|NCT01018511|62725684|FG000|Overall Study|Withdrawal by Subject|6|||
33348643|NCT01018511|62725685|FG001|Overall Study|Withdrawal by Subject|5|||
33348644|NCT01018511|62725686|FG002|Overall Study|Withdrawal by Subject|11|||
33348645|NCT01018511|62725687|FG003|Overall Study|Withdrawal by Subject|9|||
33348646|NCT01018511|62725684|FG000|Overall Study|Lost to Follow-up|0|||
33348647|NCT01018511|62725685|FG001|Overall Study|Lost to Follow-up|0|||
33348648|NCT01018511|62725686|FG002|Overall Study|Lost to Follow-up|1|||
33348649|NCT01018511|62725687|FG003|Overall Study|Lost to Follow-up|0|||
33348650|NCT01018511|62725684|FG000|Overall Study|Protocol Violation|5|||
33348651|NCT01018511|62725685|FG001|Overall Study|Protocol Violation|8|||
33348652|NCT01018511|62725686|FG002|Overall Study|Protocol Violation|7|||
33348653|NCT01018511|62725687|FG003|Overall Study|Protocol Violation|9|||
33348654|NCT01018511|62725684|FG000|Overall Study|Miscellaneous|0|||
33348655|NCT01018511|62725685|FG001|Overall Study|Miscellaneous|2|||
33348656|NCT01018511|62725686|FG002|Overall Study|Miscellaneous|0|||
33348657|NCT01018511|62725687|FG003|Overall Study|Miscellaneous|0|||
33348658|NCT00996476|62725708|FG000|Overall Study|Withdrawal by Subject|1|||
33348659|NCT00996476|62725709|FG001|Overall Study|Withdrawal by Subject|2|||
33348660|NCT00996476|62725710|FG002|Overall Study|Withdrawal by Subject|1|||
33348661|NCT00996476|62725711|FG003|Overall Study|Withdrawal by Subject|0|||
33348662|NCT00996476|62725712|FG004|Overall Study|Withdrawal by Subject|1|||
33348663|NCT00996476|62725708|FG000|Overall Study|Adverse Event|0|||
33470996|NCT02875366|62844661|FG001|Overall Study|Noncompliance|1|||
33470997|NCT00003102|62844670|FG000|Overall Study|Physician Decision|1|||
33470998|NCT00003102|62844671|FG001|Overall Study|Physician Decision|1|||
33470999|NCT00003102|62844672|FG002|Overall Study|Physician Decision|0|||
33471000|NCT00003102|62844670|FG000|Overall Study|Progressive Disease|0|||
33471001|NCT00003102|62844671|FG001|Overall Study|Progressive Disease|1|||
33471002|NCT00003102|62844672|FG002|Overall Study|Progressive Disease|0|||
33471003|NCT00003102|62844670|FG000|Overall Study|Adverse Event|0|||
33471004|NCT00003102|62844671|FG001|Overall Study|Adverse Event|1|||
33471005|NCT00003102|62844672|FG002|Overall Study|Adverse Event|1|||
33471006|NCT00003102|62844670|FG000|Overall Study|Death|0|||
33471007|NCT00003102|62844671|FG001|Overall Study|Death|0|||
33471008|NCT00003102|62844672|FG002|Overall Study|Death|1|||
33471009|NCT00002850|62844683|FG000|Overall Study|Death|4|||
33471010|NCT00002850|62844684|FG001|Overall Study|Death|1|||
33471011|NCT00002850|62844685|FG002|Overall Study|Death|3|||
33471012|NCT00002850|62844683|FG000|Overall Study|Protocol Violation|1|||
33471013|NCT00002850|62844684|FG001|Overall Study|Protocol Violation|0|||
33471014|NCT00002850|62844685|FG002|Overall Study|Protocol Violation|1|||
33471015|NCT00002850|62844683|FG000|Overall Study|Withdrawal by Subject|0|||
33471016|NCT00002850|62844684|FG001|Overall Study|Withdrawal by Subject|1|||
33471017|NCT00002850|62844685|FG002|Overall Study|Withdrawal by Subject|0|||
33471018|NCT00002766|62844695|FG000|Overall Study|Withdrawal by Subject|0|||
33471019|NCT00002766|62844696|FG001|Overall Study|Withdrawal by Subject|1|||
33471020|NCT00002766|62844695|FG000|Overall Study|Patient Not Treated|1|||
33471021|NCT00002766|62844696|FG001|Overall Study|Patient Not Treated|2|||
33471022|NCT00002766|62844695|FG000|Overall Study|Adverse Event|1|||
33348664|NCT00996476|62725709|FG001|Overall Study|Adverse Event|1|||
33348665|NCT00996476|62725710|FG002|Overall Study|Adverse Event|0|||
33348666|NCT00996476|62725711|FG003|Overall Study|Adverse Event|0|||
33348667|NCT00996476|62725712|FG004|Overall Study|Adverse Event|1|||
33348668|NCT02269267|62725729|FG000|Overall Study|Death|5|||
33348669|NCT01017731|62725733|FG000|Overall Study|Lost to Follow-up|2|||
33348670|NCT01017731|62725733|FG000|Overall Study|Withdrawal by Subject|3|||
33348671|NCT01017731|62725733|FG000|Overall Study|Physician Decision|2|||
33348672|NCT01017731|62725733|FG000|Overall Study|Adverse Event|1|||
33348673|NCT01035905|62725740|FG000|Overall Study|Lack of Efficacy|1|||
33348674|NCT01035905|62725741|FG001|Overall Study|Lack of Efficacy|1|||
33471023|NCT00002766|62844696|FG001|Overall Study|Adverse Event|1|||
33471024|NCT00002766|62844695|FG000|Overall Study|Protocol Violation|1|||
33471025|NCT00002766|62844696|FG001|Overall Study|Protocol Violation|0|||
33471026|NCT02306122|62844709|FG000|Initial Physician Randomization|Physician Decision|0|||
33471027|NCT02306122|62844710|FG001|Initial Physician Randomization|Physician Decision|0|||
33471028|NCT02306122|62844711|FG002|Initial Physician Randomization|Physician Decision|0|||
33471029|NCT02306122|62844712|FG003|Initial Physician Randomization|Physician Decision|0|||
33471030|NCT02306122|62844713|FG004|Initial Physician Randomization|Physician Decision|0|||
33471031|NCT02306122|62844714|FG005|Initial Physician Randomization|Physician Decision|0|||
33471032|NCT02306122|62844715|FG006|Initial Physician Randomization|Physician Decision|0|||
33471033|NCT02306122|62844716|FG007|Initial Physician Randomization|Physician Decision|0|||
33471034|NCT02306122|62844717|FG008|Initial Physician Randomization|Physician Decision|1|||
33471035|NCT02306122|62844718|FG009|Initial Physician Randomization|Physician Decision|0|||
33471036|NCT02306122|62844719|FG010|Initial Physician Randomization|Physician Decision|0|||
33471037|NCT00001962|62844737|FG000|Overall Study|Lack of Efficacy|18|||
33471038|NCT00001962|62844737|FG000|Overall Study|Lack of Accrual|6|||
33471039|NCT00001962|62844737|FG000|Overall Study|Death|1|||
33471040|NCT00001962|62844737|FG000|Overall Study|Lost to Follow-up|2|||
33471041|NCT00001962|62844737|FG000|Overall Study|Adverse Event|1|||
33471042|NCT00028002|62844741|FG000|Overall Study|Withdrawal by Subject|3|||
33471043|NCT00028002|62844741|FG000|Overall Study|Ineligible|8|||
33471044|NCT00256997|62844748|FG000|Overall Study|Protocol Violation|1|||
33471045|NCT00256997|62844749|FG001|Overall Study|Protocol Violation|4|||
33471046|NCT00256997|62844748|FG000|Overall Study|Lack of Efficacy|1|||
33471047|NCT00256997|62844749|FG001|Overall Study|Lack of Efficacy|4|||
33471048|NCT00256997|62844748|FG000|Overall Study|Death|2|||
33471049|NCT00256997|62844749|FG001|Overall Study|Death|0|||
33471050|NCT00256997|62844748|FG000|Overall Study|Adverse Event|4|||
33471051|NCT00256997|62844749|FG001|Overall Study|Adverse Event|0|||
33471052|NCT00256997|62844748|FG000|Overall Study|Lost to Follow-up|3|||
33471053|NCT00256997|62844749|FG001|Overall Study|Lost to Follow-up|5|||
33471054|NCT00256997|62844748|FG000|Overall Study|Withdrawal by Subject|13|||
33471055|NCT00256997|62844749|FG001|Overall Study|Withdrawal by Subject|3|||
33471056|NCT00256997|62844748|FG000|Overall Study|Started but not treated|2|||
33471057|NCT00256997|62844749|FG001|Overall Study|Started but not treated|0|||
33471058|NCT00256997|62844748|FG000|Overall Study|Other|5|||
33471059|NCT00256997|62844749|FG001|Overall Study|Other|8|||
33471060|NCT00256997|62844748|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
33471061|NCT00256997|62844749|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
33471062|NCT00256997|62844748|FG000|Overall Study|Participant Non-compliant|3|||
33471063|NCT00256997|62844749|FG001|Overall Study|Participant Non-compliant|6|||
33471064|NCT00256997|62844748|FG000|Overall Study|Investigator Withdrew Participant|2|||
33471065|NCT00256997|62844749|FG001|Overall Study|Investigator Withdrew Participant|1|||
33471066|NCT00027846|62844759|FG000|Overall Study|Lost to Follow-up|0|||
33471067|NCT00027846|62844760|FG001|Overall Study|Lost to Follow-up|41|||
33471068|NCT00027846|62844761|FG002|Overall Study|Lost to Follow-up|9|||
33471069|NCT00027846|62844759|FG000|Overall Study|Withdrawal by Subject|0|||
33471070|NCT00027846|62844760|FG001|Overall Study|Withdrawal by Subject|14|||
33471071|NCT00027846|62844761|FG002|Overall Study|Withdrawal by Subject|7|||
33471072|NCT00027846|62844759|FG000|Overall Study|Ineligible for study|2|||
33471073|NCT00027846|62844760|FG001|Overall Study|Ineligible for study|6|||
33471074|NCT00027846|62844761|FG002|Overall Study|Ineligible for study|14|||
33471075|NCT00027846|62844759|FG000|Overall Study|Entry into another COG therapeutic study|0|||
33471076|NCT00027846|62844760|FG001|Overall Study|Entry into another COG therapeutic study|5|||
33471077|NCT00027846|62844761|FG002|Overall Study|Entry into another COG therapeutic study|2|||
33471078|NCT00027846|62844759|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
33471079|NCT00027846|62844760|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
33471080|NCT00027846|62844761|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
33471081|NCT00027378|62844773|FG000|Overall Study|Physician Decision|0|||
33471082|NCT00027378|62844774|FG001|Overall Study|Physician Decision|3|||
33471083|NCT00235391|62844786|FG000|Overall Study|Adverse Event|4|||
33471084|NCT00235391|62844787|FG001|Overall Study|Adverse Event|5|||
33471085|NCT00235391|62844788|FG002|Overall Study|Adverse Event|10|||
33471086|NCT00235391|62844789|FG003|Overall Study|Adverse Event|72|||
33471087|NCT00235391|62844790|FG004|Overall Study|Adverse Event|5|||
33471088|NCT00235391|62844791|FG005|Overall Study|Adverse Event|2|||
33471089|NCT00235391|62844786|FG000|Overall Study|Abnormal laboratory value(s)|3|||
33471090|NCT00235391|62844787|FG001|Overall Study|Abnormal laboratory value(s)|5|||
33471091|NCT00235391|62844788|FG002|Overall Study|Abnormal laboratory value(s)|4|||
33471092|NCT00235391|62844789|FG003|Overall Study|Abnormal laboratory value(s)|27|||
33471093|NCT00235391|62844790|FG004|Overall Study|Abnormal laboratory value(s)|1|||
33471094|NCT00235391|62844791|FG005|Overall Study|Abnormal laboratory value(s)|2|||
33471095|NCT00235391|62844786|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33471096|NCT00235391|62844787|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33471097|NCT00235391|62844788|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
33471098|NCT00235391|62844789|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
33471099|NCT00235391|62844790|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
33471100|NCT00235391|62844791|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
33471101|NCT00235391|62844786|FG000|Overall Study|Condition no longer requires treatment|3|||
33471102|NCT00235391|62844787|FG001|Overall Study|Condition no longer requires treatment|0|||
33471103|NCT00235391|62844788|FG002|Overall Study|Condition no longer requires treatment|0|||
33471104|NCT00235391|62844789|FG003|Overall Study|Condition no longer requires treatment|11|||
33471105|NCT00235391|62844790|FG004|Overall Study|Condition no longer requires treatment|1|||
33471106|NCT00235391|62844791|FG005|Overall Study|Condition no longer requires treatment|0|||
33471107|NCT00235391|62844786|FG000|Overall Study|Protocol deviation|0|||
33471108|NCT00235391|62844787|FG001|Overall Study|Protocol deviation|0|||
33471109|NCT00235391|62844788|FG002|Overall Study|Protocol deviation|1|||
33471110|NCT00235391|62844789|FG003|Overall Study|Protocol deviation|11|||
33471111|NCT00235391|62844790|FG004|Overall Study|Protocol deviation|0|||
33471112|NCT00235391|62844791|FG005|Overall Study|Protocol deviation|0|||
33471113|NCT00235391|62844786|FG000|Overall Study|Withdrawal by Subject|2|||
33471114|NCT00235391|62844787|FG001|Overall Study|Withdrawal by Subject|3|||
33471115|NCT00235391|62844788|FG002|Overall Study|Withdrawal by Subject|3|||
33471116|NCT00235391|62844789|FG003|Overall Study|Withdrawal by Subject|61|||
33471117|NCT00235391|62844790|FG004|Overall Study|Withdrawal by Subject|5|||
33471118|NCT00235391|62844791|FG005|Overall Study|Withdrawal by Subject|0|||
33471119|NCT00235391|62844786|FG000|Overall Study|Lost to Follow-up|0|||
33471120|NCT00235391|62844787|FG001|Overall Study|Lost to Follow-up|3|||
33471121|NCT00235391|62844788|FG002|Overall Study|Lost to Follow-up|3|||
33471122|NCT00235391|62844789|FG003|Overall Study|Lost to Follow-up|16|||
33471123|NCT00235391|62844790|FG004|Overall Study|Lost to Follow-up|0|||
33471124|NCT00235391|62844791|FG005|Overall Study|Lost to Follow-up|0|||
33471125|NCT00235391|62844786|FG000|Overall Study|Administrative problems|0|||
33471126|NCT00235391|62844787|FG001|Overall Study|Administrative problems|0|||
33471127|NCT00235391|62844788|FG002|Overall Study|Administrative problems|0|||
33471128|NCT00235391|62844789|FG003|Overall Study|Administrative problems|1|||
33471129|NCT00235391|62844790|FG004|Overall Study|Administrative problems|0|||
33471130|NCT00235391|62844791|FG005|Overall Study|Administrative problems|0|||
33471131|NCT00235391|62844786|FG000|Overall Study|Death|0|||
33471132|NCT00235391|62844787|FG001|Overall Study|Death|0|||
33471133|NCT00235391|62844788|FG002|Overall Study|Death|1|||
33471134|NCT00235391|62844789|FG003|Overall Study|Death|4|||
33471135|NCT00235391|62844790|FG004|Overall Study|Death|0|||
33471136|NCT00235391|62844791|FG005|Overall Study|Death|0|||
33471137|NCT00234533|62844835|FG000|Overall Study|Withdrawal by Subject|6|||
33471138|NCT00234533|62844835|FG000|Overall Study|Adverse Event|2|||
33471139|NCT00234533|62844835|FG000|Overall Study|Enrolled but not treated|3|||
33471140|NCT00026208|62844842|FG000|Overall Study|Complications of auto accident|1|||
33471141|NCT00026208|62844843|FG001|Overall Study|Complications of auto accident|0|||
33471142|NCT00025662|62844849|FG000|Overall Study|Withdrawal by Subject|2|||
33471143|NCT00025662|62844849|FG000|Overall Study|Technical failure of manipulation|1|||
33471144|NCT00025506|62844853|FG000|Overall Study|Ineligible: clerical error|1|||
33471145|NCT00025506|62844853|FG000|Overall Study|Ineligible: wrong cell type|5|||
33471146|NCT00025506|62844853|FG000|Overall Study|Ineligible: inadequate pathology|2|||
33348675|NCT00779584|62725765|FG000|Overall Study|Protocol Violation|0|||
33348676|NCT00779584|62725766|FG001|Overall Study|Protocol Violation|0|||
33348677|NCT00779584|62725767|FG002|Overall Study|Protocol Violation|0|||
33348678|NCT00779584|62725768|FG003|Overall Study|Protocol Violation|0|||
33348679|NCT00779584|62725769|FG004|Overall Study|Protocol Violation|0|||
33348680|NCT00779584|62725770|FG005|Overall Study|Protocol Violation|1|||
33348681|NCT00779584|62725771|FG006|Overall Study|Protocol Violation|0|||
33348682|NCT00779584|62725772|FG007|Overall Study|Protocol Violation|0|||
33348683|NCT00779584|62725773|FG008|Overall Study|Protocol Violation|0|||
33348684|NCT00779584|62725765|FG000|Overall Study|Withdrawal by Subject|1|||
33348685|NCT00779584|62725766|FG001|Overall Study|Withdrawal by Subject|1|||
33348686|NCT00779584|62725767|FG002|Overall Study|Withdrawal by Subject|2|||
33348687|NCT00779584|62725768|FG003|Overall Study|Withdrawal by Subject|0|||
33348688|NCT00779584|62725769|FG004|Overall Study|Withdrawal by Subject|0|||
33348689|NCT00779584|62725770|FG005|Overall Study|Withdrawal by Subject|2|||
33348690|NCT00779584|62725771|FG006|Overall Study|Withdrawal by Subject|1|||
33348691|NCT00779584|62725772|FG007|Overall Study|Withdrawal by Subject|0|||
33471147|NCT00025506|62844853|FG000|Overall Study|Never Treated|2|||
33471148|NCT00024258|62844862|FG000|Overall Study|Withdrawal by Subject|1|||
33471149|NCT00024258|62844862|FG000|Overall Study|Disease Progression|8|||
33471150|NCT00023712|62844868|FG000|Overall Study|Not platinum sensitive|1|||
33471151|NCT00023712|62844869|FG001|Overall Study|Not platinum sensitive|0|||
33471152|NCT00023712|62844868|FG000|Overall Study|Never treated|1|||
33348692|NCT00779584|62725773|FG008|Overall Study|Withdrawal by Subject|0|||
33348693|NCT00779584|62725765|FG000|Overall Study|Lost to Follow-up|0|||
33348694|NCT00779584|62725766|FG001|Overall Study|Lost to Follow-up|0|||
33348695|NCT00779584|62725767|FG002|Overall Study|Lost to Follow-up|0|||
33348696|NCT00779584|62725768|FG003|Overall Study|Lost to Follow-up|0|||
33348697|NCT00779584|62725769|FG004|Overall Study|Lost to Follow-up|1|||
33348698|NCT00779584|62725770|FG005|Overall Study|Lost to Follow-up|0|||
33348699|NCT00779584|62725771|FG006|Overall Study|Lost to Follow-up|0|||
33471153|NCT00023712|62844869|FG001|Overall Study|Never treated|1|||
33471154|NCT00023322|62844885|FG000|Overall Study|Lost to Follow-up|1|||
33348700|NCT00779584|62725772|FG007|Overall Study|Lost to Follow-up|0|||
33348701|NCT00779584|62725773|FG008|Overall Study|Lost to Follow-up|0|||
33348702|NCT00779584|62725765|FG000|Overall Study|Progression of Disease|0|||
33348703|NCT00779584|62725766|FG001|Overall Study|Progression of Disease|1|||
33348704|NCT00779584|62725767|FG002|Overall Study|Progression of Disease|2|||
33348705|NCT00779584|62725768|FG003|Overall Study|Progression of Disease|6|||
33348706|NCT00779584|62725769|FG004|Overall Study|Progression of Disease|5|||
33348707|NCT00779584|62725770|FG005|Overall Study|Progression of Disease|1|||
33348708|NCT00779584|62725771|FG006|Overall Study|Progression of Disease|4|||
33348709|NCT00779584|62725772|FG007|Overall Study|Progression of Disease|2|||
33348710|NCT00779584|62725773|FG008|Overall Study|Progression of Disease|1|||
33348711|NCT00779584|62725765|FG000|Overall Study|Adverse Event|1|||
33348712|NCT00779584|62725766|FG001|Overall Study|Adverse Event|0|||
33348713|NCT00779584|62725767|FG002|Overall Study|Adverse Event|2|||
33348714|NCT00779584|62725768|FG003|Overall Study|Adverse Event|0|||
33348715|NCT00779584|62725769|FG004|Overall Study|Adverse Event|0|||
33348716|NCT00779584|62725770|FG005|Overall Study|Adverse Event|0|||
33348717|NCT00779584|62725771|FG006|Overall Study|Adverse Event|2|||
33348718|NCT00779584|62725772|FG007|Overall Study|Adverse Event|1|||
33348719|NCT00779584|62725773|FG008|Overall Study|Adverse Event|1|||
33348720|NCT00779584|62725765|FG000|Overall Study|Symptomatic Deterioration|1|||
33348721|NCT00779584|62725766|FG001|Overall Study|Symptomatic Deterioration|1|||
33348722|NCT00779584|62725767|FG002|Overall Study|Symptomatic Deterioration|1|||
33348723|NCT00779584|62725768|FG003|Overall Study|Symptomatic Deterioration|0|||
33348724|NCT00779584|62725769|FG004|Overall Study|Symptomatic Deterioration|0|||
33348725|NCT00779584|62725770|FG005|Overall Study|Symptomatic Deterioration|1|||
33348726|NCT00779584|62725771|FG006|Overall Study|Symptomatic Deterioration|1|||
33348727|NCT00779584|62725772|FG007|Overall Study|Symptomatic Deterioration|0|||
33348728|NCT00779584|62725773|FG008|Overall Study|Symptomatic Deterioration|0|||
33348729|NCT00779584|62725765|FG000|Overall Study|Ongoing in Study|0|||
33348730|NCT00779584|62725766|FG001|Overall Study|Ongoing in Study|0|||
33348731|NCT00779584|62725767|FG002|Overall Study|Ongoing in Study|0|||
33348732|NCT00779584|62725768|FG003|Overall Study|Ongoing in Study|0|||
33348733|NCT00779584|62725769|FG004|Overall Study|Ongoing in Study|1|||
33348734|NCT00779584|62725770|FG005|Overall Study|Ongoing in Study|1|||
33348735|NCT00779584|62725771|FG006|Overall Study|Ongoing in Study|0|||
33348736|NCT00779584|62725772|FG007|Overall Study|Ongoing in Study|0|||
33348737|NCT00779584|62725773|FG008|Overall Study|Ongoing in Study|0|||
33348738|NCT00995930|62725795|FG000|Overall Study|Protocol deviation|2|||
33348739|NCT00995930|62725796|FG001|Overall Study|Protocol deviation|5|||
33348740|NCT00995930|62725795|FG000|Overall Study|Death|0|||
33348741|NCT00995930|62725796|FG001|Overall Study|Death|1|||
33348742|NCT00995930|62725795|FG000|Overall Study|Administrative problems|4|||
33348743|NCT00995930|62725796|FG001|Overall Study|Administrative problems|2|||
33348744|NCT00995930|62725795|FG000|Overall Study|Lost to Follow-up|1|||
33348745|NCT00995930|62725796|FG001|Overall Study|Lost to Follow-up|2|||
33348746|NCT00995930|62725795|FG000|Overall Study|Withdrawal by Subject|3|||
33348747|NCT00995930|62725796|FG001|Overall Study|Withdrawal by Subject|4|||
33348748|NCT00995930|62725795|FG000|Overall Study|Adverse Event|11|||
33348749|NCT00995930|62725796|FG001|Overall Study|Adverse Event|14|||
33348750|NCT00779506|62725803|FG000|Overall Study|Screening Failed|2|||
33348751|NCT00779506|62725803|FG000|Overall Study|Adverse Event|4|||
33348752|NCT00779506|62725803|FG000|Overall Study|Lack of Efficacy|11|||
33348753|NCT00779506|62725803|FG000|Overall Study|Protocol Violation|5|||
33654951|NCT01899053|63068987|FG007|Overall Study|Progressive Disease|1|||
33654952|NCT01899053|63068988|FG008|Overall Study|Progressive Disease|4|||
33654953|NCT01899053|63068989|FG009|Overall Study|Progressive Disease|3|||
33654954|NCT01899053|63068990|FG010|Overall Study|Progressive Disease|12|||
33654955|NCT01899053|63068991|FG011|Overall Study|Progressive Disease|5|||
33654956|NCT01899053|63068992|FG012|Overall Study|Progressive Disease|8|||
33654957|NCT01899053|63068993|FG013|Overall Study|Progressive Disease|17|||
33654958|NCT01899053|63068980|FG000|Overall Study|Adverse Event|1|||
33654959|NCT01899053|63068981|FG001|Overall Study|Adverse Event|1|||
33348754|NCT00779506|62725803|FG000|Overall Study|Withdrawal by Subject|6|||
33654960|NCT01899053|63068982|FG002|Overall Study|Adverse Event|1|||
33654961|NCT01899053|63068983|FG003|Overall Study|Adverse Event|3|||
33348755|NCT00779506|62725803|FG000|Overall Study|Lost to Follow-up|1|||
33348756|NCT00995774|62725809|FG000|Training Period 2|Withdrawal by Subject|2|||
33348757|NCT00995774|62725810|FG001|Training Period 2|Withdrawal by Subject|0|||
33348758|NCT00765388|62725816|FG000|Period 1|Lack of Efficacy|1|||
33348759|NCT00765388|62725817|FG001|Period 1|Lack of Efficacy|2|||
33348760|NCT00765388|62725816|FG000|Period 1|Lost to Follow-up|0|||
33654962|NCT01899053|63068984|FG004|Overall Study|Adverse Event|1|||
33654963|NCT01899053|63068985|FG005|Overall Study|Adverse Event|1|||
33348761|NCT00765388|62725817|FG001|Period 1|Lost to Follow-up|1|||
33348762|NCT00765388|62725816|FG000|Period 1|Herpes Zoster|0|||
33348763|NCT00765388|62725817|FG001|Period 1|Herpes Zoster|1|||
33348764|NCT00765388|62725816|FG000|Period 1|Hip operation|0|||
33654964|NCT01899053|63068986|FG006|Overall Study|Adverse Event|1|||
33654965|NCT01899053|63068987|FG007|Overall Study|Adverse Event|0|||
33654966|NCT01899053|63068988|FG008|Overall Study|Adverse Event|2|||
33654967|NCT01899053|63068989|FG009|Overall Study|Adverse Event|0|||
33654968|NCT01899053|63068990|FG010|Overall Study|Adverse Event|3|||
33654969|NCT01899053|63068991|FG011|Overall Study|Adverse Event|1|||
33654970|NCT01899053|63068992|FG012|Overall Study|Adverse Event|2|||
33654971|NCT01899053|63068993|FG013|Overall Study|Adverse Event|2|||
33654972|NCT01899053|63068980|FG000|Overall Study|Reason Not Specified|0|||
33654973|NCT01899053|63068981|FG001|Overall Study|Reason Not Specified|0|||
33348765|NCT00765388|62725817|FG001|Period 1|Hip operation|1|||
33348766|NCT00769132|62725832|FG000|Period 1|Adverse Event|1|||
33348767|NCT00769132|62725833|FG001|Period 1|Adverse Event|0|||
33348768|NCT00769132|62725834|FG002|Period 1|Adverse Event|0|||
33348769|NCT00769132|62725835|FG003|Period 1|Adverse Event|1|||
33348770|NCT00769132|62725832|FG000|Period 2|Withdrawal by Subject|0|||
33348771|NCT00769132|62725833|FG001|Period 2|Withdrawal by Subject|0|||
33348772|NCT00769132|62725834|FG002|Period 2|Withdrawal by Subject|0|||
33348773|NCT00769132|62725835|FG003|Period 2|Withdrawal by Subject|1|||
33348774|NCT00769132|62725832|FG000|Period 3|Withdrawal by Subject|1|||
33348775|NCT00769132|62725833|FG001|Period 3|Withdrawal by Subject|0|||
33348776|NCT00769132|62725834|FG002|Period 3|Withdrawal by Subject|0|||
33348777|NCT00769132|62725835|FG003|Period 3|Withdrawal by Subject|0|||
33348778|NCT00769132|62725832|FG000|Period 4|Withdrawal by Subject|0|||
33348779|NCT00769132|62725833|FG001|Period 4|Withdrawal by Subject|1|||
33348780|NCT00769132|62725834|FG002|Period 4|Withdrawal by Subject|0|||
33348781|NCT00769132|62725835|FG003|Period 4|Withdrawal by Subject|0|||
33348782|NCT00991952|62725847|FG000|Overall Study|Adverse Event|0|||
33348783|NCT00991952|62725848|FG001|Overall Study|Adverse Event|1|||
33348784|NCT00779038|62725854|FG000|Overall Study|Study Prematurely Terminated|13|||
33348785|NCT00765076|62725861|FG000|Overall Study|Adverse Event|1|||
33348786|NCT00765076|62725862|FG001|Overall Study|Adverse Event|0|||
33348787|NCT00765076|62725863|FG002|Overall Study|Adverse Event|0|||
33348788|NCT00765076|62725861|FG000|Overall Study|Withdrawal by Subject|0|||
33348789|NCT00765076|62725862|FG001|Overall Study|Withdrawal by Subject|0|||
33348790|NCT00765076|62725863|FG002|Overall Study|Withdrawal by Subject|1|||
33348791|NCT00994682|62725873|FG000|Double Bilnd|Withdrawal by Subject|5|||
33348792|NCT00994682|62725874|FG001|Double Bilnd|Withdrawal by Subject|6|||
33348793|NCT00994682|62725873|FG000|Double Bilnd|Lost to Follow-up|3|||
33348794|NCT00994682|62725874|FG001|Double Bilnd|Lost to Follow-up|3|||
33348795|NCT00994682|62725873|FG000|Double Bilnd|Adverse Event|1|||
33348796|NCT00994682|62725874|FG001|Double Bilnd|Adverse Event|0|||
33348797|NCT00994682|62725873|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
33348798|NCT00994682|62725874|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
33348799|NCT00994682|62725873|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
33348800|NCT00994682|62725874|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
33348801|NCT00994682|62725873|FG000|Pioglitazone Open Label|Physician Decision|6|||
33348802|NCT00994682|62725874|FG001|Pioglitazone Open Label|Physician Decision|1|||
33471155|NCT04640168|62844891|FG000|Overall Study|Withdrawal by Subject|8|||
33471156|NCT04640168|62844892|FG001|Overall Study|Withdrawal by Subject|7|||
33471157|NCT04640168|62844891|FG000|Overall Study|Lost to Follow-up|1|||
33471158|NCT04640168|62844892|FG001|Overall Study|Lost to Follow-up|0|||
33348803|NCT00768898|62725884|FG000|Overall Study|Unrelated injury|1|||
33471159|NCT04640168|62844891|FG000|Overall Study|Enrolled but not treated|12|||
33471160|NCT04640168|62844892|FG001|Overall Study|Enrolled but not treated|12|||
33471161|NCT00022698|62844900|FG000|Overall Study|Adverse Event|5|||
33471162|NCT00022698|62844901|FG001|Overall Study|Adverse Event|9|||
33471163|NCT00022698|62844900|FG000|Overall Study|Death|0|||
33471164|NCT00022698|62844901|FG001|Overall Study|Death|2|||
33471165|NCT00022698|62844900|FG000|Overall Study|Failure to return|0|||
33471166|NCT00022698|62844901|FG001|Overall Study|Failure to return|1|||
33471167|NCT00022698|62844900|FG000|Overall Study|Refused treatment|0|||
33348804|NCT00768898|62725884|FG000|Overall Study|Headache|1|||
33348805|NCT00994448|62725895|FG000|Overall Study|Adverse Event|1|||
33348806|NCT00994448|62725896|FG001|Overall Study|Adverse Event|0|||
33348807|NCT00994448|62725895|FG000|Overall Study|Lost to Follow-up|5|||
33348808|NCT00994448|62725896|FG001|Overall Study|Lost to Follow-up|1|||
33348809|NCT00994448|62725895|FG000|Overall Study|Withdrawal by Subject|1|||
33348810|NCT00994448|62725896|FG001|Overall Study|Withdrawal by Subject|1|||
33348811|NCT00994448|62725895|FG000|Overall Study|Physician Decision|1|||
33348812|NCT00994448|62725896|FG001|Overall Study|Physician Decision|0|||
33348813|NCT00991406|62725902|FG000|Overall Study|One participant did not respond to FES.|1|||
33348814|NCT01017575|62725911|FG000|Overall Study|Lack of Efficacy|0|||
33471168|NCT00022698|62844901|FG001|Overall Study|Refused treatment|2|||
33471169|NCT00022698|62844900|FG000|Overall Study|Insufficient therapeutic response|2|||
33471170|NCT00022698|62844901|FG001|Overall Study|Insufficient therapeutic response|14|||
33654974|NCT01899053|63068982|FG002|Overall Study|Reason Not Specified|0|||
33654975|NCT01899053|63068983|FG003|Overall Study|Reason Not Specified|0|||
33654976|NCT01899053|63068984|FG004|Overall Study|Reason Not Specified|0|||
33348815|NCT01017575|62725912|FG001|Overall Study|Lack of Efficacy|1|||
33348816|NCT01017575|62725913|FG002|Overall Study|Lack of Efficacy|0|||
33348817|NCT01017575|62725914|FG003|Overall Study|Lack of Efficacy|1|||
33348818|NCT01017575|62725915|FG004|Overall Study|Lack of Efficacy|1|||
33348819|NCT01017575|62725911|FG000|Overall Study|Adverse Event|0|||
33348820|NCT01017575|62725912|FG001|Overall Study|Adverse Event|1|||
33348821|NCT01017575|62725913|FG002|Overall Study|Adverse Event|0|||
33348822|NCT01017575|62725914|FG003|Overall Study|Adverse Event|0|||
33348823|NCT01017575|62725915|FG004|Overall Study|Adverse Event|2|||
33348824|NCT01017575|62725911|FG000|Overall Study|Withdrawal by Subject|1|||
33348825|NCT01017575|62725912|FG001|Overall Study|Withdrawal by Subject|0|||
33348826|NCT01017575|62725913|FG002|Overall Study|Withdrawal by Subject|0|||
33471171|NCT00022698|62844900|FG000|Overall Study|Administrative /other|1|||
33471172|NCT00022698|62844901|FG001|Overall Study|Administrative /other|7|||
33348827|NCT01017575|62725914|FG003|Overall Study|Withdrawal by Subject|0|||
33348828|NCT01017575|62725915|FG004|Overall Study|Withdrawal by Subject|0|||
33348829|NCT01017263|62725927|FG000|Overall Study|not eligible|12|||
33348830|NCT00768664|62725931|FG000|Overall Study|Death|57|||
33348831|NCT00768664|62725931|FG000|Overall Study|Lost to Follow-up|2|||
33348832|NCT00768664|62725931|FG000|Overall Study|Other|9|||
33348833|NCT00768664|62725931|FG000|Overall Study|Participant refused|1|||
33348834|NCT00778336|62725939|FG000|Index Procedure-Discharge|Death|6|||
33348835|NCT00778336|62725940|FG001|Index Procedure-Discharge|Death|3|||
33348836|NCT00778336|62725941|FG002|Index Procedure-Discharge|Death|2|||
33348837|NCT00778336|62725942|FG003|Index Procedure-Discharge|Death|0|||
33348838|NCT00778336|62725939|FG000|3 Month Follow Up|Lost to Follow-up|15|||
33348839|NCT00778336|62725940|FG001|3 Month Follow Up|Lost to Follow-up|20|||
33348840|NCT00778336|62725941|FG002|3 Month Follow Up|Lost to Follow-up|3|||
33348841|NCT00778336|62725942|FG003|3 Month Follow Up|Lost to Follow-up|0|||
33348842|NCT00778336|62725939|FG000|3 Month Follow Up|Death|8|||
33348843|NCT00778336|62725940|FG001|3 Month Follow Up|Death|3|||
33348844|NCT00778336|62725941|FG002|3 Month Follow Up|Death|2|||
33348845|NCT00778336|62725942|FG003|3 Month Follow Up|Death|0|||
33348846|NCT01253161|62725952|FG000|Overall Study|Adverse Event|1|||
33348847|NCT00581113|62725958|FG000|Overall Study|Withdrawal by Subject|0|||
33348848|NCT00581113|62725959|FG001|Overall Study|Withdrawal by Subject|1|||
33348849|NCT01016015|62725965|FG000|Overall Study|Not Treated|3|||
33348850|NCT01016015|62725965|FG000|Overall Study|Withdrawal by Subject|1|||
33348851|NCT01016015|62725965|FG000|Overall Study|Adverse Event|15|||
33348852|NCT01015703|62725974|FG000|Overall Study|Withdrawal by Subject|0|||
33348853|NCT01015703|62725975|FG001|Overall Study|Withdrawal by Subject|1|||
33348854|NCT01015703|62725976|FG002|Overall Study|Withdrawal by Subject|0|||
33348855|NCT01015703|62725977|FG003|Overall Study|Withdrawal by Subject|0|||
33348856|NCT01015703|62725978|FG004|Overall Study|Withdrawal by Subject|0|||
33348857|NCT01015703|62725974|FG000|Overall Study|Adverse Event|1|||
33348858|NCT01015703|62725975|FG001|Overall Study|Adverse Event|0|||
33348859|NCT01015703|62725976|FG002|Overall Study|Adverse Event|0|||
33348860|NCT01015703|62725977|FG003|Overall Study|Adverse Event|0|||
33348861|NCT01015703|62725978|FG004|Overall Study|Adverse Event|0|||
33348862|NCT01015703|62725974|FG000|Overall Study|Protocol Violation|1|||
33348863|NCT01015703|62725975|FG001|Overall Study|Protocol Violation|0|||
33348864|NCT01015703|62725976|FG002|Overall Study|Protocol Violation|0|||
33348865|NCT01015703|62725977|FG003|Overall Study|Protocol Violation|0|||
33348866|NCT01015703|62725978|FG004|Overall Study|Protocol Violation|0|||
33348867|NCT04439071|62725992|FG000|Overall Study|Lost to Follow-up|0|||
33348868|NCT04439071|62725993|FG001|Overall Study|Lost to Follow-up|3|||
33348869|NCT04439071|62725992|FG000|Overall Study|Withdrawal by Subject|3|||
33348870|NCT04439071|62725993|FG001|Overall Study|Withdrawal by Subject|8|||
33348871|NCT04439071|62725992|FG000|Overall Study|Death|6|||
33348872|NCT04439071|62725993|FG001|Overall Study|Death|4|||
33471173|NCT04625972|62844911|FG000|Overall Study|Physician Decision|1|||
33471174|NCT04625972|62844912|FG001|Overall Study|Physician Decision|0|||
33471175|NCT04625972|62844911|FG000|Overall Study|Protocol Violation|0|||
33471176|NCT04625972|62844912|FG001|Overall Study|Protocol Violation|1|||
33348873|NCT04439071|62725992|FG000|Overall Study|Other than specified|3|||
33348874|NCT04439071|62725993|FG001|Overall Study|Other than specified|3|||
33348875|NCT04439071|62725992|FG000|Overall Study|Randomized but not treated|2|||
33348876|NCT04439071|62725993|FG001|Overall Study|Randomized but not treated|0|||
33348877|NCT01017029|62726001|FG000|Overall Study|Lost to Follow-up|1|||
33348878|NCT01017029|62726002|FG001|Overall Study|Lost to Follow-up|0|||
33348879|NCT01017029|62726001|FG000|Overall Study|Administrative problem|0|||
33471177|NCT04625972|62844911|FG000|Overall Study|Ongoing in Study|741|||
33348880|NCT01017029|62726002|FG001|Overall Study|Administrative problem|1|||
33348881|NCT01017029|62726001|FG000|Overall Study|Death|3|||
33348882|NCT01017029|62726002|FG001|Overall Study|Death|1|||
33348883|NCT00994214|62726012|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
33348884|NCT00994214|62726013|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
33348885|NCT00994214|62726014|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
33348886|NCT00994214|62726015|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
33348887|NCT00994214|62726012|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
33348888|NCT00994214|62726013|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
33348889|NCT00994214|62726014|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
33348890|NCT00994214|62726015|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
33348891|NCT00994214|62726012|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
33348892|NCT00994214|62726013|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
33348893|NCT00994214|62726014|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
33348894|NCT00994214|62726015|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
33348895|NCT00994214|62726012|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
33348896|NCT00994214|62726013|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
33348897|NCT00994214|62726014|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
33348898|NCT00994214|62726015|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
33348899|NCT00994214|62726012|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
33348900|NCT00994214|62726013|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
33348901|NCT00994214|62726014|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
33348902|NCT00994214|62726015|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
33348903|NCT00994214|62726012|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
33348904|NCT00994214|62726013|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
33348905|NCT00994214|62726014|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
33348906|NCT00994214|62726015|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
33348907|NCT01034657|62726043|FG000|Core Phase|Withdrawal by Subject|1|||
33348908|NCT01034657|62726044|FG001|Core Phase|Withdrawal by Subject|0|||
33348909|NCT01034657|62726045|FG002|Core Phase|Withdrawal by Subject|0|||
33348910|NCT01034657|62726043|FG000|Core Phase|Lack of Efficacy|2|||
33348911|NCT01034657|62726044|FG001|Core Phase|Lack of Efficacy|0|||
33348912|NCT01034657|62726045|FG002|Core Phase|Lack of Efficacy|0|||
33471178|NCT04625972|62844912|FG001|Overall Study|Ongoing in Study|369|||
33471179|NCT04625972|62844911|FG000|Overall Study|Lost to Follow-up|2|||
33471180|NCT04625972|62844912|FG001|Overall Study|Lost to Follow-up|0|||
33471181|NCT04625972|62844911|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|5|||
33471182|NCT04625972|62844912|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|2|||
33471183|NCT04625972|62844911|FG000|Overall Study|Withdrawal by Subject|7|||
33348913|NCT01034657|62726043|FG000|Core Phase|Abnormal laboratory value|1|||
33348914|NCT01034657|62726044|FG001|Core Phase|Abnormal laboratory value|0|||
33348915|NCT01034657|62726045|FG002|Core Phase|Abnormal laboratory value|0|||
33348916|NCT01034657|62726043|FG000|Core Phase|Adverse Event|8|||
33348917|NCT01034657|62726044|FG001|Core Phase|Adverse Event|0|||
33348918|NCT01034657|62726045|FG002|Core Phase|Adverse Event|0|||
33348919|NCT01034657|62726043|FG000|Core Phase|Protocol Violation|2|||
33348920|NCT01034657|62726044|FG001|Core Phase|Protocol Violation|0|||
33348921|NCT01034657|62726045|FG002|Core Phase|Protocol Violation|0|||
33348922|NCT01034657|62726043|FG000|Randomized Phase|Withdrawal by Subject|0|||
33348923|NCT01034657|62726044|FG001|Randomized Phase|Withdrawal by Subject|2|||
33348924|NCT01034657|62726045|FG002|Randomized Phase|Withdrawal by Subject|0|||
33348925|NCT01034657|62726043|FG000|Randomized Phase|Lack of Efficacy|5|||
33348926|NCT01034657|62726044|FG001|Randomized Phase|Lack of Efficacy|1|||
33348927|NCT01034657|62726045|FG002|Randomized Phase|Lack of Efficacy|0|||
33348928|NCT01034657|62726043|FG000|Randomized Phase|Abnormal laboratory value|0|||
33348929|NCT01034657|62726044|FG001|Randomized Phase|Abnormal laboratory value|1|||
33348930|NCT01034657|62726045|FG002|Randomized Phase|Abnormal laboratory value|0|||
33348931|NCT01034657|62726043|FG000|Randomized Phase|Adverse Event|0|||
33348932|NCT01034657|62726044|FG001|Randomized Phase|Adverse Event|2|||
33348933|NCT01034657|62726045|FG002|Randomized Phase|Adverse Event|1|||
33348934|NCT01014767|62726059|FG000|Overall Study|PI left institution, data unavailable|12|||
33348935|NCT01014767|62726060|FG001|Overall Study|PI left institution, data unavailable|1|||
33348936|NCT01014767|62726061|FG002|Overall Study|PI left institution, data unavailable|4|||
33348937|NCT01014767|62726062|FG003|Overall Study|PI left institution, data unavailable|1|||
33348938|NCT02016781|62726074|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
33348939|NCT02016781|62726075|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
33348940|NCT02016781|62726074|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
33348941|NCT02016781|62726075|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
33348942|NCT02016781|62726074|FG000|Final Database Lock|Withdrawal by Subject|2|||
33471184|NCT04625972|62844912|FG001|Overall Study|Withdrawal by Subject|3|||
33471185|NCT00234065|62844920|FG000|Overall Study|Adverse Event|268|||
33471186|NCT00234065|62844921|FG001|Overall Study|Adverse Event|166|||
33348943|NCT02016781|62726075|FG001|Final Database Lock|Withdrawal by Subject|1|||
33348944|NCT02016781|62726074|FG000|Final Database Lock|Lost to Follow-up|11|||
33471187|NCT00234065|62844920|FG000|Overall Study|Withdrawal by Subject|73|||
33471188|NCT00234065|62844921|FG001|Overall Study|Withdrawal by Subject|56|||
33348945|NCT02016781|62726075|FG001|Final Database Lock|Lost to Follow-up|4|||
33348946|NCT02016781|62726074|FG000|Final Database Lock|Missing data|0|||
33348947|NCT02016781|62726075|FG001|Final Database Lock|Missing data|3|||
33348948|NCT01014689|62726083|FG000|Overall Study|Lack of Efficacy|0|||
33348949|NCT01014689|62726084|FG001|Overall Study|Lack of Efficacy|1|||
33348950|NCT01014689|62726083|FG000|Overall Study|Adverse Event|3|||
33348951|NCT01014689|62726084|FG001|Overall Study|Adverse Event|0|||
33348952|NCT01014689|62726083|FG000|Overall Study|Withdrawal by Subject|5|||
33348953|NCT01014689|62726084|FG001|Overall Study|Withdrawal by Subject|4|||
33348954|NCT01014689|62726083|FG000|Overall Study|Protocol Violation|1|||
33348955|NCT01014689|62726084|FG001|Overall Study|Protocol Violation|1|||
33348956|NCT01014689|62726083|FG000|Overall Study|Lost to Follow-up|3|||
33348957|NCT01014689|62726084|FG001|Overall Study|Lost to Follow-up|7|||
33348958|NCT01014689|62726083|FG000|Overall Study|Pregnancy|1|||
33348959|NCT01014689|62726084|FG001|Overall Study|Pregnancy|0|||
33348960|NCT01014533|62726092|FG000|Overall Study|Protocol Violation|3|||
33348961|NCT01014533|62726093|FG001|Overall Study|Protocol Violation|2|||
33348962|NCT01014533|62726092|FG000|Overall Study|Withdrawal by Subject|2|||
33348963|NCT01014533|62726093|FG001|Overall Study|Withdrawal by Subject|0|||
33348964|NCT01014533|62726092|FG000|Overall Study|unable to come to appointment|0|||
33348965|NCT01014533|62726093|FG001|Overall Study|unable to come to appointment|3|||
33348966|NCT01014143|62726116|FG000|Second Intervention|Lost to Follow-up|2|||
33348967|NCT01014143|62726117|FG001|Second Intervention|Lost to Follow-up|0|||
33348968|NCT01014143|62726118|FG002|Second Intervention|Lost to Follow-up|0|||
33348969|NCT01013753|62726126|FG000|Overall Study|Adverse Event|8|||
33348970|NCT01013753|62726126|FG000|Overall Study|Protocol Violation|3|||
33348971|NCT01013753|62726126|FG000|Overall Study|Lost to Follow-up|1|||
33348972|NCT01013753|62726126|FG000|Overall Study|Withdrawal by Subject|2|||
33348973|NCT01013753|62726126|FG000|Overall Study|Other|2|||
33348974|NCT00757042|62726151|FG000|Overall Study|Lost to Follow-up|0|||
33348975|NCT00757042|62726152|FG001|Overall Study|Lost to Follow-up|0|||
33348976|NCT00757042|62726153|FG002|Overall Study|Lost to Follow-up|0|||
33348977|NCT00757042|62726154|FG003|Overall Study|Lost to Follow-up|0|||
33348978|NCT00757042|62726155|FG004|Overall Study|Lost to Follow-up|0|||
33348979|NCT00757042|62726156|FG005|Overall Study|Lost to Follow-up|0|||
33348980|NCT00757042|62726157|FG006|Overall Study|Lost to Follow-up|0|||
33348981|NCT00757042|62726158|FG007|Overall Study|Lost to Follow-up|0|||
33348982|NCT00757042|62726159|FG008|Overall Study|Lost to Follow-up|1|||
33348983|NCT00757042|62726160|FG009|Overall Study|Lost to Follow-up|0|||
33348984|NCT00757042|62726161|FG010|Overall Study|Lost to Follow-up|0|||
33348985|NCT00757042|62726151|FG000|Overall Study|Ineligibility Determined|0|||
33348986|NCT00757042|62726152|FG001|Overall Study|Ineligibility Determined|0|||
33348987|NCT00757042|62726153|FG002|Overall Study|Ineligibility Determined|0|||
33348988|NCT00757042|62726154|FG003|Overall Study|Ineligibility Determined|0|||
33348989|NCT00757042|62726155|FG004|Overall Study|Ineligibility Determined|0|||
33348990|NCT00757042|62726156|FG005|Overall Study|Ineligibility Determined|0|||
33348991|NCT00757042|62726157|FG006|Overall Study|Ineligibility Determined|0|||
33348992|NCT00757042|62726158|FG007|Overall Study|Ineligibility Determined|0|||
33348993|NCT00757042|62726159|FG008|Overall Study|Ineligibility Determined|0|||
33348994|NCT00757042|62726160|FG009|Overall Study|Ineligibility Determined|0|||
33348995|NCT00757042|62726161|FG010|Overall Study|Ineligibility Determined|1|||
33348996|NCT00757042|62726151|FG000|Overall Study|Withdrawal by Subject|0|||
33348997|NCT00757042|62726152|FG001|Overall Study|Withdrawal by Subject|0|||
33348998|NCT00757042|62726153|FG002|Overall Study|Withdrawal by Subject|0|||
33348999|NCT00757042|62726154|FG003|Overall Study|Withdrawal by Subject|0|||
33349000|NCT00757042|62726155|FG004|Overall Study|Withdrawal by Subject|0|||
33349001|NCT00757042|62726156|FG005|Overall Study|Withdrawal by Subject|0|||
33349002|NCT00757042|62726157|FG006|Overall Study|Withdrawal by Subject|0|||
33349003|NCT00757042|62726158|FG007|Overall Study|Withdrawal by Subject|0|||
33349004|NCT00757042|62726159|FG008|Overall Study|Withdrawal by Subject|0|||
33349005|NCT00757042|62726160|FG009|Overall Study|Withdrawal by Subject|1|||
33349006|NCT00757042|62726161|FG010|Overall Study|Withdrawal by Subject|0|||
33349007|NCT01013597|62726192|FG000|Overall Study|Withdrawal by Subject|1|||
33349008|NCT01013285|62726211|FG000|Overall Study|Death|48|||
33349009|NCT01013285|62726212|FG001|Overall Study|Death|89|||
33349010|NCT01033643|62726222|FG000|Overall Study|Withdrew Consent|0|||
33349011|NCT01033643|62726223|FG001|Overall Study|Withdrew Consent|3|||
33349012|NCT01033643|62726224|FG002|Overall Study|Withdrew Consent|0|||
33349013|NCT01033643|62726225|FG003|Overall Study|Withdrew Consent|0|||
33349014|NCT01033643|62726226|FG004|Overall Study|Withdrew Consent|0|||
33349015|NCT01033643|62726227|FG005|Overall Study|Withdrew Consent|1|||
33349016|NCT01013207|62726241|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
33349017|NCT01033487|62726245|FG000|Fourth Intervention Period|Adverse Event|0|||
33349018|NCT01033487|62726246|FG001|Fourth Intervention Period|Adverse Event|0|||
33349019|NCT01033487|62726247|FG002|Fourth Intervention Period|Adverse Event|0|||
33349020|NCT01033487|62726248|FG003|Fourth Intervention Period|Adverse Event|0|||
33349021|NCT01033487|62726249|FG004|Fourth Intervention Period|Adverse Event|0|||
33349022|NCT01033487|62726250|FG005|Fourth Intervention Period|Adverse Event|0|||
33349023|NCT01033487|62726251|FG006|Fourth Intervention Period|Adverse Event|0|||
33349024|NCT01033487|62726252|FG007|Fourth Intervention Period|Adverse Event|0|||
33349025|NCT01033487|62726253|FG008|Fourth Intervention Period|Adverse Event|1|||
33349026|NCT01033487|62726254|FG009|Fourth Intervention Period|Adverse Event|0|||
33349027|NCT01033019|62726270|FG000|Overall Study|Withdrawal by Subject|1|||
33349028|NCT01033019|62726271|FG001|Overall Study|Withdrawal by Subject|0|||
33349029|NCT00603447|62726285|FG000|Overall Study|Adverse Event|0|||
33349030|NCT00603447|62726286|FG001|Overall Study|Adverse Event|1|||
33349031|NCT00603447|62726287|FG002|Overall Study|Adverse Event|1|||
33349032|NCT00603447|62726288|FG003|Overall Study|Adverse Event|2|||
33349033|NCT00603447|62726289|FG004|Overall Study|Adverse Event|1|||
33349034|NCT00603447|62726290|FG005|Overall Study|Adverse Event|2|||
33349035|NCT00603447|62726291|FG006|Overall Study|Adverse Event|10|||
33349036|NCT00603447|62726285|FG000|Overall Study|Other|0|||
33349037|NCT00603447|62726286|FG001|Overall Study|Other|0|||
33349038|NCT00603447|62726287|FG002|Overall Study|Other|1|||
33349039|NCT00603447|62726288|FG003|Overall Study|Other|0|||
33349040|NCT00603447|62726289|FG004|Overall Study|Other|3|||
33349041|NCT00603447|62726290|FG005|Overall Study|Other|0|||
33349042|NCT00603447|62726291|FG006|Overall Study|Other|13|||
33349043|NCT00603447|62726285|FG000|Overall Study|Withdrew Consent|0|||
33349044|NCT00603447|62726286|FG001|Overall Study|Withdrew Consent|2|||
33349045|NCT00603447|62726287|FG002|Overall Study|Withdrew Consent|0|||
33349046|NCT00603447|62726288|FG003|Overall Study|Withdrew Consent|0|||
33349047|NCT00603447|62726289|FG004|Overall Study|Withdrew Consent|1|||
33349048|NCT00603447|62726290|FG005|Overall Study|Withdrew Consent|0|||
33471189|NCT00234065|62844920|FG000|Overall Study|Physician Decision|23|||
33471190|NCT00234065|62844921|FG001|Overall Study|Physician Decision|22|||
33471191|NCT00234065|62844920|FG000|Overall Study|Not Classified|111|||
33471192|NCT00234065|62844921|FG001|Overall Study|Not Classified|112|||
33471193|NCT00233987|62844927|FG000|Overall Study|Withdrawal by Subject|1|||
33471194|NCT00233987|62844927|FG000|Overall Study|Lack of Efficacy|2|||
33471195|NCT00233987|62844927|FG000|Overall Study|Reason Under Review|1|||
33471196|NCT00233987|62844927|FG000|Overall Study|Other - Not Protocol Specified|5|||
33471197|NCT00233987|62844927|FG000|Overall Study|Eligible but No Treatment Received|2|||
33548960|NCT02901431|62940298|FG004|PK Part|Stopped treatment after 8 weeks|0|||
33548961|NCT02901431|62940299|FG005|PK Part|Stopped treatment after 8 weeks|0|||
33548962|NCT02901431|62940300|FG006|PK Part|Stopped treatment after 8 weeks|0|||
33349049|NCT00603447|62726291|FG006|Overall Study|Withdrew Consent|1|||
33349050|NCT00778258|62726316|FG000|Overall Study|Adverse Event|1|||
33349051|NCT00778258|62726317|FG001|Overall Study|Adverse Event|0|||
33349052|NCT00778258|62726318|FG002|Overall Study|Adverse Event|0|||
33349053|NCT00778258|62726319|FG003|Overall Study|Adverse Event|0|||
33349054|NCT00778258|62726320|FG004|Overall Study|Adverse Event|0|||
33349055|NCT00778258|62726321|FG005|Overall Study|Adverse Event|1|||
33349056|NCT00778258|62726322|FG006|Overall Study|Adverse Event|0|||
33349057|NCT00778258|62726323|FG007|Overall Study|Adverse Event|0|||
33349058|NCT00778258|62726324|FG008|Overall Study|Adverse Event|0|||
33349059|NCT00778258|62726316|FG000|Overall Study|Lost to Follow-up|0|||
33349060|NCT00778258|62726317|FG001|Overall Study|Lost to Follow-up|0|||
33349061|NCT00778258|62726318|FG002|Overall Study|Lost to Follow-up|2|||
33349062|NCT00778258|62726319|FG003|Overall Study|Lost to Follow-up|0|||
33349063|NCT00778258|62726320|FG004|Overall Study|Lost to Follow-up|0|||
33349064|NCT00778258|62726321|FG005|Overall Study|Lost to Follow-up|3|||
33349065|NCT00778258|62726322|FG006|Overall Study|Lost to Follow-up|2|||
33349066|NCT00778258|62726323|FG007|Overall Study|Lost to Follow-up|2|||
33349067|NCT00778258|62726324|FG008|Overall Study|Lost to Follow-up|0|||
33349068|NCT00778258|62726316|FG000|Overall Study|Withdrawal by Subject|6|||
33349069|NCT00778258|62726317|FG001|Overall Study|Withdrawal by Subject|2|||
33349070|NCT00778258|62726318|FG002|Overall Study|Withdrawal by Subject|8|||
33349071|NCT00778258|62726319|FG003|Overall Study|Withdrawal by Subject|2|||
33349072|NCT00778258|62726320|FG004|Overall Study|Withdrawal by Subject|0|||
33349073|NCT00778258|62726321|FG005|Overall Study|Withdrawal by Subject|6|||
33349074|NCT00778258|62726322|FG006|Overall Study|Withdrawal by Subject|12|||
33349075|NCT00778258|62726323|FG007|Overall Study|Withdrawal by Subject|12|||
33349076|NCT00778258|62726324|FG008|Overall Study|Withdrawal by Subject|4|||
33471198|NCT00233987|62844927|FG000|Overall Study|Ineligible|4|||
33471199|NCT04623242|62844936|FG000|Overall Study|Withdrawal by Subject|7|||
33548963|NCT02901431|62940301|FG007|PK Part|Stopped treatment after 8 weeks|0|||
33349077|NCT00778258|62726316|FG000|Overall Study|New Contraindication|0|||
33471200|NCT04623242|62844937|FG001|Overall Study|Withdrawal by Subject|12|||
33349078|NCT00778258|62726317|FG001|Overall Study|New Contraindication|0|||
33349079|NCT00778258|62726318|FG002|Overall Study|New Contraindication|0|||
33349080|NCT00778258|62726319|FG003|Overall Study|New Contraindication|0|||
33349081|NCT00778258|62726320|FG004|Overall Study|New Contraindication|0|||
33349082|NCT00778258|62726321|FG005|Overall Study|New Contraindication|0|||
33349083|NCT00778258|62726322|FG006|Overall Study|New Contraindication|0|||
33349084|NCT00778258|62726323|FG007|Overall Study|New Contraindication|1|||
33471201|NCT04623242|62844938|FG002|Overall Study|Withdrawal by Subject|5|||
33349085|NCT00778258|62726324|FG008|Overall Study|New Contraindication|0|||
33349086|NCT00778258|62726316|FG000|Overall Study|Non-compliance|0|||
33349087|NCT00778258|62726317|FG001|Overall Study|Non-compliance|0|||
33349088|NCT00778258|62726318|FG002|Overall Study|Non-compliance|0|||
33349089|NCT00778258|62726319|FG003|Overall Study|Non-compliance|1|||
33349090|NCT00778258|62726320|FG004|Overall Study|Non-compliance|0|||
33349091|NCT00778258|62726321|FG005|Overall Study|Non-compliance|0|||
33349092|NCT00778258|62726322|FG006|Overall Study|Non-compliance|0|||
33349093|NCT00778258|62726323|FG007|Overall Study|Non-compliance|0|||
33349094|NCT00778258|62726324|FG008|Overall Study|Non-compliance|0|||
33349095|NCT00778258|62726316|FG000|Overall Study|Other|0|||
33349096|NCT00778258|62726317|FG001|Overall Study|Other|0|||
33349097|NCT00778258|62726318|FG002|Overall Study|Other|0|||
33349098|NCT00778258|62726319|FG003|Overall Study|Other|0|||
33349099|NCT00778258|62726320|FG004|Overall Study|Other|0|||
33349100|NCT00778258|62726321|FG005|Overall Study|Other|0|||
33349101|NCT00778258|62726322|FG006|Overall Study|Other|1|||
33349102|NCT00778258|62726323|FG007|Overall Study|Other|0|||
33349103|NCT00778258|62726324|FG008|Overall Study|Other|0|||
33349104|NCT00988208|62726352|FG000|Overall Study|Adverse Event|71|||
33349105|NCT00988208|62726353|FG001|Overall Study|Adverse Event|122|||
33349106|NCT00988208|62726352|FG000|Overall Study|Disease Progression|103|||
33349107|NCT00988208|62726353|FG001|Overall Study|Disease Progression|89|||
33349108|NCT00988208|62726352|FG000|Overall Study|Withdrawal by Subject|50|||
33349109|NCT00988208|62726353|FG001|Overall Study|Withdrawal by Subject|57|||
33349110|NCT00988208|62726352|FG000|Overall Study|Death|9|||
33349111|NCT00988208|62726353|FG001|Overall Study|Death|15|||
33349112|NCT00988208|62726352|FG000|Overall Study|Lost to Follow-up|2|||
33349113|NCT00988208|62726353|FG001|Overall Study|Lost to Follow-up|3|||
33349114|NCT00988208|62726352|FG000|Overall Study|Protocol Violation|9|||
33349115|NCT00988208|62726353|FG001|Overall Study|Protocol Violation|2|||
33349116|NCT00988208|62726352|FG000|Overall Study|Sponsor Decision|102|||
33349117|NCT00988208|62726353|FG001|Overall Study|Sponsor Decision|78|||
33349118|NCT00988208|62726352|FG000|Overall Study|Clinical Progression|17|||
33349119|NCT00988208|62726353|FG001|Overall Study|Clinical Progression|16|||
33349120|NCT00988208|62726352|FG000|Overall Study|Biochemical Progression|21|||
33349121|NCT00988208|62726353|FG001|Overall Study|Biochemical Progression|7|||
33349122|NCT00988208|62726352|FG000|Overall Study|Clinical Deterioration|7|||
33349123|NCT00988208|62726353|FG001|Overall Study|Clinical Deterioration|14|||
33349124|NCT00988208|62726352|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
33349125|NCT00988208|62726353|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
33349126|NCT00988208|62726352|FG000|Overall Study|Other|8|||
33349127|NCT00988208|62726353|FG001|Overall Study|Other|3|||
33349128|NCT00990704|62726361|FG000|Overall Study|Adverse Event|1|||
33349129|NCT00990704|62726362|FG001|Overall Study|Adverse Event|1|||
33349130|NCT00990704|62726361|FG000|Overall Study|Physician Decision|0|||
33349131|NCT00990704|62726362|FG001|Overall Study|Physician Decision|1|||
33349132|NCT04089553|62726370|FG000|Overall Study|Death|12|||
33349133|NCT04089553|62726371|FG001|Overall Study|Death|11|||
33349134|NCT04089553|62726370|FG000|Overall Study|Lost to Follow-up|2|||
33349135|NCT04089553|62726371|FG001|Overall Study|Lost to Follow-up|2|||
33349136|NCT04089553|62726370|FG000|Overall Study|Progressive disease|0|||
33349137|NCT04089553|62726371|FG001|Overall Study|Progressive disease|1|||
33349138|NCT04089553|62726370|FG000|Overall Study|Withdrawal by Subject|5|||
33349139|NCT04089553|62726371|FG001|Overall Study|Withdrawal by Subject|2|||
33349140|NCT04089553|62726370|FG000|Overall Study|Other|6|||
33349141|NCT04089553|62726371|FG001|Overall Study|Other|2|||
33349142|NCT00993668|62726380|FG000|Single-Blind Period|Adverse Event|1|||
33349143|NCT00993668|62726381|FG001|Single-Blind Period|Adverse Event|1|||
33349144|NCT00993668|62726380|FG000|Single-Blind Period|Lack of Efficacy|0|||
33349145|NCT00993668|62726381|FG001|Single-Blind Period|Lack of Efficacy|1|||
33349146|NCT00993668|62726380|FG000|Single-Blind Period|Lost to Follow-up|3|||
33349147|NCT00993668|62726381|FG001|Single-Blind Period|Lost to Follow-up|1|||
33349148|NCT00993668|62726380|FG000|Open-Label Period|Adverse Event|9|||
33349149|NCT00993668|62726381|FG001|Open-Label Period|Adverse Event|8|||
33349150|NCT00993668|62726380|FG000|Open-Label Period|Lack of Efficacy|4|||
33349151|NCT00993668|62726381|FG001|Open-Label Period|Lack of Efficacy|3|||
33349152|NCT00993668|62726380|FG000|Open-Label Period|Withdrawal by Subject|4|||
33349153|NCT00993668|62726381|FG001|Open-Label Period|Withdrawal by Subject|3|||
33349154|NCT00993668|62726380|FG000|Open-Label Period|Lost to Follow-up|6|||
33471202|NCT04623242|62844939|FG003|Overall Study|Withdrawal by Subject|7|||
33349155|NCT00993668|62726381|FG001|Open-Label Period|Lost to Follow-up|1|||
33349156|NCT00778102|62726390|FG000|Overall Study|Adverse Event|8|||
33349157|NCT00778102|62726391|FG001|Overall Study|Adverse Event|5|||
33349158|NCT00778102|62726390|FG000|Overall Study|Death|1|||
33349159|NCT00778102|62726391|FG001|Overall Study|Death|1|||
33349160|NCT00778102|62726390|FG000|Overall Study|Lost to Follow-up|1|||
33349161|NCT00778102|62726391|FG001|Overall Study|Lost to Follow-up|0|||
33349162|NCT00778102|62726390|FG000|Overall Study|Violation of Selection Criteria|1|||
33349163|NCT00778102|62726391|FG001|Overall Study|Violation of Selection Criteria|1|||
33349164|NCT00778102|62726390|FG000|Overall Study|Protocol Violation|0|||
33349165|NCT00778102|62726391|FG001|Overall Study|Protocol Violation|1|||
33349166|NCT00778102|62726390|FG000|Overall Study|Refused Treatment|2|||
33349167|NCT00778102|62726391|FG001|Overall Study|Refused Treatment|3|||
33349168|NCT00778102|62726390|FG000|Overall Study|Withdrawal by Subject|1|||
33349169|NCT00778102|62726391|FG001|Overall Study|Withdrawal by Subject|1|||
33471203|NCT04623242|62844940|FG004|Overall Study|Withdrawal by Subject|0|||
33654977|NCT01899053|63068985|FG005|Overall Study|Reason Not Specified|0|||
33654978|NCT01899053|63068986|FG006|Overall Study|Reason Not Specified|1|||
33654979|NCT01899053|63068987|FG007|Overall Study|Reason Not Specified|0|||
33654980|NCT01899053|63068988|FG008|Overall Study|Reason Not Specified|0|||
33654981|NCT01899053|63068989|FG009|Overall Study|Reason Not Specified|0|||
33654982|NCT01899053|63068990|FG010|Overall Study|Reason Not Specified|0|||
33654983|NCT01899053|63068991|FG011|Overall Study|Reason Not Specified|0|||
33654984|NCT01899053|63068992|FG012|Overall Study|Reason Not Specified|1|||
33654985|NCT01899053|63068993|FG013|Overall Study|Reason Not Specified|0|||
33654986|NCT01899053|63068980|FG000|Overall Study|Withdrawal by Subject|1|||
33654987|NCT01899053|63068981|FG001|Overall Study|Withdrawal by Subject|1|||
33654988|NCT01899053|63068982|FG002|Overall Study|Withdrawal by Subject|2|||
33654989|NCT01899053|63068983|FG003|Overall Study|Withdrawal by Subject|0|||
33654990|NCT01899053|63068984|FG004|Overall Study|Withdrawal by Subject|2|||
33654991|NCT01899053|63068985|FG005|Overall Study|Withdrawal by Subject|0|||
33654992|NCT01899053|63068986|FG006|Overall Study|Withdrawal by Subject|0|||
33654993|NCT01899053|63068987|FG007|Overall Study|Withdrawal by Subject|1|||
33654994|NCT01899053|63068988|FG008|Overall Study|Withdrawal by Subject|0|||
33654995|NCT01899053|63068989|FG009|Overall Study|Withdrawal by Subject|0|||
33654996|NCT01899053|63068990|FG010|Overall Study|Withdrawal by Subject|0|||
33654997|NCT01899053|63068991|FG011|Overall Study|Withdrawal by Subject|0|||
33654998|NCT01899053|63068992|FG012|Overall Study|Withdrawal by Subject|1|||
33654999|NCT01899053|63068993|FG013|Overall Study|Withdrawal by Subject|1|||
33655000|NCT01899053|63068980|FG000|Overall Study|Protocol Violation|0|||
33655001|NCT01899053|63068981|FG001|Overall Study|Protocol Violation|0|||
33655002|NCT01899053|63068982|FG002|Overall Study|Protocol Violation|1|||
33655003|NCT01899053|63068983|FG003|Overall Study|Protocol Violation|0|||
33655004|NCT01899053|63068984|FG004|Overall Study|Protocol Violation|0|||
33655005|NCT01899053|63068985|FG005|Overall Study|Protocol Violation|0|||
33655006|NCT01899053|63068986|FG006|Overall Study|Protocol Violation|0|||
33655007|NCT01899053|63068987|FG007|Overall Study|Protocol Violation|0|||
33655008|NCT01899053|63068988|FG008|Overall Study|Protocol Violation|0|||
33655009|NCT01899053|63068989|FG009|Overall Study|Protocol Violation|0|||
33655010|NCT01899053|63068990|FG010|Overall Study|Protocol Violation|0|||
33655011|NCT01899053|63068991|FG011|Overall Study|Protocol Violation|0|||
33655012|NCT01899053|63068992|FG012|Overall Study|Protocol Violation|0|||
33655013|NCT01899053|63068993|FG013|Overall Study|Protocol Violation|0|||
33655014|NCT01899053|63068980|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
33655015|NCT01899053|63068981|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
33655016|NCT01899053|63068982|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
33655017|NCT01899053|63068983|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
33655018|NCT01899053|63068984|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
33349170|NCT00778102|62726390|FG000|Overall Study|Administrative Reason|7|||
33471204|NCT04623242|62844936|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
33548964|NCT02901431|62940302|FG008|PK Part|Stopped treatment after 8 weeks|0|||
33655019|NCT01899053|63068985|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
33655020|NCT01899053|63068986|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
33655021|NCT01899053|63068987|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
33655022|NCT01899053|63068988|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
33655023|NCT01899053|63068989|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
33655024|NCT01899053|63068990|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
33655025|NCT01899053|63068991|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
33655026|NCT01899053|63068992|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
33655027|NCT01899053|63068993|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
33349171|NCT00778102|62726391|FG001|Overall Study|Administrative Reason|10|||
33349172|NCT00756886|62726399|FG000|Overall Study|Lost to Follow-up|1|||
33349173|NCT00756886|62726400|FG001|Overall Study|Lost to Follow-up|0|||
33655028|NCT01899053|63068980|FG000|Overall Study|Symptomatic Deterioration|0|||
33655029|NCT01899053|63068981|FG001|Overall Study|Symptomatic Deterioration|0|||
33655030|NCT01899053|63068982|FG002|Overall Study|Symptomatic Deterioration|0|||
33655031|NCT01899053|63068983|FG003|Overall Study|Symptomatic Deterioration|0|||
33655032|NCT01899053|63068984|FG004|Overall Study|Symptomatic Deterioration|0|||
33655033|NCT01899053|63068985|FG005|Overall Study|Symptomatic Deterioration|1|||
33655034|NCT01899053|63068986|FG006|Overall Study|Symptomatic Deterioration|0|||
33655035|NCT01899053|63068987|FG007|Overall Study|Symptomatic Deterioration|1|||
33655036|NCT01899053|63068988|FG008|Overall Study|Symptomatic Deterioration|0|||
33655037|NCT01899053|63068989|FG009|Overall Study|Symptomatic Deterioration|0|||
33349174|NCT00756886|62726399|FG000|Overall Study|Adverse Event|0|||
33471205|NCT04623242|62844937|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
33471206|NCT04623242|62844938|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
33471207|NCT04623242|62844939|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
33471208|NCT04623242|62844940|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
33471209|NCT04623242|62844936|FG000|Overall Study|Subject unblinded to mutation status|0|||
33471210|NCT04623242|62844937|FG001|Overall Study|Subject unblinded to mutation status|0|||
33471211|NCT04623242|62844938|FG002|Overall Study|Subject unblinded to mutation status|0|||
33471212|NCT04623242|62844939|FG003|Overall Study|Subject unblinded to mutation status|13|||
33471213|NCT04623242|62844940|FG004|Overall Study|Subject unblinded to mutation status|0|||
33471214|NCT00233363|62844957|FG000|Overall Study|Adverse Event|1|||
33471215|NCT00233363|62844958|FG001|Overall Study|Adverse Event|2|||
33471216|NCT00233363|62844957|FG000|Overall Study|Lack of Efficacy|0|||
33471217|NCT00233363|62844958|FG001|Overall Study|Lack of Efficacy|2|||
33471218|NCT00233363|62844957|FG000|Overall Study|Withdrawal by Subject|1|||
33349175|NCT00756886|62726400|FG001|Overall Study|Adverse Event|3|||
33349176|NCT00756886|62726399|FG000|Overall Study|Lack of Efficacy|1|||
33349177|NCT00756886|62726400|FG001|Overall Study|Lack of Efficacy|0|||
33349178|NCT00756886|62726399|FG000|Overall Study|Ineligible|9|||
33349179|NCT00756886|62726400|FG001|Overall Study|Ineligible|4|||
33349180|NCT00756730|62726408|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
33349181|NCT00756730|62726409|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
33349182|NCT00756730|62726408|FG000|Overall Study|persistent low-level viremmia|0|||
33349183|NCT00756730|62726409|FG001|Overall Study|persistent low-level viremmia|1|||
33349184|NCT00984620|62726417|FG000|Overall Study|Adverse Event|5|||
33349185|NCT00984620|62726418|FG001|Overall Study|Adverse Event|5|||
33349186|NCT00984620|62726417|FG000|Overall Study|Lost to Follow-up|1|||
33349187|NCT00984620|62726418|FG001|Overall Study|Lost to Follow-up|1|||
33349188|NCT00984620|62726417|FG000|Overall Study|Withdrawal by Subject|0|||
33349189|NCT00984620|62726418|FG001|Overall Study|Withdrawal by Subject|2|||
33349190|NCT00984620|62726417|FG000|Overall Study|reason other than listed above|0|||
33349191|NCT00984620|62726418|FG001|Overall Study|reason other than listed above|4|||
33349192|NCT00777946|62726429|FG000|Overall Study|Adverse Event|11|||
33349193|NCT00777946|62726430|FG001|Overall Study|Adverse Event|1|||
33349194|NCT00777946|62726431|FG002|Overall Study|Adverse Event|3|||
33349195|NCT00777946|62726429|FG000|Overall Study|Lack of Efficacy|0|||
33349196|NCT00777946|62726430|FG001|Overall Study|Lack of Efficacy|0|||
33349197|NCT00777946|62726431|FG002|Overall Study|Lack of Efficacy|9|||
33349198|NCT00777946|62726429|FG000|Overall Study|Condition no longer required study drug|1|||
33349199|NCT00777946|62726430|FG001|Overall Study|Condition no longer required study drug|0|||
33349200|NCT00777946|62726431|FG002|Overall Study|Condition no longer required study drug|0|||
33349201|NCT00777946|62726429|FG000|Overall Study|Patient withdrew consent|3|||
33349202|NCT00777946|62726430|FG001|Overall Study|Patient withdrew consent|2|||
33349203|NCT00777946|62726431|FG002|Overall Study|Patient withdrew consent|3|||
33349204|NCT00777946|62726429|FG000|Overall Study|Lost to Follow-up|3|||
33349205|NCT00777946|62726430|FG001|Overall Study|Lost to Follow-up|1|||
33349206|NCT00777946|62726431|FG002|Overall Study|Lost to Follow-up|0|||
33349207|NCT00777946|62726429|FG000|Overall Study|Protocol deviation|2|||
33349208|NCT00777946|62726430|FG001|Overall Study|Protocol deviation|1|||
33349209|NCT00777946|62726431|FG002|Overall Study|Protocol deviation|1|||
33349210|NCT00777946|62726429|FG000|Overall Study|Randomized in error|1|||
33349211|NCT00777946|62726430|FG001|Overall Study|Randomized in error|1|||
33349212|NCT00777946|62726431|FG002|Overall Study|Randomized in error|0|||
33349213|NCT00990314|62726439|FG000|Overall Study|Death|2|||
33349214|NCT00990314|62726439|FG000|Overall Study|Adverse Event|2|||
33349215|NCT00990314|62726439|FG000|Overall Study|Withdrawal by Subject|3|||
33349216|NCT00990314|62726439|FG000|Overall Study|Non-Compliance|1|||
33349217|NCT00990314|62726439|FG000|Overall Study|Physician Decision|3|||
33349218|NCT00990314|62726439|FG000|Overall Study|Lack of Efficacy|1|||
33349219|NCT00756652|62726445|FG000|Original Phase|Withdrawal by Subject|864|||
33655038|NCT01899053|63068990|FG010|Overall Study|Symptomatic Deterioration|0|||
33349220|NCT00756652|62726446|FG001|Original Phase|Withdrawal by Subject|23|||
33655039|NCT01899053|63068991|FG011|Overall Study|Symptomatic Deterioration|1|||
33349221|NCT00756652|62726445|FG000|Original Phase|Lost to Follow-up|601|||
33349222|NCT00756652|62726446|FG001|Original Phase|Lost to Follow-up|0|||
33349223|NCT00756652|62726445|FG000|Original Phase|Other Discontinuation|797|||
33349224|NCT00756652|62726446|FG001|Original Phase|Other Discontinuation|5|||
33349225|NCT00756652|62726445|FG000|Original Phase|Participant Noncompliance|18622|||
33349226|NCT00756652|62726446|FG001|Original Phase|Participant Noncompliance|424|||
33349227|NCT00756652|62726445|FG000|Original Phase|Unknown Discontinuation Reason|2|||
33349228|NCT00756652|62726446|FG001|Original Phase|Unknown Discontinuation Reason|0|||
33349229|NCT00756652|62726445|FG000|Original Phase|Participants without data|3259|||
33349230|NCT00756652|62726446|FG001|Original Phase|Participants without data|466|||
33349231|NCT00756652|62726445|FG000|Original Phase|Death|168|||
33349232|NCT00756652|62726446|FG001|Original Phase|Death|1|||
33349233|NCT00756652|62726445|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
33349234|NCT00756652|62726446|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
33349235|NCT00756652|62726445|FG000|Re-Op Phase|Withdrawal by Subject|62|||
33349236|NCT00756652|62726446|FG001|Re-Op Phase|Withdrawal by Subject|0|||
33349237|NCT00756652|62726445|FG000|Re-Op Phase|Death|6|||
33349238|NCT00756652|62726446|FG001|Re-Op Phase|Death|0|||
33349239|NCT00756652|62726445|FG000|Re-Op Phase|Lost to Follow-up|340|||
33349240|NCT00756652|62726446|FG001|Re-Op Phase|Lost to Follow-up|0|||
33349241|NCT00756652|62726445|FG000|Re-Op Phase|Site Closed|2454|||
33349242|NCT00756652|62726446|FG001|Re-Op Phase|Site Closed|0|||
33349243|NCT00756652|62726445|FG000|Re-Op Phase|Withdrawn after explant|14|||
33349244|NCT00756652|62726446|FG001|Re-Op Phase|Withdrawn after explant|0|||
33349245|NCT00777556|62726450|FG000|Overall Study|Inappropriate self-selection|34|||
33349246|NCT00777556|62726450|FG000|Overall Study|Dispensed but did not use product|12|||
33349247|NCT00777556|62726450|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
33349248|NCT00602979|62726459|FG000|Overall Study|Lost to Follow-up|3|||
33349249|NCT00602979|62726460|FG001|Overall Study|Lost to Follow-up|2|||
33349250|NCT00602979|62726461|FG002|Overall Study|Lost to Follow-up|3|||
33349251|NCT00602979|62726462|FG003|Overall Study|Lost to Follow-up|2|||
33349252|NCT00602979|62726463|FG004|Overall Study|Lost to Follow-up|3|||
33349253|NCT00602979|62726459|FG000|Overall Study|Failed Intubation|0|||
33349254|NCT00602979|62726460|FG001|Overall Study|Failed Intubation|1|||
33349255|NCT00602979|62726461|FG002|Overall Study|Failed Intubation|0|||
33349256|NCT00602979|62726462|FG003|Overall Study|Failed Intubation|1|||
33349257|NCT00602979|62726463|FG004|Overall Study|Failed Intubation|0|||
33349258|NCT04081363|62726477|FG000|Overall Study|Withdrawal by Subject|1|||
33349259|NCT04081363|62726478|FG001|Overall Study|Withdrawal by Subject|0|||
33349260|NCT00993044|62726484|FG000|Irinotecan 50 mg|Physician Decision|1|||
33349261|NCT00777088|62726498|FG000|Overall Study|PED Treatment not attempted|1|||
33349262|NCT00763282|62726514|FG000|Overall Study|Withdrawal by Subject|6|||
33349263|NCT00763282|62726515|FG001|Overall Study|Withdrawal by Subject|5|||
33349264|NCT00763282|62726514|FG000|Overall Study|Death|4|||
33349265|NCT00763282|62726515|FG001|Overall Study|Death|3|||
33349266|NCT00763282|62726514|FG000|Overall Study|Lost to Follow-up|22|||
33349267|NCT00763282|62726515|FG001|Overall Study|Lost to Follow-up|26|||
33349268|NCT00988598|62726525|FG000|Overall Study|Withdrawal by Subject|2|||
33349269|NCT00988598|62726526|FG001|Overall Study|Withdrawal by Subject|0|||
33349270|NCT00979628|62726535|FG000|Overall Study|received regimen < 24 hours|7|||
33349271|NCT00979628|62726536|FG001|Overall Study|received regimen < 24 hours|6|||
33349272|NCT00979628|62726537|FG002|Overall Study|received regimen < 24 hours|5|||
33349273|NCT00979628|62726535|FG000|Overall Study|received steroids|1|||
33349274|NCT00979628|62726536|FG001|Overall Study|received steroids|1|||
33349275|NCT00979628|62726537|FG002|Overall Study|received steroids|0|||
33349276|NCT00979628|62726535|FG000|Overall Study|transferred to ICU|1|||
33349277|NCT00979628|62726536|FG001|Overall Study|transferred to ICU|2|||
33349278|NCT00979628|62726537|FG002|Overall Study|transferred to ICU|1|||
33349279|NCT00762970|62726551|FG000|Overall Study|Withdrawal by Subject|7|||
33349280|NCT00762970|62726552|FG001|Overall Study|Withdrawal by Subject|4|||
33349281|NCT00762970|62726553|FG002|Overall Study|Withdrawal by Subject|0|||
33349282|NCT00762970|62726551|FG000|Overall Study|Protocol Violation|3|||
33349283|NCT00762970|62726552|FG001|Overall Study|Protocol Violation|1|||
33349284|NCT00762970|62726553|FG002|Overall Study|Protocol Violation|1|||
33349285|NCT00762970|62726551|FG000|Overall Study|Lost to Follow-up|1|||
33349286|NCT00762970|62726552|FG001|Overall Study|Lost to Follow-up|2|||
33349287|NCT00762970|62726553|FG002|Overall Study|Lost to Follow-up|0|||
33349288|NCT00762970|62726551|FG000|Overall Study|Difficulty of handling lens|1|||
33349289|NCT00762970|62726552|FG001|Overall Study|Difficulty of handling lens|2|||
33349290|NCT00762970|62726553|FG002|Overall Study|Difficulty of handling lens|0|||
33349291|NCT00988442|62726563|FG000|Overall Study|Death|1|||
33349292|NCT00988442|62726564|FG001|Overall Study|Death|2|||
33349293|NCT00988442|62726563|FG000|Overall Study|Lost to Follow-up|0|||
33349294|NCT00988442|62726564|FG001|Overall Study|Lost to Follow-up|1|||
33349295|NCT00988442|62726563|FG000|Overall Study|Early Study Closure|29|||
33349296|NCT00988442|62726564|FG001|Overall Study|Early Study Closure|25|||
33349297|NCT03258723|62726573|FG000|Overall Study|COVID Interruption of study|54|||
33349298|NCT03258723|62726573|FG000|Overall Study|Lost to Follow-up|8|||
33349299|NCT00992186|62726577|FG000|Overall Study|Withdrawal by Subject|2|||
33349300|NCT00992186|62726577|FG000|Overall Study|Protocol Violation|1|||
33349301|NCT00992186|62726577|FG000|Overall Study|Physician Decision|1|||
33349302|NCT00992186|62726577|FG000|Overall Study|Adverse Event|9|||
33349303|NCT00992186|62726577|FG000|Overall Study|Progressive Disease|30|||
33349304|NCT00992186|62726577|FG000|Overall Study|Refusal To Receive Study Agent|3|||
33349305|NCT00992108|62726584|FG000|Overall Study|Lost to Follow-up|0|||
33349306|NCT00992108|62726585|FG001|Overall Study|Lost to Follow-up|1|||
33349307|NCT00752986|62726594|FG000|Overall Study|Withdrawal by Subject|2|||
33349308|NCT00752986|62726595|FG001|Overall Study|Withdrawal by Subject|1|||
33349309|NCT00752986|62726596|FG002|Overall Study|Withdrawal by Subject|2|||
33349310|NCT00752986|62726594|FG000|Overall Study|Protocol Violation|3|||
33349311|NCT00752986|62726595|FG001|Overall Study|Protocol Violation|0|||
33349312|NCT00752986|62726596|FG002|Overall Study|Protocol Violation|0|||
33349313|NCT03483103|62726604|FG000|Pre-Treatment Phase|Other reasons|1|||
33349314|NCT03483103|62726604|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
33349315|NCT03483103|62726604|FG000|Pre-Treatment Phase|Disease-related complications|1|||
33349316|NCT03483103|62726604|FG000|Pre-Treatment Phase|Death|5|||
33349317|NCT03483103|62726604|FG000|Treatment Phase|Withdrawal by Subject|6|||
33349318|NCT03483103|62726604|FG000|Treatment Phase|Other reasons|2|||
33349319|NCT03483103|62726604|FG000|Treatment Phase|Death|20|||
33349320|NCT03483103|62726604|FG000|Treatment Phase|Ongoing in study|26|||
33349321|NCT03483103|62726604|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
33349322|NCT03483103|62726604|FG000|Treatment Phase|Received nonconforming product|1|||
33349323|NCT00762892|62726610|FG000|Overall Study|Lost to Follow-up|2|||
33349324|NCT00762892|62726611|FG001|Overall Study|Lost to Follow-up|5|||
33349325|NCT00762892|62726610|FG000|Overall Study|Withdrawal by Subject|0|||
33349326|NCT00762892|62726611|FG001|Overall Study|Withdrawal by Subject|1|||
33349327|NCT00762892|62726610|FG000|Overall Study|Death|1|||
33349328|NCT00762892|62726611|FG001|Overall Study|Death|0|||
33349329|NCT00762892|62726610|FG000|Overall Study|Pregnancy|1|||
33349330|NCT00762892|62726611|FG001|Overall Study|Pregnancy|0|||
33349331|NCT00762892|62726610|FG000|Overall Study|Incarceration|1|||
33349332|NCT00762892|62726611|FG001|Overall Study|Incarceration|0|||
33349333|NCT00755716|62726620|FG000|Overall Study|Adverse Event|1|||
33349334|NCT00755716|62726621|FG001|Overall Study|Adverse Event|4|||
33349335|NCT00755716|62726622|FG002|Overall Study|Adverse Event|1|||
33349336|NCT00755716|62726620|FG000|Overall Study|Lack of Efficacy|2|||
33349337|NCT00755716|62726621|FG001|Overall Study|Lack of Efficacy|0|||
33349338|NCT00755716|62726622|FG002|Overall Study|Lack of Efficacy|0|||
33349339|NCT00755716|62726620|FG000|Overall Study|Lost to Follow-up|5|||
33349340|NCT00755716|62726621|FG001|Overall Study|Lost to Follow-up|3|||
33349341|NCT00755716|62726622|FG002|Overall Study|Lost to Follow-up|1|||
33349342|NCT00755716|62726620|FG000|Overall Study|work schedule issues|0|||
33471219|NCT00233363|62844958|FG001|Overall Study|Withdrawal by Subject|1|||
33471220|NCT00233363|62844957|FG000|Overall Study|Aggravation of complication|1|||
33471221|NCT00233363|62844958|FG001|Overall Study|Aggravation of complication|0|||
33471222|NCT01147666|62844979|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
33471223|NCT01147666|62844980|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
33471224|NCT01147666|62844981|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
33471225|NCT01147666|62844982|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33471226|NCT01147666|62844983|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33471227|NCT01147666|62844984|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33471228|NCT01147666|62844985|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33471229|NCT01147666|62844986|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33471230|NCT01147666|62844987|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33471231|NCT01147666|62844988|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33471232|NCT01147666|62844989|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33471233|NCT01147666|62844990|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33471234|NCT01147666|62844991|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
33471235|NCT01147666|62844992|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33471236|NCT01147666|62844993|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33471237|NCT01147666|62844979|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
33471238|NCT01147666|62844980|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
33471239|NCT01147666|62844981|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
33471240|NCT01147666|62844982|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
33471241|NCT01147666|62844983|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
33471242|NCT01147666|62844984|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
33471243|NCT01147666|62844985|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
33471244|NCT01147666|62844986|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
33471245|NCT01147666|62844987|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
33349343|NCT00755716|62726621|FG001|Overall Study|work schedule issues|1|||
33548965|NCT02901431|62940303|FG009|PK Part|Stopped treatment after 8 weeks|0|||
33655040|NCT01899053|63068992|FG012|Overall Study|Symptomatic Deterioration|2|||
33655041|NCT01899053|63068993|FG013|Overall Study|Symptomatic Deterioration|0|||
33349344|NCT00755716|62726622|FG002|Overall Study|work schedule issues|1|||
33349345|NCT00755326|62726632|FG000|Overall Study|Lost to Follow-up|2|||
33349346|NCT00755326|62726633|FG001|Overall Study|Lost to Follow-up|3|||
33349347|NCT03084471|62726640|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
33349348|NCT03084471|62726640|FG000|Overall Study|Condition under investigation worsened|84|||
33349349|NCT03084471|62726640|FG000|Overall Study|Lack of therapeutic response|2|||
33349350|NCT03084471|62726640|FG000|Overall Study|Protocol Violation|1|||
33349351|NCT03084471|62726640|FG000|Overall Study|Adverse Event|73|||
33349352|NCT03084471|62726640|FG000|Overall Study|Withdrawal by Subject|12|||
33349353|NCT03084471|62726640|FG000|Overall Study|Disease relapse|181|||
33349354|NCT03084471|62726640|FG000|Overall Study|Subjective disease progression|359|||
33349355|NCT03084471|62726640|FG000|Overall Study|Other (as recorded)|33|||
33349356|NCT03084471|62726640|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
33349357|NCT00754936|62726647|FG000|Overall Study|Lost to Follow-up|3|||
33349358|NCT00754936|62726647|FG000|Overall Study|Physician Decision|1|||
33349359|NCT00754936|62726647|FG000|Overall Study|Withdrawal by Subject|2|||
33349360|NCT00754936|62726647|FG000|Overall Study|Side Effects|3|||
33349361|NCT00754936|62726647|FG000|Overall Study|Inter-current medical events|3|||
33349362|NCT00762502|62726654|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
33349363|NCT00762502|62726655|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
33349364|NCT00762502|62726656|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
33349365|NCT00762502|62726654|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
33349366|NCT00762502|62726655|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
33349367|NCT00762502|62726656|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
33349368|NCT00762502|62726654|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
33349369|NCT00762502|62726655|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
33349370|NCT00762502|62726656|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
33349371|NCT00762268|62726664|FG000|Overall Study|Withdrawal by Subject|3|||
33349372|NCT00762268|62726665|FG001|Overall Study|Withdrawal by Subject|3|||
33349373|NCT00975884|62726673|FG000|Overall Study|Adverse Event|1|||
33349374|NCT00975884|62726674|FG001|Overall Study|Adverse Event|0|||
33349375|NCT00975884|62726673|FG000|Overall Study|Lost to Follow-up|5|||
33349376|NCT00975884|62726674|FG001|Overall Study|Lost to Follow-up|3|||
33349377|NCT00975884|62726673|FG000|Overall Study|Withdrawal by Subject|9|||
33349378|NCT00975884|62726674|FG001|Overall Study|Withdrawal by Subject|9|||
33471246|NCT01147666|62844988|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
33471247|NCT01147666|62844989|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
33471248|NCT01147666|62844990|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
33471249|NCT01147666|62844991|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
33471250|NCT01147666|62844992|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
33349379|NCT00975884|62726673|FG000|Overall Study|Other|1|||
33349380|NCT00975884|62726674|FG001|Overall Study|Other|3|||
33349381|NCT00578227|62726693|FG000|Overall Study|Lost to Follow-up|0|||
33349382|NCT00578227|62726694|FG001|Overall Study|Lost to Follow-up|1|||
33349383|NCT00578227|62726695|FG002|Overall Study|Lost to Follow-up|1|||
33349384|NCT00578227|62726693|FG000|Overall Study|Withdrawal by Subject|5|||
33349385|NCT00578227|62726694|FG001|Overall Study|Withdrawal by Subject|1|||
33349386|NCT00578227|62726695|FG002|Overall Study|Withdrawal by Subject|3|||
33349387|NCT00978380|62726705|FG000|Overall Study|Protocol Violation|2|||
33349388|NCT00978380|62726705|FG000|Overall Study|Withdrawal criteria|9|||
33349389|NCT00978380|62726705|FG000|Overall Study|Unclassified|8|||
33349390|NCT00577993|62726713|FG000|Overall Study|Adverse Event|1|||
33349391|NCT00577993|62726714|FG001|Overall Study|Adverse Event|0|||
33349392|NCT00577993|62726715|FG002|Overall Study|Adverse Event|0|||
33349393|NCT00577993|62726713|FG000|Overall Study|Death|0|||
33349394|NCT00577993|62726714|FG001|Overall Study|Death|1|||
33349395|NCT00577993|62726715|FG002|Overall Study|Death|1|||
33349396|NCT00577993|62726713|FG000|Overall Study|Lack of Efficacy|0|||
33349397|NCT00577993|62726714|FG001|Overall Study|Lack of Efficacy|1|||
33349398|NCT00577993|62726715|FG002|Overall Study|Lack of Efficacy|0|||
33349399|NCT00577993|62726713|FG000|Overall Study|Protocol Violation|2|||
33349400|NCT00577993|62726714|FG001|Overall Study|Protocol Violation|3|||
33349401|NCT00577993|62726715|FG002|Overall Study|Protocol Violation|0|||
33349402|NCT00577993|62726713|FG000|Overall Study|Withdrawal by Subject|1|||
33349403|NCT00577993|62726714|FG001|Overall Study|Withdrawal by Subject|0|||
33349404|NCT00577993|62726715|FG002|Overall Study|Withdrawal by Subject|2|||
33349405|NCT00577993|62726713|FG000|Overall Study|Conversion|2|||
33349406|NCT00577993|62726714|FG001|Overall Study|Conversion|5|||
33349407|NCT00577993|62726715|FG002|Overall Study|Conversion|0|||
33349408|NCT00577993|62726713|FG000|Overall Study|Uninsured|1|||
33349409|NCT00577993|62726714|FG001|Overall Study|Uninsured|0|||
33349410|NCT00577993|62726715|FG002|Overall Study|Uninsured|0|||
33349411|NCT00975806|62726724|FG000|Overall Study|Adverse Event|2|||
33349412|NCT00975806|62726725|FG001|Overall Study|Adverse Event|1|||
33349413|NCT00975806|62726726|FG002|Overall Study|Adverse Event|2|||
33349414|NCT00975806|62726724|FG000|Overall Study|Disease Progression|1|||
33349415|NCT00975806|62726725|FG001|Overall Study|Disease Progression|5|||
33471251|NCT01147666|62844993|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
33349416|NCT00975806|62726726|FG002|Overall Study|Disease Progression|1|||
33349417|NCT00975806|62726724|FG000|Overall Study|Withdrawal by Subject|1|||
33349418|NCT00975806|62726725|FG001|Overall Study|Withdrawal by Subject|0|||
33349419|NCT00975806|62726726|FG002|Overall Study|Withdrawal by Subject|0|||
33349420|NCT00975806|62726724|FG000|Overall Study|Death|0|||
33471252|NCT01147666|62844979|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
33349421|NCT00975806|62726725|FG001|Overall Study|Death|1|||
33349422|NCT00975806|62726726|FG002|Overall Study|Death|0|||
33349423|NCT00975806|62726724|FG000|Overall Study|Physician decision and disease related|1|||
33349424|NCT00975806|62726725|FG001|Overall Study|Physician decision and disease related|0|||
33349425|NCT00975806|62726726|FG002|Overall Study|Physician decision and disease related|1|||
33349426|NCT00978068|62726738|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
33349427|NCT00978068|62726739|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
33349428|NCT00978068|62726738|FG000|Overall Study|Death|1|||
33349429|NCT00978068|62726739|FG001|Overall Study|Death|2|||
33349430|NCT00978068|62726738|FG000|Overall Study|Lost to Follow-up|1|||
33349431|NCT00978068|62726739|FG001|Overall Study|Lost to Follow-up|2|||
33471253|NCT01147666|62844980|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
33471254|NCT01147666|62844981|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
33471255|NCT01147666|62844982|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
33471256|NCT01147666|62844983|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
33471257|NCT01147666|62844984|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
33471258|NCT01147666|62844985|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
33471259|NCT01147666|62844986|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
33471260|NCT01147666|62844987|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
33471261|NCT01147666|62844988|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
33471262|NCT01147666|62844989|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
33471263|NCT01147666|62844990|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
33471264|NCT01147666|62844991|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
33471265|NCT01147666|62844992|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
33471266|NCT01147666|62844993|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
33471267|NCT01147666|62844979|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
33471268|NCT01147666|62844980|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33471269|NCT01147666|62844981|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33471270|NCT01147666|62844982|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
33471271|NCT01147666|62844983|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33471272|NCT01147666|62844984|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33471273|NCT01147666|62844985|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33471274|NCT01147666|62844986|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33471275|NCT01147666|62844987|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33471276|NCT01147666|62844988|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33349432|NCT00978068|62726738|FG000|Overall Study|Physician Decision|0|||
33349433|NCT00978068|62726739|FG001|Overall Study|Physician Decision|1|||
33349434|NCT00978068|62726738|FG000|Overall Study|Unable to Comply with Study|0|||
33349435|NCT00978068|62726739|FG001|Overall Study|Unable to Comply with Study|2|||
33349436|NCT00603525|62726751|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
33349437|NCT00603525|62726752|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
33349438|NCT00603525|62726753|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
33349439|NCT00603525|62726751|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
33349440|NCT00603525|62726752|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
33349441|NCT00603525|62726753|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
33349442|NCT00603525|62726751|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
33349443|NCT00603525|62726752|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
33349444|NCT00603525|62726753|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
33349445|NCT00603525|62726751|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
33548966|NCT02901431|62940304|FG010|PK Part|Stopped treatment after 8 weeks|0|||
33548967|NCT02901431|62940305|FG011|PK Part|Stopped treatment after 8 weeks|0|||
33548968|NCT02901431|62940306|FG012|PK Part|Stopped treatment after 8 weeks|0|||
33349446|NCT00603525|62726752|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
33349447|NCT00603525|62726753|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33349448|NCT00603525|62726751|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
33349449|NCT00603525|62726752|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
33349450|NCT00603525|62726753|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33349451|NCT00603525|62726751|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
33548969|NCT02901431|62940294|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
33655042|NCT01888367|63069098|FG000|Overall Study|Physician Decision|3|||
33349452|NCT00603525|62726752|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
33349453|NCT00603525|62726753|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
33471277|NCT01147666|62844989|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
33471278|NCT01147666|62844990|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33471279|NCT01147666|62844991|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33471280|NCT01147666|62844992|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33349454|NCT00603525|62726751|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
33471281|NCT01147666|62844993|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33471282|NCT01147666|62844979|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33471283|NCT01147666|62844980|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33471284|NCT01147666|62844981|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33471285|NCT01147666|62844982|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33471286|NCT01147666|62844983|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
33471287|NCT01147666|62844984|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
33349455|NCT00603525|62726752|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
33349456|NCT00603525|62726753|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
33349457|NCT00603525|62726751|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
33349458|NCT00603525|62726752|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
33349459|NCT00603525|62726753|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
33349460|NCT00603525|62726751|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
33349461|NCT00603525|62726752|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
33349462|NCT00603525|62726753|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
33349463|NCT00603525|62726751|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
33349464|NCT00603525|62726752|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
33349465|NCT00603525|62726753|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
33349466|NCT00603525|62726751|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
33349467|NCT00603525|62726752|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
33349468|NCT00603525|62726753|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
33349469|NCT00603525|62726751|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
33349470|NCT00603525|62726752|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
33349471|NCT00603525|62726753|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
33349472|NCT00603525|62726751|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
33349473|NCT00603525|62726752|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
33349474|NCT00603525|62726753|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
33349475|NCT00603525|62726751|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
33349476|NCT00603525|62726752|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
33349477|NCT00603525|62726753|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
33349478|NCT00603525|62726751|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
33349479|NCT00603525|62726752|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
33349480|NCT00603525|62726753|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
33349481|NCT00762034|62726766|FG000|Induction Period|Protocol Violation|1|||
33349482|NCT00762034|62726767|FG001|Induction Period|Protocol Violation|2|||
33349483|NCT00762034|62726766|FG000|Induction Period|Entry Criterion Not Met|12|||
33349484|NCT00762034|62726767|FG001|Induction Period|Entry Criterion Not Met|11|||
33349485|NCT00762034|62726766|FG000|Induction Period|Adverse Event|27|||
33349486|NCT00762034|62726767|FG001|Induction Period|Adverse Event|38|||
33349487|NCT00762034|62726766|FG000|Induction Period|Lost to Follow-up|1|||
33349488|NCT00762034|62726767|FG001|Induction Period|Lost to Follow-up|1|||
33349489|NCT00762034|62726766|FG000|Induction Period|Progressive Disease|73|||
33349490|NCT00762034|62726767|FG001|Induction Period|Progressive Disease|55|||
33349491|NCT00762034|62726766|FG000|Induction Period|Physician Decision|21|||
33349492|NCT00762034|62726767|FG001|Induction Period|Physician Decision|20|||
33349493|NCT00762034|62726766|FG000|Induction Period|Withdrawal by Subject|15|||
33349494|NCT00762034|62726767|FG001|Induction Period|Withdrawal by Subject|19|||
33349495|NCT00762034|62726766|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
33349496|NCT00762034|62726767|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
33349497|NCT00762034|62726766|FG000|Induction Period|Deaths Due to Study Disease|9|||
33471288|NCT01147666|62844985|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33471289|NCT01147666|62844986|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
33471290|NCT01147666|62844987|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33471291|NCT01147666|62844988|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
33471292|NCT01147666|62844989|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33471293|NCT01147666|62844990|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
33471294|NCT01147666|62844991|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33471295|NCT01147666|62844992|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
33471296|NCT01147666|62844993|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33471297|NCT01147666|62844979|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33471298|NCT01147666|62844980|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33471299|NCT01147666|62844981|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33471300|NCT01147666|62844982|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
33471301|NCT01147666|62844983|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33471302|NCT01147666|62844984|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33471303|NCT01147666|62844985|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33349498|NCT00762034|62726767|FG001|Induction Period|Deaths Due to Study Disease|9|||
33349499|NCT00762034|62726766|FG000|Maintenance Period|Protocol Violation|1|||
33349500|NCT00762034|62726767|FG001|Maintenance Period|Protocol Violation|3|||
33349501|NCT00762034|62726766|FG000|Maintenance Period|Entry Criterion Not Met|0|||
33349502|NCT00762034|62726767|FG001|Maintenance Period|Entry Criterion Not Met|2|||
33349503|NCT00762034|62726766|FG000|Maintenance Period|Adverse Event|42|||
33349504|NCT00762034|62726767|FG001|Maintenance Period|Adverse Event|26|||
33349505|NCT00762034|62726766|FG000|Maintenance Period|Progressive Disease|186|||
33349506|NCT00762034|62726767|FG001|Maintenance Period|Progressive Disease|224|||
33349507|NCT00762034|62726766|FG000|Maintenance Period|Physician Decision|25|||
33349508|NCT00762034|62726767|FG001|Maintenance Period|Physician Decision|20|||
33349509|NCT00762034|62726766|FG000|Maintenance Period|Withdrawal by Subject|34|||
33349510|NCT00762034|62726767|FG001|Maintenance Period|Withdrawal by Subject|14|||
33349511|NCT00762034|62726766|FG000|Maintenance Period|Death not due to study disease|2|||
33349512|NCT00762034|62726767|FG001|Maintenance Period|Death not due to study disease|5|||
33349513|NCT00762034|62726766|FG000|Maintenance Period|Death due to study disease|3|||
33349514|NCT00762034|62726767|FG001|Maintenance Period|Death due to study disease|3|||
33349515|NCT00762034|62726766|FG000|Maintenance Period|Other|1|||
33349516|NCT00762034|62726767|FG001|Maintenance Period|Other|1|||
33349517|NCT00761956|62726799|FG000|Overall Study|Lost to Follow-up|6|||
33349518|NCT00761956|62726800|FG001|Overall Study|Lost to Follow-up|11|||
33349519|NCT00761956|62726799|FG000|Overall Study|Withdrawal by Subject|3|||
33349520|NCT00761956|62726800|FG001|Overall Study|Withdrawal by Subject|8|||
33349521|NCT00761956|62726799|FG000|Overall Study|Death|0|||
33349522|NCT00761956|62726800|FG001|Overall Study|Death|1|||
33349523|NCT00761956|62726799|FG000|Overall Study|Adverse Event|26|||
33349524|NCT00761956|62726800|FG001|Overall Study|Adverse Event|34|||
33349525|NCT00754624|62726806|FG000|Overall Study|Adverse Event|16|||
33349526|NCT00754624|62726806|FG000|Overall Study|Death|1|||
33349527|NCT00754624|62726806|FG000|Overall Study|Physician Decision|8|||
33349528|NCT00754624|62726806|FG000|Overall Study|Protocol Violation|1|||
33349529|NCT00754624|62726806|FG000|Overall Study|Withdrawal by Subject|28|||
33349530|NCT00754624|62726806|FG000|Overall Study|Various|12|||
33349531|NCT00754624|62726806|FG000|Overall Study|Lost to Follow-up|3|||
33349532|NCT00586846|62726819|FG000|Overall Study|Physician Decision|1|||
33349533|NCT00586846|62726819|FG000|Overall Study|Death|1|||
33349534|NCT00586846|62726819|FG000|Overall Study|Evaluable for Toxicity Only|4|||
33349535|NCT00973700|62726828|FG000|Overall Study|Withdrawal by Subject|2|||
33349536|NCT00973700|62726829|FG001|Overall Study|Withdrawal by Subject|2|||
33349537|NCT00973700|62726830|FG002|Overall Study|Withdrawal by Subject|8|||
33349538|NCT00973700|62726831|FG003|Overall Study|Withdrawal by Subject|4|||
33349539|NCT00973700|62726832|FG004|Overall Study|Withdrawal by Subject|4|||
33349540|NCT00973700|62726828|FG000|Overall Study|Lost to Follow-up|5|||
33349541|NCT00973700|62726829|FG001|Overall Study|Lost to Follow-up|0|||
33349542|NCT00973700|62726830|FG002|Overall Study|Lost to Follow-up|1|||
33349543|NCT00973700|62726831|FG003|Overall Study|Lost to Follow-up|8|||
33349544|NCT00973700|62726832|FG004|Overall Study|Lost to Follow-up|5|||
33349545|NCT00973700|62726828|FG000|Overall Study|Inappropriate enrolment|0|||
33349546|NCT00973700|62726829|FG001|Overall Study|Inappropriate enrolment|0|||
33349547|NCT00973700|62726830|FG002|Overall Study|Inappropriate enrolment|0|||
33349548|NCT00973700|62726831|FG003|Overall Study|Inappropriate enrolment|4|||
33349549|NCT00973700|62726832|FG004|Overall Study|Inappropriate enrolment|0|||
33349550|NCT00973700|62726828|FG000|Overall Study|Unable to Classify|0|||
33349551|NCT00973700|62726829|FG001|Overall Study|Unable to Classify|0|||
33349552|NCT00973700|62726830|FG002|Overall Study|Unable to Classify|1|||
33349553|NCT00973700|62726831|FG003|Overall Study|Unable to Classify|2|||
33349554|NCT00973700|62726832|FG004|Overall Study|Unable to Classify|1|||
33349555|NCT00754390|62726859|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
33349556|NCT00754390|62726859|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
33349557|NCT00754390|62726859|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
33349558|NCT00754390|62726859|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
33349559|NCT00754234|62726866|FG000|Overall Study|Withdrawal by Subject|3|||
33349560|NCT00753922|62726874|FG000|Overall Study|Lost to Follow-up|155|||
33349561|NCT00753922|62726875|FG001|Overall Study|Lost to Follow-up|24|||
33349562|NCT00753922|62726876|FG002|Overall Study|Lost to Follow-up|28|||
33349563|NCT00753922|62726877|FG003|Overall Study|Lost to Follow-up|5|||
33349564|NCT00753922|62726874|FG000|Overall Study|Withdrawal by Subject|9|||
33349565|NCT00753922|62726875|FG001|Overall Study|Withdrawal by Subject|11|||
33349566|NCT00753922|62726876|FG002|Overall Study|Withdrawal by Subject|4|||
33349567|NCT00753922|62726877|FG003|Overall Study|Withdrawal by Subject|2|||
33349568|NCT00753922|62726874|FG000|Overall Study|Patient Non-compliance|55|||
33349569|NCT00753922|62726875|FG001|Overall Study|Patient Non-compliance|22|||
33349570|NCT00753922|62726876|FG002|Overall Study|Patient Non-compliance|14|||
33349571|NCT00753922|62726877|FG003|Overall Study|Patient Non-compliance|11|||
33349572|NCT00753922|62726874|FG000|Overall Study|Patients Not Completing Visit|11|||
33349573|NCT00753922|62726875|FG001|Overall Study|Patients Not Completing Visit|0|||
33349574|NCT00753922|62726876|FG002|Overall Study|Patients Not Completing Visit|1|||
33349575|NCT00753922|62726877|FG003|Overall Study|Patients Not Completing Visit|0|||
33349576|NCT00753922|62726874|FG000|Overall Study|Death|2|||
33349577|NCT00753922|62726875|FG001|Overall Study|Death|23|||
33349578|NCT00753922|62726876|FG002|Overall Study|Death|2|||
33349579|NCT00753922|62726877|FG003|Overall Study|Death|1|||
33349580|NCT00753922|62726874|FG000|Overall Study|Discontinuation Due to Explantation|14|||
33349581|NCT00753922|62726875|FG001|Overall Study|Discontinuation Due to Explantation|14|||
33349582|NCT00753922|62726876|FG002|Overall Study|Discontinuation Due to Explantation|14|||
33349583|NCT00753922|62726877|FG003|Overall Study|Discontinuation Due to Explantation|4|||
33349584|NCT00761176|62726889|FG000|Overall Study|Death|1|||
33349585|NCT00761176|62726890|FG001|Overall Study|Death|0|||
33349586|NCT00761176|62726889|FG000|Overall Study|Withdrawal by Subject|1|||
33349587|NCT00761176|62726890|FG001|Overall Study|Withdrawal by Subject|1|||
33349588|NCT00760552|62726898|FG000|Overall Study|Death|2|||
33349589|NCT00760552|62726899|FG001|Overall Study|Death|0|||
33349590|NCT00760552|62726898|FG000|Overall Study|Lost to Follow-up|11|||
33349591|NCT00760552|62726899|FG001|Overall Study|Lost to Follow-up|10|||
33349592|NCT00753766|62726907|FG000|Overall Study|Physician Decision|1|||
33349593|NCT00753766|62726908|FG001|Overall Study|Physician Decision|0|||
33349594|NCT00976898|62726915|FG000|Overall Study|Protocol Violation|1|||
33349595|NCT00976898|62726915|FG000|Overall Study|Adverse Event|1|||
33349596|NCT00976898|62726915|FG000|Overall Study|Physician Decision|1|||
33349597|NCT00976898|62726915|FG000|Overall Study|Liver Transplant|1|||
33349598|NCT00976898|62726915|FG000|Overall Study|Progressive Disease|1|||
33349599|NCT02620579|62726927|FG000|Overall Study|Physician Decision|0|||
33349600|NCT02620579|62726928|FG001|Overall Study|Physician Decision|0|||
33349601|NCT02620579|62726929|FG002|Overall Study|Physician Decision|0|||
33349602|NCT02620579|62726930|FG003|Overall Study|Physician Decision|1|||
33349603|NCT02620579|62726927|FG000|Overall Study|Withdrawal by Subject|0|||
33349604|NCT02620579|62726928|FG001|Overall Study|Withdrawal by Subject|1|||
33349605|NCT02620579|62726929|FG002|Overall Study|Withdrawal by Subject|1|||
33349606|NCT02620579|62726930|FG003|Overall Study|Withdrawal by Subject|0|||
33349607|NCT00753688|62726946|FG000|Overall Study|Death|102|||
33349608|NCT00753688|62726947|FG001|Overall Study|Death|203|||
33349609|NCT00753688|62726946|FG000|Overall Study|Missing|4|||
33349610|NCT00753688|62726947|FG001|Overall Study|Missing|9|||
33349611|NCT00753688|62726946|FG000|Overall Study|Participant Withdrew Consent|2|||
33349612|NCT00753688|62726947|FG001|Overall Study|Participant Withdrew Consent|2|||
33349613|NCT00753688|62726946|FG000|Overall Study|Ongoing - in Follow-up|15|||
33349614|NCT00753688|62726947|FG001|Overall Study|Ongoing - in Follow-up|31|||
33349615|NCT00753688|62726946|FG000|Overall Study|Adverse Event|0|||
33349616|NCT00753688|62726947|FG001|Overall Study|Adverse Event|1|||
33349617|NCT00586612|62726955|FG000|Primary Phase|Protocol Violation|1|||
33349618|NCT00586612|62726956|FG001|Primary Phase|Protocol Violation|0|||
33349619|NCT00586612|62726955|FG000|Primary Phase|Lost to Follow-up|0|||
33349620|NCT00586612|62726956|FG001|Primary Phase|Lost to Follow-up|1|||
33349621|NCT00586612|62726955|FG000|Primary Phase|Withdrawal by Subject|0|||
33349622|NCT00586612|62726956|FG001|Primary Phase|Withdrawal by Subject|2|||
33349623|NCT00586612|62726955|FG000|Booster Phase|Lost to Follow-up|3|||
33349624|NCT00586612|62726956|FG001|Booster Phase|Lost to Follow-up|1|||
33349625|NCT00586690|62726964|FG000|Overall Study|Death|2|||
33349626|NCT00586690|62726965|FG001|Overall Study|Death|0|||
33349627|NCT00586690|62726964|FG000|Overall Study|Disease Progression|10|||
33349628|NCT00586690|62726965|FG001|Overall Study|Disease Progression|0|||
33349629|NCT00586690|62726964|FG000|Overall Study|Adverse Event|1|||
33349630|NCT00586690|62726965|FG001|Overall Study|Adverse Event|0|||
33349631|NCT00586690|62726964|FG000|Overall Study|Lack of Efficacy|2|||
33349632|NCT00586690|62726965|FG001|Overall Study|Lack of Efficacy|0|||
33349633|NCT00586690|62726964|FG000|Overall Study|Lab can't accommodate|1|||
33349634|NCT00586690|62726965|FG001|Overall Study|Lab can't accommodate|0|||
33548970|NCT02901431|62940295|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33548971|NCT02901431|62940296|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
33548972|NCT02901431|62940297|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33349635|NCT00976820|62726974|FG000|Overall Study|Lost to Follow-up|5|||
33349636|NCT00976820|62726975|FG001|Overall Study|Lost to Follow-up|16|||
33548973|NCT02901431|62940298|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33548974|NCT02901431|62940299|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33349637|NCT00976820|62726976|FG002|Overall Study|Lost to Follow-up|2|||
33349638|NCT00976820|62726977|FG003|Overall Study|Lost to Follow-up|3|||
33349639|NCT00976820|62726974|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
33349640|NCT00976820|62726975|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
33349641|NCT00976820|62726976|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
33349642|NCT00976820|62726977|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
33349643|NCT00976820|62726974|FG000|Overall Study|Withdrawal by Subject|2|||
33349644|NCT00976820|62726975|FG001|Overall Study|Withdrawal by Subject|4|||
33349645|NCT00976820|62726976|FG002|Overall Study|Withdrawal by Subject|1|||
33349646|NCT00976820|62726977|FG003|Overall Study|Withdrawal by Subject|4|||
33349647|NCT00760474|62727028|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
33349648|NCT00760474|62727029|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
33349649|NCT00760474|62727028|FG000|Placebo Washout Period|Other|0|||
33349650|NCT00760474|62727029|FG001|Placebo Washout Period|Other|1|||
33349651|NCT00760474|62727028|FG000|Period 2 (P2)|Lost to Follow-up|1|||
33349652|NCT00760474|62727029|FG001|Period 2 (P2)|Lost to Follow-up|0|||
33349653|NCT00760474|62727028|FG000|Period 2 (P2)|Adverse Event|0|||
33349654|NCT00760474|62727029|FG001|Period 2 (P2)|Adverse Event|1|||
33349655|NCT00975416|62727038|FG000|Overall Study|early discharge from tx|3|||
33349656|NCT00975416|62727039|FG001|Overall Study|early discharge from tx|5|||
33349657|NCT00760084|62727046|FG000|Overall Study|Physician Decision|5|||
33349658|NCT00760084|62727046|FG000|Overall Study|Withdrawal by Subject|2|||
33349659|NCT00760084|62727046|FG000|Overall Study|Progressive Disease|3|||
33349660|NCT00752206|62727052|FG000|Overall Study|Disease progression|8|||
33349661|NCT00752206|62727053|FG001|Overall Study|Disease progression|11|||
33349662|NCT00752206|62727052|FG000|Overall Study|Pregnancy|1|||
33349663|NCT00752206|62727053|FG001|Overall Study|Pregnancy|0|||
33349664|NCT00752128|62727059|FG000|Overall Study|Withdrawal by Subject|4|||
33349665|NCT00976508|62727066|FG000|Overall Study|Death|7|||
33349666|NCT00976508|62727067|FG001|Overall Study|Death|1|||
33349667|NCT00976508|62727066|FG000|Overall Study|Lost to Follow-up|1|||
33349668|NCT00976508|62727067|FG001|Overall Study|Lost to Follow-up|0|||
33349669|NCT00976508|62727066|FG000|Overall Study|Withdrawal by Subject|1|||
33349670|NCT00976508|62727067|FG001|Overall Study|Withdrawal by Subject|0|||
33349671|NCT00976508|62727066|FG000|Overall Study|Disease Progression|4|||
33349672|NCT00976508|62727067|FG001|Overall Study|Disease Progression|4|||
33349673|NCT00976508|62727066|FG000|Overall Study|Subject Enrolled in Hospice|1|||
33349674|NCT00976508|62727067|FG001|Overall Study|Subject Enrolled in Hospice|0|||
33349675|NCT00976508|62727066|FG000|Overall Study|Terminated by the Sponsor|0|||
33349676|NCT00976508|62727067|FG001|Overall Study|Terminated by the Sponsor|1|||
33349677|NCT00973622|62727078|FG000|Overall Study|did not attend MRI|14|||
33349678|NCT00973622|62727079|FG001|Overall Study|did not attend MRI|3|||
33349679|NCT00973622|62727078|FG000|Overall Study|did not pass MRI screen|6|||
33349680|NCT00973622|62727079|FG001|Overall Study|did not pass MRI screen|0|||
33349681|NCT00973622|62727078|FG000|Overall Study|did not complete rTMS sessions|11|||
33349682|NCT00973622|62727079|FG001|Overall Study|did not complete rTMS sessions|2|||
33349683|NCT04044716|62727087|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
33349684|NCT04044716|62727088|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
33349685|NCT04044716|62727089|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
33349686|NCT04044716|62727087|FG000|Overall Study|Lost to Follow-up|2|||
33349687|NCT04044716|62727088|FG001|Overall Study|Lost to Follow-up|3|||
33349688|NCT04044716|62727089|FG002|Overall Study|Lost to Follow-up|0|||
33349689|NCT00753454|62727096|FG000|Overall Study|Adverse Event|4|||
33349690|NCT00753454|62727096|FG000|Overall Study|Lack of Efficacy|1|||
33349691|NCT00753454|62727096|FG000|Overall Study|Lost to Follow-up|3|||
33349692|NCT00753454|62727096|FG000|Overall Study|Withdrawal by Subject|5|||
33349693|NCT00753454|62727096|FG000|Overall Study|Investigator Decision|1|||
33349694|NCT00976274|62727102|FG000|Overall Study|Lost to Follow-up|5|||
33349695|NCT00976274|62727103|FG001|Overall Study|Lost to Follow-up|5|||
33349696|NCT00976274|62727102|FG000|Overall Study|Withdrawal by Subject|1|||
33349697|NCT00976274|62727103|FG001|Overall Study|Withdrawal by Subject|1|||
33349698|NCT00976274|62727102|FG000|Overall Study|Physician Decision|1|||
33349699|NCT00976274|62727103|FG001|Overall Study|Physician Decision|2|||
33349700|NCT00759148|62727111|FG000|Overall Study|Adverse Event|1|||
33349701|NCT00759148|62727112|FG001|Overall Study|Adverse Event|6|||
33349702|NCT00759148|62727111|FG000|Overall Study|Withdrawal by Subject|3|||
33349703|NCT00759148|62727112|FG001|Overall Study|Withdrawal by Subject|7|||
33471304|NCT01147666|62844986|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33471305|NCT01147666|62844987|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33471306|NCT01147666|62844988|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33471307|NCT01147666|62844989|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
33471308|NCT01147666|62844990|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33471309|NCT01147666|62844991|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33471310|NCT01147666|62844992|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33349704|NCT00759148|62727111|FG000|Overall Study|Lost to Follow-up|3|||
33349705|NCT00759148|62727112|FG001|Overall Study|Lost to Follow-up|9|||
33349706|NCT00759148|62727111|FG000|Overall Study|Treatment Failure|6|||
33349707|NCT00759148|62727112|FG001|Overall Study|Treatment Failure|10|||
33349708|NCT00759148|62727111|FG000|Overall Study|Reason not given|1|||
33349709|NCT00759148|62727112|FG001|Overall Study|Reason not given|0|||
33349710|NCT02794285|62727122|FG000|Overall Study|Adverse Event|11|||
33349711|NCT02794285|62727123|FG001|Overall Study|Adverse Event|4|||
33349712|NCT02794285|62727124|FG002|Overall Study|Adverse Event|5|||
33349713|NCT02794285|62727125|FG003|Overall Study|Adverse Event|8|||
33349714|NCT02794285|62727122|FG000|Overall Study|Condition Under Investigation Improved|1|||
33349715|NCT02794285|62727123|FG001|Overall Study|Condition Under Investigation Improved|0|||
33471311|NCT01147666|62844993|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33471312|NCT01147666|62844979|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33349716|NCT02794285|62727124|FG002|Overall Study|Condition Under Investigation Improved|0|||
33349717|NCT02794285|62727125|FG003|Overall Study|Condition Under Investigation Improved|0|||
33349718|NCT02794285|62727122|FG000|Overall Study|Condition Under Investigation Worsened|0|||
33349719|NCT02794285|62727123|FG001|Overall Study|Condition Under Investigation Worsened|2|||
33349720|NCT02794285|62727124|FG002|Overall Study|Condition Under Investigation Worsened|1|||
33349721|NCT02794285|62727125|FG003|Overall Study|Condition Under Investigation Worsened|0|||
33349722|NCT02794285|62727122|FG000|Overall Study|Death|2|||
33349723|NCT02794285|62727123|FG001|Overall Study|Death|1|||
33349724|NCT02794285|62727124|FG002|Overall Study|Death|2|||
33349725|NCT02794285|62727125|FG003|Overall Study|Death|0|||
33349726|NCT02794285|62727122|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
33349727|NCT02794285|62727123|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
33349728|NCT02794285|62727124|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
33349729|NCT02794285|62727125|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
33349730|NCT02794285|62727122|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
33349731|NCT02794285|62727123|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
33349732|NCT02794285|62727124|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
33349733|NCT02794285|62727125|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
33349734|NCT02794285|62727122|FG000|Overall Study|Lack of Efficacy|10|||
33349735|NCT02794285|62727123|FG001|Overall Study|Lack of Efficacy|6|||
33349736|NCT02794285|62727124|FG002|Overall Study|Lack of Efficacy|3|||
33349737|NCT02794285|62727125|FG003|Overall Study|Lack of Efficacy|3|||
33349738|NCT02794285|62727122|FG000|Overall Study|Lost to Follow-up|5|||
33349739|NCT02794285|62727123|FG001|Overall Study|Lost to Follow-up|6|||
33349740|NCT02794285|62727124|FG002|Overall Study|Lost to Follow-up|3|||
33349741|NCT02794285|62727125|FG003|Overall Study|Lost to Follow-up|1|||
33349742|NCT02794285|62727122|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
33349743|NCT02794285|62727123|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
33349744|NCT02794285|62727124|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
33349745|NCT02794285|62727125|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
33349746|NCT02794285|62727122|FG000|Overall Study|Withdrawal by Subject|38|||
33349747|NCT02794285|62727123|FG001|Overall Study|Withdrawal by Subject|29|||
33349748|NCT02794285|62727124|FG002|Overall Study|Withdrawal by Subject|20|||
33349749|NCT02794285|62727125|FG003|Overall Study|Withdrawal by Subject|12|||
33349750|NCT02794285|62727122|FG000|Overall Study|Missing|1|||
33349751|NCT02794285|62727123|FG001|Overall Study|Missing|0|||
33349752|NCT02794285|62727124|FG002|Overall Study|Missing|0|||
33349753|NCT02794285|62727125|FG003|Overall Study|Missing|0|||
33349754|NCT02794285|62727122|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
33349755|NCT02794285|62727123|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
33349756|NCT02794285|62727124|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
33349757|NCT02794285|62727125|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
33349758|NCT02794285|62727122|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
33349759|NCT02794285|62727123|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
33349760|NCT02794285|62727124|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
33349761|NCT02794285|62727125|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
33349762|NCT00970268|62727137|FG000|Overall Study|Withdrawal by Subject|12|||
33349763|NCT00970268|62727138|FG001|Overall Study|Withdrawal by Subject|19|||
33349764|NCT00970268|62727137|FG000|Overall Study|Adverse Event|15|||
33349765|NCT00970268|62727138|FG001|Overall Study|Adverse Event|12|||
33349766|NCT00970268|62727137|FG000|Overall Study|Lack of Efficacy|3|||
33349767|NCT00970268|62727138|FG001|Overall Study|Lack of Efficacy|6|||
33349768|NCT00970268|62727137|FG000|Overall Study|Protocol Violation|4|||
33349769|NCT00970268|62727138|FG001|Overall Study|Protocol Violation|7|||
33349770|NCT00970268|62727137|FG000|Overall Study|Other Reason|3|||
33349771|NCT00970268|62727138|FG001|Overall Study|Other Reason|1|||
33349772|NCT00970268|62727137|FG000|Overall Study|COPD Exacerbation|4|||
33349773|NCT00970268|62727138|FG001|Overall Study|COPD Exacerbation|2|||
33349774|NCT00970268|62727137|FG000|Overall Study|Lost to Follow-up|1|||
33349775|NCT00970268|62727138|FG001|Overall Study|Lost to Follow-up|2|||
33349776|NCT00970268|62727137|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
33471313|NCT01147666|62844980|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33655043|NCT01888367|63069099|FG001|Overall Study|Physician Decision|4|||
33349777|NCT00970268|62727138|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
33349778|NCT00969332|62727150|FG000|Overall Study|Physician Decision|8|||
33349779|NCT00969332|62727150|FG000|Overall Study|Withdrawal by Subject|3|||
33349780|NCT00968864|62727155|FG000|Overall Study|Protocol exception/ not evaluable|1|||
33349781|NCT00758680|62727164|FG000|Overall Study|Adverse Event|0|||
33349782|NCT00758680|62727165|FG001|Overall Study|Adverse Event|0|||
33349783|NCT00758680|62727166|FG002|Overall Study|Adverse Event|0|||
33349784|NCT00758680|62727167|FG003|Overall Study|Adverse Event|0|||
33349785|NCT00758680|62727168|FG004|Overall Study|Adverse Event|0|||
33349786|NCT00758680|62727169|FG005|Overall Study|Adverse Event|0|||
33349787|NCT00758680|62727170|FG006|Overall Study|Adverse Event|0|||
33349788|NCT00758680|62727171|FG007|Overall Study|Adverse Event|1|||
33349789|NCT00758680|62727172|FG008|Overall Study|Adverse Event|0|||
33349790|NCT00758680|62727173|FG009|Overall Study|Adverse Event|1|||
33349791|NCT00758680|62727164|FG000|Overall Study|Laboratory Adverse Event|0|||
33349792|NCT00758680|62727165|FG001|Overall Study|Laboratory Adverse Event|0|||
33349793|NCT00758680|62727166|FG002|Overall Study|Laboratory Adverse Event|0|||
33349794|NCT00758680|62727167|FG003|Overall Study|Laboratory Adverse Event|0|||
33471314|NCT01147666|62844981|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33471315|NCT01147666|62844982|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33471316|NCT01147666|62844983|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33471317|NCT01147666|62844984|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33471318|NCT01147666|62844985|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33471319|NCT01147666|62844986|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33471320|NCT01147666|62844987|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33471321|NCT01147666|62844988|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33471322|NCT01147666|62844989|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33471323|NCT01147666|62844990|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
33471324|NCT01147666|62844991|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
33471325|NCT01147666|62844992|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33349795|NCT00758680|62727168|FG004|Overall Study|Laboratory Adverse Event|0|||
33349796|NCT00758680|62727169|FG005|Overall Study|Laboratory Adverse Event|0|||
33349797|NCT00758680|62727170|FG006|Overall Study|Laboratory Adverse Event|0|||
33349798|NCT00758680|62727171|FG007|Overall Study|Laboratory Adverse Event|0|||
33349799|NCT00758680|62727172|FG008|Overall Study|Laboratory Adverse Event|1|||
33548975|NCT02901431|62940300|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33548976|NCT02901431|62940301|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33548977|NCT02901431|62940302|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33655044|NCT01888367|63069100|FG002|Overall Study|Physician Decision|2|||
33349800|NCT00758680|62727173|FG009|Overall Study|Laboratory Adverse Event|0|||
33349801|NCT00758680|62727164|FG000|Overall Study|Withdrawal by Subject|0|||
33349802|NCT00758680|62727165|FG001|Overall Study|Withdrawal by Subject|0|||
33349803|NCT00758680|62727166|FG002|Overall Study|Withdrawal by Subject|0|||
33349804|NCT00758680|62727167|FG003|Overall Study|Withdrawal by Subject|0|||
33349805|NCT00758680|62727168|FG004|Overall Study|Withdrawal by Subject|0|||
33349806|NCT00758680|62727169|FG005|Overall Study|Withdrawal by Subject|0|||
33349807|NCT00758680|62727170|FG006|Overall Study|Withdrawal by Subject|1|||
33349808|NCT00758680|62727171|FG007|Overall Study|Withdrawal by Subject|0|||
33349809|NCT00758680|62727172|FG008|Overall Study|Withdrawal by Subject|1|||
33349810|NCT00758680|62727173|FG009|Overall Study|Withdrawal by Subject|0|||
33349811|NCT00758602|62727198|FG000|Overall Study|Adverse Event|11|||
33349812|NCT00758602|62727199|FG001|Overall Study|Adverse Event|10|||
33349813|NCT00758602|62727198|FG000|Overall Study|Lost to Follow-up|4|||
33349814|NCT00758602|62727199|FG001|Overall Study|Lost to Follow-up|3|||
33471326|NCT01147666|62844993|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
33471327|NCT01147666|62844979|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
33471328|NCT01147666|62844980|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
33471329|NCT01147666|62844981|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
33471330|NCT01147666|62844982|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
33471331|NCT01147666|62844983|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
33471332|NCT01147666|62844984|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
33471333|NCT01147666|62844985|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
33471334|NCT01147666|62844986|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
33471335|NCT01147666|62844987|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
33471336|NCT01147666|62844988|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
33471337|NCT01147666|62844989|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
33471338|NCT01147666|62844990|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
33471339|NCT01147666|62844991|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
33471340|NCT01147666|62844992|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
33655045|NCT01888367|63069098|FG000|Overall Study|Death|2|||
33655046|NCT01888367|63069099|FG001|Overall Study|Death|0|||
33349815|NCT00758602|62727198|FG000|Overall Study|Withdrawal by Subject|1|||
33471341|NCT01147666|62844993|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
33471342|NCT01147666|62844979|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33471343|NCT01147666|62844980|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33548978|NCT02901431|62940303|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33655047|NCT01888367|63069100|FG002|Overall Study|Death|1|||
33349816|NCT00758602|62727199|FG001|Overall Study|Withdrawal by Subject|3|||
33349817|NCT00758602|62727198|FG000|Overall Study|Protocol Violation|0|||
33349818|NCT00758602|62727199|FG001|Overall Study|Protocol Violation|2|||
33349819|NCT00758602|62727198|FG000|Overall Study|Death|0|||
33349820|NCT00758602|62727199|FG001|Overall Study|Death|1|||
33349821|NCT00758602|62727198|FG000|Overall Study|Reason not specified|3|||
33349822|NCT00758602|62727199|FG001|Overall Study|Reason not specified|3|||
33349823|NCT00711529|62727208|FG000|Overall Study|Protocol Violation|2|||
33349824|NCT00711529|62727209|FG001|Overall Study|Protocol Violation|0|||
33349825|NCT00711529|62727208|FG000|Overall Study|Withdrawal by Subject|2|||
33349826|NCT00711529|62727209|FG001|Overall Study|Withdrawal by Subject|6|||
33349827|NCT00601419|62727215|FG000|Overall Study|Lost to Follow-up|3|||
33349828|NCT00601419|62727215|FG000|Overall Study|Missed Visits|1|||
33349829|NCT00712933|62727235|FG000|Overall Study|Adverse Event|69|||
33349830|NCT00712933|62727235|FG000|Overall Study|Lack of Efficacy|6|||
33349831|NCT00712933|62727235|FG000|Overall Study|Lost to Follow-up|22|||
33349832|NCT00712933|62727235|FG000|Overall Study|Non-compliance with study drug|13|||
33349833|NCT00712933|62727235|FG000|Overall Study|Other Pregnancy|37|||
33349834|NCT00712933|62727235|FG000|Overall Study|Sponsor decision|14|||
33349835|NCT00712933|62727235|FG000|Overall Study|Withdrew consent|4|||
33349836|NCT00712933|62727235|FG000|Overall Study|Hip replacement surgery|1|||
33349837|NCT00712933|62727235|FG000|Overall Study|Involved in Clinical research|3|||
33349838|NCT00712933|62727235|FG000|Overall Study|Participant hospitalized|1|||
33349839|NCT00712933|62727235|FG000|Overall Study|Participant travelled overseas|2|||
33349840|NCT00712933|62727235|FG000|Overall Study|Death of patient|1|||
33349841|NCT00712933|62727235|FG000|Overall Study|Other Physician decision|1|||
33349842|NCT00712933|62727235|FG000|Overall Study|Not committed to contraception|1|||
33349843|NCT00712933|62727235|FG000|Overall Study|Participant received medication|1|||
33349844|NCT00712933|62727235|FG000|Overall Study|Physician Decision|36|||
33349845|NCT00712933|62727235|FG000|Overall Study|Protocol Violation|4|||
33349846|NCT00712933|62727235|FG000|Overall Study|Withdrawal by Subject|151|||
33349847|NCT00712543|62727245|FG000|Day 8-14|Lost to Follow-up|0|||
33349848|NCT00712543|62727246|FG001|Day 8-14|Lost to Follow-up|2|||
33349849|NCT00709111|62727252|FG000|Overall Study|Withdrawal by Subject|1|||
33349850|NCT00709111|62727252|FG000|Overall Study|Unable to attend clinic visits|1|||
33349851|NCT00710749|62727256|FG000|First Intervention|Withdrawal by Subject|1|||
33471344|NCT01147666|62844981|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33471345|NCT01147666|62844982|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33471346|NCT01147666|62844983|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
33471347|NCT01147666|62844984|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
33471348|NCT01147666|62844985|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
33471349|NCT01147666|62844986|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
33471350|NCT01147666|62844987|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33471351|NCT01147666|62844988|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
33471352|NCT01147666|62844989|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33471353|NCT01147666|62844990|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33471354|NCT01147666|62844991|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
33471355|NCT01147666|62844992|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33471356|NCT01147666|62844993|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
33471357|NCT01147666|62844979|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33471358|NCT01147666|62844980|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33471359|NCT01147666|62844981|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33471360|NCT01147666|62844982|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
33471361|NCT01147666|62844983|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33471362|NCT01147666|62844984|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33471363|NCT01147666|62844985|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33471364|NCT01147666|62844986|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33471365|NCT01147666|62844987|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33471366|NCT01147666|62844988|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33471367|NCT01147666|62844989|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33471368|NCT01147666|62844990|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33471369|NCT01147666|62844991|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33471370|NCT01147666|62844992|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33471371|NCT01147666|62844993|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33471372|NCT01147666|62844979|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33349852|NCT00710749|62727257|FG001|First Intervention|Withdrawal by Subject|0|||
33349853|NCT00699907|62727277|FG000|Overall Study|Withdrawal by Subject|2|||
33349854|NCT00699907|62727278|FG001|Overall Study|Withdrawal by Subject|1|||
33349855|NCT00699907|62727279|FG002|Overall Study|Withdrawal by Subject|0|||
33471373|NCT01147666|62844980|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33471374|NCT01147666|62844981|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33471375|NCT01147666|62844982|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33471376|NCT01147666|62844983|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
33349856|NCT00699907|62727277|FG000|Overall Study|No usable sample|0|||
33349857|NCT00699907|62727278|FG001|Overall Study|No usable sample|9|||
33471377|NCT01147666|62844984|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
33471378|NCT01147666|62844985|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33471379|NCT01147666|62844986|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
33471380|NCT01147666|62844987|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33471381|NCT01147666|62844988|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
33471382|NCT01147666|62844989|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33471383|NCT01147666|62844990|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33471384|NCT01147666|62844991|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33471385|NCT01147666|62844992|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
33471386|NCT01147666|62844993|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33471387|NCT01147666|62844979|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33471388|NCT01147666|62844980|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33471389|NCT01147666|62844981|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33471390|NCT01147666|62844982|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
33471391|NCT01147666|62844983|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33471392|NCT01147666|62844984|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33471393|NCT01147666|62844985|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33548979|NCT02901431|62940304|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33349858|NCT00699907|62727279|FG002|Overall Study|No usable sample|8|||
33349859|NCT00710593|62727289|FG000|Overall Study|Incarceration|1|||
33349860|NCT00710593|62727290|FG001|Overall Study|Incarceration|0|||
33349861|NCT00710593|62727289|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
33349862|NCT00710593|62727290|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
33349863|NCT00710593|62727289|FG000|Overall Study|Lost to Follow-up|3|||
33349864|NCT00710593|62727290|FG001|Overall Study|Lost to Follow-up|1|||
33349865|NCT00710593|62727289|FG000|Overall Study|Moved out of area|1|||
33349866|NCT00710593|62727290|FG001|Overall Study|Moved out of area|0|||
33349867|NCT00710593|62727289|FG000|Overall Study|Failure to adhere or complete study eval|1|||
33349868|NCT00710593|62727290|FG001|Overall Study|Failure to adhere or complete study eval|1|||
33349869|NCT00710593|62727289|FG000|Overall Study|Protocol Violation|1|||
33349870|NCT00710593|62727290|FG001|Overall Study|Protocol Violation|1|||
33349871|NCT00710593|62727289|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
33349872|NCT00710593|62727290|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
33349873|NCT00599313|62727312|FG000|Overall Study|Adverse Event|19|||
33349874|NCT00599313|62727312|FG000|Overall Study|Disease Progression|12|||
33349875|NCT00599313|62727312|FG000|Overall Study|Patient Request|4|||
33349876|NCT00599313|62727312|FG000|Overall Study|Ineligible|1|||
33349877|NCT00708175|62727318|FG000|Overall Study|Adverse Event|4|||
33349878|NCT00708175|62727319|FG001|Overall Study|Adverse Event|5|||
33349879|NCT00708175|62727318|FG000|Overall Study|Protocol Violation|2|||
33349880|NCT00708175|62727319|FG001|Overall Study|Protocol Violation|3|||
33349881|NCT00708175|62727318|FG000|Overall Study|Lost to Follow-up|5|||
33349882|NCT00708175|62727319|FG001|Overall Study|Lost to Follow-up|3|||
33349883|NCT00708175|62727318|FG000|Overall Study|Withdrawal by Subject|5|||
33349884|NCT00708175|62727319|FG001|Overall Study|Withdrawal by Subject|7|||
33349885|NCT00708175|62727318|FG000|Overall Study|BMD loss >7%|2|||
33349886|NCT00708175|62727319|FG001|Overall Study|BMD loss >7%|3|||
33349887|NCT00707239|62727328|FG000|Overall Study|Adverse Event|5|||
33349888|NCT00707239|62727329|FG001|Overall Study|Adverse Event|3|||
33349889|NCT00707239|62727330|FG002|Overall Study|Adverse Event|2|||
33349890|NCT00707239|62727328|FG000|Overall Study|Death|3|||
33349891|NCT00707239|62727329|FG001|Overall Study|Death|1|||
33349892|NCT00707239|62727330|FG002|Overall Study|Death|3|||
33349893|NCT00707239|62727328|FG000|Overall Study|Physician Decision|1|||
33349894|NCT00707239|62727329|FG001|Overall Study|Physician Decision|1|||
33349895|NCT00707239|62727330|FG002|Overall Study|Physician Decision|2|||
33349896|NCT00707239|62727328|FG000|Overall Study|Protocol Violation|0|||
33349897|NCT00707239|62727329|FG001|Overall Study|Protocol Violation|0|||
33349898|NCT00707239|62727330|FG002|Overall Study|Protocol Violation|1|||
33349899|NCT00707239|62727328|FG000|Overall Study|Lack of Efficacy|1|||
33349900|NCT00707239|62727329|FG001|Overall Study|Lack of Efficacy|2|||
33349901|NCT00707239|62727330|FG002|Overall Study|Lack of Efficacy|0|||
33548980|NCT02901431|62940305|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33349902|NCT00707239|62727328|FG000|Overall Study|Randomized, but not treated|1|||
33349903|NCT00707239|62727329|FG001|Overall Study|Randomized, but not treated|1|||
33349904|NCT00707239|62727330|FG002|Overall Study|Randomized, but not treated|1|||
33349905|NCT00707239|62727328|FG000|Overall Study|Other|8|||
33548981|NCT02901431|62940306|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33548982|NCT02901431|62940294|FG000|PK Part|Discontinued per Sponsor|0|||
33349906|NCT00707239|62727329|FG001|Overall Study|Other|3|||
33349907|NCT00707239|62727330|FG002|Overall Study|Other|5|||
33349908|NCT00968708|62727343|FG000|Overall Study|Adverse Event|169|||
33349909|NCT00968708|62727344|FG001|Overall Study|Adverse Event|150|||
33349910|NCT00968708|62727343|FG000|Overall Study|Major Protocol Deviation|0|||
33349911|NCT00968708|62727344|FG001|Overall Study|Major Protocol Deviation|1|||
33349912|NCT00968708|62727343|FG000|Overall Study|Lost to Follow-up|19|||
33349913|NCT00968708|62727344|FG001|Overall Study|Lost to Follow-up|11|||
33349914|NCT00968708|62727343|FG000|Overall Study|Voluntary Withdrawal|104|||
33349915|NCT00968708|62727344|FG001|Overall Study|Voluntary Withdrawal|101|||
33349916|NCT00968708|62727343|FG000|Overall Study|Investigator Discretion|0|||
33349917|NCT00968708|62727344|FG001|Overall Study|Investigator Discretion|1|||
33349918|NCT00968708|62727343|FG000|Overall Study|Other|26|||
33349919|NCT00968708|62727344|FG001|Overall Study|Other|34|||
33349920|NCT00967694|62727350|FG000|Overall Study|Withdrawal by Subject|6|||
33349921|NCT00967616|62727356|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
33349922|NCT00967616|62727357|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
33349923|NCT00967616|62727356|FG000|Overall Study|Death|0|||
33349924|NCT00967616|62727357|FG001|Overall Study|Death|3|||
33349925|NCT00967616|62727356|FG000|Overall Study|Withdrawal by Subject|8|||
33349926|NCT00967616|62727357|FG001|Overall Study|Withdrawal by Subject|4|||
33349927|NCT00967616|62727356|FG000|Overall Study|Progressive Disease|31|||
33349928|NCT00967616|62727357|FG001|Overall Study|Progressive Disease|18|||
33349929|NCT00967616|62727356|FG000|Overall Study|Other|8|||
33349930|NCT00967616|62727357|FG001|Overall Study|Other|8|||
33349931|NCT00967616|62727356|FG000|Overall Study|Protocol Violation|1|||
33349932|NCT00967616|62727357|FG001|Overall Study|Protocol Violation|0|||
33349933|NCT00971204|62727367|FG000|Overall Study|Did not meet all criteria-not treated|14|||
33349934|NCT00971204|62727367|FG000|Overall Study|Lost to Follow-up|10|||
33349935|NCT00974090|62727373|FG000|Period 1: Double Blind Period|Adverse Event|2|||
33349936|NCT00974090|62727374|FG001|Period 1: Double Blind Period|Adverse Event|1|||
33349937|NCT00974090|62727373|FG000|Period 1: Double Blind Period|Physician Decision|1|||
33349938|NCT00974090|62727374|FG001|Period 1: Double Blind Period|Physician Decision|0|||
33349939|NCT00974090|62727373|FG000|Period 2: Open-label Period|Adverse Event|4|||
33349940|NCT00974090|62727374|FG001|Period 2: Open-label Period|Adverse Event|6|||
33349941|NCT00974090|62727373|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
33349942|NCT00974090|62727374|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
33349943|NCT00974090|62727373|FG000|Period 2: Open-label Period|Physician Decision|0|||
33349944|NCT00974090|62727374|FG001|Period 2: Open-label Period|Physician Decision|3|||
33349945|NCT00974090|62727373|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
33471394|NCT01147666|62844986|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33471395|NCT01147666|62844987|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33471396|NCT01147666|62844988|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33471397|NCT01147666|62844989|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
33471398|NCT01147666|62844990|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33471399|NCT01147666|62844991|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33471400|NCT01147666|62844992|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33471401|NCT01147666|62844993|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33471402|NCT01147666|62844979|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33471403|NCT01147666|62844980|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33471404|NCT01147666|62844981|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33349946|NCT00974090|62727374|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
33349947|NCT00971048|62727386|FG000|Overall Study|Protocol Violation|1|||
33349948|NCT00971048|62727387|FG001|Overall Study|Protocol Violation|2|||
33349949|NCT00971048|62727388|FG002|Overall Study|Protocol Violation|0|||
33349950|NCT00971048|62727389|FG003|Overall Study|Protocol Violation|1|||
33349951|NCT00971048|62727386|FG000|Overall Study|Adverse Event|0|||
33349952|NCT00971048|62727387|FG001|Overall Study|Adverse Event|0|||
33349953|NCT00971048|62727388|FG002|Overall Study|Adverse Event|1|||
33349954|NCT00971048|62727389|FG003|Overall Study|Adverse Event|0|||
33349955|NCT00971048|62727386|FG000|Overall Study|Physician Decision|0|||
33349956|NCT00971048|62727387|FG001|Overall Study|Physician Decision|0|||
33349957|NCT00971048|62727388|FG002|Overall Study|Physician Decision|0|||
33349958|NCT00971048|62727389|FG003|Overall Study|Physician Decision|1|||
33349959|NCT00699751|62727403|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
33349960|NCT00699751|62727404|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
33349961|NCT00699751|62727403|FG000|Period 1: Without/Before Drug Switch|Death|28|||
33349962|NCT00699751|62727404|FG001|Period 1: Without/Before Drug Switch|Death|29|||
33471405|NCT01147666|62844982|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33471406|NCT01147666|62844983|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33349963|NCT00699751|62727403|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
33349964|NCT00699751|62727404|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
33471407|NCT01147666|62844984|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33349965|NCT00699751|62727403|FG000|Period 1: Without/Before Drug Switch|Other|30|||
33349966|NCT00699751|62727404|FG001|Period 1: Without/Before Drug Switch|Other|20|||
33349967|NCT00699751|62727403|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
33349968|NCT00699751|62727404|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
33471408|NCT01147666|62844985|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33349969|NCT00699751|62727403|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
33349970|NCT00699751|62727404|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
33349971|NCT00699751|62727403|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
33349972|NCT00699751|62727404|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
33349973|NCT00699751|62727403|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
33349974|NCT00699751|62727404|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
33349975|NCT00970502|62727411|FG000|Overall Study|Withdrawal by Subject|1|||
33349976|NCT00967226|62727421|FG000|Overall Study|Adverse Event|0|||
33349977|NCT00967226|62727422|FG001|Overall Study|Adverse Event|5|||
33349978|NCT00967226|62727421|FG000|Overall Study|Protocol Violation|2|||
33349979|NCT00967226|62727422|FG001|Overall Study|Protocol Violation|0|||
33349980|NCT00967226|62727421|FG000|Overall Study|Physician Decision|0|||
33349981|NCT00967226|62727422|FG001|Overall Study|Physician Decision|1|||
33349982|NCT00706381|62727456|FG000|Overall Study|Lost to Follow-up|0|||
33349983|NCT00706381|62727457|FG001|Overall Study|Lost to Follow-up|1|||
33349984|NCT00706381|62727458|FG002|Overall Study|Lost to Follow-up|1|||
33349985|NCT00706381|62727459|FG003|Overall Study|Lost to Follow-up|0|||
33349986|NCT00964886|62727476|FG000|Overall Study|Lost to Follow-up|2|||
33349987|NCT00964886|62727477|FG001|Overall Study|Lost to Follow-up|2|||
33349988|NCT00964886|62727478|FG002|Overall Study|Lost to Follow-up|6|||
33349989|NCT00964886|62727479|FG003|Overall Study|Lost to Follow-up|4|||
33471409|NCT01147666|62844986|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33471410|NCT01147666|62844987|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33471411|NCT01147666|62844988|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33471412|NCT01147666|62844989|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33471413|NCT01147666|62844990|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33471414|NCT01147666|62844991|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
33471415|NCT01147666|62844992|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33471416|NCT01147666|62844993|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33349990|NCT00964886|62727476|FG000|Overall Study|Withdrawal by Subject|6|||
33349991|NCT00964886|62727477|FG001|Overall Study|Withdrawal by Subject|2|||
33349992|NCT00964886|62727478|FG002|Overall Study|Withdrawal by Subject|5|||
33349993|NCT00964886|62727479|FG003|Overall Study|Withdrawal by Subject|3|||
33349994|NCT00964886|62727476|FG000|Overall Study|Adverse Event|3|||
33349995|NCT00964886|62727477|FG001|Overall Study|Adverse Event|1|||
33349996|NCT00964886|62727478|FG002|Overall Study|Adverse Event|5|||
33349997|NCT00964886|62727479|FG003|Overall Study|Adverse Event|2|||
33349998|NCT00964886|62727476|FG000|Overall Study|Protocol Violation|0|||
33349999|NCT00964886|62727477|FG001|Overall Study|Protocol Violation|2|||
33471417|NCT01147666|62844979|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33471418|NCT01147666|62844980|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33471419|NCT01147666|62844981|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33471420|NCT01147666|62844982|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33350000|NCT00964886|62727478|FG002|Overall Study|Protocol Violation|0|||
33350001|NCT00964886|62727479|FG003|Overall Study|Protocol Violation|0|||
33350002|NCT00705757|62727496|FG000|Overall Study|Lack of Efficacy|5|||
33350003|NCT00705757|62727497|FG001|Overall Study|Lack of Efficacy|1|||
33350004|NCT00705757|62727498|FG002|Overall Study|Lack of Efficacy|3|||
33350005|NCT00705757|62727496|FG000|Overall Study|Lost to Follow-up|7|||
33350006|NCT00705757|62727497|FG001|Overall Study|Lost to Follow-up|6|||
33350007|NCT00705757|62727498|FG002|Overall Study|Lost to Follow-up|6|||
33350008|NCT00705757|62727496|FG000|Overall Study|Withdrawal by Subject|1|||
33350009|NCT00705757|62727497|FG001|Overall Study|Withdrawal by Subject|1|||
33350010|NCT00705757|62727498|FG002|Overall Study|Withdrawal by Subject|2|||
33350011|NCT00960752|62727526|FG000|Overall Study|Adverse Event|0|||
33350012|NCT00960752|62727527|FG001|Overall Study|Adverse Event|0|||
33350013|NCT00960752|62727528|FG002|Overall Study|Adverse Event|1|||
33350014|NCT00960752|62727526|FG000|Overall Study|Progression|0|||
33350015|NCT00960752|62727527|FG001|Overall Study|Progression|0|||
33471421|NCT01147666|62844983|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33471422|NCT01147666|62844984|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33350016|NCT00960752|62727528|FG002|Overall Study|Progression|1|||
33350017|NCT00758524|62727542|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
33350018|NCT00758524|62727543|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
33350019|NCT00758524|62727544|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
33350020|NCT00758524|62727545|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33350021|NCT00758524|62727546|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
33350022|NCT00758524|62727547|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
33350023|NCT00758524|62727548|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33350024|NCT00758524|62727549|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33471423|NCT01147666|62844985|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33471424|NCT01147666|62844986|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33471425|NCT01147666|62844987|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33471426|NCT01147666|62844988|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33471427|NCT01147666|62844989|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33471428|NCT01147666|62844990|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33471429|NCT01147666|62844991|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
33350025|NCT00758524|62727550|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33350026|NCT00758524|62727551|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33350027|NCT00758524|62727552|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33350028|NCT00758524|62727553|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33350029|NCT00758524|62727554|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33350030|NCT00758524|62727555|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33350031|NCT00758524|62727556|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33350032|NCT00758524|62727557|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33350033|NCT00758524|62727558|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33350034|NCT00758524|62727542|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
33350035|NCT00758524|62727543|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33350036|NCT00758524|62727544|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
33350037|NCT00758524|62727545|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
33350038|NCT00758524|62727546|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
33350039|NCT00758524|62727547|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
33350040|NCT00758524|62727548|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33350041|NCT00758524|62727549|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33350042|NCT00758524|62727550|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33350043|NCT00758524|62727551|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33350044|NCT00758524|62727552|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33350045|NCT00758524|62727553|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33350046|NCT00758524|62727554|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33350047|NCT00758524|62727555|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33350048|NCT00758524|62727556|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33350049|NCT00758524|62727557|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33350050|NCT00758524|62727558|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33350051|NCT00758524|62727542|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
33350052|NCT00758524|62727543|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
33350053|NCT00758524|62727544|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
33350054|NCT00758524|62727545|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
33350055|NCT00758524|62727546|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
33350056|NCT00758524|62727547|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
33350057|NCT00758524|62727548|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33350058|NCT00758524|62727549|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33350059|NCT00758524|62727550|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33350060|NCT00758524|62727551|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33350061|NCT00758524|62727552|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33350062|NCT00758524|62727553|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33350063|NCT00758524|62727554|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33350064|NCT00758524|62727555|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33350065|NCT00758524|62727556|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33350066|NCT00758524|62727557|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33350067|NCT00758524|62727558|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33350068|NCT00758524|62727542|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33471430|NCT01147666|62844992|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33471431|NCT01147666|62844993|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
33471432|NCT00256295|62845055|FG000|Overall Study|Withdrawal by Subject|3|||
33471433|NCT00256295|62845055|FG000|Overall Study|Death|1|||
33471434|NCT02877004|62845062|FG000|Overall Study|Pregnancy|0|||
33471435|NCT02877004|62845063|FG001|Overall Study|Pregnancy|0|||
33471436|NCT02877004|62845064|FG002|Overall Study|Pregnancy|1|||
33471437|NCT04617860|62845094|FG000|Overall Study|Adverse Event|0|||
33471438|NCT04617860|62845095|FG001|Overall Study|Adverse Event|2|||
33471439|NCT04617860|62845096|FG002|Overall Study|Adverse Event|2|||
33471440|NCT04617860|62845094|FG000|Overall Study|Withdrawal by Subject|0|||
33471441|NCT04617860|62845095|FG001|Overall Study|Withdrawal by Subject|0|||
33471442|NCT04617860|62845096|FG002|Overall Study|Withdrawal by Subject|2|||
33471443|NCT04617860|62845094|FG000|Overall Study|Physician Decision|0|||
33471444|NCT04617860|62845095|FG001|Overall Study|Physician Decision|1|||
33655048|NCT01888367|63069098|FG000|Overall Study|Withdrawal by Subject|1|||
33655049|NCT01888367|63069099|FG001|Overall Study|Withdrawal by Subject|0|||
33655050|NCT01888367|63069100|FG002|Overall Study|Withdrawal by Subject|1|||
33655051|NCT01888367|63069098|FG000|Overall Study|Lost to Follow-up|1|||
33471445|NCT04617860|62845096|FG002|Overall Study|Physician Decision|0|||
33471446|NCT04617860|62845094|FG000|Overall Study|Sponsor Decision|0|||
33471447|NCT04617860|62845095|FG001|Overall Study|Sponsor Decision|3|||
33471448|NCT04617860|62845096|FG002|Overall Study|Sponsor Decision|1|||
33471449|NCT04617860|62845094|FG000|Overall Study|Termination of Study by Sponsor|8|||
33471450|NCT04617860|62845095|FG001|Overall Study|Termination of Study by Sponsor|4|||
33471451|NCT04617860|62845096|FG002|Overall Study|Termination of Study by Sponsor|13|||
33471452|NCT04608500|62845108|FG000|Overall Study|Adverse Event|2|||
33471453|NCT04608500|62845109|FG001|Overall Study|Adverse Event|0|||
33471454|NCT04608500|62845108|FG000|Overall Study|Lost to Follow-up|15|||
33471455|NCT04608500|62845109|FG001|Overall Study|Lost to Follow-up|9|||
33471456|NCT04608500|62845108|FG000|Overall Study|Participant request|11|||
33471457|NCT04608500|62845109|FG001|Overall Study|Participant request|7|||
33471458|NCT04608500|62845108|FG000|Overall Study|Protocol Violation|1|||
33655052|NCT01888367|63069099|FG001|Overall Study|Lost to Follow-up|1|||
33655053|NCT01888367|63069100|FG002|Overall Study|Lost to Follow-up|0|||
33655054|NCT01888367|63069098|FG000|Overall Study|Protocol Violation|0|||
33655055|NCT01888367|63069099|FG001|Overall Study|Protocol Violation|0|||
33655056|NCT01888367|63069100|FG002|Overall Study|Protocol Violation|1|||
33655057|NCT01888367|63069098|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
33350069|NCT00758524|62727543|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
33350070|NCT00758524|62727544|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
33350071|NCT00758524|62727545|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33350072|NCT00758524|62727546|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
33350073|NCT00758524|62727547|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
33350074|NCT00758524|62727548|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33350075|NCT00758524|62727549|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33350076|NCT00758524|62727550|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33350077|NCT00758524|62727551|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33350078|NCT00758524|62727552|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33350079|NCT00758524|62727553|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33350080|NCT00758524|62727554|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33350081|NCT00758524|62727555|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33350082|NCT00758524|62727556|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33350083|NCT00758524|62727557|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33350084|NCT00758524|62727558|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33350085|NCT00758524|62727542|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33350086|NCT00758524|62727543|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33350087|NCT00758524|62727544|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
33655058|NCT01888367|63069099|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
33655059|NCT01888367|63069100|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
33655060|NCT01898195|63069126|FG000|Smoking Abstinence|Did not have good measurements|35|||
33655061|NCT01898195|63069127|FG001|Smoking Abstinence|Did not have good measurements|38|||
33655062|NCT01898195|63069128|FG002|Smoking Abstinence|Did not have good measurements|36|||
33655063|NCT01897727|63069142|FG000|Overall Study|Exclusion: central sleep apnea|0|||
33655064|NCT01897727|63069143|FG001|Overall Study|Exclusion: central sleep apnea|1|||
33655065|NCT01897493|63069149|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
33655066|NCT01887353|63069158|FG000|Overall Study|Study stopped early|4|||
33655067|NCT01887353|63069159|FG001|Overall Study|Study stopped early|3|||
33655068|NCT01896869|63069181|FG000|Overall Study|Withdrawal by Subject|0|||
33655069|NCT01896869|63069182|FG001|Overall Study|Withdrawal by Subject|6|||
33655070|NCT01896869|63069181|FG000|Overall Study|Lost to Follow-up|1|||
33655071|NCT01896869|63069182|FG001|Overall Study|Lost to Follow-up|0|||
33655072|NCT01896557|63069192|FG000|Clopidogrel Alone|Adverse Event|1|||
33655073|NCT01896557|63069193|FG001|Clopidogrel Alone|Adverse Event|0|||
33655074|NCT01896557|63069192|FG000|Clopidogrel + GI Protector|low adherence|1|||
33655075|NCT01896557|63069193|FG001|Clopidogrel + GI Protector|low adherence|1|||
33350088|NCT00758524|62727545|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
33350089|NCT00758524|62727546|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33350090|NCT00758524|62727547|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33350091|NCT00758524|62727548|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33471459|NCT04608500|62845109|FG001|Overall Study|Protocol Violation|0|||
33471460|NCT04608500|62845108|FG000|Overall Study|Other|6|||
33471461|NCT04608500|62845109|FG001|Overall Study|Other|2|||
33471462|NCT04585646|62845115|FG000|First Intervention|Physician Decision|1|||
33471463|NCT04585646|62845116|FG001|First Intervention|Physician Decision|0|||
33471464|NCT04585646|62845115|FG000|First Intervention|Lost to Follow-up|0|||
33655076|NCT01896557|63069192|FG000|Clopidogrel + GI Protector|Reading error|1|||
33655077|NCT01896557|63069193|FG001|Clopidogrel + GI Protector|Reading error|3|||
33655078|NCT01886105|63069208|FG000|Overall Study|Lack of Efficacy|3|||
33655079|NCT01895777|63069237|FG000|Overall Study|Adverse Event|1|||
33655080|NCT01895777|63069238|FG001|Overall Study|Adverse Event|2|||
33655081|NCT01895777|63069237|FG000|Overall Study|Lost to Follow-up|2|||
33350092|NCT00758524|62727549|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33350093|NCT00758524|62727550|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33350094|NCT00758524|62727551|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33350095|NCT00758524|62727552|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33350096|NCT00758524|62727553|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33350097|NCT00758524|62727554|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33350098|NCT00758524|62727555|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33350099|NCT00758524|62727556|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33350100|NCT00758524|62727557|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33350101|NCT00758524|62727558|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33350102|NCT00758524|62727542|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33350103|NCT00758524|62727543|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33350104|NCT00758524|62727544|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33350105|NCT00758524|62727545|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33350106|NCT00758524|62727546|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
33350107|NCT00758524|62727547|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33350108|NCT00758524|62727548|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33350109|NCT00758524|62727549|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33350110|NCT00758524|62727550|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33350111|NCT00758524|62727551|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33350112|NCT00758524|62727552|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33350113|NCT00758524|62727553|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33350114|NCT00758524|62727554|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33350115|NCT00758524|62727555|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33350116|NCT00758524|62727556|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33350117|NCT00758524|62727557|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33350118|NCT00758524|62727558|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33471465|NCT04585646|62845116|FG001|First Intervention|Lost to Follow-up|3|||
33471466|NCT04585646|62845115|FG000|First Intervention|Withdrawal by Subject|0|||
33471467|NCT04585646|62845116|FG001|First Intervention|Withdrawal by Subject|1|||
33471468|NCT04584788|62845132|FG000|Overall Study|Physician Decision|8|||
33471469|NCT04584788|62845132|FG000|Overall Study|Withdrawal by Subject|1|||
33471470|NCT04584788|62845132|FG000|Overall Study|Adverse Event|3|||
33471471|NCT04575038|62845138|FG000|Overall Study|Withdrawal by Subject|1|||
33471472|NCT04575038|62845139|FG001|Overall Study|Withdrawal by Subject|1|||
33471473|NCT03066622|62845147|FG000|Overall Study|Lost to Follow-up|24|||
33471474|NCT03066622|62845148|FG001|Overall Study|Lost to Follow-up|25|||
33471475|NCT03066622|62845147|FG000|Overall Study|Withdrawal by Subject|2|||
33471476|NCT03066622|62845148|FG001|Overall Study|Withdrawal by Subject|1|||
33471477|NCT04501952|62845180|FG000|Overall Study|Adverse Event|0|||
33471478|NCT04501952|62845181|FG001|Overall Study|Adverse Event|3|||
33471479|NCT04501952|62845180|FG000|Overall Study|Investigator's Discretion|0|||
33471480|NCT04501952|62845181|FG001|Overall Study|Investigator's Discretion|1|||
33471481|NCT04501952|62845180|FG000|Overall Study|Protocol Violation|1|||
33471482|NCT04501952|62845181|FG001|Overall Study|Protocol Violation|1|||
33471483|NCT04501952|62845180|FG000|Overall Study|Withdrew Consent|5|||
33471484|NCT04501952|62845181|FG001|Overall Study|Withdrew Consent|4|||
33471485|NCT04501952|62845180|FG000|Overall Study|Lost to Follow-up|7|||
33471486|NCT04501952|62845181|FG001|Overall Study|Lost to Follow-up|2|||
33471487|NCT04501952|62845180|FG000|Overall Study|Randomized and Never Treated|13|||
33471488|NCT04501952|62845181|FG001|Overall Study|Randomized and Never Treated|9|||
33471489|NCT02930122|62845199|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
33471490|NCT02930122|62845200|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
33471491|NCT03697460|62845207|FG000|Overall Study|Withdrawal by Subject|3|||
33471492|NCT00070018|62845211|FG000|Overall Study|Adverse Event|2|||
33471493|NCT00070018|62845211|FG000|Overall Study|Lack of Efficacy|1|||
33471494|NCT00070018|62845211|FG000|Overall Study|Withdrawal by Subject|1|||
33471495|NCT00231413|62845222|FG000|Overall Study|Non-serious AE|0|||
33471496|NCT00231413|62845223|FG001|Overall Study|Non-serious AE|0|||
33655082|NCT01895777|63069238|FG001|Overall Study|Lost to Follow-up|0|||
33350119|NCT00758524|62727542|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33471497|NCT00231413|62845224|FG002|Overall Study|Non-serious AE|1|||
33655083|NCT01895777|63069237|FG000|Overall Study|Not treated|1|||
33350120|NCT00758524|62727543|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
33471498|NCT00231413|62845225|FG003|Overall Study|Non-serious AE|0|||
33350121|NCT00758524|62727544|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33471499|NCT00231413|62845226|FG004|Overall Study|Non-serious AE|0|||
33471500|NCT00231413|62845227|FG005|Overall Study|Non-serious AE|0|||
33471501|NCT00231413|62845228|FG006|Overall Study|Non-serious AE|1|||
33471502|NCT00231413|62845222|FG000|Overall Study|Withdrawal by Subject|3|||
33655084|NCT01895777|63069238|FG001|Overall Study|Not treated|0|||
33350122|NCT00758524|62727545|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33350123|NCT00758524|62727546|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33350124|NCT00758524|62727547|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33350125|NCT00758524|62727548|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33350126|NCT00758524|62727549|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33350127|NCT00758524|62727550|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33350128|NCT00758524|62727551|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33350129|NCT00758524|62727552|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33350130|NCT00758524|62727553|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33350131|NCT00758524|62727554|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33350132|NCT00758524|62727555|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33350133|NCT00758524|62727556|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33350134|NCT00758524|62727557|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33350135|NCT00758524|62727558|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33350136|NCT00758524|62727542|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350137|NCT00758524|62727543|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
33350138|NCT00758524|62727544|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350139|NCT00758524|62727545|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350140|NCT00758524|62727546|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350141|NCT00758524|62727547|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350142|NCT00758524|62727548|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350143|NCT00758524|62727549|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350144|NCT00758524|62727550|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350145|NCT00758524|62727551|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350146|NCT00758524|62727552|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350147|NCT00758524|62727553|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350148|NCT00758524|62727554|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350149|NCT00758524|62727555|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350150|NCT00758524|62727556|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350151|NCT00758524|62727557|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350152|NCT00758524|62727558|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33350153|NCT00758524|62727542|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350154|NCT00758524|62727543|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350155|NCT00758524|62727544|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350156|NCT00758524|62727545|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350157|NCT00758524|62727546|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350158|NCT00758524|62727547|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350159|NCT00758524|62727548|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350160|NCT00758524|62727549|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350161|NCT00758524|62727550|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
33350162|NCT00758524|62727551|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350163|NCT00758524|62727552|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350164|NCT00758524|62727553|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350165|NCT00758524|62727554|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350166|NCT00758524|62727555|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350167|NCT00758524|62727556|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350168|NCT00758524|62727557|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350169|NCT00758524|62727558|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33350170|NCT00758524|62727542|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33350171|NCT00758524|62727543|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33350172|NCT00758524|62727544|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33350173|NCT00758524|62727545|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33350174|NCT00758524|62727546|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33350175|NCT00758524|62727547|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33350176|NCT00758524|62727548|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
33350177|NCT00758524|62727549|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33350178|NCT00758524|62727550|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33350179|NCT00758524|62727551|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33350180|NCT00758524|62727552|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33350181|NCT00758524|62727553|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33350182|NCT00758524|62727554|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33548983|NCT02901431|62940295|FG001|PK Part|Discontinued per Sponsor|3|||
33350183|NCT00758524|62727555|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33350184|NCT00758524|62727556|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33350185|NCT00758524|62727557|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33350186|NCT00758524|62727558|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33350187|NCT00757588|62727598|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
33350188|NCT00757588|62727599|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
33350189|NCT00757588|62727598|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
33350190|NCT00757588|62727599|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
33350191|NCT00757588|62727598|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
33350192|NCT00757588|62727599|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
33350193|NCT00757588|62727598|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
33350194|NCT00757588|62727599|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
33350195|NCT00757588|62727598|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
33350196|NCT00757588|62727599|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
33350197|NCT00757588|62727598|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
33350198|NCT00757588|62727599|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
33350199|NCT00757588|62727598|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
33350200|NCT00757588|62727599|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
33350201|NCT00757588|62727598|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
33350202|NCT00757588|62727599|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
33350203|NCT00757588|62727598|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
33350204|NCT00757588|62727599|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
33350205|NCT00757588|62727598|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
33350206|NCT00757588|62727599|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
33350207|NCT00757588|62727598|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
33350208|NCT00757588|62727599|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
33350209|NCT00757588|62727598|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
33350210|NCT00757588|62727599|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
33350211|NCT00757588|62727598|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
33350212|NCT00757588|62727599|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
33350213|NCT00757588|62727598|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
33350214|NCT00757588|62727599|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
33350215|NCT00757588|62727598|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
33350216|NCT00757588|62727599|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
33350217|NCT00757588|62727598|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
33350218|NCT00757588|62727599|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
33350219|NCT00744796|62727605|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
33350220|NCT00705679|62727614|FG000|Overall Study|Adverse Event|1|||
33350221|NCT00705679|62727615|FG001|Overall Study|Adverse Event|1|||
33350222|NCT00705679|62727616|FG002|Overall Study|Adverse Event|0|||
33350223|NCT00705679|62727617|FG003|Overall Study|Adverse Event|0|||
33350224|NCT00705679|62727618|FG004|Overall Study|Adverse Event|0|||
33350225|NCT00705679|62727614|FG000|Overall Study|Death|0|||
33350226|NCT00705679|62727615|FG001|Overall Study|Death|0|||
33350227|NCT00705679|62727616|FG002|Overall Study|Death|3|||
33350228|NCT00705679|62727617|FG003|Overall Study|Death|2|||
33350229|NCT00705679|62727618|FG004|Overall Study|Death|1|||
33350230|NCT00705679|62727614|FG000|Overall Study|Lost to Follow-up|32|||
33350231|NCT00705679|62727615|FG001|Overall Study|Lost to Follow-up|60|||
33350232|NCT00705679|62727616|FG002|Overall Study|Lost to Follow-up|44|||
33350233|NCT00705679|62727617|FG003|Overall Study|Lost to Follow-up|30|||
33350234|NCT00705679|62727618|FG004|Overall Study|Lost to Follow-up|35|||
33350235|NCT00705679|62727614|FG000|Overall Study|Physician Decision|0|||
33350236|NCT00705679|62727615|FG001|Overall Study|Physician Decision|1|||
33350237|NCT00705679|62727616|FG002|Overall Study|Physician Decision|0|||
33350238|NCT00705679|62727617|FG003|Overall Study|Physician Decision|1|||
33350239|NCT00705679|62727618|FG004|Overall Study|Physician Decision|0|||
33350240|NCT00705679|62727614|FG000|Overall Study|Withdrawal by Subject|32|||
33350241|NCT00705679|62727615|FG001|Overall Study|Withdrawal by Subject|77|||
33350242|NCT00705679|62727616|FG002|Overall Study|Withdrawal by Subject|68|||
33350243|NCT00705679|62727617|FG003|Overall Study|Withdrawal by Subject|47|||
33350244|NCT00705679|62727618|FG004|Overall Study|Withdrawal by Subject|33|||
33350245|NCT00751348|62727641|FG000|Overall Study|Withdrawal by Subject|5|||
33350246|NCT00751348|62727642|FG001|Overall Study|Withdrawal by Subject|2|||
33350247|NCT00751348|62727641|FG000|Overall Study|Migration from study area|1|||
33350248|NCT00751348|62727642|FG001|Overall Study|Migration from study area|0|||
33350249|NCT00751114|62727650|FG000|Overall Study|Adverse Event|2|||
33350250|NCT00751114|62727651|FG001|Overall Study|Adverse Event|4|||
33350251|NCT00751114|62727650|FG000|Overall Study|Protocol Violation|8|||
33350252|NCT00751114|62727651|FG001|Overall Study|Protocol Violation|9|||
33350253|NCT00751114|62727650|FG000|Overall Study|Withdrawal by Subject|9|||
33350254|NCT00751114|62727651|FG001|Overall Study|Withdrawal by Subject|4|||
33350255|NCT00751114|62727650|FG000|Overall Study|Lost to Follow-up|4|||
33350256|NCT00751114|62727651|FG001|Overall Study|Lost to Follow-up|7|||
33350257|NCT00751114|62727650|FG000|Overall Study|Lack of Efficacy|0|||
33350258|NCT00751114|62727651|FG001|Overall Study|Lack of Efficacy|7|||
33350259|NCT00751114|62727650|FG000|Overall Study|Not Treated|13|||
33350260|NCT00751114|62727651|FG001|Overall Study|Not Treated|1|||
33350261|NCT00751114|62727650|FG000|Overall Study|Out of country for 2 months|1|||
33350262|NCT00751114|62727651|FG001|Overall Study|Out of country for 2 months|0|||
33350263|NCT00751114|62727650|FG000|Overall Study|Move to another city|1|||
33350264|NCT00751114|62727651|FG001|Overall Study|Move to another city|0|||
33350265|NCT00960440|62727661|FG000|Overall Study|Death|0|||
33350266|NCT00960440|62727662|FG001|Overall Study|Death|0|||
33350267|NCT00960440|62727663|FG002|Overall Study|Death|0|||
33350268|NCT00960440|62727664|FG003|Overall Study|Death|1|||
33350269|NCT00960440|62727661|FG000|Overall Study|Adverse Event|12|||
33350270|NCT00960440|62727662|FG001|Overall Study|Adverse Event|12|||
33350271|NCT00960440|62727663|FG002|Overall Study|Adverse Event|4|||
33350272|NCT00960440|62727664|FG003|Overall Study|Adverse Event|4|||
33350273|NCT00960440|62727661|FG000|Overall Study|Lack of Efficacy|2|||
33350274|NCT00960440|62727662|FG001|Overall Study|Lack of Efficacy|5|||
33350275|NCT00960440|62727663|FG002|Overall Study|Lack of Efficacy|3|||
33350276|NCT00960440|62727664|FG003|Overall Study|Lack of Efficacy|8|||
33350277|NCT00960440|62727661|FG000|Overall Study|Protocol Violation|2|||
33350278|NCT00960440|62727662|FG001|Overall Study|Protocol Violation|8|||
33350279|NCT00960440|62727663|FG002|Overall Study|Protocol Violation|3|||
33350280|NCT00960440|62727664|FG003|Overall Study|Protocol Violation|4|||
33350281|NCT00960440|62727661|FG000|Overall Study|Withdrawal by Subject|9|||
33350282|NCT00960440|62727662|FG001|Overall Study|Withdrawal by Subject|5|||
33350283|NCT00960440|62727663|FG002|Overall Study|Withdrawal by Subject|2|||
33350284|NCT00960440|62727664|FG003|Overall Study|Withdrawal by Subject|1|||
33350285|NCT00960440|62727661|FG000|Overall Study|Other|1|||
33350286|NCT00960440|62727662|FG001|Overall Study|Other|1|||
33350287|NCT00960440|62727663|FG002|Overall Study|Other|1|||
33350288|NCT00960440|62727664|FG003|Overall Study|Other|0|||
33350289|NCT04909853|62727708|FG000|Part 1|Assigned but not treated|0|||
33350290|NCT04909853|62727709|FG001|Part 1|Assigned but not treated|0|||
33350291|NCT04909853|62727710|FG002|Part 1|Assigned but not treated|1|||
33350292|NCT04909853|62727711|FG003|Part 1|Assigned but not treated|0|||
33350293|NCT04909853|62727708|FG000|Part 2|Adverse Event|0|||
33350294|NCT04909853|62727709|FG001|Part 2|Adverse Event|0|||
33350295|NCT04909853|62727710|FG002|Part 2|Adverse Event|0|||
33350296|NCT04909853|62727711|FG003|Part 2|Adverse Event|1|||
33350297|NCT04811664|62727724|FG000|Overall Study|Lost to Follow-up|78|||
33350298|NCT04811664|62727725|FG001|Overall Study|Lost to Follow-up|125|||
33350299|NCT04811664|62727726|FG002|Overall Study|Lost to Follow-up|46|||
33350300|NCT04811664|62727724|FG000|Overall Study|Withdrawal by Subject|39|||
33350301|NCT04811664|62727725|FG001|Overall Study|Withdrawal by Subject|76|||
33350302|NCT04811664|62727726|FG002|Overall Study|Withdrawal by Subject|12|||
33350303|NCT04811664|62727724|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
33350304|NCT04811664|62727725|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
33350305|NCT04811664|62727726|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
33350306|NCT04811664|62727724|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
33350307|NCT04811664|62727725|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
33350308|NCT04811664|62727726|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
33350309|NCT04811664|62727724|FG000|Overall Study|Protocol Violation|0|||
33350310|NCT04811664|62727725|FG001|Overall Study|Protocol Violation|5|||
33350311|NCT04811664|62727726|FG002|Overall Study|Protocol Violation|11|||
33350312|NCT04811664|62727724|FG000|Overall Study|Study Terminated by Sponsor|4|||
33350313|NCT04811664|62727725|FG001|Overall Study|Study Terminated by Sponsor|3|||
33350314|NCT04811664|62727726|FG002|Overall Study|Study Terminated by Sponsor|34|||
33350315|NCT04811664|62727724|FG000|Overall Study|Early Study Closure|3|||
33350316|NCT04811664|62727725|FG001|Overall Study|Early Study Closure|7|||
33350317|NCT04811664|62727726|FG002|Overall Study|Early Study Closure|79|||
33350318|NCT04811664|62727724|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
33350319|NCT04811664|62727725|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
33350320|NCT04811664|62727726|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
33350321|NCT04119414|62727743|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
33350322|NCT03762265|62727772|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
33350323|NCT03762265|62727773|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
33350324|NCT03762265|62727772|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
33350325|NCT03762265|62727773|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
33655085|NCT01895777|63069237|FG000|Overall Study|Other reasons|3|||
33350326|NCT03762265|62727772|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
33350327|NCT03762265|62727773|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
33350328|NCT03762265|62727772|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
33350329|NCT03762265|62727773|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
33350330|NCT03762265|62727772|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
33350331|NCT03762265|62727773|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
33350332|NCT03762265|62727772|FG000|BT Period: Weeks 1 to 37|Other|0|||
33350333|NCT03762265|62727773|FG001|BT Period: Weeks 1 to 37|Other|1|||
33350334|NCT03762265|62727772|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
33350335|NCT03762265|62727773|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
33350336|NCT03762265|62727772|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
33350337|NCT03762265|62727773|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
33350338|NCT03762265|62727772|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
33350339|NCT03762265|62727773|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
33350340|NCT03762265|62727772|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
33350341|NCT03762265|62727773|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
33350342|NCT03762265|62727772|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
33350343|NCT03762265|62727773|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
33350344|NCT03762265|62727772|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
33350345|NCT03762265|62727773|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
33350346|NCT03762265|62727772|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
33350347|NCT03762265|62727773|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
33350348|NCT03762265|62727772|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
33350349|NCT03762265|62727773|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
33350350|NCT03762265|62727772|FG000|LTE Period: Weeks 61 to 109|Other|1|||
33350351|NCT03762265|62727773|FG001|LTE Period: Weeks 61 to 109|Other|0|||
33350352|NCT03713632|62727809|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
33350353|NCT03713632|62727810|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
33350354|NCT03713632|62727811|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
33350355|NCT03713632|62727812|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
33350356|NCT03713632|62727813|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
33350357|NCT03713632|62727809|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
33350358|NCT03713632|62727810|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
33350359|NCT03713632|62727811|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
33350360|NCT03713632|62727812|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
33350361|NCT03713632|62727813|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
33350362|NCT03713632|62727809|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
33350363|NCT03713632|62727810|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
33350364|NCT03713632|62727811|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
33350365|NCT03713632|62727812|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
33350366|NCT03713632|62727813|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
33350367|NCT03713632|62727809|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
33350368|NCT03713632|62727810|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
33350369|NCT03713632|62727811|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
33350370|NCT03713632|62727812|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
33350371|NCT03713632|62727813|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
33350372|NCT03713632|62727809|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
33350373|NCT03713632|62727810|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
33350374|NCT03713632|62727811|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
33350375|NCT03713632|62727812|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
33350376|NCT03713632|62727813|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
33350377|NCT03713632|62727809|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
33350378|NCT03713632|62727810|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
33350379|NCT03713632|62727811|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
33350380|NCT03713632|62727812|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
33350381|NCT03713632|62727813|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
33350382|NCT03713632|62727809|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
33350383|NCT03713632|62727810|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
33350384|NCT03713632|62727811|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
33350385|NCT03713632|62727812|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
33350386|NCT03713632|62727813|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
33350387|NCT03713632|62727809|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
33350388|NCT03713632|62727810|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
33350389|NCT03713632|62727811|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
33350390|NCT03713632|62727812|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
33350391|NCT03713632|62727813|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
33350392|NCT03713632|62727809|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
33350393|NCT03713632|62727810|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
33350394|NCT03713632|62727811|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
33350395|NCT03713632|62727812|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
33350396|NCT03713632|62727813|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
33471503|NCT00231413|62845223|FG001|Overall Study|Withdrawal by Subject|1|||
33350397|NCT03713632|62727809|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
33350398|NCT03713632|62727810|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
33350399|NCT03713632|62727811|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
33350400|NCT03713632|62727812|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
33350401|NCT03713632|62727813|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
33350402|NCT03713632|62727809|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
33350403|NCT03713632|62727810|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
33350404|NCT03713632|62727811|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
33350405|NCT03713632|62727812|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
33350406|NCT03713632|62727813|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
33350407|NCT03713632|62727809|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
33350408|NCT03713632|62727810|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
33350409|NCT03713632|62727811|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
33350410|NCT03713632|62727812|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
33350411|NCT03713632|62727813|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
33350412|NCT03713632|62727809|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
33350413|NCT03713632|62727810|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
33350414|NCT03713632|62727811|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
33350415|NCT03713632|62727812|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
33350416|NCT03713632|62727813|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
33350417|NCT03713632|62727809|FG000|Treatment Period 2 (After Week 16)|Death|0|||
33350418|NCT03713632|62727810|FG001|Treatment Period 2 (After Week 16)|Death|1|||
33350419|NCT03713632|62727811|FG002|Treatment Period 2 (After Week 16)|Death|0|||
33350420|NCT03713632|62727812|FG003|Treatment Period 2 (After Week 16)|Death|0|||
33350421|NCT03713632|62727813|FG004|Treatment Period 2 (After Week 16)|Death|0|||
33350422|NCT03713632|62727809|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
33350423|NCT03713632|62727810|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
33350424|NCT03713632|62727811|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
33350425|NCT03713632|62727812|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
33350426|NCT03713632|62727813|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
33350427|NCT03704051|62727824|FG000|Overall Study|Withdrawal by Subject|4|||
33350428|NCT03704051|62727825|FG001|Overall Study|Withdrawal by Subject|0|||
33350429|NCT03642938|62727841|FG000|Overall Study|Withdrawal by Subject|0|||
33350430|NCT03642938|62727842|FG001|Overall Study|Withdrawal by Subject|0|||
33350431|NCT03642938|62727843|FG002|Overall Study|Withdrawal by Subject|0|||
33350432|NCT03642938|62727844|FG003|Overall Study|Withdrawal by Subject|1|||
33350433|NCT03562767|62727857|FG000|Overall Study|Physician Decision|2|||
33350434|NCT03562767|62727858|FG001|Overall Study|Physician Decision|0|||
33350435|NCT03562767|62727859|FG002|Overall Study|Physician Decision|0|||
33350436|NCT03562767|62727857|FG000|Overall Study|Logistic Reason|1|||
33350437|NCT03562767|62727858|FG001|Overall Study|Logistic Reason|3|||
33350438|NCT03562767|62727859|FG002|Overall Study|Logistic Reason|0|||
33350439|NCT03406156|62727873|FG000|Overall Study|Death|6|||
33350440|NCT03406156|62727874|FG001|Overall Study|Death|2|||
33350441|NCT03406156|62727873|FG000|Overall Study|Withdrawal by Subject|0|||
33350442|NCT03406156|62727874|FG001|Overall Study|Withdrawal by Subject|2|||
33350443|NCT03406156|62727873|FG000|Overall Study|COVID-19 infection|1|||
33350444|NCT03406156|62727874|FG001|Overall Study|COVID-19 infection|0|||
33350445|NCT03406156|62727873|FG000|Overall Study|Non-compliance with study procedures|0|||
33350446|NCT03406156|62727874|FG001|Overall Study|Non-compliance with study procedures|1|||
33350447|NCT03406156|62727873|FG000|Overall Study|Other, not specified|0|||
33350448|NCT03406156|62727874|FG001|Overall Study|Other, not specified|1|||
33350449|NCT03358472|62727885|FG000|Overall Study|Death|6|||
33350450|NCT03358472|62727886|FG001|Overall Study|Death|3|||
33350451|NCT03358472|62727887|FG002|Overall Study|Death|10|||
33350452|NCT03358472|62727885|FG000|Overall Study|Physician Decision|0|||
33350453|NCT03358472|62727886|FG001|Overall Study|Physician Decision|1|||
33471504|NCT00231413|62845224|FG002|Overall Study|Withdrawal by Subject|4|||
33350454|NCT03358472|62727887|FG002|Overall Study|Physician Decision|0|||
33350455|NCT03358472|62727885|FG000|Overall Study|Withdrawal by Subject|0|||
33471505|NCT00231413|62845225|FG003|Overall Study|Withdrawal by Subject|2|||
33655086|NCT01895777|63069238|FG001|Overall Study|Other reasons|2|||
33350456|NCT03358472|62727886|FG001|Overall Study|Withdrawal by Subject|0|||
33350457|NCT03358472|62727887|FG002|Overall Study|Withdrawal by Subject|1|||
33350458|NCT03358472|62727885|FG000|Overall Study|On-going at clinical cut off date|9|||
33350459|NCT03358472|62727886|FG001|Overall Study|On-going at clinical cut off date|6|||
33350460|NCT03358472|62727887|FG002|Overall Study|On-going at clinical cut off date|5|||
33350461|NCT03333941|62727895|FG000|Overall Study|Lost to Follow-up|10|||
33350462|NCT03333941|62727895|FG000|Overall Study|Death|2|||
33350463|NCT03333941|62727895|FG000|Overall Study|Adverse Event|1|||
33350464|NCT03315754|62727899|FG000|Overall Study|COVID-19 complications leading to death|1|||
33350465|NCT03315754|62727899|FG000|Overall Study|insurance coverage issue|1|||
33471506|NCT00231413|62845226|FG004|Overall Study|Withdrawal by Subject|2|||
33350466|NCT02836236|62727918|FG000|Overall Study|Randomized but Never Treated|1|||
33350467|NCT02836236|62727919|FG001|Overall Study|Randomized but Never Treated|0|||
33350468|NCT02836236|62727918|FG000|Overall Study|Withdrew Consent|2|||
33350469|NCT02836236|62727919|FG001|Overall Study|Withdrew Consent|0|||
33350470|NCT02836236|62727918|FG000|Overall Study|Adverse Event|0|||
33350471|NCT02836236|62727919|FG001|Overall Study|Adverse Event|1|||
33350472|NCT02836236|62727918|FG000|Overall Study|Investigator's Discretion|1|||
33350473|NCT02836236|62727919|FG001|Overall Study|Investigator's Discretion|0|||
33350474|NCT02836236|62727918|FG000|Overall Study|Still on Study|101|||
33350475|NCT02836236|62727919|FG001|Overall Study|Still on Study|49|||
33350476|NCT02440711|62727927|FG000|Second Intervention|Lost to Follow-up|1|||
33350477|NCT02440711|62727928|FG001|Second Intervention|Lost to Follow-up|0|||
33350478|NCT02358031|62727939|FG000|Overall Study|Death|226|||
33350479|NCT02358031|62727940|FG001|Overall Study|Death|204|||
33350480|NCT02358031|62727941|FG002|Overall Study|Death|249|||
33350481|NCT02358031|62727939|FG000|Overall Study|Lost to Follow-up|0|||
33350482|NCT02358031|62727940|FG001|Overall Study|Lost to Follow-up|1|||
33350483|NCT02358031|62727941|FG002|Overall Study|Lost to Follow-up|1|||
33350484|NCT02358031|62727939|FG000|Overall Study|Withdrawal by Subject|14|||
33350485|NCT02358031|62727940|FG001|Overall Study|Withdrawal by Subject|12|||
33350486|NCT02358031|62727941|FG002|Overall Study|Withdrawal by Subject|17|||
33350487|NCT02358031|62727939|FG000|Overall Study|Ongoing in Study|61|||
33350488|NCT02358031|62727940|FG001|Overall Study|Ongoing in Study|64|||
33350489|NCT02358031|62727941|FG002|Overall Study|Ongoing in Study|33|||
33350490|NCT02258451|62727951|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|88|||
33350491|NCT02258451|62727952|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|95|||
33350492|NCT02258451|62727951|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|6|||
33350493|NCT02258451|62727952|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
33350494|NCT02258451|62727951|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
33350495|NCT02258451|62727952|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
33350496|NCT02258451|62727951|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
33350497|NCT02258451|62727952|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
33350498|NCT02258451|62727951|FG000|Overall Study|Death|4|||
33350499|NCT02258451|62727952|FG001|Overall Study|Death|3|||
33350500|NCT02258451|62727951|FG000|Overall Study|Withdrawal by Subject|21|||
33350501|NCT02258451|62727952|FG001|Overall Study|Withdrawal by Subject|12|||
33350502|NCT02258451|62727951|FG000|Overall Study|Discontinuation all treatment due to TS-1 started|1|||
33350503|NCT02258451|62727952|FG001|Overall Study|Discontinuation all treatment due to TS-1 started|0|||
33350504|NCT02258451|62727951|FG000|Overall Study|Discontinuation all treatment due to event point reached|1|||
33350505|NCT02258451|62727952|FG001|Overall Study|Discontinuation all treatment due to event point reached|1|||
33350506|NCT02258451|62727951|FG000|Overall Study|Physician Decision|0|||
33350507|NCT02258451|62727952|FG001|Overall Study|Physician Decision|2|||
33350508|NCT02258451|62727951|FG000|Overall Study|Never treated|2|||
33350509|NCT02258451|62727952|FG001|Overall Study|Never treated|3|||
33350510|NCT02258451|62727951|FG000|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|3|||
33350511|NCT02258451|62727952|FG001|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|11|||
33350512|NCT02223767|62727962|FG000|Overall Study|Withdrawal by Subject|4|||
33350513|NCT02223767|62727963|FG001|Overall Study|Withdrawal by Subject|4|||
33350514|NCT01956773|62727982|FG000|Overall Study|Lost to Follow-up|628|||
33350515|NCT01956773|62727983|FG001|Overall Study|Lost to Follow-up|1|||
33350516|NCT01946529|62727992|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
33350517|NCT01946529|62727993|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
33350518|NCT01946529|62727994|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
33350519|NCT01946529|62727992|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
33350520|NCT01946529|62727993|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
33350521|NCT01946529|62727994|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
33350522|NCT01666808|62728016|FG000|Overall Study|Lost to Follow-up|9|||
33350523|NCT01666808|62728017|FG001|Overall Study|Lost to Follow-up|15|||
33350524|NCT01666808|62728016|FG000|Overall Study|Withdrawal by Subject|3|||
33350525|NCT01666808|62728017|FG001|Overall Study|Withdrawal by Subject|1|||
33350526|NCT01666808|62728016|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
33350527|NCT01666808|62728017|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
33655087|NCT01895777|63069237|FG000|Overall Study|Non-compliance with the CTP|2|||
33655088|NCT01895777|63069238|FG001|Overall Study|Non-compliance with the CTP|1|||
33350528|NCT00964028|62728034|FG000|Overall Study|Withdrawal by Subject|0|||
33350529|NCT00964028|62728035|FG001|Overall Study|Withdrawal by Subject|1|||
33350530|NCT00960206|62728044|FG000|Overall Study|Death|7|||
33655089|NCT01885559|63069266|FG000|Overall Study|Lost to Follow-up|15|||
33655090|NCT01885559|63069267|FG001|Overall Study|Lost to Follow-up|16|||
33350531|NCT00960206|62728045|FG001|Overall Study|Death|4|||
33350532|NCT00960206|62728046|FG002|Overall Study|Death|1|||
33350533|NCT00960206|62728044|FG000|Overall Study|Unwilling/Unable to return|1|||
33350534|NCT00960206|62728045|FG001|Overall Study|Unwilling/Unable to return|2|||
33350535|NCT00960206|62728046|FG002|Overall Study|Unwilling/Unable to return|0|||
33350536|NCT00960206|62728044|FG000|Overall Study|Lost to Follow-up|8|||
33350537|NCT00960206|62728045|FG001|Overall Study|Lost to Follow-up|14|||
33350538|NCT00960206|62728046|FG002|Overall Study|Lost to Follow-up|8|||
33350539|NCT00960206|62728044|FG000|Overall Study|Withdrawal by Subject|2|||
33350540|NCT00960206|62728045|FG001|Overall Study|Withdrawal by Subject|4|||
33350541|NCT00960206|62728046|FG002|Overall Study|Withdrawal by Subject|0|||
33350542|NCT00960206|62728044|FG000|Overall Study|Revision of study component|2|||
33350543|NCT00960206|62728045|FG001|Overall Study|Revision of study component|2|||
33350544|NCT00960206|62728046|FG002|Overall Study|Revision of study component|2|||
33350545|NCT00960206|62728044|FG000|Overall Study|Missing 10 year data|20|||
33350546|NCT00960206|62728045|FG001|Overall Study|Missing 10 year data|1|||
33350547|NCT00960206|62728046|FG002|Overall Study|Missing 10 year data|1|||
33350548|NCT00751036|62728057|FG000|Overall Study|Disease Progression|28|||
33350549|NCT00751036|62728058|FG001|Overall Study|Disease Progression|29|||
33350550|NCT00751036|62728057|FG000|Overall Study|Adverse Event|6|||
33350551|NCT00751036|62728058|FG001|Overall Study|Adverse Event|4|||
33350552|NCT00751036|62728057|FG000|Overall Study|Administrative Problems|3|||
33350553|NCT00751036|62728058|FG001|Overall Study|Administrative Problems|4|||
33350554|NCT00751036|62728057|FG000|Overall Study|Withdrawal by Subject|5|||
33350555|NCT00751036|62728058|FG001|Overall Study|Withdrawal by Subject|2|||
33350556|NCT00751036|62728057|FG000|Overall Study|Death|3|||
33350557|NCT00751036|62728058|FG001|Overall Study|Death|3|||
33350558|NCT00751036|62728057|FG000|Overall Study|Lost to Follow-up|0|||
33350559|NCT00751036|62728058|FG001|Overall Study|Lost to Follow-up|1|||
33350560|NCT00751036|62728057|FG000|Overall Study|Protocol Violation|1|||
33350561|NCT00751036|62728058|FG001|Overall Study|Protocol Violation|0|||
33350562|NCT00751036|62728057|FG000|Overall Study|Missing end of Treatment Page|2|||
33350563|NCT00751036|62728058|FG001|Overall Study|Missing end of Treatment Page|3|||
33350564|NCT00961298|62728064|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
33350565|NCT00961298|62728064|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
33350566|NCT00961298|62728064|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
33350567|NCT00744328|62728071|FG000|Overall Study|Lost to Follow-up|2|||
33350568|NCT00744328|62728072|FG001|Overall Study|Lost to Follow-up|5|||
33350569|NCT00744328|62728073|FG002|Overall Study|Lost to Follow-up|3|||
33350570|NCT00744328|62728071|FG000|Overall Study|Withdrawal by Subject|5|||
33350571|NCT00744328|62728072|FG001|Overall Study|Withdrawal by Subject|3|||
33350572|NCT00744328|62728073|FG002|Overall Study|Withdrawal by Subject|4|||
33350573|NCT00744328|62728071|FG000|Overall Study|Found ineligible after randomization|0|||
33350574|NCT00744328|62728072|FG001|Overall Study|Found ineligible after randomization|0|||
33350575|NCT00744328|62728073|FG002|Overall Study|Found ineligible after randomization|1|||
33350576|NCT03245840|62728083|FG000|Overall Study|Adverse Event|6|||
33350577|NCT03245840|62728084|FG001|Overall Study|Adverse Event|0|||
33350578|NCT03245840|62728083|FG000|Overall Study|Death|2|||
33471507|NCT00231413|62845227|FG005|Overall Study|Withdrawal by Subject|0|||
33471508|NCT00231413|62845228|FG006|Overall Study|Withdrawal by Subject|3|||
33471509|NCT00231413|62845222|FG000|Overall Study|Migrated/moved from study area|0|||
33471510|NCT00231413|62845223|FG001|Overall Study|Migrated/moved from study area|0|||
33471511|NCT00231413|62845224|FG002|Overall Study|Migrated/moved from study area|1|||
33471512|NCT00231413|62845225|FG003|Overall Study|Migrated/moved from study area|0|||
33471513|NCT00231413|62845226|FG004|Overall Study|Migrated/moved from study area|0|||
33471514|NCT00231413|62845227|FG005|Overall Study|Migrated/moved from study area|1|||
33471515|NCT00231413|62845228|FG006|Overall Study|Migrated/moved from study area|0|||
33471516|NCT00231413|62845222|FG000|Overall Study|Lost to Follow-up|4|||
33471517|NCT00231413|62845223|FG001|Overall Study|Lost to Follow-up|4|||
33471518|NCT00231413|62845224|FG002|Overall Study|Lost to Follow-up|1|||
33471519|NCT00231413|62845225|FG003|Overall Study|Lost to Follow-up|1|||
33350579|NCT03245840|62728084|FG001|Overall Study|Death|0|||
33471520|NCT00231413|62845226|FG004|Overall Study|Lost to Follow-up|1|||
33471521|NCT00231413|62845227|FG005|Overall Study|Lost to Follow-up|4|||
33350580|NCT03245840|62728083|FG000|Overall Study|Withdrawal by Subject|31|||
33350581|NCT03245840|62728084|FG001|Overall Study|Withdrawal by Subject|1|||
33350582|NCT03245840|62728083|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
33350583|NCT03245840|62728084|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33350584|NCT03245840|62728083|FG000|Overall Study|Physician Decision|4|||
33350585|NCT03245840|62728084|FG001|Overall Study|Physician Decision|1|||
33350586|NCT03245840|62728083|FG000|Overall Study|Study Terminated by Sponsor|56|||
33350587|NCT03245840|62728084|FG001|Overall Study|Study Terminated by Sponsor|6|||
33471522|NCT00231413|62845228|FG006|Overall Study|Lost to Follow-up|0|||
33471523|NCT00231413|62845222|FG000|Overall Study|Pregnancy|1|||
33471524|NCT00231413|62845223|FG001|Overall Study|Pregnancy|0|||
33471525|NCT00231413|62845224|FG002|Overall Study|Pregnancy|0|||
33471526|NCT00231413|62845225|FG003|Overall Study|Pregnancy|0|||
33471527|NCT00231413|62845226|FG004|Overall Study|Pregnancy|0|||
33471528|NCT00231413|62845227|FG005|Overall Study|Pregnancy|0|||
33471529|NCT00231413|62845228|FG006|Overall Study|Pregnancy|0|||
33471530|NCT04494646|62845246|FG000|Overall Study|Adverse Event|0|||
33471531|NCT04494646|62845247|FG001|Overall Study|Adverse Event|1|||
33471532|NCT04494646|62845246|FG000|Overall Study|Withdrawal by Subject|0|||
33350588|NCT03245840|62728083|FG000|Overall Study|Site Terminated by Sponsor|4|||
33350589|NCT03245840|62728084|FG001|Overall Study|Site Terminated by Sponsor|0|||
33350590|NCT03245840|62728083|FG000|Overall Study|Lost to Follow-up|12|||
33350591|NCT03245840|62728084|FG001|Overall Study|Lost to Follow-up|2|||
33350592|NCT03245840|62728083|FG000|Overall Study|Pregnancy|2|||
33350593|NCT03245840|62728084|FG001|Overall Study|Pregnancy|0|||
33350594|NCT03245840|62728083|FG000|Overall Study|Non-Compliance with Study Drug|2|||
33350595|NCT03245840|62728084|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33350596|NCT03245840|62728083|FG000|Overall Study|Not treated|1|||
33350597|NCT03245840|62728084|FG001|Overall Study|Not treated|1|||
33350598|NCT00959894|62728090|FG000|Overall Study|Lost to Follow-up|10|||
33350599|NCT00959894|62728090|FG000|Overall Study|Adverse Event|3|||
33350600|NCT00959894|62728090|FG000|Overall Study|Withdrawal by Subject|1|||
33350601|NCT00959894|62728090|FG000|Overall Study|Need for contraindicated medication|1|||
33350602|NCT00959894|62728090|FG000|Overall Study|Subject moved out of town|1|||
33350603|NCT00750880|62728095|FG000|Overall Study|Adverse Event|76|||
33350604|NCT00750880|62728095|FG000|Overall Study|Death|4|||
33350605|NCT00750880|62728095|FG000|Overall Study|Lack of Efficacy|46|||
33350606|NCT00750880|62728095|FG000|Overall Study|Lost to Follow-up|10|||
33350607|NCT00750880|62728095|FG000|Overall Study|Protocol Violation|15|||
33350608|NCT00750880|62728095|FG000|Overall Study|Withdrawal by Subject|33|||
33350609|NCT00750880|62728095|FG000|Overall Study|Physician Decision|20|||
33350610|NCT00750880|62728095|FG000|Overall Study|Administrative|11|||
33350611|NCT00746590|62728100|FG000|Overall Study|Death|1|||
33350612|NCT01032629|62728107|FG000|Overall Study|Closed Site|21|||
33350613|NCT01032629|62728108|FG001|Overall Study|Closed Site|18|||
33350614|NCT01032629|62728109|FG002|Overall Study|Closed Site|16|||
33350615|NCT01032629|62728107|FG000|Overall Study|Withdrawal by Subject|50|||
33350616|NCT01032629|62728108|FG001|Overall Study|Withdrawal by Subject|36|||
33350617|NCT01032629|62728109|FG002|Overall Study|Withdrawal by Subject|35|||
33350618|NCT01032629|62728107|FG000|Overall Study|Lost to Follow-up|74|||
33350619|NCT01032629|62728108|FG001|Overall Study|Lost to Follow-up|47|||
33350620|NCT01032629|62728109|FG002|Overall Study|Lost to Follow-up|37|||
33350621|NCT00749944|62728120|FG000|Overall Study|Lost to Follow-up|2|||
33350622|NCT00749944|62728121|FG001|Overall Study|Lost to Follow-up|1|||
33350623|NCT00749944|62728120|FG000|Overall Study|Other|1|||
33350624|NCT00749944|62728121|FG001|Overall Study|Other|0|||
33350625|NCT00749944|62728120|FG000|Overall Study|Withdrawal by Subject|2|||
33350626|NCT00749944|62728121|FG001|Overall Study|Withdrawal by Subject|0|||
33350627|NCT00749398|62728127|FG000|Overall Study|Lack of Efficacy|7|||
33350628|NCT00749398|62728127|FG000|Overall Study|Adverse Event|4|||
33350629|NCT00749398|62728127|FG000|Overall Study|Serious adverse event|11|||
33350630|NCT00749398|62728127|FG000|Overall Study|Withdrawal by Subject|17|||
33350631|NCT00749398|62728127|FG000|Overall Study|Lost to Follow-up|11|||
33350632|NCT00749398|62728127|FG000|Overall Study|Reason not specified|2|||
33350633|NCT00749398|62728127|FG000|Overall Study|Unknown reason|1|||
33350634|NCT00746356|62728131|FG000|Overall Study|Withdrawal by Subject|2|||
33350635|NCT00746356|62728132|FG001|Overall Study|Withdrawal by Subject|3|||
33350636|NCT00746356|62728131|FG000|Overall Study|Death|7|||
33350637|NCT00746356|62728132|FG001|Overall Study|Death|3|||
33350638|NCT00746356|62728131|FG000|Overall Study|Lost to Follow-up|1|||
33350639|NCT00746356|62728132|FG001|Overall Study|Lost to Follow-up|0|||
33350640|NCT00746356|62728131|FG000|Overall Study|Removal of Device|0|||
33350641|NCT00746356|62728132|FG001|Overall Study|Removal of Device|1|||
33471533|NCT04494646|62845247|FG001|Overall Study|Withdrawal by Subject|1|||
33350642|NCT00746356|62728131|FG000|Overall Study|Patient relocated|1|||
33471534|NCT04529096|62845255|FG000|Overall Study|Adverse Event|6|||
33471535|NCT04529096|62845256|FG001|Overall Study|Adverse Event|1|||
33350643|NCT00746356|62728132|FG001|Overall Study|Patient relocated|0|||
33350644|NCT01012973|62728142|FG000|Overall Study|Adverse Event|5|||
33350645|NCT01012973|62728143|FG001|Overall Study|Adverse Event|5|||
33350646|NCT01012973|62728142|FG000|Overall Study|Lack of Efficacy|0|||
33350647|NCT01012973|62728143|FG001|Overall Study|Lack of Efficacy|5|||
33350648|NCT01012973|62728142|FG000|Overall Study|Lost to Follow-up|1|||
33350649|NCT01012973|62728143|FG001|Overall Study|Lost to Follow-up|0|||
33350650|NCT01012973|62728142|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
33350651|NCT01012973|62728143|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
33350652|NCT01012973|62728142|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
33350653|NCT01012973|62728143|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
33350654|NCT01012973|62728142|FG000|Overall Study|Protocol Violation|5|||
33471536|NCT04529096|62845255|FG000|Overall Study|Lack of Efficacy|1|||
33471537|NCT04529096|62845256|FG001|Overall Study|Lack of Efficacy|0|||
33471538|NCT04529096|62845255|FG000|Overall Study|Lost to Follow-up|1|||
33350655|NCT01012973|62728143|FG001|Overall Study|Protocol Violation|2|||
33350656|NCT01012973|62728142|FG000|Overall Study|Withdrawal by Subject|4|||
33350657|NCT01012973|62728143|FG001|Overall Study|Withdrawal by Subject|6|||
33350658|NCT00748540|62728153|FG000|Overall Study|Physician Decision|1|||
33350659|NCT01012739|62728157|FG000|Treatment Period 1|Adverse Event|0|||
33350660|NCT01012739|62728158|FG001|Treatment Period 1|Adverse Event|0|||
33350661|NCT01012739|62728159|FG002|Treatment Period 1|Adverse Event|0|||
33350662|NCT01012739|62728160|FG003|Treatment Period 1|Adverse Event|1|||
33350663|NCT01012739|62728157|FG000|Treatment Period 2|Abnormal test procedure results|0|||
33350664|NCT01012739|62728158|FG001|Treatment Period 2|Abnormal test procedure results|0|||
33350665|NCT01012739|62728159|FG002|Treatment Period 2|Abnormal test procedure results|0|||
33350666|NCT01012739|62728160|FG003|Treatment Period 2|Abnormal test procedure results|1|||
33350667|NCT00742924|62728175|FG000|Overall Study|Adverse Event|0|||
33350668|NCT00742924|62728176|FG001|Overall Study|Adverse Event|0|||
33350669|NCT00742924|62728177|FG002|Overall Study|Adverse Event|1|||
33350670|NCT00742924|62728178|FG003|Overall Study|Adverse Event|1|||
33350671|NCT00742924|62728175|FG000|Overall Study|Lack of Efficacy|5|||
33350672|NCT00742924|62728176|FG001|Overall Study|Lack of Efficacy|1|||
33350673|NCT00742924|62728177|FG002|Overall Study|Lack of Efficacy|2|||
33350674|NCT00742924|62728178|FG003|Overall Study|Lack of Efficacy|4|||
33350675|NCT00742924|62728175|FG000|Overall Study|Physician Decision|0|||
33350676|NCT00742924|62728176|FG001|Overall Study|Physician Decision|0|||
33350677|NCT00742924|62728177|FG002|Overall Study|Physician Decision|0|||
33350678|NCT00742924|62728178|FG003|Overall Study|Physician Decision|1|||
33350679|NCT00742924|62728175|FG000|Overall Study|Withdrawal by Subject|0|||
33350680|NCT00742924|62728176|FG001|Overall Study|Withdrawal by Subject|1|||
33350681|NCT00742924|62728177|FG002|Overall Study|Withdrawal by Subject|1|||
33350682|NCT00742924|62728178|FG003|Overall Study|Withdrawal by Subject|0|||
33350683|NCT00698815|62728191|FG000|Overall Study|Death|1|||
33350684|NCT00698815|62728192|FG001|Overall Study|Death|2|||
33350685|NCT00698815|62728193|FG002|Overall Study|Death|4|||
33350686|NCT00698815|62728191|FG000|Overall Study|Withdrawal by Subject|6|||
33350687|NCT00698815|62728192|FG001|Overall Study|Withdrawal by Subject|3|||
33350688|NCT00698815|62728193|FG002|Overall Study|Withdrawal by Subject|2|||
33350689|NCT00698815|62728191|FG000|Overall Study|MD discretion|2|||
33350690|NCT00698815|62728192|FG001|Overall Study|MD discretion|7|||
33350691|NCT00698815|62728193|FG002|Overall Study|MD discretion|2|||
33350692|NCT00698815|62728191|FG000|Overall Study|Did not receive protocol treatment|1|||
33350693|NCT00698815|62728192|FG001|Overall Study|Did not receive protocol treatment|2|||
33350694|NCT00698815|62728193|FG002|Overall Study|Did not receive protocol treatment|2|||
33350695|NCT00745498|62728204|FG000|Overall Study|Lost to Follow-up|1|||
33350696|NCT00745498|62728205|FG001|Overall Study|Lost to Follow-up|1|||
33350697|NCT00745498|62728206|FG002|Overall Study|Lost to Follow-up|3|||
33350698|NCT00745498|62728204|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
33350699|NCT00745498|62728205|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
33350700|NCT00745498|62728206|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
33350701|NCT00745498|62728204|FG000|Overall Study|Non-PDR related VH|0|||
33350702|NCT00745498|62728205|FG001|Overall Study|Non-PDR related VH|1|||
33350703|NCT00745498|62728206|FG002|Overall Study|Non-PDR related VH|1|||
33350704|NCT00745498|62728204|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
33350705|NCT00745498|62728205|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
33350706|NCT00745498|62728206|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
33350707|NCT00744874|62728214|FG000|Overall Study|Lost to Follow-up|1|||
33350708|NCT00744874|62728214|FG000|Overall Study|Withdrawal by Subject|1|||
33350709|NCT00744874|62728214|FG000|Overall Study|Study Device not available at procedure|1|||
33350710|NCT00744874|62728214|FG000|Overall Study|Unable to accomodate schedule|1|||
33350711|NCT00576901|62728225|FG000|Overall Study|Withdrawal by Subject|1|||
33350712|NCT00576901|62728225|FG000|Overall Study|Disease course|1|||
33471539|NCT04529096|62845256|FG001|Overall Study|Lost to Follow-up|1|||
33471540|NCT04529096|62845255|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33471541|NCT04529096|62845256|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33350713|NCT00576901|62728225|FG000|Overall Study|Protocol Violation|1|||
33350714|NCT00699283|62728231|FG000|Overall Study|Lack of Efficacy|15|||
33350715|NCT00699283|62728232|FG001|Overall Study|Lack of Efficacy|5|||
33350716|NCT00699283|62728231|FG000|Overall Study|Lost to Follow-up|2|||
33350717|NCT00699283|62728232|FG001|Overall Study|Lost to Follow-up|0|||
33350718|NCT00699283|62728231|FG000|Overall Study|Withdrawal by Subject|1|||
33350719|NCT00699283|62728232|FG001|Overall Study|Withdrawal by Subject|0|||
33350720|NCT00699283|62728231|FG000|Overall Study|Other Reason|5|||
33350721|NCT00699283|62728232|FG001|Overall Study|Other Reason|1|||
33350722|NCT00699283|62728231|FG000|Overall Study|SAE, non-fatal|1|||
33350723|NCT00699283|62728232|FG001|Overall Study|SAE, non-fatal|1|||
33350724|NCT00699283|62728231|FG000|Overall Study|AE, non-serious non-fatal|8|||
33350725|NCT00699283|62728232|FG001|Overall Study|AE, non-serious non-fatal|1|||
33350726|NCT00699283|62728231|FG000|Overall Study|AE of unknown type|1|||
33350727|NCT00699283|62728232|FG001|Overall Study|AE of unknown type|0|||
33471542|NCT04529096|62845255|FG000|Overall Study|Physician Decision|1|||
33471543|NCT04529096|62845256|FG001|Overall Study|Physician Decision|3|||
33471544|NCT04529096|62845255|FG000|Overall Study|Withdrawal by Subject|5|||
33471545|NCT04529096|62845256|FG001|Overall Study|Withdrawal by Subject|0|||
33471546|NCT00231179|62845264|FG000|Overall Study|Lost to Follow-up|21|||
33471547|NCT00231179|62845265|FG001|Overall Study|Lost to Follow-up|21|||
33471548|NCT00231179|62845264|FG000|Overall Study|Withdrawal by Subject|3|||
33471549|NCT00231179|62845265|FG001|Overall Study|Withdrawal by Subject|3|||
33471550|NCT00229931|62845273|FG000|Overall Study|Death|1|||
33471551|NCT00229931|62845274|FG001|Overall Study|Death|0|||
33350728|NCT00740584|62728237|FG000|Overall Study|Withdrawal by Subject|1|||
33350729|NCT01023815|62728246|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
33350730|NCT01023815|62728247|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
33350731|NCT01023815|62728248|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
33350732|NCT01023815|62728249|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
33350733|NCT01023815|62728246|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
33471552|NCT00229931|62845273|FG000|Overall Study|Lost to Follow-up|3|||
33350734|NCT01023815|62728247|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
33350735|NCT01023815|62728248|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
33350736|NCT01023815|62728249|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
33350737|NCT01023815|62728246|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
33350738|NCT01023815|62728247|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
33350739|NCT01023815|62728248|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
33350740|NCT01023815|62728249|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
33350741|NCT01023815|62728246|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
33350742|NCT01023815|62728247|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
33350743|NCT01023815|62728248|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
33350744|NCT01023815|62728249|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
33350745|NCT01023815|62728246|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
33350746|NCT01023815|62728247|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
33350747|NCT01023815|62728248|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
33350748|NCT01023815|62728249|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
33350749|NCT01023659|62728263|FG000|Overall Study|Lost to Follow-up|73|||
33350750|NCT01023659|62728264|FG001|Overall Study|Lost to Follow-up|228|||
33350751|NCT01023659|62728265|FG002|Overall Study|Lost to Follow-up|99|||
33471553|NCT00229931|62845274|FG001|Overall Study|Lost to Follow-up|2|||
33471554|NCT03135028|62845280|FG000|Overall Study|Death|6|||
33471555|NCT03135028|62845280|FG000|Overall Study|Study Terminated by Sponsor|2|||
33471556|NCT03135028|62845280|FG000|Overall Study|Withdrew Consent|1|||
33471557|NCT00228917|62845292|FG000|Overall Study|Migrated/moved from study area|0|||
33471558|NCT00228917|62845293|FG001|Overall Study|Migrated/moved from study area|0|||
33471559|NCT00228917|62845294|FG002|Overall Study|Migrated/moved from study area|0|||
33471560|NCT00228917|62845295|FG003|Overall Study|Migrated/moved from study area|0|||
33471561|NCT00228917|62845296|FG004|Overall Study|Migrated/moved from study area|0|||
33471562|NCT00228917|62845297|FG005|Overall Study|Migrated/moved from study area|2|||
33471563|NCT00228917|62845298|FG006|Overall Study|Migrated/moved from study area|0|||
33471564|NCT00228917|62845299|FG007|Overall Study|Migrated/moved from study area|0|||
33471565|NCT00227903|62845315|FG000|Overall Study|Withdrawal by Subject|2|||
33471566|NCT00227903|62845316|FG001|Overall Study|Withdrawal by Subject|5|||
33471567|NCT00227903|62845315|FG000|Overall Study|Subject moved out of area|1|||
33471568|NCT00227903|62845316|FG001|Overall Study|Subject moved out of area|2|||
33471569|NCT00227903|62845315|FG000|Overall Study|Lost to Follow-up|1|||
33471570|NCT00227903|62845316|FG001|Overall Study|Lost to Follow-up|3|||
33471571|NCT00227903|62845315|FG000|Overall Study|Miscarriage|1|||
33471572|NCT00227903|62845316|FG001|Overall Study|Miscarriage|0|||
33471573|NCT04411628|62845326|FG000|Overall Study|Withdrawal by Subject|1|||
33471574|NCT04411628|62845327|FG001|Overall Study|Withdrawal by Subject|1|||
33471575|NCT04411628|62845328|FG002|Overall Study|Withdrawal by Subject|2|||
33471576|NCT04411628|62845329|FG003|Overall Study|Withdrawal by Subject|0|||
33350752|NCT00740116|62728276|FG000|Overall Study|Withdrawal by Subject|1|||
33350753|NCT00740116|62728277|FG001|Overall Study|Withdrawal by Subject|1|||
33655091|NCT01885559|63069266|FG000|Overall Study|Less than full participation|9|||
33350754|NCT00740116|62728276|FG000|Overall Study|Protocol Violation|1|||
33471577|NCT04411628|62845326|FG000|Overall Study|Lost to Follow-up|0|||
33471578|NCT04411628|62845327|FG001|Overall Study|Lost to Follow-up|1|||
33471579|NCT04411628|62845328|FG002|Overall Study|Lost to Follow-up|0|||
33655092|NCT01885559|63069267|FG001|Overall Study|Less than full participation|19|||
33350755|NCT00740116|62728277|FG001|Overall Study|Protocol Violation|4|||
33350756|NCT00698581|62728287|FG000|Overall Study|Lack of Efficacy|23|||
33471580|NCT04411628|62845329|FG003|Overall Study|Lost to Follow-up|0|||
33471581|NCT00227591|62845342|FG000|Overall Study|Withdrawal by Subject|1|||
33471582|NCT04512482|62845348|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
33471583|NCT04512482|62845349|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
33655093|NCT01885559|63069266|FG000|Overall Study|Protocol Violation|0|||
33350757|NCT00698581|62728288|FG001|Overall Study|Lack of Efficacy|11|||
33350758|NCT00698581|62728287|FG000|Overall Study|Withdrawal by Subject|6|||
33350759|NCT00698581|62728288|FG001|Overall Study|Withdrawal by Subject|0|||
33350760|NCT00698581|62728287|FG000|Overall Study|Other reason|9|||
33350761|NCT00698581|62728288|FG001|Overall Study|Other reason|1|||
33350762|NCT00698581|62728287|FG000|Overall Study|SAE, non-fatal|1|||
33350763|NCT00698581|62728288|FG001|Overall Study|SAE, non-fatal|0|||
33350764|NCT00698581|62728287|FG000|Overall Study|AE, non-serious non-fatal|4|||
33350765|NCT00698581|62728288|FG001|Overall Study|AE, non-serious non-fatal|0|||
33350766|NCT00698581|62728287|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33350767|NCT00698581|62728288|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
33350768|NCT00698581|62728287|FG000|Overall Study|AE of unknown type|1|||
33350769|NCT00698581|62728288|FG001|Overall Study|AE of unknown type|0|||
33350770|NCT01023581|62728302|FG000|Overall Study|Adverse Event|4|||
33350771|NCT01023581|62728303|FG001|Overall Study|Adverse Event|4|||
33350772|NCT01023581|62728304|FG002|Overall Study|Adverse Event|7|||
33350773|NCT01023581|62728305|FG003|Overall Study|Adverse Event|3|||
33350774|NCT01023581|62728306|FG004|Overall Study|Adverse Event|2|||
33350775|NCT01023581|62728307|FG005|Overall Study|Adverse Event|5|||
33350776|NCT01023581|62728308|FG006|Overall Study|Adverse Event|11|||
33350777|NCT01023581|62728302|FG000|Overall Study|Major protocol deviation|2|||
33350778|NCT01023581|62728303|FG001|Overall Study|Major protocol deviation|0|||
33350779|NCT01023581|62728304|FG002|Overall Study|Major protocol deviation|3|||
33350780|NCT01023581|62728305|FG003|Overall Study|Major protocol deviation|0|||
33350781|NCT01023581|62728306|FG004|Overall Study|Major protocol deviation|0|||
33350782|NCT01023581|62728307|FG005|Overall Study|Major protocol deviation|0|||
33350783|NCT01023581|62728308|FG006|Overall Study|Major protocol deviation|0|||
33350784|NCT01023581|62728302|FG000|Overall Study|Lost to Follow-up|4|||
33350785|NCT01023581|62728303|FG001|Overall Study|Lost to Follow-up|8|||
33350786|NCT01023581|62728304|FG002|Overall Study|Lost to Follow-up|7|||
33350787|NCT01023581|62728305|FG003|Overall Study|Lost to Follow-up|2|||
33350788|NCT01023581|62728306|FG004|Overall Study|Lost to Follow-up|5|||
33350789|NCT01023581|62728307|FG005|Overall Study|Lost to Follow-up|2|||
33350790|NCT01023581|62728308|FG006|Overall Study|Lost to Follow-up|2|||
33350791|NCT01023581|62728302|FG000|Overall Study|Withdrawal by Subject|13|||
33350792|NCT01023581|62728303|FG001|Overall Study|Withdrawal by Subject|8|||
33350793|NCT01023581|62728304|FG002|Overall Study|Withdrawal by Subject|16|||
33350794|NCT01023581|62728305|FG003|Overall Study|Withdrawal by Subject|10|||
33350795|NCT01023581|62728306|FG004|Overall Study|Withdrawal by Subject|6|||
33350796|NCT01023581|62728307|FG005|Overall Study|Withdrawal by Subject|8|||
33350797|NCT01023581|62728308|FG006|Overall Study|Withdrawal by Subject|5|||
33350798|NCT01023581|62728302|FG000|Overall Study|Pregnancy|0|||
33350799|NCT01023581|62728303|FG001|Overall Study|Pregnancy|0|||
33350800|NCT01023581|62728304|FG002|Overall Study|Pregnancy|0|||
33350801|NCT01023581|62728305|FG003|Overall Study|Pregnancy|2|||
33350802|NCT01023581|62728306|FG004|Overall Study|Pregnancy|0|||
33350803|NCT01023581|62728307|FG005|Overall Study|Pregnancy|1|||
33350804|NCT01023581|62728308|FG006|Overall Study|Pregnancy|0|||
33350805|NCT01023581|62728302|FG000|Overall Study|Lack of Efficacy|9|||
33350806|NCT01023581|62728303|FG001|Overall Study|Lack of Efficacy|3|||
33350807|NCT01023581|62728304|FG002|Overall Study|Lack of Efficacy|6|||
33471584|NCT00226811|62845355|FG000|Overall Study|Death|8|||
33471585|NCT00226811|62845355|FG000|Overall Study|Adverse Event|11|||
33471586|NCT00226811|62845355|FG000|Overall Study|Lack of Efficacy|55|||
33471587|NCT00226811|62845355|FG000|Overall Study|Withdrawal by Subject|2|||
33471588|NCT02951052|62845361|FG000|Overall Study|Adverse Event|13|||
33471589|NCT02951052|62845362|FG001|Overall Study|Adverse Event|5|||
33471590|NCT02951052|62845361|FG000|Overall Study|Withdrawal by Subject|1|||
33350808|NCT01023581|62728305|FG003|Overall Study|Lack of Efficacy|2|||
33350809|NCT01023581|62728306|FG004|Overall Study|Lack of Efficacy|1|||
33350810|NCT01023581|62728307|FG005|Overall Study|Lack of Efficacy|2|||
33350811|NCT01023581|62728308|FG006|Overall Study|Lack of Efficacy|1|||
33350812|NCT01023581|62728302|FG000|Overall Study|Physician Decision|2|||
33350813|NCT01023581|62728303|FG001|Overall Study|Physician Decision|0|||
33350814|NCT01023581|62728304|FG002|Overall Study|Physician Decision|2|||
33350815|NCT01023581|62728305|FG003|Overall Study|Physician Decision|1|||
33350816|NCT01023581|62728306|FG004|Overall Study|Physician Decision|1|||
33350817|NCT01023581|62728307|FG005|Overall Study|Physician Decision|1|||
33350818|NCT01023581|62728308|FG006|Overall Study|Physician Decision|1|||
33350819|NCT01023581|62728302|FG000|Overall Study|Other|1|||
33350820|NCT01023581|62728303|FG001|Overall Study|Other|0|||
33350821|NCT01023581|62728304|FG002|Overall Study|Other|1|||
33350822|NCT01023581|62728305|FG003|Overall Study|Other|0|||
33471591|NCT02951052|62845362|FG001|Overall Study|Withdrawal by Subject|5|||
33350823|NCT01023581|62728306|FG004|Overall Study|Other|1|||
33350824|NCT01023581|62728307|FG005|Overall Study|Other|0|||
33350825|NCT01023581|62728308|FG006|Overall Study|Other|0|||
33350826|NCT00962780|62728326|FG000|Overall Study|Death|0|||
33350827|NCT00962780|62728327|FG001|Overall Study|Death|1|||
33350828|NCT00962780|62728326|FG000|Overall Study|Protocol Violation|9|||
33350829|NCT00962780|62728327|FG001|Overall Study|Protocol Violation|4|||
33350830|NCT00962780|62728326|FG000|Overall Study|Withdrawal by Subject|1|||
33350831|NCT00962780|62728327|FG001|Overall Study|Withdrawal by Subject|8|||
33350832|NCT00962780|62728326|FG000|Overall Study|Other|0|||
33350833|NCT00962780|62728327|FG001|Overall Study|Other|1|||
33350834|NCT00739882|62728341|FG000|Double-blind Period|Adverse Event|1|||
33350835|NCT00739882|62728342|FG001|Double-blind Period|Adverse Event|2|||
33350836|NCT00739882|62728341|FG000|Double-blind Period|Protocol Violation|1|||
33350837|NCT00739882|62728342|FG001|Double-blind Period|Protocol Violation|0|||
33350838|NCT00739882|62728341|FG000|Double-blind Period|Lack of Efficacy|1|||
33350839|NCT00739882|62728342|FG001|Double-blind Period|Lack of Efficacy|1|||
33350840|NCT00739882|62728341|FG000|Double-blind Period|Other|16|||
33350841|NCT00739882|62728342|FG001|Double-blind Period|Other|8|||
33350842|NCT00739882|62728341|FG000|Open-label Period|Adverse Event|1|||
33350843|NCT00739882|62728342|FG001|Open-label Period|Adverse Event|0|||
33350844|NCT00739882|62728341|FG000|Open-label Period|Other|9|||
33350845|NCT00739882|62728342|FG001|Open-label Period|Other|5|||
33350846|NCT00961220|62728350|FG000|Overall Study|Adverse Event|3|||
33350847|NCT00961220|62728350|FG000|Overall Study|Lack of Efficacy|1|||
33350848|NCT00961220|62728350|FG000|Overall Study|No IV access for O6BG|1|||
33350849|NCT00961220|62728350|FG000|Overall Study|O6BG no longer supplied|1|||
33350850|NCT00961220|62728350|FG000|Overall Study|Complete Response prior to 12 courses|1|||
33350851|NCT00734656|62728356|FG000|Lab Session 1|Withdrawal by Subject|2|||
33350852|NCT00734656|62728357|FG001|Lab Session 1|Withdrawal by Subject|0|||
33350853|NCT00734656|62728358|FG002|Lab Session 1|Withdrawal by Subject|0|||
33350854|NCT00734656|62728359|FG003|Lab Session 1|Withdrawal by Subject|0|||
33350855|NCT00734656|62728356|FG000|Washout 1|Withdrawal by Subject|1|||
33350856|NCT00734656|62728357|FG001|Washout 1|Withdrawal by Subject|5|||
33350857|NCT00734656|62728358|FG002|Washout 1|Withdrawal by Subject|2|||
33350858|NCT00734656|62728359|FG003|Washout 1|Withdrawal by Subject|3|||
33350859|NCT00734656|62728356|FG000|Lab Session 2|Withdrawal by Subject|1|||
33350860|NCT00734656|62728357|FG001|Lab Session 2|Withdrawal by Subject|0|||
33350861|NCT00734656|62728358|FG002|Lab Session 2|Withdrawal by Subject|0|||
33350862|NCT00734656|62728359|FG003|Lab Session 2|Withdrawal by Subject|1|||
33350863|NCT00734656|62728356|FG000|Washout 2|Withdrawal by Subject|1|||
33350864|NCT00734656|62728357|FG001|Washout 2|Withdrawal by Subject|1|||
33350865|NCT00734656|62728358|FG002|Washout 2|Withdrawal by Subject|1|||
33350866|NCT00734656|62728359|FG003|Washout 2|Withdrawal by Subject|0|||
33350867|NCT00734656|62728356|FG000|Washout 3|Withdrawal by Subject|1|||
33350868|NCT00734656|62728357|FG001|Washout 3|Withdrawal by Subject|0|||
33350869|NCT00734656|62728358|FG002|Washout 3|Withdrawal by Subject|0|||
33350870|NCT00734656|62728359|FG003|Washout 3|Withdrawal by Subject|1|||
33350871|NCT00734656|62728356|FG000|Lab Session 4|Withdrawal by Subject|0|||
33350872|NCT00734656|62728357|FG001|Lab Session 4|Withdrawal by Subject|0|||
33350873|NCT00734656|62728358|FG002|Lab Session 4|Withdrawal by Subject|0|||
33350874|NCT00734656|62728359|FG003|Lab Session 4|Withdrawal by Subject|1|||
33350875|NCT00961064|62728369|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
33350876|NCT00961064|62728369|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
33350877|NCT00961064|62728369|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
33350878|NCT00961064|62728369|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
33350879|NCT00961064|62728369|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
33350880|NCT00961064|62728369|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
33350881|NCT00961064|62728369|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
33350882|NCT00961064|62728369|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
33350883|NCT00739648|62728376|FG000|Overall Study|Adverse Event|3|||
33350884|NCT00739648|62728377|FG001|Overall Study|Adverse Event|15|||
33350885|NCT00739648|62728376|FG000|Overall Study|Withdrawal by Subject|13|||
33350886|NCT00739648|62728377|FG001|Overall Study|Withdrawal by Subject|25|||
33350887|NCT00739648|62728376|FG000|Overall Study|Lost to Follow-up|4|||
33350888|NCT00739648|62728377|FG001|Overall Study|Lost to Follow-up|7|||
33350889|NCT00739648|62728376|FG000|Overall Study|Death|2|||
33350890|NCT00739648|62728377|FG001|Overall Study|Death|0|||
33350891|NCT00739648|62728376|FG000|Overall Study|Do not know|4|||
33350892|NCT00739648|62728377|FG001|Overall Study|Do not know|6|||
33350893|NCT01032239|62728389|FG000|Overall Study|Lost to Follow-up|3|||
33350894|NCT01032239|62728390|FG001|Overall Study|Lost to Follow-up|2|||
33350895|NCT01032239|62728389|FG000|Overall Study|Withdrawal by Subject|2|||
33350896|NCT01032239|62728390|FG001|Overall Study|Withdrawal by Subject|3|||
33350897|NCT01032239|62728389|FG000|Overall Study|Death|1|||
33350898|NCT01032239|62728390|FG001|Overall Study|Death|0|||
33350899|NCT01032239|62728389|FG000|Overall Study|Protocol Violation|1|||
33350900|NCT01032239|62728390|FG001|Overall Study|Protocol Violation|0|||
33350901|NCT00734578|62728399|FG000|Overall Study|Adverse Event|4|||
33350902|NCT00734578|62728400|FG001|Overall Study|Adverse Event|6|||
33350903|NCT00734578|62728401|FG002|Overall Study|Adverse Event|1|||
33350904|NCT00734578|62728399|FG000|Overall Study|Protocol Violation|8|||
33350905|NCT00734578|62728400|FG001|Overall Study|Protocol Violation|6|||
33350906|NCT00734578|62728401|FG002|Overall Study|Protocol Violation|3|||
33350907|NCT00734578|62728399|FG000|Overall Study|Withdrawal by Subject|7|||
33350908|NCT00734578|62728400|FG001|Overall Study|Withdrawal by Subject|8|||
33350909|NCT00734578|62728401|FG002|Overall Study|Withdrawal by Subject|11|||
33350910|NCT00734578|62728399|FG000|Overall Study|Lost to Follow-up|9|||
33350911|NCT00734578|62728400|FG001|Overall Study|Lost to Follow-up|3|||
33350912|NCT00734578|62728401|FG002|Overall Study|Lost to Follow-up|5|||
33350913|NCT00734578|62728399|FG000|Overall Study|Lack of Efficacy|3|||
33350914|NCT00734578|62728400|FG001|Overall Study|Lack of Efficacy|2|||
33350915|NCT00734578|62728401|FG002|Overall Study|Lack of Efficacy|5|||
33350916|NCT00734578|62728399|FG000|Overall Study|Randomized in error|1|||
33350917|NCT00734578|62728400|FG001|Overall Study|Randomized in error|0|||
33350918|NCT00734578|62728401|FG002|Overall Study|Randomized in error|0|||
33350919|NCT00734578|62728399|FG000|Overall Study|Exclusion criteria|1|||
33350920|NCT00734578|62728400|FG001|Overall Study|Exclusion criteria|0|||
33350921|NCT00734578|62728401|FG002|Overall Study|Exclusion criteria|0|||
33350922|NCT00739102|62728409|FG000|Overall Study|Death|5|||
33350923|NCT00739102|62728409|FG000|Overall Study|Withdrawal by Subject|10|||
33350924|NCT00959192|62728417|FG000|Overall Study|Adverse Event|1|||
33350925|NCT00959192|62728418|FG001|Overall Study|Adverse Event|1|||
33350926|NCT00959192|62728419|FG002|Overall Study|Adverse Event|1|||
33350927|NCT00959192|62728420|FG003|Overall Study|Adverse Event|0|||
33350928|NCT00959192|62728417|FG000|Overall Study|Investigator Request|1|||
33350929|NCT00959192|62728418|FG001|Overall Study|Investigator Request|0|||
33350930|NCT00959192|62728419|FG002|Overall Study|Investigator Request|0|||
33350931|NCT00959192|62728420|FG003|Overall Study|Investigator Request|0|||
33350932|NCT00959192|62728417|FG000|Overall Study|Caregiver Request|0|||
33350933|NCT00959192|62728418|FG001|Overall Study|Caregiver Request|0|||
33350934|NCT00959192|62728419|FG002|Overall Study|Caregiver Request|2|||
33350935|NCT00959192|62728420|FG003|Overall Study|Caregiver Request|1|||
33350936|NCT00696787|62728434|FG000|Overall Study|Adverse Event|1|||
33350937|NCT00696787|62728435|FG001|Overall Study|Adverse Event|0|||
33350938|NCT00696787|62728436|FG002|Overall Study|Adverse Event|6|||
33350939|NCT00696787|62728434|FG000|Overall Study|Discontinuation by Sponsor|9|||
33350940|NCT00696787|62728435|FG001|Overall Study|Discontinuation by Sponsor|13|||
33350941|NCT00696787|62728436|FG002|Overall Study|Discontinuation by Sponsor|14|||
33350942|NCT00696787|62728434|FG000|Overall Study|Lack of Efficacy|0|||
33350943|NCT00696787|62728435|FG001|Overall Study|Lack of Efficacy|1|||
33350944|NCT00696787|62728436|FG002|Overall Study|Lack of Efficacy|0|||
33350945|NCT00696787|62728434|FG000|Overall Study|Lost to Follow-up|4|||
33350946|NCT00696787|62728435|FG001|Overall Study|Lost to Follow-up|0|||
33350947|NCT00696787|62728436|FG002|Overall Study|Lost to Follow-up|3|||
33350948|NCT00696787|62728434|FG000|Overall Study|Withdrawal by Subject|0|||
33350949|NCT00696787|62728435|FG001|Overall Study|Withdrawal by Subject|3|||
33350950|NCT00696787|62728436|FG002|Overall Study|Withdrawal by Subject|2|||
33350951|NCT00696787|62728434|FG000|Overall Study|Failed to return|1|||
33350952|NCT00696787|62728435|FG001|Overall Study|Failed to return|3|||
33350953|NCT00696787|62728436|FG002|Overall Study|Failed to return|1|||
33350954|NCT01012037|62728447|FG000|Overall Study|Adverse Event|0|||
33350955|NCT01012037|62728448|FG001|Overall Study|Adverse Event|8|||
33350956|NCT01012037|62728449|FG002|Overall Study|Adverse Event|3|||
33350957|NCT01012037|62728447|FG000|Overall Study|Protocol Violation|0|||
33350958|NCT01012037|62728448|FG001|Overall Study|Protocol Violation|3|||
33350959|NCT01012037|62728449|FG002|Overall Study|Protocol Violation|5|||
33350960|NCT01012037|62728447|FG000|Overall Study|Withdrawal by Subject|0|||
33350961|NCT01012037|62728448|FG001|Overall Study|Withdrawal by Subject|4|||
33350962|NCT01012037|62728449|FG002|Overall Study|Withdrawal by Subject|1|||
33350963|NCT01012037|62728447|FG000|Overall Study|Other reason (not specified)|1|||
33350964|NCT01012037|62728448|FG001|Overall Study|Other reason (not specified)|1|||
33350965|NCT01012037|62728449|FG002|Overall Study|Other reason (not specified)|1|||
33350966|NCT00734032|62728461|FG000|Overall Study|Adverse Event|0|||
33350967|NCT00734032|62728462|FG001|Overall Study|Adverse Event|1|||
33350968|NCT00734032|62728463|FG002|Overall Study|Adverse Event|0|||
33350969|NCT00734032|62728464|FG003|Overall Study|Adverse Event|0|||
33350970|NCT01010633|62728476|FG000|Overall Study|Adverse Event|1|||
33350971|NCT01010633|62728477|FG001|Overall Study|Adverse Event|1|||
33350972|NCT01010633|62728476|FG000|Overall Study|Protocol Violation|1|||
33350973|NCT01010633|62728477|FG001|Overall Study|Protocol Violation|2|||
33350974|NCT01010633|62728476|FG000|Overall Study|Withdrawal by Subject|2|||
33350975|NCT01010633|62728477|FG001|Overall Study|Withdrawal by Subject|1|||
33350976|NCT01010633|62728476|FG000|Overall Study|Investigator decision|0|||
33350977|NCT01010633|62728477|FG001|Overall Study|Investigator decision|1|||
33350978|NCT00733954|62728485|FG000|Overall Study|Lost to Follow-up|5|||
33350979|NCT00733954|62728486|FG001|Overall Study|Lost to Follow-up|2|||
33350980|NCT00733954|62728485|FG000|Overall Study|Protocol Violation|1|||
33350981|NCT00733954|62728486|FG001|Overall Study|Protocol Violation|0|||
33350982|NCT00733954|62728485|FG000|Overall Study|Withdrawal by Subject|2|||
33350983|NCT00733954|62728486|FG001|Overall Study|Withdrawal by Subject|0|||
33350984|NCT00733408|62728492|FG000|Overall Study|Adverse Event|4|||
33350985|NCT01010867|62728496|FG000|Overall Study|< 50% adherence to probiotic|1|||
33350986|NCT00576823|62728503|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
33350987|NCT00576823|62728504|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
33350988|NCT00576823|62728505|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
33350989|NCT00576823|62728503|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
33350990|NCT00576823|62728504|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
33350991|NCT00576823|62728505|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
33350992|NCT00732940|62728518|FG000|Overall Study|Withdrawal by Subject|1|||
33350993|NCT00732940|62728519|FG001|Overall Study|Withdrawal by Subject|2|||
33350994|NCT00732940|62728518|FG000|Overall Study|Adverse Event|0|||
33350995|NCT00732940|62728519|FG001|Overall Study|Adverse Event|1|||
33350996|NCT00732940|62728518|FG000|Overall Study|Lost to Follow-up|1|||
33350997|NCT00732940|62728519|FG001|Overall Study|Lost to Follow-up|0|||
33350998|NCT00962390|62728529|FG000|Overall Study|Adverse Event|0|||
33350999|NCT00962390|62728530|FG001|Overall Study|Adverse Event|0|||
33351000|NCT00962390|62728531|FG002|Overall Study|Adverse Event|3|||
33351001|NCT00962390|62728532|FG003|Overall Study|Adverse Event|1|||
33351002|NCT00962390|62728529|FG000|Overall Study|Lost to Follow-up|2|||
33351003|NCT00962390|62728530|FG001|Overall Study|Lost to Follow-up|2|||
33351004|NCT00962390|62728531|FG002|Overall Study|Lost to Follow-up|0|||
33351005|NCT00962390|62728532|FG003|Overall Study|Lost to Follow-up|0|||
33351006|NCT00962390|62728529|FG000|Overall Study|Protocol Violation|1|||
33351007|NCT00962390|62728530|FG001|Overall Study|Protocol Violation|0|||
33351008|NCT00962390|62728531|FG002|Overall Study|Protocol Violation|0|||
33351009|NCT00962390|62728532|FG003|Overall Study|Protocol Violation|0|||
33351010|NCT00962390|62728529|FG000|Overall Study|Withdrawal by Subject|1|||
33351011|NCT00962390|62728530|FG001|Overall Study|Withdrawal by Subject|1|||
33351012|NCT00962390|62728531|FG002|Overall Study|Withdrawal by Subject|1|||
33351013|NCT00962390|62728532|FG003|Overall Study|Withdrawal by Subject|0|||
33351014|NCT00732472|62728546|FG000|Overall Study|Adverse Event|0|||
33351015|NCT00732472|62728547|FG001|Overall Study|Adverse Event|1|||
33351016|NCT00732472|62728548|FG002|Overall Study|Adverse Event|1|||
33351017|NCT00732472|62728549|FG003|Overall Study|Adverse Event|1|||
33351018|NCT00732472|62728546|FG000|Overall Study|Protocol Violation|0|||
33351019|NCT00732472|62728547|FG001|Overall Study|Protocol Violation|0|||
33351020|NCT00732472|62728548|FG002|Overall Study|Protocol Violation|0|||
33351021|NCT00732472|62728549|FG003|Overall Study|Protocol Violation|1|||
33351022|NCT00732472|62728546|FG000|Overall Study|Withdrawal by Subject|0|||
33351023|NCT00732472|62728547|FG001|Overall Study|Withdrawal by Subject|2|||
33351024|NCT00732472|62728548|FG002|Overall Study|Withdrawal by Subject|0|||
33351025|NCT00732472|62728549|FG003|Overall Study|Withdrawal by Subject|1|||
33351026|NCT00960986|62728564|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
33351027|NCT00960986|62728565|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
33351028|NCT00960986|62728566|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
33351029|NCT00960986|62728567|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
33351030|NCT00960986|62728564|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
33351031|NCT00960986|62728565|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
33351032|NCT00960986|62728566|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
33351033|NCT00960986|62728567|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
33351034|NCT00960986|62728564|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
33351035|NCT00960986|62728565|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
33351036|NCT00960986|62728566|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
33351037|NCT00960986|62728567|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
33351038|NCT00960986|62728564|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
33351039|NCT00960986|62728565|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
33351040|NCT00960986|62728566|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
33351041|NCT00960986|62728567|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
33351042|NCT00960986|62728564|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
33351043|NCT00960986|62728565|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
33351044|NCT00960986|62728566|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
33351045|NCT00960986|62728567|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
33351046|NCT00960986|62728564|FG000|Period 3 (7-week Therapy Period)|Death|0|||
33351047|NCT00960986|62728565|FG001|Period 3 (7-week Therapy Period)|Death|0|||
33351048|NCT00960986|62728566|FG002|Period 3 (7-week Therapy Period)|Death|1|||
33351049|NCT00960986|62728567|FG003|Period 3 (7-week Therapy Period)|Death|0|||
33351050|NCT00960986|62728564|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
33351051|NCT00960986|62728565|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
33351052|NCT00960986|62728566|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
33351053|NCT00960986|62728567|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
33351054|NCT00960986|62728564|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
33351055|NCT00960986|62728565|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
33351056|NCT00960986|62728566|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
33351057|NCT00960986|62728567|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
33351058|NCT00960986|62728564|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
33351059|NCT00960986|62728565|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
33351060|NCT00960986|62728566|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
33351061|NCT00960986|62728567|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
33351062|NCT00960986|62728564|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
33351063|NCT00960986|62728565|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
33351064|NCT00960986|62728566|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
33351065|NCT00960986|62728567|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
33351066|NCT00732238|62728579|FG000|Overall Study|Bacteremia|4|||
33351067|NCT00732238|62728580|FG001|Overall Study|Bacteremia|1|||
33351068|NCT00732238|62728579|FG000|Overall Study|Asymptomatic bacteriuria|1|||
33351069|NCT00732238|62728580|FG001|Overall Study|Asymptomatic bacteriuria|0|||
33351070|NCT00958880|62728590|FG000|Overall Study|Lost to Follow-up|2|||
33351071|NCT00958880|62728591|FG001|Overall Study|Lost to Follow-up|2|||
33351072|NCT00732160|62728601|FG000|Overall Study|Adverse Event|1|||
33351073|NCT00732160|62728602|FG001|Overall Study|Adverse Event|0|||
33351074|NCT00732160|62728603|FG002|Overall Study|Adverse Event|1|||
33351075|NCT00732160|62728604|FG003|Overall Study|Adverse Event|1|||
33351076|NCT00732160|62728601|FG000|Overall Study|scheduling|4|||
33351077|NCT00732160|62728602|FG001|Overall Study|scheduling|4|||
33351078|NCT00732160|62728603|FG002|Overall Study|scheduling|2|||
33351079|NCT00732160|62728604|FG003|Overall Study|scheduling|1|||
33351080|NCT00958724|62728614|FG000|Overall Study|Disease Progression|6|||
33351081|NCT00738400|62728620|FG000|Overall Study|Adverse Event|3|||
33351082|NCT00738400|62728621|FG001|Overall Study|Adverse Event|1|||
33351083|NCT00738400|62728620|FG000|Overall Study|Withdrawal by Subject|0|||
33351084|NCT00738400|62728621|FG001|Overall Study|Withdrawal by Subject|1|||
33351085|NCT00738400|62728620|FG000|Overall Study|Lack of Efficacy|0|||
33351086|NCT00738400|62728621|FG001|Overall Study|Lack of Efficacy|1|||
33351087|NCT00738400|62728620|FG000|Overall Study|Lost to Follow-up|0|||
33351088|NCT00738400|62728621|FG001|Overall Study|Lost to Follow-up|3|||
33351089|NCT00738400|62728620|FG000|Overall Study|Protocol Violation|1|||
33351090|NCT00738400|62728621|FG001|Overall Study|Protocol Violation|0|||
33351091|NCT00738400|62728620|FG000|Overall Study|Non-compliant with study medication|0|||
33351092|NCT00738400|62728621|FG001|Overall Study|Non-compliant with study medication|1|||
33351093|NCT01009463|62728631|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
33351094|NCT01009463|62728632|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33351095|NCT01009463|62728633|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33351096|NCT01009463|62728634|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33351097|NCT01009463|62728635|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33351098|NCT01009463|62728631|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
33351099|NCT01009463|62728632|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
33351100|NCT01009463|62728633|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
33351101|NCT01009463|62728634|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
33351102|NCT01009463|62728635|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
33351103|NCT01009463|62728631|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
33351104|NCT01009463|62728632|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33351105|NCT01009463|62728633|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33351106|NCT01009463|62728634|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33351107|NCT01009463|62728635|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33351108|NCT01009463|62728631|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
33351109|NCT01009463|62728632|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
33351110|NCT01009463|62728633|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
33351111|NCT01009463|62728634|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
33351112|NCT01009463|62728635|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
33471592|NCT02951052|62845361|FG000|Overall Study|Physician Decision|2|||
33471593|NCT02951052|62845362|FG001|Overall Study|Physician Decision|0|||
33471594|NCT02951052|62845361|FG000|Overall Study|Lost to Follow-up|1|||
33471595|NCT02951052|62845362|FG001|Overall Study|Lost to Follow-up|1|||
33351113|NCT01009463|62728631|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
33351114|NCT01009463|62728632|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33351115|NCT01009463|62728633|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33351116|NCT01009463|62728634|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33351117|NCT01009463|62728635|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33351118|NCT01009463|62728631|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
33351119|NCT01009463|62728632|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
33351120|NCT01009463|62728633|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
33351121|NCT01009463|62728634|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
33351122|NCT01009463|62728635|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
33351123|NCT01009463|62728631|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
33351124|NCT01009463|62728632|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
33351125|NCT01009463|62728633|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
33351126|NCT01009463|62728634|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
33351127|NCT01009463|62728635|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
33351128|NCT01009463|62728631|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
33351129|NCT01009463|62728632|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
33351130|NCT01009463|62728633|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
33351131|NCT01009463|62728634|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
33351132|NCT01009463|62728635|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
33351133|NCT01009463|62728631|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
33351134|NCT01009463|62728632|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
33351135|NCT01009463|62728633|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
33351136|NCT01009463|62728634|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
33351137|NCT01009463|62728635|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
33351138|NCT01009463|62728631|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
33351139|NCT01009463|62728632|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
33351140|NCT01009463|62728633|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
33351141|NCT01009463|62728634|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
33351142|NCT01009463|62728635|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
33351143|NCT01009463|62728631|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
33351144|NCT01009463|62728632|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
33351145|NCT01009463|62728633|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
33351146|NCT01009463|62728634|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
33351147|NCT01009463|62728635|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
33351148|NCT01009463|62728631|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33351149|NCT01009463|62728632|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
33351150|NCT01009463|62728633|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
33351151|NCT01009463|62728634|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
33351152|NCT01009463|62728635|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
33351153|NCT01009463|62728631|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
33351154|NCT01009463|62728632|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
33351155|NCT01009463|62728633|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
33351156|NCT01009463|62728634|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
33351157|NCT01009463|62728635|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
33351158|NCT00958568|62728646|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
33351159|NCT00958568|62728647|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
33351160|NCT00958568|62728648|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
33351161|NCT00958568|62728649|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
33351162|NCT00958568|62728646|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
33351163|NCT00958568|62728647|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
33351164|NCT00958568|62728648|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
33351165|NCT00958568|62728649|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
33351166|NCT00958568|62728646|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
33351167|NCT00958568|62728647|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
33351168|NCT00958568|62728648|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
33351169|NCT00958568|62728649|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
33351170|NCT00958568|62728646|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
33548984|NCT02901431|62940296|FG002|PK Part|Discontinued per Sponsor|0|||
33655094|NCT01885559|63069267|FG001|Overall Study|Protocol Violation|1|||
33351171|NCT00958568|62728647|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
33351172|NCT00958568|62728648|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
33471596|NCT02951052|62845361|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
33471597|NCT02951052|62845362|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
33655095|NCT01884545|63069277|FG000|Overall Study|Lost to Follow-up|6|||
33351173|NCT00958568|62728649|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
33351174|NCT00958568|62728646|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
33471598|NCT02951052|62845361|FG000|Overall Study|Protocol Violation|5|||
33471599|NCT02951052|62845362|FG001|Overall Study|Protocol Violation|3|||
33471600|NCT02951052|62845361|FG000|Overall Study|Lack of Efficacy|3|||
33471601|NCT02951052|62845362|FG001|Overall Study|Lack of Efficacy|4|||
33471602|NCT02951052|62845361|FG000|Overall Study|Ongoing|1|||
33471603|NCT02951052|62845362|FG001|Overall Study|Ongoing|0|||
33471604|NCT00226655|62845372|FG000|Overall Study|Death|13|||
33471605|NCT00226655|62845372|FG000|Overall Study|Withdrawal by Subject|15|||
33351175|NCT00958568|62728647|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
33351176|NCT00958568|62728648|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
33351177|NCT00958568|62728649|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
33351178|NCT00958568|62728646|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
33351179|NCT00958568|62728647|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
33351180|NCT00958568|62728648|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
33351181|NCT00958568|62728649|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
33351182|NCT00958568|62728646|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
33351183|NCT00958568|62728647|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
33351184|NCT00958568|62728648|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
33351185|NCT00958568|62728649|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
33351186|NCT00958568|62728646|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
33351187|NCT00958568|62728647|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
33351188|NCT00958568|62728648|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
33351189|NCT00958568|62728649|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
33351190|NCT00958568|62728646|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
33351191|NCT00958568|62728647|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
33351192|NCT00958568|62728648|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
33351193|NCT00958568|62728649|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
33351194|NCT00958568|62728646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
33351195|NCT00958568|62728647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
33351196|NCT00958568|62728648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
33351197|NCT00958568|62728649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
33351198|NCT00958568|62728646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
33351199|NCT00958568|62728647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
33351200|NCT00958568|62728648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
33351201|NCT00958568|62728649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
33351202|NCT00958568|62728646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
33351203|NCT00958568|62728647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
33351204|NCT00958568|62728648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
33351205|NCT00958568|62728649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
33351206|NCT00958568|62728646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
33351207|NCT00958568|62728647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
33351208|NCT00958568|62728648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
33351209|NCT00958568|62728649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
33471606|NCT00226655|62845372|FG000|Overall Study|Adverse Event|35|||
33471607|NCT00226655|62845372|FG000|Overall Study|Physician Decision|6|||
33471608|NCT00226655|62845372|FG000|Overall Study|Clinical deterioration|10|||
33471609|NCT03124108|62845388|FG000|Overall Study|Adverse Event|0|||
33471610|NCT03124108|62845389|FG001|Overall Study|Adverse Event|1|||
33351210|NCT00958568|62728646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
33351211|NCT00958568|62728647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
33351212|NCT00958568|62728648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
33351213|NCT00958568|62728649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
33351214|NCT00958568|62728646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
33351215|NCT00958568|62728647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
33351216|NCT00958568|62728648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
33351217|NCT00958568|62728649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
33351218|NCT00958568|62728646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
33471611|NCT03124108|62845390|FG002|Overall Study|Adverse Event|0|||
33471612|NCT04475588|62845402|FG000|Overall Study|Adverse Event|2|||
33471613|NCT04475588|62845403|FG001|Overall Study|Adverse Event|0|||
33471614|NCT04353596|62845412|FG000|Overall Study|Protocol Violation|4|||
33471615|NCT04353596|62845413|FG001|Overall Study|Protocol Violation|4|||
33471616|NCT04353596|62845412|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
33471617|NCT04353596|62845413|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
33655096|NCT01884545|63069278|FG001|Overall Study|Lost to Follow-up|4|||
33655097|NCT01884545|63069279|FG002|Overall Study|Lost to Follow-up|9|||
33351219|NCT00958568|62728647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
33351220|NCT00958568|62728648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
33351221|NCT00958568|62728649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
33351222|NCT00958568|62728646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
33351223|NCT00958568|62728647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
33351224|NCT00958568|62728648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
33351225|NCT00958568|62728649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
33351226|NCT00958568|62728646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
33351227|NCT00958568|62728647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
33351228|NCT00958568|62728648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
33351229|NCT00958568|62728649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
33351230|NCT00958568|62728646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
33351231|NCT00958568|62728647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
33351232|NCT00958568|62728648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
33351233|NCT00958568|62728649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
33351234|NCT00958568|62728646|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
33351235|NCT00958568|62728647|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
33351236|NCT00958568|62728648|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
33351237|NCT00958568|62728649|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
33351238|NCT00958568|62728646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
33351239|NCT00958568|62728647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
33351240|NCT00958568|62728648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
33351241|NCT00958568|62728649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
33351242|NCT00958568|62728646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
33351243|NCT00958568|62728647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
33351244|NCT00958568|62728648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
33351245|NCT00958568|62728649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
33351246|NCT00958568|62728646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
33351247|NCT00958568|62728647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
33351248|NCT00958568|62728648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
33351249|NCT00958568|62728649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
33351250|NCT00958568|62728646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
33351251|NCT00958568|62728647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
33351252|NCT00958568|62728648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
33351253|NCT00958568|62728649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
33351254|NCT00958568|62728646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
33351255|NCT00958568|62728647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
33351256|NCT00958568|62728648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
33351257|NCT00958568|62728649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
33351258|NCT00958568|62728646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
33351259|NCT00958568|62728647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
33351260|NCT00958568|62728648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
33351261|NCT00958568|62728649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
33351262|NCT00958568|62728646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
33351263|NCT00958568|62728647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
33351264|NCT00958568|62728648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
33351265|NCT00958568|62728649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
33351266|NCT00958568|62728646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
33351267|NCT00958568|62728647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
33351268|NCT00958568|62728648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
33351269|NCT00958568|62728649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
33351270|NCT00958568|62728646|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
33351271|NCT00958568|62728647|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
33351272|NCT00958568|62728648|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
33351273|NCT00958568|62728649|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
33351274|NCT00958412|62728660|FG000|Overall Study|Study prematurely terminated|18|||
33351275|NCT00958256|62728664|FG000|Overall Study|Adverse Event|3|||
33351276|NCT00696709|62728673|FG000|Overall Study|Withdrawal by Subject|1|||
33351277|NCT00696709|62728674|FG001|Overall Study|Withdrawal by Subject|2|||
33351278|NCT00696709|62728675|FG002|Overall Study|Withdrawal by Subject|1|||
33351279|NCT00696709|62728676|FG003|Overall Study|Withdrawal by Subject|4|||
33351280|NCT00696709|62728677|FG004|Overall Study|Withdrawal by Subject|3|||
33351281|NCT00696709|62728673|FG000|Overall Study|Protocol Violation|1|||
33351282|NCT00696709|62728674|FG001|Overall Study|Protocol Violation|0|||
33351283|NCT00696709|62728675|FG002|Overall Study|Protocol Violation|0|||
33351284|NCT00696709|62728676|FG003|Overall Study|Protocol Violation|0|||
33351285|NCT00696709|62728677|FG004|Overall Study|Protocol Violation|0|||
33351286|NCT00696709|62728673|FG000|Overall Study|Lost to Follow-up|1|||
33351287|NCT00696709|62728674|FG001|Overall Study|Lost to Follow-up|1|||
33351288|NCT00696709|62728675|FG002|Overall Study|Lost to Follow-up|0|||
33351289|NCT00696709|62728676|FG003|Overall Study|Lost to Follow-up|0|||
33351290|NCT00696709|62728677|FG004|Overall Study|Lost to Follow-up|0|||
33351291|NCT00696709|62728673|FG000|Overall Study|Adverse Event|0|||
33351292|NCT00696709|62728674|FG001|Overall Study|Adverse Event|0|||
33351293|NCT00696709|62728675|FG002|Overall Study|Adverse Event|0|||
33351294|NCT00696709|62728676|FG003|Overall Study|Adverse Event|1|||
33351295|NCT00696709|62728677|FG004|Overall Study|Adverse Event|0|||
33351296|NCT01006265|62728697|FG000|Overall Study|Lost to Follow-up|1|||
33351297|NCT01006265|62728698|FG001|Overall Study|Lost to Follow-up|0|||
33351298|NCT01006265|62728699|FG002|Overall Study|Lost to Follow-up|1|||
33351299|NCT01006265|62728700|FG003|Overall Study|Lost to Follow-up|0|||
33351300|NCT01006265|62728697|FG000|Overall Study|Withdrawal by Subject|4|||
33351301|NCT01006265|62728698|FG001|Overall Study|Withdrawal by Subject|7|||
33351302|NCT01006265|62728699|FG002|Overall Study|Withdrawal by Subject|5|||
33351303|NCT01006265|62728700|FG003|Overall Study|Withdrawal by Subject|5|||
33351304|NCT01006265|62728697|FG000|Overall Study|Administrative reason|1|||
33351305|NCT01006265|62728698|FG001|Overall Study|Administrative reason|2|||
33351306|NCT01006265|62728699|FG002|Overall Study|Administrative reason|3|||
33351307|NCT01006265|62728700|FG003|Overall Study|Administrative reason|0|||
33351308|NCT01008995|62728712|FG000|Controlled Period|Adverse Event|1|||
33351309|NCT01008995|62728713|FG001|Controlled Period|Adverse Event|2|||
33351310|NCT01008995|62728714|FG002|Controlled Period|Adverse Event|0|||
33351311|NCT01008995|62728715|FG003|Controlled Period|Adverse Event|0|||
33351312|NCT01008995|62728712|FG000|Controlled Period|Other|2|||
33351313|NCT01008995|62728713|FG001|Controlled Period|Other|1|||
33351314|NCT01008995|62728714|FG002|Controlled Period|Other|0|||
33351315|NCT01008995|62728715|FG003|Controlled Period|Other|0|||
33351316|NCT01008995|62728712|FG000|After Controlled Period|Adverse Event|0|||
33351317|NCT01008995|62728713|FG001|After Controlled Period|Adverse Event|0|||
33351318|NCT01008995|62728714|FG002|After Controlled Period|Adverse Event|1|||
33351319|NCT01008995|62728715|FG003|After Controlled Period|Adverse Event|1|||
33351320|NCT01008995|62728712|FG000|After Controlled Period|Other|0|||
33351321|NCT01008995|62728713|FG001|After Controlled Period|Other|0|||
33351322|NCT01008995|62728714|FG002|After Controlled Period|Other|1|||
33351323|NCT01008995|62728715|FG003|After Controlled Period|Other|0|||
33351324|NCT00957944|62728725|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
33471618|NCT04350788|62845421|FG000|Overall Study|Lost to Follow-up|6|||
33471619|NCT04350788|62845422|FG001|Overall Study|Lost to Follow-up|2|||
33471620|NCT04350788|62845421|FG000|Overall Study|Withdrawal by Subject|2|||
33548985|NCT02901431|62940297|FG003|PK Part|Discontinued per Sponsor|0|||
33351325|NCT00957944|62728726|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
33351326|NCT01005875|62728732|FG000|Overall Study|Death|3|||
33351327|NCT01005719|62728736|FG000|Period 1|Adverse Event|0|||
33351328|NCT01005719|62728737|FG001|Period 1|Adverse Event|0|||
33471621|NCT04350788|62845422|FG001|Overall Study|Withdrawal by Subject|4|||
33471622|NCT04350788|62845421|FG000|Overall Study|Protocol Violation|4|||
33471623|NCT04350788|62845422|FG001|Overall Study|Protocol Violation|0|||
33548986|NCT02901431|62940298|FG004|PK Part|Discontinued per Sponsor|0|||
33351329|NCT01005719|62728738|FG002|Period 1|Adverse Event|0|||
33351330|NCT01005719|62728739|FG003|Period 1|Adverse Event|1|||
33351331|NCT01005719|62728740|FG004|Period 1|Adverse Event|0|||
33351332|NCT01005719|62728741|FG005|Period 1|Adverse Event|0|||
33351333|NCT01005719|62728736|FG000|Period 1|Delay in completing study procedures|0|||
33351334|NCT01005719|62728737|FG001|Period 1|Delay in completing study procedures|0|||
33351335|NCT01005719|62728738|FG002|Period 1|Delay in completing study procedures|0|||
33351336|NCT01005719|62728739|FG003|Period 1|Delay in completing study procedures|0|||
33471624|NCT03852316|62845433|FG000|Overall Study|Protocol Violation|1|||
33548987|NCT02901431|62940299|FG005|PK Part|Discontinued per Sponsor|0|||
33351337|NCT01005719|62728740|FG004|Period 1|Delay in completing study procedures|0|||
33351338|NCT01005719|62728741|FG005|Period 1|Delay in completing study procedures|1|||
33351339|NCT01005719|62728736|FG000|Period 2|Adverse Event|0|||
33351340|NCT01005719|62728737|FG001|Period 2|Adverse Event|0|||
33351341|NCT01005719|62728738|FG002|Period 2|Adverse Event|0|||
33351342|NCT01005719|62728739|FG003|Period 2|Adverse Event|0|||
33351343|NCT01005719|62728740|FG004|Period 2|Adverse Event|1|||
33351344|NCT01005719|62728741|FG005|Period 2|Adverse Event|1|||
33351345|NCT00953576|62728752|FG000|Overall Study|Adverse Event|0|||
33351346|NCT00953576|62728753|FG001|Overall Study|Adverse Event|1|||
33351347|NCT00953576|62728752|FG000|Overall Study|Ineligible after Consent|2|||
33351348|NCT00953576|62728753|FG001|Overall Study|Ineligible after Consent|0|||
33351349|NCT01005329|62728768|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
33351350|NCT01005251|62728778|FG000|Overall Study|Withdrawal by Subject|2|||
33351351|NCT01005251|62728779|FG001|Overall Study|Withdrawal by Subject|5|||
33351352|NCT01005251|62728780|FG002|Overall Study|Withdrawal by Subject|3|||
33351353|NCT01005251|62728781|FG003|Overall Study|Withdrawal by Subject|4|||
33351354|NCT01005251|62728782|FG004|Overall Study|Withdrawal by Subject|9|||
33351355|NCT01005251|62728778|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
33351356|NCT01005251|62728779|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33351357|NCT01005251|62728780|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
33351358|NCT01005251|62728781|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
33351359|NCT01005251|62728782|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
33351360|NCT01005251|62728778|FG000|Overall Study|Adverse Event|2|||
33351361|NCT01005251|62728779|FG001|Overall Study|Adverse Event|6|||
33351362|NCT01005251|62728780|FG002|Overall Study|Adverse Event|8|||
33351363|NCT01005251|62728781|FG003|Overall Study|Adverse Event|5|||
33351364|NCT01005251|62728782|FG004|Overall Study|Adverse Event|4|||
33351365|NCT01005251|62728778|FG000|Overall Study|Protocol Violation|1|||
33351366|NCT01005251|62728779|FG001|Overall Study|Protocol Violation|0|||
33351367|NCT01005251|62728780|FG002|Overall Study|Protocol Violation|0|||
33351368|NCT01005251|62728781|FG003|Overall Study|Protocol Violation|0|||
33351369|NCT01005251|62728782|FG004|Overall Study|Protocol Violation|2|||
33351370|NCT01005251|62728778|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
33351371|NCT01005251|62728779|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
33351372|NCT01005251|62728780|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
33351373|NCT01005251|62728781|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
33351374|NCT01005251|62728782|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
33351375|NCT01005251|62728778|FG000|Overall Study|Lost to Follow-up|1|||
33351376|NCT01005251|62728779|FG001|Overall Study|Lost to Follow-up|4|||
33351377|NCT01005251|62728780|FG002|Overall Study|Lost to Follow-up|2|||
33351378|NCT01005251|62728781|FG003|Overall Study|Lost to Follow-up|0|||
33351379|NCT01005251|62728782|FG004|Overall Study|Lost to Follow-up|0|||
33351380|NCT01005251|62728778|FG000|Overall Study|Physician Decision|0|||
33351381|NCT01005251|62728779|FG001|Overall Study|Physician Decision|0|||
33351382|NCT01005251|62728780|FG002|Overall Study|Physician Decision|0|||
33351383|NCT01005251|62728781|FG003|Overall Study|Physician Decision|0|||
33351384|NCT01005251|62728782|FG004|Overall Study|Physician Decision|2|||
33351385|NCT01005251|62728778|FG000|Overall Study|Patient moved|1|||
33351386|NCT01005251|62728779|FG001|Overall Study|Patient moved|0|||
33351387|NCT01005251|62728780|FG002|Overall Study|Patient moved|0|||
33351388|NCT01005251|62728781|FG003|Overall Study|Patient moved|0|||
33351389|NCT01005251|62728782|FG004|Overall Study|Patient moved|0|||
33351390|NCT01005251|62728778|FG000|Overall Study|Wrong drug dispensed|0|||
33351391|NCT01005251|62728779|FG001|Overall Study|Wrong drug dispensed|1|||
33351392|NCT01005251|62728780|FG002|Overall Study|Wrong drug dispensed|0|||
33351393|NCT01005251|62728781|FG003|Overall Study|Wrong drug dispensed|0|||
33351394|NCT01005251|62728782|FG004|Overall Study|Wrong drug dispensed|0|||
33351395|NCT01005251|62728778|FG000|Overall Study|Randomized in error|0|||
33351396|NCT01005251|62728779|FG001|Overall Study|Randomized in error|0|||
33351397|NCT01005251|62728780|FG002|Overall Study|Randomized in error|1|||
33351398|NCT01005251|62728781|FG003|Overall Study|Randomized in error|1|||
33351399|NCT01005251|62728782|FG004|Overall Study|Randomized in error|0|||
33351400|NCT01005251|62728778|FG000|Overall Study|Lack of Efficacy|0|||
33351401|NCT01005251|62728779|FG001|Overall Study|Lack of Efficacy|0|||
33351402|NCT01005251|62728780|FG002|Overall Study|Lack of Efficacy|1|||
33351403|NCT01005251|62728781|FG003|Overall Study|Lack of Efficacy|1|||
33351404|NCT01005251|62728782|FG004|Overall Study|Lack of Efficacy|0|||
33351405|NCT03048578|62728796|FG000|Overall Study|Withdrawal by Subject|5|||
33351406|NCT03048578|62728797|FG001|Overall Study|Withdrawal by Subject|6|||
33351407|NCT03048578|62728796|FG000|Overall Study|Lost to Follow-up|22|||
33351408|NCT03048578|62728797|FG001|Overall Study|Lost to Follow-up|10|||
33351409|NCT03048578|62728796|FG000|Overall Study|Adverse Event|1|||
33351410|NCT03048578|62728797|FG001|Overall Study|Adverse Event|2|||
33351411|NCT03048578|62728796|FG000|Overall Study|Terminated|3|||
33351412|NCT03048578|62728797|FG001|Overall Study|Terminated|2|||
33351413|NCT01008449|62728805|FG000|Overall Study|Lost to Follow-up|29|||
33351414|NCT01008449|62728806|FG001|Overall Study|Lost to Follow-up|19|||
33351415|NCT00696241|62728817|FG000|Overall Study|Adverse Event|11|||
33351416|NCT00696241|62728818|FG001|Overall Study|Adverse Event|3|||
33351417|NCT00696241|62728819|FG002|Overall Study|Adverse Event|6|||
33351418|NCT00696241|62728820|FG003|Overall Study|Adverse Event|4|||
33351419|NCT00696241|62728821|FG004|Overall Study|Adverse Event|5|||
33351420|NCT00696241|62728817|FG000|Overall Study|Protocol Violation|1|||
33351421|NCT00696241|62728818|FG001|Overall Study|Protocol Violation|1|||
33351422|NCT00696241|62728819|FG002|Overall Study|Protocol Violation|2|||
33351423|NCT00696241|62728820|FG003|Overall Study|Protocol Violation|0|||
33351424|NCT00696241|62728821|FG004|Overall Study|Protocol Violation|3|||
33351425|NCT00696241|62728817|FG000|Overall Study|Lost to Follow-up|1|||
33351426|NCT00696241|62728818|FG001|Overall Study|Lost to Follow-up|4|||
33351427|NCT00696241|62728819|FG002|Overall Study|Lost to Follow-up|1|||
33351428|NCT00696241|62728820|FG003|Overall Study|Lost to Follow-up|2|||
33351429|NCT00696241|62728821|FG004|Overall Study|Lost to Follow-up|0|||
33351430|NCT00696241|62728817|FG000|Overall Study|Withdrawal by Subject|4|||
33351431|NCT00696241|62728818|FG001|Overall Study|Withdrawal by Subject|8|||
33351432|NCT00696241|62728819|FG002|Overall Study|Withdrawal by Subject|6|||
33351433|NCT00696241|62728820|FG003|Overall Study|Withdrawal by Subject|1|||
33351434|NCT00696241|62728821|FG004|Overall Study|Withdrawal by Subject|0|||
33351435|NCT00696241|62728817|FG000|Overall Study|Lack of Efficacy|1|||
33351436|NCT00696241|62728818|FG001|Overall Study|Lack of Efficacy|5|||
33351437|NCT00696241|62728819|FG002|Overall Study|Lack of Efficacy|4|||
33351438|NCT00696241|62728820|FG003|Overall Study|Lack of Efficacy|5|||
33351439|NCT00696241|62728821|FG004|Overall Study|Lack of Efficacy|3|||
33351440|NCT00696241|62728817|FG000|Overall Study|Other|6|||
33471625|NCT03852316|62845433|FG000|Overall Study|Withdrawal by Subject|2|||
33471626|NCT03852316|62845433|FG000|Overall Study|Enrolled but Device not Utilized|1|||
33471627|NCT04335812|62845439|FG000|Overall Study|Withdrawal by Subject|1|||
33655098|NCT01884545|63069280|FG003|Overall Study|Lost to Follow-up|4|||
33655099|NCT01884545|63069277|FG000|Overall Study|Patient withdrawn|7|||
33655100|NCT01884545|63069278|FG001|Overall Study|Patient withdrawn|12|||
33655101|NCT01884545|63069279|FG002|Overall Study|Patient withdrawn|5|||
33655102|NCT01884545|63069280|FG003|Overall Study|Patient withdrawn|5|||
33655103|NCT01884545|63069277|FG000|Overall Study|Non-adherence|0|||
33655104|NCT01884545|63069278|FG001|Overall Study|Non-adherence|2|||
33655105|NCT01884545|63069279|FG002|Overall Study|Non-adherence|0|||
33655106|NCT01884545|63069280|FG003|Overall Study|Non-adherence|0|||
33655107|NCT01895543|63069290|FG000|Overall Study|Withdrawal by Subject|43|||
33655108|NCT01895543|63069290|FG000|Overall Study|Lost to Follow-up|25|||
33655109|NCT01895543|63069290|FG000|Overall Study|Adverse Event|28|||
33655110|NCT01895543|63069290|FG000|Overall Study|Subject's substantial non-compliance|6|||
33655111|NCT01895543|63069290|FG000|Overall Study|Protocol Violation|1|||
33655112|NCT01895543|63069290|FG000|Overall Study|Physician Decision|2|||
33655113|NCT01895543|63069290|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
33655114|NCT04828161|63069387|FG000|Overall Study|Withdrawal by Subject|0|||
33655115|NCT04828161|63069388|FG001|Overall Study|Withdrawal by Subject|3|||
33655116|NCT04828161|63069389|FG002|Overall Study|Withdrawal by Subject|3|||
33655117|NCT04828161|63069390|FG003|Overall Study|Withdrawal by Subject|4|||
33655118|NCT04828161|63069387|FG000|Overall Study|Lost to Follow-up|1|||
33655119|NCT04828161|63069388|FG001|Overall Study|Lost to Follow-up|4|||
33655120|NCT04828161|63069389|FG002|Overall Study|Lost to Follow-up|2|||
33655121|NCT04828161|63069390|FG003|Overall Study|Lost to Follow-up|2|||
33655122|NCT04828161|63069387|FG000|Overall Study|Other|2|||
33655123|NCT04828161|63069388|FG001|Overall Study|Other|0|||
33655124|NCT04828161|63069389|FG002|Overall Study|Other|2|||
33655125|NCT04828161|63069390|FG003|Overall Study|Other|0|||
33655126|NCT04828161|63069387|FG000|Overall Study|Death|0|||
33655127|NCT04828161|63069388|FG001|Overall Study|Death|0|||
33655128|NCT04828161|63069389|FG002|Overall Study|Death|0|||
33655129|NCT04828161|63069390|FG003|Overall Study|Death|2|||
33351441|NCT00696241|62728818|FG001|Overall Study|Other|1|||
33351442|NCT00696241|62728819|FG002|Overall Study|Other|5|||
33351443|NCT00696241|62728820|FG003|Overall Study|Other|2|||
33351444|NCT00696241|62728821|FG004|Overall Study|Other|1|||
33351445|NCT00957008|62728837|FG000|Overall Study|Withdrawal by Subject|13|||
33351446|NCT00957008|62728838|FG001|Overall Study|Withdrawal by Subject|10|||
33351447|NCT00957008|62728839|FG002|Overall Study|Withdrawal by Subject|12|||
33351448|NCT00957008|62728840|FG003|Overall Study|Withdrawal by Subject|16|||
33471628|NCT04335812|62845440|FG001|Overall Study|Withdrawal by Subject|3|||
33655130|NCT01895309|63069488|FG000|Overall Study|Adverse Event|13|||
33351449|NCT00957008|62728837|FG000|Overall Study|Lost to Follow-up|3|||
33655131|NCT01895309|63069489|FG001|Overall Study|Adverse Event|17|||
33655132|NCT01895309|63069488|FG000|Overall Study|Protocol Violation|1|||
33655133|NCT01895309|63069489|FG001|Overall Study|Protocol Violation|0|||
33655134|NCT01895309|63069488|FG000|Overall Study|Lack of Efficacy|1|||
33655135|NCT01895309|63069489|FG001|Overall Study|Lack of Efficacy|3|||
33655136|NCT01895309|63069488|FG000|Overall Study|Lost to Follow-up|1|||
33655137|NCT01895309|63069489|FG001|Overall Study|Lost to Follow-up|3|||
33655138|NCT01895309|63069488|FG000|Overall Study|Physician Decision|15|||
33351450|NCT00957008|62728838|FG001|Overall Study|Lost to Follow-up|1|||
33351451|NCT00957008|62728839|FG002|Overall Study|Lost to Follow-up|3|||
33351452|NCT00957008|62728840|FG003|Overall Study|Lost to Follow-up|4|||
33351453|NCT00957008|62728837|FG000|Overall Study|Physician Decision|1|||
33351454|NCT00957008|62728838|FG001|Overall Study|Physician Decision|0|||
33351455|NCT00957008|62728839|FG002|Overall Study|Physician Decision|1|||
33351456|NCT00957008|62728840|FG003|Overall Study|Physician Decision|1|||
33351457|NCT00957008|62728837|FG000|Overall Study|Relocated; Family conflict|4|||
33351458|NCT00957008|62728838|FG001|Overall Study|Relocated; Family conflict|1|||
33351459|NCT00957008|62728839|FG002|Overall Study|Relocated; Family conflict|1|||
33351460|NCT00957008|62728840|FG003|Overall Study|Relocated; Family conflict|3|||
33351461|NCT00952484|62728857|FG000|Overall Study|Withdrawal by Subject|0|||
33351462|NCT00952484|62728858|FG001|Overall Study|Withdrawal by Subject|1|||
33351463|NCT00952484|62728859|FG002|Overall Study|Withdrawal by Subject|0|||
33351464|NCT00689611|62728870|FG000|Overall Study|Death|6|||
33351465|NCT00689611|62728871|FG001|Overall Study|Death|9|||
33351466|NCT00689611|62728870|FG000|Overall Study|Withdrawal by Subject|8|||
33351467|NCT00689611|62728871|FG001|Overall Study|Withdrawal by Subject|9|||
33351468|NCT00689611|62728870|FG000|Overall Study|Lost to Follow-up|27|||
33351469|NCT00689611|62728871|FG001|Overall Study|Lost to Follow-up|28|||
33351470|NCT00689299|62728880|FG000|Overall Study|Adverse Event|2|||
33351471|NCT00689299|62728881|FG001|Overall Study|Adverse Event|1|||
33351472|NCT00689299|62728882|FG002|Overall Study|Adverse Event|1|||
33351473|NCT00689299|62728880|FG000|Overall Study|Lost to Follow-up|0|||
33351474|NCT00689299|62728881|FG001|Overall Study|Lost to Follow-up|1|||
33351475|NCT00689299|62728882|FG002|Overall Study|Lost to Follow-up|1|||
33351476|NCT00689299|62728880|FG000|Overall Study|Withdrawal by Subject|4|||
33351477|NCT00689299|62728881|FG001|Overall Study|Withdrawal by Subject|1|||
33351478|NCT00689299|62728882|FG002|Overall Study|Withdrawal by Subject|3|||
33351479|NCT00689299|62728880|FG000|Overall Study|Protocol Violation|1|||
33351480|NCT00689299|62728881|FG001|Overall Study|Protocol Violation|0|||
33351481|NCT00689299|62728882|FG002|Overall Study|Protocol Violation|0|||
33351482|NCT02506244|62728893|FG000|Overall Study|Did not undergo active monitoring|458|||
33351483|NCT02506244|62728894|FG001|Overall Study|Did not undergo active monitoring|459|||
33351484|NCT02506244|62728895|FG002|Overall Study|Did not undergo active monitoring|0|||
33351485|NCT00948974|62728905|FG000|Overall Study|Lost to Follow-up|23|||
33351486|NCT00948974|62728906|FG001|Overall Study|Lost to Follow-up|20|||
33351487|NCT01007435|62728916|FG000|Overall Study|Adverse Event|16|||
33351488|NCT01007435|62728917|FG001|Overall Study|Adverse Event|25|||
33351489|NCT01007435|62728918|FG002|Overall Study|Adverse Event|47|||
33351490|NCT01007435|62728919|FG003|Overall Study|Adverse Event|31|||
33351491|NCT01007435|62728916|FG000|Overall Study|Death|2|||
33351492|NCT01007435|62728917|FG001|Overall Study|Death|4|||
33351493|NCT01007435|62728918|FG002|Overall Study|Death|2|||
33351494|NCT01007435|62728919|FG003|Overall Study|Death|1|||
33351495|NCT01007435|62728916|FG000|Overall Study|Insufficient Therapeutic Response|21|||
33351496|NCT01007435|62728917|FG001|Overall Study|Insufficient Therapeutic Response|7|||
33351497|NCT01007435|62728918|FG002|Overall Study|Insufficient Therapeutic Response|2|||
33351498|NCT01007435|62728919|FG003|Overall Study|Insufficient Therapeutic Response|9|||
33351499|NCT01007435|62728916|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
33351500|NCT01007435|62728917|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
33351501|NCT01007435|62728918|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
33351502|NCT01007435|62728919|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
33351503|NCT01007435|62728916|FG000|Overall Study|Other Protocol Violation|2|||
33351504|NCT01007435|62728917|FG001|Overall Study|Other Protocol Violation|0|||
33351505|NCT01007435|62728918|FG002|Overall Study|Other Protocol Violation|1|||
33351506|NCT01007435|62728919|FG003|Overall Study|Other Protocol Violation|0|||
33351507|NCT01007435|62728916|FG000|Overall Study|Refused Treatment|13|||
33351508|NCT01007435|62728917|FG001|Overall Study|Refused Treatment|13|||
33351509|NCT01007435|62728918|FG002|Overall Study|Refused Treatment|5|||
33351510|NCT01007435|62728919|FG003|Overall Study|Refused Treatment|8|||
33351511|NCT01007435|62728916|FG000|Overall Study|Failure to Return|5|||
33351512|NCT01007435|62728917|FG001|Overall Study|Failure to Return|4|||
33471629|NCT04335812|62845439|FG000|Overall Study|Lost to Follow-up|12|||
33471630|NCT04335812|62845440|FG001|Overall Study|Lost to Follow-up|12|||
33471631|NCT04335812|62845439|FG000|Overall Study|Did not engage in the intervention|22|||
33351513|NCT01007435|62728918|FG002|Overall Study|Failure to Return|3|||
33351514|NCT01007435|62728919|FG003|Overall Study|Failure to Return|6|||
33351515|NCT01007435|62728916|FG000|Overall Study|Reason not Specified|1|||
33351516|NCT01007435|62728917|FG001|Overall Study|Reason not Specified|1|||
33351517|NCT01007435|62728918|FG002|Overall Study|Reason not Specified|2|||
33351518|NCT01007435|62728919|FG003|Overall Study|Reason not Specified|1|||
33351519|NCT00948896|62728937|FG000|Randomization to 24 Months of Age|Death|1|||
33351520|NCT00948896|62728938|FG001|Randomization to 24 Months of Age|Death|0|||
33351521|NCT00948896|62728939|FG002|Randomization to 24 Months of Age|Death|0|||
33351522|NCT00948896|62728940|FG003|Randomization to 24 Months of Age|Death|0|||
33351523|NCT00948896|62728941|FG004|Randomization to 24 Months of Age|Death|2|||
33351524|NCT00948896|62728942|FG005|Randomization to 24 Months of Age|Death|1|||
33351525|NCT00948896|62728943|FG006|Randomization to 24 Months of Age|Death|2|||
33351526|NCT00948896|62728944|FG007|Randomization to 24 Months of Age|Death|1|||
33351527|NCT00948896|62728937|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
33351528|NCT00948896|62728938|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
33351529|NCT00948896|62728939|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
33351530|NCT00948896|62728940|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
33351531|NCT00948896|62728941|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
33351532|NCT00948896|62728942|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
33351533|NCT00948896|62728943|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
33351534|NCT00948896|62728944|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
33351535|NCT00948896|62728937|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
33351536|NCT00948896|62728938|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
33351537|NCT00948896|62728939|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
33351538|NCT00948896|62728940|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
33351539|NCT00948896|62728941|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
33351540|NCT00948896|62728942|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
33351541|NCT00948896|62728943|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
33351542|NCT00948896|62728944|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
33351543|NCT00948896|62728937|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
33351544|NCT00948896|62728938|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
33351545|NCT00948896|62728939|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
33351546|NCT00948896|62728940|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
33351547|NCT00948896|62728941|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
33351548|NCT00948896|62728942|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
33351549|NCT00948896|62728943|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
33351550|NCT00948896|62728944|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
33351551|NCT00948896|62728937|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
33351552|NCT00948896|62728938|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
33351553|NCT00948896|62728939|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
33351554|NCT00948896|62728940|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
33351555|NCT00948896|62728941|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
33351556|NCT00948896|62728942|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
33351557|NCT00948896|62728943|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
33351558|NCT00948896|62728944|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
33351559|NCT00948896|62728937|FG000|24 Months of Age to 36 Months of Age|Death|0|||
33351560|NCT00948896|62728938|FG001|24 Months of Age to 36 Months of Age|Death|2|||
33351561|NCT00948896|62728939|FG002|24 Months of Age to 36 Months of Age|Death|2|||
33351562|NCT00948896|62728940|FG003|24 Months of Age to 36 Months of Age|Death|0|||
33471632|NCT04335812|62845440|FG001|Overall Study|Did not engage in the intervention|18|||
33471633|NCT03127384|62845446|FG000|Overall Study|Lost to Follow-up|4|||
33471634|NCT03127384|62845446|FG000|Overall Study|Subject request|2|||
33471635|NCT04398134|62845473|FG000|Overall Study|Adverse Event|0|||
33471636|NCT04398134|62845474|FG001|Overall Study|Adverse Event|0|||
33471637|NCT04398134|62845475|FG002|Overall Study|Adverse Event|1|||
33471638|NCT04398134|62845476|FG003|Overall Study|Adverse Event|0|||
33471639|NCT04398134|62845473|FG000|Overall Study|Withdrawal by Subject|2|||
33471640|NCT04398134|62845474|FG001|Overall Study|Withdrawal by Subject|0|||
33471641|NCT04398134|62845475|FG002|Overall Study|Withdrawal by Subject|0|||
33471642|NCT04398134|62845476|FG003|Overall Study|Withdrawal by Subject|1|||
33471643|NCT04398134|62845473|FG000|Overall Study|Study Terminated by Sponsor|30|||
33471644|NCT04398134|62845474|FG001|Overall Study|Study Terminated by Sponsor|11|||
33471645|NCT04398134|62845475|FG002|Overall Study|Study Terminated by Sponsor|32|||
33471646|NCT04398134|62845476|FG003|Overall Study|Study Terminated by Sponsor|11|||
33471647|NCT03122860|62845492|FG000|Overall Study|Discontinued Before Treatment|1|||
33471648|NCT03122860|62845493|FG001|Overall Study|Discontinued Before Treatment|1|||
33471649|NCT03122860|62845494|FG002|Overall Study|Discontinued Before Treatment|2|||
33471650|NCT03122860|62845495|FG003|Overall Study|Discontinued Before Treatment|0|||
33471651|NCT03122860|62845496|FG004|Overall Study|Discontinued Before Treatment|1|||
33471652|NCT03122860|62845497|FG005|Overall Study|Discontinued Before Treatment|0|||
33471653|NCT03122860|62845492|FG000|Overall Study|Adverse Event|1|||
33471654|NCT03122860|62845493|FG001|Overall Study|Adverse Event|0|||
33471655|NCT03122860|62845494|FG002|Overall Study|Adverse Event|1|||
33471656|NCT03122860|62845495|FG003|Overall Study|Adverse Event|1|||
33471657|NCT03122860|62845496|FG004|Overall Study|Adverse Event|0|||
33471658|NCT03122860|62845497|FG005|Overall Study|Adverse Event|0|||
33471659|NCT03122860|62845492|FG000|Overall Study|Lost to Follow-up|5|||
33351563|NCT00948896|62728941|FG004|24 Months of Age to 36 Months of Age|Death|0|||
33351564|NCT00948896|62728942|FG005|24 Months of Age to 36 Months of Age|Death|1|||
33351565|NCT00948896|62728943|FG006|24 Months of Age to 36 Months of Age|Death|0|||
33351566|NCT00948896|62728944|FG007|24 Months of Age to 36 Months of Age|Death|0|||
33351567|NCT00948896|62728937|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
33351568|NCT00948896|62728938|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
33351569|NCT00948896|62728939|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
33351570|NCT00948896|62728940|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
33351571|NCT00948896|62728941|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
33351572|NCT00948896|62728942|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
33351573|NCT00948896|62728943|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
33351574|NCT00948896|62728944|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
33471660|NCT03122860|62845493|FG001|Overall Study|Lost to Follow-up|2|||
33471661|NCT03122860|62845494|FG002|Overall Study|Lost to Follow-up|3|||
33471662|NCT03122860|62845495|FG003|Overall Study|Lost to Follow-up|3|||
33471663|NCT03122860|62845496|FG004|Overall Study|Lost to Follow-up|5|||
33471664|NCT03122860|62845497|FG005|Overall Study|Lost to Follow-up|4|||
33471665|NCT03122860|62845492|FG000|Overall Study|Subject Non-Compliance|0|||
33471666|NCT03122860|62845493|FG001|Overall Study|Subject Non-Compliance|0|||
33471667|NCT03122860|62845494|FG002|Overall Study|Subject Non-Compliance|1|||
33471668|NCT03122860|62845495|FG003|Overall Study|Subject Non-Compliance|0|||
33471669|NCT03122860|62845496|FG004|Overall Study|Subject Non-Compliance|0|||
33471670|NCT03122860|62845497|FG005|Overall Study|Subject Non-Compliance|0|||
33471671|NCT03122860|62845492|FG000|Overall Study|Withdrawal by Subject|3|||
33351575|NCT00948896|62728937|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
33471672|NCT03122860|62845493|FG001|Overall Study|Withdrawal by Subject|2|||
33471673|NCT03122860|62845494|FG002|Overall Study|Withdrawal by Subject|5|||
33471674|NCT03122860|62845495|FG003|Overall Study|Withdrawal by Subject|7|||
33471675|NCT03122860|62845496|FG004|Overall Study|Withdrawal by Subject|9|||
33471676|NCT03122860|62845497|FG005|Overall Study|Withdrawal by Subject|8|||
33471677|NCT03798366|62845514|FG000|Overall Study|Lost to Follow-up|0|||
33471678|NCT03798366|62845515|FG001|Overall Study|Lost to Follow-up|1|||
33471679|NCT04327388|62845524|FG000|Overall Study|Adverse Event|17|||
33471680|NCT04327388|62845525|FG001|Overall Study|Adverse Event|18|||
33471681|NCT04327388|62845526|FG002|Overall Study|Adverse Event|9|||
33471682|NCT04327388|62845524|FG000|Overall Study|Other|1|||
33471683|NCT04327388|62845525|FG001|Overall Study|Other|2|||
33471684|NCT04327388|62845526|FG002|Overall Study|Other|0|||
33471685|NCT04327388|62845524|FG000|Overall Study|Randomized and not treated|2|||
33471686|NCT04327388|62845525|FG001|Overall Study|Randomized and not treated|0|||
33471687|NCT04327388|62845526|FG002|Overall Study|Randomized and not treated|2|||
33471688|NCT03796728|62845534|FG000|Overall Study|Lost to Follow-up|8|||
33471689|NCT03796728|62845534|FG000|Overall Study|Reason not Specified|16|||
33471690|NCT00352534|62845540|FG000|Initial Staging|Ineligible|8|||
33471691|NCT00352534|62845541|FG001|Initial Staging|Ineligible|9|||
33471692|NCT00352534|62845542|FG002|Initial Staging|Ineligible|0|||
33471693|NCT00352534|62845543|FG003|Initial Staging|Ineligible|0|||
33471694|NCT00352534|62845544|FG004|Initial Staging|Ineligible|0|||
33471695|NCT00352534|62845545|FG005|Initial Staging|Ineligible|0|||
33471696|NCT00352534|62845546|FG006|Initial Staging|Ineligible|0|||
33471697|NCT00352534|62845540|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
33471698|NCT00352534|62845541|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
33471699|NCT00352534|62845542|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
33471700|NCT00352534|62845543|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
33548988|NCT02901431|62940300|FG006|PK Part|Discontinued per Sponsor|0|||
33548989|NCT02901431|62940301|FG007|PK Part|Discontinued per Sponsor|0|||
33548990|NCT02901431|62940302|FG008|PK Part|Discontinued per Sponsor|0|||
33471701|NCT00352534|62845544|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
33471702|NCT00352534|62845545|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
33471703|NCT00352534|62845546|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
33471704|NCT00352534|62845540|FG000|Final Risk Group Assignment|Physician Decision|0|||
33548991|NCT02901431|62940303|FG009|PK Part|Discontinued per Sponsor|0|||
33548992|NCT02901431|62940304|FG010|PK Part|Discontinued per Sponsor|0|||
33655139|NCT01895309|63069489|FG001|Overall Study|Physician Decision|10|||
33655140|NCT01895309|63069488|FG000|Overall Study|Withdrawal by Subject|9|||
33471705|NCT00352534|62845541|FG001|Final Risk Group Assignment|Physician Decision|0|||
33471706|NCT00352534|62845542|FG002|Final Risk Group Assignment|Physician Decision|0|||
33655141|NCT01895309|63069489|FG001|Overall Study|Withdrawal by Subject|18|||
33655142|NCT01884311|63069499|FG000|Overall Study|Withdrawal by Subject|3|||
33655143|NCT01884311|63069499|FG000|Overall Study|withdrew consent due to AEs|1|||
33655144|NCT01884311|63069499|FG000|Overall Study|Precautionary measure|1|||
33471707|NCT00352534|62845543|FG003|Final Risk Group Assignment|Physician Decision|0|||
33655145|NCT01884077|63069539|FG000|Overall Study|screen fail|0|||
33471708|NCT00352534|62845544|FG004|Final Risk Group Assignment|Physician Decision|0|||
33471709|NCT00352534|62845545|FG005|Final Risk Group Assignment|Physician Decision|8|||
33548993|NCT02901431|62940305|FG011|PK Part|Discontinued per Sponsor|0|||
33548994|NCT02901431|62940306|FG012|PK Part|Discontinued per Sponsor|0|||
33655146|NCT01884077|63069540|FG001|Overall Study|screen fail|2|||
33471710|NCT00352534|62845546|FG006|Final Risk Group Assignment|Physician Decision|0|||
33471711|NCT00352534|62845540|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
33471712|NCT00352534|62845541|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
33471713|NCT00352534|62845542|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
33351576|NCT00948896|62728938|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
33351577|NCT00948896|62728939|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
33351578|NCT00948896|62728940|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
33351579|NCT00948896|62728941|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
33351580|NCT00948896|62728942|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
33351581|NCT00948896|62728943|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
33351582|NCT00948896|62728944|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
33351583|NCT00948896|62728937|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
33351584|NCT00948896|62728938|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
33351585|NCT00948896|62728939|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
33351586|NCT00948896|62728940|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
33351587|NCT00948896|62728941|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
33351588|NCT00948896|62728942|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
33351589|NCT00948896|62728943|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
33351590|NCT00948896|62728944|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
33351591|NCT00948896|62728937|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
33351592|NCT00948896|62728938|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
33471714|NCT00352534|62845543|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
33471715|NCT00352534|62845544|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
33351593|NCT00948896|62728939|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
33351594|NCT00948896|62728940|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
33351595|NCT00948896|62728941|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
33351596|NCT00948896|62728942|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
33351597|NCT00948896|62728943|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
33351598|NCT00948896|62728944|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
33351599|NCT01004159|62728966|FG000|Overall Study|Adverse Event|2|||
33351600|NCT01004159|62728966|FG000|Overall Study|Disease Progression|18|||
33351601|NCT00948818|62728972|FG000|Overall Study|Adverse Event|10|||
33351602|NCT00948818|62728973|FG001|Overall Study|Adverse Event|32|||
33351603|NCT00948818|62728972|FG000|Overall Study|Protocol Violation|9|||
33351604|NCT00948818|62728973|FG001|Overall Study|Protocol Violation|10|||
33471716|NCT00352534|62845545|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
33471717|NCT00352534|62845546|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
33471718|NCT00352534|62845540|FG000|Final Risk Group Assignment|Ineligible|0|||
33471719|NCT00352534|62845541|FG001|Final Risk Group Assignment|Ineligible|0|||
33471720|NCT00352534|62845542|FG002|Final Risk Group Assignment|Ineligible|3|||
33471721|NCT00352534|62845543|FG003|Final Risk Group Assignment|Ineligible|1|||
33471722|NCT00352534|62845544|FG004|Final Risk Group Assignment|Ineligible|0|||
33471723|NCT00352534|62845545|FG005|Final Risk Group Assignment|Ineligible|13|||
33471724|NCT00352534|62845546|FG006|Final Risk Group Assignment|Ineligible|0|||
33471725|NCT00352534|62845540|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
33471726|NCT00352534|62845541|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
33351605|NCT00948818|62728972|FG000|Overall Study|Withdrawal by Subject|25|||
33351606|NCT00948818|62728973|FG001|Overall Study|Withdrawal by Subject|25|||
33351607|NCT00948818|62728972|FG000|Overall Study|Lost to Follow-up|10|||
33351608|NCT00948818|62728973|FG001|Overall Study|Lost to Follow-up|17|||
33351609|NCT00948818|62728972|FG000|Overall Study|Lack of Efficacy|4|||
33351610|NCT00948818|62728973|FG001|Overall Study|Lack of Efficacy|5|||
33351611|NCT00948818|62728972|FG000|Overall Study|Other Reason|4|||
33471727|NCT00352534|62845542|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
33471728|NCT00352534|62845543|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
33471729|NCT00352534|62845544|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
33471730|NCT00352534|62845545|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
33471731|NCT00352534|62845546|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
33471732|NCT00352534|62845540|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
33471733|NCT00352534|62845541|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
33471734|NCT00352534|62845542|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
33471735|NCT00352534|62845543|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
33471736|NCT00352534|62845544|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
33471737|NCT00352534|62845545|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
33471738|NCT00352534|62845546|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
33351612|NCT00948818|62728973|FG001|Overall Study|Other Reason|5|||
33471739|NCT00352534|62845540|FG000|Final Risk Group Assignment|Death|0|||
33351613|NCT00948506|62728984|FG000|Overall Study|Withdrawal by Subject|3|||
33471740|NCT00352534|62845541|FG001|Final Risk Group Assignment|Death|0|||
33471741|NCT00352534|62845542|FG002|Final Risk Group Assignment|Death|0|||
33471742|NCT00352534|62845543|FG003|Final Risk Group Assignment|Death|0|||
33471743|NCT00352534|62845544|FG004|Final Risk Group Assignment|Death|0|||
33471744|NCT00352534|62845545|FG005|Final Risk Group Assignment|Death|2|||
33471745|NCT00352534|62845546|FG006|Final Risk Group Assignment|Death|0|||
33471746|NCT04323800|62845558|FG000|Overall Study|Withdrawal by Subject|4|||
33471747|NCT04323800|62845559|FG001|Overall Study|Withdrawal by Subject|4|||
33471748|NCT04323800|62845558|FG000|Overall Study|Incomplete transfusion|1|||
33471749|NCT04323800|62845559|FG001|Overall Study|Incomplete transfusion|0|||
33471750|NCT04323800|62845558|FG000|Overall Study|Other|0|||
33471751|NCT04323800|62845559|FG001|Overall Study|Other|1|||
33471752|NCT04323800|62845558|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
33471753|NCT04323800|62845559|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
33471754|NCT04321460|62845567|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
33471755|NCT04321460|62845568|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
33471756|NCT03122548|62845574|FG000|Overall Study|Death|2|||
33471757|NCT03122548|62845574|FG000|Overall Study|Progression - subject went into hospice|1|||
33471758|NCT03122548|62845574|FG000|Overall Study|Study Terminated by Sponsor|2|||
33471759|NCT04459598|62845580|FG000|Overall Study|Adverse Event|1|||
33471760|NCT04459598|62845581|FG001|Overall Study|Adverse Event|1|||
33471761|NCT02929498|62845590|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
33471762|NCT02929498|62845591|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
33471763|NCT02929498|62845592|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
33471764|NCT02929498|62845590|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
33471765|NCT02929498|62845591|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
33351614|NCT00948506|62728985|FG001|Overall Study|Withdrawal by Subject|1|||
33351615|NCT00955682|62728996|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
33351616|NCT00955682|62728997|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
33351617|NCT00689221|62729013|FG000|Overall Study|Ongoing at cut-off date|39|||
33351618|NCT00689221|62729014|FG001|Overall Study|Ongoing at cut-off date|36|||
33351619|NCT01875445|62729022|FG000|Overall Study|Lost to Follow-up|5|||
33351620|NCT01875445|62729023|FG001|Overall Study|Lost to Follow-up|0|||
33351621|NCT01875445|62729022|FG000|Overall Study|Withdrawal by Subject|2|||
33351622|NCT01875445|62729023|FG001|Overall Study|Withdrawal by Subject|0|||
33351623|NCT00688909|62729029|FG000|Overall Study|Adverse Event|28|||
33351624|NCT00688909|62729029|FG000|Overall Study|Patient withdrew consent|2|||
33351625|NCT00688909|62729029|FG000|Overall Study|Administrative problems|1|||
33351626|NCT00688909|62729029|FG000|Overall Study|Protocol Violation|2|||
33351627|NCT00948428|62729037|FG000|Overall Study|Withdrawal by Subject|6|||
33351628|NCT00948428|62729038|FG001|Overall Study|Withdrawal by Subject|12|||
33351629|NCT00948428|62729039|FG002|Overall Study|Withdrawal by Subject|7|||
33351630|NCT00948428|62729037|FG000|Overall Study|Adverse Event|6|||
33351631|NCT00948428|62729038|FG001|Overall Study|Adverse Event|3|||
33351632|NCT00948428|62729039|FG002|Overall Study|Adverse Event|0|||
33351633|NCT00948428|62729037|FG000|Overall Study|Lost to Follow-up|2|||
33351634|NCT00948428|62729038|FG001|Overall Study|Lost to Follow-up|1|||
33351635|NCT00948428|62729039|FG002|Overall Study|Lost to Follow-up|1|||
33351636|NCT00948428|62729037|FG000|Overall Study|Death|2|||
33351637|NCT00948428|62729038|FG001|Overall Study|Death|0|||
33351638|NCT00948428|62729039|FG002|Overall Study|Death|0|||
33351639|NCT00948428|62729037|FG000|Overall Study|Intercurrent Illness|1|||
33351640|NCT00948428|62729038|FG001|Overall Study|Intercurrent Illness|0|||
33351641|NCT00948428|62729039|FG002|Overall Study|Intercurrent Illness|0|||
33351642|NCT00948428|62729037|FG000|Overall Study|Non-compliance|1|||
33351643|NCT00948428|62729038|FG001|Overall Study|Non-compliance|2|||
33351644|NCT00948428|62729039|FG002|Overall Study|Non-compliance|0|||
33351645|NCT00948194|62729049|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
33351646|NCT00948194|62729050|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
33351647|NCT00691483|62729058|FG000|Overall Study|Adverse Event|14|||
33351648|NCT00691483|62729059|FG001|Overall Study|Adverse Event|6|||
33351649|NCT00691483|62729058|FG000|Overall Study|Lost to Follow-up|17|||
33471766|NCT02929498|62845592|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
33471767|NCT03792672|62845598|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
33471768|NCT03792672|62845599|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
33351650|NCT00691483|62729059|FG001|Overall Study|Lost to Follow-up|10|||
33351651|NCT00691483|62729058|FG000|Overall Study|Withdrawal by Subject|24|||
33471769|NCT03792672|62845600|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
33471770|NCT03792672|62845601|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
33471771|NCT03792672|62845602|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
33655147|NCT01884077|63069539|FG000|Overall Study|canceled surgery|2|||
33351652|NCT00691483|62729059|FG001|Overall Study|Withdrawal by Subject|7|||
33351653|NCT00691483|62729058|FG000|Overall Study|Other known cause|6|||
33351654|NCT00691483|62729059|FG001|Overall Study|Other known cause|1|||
33351655|NCT00691483|62729058|FG000|Overall Study|Randomized by not treated|7|||
33351656|NCT00691483|62729059|FG001|Overall Study|Randomized by not treated|1|||
33351657|NCT00691093|62729065|FG000|Overall Study|Adverse Event|1|||
33351658|NCT00691093|62729065|FG000|Overall Study|Lost to Follow-up|1|||
33351659|NCT00691093|62729065|FG000|Overall Study|Lack of Efficacy|1|||
33351660|NCT00691093|62729065|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
33351661|NCT00947882|62729078|FG000|Overall Study|Adverse Event|0|||
33351662|NCT00947882|62729079|FG001|Overall Study|Adverse Event|1|||
33351663|NCT00947882|62729080|FG002|Overall Study|Adverse Event|4|||
33351664|NCT00947882|62729081|FG003|Overall Study|Adverse Event|4|||
33351665|NCT00947882|62729078|FG000|Overall Study|Withdrawal by Subject|2|||
33351666|NCT00947882|62729079|FG001|Overall Study|Withdrawal by Subject|0|||
33351667|NCT00947882|62729080|FG002|Overall Study|Withdrawal by Subject|8|||
33351668|NCT00947882|62729081|FG003|Overall Study|Withdrawal by Subject|2|||
33351669|NCT00947882|62729078|FG000|Overall Study|Protocol Violation|0|||
33351670|NCT00947882|62729079|FG001|Overall Study|Protocol Violation|0|||
33351671|NCT00947882|62729080|FG002|Overall Study|Protocol Violation|1|||
33351672|NCT00947882|62729081|FG003|Overall Study|Protocol Violation|0|||
33351673|NCT00947882|62729078|FG000|Overall Study|Lost to Follow-up|0|||
33351674|NCT00947882|62729079|FG001|Overall Study|Lost to Follow-up|2|||
33351675|NCT00947882|62729080|FG002|Overall Study|Lost to Follow-up|1|||
33351676|NCT00947882|62729081|FG003|Overall Study|Lost to Follow-up|0|||
33351677|NCT00947882|62729078|FG000|Overall Study|Other/Unknown|10|||
33351678|NCT00947882|62729079|FG001|Overall Study|Other/Unknown|13|||
33351679|NCT00947882|62729080|FG002|Overall Study|Other/Unknown|3|||
33351680|NCT00947882|62729081|FG003|Overall Study|Other/Unknown|6|||
33351681|NCT00947882|62729078|FG000|Overall Study|Trial Terminated by Sponsor|62|||
33351682|NCT00947882|62729079|FG001|Overall Study|Trial Terminated by Sponsor|61|||
33351683|NCT00947882|62729080|FG002|Overall Study|Trial Terminated by Sponsor|62|||
33351684|NCT00947882|62729081|FG003|Overall Study|Trial Terminated by Sponsor|70|||
33351685|NCT00688753|62729092|FG000|Overall Study|Disease progression|55|||
33351686|NCT00688753|62729092|FG000|Overall Study|Missing|1|||
33351687|NCT00688753|62729092|FG000|Overall Study|Death|9|||
33351688|NCT00688753|62729092|FG000|Overall Study|Withdrawal by Subject|3|||
33351689|NCT00688753|62729092|FG000|Overall Study|Adverse Event|20|||
33351690|NCT00688753|62729092|FG000|Overall Study|Protocol Violation|1|||
33351691|NCT00688753|62729092|FG000|Overall Study|Lost to Follow-up|3|||
33351692|NCT00951080|62729098|FG000|Overall Study|Adverse Event|3|||
33351693|NCT00951080|62729099|FG001|Overall Study|Adverse Event|3|||
33351694|NCT00951080|62729098|FG000|Overall Study|Lost to Follow-up|0|||
33351695|NCT00951080|62729099|FG001|Overall Study|Lost to Follow-up|1|||
33351696|NCT00951080|62729098|FG000|Overall Study|Physician Decision|4|||
33351697|NCT00951080|62729099|FG001|Overall Study|Physician Decision|1|||
33351698|NCT00951080|62729098|FG000|Overall Study|Other|19|||
33351699|NCT00951080|62729099|FG001|Overall Study|Other|22|||
33351700|NCT00946322|62729105|FG000|Pre-treatment|participant failure to follow up|1|||
33351701|NCT00946322|62729105|FG000|Post-treatment|participant failure to follow up|2|||
33351702|NCT00950690|62729109|FG000|Overall Study|Death|4|||
33351703|NCT00950690|62729109|FG000|Overall Study|Adverse Event|15|||
33351704|NCT00950690|62729109|FG000|Overall Study|Lack of Efficacy|22|||
33351705|NCT00950690|62729109|FG000|Overall Study|Lost to Follow-up|40|||
33351706|NCT00950690|62729109|FG000|Overall Study|Other|163|||
33351707|NCT00694369|62729118|FG000|Overall Study|Adverse Event|0|||
33351708|NCT00694369|62729119|FG001|Overall Study|Adverse Event|1|||
33351709|NCT00694369|62729120|FG002|Overall Study|Adverse Event|0|||
33351710|NCT00694369|62729121|FG003|Overall Study|Adverse Event|1|||
33351711|NCT00694369|62729122|FG004|Overall Study|Adverse Event|3|||
33351712|NCT00694369|62729118|FG000|Overall Study|Lost to Follow-up|0|||
33471772|NCT03792672|62845603|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
33471773|NCT03792672|62845598|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
33471774|NCT03792672|62845599|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
33471775|NCT03792672|62845600|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
33471776|NCT03792672|62845601|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
33351713|NCT00694369|62729119|FG001|Overall Study|Lost to Follow-up|0|||
33351714|NCT00694369|62729120|FG002|Overall Study|Lost to Follow-up|1|||
33471777|NCT03792672|62845602|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
33351715|NCT00694369|62729121|FG003|Overall Study|Lost to Follow-up|1|||
33351716|NCT00694369|62729122|FG004|Overall Study|Lost to Follow-up|0|||
33351717|NCT00694369|62729118|FG000|Overall Study|Physician Decision|0|||
33351718|NCT00694369|62729119|FG001|Overall Study|Physician Decision|0|||
33351719|NCT00694369|62729120|FG002|Overall Study|Physician Decision|0|||
33351720|NCT00694369|62729121|FG003|Overall Study|Physician Decision|0|||
33351721|NCT00694369|62729122|FG004|Overall Study|Physician Decision|1|||
33351722|NCT00694369|62729118|FG000|Overall Study|Protocol Violation|0|||
33351723|NCT00694369|62729119|FG001|Overall Study|Protocol Violation|1|||
33351724|NCT00694369|62729120|FG002|Overall Study|Protocol Violation|0|||
33351725|NCT00694369|62729121|FG003|Overall Study|Protocol Violation|0|||
33351726|NCT00694369|62729122|FG004|Overall Study|Protocol Violation|0|||
33471778|NCT03792672|62845603|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
33471779|NCT03792672|62845598|FG000|Treatment Period 4 (2 Days)|Other|1|||
33471780|NCT03792672|62845599|FG001|Treatment Period 4 (2 Days)|Other|0|||
33471781|NCT03792672|62845600|FG002|Treatment Period 4 (2 Days)|Other|0|||
33471782|NCT03792672|62845601|FG003|Treatment Period 4 (2 Days)|Other|0|||
33471783|NCT03792672|62845602|FG004|Treatment Period 4 (2 Days)|Other|0|||
33471784|NCT03792672|62845603|FG005|Treatment Period 4 (2 Days)|Other|0|||
33471785|NCT03120676|62845618|FG000|Overall Study|Not treated|1|||
33471786|NCT03120520|62845626|FG000|Overall Study|Lost to Follow-up|1|||
33471787|NCT03120520|62845627|FG001|Overall Study|Lost to Follow-up|1|||
33471788|NCT03120520|62845628|FG002|Overall Study|Lost to Follow-up|1|||
33471789|NCT03120520|62845629|FG003|Overall Study|Lost to Follow-up|1|||
33351727|NCT00694369|62729118|FG000|Overall Study|Withdrawal by Subject|1|||
33351728|NCT00694369|62729119|FG001|Overall Study|Withdrawal by Subject|1|||
33351729|NCT00694369|62729120|FG002|Overall Study|Withdrawal by Subject|1|||
33351730|NCT00694369|62729121|FG003|Overall Study|Withdrawal by Subject|1|||
33471790|NCT03120520|62845626|FG000|Overall Study|Withdrawal by Subject|3|||
33471791|NCT03120520|62845627|FG001|Overall Study|Withdrawal by Subject|2|||
33351731|NCT00694369|62729122|FG004|Overall Study|Withdrawal by Subject|2|||
33471792|NCT03120520|62845628|FG002|Overall Study|Withdrawal by Subject|3|||
33471793|NCT03120520|62845629|FG003|Overall Study|Withdrawal by Subject|2|||
33471794|NCT03120520|62845626|FG000|Overall Study|Other|0|||
33351732|NCT03412747|62729137|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
33351733|NCT03412747|62729138|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
33351734|NCT03412747|62729139|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
33351735|NCT03412747|62729137|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
33351736|NCT03412747|62729138|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
33351737|NCT03412747|62729139|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
33351738|NCT03412747|62729137|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
33351739|NCT03412747|62729138|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
33351740|NCT03412747|62729139|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
33351741|NCT03412747|62729137|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
33351742|NCT03412747|62729138|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
33351743|NCT03412747|62729139|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
33351744|NCT03412747|62729137|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
33351745|NCT03412747|62729138|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
33351746|NCT03412747|62729139|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
33351747|NCT03412747|62729137|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
33351748|NCT03412747|62729138|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
33351749|NCT03412747|62729139|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
33351750|NCT03412747|62729137|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
33351751|NCT03412747|62729138|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
33351752|NCT03412747|62729139|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
33351753|NCT03412747|62729137|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
33351754|NCT03412747|62729138|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
33351755|NCT03412747|62729139|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
33351756|NCT03412747|62729137|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
33351757|NCT03412747|62729138|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
33351758|NCT03412747|62729139|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
33351759|NCT03412747|62729137|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
33351760|NCT03412747|62729138|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
33351761|NCT03412747|62729139|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
33351762|NCT03412747|62729137|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
33351763|NCT03412747|62729138|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
33351764|NCT03412747|62729139|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
33351765|NCT03412747|62729137|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
33351766|NCT03412747|62729138|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
33351767|NCT03412747|62729139|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
33351768|NCT03412747|62729137|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
33351769|NCT03412747|62729138|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
33351770|NCT03412747|62729139|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
33351771|NCT03412747|62729137|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
33351772|NCT03412747|62729138|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
33351773|NCT03412747|62729139|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
33351774|NCT03412747|62729137|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
33351775|NCT03412747|62729138|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
33351776|NCT03412747|62729139|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
33351777|NCT03412747|62729137|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
33351778|NCT03412747|62729138|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
33351779|NCT03412747|62729139|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
33351780|NCT00513019|62729159|FG000|Overall Study|Adverse Event|1|||
33351781|NCT00513019|62729160|FG001|Overall Study|Adverse Event|0|||
33351782|NCT00513019|62729159|FG000|Overall Study|Withdrawal by Subject|4|||
33351783|NCT00513019|62729160|FG001|Overall Study|Withdrawal by Subject|5|||
33351784|NCT00954512|62729181|FG000|Overall Study|Withdrawal by Subject|0|||
33351785|NCT00954512|62729182|FG001|Overall Study|Withdrawal by Subject|0|||
33351786|NCT00954512|62729183|FG002|Overall Study|Withdrawal by Subject|0|||
33351787|NCT00954512|62729184|FG003|Overall Study|Withdrawal by Subject|0|||
33351788|NCT00954512|62729185|FG004|Overall Study|Withdrawal by Subject|0|||
33351789|NCT00954512|62729186|FG005|Overall Study|Withdrawal by Subject|1|||
33351790|NCT00954512|62729181|FG000|Overall Study|Adverse Event|0|||
33351791|NCT00954512|62729182|FG001|Overall Study|Adverse Event|0|||
33351792|NCT00954512|62729183|FG002|Overall Study|Adverse Event|0|||
33548995|NCT02901431|62940294|FG000|PK Part|Withdrawal by Subject|1|||
33548996|NCT02901431|62940295|FG001|PK Part|Withdrawal by Subject|1|||
33351793|NCT00954512|62729184|FG003|Overall Study|Adverse Event|0|||
33351794|NCT00954512|62729185|FG004|Overall Study|Adverse Event|1|||
33351795|NCT00954512|62729186|FG005|Overall Study|Adverse Event|2|||
33351796|NCT00954512|62729181|FG000|Overall Study|Physician Decision|0|||
33548997|NCT02901431|62940296|FG002|PK Part|Withdrawal by Subject|3|||
33351797|NCT00954512|62729182|FG001|Overall Study|Physician Decision|1|||
33351798|NCT00954512|62729183|FG002|Overall Study|Physician Decision|0|||
33351799|NCT00954512|62729184|FG003|Overall Study|Physician Decision|1|||
33351800|NCT00954512|62729185|FG004|Overall Study|Physician Decision|0|||
33351801|NCT00954512|62729186|FG005|Overall Study|Physician Decision|0|||
33351802|NCT00954512|62729181|FG000|Overall Study|Symptomatic Deterioration|0|||
33351803|NCT00954512|62729182|FG001|Overall Study|Symptomatic Deterioration|1|||
33471795|NCT03120520|62845627|FG001|Overall Study|Other|1|||
33471796|NCT03120520|62845628|FG002|Overall Study|Other|0|||
33471797|NCT03120520|62845629|FG003|Overall Study|Other|0|||
33471798|NCT03787212|62845639|FG000|Period 1|Study Termination|2|||
33471799|NCT03787212|62845640|FG001|Period 1|Study Termination|2|||
33471800|NCT03125200|62845653|FG000|Overall Study|Study Termination|0|||
33471801|NCT03125200|62845654|FG001|Overall Study|Study Termination|0|||
33471802|NCT03125200|62845655|FG002|Overall Study|Study Termination|0|||
33471803|NCT03125200|62845656|FG003|Overall Study|Study Termination|1|||
33471804|NCT03125200|62845657|FG004|Overall Study|Study Termination|1|||
33351804|NCT00954512|62729183|FG002|Overall Study|Symptomatic Deterioration|0|||
33351805|NCT00954512|62729184|FG003|Overall Study|Symptomatic Deterioration|0|||
33351806|NCT00954512|62729185|FG004|Overall Study|Symptomatic Deterioration|2|||
33351807|NCT00954512|62729186|FG005|Overall Study|Symptomatic Deterioration|0|||
33351808|NCT00954512|62729181|FG000|Overall Study|Progression of Disease|2|||
33351809|NCT00954512|62729182|FG001|Overall Study|Progression of Disease|1|||
33351810|NCT00954512|62729183|FG002|Overall Study|Progression of Disease|0|||
33351811|NCT00954512|62729184|FG003|Overall Study|Progression of Disease|1|||
33351812|NCT00954512|62729185|FG004|Overall Study|Progression of Disease|1|||
33351813|NCT00954512|62729186|FG005|Overall Study|Progression of Disease|1|||
33351814|NCT00691015|62729199|FG000|Overall Study|Refused further treatment|1|||
33351815|NCT00950300|62729205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
33351816|NCT00950300|62729206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
33351817|NCT00950300|62729205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
33351818|NCT00950300|62729206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
33351819|NCT00950300|62729205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
33351820|NCT00950300|62729206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
33351821|NCT00950300|62729205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
33351822|NCT00950300|62729206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
33471805|NCT03125200|62845658|FG005|Overall Study|Study Termination|2|||
33471806|NCT03125200|62845659|FG006|Overall Study|Study Termination|1|||
33471807|NCT03125200|62845653|FG000|Overall Study|Clinical Progression|0|||
33471808|NCT03125200|62845654|FG001|Overall Study|Clinical Progression|0|||
33471809|NCT03125200|62845655|FG002|Overall Study|Clinical Progression|0|||
33471810|NCT03125200|62845656|FG003|Overall Study|Clinical Progression|1|||
33548998|NCT02901431|62940297|FG003|PK Part|Withdrawal by Subject|0|||
33351823|NCT00950300|62729205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
33351824|NCT00950300|62729206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
33351825|NCT00950300|62729205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
33351826|NCT00950300|62729206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
33351827|NCT00950300|62729205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
33351828|NCT00950300|62729206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
33351829|NCT00950300|62729205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
33351830|NCT00950300|62729206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
33351831|NCT00950300|62729205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
33351832|NCT00950300|62729206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
33351833|NCT00950300|62729205|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
33351834|NCT00950300|62729206|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
33351835|NCT00950300|62729205|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
33351836|NCT00950300|62729206|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
33351837|NCT00950300|62729205|FG000|TFFU Period|Death|4|||
33351838|NCT00950300|62729206|FG001|TFFU Period|Death|1|||
33471811|NCT03125200|62845657|FG004|Overall Study|Clinical Progression|0|||
33471812|NCT03125200|62845658|FG005|Overall Study|Clinical Progression|1|||
33471813|NCT03125200|62845659|FG006|Overall Study|Clinical Progression|0|||
33471814|NCT03125200|62845653|FG000|Overall Study|Progressive Disease|2|||
33351839|NCT00950300|62729205|FG000|TFFU Period|Refused Treatment|10|||
33351840|NCT00950300|62729206|FG001|TFFU Period|Refused Treatment|11|||
33471815|NCT03125200|62845654|FG001|Overall Study|Progressive Disease|1|||
33471816|NCT03125200|62845655|FG002|Overall Study|Progressive Disease|2|||
33471817|NCT03125200|62845656|FG003|Overall Study|Progressive Disease|1|||
33471818|NCT03125200|62845657|FG004|Overall Study|Progressive Disease|2|||
33471819|NCT03125200|62845658|FG005|Overall Study|Progressive Disease|0|||
33471820|NCT03125200|62845659|FG006|Overall Study|Progressive Disease|1|||
33471821|NCT03125200|62845653|FG000|Overall Study|Lack of Efficacy|0|||
33351841|NCT00950300|62729205|FG000|TFFU Period|Failure to Return|16|||
33351842|NCT00950300|62729206|FG001|TFFU Period|Failure to Return|16|||
33351843|NCT00950300|62729205|FG000|TFFU Period|Recurrence of Disease|63|||
33351844|NCT00950300|62729206|FG001|TFFU Period|Recurrence of Disease|72|||
33351845|NCT00950300|62729205|FG000|TFFU Period|Other|4|||
33351846|NCT00950300|62729206|FG001|TFFU Period|Other|3|||
33351847|NCT00950300|62729205|FG000|SFU Period|Death|44|||
33351848|NCT00950300|62729206|FG001|SFU Period|Death|42|||
33351849|NCT00950300|62729205|FG000|SFU Period|Lost to Follow-up|30|||
33351850|NCT00950300|62729206|FG001|SFU Period|Lost to Follow-up|28|||
33351851|NCT00950300|62729205|FG000|SFU Period|Withdrawal by Subject|4|||
33351852|NCT00950300|62729206|FG001|SFU Period|Withdrawal by Subject|8|||
33351853|NCT00949988|62729213|FG000|Overall Study|Withdrawal by Subject|3|||
33351854|NCT00731692|62729220|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
33351855|NCT00731692|62729221|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
33351856|NCT00731692|62729222|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
33351857|NCT00731692|62729220|FG000|Core Study (36 Months)|Physician Decision|1|||
33548999|NCT02901431|62940298|FG004|PK Part|Withdrawal by Subject|0|||
33549000|NCT02901431|62940299|FG005|PK Part|Withdrawal by Subject|0|||
33549001|NCT02901431|62940300|FG006|PK Part|Withdrawal by Subject|0|||
33549002|NCT02901431|62940301|FG007|PK Part|Withdrawal by Subject|0|||
33549003|NCT02901431|62940302|FG008|PK Part|Withdrawal by Subject|0|||
33549004|NCT02901431|62940303|FG009|PK Part|Withdrawal by Subject|0|||
33549005|NCT02901431|62940304|FG010|PK Part|Withdrawal by Subject|0|||
33351858|NCT00731692|62729221|FG001|Core Study (36 Months)|Physician Decision|0|||
33351859|NCT00731692|62729222|FG002|Core Study (36 Months)|Physician Decision|2|||
33351860|NCT00731692|62729220|FG000|Core Study (36 Months)|Death|2|||
33351861|NCT00731692|62729221|FG001|Core Study (36 Months)|Death|1|||
33351862|NCT00731692|62729222|FG002|Core Study (36 Months)|Death|2|||
33351863|NCT00731692|62729220|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
33351864|NCT00731692|62729221|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
33351865|NCT00731692|62729222|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
33351866|NCT00731692|62729220|FG000|Core Study (36 Months)|Administrative|2|||
33351867|NCT00731692|62729221|FG001|Core Study (36 Months)|Administrative|2|||
33351868|NCT00731692|62729222|FG002|Core Study (36 Months)|Administrative|6|||
33351869|NCT00731692|62729220|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
33351870|NCT00731692|62729221|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
33351871|NCT00731692|62729222|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
33351872|NCT00731692|62729220|FG000|Core Study (36 Months)|Protocol Violation|4|||
33351873|NCT00731692|62729221|FG001|Core Study (36 Months)|Protocol Violation|5|||
33351874|NCT00731692|62729222|FG002|Core Study (36 Months)|Protocol Violation|8|||
33351875|NCT00731692|62729220|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
33351876|NCT00731692|62729221|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
33351877|NCT00731692|62729222|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
33351878|NCT00731692|62729220|FG000|Core Study (36 Months)|Adverse Event|25|||
33351879|NCT00731692|62729221|FG001|Core Study (36 Months)|Adverse Event|28|||
33351880|NCT00731692|62729222|FG002|Core Study (36 Months)|Adverse Event|29|||
33351881|NCT00731692|62729220|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
33351882|NCT00731692|62729221|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
33351883|NCT00731692|62729222|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
33351884|NCT00731692|62729220|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
33351885|NCT00731692|62729221|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
33351886|NCT00731692|62729222|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
33351887|NCT00731692|62729220|FG000|Extension Phase|Abnormal test procedure|0|||
33351888|NCT00731692|62729221|FG001|Extension Phase|Abnormal test procedure|0|||
33351889|NCT00731692|62729222|FG002|Extension Phase|Abnormal test procedure|1|||
33351890|NCT00731692|62729220|FG000|Extension Phase|Abnormal lab values|0|||
33351891|NCT00731692|62729221|FG001|Extension Phase|Abnormal lab values|0|||
33351892|NCT00731692|62729222|FG002|Extension Phase|Abnormal lab values|1|||
33351893|NCT00731692|62729220|FG000|Extension Phase|Lost to Follow-up|0|||
33351894|NCT00731692|62729221|FG001|Extension Phase|Lost to Follow-up|1|||
33351895|NCT00731692|62729222|FG002|Extension Phase|Lost to Follow-up|4|||
33351896|NCT00731692|62729220|FG000|Extension Phase|Withdrawal by Subject|4|||
33351897|NCT00731692|62729221|FG001|Extension Phase|Withdrawal by Subject|5|||
33351898|NCT00731692|62729222|FG002|Extension Phase|Withdrawal by Subject|3|||
33351899|NCT00731692|62729220|FG000|Extension Phase|Adverse Event|1|||
33351900|NCT00731692|62729221|FG001|Extension Phase|Adverse Event|1|||
33351901|NCT00731692|62729222|FG002|Extension Phase|Adverse Event|15|||
33351902|NCT00687193|62729244|FG000|Overall Study|Adverse Event|0|||
33549006|NCT02901431|62940305|FG011|PK Part|Withdrawal by Subject|0|||
33351903|NCT00687193|62729245|FG001|Overall Study|Adverse Event|1|||
33351904|NCT00687193|62729246|FG002|Overall Study|Adverse Event|2|||
33351905|NCT00687193|62729247|FG003|Overall Study|Adverse Event|3|||
33351906|NCT00687193|62729248|FG004|Overall Study|Adverse Event|0|||
33351907|NCT00687193|62729249|FG005|Overall Study|Adverse Event|2|||
33351908|NCT00687193|62729244|FG000|Overall Study|Lack of Efficacy|1|||
33549007|NCT02901431|62940306|FG012|PK Part|Withdrawal by Subject|0|||
33351909|NCT00687193|62729245|FG001|Overall Study|Lack of Efficacy|1|||
33351910|NCT00687193|62729246|FG002|Overall Study|Lack of Efficacy|0|||
33351911|NCT00687193|62729247|FG003|Overall Study|Lack of Efficacy|0|||
33351912|NCT00687193|62729248|FG004|Overall Study|Lack of Efficacy|0|||
33351913|NCT00687193|62729249|FG005|Overall Study|Lack of Efficacy|2|||
33351914|NCT00687193|62729244|FG000|Overall Study|Protocol Violation|1|||
33351915|NCT00687193|62729245|FG001|Overall Study|Protocol Violation|2|||
33351916|NCT00687193|62729246|FG002|Overall Study|Protocol Violation|0|||
33351917|NCT00687193|62729247|FG003|Overall Study|Protocol Violation|1|||
33351918|NCT00687193|62729248|FG004|Overall Study|Protocol Violation|2|||
33351919|NCT00687193|62729249|FG005|Overall Study|Protocol Violation|0|||
33351920|NCT00730912|62729269|FG000|Overall Study|Discontinued|0|||
33351921|NCT00730912|62729270|FG001|Overall Study|Discontinued|0|||
33351922|NCT00730912|62729271|FG002|Overall Study|Discontinued|1|||
33655148|NCT01884077|63069540|FG001|Overall Study|canceled surgery|0|||
33655149|NCT01884077|63069539|FG000|Overall Study|Lost to Follow-up|0|||
33655150|NCT01884077|63069540|FG001|Overall Study|Lost to Follow-up|4|||
33655151|NCT01884077|63069539|FG000|Overall Study|study closed|6|||
33655152|NCT01884077|63069540|FG001|Overall Study|study closed|4|||
33351929|NCT00730756|62729294|FG000|Overall Study|Adverse Event|2|||
33351930|NCT00730756|62729295|FG001|Overall Study|Adverse Event|0|||
33351931|NCT00730756|62729294|FG000|Overall Study|Lack of Efficacy|1|||
33351932|NCT00730756|62729295|FG001|Overall Study|Lack of Efficacy|1|||
33351933|NCT00730756|62729294|FG000|Overall Study|Protocol Deviation|1|||
33351934|NCT00730756|62729295|FG001|Overall Study|Protocol Deviation|2|||
33351935|NCT00730756|62729294|FG000|Overall Study|Lost to Follow-up|0|||
33351936|NCT00730756|62729295|FG001|Overall Study|Lost to Follow-up|1|||
33351937|NCT00730756|62729294|FG000|Overall Study|Withdrew Consent|0|||
33351938|NCT00730756|62729295|FG001|Overall Study|Withdrew Consent|1|||
33351939|NCT00730132|62729301|FG000|Overall Study|Protocol Violation|154|||
33351940|NCT00730132|62729301|FG000|Overall Study|Death|1|||
33351941|NCT00737464|62729308|FG000|Overall Study|Adverse Event|1|||
33351942|NCT00737464|62729308|FG000|Overall Study|Death|6|||
33351943|NCT00737464|62729308|FG000|Overall Study|Other - Failure to Return|1|||
33351944|NCT00737464|62729308|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
33351945|NCT00737464|62729308|FG000|Overall Study|Other reasons|4|||
33351946|NCT00729586|62729314|FG000|Overall Study|Ineligible|0|||
33351947|NCT00729586|62729315|FG001|Overall Study|Ineligible|1|||
33351948|NCT00729586|62729314|FG000|Overall Study|never treated|1|||
33351949|NCT00729586|62729315|FG001|Overall Study|never treated|0|||
33351950|NCT00949910|62729322|FG000|Overall Study|Progressive Disease|3750|||
33351951|NCT00949910|62729322|FG000|Overall Study|Symptomatic Deterioration|1088|||
33351952|NCT00949910|62729322|FG000|Overall Study|Lost to Follow-up|100|||
33351953|NCT00949910|62729322|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
33351954|NCT00949910|62729322|FG000|Overall Study|Participant Refusal|390|||
33351955|NCT00949910|62729322|FG000|Overall Study|Death Due to Malignant Disease|456|||
33351956|NCT00949910|62729322|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
33351957|NCT00949910|62729322|FG000|Overall Study|Death Due to Adverse Event|115|||
33351958|NCT00949910|62729322|FG000|Overall Study|Death Due to Toxicity|3|||
33351959|NCT00949910|62729322|FG000|Overall Study|Death from Unknown Cause|5|||
33351960|NCT00949910|62729322|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
33351961|NCT00949910|62729322|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
33351962|NCT00949910|62729322|FG000|Overall Study|Switched to Commercial Treatment|4|||
33351963|NCT00949910|62729322|FG000|Overall Study|Violation of Eligibility|23|||
33351964|NCT00949910|62729322|FG000|Overall Study|Logistical Reasons|13|||
33351965|NCT00949910|62729322|FG000|Overall Study|Non-Compliance|10|||
33351966|NCT00949910|62729322|FG000|Overall Study|Prolonged Dosing Interruption|4|||
33351967|NCT00949910|62729322|FG000|Overall Study|Adverse Event|83|||
33351968|NCT00949910|62729322|FG000|Overall Study|Serious Adverse Event|6|||
33351969|NCT00949910|62729322|FG000|Overall Study|Physician/Participant Decision|7|||
33351970|NCT00949910|62729322|FG000|Overall Study|Other|4|||
33351971|NCT00949910|62729322|FG000|Overall Study|No Data|9|||
33351972|NCT00686959|62729328|FG000|Overall Study|Participants censored (no death events)|124|||
33351973|NCT00686959|62729329|FG001|Overall Study|Participants censored (no death events)|117|||
33351974|NCT00946088|62729337|FG000|Overall Study|Withdrawal by Subject|0|||
33351975|NCT00946088|62729338|FG001|Overall Study|Withdrawal by Subject|1|||
33351976|NCT00736996|62729349|FG000|Overall Study|Lost to Follow-up|1|||
33351977|NCT00736996|62729350|FG001|Overall Study|Lost to Follow-up|9|||
33351978|NCT00736996|62729351|FG002|Overall Study|Lost to Follow-up|2|||
33351979|NCT00728962|62729365|FG000|Implant Placement Surgery|Adverse Event|8|||
33351980|NCT00728962|62729365|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
33351981|NCT00728962|62729365|FG000|Implant Placement Surgery|Protocol Violation|1|||
33351982|NCT00728962|62729365|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
33351983|NCT00728962|62729365|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
33351984|NCT00954122|62729369|FG000|Overall Study|Withdrawal by Subject|5|||
33351985|NCT00954122|62729369|FG000|Overall Study|Adverse Event|1|||
33351986|NCT00954122|62729369|FG000|Overall Study|Safety Reason|1|||
33351987|NCT00586066|62729376|FG000|Overall Study|Lost to Follow-up|6|||
33351988|NCT00586066|62729377|FG001|Overall Study|Lost to Follow-up|3|||
33351989|NCT00586066|62729376|FG000|Overall Study|Lack of Efficacy|5|||
33351990|NCT00586066|62729377|FG001|Overall Study|Lack of Efficacy|3|||
33351991|NCT00586066|62729376|FG000|Overall Study|Adverse Event|2|||
33351992|NCT00586066|62729377|FG001|Overall Study|Adverse Event|2|||
33351993|NCT00586066|62729376|FG000|Overall Study|Physician Decision|1|||
33351994|NCT00586066|62729377|FG001|Overall Study|Physician Decision|0|||
33351995|NCT00586066|62729376|FG000|Overall Study|Withdrawal of consent|4|||
33351996|NCT00586066|62729377|FG001|Overall Study|Withdrawal of consent|2|||
33351997|NCT01186016|62729385|FG000|Overall Study|Withdrawal by Subject|46|||
33351998|NCT01186016|62729386|FG001|Overall Study|Withdrawal by Subject|29|||
33351999|NCT00728884|62729392|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
33352000|NCT00728884|62729392|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
33352001|NCT00728494|62729398|FG000|Overall Study|Adverse Event|7|||
33352002|NCT00728494|62729399|FG001|Overall Study|Adverse Event|0|||
33352003|NCT00728494|62729398|FG000|Overall Study|Withdrawal by Subject|0|||
33352004|NCT00728494|62729399|FG001|Overall Study|Withdrawal by Subject|2|||
33352005|NCT00728494|62729398|FG000|Overall Study|Lack of Efficacy|2|||
33352006|NCT00728494|62729399|FG001|Overall Study|Lack of Efficacy|4|||
33352007|NCT00728494|62729398|FG000|Overall Study|No data available|0|||
33352008|NCT00728494|62729399|FG001|Overall Study|No data available|1|||
33352009|NCT00728416|62729407|FG000|Overall Study|Adverse Event|1|||
33352010|NCT00728416|62729408|FG001|Overall Study|Adverse Event|1|||
33352011|NCT00728416|62729407|FG000|Overall Study|Treatment Failure|0|||
33352012|NCT00728416|62729408|FG001|Overall Study|Treatment Failure|1|||
33352013|NCT00728416|62729407|FG000|Overall Study|Withdrawal by Subject|1|||
33352014|NCT00728416|62729408|FG001|Overall Study|Withdrawal by Subject|0|||
33352015|NCT00728182|62729416|FG000|Overall Study|Adverse Event|1|||
33352016|NCT00728182|62729417|FG001|Overall Study|Adverse Event|0|||
33352017|NCT00728182|62729416|FG000|Overall Study|Lost to Follow-up|2|||
33352018|NCT00728182|62729417|FG001|Overall Study|Lost to Follow-up|0|||
33352019|NCT00728182|62729416|FG000|Overall Study|Death|0|||
33352020|NCT00728182|62729417|FG001|Overall Study|Death|2|||
33352021|NCT00728182|62729416|FG000|Overall Study|Protocol Noncompliance|0|||
33352022|NCT00728182|62729417|FG001|Overall Study|Protocol Noncompliance|1|||
33352023|NCT00941330|62729427|FG000|Overall Study|Other|1|||
33352024|NCT00941330|62729428|FG001|Overall Study|Other|0|||
33352025|NCT00941330|62729427|FG000|Overall Study|Physician Decision|0|||
33352026|NCT00941330|62729428|FG001|Overall Study|Physician Decision|2|||
33352027|NCT00686881|62729436|FG000|Overall Study|Withdrawal by Subject|11|||
33352028|NCT00686881|62729437|FG001|Overall Study|Withdrawal by Subject|18|||
33352029|NCT00686881|62729436|FG000|Overall Study|Lost to Follow-up|0|||
33352030|NCT00686881|62729437|FG001|Overall Study|Lost to Follow-up|1|||
33352031|NCT00686881|62729436|FG000|Overall Study|Treatment-related adverse event|10|||
33352032|NCT00686881|62729437|FG001|Overall Study|Treatment-related adverse event|9|||
33352033|NCT00686881|62729436|FG000|Overall Study|Met discontinuation criteria|5|||
33352034|NCT00686881|62729437|FG001|Overall Study|Met discontinuation criteria|0|||
33352035|NCT00686881|62729436|FG000|Overall Study|Onset of malignant tumor|11|||
33352036|NCT00686881|62729437|FG001|Overall Study|Onset of malignant tumor|11|||
33471822|NCT03125200|62845654|FG001|Overall Study|Lack of Efficacy|0|||
33471823|NCT03125200|62845655|FG002|Overall Study|Lack of Efficacy|0|||
33471824|NCT03125200|62845656|FG003|Overall Study|Lack of Efficacy|1|||
33352037|NCT00686881|62729436|FG000|Overall Study|Lack of Efficacy|4|||
33352038|NCT00686881|62729437|FG001|Overall Study|Lack of Efficacy|3|||
33352039|NCT00686881|62729436|FG000|Overall Study|Physician Decision|1|||
33352040|NCT00686881|62729437|FG001|Overall Study|Physician Decision|0|||
33352041|NCT00686881|62729436|FG000|Overall Study|Circumstances of site|1|||
33352042|NCT00686881|62729437|FG001|Overall Study|Circumstances of site|1|||
33352043|NCT00686881|62729436|FG000|Overall Study|Did not meet protocol eligibility|1|||
33352044|NCT00686881|62729437|FG001|Overall Study|Did not meet protocol eligibility|0|||
33352045|NCT00686881|62729436|FG000|Overall Study|Irregular visits|1|||
33352046|NCT00686881|62729437|FG001|Overall Study|Irregular visits|0|||
33549008|NCT02901431|62940294|FG000|Main Treatment Part|Adverse Event|0|||
33352047|NCT00686881|62729436|FG000|Overall Study|Study discontinuation|35|||
33352048|NCT00686881|62729437|FG001|Overall Study|Study discontinuation|32|||
33352049|NCT00686881|62729436|FG000|Overall Study|Never received study drug|2|||
33352050|NCT00686881|62729437|FG001|Overall Study|Never received study drug|6|||
33352051|NCT00727714|62729445|FG000|Overall Study|Lost to Follow-up|2|||
33352052|NCT00727558|62729451|FG000|Overall Study|Lens issue|0|||
33352053|NCT00727558|62729452|FG001|Overall Study|Lens issue|1|||
33352054|NCT00727558|62729451|FG000|Overall Study|Adverse Event|0|||
33352055|NCT00727558|62729452|FG001|Overall Study|Adverse Event|1|||
33352056|NCT00727558|62729451|FG000|Overall Study|Subject unable to return for follow-up|1|||
33471825|NCT03125200|62845657|FG004|Overall Study|Lack of Efficacy|0|||
33352057|NCT00727558|62729452|FG001|Overall Study|Subject unable to return for follow-up|1|||
33352058|NCT00727558|62729451|FG000|Overall Study|Lost to Follow-up|1|||
33352059|NCT00727558|62729452|FG001|Overall Study|Lost to Follow-up|0|||
33352060|NCT00688597|62729461|FG000|Overall Study|Adverse Event|2|||
33352061|NCT00688597|62729462|FG001|Overall Study|Adverse Event|0|||
33352062|NCT00688597|62729463|FG002|Overall Study|Adverse Event|0|||
33352063|NCT00688597|62729461|FG000|Overall Study|Physician Decision|1|||
33352064|NCT00688597|62729462|FG001|Overall Study|Physician Decision|0|||
33352065|NCT00688597|62729463|FG002|Overall Study|Physician Decision|0|||
33352066|NCT00735904|62729471|FG000|Overall Study|Adverse Event|3|||
33471826|NCT03125200|62845658|FG005|Overall Study|Lack of Efficacy|0|||
33471827|NCT03125200|62845659|FG006|Overall Study|Lack of Efficacy|0|||
33471828|NCT03125200|62845653|FG000|Overall Study|Toxicity|0|||
33471829|NCT03125200|62845654|FG001|Overall Study|Toxicity|0|||
33471830|NCT03125200|62845655|FG002|Overall Study|Toxicity|0|||
33471831|NCT03125200|62845656|FG003|Overall Study|Toxicity|1|||
33471832|NCT03125200|62845657|FG004|Overall Study|Toxicity|0|||
33471833|NCT03125200|62845658|FG005|Overall Study|Toxicity|0|||
33471834|NCT03125200|62845659|FG006|Overall Study|Toxicity|0|||
33352067|NCT00735904|62729471|FG000|Overall Study|Death|20|||
33471835|NCT03125200|62845653|FG000|Overall Study|Consent Withdrawn by Subject|0|||
33471836|NCT03125200|62845654|FG001|Overall Study|Consent Withdrawn by Subject|1|||
33471837|NCT03125200|62845655|FG002|Overall Study|Consent Withdrawn by Subject|0|||
33352068|NCT00735904|62729471|FG000|Overall Study|Protocol Violation|1|||
33471838|NCT03125200|62845656|FG003|Overall Study|Consent Withdrawn by Subject|0|||
33471839|NCT03125200|62845657|FG004|Overall Study|Consent Withdrawn by Subject|1|||
33471840|NCT03125200|62845658|FG005|Overall Study|Consent Withdrawn by Subject|0|||
33471841|NCT03125200|62845659|FG006|Overall Study|Consent Withdrawn by Subject|1|||
33471842|NCT03132220|62845680|FG000|Overall Study|Lost to Follow-up|17|||
33471843|NCT03132220|62845681|FG001|Overall Study|Lost to Follow-up|8|||
33471844|NCT03132220|62845680|FG000|Overall Study|Withdrawal by Subject|1|||
33471845|NCT03132220|62845681|FG001|Overall Study|Withdrawal by Subject|4|||
33471846|NCT03119662|62845689|FG000|Overall Study|Withdrawal by Subject|0|||
33471847|NCT03119662|62845690|FG001|Overall Study|Withdrawal by Subject|1|||
33471848|NCT02728804|62845696|FG000|Overall Study|Ineligible|3|||
33471849|NCT02728804|62845696|FG000|Overall Study|Did not complete baseline questionnaire|9|||
33352069|NCT00735904|62729471|FG000|Overall Study|Withdrawal by Subject|1|||
33352070|NCT00735904|62729471|FG000|Overall Study|Study Terminated by Sponsor|5|||
33352071|NCT00735904|62729471|FG000|Overall Study|Other|8|||
33352072|NCT00688519|62729477|FG000|Overall Study|Adverse Event|2|||
33352073|NCT00688519|62729478|FG001|Overall Study|Adverse Event|3|||
33352074|NCT00688519|62729477|FG000|Overall Study|Lost to Follow-up|3|||
33352075|NCT00688519|62729478|FG001|Overall Study|Lost to Follow-up|3|||
33352076|NCT00688519|62729477|FG000|Overall Study|Lack of Efficacy|3|||
33352077|NCT00688519|62729478|FG001|Overall Study|Lack of Efficacy|1|||
33352078|NCT00688519|62729477|FG000|Overall Study|Withdrawal by Subject|7|||
33352079|NCT00688519|62729478|FG001|Overall Study|Withdrawal by Subject|6|||
33352080|NCT00688519|62729477|FG000|Overall Study|Prohibited medication|1|||
33352081|NCT00688519|62729478|FG001|Overall Study|Prohibited medication|0|||
33352082|NCT00688519|62729477|FG000|Overall Study|Non-compliance|0|||
33352083|NCT00688519|62729478|FG001|Overall Study|Non-compliance|1|||
33352084|NCT00688519|62729477|FG000|Overall Study|Subject moved out of state|1|||
33352085|NCT00688519|62729478|FG001|Overall Study|Subject moved out of state|0|||
33352086|NCT00688519|62729477|FG000|Overall Study|Investigator decision|1|||
33352087|NCT00688519|62729478|FG001|Overall Study|Investigator decision|0|||
33352088|NCT00688519|62729477|FG000|Overall Study|Subject moved out of area|1|||
33352089|NCT00688519|62729478|FG001|Overall Study|Subject moved out of area|0|||
33352090|NCT00688519|62729477|FG000|Overall Study|Pregnancy|0|||
33352091|NCT00688519|62729478|FG001|Overall Study|Pregnancy|1|||
33352092|NCT00721630|62729484|FG000|Overall Study|Participant found to be ineligible|1|||
33352093|NCT00686725|62729490|FG000|Overall Study|Adverse Event|1|||
33352094|NCT00686725|62729491|FG001|Overall Study|Adverse Event|1|||
33352095|NCT00686725|62729490|FG000|Overall Study|Progressive Disease|17|||
33352096|NCT00686725|62729491|FG001|Overall Study|Progressive Disease|23|||
33352097|NCT00686725|62729490|FG000|Overall Study|Lost to Follow-up|7|||
33352098|NCT00686725|62729491|FG001|Overall Study|Lost to Follow-up|5|||
33471850|NCT02728804|62845696|FG000|Overall Study|Death|99|||
33471851|NCT02699554|62845712|FG000|Overall Study|Lost to Follow-up|9|||
33471852|NCT03783780|62845726|FG000|Overall Study|Withdrawn prior to completion|1|||
33471853|NCT03783702|62845733|FG000|Overall Study|Lost to Follow-up|6|||
33471854|NCT03783702|62845734|FG001|Overall Study|Lost to Follow-up|8|||
33471855|NCT03783702|62845733|FG000|Overall Study|Protocol Violation|1|||
33471856|NCT03783702|62845734|FG001|Overall Study|Protocol Violation|3|||
33471857|NCT03575572|62845742|FG000|Overall Study|Withdrawal by Subject|2|||
33471858|NCT03575572|62845742|FG000|Overall Study|Physician Decision|2|||
33471859|NCT03116698|62845768|FG000|Overall Study|Adverse Event|1|||
33471860|NCT03116698|62845769|FG001|Overall Study|Adverse Event|1|||
33471861|NCT03116698|62845770|FG002|Overall Study|Adverse Event|1|||
33471862|NCT03116698|62845771|FG003|Overall Study|Adverse Event|0|||
33471863|NCT03116698|62845768|FG000|Overall Study|Withdrawal by Subject|1|||
33471864|NCT03116698|62845769|FG001|Overall Study|Withdrawal by Subject|4|||
33471865|NCT03116698|62845770|FG002|Overall Study|Withdrawal by Subject|5|||
33471866|NCT03116698|62845771|FG003|Overall Study|Withdrawal by Subject|2|||
33471867|NCT03116698|62845768|FG000|Overall Study|Lost to Follow-up|2|||
33471868|NCT03116698|62845769|FG001|Overall Study|Lost to Follow-up|0|||
33471869|NCT03116698|62845770|FG002|Overall Study|Lost to Follow-up|0|||
33471870|NCT03116698|62845771|FG003|Overall Study|Lost to Follow-up|0|||
33352099|NCT00686725|62729490|FG000|Overall Study|Death|6|||
33352100|NCT00686725|62729491|FG001|Overall Study|Death|3|||
33352101|NCT00686725|62729490|FG000|Overall Study|Withdrawal by Subject|13|||
33471871|NCT03116698|62845768|FG000|Overall Study|Physician Decision|1|||
33471872|NCT03116698|62845769|FG001|Overall Study|Physician Decision|1|||
33471873|NCT03116698|62845770|FG002|Overall Study|Physician Decision|0|||
33471874|NCT03116698|62845771|FG003|Overall Study|Physician Decision|0|||
33352102|NCT00686725|62729491|FG001|Overall Study|Withdrawal by Subject|4|||
33471875|NCT03116698|62845768|FG000|Overall Study|Protocol Violation|1|||
33471876|NCT03116698|62845769|FG001|Overall Study|Protocol Violation|0|||
33471877|NCT03116698|62845770|FG002|Overall Study|Protocol Violation|0|||
33471878|NCT03116698|62845771|FG003|Overall Study|Protocol Violation|0|||
33471879|NCT03116698|62845768|FG000|Overall Study|Death|0|||
33352103|NCT00686725|62729490|FG000|Overall Study|Protocol Violation|1|||
33352104|NCT00686725|62729491|FG001|Overall Study|Protocol Violation|3|||
33352105|NCT00686725|62729490|FG000|Overall Study|Other|1|||
33352106|NCT00686725|62729491|FG001|Overall Study|Other|3|||
33471880|NCT03116698|62845769|FG001|Overall Study|Death|0|||
33471881|NCT03116698|62845770|FG002|Overall Study|Death|2|||
33471882|NCT03116698|62845771|FG003|Overall Study|Death|0|||
33471883|NCT03116152|62845783|FG000|Overall Study|Disease Progression|49|||
33471884|NCT03116152|62845784|FG001|Overall Study|Disease Progression|47|||
33655153|NCT01894919|63069559|FG000|Overall Study|Withdrawal by Subject|1|||
33655154|NCT01894919|63069560|FG001|Overall Study|Withdrawal by Subject|0|||
33655155|NCT01894919|63069561|FG002|Overall Study|Withdrawal by Subject|0|||
33352107|NCT00727402|62729497|FG000|Overall Study|Physician Decision|116|||
33352108|NCT00727246|62729505|FG000|Overall Study|could not complete MRI|0|||
33352109|NCT00727246|62729506|FG001|Overall Study|could not complete MRI|1|||
33352110|NCT00727246|62729507|FG002|Overall Study|could not complete MRI|0|||
33352111|NCT00727246|62729508|FG003|Overall Study|could not complete MRI|1|||
33352112|NCT00727246|62729505|FG000|Overall Study|incidental finding|0|||
33352113|NCT00727246|62729506|FG001|Overall Study|incidental finding|0|||
33352114|NCT00727246|62729507|FG002|Overall Study|incidental finding|0|||
33352115|NCT00727246|62729508|FG003|Overall Study|incidental finding|1|||
33352116|NCT00727246|62729505|FG000|Overall Study|withdrawn|0|||
33352117|NCT00727246|62729506|FG001|Overall Study|withdrawn|0|||
33352118|NCT00727246|62729507|FG002|Overall Study|withdrawn|1|||
33352119|NCT00727246|62729508|FG003|Overall Study|withdrawn|0|||
33352120|NCT00686647|62729518|FG000|Overall Study|Lost to Follow-up|1|||
33352121|NCT00686647|62729518|FG000|Overall Study|Death|1|||
33352122|NCT00687973|62729525|FG000|Overall Study|Adverse Event|18|||
33471885|NCT03116152|62845783|FG000|Overall Study|Death|5|||
33655156|NCT01894919|63069562|FG003|Overall Study|Withdrawal by Subject|0|||
33655157|NCT01894919|63069563|FG004|Overall Study|Withdrawal by Subject|1|||
33655158|NCT01894919|63069564|FG005|Overall Study|Withdrawal by Subject|0|||
33655159|NCT01894919|63069565|FG006|Overall Study|Withdrawal by Subject|0|||
33655160|NCT01894919|63069566|FG007|Overall Study|Withdrawal by Subject|0|||
33655161|NCT01894919|63069567|FG008|Overall Study|Withdrawal by Subject|0|||
33655162|NCT01894919|63069568|FG009|Overall Study|Withdrawal by Subject|1|||
33655163|NCT01894919|63069569|FG010|Overall Study|Withdrawal by Subject|1|||
33655164|NCT01894919|63069570|FG011|Overall Study|Withdrawal by Subject|0|||
33655165|NCT01894919|63069571|FG012|Overall Study|Withdrawal by Subject|0|||
33655166|NCT01894919|63069559|FG000|Overall Study|Adverse Event|0|||
33655167|NCT01894919|63069560|FG001|Overall Study|Adverse Event|0|||
33655168|NCT01894919|63069561|FG002|Overall Study|Adverse Event|0|||
33655169|NCT01894919|63069562|FG003|Overall Study|Adverse Event|0|||
33655170|NCT01894919|63069563|FG004|Overall Study|Adverse Event|0|||
33655171|NCT01894919|63069564|FG005|Overall Study|Adverse Event|0|||
33655172|NCT01894919|63069565|FG006|Overall Study|Adverse Event|0|||
33655173|NCT01894919|63069566|FG007|Overall Study|Adverse Event|0|||
33655174|NCT01894919|63069567|FG008|Overall Study|Adverse Event|0|||
33655175|NCT01894919|63069568|FG009|Overall Study|Adverse Event|0|||
33655176|NCT01894919|63069569|FG010|Overall Study|Adverse Event|1|||
33655177|NCT01894919|63069570|FG011|Overall Study|Adverse Event|0|||
33655178|NCT01894919|63069571|FG012|Overall Study|Adverse Event|0|||
33655179|NCT01894919|63069559|FG000|Overall Study|Other-Unspecified|1|||
33655180|NCT01894919|63069560|FG001|Overall Study|Other-Unspecified|0|||
33352123|NCT00687973|62729526|FG001|Overall Study|Adverse Event|28|||
33352124|NCT00687973|62729525|FG000|Overall Study|Lack of Efficacy|2|||
33352125|NCT00687973|62729526|FG001|Overall Study|Lack of Efficacy|3|||
33471886|NCT03116152|62845784|FG001|Overall Study|Death|2|||
33471887|NCT03116152|62845783|FG000|Overall Study|Adverse Event|21|||
33471888|NCT03116152|62845784|FG001|Overall Study|Adverse Event|7|||
33471889|NCT03116152|62845783|FG000|Overall Study|Protocol Violation|2|||
33471890|NCT03116152|62845784|FG001|Overall Study|Protocol Violation|2|||
33471891|NCT03116152|62845783|FG000|Overall Study|Withdrawal by Subject|0|||
33655181|NCT01894919|63069561|FG002|Overall Study|Other-Unspecified|0|||
33655182|NCT01894919|63069562|FG003|Overall Study|Other-Unspecified|0|||
33655183|NCT01894919|63069563|FG004|Overall Study|Other-Unspecified|0|||
33655184|NCT01894919|63069564|FG005|Overall Study|Other-Unspecified|0|||
33655185|NCT01894919|63069565|FG006|Overall Study|Other-Unspecified|0|||
33655186|NCT01894919|63069566|FG007|Overall Study|Other-Unspecified|0|||
33655187|NCT01894919|63069567|FG008|Overall Study|Other-Unspecified|0|||
33655188|NCT01894919|63069568|FG009|Overall Study|Other-Unspecified|0|||
33352126|NCT00687973|62729525|FG000|Overall Study|Protocol Violation|1|||
33352127|NCT00687973|62729526|FG001|Overall Study|Protocol Violation|2|||
33352128|NCT00687973|62729525|FG000|Overall Study|Administrative Reasons|0|||
33352129|NCT00687973|62729526|FG001|Overall Study|Administrative Reasons|2|||
33352130|NCT00687973|62729525|FG000|Overall Study|Withdrawal by Subject|3|||
33352131|NCT00687973|62729526|FG001|Overall Study|Withdrawal by Subject|3|||
33352132|NCT00721396|62729537|FG000|Overall Study|Adverse Event|4|||
33352133|NCT00721396|62729538|FG001|Overall Study|Adverse Event|7|||
33352134|NCT00721396|62729539|FG002|Overall Study|Adverse Event|2|||
33352135|NCT00721396|62729540|FG003|Overall Study|Adverse Event|0|||
33352136|NCT00721396|62729537|FG000|Overall Study|Withdrawal by Subject|12|||
33352137|NCT00721396|62729538|FG001|Overall Study|Withdrawal by Subject|15|||
33352138|NCT00721396|62729539|FG002|Overall Study|Withdrawal by Subject|3|||
33352139|NCT00721396|62729540|FG003|Overall Study|Withdrawal by Subject|7|||
33352140|NCT00721396|62729537|FG000|Overall Study|Lost to Follow-up|7|||
33352141|NCT00721396|62729538|FG001|Overall Study|Lost to Follow-up|9|||
33352142|NCT00721396|62729539|FG002|Overall Study|Lost to Follow-up|3|||
33352143|NCT00721396|62729540|FG003|Overall Study|Lost to Follow-up|3|||
33352144|NCT00721396|62729537|FG000|Overall Study|Protocol Violation|4|||
33352145|NCT00721396|62729538|FG001|Overall Study|Protocol Violation|3|||
33352146|NCT00721396|62729539|FG002|Overall Study|Protocol Violation|1|||
33352147|NCT00721396|62729540|FG003|Overall Study|Protocol Violation|0|||
33352148|NCT00721396|62729537|FG000|Overall Study|Inappropriate enrollment|0|||
33352149|NCT00721396|62729538|FG001|Overall Study|Inappropriate enrollment|2|||
33352150|NCT00721396|62729539|FG002|Overall Study|Inappropriate enrollment|0|||
33352151|NCT00721396|62729540|FG003|Overall Study|Inappropriate enrollment|0|||
33352152|NCT00721396|62729537|FG000|Overall Study|Administrative reason|3|||
33352153|NCT00721396|62729538|FG001|Overall Study|Administrative reason|0|||
33352154|NCT00721396|62729539|FG002|Overall Study|Administrative reason|1|||
33352155|NCT00721396|62729540|FG003|Overall Study|Administrative reason|0|||
33352156|NCT00943826|62729557|FG000|Concurrent Phase|Adverse Event|50|||
33352157|NCT00943826|62729558|FG001|Concurrent Phase|Adverse Event|27|||
33352158|NCT00943826|62729557|FG000|Concurrent Phase|Withdrew consent|3|||
33352159|NCT00943826|62729558|FG001|Concurrent Phase|Withdrew consent|7|||
33352160|NCT00943826|62729557|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
33352161|NCT00943826|62729558|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
33352162|NCT00943826|62729557|FG000|Concurrent Phase|Administrative reasons|2|||
33352163|NCT00943826|62729558|FG001|Concurrent Phase|Administrative reasons|1|||
33352164|NCT00943826|62729557|FG000|Concurrent Phase|Protocol Violation|1|||
33352165|NCT00943826|62729558|FG001|Concurrent Phase|Protocol Violation|0|||
33352166|NCT00943826|62729557|FG000|Maintenance Phase|Adverse Event|31|||
33352167|NCT00943826|62729558|FG001|Maintenance Phase|Adverse Event|30|||
33352168|NCT00943826|62729557|FG000|Maintenance Phase|Withdrew consent|2|||
33352169|NCT00943826|62729558|FG001|Maintenance Phase|Withdrew consent|4|||
33352170|NCT00943826|62729557|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
33352171|NCT00943826|62729558|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
33352172|NCT00943826|62729557|FG000|Maintenance Phase|Administrative reasons|4|||
33352173|NCT00943826|62729558|FG001|Maintenance Phase|Administrative reasons|1|||
33352174|NCT00943826|62729557|FG000|Maintenance Phase|Failure to return|0|||
33352175|NCT00943826|62729558|FG001|Maintenance Phase|Failure to return|1|||
33352176|NCT00943826|62729557|FG000|Monotherapy Phase|Adverse Event|42|||
33352177|NCT00943826|62729558|FG001|Monotherapy Phase|Adverse Event|5|||
33352178|NCT00943826|62729557|FG000|Monotherapy Phase|Administrative reasons|11|||
33352179|NCT00943826|62729558|FG001|Monotherapy Phase|Administrative reasons|5|||
33352180|NCT00943826|62729557|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
33352181|NCT00943826|62729558|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
33352182|NCT00943826|62729557|FG000|Monotherapy Phase|Withdrew Consent|2|||
33352183|NCT00943826|62729558|FG001|Monotherapy Phase|Withdrew Consent|3|||
33352184|NCT00943826|62729557|FG000|Monotherapy Phase|Failure to return|2|||
33352185|NCT00943826|62729558|FG001|Monotherapy Phase|Failure to return|1|||
33352186|NCT00943826|62729557|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
33352187|NCT00943826|62729558|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
33352188|NCT00943826|62729557|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
33352189|NCT00943826|62729558|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
33352190|NCT00943826|62729557|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
33352191|NCT00943826|62729558|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
33352192|NCT00943826|62729557|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
33352193|NCT00943826|62729558|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
33352194|NCT01004003|62729574|FG000|Overall Study|Progressive disease|2|||
33352195|NCT01004003|62729575|FG001|Overall Study|Progressive disease|1|||
33471892|NCT03116152|62845784|FG001|Overall Study|Withdrawal by Subject|1|||
33352196|NCT01004003|62729576|FG002|Overall Study|Progressive disease|1|||
33352197|NCT01004003|62729577|FG003|Overall Study|Progressive disease|0|||
33352198|NCT01004003|62729578|FG004|Overall Study|Progressive disease|2|||
33352199|NCT01004003|62729579|FG005|Overall Study|Progressive disease|1|||
33352200|NCT01004003|62729580|FG006|Overall Study|Progressive disease|1|||
33352201|NCT01004003|62729581|FG007|Overall Study|Progressive disease|39|||
33352202|NCT01004003|62729582|FG008|Overall Study|Progressive disease|22|||
33352203|NCT01004003|62729574|FG000|Overall Study|Adverse Event|4|||
33352204|NCT01004003|62729575|FG001|Overall Study|Adverse Event|2|||
33352205|NCT01004003|62729576|FG002|Overall Study|Adverse Event|3|||
33352206|NCT01004003|62729577|FG003|Overall Study|Adverse Event|3|||
33352207|NCT01004003|62729578|FG004|Overall Study|Adverse Event|2|||
33352208|NCT01004003|62729579|FG005|Overall Study|Adverse Event|2|||
33352209|NCT01004003|62729580|FG006|Overall Study|Adverse Event|7|||
33352210|NCT01004003|62729581|FG007|Overall Study|Adverse Event|21|||
33352211|NCT01004003|62729582|FG008|Overall Study|Adverse Event|6|||
33352212|NCT01004003|62729574|FG000|Overall Study|Refused to continue taking trial med.|0|||
33352213|NCT01004003|62729575|FG001|Overall Study|Refused to continue taking trial med.|0|||
33352214|NCT01004003|62729576|FG002|Overall Study|Refused to continue taking trial med.|0|||
33352215|NCT01004003|62729577|FG003|Overall Study|Refused to continue taking trial med.|0|||
33352216|NCT01004003|62729578|FG004|Overall Study|Refused to continue taking trial med.|0|||
33352217|NCT01004003|62729579|FG005|Overall Study|Refused to continue taking trial med.|0|||
33352218|NCT01004003|62729580|FG006|Overall Study|Refused to continue taking trial med.|0|||
33352219|NCT01004003|62729581|FG007|Overall Study|Refused to continue taking trial med.|0|||
33352220|NCT01004003|62729582|FG008|Overall Study|Refused to continue taking trial med.|2|||
33352221|NCT01004003|62729574|FG000|Overall Study|Other|0|||
33352222|NCT01004003|62729575|FG001|Overall Study|Other|0|||
33352223|NCT01004003|62729576|FG002|Overall Study|Other|0|||
33352224|NCT01004003|62729577|FG003|Overall Study|Other|0|||
33352225|NCT01004003|62729578|FG004|Overall Study|Other|0|||
33352226|NCT01004003|62729579|FG005|Overall Study|Other|1|||
33352227|NCT01004003|62729580|FG006|Overall Study|Other|0|||
33352228|NCT01004003|62729581|FG007|Overall Study|Other|0|||
33352229|NCT01004003|62729582|FG008|Overall Study|Other|0|||
33352230|NCT00943670|62729604|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
33352231|NCT00943670|62729604|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
33352232|NCT00943670|62729604|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
33352233|NCT00943670|62729604|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
33352234|NCT00943670|62729604|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
33352235|NCT00943670|62729604|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
33352236|NCT00943670|62729604|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
33352237|NCT00943670|62729604|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
33352238|NCT00943670|62729604|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
33352239|NCT00943670|62729604|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
33352240|NCT00938366|62729621|FG000|Overall Study|Withdrawal by Subject|1|||
33352241|NCT00938366|62729622|FG001|Overall Study|Withdrawal by Subject|0|||
33352242|NCT00943592|62729628|FG000|Overall Study|Death|3|||
33352243|NCT00943124|62729632|FG000|Period 1|Withdrawal by Subject|1|||
33352244|NCT00943124|62729633|FG001|Period 1|Withdrawal by Subject|1|||
33352245|NCT00943124|62729632|FG000|Period 1|Did Not Follow Study Procedures|1|||
33352246|NCT00943124|62729633|FG001|Period 1|Did Not Follow Study Procedures|0|||
33352247|NCT00943124|62729632|FG000|Period 1|Personal Reasons|0|||
33352248|NCT00943124|62729633|FG001|Period 1|Personal Reasons|1|||
33352249|NCT00726622|62729641|FG000|Overall Study|Withdrawal by Subject|16|||
33352250|NCT00726622|62729642|FG001|Overall Study|Withdrawal by Subject|2|||
33352251|NCT00726622|62729641|FG000|Overall Study|Physician Decision|0|||
33352252|NCT00726622|62729642|FG001|Overall Study|Physician Decision|1|||
33352253|NCT00726622|62729641|FG000|Overall Study|Metastasis|2|||
33352254|NCT00726622|62729642|FG001|Overall Study|Metastasis|0|||
33352255|NCT00940316|62729651|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
33352256|NCT00940316|62729652|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
33352257|NCT00940316|62729653|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
33352258|NCT00940316|62729651|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
33352259|NCT00940316|62729652|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
33352260|NCT00940316|62729653|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
33352261|NCT00940316|62729651|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
33352262|NCT00940316|62729652|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
33352263|NCT00940316|62729653|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
33352264|NCT00940316|62729651|FG000|Treated After Cycle 5|Adverse Event|0|||
33352265|NCT00940316|62729652|FG001|Treated After Cycle 5|Adverse Event|0|||
33352266|NCT00940316|62729653|FG002|Treated After Cycle 5|Adverse Event|1|||
33352267|NCT00940316|62729651|FG000|Treated After Cycle 5|Progressive disease|0|||
33352268|NCT00940316|62729652|FG001|Treated After Cycle 5|Progressive disease|1|||
33352269|NCT00940316|62729653|FG002|Treated After Cycle 5|Progressive disease|0|||
33352270|NCT00726388|62729669|FG000|Overall Study|Withdrawal by Subject|5|||
33352271|NCT00726388|62729669|FG000|Overall Study|Adverse Event|3|||
33352272|NCT00726388|62729669|FG000|Overall Study|Lost to Follow-up|10|||
33352273|NCT00726388|62729669|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
33352274|NCT00726388|62729669|FG000|Overall Study|Other|5|||
33352275|NCT00726388|62729669|FG000|Overall Study|Enrolled, Not Treated|79|||
33352276|NCT00572455|62729687|FG000|Stage I (14 Days)|Adverse Event|0|||
33352277|NCT00572455|62729688|FG001|Stage I (14 Days)|Adverse Event|0|||
33352278|NCT00572455|62729689|FG002|Stage I (14 Days)|Adverse Event|0|||
33352279|NCT00572455|62729690|FG003|Stage I (14 Days)|Adverse Event|0|||
33352280|NCT00572455|62729691|FG004|Stage I (14 Days)|Adverse Event|0|||
33352281|NCT00572455|62729692|FG005|Stage I (14 Days)|Adverse Event|3|||
33352282|NCT00572455|62729693|FG006|Stage I (14 Days)|Adverse Event|0|||
33352283|NCT00572455|62729694|FG007|Stage I (14 Days)|Adverse Event|0|||
33352284|NCT00572455|62729695|FG008|Stage I (14 Days)|Adverse Event|0|||
33352285|NCT00572455|62729696|FG009|Stage I (14 Days)|Adverse Event|0|||
33352286|NCT00572455|62729697|FG010|Stage I (14 Days)|Adverse Event|0|||
33352287|NCT00572455|62729698|FG011|Stage I (14 Days)|Adverse Event|0|||
33352288|NCT00572455|62729699|FG012|Stage I (14 Days)|Adverse Event|0|||
33352289|NCT00572455|62729700|FG013|Stage I (14 Days)|Adverse Event|0|||
33352290|NCT00572455|62729687|FG000|Stage I (14 Days)|Other|0|||
33352291|NCT00572455|62729688|FG001|Stage I (14 Days)|Other|0|||
33352292|NCT00572455|62729689|FG002|Stage I (14 Days)|Other|0|||
33352293|NCT00572455|62729690|FG003|Stage I (14 Days)|Other|0|||
33352294|NCT00572455|62729691|FG004|Stage I (14 Days)|Other|1|||
33352295|NCT00572455|62729692|FG005|Stage I (14 Days)|Other|0|||
33352296|NCT00572455|62729693|FG006|Stage I (14 Days)|Other|0|||
33352297|NCT00572455|62729694|FG007|Stage I (14 Days)|Other|0|||
33352298|NCT00572455|62729695|FG008|Stage I (14 Days)|Other|0|||
33352299|NCT00572455|62729696|FG009|Stage I (14 Days)|Other|0|||
33352300|NCT00572455|62729697|FG010|Stage I (14 Days)|Other|0|||
33352301|NCT00572455|62729698|FG011|Stage I (14 Days)|Other|0|||
33352302|NCT00572455|62729699|FG012|Stage I (14 Days)|Other|0|||
33352303|NCT00572455|62729700|FG013|Stage I (14 Days)|Other|0|||
33352304|NCT00572455|62729687|FG000|Stage II (28 Days)|Adverse Event|0|||
33352305|NCT00572455|62729688|FG001|Stage II (28 Days)|Adverse Event|0|||
33352306|NCT00572455|62729689|FG002|Stage II (28 Days)|Adverse Event|0|||
33352307|NCT00572455|62729690|FG003|Stage II (28 Days)|Adverse Event|0|||
33352308|NCT00572455|62729691|FG004|Stage II (28 Days)|Adverse Event|0|||
33352309|NCT00572455|62729692|FG005|Stage II (28 Days)|Adverse Event|0|||
33352310|NCT00572455|62729693|FG006|Stage II (28 Days)|Adverse Event|0|||
33352311|NCT00572455|62729694|FG007|Stage II (28 Days)|Adverse Event|0|||
33352312|NCT00572455|62729695|FG008|Stage II (28 Days)|Adverse Event|1|||
33352313|NCT00572455|62729696|FG009|Stage II (28 Days)|Adverse Event|3|||
33352314|NCT00572455|62729697|FG010|Stage II (28 Days)|Adverse Event|3|||
33352315|NCT00572455|62729698|FG011|Stage II (28 Days)|Adverse Event|4|||
33352316|NCT00572455|62729699|FG012|Stage II (28 Days)|Adverse Event|5|||
33352317|NCT00572455|62729700|FG013|Stage II (28 Days)|Adverse Event|1|||
33352318|NCT00572455|62729687|FG000|Stage II (28 Days)|Death|0|||
33352319|NCT00572455|62729688|FG001|Stage II (28 Days)|Death|0|||
33352320|NCT00572455|62729689|FG002|Stage II (28 Days)|Death|0|||
33352321|NCT00572455|62729690|FG003|Stage II (28 Days)|Death|0|||
33352322|NCT00572455|62729691|FG004|Stage II (28 Days)|Death|0|||
33352323|NCT00572455|62729692|FG005|Stage II (28 Days)|Death|0|||
33352324|NCT00572455|62729693|FG006|Stage II (28 Days)|Death|0|||
33352325|NCT00572455|62729694|FG007|Stage II (28 Days)|Death|0|||
33352326|NCT00572455|62729695|FG008|Stage II (28 Days)|Death|1|||
33352327|NCT00572455|62729696|FG009|Stage II (28 Days)|Death|0|||
33352328|NCT00572455|62729697|FG010|Stage II (28 Days)|Death|0|||
33352329|NCT00572455|62729698|FG011|Stage II (28 Days)|Death|0|||
33352330|NCT00572455|62729699|FG012|Stage II (28 Days)|Death|0|||
33655189|NCT01894919|63069569|FG010|Overall Study|Other-Unspecified|0|||
33655190|NCT01894919|63069570|FG011|Overall Study|Other-Unspecified|0|||
33655191|NCT01894919|63069571|FG012|Overall Study|Other-Unspecified|0|||
33352331|NCT00572455|62729700|FG013|Stage II (28 Days)|Death|0|||
33352332|NCT00572455|62729687|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
33352333|NCT00572455|62729688|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
33352334|NCT00572455|62729689|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
33352335|NCT00572455|62729690|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
33352336|NCT00572455|62729691|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
33352337|NCT00572455|62729692|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
33352338|NCT00572455|62729693|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
33352339|NCT00572455|62729694|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
33352340|NCT00572455|62729695|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
33655192|NCT01894919|63069559|FG000|Overall Study|Lost to Follow-up|0|||
33352341|NCT00572455|62729696|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
33352342|NCT00572455|62729697|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
33352343|NCT00572455|62729698|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
33352344|NCT00572455|62729699|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
33352345|NCT00572455|62729700|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
33352346|NCT00572455|62729687|FG000|Stage II (28 Days)|Other|0|||
33352347|NCT00572455|62729688|FG001|Stage II (28 Days)|Other|0|||
33352348|NCT00572455|62729689|FG002|Stage II (28 Days)|Other|0|||
33352349|NCT00572455|62729690|FG003|Stage II (28 Days)|Other|0|||
33352350|NCT00572455|62729691|FG004|Stage II (28 Days)|Other|0|||
33352351|NCT00572455|62729692|FG005|Stage II (28 Days)|Other|0|||
33352352|NCT00572455|62729693|FG006|Stage II (28 Days)|Other|0|||
33352353|NCT00572455|62729694|FG007|Stage II (28 Days)|Other|0|||
33352354|NCT00572455|62729695|FG008|Stage II (28 Days)|Other|1|||
33352355|NCT00572455|62729696|FG009|Stage II (28 Days)|Other|0|||
33352356|NCT00572455|62729697|FG010|Stage II (28 Days)|Other|0|||
33352357|NCT00572455|62729698|FG011|Stage II (28 Days)|Other|0|||
33352358|NCT00572455|62729699|FG012|Stage II (28 Days)|Other|0|||
33352359|NCT00572455|62729700|FG013|Stage II (28 Days)|Other|0|||
33352360|NCT00572455|62729687|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
33352361|NCT00572455|62729688|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
33352362|NCT00572455|62729689|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
33352363|NCT00572455|62729690|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
33352364|NCT00572455|62729691|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
33352365|NCT00572455|62729692|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
33352366|NCT00572455|62729693|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
33352367|NCT00572455|62729694|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
33352368|NCT00572455|62729695|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
33352369|NCT00572455|62729696|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
33352370|NCT00572455|62729697|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
33352371|NCT00572455|62729698|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
33352372|NCT00572455|62729699|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
33352373|NCT00572455|62729700|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
33352374|NCT01003691|62729734|FG000|Overall Study|Adverse Event|0|||
33352375|NCT01003691|62729735|FG001|Overall Study|Adverse Event|0|||
33352376|NCT01003691|62729736|FG002|Overall Study|Adverse Event|0|||
33352377|NCT01003691|62729737|FG003|Overall Study|Adverse Event|1|||
33352378|NCT00686335|62729748|FG000|Run-in Period|Adverse Event|1|||
33352379|NCT00686335|62729748|FG000|Run-in Period|asthma exacerbation|1|||
33352380|NCT00686335|62729748|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
33352381|NCT01002989|62729754|FG000|Overall Study|exclusion criteria, no consent|5|||
33352382|NCT00685945|62729758|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
33352383|NCT01007123|62729772|FG000|Overall Study|Adverse Event|3|||
33352384|NCT01007123|62729773|FG001|Overall Study|Adverse Event|4|||
33352385|NCT01007123|62729774|FG002|Overall Study|Adverse Event|7|||
33352386|NCT01007123|62729775|FG003|Overall Study|Adverse Event|1|||
33352387|NCT01007123|62729772|FG000|Overall Study|Lack of Efficacy|1|||
33352388|NCT01007123|62729773|FG001|Overall Study|Lack of Efficacy|0|||
33352389|NCT01007123|62729774|FG002|Overall Study|Lack of Efficacy|1|||
33352390|NCT01007123|62729775|FG003|Overall Study|Lack of Efficacy|4|||
33352391|NCT01007123|62729772|FG000|Overall Study|Protocol Violation|1|||
33352392|NCT01007123|62729773|FG001|Overall Study|Protocol Violation|1|||
33352393|NCT01007123|62729774|FG002|Overall Study|Protocol Violation|2|||
33352394|NCT01007123|62729775|FG003|Overall Study|Protocol Violation|1|||
33352395|NCT01007123|62729772|FG000|Overall Study|Withdrawal by Subject|1|||
33352396|NCT01007123|62729773|FG001|Overall Study|Withdrawal by Subject|0|||
33352397|NCT01007123|62729774|FG002|Overall Study|Withdrawal by Subject|1|||
33352398|NCT01007123|62729775|FG003|Overall Study|Withdrawal by Subject|0|||
33352399|NCT01007123|62729772|FG000|Overall Study|Lost to Follow-up|0|||
33352400|NCT01007123|62729773|FG001|Overall Study|Lost to Follow-up|1|||
33352401|NCT01007123|62729774|FG002|Overall Study|Lost to Follow-up|0|||
33352402|NCT01007123|62729775|FG003|Overall Study|Lost to Follow-up|0|||
33352403|NCT00687739|62729790|FG000|Overall Study|Lost to Follow-up|2|||
33352404|NCT00687739|62729791|FG001|Overall Study|Lost to Follow-up|2|||
33352405|NCT00687739|62729792|FG002|Overall Study|Lost to Follow-up|1|||
33352406|NCT00687739|62729793|FG003|Overall Study|Lost to Follow-up|2|||
33352407|NCT00687739|62729790|FG000|Overall Study|Adverse Event|0|||
33352408|NCT00687739|62729791|FG001|Overall Study|Adverse Event|1|||
33352409|NCT00687739|62729792|FG002|Overall Study|Adverse Event|1|||
33471893|NCT03116152|62845783|FG000|Overall Study|Physician Decision|3|||
33471894|NCT03116152|62845784|FG001|Overall Study|Physician Decision|2|||
33471895|NCT03116152|62845783|FG000|Overall Study|other|11|||
33471896|NCT03116152|62845784|FG001|Overall Study|other|34|||
33471897|NCT00226499|62845795|FG000|Overall Study|Adverse Event|10|||
33471898|NCT00226499|62845796|FG001|Overall Study|Adverse Event|6|||
33471899|NCT00226499|62845797|FG002|Overall Study|Adverse Event|3|||
33471900|NCT00226499|62845795|FG000|Overall Study|Others|1064|||
33471901|NCT00226499|62845796|FG001|Overall Study|Others|1066|||
33471902|NCT00226499|62845797|FG002|Overall Study|Others|356|||
33352410|NCT00687739|62729793|FG003|Overall Study|Adverse Event|0|||
33352411|NCT01006889|62729805|FG000|Overall Study|Withdrawal by Subject|3|||
33352412|NCT01001429|62729812|FG000|Overall Study|surgery cancelled|0|||
33352413|NCT01001429|62729813|FG001|Overall Study|surgery cancelled|1|||
33471903|NCT01400776|62845811|FG000|Overall Study|Adverse Event|7|||
33352414|NCT01000961|62729843|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
33352415|NCT01000961|62729844|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33471904|NCT01400776|62845812|FG001|Overall Study|Adverse Event|2|||
33352416|NCT01000961|62729843|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
33352417|NCT01000961|62729844|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
33352418|NCT01000805|62729854|FG000|Overall Study|Adverse Event|21|||
33352419|NCT01000805|62729855|FG001|Overall Study|Adverse Event|9|||
33352420|NCT01000805|62729854|FG000|Overall Study|Lack of Efficacy|5|||
33352421|NCT01000805|62729855|FG001|Overall Study|Lack of Efficacy|16|||
33352422|NCT01000805|62729854|FG000|Overall Study|Lost to Follow-up|16|||
33352423|NCT01000805|62729855|FG001|Overall Study|Lost to Follow-up|21|||
33352424|NCT01000805|62729854|FG000|Overall Study|Physician Decision|0|||
33352425|NCT01000805|62729855|FG001|Overall Study|Physician Decision|1|||
33352426|NCT01000805|62729854|FG000|Overall Study|Protocol Violation|12|||
33352427|NCT01000805|62729855|FG001|Overall Study|Protocol Violation|8|||
33352428|NCT01000805|62729854|FG000|Overall Study|Withdrawal by Subject|16|||
33352429|NCT01000805|62729855|FG001|Overall Study|Withdrawal by Subject|6|||
33352430|NCT01000805|62729854|FG000|Overall Study|Sponsor Decision|0|||
33352431|NCT01000805|62729855|FG001|Overall Study|Sponsor Decision|1|||
33352432|NCT00684307|62729867|FG000|Overall Study|Adverse Event|11|||
33352433|NCT00684307|62729868|FG001|Overall Study|Adverse Event|6|||
33352434|NCT00684307|62729869|FG002|Overall Study|Adverse Event|15|||
33352435|NCT00684307|62729870|FG003|Overall Study|Adverse Event|16|||
33352436|NCT00684307|62729871|FG004|Overall Study|Adverse Event|8|||
33352437|NCT00684307|62729867|FG000|Overall Study|Development of increasing Liver Function|0|||
33352438|NCT00684307|62729868|FG001|Overall Study|Development of increasing Liver Function|2|||
33352439|NCT00684307|62729869|FG002|Overall Study|Development of increasing Liver Function|0|||
33352440|NCT00684307|62729870|FG003|Overall Study|Development of increasing Liver Function|1|||
33352441|NCT00684307|62729871|FG004|Overall Study|Development of increasing Liver Function|0|||
33352442|NCT00684307|62729867|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
33352443|NCT00684307|62729868|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
33352444|NCT00684307|62729869|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
33352445|NCT00684307|62729870|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
33352446|NCT00684307|62729871|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
33352447|NCT00684307|62729867|FG000|Overall Study|Incorrect enrolment or randomization|4|||
33352448|NCT00684307|62729868|FG001|Overall Study|Incorrect enrolment or randomization|0|||
33352449|NCT00684307|62729869|FG002|Overall Study|Incorrect enrolment or randomization|0|||
33352450|NCT00684307|62729870|FG003|Overall Study|Incorrect enrolment or randomization|0|||
33352451|NCT00684307|62729871|FG004|Overall Study|Incorrect enrolment or randomization|0|||
33352452|NCT00684307|62729867|FG000|Overall Study|Interupted IP for more than 7 days|0|||
33352453|NCT00684307|62729868|FG001|Overall Study|Interupted IP for more than 7 days|4|||
33352454|NCT00684307|62729869|FG002|Overall Study|Interupted IP for more than 7 days|1|||
33352455|NCT00684307|62729870|FG003|Overall Study|Interupted IP for more than 7 days|3|||
33352456|NCT00684307|62729871|FG004|Overall Study|Interupted IP for more than 7 days|3|||
33352457|NCT00684307|62729867|FG000|Overall Study|Severe non compliance to protocol|1|||
33352458|NCT00684307|62729868|FG001|Overall Study|Severe non compliance to protocol|0|||
33352459|NCT00684307|62729869|FG002|Overall Study|Severe non compliance to protocol|0|||
33352460|NCT00684307|62729870|FG003|Overall Study|Severe non compliance to protocol|1|||
33352461|NCT00684307|62729871|FG004|Overall Study|Severe non compliance to protocol|2|||
33352462|NCT00684307|62729867|FG000|Overall Study|Participant not willing to continue|7|||
33352463|NCT00684307|62729868|FG001|Overall Study|Participant not willing to continue|10|||
33352464|NCT00684307|62729869|FG002|Overall Study|Participant not willing to continue|11|||
33352465|NCT00684307|62729870|FG003|Overall Study|Participant not willing to continue|5|||
33352466|NCT00684307|62729871|FG004|Overall Study|Participant not willing to continue|8|||
33352467|NCT00684307|62729867|FG000|Overall Study|Criteria from the CSR|0|||
33352468|NCT00684307|62729868|FG001|Overall Study|Criteria from the CSR|0|||
33352469|NCT00684307|62729869|FG002|Overall Study|Criteria from the CSR|1|||
33352470|NCT00684307|62729870|FG003|Overall Study|Criteria from the CSR|3|||
33352471|NCT00684307|62729871|FG004|Overall Study|Criteria from the CSR|3|||
33352472|NCT00683917|62729886|FG000|Overall Study|Study prematurely terminated|10|||
33352473|NCT00687271|62729898|FG000|Overall Study|Adverse Event|1|||
33352474|NCT00687271|62729899|FG001|Overall Study|Adverse Event|3|||
33352475|NCT00687271|62729900|FG002|Overall Study|Adverse Event|1|||
33471905|NCT01400776|62845813|FG002|Overall Study|Adverse Event|9|||
33352476|NCT00687271|62729901|FG003|Overall Study|Adverse Event|0|||
33352477|NCT00687271|62729898|FG000|Overall Study|Lost to Follow-up|0|||
33352478|NCT00687271|62729899|FG001|Overall Study|Lost to Follow-up|1|||
33352479|NCT00687271|62729900|FG002|Overall Study|Lost to Follow-up|0|||
33352480|NCT00687271|62729901|FG003|Overall Study|Lost to Follow-up|0|||
33352481|NCT00687271|62729898|FG000|Overall Study|Protocol Violation|2|||
33352482|NCT00687271|62729899|FG001|Overall Study|Protocol Violation|1|||
33352483|NCT00687271|62729900|FG002|Overall Study|Protocol Violation|1|||
33352484|NCT00687271|62729901|FG003|Overall Study|Protocol Violation|0|||
33352485|NCT00687271|62729898|FG000|Overall Study|Withdrawal by Subject|0|||
33352486|NCT00687271|62729899|FG001|Overall Study|Withdrawal by Subject|1|||
33655193|NCT01894919|63069560|FG001|Overall Study|Lost to Follow-up|0|||
33352487|NCT00687271|62729900|FG002|Overall Study|Withdrawal by Subject|3|||
33471906|NCT01400776|62845814|FG003|Overall Study|Adverse Event|2|||
33655194|NCT01894919|63069561|FG002|Overall Study|Lost to Follow-up|0|||
33655195|NCT01894919|63069562|FG003|Overall Study|Lost to Follow-up|0|||
33352488|NCT00687271|62729901|FG003|Overall Study|Withdrawal by Subject|0|||
33352489|NCT04617275|62729919|FG000|Treatment Period|Adverse Event|1|||
33352490|NCT04617275|62729920|FG001|Treatment Period|Adverse Event|6|||
33352491|NCT04617275|62729921|FG002|Treatment Period|Adverse Event|4|||
33352492|NCT04617275|62729922|FG003|Treatment Period|Adverse Event|6|||
33352493|NCT04617275|62729923|FG004|Treatment Period|Adverse Event|7|||
33352494|NCT04617275|62729924|FG005|Treatment Period|Adverse Event|8|||
33352495|NCT04617275|62729925|FG006|Treatment Period|Adverse Event|0|||
33352496|NCT04617275|62729926|FG007|Treatment Period|Adverse Event|12|||
33352497|NCT04617275|62729919|FG000|Treatment Period|Lost to Follow-up|0|||
33352498|NCT04617275|62729920|FG001|Treatment Period|Lost to Follow-up|0|||
33352499|NCT04617275|62729921|FG002|Treatment Period|Lost to Follow-up|2|||
33352500|NCT04617275|62729922|FG003|Treatment Period|Lost to Follow-up|0|||
33352501|NCT04617275|62729923|FG004|Treatment Period|Lost to Follow-up|0|||
33352502|NCT04617275|62729924|FG005|Treatment Period|Lost to Follow-up|3|||
33352503|NCT04617275|62729925|FG006|Treatment Period|Lost to Follow-up|0|||
33352504|NCT04617275|62729926|FG007|Treatment Period|Lost to Follow-up|2|||
33352505|NCT04617275|62729919|FG000|Treatment Period|No longer meets eligibility criteria|0|||
33352506|NCT04617275|62729920|FG001|Treatment Period|No longer meets eligibility criteria|0|||
33352507|NCT04617275|62729921|FG002|Treatment Period|No longer meets eligibility criteria|0|||
33352508|NCT04617275|62729922|FG003|Treatment Period|No longer meets eligibility criteria|1|||
33352509|NCT04617275|62729923|FG004|Treatment Period|No longer meets eligibility criteria|0|||
33352510|NCT04617275|62729924|FG005|Treatment Period|No longer meets eligibility criteria|0|||
33352511|NCT04617275|62729925|FG006|Treatment Period|No longer meets eligibility criteria|0|||
33352512|NCT04617275|62729926|FG007|Treatment Period|No longer meets eligibility criteria|0|||
33352513|NCT04617275|62729919|FG000|Treatment Period|Other|0|||
33352514|NCT04617275|62729920|FG001|Treatment Period|Other|1|||
33352515|NCT04617275|62729921|FG002|Treatment Period|Other|0|||
33352516|NCT04617275|62729922|FG003|Treatment Period|Other|0|||
33352517|NCT04617275|62729923|FG004|Treatment Period|Other|0|||
33352518|NCT04617275|62729924|FG005|Treatment Period|Other|0|||
33352519|NCT04617275|62729925|FG006|Treatment Period|Other|0|||
33352520|NCT04617275|62729926|FG007|Treatment Period|Other|0|||
33352521|NCT04617275|62729919|FG000|Treatment Period|Withdrawal by Subject|2|||
33352522|NCT04617275|62729920|FG001|Treatment Period|Withdrawal by Subject|0|||
33352523|NCT04617275|62729921|FG002|Treatment Period|Withdrawal by Subject|0|||
33352524|NCT04617275|62729922|FG003|Treatment Period|Withdrawal by Subject|2|||
33352525|NCT04617275|62729923|FG004|Treatment Period|Withdrawal by Subject|2|||
33352526|NCT04617275|62729924|FG005|Treatment Period|Withdrawal by Subject|0|||
33352527|NCT04617275|62729925|FG006|Treatment Period|Withdrawal by Subject|1|||
33655196|NCT01894919|63069563|FG004|Overall Study|Lost to Follow-up|2|||
33655197|NCT01894919|63069564|FG005|Overall Study|Lost to Follow-up|0|||
33655198|NCT01894919|63069565|FG006|Overall Study|Lost to Follow-up|0|||
33655199|NCT01894919|63069566|FG007|Overall Study|Lost to Follow-up|0|||
33655200|NCT01894919|63069567|FG008|Overall Study|Lost to Follow-up|0|||
33655201|NCT01894919|63069568|FG009|Overall Study|Lost to Follow-up|0|||
33471907|NCT01400776|62845811|FG000|Overall Study|Lost to Follow-up|1|||
33471908|NCT01400776|62845812|FG001|Overall Study|Lost to Follow-up|0|||
33471909|NCT01400776|62845813|FG002|Overall Study|Lost to Follow-up|4|||
33471910|NCT01400776|62845814|FG003|Overall Study|Lost to Follow-up|1|||
33471911|NCT01400776|62845811|FG000|Overall Study|Withdrew Consent|4|||
33655202|NCT01894919|63069569|FG010|Overall Study|Lost to Follow-up|0|||
33471912|NCT01400776|62845812|FG001|Overall Study|Withdrew Consent|2|||
33655203|NCT01894919|63069570|FG011|Overall Study|Lost to Follow-up|0|||
33655204|NCT01894919|63069571|FG012|Overall Study|Lost to Follow-up|0|||
33352528|NCT04617275|62729926|FG007|Treatment Period|Withdrawal by Subject|2|||
33352529|NCT04617275|62729919|FG000|Follow-up Period|Adverse Event|1|||
33352530|NCT04617275|62729920|FG001|Follow-up Period|Adverse Event|1|||
33352531|NCT04617275|62729921|FG002|Follow-up Period|Adverse Event|2|||
33471913|NCT01400776|62845813|FG002|Overall Study|Withdrew Consent|6|||
33471914|NCT01400776|62845814|FG003|Overall Study|Withdrew Consent|1|||
33655205|NCT01894841|63069615|FG000|Overall Study|Withdrawal by Subject|9|||
33655206|NCT01894841|63069616|FG001|Overall Study|Withdrawal by Subject|4|||
33655207|NCT01894841|63069615|FG000|Overall Study|Withdrawn by investigator|2|||
33655208|NCT01894841|63069616|FG001|Overall Study|Withdrawn by investigator|2|||
33352532|NCT04617275|62729922|FG003|Follow-up Period|Adverse Event|3|||
33352533|NCT04617275|62729923|FG004|Follow-up Period|Adverse Event|4|||
33352534|NCT04617275|62729924|FG005|Follow-up Period|Adverse Event|3|||
33352535|NCT04617275|62729925|FG006|Follow-up Period|Adverse Event|0|||
33352536|NCT04617275|62729926|FG007|Follow-up Period|Adverse Event|3|||
33352537|NCT04617275|62729919|FG000|Follow-up Period|Lost to Follow-up|0|||
33352538|NCT04617275|62729920|FG001|Follow-up Period|Lost to Follow-up|1|||
33352539|NCT04617275|62729921|FG002|Follow-up Period|Lost to Follow-up|2|||
33352540|NCT04617275|62729922|FG003|Follow-up Period|Lost to Follow-up|0|||
33352541|NCT04617275|62729923|FG004|Follow-up Period|Lost to Follow-up|0|||
33352542|NCT04617275|62729924|FG005|Follow-up Period|Lost to Follow-up|4|||
33352543|NCT04617275|62729925|FG006|Follow-up Period|Lost to Follow-up|0|||
33352544|NCT04617275|62729926|FG007|Follow-up Period|Lost to Follow-up|3|||
33352545|NCT04617275|62729919|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
33352546|NCT04617275|62729920|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
33352547|NCT04617275|62729921|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
33352548|NCT04617275|62729922|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
33352549|NCT04617275|62729923|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
33352550|NCT04617275|62729924|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
33352551|NCT04617275|62729925|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
33352552|NCT04617275|62729926|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
33352553|NCT04617275|62729919|FG000|Follow-up Period|Other|0|||
33352554|NCT04617275|62729920|FG001|Follow-up Period|Other|1|||
33352555|NCT04617275|62729921|FG002|Follow-up Period|Other|0|||
33352556|NCT04617275|62729922|FG003|Follow-up Period|Other|0|||
33352557|NCT04617275|62729923|FG004|Follow-up Period|Other|0|||
33352558|NCT04617275|62729924|FG005|Follow-up Period|Other|0|||
33655209|NCT01894841|63069615|FG000|Overall Study|Lost to Follow-up|7|||
33655210|NCT01894841|63069616|FG001|Overall Study|Lost to Follow-up|3|||
33655211|NCT01894607|63069626|FG000|Overall Study|Ineligible|1|||
33655212|NCT01883453|63069632|FG000|Overall Study|No episode of common cold|25|||
33655213|NCT01883453|63069633|FG001|Overall Study|No episode of common cold|23|||
33655214|NCT01882985|63069667|FG000|Overall Study|Lost to Follow-up|1|||
33655215|NCT01882985|63069667|FG000|Overall Study|Withdrawal by Subject|1|||
33655216|NCT01893905|63069680|FG000|Overall Study|Withdrawal by Subject|1|||
33655217|NCT01893905|63069681|FG001|Overall Study|Withdrawal by Subject|0|||
33655218|NCT01893905|63069680|FG000|Overall Study|Adverse Event|9|||
33655219|NCT01893905|63069681|FG001|Overall Study|Adverse Event|3|||
33655220|NCT01893905|63069680|FG000|Overall Study|Lack of Efficacy|5|||
33352559|NCT04617275|62729925|FG006|Follow-up Period|Other|0|||
33352560|NCT04617275|62729926|FG007|Follow-up Period|Other|0|||
33352561|NCT04617275|62729919|FG000|Follow-up Period|Withdrawal by Subject|2|||
33352562|NCT04617275|62729920|FG001|Follow-up Period|Withdrawal by Subject|0|||
33352563|NCT04617275|62729921|FG002|Follow-up Period|Withdrawal by Subject|0|||
33352564|NCT04617275|62729922|FG003|Follow-up Period|Withdrawal by Subject|2|||
33352565|NCT04617275|62729923|FG004|Follow-up Period|Withdrawal by Subject|2|||
33352566|NCT04617275|62729924|FG005|Follow-up Period|Withdrawal by Subject|0|||
33352567|NCT04617275|62729925|FG006|Follow-up Period|Withdrawal by Subject|1|||
33352568|NCT04617275|62729926|FG007|Follow-up Period|Withdrawal by Subject|2|||
33352569|NCT01031537|62729961|FG000|Overall Study|medical reasons not related to study|3|||
33352570|NCT01031537|62729961|FG000|Overall Study|Lack of Efficacy|1|||
33352571|NCT01031537|62729961|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
33352572|NCT01031537|62729961|FG000|Overall Study|moved, met exclusion criteria|10|||
33352573|NCT01031537|62729961|FG000|Overall Study|Withdrawal by Subject|5|||
33352574|NCT01031537|62729961|FG000|Overall Study|PI removal, no longer met eligibility|12|||
33352575|NCT01031381|62729965|FG000|Overall Study|Physician Decision|3|||
33352576|NCT01031381|62729965|FG000|Overall Study|Withdrawal by Subject|6|||
33352577|NCT00685399|62729977|FG000|Treatment Period 1|Withdrawal by Subject|2|||
33352578|NCT00685399|62729978|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33352579|NCT00685399|62729979|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33352580|NCT00685399|62729980|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33352581|NCT00685399|62729981|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33352582|NCT00685399|62729982|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33352583|NCT00685399|62729983|FG006|Treatment Period 1|Withdrawal by Subject|0|||
33352584|NCT00685399|62729984|FG007|Treatment Period 1|Withdrawal by Subject|0|||
33352585|NCT00685399|62729977|FG000|Treatment Period 1|Protocol Violation|1|||
33655221|NCT01893905|63069681|FG001|Overall Study|Lack of Efficacy|7|||
33655222|NCT01893905|63069680|FG000|Overall Study|Lost to Follow-up|1|||
33655223|NCT01893905|63069681|FG001|Overall Study|Lost to Follow-up|0|||
33352586|NCT00685399|62729978|FG001|Treatment Period 1|Protocol Violation|0|||
33352587|NCT00685399|62729979|FG002|Treatment Period 1|Protocol Violation|0|||
33352588|NCT00685399|62729980|FG003|Treatment Period 1|Protocol Violation|0|||
33352589|NCT00685399|62729981|FG004|Treatment Period 1|Protocol Violation|0|||
33352590|NCT00685399|62729982|FG005|Treatment Period 1|Protocol Violation|0|||
33352591|NCT00685399|62729983|FG006|Treatment Period 1|Protocol Violation|0|||
33352592|NCT00685399|62729984|FG007|Treatment Period 1|Protocol Violation|0|||
33352593|NCT00685399|62729977|FG000|Treatment Period 1|Administrative|2|||
33352594|NCT00685399|62729978|FG001|Treatment Period 1|Administrative|0|||
33352595|NCT00685399|62729979|FG002|Treatment Period 1|Administrative|0|||
33352596|NCT00685399|62729980|FG003|Treatment Period 1|Administrative|0|||
33352597|NCT00685399|62729981|FG004|Treatment Period 1|Administrative|0|||
33352598|NCT00685399|62729982|FG005|Treatment Period 1|Administrative|0|||
33352599|NCT00685399|62729983|FG006|Treatment Period 1|Administrative|0|||
33352600|NCT00685399|62729984|FG007|Treatment Period 1|Administrative|0|||
33352601|NCT00685399|62729977|FG000|Treatment Period 1|Lack of Efficacy|1|||
33352602|NCT00685399|62729978|FG001|Treatment Period 1|Lack of Efficacy|0|||
33352603|NCT00685399|62729979|FG002|Treatment Period 1|Lack of Efficacy|0|||
33352604|NCT00685399|62729980|FG003|Treatment Period 1|Lack of Efficacy|0|||
33352605|NCT00685399|62729981|FG004|Treatment Period 1|Lack of Efficacy|0|||
33352606|NCT00685399|62729982|FG005|Treatment Period 1|Lack of Efficacy|0|||
33352607|NCT00685399|62729983|FG006|Treatment Period 1|Lack of Efficacy|0|||
33352608|NCT00685399|62729984|FG007|Treatment Period 1|Lack of Efficacy|0|||
33352609|NCT00685399|62729977|FG000|Treatment Period 2|Administrative Problems|0|||
33352610|NCT00685399|62729978|FG001|Treatment Period 2|Administrative Problems|2|||
33352611|NCT00685399|62729979|FG002|Treatment Period 2|Administrative Problems|1|||
33352612|NCT00685399|62729980|FG003|Treatment Period 2|Administrative Problems|0|||
33352613|NCT00685399|62729981|FG004|Treatment Period 2|Administrative Problems|0|||
33352614|NCT00685399|62729982|FG005|Treatment Period 2|Administrative Problems|0|||
33352615|NCT00685399|62729983|FG006|Treatment Period 2|Administrative Problems|0|||
33352616|NCT00685399|62729984|FG007|Treatment Period 2|Administrative Problems|0|||
33352617|NCT00685399|62729977|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33352618|NCT00685399|62729978|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33352619|NCT00685399|62729979|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33352620|NCT00685399|62729980|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33352621|NCT00685399|62729981|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33352622|NCT00685399|62729982|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33352623|NCT00685399|62729983|FG006|Treatment Period 2|Withdrawal by Subject|0|||
33352624|NCT00685399|62729984|FG007|Treatment Period 2|Withdrawal by Subject|2|||
33352625|NCT00685399|62729977|FG000|Treatment Period 2|Adverse Event|0|||
33352626|NCT00685399|62729978|FG001|Treatment Period 2|Adverse Event|0|||
33352627|NCT00685399|62729979|FG002|Treatment Period 2|Adverse Event|0|||
33352628|NCT00685399|62729980|FG003|Treatment Period 2|Adverse Event|0|||
33352629|NCT00685399|62729981|FG004|Treatment Period 2|Adverse Event|0|||
33352630|NCT00685399|62729982|FG005|Treatment Period 2|Adverse Event|1|||
33352631|NCT00685399|62729983|FG006|Treatment Period 2|Adverse Event|0|||
33352632|NCT00685399|62729984|FG007|Treatment Period 2|Adverse Event|0|||
33352633|NCT00685399|62729977|FG000|Treatment Period 2|Lack of Efficacy|0|||
33352634|NCT00685399|62729978|FG001|Treatment Period 2|Lack of Efficacy|10|||
33352635|NCT00685399|62729979|FG002|Treatment Period 2|Lack of Efficacy|2|||
33352636|NCT00685399|62729980|FG003|Treatment Period 2|Lack of Efficacy|0|||
33352637|NCT00685399|62729981|FG004|Treatment Period 2|Lack of Efficacy|0|||
33352638|NCT00685399|62729982|FG005|Treatment Period 2|Lack of Efficacy|1|||
33471915|NCT01400776|62845811|FG000|Overall Study|Protocol Deviation|6|||
33471916|NCT01400776|62845812|FG001|Overall Study|Protocol Deviation|1|||
33471917|NCT01400776|62845813|FG002|Overall Study|Protocol Deviation|5|||
33471918|NCT01400776|62845814|FG003|Overall Study|Protocol Deviation|2|||
33471919|NCT01400776|62845811|FG000|Overall Study|Reason not Specified|3|||
33471920|NCT01400776|62845812|FG001|Overall Study|Reason not Specified|0|||
33471921|NCT01400776|62845813|FG002|Overall Study|Reason not Specified|4|||
33471922|NCT01400776|62845814|FG003|Overall Study|Reason not Specified|3|||
33471923|NCT03131596|62845826|FG000|Overall Study|Protocol Violation|3|||
33471924|NCT03131596|62845827|FG001|Overall Study|Protocol Violation|3|||
33471925|NCT03131596|62845826|FG000|Overall Study|Lost to Follow-up|3|||
33471926|NCT03131596|62845827|FG001|Overall Study|Lost to Follow-up|0|||
33471927|NCT00255047|62845841|FG000|Overall Study|Serious Adverse Events|2|||
33471928|NCT00255047|62845842|FG001|Overall Study|Serious Adverse Events|1|||
33471929|NCT00255047|62845843|FG002|Overall Study|Serious Adverse Events|2|||
33471930|NCT00255047|62845844|FG003|Overall Study|Serious Adverse Events|1|||
33352639|NCT00685399|62729983|FG006|Treatment Period 2|Lack of Efficacy|0|||
33352640|NCT00685399|62729984|FG007|Treatment Period 2|Lack of Efficacy|0|||
33352641|NCT00685399|62729977|FG000|Extension|Administrative Issues|0|||
33352642|NCT00685399|62729978|FG001|Extension|Administrative Issues|0|||
33352643|NCT00685399|62729979|FG002|Extension|Administrative Issues|0|||
33352644|NCT00685399|62729980|FG003|Extension|Administrative Issues|1|||
33352645|NCT00685399|62729981|FG004|Extension|Administrative Issues|0|||
33352646|NCT00685399|62729982|FG005|Extension|Administrative Issues|0|||
33352647|NCT00685399|62729983|FG006|Extension|Administrative Issues|0|||
33352648|NCT00685399|62729984|FG007|Extension|Administrative Issues|0|||
33352649|NCT00685399|62729977|FG000|Extension|Withdrawal by Subject|0|||
33352650|NCT00685399|62729978|FG001|Extension|Withdrawal by Subject|0|||
33352651|NCT00685399|62729979|FG002|Extension|Withdrawal by Subject|0|||
33352652|NCT00685399|62729980|FG003|Extension|Withdrawal by Subject|1|||
33352653|NCT00685399|62729981|FG004|Extension|Withdrawal by Subject|0|||
33352654|NCT00685399|62729982|FG005|Extension|Withdrawal by Subject|0|||
33352655|NCT00685399|62729983|FG006|Extension|Withdrawal by Subject|0|||
33352656|NCT00685399|62729984|FG007|Extension|Withdrawal by Subject|0|||
33352657|NCT00685399|62729977|FG000|Extension|Protocol Violation|0|||
33471931|NCT00255047|62845841|FG000|Overall Study|Adverse Event|0|||
33471932|NCT00255047|62845842|FG001|Overall Study|Adverse Event|3|||
33352658|NCT00685399|62729978|FG001|Extension|Protocol Violation|0|||
33352659|NCT00685399|62729979|FG002|Extension|Protocol Violation|0|||
33352660|NCT00685399|62729980|FG003|Extension|Protocol Violation|1|||
33352661|NCT00685399|62729981|FG004|Extension|Protocol Violation|0|||
33471933|NCT00255047|62845843|FG002|Overall Study|Adverse Event|2|||
33352662|NCT00685399|62729982|FG005|Extension|Protocol Violation|0|||
33352663|NCT00685399|62729983|FG006|Extension|Protocol Violation|0|||
33352664|NCT00685399|62729984|FG007|Extension|Protocol Violation|0|||
33471934|NCT00255047|62845844|FG003|Overall Study|Adverse Event|1|||
33352665|NCT00685399|62729977|FG000|Extension|Lack of Efficacy|0|||
33471935|NCT00255047|62845841|FG000|Overall Study|Protocol Violation|13|||
33352666|NCT00685399|62729978|FG001|Extension|Lack of Efficacy|0|||
33352667|NCT00685399|62729979|FG002|Extension|Lack of Efficacy|0|||
33352668|NCT00685399|62729980|FG003|Extension|Lack of Efficacy|2|||
33352669|NCT00685399|62729981|FG004|Extension|Lack of Efficacy|0|||
33352670|NCT00685399|62729982|FG005|Extension|Lack of Efficacy|0|||
33352671|NCT00685399|62729983|FG006|Extension|Lack of Efficacy|0|||
33352672|NCT00685399|62729984|FG007|Extension|Lack of Efficacy|0|||
33352673|NCT00685399|62729977|FG000|Extension|Adverse Event|0|||
33352674|NCT00685399|62729978|FG001|Extension|Adverse Event|0|||
33352675|NCT00685399|62729979|FG002|Extension|Adverse Event|0|||
33352676|NCT00685399|62729980|FG003|Extension|Adverse Event|2|||
33352677|NCT00685399|62729981|FG004|Extension|Adverse Event|0|||
33352678|NCT00685399|62729982|FG005|Extension|Adverse Event|0|||
33352679|NCT00685399|62729983|FG006|Extension|Adverse Event|0|||
33352680|NCT00685399|62729984|FG007|Extension|Adverse Event|0|||
33352681|NCT00685165|62730011|FG000|Washout Period of 14 Days|Adverse Event|1|||
33352682|NCT00685165|62730012|FG001|Washout Period of 14 Days|Adverse Event|0|||
33352683|NCT00683449|62730023|FG000|Overall Study|Lost to Follow-up|0|||
33352684|NCT00683449|62730024|FG001|Overall Study|Lost to Follow-up|1|||
33352685|NCT00683449|62730025|FG002|Overall Study|Lost to Follow-up|0|||
33352686|NCT00683449|62730026|FG003|Overall Study|Lost to Follow-up|0|||
33352687|NCT00683449|62730027|FG004|Overall Study|Lost to Follow-up|0|||
33352688|NCT00683293|62730046|FG000|Overall Study|Withdrawal by Subject|2|||
33352689|NCT00683293|62730047|FG001|Overall Study|Withdrawal by Subject|3|||
33352690|NCT00726232|62730059|FG000|Initial Phase (Dose-finding)|Death|0|||
33352691|NCT00726232|62730060|FG001|Initial Phase (Dose-finding)|Death|0|||
33352692|NCT00726232|62730061|FG002|Initial Phase (Dose-finding)|Death|0|||
33352693|NCT00726232|62730062|FG003|Initial Phase (Dose-finding)|Death|0|||
33352694|NCT00726232|62730063|FG004|Initial Phase (Dose-finding)|Death|1|||
33352695|NCT00726232|62730064|FG005|Initial Phase (Dose-finding)|Death|0|||
33352696|NCT00726232|62730065|FG006|Initial Phase (Dose-finding)|Death|0|||
33352697|NCT00726232|62730066|FG007|Initial Phase (Dose-finding)|Death|0|||
33352698|NCT00726232|62730059|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
33352699|NCT00726232|62730060|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
33352700|NCT00726232|62730061|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
33352701|NCT00726232|62730062|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
33352702|NCT00726232|62730063|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
33352703|NCT00726232|62730064|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
33352704|NCT00726232|62730065|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
33352705|NCT00726232|62730066|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
33352706|NCT00726232|62730059|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
33352707|NCT00726232|62730060|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
33352708|NCT00726232|62730061|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
33352709|NCT00726232|62730062|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
33352710|NCT00726232|62730063|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
33352711|NCT00726232|62730064|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
33352712|NCT00726232|62730065|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
33352713|NCT00726232|62730066|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
33352714|NCT00726232|62730059|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
33352715|NCT00726232|62730060|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
33352716|NCT00726232|62730061|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
33352717|NCT00726232|62730062|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
33352718|NCT00726232|62730063|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
33352719|NCT00726232|62730064|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
33352720|NCT00726232|62730065|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
33352721|NCT00726232|62730066|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
33352722|NCT00726232|62730059|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
33352723|NCT00726232|62730060|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
33352724|NCT00726232|62730061|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
33352725|NCT00726232|62730062|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
33352726|NCT00726232|62730063|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
33352727|NCT00726232|62730064|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
33352728|NCT00726232|62730065|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
33352729|NCT00726232|62730066|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
33352730|NCT00726232|62730059|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
33352731|NCT00726232|62730060|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
33352732|NCT00726232|62730061|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
33352733|NCT00726232|62730062|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
33352734|NCT00726232|62730063|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
33352735|NCT00726232|62730064|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
33352736|NCT00726232|62730065|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
33352737|NCT00726232|62730066|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
33352738|NCT00726232|62730059|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
33352739|NCT00726232|62730060|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
33352740|NCT00726232|62730061|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
33352741|NCT00726232|62730062|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
33352742|NCT00726232|62730063|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
33352743|NCT00726232|62730064|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
33352744|NCT00726232|62730065|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
33352745|NCT00726232|62730066|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
33352746|NCT00726232|62730059|FG000|Expansion Phase|Death|0|||
33352747|NCT00726232|62730060|FG001|Expansion Phase|Death|0|||
33352748|NCT00726232|62730061|FG002|Expansion Phase|Death|0|||
33352749|NCT00726232|62730062|FG003|Expansion Phase|Death|0|||
33352750|NCT00726232|62730063|FG004|Expansion Phase|Death|0|||
33352751|NCT00726232|62730064|FG005|Expansion Phase|Death|0|||
33352752|NCT00726232|62730065|FG006|Expansion Phase|Death|0|||
33352753|NCT00726232|62730066|FG007|Expansion Phase|Death|1|||
33352754|NCT00726232|62730059|FG000|Expansion Phase|Adverse Event|0|||
33352755|NCT00726232|62730060|FG001|Expansion Phase|Adverse Event|0|||
33352756|NCT00726232|62730061|FG002|Expansion Phase|Adverse Event|0|||
33352757|NCT00726232|62730062|FG003|Expansion Phase|Adverse Event|0|||
33352758|NCT00726232|62730063|FG004|Expansion Phase|Adverse Event|0|||
33352759|NCT00726232|62730064|FG005|Expansion Phase|Adverse Event|0|||
33352760|NCT00726232|62730065|FG006|Expansion Phase|Adverse Event|6|||
33352761|NCT00726232|62730066|FG007|Expansion Phase|Adverse Event|11|||
33352762|NCT00726232|62730059|FG000|Expansion Phase|Withdrawal by Subject|0|||
33352763|NCT00726232|62730060|FG001|Expansion Phase|Withdrawal by Subject|0|||
33352764|NCT00726232|62730061|FG002|Expansion Phase|Withdrawal by Subject|0|||
33352765|NCT00726232|62730062|FG003|Expansion Phase|Withdrawal by Subject|0|||
33352766|NCT00726232|62730063|FG004|Expansion Phase|Withdrawal by Subject|0|||
33352767|NCT00726232|62730064|FG005|Expansion Phase|Withdrawal by Subject|0|||
33352768|NCT00726232|62730065|FG006|Expansion Phase|Withdrawal by Subject|2|||
33352769|NCT00726232|62730066|FG007|Expansion Phase|Withdrawal by Subject|3|||
33352770|NCT00726232|62730059|FG000|Expansion Phase|Disease progression|0|||
33352771|NCT00726232|62730060|FG001|Expansion Phase|Disease progression|0|||
33352772|NCT00726232|62730061|FG002|Expansion Phase|Disease progression|0|||
33352773|NCT00726232|62730062|FG003|Expansion Phase|Disease progression|0|||
33471936|NCT00255047|62845842|FG001|Overall Study|Protocol Violation|13|||
33471937|NCT00255047|62845843|FG002|Overall Study|Protocol Violation|16|||
33471938|NCT00255047|62845844|FG003|Overall Study|Protocol Violation|20|||
33471939|NCT00255047|62845841|FG000|Overall Study|Lost to Follow-up|9|||
33471940|NCT00255047|62845842|FG001|Overall Study|Lost to Follow-up|8|||
33352774|NCT00726232|62730063|FG004|Expansion Phase|Disease progression|0|||
33352775|NCT00726232|62730064|FG005|Expansion Phase|Disease progression|0|||
33352776|NCT00726232|62730065|FG006|Expansion Phase|Disease progression|4|||
33352777|NCT00726232|62730066|FG007|Expansion Phase|Disease progression|0|||
33352778|NCT00726232|62730059|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
33352779|NCT00726232|62730060|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
33352780|NCT00726232|62730061|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
33352781|NCT00726232|62730062|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
33352782|NCT00726232|62730063|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
33352783|NCT00726232|62730064|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
33352784|NCT00726232|62730065|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
33471941|NCT00255047|62845843|FG002|Overall Study|Lost to Follow-up|5|||
33471942|NCT00255047|62845844|FG003|Overall Study|Lost to Follow-up|6|||
33471943|NCT00255047|62845841|FG000|Overall Study|Withdrawal by Subject|24|||
33352785|NCT00726232|62730066|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
33352786|NCT00726232|62730059|FG000|Expansion Phase|Per Investigator: lack of response|0|||
33352787|NCT00726232|62730060|FG001|Expansion Phase|Per Investigator: lack of response|0|||
33352788|NCT00726232|62730061|FG002|Expansion Phase|Per Investigator: lack of response|0|||
33352789|NCT00726232|62730062|FG003|Expansion Phase|Per Investigator: lack of response|0|||
33352790|NCT00726232|62730063|FG004|Expansion Phase|Per Investigator: lack of response|0|||
33352791|NCT00726232|62730064|FG005|Expansion Phase|Per Investigator: lack of response|0|||
33352792|NCT00726232|62730065|FG006|Expansion Phase|Per Investigator: lack of response|1|||
33352793|NCT00726232|62730066|FG007|Expansion Phase|Per Investigator: lack of response|7|||
33471944|NCT00255047|62845842|FG001|Overall Study|Withdrawal by Subject|23|||
33471945|NCT00255047|62845843|FG002|Overall Study|Withdrawal by Subject|25|||
33471946|NCT00255047|62845844|FG003|Overall Study|Withdrawal by Subject|18|||
33471947|NCT00225251|62845856|FG000|Overall Study|Withdrawal by Subject|1|||
33352794|NCT00726232|62730059|FG000|Expansion Phase|Unspecified reason|0|||
33352795|NCT00726232|62730060|FG001|Expansion Phase|Unspecified reason|0|||
33352796|NCT00726232|62730061|FG002|Expansion Phase|Unspecified reason|0|||
33352797|NCT00726232|62730062|FG003|Expansion Phase|Unspecified reason|0|||
33352798|NCT00726232|62730063|FG004|Expansion Phase|Unspecified reason|0|||
33352799|NCT00726232|62730064|FG005|Expansion Phase|Unspecified reason|0|||
33352800|NCT00726232|62730065|FG006|Expansion Phase|Unspecified reason|1|||
33352801|NCT00726232|62730066|FG007|Expansion Phase|Unspecified reason|0|||
33352802|NCT00720382|62730087|FG000|Overall Study|Adverse Event|54|||
33352803|NCT00720382|62730088|FG001|Overall Study|Adverse Event|17|||
33352804|NCT00720382|62730087|FG000|Overall Study|Lack of Efficacy|18|||
33352805|NCT00720382|62730088|FG001|Overall Study|Lack of Efficacy|7|||
33352806|NCT00720382|62730087|FG000|Overall Study|Non-Compliance|15|||
33352807|NCT00720382|62730088|FG001|Overall Study|Non-Compliance|5|||
33352808|NCT00720382|62730087|FG000|Overall Study|Withdrawal by Subject|47|||
33352809|NCT00720382|62730088|FG001|Overall Study|Withdrawal by Subject|11|||
33352810|NCT00720382|62730087|FG000|Overall Study|Lost to Follow-up|28|||
33352811|NCT00720382|62730088|FG001|Overall Study|Lost to Follow-up|14|||
33352812|NCT00720382|62730087|FG000|Overall Study|administrative|14|||
33352813|NCT00720382|62730088|FG001|Overall Study|administrative|5|||
33352814|NCT00720226|62730096|FG000|Overall Study|Withdrawal by Subject|7|||
33352815|NCT00720226|62730097|FG001|Overall Study|Withdrawal by Subject|4|||
33352816|NCT00725920|62730105|FG000|Overall Study|Lack of Efficacy|3|||
33352817|NCT00725920|62730106|FG001|Overall Study|Lack of Efficacy|6|||
33352818|NCT00725842|62730112|FG000|Overall Study|Lost to Follow-up|19|||
33352819|NCT00725842|62730112|FG000|Overall Study|Death|1|||
33352820|NCT00725842|62730112|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
33352821|NCT00725842|62730112|FG000|Overall Study|Consent date prior to study start date|5|||
33352822|NCT00725842|62730112|FG000|Overall Study|Inclusion criterion not met|1|||
33352823|NCT00725842|62730112|FG000|Overall Study|No Visit 1 data|1|||
33352824|NCT00725764|62730116|FG000|Overall Study|Withdrawal by Subject|2|||
33352825|NCT00725764|62730116|FG000|Overall Study|Physician Decision|1|||
33352826|NCT00725764|62730116|FG000|Overall Study|Progressive Disease|7|||
33352827|NCT00725764|62730116|FG000|Overall Study|Lost to Follow-up|1|||
33352828|NCT00725764|62730116|FG000|Overall Study|Death|1|||
33352829|NCT00725764|62730116|FG000|Overall Study|Participant non compliant with protocol|1|||
33352830|NCT00725764|62730116|FG000|Overall Study|Decline in performance status|1|||
33352831|NCT00725608|62730121|FG000|Overall Study|Lost to Follow-up|60|||
33471948|NCT00225251|62845857|FG001|Overall Study|Withdrawal by Subject|1|||
33655224|NCT01893905|63069680|FG000|Overall Study|Protocol Violation|6|||
33655225|NCT01893905|63069681|FG001|Overall Study|Protocol Violation|1|||
33352832|NCT00725608|62730121|FG000|Overall Study|Adverse Event|14|||
33352833|NCT00725608|62730121|FG000|Overall Study|Individual reasons|86|||
33352834|NCT00725608|62730121|FG000|Overall Study|Other|7|||
33352835|NCT00725452|62730125|FG000|Overall Study|Adverse Event|3|||
33352836|NCT00725452|62730125|FG000|Overall Study|Lack of Efficacy|2|||
33352837|NCT00725452|62730125|FG000|Overall Study|Reason not specified|1|||
33352838|NCT00725452|62730125|FG000|Overall Study|Physician Decision|1|||
33352839|NCT00725452|62730125|FG000|Overall Study|Withdrawal by Subject|3|||
33352840|NCT00725452|62730125|FG000|Overall Study|Lost to Follow-up|1|||
33352841|NCT00725296|62730129|FG000|Overall Study|Adverse Event|11|||
33352842|NCT00725296|62730129|FG000|Overall Study|Lack of Efficacy|7|||
33352843|NCT00725296|62730129|FG000|Overall Study|Withdrawal by Subject|3|||
33352844|NCT00725296|62730129|FG000|Overall Study|Non-Compliance|2|||
33352845|NCT00725296|62730129|FG000|Overall Study|Lost to Follow-up|1|||
33352846|NCT00725296|62730129|FG000|Overall Study|Other|38|||
33352847|NCT00719680|62730134|FG000|Overall Study|Adverse Event|1|||
33352848|NCT00719680|62730134|FG000|Overall Study|Lost to Follow-up|1|||
33352849|NCT00719680|62730134|FG000|Overall Study|Withdrawal by Subject|3|||
33352850|NCT00719212|62730138|FG000|Overall Study|Death|41|||
33352851|NCT00719212|62730138|FG000|Overall Study|Lost to Follow-up|2|||
33352852|NCT00719212|62730138|FG000|Overall Study|Withdrawal by Subject|1|||
33352853|NCT00585052|62730142|FG000|Overall Study|Withdrawal by Subject|1|||
33352854|NCT00724282|62730146|FG000|Overall Study|Withdrawal by Subject|3|||
33352855|NCT00724282|62730146|FG000|Overall Study|Physician Decision|1|||
33352856|NCT00724126|62730152|FG000|Overall Study|Adverse Event|2|||
33352857|NCT00724126|62730153|FG001|Overall Study|Adverse Event|0|||
33352858|NCT00724126|62730152|FG000|Overall Study|Withdrawal by Subject|8|||
33352859|NCT00724126|62730153|FG001|Overall Study|Withdrawal by Subject|6|||
33352860|NCT00724126|62730152|FG000|Overall Study|Lost to Follow-up|6|||
33352861|NCT00724126|62730153|FG001|Overall Study|Lost to Follow-up|6|||
33352862|NCT00724126|62730152|FG000|Overall Study|Noncompliance|2|||
33471949|NCT00254501|62845865|FG000|Overall Study|Lost to Follow-up|1|||
33471950|NCT00254501|62845866|FG001|Overall Study|Lost to Follow-up|1|||
33352863|NCT00724126|62730153|FG001|Overall Study|Noncompliance|1|||
33352864|NCT00724126|62730152|FG000|Overall Study|Subject randomized although ineligible|1|||
33352865|NCT00724126|62730153|FG001|Overall Study|Subject randomized although ineligible|1|||
33352866|NCT00724126|62730152|FG000|Overall Study|Subject had to leave vicinity of site|0|||
33352867|NCT00724126|62730153|FG001|Overall Study|Subject had to leave vicinity of site|1|||
33352868|NCT00723892|62730161|FG000|Overall Study|Participant not tracked|33|||
33471951|NCT00253643|62845878|FG000|Overall Study|Withdrawal by Subject|0|||
33352869|NCT00723892|62730162|FG001|Overall Study|Participant not tracked|35|||
33352870|NCT00723892|62730161|FG000|Overall Study|Virological criterion|24|||
33352871|NCT00723892|62730162|FG001|Overall Study|Virological criterion|9|||
33352872|NCT00723892|62730161|FG000|Overall Study|Withdrawal by Subject|6|||
33352873|NCT00723892|62730162|FG001|Overall Study|Withdrawal by Subject|9|||
33352874|NCT00723892|62730161|FG000|Overall Study|End planned|11|||
33352875|NCT00723892|62730162|FG001|Overall Study|End planned|7|||
33352876|NCT00723892|62730161|FG000|Overall Study|Bad tolerance|5|||
33352877|NCT00723892|62730162|FG001|Overall Study|Bad tolerance|5|||
33352878|NCT00723892|62730161|FG000|Overall Study|Multiple reasons|17|||
33352879|NCT00723892|62730162|FG001|Overall Study|Multiple reasons|12|||
33352880|NCT00723892|62730161|FG000|Overall Study|Other|6|||
33352881|NCT00723892|62730162|FG001|Overall Study|Other|3|||
33352882|NCT00723892|62730161|FG000|Overall Study|Study end|1|||
33352883|NCT00723892|62730162|FG001|Overall Study|Study end|3|||
33352884|NCT00723892|62730161|FG000|Overall Study|Weight loss|1|||
33352885|NCT00723892|62730162|FG001|Overall Study|Weight loss|3|||
33352886|NCT00723892|62730161|FG000|Overall Study|Alcohol abuse|0|||
33352887|NCT00723892|62730162|FG001|Overall Study|Alcohol abuse|1|||
33352888|NCT00723892|62730161|FG000|Overall Study|Intercurrent infection|2|||
33352889|NCT00723892|62730162|FG001|Overall Study|Intercurrent infection|0|||
33352890|NCT00723892|62730161|FG000|Overall Study|Drug addiction|1|||
33352891|NCT00723892|62730162|FG001|Overall Study|Drug addiction|0|||
33352892|NCT00718666|62730171|FG000|Booster Phase Year 5|No active participation request|0|||
33352893|NCT00718666|62730172|FG001|Booster Phase Year 5|No active participation request|0|||
33352894|NCT00718666|62730173|FG002|Booster Phase Year 5|No active participation request|1|||
33352895|NCT00718666|62730171|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
33352896|NCT00718666|62730172|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
33352897|NCT00718666|62730173|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
33352898|NCT00718666|62730171|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
33352899|NCT00718666|62730172|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
33352900|NCT00718666|62730173|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
33352901|NCT00718666|62730171|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
33352902|NCT00718666|62730172|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
33352903|NCT00718666|62730173|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
33352904|NCT03950440|62730194|FG000|Overall Study|Death|8|||
33352905|NCT03950440|62730195|FG001|Overall Study|Death|2|||
33352906|NCT03950440|62730196|FG002|Overall Study|Death|1|||
33352907|NCT00718510|62730206|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
33352908|NCT00718510|62730207|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33352909|NCT00718510|62730206|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
33352910|NCT00718510|62730207|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
33352911|NCT00585286|62730213|FG000|Overall Study|Lost to Follow-up|1|||
33352912|NCT00723190|62730217|FG000|Overall Study|Withdrawal by Subject|45|||
33352913|NCT00723190|62730217|FG000|Overall Study|Lost to Follow-up|37|||
33352914|NCT00723190|62730217|FG000|Overall Study|Adverse Event|18|||
33352915|NCT00723190|62730217|FG000|Overall Study|Lack of Efficacy|16|||
33352916|NCT00723190|62730217|FG000|Overall Study|Protocol Violation|15|||
33352917|NCT00723190|62730217|FG000|Overall Study|Other-Premature Discontinuation|9|||
33352918|NCT00723190|62730217|FG000|Overall Study|Other-Not included in safety population|2|||
33352919|NCT00722800|62730223|FG000|Overall Study|Withdrawal by Subject|1|||
33352920|NCT00722800|62730224|FG001|Overall Study|Withdrawal by Subject|0|||
33352921|NCT00722800|62730223|FG000|Overall Study|Physician Decision|1|||
33352922|NCT00722800|62730224|FG001|Overall Study|Physician Decision|0|||
33352923|NCT00718042|62730236|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
33471952|NCT00253643|62845879|FG001|Overall Study|Withdrawal by Subject|0|||
33471953|NCT00253643|62845880|FG002|Overall Study|Withdrawal by Subject|1|||
33471954|NCT00253643|62845881|FG003|Overall Study|Withdrawal by Subject|1|||
33471955|NCT00253643|62845878|FG000|Overall Study|Non-Compliance|0|||
33352924|NCT00718042|62730237|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
33352925|NCT00718042|62730238|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
33352926|NCT00718042|62730239|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
33471956|NCT00253643|62845879|FG001|Overall Study|Non-Compliance|0|||
33352927|NCT00718042|62730240|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
33352928|NCT00718042|62730241|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
33352929|NCT00718042|62730236|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
33352930|NCT00718042|62730237|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
33352931|NCT00718042|62730238|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
33352932|NCT00718042|62730239|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
33352933|NCT00718042|62730240|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
33352934|NCT00718042|62730241|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
33352935|NCT00718042|62730236|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
33352936|NCT00718042|62730237|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
33352937|NCT00718042|62730238|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
33352938|NCT00718042|62730239|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
33471957|NCT00253643|62845880|FG002|Overall Study|Non-Compliance|0|||
33352939|NCT00718042|62730240|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
33352940|NCT00718042|62730241|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
33352941|NCT00718042|62730236|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
33352942|NCT00718042|62730237|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
33352943|NCT00718042|62730238|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
33352944|NCT00718042|62730239|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
33352945|NCT00718042|62730240|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
33352946|NCT00718042|62730241|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
33352947|NCT00718042|62730236|FG000|Donor Follow-up|Lost to Follow-up|13|||
33352948|NCT00718042|62730237|FG001|Donor Follow-up|Lost to Follow-up|0|||
33352949|NCT00718042|62730238|FG002|Donor Follow-up|Lost to Follow-up|0|||
33352950|NCT00718042|62730239|FG003|Donor Follow-up|Lost to Follow-up|0|||
33352951|NCT00718042|62730240|FG004|Donor Follow-up|Lost to Follow-up|19|||
33352952|NCT00718042|62730241|FG005|Donor Follow-up|Lost to Follow-up|0|||
33352953|NCT00741598|62730255|FG000|Overall Study|Lost to Follow-up|3|||
33352954|NCT00741598|62730256|FG001|Overall Study|Lost to Follow-up|4|||
33352955|NCT00741598|62730255|FG000|Overall Study|Lack of Efficacy|1|||
33352956|NCT00741598|62730256|FG001|Overall Study|Lack of Efficacy|2|||
33352957|NCT00741598|62730255|FG000|Overall Study|Physician Decision|1|||
33352958|NCT00741598|62730256|FG001|Overall Study|Physician Decision|1|||
33352959|NCT00741598|62730255|FG000|Overall Study|Pregnancy|1|||
33352960|NCT00741598|62730256|FG001|Overall Study|Pregnancy|0|||
33352961|NCT00741598|62730255|FG000|Overall Study|Withdrawal by Subject|3|||
33352962|NCT00741598|62730256|FG001|Overall Study|Withdrawal by Subject|2|||
33352963|NCT00717886|62730263|FG000|Overall Study|Withdrawal by Subject|3|||
33352964|NCT00717886|62730263|FG000|Overall Study|Treatment Failure|1|||
33352965|NCT00741286|62730269|FG000|Overall Study|Lost to Follow-up|15|||
33352966|NCT00741286|62730270|FG001|Overall Study|Lost to Follow-up|10|||
33352967|NCT00741286|62730269|FG000|Overall Study|Adverse Event|1|||
33352968|NCT00741286|62730270|FG001|Overall Study|Adverse Event|6|||
33352969|NCT00741286|62730269|FG000|Overall Study|Protocol Violation|3|||
33352970|NCT00741286|62730270|FG001|Overall Study|Protocol Violation|2|||
33352971|NCT00741286|62730269|FG000|Overall Study|Primary Outcome|1|||
33352972|NCT00741286|62730270|FG001|Overall Study|Primary Outcome|1|||
33352973|NCT00716482|62730276|FG000|Overall Study|Lost to Follow-up|6|||
33549009|NCT02901431|62940295|FG001|Main Treatment Part|Adverse Event|0|||
33549010|NCT02901431|62940296|FG002|Main Treatment Part|Adverse Event|0|||
33549011|NCT02901431|62940297|FG003|Main Treatment Part|Adverse Event|3|||
33549012|NCT02901431|62940298|FG004|Main Treatment Part|Adverse Event|3|||
33549013|NCT02901431|62940299|FG005|Main Treatment Part|Adverse Event|4|||
33549014|NCT02901431|62940300|FG006|Main Treatment Part|Adverse Event|1|||
33549015|NCT02901431|62940301|FG007|Main Treatment Part|Adverse Event|0|||
33549016|NCT02901431|62940302|FG008|Main Treatment Part|Adverse Event|0|||
33549017|NCT02901431|62940303|FG009|Main Treatment Part|Adverse Event|0|||
33352974|NCT00716482|62730276|FG000|Overall Study|Inadequate acquisition or analysis|50|||
33352975|NCT00716482|62730276|FG000|Overall Study|no pathology obtained|10|||
33352976|NCT00716482|62730276|FG000|Overall Study|technical/machine error|28|||
33352977|NCT00716482|62730276|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
33352978|NCT00716092|62730289|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
33352979|NCT00716092|62730290|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
33352980|NCT00716092|62730291|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
33352981|NCT00715624|62730301|FG000|Overall Study|Adverse Event|12|||
33352982|NCT00715624|62730302|FG001|Overall Study|Adverse Event|37|||
33352983|NCT00715624|62730301|FG000|Overall Study|Lack of Efficacy|11|||
33352984|NCT00715624|62730302|FG001|Overall Study|Lack of Efficacy|11|||
33352985|NCT00715624|62730301|FG000|Overall Study|Lost to Follow-up|1|||
33352986|NCT00715624|62730302|FG001|Overall Study|Lost to Follow-up|2|||
33352987|NCT00715624|62730301|FG000|Overall Study|Protocol Violation|1|||
33352988|NCT00715624|62730302|FG001|Overall Study|Protocol Violation|0|||
33352989|NCT00715624|62730301|FG000|Overall Study|Withdrawal by Subject|11|||
33352990|NCT00715624|62730302|FG001|Overall Study|Withdrawal by Subject|25|||
33352991|NCT00715624|62730301|FG000|Overall Study|Familial and personal reasons|10|||
33352992|NCT00715624|62730302|FG001|Overall Study|Familial and personal reasons|22|||
33352993|NCT00715624|62730301|FG000|Overall Study|Poor compliance|6|||
33352994|NCT00715624|62730302|FG001|Overall Study|Poor compliance|13|||
33549018|NCT02901431|62940304|FG010|Main Treatment Part|Adverse Event|0|||
33549019|NCT02901431|62940305|FG011|Main Treatment Part|Adverse Event|0|||
33549020|NCT02901431|62940306|FG012|Main Treatment Part|Adverse Event|0|||
33352995|NCT00715624|62730301|FG000|Overall Study|Sponsor decision|0|||
33352996|NCT00715624|62730302|FG001|Overall Study|Sponsor decision|4|||
33352997|NCT00715624|62730301|FG000|Overall Study|Incorrect randomization (not treated)|0|||
33352998|NCT00715624|62730302|FG001|Overall Study|Incorrect randomization (not treated)|1|||
33549021|NCT02901431|62940294|FG000|Main Treatment Part|Lack of Efficacy|0|||
33352999|NCT00715624|62730301|FG000|Overall Study|Other|0|||
33353000|NCT00715624|62730302|FG001|Overall Study|Other|1|||
33353001|NCT00576199|62730308|FG000|Overall Study|Adverse Event|12|||
33353002|NCT00576199|62730308|FG000|Overall Study|Insufficient Therapeutic Response|14|||
33353003|NCT00576199|62730308|FG000|Overall Study|Refused Treatment|2|||
33353004|NCT00576199|62730308|FG000|Overall Study|Reason Unspecified|2|||
33353005|NCT00715078|62730315|FG000|Overall Study|Death|29|||
33353006|NCT00715078|62730316|FG001|Overall Study|Death|36|||
33353007|NCT00715078|62730317|FG002|Overall Study|Death|36|||
33353008|NCT00715078|62730315|FG000|Overall Study|Withdrawal by Subject|1|||
33353009|NCT00715078|62730316|FG001|Overall Study|Withdrawal by Subject|0|||
33353010|NCT00715078|62730317|FG002|Overall Study|Withdrawal by Subject|1|||
33353011|NCT00715078|62730315|FG000|Overall Study|Unable to start due to disease prog.|0|||
33353012|NCT00715078|62730316|FG001|Overall Study|Unable to start due to disease prog.|0|||
33353013|NCT00715078|62730317|FG002|Overall Study|Unable to start due to disease prog.|1|||
33353014|NCT00679627|62730327|FG000|Overall Study|Death|41|||
33353015|NCT00679627|62730328|FG001|Overall Study|Death|29|||
33353016|NCT00679627|62730327|FG000|Overall Study|Adverse Event|43|||
33353017|NCT00679627|62730328|FG001|Overall Study|Adverse Event|53|||
33353018|NCT00679627|62730327|FG000|Overall Study|Withdrawal by Subject|168|||
33353019|NCT00679627|62730328|FG001|Overall Study|Withdrawal by Subject|172|||
33353020|NCT00679627|62730327|FG000|Overall Study|Lost to Follow-up|22|||
33353021|NCT00679627|62730328|FG001|Overall Study|Lost to Follow-up|26|||
33471958|NCT00253643|62845881|FG003|Overall Study|Non-Compliance|2|||
33471959|NCT00221195|62845893|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
33471960|NCT00221195|62845894|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
33471961|NCT00221195|62845893|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
33471962|NCT00221195|62845894|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
33471963|NCT00221195|62845893|FG000|Washout Period (Months 7-9)|Death|0|||
33471964|NCT00221195|62845894|FG001|Washout Period (Months 7-9)|Death|1|||
33471965|NCT00221195|62845893|FG000|Therapy 2 (Months 10-15)|Death|1|||
33471966|NCT00221195|62845894|FG001|Therapy 2 (Months 10-15)|Death|0|||
33471967|NCT00221195|62845893|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
33471968|NCT00221195|62845894|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
33471969|NCT00220805|62845903|FG000|Overall Study|Adverse Event|1|||
33471970|NCT00220805|62845904|FG001|Overall Study|Adverse Event|3|||
33471971|NCT00220805|62845903|FG000|Overall Study|Withdrawal by Subject|3|||
33471972|NCT00220805|62845904|FG001|Overall Study|Withdrawal by Subject|0|||
33471973|NCT00220805|62845903|FG000|Overall Study|Lack of Efficacy|1|||
33471974|NCT00220805|62845904|FG001|Overall Study|Lack of Efficacy|0|||
33471975|NCT00220805|62845903|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
33471976|NCT00220805|62845904|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
33471977|NCT00220727|62845912|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
33471978|NCT00220727|62845913|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
33471979|NCT04495816|62845923|FG000|Overall Study|Lost to Follow-up|10|||
33471980|NCT04495816|62845924|FG001|Overall Study|Lost to Follow-up|4|||
33471981|NCT04495816|62845923|FG000|Overall Study|Withdrawal by Subject|3|||
33471982|NCT04495816|62845924|FG001|Overall Study|Withdrawal by Subject|5|||
33471983|NCT03971357|62845932|FG000|Overall Study|Lack of Efficacy|0|||
33471984|NCT03971357|62845933|FG001|Overall Study|Lack of Efficacy|1|||
33471985|NCT04310566|62845939|FG000|Period 1|Study Termination due to COVID-19|15|||
33471986|NCT04310566|62845940|FG001|Period 1|Study Termination due to COVID-19|17|||
33471987|NCT04310566|62845939|FG000|Period 1|Protocol Violation|0|||
33471988|NCT04310566|62845940|FG001|Period 1|Protocol Violation|1|||
33471989|NCT04310566|62845939|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
33471990|NCT04310566|62845940|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
33471991|NCT04310566|62845939|FG000|Period 1|Lost to Follow-up|1|||
33471992|NCT04310566|62845940|FG001|Period 1|Lost to Follow-up|0|||
33471993|NCT04310566|62845939|FG000|Period 1|Withdrawal by Subject|0|||
33471994|NCT04310566|62845940|FG001|Period 1|Withdrawal by Subject|1|||
33471995|NCT04310566|62845939|FG000|Period 2|Study Termination|7|||
33353022|NCT00679627|62730327|FG000|Overall Study|Early Study Closure|425|||
33353023|NCT00679627|62730328|FG001|Overall Study|Early Study Closure|405|||
33471996|NCT04310566|62845940|FG001|Period 2|Study Termination|5|||
33471997|NCT00252239|62845950|FG000|Overall Study|Withdrawal by Subject|1|||
33471998|NCT00252239|62845951|FG001|Overall Study|Withdrawal by Subject|0|||
33471999|NCT00252239|62845952|FG002|Overall Study|Withdrawal by Subject|0|||
33472000|NCT00252239|62845953|FG003|Overall Study|Withdrawal by Subject|1|||
33472001|NCT00252239|62845950|FG000|Overall Study|Lost to Follow-up|0|||
33472002|NCT00252239|62845951|FG001|Overall Study|Lost to Follow-up|0|||
33472003|NCT00252239|62845952|FG002|Overall Study|Lost to Follow-up|2|||
33472004|NCT00252239|62845953|FG003|Overall Study|Lost to Follow-up|0|||
33472005|NCT03103906|62845965|FG000|Overall Study|Adverse Event|2|||
33655226|NCT01893905|63069680|FG000|Overall Study|Lack of adherence to treatment|2|||
33472006|NCT03103906|62845966|FG001|Overall Study|Adverse Event|3|||
33353024|NCT00714688|62730337|FG000|Overall Study|Lack of Efficacy|14|||
33353025|NCT00714688|62730338|FG001|Overall Study|Lack of Efficacy|1|||
33353026|NCT00714688|62730339|FG002|Overall Study|Lack of Efficacy|4|||
33353027|NCT00714688|62730337|FG000|Overall Study|Withdrawal by Subject|4|||
33353028|NCT00714688|62730338|FG001|Overall Study|Withdrawal by Subject|3|||
33353029|NCT00714688|62730339|FG002|Overall Study|Withdrawal by Subject|3|||
33353030|NCT00714688|62730337|FG000|Overall Study|Lost to Follow-up|5|||
33353031|NCT00714688|62730338|FG001|Overall Study|Lost to Follow-up|2|||
33353032|NCT00714688|62730339|FG002|Overall Study|Lost to Follow-up|0|||
33353033|NCT00714688|62730337|FG000|Overall Study|Adverse Event|2|||
33353034|NCT00714688|62730338|FG001|Overall Study|Adverse Event|15|||
33353035|NCT00714688|62730339|FG002|Overall Study|Adverse Event|19|||
33353036|NCT00714688|62730337|FG000|Overall Study|Subject Non-compliant|3|||
33353037|NCT00714688|62730338|FG001|Overall Study|Subject Non-compliant|5|||
33353038|NCT00714688|62730339|FG002|Overall Study|Subject Non-compliant|5|||
33353039|NCT00714688|62730337|FG000|Overall Study|Ineligible to Continue the Study|0|||
33353040|NCT00714688|62730338|FG001|Overall Study|Ineligible to Continue the Study|1|||
33353041|NCT00714688|62730339|FG002|Overall Study|Ineligible to Continue the Study|1|||
33353042|NCT00714688|62730337|FG000|Overall Study|Sponsor's Decision|0|||
33353043|NCT00714688|62730338|FG001|Overall Study|Sponsor's Decision|2|||
33353044|NCT00714688|62730339|FG002|Overall Study|Sponsor's Decision|0|||
33353045|NCT00714688|62730337|FG000|Overall Study|Other|1|||
33353046|NCT00714688|62730338|FG001|Overall Study|Other|6|||
33353047|NCT00714688|62730339|FG002|Overall Study|Other|5|||
33353048|NCT00679549|62730349|FG000|Overall Study|dropout|2|||
33353049|NCT00679549|62730350|FG001|Overall Study|dropout|4|||
33353050|NCT00679549|62730349|FG000|Overall Study|missing outcome echocardiograms|4|||
33353051|NCT00679549|62730350|FG001|Overall Study|missing outcome echocardiograms|5|||
33353052|NCT01031069|62730360|FG000|Overall Study|Serious Adverse Event|0|||
33353053|NCT01031069|62730361|FG001|Overall Study|Serious Adverse Event|1|||
33353054|NCT01031069|62730362|FG002|Overall Study|Serious Adverse Event|0|||
33353055|NCT01031069|62730363|FG003|Overall Study|Serious Adverse Event|0|||
33353056|NCT01031069|62730360|FG000|Overall Study|Withdrawal by Subject|2|||
33353057|NCT01031069|62730361|FG001|Overall Study|Withdrawal by Subject|3|||
33353058|NCT01031069|62730362|FG002|Overall Study|Withdrawal by Subject|18|||
33353059|NCT01031069|62730363|FG003|Overall Study|Withdrawal by Subject|18|||
33353060|NCT01031069|62730360|FG000|Overall Study|Migrated/moved from study area|1|||
33353061|NCT01031069|62730361|FG001|Overall Study|Migrated/moved from study area|2|||
33353062|NCT01031069|62730362|FG002|Overall Study|Migrated/moved from study area|1|||
33353063|NCT01031069|62730363|FG003|Overall Study|Migrated/moved from study area|1|||
33353064|NCT01031069|62730360|FG000|Overall Study|Lost to Follow-up|9|||
33353065|NCT01031069|62730361|FG001|Overall Study|Lost to Follow-up|5|||
33353066|NCT01031069|62730362|FG002|Overall Study|Lost to Follow-up|21|||
33353067|NCT01031069|62730363|FG003|Overall Study|Lost to Follow-up|15|||
33353068|NCT01031069|62730360|FG000|Overall Study|Other|0|||
33472007|NCT03103906|62845965|FG000|Overall Study|Other|2|||
33472008|NCT03103906|62845966|FG001|Overall Study|Other|0|||
33472009|NCT04799158|62845976|FG000|Run-In Period|Adverse Event|6|||
33472010|NCT04799158|62845977|FG001|Run-In Period|Adverse Event|0|||
33472011|NCT04799158|62845978|FG002|Run-In Period|Adverse Event|0|||
33472012|NCT04799158|62845979|FG003|Run-In Period|Adverse Event|0|||
33472013|NCT04799158|62845980|FG004|Run-In Period|Adverse Event|0|||
33472014|NCT04799158|62845976|FG000|Run-In Period|Lost to Follow-up|4|||
33472015|NCT04799158|62845977|FG001|Run-In Period|Lost to Follow-up|0|||
33472016|NCT04799158|62845978|FG002|Run-In Period|Lost to Follow-up|0|||
33353069|NCT01031069|62730361|FG001|Overall Study|Other|0|||
33353070|NCT01031069|62730362|FG002|Overall Study|Other|1|||
33353071|NCT01031069|62730363|FG003|Overall Study|Other|0|||
33472017|NCT04799158|62845979|FG003|Run-In Period|Lost to Follow-up|0|||
33472018|NCT04799158|62845980|FG004|Run-In Period|Lost to Follow-up|0|||
33472019|NCT04799158|62845976|FG000|Run-In Period|Significant Protocol Deviation|1|||
33549022|NCT02901431|62940295|FG001|Main Treatment Part|Lack of Efficacy|0|||
33353072|NCT00679081|62730375|FG000|Overall Study|Lost to Follow-up|1|||
33353073|NCT00682435|62730383|FG000|Overall Study|Insufficient data|5|||
33549023|NCT02901431|62940296|FG002|Main Treatment Part|Lack of Efficacy|0|||
33549024|NCT02901431|62940297|FG003|Main Treatment Part|Lack of Efficacy|1|||
33353074|NCT00682435|62730383|FG000|Overall Study|Erroneously enrolled twice|2|||
33353075|NCT00713830|62730389|FG000|Overall Study|Adverse Event|23|||
33353076|NCT00713830|62730390|FG001|Overall Study|Adverse Event|71|||
33472020|NCT04799158|62845977|FG001|Run-In Period|Significant Protocol Deviation|0|||
33549025|NCT02901431|62940298|FG004|Main Treatment Part|Lack of Efficacy|0|||
33353077|NCT00713830|62730389|FG000|Overall Study|Lack of Efficacy|24|||
33353078|NCT00713830|62730390|FG001|Overall Study|Lack of Efficacy|16|||
33353079|NCT00713830|62730389|FG000|Overall Study|Lost to Follow-up|2|||
33472021|NCT04799158|62845978|FG002|Run-In Period|Significant Protocol Deviation|0|||
33472022|NCT04799158|62845979|FG003|Run-In Period|Significant Protocol Deviation|0|||
33353080|NCT00713830|62730390|FG001|Overall Study|Lost to Follow-up|9|||
33353081|NCT00713830|62730389|FG000|Overall Study|Withdrawal by Subject|13|||
33353082|NCT00713830|62730390|FG001|Overall Study|Withdrawal by Subject|23|||
33353083|NCT00713830|62730389|FG000|Overall Study|Poor Compliance to Protocol|7|||
33353084|NCT00713830|62730390|FG001|Overall Study|Poor Compliance to Protocol|14|||
33353085|NCT00713830|62730389|FG000|Overall Study|Familial and Personal Reasons|9|||
33353086|NCT00713830|62730390|FG001|Overall Study|Familial and Personal Reasons|34|||
33353087|NCT00713830|62730389|FG000|Overall Study|Sponsor Decision|4|||
33353088|NCT00713830|62730390|FG001|Overall Study|Sponsor Decision|10|||
33353089|NCT00681811|62730398|FG000|Overall Study|Adverse Event|1|||
33353090|NCT00681811|62730399|FG001|Overall Study|Adverse Event|1|||
33353091|NCT00681811|62730398|FG000|Overall Study|Withdrawal by Subject|2|||
33353092|NCT00681811|62730399|FG001|Overall Study|Withdrawal by Subject|2|||
33353093|NCT00681811|62730398|FG000|Overall Study|Non-compliance|0|||
33353094|NCT00681811|62730399|FG001|Overall Study|Non-compliance|1|||
33353095|NCT00681187|62730418|FG000|Overall Study|Withdrawal by Subject|1|||
33353096|NCT00681187|62730419|FG001|Overall Study|Withdrawal by Subject|0|||
33353097|NCT00681187|62730418|FG000|Overall Study|Death|0|||
33353098|NCT00681187|62730419|FG001|Overall Study|Death|1|||
33353099|NCT00681187|62730418|FG000|Overall Study|Adverse Event|0|||
33353100|NCT00681187|62730419|FG001|Overall Study|Adverse Event|1|||
33353101|NCT00681109|62730441|FG000|Overall Study|Lost to Follow-up|2|||
33353102|NCT00681109|62730442|FG001|Overall Study|Lost to Follow-up|6|||
33353103|NCT00681109|62730443|FG002|Overall Study|Lost to Follow-up|0|||
33353104|NCT00680407|62730457|FG000|Overall Study|Lost to Follow-up|3|||
33353105|NCT00680407|62730458|FG001|Overall Study|Lost to Follow-up|3|||
33353106|NCT00680407|62730459|FG002|Overall Study|Lost to Follow-up|1|||
33353107|NCT00680407|62730457|FG000|Overall Study|Withdrawal by Subject|5|||
33353108|NCT00680407|62730458|FG001|Overall Study|Withdrawal by Subject|2|||
33353109|NCT00680407|62730459|FG002|Overall Study|Withdrawal by Subject|2|||
33353110|NCT00677365|62730471|FG000|Overall Study|Adverse Event|2|||
33353111|NCT00677365|62730472|FG001|Overall Study|Adverse Event|1|||
33353112|NCT00677365|62730473|FG002|Overall Study|Adverse Event|1|||
33353113|NCT00677365|62730474|FG003|Overall Study|Adverse Event|2|||
33353114|NCT00677365|62730471|FG000|Overall Study|Withdrawal by Subject|0|||
33353115|NCT00677365|62730472|FG001|Overall Study|Withdrawal by Subject|0|||
33353116|NCT00677365|62730473|FG002|Overall Study|Withdrawal by Subject|1|||
33353117|NCT00677365|62730474|FG003|Overall Study|Withdrawal by Subject|0|||
33353118|NCT00677365|62730471|FG000|Overall Study|Other reason|0|||
33353119|NCT00677365|62730472|FG001|Overall Study|Other reason|0|||
33353120|NCT00677365|62730473|FG002|Overall Study|Other reason|0|||
33353121|NCT00677365|62730474|FG003|Overall Study|Other reason|1|||
33353122|NCT00680017|62730486|FG000|Overall Study|Adverse Event|13|||
33353123|NCT00680017|62730487|FG001|Overall Study|Adverse Event|7|||
33353124|NCT00680017|62730486|FG000|Overall Study|Withdrawal by Subject|2|||
33353125|NCT00680017|62730487|FG001|Overall Study|Withdrawal by Subject|5|||
33472023|NCT04799158|62845980|FG004|Run-In Period|Significant Protocol Deviation|0|||
33472024|NCT04799158|62845976|FG000|Run-In Period|Withdrawal by Subject|11|||
33472025|NCT04799158|62845977|FG001|Run-In Period|Withdrawal by Subject|0|||
33472026|NCT04799158|62845978|FG002|Run-In Period|Withdrawal by Subject|0|||
33472027|NCT04799158|62845979|FG003|Run-In Period|Withdrawal by Subject|0|||
33472028|NCT04799158|62845980|FG004|Run-In Period|Withdrawal by Subject|0|||
33472029|NCT04799158|62845976|FG000|Run-In Period|Miscellaneous|3|||
33472030|NCT04799158|62845977|FG001|Run-In Period|Miscellaneous|0|||
33472031|NCT04799158|62845978|FG002|Run-In Period|Miscellaneous|0|||
33472032|NCT04799158|62845979|FG003|Run-In Period|Miscellaneous|0|||
33472033|NCT04799158|62845980|FG004|Run-In Period|Miscellaneous|0|||
33472034|NCT04799158|62845976|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
33472035|NCT04799158|62845977|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
33353126|NCT00680017|62730486|FG000|Overall Study|Lost to Follow-up|2|||
33353127|NCT00680017|62730487|FG001|Overall Study|Lost to Follow-up|0|||
33353128|NCT00676663|62730495|FG000|Overall Study|Death|43|||
33472036|NCT04799158|62845978|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
33472037|NCT04799158|62845979|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
33353129|NCT00676663|62730496|FG001|Overall Study|Death|27|||
33353130|NCT00676663|62730495|FG000|Overall Study|Withdrew Consent|1|||
33353131|NCT00676663|62730496|FG001|Overall Study|Withdrew Consent|8|||
33472038|NCT04799158|62845980|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
33472039|NCT04799158|62845976|FG000|On-Demand Treatment Period|Adverse Event|0|||
33472040|NCT04799158|62845977|FG001|On-Demand Treatment Period|Adverse Event|1|||
33549026|NCT02901431|62940299|FG005|Main Treatment Part|Lack of Efficacy|0|||
33353132|NCT00676663|62730495|FG000|Overall Study|Lost to Follow-up|1|||
33353133|NCT00676663|62730496|FG001|Overall Study|Lost to Follow-up|3|||
33353134|NCT00678691|62730506|FG000|Overall Study|Adverse Event|6|||
33353135|NCT00678691|62730507|FG001|Overall Study|Adverse Event|4|||
33353136|NCT00679939|62730515|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
33353137|NCT00679939|62730516|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
33353138|NCT00679939|62730515|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
33353139|NCT00679939|62730516|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
33353140|NCT00679939|62730515|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
33353141|NCT00679939|62730516|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
33353142|NCT00679939|62730515|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
33353143|NCT00679939|62730516|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
33353144|NCT00679939|62730515|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
33353145|NCT00679939|62730516|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
33353146|NCT00679939|62730515|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
33353147|NCT00679939|62730516|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
33353148|NCT00679939|62730515|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
33353149|NCT00679939|62730516|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
33353150|NCT00679939|62730515|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
33353151|NCT00679939|62730516|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
33353152|NCT00679939|62730515|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
33353153|NCT00679939|62730516|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
33353154|NCT00679939|62730515|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
33353155|NCT00679939|62730516|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
33353156|NCT00673933|62730526|FG000|Overall Study|Withdrawal by Subject|2|||
33353157|NCT00673933|62730526|FG000|Overall Study|Lost to Follow-up|1|||
33353158|NCT00571519|62730539|FG000|Overall Study|Subject withdrew consent|0|||
33353159|NCT00571519|62730540|FG001|Overall Study|Subject withdrew consent|1|||
33353160|NCT00571519|62730541|FG002|Overall Study|Subject withdrew consent|0|||
33353161|NCT00571519|62730542|FG003|Overall Study|Subject withdrew consent|2|||
33353162|NCT00571519|62730543|FG004|Overall Study|Subject withdrew consent|1|||
33353163|NCT00571519|62730544|FG005|Overall Study|Subject withdrew consent|1|||
33353164|NCT00571519|62730545|FG006|Overall Study|Subject withdrew consent|2|||
33353165|NCT00571519|62730539|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
33353166|NCT00571519|62730540|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
33353167|NCT00571519|62730541|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
33353168|NCT00571519|62730542|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
33353169|NCT00571519|62730543|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
33353170|NCT00571519|62730544|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
33472041|NCT04799158|62845978|FG002|On-Demand Treatment Period|Adverse Event|0|||
33472042|NCT04799158|62845979|FG003|On-Demand Treatment Period|Adverse Event|0|||
33549027|NCT02901431|62940300|FG006|Main Treatment Part|Lack of Efficacy|0|||
33549028|NCT02901431|62940301|FG007|Main Treatment Part|Lack of Efficacy|0|||
33549029|NCT02901431|62940302|FG008|Main Treatment Part|Lack of Efficacy|0|||
33549030|NCT02901431|62940303|FG009|Main Treatment Part|Lack of Efficacy|0|||
33353171|NCT00571519|62730545|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
33353172|NCT00571519|62730539|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
33353173|NCT00571519|62730540|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
33353174|NCT00571519|62730541|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
33353175|NCT00571519|62730542|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
33353176|NCT00571519|62730543|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
33353177|NCT00571519|62730544|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
33353178|NCT00571519|62730545|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
33353179|NCT00571519|62730539|FG000|Overall Study|Termination of study by Sponsor|2|||
33353180|NCT00571519|62730540|FG001|Overall Study|Termination of study by Sponsor|7|||
33353181|NCT00571519|62730541|FG002|Overall Study|Termination of study by Sponsor|10|||
33353182|NCT00571519|62730542|FG003|Overall Study|Termination of study by Sponsor|24|||
33353183|NCT00571519|62730543|FG004|Overall Study|Termination of study by Sponsor|8|||
33353184|NCT00571519|62730544|FG005|Overall Study|Termination of study by Sponsor|9|||
33353185|NCT00571519|62730545|FG006|Overall Study|Termination of study by Sponsor|22|||
33353186|NCT00571519|62730539|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
33353187|NCT00571519|62730540|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
33353188|NCT00571519|62730541|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
33353189|NCT00571519|62730542|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
33353190|NCT00571519|62730543|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
33472043|NCT04799158|62845980|FG004|On-Demand Treatment Period|Adverse Event|1|||
33472044|NCT04799158|62845976|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
33472045|NCT04799158|62845977|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
33472046|NCT04799158|62845978|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
33472047|NCT04799158|62845979|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
33472048|NCT04799158|62845980|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
33472049|NCT04799158|62845976|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
33549031|NCT02901431|62940304|FG010|Main Treatment Part|Lack of Efficacy|0|||
33549032|NCT02901431|62940305|FG011|Main Treatment Part|Lack of Efficacy|0|||
33549033|NCT02901431|62940306|FG012|Main Treatment Part|Lack of Efficacy|0|||
33549034|NCT02901431|62940294|FG000|Main Treatment Part|Lost to Follow-up|0|||
33353191|NCT00571519|62730544|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
33353192|NCT00571519|62730545|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
33353193|NCT00676195|62730561|FG000|Overall Study|Lost to Follow-up|1|||
33353194|NCT00676195|62730561|FG000|Overall Study|Adverse Event|1|||
33353195|NCT00676195|62730561|FG000|Overall Study|Physician Decision|1|||
33472050|NCT04799158|62845977|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
33472051|NCT04799158|62845978|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
33472052|NCT04799158|62845979|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
33472053|NCT04799158|62845980|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
33472054|NCT04799158|62845976|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
33472055|NCT04799158|62845977|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
33472056|NCT04799158|62845978|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
33472057|NCT04799158|62845979|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
33472058|NCT04799158|62845980|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
33472059|NCT04799158|62845976|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
33472060|NCT04799158|62845977|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
33472061|NCT04799158|62845978|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
33472062|NCT04799158|62845979|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
33472063|NCT04799158|62845980|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
33472064|NCT04799158|62845976|FG000|On-Demand Treatment Period|Miscellaneous|0|||
33472065|NCT04799158|62845977|FG001|On-Demand Treatment Period|Miscellaneous|0|||
33472066|NCT04799158|62845978|FG002|On-Demand Treatment Period|Miscellaneous|0|||
33472067|NCT04799158|62845979|FG003|On-Demand Treatment Period|Miscellaneous|0|||
33472068|NCT04799158|62845980|FG004|On-Demand Treatment Period|Miscellaneous|1|||
33472069|NCT01319422|62845993|FG000|Overall Study|Withdrawal by Subject|1|||
33472070|NCT01319422|62845994|FG001|Overall Study|Withdrawal by Subject|0|||
33472071|NCT03102034|62846002|FG000|Overall Study|Withdrawal by Subject|1|||
33472072|NCT03102034|62846003|FG001|Overall Study|Withdrawal by Subject|0|||
33472073|NCT03774576|62846009|FG000|Period 2|Adverse Event|1|||
33472074|NCT02928952|62846020|FG000|Overall Study|Lost to Follow-up|5|||
33472075|NCT02928952|62846021|FG001|Overall Study|Lost to Follow-up|5|||
33472076|NCT02928952|62846020|FG000|Overall Study|Withdrawal by Subject|5|||
33472077|NCT02928952|62846021|FG001|Overall Study|Withdrawal by Subject|1|||
33472078|NCT02928952|62846020|FG000|Overall Study|Physician Decision|0|||
33472079|NCT02928952|62846021|FG001|Overall Study|Physician Decision|1|||
33472080|NCT03773796|62846027|FG000|Overall Study|Adverse Event|1|||
33472081|NCT03773796|62846027|FG000|Overall Study|Withdrawal by Subject|1|||
33472082|NCT03773796|62846027|FG000|Overall Study|Lack of Efficacy|1|||
33472083|NCT02927938|62846035|FG000|Overall Study|Death|0|||
33472084|NCT02927938|62846036|FG001|Overall Study|Death|1|||
33472085|NCT02927938|62846037|FG002|Overall Study|Death|0|||
33472086|NCT02927938|62846038|FG003|Overall Study|Death|4|||
33472087|NCT02927938|62846035|FG000|Overall Study|Early Study Termination|1|||
33472088|NCT02927938|62846036|FG001|Overall Study|Early Study Termination|5|||
33472089|NCT02927938|62846037|FG002|Overall Study|Early Study Termination|4|||
33472090|NCT02927938|62846038|FG003|Overall Study|Early Study Termination|3|||
33472091|NCT03765138|62846046|FG000|Overall Study|Lost to Follow-up|1|||
33472092|NCT03768726|62846053|FG000|Treatment Phase|Adverse Event|2|||
33472093|NCT03768726|62846054|FG001|Treatment Phase|Adverse Event|2|||
33472094|NCT03768726|62846053|FG000|Treatment Phase|Lost to Follow-up|1|||
33472095|NCT03768726|62846054|FG001|Treatment Phase|Lost to Follow-up|0|||
33472096|NCT03768726|62846053|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
33472097|NCT03768726|62846054|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
33472098|NCT03768726|62846053|FG000|Treatment Phase|Withdrawal by Subject|3|||
33472099|NCT03768726|62846054|FG001|Treatment Phase|Withdrawal by Subject|1|||
33472100|NCT03768726|62846053|FG000|Follow-Up|Adverse Event|2|||
33472101|NCT03768726|62846054|FG001|Follow-Up|Adverse Event|2|||
33472102|NCT03768726|62846053|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
33472103|NCT03768726|62846054|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
33472104|NCT03768726|62846053|FG000|Follow-Up|Withdrawal by Subject|2|||
33472105|NCT03768726|62846054|FG001|Follow-Up|Withdrawal by Subject|0|||
33549035|NCT02901431|62940295|FG001|Main Treatment Part|Lost to Follow-up|0|||
33655227|NCT01893905|63069681|FG001|Overall Study|Lack of adherence to treatment|0|||
33655228|NCT01893905|63069680|FG000|Overall Study|Other reason|1|||
33472106|NCT03768726|62846053|FG000|Follow-Up|Other|1|||
33472107|NCT03768726|62846054|FG001|Follow-Up|Other|0|||
33472108|NCT03769896|62846062|FG000|Open-label Phase|Lack of Efficacy|5|||
33472109|NCT03769896|62846063|FG001|Open-label Phase|Lack of Efficacy|0|||
33472110|NCT03769896|62846062|FG000|Open-label Phase|Adverse Event|3|||
33472111|NCT03769896|62846063|FG001|Open-label Phase|Adverse Event|0|||
33472112|NCT03769896|62846062|FG000|Open-label Phase|Withdrawal by Subject|1|||
33353196|NCT00675103|62730566|FG000|Overall Study|Lack of Efficacy|2|||
33353197|NCT00675103|62730566|FG000|Overall Study|Adverse Event|1|||
33353198|NCT00675025|62730572|FG000|Overall Study|Study Terminated by Sponsor|38|||
33353199|NCT00675025|62730573|FG001|Overall Study|Study Terminated by Sponsor|42|||
33353200|NCT00675025|62730572|FG000|Overall Study|Adverse Event|6|||
33353201|NCT00675025|62730573|FG001|Overall Study|Adverse Event|11|||
33353202|NCT00675025|62730572|FG000|Overall Study|Lost to Follow-up|6|||
33353203|NCT00675025|62730573|FG001|Overall Study|Lost to Follow-up|4|||
33353204|NCT00675025|62730572|FG000|Overall Study|Withdrawal by Subject|4|||
33353205|NCT00675025|62730573|FG001|Overall Study|Withdrawal by Subject|6|||
33353206|NCT00678379|62730591|FG000|Overall Study|Injection performed after tonsillectomy|2|||
33353207|NCT00678379|62730592|FG001|Overall Study|Injection performed after tonsillectomy|0|||
33353208|NCT00678379|62730593|FG002|Overall Study|Injection performed after tonsillectomy|1|||
33353209|NCT00678379|62730591|FG000|Overall Study|Incomplete Data|4|||
33353210|NCT00678379|62730592|FG001|Overall Study|Incomplete Data|3|||
33353211|NCT00678379|62730593|FG002|Overall Study|Incomplete Data|3|||
33353212|NCT00674323|62730604|FG000|Overall Study|Adverse Event|0|||
33353213|NCT00674323|62730605|FG001|Overall Study|Adverse Event|1|||
33353214|NCT00674323|62730606|FG002|Overall Study|Adverse Event|0|||
33353215|NCT00674323|62730604|FG000|Overall Study|Protocol Violation|1|||
33353216|NCT00674323|62730605|FG001|Overall Study|Protocol Violation|0|||
33353217|NCT00674323|62730606|FG002|Overall Study|Protocol Violation|0|||
33353218|NCT00678301|62730616|FG000|Overall Study|Non-compliance with study procedures|0|||
33353219|NCT00678301|62730617|FG001|Overall Study|Non-compliance with study procedures|1|||
33353220|NCT00678301|62730616|FG000|Overall Study|Adverse Event|1|||
33353221|NCT00678301|62730617|FG001|Overall Study|Adverse Event|0|||
33353222|NCT00678301|62730616|FG000|Overall Study|Withdrawal by Subject|4|||
33353223|NCT00678301|62730617|FG001|Overall Study|Withdrawal by Subject|0|||
33353224|NCT00678301|62730616|FG000|Overall Study|Lost to Follow-up|3|||
33353225|NCT00678301|62730617|FG001|Overall Study|Lost to Follow-up|1|||
33353226|NCT00939770|62730631|FG000|Overall Study|Adverse Event|1|||
33353227|NCT00939770|62730632|FG001|Overall Study|Adverse Event|1|||
33353228|NCT00939770|62730633|FG002|Overall Study|Adverse Event|0|||
33353229|NCT00939770|62730634|FG003|Overall Study|Adverse Event|0|||
33353230|NCT00939770|62730635|FG004|Overall Study|Adverse Event|6|||
33353231|NCT00939770|62730636|FG005|Overall Study|Adverse Event|2|||
33353232|NCT00939770|62730637|FG006|Overall Study|Adverse Event|1|||
33353233|NCT00939770|62730638|FG007|Overall Study|Adverse Event|1|||
33353234|NCT00939770|62730631|FG000|Overall Study|Lack of Efficacy|4|||
33353235|NCT00939770|62730632|FG001|Overall Study|Lack of Efficacy|6|||
33353236|NCT00939770|62730633|FG002|Overall Study|Lack of Efficacy|13|||
33353237|NCT00939770|62730634|FG003|Overall Study|Lack of Efficacy|9|||
33353238|NCT00939770|62730635|FG004|Overall Study|Lack of Efficacy|16|||
33353239|NCT00939770|62730636|FG005|Overall Study|Lack of Efficacy|8|||
33353240|NCT00939770|62730637|FG006|Overall Study|Lack of Efficacy|11|||
33353241|NCT00939770|62730638|FG007|Overall Study|Lack of Efficacy|1|||
33353242|NCT00939770|62730631|FG000|Overall Study|Lost to Follow-up|0|||
33353243|NCT00939770|62730632|FG001|Overall Study|Lost to Follow-up|0|||
33353244|NCT00939770|62730633|FG002|Overall Study|Lost to Follow-up|0|||
33353245|NCT00939770|62730634|FG003|Overall Study|Lost to Follow-up|0|||
33353246|NCT00939770|62730635|FG004|Overall Study|Lost to Follow-up|1|||
33353247|NCT00939770|62730636|FG005|Overall Study|Lost to Follow-up|0|||
33353248|NCT00939770|62730637|FG006|Overall Study|Lost to Follow-up|0|||
33353249|NCT00939770|62730638|FG007|Overall Study|Lost to Follow-up|0|||
33353250|NCT00939770|62730631|FG000|Overall Study|Physician Decision|0|||
33353251|NCT00939770|62730632|FG001|Overall Study|Physician Decision|0|||
33353252|NCT00939770|62730633|FG002|Overall Study|Physician Decision|2|||
33353253|NCT00939770|62730634|FG003|Overall Study|Physician Decision|0|||
33353254|NCT00939770|62730635|FG004|Overall Study|Physician Decision|7|||
33353255|NCT00939770|62730636|FG005|Overall Study|Physician Decision|1|||
33353256|NCT00939770|62730637|FG006|Overall Study|Physician Decision|0|||
33353257|NCT00939770|62730638|FG007|Overall Study|Physician Decision|6|||
33353258|NCT00939770|62730631|FG000|Overall Study|Protocol Violation|0|||
33353259|NCT00939770|62730632|FG001|Overall Study|Protocol Violation|0|||
33353260|NCT00939770|62730633|FG002|Overall Study|Protocol Violation|0|||
33353261|NCT00939770|62730634|FG003|Overall Study|Protocol Violation|0|||
33353262|NCT00939770|62730635|FG004|Overall Study|Protocol Violation|1|||
33353263|NCT00939770|62730636|FG005|Overall Study|Protocol Violation|0|||
33353264|NCT00939770|62730637|FG006|Overall Study|Protocol Violation|0|||
33353265|NCT00939770|62730638|FG007|Overall Study|Protocol Violation|0|||
33353266|NCT00939770|62730631|FG000|Overall Study|Withdrawal by Subject|0|||
33353267|NCT00939770|62730632|FG001|Overall Study|Withdrawal by Subject|1|||
33353268|NCT00939770|62730633|FG002|Overall Study|Withdrawal by Subject|5|||
33353269|NCT00939770|62730634|FG003|Overall Study|Withdrawal by Subject|2|||
33353270|NCT00939770|62730635|FG004|Overall Study|Withdrawal by Subject|6|||
33353271|NCT00939770|62730636|FG005|Overall Study|Withdrawal by Subject|0|||
33353272|NCT00939770|62730637|FG006|Overall Study|Withdrawal by Subject|2|||
33353273|NCT00939770|62730638|FG007|Overall Study|Withdrawal by Subject|2|||
33353274|NCT00939692|62730671|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
33353275|NCT00939692|62730672|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
33353276|NCT00939692|62730671|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
33353277|NCT00939692|62730672|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
33353278|NCT04672252|62730680|FG000|Overall Study|Protocol Violation|1|||
33353279|NCT04672252|62730681|FG001|Overall Study|Protocol Violation|0|||
33353280|NCT00584740|62730689|FG000|Overall Study|Adverse Event|1|||
33353281|NCT00584740|62730690|FG001|Overall Study|Adverse Event|1|||
33353282|NCT00584740|62730689|FG000|Overall Study|Lack of Efficacy|8|||
33353283|NCT00584740|62730690|FG001|Overall Study|Lack of Efficacy|2|||
33353284|NCT00584740|62730689|FG000|Overall Study|Withdrawal by Subject|3|||
33353285|NCT00584740|62730690|FG001|Overall Study|Withdrawal by Subject|2|||
33353286|NCT00584740|62730689|FG000|Overall Study|Lost to Follow-up|0|||
33353287|NCT00584740|62730690|FG001|Overall Study|Lost to Follow-up|1|||
33353288|NCT00942968|62730696|FG000|Overall Study|Adverse Event|60|||
33353289|NCT00942968|62730696|FG000|Overall Study|Death|76|||
33353290|NCT00942968|62730696|FG000|Overall Study|Protocol Violation|9|||
33353291|NCT00942968|62730696|FG000|Overall Study|Lost to Follow-up|4|||
33353292|NCT00942968|62730696|FG000|Overall Study|Withdrawal by Subject|44|||
33353293|NCT00942968|62730696|FG000|Overall Study|Sponsor request|5|||
33472113|NCT03769896|62846063|FG001|Open-label Phase|Withdrawal by Subject|0|||
33472114|NCT05047601|62846073|FG000|Overall Study|Lost to Follow-up|9|||
33472115|NCT05047601|62846074|FG001|Overall Study|Lost to Follow-up|11|||
33472116|NCT05047601|62846075|FG002|Overall Study|Lost to Follow-up|7|||
33472117|NCT05047601|62846073|FG000|Overall Study|Withdrawal by Subject|25|||
33472118|NCT05047601|62846074|FG001|Overall Study|Withdrawal by Subject|36|||
33472119|NCT05047601|62846075|FG002|Overall Study|Withdrawal by Subject|23|||
33472120|NCT05047601|62846073|FG000|Overall Study|Other|10|||
33472121|NCT05047601|62846074|FG001|Overall Study|Other|6|||
33472122|NCT05047601|62846075|FG002|Overall Study|Other|5|||
33472123|NCT04658784|62846089|FG000|6-month Follow-up|Lost to Follow-up|2|||
33472124|NCT04658784|62846090|FG001|6-month Follow-up|Lost to Follow-up|5|||
33472125|NCT04606394|62846096|FG000|Overall Study|Withdrawal by Subject|3|||
33472126|NCT04606394|62846096|FG000|Overall Study|Exclusion criteria screen failure|12|||
33472127|NCT04585451|62846110|FG000|Overall Study|Withdrawal by Subject|26|||
33472128|NCT04585451|62846111|FG001|Overall Study|Withdrawal by Subject|0|||
33472129|NCT04576988|62846118|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
33472130|NCT04576988|62846119|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
33472131|NCT04576988|62846118|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
33472132|NCT04576988|62846119|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
33472133|NCT04576988|62846118|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
33472134|NCT04576988|62846119|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
33353294|NCT00942968|62730696|FG000|Overall Study|Physician Decision|11|||
33353295|NCT00942968|62730696|FG000|Overall Study|Progression of disease|12|||
33353296|NCT00942968|62730696|FG000|Overall Study|Inferior vena cava filter placement|4|||
33353297|NCT00942968|62730696|FG000|Overall Study|Pulmonary embolism (PE)|1|||
33353298|NCT00942968|62730696|FG000|Overall Study|Participant required pancreatic biopsy|1|||
33472135|NCT04576988|62846118|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
33472136|NCT04576988|62846119|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
33472137|NCT04576988|62846118|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
33472138|NCT04576988|62846119|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
33472139|NCT04576988|62846118|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
33472140|NCT04576988|62846119|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
33353299|NCT00942968|62730696|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
33353300|NCT00942734|62730700|FG000|Overall Study|Adverse Event|2|||
33353301|NCT00942734|62730700|FG000|Overall Study|Protocol Violation|3|||
33353302|NCT00942734|62730700|FG000|Overall Study|Disease Progression|2|||
33353303|NCT00942734|62730700|FG000|Overall Study|Physician Decision|1|||
33353304|NCT00584194|62730704|FG000|Overall Study|Other|135|||
33353305|NCT00942422|62730708|FG000|Overall Study|Withdrawal by Subject|1|||
33353306|NCT00942422|62730708|FG000|Overall Study|Death|1|||
33353307|NCT00942422|62730708|FG000|Overall Study|Progressive diease|1|||
33353308|NCT00677833|62730716|FG000|Overall Study|Withdrawal by Subject|4|||
33353309|NCT00677833|62730717|FG001|Overall Study|Withdrawal by Subject|0|||
33353310|NCT00677833|62730718|FG002|Overall Study|Withdrawal by Subject|1|||
33353311|NCT00677833|62730719|FG003|Overall Study|Withdrawal by Subject|3|||
33353312|NCT00677833|62730716|FG000|Overall Study|Lost to Follow-up|0|||
33353313|NCT00677833|62730717|FG001|Overall Study|Lost to Follow-up|0|||
33353314|NCT00677833|62730718|FG002|Overall Study|Lost to Follow-up|1|||
33353315|NCT00677833|62730719|FG003|Overall Study|Lost to Follow-up|0|||
33353316|NCT00942266|62730729|FG000|Overall Study|Withdrawal by Subject|1|||
33353317|NCT00942266|62730730|FG001|Overall Study|Withdrawal by Subject|0|||
33353318|NCT00942266|62730729|FG000|Overall Study|Adverse Event|2|||
33353319|NCT00942266|62730730|FG001|Overall Study|Adverse Event|1|||
33353320|NCT00942266|62730729|FG000|Overall Study|Disease Progression|38|||
33353321|NCT00942266|62730730|FG001|Overall Study|Disease Progression|11|||
33353322|NCT00942266|62730729|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
33353323|NCT00942266|62730730|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
33353324|NCT00942266|62730729|FG000|Overall Study|Intercurrent illness|0|||
33353325|NCT00942266|62730730|FG001|Overall Study|Intercurrent illness|1|||
33353326|NCT00942266|62730729|FG000|Overall Study|Physician Decision|2|||
33472141|NCT04576988|62846118|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
33472142|NCT04576988|62846119|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
33472143|NCT04576988|62846118|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
33472144|NCT04576988|62846119|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
33472145|NCT04576988|62846118|FG000|Long Term Double Blind (LTDB)|Death|2|||
33472146|NCT04576988|62846119|FG001|Long Term Double Blind (LTDB)|Death|1|||
33472147|NCT04576988|62846118|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
33472148|NCT04576988|62846119|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
33472149|NCT04362189|62846151|FG000|Overall Study|Lost to Follow-up|0|||
33472150|NCT04362189|62846152|FG001|Overall Study|Lost to Follow-up|1|||
33472151|NCT04362189|62846151|FG000|Overall Study|Withdrawal by Subject|1|||
33472152|NCT04362189|62846152|FG001|Overall Study|Withdrawal by Subject|0|||
33472153|NCT04362189|62846151|FG000|Overall Study|FDA Clinical Hold|7|||
33472154|NCT04362189|62846152|FG001|Overall Study|FDA Clinical Hold|2|||
33549036|NCT02901431|62940296|FG002|Main Treatment Part|Lost to Follow-up|0|||
33655229|NCT01893905|63069681|FG001|Overall Study|Other reason|3|||
33353327|NCT00942266|62730730|FG001|Overall Study|Physician Decision|0|||
33353328|NCT00942266|62730729|FG000|Overall Study|medical deterioration (pneumonia)|0|||
33353329|NCT00942266|62730730|FG001|Overall Study|medical deterioration (pneumonia)|1|||
33353330|NCT00942188|62730740|FG000|Overall Study|Adverse Event|0|||
33353331|NCT00942188|62730741|FG001|Overall Study|Adverse Event|3|||
33353332|NCT00942188|62730742|FG002|Overall Study|Adverse Event|2|||
33353333|NCT00942188|62730743|FG003|Overall Study|Adverse Event|0|||
33353334|NCT00942188|62730740|FG000|Overall Study|Lack of Efficacy|0|||
33353335|NCT00942188|62730741|FG001|Overall Study|Lack of Efficacy|0|||
33353336|NCT00942188|62730742|FG002|Overall Study|Lack of Efficacy|0|||
33353337|NCT00942188|62730743|FG003|Overall Study|Lack of Efficacy|1|||
33353338|NCT00942188|62730740|FG000|Overall Study|Protocol Violation|1|||
33353339|NCT00942188|62730741|FG001|Overall Study|Protocol Violation|1|||
33353340|NCT00942188|62730742|FG002|Overall Study|Protocol Violation|0|||
33353341|NCT00942188|62730743|FG003|Overall Study|Protocol Violation|0|||
33353342|NCT00942188|62730740|FG000|Overall Study|Lost to Follow-up|2|||
33353343|NCT00942188|62730741|FG001|Overall Study|Lost to Follow-up|1|||
33353344|NCT00942188|62730742|FG002|Overall Study|Lost to Follow-up|2|||
33353345|NCT00942188|62730743|FG003|Overall Study|Lost to Follow-up|0|||
33353346|NCT00942188|62730740|FG000|Overall Study|Withdrawal by Subject|1|||
33353347|NCT00942188|62730741|FG001|Overall Study|Withdrawal by Subject|3|||
33353348|NCT00942188|62730742|FG002|Overall Study|Withdrawal by Subject|4|||
33353349|NCT00942188|62730743|FG003|Overall Study|Withdrawal by Subject|2|||
33353350|NCT00942188|62730740|FG000|Overall Study|Physician Decision|0|||
33353351|NCT00942188|62730741|FG001|Overall Study|Physician Decision|0|||
33549037|NCT02901431|62940297|FG003|Main Treatment Part|Lost to Follow-up|3|||
33549038|NCT02901431|62940298|FG004|Main Treatment Part|Lost to Follow-up|1|||
33549039|NCT02901431|62940299|FG005|Main Treatment Part|Lost to Follow-up|2|||
33353352|NCT00942188|62730742|FG002|Overall Study|Physician Decision|1|||
33472155|NCT04362189|62846151|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
33353353|NCT00942188|62730743|FG003|Overall Study|Physician Decision|0|||
33353354|NCT00942188|62730740|FG000|Overall Study|Sponsor Decision|0|||
33353355|NCT00942188|62730741|FG001|Overall Study|Sponsor Decision|2|||
33353356|NCT00942188|62730742|FG002|Overall Study|Sponsor Decision|0|||
33353357|NCT00942188|62730743|FG003|Overall Study|Sponsor Decision|1|||
33353358|NCT00673231|62730757|FG000|Overall Study|Withdrawal by Subject|14|||
33353359|NCT00673231|62730758|FG001|Overall Study|Withdrawal by Subject|10|||
33353360|NCT00673231|62730759|FG002|Overall Study|Withdrawal by Subject|8|||
33353361|NCT00673231|62730760|FG003|Overall Study|Withdrawal by Subject|6|||
33353362|NCT00673231|62730757|FG000|Overall Study|Adverse Event|6|||
33353363|NCT00673231|62730758|FG001|Overall Study|Adverse Event|5|||
33353364|NCT00673231|62730759|FG002|Overall Study|Adverse Event|9|||
33353365|NCT00673231|62730760|FG003|Overall Study|Adverse Event|6|||
33353366|NCT00673231|62730757|FG000|Overall Study|Lost to Follow-up|1|||
33353367|NCT00673231|62730758|FG001|Overall Study|Lost to Follow-up|2|||
33353368|NCT00673231|62730759|FG002|Overall Study|Lost to Follow-up|1|||
33353369|NCT00673231|62730760|FG003|Overall Study|Lost to Follow-up|2|||
33353370|NCT00673231|62730757|FG000|Overall Study|Death|0|||
33353371|NCT00673231|62730758|FG001|Overall Study|Death|0|||
33353372|NCT00673231|62730759|FG002|Overall Study|Death|1|||
33353373|NCT00673231|62730760|FG003|Overall Study|Death|0|||
33353374|NCT00673231|62730757|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
33353375|NCT00673231|62730758|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
33353376|NCT00673231|62730759|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
33353377|NCT00673231|62730760|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
33353378|NCT00672841|62730772|FG000|Overall Study|Comfort care|1|||
33353379|NCT00672841|62730773|FG001|Overall Study|Comfort care|4|||
33353380|NCT00672841|62730772|FG000|Overall Study|icteric specimens|0|||
33353381|NCT00672841|62730773|FG001|Overall Study|icteric specimens|3|||
33353382|NCT00672841|62730772|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
33353383|NCT00672841|62730773|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
33472156|NCT04362189|62846152|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
33472157|NCT04362189|62846151|FG000|Overall Study|Adverse Event|0|||
33472158|NCT04362189|62846152|FG001|Overall Study|Adverse Event|2|||
33472159|NCT04362189|62846151|FG000|Overall Study|Death|4|||
33472160|NCT04362189|62846152|FG001|Overall Study|Death|1|||
33472161|NCT04181788|62846226|FG000|TREATMENT|Adverse Event|0|||
33472162|NCT04181788|62846227|FG001|TREATMENT|Adverse Event|2|||
33472163|NCT04181788|62846228|FG002|TREATMENT|Adverse Event|1|||
33472164|NCT04181788|62846229|FG003|TREATMENT|Adverse Event|0|||
33472165|NCT04181788|62846230|FG004|TREATMENT|Adverse Event|1|||
33472166|NCT04181788|62846231|FG005|TREATMENT|Adverse Event|3|||
33549040|NCT02901431|62940300|FG006|Main Treatment Part|Lost to Follow-up|3|||
33549041|NCT02901431|62940301|FG007|Main Treatment Part|Lost to Follow-up|0|||
33549042|NCT02901431|62940302|FG008|Main Treatment Part|Lost to Follow-up|0|||
33549043|NCT02901431|62940303|FG009|Main Treatment Part|Lost to Follow-up|0|||
33549044|NCT02901431|62940304|FG010|Main Treatment Part|Lost to Follow-up|0|||
33549045|NCT02901431|62940305|FG011|Main Treatment Part|Lost to Follow-up|0|||
33549046|NCT02901431|62940306|FG012|Main Treatment Part|Lost to Follow-up|0|||
33549047|NCT02901431|62940294|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
33549048|NCT02901431|62940295|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
33549049|NCT02901431|62940296|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
33549050|NCT02901431|62940297|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
33549051|NCT02901431|62940298|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
33353384|NCT00672841|62730772|FG000|Overall Study|Adverse Event|0|||
33353385|NCT00672841|62730773|FG001|Overall Study|Adverse Event|3|||
33353386|NCT00672841|62730772|FG000|Overall Study|Pregnancy|0|||
33353387|NCT00672841|62730773|FG001|Overall Study|Pregnancy|1|||
33353388|NCT00673465|62730782|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
33353389|NCT00673465|62730783|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
33353390|NCT00673465|62730784|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
33353391|NCT00673465|62730785|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
33353392|NCT00673465|62730786|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
33353393|NCT00673465|62730787|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
33353394|NCT00673465|62730788|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
33353395|NCT00673465|62730789|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
33353396|NCT00673465|62730790|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
33353397|NCT00673465|62730791|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
33353398|NCT00673465|62730792|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
33549052|NCT02901431|62940299|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
33549053|NCT02901431|62940300|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
33655230|NCT01893827|63069694|FG000|Overall Study|Lost to Follow-up|19|||
33353399|NCT00673465|62730793|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
33353400|NCT00673465|62730782|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
33353401|NCT00673465|62730783|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
33353402|NCT00673465|62730784|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
33353403|NCT00673465|62730785|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
33353404|NCT00673465|62730786|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
33353405|NCT00673465|62730787|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
33353406|NCT00673465|62730788|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
33472167|NCT04181788|62846226|FG000|TREATMENT|Death|0|||
33472168|NCT04181788|62846227|FG001|TREATMENT|Death|0|||
33549054|NCT02901431|62940301|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
33353407|NCT00673465|62730789|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
33353408|NCT00673465|62730790|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
33353409|NCT00673465|62730791|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
33353410|NCT00673465|62730792|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
33353411|NCT00673465|62730793|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
33353412|NCT00941798|62730803|FG000|Overall Study|Withdrawal by Subject|72|||
33353413|NCT00941798|62730804|FG001|Overall Study|Withdrawal by Subject|74|||
33353414|NCT00941798|62730803|FG000|Overall Study|Adverse Event|43|||
33353415|NCT00941798|62730804|FG001|Overall Study|Adverse Event|23|||
33353416|NCT00941798|62730803|FG000|Overall Study|Lost to Follow-up|29|||
33353417|NCT00941798|62730804|FG001|Overall Study|Lost to Follow-up|23|||
33353418|NCT00941798|62730803|FG000|Overall Study|Protocol Violation|17|||
33353419|NCT00941798|62730804|FG001|Overall Study|Protocol Violation|20|||
33353420|NCT00941798|62730803|FG000|Overall Study|Administrative problems|13|||
33353421|NCT00941798|62730804|FG001|Overall Study|Administrative problems|23|||
33353422|NCT00941798|62730803|FG000|Overall Study|Lack of Efficacy|10|||
33353423|NCT00941798|62730804|FG001|Overall Study|Lack of Efficacy|17|||
33353424|NCT00941798|62730803|FG000|Overall Study|Patient's inability to use device|6|||
33353425|NCT00941798|62730804|FG001|Overall Study|Patient's inability to use device|1|||
33353426|NCT00941798|62730803|FG000|Overall Study|Abnormal test procedure results|3|||
33353427|NCT00941798|62730804|FG001|Overall Study|Abnormal test procedure results|1|||
33353428|NCT00941798|62730803|FG000|Overall Study|Abnormal laboratory values|1|||
33353429|NCT00941798|62730804|FG001|Overall Study|Abnormal laboratory values|2|||
33353430|NCT00941798|62730803|FG000|Overall Study|Death|0|||
33353431|NCT00941798|62730804|FG001|Overall Study|Death|1|||
33353432|NCT00583102|62730810|FG000|Overall Study|Adverse Event|3|||
33353433|NCT05208866|62730818|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
33353434|NCT04745351|62730833|FG000|Overall Study|Death|51|||
33353435|NCT04745351|62730834|FG001|Overall Study|Death|25|||
33353436|NCT04745351|62730833|FG000|Overall Study|Lost to Follow-up|9|||
33353437|NCT04745351|62730834|FG001|Overall Study|Lost to Follow-up|3|||
33353438|NCT04745351|62730833|FG000|Overall Study|Randomized but Never Treated|3|||
33353439|NCT04745351|62730834|FG001|Overall Study|Randomized but Never Treated|3|||
33353440|NCT04745351|62730833|FG000|Overall Study|Adverse Event|4|||
33353441|NCT04745351|62730834|FG001|Overall Study|Adverse Event|0|||
33353442|NCT04745351|62730833|FG000|Overall Study|Withdrew Consent|1|||
33353443|NCT04745351|62730834|FG001|Overall Study|Withdrew Consent|2|||
33472169|NCT04181788|62846228|FG002|TREATMENT|Death|0|||
33472170|NCT04181788|62846229|FG003|TREATMENT|Death|0|||
33472171|NCT04181788|62846230|FG004|TREATMENT|Death|8|||
33472172|NCT04181788|62846231|FG005|TREATMENT|Death|8|||
33472173|NCT04181788|62846226|FG000|TREATMENT|Physician Decision|0|||
33472174|NCT04181788|62846227|FG001|TREATMENT|Physician Decision|0|||
33472175|NCT04181788|62846228|FG002|TREATMENT|Physician Decision|0|||
33472176|NCT04181788|62846229|FG003|TREATMENT|Physician Decision|0|||
33472177|NCT04181788|62846230|FG004|TREATMENT|Physician Decision|0|||
33353444|NCT04745351|62730833|FG000|Overall Study|Investigator's Discretion|2|||
33353445|NCT04745351|62730834|FG001|Overall Study|Investigator's Discretion|0|||
33353446|NCT04745351|62730833|FG000|Overall Study|Protocol Violation|1|||
33353447|NCT04745351|62730834|FG001|Overall Study|Protocol Violation|0|||
33353448|NCT04427501|62730859|FG000|Overall Study|Death|0|||
33353449|NCT04427501|62730860|FG001|Overall Study|Death|0|||
33353450|NCT04427501|62730861|FG002|Overall Study|Death|0|||
33472178|NCT04181788|62846231|FG005|TREATMENT|Physician Decision|1|||
33472179|NCT04181788|62846226|FG000|TREATMENT|Progressive disease|3|||
33472180|NCT04181788|62846227|FG001|TREATMENT|Progressive disease|3|||
33472181|NCT04181788|62846228|FG002|TREATMENT|Progressive disease|5|||
33472182|NCT04181788|62846229|FG003|TREATMENT|Progressive disease|7|||
33472183|NCT04181788|62846230|FG004|TREATMENT|Progressive disease|20|||
33472184|NCT04181788|62846231|FG005|TREATMENT|Progressive disease|38|||
33472185|NCT04181788|62846226|FG000|TREATMENT|Global deterioration of health status|0|||
33353451|NCT04427501|62730862|FG003|Overall Study|Death|0|||
33353452|NCT04427501|62730863|FG004|Overall Study|Death|0|||
33353453|NCT04427501|62730864|FG005|Overall Study|Death|15|||
33353454|NCT04427501|62730865|FG006|Overall Study|Death|0|||
33353455|NCT04427501|62730866|FG007|Overall Study|Death|0|||
33353456|NCT04427501|62730867|FG008|Overall Study|Death|0|||
33353457|NCT04427501|62730868|FG009|Overall Study|Death|0|||
33353458|NCT04427501|62730859|FG000|Overall Study|Lost to Follow-up|5|||
33353459|NCT04427501|62730860|FG001|Overall Study|Lost to Follow-up|1|||
33353460|NCT04427501|62730861|FG002|Overall Study|Lost to Follow-up|2|||
33353461|NCT04427501|62730862|FG003|Overall Study|Lost to Follow-up|0|||
33353462|NCT04427501|62730863|FG004|Overall Study|Lost to Follow-up|2|||
33353463|NCT04427501|62730864|FG005|Overall Study|Lost to Follow-up|11|||
33353464|NCT04427501|62730865|FG006|Overall Study|Lost to Follow-up|10|||
33353465|NCT04427501|62730866|FG007|Overall Study|Lost to Follow-up|10|||
33353466|NCT04427501|62730867|FG008|Overall Study|Lost to Follow-up|2|||
33353467|NCT04427501|62730868|FG009|Overall Study|Lost to Follow-up|5|||
33353468|NCT04427501|62730859|FG000|Overall Study|Physician Decision|0|||
33353469|NCT04427501|62730860|FG001|Overall Study|Physician Decision|3|||
33353470|NCT04427501|62730861|FG002|Overall Study|Physician Decision|0|||
33353471|NCT04427501|62730862|FG003|Overall Study|Physician Decision|0|||
33353472|NCT04427501|62730863|FG004|Overall Study|Physician Decision|0|||
33353473|NCT04427501|62730864|FG005|Overall Study|Physician Decision|0|||
33353474|NCT04427501|62730865|FG006|Overall Study|Physician Decision|2|||
33353475|NCT04427501|62730866|FG007|Overall Study|Physician Decision|0|||
33353476|NCT04427501|62730867|FG008|Overall Study|Physician Decision|0|||
33353477|NCT04427501|62730868|FG009|Overall Study|Physician Decision|0|||
33353478|NCT04427501|62730859|FG000|Overall Study|Withdrawal by Subject|9|||
33353479|NCT04427501|62730860|FG001|Overall Study|Withdrawal by Subject|2|||
33353480|NCT04427501|62730861|FG002|Overall Study|Withdrawal by Subject|2|||
33353481|NCT04427501|62730862|FG003|Overall Study|Withdrawal by Subject|3|||
33353482|NCT04427501|62730863|FG004|Overall Study|Withdrawal by Subject|7|||
33353483|NCT04427501|62730864|FG005|Overall Study|Withdrawal by Subject|25|||
33353484|NCT04427501|62730865|FG006|Overall Study|Withdrawal by Subject|15|||
33353485|NCT04427501|62730866|FG007|Overall Study|Withdrawal by Subject|7|||
33353486|NCT04427501|62730867|FG008|Overall Study|Withdrawal by Subject|4|||
33353487|NCT04427501|62730868|FG009|Overall Study|Withdrawal by Subject|1|||
33353488|NCT04427501|62730859|FG000|Overall Study|Other - as reported by the investigator|1|||
33353489|NCT04427501|62730860|FG001|Overall Study|Other - as reported by the investigator|0|||
33353490|NCT04427501|62730861|FG002|Overall Study|Other - as reported by the investigator|0|||
33353491|NCT04427501|62730862|FG003|Overall Study|Other - as reported by the investigator|0|||
33353492|NCT04427501|62730863|FG004|Overall Study|Other - as reported by the investigator|0|||
33472186|NCT04181788|62846227|FG001|TREATMENT|Global deterioration of health status|2|||
33472187|NCT04181788|62846228|FG002|TREATMENT|Global deterioration of health status|0|||
33353493|NCT04427501|62730864|FG005|Overall Study|Other - as reported by the investigator|6|||
33353494|NCT04427501|62730865|FG006|Overall Study|Other - as reported by the investigator|6|||
33472188|NCT04181788|62846229|FG003|TREATMENT|Global deterioration of health status|0|||
33353495|NCT04427501|62730866|FG007|Overall Study|Other - as reported by the investigator|0|||
33353496|NCT04427501|62730867|FG008|Overall Study|Other - as reported by the investigator|0|||
33353497|NCT04427501|62730868|FG009|Overall Study|Other - as reported by the investigator|0|||
33472189|NCT04181788|62846230|FG004|TREATMENT|Global deterioration of health status|2|||
33472190|NCT04181788|62846231|FG005|TREATMENT|Global deterioration of health status|8|||
33472191|NCT04181788|62846226|FG000|TREATMENT|Withdrawal by Subject|1|||
33472192|NCT04181788|62846227|FG001|TREATMENT|Withdrawal by Subject|2|||
33549055|NCT02901431|62940302|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
33549056|NCT02901431|62940303|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
33549057|NCT02901431|62940304|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
33549058|NCT02901431|62940305|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
33549059|NCT02901431|62940306|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
33655231|NCT01893827|63069695|FG001|Overall Study|Lost to Follow-up|26|||
33655232|NCT01882907|63069703|FG000|Overall Study|Adverse Event|3|||
33353498|NCT03439124|62730920|FG000|Overall Study|Adverse Event|2|||
33353499|NCT03439124|62730921|FG001|Overall Study|Adverse Event|0|||
33353500|NCT03439124|62730920|FG000|Overall Study|Lost to Follow-up|1|||
33353501|NCT03439124|62730921|FG001|Overall Study|Lost to Follow-up|0|||
33549060|NCT02901431|62940294|FG000|Main Treatment Part|Physician Decision|0|||
33353502|NCT03439124|62730920|FG000|Overall Study|Other reasons|1|||
33353503|NCT03439124|62730921|FG001|Overall Study|Other reasons|0|||
33353504|NCT03212989|62730940|FG000|Overall Study|Physician Decision|8|||
33472193|NCT04181788|62846228|FG002|TREATMENT|Withdrawal by Subject|0|||
33549061|NCT02901431|62940295|FG001|Main Treatment Part|Physician Decision|0|||
33353505|NCT03200548|62730948|FG000|Overall Study|Withdrawal by Subject|5|||
33353506|NCT03200548|62730949|FG001|Overall Study|Withdrawal by Subject|11|||
33353507|NCT03200548|62730950|FG002|Overall Study|Withdrawal by Subject|7|||
33353508|NCT03200548|62730951|FG003|Overall Study|Withdrawal by Subject|6|||
33353509|NCT03158688|62730963|FG000|Overall Study|Withdrawal by Subject|14|||
33353510|NCT03158688|62730964|FG001|Overall Study|Withdrawal by Subject|28|||
33353511|NCT03158688|62730963|FG000|Overall Study|Decision by sponsor|13|||
33353512|NCT03158688|62730964|FG001|Overall Study|Decision by sponsor|37|||
33353513|NCT03158688|62730963|FG000|Overall Study|Lost to Follow-up|4|||
33353514|NCT03158688|62730964|FG001|Overall Study|Lost to Follow-up|3|||
33353515|NCT03158688|62730963|FG000|Overall Study|Death|74|||
33353516|NCT03158688|62730964|FG001|Overall Study|Death|142|||
33353517|NCT03138733|62730972|FG000|Overall Study|Death|17|||
33353518|NCT03138733|62730973|FG001|Overall Study|Death|18|||
33353519|NCT03138733|62730972|FG000|Overall Study|Withdrawal by Subject|11|||
33353520|NCT03138733|62730973|FG001|Overall Study|Withdrawal by Subject|6|||
33353521|NCT03138733|62730972|FG000|Overall Study|Lost to Follow-up|3|||
33353522|NCT03138733|62730973|FG001|Overall Study|Lost to Follow-up|2|||
33353523|NCT03138733|62730972|FG000|Overall Study|Adverse Event|1|||
33353524|NCT03138733|62730973|FG001|Overall Study|Adverse Event|0|||
33353525|NCT03138733|62730972|FG000|Overall Study|Protocol Violation|1|||
33353526|NCT03138733|62730973|FG001|Overall Study|Protocol Violation|3|||
33353527|NCT03138733|62730972|FG000|Overall Study|Administrative or logistical reason|1|||
33353528|NCT03138733|62730973|FG001|Overall Study|Administrative or logistical reason|0|||
33353529|NCT03138733|62730972|FG000|Overall Study|The patient was transferred to another hospital|1|||
33353530|NCT03138733|62730973|FG001|Overall Study|The patient was transferred to another hospital|0|||
33353531|NCT03137173|62730981|FG000|Overall Study|Withdrawal by Subject|8|||
33353532|NCT03137173|62730982|FG001|Overall Study|Withdrawal by Subject|13|||
33353533|NCT03137173|62730981|FG000|Overall Study|Death|1|||
33353534|NCT03137173|62730982|FG001|Overall Study|Death|3|||
33353535|NCT03137173|62730981|FG000|Overall Study|Physician Decision|1|||
33353536|NCT03137173|62730982|FG001|Overall Study|Physician Decision|0|||
33353537|NCT03137173|62730981|FG000|Overall Study|Lost to Follow-up|13|||
33353538|NCT03137173|62730982|FG001|Overall Study|Lost to Follow-up|18|||
33353539|NCT03137173|62730981|FG000|Overall Study|Other reasons|3|||
33353540|NCT03137173|62730982|FG001|Overall Study|Other reasons|2|||
33353541|NCT02087423|62731008|FG000|Overall Study|Withdrawal by Subject|20|||
33353542|NCT02087423|62731009|FG001|Overall Study|Withdrawal by Subject|20|||
33353543|NCT02087423|62731010|FG002|Overall Study|Withdrawal by Subject|3|||
33353544|NCT02087423|62731008|FG000|Overall Study|Death|68|||
33353545|NCT02087423|62731009|FG001|Overall Study|Death|207|||
33353546|NCT02087423|62731010|FG002|Overall Study|Death|40|||
33353547|NCT02087423|62731008|FG000|Overall Study|Lost to Follow-up|0|||
33353548|NCT02087423|62731009|FG001|Overall Study|Lost to Follow-up|2|||
33353549|NCT02087423|62731010|FG002|Overall Study|Lost to Follow-up|0|||
33353550|NCT02087423|62731008|FG000|Overall Study|Terminated from study at final DCO|23|||
33353551|NCT02087423|62731009|FG001|Overall Study|Terminated from study at final DCO|36|||
33353552|NCT02087423|62731010|FG002|Overall Study|Terminated from study at final DCO|25|||
33353553|NCT01575808|62731044|FG000|Overall Study|Death|2|||
33353554|NCT01575808|62731045|FG001|Overall Study|Death|0|||
33353555|NCT01575808|62731044|FG000|Overall Study|Withdrawal by Subject|1|||
33353556|NCT01575808|62731045|FG001|Overall Study|Withdrawal by Subject|0|||
33353557|NCT01546753|62731055|FG000|Overall Study|anxiety|1|||
33353558|NCT01546753|62731056|FG001|Overall Study|anxiety|1|||
33353559|NCT01546753|62731055|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
33353560|NCT01546753|62731056|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
33353561|NCT00941720|62731069|FG000|Overall Study|Withdrawal by Subject|1|||
33353562|NCT00941720|62731069|FG000|Overall Study|Insurance denied participation|11|||
33353563|NCT00941720|62731069|FG000|Overall Study|ineligible|2|||
33353564|NCT00933686|62731075|FG000|Overall Study|Protocol Violation|0|||
33353565|NCT00933686|62731076|FG001|Overall Study|Protocol Violation|1|||
33353566|NCT00933686|62731075|FG000|Overall Study|Lost to Follow-up|2|||
33353567|NCT00933686|62731076|FG001|Overall Study|Lost to Follow-up|2|||
33353568|NCT00933686|62731075|FG000|Overall Study|Withdrawal by Subject|6|||
33353569|NCT00933686|62731076|FG001|Overall Study|Withdrawal by Subject|5|||
33353570|NCT00933686|62731075|FG000|Overall Study|Adverse Event|1|||
33353571|NCT00933686|62731076|FG001|Overall Study|Adverse Event|1|||
33353572|NCT00933686|62731075|FG000|Overall Study|Physician Decision|1|||
33353573|NCT00933686|62731076|FG001|Overall Study|Physician Decision|0|||
33353574|NCT00933686|62731075|FG000|Overall Study|Failure to show up at endpoint visits|0|||
33353575|NCT00933686|62731076|FG001|Overall Study|Failure to show up at endpoint visits|2|||
33353576|NCT00937040|62731084|FG000|Overall Study|Adverse Event|5|||
33353577|NCT00937040|62731085|FG001|Overall Study|Adverse Event|8|||
33353578|NCT00937040|62731084|FG000|Overall Study|Lost to Follow-up|12|||
33353579|NCT00937040|62731085|FG001|Overall Study|Lost to Follow-up|12|||
33353580|NCT00937040|62731084|FG000|Overall Study|Protocol Violation|3|||
33353581|NCT00937040|62731085|FG001|Overall Study|Protocol Violation|0|||
33353582|NCT00937040|62731084|FG000|Overall Study|Withdrawal by Subject|13|||
33353583|NCT00937040|62731085|FG001|Overall Study|Withdrawal by Subject|7|||
33353584|NCT00937040|62731084|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
33353585|NCT00937040|62731085|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
33353586|NCT00937040|62731084|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
33353587|NCT00937040|62731085|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
33353588|NCT00673387|62731099|FG000|Overall Study|Withdrawal by Subject|15|||
33353589|NCT00673387|62731100|FG001|Overall Study|Withdrawal by Subject|16|||
33353590|NCT00673387|62731101|FG002|Overall Study|Withdrawal by Subject|20|||
33353591|NCT00673387|62731102|FG003|Overall Study|Withdrawal by Subject|16|||
33353592|NCT00673387|62731103|FG004|Overall Study|Withdrawal by Subject|18|||
33353593|NCT00673387|62731104|FG005|Overall Study|Withdrawal by Subject|21|||
33353594|NCT00673387|62731105|FG006|Overall Study|Withdrawal by Subject|15|||
33353595|NCT00673387|62731106|FG007|Overall Study|Withdrawal by Subject|21|||
33353596|NCT00673387|62731099|FG000|Overall Study|Adverse Event|3|||
33353597|NCT00673387|62731100|FG001|Overall Study|Adverse Event|1|||
33353598|NCT00673387|62731101|FG002|Overall Study|Adverse Event|5|||
33353599|NCT00673387|62731102|FG003|Overall Study|Adverse Event|2|||
33353600|NCT00673387|62731103|FG004|Overall Study|Adverse Event|6|||
33353601|NCT00673387|62731104|FG005|Overall Study|Adverse Event|2|||
33353602|NCT00673387|62731105|FG006|Overall Study|Adverse Event|5|||
33353603|NCT00673387|62731106|FG007|Overall Study|Adverse Event|5|||
33353604|NCT00673387|62731099|FG000|Overall Study|Physician Decision|0|||
33353605|NCT00673387|62731100|FG001|Overall Study|Physician Decision|0|||
33353606|NCT00673387|62731101|FG002|Overall Study|Physician Decision|0|||
33353607|NCT00673387|62731102|FG003|Overall Study|Physician Decision|0|||
33353608|NCT00673387|62731103|FG004|Overall Study|Physician Decision|0|||
33353609|NCT00673387|62731104|FG005|Overall Study|Physician Decision|5|||
33353610|NCT00673387|62731105|FG006|Overall Study|Physician Decision|1|||
33353611|NCT00673387|62731106|FG007|Overall Study|Physician Decision|1|||
33353612|NCT00673387|62731099|FG000|Overall Study|Protocol Violation|3|||
33353613|NCT00673387|62731100|FG001|Overall Study|Protocol Violation|0|||
33353614|NCT00673387|62731101|FG002|Overall Study|Protocol Violation|1|||
33353615|NCT00673387|62731102|FG003|Overall Study|Protocol Violation|2|||
33353616|NCT00673387|62731103|FG004|Overall Study|Protocol Violation|0|||
33353617|NCT00673387|62731104|FG005|Overall Study|Protocol Violation|1|||
33353618|NCT00673387|62731105|FG006|Overall Study|Protocol Violation|1|||
33353619|NCT00673387|62731106|FG007|Overall Study|Protocol Violation|3|||
33353620|NCT00673387|62731099|FG000|Overall Study|Lost to Follow-up|8|||
33353621|NCT00673387|62731100|FG001|Overall Study|Lost to Follow-up|6|||
33353622|NCT00673387|62731101|FG002|Overall Study|Lost to Follow-up|5|||
33353623|NCT00673387|62731102|FG003|Overall Study|Lost to Follow-up|6|||
33353624|NCT00673387|62731103|FG004|Overall Study|Lost to Follow-up|6|||
33353625|NCT00673387|62731104|FG005|Overall Study|Lost to Follow-up|5|||
33353626|NCT00673387|62731105|FG006|Overall Study|Lost to Follow-up|8|||
33353627|NCT00673387|62731106|FG007|Overall Study|Lost to Follow-up|5|||
33353628|NCT00933608|62731136|FG000|Overall Study|Adverse Event|4|||
33353629|NCT00933608|62731137|FG001|Overall Study|Adverse Event|2|||
33353630|NCT00933608|62731136|FG000|Overall Study|Physician Decision|1|||
33353631|NCT00933608|62731137|FG001|Overall Study|Physician Decision|0|||
33353632|NCT00574951|62731143|FG000|Overall Study|Ineligible - improper prior treatment|1|||
33353633|NCT01557751|62731147|FG000|Overall Study|Physician Decision|3|||
33353634|NCT00936884|62731153|FG000|Double-blind|Withdrawal by Subject|6|||
33353635|NCT00936884|62731154|FG001|Double-blind|Withdrawal by Subject|4|||
33353636|NCT00936884|62731155|FG002|Double-blind|Withdrawal by Subject|0|||
33353637|NCT00936884|62731153|FG000|Double-blind|Death|2|||
33353638|NCT00936884|62731154|FG001|Double-blind|Death|1|||
33353639|NCT00936884|62731155|FG002|Double-blind|Death|0|||
33353640|NCT00936884|62731153|FG000|Double-blind|Lack of Efficacy|1|||
33353641|NCT00936884|62731154|FG001|Double-blind|Lack of Efficacy|1|||
33353642|NCT00936884|62731155|FG002|Double-blind|Lack of Efficacy|0|||
33353643|NCT00936884|62731153|FG000|Double-blind|Adverse Event|1|||
33353644|NCT00936884|62731154|FG001|Double-blind|Adverse Event|0|||
33353645|NCT00936884|62731155|FG002|Double-blind|Adverse Event|0|||
33353646|NCT00936884|62731153|FG000|Double-blind|Physician Decision|1|||
33353647|NCT00936884|62731154|FG001|Double-blind|Physician Decision|0|||
33472194|NCT04181788|62846229|FG003|TREATMENT|Withdrawal by Subject|0|||
33353648|NCT00936884|62731155|FG002|Double-blind|Physician Decision|0|||
33353649|NCT00936884|62731153|FG000|Double-blind|No post baseline diary entry|1|||
33353650|NCT00936884|62731154|FG001|Double-blind|No post baseline diary entry|0|||
33353651|NCT00936884|62731155|FG002|Double-blind|No post baseline diary entry|0|||
33472195|NCT04181788|62846230|FG004|TREATMENT|Withdrawal by Subject|3|||
33472196|NCT04181788|62846231|FG005|TREATMENT|Withdrawal by Subject|5|||
33472197|NCT04181788|62846226|FG000|TREATMENT|Other unspecified|0|||
33472198|NCT04181788|62846227|FG001|TREATMENT|Other unspecified|0|||
33472199|NCT04181788|62846228|FG002|TREATMENT|Other unspecified|0|||
33472200|NCT04181788|62846229|FG003|TREATMENT|Other unspecified|0|||
33472201|NCT04181788|62846230|FG004|TREATMENT|Other unspecified|0|||
33472202|NCT04181788|62846231|FG005|TREATMENT|Other unspecified|2|||
33472203|NCT04181788|62846226|FG000|TREATMENT|Ongoing|0|||
33472204|NCT04181788|62846227|FG001|TREATMENT|Ongoing|3|||
33472205|NCT04181788|62846228|FG002|TREATMENT|Ongoing|0|||
33472206|NCT04181788|62846229|FG003|TREATMENT|Ongoing|5|||
33472207|NCT04181788|62846230|FG004|TREATMENT|Ongoing|7|||
33472208|NCT04181788|62846231|FG005|TREATMENT|Ongoing|15|||
33472209|NCT04181788|62846226|FG000|FOLLOW-UP|Death|0|||
33472210|NCT04181788|62846227|FG001|FOLLOW-UP|Death|0|||
33472211|NCT04181788|62846228|FG002|FOLLOW-UP|Death|1|||
33472212|NCT04181788|62846229|FG003|FOLLOW-UP|Death|2|||
33472213|NCT04181788|62846230|FG004|FOLLOW-UP|Death|8|||
33472214|NCT04181788|62846231|FG005|FOLLOW-UP|Death|20|||
33472215|NCT04181788|62846226|FG000|FOLLOW-UP|Lost to Follow-up|0|||
33472216|NCT04181788|62846227|FG001|FOLLOW-UP|Lost to Follow-up|0|||
33472217|NCT04181788|62846228|FG002|FOLLOW-UP|Lost to Follow-up|0|||
33472218|NCT04181788|62846229|FG003|FOLLOW-UP|Lost to Follow-up|0|||
33472219|NCT04181788|62846230|FG004|FOLLOW-UP|Lost to Follow-up|0|||
33655233|NCT01882907|63069704|FG001|Overall Study|Adverse Event|1|||
33472220|NCT04181788|62846231|FG005|FOLLOW-UP|Lost to Follow-up|2|||
33472221|NCT04181788|62846226|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
33472222|NCT04181788|62846227|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
33472223|NCT04181788|62846228|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
33472224|NCT04181788|62846229|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
33472225|NCT04181788|62846230|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
33472226|NCT04181788|62846231|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
33472227|NCT04181788|62846226|FG000|FOLLOW-UP|Other unspecified|0|||
33353652|NCT00936884|62731153|FG000|Double-blind|Did not receive study drug|0|||
33353653|NCT00936884|62731154|FG001|Double-blind|Did not receive study drug|1|||
33353654|NCT00936884|62731155|FG002|Double-blind|Did not receive study drug|0|||
33353655|NCT00668863|62731171|FG000|Overall Study|Objective Progression or Relapse|42|||
33353656|NCT00668863|62731171|FG000|Overall Study|Adverse Event|13|||
33353657|NCT00668863|62731171|FG000|Overall Study|Study Terminated by Sponsor|8|||
33353658|NCT00668863|62731171|FG000|Overall Study|Global Deterioration of Health Status|4|||
33353659|NCT00668863|62731171|FG000|Overall Study|Withdrawal by Subject|1|||
33353660|NCT00668863|62731171|FG000|Overall Study|Surgery|1|||
33353661|NCT00668863|62731171|FG000|Overall Study|Subject's work scheduling problem|1|||
33353662|NCT00668863|62731171|FG000|Overall Study|Physician Decision|1|||
33353663|NCT00935012|62731175|FG000|Overall Study|Death|19|||
33353664|NCT00935012|62731175|FG000|Overall Study|Withdrawal by Subject|3|||
33353665|NCT00935012|62731175|FG000|Overall Study|Other|5|||
33353666|NCT00935012|62731175|FG000|Overall Study|Adverse Event|2|||
33353667|NCT00932360|62731179|FG000|Washout (One Week)|Withdrawal by Subject|0|||
33353668|NCT00932360|62731180|FG001|Washout (One Week)|Withdrawal by Subject|0|||
33353669|NCT00932360|62731181|FG002|Washout (One Week)|Withdrawal by Subject|0|||
33353670|NCT00932360|62731182|FG003|Washout (One Week)|Withdrawal by Subject|0|||
33353671|NCT00932360|62731183|FG004|Washout (One Week)|Withdrawal by Subject|2|||
33353672|NCT00932360|62731184|FG005|Washout (One Week)|Withdrawal by Subject|0|||
33353673|NCT00668707|62731200|FG000|Overall Study|Cancer Recurrence|58|||
33353674|NCT00668707|62731201|FG001|Overall Study|Cancer Recurrence|58|||
33353675|NCT00668707|62731200|FG000|Overall Study|Withdrawal by Subject|117|||
33353676|NCT00668707|62731201|FG001|Overall Study|Withdrawal by Subject|100|||
33353677|NCT00668707|62731200|FG000|Overall Study|Lost to Follow-up|3|||
33353678|NCT00668707|62731201|FG001|Overall Study|Lost to Follow-up|6|||
33353679|NCT00668707|62731200|FG000|Overall Study|Protocol Violation|10|||
33353680|NCT00668707|62731201|FG001|Overall Study|Protocol Violation|12|||
33353681|NCT00668707|62731200|FG000|Overall Study|Death|11|||
33353682|NCT00668707|62731201|FG001|Overall Study|Death|4|||
33353683|NCT00668395|62731215|FG000|Overall Study|Withdrawal by Subject|4|||
33353684|NCT00668395|62731216|FG001|Overall Study|Withdrawal by Subject|4|||
33353685|NCT00668395|62731217|FG002|Overall Study|Withdrawal by Subject|1|||
33353686|NCT00668395|62731215|FG000|Overall Study|Adverse Event|1|||
33353687|NCT00668395|62731216|FG001|Overall Study|Adverse Event|1|||
33353688|NCT00668395|62731217|FG002|Overall Study|Adverse Event|0|||
33353689|NCT00668395|62731215|FG000|Overall Study|Physician Decision|1|||
33353690|NCT00668395|62731216|FG001|Overall Study|Physician Decision|1|||
33353691|NCT00668395|62731217|FG002|Overall Study|Physician Decision|0|||
33655234|NCT01882907|63069703|FG000|Overall Study|Lack of Efficacy|0|||
33655235|NCT01882907|63069704|FG001|Overall Study|Lack of Efficacy|3|||
33655236|NCT01882907|63069703|FG000|Overall Study|Lost to Follow-up|1|||
33353692|NCT00668317|62731225|FG000|Overall Study|Adverse Event|2|||
33353693|NCT00670111|62731246|FG000|Enrollment to One Month|Testing Failure|0|||
33655237|NCT01882907|63069704|FG001|Overall Study|Lost to Follow-up|4|||
33353694|NCT00670111|62731247|FG001|Enrollment to One Month|Testing Failure|0|||
33353695|NCT00670111|62731248|FG002|Enrollment to One Month|Testing Failure|13|||
33353696|NCT00670111|62731246|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
33353697|NCT00670111|62731247|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
33472228|NCT04181788|62846227|FG001|FOLLOW-UP|Other unspecified|1|||
33472229|NCT04181788|62846228|FG002|FOLLOW-UP|Other unspecified|0|||
33472230|NCT04181788|62846229|FG003|FOLLOW-UP|Other unspecified|0|||
33472231|NCT04181788|62846230|FG004|FOLLOW-UP|Other unspecified|0|||
33472232|NCT04181788|62846231|FG005|FOLLOW-UP|Other unspecified|3|||
33472233|NCT04181788|62846226|FG000|FOLLOW-UP|Ongoing|0|||
33472234|NCT04181788|62846227|FG001|FOLLOW-UP|Ongoing|0|||
33353698|NCT00670111|62731248|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
33353699|NCT00670111|62731246|FG000|Enrollment to One Month|Physician Decision|1|||
33353700|NCT00670111|62731247|FG001|Enrollment to One Month|Physician Decision|0|||
33353701|NCT00670111|62731248|FG002|Enrollment to One Month|Physician Decision|0|||
33353702|NCT00672139|62731258|FG000|Overall Study|Death|14|||
33353703|NCT00672139|62731259|FG001|Overall Study|Death|23|||
33353704|NCT00672139|62731258|FG000|Overall Study|Withdrawal by Subject|2|||
33353705|NCT00672139|62731259|FG001|Overall Study|Withdrawal by Subject|11|||
33353706|NCT00672139|62731258|FG000|Overall Study|Adverse Event|4|||
33353707|NCT00672139|62731259|FG001|Overall Study|Adverse Event|7|||
33353708|NCT00672139|62731258|FG000|Overall Study|Physician Decision|2|||
33353709|NCT00672139|62731259|FG001|Overall Study|Physician Decision|0|||
33353710|NCT00672139|62731258|FG000|Overall Study|Lack of Efficacy|4|||
33353711|NCT00672139|62731259|FG001|Overall Study|Lack of Efficacy|1|||
33353712|NCT00672139|62731258|FG000|Overall Study|Protocol Violation|1|||
33353713|NCT00672139|62731259|FG001|Overall Study|Protocol Violation|1|||
33353714|NCT00672139|62731258|FG000|Overall Study|hospice discharge, caregiver requests|3|||
33353715|NCT00672139|62731259|FG001|Overall Study|hospice discharge, caregiver requests|2|||
33353716|NCT00570739|62731269|FG000|Overall Study|Adverse Event|8|||
33353717|NCT00570739|62731270|FG001|Overall Study|Adverse Event|6|||
33353718|NCT00570739|62731271|FG002|Overall Study|Adverse Event|2|||
33353719|NCT00570739|62731272|FG003|Overall Study|Adverse Event|2|||
33353720|NCT00570739|62731269|FG000|Overall Study|Lost to Follow-up|4|||
33353721|NCT00570739|62731270|FG001|Overall Study|Lost to Follow-up|5|||
33353722|NCT00570739|62731271|FG002|Overall Study|Lost to Follow-up|4|||
33353723|NCT00570739|62731272|FG003|Overall Study|Lost to Follow-up|1|||
33353724|NCT00570739|62731269|FG000|Overall Study|Physician Decision|1|||
33353725|NCT00570739|62731270|FG001|Overall Study|Physician Decision|1|||
33353726|NCT00570739|62731271|FG002|Overall Study|Physician Decision|0|||
33353727|NCT00570739|62731272|FG003|Overall Study|Physician Decision|0|||
33353728|NCT00570739|62731269|FG000|Overall Study|Withdrawal by Subject|7|||
33353729|NCT00570739|62731270|FG001|Overall Study|Withdrawal by Subject|7|||
33353730|NCT00570739|62731271|FG002|Overall Study|Withdrawal by Subject|3|||
33353731|NCT00570739|62731272|FG003|Overall Study|Withdrawal by Subject|5|||
33353732|NCT00570739|62731269|FG000|Overall Study|Required restricted medication|0|||
33353733|NCT00570739|62731270|FG001|Overall Study|Required restricted medication|0|||
33353734|NCT00570739|62731271|FG002|Overall Study|Required restricted medication|1|||
33353735|NCT00570739|62731272|FG003|Overall Study|Required restricted medication|0|||
33353736|NCT00570739|62731269|FG000|Overall Study|Met discontinuation criteria|1|||
33353737|NCT00570739|62731270|FG001|Overall Study|Met discontinuation criteria|0|||
33353738|NCT00570739|62731271|FG002|Overall Study|Met discontinuation criteria|1|||
33353739|NCT00570739|62731272|FG003|Overall Study|Met discontinuation criteria|1|||
33353740|NCT00570739|62731269|FG000|Overall Study|Other|0|||
33353741|NCT00570739|62731270|FG001|Overall Study|Other|2|||
33353742|NCT00570739|62731271|FG002|Overall Study|Other|5|||
33353743|NCT00570739|62731272|FG003|Overall Study|Other|3|||
33353744|NCT03689530|62731304|FG000|Overall Study|Withdrawal by Subject|53|||
33353745|NCT03689530|62731305|FG001|Overall Study|Withdrawal by Subject|16|||
33353746|NCT04188106|62731311|FG000|Overall Study|Lost to Follow-up|5|||
33353747|NCT04188106|62731311|FG000|Overall Study|Non-Compliance|1|||
33353748|NCT00669955|62731319|FG000|Overall Study|Adverse Event|3|||
33353749|NCT00669955|62731320|FG001|Overall Study|Adverse Event|5|||
33353750|NCT00669955|62731319|FG000|Overall Study|Death|0|||
33353751|NCT00669955|62731320|FG001|Overall Study|Death|1|||
33353752|NCT00669955|62731319|FG000|Overall Study|Withdrawal by Subject|2|||
33353753|NCT00669955|62731320|FG001|Overall Study|Withdrawal by Subject|3|||
33353754|NCT00669955|62731319|FG000|Overall Study|Lost to Follow-up|5|||
33353755|NCT00669955|62731320|FG001|Overall Study|Lost to Follow-up|7|||
33353756|NCT00669955|62731319|FG000|Overall Study|Protocol Violation|2|||
33353757|NCT00669955|62731320|FG001|Overall Study|Protocol Violation|7|||
33353758|NCT00669955|62731319|FG000|Overall Study|Investigator Sponsor Judgement|0|||
33353759|NCT00669955|62731320|FG001|Overall Study|Investigator Sponsor Judgement|1|||
33353760|NCT00669955|62731319|FG000|Overall Study|not compliant with study drug/visit|2|||
33353761|NCT00669955|62731320|FG001|Overall Study|not compliant with study drug/visit|3|||
33353762|NCT00671749|62731326|FG000|Overall Study|Adverse Event|2|||
33353763|NCT00671749|62731326|FG000|Overall Study|Withdrawal by Subject|4|||
33353764|NCT00671749|62731326|FG000|Overall Study|Protocol Violation|1|||
33353765|NCT00671749|62731326|FG000|Overall Study|Lost to Follow-up|1|||
33353766|NCT00669877|62731330|FG000|Overall Study|Disease Progression/Death|4|||
33353767|NCT00882999|62731341|FG000|Overall Study|Adverse Event|0|||
33353768|NCT00882999|62731342|FG001|Overall Study|Adverse Event|0|||
33353769|NCT00882999|62731343|FG002|Overall Study|Adverse Event|0|||
33353770|NCT00882999|62731344|FG003|Overall Study|Adverse Event|0|||
33353771|NCT00882999|62731345|FG004|Overall Study|Adverse Event|1|||
33353772|NCT00882999|62731346|FG005|Overall Study|Adverse Event|0|||
33353773|NCT00882999|62731347|FG006|Overall Study|Adverse Event|0|||
33353774|NCT00882999|62731341|FG000|Overall Study|Death|0|||
33353775|NCT00882999|62731342|FG001|Overall Study|Death|1|||
33353776|NCT00882999|62731343|FG002|Overall Study|Death|0|||
33353777|NCT00882999|62731344|FG003|Overall Study|Death|0|||
33353778|NCT00882999|62731345|FG004|Overall Study|Death|0|||
33353779|NCT00882999|62731346|FG005|Overall Study|Death|0|||
33353780|NCT00882999|62731347|FG006|Overall Study|Death|0|||
33353781|NCT00882999|62731341|FG000|Overall Study|Withdrawal by Subject|7|||
33353782|NCT00882999|62731342|FG001|Overall Study|Withdrawal by Subject|6|||
33353783|NCT00882999|62731343|FG002|Overall Study|Withdrawal by Subject|3|||
33353784|NCT00882999|62731344|FG003|Overall Study|Withdrawal by Subject|3|||
33353785|NCT00882999|62731345|FG004|Overall Study|Withdrawal by Subject|6|||
33353786|NCT00882999|62731346|FG005|Overall Study|Withdrawal by Subject|5|||
33353787|NCT00882999|62731347|FG006|Overall Study|Withdrawal by Subject|5|||
33353788|NCT00882999|62731341|FG000|Overall Study|Lost to Follow-up|0|||
33353789|NCT00882999|62731342|FG001|Overall Study|Lost to Follow-up|1|||
33353790|NCT00882999|62731343|FG002|Overall Study|Lost to Follow-up|1|||
33353791|NCT00882999|62731344|FG003|Overall Study|Lost to Follow-up|2|||
33353792|NCT00882999|62731345|FG004|Overall Study|Lost to Follow-up|1|||
33353793|NCT00882999|62731346|FG005|Overall Study|Lost to Follow-up|1|||
33353794|NCT00882999|62731347|FG006|Overall Study|Lost to Follow-up|2|||
33353795|NCT00882999|62731341|FG000|Overall Study|Physician Decision|1|||
33353796|NCT00882999|62731342|FG001|Overall Study|Physician Decision|0|||
33353797|NCT00882999|62731343|FG002|Overall Study|Physician Decision|0|||
33353798|NCT00882999|62731344|FG003|Overall Study|Physician Decision|0|||
33353799|NCT00882999|62731345|FG004|Overall Study|Physician Decision|0|||
33353800|NCT00882999|62731346|FG005|Overall Study|Physician Decision|1|||
33353801|NCT00882999|62731347|FG006|Overall Study|Physician Decision|1|||
33353802|NCT00671437|62731370|FG000|Overall Study|Progressive disease before C1 week 8|8|||
33353803|NCT00671437|62731370|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
33353804|NCT00671437|62731370|FG000|Overall Study|Adverse Event|3|||
33353805|NCT00671437|62731370|FG000|Overall Study|Ineligible post-hoc|1|||
33353806|NCT00882921|62731382|FG000|Overall Study|Death|2|||
33353807|NCT00882921|62731382|FG000|Overall Study|Other|3|||
33353808|NCT00882921|62731382|FG000|Overall Study|Lost to Follow-up|2|||
33353809|NCT00882921|62731382|FG000|Overall Study|Termination By Investigator|3|||
33472235|NCT04181788|62846228|FG002|FOLLOW-UP|Ongoing|1|||
33472236|NCT04181788|62846229|FG003|FOLLOW-UP|Ongoing|3|||
33472237|NCT04181788|62846230|FG004|FOLLOW-UP|Ongoing|2|||
33472238|NCT04181788|62846231|FG005|FOLLOW-UP|Ongoing|2|||
33472239|NCT04120194|62846254|FG000|Overall Study|Lost to Follow-up|11|||
33353810|NCT00882921|62731382|FG000|Overall Study|Withdrawal Of Consent|1|||
33353811|NCT00582712|62731387|FG000|Overall Study|Adverse Event|1|||
33353812|NCT00582712|62731387|FG000|Overall Study|Lack of Efficacy|1|||
33353813|NCT00582712|62731387|FG000|Overall Study|Withdrawal by Subject|1|||
33353814|NCT00582712|62731387|FG000|Overall Study|Complicating disease requiring treatment|1|||
33353815|NCT00582790|62731391|FG000|Overall Study|Rapid progression of disease|1|||
33353816|NCT00881751|62731398|FG000|Overall Study|Physician Decision|0|||
33353817|NCT00881751|62731399|FG001|Overall Study|Physician Decision|1|||
33353818|NCT00881751|62731398|FG000|Overall Study|Adverse Event|0|||
33353819|NCT00881751|62731399|FG001|Overall Study|Adverse Event|2|||
33472240|NCT04120194|62846255|FG001|Overall Study|Lost to Follow-up|8|||
33353820|NCT00881751|62731398|FG000|Overall Study|Withdrawal by Subject|0|||
33353821|NCT00881751|62731399|FG001|Overall Study|Withdrawal by Subject|2|||
33353822|NCT00934856|62731411|FG000|Feasibility Part|Progressive disease|4|||
33353823|NCT00934856|62731412|FG001|Feasibility Part|Progressive disease|4|||
33353824|NCT00934856|62731413|FG002|Feasibility Part|Progressive disease|2|||
33353825|NCT00934856|62731414|FG003|Feasibility Part|Progressive disease|3|||
33353826|NCT00934856|62731415|FG004|Feasibility Part|Progressive disease|0|||
33353827|NCT00934856|62731416|FG005|Feasibility Part|Progressive disease|0|||
33353828|NCT00934856|62731411|FG000|Feasibility Part|Physician Decision|0|||
33353829|NCT00934856|62731412|FG001|Feasibility Part|Physician Decision|0|||
33353830|NCT00934856|62731413|FG002|Feasibility Part|Physician Decision|1|||
33353831|NCT00934856|62731414|FG003|Feasibility Part|Physician Decision|0|||
33353832|NCT00934856|62731415|FG004|Feasibility Part|Physician Decision|0|||
33472241|NCT04120194|62846254|FG000|Overall Study|Adverse Event|4|||
33353833|NCT00934856|62731416|FG005|Feasibility Part|Physician Decision|0|||
33353834|NCT00934856|62731411|FG000|Feasibility Part|Adverse Event|1|||
33353835|NCT00934856|62731412|FG001|Feasibility Part|Adverse Event|1|||
33353836|NCT00934856|62731413|FG002|Feasibility Part|Adverse Event|0|||
33353837|NCT00934856|62731414|FG003|Feasibility Part|Adverse Event|1|||
33353838|NCT00934856|62731415|FG004|Feasibility Part|Adverse Event|0|||
33353839|NCT00934856|62731416|FG005|Feasibility Part|Adverse Event|2|||
33353840|NCT00934856|62731411|FG000|Feasibility Part|Withdrawal by Subject|0|||
33353841|NCT00934856|62731412|FG001|Feasibility Part|Withdrawal by Subject|0|||
33353842|NCT00934856|62731413|FG002|Feasibility Part|Withdrawal by Subject|0|||
33353843|NCT00934856|62731414|FG003|Feasibility Part|Withdrawal by Subject|1|||
33353844|NCT00934856|62731415|FG004|Feasibility Part|Withdrawal by Subject|0|||
33353845|NCT00934856|62731416|FG005|Feasibility Part|Withdrawal by Subject|1|||
33353846|NCT00934856|62731411|FG000|Extension Part|Adverse Event|0|||
33353847|NCT00934856|62731412|FG001|Extension Part|Adverse Event|0|||
33353848|NCT00934856|62731413|FG002|Extension Part|Adverse Event|0|||
33353849|NCT00934856|62731414|FG003|Extension Part|Adverse Event|1|||
33353850|NCT00934856|62731415|FG004|Extension Part|Adverse Event|4|||
33353851|NCT00934856|62731416|FG005|Extension Part|Adverse Event|4|||
33472242|NCT04120194|62846255|FG001|Overall Study|Adverse Event|5|||
33353852|NCT00934856|62731411|FG000|Extension Part|Progressive disease|0|||
33353853|NCT00934856|62731412|FG001|Extension Part|Progressive disease|0|||
33353854|NCT00934856|62731413|FG002|Extension Part|Progressive disease|0|||
33353855|NCT00934856|62731414|FG003|Extension Part|Progressive disease|1|||
33353856|NCT00934856|62731415|FG004|Extension Part|Progressive disease|0|||
33353857|NCT00934856|62731416|FG005|Extension Part|Progressive disease|0|||
33353858|NCT00934856|62731411|FG000|Extension Part|Non-compliance with drug|0|||
33353859|NCT00934856|62731412|FG001|Extension Part|Non-compliance with drug|0|||
33353860|NCT00934856|62731413|FG002|Extension Part|Non-compliance with drug|0|||
33353861|NCT00934856|62731414|FG003|Extension Part|Non-compliance with drug|0|||
33353862|NCT00934856|62731415|FG004|Extension Part|Non-compliance with drug|0|||
33353863|NCT00934856|62731416|FG005|Extension Part|Non-compliance with drug|1|||
33353864|NCT00934700|62731450|FG000|Overall Study|missing scan|5|||
33353865|NCT00934700|62731451|FG001|Overall Study|missing scan|9|||
33353866|NCT00934700|62731450|FG000|Overall Study|Death|8|||
33353867|NCT00934700|62731451|FG001|Overall Study|Death|3|||
33353868|NCT00930176|62731458|FG000|Overall Study|Death|1|||
33353869|NCT00669409|62731468|FG000|Part 2|Withdrawal by Subject|0|||
33353870|NCT00669409|62731469|FG001|Part 2|Withdrawal by Subject|0|||
33353871|NCT00669409|62731470|FG002|Part 2|Withdrawal by Subject|0|||
33353872|NCT00669409|62731471|FG003|Part 2|Withdrawal by Subject|0|||
33353873|NCT00669409|62731472|FG004|Part 2|Withdrawal by Subject|0|||
33353874|NCT00669409|62731473|FG005|Part 2|Withdrawal by Subject|0|||
33353875|NCT00669409|62731474|FG006|Part 2|Withdrawal by Subject|0|||
33353876|NCT00669409|62731475|FG007|Part 2|Withdrawal by Subject|0|||
33353877|NCT00669409|62731476|FG008|Part 2|Withdrawal by Subject|0|||
33353878|NCT00669409|62731477|FG009|Part 2|Withdrawal by Subject|1|||
33353879|NCT00669409|62731478|FG010|Part 2|Withdrawal by Subject|0|||
33353880|NCT00669331|62731507|FG000|Randomisation to First Dose|Adverse Event|1|||
33353881|NCT00669331|62731508|FG001|Randomisation to First Dose|Adverse Event|0|||
33353882|NCT00669331|62731507|FG000|Randomisation to First Dose|Protocol Violation|1|||
33353883|NCT00669331|62731508|FG001|Randomisation to First Dose|Protocol Violation|0|||
33353884|NCT00669331|62731507|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
33353885|NCT00669331|62731508|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
33353886|NCT00669331|62731507|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
33353887|NCT00669331|62731508|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
33353888|NCT00669331|62731507|FG000|Randomisation to First Dose|Death|1|||
33353889|NCT00669331|62731508|FG001|Randomisation to First Dose|Death|0|||
33353890|NCT00669331|62731507|FG000|Randomisation to First Dose|Sponsor decision|0|||
33353891|NCT00669331|62731508|FG001|Randomisation to First Dose|Sponsor decision|1|||
33353892|NCT00669331|62731507|FG000|Randomisation to First Dose|Randomised in error|3|||
33353893|NCT00669331|62731508|FG001|Randomisation to First Dose|Randomised in error|10|||
33472243|NCT04120194|62846254|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
33472244|NCT04120194|62846255|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
33472245|NCT04120194|62846254|FG000|Overall Study|Miscellaneous|4|||
33472246|NCT04120194|62846255|FG001|Overall Study|Miscellaneous|5|||
33472247|NCT04050670|62846261|FG000|Period 3|Physician Decision|0|||
33472248|NCT04050670|62846262|FG001|Period 3|Physician Decision|1|||
33472249|NCT04050670|62846263|FG002|Period 3|Physician Decision|0|||
33472250|NCT04016714|62846286|FG000|Overall Study|Death|1|||
33472251|NCT04016714|62846287|FG001|Overall Study|Death|0|||
33472252|NCT04016714|62846286|FG000|Overall Study|Lost to Follow-up|3|||
33472253|NCT04016714|62846287|FG001|Overall Study|Lost to Follow-up|1|||
33472254|NCT04016714|62846286|FG000|Overall Study|Physician Decision|3|||
33472255|NCT04016714|62846287|FG001|Overall Study|Physician Decision|3|||
33472256|NCT04016714|62846286|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
33472257|NCT04016714|62846287|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
33472258|NCT03997409|62846296|FG000|Overall Study|Protocol Violation|1|||
33472259|NCT03997409|62846297|FG001|Overall Study|Protocol Violation|1|||
33472260|NCT03997409|62846298|FG002|Overall Study|Protocol Violation|0|||
33549062|NCT02901431|62940296|FG002|Main Treatment Part|Physician Decision|0|||
33549063|NCT02901431|62940297|FG003|Main Treatment Part|Physician Decision|1|||
33549064|NCT02901431|62940298|FG004|Main Treatment Part|Physician Decision|0|||
33549065|NCT02901431|62940299|FG005|Main Treatment Part|Physician Decision|0|||
33549066|NCT02901431|62940300|FG006|Main Treatment Part|Physician Decision|1|||
33549067|NCT02901431|62940301|FG007|Main Treatment Part|Physician Decision|0|||
33549068|NCT02901431|62940302|FG008|Main Treatment Part|Physician Decision|0|||
33549069|NCT02901431|62940303|FG009|Main Treatment Part|Physician Decision|0|||
33655238|NCT01882907|63069703|FG000|Overall Study|Protocol Violation|10|||
33353894|NCT00669331|62731507|FG000|Blinded Treatment Period|Adverse Event|16|||
33353895|NCT00669331|62731508|FG001|Blinded Treatment Period|Adverse Event|10|||
33353896|NCT00669331|62731507|FG000|Blinded Treatment Period|Protocol Violation|1|||
33353897|NCT00669331|62731508|FG001|Blinded Treatment Period|Protocol Violation|1|||
33353898|NCT00669331|62731507|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
33353899|NCT00669331|62731508|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
33353900|NCT00669331|62731507|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
33353901|NCT00669331|62731508|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
33353902|NCT00669331|62731507|FG000|Blinded Treatment Period|Death|0|||
33353903|NCT00669331|62731508|FG001|Blinded Treatment Period|Death|2|||
33353904|NCT00669331|62731507|FG000|Blinded Treatment Period|Physician Decision|3|||
33353905|NCT00669331|62731508|FG001|Blinded Treatment Period|Physician Decision|3|||
33353906|NCT00669331|62731507|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
33472261|NCT03997409|62846296|FG000|Overall Study|Withdrawal by Subject|3|||
33549070|NCT02901431|62940304|FG010|Main Treatment Part|Physician Decision|0|||
33472262|NCT03997409|62846297|FG001|Overall Study|Withdrawal by Subject|0|||
33353907|NCT00669331|62731508|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
33353908|NCT00932126|62731516|FG000|Overall Study|Adverse Event|0|||
33353909|NCT00932126|62731517|FG001|Overall Study|Adverse Event|0|||
33353910|NCT00932126|62731518|FG002|Overall Study|Adverse Event|0|||
33353911|NCT00932126|62731519|FG003|Overall Study|Adverse Event|0|||
33353912|NCT00932126|62731520|FG004|Overall Study|Adverse Event|0|||
33353913|NCT00932126|62731521|FG005|Overall Study|Adverse Event|0|||
33353914|NCT00932126|62731522|FG006|Overall Study|Adverse Event|1|||
33353915|NCT00932126|62731523|FG007|Overall Study|Adverse Event|2|||
33353916|NCT00932126|62731516|FG000|Overall Study|Protocol Violation|0|||
33353917|NCT00932126|62731517|FG001|Overall Study|Protocol Violation|0|||
33353918|NCT00932126|62731518|FG002|Overall Study|Protocol Violation|0|||
33353919|NCT00932126|62731519|FG003|Overall Study|Protocol Violation|0|||
33353920|NCT00932126|62731520|FG004|Overall Study|Protocol Violation|1|||
33353921|NCT00932126|62731521|FG005|Overall Study|Protocol Violation|0|||
33353922|NCT00932126|62731522|FG006|Overall Study|Protocol Violation|0|||
33353923|NCT00932126|62731523|FG007|Overall Study|Protocol Violation|0|||
33353924|NCT00932126|62731516|FG000|Overall Study|Withdrawal by Subject|0|||
33353925|NCT00932126|62731517|FG001|Overall Study|Withdrawal by Subject|0|||
33353926|NCT00932126|62731518|FG002|Overall Study|Withdrawal by Subject|1|||
33353927|NCT00932126|62731519|FG003|Overall Study|Withdrawal by Subject|0|||
33353928|NCT00932126|62731520|FG004|Overall Study|Withdrawal by Subject|0|||
33353929|NCT00932126|62731521|FG005|Overall Study|Withdrawal by Subject|0|||
33353930|NCT00932126|62731522|FG006|Overall Study|Withdrawal by Subject|0|||
33353931|NCT00932126|62731523|FG007|Overall Study|Withdrawal by Subject|1|||
33353932|NCT00932126|62731516|FG000|Overall Study|Objective progression or relapse|3|||
33353933|NCT00932126|62731517|FG001|Overall Study|Objective progression or relapse|3|||
33353934|NCT00932126|62731518|FG002|Overall Study|Objective progression or relapse|2|||
33353935|NCT00932126|62731519|FG003|Overall Study|Objective progression or relapse|3|||
33353936|NCT00932126|62731520|FG004|Overall Study|Objective progression or relapse|3|||
33353937|NCT00932126|62731521|FG005|Overall Study|Objective progression or relapse|3|||
33353938|NCT00932126|62731522|FG006|Overall Study|Objective progression or relapse|3|||
33353939|NCT00932126|62731523|FG007|Overall Study|Objective progression or relapse|5|||
33353940|NCT00932126|62731516|FG000|Overall Study|Other|0|||
33353941|NCT00932126|62731517|FG001|Overall Study|Other|0|||
33353942|NCT00932126|62731518|FG002|Overall Study|Other|0|||
33353943|NCT00932126|62731519|FG003|Overall Study|Other|0|||
33353944|NCT00932126|62731520|FG004|Overall Study|Other|1|||
33353945|NCT00932126|62731521|FG005|Overall Study|Other|0|||
33353946|NCT00932126|62731522|FG006|Overall Study|Other|1|||
33353947|NCT00932126|62731523|FG007|Overall Study|Other|2|||
33353948|NCT00667225|62731545|FG000|Overall Study|Subject had no more lesions to treat.|1|||
33353949|NCT00667225|62731546|FG001|Overall Study|Subject had no more lesions to treat.|0|||
33353950|NCT00667225|62731545|FG000|Overall Study|Lost to Follow-up|0|||
33472263|NCT03997409|62846298|FG002|Overall Study|Withdrawal by Subject|0|||
33472264|NCT03997409|62846296|FG000|Overall Study|Lost to Follow-up|0|||
33353951|NCT00667225|62731546|FG001|Overall Study|Lost to Follow-up|1|||
33472265|NCT03997409|62846297|FG001|Overall Study|Lost to Follow-up|0|||
33353952|NCT00929864|62731554|FG000|Overall Study|Death|1|||
33353953|NCT00929864|62731555|FG001|Overall Study|Death|1|||
33353954|NCT00929864|62731554|FG000|Overall Study|Adverse Event|11|||
33353955|NCT00929864|62731555|FG001|Overall Study|Adverse Event|30|||
33472266|NCT03997409|62846298|FG002|Overall Study|Lost to Follow-up|1|||
33353956|NCT00929864|62731554|FG000|Overall Study|Lack of Efficacy|19|||
33353957|NCT00929864|62731555|FG001|Overall Study|Lack of Efficacy|16|||
33353958|NCT00929864|62731554|FG000|Overall Study|Lost to Follow-up|7|||
33353959|NCT00929864|62731555|FG001|Overall Study|Lost to Follow-up|12|||
33353960|NCT00929864|62731554|FG000|Overall Study|Withdrawal by Subject|20|||
33353961|NCT00929864|62731555|FG001|Overall Study|Withdrawal by Subject|9|||
33353962|NCT00929864|62731554|FG000|Overall Study|No longer met criteria|2|||
33353963|NCT00929864|62731555|FG001|Overall Study|No longer met criteria|1|||
33353964|NCT00929864|62731554|FG000|Overall Study|Poor or non-compliance|3|||
33353965|NCT00929864|62731555|FG001|Overall Study|Poor or non-compliance|3|||
33353966|NCT00929864|62731554|FG000|Overall Study|Pregnancy|0|||
33353967|NCT00929864|62731555|FG001|Overall Study|Pregnancy|3|||
33353968|NCT00929864|62731554|FG000|Overall Study|Administrative reason by Sponsor|1|||
33353969|NCT00929864|62731555|FG001|Overall Study|Administrative reason by Sponsor|1|||
33353970|NCT00929864|62731554|FG000|Overall Study|Non-specified|2|||
33353971|NCT00929864|62731555|FG001|Overall Study|Non-specified|7|||
33353972|NCT00597753|62731563|FG000|Overall Study|Adverse Event|6|||
33353973|NCT00597753|62731564|FG001|Overall Study|Adverse Event|2|||
33353974|NCT00597753|62731563|FG000|Overall Study|Death|55|||
33353975|NCT00597753|62731564|FG001|Overall Study|Death|29|||
33353976|NCT00597753|62731563|FG000|Overall Study|Lack of Efficacy|2|||
33353977|NCT00597753|62731564|FG001|Overall Study|Lack of Efficacy|0|||
33353978|NCT00597753|62731563|FG000|Overall Study|Lost to Follow-up|10|||
33353979|NCT00597753|62731564|FG001|Overall Study|Lost to Follow-up|3|||
33353980|NCT00597753|62731563|FG000|Overall Study|Physician Decision|5|||
33353981|NCT00597753|62731564|FG001|Overall Study|Physician Decision|1|||
33353982|NCT00597753|62731563|FG000|Overall Study|Pregnancy|1|||
33353983|NCT00597753|62731564|FG001|Overall Study|Pregnancy|0|||
33353984|NCT00597753|62731563|FG000|Overall Study|Withdrawal by Subject|35|||
33353985|NCT00597753|62731564|FG001|Overall Study|Withdrawal by Subject|12|||
33353986|NCT00597753|62731563|FG000|Overall Study|Discontinued Dialysis|0|||
33353987|NCT00597753|62731564|FG001|Overall Study|Discontinued Dialysis|1|||
33353988|NCT00597753|62731563|FG000|Overall Study|Never dosed|2|||
33353989|NCT00597753|62731564|FG001|Overall Study|Never dosed|0|||
33353990|NCT00597753|62731563|FG000|Overall Study|Noncompliance|2|||
33353991|NCT00597753|62731564|FG001|Overall Study|Noncompliance|1|||
33353992|NCT00597753|62731563|FG000|Overall Study|Relocation|17|||
33353993|NCT00597753|62731564|FG001|Overall Study|Relocation|6|||
33353994|NCT00597753|62731563|FG000|Overall Study|Renal transplant|10|||
33353995|NCT00597753|62731564|FG001|Overall Study|Renal transplant|3|||
33353996|NCT00597753|62731563|FG000|Overall Study|Site closed by sponsor|19|||
33353997|NCT00597753|62731564|FG001|Overall Study|Site closed by sponsor|7|||
33353998|NCT00597753|62731563|FG000|Overall Study|Site elected to close|2|||
33353999|NCT00597753|62731564|FG001|Overall Study|Site elected to close|4|||
33354000|NCT00665431|62731573|FG000|Overall Study|Adverse Event|16|||
33354001|NCT00665431|62731574|FG001|Overall Study|Adverse Event|22|||
33354002|NCT00665431|62731575|FG002|Overall Study|Adverse Event|6|||
33354003|NCT00665431|62731573|FG000|Overall Study|Withdrawal by Subject|17|||
33354004|NCT00665431|62731574|FG001|Overall Study|Withdrawal by Subject|25|||
33354005|NCT00665431|62731575|FG002|Overall Study|Withdrawal by Subject|15|||
33354006|NCT00665431|62731573|FG000|Overall Study|Lost to Follow-up|3|||
33354007|NCT00665431|62731574|FG001|Overall Study|Lost to Follow-up|3|||
33354008|NCT00665431|62731575|FG002|Overall Study|Lost to Follow-up|1|||
33354009|NCT00665431|62731573|FG000|Overall Study|Other|4|||
33354010|NCT00665431|62731574|FG001|Overall Study|Other|7|||
33354011|NCT00665431|62731575|FG002|Overall Study|Other|2|||
33354012|NCT00934622|62731583|FG000|Overall Study|Lost to Follow-up|7|||
33354013|NCT00934622|62731583|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
33354014|NCT00881361|62731589|FG000|Overall Study|Terminated prior to surgery|27|||
33354015|NCT00881361|62731590|FG001|Overall Study|Terminated prior to surgery|7|||
33354016|NCT00881361|62731591|FG002|Overall Study|Terminated prior to surgery|0|||
33354017|NCT00881361|62731589|FG000|Overall Study|Ineligible|17|||
33354018|NCT00881361|62731590|FG001|Overall Study|Ineligible|2|||
33472267|NCT03946124|62846306|FG000|Overall Study|Withdrawal by Subject|19|||
33472268|NCT03812029|62846315|FG000|Overall Study|Protocol Violation|1|||
33472269|NCT03812029|62846316|FG001|Overall Study|Protocol Violation|0|||
33472270|NCT03812029|62846317|FG002|Overall Study|Protocol Violation|0|||
33472271|NCT03812029|62846318|FG003|Overall Study|Protocol Violation|1|||
33472272|NCT03812029|62846319|FG004|Overall Study|Protocol Violation|0|||
33472273|NCT03812029|62846315|FG000|Overall Study|Withdrawal by Subject|1|||
33472274|NCT03812029|62846316|FG001|Overall Study|Withdrawal by Subject|0|||
33472275|NCT03812029|62846317|FG002|Overall Study|Withdrawal by Subject|0|||
33354019|NCT00881361|62731591|FG002|Overall Study|Ineligible|2|||
33354020|NCT01000727|62731602|FG000|Overall Study|Lost to Follow-up|41|||
33354021|NCT01000727|62731603|FG001|Overall Study|Lost to Follow-up|43|||
33354022|NCT01000727|62731602|FG000|Overall Study|Withdrawal by Subject|111|||
33354023|NCT01000727|62731603|FG001|Overall Study|Withdrawal by Subject|109|||
33354024|NCT01000727|62731602|FG000|Overall Study|Study closed/terminated|23|||
33354025|NCT01000727|62731603|FG001|Overall Study|Study closed/terminated|24|||
33354026|NCT00881205|62731613|FG000|Overall Study|Adverse Event|8|||
33354027|NCT00881205|62731614|FG001|Overall Study|Adverse Event|3|||
33354028|NCT00881205|62731613|FG000|Overall Study|Withdrawal by Subject|1|||
33354029|NCT00881205|62731614|FG001|Overall Study|Withdrawal by Subject|2|||
33655239|NCT01882907|63069704|FG001|Overall Study|Protocol Violation|14|||
33354030|NCT00881205|62731613|FG000|Overall Study|Lost to Follow-up|0|||
33354031|NCT00881205|62731614|FG001|Overall Study|Lost to Follow-up|1|||
33354032|NCT00881205|62731613|FG000|Overall Study|Administrative problems|1|||
33354033|NCT00881205|62731614|FG001|Overall Study|Administrative problems|1|||
33354034|NCT00881205|62731613|FG000|Overall Study|Condition no longer requires drug|1|||
33354035|NCT00881205|62731614|FG001|Overall Study|Condition no longer requires drug|0|||
33354036|NCT00879879|62731621|FG000|Overall Study|Death|1|||
33354037|NCT00879879|62731621|FG000|Overall Study|Withdrawal by Subject|1|||
33354038|NCT00879879|62731621|FG000|Overall Study|Physician Decision|1|||
33354039|NCT00661999|62731630|FG000|Overall Study|Adverse Event|11|||
33354040|NCT00661999|62731631|FG001|Overall Study|Adverse Event|5|||
33354041|NCT00661999|62731632|FG002|Overall Study|Adverse Event|8|||
33354042|NCT00661999|62731630|FG000|Overall Study|Death|8|||
33354043|NCT00661999|62731631|FG001|Overall Study|Death|6|||
33354044|NCT00661999|62731632|FG002|Overall Study|Death|3|||
33354045|NCT00661999|62731630|FG000|Overall Study|Other Reasons|5|||
33354046|NCT00661999|62731631|FG001|Overall Study|Other Reasons|12|||
33354047|NCT00661999|62731632|FG002|Overall Study|Other Reasons|23|||
33354048|NCT00661999|62731630|FG000|Overall Study|Withdrawal by Subject|30|||
33354049|NCT00661999|62731631|FG001|Overall Study|Withdrawal by Subject|23|||
33354050|NCT00661999|62731632|FG002|Overall Study|Withdrawal by Subject|14|||
33354051|NCT00661999|62731630|FG000|Overall Study|Alternative Treatment|1|||
33354052|NCT00661999|62731631|FG001|Overall Study|Alternative Treatment|0|||
33354053|NCT00661999|62731632|FG002|Overall Study|Alternative Treatment|0|||
33354054|NCT00661999|62731630|FG000|Overall Study|Other Medical Problems|4|||
33354055|NCT00661999|62731631|FG001|Overall Study|Other Medical Problems|4|||
33354056|NCT00661999|62731632|FG002|Overall Study|Other Medical Problems|9|||
33354057|NCT00665353|62731640|FG000|Study Step 1|Adverse Event|1|||
33354058|NCT00665353|62731640|FG000|Study Step 1|Withdrawal by Subject|2|||
33354059|NCT00665353|62731640|FG000|Study Step 2|Lost to Follow-up|2|||
33354060|NCT00665353|62731640|FG000|Study Step 2|Lack of Efficacy|12|||
33354061|NCT00597207|62731646|FG000|Overall Study|Lost to Follow-up|5|||
33354062|NCT00597207|62731647|FG001|Overall Study|Lost to Follow-up|7|||
33354063|NCT00879645|62731657|FG000|Overall Study|Adverse Event|1|||
33354064|NCT00879645|62731658|FG001|Overall Study|Adverse Event|0|||
33354065|NCT00879645|62731659|FG002|Overall Study|Adverse Event|0|||
33354066|NCT00879645|62731660|FG003|Overall Study|Adverse Event|0|||
33354067|NCT00664105|62731670|FG000|Overall Study|Death|3|||
33354068|NCT00664105|62731670|FG000|Overall Study|Withdrawal by Subject|5|||
33354069|NCT00664105|62731670|FG000|Overall Study|Adverse Event|9|||
33354070|NCT00664105|62731670|FG000|Overall Study|Disease progression|7|||
33354071|NCT00661687|62731675|FG000|Overall Study|Study related symptoms and complaints|5|||
33354072|NCT00661687|62731675|FG000|Overall Study|Positive slit lamp findings|4|||
33354073|NCT00661687|62731675|FG000|Overall Study|Inability to maintain wearing schedule|3|||
33354074|NCT00661687|62731675|FG000|Overall Study|Physician Decision|1|||
33354075|NCT00661687|62731675|FG000|Overall Study|Adverse Event|2|||
33354076|NCT00596817|62731684|FG000|Open-label Period|Adverse Event|0|||
33354077|NCT00596817|62731685|FG001|Open-label Period|Adverse Event|49|||
33354078|NCT00596817|62731684|FG000|Open-label Period|Lack of Efficacy|0|||
33354079|NCT00596817|62731685|FG001|Open-label Period|Lack of Efficacy|33|||
33354080|NCT00596817|62731684|FG000|Open-label Period|Other Reasons|0|||
33354081|NCT00596817|62731685|FG001|Open-label Period|Other Reasons|65|||
33354082|NCT00596817|62731684|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
33354083|NCT00596817|62731685|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
33354084|NCT00596817|62731684|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
33354085|NCT00596817|62731685|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
33354086|NCT00596817|62731684|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
33354087|NCT00596817|62731685|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
33354088|NCT00596817|62731684|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
33354089|NCT00596817|62731685|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
33354090|NCT00596817|62731684|FG000|Double-blind Period|Adverse Event|5|||
33354091|NCT00596817|62731685|FG001|Double-blind Period|Adverse Event|16|||
33354092|NCT00596817|62731684|FG000|Double-blind Period|Lack of Efficacy|52|||
33354093|NCT00596817|62731685|FG001|Double-blind Period|Lack of Efficacy|28|||
33354094|NCT00596817|62731684|FG000|Double-blind Period|Non-compliance With Study Product|3|||
33354095|NCT00596817|62731685|FG001|Double-blind Period|Non-compliance With Study Product|4|||
33354096|NCT00596817|62731684|FG000|Double-blind Period|Protocol Violation|11|||
33354097|NCT00596817|62731685|FG001|Double-blind Period|Protocol Violation|8|||
33354098|NCT00596817|62731684|FG000|Double-blind Period|Withdrawal of Consent|7|||
33354099|NCT00596817|62731685|FG001|Double-blind Period|Withdrawal of Consent|3|||
33354100|NCT00596817|62731684|FG000|Double-blind Period|Lost to Follow-up|0|||
33354101|NCT00596817|62731685|FG001|Double-blind Period|Lost to Follow-up|2|||
33354102|NCT00596817|62731684|FG000|Double-blind Period|Other Reasons|10|||
33354103|NCT00596817|62731685|FG001|Double-blind Period|Other Reasons|18|||
33354104|NCT01000649|62731696|FG000|Overall Study|Adverse Event|5|||
33354105|NCT01000649|62731697|FG001|Overall Study|Adverse Event|1|||
33354106|NCT01000649|62731698|FG002|Overall Study|Adverse Event|2|||
33354107|NCT01000649|62731699|FG003|Overall Study|Adverse Event|4|||
33354108|NCT01000649|62731696|FG000|Overall Study|Lost to Follow-up|0|||
33354109|NCT01000649|62731697|FG001|Overall Study|Lost to Follow-up|2|||
33354110|NCT01000649|62731698|FG002|Overall Study|Lost to Follow-up|0|||
33354111|NCT01000649|62731699|FG003|Overall Study|Lost to Follow-up|2|||
33354112|NCT00879411|62731708|FG000|Overall Study|lost to follow-up (non-AE)|162|||
33354113|NCT01000493|62731714|FG000|Overall Study|Adverse Event|3|||
33354114|NCT01000493|62731715|FG001|Overall Study|Adverse Event|6|||
33354115|NCT01000493|62731714|FG000|Overall Study|Lack of Efficacy|1|||
33354116|NCT01000493|62731715|FG001|Overall Study|Lack of Efficacy|1|||
33354117|NCT01000493|62731714|FG000|Overall Study|Protocol Violation|1|||
33354118|NCT01000493|62731715|FG001|Overall Study|Protocol Violation|8|||
33354119|NCT01000493|62731714|FG000|Overall Study|Study closed/terminated|25|||
33354120|NCT01000493|62731715|FG001|Overall Study|Study closed/terminated|23|||
33354121|NCT01000493|62731714|FG000|Overall Study|Lost to Follow-up|5|||
33354122|NCT01000493|62731715|FG001|Overall Study|Lost to Follow-up|9|||
33354123|NCT01000493|62731714|FG000|Overall Study|Physician Decision|1|||
33354124|NCT01000493|62731715|FG001|Overall Study|Physician Decision|1|||
33354125|NCT01000493|62731714|FG000|Overall Study|Withdrawal by Subject|3|||
33354126|NCT01000493|62731715|FG001|Overall Study|Withdrawal by Subject|7|||
33354127|NCT00666757|62731723|FG000|Overall Study|Lost to Follow-up|39|||
33354128|NCT00666757|62731724|FG001|Overall Study|Lost to Follow-up|35|||
33354129|NCT00666757|62731723|FG000|Overall Study|Protocol Violation|23|||
33354130|NCT00666757|62731724|FG001|Overall Study|Protocol Violation|24|||
33354131|NCT00666757|62731723|FG000|Overall Study|Adverse Event|22|||
33354132|NCT00666757|62731724|FG001|Overall Study|Adverse Event|12|||
33354133|NCT00666757|62731723|FG000|Overall Study|Withdrawal by Subject|13|||
33354134|NCT00666757|62731724|FG001|Overall Study|Withdrawal by Subject|17|||
33354135|NCT00666757|62731723|FG000|Overall Study|Lack of Efficacy|3|||
33354136|NCT00666757|62731724|FG001|Overall Study|Lack of Efficacy|6|||
33354137|NCT00666757|62731723|FG000|Overall Study|Physician Decision|0|||
33354138|NCT00666757|62731724|FG001|Overall Study|Physician Decision|2|||
33354139|NCT00666757|62731723|FG000|Overall Study|Sponsor decision|0|||
33354140|NCT00666757|62731724|FG001|Overall Study|Sponsor decision|1|||
33354141|NCT01000337|62731735|FG000|Overall Study|Lost to Follow-up|4|||
33354142|NCT01000337|62731736|FG001|Overall Study|Lost to Follow-up|3|||
33354143|NCT00666679|62731744|FG000|First Intervention|Lost to Follow-up|1|||
33354144|NCT00666679|62731745|FG001|First Intervention|Lost to Follow-up|0|||
33354145|NCT00666679|62731744|FG000|First Intervention|Protocol Violation|1|||
33354146|NCT00666679|62731745|FG001|First Intervention|Protocol Violation|0|||
33354147|NCT00666679|62731744|FG000|First Intervention|Withdrawal by Subject|1|||
33354148|NCT00666679|62731745|FG001|First Intervention|Withdrawal by Subject|0|||
33354149|NCT00666679|62731744|FG000|First Intervention|Randomized did not start treatment|1|||
33354150|NCT00666679|62731745|FG001|First Intervention|Randomized did not start treatment|1|||
33354151|NCT00666679|62731744|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
33354152|NCT00666679|62731745|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
33354153|NCT00666679|62731744|FG000|Washout Period of 1 Week|Protocol Violation|0|||
33354154|NCT00666679|62731745|FG001|Washout Period of 1 Week|Protocol Violation|1|||
33354155|NCT00666679|62731744|FG000|Second Intervention|Adverse Event|1|||
33354156|NCT00666679|62731745|FG001|Second Intervention|Adverse Event|0|||
33354157|NCT00666679|62731744|FG000|Second Intervention|Death|0|||
33354158|NCT00666679|62731745|FG001|Second Intervention|Death|1|||
33354159|NCT00595413|62731755|FG000|Overall Study|Adverse Event|0|||
33354160|NCT00595413|62731756|FG001|Overall Study|Adverse Event|2|||
33354161|NCT00595413|62731757|FG002|Overall Study|Adverse Event|1|||
33354162|NCT00595413|62731758|FG003|Overall Study|Adverse Event|1|||
33354163|NCT00595413|62731755|FG000|Overall Study|Lost to Follow-up|2|||
33354164|NCT00595413|62731756|FG001|Overall Study|Lost to Follow-up|2|||
33354165|NCT00595413|62731757|FG002|Overall Study|Lost to Follow-up|1|||
33354166|NCT00595413|62731758|FG003|Overall Study|Lost to Follow-up|3|||
33655240|NCT01882907|63069703|FG000|Overall Study|Withdrawal by Subject|0|||
33655241|NCT01882907|63069704|FG001|Overall Study|Withdrawal by Subject|6|||
33655242|NCT01893281|63069726|FG000|Overall Study|Adverse Event|1|||
33655243|NCT01893281|63069726|FG000|Overall Study|Protocol Violation|1|||
33354167|NCT00595413|62731755|FG000|Overall Study|Death|0|||
33354168|NCT00595413|62731756|FG001|Overall Study|Death|0|||
33354169|NCT00595413|62731757|FG002|Overall Study|Death|1|||
33354170|NCT00595413|62731758|FG003|Overall Study|Death|0|||
33655244|NCT01893281|63069726|FG000|Overall Study|Withdrawal by Subject|1|||
33354171|NCT00595413|62731755|FG000|Overall Study|Other|5|||
33354172|NCT00595413|62731756|FG001|Overall Study|Other|1|||
33354173|NCT00595413|62731757|FG002|Overall Study|Other|5|||
33354174|NCT00595413|62731758|FG003|Overall Study|Other|0|||
33354175|NCT01000025|62731770|FG000|Overall Study|Adverse Event|43|||
33354176|NCT01000025|62731771|FG001|Overall Study|Adverse Event|2|||
33354177|NCT01000025|62731770|FG000|Overall Study|Withdrawal by Subject|13|||
33354178|NCT01000025|62731771|FG001|Overall Study|Withdrawal by Subject|8|||
33354179|NCT01000025|62731770|FG000|Overall Study|Death|23|||
33354180|NCT01000025|62731771|FG001|Overall Study|Death|13|||
33354181|NCT01000025|62731770|FG000|Overall Study|Lack of Efficacy|363|||
33354182|NCT01000025|62731771|FG001|Overall Study|Lack of Efficacy|208|||
33354183|NCT01000025|62731770|FG000|Overall Study|Intercurrent Illness|26|||
33354184|NCT01000025|62731771|FG001|Overall Study|Intercurrent Illness|7|||
33354185|NCT00595335|62731779|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
33354186|NCT00595335|62731780|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
33354187|NCT00595335|62731779|FG000|Baseline to Six Months|Disease Progression|1|||
33354188|NCT00595335|62731780|FG001|Baseline to Six Months|Disease Progression|1|||
33354189|NCT00595335|62731779|FG000|Baseline to Six Months|Adverse Event|1|||
33354190|NCT00595335|62731780|FG001|Baseline to Six Months|Adverse Event|0|||
33354191|NCT00595335|62731779|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
33354192|NCT00595335|62731780|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
33354193|NCT00595335|62731779|FG000|Six Months to Twelve Months|Disease Progression|1|||
33354194|NCT00595335|62731780|FG001|Six Months to Twelve Months|Disease Progression|0|||
33354195|NCT00661609|62731790|FG000|Overall Study|Adverse Event|4|||
33354196|NCT00661609|62731790|FG000|Overall Study|Death|20|||
33354197|NCT00661609|62731790|FG000|Overall Study|Withdrawal by Subject|2|||
33354198|NCT00661609|62731790|FG000|Overall Study|PI Decision|1|||
33354199|NCT00661609|62731790|FG000|Overall Study|Survival follow up stage discontinued|11|||
33354200|NCT00661609|62731790|FG000|Overall Study|Disease progression|3|||
33354201|NCT00661531|62731794|FG000|Overall Study|Withdrawal by Subject|3|||
33354202|NCT00998309|62731798|FG000|Overall Study|Protocol Violation|4|||
33354203|NCT00999713|62731852|FG000|Overall Study|Physician Decision|2|||
33354204|NCT00999713|62731853|FG001|Overall Study|Physician Decision|0|||
33354205|NCT00997373|62731861|FG000|Overall Study|Withdrawal by Subject|5|||
33354206|NCT00997373|62731862|FG001|Overall Study|Withdrawal by Subject|0|||
33354207|NCT00997373|62731861|FG000|Overall Study|wrong tumor type|4|||
33354208|NCT00997373|62731862|FG001|Overall Study|wrong tumor type|0|||
33354209|NCT00997373|62731861|FG000|Overall Study|could not have hysterectomy|6|||
33354210|NCT00997373|62731862|FG001|Overall Study|could not have hysterectomy|0|||
33354211|NCT00663871|62731870|FG000|Overall Study|Lost to Follow-up|5|||
33354212|NCT00663871|62731871|FG001|Overall Study|Lost to Follow-up|5|||
33354213|NCT00663871|62731870|FG000|Overall Study|Withdrawal by Subject|5|||
33354214|NCT00663871|62731871|FG001|Overall Study|Withdrawal by Subject|2|||
33354215|NCT04152447|62731881|FG000|Overall Study|Lost to Follow-up|1|||
33354216|NCT04152447|62731882|FG001|Overall Study|Lost to Follow-up|0|||
33354217|NCT04152447|62731881|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
33354218|NCT04152447|62731882|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
33354219|NCT04152447|62731881|FG000|Overall Study|Withdrawal by Subject|0|||
33354220|NCT04152447|62731882|FG001|Overall Study|Withdrawal by Subject|1|||
33354221|NCT04152447|62731881|FG000|Overall Study|Found ineligible after enrolling|1|||
33354222|NCT04152447|62731882|FG001|Overall Study|Found ineligible after enrolling|1|||
33354223|NCT04152447|62731881|FG000|Overall Study|Did not receive VR headset in time.|0|||
33354224|NCT04152447|62731882|FG001|Overall Study|Did not receive VR headset in time.|2|||
33354225|NCT00996593|62731888|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
33354226|NCT00996593|62731888|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
33354227|NCT00996593|62731888|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
33354228|NCT00996593|62731888|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
33354229|NCT00996593|62731888|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
33354230|NCT00996593|62731888|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
33354231|NCT00996593|62731888|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
33354232|NCT00996593|62731888|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
33354233|NCT00996593|62731888|FG000|Long-Term Follow-Up|Site Closed|1|||
33354234|NCT00570661|62731892|FG000|Overall Study|Disease worsening|5|||
33354235|NCT00570661|62731892|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
33354236|NCT00570661|62731892|FG000|Overall Study|Adverse Event|1|||
33354237|NCT00934544|62731899|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
33354238|NCT00934544|62731900|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
33354239|NCT00934544|62731901|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
33354240|NCT00934544|62731899|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
33354241|NCT00934544|62731900|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
33354242|NCT00934544|62731901|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
33354243|NCT00934544|62731899|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
33354244|NCT00934544|62731900|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
33354245|NCT00934544|62731901|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
33354246|NCT00934544|62731899|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
33354247|NCT00934544|62731900|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
33354248|NCT00934544|62731901|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
33354249|NCT00934544|62731899|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
33354250|NCT00934544|62731900|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
33354251|NCT00934544|62731901|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
33354252|NCT00934544|62731899|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
33354253|NCT00934544|62731900|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
33354254|NCT00934544|62731901|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
33354255|NCT00934544|62731899|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
33354256|NCT00934544|62731900|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
33354257|NCT00934544|62731901|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
33354258|NCT00934544|62731899|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
33354259|NCT00934544|62731900|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
33354260|NCT00934544|62731901|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
33354261|NCT00934544|62731899|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
33354262|NCT00934544|62731900|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
33354263|NCT00934544|62731901|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
33354264|NCT00934544|62731899|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
33354265|NCT00934544|62731900|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
33354266|NCT00934544|62731901|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
33354267|NCT00934544|62731899|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
33354268|NCT00934544|62731900|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
33354269|NCT00934544|62731901|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
33354270|NCT00934544|62731899|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
33354271|NCT00934544|62731900|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
33354272|NCT00934544|62731901|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
33354273|NCT00934544|62731899|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
33354274|NCT00934544|62731900|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
33354275|NCT00934544|62731901|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
33354276|NCT00934544|62731899|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
33354277|NCT00934544|62731900|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
33354278|NCT00934544|62731901|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
33354279|NCT00934544|62731899|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
33354280|NCT00934544|62731900|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
33354281|NCT00934544|62731901|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
33354282|NCT00934544|62731899|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
33354283|NCT00934544|62731900|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
33354284|NCT00934544|62731901|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
33354285|NCT00999167|62731920|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
33354286|NCT00999167|62731921|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
33354287|NCT00999167|62731922|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
33354288|NCT00999167|62731920|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
33354289|NCT00999167|62731921|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
33354290|NCT00999167|62731922|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
33354291|NCT00999167|62731920|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
33354292|NCT00999167|62731921|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
33354293|NCT00999167|62731922|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
33354294|NCT00999167|62731920|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
33354295|NCT00999167|62731921|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
33354296|NCT00999167|62731922|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
33354297|NCT00999167|62731920|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
33354298|NCT00999167|62731921|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
33354299|NCT00999167|62731922|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
33354300|NCT00999167|62731920|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
33354301|NCT00999167|62731921|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
33472276|NCT03812029|62846318|FG003|Overall Study|Withdrawal by Subject|2|||
33472277|NCT03812029|62846319|FG004|Overall Study|Withdrawal by Subject|2|||
33472278|NCT03812029|62846315|FG000|Overall Study|Stopping rules|0|||
33472279|NCT03812029|62846316|FG001|Overall Study|Stopping rules|1|||
33472280|NCT03812029|62846317|FG002|Overall Study|Stopping rules|0|||
33472281|NCT03812029|62846318|FG003|Overall Study|Stopping rules|0|||
33472282|NCT03812029|62846319|FG004|Overall Study|Stopping rules|0|||
33472283|NCT03812029|62846315|FG000|Overall Study|Adverse Event|0|||
33472284|NCT03812029|62846316|FG001|Overall Study|Adverse Event|9|||
33472285|NCT03812029|62846317|FG002|Overall Study|Adverse Event|0|||
33472286|NCT03812029|62846318|FG003|Overall Study|Adverse Event|3|||
33472287|NCT03812029|62846319|FG004|Overall Study|Adverse Event|5|||
33472288|NCT03812029|62846315|FG000|Overall Study|Lost to Follow-up|0|||
33354302|NCT00999167|62731922|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
33354303|NCT00999167|62731920|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
33354304|NCT00999167|62731921|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
33354305|NCT00999167|62731922|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
33354306|NCT00999167|62731920|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
33354307|NCT00999167|62731921|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
33354308|NCT00999167|62731922|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
33354309|NCT00570505|62731932|FG000|Overall Study|Adverse Event|7|||
33354310|NCT00570505|62731932|FG000|Overall Study|Withdrawal by Subject|7|||
33354311|NCT00570505|62731932|FG000|Overall Study|Lost to Follow-up|23|||
33354312|NCT00570505|62731932|FG000|Overall Study|Other loss to follow-up|4|||
33354313|NCT00931892|62731938|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
33354314|NCT00931892|62731939|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
33354315|NCT00666211|62731987|FG000|Overall Study|Withdrawal by Subject|10|||
33354316|NCT00666211|62731988|FG001|Overall Study|Withdrawal by Subject|13|||
33354317|NCT00666211|62731987|FG000|Overall Study|went off medication, no more pain|1|||
33354318|NCT00666211|62731988|FG001|Overall Study|went off medication, no more pain|0|||
33354319|NCT00666211|62731987|FG000|Overall Study|patient non-compliant|6|||
33354320|NCT00666211|62731988|FG001|Overall Study|patient non-compliant|6|||
33354321|NCT00666211|62731987|FG000|Overall Study|disease progression|1|||
33354322|NCT00666211|62731988|FG001|Overall Study|disease progression|8|||
33354323|NCT00666211|62731987|FG000|Overall Study|Lost to Follow-up|2|||
33354324|NCT00666211|62731988|FG001|Overall Study|Lost to Follow-up|0|||
33354325|NCT00666211|62731987|FG000|Overall Study|toxicity|0|||
33354326|NCT00666211|62731988|FG001|Overall Study|toxicity|2|||
33354327|NCT00666211|62731987|FG000|Overall Study|hospital admission|0|||
33472289|NCT03812029|62846316|FG001|Overall Study|Lost to Follow-up|0|||
33472290|NCT03812029|62846317|FG002|Overall Study|Lost to Follow-up|0|||
33472291|NCT03812029|62846318|FG003|Overall Study|Lost to Follow-up|0|||
33472292|NCT03812029|62846319|FG004|Overall Study|Lost to Follow-up|3|||
33354328|NCT00666211|62731988|FG001|Overall Study|hospital admission|5|||
33354329|NCT00666211|62731987|FG000|Overall Study|Death|0|||
33354330|NCT00666211|62731988|FG001|Overall Study|Death|2|||
33354331|NCT00666211|62731987|FG000|Overall Study|off tx for other complicating disease|0|||
33354332|NCT00666211|62731988|FG001|Overall Study|off tx for other complicating disease|1|||
33354333|NCT00666211|62731987|FG000|Overall Study|Physician Decision|0|||
33354334|NCT00666211|62731988|FG001|Overall Study|Physician Decision|1|||
33354335|NCT00878709|62731996|FG000|Overall Study|Withdrawal by Subject|197|||
33354336|NCT00878709|62731997|FG001|Overall Study|Withdrawal by Subject|120|||
33354337|NCT00878709|62731996|FG000|Overall Study|Lost to Follow-up|35|||
33354338|NCT00878709|62731997|FG001|Overall Study|Lost to Follow-up|33|||
33354339|NCT00878709|62731996|FG000|Overall Study|Other Reasons|93|||
33354340|NCT00878709|62731997|FG001|Overall Study|Other Reasons|84|||
33354341|NCT00927758|62732004|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
33354342|NCT00927758|62732005|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
33354343|NCT00927758|62732006|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
33354344|NCT00927758|62732007|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
33354345|NCT00927758|62732008|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
33354346|NCT00927758|62732009|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
33354347|NCT00927758|62732004|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
33354348|NCT00927758|62732005|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
33354349|NCT00927758|62732006|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
33354350|NCT00927758|62732007|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
33354351|NCT00927758|62732008|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
33354352|NCT00927758|62732009|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
33354353|NCT00927368|62732020|FG000|Overall Study|enrollment in another study|1|||
33354354|NCT00927368|62732021|FG001|Overall Study|enrollment in another study|1|||
33354355|NCT00927368|62732022|FG002|Overall Study|enrollment in another study|2|||
33354356|NCT00927368|62732020|FG000|Overall Study|Lost to Follow-up|4|||
33354357|NCT00927368|62732021|FG001|Overall Study|Lost to Follow-up|0|||
33472293|NCT03747575|62846337|FG000|Overall Study|Withdrawal by Subject|6|||
33472294|NCT03747575|62846338|FG001|Overall Study|Withdrawal by Subject|3|||
33472295|NCT03747575|62846337|FG000|Overall Study|Lost to Follow-up|3|||
33472296|NCT03747575|62846338|FG001|Overall Study|Lost to Follow-up|3|||
33472297|NCT03747575|62846337|FG000|Overall Study|Adverse Event|0|||
33472298|NCT03747575|62846338|FG001|Overall Study|Adverse Event|1|||
33472299|NCT03657043|62846347|FG000|Overall Study|Withdrawal by Subject|1|||
33472300|NCT03657043|62846348|FG001|Overall Study|Withdrawal by Subject|1|||
33472301|NCT03657043|62846349|FG002|Overall Study|Withdrawal by Subject|0|||
33549071|NCT02901431|62940305|FG011|Main Treatment Part|Physician Decision|0|||
33655245|NCT01893203|63069730|FG000|Overall Study|Withdrawal by Subject|1|||
33472302|NCT03657043|62846350|FG003|Overall Study|Withdrawal by Subject|0|||
33655246|NCT01882829|63069734|FG000|Overall Study|Adverse Event|4|||
33472303|NCT03657043|62846351|FG004|Overall Study|Withdrawal by Subject|4|||
33472304|NCT03657043|62846347|FG000|Overall Study|Study closure by Sponsor|0|||
33472305|NCT03657043|62846348|FG001|Overall Study|Study closure by Sponsor|2|||
33472306|NCT03657043|62846349|FG002|Overall Study|Study closure by Sponsor|0|||
33472307|NCT03657043|62846350|FG003|Overall Study|Study closure by Sponsor|0|||
33472308|NCT03657043|62846351|FG004|Overall Study|Study closure by Sponsor|17|||
33655247|NCT01882829|63069734|FG000|Overall Study|Protocol Violation|1|||
33655248|NCT01882829|63069734|FG000|Overall Study|Withdrawal by Subject|1|||
33655249|NCT01882439|63069818|FG000|Overall Study|Adverse event related to study drug|3|||
33354358|NCT00927368|62732022|FG002|Overall Study|Lost to Follow-up|0|||
33354359|NCT00927368|62732020|FG000|Overall Study|equipment failure|1|||
33354360|NCT00927368|62732021|FG001|Overall Study|equipment failure|0|||
33354361|NCT00927368|62732022|FG002|Overall Study|equipment failure|0|||
33354362|NCT00927368|62732020|FG000|Overall Study|ineligible post randomization|0|||
33354363|NCT00927368|62732021|FG001|Overall Study|ineligible post randomization|3|||
33354364|NCT00927368|62732022|FG002|Overall Study|ineligible post randomization|1|||
33354365|NCT00927368|62732020|FG000|Overall Study|cancellation of surgery|0|||
33354366|NCT00927368|62732021|FG001|Overall Study|cancellation of surgery|1|||
33354367|NCT00927368|62732022|FG002|Overall Study|cancellation of surgery|2|||
33354368|NCT00662857|62732030|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
33354369|NCT00662857|62732031|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
33354370|NCT00662857|62732030|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
33354371|NCT00662857|62732031|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
33354372|NCT00662857|62732030|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
33354373|NCT00662857|62732031|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
33655250|NCT01882439|63069819|FG001|Overall Study|Adverse event related to study drug|8|||
33354374|NCT00878553|62732044|FG000|Sleep Study|Withdrawal by Subject|2|||
33354375|NCT00878553|62732045|FG001|Sleep Study|Withdrawal by Subject|0|||
33655251|NCT01882439|63069820|FG002|Overall Study|Adverse event related to study drug|1|||
33655252|NCT01882439|63069821|FG003|Overall Study|Adverse event related to study drug|2|||
33655253|NCT01882439|63069818|FG000|Overall Study|Pregnancy|0|||
33655254|NCT01882439|63069819|FG001|Overall Study|Pregnancy|1|||
33655255|NCT01882439|63069820|FG002|Overall Study|Pregnancy|0|||
33655256|NCT01882439|63069821|FG003|Overall Study|Pregnancy|0|||
33655257|NCT01882439|63069818|FG000|Overall Study|Protocol Violation|2|||
33655258|NCT01882439|63069819|FG001|Overall Study|Protocol Violation|2|||
33655259|NCT01882439|63069820|FG002|Overall Study|Protocol Violation|0|||
33655260|NCT01882439|63069821|FG003|Overall Study|Protocol Violation|1|||
33655261|NCT01882439|63069818|FG000|Overall Study|No longer willing to participate|1|||
33655262|NCT01882439|63069819|FG001|Overall Study|No longer willing to participate|4|||
33655263|NCT01882439|63069820|FG002|Overall Study|No longer willing to participate|2|||
33655264|NCT01882439|63069821|FG003|Overall Study|No longer willing to participate|3|||
33655265|NCT01882439|63069818|FG000|Overall Study|Medication error with no associated AE|0|||
33655266|NCT01882439|63069819|FG001|Overall Study|Medication error with no associated AE|0|||
33655267|NCT01882439|63069820|FG002|Overall Study|Medication error with no associated AE|2|||
33655268|NCT01882439|63069821|FG003|Overall Study|Medication error with no associated AE|0|||
33655269|NCT01882439|63069818|FG000|Overall Study|Insufficient clinical response|1|||
33655270|NCT01882439|63069819|FG001|Overall Study|Insufficient clinical response|4|||
33354376|NCT00878553|62732046|FG002|Sleep Study|Withdrawal by Subject|0|||
33354377|NCT00878553|62732047|FG003|Sleep Study|Withdrawal by Subject|0|||
33354378|NCT00878553|62732048|FG004|Sleep Study|Withdrawal by Subject|0|||
33655271|NCT01882439|63069820|FG002|Overall Study|Insufficient clinical response|4|||
33354379|NCT00878553|62732044|FG000|Sleep Study|Lost to Follow-up|1|||
33354380|NCT00878553|62732045|FG001|Sleep Study|Lost to Follow-up|0|||
33655272|NCT01882439|63069821|FG003|Overall Study|Insufficient clinical response|2|||
33655273|NCT01882439|63069818|FG000|Overall Study|Adverse event unrelated to study drug|2|||
33655274|NCT01882439|63069819|FG001|Overall Study|Adverse event unrelated to study drug|2|||
33655275|NCT01882439|63069820|FG002|Overall Study|Adverse event unrelated to study drug|1|||
33354381|NCT00878553|62732046|FG002|Sleep Study|Lost to Follow-up|0|||
33354382|NCT00878553|62732047|FG003|Sleep Study|Lost to Follow-up|0|||
33354383|NCT00878553|62732048|FG004|Sleep Study|Lost to Follow-up|0|||
33354384|NCT00878553|62732044|FG000|Sleep Study|car accident|1|||
33354385|NCT00878553|62732045|FG001|Sleep Study|car accident|0|||
33354386|NCT00878553|62732046|FG002|Sleep Study|car accident|0|||
33354387|NCT00878553|62732047|FG003|Sleep Study|car accident|0|||
33354388|NCT00878553|62732048|FG004|Sleep Study|car accident|0|||
33354389|NCT00878553|62732044|FG000|Sleep Study|family emergency|1|||
33354390|NCT00878553|62732045|FG001|Sleep Study|family emergency|0|||
33354391|NCT00878553|62732046|FG002|Sleep Study|family emergency|0|||
33354392|NCT00878553|62732047|FG003|Sleep Study|family emergency|0|||
33354393|NCT00878553|62732048|FG004|Sleep Study|family emergency|0|||
33354394|NCT00878553|62732044|FG000|PK Study|Withdrawal by Subject|0|||
33354395|NCT00878553|62732045|FG001|PK Study|Withdrawal by Subject|0|||
33354396|NCT00878553|62732046|FG002|PK Study|Withdrawal by Subject|0|||
33354397|NCT00878553|62732047|FG003|PK Study|Withdrawal by Subject|1|||
33354398|NCT00878553|62732048|FG004|PK Study|Withdrawal by Subject|0|||
33354399|NCT00996437|62732067|FG000|Overall Study|Death|1|||
33354400|NCT00996437|62732068|FG001|Overall Study|Death|0|||
33354401|NCT00996437|62732067|FG000|Overall Study|Dropped|2|||
33354402|NCT00996437|62732068|FG001|Overall Study|Dropped|2|||
33354403|NCT00996437|62732067|FG000|Overall Study|Missed|2|||
33472309|NCT03657043|62846347|FG000|Overall Study|Lost to Follow-up|0|||
33472310|NCT03657043|62846348|FG001|Overall Study|Lost to Follow-up|0|||
33472311|NCT03657043|62846349|FG002|Overall Study|Lost to Follow-up|0|||
33472312|NCT03657043|62846350|FG003|Overall Study|Lost to Follow-up|0|||
33472313|NCT03657043|62846351|FG004|Overall Study|Lost to Follow-up|4|||
33472314|NCT03657043|62846347|FG000|Overall Study|Death|6|||
33472315|NCT03657043|62846348|FG001|Overall Study|Death|5|||
33472316|NCT03657043|62846349|FG002|Overall Study|Death|0|||
33472317|NCT03657043|62846350|FG003|Overall Study|Death|0|||
33472318|NCT03657043|62846351|FG004|Overall Study|Death|53|||
33472319|NCT03657043|62846347|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
33472320|NCT03657043|62846348|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
33472321|NCT03657043|62846349|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
33472322|NCT03657043|62846350|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
33472323|NCT03657043|62846351|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
33472324|NCT03657043|62846347|FG000|Overall Study|Adverse Event|0|||
33472325|NCT03657043|62846348|FG001|Overall Study|Adverse Event|0|||
33472326|NCT03657043|62846349|FG002|Overall Study|Adverse Event|0|||
33472327|NCT03657043|62846350|FG003|Overall Study|Adverse Event|0|||
33472328|NCT03657043|62846351|FG004|Overall Study|Adverse Event|2|||
33472329|NCT03657043|62846347|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
33472330|NCT03657043|62846348|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
33472331|NCT03657043|62846349|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
33472332|NCT03657043|62846350|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
33472333|NCT03657043|62846351|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
33472334|NCT03657043|62846347|FG000|Overall Study|Withdrawal - declined follow-up|0|||
33472335|NCT03657043|62846348|FG001|Overall Study|Withdrawal - declined follow-up|0|||
33472336|NCT03657043|62846349|FG002|Overall Study|Withdrawal - declined follow-up|0|||
33472337|NCT03657043|62846350|FG003|Overall Study|Withdrawal - declined follow-up|0|||
33472338|NCT03657043|62846351|FG004|Overall Study|Withdrawal - declined follow-up|1|||
33655276|NCT01882439|63069821|FG003|Overall Study|Adverse event unrelated to study drug|1|||
33655277|NCT01892657|63069868|FG000|Overall Study|Withdrawal by Subject|6|||
33655278|NCT01892657|63069868|FG000|Overall Study|Protocol Violation|12|||
33655279|NCT01881737|63069895|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
33655280|NCT01881737|63069895|FG000|Overall Study|Withdrawal by Subject|1|||
33354404|NCT00996437|62732068|FG001|Overall Study|Missed|5|||
33354405|NCT00662311|62732077|FG000|Overall Study|Respiratory Infection|1|||
33354406|NCT00662311|62732078|FG001|Overall Study|Respiratory Infection|0|||
33354407|NCT00662311|62732079|FG002|Overall Study|Respiratory Infection|0|||
33354408|NCT00929708|62732092|FG000|Overall Study|Protocol Violation|2|||
33472339|NCT03646669|62846361|FG000|Overall Study|Withdrawal by Subject|5|||
33472340|NCT03646669|62846362|FG001|Overall Study|Withdrawal by Subject|0|||
33655281|NCT01881737|63069895|FG000|Overall Study|Worsening of baseline behavior|1|||
33354409|NCT00929708|62732093|FG001|Overall Study|Protocol Violation|1|||
33354410|NCT00929708|62732094|FG002|Overall Study|Protocol Violation|1|||
33655282|NCT01892501|63069931|FG000|Overall Study|Protocol Violation|2|||
33354411|NCT00929708|62732095|FG003|Overall Study|Protocol Violation|1|||
33354412|NCT00929708|62732096|FG004|Overall Study|Protocol Violation|1|||
33472341|NCT03631706|62846370|FG000|Overall Study|Randomized, not treated|1|||
33472342|NCT03631706|62846371|FG001|Overall Study|Randomized, not treated|0|||
33472343|NCT03631706|62846370|FG000|Overall Study|Treatment ongoing|26|||
33472344|NCT03631706|62846371|FG001|Overall Study|Treatment ongoing|57|||
33472345|NCT03631706|62846370|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
33472346|NCT03631706|62846371|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
33472347|NCT03619876|62846379|FG000|Overall Study|Withdrawal by Subject|1|||
33472348|NCT03619876|62846380|FG001|Overall Study|Withdrawal by Subject|2|||
33472349|NCT03619876|62846379|FG000|Overall Study|Withdrawal due to incidental finding|0|||
33472350|NCT03619876|62846380|FG001|Overall Study|Withdrawal due to incidental finding|2|||
33472351|NCT03526861|62846402|FG000|Initial Treatment Period|Not dosed|1|||
33472352|NCT03526861|62846403|FG001|Initial Treatment Period|Not dosed|1|||
33472353|NCT03526861|62846404|FG002|Initial Treatment Period|Not dosed|1|||
33472354|NCT03526861|62846405|FG003|Initial Treatment Period|Not dosed|0|||
33655283|NCT01892501|63069931|FG000|Overall Study|Puncture not carried out|9|||
33655284|NCT01892501|63069931|FG000|Overall Study|Radiological monitoring not carried out|5|||
33655285|NCT01892501|63069931|FG000|Overall Study|Non-contributory histological result|12|||
33655286|NCT01892345|63069946|FG000|Overall Study|Adverse Event|0|||
33354413|NCT00929708|62732092|FG000|Overall Study|Withdrawal by Subject|2|||
33354414|NCT00929708|62732093|FG001|Overall Study|Withdrawal by Subject|0|||
33354415|NCT00929708|62732094|FG002|Overall Study|Withdrawal by Subject|0|||
33354416|NCT00929708|62732095|FG003|Overall Study|Withdrawal by Subject|2|||
33354417|NCT00929708|62732096|FG004|Overall Study|Withdrawal by Subject|1|||
33354418|NCT00929708|62732092|FG000|Overall Study|Adverse Event|0|||
33354419|NCT00929708|62732093|FG001|Overall Study|Adverse Event|0|||
33354420|NCT00929708|62732094|FG002|Overall Study|Adverse Event|0|||
33354421|NCT00929708|62732095|FG003|Overall Study|Adverse Event|0|||
33354422|NCT00929708|62732096|FG004|Overall Study|Adverse Event|3|||
33354423|NCT00929708|62732092|FG000|Overall Study|Physician Decision|0|||
33354424|NCT00929708|62732093|FG001|Overall Study|Physician Decision|2|||
33354425|NCT00929708|62732094|FG002|Overall Study|Physician Decision|2|||
33354426|NCT00929708|62732095|FG003|Overall Study|Physician Decision|2|||
33354427|NCT00929708|62732096|FG004|Overall Study|Physician Decision|1|||
33354428|NCT00929708|62732092|FG000|Overall Study|Lost to Follow-up|0|||
33354429|NCT00929708|62732093|FG001|Overall Study|Lost to Follow-up|0|||
33354430|NCT00929708|62732094|FG002|Overall Study|Lost to Follow-up|0|||
33354431|NCT00929708|62732095|FG003|Overall Study|Lost to Follow-up|1|||
33354432|NCT00929708|62732096|FG004|Overall Study|Lost to Follow-up|0|||
33354433|NCT00996281|62732110|FG000|Overall Study|Adverse Event|75|||
33472355|NCT03526861|62846406|FG004|Initial Treatment Period|Not dosed|0|||
33655287|NCT01892345|63069947|FG001|Overall Study|Adverse Event|2|||
33655288|NCT01892345|63069946|FG000|Overall Study|Death|1|||
33655289|NCT01892345|63069947|FG001|Overall Study|Death|0|||
33655290|NCT01892345|63069946|FG000|Overall Study|Lost to Follow-up|3|||
33655291|NCT01892345|63069947|FG001|Overall Study|Lost to Follow-up|0|||
33655292|NCT01892345|63069946|FG000|Overall Study|Withdrawal by Subject|12|||
33655293|NCT01892345|63069947|FG001|Overall Study|Withdrawal by Subject|1|||
33655294|NCT01892189|63070024|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
33655295|NCT01892189|63070025|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
33655296|NCT01892189|63070026|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
33655297|NCT01892189|63070027|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
33655298|NCT01892189|63070028|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
33655299|NCT01892189|63070029|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
33655300|NCT01892189|63070030|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
33655301|NCT01892189|63070031|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
33655302|NCT01892189|63070032|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
33655303|NCT01892189|63070024|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33655304|NCT01892189|63070025|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33354434|NCT00996281|62732111|FG001|Overall Study|Adverse Event|37|||
33354435|NCT00996281|62732110|FG000|Overall Study|Major Protocol Deviation|6|||
33472356|NCT03526861|62846407|FG005|Initial Treatment Period|Not dosed|0|||
33472357|NCT03526861|62846408|FG006|Initial Treatment Period|Not dosed|0|||
33472358|NCT03526861|62846409|FG007|Initial Treatment Period|Not dosed|0|||
33472359|NCT03526861|62846410|FG008|Initial Treatment Period|Not dosed|0|||
33472360|NCT03526861|62846402|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
33655305|NCT01892189|63070026|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
33655306|NCT01892189|63070027|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
33655307|NCT01892189|63070028|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33354436|NCT00996281|62732111|FG001|Overall Study|Major Protocol Deviation|7|||
33354437|NCT00996281|62732110|FG000|Overall Study|Lost to Follow-up|14|||
33655308|NCT01892189|63070029|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33354438|NCT00996281|62732111|FG001|Overall Study|Lost to Follow-up|16|||
33354439|NCT00996281|62732110|FG000|Overall Study|Withdrawal by Subject|31|||
33354440|NCT00996281|62732111|FG001|Overall Study|Withdrawal by Subject|20|||
33354441|NCT00996281|62732110|FG000|Overall Study|Lack of Efficacy|0|||
33354442|NCT00996281|62732111|FG001|Overall Study|Lack of Efficacy|2|||
33354443|NCT00996281|62732110|FG000|Overall Study|Other|5|||
33354444|NCT00996281|62732111|FG001|Overall Study|Other|7|||
33354445|NCT00996203|62732117|FG000|Overall Study|Adverse Event|3|||
33472361|NCT03526861|62846403|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
33472362|NCT03526861|62846404|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
33472363|NCT03526861|62846405|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472364|NCT03526861|62846406|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472365|NCT03526861|62846407|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472366|NCT03526861|62846408|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33354446|NCT00996203|62732117|FG000|Overall Study|Lost to Follow-up|1|||
33354447|NCT00996203|62732117|FG000|Overall Study|Lack of Efficacy|1|||
33354448|NCT00996203|62732117|FG000|Overall Study|Protocol Violation|2|||
33354449|NCT00877929|62732124|FG000|Overall Study|Adverse Event|11|||
33354450|NCT00877929|62732125|FG001|Overall Study|Adverse Event|20|||
33354451|NCT00877929|62732124|FG000|Overall Study|Protocol Violation|3|||
33472367|NCT03526861|62846409|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472368|NCT03526861|62846410|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472369|NCT03526861|62846402|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
33472370|NCT03526861|62846403|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
33472371|NCT03526861|62846404|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
33472372|NCT03526861|62846405|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
33472373|NCT03526861|62846406|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
33472374|NCT03526861|62846407|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
33472375|NCT03526861|62846408|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
33472376|NCT03526861|62846409|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
33472377|NCT03526861|62846410|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
33472378|NCT03526861|62846402|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33472379|NCT03526861|62846403|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33472380|NCT03526861|62846404|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33472381|NCT03526861|62846405|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
33472382|NCT03526861|62846406|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
33549072|NCT02901431|62940306|FG012|Main Treatment Part|Physician Decision|0|||
33549073|NCT02901431|62940294|FG000|Main Treatment Part|Withdrawal by Subject|0|||
33549074|NCT02901431|62940295|FG001|Main Treatment Part|Withdrawal by Subject|0|||
33549075|NCT02901431|62940296|FG002|Main Treatment Part|Withdrawal by Subject|0|||
33549076|NCT02901431|62940297|FG003|Main Treatment Part|Withdrawal by Subject|18|||
33549077|NCT02901431|62940298|FG004|Main Treatment Part|Withdrawal by Subject|3|||
33354452|NCT00877929|62732125|FG001|Overall Study|Protocol Violation|3|||
33354453|NCT00877929|62732124|FG000|Overall Study|Lost to Follow-up|0|||
33354454|NCT00877929|62732125|FG001|Overall Study|Lost to Follow-up|1|||
33354455|NCT00877929|62732124|FG000|Overall Study|Withdrawal by Subject|4|||
33354456|NCT00877929|62732125|FG001|Overall Study|Withdrawal by Subject|4|||
33354457|NCT00877929|62732124|FG000|Overall Study|Lack of Efficacy|0|||
33354458|NCT00877929|62732125|FG001|Overall Study|Lack of Efficacy|1|||
33354459|NCT00877929|62732124|FG000|Overall Study|Other reason (not specified)|2|||
33354460|NCT00877929|62732125|FG001|Overall Study|Other reason (not specified)|6|||
33354461|NCT00931268|62732135|FG000|Overall Study|Lost to Follow-up|6|||
33354462|NCT00996125|62732141|FG000|Overall Study|Adverse Event|0|||
33354463|NCT00996125|62732142|FG001|Overall Study|Adverse Event|2|||
33354464|NCT00996125|62732141|FG000|Overall Study|Lost to Follow-up|1|||
33354465|NCT00996125|62732142|FG001|Overall Study|Lost to Follow-up|6|||
33354466|NCT00996125|62732141|FG000|Overall Study|Withdrawal by Subject|4|||
33354467|NCT00996125|62732142|FG001|Overall Study|Withdrawal by Subject|3|||
33354468|NCT04211363|62732150|FG000|Overall Study|Adverse Event|5|||
33354469|NCT04211363|62732151|FG001|Overall Study|Adverse Event|2|||
33354470|NCT04211363|62732150|FG000|Overall Study|Physician Decision|0|||
33354471|NCT04211363|62732151|FG001|Overall Study|Physician Decision|1|||
33354472|NCT04211363|62732150|FG000|Overall Study|Protocol Violation|1|||
33354473|NCT04211363|62732151|FG001|Overall Study|Protocol Violation|0|||
33354474|NCT04211363|62732150|FG000|Overall Study|Pregnancy|1|||
33354475|NCT04211363|62732151|FG001|Overall Study|Pregnancy|0|||
33354476|NCT04211363|62732150|FG000|Overall Study|Lost to Follow-up|12|||
33354477|NCT04211363|62732151|FG001|Overall Study|Lost to Follow-up|4|||
33354478|NCT04211363|62732150|FG000|Overall Study|Withdrawal by Subject|11|||
33354479|NCT04211363|62732151|FG001|Overall Study|Withdrawal by Subject|11|||
33354480|NCT04211363|62732150|FG000|Overall Study|Other|1|||
33354481|NCT04211363|62732151|FG001|Overall Study|Other|2|||
33354482|NCT00995345|62732162|FG000|Overall Study|Withdrawal by Subject|4|||
33354483|NCT00995345|62732163|FG001|Overall Study|Withdrawal by Subject|2|||
33354484|NCT00995345|62732164|FG002|Overall Study|Withdrawal by Subject|1|||
33354485|NCT00995345|62732165|FG003|Overall Study|Withdrawal by Subject|3|||
33354486|NCT00995345|62732166|FG004|Overall Study|Withdrawal by Subject|1|||
33354487|NCT00995345|62732162|FG000|Overall Study|Adverse Event|3|||
33354488|NCT00995345|62732163|FG001|Overall Study|Adverse Event|1|||
33354489|NCT00995345|62732164|FG002|Overall Study|Adverse Event|2|||
33354490|NCT00995345|62732165|FG003|Overall Study|Adverse Event|0|||
33354491|NCT00995345|62732166|FG004|Overall Study|Adverse Event|1|||
33354492|NCT00995345|62732162|FG000|Overall Study|Lost to Follow-up|2|||
33354493|NCT00995345|62732163|FG001|Overall Study|Lost to Follow-up|2|||
33354494|NCT00995345|62732164|FG002|Overall Study|Lost to Follow-up|2|||
33354495|NCT00995345|62732165|FG003|Overall Study|Lost to Follow-up|1|||
33354496|NCT00995345|62732166|FG004|Overall Study|Lost to Follow-up|0|||
33354497|NCT00995345|62732162|FG000|Overall Study|all other reasons combined|2|||
33354498|NCT00995345|62732163|FG001|Overall Study|all other reasons combined|2|||
33354499|NCT00995345|62732164|FG002|Overall Study|all other reasons combined|2|||
33354500|NCT00995345|62732165|FG003|Overall Study|all other reasons combined|1|||
33354501|NCT00995345|62732166|FG004|Overall Study|all other reasons combined|3|||
33354502|NCT00660907|62732180|FG000|Overall Study|Incorrect Enrollment|1|||
33354503|NCT00660907|62732181|FG001|Overall Study|Incorrect Enrollment|1|||
33472383|NCT03526861|62846407|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33472384|NCT03526861|62846408|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
33472385|NCT03526861|62846409|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33472386|NCT03526861|62846410|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33472387|NCT03526861|62846402|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
33472388|NCT03526861|62846403|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
33472389|NCT03526861|62846404|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
33472390|NCT03526861|62846405|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
33472391|NCT03526861|62846406|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
33472392|NCT03526861|62846407|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
33472393|NCT03526861|62846408|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
33472394|NCT03526861|62846409|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
33472395|NCT03526861|62846410|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
33472396|NCT03526861|62846402|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472397|NCT03526861|62846403|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472398|NCT03526861|62846404|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472399|NCT03526861|62846405|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
33472400|NCT03526861|62846406|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472401|NCT03526861|62846407|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472402|NCT03526861|62846408|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33549078|NCT02901431|62940299|FG005|Main Treatment Part|Withdrawal by Subject|5|||
33549079|NCT02901431|62940300|FG006|Main Treatment Part|Withdrawal by Subject|6|||
33354504|NCT00660907|62732180|FG000|Overall Study|Adverse Event|33|||
33354505|NCT00660907|62732181|FG001|Overall Study|Adverse Event|19|||
33354506|NCT00660907|62732180|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
33354507|NCT00660907|62732181|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
33354508|NCT00660907|62732180|FG000|Overall Study|Withdrawal by Subject|23|||
33354509|NCT00660907|62732181|FG001|Overall Study|Withdrawal by Subject|32|||
33354510|NCT00660907|62732180|FG000|Overall Study|Lost to Follow-up|3|||
33354511|NCT00660907|62732181|FG001|Overall Study|Lost to Follow-up|3|||
33354512|NCT00660907|62732180|FG000|Overall Study|Poor/Non-Compliance|5|||
33354513|NCT00660907|62732181|FG001|Overall Study|Poor/Non-Compliance|1|||
33354514|NCT00660907|62732180|FG000|Overall Study|Safety|1|||
33354515|NCT00660907|62732181|FG001|Overall Study|Safety|0|||
33354516|NCT00660907|62732180|FG000|Overall Study|Death|1|||
33354517|NCT00660907|62732181|FG001|Overall Study|Death|3|||
33354518|NCT00660907|62732180|FG000|Overall Study|Various|11|||
33354519|NCT00660907|62732181|FG001|Overall Study|Various|8|||
33354520|NCT00877773|62732187|FG000|Overall Study|Disease Progression|44|||
33354521|NCT00659815|62732193|FG000|Overall Study|Study related symptoms and complaints|2|||
33354522|NCT00659815|62732194|FG001|Overall Study|Study related symptoms and complaints|1|||
33354523|NCT00659815|62732193|FG000|Overall Study|Inability to maintain wearing schedule|1|||
33354524|NCT00659815|62732194|FG001|Overall Study|Inability to maintain wearing schedule|2|||
33354525|NCT00659815|62732193|FG000|Overall Study|Withdrawal by Subject|1|||
33354526|NCT00659815|62732194|FG001|Overall Study|Withdrawal by Subject|1|||
33354527|NCT00994643|62732200|FG000|Overall Study|Withdrawal by Subject|1|||
33354528|NCT00660829|62732206|FG000|Overall Study|Adverse Event|3|||
33354529|NCT00660829|62732207|FG001|Overall Study|Adverse Event|4|||
33354530|NCT00660829|62732206|FG000|Overall Study|Lack of Efficacy|2|||
33354531|NCT00660829|62732207|FG001|Overall Study|Lack of Efficacy|3|||
33354532|NCT00660829|62732206|FG000|Overall Study|Non-Compliance|0|||
33472403|NCT03526861|62846409|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472404|NCT03526861|62846410|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472405|NCT03526861|62846402|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33472406|NCT03526861|62846403|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33472407|NCT03526861|62846404|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33472408|NCT03526861|62846405|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33472409|NCT03526861|62846406|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33472410|NCT03526861|62846407|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33472411|NCT03526861|62846408|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33472412|NCT03526861|62846409|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33472413|NCT03526861|62846410|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
33472414|NCT03526861|62846402|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33472415|NCT03526861|62846403|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33472416|NCT03526861|62846404|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33472417|NCT03526861|62846405|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33472418|NCT03526861|62846406|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33472419|NCT03526861|62846407|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33472420|NCT03526861|62846408|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33472421|NCT03526861|62846409|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33472422|NCT03526861|62846410|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
33472423|NCT03526861|62846402|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33354533|NCT00660829|62732207|FG001|Overall Study|Non-Compliance|4|||
33354534|NCT00660829|62732206|FG000|Overall Study|Withdrawal by Subject|1|||
33354535|NCT00660829|62732207|FG001|Overall Study|Withdrawal by Subject|2|||
33354536|NCT00660829|62732206|FG000|Overall Study|Lost to Follow-up|3|||
33354537|NCT00660829|62732207|FG001|Overall Study|Lost to Follow-up|2|||
33354538|NCT00660829|62732206|FG000|Overall Study|Other|9|||
33354539|NCT00660829|62732207|FG001|Overall Study|Other|4|||
33354540|NCT00877383|62732215|FG000|Overall Study|Adverse Event|13|||
33354541|NCT00877383|62732216|FG001|Overall Study|Adverse Event|14|||
33354542|NCT00877383|62732215|FG000|Overall Study|Lost to Follow-up|5|||
33354543|NCT00877383|62732216|FG001|Overall Study|Lost to Follow-up|3|||
33354544|NCT00877383|62732215|FG000|Overall Study|Subject withdrew consent|3|||
33354545|NCT00877383|62732216|FG001|Overall Study|Subject withdrew consent|12|||
33354546|NCT00877383|62732215|FG000|Overall Study|Subject no longer requires study drug|2|||
33354547|NCT00877383|62732216|FG001|Overall Study|Subject no longer requires study drug|0|||
33354548|NCT00877383|62732215|FG000|Overall Study|Administrative problems|2|||
33354549|NCT00877383|62732216|FG001|Overall Study|Administrative problems|0|||
33354550|NCT00877383|62732215|FG000|Overall Study|Protocol deviation|2|||
33354551|NCT00877383|62732216|FG001|Overall Study|Protocol deviation|6|||
33354552|NCT00877383|62732215|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33354553|NCT00877383|62732216|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33354554|NCT00877383|62732215|FG000|Overall Study|Death|1|||
33354555|NCT00877383|62732216|FG001|Overall Study|Death|2|||
33354556|NCT00993473|62732224|FG000|Overall Study|Adverse Event|0|||
33354557|NCT00993473|62732225|FG001|Overall Study|Adverse Event|2|||
33354558|NCT00993473|62732224|FG000|Overall Study|Protocol Violation|1|||
33354559|NCT00993473|62732225|FG001|Overall Study|Protocol Violation|2|||
33354560|NCT00993473|62732224|FG000|Overall Study|Lost to Follow-up|1|||
33354561|NCT00993473|62732225|FG001|Overall Study|Lost to Follow-up|0|||
33354562|NCT00993473|62732224|FG000|Overall Study|Withdrawal by Subject|1|||
33354563|NCT00993473|62732225|FG001|Overall Study|Withdrawal by Subject|5|||
33354564|NCT00993473|62732224|FG000|Overall Study|Technical problem with CGM device|0|||
33354565|NCT00993473|62732225|FG001|Overall Study|Technical problem with CGM device|1|||
33354566|NCT00993473|62732224|FG000|Overall Study|Family event|1|||
33354567|NCT00993473|62732225|FG001|Overall Study|Family event|0|||
33354568|NCT00660595|62732233|FG000|Overall Study|Lost to Follow-up|0|||
33354569|NCT00660595|62732234|FG001|Overall Study|Lost to Follow-up|1|||
33354570|NCT00660595|62732233|FG000|Overall Study|Did not consent to participate in study|12|||
33354571|NCT00660595|62732234|FG001|Overall Study|Did not consent to participate in study|8|||
33354572|NCT00660595|62732233|FG000|Overall Study|Participant left hospital|1|||
33354573|NCT00660595|62732234|FG001|Overall Study|Participant left hospital|0|||
33354574|NCT00660595|62732233|FG000|Overall Study|Non Specified reasons|5|||
33354575|NCT00660595|62732234|FG001|Overall Study|Non Specified reasons|0|||
33354576|NCT00929240|62732240|FG000|Initial Treatment Phase|Adverse Event|31|||
33354577|NCT00929240|62732241|FG001|Initial Treatment Phase|Adverse Event|0|||
33354578|NCT00929240|62732242|FG002|Initial Treatment Phase|Adverse Event|0|||
33354579|NCT00929240|62732240|FG000|Initial Treatment Phase|Disease progression|41|||
33354580|NCT00929240|62732241|FG001|Initial Treatment Phase|Disease progression|0|||
33354581|NCT00929240|62732242|FG002|Initial Treatment Phase|Disease progression|0|||
33354582|NCT00929240|62732240|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
33354583|NCT00929240|62732241|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
33354584|NCT00929240|62732242|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
33354585|NCT00929240|62732240|FG000|Initial Treatment Phase|Protocol Violation|5|||
33354586|NCT00929240|62732241|FG001|Initial Treatment Phase|Protocol Violation|0|||
33354587|NCT00929240|62732242|FG002|Initial Treatment Phase|Protocol Violation|0|||
33354588|NCT00929240|62732240|FG000|Initial Treatment Phase|Death|2|||
33354589|NCT00929240|62732241|FG001|Initial Treatment Phase|Death|0|||
33354590|NCT00929240|62732242|FG002|Initial Treatment Phase|Death|0|||
33354591|NCT00929240|62732240|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
33354592|NCT00929240|62732241|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
33354593|NCT00929240|62732242|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
33354594|NCT00929240|62732240|FG000|Initial Treatment Phase|Physician Decision|4|||
33354595|NCT00929240|62732241|FG001|Initial Treatment Phase|Physician Decision|0|||
33354596|NCT00929240|62732242|FG002|Initial Treatment Phase|Physician Decision|0|||
33354597|NCT00929240|62732240|FG000|Maintenance Phase|Disease progression|0|||
33354598|NCT00929240|62732241|FG001|Maintenance Phase|Disease progression|73|||
33354599|NCT00929240|62732242|FG002|Maintenance Phase|Disease progression|60|||
33354600|NCT00929240|62732240|FG000|Maintenance Phase|Adverse Event|0|||
33354601|NCT00929240|62732241|FG001|Maintenance Phase|Adverse Event|9|||
33354602|NCT00929240|62732242|FG002|Maintenance Phase|Adverse Event|12|||
33354603|NCT00929240|62732240|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33354604|NCT00929240|62732241|FG001|Maintenance Phase|Withdrawal by Subject|2|||
33354605|NCT00929240|62732242|FG002|Maintenance Phase|Withdrawal by Subject|6|||
33354606|NCT00929240|62732240|FG000|Maintenance Phase|Protocol Violation|0|||
33354607|NCT00929240|62732241|FG001|Maintenance Phase|Protocol Violation|1|||
33354608|NCT00929240|62732242|FG002|Maintenance Phase|Protocol Violation|0|||
33354609|NCT00929240|62732240|FG000|Maintenance Phase|Health authority/Study termination|0|||
33354610|NCT00929240|62732241|FG001|Maintenance Phase|Health authority/Study termination|1|||
33354611|NCT00929240|62732242|FG002|Maintenance Phase|Health authority/Study termination|2|||
33354612|NCT00929240|62732240|FG000|Maintenance Phase|Physician Decision|0|||
33354613|NCT00929240|62732241|FG001|Maintenance Phase|Physician Decision|2|||
33354614|NCT00929240|62732242|FG002|Maintenance Phase|Physician Decision|1|||
33354615|NCT00929240|62732240|FG000|Maintenance Phase|Change of treatment|0|||
33354616|NCT00929240|62732241|FG001|Maintenance Phase|Change of treatment|4|||
33354617|NCT00929240|62732242|FG002|Maintenance Phase|Change of treatment|0|||
33354618|NCT00929240|62732240|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
33354619|NCT00929240|62732241|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
33354620|NCT00929240|62732242|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
33354621|NCT00929240|62732240|FG000|Maintenance Phase|Participant not treated|0|||
33354622|NCT00929240|62732241|FG001|Maintenance Phase|Participant not treated|2|||
33354623|NCT00929240|62732242|FG002|Maintenance Phase|Participant not treated|0|||
33354624|NCT00993317|62732253|FG000|Overall Study|Adverse Event|2|||
33354625|NCT00993317|62732254|FG001|Overall Study|Adverse Event|4|||
33354626|NCT00993317|62732253|FG000|Overall Study|Lack of Efficacy|18|||
33354627|NCT00993317|62732254|FG001|Overall Study|Lack of Efficacy|18|||
33354628|NCT00993317|62732253|FG000|Overall Study|Withdrawal by Subject|0|||
33354629|NCT00993317|62732254|FG001|Overall Study|Withdrawal by Subject|2|||
33354630|NCT00993317|62732253|FG000|Overall Study|Investigator's opinion|0|||
33354631|NCT00993317|62732254|FG001|Overall Study|Investigator's opinion|1|||
33354632|NCT00993317|62732253|FG000|Overall Study|Early study termination at the site|1|||
33354633|NCT00993317|62732254|FG001|Overall Study|Early study termination at the site|0|||
33354634|NCT01030133|62732262|FG000|Overall Study|failed to experience pain at level 7/10|2|||
33354635|NCT01030133|62732263|FG001|Overall Study|failed to experience pain at level 7/10|2|||
33354636|NCT00877071|62732273|FG000|Overall Study|disease progression|2|||
33354637|NCT00987389|62732279|FG000|Overall Study|Ineligible|0|||
33354638|NCT00987389|62732280|FG001|Overall Study|Ineligible|3|||
33354639|NCT00987389|62732281|FG002|Overall Study|Ineligible|0|||
33354640|NCT00987389|62732282|FG003|Overall Study|Ineligible|0|||
33354641|NCT00987389|62732279|FG000|Overall Study|Lost to Follow-up|4|||
33354642|NCT00987389|62732280|FG001|Overall Study|Lost to Follow-up|1|||
33354643|NCT00987389|62732281|FG002|Overall Study|Lost to Follow-up|3|||
33354644|NCT00987389|62732282|FG003|Overall Study|Lost to Follow-up|1|||
33354645|NCT00987389|62732279|FG000|Overall Study|Withdrawal by Subject|4|||
33354646|NCT00987389|62732280|FG001|Overall Study|Withdrawal by Subject|3|||
33354647|NCT00987389|62732281|FG002|Overall Study|Withdrawal by Subject|2|||
33354648|NCT00987389|62732282|FG003|Overall Study|Withdrawal by Subject|1|||
33354649|NCT00987389|62732279|FG000|Overall Study|Withdrawn from Treatment|0|||
33354650|NCT00987389|62732280|FG001|Overall Study|Withdrawn from Treatment|1|||
33472424|NCT03526861|62846403|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472425|NCT03526861|62846404|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472426|NCT03526861|62846405|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472427|NCT03526861|62846406|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472428|NCT03526861|62846407|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33354651|NCT00987389|62732281|FG002|Overall Study|Withdrawn from Treatment|0|||
33354652|NCT00987389|62732282|FG003|Overall Study|Withdrawn from Treatment|0|||
33354653|NCT00987389|62732279|FG000|Overall Study|Multiple different reasons|1|||
33354654|NCT00987389|62732280|FG001|Overall Study|Multiple different reasons|0|||
33354655|NCT00987389|62732281|FG002|Overall Study|Multiple different reasons|3|||
33354656|NCT00987389|62732282|FG003|Overall Study|Multiple different reasons|1|||
33354657|NCT00929162|62732292|FG000|Overall Study|Adverse Event|8|||
33354658|NCT00929162|62732293|FG001|Overall Study|Adverse Event|5|||
33354659|NCT00929162|62732292|FG000|Overall Study|Withdrawal by Subject|3|||
33354660|NCT00929162|62732293|FG001|Overall Study|Withdrawal by Subject|1|||
33354661|NCT00929162|62732292|FG000|Overall Study|Protocol Violation|32|||
33354662|NCT00929162|62732293|FG001|Overall Study|Protocol Violation|30|||
33354663|NCT00929162|62732292|FG000|Overall Study|Other termination reason|5|||
33354664|NCT00929162|62732293|FG001|Overall Study|Other termination reason|6|||
33354665|NCT00992459|62732301|FG000|Overall Study|Withdrawal by Subject|0|||
33354666|NCT00992459|62732302|FG001|Overall Study|Withdrawal by Subject|1|||
33354667|NCT00992459|62732301|FG000|Overall Study|Adverse Event|1|||
33354668|NCT00992459|62732302|FG001|Overall Study|Adverse Event|0|||
33354669|NCT00930722|62732308|FG000|Overall Study|Lost to Follow-up|16|||
33354670|NCT00930722|62732308|FG000|Overall Study|No longer willing to participate|9|||
33354671|NCT00930722|62732308|FG000|Overall Study|Study terminated by sponsor|2|||
33354672|NCT00992225|62732312|FG000|Overall Study|Entry Criteria Not Met|8|||
33354673|NCT00992225|62732312|FG000|Overall Study|Adverse Event|2|||
33354674|NCT00659581|62732316|FG000|Overall Study|Adverse Event|1006|||
33354675|NCT00659581|62732316|FG000|Overall Study|Lack of Efficacy|1183|||
33354676|NCT00659581|62732316|FG000|Overall Study|Other|6393|||
33354677|NCT00991289|62732320|FG000|Overall Study|Adverse Event|1|||
33354678|NCT00991289|62732320|FG000|Overall Study|Physician Decision|2|||
33354679|NCT00991289|62732320|FG000|Overall Study|Withdrawal by Subject|3|||
33354680|NCT00991289|62732320|FG000|Overall Study|Lost to Follow-up|4|||
33354681|NCT00991289|62732320|FG000|Overall Study|Protocol Violation|2|||
33354682|NCT00930644|62732324|FG000|Overall Study|Withdrawal by Subject|4|||
33354683|NCT00930644|62732324|FG000|Overall Study|Physician Decision|2|||
33354684|NCT00930644|62732324|FG000|Overall Study|Death|1|||
33354685|NCT00930644|62732324|FG000|Overall Study|Adverse Event|16|||
33354686|NCT00990821|62732345|FG000|Overall Study|Withdrawal by Subject|0|||
33354687|NCT00990821|62732346|FG001|Overall Study|Withdrawal by Subject|2|||
33354688|NCT00990821|62732347|FG002|Overall Study|Withdrawal by Subject|0|||
33354689|NCT00990821|62732348|FG003|Overall Study|Withdrawal by Subject|0|||
33354690|NCT00990821|62732349|FG004|Overall Study|Withdrawal by Subject|3|||
33354691|NCT00990821|62732350|FG005|Overall Study|Withdrawal by Subject|3|||
33354692|NCT00990821|62732351|FG006|Overall Study|Withdrawal by Subject|1|||
33354693|NCT00990821|62732352|FG007|Overall Study|Withdrawal by Subject|0|||
33354694|NCT00990821|62732353|FG008|Overall Study|Withdrawal by Subject|0|||
33354695|NCT00990821|62732354|FG009|Overall Study|Withdrawal by Subject|1|||
33354696|NCT00990821|62732355|FG010|Overall Study|Withdrawal by Subject|3|||
33354697|NCT00990821|62732356|FG011|Overall Study|Withdrawal by Subject|5|||
33354698|NCT00990821|62732357|FG012|Overall Study|Withdrawal by Subject|2|||
33354699|NCT00990821|62732358|FG013|Overall Study|Withdrawal by Subject|1|||
33354700|NCT00990665|62732375|FG000|Overall Study|Unsuccessful Implant|8|||
33354701|NCT00990665|62732375|FG000|Overall Study|Death|29|||
33354702|NCT00990665|62732375|FG000|Overall Study|Heart Transplant|1|||
33354703|NCT00990665|62732375|FG000|Overall Study|Withdrawal by Subject|6|||
33354704|NCT00990665|62732375|FG000|Overall Study|Lost to Follow-up|1|||
33354705|NCT00990665|62732375|FG000|Overall Study|System Explant|3|||
33354706|NCT00658567|62732384|FG000|Overall Study|Adverse Event|5|||
33354707|NCT00658567|62732385|FG001|Overall Study|Adverse Event|2|||
33354708|NCT00658567|62732386|FG002|Overall Study|Adverse Event|3|||
33354709|NCT00658567|62732384|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
33354710|NCT00658567|62732385|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
33354711|NCT00658567|62732386|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
33354712|NCT00658567|62732384|FG000|Overall Study|Physician Decision|0|||
33354713|NCT00658567|62732385|FG001|Overall Study|Physician Decision|1|||
33354714|NCT00658567|62732386|FG002|Overall Study|Physician Decision|0|||
33354715|NCT00658567|62732384|FG000|Overall Study|At Discretion of Sponsor|1|||
33472429|NCT03526861|62846408|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472430|NCT03526861|62846409|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33472431|NCT03526861|62846410|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
33472432|NCT03515811|62846432|FG000|Overall Study|Lost to Follow-up|2|||
33354716|NCT00658567|62732385|FG001|Overall Study|At Discretion of Sponsor|1|||
33354717|NCT00658567|62732386|FG002|Overall Study|At Discretion of Sponsor|1|||
33354718|NCT00875433|62732394|FG000|Overall Study|Progressive disease|41|||
33354719|NCT00875433|62732394|FG000|Overall Study|Other Adverse Event|14|||
33354720|NCT00875433|62732394|FG000|Overall Study|Withdrawal by Subject|2|||
33354721|NCT00875433|62732394|FG000|Overall Study|Other|3|||
33354722|NCT00985985|62732402|FG000|Overall Study|Adverse Event|4|||
33354723|NCT00985985|62732403|FG001|Overall Study|Adverse Event|2|||
33472433|NCT03515811|62846433|FG001|Overall Study|Lost to Follow-up|1|||
33472434|NCT03515811|62846432|FG000|Overall Study|Protocol Violation|1|||
33472435|NCT03515811|62846433|FG001|Overall Study|Protocol Violation|1|||
33472436|NCT03515811|62846432|FG000|Overall Study|Death|1|||
33354724|NCT00985985|62732404|FG002|Overall Study|Adverse Event|2|||
33354725|NCT00985985|62732405|FG003|Overall Study|Adverse Event|2|||
33354726|NCT00985985|62732402|FG000|Overall Study|Lost to Follow-up|4|||
33354727|NCT00985985|62732403|FG001|Overall Study|Lost to Follow-up|11|||
33354728|NCT00985985|62732404|FG002|Overall Study|Lost to Follow-up|2|||
33354729|NCT00985985|62732405|FG003|Overall Study|Lost to Follow-up|3|||
33354730|NCT00985985|62732402|FG000|Overall Study|Protocol Violation|1|||
33354731|NCT00985985|62732403|FG001|Overall Study|Protocol Violation|2|||
33354732|NCT00985985|62732404|FG002|Overall Study|Protocol Violation|0|||
33354733|NCT00985985|62732405|FG003|Overall Study|Protocol Violation|1|||
33354734|NCT00985985|62732402|FG000|Overall Study|Lack of Efficacy|5|||
33354735|NCT00985985|62732403|FG001|Overall Study|Lack of Efficacy|6|||
33354736|NCT00985985|62732404|FG002|Overall Study|Lack of Efficacy|1|||
33354737|NCT00985985|62732405|FG003|Overall Study|Lack of Efficacy|3|||
33354738|NCT00985985|62732402|FG000|Overall Study|Withdrawal by Subject|4|||
33354739|NCT00985985|62732403|FG001|Overall Study|Withdrawal by Subject|2|||
33354740|NCT00985985|62732404|FG002|Overall Study|Withdrawal by Subject|2|||
33354741|NCT00985985|62732405|FG003|Overall Study|Withdrawal by Subject|2|||
33354742|NCT00985985|62732402|FG000|Overall Study|Other Reason|6|||
33472437|NCT03515811|62846433|FG001|Overall Study|Death|1|||
33472438|NCT03515811|62846432|FG000|Overall Study|Withdrawal by Subject|0|||
33472439|NCT03515811|62846433|FG001|Overall Study|Withdrawal by Subject|2|||
33472440|NCT03515811|62846432|FG000|Overall Study|Technical Problems|1|||
33472441|NCT03515811|62846433|FG001|Overall Study|Technical Problems|0|||
33472442|NCT03515811|62846432|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
33472443|NCT03515811|62846433|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
33472444|NCT03515811|62846432|FG000|Overall Study|COVID-19|0|||
33472445|NCT03515811|62846433|FG001|Overall Study|COVID-19|1|||
33472446|NCT03510884|62846446|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
33472447|NCT03510884|62846447|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
33472448|NCT03510884|62846448|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
33549080|NCT02901431|62940301|FG007|Main Treatment Part|Withdrawal by Subject|0|||
33549081|NCT02901431|62940302|FG008|Main Treatment Part|Withdrawal by Subject|0|||
33549082|NCT02901431|62940303|FG009|Main Treatment Part|Withdrawal by Subject|0|||
33549083|NCT02901431|62940304|FG010|Main Treatment Part|Withdrawal by Subject|0|||
33549084|NCT02901431|62940305|FG011|Main Treatment Part|Withdrawal by Subject|0|||
33549085|NCT02901431|62940306|FG012|Main Treatment Part|Withdrawal by Subject|0|||
33549086|NCT02901431|62940294|FG000|Open Label Part|Adverse Event|0|||
33655309|NCT01892189|63070030|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
33354743|NCT00985985|62732403|FG001|Overall Study|Other Reason|1|||
33354744|NCT00985985|62732404|FG002|Overall Study|Other Reason|4|||
33354745|NCT00985985|62732405|FG003|Overall Study|Other Reason|2|||
33354746|NCT00923936|62732422|FG000|Overall Study|progressive disease on study|2|||
33354747|NCT00923936|62732423|FG001|Overall Study|progressive disease on study|1|||
33354748|NCT00923936|62732422|FG000|Overall Study|Adverse Event|2|||
33472449|NCT03510884|62846449|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
33472450|NCT03510884|62846446|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
33472451|NCT03510884|62846447|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
33472452|NCT03510884|62846448|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
33472453|NCT03510884|62846449|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
33472454|NCT03510884|62846446|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
33472455|NCT03510884|62846447|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
33472456|NCT03510884|62846448|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
33472457|NCT03510884|62846449|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
33472458|NCT03510884|62846446|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
33472459|NCT03510884|62846447|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
33472460|NCT03510884|62846448|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
33472461|NCT03510884|62846449|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
33472462|NCT03510884|62846446|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
33472463|NCT03510884|62846447|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
33472464|NCT03510884|62846448|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
33472465|NCT03510884|62846449|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
33472466|NCT03510884|62846446|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
33472467|NCT03510884|62846447|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
33472468|NCT03510884|62846448|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
33549087|NCT02901431|62940295|FG001|Open Label Part|Adverse Event|0|||
33655310|NCT01892189|63070031|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33354749|NCT00923936|62732423|FG001|Overall Study|Adverse Event|1|||
33354750|NCT00923936|62732422|FG000|Overall Study|Lost to follow up|2|||
33354751|NCT00923936|62732423|FG001|Overall Study|Lost to follow up|0|||
33354752|NCT00923936|62732422|FG000|Overall Study|Continuing in follow up period|2|||
33354753|NCT00923936|62732423|FG001|Overall Study|Continuing in follow up period|1|||
33354754|NCT00924950|62732431|FG000|Overall Study|Lost to Follow-up|2|||
33354755|NCT00988637|62732440|FG000|Overall Study|Lost to Follow-up|2|||
33354756|NCT00988637|62732441|FG001|Overall Study|Lost to Follow-up|1|||
33472469|NCT03510884|62846449|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
33472470|NCT03510884|62846446|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
33472471|NCT03510884|62846447|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
33472472|NCT03510884|62846448|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
33472473|NCT03510884|62846449|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
33549088|NCT02901431|62940296|FG002|Open Label Part|Adverse Event|0|||
33354757|NCT00988637|62732440|FG000|Overall Study|Withdrawal by Subject|1|||
33354758|NCT00988637|62732441|FG001|Overall Study|Withdrawal by Subject|1|||
33354759|NCT00988637|62732440|FG000|Overall Study|non-compliance with study drug|0|||
33354760|NCT00988637|62732441|FG001|Overall Study|non-compliance with study drug|1|||
33354766|NCT00923156|62732471|FG000|Overall Study|Adverse Event|0|||
33354767|NCT00923156|62732472|FG001|Overall Study|Adverse Event|2|||
33354768|NCT00923156|62732473|FG002|Overall Study|Adverse Event|1|||
33354769|NCT00923156|62732471|FG000|Overall Study|Abnormal laboratory values|0|||
33354770|NCT00923156|62732472|FG001|Overall Study|Abnormal laboratory values|0|||
33354771|NCT00923156|62732473|FG002|Overall Study|Abnormal laboratory values|1|||
33354772|NCT00923156|62732471|FG000|Overall Study|Withdrawal by Subject|0|||
33354773|NCT00923156|62732472|FG001|Overall Study|Withdrawal by Subject|1|||
33354774|NCT00923156|62732473|FG002|Overall Study|Withdrawal by Subject|0|||
33354775|NCT00923156|62732471|FG000|Overall Study|Death|0|||
33354776|NCT00923156|62732472|FG001|Overall Study|Death|1|||
33354777|NCT00923156|62732473|FG002|Overall Study|Death|0|||
33354778|NCT00923156|62732471|FG000|Overall Study|Lack of Efficacy|0|||
33354779|NCT00923156|62732472|FG001|Overall Study|Lack of Efficacy|0|||
33354780|NCT00923156|62732473|FG002|Overall Study|Lack of Efficacy|1|||
33354781|NCT00874731|62732481|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
33354782|NCT00874731|62732482|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
33354783|NCT00874731|62732483|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
33354784|NCT00874731|62732481|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
33354785|NCT00874731|62732482|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
33354786|NCT00874731|62732483|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
33354787|NCT00874731|62732481|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
33354788|NCT00874731|62732482|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
33354789|NCT00874731|62732483|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
33354790|NCT00924638|62732493|FG000|Overall Study|Death|3|||
33354791|NCT00924638|62732494|FG001|Overall Study|Death|2|||
33354792|NCT00924638|62732493|FG000|Overall Study|Lost to Follow-up|1|||
33354793|NCT00924638|62732494|FG001|Overall Study|Lost to Follow-up|1|||
33354794|NCT00924638|62732493|FG000|Overall Study|Withdrawal by Subject|5|||
33354795|NCT00924638|62732494|FG001|Overall Study|Withdrawal by Subject|7|||
33354796|NCT00924638|62732493|FG000|Overall Study|Physician Decision|3|||
33354797|NCT00924638|62732494|FG001|Overall Study|Physician Decision|3|||
33354798|NCT00874497|62732502|FG000|Overall Study|Lost to Follow-up|2|||
33354799|NCT00874497|62732503|FG001|Overall Study|Lost to Follow-up|4|||
33354800|NCT00874497|62732502|FG000|Overall Study|Adverse Event|9|||
33354801|NCT00874497|62732503|FG001|Overall Study|Adverse Event|4|||
33354802|NCT00874497|62732502|FG000|Overall Study|Sponsor Discontinued Trial|7|||
33354803|NCT00874497|62732503|FG001|Overall Study|Sponsor Discontinued Trial|3|||
33354804|NCT00874497|62732502|FG000|Overall Study|Met Withdrawal Criteria|4|||
33354805|NCT00874497|62732503|FG001|Overall Study|Met Withdrawal Criteria|2|||
33354806|NCT00874497|62732502|FG000|Overall Study|Physician Decision|1|||
33354807|NCT00874497|62732503|FG001|Overall Study|Physician Decision|1|||
33354808|NCT00874497|62732502|FG000|Overall Study|Withdrawal by Subject|5|||
33354809|NCT00874497|62732503|FG001|Overall Study|Withdrawal by Subject|4|||
33354810|NCT00924560|62732512|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
33354811|NCT00924560|62732513|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
33354812|NCT00924560|62732514|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
33354813|NCT00924560|62732512|FG000|Overall Study|Non Compliance with the Protocol|20|||
33354814|NCT00924560|62732513|FG001|Overall Study|Non Compliance with the Protocol|15|||
33354815|NCT00924560|62732514|FG002|Overall Study|Non Compliance with the Protocol|4|||
33354816|NCT00924560|62732512|FG000|Overall Study|Physician Decision|2|||
33354817|NCT00924560|62732513|FG001|Overall Study|Physician Decision|3|||
33354818|NCT00924560|62732514|FG002|Overall Study|Physician Decision|4|||
33354819|NCT00924560|62732512|FG000|Overall Study|Withdrawal by Subject|50|||
33354820|NCT00924560|62732513|FG001|Overall Study|Withdrawal by Subject|44|||
33354821|NCT00924560|62732514|FG002|Overall Study|Withdrawal by Subject|18|||
33354822|NCT00924560|62732512|FG000|Overall Study|Adverse Event|39|||
33354823|NCT00924560|62732513|FG001|Overall Study|Adverse Event|33|||
33549089|NCT02901431|62940297|FG003|Open Label Part|Adverse Event|0|||
33549090|NCT02901431|62940298|FG004|Open Label Part|Adverse Event|0|||
33549091|NCT02901431|62940299|FG005|Open Label Part|Adverse Event|0|||
33549092|NCT02901431|62940300|FG006|Open Label Part|Adverse Event|0|||
33549093|NCT02901431|62940301|FG007|Open Label Part|Adverse Event|0|||
33549094|NCT02901431|62940302|FG008|Open Label Part|Adverse Event|4|||
33354824|NCT00924560|62732514|FG002|Overall Study|Adverse Event|0|||
33354825|NCT00924560|62732512|FG000|Overall Study|Pregnancy|5|||
33354826|NCT00924560|62732513|FG001|Overall Study|Pregnancy|7|||
33354827|NCT00924560|62732514|FG002|Overall Study|Pregnancy|1|||
33354828|NCT00924560|62732512|FG000|Overall Study|Lost to Follow-up|78|||
33354829|NCT00924560|62732513|FG001|Overall Study|Lost to Follow-up|94|||
33354830|NCT00924560|62732514|FG002|Overall Study|Lost to Follow-up|45|||
33354831|NCT00924560|62732512|FG000|Overall Study|Miscellaneous Reasons|13|||
33549095|NCT02901431|62940303|FG009|Open Label Part|Adverse Event|4|||
33549096|NCT02901431|62940304|FG010|Open Label Part|Adverse Event|0|||
33549097|NCT02901431|62940305|FG011|Open Label Part|Adverse Event|4|||
33549098|NCT02901431|62940306|FG012|Open Label Part|Adverse Event|1|||
33549099|NCT02901431|62940294|FG000|Open Label Part|Lost to Follow-up|0|||
33549100|NCT02901431|62940295|FG001|Open Label Part|Lost to Follow-up|0|||
33354832|NCT00924560|62732513|FG001|Overall Study|Miscellaneous Reasons|10|||
33354833|NCT00924560|62732514|FG002|Overall Study|Miscellaneous Reasons|10|||
33354834|NCT00923078|62732527|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
33354835|NCT00923078|62732528|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
33354836|NCT00923078|62732529|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
33354837|NCT00923078|62732527|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
33354838|NCT00923078|62732528|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
33354839|NCT00923078|62732529|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
33354840|NCT00978731|62732540|FG000|Overall Study|Death|4|||
33354841|NCT00978731|62732541|FG001|Overall Study|Death|1|||
33354842|NCT00978731|62732542|FG002|Overall Study|Death|1|||
33354843|NCT00978731|62732543|FG003|Overall Study|Death|0|||
33354844|NCT00978731|62732540|FG000|Overall Study|Lost to Follow-up|0|||
33354845|NCT00978731|62732541|FG001|Overall Study|Lost to Follow-up|0|||
33354846|NCT00978731|62732542|FG002|Overall Study|Lost to Follow-up|0|||
33354847|NCT00978731|62732543|FG003|Overall Study|Lost to Follow-up|1|||
33354848|NCT00978731|62732540|FG000|Overall Study|Adverse Event|5|||
33354849|NCT00978731|62732541|FG001|Overall Study|Adverse Event|2|||
33354850|NCT00978731|62732542|FG002|Overall Study|Adverse Event|0|||
33354851|NCT00978731|62732543|FG003|Overall Study|Adverse Event|0|||
33354852|NCT00978731|62732540|FG000|Overall Study|Participant's request|1|||
33354853|NCT00978731|62732541|FG001|Overall Study|Participant's request|0|||
33354854|NCT00978731|62732542|FG002|Overall Study|Participant's request|0|||
33354855|NCT00978731|62732543|FG003|Overall Study|Participant's request|0|||
33354856|NCT00978731|62732540|FG000|Overall Study|Administrative reason|3|||
33354857|NCT00978731|62732541|FG001|Overall Study|Administrative reason|3|||
33354858|NCT00978731|62732542|FG002|Overall Study|Administrative reason|1|||
33354859|NCT00978731|62732543|FG003|Overall Study|Administrative reason|0|||
33354860|NCT00978731|62732540|FG000|Overall Study|Deterioration without progression|0|||
33354861|NCT00978731|62732541|FG001|Overall Study|Deterioration without progression|1|||
33354862|NCT00978731|62732542|FG002|Overall Study|Deterioration without progression|0|||
33354863|NCT00978731|62732543|FG003|Overall Study|Deterioration without progression|0|||
33354864|NCT00978731|62732540|FG000|Overall Study|Disease progression/relapse|5|||
33354865|NCT00978731|62732541|FG001|Overall Study|Disease progression/relapse|4|||
33354866|NCT00978731|62732542|FG002|Overall Study|Disease progression/relapse|2|||
33354867|NCT00978731|62732543|FG003|Overall Study|Disease progression/relapse|2|||
33354868|NCT00978731|62732540|FG000|Overall Study|Study closure|3|||
33354869|NCT00978731|62732541|FG001|Overall Study|Study closure|4|||
33354870|NCT00978731|62732542|FG002|Overall Study|Study closure|1|||
33354871|NCT00978731|62732543|FG003|Overall Study|Study closure|1|||
33354872|NCT00978731|62732540|FG000|Overall Study|No response|1|||
33472474|NCT03510884|62846446|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
33472475|NCT03510884|62846447|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
33472476|NCT03510884|62846448|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
33472477|NCT03510884|62846449|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
33472478|NCT03510884|62846446|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
33472479|NCT03510884|62846447|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
33472480|NCT03510884|62846448|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
33472481|NCT03510884|62846449|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
33472482|NCT03510884|62846446|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
33472483|NCT03510884|62846447|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
33472484|NCT03510884|62846448|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
33472485|NCT03510884|62846449|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
33472486|NCT03488472|62846487|FG000|Overall Study|disease progression additional mets|1|||
33472487|NCT03456453|62846493|FG000|Overall Study|Withdrawal by Subject|2|||
33472488|NCT03456453|62846494|FG001|Overall Study|Withdrawal by Subject|0|||
33472489|NCT03456453|62846493|FG000|Overall Study|Not released to community|1|||
33472490|NCT03456453|62846494|FG001|Overall Study|Not released to community|5|||
33472491|NCT03456453|62846493|FG000|Overall Study|Lost to Follow-up|0|||
33472492|NCT03456453|62846494|FG001|Overall Study|Lost to Follow-up|2|||
33472493|NCT03455829|62846505|FG000|Overall Study|Death|2|||
33472494|NCT03455829|62846506|FG001|Overall Study|Death|3|||
33472495|NCT03455829|62846507|FG002|Overall Study|Death|2|||
33472496|NCT03455829|62846508|FG003|Overall Study|Death|4|||
33354873|NCT00978731|62732541|FG001|Overall Study|No response|0|||
33354874|NCT00978731|62732542|FG002|Overall Study|No response|0|||
33354875|NCT00978731|62732543|FG003|Overall Study|No response|0|||
33354876|NCT05056870|62732557|FG000|Period 1|Site COVID-19 Related|3|||
33354877|NCT05056870|62732558|FG001|Period 1|Site COVID-19 Related|3|||
33354878|NCT05056870|62732557|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
33354879|NCT05056870|62732558|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
33354880|NCT05056870|62732557|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
33354881|NCT05056870|62732558|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
33472497|NCT03455829|62846509|FG004|Overall Study|Death|2|||
33472498|NCT03455829|62846505|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
33472499|NCT03455829|62846506|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
33472500|NCT03455829|62846507|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
33472501|NCT03455829|62846508|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
33472502|NCT03455829|62846509|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
33472503|NCT03455829|62846505|FG000|Overall Study|Disease progression|0|||
33472504|NCT03455829|62846506|FG001|Overall Study|Disease progression|0|||
33472505|NCT03455829|62846507|FG002|Overall Study|Disease progression|0|||
33472506|NCT03455829|62846508|FG003|Overall Study|Disease progression|1|||
33472507|NCT03455829|62846509|FG004|Overall Study|Disease progression|1|||
33472508|NCT03441334|62846523|FG000|Overall Study|Withdrawal by Subject|1|||
33472509|NCT03441334|62846524|FG001|Overall Study|Withdrawal by Subject|0|||
33472510|NCT03429244|62846555|FG000|Overall Study|Withdrawal by Subject|2|||
33472511|NCT03429244|62846556|FG001|Overall Study|Withdrawal by Subject|1|||
33472512|NCT03429244|62846557|FG002|Overall Study|Withdrawal by Subject|1|||
33472513|NCT03370276|62846573|FG000|Overall Study|Death|0|||
33472514|NCT03370276|62846574|FG001|Overall Study|Death|2|||
33472515|NCT03370276|62846575|FG002|Overall Study|Death|5|||
33472516|NCT03250117|62846583|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
33472517|NCT03250117|62846584|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
33472518|NCT03250117|62846585|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
33472519|NCT03250117|62846586|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
33472520|NCT03230838|62846592|FG000|Overall Study|Withdrawal by Subject|3|||
33472521|NCT03230838|62846593|FG001|Overall Study|Withdrawal by Subject|0|||
33472522|NCT03230838|62846592|FG000|Overall Study|Temperature excursion|1|||
33472523|NCT03230838|62846593|FG001|Overall Study|Temperature excursion|0|||
33472524|NCT03217136|62846601|FG000|Overall Study|Lost to Follow-up|2|||
33472525|NCT03217136|62846602|FG001|Overall Study|Lost to Follow-up|1|||
33472526|NCT03217136|62846601|FG000|Overall Study|Site Randomized Participant in Error|0|||
33472527|NCT03217136|62846602|FG001|Overall Study|Site Randomized Participant in Error|1|||
33472528|NCT03217136|62846601|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
33472529|NCT03217136|62846602|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
33472530|NCT03217136|62846601|FG000|Overall Study|Dispensing Error|1|||
33472531|NCT03217136|62846602|FG001|Overall Study|Dispensing Error|0|||
33354882|NCT05056870|62732557|FG000|Period 2|COVID-19 Related|1|||
33354883|NCT05056870|62732558|FG001|Period 2|COVID-19 Related|0|||
33354884|NCT05056870|62732557|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
33354885|NCT05056870|62732558|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
33354886|NCT04488822|62732582|FG000|Overall Study|Adverse Event|8|||
33354887|NCT04488822|62732582|FG000|Overall Study|Withdrawal by Subject|1|||
33354888|NCT04396626|62732595|FG000|Overall Study|Premature termination of study|975|||
33354889|NCT04242186|62732599|FG000|Overall Study|Death|5|||
33354890|NCT03934216|62732606|FG000|Randomization|Randomized in Error|1|||
33354891|NCT03934216|62732607|FG001|Randomization|Randomized in Error|1|||
33354892|NCT03934216|62732606|FG000|Treatment Period|Adverse Event|10|||
33354893|NCT03934216|62732607|FG001|Treatment Period|Adverse Event|3|||
33354894|NCT03934216|62732606|FG000|Treatment Period|Withdrawal by Participant|6|||
33354895|NCT03934216|62732607|FG001|Treatment Period|Withdrawal by Participant|2|||
33354896|NCT03934216|62732606|FG000|Treatment Period|Other Reasons|2|||
33354897|NCT03934216|62732607|FG001|Treatment Period|Other Reasons|2|||
33354898|NCT03183128|62732653|FG000|Overall Study|Adverse Event|1|||
33354899|NCT03183128|62732654|FG001|Overall Study|Adverse Event|2|||
33354900|NCT03183128|62732653|FG000|Overall Study|Withdrawal by Subject|1|||
33354901|NCT03183128|62732654|FG001|Overall Study|Withdrawal by Subject|8|||
33354902|NCT03183128|62732653|FG000|Overall Study|Protocol Violation|2|||
33354903|NCT03183128|62732654|FG001|Overall Study|Protocol Violation|0|||
33354904|NCT03183128|62732653|FG000|Overall Study|Lack of Efficacy|4|||
33354905|NCT03183128|62732654|FG001|Overall Study|Lack of Efficacy|27|||
33354906|NCT03183128|62732653|FG000|Overall Study|Lost to Follow-up|1|||
33354907|NCT03183128|62732654|FG001|Overall Study|Lost to Follow-up|0|||
33549101|NCT02901431|62940296|FG002|Open Label Part|Lost to Follow-up|0|||
33354908|NCT03183128|62732653|FG000|Overall Study|Death|2|||
33354909|NCT03183128|62732654|FG001|Overall Study|Death|0|||
33354910|NCT03183128|62732653|FG000|Overall Study|Physician Decision|1|||
33354911|NCT03183128|62732654|FG001|Overall Study|Physician Decision|0|||
33354912|NCT02308488|62732696|FG000|Overall Study|Withdrawal by Subject|2|||
33354913|NCT02159950|62732702|FG000|Overall Study|Adverse Event|0|||
33354914|NCT02159950|62732703|FG001|Overall Study|Adverse Event|1|||
33354915|NCT02159950|62732702|FG000|Overall Study|Progression|0|||
33354916|NCT02159950|62732703|FG001|Overall Study|Progression|1|||
33354917|NCT02152137|62732709|FG000|Overall Study|Withdrawal by Subject|1|||
33354918|NCT02152137|62732709|FG000|Overall Study|Originally assigned to Arm B|3|||
33354919|NCT02007512|62732717|FG000|Double Blind Treatment Period|Adverse Event|4|||
33354920|NCT02007512|62732718|FG001|Double Blind Treatment Period|Adverse Event|2|||
33354921|NCT02007512|62732719|FG002|Double Blind Treatment Period|Adverse Event|6|||
33354922|NCT02007512|62732720|FG003|Double Blind Treatment Period|Adverse Event|2|||
33354923|NCT02007512|62732717|FG000|Double Blind Treatment Period|Death|1|||
33354924|NCT02007512|62732718|FG001|Double Blind Treatment Period|Death|0|||
33549102|NCT02901431|62940297|FG003|Open Label Part|Lost to Follow-up|0|||
33549103|NCT02901431|62940298|FG004|Open Label Part|Lost to Follow-up|0|||
33354925|NCT02007512|62732719|FG002|Double Blind Treatment Period|Death|0|||
33354926|NCT02007512|62732720|FG003|Double Blind Treatment Period|Death|0|||
33354927|NCT02007512|62732717|FG000|Double Blind Treatment Period|Disease progression|44|||
33354928|NCT02007512|62732718|FG001|Double Blind Treatment Period|Disease progression|49|||
33354929|NCT02007512|62732719|FG002|Double Blind Treatment Period|Disease progression|45|||
33354930|NCT02007512|62732720|FG003|Double Blind Treatment Period|Disease progression|51|||
33354931|NCT02007512|62732717|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
33354932|NCT02007512|62732718|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
33354933|NCT02007512|62732719|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
33354934|NCT02007512|62732720|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
33354935|NCT02007512|62732717|FG000|Double Blind Treatment Period|Protocol Violation|0|||
33354936|NCT02007512|62732718|FG001|Double Blind Treatment Period|Protocol Violation|0|||
33354937|NCT02007512|62732719|FG002|Double Blind Treatment Period|Protocol Violation|0|||
33354938|NCT02007512|62732720|FG003|Double Blind Treatment Period|Protocol Violation|1|||
33354939|NCT02007512|62732717|FG000|Double Blind Treatment Period|Other|0|||
33354940|NCT02007512|62732718|FG001|Double Blind Treatment Period|Other|0|||
33354941|NCT02007512|62732719|FG002|Double Blind Treatment Period|Other|1|||
33354942|NCT02007512|62732720|FG003|Double Blind Treatment Period|Other|2|||
33354943|NCT02007512|62732717|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
33354944|NCT02007512|62732718|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
33354945|NCT02007512|62732719|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
33354946|NCT02007512|62732720|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
33354947|NCT02007512|62732717|FG000|Open Label Treatment Period|Adverse Event|0|||
33354948|NCT02007512|62732718|FG001|Open Label Treatment Period|Adverse Event|1|||
33354949|NCT02007512|62732719|FG002|Open Label Treatment Period|Adverse Event|0|||
33354950|NCT02007512|62732720|FG003|Open Label Treatment Period|Adverse Event|0|||
33354951|NCT02007512|62732717|FG000|Open Label Treatment Period|Other|0|||
33354952|NCT02007512|62732718|FG001|Open Label Treatment Period|Other|0|||
33354953|NCT02007512|62732719|FG002|Open Label Treatment Period|Other|0|||
33354954|NCT02007512|62732720|FG003|Open Label Treatment Period|Other|1|||
33354955|NCT02007512|62732717|FG000|Open Label Treatment Period|Disease progression|0|||
33354956|NCT02007512|62732718|FG001|Open Label Treatment Period|Disease progression|17|||
33354957|NCT02007512|62732719|FG002|Open Label Treatment Period|Disease progression|0|||
33354958|NCT02007512|62732720|FG003|Open Label Treatment Period|Disease progression|11|||
33354959|NCT02007512|62732717|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
33354960|NCT02007512|62732718|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
33354961|NCT02007512|62732719|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
33354962|NCT02007512|62732720|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
33354963|NCT01942135|62732735|FG000|Overall Study|Adverse Event|9|||
33354964|NCT01942135|62732736|FG001|Overall Study|Adverse Event|3|||
33354965|NCT01942135|62732735|FG000|Overall Study|Global deterioration of health status|8|||
33354966|NCT01942135|62732736|FG001|Overall Study|Global deterioration of health status|3|||
33354967|NCT01942135|62732735|FG000|Overall Study|Randomized Not Treated|2|||
33472532|NCT03217136|62846601|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
33472533|NCT03217136|62846602|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33472534|NCT03213665|62846608|FG000|Overall Study|Adverse Event|1|||
33472535|NCT03213665|62846608|FG000|Overall Study|Physician Decision|2|||
33472536|NCT03213665|62846608|FG000|Overall Study|Withdrawal by Subject|3|||
33472537|NCT03213665|62846608|FG000|Overall Study|Progressive Disease|13|||
33472538|NCT03179761|62846614|FG000|Overall Study|Death|2|||
33354968|NCT01942135|62732736|FG001|Overall Study|Randomized Not Treated|2|||
33354969|NCT01942135|62732735|FG000|Overall Study|Death|0|||
33354970|NCT01942135|62732736|FG001|Overall Study|Death|1|||
33354971|NCT01942135|62732735|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85|||
33354972|NCT01942135|62732736|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87|||
33354973|NCT01942135|62732735|FG000|Overall Study|Participant Refused toContinue Treatment|1|||
33354974|NCT01942135|62732736|FG001|Overall Study|Participant Refused toContinue Treatment|1|||
33472539|NCT03179761|62846615|FG001|Overall Study|Death|5|||
33472540|NCT03179761|62846614|FG000|Overall Study|Lost to Follow-up|2|||
33472541|NCT03179761|62846615|FG001|Overall Study|Lost to Follow-up|2|||
33472542|NCT03179761|62846614|FG000|Overall Study|Protocol Violation|1|||
33472543|NCT03179761|62846615|FG001|Overall Study|Protocol Violation|0|||
33549104|NCT02901431|62940299|FG005|Open Label Part|Lost to Follow-up|0|||
33354975|NCT01942135|62732735|FG000|Overall Study|Withdrawal by Subject|4|||
33354976|NCT01942135|62732736|FG001|Overall Study|Withdrawal by Subject|2|||
33354977|NCT01942135|62732735|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238|||
33354978|NCT01942135|62732736|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75|||
33354979|NCT01889238|62732742|FG000|Overall Study|Treatment ongoing|9|||
33354980|NCT01696968|62732765|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
33354981|NCT01696968|62732766|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
33354982|NCT01696968|62732765|FG000|Overall Study|Died Before Randomization|3|||
33354983|NCT01696968|62732766|FG001|Overall Study|Died Before Randomization|8|||
33354984|NCT01696968|62732765|FG000|Overall Study|Died Before ASU (Control)|278|||
33354985|NCT01696968|62732766|FG001|Overall Study|Died Before ASU (Control)|0|||
33354986|NCT01696968|62732765|FG000|Overall Study|Refused ASU (Control)|920|||
33354987|NCT01696968|62732766|FG001|Overall Study|Refused ASU (Control)|0|||
33354988|NCT01696968|62732765|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
33354989|NCT01696968|62732766|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
33354990|NCT00978341|62732778|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
33354991|NCT00978341|62732779|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
33354992|NCT00978029|62732789|FG000|Overall Study|Adverse Event|1|||
33354993|NCT00978029|62732790|FG001|Overall Study|Adverse Event|2|||
33354994|NCT00978029|62732791|FG002|Overall Study|Adverse Event|5|||
33354995|NCT00978029|62732789|FG000|Overall Study|Withdrawal by Subject|0|||
33354996|NCT00978029|62732790|FG001|Overall Study|Withdrawal by Subject|0|||
33354997|NCT00978029|62732791|FG002|Overall Study|Withdrawal by Subject|1|||
33354998|NCT00978029|62732789|FG000|Overall Study|Protocol Violation|0|||
33354999|NCT00978029|62732790|FG001|Overall Study|Protocol Violation|1|||
33355000|NCT00978029|62732791|FG002|Overall Study|Protocol Violation|0|||
33355001|NCT00871377|62732799|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
33355002|NCT00871377|62732800|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
33355003|NCT00871377|62732801|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
33355004|NCT00871377|62732802|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
33355005|NCT00871377|62732803|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
33355006|NCT00871377|62732804|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
33355007|NCT00871377|62732799|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
33355008|NCT00871377|62732800|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
33355009|NCT00871377|62732801|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
33355010|NCT00871377|62732802|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
33355011|NCT00871377|62732803|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
33355012|NCT00871377|62732804|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
33355013|NCT00871377|62732799|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
33355014|NCT00871377|62732800|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
33355015|NCT00871377|62732801|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
33355016|NCT00871377|62732802|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
33355017|NCT00871377|62732803|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
33355018|NCT00871377|62732804|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
33472544|NCT03179761|62846614|FG000|Overall Study|Withdrawal by Subject|1|||
33472545|NCT03179761|62846615|FG001|Overall Study|Withdrawal by Subject|4|||
33472546|NCT03179761|62846614|FG000|Overall Study|Investigator Request|0|||
33472547|NCT03179761|62846615|FG001|Overall Study|Investigator Request|2|||
33472548|NCT03173248|62846623|FG000|Overall Study|Death|28|||
33472549|NCT03173248|62846624|FG001|Overall Study|Death|46|||
33472550|NCT03173248|62846623|FG000|Overall Study|Lost to Follow-up|0|||
33472551|NCT03173248|62846624|FG001|Overall Study|Lost to Follow-up|1|||
33472552|NCT03173248|62846623|FG000|Overall Study|Withdrawal by Subject|6|||
33472553|NCT03173248|62846624|FG001|Overall Study|Withdrawal by Subject|4|||
33472554|NCT03173248|62846623|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
33472555|NCT03173248|62846624|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
33472556|NCT03155841|62846632|FG000|Overall Study|Protocol Violation|3|||
33472557|NCT03155841|62846633|FG001|Overall Study|Protocol Violation|4|||
33472558|NCT03122886|62846641|FG000|Overall Study|Withdrawal by Subject|1|||
33472559|NCT03122886|62846642|FG001|Overall Study|Withdrawal by Subject|2|||
33472560|NCT03114891|62846652|FG000|First Treatment Round|Lost to Follow-up|0|||
33549105|NCT02901431|62940300|FG006|Open Label Part|Lost to Follow-up|0|||
33355019|NCT00871377|62732799|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
33549106|NCT02901431|62940301|FG007|Open Label Part|Lost to Follow-up|0|||
33355020|NCT00871377|62732800|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
33355021|NCT00871377|62732801|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
33355022|NCT00871377|62732802|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
33355023|NCT00871377|62732803|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
33355024|NCT00871377|62732804|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
33355025|NCT00871377|62732799|FG000|Third Intervention (10 Weeks)|Death|0|||
33355026|NCT00871377|62732800|FG001|Third Intervention (10 Weeks)|Death|0|||
33355027|NCT00871377|62732801|FG002|Third Intervention (10 Weeks)|Death|0|||
33472561|NCT03114891|62846653|FG001|First Treatment Round|Lost to Follow-up|1|||
33472562|NCT03114891|62846654|FG002|First Treatment Round|Lost to Follow-up|1|||
33355028|NCT00871377|62732802|FG003|Third Intervention (10 Weeks)|Death|1|||
33355029|NCT00871377|62732803|FG004|Third Intervention (10 Weeks)|Death|0|||
33355030|NCT00871377|62732804|FG005|Third Intervention (10 Weeks)|Death|0|||
33355031|NCT00977561|62732814|FG000|Overall Study|Death|3|||
33355032|NCT00977561|62732815|FG001|Overall Study|Death|2|||
33355033|NCT00977561|62732814|FG000|Overall Study|Study terminated|0|||
33355034|NCT00977561|62732815|FG001|Overall Study|Study terminated|2|||
33355035|NCT00977561|62732814|FG000|Overall Study|Other|2|||
33355036|NCT00977561|62732815|FG001|Overall Study|Other|0|||
33355037|NCT00594165|62732823|FG000|Overall Study|Major protocol violation|1|||
33355038|NCT00594165|62732823|FG000|Overall Study|Lack of Efficacy|12|||
33355039|NCT00594165|62732823|FG000|Overall Study|Adverse Event|52|||
33355040|NCT00594165|62732823|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
33355041|NCT00594165|62732823|FG000|Overall Study|Subject withdrew consent|27|||
33355042|NCT00594165|62732823|FG000|Overall Study|Study ended per sponsor|102|||
33355043|NCT00594165|62732823|FG000|Overall Study|Lost to Follow-up|4|||
33355044|NCT00594165|62732823|FG000|Overall Study|Other: PI discretion|5|||
33355045|NCT00594165|62732823|FG000|Overall Study|Other: Subject moving|3|||
33355046|NCT00594165|62732823|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
33355047|NCT00594165|62732823|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
33355048|NCT00594165|62732823|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
33472563|NCT03114891|62846655|FG003|First Treatment Round|Lost to Follow-up|0|||
33472564|NCT03114891|62846652|FG000|First Treatment Round|Withdrawal by Subject|0|||
33355049|NCT00594165|62732823|FG000|Overall Study|Other: Site terminated participation|2|||
33472565|NCT03114891|62846653|FG001|First Treatment Round|Withdrawal by Subject|2|||
33472566|NCT03114891|62846654|FG002|First Treatment Round|Withdrawal by Subject|0|||
33472567|NCT03114891|62846655|FG003|First Treatment Round|Withdrawal by Subject|1|||
33472568|NCT03114891|62846652|FG000|3 Week Break|Lost to Follow-up|1|||
33472569|NCT03114891|62846653|FG001|3 Week Break|Lost to Follow-up|0|||
33472570|NCT03114891|62846654|FG002|3 Week Break|Lost to Follow-up|0|||
33472571|NCT03114891|62846655|FG003|3 Week Break|Lost to Follow-up|1|||
33472572|NCT03114891|62846652|FG000|3 Week Break|Withdrawal by Subject|0|||
33472573|NCT03114891|62846653|FG001|3 Week Break|Withdrawal by Subject|1|||
33472574|NCT03114891|62846654|FG002|3 Week Break|Withdrawal by Subject|0|||
33472575|NCT03114891|62846655|FG003|3 Week Break|Withdrawal by Subject|0|||
33472576|NCT03114891|62846652|FG000|Second Treatment Round|Lost to Follow-up|1|||
33472577|NCT03114891|62846653|FG001|Second Treatment Round|Lost to Follow-up|0|||
33472578|NCT03114891|62846654|FG002|Second Treatment Round|Lost to Follow-up|0|||
33472579|NCT03114891|62846655|FG003|Second Treatment Round|Lost to Follow-up|0|||
33472580|NCT03114891|62846652|FG000|Second Treatment Round|Physician Decision|1|||
33472581|NCT03114891|62846653|FG001|Second Treatment Round|Physician Decision|0|||
33472582|NCT03114891|62846654|FG002|Second Treatment Round|Physician Decision|0|||
33472583|NCT03114891|62846655|FG003|Second Treatment Round|Physician Decision|0|||
33472584|NCT03057847|62846697|FG000|Overall Study|Lost to Follow-up|16|||
33472585|NCT02946463|62846725|FG000|Primary Evaluation Period|Physician Decision|0|||
33472586|NCT02946463|62846726|FG001|Primary Evaluation Period|Physician Decision|1|||
33472587|NCT02946463|62846725|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
33355050|NCT00975923|62732829|FG000|Overall Study|Withdrawal by Subject|0|||
33355051|NCT00975923|62732830|FG001|Overall Study|Withdrawal by Subject|1|||
33355052|NCT00928070|62732839|FG000|Overall Study|Lost to Follow-up|1|||
33355053|NCT00928070|62732840|FG001|Overall Study|Lost to Follow-up|2|||
33355054|NCT00928070|62732839|FG000|Overall Study|Withdrawal by Subject|10|||
33355055|NCT00928070|62732840|FG001|Overall Study|Withdrawal by Subject|3|||
33355056|NCT00928070|62732839|FG000|Overall Study|Adverse Event|14|||
33355057|NCT00928070|62732840|FG001|Overall Study|Adverse Event|26|||
33355058|NCT00928070|62732839|FG000|Overall Study|Lack of Efficacy|9|||
33355059|NCT00928070|62732840|FG001|Overall Study|Lack of Efficacy|5|||
33355060|NCT00928070|62732839|FG000|Overall Study|Did not meet entrance criteria|16|||
33472588|NCT02946463|62846726|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
33355061|NCT00928070|62732840|FG001|Overall Study|Did not meet entrance criteria|9|||
33355062|NCT00928070|62732839|FG000|Overall Study|Protocol Violation|6|||
33355063|NCT00928070|62732840|FG001|Overall Study|Protocol Violation|5|||
33355064|NCT00928070|62732839|FG000|Overall Study|Randomized but not treated|2|||
33355065|NCT00928070|62732840|FG001|Overall Study|Randomized but not treated|2|||
33355066|NCT00928070|62732839|FG000|Overall Study|Other|5|||
33355067|NCT00928070|62732840|FG001|Overall Study|Other|5|||
33355068|NCT00924404|62732848|FG000|Overall Study|Lost to Follow-up|6|||
33472589|NCT02928224|62846736|FG000|Overall Study|Randomized, Not Treated|0|||
33472590|NCT02928224|62846737|FG001|Overall Study|Randomized, Not Treated|2|||
33472591|NCT02928224|62846738|FG002|Overall Study|Randomized, Not Treated|4|||
33472592|NCT02928224|62846739|FG003|Overall Study|Randomized, Not Treated|28|||
33472593|NCT02928224|62846736|FG000|Overall Study|Treatment Ongoing|6|||
33472594|NCT02928224|62846737|FG001|Overall Study|Treatment Ongoing|78|||
33472595|NCT02928224|62846738|FG002|Overall Study|Treatment Ongoing|78|||
33355069|NCT00924404|62732849|FG001|Overall Study|Lost to Follow-up|4|||
33355070|NCT00976937|62732857|FG000|Overall Study|Adverse Event|4|||
33355071|NCT00976937|62732858|FG001|Overall Study|Adverse Event|5|||
33355072|NCT00976937|62732857|FG000|Overall Study|Lost to Follow-up|2|||
33355073|NCT00976937|62732858|FG001|Overall Study|Lost to Follow-up|1|||
33355074|NCT00976937|62732857|FG000|Overall Study|Withdrawal by Subject|5|||
33355075|NCT00976937|62732858|FG001|Overall Study|Withdrawal by Subject|3|||
33355076|NCT00976937|62732857|FG000|Overall Study|Poor compliance to protocol|3|||
33355077|NCT00976937|62732858|FG001|Overall Study|Poor compliance to protocol|0|||
33355078|NCT00976937|62732857|FG000|Overall Study|Personal and Familial Reason|2|||
33355079|NCT00976937|62732858|FG001|Overall Study|Personal and Familial Reason|2|||
33355080|NCT00976703|62732866|FG000|Overall Study|Physician Decision|1|||
33355081|NCT00976703|62732867|FG001|Overall Study|Physician Decision|1|||
33355082|NCT00976703|62732866|FG000|Overall Study|ineligible for study|2|||
33355083|NCT00976703|62732867|FG001|Overall Study|ineligible for study|2|||
33355084|NCT00975689|62732875|FG000|Overall Study|Adverse Event|0|||
33355085|NCT00975689|62732876|FG001|Overall Study|Adverse Event|3|||
33355086|NCT00975689|62732875|FG000|Overall Study|Withdrawal by Subject|1|||
33355087|NCT00975689|62732876|FG001|Overall Study|Withdrawal by Subject|0|||
33355088|NCT00975689|62732875|FG000|Overall Study|Physician Decision|1|||
33355089|NCT00975689|62732876|FG001|Overall Study|Physician Decision|0|||
33355090|NCT00922766|62732882|FG000|Overall Study|Death|3|||
33355091|NCT00922766|62732882|FG000|Overall Study|Withdrawal by Subject|2|||
33355092|NCT00922766|62732882|FG000|Overall Study|Other|1|||
33355093|NCT00922766|62732882|FG000|Overall Study|Adverse Event|1|||
33355094|NCT00917852|62732886|FG000|Overall Study|Death|6|||
33355095|NCT00976391|62732893|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
33355096|NCT00976391|62732894|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
33355097|NCT00976391|62732893|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
33355098|NCT00976391|62732894|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
33355099|NCT00976391|62732893|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
33355100|NCT00976391|62732894|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
33355101|NCT00976391|62732893|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
33355102|NCT00976391|62732894|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
33355103|NCT00976391|62732893|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
33355104|NCT00976391|62732894|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
33355105|NCT00976391|62732893|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
33355106|NCT00976391|62732894|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
33355107|NCT00976391|62732893|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
33355108|NCT00976391|62732894|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
33355109|NCT00976391|62732893|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
33355110|NCT00976391|62732894|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
33355111|NCT00976391|62732893|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
33472596|NCT02928224|62846739|FG003|Overall Study|Treatment Ongoing|37|||
33472597|NCT02928224|62846736|FG000|Overall Study|Progressive Disease|23|||
33472598|NCT02928224|62846737|FG001|Overall Study|Progressive Disease|104|||
33472599|NCT02928224|62846738|FG002|Overall Study|Progressive Disease|101|||
33472600|NCT02928224|62846739|FG003|Overall Study|Progressive Disease|103|||
33355112|NCT00976391|62732894|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
33355113|NCT00976391|62732893|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
33355114|NCT00976391|62732894|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
33355115|NCT00976391|62732893|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
33355116|NCT00976391|62732894|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
33355117|NCT00976391|62732893|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
33355118|NCT00976391|62732894|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
33355119|NCT00976391|62732893|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
33355120|NCT00976391|62732894|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
33355121|NCT00976391|62732893|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
33355122|NCT00976391|62732894|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
33355123|NCT00917462|62732900|FG000|Overall Study|Clinical Deterioration|1|||
33355124|NCT00979901|62732908|FG000|Overall Study|Adverse Event|1|||
33355125|NCT00979901|62732909|FG001|Overall Study|Adverse Event|3|||
33355126|NCT00979901|62732910|FG002|Overall Study|Adverse Event|9|||
33355127|NCT00979901|62732911|FG003|Overall Study|Adverse Event|2|||
33355128|NCT00979901|62732908|FG000|Overall Study|Lack of Efficacy|8|||
33355129|NCT00979901|62732909|FG001|Overall Study|Lack of Efficacy|4|||
33355130|NCT00979901|62732910|FG002|Overall Study|Lack of Efficacy|9|||
33355131|NCT00979901|62732911|FG003|Overall Study|Lack of Efficacy|0|||
33355132|NCT00979901|62732908|FG000|Overall Study|Lost to Follow-up|1|||
33549107|NCT02901431|62940302|FG008|Open Label Part|Lost to Follow-up|2|||
33355133|NCT00979901|62732909|FG001|Overall Study|Lost to Follow-up|1|||
33355134|NCT00979901|62732910|FG002|Overall Study|Lost to Follow-up|2|||
33472601|NCT02928224|62846736|FG000|Overall Study|Adverse Event|2|||
33472602|NCT02928224|62846737|FG001|Overall Study|Adverse Event|11|||
33355135|NCT00979901|62732911|FG003|Overall Study|Lost to Follow-up|0|||
33355136|NCT00979901|62732908|FG000|Overall Study|Protocol Violation|2|||
33355137|NCT00979901|62732909|FG001|Overall Study|Protocol Violation|2|||
33472603|NCT02928224|62846738|FG002|Overall Study|Adverse Event|11|||
33355138|NCT00979901|62732910|FG002|Overall Study|Protocol Violation|7|||
33355139|NCT00979901|62732911|FG003|Overall Study|Protocol Violation|1|||
33355140|NCT00979901|62732908|FG000|Overall Study|Withdrawal by Subject|2|||
33355141|NCT00979901|62732909|FG001|Overall Study|Withdrawal by Subject|1|||
33355142|NCT00979901|62732910|FG002|Overall Study|Withdrawal by Subject|1|||
33355143|NCT00979901|62732911|FG003|Overall Study|Withdrawal by Subject|1|||
33355144|NCT00979901|62732908|FG000|Overall Study|Noncompliance|1|||
33355145|NCT00979901|62732909|FG001|Overall Study|Noncompliance|0|||
33355146|NCT00979901|62732910|FG002|Overall Study|Noncompliance|0|||
33355147|NCT00979901|62732911|FG003|Overall Study|Noncompliance|0|||
33355148|NCT00979901|62732908|FG000|Overall Study|out-of-state|1|||
33355149|NCT00979901|62732909|FG001|Overall Study|out-of-state|0|||
33355150|NCT00979901|62732910|FG002|Overall Study|out-of-state|0|||
33355151|NCT00979901|62732911|FG003|Overall Study|out-of-state|0|||
33355152|NCT00979901|62732908|FG000|Overall Study|vacation|1|||
33355153|NCT00979901|62732909|FG001|Overall Study|vacation|0|||
33355154|NCT00979901|62732910|FG002|Overall Study|vacation|0|||
33355155|NCT00979901|62732911|FG003|Overall Study|vacation|0|||
33355156|NCT00979901|62732908|FG000|Overall Study|elevated lab values pre-randomization|1|||
33355157|NCT00979901|62732909|FG001|Overall Study|elevated lab values pre-randomization|0|||
33355158|NCT00979901|62732910|FG002|Overall Study|elevated lab values pre-randomization|0|||
33355159|NCT00979901|62732911|FG003|Overall Study|elevated lab values pre-randomization|0|||
33355160|NCT00979901|62732908|FG000|Overall Study|Discontinued in Error|0|||
33355161|NCT00979901|62732909|FG001|Overall Study|Discontinued in Error|1|||
33355162|NCT00979901|62732910|FG002|Overall Study|Discontinued in Error|0|||
33355163|NCT00979901|62732911|FG003|Overall Study|Discontinued in Error|0|||
33355164|NCT00979901|62732908|FG000|Overall Study|Left Country|0|||
33355165|NCT00979901|62732909|FG001|Overall Study|Left Country|0|||
33355166|NCT00979901|62732910|FG002|Overall Study|Left Country|1|||
33355167|NCT00979901|62732911|FG003|Overall Study|Left Country|0|||
33355168|NCT00979901|62732908|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
33355169|NCT00979901|62732909|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
33355170|NCT00979901|62732910|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
33355171|NCT00979901|62732911|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
33355172|NCT00975611|62732920|FG000|Overall Study|Screen Fail|16|||
33355173|NCT00975611|62732920|FG000|Overall Study|Physician Decision|1|||
33355174|NCT00970307|62732927|FG000|Overall Study|Serious Adverse Event|1|||
33355175|NCT00970307|62732928|FG001|Overall Study|Serious Adverse Event|0|||
33355176|NCT00970307|62732929|FG002|Overall Study|Serious Adverse Event|0|||
33355177|NCT00970307|62732927|FG000|Overall Study|Withdrawal by Subject|2|||
33355178|NCT00970307|62732928|FG001|Overall Study|Withdrawal by Subject|3|||
33355179|NCT00970307|62732929|FG002|Overall Study|Withdrawal by Subject|2|||
33355180|NCT00917384|62732939|FG000|Overall Study|Lost to Follow-up|4|||
33355181|NCT00917384|62732940|FG001|Overall Study|Lost to Follow-up|2|||
33355182|NCT00917384|62732939|FG000|Overall Study|Withdrawal by Subject|10|||
33355183|NCT00917384|62732940|FG001|Overall Study|Withdrawal by Subject|2|||
33355184|NCT00864513|62732946|FG000|Overall Study|Withdrawal by Subject|3|||
33355185|NCT00917150|62732954|FG000|Overall Study|Adverse Event|12|||
33655311|NCT01892189|63070032|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
33655312|NCT01892189|63070024|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33655313|NCT01892189|63070025|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33655314|NCT01892189|63070026|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33655315|NCT01892189|63070027|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33655316|NCT01892189|63070028|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33655317|NCT01892189|63070029|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
33655318|NCT01892189|63070030|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33655319|NCT01892189|63070031|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33655320|NCT01892189|63070032|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33655321|NCT01881425|63070063|FG000|Overall Study|Death|5|||
33655322|NCT01881425|63070064|FG001|Overall Study|Death|1|||
33655323|NCT01881425|63070063|FG000|Overall Study|Withdrawal by Subject|8|||
33655324|NCT01881425|63070064|FG001|Overall Study|Withdrawal by Subject|3|||
33655325|NCT01881425|63070063|FG000|Overall Study|Physician Decision|2|||
33655326|NCT01881425|63070064|FG001|Overall Study|Physician Decision|1|||
33655327|NCT01881425|63070063|FG000|Overall Study|Adverse Event|3|||
33655328|NCT01881425|63070064|FG001|Overall Study|Adverse Event|0|||
33355186|NCT00917150|62732955|FG001|Overall Study|Adverse Event|7|||
33355187|NCT00917150|62732956|FG002|Overall Study|Adverse Event|12|||
33355188|NCT00917150|62732957|FG003|Overall Study|Adverse Event|11|||
33655329|NCT01881425|63070063|FG000|Overall Study|General Anesthesia panic attack|0|||
33355189|NCT00917150|62732954|FG000|Overall Study|Death|1|||
33655330|NCT01881425|63070064|FG001|Overall Study|General Anesthesia panic attack|1|||
33472604|NCT02928224|62846739|FG003|Overall Study|Adverse Event|10|||
33472605|NCT02928224|62846736|FG000|Overall Study|Changes in Patient's Condition|3|||
33472606|NCT02928224|62846737|FG001|Overall Study|Changes in Patient's Condition|9|||
33472607|NCT02928224|62846738|FG002|Overall Study|Changes in Patient's Condition|9|||
33472608|NCT02928224|62846739|FG003|Overall Study|Changes in Patient's Condition|13|||
33472609|NCT02928224|62846736|FG000|Overall Study|Death|1|||
33472610|NCT02928224|62846737|FG001|Overall Study|Death|7|||
33472611|NCT02928224|62846738|FG002|Overall Study|Death|5|||
33472612|NCT02928224|62846739|FG003|Overall Study|Death|11|||
33472613|NCT02928224|62846736|FG000|Overall Study|Withdrawal by Subject|1|||
33472614|NCT02928224|62846737|FG001|Overall Study|Withdrawal by Subject|4|||
33472615|NCT02928224|62846738|FG002|Overall Study|Withdrawal by Subject|3|||
33472616|NCT02928224|62846739|FG003|Overall Study|Withdrawal by Subject|9|||
33472617|NCT02928224|62846736|FG000|Overall Study|Dose Interruptions>28|1|||
33472618|NCT02928224|62846737|FG001|Overall Study|Dose Interruptions>28|2|||
33472619|NCT02928224|62846738|FG002|Overall Study|Dose Interruptions>28|2|||
33472620|NCT02928224|62846739|FG003|Overall Study|Dose Interruptions>28|4|||
33472621|NCT02928224|62846736|FG000|Overall Study|Patient Decision to Discontinue Drug|0|||
33472622|NCT02928224|62846737|FG001|Overall Study|Patient Decision to Discontinue Drug|2|||
33472623|NCT02928224|62846738|FG002|Overall Study|Patient Decision to Discontinue Drug|2|||
33472624|NCT02928224|62846739|FG003|Overall Study|Patient Decision to Discontinue Drug|4|||
33472625|NCT02928224|62846736|FG000|Overall Study|Physician Decision|0|||
33472626|NCT02928224|62846737|FG001|Overall Study|Physician Decision|2|||
33472627|NCT02928224|62846738|FG002|Overall Study|Physician Decision|4|||
33472628|NCT02928224|62846739|FG003|Overall Study|Physician Decision|2|||
33472629|NCT02928224|62846736|FG000|Overall Study|not listed|0|||
33472630|NCT02928224|62846737|FG001|Overall Study|not listed|3|||
33472631|NCT02928224|62846738|FG002|Overall Study|not listed|1|||
33472632|NCT02928224|62846739|FG003|Overall Study|not listed|0|||
33472633|NCT02860039|62846779|FG000|Overall Study|Death|4|||
33472634|NCT02860039|62846780|FG001|Overall Study|Death|0|||
33472635|NCT02860039|62846779|FG000|Overall Study|Lost to Follow-up|2|||
33472636|NCT02860039|62846780|FG001|Overall Study|Lost to Follow-up|2|||
33472637|NCT02860039|62846779|FG000|Overall Study|Protocol Violation|3|||
33472638|NCT02860039|62846780|FG001|Overall Study|Protocol Violation|1|||
33472639|NCT02860039|62846779|FG000|Overall Study|Withdrawal by Subject|1|||
33472640|NCT02860039|62846780|FG001|Overall Study|Withdrawal by Subject|0|||
33472641|NCT02860039|62846779|FG000|Overall Study|Not otherwise eligible|1|||
33472642|NCT02860039|62846780|FG001|Overall Study|Not otherwise eligible|1|||
33472643|NCT02761694|62846810|FG000|Overall Study|Lack of Efficacy|0|||
33472644|NCT02761694|62846811|FG001|Overall Study|Lack of Efficacy|0|||
33472645|NCT02761694|62846812|FG002|Overall Study|Lack of Efficacy|0|||
33472646|NCT02761694|62846813|FG003|Overall Study|Lack of Efficacy|0|||
33472647|NCT02761694|62846814|FG004|Overall Study|Lack of Efficacy|0|||
33472648|NCT02761694|62846815|FG005|Overall Study|Lack of Efficacy|0|||
33472649|NCT02761694|62846816|FG006|Overall Study|Lack of Efficacy|6|||
33472650|NCT02761694|62846817|FG007|Overall Study|Lack of Efficacy|0|||
33472651|NCT02761694|62846818|FG008|Overall Study|Lack of Efficacy|0|||
33472652|NCT02761694|62846819|FG009|Overall Study|Lack of Efficacy|1|||
33472653|NCT02761694|62846820|FG010|Overall Study|Lack of Efficacy|1|||
33472654|NCT02761694|62846821|FG011|Overall Study|Lack of Efficacy|4|||
33472655|NCT02761694|62846810|FG000|Overall Study|Death|0|||
33472656|NCT02761694|62846811|FG001|Overall Study|Death|0|||
33472657|NCT02761694|62846812|FG002|Overall Study|Death|0|||
33472658|NCT02761694|62846813|FG003|Overall Study|Death|0|||
33472659|NCT02761694|62846814|FG004|Overall Study|Death|0|||
33472660|NCT02761694|62846815|FG005|Overall Study|Death|0|||
33472661|NCT02761694|62846816|FG006|Overall Study|Death|2|||
33472662|NCT02761694|62846817|FG007|Overall Study|Death|0|||
33472663|NCT02761694|62846818|FG008|Overall Study|Death|2|||
33472664|NCT02761694|62846819|FG009|Overall Study|Death|2|||
33472665|NCT02761694|62846820|FG010|Overall Study|Death|1|||
33472666|NCT02761694|62846821|FG011|Overall Study|Death|0|||
33472667|NCT02761694|62846810|FG000|Overall Study|Physician Decision|0|||
33472668|NCT02761694|62846811|FG001|Overall Study|Physician Decision|0|||
33472669|NCT02761694|62846812|FG002|Overall Study|Physician Decision|0|||
33472670|NCT02761694|62846813|FG003|Overall Study|Physician Decision|0|||
33472671|NCT02761694|62846814|FG004|Overall Study|Physician Decision|0|||
33472672|NCT02761694|62846815|FG005|Overall Study|Physician Decision|0|||
33472673|NCT02761694|62846816|FG006|Overall Study|Physician Decision|1|||
33472674|NCT02761694|62846817|FG007|Overall Study|Physician Decision|0|||
33472675|NCT02761694|62846818|FG008|Overall Study|Physician Decision|0|||
33472676|NCT02761694|62846819|FG009|Overall Study|Physician Decision|0|||
33472677|NCT02761694|62846820|FG010|Overall Study|Physician Decision|0|||
33472678|NCT02761694|62846821|FG011|Overall Study|Physician Decision|0|||
33472679|NCT02761694|62846810|FG000|Overall Study|Withdrawal by Subject|0|||
33472680|NCT02761694|62846811|FG001|Overall Study|Withdrawal by Subject|0|||
33472681|NCT02761694|62846812|FG002|Overall Study|Withdrawal by Subject|0|||
33472682|NCT02761694|62846813|FG003|Overall Study|Withdrawal by Subject|1|||
33472683|NCT02761694|62846814|FG004|Overall Study|Withdrawal by Subject|0|||
33472684|NCT02761694|62846815|FG005|Overall Study|Withdrawal by Subject|0|||
33355190|NCT00917150|62732955|FG001|Overall Study|Death|4|||
33355191|NCT00917150|62732956|FG002|Overall Study|Death|3|||
33355192|NCT00917150|62732957|FG003|Overall Study|Death|2|||
33355193|NCT00917150|62732954|FG000|Overall Study|Lost to Follow-up|1|||
33355194|NCT00917150|62732955|FG001|Overall Study|Lost to Follow-up|0|||
33355195|NCT00917150|62732956|FG002|Overall Study|Lost to Follow-up|4|||
33355196|NCT00917150|62732957|FG003|Overall Study|Lost to Follow-up|2|||
33355197|NCT00917150|62732954|FG000|Overall Study|Physician Decision|0|||
33355198|NCT00917150|62732955|FG001|Overall Study|Physician Decision|2|||
33355199|NCT00917150|62732956|FG002|Overall Study|Physician Decision|0|||
33355200|NCT00917150|62732957|FG003|Overall Study|Physician Decision|1|||
33355201|NCT00917150|62732954|FG000|Overall Study|Protocol Violation|5|||
33355202|NCT00917150|62732955|FG001|Overall Study|Protocol Violation|5|||
33472685|NCT02761694|62846816|FG006|Overall Study|Withdrawal by Subject|4|||
33472686|NCT02761694|62846817|FG007|Overall Study|Withdrawal by Subject|0|||
33472687|NCT02761694|62846818|FG008|Overall Study|Withdrawal by Subject|2|||
33472688|NCT02761694|62846819|FG009|Overall Study|Withdrawal by Subject|1|||
33472689|NCT02761694|62846820|FG010|Overall Study|Withdrawal by Subject|0|||
33472690|NCT02761694|62846821|FG011|Overall Study|Withdrawal by Subject|0|||
33472691|NCT02761694|62846810|FG000|Overall Study|Lost to Follow-up|0|||
33472692|NCT02761694|62846811|FG001|Overall Study|Lost to Follow-up|0|||
33472693|NCT02761694|62846812|FG002|Overall Study|Lost to Follow-up|0|||
33355203|NCT00917150|62732956|FG002|Overall Study|Protocol Violation|3|||
33355204|NCT00917150|62732957|FG003|Overall Study|Protocol Violation|5|||
33472694|NCT02761694|62846813|FG003|Overall Study|Lost to Follow-up|0|||
33472695|NCT02761694|62846814|FG004|Overall Study|Lost to Follow-up|0|||
33472696|NCT02761694|62846815|FG005|Overall Study|Lost to Follow-up|0|||
33472697|NCT02761694|62846816|FG006|Overall Study|Lost to Follow-up|1|||
33472698|NCT02761694|62846817|FG007|Overall Study|Lost to Follow-up|0|||
33472699|NCT02761694|62846818|FG008|Overall Study|Lost to Follow-up|0|||
33472700|NCT02761694|62846819|FG009|Overall Study|Lost to Follow-up|0|||
33472701|NCT02761694|62846820|FG010|Overall Study|Lost to Follow-up|0|||
33472702|NCT02761694|62846821|FG011|Overall Study|Lost to Follow-up|1|||
33472703|NCT02761694|62846810|FG000|Overall Study|Adverse Event|0|||
33355205|NCT00917150|62732954|FG000|Overall Study|Withdrawal by Subject|15|||
33472704|NCT02761694|62846811|FG001|Overall Study|Adverse Event|0|||
33355206|NCT00917150|62732955|FG001|Overall Study|Withdrawal by Subject|16|||
33355207|NCT00917150|62732956|FG002|Overall Study|Withdrawal by Subject|18|||
33355208|NCT00917150|62732957|FG003|Overall Study|Withdrawal by Subject|11|||
33355209|NCT00917150|62732954|FG000|Overall Study|Other than specified|3|||
33355210|NCT00917150|62732955|FG001|Overall Study|Other than specified|3|||
33355211|NCT00917150|62732956|FG002|Overall Study|Other than specified|2|||
33355212|NCT00917150|62732957|FG003|Overall Study|Other than specified|2|||
33355213|NCT00659425|62732977|FG000|Overall Study|Disease progression|1|||
33355214|NCT00659425|62732978|FG001|Overall Study|Disease progression|0|||
33355215|NCT00659425|62732979|FG002|Overall Study|Disease progression|0|||
33355216|NCT00659425|62732980|FG003|Overall Study|Disease progression|1|||
33355217|NCT00659425|62732981|FG004|Overall Study|Disease progression|0|||
33355218|NCT00659425|62732982|FG005|Overall Study|Disease progression|2|||
33355219|NCT00659425|62732983|FG006|Overall Study|Disease progression|4|||
33355220|NCT00659425|62732984|FG007|Overall Study|Disease progression|3|||
33355221|NCT00659425|62732985|FG008|Overall Study|Disease progression|5|||
33355222|NCT00659425|62732986|FG009|Overall Study|Disease progression|3|||
33472705|NCT02761694|62846812|FG002|Overall Study|Adverse Event|0|||
33472706|NCT02761694|62846813|FG003|Overall Study|Adverse Event|0|||
33472707|NCT02761694|62846814|FG004|Overall Study|Adverse Event|0|||
33472708|NCT02761694|62846815|FG005|Overall Study|Adverse Event|0|||
33472709|NCT02761694|62846816|FG006|Overall Study|Adverse Event|1|||
33472710|NCT02761694|62846817|FG007|Overall Study|Adverse Event|0|||
33355223|NCT00659425|62732977|FG000|Overall Study|Death|0|||
33355224|NCT00659425|62732978|FG001|Overall Study|Death|0|||
33355225|NCT00659425|62732979|FG002|Overall Study|Death|0|||
33355226|NCT00659425|62732980|FG003|Overall Study|Death|1|||
33355227|NCT00659425|62732981|FG004|Overall Study|Death|0|||
33355228|NCT00659425|62732982|FG005|Overall Study|Death|0|||
33355229|NCT00659425|62732983|FG006|Overall Study|Death|1|||
33355230|NCT00659425|62732984|FG007|Overall Study|Death|0|||
33355231|NCT00659425|62732985|FG008|Overall Study|Death|0|||
33355232|NCT00659425|62732986|FG009|Overall Study|Death|0|||
33355233|NCT00659425|62732977|FG000|Overall Study|Adverse Event|0|||
33355234|NCT00659425|62732978|FG001|Overall Study|Adverse Event|0|||
33355235|NCT00659425|62732979|FG002|Overall Study|Adverse Event|0|||
33355236|NCT00659425|62732980|FG003|Overall Study|Adverse Event|0|||
33355237|NCT00659425|62732981|FG004|Overall Study|Adverse Event|0|||
33355238|NCT00659425|62732982|FG005|Overall Study|Adverse Event|1|||
33355239|NCT00659425|62732983|FG006|Overall Study|Adverse Event|0|||
33355240|NCT00659425|62732984|FG007|Overall Study|Adverse Event|3|||
33355241|NCT00659425|62732985|FG008|Overall Study|Adverse Event|1|||
33355242|NCT00659425|62732986|FG009|Overall Study|Adverse Event|4|||
33355243|NCT00659425|62732977|FG000|Overall Study|Investigator Discretion|0|||
33355244|NCT00659425|62732978|FG001|Overall Study|Investigator Discretion|0|||
33355245|NCT00659425|62732979|FG002|Overall Study|Investigator Discretion|0|||
33355246|NCT00659425|62732980|FG003|Overall Study|Investigator Discretion|0|||
33355247|NCT00659425|62732981|FG004|Overall Study|Investigator Discretion|0|||
33355248|NCT00659425|62732982|FG005|Overall Study|Investigator Discretion|1|||
33355249|NCT00659425|62732983|FG006|Overall Study|Investigator Discretion|0|||
33355250|NCT00659425|62732984|FG007|Overall Study|Investigator Discretion|3|||
33355251|NCT00659425|62732985|FG008|Overall Study|Investigator Discretion|0|||
33355252|NCT00659425|62732986|FG009|Overall Study|Investigator Discretion|0|||
33472711|NCT02761694|62846818|FG008|Overall Study|Adverse Event|1|||
33355253|NCT00659425|62732977|FG000|Overall Study|Other|0|||
33355254|NCT00659425|62732978|FG001|Overall Study|Other|1|||
33355255|NCT00659425|62732979|FG002|Overall Study|Other|1|||
33355256|NCT00659425|62732980|FG003|Overall Study|Other|2|||
33355257|NCT00659425|62732981|FG004|Overall Study|Other|4|||
33355258|NCT00659425|62732982|FG005|Overall Study|Other|0|||
33355259|NCT00659425|62732983|FG006|Overall Study|Other|3|||
33355260|NCT00659425|62732984|FG007|Overall Study|Other|2|||
33355261|NCT00659425|62732985|FG008|Overall Study|Other|0|||
33355262|NCT00659425|62732986|FG009|Overall Study|Other|6|||
33472712|NCT02761694|62846819|FG009|Overall Study|Adverse Event|0|||
33472713|NCT02761694|62846820|FG010|Overall Study|Adverse Event|0|||
33472714|NCT02761694|62846821|FG011|Overall Study|Adverse Event|1|||
33355263|NCT00656851|62733023|FG000|Overall Study|Withdrawal by Subject|0|||
33355264|NCT00656851|62733024|FG001|Overall Study|Withdrawal by Subject|4|||
33355265|NCT00656617|62733030|FG000|Overall Study|Adverse Event|1|||
33355266|NCT00656617|62733030|FG000|Overall Study|Death|2|||
33355267|NCT00656617|62733030|FG000|Overall Study|Insurance Issues|2|||
33355268|NCT00656617|62733030|FG000|Overall Study|Move to different clinical trial|2|||
33472715|NCT02761694|62846810|FG000|Overall Study|Other|4|||
33472716|NCT02761694|62846811|FG001|Overall Study|Other|4|||
33472717|NCT02761694|62846812|FG002|Overall Study|Other|1|||
33355269|NCT00659269|62733037|FG000|Overall Study|Physician Decision|1|||
33355270|NCT00659269|62733038|FG001|Overall Study|Physician Decision|1|||
33355271|NCT00658333|62733055|FG000|Overall Study|Adverse Event|2|||
33355272|NCT00658333|62733056|FG001|Overall Study|Adverse Event|1|||
33355273|NCT00570037|62733064|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
33472718|NCT02761694|62846813|FG003|Overall Study|Other|2|||
33472719|NCT02761694|62846814|FG004|Overall Study|Other|3|||
33472720|NCT02761694|62846815|FG005|Overall Study|Other|3|||
33472721|NCT02761694|62846816|FG006|Overall Study|Other|18|||
33472722|NCT02761694|62846817|FG007|Overall Study|Other|8|||
33472723|NCT02761694|62846818|FG008|Overall Study|Other|0|||
33355274|NCT00570037|62733065|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
33355275|NCT00863655|62733073|FG000|Overall Study|Protocol Violation|4|||
33355276|NCT00863655|62733074|FG001|Overall Study|Protocol Violation|0|||
33355277|NCT00863655|62733073|FG000|Overall Study|Adverse Event|52|||
33355278|NCT00863655|62733074|FG001|Overall Study|Adverse Event|8|||
33355279|NCT00863655|62733073|FG000|Overall Study|Withdrawal by Subject|47|||
33355280|NCT00863655|62733074|FG001|Overall Study|Withdrawal by Subject|7|||
33355281|NCT00863655|62733073|FG000|Overall Study|Administrative problems|1|||
33355282|NCT00863655|62733074|FG001|Overall Study|Administrative problems|0|||
33355283|NCT00863655|62733073|FG000|Overall Study|Death|7|||
33355284|NCT00863655|62733074|FG001|Overall Study|Death|1|||
33355285|NCT00863655|62733073|FG000|Overall Study|New cancer therapy|5|||
33355286|NCT00863655|62733074|FG001|Overall Study|New cancer therapy|1|||
33355287|NCT00863655|62733073|FG000|Overall Study|Disease progression|364|||
33355288|NCT00863655|62733074|FG001|Overall Study|Disease progression|221|||
33355289|NCT00863655|62733073|FG000|Overall Study|Treatment completed as per protocol|5|||
33355290|NCT00863655|62733074|FG001|Overall Study|Treatment completed as per protocol|1|||
33355291|NCT00658723|62733082|FG000|Overall Study|Lost to Follow-up|0|||
33355292|NCT00658723|62733083|FG001|Overall Study|Lost to Follow-up|2|||
33355293|NCT00658723|62733084|FG002|Overall Study|Lost to Follow-up|2|||
33355294|NCT00658723|62733082|FG000|Overall Study|Death|2|||
33355295|NCT00658723|62733083|FG001|Overall Study|Death|1|||
33355296|NCT00658723|62733084|FG002|Overall Study|Death|4|||
33355297|NCT00658723|62733082|FG000|Overall Study|Scheduling Issue|1|||
33355298|NCT00658723|62733083|FG001|Overall Study|Scheduling Issue|1|||
33355299|NCT00658723|62733084|FG002|Overall Study|Scheduling Issue|0|||
33355300|NCT00658723|62733082|FG000|Overall Study|Withdrawal by Subject|1|||
33355301|NCT00658723|62733083|FG001|Overall Study|Withdrawal by Subject|0|||
33355302|NCT00658723|62733084|FG002|Overall Study|Withdrawal by Subject|1|||
33355303|NCT00593385|62733095|FG000|Overall Study|Death|14|||
33355304|NCT00593385|62733095|FG000|Overall Study|Lost to Follow-up|17|||
33355305|NCT00593385|62733095|FG000|Overall Study|Withdrawal by Subject|9|||
33355306|NCT00658021|62733104|FG000|28-Week Treatment Period|Adverse Event|3|||
33355307|NCT00658021|62733105|FG001|28-Week Treatment Period|Adverse Event|1|||
33355308|NCT00658021|62733106|FG002|28-Week Treatment Period|Adverse Event|0|||
33355309|NCT00658021|62733104|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
33355310|NCT00658021|62733105|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
33355311|NCT00658021|62733106|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
33355312|NCT00658021|62733104|FG000|28-Week Treatment Period|Protocol Violation|0|||
33355313|NCT00658021|62733105|FG001|28-Week Treatment Period|Protocol Violation|2|||
33355314|NCT00658021|62733106|FG002|28-Week Treatment Period|Protocol Violation|1|||
33355315|NCT00658021|62733104|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
33355316|NCT00658021|62733105|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
33355317|NCT00658021|62733106|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
33355318|NCT00658021|62733104|FG000|28-Week Treatment Period|Physician Decision|1|||
33355319|NCT00658021|62733105|FG001|28-Week Treatment Period|Physician Decision|2|||
33355320|NCT00658021|62733106|FG002|28-Week Treatment Period|Physician Decision|1|||
33355321|NCT00658021|62733104|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
33472724|NCT02761694|62846819|FG009|Overall Study|Other|1|||
33472725|NCT02761694|62846820|FG010|Overall Study|Other|1|||
33472726|NCT02761694|62846821|FG011|Overall Study|Other|0|||
33472727|NCT02726386|62846850|FG000|Overall Study|Adverse Event|17|||
33472728|NCT02726386|62846851|FG001|Overall Study|Adverse Event|20|||
33472729|NCT02726386|62846850|FG000|Overall Study|Withdrawal by Subject|14|||
33472730|NCT02726386|62846851|FG001|Overall Study|Withdrawal by Subject|28|||
33472731|NCT02726386|62846850|FG000|Overall Study|Other reasons|7|||
33472732|NCT02726386|62846851|FG001|Overall Study|Other reasons|8|||
33472733|NCT02574481|62846873|FG000|Overall Study|Withdrawal by Subject|29|||
33549108|NCT02901431|62940303|FG009|Open Label Part|Lost to Follow-up|2|||
33355322|NCT00658021|62733105|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
33355323|NCT00658021|62733106|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
33355324|NCT00658021|62733104|FG000|28-Week Treatment Period|Loss of glucose control|1|||
33355325|NCT00658021|62733105|FG001|28-Week Treatment Period|Loss of glucose control|1|||
33355326|NCT00658021|62733106|FG002|28-Week Treatment Period|Loss of glucose control|10|||
33355327|NCT00658021|62733104|FG000|28-Week Treatment Period|Other|2|||
33355328|NCT00658021|62733105|FG001|28-Week Treatment Period|Other|3|||
33355329|NCT00658021|62733106|FG002|28-Week Treatment Period|Other|1|||
33355330|NCT00658021|62733104|FG000|28-Week Treatment Period|Did not receive treatment|2|||
33472734|NCT02574481|62846874|FG001|Overall Study|Withdrawal by Subject|15|||
33472735|NCT02574481|62846875|FG002|Overall Study|Withdrawal by Subject|4|||
33472736|NCT02574481|62846876|FG003|Overall Study|Withdrawal by Subject|1|||
33472737|NCT02574481|62846873|FG000|Overall Study|Adverse Event|5|||
33472738|NCT02574481|62846874|FG001|Overall Study|Adverse Event|1|||
33472739|NCT02574481|62846875|FG002|Overall Study|Adverse Event|1|||
33472740|NCT02574481|62846876|FG003|Overall Study|Adverse Event|0|||
33472741|NCT02574481|62846873|FG000|Overall Study|Visit Missed|15|||
33472742|NCT02574481|62846874|FG001|Overall Study|Visit Missed|7|||
33472743|NCT02574481|62846875|FG002|Overall Study|Visit Missed|5|||
33472744|NCT02574481|62846876|FG003|Overall Study|Visit Missed|0|||
33472745|NCT02574481|62846873|FG000|Overall Study|Other|7|||
33472746|NCT02574481|62846874|FG001|Overall Study|Other|2|||
33355331|NCT00658021|62733105|FG001|28-Week Treatment Period|Did not receive treatment|0|||
33355332|NCT00658021|62733106|FG002|28-Week Treatment Period|Did not receive treatment|0|||
33472747|NCT02574481|62846875|FG002|Overall Study|Other|0|||
33472748|NCT02574481|62846876|FG003|Overall Study|Other|0|||
33472749|NCT02574481|62846873|FG000|Overall Study|Death|48|||
33355333|NCT00658021|62733104|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
33355334|NCT00658021|62733105|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
33355335|NCT00658021|62733106|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
33355336|NCT00658021|62733104|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
33355337|NCT00658021|62733105|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
33472750|NCT02574481|62846874|FG001|Overall Study|Death|26|||
33472751|NCT02574481|62846875|FG002|Overall Study|Death|12|||
33472752|NCT02574481|62846876|FG003|Overall Study|Death|4|||
33472753|NCT02574481|62846873|FG000|Overall Study|Physician Decision|5|||
33472754|NCT02574481|62846874|FG001|Overall Study|Physician Decision|2|||
33472755|NCT02574481|62846875|FG002|Overall Study|Physician Decision|0|||
33472756|NCT02574481|62846876|FG003|Overall Study|Physician Decision|0|||
33472757|NCT02574481|62846873|FG000|Overall Study|Lost to Follow-up|5|||
33472758|NCT02574481|62846874|FG001|Overall Study|Lost to Follow-up|1|||
33472759|NCT02574481|62846875|FG002|Overall Study|Lost to Follow-up|3|||
33472760|NCT02574481|62846876|FG003|Overall Study|Lost to Follow-up|0|||
33472761|NCT02438722|62846891|FG000|Overall Study|Adverse Event|12|||
33472762|NCT02438722|62846892|FG001|Overall Study|Adverse Event|9|||
33472763|NCT02438722|62846891|FG000|Overall Study|Refusal unrelated to AE|2|||
33472764|NCT02438722|62846892|FG001|Overall Study|Refusal unrelated to AE|5|||
33472765|NCT02438722|62846891|FG000|Overall Study|Disease progression/relapse|46|||
33472766|NCT02438722|62846892|FG001|Overall Study|Disease progression/relapse|51|||
33472767|NCT02438722|62846891|FG000|Overall Study|Death|0|||
33472768|NCT02438722|62846892|FG001|Overall Study|Death|3|||
33472769|NCT02438722|62846891|FG000|Overall Study|Physician Decision|2|||
33472770|NCT02438722|62846892|FG001|Overall Study|Physician Decision|2|||
33472771|NCT02438722|62846891|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
33472772|NCT02438722|62846892|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
33472773|NCT02438722|62846891|FG000|Overall Study|Withdrawal by Subject|0|||
33472774|NCT02438722|62846892|FG001|Overall Study|Withdrawal by Subject|1|||
33472775|NCT02438722|62846891|FG000|Overall Study|On protocol treatment|15|||
33472776|NCT02438722|62846892|FG001|Overall Study|On protocol treatment|14|||
33472777|NCT02438722|62846891|FG000|Overall Study|Did not receive protocol treatment|5|||
33472778|NCT02438722|62846892|FG001|Overall Study|Did not receive protocol treatment|0|||
33472779|NCT02376829|62846909|FG000|Overall Study|Withdrawal by Subject|27|||
33549109|NCT02901431|62940304|FG010|Open Label Part|Lost to Follow-up|1|||
33549110|NCT02901431|62940305|FG011|Open Label Part|Lost to Follow-up|1|||
33549111|NCT02901431|62940306|FG012|Open Label Part|Lost to Follow-up|1|||
33549112|NCT02901431|62940294|FG000|Open Label Part|Physician Decision|0|||
33549113|NCT02901431|62940295|FG001|Open Label Part|Physician Decision|0|||
33549114|NCT02901431|62940296|FG002|Open Label Part|Physician Decision|0|||
33472780|NCT02376829|62846910|FG001|Overall Study|Withdrawal by Subject|44|||
33472781|NCT02297438|62846919|FG000|Overall Study|Death|79|||
33472782|NCT02297438|62846920|FG001|Overall Study|Death|86|||
33472783|NCT02297438|62846919|FG000|Overall Study|Lost to Follow-up|9|||
33472784|NCT02297438|62846920|FG001|Overall Study|Lost to Follow-up|7|||
33472785|NCT02297438|62846919|FG000|Overall Study|Withdrawal by Subject|7|||
33472786|NCT02297438|62846920|FG001|Overall Study|Withdrawal by Subject|0|||
33472787|NCT02297438|62846919|FG000|Overall Study|Other|9|||
33472788|NCT02297438|62846920|FG001|Overall Study|Other|5|||
33549115|NCT02901431|62940297|FG003|Open Label Part|Physician Decision|0|||
33549116|NCT02901431|62940298|FG004|Open Label Part|Physician Decision|0|||
33549117|NCT02901431|62940299|FG005|Open Label Part|Physician Decision|0|||
33549118|NCT02901431|62940300|FG006|Open Label Part|Physician Decision|0|||
33549119|NCT02901431|62940301|FG007|Open Label Part|Physician Decision|0|||
33549120|NCT02901431|62940302|FG008|Open Label Part|Physician Decision|1|||
33549121|NCT02901431|62940303|FG009|Open Label Part|Physician Decision|1|||
33472789|NCT02297438|62846919|FG000|Overall Study|Ongoing|65|||
33472790|NCT02297438|62846920|FG001|Overall Study|Ongoing|73|||
33355338|NCT00658021|62733106|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
33355339|NCT00920816|62733120|FG000|Overall Study|Death|116|||
33355340|NCT00920816|62733121|FG001|Overall Study|Death|63|||
33355341|NCT00920816|62733122|FG002|Overall Study|Death|8|||
33355342|NCT00920816|62733123|FG003|Overall Study|Death|3|||
33355343|NCT00920816|62733120|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
33355344|NCT00920816|62733121|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
33355345|NCT00920816|62733122|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
33355346|NCT00920816|62733123|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
33355347|NCT00920816|62733120|FG000|Overall Study|Global deterioration of health status|2|||
33355348|NCT00920816|62733121|FG001|Overall Study|Global deterioration of health status|0|||
33355349|NCT00920816|62733122|FG002|Overall Study|Global deterioration of health status|0|||
33355350|NCT00920816|62733123|FG003|Overall Study|Global deterioration of health status|0|||
33355351|NCT00920816|62733120|FG000|Overall Study|Objective progression or relapse|6|||
33355352|NCT00920816|62733121|FG001|Overall Study|Objective progression or relapse|2|||
33355353|NCT00920816|62733122|FG002|Overall Study|Objective progression or relapse|0|||
33355354|NCT00920816|62733123|FG003|Overall Study|Objective progression or relapse|0|||
33472791|NCT02297139|62846928|FG000|Overall Study|Disease progression|0|||
33472792|NCT02297139|62846929|FG001|Overall Study|Disease progression|1|||
33472793|NCT02297139|62846928|FG000|Overall Study|Study drug toxicity|0|||
33472794|NCT02297139|62846929|FG001|Overall Study|Study drug toxicity|4|||
33472795|NCT02297139|62846928|FG000|Overall Study|Participant request to discontinue study treatment|0|||
33472796|NCT02297139|62846929|FG001|Overall Study|Participant request to discontinue study treatment|1|||
33355355|NCT00920816|62733120|FG000|Overall Study|Other|26|||
33355356|NCT00920816|62733121|FG001|Overall Study|Other|15|||
33355357|NCT00920816|62733122|FG002|Overall Study|Other|1|||
33355358|NCT00920816|62733123|FG003|Overall Study|Other|2|||
33355359|NCT00920816|62733120|FG000|Overall Study|Lost to Follow-up|11|||
33355360|NCT00920816|62733121|FG001|Overall Study|Lost to Follow-up|2|||
33355361|NCT00920816|62733122|FG002|Overall Study|Lost to Follow-up|0|||
33355362|NCT00920816|62733123|FG003|Overall Study|Lost to Follow-up|0|||
33355363|NCT00920816|62733120|FG000|Overall Study|Adverse Event|1|||
33355364|NCT00920816|62733121|FG001|Overall Study|Adverse Event|1|||
33355365|NCT00920816|62733122|FG002|Overall Study|Adverse Event|1|||
33355366|NCT00920816|62733123|FG003|Overall Study|Adverse Event|0|||
33355367|NCT00920816|62733120|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
33355368|NCT00920816|62733121|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
33355369|NCT00920816|62733122|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
33355370|NCT00920816|62733123|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
33355371|NCT00920816|62733120|FG000|Overall Study|Randomized but not treated|3|||
33355372|NCT00920816|62733121|FG001|Overall Study|Randomized but not treated|0|||
33355373|NCT00920816|62733122|FG002|Overall Study|Randomized but not treated|0|||
33355374|NCT00920816|62733123|FG003|Overall Study|Randomized but not treated|0|||
33355375|NCT00657709|62733138|FG000|Overall Study|AE or Death|7|||
33355376|NCT00657709|62733139|FG001|Overall Study|AE or Death|7|||
33355377|NCT00657709|62733140|FG002|Overall Study|AE or Death|6|||
33355378|NCT00657709|62733141|FG003|Overall Study|AE or Death|7|||
33355379|NCT00657709|62733142|FG004|Overall Study|AE or Death|1|||
33355380|NCT00657709|62733138|FG000|Overall Study|Withdrawal by Subject|7|||
33355381|NCT00657709|62733139|FG001|Overall Study|Withdrawal by Subject|15|||
33355382|NCT00657709|62733140|FG002|Overall Study|Withdrawal by Subject|15|||
33355383|NCT00657709|62733141|FG003|Overall Study|Withdrawal by Subject|5|||
33355384|NCT00657709|62733142|FG004|Overall Study|Withdrawal by Subject|9|||
33355385|NCT00657709|62733138|FG000|Overall Study|Lost to Follow-up|9|||
33355386|NCT00657709|62733139|FG001|Overall Study|Lost to Follow-up|9|||
33355387|NCT00657709|62733140|FG002|Overall Study|Lost to Follow-up|7|||
33355388|NCT00657709|62733141|FG003|Overall Study|Lost to Follow-up|1|||
33355389|NCT00657709|62733142|FG004|Overall Study|Lost to Follow-up|21|||
33355390|NCT00657709|62733138|FG000|Overall Study|Protocol Violation|0|||
33355391|NCT00657709|62733139|FG001|Overall Study|Protocol Violation|2|||
33355392|NCT00657709|62733140|FG002|Overall Study|Protocol Violation|0|||
33355393|NCT00657709|62733141|FG003|Overall Study|Protocol Violation|1|||
33472797|NCT02297139|62846928|FG000|Overall Study|Maximum clinical benefit|1|||
33355394|NCT00657709|62733142|FG004|Overall Study|Protocol Violation|2|||
33355395|NCT00915356|62733169|FG000|Overall Study|Withdrawal by Subject|1|||
33355396|NCT00915356|62733170|FG001|Overall Study|Withdrawal by Subject|0|||
33355397|NCT00915356|62733171|FG002|Overall Study|Withdrawal by Subject|0|||
33355398|NCT00915356|62733172|FG003|Overall Study|Withdrawal by Subject|0|||
33355399|NCT00915356|62733173|FG004|Overall Study|Withdrawal by Subject|0|||
33355400|NCT00657553|62733187|FG000|Overall Study|low accrual, no analysis run|5|||
33355401|NCT00657553|62733188|FG001|Overall Study|low accrual, no analysis run|5|||
33355402|NCT00862719|62733198|FG000|Overall Study|Disease Progression|5|||
33355403|NCT00862719|62733199|FG001|Overall Study|Disease Progression|0|||
33355404|NCT00862719|62733200|FG002|Overall Study|Disease Progression|1|||
33355405|NCT00862719|62733201|FG003|Overall Study|Disease Progression|0|||
33355406|NCT00862719|62733198|FG000|Overall Study|Death|5|||
33355407|NCT00862719|62733199|FG001|Overall Study|Death|6|||
33355408|NCT00862719|62733200|FG002|Overall Study|Death|1|||
33355409|NCT00862719|62733201|FG003|Overall Study|Death|1|||
33355410|NCT00862719|62733198|FG000|Overall Study|Engraftment failure|0|||
33355411|NCT00862719|62733199|FG001|Overall Study|Engraftment failure|0|||
33355412|NCT00862719|62733200|FG002|Overall Study|Engraftment failure|1|||
33355413|NCT00862719|62733201|FG003|Overall Study|Engraftment failure|0|||
33355414|NCT00862719|62733198|FG000|Overall Study|Veno-Occlusive Disease|0|||
33355415|NCT00862719|62733199|FG001|Overall Study|Veno-Occlusive Disease|0|||
33355416|NCT00862719|62733200|FG002|Overall Study|Veno-Occlusive Disease|1|||
33355417|NCT00862719|62733201|FG003|Overall Study|Veno-Occlusive Disease|0|||
33355418|NCT00862641|62733215|FG000|Overall Study|Randomized, but drug not received|1|||
33355419|NCT00862641|62733216|FG001|Overall Study|Randomized, but drug not received|4|||
33355420|NCT00862641|62733217|FG002|Overall Study|Randomized, but drug not received|1|||
33355421|NCT00862641|62733218|FG003|Overall Study|Randomized, but drug not received|4|||
33355422|NCT00861471|62733228|FG000|Overall Study|Withdrawal by Subject|1|||
33355423|NCT00861471|62733228|FG000|Overall Study|Adverse Event|2|||
33355424|NCT00861471|62733228|FG000|Overall Study|Lack of Efficacy|3|||
33355425|NCT00861471|62733228|FG000|Overall Study|treatment for lumbar laminectomy|1|||
33355426|NCT00861471|62733228|FG000|Overall Study|Physician Decision|2|||
33355427|NCT00860067|62733235|FG000|Overall Study|Lost to Follow-up|46|||
33355428|NCT00860067|62733236|FG001|Overall Study|Lost to Follow-up|9|||
33355429|NCT00860067|62733237|FG002|Overall Study|Lost to Follow-up|9|||
33355430|NCT00860067|62733235|FG000|Overall Study|Withdrawal by Subject|4|||
33355431|NCT00860067|62733236|FG001|Overall Study|Withdrawal by Subject|0|||
33355432|NCT00860067|62733237|FG002|Overall Study|Withdrawal by Subject|0|||
33355433|NCT00860067|62733235|FG000|Overall Study|Pregnancy|1|||
33472798|NCT02297139|62846929|FG001|Overall Study|Maximum clinical benefit|0|||
33472799|NCT02297139|62846928|FG000|Overall Study|Administrative reason by sponsor|0|||
33472800|NCT02297139|62846929|FG001|Overall Study|Administrative reason by sponsor|2|||
33472801|NCT02297139|62846928|FG000|Overall Study|Other reasons|0|||
33355434|NCT00860067|62733236|FG001|Overall Study|Pregnancy|0|||
33355435|NCT00860067|62733237|FG002|Overall Study|Pregnancy|0|||
33472802|NCT02297139|62846929|FG001|Overall Study|Other reasons|8|||
33472803|NCT02142959|62846938|FG000|Overall Study|Adverse Event|1|||
33472804|NCT02142959|62846939|FG001|Overall Study|Adverse Event|0|||
33472805|NCT02142959|62846940|FG002|Overall Study|Adverse Event|0|||
33472806|NCT02142959|62846938|FG000|Overall Study|Death|0|||
33355436|NCT00858117|62733248|FG000|Treatment on Study|Adverse Event|2|||
33355437|NCT00858117|62733248|FG000|Follow up for 5 Years|Death|4|||
33355438|NCT00858117|62733248|FG000|Follow up for 5 Years|No further data collected for study|9|||
33355439|NCT00652951|62733255|FG000|Booster Phase|Adverse event, non-fatal|0|||
33355440|NCT00652951|62733256|FG001|Booster Phase|Adverse event, non-fatal|1|||
33355441|NCT00652951|62733257|FG002|Booster Phase|Adverse event, non-fatal|0|||
33355442|NCT00652951|62733255|FG000|Booster Phase|Other|1|||
33355443|NCT00652951|62733256|FG001|Booster Phase|Other|0|||
33472807|NCT02142959|62846939|FG001|Overall Study|Death|1|||
33472808|NCT02142959|62846940|FG002|Overall Study|Death|0|||
33472809|NCT02142959|62846938|FG000|Overall Study|Withdrawal by Subject|3|||
33472810|NCT02142959|62846939|FG001|Overall Study|Withdrawal by Subject|1|||
33472811|NCT02142959|62846940|FG002|Overall Study|Withdrawal by Subject|3|||
33472812|NCT02142959|62846938|FG000|Overall Study|Administrative Reasons|1|||
33472813|NCT02142959|62846939|FG001|Overall Study|Administrative Reasons|0|||
33472814|NCT02142959|62846940|FG002|Overall Study|Administrative Reasons|1|||
33472815|NCT02142959|62846938|FG000|Overall Study|Missing|0|||
33472816|NCT02142959|62846939|FG001|Overall Study|Missing|1|||
33472817|NCT02142959|62846940|FG002|Overall Study|Missing|0|||
33472818|NCT02142959|62846938|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
33472819|NCT02142959|62846939|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
33472820|NCT02142959|62846940|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
33472821|NCT02142959|62846938|FG000|Overall Study|Patient didn't complete end of study visit|0|||
33549122|NCT02901431|62940304|FG010|Open Label Part|Physician Decision|0|||
33355444|NCT00652951|62733257|FG002|Booster Phase|Other|0|||
33355445|NCT00848211|62733269|FG000|Overall Study|Protocol Violation|0|||
33355446|NCT00848211|62733270|FG001|Overall Study|Protocol Violation|1|||
33355447|NCT00848211|62733271|FG002|Overall Study|Protocol Violation|1|||
33355448|NCT00848211|62733272|FG003|Overall Study|Protocol Violation|0|||
33355449|NCT00848211|62733269|FG000|Overall Study|Adverse Event|0|||
33355450|NCT00848211|62733270|FG001|Overall Study|Adverse Event|0|||
33355451|NCT00848211|62733271|FG002|Overall Study|Adverse Event|0|||
33355452|NCT00848211|62733272|FG003|Overall Study|Adverse Event|0|||
33355453|NCT00592683|62733284|FG000|Overall Study|Found ineligible|0|||
33355454|NCT00592683|62733285|FG001|Overall Study|Found ineligible|1|||
33355455|NCT00592683|62733284|FG000|Overall Study|Withdrawal by Subject|1|||
33355456|NCT00592683|62733285|FG001|Overall Study|Withdrawal by Subject|0|||
33355457|NCT00592683|62733284|FG000|Overall Study|Adverse Event|0|||
33355458|NCT00592683|62733285|FG001|Overall Study|Adverse Event|2|||
33355459|NCT00592683|62733284|FG000|Overall Study|Protocol Violation|1|||
33355460|NCT00592683|62733285|FG001|Overall Study|Protocol Violation|0|||
33355461|NCT00592683|62733284|FG000|Overall Study|Study drug expired|1|||
33355462|NCT00592683|62733285|FG001|Overall Study|Study drug expired|0|||
33355463|NCT00592683|62733284|FG000|Overall Study|Other|1|||
33355464|NCT00592683|62733285|FG001|Overall Study|Other|0|||
33355465|NCT00592683|62733284|FG000|Overall Study|Lost to Follow-up|0|||
33355466|NCT00592683|62733285|FG001|Overall Study|Lost to Follow-up|1|||
33355467|NCT00847665|62733293|FG000|Overall Study|Withdrawal by Subject|1|||
33355468|NCT00847665|62733294|FG001|Overall Study|Withdrawal by Subject|0|||
33355469|NCT00916370|62733302|FG000|Overall Study|Death|3|||
33355470|NCT00916370|62733303|FG001|Overall Study|Death|1|||
33355471|NCT00916370|62733302|FG000|Overall Study|Withdrawal by Subject|2|||
33355472|NCT00916370|62733303|FG001|Overall Study|Withdrawal by Subject|0|||
33355473|NCT00916370|62733302|FG000|Overall Study|Physician Decision|0|||
33355474|NCT00916370|62733303|FG001|Overall Study|Physician Decision|1|||
33355475|NCT00847197|62733312|FG000|Overall Study|Adverse Event|21|||
33355476|NCT00847197|62733313|FG001|Overall Study|Adverse Event|3|||
33355477|NCT00847197|62733312|FG000|Overall Study|Protocol Violation|0|||
33355478|NCT00847197|62733313|FG001|Overall Study|Protocol Violation|1|||
33355479|NCT00847197|62733312|FG000|Overall Study|Withdrawal by Subject|3|||
33355480|NCT00847197|62733313|FG001|Overall Study|Withdrawal by Subject|1|||
33355481|NCT00654901|62733323|FG000|Overall Study|Lost to Follow-up|1|||
33355482|NCT00654901|62733324|FG001|Overall Study|Lost to Follow-up|0|||
33472822|NCT02142959|62846939|FG001|Overall Study|Patient didn't complete end of study visit|0|||
33472823|NCT02142959|62846940|FG002|Overall Study|Patient didn't complete end of study visit|1|||
33472824|NCT02100722|62846959|FG000|Overall Study|Withdrawal pre-procedure|4|||
33472825|NCT02100722|62846960|FG001|Overall Study|Withdrawal pre-procedure|9|||
33472826|NCT02100722|62846959|FG000|Overall Study|Withdrawal post-procedure|0|||
33472827|NCT02100722|62846960|FG001|Overall Study|Withdrawal post-procedure|3|||
33472828|NCT02100722|62846959|FG000|Overall Study|Lost to Follow-up|2|||
33472829|NCT02100722|62846960|FG001|Overall Study|Lost to Follow-up|2|||
33472830|NCT02100722|62846959|FG000|Overall Study|Continuing on study|751|||
33472831|NCT02100722|62846960|FG001|Overall Study|Continuing on study|729|||
33472832|NCT02028988|62846976|FG000|Overall Study|Withdrawal by Subject|2|||
33472833|NCT02004236|62846983|FG000|Overall Study|Lack of Efficacy|0|||
33472834|NCT02004236|62846984|FG001|Overall Study|Lack of Efficacy|0|||
33472835|NCT02004236|62846985|FG002|Overall Study|Lack of Efficacy|16|||
33472836|NCT01784068|62847012|FG000|NTCS Phase|Adverse Event|5|||
33472837|NCT01784068|62847013|FG001|NTCS Phase|Adverse Event|0|||
33472838|NCT01784068|62847012|FG000|NTCS Phase|Physician Decision|2|||
33472839|NCT01784068|62847013|FG001|NTCS Phase|Physician Decision|0|||
33472840|NCT01784068|62847012|FG000|NTCS Phase|Patient/guardian decision|3|||
33472841|NCT01784068|62847013|FG001|NTCS Phase|Patient/guardian decision|0|||
33472842|NCT01784068|62847012|FG000|NTCS Phase|Death|2|||
33472843|NCT01784068|62847013|FG001|NTCS Phase|Death|0|||
33472844|NCT01784068|62847012|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
33472845|NCT01784068|62847013|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
33472846|NCT01784068|62847012|FG000|TFR Phase|Physician Decision|0|||
33472847|NCT01784068|62847013|FG001|TFR Phase|Physician Decision|1|||
33355483|NCT00654901|62733325|FG002|Overall Study|Lost to Follow-up|1|||
33355484|NCT00654901|62733326|FG003|Overall Study|Lost to Follow-up|0|||
33355485|NCT00654901|62733323|FG000|Overall Study|Withdrawal by Subject|3|||
33355486|NCT00654901|62733324|FG001|Overall Study|Withdrawal by Subject|0|||
33355487|NCT00654901|62733325|FG002|Overall Study|Withdrawal by Subject|1|||
33355488|NCT00654901|62733326|FG003|Overall Study|Withdrawal by Subject|0|||
33355489|NCT00846807|62733336|FG000|Overall Study|Adverse Event|270|||
33472848|NCT01784068|62847012|FG000|TFR Phase|Patient/guardian decision|0|||
33472849|NCT01784068|62847013|FG001|TFR Phase|Patient/guardian decision|3|||
33355490|NCT00846807|62733336|FG000|Overall Study|Lost to Follow-up|94|||
33355491|NCT00846807|62733336|FG000|Overall Study|Withdrawal by Subject|56|||
33472850|NCT01784068|62847012|FG000|TFR Phase|Death|0|||
33472851|NCT01784068|62847013|FG001|TFR Phase|Death|1|||
33472852|NCT01784068|62847012|FG000|TFR Phase|Lack of Efficacy|0|||
33472853|NCT01784068|62847013|FG001|TFR Phase|Lack of Efficacy|88|||
33355492|NCT00846807|62733336|FG000|Overall Study|Non compliant with European label|7|||
33355493|NCT00846807|62733336|FG000|Overall Study|Switch to other anticoagulants|89|||
33355494|NCT00846807|62733336|FG000|Overall Study|No prescription after hospital discharge|56|||
33355495|NCT00846807|62733336|FG000|Overall Study|Other|60|||
33355496|NCT00846495|62733342|FG000|Overall Study|Lost to Follow-up|1|||
33355497|NCT00846495|62733343|FG001|Overall Study|Lost to Follow-up|0|||
33355498|NCT00846495|62733342|FG000|Overall Study|Adverse Event|5|||
33355499|NCT00846495|62733343|FG001|Overall Study|Adverse Event|1|||
33355500|NCT00846495|62733342|FG000|Overall Study|Lack of Efficacy|1|||
33355501|NCT00846495|62733343|FG001|Overall Study|Lack of Efficacy|2|||
33355502|NCT00846495|62733342|FG000|Overall Study|Physician Decision|1|||
33355503|NCT00846495|62733343|FG001|Overall Study|Physician Decision|0|||
33355504|NCT00654745|62733349|FG000|Overall Study|Adverse Event|12|||
33355505|NCT00654745|62733349|FG000|Overall Study|Lost to Follow-up|7|||
33355506|NCT00654745|62733349|FG000|Overall Study|Protocol Violation|11|||
33355507|NCT00654745|62733349|FG000|Overall Study|Withdrawal by Subject|10|||
33355508|NCT00654745|62733349|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
33355509|NCT00846027|62733359|FG000|Overall Study|Death|3|||
33355510|NCT00846027|62733359|FG000|Overall Study|Disease Progression|30|||
33355511|NCT00846027|62733359|FG000|Overall Study|Toxicity|12|||
33355512|NCT00846027|62733359|FG000|Overall Study|Patient Decision|7|||
33355513|NCT00846027|62733359|FG000|Overall Study|Investigator Discretion|29|||
33355514|NCT00846027|62733359|FG000|Overall Study|Protocol Violation|2|||
33355515|NCT00846027|62733359|FG000|Overall Study|Subject Not Treated|7|||
33355516|NCT00646399|62733365|FG000|Overall Study|Death|63|||
33355517|NCT00646399|62733366|FG001|Overall Study|Death|53|||
33355518|NCT00646399|62733365|FG000|Overall Study|Withdrawal by Subject|9|||
33355519|NCT00646399|62733366|FG001|Overall Study|Withdrawal by Subject|10|||
33355520|NCT00646399|62733365|FG000|Overall Study|Other Reason|11|||
33355521|NCT00646399|62733366|FG001|Overall Study|Other Reason|11|||
33355522|NCT00652327|62733374|FG000|Overall Study|Adverse Event|0|||
33355523|NCT00652327|62733375|FG001|Overall Study|Adverse Event|2|||
33355524|NCT00652327|62733374|FG000|Overall Study|Lost to Follow-up|0|||
33355525|NCT00652327|62733375|FG001|Overall Study|Lost to Follow-up|3|||
33355526|NCT00645853|62733383|FG000|Overall Study|Adverse Event|18|||
33355527|NCT00645853|62733384|FG001|Overall Study|Adverse Event|7|||
33472854|NCT01642251|62847027|FG000|Overall Study|Progressive disease|0|||
33472855|NCT01642251|62847028|FG001|Overall Study|Progressive disease|0|||
33472856|NCT01642251|62847029|FG002|Overall Study|Progressive disease|3|||
33472857|NCT01642251|62847030|FG003|Overall Study|Progressive disease|3|||
33472858|NCT01642251|62847027|FG000|Overall Study|Adverse Event|0|||
33472859|NCT01642251|62847028|FG001|Overall Study|Adverse Event|0|||
33472860|NCT01642251|62847029|FG002|Overall Study|Adverse Event|5|||
33355528|NCT00645853|62733383|FG000|Overall Study|AZ study closure in Hungary|60|||
33472861|NCT01642251|62847030|FG003|Overall Study|Adverse Event|4|||
33472862|NCT01642251|62847027|FG000|Overall Study|Death|0|||
33355529|NCT00645853|62733384|FG001|Overall Study|AZ study closure in Hungary|40|||
33355530|NCT00645853|62733383|FG000|Overall Study|Withdrawal by Subject|5|||
33355531|NCT00645853|62733384|FG001|Overall Study|Withdrawal by Subject|2|||
33355532|NCT00645853|62733383|FG000|Overall Study|Protocol Violation|0|||
33472863|NCT01642251|62847028|FG001|Overall Study|Death|0|||
33472864|NCT01642251|62847029|FG002|Overall Study|Death|1|||
33472865|NCT01642251|62847030|FG003|Overall Study|Death|3|||
33472866|NCT01642251|62847027|FG000|Overall Study|Withdrawal by Subject|0|||
33472867|NCT01642251|62847028|FG001|Overall Study|Withdrawal by Subject|0|||
33472868|NCT01642251|62847029|FG002|Overall Study|Withdrawal by Subject|1|||
33472869|NCT01642251|62847030|FG003|Overall Study|Withdrawal by Subject|3|||
33472870|NCT01642251|62847027|FG000|Overall Study|Alternative therapy|0|||
33472871|NCT01642251|62847028|FG001|Overall Study|Alternative therapy|0|||
33472872|NCT01642251|62847029|FG002|Overall Study|Alternative therapy|0|||
33472873|NCT01642251|62847030|FG003|Overall Study|Alternative therapy|2|||
33472874|NCT01642251|62847027|FG000|Overall Study|Other complicating disease|0|||
33472875|NCT01642251|62847028|FG001|Overall Study|Other complicating disease|0|||
33472876|NCT01642251|62847029|FG002|Overall Study|Other complicating disease|1|||
33472877|NCT01642251|62847030|FG003|Overall Study|Other complicating disease|0|||
33472878|NCT01642251|62847027|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
33472879|NCT01642251|62847028|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
33472880|NCT01642251|62847029|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
33472881|NCT01642251|62847030|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
33355533|NCT00645853|62733384|FG001|Overall Study|Protocol Violation|2|||
33355534|NCT00645853|62733383|FG000|Overall Study|Discontinuation criteria|2|||
33355535|NCT00645853|62733384|FG001|Overall Study|Discontinuation criteria|2|||
33355536|NCT00645853|62733383|FG000|Overall Study|recall of ICF, planned operation, death|7|||
33355537|NCT00645853|62733384|FG001|Overall Study|recall of ICF, planned operation, death|4|||
33355538|NCT00652093|62733396|FG000|Overall Study|Withdrawal by Subject|0|||
33355539|NCT00652093|62733397|FG001|Overall Study|Withdrawal by Subject|0|||
33355540|NCT00652093|62733398|FG002|Overall Study|Withdrawal by Subject|1|||
33355541|NCT00652093|62733399|FG003|Overall Study|Withdrawal by Subject|0|||
33355542|NCT00652093|62733400|FG004|Overall Study|Withdrawal by Subject|1|||
33355543|NCT00652093|62733401|FG005|Overall Study|Withdrawal by Subject|0|||
33355544|NCT00652093|62733396|FG000|Overall Study|Physician Decision|0|||
33355545|NCT00652093|62733397|FG001|Overall Study|Physician Decision|0|||
33355546|NCT00652093|62733398|FG002|Overall Study|Physician Decision|0|||
33355547|NCT00652093|62733399|FG003|Overall Study|Physician Decision|0|||
33355548|NCT00652093|62733400|FG004|Overall Study|Physician Decision|1|||
33355549|NCT00652093|62733401|FG005|Overall Study|Physician Decision|0|||
33355550|NCT00651937|62733417|FG000|Overall Study|Withdrawal by Subject|4|||
33355551|NCT00651937|62733418|FG001|Overall Study|Withdrawal by Subject|1|||
33355552|NCT00654355|62733426|FG000|Overall Study|Lost to Follow-up|2|||
33355553|NCT00654355|62733427|FG001|Overall Study|Lost to Follow-up|2|||
33355554|NCT00651313|62733435|FG000|Overall Study|Adverse Event|0|||
33355555|NCT00651313|62733436|FG001|Overall Study|Adverse Event|1|||
33355556|NCT00651313|62733435|FG000|Overall Study|Withdrawal by Subject|3|||
33355557|NCT00651313|62733436|FG001|Overall Study|Withdrawal by Subject|1|||
33355558|NCT00651313|62733435|FG000|Overall Study|Lost to Follow-up|1|||
33355559|NCT00651313|62733436|FG001|Overall Study|Lost to Follow-up|1|||
33355560|NCT00651313|62733435|FG000|Overall Study|Adminstrative Discontinuation|2|||
33355561|NCT00651313|62733436|FG001|Overall Study|Adminstrative Discontinuation|3|||
33355562|NCT00969761|62733454|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
33355563|NCT00969761|62733455|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33355564|NCT00969761|62733456|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33355565|NCT00969761|62733457|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
33355566|NCT00969761|62733458|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33355567|NCT00969761|62733459|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33355568|NCT00969761|62733460|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33355569|NCT00969761|62733461|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33355570|NCT00969761|62733462|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
33355571|NCT00969761|62733463|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
33355572|NCT00969761|62733464|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33355573|NCT00969761|62733465|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33355574|NCT00969761|62733454|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33355575|NCT00969761|62733455|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33355576|NCT00969761|62733456|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
33355577|NCT00969761|62733457|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33355578|NCT00969761|62733458|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33355579|NCT00969761|62733459|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33355580|NCT00969761|62733460|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33355581|NCT00969761|62733461|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33355582|NCT00969761|62733462|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33355583|NCT00969761|62733463|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33472882|NCT01606137|62847039|FG000|Overall Study|Adverse Event|85|||
33472883|NCT01606137|62847039|FG000|Overall Study|Withdrawal by Subject|74|||
33472884|NCT01606137|62847039|FG000|Overall Study|Lack of Efficacy|56|||
33472885|NCT01606137|62847039|FG000|Overall Study|Lost to Follow-up|15|||
33472886|NCT01606137|62847039|FG000|Overall Study|Protocol Violation|1|||
33355584|NCT00969761|62733464|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33355585|NCT00969761|62733465|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33355586|NCT00969761|62733454|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33355587|NCT00969761|62733455|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33355588|NCT00969761|62733456|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
33355589|NCT00969761|62733457|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33355590|NCT00969761|62733458|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33355591|NCT00969761|62733459|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33355592|NCT00969761|62733460|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33355593|NCT00969761|62733461|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33355594|NCT00969761|62733462|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33355595|NCT00969761|62733463|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33355596|NCT00969761|62733464|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33355597|NCT00969761|62733465|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33355598|NCT00969761|62733454|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33355599|NCT00969761|62733455|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33355600|NCT00969761|62733456|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33355601|NCT00969761|62733457|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33355602|NCT00969761|62733458|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33355603|NCT00969761|62733459|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33355604|NCT00969761|62733460|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33355605|NCT00969761|62733461|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33355606|NCT00969761|62733462|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
33355607|NCT00969761|62733463|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33355608|NCT00969761|62733464|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33355609|NCT00969761|62733465|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33355610|NCT00969761|62733454|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
33355611|NCT00969761|62733455|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
33355612|NCT00969761|62733456|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
33355613|NCT00969761|62733457|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
33355614|NCT00969761|62733458|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
33355615|NCT00969761|62733459|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
33355616|NCT00969761|62733460|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
33355617|NCT00969761|62733461|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
33355618|NCT00969761|62733462|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
33355619|NCT00969761|62733463|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
33355620|NCT00969761|62733464|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
33355621|NCT00969761|62733465|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
33355622|NCT00969761|62733454|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33355623|NCT00969761|62733455|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33355624|NCT00969761|62733456|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33355625|NCT00969761|62733457|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
33355626|NCT00969761|62733458|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
33355627|NCT00969761|62733459|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33355628|NCT00969761|62733460|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33355629|NCT00969761|62733461|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33355630|NCT00969761|62733462|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
33355631|NCT00969761|62733463|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33355632|NCT00969761|62733464|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33355633|NCT00969761|62733465|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33355634|NCT00845871|62733491|FG000|Assessment Period|Adverse Event|2|||
33355635|NCT00845871|62733491|FG000|Assessment Period|Abnormal laboratory values|1|||
33355636|NCT00845871|62733491|FG000|Assessment Period|Abnormal test procedure results|1|||
33355637|NCT00845871|62733491|FG000|Assessment Period|Patient withdrew consent|3|||
33355638|NCT00915278|62733521|FG000|Overall Study|Death|1|||
33355639|NCT00915278|62733522|FG001|Overall Study|Death|0|||
33355640|NCT00915278|62733523|FG002|Overall Study|Death|0|||
33355641|NCT00915278|62733524|FG003|Overall Study|Death|0|||
33355642|NCT00915278|62733525|FG004|Overall Study|Death|0|||
33355643|NCT00915278|62733526|FG005|Overall Study|Death|0|||
33355644|NCT00915278|62733521|FG000|Overall Study|Lost to Follow-up|0|||
33355645|NCT00915278|62733522|FG001|Overall Study|Lost to Follow-up|1|||
33355646|NCT00915278|62733523|FG002|Overall Study|Lost to Follow-up|0|||
33355647|NCT00915278|62733524|FG003|Overall Study|Lost to Follow-up|0|||
33355648|NCT00915278|62733525|FG004|Overall Study|Lost to Follow-up|0|||
33355649|NCT00915278|62733526|FG005|Overall Study|Lost to Follow-up|0|||
33355650|NCT00915278|62733521|FG000|Overall Study|Withdrawal by Subject|0|||
33355651|NCT00915278|62733522|FG001|Overall Study|Withdrawal by Subject|1|||
33355652|NCT00915278|62733523|FG002|Overall Study|Withdrawal by Subject|0|||
33355653|NCT00915278|62733524|FG003|Overall Study|Withdrawal by Subject|0|||
33355654|NCT00915278|62733525|FG004|Overall Study|Withdrawal by Subject|1|||
33355655|NCT00915278|62733526|FG005|Overall Study|Withdrawal by Subject|4|||
33355656|NCT00915278|62733521|FG000|Overall Study|Adverse Event|4|||
33355657|NCT00915278|62733522|FG001|Overall Study|Adverse Event|1|||
33355658|NCT00915278|62733523|FG002|Overall Study|Adverse Event|0|||
33355659|NCT00915278|62733524|FG003|Overall Study|Adverse Event|0|||
33355660|NCT00915278|62733525|FG004|Overall Study|Adverse Event|0|||
33355661|NCT00915278|62733526|FG005|Overall Study|Adverse Event|0|||
33355662|NCT00915278|62733521|FG000|Overall Study|Progressive disease/clinical progression|0|||
33355663|NCT00915278|62733522|FG001|Overall Study|Progressive disease/clinical progression|0|||
33355664|NCT00915278|62733523|FG002|Overall Study|Progressive disease/clinical progression|0|||
33355665|NCT00915278|62733524|FG003|Overall Study|Progressive disease/clinical progression|3|||
33355666|NCT00915278|62733525|FG004|Overall Study|Progressive disease/clinical progression|1|||
33355667|NCT00915278|62733526|FG005|Overall Study|Progressive disease/clinical progression|2|||
33355668|NCT00915278|62733521|FG000|Overall Study|Infusion related AEs|0|||
33355669|NCT00915278|62733522|FG001|Overall Study|Infusion related AEs|0|||
33355670|NCT00915278|62733523|FG002|Overall Study|Infusion related AEs|0|||
33355671|NCT00915278|62733524|FG003|Overall Study|Infusion related AEs|0|||
33355672|NCT00915278|62733525|FG004|Overall Study|Infusion related AEs|0|||
33355673|NCT00915278|62733526|FG005|Overall Study|Infusion related AEs|2|||
33355674|NCT00915278|62733521|FG000|Overall Study|Admission to hospice|0|||
33472887|NCT01606137|62847039|FG000|Overall Study|Patient non-compliance|9|||
33472888|NCT01606137|62847039|FG000|Overall Study|Death|1|||
33472889|NCT01606137|62847039|FG000|Overall Study|Decreased/no pain|4|||
33472890|NCT01606137|62847039|FG000|Overall Study|Issues with driving|4|||
33472891|NCT01606137|62847039|FG000|Overall Study|multiple sclerosis less stable|1|||
33472892|NCT01606137|62847039|FG000|Overall Study|Increased bilirubin|1|||
33472893|NCT01606137|62847039|FG000|Overall Study|Spray causes nausea|1|||
33472894|NCT01606137|62847039|FG000|Overall Study|Not enough improvement|4|||
33472895|NCT01606137|62847039|FG000|Overall Study|Wanted to try another treatment|1|||
33472896|NCT01606137|62847039|FG000|Overall Study|Patient leaving country|1|||
33472897|NCT01606137|62847039|FG000|Overall Study|Personal reasons|1|||
33472898|NCT01606137|62847039|FG000|Overall Study|Unable to tolerate study med. taste|1|||
33472899|NCT01606137|62847039|FG000|Overall Study|Patient moving|1|||
33355675|NCT00915278|62733522|FG001|Overall Study|Admission to hospice|0|||
33355676|NCT00915278|62733523|FG002|Overall Study|Admission to hospice|1|||
33355677|NCT00915278|62733524|FG003|Overall Study|Admission to hospice|0|||
33355678|NCT00915278|62733525|FG004|Overall Study|Admission to hospice|0|||
33355679|NCT00915278|62733526|FG005|Overall Study|Admission to hospice|0|||
33355680|NCT00844857|62733542|FG000|Overall Study|Adverse Event|24|||
33355681|NCT00844857|62733543|FG001|Overall Study|Adverse Event|5|||
33355682|NCT00844857|62733542|FG000|Overall Study|Sponsor Decision|1|||
33355683|NCT00844857|62733543|FG001|Overall Study|Sponsor Decision|1|||
33355684|NCT00844857|62733542|FG000|Overall Study|Physician Decision|2|||
33472900|NCT01606137|62847039|FG000|Overall Study|Unable to collect consistent data|1|||
33472901|NCT01532518|62847046|FG000|Overall Study|Withdrawal by Subject|0|||
33355685|NCT00844857|62733543|FG001|Overall Study|Physician Decision|0|||
33472902|NCT01532518|62847047|FG001|Overall Study|Withdrawal by Subject|0|||
33472903|NCT01532518|62847048|FG002|Overall Study|Withdrawal by Subject|1|||
33472904|NCT00844285|62847076|FG000|Overall Study|Other|0|||
33472905|NCT00844285|62847077|FG001|Overall Study|Other|1|||
33472906|NCT00844285|62847078|FG002|Overall Study|Other|0|||
33472907|NCT00844285|62847076|FG000|Overall Study|Other than specified|95|||
33472908|NCT00844285|62847077|FG001|Overall Study|Other than specified|129|||
33355686|NCT00844857|62733542|FG000|Overall Study|Parent/Caregiver Decision|6|||
33355687|NCT00844857|62733543|FG001|Overall Study|Parent/Caregiver Decision|2|||
33355688|NCT00844857|62733542|FG000|Overall Study|Withdrawal by Subject|8|||
33355689|NCT00844857|62733543|FG001|Overall Study|Withdrawal by Subject|7|||
33355690|NCT00844857|62733542|FG000|Overall Study|Protocol Violation|6|||
33472909|NCT00844285|62847078|FG002|Overall Study|Other than specified|12|||
33472910|NCT00844285|62847076|FG000|Overall Study|Site closure|256|||
33472911|NCT00844285|62847077|FG001|Overall Study|Site closure|450|||
33472912|NCT00844285|62847078|FG002|Overall Study|Site closure|50|||
33355691|NCT00844857|62733543|FG001|Overall Study|Protocol Violation|0|||
33355692|NCT00844857|62733542|FG000|Overall Study|Lack of Efficacy|5|||
33355693|NCT00844857|62733543|FG001|Overall Study|Lack of Efficacy|5|||
33472913|NCT00844285|62847076|FG000|Overall Study|Follow-up < 8 years|16|||
33472914|NCT00844285|62847077|FG001|Overall Study|Follow-up < 8 years|23|||
33355694|NCT00844857|62733542|FG000|Overall Study|Clinical Relapse|0|||
33355695|NCT00844857|62733543|FG001|Overall Study|Clinical Relapse|1|||
33355696|NCT00844857|62733542|FG000|Overall Study|Entry Criteria Not Met|0|||
33355697|NCT00844857|62733543|FG001|Overall Study|Entry Criteria Not Met|1|||
33355698|NCT00844857|62733542|FG000|Overall Study|Lost to Follow-up|2|||
33355699|NCT00844857|62733543|FG001|Overall Study|Lost to Follow-up|3|||
33355700|NCT00844857|62733542|FG000|Overall Study|Did Not Take Study Drug|3|||
33355701|NCT00844857|62733543|FG001|Overall Study|Did Not Take Study Drug|1|||
33355702|NCT00844857|62733542|FG000|Overall Study|Good Clinical Practice Violations|21|||
33355703|NCT00844857|62733543|FG001|Overall Study|Good Clinical Practice Violations|11|||
33355704|NCT00569803|62733560|FG000|Overall Study|Lost to Follow-up|1|||
33355705|NCT00569803|62733561|FG001|Overall Study|Lost to Follow-up|0|||
33355706|NCT00569803|62733562|FG002|Overall Study|Lost to Follow-up|0|||
33355707|NCT00569803|62733563|FG003|Overall Study|Lost to Follow-up|0|||
33355708|NCT00569803|62733564|FG004|Overall Study|Lost to Follow-up|0|||
33355709|NCT00569803|62733565|FG005|Overall Study|Lost to Follow-up|0|||
33355710|NCT00569803|62733566|FG006|Overall Study|Lost to Follow-up|0|||
33355711|NCT00569803|62733567|FG007|Overall Study|Lost to Follow-up|0|||
33355712|NCT00569803|62733560|FG000|Overall Study|injection syringe leaked during dosing|0|||
33355713|NCT00569803|62733561|FG001|Overall Study|injection syringe leaked during dosing|0|||
33355714|NCT00569803|62733562|FG002|Overall Study|injection syringe leaked during dosing|0|||
33355715|NCT00569803|62733563|FG003|Overall Study|injection syringe leaked during dosing|1|||
33355716|NCT00569803|62733564|FG004|Overall Study|injection syringe leaked during dosing|0|||
33355717|NCT00569803|62733565|FG005|Overall Study|injection syringe leaked during dosing|0|||
33355718|NCT00569803|62733566|FG006|Overall Study|injection syringe leaked during dosing|0|||
33472915|NCT00844285|62847078|FG002|Overall Study|Follow-up < 8 years|4|||
33472916|NCT00844285|62847076|FG000|Overall Study|Protocol Violation|26|||
33472917|NCT00844285|62847077|FG001|Overall Study|Protocol Violation|28|||
33472918|NCT00844285|62847078|FG002|Overall Study|Protocol Violation|54|||
33472919|NCT00844285|62847076|FG000|Overall Study|Death|22|||
33472920|NCT00844285|62847077|FG001|Overall Study|Death|21|||
33472921|NCT00844285|62847078|FG002|Overall Study|Death|8|||
33472922|NCT00844285|62847076|FG000|Overall Study|Withdrew Consent|344|||
33472923|NCT00844285|62847077|FG001|Overall Study|Withdrew Consent|466|||
33472924|NCT00844285|62847078|FG002|Overall Study|Withdrew Consent|70|||
33472925|NCT00844285|62847076|FG000|Overall Study|Lost to Follow-up|330|||
33472926|NCT00844285|62847077|FG001|Overall Study|Lost to Follow-up|486|||
33472927|NCT00844285|62847078|FG002|Overall Study|Lost to Follow-up|74|||
33472928|NCT00711646|62847106|FG000|Overall Study|Adverse Event|6|||
33355719|NCT00569803|62733567|FG007|Overall Study|injection syringe leaked during dosing|0|||
33472929|NCT00711646|62847107|FG001|Overall Study|Adverse Event|1|||
33472930|NCT00711646|62847106|FG000|Overall Study|Withdrawal by Subject|4|||
33472931|NCT00711646|62847107|FG001|Overall Study|Withdrawal by Subject|0|||
33472932|NCT00711646|62847106|FG000|Overall Study|Protocol Violation|0|||
33472933|NCT00711646|62847107|FG001|Overall Study|Protocol Violation|1|||
33472934|NCT00711646|62847106|FG000|Overall Study|Lost to Follow-up|1|||
33472935|NCT00711646|62847107|FG001|Overall Study|Lost to Follow-up|0|||
33472936|NCT00711646|62847106|FG000|Overall Study|administrative decision|0|||
33472937|NCT00711646|62847107|FG001|Overall Study|administrative decision|1|||
33472938|NCT00711646|62847106|FG000|Overall Study|patient non-compliance|1|||
33472939|NCT00711646|62847107|FG001|Overall Study|patient non-compliance|0|||
33472940|NCT00640133|62847133|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
33472941|NCT00640133|62847134|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
33472942|NCT00640133|62847133|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
33472943|NCT00640133|62847134|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
33472944|NCT00640133|62847133|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
33472945|NCT00640133|62847134|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
33472946|NCT00379340|62847161|FG000|Overall Study|Death|0|||
33472947|NCT00379340|62847162|FG001|Overall Study|Death|0|||
33472948|NCT00379340|62847163|FG002|Overall Study|Death|0|||
33472949|NCT00379340|62847164|FG003|Overall Study|Death|2|||
33472950|NCT00379340|62847165|FG004|Overall Study|Death|0|||
33472951|NCT00379340|62847161|FG000|Overall Study|Lack of Efficacy|6|||
33472952|NCT00379340|62847162|FG001|Overall Study|Lack of Efficacy|1|||
33472953|NCT00379340|62847163|FG002|Overall Study|Lack of Efficacy|0|||
33472954|NCT00379340|62847164|FG003|Overall Study|Lack of Efficacy|4|||
33472955|NCT00379340|62847165|FG004|Overall Study|Lack of Efficacy|3|||
33472956|NCT00379340|62847161|FG000|Overall Study|Physician Decision|6|||
33472957|NCT00379340|62847162|FG001|Overall Study|Physician Decision|2|||
33472958|NCT00379340|62847163|FG002|Overall Study|Physician Decision|1|||
33472959|NCT00379340|62847164|FG003|Overall Study|Physician Decision|2|||
33472960|NCT00379340|62847165|FG004|Overall Study|Physician Decision|3|||
33472961|NCT00379340|62847161|FG000|Overall Study|Withdrawal by Subject|0|||
33472962|NCT00379340|62847162|FG001|Overall Study|Withdrawal by Subject|0|||
33355720|NCT00569803|62733560|FG000|Overall Study|Withdrawal by Subject|0|||
33355721|NCT00569803|62733561|FG001|Overall Study|Withdrawal by Subject|0|||
33355722|NCT00569803|62733562|FG002|Overall Study|Withdrawal by Subject|0|||
33472963|NCT00379340|62847163|FG002|Overall Study|Withdrawal by Subject|0|||
33472964|NCT00379340|62847164|FG003|Overall Study|Withdrawal by Subject|1|||
33472965|NCT00379340|62847165|FG004|Overall Study|Withdrawal by Subject|0|||
33472966|NCT00379340|62847161|FG000|Overall Study|Refusal of further protocol therapy|1|||
33472967|NCT00379340|62847162|FG001|Overall Study|Refusal of further protocol therapy|0|||
33472968|NCT00379340|62847163|FG002|Overall Study|Refusal of further protocol therapy|1|||
33472969|NCT00379340|62847164|FG003|Overall Study|Refusal of further protocol therapy|1|||
33472970|NCT00379340|62847165|FG004|Overall Study|Refusal of further protocol therapy|7|||
33472971|NCT00379340|62847161|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
33472972|NCT00379340|62847162|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
33472973|NCT00379340|62847163|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
33472974|NCT00379340|62847164|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
33472975|NCT00379340|62847165|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
33472976|NCT00379340|62847161|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
33472977|NCT00379340|62847162|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
33472978|NCT00379340|62847163|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
33472979|NCT00379340|62847164|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
33472980|NCT00379340|62847165|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
33472981|NCT00301808|62847178|FG000|Overall Study|Adverse Event|5|||
33472982|NCT00301808|62847178|FG000|Overall Study|Death|3|||
33472983|NCT00301808|62847178|FG000|Overall Study|Lack of Efficacy|4|||
33472984|NCT04979858|62847206|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
33472985|NCT04979858|62847207|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
33549123|NCT02901431|62940305|FG011|Open Label Part|Physician Decision|0|||
33549124|NCT02901431|62940306|FG012|Open Label Part|Physician Decision|0|||
33549125|NCT02901431|62940294|FG000|Open Label Part|Study Terminated By Sponsor|0|||
33549126|NCT02901431|62940295|FG001|Open Label Part|Study Terminated By Sponsor|0|||
33549127|NCT02901431|62940296|FG002|Open Label Part|Study Terminated By Sponsor|0|||
33355723|NCT00569803|62733563|FG003|Overall Study|Withdrawal by Subject|0|||
33355724|NCT00569803|62733564|FG004|Overall Study|Withdrawal by Subject|0|||
33355725|NCT00569803|62733565|FG005|Overall Study|Withdrawal by Subject|0|||
33355726|NCT00569803|62733566|FG006|Overall Study|Withdrawal by Subject|0|||
33355727|NCT00569803|62733567|FG007|Overall Study|Withdrawal by Subject|1|||
33355728|NCT00920426|62733592|FG000|ITZ111451|Adverse Event|1|||
33355729|NCT00920426|62733593|FG001|ITZ111451|Adverse Event|0|||
33355730|NCT00920426|62733594|FG002|ITZ111451|Adverse Event|0|||
33355731|NCT00920426|62733595|FG003|ITZ111451|Adverse Event|0|||
33355732|NCT00644995|62733609|FG000|Overall Study|Lost to Follow-up|1|||
33355733|NCT00644995|62733610|FG001|Overall Study|Lost to Follow-up|4|||
33355734|NCT00644995|62733609|FG000|Overall Study|Refused|1|||
33355735|NCT00644995|62733610|FG001|Overall Study|Refused|0|||
33355736|NCT00914966|62733618|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
33355737|NCT00914966|62733618|FG000|Step 1: 1500 Units|Physician Decision|1|||
33355738|NCT00914966|62733618|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
33355739|NCT00914810|62733629|FG000|Overall Study|Withdrawal by Subject|1|||
33355740|NCT00914810|62733630|FG001|Overall Study|Withdrawal by Subject|0|||
33355741|NCT00914810|62733629|FG000|Overall Study|Relocated out of state|1|||
33355742|NCT00914810|62733630|FG001|Overall Study|Relocated out of state|0|||
33355743|NCT00914810|62733629|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
33355744|NCT00914810|62733630|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
33355745|NCT00644917|62733636|FG000|Overall Study|Withdrawal by Subject|2|||
33355746|NCT00914732|62733647|FG000|Overall Study|Lost to Follow-up|6|||
33355747|NCT00914732|62733648|FG001|Overall Study|Lost to Follow-up|7|||
33355748|NCT00914732|62733649|FG002|Overall Study|Lost to Follow-up|9|||
33355749|NCT00914732|62733647|FG000|Overall Study|Withdrawal by Subject|3|||
33355750|NCT00914732|62733648|FG001|Overall Study|Withdrawal by Subject|0|||
33355751|NCT00914732|62733649|FG002|Overall Study|Withdrawal by Subject|2|||
33355752|NCT00914732|62733647|FG000|Overall Study|Adverse Event|1|||
33355753|NCT00914732|62733648|FG001|Overall Study|Adverse Event|0|||
33472986|NCT04030598|62847255|FG000|Overall Study|Voluntary Withdrawal|0|||
33549128|NCT02901431|62940297|FG003|Open Label Part|Study Terminated By Sponsor|0|||
33355754|NCT00914732|62733649|FG002|Overall Study|Adverse Event|0|||
33355755|NCT00844545|62733658|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
33549129|NCT02901431|62940298|FG004|Open Label Part|Study Terminated By Sponsor|0|||
33549130|NCT02901431|62940299|FG005|Open Label Part|Study Terminated By Sponsor|0|||
33355756|NCT00844545|62733658|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
33355757|NCT00844545|62733658|FG000|Extension Treatment Period|Adverse Event|2|||
33355758|NCT00844545|62733658|FG000|Post Treatment Period|Withdrawal by Subject|1|||
33355759|NCT00651157|62733663|FG000|Overall Study|Death|1|||
33355760|NCT00651157|62733663|FG000|Overall Study|Protocol Violation|1|||
33355761|NCT00843843|62733669|FG000|Overall Study|Physician Decision|1|||
33355762|NCT00843843|62733670|FG001|Overall Study|Physician Decision|1|||
33355763|NCT00843843|62733669|FG000|Overall Study|Protocol Violation|1|||
33355764|NCT00843843|62733670|FG001|Overall Study|Protocol Violation|1|||
33355765|NCT00650845|62733678|FG000|Overall Study|Withdrawal by Subject|5|||
33355766|NCT00650845|62733679|FG001|Overall Study|Withdrawal by Subject|0|||
33355767|NCT00650845|62733678|FG000|Overall Study|Protocol Violation|0|||
33355768|NCT00650845|62733679|FG001|Overall Study|Protocol Violation|13|||
33472987|NCT04030598|62847256|FG001|Overall Study|Voluntary Withdrawal|1|||
33472988|NCT04030598|62847257|FG002|Overall Study|Voluntary Withdrawal|0|||
33472989|NCT03830164|62847277|FG000|Overall Study|Adverse Event|0|||
33472990|NCT03830164|62847278|FG001|Overall Study|Adverse Event|2|||
33472991|NCT03830164|62847279|FG002|Overall Study|Adverse Event|0|||
33472992|NCT03830164|62847277|FG000|Overall Study|Lack of Efficacy|1|||
33472993|NCT03830164|62847278|FG001|Overall Study|Lack of Efficacy|5|||
33472994|NCT03830164|62847279|FG002|Overall Study|Lack of Efficacy|0|||
33472995|NCT03830164|62847277|FG000|Overall Study|Lost to Follow-up|0|||
33472996|NCT03830164|62847278|FG001|Overall Study|Lost to Follow-up|1|||
33472997|NCT03830164|62847279|FG002|Overall Study|Lost to Follow-up|0|||
33472998|NCT03830164|62847277|FG000|Overall Study|Withdrawal by Subject|1|||
33472999|NCT03830164|62847278|FG001|Overall Study|Withdrawal by Subject|0|||
33473000|NCT03830164|62847279|FG002|Overall Study|Withdrawal by Subject|0|||
33473001|NCT03777436|62847289|FG000|Placebo-controlled Phase|Adverse Event|8|||
33473002|NCT03777436|62847290|FG001|Placebo-controlled Phase|Adverse Event|10|||
33473003|NCT03777436|62847291|FG002|Placebo-controlled Phase|Adverse Event|0|||
33473004|NCT03777436|62847289|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
33473005|NCT03777436|62847290|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
33473006|NCT03777436|62847291|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
33473007|NCT03777436|62847289|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
33473008|NCT03777436|62847290|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
33473009|NCT03777436|62847291|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
33473010|NCT03777436|62847289|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
33473011|NCT03777436|62847290|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
33473012|NCT03777436|62847291|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
33473013|NCT03777436|62847289|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
33473014|NCT03777436|62847290|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
33473015|NCT03777436|62847291|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
33473016|NCT03777436|62847289|FG000|Placebo-controlled Phase|Physician Decision|0|||
33473017|NCT03777436|62847290|FG001|Placebo-controlled Phase|Physician Decision|1|||
33473018|NCT03777436|62847291|FG002|Placebo-controlled Phase|Physician Decision|0|||
33473019|NCT03777436|62847289|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
33473020|NCT03777436|62847290|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
33473021|NCT03777436|62847291|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
33473022|NCT03777436|62847289|FG000|Apremilast Extension Phase|Adverse Event|0|||
33473023|NCT03777436|62847290|FG001|Apremilast Extension Phase|Adverse Event|0|||
33473024|NCT03777436|62847291|FG002|Apremilast Extension Phase|Adverse Event|6|||
33473025|NCT03777436|62847289|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
33473026|NCT03777436|62847290|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
33473027|NCT03777436|62847291|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
33473028|NCT03777436|62847289|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
33473029|NCT03777436|62847290|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
33473030|NCT03777436|62847291|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
33355769|NCT00842985|62733686|FG000|Screening|Did not meet entrance requirements|27|||
33355770|NCT00842985|62733686|FG000|First Intervention|Withdrawal by Subject|3|||
33355771|NCT00842985|62733686|FG000|First Intervention|Protocol Violation|3|||
33355772|NCT00842985|62733686|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
33355773|NCT00842985|62733686|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
33355774|NCT00842829|62733695|FG000|Dose Titration Period|Adverse Event|11|||
33355775|NCT00842829|62733696|FG001|Dose Titration Period|Adverse Event|10|||
33355776|NCT00842829|62733697|FG002|Dose Titration Period|Adverse Event|0|||
33355777|NCT00842829|62733695|FG000|Dose Titration Period|Lack of Efficacy|4|||
33355778|NCT00842829|62733696|FG001|Dose Titration Period|Lack of Efficacy|1|||
33355779|NCT00842829|62733697|FG002|Dose Titration Period|Lack of Efficacy|0|||
33473031|NCT03777436|62847289|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
33473032|NCT03777436|62847290|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
33473033|NCT03777436|62847291|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
33473034|NCT03777436|62847289|FG000|Apremilast Extension Phase|Miscellaneous|0|||
33473035|NCT03777436|62847290|FG001|Apremilast Extension Phase|Miscellaneous|0|||
33473036|NCT03777436|62847291|FG002|Apremilast Extension Phase|Miscellaneous|1|||
33355780|NCT00842829|62733695|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
33355781|NCT00842829|62733696|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
33355782|NCT00842829|62733697|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
33355783|NCT00842829|62733695|FG000|Dose Titration Period|Withdrawal by Subject|2|||
33355784|NCT00842829|62733696|FG001|Dose Titration Period|Withdrawal by Subject|6|||
33355785|NCT00842829|62733697|FG002|Dose Titration Period|Withdrawal by Subject|0|||
33355786|NCT00842829|62733695|FG000|Dose Titration Period|Other|5|||
33355787|NCT00842829|62733696|FG001|Dose Titration Period|Other|4|||
33355788|NCT00842829|62733697|FG002|Dose Titration Period|Other|0|||
33355789|NCT00842829|62733695|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
33355790|NCT00842829|62733696|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
33355791|NCT00842829|62733697|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
33355792|NCT00842829|62733695|FG000|Dose Titration Period|Non-compliance to study drug|2|||
33355793|NCT00842829|62733696|FG001|Dose Titration Period|Non-compliance to study drug|1|||
33355794|NCT00842829|62733697|FG002|Dose Titration Period|Non-compliance to study drug|0|||
33355795|NCT00842829|62733695|FG000|Treatment Period|Adverse Event|0|||
33355796|NCT00842829|62733696|FG001|Treatment Period|Adverse Event|0|||
33355797|NCT00842829|62733697|FG002|Treatment Period|Adverse Event|15|||
33355798|NCT00842829|62733695|FG000|Treatment Period|Lack of Efficacy|0|||
33355799|NCT00842829|62733696|FG001|Treatment Period|Lack of Efficacy|0|||
33355800|NCT00842829|62733697|FG002|Treatment Period|Lack of Efficacy|6|||
33355801|NCT00842829|62733695|FG000|Treatment Period|Unstable persistent cancer pain|0|||
33355802|NCT00842829|62733696|FG001|Treatment Period|Unstable persistent cancer pain|0|||
33355803|NCT00842829|62733697|FG002|Treatment Period|Unstable persistent cancer pain|5|||
33355804|NCT00842829|62733695|FG000|Treatment Period|Withdrawal by Subject|0|||
33355805|NCT00842829|62733696|FG001|Treatment Period|Withdrawal by Subject|0|||
33355806|NCT00842829|62733697|FG002|Treatment Period|Withdrawal by Subject|11|||
33355807|NCT00842829|62733695|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
33355808|NCT00842829|62733696|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
33355809|NCT00842829|62733697|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
33355810|NCT00842829|62733695|FG000|Treatment Period|Protocol Violation|0|||
33355811|NCT00842829|62733696|FG001|Treatment Period|Protocol Violation|0|||
33355812|NCT00842829|62733697|FG002|Treatment Period|Protocol Violation|2|||
33473037|NCT03156023|62847307|FG000|Overall Study|Withdrawal by Subject|1|||
33473038|NCT03156023|62847308|FG001|Overall Study|Withdrawal by Subject|0|||
33473039|NCT03156023|62847309|FG002|Overall Study|Withdrawal by Subject|2|||
33473040|NCT03156023|62847310|FG003|Overall Study|Withdrawal by Subject|1|||
33473041|NCT03156023|62847311|FG004|Overall Study|Withdrawal by Subject|1|||
33473042|NCT03156023|62847307|FG000|Overall Study|Lost to Follow-up|0|||
33473043|NCT03156023|62847308|FG001|Overall Study|Lost to Follow-up|0|||
33473044|NCT03156023|62847309|FG002|Overall Study|Lost to Follow-up|0|||
33473045|NCT03156023|62847310|FG003|Overall Study|Lost to Follow-up|0|||
33473046|NCT03156023|62847311|FG004|Overall Study|Lost to Follow-up|1|||
33473047|NCT03025880|62847329|FG000|Overall Study|Adverse Event|1|||
33473048|NCT03025880|62847330|FG001|Overall Study|Adverse Event|0|||
33473049|NCT03025880|62847329|FG000|Overall Study|Death|1|||
33473050|NCT03025880|62847330|FG001|Overall Study|Death|1|||
33473051|NCT03025880|62847329|FG000|Overall Study|Withdrawal by Subject|0|||
33473052|NCT03025880|62847330|FG001|Overall Study|Withdrawal by Subject|1|||
33473053|NCT03025880|62847329|FG000|Overall Study|Physician Decision|0|||
33473054|NCT03025880|62847330|FG001|Overall Study|Physician Decision|1|||
33473055|NCT03025880|62847329|FG000|Overall Study|Progressive Disease|12|||
33355813|NCT00842829|62733695|FG000|Treatment Period|Other|0|||
33355814|NCT00842829|62733696|FG001|Treatment Period|Other|0|||
33355815|NCT00842829|62733697|FG002|Treatment Period|Other|18|||
33355816|NCT00842829|62733695|FG000|Treatment Period|Non-compliance to study procedures|0|||
33355817|NCT00842829|62733696|FG001|Treatment Period|Non-compliance to study procedures|0|||
33355818|NCT00842829|62733697|FG002|Treatment Period|Non-compliance to study procedures|4|||
33355819|NCT00842829|62733695|FG000|Treatment Period|Unclear completion status|0|||
33355820|NCT00842829|62733696|FG001|Treatment Period|Unclear completion status|0|||
33355821|NCT00842829|62733697|FG002|Treatment Period|Unclear completion status|1|||
33355822|NCT00842829|62733695|FG000|Continuation Period|Adverse Event|0|||
33355823|NCT00842829|62733696|FG001|Continuation Period|Adverse Event|0|||
33355824|NCT00842829|62733697|FG002|Continuation Period|Adverse Event|32|||
33355825|NCT00842829|62733695|FG000|Continuation Period|Lack of Efficacy|0|||
33355826|NCT00842829|62733696|FG001|Continuation Period|Lack of Efficacy|0|||
33355827|NCT00842829|62733697|FG002|Continuation Period|Lack of Efficacy|6|||
33355828|NCT00842829|62733695|FG000|Continuation Period|Unstable persistent cancer pain|0|||
33473056|NCT03025880|62847330|FG001|Overall Study|Progressive Disease|19|||
33473057|NCT02027376|62847347|FG000|Overall Study|Death|1|||
33473058|NCT02027376|62847348|FG001|Overall Study|Death|0|||
33473059|NCT02027376|62847349|FG002|Overall Study|Death|0|||
33355829|NCT00842829|62733696|FG001|Continuation Period|Unstable persistent cancer pain|0|||
33355830|NCT00842829|62733697|FG002|Continuation Period|Unstable persistent cancer pain|3|||
33355831|NCT00842829|62733695|FG000|Continuation Period|Withdrawal by Subject|0|||
33355832|NCT00842829|62733696|FG001|Continuation Period|Withdrawal by Subject|0|||
33355833|NCT00842829|62733697|FG002|Continuation Period|Withdrawal by Subject|10|||
33355834|NCT00842829|62733695|FG000|Continuation Period|Other|0|||
33355835|NCT00842829|62733696|FG001|Continuation Period|Other|0|||
33355836|NCT00842829|62733697|FG002|Continuation Period|Other|7|||
33355837|NCT00842829|62733695|FG000|Continuation Period|Non-compliance to study procedures|0|||
33355838|NCT00842829|62733696|FG001|Continuation Period|Non-compliance to study procedures|0|||
33355839|NCT00842829|62733697|FG002|Continuation Period|Non-compliance to study procedures|2|||
33355840|NCT00842829|62733695|FG000|Continuation Period|Non-compliance to study drug|0|||
33355841|NCT00842829|62733696|FG001|Continuation Period|Non-compliance to study drug|0|||
33355842|NCT00842829|62733697|FG002|Continuation Period|Non-compliance to study drug|1|||
33355843|NCT00653263|62733709|FG000|Overall Study|Withdrawal by Subject|1|||
33355844|NCT00653263|62733709|FG000|Overall Study|Physician Decision|1|||
33355845|NCT00842361|62733715|FG000|Overall Study|Protocol Violation|1|||
33355846|NCT00842361|62733716|FG001|Overall Study|Protocol Violation|0|||
33355847|NCT00842361|62733715|FG000|Overall Study|Unclassified|0|||
33355848|NCT00842361|62733716|FG001|Overall Study|Unclassified|2|||
33355849|NCT00841035|62733722|FG000|Phase 1 Overall Study|Physician Decision|13|||
33355850|NCT00642811|62733733|FG000|Overall Study|Adverse Event|2|||
33355851|NCT00642811|62733734|FG001|Overall Study|Adverse Event|3|||
33355852|NCT00642811|62733735|FG002|Overall Study|Adverse Event|0|||
33355853|NCT00642811|62733736|FG003|Overall Study|Adverse Event|0|||
33355854|NCT00642811|62733737|FG004|Overall Study|Adverse Event|0|||
33355855|NCT00642811|62733738|FG005|Overall Study|Adverse Event|1|||
33355856|NCT00642811|62733733|FG000|Overall Study|Developement of discontinuation criteria|0|||
33355857|NCT00642811|62733734|FG001|Overall Study|Developement of discontinuation criteria|0|||
33355858|NCT00642811|62733735|FG002|Overall Study|Developement of discontinuation criteria|0|||
33355859|NCT00642811|62733736|FG003|Overall Study|Developement of discontinuation criteria|0|||
33355860|NCT00642811|62733737|FG004|Overall Study|Developement of discontinuation criteria|1|||
33355861|NCT00642811|62733738|FG005|Overall Study|Developement of discontinuation criteria|0|||
33355862|NCT00642811|62733733|FG000|Overall Study|Severe Non-compliance to protocol|1|||
33355863|NCT00642811|62733734|FG001|Overall Study|Severe Non-compliance to protocol|0|||
33355864|NCT00642811|62733735|FG002|Overall Study|Severe Non-compliance to protocol|0|||
33355865|NCT00642811|62733736|FG003|Overall Study|Severe Non-compliance to protocol|0|||
33355866|NCT00642811|62733737|FG004|Overall Study|Severe Non-compliance to protocol|0|||
33355867|NCT00642811|62733738|FG005|Overall Study|Severe Non-compliance to protocol|0|||
33355868|NCT00642811|62733733|FG000|Overall Study|Other|0|||
33355869|NCT00642811|62733734|FG001|Overall Study|Other|1|||
33355870|NCT00642811|62733735|FG002|Overall Study|Other|0|||
33355871|NCT00642811|62733736|FG003|Overall Study|Other|1|||
33355872|NCT00642811|62733737|FG004|Overall Study|Other|0|||
33355873|NCT00642811|62733738|FG005|Overall Study|Other|0|||
33355874|NCT00838929|62733755|FG000|Overall Study|Protocol Violation|0|||
33355875|NCT00838929|62733756|FG001|Overall Study|Protocol Violation|1|||
33355876|NCT00838929|62733757|FG002|Overall Study|Protocol Violation|0|||
33355877|NCT00838929|62733755|FG000|Overall Study|Disease progression|0|||
33355878|NCT00838929|62733756|FG001|Overall Study|Disease progression|2|||
33355879|NCT00838929|62733757|FG002|Overall Study|Disease progression|1|||
33355880|NCT00916058|62733770|FG000|Phase 1|Screen Failure|0|||
33355881|NCT00916058|62733771|FG001|Phase 1|Screen Failure|0|||
33355882|NCT00916058|62733772|FG002|Phase 1|Screen Failure|0|||
33355883|NCT00916058|62733773|FG003|Phase 1|Screen Failure|0|||
33355884|NCT00916058|62733774|FG004|Phase 1|Screen Failure|0|||
33355885|NCT00916058|62733775|FG005|Phase 1|Screen Failure|1|||
33355886|NCT00916058|62733776|FG006|Phase 1|Screen Failure|0|||
33355887|NCT00916058|62733770|FG000|Phase 2|Screen Failure|0|||
33355888|NCT00916058|62733771|FG001|Phase 2|Screen Failure|0|||
33355889|NCT00916058|62733772|FG002|Phase 2|Screen Failure|0|||
33355890|NCT00916058|62733773|FG003|Phase 2|Screen Failure|0|||
33355891|NCT00916058|62733774|FG004|Phase 2|Screen Failure|0|||
33355892|NCT00916058|62733775|FG005|Phase 2|Screen Failure|0|||
33355893|NCT00916058|62733776|FG006|Phase 2|Screen Failure|3|||
33355894|NCT00912782|62733796|FG000|Overall Study|Death|2|||
33355895|NCT00912782|62733797|FG001|Overall Study|Death|1|||
33355896|NCT00912782|62733796|FG000|Overall Study|Lost to Follow-up|0|||
33355897|NCT00912782|62733797|FG001|Overall Study|Lost to Follow-up|1|||
33355898|NCT00912782|62733796|FG000|Overall Study|Did not receive vascular access type|1|||
33355899|NCT00912782|62733797|FG001|Overall Study|Did not receive vascular access type|2|||
33355900|NCT00912782|62733796|FG000|Overall Study|Relocated before study completion|0|||
33355901|NCT00912782|62733797|FG001|Overall Study|Relocated before study completion|1|||
33355902|NCT03444038|62733803|FG000|Overall Study|Adverse Event|12|||
33355903|NCT03444038|62733803|FG000|Overall Study|Withdrawal by Subject|7|||
33355904|NCT03444038|62733803|FG000|Overall Study|Lost to Follow-up|1|||
33355905|NCT03444038|62733803|FG000|Overall Study|Physician Decision|2|||
33355906|NCT03444038|62733803|FG000|Overall Study|Lack of Efficacy|7|||
33355907|NCT00911534|62733809|FG000|Overall Study|Adverse Event|4|||
33355908|NCT00911534|62733810|FG001|Overall Study|Adverse Event|4|||
33355909|NCT00911534|62733809|FG000|Overall Study|Lost to Follow-up|2|||
33355910|NCT00911534|62733810|FG001|Overall Study|Lost to Follow-up|4|||
33355911|NCT00911534|62733809|FG000|Overall Study|Withdrawal by Subject|2|||
33355912|NCT00911534|62733810|FG001|Overall Study|Withdrawal by Subject|1|||
33355913|NCT00911534|62733809|FG000|Overall Study|Lack of Efficacy|4|||
33355914|NCT00911534|62733810|FG001|Overall Study|Lack of Efficacy|1|||
33355915|NCT00911534|62733809|FG000|Overall Study|Withdrawal of consent|1|||
33355916|NCT00911534|62733810|FG001|Overall Study|Withdrawal of consent|4|||
33355917|NCT00911534|62733809|FG000|Overall Study|Other|2|||
33355918|NCT00911534|62733810|FG001|Overall Study|Other|2|||
33355919|NCT00911300|62733818|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
33355920|NCT00911300|62733819|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
33355921|NCT00911300|62733818|FG000|Overall Study|Death|1|||
33355922|NCT00911300|62733819|FG001|Overall Study|Death|0|||
33355923|NCT00911300|62733818|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
33355924|NCT00911300|62733819|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
33355925|NCT00911300|62733818|FG000|Overall Study|Adverse Event|14|||
33355926|NCT00911300|62733819|FG001|Overall Study|Adverse Event|6|||
33355927|NCT00911300|62733818|FG000|Overall Study|Protocol Violation|3|||
33355928|NCT00911300|62733819|FG001|Overall Study|Protocol Violation|2|||
33355929|NCT00911300|62733818|FG000|Overall Study|Consent Withdrawn|4|||
33355930|NCT00911300|62733819|FG001|Overall Study|Consent Withdrawn|12|||
33355931|NCT00911300|62733818|FG000|Overall Study|Coronary Angiography Performed|1|||
33355932|NCT00911300|62733819|FG001|Overall Study|Coronary Angiography Performed|0|||
33355933|NCT00911300|62733818|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
33355934|NCT00911300|62733819|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
33473060|NCT01924533|62847361|FG000|Overall Study|Death|181|||
33473061|NCT01924533|62847362|FG001|Overall Study|Death|200|||
33473062|NCT01924533|62847361|FG000|Overall Study|Lost to Follow-up|0|||
33473063|NCT01924533|62847362|FG001|Overall Study|Lost to Follow-up|1|||
33473064|NCT01924533|62847361|FG000|Overall Study|Withdrawal by Subject|7|||
33473065|NCT01924533|62847362|FG001|Overall Study|Withdrawal by Subject|3|||
33355935|NCT00911300|62733818|FG000|Overall Study|Received Commercial Treatment|1|||
33355936|NCT00911300|62733819|FG001|Overall Study|Received Commercial Treatment|0|||
33355937|NCT00911300|62733818|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
33355938|NCT00911300|62733819|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
33355939|NCT00911300|62733818|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
33355940|NCT00911300|62733819|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
33355941|NCT00911300|62733818|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
33355942|NCT00911300|62733819|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
33355943|NCT00911300|62733818|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
33355944|NCT00911300|62733819|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
33355945|NCT00911300|62733818|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
33355946|NCT00911300|62733819|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
33355947|NCT00911300|62733818|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
33355948|NCT00911300|62733819|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
33355949|NCT00911300|62733818|FG000|Overall Study|International Normalized Ratio Too High|0|||
33355950|NCT00911300|62733819|FG001|Overall Study|International Normalized Ratio Too High|1|||
33355951|NCT00911300|62733818|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
33355952|NCT00911300|62733819|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
33355953|NCT00911300|62733818|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
33355954|NCT00911300|62733819|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
33355955|NCT00911300|62733818|FG000|Overall Study|Physician Decision|0|||
33355956|NCT00911300|62733819|FG001|Overall Study|Physician Decision|1|||
33355957|NCT00911300|62733818|FG000|Overall Study|Treatment Stopped by Mistake|0|||
33473066|NCT01924533|62847361|FG000|Overall Study|Other Eligibility criteria|1|||
33355958|NCT00911300|62733819|FG001|Overall Study|Treatment Stopped by Mistake|1|||
33355959|NCT00911300|62733818|FG000|Overall Study|Randomized; No Study Medication Received|0|||
33355960|NCT00911300|62733819|FG001|Overall Study|Randomized; No Study Medication Received|2|||
33355961|NCT00911144|62733828|FG000|Overall Study|Withdrawal by Subject|16|||
33355962|NCT00911144|62733829|FG001|Overall Study|Withdrawal by Subject|5|||
33355963|NCT00910988|62733839|FG000|Overall Study|Lost to Follow-up|2|||
33473067|NCT01924533|62847362|FG001|Overall Study|Other Eligibility criteria|1|||
33473068|NCT01606436|62847368|FG000|Overall Study|Withdrawal by Subject|0|||
33473069|NCT01606436|62847369|FG001|Overall Study|Withdrawal by Subject|0|||
33355964|NCT00910988|62733840|FG001|Overall Study|Lost to Follow-up|4|||
33355965|NCT00910988|62733841|FG002|Overall Study|Lost to Follow-up|3|||
33355966|NCT00910988|62733842|FG003|Overall Study|Lost to Follow-up|0|||
33355967|NCT00644059|62733871|FG000|Overall Study|Lost to Follow-up|37|||
33355968|NCT00644059|62733872|FG001|Overall Study|Lost to Follow-up|34|||
33355969|NCT00644059|62733873|FG002|Overall Study|Lost to Follow-up|16|||
33355970|NCT00644059|62733871|FG000|Overall Study|Withdrawal by Subject|52|||
33355971|NCT00644059|62733872|FG001|Overall Study|Withdrawal by Subject|60|||
33355972|NCT00644059|62733873|FG002|Overall Study|Withdrawal by Subject|30|||
33355973|NCT00644059|62733871|FG000|Overall Study|Adverse Event|8|||
33355974|NCT00644059|62733872|FG001|Overall Study|Adverse Event|5|||
33355975|NCT00644059|62733873|FG002|Overall Study|Adverse Event|1|||
33355976|NCT00644059|62733871|FG000|Overall Study|Inappropriate Enrollment|1|||
33355977|NCT00644059|62733872|FG001|Overall Study|Inappropriate Enrollment|3|||
33355978|NCT00644059|62733873|FG002|Overall Study|Inappropriate Enrollment|0|||
33355979|NCT00644059|62733871|FG000|Overall Study|Protocol Deviation/violation|20|||
33355980|NCT00644059|62733872|FG001|Overall Study|Protocol Deviation/violation|19|||
33355981|NCT00644059|62733873|FG002|Overall Study|Protocol Deviation/violation|15|||
33355982|NCT00644059|62733871|FG000|Overall Study|Unable to classify|6|||
33355983|NCT00644059|62733872|FG001|Overall Study|Unable to classify|2|||
33355984|NCT00644059|62733873|FG002|Overall Study|Unable to classify|3|||
33355985|NCT00643279|62733924|FG000|Overall Study|Death|13|||
33355986|NCT00643279|62733925|FG001|Overall Study|Death|11|||
33355987|NCT00643279|62733924|FG000|Overall Study|Withdrawal by Subject|3|||
33355988|NCT00643279|62733925|FG001|Overall Study|Withdrawal by Subject|0|||
33355989|NCT00643279|62733924|FG000|Overall Study|Lost to Follow-up|0|||
33355990|NCT00643279|62733925|FG001|Overall Study|Lost to Follow-up|1|||
33355991|NCT00643279|62733924|FG000|Overall Study|Physician Decision|0|||
33355992|NCT00643279|62733925|FG001|Overall Study|Physician Decision|1|||
33355993|NCT00910910|62733935|FG000|Overall Study|Adverse Event|63|||
33355994|NCT00910910|62733936|FG001|Overall Study|Adverse Event|35|||
33355995|NCT00910910|62733935|FG000|Overall Study|PD without histologic change|27|||
33355996|NCT00910910|62733936|FG001|Overall Study|PD without histologic change|23|||
33355997|NCT00910910|62733935|FG000|Overall Study|PD with histologic change|0|||
33355998|NCT00910910|62733936|FG001|Overall Study|PD with histologic change|2|||
33355999|NCT00910910|62733935|FG000|Overall Study|Withdrawal by Subject|7|||
33356000|NCT00910910|62733936|FG001|Overall Study|Withdrawal by Subject|5|||
33356001|NCT00910910|62733935|FG000|Overall Study|Lost to Follow-up|2|||
33356002|NCT00910910|62733936|FG001|Overall Study|Lost to Follow-up|2|||
33356003|NCT00910910|62733935|FG000|Overall Study|Death|9|||
33356004|NCT00910910|62733936|FG001|Overall Study|Death|3|||
33356005|NCT00910910|62733935|FG000|Overall Study|Protocol Violation|2|||
33356006|NCT00910910|62733936|FG001|Overall Study|Protocol Violation|2|||
33356007|NCT00910910|62733935|FG000|Overall Study|Completed 13 cycles of treatment|0|||
33356008|NCT00910910|62733936|FG001|Overall Study|Completed 13 cycles of treatment|118|||
33356009|NCT00910910|62733935|FG000|Overall Study|Other|114|||
33356010|NCT00910910|62733936|FG001|Overall Study|Other|32|||
33356011|NCT00910910|62733935|FG000|Overall Study|Untreated before cycle 1|1|||
33356012|NCT00910910|62733936|FG001|Overall Study|Untreated before cycle 1|2|||
33356013|NCT00911768|62733944|FG000|Overall Study|Protocol Violation|5|||
33356014|NCT00911768|62733945|FG001|Overall Study|Protocol Violation|4|||
33356015|NCT00911768|62733944|FG000|Overall Study|Withdrawal by Subject|1|||
33356016|NCT00911768|62733945|FG001|Overall Study|Withdrawal by Subject|0|||
33356017|NCT00909038|62733951|FG000|Overall Study|Protocol Violation|187|||
33356018|NCT00909038|62733951|FG000|Overall Study|Non-evaluable Subjects|230|||
33356019|NCT00909428|62733958|FG000|Overall Study|Lost to Follow-up|13|||
33356020|NCT00909428|62733959|FG001|Overall Study|Lost to Follow-up|10|||
33356021|NCT00909428|62733960|FG002|Overall Study|Lost to Follow-up|9|||
33356022|NCT00908960|62733970|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
33356023|NCT00908960|62733971|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
33356024|NCT00908960|62733972|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
33356025|NCT00650767|62733990|FG000|Overall Study|Adverse Event|0|||
33356026|NCT00650767|62733991|FG001|Overall Study|Adverse Event|3|||
33356027|NCT00650767|62733992|FG002|Overall Study|Adverse Event|10|||
33356028|NCT00650767|62733993|FG003|Overall Study|Adverse Event|8|||
33356029|NCT00650767|62733990|FG000|Overall Study|Death|1|||
33356030|NCT00650767|62733991|FG001|Overall Study|Death|0|||
33356031|NCT00650767|62733992|FG002|Overall Study|Death|0|||
33356032|NCT00650767|62733993|FG003|Overall Study|Death|0|||
33356033|NCT00650767|62733990|FG000|Overall Study|Withdrawal by Subject|2|||
33356034|NCT00650767|62733991|FG001|Overall Study|Withdrawal by Subject|4|||
33356035|NCT00650767|62733992|FG002|Overall Study|Withdrawal by Subject|3|||
33356036|NCT00650767|62733993|FG003|Overall Study|Withdrawal by Subject|3|||
33356037|NCT00650767|62733990|FG000|Overall Study|Lost to Follow-up|1|||
33356038|NCT00650767|62733991|FG001|Overall Study|Lost to Follow-up|1|||
33356039|NCT00650767|62733992|FG002|Overall Study|Lost to Follow-up|1|||
33356040|NCT00650767|62733993|FG003|Overall Study|Lost to Follow-up|0|||
33356041|NCT00650767|62733990|FG000|Overall Study|Other|1|||
33356042|NCT00650767|62733991|FG001|Overall Study|Other|1|||
33356043|NCT00650767|62733992|FG002|Overall Study|Other|0|||
33356044|NCT00650767|62733993|FG003|Overall Study|Other|0|||
33356045|NCT00973349|62734019|FG000|Overall Study|Adverse Event|0|||
33356046|NCT00973349|62734020|FG001|Overall Study|Adverse Event|0|||
33356047|NCT00973349|62734021|FG002|Overall Study|Adverse Event|0|||
33356048|NCT00973349|62734022|FG003|Overall Study|Adverse Event|0|||
33356049|NCT00973349|62734023|FG004|Overall Study|Adverse Event|1|||
33356050|NCT00973349|62734024|FG005|Overall Study|Adverse Event|0|||
33356051|NCT00973349|62734025|FG006|Overall Study|Adverse Event|0|||
33356052|NCT00973349|62734026|FG007|Overall Study|Adverse Event|0|||
33356053|NCT00973349|62734027|FG008|Overall Study|Adverse Event|1|||
33356054|NCT00973349|62734028|FG009|Overall Study|Adverse Event|0|||
33356055|NCT00973349|62734029|FG010|Overall Study|Adverse Event|0|||
33356056|NCT00973349|62734030|FG011|Overall Study|Adverse Event|0|||
33356057|NCT00973349|62734031|FG012|Overall Study|Adverse Event|0|||
33356058|NCT00973349|62734032|FG013|Overall Study|Adverse Event|0|||
33356059|NCT00973349|62734033|FG014|Overall Study|Adverse Event|1|||
33473070|NCT01606436|62847370|FG002|Overall Study|Withdrawal by Subject|1|||
33473071|NCT01606436|62847371|FG003|Overall Study|Withdrawal by Subject|1|||
33473072|NCT01606436|62847372|FG004|Overall Study|Withdrawal by Subject|1|||
33473073|NCT01606436|62847373|FG005|Overall Study|Withdrawal by Subject|0|||
33473074|NCT01606436|62847368|FG000|Overall Study|Adverse Event|0|||
33473075|NCT01606436|62847369|FG001|Overall Study|Adverse Event|0|||
33473076|NCT01606436|62847370|FG002|Overall Study|Adverse Event|1|||
33473077|NCT01606436|62847371|FG003|Overall Study|Adverse Event|0|||
33473078|NCT01606436|62847372|FG004|Overall Study|Adverse Event|0|||
33473079|NCT01606436|62847373|FG005|Overall Study|Adverse Event|0|||
33655331|NCT01881425|63070063|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
33655332|NCT01881425|63070064|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
33655333|NCT01881425|63070063|FG000|Overall Study|Lost to Follow-up|7|||
33655334|NCT01881425|63070064|FG001|Overall Study|Lost to Follow-up|2|||
33655335|NCT01891721|63070083|FG000|Overall Study|Lost to Follow-up|10|||
33655336|NCT01891721|63070084|FG001|Overall Study|Lost to Follow-up|5|||
33655337|NCT01891721|63070085|FG002|Overall Study|Lost to Follow-up|1|||
33655338|NCT01880957|63070104|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
33655339|NCT01880957|63070105|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
33655340|NCT01880957|63070104|FG000|Overall Study|Lost to Follow-up|11|||
33655341|NCT01880957|63070105|FG001|Overall Study|Lost to Follow-up|0|||
33655342|NCT01880957|63070104|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
33655343|NCT01880957|63070105|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
33655344|NCT04152837|63070120|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
33655345|NCT04152837|63070120|FG000|Maintenance Period|Adverse Event|1|||
33655346|NCT04152837|63070120|FG000|Maintenance Period|Withdrawal by Subject|1|||
33655347|NCT04152837|63070120|FG000|Maintenance Period|Sponsor Termination of Study|2|||
33655348|NCT01879553|63070139|FG000|Overall Study|Withdrawal by Subject|1|||
33655349|NCT01879553|63070140|FG001|Overall Study|Withdrawal by Subject|0|||
33655350|NCT01890785|63070161|FG000|Third Intervention|Withdrawal by Subject|0|||
33655351|NCT01890785|63070162|FG001|Third Intervention|Withdrawal by Subject|1|||
33655352|NCT01890785|63070163|FG002|Third Intervention|Withdrawal by Subject|0|||
33655353|NCT01890785|63070164|FG003|Third Intervention|Withdrawal by Subject|0|||
33655354|NCT01890785|63070165|FG004|Third Intervention|Withdrawal by Subject|0|||
33655355|NCT01890785|63070166|FG005|Third Intervention|Withdrawal by Subject|0|||
33655356|NCT01878383|63070190|FG000|Overall Study|Lost to Follow-up|0|||
33655357|NCT01878383|63070191|FG001|Overall Study|Lost to Follow-up|1499|||
33655358|NCT01878149|63070199|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
33655359|NCT01878149|63070200|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
33655360|NCT01863953|63070222|FG000|Overall Study|Adverse Event|0|||
33655361|NCT01863953|63070223|FG001|Overall Study|Adverse Event|0|||
33655362|NCT01863953|63070224|FG002|Overall Study|Adverse Event|1|||
33356060|NCT00973349|62734034|FG015|Overall Study|Adverse Event|0|||
33356061|NCT00973349|62734019|FG000|Overall Study|Withdrawal by Subject|1|||
33356062|NCT00973349|62734020|FG001|Overall Study|Withdrawal by Subject|2|||
33473080|NCT01606436|62847368|FG000|Overall Study|Sponsor Decision|0|||
33473081|NCT01606436|62847369|FG001|Overall Study|Sponsor Decision|0|||
33356063|NCT00973349|62734021|FG002|Overall Study|Withdrawal by Subject|2|||
33473082|NCT01606436|62847370|FG002|Overall Study|Sponsor Decision|0|||
33473083|NCT01606436|62847371|FG003|Overall Study|Sponsor Decision|1|||
33356064|NCT00973349|62734022|FG003|Overall Study|Withdrawal by Subject|3|||
33473084|NCT01606436|62847372|FG004|Overall Study|Sponsor Decision|0|||
33655363|NCT03049449|63070500|FG000|Overall Study|Did not receive treatment.|0|||
33655364|NCT03049449|63070501|FG001|Overall Study|Did not receive treatment.|0|||
33655365|NCT03049449|63070502|FG002|Overall Study|Did not receive treatment.|0|||
33655366|NCT03049449|63070503|FG003|Overall Study|Did not receive treatment.|0|||
33655367|NCT03049449|63070504|FG004|Overall Study|Did not receive treatment.|0|||
33655368|NCT03049449|63070505|FG005|Overall Study|Did not receive treatment.|0|||
33356065|NCT00973349|62734023|FG004|Overall Study|Withdrawal by Subject|2|||
33356066|NCT00973349|62734024|FG005|Overall Study|Withdrawal by Subject|0|||
33356067|NCT00973349|62734025|FG006|Overall Study|Withdrawal by Subject|2|||
33356068|NCT00973349|62734026|FG007|Overall Study|Withdrawal by Subject|2|||
33356069|NCT00973349|62734027|FG008|Overall Study|Withdrawal by Subject|0|||
33356070|NCT00973349|62734028|FG009|Overall Study|Withdrawal by Subject|2|||
33356071|NCT00973349|62734029|FG010|Overall Study|Withdrawal by Subject|0|||
33356072|NCT00973349|62734030|FG011|Overall Study|Withdrawal by Subject|1|||
33356073|NCT00973349|62734031|FG012|Overall Study|Withdrawal by Subject|0|||
33356074|NCT00973349|62734032|FG013|Overall Study|Withdrawal by Subject|0|||
33356075|NCT00973349|62734033|FG014|Overall Study|Withdrawal by Subject|0|||
33356076|NCT00973349|62734034|FG015|Overall Study|Withdrawal by Subject|0|||
33356077|NCT00973349|62734019|FG000|Overall Study|Lost to Follow-up|3|||
33356078|NCT00973349|62734020|FG001|Overall Study|Lost to Follow-up|1|||
33356079|NCT00973349|62734021|FG002|Overall Study|Lost to Follow-up|2|||
33356080|NCT00973349|62734022|FG003|Overall Study|Lost to Follow-up|2|||
33356081|NCT00973349|62734023|FG004|Overall Study|Lost to Follow-up|1|||
33356082|NCT00973349|62734024|FG005|Overall Study|Lost to Follow-up|3|||
33356083|NCT00973349|62734025|FG006|Overall Study|Lost to Follow-up|0|||
33356084|NCT00973349|62734026|FG007|Overall Study|Lost to Follow-up|1|||
33356085|NCT00973349|62734027|FG008|Overall Study|Lost to Follow-up|2|||
33356086|NCT00973349|62734028|FG009|Overall Study|Lost to Follow-up|1|||
33356087|NCT00973349|62734029|FG010|Overall Study|Lost to Follow-up|0|||
33356088|NCT00973349|62734030|FG011|Overall Study|Lost to Follow-up|1|||
33356089|NCT00973349|62734031|FG012|Overall Study|Lost to Follow-up|0|||
33356090|NCT00973349|62734032|FG013|Overall Study|Lost to Follow-up|0|||
33356091|NCT00973349|62734033|FG014|Overall Study|Lost to Follow-up|0|||
33356092|NCT00973349|62734034|FG015|Overall Study|Lost to Follow-up|1|||
33356093|NCT00973349|62734019|FG000|Overall Study|Inappropriate enrolment|0|||
33356094|NCT00973349|62734020|FG001|Overall Study|Inappropriate enrolment|0|||
33356095|NCT00973349|62734021|FG002|Overall Study|Inappropriate enrolment|1|||
33356096|NCT00973349|62734022|FG003|Overall Study|Inappropriate enrolment|0|||
33356097|NCT00973349|62734023|FG004|Overall Study|Inappropriate enrolment|0|||
33356098|NCT00973349|62734024|FG005|Overall Study|Inappropriate enrolment|0|||
33356099|NCT00973349|62734025|FG006|Overall Study|Inappropriate enrolment|0|||
33356100|NCT00973349|62734026|FG007|Overall Study|Inappropriate enrolment|0|||
33473085|NCT01606436|62847373|FG005|Overall Study|Sponsor Decision|0|||
33473086|NCT00219557|62847384|FG000|Phase 1|Lack of Efficacy|3|||
33356101|NCT00973349|62734027|FG008|Overall Study|Inappropriate enrolment|0|||
33356102|NCT00973349|62734028|FG009|Overall Study|Inappropriate enrolment|2|||
33356103|NCT00973349|62734029|FG010|Overall Study|Inappropriate enrolment|0|||
33356104|NCT00973349|62734030|FG011|Overall Study|Inappropriate enrolment|0|||
33356105|NCT00973349|62734031|FG012|Overall Study|Inappropriate enrolment|1|||
33356106|NCT00973349|62734032|FG013|Overall Study|Inappropriate enrolment|0|||
33356107|NCT00973349|62734033|FG014|Overall Study|Inappropriate enrolment|1|||
33356108|NCT00973349|62734034|FG015|Overall Study|Inappropriate enrolment|1|||
33356109|NCT00973349|62734019|FG000|Overall Study|Protocol Violation|0|||
33356110|NCT00973349|62734020|FG001|Overall Study|Protocol Violation|0|||
33356111|NCT00973349|62734021|FG002|Overall Study|Protocol Violation|0|||
33356112|NCT00973349|62734022|FG003|Overall Study|Protocol Violation|0|||
33356113|NCT00973349|62734023|FG004|Overall Study|Protocol Violation|0|||
33356114|NCT00973349|62734024|FG005|Overall Study|Protocol Violation|0|||
33356115|NCT00973349|62734025|FG006|Overall Study|Protocol Violation|0|||
33356116|NCT00973349|62734026|FG007|Overall Study|Protocol Violation|0|||
33356117|NCT00973349|62734027|FG008|Overall Study|Protocol Violation|1|||
33356118|NCT00973349|62734028|FG009|Overall Study|Protocol Violation|0|||
33356119|NCT00973349|62734029|FG010|Overall Study|Protocol Violation|0|||
33356120|NCT00973349|62734030|FG011|Overall Study|Protocol Violation|0|||
33356121|NCT00973349|62734031|FG012|Overall Study|Protocol Violation|0|||
33473087|NCT00219557|62847385|FG001|Phase 1|Lack of Efficacy|0|||
33473088|NCT00219557|62847386|FG002|Phase 1|Lack of Efficacy|0|||
33356122|NCT00973349|62734032|FG013|Overall Study|Protocol Violation|0|||
33356123|NCT00973349|62734033|FG014|Overall Study|Protocol Violation|0|||
33356124|NCT00973349|62734034|FG015|Overall Study|Protocol Violation|0|||
33356125|NCT00973349|62734019|FG000|Overall Study|Unable to classify|0|||
33356126|NCT00973349|62734020|FG001|Overall Study|Unable to classify|0|||
33356127|NCT00973349|62734021|FG002|Overall Study|Unable to classify|0|||
33356128|NCT00973349|62734022|FG003|Overall Study|Unable to classify|0|||
33356129|NCT00973349|62734023|FG004|Overall Study|Unable to classify|1|||
33356130|NCT00973349|62734024|FG005|Overall Study|Unable to classify|1|||
33356131|NCT00973349|62734025|FG006|Overall Study|Unable to classify|0|||
33356132|NCT00973349|62734026|FG007|Overall Study|Unable to classify|0|||
33356133|NCT00973349|62734027|FG008|Overall Study|Unable to classify|0|||
33356134|NCT00973349|62734028|FG009|Overall Study|Unable to classify|1|||
33356135|NCT00973349|62734029|FG010|Overall Study|Unable to classify|0|||
33356136|NCT00973349|62734030|FG011|Overall Study|Unable to classify|0|||
33356137|NCT00973349|62734031|FG012|Overall Study|Unable to classify|0|||
33356138|NCT00973349|62734032|FG013|Overall Study|Unable to classify|0|||
33473089|NCT00219557|62847384|FG000|Phase 1|Adverse Event|2|||
33473090|NCT00219557|62847385|FG001|Phase 1|Adverse Event|0|||
33473091|NCT00219557|62847386|FG002|Phase 1|Adverse Event|0|||
33473092|NCT00219557|62847384|FG000|Phase 1|Withdrawal by Subject|1|||
33473093|NCT00219557|62847385|FG001|Phase 1|Withdrawal by Subject|0|||
33473094|NCT00219557|62847386|FG002|Phase 1|Withdrawal by Subject|0|||
33473095|NCT00219557|62847384|FG000|Phase 1|Started chemotherapy at other institute|1|||
33356139|NCT00973349|62734033|FG014|Overall Study|Unable to classify|0|||
33356140|NCT00973349|62734034|FG015|Overall Study|Unable to classify|0|||
33356141|NCT00643201|62734062|FG000|Randomized, Completed 6 Months of Study|Death|20|||
33356142|NCT00643201|62734063|FG001|Randomized, Completed 6 Months of Study|Death|26|||
33356143|NCT00643201|62734062|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
33356144|NCT00643201|62734063|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
33356145|NCT00643201|62734062|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
33356146|NCT00643201|62734063|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
33356147|NCT00643201|62734062|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
33356148|NCT00643201|62734063|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
33356149|NCT00643201|62734062|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
33356150|NCT00643201|62734063|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
33356151|NCT00643201|62734062|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
33356152|NCT00643201|62734063|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
33356153|NCT00643201|62734062|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
33356154|NCT00643201|62734063|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
33356155|NCT00643201|62734062|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
33356156|NCT00643201|62734063|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
33356157|NCT00643201|62734062|FG000|Randomized, Completed 6 Months of Study|Other|107|||
33356158|NCT00643201|62734063|FG001|Randomized, Completed 6 Months of Study|Other|107|||
33356159|NCT00643201|62734062|FG000|Completed Study Follow Up|Death|28|||
33356160|NCT00643201|62734063|FG001|Completed Study Follow Up|Death|34|||
33356161|NCT00643201|62734062|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
33356162|NCT00643201|62734063|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
33356163|NCT00643201|62734062|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
33356164|NCT00643201|62734063|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
33356165|NCT00643201|62734062|FG000|Completed Study Follow Up|non-specified|1|||
33356166|NCT00643201|62734063|FG001|Completed Study Follow Up|non-specified|0|||
33356167|NCT00643123|62734073|FG000|Overall Study|Lost to Follow-up|4|||
33356168|NCT00643123|62734074|FG001|Overall Study|Lost to Follow-up|0|||
33356169|NCT00643123|62734073|FG000|Overall Study|Withdrawal by Subject|1|||
33356170|NCT00643123|62734074|FG001|Overall Study|Withdrawal by Subject|1|||
33356171|NCT00968981|62734083|FG000|Overall Study|Adverse Event|2|||
33356172|NCT00968981|62734084|FG001|Overall Study|Adverse Event|0|||
33356173|NCT00968981|62734085|FG002|Overall Study|Adverse Event|0|||
33356174|NCT00968981|62734083|FG000|Overall Study|Disease Progression|14|||
33356175|NCT00968981|62734084|FG001|Overall Study|Disease Progression|16|||
33356176|NCT00968981|62734085|FG002|Overall Study|Disease Progression|13|||
33356177|NCT00968981|62734083|FG000|Overall Study|Lost to Follow-up|0|||
33356178|NCT00968981|62734084|FG001|Overall Study|Lost to Follow-up|0|||
33356179|NCT00968981|62734085|FG002|Overall Study|Lost to Follow-up|1|||
33356180|NCT00968981|62734083|FG000|Overall Study|Physician Decision|5|||
33356181|NCT00968981|62734084|FG001|Overall Study|Physician Decision|3|||
33356182|NCT00968981|62734085|FG002|Overall Study|Physician Decision|5|||
33356183|NCT00968981|62734083|FG000|Overall Study|Withdrawal by Subject|1|||
33356184|NCT00968981|62734084|FG001|Overall Study|Withdrawal by Subject|3|||
33356185|NCT00968981|62734085|FG002|Overall Study|Withdrawal by Subject|3|||
33356186|NCT00641719|62734096|FG000|Overall Study|Lack of Efficacy|1|||
33473096|NCT00219557|62847385|FG001|Phase 1|Started chemotherapy at other institute|0|||
33473097|NCT00219557|62847386|FG002|Phase 1|Started chemotherapy at other institute|0|||
33473098|NCT00219557|62847384|FG000|Phase 2|Lack of Efficacy|0|||
33473099|NCT00219557|62847385|FG001|Phase 2|Lack of Efficacy|21|||
33473100|NCT00219557|62847386|FG002|Phase 2|Lack of Efficacy|15|||
33473101|NCT00219557|62847384|FG000|Phase 2|Adverse Event|0|||
33473102|NCT00219557|62847385|FG001|Phase 2|Adverse Event|22|||
33356187|NCT00641719|62734097|FG001|Overall Study|Lack of Efficacy|2|||
33356188|NCT00641719|62734096|FG000|Overall Study|Adverse Event|24|||
33356189|NCT00641719|62734097|FG001|Overall Study|Adverse Event|29|||
33356190|NCT00641719|62734096|FG000|Overall Study|Withdrawal by Subject|4|||
33356191|NCT00641719|62734097|FG001|Overall Study|Withdrawal by Subject|4|||
33356192|NCT00641719|62734096|FG000|Overall Study|Reason Not Specified|1|||
33356193|NCT00641719|62734097|FG001|Overall Study|Reason Not Specified|2|||
33356194|NCT00648895|62734105|FG000|Overall Study|Lack of Efficacy|0|||
33356195|NCT00648895|62734106|FG001|Overall Study|Lack of Efficacy|1|||
33356196|NCT00975221|62734114|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
33473103|NCT00219557|62847386|FG002|Phase 2|Adverse Event|2|||
33473104|NCT00219557|62847384|FG000|Phase 2|Death|0|||
33473105|NCT00219557|62847385|FG001|Phase 2|Death|8|||
33473106|NCT00219557|62847386|FG002|Phase 2|Death|2|||
33356197|NCT00975221|62734115|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
33356198|NCT00975221|62734114|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
33356199|NCT00975221|62734115|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
33356200|NCT00975221|62734114|FG000|Titration Phase (Weeks 1-12)|Other|0|||
33356201|NCT00975221|62734115|FG001|Titration Phase (Weeks 1-12)|Other|1|||
33356202|NCT00975221|62734114|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
33356203|NCT00975221|62734115|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
33356204|NCT00975221|62734114|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
33356205|NCT00975221|62734115|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
33356206|NCT00975221|62734114|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
33356207|NCT00975221|62734115|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
33356208|NCT00972179|62734130|FG000|Overall Study|Noncompliance|1|||
33356209|NCT00972179|62734131|FG001|Overall Study|Noncompliance|0|||
33356210|NCT00972179|62734132|FG002|Overall Study|Noncompliance|0|||
33356211|NCT00972179|62734133|FG003|Overall Study|Noncompliance|0|||
33356212|NCT00972179|62734134|FG004|Overall Study|Noncompliance|1|||
33356213|NCT00972179|62734135|FG005|Overall Study|Noncompliance|0|||
33356214|NCT00972179|62734136|FG006|Overall Study|Noncompliance|1|||
33356215|NCT00972179|62734130|FG000|Overall Study|Withdrawal by Subject|0|||
33356216|NCT00972179|62734131|FG001|Overall Study|Withdrawal by Subject|3|||
33356217|NCT00972179|62734132|FG002|Overall Study|Withdrawal by Subject|0|||
33356218|NCT00972179|62734133|FG003|Overall Study|Withdrawal by Subject|1|||
33356219|NCT00972179|62734134|FG004|Overall Study|Withdrawal by Subject|0|||
33356220|NCT00972179|62734135|FG005|Overall Study|Withdrawal by Subject|0|||
33356221|NCT00972179|62734136|FG006|Overall Study|Withdrawal by Subject|2|||
33356222|NCT00972179|62734130|FG000|Overall Study|Administrative Decision|0|||
33356223|NCT00972179|62734131|FG001|Overall Study|Administrative Decision|0|||
33356224|NCT00972179|62734132|FG002|Overall Study|Administrative Decision|0|||
33356225|NCT00972179|62734133|FG003|Overall Study|Administrative Decision|0|||
33356226|NCT00972179|62734134|FG004|Overall Study|Administrative Decision|1|||
33356227|NCT00972179|62734135|FG005|Overall Study|Administrative Decision|0|||
33356228|NCT00972179|62734136|FG006|Overall Study|Administrative Decision|0|||
33356229|NCT00972179|62734130|FG000|Overall Study|Lost to Follow-up|0|||
33356230|NCT00972179|62734131|FG001|Overall Study|Lost to Follow-up|0|||
33356231|NCT00972179|62734132|FG002|Overall Study|Lost to Follow-up|1|||
33356232|NCT00972179|62734133|FG003|Overall Study|Lost to Follow-up|0|||
33356233|NCT00972179|62734134|FG004|Overall Study|Lost to Follow-up|0|||
33356234|NCT00972179|62734135|FG005|Overall Study|Lost to Follow-up|3|||
33356235|NCT00972179|62734136|FG006|Overall Study|Lost to Follow-up|1|||
33356236|NCT00906698|62734162|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
33356237|NCT00906698|62734163|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
33356238|NCT00906698|62734164|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
33356239|NCT00906698|62734165|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
33356240|NCT00906698|62734166|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
33356241|NCT00906698|62734167|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
33356242|NCT00906698|62734162|FG000|Overall Study|Adverse Event|0|||
33356243|NCT00906698|62734163|FG001|Overall Study|Adverse Event|0|||
33356244|NCT00906698|62734164|FG002|Overall Study|Adverse Event|2|||
33356245|NCT00906698|62734165|FG003|Overall Study|Adverse Event|0|||
33356246|NCT00906698|62734166|FG004|Overall Study|Adverse Event|4|||
33356247|NCT00906698|62734167|FG005|Overall Study|Adverse Event|1|||
33356248|NCT00906698|62734162|FG000|Overall Study|Disease progression|3|||
33356249|NCT00906698|62734163|FG001|Overall Study|Disease progression|12|||
33356250|NCT00906698|62734164|FG002|Overall Study|Disease progression|4|||
33356251|NCT00906698|62734165|FG003|Overall Study|Disease progression|4|||
33356252|NCT00906698|62734166|FG004|Overall Study|Disease progression|12|||
33356253|NCT00906698|62734167|FG005|Overall Study|Disease progression|4|||
33356254|NCT00906698|62734162|FG000|Overall Study|Withdrawal by Subject|0|||
33356255|NCT00906698|62734163|FG001|Overall Study|Withdrawal by Subject|0|||
33356256|NCT00906698|62734164|FG002|Overall Study|Withdrawal by Subject|0|||
33356257|NCT00906698|62734165|FG003|Overall Study|Withdrawal by Subject|0|||
33356258|NCT00906698|62734166|FG004|Overall Study|Withdrawal by Subject|1|||
33356259|NCT00906698|62734167|FG005|Overall Study|Withdrawal by Subject|0|||
33356260|NCT00906698|62734162|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
33356261|NCT00906698|62734163|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
33356262|NCT00906698|62734164|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
33356263|NCT00906698|62734165|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
33356264|NCT00906698|62734166|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
33356265|NCT00906698|62734167|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
33356266|NCT00972023|62734199|FG000|Overall Study|Withdrawal by Subject|1|||
33356267|NCT00971945|62734205|FG000|Overall Study|Progressive Disease|3|||
33356268|NCT00971945|62734205|FG000|Overall Study|Change in treatment policy|1|||
33356269|NCT00971945|62734205|FG000|Overall Study|Other reasons|2|||
33356270|NCT00971867|62734209|FG000|Overall Study|Adverse Event|4|||
33356271|NCT00971867|62734209|FG000|Overall Study|Participant Withdrew Consent|1|||
33356272|NCT00971867|62734209|FG000|Overall Study|Disease Progression|6|||
33356273|NCT00971321|62734215|FG000|Up to Month 7|Withdrawal by Subject|1|||
33356274|NCT00971321|62734216|FG001|Up to Month 7|Withdrawal by Subject|0|||
33356275|NCT00971321|62734215|FG000|Up to Month 7|Migrated/moved from study area|3|||
33356276|NCT00971321|62734216|FG001|Up to Month 7|Migrated/moved from study area|2|||
33356277|NCT00971321|62734215|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
33356278|NCT00971321|62734216|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
33356279|NCT00971321|62734215|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
33356280|NCT00971321|62734216|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
33356281|NCT00971321|62734215|FG000|Up to Month 11-12|Lost to Follow-up|1|||
33356282|NCT00971321|62734216|FG001|Up to Month 11-12|Lost to Follow-up|0|||
33473107|NCT00219557|62847384|FG000|Phase 2|Other|0|||
33473108|NCT00219557|62847385|FG001|Phase 2|Other|8|||
33473109|NCT00219557|62847386|FG002|Phase 2|Other|6|||
33473110|NCT00219557|62847384|FG000|Phase 2|Withdrawal by Subject|0|||
33473111|NCT00219557|62847385|FG001|Phase 2|Withdrawal by Subject|9|||
33473112|NCT00219557|62847386|FG002|Phase 2|Withdrawal by Subject|5|||
33473113|NCT00219557|62847384|FG000|Phase 2|Treatment not received|0|||
33473114|NCT00219557|62847385|FG001|Phase 2|Treatment not received|1|||
33473115|NCT00219557|62847386|FG002|Phase 2|Treatment not received|3|||
33473116|NCT00251927|62847401|FG000|Overall Study|Adverse Event|3|||
33473117|NCT00251927|62847402|FG001|Overall Study|Adverse Event|15|||
33473118|NCT00251927|62847401|FG000|Overall Study|Lack of Efficacy|22|||
33473119|NCT00251927|62847402|FG001|Overall Study|Lack of Efficacy|16|||
33473120|NCT00251927|62847401|FG000|Overall Study|Lost to Follow-up|22|||
33473121|NCT00251927|62847402|FG001|Overall Study|Lost to Follow-up|8|||
33473122|NCT00251927|62847401|FG000|Overall Study|Protocol Violation|1|||
33473123|NCT00251927|62847402|FG001|Overall Study|Protocol Violation|2|||
33473124|NCT00251927|62847401|FG000|Overall Study|Pregnancy|2|||
33473125|NCT00251927|62847402|FG001|Overall Study|Pregnancy|0|||
33473126|NCT00251927|62847401|FG000|Overall Study|Withdrawal by Subject|40|||
33473127|NCT00251927|62847402|FG001|Overall Study|Withdrawal by Subject|25|||
33356283|NCT00648739|62734222|FG000|Overall Study|Adverse Event|1|||
33356284|NCT00648739|62734223|FG001|Overall Study|Adverse Event|0|||
33356285|NCT00648739|62734224|FG002|Overall Study|Adverse Event|1|||
33356286|NCT00648739|62734225|FG003|Overall Study|Adverse Event|2|||
33356287|NCT00648739|62734226|FG004|Overall Study|Adverse Event|1|||
33356288|NCT00648739|62734227|FG005|Overall Study|Adverse Event|0|||
33356289|NCT00648739|62734228|FG006|Overall Study|Adverse Event|0|||
33356290|NCT00648739|62734222|FG000|Overall Study|Withdrawal by Subject|1|||
33356291|NCT00648739|62734223|FG001|Overall Study|Withdrawal by Subject|0|||
33356292|NCT00648739|62734224|FG002|Overall Study|Withdrawal by Subject|1|||
33356293|NCT00648739|62734225|FG003|Overall Study|Withdrawal by Subject|0|||
33356294|NCT00648739|62734226|FG004|Overall Study|Withdrawal by Subject|0|||
33356295|NCT00648739|62734227|FG005|Overall Study|Withdrawal by Subject|2|||
33356296|NCT00648739|62734228|FG006|Overall Study|Withdrawal by Subject|0|||
33356297|NCT00648739|62734222|FG000|Overall Study|Lack of Efficacy|0|||
33356298|NCT00648739|62734223|FG001|Overall Study|Lack of Efficacy|0|||
33356299|NCT00648739|62734224|FG002|Overall Study|Lack of Efficacy|0|||
33356300|NCT00648739|62734225|FG003|Overall Study|Lack of Efficacy|0|||
33356301|NCT00648739|62734226|FG004|Overall Study|Lack of Efficacy|1|||
33356302|NCT00648739|62734227|FG005|Overall Study|Lack of Efficacy|2|||
33356303|NCT00648739|62734228|FG006|Overall Study|Lack of Efficacy|0|||
33356304|NCT00648739|62734222|FG000|Overall Study|Investigator Considered it Advisable|0|||
33356305|NCT00648739|62734223|FG001|Overall Study|Investigator Considered it Advisable|0|||
33356306|NCT00648739|62734224|FG002|Overall Study|Investigator Considered it Advisable|0|||
33356307|NCT00648739|62734225|FG003|Overall Study|Investigator Considered it Advisable|0|||
33356308|NCT00648739|62734226|FG004|Overall Study|Investigator Considered it Advisable|0|||
33356309|NCT00648739|62734227|FG005|Overall Study|Investigator Considered it Advisable|1|||
33356310|NCT00648739|62734228|FG006|Overall Study|Investigator Considered it Advisable|1|||
33356311|NCT00648739|62734222|FG000|Overall Study|Death|0|||
33356312|NCT00648739|62734223|FG001|Overall Study|Death|1|||
33356313|NCT00648739|62734224|FG002|Overall Study|Death|0|||
33473128|NCT00251927|62847401|FG000|Overall Study|Study-specific discont. achieved|13|||
33473129|NCT00251927|62847402|FG001|Overall Study|Study-specific discont. achieved|2|||
33356314|NCT00648739|62734225|FG003|Overall Study|Death|0|||
33356315|NCT00648739|62734226|FG004|Overall Study|Death|0|||
33549131|NCT02901431|62940300|FG006|Open Label Part|Study Terminated By Sponsor|0|||
33549132|NCT02901431|62940301|FG007|Open Label Part|Study Terminated By Sponsor|0|||
33356316|NCT00648739|62734227|FG005|Overall Study|Death|0|||
33356317|NCT00648739|62734228|FG006|Overall Study|Death|0|||
33473130|NCT00251927|62847401|FG000|Overall Study|Study procedure non-compliance|5|||
33473131|NCT00251927|62847402|FG001|Overall Study|Study procedure non-compliance|6|||
33473132|NCT00165503|62847409|FG000|Overall Study|Death|1|||
33473133|NCT00165503|62847409|FG000|Overall Study|Lost to Follow-up|12|||
33356318|NCT00648739|62734222|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
33356319|NCT00648739|62734223|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
33356320|NCT00648739|62734224|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
33356321|NCT00648739|62734225|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
33356322|NCT00648739|62734226|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
33356323|NCT00648739|62734227|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
33356324|NCT00648739|62734228|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
33356325|NCT00648739|62734222|FG000|Overall Study|Follow-up Visits Not Completed|0|||
33356326|NCT00648739|62734223|FG001|Overall Study|Follow-up Visits Not Completed|1|||
33356327|NCT00648739|62734224|FG002|Overall Study|Follow-up Visits Not Completed|0|||
33356328|NCT00648739|62734225|FG003|Overall Study|Follow-up Visits Not Completed|0|||
33356329|NCT00648739|62734226|FG004|Overall Study|Follow-up Visits Not Completed|0|||
33356330|NCT00648739|62734227|FG005|Overall Study|Follow-up Visits Not Completed|0|||
33356331|NCT00648739|62734228|FG006|Overall Study|Follow-up Visits Not Completed|0|||
33356332|NCT00648037|62734249|FG000|Overall Study|Not Treated|1|||
33356333|NCT00648037|62734249|FG000|Overall Study|Withdrawal by Subject|1|||
33356334|NCT00648037|62734249|FG000|Overall Study|Adverse Event|11|||
33356335|NCT00648037|62734249|FG000|Overall Study|Relapse|2|||
33356336|NCT00648037|62734249|FG000|Overall Study|Other|1|||
33356337|NCT00627523|62734255|FG000|Overall Study|Lack of Efficacy|1|||
33356338|NCT00627523|62734256|FG001|Overall Study|Lack of Efficacy|0|||
33356339|NCT00627523|62734255|FG000|Overall Study|Withdrawal by Subject|0|||
33356340|NCT00627523|62734256|FG001|Overall Study|Withdrawal by Subject|2|||
33356341|NCT00627523|62734255|FG000|Overall Study|Other|1|||
33356342|NCT00627523|62734256|FG001|Overall Study|Other|0|||
33356343|NCT00640393|62734262|FG000|Part 1|Lost to Follow-up|2|||
33356344|NCT00640393|62734263|FG001|Part 1|Lost to Follow-up|0|||
33356345|NCT00640393|62734264|FG002|Part 1|Lost to Follow-up|0|||
33356346|NCT00640393|62734262|FG000|Part 1|Withdrawal by Subject|3|||
33356347|NCT00640393|62734263|FG001|Part 1|Withdrawal by Subject|0|||
33356348|NCT00640393|62734264|FG002|Part 1|Withdrawal by Subject|0|||
33356349|NCT00640393|62734262|FG000|Randomization|Withdrawn per protocol|17|||
33356350|NCT00640393|62734263|FG001|Randomization|Withdrawn per protocol|0|||
33356351|NCT00640393|62734264|FG002|Randomization|Withdrawn per protocol|0|||
33356352|NCT00640393|62734262|FG000|Randomization|Never randomized by site|2|||
33356353|NCT00640393|62734263|FG001|Randomization|Never randomized by site|0|||
33356354|NCT00640393|62734264|FG002|Randomization|Never randomized by site|0|||
33356355|NCT00640393|62734262|FG000|Part 2|Lost to Follow-up|0|||
33356356|NCT00640393|62734263|FG001|Part 2|Lost to Follow-up|2|||
33356357|NCT00640393|62734264|FG002|Part 2|Lost to Follow-up|2|||
33356358|NCT00640393|62734262|FG000|Part 2|Withdrawal by Subject|0|||
33356359|NCT00640393|62734263|FG001|Part 2|Withdrawal by Subject|6|||
33356360|NCT00640393|62734264|FG002|Part 2|Withdrawal by Subject|1|||
33356361|NCT00640393|62734262|FG000|Part 2|Non-adherence|0|||
33356362|NCT00640393|62734263|FG001|Part 2|Non-adherence|1|||
33356363|NCT00640393|62734264|FG002|Part 2|Non-adherence|0|||
33356364|NCT00640393|62734262|FG000|Part 2|Adverse Event|0|||
33356365|NCT00640393|62734263|FG001|Part 2|Adverse Event|1|||
33356366|NCT00640393|62734264|FG002|Part 2|Adverse Event|0|||
33356367|NCT00907478|62734275|FG000|Overall Study|Ineligibility determined|0|||
33473134|NCT00165503|62847409|FG000|Overall Study|Unresectable|3|||
33473135|NCT00162773|62847413|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
33473136|NCT00209339|62847417|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
33473137|NCT00209339|62847417|FG000|At 12 Months Follow-up|Death|1|||
33473138|NCT00209339|62847417|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
33473139|NCT00209339|62847417|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
33473140|NCT00209339|62847417|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
33473141|NCT00209339|62847417|FG000|At 24 Months Follow-up|Death|1|||
33473142|NCT00209339|62847417|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
33473143|NCT00209339|62847417|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
33473144|NCT00209339|62847417|FG000|At 4 Years Follow-up|Death|1|||
33473145|NCT00209339|62847417|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
33356368|NCT00907478|62734276|FG001|Overall Study|Ineligibility determined|0|||
33356369|NCT00907478|62734277|FG002|Overall Study|Ineligibility determined|1|||
33356370|NCT00907478|62734275|FG000|Overall Study|Noncompliance|0|||
33356371|NCT00907478|62734276|FG001|Overall Study|Noncompliance|0|||
33356372|NCT00907478|62734277|FG002|Overall Study|Noncompliance|1|||
33356373|NCT00907478|62734275|FG000|Overall Study|Adverse Event|3|||
33356374|NCT00907478|62734276|FG001|Overall Study|Adverse Event|1|||
33356375|NCT00907478|62734277|FG002|Overall Study|Adverse Event|2|||
33356376|NCT00907478|62734275|FG000|Overall Study|Withdrawal by Subject|8|||
33473146|NCT00209339|62847417|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
33473147|NCT00209339|62847417|FG000|At 5 Years Follow-up|Death|1|||
33356377|NCT00907478|62734276|FG001|Overall Study|Withdrawal by Subject|9|||
33356378|NCT00907478|62734277|FG002|Overall Study|Withdrawal by Subject|6|||
33356379|NCT00907478|62734275|FG000|Overall Study|Requirement for alternative therapy|1|||
33356380|NCT00907478|62734276|FG001|Overall Study|Requirement for alternative therapy|2|||
33356381|NCT00907478|62734277|FG002|Overall Study|Requirement for alternative therapy|3|||
33356382|NCT00907478|62734275|FG000|Overall Study|Physician Decision|2|||
33356383|NCT00907478|62734276|FG001|Overall Study|Physician Decision|0|||
33356384|NCT00907478|62734277|FG002|Overall Study|Physician Decision|3|||
33356385|NCT00907478|62734275|FG000|Overall Study|Death|4|||
33356386|NCT00907478|62734276|FG001|Overall Study|Death|2|||
33356387|NCT00907478|62734277|FG002|Overall Study|Death|1|||
33356388|NCT00907478|62734275|FG000|Overall Study|Protocol-specified criteria|5|||
33356389|NCT00907478|62734276|FG001|Overall Study|Protocol-specified criteria|2|||
33356390|NCT00907478|62734277|FG002|Overall Study|Protocol-specified criteria|3|||
33356391|NCT00907478|62734275|FG000|Overall Study|Pregnancy|0|||
33356392|NCT00907478|62734276|FG001|Overall Study|Pregnancy|1|||
33356393|NCT00907478|62734277|FG002|Overall Study|Pregnancy|1|||
33356394|NCT00907478|62734275|FG000|Overall Study|Lost to Follow-up|1|||
33356395|NCT00907478|62734276|FG001|Overall Study|Lost to Follow-up|0|||
33356396|NCT00907478|62734277|FG002|Overall Study|Lost to Follow-up|0|||
33356397|NCT00907478|62734275|FG000|Overall Study|Other|3|||
33356398|NCT00907478|62734276|FG001|Overall Study|Other|0|||
33356399|NCT00907478|62734277|FG002|Overall Study|Other|1|||
33356400|NCT00627445|62734289|FG000|Overall Study|Adverse Event|3|||
33356401|NCT00627445|62734290|FG001|Overall Study|Adverse Event|3|||
33356402|NCT00627445|62734289|FG000|Overall Study|Lack of Efficacy|0|||
33356403|NCT00627445|62734290|FG001|Overall Study|Lack of Efficacy|1|||
33356404|NCT00627445|62734289|FG000|Overall Study|Other|6|||
33356405|NCT00627445|62734290|FG001|Overall Study|Other|8|||
33356406|NCT00905840|62734298|FG000|Overall Study|Lost to Follow-up|11|||
33356407|NCT00905840|62734298|FG000|Overall Study|Death|3|||
33356408|NCT00905840|62734298|FG000|Overall Study|Withdrawal by Subject|1|||
33356409|NCT00905840|62734298|FG000|Overall Study|Adverse Event|1|||
33356410|NCT00626821|62734305|FG000|Overall Study|Adverse Event|44|||
33356411|NCT00626821|62734305|FG000|Overall Study|Protocol Violation|33|||
33356412|NCT00626821|62734305|FG000|Overall Study|Withdrawal by Subject|10|||
33356413|NCT00626821|62734305|FG000|Overall Study|Physician Decision|9|||
33356414|NCT00626821|62734305|FG000|Overall Study|Product dysfunction|21|||
33356415|NCT00626821|62734305|FG000|Overall Study|other/unknown reason|104|||
33356416|NCT00625183|62734309|FG000|Overall Study|Disease Progression|1|||
33356417|NCT00904982|62734319|FG000|Overall Study|Withdrawal by Subject|2|||
33356418|NCT00904982|62734320|FG001|Overall Study|Withdrawal by Subject|0|||
33356419|NCT00904982|62734321|FG002|Overall Study|Withdrawal by Subject|0|||
33356420|NCT00904982|62734322|FG003|Overall Study|Withdrawal by Subject|0|||
33356421|NCT00640315|62734334|FG000|Overall Study|Withdrawal by Subject|0|||
33356422|NCT00640315|62734335|FG001|Overall Study|Withdrawal by Subject|1|||
33356423|NCT00904748|62734341|FG000|Overall Study|Withdrawal by Subject|1|||
33356424|NCT00904748|62734342|FG001|Overall Study|Withdrawal by Subject|1|||
33356425|NCT00904748|62734343|FG002|Overall Study|Withdrawal by Subject|1|||
33356426|NCT00904748|62734344|FG003|Overall Study|Withdrawal by Subject|2|||
33356427|NCT00904748|62734345|FG004|Overall Study|Withdrawal by Subject|0|||
33356428|NCT00904748|62734346|FG005|Overall Study|Withdrawal by Subject|0|||
33356429|NCT00904748|62734341|FG000|Overall Study|Adverse Event|0|||
33356430|NCT00904748|62734342|FG001|Overall Study|Adverse Event|0|||
33356431|NCT00904748|62734343|FG002|Overall Study|Adverse Event|0|||
33356432|NCT00904748|62734344|FG003|Overall Study|Adverse Event|0|||
33356433|NCT00904748|62734345|FG004|Overall Study|Adverse Event|1|||
33356434|NCT00904748|62734346|FG005|Overall Study|Adverse Event|0|||
33356435|NCT00574405|62734357|FG000|Overall Study|Withdrawal by Subject|3|||
33356436|NCT00574405|62734358|FG001|Overall Study|Withdrawal by Subject|2|||
33356437|NCT00971243|62734369|FG000|Double Blind Period|Adverse Event|2|||
33356438|NCT00971243|62734370|FG001|Double Blind Period|Adverse Event|3|||
33356439|NCT00971243|62734371|FG002|Double Blind Period|Adverse Event|2|||
33356440|NCT00971243|62734372|FG003|Double Blind Period|Adverse Event|2|||
33473148|NCT03823391|62847423|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
33549133|NCT02901431|62940302|FG008|Open Label Part|Study Terminated By Sponsor|35|||
33356441|NCT00971243|62734373|FG004|Double Blind Period|Adverse Event|3|||
33356442|NCT00971243|62734369|FG000|Double Blind Period|Lost to Follow-up|0|||
33356443|NCT00971243|62734370|FG001|Double Blind Period|Lost to Follow-up|1|||
33356444|NCT00971243|62734371|FG002|Double Blind Period|Lost to Follow-up|1|||
33356445|NCT00971243|62734372|FG003|Double Blind Period|Lost to Follow-up|0|||
33356446|NCT00971243|62734373|FG004|Double Blind Period|Lost to Follow-up|1|||
33356447|NCT00971243|62734369|FG000|Double Blind Period|Physician Decision|10|||
33356448|NCT00971243|62734370|FG001|Double Blind Period|Physician Decision|6|||
33356449|NCT00971243|62734371|FG002|Double Blind Period|Physician Decision|7|||
33356450|NCT00971243|62734372|FG003|Double Blind Period|Physician Decision|6|||
33356451|NCT00971243|62734373|FG004|Double Blind Period|Physician Decision|7|||
33356452|NCT00971243|62734369|FG000|Double Blind Period|Protocol Violation|2|||
33356453|NCT00971243|62734370|FG001|Double Blind Period|Protocol Violation|0|||
33356454|NCT00971243|62734371|FG002|Double Blind Period|Protocol Violation|3|||
33356455|NCT00971243|62734372|FG003|Double Blind Period|Protocol Violation|2|||
33356456|NCT00971243|62734373|FG004|Double Blind Period|Protocol Violation|2|||
33356457|NCT00971243|62734369|FG000|Double Blind Period|Withdrawal by Subject|4|||
33356458|NCT00971243|62734370|FG001|Double Blind Period|Withdrawal by Subject|1|||
33356459|NCT00971243|62734371|FG002|Double Blind Period|Withdrawal by Subject|4|||
33356460|NCT00971243|62734372|FG003|Double Blind Period|Withdrawal by Subject|4|||
33356461|NCT00971243|62734373|FG004|Double Blind Period|Withdrawal by Subject|4|||
33356462|NCT00971243|62734369|FG000|Double Blind Period|Other reasons|1|||
33356463|NCT00971243|62734370|FG001|Double Blind Period|Other reasons|0|||
33356464|NCT00971243|62734371|FG002|Double Blind Period|Other reasons|2|||
33473149|NCT03823391|62847424|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
33473150|NCT03823391|62847423|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
33473151|NCT03823391|62847424|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
33473152|NCT00209027|62847434|FG000|Overall Study|study terminated|10|||
33473153|NCT00209027|62847435|FG001|Overall Study|study terminated|0|||
33473154|NCT00208325|62847445|FG000|Overall Study|Death|18|||
33473155|NCT00208325|62847446|FG001|Overall Study|Death|19|||
33473156|NCT00208325|62847447|FG002|Overall Study|Death|7|||
33473157|NCT00208325|62847448|FG003|Overall Study|Death|5|||
33473158|NCT00208325|62847445|FG000|Overall Study|Withdrawal by Subject|0|||
33473159|NCT00208325|62847446|FG001|Overall Study|Withdrawal by Subject|1|||
33473160|NCT00208325|62847447|FG002|Overall Study|Withdrawal by Subject|0|||
33473161|NCT00208325|62847448|FG003|Overall Study|Withdrawal by Subject|0|||
33473162|NCT00208325|62847445|FG000|Overall Study|Revision|4|||
33473163|NCT00208325|62847446|FG001|Overall Study|Revision|1|||
33473164|NCT00208325|62847447|FG002|Overall Study|Revision|0|||
33356465|NCT00971243|62734372|FG003|Double Blind Period|Other reasons|0|||
33356466|NCT00971243|62734373|FG004|Double Blind Period|Other reasons|1|||
33356467|NCT00971243|62734369|FG000|Open-label Period|Adverse Event|1|||
33356468|NCT00971243|62734370|FG001|Open-label Period|Adverse Event|0|||
33356469|NCT00971243|62734371|FG002|Open-label Period|Adverse Event|1|||
33356470|NCT00971243|62734372|FG003|Open-label Period|Adverse Event|1|||
33356471|NCT00971243|62734373|FG004|Open-label Period|Adverse Event|0|||
33356472|NCT00971243|62734369|FG000|Open-label Period|Physician Decision|5|||
33356473|NCT00971243|62734370|FG001|Open-label Period|Physician Decision|9|||
33356474|NCT00971243|62734371|FG002|Open-label Period|Physician Decision|3|||
33356475|NCT00971243|62734372|FG003|Open-label Period|Physician Decision|7|||
33356476|NCT00971243|62734373|FG004|Open-label Period|Physician Decision|2|||
33356477|NCT00971243|62734369|FG000|Open-label Period|Protocol Violation|1|||
33356478|NCT00971243|62734370|FG001|Open-label Period|Protocol Violation|1|||
33356479|NCT00971243|62734371|FG002|Open-label Period|Protocol Violation|1|||
33356480|NCT00971243|62734372|FG003|Open-label Period|Protocol Violation|0|||
33356481|NCT00971243|62734373|FG004|Open-label Period|Protocol Violation|1|||
33356482|NCT00971243|62734369|FG000|Open-label Period|Withdrawal by Subject|1|||
33356483|NCT00971243|62734370|FG001|Open-label Period|Withdrawal by Subject|0|||
33356484|NCT00971243|62734371|FG002|Open-label Period|Withdrawal by Subject|0|||
33356485|NCT00971243|62734372|FG003|Open-label Period|Withdrawal by Subject|2|||
33356486|NCT00971243|62734373|FG004|Open-label Period|Withdrawal by Subject|1|||
33356487|NCT00971243|62734369|FG000|Open-label Period|Other reason|0|||
33356488|NCT00971243|62734370|FG001|Open-label Period|Other reason|0|||
33473165|NCT00208325|62847448|FG003|Overall Study|Revision|4|||
33473166|NCT00208325|62847445|FG000|Overall Study|Lost to Follow-up|1|||
33473167|NCT00208325|62847446|FG001|Overall Study|Lost to Follow-up|0|||
33473168|NCT00208325|62847447|FG002|Overall Study|Lost to Follow-up|2|||
33473169|NCT00208325|62847448|FG003|Overall Study|Lost to Follow-up|0|||
33473170|NCT00208325|62847445|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
33473171|NCT00208325|62847446|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
33473172|NCT00208325|62847447|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
33473173|NCT00208325|62847448|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
33473174|NCT00208325|62847445|FG000|Overall Study|Does not wish to Continue in Study|5|||
33356489|NCT00971243|62734371|FG002|Open-label Period|Other reason|0|||
33356490|NCT00971243|62734372|FG003|Open-label Period|Other reason|0|||
33356491|NCT00971243|62734373|FG004|Open-label Period|Other reason|2|||
33356492|NCT00568555|62734387|FG000|Overall Study|Withdrawal by Subject|1|||
33356493|NCT00568555|62734388|FG001|Overall Study|Withdrawal by Subject|1|||
33356494|NCT00904670|62734396|FG000|Open Label Phase|Withdrawal by Subject|2|||
33356495|NCT00904670|62734397|FG001|Open Label Phase|Withdrawal by Subject|0|||
33356496|NCT00904670|62734396|FG000|Open Label Phase|Adverse Event|2|||
33356497|NCT00904670|62734397|FG001|Open Label Phase|Adverse Event|0|||
33356498|NCT00904670|62734396|FG000|Open Label Phase|Lack of Efficacy|1|||
33356499|NCT00904670|62734397|FG001|Open Label Phase|Lack of Efficacy|0|||
33356500|NCT00904670|62734396|FG000|Open Label Phase|Lost to Follow-up|1|||
33356501|NCT00904670|62734397|FG001|Open Label Phase|Lost to Follow-up|0|||
33356502|NCT00638443|62734405|FG000|First Intervention|Adverse Event|2|||
33356503|NCT00638443|62734406|FG001|First Intervention|Adverse Event|1|||
33473175|NCT00208325|62847446|FG001|Overall Study|Does not wish to Continue in Study|8|||
33473176|NCT00208325|62847447|FG002|Overall Study|Does not wish to Continue in Study|3|||
33473177|NCT00208325|62847448|FG003|Overall Study|Does not wish to Continue in Study|2|||
33473178|NCT00208325|62847445|FG000|Overall Study|Other|2|||
33473179|NCT00208325|62847446|FG001|Overall Study|Other|1|||
33356504|NCT00636181|62734417|FG000|Overall Study|Withdrawal by Subject|8|||
33356505|NCT00636181|62734418|FG001|Overall Study|Withdrawal by Subject|6|||
33356506|NCT00636181|62734419|FG002|Overall Study|Withdrawal by Subject|10|||
33356507|NCT00968669|62734431|FG000|Overall Study|Lost to Follow-up|5|||
33356508|NCT00968669|62734432|FG001|Overall Study|Lost to Follow-up|2|||
33356509|NCT00968669|62734433|FG002|Overall Study|Lost to Follow-up|1|||
33356510|NCT00968669|62734434|FG003|Overall Study|Lost to Follow-up|4|||
33356511|NCT00968669|62734431|FG000|Overall Study|Withdrawal by Subject|9|||
33356512|NCT00968669|62734432|FG001|Overall Study|Withdrawal by Subject|7|||
33356513|NCT00968669|62734433|FG002|Overall Study|Withdrawal by Subject|5|||
33356514|NCT00968669|62734434|FG003|Overall Study|Withdrawal by Subject|3|||
33356515|NCT00968669|62734431|FG000|Overall Study|Pregnancy|0|||
33356516|NCT00968669|62734432|FG001|Overall Study|Pregnancy|0|||
33356517|NCT00968669|62734433|FG002|Overall Study|Pregnancy|2|||
33356518|NCT00968669|62734434|FG003|Overall Study|Pregnancy|0|||
33356519|NCT00968669|62734431|FG000|Overall Study|AE|1|||
33356520|NCT00968669|62734432|FG001|Overall Study|AE|0|||
33356521|NCT00968669|62734433|FG002|Overall Study|AE|0|||
33356522|NCT00968669|62734434|FG003|Overall Study|AE|0|||
33356523|NCT00968669|62734431|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
33356524|NCT00968669|62734432|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
33356525|NCT00968669|62734433|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
33356526|NCT00968669|62734434|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
33356527|NCT00968669|62734431|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
33356528|NCT00968669|62734432|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
33356529|NCT00968669|62734433|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
33356530|NCT00968669|62734434|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
33356531|NCT00968669|62734431|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
33356532|NCT00968669|62734432|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
33356533|NCT00968669|62734433|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
33356534|NCT00968669|62734434|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
33356535|NCT00968669|62734431|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
33356536|NCT00968669|62734432|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
33356537|NCT00968669|62734433|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
33356538|NCT00968669|62734434|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
33356539|NCT00968669|62734431|FG000|Overall Study|EARLY WITHDRAWAL|0|||
33356540|NCT00968669|62734432|FG001|Overall Study|EARLY WITHDRAWAL|1|||
33356541|NCT00968669|62734433|FG002|Overall Study|EARLY WITHDRAWAL|0|||
33356542|NCT00968669|62734434|FG003|Overall Study|EARLY WITHDRAWAL|0|||
33356543|NCT00968669|62734431|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
33356544|NCT00968669|62734432|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
33356545|NCT00968669|62734433|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
33356546|NCT00968669|62734434|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
33356547|NCT00968669|62734431|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
33356548|NCT00968669|62734432|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
33356549|NCT00968669|62734433|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
33356550|NCT00968669|62734434|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
33356551|NCT00968669|62734431|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
33356552|NCT00968669|62734432|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
33356553|NCT00968669|62734433|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
33356554|NCT00968669|62734434|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
33356555|NCT00968669|62734431|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
33356556|NCT00968669|62734432|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
33356557|NCT00968669|62734433|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
33356558|NCT00968669|62734434|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
33356559|NCT00968669|62734431|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
33356560|NCT00968669|62734432|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
33356561|NCT00968669|62734433|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
33356562|NCT00968669|62734434|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
33356563|NCT00968669|62734431|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
33356564|NCT00968669|62734432|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
33356565|NCT00968669|62734433|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
33356566|NCT00968669|62734434|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
33356567|NCT00968669|62734431|FG000|Overall Study|SPONSOR DECISION|0|||
33356568|NCT00968669|62734432|FG001|Overall Study|SPONSOR DECISION|1|||
33356569|NCT00968669|62734433|FG002|Overall Study|SPONSOR DECISION|0|||
33356570|NCT00968669|62734434|FG003|Overall Study|SPONSOR DECISION|0|||
33356571|NCT00968669|62734431|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
33549134|NCT02901431|62940303|FG009|Open Label Part|Study Terminated By Sponsor|12|||
33549135|NCT02901431|62940304|FG010|Open Label Part|Study Terminated By Sponsor|21|||
33356572|NCT00968669|62734432|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
33356573|NCT00968669|62734433|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
33356574|NCT00968669|62734434|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
33356575|NCT00968669|62734431|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
33356576|NCT00968669|62734432|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
33356577|NCT00968669|62734433|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
33356578|NCT00968669|62734434|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
33356579|NCT00968669|62734431|FG000|Overall Study|SUBJECT INCARCERATED|0|||
33356580|NCT00968669|62734432|FG001|Overall Study|SUBJECT INCARCERATED|1|||
33356581|NCT00968669|62734433|FG002|Overall Study|SUBJECT INCARCERATED|0|||
33356582|NCT00968669|62734434|FG003|Overall Study|SUBJECT INCARCERATED|0|||
33356583|NCT00968669|62734431|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
33356584|NCT00968669|62734432|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
33356585|NCT00968669|62734433|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
33356586|NCT00968669|62734434|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
33356587|NCT00968669|62734431|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
33356588|NCT00968669|62734432|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
33356589|NCT00968669|62734433|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
33356590|NCT00968669|62734434|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
33356591|NCT00568399|62734444|FG000|Overall Study|Death|2|||
33356592|NCT00568399|62734444|FG000|Overall Study|Adverse Event|5|||
33356593|NCT00568399|62734444|FG000|Overall Study|Withdrawal by Subject|8|||
33356594|NCT00975143|62734450|FG000|Overall Study|Adverse Event|19|||
33356595|NCT00975143|62734451|FG001|Overall Study|Adverse Event|15|||
33356596|NCT00975143|62734450|FG000|Overall Study|Withdrawal by Subject|15|||
33356597|NCT00975143|62734451|FG001|Overall Study|Withdrawal by Subject|15|||
33356598|NCT00975143|62734450|FG000|Overall Study|Lost to Follow-up|20|||
33356599|NCT00975143|62734451|FG001|Overall Study|Lost to Follow-up|16|||
33356600|NCT00975143|62734450|FG000|Overall Study|Non-compliance|5|||
33356601|NCT00975143|62734451|FG001|Overall Study|Non-compliance|8|||
33356602|NCT00975143|62734450|FG000|Overall Study|Physician Decision|1|||
33356603|NCT00975143|62734451|FG001|Overall Study|Physician Decision|2|||
33356604|NCT00975143|62734450|FG000|Overall Study|Details not available|10|||
33356605|NCT00975143|62734451|FG001|Overall Study|Details not available|4|||
33356606|NCT00974675|62734474|FG000|Overall Study|Adverse Event|2|||
33356607|NCT00974675|62734475|FG001|Overall Study|Adverse Event|1|||
33356608|NCT00974675|62734476|FG002|Overall Study|Adverse Event|1|||
33356609|NCT00974675|62734477|FG003|Overall Study|Adverse Event|1|||
33356610|NCT00974675|62734474|FG000|Overall Study|Physician Decision|0|||
33356611|NCT00974675|62734475|FG001|Overall Study|Physician Decision|0|||
33356612|NCT00974675|62734476|FG002|Overall Study|Physician Decision|1|||
33473180|NCT00208325|62847447|FG002|Overall Study|Other|1|||
33473181|NCT00208325|62847448|FG003|Overall Study|Other|0|||
33473182|NCT00208325|62847445|FG000|Overall Study|Mis-Randomized|17|||
33473183|NCT00208325|62847446|FG001|Overall Study|Mis-Randomized|20|||
33473184|NCT00208325|62847447|FG002|Overall Study|Mis-Randomized|0|||
33473185|NCT00208325|62847448|FG003|Overall Study|Mis-Randomized|0|||
33473186|NCT00160667|62847461|FG000|Overall Study|Adverse Event|3|||
33473187|NCT00160667|62847462|FG001|Overall Study|Adverse Event|1|||
33473188|NCT00160667|62847463|FG002|Overall Study|Adverse Event|4|||
33473189|NCT00160667|62847461|FG000|Overall Study|Withdrawal by Subject|2|||
33473190|NCT00160667|62847462|FG001|Overall Study|Withdrawal by Subject|0|||
33473191|NCT00160667|62847463|FG002|Overall Study|Withdrawal by Subject|1|||
33473192|NCT00160667|62847461|FG000|Overall Study|Lack of Efficacy|0|||
33473193|NCT00160667|62847462|FG001|Overall Study|Lack of Efficacy|1|||
33473194|NCT00160667|62847463|FG002|Overall Study|Lack of Efficacy|0|||
33473195|NCT00160667|62847461|FG000|Overall Study|Protocol Violation|0|||
33473196|NCT00160667|62847462|FG001|Overall Study|Protocol Violation|1|||
33473197|NCT00160667|62847463|FG002|Overall Study|Protocol Violation|0|||
33473198|NCT00160667|62847461|FG000|Overall Study|Patient decision|0|||
33473199|NCT00160667|62847462|FG001|Overall Study|Patient decision|0|||
33473200|NCT00160667|62847463|FG002|Overall Study|Patient decision|1|||
33473201|NCT00206375|62847475|FG000|Overall Study|Lost to Follow-up|1|||
33473202|NCT00206375|62847476|FG001|Overall Study|Lost to Follow-up|0|||
33473203|NCT00206375|62847477|FG002|Overall Study|Lost to Follow-up|0|||
33473204|NCT00206375|62847475|FG000|Overall Study|Withdrawal by Subject|2|||
33356613|NCT00974675|62734477|FG003|Overall Study|Physician Decision|0|||
33356614|NCT00974675|62734474|FG000|Overall Study|Participant on holiday; unable to attend|0|||
33473205|NCT00206375|62847476|FG001|Overall Study|Withdrawal by Subject|1|||
33473206|NCT00206375|62847477|FG002|Overall Study|Withdrawal by Subject|3|||
33473207|NCT00206375|62847475|FG000|Overall Study|Study terminated due to lack of funds|0|||
33473208|NCT00206375|62847476|FG001|Overall Study|Study terminated due to lack of funds|1|||
33356615|NCT00974675|62734475|FG001|Overall Study|Participant on holiday; unable to attend|0|||
33356616|NCT00974675|62734476|FG002|Overall Study|Participant on holiday; unable to attend|0|||
33356617|NCT00974675|62734477|FG003|Overall Study|Participant on holiday; unable to attend|1|||
33473209|NCT00206375|62847477|FG002|Overall Study|Study terminated due to lack of funds|1|||
33473210|NCT00160199|62847487|FG000|Overall Study|Adverse Event|5|||
33473211|NCT00160199|62847488|FG001|Overall Study|Adverse Event|14|||
33473212|NCT00160199|62847487|FG000|Overall Study|Lack of Efficacy|0|||
33473213|NCT00160199|62847488|FG001|Overall Study|Lack of Efficacy|1|||
33473214|NCT00160199|62847487|FG000|Overall Study|Lost to Follow-up|7|||
33473215|NCT00160199|62847488|FG001|Overall Study|Lost to Follow-up|7|||
33473216|NCT00160199|62847487|FG000|Overall Study|Withdrawal by Subject|4|||
33473217|NCT00160199|62847488|FG001|Overall Study|Withdrawal by Subject|6|||
33473218|NCT00160199|62847487|FG000|Overall Study|Administrative|0|||
33473219|NCT00160199|62847488|FG001|Overall Study|Administrative|1|||
33473220|NCT00160199|62847487|FG000|Overall Study|Protocol Violation|8|||
33473221|NCT00160199|62847488|FG001|Overall Study|Protocol Violation|8|||
33356618|NCT00634933|62734490|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
33356619|NCT00634933|62734491|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
33356620|NCT00634933|62734492|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
33356621|NCT00634933|62734493|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
33356622|NCT00634933|62734494|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
33356623|NCT00634933|62734490|FG000|Part A: Baseline to Week 24|Death|1|||
33356624|NCT00634933|62734491|FG001|Part A: Baseline to Week 24|Death|0|||
33356625|NCT00634933|62734492|FG002|Part A: Baseline to Week 24|Death|0|||
33356626|NCT00634933|62734493|FG003|Part A: Baseline to Week 24|Death|0|||
33356627|NCT00634933|62734494|FG004|Part A: Baseline to Week 24|Death|0|||
33356628|NCT00634933|62734490|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
33356629|NCT00634933|62734491|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
33356630|NCT00634933|62734492|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
33356631|NCT00634933|62734493|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
33356632|NCT00634933|62734494|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
33356633|NCT00634933|62734490|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
33356634|NCT00634933|62734491|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
33356635|NCT00634933|62734492|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
33356636|NCT00634933|62734493|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
33356637|NCT00634933|62734494|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
33356638|NCT00634933|62734490|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
33356639|NCT00634933|62734491|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
33356640|NCT00634933|62734492|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
33356641|NCT00634933|62734493|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
33356642|NCT00634933|62734494|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
33356643|NCT00634933|62734490|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
33356644|NCT00634933|62734491|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
33356645|NCT00634933|62734492|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
33473222|NCT00157157|62847494|FG000|Overall Study|Withdrawal by Subject|6|||
33473223|NCT00157157|62847494|FG000|Overall Study|Physician Decision|1|||
33473224|NCT00157157|62847494|FG000|Overall Study|Lost to Follow-up|1|||
33473225|NCT00157157|62847494|FG000|Overall Study|Enrolled in another study|1|||
33473226|NCT00157157|62847494|FG000|Overall Study|Met exclusion criteria|1|||
33473227|NCT00157157|62847494|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
33473228|NCT00203411|62847505|FG000|Follow-up|Progressive Disease|4|||
33473229|NCT00203021|62847512|FG000|Overall Study|Death|4|||
33473230|NCT00203021|62847513|FG001|Overall Study|Death|1|||
33473231|NCT00203021|62847512|FG000|Overall Study|Adverse Event|10|||
33473232|NCT00203021|62847513|FG001|Overall Study|Adverse Event|5|||
33473233|NCT00203021|62847512|FG000|Overall Study|Withdrawal by Subject|45|||
33473234|NCT00203021|62847513|FG001|Overall Study|Withdrawal by Subject|48|||
33473235|NCT00203021|62847512|FG000|Overall Study|Lost to Follow-up|9|||
33473236|NCT00203021|62847513|FG001|Overall Study|Lost to Follow-up|7|||
33473237|NCT00203021|62847512|FG000|Overall Study|Other than specified|11|||
33473238|NCT00203021|62847513|FG001|Overall Study|Other than specified|16|||
33473239|NCT00201851|62847522|FG000|Overall Study|Lost to Follow-up|2|||
33473240|NCT00201851|62847523|FG001|Overall Study|Lost to Follow-up|1|||
33473241|NCT00201851|62847524|FG002|Overall Study|Lost to Follow-up|0|||
33473242|NCT00201851|62847522|FG000|Overall Study|Ineligible post enrollment|6|||
33473243|NCT00201851|62847523|FG001|Overall Study|Ineligible post enrollment|1|||
33473244|NCT00201851|62847524|FG002|Overall Study|Ineligible post enrollment|1|||
33473245|NCT00200057|62847532|FG000|Overall Study|Lack of Efficacy|3|||
33473246|NCT00200057|62847532|FG000|Overall Study|Exited due to terminal illness of PI|2|||
33473247|NCT00200057|62847532|FG000|Overall Study|Withdrawal by Subject|1|||
33356646|NCT00634933|62734493|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
33356647|NCT00634933|62734494|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
33356648|NCT00634933|62734490|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
33473248|NCT00200057|62847532|FG000|Overall Study|Change in medical condition|1|||
33473249|NCT00200057|62847532|FG000|Overall Study|Infection|1|||
33473250|NCT00200057|62847532|FG000|Overall Study|Death|1|||
33473251|NCT03129100|62847541|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
33473252|NCT03129100|62847542|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
33473253|NCT03129100|62847543|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
33473254|NCT03129100|62847544|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
33356649|NCT00634933|62734491|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
33356650|NCT00634933|62734492|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
33356651|NCT00634933|62734493|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
33356652|NCT00634933|62734494|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
33356653|NCT00634933|62734490|FG000|Part A: Baseline to Week 24|Other|1|||
33356654|NCT00634933|62734491|FG001|Part A: Baseline to Week 24|Other|8|||
33356655|NCT00634933|62734492|FG002|Part A: Baseline to Week 24|Other|5|||
33356656|NCT00634933|62734493|FG003|Part A: Baseline to Week 24|Other|0|||
33356657|NCT00634933|62734494|FG004|Part A: Baseline to Week 24|Other|0|||
33356658|NCT00634933|62734490|FG000|Between Part A and Part B|Physician Decision|0|||
33356659|NCT00634933|62734491|FG001|Between Part A and Part B|Physician Decision|1|||
33356660|NCT00634933|62734492|FG002|Between Part A and Part B|Physician Decision|0|||
33356661|NCT00634933|62734493|FG003|Between Part A and Part B|Physician Decision|0|||
33356662|NCT00634933|62734494|FG004|Between Part A and Part B|Physician Decision|0|||
33356663|NCT00634933|62734490|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
33356664|NCT00634933|62734491|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
33356665|NCT00634933|62734492|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
33356666|NCT00634933|62734493|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
33356667|NCT00634933|62734494|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
33356668|NCT00634933|62734490|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
33356669|NCT00634933|62734491|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
33356670|NCT00634933|62734492|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
33356671|NCT00634933|62734493|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
33356672|NCT00634933|62734494|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
33356673|NCT00634933|62734490|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
33356674|NCT00634933|62734491|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
33356675|NCT00634933|62734492|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
33356676|NCT00634933|62734493|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
33356677|NCT00634933|62734494|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
33356678|NCT00634933|62734490|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
33356679|NCT00634933|62734491|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
33356680|NCT00634933|62734492|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
33356681|NCT00634933|62734493|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
33356682|NCT00634933|62734494|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
33356683|NCT00634933|62734490|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
33356684|NCT00634933|62734491|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
33356685|NCT00634933|62734492|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
33356686|NCT00634933|62734493|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
33356687|NCT00634933|62734494|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
33356688|NCT00634933|62734490|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
33356689|NCT00634933|62734491|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
33356690|NCT00634933|62734492|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
33356691|NCT00634933|62734493|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
33356692|NCT00634933|62734494|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
33356693|NCT00634933|62734490|FG000|Part B: Week 24 to Week 52|Other|0|||
33356694|NCT00634933|62734491|FG001|Part B: Week 24 to Week 52|Other|0|||
33356695|NCT00634933|62734492|FG002|Part B: Week 24 to Week 52|Other|5|||
33356696|NCT00634933|62734493|FG003|Part B: Week 24 to Week 52|Other|0|||
33356697|NCT00634933|62734494|FG004|Part B: Week 24 to Week 52|Other|1|||
33356698|NCT00967499|62734508|FG000|Overall Study|Adverse Event|0|||
33356699|NCT00967499|62734509|FG001|Overall Study|Adverse Event|1|||
33356700|NCT00967499|62734508|FG000|Overall Study|Protocol Violation|1|||
33356701|NCT00967499|62734509|FG001|Overall Study|Protocol Violation|0|||
33356702|NCT00967499|62734508|FG000|Overall Study|Sponsor Decision|1|||
33356703|NCT00967499|62734509|FG001|Overall Study|Sponsor Decision|0|||
33356704|NCT00967499|62734508|FG000|Overall Study|Randomized but not treated|63|||
33356705|NCT00967499|62734509|FG001|Overall Study|Randomized but not treated|59|||
33356706|NCT03909971|62734517|FG000|Overall Study|Other Reasons Not Specified|0|||
33356707|NCT03909971|62734518|FG001|Overall Study|Other Reasons Not Specified|1|||
33549136|NCT02901431|62940305|FG011|Open Label Part|Study Terminated By Sponsor|31|||
33549137|NCT02901431|62940306|FG012|Open Label Part|Study Terminated By Sponsor|0|||
33549138|NCT02901431|62940294|FG000|Open Label Part|Withdrawal by Subject|0|||
33356708|NCT03909971|62734517|FG000|Overall Study|Global Deterioration of Health Status|2|||
33356709|NCT03909971|62734518|FG001|Overall Study|Global Deterioration of Health Status|1|||
33356710|NCT03909971|62734517|FG000|Overall Study|Progressive Disease|6|||
33356711|NCT03909971|62734518|FG001|Overall Study|Progressive Disease|14|||
33356712|NCT03909971|62734517|FG000|Overall Study|Death|2|||
33473255|NCT03129100|62847545|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
33549139|NCT02901431|62940295|FG001|Open Label Part|Withdrawal by Subject|0|||
33356713|NCT03909971|62734518|FG001|Overall Study|Death|6|||
33473256|NCT03129100|62847546|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
33473257|NCT03129100|62847547|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
33473258|NCT03129100|62847548|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
33473259|NCT03129100|62847549|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
33473260|NCT03129100|62847550|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
33473261|NCT03129100|62847551|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
33473262|NCT03129100|62847552|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
33473263|NCT03129100|62847553|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
33473264|NCT03129100|62847554|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
33473265|NCT03129100|62847555|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
33473266|NCT03129100|62847556|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
33473267|NCT03129100|62847557|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
33473268|NCT03129100|62847558|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
33473269|NCT03129100|62847559|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
33473270|NCT03129100|62847560|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
33473271|NCT03129100|62847561|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
33473272|NCT03129100|62847562|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
33356714|NCT00967343|62734525|FG000|Overall Study|Study termination by sponsor|12|||
33356715|NCT00967343|62734525|FG000|Overall Study|Death|24|||
33356716|NCT00967343|62734525|FG000|Overall Study|Relapse|1|||
33356717|NCT00967343|62734525|FG000|Overall Study|Lost to Follow-up|1|||
33356718|NCT00973973|62734531|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
33356719|NCT00973973|62734532|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
33356720|NCT00973973|62734531|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
33356721|NCT00973973|62734532|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
33356722|NCT00973973|62734531|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
33356723|NCT00973973|62734532|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
33356724|NCT00973973|62734531|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
33356725|NCT00973973|62734532|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
33356726|NCT00973973|62734531|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
33356727|NCT00973973|62734532|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
33356728|NCT00973973|62734531|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
33356729|NCT00973973|62734532|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
33356730|NCT00973973|62734531|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
33356731|NCT00973973|62734532|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
33356732|NCT00973973|62734531|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
33356733|NCT00973973|62734532|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
33356734|NCT00973973|62734531|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
33356735|NCT00973973|62734532|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
33356736|NCT00973973|62734531|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
33356737|NCT00973973|62734532|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
33356738|NCT00973973|62734531|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
33356739|NCT00973973|62734532|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
33356740|NCT00973973|62734531|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
33356741|NCT00973973|62734532|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
33356742|NCT00633139|62734541|FG000|Overall Study|Non compliance|0|||
33356743|NCT00633139|62734542|FG001|Overall Study|Non compliance|0|||
33356744|NCT00633139|62734543|FG002|Overall Study|Non compliance|1|||
33356745|NCT00633139|62734541|FG000|Overall Study|Withdrawal by Subject|0|||
33356746|NCT00633139|62734542|FG001|Overall Study|Withdrawal by Subject|1|||
33356747|NCT00633139|62734543|FG002|Overall Study|Withdrawal by Subject|0|||
33356748|NCT00965081|62734553|FG000|Overall Study|Adverse Event|14|||
33356749|NCT00965081|62734554|FG001|Overall Study|Adverse Event|9|||
33356750|NCT00965081|62734553|FG000|Overall Study|Lack of Efficacy|2|||
33356751|NCT00965081|62734554|FG001|Overall Study|Lack of Efficacy|5|||
33356752|NCT00965081|62734553|FG000|Overall Study|Lost to Follow-up|4|||
33356753|NCT00965081|62734554|FG001|Overall Study|Lost to Follow-up|5|||
33356754|NCT00965081|62734553|FG000|Overall Study|Physician Decision|2|||
33473273|NCT03129100|62847563|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
33473274|NCT03129100|62847564|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
33356755|NCT00965081|62734554|FG001|Overall Study|Physician Decision|0|||
33356756|NCT00965081|62734553|FG000|Overall Study|Protocol Violation|2|||
33356757|NCT00965081|62734554|FG001|Overall Study|Protocol Violation|5|||
33356758|NCT00965081|62734553|FG000|Overall Study|Sponsor Decision|1|||
33356759|NCT00965081|62734554|FG001|Overall Study|Sponsor Decision|0|||
33356760|NCT00965081|62734553|FG000|Overall Study|Withdrawal by Subject|4|||
33356761|NCT00965081|62734554|FG001|Overall Study|Withdrawal by Subject|7|||
33473275|NCT03129100|62847565|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
33473276|NCT03129100|62847566|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
33473277|NCT03129100|62847541|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
33356762|NCT00965081|62734553|FG000|Overall Study|Switched to Rescue Arm|5|||
33356763|NCT00965081|62734554|FG001|Overall Study|Switched to Rescue Arm|12|||
33356764|NCT00961649|62734565|FG000|Overall Study|Adverse Event|4|||
33356765|NCT00961649|62734566|FG001|Overall Study|Adverse Event|0|||
33356766|NCT00961649|62734567|FG002|Overall Study|Adverse Event|0|||
33356767|NCT00961649|62734568|FG003|Overall Study|Adverse Event|2|||
33356768|NCT00961649|62734565|FG000|Overall Study|Inadequate control of IOP|0|||
33356769|NCT00961649|62734566|FG001|Overall Study|Inadequate control of IOP|0|||
33356770|NCT00961649|62734567|FG002|Overall Study|Inadequate control of IOP|0|||
33356771|NCT00961649|62734568|FG003|Overall Study|Inadequate control of IOP|1|||
33356772|NCT00961649|62734565|FG000|Overall Study|Patient has travel plans during holidays|0|||
33356773|NCT00961649|62734566|FG001|Overall Study|Patient has travel plans during holidays|0|||
33356774|NCT00961649|62734567|FG002|Overall Study|Patient has travel plans during holidays|1|||
33356775|NCT00961649|62734568|FG003|Overall Study|Patient has travel plans during holidays|0|||
33356776|NCT00961649|62734565|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
33356777|NCT00961649|62734566|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
33356778|NCT00961649|62734567|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
33356779|NCT00961649|62734568|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
33356780|NCT00961649|62734565|FG000|Overall Study|Study terminated by sponsor|4|||
33356781|NCT00961649|62734566|FG001|Overall Study|Study terminated by sponsor|4|||
33356782|NCT00961649|62734567|FG002|Overall Study|Study terminated by sponsor|4|||
33356783|NCT00961649|62734568|FG003|Overall Study|Study terminated by sponsor|1|||
33356784|NCT00632125|62734578|FG000|Overall Study|Death|82|||
33356785|NCT00632125|62734578|FG000|Overall Study|Withdrawal by Subject|44|||
33356786|NCT00632125|62734578|FG000|Overall Study|Adverse Event|36|||
33356787|NCT00632125|62734578|FG000|Overall Study|Renal transplantation|17|||
33356788|NCT00632125|62734578|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
33356789|NCT00632125|62734578|FG000|Overall Study|Non-compliance|8|||
33356790|NCT00632125|62734578|FG000|Overall Study|Development of uncontrolled hypertension|5|||
33356791|NCT00632125|62734578|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
33356792|NCT00903968|62734584|FG000|Overall Study|Adverse Event|0|||
33356793|NCT00903968|62734585|FG001|Overall Study|Adverse Event|0|||
33356794|NCT00903968|62734586|FG002|Overall Study|Adverse Event|0|||
33356795|NCT00903968|62734587|FG003|Overall Study|Adverse Event|0|||
33356796|NCT00903968|62734588|FG004|Overall Study|Adverse Event|0|||
33356797|NCT00903968|62734589|FG005|Overall Study|Adverse Event|0|||
33356798|NCT00903968|62734590|FG006|Overall Study|Adverse Event|1|||
33356799|NCT00903968|62734591|FG007|Overall Study|Adverse Event|8|||
33356800|NCT00903968|62734584|FG000|Overall Study|DLT|0|||
33356801|NCT00903968|62734585|FG001|Overall Study|DLT|0|||
33356802|NCT00903968|62734586|FG002|Overall Study|DLT|0|||
33356803|NCT00903968|62734587|FG003|Overall Study|DLT|0|||
33356804|NCT00903968|62734588|FG004|Overall Study|DLT|0|||
33356805|NCT00903968|62734589|FG005|Overall Study|DLT|0|||
33356806|NCT00903968|62734590|FG006|Overall Study|DLT|2|||
33356807|NCT00903968|62734591|FG007|Overall Study|DLT|0|||
33356808|NCT00903968|62734584|FG000|Overall Study|Withdrawal by Subject|1|||
33356809|NCT00903968|62734585|FG001|Overall Study|Withdrawal by Subject|0|||
33356810|NCT00903968|62734586|FG002|Overall Study|Withdrawal by Subject|1|||
33356811|NCT00903968|62734587|FG003|Overall Study|Withdrawal by Subject|0|||
33356812|NCT00903968|62734588|FG004|Overall Study|Withdrawal by Subject|1|||
33356813|NCT00903968|62734589|FG005|Overall Study|Withdrawal by Subject|1|||
33356814|NCT00903968|62734590|FG006|Overall Study|Withdrawal by Subject|0|||
33356815|NCT00903968|62734591|FG007|Overall Study|Withdrawal by Subject|4|||
33356816|NCT00903968|62734584|FG000|Overall Study|Non-Compliance|0|||
33356817|NCT00903968|62734585|FG001|Overall Study|Non-Compliance|0|||
33356818|NCT00903968|62734586|FG002|Overall Study|Non-Compliance|0|||
33356819|NCT00903968|62734587|FG003|Overall Study|Non-Compliance|0|||
33356820|NCT00903968|62734588|FG004|Overall Study|Non-Compliance|0|||
33356821|NCT00903968|62734589|FG005|Overall Study|Non-Compliance|1|||
33356822|NCT00903968|62734590|FG006|Overall Study|Non-Compliance|0|||
33356823|NCT00903968|62734591|FG007|Overall Study|Non-Compliance|0|||
33356824|NCT00903968|62734584|FG000|Overall Study|Physician Decision|0|||
33356825|NCT00903968|62734585|FG001|Overall Study|Physician Decision|0|||
33356826|NCT00903968|62734586|FG002|Overall Study|Physician Decision|0|||
33356827|NCT00903968|62734587|FG003|Overall Study|Physician Decision|0|||
33356828|NCT00903968|62734588|FG004|Overall Study|Physician Decision|0|||
33356829|NCT00903968|62734589|FG005|Overall Study|Physician Decision|1|||
33356830|NCT00903968|62734590|FG006|Overall Study|Physician Decision|0|||
33356831|NCT00903968|62734591|FG007|Overall Study|Physician Decision|0|||
33356832|NCT00903968|62734584|FG000|Overall Study|Progressive Disease|2|||
33356833|NCT00903968|62734585|FG001|Overall Study|Progressive Disease|3|||
33356834|NCT00903968|62734586|FG002|Overall Study|Progressive Disease|2|||
33356835|NCT00903968|62734587|FG003|Overall Study|Progressive Disease|3|||
33356836|NCT00903968|62734588|FG004|Overall Study|Progressive Disease|3|||
33356837|NCT00903968|62734589|FG005|Overall Study|Progressive Disease|3|||
33356838|NCT00903968|62734590|FG006|Overall Study|Progressive Disease|0|||
33356839|NCT00903968|62734591|FG007|Overall Study|Progressive Disease|18|||
33356840|NCT00903968|62734584|FG000|Overall Study|Lack of Efficacy|0|||
33356841|NCT00903968|62734585|FG001|Overall Study|Lack of Efficacy|0|||
33356842|NCT00903968|62734586|FG002|Overall Study|Lack of Efficacy|0|||
33356843|NCT00903968|62734587|FG003|Overall Study|Lack of Efficacy|0|||
33356844|NCT00903968|62734588|FG004|Overall Study|Lack of Efficacy|0|||
33356845|NCT00903968|62734589|FG005|Overall Study|Lack of Efficacy|0|||
33356846|NCT00903968|62734590|FG006|Overall Study|Lack of Efficacy|0|||
33356847|NCT00903968|62734591|FG007|Overall Study|Lack of Efficacy|3|||
33356848|NCT00903344|62734614|FG000|Overall Study|Pregnancy|2|||
33356849|NCT00903344|62734615|FG001|Overall Study|Pregnancy|3|||
33356850|NCT00903344|62734614|FG000|Overall Study|Lost to Follow-up|3|||
33356851|NCT00903344|62734615|FG001|Overall Study|Lost to Follow-up|0|||
33356852|NCT00903032|62734623|FG000|Overall Study|Withdrawal by Subject|5|||
33356853|NCT00903032|62734624|FG001|Overall Study|Withdrawal by Subject|3|||
33356854|NCT00903032|62734623|FG000|Overall Study|Lost to Follow-up|2|||
33473278|NCT03129100|62847542|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473279|NCT03129100|62847543|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33356855|NCT00903032|62734624|FG001|Overall Study|Lost to Follow-up|2|||
33356856|NCT00902564|62734639|FG000|Overall Study|Withdrawal by Subject|2|||
33356857|NCT00626197|62734646|FG000|Overall Study|Did not cooperate|2|||
33356858|NCT00626197|62734647|FG001|Overall Study|Did not cooperate|6|||
33473280|NCT03129100|62847544|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473281|NCT03129100|62847545|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473282|NCT03129100|62847546|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473283|NCT03129100|62847547|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33655369|NCT03049449|63070506|FG006|Overall Study|Did not receive treatment.|0|||
33655370|NCT03049449|63070507|FG007|Overall Study|Did not receive treatment.|0|||
33473284|NCT03129100|62847548|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473285|NCT03129100|62847549|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473286|NCT03129100|62847550|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473287|NCT03129100|62847551|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473288|NCT03129100|62847552|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473289|NCT03129100|62847553|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473290|NCT03129100|62847554|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473291|NCT03129100|62847555|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473292|NCT03129100|62847556|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473293|NCT03129100|62847557|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473294|NCT03129100|62847558|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473295|NCT03129100|62847559|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473296|NCT03129100|62847560|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473297|NCT03129100|62847561|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473298|NCT03129100|62847562|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473299|NCT03129100|62847563|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33655371|NCT03049449|63070508|FG008|Overall Study|Did not receive treatment.|1|||
33655372|NCT03049449|63070509|FG009|Overall Study|Did not receive treatment.|0|||
33655373|NCT03049449|63070500|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
33655374|NCT03049449|63070501|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
33655375|NCT03049449|63070502|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
33655376|NCT03049449|63070503|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
33655377|NCT03049449|63070504|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
33356859|NCT00626197|62734648|FG002|Overall Study|Did not cooperate|1|||
33356860|NCT00626197|62734646|FG000|Overall Study|Failure to return|6|||
33356861|NCT00626197|62734647|FG001|Overall Study|Failure to return|5|||
33356862|NCT00626197|62734648|FG002|Overall Study|Failure to return|6|||
33356863|NCT00626197|62734646|FG000|Overall Study|Adverse event, serious fatal|3|||
33356864|NCT00626197|62734647|FG001|Overall Study|Adverse event, serious fatal|6|||
33473300|NCT03129100|62847564|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33356865|NCT00626197|62734648|FG002|Overall Study|Adverse event, serious fatal|6|||
33473301|NCT03129100|62847565|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33655378|NCT03049449|63070505|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
33356866|NCT00626197|62734646|FG000|Overall Study|Adverse Event|1|||
33356867|NCT00626197|62734647|FG001|Overall Study|Adverse Event|1|||
33356868|NCT00626197|62734648|FG002|Overall Study|Adverse Event|2|||
33356869|NCT00626197|62734646|FG000|Overall Study|Withdrawal by Subject|17|||
33356870|NCT00626197|62734647|FG001|Overall Study|Withdrawal by Subject|17|||
33356871|NCT00626197|62734648|FG002|Overall Study|Withdrawal by Subject|7|||
33356872|NCT00626197|62734646|FG000|Overall Study|Administrative reasons|15|||
33356873|NCT00626197|62734647|FG001|Overall Study|Administrative reasons|19|||
33473302|NCT03129100|62847566|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33473303|NCT03129100|62847541|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
33473304|NCT03129100|62847542|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
33473305|NCT03129100|62847543|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473306|NCT03129100|62847544|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473307|NCT03129100|62847545|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473308|NCT03129100|62847546|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473309|NCT03129100|62847547|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473310|NCT03129100|62847548|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473311|NCT03129100|62847549|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473312|NCT03129100|62847550|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473313|NCT03129100|62847551|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473314|NCT03129100|62847552|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473315|NCT03129100|62847553|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473316|NCT03129100|62847554|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473317|NCT03129100|62847555|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473318|NCT03129100|62847556|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473319|NCT03129100|62847557|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473320|NCT03129100|62847558|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473321|NCT03129100|62847559|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473322|NCT03129100|62847560|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473323|NCT03129100|62847561|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473324|NCT03129100|62847562|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473325|NCT03129100|62847563|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33356874|NCT00626197|62734648|FG002|Overall Study|Administrative reasons|55|||
33473326|NCT03129100|62847564|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473327|NCT03129100|62847565|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473328|NCT03129100|62847566|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33473329|NCT03129100|62847541|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
33473330|NCT03129100|62847542|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
33473331|NCT03129100|62847543|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473332|NCT03129100|62847544|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473333|NCT03129100|62847545|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473334|NCT03129100|62847546|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33549140|NCT02901431|62940296|FG002|Open Label Part|Withdrawal by Subject|0|||
33549141|NCT02901431|62940297|FG003|Open Label Part|Withdrawal by Subject|0|||
33549142|NCT02901431|62940298|FG004|Open Label Part|Withdrawal by Subject|0|||
33549143|NCT02901431|62940299|FG005|Open Label Part|Withdrawal by Subject|0|||
33549144|NCT02901431|62940300|FG006|Open Label Part|Withdrawal by Subject|0|||
33549145|NCT02901431|62940301|FG007|Open Label Part|Withdrawal by Subject|0|||
33549146|NCT02901431|62940302|FG008|Open Label Part|Withdrawal by Subject|6|||
33549147|NCT02901431|62940303|FG009|Open Label Part|Withdrawal by Subject|5|||
33549148|NCT02901431|62940304|FG010|Open Label Part|Withdrawal by Subject|7|||
33549149|NCT02901431|62940305|FG011|Open Label Part|Withdrawal by Subject|3|||
33549150|NCT02901431|62940306|FG012|Open Label Part|Withdrawal by Subject|1|||
33549151|NCT02873377|62940333|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
33549152|NCT02873377|62940334|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
33549153|NCT02873377|62940333|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
33549154|NCT02873377|62940334|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
33549155|NCT02966795|62940343|FG000|Overall Study|Patient Left the Country|0|||
33549156|NCT02966795|62940344|FG001|Overall Study|Patient Left the Country|1|||
33549157|NCT02873221|62940352|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
33549158|NCT02873221|62940353|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
33549159|NCT02873221|62940354|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
33356875|NCT00626275|62734662|FG000|Part A - Treatment Period 1|Adverse Event|1|||
33473335|NCT03129100|62847547|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473336|NCT03129100|62847548|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473337|NCT03129100|62847549|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473338|NCT03129100|62847550|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473339|NCT03129100|62847551|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473340|NCT03129100|62847552|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473341|NCT03129100|62847553|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33549160|NCT02873221|62940352|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
33549161|NCT02873221|62940353|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
33549162|NCT02873221|62940354|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
33549163|NCT02873221|62940352|FG000|Treatment Period|Protocol Violation|2|||
33356876|NCT00626275|62734663|FG001|Part A - Treatment Period 1|Adverse Event|0|||
33356877|NCT00626275|62734664|FG002|Part A - Treatment Period 1|Adverse Event|0|||
33356878|NCT00626275|62734665|FG003|Part A - Treatment Period 1|Adverse Event|0|||
33356879|NCT00626275|62734666|FG004|Part A - Treatment Period 1|Adverse Event|0|||
33356880|NCT00626275|62734667|FG005|Part A - Treatment Period 1|Adverse Event|0|||
33356881|NCT00626275|62734668|FG006|Part A - Treatment Period 1|Adverse Event|0|||
33356882|NCT00626275|62734669|FG007|Part A - Treatment Period 1|Adverse Event|0|||
33356883|NCT00626275|62734662|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
33356884|NCT00626275|62734663|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
33356885|NCT00626275|62734664|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
33356886|NCT00626275|62734665|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
33356887|NCT00626275|62734666|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
33356888|NCT00626275|62734667|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
33356889|NCT00626275|62734668|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
33356890|NCT00626275|62734669|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
33356891|NCT00626275|62734662|FG000|Part B|Lost to Follow-up|0|||
33356892|NCT00626275|62734663|FG001|Part B|Lost to Follow-up|0|||
33356893|NCT00626275|62734664|FG002|Part B|Lost to Follow-up|0|||
33356894|NCT00626275|62734665|FG003|Part B|Lost to Follow-up|0|||
33356895|NCT00626275|62734666|FG004|Part B|Lost to Follow-up|0|||
33356896|NCT00626275|62734667|FG005|Part B|Lost to Follow-up|0|||
33549164|NCT02873221|62940353|FG001|Treatment Period|Protocol Violation|5|||
33549165|NCT02873221|62940354|FG002|Treatment Period|Protocol Violation|8|||
33549166|NCT02873221|62940352|FG000|Treatment Period|Pregnancy|4|||
33549167|NCT02873221|62940353|FG001|Treatment Period|Pregnancy|6|||
33356897|NCT00626275|62734668|FG006|Part B|Lost to Follow-up|1|||
33356898|NCT00626275|62734669|FG007|Part B|Lost to Follow-up|0|||
33356899|NCT00626275|62734662|FG000|Part B|Withdrawal by Subject|0|||
33356900|NCT00626275|62734663|FG001|Part B|Withdrawal by Subject|0|||
33356901|NCT00626275|62734664|FG002|Part B|Withdrawal by Subject|0|||
33356902|NCT00626275|62734665|FG003|Part B|Withdrawal by Subject|0|||
33356903|NCT00626275|62734666|FG004|Part B|Withdrawal by Subject|0|||
33356904|NCT00626275|62734667|FG005|Part B|Withdrawal by Subject|0|||
33356905|NCT00626275|62734668|FG006|Part B|Withdrawal by Subject|0|||
33356906|NCT00626275|62734669|FG007|Part B|Withdrawal by Subject|1|||
33356907|NCT00623935|62734683|FG000|Overall Study|Death|1|||
33356908|NCT00623935|62734683|FG000|Overall Study|Patient Declined Transplant|1|||
33356909|NCT00623779|62734690|FG000|Overall Study|Adverse Event|1|||
33356910|NCT00623779|62734691|FG001|Overall Study|Adverse Event|3|||
33356911|NCT00623779|62734692|FG002|Overall Study|Adverse Event|0|||
33356912|NCT00623779|62734690|FG000|Overall Study|Criteria from CSR|2|||
33473342|NCT03129100|62847554|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473343|NCT03129100|62847555|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473344|NCT03129100|62847556|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473345|NCT03129100|62847557|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473346|NCT03129100|62847558|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473347|NCT03129100|62847559|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473348|NCT03129100|62847560|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473349|NCT03129100|62847561|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473350|NCT03129100|62847562|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33356913|NCT00623779|62734691|FG001|Overall Study|Criteria from CSR|0|||
33356914|NCT00623779|62734692|FG002|Overall Study|Criteria from CSR|1|||
33473351|NCT03129100|62847563|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473352|NCT03129100|62847564|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473353|NCT03129100|62847565|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473354|NCT03129100|62847566|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33473355|NCT03129100|62847541|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473356|NCT03129100|62847542|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
33356915|NCT00629707|62734723|FG000|Overall Study|Withdrawal by Subject|0|||
33356916|NCT00629707|62734724|FG001|Overall Study|Withdrawal by Subject|1|||
33356917|NCT00629707|62734723|FG000|Overall Study|Physician Decision|0|||
33356918|NCT00629707|62734724|FG001|Overall Study|Physician Decision|1|||
33356919|NCT00902330|62734732|FG000|Overall Study|Too overwhelmed by treatment|2|||
33356920|NCT00902330|62734733|FG001|Overall Study|Too overwhelmed by treatment|5|||
33356921|NCT00902330|62734732|FG000|Overall Study|Adverse Event|1|||
33356922|NCT00902330|62734733|FG001|Overall Study|Adverse Event|0|||
33356923|NCT00902330|62734732|FG000|Overall Study|No post baseline data|1|||
33356924|NCT00902330|62734733|FG001|Overall Study|No post baseline data|0|||
33356925|NCT00901394|62734770|FG000|Overall Study|Physician Decision|1|||
33549168|NCT02873221|62940354|FG002|Treatment Period|Pregnancy|3|||
33356926|NCT00901394|62734771|FG001|Overall Study|Physician Decision|1|||
33473357|NCT03129100|62847543|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473358|NCT03129100|62847544|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473359|NCT03129100|62847545|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473360|NCT03129100|62847546|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473361|NCT03129100|62847547|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473362|NCT03129100|62847548|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473363|NCT03129100|62847549|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473364|NCT03129100|62847550|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473365|NCT03129100|62847551|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473366|NCT03129100|62847552|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473367|NCT03129100|62847553|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473368|NCT03129100|62847554|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473369|NCT03129100|62847555|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473370|NCT03129100|62847556|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473371|NCT03129100|62847557|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473372|NCT03129100|62847558|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473373|NCT03129100|62847559|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473374|NCT03129100|62847560|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473375|NCT03129100|62847561|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473376|NCT03129100|62847562|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473377|NCT03129100|62847563|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473378|NCT03129100|62847564|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473379|NCT03129100|62847565|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473380|NCT03129100|62847566|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
33473381|NCT03129100|62847541|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473382|NCT03129100|62847542|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33356927|NCT00901394|62734772|FG002|Overall Study|Physician Decision|2|||
33356928|NCT00896532|62734788|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356929|NCT00896532|62734789|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356930|NCT00896532|62734790|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356931|NCT00896532|62734791|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
33356932|NCT00896532|62734792|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356933|NCT00896532|62734793|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
33356934|NCT00896532|62734794|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356935|NCT00896532|62734795|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356936|NCT00896532|62734796|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356937|NCT00896532|62734797|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356938|NCT00896532|62734798|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356939|NCT00896532|62734799|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356940|NCT00896532|62734800|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356941|NCT00896532|62734801|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356942|NCT00896532|62734802|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356943|NCT00896532|62734803|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33473383|NCT03129100|62847543|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
33473384|NCT03129100|62847544|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
33473385|NCT03129100|62847545|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473386|NCT03129100|62847546|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
33473387|NCT03129100|62847547|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473388|NCT03129100|62847548|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473389|NCT03129100|62847549|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473390|NCT03129100|62847550|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473391|NCT03129100|62847551|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473392|NCT03129100|62847552|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473393|NCT03129100|62847553|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473394|NCT03129100|62847554|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473395|NCT03129100|62847555|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473396|NCT03129100|62847556|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473397|NCT03129100|62847557|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473398|NCT03129100|62847558|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473399|NCT03129100|62847559|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473400|NCT03129100|62847560|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473401|NCT03129100|62847561|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473402|NCT03129100|62847562|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473403|NCT03129100|62847563|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33549169|NCT02873221|62940352|FG000|Treatment Period|Lack of Qualifying Event|0|||
33356944|NCT00896532|62734804|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356945|NCT00896532|62734805|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356946|NCT00896532|62734806|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356947|NCT00896532|62734807|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356948|NCT00896532|62734808|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356949|NCT00896532|62734809|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356950|NCT00896532|62734810|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33356951|NCT00896532|62734788|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
33356952|NCT00896532|62734789|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
33356953|NCT00896532|62734790|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
33356954|NCT00896532|62734791|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
33356955|NCT00896532|62734792|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
33356956|NCT00896532|62734793|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
33356957|NCT00896532|62734794|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
33356958|NCT00896532|62734795|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33356959|NCT00896532|62734796|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33356960|NCT00896532|62734797|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33356961|NCT00896532|62734798|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33356962|NCT00896532|62734799|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33356963|NCT00896532|62734800|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33356964|NCT00896532|62734801|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33473404|NCT03129100|62847564|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473405|NCT03129100|62847565|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473406|NCT03129100|62847566|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33473407|NCT03129100|62847541|FG000|Period2 Extension Period (Group A and B)|Death|0|||
33473408|NCT03129100|62847542|FG001|Period2 Extension Period (Group A and B)|Death|0|||
33473409|NCT03129100|62847543|FG002|Period2 Extension Period (Group A and B)|Death|1|||
33473410|NCT03129100|62847544|FG003|Period2 Extension Period (Group A and B)|Death|0|||
33473411|NCT03129100|62847545|FG004|Period2 Extension Period (Group A and B)|Death|0|||
33473412|NCT03129100|62847546|FG005|Period2 Extension Period (Group A and B)|Death|0|||
33473413|NCT03129100|62847547|FG006|Period2 Extension Period (Group A and B)|Death|0|||
33473414|NCT03129100|62847548|FG007|Period2 Extension Period (Group A and B)|Death|0|||
33473415|NCT03129100|62847549|FG008|Period2 Extension Period (Group A and B)|Death|0|||
33473416|NCT03129100|62847550|FG009|Period2 Extension Period (Group A and B)|Death|0|||
33473417|NCT03129100|62847551|FG010|Period2 Extension Period (Group A and B)|Death|0|||
33473418|NCT03129100|62847552|FG011|Period2 Extension Period (Group A and B)|Death|0|||
33473419|NCT03129100|62847553|FG012|Period2 Extension Period (Group A and B)|Death|0|||
33473420|NCT03129100|62847554|FG013|Period2 Extension Period (Group A and B)|Death|0|||
33473421|NCT03129100|62847555|FG014|Period2 Extension Period (Group A and B)|Death|0|||
33473422|NCT03129100|62847556|FG015|Period2 Extension Period (Group A and B)|Death|0|||
33473423|NCT03129100|62847557|FG016|Period2 Extension Period (Group A and B)|Death|0|||
33473424|NCT03129100|62847558|FG017|Period2 Extension Period (Group A and B)|Death|0|||
33473425|NCT03129100|62847559|FG018|Period2 Extension Period (Group A and B)|Death|0|||
33473426|NCT03129100|62847560|FG019|Period2 Extension Period (Group A and B)|Death|0|||
33473427|NCT03129100|62847561|FG020|Period2 Extension Period (Group A and B)|Death|0|||
33473428|NCT03129100|62847562|FG021|Period2 Extension Period (Group A and B)|Death|0|||
33473429|NCT03129100|62847563|FG022|Period2 Extension Period (Group A and B)|Death|0|||
33473430|NCT03129100|62847564|FG023|Period2 Extension Period (Group A and B)|Death|0|||
33473431|NCT03129100|62847565|FG024|Period2 Extension Period (Group A and B)|Death|0|||
33473432|NCT03129100|62847566|FG025|Period2 Extension Period (Group A and B)|Death|0|||
33473433|NCT03129100|62847541|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473434|NCT03129100|62847542|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473435|NCT03129100|62847543|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
33473436|NCT03129100|62847544|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
33473437|NCT03129100|62847545|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
33473438|NCT03129100|62847546|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
33473439|NCT03129100|62847547|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
33473440|NCT03129100|62847548|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473441|NCT03129100|62847549|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473442|NCT03129100|62847550|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473443|NCT03129100|62847551|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473444|NCT03129100|62847552|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473445|NCT03129100|62847553|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473446|NCT03129100|62847554|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473447|NCT03129100|62847555|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33356965|NCT00896532|62734802|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33356966|NCT00896532|62734803|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33356967|NCT00896532|62734804|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33356968|NCT00896532|62734805|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33356969|NCT00896532|62734806|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33356970|NCT00896532|62734807|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33356971|NCT00896532|62734808|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33356972|NCT00896532|62734809|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33356973|NCT00896532|62734810|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33356974|NCT00896532|62734788|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
33356975|NCT00896532|62734789|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
33356976|NCT00896532|62734790|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
33356977|NCT00896532|62734791|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
33356978|NCT00896532|62734792|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
33356979|NCT00896532|62734793|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
33356980|NCT00896532|62734794|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
33356981|NCT00896532|62734795|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
33356982|NCT00896532|62734796|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33356983|NCT00896532|62734797|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33356984|NCT00896532|62734798|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33356985|NCT00896532|62734799|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33356986|NCT00896532|62734800|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33356987|NCT00896532|62734801|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33356988|NCT00896532|62734802|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33356989|NCT00896532|62734803|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33356990|NCT00896532|62734804|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33356991|NCT00896532|62734805|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33356992|NCT00896532|62734806|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33356993|NCT00896532|62734807|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33356994|NCT00896532|62734808|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33356995|NCT00896532|62734809|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33356996|NCT00896532|62734810|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33356997|NCT00896532|62734788|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33356998|NCT00896532|62734789|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33356999|NCT00896532|62734790|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
33357000|NCT00896532|62734791|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357001|NCT00896532|62734792|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
33357002|NCT00896532|62734793|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357003|NCT00896532|62734794|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357004|NCT00896532|62734795|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357005|NCT00896532|62734796|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357006|NCT00896532|62734797|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357007|NCT00896532|62734798|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357008|NCT00896532|62734799|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357009|NCT00896532|62734800|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357010|NCT00896532|62734801|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357011|NCT00896532|62734802|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357012|NCT00896532|62734803|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357013|NCT00896532|62734804|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357014|NCT00896532|62734805|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357015|NCT00896532|62734806|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357016|NCT00896532|62734807|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357017|NCT00896532|62734808|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357018|NCT00896532|62734809|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357019|NCT00896532|62734810|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33357020|NCT00896532|62734788|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
33357021|NCT00896532|62734789|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357022|NCT00896532|62734790|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357023|NCT00896532|62734791|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
33357024|NCT00896532|62734792|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357025|NCT00896532|62734793|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357026|NCT00896532|62734794|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357027|NCT00896532|62734795|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357028|NCT00896532|62734796|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357029|NCT00896532|62734797|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357030|NCT00896532|62734798|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357031|NCT00896532|62734799|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357032|NCT00896532|62734800|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357033|NCT00896532|62734801|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357034|NCT00896532|62734802|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357035|NCT00896532|62734803|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357036|NCT00896532|62734804|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357037|NCT00896532|62734805|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357038|NCT00896532|62734806|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357039|NCT00896532|62734807|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357040|NCT00896532|62734808|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357041|NCT00896532|62734809|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357042|NCT00896532|62734810|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33357043|NCT00896532|62734788|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357044|NCT00896532|62734789|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357045|NCT00896532|62734790|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
33357046|NCT00896532|62734791|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357047|NCT00896532|62734792|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357048|NCT00896532|62734793|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357049|NCT00896532|62734794|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357050|NCT00896532|62734795|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33473448|NCT03129100|62847556|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33357051|NCT00896532|62734796|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33473449|NCT03129100|62847557|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33549170|NCT02873221|62940353|FG001|Treatment Period|Lack of Qualifying Event|3|||
33549171|NCT02873221|62940354|FG002|Treatment Period|Lack of Qualifying Event|1|||
33549172|NCT02873221|62940352|FG000|Treatment Period|Withdrawal of Consent|52|||
33549173|NCT02873221|62940353|FG001|Treatment Period|Withdrawal of Consent|51|||
33549174|NCT02873221|62940354|FG002|Treatment Period|Withdrawal of Consent|41|||
33549175|NCT02873221|62940352|FG000|Treatment Period|Lack of Efficacy|0|||
33549176|NCT02873221|62940353|FG001|Treatment Period|Lack of Efficacy|17|||
33549177|NCT02873221|62940354|FG002|Treatment Period|Lack of Efficacy|12|||
33549178|NCT02873221|62940352|FG000|Treatment Period|Adverse Event|4|||
33549179|NCT02873221|62940353|FG001|Treatment Period|Adverse Event|9|||
33549180|NCT02873221|62940354|FG002|Treatment Period|Adverse Event|11|||
33549181|NCT02873221|62940352|FG000|Treatment Period|Lost to Follow-up|26|||
33549182|NCT02873221|62940353|FG001|Treatment Period|Lost to Follow-up|30|||
33549183|NCT02873221|62940354|FG002|Treatment Period|Lost to Follow-up|26|||
33549184|NCT02873221|62940352|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
33549185|NCT02873221|62940353|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
33549186|NCT02873221|62940354|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
33549187|NCT02873221|62940352|FG000|Safety Follow-up Period|Protocol Violation|0|||
33549188|NCT02873221|62940353|FG001|Safety Follow-up Period|Protocol Violation|0|||
33549189|NCT02873221|62940354|FG002|Safety Follow-up Period|Protocol Violation|1|||
33549190|NCT02873221|62940352|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
33549191|NCT02873221|62940353|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
33549192|NCT02873221|62940354|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
33549193|NCT02873221|62940352|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
33549194|NCT02873221|62940353|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
33549195|NCT02873221|62940354|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
33549196|NCT02968979|62940362|FG000|Overall Study|Protocol Violation|7|||
33549197|NCT02968979|62940362|FG000|Overall Study|Withdrawal by Subject|1|||
33549198|NCT02966015|62940414|FG000|Inclusion Visit|did not answer questionnaire|8|||
33549199|NCT02966015|62940415|FG001|Inclusion Visit|did not answer questionnaire|3|||
33549200|NCT02968433|62940421|FG000|Overall Study|Withdrawal by Subject|1|||
33549201|NCT02872285|62940433|FG000|Overall Study|Withdrawal by Subject|2|||
33549202|NCT02872285|62940434|FG001|Overall Study|Withdrawal by Subject|0|||
33549203|NCT02872285|62940433|FG000|Overall Study|Lost to Follow-up|2|||
33549204|NCT02872285|62940434|FG001|Overall Study|Lost to Follow-up|2|||
33549205|NCT02872285|62940433|FG000|Overall Study|Discontinued due to back surgery|1|||
33549206|NCT02872285|62940434|FG001|Overall Study|Discontinued due to back surgery|0|||
33549207|NCT02871739|62940444|FG000|Overall Study|Lost to Follow-up|3|||
33549208|NCT02871739|62940445|FG001|Overall Study|Lost to Follow-up|2|||
33357052|NCT00896532|62734797|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357053|NCT00896532|62734798|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357054|NCT00896532|62734799|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357055|NCT00896532|62734800|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357056|NCT00896532|62734801|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357057|NCT00896532|62734802|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357058|NCT00896532|62734803|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357059|NCT00896532|62734804|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357060|NCT00896532|62734805|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357061|NCT00896532|62734806|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357062|NCT00896532|62734807|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357063|NCT00896532|62734808|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357064|NCT00896532|62734809|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357065|NCT00896532|62734810|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33357066|NCT00896532|62734788|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357067|NCT00896532|62734789|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357068|NCT00896532|62734790|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
33357069|NCT00896532|62734791|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357070|NCT00896532|62734792|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357071|NCT00896532|62734793|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357072|NCT00896532|62734794|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357073|NCT00896532|62734795|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357074|NCT00896532|62734796|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357075|NCT00896532|62734797|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357076|NCT00896532|62734798|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357077|NCT00896532|62734799|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357078|NCT00896532|62734800|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357079|NCT00896532|62734801|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357080|NCT00896532|62734802|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357081|NCT00896532|62734803|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357082|NCT00896532|62734804|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357083|NCT00896532|62734805|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357084|NCT00896532|62734806|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357085|NCT00896532|62734807|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357086|NCT00896532|62734808|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357087|NCT00896532|62734809|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357088|NCT00896532|62734810|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33357089|NCT00896532|62734788|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357090|NCT00896532|62734789|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357091|NCT00896532|62734790|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357092|NCT00896532|62734791|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
33357093|NCT00896532|62734792|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357094|NCT00896532|62734793|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357095|NCT00896532|62734794|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357096|NCT00896532|62734795|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357097|NCT00896532|62734796|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357098|NCT00896532|62734797|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357099|NCT00896532|62734798|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357100|NCT00896532|62734799|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357101|NCT00896532|62734800|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33473450|NCT03129100|62847558|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33655379|NCT03049449|63070506|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
33655380|NCT03049449|63070507|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
33655381|NCT03049449|63070508|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
33655382|NCT03049449|63070509|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
33655383|NCT03049449|63070500|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33357102|NCT00896532|62734801|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357103|NCT00896532|62734802|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357104|NCT00896532|62734803|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357105|NCT00896532|62734804|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357106|NCT00896532|62734805|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357107|NCT00896532|62734806|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357108|NCT00896532|62734807|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357109|NCT00896532|62734808|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357110|NCT00896532|62734809|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357111|NCT00896532|62734810|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33357112|NCT00896532|62734788|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357113|NCT00896532|62734789|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
33357114|NCT00896532|62734790|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357115|NCT00896532|62734791|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
33357116|NCT00896532|62734792|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
33357117|NCT00896532|62734793|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357118|NCT00896532|62734794|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33473451|NCT03129100|62847559|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473452|NCT03129100|62847560|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473453|NCT03129100|62847561|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473454|NCT03129100|62847562|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473455|NCT03129100|62847563|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473456|NCT03129100|62847564|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473457|NCT03129100|62847565|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473458|NCT03129100|62847566|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33473459|NCT03129100|62847541|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473460|NCT03129100|62847542|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473461|NCT03129100|62847543|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
33473462|NCT03129100|62847544|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473463|NCT03129100|62847545|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473464|NCT03129100|62847546|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473465|NCT03129100|62847547|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473466|NCT03129100|62847548|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473467|NCT03129100|62847549|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473468|NCT03129100|62847550|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473469|NCT03129100|62847551|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473470|NCT03129100|62847552|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473471|NCT03129100|62847553|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473472|NCT03129100|62847554|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473473|NCT03129100|62847555|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473474|NCT03129100|62847556|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473475|NCT03129100|62847557|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473476|NCT03129100|62847558|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473477|NCT03129100|62847559|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473478|NCT03129100|62847560|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473479|NCT03129100|62847561|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33357119|NCT00896532|62734795|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357120|NCT00896532|62734796|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357121|NCT00896532|62734797|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357122|NCT00896532|62734798|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357123|NCT00896532|62734799|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357124|NCT00896532|62734800|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357125|NCT00896532|62734801|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357126|NCT00896532|62734802|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357127|NCT00896532|62734803|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357128|NCT00896532|62734804|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357129|NCT00896532|62734805|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357130|NCT00896532|62734806|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357131|NCT00896532|62734807|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357132|NCT00896532|62734808|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357133|NCT00896532|62734809|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357134|NCT00896532|62734810|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33357135|NCT00896532|62734788|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33473480|NCT03129100|62847562|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33357136|NCT00896532|62734789|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357137|NCT00896532|62734790|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357138|NCT00896532|62734791|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357139|NCT00896532|62734792|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357140|NCT00896532|62734793|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357141|NCT00896532|62734794|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357142|NCT00896532|62734795|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357143|NCT00896532|62734796|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
33357144|NCT00896532|62734797|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357145|NCT00896532|62734798|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357146|NCT00896532|62734799|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357147|NCT00896532|62734800|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357148|NCT00896532|62734801|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357149|NCT00896532|62734802|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357150|NCT00896532|62734803|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357151|NCT00896532|62734804|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357152|NCT00896532|62734805|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357153|NCT00896532|62734806|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357154|NCT00896532|62734807|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357155|NCT00896532|62734808|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357156|NCT00896532|62734809|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33655384|NCT03049449|63070501|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33655385|NCT03049449|63070502|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33655386|NCT03049449|63070503|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33655387|NCT03049449|63070504|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33655388|NCT03049449|63070505|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33357157|NCT00896532|62734810|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33357158|NCT00896532|62734788|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357159|NCT00896532|62734789|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357160|NCT00896532|62734790|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357161|NCT00896532|62734791|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357162|NCT00896532|62734792|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357163|NCT00896532|62734793|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357164|NCT00896532|62734794|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357165|NCT00896532|62734795|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357166|NCT00896532|62734796|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357167|NCT00896532|62734797|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357168|NCT00896532|62734798|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357169|NCT00896532|62734799|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33473481|NCT03129100|62847563|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473482|NCT03129100|62847564|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473483|NCT03129100|62847565|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33357170|NCT00896532|62734800|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
33357171|NCT00896532|62734801|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357172|NCT00896532|62734802|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357173|NCT00896532|62734803|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357174|NCT00896532|62734804|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357175|NCT00896532|62734805|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357176|NCT00896532|62734806|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357177|NCT00896532|62734807|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357178|NCT00896532|62734808|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357179|NCT00896532|62734809|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357180|NCT00896532|62734810|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33357181|NCT00896532|62734788|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357182|NCT00896532|62734789|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357183|NCT00896532|62734790|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357184|NCT00896532|62734791|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357185|NCT00896532|62734792|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357186|NCT00896532|62734793|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357187|NCT00896532|62734794|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357188|NCT00896532|62734795|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357189|NCT00896532|62734796|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357190|NCT00896532|62734797|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357191|NCT00896532|62734798|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
33357192|NCT00896532|62734799|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357193|NCT00896532|62734800|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
33357194|NCT00896532|62734801|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357195|NCT00896532|62734802|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357196|NCT00896532|62734803|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357197|NCT00896532|62734804|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357198|NCT00896532|62734805|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357199|NCT00896532|62734806|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357200|NCT00896532|62734807|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357201|NCT00896532|62734808|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357202|NCT00896532|62734809|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357203|NCT00896532|62734810|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33357204|NCT00896532|62734788|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357205|NCT00896532|62734789|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357206|NCT00896532|62734790|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357207|NCT00896532|62734791|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357208|NCT00896532|62734792|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357209|NCT00896532|62734793|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357210|NCT00896532|62734794|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357211|NCT00896532|62734795|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357212|NCT00896532|62734796|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357213|NCT00896532|62734797|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357214|NCT00896532|62734798|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357215|NCT00896532|62734799|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357216|NCT00896532|62734800|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
33357217|NCT00896532|62734801|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
33357218|NCT00896532|62734802|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357219|NCT00896532|62734803|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357220|NCT00896532|62734804|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357221|NCT00896532|62734805|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357222|NCT00896532|62734806|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357223|NCT00896532|62734807|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357224|NCT00896532|62734808|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357225|NCT00896532|62734809|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357226|NCT00896532|62734810|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33357227|NCT00896532|62734788|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
33357228|NCT00896532|62734789|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
33357229|NCT00896532|62734790|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
33357230|NCT00896532|62734791|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
33357231|NCT00896532|62734792|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
33357232|NCT00896532|62734793|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
33357233|NCT00896532|62734794|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
33357234|NCT00896532|62734795|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
33357235|NCT00896532|62734796|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
33357236|NCT00896532|62734797|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
33357237|NCT00896532|62734798|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
33357238|NCT00896532|62734799|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
33357239|NCT00896532|62734800|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
33357240|NCT00896532|62734801|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
33357241|NCT00896532|62734802|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
33357242|NCT00896532|62734803|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
33357243|NCT00896532|62734804|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
33357244|NCT00896532|62734805|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
33357245|NCT00896532|62734806|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
33357246|NCT00896532|62734807|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
33357247|NCT00896532|62734808|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
33357248|NCT00896532|62734809|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
33357249|NCT00896532|62734810|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
33357250|NCT00896532|62734788|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357251|NCT00896532|62734789|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357252|NCT00896532|62734790|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357253|NCT00896532|62734791|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357254|NCT00896532|62734792|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357255|NCT00896532|62734793|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357256|NCT00896532|62734794|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357257|NCT00896532|62734795|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357258|NCT00896532|62734796|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357259|NCT00896532|62734797|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357260|NCT00896532|62734798|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357261|NCT00896532|62734799|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357262|NCT00896532|62734800|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357263|NCT00896532|62734801|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357264|NCT00896532|62734802|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357265|NCT00896532|62734803|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
33357266|NCT00896532|62734804|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
33357267|NCT00896532|62734805|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357268|NCT00896532|62734806|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357269|NCT00896532|62734807|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357270|NCT00896532|62734808|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357271|NCT00896532|62734809|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357272|NCT00896532|62734810|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33357273|NCT00896532|62734788|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357274|NCT00896532|62734789|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357275|NCT00896532|62734790|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357276|NCT00896532|62734791|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357277|NCT00896532|62734792|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357278|NCT00896532|62734793|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357279|NCT00896532|62734794|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357280|NCT00896532|62734795|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357281|NCT00896532|62734796|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357282|NCT00896532|62734797|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357283|NCT00896532|62734798|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357284|NCT00896532|62734799|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357285|NCT00896532|62734800|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357286|NCT00896532|62734801|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357287|NCT00896532|62734802|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357288|NCT00896532|62734803|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
33357289|NCT00896532|62734804|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
33357290|NCT00896532|62734805|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
33357291|NCT00896532|62734806|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357292|NCT00896532|62734807|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33473484|NCT03129100|62847566|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33473485|NCT03129100|62847541|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473486|NCT03129100|62847542|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473487|NCT03129100|62847543|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
33473488|NCT03129100|62847544|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473489|NCT03129100|62847545|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473490|NCT03129100|62847546|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473491|NCT03129100|62847547|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473492|NCT03129100|62847548|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473493|NCT03129100|62847549|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473494|NCT03129100|62847550|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473495|NCT03129100|62847551|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473496|NCT03129100|62847552|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473497|NCT03129100|62847553|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473498|NCT03129100|62847554|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473499|NCT03129100|62847555|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473500|NCT03129100|62847556|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473501|NCT03129100|62847557|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473502|NCT03129100|62847558|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473503|NCT03129100|62847559|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473504|NCT03129100|62847560|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473505|NCT03129100|62847561|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473506|NCT03129100|62847562|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473507|NCT03129100|62847563|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473508|NCT03129100|62847564|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473509|NCT03129100|62847565|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473510|NCT03129100|62847566|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33473511|NCT03129100|62847541|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473512|NCT03129100|62847542|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473513|NCT03129100|62847543|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
33473514|NCT03129100|62847544|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473515|NCT03129100|62847545|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473516|NCT03129100|62847546|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473517|NCT03129100|62847547|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473518|NCT03129100|62847548|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473519|NCT03129100|62847549|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473520|NCT03129100|62847550|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473521|NCT03129100|62847551|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473522|NCT03129100|62847552|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473523|NCT03129100|62847553|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473524|NCT03129100|62847554|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473525|NCT03129100|62847555|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473526|NCT03129100|62847556|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473527|NCT03129100|62847557|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473528|NCT03129100|62847558|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473529|NCT03129100|62847559|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473530|NCT03129100|62847560|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33655389|NCT03049449|63070506|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33655390|NCT03049449|63070507|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
33655391|NCT03049449|63070508|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33655392|NCT03049449|63070509|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
33655393|NCT02989857|63070632|FG000|Randomization Phase|Not Treated|3|||
33655394|NCT02989857|63070633|FG001|Randomization Phase|Not Treated|2|||
33655395|NCT02989857|63070634|FG002|Randomization Phase|Not Treated|0|||
33655396|NCT01877915|63070645|FG000|Overall Study|Lost to Follow-up|10|||
33655397|NCT01877915|63070646|FG001|Overall Study|Lost to Follow-up|9|||
33655398|NCT01877915|63070645|FG000|Overall Study|Withdrawal by Subject|42|||
33655399|NCT01877915|63070646|FG001|Overall Study|Withdrawal by Subject|55|||
33655400|NCT01877915|63070645|FG000|Overall Study|Other|2|||
33473531|NCT03129100|62847561|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473532|NCT03129100|62847562|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473533|NCT03129100|62847563|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473534|NCT03129100|62847564|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473535|NCT03129100|62847565|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33473536|NCT03129100|62847566|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33357293|NCT00896532|62734808|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357294|NCT00896532|62734809|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357295|NCT00896532|62734810|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33357296|NCT00896532|62734788|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357297|NCT00896532|62734789|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357298|NCT00896532|62734790|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33473537|NCT03129100|62847541|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473538|NCT03129100|62847542|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473539|NCT03129100|62847543|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473540|NCT03129100|62847544|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473541|NCT03129100|62847545|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
33473542|NCT03129100|62847546|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
33473543|NCT03129100|62847547|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
33473544|NCT03129100|62847548|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473545|NCT03129100|62847549|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473546|NCT03129100|62847550|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473547|NCT03129100|62847551|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473548|NCT03129100|62847552|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473549|NCT03129100|62847553|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473550|NCT03129100|62847554|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473551|NCT03129100|62847555|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473552|NCT03129100|62847556|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473553|NCT03129100|62847557|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473554|NCT03129100|62847558|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473555|NCT03129100|62847559|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473556|NCT03129100|62847560|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473557|NCT03129100|62847561|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473558|NCT03129100|62847562|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473559|NCT03129100|62847563|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473560|NCT03129100|62847564|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473561|NCT03129100|62847565|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473562|NCT03129100|62847566|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33473563|NCT03129100|62847541|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473564|NCT03129100|62847542|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473565|NCT03129100|62847543|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473566|NCT03129100|62847544|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473567|NCT03129100|62847545|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473568|NCT03129100|62847546|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473569|NCT03129100|62847547|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473570|NCT03129100|62847548|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33655401|NCT01877915|63070646|FG001|Overall Study|Other|4|||
33655402|NCT01876979|63070654|FG000|Overall Study|Physician Decision|2|||
33655403|NCT01876979|63070655|FG001|Overall Study|Physician Decision|3|||
33655404|NCT01860989|63070661|FG000|Overall Study|Unsatisfactory therapeutic|5|||
33655405|NCT01860677|63070677|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
33357299|NCT00896532|62734791|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357300|NCT00896532|62734792|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357301|NCT00896532|62734793|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357302|NCT00896532|62734794|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357303|NCT00896532|62734795|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357304|NCT00896532|62734796|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357305|NCT00896532|62734797|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357306|NCT00896532|62734798|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357307|NCT00896532|62734799|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357308|NCT00896532|62734800|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357309|NCT00896532|62734801|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357310|NCT00896532|62734802|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357311|NCT00896532|62734803|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357312|NCT00896532|62734804|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
33357313|NCT00896532|62734805|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357314|NCT00896532|62734806|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357315|NCT00896532|62734807|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357316|NCT00896532|62734808|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357317|NCT00896532|62734809|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357318|NCT00896532|62734810|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33357319|NCT00896532|62734788|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
33357320|NCT00896532|62734789|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
33357321|NCT00896532|62734790|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
33357322|NCT00896532|62734791|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
33357323|NCT00896532|62734792|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
33357324|NCT00896532|62734793|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
33357325|NCT00896532|62734794|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
33357326|NCT00896532|62734795|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
33357327|NCT00896532|62734796|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
33357328|NCT00896532|62734797|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
33357329|NCT00896532|62734798|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
33357330|NCT00896532|62734799|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
33357331|NCT00896532|62734800|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
33357332|NCT00896532|62734801|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
33357333|NCT00896532|62734802|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
33357334|NCT00896532|62734803|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
33357335|NCT00896532|62734804|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
33357336|NCT00896532|62734805|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
33357337|NCT00896532|62734806|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
33357338|NCT00896532|62734807|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
33357339|NCT00896532|62734808|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
33357340|NCT00896532|62734809|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
33357341|NCT00896532|62734810|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
33357342|NCT00896532|62734788|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357343|NCT00896532|62734789|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357344|NCT00896532|62734790|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357345|NCT00896532|62734791|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357346|NCT00896532|62734792|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357347|NCT00896532|62734793|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357348|NCT00896532|62734794|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357349|NCT00896532|62734795|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357350|NCT00896532|62734796|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357351|NCT00896532|62734797|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357352|NCT00896532|62734798|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357353|NCT00896532|62734799|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357354|NCT00896532|62734800|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357355|NCT00896532|62734801|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357356|NCT00896532|62734802|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357357|NCT00896532|62734803|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357358|NCT00896532|62734804|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
33357359|NCT00896532|62734805|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357360|NCT00896532|62734806|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357361|NCT00896532|62734807|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33473571|NCT03129100|62847549|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33357362|NCT00896532|62734808|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357363|NCT00896532|62734809|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357364|NCT00896532|62734810|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33357365|NCT00896532|62734788|FG000|Months 48-72: Follow-on Phase|Death|0|||
33357366|NCT00896532|62734789|FG001|Months 48-72: Follow-on Phase|Death|0|||
33357367|NCT00896532|62734790|FG002|Months 48-72: Follow-on Phase|Death|0|||
33357368|NCT00896532|62734791|FG003|Months 48-72: Follow-on Phase|Death|0|||
33357369|NCT00896532|62734792|FG004|Months 48-72: Follow-on Phase|Death|0|||
33357370|NCT00896532|62734793|FG005|Months 48-72: Follow-on Phase|Death|0|||
33357371|NCT00896532|62734794|FG006|Months 48-72: Follow-on Phase|Death|0|||
33357372|NCT00896532|62734795|FG007|Months 48-72: Follow-on Phase|Death|0|||
33357373|NCT00896532|62734796|FG008|Months 48-72: Follow-on Phase|Death|0|||
33357374|NCT00896532|62734797|FG009|Months 48-72: Follow-on Phase|Death|0|||
33357375|NCT00896532|62734798|FG010|Months 48-72: Follow-on Phase|Death|0|||
33357376|NCT00896532|62734799|FG011|Months 48-72: Follow-on Phase|Death|0|||
33357377|NCT00896532|62734800|FG012|Months 48-72: Follow-on Phase|Death|0|||
33357378|NCT00896532|62734801|FG013|Months 48-72: Follow-on Phase|Death|0|||
33357379|NCT00896532|62734802|FG014|Months 48-72: Follow-on Phase|Death|0|||
33357380|NCT00896532|62734803|FG015|Months 48-72: Follow-on Phase|Death|0|||
33357381|NCT00896532|62734804|FG016|Months 48-72: Follow-on Phase|Death|0|||
33357382|NCT00896532|62734805|FG017|Months 48-72: Follow-on Phase|Death|0|||
33357383|NCT00896532|62734806|FG018|Months 48-72: Follow-on Phase|Death|1|||
33357384|NCT00896532|62734807|FG019|Months 48-72: Follow-on Phase|Death|0|||
33357385|NCT00896532|62734808|FG020|Months 48-72: Follow-on Phase|Death|0|||
33357386|NCT00896532|62734809|FG021|Months 48-72: Follow-on Phase|Death|0|||
33357387|NCT00896532|62734810|FG022|Months 48-72: Follow-on Phase|Death|0|||
33357388|NCT00896532|62734788|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357389|NCT00896532|62734789|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357390|NCT00896532|62734790|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357391|NCT00896532|62734791|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357392|NCT00896532|62734792|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357393|NCT00896532|62734793|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357394|NCT00896532|62734794|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357395|NCT00896532|62734795|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357396|NCT00896532|62734796|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357397|NCT00896532|62734797|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357398|NCT00896532|62734798|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357399|NCT00896532|62734799|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357400|NCT00896532|62734800|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33473572|NCT03129100|62847550|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
33473573|NCT03129100|62847551|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473574|NCT03129100|62847552|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473575|NCT03129100|62847553|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473576|NCT03129100|62847554|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473577|NCT03129100|62847555|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473578|NCT03129100|62847556|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473579|NCT03129100|62847557|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473580|NCT03129100|62847558|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473581|NCT03129100|62847559|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473582|NCT03129100|62847560|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473583|NCT03129100|62847561|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473584|NCT03129100|62847562|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33357401|NCT00896532|62734801|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357402|NCT00896532|62734802|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33473585|NCT03129100|62847563|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33357403|NCT00896532|62734803|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357404|NCT00896532|62734804|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357405|NCT00896532|62734805|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357406|NCT00896532|62734806|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357407|NCT00896532|62734807|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357408|NCT00896532|62734808|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357409|NCT00896532|62734809|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
33357410|NCT00896532|62734810|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33357411|NCT00896532|62734788|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357412|NCT00896532|62734789|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357413|NCT00896532|62734790|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357414|NCT00896532|62734791|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357415|NCT00896532|62734792|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357416|NCT00896532|62734793|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357417|NCT00896532|62734794|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357418|NCT00896532|62734795|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357419|NCT00896532|62734796|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357420|NCT00896532|62734797|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357421|NCT00896532|62734798|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357422|NCT00896532|62734799|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357423|NCT00896532|62734800|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357424|NCT00896532|62734801|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357425|NCT00896532|62734802|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357426|NCT00896532|62734803|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357427|NCT00896532|62734804|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357428|NCT00896532|62734805|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357429|NCT00896532|62734806|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357430|NCT00896532|62734807|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357431|NCT00896532|62734808|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357432|NCT00896532|62734809|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
33357433|NCT00896532|62734810|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33357434|NCT00574873|62734859|FG000|Overall Study|Withdrawal by Subject|18|||
33357435|NCT00574873|62734860|FG001|Overall Study|Withdrawal by Subject|19|||
33357436|NCT00574873|62734859|FG000|Overall Study|Investigator request|18|||
33357437|NCT00574873|62734860|FG001|Overall Study|Investigator request|8|||
33357438|NCT00574873|62734859|FG000|Overall Study|Death|15|||
33357439|NCT00574873|62734860|FG001|Overall Study|Death|14|||
33357440|NCT00574873|62734859|FG000|Overall Study|Lost to Follow-up|14|||
33357441|NCT00574873|62734860|FG001|Overall Study|Lost to Follow-up|5|||
33357442|NCT00574873|62734859|FG000|Overall Study|Other|40|||
33357443|NCT00574873|62734860|FG001|Overall Study|Other|4|||
33357444|NCT00574873|62734859|FG000|Overall Study|Discontinuation of study by sponsor|5|||
33357445|NCT00574873|62734860|FG001|Overall Study|Discontinuation of study by sponsor|199|||
33357446|NCT00574873|62734859|FG000|Overall Study|Blank, site closed per local regulations|2|||
33357447|NCT00574873|62734860|FG001|Overall Study|Blank, site closed per local regulations|2|||
33357448|NCT00574873|62734859|FG000|Overall Study|Extension Study|126|||
33357449|NCT00574873|62734860|FG001|Overall Study|Extension Study|0|||
33357450|NCT00902174|62734868|FG000|Overall Study|Adverse Event|27|||
33357451|NCT00902174|62734869|FG001|Overall Study|Adverse Event|7|||
33357452|NCT00902174|62734868|FG000|Overall Study|Lack of Efficacy|1|||
33357453|NCT00902174|62734869|FG001|Overall Study|Lack of Efficacy|5|||
33357454|NCT00902174|62734868|FG000|Overall Study|Death|2|||
33357455|NCT00902174|62734869|FG001|Overall Study|Death|2|||
33357456|NCT00902174|62734868|FG000|Overall Study|Withdrawal by Subject|2|||
33357457|NCT00902174|62734869|FG001|Overall Study|Withdrawal by Subject|1|||
33357458|NCT00902174|62734868|FG000|Overall Study|Abnormal labs|1|||
33357459|NCT00902174|62734869|FG001|Overall Study|Abnormal labs|1|||
33357460|NCT00902174|62734868|FG000|Overall Study|Protocol Violation|1|||
33357461|NCT00902174|62734869|FG001|Overall Study|Protocol Violation|1|||
33357462|NCT00902174|62734868|FG000|Overall Study|Administration problem|0|||
33357463|NCT00902174|62734869|FG001|Overall Study|Administration problem|1|||
33357464|NCT00623623|62734893|FG000|Overall Study|Previous enrolment into this study|1|||
33357465|NCT00623623|62734894|FG001|Overall Study|Previous enrolment into this study|1|||
33357466|NCT00896454|62734900|FG000|Overall Study|Death|10|||
33357467|NCT00896454|62734900|FG000|Overall Study|Adverse Event|8|||
33357468|NCT00896454|62734900|FG000|Overall Study|Disease Progression|5|||
33357469|NCT00896454|62734900|FG000|Overall Study|Other|4|||
33357470|NCT00896454|62734900|FG000|Overall Study|Requirement for alternative therapy|3|||
33357471|NCT00896454|62734900|FG000|Overall Study|Ongoing in study|2|||
33357472|NCT00896454|62734900|FG000|Overall Study|Withdrawal by Subject|1|||
33357473|NCT00629239|62734906|FG000|Overall Study|Adverse Event|7|||
33357474|NCT00629239|62734907|FG001|Overall Study|Adverse Event|4|||
33357475|NCT00629239|62734906|FG000|Overall Study|Physician Decision|1|||
33357476|NCT00629239|62734907|FG001|Overall Study|Physician Decision|0|||
33357477|NCT00625807|62734915|FG000|Overall Study|schedule conflict|2|||
33357478|NCT00625807|62734916|FG001|Overall Study|schedule conflict|8|||
33357479|NCT00629083|62734926|FG000|Overall Study|Adverse Event|0|||
33357480|NCT00629083|62734927|FG001|Overall Study|Adverse Event|2|||
33357481|NCT00629083|62734926|FG000|Overall Study|Lack of Efficacy|3|||
33357482|NCT00629083|62734927|FG001|Overall Study|Lack of Efficacy|1|||
33357483|NCT00629083|62734926|FG000|Overall Study|Withdrawal by Subject|10|||
33357484|NCT00629083|62734927|FG001|Overall Study|Withdrawal by Subject|2|||
33357485|NCT00629083|62734926|FG000|Overall Study|Lost to Follow-up|12|||
33357486|NCT00629083|62734927|FG001|Overall Study|Lost to Follow-up|8|||
33357487|NCT00629083|62734926|FG000|Overall Study|Moved out of country/state|2|||
33357488|NCT00629083|62734927|FG001|Overall Study|Moved out of country/state|1|||
33357489|NCT00629083|62734926|FG000|Overall Study|Refused to return for 12 month visit|1|||
33357490|NCT00629083|62734927|FG001|Overall Study|Refused to return for 12 month visit|0|||
33357491|NCT00901628|62734937|FG000|Overall Study|disconnection of catheter|4|||
33357492|NCT00901628|62734938|FG001|Overall Study|disconnection of catheter|8|||
33357493|NCT00901628|62734937|FG000|Overall Study|disconnection of drain|0|||
33357494|NCT00901628|62734938|FG001|Overall Study|disconnection of drain|1|||
33357495|NCT00901628|62734937|FG000|Overall Study|peroneal nerve palsy|0|||
33357496|NCT00901628|62734938|FG001|Overall Study|peroneal nerve palsy|1|||
33357497|NCT00623545|62734944|FG000|Overall Study|Adverse Event|6|||
33357498|NCT00623545|62734944|FG000|Overall Study|Withdrawal by Subject|4|||
33357499|NCT00628927|62734951|FG000|Overall Study|Problems performing blood draw|6|||
33357500|NCT00628927|62734952|FG001|Overall Study|Problems performing blood draw|0|||
33357501|NCT00628927|62734951|FG000|Overall Study|Lost to Follow-up|1|||
33357502|NCT00628927|62734952|FG001|Overall Study|Lost to Follow-up|0|||
33357503|NCT00628927|62734951|FG000|Overall Study|Equipment failure|1|||
33357504|NCT00628927|62734952|FG001|Overall Study|Equipment failure|0|||
33357505|NCT00623467|62734963|FG000|Overall Study|Lost to Follow-up|1|||
33357506|NCT00623467|62734963|FG000|Overall Study|Protocol Violation|4|||
33357507|NCT00623467|62734963|FG000|Overall Study|Withdrawal by Subject|2|||
33357508|NCT00838539|62734981|FG000|Overall Study|Disease Progression|2|||
33357509|NCT00838539|62734982|FG001|Overall Study|Disease Progression|4|||
33357510|NCT00838539|62734983|FG002|Overall Study|Disease Progression|3|||
33357511|NCT00838539|62734984|FG003|Overall Study|Disease Progression|2|||
33357512|NCT00838539|62734985|FG004|Overall Study|Disease Progression|4|||
33357513|NCT00838539|62734986|FG005|Overall Study|Disease Progression|2|||
33357514|NCT00838539|62734987|FG006|Overall Study|Disease Progression|3|||
33357515|NCT00838539|62734988|FG007|Overall Study|Disease Progression|4|||
33357516|NCT00838539|62734989|FG008|Overall Study|Disease Progression|4|||
33357517|NCT00838539|62734990|FG009|Overall Study|Disease Progression|5|||
33357518|NCT00838539|62734991|FG010|Overall Study|Disease Progression|1|||
33357519|NCT00838539|62734992|FG011|Overall Study|Disease Progression|4|||
33357520|NCT00838539|62734981|FG000|Overall Study|Adverse Event|1|||
33357521|NCT00838539|62734982|FG001|Overall Study|Adverse Event|1|||
33357522|NCT00838539|62734983|FG002|Overall Study|Adverse Event|1|||
33357523|NCT00838539|62734984|FG003|Overall Study|Adverse Event|1|||
33357524|NCT00838539|62734985|FG004|Overall Study|Adverse Event|2|||
33357525|NCT00838539|62734986|FG005|Overall Study|Adverse Event|1|||
33357526|NCT00838539|62734987|FG006|Overall Study|Adverse Event|0|||
33357527|NCT00838539|62734988|FG007|Overall Study|Adverse Event|2|||
33357528|NCT00838539|62734989|FG008|Overall Study|Adverse Event|0|||
33357529|NCT00838539|62734990|FG009|Overall Study|Adverse Event|1|||
33357530|NCT00838539|62734991|FG010|Overall Study|Adverse Event|2|||
33357531|NCT00838539|62734992|FG011|Overall Study|Adverse Event|0|||
33357532|NCT00838539|62734981|FG000|Overall Study|Withdrawal by Subject|0|||
33357533|NCT00838539|62734982|FG001|Overall Study|Withdrawal by Subject|1|||
33357534|NCT00838539|62734983|FG002|Overall Study|Withdrawal by Subject|0|||
33357535|NCT00838539|62734984|FG003|Overall Study|Withdrawal by Subject|0|||
33357536|NCT00838539|62734985|FG004|Overall Study|Withdrawal by Subject|0|||
33357537|NCT00838539|62734986|FG005|Overall Study|Withdrawal by Subject|0|||
33357538|NCT00838539|62734987|FG006|Overall Study|Withdrawal by Subject|0|||
33357539|NCT00838539|62734988|FG007|Overall Study|Withdrawal by Subject|0|||
33357540|NCT00838539|62734989|FG008|Overall Study|Withdrawal by Subject|0|||
33357541|NCT00838539|62734990|FG009|Overall Study|Withdrawal by Subject|1|||
33357542|NCT00838539|62734991|FG010|Overall Study|Withdrawal by Subject|2|||
33357543|NCT00838539|62734992|FG011|Overall Study|Withdrawal by Subject|0|||
33357544|NCT00838539|62734981|FG000|Overall Study|Death|0|||
33357545|NCT00838539|62734982|FG001|Overall Study|Death|0|||
33357546|NCT00838539|62734983|FG002|Overall Study|Death|0|||
33473586|NCT03129100|62847564|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33357547|NCT00838539|62734984|FG003|Overall Study|Death|0|||
33357548|NCT00838539|62734985|FG004|Overall Study|Death|0|||
33357549|NCT00838539|62734986|FG005|Overall Study|Death|0|||
33357550|NCT00838539|62734987|FG006|Overall Study|Death|1|||
33357551|NCT00838539|62734988|FG007|Overall Study|Death|0|||
33357552|NCT00838539|62734989|FG008|Overall Study|Death|0|||
33357553|NCT00838539|62734990|FG009|Overall Study|Death|0|||
33357554|NCT00838539|62734991|FG010|Overall Study|Death|0|||
33357555|NCT00838539|62734992|FG011|Overall Study|Death|0|||
33357556|NCT00838539|62734981|FG000|Overall Study|Physician Decision|0|||
33357557|NCT00838539|62734982|FG001|Overall Study|Physician Decision|0|||
33357558|NCT00838539|62734983|FG002|Overall Study|Physician Decision|0|||
33357559|NCT00838539|62734984|FG003|Overall Study|Physician Decision|0|||
33357560|NCT00838539|62734985|FG004|Overall Study|Physician Decision|0|||
33357561|NCT00838539|62734986|FG005|Overall Study|Physician Decision|0|||
33357562|NCT00838539|62734987|FG006|Overall Study|Physician Decision|0|||
33357563|NCT00838539|62734988|FG007|Overall Study|Physician Decision|0|||
33357564|NCT00838539|62734989|FG008|Overall Study|Physician Decision|1|||
33357565|NCT00838539|62734990|FG009|Overall Study|Physician Decision|0|||
33357566|NCT00838539|62734991|FG010|Overall Study|Physician Decision|0|||
33357567|NCT00838539|62734992|FG011|Overall Study|Physician Decision|0|||
33357568|NCT00838539|62734981|FG000|Overall Study|Clinical Progression|0|||
33357569|NCT00838539|62734982|FG001|Overall Study|Clinical Progression|0|||
33357570|NCT00838539|62734983|FG002|Overall Study|Clinical Progression|0|||
33357571|NCT00838539|62734984|FG003|Overall Study|Clinical Progression|0|||
33357572|NCT00838539|62734985|FG004|Overall Study|Clinical Progression|0|||
33473587|NCT03129100|62847565|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473588|NCT03129100|62847566|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33473589|NCT03129100|62847541|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473590|NCT03129100|62847542|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473591|NCT03129100|62847543|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473592|NCT03129100|62847544|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473593|NCT03129100|62847545|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473594|NCT03129100|62847546|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473595|NCT03129100|62847547|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473596|NCT03129100|62847548|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473597|NCT03129100|62847549|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473598|NCT03129100|62847550|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473599|NCT03129100|62847551|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473600|NCT03129100|62847552|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
33473601|NCT03129100|62847553|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473602|NCT03129100|62847554|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473603|NCT03129100|62847555|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473604|NCT03129100|62847556|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473605|NCT03129100|62847557|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473606|NCT03129100|62847558|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473607|NCT03129100|62847559|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473608|NCT03129100|62847560|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473609|NCT03129100|62847561|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473610|NCT03129100|62847562|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473611|NCT03129100|62847563|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473612|NCT03129100|62847564|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473613|NCT03129100|62847565|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473614|NCT03129100|62847566|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33473615|NCT03129100|62847541|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473616|NCT03129100|62847542|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473617|NCT03129100|62847543|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473618|NCT03129100|62847544|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473619|NCT03129100|62847545|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33357573|NCT00838539|62734986|FG005|Overall Study|Clinical Progression|0|||
33357574|NCT00838539|62734987|FG006|Overall Study|Clinical Progression|1|||
33357575|NCT00838539|62734988|FG007|Overall Study|Clinical Progression|0|||
33357576|NCT00838539|62734989|FG008|Overall Study|Clinical Progression|0|||
33357577|NCT00838539|62734990|FG009|Overall Study|Clinical Progression|0|||
33357578|NCT00838539|62734991|FG010|Overall Study|Clinical Progression|0|||
33357579|NCT00838539|62734992|FG011|Overall Study|Clinical Progression|0|||
33357580|NCT00838539|62734981|FG000|Overall Study|Symptomatic Deterioration|0|||
33357581|NCT00838539|62734982|FG001|Overall Study|Symptomatic Deterioration|0|||
33357582|NCT00838539|62734983|FG002|Overall Study|Symptomatic Deterioration|1|||
33357583|NCT00838539|62734984|FG003|Overall Study|Symptomatic Deterioration|1|||
33357584|NCT00838539|62734985|FG004|Overall Study|Symptomatic Deterioration|0|||
33357585|NCT00838539|62734986|FG005|Overall Study|Symptomatic Deterioration|1|||
33357586|NCT00838539|62734987|FG006|Overall Study|Symptomatic Deterioration|0|||
33357587|NCT00838539|62734988|FG007|Overall Study|Symptomatic Deterioration|0|||
33357588|NCT00838539|62734989|FG008|Overall Study|Symptomatic Deterioration|0|||
33357589|NCT00838539|62734990|FG009|Overall Study|Symptomatic Deterioration|1|||
33357590|NCT00838539|62734991|FG010|Overall Study|Symptomatic Deterioration|0|||
33357591|NCT00838539|62734992|FG011|Overall Study|Symptomatic Deterioration|0|||
33357592|NCT00837759|62735032|FG000|Overall Study|Protocol Violation|3|||
33357593|NCT00837759|62735032|FG000|Overall Study|Lost to Follow-up|1|||
33473620|NCT03129100|62847546|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473621|NCT03129100|62847547|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473622|NCT03129100|62847548|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473623|NCT03129100|62847549|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473624|NCT03129100|62847550|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473625|NCT03129100|62847551|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473626|NCT03129100|62847552|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
33473627|NCT03129100|62847553|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
33473628|NCT03129100|62847554|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
33473629|NCT03129100|62847555|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
33473630|NCT03129100|62847556|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473631|NCT03129100|62847557|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473632|NCT03129100|62847558|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473633|NCT03129100|62847559|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473634|NCT03129100|62847560|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473635|NCT03129100|62847561|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473636|NCT03129100|62847562|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473637|NCT03129100|62847563|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473638|NCT03129100|62847564|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473639|NCT03129100|62847565|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473640|NCT03129100|62847566|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33473641|NCT03129100|62847541|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473642|NCT03129100|62847542|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473643|NCT03129100|62847543|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473644|NCT03129100|62847544|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473645|NCT03129100|62847545|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473646|NCT03129100|62847546|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473647|NCT03129100|62847547|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473648|NCT03129100|62847548|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473649|NCT03129100|62847549|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473650|NCT03129100|62847550|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473651|NCT03129100|62847551|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473652|NCT03129100|62847552|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
33473653|NCT03129100|62847553|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473654|NCT03129100|62847554|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
33473655|NCT03129100|62847555|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
33473656|NCT03129100|62847556|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473657|NCT03129100|62847557|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473658|NCT03129100|62847558|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473659|NCT03129100|62847559|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473660|NCT03129100|62847560|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473661|NCT03129100|62847561|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473662|NCT03129100|62847562|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473663|NCT03129100|62847563|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473664|NCT03129100|62847564|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473665|NCT03129100|62847565|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473666|NCT03129100|62847566|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33473667|NCT03129100|62847541|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473668|NCT03129100|62847542|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473669|NCT03129100|62847543|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473670|NCT03129100|62847544|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473671|NCT03129100|62847545|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473672|NCT03129100|62847546|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473673|NCT03129100|62847547|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473674|NCT03129100|62847548|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473675|NCT03129100|62847549|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33357594|NCT00891774|62735036|FG000|Overall Study|Lost to Follow-up|5|||
33357595|NCT00891774|62735036|FG000|Overall Study|Illness (Self/Mother)|3|||
33357596|NCT00891774|62735036|FG000|Overall Study|Withdrawal by Subject|2|||
33357597|NCT00891774|62735036|FG000|Overall Study|Protocol Violation|4|||
33357598|NCT05421754|62735040|FG000|Overall Study|Technical issue with sensor|1|||
33357599|NCT04644276|62735062|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
33357600|NCT04644276|62735063|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
33357601|NCT04644276|62735064|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
33357602|NCT03845296|62735093|FG000|Overall Study|On Treatment|2|||
33357603|NCT03845296|62735094|FG001|Overall Study|On Treatment|1|||
33357604|NCT03845296|62735093|FG000|Overall Study|Adverse Event|4|||
33357605|NCT03845296|62735094|FG001|Overall Study|Adverse Event|11|||
33357606|NCT03845296|62735093|FG000|Overall Study|Refusal unrelated to adverse event|0|||
33357607|NCT03845296|62735094|FG001|Overall Study|Refusal unrelated to adverse event|1|||
33357608|NCT03845296|62735093|FG000|Overall Study|Progression/relapse|14|||
33357609|NCT03845296|62735094|FG001|Overall Study|Progression/relapse|18|||
33357610|NCT03845296|62735093|FG000|Overall Study|Death|4|||
33357611|NCT03845296|62735094|FG001|Overall Study|Death|0|||
33357612|NCT03845296|62735093|FG000|Overall Study|Other - not protocol specified|1|||
33357613|NCT03845296|62735094|FG001|Overall Study|Other - not protocol specified|3|||
33357614|NCT02115282|62735141|FG000|Overall Study|Disease progression during treatment|216|||
33357615|NCT02115282|62735142|FG001|Overall Study|Disease progression during treatment|229|||
33357616|NCT02115282|62735141|FG000|Overall Study|Adverse Event|49|||
33357617|NCT02115282|62735142|FG001|Overall Study|Adverse Event|23|||
33357618|NCT02115282|62735141|FG000|Overall Study|Death|1|||
33357619|NCT02115282|62735142|FG001|Overall Study|Death|3|||
33357620|NCT02115282|62735141|FG000|Overall Study|Alternative therapy|1|||
33357621|NCT02115282|62735142|FG001|Overall Study|Alternative therapy|1|||
33357622|NCT02115282|62735141|FG000|Overall Study|Complicating disease|0|||
33357623|NCT02115282|62735142|FG001|Overall Study|Complicating disease|3|||
33357624|NCT02115282|62735141|FG000|Overall Study|Withdrawal by Subject|12|||
33357625|NCT02115282|62735142|FG001|Overall Study|Withdrawal by Subject|10|||
33357626|NCT02115282|62735141|FG000|Overall Study|Symptomatic progression/deterioration|7|||
33357627|NCT02115282|62735142|FG001|Overall Study|Symptomatic progression/deterioration|18|||
33357628|NCT02115282|62735141|FG000|Overall Study|Non-compliance|5|||
33357629|NCT02115282|62735142|FG001|Overall Study|Non-compliance|1|||
33357630|NCT02115282|62735141|FG000|Overall Study|Protocol Violation|2|||
33357631|NCT02115282|62735142|FG001|Overall Study|Protocol Violation|2|||
33357632|NCT02115282|62735141|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
33473676|NCT03129100|62847550|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473677|NCT03129100|62847551|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473678|NCT03129100|62847552|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473679|NCT03129100|62847553|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473680|NCT03129100|62847554|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473681|NCT03129100|62847555|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473682|NCT03129100|62847556|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
33473683|NCT03129100|62847557|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473684|NCT03129100|62847558|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473685|NCT03129100|62847559|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473686|NCT03129100|62847560|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473687|NCT03129100|62847561|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473688|NCT03129100|62847562|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473689|NCT03129100|62847563|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33357633|NCT02115282|62735142|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
33357634|NCT02115282|62735141|FG000|Overall Study|Not start protocol therapy|9|||
33473690|NCT03129100|62847564|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473691|NCT03129100|62847565|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473692|NCT03129100|62847566|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33473693|NCT03129100|62847541|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473694|NCT03129100|62847542|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473695|NCT03129100|62847543|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33549209|NCT02871739|62940446|FG002|Overall Study|Lost to Follow-up|0|||
33549210|NCT02871739|62940447|FG003|Overall Study|Lost to Follow-up|2|||
33549211|NCT02896361|62940457|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
33655406|NCT01860677|63070678|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
33549212|NCT02896361|62940458|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
33357635|NCT02115282|62735142|FG001|Overall Study|Not start protocol therapy|10|||
33357636|NCT01596621|62735150|FG000|Overall Study|Death|4|||
33357637|NCT01596621|62735150|FG000|Overall Study|Withdrawal by Subject|9|||
33357638|NCT01596621|62735150|FG000|Overall Study|Disease Progression|49|||
33357639|NCT01596621|62735150|FG000|Overall Study|Lost to Follow-up|3|||
33357640|NCT01596621|62735150|FG000|Overall Study|Other than specified|13|||
33473696|NCT03129100|62847544|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473697|NCT03129100|62847545|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473698|NCT03129100|62847546|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473699|NCT03129100|62847547|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473700|NCT03129100|62847548|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473701|NCT03129100|62847549|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473702|NCT03129100|62847550|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473703|NCT03129100|62847551|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473704|NCT03129100|62847552|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473705|NCT03129100|62847553|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
33473706|NCT03129100|62847554|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473707|NCT03129100|62847555|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
33473708|NCT03129100|62847556|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
33473709|NCT03129100|62847557|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473710|NCT03129100|62847558|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473711|NCT03129100|62847559|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473712|NCT03129100|62847560|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473713|NCT03129100|62847561|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473714|NCT03129100|62847562|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473715|NCT03129100|62847563|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473716|NCT03129100|62847564|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473717|NCT03129100|62847565|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473718|NCT03129100|62847566|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33473719|NCT03129100|62847541|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473720|NCT03129100|62847542|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473721|NCT03129100|62847543|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473722|NCT03129100|62847544|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473723|NCT03129100|62847545|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473724|NCT03129100|62847546|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473725|NCT03129100|62847547|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473726|NCT03129100|62847548|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473727|NCT03129100|62847549|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473728|NCT03129100|62847550|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473729|NCT03129100|62847551|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473730|NCT03129100|62847552|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473731|NCT03129100|62847553|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473732|NCT03129100|62847554|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473733|NCT03129100|62847555|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473734|NCT03129100|62847556|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473735|NCT03129100|62847557|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473736|NCT03129100|62847558|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
33473737|NCT03129100|62847559|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473738|NCT03129100|62847560|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
33473739|NCT03129100|62847561|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473740|NCT03129100|62847562|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473741|NCT03129100|62847563|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33473742|NCT03129100|62847564|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33549213|NCT02896361|62940459|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
33549214|NCT02896361|62940457|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
33549215|NCT02896361|62940458|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
33549216|NCT02896361|62940459|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
33549217|NCT02962739|62940482|FG000|Overall Study|Withdrawal by Subject|0|||
33549218|NCT02962739|62940483|FG001|Overall Study|Withdrawal by Subject|1|||
33549219|NCT02962739|62940484|FG002|Overall Study|Withdrawal by Subject|0|||
33549220|NCT02962739|62940485|FG003|Overall Study|Withdrawal by Subject|0|||
33473743|NCT03129100|62847565|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33549221|NCT02962739|62940486|FG004|Overall Study|Withdrawal by Subject|0|||
33549222|NCT02962739|62940487|FG005|Overall Study|Withdrawal by Subject|0|||
33549223|NCT02962739|62940482|FG000|Overall Study|Protocol Violation|0|||
33549224|NCT02962739|62940483|FG001|Overall Study|Protocol Violation|0|||
33357641|NCT01337245|62735154|FG000|Overall Study|Lost to Follow-up|1|||
33473744|NCT03129100|62847566|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33549225|NCT02962739|62940484|FG002|Overall Study|Protocol Violation|1|||
33549226|NCT02962739|62940485|FG003|Overall Study|Protocol Violation|0|||
33549227|NCT02962739|62940486|FG004|Overall Study|Protocol Violation|1|||
33549228|NCT02962739|62940487|FG005|Overall Study|Protocol Violation|0|||
33549229|NCT01344629|62940495|FG000|Crossover Period 2|Withdrawal by Subject|0|||
33549230|NCT01344629|62940496|FG001|Crossover Period 2|Withdrawal by Subject|1|||
33549231|NCT01092117|62940502|FG000|Index Procedure to 1 Month|Death|1|||
33549232|NCT01092117|62940502|FG000|1 Month|Death|1|||
33549233|NCT01092117|62940502|FG000|1 Month|Withdrawal by Subject|1|||
33549234|NCT01092117|62940502|FG000|1 Month|Lost to Follow-up|1|||
33549235|NCT01092117|62940502|FG000|6 Months|Death|2|||
33549236|NCT01092117|62940502|FG000|6 Months|Withdrawal by Subject|3|||
33549237|NCT01092117|62940502|FG000|12 Month|Death|11|||
33549238|NCT01092117|62940502|FG000|12 Month|Withdrawal by Subject|2|||
33549239|NCT01092117|62940502|FG000|12 Month|Lost to Follow-up|1|||
33549240|NCT01092117|62940502|FG000|Year 2|Death|5|||
33357642|NCT00566098|62735164|FG000|Collection of MILs|Withdrawal by Subject|1|||
33357643|NCT00566098|62735164|FG000|Collection of MILs|Relapsed|1|||
33357644|NCT00566098|62735164|FG000|Generation of MILs Product|Relapsed|1|||
33357645|NCT00566098|62735164|FG000|Administration of ASCT+MILs|Death|10|||
33357646|NCT00566098|62735164|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
33357647|NCT00248287|62735171|FG000|Overall Study|Adverse Event|11|||
33357648|NCT00248287|62735172|FG001|Overall Study|Adverse Event|10|||
33357649|NCT00248287|62735171|FG000|Overall Study|Death|1|||
33357650|NCT00248287|62735172|FG001|Overall Study|Death|0|||
33357651|NCT00248287|62735171|FG000|Overall Study|Lost to Follow-up|0|||
33357652|NCT00248287|62735172|FG001|Overall Study|Lost to Follow-up|1|||
33357653|NCT00248287|62735171|FG000|Overall Study|Investigator Request|4|||
33357654|NCT00248287|62735172|FG001|Overall Study|Investigator Request|3|||
33357655|NCT00248287|62735171|FG000|Overall Study|Patient Request|5|||
33357656|NCT00248287|62735172|FG001|Overall Study|Patient Request|3|||
33357657|NCT00248287|62735171|FG000|Overall Study|Other|3|||
33357658|NCT00248287|62735172|FG001|Overall Study|Other|2|||
33357659|NCT00837213|62735180|FG000|Overall Study|Lost to Follow-up|3|||
33357660|NCT00837213|62735181|FG001|Overall Study|Lost to Follow-up|2|||
33357661|NCT00837213|62735180|FG000|Overall Study|Withdrawal by Subject|2|||
33357662|NCT00837213|62735181|FG001|Overall Study|Withdrawal by Subject|2|||
33357663|NCT00837213|62735180|FG000|Overall Study|not stated|1|||
33357664|NCT00837213|62735181|FG001|Overall Study|not stated|1|||
33357665|NCT00902486|62735191|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
33357666|NCT00902486|62735192|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
33357667|NCT00902486|62735193|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
33357668|NCT00902486|62735194|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
33357669|NCT00902486|62735195|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
33357670|NCT00902486|62735196|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
33357671|NCT00902486|62735191|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
33357672|NCT00902486|62735192|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
33357673|NCT00902486|62735193|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
33357674|NCT00902486|62735194|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
33357675|NCT00902486|62735195|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
33357676|NCT00902486|62735196|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
33357677|NCT00902486|62735191|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
33357678|NCT00902486|62735192|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
33357679|NCT00902486|62735193|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
33357680|NCT00902486|62735194|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
33357681|NCT00902486|62735195|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
33357682|NCT00902486|62735196|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
33357683|NCT00902486|62735191|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
33357684|NCT00902486|62735192|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
33357685|NCT00902486|62735193|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
33357686|NCT00902486|62735194|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
33473745|NCT03129100|62847541|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473746|NCT03129100|62847542|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473747|NCT03129100|62847543|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473748|NCT03129100|62847544|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473749|NCT03129100|62847545|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473750|NCT03129100|62847546|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473751|NCT03129100|62847547|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473752|NCT03129100|62847548|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33549241|NCT01092117|62940502|FG000|Year 2|Withdrawal by Subject|4|||
33549242|NCT01092117|62940502|FG000|Year 2|Lost to Follow-up|1|||
33655407|NCT01876901|63070696|FG000|Overall Study|Protocol Violation|10|||
33357687|NCT00902486|62735195|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
33357688|NCT00902486|62735196|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
33357689|NCT00902486|62735191|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
33357690|NCT00902486|62735192|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
33357691|NCT00902486|62735193|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
33357692|NCT00902486|62735194|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
33473753|NCT03129100|62847549|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33549243|NCT01092117|62940502|FG000|Year 3|Death|7|||
33549244|NCT01092117|62940502|FG000|Year 3|Withdrawal by Subject|9|||
33357693|NCT00902486|62735195|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
33357694|NCT00902486|62735196|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
33357695|NCT00902486|62735191|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
33357696|NCT00902486|62735192|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
33357697|NCT00902486|62735193|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
33357698|NCT00902486|62735194|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
33357699|NCT00902486|62735195|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
33357700|NCT00902486|62735196|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
33357701|NCT00902486|62735191|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
33357702|NCT00902486|62735192|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
33473754|NCT03129100|62847550|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473755|NCT03129100|62847551|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473756|NCT03129100|62847552|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473757|NCT03129100|62847553|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473758|NCT03129100|62847554|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473759|NCT03129100|62847555|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473760|NCT03129100|62847556|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33549245|NCT01092117|62940502|FG000|Year 3|Lost to Follow-up|3|||
33357703|NCT00902486|62735193|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
33357704|NCT00902486|62735194|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
33357705|NCT00902486|62735195|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
33357706|NCT00902486|62735196|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
33357707|NCT00902486|62735191|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
33357708|NCT00902486|62735192|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
33357709|NCT00902486|62735193|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
33357710|NCT00902486|62735194|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
33357711|NCT00902486|62735195|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
33357712|NCT00902486|62735196|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
33357713|NCT00902486|62735191|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
33357714|NCT00902486|62735192|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
33357715|NCT00902486|62735193|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
33357716|NCT00902486|62735194|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
33357717|NCT00902486|62735195|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
33357718|NCT00902486|62735196|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
33357719|NCT00902486|62735191|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
33357720|NCT00902486|62735192|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
33357721|NCT00902486|62735193|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
33357722|NCT00902486|62735194|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
33357723|NCT00902486|62735195|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
33357724|NCT00902486|62735196|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
33357725|NCT00902486|62735191|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
33357726|NCT00902486|62735192|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
33357727|NCT00902486|62735193|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
33357728|NCT00902486|62735194|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
33357729|NCT00902486|62735195|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
33357730|NCT00902486|62735196|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
33357731|NCT00836745|62735226|FG000|Overall Study|Death|2|||
33357732|NCT00836745|62735226|FG000|Overall Study|Lost to Follow-up|10|||
33357733|NCT00836745|62735226|FG000|Overall Study|Adverse Event|3|||
33357734|NCT00836745|62735226|FG000|Overall Study|Objective progression or relapse|4|||
33357735|NCT00836745|62735226|FG000|Overall Study|Other|2|||
33357736|NCT00891618|62735230|FG000|Overall Study|Withdrawal by Subject|1|||
33357737|NCT00836589|62735234|FG000|Overall Study|Lost to Follow-up|246|||
33357738|NCT00836589|62735234|FG000|Overall Study|Death|429|||
33357739|NCT00836589|62735234|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
33357740|NCT00574795|62735246|FG000|Infant Series|Withdrawal by Subject|2|||
33357741|NCT00574795|62735246|FG000|Infant Series|Protocol Violation|2|||
33357742|NCT00574795|62735246|FG000|Infant Series|Adverse Event|1|||
33357743|NCT00574795|62735246|FG000|After Infant Series|Withdrawal by Subject|1|||
33357744|NCT00574795|62735246|FG000|After Infant Series|Adverse Event|2|||
33357745|NCT00574795|62735246|FG000|Toddler Dose|Withdrawal by Subject|1|||
33357746|NCT02297516|62735263|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
33357747|NCT02297516|62735264|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
33357748|NCT02297516|62735263|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
33357749|NCT02297516|62735264|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
33357750|NCT02297516|62735263|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
33549246|NCT01092117|62940502|FG000|Year 4|Death|8|||
33357751|NCT02297516|62735264|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
33357752|NCT00836277|62735277|FG000|Overall Study|Not evaluable for response|6|||
33357753|NCT00835731|62735283|FG000|Overall Study|Withdrawal by Subject|1|||
33357754|NCT00835731|62735284|FG001|Overall Study|Withdrawal by Subject|0|||
33357755|NCT00835731|62735283|FG000|Overall Study|Physician Decision|1|||
33357756|NCT00835731|62735284|FG001|Overall Study|Physician Decision|1|||
33357757|NCT00835341|62735292|FG000|Overall Study|Lost to Follow-up|3|||
33357758|NCT00835341|62735293|FG001|Overall Study|Lost to Follow-up|12|||
33357759|NCT00574249|62735301|FG000|Overall Study|Adverse Event|6|||
33357760|NCT00574249|62735302|FG001|Overall Study|Adverse Event|18|||
33357761|NCT00574249|62735301|FG000|Overall Study|Lack of Efficacy|5|||
33357762|NCT00574249|62735302|FG001|Overall Study|Lack of Efficacy|3|||
33357763|NCT00574249|62735301|FG000|Overall Study|Lost to Follow-up|4|||
33357764|NCT00574249|62735302|FG001|Overall Study|Lost to Follow-up|3|||
33357765|NCT00574249|62735301|FG000|Overall Study|Protocol Violation|5|||
33357766|NCT00574249|62735302|FG001|Overall Study|Protocol Violation|2|||
33357767|NCT00574249|62735301|FG000|Overall Study|History of carcinoma|1|||
33357768|NCT00574249|62735302|FG001|Overall Study|History of carcinoma|0|||
33357769|NCT00574249|62735301|FG000|Overall Study|Withdrawal by Subject|3|||
33357770|NCT00574249|62735302|FG001|Overall Study|Withdrawal by Subject|0|||
33357771|NCT00574249|62735301|FG000|Overall Study|Physician Decision|1|||
33357772|NCT00574249|62735302|FG001|Overall Study|Physician Decision|0|||
33357773|NCT00574249|62735301|FG000|Overall Study|Pregnancy|1|||
33357774|NCT00574249|62735302|FG001|Overall Study|Pregnancy|0|||
33357775|NCT00574249|62735301|FG000|Overall Study|Excluded by company|0|||
33357776|NCT00574249|62735302|FG001|Overall Study|Excluded by company|1|||
33357777|NCT00574249|62735301|FG000|Overall Study|PPD test taken twice|0|||
33357778|NCT00574249|62735302|FG001|Overall Study|PPD test taken twice|1|||
33357779|NCT00891228|62735311|FG000|Overall Study|Adverse Event|0|||
33357780|NCT00891228|62735312|FG001|Overall Study|Adverse Event|2|||
33357781|NCT00891228|62735313|FG002|Overall Study|Adverse Event|3|||
33357782|NCT00891228|62735311|FG000|Overall Study|Withdrawal by Subject|2|||
33357783|NCT00891228|62735312|FG001|Overall Study|Withdrawal by Subject|4|||
33357784|NCT00891228|62735313|FG002|Overall Study|Withdrawal by Subject|5|||
33357785|NCT00891228|62735311|FG000|Overall Study|Protocol Violation|3|||
33357786|NCT00891228|62735312|FG001|Overall Study|Protocol Violation|1|||
33357787|NCT00891228|62735313|FG002|Overall Study|Protocol Violation|2|||
33357788|NCT00891228|62735311|FG000|Overall Study|Physician Decision|2|||
33357789|NCT00891228|62735312|FG001|Overall Study|Physician Decision|1|||
33357790|NCT00891228|62735313|FG002|Overall Study|Physician Decision|0|||
33357791|NCT00891228|62735311|FG000|Overall Study|Lost to Follow-up|4|||
33357792|NCT00891228|62735312|FG001|Overall Study|Lost to Follow-up|4|||
33357793|NCT00891228|62735313|FG002|Overall Study|Lost to Follow-up|5|||
33357794|NCT00891228|62735311|FG000|Overall Study|Pregnancy|0|||
33357795|NCT00891228|62735312|FG001|Overall Study|Pregnancy|1|||
33357796|NCT00891228|62735313|FG002|Overall Study|Pregnancy|0|||
33357797|NCT00896168|62735323|FG000|Overall Study|Adverse Event|4|||
33357798|NCT00896168|62735324|FG001|Overall Study|Adverse Event|7|||
33357799|NCT00896168|62735323|FG000|Overall Study|Treatment failure|8|||
33357800|NCT00896168|62735324|FG001|Overall Study|Treatment failure|10|||
33357801|NCT00896168|62735323|FG000|Overall Study|Lost to Follow-up|1|||
33357802|NCT00896168|62735324|FG001|Overall Study|Lost to Follow-up|1|||
33357803|NCT00896168|62735323|FG000|Overall Study|Other|1|||
33357804|NCT00896168|62735324|FG001|Overall Study|Other|1|||
33357805|NCT00833703|62735332|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
33357806|NCT00833703|62735333|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
33357807|NCT00833547|62735341|FG000|Overall Study|Withdrawal by Subject|2|||
33357808|NCT00833547|62735342|FG001|Overall Study|Withdrawal by Subject|2|||
33357809|NCT00833469|62735348|FG000|Overall Study|Withdrawal by Subject|1|||
33357810|NCT00833469|62735348|FG000|Overall Study|Lost to Follow-up|1|||
33357811|NCT00832377|62735352|FG000|Overall Study|Protocol Violation|1|||
33357812|NCT00892008|62735356|FG000|Overall Study|Death|5|||
33357813|NCT00892008|62735356|FG000|Overall Study|Lack of Efficacy|3|||
33357814|NCT00892008|62735356|FG000|Overall Study|Lost to Follow-up|142|||
33357815|NCT00892008|62735356|FG000|Overall Study|Other|378|||
33357816|NCT00892008|62735356|FG000|Overall Study|Adverse Event|37|||
33357817|NCT00623233|62735360|FG000|Overall Study|Adverse Event|10|||
33357818|NCT00623233|62735360|FG000|Overall Study|Physician Decision|10|||
33357819|NCT00623233|62735360|FG000|Overall Study|Lost to Follow-up|1|||
33357820|NCT00623233|62735360|FG000|Overall Study|Withdrawal by Subject|3|||
33357821|NCT03369236|62735375|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
33357822|NCT03369236|62735376|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
33357823|NCT03369236|62735375|FG000|Open-label Extension Period|Lack of Efficacy|2|||
33357824|NCT03369236|62735376|FG001|Open-label Extension Period|Lack of Efficacy|1|||
33357825|NCT03369236|62735375|FG000|Open-label Extension Period|Adverse Event|0|||
33357826|NCT03369236|62735376|FG001|Open-label Extension Period|Adverse Event|1|||
33357827|NCT03369236|62735375|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
33549247|NCT01092117|62940502|FG000|Year 4|Withdrawal by Subject|4|||
33357828|NCT03369236|62735376|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
33357829|NCT00621751|62735390|FG000|Overall Study|Adverse Event|0|||
33357830|NCT00621751|62735391|FG001|Overall Study|Adverse Event|1|||
33357831|NCT00891930|62735408|FG000|Part 1: Panitumumab +Irinotecan|Death|38|||
33357832|NCT00891930|62735408|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1|||
33357833|NCT00891930|62735408|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1|||
33357834|NCT00891930|62735408|FG000|Part 2: Panitumumab + Ganitumab|Death|30|||
33357835|NCT00891930|62735408|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1|||
33357836|NCT00891462|62735419|FG000|Overall Study|Withdrawal by Subject|9|||
33357837|NCT00891462|62735420|FG001|Overall Study|Withdrawal by Subject|6|||
33357838|NCT00891462|62735421|FG002|Overall Study|Withdrawal by Subject|7|||
33357839|NCT00891462|62735419|FG000|Overall Study|Adverse Event|7|||
33357840|NCT00891462|62735420|FG001|Overall Study|Adverse Event|8|||
33357841|NCT00891462|62735421|FG002|Overall Study|Adverse Event|7|||
33357842|NCT00891462|62735419|FG000|Overall Study|Lack of Efficacy|10|||
33357843|NCT00891462|62735420|FG001|Overall Study|Lack of Efficacy|5|||
33357844|NCT00891462|62735421|FG002|Overall Study|Lack of Efficacy|1|||
33357845|NCT00891462|62735419|FG000|Overall Study|COPD exacerbation|7|||
33357846|NCT00891462|62735420|FG001|Overall Study|COPD exacerbation|4|||
33357847|NCT00891462|62735421|FG002|Overall Study|COPD exacerbation|1|||
33357848|NCT00891462|62735419|FG000|Overall Study|Other Reason|2|||
33357849|NCT00891462|62735420|FG001|Overall Study|Other Reason|5|||
33357850|NCT00891462|62735421|FG002|Overall Study|Other Reason|3|||
33357851|NCT00891462|62735419|FG000|Overall Study|Protocol Violation|2|||
33357852|NCT00891462|62735420|FG001|Overall Study|Protocol Violation|1|||
33357853|NCT00891462|62735421|FG002|Overall Study|Protocol Violation|3|||
33357854|NCT00891462|62735419|FG000|Overall Study|Inclusion/exclusion criteria|0|||
33357855|NCT00891462|62735420|FG001|Overall Study|Inclusion/exclusion criteria|2|||
33357856|NCT00891462|62735421|FG002|Overall Study|Inclusion/exclusion criteria|2|||
33357857|NCT00891462|62735419|FG000|Overall Study|Lost to Follow-up|0|||
33357858|NCT00891462|62735420|FG001|Overall Study|Lost to Follow-up|2|||
33357859|NCT00891462|62735421|FG002|Overall Study|Lost to Follow-up|0|||
33357860|NCT00900146|62735436|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
33357861|NCT00900146|62735437|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
33357862|NCT00900146|62735438|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
33357863|NCT00900146|62735439|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
33357864|NCT00900146|62735440|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
33357865|NCT00900146|62735436|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
33357866|NCT00900146|62735437|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
33357867|NCT00900146|62735438|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
33357868|NCT00900146|62735439|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
33357869|NCT00900146|62735440|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
33357870|NCT00900146|62735436|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
33357871|NCT00900146|62735437|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
33357872|NCT00900146|62735438|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
33473761|NCT03129100|62847557|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473762|NCT03129100|62847558|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473763|NCT03129100|62847559|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473764|NCT03129100|62847560|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473765|NCT03129100|62847561|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
33473766|NCT03129100|62847562|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473767|NCT03129100|62847563|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473768|NCT03129100|62847564|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33357873|NCT00900146|62735439|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
33357874|NCT00900146|62735440|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
33357875|NCT00900146|62735436|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
33357876|NCT00900146|62735437|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
33357877|NCT00900146|62735438|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
33473769|NCT03129100|62847565|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473770|NCT03129100|62847566|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33473771|NCT03129100|62847541|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
33473772|NCT03129100|62847542|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
33473773|NCT03129100|62847543|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
33357878|NCT00900146|62735439|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
33357879|NCT00900146|62735440|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
33357880|NCT00900146|62735436|FG000|Intermediate: Period III|Lost to Follow-up|2|||
33357881|NCT00900146|62735437|FG001|Intermediate: Period III|Lost to Follow-up|0|||
33357882|NCT00900146|62735438|FG002|Intermediate: Period III|Lost to Follow-up|0|||
33357883|NCT00900146|62735439|FG003|Intermediate: Period III|Lost to Follow-up|0|||
33357884|NCT00900146|62735440|FG004|Intermediate: Period III|Lost to Follow-up|1|||
33357885|NCT00900146|62735436|FG000|Intermediate: Period III|Administrative problems|85|||
33357886|NCT00900146|62735437|FG001|Intermediate: Period III|Administrative problems|92|||
33357887|NCT00900146|62735438|FG002|Intermediate: Period III|Administrative problems|84|||
33357888|NCT00900146|62735439|FG003|Intermediate: Period III|Administrative problems|90|||
33357889|NCT00900146|62735440|FG004|Intermediate: Period III|Administrative problems|163|||
33357890|NCT00895310|62735452|FG000|Overall Study|Withdrawal by Subject|1|||
33357891|NCT00895154|62735458|FG000|Overall Study|Lost to Follow-up|1|||
33357892|NCT00895154|62735459|FG001|Overall Study|Lost to Follow-up|1|||
33357893|NCT00895154|62735458|FG000|Overall Study|Withdrawal by Subject|0|||
33357894|NCT00895154|62735459|FG001|Overall Study|Withdrawal by Subject|1|||
33357895|NCT00888654|62735465|FG000|Overall Study|Problems swallowing oral meds.|1|||
33357896|NCT00888654|62735465|FG000|Overall Study|Not enough oral meds before surgery|3|||
33357897|NCT00888654|62735465|FG000|Overall Study|Surgery aborted|2|||
33357898|NCT00888654|62735465|FG000|Overall Study|Withdrawal by Subject|1|||
33357899|NCT00888654|62735465|FG000|Overall Study|Inelig. due to contraindication of med|1|||
33357900|NCT00888654|62735465|FG000|Overall Study|Change in surg date|1|||
33357901|NCT00888654|62735465|FG000|Overall Study|Stopped meds due to headaches|1|||
33357902|NCT00899678|62735472|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
33357903|NCT00899678|62735473|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
33357904|NCT00899678|62735474|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
33357905|NCT00899678|62735472|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
33357906|NCT00899678|62735473|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
33357907|NCT00899678|62735474|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
33357908|NCT00899678|62735472|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
33357909|NCT00899678|62735473|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
33357910|NCT00899678|62735474|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
33357911|NCT00899678|62735472|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
33357912|NCT00899678|62735473|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
33357913|NCT00899678|62735474|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
33357914|NCT00899678|62735472|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
33357915|NCT00899678|62735473|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
33357916|NCT00899678|62735474|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
33357917|NCT00899678|62735472|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
33357918|NCT00899678|62735473|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
33357919|NCT00899678|62735474|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
33357920|NCT00899678|62735472|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
33357921|NCT00899678|62735473|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
33357922|NCT00899678|62735474|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
33473774|NCT03129100|62847544|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
33357923|NCT00899678|62735472|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
33357924|NCT00899678|62735473|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
33357925|NCT00899678|62735474|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
33357926|NCT00899678|62735472|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
33357927|NCT00899678|62735473|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
33357928|NCT00899678|62735474|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
33357929|NCT00887484|62735482|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
33357930|NCT00887484|62735482|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
33357931|NCT00887484|62735482|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
33357932|NCT00886938|62735491|FG000|Overall Study|Adverse Event|1|||
33357933|NCT00886938|62735491|FG000|Overall Study|Withdrawal by Subject|1|||
33357934|NCT00620659|62735495|FG000|Treatment Period 1|Adverse Event|1|||
33473775|NCT03129100|62847545|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
33473776|NCT03129100|62847546|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
33549248|NCT01092117|62940502|FG000|Year 4|Lost to Follow-up|4|||
33357935|NCT00620659|62735496|FG001|Treatment Period 1|Adverse Event|0|||
33473777|NCT03129100|62847547|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
33473778|NCT03129100|62847548|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
33473779|NCT03129100|62847549|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
33549249|NCT01065779|62940515|FG000|Overall Study|Duplicate Investigation|1|||
33357936|NCT00620659|62735497|FG002|Treatment Period 1|Adverse Event|0|||
33357937|NCT00620659|62735498|FG003|Treatment Period 1|Adverse Event|3|||
33357938|NCT00620659|62735499|FG004|Treatment Period 1|Adverse Event|0|||
33357939|NCT00620659|62735500|FG005|Treatment Period 1|Adverse Event|0|||
33357940|NCT00620659|62735495|FG000|Treatment Period 1|Protocol Violation|1|||
33357941|NCT00620659|62735496|FG001|Treatment Period 1|Protocol Violation|0|||
33357942|NCT00620659|62735497|FG002|Treatment Period 1|Protocol Violation|0|||
33357943|NCT00620659|62735498|FG003|Treatment Period 1|Protocol Violation|0|||
33357944|NCT00620659|62735499|FG004|Treatment Period 1|Protocol Violation|0|||
33357945|NCT00620659|62735500|FG005|Treatment Period 1|Protocol Violation|0|||
33357946|NCT00620659|62735495|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33357947|NCT00620659|62735496|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33357948|NCT00620659|62735497|FG002|Treatment Period 1|Withdrawal by Subject|1|||
33357949|NCT00620659|62735498|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33357950|NCT00620659|62735499|FG004|Treatment Period 1|Withdrawal by Subject|1|||
33357951|NCT00620659|62735500|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33357952|NCT00620659|62735495|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
33357953|NCT00620659|62735496|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
33357954|NCT00620659|62735497|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
33357955|NCT00620659|62735498|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
33357956|NCT00620659|62735499|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
33357957|NCT00620659|62735500|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
33357958|NCT00620659|62735495|FG000|Treatment Period 2|Adverse Event|0|||
33357959|NCT00620659|62735496|FG001|Treatment Period 2|Adverse Event|3|||
33357960|NCT00620659|62735497|FG002|Treatment Period 2|Adverse Event|0|||
33357961|NCT00620659|62735498|FG003|Treatment Period 2|Adverse Event|0|||
33357962|NCT00620659|62735499|FG004|Treatment Period 2|Adverse Event|2|||
33357963|NCT00620659|62735500|FG005|Treatment Period 2|Adverse Event|0|||
33357964|NCT00620659|62735495|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33357965|NCT00620659|62735496|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33357966|NCT00620659|62735497|FG002|Treatment Period 2|Withdrawal by Subject|1|||
33357967|NCT00620659|62735498|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33357968|NCT00620659|62735499|FG004|Treatment Period 2|Withdrawal by Subject|3|||
33357969|NCT00620659|62735500|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33357970|NCT00620659|62735495|FG000|Placebo Washout Period 2|Adverse Event|2|||
33357971|NCT00620659|62735496|FG001|Placebo Washout Period 2|Adverse Event|0|||
33357972|NCT00620659|62735497|FG002|Placebo Washout Period 2|Adverse Event|0|||
33357973|NCT00620659|62735498|FG003|Placebo Washout Period 2|Adverse Event|0|||
33357974|NCT00620659|62735499|FG004|Placebo Washout Period 2|Adverse Event|0|||
33357975|NCT00620659|62735500|FG005|Placebo Washout Period 2|Adverse Event|0|||
33473780|NCT03129100|62847550|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
33473781|NCT03129100|62847551|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
33473782|NCT03129100|62847552|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
33473783|NCT03129100|62847553|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
33473784|NCT03129100|62847554|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
33473785|NCT03129100|62847555|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
33473786|NCT03129100|62847556|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
33473787|NCT03129100|62847557|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
33473788|NCT03129100|62847558|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
33473789|NCT03129100|62847559|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
33473790|NCT03129100|62847560|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
33473791|NCT03129100|62847561|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
33473792|NCT03129100|62847562|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
33357976|NCT00620659|62735495|FG000|Treatment Period 3|Adverse Event|0|||
33357977|NCT00620659|62735496|FG001|Treatment Period 3|Adverse Event|2|||
33357978|NCT00620659|62735497|FG002|Treatment Period 3|Adverse Event|0|||
33357979|NCT00620659|62735498|FG003|Treatment Period 3|Adverse Event|0|||
33357980|NCT00620659|62735499|FG004|Treatment Period 3|Adverse Event|0|||
33357981|NCT00620659|62735500|FG005|Treatment Period 3|Adverse Event|0|||
33357982|NCT00620659|62735495|FG000|Treatment Period 3|Withdrawal by Subject|0|||
33357983|NCT00620659|62735496|FG001|Treatment Period 3|Withdrawal by Subject|0|||
33357984|NCT00620659|62735497|FG002|Treatment Period 3|Withdrawal by Subject|0|||
33357985|NCT00620659|62735498|FG003|Treatment Period 3|Withdrawal by Subject|1|||
33357986|NCT00620659|62735499|FG004|Treatment Period 3|Withdrawal by Subject|0|||
33357987|NCT00620659|62735500|FG005|Treatment Period 3|Withdrawal by Subject|0|||
33357988|NCT00894686|62735513|FG000|Overall Study|Withdrawal by Subject|50|||
33473793|NCT03129100|62847563|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
33357989|NCT00894686|62735513|FG000|Overall Study|Physician Decision|1|||
33357990|NCT00894686|62735513|FG000|Overall Study|Other|5|||
33473794|NCT03129100|62847564|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
33357991|NCT00885846|62735520|FG000|Overall Study|Withdrawal by Subject|2|||
33357992|NCT00885846|62735521|FG001|Overall Study|Withdrawal by Subject|5|||
33357993|NCT00885846|62735522|FG002|Overall Study|Withdrawal by Subject|2|||
33357994|NCT00621517|62735532|FG000|Overall Study|Lost to Follow-up|3|||
33473795|NCT03129100|62847565|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
33473796|NCT03129100|62847566|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
33473797|NCT03129100|62847541|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473798|NCT03129100|62847542|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473799|NCT03129100|62847543|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473800|NCT03129100|62847544|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473801|NCT03129100|62847545|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473802|NCT03129100|62847546|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473803|NCT03129100|62847547|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473804|NCT03129100|62847548|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473805|NCT03129100|62847549|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473806|NCT03129100|62847550|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473807|NCT03129100|62847551|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473808|NCT03129100|62847552|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473809|NCT03129100|62847553|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473810|NCT03129100|62847554|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473811|NCT03129100|62847555|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473812|NCT03129100|62847556|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473813|NCT03129100|62847557|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473814|NCT03129100|62847558|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473815|NCT03129100|62847559|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473816|NCT03129100|62847560|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473817|NCT03129100|62847561|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
33473818|NCT03129100|62847562|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473819|NCT03129100|62847563|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473820|NCT03129100|62847564|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473821|NCT03129100|62847565|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473822|NCT03129100|62847566|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33473823|NCT03129100|62847541|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
33473824|NCT03129100|62847542|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
33473825|NCT03129100|62847543|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
33473826|NCT03129100|62847544|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
33473827|NCT03129100|62847545|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
33473828|NCT03129100|62847546|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
33473829|NCT03129100|62847547|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
33473830|NCT03129100|62847548|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
33473831|NCT03129100|62847549|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
33473832|NCT03129100|62847550|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
33473833|NCT03129100|62847551|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
33473834|NCT03129100|62847552|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
33473835|NCT03129100|62847553|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
33473836|NCT03129100|62847554|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
33473837|NCT03129100|62847555|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
33473838|NCT03129100|62847556|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
33473839|NCT03129100|62847557|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
33473840|NCT03129100|62847558|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
33473841|NCT03129100|62847559|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
33473842|NCT03129100|62847560|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
33473843|NCT03129100|62847561|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
33473844|NCT03129100|62847562|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
33473845|NCT03129100|62847563|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
33473846|NCT03129100|62847564|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
33473847|NCT03129100|62847565|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
33473848|NCT03129100|62847566|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
33473849|NCT03129100|62847541|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473850|NCT03129100|62847542|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473851|NCT03129100|62847543|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473852|NCT03129100|62847544|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473853|NCT03129100|62847545|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473854|NCT03129100|62847546|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473855|NCT03129100|62847547|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473856|NCT03129100|62847548|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473857|NCT03129100|62847549|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473858|NCT03129100|62847550|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473859|NCT03129100|62847551|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33357995|NCT00621517|62735533|FG001|Overall Study|Lost to Follow-up|3|||
33473860|NCT03129100|62847552|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473861|NCT03129100|62847553|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473862|NCT03129100|62847554|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473863|NCT03129100|62847555|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473864|NCT03129100|62847556|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473865|NCT03129100|62847557|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473866|NCT03129100|62847558|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473867|NCT03129100|62847559|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473868|NCT03129100|62847560|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473869|NCT03129100|62847561|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473870|NCT03129100|62847562|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473871|NCT03129100|62847563|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473872|NCT03129100|62847564|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33473873|NCT03129100|62847565|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
33473874|NCT03129100|62847566|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
33473875|NCT03129100|62847541|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473876|NCT03129100|62847542|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473877|NCT03129100|62847543|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473878|NCT03129100|62847544|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473879|NCT03129100|62847545|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473880|NCT03129100|62847546|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473881|NCT03129100|62847547|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473882|NCT03129100|62847548|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473883|NCT03129100|62847549|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473884|NCT03129100|62847550|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473885|NCT03129100|62847551|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473886|NCT03129100|62847552|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473887|NCT03129100|62847553|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473888|NCT03129100|62847554|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473889|NCT03129100|62847555|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473890|NCT03129100|62847556|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473891|NCT03129100|62847557|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473892|NCT03129100|62847558|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473893|NCT03129100|62847559|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473894|NCT03129100|62847560|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473895|NCT03129100|62847561|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473896|NCT03129100|62847562|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473897|NCT03129100|62847563|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33473898|NCT03129100|62847564|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
33473899|NCT03129100|62847565|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
33473900|NCT03129100|62847566|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
33473901|NCT03129100|62847541|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473902|NCT03129100|62847542|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473903|NCT03129100|62847543|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473904|NCT03129100|62847544|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473905|NCT03129100|62847545|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473906|NCT03129100|62847546|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473907|NCT03129100|62847547|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473908|NCT03129100|62847548|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473909|NCT03129100|62847549|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473910|NCT03129100|62847550|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473911|NCT03129100|62847551|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473912|NCT03129100|62847552|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473913|NCT03129100|62847553|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473914|NCT03129100|62847554|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473915|NCT03129100|62847555|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473916|NCT03129100|62847556|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473917|NCT03129100|62847557|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473918|NCT03129100|62847558|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473919|NCT03129100|62847559|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473920|NCT03129100|62847560|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473921|NCT03129100|62847561|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473922|NCT03129100|62847562|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473923|NCT03129100|62847563|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473924|NCT03129100|62847564|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33655408|NCT01876901|63070697|FG001|Overall Study|Protocol Violation|2|||
33473925|NCT03129100|62847565|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
33473926|NCT03129100|62847566|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33473927|NCT03129100|62847541|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473928|NCT03129100|62847542|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473929|NCT03129100|62847543|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473930|NCT03129100|62847544|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473931|NCT03129100|62847545|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473932|NCT03129100|62847546|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473933|NCT03129100|62847547|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473934|NCT03129100|62847548|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473935|NCT03129100|62847549|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473936|NCT03129100|62847550|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473937|NCT03129100|62847551|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473938|NCT03129100|62847552|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473939|NCT03129100|62847553|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473940|NCT03129100|62847554|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473941|NCT03129100|62847555|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473942|NCT03129100|62847556|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473943|NCT03129100|62847557|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473944|NCT03129100|62847558|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473945|NCT03129100|62847559|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473946|NCT03129100|62847560|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473947|NCT03129100|62847561|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473948|NCT03129100|62847562|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473949|NCT03129100|62847563|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473950|NCT03129100|62847564|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473951|NCT03129100|62847565|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33473952|NCT03129100|62847566|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
33473953|NCT03129100|62847541|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
33473954|NCT03129100|62847542|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
33549250|NCT01065779|62940515|FG000|Overall Study|Investigation Before Contract Date|37|||
33357996|NCT00621517|62735532|FG000|Overall Study|Withdrawal by Subject|3|||
33357997|NCT00621517|62735533|FG001|Overall Study|Withdrawal by Subject|4|||
33357998|NCT00621517|62735532|FG000|Overall Study|Adverse Event|1|||
33357999|NCT00621517|62735533|FG001|Overall Study|Adverse Event|0|||
33358000|NCT00573937|62735541|FG000|Overall Study|Study Terminated|0|||
33358001|NCT00573937|62735542|FG001|Overall Study|Study Terminated|1|||
33358002|NCT00573859|62735548|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
33358003|NCT00573859|62735548|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
33358004|NCT00831441|62735554|FG000|Randomized|Death|82|||
33358005|NCT00831441|62735555|FG001|Randomized|Death|81|||
33358006|NCT00831441|62735554|FG000|Randomized|Adverse Event|248|||
33358007|NCT00831441|62735555|FG001|Randomized|Adverse Event|321|||
33358008|NCT00831441|62735554|FG000|Randomized|Emergency procedure|2|||
33358009|NCT00831441|62735555|FG001|Randomized|Emergency procedure|2|||
33358010|NCT00831441|62735554|FG000|Randomized|Elective procedure|26|||
33358011|NCT00831441|62735555|FG001|Randomized|Elective procedure|25|||
33358012|NCT00831441|62735554|FG000|Randomized|Physician Decision|26|||
33358013|NCT00831441|62735555|FG001|Randomized|Physician Decision|35|||
33358014|NCT00831441|62735554|FG000|Randomized|No longer met criteria|13|||
33358015|NCT00831441|62735555|FG001|Randomized|No longer met criteria|19|||
33358016|NCT00831441|62735554|FG000|Randomized|Withdrawal by Subject|178|||
33358017|NCT00831441|62735555|FG001|Randomized|Withdrawal by Subject|212|||
33358018|NCT00831441|62735554|FG000|Randomized|Lost to Follow-up|26|||
33358019|NCT00831441|62735555|FG001|Randomized|Lost to Follow-up|35|||
33358020|NCT00831441|62735554|FG000|Randomized|Administrative reason by sponsor|2780|||
33358021|NCT00831441|62735555|FG001|Randomized|Administrative reason by sponsor|2671|||
33358022|NCT00831441|62735554|FG000|Randomized|poor/non-compliance|30|||
33358023|NCT00831441|62735555|FG001|Randomized|poor/non-compliance|38|||
33358024|NCT00831441|62735554|FG000|Randomized|non-specified|276|||
33358025|NCT00831441|62735555|FG001|Randomized|non-specified|266|||
33358026|NCT00831441|62735554|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
33358027|NCT00831441|62735555|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
33473955|NCT03129100|62847543|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
33473956|NCT03129100|62847544|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
33473957|NCT03129100|62847545|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
33549251|NCT01065779|62940515|FG000|Overall Study|Non-enrollment Period Administration|10|||
33358028|NCT00831441|62735554|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
33358029|NCT00831441|62735555|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
33358030|NCT00831441|62735554|FG000|Follow Up (30 Days)|Death|63|||
33358031|NCT00831441|62735555|FG001|Follow Up (30 Days)|Death|86|||
33358032|NCT00831441|62735554|FG000|Follow Up (30 Days)|non-specified|16|||
33358033|NCT00831441|62735555|FG001|Follow Up (30 Days)|non-specified|26|||
33358034|NCT00831441|62735554|FG000|Follow Up (30 Days)|missing end of study status|0|||
33358035|NCT00831441|62735555|FG001|Follow Up (30 Days)|missing end of study status|1|||
33358036|NCT00831129|62735564|FG000|Overall Study|Adverse Event|0|||
33358037|NCT00831129|62735565|FG001|Overall Study|Adverse Event|1|||
33358038|NCT00831129|62735564|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
33358039|NCT00831129|62735565|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
33358040|NCT00620113|62735575|FG000|Overall Study|Adverse Event|3|||
33358041|NCT00620113|62735576|FG001|Overall Study|Adverse Event|2|||
33358042|NCT00620113|62735577|FG002|Overall Study|Adverse Event|2|||
33358043|NCT00620113|62735578|FG003|Overall Study|Adverse Event|1|||
33358044|NCT00620113|62735575|FG000|Overall Study|Lack of Efficacy|2|||
33358045|NCT00620113|62735576|FG001|Overall Study|Lack of Efficacy|3|||
33358046|NCT00620113|62735577|FG002|Overall Study|Lack of Efficacy|0|||
33358047|NCT00620113|62735578|FG003|Overall Study|Lack of Efficacy|2|||
33358048|NCT00620113|62735575|FG000|Overall Study|Physician Decision|1|||
33358049|NCT00620113|62735576|FG001|Overall Study|Physician Decision|0|||
33358050|NCT00620113|62735577|FG002|Overall Study|Physician Decision|0|||
33358051|NCT00620113|62735578|FG003|Overall Study|Physician Decision|2|||
33358052|NCT00620113|62735575|FG000|Overall Study|Protocol Violation|2|||
33358053|NCT00620113|62735576|FG001|Overall Study|Protocol Violation|1|||
33358054|NCT00620113|62735577|FG002|Overall Study|Protocol Violation|0|||
33358055|NCT00620113|62735578|FG003|Overall Study|Protocol Violation|0|||
33358056|NCT00620113|62735575|FG000|Overall Study|Withdrawal by Subject|5|||
33655409|NCT01876901|63070696|FG000|Overall Study|No or other surgical intervention|7|||
33655410|NCT01876901|63070697|FG001|Overall Study|No or other surgical intervention|5|||
33655411|NCT01876823|63070704|FG000|Overall Study|Withdrawal by Subject|5|||
33655412|NCT01876823|63070704|FG000|Overall Study|Physician Decision|2|||
33655413|NCT01876823|63070704|FG000|Overall Study|Patients moved|2|||
33655414|NCT01876511|63070711|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
33655415|NCT01876511|63070712|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
33655416|NCT01876511|63070713|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
33655417|NCT01876511|63070711|FG000|Overall Study|Death (unrelated)|3|||
33655418|NCT01876511|63070712|FG001|Overall Study|Death (unrelated)|0|||
33655419|NCT01876511|63070713|FG002|Overall Study|Death (unrelated)|2|||
33655420|NCT01876511|63070711|FG000|Overall Study|Drug-related Toxicity|5|||
33655421|NCT01876511|63070712|FG001|Overall Study|Drug-related Toxicity|1|||
33655422|NCT01876511|63070713|FG002|Overall Study|Drug-related Toxicity|6|||
33655423|NCT01876511|63070711|FG000|Overall Study|Patient Decision|3|||
33655424|NCT01876511|63070712|FG001|Overall Study|Patient Decision|0|||
33655425|NCT01876511|63070713|FG002|Overall Study|Patient Decision|6|||
33655426|NCT01876511|63070711|FG000|Overall Study|Physician Decision|1|||
33655427|NCT01876511|63070712|FG001|Overall Study|Physician Decision|0|||
33655428|NCT01876511|63070713|FG002|Overall Study|Physician Decision|1|||
33655429|NCT01993719|63070728|FG000|First Drug Administration|Not treated|1|||
33655430|NCT01993719|63070729|FG001|First Drug Administration|Not treated|0|||
33655431|NCT01993719|63070730|FG002|First Drug Administration|Not treated|0|||
33655432|NCT01993719|63070731|FG003|First Drug Administration|Not treated|0|||
33655433|NCT01993719|63070732|FG004|First Drug Administration|Not treated|0|||
33655434|NCT00638235|63070774|FG000|Overall Study|Lost to Follow-up|31|||
33655435|NCT00638235|63070775|FG001|Overall Study|Lost to Follow-up|3|||
33655436|NCT00638235|63070776|FG002|Overall Study|Lost to Follow-up|18|||
33655437|NCT00638235|63070777|FG003|Overall Study|Lost to Follow-up|10|||
33655438|NCT00638235|63070778|FG004|Overall Study|Lost to Follow-up|13|||
33655439|NCT00638235|63070779|FG005|Overall Study|Lost to Follow-up|26|||
33655440|NCT00638235|63070780|FG006|Overall Study|Lost to Follow-up|0|||
33655441|NCT00638235|63070781|FG007|Overall Study|Lost to Follow-up|1|||
33655442|NCT00638235|63070782|FG008|Overall Study|Lost to Follow-up|18|||
33655443|NCT00638157|63070811|FG000|Overall Study|Adverse Event|0|||
33655444|NCT00638157|63070812|FG001|Overall Study|Adverse Event|1|||
33655445|NCT00638157|63070811|FG000|Overall Study|Clinical (symptomatic) failure|1|||
33655446|NCT00638157|63070812|FG001|Overall Study|Clinical (symptomatic) failure|1|||
33655447|NCT00638157|63070811|FG000|Overall Study|Microbiological failure|1|||
33655448|NCT00638157|63070812|FG001|Overall Study|Microbiological failure|0|||
33655449|NCT00638157|63070811|FG000|Overall Study|Lost to Follow-up|1|||
33358057|NCT00620113|62735576|FG001|Overall Study|Withdrawal by Subject|1|||
33358058|NCT00620113|62735577|FG002|Overall Study|Withdrawal by Subject|3|||
33358059|NCT00620113|62735578|FG003|Overall Study|Withdrawal by Subject|5|||
33358060|NCT00830115|62735588|FG000|Overall Study|Adverse Event|2|||
33655450|NCT00638157|63070812|FG001|Overall Study|Lost to Follow-up|0|||
33655451|NCT00638157|63070811|FG000|Overall Study|Physician Decision|1|||
33655452|NCT00638157|63070812|FG001|Overall Study|Physician Decision|0|||
33655453|NCT00638157|63070811|FG000|Overall Study|Other|1|||
33655454|NCT00638157|63070812|FG001|Overall Study|Other|2|||
33358061|NCT00830115|62735588|FG000|Overall Study|Improvement/recovery|1|||
33655455|NCT00638157|63070811|FG000|Overall Study|Randomized, not treated|2|||
33655456|NCT00638157|63070812|FG001|Overall Study|Randomized, not treated|0|||
33655457|NCT00637377|63070823|FG000|Overall Study|Adverse Event|2|||
33358062|NCT00830037|62735596|FG000|Overall Study|Withdrawal by Subject|2|||
33358063|NCT00830037|62735597|FG001|Overall Study|Withdrawal by Subject|3|||
33358064|NCT00830037|62735596|FG000|Overall Study|Lost to Follow-up|1|||
33358065|NCT00830037|62735597|FG001|Overall Study|Lost to Follow-up|2|||
33358066|NCT00830037|62735596|FG000|Overall Study|Active when terminated by DSMB|15|||
33358067|NCT00830037|62735597|FG001|Overall Study|Active when terminated by DSMB|14|||
33358068|NCT00829413|62735603|FG000|Overall Study|No study drug admimnistered|13|||
33358069|NCT00829413|62735603|FG000|Overall Study|Training Patients|67|||
33358070|NCT00829413|62735603|FG000|Overall Study|No truth standard procedure available|9|||
33358071|NCT00829413|62735603|FG000|Overall Study|Technically inadequate truth standard|2|||
33358072|NCT00829413|62735603|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
33358073|NCT00829179|62735614|FG000|Overall Study|Withdrawal by Subject|1|||
33358074|NCT00591591|62735620|FG000|Overall Study|Withdrawal by Subject|1|||
33358075|NCT00591591|62735621|FG001|Overall Study|Withdrawal by Subject|37|||
33358076|NCT00591591|62735620|FG000|Overall Study|Lack of Efficacy|10|||
33358077|NCT00591591|62735621|FG001|Overall Study|Lack of Efficacy|2|||
33358078|NCT00828945|62735627|FG000|Overall Study|Death|4|||
33358079|NCT00828945|62735627|FG000|Overall Study|Participant was missing|1|||
33358080|NCT00828945|62735627|FG000|Overall Study|Other|36|||
33358081|NCT00966875|62735640|FG000|Part A|Adverse Event|2|||
33358082|NCT00966875|62735641|FG001|Part A|Adverse Event|1|||
33358083|NCT00966875|62735642|FG002|Part A|Adverse Event|0|||
33358084|NCT00966875|62735643|FG003|Part A|Adverse Event|1|||
33358085|NCT00966875|62735644|FG004|Part A|Adverse Event|0|||
33358086|NCT00966875|62735645|FG005|Part A|Adverse Event|1|||
33358087|NCT00966875|62735646|FG006|Part A|Adverse Event|0|||
33358088|NCT00966875|62735647|FG007|Part A|Adverse Event|3|||
33358089|NCT00966875|62735648|FG008|Part A|Adverse Event|3|||
33358090|NCT00966875|62735640|FG000|Part A|Entry Criteria|0|||
33358091|NCT00966875|62735641|FG001|Part A|Entry Criteria|0|||
33358092|NCT00966875|62735642|FG002|Part A|Entry Criteria|0|||
33358093|NCT00966875|62735643|FG003|Part A|Entry Criteria|0|||
33358094|NCT00966875|62735644|FG004|Part A|Entry Criteria|0|||
33358095|NCT00966875|62735645|FG005|Part A|Entry Criteria|2|||
33358096|NCT00966875|62735646|FG006|Part A|Entry Criteria|0|||
33358097|NCT00966875|62735647|FG007|Part A|Entry Criteria|0|||
33358098|NCT00966875|62735648|FG008|Part A|Entry Criteria|0|||
33358099|NCT00966875|62735640|FG000|Part A|Lack of Efficacy|0|||
33358100|NCT00966875|62735641|FG001|Part A|Lack of Efficacy|1|||
33358101|NCT00966875|62735642|FG002|Part A|Lack of Efficacy|0|||
33358102|NCT00966875|62735643|FG003|Part A|Lack of Efficacy|0|||
33358103|NCT00966875|62735644|FG004|Part A|Lack of Efficacy|0|||
33358104|NCT00966875|62735645|FG005|Part A|Lack of Efficacy|0|||
33358105|NCT00966875|62735646|FG006|Part A|Lack of Efficacy|4|||
33473958|NCT03129100|62847546|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
33473959|NCT03129100|62847547|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
33473960|NCT03129100|62847548|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
33473961|NCT03129100|62847549|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
33473962|NCT03129100|62847550|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
33473963|NCT03129100|62847551|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
33473964|NCT03129100|62847552|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
33473965|NCT03129100|62847553|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
33473966|NCT03129100|62847554|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
33473967|NCT03129100|62847555|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
33473968|NCT03129100|62847556|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
33473969|NCT03129100|62847557|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
33473970|NCT03129100|62847558|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
33473971|NCT03129100|62847559|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
33549252|NCT01065779|62940515|FG000|Overall Study|Not Administered With Study Drug|17|||
33549253|NCT01065779|62940515|FG000|Overall Study|Failed to Follow-up|10|||
33358106|NCT00966875|62735647|FG007|Part A|Lack of Efficacy|0|||
33358107|NCT00966875|62735648|FG008|Part A|Lack of Efficacy|0|||
33358108|NCT00966875|62735640|FG000|Part A|Lost to Follow-up|2|||
33358109|NCT00966875|62735641|FG001|Part A|Lost to Follow-up|0|||
33358110|NCT00966875|62735642|FG002|Part A|Lost to Follow-up|0|||
33549254|NCT01065779|62940515|FG000|Overall Study|Inclusion Criteria Violation|7|||
33358111|NCT00966875|62735643|FG003|Part A|Lost to Follow-up|0|||
33358112|NCT00966875|62735644|FG004|Part A|Lost to Follow-up|0|||
33358113|NCT00966875|62735645|FG005|Part A|Lost to Follow-up|1|||
33358114|NCT00966875|62735646|FG006|Part A|Lost to Follow-up|0|||
33358115|NCT00966875|62735647|FG007|Part A|Lost to Follow-up|0|||
33358116|NCT00966875|62735648|FG008|Part A|Lost to Follow-up|0|||
33358117|NCT00966875|62735640|FG000|Part A|Parent/Caregiver Decision|0|||
33358118|NCT00966875|62735641|FG001|Part A|Parent/Caregiver Decision|0|||
33358119|NCT00966875|62735642|FG002|Part A|Parent/Caregiver Decision|0|||
33358120|NCT00966875|62735643|FG003|Part A|Parent/Caregiver Decision|1|||
33358121|NCT00966875|62735644|FG004|Part A|Parent/Caregiver Decision|0|||
33358122|NCT00966875|62735645|FG005|Part A|Parent/Caregiver Decision|0|||
33473972|NCT03129100|62847560|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
33473973|NCT03129100|62847561|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
33358123|NCT00966875|62735646|FG006|Part A|Parent/Caregiver Decision|0|||
33358124|NCT00966875|62735647|FG007|Part A|Parent/Caregiver Decision|0|||
33358125|NCT00966875|62735648|FG008|Part A|Parent/Caregiver Decision|0|||
33358126|NCT00966875|62735640|FG000|Part A|Physician Decision|0|||
33358127|NCT00966875|62735641|FG001|Part A|Physician Decision|0|||
33358128|NCT00966875|62735642|FG002|Part A|Physician Decision|0|||
33358129|NCT00966875|62735643|FG003|Part A|Physician Decision|0|||
33358130|NCT00966875|62735644|FG004|Part A|Physician Decision|1|||
33358131|NCT00966875|62735645|FG005|Part A|Physician Decision|0|||
33358132|NCT00966875|62735646|FG006|Part A|Physician Decision|1|||
33358133|NCT00966875|62735647|FG007|Part A|Physician Decision|0|||
33358134|NCT00966875|62735648|FG008|Part A|Physician Decision|2|||
33655458|NCT00637377|63070824|FG001|Overall Study|Adverse Event|6|||
33655459|NCT00637377|63070825|FG002|Overall Study|Adverse Event|8|||
33655460|NCT00637377|63070826|FG003|Overall Study|Adverse Event|9|||
33655461|NCT00637377|63070823|FG000|Overall Study|Death|1|||
33655462|NCT00637377|63070824|FG001|Overall Study|Death|3|||
33655463|NCT00637377|63070825|FG002|Overall Study|Death|2|||
33655464|NCT00637377|63070826|FG003|Overall Study|Death|1|||
33655465|NCT00637377|63070823|FG000|Overall Study|Lack of Efficacy|0|||
33655466|NCT00637377|63070824|FG001|Overall Study|Lack of Efficacy|0|||
33655467|NCT00637377|63070825|FG002|Overall Study|Lack of Efficacy|1|||
33655468|NCT00637377|63070826|FG003|Overall Study|Lack of Efficacy|1|||
33655469|NCT00637377|63070823|FG000|Overall Study|Lost to Follow-up|4|||
33655470|NCT00637377|63070824|FG001|Overall Study|Lost to Follow-up|1|||
33655471|NCT00637377|63070825|FG002|Overall Study|Lost to Follow-up|2|||
33655472|NCT00637377|63070826|FG003|Overall Study|Lost to Follow-up|2|||
33655473|NCT00637377|63070823|FG000|Overall Study|Protocol Violation|2|||
33473974|NCT03129100|62847562|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
33473975|NCT03129100|62847563|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
33473976|NCT03129100|62847564|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
33473977|NCT03129100|62847565|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
33473978|NCT03129100|62847566|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
33473979|NCT03101020|62847605|FG000|Overall Study|Lack of time to participate|1|||
33473980|NCT03101020|62847606|FG001|Overall Study|Lack of time to participate|0|||
33473981|NCT03101020|62847605|FG000|Overall Study|Ran over by a car|0|||
33473982|NCT03101020|62847606|FG001|Overall Study|Ran over by a car|1|||
33473983|NCT03101020|62847605|FG000|Overall Study|Withdrawal by Subject|0|||
33655474|NCT00637377|63070824|FG001|Overall Study|Protocol Violation|1|||
33655475|NCT00637377|63070825|FG002|Overall Study|Protocol Violation|1|||
33655476|NCT00637377|63070826|FG003|Overall Study|Protocol Violation|0|||
33358135|NCT00966875|62735640|FG000|Part A|Sponsor Decision|0|||
33358136|NCT00966875|62735641|FG001|Part A|Sponsor Decision|0|||
33358137|NCT00966875|62735642|FG002|Part A|Sponsor Decision|1|||
33358138|NCT00966875|62735643|FG003|Part A|Sponsor Decision|0|||
33358139|NCT00966875|62735644|FG004|Part A|Sponsor Decision|1|||
33358140|NCT00966875|62735645|FG005|Part A|Sponsor Decision|0|||
33358141|NCT00966875|62735646|FG006|Part A|Sponsor Decision|0|||
33358142|NCT00966875|62735647|FG007|Part A|Sponsor Decision|2|||
33358143|NCT00966875|62735648|FG008|Part A|Sponsor Decision|1|||
33358144|NCT00966875|62735640|FG000|Part A|Withdrawal by Subject|2|||
33358145|NCT00966875|62735641|FG001|Part A|Withdrawal by Subject|2|||
33358146|NCT00966875|62735642|FG002|Part A|Withdrawal by Subject|1|||
33358147|NCT00966875|62735643|FG003|Part A|Withdrawal by Subject|1|||
33358148|NCT00966875|62735644|FG004|Part A|Withdrawal by Subject|3|||
33358149|NCT00966875|62735645|FG005|Part A|Withdrawal by Subject|0|||
33358150|NCT00966875|62735646|FG006|Part A|Withdrawal by Subject|5|||
33358151|NCT00966875|62735647|FG007|Part A|Withdrawal by Subject|1|||
33358152|NCT00966875|62735648|FG008|Part A|Withdrawal by Subject|1|||
33473984|NCT03101020|62847606|FG001|Overall Study|Withdrawal by Subject|2|||
33473985|NCT03100942|62847616|FG000|Randomized Treatment Period|Withdrew Consent|4|||
33655477|NCT00637377|63070823|FG000|Overall Study|Withdrawal by Subject|11|||
33358153|NCT00966875|62735640|FG000|Part A|Protocol Violation|0|||
33358154|NCT00966875|62735641|FG001|Part A|Protocol Violation|0|||
33473986|NCT03100942|62847617|FG001|Randomized Treatment Period|Withdrew Consent|5|||
33473987|NCT03100942|62847618|FG002|Randomized Treatment Period|Withdrew Consent|3|||
33473988|NCT03100942|62847619|FG003|Randomized Treatment Period|Withdrew Consent|3|||
33655478|NCT00637377|63070824|FG001|Overall Study|Withdrawal by Subject|15|||
33655479|NCT00637377|63070825|FG002|Overall Study|Withdrawal by Subject|13|||
33655480|NCT00637377|63070826|FG003|Overall Study|Withdrawal by Subject|11|||
33655481|NCT00637377|63070823|FG000|Overall Study|Other (no further information available)|7|||
33358155|NCT00966875|62735642|FG002|Part A|Protocol Violation|0|||
33358156|NCT00966875|62735643|FG003|Part A|Protocol Violation|0|||
33358157|NCT00966875|62735644|FG004|Part A|Protocol Violation|0|||
33358158|NCT00966875|62735645|FG005|Part A|Protocol Violation|0|||
33358159|NCT00966875|62735646|FG006|Part A|Protocol Violation|2|||
33358160|NCT00966875|62735647|FG007|Part A|Protocol Violation|1|||
33358161|NCT00966875|62735648|FG008|Part A|Protocol Violation|1|||
33358162|NCT00966875|62735640|FG000|Part B|Adverse Event|0|||
33358163|NCT00966875|62735641|FG001|Part B|Adverse Event|1|||
33358164|NCT00966875|62735642|FG002|Part B|Adverse Event|1|||
33358165|NCT00966875|62735643|FG003|Part B|Adverse Event|0|||
33358166|NCT00966875|62735644|FG004|Part B|Adverse Event|1|||
33358167|NCT00966875|62735645|FG005|Part B|Adverse Event|0|||
33358168|NCT00966875|62735646|FG006|Part B|Adverse Event|5|||
33358169|NCT00966875|62735647|FG007|Part B|Adverse Event|2|||
33358170|NCT00966875|62735648|FG008|Part B|Adverse Event|2|||
33358171|NCT00966875|62735640|FG000|Part B|Death|0|||
33358172|NCT00966875|62735641|FG001|Part B|Death|0|||
33358173|NCT00966875|62735642|FG002|Part B|Death|1|||
33358174|NCT00966875|62735643|FG003|Part B|Death|0|||
33358175|NCT00966875|62735644|FG004|Part B|Death|0|||
33358176|NCT00966875|62735645|FG005|Part B|Death|0|||
33358177|NCT00966875|62735646|FG006|Part B|Death|0|||
33358178|NCT00966875|62735647|FG007|Part B|Death|1|||
33358179|NCT00966875|62735648|FG008|Part B|Death|0|||
33358180|NCT00966875|62735640|FG000|Part B|Lack of Efficacy|2|||
33358181|NCT00966875|62735641|FG001|Part B|Lack of Efficacy|1|||
33473989|NCT03100942|62847620|FG004|Randomized Treatment Period|Withdrew Consent|0|||
33473990|NCT03100942|62847621|FG005|Randomized Treatment Period|Withdrew Consent|0|||
33473991|NCT03100942|62847622|FG006|Randomized Treatment Period|Withdrew Consent|0|||
33473992|NCT03100942|62847616|FG000|Randomized Treatment Period|Adverse Event|5|||
33473993|NCT03100942|62847617|FG001|Randomized Treatment Period|Adverse Event|2|||
33473994|NCT03100942|62847618|FG002|Randomized Treatment Period|Adverse Event|1|||
33473995|NCT03100942|62847619|FG003|Randomized Treatment Period|Adverse Event|0|||
33473996|NCT03100942|62847620|FG004|Randomized Treatment Period|Adverse Event|0|||
33473997|NCT03100942|62847621|FG005|Randomized Treatment Period|Adverse Event|0|||
33473998|NCT03100942|62847622|FG006|Randomized Treatment Period|Adverse Event|0|||
33473999|NCT03100942|62847616|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
33474000|NCT03100942|62847617|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
33474001|NCT03100942|62847618|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
33474002|NCT03100942|62847619|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
33474003|NCT03100942|62847620|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
33474004|NCT03100942|62847621|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
33474005|NCT03100942|62847622|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
33474006|NCT03100942|62847616|FG000|Randomized Treatment Period|Protocol Violation|0|||
33474007|NCT03100942|62847617|FG001|Randomized Treatment Period|Protocol Violation|1|||
33474008|NCT03100942|62847618|FG002|Randomized Treatment Period|Protocol Violation|1|||
33474009|NCT03100942|62847619|FG003|Randomized Treatment Period|Protocol Violation|1|||
33474010|NCT03100942|62847620|FG004|Randomized Treatment Period|Protocol Violation|0|||
33474011|NCT03100942|62847621|FG005|Randomized Treatment Period|Protocol Violation|0|||
33474012|NCT03100942|62847622|FG006|Randomized Treatment Period|Protocol Violation|0|||
33474013|NCT03100942|62847616|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
33474014|NCT03100942|62847617|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
33474015|NCT03100942|62847618|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
33474016|NCT03100942|62847619|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
33474017|NCT03100942|62847620|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
33474018|NCT03100942|62847621|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
33474019|NCT03100942|62847622|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
33474020|NCT03100942|62847616|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
33474021|NCT03100942|62847617|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
33474022|NCT03100942|62847618|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
33474023|NCT03100942|62847619|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
33474024|NCT03100942|62847620|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
33474025|NCT03100942|62847621|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
33474026|NCT03100942|62847622|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
33474027|NCT03100942|62847616|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
33474028|NCT03100942|62847617|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
33474029|NCT03100942|62847618|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
33474030|NCT03100942|62847619|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
33474031|NCT03100942|62847620|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
33310158|NCT01168401|62685529|FG000|Overall Study|Withdrawal by Subject|0|||
33310159|NCT01168401|62685530|FG001|Overall Study|Withdrawal by Subject|0|||
33310160|NCT01168401|62685531|FG002|Overall Study|Withdrawal by Subject|0|||
33310161|NCT01168401|62685532|FG003|Overall Study|Withdrawal by Subject|1|||
33310162|NCT01168401|62685533|FG004|Overall Study|Withdrawal by Subject|0|||
33310163|NCT01168401|62685534|FG005|Overall Study|Withdrawal by Subject|0|||
33310164|NCT01168401|62685535|FG006|Overall Study|Withdrawal by Subject|0|||
33310165|NCT01168401|62685536|FG007|Overall Study|Withdrawal by Subject|0|||
33310166|NCT01168401|62685537|FG008|Overall Study|Withdrawal by Subject|0|||
33310167|NCT01168401|62685538|FG009|Overall Study|Withdrawal by Subject|0|||
33310168|NCT01168401|62685539|FG010|Overall Study|Withdrawal by Subject|0|||
33358182|NCT00966875|62735642|FG002|Part B|Lack of Efficacy|1|||
33358183|NCT00966875|62735643|FG003|Part B|Lack of Efficacy|1|||
33358184|NCT00966875|62735644|FG004|Part B|Lack of Efficacy|2|||
33358185|NCT00966875|62735645|FG005|Part B|Lack of Efficacy|3|||
33358186|NCT00966875|62735646|FG006|Part B|Lack of Efficacy|12|||
33358187|NCT00966875|62735647|FG007|Part B|Lack of Efficacy|9|||
33358188|NCT00966875|62735648|FG008|Part B|Lack of Efficacy|6|||
33358189|NCT00966875|62735640|FG000|Part B|Lost to Follow-up|0|||
33358190|NCT00966875|62735641|FG001|Part B|Lost to Follow-up|0|||
33358191|NCT00966875|62735642|FG002|Part B|Lost to Follow-up|0|||
33358192|NCT00966875|62735643|FG003|Part B|Lost to Follow-up|1|||
33358193|NCT00966875|62735644|FG004|Part B|Lost to Follow-up|0|||
33474032|NCT03100942|62847621|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
33474033|NCT03100942|62847622|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
33474034|NCT03099694|62847637|FG000|Overall Study|Withdrawal by Subject|11|||
33474035|NCT03099694|62847638|FG001|Overall Study|Withdrawal by Subject|13|||
33474036|NCT03099694|62847637|FG000|Overall Study|Lost to Follow-up|9|||
33474037|NCT03099694|62847638|FG001|Overall Study|Lost to Follow-up|5|||
33474038|NCT03099538|62847645|FG000|Overall Study|Lack of Efficacy|3|||
33474039|NCT03099304|62847654|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
33474040|NCT03099304|62847655|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
33474041|NCT03099304|62847656|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
33474042|NCT03099304|62847657|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
33474043|NCT03099304|62847658|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
33474044|NCT03099304|62847659|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
33474045|NCT03099304|62847654|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
33474046|NCT03099304|62847655|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
33474047|NCT03099304|62847656|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
33474048|NCT03099304|62847657|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
33474049|NCT03099304|62847658|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
33474050|NCT03099304|62847659|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
33474051|NCT03099304|62847654|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
33474052|NCT03099304|62847655|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
33474053|NCT03099304|62847656|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
33474054|NCT03099304|62847657|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
33474055|NCT03099304|62847658|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
33474056|NCT03099304|62847659|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
33474057|NCT03099304|62847654|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
33474058|NCT03099304|62847655|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
33474059|NCT03099304|62847656|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
33474060|NCT03099304|62847657|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
33474061|NCT03099304|62847658|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
33474062|NCT03099304|62847659|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
33474063|NCT03099304|62847654|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
33474064|NCT03099304|62847655|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
33474065|NCT03099304|62847656|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
33474066|NCT03099304|62847657|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
33474067|NCT03099304|62847658|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
33474068|NCT03099304|62847659|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
33474069|NCT03099304|62847654|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
33474070|NCT03099304|62847655|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
33474071|NCT03099304|62847656|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
33474072|NCT03099304|62847657|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
33474073|NCT03099304|62847658|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
33474074|NCT03099304|62847659|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
33474075|NCT03099304|62847654|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
33474076|NCT03099304|62847655|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
33474077|NCT03099304|62847656|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
33474078|NCT03099304|62847657|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
33474079|NCT03099304|62847658|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
33474080|NCT03099304|62847659|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
33474081|NCT03099304|62847654|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
33474082|NCT03099304|62847655|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
33474083|NCT03099304|62847656|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
33474084|NCT03099304|62847657|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
33474085|NCT03099304|62847658|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
33474086|NCT03099304|62847659|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
33474087|NCT03099304|62847654|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
33655482|NCT00637377|63070824|FG001|Overall Study|Other (no further information available)|6|||
33358194|NCT00966875|62735645|FG005|Part B|Lost to Follow-up|0|||
33358195|NCT00966875|62735646|FG006|Part B|Lost to Follow-up|0|||
33358196|NCT00966875|62735647|FG007|Part B|Lost to Follow-up|0|||
33358197|NCT00966875|62735648|FG008|Part B|Lost to Follow-up|1|||
33358198|NCT00966875|62735640|FG000|Part B|Physician Decision|0|||
33358199|NCT00966875|62735641|FG001|Part B|Physician Decision|0|||
33358200|NCT00966875|62735642|FG002|Part B|Physician Decision|1|||
33358201|NCT00966875|62735643|FG003|Part B|Physician Decision|0|||
33358202|NCT00966875|62735644|FG004|Part B|Physician Decision|2|||
33358203|NCT00966875|62735645|FG005|Part B|Physician Decision|1|||
33358204|NCT00966875|62735646|FG006|Part B|Physician Decision|0|||
33358205|NCT00966875|62735647|FG007|Part B|Physician Decision|0|||
33358206|NCT00966875|62735648|FG008|Part B|Physician Decision|2|||
33358207|NCT00966875|62735640|FG000|Part B|Sponsor Decision|1|||
33358208|NCT00966875|62735641|FG001|Part B|Sponsor Decision|0|||
33358209|NCT00966875|62735642|FG002|Part B|Sponsor Decision|0|||
33358210|NCT00966875|62735643|FG003|Part B|Sponsor Decision|0|||
33358211|NCT00966875|62735644|FG004|Part B|Sponsor Decision|0|||
33358212|NCT00966875|62735645|FG005|Part B|Sponsor Decision|1|||
33358213|NCT00966875|62735646|FG006|Part B|Sponsor Decision|0|||
33358214|NCT00966875|62735647|FG007|Part B|Sponsor Decision|2|||
33358215|NCT00966875|62735648|FG008|Part B|Sponsor Decision|1|||
33358216|NCT00966875|62735640|FG000|Part B|Withdrawal by Subject|2|||
33358217|NCT00966875|62735641|FG001|Part B|Withdrawal by Subject|1|||
33358218|NCT00966875|62735642|FG002|Part B|Withdrawal by Subject|2|||
33358219|NCT00966875|62735643|FG003|Part B|Withdrawal by Subject|1|||
33358220|NCT00966875|62735644|FG004|Part B|Withdrawal by Subject|2|||
33358221|NCT00966875|62735645|FG005|Part B|Withdrawal by Subject|1|||
33358222|NCT00966875|62735646|FG006|Part B|Withdrawal by Subject|4|||
33358223|NCT00966875|62735647|FG007|Part B|Withdrawal by Subject|5|||
33358224|NCT00966875|62735648|FG008|Part B|Withdrawal by Subject|5|||
33358225|NCT00966875|62735640|FG000|Part B|Entry Criteria|0|||
33358226|NCT00966875|62735641|FG001|Part B|Entry Criteria|0|||
33358227|NCT00966875|62735642|FG002|Part B|Entry Criteria|0|||
33358228|NCT00966875|62735643|FG003|Part B|Entry Criteria|0|||
33358229|NCT00966875|62735644|FG004|Part B|Entry Criteria|0|||
33358230|NCT00966875|62735645|FG005|Part B|Entry Criteria|0|||
33358231|NCT00966875|62735646|FG006|Part B|Entry Criteria|1|||
33358232|NCT00966875|62735647|FG007|Part B|Entry Criteria|0|||
33358233|NCT00966875|62735648|FG008|Part B|Entry Criteria|1|||
33358234|NCT00828711|62735724|FG000|Overall Study|Lost to Follow-up|1|||
33358235|NCT00828711|62735725|FG001|Overall Study|Lost to Follow-up|0|||
33358236|NCT00828711|62735726|FG002|Overall Study|Lost to Follow-up|0|||
33358237|NCT00966719|62735736|FG000|Overall Study|Lost to Follow-up|6|||
33358238|NCT00966719|62735737|FG001|Overall Study|Lost to Follow-up|11|||
33358239|NCT00818649|62735743|FG000|Overall Study|Declining performance status|2|||
33358240|NCT00818649|62735743|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
33358241|NCT00818649|62735743|FG000|Overall Study|Adverse Event|1|||
33358242|NCT00961571|62735748|FG000|Overall Study|Physician Decision|39|||
33358243|NCT00964223|62735752|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
33358244|NCT00620815|62735760|FG000|Overall Study|Adverse Event|1|||
33358245|NCT00620815|62735761|FG001|Overall Study|Adverse Event|1|||
33358246|NCT00620815|62735762|FG002|Overall Study|Adverse Event|2|||
33358247|NCT00620815|62735760|FG000|Overall Study|Withdrawal by Subject|1|||
33358248|NCT00620815|62735761|FG001|Overall Study|Withdrawal by Subject|2|||
33358249|NCT00620815|62735762|FG002|Overall Study|Withdrawal by Subject|0|||
33358250|NCT00620815|62735760|FG000|Overall Study|Lost to Follow-up|1|||
33358251|NCT00620815|62735761|FG001|Overall Study|Lost to Follow-up|6|||
33358252|NCT00620815|62735762|FG002|Overall Study|Lost to Follow-up|3|||
33358253|NCT00620815|62735760|FG000|Overall Study|Inappropriate enrolment|0|||
33358254|NCT00620815|62735761|FG001|Overall Study|Inappropriate enrolment|0|||
33358255|NCT00620815|62735762|FG002|Overall Study|Inappropriate enrolment|1|||
33358256|NCT00620815|62735760|FG000|Overall Study|Protocol Violation|1|||
33358257|NCT00620815|62735761|FG001|Overall Study|Protocol Violation|2|||
33358258|NCT00620815|62735762|FG002|Overall Study|Protocol Violation|1|||
33358259|NCT03372941|62735788|FG000|Overall Study|Lost to Follow-up|2|||
33358260|NCT03372941|62735789|FG001|Overall Study|Lost to Follow-up|4|||
33358261|NCT00619957|62735797|FG000|Month 24 Double-Blind|Adverse Event|9|||
33655483|NCT00637377|63070825|FG002|Overall Study|Other (no further information available)|10|||
33358262|NCT00619957|62735798|FG001|Month 24 Double-Blind|Adverse Event|7|||
33358263|NCT00619957|62735797|FG000|Month 24 Double-Blind|Protocol Violation|1|||
33358264|NCT00619957|62735798|FG001|Month 24 Double-Blind|Protocol Violation|0|||
33358265|NCT00619957|62735797|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
33358266|NCT00619957|62735798|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
33358267|NCT00619957|62735797|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
33358268|NCT00619957|62735798|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
33358269|NCT00619957|62735797|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
33358270|NCT00619957|62735798|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
33358271|NCT00619957|62735797|FG000|Month 48 Open-Label|Adverse Event|4|||
33358272|NCT00619957|62735798|FG001|Month 48 Open-Label|Adverse Event|4|||
33358273|NCT00619957|62735797|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
33358274|NCT00619957|62735798|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
33358275|NCT00619957|62735797|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
33358276|NCT00619957|62735798|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
33358277|NCT00961415|62735808|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
33358278|NCT00961415|62735809|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
33358279|NCT00961415|62735810|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
33358280|NCT00961415|62735808|FG000|Induction Treatment Phase|Death|77|||
33358281|NCT00961415|62735809|FG001|Induction Treatment Phase|Death|0|||
33358282|NCT00961415|62735810|FG002|Induction Treatment Phase|Death|0|||
33358283|NCT00961415|62735808|FG000|Induction Treatment Phase|Protocol Violation|1|||
33358284|NCT00961415|62735809|FG001|Induction Treatment Phase|Protocol Violation|0|||
33358285|NCT00961415|62735810|FG002|Induction Treatment Phase|Protocol Violation|0|||
33358286|NCT00961415|62735808|FG000|Induction Treatment Phase|Physician Decision|2|||
33358287|NCT00961415|62735809|FG001|Induction Treatment Phase|Physician Decision|0|||
33358288|NCT00961415|62735810|FG002|Induction Treatment Phase|Physician Decision|0|||
33358289|NCT00961415|62735808|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
33358290|NCT00961415|62735809|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
33358291|NCT00961415|62735810|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
33358292|NCT00961415|62735808|FG000|Induction Treatment Phase|Other Reason|5|||
33358293|NCT00961415|62735809|FG001|Induction Treatment Phase|Other Reason|0|||
33358294|NCT00961415|62735810|FG002|Induction Treatment Phase|Other Reason|0|||
33358295|NCT00961415|62735808|FG000|Maintenance Treatment Phase|Death|0|||
33358296|NCT00961415|62735809|FG001|Maintenance Treatment Phase|Death|42|||
33358297|NCT00961415|62735810|FG002|Maintenance Treatment Phase|Death|34|||
33358298|NCT00961415|62735808|FG000|Maintenance Treatment Phase|Investigators decision|0|||
33358299|NCT00961415|62735809|FG001|Maintenance Treatment Phase|Investigators decision|2|||
33358300|NCT00961415|62735810|FG002|Maintenance Treatment Phase|Investigators decision|0|||
33358301|NCT00961415|62735808|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33358302|NCT00961415|62735809|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
33358303|NCT00961415|62735810|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
33358304|NCT00961415|62735808|FG000|Maintenance Treatment Phase|Other reason|0|||
33358305|NCT00961415|62735809|FG001|Maintenance Treatment Phase|Other reason|1|||
33358306|NCT00961415|62735810|FG002|Maintenance Treatment Phase|Other reason|3|||
33358307|NCT00963599|62735828|FG000|Overall Study|Adverse Event|2|||
33358308|NCT00963599|62735829|FG001|Overall Study|Adverse Event|0|||
33358309|NCT00963599|62735830|FG002|Overall Study|Adverse Event|1|||
33358310|NCT00963599|62735831|FG003|Overall Study|Adverse Event|2|||
33358311|NCT00963599|62735828|FG000|Overall Study|Lack of Efficacy|0|||
33358312|NCT00963599|62735829|FG001|Overall Study|Lack of Efficacy|2|||
33358313|NCT00963599|62735830|FG002|Overall Study|Lack of Efficacy|1|||
33358314|NCT00963599|62735831|FG003|Overall Study|Lack of Efficacy|4|||
33358315|NCT00963599|62735828|FG000|Overall Study|Lost to Follow-up|0|||
33358316|NCT00963599|62735829|FG001|Overall Study|Lost to Follow-up|1|||
33358317|NCT00963599|62735830|FG002|Overall Study|Lost to Follow-up|1|||
33358318|NCT00963599|62735831|FG003|Overall Study|Lost to Follow-up|1|||
33358319|NCT00963599|62735828|FG000|Overall Study|Protocol Violation|2|||
33358320|NCT00963599|62735829|FG001|Overall Study|Protocol Violation|2|||
33358321|NCT00963599|62735830|FG002|Overall Study|Protocol Violation|3|||
33358322|NCT00963599|62735831|FG003|Overall Study|Protocol Violation|4|||
33358323|NCT00963599|62735828|FG000|Overall Study|Withdrawal by Subject|2|||
33358324|NCT00963599|62735829|FG001|Overall Study|Withdrawal by Subject|1|||
33358325|NCT00963599|62735830|FG002|Overall Study|Withdrawal by Subject|3|||
33358326|NCT00963599|62735831|FG003|Overall Study|Withdrawal by Subject|3|||
33474088|NCT03099304|62847655|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
33474089|NCT03099304|62847656|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
33474090|NCT03099304|62847657|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
33474091|NCT03099304|62847658|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
33474092|NCT03099304|62847659|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
33474093|NCT03099304|62847654|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
33474094|NCT03099304|62847655|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
33474095|NCT03099304|62847656|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
33474096|NCT03099304|62847657|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
33474097|NCT03099304|62847658|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
33474098|NCT03099304|62847659|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
33549255|NCT02963441|62940519|FG000|Overall Study|Protocol violation or withdrawn|8|||
33549256|NCT02963441|62940519|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
33549257|NCT02963441|62940519|FG000|Overall Study|IDx-DR insufficient quality|33|||
33549258|NCT01345253|62940526|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
33358327|NCT00619801|62735843|FG000|Overall Study|Lack of Efficacy|0|||
33358328|NCT00619801|62735844|FG001|Overall Study|Lack of Efficacy|1|||
33358329|NCT00619801|62735843|FG000|Overall Study|Withdrawal by Subject|1|||
33358330|NCT00619801|62735844|FG001|Overall Study|Withdrawal by Subject|1|||
33358331|NCT00619801|62735843|FG000|Overall Study|Loss of efficacy|0|||
33358332|NCT00619801|62735844|FG001|Overall Study|Loss of efficacy|1|||
33358333|NCT00962741|62735850|FG000|Overall Study|Failed to return|3|||
33358334|NCT00962741|62735850|FG000|Overall Study|Lost to Follow-up|2|||
33358335|NCT00962741|62735850|FG000|Overall Study|Withdrawal by Subject|1|||
33358336|NCT00962741|62735850|FG000|Overall Study|Lack of Efficacy|1|||
33358337|NCT00962741|62735850|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
33474099|NCT03099304|62847654|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
33474100|NCT03099304|62847655|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
33474101|NCT03099304|62847656|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
33474102|NCT03099304|62847657|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
33474103|NCT03099304|62847658|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
33474104|NCT03099304|62847659|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
33474105|NCT03099304|62847654|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
33474106|NCT03099304|62847655|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
33474107|NCT03099304|62847656|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
33474108|NCT03099304|62847657|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
33474109|NCT03099304|62847658|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
33474110|NCT03099304|62847659|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
33474111|NCT03099304|62847654|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
33474112|NCT03099304|62847655|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
33474113|NCT03099304|62847656|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
33474114|NCT03099304|62847657|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
33474115|NCT03099304|62847658|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
33474116|NCT03099304|62847659|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
33474117|NCT03099304|62847654|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
33474118|NCT03099304|62847655|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
33474119|NCT03099304|62847656|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
33474120|NCT03099304|62847657|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
33474121|NCT03099304|62847658|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
33474122|NCT03099304|62847659|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
33474123|NCT03099304|62847654|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
33474124|NCT03099304|62847655|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
33474125|NCT03099304|62847656|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
33474126|NCT03099304|62847657|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
33474127|NCT03099304|62847658|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
33474128|NCT03099304|62847659|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
33474129|NCT03099304|62847654|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
33474130|NCT03099304|62847655|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
33474131|NCT03099304|62847656|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
33358338|NCT00619645|62735854|FG000|Overall Study|Adverse Event|1|||
33358339|NCT00619177|62735858|FG000|Overall Study|Adverse Event|18|||
33358340|NCT00619177|62735858|FG000|Overall Study|Lost to Follow-up|2|||
33358341|NCT00619177|62735858|FG000|Overall Study|Lack of Efficacy|1|||
33358342|NCT00619177|62735858|FG000|Overall Study|Missing termination information|481|||
33358343|NCT00619177|62735858|FG000|Overall Study|Not specified reasons|6|||
33358344|NCT00818259|62735869|FG000|Part I|Withdrawal by Subject|1|||
33358345|NCT00818259|62735870|FG001|Part I|Withdrawal by Subject|0|||
33358346|NCT00818259|62735871|FG002|Part I|Withdrawal by Subject|0|||
33358347|NCT00818259|62735872|FG003|Part I|Withdrawal by Subject|0|||
33358348|NCT00818259|62735873|FG004|Part I|Withdrawal by Subject|0|||
33358349|NCT00818259|62735874|FG005|Part I|Withdrawal by Subject|0|||
33358350|NCT00818259|62735875|FG006|Part I|Withdrawal by Subject|0|||
33358351|NCT00818259|62735876|FG007|Part I|Withdrawal by Subject|0|||
33358352|NCT00818259|62735877|FG008|Part I|Withdrawal by Subject|0|||
33358353|NCT00818259|62735869|FG000|Part II|Physician Decision|0|||
33358354|NCT00818259|62735870|FG001|Part II|Physician Decision|0|||
33358355|NCT00818259|62735871|FG002|Part II|Physician Decision|1|||
33358356|NCT00818259|62735872|FG003|Part II|Physician Decision|0|||
33474132|NCT03099304|62847657|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
33474133|NCT03099304|62847658|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
33474134|NCT03099304|62847659|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
33474135|NCT03099304|62847654|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
33474136|NCT03099304|62847655|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
33474137|NCT03099304|62847656|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
33474138|NCT03099304|62847657|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
33474139|NCT03099304|62847658|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
33474140|NCT03099304|62847659|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
33474141|NCT03097588|62847686|FG000|Overall Study|Adverse Event|1|||
33474142|NCT01631214|62847692|FG000|Overall Study|Withdrawal by Subject|276|||
33474143|NCT01631214|62847693|FG001|Overall Study|Withdrawal by Subject|290|||
33474144|NCT01631214|62847692|FG000|Overall Study|Death|113|||
33474145|NCT01631214|62847693|FG001|Overall Study|Death|106|||
33358357|NCT00818259|62735873|FG004|Part II|Physician Decision|0|||
33358358|NCT00818259|62735874|FG005|Part II|Physician Decision|0|||
33474146|NCT01631214|62847692|FG000|Overall Study|Lost to Follow-up|54|||
33358359|NCT00818259|62735875|FG006|Part II|Physician Decision|0|||
33474147|NCT01631214|62847693|FG001|Overall Study|Lost to Follow-up|40|||
33474148|NCT01631214|62847692|FG000|Overall Study|Adverse Event|45|||
33474149|NCT01631214|62847693|FG001|Overall Study|Adverse Event|45|||
33474150|NCT01631214|62847692|FG000|Overall Study|Other|22|||
33474151|NCT01631214|62847693|FG001|Overall Study|Other|19|||
33474152|NCT01631214|62847692|FG000|Overall Study|Noncompliance|16|||
33474153|NCT01631214|62847693|FG001|Overall Study|Noncompliance|15|||
33474154|NCT01631214|62847692|FG000|Overall Study|Requirement for Alternative Therapy|8|||
33474155|NCT01631214|62847693|FG001|Overall Study|Requirement for Alternative Therapy|3|||
33474156|NCT01631214|62847692|FG000|Overall Study|Protocol Deviation|4|||
33474157|NCT01631214|62847693|FG001|Overall Study|Protocol Deviation|3|||
33474158|NCT01631214|62847692|FG000|Overall Study|Ineligibility determined|5|||
33474159|NCT01631214|62847693|FG001|Overall Study|Ineligibility determined|2|||
33474160|NCT01631214|62847692|FG000|Overall Study|Administrative Decision|1|||
33474161|NCT01631214|62847693|FG001|Overall Study|Administrative Decision|0|||
33474162|NCT03093454|62847703|FG000|Overall Study|Withdrawal by Subject|1|||
33474163|NCT03093454|62847704|FG001|Overall Study|Withdrawal by Subject|1|||
33474164|NCT03093454|62847703|FG000|Overall Study|Scheduling conflict|3|||
33474165|NCT03093454|62847704|FG001|Overall Study|Scheduling conflict|1|||
33474166|NCT03093454|62847703|FG000|Overall Study|Physician Decision|2|||
33474167|NCT03093454|62847704|FG001|Overall Study|Physician Decision|1|||
33474168|NCT00468130|62847725|FG000|Overall Study|Adverse Event|2|||
33474169|NCT00468130|62847726|FG001|Overall Study|Adverse Event|1|||
33474170|NCT00468130|62847725|FG000|Overall Study|Withdrawal by Subject|0|||
33474171|NCT00468130|62847726|FG001|Overall Study|Withdrawal by Subject|1|||
33474172|NCT00911820|62847736|FG000|Overall Study|RECIST progression|12|||
33474173|NCT00911820|62847737|FG001|Overall Study|RECIST progression|8|||
33474174|NCT00911820|62847736|FG000|Overall Study|Adverse Event|8|||
33474175|NCT00911820|62847737|FG001|Overall Study|Adverse Event|8|||
33474176|NCT00911820|62847736|FG000|Overall Study|Clinical Progression|7|||
33474177|NCT00911820|62847737|FG001|Overall Study|Clinical Progression|5|||
33474178|NCT00911820|62847736|FG000|Overall Study|Physician Decision|5|||
33474179|NCT00911820|62847737|FG001|Overall Study|Physician Decision|9|||
33474180|NCT00911820|62847736|FG000|Overall Study|Decline in Performance Status|4|||
33474181|NCT00911820|62847737|FG001|Overall Study|Decline in Performance Status|2|||
33474182|NCT00911820|62847736|FG000|Overall Study|Withdrawal by Subject|3|||
33474183|NCT00911820|62847737|FG001|Overall Study|Withdrawal by Subject|4|||
33474184|NCT00911820|62847736|FG000|Overall Study|Death|1|||
33474185|NCT00911820|62847737|FG001|Overall Study|Death|2|||
33474186|NCT00911820|62847736|FG000|Overall Study|Pursue surgery|1|||
33474187|NCT00911820|62847737|FG001|Overall Study|Pursue surgery|1|||
33474188|NCT00911820|62847736|FG000|Overall Study|Pursue Radiation|1|||
33474189|NCT00911820|62847737|FG001|Overall Study|Pursue Radiation|0|||
33474190|NCT00911820|62847736|FG000|Overall Study|Still on Therapy|2|||
33474191|NCT00911820|62847737|FG001|Overall Study|Still on Therapy|2|||
33474192|NCT00911820|62847736|FG000|Overall Study|Pathology Not Confirmed|1|||
33474193|NCT00911820|62847737|FG001|Overall Study|Pathology Not Confirmed|0|||
33474194|NCT00911820|62847736|FG000|Overall Study|Withdraw before Receive Treatment|0|||
33474195|NCT00911820|62847737|FG001|Overall Study|Withdraw before Receive Treatment|2|||
33474196|NCT00246324|62847752|FG000|Overall Study|Withdrawal by Subject|1|||
33549259|NCT01345253|62940527|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
33549260|NCT01345253|62940526|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
33549261|NCT01345253|62940527|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
33549262|NCT01345253|62940526|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
33549263|NCT01345253|62940527|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
33549264|NCT01345253|62940526|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
33358360|NCT00818259|62735876|FG007|Part II|Physician Decision|0|||
33358361|NCT00818259|62735877|FG008|Part II|Physician Decision|0|||
33358362|NCT00818259|62735869|FG000|Part II|Lack of Efficacy|0|||
33358363|NCT00818259|62735870|FG001|Part II|Lack of Efficacy|0|||
33358364|NCT00818259|62735871|FG002|Part II|Lack of Efficacy|0|||
33358365|NCT00818259|62735872|FG003|Part II|Lack of Efficacy|1|||
33358366|NCT00818259|62735873|FG004|Part II|Lack of Efficacy|0|||
33358367|NCT00818259|62735874|FG005|Part II|Lack of Efficacy|0|||
33358368|NCT00818259|62735875|FG006|Part II|Lack of Efficacy|0|||
33358369|NCT00818259|62735876|FG007|Part II|Lack of Efficacy|0|||
33358370|NCT00818259|62735877|FG008|Part II|Lack of Efficacy|0|||
33358371|NCT00818259|62735869|FG000|Part II|Not Treated|0|||
33474197|NCT04234984|62847758|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
33474198|NCT04234984|62847758|FG000|Follow-up at the Second Time Point|Death|1|||
33358372|NCT00818259|62735870|FG001|Part II|Not Treated|0|||
33474199|NCT04234984|62847758|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
33474200|NCT03922750|62847772|FG000|Overall Study|Unclassified|0|||
33474201|NCT03922750|62847773|FG001|Overall Study|Unclassified|0|||
33474202|NCT03922750|62847774|FG002|Overall Study|Unclassified|1|||
33474203|NCT03922750|62847772|FG000|Overall Study|Adverse Event|0|||
33358373|NCT00818259|62735871|FG002|Part II|Not Treated|0|||
33358374|NCT00818259|62735872|FG003|Part II|Not Treated|1|||
33358375|NCT00818259|62735873|FG004|Part II|Not Treated|0|||
33358376|NCT00818259|62735874|FG005|Part II|Not Treated|0|||
33358377|NCT00818259|62735875|FG006|Part II|Not Treated|0|||
33358378|NCT00818259|62735876|FG007|Part II|Not Treated|0|||
33358379|NCT00818259|62735877|FG008|Part II|Not Treated|0|||
33358380|NCT00818259|62735869|FG000|Part IV|Physician Decision|0|||
33358381|NCT00818259|62735870|FG001|Part IV|Physician Decision|0|||
33358382|NCT00818259|62735871|FG002|Part IV|Physician Decision|0|||
33358383|NCT00818259|62735872|FG003|Part IV|Physician Decision|0|||
33358384|NCT00818259|62735873|FG004|Part IV|Physician Decision|0|||
33358385|NCT00818259|62735874|FG005|Part IV|Physician Decision|1|||
33358386|NCT00818259|62735875|FG006|Part IV|Physician Decision|0|||
33358387|NCT00818259|62735876|FG007|Part IV|Physician Decision|0|||
33358388|NCT00818259|62735877|FG008|Part IV|Physician Decision|0|||
33358389|NCT00818259|62735869|FG000|Part V|Adverse Event|0|||
33358390|NCT00818259|62735870|FG001|Part V|Adverse Event|0|||
33358391|NCT00818259|62735871|FG002|Part V|Adverse Event|0|||
33358392|NCT00818259|62735872|FG003|Part V|Adverse Event|0|||
33358393|NCT00818259|62735873|FG004|Part V|Adverse Event|0|||
33358394|NCT00818259|62735874|FG005|Part V|Adverse Event|0|||
33358395|NCT00818259|62735875|FG006|Part V|Adverse Event|0|||
33358396|NCT00818259|62735876|FG007|Part V|Adverse Event|1|||
33358397|NCT00818259|62735877|FG008|Part V|Adverse Event|0|||
33358398|NCT00619099|62735895|FG000|Overall Study|Progressive Disease|7|||
33474204|NCT03922750|62847773|FG001|Overall Study|Adverse Event|1|||
33474205|NCT03922750|62847774|FG002|Overall Study|Adverse Event|0|||
33474206|NCT04634253|62847796|FG000|Overall Study|Adverse Event|1|||
33474207|NCT04634253|62847797|FG001|Overall Study|Adverse Event|1|||
33474208|NCT04634253|62847798|FG002|Overall Study|Adverse Event|0|||
33358399|NCT00619099|62735896|FG001|Overall Study|Progressive Disease|5|||
33358400|NCT00619099|62735895|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
33358401|NCT00619099|62735896|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
33358402|NCT00619099|62735895|FG000|Overall Study|Adverse Event|4|||
33358403|NCT00619099|62735896|FG001|Overall Study|Adverse Event|3|||
33358404|NCT00619099|62735895|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
33358405|NCT00619099|62735896|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
33358406|NCT00619099|62735895|FG000|Overall Study|Withdrawal by Subject|10|||
33358407|NCT00619099|62735896|FG001|Overall Study|Withdrawal by Subject|2|||
33358408|NCT00619099|62735895|FG000|Overall Study|Physician Decision|9|||
33358409|NCT00619099|62735896|FG001|Overall Study|Physician Decision|6|||
33358410|NCT00962585|62735906|FG000|Overall Study|Adverse Event|0|||
33358411|NCT00962585|62735907|FG001|Overall Study|Adverse Event|2|||
33358412|NCT00962585|62735908|FG002|Overall Study|Adverse Event|1|||
33358413|NCT00962585|62735909|FG003|Overall Study|Adverse Event|0|||
33358414|NCT00962585|62735906|FG000|Overall Study|Lost to Follow-up|3|||
33358415|NCT00962585|62735907|FG001|Overall Study|Lost to Follow-up|0|||
33358416|NCT00962585|62735908|FG002|Overall Study|Lost to Follow-up|1|||
33358417|NCT00962585|62735909|FG003|Overall Study|Lost to Follow-up|0|||
33358418|NCT00962585|62735906|FG000|Overall Study|Protocol Violation|0|||
33358419|NCT00962585|62735907|FG001|Overall Study|Protocol Violation|0|||
33358420|NCT00962585|62735908|FG002|Overall Study|Protocol Violation|1|||
33358421|NCT00962585|62735909|FG003|Overall Study|Protocol Violation|0|||
33358422|NCT00962585|62735906|FG000|Overall Study|Withdrawal by Subject|1|||
33358423|NCT00962585|62735907|FG001|Overall Study|Withdrawal by Subject|0|||
33358424|NCT00962585|62735908|FG002|Overall Study|Withdrawal by Subject|0|||
33358425|NCT00962585|62735909|FG003|Overall Study|Withdrawal by Subject|0|||
33358426|NCT00962585|62735906|FG000|Overall Study|Withdrew Consent|2|||
33358427|NCT00962585|62735907|FG001|Overall Study|Withdrew Consent|0|||
33358428|NCT00962585|62735908|FG002|Overall Study|Withdrew Consent|0|||
33358429|NCT00962585|62735909|FG003|Overall Study|Withdrew Consent|0|||
33358430|NCT00621985|62735921|FG000|Dexamethasone Admission|Adverse Event|1|||
33358431|NCT00961259|62735931|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
33474209|NCT04634253|62847796|FG000|Overall Study|Physician Decision|0|||
33358432|NCT00961259|62735932|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
33358433|NCT00961259|62735933|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
33358434|NCT00961181|62735942|FG000|Overall Study|Death|2|||
33358435|NCT00961181|62735942|FG000|Overall Study|Withdrawal by Subject|2|||
33358436|NCT00961181|62735942|FG000|Overall Study|Lost to Follow-up|1|||
33358437|NCT00817635|62735951|FG000|Overall Study|Adverse Event|1|||
33358438|NCT00817635|62735952|FG001|Overall Study|Adverse Event|0|||
33358439|NCT00817635|62735953|FG002|Overall Study|Adverse Event|0|||
33358440|NCT00817635|62735954|FG003|Overall Study|Adverse Event|1|||
33549265|NCT01345253|62940527|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
33358441|NCT00817635|62735955|FG004|Overall Study|Adverse Event|1|||
33358442|NCT00817635|62735951|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
33358443|NCT00817635|62735952|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
33358444|NCT00817635|62735953|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
33358445|NCT00817635|62735954|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
33474210|NCT04634253|62847797|FG001|Overall Study|Physician Decision|1|||
33358446|NCT00817635|62735955|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
33358447|NCT00817635|62735951|FG000|Overall Study|Withdrawal by Subject|2|||
33358448|NCT00817635|62735952|FG001|Overall Study|Withdrawal by Subject|1|||
33358449|NCT00817635|62735953|FG002|Overall Study|Withdrawal by Subject|0|||
33358450|NCT00817635|62735954|FG003|Overall Study|Withdrawal by Subject|1|||
33358451|NCT00817635|62735955|FG004|Overall Study|Withdrawal by Subject|2|||
33358452|NCT00817635|62735951|FG000|Overall Study|Lost to Follow-up|0|||
33358453|NCT00817635|62735952|FG001|Overall Study|Lost to Follow-up|1|||
33358454|NCT00817635|62735953|FG002|Overall Study|Lost to Follow-up|0|||
33358455|NCT00817635|62735954|FG003|Overall Study|Lost to Follow-up|1|||
33358456|NCT00817635|62735955|FG004|Overall Study|Lost to Follow-up|0|||
33358457|NCT00817635|62735951|FG000|Overall Study|Administrative Problems|0|||
33358458|NCT00817635|62735952|FG001|Overall Study|Administrative Problems|0|||
33358459|NCT00817635|62735953|FG002|Overall Study|Administrative Problems|0|||
33358460|NCT00817635|62735954|FG003|Overall Study|Administrative Problems|0|||
33358461|NCT00817635|62735955|FG004|Overall Study|Administrative Problems|1|||
33358462|NCT00817635|62735951|FG000|Overall Study|Protocol Violation|5|||
33358463|NCT00817635|62735952|FG001|Overall Study|Protocol Violation|1|||
33358464|NCT00817635|62735953|FG002|Overall Study|Protocol Violation|3|||
33358465|NCT00817635|62735954|FG003|Overall Study|Protocol Violation|2|||
33358466|NCT00817635|62735955|FG004|Overall Study|Protocol Violation|3|||
33358467|NCT00817479|62735976|FG000|Overall Study|Physician Decision|1|||
33358468|NCT00817479|62735977|FG001|Overall Study|Physician Decision|1|||
33358469|NCT00961961|62735987|FG000|Phase I|Withdrawal by Subject|7|||
33358470|NCT00961961|62735988|FG001|Phase I|Withdrawal by Subject|0|||
33358471|NCT00961961|62735989|FG002|Phase I|Withdrawal by Subject|0|||
33358472|NCT00961961|62735990|FG003|Phase I|Withdrawal by Subject|0|||
33358473|NCT00961961|62735987|FG000|Phase I|Lost to Follow-up|10|||
33358474|NCT00961961|62735988|FG001|Phase I|Lost to Follow-up|0|||
33358475|NCT00961961|62735989|FG002|Phase I|Lost to Follow-up|0|||
33358476|NCT00961961|62735990|FG003|Phase I|Lost to Follow-up|0|||
33358477|NCT00961961|62735987|FG000|Phase I|Lack of Efficacy|94|||
33358478|NCT00961961|62735988|FG001|Phase I|Lack of Efficacy|0|||
33358479|NCT00961961|62735989|FG002|Phase I|Lack of Efficacy|0|||
33358480|NCT00961961|62735990|FG003|Phase I|Lack of Efficacy|0|||
33358481|NCT00961961|62735987|FG000|Phase I|Adverse Event|7|||
33358482|NCT00961961|62735988|FG001|Phase I|Adverse Event|0|||
33358483|NCT00961961|62735989|FG002|Phase I|Adverse Event|0|||
33358484|NCT00961961|62735990|FG003|Phase I|Adverse Event|0|||
33474211|NCT04634253|62847798|FG002|Overall Study|Physician Decision|0|||
33474212|NCT04634253|62847796|FG000|Overall Study|Withdrawal by Subject|1|||
33474213|NCT04634253|62847797|FG001|Overall Study|Withdrawal by Subject|0|||
33474214|NCT04634253|62847798|FG002|Overall Study|Withdrawal by Subject|3|||
33474215|NCT03725982|62847904|FG000|First Intervention|Withdrawal by Subject|0|||
33474216|NCT03725982|62847905|FG001|First Intervention|Withdrawal by Subject|1|||
33474217|NCT03725982|62847904|FG000|First Intervention|Physician Decision|1|||
33474218|NCT03725982|62847905|FG001|First Intervention|Physician Decision|1|||
33474219|NCT03354273|62847975|FG000|Overall Study|Adverse Event|5|||
33474220|NCT03354273|62847975|FG000|Overall Study|Screen Failure|21|||
33474221|NCT03354273|62847975|FG000|Overall Study|Withdrawal by Subject|34|||
33474222|NCT03354273|62847975|FG000|Overall Study|Technical Problems|30|||
33474223|NCT03354273|62847975|FG000|Overall Study|Lost to Follow-up|4|||
33474224|NCT03354273|62847975|FG000|Overall Study|Investigator Decision|3|||
33474225|NCT03354273|62847975|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
33474226|NCT03354273|62847975|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
33474227|NCT03354273|62847975|FG000|Overall Study|COVID-19 Restrictions|9|||
33474228|NCT03354273|62847975|FG000|Overall Study|Other|5|||
33474229|NCT03282123|62847986|FG000|Overall Study|Withdrawal by Subject|5|||
33474230|NCT02759185|62848014|FG000|Stage 1|Adverse Event|0|||
33474231|NCT02759185|62848015|FG001|Stage 1|Adverse Event|1|||
33474232|NCT02759185|62848016|FG002|Stage 1|Adverse Event|3|||
33474233|NCT02759185|62848017|FG003|Stage 1|Adverse Event|0|||
33474234|NCT02759185|62848018|FG004|Stage 1|Adverse Event|0|||
33474235|NCT02759185|62848019|FG005|Stage 1|Adverse Event|0|||
33549266|NCT01345253|62940526|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
33358485|NCT00961961|62735987|FG000|Phase I|Physician Decision|8|||
33358486|NCT00961961|62735988|FG001|Phase I|Physician Decision|0|||
33358487|NCT00961961|62735989|FG002|Phase I|Physician Decision|0|||
33358488|NCT00961961|62735990|FG003|Phase I|Physician Decision|0|||
33358489|NCT00961961|62735987|FG000|Phase II|Lost to Follow-up|0|||
33358490|NCT00961961|62735988|FG001|Phase II|Lost to Follow-up|0|||
33358491|NCT00961961|62735989|FG002|Phase II|Lost to Follow-up|10|||
33358492|NCT00961961|62735990|FG003|Phase II|Lost to Follow-up|7|||
33358493|NCT00961961|62735987|FG000|Phase II|Adverse Event|0|||
33474236|NCT02759185|62848020|FG006|Stage 1|Adverse Event|0|||
33474237|NCT02759185|62848014|FG000|Stage 1|Withdrawal by Subject|1|||
33358494|NCT00961961|62735988|FG001|Phase II|Adverse Event|0|||
33358495|NCT00961961|62735989|FG002|Phase II|Adverse Event|0|||
33358496|NCT00961961|62735990|FG003|Phase II|Adverse Event|1|||
33358497|NCT00961961|62735987|FG000|Phase II|Physician Decision|0|||
33474238|NCT02759185|62848015|FG001|Stage 1|Withdrawal by Subject|0|||
33474239|NCT02759185|62848016|FG002|Stage 1|Withdrawal by Subject|0|||
33358498|NCT00961961|62735988|FG001|Phase II|Physician Decision|0|||
33358499|NCT00961961|62735989|FG002|Phase II|Physician Decision|1|||
33358500|NCT00961961|62735990|FG003|Phase II|Physician Decision|0|||
33358501|NCT00961961|62735987|FG000|Phase II|Withdrawal by Subject|0|||
33358502|NCT00961961|62735988|FG001|Phase II|Withdrawal by Subject|0|||
33358503|NCT00961961|62735989|FG002|Phase II|Withdrawal by Subject|1|||
33358504|NCT00961961|62735990|FG003|Phase II|Withdrawal by Subject|0|||
33358505|NCT00817089|62736014|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
33358506|NCT00817089|62736015|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
33358507|NCT00817089|62736016|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
33358508|NCT00817089|62736017|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
33358509|NCT00817089|62736014|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
33358510|NCT00817089|62736015|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
33358511|NCT00817089|62736016|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
33358512|NCT00817089|62736017|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
33358513|NCT00815919|62736031|FG000|Overall Study|Unrelated Fungal Infection|1|||
33358514|NCT00815919|62736031|FG000|Overall Study|AML Relapse|1|||
33655484|NCT00637377|63070826|FG003|Overall Study|Other (no further information available)|5|||
33655485|NCT00636987|63070836|FG000|Overall Study|Death|44|||
33655486|NCT00636987|63070836|FG000|Overall Study|Explanted|13|||
33358515|NCT00815919|62736031|FG000|Overall Study|Lack of Efficacy|2|||
33358516|NCT00957905|62736037|FG000|Part B|Not Treated|0|||
33358517|NCT00957905|62736038|FG001|Part B|Not Treated|1|||
33358518|NCT00957905|62736037|FG000|Part B|Physician Decision|0|||
33358519|NCT00957905|62736038|FG001|Part B|Physician Decision|1|||
33358520|NCT00957905|62736037|FG000|Part B|Death|0|||
33358521|NCT00957905|62736038|FG001|Part B|Death|1|||
33358522|NCT00957905|62736037|FG000|Part B|Protocol Violation|0|||
33358523|NCT00957905|62736038|FG001|Part B|Protocol Violation|1|||
33358524|NCT00960323|62736044|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
33358525|NCT00617929|62736052|FG000|Overall Study|Physician Decision|1|||
33358526|NCT00815295|62736059|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
33358527|NCT00815295|62736060|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
33358528|NCT00815295|62736061|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
33358529|NCT00814983|62736071|FG000|Overall Study|Screen failure|1|||
33358530|NCT00814983|62736072|FG001|Overall Study|Screen failure|0|||
33358531|NCT00814983|62736071|FG000|Overall Study|Withdrawal by Subject|1|||
33358532|NCT00814983|62736072|FG001|Overall Study|Withdrawal by Subject|0|||
33358533|NCT00814983|62736071|FG000|Overall Study|Graft failure|1|||
33358534|NCT00814983|62736072|FG001|Overall Study|Graft failure|0|||
33358535|NCT00960869|62736080|FG000|Overall Study|Adverse Event|17|||
33358536|NCT00960869|62736081|FG001|Overall Study|Adverse Event|26|||
33358537|NCT00960869|62736080|FG000|Overall Study|Withdrawal by Subject|16|||
33358538|NCT00960869|62736081|FG001|Overall Study|Withdrawal by Subject|14|||
33358539|NCT00960869|62736080|FG000|Overall Study|Lost to Follow-up|1|||
33358540|NCT00960869|62736081|FG001|Overall Study|Lost to Follow-up|4|||
33358541|NCT00960869|62736080|FG000|Overall Study|Misc|19|||
33358542|NCT00960869|62736081|FG001|Overall Study|Misc|18|||
33358543|NCT00618787|62736089|FG000|Overall Study|Adverse Event|0|||
33358544|NCT00618787|62736090|FG001|Overall Study|Adverse Event|1|||
33358545|NCT00618787|62736089|FG000|Overall Study|Withdrawal by Subject|2|||
33358546|NCT00618787|62736090|FG001|Overall Study|Withdrawal by Subject|1|||
33358547|NCT00618787|62736089|FG000|Overall Study|Lost to Follow-up|1|||
33358548|NCT00618787|62736090|FG001|Overall Study|Lost to Follow-up|0|||
33358549|NCT00813813|62736098|FG000|Overall Study|Withdrawal by Subject|1|||
33358550|NCT00813813|62736099|FG001|Overall Study|Withdrawal by Subject|1|||
33474240|NCT02759185|62848017|FG003|Stage 1|Withdrawal by Subject|0|||
33474241|NCT02759185|62848018|FG004|Stage 1|Withdrawal by Subject|0|||
33474242|NCT02759185|62848019|FG005|Stage 1|Withdrawal by Subject|0|||
33474243|NCT02759185|62848020|FG006|Stage 1|Withdrawal by Subject|0|||
33474244|NCT02759185|62848014|FG000|Stage 2|Adverse Event|0|||
33474245|NCT02759185|62848015|FG001|Stage 2|Adverse Event|0|||
33474246|NCT02759185|62848016|FG002|Stage 2|Adverse Event|0|||
33474247|NCT02759185|62848017|FG003|Stage 2|Adverse Event|0|||
33474248|NCT02759185|62848018|FG004|Stage 2|Adverse Event|1|||
33474249|NCT02759185|62848019|FG005|Stage 2|Adverse Event|2|||
33474250|NCT02759185|62848020|FG006|Stage 2|Adverse Event|0|||
33474251|NCT02759185|62848014|FG000|Stage 2|Withdrawal by Subject|0|||
33358551|NCT00813813|62736098|FG000|Overall Study|Lost to Follow-up|2|||
33358552|NCT00813813|62736099|FG001|Overall Study|Lost to Follow-up|7|||
33358553|NCT00813813|62736098|FG000|Overall Study|Other|0|||
33358554|NCT00813813|62736099|FG001|Overall Study|Other|1|||
33358555|NCT05317312|62736109|FG000|Overall Study|Withdrawal by Subject|0|||
33655487|NCT00636987|63070836|FG000|Overall Study|Lost to Follow-up|63|||
33358556|NCT05317312|62736110|FG001|Overall Study|Withdrawal by Subject|1|||
33358557|NCT05317312|62736111|FG002|Overall Study|Withdrawal by Subject|0|||
33358558|NCT05317312|62736112|FG003|Overall Study|Withdrawal by Subject|0|||
33474252|NCT02759185|62848015|FG001|Stage 2|Withdrawal by Subject|0|||
33474253|NCT02759185|62848016|FG002|Stage 2|Withdrawal by Subject|0|||
33474254|NCT02759185|62848017|FG003|Stage 2|Withdrawal by Subject|0|||
33474255|NCT02759185|62848018|FG004|Stage 2|Withdrawal by Subject|1|||
33474256|NCT02759185|62848019|FG005|Stage 2|Withdrawal by Subject|1|||
33474257|NCT02759185|62848020|FG006|Stage 2|Withdrawal by Subject|1|||
33474258|NCT02008396|62848057|FG000|Overall Study|Protocol Violation|0|||
33474259|NCT02008396|62848058|FG001|Overall Study|Protocol Violation|1|||
33474260|NCT01844518|62848076|FG000|Overall Study|Adverse Event|7|||
33474261|NCT01844518|62848077|FG001|Overall Study|Adverse Event|1|||
33474262|NCT01844518|62848076|FG000|Overall Study|Lack of Efficacy|17|||
33358559|NCT05317312|62736109|FG000|Overall Study|Lost to Follow-up|0|||
33358560|NCT05317312|62736110|FG001|Overall Study|Lost to Follow-up|0|||
33358561|NCT05317312|62736111|FG002|Overall Study|Lost to Follow-up|0|||
33358562|NCT05317312|62736112|FG003|Overall Study|Lost to Follow-up|1|||
33358563|NCT05317312|62736109|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
33358564|NCT05317312|62736110|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
33358565|NCT05317312|62736111|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
33358566|NCT05317312|62736112|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
33358567|NCT04644315|62736122|FG000|Overall Study|Subject withdrawal of consent|1|||
33358572|NCT04410523|62736147|FG000|Overall Study|Study terminated by sponsor|1|||
33358573|NCT04410523|62736148|FG001|Overall Study|Study terminated by sponsor|3|||
33358574|NCT04410523|62736149|FG002|Overall Study|Study terminated by sponsor|2|||
33358575|NCT04410523|62736150|FG003|Overall Study|Study terminated by sponsor|6|||
33358576|NCT04410523|62736151|FG004|Overall Study|Study terminated by sponsor|3|||
33358577|NCT04410523|62736152|FG005|Overall Study|Study terminated by sponsor|4|||
33358578|NCT04410523|62736147|FG000|Overall Study|Adverse Event|1|||
33358579|NCT04410523|62736148|FG001|Overall Study|Adverse Event|0|||
33358580|NCT04410523|62736149|FG002|Overall Study|Adverse Event|0|||
33358581|NCT04410523|62736150|FG003|Overall Study|Adverse Event|0|||
33358582|NCT04410523|62736151|FG004|Overall Study|Adverse Event|0|||
33358583|NCT04410523|62736152|FG005|Overall Study|Adverse Event|2|||
33358584|NCT04410523|62736147|FG000|Overall Study|Lost to Follow-up|0|||
33358585|NCT04410523|62736148|FG001|Overall Study|Lost to Follow-up|1|||
33358586|NCT04410523|62736149|FG002|Overall Study|Lost to Follow-up|0|||
33358587|NCT04410523|62736150|FG003|Overall Study|Lost to Follow-up|0|||
33358588|NCT04410523|62736151|FG004|Overall Study|Lost to Follow-up|0|||
33358589|NCT04410523|62736152|FG005|Overall Study|Lost to Follow-up|0|||
33358590|NCT04410523|62736147|FG000|Overall Study|Physician Decision|0|||
33358591|NCT04410523|62736148|FG001|Overall Study|Physician Decision|1|||
33358592|NCT04410523|62736149|FG002|Overall Study|Physician Decision|0|||
33358593|NCT04410523|62736150|FG003|Overall Study|Physician Decision|0|||
33358594|NCT04410523|62736151|FG004|Overall Study|Physician Decision|0|||
33358595|NCT04410523|62736152|FG005|Overall Study|Physician Decision|0|||
33358596|NCT04410523|62736147|FG000|Overall Study|Pregnancy|0|||
33358597|NCT04410523|62736148|FG001|Overall Study|Pregnancy|0|||
33358598|NCT04410523|62736149|FG002|Overall Study|Pregnancy|0|||
33358599|NCT04410523|62736150|FG003|Overall Study|Pregnancy|0|||
33358600|NCT04410523|62736151|FG004|Overall Study|Pregnancy|0|||
33358601|NCT04410523|62736152|FG005|Overall Study|Pregnancy|1|||
33358602|NCT04410523|62736147|FG000|Overall Study|Protocol deviation|0|||
33358603|NCT04410523|62736148|FG001|Overall Study|Protocol deviation|0|||
33358604|NCT04410523|62736149|FG002|Overall Study|Protocol deviation|0|||
33358605|NCT04410523|62736150|FG003|Overall Study|Protocol deviation|0|||
33358606|NCT04410523|62736151|FG004|Overall Study|Protocol deviation|0|||
33358607|NCT04410523|62736152|FG005|Overall Study|Protocol deviation|2|||
33474263|NCT01844518|62848077|FG001|Overall Study|Lack of Efficacy|5|||
33474264|NCT01844518|62848076|FG000|Overall Study|Participant's request to discontinue|4|||
33474265|NCT01844518|62848077|FG001|Overall Study|Participant's request to discontinue|1|||
33474266|NCT01844518|62848076|FG000|Overall Study|Poor/Non-compliance|1|||
33474267|NCT01844518|62848077|FG001|Overall Study|Poor/Non-compliance|0|||
33474268|NCT01844518|62848076|FG000|Overall Study|No Longer Met Study Criteria|2|||
33474269|NCT01844518|62848077|FG001|Overall Study|No Longer Met Study Criteria|0|||
33549267|NCT01345253|62940527|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
33358608|NCT04410523|62736147|FG000|Overall Study|Subject decision|2|||
33549268|NCT01345253|62940526|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
33358609|NCT04410523|62736148|FG001|Overall Study|Subject decision|0|||
33358610|NCT04410523|62736149|FG002|Overall Study|Subject decision|0|||
33358611|NCT04410523|62736150|FG003|Overall Study|Subject decision|1|||
33358612|NCT04410523|62736151|FG004|Overall Study|Subject decision|0|||
33358613|NCT04410523|62736152|FG005|Overall Study|Subject decision|1|||
33358614|NCT04154189|62736191|FG000|Overall Study|Death|16|||
33358615|NCT04154189|62736192|FG001|Overall Study|Death|15|||
33358616|NCT04154189|62736191|FG000|Overall Study|Withdrawal by Subject|4|||
33358617|NCT04154189|62736192|FG001|Overall Study|Withdrawal by Subject|6|||
33474270|NCT01844518|62848076|FG000|Overall Study|Withdrawal by Subject|9|||
33474271|NCT01844518|62848077|FG001|Overall Study|Withdrawal by Subject|0|||
33474272|NCT01844518|62848076|FG000|Overall Study|Pregnancy|1|||
33474273|NCT01844518|62848077|FG001|Overall Study|Pregnancy|0|||
33474274|NCT01793610|62848113|FG000|Overall Study|Withdrawal by Subject|1|||
33474275|NCT01793610|62848114|FG001|Overall Study|Withdrawal by Subject|0|||
33474276|NCT01793610|62848115|FG002|Overall Study|Withdrawal by Subject|1|||
33474277|NCT01039584|62848163|FG000|Overall Study|Withdrawal by Subject|4|||
33474278|NCT01039584|62848164|FG001|Overall Study|Withdrawal by Subject|2|||
33474279|NCT01039584|62848165|FG002|Overall Study|Withdrawal by Subject|1|||
33474280|NCT01039584|62848163|FG000|Overall Study|Protocol Violation|10|||
33474281|NCT01039584|62848164|FG001|Overall Study|Protocol Violation|4|||
33474282|NCT01039584|62848165|FG002|Overall Study|Protocol Violation|6|||
33474283|NCT01039584|62848163|FG000|Overall Study|Lost to Follow-up|5|||
33474284|NCT01039584|62848164|FG001|Overall Study|Lost to Follow-up|3|||
33474285|NCT01039584|62848165|FG002|Overall Study|Lost to Follow-up|4|||
33474286|NCT01039584|62848163|FG000|Overall Study|Negative Baseline culture for Candida|59|||
33474287|NCT01039584|62848164|FG001|Overall Study|Negative Baseline culture for Candida|59|||
33358618|NCT04154189|62736191|FG000|Overall Study|Ongoing|20|||
33358619|NCT04154189|62736192|FG001|Overall Study|Ongoing|20|||
33358620|NCT03749109|62736202|FG000|Overall Study|Adverse Event|2|||
33358621|NCT03749109|62736203|FG001|Overall Study|Adverse Event|0|||
33358622|NCT03709706|62736212|FG000|Overall Study|Adverse Event|0|||
33474288|NCT01039584|62848165|FG002|Overall Study|Negative Baseline culture for Candida|24|||
33474289|NCT01039584|62848163|FG000|Overall Study|Lack of Efficacy|7|||
33474290|NCT01039584|62848164|FG001|Overall Study|Lack of Efficacy|6|||
33474291|NCT01039584|62848165|FG002|Overall Study|Lack of Efficacy|10|||
33474292|NCT01039584|62848163|FG000|Overall Study|other|1|||
33474293|NCT01039584|62848164|FG001|Overall Study|other|3|||
33474294|NCT01039584|62848165|FG002|Overall Study|other|1|||
33474295|NCT01039584|62848163|FG000|Overall Study|Pap smear with significant pathology|10|||
33474296|NCT01039584|62848164|FG001|Overall Study|Pap smear with significant pathology|10|||
33474297|NCT01039584|62848165|FG002|Overall Study|Pap smear with significant pathology|3|||
33474298|NCT01039584|62848163|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
33474299|NCT01039584|62848164|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
33474300|NCT01039584|62848165|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
33474301|NCT00920387|62848175|FG000|Stage 1|Adverse Event|1|||
33474302|NCT00920387|62848176|FG001|Stage 1|Adverse Event|0|||
33474303|NCT00920387|62848177|FG002|Stage 1|Adverse Event|0|||
33474304|NCT00679783|62848202|FG000|Overall Study|Adverse Event|0|||
33474305|NCT00679783|62848203|FG001|Overall Study|Adverse Event|0|||
33474306|NCT00679783|62848204|FG002|Overall Study|Adverse Event|0|||
33474307|NCT00679783|62848205|FG003|Overall Study|Adverse Event|3|||
33474308|NCT00679783|62848206|FG004|Overall Study|Adverse Event|0|||
33474309|NCT00679783|62848207|FG005|Overall Study|Adverse Event|0|||
33474310|NCT00679783|62848208|FG006|Overall Study|Adverse Event|1|||
33474311|NCT00679783|62848202|FG000|Overall Study|Lack of Efficacy|0|||
33474312|NCT00679783|62848203|FG001|Overall Study|Lack of Efficacy|1|||
33474313|NCT00679783|62848204|FG002|Overall Study|Lack of Efficacy|0|||
33474314|NCT00679783|62848205|FG003|Overall Study|Lack of Efficacy|2|||
33474315|NCT00679783|62848206|FG004|Overall Study|Lack of Efficacy|0|||
33474316|NCT00679783|62848207|FG005|Overall Study|Lack of Efficacy|0|||
33474317|NCT00679783|62848208|FG006|Overall Study|Lack of Efficacy|0|||
33474318|NCT00679783|62848202|FG000|Overall Study|Withdrawal by Subject|0|||
33474319|NCT00679783|62848203|FG001|Overall Study|Withdrawal by Subject|0|||
33474320|NCT00679783|62848204|FG002|Overall Study|Withdrawal by Subject|1|||
33474321|NCT00679783|62848205|FG003|Overall Study|Withdrawal by Subject|1|||
33474322|NCT00679783|62848206|FG004|Overall Study|Withdrawal by Subject|0|||
33474323|NCT00679783|62848207|FG005|Overall Study|Withdrawal by Subject|0|||
33474324|NCT00679783|62848208|FG006|Overall Study|Withdrawal by Subject|0|||
33474325|NCT00679783|62848202|FG000|Overall Study|Not Captured|0|||
33474326|NCT00679783|62848203|FG001|Overall Study|Not Captured|0|||
33474327|NCT00679783|62848204|FG002|Overall Study|Not Captured|0|||
33474328|NCT00679783|62848205|FG003|Overall Study|Not Captured|5|||
33474329|NCT00679783|62848206|FG004|Overall Study|Not Captured|0|||
33474330|NCT00679783|62848207|FG005|Overall Study|Not Captured|0|||
33549269|NCT01345253|62940527|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
33549270|NCT01345253|62940526|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
33474331|NCT00679783|62848208|FG006|Overall Study|Not Captured|0|||
33474332|NCT00679783|62848202|FG000|Overall Study|Ongoing at data cut-off|2|||
33474333|NCT00679783|62848203|FG001|Overall Study|Ongoing at data cut-off|2|||
33474334|NCT00679783|62848204|FG002|Overall Study|Ongoing at data cut-off|0|||
33474335|NCT00679783|62848205|FG003|Overall Study|Ongoing at data cut-off|9|||
33474336|NCT00679783|62848206|FG004|Overall Study|Ongoing at data cut-off|1|||
33474337|NCT00679783|62848207|FG005|Overall Study|Ongoing at data cut-off|0|||
33474338|NCT00679783|62848208|FG006|Overall Study|Ongoing at data cut-off|0|||
33474339|NCT03896490|62848230|FG000|Overall Study|Withdrawal by Subject|1|||
33474340|NCT03896490|62848231|FG001|Overall Study|Withdrawal by Subject|1|||
33358623|NCT03709706|62736213|FG001|Overall Study|Adverse Event|1|||
33358624|NCT03709706|62736212|FG000|Overall Study|Physician Decision|14|||
33358625|NCT03709706|62736213|FG001|Overall Study|Physician Decision|8|||
33358626|NCT03709706|62736212|FG000|Overall Study|Withdrawal by Subject|2|||
33358627|NCT03709706|62736213|FG001|Overall Study|Withdrawal by Subject|1|||
33358628|NCT03709706|62736212|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
33358629|NCT03709706|62736213|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
33358630|NCT03497689|62736220|FG000|Overall Study|Adverse Event|2|||
33358631|NCT03497689|62736220|FG000|Overall Study|Death|1|||
33358632|NCT03497689|62736220|FG000|Overall Study|Physician Decision|1|||
33358633|NCT03497689|62736220|FG000|Overall Study|Withdrawal by Subject|1|||
33358634|NCT03497689|62736220|FG000|Overall Study|Protocol Violation|2|||
33358635|NCT03492437|62736224|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33358636|NCT03492437|62736225|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33358637|NCT03193853|62736231|FG000|Overall Study|Death|6|||
33358638|NCT03100149|62736238|FG000|Overall Study|Adverse Event|0|||
33358639|NCT03100149|62736239|FG001|Overall Study|Adverse Event|1|||
33358640|NCT03100149|62736240|FG002|Overall Study|Adverse Event|0|||
33358641|NCT03100149|62736238|FG000|Overall Study|Participant Moved out of Country|0|||
33474341|NCT03617172|62848239|FG000|Overall Study|Lost to Follow-up|1|||
33474342|NCT03617172|62848240|FG001|Overall Study|Lost to Follow-up|0|||
33474343|NCT03760146|62848252|FG000|Overall Study|Adverse Event|11|||
33358642|NCT03100149|62736239|FG001|Overall Study|Participant Moved out of Country|0|||
33358643|NCT03100149|62736240|FG002|Overall Study|Participant Moved out of Country|1|||
33358644|NCT03100149|62736238|FG000|Overall Study|Withdrawal by Subject|0|||
33358645|NCT03100149|62736239|FG001|Overall Study|Withdrawal by Subject|3|||
33358646|NCT03100149|62736240|FG002|Overall Study|Withdrawal by Subject|1|||
33358647|NCT02756637|62736250|FG000|Overall Study|Not eligible for initial SWOG study|10|||
33474344|NCT03760146|62848253|FG001|Overall Study|Adverse Event|8|||
33474345|NCT03760146|62848254|FG002|Overall Study|Adverse Event|0|||
33474346|NCT03760146|62848255|FG003|Overall Study|Adverse Event|0|||
33474347|NCT03760146|62848256|FG004|Overall Study|Adverse Event|0|||
33474348|NCT03760146|62848257|FG005|Overall Study|Adverse Event|0|||
33474349|NCT03760146|62848252|FG000|Overall Study|Death|1|||
33474350|NCT03760146|62848253|FG001|Overall Study|Death|0|||
33474351|NCT03760146|62848254|FG002|Overall Study|Death|0|||
33474352|NCT03760146|62848255|FG003|Overall Study|Death|0|||
33474353|NCT03760146|62848256|FG004|Overall Study|Death|0|||
33474354|NCT03760146|62848257|FG005|Overall Study|Death|0|||
33474355|NCT03760146|62848252|FG000|Overall Study|Lost to Follow-up|41|||
33358648|NCT02756637|62736251|FG001|Overall Study|Not eligible for initial SWOG study|10|||
33358649|NCT02756637|62736250|FG000|Overall Study|No available NLR value|44|||
33358650|NCT02756637|62736251|FG001|Overall Study|No available NLR value|44|||
33358651|NCT02756637|62736250|FG000|Overall Study|Did not complete curative therapy|33|||
33358652|NCT02756637|62736251|FG001|Overall Study|Did not complete curative therapy|0|||
33358653|NCT02041195|62736265|FG000|Overall Study|Adverse Event|1|||
33358654|NCT02041195|62736266|FG001|Overall Study|Adverse Event|2|||
33358655|NCT02041195|62736267|FG002|Overall Study|Adverse Event|0|||
33358656|NCT02041195|62736268|FG003|Overall Study|Adverse Event|0|||
33358657|NCT02041195|62736269|FG004|Overall Study|Adverse Event|0|||
33358658|NCT02041195|62736270|FG005|Overall Study|Adverse Event|0|||
33358659|NCT02041195|62736271|FG006|Overall Study|Adverse Event|3|||
33358660|NCT02041195|62736272|FG007|Overall Study|Adverse Event|0|||
33358661|NCT02041195|62736265|FG000|Overall Study|Withdrawal by Subject|1|||
33358662|NCT02041195|62736266|FG001|Overall Study|Withdrawal by Subject|0|||
33358663|NCT02041195|62736267|FG002|Overall Study|Withdrawal by Subject|0|||
33358664|NCT02041195|62736268|FG003|Overall Study|Withdrawal by Subject|0|||
33358665|NCT02041195|62736269|FG004|Overall Study|Withdrawal by Subject|0|||
33358666|NCT02041195|62736270|FG005|Overall Study|Withdrawal by Subject|0|||
33358667|NCT02041195|62736271|FG006|Overall Study|Withdrawal by Subject|4|||
33358668|NCT02041195|62736272|FG007|Overall Study|Withdrawal by Subject|3|||
33358669|NCT02041195|62736265|FG000|Overall Study|Unable to comply with study visits|0|||
33358670|NCT02041195|62736266|FG001|Overall Study|Unable to comply with study visits|1|||
33358671|NCT02041195|62736267|FG002|Overall Study|Unable to comply with study visits|0|||
33358672|NCT02041195|62736268|FG003|Overall Study|Unable to comply with study visits|0|||
33358673|NCT02041195|62736269|FG004|Overall Study|Unable to comply with study visits|1|||
33474356|NCT03760146|62848253|FG001|Overall Study|Lost to Follow-up|28|||
33549271|NCT01345253|62940527|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
33549272|NCT01345253|62940526|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
33358674|NCT02041195|62736270|FG005|Overall Study|Unable to comply with study visits|0|||
33358675|NCT02041195|62736271|FG006|Overall Study|Unable to comply with study visits|0|||
33358676|NCT02041195|62736272|FG007|Overall Study|Unable to comply with study visits|0|||
33358677|NCT01771107|62736302|FG000|Overall Study|Adverse Event|1|||
33358678|NCT01771107|62736303|FG001|Overall Study|Adverse Event|3|||
33358679|NCT01771107|62736302|FG000|Overall Study|Withdrawal by Subject|0|||
33474357|NCT03760146|62848254|FG002|Overall Study|Lost to Follow-up|9|||
33474358|NCT03760146|62848255|FG003|Overall Study|Lost to Follow-up|2|||
33358680|NCT01771107|62736303|FG001|Overall Study|Withdrawal by Subject|2|||
33358681|NCT01771107|62736302|FG000|Overall Study|Lost to Follow-up|0|||
33358682|NCT01771107|62736303|FG001|Overall Study|Lost to Follow-up|1|||
33358683|NCT01771107|62736302|FG000|Overall Study|participant moved|0|||
33358684|NCT01771107|62736303|FG001|Overall Study|participant moved|1|||
33358685|NCT01771107|62736302|FG000|Overall Study|Other|0|||
33358686|NCT01771107|62736303|FG001|Overall Study|Other|1|||
33358687|NCT01583218|62736342|FG000|Overall Study|Withdrawal by Subject|43|||
33358688|NCT01583218|62736343|FG001|Overall Study|Withdrawal by Subject|29|||
33358689|NCT01583218|62736342|FG000|Overall Study|Death|206|||
33358690|NCT01583218|62736343|FG001|Overall Study|Death|211|||
33358691|NCT01583218|62736342|FG000|Overall Study|Lost to Follow-up|11|||
33358692|NCT01583218|62736343|FG001|Overall Study|Lost to Follow-up|17|||
33358693|NCT01583218|62736342|FG000|Overall Study|Adverse event or serious adverse event|3|||
33358694|NCT01583218|62736343|FG001|Overall Study|Adverse event or serious adverse event|3|||
33358695|NCT01583218|62736342|FG000|Overall Study|Patient /Family decision|3|||
33358696|NCT01583218|62736343|FG001|Overall Study|Patient /Family decision|0|||
33358697|NCT01583218|62736342|FG000|Overall Study|Cannot contact patient directly|1|||
33358698|NCT01583218|62736343|FG001|Overall Study|Cannot contact patient directly|2|||
33358699|NCT01583218|62736342|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
33358700|NCT01583218|62736343|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
33358701|NCT01583218|62736342|FG000|Overall Study|Patient did not wish to attend visits|0|||
33358702|NCT01583218|62736343|FG001|Overall Study|Patient did not wish to attend visits|1|||
33358703|NCT01583218|62736342|FG000|Overall Study|Patient randomized but not dosed|17|||
33358704|NCT01583218|62736343|FG001|Overall Study|Patient randomized but not dosed|16|||
33358705|NCT01583218|62736342|FG000|Overall Study|Patient was assessed via phone in person|1|||
33358706|NCT01583218|62736343|FG001|Overall Study|Patient was assessed via phone in person|0|||
33358707|NCT01583218|62736342|FG000|Overall Study|Patient deemed ineligible after random|2|||
33358708|NCT01583218|62736343|FG001|Overall Study|Patient deemed ineligible after random|0|||
33358709|NCT01583218|62736342|FG000|Overall Study|Patient was early terminated from study|0|||
33358710|NCT01583218|62736343|FG001|Overall Study|Patient was early terminated from study|1|||
33358711|NCT01583218|62736342|FG000|Overall Study|Patient was randomized due to mistake|1|||
33358712|NCT01583218|62736343|FG001|Overall Study|Patient was randomized due to mistake|0|||
33358713|NCT01583218|62736342|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
33358714|NCT01583218|62736343|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
33358715|NCT01583218|62736342|FG000|Overall Study|Withdraw of consent on day of random|1|||
33358716|NCT01583218|62736343|FG001|Overall Study|Withdraw of consent on day of random|0|||
33358717|NCT00742859|62736353|FG000|Overall Study|Adverse Event|5|||
33358718|NCT00742859|62736354|FG001|Overall Study|Adverse Event|6|||
33358719|NCT00742859|62736355|FG002|Overall Study|Adverse Event|3|||
33358720|NCT00742859|62736356|FG003|Overall Study|Adverse Event|1|||
33358721|NCT00742859|62736353|FG000|Overall Study|Death|1|||
33358722|NCT00742859|62736354|FG001|Overall Study|Death|0|||
33358723|NCT00742859|62736355|FG002|Overall Study|Death|0|||
33358724|NCT00742859|62736356|FG003|Overall Study|Death|1|||
33358725|NCT00742859|62736353|FG000|Overall Study|Physician Decision|1|||
33358726|NCT00742859|62736354|FG001|Overall Study|Physician Decision|2|||
33358727|NCT00742859|62736355|FG002|Overall Study|Physician Decision|0|||
33358728|NCT00742859|62736356|FG003|Overall Study|Physician Decision|0|||
33358729|NCT00742859|62736353|FG000|Overall Study|Withdrawal by Subject|4|||
33358730|NCT00742859|62736354|FG001|Overall Study|Withdrawal by Subject|2|||
33358731|NCT00742859|62736355|FG002|Overall Study|Withdrawal by Subject|4|||
33358732|NCT00742859|62736356|FG003|Overall Study|Withdrawal by Subject|1|||
33358733|NCT00742859|62736353|FG000|Overall Study|Endpoint|0|||
33358734|NCT00742859|62736354|FG001|Overall Study|Endpoint|1|||
33358735|NCT00742859|62736355|FG002|Overall Study|Endpoint|1|||
33358736|NCT00742859|62736356|FG003|Overall Study|Endpoint|2|||
33358737|NCT00742859|62736353|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
33358738|NCT00742859|62736354|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
33358739|NCT00742859|62736355|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
33358740|NCT00742859|62736356|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
33474359|NCT03760146|62848256|FG004|Overall Study|Lost to Follow-up|14|||
33474360|NCT03760146|62848257|FG005|Overall Study|Lost to Follow-up|8|||
33358741|NCT00742859|62736353|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
33358742|NCT00742859|62736354|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
33474361|NCT03760146|62848252|FG000|Overall Study|No longer met eligibility criteria|3|||
33474362|NCT03760146|62848253|FG001|Overall Study|No longer met eligibility criteria|9|||
33474363|NCT03760146|62848254|FG002|Overall Study|No longer met eligibility criteria|0|||
33358743|NCT00742859|62736355|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
33358744|NCT00742859|62736356|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
33358745|NCT00742859|62736353|FG000|Overall Study|Sponsor request patient out of town|0|||
33474364|NCT03760146|62848255|FG003|Overall Study|No longer met eligibility criteria|0|||
33474365|NCT03760146|62848256|FG004|Overall Study|No longer met eligibility criteria|1|||
33358746|NCT00742859|62736354|FG001|Overall Study|Sponsor request patient out of town|0|||
33358747|NCT00742859|62736355|FG002|Overall Study|Sponsor request patient out of town|1|||
33358748|NCT00742859|62736356|FG003|Overall Study|Sponsor request patient out of town|1|||
33358749|NCT00742859|62736353|FG000|Overall Study|Site error|0|||
33474366|NCT03760146|62848257|FG005|Overall Study|No longer met eligibility criteria|0|||
33474367|NCT03760146|62848252|FG000|Overall Study|Protocol Violation|21|||
33474368|NCT03760146|62848253|FG001|Overall Study|Protocol Violation|13|||
33474369|NCT03760146|62848254|FG002|Overall Study|Protocol Violation|1|||
33474370|NCT03760146|62848255|FG003|Overall Study|Protocol Violation|0|||
33474371|NCT03760146|62848256|FG004|Overall Study|Protocol Violation|1|||
33474372|NCT03760146|62848257|FG005|Overall Study|Protocol Violation|0|||
33474373|NCT03760146|62848252|FG000|Overall Study|Withdrawal by Subject|19|||
33474374|NCT03760146|62848253|FG001|Overall Study|Withdrawal by Subject|20|||
33474375|NCT03760146|62848254|FG002|Overall Study|Withdrawal by Subject|1|||
33474376|NCT03760146|62848255|FG003|Overall Study|Withdrawal by Subject|0|||
33474377|NCT03760146|62848256|FG004|Overall Study|Withdrawal by Subject|1|||
33474378|NCT03760146|62848257|FG005|Overall Study|Withdrawal by Subject|0|||
33474379|NCT03760068|62848277|FG000|Overall Study|Withdrawal by Subject|7|||
33474380|NCT03760068|62848278|FG001|Overall Study|Withdrawal by Subject|8|||
33474381|NCT03760068|62848277|FG000|Overall Study|Adverse Event|1|||
33474382|NCT03760068|62848278|FG001|Overall Study|Adverse Event|2|||
33474383|NCT03760068|62848277|FG000|Overall Study|Administrative Decision by Sponsor|0|||
33474384|NCT03760068|62848278|FG001|Overall Study|Administrative Decision by Sponsor|2|||
33474385|NCT03760068|62848277|FG000|Overall Study|Physician Decision|1|||
33358750|NCT00742859|62736354|FG001|Overall Study|Site error|0|||
33358751|NCT00742859|62736355|FG002|Overall Study|Site error|1|||
33358752|NCT00742859|62736356|FG003|Overall Study|Site error|1|||
33358753|NCT00667342|62736369|FG000|Overall Study|Protocol Violation|1|||
33358754|NCT00667342|62736370|FG001|Overall Study|Protocol Violation|0|||
33358755|NCT00667342|62736371|FG002|Overall Study|Protocol Violation|0|||
33358756|NCT00667342|62736369|FG000|Overall Study|Withdrawal by Subject|1|||
33358757|NCT00667342|62736370|FG001|Overall Study|Withdrawal by Subject|0|||
33358758|NCT00667342|62736371|FG002|Overall Study|Withdrawal by Subject|0|||
33358759|NCT00667342|62736369|FG000|Overall Study|Physician Decision|3|||
33358760|NCT00667342|62736370|FG001|Overall Study|Physician Decision|0|||
33358761|NCT00667342|62736371|FG002|Overall Study|Physician Decision|0|||
33358762|NCT00667342|62736369|FG000|Overall Study|Relapse or tumor progression|9|||
33358763|NCT00667342|62736370|FG001|Overall Study|Relapse or tumor progression|0|||
33358764|NCT00667342|62736371|FG002|Overall Study|Relapse or tumor progression|7|||
33358765|NCT00667342|62736369|FG000|Overall Study|Adverse Event|0|||
33358766|NCT00667342|62736370|FG001|Overall Study|Adverse Event|0|||
33358767|NCT00667342|62736371|FG002|Overall Study|Adverse Event|1|||
33358768|NCT00667342|62736369|FG000|Overall Study|Ineligible|0|||
33358769|NCT00667342|62736370|FG001|Overall Study|Ineligible|0|||
33358770|NCT00667342|62736371|FG002|Overall Study|Ineligible|1|||
33358771|NCT00375609|62736388|FG000|Overall Study|Did not receive treatment|1|||
33358772|NCT00375609|62736389|FG001|Overall Study|Did not receive treatment|0|||
33358773|NCT00375609|62736390|FG002|Overall Study|Did not receive treatment|0|||
33358774|NCT00375609|62736388|FG000|Overall Study|Adverse Event|0|||
33358775|NCT00375609|62736389|FG001|Overall Study|Adverse Event|3|||
33358776|NCT00375609|62736390|FG002|Overall Study|Adverse Event|0|||
33358777|NCT00375609|62736388|FG000|Overall Study|Lost to Follow-up|1|||
33474386|NCT03760068|62848278|FG001|Overall Study|Physician Decision|2|||
33474387|NCT03760068|62848277|FG000|Overall Study|Lost to Follow-up|4|||
33474388|NCT03760068|62848278|FG001|Overall Study|Lost to Follow-up|9|||
33474389|NCT03760068|62848277|FG000|Overall Study|Subject Moved Out of State|1|||
33474390|NCT03760068|62848278|FG001|Overall Study|Subject Moved Out of State|0|||
33474391|NCT03759600|62848285|FG000|Overall Study|Ongoing at Data Cut-off|16|||
33474392|NCT03759600|62848285|FG000|Overall Study|Adverse Event|1|||
33474393|NCT03759600|62848285|FG000|Overall Study|Progressive Disease|3|||
33358778|NCT00375609|62736389|FG001|Overall Study|Lost to Follow-up|0|||
33358779|NCT00375609|62736390|FG002|Overall Study|Lost to Follow-up|0|||
33358780|NCT00375609|62736388|FG000|Overall Study|Physician Decision|0|||
33358781|NCT00375609|62736389|FG001|Overall Study|Physician Decision|0|||
33474394|NCT04724733|62848292|FG000|Overall Study|Lost to Follow-up|1|||
33474395|NCT04724733|62848293|FG001|Overall Study|Lost to Follow-up|1|||
33474396|NCT04724733|62848294|FG002|Overall Study|Lost to Follow-up|1|||
33474397|NCT04635839|62848304|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
33358782|NCT00375609|62736390|FG002|Overall Study|Physician Decision|1|||
33358783|NCT00375609|62736388|FG000|Overall Study|Withdrawal by Subject|1|||
33358784|NCT00375609|62736389|FG001|Overall Study|Withdrawal by Subject|4|||
33474398|NCT04635839|62848305|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
33474399|NCT04493502|62848313|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
33474400|NCT04493502|62848314|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
33474401|NCT04493502|62848313|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
33474402|NCT04493502|62848314|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
33474403|NCT04493502|62848313|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
33474404|NCT04493502|62848314|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
33474405|NCT04493502|62848313|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
33474406|NCT04493502|62848314|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
33474407|NCT04493502|62848313|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
33358785|NCT00375609|62736390|FG002|Overall Study|Withdrawal by Subject|0|||
33358786|NCT00375609|62736388|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
33358787|NCT00375609|62736389|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
33358788|NCT00375609|62736390|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
33655488|NCT00636987|63070836|FG000|Overall Study|5 year visit window not complete|69|||
33655489|NCT00636441|63070991|FG000|Overall Study|Adverse Event|0|||
33358789|NCT00960011|62736400|FG000|Overall Study|Death|5|||
33358790|NCT00960011|62736401|FG001|Overall Study|Death|0|||
33358791|NCT00960011|62736400|FG000|Overall Study|Lost to Follow-up|6|||
33358792|NCT00960011|62736401|FG001|Overall Study|Lost to Follow-up|2|||
33358793|NCT00617851|62736445|FG000|Overall Study|Death|0|||
33358794|NCT00617851|62736446|FG001|Overall Study|Death|0|||
33358795|NCT00617851|62736447|FG002|Overall Study|Death|0|||
33358796|NCT00617851|62736448|FG003|Overall Study|Death|1|||
33358797|NCT00617851|62736445|FG000|Overall Study|Withdrawal by Subject|14|||
33358798|NCT00617851|62736446|FG001|Overall Study|Withdrawal by Subject|7|||
33358799|NCT00617851|62736447|FG002|Overall Study|Withdrawal by Subject|12|||
33358800|NCT00617851|62736448|FG003|Overall Study|Withdrawal by Subject|4|||
33358801|NCT00617851|62736445|FG000|Overall Study|Lost to Follow-up|27|||
33358802|NCT00617851|62736446|FG001|Overall Study|Lost to Follow-up|29|||
33358803|NCT00617851|62736447|FG002|Overall Study|Lost to Follow-up|31|||
33358804|NCT00617851|62736448|FG003|Overall Study|Lost to Follow-up|19|||
33358805|NCT00617851|62736445|FG000|Overall Study|Inappropriate Enrollment|5|||
33358806|NCT00617851|62736446|FG001|Overall Study|Inappropriate Enrollment|4|||
33358807|NCT00617851|62736447|FG002|Overall Study|Inappropriate Enrollment|1|||
33358808|NCT00617851|62736448|FG003|Overall Study|Inappropriate Enrollment|1|||
33358809|NCT00617851|62736445|FG000|Overall Study|Unable to classify|1|||
33358810|NCT00617851|62736446|FG001|Overall Study|Unable to classify|0|||
33358811|NCT00617851|62736447|FG002|Overall Study|Unable to classify|1|||
33358812|NCT00617851|62736448|FG003|Overall Study|Unable to classify|0|||
33358813|NCT00812955|62736472|FG000|Overall Study|Adverse Event|7|||
33358814|NCT00812955|62736473|FG001|Overall Study|Adverse Event|6|||
33358815|NCT00812955|62736474|FG002|Overall Study|Adverse Event|3|||
33358816|NCT00812955|62736475|FG003|Overall Study|Adverse Event|4|||
33358817|NCT00812955|62736472|FG000|Overall Study|Lost to Follow-up|2|||
33358818|NCT00812955|62736473|FG001|Overall Study|Lost to Follow-up|1|||
33358819|NCT00812955|62736474|FG002|Overall Study|Lost to Follow-up|1|||
33358820|NCT00812955|62736475|FG003|Overall Study|Lost to Follow-up|2|||
33358821|NCT00812955|62736472|FG000|Overall Study|Withdrawal by Subject|1|||
33358822|NCT00812955|62736473|FG001|Overall Study|Withdrawal by Subject|0|||
33358823|NCT00812955|62736474|FG002|Overall Study|Withdrawal by Subject|1|||
33358824|NCT00812955|62736475|FG003|Overall Study|Withdrawal by Subject|2|||
33358825|NCT00812955|62736472|FG000|Overall Study|randomized in error|0|||
33358826|NCT00812955|62736473|FG001|Overall Study|randomized in error|0|||
33358827|NCT00812955|62736474|FG002|Overall Study|randomized in error|1|||
33358828|NCT00812955|62736475|FG003|Overall Study|randomized in error|0|||
33358829|NCT00619489|62736491|FG000|Overall Study|Adverse Event|0|||
33358830|NCT00619489|62736492|FG001|Overall Study|Adverse Event|7|||
33358831|NCT00619489|62736491|FG000|Overall Study|Withdrawal by Subject|1|||
33358832|NCT00619489|62736492|FG001|Overall Study|Withdrawal by Subject|1|||
33358833|NCT00619489|62736491|FG000|Overall Study|Lack of Efficacy|0|||
33358834|NCT00619489|62736492|FG001|Overall Study|Lack of Efficacy|11|||
33358835|NCT00619489|62736491|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
33358836|NCT00619489|62736492|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
33358837|NCT00959699|62736500|FG000|Treatment Period|Adverse Event|3|||
33358838|NCT00959699|62736501|FG001|Treatment Period|Adverse Event|13|||
33358839|NCT00959699|62736500|FG000|Treatment Period|Lack of Efficacy|15|||
33358840|NCT00959699|62736501|FG001|Treatment Period|Lack of Efficacy|6|||
33358841|NCT00959699|62736500|FG000|Treatment Period|Lost to Follow-up|0|||
33358842|NCT00959699|62736501|FG001|Treatment Period|Lost to Follow-up|1|||
33358843|NCT00959699|62736500|FG000|Treatment Period|Withdrawal by Subject|1|||
33358844|NCT00959699|62736501|FG001|Treatment Period|Withdrawal by Subject|3|||
33358845|NCT00959699|62736500|FG000|Treatment Period|Non-Compliance with Protocol|0|||
33358846|NCT00959699|62736501|FG001|Treatment Period|Non-Compliance with Protocol|1|||
33358847|NCT00959699|62736500|FG000|Treatment Period|Did not receive treatment|0|||
33358848|NCT00959699|62736501|FG001|Treatment Period|Did not receive treatment|1|||
33358849|NCT00959699|62736500|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
33358850|NCT00959699|62736501|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
33358851|NCT00959699|62736500|FG000|Follow-up Period|Lost to Follow-up|3|||
33474408|NCT04493502|62848314|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
33474409|NCT04493502|62848313|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
33474410|NCT04493502|62848314|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
33474411|NCT04493502|62848313|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
33549273|NCT01345253|62940527|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
33549274|NCT01345253|62940526|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
33549275|NCT01345253|62940527|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
33549276|NCT01345253|62940526|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
33549277|NCT01345253|62940527|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
33549278|NCT01345253|62940526|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
33549279|NCT01345253|62940527|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
33549280|NCT01345253|62940526|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
33549281|NCT01345253|62940527|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
33549282|NCT01345253|62940526|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
33549283|NCT01345253|62940527|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
33549284|NCT01345253|62940526|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
33358852|NCT00959699|62736501|FG001|Follow-up Period|Lost to Follow-up|2|||
33358853|NCT00959699|62736500|FG000|Follow-up Period|Withdrawal by Subject|3|||
33358854|NCT00959699|62736501|FG001|Follow-up Period|Withdrawal by Subject|4|||
33358855|NCT00617773|62736508|FG000|Overall Study|Physician Decision|1|||
33358856|NCT00617773|62736508|FG000|Overall Study|Lack of compliance with the protocol|1|||
33358857|NCT00617773|62736508|FG000|Overall Study|Withdrawal by Subject|1|||
33358858|NCT00617773|62736508|FG000|Overall Study|Death|1|||
33358859|NCT00617773|62736508|FG000|Overall Study|Progressive disease|19|||
33358860|NCT00617773|62736508|FG000|Overall Study|Protocol Violation|1|||
33358861|NCT00956813|62736514|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
33358862|NCT00956813|62736515|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
33358863|NCT00956813|62736514|FG000|Flaxseed and Placebo|Ineligible|3|||
33358864|NCT00956813|62736515|FG001|Flaxseed and Placebo|Ineligible|1|||
33358865|NCT00955955|62736525|FG000|Overall Study|Lost to Follow-up|2|||
33358866|NCT00955955|62736526|FG001|Overall Study|Lost to Follow-up|0|||
33358867|NCT00955955|62736527|FG002|Overall Study|Lost to Follow-up|0|||
33358868|NCT00955721|62736543|FG000|Overall Study|Physician Decision|1|||
33358869|NCT00955721|62736544|FG001|Overall Study|Physician Decision|0|||
33358870|NCT00955721|62736543|FG000|Overall Study|Death|1|||
33358871|NCT00955721|62736544|FG001|Overall Study|Death|0|||
33358872|NCT00955721|62736543|FG000|Overall Study|Withdrawal by Subject|1|||
33358873|NCT00955721|62736544|FG001|Overall Study|Withdrawal by Subject|0|||
33358874|NCT00573469|62736554|FG000|Overall Study|Adverse Event|1|||
33358875|NCT00573469|62736555|FG001|Overall Study|Adverse Event|1|||
33358876|NCT00573469|62736556|FG002|Overall Study|Adverse Event|1|||
33358877|NCT00573469|62736554|FG000|Overall Study|Withdrawal by Subject|0|||
33358878|NCT00573469|62736555|FG001|Overall Study|Withdrawal by Subject|2|||
33358879|NCT00573469|62736556|FG002|Overall Study|Withdrawal by Subject|0|||
33358880|NCT00573469|62736554|FG000|Overall Study|Other|5|||
33358881|NCT00573469|62736555|FG001|Overall Study|Other|1|||
33474412|NCT04493502|62848314|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
33474413|NCT04493502|62848313|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
33474414|NCT04493502|62848314|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
33474415|NCT04493502|62848313|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
33474416|NCT04493502|62848314|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
33474417|NCT04493502|62848313|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
33474418|NCT04493502|62848314|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
33474419|NCT04493502|62848313|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
33474420|NCT04493502|62848314|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
33474421|NCT04493502|62848313|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
33474422|NCT04493502|62848314|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
33474423|NCT04493502|62848313|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
33655490|NCT00636441|63070992|FG001|Overall Study|Adverse Event|1|||
33310169|NCT01287065|62685563|FG000|Treatment Period 1|Adverse Event|0|||
33310170|NCT01287065|62685564|FG001|Treatment Period 1|Adverse Event|0|||
33310171|NCT01287065|62685565|FG002|Treatment Period 1|Adverse Event|0|||
33310172|NCT01287065|62685566|FG003|Treatment Period 1|Adverse Event|0|||
33310173|NCT01287065|62685567|FG004|Treatment Period 1|Adverse Event|1|||
33310174|NCT01287065|62685568|FG005|Treatment Period 1|Adverse Event|0|||
33310175|NCT01287065|62685563|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33310176|NCT01287065|62685564|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33310177|NCT01287065|62685565|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33310178|NCT01287065|62685566|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33310179|NCT01287065|62685567|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33310180|NCT01287065|62685568|FG005|Treatment Period 1|Withdrawal by Subject|1|||
33310181|NCT01167153|62685578|FG000|Overall Study|Non-effective therapy|1|||
33310182|NCT01167153|62685579|FG001|Overall Study|Non-effective therapy|4|||
33310183|NCT01167153|62685578|FG000|Overall Study|AE including clinical laboratory AE|2|||
33310184|NCT01167153|62685579|FG001|Overall Study|AE including clinical laboratory AE|8|||
33358882|NCT00573469|62736556|FG002|Overall Study|Other|3|||
33358883|NCT00812565|62736572|FG000|Overall Study|Did Not Receive Study Medication|1|||
33358884|NCT00812565|62736573|FG001|Overall Study|Did Not Receive Study Medication|1|||
33358885|NCT00812565|62736574|FG002|Overall Study|Did Not Receive Study Medication|0|||
33358886|NCT00812565|62736575|FG003|Overall Study|Did Not Receive Study Medication|0|||
33358887|NCT00812565|62736576|FG004|Overall Study|Did Not Receive Study Medication|0|||
33358888|NCT00812565|62736577|FG005|Overall Study|Did Not Receive Study Medication|0|||
33358889|NCT00812565|62736578|FG006|Overall Study|Did Not Receive Study Medication|0|||
33358890|NCT00812565|62736579|FG007|Overall Study|Did Not Receive Study Medication|0|||
33358891|NCT00812565|62736572|FG000|Overall Study|Adverse Event|0|||
33358892|NCT00812565|62736573|FG001|Overall Study|Adverse Event|0|||
33358893|NCT00812565|62736574|FG002|Overall Study|Adverse Event|0|||
33358894|NCT00812565|62736575|FG003|Overall Study|Adverse Event|2|||
33358895|NCT00812565|62736576|FG004|Overall Study|Adverse Event|0|||
33474424|NCT04493502|62848314|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
33474425|NCT04147858|62848325|FG000|Overall Study|Adverse Event|6|||
33474426|NCT04147858|62848326|FG001|Overall Study|Adverse Event|6|||
33474427|NCT04147858|62848327|FG002|Overall Study|Adverse Event|6|||
33474428|NCT04147858|62848325|FG000|Overall Study|Lack of Efficacy|3|||
33474429|NCT04147858|62848326|FG001|Overall Study|Lack of Efficacy|3|||
33474430|NCT04147858|62848327|FG002|Overall Study|Lack of Efficacy|1|||
33474431|NCT04147858|62848325|FG000|Overall Study|Lost to Follow-up|1|||
33474432|NCT04147858|62848326|FG001|Overall Study|Lost to Follow-up|6|||
33655491|NCT00636441|63070993|FG002|Overall Study|Adverse Event|1|||
33655492|NCT00636441|63070994|FG003|Overall Study|Adverse Event|0|||
33655493|NCT00636441|63070995|FG004|Overall Study|Adverse Event|0|||
33655494|NCT00636441|63070996|FG005|Overall Study|Adverse Event|1|||
33655495|NCT00636441|63070997|FG006|Overall Study|Adverse Event|0|||
33655496|NCT00636441|63070991|FG000|Overall Study|Late, ineligible|0|||
33655497|NCT00636441|63070992|FG001|Overall Study|Late, ineligible|0|||
33655498|NCT00636441|63070993|FG002|Overall Study|Late, ineligible|0|||
33655499|NCT00636441|63070994|FG003|Overall Study|Late, ineligible|0|||
33655500|NCT00636441|63070995|FG004|Overall Study|Late, ineligible|0|||
33655501|NCT00636441|63070996|FG005|Overall Study|Late, ineligible|0|||
33655502|NCT00636441|63070997|FG006|Overall Study|Late, ineligible|1|||
33655503|NCT00636441|63070991|FG000|Overall Study|Screen Failure|0|||
33655504|NCT00636441|63070992|FG001|Overall Study|Screen Failure|0|||
33655505|NCT00636441|63070993|FG002|Overall Study|Screen Failure|0|||
33655506|NCT00636441|63070994|FG003|Overall Study|Screen Failure|0|||
33655507|NCT00636441|63070995|FG004|Overall Study|Screen Failure|0|||
33655508|NCT00636441|63070996|FG005|Overall Study|Screen Failure|0|||
33655509|NCT00636441|63070997|FG006|Overall Study|Screen Failure|17|||
33655510|NCT00636363|63071020|FG000|Overall Study|Conjunctivitis|0|||
33655511|NCT00636363|63071021|FG001|Overall Study|Conjunctivitis|0|||
33655512|NCT00636363|63071022|FG002|Overall Study|Conjunctivitis|1|||
33655513|NCT00636363|63071020|FG000|Overall Study|Adverse Event|0|||
33655514|NCT00636363|63071021|FG001|Overall Study|Adverse Event|0|||
33655515|NCT00636363|63071022|FG002|Overall Study|Adverse Event|1|||
33655516|NCT00636363|63071020|FG000|Overall Study|Positive slit lamp finding|0|||
33655517|NCT00636363|63071021|FG001|Overall Study|Positive slit lamp finding|2|||
33655518|NCT00636363|63071022|FG002|Overall Study|Positive slit lamp finding|1|||
33655519|NCT00636363|63071020|FG000|Overall Study|Study related symptoms/complaints|8|||
33655520|NCT00636363|63071021|FG001|Overall Study|Study related symptoms/complaints|7|||
33655521|NCT00636363|63071022|FG002|Overall Study|Study related symptoms/complaints|4|||
33655522|NCT00636363|63071020|FG000|Overall Study|Met ineligibility criteria|0|||
33655523|NCT00636363|63071021|FG001|Overall Study|Met ineligibility criteria|0|||
33655524|NCT00636363|63071022|FG002|Overall Study|Met ineligibility criteria|3|||
33655525|NCT00636363|63071020|FG000|Overall Study|Missed > 1 visit|0|||
33655526|NCT00636363|63071021|FG001|Overall Study|Missed > 1 visit|1|||
33655527|NCT00636363|63071022|FG002|Overall Study|Missed > 1 visit|3|||
33655528|NCT00636363|63071020|FG000|Overall Study|Lack of motivation|1|||
33655529|NCT00636363|63071021|FG001|Overall Study|Lack of motivation|0|||
33655530|NCT00636363|63071022|FG002|Overall Study|Lack of motivation|1|||
33655531|NCT00636363|63071020|FG000|Overall Study|Protocol Violation|0|||
33474433|NCT04147858|62848327|FG002|Overall Study|Lost to Follow-up|2|||
33474434|NCT04147858|62848325|FG000|Overall Study|Withdrawal by Subject|3|||
33474435|NCT04147858|62848326|FG001|Overall Study|Withdrawal by Subject|4|||
33655532|NCT00636363|63071021|FG001|Overall Study|Protocol Violation|3|||
33655533|NCT00636363|63071022|FG002|Overall Study|Protocol Violation|0|||
33655534|NCT00636363|63071020|FG000|Overall Study|Lost to Follow-up|3|||
33655535|NCT00636363|63071021|FG001|Overall Study|Lost to Follow-up|4|||
33655536|NCT00636363|63071022|FG002|Overall Study|Lost to Follow-up|2|||
33655537|NCT00636363|63071020|FG000|Overall Study|Withdrawal by Subject|1|||
33655538|NCT00636363|63071021|FG001|Overall Study|Withdrawal by Subject|3|||
33358896|NCT00812565|62736577|FG005|Overall Study|Adverse Event|0|||
33655539|NCT00636363|63071022|FG002|Overall Study|Withdrawal by Subject|2|||
33655540|NCT00636207|63071064|FG000|Overall Study|Adverse Event|1|||
33655541|NCT00636207|63071065|FG001|Overall Study|Adverse Event|0|||
33358897|NCT00812565|62736578|FG006|Overall Study|Adverse Event|0|||
33358898|NCT00812565|62736579|FG007|Overall Study|Adverse Event|1|||
33358899|NCT00812565|62736572|FG000|Overall Study|Did Not Come to Study Visit|1|||
33358900|NCT00812565|62736573|FG001|Overall Study|Did Not Come to Study Visit|0|||
33358901|NCT00812565|62736574|FG002|Overall Study|Did Not Come to Study Visit|0|||
33358902|NCT00812565|62736575|FG003|Overall Study|Did Not Come to Study Visit|0|||
33358903|NCT00812565|62736576|FG004|Overall Study|Did Not Come to Study Visit|0|||
33358904|NCT00812565|62736577|FG005|Overall Study|Did Not Come to Study Visit|0|||
33358905|NCT00812565|62736578|FG006|Overall Study|Did Not Come to Study Visit|0|||
33358906|NCT00812565|62736579|FG007|Overall Study|Did Not Come to Study Visit|0|||
33358907|NCT00812565|62736572|FG000|Overall Study|Withdrawal of Consent|1|||
33358908|NCT00812565|62736573|FG001|Overall Study|Withdrawal of Consent|0|||
33358909|NCT00812565|62736574|FG002|Overall Study|Withdrawal of Consent|0|||
33358910|NCT00812565|62736575|FG003|Overall Study|Withdrawal of Consent|0|||
33358911|NCT00812565|62736576|FG004|Overall Study|Withdrawal of Consent|1|||
33358912|NCT00812565|62736577|FG005|Overall Study|Withdrawal of Consent|0|||
33358913|NCT00812565|62736578|FG006|Overall Study|Withdrawal of Consent|0|||
33358914|NCT00812565|62736579|FG007|Overall Study|Withdrawal of Consent|0|||
33358915|NCT00812565|62736572|FG000|Overall Study|Reason Not Specified|0|||
33358916|NCT00812565|62736573|FG001|Overall Study|Reason Not Specified|0|||
33358917|NCT00812565|62736574|FG002|Overall Study|Reason Not Specified|0|||
33358918|NCT00812565|62736575|FG003|Overall Study|Reason Not Specified|0|||
33358919|NCT00812565|62736576|FG004|Overall Study|Reason Not Specified|0|||
33358920|NCT00812565|62736577|FG005|Overall Study|Reason Not Specified|1|||
33358921|NCT00812565|62736578|FG006|Overall Study|Reason Not Specified|0|||
33358922|NCT00812565|62736579|FG007|Overall Study|Reason Not Specified|0|||
33358923|NCT00812487|62736599|FG000|Overall Study|Lost to Follow-up|2|||
33358924|NCT00812487|62736600|FG001|Overall Study|Lost to Follow-up|0|||
33358925|NCT00812487|62736599|FG000|Overall Study|Withdrawal by Subject|3|||
33358926|NCT00812487|62736600|FG001|Overall Study|Withdrawal by Subject|2|||
33358927|NCT00812487|62736599|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
33358928|NCT00812487|62736600|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
33358929|NCT00812487|62736599|FG000|Overall Study|Protocol Violation|0|||
33358930|NCT00812487|62736600|FG001|Overall Study|Protocol Violation|1|||
33358931|NCT00617461|62736610|FG000|First Treatment Intervention Period|Adverse Event|2|||
33358932|NCT00617461|62736611|FG001|First Treatment Intervention Period|Adverse Event|0|||
33358933|NCT00617461|62736610|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
33358934|NCT00617461|62736611|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
33358935|NCT00617461|62736610|FG000|First Treatment Intervention Period|Protocol Violation|2|||
33358936|NCT00617461|62736611|FG001|First Treatment Intervention Period|Protocol Violation|1|||
33358937|NCT00617461|62736610|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
33358938|NCT00617461|62736611|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
33358939|NCT00617461|62736610|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
33358940|NCT00617461|62736611|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
33358941|NCT00617461|62736610|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
33358942|NCT00617461|62736611|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
33358943|NCT00617461|62736610|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
33358944|NCT00617461|62736611|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
33358945|NCT00617461|62736610|FG000|Second Treatment Intervention Period|Adverse Event|0|||
33358946|NCT00617461|62736611|FG001|Second Treatment Intervention Period|Adverse Event|1|||
33358947|NCT00617461|62736610|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
33358948|NCT00617461|62736611|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
33358949|NCT00617461|62736610|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
33358950|NCT00617461|62736611|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
33358951|NCT00617461|62736610|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
33358952|NCT00617461|62736611|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
33358953|NCT00812331|62736638|FG000|Overall Study|Adverse Event|1|||
33358954|NCT00812331|62736639|FG001|Overall Study|Adverse Event|0|||
33358955|NCT00812331|62736640|FG002|Overall Study|Adverse Event|0|||
33358956|NCT00812331|62736641|FG003|Overall Study|Adverse Event|0|||
33358957|NCT00812331|62736642|FG004|Overall Study|Adverse Event|0|||
33358958|NCT00812253|62736652|FG000|Overall Study|Withdrawal by Subject|3|||
33358959|NCT00812253|62736653|FG001|Overall Study|Withdrawal by Subject|2|||
33358960|NCT00812253|62736652|FG000|Overall Study|Protocol Violation|1|||
33358961|NCT00812253|62736653|FG001|Overall Study|Protocol Violation|1|||
33549285|NCT01345253|62940527|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
33358962|NCT00812253|62736652|FG000|Overall Study|Lost to Follow-up|2|||
33358963|NCT00812253|62736653|FG001|Overall Study|Lost to Follow-up|0|||
33358964|NCT00616759|62736661|FG000|Overall Study|Physician Decision|2|||
33358965|NCT00616759|62736662|FG001|Overall Study|Physician Decision|0|||
33358966|NCT00616759|62736661|FG000|Overall Study|Withdrawal by Subject|1|||
33358967|NCT00616759|62736662|FG001|Overall Study|Withdrawal by Subject|2|||
33358968|NCT00812097|62736672|FG000|Overall Study|Death|3|||
33358969|NCT00812097|62736673|FG001|Overall Study|Death|10|||
33358970|NCT00812097|62736674|FG002|Overall Study|Death|3|||
33358971|NCT00812097|62736675|FG003|Overall Study|Death|3|||
33358972|NCT00812097|62736672|FG000|Overall Study|Withdrawal by Subject|14|||
33358973|NCT00812097|62736673|FG001|Overall Study|Withdrawal by Subject|12|||
33358974|NCT00812097|62736674|FG002|Overall Study|Withdrawal by Subject|8|||
33358975|NCT00812097|62736675|FG003|Overall Study|Withdrawal by Subject|2|||
33358976|NCT00812097|62736672|FG000|Overall Study|Lost to Follow-up|90|||
33358977|NCT00812097|62736673|FG001|Overall Study|Lost to Follow-up|14|||
33358978|NCT00812097|62736674|FG002|Overall Study|Lost to Follow-up|17|||
33358979|NCT00812097|62736675|FG003|Overall Study|Lost to Follow-up|5|||
33358980|NCT00812097|62736672|FG000|Overall Study|Explantation of study device(s)|27|||
33358981|NCT00812097|62736673|FG001|Overall Study|Explantation of study device(s)|29|||
33358982|NCT00812097|62736674|FG002|Overall Study|Explantation of study device(s)|14|||
33358983|NCT00812097|62736675|FG003|Overall Study|Explantation of study device(s)|20|||
33358984|NCT00812097|62736672|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
33358985|NCT00812097|62736673|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
33358986|NCT00812097|62736674|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
33358987|NCT00812097|62736675|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
33358988|NCT00811941|62736687|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
33358989|NCT00811941|62736688|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
33358990|NCT00811941|62736687|FG000|All Treated Patients|Adverse Event|2|||
33358991|NCT00811941|62736688|FG001|All Treated Patients|Adverse Event|43|||
33358992|NCT00811941|62736687|FG000|All Treated Patients|Lack of Efficacy|2|||
33358993|NCT00811941|62736688|FG001|All Treated Patients|Lack of Efficacy|3|||
33358994|NCT00811941|62736687|FG000|All Treated Patients|Non-compliance|1|||
33358995|NCT00811941|62736688|FG001|All Treated Patients|Non-compliance|8|||
33358996|NCT00811941|62736687|FG000|All Treated Patients|Protocol Violation|5|||
33358997|NCT00811941|62736688|FG001|All Treated Patients|Protocol Violation|17|||
33358998|NCT00811941|62736687|FG000|All Treated Patients|Withdrawal by Subject|35|||
33358999|NCT00811941|62736688|FG001|All Treated Patients|Withdrawal by Subject|94|||
33359000|NCT00811941|62736687|FG000|All Treated Patients|Lost to Follow-up|3|||
33359001|NCT00811941|62736688|FG001|All Treated Patients|Lost to Follow-up|12|||
33359002|NCT00811941|62736687|FG000|All Treated Patients|Other Reason|4|||
33359003|NCT00811941|62736688|FG001|All Treated Patients|Other Reason|14|||
33359004|NCT00811473|62736696|FG000|Overall Study|Adverse Event|3|||
33359005|NCT00811473|62736697|FG001|Overall Study|Adverse Event|12|||
33359006|NCT00811473|62736696|FG000|Overall Study|Lost to Follow-up|5|||
33359007|NCT00811473|62736697|FG001|Overall Study|Lost to Follow-up|1|||
33359008|NCT00811473|62736696|FG000|Overall Study|Withdrawal by Subject|2|||
33359009|NCT00811473|62736697|FG001|Overall Study|Withdrawal by Subject|4|||
33359010|NCT00811473|62736696|FG000|Overall Study|Severe non-compliance to protocol|2|||
33359011|NCT00811473|62736697|FG001|Overall Study|Severe non-compliance to protocol|4|||
33359012|NCT00811473|62736696|FG000|Overall Study|Lack of therapeutic response|4|||
33359013|NCT00811473|62736697|FG001|Overall Study|Lack of therapeutic response|1|||
33359014|NCT00811473|62736696|FG000|Overall Study|Condition under investigation worsened|1|||
33359015|NCT00811473|62736697|FG001|Overall Study|Condition under investigation worsened|3|||
33359016|NCT00811473|62736696|FG000|Overall Study|Other 2|4|||
33359017|NCT00811473|62736697|FG001|Overall Study|Other 2|1|||
33359018|NCT00811473|62736696|FG000|Overall Study|Incorrect Enrollment|1|||
33359019|NCT00811473|62736697|FG001|Overall Study|Incorrect Enrollment|0|||
33359020|NCT00811473|62736696|FG000|Overall Study|Safety Reasons|1|||
33359021|NCT00811473|62736697|FG001|Overall Study|Safety Reasons|0|||
33359022|NCT00617305|62736710|FG000|Overall Study|Adverse Event|4|||
33359023|NCT00617305|62736711|FG001|Overall Study|Adverse Event|0|||
33359024|NCT00617305|62736712|FG002|Overall Study|Adverse Event|0|||
33359025|NCT00617305|62736710|FG000|Overall Study|Death|1|||
33359026|NCT00617305|62736711|FG001|Overall Study|Death|0|||
33359027|NCT00617305|62736712|FG002|Overall Study|Death|0|||
33359028|NCT00617305|62736710|FG000|Overall Study|Physician Decision|1|||
33359029|NCT00617305|62736711|FG001|Overall Study|Physician Decision|0|||
33359030|NCT00617305|62736712|FG002|Overall Study|Physician Decision|0|||
33359031|NCT00617305|62736710|FG000|Overall Study|Protocol Violation|1|||
33359032|NCT00617305|62736711|FG001|Overall Study|Protocol Violation|0|||
33359033|NCT00617305|62736712|FG002|Overall Study|Protocol Violation|1|||
33359034|NCT00617305|62736710|FG000|Overall Study|Withdrawal by Subject|1|||
33359035|NCT00617305|62736711|FG001|Overall Study|Withdrawal by Subject|0|||
33359036|NCT00617305|62736712|FG002|Overall Study|Withdrawal by Subject|0|||
33359037|NCT00811395|62736729|FG000|Extension Treatment|Adverse Event|1|||
33359038|NCT00811395|62736730|FG001|Extension Treatment|Adverse Event|2|||
33359039|NCT00811395|62736731|FG002|Extension Treatment|Adverse Event|2|||
33359040|NCT00811395|62736732|FG003|Extension Treatment|Adverse Event|2|||
33359041|NCT00811395|62736733|FG004|Extension Treatment|Adverse Event|0|||
33359042|NCT00811395|62736734|FG005|Extension Treatment|Adverse Event|1|||
33359043|NCT00811395|62736729|FG000|Extension Treatment|Progressive disease|1|||
33359044|NCT00811395|62736730|FG001|Extension Treatment|Progressive disease|1|||
33359045|NCT00811395|62736731|FG002|Extension Treatment|Progressive disease|0|||
33359046|NCT00811395|62736732|FG003|Extension Treatment|Progressive disease|0|||
33359047|NCT00811395|62736733|FG004|Extension Treatment|Progressive disease|0|||
33359048|NCT00811395|62736734|FG005|Extension Treatment|Progressive disease|0|||
33359049|NCT00811395|62736729|FG000|Extension Treatment|Participant did not wish to continue|0|||
33359050|NCT00811395|62736730|FG001|Extension Treatment|Participant did not wish to continue|3|||
33359051|NCT00811395|62736731|FG002|Extension Treatment|Participant did not wish to continue|0|||
33359052|NCT00811395|62736732|FG003|Extension Treatment|Participant did not wish to continue|1|||
33359053|NCT00811395|62736733|FG004|Extension Treatment|Participant did not wish to continue|0|||
33359054|NCT00811395|62736734|FG005|Extension Treatment|Participant did not wish to continue|1|||
33359055|NCT00811395|62736729|FG000|Extension Treatment|Other than above|0|||
33359056|NCT00811395|62736730|FG001|Extension Treatment|Other than above|0|||
33359057|NCT00811395|62736731|FG002|Extension Treatment|Other than above|1|||
33359058|NCT00811395|62736732|FG003|Extension Treatment|Other than above|0|||
33359059|NCT00811395|62736733|FG004|Extension Treatment|Other than above|0|||
33474436|NCT04147858|62848327|FG002|Overall Study|Withdrawal by Subject|10|||
33474437|NCT04147858|62848325|FG000|Overall Study|Subject Noncompliance, Other|4|||
33474438|NCT04147858|62848326|FG001|Overall Study|Subject Noncompliance, Other|3|||
33474439|NCT04147858|62848327|FG002|Overall Study|Subject Noncompliance, Other|1|||
33474440|NCT04146896|62848337|FG000|Overall Study|Adverse Event|5|||
33359060|NCT00811395|62736734|FG005|Extension Treatment|Other than above|0|||
33359061|NCT00955409|62736761|FG000|Overall Study|Lack of Efficacy|1|||
33359062|NCT00955409|62736762|FG001|Overall Study|Lack of Efficacy|0|||
33359063|NCT00955409|62736763|FG002|Overall Study|Lack of Efficacy|0|||
33359064|NCT00955409|62736764|FG003|Overall Study|Lack of Efficacy|0|||
33359065|NCT00955409|62736765|FG004|Overall Study|Lack of Efficacy|0|||
33359066|NCT00955409|62736766|FG005|Overall Study|Lack of Efficacy|0|||
33359067|NCT00955409|62736767|FG006|Overall Study|Lack of Efficacy|0|||
33359068|NCT00955409|62736768|FG007|Overall Study|Lack of Efficacy|0|||
33359069|NCT00955409|62736769|FG008|Overall Study|Lack of Efficacy|0|||
33359070|NCT00955409|62736770|FG009|Overall Study|Lack of Efficacy|0|||
33359071|NCT00955409|62736761|FG000|Overall Study|Withdrawal by Subject|1|||
33359072|NCT00955409|62736762|FG001|Overall Study|Withdrawal by Subject|0|||
33359073|NCT00955409|62736763|FG002|Overall Study|Withdrawal by Subject|5|||
33359074|NCT00955409|62736764|FG003|Overall Study|Withdrawal by Subject|2|||
33359075|NCT00955409|62736765|FG004|Overall Study|Withdrawal by Subject|0|||
33359076|NCT00955409|62736766|FG005|Overall Study|Withdrawal by Subject|0|||
33359077|NCT00955409|62736767|FG006|Overall Study|Withdrawal by Subject|2|||
33359078|NCT00955409|62736768|FG007|Overall Study|Withdrawal by Subject|0|||
33359079|NCT00955409|62736769|FG008|Overall Study|Withdrawal by Subject|1|||
33359080|NCT00955409|62736770|FG009|Overall Study|Withdrawal by Subject|0|||
33474441|NCT04146896|62848338|FG001|Overall Study|Adverse Event|8|||
33474442|NCT04146896|62848337|FG000|Overall Study|Lack of Efficacy|3|||
33474443|NCT04146896|62848338|FG001|Overall Study|Lack of Efficacy|2|||
33474444|NCT04146896|62848337|FG000|Overall Study|Lost to Follow-up|0|||
33474445|NCT04146896|62848338|FG001|Overall Study|Lost to Follow-up|1|||
33474446|NCT04146896|62848337|FG000|Overall Study|Non-compliance|5|||
33549286|NCT01345253|62940526|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
33549287|NCT01345253|62940527|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
33549288|NCT02477800|62940538|FG000|Placebo-Controlled Period|Adverse Event|16|||
33549289|NCT02477800|62940539|FG001|Placebo-Controlled Period|Adverse Event|25|||
33549290|NCT02477800|62940540|FG002|Placebo-Controlled Period|Adverse Event|28|||
33549291|NCT02477800|62940541|FG003|Placebo-Controlled Period|Adverse Event|0|||
33549292|NCT02477800|62940542|FG004|Placebo-Controlled Period|Adverse Event|0|||
33549293|NCT02477800|62940543|FG005|Placebo-Controlled Period|Adverse Event|0|||
33549294|NCT02477800|62940544|FG006|Placebo-Controlled Period|Adverse Event|0|||
33549295|NCT02477800|62940538|FG000|Placebo-Controlled Period|Change of Treatment|1|||
33359081|NCT00955409|62736761|FG000|Overall Study|Caregiver Request|2|||
33549296|NCT02477800|62940539|FG001|Placebo-Controlled Period|Change of Treatment|2|||
33549297|NCT02477800|62940540|FG002|Placebo-Controlled Period|Change of Treatment|1|||
33359082|NCT00955409|62736762|FG001|Overall Study|Caregiver Request|0|||
33359083|NCT00955409|62736763|FG002|Overall Study|Caregiver Request|6|||
33359084|NCT00955409|62736764|FG003|Overall Study|Caregiver Request|5|||
33359085|NCT00955409|62736765|FG004|Overall Study|Caregiver Request|0|||
33359086|NCT00955409|62736766|FG005|Overall Study|Caregiver Request|2|||
33359087|NCT00955409|62736767|FG006|Overall Study|Caregiver Request|3|||
33359088|NCT00955409|62736768|FG007|Overall Study|Caregiver Request|1|||
33359089|NCT00955409|62736769|FG008|Overall Study|Caregiver Request|3|||
33359090|NCT00955409|62736770|FG009|Overall Study|Caregiver Request|0|||
33359091|NCT00955409|62736761|FG000|Overall Study|Investigator Request|0|||
33474447|NCT04146896|62848338|FG001|Overall Study|Non-compliance|4|||
33549298|NCT02477800|62940541|FG003|Placebo-Controlled Period|Change of Treatment|0|||
33474448|NCT04146896|62848337|FG000|Overall Study|Withdrawal by Subject|3|||
33474449|NCT04146896|62848338|FG001|Overall Study|Withdrawal by Subject|5|||
33474450|NCT04146896|62848337|FG000|Overall Study|Randomized in error|1|||
33474451|NCT04146896|62848338|FG001|Overall Study|Randomized in error|2|||
33474452|NCT04072887|62848350|FG000|Overall Study|Withdrawal by Subject|3|||
33474453|NCT04072887|62848351|FG001|Overall Study|Withdrawal by Subject|8|||
33359092|NCT00955409|62736762|FG001|Overall Study|Investigator Request|0|||
33359093|NCT00955409|62736763|FG002|Overall Study|Investigator Request|1|||
33359094|NCT00955409|62736764|FG003|Overall Study|Investigator Request|0|||
33359095|NCT00955409|62736765|FG004|Overall Study|Investigator Request|0|||
33359096|NCT00955409|62736766|FG005|Overall Study|Investigator Request|0|||
33359097|NCT00955409|62736767|FG006|Overall Study|Investigator Request|0|||
33359098|NCT00955409|62736768|FG007|Overall Study|Investigator Request|0|||
33359099|NCT00955409|62736769|FG008|Overall Study|Investigator Request|0|||
33359100|NCT00955409|62736770|FG009|Overall Study|Investigator Request|0|||
33359101|NCT00955409|62736761|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
33359102|NCT00955409|62736762|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
33359103|NCT00955409|62736763|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
33359104|NCT00955409|62736764|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
33359105|NCT00955409|62736765|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
33359106|NCT00955409|62736766|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
33359107|NCT00955409|62736767|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
33359108|NCT00955409|62736768|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
33359109|NCT00955409|62736769|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
33359110|NCT00955409|62736770|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
33359111|NCT00955409|62736761|FG000|Overall Study|Lost to Follow-up|0|||
33359112|NCT00955409|62736762|FG001|Overall Study|Lost to Follow-up|0|||
33359113|NCT00955409|62736763|FG002|Overall Study|Lost to Follow-up|1|||
33359114|NCT00955409|62736764|FG003|Overall Study|Lost to Follow-up|0|||
33359115|NCT00955409|62736765|FG004|Overall Study|Lost to Follow-up|0|||
33359116|NCT00955409|62736766|FG005|Overall Study|Lost to Follow-up|0|||
33359117|NCT00955409|62736767|FG006|Overall Study|Lost to Follow-up|1|||
33359118|NCT00955409|62736768|FG007|Overall Study|Lost to Follow-up|0|||
33359119|NCT00955409|62736769|FG008|Overall Study|Lost to Follow-up|0|||
33359120|NCT00955409|62736770|FG009|Overall Study|Lost to Follow-up|0|||
33359121|NCT00955409|62736761|FG000|Overall Study|Failed to Return|2|||
33359122|NCT00955409|62736762|FG001|Overall Study|Failed to Return|0|||
33359123|NCT00955409|62736763|FG002|Overall Study|Failed to Return|0|||
33359124|NCT00955409|62736764|FG003|Overall Study|Failed to Return|0|||
33359125|NCT00955409|62736765|FG004|Overall Study|Failed to Return|0|||
33359126|NCT00955409|62736766|FG005|Overall Study|Failed to Return|0|||
33359127|NCT00955409|62736767|FG006|Overall Study|Failed to Return|0|||
33359128|NCT00955409|62736768|FG007|Overall Study|Failed to Return|2|||
33359129|NCT00955409|62736769|FG008|Overall Study|Failed to Return|0|||
33359130|NCT00955409|62736770|FG009|Overall Study|Failed to Return|0|||
33359131|NCT00955409|62736761|FG000|Overall Study|Adverse Event (AE)|2|||
33474454|NCT04072887|62848352|FG002|Overall Study|Withdrawal by Subject|1|||
33474455|NCT04072887|62848353|FG003|Overall Study|Withdrawal by Subject|3|||
33474456|NCT04072887|62848354|FG004|Overall Study|Withdrawal by Subject|3|||
33474457|NCT04072887|62848355|FG005|Overall Study|Withdrawal by Subject|13|||
33474458|NCT04072887|62848350|FG000|Overall Study|Adverse Event|2|||
33474459|NCT04072887|62848351|FG001|Overall Study|Adverse Event|4|||
33474460|NCT04072887|62848352|FG002|Overall Study|Adverse Event|1|||
33474461|NCT04072887|62848353|FG003|Overall Study|Adverse Event|4|||
33474462|NCT04072887|62848354|FG004|Overall Study|Adverse Event|0|||
33549299|NCT02477800|62940542|FG004|Placebo-Controlled Period|Change of Treatment|0|||
33549300|NCT02477800|62940543|FG005|Placebo-Controlled Period|Change of Treatment|0|||
33549301|NCT02477800|62940544|FG006|Placebo-Controlled Period|Change of Treatment|0|||
33549302|NCT02477800|62940538|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
33549303|NCT02477800|62940539|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
33549304|NCT02477800|62940540|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
33549305|NCT02477800|62940541|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
33549306|NCT02477800|62940542|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
33549307|NCT02477800|62940543|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
33655542|NCT00636207|63071066|FG002|Overall Study|Adverse Event|0|||
33359132|NCT00955409|62736762|FG001|Overall Study|Adverse Event (AE)|0|||
33359133|NCT00955409|62736763|FG002|Overall Study|Adverse Event (AE)|0|||
33359134|NCT00955409|62736764|FG003|Overall Study|Adverse Event (AE)|0|||
33359135|NCT00955409|62736765|FG004|Overall Study|Adverse Event (AE)|0|||
33359136|NCT00955409|62736766|FG005|Overall Study|Adverse Event (AE)|1|||
33359137|NCT00955409|62736767|FG006|Overall Study|Adverse Event (AE)|2|||
33474463|NCT04072887|62848355|FG005|Overall Study|Adverse Event|1|||
33359138|NCT00955409|62736768|FG007|Overall Study|Adverse Event (AE)|0|||
33359139|NCT00955409|62736769|FG008|Overall Study|Adverse Event (AE)|2|||
33359140|NCT00955409|62736770|FG009|Overall Study|Adverse Event (AE)|0|||
33359141|NCT00955409|62736761|FG000|Overall Study|Reason not Specified|2|||
33359142|NCT00955409|62736762|FG001|Overall Study|Reason not Specified|1|||
33474464|NCT04072887|62848350|FG000|Overall Study|Physician Decision|2|||
33474465|NCT04072887|62848351|FG001|Overall Study|Physician Decision|0|||
33474466|NCT04072887|62848352|FG002|Overall Study|Physician Decision|0|||
33474467|NCT04072887|62848353|FG003|Overall Study|Physician Decision|0|||
33474468|NCT04072887|62848354|FG004|Overall Study|Physician Decision|0|||
33474469|NCT04072887|62848355|FG005|Overall Study|Physician Decision|1|||
33474470|NCT04072887|62848350|FG000|Overall Study|Lost to Follow-up|1|||
33474471|NCT04072887|62848351|FG001|Overall Study|Lost to Follow-up|3|||
33474472|NCT04072887|62848352|FG002|Overall Study|Lost to Follow-up|0|||
33474473|NCT04072887|62848353|FG003|Overall Study|Lost to Follow-up|0|||
33474474|NCT04072887|62848354|FG004|Overall Study|Lost to Follow-up|0|||
33474475|NCT04072887|62848355|FG005|Overall Study|Lost to Follow-up|0|||
33474476|NCT04072887|62848350|FG000|Overall Study|Death|0|||
33474477|NCT04072887|62848351|FG001|Overall Study|Death|2|||
33474478|NCT04072887|62848352|FG002|Overall Study|Death|0|||
33474479|NCT04072887|62848353|FG003|Overall Study|Death|2|||
33474480|NCT04072887|62848354|FG004|Overall Study|Death|3|||
33474481|NCT04072887|62848355|FG005|Overall Study|Death|0|||
33474482|NCT03516812|62848448|FG000|Overall Study|Adverse Event|4|||
33474483|NCT03516812|62848448|FG000|Overall Study|Lack of Efficacy|2|||
33474484|NCT03122119|62848479|FG000|Overall Study|Did not meet eligibility critria|1|||
33474485|NCT02613169|62848485|FG000|Overall Study|Withdrawal by Subject|4|||
33474486|NCT02613169|62848486|FG001|Overall Study|Withdrawal by Subject|1|||
33474487|NCT02613169|62848485|FG000|Overall Study|Lost to Follow-up|0|||
33474488|NCT02613169|62848486|FG001|Overall Study|Lost to Follow-up|5|||
33474489|NCT02613169|62848485|FG000|Overall Study|HIV|0|||
33474490|NCT02613169|62848486|FG001|Overall Study|HIV|2|||
33474491|NCT02613169|62848485|FG000|Overall Study|No TB infection endpoint|14|||
33474492|NCT02613169|62848486|FG001|Overall Study|No TB infection endpoint|9|||
33474493|NCT02352948|62848498|FG000|Overall Study|Death|47|||
33474494|NCT02352948|62848499|FG001|Overall Study|Death|48|||
33474495|NCT02352948|62848500|FG002|Overall Study|Death|114|||
33474496|NCT02352948|62848501|FG003|Overall Study|Death|74|||
33474497|NCT02352948|62848502|FG004|Overall Study|Death|77|||
33549308|NCT02477800|62940544|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
33474498|NCT02352948|62848503|FG005|Overall Study|Death|44|||
33474499|NCT02352948|62848498|FG000|Overall Study|Lost to Follow-up|1|||
33474500|NCT02352948|62848499|FG001|Overall Study|Lost to Follow-up|0|||
33549309|NCT02477800|62940538|FG000|Placebo-Controlled Period|Death|0|||
33549310|NCT02477800|62940539|FG001|Placebo-Controlled Period|Death|3|||
33549311|NCT02477800|62940540|FG002|Placebo-Controlled Period|Death|2|||
33549312|NCT02477800|62940541|FG003|Placebo-Controlled Period|Death|0|||
33549313|NCT02477800|62940542|FG004|Placebo-Controlled Period|Death|0|||
33549314|NCT02477800|62940543|FG005|Placebo-Controlled Period|Death|0|||
33549315|NCT02477800|62940544|FG006|Placebo-Controlled Period|Death|0|||
33549316|NCT02477800|62940538|FG000|Placebo-Controlled Period|Disease Progression|1|||
33549317|NCT02477800|62940539|FG001|Placebo-Controlled Period|Disease Progression|0|||
33655543|NCT00636207|63071067|FG003|Overall Study|Adverse Event|0|||
33310185|NCT01167153|62685578|FG000|Overall Study|Hypotension|1|||
33310186|NCT01167153|62685579|FG001|Overall Study|Hypotension|0|||
33310187|NCT01167153|62685578|FG000|Overall Study|Lost to Follow-up|7|||
33310188|NCT01167153|62685579|FG001|Overall Study|Lost to Follow-up|9|||
33310189|NCT01167153|62685578|FG000|Overall Study|Non-compliance to concomitant medication|0|||
33310190|NCT01167153|62685579|FG001|Overall Study|Non-compliance to concomitant medication|2|||
33310191|NCT01167153|62685578|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
33310192|NCT01167153|62685579|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
33310193|NCT01167153|62685578|FG000|Overall Study|Withdrawal consent|1|||
33310194|NCT01167153|62685579|FG001|Overall Study|Withdrawal consent|1|||
33310195|NCT01167153|62685578|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
33310196|NCT01167153|62685579|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
33310197|NCT01166763|62685585|FG000|Overall Study|Withdrawal by Subject|3|||
33310198|NCT01166373|62685593|FG000|Overall Study|Lost to Follow-up|3|||
33310199|NCT01166373|62685594|FG001|Overall Study|Lost to Follow-up|2|||
33310200|NCT01166373|62685595|FG002|Overall Study|Lost to Follow-up|2|||
33310201|NCT01166373|62685596|FG003|Overall Study|Lost to Follow-up|2|||
33310202|NCT01166373|62685593|FG000|Overall Study|Withdrawal by Subject|1|||
33310203|NCT01166373|62685594|FG001|Overall Study|Withdrawal by Subject|2|||
33310204|NCT01166373|62685595|FG002|Overall Study|Withdrawal by Subject|2|||
33310205|NCT01166373|62685596|FG003|Overall Study|Withdrawal by Subject|3|||
33310206|NCT01166373|62685593|FG000|Overall Study|Physician Decision|1|||
33310207|NCT01166373|62685594|FG001|Overall Study|Physician Decision|0|||
33310208|NCT01166373|62685595|FG002|Overall Study|Physician Decision|0|||
33310209|NCT01166373|62685596|FG003|Overall Study|Physician Decision|0|||
33310210|NCT00963235|62685608|FG000|Overall Study|Withdrawal by Subject|22|||
33310211|NCT00963235|62685608|FG000|Overall Study|Lost to Follow-up|14|||
33310212|NCT00963235|62685608|FG000|Overall Study|Failed to return|9|||
33310213|NCT00963235|62685608|FG000|Overall Study|Protocol Violation|7|||
33310214|NCT00963235|62685608|FG000|Overall Study|Adverse Event|5|||
33310215|NCT00963235|62685608|FG000|Overall Study|Physician Decision|2|||
33549318|NCT02477800|62940540|FG002|Placebo-Controlled Period|Disease Progression|1|||
33549319|NCT02477800|62940541|FG003|Placebo-Controlled Period|Disease Progression|0|||
33359143|NCT00955409|62736763|FG002|Overall Study|Reason not Specified|13|||
33474501|NCT02352948|62848500|FG002|Overall Study|Lost to Follow-up|2|||
33474502|NCT02352948|62848501|FG003|Overall Study|Lost to Follow-up|1|||
33549320|NCT02477800|62940542|FG004|Placebo-Controlled Period|Disease Progression|0|||
33549321|NCT02477800|62940543|FG005|Placebo-Controlled Period|Disease Progression|0|||
33549322|NCT02477800|62940544|FG006|Placebo-Controlled Period|Disease Progression|0|||
33549323|NCT02477800|62940538|FG000|Placebo-Controlled Period|Investigator Decision|3|||
33549324|NCT02477800|62940539|FG001|Placebo-Controlled Period|Investigator Decision|2|||
33549325|NCT02477800|62940540|FG002|Placebo-Controlled Period|Investigator Decision|1|||
33549326|NCT02477800|62940541|FG003|Placebo-Controlled Period|Investigator Decision|0|||
33549327|NCT02477800|62940542|FG004|Placebo-Controlled Period|Investigator Decision|0|||
33549328|NCT02477800|62940543|FG005|Placebo-Controlled Period|Investigator Decision|0|||
33549329|NCT02477800|62940544|FG006|Placebo-Controlled Period|Investigator Decision|0|||
33549330|NCT02477800|62940538|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
33549331|NCT02477800|62940539|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
33549332|NCT02477800|62940540|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
33549333|NCT02477800|62940541|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
33549334|NCT02477800|62940542|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
33549335|NCT02477800|62940543|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
33549336|NCT02477800|62940544|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
33549337|NCT02477800|62940538|FG000|Placebo-Controlled Period|Relocation|2|||
33549338|NCT02477800|62940539|FG001|Placebo-Controlled Period|Relocation|0|||
33549339|NCT02477800|62940540|FG002|Placebo-Controlled Period|Relocation|0|||
33549340|NCT02477800|62940541|FG003|Placebo-Controlled Period|Relocation|0|||
33549341|NCT02477800|62940542|FG004|Placebo-Controlled Period|Relocation|0|||
33549342|NCT02477800|62940543|FG005|Placebo-Controlled Period|Relocation|0|||
33549343|NCT02477800|62940544|FG006|Placebo-Controlled Period|Relocation|0|||
33549344|NCT02477800|62940538|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
33549345|NCT02477800|62940539|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
33549346|NCT02477800|62940540|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
33549347|NCT02477800|62940541|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
33549348|NCT02477800|62940542|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
33549349|NCT02477800|62940543|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
33549350|NCT02477800|62940544|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
33549351|NCT02477800|62940538|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
33549352|NCT02477800|62940539|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
33549353|NCT02477800|62940540|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
33549354|NCT02477800|62940541|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
33549355|NCT02477800|62940542|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
33549356|NCT02477800|62940543|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
33549357|NCT02477800|62940544|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
33549358|NCT02477800|62940538|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
33549359|NCT02477800|62940539|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
33549360|NCT02477800|62940540|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
33549361|NCT02477800|62940541|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
33549362|NCT02477800|62940542|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
33549363|NCT02477800|62940543|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
33474503|NCT02352948|62848502|FG004|Overall Study|Lost to Follow-up|2|||
33474504|NCT02352948|62848503|FG005|Overall Study|Lost to Follow-up|1|||
33474505|NCT02352948|62848498|FG000|Overall Study|Withdrawal by Subject|1|||
33474506|NCT02352948|62848499|FG001|Overall Study|Withdrawal by Subject|10|||
33474507|NCT02352948|62848500|FG002|Overall Study|Withdrawal by Subject|11|||
33474508|NCT02352948|62848501|FG003|Overall Study|Withdrawal by Subject|23|||
33474509|NCT02352948|62848502|FG004|Overall Study|Withdrawal by Subject|9|||
33474510|NCT02352948|62848503|FG005|Overall Study|Withdrawal by Subject|4|||
33474511|NCT02352948|62848498|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33474512|NCT02352948|62848499|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33474513|NCT02352948|62848500|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
33474514|NCT02352948|62848501|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
33474515|NCT02352948|62848502|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
33474516|NCT02352948|62848503|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
33474517|NCT02352948|62848498|FG000|Overall Study|Other|0|||
33474518|NCT02352948|62848499|FG001|Overall Study|Other|0|||
33474519|NCT02352948|62848500|FG002|Overall Study|Other|2|||
33474520|NCT02352948|62848501|FG003|Overall Study|Other|0|||
33474521|NCT02352948|62848502|FG004|Overall Study|Other|0|||
33474522|NCT02352948|62848503|FG005|Overall Study|Other|0|||
33549364|NCT02477800|62940544|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
33549365|NCT02477800|62940538|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
33549366|NCT02477800|62940539|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
33359144|NCT00955409|62736764|FG003|Overall Study|Reason not Specified|1|||
33359145|NCT00955409|62736765|FG004|Overall Study|Reason not Specified|2|||
33359146|NCT00955409|62736766|FG005|Overall Study|Reason not Specified|0|||
33359147|NCT00955409|62736767|FG006|Overall Study|Reason not Specified|16|||
33359148|NCT00955409|62736768|FG007|Overall Study|Reason not Specified|0|||
33359149|NCT00955409|62736769|FG008|Overall Study|Reason not Specified|8|||
33359150|NCT00955409|62736770|FG009|Overall Study|Reason not Specified|1|||
33359151|NCT00615901|62736796|FG000|Overall Study|Withdrawal by Subject|2|||
33359152|NCT00615901|62736796|FG000|Overall Study|Adverse Event|7|||
33359153|NCT00616603|62736808|FG000|Overall Study|Physician Decision|2|||
33359154|NCT00616603|62736809|FG001|Overall Study|Physician Decision|0|||
33359155|NCT00616603|62736810|FG002|Overall Study|Physician Decision|2|||
33359156|NCT00810693|62736821|FG000|Treatment Period|Adverse Event|8|||
33359157|NCT00810693|62736822|FG001|Treatment Period|Adverse Event|1|||
33359158|NCT00810693|62736823|FG002|Treatment Period|Adverse Event|7|||
33359159|NCT00810693|62736821|FG000|Treatment Period|Death|0|||
33359160|NCT00810693|62736822|FG001|Treatment Period|Death|1|||
33359161|NCT00810693|62736823|FG002|Treatment Period|Death|2|||
33359162|NCT00810693|62736821|FG000|Treatment Period|Lack of Efficacy|0|||
33359163|NCT00810693|62736822|FG001|Treatment Period|Lack of Efficacy|0|||
33359164|NCT00810693|62736823|FG002|Treatment Period|Lack of Efficacy|1|||
33359165|NCT00810693|62736821|FG000|Treatment Period|Lost to Follow-up|1|||
33359166|NCT00810693|62736822|FG001|Treatment Period|Lost to Follow-up|0|||
33359167|NCT00810693|62736823|FG002|Treatment Period|Lost to Follow-up|0|||
33359168|NCT00810693|62736821|FG000|Treatment Period|Non-compliance|1|||
33359169|NCT00810693|62736822|FG001|Treatment Period|Non-compliance|0|||
33359170|NCT00810693|62736823|FG002|Treatment Period|Non-compliance|0|||
33359171|NCT00810693|62736821|FG000|Treatment Period|Protocol Violation|1|||
33359172|NCT00810693|62736822|FG001|Treatment Period|Protocol Violation|2|||
33359173|NCT00810693|62736823|FG002|Treatment Period|Protocol Violation|2|||
33359174|NCT00810693|62736821|FG000|Treatment Period|Withdrawal by Subject|6|||
33359175|NCT00810693|62736822|FG001|Treatment Period|Withdrawal by Subject|2|||
33359176|NCT00810693|62736823|FG002|Treatment Period|Withdrawal by Subject|3|||
33359177|NCT00810693|62736821|FG000|Treatment Period|Not treated|0|||
33474523|NCT01974765|62848523|FG000|Overall Study|Withdrawal by Subject|1|||
33474524|NCT01974765|62848523|FG000|Overall Study|Death|1|||
33474525|NCT01974765|62848523|FG000|Overall Study|Adverse Event|2|||
33474526|NCT01725217|62848530|FG000|Overall Study|Withdrawal by Subject|1|||
33474527|NCT01725217|62848531|FG001|Overall Study|Withdrawal by Subject|0|||
33474528|NCT01725217|62848532|FG002|Overall Study|Withdrawal by Subject|0|||
33474529|NCT01344057|62848558|FG000|Overall Study|Premature Withdrawal|1|||
33474530|NCT00886782|62848565|FG000|Overall Study|Disease progression|3|||
33359178|NCT00810693|62736822|FG001|Treatment Period|Not treated|1|||
33359179|NCT00810693|62736823|FG002|Treatment Period|Not treated|1|||
33359180|NCT00810693|62736821|FG000|Follow-up Period (FUP)|Adverse Event|3|||
33359181|NCT00810693|62736822|FG001|Follow-up Period (FUP)|Adverse Event|1|||
33359182|NCT00810693|62736823|FG002|Follow-up Period (FUP)|Adverse Event|1|||
33359183|NCT00810693|62736821|FG000|Follow-up Period (FUP)|Death|2|||
33359184|NCT00810693|62736822|FG001|Follow-up Period (FUP)|Death|0|||
33359185|NCT00810693|62736823|FG002|Follow-up Period (FUP)|Death|1|||
33359186|NCT00810693|62736821|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
33359187|NCT00810693|62736822|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
33359188|NCT00810693|62736823|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
33359189|NCT00810693|62736821|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
33359190|NCT00810693|62736822|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
33359191|NCT00810693|62736823|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
33359192|NCT00810693|62736821|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
33359193|NCT00810693|62736822|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
33359194|NCT00810693|62736823|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
33359195|NCT00573313|62736835|FG000|Overall Study|Protocol Violation|5|||
33359196|NCT00573313|62736836|FG001|Overall Study|Protocol Violation|0|||
33474531|NCT00886782|62848566|FG001|Overall Study|Disease progression|3|||
33474532|NCT00886782|62848567|FG002|Overall Study|Disease progression|3|||
33474533|NCT00886782|62848565|FG000|Overall Study|Study drug toxicity|0|||
33474534|NCT00886782|62848566|FG001|Overall Study|Study drug toxicity|0|||
33359197|NCT00573313|62736837|FG002|Overall Study|Protocol Violation|6|||
33359198|NCT00573313|62736838|FG003|Overall Study|Protocol Violation|0|||
33359199|NCT00953615|62736845|FG000|Overall Study|Adverse Event|1|||
33359200|NCT00810615|62736851|FG000|Overall Study|Withdrawal by Subject|1|||
33359201|NCT00810615|62736852|FG001|Overall Study|Withdrawal by Subject|1|||
33359202|NCT00573391|62736872|FG000|Overall Study|study stopped|2|||
33359203|NCT00573391|62736873|FG001|Overall Study|study stopped|2|||
33359204|NCT00573391|62736872|FG000|Overall Study|Death|1|||
33359205|NCT00573391|62736873|FG001|Overall Study|Death|0|||
33359206|NCT00590967|62736881|FG000|Overall Study|Withdrawal by Subject|1|||
33474535|NCT00886782|62848567|FG002|Overall Study|Study drug toxicity|1|||
33359207|NCT00590967|62736882|FG001|Overall Study|Withdrawal by Subject|1|||
33359208|NCT00590967|62736881|FG000|Overall Study|Ineligible|1|||
33359209|NCT00590967|62736882|FG001|Overall Study|Ineligible|0|||
33359210|NCT00590967|62736881|FG000|Overall Study|Poor performance status|0|||
33359211|NCT00590967|62736882|FG001|Overall Study|Poor performance status|1|||
33359212|NCT00590967|62736881|FG000|Overall Study|Non-compliant|0|||
33359213|NCT00590967|62736882|FG001|Overall Study|Non-compliant|2|||
33359214|NCT00590967|62736881|FG000|Overall Study|Did not sign consent form|0|||
33359215|NCT00590967|62736882|FG001|Overall Study|Did not sign consent form|1|||
33359216|NCT00590967|62736881|FG000|Overall Study|Did not receive chemo per protocol|1|||
33359217|NCT00590967|62736882|FG001|Overall Study|Did not receive chemo per protocol|0|||
33359218|NCT00590577|62736892|FG000|Overall Study|Lack of Efficacy|31|||
33359219|NCT00590577|62736893|FG001|Overall Study|Lack of Efficacy|28|||
33359220|NCT00590577|62736894|FG002|Overall Study|Lack of Efficacy|23|||
33359221|NCT00590577|62736895|FG003|Overall Study|Lack of Efficacy|45|||
33359222|NCT00590577|62736892|FG000|Overall Study|Withdrawal by Subject|23|||
33359223|NCT00590577|62736893|FG001|Overall Study|Withdrawal by Subject|28|||
33359224|NCT00590577|62736894|FG002|Overall Study|Withdrawal by Subject|30|||
33359225|NCT00590577|62736895|FG003|Overall Study|Withdrawal by Subject|26|||
33359226|NCT00590577|62736892|FG000|Overall Study|Adverse Event|10|||
33359227|NCT00590577|62736893|FG001|Overall Study|Adverse Event|10|||
33359228|NCT00590577|62736894|FG002|Overall Study|Adverse Event|13|||
33359229|NCT00590577|62736895|FG003|Overall Study|Adverse Event|11|||
33359230|NCT00590577|62736892|FG000|Overall Study|Lost to Follow-up|12|||
33359231|NCT00590577|62736893|FG001|Overall Study|Lost to Follow-up|6|||
33359232|NCT00590577|62736894|FG002|Overall Study|Lost to Follow-up|6|||
33359233|NCT00590577|62736895|FG003|Overall Study|Lost to Follow-up|9|||
33359234|NCT00590577|62736892|FG000|Overall Study|Pregnancy|0|||
33359235|NCT00590577|62736893|FG001|Overall Study|Pregnancy|1|||
33359236|NCT00590577|62736894|FG002|Overall Study|Pregnancy|0|||
33359237|NCT00590577|62736895|FG003|Overall Study|Pregnancy|0|||
33359238|NCT00590577|62736892|FG000|Overall Study|Various reasons|1|||
33359239|NCT00590577|62736893|FG001|Overall Study|Various reasons|3|||
33359240|NCT00590577|62736894|FG002|Overall Study|Various reasons|1|||
33359241|NCT00590577|62736895|FG003|Overall Study|Various reasons|2|||
33359242|NCT00614575|62736905|FG000|Overall Study|Adverse Event|106|||
33359243|NCT00614575|62736905|FG000|Overall Study|Lost to Follow-up|55|||
33359244|NCT00614575|62736905|FG000|Overall Study|Lack of Efficacy|14|||
33359245|NCT00614575|62736905|FG000|Overall Study|Withdrawal by Subject|6|||
33359246|NCT00614575|62736905|FG000|Overall Study|Death|3|||
33359247|NCT00614575|62736905|FG000|Overall Study|Physician Decision|2|||
33359248|NCT00614575|62736905|FG000|Overall Study|No data were collected.|18|||
33359249|NCT00614575|62736905|FG000|Overall Study|Irregularly enrolled patients|23|||
33359250|NCT00614575|62736905|FG000|Overall Study|No treatment|1|||
33359251|NCT00805935|62736913|FG000|Overall Study|Stimulation Failure|1|||
33359252|NCT00805935|62736914|FG001|Overall Study|Stimulation Failure|5|||
33359253|NCT00805935|62736915|FG002|Overall Study|Stimulation Failure|2|||
33359254|NCT00805935|62736916|FG003|Overall Study|Stimulation Failure|2|||
33359255|NCT00805935|62736913|FG000|Overall Study|Cycle cancelled|0|||
33359256|NCT00805935|62736914|FG001|Overall Study|Cycle cancelled|0|||
33359257|NCT00805935|62736915|FG002|Overall Study|Cycle cancelled|2|||
33359258|NCT00805935|62736916|FG003|Overall Study|Cycle cancelled|0|||
33359259|NCT00805935|62736913|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
33359260|NCT00805935|62736914|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
33359261|NCT00805935|62736915|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
33359262|NCT00805935|62736916|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
33359263|NCT00805935|62736913|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
33359264|NCT00805935|62736914|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
33359265|NCT00805935|62736915|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
33359266|NCT00805935|62736916|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
33359267|NCT00805935|62736913|FG000|Overall Study|Lost to Follow-up|1|||
33359268|NCT00805935|62736914|FG001|Overall Study|Lost to Follow-up|0|||
33359269|NCT00805935|62736915|FG002|Overall Study|Lost to Follow-up|0|||
33359270|NCT00805935|62736916|FG003|Overall Study|Lost to Follow-up|0|||
33359271|NCT00805935|62736913|FG000|Overall Study|No positive serum pregnancy|8|||
33359272|NCT00805935|62736914|FG001|Overall Study|No positive serum pregnancy|7|||
33359273|NCT00805935|62736915|FG002|Overall Study|No positive serum pregnancy|6|||
33359274|NCT00805935|62736916|FG003|Overall Study|No positive serum pregnancy|5|||
33359275|NCT00805935|62736913|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
33359276|NCT00805935|62736914|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
33359277|NCT00805935|62736915|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
33359278|NCT00805935|62736916|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
33359279|NCT00805935|62736913|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
33359280|NCT00805935|62736914|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
33359281|NCT00805935|62736915|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
33359282|NCT00805935|62736916|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
33359283|NCT00805935|62736913|FG000|Overall Study|Biochemical pregnancy|0|||
33474536|NCT00886782|62848565|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
33359284|NCT00805935|62736914|FG001|Overall Study|Biochemical pregnancy|1|||
33359285|NCT00805935|62736915|FG002|Overall Study|Biochemical pregnancy|0|||
33359286|NCT00805935|62736916|FG003|Overall Study|Biochemical pregnancy|0|||
33359287|NCT00805935|62736913|FG000|Overall Study|Chemical pregnancy|0|||
33359288|NCT00805935|62736914|FG001|Overall Study|Chemical pregnancy|5|||
33359289|NCT00805935|62736915|FG002|Overall Study|Chemical pregnancy|3|||
33359290|NCT00805935|62736916|FG003|Overall Study|Chemical pregnancy|2|||
33359291|NCT00805935|62736913|FG000|Overall Study|Ectopic pregnancy|0|||
33359292|NCT00805935|62736914|FG001|Overall Study|Ectopic pregnancy|0|||
33359293|NCT00805935|62736915|FG002|Overall Study|Ectopic pregnancy|1|||
33359294|NCT00805935|62736916|FG003|Overall Study|Ectopic pregnancy|0|||
33359295|NCT00805935|62736913|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
33359296|NCT00805935|62736914|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
33359297|NCT00805935|62736915|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
33359298|NCT00805935|62736916|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
33359299|NCT00805545|62736930|FG000|Overall Study|Protocol Violation|3|||
33359300|NCT00805545|62736931|FG001|Overall Study|Protocol Violation|2|||
33359301|NCT00805545|62736930|FG000|Overall Study|Protocol Violation|3|||
33359302|NCT00805545|62736931|FG001|Overall Study|Protocol Violation|1|||
33359303|NCT00590031|62736963|FG000|Overall Study|Adverse Event|3|||
33359304|NCT00590031|62736963|FG000|Overall Study|Withdrawal by Subject|1|||
33359305|NCT00590031|62736963|FG000|Overall Study|Metastatic Disease|1|||
33359306|NCT00590031|62736963|FG000|Overall Study|Admin Hold|1|||
33359307|NCT00615199|62736971|FG000|Overall Study|Adverse Event|3|||
33359308|NCT00615199|62736972|FG001|Overall Study|Adverse Event|1|||
33359309|NCT00615199|62736973|FG002|Overall Study|Adverse Event|1|||
33359310|NCT00615199|62736974|FG003|Overall Study|Adverse Event|0|||
33359311|NCT00615199|62736971|FG000|Overall Study|Lack of Efficacy|2|||
33359312|NCT00615199|62736972|FG001|Overall Study|Lack of Efficacy|0|||
33359313|NCT00615199|62736973|FG002|Overall Study|Lack of Efficacy|0|||
33359314|NCT00615199|62736974|FG003|Overall Study|Lack of Efficacy|1|||
33359315|NCT00615199|62736971|FG000|Overall Study|Lost to Follow-up|1|||
33359316|NCT00615199|62736972|FG001|Overall Study|Lost to Follow-up|0|||
33359317|NCT00615199|62736973|FG002|Overall Study|Lost to Follow-up|0|||
33359318|NCT00615199|62736974|FG003|Overall Study|Lost to Follow-up|0|||
33359319|NCT00615199|62736971|FG000|Overall Study|Other|0|||
33359320|NCT00615199|62736972|FG001|Overall Study|Other|0|||
33359321|NCT00615199|62736973|FG002|Overall Study|Other|0|||
33359322|NCT00615199|62736974|FG003|Overall Study|Other|1|||
33359323|NCT00615199|62736971|FG000|Overall Study|Withdrawal by Subject|2|||
33359324|NCT00615199|62736972|FG001|Overall Study|Withdrawal by Subject|1|||
33359325|NCT00615199|62736973|FG002|Overall Study|Withdrawal by Subject|0|||
33359326|NCT00615199|62736974|FG003|Overall Study|Withdrawal by Subject|0|||
33359327|NCT00613951|62736987|FG000|Overall Study|Adverse Event|1|||
33359328|NCT00613951|62736988|FG001|Overall Study|Adverse Event|0|||
33359329|NCT00613951|62736989|FG002|Overall Study|Adverse Event|1|||
33359330|NCT00613951|62736987|FG000|Overall Study|Lack of Efficacy|0|||
33359331|NCT00613951|62736988|FG001|Overall Study|Lack of Efficacy|1|||
33359332|NCT00613951|62736989|FG002|Overall Study|Lack of Efficacy|1|||
33474537|NCT00886782|62848566|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
33474538|NCT00886782|62848567|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
33474539|NCT00583024|62848575|FG000|Overall Study|Lost to Follow-up|4|||
33474540|NCT03435640|62848590|FG000|Overall Study|Withdrawal by Subject|0|||
33474541|NCT03435640|62848591|FG001|Overall Study|Withdrawal by Subject|1|||
33474542|NCT03435640|62848592|FG002|Overall Study|Withdrawal by Subject|0|||
33474543|NCT03435640|62848593|FG003|Overall Study|Withdrawal by Subject|2|||
33474544|NCT03435640|62848594|FG004|Overall Study|Withdrawal by Subject|0|||
33474545|NCT03435640|62848595|FG005|Overall Study|Withdrawal by Subject|0|||
33474546|NCT03435640|62848596|FG006|Overall Study|Withdrawal by Subject|3|||
33474547|NCT03435640|62848597|FG007|Overall Study|Withdrawal by Subject|0|||
33359333|NCT00613951|62736987|FG000|Overall Study|Protocol Violation|1|||
33359334|NCT00613951|62736988|FG001|Overall Study|Protocol Violation|1|||
33359335|NCT00613951|62736989|FG002|Overall Study|Protocol Violation|1|||
33359336|NCT00613951|62736987|FG000|Overall Study|Unclassified|5|||
33474548|NCT03435640|62848598|FG008|Overall Study|Withdrawal by Subject|0|||
33474549|NCT03435640|62848599|FG009|Overall Study|Withdrawal by Subject|2|||
33359337|NCT00613951|62736988|FG001|Overall Study|Unclassified|3|||
33359338|NCT00613951|62736989|FG002|Overall Study|Unclassified|2|||
33359339|NCT00805467|62737004|FG000|Overall Study|Lack of Efficacy|0|||
33359340|NCT00805467|62737005|FG001|Overall Study|Lack of Efficacy|8|||
33359341|NCT00805467|62737006|FG002|Overall Study|Lack of Efficacy|13|||
33359342|NCT00805467|62737007|FG003|Overall Study|Lack of Efficacy|86|||
33359343|NCT00805467|62737004|FG000|Overall Study|Lost to Follow-up|0|||
33359344|NCT00805467|62737005|FG001|Overall Study|Lost to Follow-up|1|||
33474550|NCT03435640|62848600|FG010|Overall Study|Withdrawal by Subject|3|||
33474551|NCT03435640|62848590|FG000|Overall Study|Lost to Follow-up|0|||
33359345|NCT00805467|62737006|FG002|Overall Study|Lost to Follow-up|7|||
33359346|NCT00805467|62737007|FG003|Overall Study|Lost to Follow-up|21|||
33359347|NCT00805467|62737004|FG000|Overall Study|Withdrawal by Subject|0|||
33359348|NCT00805467|62737005|FG001|Overall Study|Withdrawal by Subject|6|||
33359349|NCT00805467|62737006|FG002|Overall Study|Withdrawal by Subject|45|||
33359350|NCT00805467|62737007|FG003|Overall Study|Withdrawal by Subject|50|||
33359351|NCT00805467|62737004|FG000|Overall Study|Protocol Violation|0|||
33474552|NCT03435640|62848591|FG001|Overall Study|Lost to Follow-up|0|||
33474553|NCT03435640|62848592|FG002|Overall Study|Lost to Follow-up|1|||
33474554|NCT03435640|62848593|FG003|Overall Study|Lost to Follow-up|0|||
33474555|NCT03435640|62848594|FG004|Overall Study|Lost to Follow-up|0|||
33474556|NCT03435640|62848595|FG005|Overall Study|Lost to Follow-up|0|||
33474557|NCT03435640|62848596|FG006|Overall Study|Lost to Follow-up|0|||
33474558|NCT03435640|62848597|FG007|Overall Study|Lost to Follow-up|0|||
33474559|NCT03435640|62848598|FG008|Overall Study|Lost to Follow-up|0|||
33359352|NCT00805467|62737005|FG001|Overall Study|Protocol Violation|3|||
33359353|NCT00805467|62737006|FG002|Overall Study|Protocol Violation|0|||
33474560|NCT03435640|62848599|FG009|Overall Study|Lost to Follow-up|0|||
33474561|NCT03435640|62848600|FG010|Overall Study|Lost to Follow-up|0|||
33474562|NCT00655876|62848628|FG000|Overall Study|Protocol Violation|9|||
33474563|NCT00655876|62848629|FG001|Overall Study|Protocol Violation|7|||
33474564|NCT03092752|62848635|FG000|Overall Study|Aged <40 years|14209|||
33474565|NCT03092752|62848635|FG000|Overall Study|At least one claim with T2DM|61299|||
33474566|NCT03092752|62848635|FG000|Overall Study|Having no claim of study drugs|29282|||
33474567|NCT03092752|62848635|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
33474568|NCT03092752|62848635|FG000|Overall Study|<6 month history|245900|||
33474569|NCT03750552|62848658|FG000|Overall Study|Adverse Event|5|||
33474570|NCT03750552|62848659|FG001|Overall Study|Adverse Event|1|||
33474571|NCT03750552|62848658|FG000|Overall Study|Withdrawal by Subject|1|||
33474572|NCT03750552|62848659|FG001|Overall Study|Withdrawal by Subject|1|||
33474573|NCT03750552|62848658|FG000|Overall Study|Other|2|||
33474574|NCT03750552|62848659|FG001|Overall Study|Other|0|||
33474575|NCT03750240|62848666|FG000|Overall Study|Technical Difficulties|2|||
33474576|NCT03091738|62848670|FG000|Overall Study|Adverse Event|1|||
33474577|NCT03091738|62848670|FG000|Overall Study|Lost to Follow-up|1|||
33474578|NCT03193216|62848676|FG000|Overall Study|Lost to Follow-up|1|||
33474579|NCT03193216|62848677|FG001|Overall Study|Lost to Follow-up|0|||
33474580|NCT03193216|62848676|FG000|Overall Study|Withdrawal by Subject|5|||
33474581|NCT03193216|62848677|FG001|Overall Study|Withdrawal by Subject|0|||
33474582|NCT03193216|62848676|FG000|Overall Study|Physician Decision|4|||
33474583|NCT03193216|62848677|FG001|Overall Study|Physician Decision|0|||
33474584|NCT03091348|62848685|FG000|Overall Study|Lost to Follow-up|2|||
33359354|NCT00805467|62737007|FG003|Overall Study|Protocol Violation|5|||
33359355|NCT00805467|62737004|FG000|Overall Study|Adverse Event|0|||
33359356|NCT00805467|62737005|FG001|Overall Study|Adverse Event|13|||
33359357|NCT00805467|62737006|FG002|Overall Study|Adverse Event|26|||
33359358|NCT00805467|62737007|FG003|Overall Study|Adverse Event|57|||
33359359|NCT00805467|62737004|FG000|Overall Study|Death|0|||
33359360|NCT00805467|62737005|FG001|Overall Study|Death|2|||
33359361|NCT00805467|62737006|FG002|Overall Study|Death|7|||
33359362|NCT00805467|62737007|FG003|Overall Study|Death|5|||
33359363|NCT00805467|62737004|FG000|Overall Study|Physician Decision|0|||
33359364|NCT00805467|62737005|FG001|Overall Study|Physician Decision|1|||
33359365|NCT00805467|62737006|FG002|Overall Study|Physician Decision|2|||
33359366|NCT00805467|62737007|FG003|Overall Study|Physician Decision|6|||
33359367|NCT00805467|62737004|FG000|Overall Study|Not reported|0|||
33359368|NCT00805467|62737005|FG001|Overall Study|Not reported|0|||
33359369|NCT00805467|62737006|FG002|Overall Study|Not reported|3|||
33359370|NCT00805467|62737007|FG003|Overall Study|Not reported|7|||
33359371|NCT00958841|62737017|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33474585|NCT03091348|62848686|FG001|Overall Study|Lost to Follow-up|1|||
33474586|NCT03751098|62848693|FG000|Overall Study|Withdrawal by Subject|0|||
33474587|NCT03751098|62848694|FG001|Overall Study|Withdrawal by Subject|1|||
33474588|NCT03751020|62848705|FG000|Overall Study|Withdrawal by Subject|2|||
33474589|NCT03751020|62848706|FG001|Overall Study|Withdrawal by Subject|0|||
33310216|NCT00963235|62685608|FG000|Overall Study|Other|1|||
33359372|NCT00958841|62737017|FG000|Overall Study|Abnormal test procedure result(s)|3|||
33359373|NCT00958841|62737017|FG000|Overall Study|Administrative problems|1|||
33359374|NCT00958841|62737017|FG000|Overall Study|Adverse Event|8|||
33474590|NCT03751020|62848707|FG002|Overall Study|Withdrawal by Subject|0|||
33474591|NCT03751020|62848705|FG000|Overall Study|Lost to Follow-up|7|||
33474592|NCT03751020|62848706|FG001|Overall Study|Lost to Follow-up|4|||
33474593|NCT03751020|62848707|FG002|Overall Study|Lost to Follow-up|10|||
33474594|NCT03090100|62848717|FG000|Overall Study|Adverse Event|9|||
33474595|NCT03090100|62848718|FG001|Overall Study|Adverse Event|11|||
33474596|NCT03090100|62848717|FG000|Overall Study|Pregnancy|1|||
33474597|NCT03090100|62848718|FG001|Overall Study|Pregnancy|1|||
33359375|NCT00958841|62737017|FG000|Overall Study|New cancer therapy|5|||
33359376|NCT00958841|62737017|FG000|Overall Study|Withdrawal by Subject|1|||
33359377|NCT00958841|62737017|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
33359378|NCT00958841|62737017|FG000|Overall Study|Completed M6/did not enter extension|27|||
33474598|NCT03090100|62848717|FG000|Overall Study|Lack of Efficacy|2|||
33474599|NCT03090100|62848718|FG001|Overall Study|Lack of Efficacy|7|||
33474600|NCT03090100|62848717|FG000|Overall Study|Lost to Follow-up|2|||
33474601|NCT03090100|62848718|FG001|Overall Study|Lost to Follow-up|2|||
33474602|NCT03090100|62848717|FG000|Overall Study|Withdrawal by Subject|7|||
33474603|NCT03090100|62848718|FG001|Overall Study|Withdrawal by Subject|19|||
33474604|NCT03090100|62848717|FG000|Overall Study|Protocol Violation|2|||
33474605|NCT03090100|62848718|FG001|Overall Study|Protocol Violation|6|||
33474606|NCT03090100|62848717|FG000|Overall Study|Non-compliance|2|||
33474607|NCT03090100|62848718|FG001|Overall Study|Non-compliance|0|||
33474608|NCT03090100|62848717|FG000|Overall Study|Other|2|||
33474609|NCT03090100|62848718|FG001|Overall Study|Other|2|||
33474610|NCT03089944|62848724|FG000|Overall Study|Lost to Follow-up|8|||
33474611|NCT03089944|62848724|FG000|Overall Study|Withdrew Consent|2|||
33359379|NCT00958841|62737017|FG000|Overall Study|Discontinued prior to M*|28|||
33359380|NCT03927105|62737080|FG000|Overall Study|Death|1|||
33359381|NCT03927105|62737080|FG000|Overall Study|In observation for potential re-treatment|2|||
33359382|NCT03927105|62737080|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
33359383|NCT00613327|62737084|FG000|Overall Study|Adverse Event|38|||
33359384|NCT00613327|62737084|FG000|Overall Study|Lost to Follow-up|8|||
33359385|NCT00613327|62737084|FG000|Overall Study|Withdrawal by Subject|6|||
33359386|NCT00613327|62737084|FG000|Overall Study|Protocol Violation|2|||
33359387|NCT00613327|62737084|FG000|Overall Study|Other|47|||
33359388|NCT00954941|62737090|FG000|Overall Study|Received treatment at home|1|||
33359389|NCT00954941|62737091|FG001|Overall Study|Received treatment at home|0|||
33359390|NCT00954941|62737090|FG000|Overall Study|Withdrawal by Subject|1|||
33359391|NCT00954941|62737091|FG001|Overall Study|Withdrawal by Subject|0|||
33359392|NCT00954941|62737090|FG000|Overall Study|Insurance Denial|2|||
33359393|NCT00954941|62737091|FG001|Overall Study|Insurance Denial|2|||
33359394|NCT00954941|62737090|FG000|Overall Study|Physician Decision|2|||
33359395|NCT00954941|62737091|FG001|Overall Study|Physician Decision|2|||
33359396|NCT00954941|62737090|FG000|Overall Study|Ineligible|2|||
33359397|NCT00954941|62737091|FG001|Overall Study|Ineligible|2|||
33359398|NCT00954941|62737090|FG000|Overall Study|Adverse Event|0|||
33359399|NCT00954941|62737091|FG001|Overall Study|Adverse Event|1|||
33359400|NCT00954707|62737097|FG000|Overall Study|Death|34|||
33359401|NCT00954707|62737097|FG000|Overall Study|Withdrawal by Subject|100|||
33359402|NCT00954707|62737097|FG000|Overall Study|Lost to Follow-up|33|||
33359403|NCT00589797|62737103|FG000|Overall Study|Death|1|||
33359404|NCT00589797|62737104|FG001|Overall Study|Death|0|||
33359405|NCT00589797|62737103|FG000|Overall Study|Lost to Follow-up|12|||
33359406|NCT00589797|62737104|FG001|Overall Study|Lost to Follow-up|9|||
33359407|NCT00589797|62737103|FG000|Overall Study|Physician Decision|8|||
33359408|NCT00589797|62737104|FG001|Overall Study|Physician Decision|3|||
33359409|NCT00589797|62737103|FG000|Overall Study|Withdrawal by Subject|6|||
33359410|NCT00589797|62737104|FG001|Overall Study|Withdrawal by Subject|5|||
33359411|NCT00589797|62737103|FG000|Overall Study|Non-Randomized Training Subjects|46|||
33359412|NCT00589797|62737104|FG001|Overall Study|Non-Randomized Training Subjects|6|||
33359413|NCT00613171|62737110|FG000|Overall Study|Adverse Event|7|||
33359414|NCT00613171|62737110|FG000|Overall Study|Withdrawal by Subject|3|||
33359415|NCT00613171|62737110|FG000|Overall Study|Reason not Specified|4|||
33359416|NCT00896480|62737115|FG000|Overall Study|Disease progression/recurrence|21|||
33359417|NCT00953225|62737124|FG000|Overall Study|Withdrawal by Subject|2|||
33359418|NCT00953225|62737125|FG001|Overall Study|Withdrawal by Subject|0|||
33359419|NCT00613015|62737137|FG000|Overall Study|Lost to Follow-up|0|||
33359420|NCT00613015|62737138|FG001|Overall Study|Lost to Follow-up|1|||
33359421|NCT00613015|62737139|FG002|Overall Study|Lost to Follow-up|3|||
33359422|NCT00613015|62737140|FG003|Overall Study|Lost to Follow-up|3|||
33359423|NCT00613015|62737141|FG004|Overall Study|Lost to Follow-up|2|||
33359424|NCT00613015|62737142|FG005|Overall Study|Lost to Follow-up|3|||
33359425|NCT00803595|62737159|FG000|Overall Study|Adverse Event|3|||
33359426|NCT00803595|62737160|FG001|Overall Study|Adverse Event|4|||
33359427|NCT00803595|62737161|FG002|Overall Study|Adverse Event|1|||
33359428|NCT00803595|62737159|FG000|Overall Study|Protocol Violation|7|||
33474612|NCT03089944|62848724|FG000|Overall Study|Adverse Event|1|||
33474613|NCT03089944|62848724|FG000|Overall Study|Other|1|||
33474614|NCT03739866|62848747|FG000|Overall Study|Lost to Follow-up|0|||
33474615|NCT03739866|62848748|FG001|Overall Study|Lost to Follow-up|0|||
33474616|NCT03739866|62848749|FG002|Overall Study|Lost to Follow-up|0|||
33474617|NCT03739866|62848750|FG003|Overall Study|Lost to Follow-up|1|||
33474618|NCT03739866|62848751|FG004|Overall Study|Lost to Follow-up|0|||
33474619|NCT03739866|62848752|FG005|Overall Study|Lost to Follow-up|0|||
33474620|NCT03739866|62848753|FG006|Overall Study|Lost to Follow-up|0|||
33359429|NCT00803595|62737160|FG001|Overall Study|Protocol Violation|2|||
33359430|NCT00803595|62737161|FG002|Overall Study|Protocol Violation|12|||
33359431|NCT00803595|62737159|FG000|Overall Study|Withdrawal by Subject|5|||
33359432|NCT00803595|62737160|FG001|Overall Study|Withdrawal by Subject|2|||
33359433|NCT00803595|62737161|FG002|Overall Study|Withdrawal by Subject|3|||
33359434|NCT00953927|62737171|FG000|Overall Study|Lost to Follow-up|61|||
33359435|NCT00953927|62737172|FG001|Overall Study|Lost to Follow-up|65|||
33359436|NCT00953927|62737171|FG000|Overall Study|Withdrawal by Subject|36|||
33474621|NCT03739866|62848754|FG007|Overall Study|Lost to Follow-up|0|||
33359437|NCT00953927|62737172|FG001|Overall Study|Withdrawal by Subject|25|||
33359438|NCT00953927|62737171|FG000|Overall Study|Death|7|||
33359439|NCT00953927|62737172|FG001|Overall Study|Death|4|||
33359440|NCT00953927|62737171|FG000|Overall Study|Other study discontinuation|1|||
33359441|NCT00953927|62737172|FG001|Overall Study|Other study discontinuation|1|||
33359442|NCT00611767|62737180|FG000|Overall Study|Withdrawal by Subject|4|||
33359443|NCT00611767|62737181|FG001|Overall Study|Withdrawal by Subject|1|||
33359444|NCT00611767|62737180|FG000|Overall Study|Thiopental not available|3|||
33359445|NCT00611767|62737181|FG001|Overall Study|Thiopental not available|0|||
33359446|NCT00611767|62737180|FG000|Overall Study|didn't like the medication|1|||
33359447|NCT00611767|62737181|FG001|Overall Study|didn't like the medication|1|||
33359448|NCT00611767|62737180|FG000|Overall Study|Physician Decision|1|||
33359449|NCT00611767|62737181|FG001|Overall Study|Physician Decision|0|||
33359450|NCT00803361|62737189|FG000|Overall Study|Adverse Event|13|||
33359451|NCT00803361|62737190|FG001|Overall Study|Adverse Event|3|||
33359452|NCT00803361|62737189|FG000|Overall Study|Lack of Efficacy|4|||
33359453|NCT00803361|62737190|FG001|Overall Study|Lack of Efficacy|13|||
33359454|NCT00803361|62737189|FG000|Overall Study|Lost to Follow-up|1|||
33359455|NCT00803361|62737190|FG001|Overall Study|Lost to Follow-up|2|||
33359456|NCT00803361|62737189|FG000|Overall Study|Physician Decision|1|||
33359457|NCT00803361|62737190|FG001|Overall Study|Physician Decision|0|||
33359458|NCT00803361|62737189|FG000|Overall Study|Protocol Violation|2|||
33359459|NCT00803361|62737190|FG001|Overall Study|Protocol Violation|4|||
33359460|NCT00803361|62737189|FG000|Overall Study|Withdrawal by Subject|5|||
33359461|NCT00803361|62737190|FG001|Overall Study|Withdrawal by Subject|6|||
33359462|NCT00611533|62737196|FG000|First Intervention (6 Weeks)|Never started study|0|||
33359463|NCT00611533|62737197|FG001|First Intervention (6 Weeks)|Never started study|1|||
33359464|NCT00611533|62737196|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
33359465|NCT00611533|62737197|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
33359466|NCT00611533|62737196|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
33359467|NCT00611533|62737197|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
33359468|NCT00953147|62737216|FG000|Overall Study|Adverse Event|8|||
33359469|NCT00953147|62737217|FG001|Overall Study|Adverse Event|16|||
33359470|NCT00953147|62737218|FG002|Overall Study|Adverse Event|6|||
33359471|NCT00953147|62737216|FG000|Overall Study|Protocol Violation|2|||
33359472|NCT00953147|62737217|FG001|Overall Study|Protocol Violation|8|||
33359473|NCT00953147|62737218|FG002|Overall Study|Protocol Violation|4|||
33359474|NCT00953147|62737216|FG000|Overall Study|Withdrawal by Subject|13|||
33359475|NCT00953147|62737217|FG001|Overall Study|Withdrawal by Subject|15|||
33359476|NCT00953147|62737218|FG002|Overall Study|Withdrawal by Subject|12|||
33359477|NCT00953147|62737216|FG000|Overall Study|Lost to Follow-up|8|||
33359478|NCT00953147|62737217|FG001|Overall Study|Lost to Follow-up|9|||
33359479|NCT00953147|62737218|FG002|Overall Study|Lost to Follow-up|4|||
33359480|NCT00953147|62737216|FG000|Overall Study|Physician Decision|2|||
33359481|NCT00953147|62737217|FG001|Overall Study|Physician Decision|7|||
33359482|NCT00953147|62737218|FG002|Overall Study|Physician Decision|3|||
33359483|NCT00953147|62737216|FG000|Overall Study|Other|4|||
33359484|NCT00953147|62737217|FG001|Overall Study|Other|11|||
33359485|NCT00953147|62737218|FG002|Overall Study|Other|13|||
33359486|NCT00803205|62737228|FG000|Overall Study|Adverse Event|7|||
33359487|NCT00803205|62737229|FG001|Overall Study|Adverse Event|2|||
33359488|NCT00803205|62737228|FG000|Overall Study|Lost to Follow-up|1|||
33359489|NCT00803205|62737229|FG001|Overall Study|Lost to Follow-up|0|||
33359490|NCT00803205|62737228|FG000|Overall Study|Withdrawal by Subject|9|||
33359491|NCT00803205|62737229|FG001|Overall Study|Withdrawal by Subject|9|||
33359492|NCT00803205|62737228|FG000|Overall Study|Physician Decision|1|||
33359493|NCT00803205|62737229|FG001|Overall Study|Physician Decision|0|||
33359494|NCT00803205|62737228|FG000|Overall Study|Protocol Violation|1|||
33359495|NCT00803205|62737229|FG001|Overall Study|Protocol Violation|1|||
33359496|NCT00803205|62737228|FG000|Overall Study|Medical Monitor Decision|1|||
33359497|NCT00803205|62737229|FG001|Overall Study|Medical Monitor Decision|0|||
33359498|NCT00803205|62737228|FG000|Overall Study|Acquired a Lung Infection|0|||
33359499|NCT00803205|62737229|FG001|Overall Study|Acquired a Lung Infection|1|||
33359500|NCT00803205|62737228|FG000|Overall Study|Sponsor Decision|0|||
33359501|NCT00803205|62737229|FG001|Overall Study|Sponsor Decision|1|||
33359502|NCT00952523|62737235|FG000|Overall Study|Withdrawal by Subject|7|||
33359503|NCT02232737|62737244|FG000|Overall Study|Lost to Follow-up|18|||
33359504|NCT02232737|62737245|FG001|Overall Study|Lost to Follow-up|28|||
33359505|NCT02232737|62737246|FG002|Overall Study|Lost to Follow-up|33|||
33359506|NCT02232737|62737244|FG000|Overall Study|Personal reasons|7|||
33359507|NCT02232737|62737245|FG001|Overall Study|Personal reasons|8|||
33359508|NCT02232737|62737246|FG002|Overall Study|Personal reasons|14|||
33359509|NCT02232737|62737244|FG000|Overall Study|Adverse Event|6|||
33359510|NCT02232737|62737245|FG001|Overall Study|Adverse Event|3|||
33359511|NCT02232737|62737246|FG002|Overall Study|Adverse Event|8|||
33359512|NCT02232737|62737244|FG000|Overall Study|Incarcerated|2|||
33359513|NCT02232737|62737245|FG001|Overall Study|Incarcerated|1|||
33359514|NCT02232737|62737246|FG002|Overall Study|Incarcerated|2|||
33359515|NCT02232737|62737244|FG000|Overall Study|Withdrawal by Subject|0|||
33359516|NCT02232737|62737245|FG001|Overall Study|Withdrawal by Subject|1|||
33359517|NCT02232737|62737246|FG002|Overall Study|Withdrawal by Subject|2|||
33359518|NCT02232737|62737244|FG000|Overall Study|Death|0|||
33359519|NCT02232737|62737245|FG001|Overall Study|Death|1|||
33359520|NCT02232737|62737246|FG002|Overall Study|Death|1|||
33359521|NCT02232737|62737244|FG000|Overall Study|Physician Decision|1|||
33359522|NCT02232737|62737245|FG001|Overall Study|Physician Decision|3|||
33359523|NCT02232737|62737246|FG002|Overall Study|Physician Decision|1|||
33359524|NCT02232737|62737244|FG000|Overall Study|Protocol Violation|1|||
33359525|NCT02232737|62737245|FG001|Overall Study|Protocol Violation|0|||
33359526|NCT02232737|62737246|FG002|Overall Study|Protocol Violation|1|||
33359527|NCT02232737|62737244|FG000|Overall Study|Reason unknown|1|||
33359528|NCT02232737|62737245|FG001|Overall Study|Reason unknown|0|||
33359529|NCT02232737|62737246|FG002|Overall Study|Reason unknown|0|||
33359530|NCT00952367|62737254|FG000|Overall Study|Withdrawal by Subject|2|||
33359531|NCT00952367|62737254|FG000|Overall Study|Noncoordination|1|||
33359532|NCT00952367|62737254|FG000|Overall Study|Protocol Violation|3|||
33549367|NCT02477800|62940540|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
33655544|NCT00636207|63071068|FG004|Overall Study|Adverse Event|0|||
33359533|NCT00948857|62737260|FG000|Overall Study|Lost to Follow-up|1|||
33359534|NCT00948857|62737261|FG001|Overall Study|Lost to Follow-up|0|||
33359535|NCT00948389|62737276|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
33359536|NCT00948389|62737277|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
33359537|NCT00948389|62737278|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
33359538|NCT00948389|62737279|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
33359539|NCT00948389|62737280|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
33359540|NCT00948389|62737276|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
33359541|NCT00948389|62737277|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
33359542|NCT00948389|62737278|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
33359543|NCT00948389|62737279|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
33359544|NCT00948389|62737280|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
33359545|NCT00948389|62737276|FG000|Overall Study|Both Progression and Toxicity|1|||
33359546|NCT00948389|62737277|FG001|Overall Study|Both Progression and Toxicity|0|||
33359547|NCT00948389|62737278|FG002|Overall Study|Both Progression and Toxicity|0|||
33359548|NCT00948389|62737279|FG003|Overall Study|Both Progression and Toxicity|0|||
33359549|NCT00948389|62737280|FG004|Overall Study|Both Progression and Toxicity|0|||
33359550|NCT00948155|62737296|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
33359551|NCT00948155|62737297|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
33359552|NCT00948155|62737296|FG000|Washout 14 Days|Lost to Follow-up|1|||
33359553|NCT00948155|62737297|FG001|Washout 14 Days|Lost to Follow-up|2|||
33359554|NCT00958217|62737307|FG000|Overall Study|Death|2|||
33359555|NCT00958217|62737308|FG001|Overall Study|Death|1|||
33359556|NCT00958217|62737307|FG000|Overall Study|Withdrawal by Subject|4|||
33359557|NCT00958217|62737308|FG001|Overall Study|Withdrawal by Subject|3|||
33359558|NCT00958217|62737307|FG000|Overall Study|Lost to Follow-up|17|||
33359559|NCT00958217|62737308|FG001|Overall Study|Lost to Follow-up|19|||
33359560|NCT00958217|62737307|FG000|Overall Study|Moved out of area|1|||
33359561|NCT00958217|62737308|FG001|Overall Study|Moved out of area|1|||
33359562|NCT00958217|62737307|FG000|Overall Study|Inpatient hospitalization|0|||
33359563|NCT00958217|62737308|FG001|Overall Study|Inpatient hospitalization|1|||
33359564|NCT00891020|62737318|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
33359565|NCT00891020|62737319|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
33359566|NCT00891020|62737320|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
33359567|NCT00891020|62737318|FG000|24 Week Treatment Period|Death|0|||
33359568|NCT00891020|62737319|FG001|24 Week Treatment Period|Death|2|||
33359569|NCT00891020|62737320|FG002|24 Week Treatment Period|Death|0|||
33359570|NCT00891020|62737318|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
33359571|NCT00891020|62737319|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
33359572|NCT00891020|62737320|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
33359573|NCT00891020|62737318|FG000|24 Week Treatment Period|Failure to return|4|||
33359574|NCT00891020|62737319|FG001|24 Week Treatment Period|Failure to return|5|||
33359575|NCT00891020|62737320|FG002|24 Week Treatment Period|Failure to return|5|||
33359576|NCT00891020|62737318|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
33359577|NCT00891020|62737319|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
33359578|NCT00891020|62737320|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
33359579|NCT00891020|62737318|FG000|24 Week Treatment Period|Other protocol violation|1|||
33359580|NCT00891020|62737319|FG001|24 Week Treatment Period|Other protocol violation|1|||
33359581|NCT00891020|62737320|FG002|24 Week Treatment Period|Other protocol violation|2|||
33359582|NCT00891020|62737318|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
33359583|NCT00891020|62737319|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
33655545|NCT00636207|63071069|FG005|Overall Study|Adverse Event|0|||
33359584|NCT00891020|62737320|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
33359585|NCT00891020|62737318|FG000|24 Week Treatment Period|Withdrew consent|6|||
33655546|NCT00636207|63071070|FG006|Overall Study|Adverse Event|0|||
33359586|NCT00891020|62737319|FG001|24 Week Treatment Period|Withdrew consent|3|||
33359587|NCT00891020|62737320|FG002|24 Week Treatment Period|Withdrew consent|15|||
33359588|NCT00891020|62737318|FG000|24 Week Treatment Period|Administrative/Other|5|||
33359589|NCT00891020|62737319|FG001|24 Week Treatment Period|Administrative/Other|6|||
33474622|NCT03739866|62848747|FG000|Overall Study|Enrolled but not treated|0|||
33474623|NCT03739866|62848748|FG001|Overall Study|Enrolled but not treated|0|||
33359590|NCT00891020|62737320|FG002|24 Week Treatment Period|Administrative/Other|1|||
33359591|NCT00891020|62737318|FG000|Long-term Extension Period|Adverse Event|1|||
33359592|NCT00891020|62737319|FG001|Long-term Extension Period|Adverse Event|11|||
33359593|NCT00891020|62737320|FG002|Long-term Extension Period|Adverse Event|10|||
33359594|NCT00891020|62737318|FG000|Long-term Extension Period|Death|0|||
33359595|NCT00891020|62737319|FG001|Long-term Extension Period|Death|0|||
33359596|NCT00891020|62737320|FG002|Long-term Extension Period|Death|1|||
33359597|NCT00891020|62737318|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
33359598|NCT00891020|62737319|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
33359599|NCT00891020|62737320|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
33359600|NCT00891020|62737318|FG000|Long-term Extension Period|Protocol Violation|0|||
33359601|NCT00891020|62737319|FG001|Long-term Extension Period|Protocol Violation|1|||
33474624|NCT03739866|62848749|FG002|Overall Study|Enrolled but not treated|1|||
33474625|NCT03739866|62848750|FG003|Overall Study|Enrolled but not treated|0|||
33474626|NCT03739866|62848751|FG004|Overall Study|Enrolled but not treated|1|||
33474627|NCT03739866|62848752|FG005|Overall Study|Enrolled but not treated|0|||
33474628|NCT03739866|62848753|FG006|Overall Study|Enrolled but not treated|0|||
33474629|NCT03739866|62848754|FG007|Overall Study|Enrolled but not treated|0|||
33474630|NCT03739242|62848778|FG000|Overall Study|Withdrawal by Subject|1|||
33474631|NCT03739242|62848779|FG001|Overall Study|Withdrawal by Subject|1|||
33474632|NCT03739242|62848778|FG000|Overall Study|Protocol Violation|0|||
33474633|NCT03739242|62848779|FG001|Overall Study|Protocol Violation|1|||
33474634|NCT02849626|62848836|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
33474635|NCT02849626|62848837|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
33474636|NCT02849626|62848838|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
33474637|NCT02849626|62848839|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
33474638|NCT02849626|62848836|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
33474639|NCT02849626|62848837|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
33474640|NCT02849626|62848838|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
33474641|NCT02849626|62848839|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
33474642|NCT02849626|62848836|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
33474643|NCT02849626|62848837|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
33474644|NCT02849626|62848838|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
33474645|NCT02849626|62848839|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
33359602|NCT00891020|62737320|FG002|Long-term Extension Period|Protocol Violation|1|||
33359603|NCT00891020|62737318|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
33359604|NCT00891020|62737319|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
33359605|NCT00891020|62737320|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
33359606|NCT00891020|62737318|FG000|Long-term Extension Period|Failure to return|0|||
33359607|NCT00891020|62737319|FG001|Long-term Extension Period|Failure to return|2|||
33359608|NCT00891020|62737320|FG002|Long-term Extension Period|Failure to return|3|||
33359609|NCT00891020|62737318|FG000|Long-term Extension Period|Administrative|1|||
33359610|NCT00891020|62737319|FG001|Long-term Extension Period|Administrative|2|||
33474646|NCT02849626|62848836|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
33474647|NCT02849626|62848837|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
33474648|NCT02849626|62848838|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
33549368|NCT02477800|62940541|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33549369|NCT02477800|62940542|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33549370|NCT02477800|62940543|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33549371|NCT02477800|62940544|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33549372|NCT02477800|62940538|FG000|Placebo-Controlled Period|Reason not Specified|161|||
33549373|NCT02477800|62940539|FG001|Placebo-Controlled Period|Reason not Specified|161|||
33549374|NCT02477800|62940540|FG002|Placebo-Controlled Period|Reason not Specified|189|||
33359611|NCT00891020|62737320|FG002|Long-term Extension Period|Administrative|2|||
33549375|NCT02477800|62940541|FG003|Placebo-Controlled Period|Reason not Specified|0|||
33359612|NCT00611455|62737332|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
33359613|NCT00611455|62737333|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
33359614|NCT00611455|62737334|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
33359615|NCT00611455|62737332|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
33359616|NCT00611455|62737333|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
33474649|NCT02849626|62848839|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
33474650|NCT02849626|62848836|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
33474651|NCT02849626|62848837|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
33474652|NCT02849626|62848838|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
33474653|NCT02849626|62848839|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
33359617|NCT00611455|62737334|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
33359618|NCT00611455|62737332|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
33359619|NCT00611455|62737333|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
33359620|NCT00611455|62737334|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
33474654|NCT02849626|62848836|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
33474655|NCT02849626|62848837|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
33474656|NCT02849626|62848838|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
33359621|NCT00611455|62737332|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
33359622|NCT00611455|62737333|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
33359623|NCT00611455|62737334|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33359624|NCT00611455|62737332|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
33359625|NCT00611455|62737333|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
33359626|NCT00611455|62737334|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
33359627|NCT00611455|62737332|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
33359628|NCT00611455|62737333|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
33359629|NCT00611455|62737334|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
33359630|NCT00611455|62737332|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
33359631|NCT00611455|62737333|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
33359632|NCT00611455|62737334|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
33359633|NCT00611455|62737332|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
33359634|NCT00611455|62737333|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
33359635|NCT00611455|62737334|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
33359636|NCT00611455|62737332|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
33359637|NCT00611455|62737333|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
33359638|NCT00611455|62737334|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
33359639|NCT00611455|62737332|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
33359640|NCT00611455|62737333|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
33359641|NCT00611455|62737334|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
33359642|NCT00611455|62737332|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
33359643|NCT00611455|62737333|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
33359644|NCT00611455|62737334|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
33359645|NCT00611455|62737332|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
33359646|NCT00611455|62737333|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
33359647|NCT00611455|62737334|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
33359648|NCT00611455|62737332|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
33359649|NCT00611455|62737333|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
33359650|NCT00611455|62737334|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
33359651|NCT00611455|62737332|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
33359652|NCT00611455|62737333|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
33359653|NCT00611455|62737334|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
33359654|NCT00611455|62737332|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
33359655|NCT00611455|62737333|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
33359656|NCT00611455|62737334|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
33359657|NCT00611455|62737332|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
33359658|NCT00611455|62737333|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
33359659|NCT00611455|62737334|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
33359660|NCT00611455|62737332|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
33359661|NCT00611455|62737333|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
33359662|NCT00611455|62737334|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
33359663|NCT00611455|62737332|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
33359664|NCT00611455|62737333|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
33359665|NCT00611455|62737334|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
33359666|NCT00611455|62737332|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
33359667|NCT00611455|62737333|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
33359668|NCT00611455|62737334|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
33359669|NCT00611455|62737332|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
33359670|NCT00611455|62737333|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
33359671|NCT00611455|62737334|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
33359672|NCT00611455|62737332|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
33474657|NCT02849626|62848839|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
33474658|NCT02849626|62848836|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
33359673|NCT00611455|62737333|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
33359674|NCT00611455|62737334|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
33474659|NCT02849626|62848837|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
33359675|NCT00952289|62737346|FG000|All Participants|Death|9|||
33359676|NCT00952289|62737347|FG001|All Participants|Death|9|||
33359677|NCT00952289|62737346|FG000|All Participants|Adverse Event|8|||
33359678|NCT00952289|62737347|FG001|All Participants|Adverse Event|8|||
33359679|NCT00952289|62737346|FG000|All Participants|Disease progression|3|||
33359680|NCT00952289|62737347|FG001|All Participants|Disease progression|12|||
33359681|NCT00952289|62737346|FG000|All Participants|Withdrawal by Subject|1|||
33359682|NCT00952289|62737347|FG001|All Participants|Withdrawal by Subject|10|||
33359683|NCT00952289|62737346|FG000|All Participants|Data lost during site relocation|0|||
33359684|NCT00952289|62737347|FG001|All Participants|Data lost during site relocation|1|||
33359685|NCT00952289|62737346|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
33359686|NCT00952289|62737347|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
33359687|NCT00952289|62737346|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
33359688|NCT00952289|62737347|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
33359689|NCT00952289|62737346|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
33359690|NCT00952289|62737347|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
33359691|NCT00952289|62737346|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
33359692|NCT00952289|62737347|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
33359693|NCT00952289|62737346|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
33359694|NCT00952289|62737347|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
33359695|NCT00947531|62737355|FG000|Overall Study|Withdrawal by Subject|10|||
33359696|NCT00947531|62737356|FG001|Overall Study|Withdrawal by Subject|7|||
33359697|NCT00947531|62737355|FG000|Overall Study|Administrative Reason|0|||
33359698|NCT00947531|62737356|FG001|Overall Study|Administrative Reason|1|||
33359699|NCT00947531|62737355|FG000|Overall Study|Adverse Event|2|||
33359700|NCT00947531|62737356|FG001|Overall Study|Adverse Event|2|||
33359701|NCT00947531|62737355|FG000|Overall Study|Lack of Efficacy|1|||
33359702|NCT00947531|62737356|FG001|Overall Study|Lack of Efficacy|0|||
33359703|NCT00947531|62737355|FG000|Overall Study|Other|1|||
33359704|NCT00947531|62737356|FG001|Overall Study|Other|1|||
33359705|NCT00612313|62737364|FG000|Overall Study|Withdrawal by Subject|6|||
33359706|NCT00612313|62737365|FG001|Overall Study|Withdrawal by Subject|9|||
33359707|NCT00612313|62737364|FG000|Overall Study|Lost to Follow-up|11|||
33359708|NCT00612313|62737365|FG001|Overall Study|Lost to Follow-up|4|||
33359709|NCT00890552|62737377|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
33359710|NCT00890552|62737377|FG000|On-treatment|Early prog disease/ death|10|||
33359711|NCT00946985|62737381|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
33359712|NCT00946985|62737381|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
33359713|NCT00946985|62737381|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
33359714|NCT00946985|62737381|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
33359715|NCT00946985|62737381|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
33359716|NCT00946985|62737381|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
33359717|NCT00946985|62737381|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
33359718|NCT00946985|62737381|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
33359719|NCT00946985|62737381|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
33359720|NCT00611923|62737387|FG000|Overall Study|Withdrawal by Subject|2|||
33359721|NCT00611923|62737388|FG001|Overall Study|Withdrawal by Subject|2|||
33359722|NCT00609973|62737398|FG000|Overall Study|Adverse Event|2|||
33359723|NCT00609973|62737399|FG001|Overall Study|Adverse Event|1|||
33359724|NCT00609973|62737398|FG000|Overall Study|Protocol Violation|4|||
33359725|NCT00609973|62737399|FG001|Overall Study|Protocol Violation|3|||
33359726|NCT00609973|62737398|FG000|Overall Study|Lost to Follow-up|2|||
33359727|NCT00609973|62737399|FG001|Overall Study|Lost to Follow-up|1|||
33359728|NCT00609973|62737398|FG000|Overall Study|Withdrawal by Subject|0|||
33359729|NCT00609973|62737399|FG001|Overall Study|Withdrawal by Subject|1|||
33359730|NCT00803049|62737409|FG000|Overall Study|Adverse Event|21|||
33359731|NCT00803049|62737410|FG001|Overall Study|Adverse Event|33|||
33359732|NCT00803049|62737411|FG002|Overall Study|Adverse Event|13|||
33359733|NCT00803049|62737412|FG003|Overall Study|Adverse Event|27|||
33359734|NCT00803049|62737409|FG000|Overall Study|Lack of Efficacy|10|||
33474660|NCT02849626|62848838|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
33474661|NCT02849626|62848839|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
33474662|NCT02849626|62848836|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
33474663|NCT02849626|62848837|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
33359735|NCT00803049|62737410|FG001|Overall Study|Lack of Efficacy|19|||
33359736|NCT00803049|62737411|FG002|Overall Study|Lack of Efficacy|6|||
33359737|NCT00803049|62737412|FG003|Overall Study|Lack of Efficacy|13|||
33359738|NCT00803049|62737409|FG000|Overall Study|Lost to Follow-up|0|||
33359739|NCT00803049|62737410|FG001|Overall Study|Lost to Follow-up|2|||
33359740|NCT00803049|62737411|FG002|Overall Study|Lost to Follow-up|0|||
33359741|NCT00803049|62737412|FG003|Overall Study|Lost to Follow-up|3|||
33359742|NCT00803049|62737409|FG000|Overall Study|Death|2|||
33359743|NCT00803049|62737410|FG001|Overall Study|Death|1|||
33359744|NCT00803049|62737411|FG002|Overall Study|Death|0|||
33359745|NCT00803049|62737412|FG003|Overall Study|Death|2|||
33359746|NCT00803049|62737409|FG000|Overall Study|Progressive Disease|6|||
33359747|NCT00803049|62737410|FG001|Overall Study|Progressive Disease|10|||
33359748|NCT00803049|62737411|FG002|Overall Study|Progressive Disease|6|||
33359749|NCT00803049|62737412|FG003|Overall Study|Progressive Disease|6|||
33359750|NCT00803049|62737409|FG000|Overall Study|Withdrawal by Subject|19|||
33359751|NCT00803049|62737410|FG001|Overall Study|Withdrawal by Subject|43|||
33359752|NCT00803049|62737411|FG002|Overall Study|Withdrawal by Subject|16|||
33359753|NCT00803049|62737412|FG003|Overall Study|Withdrawal by Subject|44|||
33359754|NCT00803049|62737409|FG000|Overall Study|Protocol Violation|0|||
33359755|NCT00803049|62737410|FG001|Overall Study|Protocol Violation|1|||
33359756|NCT00803049|62737411|FG002|Overall Study|Protocol Violation|1|||
33359757|NCT00803049|62737412|FG003|Overall Study|Protocol Violation|0|||
33359758|NCT00803049|62737409|FG000|Overall Study|Randomized and Not Treated|0|||
33359759|NCT00803049|62737410|FG001|Overall Study|Randomized and Not Treated|0|||
33359760|NCT00803049|62737411|FG002|Overall Study|Randomized and Not Treated|0|||
33359761|NCT00803049|62737412|FG003|Overall Study|Randomized and Not Treated|2|||
33359762|NCT00803049|62737409|FG000|Overall Study|Other than Specified Above|3|||
33359763|NCT00803049|62737410|FG001|Overall Study|Other than Specified Above|9|||
33359764|NCT00803049|62737411|FG002|Overall Study|Other than Specified Above|2|||
33359765|NCT00803049|62737412|FG003|Overall Study|Other than Specified Above|5|||
33359766|NCT00890084|62737422|FG000|Overall Study|Adverse Event|16|||
33359767|NCT00890084|62737422|FG000|Overall Study|Lost to Follow-up|126|||
33359768|NCT00802893|62737435|FG000|Overall Study|study terminated|3|||
33359769|NCT00608569|62737456|FG000|Overall Study|Death|4|||
33359770|NCT00608569|62737457|FG001|Overall Study|Death|3|||
33359771|NCT00608569|62737456|FG000|Overall Study|Lost to Follow-up|4|||
33359772|NCT00608569|62737457|FG001|Overall Study|Lost to Follow-up|5|||
33359773|NCT00608569|62737456|FG000|Overall Study|Withdrawal by Subject|1|||
33359774|NCT00608569|62737457|FG001|Overall Study|Withdrawal by Subject|0|||
33359775|NCT00608569|62737456|FG000|Overall Study|Adverse Event|1|||
33359776|NCT00608569|62737457|FG001|Overall Study|Adverse Event|0|||
33359777|NCT00608569|62737456|FG000|Overall Study|Unable to adhere with study requirements|0|||
33359778|NCT00608569|62737457|FG001|Overall Study|Unable to adhere with study requirements|1|||
33359779|NCT00610675|62737463|FG000|Overall Study|Untreated|4|||
33359780|NCT00610675|62737463|FG000|Overall Study|Adverse Event|67|||
33359781|NCT00610675|62737463|FG000|Overall Study|Insufficient Effect|31|||
33359782|NCT00610675|62737463|FG000|Overall Study|Withdrawal by Subject|28|||
33359783|NCT00610675|62737463|FG000|Overall Study|Reasons unrelated to trial|27|||
33359784|NCT00610675|62737463|FG000|Overall Study|Lack of Compliance|7|||
33359785|NCT00610675|62737463|FG000|Overall Study|Lost to Follow-up|31|||
33359786|NCT00610675|62737463|FG000|Overall Study|Other reason (not specified)|25|||
33359787|NCT00888134|62737467|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
33359788|NCT00888134|62737467|FG000|Follow-up|being followed for long-term survival|1|||
33359789|NCT00573157|62737474|FG000|Overall Study|Adverse Event|3|||
33359790|NCT00573157|62737475|FG001|Overall Study|Adverse Event|1|||
33359791|NCT00573157|62737474|FG000|Overall Study|Other|1|||
33359792|NCT00573157|62737475|FG001|Overall Study|Other|1|||
33359793|NCT00802737|62737484|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
33359794|NCT00802737|62737485|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
33359795|NCT00802737|62737486|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
33359796|NCT00802737|62737484|FG000|Overall Study|Death|6|||
33359797|NCT00802737|62737485|FG001|Overall Study|Death|5|||
33359798|NCT00802737|62737486|FG002|Overall Study|Death|1|||
33359799|NCT00802737|62737484|FG000|Overall Study|Adverse Event|1|||
33359800|NCT00802737|62737485|FG001|Overall Study|Adverse Event|0|||
33359801|NCT00802737|62737486|FG002|Overall Study|Adverse Event|0|||
33359802|NCT00802737|62737484|FG000|Overall Study|Received Prohibited Therapy|1|||
33359803|NCT00802737|62737485|FG001|Overall Study|Received Prohibited Therapy|0|||
33359804|NCT00802737|62737486|FG002|Overall Study|Received Prohibited Therapy|0|||
33359805|NCT00802737|62737484|FG000|Overall Study|Ongoing CLL-Treatment|0|||
33359806|NCT00802737|62737485|FG001|Overall Study|Ongoing CLL-Treatment|1|||
33359807|NCT00802737|62737486|FG002|Overall Study|Ongoing CLL-Treatment|0|||
33359808|NCT00802737|62737484|FG000|Overall Study|Participant too Unwell|0|||
33359809|NCT00802737|62737485|FG001|Overall Study|Participant too Unwell|2|||
33359810|NCT00802737|62737486|FG002|Overall Study|Participant too Unwell|0|||
33359811|NCT00588861|62737497|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
33359812|NCT00588861|62737498|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
33359813|NCT00588861|62737497|FG000|6 Months|Patients did not return for follow-up|98|||
33359814|NCT00588861|62737498|FG001|6 Months|Patients did not return for follow-up|73|||
33359815|NCT00588861|62737497|FG000|1 Year|Patients did not return for follow-up|89|||
33359816|NCT00588861|62737498|FG001|1 Year|Patients did not return for follow-up|82|||
33359817|NCT00588861|62737497|FG000|2 Years|Patients did not return for follow-up|92|||
33359818|NCT00588861|62737498|FG001|2 Years|Patients did not return for follow-up|87|||
33359819|NCT00588861|62737497|FG000|4 Years|Patients did not return for follow-up|91|||
33359820|NCT00588861|62737498|FG001|4 Years|Patients did not return for follow-up|103|||
33359821|NCT00588861|62737497|FG000|6 Years|Patients did not return for follow-up|104|||
33359822|NCT00588861|62737498|FG001|6 Years|Patients did not return for follow-up|109|||
33359823|NCT00588861|62737497|FG000|8 Years|Patients did not return for follow-up|105|||
33359824|NCT00588861|62737498|FG001|8 Years|Patients did not return for follow-up|114|||
33359825|NCT00588861|62737497|FG000|10 Years|Incomplete due to study termination|107|||
33359826|NCT00588861|62737498|FG001|10 Years|Incomplete due to study termination|114|||
33359827|NCT00887978|62737506|FG000|Overall Study|Adverse Event|18|||
33359828|NCT00887978|62737507|FG001|Overall Study|Adverse Event|5|||
33359829|NCT00887978|62737506|FG000|Overall Study|Clinical Worsening|4|||
33359830|NCT00887978|62737507|FG001|Overall Study|Clinical Worsening|4|||
33359831|NCT00887978|62737506|FG000|Overall Study|Death|2|||
33359832|NCT00887978|62737507|FG001|Overall Study|Death|3|||
33359833|NCT00887978|62737506|FG000|Overall Study|Withdrawal by Subject|1|||
33359834|NCT00887978|62737507|FG001|Overall Study|Withdrawal by Subject|2|||
33359835|NCT00887978|62737506|FG000|Overall Study|Lost to Follow-up|0|||
33359836|NCT00887978|62737507|FG001|Overall Study|Lost to Follow-up|1|||
33359837|NCT00608023|62737516|FG000|Overall Study|Withdrawal by Subject|8|||
33359838|NCT00608023|62737517|FG001|Overall Study|Withdrawal by Subject|10|||
33359839|NCT00608023|62737518|FG002|Overall Study|Withdrawal by Subject|7|||
33359840|NCT00608023|62737516|FG000|Overall Study|Adverse Event|1|||
33359841|NCT00608023|62737517|FG001|Overall Study|Adverse Event|4|||
33359842|NCT00608023|62737518|FG002|Overall Study|Adverse Event|5|||
33359843|NCT00608023|62737516|FG000|Overall Study|Lost to Follow-up|2|||
33359844|NCT00608023|62737517|FG001|Overall Study|Lost to Follow-up|2|||
33359845|NCT00608023|62737518|FG002|Overall Study|Lost to Follow-up|1|||
33359846|NCT00608023|62737516|FG000|Overall Study|Protocol Violation|1|||
33359847|NCT00608023|62737517|FG001|Overall Study|Protocol Violation|3|||
33359848|NCT00608023|62737518|FG002|Overall Study|Protocol Violation|1|||
33359849|NCT00608023|62737516|FG000|Overall Study|Unknown reason|0|||
33359850|NCT00608023|62737517|FG001|Overall Study|Unknown reason|3|||
33359851|NCT00608023|62737518|FG002|Overall Study|Unknown reason|0|||
33359852|NCT00802659|62737533|FG000|Overall Study|Physician Decision|0|||
33359853|NCT00802659|62737534|FG001|Overall Study|Physician Decision|1|||
33359854|NCT00802659|62737535|FG002|Overall Study|Physician Decision|0|||
33359855|NCT00802659|62737536|FG003|Overall Study|Physician Decision|0|||
33359856|NCT00607789|62737548|FG000|Overall Study|Adverse Event|3|||
33359857|NCT00607789|62737549|FG001|Overall Study|Adverse Event|0|||
33359858|NCT00607789|62737548|FG000|Overall Study|Lack of Efficacy|0|||
33359859|NCT00607789|62737549|FG001|Overall Study|Lack of Efficacy|1|||
33359860|NCT00607789|62737548|FG000|Overall Study|Inadequate adherence|3|||
33359861|NCT00607789|62737549|FG001|Overall Study|Inadequate adherence|0|||
33359862|NCT00607789|62737548|FG000|Overall Study|Lost to Follow-up|0|||
33359863|NCT00607789|62737549|FG001|Overall Study|Lost to Follow-up|5|||
33359864|NCT00607789|62737548|FG000|Overall Study|Withdrawal by Subject|1|||
33359865|NCT00607789|62737549|FG001|Overall Study|Withdrawal by Subject|0|||
33359866|NCT00887822|62737557|FG000|Overall Study|Insufficient therapeutic response|53|||
33359867|NCT00887822|62737558|FG001|Overall Study|Insufficient therapeutic response|55|||
33359868|NCT00887822|62737557|FG000|Overall Study|Adverse Event|14|||
33359869|NCT00887822|62737558|FG001|Overall Study|Adverse Event|17|||
33359870|NCT00887822|62737557|FG000|Overall Study|Failure to return|11|||
33359871|NCT00887822|62737558|FG001|Overall Study|Failure to return|11|||
33359872|NCT00887822|62737557|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
33359873|NCT00887822|62737558|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
33359874|NCT00887822|62737557|FG000|Overall Study|Administrative/Other than specified|5|||
33359875|NCT00887822|62737558|FG001|Overall Study|Administrative/Other than specified|4|||
33359876|NCT00887822|62737557|FG000|Overall Study|Death|2|||
33359877|NCT00887822|62737558|FG001|Overall Study|Death|3|||
33359878|NCT00887822|62737557|FG000|Overall Study|Protocol Violation|0|||
33359879|NCT00887822|62737558|FG001|Overall Study|Protocol Violation|1|||
33359880|NCT00887822|62737557|FG000|Overall Study|Randomized but not treated|0|||
33359881|NCT00887822|62737558|FG001|Overall Study|Randomized but not treated|1|||
33359882|NCT00951665|62737570|FG000|Phase 1b|Adverse Event|2|||
33359883|NCT00951665|62737571|FG001|Phase 1b|Adverse Event|1|||
33359884|NCT00951665|62737572|FG002|Phase 1b|Adverse Event|0|||
33359885|NCT00951665|62737573|FG003|Phase 1b|Adverse Event|1|||
33359886|NCT00951665|62737574|FG004|Phase 1b|Adverse Event|0|||
33359887|NCT00951665|62737575|FG005|Phase 1b|Adverse Event|0|||
33359888|NCT00951665|62737570|FG000|Phase 1b|Death|1|||
33359889|NCT00951665|62737571|FG001|Phase 1b|Death|0|||
33359890|NCT00951665|62737572|FG002|Phase 1b|Death|2|||
33359891|NCT00951665|62737573|FG003|Phase 1b|Death|0|||
33359892|NCT00951665|62737574|FG004|Phase 1b|Death|0|||
33359893|NCT00951665|62737575|FG005|Phase 1b|Death|0|||
33359894|NCT00951665|62737570|FG000|Phase 1b|Physician Decision|4|||
33359895|NCT00951665|62737571|FG001|Phase 1b|Physician Decision|0|||
33359896|NCT00951665|62737572|FG002|Phase 1b|Physician Decision|1|||
33359897|NCT00951665|62737573|FG003|Phase 1b|Physician Decision|0|||
33359898|NCT00951665|62737574|FG004|Phase 1b|Physician Decision|0|||
33359899|NCT00951665|62737575|FG005|Phase 1b|Physician Decision|0|||
33359900|NCT00951665|62737570|FG000|Phase 1b|Withdrawal by Subject|0|||
33359901|NCT00951665|62737571|FG001|Phase 1b|Withdrawal by Subject|1|||
33359902|NCT00951665|62737572|FG002|Phase 1b|Withdrawal by Subject|0|||
33359903|NCT00951665|62737573|FG003|Phase 1b|Withdrawal by Subject|0|||
33359904|NCT00951665|62737574|FG004|Phase 1b|Withdrawal by Subject|0|||
33359905|NCT00951665|62737575|FG005|Phase 1b|Withdrawal by Subject|0|||
33359906|NCT00951665|62737570|FG000|Phase 1b|Disease Progression|13|||
33359907|NCT00951665|62737571|FG001|Phase 1b|Disease Progression|2|||
33359908|NCT00951665|62737572|FG002|Phase 1b|Disease Progression|14|||
33359909|NCT00951665|62737573|FG003|Phase 1b|Disease Progression|0|||
33359910|NCT00951665|62737574|FG004|Phase 1b|Disease Progression|0|||
33359911|NCT00951665|62737575|FG005|Phase 1b|Disease Progression|0|||
33359912|NCT00951665|62737570|FG000|Phase 1b|Protocol Violation|2|||
33359913|NCT00951665|62737571|FG001|Phase 1b|Protocol Violation|0|||
33359914|NCT00951665|62737572|FG002|Phase 1b|Protocol Violation|0|||
33359915|NCT00951665|62737573|FG003|Phase 1b|Protocol Violation|0|||
33359916|NCT00951665|62737574|FG004|Phase 1b|Protocol Violation|0|||
33359917|NCT00951665|62737575|FG005|Phase 1b|Protocol Violation|0|||
33359918|NCT00951665|62737570|FG000|Phase 2a|Adverse Event|0|||
33359919|NCT00951665|62737571|FG001|Phase 2a|Adverse Event|0|||
33359920|NCT00951665|62737572|FG002|Phase 2a|Adverse Event|0|||
33359921|NCT00951665|62737573|FG003|Phase 2a|Adverse Event|0|||
33359922|NCT00951665|62737574|FG004|Phase 2a|Adverse Event|2|||
33359923|NCT00951665|62737575|FG005|Phase 2a|Adverse Event|0|||
33359924|NCT00951665|62737570|FG000|Phase 2a|Death|0|||
33359925|NCT00951665|62737571|FG001|Phase 2a|Death|0|||
33359926|NCT00951665|62737572|FG002|Phase 2a|Death|0|||
33359927|NCT00951665|62737573|FG003|Phase 2a|Death|0|||
33359928|NCT00951665|62737574|FG004|Phase 2a|Death|1|||
33359929|NCT00951665|62737575|FG005|Phase 2a|Death|1|||
33359930|NCT00951665|62737570|FG000|Phase 2a|Lost to Follow-up|0|||
33359931|NCT00951665|62737571|FG001|Phase 2a|Lost to Follow-up|0|||
33359932|NCT00951665|62737572|FG002|Phase 2a|Lost to Follow-up|0|||
33359933|NCT00951665|62737573|FG003|Phase 2a|Lost to Follow-up|0|||
33359934|NCT00951665|62737574|FG004|Phase 2a|Lost to Follow-up|1|||
33359935|NCT00951665|62737575|FG005|Phase 2a|Lost to Follow-up|0|||
33359936|NCT00951665|62737570|FG000|Phase 2a|Physician Decision|0|||
33359937|NCT00951665|62737571|FG001|Phase 2a|Physician Decision|0|||
33359938|NCT00951665|62737572|FG002|Phase 2a|Physician Decision|0|||
33359939|NCT00951665|62737573|FG003|Phase 2a|Physician Decision|0|||
33359940|NCT00951665|62737574|FG004|Phase 2a|Physician Decision|0|||
33359941|NCT00951665|62737575|FG005|Phase 2a|Physician Decision|1|||
33359942|NCT00951665|62737570|FG000|Phase 2a|Withdrawal by Subject|0|||
33359943|NCT00951665|62737571|FG001|Phase 2a|Withdrawal by Subject|0|||
33359944|NCT00951665|62737572|FG002|Phase 2a|Withdrawal by Subject|0|||
33359945|NCT00951665|62737573|FG003|Phase 2a|Withdrawal by Subject|0|||
33359946|NCT00951665|62737574|FG004|Phase 2a|Withdrawal by Subject|2|||
33359947|NCT00951665|62737575|FG005|Phase 2a|Withdrawal by Subject|0|||
33359948|NCT00951665|62737570|FG000|Phase 2a|Disease Progression|0|||
33359949|NCT00951665|62737571|FG001|Phase 2a|Disease Progression|0|||
33359950|NCT00951665|62737572|FG002|Phase 2a|Disease Progression|0|||
33359951|NCT00951665|62737573|FG003|Phase 2a|Disease Progression|0|||
33359952|NCT00951665|62737574|FG004|Phase 2a|Disease Progression|6|||
33359953|NCT00951665|62737575|FG005|Phase 2a|Disease Progression|5|||
33359954|NCT00801099|62737609|FG000|Overall Study|Lost to Follow-up|101|||
33359955|NCT00887744|62737613|FG000|Overall Study|Adverse Event|3|||
33359956|NCT00887744|62737613|FG000|Overall Study|Death|1|||
33359957|NCT00887744|62737613|FG000|Overall Study|Lost to Follow-up|3|||
33359958|NCT00887744|62737613|FG000|Overall Study|Withdrawal by Subject|18|||
33359959|NCT00887744|62737613|FG000|Overall Study|Various reasons|9|||
33359960|NCT00951509|62737617|FG000|Overall Study|Withdrawal by Subject|2|||
33359961|NCT00610441|62737629|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
33359962|NCT00610441|62737630|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
33359963|NCT00610441|62737631|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
33359964|NCT00610441|62737632|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
33359965|NCT00610441|62737629|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
33359966|NCT00610441|62737630|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
33359967|NCT00610441|62737631|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
33359968|NCT00610441|62737632|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
33359969|NCT00610441|62737629|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
33359970|NCT00610441|62737630|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
33359971|NCT00610441|62737631|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
33359972|NCT00610441|62737632|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
33359973|NCT00610441|62737629|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
33359974|NCT00610441|62737630|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
33359975|NCT00610441|62737631|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
33359976|NCT00610441|62737632|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
33359977|NCT00610441|62737629|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
33359978|NCT00610441|62737630|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
33359979|NCT00610441|62737631|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
33359980|NCT00610441|62737632|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
33359981|NCT00610441|62737629|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
33359982|NCT00610441|62737630|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
33359983|NCT00610441|62737631|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
33474664|NCT02849626|62848838|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
33474665|NCT02849626|62848839|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
33474666|NCT02849626|62848836|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
33474667|NCT02849626|62848837|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
33359984|NCT00610441|62737632|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
33359985|NCT00610441|62737629|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
33359986|NCT00610441|62737630|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
33359987|NCT00610441|62737631|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
33359988|NCT00610441|62737632|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
33359989|NCT00610441|62737629|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
33359990|NCT00610441|62737630|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
33474668|NCT02849626|62848838|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
33474669|NCT02849626|62848839|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
33474670|NCT02849626|62848836|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
33474671|NCT02849626|62848837|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
33474672|NCT02849626|62848838|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
33549376|NCT02477800|62940542|FG004|Placebo-Controlled Period|Reason not Specified|0|||
33549377|NCT02477800|62940543|FG005|Placebo-Controlled Period|Reason not Specified|0|||
33549378|NCT02477800|62940544|FG006|Placebo-Controlled Period|Reason not Specified|0|||
33549379|NCT02477800|62940538|FG000|Long Term Extension Period|Adverse Event|0|||
33549380|NCT02477800|62940539|FG001|Long Term Extension Period|Adverse Event|0|||
33549381|NCT02477800|62940540|FG002|Long Term Extension Period|Adverse Event|0|||
33655547|NCT00636207|63071064|FG000|Overall Study|Withdrawal by Subject|0|||
33655548|NCT00636207|63071065|FG001|Overall Study|Withdrawal by Subject|1|||
33655549|NCT00636207|63071066|FG002|Overall Study|Withdrawal by Subject|0|||
33655550|NCT00636207|63071067|FG003|Overall Study|Withdrawal by Subject|0|||
33655551|NCT00636207|63071068|FG004|Overall Study|Withdrawal by Subject|1|||
33655552|NCT00636207|63071069|FG005|Overall Study|Withdrawal by Subject|0|||
33655553|NCT00636207|63071070|FG006|Overall Study|Withdrawal by Subject|0|||
33655554|NCT00635661|63071091|FG000|Overall Study|Withdrawal by Subject|4|||
33655555|NCT00635427|63071180|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
33655556|NCT00635427|63071181|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
33655557|NCT00635427|63071182|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
33655558|NCT00635427|63071183|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
33549382|NCT02477800|62940541|FG003|Long Term Extension Period|Adverse Event|6|||
33549383|NCT02477800|62940542|FG004|Long Term Extension Period|Adverse Event|2|||
33549384|NCT02477800|62940543|FG005|Long Term Extension Period|Adverse Event|4|||
33549385|NCT02477800|62940544|FG006|Long Term Extension Period|Adverse Event|3|||
33549386|NCT02477800|62940538|FG000|Long Term Extension Period|Death|0|||
33549387|NCT02477800|62940539|FG001|Long Term Extension Period|Death|0|||
33549388|NCT02477800|62940540|FG002|Long Term Extension Period|Death|0|||
33549389|NCT02477800|62940541|FG003|Long Term Extension Period|Death|1|||
33549390|NCT02477800|62940542|FG004|Long Term Extension Period|Death|1|||
33549391|NCT02477800|62940543|FG005|Long Term Extension Period|Death|1|||
33549392|NCT02477800|62940544|FG006|Long Term Extension Period|Death|2|||
33549393|NCT02477800|62940538|FG000|Long Term Extension Period|Consent Withdrawn|0|||
33549394|NCT02477800|62940539|FG001|Long Term Extension Period|Consent Withdrawn|0|||
33549395|NCT02477800|62940540|FG002|Long Term Extension Period|Consent Withdrawn|0|||
33549396|NCT02477800|62940541|FG003|Long Term Extension Period|Consent Withdrawn|10|||
33549397|NCT02477800|62940542|FG004|Long Term Extension Period|Consent Withdrawn|4|||
33549398|NCT02477800|62940543|FG005|Long Term Extension Period|Consent Withdrawn|13|||
33549399|NCT02477800|62940544|FG006|Long Term Extension Period|Consent Withdrawn|16|||
33549400|NCT02477800|62940538|FG000|Long Term Extension Period|Disease Progression|0|||
33549401|NCT02477800|62940539|FG001|Long Term Extension Period|Disease Progression|0|||
33549402|NCT02477800|62940540|FG002|Long Term Extension Period|Disease Progression|0|||
33549403|NCT02477800|62940541|FG003|Long Term Extension Period|Disease Progression|3|||
33549404|NCT02477800|62940542|FG004|Long Term Extension Period|Disease Progression|1|||
33655559|NCT00635427|63071184|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
33655560|NCT00635427|63071180|FG000|Overall Study|Death|0|||
33655561|NCT00635427|63071181|FG001|Overall Study|Death|0|||
33655562|NCT00635427|63071182|FG002|Overall Study|Death|0|||
33359991|NCT00610441|62737631|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
33359992|NCT00610441|62737632|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
33359993|NCT00610441|62737629|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
33359994|NCT00610441|62737630|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
33359995|NCT00610441|62737631|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
33359996|NCT00610441|62737632|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
33359997|NCT00799617|62737646|FG000|Main Testosterone Trial|Randomized in error|1|||
33359998|NCT00799617|62737647|FG001|Main Testosterone Trial|Randomized in error|1|||
33359999|NCT00799617|62737646|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
33360000|NCT00799617|62737647|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
33360001|NCT00799617|62737646|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
33360002|NCT00799617|62737647|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
33360003|NCT00799617|62737646|FG000|Sexual Funtion Trial|No Baseline Data|4|||
33360004|NCT00799617|62737647|FG001|Sexual Funtion Trial|No Baseline Data|7|||
33360005|NCT00799617|62737646|FG000|Physical Function Trial|Lost to Follow-up|6|||
33360006|NCT00799617|62737647|FG001|Physical Function Trial|Lost to Follow-up|11|||
33360007|NCT00799617|62737646|FG000|Vitality Trial|Lost to Follow-up|7|||
33360008|NCT00799617|62737647|FG001|Vitality Trial|Lost to Follow-up|22|||
33360009|NCT00799617|62737646|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
33360010|NCT00799617|62737647|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
33360011|NCT00799617|62737646|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
33360012|NCT00799617|62737647|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
33360013|NCT00799617|62737646|FG000|Bone Trial|Month 12 scan not available|6|||
33360014|NCT00799617|62737647|FG001|Bone Trial|Month 12 scan not available|16|||
33360015|NCT00799617|62737646|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
33360016|NCT00799617|62737647|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
33360017|NCT00799617|62737646|FG000|Anemia Trial|Withdrawal by Subject|3|||
33360018|NCT00799617|62737647|FG001|Anemia Trial|Withdrawal by Subject|3|||
33360019|NCT00607087|62737656|FG000|Overall Study|Withdrawal by Subject|9|||
33360020|NCT00607087|62737657|FG001|Overall Study|Withdrawal by Subject|4|||
33360021|NCT00607087|62737658|FG002|Overall Study|Withdrawal by Subject|4|||
33360022|NCT00607087|62737656|FG000|Overall Study|Adverse Event|3|||
33360023|NCT00607087|62737657|FG001|Overall Study|Adverse Event|2|||
33360024|NCT00607087|62737658|FG002|Overall Study|Adverse Event|3|||
33360025|NCT00607087|62737656|FG000|Overall Study|Other reason|1|||
33360026|NCT00607087|62737657|FG001|Overall Study|Other reason|5|||
33360027|NCT00607087|62737658|FG002|Overall Study|Other reason|2|||
33360028|NCT00607087|62737656|FG000|Overall Study|Poor compliance to protocol|1|||
33360029|NCT00607087|62737657|FG001|Overall Study|Poor compliance to protocol|0|||
33360030|NCT00607087|62737658|FG002|Overall Study|Poor compliance to protocol|1|||
33360031|NCT00607087|62737656|FG000|Overall Study|Lost to Follow-up|1|||
33360032|NCT00607087|62737657|FG001|Overall Study|Lost to Follow-up|0|||
33360033|NCT00607087|62737658|FG002|Overall Study|Lost to Follow-up|0|||
33360034|NCT00607087|62737656|FG000|Period 1|Withdrawal by Subject|7|||
33360035|NCT00607087|62737657|FG001|Period 1|Withdrawal by Subject|2|||
33360036|NCT00607087|62737658|FG002|Period 1|Withdrawal by Subject|3|||
33360037|NCT00607087|62737656|FG000|Period 1|Adverse Event|3|||
33360038|NCT00607087|62737657|FG001|Period 1|Adverse Event|0|||
33360039|NCT00607087|62737658|FG002|Period 1|Adverse Event|0|||
33360040|NCT00607087|62737656|FG000|Period 1|Poor compliance to protocol|1|||
33360041|NCT00607087|62737657|FG001|Period 1|Poor compliance to protocol|0|||
33360042|NCT00607087|62737658|FG002|Period 1|Poor compliance to protocol|0|||
33360043|NCT00607087|62737656|FG000|Period 1|Lost to Follow-up|1|||
33360044|NCT00607087|62737657|FG001|Period 1|Lost to Follow-up|0|||
33360045|NCT00607087|62737658|FG002|Period 1|Lost to Follow-up|0|||
33360046|NCT00607087|62737656|FG000|Period 1|Other reason|0|||
33360047|NCT00607087|62737657|FG001|Period 1|Other reason|4|||
33360048|NCT00607087|62737658|FG002|Period 1|Other reason|2|||
33360049|NCT00607087|62737656|FG000|Period 2|Withdrawal by Subject|0|||
33360050|NCT00607087|62737657|FG001|Period 2|Withdrawal by Subject|1|||
33360051|NCT00607087|62737658|FG002|Period 2|Withdrawal by Subject|1|||
33360052|NCT00607087|62737656|FG000|Period 2|Other reason|1|||
33360053|NCT00607087|62737657|FG001|Period 2|Other reason|1|||
33360054|NCT00607087|62737658|FG002|Period 2|Other reason|0|||
33360055|NCT00607087|62737656|FG000|Period 2|Adverse Event|0|||
33360056|NCT00607087|62737657|FG001|Period 2|Adverse Event|1|||
33360057|NCT00607087|62737658|FG002|Period 2|Adverse Event|3|||
33360058|NCT00607087|62737656|FG000|Period 2|Poor compliance to protocol|0|||
33360059|NCT00607087|62737657|FG001|Period 2|Poor compliance to protocol|0|||
33360060|NCT00607087|62737658|FG002|Period 2|Poor compliance to protocol|1|||
33360061|NCT00607087|62737656|FG000|Period 3|Withdrawal by Subject|2|||
33360062|NCT00607087|62737657|FG001|Period 3|Withdrawal by Subject|1|||
33360063|NCT00607087|62737658|FG002|Period 3|Withdrawal by Subject|0|||
33360064|NCT00607087|62737656|FG000|Period 3|Adverse Event|0|||
33360065|NCT00607087|62737657|FG001|Period 3|Adverse Event|1|||
33360066|NCT00607087|62737658|FG002|Period 3|Adverse Event|0|||
33360067|NCT00610363|62737668|FG000|Overall Study|Non-compliance with protocol|0|||
33360068|NCT00610363|62737669|FG001|Overall Study|Non-compliance with protocol|1|||
33360069|NCT00610363|62737668|FG000|Overall Study|Adverse Event|3|||
33360070|NCT00610363|62737669|FG001|Overall Study|Adverse Event|1|||
33360071|NCT00610363|62737668|FG000|Overall Study|Lack of Efficacy|2|||
33360072|NCT00610363|62737669|FG001|Overall Study|Lack of Efficacy|0|||
33360073|NCT00610363|62737668|FG000|Overall Study|Lost to Follow-up|4|||
33360074|NCT00610363|62737669|FG001|Overall Study|Lost to Follow-up|0|||
33360075|NCT00610363|62737668|FG000|Overall Study|Withdrawal by Subject|1|||
33360076|NCT00610363|62737669|FG001|Overall Study|Withdrawal by Subject|0|||
33360077|NCT00610363|62737668|FG000|Overall Study|Other than specified above|1|||
33360078|NCT00610363|62737669|FG001|Overall Study|Other than specified above|1|||
33360079|NCT00887588|62737678|FG000|Core Period|Death|1|||
33360080|NCT00887588|62737679|FG001|Core Period|Death|1|||
33360081|NCT00887588|62737678|FG000|Core Period|Lost to Follow-up|3|||
33360082|NCT00887588|62737679|FG001|Core Period|Lost to Follow-up|1|||
33360083|NCT00887588|62737678|FG000|Core Period|Withdrawal by Subject|6|||
33360084|NCT00887588|62737679|FG001|Core Period|Withdrawal by Subject|8|||
33360085|NCT00887588|62737678|FG000|Core Period|Adverse Event|9|||
33360086|NCT00887588|62737679|FG001|Core Period|Adverse Event|11|||
33360087|NCT00887588|62737678|FG000|Extension Period|Adverse Event|4|||
33360088|NCT00887588|62737679|FG001|Extension Period|Adverse Event|4|||
33360089|NCT00887588|62737678|FG000|Extension Period|Death|0|||
33360090|NCT00887588|62737679|FG001|Extension Period|Death|1|||
33360091|NCT00887588|62737678|FG000|Extension Period|Protocol deviation|1|||
33360092|NCT00887588|62737679|FG001|Extension Period|Protocol deviation|0|||
33360093|NCT00887588|62737678|FG000|Extension Period|Lost to Follow-up|1|||
33360094|NCT00887588|62737679|FG001|Extension Period|Lost to Follow-up|0|||
33360095|NCT00945893|62737687|FG000|Overall Study|Lost to Follow-up|2|||
33360096|NCT00945893|62737688|FG001|Overall Study|Lost to Follow-up|8|||
33360097|NCT00945893|62737687|FG000|Overall Study|Withdrawal of consent|1|||
33360098|NCT00945893|62737688|FG001|Overall Study|Withdrawal of consent|2|||
33360099|NCT00799383|62737700|FG000|Overall Study|Protocol Violation|1|||
33360100|NCT00799383|62737701|FG001|Overall Study|Protocol Violation|1|||
33360101|NCT00799383|62737700|FG000|Overall Study|Adverse Event|0|||
33360102|NCT00799383|62737701|FG001|Overall Study|Adverse Event|1|||
33360103|NCT00799383|62737700|FG000|Overall Study|Lost to Follow-up|1|||
33360104|NCT00799383|62737701|FG001|Overall Study|Lost to Follow-up|2|||
33360105|NCT00799383|62737700|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
33360106|NCT00799383|62737701|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
33360107|NCT00799383|62737700|FG000|Overall Study|Withdrawal by Subject|0|||
33360108|NCT00799383|62737701|FG001|Overall Study|Withdrawal by Subject|1|||
33360109|NCT00610207|62737707|FG000|Overall Study|Lost to Follow-up|3|||
33360110|NCT00798759|62737713|FG000|Overall Study|Adverse Event|3|||
33360111|NCT00798759|62737714|FG001|Overall Study|Adverse Event|3|||
33360112|NCT00798759|62737713|FG000|Overall Study|Lost to Follow-up|1|||
33360113|NCT00798759|62737714|FG001|Overall Study|Lost to Follow-up|1|||
33360114|NCT00798759|62737713|FG000|Overall Study|Protocol Violation|4|||
33360115|NCT00798759|62737714|FG001|Overall Study|Protocol Violation|8|||
33360116|NCT00798759|62737713|FG000|Overall Study|Other|0|||
33360117|NCT00798759|62737714|FG001|Overall Study|Other|1|||
33360118|NCT00887432|62737722|FG000|Overall Study|Start Excluded Therapy|3|||
33360119|NCT00887432|62737723|FG001|Overall Study|Start Excluded Therapy|0|||
33360120|NCT00887432|62737722|FG000|Overall Study|Did not complete treatment|6|||
33360121|NCT00887432|62737723|FG001|Overall Study|Did not complete treatment|8|||
33360122|NCT00887432|62737722|FG000|Overall Study|Protocol Violation|2|||
33360123|NCT00887432|62737723|FG001|Overall Study|Protocol Violation|3|||
33474673|NCT02849626|62848839|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
33474674|NCT02849626|62848836|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
33474675|NCT02849626|62848837|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
33474676|NCT02849626|62848838|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
33474677|NCT02849626|62848839|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
33360124|NCT00887432|62737722|FG000|Overall Study|Withdrawal by Subject|3|||
33360125|NCT00887432|62737723|FG001|Overall Study|Withdrawal by Subject|2|||
33360126|NCT00887432|62737722|FG000|Overall Study|Lost to Follow-up|1|||
33360127|NCT00887432|62737723|FG001|Overall Study|Lost to Follow-up|0|||
33360128|NCT00887432|62737722|FG000|Overall Study|No reason provided|0|||
33360129|NCT00887432|62737723|FG001|Overall Study|No reason provided|1|||
33360130|NCT00951275|62737729|FG000|Overall Study|Administrative Reason|1|||
33360131|NCT00951275|62737729|FG000|Overall Study|Adverse Event|7|||
33360132|NCT00951275|62737729|FG000|Overall Study|Withdrawal by Subject|4|||
33360133|NCT00951275|62737729|FG000|Overall Study|Protocol Violation|1|||
33360134|NCT00798603|62737733|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
33360135|NCT00798603|62737733|FG000|Overall Study|Withdrawal by Subject|10|||
33474678|NCT03735498|62848857|FG000|Overall Study|Withdrawal by Subject|5|||
33474679|NCT03735498|62848857|FG000|Overall Study|one participant only completed 5 of 6 sessions|1|||
33474680|NCT02659540|62848863|FG000|Overall Study|Adverse Event|3|||
33655563|NCT00635427|63071183|FG003|Overall Study|Death|1|||
33360136|NCT00798603|62737733|FG000|Overall Study|Adverse Event|22|||
33360137|NCT00798603|62737733|FG000|Overall Study|Physician Decision|1|||
33360138|NCT00798603|62737733|FG000|Overall Study|Lack of insurance coverage|1|||
33360139|NCT00887354|62737739|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
33360140|NCT00887354|62737740|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
33360141|NCT00887354|62737739|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
33360142|NCT00887354|62737740|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
33360143|NCT00887354|62737739|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
33360144|NCT00887354|62737740|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
33360145|NCT00887354|62737739|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
33360146|NCT00887354|62737740|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
33360147|NCT00887354|62737739|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
33360148|NCT00887354|62737740|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
33360149|NCT00887354|62737739|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
33360150|NCT00887354|62737740|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
33360151|NCT00887354|62737739|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
33360152|NCT00887354|62737740|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
33360153|NCT00887354|62737739|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
33360154|NCT00887354|62737740|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
33360155|NCT00887354|62737739|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
33360156|NCT00887354|62737740|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
33360157|NCT00887354|62737739|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
33360158|NCT00887354|62737740|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
33360159|NCT00887354|62737739|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
33360160|NCT00887354|62737740|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
33360161|NCT00887354|62737739|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
33360162|NCT00887354|62737740|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
33360163|NCT00887354|62737739|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
33360164|NCT00887354|62737740|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
33360165|NCT00887354|62737739|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
33360166|NCT00887354|62737740|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
33360167|NCT00887354|62737739|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
33360168|NCT00887354|62737740|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
33360169|NCT00951041|62737749|FG000|Overall Study|Withdrawal by Subject|1|||
33360170|NCT00951041|62737750|FG001|Overall Study|Withdrawal by Subject|1|||
33360171|NCT00951041|62737749|FG000|Overall Study|Lost to Follow-up|1|||
33360172|NCT00951041|62737750|FG001|Overall Study|Lost to Follow-up|0|||
33360173|NCT00951041|62737749|FG000|Overall Study|Other|3|||
33360174|NCT00951041|62737750|FG001|Overall Study|Other|0|||
33360175|NCT02763462|62737757|FG000|Overall Study|Protocol Violation|6|||
33360176|NCT00610129|62737771|FG000|Overall Study|Not treated since patients ineligible|3|||
33360177|NCT00945815|62737775|FG000|Overall Study|Death|3|||
33360178|NCT00945815|62737775|FG000|Overall Study|Not protocol specified|1|||
33360179|NCT00945815|62737775|FG000|Overall Study|Ineligible|3|||
33360180|NCT00945815|62737775|FG000|Overall Study|Did not begin protocol therapy|1|||
33474681|NCT02659540|62848864|FG001|Overall Study|Adverse Event|2|||
33474682|NCT02659540|62848863|FG000|Overall Study|Death|1|||
33474683|NCT02659540|62848864|FG001|Overall Study|Death|0|||
33474684|NCT02659540|62848863|FG000|Overall Study|Progressive disease|2|||
33474685|NCT02659540|62848864|FG001|Overall Study|Progressive disease|6|||
33474686|NCT01097746|62848870|FG000|Overall Study|Adverse Event|4|||
33360181|NCT00606307|62737779|FG000|Overall Study|Adverse Event|2|||
33360182|NCT00606307|62737779|FG000|Overall Study|Withdrawal by Subject|2|||
33360183|NCT00606307|62737779|FG000|Overall Study|Disease progression|6|||
33474687|NCT01097746|62848870|FG000|Overall Study|taken off study before any treatment given|1|||
33474688|NCT03733470|62848900|FG000|Overall Study|PI Decision|1|||
33474689|NCT03733470|62848901|FG001|Overall Study|PI Decision|1|||
33474690|NCT03732534|62848907|FG000|Overall Study|Study terminated by Sponsor|6|||
33474691|NCT03087058|62848913|FG000|Overall Study|Withdrawal by Subject|2|||
33474692|NCT03087058|62848914|FG001|Overall Study|Withdrawal by Subject|0|||
33474693|NCT03087058|62848915|FG002|Overall Study|Withdrawal by Subject|0|||
33474694|NCT03726996|62848922|FG000|Overall Study|Parent's decision|2|||
33474695|NCT03726996|62848922|FG000|Overall Study|Study early termination|2|||
33474696|NCT03882970|62848930|FG000|Overall Study|Adverse Event|5|||
33360184|NCT00606307|62737779|FG000|Overall Study|QTc prolongation|1|||
33360185|NCT00798369|62737789|FG000|Overall Study|Subject withdrew consent|0|||
33360186|NCT00798369|62737790|FG001|Overall Study|Subject withdrew consent|0|||
33474697|NCT03882970|62848931|FG001|Overall Study|Adverse Event|7|||
33474698|NCT03882970|62848932|FG002|Overall Study|Adverse Event|3|||
33360187|NCT00798369|62737791|FG002|Overall Study|Subject withdrew consent|1|||
33360188|NCT00798369|62737792|FG003|Overall Study|Subject withdrew consent|1|||
33360189|NCT00798369|62737793|FG004|Overall Study|Subject withdrew consent|0|||
33360190|NCT00798369|62737794|FG005|Overall Study|Subject withdrew consent|2|||
33360191|NCT00798369|62737789|FG000|Overall Study|Lost to Follow-up|1|||
33360192|NCT00798369|62737790|FG001|Overall Study|Lost to Follow-up|1|||
33360193|NCT00798369|62737791|FG002|Overall Study|Lost to Follow-up|1|||
33360194|NCT00798369|62737792|FG003|Overall Study|Lost to Follow-up|0|||
33360195|NCT00798369|62737793|FG004|Overall Study|Lost to Follow-up|1|||
33360196|NCT00798369|62737794|FG005|Overall Study|Lost to Follow-up|0|||
33360197|NCT00798369|62737789|FG000|Overall Study|Adminstrative problems|0|||
33360198|NCT00798369|62737790|FG001|Overall Study|Adminstrative problems|0|||
33360199|NCT00798369|62737791|FG002|Overall Study|Adminstrative problems|0|||
33360200|NCT00798369|62737792|FG003|Overall Study|Adminstrative problems|0|||
33360201|NCT00798369|62737793|FG004|Overall Study|Adminstrative problems|0|||
33360202|NCT00798369|62737794|FG005|Overall Study|Adminstrative problems|1|||
33360203|NCT00950963|62737811|FG000|Overall Study|Lost to Follow-up|29|||
33360204|NCT00950963|62737812|FG001|Overall Study|Lost to Follow-up|24|||
33360205|NCT00608959|62737820|FG000|Part 1|Did not meet eligibility criteria|1|||
33360206|NCT00945659|62737833|FG000|Overall Study|Lost to Follow-up|7|||
33360207|NCT00945659|62737834|FG001|Overall Study|Lost to Follow-up|20|||
33360208|NCT00945659|62737835|FG002|Overall Study|Lost to Follow-up|17|||
33360209|NCT00798135|62737843|FG000|Overall Study|Disease progression, relapse|11|||
33360210|NCT00798135|62737843|FG000|Overall Study|Disease progression, refractory|1|||
33360211|NCT00798135|62737843|FG000|Overall Study|Physician Decision|1|||
33360212|NCT00941603|62737853|FG000|Overall Study|Adverse Event|10|||
33360213|NCT00941603|62737854|FG001|Overall Study|Adverse Event|15|||
33360214|NCT00941603|62737855|FG002|Overall Study|Adverse Event|5|||
33360215|NCT00941603|62737856|FG003|Overall Study|Adverse Event|1|||
33360216|NCT00941603|62737857|FG004|Overall Study|Adverse Event|4|||
33360217|NCT00941603|62737858|FG005|Overall Study|Adverse Event|0|||
33360218|NCT00941603|62737853|FG000|Overall Study|Lost to Follow-up|0|||
33360219|NCT00941603|62737854|FG001|Overall Study|Lost to Follow-up|0|||
33360220|NCT00941603|62737855|FG002|Overall Study|Lost to Follow-up|0|||
33360221|NCT00941603|62737856|FG003|Overall Study|Lost to Follow-up|1|||
33360222|NCT00941603|62737857|FG004|Overall Study|Lost to Follow-up|0|||
33360223|NCT00941603|62737858|FG005|Overall Study|Lost to Follow-up|2|||
33360224|NCT00941603|62737853|FG000|Overall Study|Withdrawal by Subject|0|||
33360225|NCT00941603|62737854|FG001|Overall Study|Withdrawal by Subject|0|||
33360226|NCT00941603|62737855|FG002|Overall Study|Withdrawal by Subject|0|||
33360227|NCT00941603|62737856|FG003|Overall Study|Withdrawal by Subject|2|||
33360228|NCT00941603|62737857|FG004|Overall Study|Withdrawal by Subject|0|||
33360229|NCT00941603|62737858|FG005|Overall Study|Withdrawal by Subject|1|||
33360230|NCT00941603|62737853|FG000|Overall Study|Protocol Violation|0|||
33360231|NCT00941603|62737854|FG001|Overall Study|Protocol Violation|1|||
33360232|NCT00941603|62737855|FG002|Overall Study|Protocol Violation|0|||
33360233|NCT00941603|62737856|FG003|Overall Study|Protocol Violation|0|||
33360234|NCT00941603|62737857|FG004|Overall Study|Protocol Violation|0|||
33360235|NCT00941603|62737858|FG005|Overall Study|Protocol Violation|0|||
33360236|NCT00941603|62737853|FG000|Overall Study|Did not meet protocol eligibility|1|||
33360237|NCT00941603|62737854|FG001|Overall Study|Did not meet protocol eligibility|0|||
33360238|NCT00941603|62737855|FG002|Overall Study|Did not meet protocol eligibility|0|||
33360239|NCT00941603|62737856|FG003|Overall Study|Did not meet protocol eligibility|0|||
33360240|NCT00941603|62737857|FG004|Overall Study|Did not meet protocol eligibility|0|||
33360241|NCT00941603|62737858|FG005|Overall Study|Did not meet protocol eligibility|0|||
33360242|NCT00797823|62737875|FG000|First Period (Initial Randomization)|Physician Decision|1|||
33360243|NCT00797823|62737876|FG001|First Period (Initial Randomization)|Physician Decision|0|||
33360244|NCT00797823|62737877|FG002|First Period (Initial Randomization)|Physician Decision|0|||
33360245|NCT00797667|62737887|FG000|Overall Study|Lack of Efficacy|0|||
33360246|NCT00797667|62737888|FG001|Overall Study|Lack of Efficacy|1|||
33360247|NCT00797667|62737889|FG002|Overall Study|Lack of Efficacy|0|||
33360248|NCT00797667|62737887|FG000|Overall Study|Lost to Follow-up|8|||
33360249|NCT00797667|62737888|FG001|Overall Study|Lost to Follow-up|12|||
33360250|NCT00797667|62737889|FG002|Overall Study|Lost to Follow-up|2|||
33360251|NCT00797667|62737887|FG000|Overall Study|Physician Decision|3|||
33360252|NCT00797667|62737888|FG001|Overall Study|Physician Decision|1|||
33360253|NCT00797667|62737889|FG002|Overall Study|Physician Decision|0|||
33360254|NCT00797667|62737887|FG000|Overall Study|Pregnancy|2|||
33360255|NCT00797667|62737888|FG001|Overall Study|Pregnancy|0|||
33360256|NCT00797667|62737889|FG002|Overall Study|Pregnancy|0|||
33360257|NCT00797667|62737887|FG000|Overall Study|Protocol Violation|2|||
33360258|NCT00797667|62737888|FG001|Overall Study|Protocol Violation|7|||
33360259|NCT00797667|62737889|FG002|Overall Study|Protocol Violation|0|||
33360260|NCT00797667|62737887|FG000|Overall Study|Study Terminated by Sponsor|217|||
33360261|NCT00797667|62737888|FG001|Overall Study|Study Terminated by Sponsor|216|||
33360262|NCT00797667|62737889|FG002|Overall Study|Study Terminated by Sponsor|115|||
33360263|NCT00797667|62737887|FG000|Overall Study|Withdrawal by Subject|9|||
33360264|NCT00797667|62737888|FG001|Overall Study|Withdrawal by Subject|14|||
33360265|NCT00797667|62737889|FG002|Overall Study|Withdrawal by Subject|2|||
33360266|NCT00797667|62737887|FG000|Overall Study|Adverse Event|19|||
33360267|NCT00797667|62737888|FG001|Overall Study|Adverse Event|8|||
33360268|NCT00797667|62737889|FG002|Overall Study|Adverse Event|8|||
33360269|NCT00950807|62737897|FG000|Treatment Period 1|Lack of Efficacy|1|||
33360270|NCT00950807|62737898|FG001|Treatment Period 1|Lack of Efficacy|0|||
33360271|NCT00950807|62737899|FG002|Treatment Period 1|Lack of Efficacy|0|||
33360272|NCT00950807|62737900|FG003|Treatment Period 1|Lack of Efficacy|0|||
33360273|NCT00950807|62737901|FG004|Treatment Period 1|Lack of Efficacy|0|||
33360274|NCT00950807|62737902|FG005|Treatment Period 1|Lack of Efficacy|1|||
33360275|NCT00950807|62737903|FG006|Treatment Period 1|Lack of Efficacy|0|||
33360276|NCT00950807|62737904|FG007|Treatment Period 1|Lack of Efficacy|0|||
33360277|NCT00950807|62737905|FG008|Treatment Period 1|Lack of Efficacy|0|||
33360278|NCT00950807|62737906|FG009|Treatment Period 1|Lack of Efficacy|0|||
33360279|NCT00950807|62737897|FG000|Treatment Period 1|Protocol Violation|1|||
33360280|NCT00950807|62737898|FG001|Treatment Period 1|Protocol Violation|0|||
33360281|NCT00950807|62737899|FG002|Treatment Period 1|Protocol Violation|0|||
33360282|NCT00950807|62737900|FG003|Treatment Period 1|Protocol Violation|0|||
33474699|NCT03882970|62848933|FG003|Overall Study|Adverse Event|1|||
33474700|NCT03882970|62848930|FG000|Overall Study|Death|1|||
33360283|NCT00950807|62737901|FG004|Treatment Period 1|Protocol Violation|0|||
33360284|NCT00950807|62737902|FG005|Treatment Period 1|Protocol Violation|0|||
33360285|NCT00950807|62737903|FG006|Treatment Period 1|Protocol Violation|0|||
33360286|NCT00950807|62737904|FG007|Treatment Period 1|Protocol Violation|0|||
33360287|NCT00950807|62737905|FG008|Treatment Period 1|Protocol Violation|0|||
33360288|NCT00950807|62737906|FG009|Treatment Period 1|Protocol Violation|0|||
33360289|NCT00950807|62737897|FG000|Treatment Period 1|Lost to Follow-up|0|||
33360290|NCT00950807|62737898|FG001|Treatment Period 1|Lost to Follow-up|0|||
33360291|NCT00950807|62737899|FG002|Treatment Period 1|Lost to Follow-up|1|||
33360292|NCT00950807|62737900|FG003|Treatment Period 1|Lost to Follow-up|0|||
33360293|NCT00950807|62737901|FG004|Treatment Period 1|Lost to Follow-up|0|||
33360294|NCT00950807|62737902|FG005|Treatment Period 1|Lost to Follow-up|0|||
33360295|NCT00950807|62737903|FG006|Treatment Period 1|Lost to Follow-up|0|||
33360296|NCT00950807|62737904|FG007|Treatment Period 1|Lost to Follow-up|0|||
33360297|NCT00950807|62737905|FG008|Treatment Period 1|Lost to Follow-up|0|||
33360298|NCT00950807|62737906|FG009|Treatment Period 1|Lost to Follow-up|0|||
33360299|NCT00950807|62737897|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33360300|NCT00950807|62737898|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33360301|NCT00950807|62737899|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33360302|NCT00950807|62737900|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33360303|NCT00950807|62737901|FG004|Treatment Period 1|Withdrawal by Subject|1|||
33360304|NCT00950807|62737902|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33360305|NCT00950807|62737903|FG006|Treatment Period 1|Withdrawal by Subject|0|||
33360306|NCT00950807|62737904|FG007|Treatment Period 1|Withdrawal by Subject|0|||
33360307|NCT00950807|62737905|FG008|Treatment Period 1|Withdrawal by Subject|1|||
33360308|NCT00950807|62737906|FG009|Treatment Period 1|Withdrawal by Subject|0|||
33360309|NCT00950807|62737897|FG000|Treatment Period 1|Adverse Event|0|||
33360310|NCT00950807|62737898|FG001|Treatment Period 1|Adverse Event|0|||
33360311|NCT00950807|62737899|FG002|Treatment Period 1|Adverse Event|0|||
33360312|NCT00950807|62737900|FG003|Treatment Period 1|Adverse Event|0|||
33360313|NCT00950807|62737901|FG004|Treatment Period 1|Adverse Event|0|||
33360314|NCT00950807|62737902|FG005|Treatment Period 1|Adverse Event|1|||
33360315|NCT00950807|62737903|FG006|Treatment Period 1|Adverse Event|0|||
33360316|NCT00950807|62737904|FG007|Treatment Period 1|Adverse Event|0|||
33360317|NCT00950807|62737905|FG008|Treatment Period 1|Adverse Event|0|||
33360318|NCT00950807|62737906|FG009|Treatment Period 1|Adverse Event|0|||
33360319|NCT00950807|62737897|FG000|Washout Period 1|Lack of Efficacy|0|||
33360320|NCT00950807|62737898|FG001|Washout Period 1|Lack of Efficacy|0|||
33360321|NCT00950807|62737899|FG002|Washout Period 1|Lack of Efficacy|0|||
33360322|NCT00950807|62737900|FG003|Washout Period 1|Lack of Efficacy|0|||
33360323|NCT00950807|62737901|FG004|Washout Period 1|Lack of Efficacy|0|||
33360324|NCT00950807|62737902|FG005|Washout Period 1|Lack of Efficacy|0|||
33360325|NCT00950807|62737903|FG006|Washout Period 1|Lack of Efficacy|1|||
33360326|NCT00950807|62737904|FG007|Washout Period 1|Lack of Efficacy|0|||
33360327|NCT00950807|62737905|FG008|Washout Period 1|Lack of Efficacy|0|||
33360328|NCT00950807|62737906|FG009|Washout Period 1|Lack of Efficacy|0|||
33360329|NCT00950807|62737897|FG000|Washout Period 1|Withdrawal by Subject|0|||
33360330|NCT00950807|62737898|FG001|Washout Period 1|Withdrawal by Subject|0|||
33360331|NCT00950807|62737899|FG002|Washout Period 1|Withdrawal by Subject|0|||
33360332|NCT00950807|62737900|FG003|Washout Period 1|Withdrawal by Subject|0|||
33360333|NCT00950807|62737901|FG004|Washout Period 1|Withdrawal by Subject|0|||
33474701|NCT03882970|62848931|FG001|Overall Study|Death|2|||
33474702|NCT03882970|62848932|FG002|Overall Study|Death|1|||
33360334|NCT00950807|62737902|FG005|Washout Period 1|Withdrawal by Subject|0|||
33360335|NCT00950807|62737903|FG006|Washout Period 1|Withdrawal by Subject|0|||
33360336|NCT00950807|62737904|FG007|Washout Period 1|Withdrawal by Subject|0|||
33360337|NCT00950807|62737905|FG008|Washout Period 1|Withdrawal by Subject|1|||
33360338|NCT00950807|62737906|FG009|Washout Period 1|Withdrawal by Subject|0|||
33360339|NCT00950807|62737897|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
33360340|NCT00950807|62737898|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
33360341|NCT00950807|62737899|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
33360342|NCT00950807|62737900|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
33360343|NCT00950807|62737901|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
33360344|NCT00950807|62737902|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
33360345|NCT00950807|62737903|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
33360346|NCT00950807|62737904|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
33360347|NCT00950807|62737905|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
33360348|NCT00950807|62737906|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
33360349|NCT00950807|62737897|FG000|Washout Period 1|Adverse Event|2|||
33360350|NCT00950807|62737898|FG001|Washout Period 1|Adverse Event|0|||
33474703|NCT03882970|62848933|FG003|Overall Study|Death|1|||
33474704|NCT03882970|62848930|FG000|Overall Study|Lost to Follow-up|8|||
33474705|NCT03882970|62848931|FG001|Overall Study|Lost to Follow-up|9|||
33474706|NCT03882970|62848932|FG002|Overall Study|Lost to Follow-up|5|||
33474707|NCT03882970|62848933|FG003|Overall Study|Lost to Follow-up|5|||
33474708|NCT03882970|62848930|FG000|Overall Study|Physician Decision|0|||
33474709|NCT03882970|62848931|FG001|Overall Study|Physician Decision|2|||
33474710|NCT03882970|62848932|FG002|Overall Study|Physician Decision|2|||
33474711|NCT03882970|62848933|FG003|Overall Study|Physician Decision|2|||
33474712|NCT03882970|62848930|FG000|Overall Study|Protocol Violation|2|||
33549405|NCT02477800|62940543|FG005|Long Term Extension Period|Disease Progression|1|||
33360351|NCT00950807|62737899|FG002|Washout Period 1|Adverse Event|0|||
33360352|NCT00950807|62737900|FG003|Washout Period 1|Adverse Event|1|||
33360353|NCT00950807|62737901|FG004|Washout Period 1|Adverse Event|1|||
33360354|NCT00950807|62737902|FG005|Washout Period 1|Adverse Event|0|||
33360355|NCT00950807|62737903|FG006|Washout Period 1|Adverse Event|0|||
33360356|NCT00950807|62737904|FG007|Washout Period 1|Adverse Event|0|||
33360357|NCT00950807|62737905|FG008|Washout Period 1|Adverse Event|0|||
33360358|NCT00950807|62737906|FG009|Washout Period 1|Adverse Event|0|||
33360359|NCT00950807|62737897|FG000|Treatment Period 2|Lack of Efficacy|1|||
33360360|NCT00950807|62737898|FG001|Treatment Period 2|Lack of Efficacy|0|||
33360361|NCT00950807|62737899|FG002|Treatment Period 2|Lack of Efficacy|0|||
33360362|NCT00950807|62737900|FG003|Treatment Period 2|Lack of Efficacy|0|||
33360363|NCT00950807|62737901|FG004|Treatment Period 2|Lack of Efficacy|0|||
33360364|NCT00950807|62737902|FG005|Treatment Period 2|Lack of Efficacy|0|||
33360365|NCT00950807|62737903|FG006|Treatment Period 2|Lack of Efficacy|0|||
33360366|NCT00950807|62737904|FG007|Treatment Period 2|Lack of Efficacy|0|||
33360367|NCT00950807|62737905|FG008|Treatment Period 2|Lack of Efficacy|0|||
33360368|NCT00950807|62737906|FG009|Treatment Period 2|Lack of Efficacy|0|||
33360369|NCT00950807|62737897|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33360370|NCT00950807|62737898|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33360371|NCT00950807|62737899|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33360372|NCT00950807|62737900|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33360373|NCT00950807|62737901|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33360374|NCT00950807|62737902|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33360375|NCT00950807|62737903|FG006|Treatment Period 2|Withdrawal by Subject|1|||
33360376|NCT00950807|62737904|FG007|Treatment Period 2|Withdrawal by Subject|2|||
33360377|NCT00950807|62737905|FG008|Treatment Period 2|Withdrawal by Subject|0|||
33360378|NCT00950807|62737906|FG009|Treatment Period 2|Withdrawal by Subject|0|||
33360379|NCT00950807|62737897|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
33360380|NCT00950807|62737898|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33360381|NCT00950807|62737899|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33360382|NCT00950807|62737900|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33360383|NCT00950807|62737901|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33360384|NCT00950807|62737902|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33360385|NCT00950807|62737903|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33360386|NCT00950807|62737904|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33360387|NCT00950807|62737905|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33360388|NCT00950807|62737906|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33360389|NCT00950807|62737897|FG000|Treatment Period 2|Adverse Event|0|||
33360390|NCT00950807|62737898|FG001|Treatment Period 2|Adverse Event|1|||
33474713|NCT03882970|62848931|FG001|Overall Study|Protocol Violation|0|||
33474714|NCT03882970|62848932|FG002|Overall Study|Protocol Violation|0|||
33474715|NCT03882970|62848933|FG003|Overall Study|Protocol Violation|0|||
33474716|NCT03882970|62848930|FG000|Overall Study|Withdrawal by Subject|8|||
33549406|NCT02477800|62940544|FG006|Long Term Extension Period|Disease Progression|0|||
33549407|NCT02477800|62940538|FG000|Long Term Extension Period|Investigator Decision|0|||
33549408|NCT02477800|62940539|FG001|Long Term Extension Period|Investigator Decision|0|||
33549409|NCT02477800|62940540|FG002|Long Term Extension Period|Investigator Decision|0|||
33549410|NCT02477800|62940541|FG003|Long Term Extension Period|Investigator Decision|0|||
33360391|NCT00950807|62737899|FG002|Treatment Period 2|Adverse Event|0|||
33474717|NCT03882970|62848931|FG001|Overall Study|Withdrawal by Subject|17|||
33474718|NCT03882970|62848932|FG002|Overall Study|Withdrawal by Subject|7|||
33360392|NCT00950807|62737900|FG003|Treatment Period 2|Adverse Event|1|||
33360393|NCT00950807|62737901|FG004|Treatment Period 2|Adverse Event|0|||
33360394|NCT00950807|62737902|FG005|Treatment Period 2|Adverse Event|1|||
33360395|NCT00950807|62737903|FG006|Treatment Period 2|Adverse Event|0|||
33360396|NCT00950807|62737904|FG007|Treatment Period 2|Adverse Event|1|||
33360397|NCT00950807|62737905|FG008|Treatment Period 2|Adverse Event|0|||
33360398|NCT00950807|62737906|FG009|Treatment Period 2|Adverse Event|0|||
33360399|NCT00950807|62737897|FG000|Washout Period 2|Lack of Efficacy|1|||
33360400|NCT00950807|62737898|FG001|Washout Period 2|Lack of Efficacy|0|||
33360401|NCT00950807|62737899|FG002|Washout Period 2|Lack of Efficacy|0|||
33360402|NCT00950807|62737900|FG003|Washout Period 2|Lack of Efficacy|0|||
33360403|NCT00950807|62737901|FG004|Washout Period 2|Lack of Efficacy|0|||
33360404|NCT00950807|62737902|FG005|Washout Period 2|Lack of Efficacy|0|||
33360405|NCT00950807|62737903|FG006|Washout Period 2|Lack of Efficacy|0|||
33360406|NCT00950807|62737904|FG007|Washout Period 2|Lack of Efficacy|0|||
33360407|NCT00950807|62737905|FG008|Washout Period 2|Lack of Efficacy|0|||
33360408|NCT00950807|62737906|FG009|Washout Period 2|Lack of Efficacy|0|||
33360409|NCT00950807|62737897|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
33360410|NCT00950807|62737898|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
33360411|NCT00950807|62737899|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
33360412|NCT00950807|62737900|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
33360413|NCT00950807|62737901|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
33360414|NCT00950807|62737902|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
33360415|NCT00950807|62737903|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
33360416|NCT00950807|62737904|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
33360417|NCT00950807|62737905|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
33360418|NCT00950807|62737906|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
33360419|NCT00950807|62737897|FG000|Washout Period 2|Adverse Event|3|||
33360420|NCT00950807|62737898|FG001|Washout Period 2|Adverse Event|0|||
33360421|NCT00950807|62737899|FG002|Washout Period 2|Adverse Event|0|||
33360422|NCT00950807|62737900|FG003|Washout Period 2|Adverse Event|1|||
33360423|NCT00950807|62737901|FG004|Washout Period 2|Adverse Event|0|||
33360424|NCT00950807|62737902|FG005|Washout Period 2|Adverse Event|0|||
33360425|NCT00950807|62737903|FG006|Washout Period 2|Adverse Event|0|||
33360426|NCT00950807|62737904|FG007|Washout Period 2|Adverse Event|0|||
33360427|NCT00950807|62737905|FG008|Washout Period 2|Adverse Event|0|||
33360428|NCT00950807|62737906|FG009|Washout Period 2|Adverse Event|0|||
33360429|NCT00950807|62737897|FG000|Treatment Period 3|Withdrawal by Subject|0|||
33360430|NCT00950807|62737898|FG001|Treatment Period 3|Withdrawal by Subject|0|||
33360431|NCT00950807|62737899|FG002|Treatment Period 3|Withdrawal by Subject|0|||
33360432|NCT00950807|62737900|FG003|Treatment Period 3|Withdrawal by Subject|0|||
33360433|NCT00950807|62737901|FG004|Treatment Period 3|Withdrawal by Subject|0|||
33360434|NCT00950807|62737902|FG005|Treatment Period 3|Withdrawal by Subject|0|||
33360435|NCT00950807|62737903|FG006|Treatment Period 3|Withdrawal by Subject|0|||
33360436|NCT00950807|62737904|FG007|Treatment Period 3|Withdrawal by Subject|0|||
33360437|NCT00950807|62737905|FG008|Treatment Period 3|Withdrawal by Subject|0|||
33360438|NCT00950807|62737906|FG009|Treatment Period 3|Withdrawal by Subject|1|||
33360439|NCT00950807|62737897|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
33360440|NCT00950807|62737898|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33360441|NCT00950807|62737899|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33360442|NCT00950807|62737900|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33360443|NCT00950807|62737901|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33360444|NCT00950807|62737902|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33360445|NCT00950807|62737903|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33360446|NCT00950807|62737904|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
33360447|NCT00950807|62737905|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33360448|NCT00950807|62737906|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33360449|NCT00950807|62737897|FG000|Treatment Period 3|Adverse Event|0|||
33360450|NCT00950807|62737898|FG001|Treatment Period 3|Adverse Event|0|||
33360451|NCT00950807|62737899|FG002|Treatment Period 3|Adverse Event|0|||
33360452|NCT00950807|62737900|FG003|Treatment Period 3|Adverse Event|0|||
33360453|NCT00950807|62737901|FG004|Treatment Period 3|Adverse Event|0|||
33360454|NCT00950807|62737902|FG005|Treatment Period 3|Adverse Event|0|||
33360455|NCT00950807|62737903|FG006|Treatment Period 3|Adverse Event|1|||
33360456|NCT00950807|62737904|FG007|Treatment Period 3|Adverse Event|0|||
33360457|NCT00950807|62737905|FG008|Treatment Period 3|Adverse Event|0|||
33360458|NCT00950807|62737906|FG009|Treatment Period 3|Adverse Event|0|||
33360459|NCT00797511|62737928|FG000|Overall Study|Withdrawal by Subject|1|||
33474719|NCT03882970|62848933|FG003|Overall Study|Withdrawal by Subject|22|||
33474720|NCT03882970|62848930|FG000|Overall Study|Personal Reason|2|||
33360460|NCT00608881|62737935|FG000|Overall Study|Death|22|||
33474721|NCT03882970|62848931|FG001|Overall Study|Personal Reason|3|||
33360461|NCT00608881|62737936|FG001|Overall Study|Death|13|||
33360462|NCT00608881|62737935|FG000|Overall Study|Adverse Event|5|||
33360463|NCT00608881|62737936|FG001|Overall Study|Adverse Event|3|||
33360464|NCT00608881|62737935|FG000|Overall Study|Lost to Follow-up|28|||
33360465|NCT00608881|62737936|FG001|Overall Study|Lost to Follow-up|14|||
33360466|NCT00608881|62737935|FG000|Overall Study|Withdrawal by Subject|18|||
33360467|NCT00608881|62737936|FG001|Overall Study|Withdrawal by Subject|29|||
33360468|NCT00608881|62737935|FG000|Overall Study|Physician Decision|5|||
33360469|NCT00608881|62737936|FG001|Overall Study|Physician Decision|5|||
33360470|NCT00608881|62737935|FG000|Overall Study|Institutionalized|1|||
33360471|NCT00608881|62737936|FG001|Overall Study|Institutionalized|2|||
33360472|NCT00945191|62737942|FG000|Overall Study|Did not achieve a complete response|18|||
33360473|NCT00945191|62737942|FG000|Overall Study|Participant relocated to another state|1|||
33360474|NCT00945191|62737942|FG000|Overall Study|Disease progression|3|||
33360475|NCT00945191|62737942|FG000|Overall Study|Serious adverse event or adverse event|1|||
33360476|NCT00945191|62737942|FG000|Overall Study|Investigator's discretion|1|||
33360477|NCT00606931|62737946|FG000|Overall Study|Withdrawal by Subject|3|||
33360478|NCT00792909|62737953|FG000|Overall Study|Withdrawal by Subject|0|||
33360479|NCT00792909|62737954|FG001|Overall Study|Withdrawal by Subject|1|||
33360480|NCT00792909|62737955|FG002|Overall Study|Withdrawal by Subject|0|||
33360481|NCT00944645|62737966|FG000|Period 2|Adverse Event|1|||
33360482|NCT00944645|62737967|FG001|Period 2|Adverse Event|0|||
33360483|NCT00944645|62737966|FG000|Period 2|Lost to Follow-up|0|||
33360484|NCT00944645|62737967|FG001|Period 2|Lost to Follow-up|3|||
33360485|NCT00944645|62737966|FG000|Period 2|Withdrawal by Subject|7|||
33360486|NCT00944645|62737967|FG001|Period 2|Withdrawal by Subject|6|||
33360487|NCT00606229|62737973|FG000|Overall Study|Adverse Event|11|||
33360488|NCT00606229|62737973|FG000|Overall Study|Lack of Efficacy|1|||
33360489|NCT00606229|62737973|FG000|Overall Study|Withdrawal by Subject|4|||
33360490|NCT00606229|62737973|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
33360491|NCT00606229|62737973|FG000|Overall Study|change of residence or other commitments|2|||
33360492|NCT00950651|62737979|FG000|Overall Study|Adverse Event|17|||
33360493|NCT00950651|62737980|FG001|Overall Study|Adverse Event|20|||
33360494|NCT00950651|62737979|FG000|Overall Study|Death|1|||
33360495|NCT00950651|62737980|FG001|Overall Study|Death|0|||
33360496|NCT00950651|62737979|FG000|Overall Study|Lack of Efficacy|2|||
33360497|NCT00950651|62737980|FG001|Overall Study|Lack of Efficacy|2|||
33360498|NCT00950651|62737979|FG000|Overall Study|Protocol Violation|3|||
33360499|NCT00950651|62737980|FG001|Overall Study|Protocol Violation|4|||
33360500|NCT00950651|62737979|FG000|Overall Study|Withdrawal by Subject|8|||
33360501|NCT00950651|62737980|FG001|Overall Study|Withdrawal by Subject|9|||
33360502|NCT00605293|62737988|FG000|Overall Study|Death|2|||
33360503|NCT00605293|62737989|FG001|Overall Study|Death|1|||
33360504|NCT00605293|62737988|FG000|Overall Study|Insufficient Therapeutic Response|2|||
33360505|NCT00605293|62737989|FG001|Overall Study|Insufficient Therapeutic Response|0|||
33360506|NCT00605293|62737988|FG000|Overall Study|Adverse Event|1|||
33360507|NCT00605293|62737989|FG001|Overall Study|Adverse Event|0|||
33360508|NCT00605293|62737988|FG000|Overall Study|Holidays Dialysis Out|1|||
33360509|NCT00605293|62737989|FG001|Overall Study|Holidays Dialysis Out|0|||
33360510|NCT00605293|62737988|FG000|Overall Study|Blood Transfusion|7|||
33360511|NCT00605293|62737989|FG001|Overall Study|Blood Transfusion|1|||
33360512|NCT00605293|62737988|FG000|Overall Study|Renal Transplantation|3|||
33360513|NCT00605293|62737989|FG001|Overall Study|Renal Transplantation|1|||
33360514|NCT00605293|62737988|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
33360515|NCT00605293|62737989|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
33360516|NCT00605293|62737988|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
33360517|NCT00605293|62737989|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
33360518|NCT00605293|62737988|FG000|Overall Study|Principal Investigator Decision|0|||
33360519|NCT00605293|62737989|FG001|Overall Study|Principal Investigator Decision|1|||
33360520|NCT00572533|62737997|FG000|Overall Study|Death|4|||
33360521|NCT00572533|62737998|FG001|Overall Study|Death|1|||
33360522|NCT00572533|62737997|FG000|Overall Study|Received Kidney Transplant|2|||
33360523|NCT00572533|62737998|FG001|Overall Study|Received Kidney Transplant|1|||
33360524|NCT00572533|62737997|FG000|Overall Study|Social Issues|1|||
33360525|NCT00572533|62737998|FG001|Overall Study|Social Issues|0|||
33360526|NCT00572533|62737997|FG000|Overall Study|Transfer out of Facility|0|||
33360527|NCT00572533|62737998|FG001|Overall Study|Transfer out of Facility|1|||
33360528|NCT00949715|62738006|FG000|Overall Study|Physician Decision|1|||
33360529|NCT00949715|62738007|FG001|Overall Study|Physician Decision|0|||
33360530|NCT00949715|62738006|FG000|Overall Study|Lost to Follow-up|1|||
33360531|NCT00949715|62738007|FG001|Overall Study|Lost to Follow-up|0|||
33360532|NCT00949715|62738006|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
33360533|NCT00949715|62738007|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
33360534|NCT00791661|62738015|FG000|7 Day Wash-out|Adverse Event|0|||
33360535|NCT00791661|62738016|FG001|7 Day Wash-out|Adverse Event|0|||
33360536|NCT00791661|62738017|FG002|7 Day Wash-out|Adverse Event|1|||
33360537|NCT00791661|62738015|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
33360538|NCT00791661|62738016|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
33360539|NCT00791661|62738017|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
33360540|NCT00943787|62738041|FG000|Overall Study|Physician Decision|4|||
33360541|NCT00943787|62738041|FG000|Overall Study|Withdrawal by Subject|3|||
33360542|NCT00949325|62738045|FG000|Overall Study|Adverse Event|0|||
33360543|NCT00949325|62738046|FG001|Overall Study|Adverse Event|2|||
33360544|NCT00949325|62738047|FG002|Overall Study|Adverse Event|0|||
33360545|NCT00943319|62738063|FG000|Overall Study|Death|1|||
33360546|NCT00790647|62738067|FG000|Overall Study|Adverse Event|1|||
33360547|NCT00790569|62738076|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
33360548|NCT00790569|62738077|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
33360549|NCT00790569|62738078|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
33360550|NCT00790569|62738076|FG000|End of Treatment (6 Month Interview)|Death|0|||
33360551|NCT00790569|62738077|FG001|End of Treatment (6 Month Interview)|Death|2|||
33360552|NCT00790569|62738078|FG002|End of Treatment (6 Month Interview)|Death|1|||
33360553|NCT00790569|62738076|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
33360554|NCT00790569|62738077|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
33360555|NCT00790569|62738078|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
33360556|NCT00790569|62738076|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
33360557|NCT00790569|62738077|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
33360558|NCT00790569|62738078|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
33360559|NCT00790569|62738076|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
33360560|NCT00790569|62738077|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
33360561|NCT00790569|62738078|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
33360562|NCT00790569|62738076|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
33360563|NCT00790569|62738077|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
33360564|NCT00790569|62738078|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
33360565|NCT00939029|62738088|FG000|Overall Study|Withdrawal by Subject|3|||
33360566|NCT00939029|62738089|FG001|Overall Study|Withdrawal by Subject|7|||
33360567|NCT00939029|62738088|FG000|Overall Study|Lost to Follow-up|3|||
33360568|NCT00939029|62738089|FG001|Overall Study|Lost to Follow-up|4|||
33360569|NCT00939029|62738088|FG000|Overall Study|Adverse Event|0|||
33360570|NCT00939029|62738089|FG001|Overall Study|Adverse Event|1|||
33360571|NCT00587847|62738095|FG000|Overall Study|Lack of Efficacy|5|||
33360572|NCT00587847|62738095|FG000|Overall Study|Adverse Event|2|||
33360573|NCT00784563|62738103|FG000|Years 1 & 2|Withdrawal by Subject|3|||
33360574|NCT00784563|62738104|FG001|Years 1 & 2|Withdrawal by Subject|2|||
33360575|NCT00784563|62738105|FG002|Years 1 & 2|Withdrawal by Subject|0|||
33360576|NCT00784563|62738103|FG000|Years 1 & 2|Adverse Event|0|||
33360577|NCT00784563|62738104|FG001|Years 1 & 2|Adverse Event|3|||
33360578|NCT00784563|62738105|FG002|Years 1 & 2|Adverse Event|0|||
33360579|NCT00784563|62738103|FG000|Year 3|Withdrawal by Subject|0|||
33360580|NCT00784563|62738104|FG001|Year 3|Withdrawal by Subject|0|||
33360581|NCT00784563|62738105|FG002|Year 3|Withdrawal by Subject|2|||
33360582|NCT00784563|62738103|FG000|Year 3|Adverse Event|0|||
33360583|NCT00784563|62738104|FG001|Year 3|Adverse Event|0|||
33360584|NCT00784563|62738105|FG002|Year 3|Adverse Event|1|||
33360585|NCT00938717|62738113|FG000|Overall Study|Adverse Event|10|||
33360586|NCT00938717|62738114|FG001|Overall Study|Adverse Event|41|||
33360587|NCT00938717|62738113|FG000|Overall Study|Protocol Violation|11|||
33360588|NCT00938717|62738114|FG001|Overall Study|Protocol Violation|8|||
33360589|NCT00938717|62738113|FG000|Overall Study|Withdrawal by Subject|26|||
33360590|NCT00938717|62738114|FG001|Overall Study|Withdrawal by Subject|24|||
33360591|NCT00938717|62738113|FG000|Overall Study|Lost to Follow-up|13|||
33360592|NCT00938717|62738114|FG001|Overall Study|Lost to Follow-up|18|||
33360593|NCT00938717|62738113|FG000|Overall Study|Lack of Efficacy|33|||
33360594|NCT00938717|62738114|FG001|Overall Study|Lack of Efficacy|15|||
33360595|NCT00938717|62738113|FG000|Overall Study|Other reason|5|||
33360596|NCT00938717|62738114|FG001|Overall Study|Other reason|2|||
33360597|NCT00587223|62738120|FG000|Overall Study|Adverse Event|1|||
33360598|NCT00938639|62738129|FG000|Overall Study|Moved away from study area|0|||
33360599|NCT00938639|62738130|FG001|Overall Study|Moved away from study area|1|||
33360600|NCT00938639|62738129|FG000|Overall Study|Lost to Follow-up|1|||
33360601|NCT00938639|62738130|FG001|Overall Study|Lost to Follow-up|2|||
33360602|NCT00938639|62738129|FG000|Overall Study|Family issues|1|||
33360603|NCT00938639|62738130|FG001|Overall Study|Family issues|1|||
33360604|NCT00938639|62738129|FG000|Overall Study|Participant noncompliance|1|||
33360605|NCT00938639|62738130|FG001|Overall Study|Participant noncompliance|0|||
33360606|NCT00783705|62738142|FG000|Overall Study|Adverse Event|2|||
33360607|NCT00783705|62738143|FG001|Overall Study|Adverse Event|0|||
33360608|NCT00783705|62738142|FG000|Overall Study|Withdrawal by Subject|3|||
33360609|NCT00783705|62738143|FG001|Overall Study|Withdrawal by Subject|2|||
33360610|NCT00783705|62738142|FG000|Overall Study|Lost to Follow-up|1|||
33360611|NCT00783705|62738143|FG001|Overall Study|Lost to Follow-up|3|||
33360612|NCT00604669|62738149|FG000|Overall Study|lack of information in chart|7|||
33360613|NCT00938327|62738153|FG000|Overall Study|Adverse Event|2|||
33360614|NCT00938327|62738153|FG000|Overall Study|Protocol Violation|1|||
33360615|NCT00938327|62738153|FG000|Overall Study|Withdrawal by Subject|4|||
33360616|NCT00938327|62738153|FG000|Overall Study|Lost to Follow-up|37|||
33360617|NCT00938327|62738153|FG000|Overall Study|2nd dose received outside of the study|7|||
33474722|NCT03882970|62848932|FG002|Overall Study|Personal Reason|1|||
33360618|NCT00938327|62738153|FG000|Overall Study|Vaccine not received as out of stock|9|||
33360619|NCT00887198|62738159|FG000|Randomized Period|Ongoing|42|||
33360620|NCT00887198|62738160|FG001|Randomized Period|Ongoing|0|||
33360621|NCT00887198|62738161|FG002|Randomized Period|Ongoing|0|||
33474723|NCT03882970|62848933|FG003|Overall Study|Personal Reason|3|||
33474724|NCT03730480|62848947|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
33474725|NCT03674112|62848954|FG000|Overall Study|Adverse Event|1|||
33474726|NCT03674112|62848955|FG001|Overall Study|Adverse Event|0|||
33474727|NCT03674112|62848954|FG000|Overall Study|Ongoing in the Study|79|||
33360622|NCT00887198|62738159|FG000|Randomized Period|Adverse Event|50|||
33360623|NCT00887198|62738160|FG001|Randomized Period|Adverse Event|33|||
33360624|NCT00887198|62738161|FG002|Randomized Period|Adverse Event|0|||
33474728|NCT03674112|62848955|FG001|Overall Study|Ongoing in the Study|80|||
33474729|NCT03668808|62848981|FG000|First Intervention|Withdrawal by Subject|2|||
33474730|NCT03668808|62848982|FG001|First Intervention|Withdrawal by Subject|2|||
33474731|NCT02982954|62848994|FG000|Overall Study|Death|55|||
33474732|NCT02982954|62848995|FG001|Overall Study|Death|29|||
33474733|NCT02982954|62848996|FG002|Overall Study|Death|15|||
33474734|NCT02982954|62848997|FG003|Overall Study|Death|20|||
33474735|NCT02982954|62848994|FG000|Overall Study|Lost to Follow-up|2|||
33474736|NCT02982954|62848995|FG001|Overall Study|Lost to Follow-up|1|||
33474737|NCT02982954|62848996|FG002|Overall Study|Lost to Follow-up|0|||
33474738|NCT02982954|62848997|FG003|Overall Study|Lost to Follow-up|0|||
33474739|NCT02982954|62848994|FG000|Overall Study|Participant withdrew consent|7|||
33474740|NCT02982954|62848995|FG001|Overall Study|Participant withdrew consent|5|||
33549411|NCT02477800|62940542|FG004|Long Term Extension Period|Investigator Decision|0|||
33549412|NCT02477800|62940543|FG005|Long Term Extension Period|Investigator Decision|0|||
33549413|NCT02477800|62940544|FG006|Long Term Extension Period|Investigator Decision|2|||
33360625|NCT00887198|62738159|FG000|Randomized Period|Lost to Follow-up|1|||
33360626|NCT00887198|62738160|FG001|Randomized Period|Lost to Follow-up|0|||
33360627|NCT00887198|62738161|FG002|Randomized Period|Lost to Follow-up|0|||
33360628|NCT00887198|62738159|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
33360629|NCT00887198|62738160|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
33360630|NCT00887198|62738161|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
33360631|NCT00887198|62738159|FG000|Randomized Period|Withdrawal by Subject|41|||
33360632|NCT00887198|62738160|FG001|Randomized Period|Withdrawal by Subject|56|||
33360633|NCT00887198|62738161|FG002|Randomized Period|Withdrawal by Subject|0|||
33360634|NCT00887198|62738159|FG000|Randomized Period|Progressive disease|366|||
33360635|NCT00887198|62738160|FG001|Randomized Period|Progressive disease|370|||
33360636|NCT00887198|62738161|FG002|Randomized Period|Progressive disease|0|||
33360637|NCT00887198|62738159|FG000|Randomized Period|Other|42|||
33360638|NCT00887198|62738160|FG001|Randomized Period|Other|30|||
33360639|NCT00887198|62738161|FG002|Randomized Period|Other|0|||
33360640|NCT00887198|62738159|FG000|Randomized Period|Randomized, Not treated|4|||
33360641|NCT00887198|62738160|FG001|Randomized Period|Randomized, Not treated|2|||
33360642|NCT00887198|62738161|FG002|Randomized Period|Randomized, Not treated|0|||
33360643|NCT00887198|62738159|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
33360644|NCT00887198|62738160|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
33360645|NCT00887198|62738161|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
33360646|NCT00887198|62738159|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
33360647|NCT00887198|62738160|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
33360648|NCT00887198|62738161|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
33360649|NCT00887198|62738159|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
33360650|NCT00887198|62738160|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
33360651|NCT00887198|62738161|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
33360652|NCT00887198|62738159|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
33360653|NCT00887198|62738160|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
33360654|NCT00887198|62738161|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
33360655|NCT00887198|62738159|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
33360656|NCT00887198|62738160|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
33360657|NCT00887198|62738161|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
33360658|NCT00887198|62738159|FG000|Cross Over (Placebo to AA)|Other|0|||
33360659|NCT00887198|62738160|FG001|Cross Over (Placebo to AA)|Other|0|||
33360660|NCT00887198|62738161|FG002|Cross Over (Placebo to AA)|Other|19|||
33360661|NCT00782067|62738169|FG000|Overall Study|Adverse Event|35|||
33360662|NCT00782067|62738169|FG000|Overall Study|Subject withdrew consent|11|||
33360663|NCT00782067|62738169|FG000|Overall Study|Lost to Follow-up|2|||
33360664|NCT00782067|62738169|FG000|Overall Study|Administrative problems|14|||
33360665|NCT00782067|62738169|FG000|Overall Study|Death|9|||
33360666|NCT00782067|62738169|FG000|Overall Study|Disease progression|43|||
33360667|NCT00782067|62738169|FG000|Overall Study|Protocol deviation|2|||
33474741|NCT02982954|62848996|FG002|Overall Study|Participant withdrew consent|1|||
33360668|NCT00886340|62738175|FG000|Overall Study|Withdrawal by Subject|0|||
33360669|NCT00886340|62738176|FG001|Overall Study|Withdrawal by Subject|7|||
33360670|NCT00605215|62738185|FG000|Overall Study|Death|0|||
33360671|NCT00605215|62738186|FG001|Overall Study|Death|0|||
33360672|NCT00605215|62738187|FG002|Overall Study|Death|1|||
33360673|NCT00605215|62738185|FG000|Overall Study|Adverse Event|19|||
33360674|NCT00605215|62738186|FG001|Overall Study|Adverse Event|21|||
33360675|NCT00605215|62738187|FG002|Overall Study|Adverse Event|26|||
33360676|NCT00605215|62738185|FG000|Overall Study|Refusal to sign the re-consent form|8|||
33360677|NCT00605215|62738186|FG001|Overall Study|Refusal to sign the re-consent form|3|||
33360678|NCT00605215|62738187|FG002|Overall Study|Refusal to sign the re-consent form|3|||
33360679|NCT00605215|62738185|FG000|Overall Study|Withdrawal by Subject|39|||
33360680|NCT00605215|62738186|FG001|Overall Study|Withdrawal by Subject|37|||
33360681|NCT00605215|62738187|FG002|Overall Study|Withdrawal by Subject|27|||
33360682|NCT00605215|62738185|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
33360683|NCT00605215|62738186|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
33360684|NCT00605215|62738187|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
33360685|NCT00605215|62738185|FG000|Overall Study|Protocol Violation|3|||
33360686|NCT00605215|62738186|FG001|Overall Study|Protocol Violation|4|||
33360687|NCT00605215|62738187|FG002|Overall Study|Protocol Violation|1|||
33360688|NCT00605215|62738185|FG000|Overall Study|Pregnancy|8|||
33360689|NCT00605215|62738186|FG001|Overall Study|Pregnancy|5|||
33360690|NCT00605215|62738187|FG002|Overall Study|Pregnancy|4|||
33360691|NCT00605215|62738185|FG000|Overall Study|Lost to Follow-up|8|||
33360692|NCT00605215|62738186|FG001|Overall Study|Lost to Follow-up|5|||
33360693|NCT00605215|62738187|FG002|Overall Study|Lost to Follow-up|2|||
33360694|NCT00605215|62738185|FG000|Overall Study|Other than specified|0|||
33360695|NCT00605215|62738186|FG001|Overall Study|Other than specified|2|||
33360696|NCT00605215|62738187|FG002|Overall Study|Other than specified|1|||
33360697|NCT00604279|62738197|FG000|Overall Study|Lack of Efficacy|22|||
33360698|NCT00604279|62738198|FG001|Overall Study|Lack of Efficacy|9|||
33360699|NCT00604279|62738197|FG000|Overall Study|Lost to Follow-up|9|||
33360700|NCT00604279|62738198|FG001|Overall Study|Lost to Follow-up|14|||
33360701|NCT00604279|62738197|FG000|Overall Study|Pregnancy|2|||
33360702|NCT00604279|62738198|FG001|Overall Study|Pregnancy|0|||
33360703|NCT00604279|62738197|FG000|Overall Study|Protocol Violation|3|||
33360704|NCT00604279|62738198|FG001|Overall Study|Protocol Violation|1|||
33360705|NCT00604279|62738197|FG000|Overall Study|Withdrawal by Subject|16|||
33360706|NCT00604279|62738198|FG001|Overall Study|Withdrawal by Subject|5|||
33360707|NCT00604279|62738197|FG000|Overall Study|Adverse Event|4|||
33360708|NCT00604279|62738198|FG001|Overall Study|Adverse Event|5|||
33360709|NCT00604279|62738197|FG000|Overall Study|Other|8|||
33360710|NCT00604279|62738198|FG001|Overall Study|Other|4|||
33360711|NCT00938015|62738204|FG000|Overall Study|Death|2|||
33360712|NCT00938015|62738204|FG000|Overall Study|Lost to Follow-up|32|||
33360713|NCT00938015|62738204|FG000|Overall Study|Adverse Event|32|||
33360714|NCT00938015|62738204|FG000|Overall Study|Non-responder|52|||
33360715|NCT00938015|62738204|FG000|Overall Study|Reason not related to Etanercept|29|||
33360716|NCT00781911|62738210|FG000|Overall Study|Adverse Event|4|||
33360717|NCT00781911|62738211|FG001|Overall Study|Adverse Event|4|||
33360718|NCT00781911|62738210|FG000|Overall Study|Withdrawal by Subject|1|||
33360719|NCT00781911|62738211|FG001|Overall Study|Withdrawal by Subject|2|||
33360720|NCT00781911|62738210|FG000|Overall Study|Physician Decision|0|||
33360721|NCT00781911|62738211|FG001|Overall Study|Physician Decision|2|||
33360722|NCT00781911|62738210|FG000|Overall Study|Sponsor Decision|1|||
33360723|NCT00781911|62738211|FG001|Overall Study|Sponsor Decision|0|||
33360724|NCT00605917|62738219|FG000|Overall Study|Protocol Violation|79|||
33360725|NCT00781599|62738256|FG000|Overall Study|Lost to Follow-up|7|||
33360726|NCT00781599|62738257|FG001|Overall Study|Lost to Follow-up|4|||
33360727|NCT00605839|62738275|FG000|Overall Study|Protocol Violation|1|||
33360728|NCT00605839|62738276|FG001|Overall Study|Protocol Violation|0|||
33360729|NCT00605839|62738277|FG002|Overall Study|Protocol Violation|0|||
33360730|NCT00781365|62738287|FG000|Overall Study|Withdrawal by Subject|13|||
33360731|NCT00781365|62738288|FG001|Overall Study|Withdrawal by Subject|8|||
33360732|NCT00781365|62738287|FG000|Overall Study|Did Not Attend Visit|20|||
33360733|NCT00781365|62738288|FG001|Overall Study|Did Not Attend Visit|28|||
33360734|NCT00781365|62738287|FG000|Overall Study|Language barrier|1|||
33360735|NCT00781365|62738288|FG001|Overall Study|Language barrier|0|||
33360736|NCT00937547|62738297|FG000|Overall Study|misdiagnosis|1|||
33360737|NCT00937547|62738298|FG001|Overall Study|misdiagnosis|6|||
33360738|NCT00937547|62738299|FG002|Overall Study|misdiagnosis|7|||
33360739|NCT00780975|62738307|FG000|Overall Study|Progressive disease|3|||
33360740|NCT00780975|62738307|FG000|Overall Study|Toxicity|5|||
33360741|NCT00780273|62738311|FG000|Overall Study|Death|1|||
33360742|NCT00780273|62738311|FG000|Overall Study|Lost to Follow-up|1|||
33360743|NCT00779259|62738316|FG000|Quinine Alone|Adverse Event|2|||
33360744|NCT00779025|62738334|FG000|Overall Study|Withdrawal by Subject|1|||
33360745|NCT00936065|62738342|FG000|Overall Study|Adverse Event|1|||
33360746|NCT00936065|62738343|FG001|Overall Study|Adverse Event|0|||
33360747|NCT00936065|62738344|FG002|Overall Study|Adverse Event|1|||
33360748|NCT00936065|62738342|FG000|Overall Study|Lack of Efficacy|1|||
33474742|NCT02982954|62848997|FG003|Overall Study|Participant withdrew consent|1|||
33474743|NCT02982954|62848994|FG000|Overall Study|Other reasons|42|||
33474744|NCT02982954|62848995|FG001|Overall Study|Other reasons|17|||
33474745|NCT02982954|62848996|FG002|Overall Study|Other reasons|12|||
33474746|NCT02982954|62848997|FG003|Overall Study|Other reasons|3|||
33474747|NCT02982954|62848994|FG000|Overall Study|Premature site closure|0|||
33474748|NCT02982954|62848995|FG001|Overall Study|Premature site closure|0|||
33474749|NCT02982954|62848996|FG002|Overall Study|Premature site closure|0|||
33474750|NCT02982954|62848997|FG003|Overall Study|Premature site closure|1|||
33474751|NCT03724968|62849009|FG000|Overall Study|Insurance issues|0|||
33474752|NCT03724968|62849010|FG001|Overall Study|Insurance issues|1|||
33474753|NCT03724968|62849009|FG000|Overall Study|Study closed|0|||
33474754|NCT03724968|62849010|FG001|Overall Study|Study closed|1|||
33474755|NCT03724812|62849016|FG000|Overall Study|Missed Visit|1|||
33474756|NCT03724812|62849016|FG000|Overall Study|Death|2|||
33474757|NCT03724812|62849016|FG000|Overall Study|Withdrawal by Subject|1|||
33360749|NCT00936065|62738343|FG001|Overall Study|Lack of Efficacy|0|||
33360750|NCT00936065|62738344|FG002|Overall Study|Lack of Efficacy|1|||
33360751|NCT00936065|62738342|FG000|Overall Study|Lost to Follow-up|1|||
33360752|NCT00936065|62738343|FG001|Overall Study|Lost to Follow-up|0|||
33360753|NCT00936065|62738344|FG002|Overall Study|Lost to Follow-up|0|||
33360754|NCT00936065|62738342|FG000|Overall Study|Protocol Violation|1|||
33360755|NCT00936065|62738343|FG001|Overall Study|Protocol Violation|2|||
33360756|NCT00936065|62738344|FG002|Overall Study|Protocol Violation|1|||
33360757|NCT00936065|62738342|FG000|Overall Study|Withdrawal by Subject|0|||
33360758|NCT00936065|62738343|FG001|Overall Study|Withdrawal by Subject|2|||
33360759|NCT00936065|62738344|FG002|Overall Study|Withdrawal by Subject|4|||
33360760|NCT04441788|62738355|FG000|Overall Study|Voluntary Withdrawl|0|||
33360761|NCT04441788|62738356|FG001|Overall Study|Voluntary Withdrawl|1|||
33360762|NCT04441788|62738357|FG002|Overall Study|Voluntary Withdrawl|0|||
33360763|NCT04441788|62738355|FG000|Overall Study|Ineligibility|1|||
33360764|NCT04441788|62738356|FG001|Overall Study|Ineligibility|0|||
33360765|NCT04441788|62738357|FG002|Overall Study|Ineligibility|0|||
33360766|NCT04441788|62738355|FG000|Overall Study|Adverse Event|0|||
33360767|NCT04441788|62738356|FG001|Overall Study|Adverse Event|0|||
33360768|NCT04441788|62738357|FG002|Overall Study|Adverse Event|4|||
33360769|NCT04441788|62738355|FG000|Overall Study|Study Terminated by Sponsor|16|||
33360770|NCT04441788|62738356|FG001|Overall Study|Study Terminated by Sponsor|16|||
33360771|NCT04441788|62738357|FG002|Overall Study|Study Terminated by Sponsor|12|||
33474758|NCT03722784|62849023|FG000|Overall Study|Withdrawal by Subject|1|||
33474759|NCT03722784|62849024|FG001|Overall Study|Withdrawal by Subject|0|||
33474760|NCT03722784|62849023|FG000|Overall Study|Physician Decision|1|||
33474761|NCT03722784|62849024|FG001|Overall Study|Physician Decision|1|||
33474762|NCT03722784|62849023|FG000|Overall Study|Protocol Violation|0|||
33474763|NCT03722784|62849024|FG001|Overall Study|Protocol Violation|1|||
33474764|NCT03722238|62849033|FG000|Overall Study|Protocol Violation|1|||
33474765|NCT03722238|62849034|FG001|Overall Study|Protocol Violation|0|||
33474766|NCT03722238|62849033|FG000|Overall Study|Physician Decision|1|||
33474767|NCT03722238|62849034|FG001|Overall Study|Physician Decision|0|||
33474768|NCT03722238|62849033|FG000|Overall Study|Death|1|||
33474769|NCT03722238|62849034|FG001|Overall Study|Death|0|||
33474770|NCT03722238|62849033|FG000|Overall Study|Lost to Follow-up|6|||
33474771|NCT03722238|62849034|FG001|Overall Study|Lost to Follow-up|0|||
33474772|NCT03722238|62849033|FG000|Overall Study|Partial missing data|44|||
33474773|NCT03722238|62849034|FG001|Overall Study|Partial missing data|1|||
33474774|NCT03722238|62849033|FG000|Overall Study|Withdrawal by Subject|2|||
33474775|NCT03722238|62849034|FG001|Overall Study|Withdrawal by Subject|0|||
33474776|NCT03722238|62849033|FG000|Overall Study|Other|4|||
33474777|NCT03722238|62849034|FG001|Overall Study|Other|0|||
33474778|NCT03722238|62849033|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
33474779|NCT03722238|62849034|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
33474780|NCT03722238|62849033|FG000|Overall Study|Did not meet risk classification group criteria|90|||
33474781|NCT03722238|62849034|FG001|Overall Study|Did not meet risk classification group criteria|0|||
33474782|NCT03722238|62849033|FG000|Overall Study|Did not sign consent|17|||
33360772|NCT00604825|62738373|FG000|Overall Study|Adverse Event|2|||
33474783|NCT03722238|62849034|FG001|Overall Study|Did not sign consent|0|||
33360773|NCT00604825|62738374|FG001|Overall Study|Adverse Event|6|||
33360774|NCT00604825|62738375|FG002|Overall Study|Adverse Event|7|||
33360775|NCT00604825|62738376|FG003|Overall Study|Adverse Event|4|||
33474784|NCT03722238|62849033|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
33474785|NCT03722238|62849034|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
33474786|NCT03722238|62849033|FG000|Overall Study|Not willing to purchase study medication|142|||
33474787|NCT03722238|62849034|FG001|Overall Study|Not willing to purchase study medication|0|||
33360776|NCT00604825|62738373|FG000|Overall Study|Lost to Follow-up|0|||
33360777|NCT00604825|62738374|FG001|Overall Study|Lost to Follow-up|3|||
33360778|NCT00604825|62738375|FG002|Overall Study|Lost to Follow-up|1|||
33474788|NCT03722238|62849033|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
33474789|NCT03722238|62849034|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
33360779|NCT00604825|62738376|FG003|Overall Study|Lost to Follow-up|0|||
33360780|NCT00604825|62738373|FG000|Overall Study|Protocol Violation|0|||
33360781|NCT00604825|62738374|FG001|Overall Study|Protocol Violation|1|||
33474790|NCT02927080|62849050|FG000|Overall Study|Withdrawal by Subject|0|||
33474791|NCT02927080|62849051|FG001|Overall Study|Withdrawal by Subject|0|||
33474792|NCT02927080|62849052|FG002|Overall Study|Withdrawal by Subject|0|||
33474793|NCT02927080|62849053|FG003|Overall Study|Withdrawal by Subject|0|||
33474794|NCT02927080|62849054|FG004|Overall Study|Withdrawal by Subject|1|||
33474795|NCT02927080|62849055|FG005|Overall Study|Withdrawal by Subject|0|||
33474796|NCT02927080|62849056|FG006|Overall Study|Withdrawal by Subject|1|||
33474797|NCT02927080|62849057|FG007|Overall Study|Withdrawal by Subject|1|||
33474798|NCT02927080|62849058|FG008|Overall Study|Withdrawal by Subject|0|||
33474799|NCT02927080|62849059|FG009|Overall Study|Withdrawal by Subject|2|||
33474800|NCT02927080|62849050|FG000|Overall Study|Willingness to comply with protocol|0|||
33474801|NCT02927080|62849051|FG001|Overall Study|Willingness to comply with protocol|0|||
33474802|NCT02927080|62849052|FG002|Overall Study|Willingness to comply with protocol|0|||
33474803|NCT02927080|62849053|FG003|Overall Study|Willingness to comply with protocol|0|||
33474804|NCT02927080|62849054|FG004|Overall Study|Willingness to comply with protocol|0|||
33474805|NCT02927080|62849055|FG005|Overall Study|Willingness to comply with protocol|0|||
33474806|NCT02927080|62849056|FG006|Overall Study|Willingness to comply with protocol|0|||
33474807|NCT02927080|62849057|FG007|Overall Study|Willingness to comply with protocol|0|||
33474808|NCT02927080|62849058|FG008|Overall Study|Willingness to comply with protocol|0|||
33474809|NCT02927080|62849059|FG009|Overall Study|Willingness to comply with protocol|1|||
33474810|NCT02927080|62849050|FG000|Overall Study|Study terminated by Sponsor|0|||
33474811|NCT02927080|62849051|FG001|Overall Study|Study terminated by Sponsor|0|||
33474812|NCT02927080|62849052|FG002|Overall Study|Study terminated by Sponsor|0|||
33474813|NCT02927080|62849053|FG003|Overall Study|Study terminated by Sponsor|0|||
33474814|NCT02927080|62849054|FG004|Overall Study|Study terminated by Sponsor|0|||
33474815|NCT02927080|62849055|FG005|Overall Study|Study terminated by Sponsor|0|||
33474816|NCT02927080|62849056|FG006|Overall Study|Study terminated by Sponsor|6|||
33474817|NCT02927080|62849057|FG007|Overall Study|Study terminated by Sponsor|7|||
33474818|NCT02927080|62849058|FG008|Overall Study|Study terminated by Sponsor|2|||
33474819|NCT02927080|62849059|FG009|Overall Study|Study terminated by Sponsor|3|||
33474820|NCT02927080|62849050|FG000|Overall Study|Adverse Event|0|||
33474821|NCT02927080|62849051|FG001|Overall Study|Adverse Event|1|||
33474822|NCT02927080|62849052|FG002|Overall Study|Adverse Event|0|||
33360782|NCT00604825|62738375|FG002|Overall Study|Protocol Violation|0|||
33360783|NCT00604825|62738376|FG003|Overall Study|Protocol Violation|0|||
33360784|NCT00604825|62738373|FG000|Overall Study|Withdrawal by Subject|4|||
33360785|NCT00604825|62738374|FG001|Overall Study|Withdrawal by Subject|3|||
33360786|NCT00604825|62738375|FG002|Overall Study|Withdrawal by Subject|5|||
33360787|NCT00604825|62738376|FG003|Overall Study|Withdrawal by Subject|5|||
33360788|NCT00604825|62738373|FG000|Overall Study|Lack of Efficacy|3|||
33360789|NCT00604825|62738374|FG001|Overall Study|Lack of Efficacy|2|||
33360790|NCT00604825|62738375|FG002|Overall Study|Lack of Efficacy|1|||
33360791|NCT00604825|62738376|FG003|Overall Study|Lack of Efficacy|0|||
33360792|NCT00604825|62738373|FG000|Overall Study|Did not meet eligibility criteria|0|||
33360793|NCT00604825|62738374|FG001|Overall Study|Did not meet eligibility criteria|0|||
33360794|NCT00604825|62738375|FG002|Overall Study|Did not meet eligibility criteria|2|||
33360795|NCT00604825|62738376|FG003|Overall Study|Did not meet eligibility criteria|0|||
33360796|NCT00604825|62738373|FG000|Overall Study|Physician Decision|0|||
33360797|NCT00604825|62738374|FG001|Overall Study|Physician Decision|0|||
33360798|NCT00604825|62738375|FG002|Overall Study|Physician Decision|0|||
33360799|NCT00604825|62738376|FG003|Overall Study|Physician Decision|1|||
33360800|NCT00604825|62738373|FG000|Overall Study|Exclusion criterion met|0|||
33360801|NCT00604825|62738374|FG001|Overall Study|Exclusion criterion met|0|||
33360802|NCT00604825|62738375|FG002|Overall Study|Exclusion criterion met|0|||
33360803|NCT00604825|62738376|FG003|Overall Study|Exclusion criterion met|1|||
33360804|NCT00937391|62738388|FG000|Stage 2|Withdrawal by Subject|1|||
33360805|NCT00937157|62738405|FG000|Overall Study|Pregnancy|1|||
33360806|NCT00937157|62738405|FG000|Overall Study|Lost to Follow-up|3|||
33360807|NCT00777153|62738412|FG000|Overall Study|Lost to Follow-up|1|||
33360808|NCT00777153|62738413|FG001|Overall Study|Lost to Follow-up|1|||
33360809|NCT00777153|62738414|FG002|Overall Study|Lost to Follow-up|0|||
33474823|NCT02927080|62849053|FG003|Overall Study|Adverse Event|0|||
33474824|NCT02927080|62849054|FG004|Overall Study|Adverse Event|0|||
33474825|NCT02927080|62849055|FG005|Overall Study|Adverse Event|0|||
33474826|NCT02927080|62849056|FG006|Overall Study|Adverse Event|0|||
33474827|NCT02927080|62849057|FG007|Overall Study|Adverse Event|1|||
33474828|NCT02927080|62849058|FG008|Overall Study|Adverse Event|0|||
33360810|NCT00777153|62738412|FG000|Overall Study|Death|85|||
33360811|NCT00777153|62738413|FG001|Overall Study|Death|73|||
33360812|NCT00777153|62738414|FG002|Overall Study|Death|33|||
33360813|NCT00777153|62738412|FG000|Overall Study|Withdrawal by Subject|3|||
33360814|NCT00777153|62738413|FG001|Overall Study|Withdrawal by Subject|4|||
33360815|NCT00777153|62738414|FG002|Overall Study|Withdrawal by Subject|3|||
33360816|NCT00777153|62738412|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
33360817|NCT00777153|62738413|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
33360818|NCT00777153|62738414|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
33360819|NCT00567541|62738428|FG000|Overall Study|Adverse Event|0|||
33360820|NCT00567541|62738429|FG001|Overall Study|Adverse Event|1|||
33360821|NCT00776997|62738435|FG000|Overall Study|Adverse Event|2|||
33360822|NCT00940823|62738441|FG000|Overall Study|Death|8|||
33360823|NCT00940823|62738442|FG001|Overall Study|Death|12|||
33360824|NCT00940823|62738441|FG000|Overall Study|Lost to Follow-up|27|||
33360825|NCT00940823|62738442|FG001|Overall Study|Lost to Follow-up|20|||
33360826|NCT00936611|62738450|FG000|Overall Study|Progressive Disease|3|||
33360827|NCT00936611|62738450|FG000|Overall Study|New Systemic Therapy|22|||
33360828|NCT00936611|62738450|FG000|Overall Study|Lost to Follow-up|1|||
33360829|NCT00936611|62738450|FG000|Overall Study|Withdrawal by Subject|2|||
33360830|NCT00936611|62738450|FG000|Overall Study|Still on Follow-up|1|||
33360831|NCT00936611|62738450|FG000|Overall Study|Still on Active Therapy|7|||
33360832|NCT00936611|62738450|FG000|Overall Study|Ineligible for Study Drug|3|||
33360833|NCT00936221|62738473|FG000|Overall Study|Withdrawal by Subject|1|||
33360834|NCT00936221|62738474|FG001|Overall Study|Withdrawal by Subject|1|||
33360835|NCT00776919|62738484|FG000|Overall Study|Withdrawal by Subject|16|||
33360836|NCT00776919|62738485|FG001|Overall Study|Withdrawal by Subject|14|||
33360837|NCT00776919|62738486|FG002|Overall Study|Withdrawal by Subject|15|||
33360838|NCT00776919|62738487|FG003|Overall Study|Withdrawal by Subject|26|||
33360839|NCT00776919|62738484|FG000|Overall Study|Lost to Follow-up|8|||
33360840|NCT00776919|62738485|FG001|Overall Study|Lost to Follow-up|12|||
33360841|NCT00776919|62738486|FG002|Overall Study|Lost to Follow-up|11|||
33360842|NCT00776919|62738487|FG003|Overall Study|Lost to Follow-up|8|||
33360843|NCT00776919|62738484|FG000|Overall Study|Adverse Event|1|||
33360844|NCT00776919|62738485|FG001|Overall Study|Adverse Event|0|||
33360845|NCT00776919|62738486|FG002|Overall Study|Adverse Event|2|||
33360846|NCT00776919|62738487|FG003|Overall Study|Adverse Event|2|||
33360847|NCT00776919|62738484|FG000|Overall Study|Protocol Violation|1|||
33360848|NCT00776919|62738485|FG001|Overall Study|Protocol Violation|2|||
33360849|NCT00776919|62738486|FG002|Overall Study|Protocol Violation|0|||
33360850|NCT00776919|62738487|FG003|Overall Study|Protocol Violation|1|||
33360851|NCT00776919|62738484|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
33360852|NCT00776919|62738485|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
33360853|NCT00776919|62738486|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
33360854|NCT00776919|62738487|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
33360855|NCT00775983|62738514|FG000|Overall Study|Protocol Violation|1|||
33360856|NCT00775983|62738515|FG001|Overall Study|Protocol Violation|2|||
33360857|NCT00775593|62738521|FG000|Overall Study|Unmet eligibility criteria|6|||
33360858|NCT00775593|62738521|FG000|Overall Study|Death|1|||
33360859|NCT00939809|62738525|FG000|Overall Study|Adverse Event|2|||
33360860|NCT00939809|62738525|FG000|Overall Study|Death|1|||
33360861|NCT00934661|62738531|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
33360862|NCT00934661|62738532|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
33360863|NCT00775437|62738538|FG000|Overall Study|Loss of efficacy|2|||
33360864|NCT00775437|62738538|FG000|Overall Study|Withdrawal by Subject|3|||
33360865|NCT00775437|62738538|FG000|Overall Study|Lost to Follow-up|1|||
33360866|NCT00775203|62738544|FG000|Overall Study|Adverse Event|25|||
33360867|NCT00775203|62738545|FG001|Overall Study|Adverse Event|6|||
33360868|NCT00775203|62738544|FG000|Overall Study|Lack of Efficacy|8|||
33360869|NCT00775203|62738545|FG001|Overall Study|Lack of Efficacy|9|||
33655564|NCT00635427|63071184|FG004|Overall Study|Death|0|||
33360870|NCT00775203|62738544|FG000|Overall Study|Withdrawal by Subject|11|||
33360871|NCT00775203|62738545|FG001|Overall Study|Withdrawal by Subject|9|||
33360872|NCT00775203|62738544|FG000|Overall Study|Lost to Follow-up|11|||
33360873|NCT00775203|62738545|FG001|Overall Study|Lost to Follow-up|15|||
33360874|NCT00775203|62738544|FG000|Overall Study|Administrative reason|2|||
33360875|NCT00775203|62738545|FG001|Overall Study|Administrative reason|0|||
33360876|NCT00775203|62738544|FG000|Overall Study|Noncompliance|4|||
33360877|NCT00775203|62738545|FG001|Overall Study|Noncompliance|2|||
33360878|NCT00775203|62738544|FG000|Overall Study|Protocol Violation|0|||
33360879|NCT00775203|62738545|FG001|Overall Study|Protocol Violation|1|||
33360880|NCT00775203|62738544|FG000|Overall Study|Entered other study|1|||
33360881|NCT00775203|62738545|FG001|Overall Study|Entered other study|0|||
33360882|NCT00775203|62738544|FG000|Overall Study|Physician Decision|0|||
33360883|NCT00775203|62738545|FG001|Overall Study|Physician Decision|1|||
33360884|NCT00568321|62738554|FG000|Overall Study|Adverse Event|1|||
33360885|NCT00568321|62738555|FG001|Overall Study|Adverse Event|0|||
33360886|NCT00568321|62738556|FG002|Overall Study|Adverse Event|0|||
33360887|NCT00568321|62738554|FG000|Overall Study|Lack of Efficacy|8|||
33360888|NCT00568321|62738555|FG001|Overall Study|Lack of Efficacy|5|||
33360889|NCT00568321|62738556|FG002|Overall Study|Lack of Efficacy|6|||
33360890|NCT00568321|62738554|FG000|Overall Study|Lost to Follow-up|0|||
33360891|NCT00568321|62738555|FG001|Overall Study|Lost to Follow-up|0|||
33360892|NCT00568321|62738556|FG002|Overall Study|Lost to Follow-up|1|||
33360893|NCT00568321|62738554|FG000|Overall Study|Withdrawal by Subject|2|||
33360894|NCT00568321|62738555|FG001|Overall Study|Withdrawal by Subject|0|||
33360895|NCT00568321|62738556|FG002|Overall Study|Withdrawal by Subject|0|||
33360896|NCT00568321|62738554|FG000|Overall Study|Protocol Violation|0|||
33360897|NCT00568321|62738555|FG001|Overall Study|Protocol Violation|0|||
33360898|NCT00568321|62738556|FG002|Overall Study|Protocol Violation|1|||
33360899|NCT00568321|62738554|FG000|Overall Study|Randomized, not treated|2|||
33360900|NCT00568321|62738555|FG001|Overall Study|Randomized, not treated|0|||
33360901|NCT00568321|62738556|FG002|Overall Study|Randomized, not treated|1|||
33360902|NCT00774345|62738568|FG000|Pre-treatment|Other reasons|2|||
33360903|NCT00774345|62738569|FG001|Pre-treatment|Other reasons|0|||
33360904|NCT00774345|62738568|FG000|Treatment|Adverse Event|61|||
33360905|NCT00774345|62738569|FG001|Treatment|Adverse Event|15|||
33360906|NCT00774345|62738568|FG000|Treatment|Progressive Disease without histologic transformation|51|||
33360907|NCT00774345|62738569|FG001|Treatment|Progressive Disease without histologic transformation|111|||
33360908|NCT00774345|62738568|FG000|Treatment|Progressive Disease with histologic transformation|4|||
33360909|NCT00774345|62738569|FG001|Treatment|Progressive Disease with histologic transformation|2|||
33360910|NCT00774345|62738568|FG000|Treatment|Withdrawal by Subject|5|||
33360911|NCT00774345|62738569|FG001|Treatment|Withdrawal by Subject|2|||
33360912|NCT00774345|62738568|FG000|Treatment|Lost to Follow-up|1|||
33360913|NCT00774345|62738569|FG001|Treatment|Lost to Follow-up|1|||
33360914|NCT00774345|62738568|FG000|Treatment|Death|4|||
33360915|NCT00774345|62738569|FG001|Treatment|Death|0|||
33360916|NCT00774345|62738568|FG000|Treatment|Other Reasons|32|||
33360917|NCT00774345|62738569|FG001|Treatment|Other Reasons|26|||
33360918|NCT00773253|62738581|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
33360919|NCT00773253|62738582|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
33360920|NCT00773175|62738592|FG000|Overall Study|Adverse Event|2|||
33360921|NCT00773175|62738593|FG001|Overall Study|Adverse Event|0|||
33360922|NCT00773175|62738592|FG000|Overall Study|Consent Withdrawn|0|||
33360923|NCT00773175|62738593|FG001|Overall Study|Consent Withdrawn|2|||
33360924|NCT00566527|62738607|FG000|Overall Study|Reason not provided|3|||
33360925|NCT00566527|62738608|FG001|Overall Study|Reason not provided|11|||
33360926|NCT00566527|62738609|FG002|Overall Study|Reason not provided|10|||
33360927|NCT00566527|62738607|FG000|Overall Study|Adverse Event|2|||
33360928|NCT00566527|62738608|FG001|Overall Study|Adverse Event|0|||
33360929|NCT00566527|62738609|FG002|Overall Study|Adverse Event|1|||
33360930|NCT00566527|62738607|FG000|Overall Study|Physician Decision|3|||
33360931|NCT00566527|62738608|FG001|Overall Study|Physician Decision|8|||
33360932|NCT00566527|62738609|FG002|Overall Study|Physician Decision|20|||
33360933|NCT00566527|62738607|FG000|Overall Study|Lost to Follow-up|3|||
33360934|NCT00566527|62738608|FG001|Overall Study|Lost to Follow-up|4|||
33360935|NCT00566527|62738609|FG002|Overall Study|Lost to Follow-up|4|||
33360936|NCT00566527|62738607|FG000|Overall Study|Withdrawal by Subject|6|||
33360937|NCT00566527|62738608|FG001|Overall Study|Withdrawal by Subject|43|||
33360938|NCT00566527|62738609|FG002|Overall Study|Withdrawal by Subject|43|||
33360939|NCT00773097|62738619|FG000|Overall Study|Withdrawal by Subject|1|||
33360940|NCT00773097|62738619|FG000|Overall Study|Physician Decision|6|||
33360941|NCT00933335|62738625|FG000|Overall Study|Lost to Follow-up|1|||
33360942|NCT00933335|62738626|FG001|Overall Study|Lost to Follow-up|3|||
33360943|NCT00933335|62738625|FG000|Overall Study|Withdrawal by Subject|0|||
33655565|NCT00635427|63071180|FG000|Overall Study|Termination Of Study By Sponsor|12|||
33360944|NCT00933335|62738626|FG001|Overall Study|Withdrawal by Subject|1|||
33360945|NCT00933335|62738625|FG000|Overall Study|Progressive Disease|0|||
33360946|NCT00933335|62738626|FG001|Overall Study|Progressive Disease|11|||
33360947|NCT00933335|62738625|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
33360948|NCT00933335|62738626|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
33360949|NCT00933335|62738625|FG000|Overall Study|Co-morbid Illness|1|||
33360950|NCT00933335|62738626|FG001|Overall Study|Co-morbid Illness|0|||
33360951|NCT00772941|62738638|FG000|Overall Study|CRFs not available|195|||
33360952|NCT00772941|62738638|FG000|Overall Study|Study not completed|16|||
33360953|NCT00772941|62738638|FG000|Overall Study|Missed Visits|374|||
33360954|NCT00772941|62738638|FG000|Overall Study|Poor Compliance|7|||
33360955|NCT00772941|62738638|FG000|Overall Study|GPSP Violation|90|||
33360956|NCT00772707|62738665|FG000|Overall Study|Withdrawn|3|||
33474829|NCT02927080|62849059|FG009|Overall Study|Adverse Event|1|||
33360957|NCT00772629|62738671|FG000|Overall Study|Subject was not vaccinated|1|||
33360958|NCT00772629|62738672|FG001|Overall Study|Subject was not vaccinated|0|||
33360959|NCT00939341|62738678|FG000|Overall Study|Adverse Event|15|||
33360960|NCT00939341|62738678|FG000|Overall Study|Pregnancy|1|||
33360961|NCT00939341|62738678|FG000|Overall Study|Lost to Follow-up|23|||
33360962|NCT00939341|62738678|FG000|Overall Study|Withdrawal by Subject|13|||
33360963|NCT00939341|62738678|FG000|Overall Study|Protocol Violation|6|||
33360964|NCT00939341|62738678|FG000|Overall Study|Incorrect enrolment|8|||
33360965|NCT04292470|62738707|FG000|Overall Study|Withdrawal by Subject|0|||
33360966|NCT04292470|62738708|FG001|Overall Study|Withdrawal by Subject|1|||
33360967|NCT04217590|62738716|FG000|Overall Study|Other|1|||
33360968|NCT04217590|62738717|FG001|Overall Study|Other|1|||
33360969|NCT04217590|62738716|FG000|Overall Study|Withdrawal by Subject|3|||
33360970|NCT04217590|62738717|FG001|Overall Study|Withdrawal by Subject|1|||
33360971|NCT04217590|62738716|FG000|Overall Study|Death|0|||
33360972|NCT04217590|62738717|FG001|Overall Study|Death|1|||
33360973|NCT03963232|62738725|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
33360974|NCT03963232|62738726|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
33360975|NCT03963232|62738725|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
33360976|NCT03963232|62738726|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
33360977|NCT03963232|62738725|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
33360978|NCT03963232|62738726|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
33360979|NCT03963232|62738725|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
33360980|NCT03963232|62738726|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
33360981|NCT03963232|62738725|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
33360982|NCT03963232|62738726|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
33360983|NCT03963232|62738725|FG000|Open-Label Treatment Phase|Adverse Event|1|||
33360984|NCT03963232|62738726|FG001|Open-Label Treatment Phase|Adverse Event|2|||
33360985|NCT03963232|62738725|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
33360986|NCT03963232|62738726|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
33360987|NCT03963232|62738725|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
33360988|NCT03963232|62738726|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
33360989|NCT03963232|62738725|FG000|Open-Label Treatment Phase|Pregnancy|1|||
33360990|NCT03963232|62738726|FG001|Open-Label Treatment Phase|Pregnancy|0|||
33360991|NCT03963232|62738725|FG000|Follow-up Phase|Withdrawal by Subject|7|||
33360992|NCT03963232|62738726|FG001|Follow-up Phase|Withdrawal by Subject|5|||
33360993|NCT03963232|62738725|FG000|Follow-up Phase|Protocol Violation|0|||
33360994|NCT03963232|62738726|FG001|Follow-up Phase|Protocol Violation|2|||
33360995|NCT03963232|62738725|FG000|Follow-up Phase|Adverse Event|0|||
33360996|NCT03963232|62738726|FG001|Follow-up Phase|Adverse Event|1|||
33360997|NCT03963232|62738725|FG000|Follow-up Phase|Lost to Follow-up|0|||
33360998|NCT03963232|62738726|FG001|Follow-up Phase|Lost to Follow-up|1|||
33360999|NCT03856593|62738750|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
33361000|NCT03856593|62738751|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
33474830|NCT02927080|62849050|FG000|Overall Study|Other|0|||
33474831|NCT02927080|62849051|FG001|Overall Study|Other|0|||
33474832|NCT02927080|62849052|FG002|Overall Study|Other|0|||
33474833|NCT02927080|62849053|FG003|Overall Study|Other|0|||
33474834|NCT02927080|62849054|FG004|Overall Study|Other|0|||
33474835|NCT02927080|62849055|FG005|Overall Study|Other|0|||
33474836|NCT02927080|62849056|FG006|Overall Study|Other|1|||
33474837|NCT02927080|62849057|FG007|Overall Study|Other|0|||
33474838|NCT02927080|62849058|FG008|Overall Study|Other|1|||
33474839|NCT02927080|62849059|FG009|Overall Study|Other|0|||
33474840|NCT02374476|62849106|FG000|VT Induced Ablation|Screening Failures|36|||
33474841|NCT02374476|62849107|FG001|VT Induced Ablation|Screening Failures|0|||
33474842|NCT02374476|62849108|FG002|VT Induced Ablation|Screening Failures|0|||
33361001|NCT03785925|62738759|FG000|Overall Study|Withdrawal by Subject|15|||
33361002|NCT03785925|62738759|FG000|Overall Study|Lost to Follow-up|1|||
33361003|NCT03427411|62738770|FG000|Overall Study|Screen failure - platelets too low|0|||
33361004|NCT03427411|62738771|FG001|Overall Study|Screen failure - platelets too low|1|||
33361005|NCT03330106|62738779|FG000|Part A|Withdrawal by Subject|1|||
33361006|NCT03330106|62738780|FG001|Part A|Withdrawal by Subject|1|||
33361007|NCT03330106|62738781|FG002|Part A|Withdrawal by Subject|0|||
33361008|NCT03330106|62738782|FG003|Part A|Withdrawal by Subject|0|||
33361009|NCT03330106|62738779|FG000|Part A|Death|2|||
33361010|NCT03330106|62738780|FG001|Part A|Death|1|||
33361011|NCT03330106|62738781|FG002|Part A|Death|0|||
33361012|NCT03330106|62738782|FG003|Part A|Death|0|||
33361013|NCT03330106|62738779|FG000|Part A|Adverse Event|0|||
33361014|NCT03330106|62738780|FG001|Part A|Adverse Event|1|||
33361015|NCT03330106|62738781|FG002|Part A|Adverse Event|0|||
33361016|NCT03330106|62738782|FG003|Part A|Adverse Event|0|||
33474843|NCT02374476|62849106|FG000|Arm Assignment|Withdrawal by Subject|0|||
33474844|NCT02374476|62849107|FG001|Arm Assignment|Withdrawal by Subject|0|||
33474845|NCT02374476|62849108|FG002|Arm Assignment|Withdrawal by Subject|1|||
33474846|NCT02918292|62849115|FG000|Study Enrollment Prior to Transplant|Death|1|||
33361017|NCT03330106|62738779|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
33361018|NCT03330106|62738780|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
33361019|NCT03330106|62738781|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
33361020|NCT03330106|62738782|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
33361021|NCT03330106|62738779|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
33361022|NCT03330106|62738780|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
33361023|NCT03330106|62738781|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
33361024|NCT03330106|62738782|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
33361025|NCT03330106|62738779|FG000|Part A|Progressive Disease|0|||
33361026|NCT03330106|62738780|FG001|Part A|Progressive Disease|1|||
33361027|NCT03330106|62738781|FG002|Part A|Progressive Disease|0|||
33361028|NCT03330106|62738782|FG003|Part A|Progressive Disease|0|||
33361029|NCT03330106|62738779|FG000|Part B|Lost to Follow-up|0|||
33361030|NCT03330106|62738780|FG001|Part B|Lost to Follow-up|0|||
33361031|NCT03330106|62738781|FG002|Part B|Lost to Follow-up|0|||
33361032|NCT03330106|62738782|FG003|Part B|Lost to Follow-up|1|||
33361033|NCT03330106|62738779|FG000|Part B|Withdrawal by Subject|0|||
33361034|NCT03330106|62738780|FG001|Part B|Withdrawal by Subject|0|||
33361035|NCT03330106|62738781|FG002|Part B|Withdrawal by Subject|4|||
33361036|NCT03330106|62738782|FG003|Part B|Withdrawal by Subject|0|||
33361037|NCT03330106|62738779|FG000|Part B|Death|0|||
33361038|NCT03330106|62738780|FG001|Part B|Death|0|||
33361039|NCT03330106|62738781|FG002|Part B|Death|2|||
33361040|NCT03330106|62738782|FG003|Part B|Death|0|||
33361041|NCT03330106|62738779|FG000|Part B|Clinical Progression|0|||
33361042|NCT03330106|62738780|FG001|Part B|Clinical Progression|0|||
33361043|NCT03330106|62738781|FG002|Part B|Clinical Progression|1|||
33361044|NCT03330106|62738782|FG003|Part B|Clinical Progression|1|||
33361045|NCT03330106|62738779|FG000|Part B|Symptomatic Deterioration|0|||
33474847|NCT02918292|62849115|FG000|Study Follow up After Transplant|Death|6|||
33474848|NCT03720210|62849119|FG000|Overall Study|Lost to Follow-up|1|||
33474849|NCT03719586|62849127|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
33474850|NCT03719586|62849128|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
33474851|NCT03719586|62849129|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
33474852|NCT03719586|62849130|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
33474853|NCT03353350|62849156|FG000|30-week Core Treatment Period|Protocol Violation|1|||
33474854|NCT03353350|62849157|FG001|30-week Core Treatment Period|Protocol Violation|1|||
33474855|NCT03353350|62849158|FG002|30-week Core Treatment Period|Protocol Violation|1|||
33474856|NCT03353350|62849159|FG003|30-week Core Treatment Period|Protocol Violation|0|||
33474857|NCT03353350|62849156|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
33474858|NCT03353350|62849157|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
33474859|NCT03353350|62849158|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
33474860|NCT03353350|62849159|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
33474861|NCT03353350|62849156|FG000|30-week Core Treatment Period|Adverse Event|0|||
33474862|NCT03353350|62849157|FG001|30-week Core Treatment Period|Adverse Event|4|||
33474863|NCT03353350|62849158|FG002|30-week Core Treatment Period|Adverse Event|2|||
33474864|NCT03353350|62849159|FG003|30-week Core Treatment Period|Adverse Event|3|||
33474865|NCT03353350|62849156|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
33474866|NCT03353350|62849157|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
33474867|NCT03353350|62849158|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
33474868|NCT03353350|62849159|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
33474869|NCT03353350|62849156|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
33474870|NCT03353350|62849157|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
33474871|NCT03353350|62849158|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
33474872|NCT03353350|62849159|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
33474873|NCT03353350|62849156|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
33474874|NCT03353350|62849157|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
33474875|NCT03353350|62849158|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
33474876|NCT03353350|62849159|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
33474877|NCT03353350|62849156|FG000|26-week Treatment Extension Period|Adverse Event|1|||
33549414|NCT02477800|62940538|FG000|Long Term Extension Period|Lost to Follow-up|0|||
33655566|NCT00635427|63071181|FG001|Overall Study|Termination Of Study By Sponsor|6|||
33361046|NCT03330106|62738780|FG001|Part B|Symptomatic Deterioration|0|||
33361047|NCT03330106|62738781|FG002|Part B|Symptomatic Deterioration|0|||
33361048|NCT03330106|62738782|FG003|Part B|Symptomatic Deterioration|1|||
33361049|NCT03330106|62738779|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
33361050|NCT03330106|62738780|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
33361051|NCT03330106|62738781|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
33474878|NCT03353350|62849157|FG001|26-week Treatment Extension Period|Adverse Event|0|||
33474879|NCT03353350|62849158|FG002|26-week Treatment Extension Period|Adverse Event|0|||
33474880|NCT03353350|62849159|FG003|26-week Treatment Extension Period|Adverse Event|1|||
33474881|NCT03353350|62849156|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
33474882|NCT03353350|62849157|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
33474883|NCT03353350|62849158|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
33474884|NCT03353350|62849159|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
33474885|NCT03032068|62849173|FG000|Overall Study|Adverse Event|1|||
33474886|NCT02674516|62849193|FG000|Overall Study|Lost to Follow-up|3|||
33474887|NCT02674516|62849194|FG001|Overall Study|Lost to Follow-up|0|||
33474888|NCT02674516|62849193|FG000|Overall Study|Protocol Violation|0|||
33474889|NCT02674516|62849194|FG001|Overall Study|Protocol Violation|4|||
33474890|NCT02674516|62849193|FG000|Overall Study|Knowledge of study hypothesis|1|||
33474891|NCT02674516|62849194|FG001|Overall Study|Knowledge of study hypothesis|0|||
33474892|NCT02463448|62849200|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
33474893|NCT02463448|62849200|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
33474894|NCT02463448|62849200|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
33474895|NCT02463448|62849200|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
33474896|NCT03794544|62849208|FG000|Overall Study|Withdrawal by Subject|1|||
33474897|NCT03794544|62849209|FG001|Overall Study|Withdrawal by Subject|1|||
33474898|NCT03794544|62849210|FG002|Overall Study|Withdrawal by Subject|0|||
33474899|NCT03794544|62849211|FG003|Overall Study|Withdrawal by Subject|0|||
33474900|NCT03794544|62849208|FG000|Overall Study|Death|0|||
33474901|NCT03794544|62849209|FG001|Overall Study|Death|0|||
33474902|NCT03794544|62849210|FG002|Overall Study|Death|0|||
33474903|NCT03794544|62849211|FG003|Overall Study|Death|1|||
33474904|NCT03794544|62849208|FG000|Overall Study|Lost to Follow-up|0|||
33474905|NCT03794544|62849209|FG001|Overall Study|Lost to Follow-up|1|||
33474906|NCT03794544|62849210|FG002|Overall Study|Lost to Follow-up|1|||
33474907|NCT03794544|62849211|FG003|Overall Study|Lost to Follow-up|0|||
33474908|NCT03794544|62849208|FG000|Overall Study|Other|0|||
33474909|NCT03794544|62849209|FG001|Overall Study|Other|1|||
33474910|NCT03794544|62849210|FG002|Overall Study|Other|0|||
33474911|NCT03794544|62849211|FG003|Overall Study|Other|0|||
33474912|NCT01804270|62849223|FG000|Overall Study|Withdrawal by Subject|1|||
33474913|NCT01804270|62849224|FG001|Overall Study|Withdrawal by Subject|1|||
33474914|NCT03107026|62849233|FG000|Overall Study|Adverse Event|2|||
33474915|NCT03107026|62849234|FG001|Overall Study|Adverse Event|14|||
33474916|NCT03107026|62849235|FG002|Overall Study|Adverse Event|23|||
33474917|NCT03107026|62849233|FG000|Overall Study|Lost to Follow-up|12|||
33474918|NCT03107026|62849234|FG001|Overall Study|Lost to Follow-up|12|||
33474919|NCT03107026|62849235|FG002|Overall Study|Lost to Follow-up|13|||
33474920|NCT03107026|62849233|FG000|Overall Study|Protocol Violation|1|||
33474921|NCT03107026|62849234|FG001|Overall Study|Protocol Violation|2|||
33549415|NCT02477800|62940539|FG001|Long Term Extension Period|Lost to Follow-up|0|||
33549416|NCT02477800|62940540|FG002|Long Term Extension Period|Lost to Follow-up|0|||
33549417|NCT02477800|62940541|FG003|Long Term Extension Period|Lost to Follow-up|0|||
33549418|NCT02477800|62940542|FG004|Long Term Extension Period|Lost to Follow-up|1|||
33655567|NCT00635427|63071182|FG002|Overall Study|Termination Of Study By Sponsor|10|||
33361052|NCT03330106|62738782|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
33361053|NCT03330106|62738779|FG000|Part B|Progressive Disease|0|||
33361054|NCT03330106|62738780|FG001|Part B|Progressive Disease|0|||
33361055|NCT03330106|62738781|FG002|Part B|Progressive Disease|11|||
33361056|NCT03330106|62738782|FG003|Part B|Progressive Disease|4|||
33361057|NCT03164564|62738794|FG000|Overall Study|Death|3|||
33474922|NCT03107026|62849235|FG002|Overall Study|Protocol Violation|0|||
33474923|NCT03107026|62849233|FG000|Overall Study|Pregnancy|1|||
33474924|NCT03107026|62849234|FG001|Overall Study|Pregnancy|0|||
33474925|NCT03107026|62849235|FG002|Overall Study|Pregnancy|0|||
33474926|NCT03107026|62849233|FG000|Overall Study|Withdrawal by Subject|13|||
33474927|NCT03107026|62849234|FG001|Overall Study|Withdrawal by Subject|5|||
33474928|NCT03107026|62849235|FG002|Overall Study|Withdrawal by Subject|17|||
33474929|NCT03107026|62849233|FG000|Overall Study|non compliance with study visits|1|||
33655568|NCT00635427|63071183|FG003|Overall Study|Termination Of Study By Sponsor|6|||
33474930|NCT03107026|62849234|FG001|Overall Study|non compliance with study visits|2|||
33474931|NCT03107026|62849235|FG002|Overall Study|non compliance with study visits|0|||
33474932|NCT03107026|62849233|FG000|Overall Study|non-compliance with study drug|2|||
33474933|NCT03107026|62849234|FG001|Overall Study|non-compliance with study drug|2|||
33474934|NCT03107026|62849235|FG002|Overall Study|non-compliance with study drug|3|||
33474935|NCT03107026|62849233|FG000|Overall Study|Physician Decision|0|||
33474936|NCT03107026|62849234|FG001|Overall Study|Physician Decision|1|||
33361058|NCT03164564|62738795|FG001|Overall Study|Death|0|||
33361059|NCT03164564|62738794|FG000|Overall Study|Withdrawal by Subject|20|||
33361060|NCT03164564|62738795|FG001|Overall Study|Withdrawal by Subject|15|||
33361061|NCT03164564|62738794|FG000|Overall Study|Lost to Follow-up|2|||
33361062|NCT03164564|62738795|FG001|Overall Study|Lost to Follow-up|0|||
33361063|NCT03164564|62738794|FG000|Overall Study|Physician Decision|0|||
33361064|NCT03164564|62738795|FG001|Overall Study|Physician Decision|1|||
33361065|NCT03164564|62738794|FG000|Overall Study|Adverse Event|0|||
33361066|NCT03164564|62738795|FG001|Overall Study|Adverse Event|1|||
33361067|NCT03164564|62738794|FG000|Overall Study|Ongoing|1586|||
33361068|NCT03164564|62738795|FG001|Overall Study|Ongoing|1586|||
33361069|NCT02821754|62738815|FG000|Overall Study|Procedure not required prior to amendment change|13|||
33361070|NCT02821754|62738816|FG001|Overall Study|Procedure not required prior to amendment change|11|||
33361071|NCT02821754|62738817|FG002|Overall Study|Procedure not required prior to amendment change|0|||
33361072|NCT02821754|62738815|FG000|Overall Study|Participant's Clinical status|2|||
33361073|NCT02821754|62738816|FG001|Overall Study|Participant's Clinical status|0|||
33361074|NCT02821754|62738817|FG002|Overall Study|Participant's Clinical status|0|||
33361075|NCT02821754|62738815|FG000|Overall Study|Participant removed for noncompliance|1|||
33361076|NCT02821754|62738816|FG001|Overall Study|Participant removed for noncompliance|0|||
33361077|NCT02821754|62738817|FG002|Overall Study|Participant removed for noncompliance|0|||
33361078|NCT02821754|62738815|FG000|Overall Study|Drug not available.|0|||
33361079|NCT02821754|62738816|FG001|Overall Study|Drug not available.|0|||
33361080|NCT02821754|62738817|FG002|Overall Study|Drug not available.|1|||
33361081|NCT02821754|62738815|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
33361082|NCT02821754|62738816|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
33361083|NCT02821754|62738817|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
33361084|NCT02742246|62738826|FG000|Overall Study|Never initiated treatment|5|||
33361085|NCT02742246|62738827|FG001|Overall Study|Never initiated treatment|3|||
33361086|NCT02742246|62738828|FG002|Overall Study|Never initiated treatment|1|||
33361087|NCT02742246|62738826|FG000|Overall Study|dropped out during treatment|14|||
33361088|NCT02742246|62738827|FG001|Overall Study|dropped out during treatment|14|||
33361089|NCT02742246|62738828|FG002|Overall Study|dropped out during treatment|11|||
33361090|NCT02742246|62738826|FG000|Overall Study|Death|1|||
33361091|NCT02742246|62738827|FG001|Overall Study|Death|0|||
33361092|NCT02742246|62738828|FG002|Overall Study|Death|0|||
33361093|NCT02708108|62738838|FG000|Overall Study|Death|1|||
33361094|NCT02708108|62738839|FG001|Overall Study|Death|2|||
33361095|NCT02708108|62738838|FG000|Overall Study|Regimen change|1|||
33361096|NCT02708108|62738839|FG001|Overall Study|Regimen change|0|||
33361097|NCT02708108|62738838|FG000|Overall Study|No MRD and no imaging available|0|||
33361098|NCT02708108|62738839|FG001|Overall Study|No MRD and no imaging available|1|||
33361099|NCT02619682|62738846|FG000|Overall Study|Withdrawal by Subject|3|||
33361100|NCT02619682|62738846|FG000|Overall Study|Lack of Efficacy|8|||
33361101|NCT02619682|62738846|FG000|Overall Study|new secondary cancer|1|||
33361102|NCT02619682|62738846|FG000|Overall Study|post surgery complications|2|||
33361103|NCT02617589|62738852|FG000|Randomization|Request to Discontinue Study Treatment|1|||
33361104|NCT02617589|62738853|FG001|Randomization|Request to Discontinue Study Treatment|3|||
33361105|NCT02617589|62738852|FG000|Randomization|Participant Withdrew Consent|1|||
33361106|NCT02617589|62738853|FG001|Randomization|Participant Withdrew Consent|2|||
33361107|NCT02617589|62738852|FG000|Treatment|Other Reasons|3|||
33361108|NCT02617589|62738853|FG001|Treatment|Other Reasons|3|||
33361109|NCT02617589|62738852|FG000|Treatment|Poor/Non Compliance|1|||
33361110|NCT02617589|62738853|FG001|Treatment|Poor/Non Compliance|1|||
33361111|NCT02617589|62738852|FG000|Treatment|Maximum Clinical Benefit|0|||
33361112|NCT02617589|62738853|FG001|Treatment|Maximum Clinical Benefit|2|||
33361113|NCT02617589|62738852|FG000|Treatment|Participant Withdrew Consent|2|||
33361114|NCT02617589|62738853|FG001|Treatment|Participant Withdrew Consent|6|||
33361115|NCT02617589|62738852|FG000|Treatment|Participant Request to Discontinue|12|||
33361116|NCT02617589|62738853|FG001|Treatment|Participant Request to Discontinue|21|||
33361117|NCT02617589|62738852|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
33361118|NCT02617589|62738853|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
33361119|NCT02617589|62738852|FG000|Treatment|Death|1|||
33361120|NCT02617589|62738853|FG001|Treatment|Death|1|||
33361121|NCT02617589|62738852|FG000|Treatment|Study Drug Toxicity|27|||
33361122|NCT02617589|62738853|FG001|Treatment|Study Drug Toxicity|20|||
33361123|NCT02617589|62738852|FG000|Treatment|Disease Progression|216|||
33361124|NCT02617589|62738853|FG001|Treatment|Disease Progression|136|||
33361125|NCT02471807|62738859|FG000|Overall Study|Death|14|||
33361126|NCT02471807|62738859|FG000|Overall Study|Withdrawal by Subject|2|||
33361127|NCT02471807|62738859|FG000|Overall Study|Explant|5|||
33361128|NCT02471807|62738859|FG000|Overall Study|Lost to Follow-up|1|||
33361129|NCT02364557|62738865|FG000|Overall Study|Protocol Violation|3|||
33361130|NCT02364557|62738866|FG001|Overall Study|Protocol Violation|1|||
33361131|NCT02337829|62738902|FG000|Overall Study|Death|0|||
33361132|NCT02337829|62738903|FG001|Overall Study|Death|1|||
33361133|NCT02337829|62738904|FG002|Overall Study|Death|0|||
33361134|NCT02337829|62738905|FG003|Overall Study|Death|0|||
33361135|NCT02337829|62738902|FG000|Overall Study|Study terminated by sponsor|12|||
33361136|NCT02337829|62738903|FG001|Overall Study|Study terminated by sponsor|10|||
33361137|NCT02337829|62738904|FG002|Overall Study|Study terminated by sponsor|5|||
33361138|NCT02337829|62738905|FG003|Overall Study|Study terminated by sponsor|6|||
33361139|NCT02337829|62738902|FG000|Overall Study|discontinued for other reasons|6|||
33361140|NCT02337829|62738903|FG001|Overall Study|discontinued for other reasons|3|||
33361141|NCT02337829|62738904|FG002|Overall Study|discontinued for other reasons|1|||
33361142|NCT02337829|62738905|FG003|Overall Study|discontinued for other reasons|4|||
33361143|NCT02257528|62738917|FG000|Overall Study|Never received study treatment|1|||
33361144|NCT01899326|62738928|FG000|Overall Study|Withdrawal by Subject|1|||
33361145|NCT01899326|62738928|FG000|Overall Study|Adverse Event|2|||
33361146|NCT01899326|62738928|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
33361147|NCT01572480|62738933|FG000|Participants Enrolled|Withdrawal by Subject|1|||
33361148|NCT01572480|62738933|FG000|Drug Administration|Discontinued drug/Off Study|1|||
33361149|NCT01572480|62738933|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
33361150|NCT01572480|62738933|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
33361151|NCT01126190|62738940|FG000|Double-Blind Phase|Death|0|||
33361152|NCT01126190|62738941|FG001|Double-Blind Phase|Death|1|||
33361153|NCT01126190|62738942|FG002|Double-Blind Phase|Death|0|||
33361154|NCT01126190|62738940|FG000|Double-Blind Phase|Adverse Event|1|||
33361155|NCT01126190|62738941|FG001|Double-Blind Phase|Adverse Event|2|||
33361156|NCT01126190|62738942|FG002|Double-Blind Phase|Adverse Event|0|||
33361157|NCT01126190|62738940|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
33361158|NCT01126190|62738941|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
33361159|NCT01126190|62738942|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
33361160|NCT01126190|62738940|FG000|Double-Blind Phase|Request of Investigator|1|||
33361161|NCT01126190|62738941|FG001|Double-Blind Phase|Request of Investigator|0|||
33361162|NCT01126190|62738942|FG002|Double-Blind Phase|Request of Investigator|0|||
33361163|NCT01126190|62738940|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
33361164|NCT01126190|62738941|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
33361165|NCT01126190|62738942|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
33361166|NCT01126190|62738940|FG000|Double-Blind Phase|Non-compliance|1|||
33361167|NCT01126190|62738941|FG001|Double-Blind Phase|Non-compliance|0|||
33361168|NCT01126190|62738942|FG002|Double-Blind Phase|Non-compliance|0|||
33361169|NCT01126190|62738940|FG000|Double-Blind Phase|Lost to Follow-up|1|||
33361170|NCT01126190|62738941|FG001|Double-Blind Phase|Lost to Follow-up|3|||
33361171|NCT01126190|62738942|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33361172|NCT01126190|62738940|FG000|Open-Label Phase|Death|0|||
33361173|NCT01126190|62738941|FG001|Open-Label Phase|Death|0|||
33361174|NCT01126190|62738942|FG002|Open-Label Phase|Death|1|||
33361175|NCT01126190|62738940|FG000|Open-Label Phase|Adverse Event|0|||
33361176|NCT01126190|62738941|FG001|Open-Label Phase|Adverse Event|0|||
33361177|NCT01126190|62738942|FG002|Open-Label Phase|Adverse Event|4|||
33361178|NCT01126190|62738940|FG000|Open-Label Phase|Withdrawal by Subject|0|||
33361179|NCT01126190|62738941|FG001|Open-Label Phase|Withdrawal by Subject|0|||
33361180|NCT01126190|62738942|FG002|Open-Label Phase|Withdrawal by Subject|6|||
33361181|NCT00939185|62738975|FG000|Overall Study|Adverse Event|3|||
33361182|NCT00939185|62738975|FG000|Overall Study|Lack of Efficacy|1|||
33361183|NCT00939185|62738975|FG000|Overall Study|Lost to Follow-up|6|||
33361184|NCT00939185|62738975|FG000|Overall Study|Other|3|||
33361185|NCT00939185|62738975|FG000|Overall Study|Withdrawal by Subject|2|||
33361186|NCT00939185|62738975|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
33361187|NCT03977155|62738982|FG000|Overall Study|Adverse Event|3|||
33361188|NCT03977155|62738983|FG001|Overall Study|Adverse Event|0|||
33361189|NCT03977155|62738984|FG002|Overall Study|Adverse Event|0|||
33361190|NCT03977155|62738982|FG000|Overall Study|Lost to Follow-up|0|||
33361191|NCT03977155|62738983|FG001|Overall Study|Lost to Follow-up|1|||
33361192|NCT03977155|62738984|FG002|Overall Study|Lost to Follow-up|0|||
33361193|NCT03977155|62738982|FG000|Overall Study|Withdrawal by Subject|1|||
33549419|NCT02477800|62940543|FG005|Long Term Extension Period|Lost to Follow-up|3|||
33549420|NCT02477800|62940544|FG006|Long Term Extension Period|Lost to Follow-up|0|||
33549421|NCT02477800|62940538|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
33361194|NCT03977155|62738983|FG001|Overall Study|Withdrawal by Subject|1|||
33361195|NCT03977155|62738984|FG002|Overall Study|Withdrawal by Subject|2|||
33361196|NCT03977155|62738982|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
33361197|NCT03977155|62738983|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
33361198|NCT03977155|62738984|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
33361199|NCT00930059|62739009|FG000|Overall Study|Death|1|||
33361200|NCT00930059|62739010|FG001|Overall Study|Death|0|||
33361201|NCT00930059|62739009|FG000|Overall Study|Did not meet entrance criteria|1|||
33361202|NCT00930059|62739010|FG001|Overall Study|Did not meet entrance criteria|1|||
33361203|NCT00930059|62739009|FG000|Overall Study|Withdrawal by Subject|3|||
33361204|NCT00930059|62739010|FG001|Overall Study|Withdrawal by Subject|4|||
33361205|NCT00930059|62739009|FG000|Overall Study|Other|1|||
33361206|NCT00930059|62739010|FG001|Overall Study|Other|0|||
33361207|NCT00930059|62739009|FG000|Overall Study|1 site terminated by sponsor|1|||
33361208|NCT00930059|62739010|FG001|Overall Study|1 site terminated by sponsor|1|||
33361209|NCT00930059|62739009|FG000|Overall Study|Adverse Event|1|||
33361210|NCT00930059|62739010|FG001|Overall Study|Adverse Event|6|||
33361211|NCT00772005|62739029|FG000|Overall Study|Adverse Event|9|||
33361212|NCT00772005|62739030|FG001|Overall Study|Adverse Event|14|||
33361213|NCT00772005|62739031|FG002|Overall Study|Adverse Event|10|||
33361214|NCT00772005|62739032|FG003|Overall Study|Adverse Event|13|||
33361215|NCT00772005|62739029|FG000|Overall Study|Lack of Efficacy|0|||
33361216|NCT00772005|62739030|FG001|Overall Study|Lack of Efficacy|1|||
33361217|NCT00772005|62739031|FG002|Overall Study|Lack of Efficacy|0|||
33361218|NCT00772005|62739032|FG003|Overall Study|Lack of Efficacy|0|||
33361219|NCT00772005|62739029|FG000|Overall Study|Withdrawal by Subject|3|||
33361220|NCT00772005|62739030|FG001|Overall Study|Withdrawal by Subject|7|||
33361221|NCT00772005|62739031|FG002|Overall Study|Withdrawal by Subject|10|||
33361222|NCT00772005|62739032|FG003|Overall Study|Withdrawal by Subject|2|||
33361223|NCT00772005|62739029|FG000|Overall Study|Protocol Violation|2|||
33361224|NCT00772005|62739030|FG001|Overall Study|Protocol Violation|4|||
33361225|NCT00772005|62739031|FG002|Overall Study|Protocol Violation|1|||
33361226|NCT00772005|62739032|FG003|Overall Study|Protocol Violation|6|||
33361227|NCT00772005|62739029|FG000|Overall Study|Lost to Follow-up|7|||
33361228|NCT00772005|62739030|FG001|Overall Study|Lost to Follow-up|3|||
33361229|NCT00772005|62739031|FG002|Overall Study|Lost to Follow-up|6|||
33361230|NCT00772005|62739032|FG003|Overall Study|Lost to Follow-up|3|||
33361231|NCT00772005|62739029|FG000|Overall Study|Non-compliance with study procedures|1|||
33361232|NCT00772005|62739030|FG001|Overall Study|Non-compliance with study procedures|1|||
33361233|NCT00772005|62739031|FG002|Overall Study|Non-compliance with study procedures|0|||
33361234|NCT00772005|62739032|FG003|Overall Study|Non-compliance with study procedures|1|||
33361235|NCT00772005|62739029|FG000|Overall Study|Non-compliance with drug administration|3|||
33361236|NCT00772005|62739030|FG001|Overall Study|Non-compliance with drug administration|0|||
33361237|NCT00772005|62739031|FG002|Overall Study|Non-compliance with drug administration|1|||
33361238|NCT00772005|62739032|FG003|Overall Study|Non-compliance with drug administration|1|||
33361239|NCT00939107|62739044|FG000|Overall Study|Lost to Follow-up|14|||
33361240|NCT00939107|62739045|FG001|Overall Study|Lost to Follow-up|12|||
33361241|NCT00927485|62739053|FG000|Overall Study|Adverse Event|4|||
33361242|NCT00927485|62739054|FG001|Overall Study|Adverse Event|2|||
33361243|NCT00927485|62739053|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
33361244|NCT00927485|62739054|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
33361245|NCT00927251|62739060|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
33361246|NCT00927095|62739067|FG000|Overall Study|Adverse Event|3|||
33361247|NCT00927095|62739068|FG001|Overall Study|Adverse Event|1|||
33361248|NCT00927095|62739069|FG002|Overall Study|Adverse Event|0|||
33361249|NCT00927095|62739067|FG000|Overall Study|Withdrawal by Subject|2|||
33361250|NCT00927095|62739068|FG001|Overall Study|Withdrawal by Subject|1|||
33361251|NCT00927095|62739069|FG002|Overall Study|Withdrawal by Subject|1|||
33361252|NCT00927095|62739067|FG000|Overall Study|Physician Decision|1|||
33361253|NCT00927095|62739068|FG001|Overall Study|Physician Decision|2|||
33361254|NCT00927095|62739069|FG002|Overall Study|Physician Decision|1|||
33361255|NCT00932165|62739077|FG000|Overall Study|Lost to Follow-up|1|||
33361256|NCT04888494|62739084|FG000|Overall Study|Lost to Follow-up|2|||
33361257|NCT04888494|62739085|FG001|Overall Study|Lost to Follow-up|3|||
33361258|NCT04888494|62739084|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
33549422|NCT02477800|62940539|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
33655569|NCT00635427|63071184|FG004|Overall Study|Termination Of Study By Sponsor|6|||
33655570|NCT00635427|63071180|FG000|Overall Study|Withdrawal Of Consent|0|||
33361259|NCT04888494|62739085|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
33361260|NCT04761822|62739145|FG000|Overall Study|Adverse Event|3|||
33361261|NCT04761822|62739146|FG001|Overall Study|Adverse Event|1|||
33361262|NCT04761822|62739147|FG002|Overall Study|Adverse Event|1|||
33361263|NCT04761822|62739148|FG003|Overall Study|Adverse Event|3|||
33361264|NCT04761822|62739145|FG000|Overall Study|Lost to Follow-up|1|||
33361265|NCT04761822|62739146|FG001|Overall Study|Lost to Follow-up|0|||
33361266|NCT04761822|62739147|FG002|Overall Study|Lost to Follow-up|2|||
33361267|NCT04761822|62739148|FG003|Overall Study|Lost to Follow-up|3|||
33361268|NCT04761822|62739145|FG000|Overall Study|Physician Decision|0|||
33361269|NCT04761822|62739146|FG001|Overall Study|Physician Decision|1|||
33361270|NCT04761822|62739147|FG002|Overall Study|Physician Decision|0|||
33655571|NCT00635427|63071181|FG001|Overall Study|Withdrawal Of Consent|0|||
33655572|NCT00635427|63071182|FG002|Overall Study|Withdrawal Of Consent|0|||
33361271|NCT04761822|62739148|FG003|Overall Study|Physician Decision|0|||
33361272|NCT04761822|62739145|FG000|Overall Study|Withdrawal by Subject|3|||
33361273|NCT04761822|62739146|FG001|Overall Study|Withdrawal by Subject|8|||
33361274|NCT04761822|62739147|FG002|Overall Study|Withdrawal by Subject|1|||
33361275|NCT04761822|62739148|FG003|Overall Study|Withdrawal by Subject|11|||
33361276|NCT04761822|62739145|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
33361277|NCT04761822|62739146|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
33361278|NCT04761822|62739147|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
33361279|NCT04761822|62739148|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
33361280|NCT04761822|62739145|FG000|Overall Study|Participant requested unblinding|0|||
33361281|NCT04761822|62739146|FG001|Overall Study|Participant requested unblinding|0|||
33361282|NCT04761822|62739147|FG002|Overall Study|Participant requested unblinding|0|||
33361283|NCT04761822|62739148|FG003|Overall Study|Participant requested unblinding|1|||
33361284|NCT04573972|62739177|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
33361285|NCT04573972|62739178|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
33655573|NCT00635427|63071183|FG003|Overall Study|Withdrawal Of Consent|2|||
33655574|NCT00635427|63071184|FG004|Overall Study|Withdrawal Of Consent|2|||
33655575|NCT00635349|63071196|FG000|Overall Study|Other|8|||
33655576|NCT00635349|63071197|FG001|Overall Study|Other|6|||
33655577|NCT00635349|63071196|FG000|Overall Study|Protocol Violation|18|||
33655578|NCT00635349|63071197|FG001|Overall Study|Protocol Violation|22|||
33655579|NCT00635349|63071196|FG000|Overall Study|Withdrawal by Subject|3|||
33474937|NCT03107026|62849235|FG002|Overall Study|Physician Decision|0|||
33474938|NCT03717480|62849243|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
33474939|NCT00005044|62849249|FG000|Overall Study|Protocol Violation|37|||
33474940|NCT00005044|62849250|FG001|Overall Study|Protocol Violation|46|||
33474941|NCT00005044|62849249|FG000|Overall Study|Withdrawal by Subject|1|||
33474942|NCT00005044|62849250|FG001|Overall Study|Withdrawal by Subject|5|||
33474943|NCT00005044|62849249|FG000|Overall Study|No protocol treatment|0|||
33474944|NCT00005044|62849250|FG001|Overall Study|No protocol treatment|1|||
33474945|NCT03084796|62849262|FG000|Overall Study|Adverse Event|4|||
33474946|NCT03084796|62849263|FG001|Overall Study|Adverse Event|5|||
33474947|NCT03084796|62849264|FG002|Overall Study|Adverse Event|6|||
33474948|NCT03084796|62849265|FG003|Overall Study|Adverse Event|2|||
33474949|NCT03084796|62849266|FG004|Overall Study|Adverse Event|3|||
33474950|NCT03084796|62849267|FG005|Overall Study|Adverse Event|5|||
33474951|NCT03084796|62849262|FG000|Overall Study|Withdrawal by Subject|3|||
33474952|NCT03084796|62849263|FG001|Overall Study|Withdrawal by Subject|5|||
33655580|NCT00635349|63071197|FG001|Overall Study|Withdrawal by Subject|8|||
33655581|NCT00635349|63071196|FG000|Overall Study|Lost to Follow-up|4|||
33655582|NCT00635349|63071197|FG001|Overall Study|Lost to Follow-up|3|||
33655583|NCT00635349|63071196|FG000|Overall Study|Adverse Event|11|||
33655584|NCT00635349|63071197|FG001|Overall Study|Adverse Event|9|||
33655585|NCT00634803|63071206|FG000|Overall Study|Lost to Follow-up|6|||
33655586|NCT00634803|63071207|FG001|Overall Study|Lost to Follow-up|7|||
33655587|NCT00634803|63071208|FG002|Overall Study|Lost to Follow-up|7|||
33655588|NCT01217385|63071224|FG000|Overall Study|Withdrawal by Subject|3|||
33361302|NCT04391309|62739223|FG000|Overall Study|Death|1|||
33361303|NCT04391309|62739224|FG001|Overall Study|Death|1|||
33361304|NCT04391309|62739223|FG000|Overall Study|Lost to Follow-up|3|||
33361305|NCT04391309|62739224|FG001|Overall Study|Lost to Follow-up|2|||
33361306|NCT04391309|62739223|FG000|Overall Study|Withdrawal by Subject|2|||
33361307|NCT04391309|62739224|FG001|Overall Study|Withdrawal by Subject|2|||
33361308|NCT04202965|62739252|FG000|Overall Study|Adverse Event|3|||
33361309|NCT04202965|62739252|FG000|Overall Study|Did not meet inclusion criteria|1|||
33361310|NCT04056624|62739260|FG000|Overall Study|Withdrawal by Subject|0|||
33361311|NCT04056624|62739261|FG001|Overall Study|Withdrawal by Subject|0|||
33361312|NCT04056624|62739262|FG002|Overall Study|Withdrawal by Subject|1|||
33361313|NCT04056624|62739260|FG000|Overall Study|Protocol Violation|1|||
33361314|NCT04056624|62739261|FG001|Overall Study|Protocol Violation|2|||
33361315|NCT04056624|62739262|FG002|Overall Study|Protocol Violation|0|||
33361316|NCT03870763|62739282|FG000|Overall Study|Study terminated by sponsor|0|||
33361317|NCT03870763|62739283|FG001|Overall Study|Study terminated by sponsor|2|||
33474953|NCT03084796|62849264|FG002|Overall Study|Withdrawal by Subject|2|||
33655589|NCT01217385|63071224|FG000|Overall Study|DOSI not performed/not eval|12|||
33361318|NCT03870763|62739284|FG002|Overall Study|Study terminated by sponsor|0|||
33474954|NCT03084796|62849265|FG003|Overall Study|Withdrawal by Subject|1|||
33361319|NCT03870763|62739282|FG000|Overall Study|Withdrawal by Subject|0|||
33361320|NCT03870763|62739283|FG001|Overall Study|Withdrawal by Subject|1|||
33474955|NCT03084796|62849266|FG004|Overall Study|Withdrawal by Subject|3|||
33474956|NCT03084796|62849267|FG005|Overall Study|Withdrawal by Subject|0|||
33361321|NCT03870763|62739284|FG002|Overall Study|Withdrawal by Subject|0|||
33361322|NCT03870763|62739282|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
33361323|NCT03870763|62739283|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
33361324|NCT03870763|62739284|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
33361325|NCT03647501|62739294|FG000|Overall Study|Lost to Follow-up|1|||
33361326|NCT03647501|62739295|FG001|Overall Study|Lost to Follow-up|1|||
33361327|NCT03647501|62739294|FG000|Overall Study|Withdrawal by Subject|0|||
33361328|NCT03647501|62739295|FG001|Overall Study|Withdrawal by Subject|1|||
33361329|NCT03587142|62739327|FG000|Overall Study|Lost to Follow-up|5|||
33361330|NCT03587142|62739328|FG001|Overall Study|Lost to Follow-up|3|||
33361331|NCT03587142|62739327|FG000|Overall Study|Did not complete the f4 visit|3|||
33361332|NCT03587142|62739328|FG001|Overall Study|Did not complete the f4 visit|7|||
33361333|NCT03493854|62739336|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
33361334|NCT03493854|62739337|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
33361335|NCT03493854|62739336|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
33361336|NCT03493854|62739337|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
33361337|NCT03493854|62739336|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
33361338|NCT03493854|62739337|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
33361339|NCT03493854|62739336|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
33361340|NCT03493854|62739337|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
33361341|NCT03493854|62739336|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
33361342|NCT03493854|62739337|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
33361343|NCT03493854|62739336|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
33361344|NCT03493854|62739337|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
33361345|NCT03493854|62739336|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
33361346|NCT03493854|62739337|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
33361347|NCT03493854|62739336|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229|||
33361348|NCT03493854|62739337|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228|||
33361349|NCT03493854|62739336|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
33361350|NCT03493854|62739337|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
33361351|NCT03493854|62739336|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
33361352|NCT03493854|62739337|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1|||
33361353|NCT03493854|62739336|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3|||
33361354|NCT03493854|62739337|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
33361355|NCT03493854|62739336|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1|||
33361356|NCT03493854|62739337|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0|||
33361357|NCT03493854|62739336|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
33361358|NCT03493854|62739337|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0|||
33361359|NCT03493854|62739336|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5|||
33361360|NCT03493854|62739337|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3|||
33361361|NCT03493854|62739336|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
33361362|NCT03493854|62739337|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
33361363|NCT03493854|62739336|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18|||
33361364|NCT03493854|62739337|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16|||
33361365|NCT03188705|62739343|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
33361366|NCT03188705|62739343|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
33361367|NCT03032484|62739348|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
33361368|NCT03032484|62739349|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
33361369|NCT03032484|62739348|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
33361370|NCT03032484|62739349|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
33361371|NCT02975349|62739358|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33361372|NCT02975349|62739359|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33361373|NCT02975349|62739360|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
33361374|NCT02975349|62739361|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
33361375|NCT02975349|62739362|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33361376|NCT02975349|62739363|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33361377|NCT02975349|62739358|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
33361378|NCT02975349|62739359|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33361379|NCT02975349|62739360|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33361380|NCT02975349|62739361|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33361381|NCT02975349|62739362|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33361382|NCT02975349|62739363|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33361383|NCT02975349|62739358|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
33361384|NCT02975349|62739359|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
33361385|NCT02975349|62739360|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
33361386|NCT02975349|62739361|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
33361387|NCT02975349|62739362|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
33361388|NCT02975349|62739363|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
33361389|NCT02975349|62739358|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
33361390|NCT02975349|62739359|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
33549423|NCT02477800|62940540|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
33361391|NCT02975349|62739360|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
33361392|NCT02975349|62739361|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
33361393|NCT02975349|62739362|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
33361394|NCT02975349|62739363|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
33361395|NCT02975349|62739358|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
33361396|NCT02975349|62739359|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
33361397|NCT02975349|62739360|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
33361398|NCT02975349|62739361|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
33361399|NCT02975349|62739362|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
33361400|NCT02975349|62739363|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
33361401|NCT02975349|62739358|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
33361402|NCT02975349|62739359|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
33361403|NCT02975349|62739360|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
33361404|NCT02975349|62739361|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
33361405|NCT02975349|62739362|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
33361406|NCT02975349|62739363|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
33361407|NCT02975349|62739358|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
33361408|NCT02975349|62739359|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
33361409|NCT02975349|62739360|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
33361410|NCT02975349|62739361|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
33361411|NCT02975349|62739362|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
33361412|NCT02975349|62739363|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
33361413|NCT02975349|62739358|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
33361414|NCT02975349|62739359|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
33361415|NCT02975349|62739360|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
33361416|NCT02975349|62739361|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
33361417|NCT02975349|62739362|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
33361418|NCT02975349|62739363|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
33361419|NCT02975349|62739358|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
33361420|NCT02975349|62739359|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
33361421|NCT02975349|62739360|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
33361422|NCT02975349|62739361|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
33361423|NCT02975349|62739362|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
33361424|NCT02975349|62739363|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
33361425|NCT02520141|62739434|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
33361426|NCT02513394|62739442|FG000|Overall Study|Withdrawal by Subject|11|||
33361427|NCT02513394|62739443|FG001|Overall Study|Withdrawal by Subject|23|||
33361428|NCT02513394|62739442|FG000|Overall Study|Ineligible|1|||
33361429|NCT02513394|62739443|FG001|Overall Study|Ineligible|0|||
33361430|NCT02329847|62739455|FG000|Overall Study|Death|4|||
33361431|NCT02329847|62739456|FG001|Overall Study|Death|4|||
33361432|NCT02329847|62739457|FG002|Overall Study|Death|22|||
33361433|NCT02329847|62739458|FG003|Overall Study|Death|12|||
33361434|NCT02329847|62739459|FG004|Overall Study|Death|20|||
33361435|NCT02329847|62739460|FG005|Overall Study|Death|13|||
33361436|NCT02329847|62739455|FG000|Overall Study|Lost to Follow-up|0|||
33361437|NCT02329847|62739456|FG001|Overall Study|Lost to Follow-up|0|||
33361438|NCT02329847|62739457|FG002|Overall Study|Lost to Follow-up|2|||
33361439|NCT02329847|62739458|FG003|Overall Study|Lost to Follow-up|3|||
33361440|NCT02329847|62739459|FG004|Overall Study|Lost to Follow-up|0|||
33361441|NCT02329847|62739460|FG005|Overall Study|Lost to Follow-up|1|||
33361442|NCT02329847|62739455|FG000|Overall Study|Physician Decision|0|||
33361443|NCT02329847|62739456|FG001|Overall Study|Physician Decision|0|||
33361444|NCT02329847|62739457|FG002|Overall Study|Physician Decision|0|||
33361445|NCT02329847|62739458|FG003|Overall Study|Physician Decision|0|||
33361446|NCT02329847|62739459|FG004|Overall Study|Physician Decision|1|||
33361447|NCT02329847|62739460|FG005|Overall Study|Physician Decision|0|||
33361448|NCT02329847|62739455|FG000|Overall Study|Withdrawal by Subject|2|||
33361449|NCT02329847|62739456|FG001|Overall Study|Withdrawal by Subject|1|||
33361450|NCT02329847|62739457|FG002|Overall Study|Withdrawal by Subject|5|||
33361451|NCT02329847|62739458|FG003|Overall Study|Withdrawal by Subject|7|||
33361452|NCT02329847|62739459|FG004|Overall Study|Withdrawal by Subject|8|||
33361453|NCT02329847|62739460|FG005|Overall Study|Withdrawal by Subject|3|||
33361454|NCT02329847|62739455|FG000|Overall Study|Other|1|||
33361455|NCT02329847|62739456|FG001|Overall Study|Other|2|||
33361456|NCT02329847|62739457|FG002|Overall Study|Other|6|||
33361457|NCT02329847|62739458|FG003|Overall Study|Other|13|||
33361458|NCT02329847|62739459|FG004|Overall Study|Other|10|||
33361459|NCT02329847|62739460|FG005|Overall Study|Other|3|||
33361460|NCT02314624|62739481|FG000|Overall Study|No participating patient|16|||
33361461|NCT02314624|62739482|FG001|Overall Study|No participating patient|13|||
33361462|NCT02314624|62739481|FG000|Overall Study|Participant withdrew|7|||
33361463|NCT02314624|62739482|FG001|Overall Study|Participant withdrew|2|||
33361464|NCT02314624|62739481|FG000|Overall Study|Lost to Follow-up|2|||
33361465|NCT02314624|62739482|FG001|Overall Study|Lost to Follow-up|5|||
33361466|NCT02314624|62739481|FG000|Overall Study|Dropped/Excluded by PI|6|||
33655590|NCT01217385|63071224|FG000|Overall Study|Central Path not Available|1|||
33655591|NCT01217385|63071224|FG000|Overall Study|Normal Breast TOI not available|10|||
33655592|NCT01378104|63071576|FG000|Overall Study|Adverse Event|8|||
33361467|NCT02314624|62739482|FG001|Overall Study|Dropped/Excluded by PI|6|||
33361468|NCT01419080|62739511|FG000|Overall Study|Withdrawal by Subject|75|||
33361469|NCT01419080|62739511|FG000|Overall Study|Death|30|||
33361470|NCT01419080|62739511|FG000|Overall Study|Lost to Follow-up|23|||
33361471|NCT01419080|62739511|FG000|Overall Study|Too Ill|3|||
33361472|NCT01164228|62739519|FG000|Overall Study|Progression|24|||
33361473|NCT01164228|62739520|FG001|Overall Study|Progression|25|||
33361474|NCT01164228|62739519|FG000|Overall Study|Adverse Event|13|||
33361475|NCT01164228|62739520|FG001|Overall Study|Adverse Event|7|||
33361476|NCT01164228|62739519|FG000|Overall Study|Death|1|||
33361477|NCT01164228|62739520|FG001|Overall Study|Death|1|||
33361478|NCT01164228|62739519|FG000|Overall Study|Withdrawal by Subject|2|||
33361479|NCT01164228|62739520|FG001|Overall Study|Withdrawal by Subject|0|||
33361480|NCT01164228|62739519|FG000|Overall Study|Physician Decision|1|||
33361481|NCT01164228|62739520|FG001|Overall Study|Physician Decision|2|||
33361482|NCT01164228|62739519|FG000|Overall Study|Symptomatic deterioration|1|||
33361483|NCT01164228|62739520|FG001|Overall Study|Symptomatic deterioration|0|||
33361484|NCT01164228|62739519|FG000|Overall Study|Never started treatment|1|||
33361485|NCT01164228|62739520|FG001|Overall Study|Never started treatment|3|||
33361486|NCT01164228|62739519|FG000|Overall Study|Ineligible|1|||
33361487|NCT01164228|62739520|FG001|Overall Study|Ineligible|0|||
33361488|NCT00554515|62739526|FG000|Overall Study|Withdrawal by Subject|3|||
33361489|NCT00554515|62739526|FG000|Overall Study|Disease progression|52|||
33361490|NCT00554515|62739526|FG000|Overall Study|Physician Decision|18|||
33361491|NCT00554515|62739526|FG000|Overall Study|Withdrawal by Subject|11|||
33361492|NCT00554515|62739526|FG000|Overall Study|Adverse Event|9|||
33361493|NCT00554515|62739526|FG000|Overall Study|Death|2|||
33361494|NCT00554515|62739526|FG000|Overall Study|Achieved Stable Disease|7|||
33361495|NCT00554515|62739526|FG000|Overall Study|Other|1|||
33361496|NCT00554515|62739526|FG000|Overall Study|Misc|15|||
33361497|NCT00049517|62739553|FG000|Induction|Disease progression|0|||
33361498|NCT00049517|62739554|FG001|Induction|Disease progression|0|||
33361499|NCT00049517|62739555|FG002|Induction|Disease progression|0|||
33361500|NCT00049517|62739556|FG003|Induction|Disease progression|0|||
33361501|NCT00049517|62739557|FG004|Induction|Disease progression|18|||
33361502|NCT00049517|62739558|FG005|Induction|Disease progression|11|||
33361503|NCT00049517|62739553|FG000|Induction|Adverse Event|0|||
33361504|NCT00049517|62739554|FG001|Induction|Adverse Event|0|||
33361505|NCT00049517|62739555|FG002|Induction|Adverse Event|0|||
33361506|NCT00049517|62739556|FG003|Induction|Adverse Event|0|||
33361507|NCT00049517|62739557|FG004|Induction|Adverse Event|5|||
33361508|NCT00049517|62739558|FG005|Induction|Adverse Event|7|||
33361509|NCT00049517|62739553|FG000|Induction|Death|0|||
33655593|NCT01378104|63071577|FG001|Overall Study|Adverse Event|8|||
33655594|NCT01378104|63071576|FG000|Overall Study|Lack of Efficacy|7|||
33655595|NCT01378104|63071577|FG001|Overall Study|Lack of Efficacy|5|||
33655596|NCT01378104|63071576|FG000|Overall Study|Withdrawal by Subject|12|||
33655597|NCT01378104|63071577|FG001|Overall Study|Withdrawal by Subject|13|||
33655598|NCT01379274|63071618|FG000|Overall Study|funding withdrawn|1|||
33655599|NCT00634569|63071819|FG000|Overall Study|Withdrawal by Subject|0|||
33655600|NCT00634569|63071820|FG001|Overall Study|Withdrawal by Subject|4|||
33655601|NCT00634569|63071819|FG000|Overall Study|Physician Decision|0|||
33655602|NCT00634569|63071820|FG001|Overall Study|Physician Decision|1|||
33655603|NCT00634179|63071865|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
33655604|NCT03877926|63071940|FG000|Overall Study|Adverse Event|1|||
33655605|NCT03877926|63071941|FG001|Overall Study|Adverse Event|0|||
33655606|NCT03877926|63071942|FG002|Overall Study|Adverse Event|0|||
33655607|NCT03877926|63071943|FG003|Overall Study|Adverse Event|0|||
33361510|NCT00049517|62739554|FG001|Induction|Death|0|||
33361511|NCT00049517|62739555|FG002|Induction|Death|0|||
33655608|NCT03877926|63071940|FG000|Overall Study|Death|2|||
33655609|NCT03877926|63071941|FG001|Overall Study|Death|2|||
33655610|NCT03877926|63071942|FG002|Overall Study|Death|2|||
33361512|NCT00049517|62739556|FG003|Induction|Death|0|||
33361513|NCT00049517|62739557|FG004|Induction|Death|9|||
33361514|NCT00049517|62739558|FG005|Induction|Death|6|||
33361515|NCT00049517|62739553|FG000|Induction|Withdrawal by Subject|0|||
33361516|NCT00049517|62739554|FG001|Induction|Withdrawal by Subject|0|||
33361517|NCT00049517|62739555|FG002|Induction|Withdrawal by Subject|0|||
33361518|NCT00049517|62739556|FG003|Induction|Withdrawal by Subject|0|||
33361519|NCT00049517|62739557|FG004|Induction|Withdrawal by Subject|1|||
33361520|NCT00049517|62739558|FG005|Induction|Withdrawal by Subject|3|||
33361521|NCT00049517|62739553|FG000|Induction|Alternative therapy|0|||
33361522|NCT00049517|62739554|FG001|Induction|Alternative therapy|0|||
33655611|NCT03877926|63071943|FG003|Overall Study|Death|0|||
33655612|NCT03877926|63071940|FG000|Overall Study|Lost to Follow-up|41|||
33655613|NCT03877926|63071941|FG001|Overall Study|Lost to Follow-up|52|||
33474957|NCT03084796|62849262|FG000|Overall Study|Protocol Violation|0|||
33474958|NCT03084796|62849263|FG001|Overall Study|Protocol Violation|0|||
33361523|NCT00049517|62739555|FG002|Induction|Alternative therapy|0|||
33361524|NCT00049517|62739556|FG003|Induction|Alternative therapy|0|||
33361525|NCT00049517|62739557|FG004|Induction|Alternative therapy|2|||
33361526|NCT00049517|62739558|FG005|Induction|Alternative therapy|2|||
33361527|NCT00049517|62739553|FG000|Induction|Other complicating disease|0|||
33361528|NCT00049517|62739554|FG001|Induction|Other complicating disease|0|||
33361529|NCT00049517|62739555|FG002|Induction|Other complicating disease|0|||
33361530|NCT00049517|62739556|FG003|Induction|Other complicating disease|0|||
33361531|NCT00049517|62739557|FG004|Induction|Other complicating disease|3|||
33361532|NCT00049517|62739558|FG005|Induction|Other complicating disease|0|||
33361533|NCT00049517|62739553|FG000|Induction|Reasons not reported|0|||
33361534|NCT00049517|62739554|FG001|Induction|Reasons not reported|0|||
33361535|NCT00049517|62739555|FG002|Induction|Reasons not reported|0|||
33361536|NCT00049517|62739556|FG003|Induction|Reasons not reported|0|||
33361537|NCT00049517|62739557|FG004|Induction|Reasons not reported|22|||
33361538|NCT00049517|62739558|FG005|Induction|Reasons not reported|25|||
33361539|NCT00049517|62739553|FG000|Conditioning/Transplant|Disease progression|14|||
33361540|NCT00049517|62739554|FG001|Conditioning/Transplant|Disease progression|6|||
33361541|NCT00049517|62739555|FG002|Conditioning/Transplant|Disease progression|10|||
33361542|NCT00049517|62739556|FG003|Conditioning/Transplant|Disease progression|6|||
33361543|NCT00049517|62739557|FG004|Conditioning/Transplant|Disease progression|0|||
33361544|NCT00049517|62739558|FG005|Conditioning/Transplant|Disease progression|0|||
33361545|NCT00049517|62739553|FG000|Conditioning/Transplant|Adverse Event|2|||
33361546|NCT00049517|62739554|FG001|Conditioning/Transplant|Adverse Event|1|||
33361547|NCT00049517|62739555|FG002|Conditioning/Transplant|Adverse Event|4|||
33361548|NCT00049517|62739556|FG003|Conditioning/Transplant|Adverse Event|8|||
33361549|NCT00049517|62739557|FG004|Conditioning/Transplant|Adverse Event|0|||
33361550|NCT00049517|62739558|FG005|Conditioning/Transplant|Adverse Event|0|||
33361551|NCT00049517|62739553|FG000|Conditioning/Transplant|Death|1|||
33361552|NCT00049517|62739554|FG001|Conditioning/Transplant|Death|0|||
33361553|NCT00049517|62739555|FG002|Conditioning/Transplant|Death|0|||
33361554|NCT00049517|62739556|FG003|Conditioning/Transplant|Death|2|||
33361555|NCT00049517|62739557|FG004|Conditioning/Transplant|Death|0|||
33361556|NCT00049517|62739558|FG005|Conditioning/Transplant|Death|0|||
33361557|NCT00049517|62739553|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
33361558|NCT00049517|62739554|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
33361559|NCT00049517|62739555|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
33361560|NCT00049517|62739556|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
33361561|NCT00049517|62739557|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
33361562|NCT00049517|62739558|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
33361563|NCT00049517|62739553|FG000|Conditioning/Transplant|Alternative therapy|4|||
33361564|NCT00049517|62739554|FG001|Conditioning/Transplant|Alternative therapy|4|||
33361565|NCT00049517|62739555|FG002|Conditioning/Transplant|Alternative therapy|2|||
33361566|NCT00049517|62739556|FG003|Conditioning/Transplant|Alternative therapy|1|||
33361567|NCT00049517|62739557|FG004|Conditioning/Transplant|Alternative therapy|1|||
33361568|NCT00049517|62739558|FG005|Conditioning/Transplant|Alternative therapy|0|||
33361569|NCT00049517|62739553|FG000|Conditioning/Transplant|Other complicating disease|2|||
33361570|NCT00049517|62739554|FG001|Conditioning/Transplant|Other complicating disease|0|||
33361571|NCT00049517|62739555|FG002|Conditioning/Transplant|Other complicating disease|0|||
33361572|NCT00049517|62739556|FG003|Conditioning/Transplant|Other complicating disease|4|||
33361573|NCT00049517|62739557|FG004|Conditioning/Transplant|Other complicating disease|0|||
33361574|NCT00049517|62739558|FG005|Conditioning/Transplant|Other complicating disease|1|||
33361575|NCT00049517|62739553|FG000|Conditioning/Transplant|Reasons not reported|25|||
33361576|NCT00049517|62739554|FG001|Conditioning/Transplant|Reasons not reported|31|||
33361577|NCT00049517|62739555|FG002|Conditioning/Transplant|Reasons not reported|18|||
33361578|NCT00049517|62739556|FG003|Conditioning/Transplant|Reasons not reported|15|||
33361579|NCT00049517|62739557|FG004|Conditioning/Transplant|Reasons not reported|5|||
33361580|NCT00049517|62739558|FG005|Conditioning/Transplant|Reasons not reported|5|||
33361581|NCT00926783|62739568|FG000|Overall Study|Incomplete CFAE Procedures|3|||
33361582|NCT00926783|62739569|FG001|Overall Study|Incomplete CFAE Procedures|3|||
33474959|NCT03084796|62849264|FG002|Overall Study|Protocol Violation|1|||
33474960|NCT03084796|62849265|FG003|Overall Study|Protocol Violation|0|||
33474961|NCT03084796|62849266|FG004|Overall Study|Protocol Violation|1|||
33474962|NCT03084796|62849267|FG005|Overall Study|Protocol Violation|1|||
33474963|NCT03084796|62849262|FG000|Overall Study|Lack of Efficacy|0|||
33474964|NCT03084796|62849263|FG001|Overall Study|Lack of Efficacy|0|||
33474965|NCT03084796|62849264|FG002|Overall Study|Lack of Efficacy|1|||
33474966|NCT03084796|62849265|FG003|Overall Study|Lack of Efficacy|0|||
33474967|NCT03084796|62849266|FG004|Overall Study|Lack of Efficacy|1|||
33474968|NCT03084796|62849267|FG005|Overall Study|Lack of Efficacy|0|||
33474969|NCT03084796|62849262|FG000|Overall Study|Lost to Follow-up|0|||
33474970|NCT03084796|62849263|FG001|Overall Study|Lost to Follow-up|0|||
33474971|NCT03084796|62849264|FG002|Overall Study|Lost to Follow-up|1|||
33361583|NCT00929669|62739575|FG000|Overall Study|elevated glucose levels|1|||
33361584|NCT00566995|62739579|FG000|Overall Study|Toxicity|4|||
33361585|NCT00566995|62739579|FG000|Overall Study|Withdrew consent|3|||
33361586|NCT00926393|62739585|FG000|Overall Study|Withdrawal by Subject|1|||
33361587|NCT00926393|62739586|FG001|Overall Study|Withdrawal by Subject|2|||
33361588|NCT00926393|62739585|FG000|Overall Study|Adverse Event|1|||
33361589|NCT00926393|62739586|FG001|Overall Study|Adverse Event|1|||
33361590|NCT00926237|62739592|FG000|Overall Study|Withdrawal by Subject|2|||
33361591|NCT00926237|62739593|FG001|Overall Study|Withdrawal by Subject|1|||
33361592|NCT00931463|62739605|FG000|Overall Study|Death|8|||
33361593|NCT00931463|62739606|FG001|Overall Study|Death|4|||
33361594|NCT00931463|62739605|FG000|Overall Study|Withdrawal by Subject|5|||
33361595|NCT00931463|62739606|FG001|Overall Study|Withdrawal by Subject|0|||
33361596|NCT00931463|62739605|FG000|Overall Study|Lost to Follow-up|4|||
33361597|NCT00931463|62739606|FG001|Overall Study|Lost to Follow-up|1|||
33361598|NCT00929201|62739612|FG000|Period 1|Withdrawal by Subject|0|||
33361599|NCT00929201|62739613|FG001|Period 1|Withdrawal by Subject|1|||
33361600|NCT00926003|62739623|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
33361601|NCT00926003|62739624|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
33361602|NCT00926003|62739625|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
33361603|NCT00926003|62739623|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
33361604|NCT00926003|62739624|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
33361605|NCT00926003|62739625|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
33361606|NCT00928889|62739635|FG000|Overall Study|Lost to Follow-up|3|||
33361607|NCT00928889|62739636|FG001|Overall Study|Lost to Follow-up|1|||
33361608|NCT00928889|62739635|FG000|Overall Study|Protocol Violation|0|||
33361609|NCT00928889|62739636|FG001|Overall Study|Protocol Violation|1|||
33361610|NCT00928889|62739635|FG000|Overall Study|Adverse Event|1|||
33361611|NCT00928889|62739636|FG001|Overall Study|Adverse Event|0|||
33361612|NCT00928889|62739635|FG000|Overall Study|Other|1|||
33361613|NCT00928889|62739636|FG001|Overall Study|Other|0|||
33361614|NCT03978091|62739648|FG000|Overall Study|Lost to Follow-up|0|||
33361615|NCT03978091|62739649|FG001|Overall Study|Lost to Follow-up|0|||
33361616|NCT03978091|62739650|FG002|Overall Study|Lost to Follow-up|1|||
33361617|NCT03978091|62739651|FG003|Overall Study|Lost to Follow-up|0|||
33361618|NCT03978091|62739652|FG004|Overall Study|Lost to Follow-up|0|||
33361619|NCT03978091|62739653|FG005|Overall Study|Lost to Follow-up|0|||
33361620|NCT03978091|62739648|FG000|Overall Study|Withdrawal by Subject|0|||
33361621|NCT03978091|62739649|FG001|Overall Study|Withdrawal by Subject|0|||
33361622|NCT03978091|62739650|FG002|Overall Study|Withdrawal by Subject|0|||
33361623|NCT03978091|62739651|FG003|Overall Study|Withdrawal by Subject|1|||
33361624|NCT03978091|62739652|FG004|Overall Study|Withdrawal by Subject|1|||
33361625|NCT03978091|62739653|FG005|Overall Study|Withdrawal by Subject|0|||
33361626|NCT00564733|62739676|FG000|Overall Study|Withdrawal by Subject|4|||
33361627|NCT00564733|62739676|FG000|Overall Study|Ineligible|5|||
33361628|NCT00931385|62739680|FG000|Overall Study|Adverse Event|2|||
33361629|NCT00931385|62739681|FG001|Overall Study|Adverse Event|1|||
33361630|NCT00931385|62739682|FG002|Overall Study|Adverse Event|0|||
33474972|NCT03084796|62849265|FG003|Overall Study|Lost to Follow-up|1|||
33474973|NCT03084796|62849266|FG004|Overall Study|Lost to Follow-up|3|||
33474974|NCT03084796|62849267|FG005|Overall Study|Lost to Follow-up|1|||
33474975|NCT03084796|62849262|FG000|Overall Study|Randomization error|0|||
33474976|NCT03084796|62849263|FG001|Overall Study|Randomization error|0|||
33474977|NCT03084796|62849264|FG002|Overall Study|Randomization error|1|||
33474978|NCT03084796|62849265|FG003|Overall Study|Randomization error|0|||
33474979|NCT03084796|62849266|FG004|Overall Study|Randomization error|0|||
33474980|NCT03084796|62849267|FG005|Overall Study|Randomization error|0|||
33474981|NCT03717012|62849283|FG000|Overall Study|Due to trial termination|1|||
33474982|NCT03717012|62849284|FG001|Overall Study|Due to trial termination|2|||
33474983|NCT03717012|62849283|FG000|Overall Study|Protocol Violation|0|||
33474984|NCT03717012|62849284|FG001|Overall Study|Protocol Violation|2|||
33474985|NCT03717012|62849283|FG000|Overall Study|Adverse Event|0|||
33549424|NCT02477800|62940541|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
33549425|NCT02477800|62940542|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
33474986|NCT03717012|62849284|FG001|Overall Study|Adverse Event|1|||
33549426|NCT02477800|62940543|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
33549427|NCT02477800|62940544|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
33361631|NCT00931385|62739683|FG003|Overall Study|Adverse Event|3|||
33474987|NCT03717012|62849283|FG000|Overall Study|Lung transplant|0|||
33549428|NCT02477800|62940538|FG000|Long Term Extension Period|Study Visit Burden|0|||
33361632|NCT00931385|62739680|FG000|Overall Study|Protocol Violation|0|||
33361633|NCT00931385|62739681|FG001|Overall Study|Protocol Violation|0|||
33361634|NCT00931385|62739682|FG002|Overall Study|Protocol Violation|1|||
33361635|NCT00931385|62739683|FG003|Overall Study|Protocol Violation|0|||
33361636|NCT00931385|62739680|FG000|Overall Study|Withdrawal by Subject|0|||
33361637|NCT00931385|62739681|FG001|Overall Study|Withdrawal by Subject|1|||
33474988|NCT03717012|62849284|FG001|Overall Study|Lung transplant|1|||
33474989|NCT03078556|62849297|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
33361638|NCT00931385|62739682|FG002|Overall Study|Withdrawal by Subject|0|||
33361639|NCT00931385|62739683|FG003|Overall Study|Withdrawal by Subject|1|||
33361640|NCT00931385|62739680|FG000|Overall Study|Lost to Follow-up|0|||
33361641|NCT00931385|62739681|FG001|Overall Study|Lost to Follow-up|0|||
33361642|NCT00931385|62739682|FG002|Overall Study|Lost to Follow-up|0|||
33361643|NCT00931385|62739683|FG003|Overall Study|Lost to Follow-up|1|||
33361644|NCT00565747|62739699|FG000|Overall Study|No embryo transfer|67|||
33361645|NCT00565747|62739700|FG001|Overall Study|No embryo transfer|73|||
33361646|NCT00563797|62739708|FG000|Overall Study|Lost to Follow-up|7|||
33361647|NCT00563797|62739709|FG001|Overall Study|Lost to Follow-up|2|||
33361648|NCT00771927|62739728|FG000|Overall Study|Adverse Event|100|||
33361649|NCT00771927|62739729|FG001|Overall Study|Adverse Event|105|||
33361650|NCT00771927|62739728|FG000|Overall Study|Lack of Efficacy|70|||
33361651|NCT00771927|62739729|FG001|Overall Study|Lack of Efficacy|42|||
33361652|NCT00771927|62739728|FG000|Overall Study|Lost to Follow-up|46|||
33361653|NCT00771927|62739729|FG001|Overall Study|Lost to Follow-up|46|||
33361654|NCT00771927|62739728|FG000|Overall Study|Withdrawal by Subject|16|||
33361655|NCT00771927|62739729|FG001|Overall Study|Withdrawal by Subject|17|||
33361656|NCT00771927|62739728|FG000|Overall Study|Other reason|23|||
33361657|NCT00771927|62739729|FG001|Overall Study|Other reason|27|||
33361658|NCT00771849|62739737|FG000|Overall Study|Lost to Follow-up|1|||
33655614|NCT03877926|63071942|FG002|Overall Study|Lost to Follow-up|45|||
33655615|NCT03877926|63071943|FG003|Overall Study|Lost to Follow-up|17|||
33361659|NCT00771849|62739738|FG001|Overall Study|Lost to Follow-up|2|||
33361660|NCT00771849|62739737|FG000|Overall Study|Withdrawal by Subject|1|||
33361661|NCT00771849|62739738|FG001|Overall Study|Withdrawal by Subject|1|||
33361662|NCT00771849|62739737|FG000|Overall Study|Not vaccinated|0|||
33361663|NCT00771849|62739738|FG001|Overall Study|Not vaccinated|1|||
33361664|NCT00564889|62739744|FG000|Overall Study|Death|7|||
33361665|NCT00564889|62739744|FG000|Overall Study|Adverse Event|12|||
33361666|NCT00564889|62739744|FG000|Overall Study|Alternative treatment|3|||
33361667|NCT00564889|62739744|FG000|Overall Study|Disease progression|3|||
33361668|NCT00564889|62739744|FG000|Overall Study|Other, not specified|4|||
33361669|NCT00560833|62739762|FG000|Overall Study|Adverse Event|16|||
33361670|NCT00560833|62739763|FG001|Overall Study|Adverse Event|10|||
33361671|NCT00560833|62739764|FG002|Overall Study|Adverse Event|25|||
33361672|NCT00560833|62739765|FG003|Overall Study|Adverse Event|23|||
33361673|NCT00560833|62739766|FG004|Overall Study|Adverse Event|35|||
33361674|NCT00560833|62739762|FG000|Overall Study|Lost to Follow-up|0|||
33361675|NCT00560833|62739763|FG001|Overall Study|Lost to Follow-up|0|||
33361676|NCT00560833|62739764|FG002|Overall Study|Lost to Follow-up|1|||
33361677|NCT00560833|62739765|FG003|Overall Study|Lost to Follow-up|0|||
33361678|NCT00560833|62739766|FG004|Overall Study|Lost to Follow-up|0|||
33361679|NCT00560833|62739762|FG000|Overall Study|Lack of Efficacy|22|||
33361680|NCT00560833|62739763|FG001|Overall Study|Lack of Efficacy|9|||
33361681|NCT00560833|62739764|FG002|Overall Study|Lack of Efficacy|6|||
33361682|NCT00560833|62739765|FG003|Overall Study|Lack of Efficacy|4|||
33361683|NCT00560833|62739766|FG004|Overall Study|Lack of Efficacy|4|||
33361684|NCT00560833|62739762|FG000|Overall Study|Participant uncooperative|5|||
33361685|NCT00560833|62739763|FG001|Overall Study|Participant uncooperative|5|||
33361686|NCT00560833|62739764|FG002|Overall Study|Participant uncooperative|4|||
33361687|NCT00560833|62739765|FG003|Overall Study|Participant uncooperative|4|||
33361688|NCT00560833|62739766|FG004|Overall Study|Participant uncooperative|2|||
33361689|NCT00560833|62739762|FG000|Overall Study|Other|1|||
33474990|NCT03078556|62849298|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
33474991|NCT03078556|62849299|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
33474992|NCT03078556|62849300|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
33474993|NCT03078556|62849297|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
33474994|NCT03078556|62849298|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
33474995|NCT03078556|62849299|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
33474996|NCT03078556|62849300|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
33474997|NCT03078556|62849297|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
33474998|NCT03078556|62849298|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
33474999|NCT03078556|62849299|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
33475000|NCT03078556|62849300|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
33475001|NCT03078556|62849297|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
33361690|NCT00560833|62739763|FG001|Overall Study|Other|1|||
33361691|NCT00560833|62739764|FG002|Overall Study|Other|3|||
33361692|NCT00560833|62739765|FG003|Overall Study|Other|0|||
33361693|NCT00560833|62739766|FG004|Overall Study|Other|0|||
33361694|NCT00560833|62739762|FG000|Overall Study|Never received drug|0|||
33361695|NCT00560833|62739763|FG001|Overall Study|Never received drug|1|||
33361696|NCT00560833|62739764|FG002|Overall Study|Never received drug|0|||
33361697|NCT00560833|62739765|FG003|Overall Study|Never received drug|0|||
33361698|NCT00560833|62739766|FG004|Overall Study|Never received drug|1|||
33361699|NCT00771615|62739787|FG000|Overall Study|Withdrawal by Subject|0|||
33361700|NCT00771615|62739788|FG001|Overall Study|Withdrawal by Subject|1|||
33361701|NCT00771615|62739789|FG002|Overall Study|Withdrawal by Subject|0|||
33361702|NCT00771615|62739790|FG003|Overall Study|Withdrawal by Subject|0|||
33361703|NCT00771615|62739791|FG004|Overall Study|Withdrawal by Subject|0|||
33361704|NCT00771615|62739792|FG005|Overall Study|Withdrawal by Subject|0|||
33361705|NCT00771615|62739793|FG006|Overall Study|Withdrawal by Subject|0|||
33361706|NCT00771615|62739794|FG007|Overall Study|Withdrawal by Subject|1|||
33361707|NCT00771615|62739795|FG008|Overall Study|Withdrawal by Subject|0|||
33361708|NCT00771615|62739787|FG000|Overall Study|Lost to Follow-up|1|||
33361709|NCT00771615|62739788|FG001|Overall Study|Lost to Follow-up|1|||
33361710|NCT00771615|62739789|FG002|Overall Study|Lost to Follow-up|1|||
33361711|NCT00771615|62739790|FG003|Overall Study|Lost to Follow-up|1|||
33361712|NCT00771615|62739791|FG004|Overall Study|Lost to Follow-up|0|||
33361713|NCT00771615|62739792|FG005|Overall Study|Lost to Follow-up|1|||
33361714|NCT00771615|62739793|FG006|Overall Study|Lost to Follow-up|1|||
33361715|NCT00771615|62739794|FG007|Overall Study|Lost to Follow-up|0|||
33361716|NCT00771615|62739795|FG008|Overall Study|Lost to Follow-up|0|||
33361717|NCT02723604|62739824|FG000|Overall Study|ineligible|1|||
33361718|NCT02723604|62739824|FG000|Overall Study|never received treatment|1|||
33361719|NCT00560755|62739828|FG000|Overall Study|Protocol Violation|15|||
33361720|NCT00560755|62739828|FG000|Overall Study|Withdrawal by Subject|26|||
33361721|NCT00560755|62739828|FG000|Overall Study|Lost to Follow-up|9|||
33361722|NCT00560755|62739828|FG000|Overall Study|Adverse Event|8|||
33361723|NCT00560755|62739828|FG000|Overall Study|Physician Decision|2|||
33361724|NCT00770991|62739835|FG000|Overall Study|Physician Decision|2|||
33361725|NCT00770991|62739836|FG001|Overall Study|Physician Decision|0|||
33361726|NCT00770991|62739835|FG000|Overall Study|Withdrawal by Subject|1|||
33361727|NCT00770991|62739836|FG001|Overall Study|Withdrawal by Subject|0|||
33361728|NCT00770991|62739835|FG000|Overall Study|Adverse Event|1|||
33361729|NCT00770991|62739836|FG001|Overall Study|Adverse Event|5|||
33361730|NCT00770991|62739835|FG000|Overall Study|Pregnancy|1|||
33361731|NCT00770991|62739836|FG001|Overall Study|Pregnancy|0|||
33361732|NCT00925769|62739847|FG000|Overall Study|Major toxicity|1|||
33361733|NCT00925769|62739848|FG001|Overall Study|Major toxicity|0|||
33361734|NCT00925769|62739849|FG002|Overall Study|Major toxicity|1|||
33361735|NCT00925769|62739850|FG003|Overall Study|Major toxicity|1|||
33361736|NCT00925769|62739851|FG004|Overall Study|Major toxicity|0|||
33361737|NCT00925769|62739852|FG005|Overall Study|Major toxicity|0|||
33361738|NCT00925769|62739847|FG000|Overall Study|Disease progression|4|||
33361739|NCT00925769|62739848|FG001|Overall Study|Disease progression|5|||
33361740|NCT00925769|62739849|FG002|Overall Study|Disease progression|3|||
33361741|NCT00925769|62739850|FG003|Overall Study|Disease progression|4|||
33361742|NCT00925769|62739851|FG004|Overall Study|Disease progression|2|||
33361743|NCT00925769|62739852|FG005|Overall Study|Disease progression|3|||
33361744|NCT00925769|62739847|FG000|Overall Study|Death|0|||
33361745|NCT00925769|62739848|FG001|Overall Study|Death|0|||
33361746|NCT00925769|62739849|FG002|Overall Study|Death|1|||
33361747|NCT00925769|62739850|FG003|Overall Study|Death|0|||
33361748|NCT00925769|62739851|FG004|Overall Study|Death|0|||
33361749|NCT00925769|62739852|FG005|Overall Study|Death|0|||
33361750|NCT00925769|62739847|FG000|Overall Study|Physician Decision|1|||
33361751|NCT00925769|62739848|FG001|Overall Study|Physician Decision|0|||
33361752|NCT00925769|62739849|FG002|Overall Study|Physician Decision|0|||
33361753|NCT00925769|62739850|FG003|Overall Study|Physician Decision|0|||
33361754|NCT00925769|62739851|FG004|Overall Study|Physician Decision|0|||
33361755|NCT00925769|62739852|FG005|Overall Study|Physician Decision|0|||
33475002|NCT03078556|62849298|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
33475003|NCT03078556|62849299|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
33475004|NCT03078556|62849300|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
33475005|NCT03714672|62849329|FG000|Overall Study|Adverse Event|0|||
33475006|NCT03714672|62849330|FG001|Overall Study|Adverse Event|0|||
33475007|NCT03714672|62849331|FG002|Overall Study|Adverse Event|3|||
33475008|NCT03714672|62849332|FG003|Overall Study|Adverse Event|0|||
33475009|NCT03714672|62849329|FG000|Overall Study|Physician Decision|0|||
33475010|NCT03714672|62849330|FG001|Overall Study|Physician Decision|1|||
33475011|NCT03714672|62849331|FG002|Overall Study|Physician Decision|0|||
33361756|NCT00925769|62739847|FG000|Overall Study|Missing documentation|0|||
33361757|NCT00925769|62739848|FG001|Overall Study|Missing documentation|1|||
33361758|NCT00925769|62739849|FG002|Overall Study|Missing documentation|0|||
33361759|NCT00925769|62739850|FG003|Overall Study|Missing documentation|0|||
33475012|NCT03714672|62849332|FG003|Overall Study|Physician Decision|0|||
33361760|NCT00925769|62739851|FG004|Overall Study|Missing documentation|0|||
33361761|NCT00925769|62739852|FG005|Overall Study|Missing documentation|0|||
33361762|NCT00925769|62739847|FG000|Overall Study|End of study visit not done|0|||
33361763|NCT00925769|62739848|FG001|Overall Study|End of study visit not done|0|||
33361764|NCT00925769|62739849|FG002|Overall Study|End of study visit not done|1|||
33361765|NCT00925769|62739850|FG003|Overall Study|End of study visit not done|0|||
33361766|NCT00925769|62739851|FG004|Overall Study|End of study visit not done|0|||
33361767|NCT00925769|62739852|FG005|Overall Study|End of study visit not done|0|||
33361768|NCT00925769|62739847|FG000|Overall Study|Participant is unable to swallow drug|0|||
33475013|NCT03714672|62849329|FG000|Overall Study|Other Reason|1|||
33361769|NCT00925769|62739848|FG001|Overall Study|Participant is unable to swallow drug|0|||
33361770|NCT00925769|62739849|FG002|Overall Study|Participant is unable to swallow drug|0|||
33361771|NCT00925769|62739850|FG003|Overall Study|Participant is unable to swallow drug|1|||
33361772|NCT00925769|62739851|FG004|Overall Study|Participant is unable to swallow drug|0|||
33361773|NCT00925769|62739852|FG005|Overall Study|Participant is unable to swallow drug|0|||
33361774|NCT00925769|62739847|FG000|Overall Study|Adverse Event|0|||
33361775|NCT00925769|62739848|FG001|Overall Study|Adverse Event|0|||
33361776|NCT00925769|62739849|FG002|Overall Study|Adverse Event|0|||
33361777|NCT00925769|62739850|FG003|Overall Study|Adverse Event|0|||
33361778|NCT00925769|62739851|FG004|Overall Study|Adverse Event|1|||
33361779|NCT00925769|62739852|FG005|Overall Study|Adverse Event|0|||
33361780|NCT00770913|62739871|FG000|Overall Study|Adverse Event|1|||
33361781|NCT00770913|62739872|FG001|Overall Study|Adverse Event|3|||
33361782|NCT00770913|62739873|FG002|Overall Study|Adverse Event|6|||
33361783|NCT00770913|62739871|FG000|Overall Study|Refusal to continue participation|6|||
33361784|NCT00770913|62739872|FG001|Overall Study|Refusal to continue participation|4|||
33361785|NCT00770913|62739873|FG002|Overall Study|Refusal to continue participation|5|||
33361786|NCT00770913|62739871|FG000|Overall Study|Physician Decision|0|||
33361787|NCT00770913|62739872|FG001|Overall Study|Physician Decision|1|||
33361788|NCT00770913|62739873|FG002|Overall Study|Physician Decision|1|||
33361789|NCT00770913|62739871|FG000|Overall Study|Protocol Violation|3|||
33361790|NCT00770913|62739872|FG001|Overall Study|Protocol Violation|0|||
33361791|NCT00770913|62739873|FG002|Overall Study|Protocol Violation|1|||
33361792|NCT00770913|62739871|FG000|Overall Study|Incorrect drug was allocated|1|||
33361793|NCT00770913|62739872|FG001|Overall Study|Incorrect drug was allocated|0|||
33361794|NCT00770913|62739873|FG002|Overall Study|Incorrect drug was allocated|0|||
33361795|NCT00562861|62739883|FG000|Overall Study|Adverse Event|1|||
33361796|NCT00562861|62739884|FG001|Overall Study|Adverse Event|1|||
33361797|NCT00562861|62739883|FG000|Overall Study|Lack of Efficacy|5|||
33361798|NCT00562861|62739884|FG001|Overall Study|Lack of Efficacy|5|||
33361799|NCT00562861|62739883|FG000|Overall Study|noncompliance, moved|7|||
33361800|NCT00562861|62739884|FG001|Overall Study|noncompliance, moved|2|||
33361801|NCT00562861|62739883|FG000|Overall Study|Lost to Follow-up|7|||
33361802|NCT00562861|62739884|FG001|Overall Study|Lost to Follow-up|3|||
33361803|NCT00770679|62739890|FG000|Overall Study|Lost to Follow-up|3|||
33361804|NCT00770679|62739890|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
33361805|NCT00770601|62739894|FG000|Overall Study|Withdrawal by Subject|1|||
33361806|NCT00770367|62739900|FG000|First Intervention|Withdrawal by Subject|0|||
33361807|NCT00770367|62739901|FG001|First Intervention|Withdrawal by Subject|2|||
33361808|NCT00770367|62739900|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
33361809|NCT00770367|62739901|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
33361810|NCT00770367|62739900|FG000|Second Intervention|Lost to Follow-up|2|||
33361811|NCT00770367|62739901|FG001|Second Intervention|Lost to Follow-up|0|||
33361812|NCT00931307|62739909|FG000|Overall Study|Lack of Efficacy|12|||
33361813|NCT00931307|62739909|FG000|Overall Study|Biomicroscopy|1|||
33361814|NCT00930761|62739915|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
33361815|NCT00930761|62739916|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
33361816|NCT00930761|62739915|FG000|Overall Study|less than 3 music therapy sessions|0|||
33361817|NCT00930761|62739916|FG001|Overall Study|less than 3 music therapy sessions|3|||
33361818|NCT00770289|62739922|FG000|Overall Study|Other|6|||
33361819|NCT00770211|62739933|FG000|Overall Study|Lost to Follow-up|1|||
33361820|NCT00770211|62739934|FG001|Overall Study|Lost to Follow-up|0|||
33361821|NCT00770211|62739933|FG000|Overall Study|Withdrawal by Subject|0|||
33361822|NCT00770211|62739934|FG001|Overall Study|Withdrawal by Subject|2|||
33361823|NCT00928187|62739943|FG000|Overall Study|Death|1|||
33361824|NCT00928187|62739944|FG001|Overall Study|Death|2|||
33361825|NCT00928187|62739945|FG002|Overall Study|Death|3|||
33361826|NCT00928187|62739943|FG000|Overall Study|Lost to Follow-up|1|||
33361827|NCT00928187|62739944|FG001|Overall Study|Lost to Follow-up|2|||
33361828|NCT00928187|62739945|FG002|Overall Study|Lost to Follow-up|1|||
33361829|NCT00928187|62739943|FG000|Overall Study|Withdrawal by Subject|0|||
33361830|NCT00928187|62739944|FG001|Overall Study|Withdrawal by Subject|1|||
33361831|NCT00928187|62739945|FG002|Overall Study|Withdrawal by Subject|1|||
33361832|NCT00928187|62739943|FG000|Overall Study|Protocol Violation|0|||
33361833|NCT00928187|62739944|FG001|Overall Study|Protocol Violation|1|||
33361834|NCT00928187|62739945|FG002|Overall Study|Protocol Violation|0|||
33361835|NCT00769119|62739955|FG000|Overall Study|Voluntary discontinuation|0|||
33361836|NCT00769119|62739956|FG001|Overall Study|Voluntary discontinuation|2|||
33361837|NCT00769119|62739955|FG000|Overall Study|Adverse Event|1|||
33361838|NCT00769119|62739956|FG001|Overall Study|Adverse Event|1|||
33361839|NCT00769119|62739955|FG000|Overall Study|Disallowed medication|1|||
33361840|NCT00769119|62739956|FG001|Overall Study|Disallowed medication|0|||
33361841|NCT00927953|62739964|FG000|Overall Study|Death|2|||
33361842|NCT00927953|62739965|FG001|Overall Study|Death|1|||
33361843|NCT00768651|62739972|FG000|Overall Study|Withdrawal by Subject|1|||
33361844|NCT00756717|62739977|FG000|Overall Study|Withdrawal by Subject|2|||
33361845|NCT04987762|62739987|FG000|Overall Study|Study was Terminated by Sponsor|103|||
33361846|NCT04817332|62740014|FG000|Overall Study|Lost to Follow-up|3|||
33361847|NCT04817332|62740015|FG001|Overall Study|Lost to Follow-up|3|||
33361848|NCT04817332|62740014|FG000|Overall Study|Protocol Violation|2|||
33361849|NCT04817332|62740015|FG001|Overall Study|Protocol Violation|0|||
33361850|NCT04797637|62740023|FG000|Overall Study|Lost to Follow-up|23|||
33361851|NCT04797637|62740024|FG001|Overall Study|Lost to Follow-up|32|||
33361852|NCT04797637|62740023|FG000|Overall Study|Withdrawal by Subject|0|||
33361853|NCT04797637|62740024|FG001|Overall Study|Withdrawal by Subject|1|||
33361854|NCT04779489|62740030|FG000|Overall Study|Physician Decision|1|||
33361855|NCT04300296|62740061|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
33361856|NCT04300296|62740062|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
33361857|NCT04300296|62740063|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
33361858|NCT04300296|62740064|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
33361859|NCT04300296|62740065|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
33475014|NCT03714672|62849330|FG001|Overall Study|Other Reason|2|||
33475015|NCT03714672|62849331|FG002|Overall Study|Other Reason|1|||
33475016|NCT03714672|62849332|FG003|Overall Study|Other Reason|1|||
33475017|NCT03714672|62849329|FG000|Overall Study|Lost to Follow-up|1|||
33475018|NCT03714672|62849330|FG001|Overall Study|Lost to Follow-up|1|||
33475019|NCT03714672|62849331|FG002|Overall Study|Lost to Follow-up|0|||
33475020|NCT03714672|62849332|FG003|Overall Study|Lost to Follow-up|0|||
33475021|NCT03083470|62849348|FG000|Overall Study|Lost to Follow-up|0|||
33361860|NCT04300296|62740066|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
33361861|NCT04300296|62740061|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
33361862|NCT04300296|62740062|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
33361863|NCT04300296|62740063|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
33361864|NCT04300296|62740064|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
33361865|NCT04300296|62740065|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
33361866|NCT04300296|62740066|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
33361867|NCT04300296|62740061|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
33361868|NCT04300296|62740062|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
33361869|NCT04300296|62740063|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
33361870|NCT04300296|62740064|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
33361871|NCT04300296|62740065|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
33361872|NCT04300296|62740066|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
33361873|NCT04300296|62740061|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
33361874|NCT04300296|62740062|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
33361875|NCT04300296|62740063|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
33361876|NCT04300296|62740064|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
33361877|NCT04300296|62740065|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
33361878|NCT04300296|62740066|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
33361879|NCT04300296|62740061|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
33361880|NCT04300296|62740062|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
33361881|NCT04300296|62740063|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
33361882|NCT04300296|62740064|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
33361883|NCT04300296|62740065|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
33361884|NCT04300296|62740066|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
33361885|NCT04300296|62740061|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
33361886|NCT04300296|62740062|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
33361887|NCT04300296|62740063|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
33361888|NCT04300296|62740064|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
33361889|NCT04300296|62740065|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
33361890|NCT04300296|62740066|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
33361891|NCT04300296|62740061|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
33361892|NCT04300296|62740062|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
33361893|NCT04300296|62740063|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
33361894|NCT04300296|62740064|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
33361895|NCT04300296|62740065|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
33361896|NCT04300296|62740066|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
33475022|NCT03083470|62849349|FG001|Overall Study|Lost to Follow-up|0|||
33361897|NCT03989440|62740110|FG000|Overall Study|COVID-19 travel restrictions|0|||
33361898|NCT03989440|62740111|FG001|Overall Study|COVID-19 travel restrictions|0|||
33361899|NCT03989440|62740112|FG002|Overall Study|COVID-19 travel restrictions|1|||
33475023|NCT03083470|62849350|FG002|Overall Study|Lost to Follow-up|0|||
33549429|NCT02477800|62940539|FG001|Long Term Extension Period|Study Visit Burden|0|||
33361900|NCT03989440|62740113|FG003|Overall Study|COVID-19 travel restrictions|0|||
33475024|NCT03083470|62849351|FG003|Overall Study|Lost to Follow-up|0|||
33655616|NCT03877926|63071940|FG000|Overall Study|Physician Decision|2|||
33361901|NCT03989440|62740114|FG004|Overall Study|COVID-19 travel restrictions|0|||
33361902|NCT03989440|62740115|FG005|Overall Study|COVID-19 travel restrictions|0|||
33361903|NCT03989440|62740110|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
33361904|NCT03989440|62740111|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
33361905|NCT03989440|62740112|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
33361906|NCT03989440|62740113|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
33361907|NCT03989440|62740114|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
33361908|NCT03989440|62740115|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
33361909|NCT03908437|62740133|FG000|Overall Study|Death|0|||
33361910|NCT03908437|62740134|FG001|Overall Study|Death|1|||
33361911|NCT03908437|62740133|FG000|Overall Study|Lost to Follow-up|31|||
33361912|NCT03908437|62740134|FG001|Overall Study|Lost to Follow-up|24|||
33361913|NCT03274895|62740168|FG000|Overall Study|Lack of Efficacy|1|||
33361914|NCT03274895|62740169|FG001|Overall Study|Lack of Efficacy|0|||
33361915|NCT03274895|62740168|FG000|Overall Study|Adverse Event|8|||
33361916|NCT03274895|62740169|FG001|Overall Study|Adverse Event|7|||
33361917|NCT03274895|62740168|FG000|Overall Study|Lost to Follow-up|1|||
33361918|NCT03274895|62740169|FG001|Overall Study|Lost to Follow-up|0|||
33361919|NCT03274895|62740168|FG000|Overall Study|Diagnosis not confirmed|3|||
33361920|NCT03274895|62740169|FG001|Overall Study|Diagnosis not confirmed|4|||
33361921|NCT03035201|62740191|FG000|Overall Study|Death|9|||
33361922|NCT03035201|62740192|FG001|Overall Study|Death|12|||
33361923|NCT03035201|62740193|FG002|Overall Study|Death|9|||
33361924|NCT03035201|62740194|FG003|Overall Study|Death|10|||
33361925|NCT03035201|62740191|FG000|Overall Study|Withdrawal by Subject|51|||
33361926|NCT03035201|62740192|FG001|Overall Study|Withdrawal by Subject|49|||
33361927|NCT03035201|62740193|FG002|Overall Study|Withdrawal by Subject|37|||
33361928|NCT03035201|62740194|FG003|Overall Study|Withdrawal by Subject|46|||
33361929|NCT03035201|62740191|FG000|Overall Study|Lost to Follow-up|67|||
33361930|NCT03035201|62740192|FG001|Overall Study|Lost to Follow-up|51|||
33361931|NCT03035201|62740193|FG002|Overall Study|Lost to Follow-up|64|||
33361932|NCT03035201|62740194|FG003|Overall Study|Lost to Follow-up|69|||
33361933|NCT02969915|62740216|FG000|Overall Study|Death|104|||
33361934|NCT02969915|62740217|FG001|Overall Study|Death|125|||
33361935|NCT02969915|62740216|FG000|Overall Study|Lost to Follow-up|108|||
33361936|NCT02969915|62740217|FG001|Overall Study|Lost to Follow-up|112|||
33361937|NCT02969915|62740216|FG000|Overall Study|Censored due to COVID-19|481|||
33361938|NCT02969915|62740217|FG001|Overall Study|Censored due to COVID-19|471|||
33361939|NCT02906332|62740223|FG000|Overall Study|Withdrawal by Subject|1|||
33361940|NCT02827877|62740246|FG000|Overall Study|Withdrawal by Subject|1|||
33361941|NCT02755597|62740252|FG000|Overall Study|Withdrew consent|27|||
33361942|NCT02755597|62740253|FG001|Overall Study|Withdrew consent|11|||
33361943|NCT02755597|62740252|FG000|Overall Study|Lost to Follow-up|1|||
33549430|NCT02477800|62940540|FG002|Long Term Extension Period|Study Visit Burden|0|||
33361944|NCT02755597|62740253|FG001|Overall Study|Lost to Follow-up|0|||
33361945|NCT02755597|62740252|FG000|Overall Study|Death|78|||
33361946|NCT02755597|62740253|FG001|Overall Study|Death|36|||
33361947|NCT02755597|62740252|FG000|Overall Study|Study terminated by Sponsor|67|||
33361948|NCT02755597|62740253|FG001|Overall Study|Study terminated by Sponsor|47|||
33361949|NCT02755597|62740252|FG000|Overall Study|Other, not specified|20|||
33361950|NCT02755597|62740253|FG001|Overall Study|Other, not specified|3|||
33361951|NCT02755597|62740252|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
33475025|NCT03083470|62849352|FG004|Overall Study|Lost to Follow-up|1|||
33361952|NCT02755597|62740253|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
33361953|NCT02598557|62740262|FG000|Overall Study|Withdrawal by Subject|1|||
33361954|NCT02598557|62740263|FG001|Overall Study|Withdrawal by Subject|0|||
33361955|NCT02598557|62740264|FG002|Overall Study|Withdrawal by Subject|1|||
33361956|NCT02598557|62740262|FG000|Overall Study|Participant did not start treatment|2|||
33361957|NCT02598557|62740263|FG001|Overall Study|Participant did not start treatment|1|||
33361958|NCT02598557|62740264|FG002|Overall Study|Participant did not start treatment|1|||
33361959|NCT02598557|62740262|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
33361960|NCT02598557|62740263|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
33361961|NCT02598557|62740264|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
33361962|NCT02598557|62740262|FG000|Overall Study|Adverse Event|1|||
33361963|NCT02598557|62740263|FG001|Overall Study|Adverse Event|1|||
33361964|NCT02598557|62740264|FG002|Overall Study|Adverse Event|0|||
33361965|NCT02576574|62740275|FG000|Overall Study|still ongoing|65|||
33361966|NCT02576574|62740276|FG001|Overall Study|still ongoing|66|||
33361967|NCT02576574|62740277|FG002|Overall Study|still ongoing|73|||
33361968|NCT02576574|62740275|FG000|Overall Study|Randomized, not treated|5|||
33361969|NCT02576574|62740276|FG001|Overall Study|Randomized, not treated|4|||
33361970|NCT02576574|62740277|FG002|Overall Study|Randomized, not treated|26|||
33361971|NCT02340780|62740287|FG000|Overall Study|Ineligible|1|||
33361972|NCT01772472|62740302|FG000|Overall Study|Death|56|||
33361973|NCT01772472|62740303|FG001|Overall Study|Death|42|||
33361974|NCT01772472|62740302|FG000|Overall Study|Physician Decision|1|||
33361975|NCT01772472|62740303|FG001|Overall Study|Physician Decision|3|||
33361976|NCT01772472|62740302|FG000|Overall Study|Other|5|||
33361977|NCT01772472|62740303|FG001|Overall Study|Other|5|||
33361978|NCT01772472|62740302|FG000|Overall Study|Lost to Follow-up|12|||
33361979|NCT01772472|62740303|FG001|Overall Study|Lost to Follow-up|8|||
33361980|NCT01772472|62740302|FG000|Overall Study|Withdrawal by Subject|72|||
33361981|NCT01772472|62740303|FG001|Overall Study|Withdrawal by Subject|50|||
33361982|NCT01772472|62740302|FG000|Overall Study|Ongoing|597|||
33361983|NCT01772472|62740303|FG001|Overall Study|Ongoing|635|||
33361984|NCT01470417|62740311|FG000|Overall Study|Disease progression|0|||
33361985|NCT01470417|62740312|FG001|Overall Study|Disease progression|2|||
33361986|NCT00820248|62740350|FG000|Overall Study|No treated|4|||
33361987|NCT00820248|62740351|FG001|Overall Study|No treated|1|||
33361988|NCT00668642|62740368|FG000|First Off-cycle|Cancer progression|1|||
33361989|NCT00668642|62740369|FG001|First Off-cycle|Cancer progression|0|||
33361990|NCT00668642|62740368|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
33361991|NCT00668642|62740369|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
33549431|NCT02477800|62940541|FG003|Long Term Extension Period|Study Visit Burden|3|||
33361992|NCT00609791|62740375|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
33361993|NCT00101101|62740388|FG000|Overall Study|never received vaccine|20|||
33361994|NCT03962101|62740392|FG000|Overall Study|Adverse Event|1|||
33361995|NCT03962101|62740392|FG000|Overall Study|Physician Decision|2|||
33361996|NCT03962101|62740392|FG000|Overall Study|Not related to medical events|1|||
33549432|NCT02477800|62940542|FG004|Long Term Extension Period|Study Visit Burden|0|||
33361997|NCT00923351|62740399|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
33361998|NCT00923351|62740400|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
33361999|NCT00923351|62740401|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
33362000|NCT00755937|62740407|FG000|Recruitment|Unknown if infliximab received|164|||
33362001|NCT00755937|62740407|FG000|Observational Follow-up|Lost to Follow-up|148|||
33362002|NCT00755079|62740413|FG000|Overall Study|Lost to Follow-up|1|||
33362003|NCT00755079|62740414|FG001|Overall Study|Lost to Follow-up|3|||
33362004|NCT00755079|62740413|FG000|Overall Study|Adverse Event|0|||
33362005|NCT00755079|62740414|FG001|Overall Study|Adverse Event|1|||
33362006|NCT00755079|62740413|FG000|Overall Study|Withdrawal by Subject|0|||
33362007|NCT00755079|62740414|FG001|Overall Study|Withdrawal by Subject|2|||
33362008|NCT00925301|62740422|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
33362009|NCT00925301|62740423|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
33362010|NCT00925301|62740424|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
33362011|NCT00925301|62740425|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
33362012|NCT00925301|62740422|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
33362013|NCT00925301|62740423|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
33362014|NCT00925301|62740424|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
33362015|NCT00925301|62740425|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
33362016|NCT00925301|62740422|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
33362017|NCT00925301|62740423|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
33362018|NCT00925301|62740424|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
33362019|NCT00925301|62740425|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
33362020|NCT00925301|62740422|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
33362021|NCT00925301|62740423|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
33362022|NCT00925301|62740424|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
33362023|NCT00925301|62740425|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
33362024|NCT00925301|62740422|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
33362025|NCT00925301|62740423|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
33362026|NCT00925301|62740424|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
33362027|NCT00925301|62740425|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
33362028|NCT00925301|62740422|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
33362029|NCT00925301|62740423|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
33362030|NCT00925301|62740424|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
33362031|NCT00925301|62740425|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
33362032|NCT00925301|62740422|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
33362033|NCT00925301|62740423|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
33362034|NCT00925301|62740424|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
33362035|NCT00925301|62740425|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
33362036|NCT00754065|62740438|FG000|Overall Study|Never received treatment|12|||
33362037|NCT00754065|62740439|FG001|Overall Study|Never received treatment|2|||
33362038|NCT00754065|62740438|FG000|Overall Study|Adverse Event|19|||
33362039|NCT00754065|62740439|FG001|Overall Study|Adverse Event|25|||
33475026|NCT03083470|62849348|FG000|Overall Study|Withdrawal by Subject|0|||
33475027|NCT03083470|62849349|FG001|Overall Study|Withdrawal by Subject|0|||
33475028|NCT03083470|62849350|FG002|Overall Study|Withdrawal by Subject|0|||
33475029|NCT03083470|62849351|FG003|Overall Study|Withdrawal by Subject|0|||
33475030|NCT03083470|62849352|FG004|Overall Study|Withdrawal by Subject|1|||
33475031|NCT05405244|62849364|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
33475032|NCT05405244|62849365|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
33475033|NCT05405244|62849364|FG000|Washout (2 Weeks)|Adverse Event|2|||
33475034|NCT05405244|62849365|FG001|Washout (2 Weeks)|Adverse Event|0|||
33475035|NCT05405244|62849364|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
33475036|NCT05405244|62849365|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
33475037|NCT03074500|62849378|FG000|Overall Study|Lost to Follow-up|1|||
33475038|NCT03074500|62849379|FG001|Overall Study|Lost to Follow-up|0|||
33475039|NCT03074500|62849380|FG002|Overall Study|Lost to Follow-up|0|||
33475040|NCT03074500|62849378|FG000|Overall Study|Lack of Efficacy|0|||
33475041|NCT03074500|62849379|FG001|Overall Study|Lack of Efficacy|1|||
33475042|NCT03074500|62849380|FG002|Overall Study|Lack of Efficacy|0|||
33475043|NCT03074500|62849378|FG000|Overall Study|Adverse Event|0|||
33362040|NCT00754065|62740438|FG000|Overall Study|Lost to Follow-up|7|||
33362041|NCT00754065|62740439|FG001|Overall Study|Lost to Follow-up|11|||
33475044|NCT03074500|62849379|FG001|Overall Study|Adverse Event|0|||
33475045|NCT03074500|62849380|FG002|Overall Study|Adverse Event|1|||
33475046|NCT03715530|62849393|FG000|Overall Study|Lost to Follow-up|3|||
33549433|NCT02477800|62940543|FG005|Long Term Extension Period|Study Visit Burden|2|||
33655617|NCT03877926|63071941|FG001|Overall Study|Physician Decision|0|||
33362042|NCT00754065|62740438|FG000|Overall Study|Protocol Violation|12|||
33362043|NCT00754065|62740439|FG001|Overall Study|Protocol Violation|10|||
33362044|NCT00754065|62740438|FG000|Overall Study|Withdrawal by Subject|4|||
33362045|NCT00754065|62740439|FG001|Overall Study|Withdrawal by Subject|5|||
33362046|NCT00754065|62740438|FG000|Overall Study|Pregnancy|6|||
33362047|NCT00754065|62740439|FG001|Overall Study|Pregnancy|0|||
33362048|NCT00754065|62740438|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
33362049|NCT00754065|62740439|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
33362050|NCT04138056|62740459|FG000|Primary Study|Lost to Follow-up|3|||
33362051|NCT04138056|62740460|FG001|Primary Study|Lost to Follow-up|4|||
33362052|NCT04138056|62740461|FG002|Primary Study|Lost to Follow-up|1|||
33362053|NCT04138056|62740462|FG003|Primary Study|Lost to Follow-up|1|||
33362054|NCT04138056|62740463|FG004|Primary Study|Lost to Follow-up|4|||
33362055|NCT04138056|62740459|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
33362056|NCT04138056|62740460|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
33362057|NCT04138056|62740461|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
33549434|NCT02477800|62940544|FG006|Long Term Extension Period|Study Visit Burden|2|||
33549435|NCT02477800|62940538|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
33362058|NCT04138056|62740462|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
33362059|NCT04138056|62740463|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
33362060|NCT04138056|62740459|FG000|Extension Study|Lost to Follow-up|1|||
33362061|NCT04138056|62740460|FG001|Extension Study|Lost to Follow-up|2|||
33362062|NCT04138056|62740461|FG002|Extension Study|Lost to Follow-up|1|||
33362063|NCT04138056|62740462|FG003|Extension Study|Lost to Follow-up|0|||
33362064|NCT04138056|62740463|FG004|Extension Study|Lost to Follow-up|1|||
33362065|NCT00753675|62740509|FG000|Overall Study|other reason|11|||
33362066|NCT00753675|62740510|FG001|Overall Study|other reason|12|||
33362067|NCT00753675|62740511|FG002|Overall Study|other reason|13|||
33362068|NCT00753675|62740509|FG000|Overall Study|Death|1|||
33362069|NCT00753675|62740510|FG001|Overall Study|Death|2|||
33362070|NCT00753675|62740511|FG002|Overall Study|Death|4|||
33362071|NCT00753675|62740509|FG000|Overall Study|Adverse Event|11|||
33362072|NCT00753675|62740510|FG001|Overall Study|Adverse Event|9|||
33362073|NCT00753675|62740511|FG002|Overall Study|Adverse Event|4|||
33362074|NCT00753675|62740509|FG000|Overall Study|Objective progression of disease|35|||
33362075|NCT00753675|62740510|FG001|Overall Study|Objective progression of disease|35|||
33362076|NCT00753675|62740511|FG002|Overall Study|Objective progression of disease|35|||
33362077|NCT00753675|62740509|FG000|Overall Study|Withdrawal by Subject|0|||
33362078|NCT00753675|62740510|FG001|Overall Study|Withdrawal by Subject|1|||
33362079|NCT00753675|62740511|FG002|Overall Study|Withdrawal by Subject|0|||
33362080|NCT00753675|62740509|FG000|Overall Study|Lost to Follow-up|1|||
33362081|NCT00753675|62740510|FG001|Overall Study|Lost to Follow-up|0|||
33362082|NCT00753675|62740511|FG002|Overall Study|Lost to Follow-up|0|||
33362083|NCT00586521|62740519|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
33362084|NCT00923273|62740528|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
33362085|NCT00923273|62740529|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
33362086|NCT00923273|62740530|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
33362087|NCT00923273|62740531|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
33362088|NCT00923273|62740532|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
33362089|NCT00923273|62740528|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
33362090|NCT00923273|62740529|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
33362091|NCT00923273|62740530|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
33362092|NCT00923273|62740531|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
33362093|NCT00923273|62740532|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
33362094|NCT00923195|62740552|FG000|Overall Study|Death|0|||
33362095|NCT00923195|62740553|FG001|Overall Study|Death|1|||
33362096|NCT00753519|62740561|FG000|Overall Study|Withdrawal by Subject|0|||
33362097|NCT00753519|62740562|FG001|Overall Study|Withdrawal by Subject|2|||
33362098|NCT00919061|62740570|FG000|Overall Study|Adverse Event|1|||
33362099|NCT00919061|62740570|FG000|Overall Study|Withdrawal by Subject|1|||
33362100|NCT00747435|62740574|FG000|Overall Study|Lost to Follow-up|2|||
33475047|NCT03715530|62849394|FG001|Overall Study|Lost to Follow-up|1|||
33475048|NCT03715530|62849395|FG002|Overall Study|Lost to Follow-up|2|||
33475049|NCT03077698|62849405|FG000|Progestin Monotherapy|Stable Disease|8|||
33475050|NCT03077698|62849406|FG001|Progestin Monotherapy|Stable Disease|0|||
33475051|NCT03077698|62849405|FG000|Progestin Monotherapy|Adverse Event|1|||
33475052|NCT03077698|62849406|FG001|Progestin Monotherapy|Adverse Event|0|||
33475053|NCT03077698|62849405|FG000|Progestin Monotherapy|Death|1|||
33475054|NCT03077698|62849406|FG001|Progestin Monotherapy|Death|0|||
33475055|NCT03077698|62849405|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
33549436|NCT02477800|62940539|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
33362101|NCT00747435|62740574|FG000|Overall Study|Withdrawal by Subject|3|||
33362102|NCT00747435|62740574|FG000|Overall Study|Still undergoing follow up|1|||
33362103|NCT00918749|62740581|FG000|Overall Study|Adverse Event|1|||
33362104|NCT00918749|62740582|FG001|Overall Study|Adverse Event|0|||
33362105|NCT00918749|62740583|FG002|Overall Study|Adverse Event|1|||
33362106|NCT00918749|62740581|FG000|Overall Study|Lost to Follow-up|0|||
33362107|NCT00918749|62740582|FG001|Overall Study|Lost to Follow-up|0|||
33362108|NCT00918749|62740583|FG002|Overall Study|Lost to Follow-up|1|||
33362109|NCT00918749|62740581|FG000|Overall Study|Withdrawal by Subject|5|||
33362110|NCT00918749|62740582|FG001|Overall Study|Withdrawal by Subject|3|||
33362111|NCT00918749|62740583|FG002|Overall Study|Withdrawal by Subject|5|||
33362112|NCT00918749|62740581|FG000|Overall Study|No Study Medication Taken|1|||
33362113|NCT00918749|62740582|FG001|Overall Study|No Study Medication Taken|0|||
33362114|NCT00918749|62740583|FG002|Overall Study|No Study Medication Taken|0|||
33362115|NCT00746733|62740591|FG000|Second Intervention|Adverse Event|1|||
33362116|NCT00746733|62740592|FG001|Second Intervention|Adverse Event|0|||
33362117|NCT00746733|62740591|FG000|Third Intervention|Withdrawal by Subject|1|||
33362118|NCT00746733|62740592|FG001|Third Intervention|Withdrawal by Subject|1|||
33362119|NCT00745875|62740607|FG000|Overall Study|Continuing study treatment|4|||
33362120|NCT00745875|62740608|FG001|Overall Study|Continuing study treatment|4|||
33362121|NCT00555217|62740616|FG000|Overall Study|Withdrawal by Subject|35|||
33362122|NCT00555217|62740617|FG001|Overall Study|Withdrawal by Subject|31|||
33362123|NCT00555217|62740616|FG000|Overall Study|Lost to Follow-up|19|||
33362124|NCT00555217|62740617|FG001|Overall Study|Lost to Follow-up|20|||
33362125|NCT00555217|62740616|FG000|Overall Study|close out sites|21|||
33362126|NCT00555217|62740617|FG001|Overall Study|close out sites|17|||
33362127|NCT00745251|62740625|FG000|Overall Study|Adverse Event|1|||
33362128|NCT00745251|62740626|FG001|Overall Study|Adverse Event|2|||
33362129|NCT00745251|62740625|FG000|Overall Study|Withdrawal by Subject|1|||
33362130|NCT00745251|62740626|FG001|Overall Study|Withdrawal by Subject|1|||
33362131|NCT00745095|62740638|FG000|Overall Study|Declined to participate|1|||
33362132|NCT00745095|62740639|FG001|Overall Study|Declined to participate|0|||
33362133|NCT00745095|62740640|FG002|Overall Study|Declined to participate|0|||
33362134|NCT00745095|62740641|FG003|Overall Study|Declined to participate|0|||
33362135|NCT00745095|62740642|FG004|Overall Study|Declined to participate|92|||
33362136|NCT00745095|62740643|FG005|Overall Study|Declined to participate|95|||
33362137|NCT00745095|62740638|FG000|Overall Study|Ineligible due to GFR criteria|0|||
33362138|NCT00745095|62740639|FG001|Overall Study|Ineligible due to GFR criteria|2|||
33362139|NCT00745095|62740640|FG002|Overall Study|Ineligible due to GFR criteria|3|||
33362140|NCT00745095|62740641|FG003|Overall Study|Ineligible due to GFR criteria|3|||
33362141|NCT00745095|62740642|FG004|Overall Study|Ineligible due to GFR criteria|30|||
33362142|NCT00745095|62740643|FG005|Overall Study|Ineligible due to GFR criteria|28|||
33362143|NCT00744939|62740664|FG000|Overall Study|Withdrawal by Subject|9|||
33362144|NCT00744939|62740664|FG000|Overall Study|Protocol Violation|13|||
33362145|NCT00744939|62740664|FG000|Overall Study|Death|24|||
33362146|NCT00744939|62740664|FG000|Overall Study|distance|4|||
33362147|NCT00744939|62740664|FG000|Overall Study|Lost to Follow-up|12|||
33362148|NCT00744939|62740664|FG000|Overall Study|Medical history exclusionary|1|||
33362149|NCT00744939|62740664|FG000|Overall Study|Did not receive Magnevist|7|||
33362150|NCT00744939|62740664|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
33362151|NCT00744939|62740664|FG000|Overall Study|coma|1|||
33362152|NCT00744939|62740664|FG000|Overall Study|incorrect race|1|||
33362153|NCT00744861|62740680|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
33362154|NCT00744861|62740681|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
33362155|NCT00744861|62740682|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
33362156|NCT00744861|62740683|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
33362157|NCT00744861|62740680|FG000|Feasibility Stage 1|Pregnancy|0|||
33362158|NCT00744861|62740681|FG001|Feasibility Stage 1|Pregnancy|1|||
33362159|NCT00744861|62740682|FG002|Feasibility Stage 1|Pregnancy|0|||
33362160|NCT00744861|62740683|FG003|Feasibility Stage 1|Pregnancy|0|||
33362161|NCT00744861|62740680|FG000|Pivotal Stage 2|Adverse Event|0|||
33549437|NCT02477800|62940540|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
33549438|NCT02477800|62940541|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
33362162|NCT00744861|62740681|FG001|Pivotal Stage 2|Adverse Event|0|||
33362163|NCT00744861|62740682|FG002|Pivotal Stage 2|Adverse Event|6|||
33362164|NCT00744861|62740683|FG003|Pivotal Stage 2|Adverse Event|11|||
33362165|NCT00744861|62740680|FG000|Pivotal Stage 2|Death|0|||
33362166|NCT00744861|62740681|FG001|Pivotal Stage 2|Death|0|||
33362167|NCT00744861|62740682|FG002|Pivotal Stage 2|Death|0|||
33362168|NCT00744861|62740683|FG003|Pivotal Stage 2|Death|1|||
33362169|NCT00744861|62740680|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
33362170|NCT00744861|62740681|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
33362171|NCT00744861|62740682|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
33362172|NCT00744861|62740683|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
33362173|NCT00744861|62740680|FG000|Pivotal Stage 2|Physician Decision|0|||
33362174|NCT00744861|62740681|FG001|Pivotal Stage 2|Physician Decision|0|||
33362175|NCT00744861|62740682|FG002|Pivotal Stage 2|Physician Decision|3|||
33362176|NCT00744861|62740683|FG003|Pivotal Stage 2|Physician Decision|1|||
33362177|NCT00744861|62740680|FG000|Pivotal Stage 2|Protocol Violation|0|||
33362178|NCT00744861|62740681|FG001|Pivotal Stage 2|Protocol Violation|0|||
33362179|NCT00744861|62740682|FG002|Pivotal Stage 2|Protocol Violation|0|||
33362180|NCT00744861|62740683|FG003|Pivotal Stage 2|Protocol Violation|1|||
33362181|NCT00744861|62740680|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
33362182|NCT00744861|62740681|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
33362183|NCT00744861|62740682|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
33362184|NCT00744861|62740683|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
33362185|NCT00744861|62740680|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
33362186|NCT00744861|62740681|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
33362187|NCT00744861|62740682|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
33362188|NCT00744861|62740683|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
33362189|NCT03969589|62740693|FG000|Overall Study|Lost to Follow-up|3|||
33475056|NCT03077698|62849406|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
33475057|NCT03077698|62849405|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
33475058|NCT03077698|62849406|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
33475059|NCT03077698|62849405|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
33475060|NCT03077698|62849406|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
33475061|NCT03077698|62849405|FG000|Safety Follow Up|Withdrawal by Subject|2|||
33475062|NCT03077698|62849406|FG001|Safety Follow Up|Withdrawal by Subject|1|||
33475063|NCT03077698|62849405|FG000|Safety Follow Up|Transfer of care to hospice|1|||
33475064|NCT03077698|62849406|FG001|Safety Follow Up|Transfer of care to hospice|0|||
33475065|NCT03079102|62849424|FG000|Overall Study|Physician Decision|0|||
33475066|NCT03079102|62849425|FG001|Overall Study|Physician Decision|1|||
33475067|NCT02434354|62849431|FG000|Overall Study|screen fail|3|||
33475068|NCT03076996|62849435|FG000|Overall Study|Withdrawal by Subject|2|||
33475069|NCT03076996|62849435|FG000|Overall Study|Lost to Follow-up|3|||
33475070|NCT03076996|62849435|FG000|Overall Study|Literacy precluded participation|1|||
33475071|NCT03078868|62849439|FG000|Overall Study|Physician Decision|3|||
33475072|NCT04524598|62849447|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
33475073|NCT04524598|62849448|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
33475074|NCT04524598|62849449|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
33475075|NCT04524598|62849450|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
33475076|NCT04524598|62849451|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
33475077|NCT04524598|62849447|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
33475078|NCT04524598|62849448|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
33475079|NCT04524598|62849449|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
33475080|NCT04524598|62849450|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
33475081|NCT04524598|62849451|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
33475082|NCT04524598|62849447|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
33475083|NCT04524598|62849448|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
33475084|NCT04524598|62849449|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
33475085|NCT04524598|62849450|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
33475086|NCT04524598|62849451|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
33475087|NCT04524598|62849447|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
33475088|NCT04524598|62849448|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
33475089|NCT04524598|62849449|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
33475090|NCT04524598|62849450|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
33475091|NCT04524598|62849451|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
33475092|NCT04524598|62849447|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
33475093|NCT04524598|62849448|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
33549439|NCT02477800|62940542|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
33549440|NCT02477800|62940543|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
33549441|NCT02477800|62940544|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
33549442|NCT02477800|62940538|FG000|Long Term Extension Period|Reason not Specified|0|||
33549443|NCT02477800|62940539|FG001|Long Term Extension Period|Reason not Specified|0|||
33549444|NCT02477800|62940540|FG002|Long Term Extension Period|Reason not Specified|0|||
33549445|NCT02477800|62940541|FG003|Long Term Extension Period|Reason not Specified|126|||
33549446|NCT02477800|62940542|FG004|Long Term Extension Period|Reason not Specified|140|||
33549447|NCT02477800|62940543|FG005|Long Term Extension Period|Reason not Specified|270|||
33549448|NCT02477800|62940544|FG006|Long Term Extension Period|Reason not Specified|224|||
33549449|NCT02957747|62940558|FG000|Overall Study|Withdrawal by Subject|0|||
33549450|NCT02957747|62940559|FG001|Overall Study|Withdrawal by Subject|3|||
33475094|NCT04524598|62849449|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
33475095|NCT04524598|62849450|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
33549451|NCT02957747|62940558|FG000|Overall Study|Lost to Follow-up|10|||
33362190|NCT03969589|62740694|FG001|Overall Study|Lost to Follow-up|2|||
33549452|NCT02957747|62940559|FG001|Overall Study|Lost to Follow-up|5|||
33549453|NCT01344161|62940568|FG000|Overall Study|Lost to Follow-up|4|||
33549454|NCT01344161|62940569|FG001|Overall Study|Lost to Follow-up|1|||
33475096|NCT04524598|62849451|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
33475097|NCT04524598|62849447|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
33475098|NCT04524598|62849448|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
33475099|NCT04524598|62849449|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
33549455|NCT01344161|62940568|FG000|Overall Study|Pregnancy|0|||
33475100|NCT04524598|62849450|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
33475101|NCT04524598|62849451|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
33475102|NCT04524598|62849447|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
33475103|NCT04524598|62849448|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
33475104|NCT04524598|62849449|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
33475105|NCT04524598|62849450|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
33475106|NCT04524598|62849451|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
33475107|NCT03075904|62849465|FG000|Overall Study|Physician Decision|3|||
33475108|NCT03075904|62849465|FG000|Overall Study|Need for Medication not Permitted|1|||
33475109|NCT03073798|62849469|FG000|Overall Study|Adverse Event|1|||
33475110|NCT03073798|62849469|FG000|Overall Study|Withdrawal by Subject|1|||
33475111|NCT03075826|62849474|FG000|Overall Study|Withdrawal by Subject|1|||
33475112|NCT03075826|62849474|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
33475113|NCT02865850|62849489|FG000|Overall Study|Death|15|||
33475114|NCT02865850|62849490|FG001|Overall Study|Death|19|||
33475115|NCT02865850|62849489|FG000|Overall Study|Withdrawal by Subject|3|||
33475116|NCT02865850|62849490|FG001|Overall Study|Withdrawal by Subject|2|||
33475117|NCT02865850|62849489|FG000|Overall Study|Lost to Follow-up|3|||
33475118|NCT02865850|62849490|FG001|Overall Study|Lost to Follow-up|2|||
33475119|NCT03711162|62849499|FG000|Overall Study|Adverse Event|5|||
33475120|NCT03711162|62849500|FG001|Overall Study|Adverse Event|2|||
33475121|NCT03711162|62849501|FG002|Overall Study|Adverse Event|4|||
33475122|NCT03711162|62849499|FG000|Overall Study|Death|11|||
33475123|NCT03711162|62849500|FG001|Overall Study|Death|7|||
33475124|NCT03711162|62849501|FG002|Overall Study|Death|8|||
33475125|NCT03711162|62849499|FG000|Overall Study|Lost to Follow-up|1|||
33475126|NCT03711162|62849500|FG001|Overall Study|Lost to Follow-up|0|||
33475127|NCT03711162|62849501|FG002|Overall Study|Lost to Follow-up|1|||
33475128|NCT03711162|62849499|FG000|Overall Study|Study Terminated by Sponsor|139|||
33475129|NCT03711162|62849500|FG001|Overall Study|Study Terminated by Sponsor|152|||
33475130|NCT03711162|62849501|FG002|Overall Study|Study Terminated by Sponsor|146|||
33475131|NCT03711162|62849499|FG000|Overall Study|Withdrawal by Subject|17|||
33475132|NCT03711162|62849500|FG001|Overall Study|Withdrawal by Subject|10|||
33475133|NCT03711162|62849501|FG002|Overall Study|Withdrawal by Subject|10|||
33475134|NCT03711162|62849499|FG000|Overall Study|Miscellaneous|1|||
33475135|NCT03711162|62849500|FG001|Overall Study|Miscellaneous|2|||
33475136|NCT03711162|62849501|FG002|Overall Study|Miscellaneous|2|||
33475137|NCT03711162|62849499|FG000|Overall Study|Not Treated|1|||
33475138|NCT03711162|62849500|FG001|Overall Study|Not Treated|0|||
33475139|NCT03711162|62849501|FG002|Overall Study|Not Treated|1|||
33475140|NCT03711162|62849499|FG000|Overall Study|Physician Decision|0|||
33475141|NCT03711162|62849500|FG001|Overall Study|Physician Decision|2|||
33475142|NCT03711162|62849501|FG002|Overall Study|Physician Decision|0|||
33475143|NCT03711162|62849499|FG000|Overall Study|Lack of Efficacy|0|||
33475144|NCT03711162|62849500|FG001|Overall Study|Lack of Efficacy|0|||
33475145|NCT03711162|62849501|FG002|Overall Study|Lack of Efficacy|2|||
33475146|NCT03711162|62849499|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
33475147|NCT03711162|62849500|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
33475148|NCT03711162|62849501|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
33549456|NCT01344161|62940569|FG001|Overall Study|Pregnancy|1|||
33549457|NCT01344161|62940568|FG000|Overall Study|Protocol Violation|1|||
33549458|NCT01344161|62940569|FG001|Overall Study|Protocol Violation|1|||
33549459|NCT02451358|62940579|FG000|Overall Study|Withdrawal by Subject|1|||
33362191|NCT03969589|62740693|FG000|Overall Study|Declined Follow-Up|0|||
33475149|NCT03072160|62849517|FG000|Overall Study|Adverse Event|3|||
33475150|NCT03072160|62849518|FG001|Overall Study|Adverse Event|1|||
33475151|NCT03072160|62849517|FG000|Overall Study|Refused further treatment|6|||
33475152|NCT03072160|62849518|FG001|Overall Study|Refused further treatment|1|||
33475153|NCT03072160|62849517|FG000|Overall Study|Physician Decision|1|||
33475154|NCT03072160|62849518|FG001|Overall Study|Physician Decision|0|||
33475155|NCT03072160|62849517|FG000|Overall Study|Disease progression on study|1|||
33475156|NCT03072160|62849518|FG001|Overall Study|Disease progression on study|1|||
33475157|NCT03072160|62849517|FG000|Overall Study|No contact|0|||
33475158|NCT03072160|62849518|FG001|Overall Study|No contact|1|||
33362192|NCT03969589|62740694|FG001|Overall Study|Declined Follow-Up|1|||
33362193|NCT00744627|62740702|FG000|Overall Study|Adverse Event|6|||
33362194|NCT00744627|62740703|FG001|Overall Study|Adverse Event|9|||
33362195|NCT00744627|62740702|FG000|Overall Study|Lack of Efficacy|7|||
33362196|NCT00744627|62740703|FG001|Overall Study|Lack of Efficacy|3|||
33362197|NCT00744627|62740702|FG000|Overall Study|Noncompliance|0|||
33362198|NCT00744627|62740703|FG001|Overall Study|Noncompliance|1|||
33362199|NCT00744627|62740702|FG000|Overall Study|Protocol Deviations|0|||
33362200|NCT00744627|62740703|FG001|Overall Study|Protocol Deviations|2|||
33362201|NCT00744627|62740702|FG000|Overall Study|Voluntary Withdrawal|9|||
33362202|NCT00744627|62740703|FG001|Overall Study|Voluntary Withdrawal|6|||
33362203|NCT00744627|62740702|FG000|Overall Study|Lost to Follow-up|2|||
33362204|NCT00744627|62740703|FG001|Overall Study|Lost to Follow-up|1|||
33362205|NCT00744627|62740702|FG000|Overall Study|Other|1|||
33362206|NCT00744627|62740703|FG001|Overall Study|Other|0|||
33362207|NCT03959137|62740709|FG000|Overall Study|Protocol Violation|6|||
33362208|NCT00562627|62740716|FG000|Overall Study|Protocol Violation|1|||
33362209|NCT00562627|62740717|FG001|Overall Study|Protocol Violation|1|||
33362210|NCT00562627|62740718|FG002|Overall Study|Protocol Violation|1|||
33362211|NCT00562159|62740728|FG000|Overall Study|Adverse Event|11|||
33362212|NCT00562159|62740729|FG001|Overall Study|Adverse Event|8|||
33362213|NCT00562159|62740728|FG000|Overall Study|Lost to Follow-up|5|||
33362214|NCT00562159|62740729|FG001|Overall Study|Lost to Follow-up|4|||
33362215|NCT00562159|62740728|FG000|Overall Study|Withdrawal by Subject|9|||
33362216|NCT00562159|62740729|FG001|Overall Study|Withdrawal by Subject|8|||
33362217|NCT00562159|62740728|FG000|Overall Study|Protocol Violation|12|||
33362218|NCT00562159|62740729|FG001|Overall Study|Protocol Violation|12|||
33362219|NCT00562159|62740728|FG000|Overall Study|Did not meet protocol eligibility|1|||
33362220|NCT00562159|62740729|FG001|Overall Study|Did not meet protocol eligibility|1|||
33362221|NCT04223778|62740738|FG000|Overall Study|Ongoing|322|||
33362222|NCT04223778|62740739|FG001|Overall Study|Ongoing|326|||
33362223|NCT04223778|62740738|FG000|Overall Study|Death|0|||
33362224|NCT04223778|62740739|FG001|Overall Study|Death|1|||
33362225|NCT04223778|62740738|FG000|Overall Study|Lost to Follow-up|1|||
33362226|NCT04223778|62740739|FG001|Overall Study|Lost to Follow-up|5|||
33362227|NCT04223778|62740738|FG000|Overall Study|Physician Decision|3|||
33362228|NCT04223778|62740739|FG001|Overall Study|Physician Decision|1|||
33362229|NCT04223778|62740738|FG000|Overall Study|Withdrawal by Subject|10|||
33362230|NCT04223778|62740739|FG001|Overall Study|Withdrawal by Subject|1|||
33362231|NCT04223778|62740738|FG000|Overall Study|Lack of Efficacy|0|||
33362232|NCT04223778|62740739|FG001|Overall Study|Lack of Efficacy|2|||
33362233|NCT00921557|62740748|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
33475159|NCT00407602|62849556|FG000|Overall Study|Death - unrelated to device|1|||
33475160|NCT00407602|62849556|FG000|Overall Study|Device explanted|5|||
33475161|NCT00407602|62849556|FG000|Overall Study|Withdrawal by Subject|1|||
33475162|NCT03057496|62849563|FG000|Overall Study|Withdrawal by Subject|8|||
33475163|NCT03057496|62849563|FG000|Overall Study|Lost to Follow-up|5|||
33475164|NCT03057496|62849563|FG000|Overall Study|Did not use device during home trial|3|||
33475165|NCT03057496|62849563|FG000|Overall Study|Device failure|2|||
33475166|NCT03708744|62849573|FG000|Overall Study|Withdrawal by Subject|0|||
33362234|NCT00921557|62740749|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
33362235|NCT00921557|62740750|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
33362236|NCT00921557|62740748|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
33362237|NCT00921557|62740749|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
33362238|NCT00921557|62740750|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
33362239|NCT00921557|62740748|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
33362240|NCT00921557|62740749|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
33362241|NCT00921557|62740750|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
33362242|NCT00921557|62740748|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
33362243|NCT00921557|62740749|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
33362244|NCT00921557|62740750|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
33362245|NCT00921557|62740748|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
33475167|NCT03708744|62849574|FG001|Overall Study|Withdrawal by Subject|0|||
33362246|NCT00921557|62740749|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
33362247|NCT00921557|62740750|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
33362248|NCT00744471|62740767|FG000|Overall Study|Randomized but not treated|1|||
33362249|NCT00744471|62740768|FG001|Overall Study|Randomized but not treated|1|||
33362250|NCT00744471|62740769|FG002|Overall Study|Randomized but not treated|4|||
33475168|NCT03708744|62849575|FG002|Overall Study|Withdrawal by Subject|1|||
33655618|NCT03877926|63071942|FG002|Overall Study|Physician Decision|2|||
33475169|NCT03708744|62849576|FG003|Overall Study|Withdrawal by Subject|0|||
33475170|NCT02574286|62849590|FG000|Overall Study|Adverse Event|3|||
33362251|NCT00744471|62740770|FG003|Overall Study|Randomized but not treated|0|||
33362252|NCT00744471|62740767|FG000|Overall Study|Death|0|||
33362253|NCT00744471|62740768|FG001|Overall Study|Death|0|||
33362254|NCT00744471|62740769|FG002|Overall Study|Death|0|||
33362255|NCT00744471|62740770|FG003|Overall Study|Death|1|||
33362256|NCT00744471|62740767|FG000|Overall Study|Adverse Event|6|||
33362257|NCT00744471|62740768|FG001|Overall Study|Adverse Event|7|||
33362258|NCT00744471|62740769|FG002|Overall Study|Adverse Event|5|||
33362259|NCT00744471|62740770|FG003|Overall Study|Adverse Event|9|||
33362260|NCT00744471|62740767|FG000|Overall Study|Withdrawal by Subject|9|||
33362261|NCT00744471|62740768|FG001|Overall Study|Withdrawal by Subject|9|||
33362262|NCT00744471|62740769|FG002|Overall Study|Withdrawal by Subject|15|||
33362263|NCT00744471|62740770|FG003|Overall Study|Withdrawal by Subject|12|||
33362264|NCT00744471|62740767|FG000|Overall Study|Protocol Violation|1|||
33362265|NCT00744471|62740768|FG001|Overall Study|Protocol Violation|4|||
33362266|NCT00744471|62740769|FG002|Overall Study|Protocol Violation|1|||
33362267|NCT00744471|62740770|FG003|Overall Study|Protocol Violation|2|||
33362268|NCT00744471|62740767|FG000|Overall Study|Entered extension study|41|||
33362269|NCT00744471|62740768|FG001|Overall Study|Entered extension study|84|||
33362270|NCT00744471|62740769|FG002|Overall Study|Entered extension study|100|||
33362271|NCT00744471|62740770|FG003|Overall Study|Entered extension study|91|||
33362272|NCT00744471|62740767|FG000|Overall Study|Other|2|||
33362273|NCT00744471|62740768|FG001|Overall Study|Other|3|||
33362274|NCT00744471|62740769|FG002|Overall Study|Other|6|||
33362275|NCT00744471|62740770|FG003|Overall Study|Other|2|||
33362276|NCT00744471|62740767|FG000|Overall Study|Lack of Efficacy|83|||
33362277|NCT00744471|62740768|FG001|Overall Study|Lack of Efficacy|37|||
33362278|NCT00744471|62740769|FG002|Overall Study|Lack of Efficacy|19|||
33362279|NCT00744471|62740770|FG003|Overall Study|Lack of Efficacy|31|||
33362280|NCT00744471|62740767|FG000|Overall Study|Lost to Follow-up|0|||
33362281|NCT00744471|62740768|FG001|Overall Study|Lost to Follow-up|0|||
33475171|NCT02574286|62849590|FG000|Overall Study|Withdrawal by Subject|2|||
33475172|NCT02083354|62849598|FG000|Overall Study|Withdrawal by Subject|9|||
33475173|NCT02083354|62849598|FG000|Overall Study|Lost to Follow-up|1|||
33362282|NCT00744471|62740769|FG002|Overall Study|Lost to Follow-up|2|||
33362283|NCT00744471|62740770|FG003|Overall Study|Lost to Follow-up|0|||
33362284|NCT00744237|62740783|FG000|Overall Study|Lack of Efficacy|1|||
33362285|NCT00744237|62740784|FG001|Overall Study|Lack of Efficacy|1|||
33362286|NCT00744237|62740785|FG002|Overall Study|Lack of Efficacy|0|||
33362287|NCT00744237|62740783|FG000|Overall Study|Withdrawal by Subject|9|||
33362288|NCT00744237|62740784|FG001|Overall Study|Withdrawal by Subject|5|||
33362289|NCT00744237|62740785|FG002|Overall Study|Withdrawal by Subject|3|||
33362290|NCT00744237|62740783|FG000|Overall Study|Lost to Follow-up|1|||
33362291|NCT00744237|62740784|FG001|Overall Study|Lost to Follow-up|1|||
33362292|NCT00744237|62740785|FG002|Overall Study|Lost to Follow-up|1|||
33362293|NCT00744237|62740783|FG000|Overall Study|Protocol Violation|3|||
33362294|NCT00744237|62740784|FG001|Overall Study|Protocol Violation|4|||
33362295|NCT00744237|62740785|FG002|Overall Study|Protocol Violation|3|||
33362296|NCT00744237|62740783|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
33362297|NCT00744237|62740784|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
33362298|NCT00744237|62740785|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
33362299|NCT00744237|62740783|FG000|Overall Study|Dosing Error|1|||
33362300|NCT00744237|62740784|FG001|Overall Study|Dosing Error|0|||
33362301|NCT00744237|62740785|FG002|Overall Study|Dosing Error|1|||
33362302|NCT00744237|62740783|FG000|Overall Study|Study Drug Error|1|||
33475174|NCT02083354|62849598|FG000|Overall Study|Adverse Event|3|||
33475175|NCT02083354|62849598|FG000|Overall Study|Disease progression|46|||
33475176|NCT02083354|62849598|FG000|Overall Study|Study closed/terminated|5|||
33475177|NCT04230486|62849602|FG000|Overall Study|Screen Failure|1|||
33475178|NCT01399918|62849608|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
33475179|NCT00112840|62849615|FG000|Overall Study|Physician Decision|1|||
33475180|NCT00112840|62849616|FG001|Overall Study|Physician Decision|0|||
33475181|NCT00112840|62849617|FG002|Overall Study|Physician Decision|0|||
33362303|NCT00744237|62740784|FG001|Overall Study|Study Drug Error|0|||
33362304|NCT00744237|62740785|FG002|Overall Study|Study Drug Error|0|||
33362305|NCT00744237|62740783|FG000|Overall Study|Prohibited Concomitant Medication|0|||
33362306|NCT00744237|62740784|FG001|Overall Study|Prohibited Concomitant Medication|0|||
33362307|NCT00744237|62740785|FG002|Overall Study|Prohibited Concomitant Medication|1|||
33362308|NCT00744237|62740783|FG000|Overall Study|Poor Compliance|0|||
33362309|NCT00744237|62740784|FG001|Overall Study|Poor Compliance|2|||
33362310|NCT00744237|62740785|FG002|Overall Study|Poor Compliance|0|||
33362311|NCT00744237|62740783|FG000|Overall Study|Administrative. Site Closed|1|||
33362312|NCT00744237|62740784|FG001|Overall Study|Administrative. Site Closed|1|||
33362313|NCT00744237|62740785|FG002|Overall Study|Administrative. Site Closed|1|||
33362314|NCT00744237|62740783|FG000|Overall Study|Adverse Event|9|||
33362315|NCT00744237|62740784|FG001|Overall Study|Adverse Event|13|||
33475182|NCT00112840|62849615|FG000|Overall Study|Withdrawal by Subject|1|||
33362316|NCT00744237|62740785|FG002|Overall Study|Adverse Event|5|||
33362317|NCT00743145|62740793|FG000|Overall Study|Withdrawal by Subject|1|||
33362318|NCT00743145|62740793|FG000|Overall Study|Adverse Event|2|||
33362319|NCT00743145|62740793|FG000|Overall Study|Pregnancy|1|||
33362320|NCT00920855|62740810|FG000|Overall Study|Adverse Event|1|||
33362321|NCT00920855|62740811|FG001|Overall Study|Adverse Event|1|||
33362322|NCT00920855|62740812|FG002|Overall Study|Adverse Event|4|||
33362323|NCT00920855|62740810|FG000|Overall Study|Withdrawal by Subject|2|||
33362324|NCT00920855|62740811|FG001|Overall Study|Withdrawal by Subject|1|||
33362325|NCT00920855|62740812|FG002|Overall Study|Withdrawal by Subject|6|||
33475183|NCT00112840|62849616|FG001|Overall Study|Withdrawal by Subject|0|||
33475184|NCT00112840|62849617|FG002|Overall Study|Withdrawal by Subject|1|||
33475185|NCT00112840|62849615|FG000|Overall Study|Protocol Violation|0|||
33475186|NCT00112840|62849616|FG001|Overall Study|Protocol Violation|0|||
33475187|NCT00112840|62849617|FG002|Overall Study|Protocol Violation|5|||
33475188|NCT02197572|62849630|FG000|Overall Study|Progressive Disease|28|||
33475189|NCT02197572|62849630|FG000|Overall Study|Withdrawal by Subject|9|||
33475190|NCT02197572|62849630|FG000|Overall Study|Adverse Event|3|||
33475191|NCT02197572|62849630|FG000|Overall Study|Reason Not Specified|4|||
33475192|NCT03176784|62849638|FG000|Overall Study|Lost to Follow-up|77|||
33475193|NCT03176784|62849639|FG001|Overall Study|Lost to Follow-up|79|||
33475194|NCT03176784|62849640|FG002|Overall Study|Lost to Follow-up|79|||
33475195|NCT03176784|62849641|FG003|Overall Study|Lost to Follow-up|49|||
33475196|NCT03176784|62849638|FG000|Overall Study|Withdrawal by Subject|28|||
33475197|NCT03176784|62849639|FG001|Overall Study|Withdrawal by Subject|34|||
33475198|NCT03176784|62849640|FG002|Overall Study|Withdrawal by Subject|34|||
33475199|NCT03176784|62849641|FG003|Overall Study|Withdrawal by Subject|21|||
33475200|NCT03049852|62849654|FG000|Overall Study|Lost to Follow-up|0|||
33475201|NCT03049852|62849655|FG001|Overall Study|Lost to Follow-up|1|||
33475202|NCT03049852|62849656|FG002|Overall Study|Lost to Follow-up|0|||
33475203|NCT05091528|62849668|FG000|Overall Study|Study Termination by Sponsor|0|||
33475204|NCT05091528|62849669|FG001|Overall Study|Study Termination by Sponsor|1|||
33475205|NCT05091528|62849670|FG002|Overall Study|Study Termination by Sponsor|0|||
33475206|NCT05091528|62849671|FG003|Overall Study|Study Termination by Sponsor|1|||
33475207|NCT01317160|62849681|FG000|Overall Study|Incorrect inclusion|1|||
33362326|NCT00920855|62740810|FG000|Overall Study|Disease progression|2|||
33362327|NCT00920855|62740811|FG001|Overall Study|Disease progression|1|||
33362328|NCT00920855|62740812|FG002|Overall Study|Disease progression|10|||
33362329|NCT00920855|62740810|FG000|Overall Study|Noncompliance to study medication|0|||
33362330|NCT00920855|62740811|FG001|Overall Study|Noncompliance to study medication|0|||
33362331|NCT00920855|62740812|FG002|Overall Study|Noncompliance to study medication|1|||
33362332|NCT00920855|62740810|FG000|Overall Study|Response plateau; started maintenance|0|||
33362333|NCT00920855|62740811|FG001|Overall Study|Response plateau; started maintenance|0|||
33362334|NCT00920855|62740812|FG002|Overall Study|Response plateau; started maintenance|1|||
33362335|NCT03738228|62740823|FG000|Overall Study|Never received study treatment|2|||
33362336|NCT03738228|62740824|FG001|Overall Study|Never received study treatment|2|||
33362337|NCT00742209|62740835|FG000|Overall Study|Adverse Event|11|||
33362338|NCT00742209|62740836|FG001|Overall Study|Adverse Event|4|||
33362339|NCT00742209|62740837|FG002|Overall Study|Adverse Event|17|||
33362340|NCT00742209|62740838|FG003|Overall Study|Adverse Event|16|||
33362341|NCT00742209|62740839|FG004|Overall Study|Adverse Event|13|||
33362342|NCT00742209|62740835|FG000|Overall Study|Participant Withdrew Consent|8|||
33362343|NCT00742209|62740836|FG001|Overall Study|Participant Withdrew Consent|4|||
33362344|NCT00742209|62740837|FG002|Overall Study|Participant Withdrew Consent|14|||
33362345|NCT00742209|62740838|FG003|Overall Study|Participant Withdrew Consent|7|||
33362346|NCT00742209|62740839|FG004|Overall Study|Participant Withdrew Consent|4|||
33362347|NCT00742209|62740835|FG000|Overall Study|Protocol Violation|6|||
33362348|NCT00742209|62740836|FG001|Overall Study|Protocol Violation|5|||
33362349|NCT00742209|62740837|FG002|Overall Study|Protocol Violation|4|||
33475208|NCT01317160|62849682|FG001|Overall Study|Incorrect inclusion|1|||
33475209|NCT01317160|62849681|FG000|Overall Study|Lost to Follow-up|3|||
33475210|NCT01317160|62849682|FG001|Overall Study|Lost to Follow-up|3|||
33475211|NCT01317160|62849681|FG000|Overall Study|Withdrawal by Subject|0|||
33475212|NCT01317160|62849682|FG001|Overall Study|Withdrawal by Subject|2|||
33475213|NCT01317004|62849703|FG000|Overall Study|Withdrawal by Subject|1|||
33475214|NCT01317004|62849704|FG001|Overall Study|Withdrawal by Subject|4|||
33475215|NCT01317004|62849703|FG000|Overall Study|Protocol Violation|0|||
33362350|NCT00742209|62740838|FG003|Overall Study|Protocol Violation|5|||
33362351|NCT00742209|62740839|FG004|Overall Study|Protocol Violation|3|||
33362352|NCT00742209|62740835|FG000|Overall Study|Lost to Follow-up|3|||
33362353|NCT00742209|62740836|FG001|Overall Study|Lost to Follow-up|4|||
33362354|NCT00742209|62740837|FG002|Overall Study|Lost to Follow-up|5|||
33362355|NCT00742209|62740838|FG003|Overall Study|Lost to Follow-up|5|||
33362356|NCT00742209|62740839|FG004|Overall Study|Lost to Follow-up|3|||
33362357|NCT00742209|62740835|FG000|Overall Study|Lack of Efficacy|6|||
33362358|NCT00742209|62740836|FG001|Overall Study|Lack of Efficacy|1|||
33362359|NCT00742209|62740837|FG002|Overall Study|Lack of Efficacy|1|||
33362360|NCT00742209|62740838|FG003|Overall Study|Lack of Efficacy|3|||
33362361|NCT00742209|62740839|FG004|Overall Study|Lack of Efficacy|1|||
33362362|NCT00742209|62740835|FG000|Overall Study|Investigator Discretion|0|||
33362363|NCT00742209|62740836|FG001|Overall Study|Investigator Discretion|0|||
33362364|NCT00742209|62740837|FG002|Overall Study|Investigator Discretion|5|||
33362365|NCT00742209|62740838|FG003|Overall Study|Investigator Discretion|1|||
33362366|NCT00742209|62740839|FG004|Overall Study|Investigator Discretion|1|||
33362367|NCT00741819|62740852|FG000|Overall Study|Adverse Event|3|||
33362368|NCT00741819|62740852|FG000|Overall Study|Withdrawal by Subject|3|||
33362369|NCT00741819|62740852|FG000|Overall Study|Death|1|||
33362370|NCT00741819|62740852|FG000|Overall Study|Disease progression|1|||
33362371|NCT00924443|62740858|FG000|Overall Study|Physician Decision|2|||
33362372|NCT00924443|62740858|FG000|Overall Study|Protocol Violation|1|||
33362373|NCT00924287|62740862|FG000|Overall Study|Death|1|||
33362374|NCT00923975|62740866|FG000|Overall Study|Did not meet inclusion criteria|1|||
33362375|NCT00918203|62740902|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
33362376|NCT00918203|62740903|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
33362377|NCT00918203|62740904|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
33362378|NCT00918203|62740902|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
33362379|NCT00918203|62740903|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
33362380|NCT00918203|62740904|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
33362381|NCT00918203|62740902|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
33362382|NCT00918203|62740903|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
33362383|NCT00918203|62740904|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
33362384|NCT00918203|62740902|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
33362385|NCT00918203|62740903|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
33362386|NCT00918203|62740904|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
33362387|NCT00918281|62740916|FG000|Overall Study|Physician Decision|29|||
33362388|NCT02770716|62740925|FG000|Overall Study|Death|101|||
33362389|NCT02770716|62740926|FG001|Overall Study|Death|45|||
33362390|NCT02770716|62740925|FG000|Overall Study|Withdrawal by Subject|4|||
33475216|NCT01317004|62849704|FG001|Overall Study|Protocol Violation|2|||
33475217|NCT01317004|62849703|FG000|Overall Study|Adverse Event|3|||
33475218|NCT01317004|62849704|FG001|Overall Study|Adverse Event|3|||
33475219|NCT01343056|62849714|FG000|Overall Study|Lost to Follow-up|7|||
33475220|NCT01343056|62849715|FG001|Overall Study|Lost to Follow-up|5|||
33475221|NCT01343056|62849716|FG002|Overall Study|Lost to Follow-up|3|||
33475222|NCT01343056|62849717|FG003|Overall Study|Lost to Follow-up|9|||
33475223|NCT01316692|62849731|FG000|Overall Study|Adverse Event|5|||
33475224|NCT01316692|62849731|FG000|Overall Study|Disease Progression|7|||
33475225|NCT01316380|62849738|FG000|Overall Study|Adverse Event|0|||
33475226|NCT01316380|62849739|FG001|Overall Study|Adverse Event|2|||
33475227|NCT01316380|62849740|FG002|Overall Study|Adverse Event|1|||
33655619|NCT03877926|63071943|FG003|Overall Study|Physician Decision|0|||
33655620|NCT03877926|63071940|FG000|Overall Study|Withdrawal by Subject|18|||
33655621|NCT03877926|63071941|FG001|Overall Study|Withdrawal by Subject|21|||
33475228|NCT01316380|62849738|FG000|Overall Study|Protocol Violation|0|||
33475229|NCT01316380|62849739|FG001|Overall Study|Protocol Violation|0|||
33475230|NCT01316380|62849740|FG002|Overall Study|Protocol Violation|1|||
33475231|NCT01316380|62849738|FG000|Overall Study|Withdrawal by Subject|1|||
33475232|NCT01316380|62849739|FG001|Overall Study|Withdrawal by Subject|2|||
33475233|NCT01316380|62849740|FG002|Overall Study|Withdrawal by Subject|0|||
33475234|NCT01316380|62849738|FG000|Overall Study|Other|0|||
33475235|NCT01316380|62849739|FG001|Overall Study|Other|1|||
33475236|NCT01316380|62849740|FG002|Overall Study|Other|1|||
33475237|NCT01316380|62849738|FG000|Overall Study|Not treated|1|||
33475238|NCT01316380|62849739|FG001|Overall Study|Not treated|0|||
33655622|NCT03877926|63071942|FG002|Overall Study|Withdrawal by Subject|12|||
33655623|NCT03877926|63071943|FG003|Overall Study|Withdrawal by Subject|4|||
33475239|NCT01316380|62849740|FG002|Overall Study|Not treated|0|||
33475240|NCT01316224|62849748|FG000|Overall Study|Protocol Violation|3|||
33475241|NCT01316224|62849748|FG000|Overall Study|Adverse Event|3|||
33475242|NCT01316224|62849748|FG000|Overall Study|Lack of Efficacy|1|||
33655624|NCT03877926|63071940|FG000|Overall Study|Other - Various|4|||
33475243|NCT01316224|62849748|FG000|Overall Study|Withdrawal by Subject|1|||
33475244|NCT01316224|62849748|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
33475245|NCT01316224|62849748|FG000|Overall Study|Other|1|||
33475246|NCT04315298|62849771|FG000|Overall Study|Withdrawal by Subject|0|||
33362391|NCT02770716|62740926|FG001|Overall Study|Withdrawal by Subject|2|||
33362392|NCT02770716|62740925|FG000|Overall Study|Lost to Follow-up|1|||
33362393|NCT02770716|62740926|FG001|Overall Study|Lost to Follow-up|0|||
33362394|NCT02770716|62740925|FG000|Overall Study|Various reasons|6|||
33362395|NCT02770716|62740926|FG001|Overall Study|Various reasons|2|||
33362396|NCT00917579|62740932|FG000|Washout >= 2 Weeks|Adverse Event|1|||
33362397|NCT00917579|62740933|FG001|Washout >= 2 Weeks|Adverse Event|0|||
33362398|NCT00917579|62740932|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
33475247|NCT04315298|62849772|FG001|Overall Study|Withdrawal by Subject|0|||
33362399|NCT00917579|62740933|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
33362400|NCT00915551|62740941|FG000|Overall Study|Withdrawal by Subject|0|||
33362401|NCT00915551|62740942|FG001|Overall Study|Withdrawal by Subject|1|||
33362402|NCT00915473|62740950|FG000|Screening|Withdrawal by Subject|1|||
33362403|NCT00915473|62740951|FG001|Screening|Withdrawal by Subject|0|||
33362404|NCT00915473|62740950|FG000|4-week Follow Up|Lost to Follow-up|1|||
33362405|NCT00915473|62740951|FG001|4-week Follow Up|Lost to Follow-up|5|||
33362406|NCT00917501|62740959|FG000|Overall Study|Lost to Follow-up|4|||
33362407|NCT00917501|62740960|FG001|Overall Study|Lost to Follow-up|1|||
33362408|NCT00917501|62740959|FG000|Overall Study|Withdrawal by Subject|3|||
33362409|NCT00917501|62740960|FG001|Overall Study|Withdrawal by Subject|1|||
33362410|NCT00917501|62740959|FG000|Overall Study|Lack of Efficacy|1|||
33362411|NCT00917501|62740960|FG001|Overall Study|Lack of Efficacy|2|||
33362412|NCT00917501|62740959|FG000|Overall Study|trouble swollowing capsules|0|||
33362413|NCT00917501|62740960|FG001|Overall Study|trouble swollowing capsules|1|||
33362414|NCT00917267|62740979|FG000|Overall Study|Adverse Event|15|||
33362415|NCT00917267|62740980|FG001|Overall Study|Adverse Event|36|||
33362416|NCT00917267|62740979|FG000|Overall Study|Physician Decision|2|||
33362417|NCT00917267|62740980|FG001|Overall Study|Physician Decision|4|||
33362418|NCT00917267|62740979|FG000|Overall Study|Protocol Violation|9|||
33362419|NCT00917267|62740980|FG001|Overall Study|Protocol Violation|18|||
33362420|NCT00917267|62740979|FG000|Overall Study|Withdrawal by Subject|5|||
33362421|NCT00917267|62740980|FG001|Overall Study|Withdrawal by Subject|12|||
33362422|NCT00917267|62740979|FG000|Overall Study|Lost to follow up|0|||
33362423|NCT00917267|62740980|FG001|Overall Study|Lost to follow up|2|||
33362424|NCT00917267|62740979|FG000|Overall Study|Entry Criteria Not Met|1|||
33362425|NCT00917267|62740980|FG001|Overall Study|Entry Criteria Not Met|0|||
33362426|NCT00917267|62740979|FG000|Overall Study|Sponsor Decision|5|||
33362427|NCT00917267|62740980|FG001|Overall Study|Sponsor Decision|5|||
33362428|NCT00917267|62740979|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
33362429|NCT00917267|62740980|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
33362430|NCT00920699|62740993|FG000|Overall Study|Withdrawal by Subject|2|||
33362431|NCT00920699|62740994|FG001|Overall Study|Withdrawal by Subject|0|||
33362432|NCT00920699|62740995|FG002|Overall Study|Withdrawal by Subject|2|||
33362433|NCT00920699|62740993|FG000|Overall Study|no longer met eligibility|0|||
33362434|NCT00920699|62740994|FG001|Overall Study|no longer met eligibility|1|||
33362435|NCT00920699|62740995|FG002|Overall Study|no longer met eligibility|0|||
33362436|NCT00920699|62740993|FG000|Overall Study|Lost to Follow-up|0|||
33362437|NCT00920699|62740994|FG001|Overall Study|Lost to Follow-up|0|||
33362438|NCT00920699|62740995|FG002|Overall Study|Lost to Follow-up|2|||
33362439|NCT03462576|62741006|FG000|Overall Study|Protocol Violation|5|||
33362440|NCT03462576|62741007|FG001|Overall Study|Protocol Violation|11|||
33362441|NCT03462576|62741008|FG002|Overall Study|Protocol Violation|7|||
33362442|NCT03462576|62741006|FG000|Overall Study|Device Malfunction|0|||
33362443|NCT03462576|62741007|FG001|Overall Study|Device Malfunction|0|||
33362444|NCT03462576|62741008|FG002|Overall Study|Device Malfunction|1|||
33362445|NCT00916721|62741018|FG000|Overall Study|Lost to Follow-up|0|||
33362446|NCT00916721|62741019|FG001|Overall Study|Lost to Follow-up|1|||
33362447|NCT00916721|62741018|FG000|Overall Study|Adverse Event|6|||
33362448|NCT00916721|62741019|FG001|Overall Study|Adverse Event|3|||
33362449|NCT00916721|62741018|FG000|Overall Study|Withdrawal by Subject|2|||
33362450|NCT00916721|62741019|FG001|Overall Study|Withdrawal by Subject|2|||
33362451|NCT00916721|62741018|FG000|Overall Study|Protocol Violation|2|||
33362452|NCT00916721|62741019|FG001|Overall Study|Protocol Violation|4|||
33362453|NCT00915005|62741027|FG000|Overall Study|Withdrawal by Subject|4|||
33362454|NCT00915005|62741028|FG001|Overall Study|Withdrawal by Subject|4|||
33362455|NCT00915005|62741027|FG000|Overall Study|Patient preferred protons therapy|6|||
33362456|NCT00915005|62741028|FG001|Overall Study|Patient preferred protons therapy|0|||
33362457|NCT00915005|62741027|FG000|Overall Study|Insurance denial|3|||
33362458|NCT00915005|62741028|FG001|Overall Study|Insurance denial|15|||
33362459|NCT01143246|62741036|FG000|Overall Study|Adverse Event|24|||
33362460|NCT01143246|62741037|FG001|Overall Study|Adverse Event|28|||
33362461|NCT01143246|62741036|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
33362462|NCT01143246|62741037|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
33362463|NCT01143246|62741036|FG000|Overall Study|Lost to Follow-up|0|||
33362464|NCT01143246|62741037|FG001|Overall Study|Lost to Follow-up|1|||
33362465|NCT01143246|62741036|FG000|Overall Study|Death|16|||
33362466|NCT01143246|62741037|FG001|Overall Study|Death|15|||
33362467|NCT01143246|62741036|FG000|Overall Study|Reason not Specified|3|||
33362468|NCT01143246|62741037|FG001|Overall Study|Reason not Specified|5|||
33362469|NCT00561925|62741051|FG000|14 Day Lead-In Period|Adverse Event|38|||
33362470|NCT00561925|62741052|FG001|14 Day Lead-In Period|Adverse Event|0|||
33362471|NCT00561925|62741053|FG002|14 Day Lead-In Period|Adverse Event|0|||
33362472|NCT00561925|62741054|FG003|14 Day Lead-In Period|Adverse Event|0|||
33362473|NCT00561925|62741055|FG004|14 Day Lead-In Period|Adverse Event|0|||
33362474|NCT00561925|62741051|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
33549460|NCT02451358|62940580|FG001|Overall Study|Withdrawal by Subject|1|||
33362475|NCT00561925|62741052|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
33362476|NCT00561925|62741053|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
33362477|NCT00561925|62741054|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
33362478|NCT00561925|62741055|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
33362479|NCT00561925|62741051|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
33362480|NCT00561925|62741052|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
33362481|NCT00561925|62741053|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
33362482|NCT00561925|62741054|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
33362483|NCT00561925|62741055|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
33362484|NCT00561925|62741051|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
33362485|NCT00561925|62741052|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
33362486|NCT00561925|62741053|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
33362487|NCT00561925|62741054|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
33362488|NCT00561925|62741055|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
33362489|NCT00561925|62741051|FG000|14 Day Lead-In Period|Other|5|||
33362490|NCT00561925|62741052|FG001|14 Day Lead-In Period|Other|0|||
33362491|NCT00561925|62741053|FG002|14 Day Lead-In Period|Other|0|||
33362492|NCT00561925|62741054|FG003|14 Day Lead-In Period|Other|0|||
33362493|NCT00561925|62741055|FG004|14 Day Lead-In Period|Other|0|||
33362494|NCT00561925|62741051|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
33362495|NCT00561925|62741052|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
33362496|NCT00561925|62741053|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
33362497|NCT00561925|62741054|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
33362498|NCT00561925|62741055|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
33362499|NCT00561925|62741051|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
33362500|NCT00561925|62741052|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
33362501|NCT00561925|62741053|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
33362502|NCT00561925|62741054|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
33362503|NCT00561925|62741055|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
33362504|NCT00561925|62741051|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
33362505|NCT00561925|62741052|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
33362506|NCT00561925|62741053|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
33362507|NCT00561925|62741054|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
33362508|NCT00561925|62741055|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
33362509|NCT00561925|62741051|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
33362510|NCT00561925|62741052|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
33362511|NCT00561925|62741053|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
33362512|NCT00561925|62741054|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
33362513|NCT00561925|62741055|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
33362514|NCT00561925|62741051|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
33362515|NCT00561925|62741052|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
33362516|NCT00561925|62741053|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
33362517|NCT00561925|62741054|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
33362518|NCT00561925|62741055|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
33362519|NCT00561925|62741051|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
33362520|NCT00561925|62741052|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
33362521|NCT00561925|62741053|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
33362522|NCT00561925|62741054|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
33362523|NCT00561925|62741055|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
33362524|NCT00561925|62741051|FG000|144-week Double-blind, Double-dummy|Death|0|||
33362525|NCT00561925|62741052|FG001|144-week Double-blind, Double-dummy|Death|6|||
33362526|NCT00561925|62741053|FG002|144-week Double-blind, Double-dummy|Death|3|||
33362527|NCT00561925|62741054|FG003|144-week Double-blind, Double-dummy|Death|0|||
33362528|NCT00561925|62741055|FG004|144-week Double-blind, Double-dummy|Death|0|||
33362529|NCT00561925|62741051|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
33362530|NCT00561925|62741052|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
33362531|NCT00561925|62741053|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
33362532|NCT00561925|62741054|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
33362533|NCT00561925|62741055|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
33362534|NCT00561925|62741051|FG000|144-week Double-blind, Double-dummy|Other|0|||
33362535|NCT00561925|62741052|FG001|144-week Double-blind, Double-dummy|Other|8|||
33362536|NCT00561925|62741053|FG002|144-week Double-blind, Double-dummy|Other|11|||
33362537|NCT00561925|62741054|FG003|144-week Double-blind, Double-dummy|Other|0|||
33362538|NCT00561925|62741055|FG004|144-week Double-blind, Double-dummy|Other|0|||
33362539|NCT00561925|62741051|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
33362540|NCT00561925|62741052|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
33362541|NCT00561925|62741053|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
33362542|NCT00561925|62741054|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
33362543|NCT00561925|62741055|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
33362544|NCT00549445|62741075|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
33362545|NCT00549445|62741076|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
33362546|NCT00601107|62741086|FG000|Overall Study|Adverse Event|0|||
33362547|NCT00601107|62741087|FG001|Overall Study|Adverse Event|1|||
33362548|NCT00601107|62741088|FG002|Overall Study|Adverse Event|3|||
33362549|NCT00601107|62741089|FG003|Overall Study|Adverse Event|0|||
33362550|NCT00601107|62741086|FG000|Overall Study|Withdrawal by Subject|5|||
33362551|NCT00601107|62741087|FG001|Overall Study|Withdrawal by Subject|4|||
33362552|NCT00601107|62741088|FG002|Overall Study|Withdrawal by Subject|7|||
33475248|NCT04315298|62849773|FG002|Overall Study|Withdrawal by Subject|0|||
33475249|NCT04315298|62849774|FG003|Overall Study|Withdrawal by Subject|2|||
33475250|NCT04315298|62849775|FG004|Overall Study|Withdrawal by Subject|2|||
33475251|NCT04315298|62849776|FG005|Overall Study|Withdrawal by Subject|2|||
33475252|NCT04315298|62849777|FG006|Overall Study|Withdrawal by Subject|0|||
33475253|NCT04315298|62849778|FG007|Overall Study|Withdrawal by Subject|1|||
33475254|NCT04315298|62849779|FG008|Overall Study|Withdrawal by Subject|1|||
33475255|NCT04315298|62849780|FG009|Overall Study|Withdrawal by Subject|1|||
33475256|NCT04315298|62849781|FG010|Overall Study|Withdrawal by Subject|0|||
33475257|NCT04315298|62849782|FG011|Overall Study|Withdrawal by Subject|0|||
33475258|NCT04315298|62849783|FG012|Overall Study|Withdrawal by Subject|0|||
33475259|NCT04315298|62849784|FG013|Overall Study|Withdrawal by Subject|0|||
33475260|NCT04315298|62849785|FG014|Overall Study|Withdrawal by Subject|0|||
33475261|NCT04315298|62849786|FG015|Overall Study|Withdrawal by Subject|0|||
33475262|NCT04315298|62849787|FG016|Overall Study|Withdrawal by Subject|0|||
33475263|NCT04315298|62849788|FG017|Overall Study|Withdrawal by Subject|0|||
33475264|NCT04315298|62849789|FG018|Overall Study|Withdrawal by Subject|0|||
33475265|NCT04315298|62849771|FG000|Overall Study|Physician Decision|0|||
33475266|NCT04315298|62849772|FG001|Overall Study|Physician Decision|0|||
33475267|NCT04315298|62849773|FG002|Overall Study|Physician Decision|0|||
33475268|NCT04315298|62849774|FG003|Overall Study|Physician Decision|0|||
33475269|NCT04315298|62849775|FG004|Overall Study|Physician Decision|1|||
33475270|NCT04315298|62849776|FG005|Overall Study|Physician Decision|0|||
33475271|NCT04315298|62849777|FG006|Overall Study|Physician Decision|0|||
33475272|NCT04315298|62849778|FG007|Overall Study|Physician Decision|0|||
33475273|NCT04315298|62849779|FG008|Overall Study|Physician Decision|0|||
33475274|NCT04315298|62849780|FG009|Overall Study|Physician Decision|0|||
33475275|NCT04315298|62849781|FG010|Overall Study|Physician Decision|0|||
33475276|NCT04315298|62849782|FG011|Overall Study|Physician Decision|0|||
33475277|NCT04315298|62849783|FG012|Overall Study|Physician Decision|0|||
33475278|NCT04315298|62849784|FG013|Overall Study|Physician Decision|0|||
33475279|NCT04315298|62849785|FG014|Overall Study|Physician Decision|0|||
33475280|NCT04315298|62849786|FG015|Overall Study|Physician Decision|0|||
33475281|NCT04315298|62849787|FG016|Overall Study|Physician Decision|0|||
33475282|NCT04315298|62849788|FG017|Overall Study|Physician Decision|0|||
33475283|NCT04315298|62849789|FG018|Overall Study|Physician Decision|0|||
33475284|NCT04315298|62849771|FG000|Overall Study|Lost to Follow-up|5|||
33475285|NCT04315298|62849772|FG001|Overall Study|Lost to Follow-up|10|||
33475286|NCT04315298|62849773|FG002|Overall Study|Lost to Follow-up|6|||
33475287|NCT04315298|62849774|FG003|Overall Study|Lost to Follow-up|8|||
33475288|NCT04315298|62849775|FG004|Overall Study|Lost to Follow-up|12|||
33362553|NCT00601107|62741089|FG003|Overall Study|Withdrawal by Subject|4|||
33362554|NCT00601107|62741086|FG000|Overall Study|Lost to Follow-up|3|||
33362555|NCT00601107|62741087|FG001|Overall Study|Lost to Follow-up|3|||
33362556|NCT00601107|62741088|FG002|Overall Study|Lost to Follow-up|0|||
33362557|NCT00601107|62741089|FG003|Overall Study|Lost to Follow-up|3|||
33362558|NCT00601107|62741086|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
33362559|NCT00601107|62741087|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
33475289|NCT04315298|62849776|FG005|Overall Study|Lost to Follow-up|13|||
33475290|NCT04315298|62849777|FG006|Overall Study|Lost to Follow-up|9|||
33475291|NCT04315298|62849778|FG007|Overall Study|Lost to Follow-up|16|||
33475292|NCT04315298|62849779|FG008|Overall Study|Lost to Follow-up|14|||
33475293|NCT04315298|62849780|FG009|Overall Study|Lost to Follow-up|0|||
33475294|NCT04315298|62849781|FG010|Overall Study|Lost to Follow-up|2|||
33475295|NCT04315298|62849782|FG011|Overall Study|Lost to Follow-up|1|||
33475296|NCT04315298|62849783|FG012|Overall Study|Lost to Follow-up|0|||
33475297|NCT04315298|62849784|FG013|Overall Study|Lost to Follow-up|0|||
33655625|NCT03877926|63071941|FG001|Overall Study|Other - Various|1|||
33655626|NCT03877926|63071942|FG002|Overall Study|Other - Various|1|||
33655627|NCT03877926|63071943|FG003|Overall Study|Other - Various|0|||
33655628|NCT03877926|63071940|FG000|Overall Study|Not Treated|3|||
33655629|NCT03877926|63071941|FG001|Overall Study|Not Treated|1|||
33655630|NCT03877926|63071942|FG002|Overall Study|Not Treated|1|||
33655631|NCT03877926|63071943|FG003|Overall Study|Not Treated|0|||
33655632|NCT02874144|63072155|FG000|Overall Study|Lost to Follow-up|3|||
33655633|NCT02874144|63072156|FG001|Overall Study|Lost to Follow-up|5|||
33655634|NCT02611830|63072186|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
33655635|NCT02611830|63072187|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
33655636|NCT02611830|63072188|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
33655637|NCT02611830|63072189|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
33655638|NCT02611830|63072186|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
33655639|NCT02611830|63072187|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
33655640|NCT02611830|63072188|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
33655641|NCT02611830|63072189|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
33655642|NCT02611830|63072186|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
33655643|NCT02611830|63072187|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
33655644|NCT02611830|63072188|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
33655645|NCT02611830|63072189|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
33655646|NCT02611830|63072186|FG000|OL Induction Phase|Lack of Efficacy|9|||
33655647|NCT02611830|63072187|FG001|OL Induction Phase|Lack of Efficacy|0|||
33655648|NCT02611830|63072188|FG002|OL Induction Phase|Lack of Efficacy|0|||
33655649|NCT02611830|63072189|FG003|OL Induction Phase|Lack of Efficacy|0|||
33655650|NCT02611830|63072186|FG000|OL Induction Phase|Reason not specified|3|||
33655651|NCT02611830|63072187|FG001|OL Induction Phase|Reason not specified|0|||
33655652|NCT02611830|63072188|FG002|OL Induction Phase|Reason not specified|0|||
33655653|NCT02611830|63072189|FG003|OL Induction Phase|Reason not specified|0|||
33655654|NCT02611830|63072186|FG000|Maintenance Phase|Lack of Efficacy|0|||
33655655|NCT02611830|63072187|FG001|Maintenance Phase|Lack of Efficacy|29|||
33655656|NCT02611830|63072188|FG002|Maintenance Phase|Lack of Efficacy|18|||
33655657|NCT02611830|63072189|FG003|Maintenance Phase|Lack of Efficacy|6|||
33655658|NCT02611830|63072186|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
33655659|NCT02611830|63072187|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
33655660|NCT02611830|63072188|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
33655661|NCT02611830|63072189|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
33655662|NCT02611830|63072186|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
33655663|NCT02611830|63072187|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
33655664|NCT02611830|63072188|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
33655665|NCT02611830|63072189|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
33655666|NCT02611830|63072186|FG000|Maintenance Phase|Lost to Follow-up|0|||
33655667|NCT02611830|63072187|FG001|Maintenance Phase|Lost to Follow-up|0|||
33655668|NCT02611830|63072188|FG002|Maintenance Phase|Lost to Follow-up|0|||
33655669|NCT02611830|63072189|FG003|Maintenance Phase|Lost to Follow-up|1|||
33655670|NCT02611830|63072186|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
33655671|NCT02611830|63072187|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
33655672|NCT02611830|63072188|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
33655673|NCT02611830|63072189|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
33655674|NCT02611830|63072186|FG000|Maintenance Phase|Pregnancy|0|||
33655675|NCT02611830|63072187|FG001|Maintenance Phase|Pregnancy|0|||
33655676|NCT02611830|63072188|FG002|Maintenance Phase|Pregnancy|1|||
33655677|NCT02611830|63072189|FG003|Maintenance Phase|Pregnancy|0|||
33655678|NCT02611830|63072186|FG000|Maintenance Phase|Reason not specified|0|||
33655679|NCT02611830|63072187|FG001|Maintenance Phase|Reason not specified|1|||
33655680|NCT02611830|63072188|FG002|Maintenance Phase|Reason not specified|4|||
33655681|NCT02611830|63072189|FG003|Maintenance Phase|Reason not specified|0|||
33655682|NCT01328574|63072375|FG000|Overall Study|Refused further treatment|1|||
33655683|NCT01328496|63072497|FG000|Overall Study|Significant Change in Health Status|1|||
33655684|NCT01328496|63072498|FG001|Overall Study|Significant Change in Health Status|0|||
33655685|NCT02734212|63072618|FG000|Overall Study|Lost to Follow-up|5|||
33655686|NCT02734212|63072619|FG001|Overall Study|Lost to Follow-up|10|||
33475298|NCT04315298|62849785|FG014|Overall Study|Lost to Follow-up|0|||
33475299|NCT04315298|62849786|FG015|Overall Study|Lost to Follow-up|2|||
33655687|NCT03786432|63072665|FG000|Overall Study|Screen Failure after consent|1|||
33655688|NCT03786432|63072665|FG000|Overall Study|Lost to Follow-up|4|||
33655689|NCT03786432|63072665|FG000|Overall Study|did not complete 12 month CT scan|1|||
33655690|NCT04604184|63072701|FG000|Overall Study|Adverse Event|5|||
33655691|NCT04604184|63072702|FG001|Overall Study|Adverse Event|5|||
33475300|NCT04315298|62849787|FG016|Overall Study|Lost to Follow-up|0|||
33475301|NCT04315298|62849788|FG017|Overall Study|Lost to Follow-up|0|||
33475302|NCT04315298|62849789|FG018|Overall Study|Lost to Follow-up|0|||
33549461|NCT02451358|62940581|FG002|Overall Study|Withdrawal by Subject|0|||
33549462|NCT02451358|62940582|FG003|Overall Study|Withdrawal by Subject|0|||
33549463|NCT02451358|62940579|FG000|Overall Study|Protocol Violation|0|||
33549464|NCT02451358|62940580|FG001|Overall Study|Protocol Violation|1|||
33549465|NCT02451358|62940581|FG002|Overall Study|Protocol Violation|1|||
33549466|NCT02451358|62940582|FG003|Overall Study|Protocol Violation|0|||
33549467|NCT02749721|62940592|FG000|Screening|Withdrawal by Subject|1|||
33549468|NCT02749721|62940592|FG000|Screening|Lost to Follow-up|2|||
33549469|NCT02749721|62940592|FG000|Screening|Protocol Violation|3|||
33549470|NCT02749721|62940592|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
33362560|NCT00601107|62741088|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
33362561|NCT00601107|62741089|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
33362562|NCT00601107|62741086|FG000|Overall Study|Worsening of Psoriasis|4|||
33475303|NCT04315298|62849771|FG000|Overall Study|Death|24|||
33475304|NCT04315298|62849772|FG001|Overall Study|Death|60|||
33475305|NCT04315298|62849773|FG002|Overall Study|Death|49|||
33475306|NCT04315298|62849774|FG003|Overall Study|Death|59|||
33475307|NCT04315298|62849775|FG004|Overall Study|Death|70|||
33475308|NCT04315298|62849776|FG005|Overall Study|Death|114|||
33475309|NCT04315298|62849777|FG006|Overall Study|Death|9|||
33475310|NCT04315298|62849778|FG007|Overall Study|Death|12|||
33362563|NCT00601107|62741087|FG001|Overall Study|Worsening of Psoriasis|1|||
33362564|NCT00601107|62741088|FG002|Overall Study|Worsening of Psoriasis|1|||
33362565|NCT00601107|62741089|FG003|Overall Study|Worsening of Psoriasis|4|||
33362566|NCT00601107|62741086|FG000|Overall Study|Undefined|1|||
33362567|NCT00601107|62741087|FG001|Overall Study|Undefined|0|||
33362568|NCT00601107|62741088|FG002|Overall Study|Undefined|1|||
33362569|NCT00601107|62741089|FG003|Overall Study|Undefined|0|||
33362570|NCT00914927|62741106|FG000|Overall Study|Adverse Event|0|||
33362571|NCT00914927|62741107|FG001|Overall Study|Adverse Event|0|||
33362572|NCT00914927|62741108|FG002|Overall Study|Adverse Event|0|||
33362573|NCT00914927|62741109|FG003|Overall Study|Adverse Event|0|||
33362574|NCT00914927|62741110|FG004|Overall Study|Adverse Event|1|||
33475311|NCT04315298|62849779|FG008|Overall Study|Death|21|||
33475312|NCT04315298|62849780|FG009|Overall Study|Death|16|||
33475313|NCT04315298|62849781|FG010|Overall Study|Death|40|||
33475314|NCT04315298|62849782|FG011|Overall Study|Death|40|||
33475315|NCT04315298|62849783|FG012|Overall Study|Death|3|||
33475316|NCT04315298|62849784|FG013|Overall Study|Death|4|||
33362575|NCT00914927|62741111|FG005|Overall Study|Adverse Event|0|||
33362576|NCT00914927|62741112|FG006|Overall Study|Adverse Event|0|||
33362577|NCT00914927|62741106|FG000|Overall Study|Withdrawal by Subject|0|||
33362578|NCT00914927|62741107|FG001|Overall Study|Withdrawal by Subject|1|||
33362579|NCT00914927|62741108|FG002|Overall Study|Withdrawal by Subject|0|||
33362580|NCT00914927|62741109|FG003|Overall Study|Withdrawal by Subject|1|||
33362581|NCT00914927|62741110|FG004|Overall Study|Withdrawal by Subject|0|||
33362582|NCT00914927|62741111|FG005|Overall Study|Withdrawal by Subject|0|||
33362583|NCT00914927|62741112|FG006|Overall Study|Withdrawal by Subject|0|||
33362584|NCT00914927|62741106|FG000|Overall Study|Lost to Follow-up|0|||
33362585|NCT00914927|62741107|FG001|Overall Study|Lost to Follow-up|0|||
33362586|NCT00914927|62741108|FG002|Overall Study|Lost to Follow-up|0|||
33362587|NCT00914927|62741109|FG003|Overall Study|Lost to Follow-up|1|||
33362588|NCT00914927|62741110|FG004|Overall Study|Lost to Follow-up|0|||
33362589|NCT00914927|62741111|FG005|Overall Study|Lost to Follow-up|0|||
33362590|NCT00914927|62741112|FG006|Overall Study|Lost to Follow-up|0|||
33362591|NCT00914927|62741106|FG000|Overall Study|Administrative/Other|2|||
33475317|NCT04315298|62849785|FG014|Overall Study|Death|6|||
33475318|NCT04315298|62849786|FG015|Overall Study|Death|4|||
33475319|NCT04315298|62849787|FG016|Overall Study|Death|3|||
33475320|NCT04315298|62849788|FG017|Overall Study|Death|1|||
33549471|NCT02749721|62940592|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
33362592|NCT00914927|62741107|FG001|Overall Study|Administrative/Other|1|||
33362593|NCT00914927|62741108|FG002|Overall Study|Administrative/Other|0|||
33362594|NCT00914927|62741109|FG003|Overall Study|Administrative/Other|0|||
33362595|NCT00914927|62741110|FG004|Overall Study|Administrative/Other|1|||
33475321|NCT04315298|62849789|FG018|Overall Study|Death|0|||
33475322|NCT04308668|62849858|FG000|Overall Study|Lost to Follow-up|32|||
33475323|NCT04308668|62849859|FG001|Overall Study|Lost to Follow-up|38|||
33475324|NCT04308668|62849858|FG000|Overall Study|Withdrawal by Subject|4|||
33475325|NCT04308668|62849859|FG001|Overall Study|Withdrawal by Subject|4|||
33362596|NCT00914927|62741111|FG005|Overall Study|Administrative/Other|0|||
33362597|NCT00914927|62741112|FG006|Overall Study|Administrative/Other|0|||
33362598|NCT00914849|62741139|FG000|Overall Study|Withdrawal by Subject|1|||
33362599|NCT00914849|62741140|FG001|Overall Study|Withdrawal by Subject|0|||
33475326|NCT04451330|62849867|FG000|Overall Study|Adverse Event|1|||
33475327|NCT04451330|62849868|FG001|Overall Study|Adverse Event|2|||
33475328|NCT04451330|62849867|FG000|Overall Study|Lost to Follow-up|5|||
33362600|NCT00914849|62741139|FG000|Overall Study|Not eligible|0|||
33362601|NCT00914849|62741140|FG001|Overall Study|Not eligible|1|||
33362602|NCT00912743|62741148|FG000|Overall Study|Adverse Event|3|||
33362603|NCT00912743|62741149|FG001|Overall Study|Adverse Event|1|||
33362604|NCT00912743|62741148|FG000|Overall Study|Lack of Efficacy|9|||
33362605|NCT00912743|62741149|FG001|Overall Study|Lack of Efficacy|18|||
33362606|NCT00912743|62741148|FG000|Overall Study|Toxicity|0|||
33362607|NCT00912743|62741149|FG001|Overall Study|Toxicity|1|||
33362608|NCT00912743|62741148|FG000|Overall Study|End of treatment form was not collected|1|||
33362609|NCT00912743|62741149|FG001|Overall Study|End of treatment form was not collected|0|||
33362610|NCT00914459|62741157|FG000|Overall Study|Protocol Violation|0|||
33362611|NCT00914459|62741158|FG001|Overall Study|Protocol Violation|1|||
33362612|NCT00914459|62741157|FG000|Overall Study|Parent/Legal guardian request|1|||
33362613|NCT00914459|62741158|FG001|Overall Study|Parent/Legal guardian request|0|||
33362614|NCT00912509|62741168|FG000|Overall Study|Lost to Follow-up|1|||
33362615|NCT00912509|62741169|FG001|Overall Study|Lost to Follow-up|0|||
33362616|NCT00912509|62741168|FG000|Overall Study|Lack of Efficacy|4|||
33362617|NCT00912509|62741169|FG001|Overall Study|Lack of Efficacy|3|||
33362618|NCT00913835|62741189|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
33362619|NCT00913835|62741190|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
33362620|NCT00913835|62741189|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
33362621|NCT00913835|62741190|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
33362622|NCT00913835|62741189|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
33362623|NCT00913835|62741190|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
33362624|NCT00913835|62741189|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
33362625|NCT00913835|62741190|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
33362626|NCT00913835|62741189|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
33362627|NCT00913835|62741190|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
33362628|NCT00913523|62741215|FG000|Overall Study|Withdrawal by Subject|3|||
33362629|NCT00913523|62741216|FG001|Overall Study|Withdrawal by Subject|2|||
33362630|NCT00913523|62741217|FG002|Overall Study|Withdrawal by Subject|2|||
33362631|NCT00913523|62741215|FG000|Overall Study|Lost to Follow-up|1|||
33362632|NCT00913523|62741216|FG001|Overall Study|Lost to Follow-up|1|||
33362633|NCT00913523|62741217|FG002|Overall Study|Lost to Follow-up|1|||
33362634|NCT00913523|62741215|FG000|Overall Study|Adverse Event|1|||
33362635|NCT00913523|62741216|FG001|Overall Study|Adverse Event|0|||
33362636|NCT00913523|62741217|FG002|Overall Study|Adverse Event|0|||
33362637|NCT00913523|62741215|FG000|Overall Study|Protocol Violation|5|||
33362638|NCT00913523|62741216|FG001|Overall Study|Protocol Violation|8|||
33362639|NCT00913523|62741217|FG002|Overall Study|Protocol Violation|8|||
33362640|NCT00913523|62741215|FG000|Overall Study|Pregnancy|1|||
33362641|NCT00913523|62741216|FG001|Overall Study|Pregnancy|3|||
33362642|NCT00913523|62741217|FG002|Overall Study|Pregnancy|0|||
33362643|NCT00913523|62741215|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
33362644|NCT00913523|62741216|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
33362645|NCT00913523|62741217|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
33362646|NCT00912197|62741227|FG000|Overall Study|Withdrawal by Subject|3|||
33362647|NCT00912197|62741228|FG001|Overall Study|Withdrawal by Subject|3|||
33362648|NCT00910247|62741236|FG000|Overall Study|Adverse Event|15|||
33362649|NCT00910247|62741236|FG000|Overall Study|Death|2|||
33362650|NCT00910247|62741236|FG000|Overall Study|Lost to Follow-up|10|||
33362651|NCT00910247|62741236|FG000|Overall Study|Physician Decision|3|||
33362652|NCT00910247|62741236|FG000|Overall Study|Protocol Violation|10|||
33362653|NCT00910247|62741236|FG000|Overall Study|Withdrawal by Subject|25|||
33362654|NCT00910247|62741236|FG000|Overall Study|Not collected|4|||
33362655|NCT00659334|62741247|FG000|Overall Study|Screen Failure|8|||
33362656|NCT00659334|62741248|FG001|Overall Study|Screen Failure|5|||
33362657|NCT00659334|62741249|FG002|Overall Study|Screen Failure|0|||
33362658|NCT00659334|62741250|FG003|Overall Study|Screen Failure|0|||
33362659|NCT00659334|62741251|FG004|Overall Study|Screen Failure|0|||
33475329|NCT04451330|62849868|FG001|Overall Study|Lost to Follow-up|0|||
33475330|NCT04451330|62849867|FG000|Overall Study|Withdrawal by Subject|3|||
33362660|NCT00659334|62741252|FG005|Overall Study|Screen Failure|0|||
33362661|NCT00659334|62741253|FG006|Overall Study|Screen Failure|1|||
33362662|NCT00910091|62741275|FG000|Pre-assignment|Withdrawal by Subject|0|||
33362663|NCT00910091|62741276|FG001|Pre-assignment|Withdrawal by Subject|2|||
33362664|NCT00910091|62741275|FG000|Treatment and Survival|Withdrawal by Subject|3|||
33362665|NCT00910091|62741276|FG001|Treatment and Survival|Withdrawal by Subject|4|||
33362666|NCT00910091|62741275|FG000|Treatment and Survival|Adverse Event|1|||
33362667|NCT00910091|62741276|FG001|Treatment and Survival|Adverse Event|0|||
33362668|NCT00909857|62741285|FG000|Overall Study|Withdrawal by Subject|6|||
33362669|NCT00909857|62741286|FG001|Overall Study|Withdrawal by Subject|10|||
33362670|NCT00909857|62741285|FG000|Overall Study|Adverse Event|5|||
33362671|NCT00909857|62741286|FG001|Overall Study|Adverse Event|5|||
33362672|NCT00909857|62741285|FG000|Overall Study|Lost to Follow-up|2|||
33362673|NCT00909857|62741286|FG001|Overall Study|Lost to Follow-up|5|||
33362674|NCT00909857|62741285|FG000|Overall Study|Protocol Violation|2|||
33362675|NCT00909857|62741286|FG001|Overall Study|Protocol Violation|1|||
33362676|NCT00909857|62741285|FG000|Overall Study|Pregnancy|1|||
33362677|NCT00909857|62741286|FG001|Overall Study|Pregnancy|0|||
33362678|NCT00909857|62741285|FG000|Overall Study|Other|1|||
33362679|NCT00909857|62741286|FG001|Overall Study|Other|0|||
33362680|NCT00909857|62741285|FG000|Overall Study|Did not receive study medication|19|||
33362681|NCT00909857|62741286|FG001|Overall Study|Did not receive study medication|24|||
33362682|NCT00911807|62741295|FG000|Overall Study|Adverse Event|2|||
33362683|NCT00911807|62741296|FG001|Overall Study|Adverse Event|1|||
33362684|NCT00911807|62741297|FG002|Overall Study|Adverse Event|5|||
33362685|NCT00911807|62741295|FG000|Overall Study|Death|0|||
33362686|NCT00911807|62741296|FG001|Overall Study|Death|0|||
33362687|NCT00911807|62741297|FG002|Overall Study|Death|1|||
33362688|NCT00911807|62741295|FG000|Overall Study|Protocol Violation|6|||
33362689|NCT00911807|62741296|FG001|Overall Study|Protocol Violation|4|||
33362690|NCT00911807|62741297|FG002|Overall Study|Protocol Violation|9|||
33362691|NCT00911807|62741295|FG000|Overall Study|Withdrawal by Subject|8|||
33362692|NCT00911807|62741296|FG001|Overall Study|Withdrawal by Subject|10|||
33362693|NCT00911807|62741297|FG002|Overall Study|Withdrawal by Subject|7|||
33362694|NCT00911807|62741295|FG000|Overall Study|Organizational reasons|1|||
33362695|NCT00911807|62741296|FG001|Overall Study|Organizational reasons|3|||
33362696|NCT00911807|62741297|FG002|Overall Study|Organizational reasons|1|||
33362697|NCT04287920|62741324|FG000|Overall Study|Lost to Follow-up|1|||
33362698|NCT04287920|62741325|FG001|Overall Study|Lost to Follow-up|1|||
33362699|NCT04287920|62741324|FG000|Overall Study|Withdrawal by Subject|0|||
33362700|NCT04287920|62741325|FG001|Overall Study|Withdrawal by Subject|3|||
33362701|NCT00909779|62741333|FG000|Overall Study|Adverse Event|53|||
33362702|NCT00909779|62741334|FG001|Overall Study|Adverse Event|55|||
33362703|NCT00909779|62741333|FG000|Overall Study|Lack of Efficacy|7|||
33362704|NCT00909779|62741334|FG001|Overall Study|Lack of Efficacy|4|||
33362705|NCT00909779|62741333|FG000|Overall Study|Lost to Follow-up|19|||
33362706|NCT00909779|62741334|FG001|Overall Study|Lost to Follow-up|15|||
33362707|NCT00909779|62741333|FG000|Overall Study|Physician Decision|8|||
33362708|NCT00909779|62741334|FG001|Overall Study|Physician Decision|2|||
33362709|NCT00909779|62741333|FG000|Overall Study|Protocol Violation|2|||
33362710|NCT00909779|62741334|FG001|Overall Study|Protocol Violation|5|||
33362711|NCT00909779|62741333|FG000|Overall Study|Withdrawal by Subject|116|||
33362712|NCT00909779|62741334|FG001|Overall Study|Withdrawal by Subject|80|||
33362713|NCT00909779|62741333|FG000|Overall Study|Site Ceasing Operation|2|||
33362714|NCT00909779|62741334|FG001|Overall Study|Site Ceasing Operation|2|||
33362715|NCT00909779|62741333|FG000|Overall Study|Medical Monitor Decision|1|||
33362716|NCT00909779|62741334|FG001|Overall Study|Medical Monitor Decision|0|||
33475331|NCT04451330|62849868|FG001|Overall Study|Withdrawal by Subject|1|||
33475332|NCT04451330|62849867|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33475333|NCT04451330|62849868|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33475334|NCT04451330|62849867|FG000|Overall Study|Other than specified|0|||
33475335|NCT04451330|62849868|FG001|Overall Study|Other than specified|1|||
33475336|NCT02493426|62849874|FG000|Overall Study|Withdrawal by Subject|0|||
33475337|NCT02493426|62849875|FG001|Overall Study|Withdrawal by Subject|1|||
33475338|NCT04448756|62849884|FG000|Overall Study|Adverse Event|0|||
33475339|NCT04448756|62849885|FG001|Overall Study|Adverse Event|1|||
33475340|NCT04448756|62849886|FG002|Overall Study|Adverse Event|0|||
33475341|NCT04448756|62849884|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
33475342|NCT04448756|62849885|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
33475343|NCT04448756|62849886|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
33475344|NCT04448756|62849884|FG000|Overall Study|Withdrawal by Subject|0|||
33475345|NCT04448756|62849885|FG001|Overall Study|Withdrawal by Subject|3|||
33549472|NCT01348139|62940598|FG000|Period 1|Adverse Event|1|||
33362717|NCT00909779|62741333|FG000|Overall Study|Noncompliance|1|||
33362718|NCT00909779|62741334|FG001|Overall Study|Noncompliance|1|||
33362719|NCT00909779|62741333|FG000|Overall Study|Randomized in error|1|||
33362720|NCT00909779|62741334|FG001|Overall Study|Randomized in error|1|||
33362721|NCT00910871|62741342|FG000|Overall Study|Adverse Event|5|||
33362722|NCT00910871|62741342|FG000|Overall Study|Death|12|||
33362723|NCT00910871|62741342|FG000|Overall Study|Lost to Follow-up|8|||
33362724|NCT00910871|62741342|FG000|Overall Study|Protocol Violation|11|||
33362725|NCT00910871|62741342|FG000|Overall Study|Withdrawal by Subject|12|||
33362726|NCT00910871|62741342|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
33362727|NCT00910871|62741342|FG000|Overall Study|Undefined|1|||
33362728|NCT02631941|62741367|FG000|Overall Study|Physician Decision|0|||
33362729|NCT02631941|62741368|FG001|Overall Study|Physician Decision|1|||
33475346|NCT04448756|62849886|FG002|Overall Study|Withdrawal by Subject|1|||
33475347|NCT04448756|62849884|FG000|Overall Study|Death|2|||
33362730|NCT02631941|62741369|FG002|Overall Study|Physician Decision|0|||
33362731|NCT02631941|62741370|FG003|Overall Study|Physician Decision|0|||
33475348|NCT04448756|62849885|FG001|Overall Study|Death|1|||
33362732|NCT02631941|62741371|FG004|Overall Study|Physician Decision|0|||
33362733|NCT02631941|62741372|FG005|Overall Study|Physician Decision|0|||
33475349|NCT04448756|62849886|FG002|Overall Study|Death|0|||
33475350|NCT04274192|62849896|FG000|Overall Study|Protocol Violation|1|||
33475351|NCT04274192|62849897|FG001|Overall Study|Protocol Violation|0|||
33475352|NCT04387136|62849907|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
33475353|NCT04387136|62849908|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
33475354|NCT04252586|62849914|FG000|Overall Study|Withdrawal by parent/guardian|3|||
33475355|NCT04252586|62849914|FG000|Overall Study|Adverse Event|1|||
33475356|NCT04252586|62849914|FG000|Overall Study|Death|2|||
33475357|NCT04252586|62849914|FG000|Overall Study|Study terminated by sponsor|4|||
33475358|NCT04252586|62849914|FG000|Overall Study|Sponsor request|10|||
33475359|NCT04252586|62849914|FG000|Overall Study|Did not complete treatment period|1|||
33475360|NCT04247828|62849919|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
33475361|NCT04507776|62849923|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
33475362|NCT04386902|62849932|FG000|Overall Study|Withdrawal by Subject|5|||
33655692|NCT04604184|63072701|FG000|Overall Study|Death|2|||
33362734|NCT02631941|62741373|FG006|Overall Study|Physician Decision|0|||
33362735|NCT02631941|62741374|FG007|Overall Study|Physician Decision|0|||
33362736|NCT02631941|62741375|FG008|Overall Study|Physician Decision|0|||
33362737|NCT02631941|62741376|FG009|Overall Study|Physician Decision|0|||
33362738|NCT02631941|62741367|FG000|Overall Study|Adverse Event|0|||
33362739|NCT02631941|62741368|FG001|Overall Study|Adverse Event|1|||
33362740|NCT02631941|62741369|FG002|Overall Study|Adverse Event|0|||
33362741|NCT02631941|62741370|FG003|Overall Study|Adverse Event|0|||
33362742|NCT02631941|62741371|FG004|Overall Study|Adverse Event|0|||
33362743|NCT02631941|62741372|FG005|Overall Study|Adverse Event|0|||
33362744|NCT02631941|62741373|FG006|Overall Study|Adverse Event|0|||
33362745|NCT02631941|62741374|FG007|Overall Study|Adverse Event|0|||
33362746|NCT02631941|62741375|FG008|Overall Study|Adverse Event|0|||
33362747|NCT02631941|62741376|FG009|Overall Study|Adverse Event|0|||
33362748|NCT02631941|62741367|FG000|Overall Study|Withdrawal by Subject|0|||
33362749|NCT02631941|62741368|FG001|Overall Study|Withdrawal by Subject|0|||
33362750|NCT02631941|62741369|FG002|Overall Study|Withdrawal by Subject|0|||
33362751|NCT02631941|62741370|FG003|Overall Study|Withdrawal by Subject|0|||
33362752|NCT02631941|62741371|FG004|Overall Study|Withdrawal by Subject|1|||
33362753|NCT02631941|62741372|FG005|Overall Study|Withdrawal by Subject|0|||
33362754|NCT02631941|62741373|FG006|Overall Study|Withdrawal by Subject|0|||
33362755|NCT02631941|62741374|FG007|Overall Study|Withdrawal by Subject|1|||
33362756|NCT02631941|62741375|FG008|Overall Study|Withdrawal by Subject|0|||
33362757|NCT02631941|62741376|FG009|Overall Study|Withdrawal by Subject|0|||
33362758|NCT02631941|62741367|FG000|Overall Study|Lost to Follow-up|0|||
33362759|NCT02631941|62741368|FG001|Overall Study|Lost to Follow-up|0|||
33362760|NCT02631941|62741369|FG002|Overall Study|Lost to Follow-up|0|||
33362761|NCT02631941|62741370|FG003|Overall Study|Lost to Follow-up|0|||
33362762|NCT02631941|62741371|FG004|Overall Study|Lost to Follow-up|0|||
33362763|NCT02631941|62741372|FG005|Overall Study|Lost to Follow-up|0|||
33362764|NCT02631941|62741373|FG006|Overall Study|Lost to Follow-up|0|||
33362765|NCT02631941|62741374|FG007|Overall Study|Lost to Follow-up|0|||
33362766|NCT02631941|62741375|FG008|Overall Study|Lost to Follow-up|1|||
33362767|NCT02631941|62741376|FG009|Overall Study|Lost to Follow-up|0|||
33362768|NCT00908375|62741388|FG000|Overall Study|Withdrawal by Subject|2|||
33362769|NCT00908375|62741389|FG001|Overall Study|Withdrawal by Subject|4|||
33362770|NCT00908375|62741388|FG000|Overall Study|Lost to Follow-up|8|||
33362771|NCT00908375|62741389|FG001|Overall Study|Lost to Follow-up|6|||
33362772|NCT00909389|62741395|FG000|Overall Study|Adverse Event|6|||
33362773|NCT00909389|62741395|FG000|Overall Study|Death|4|||
33362774|NCT00909389|62741395|FG000|Overall Study|Poor Compliance|16|||
33362775|NCT00909389|62741395|FG000|Overall Study|Lost to Follow-up|4|||
33362776|NCT00909389|62741395|FG000|Overall Study|No Information|103|||
33362777|NCT00910715|62741402|FG000|Overall Study|Lost to Follow-up|22|||
33362778|NCT00910715|62741403|FG001|Overall Study|Lost to Follow-up|26|||
33362779|NCT00910715|62741404|FG002|Overall Study|Lost to Follow-up|0|||
33362780|NCT00600483|62741475|FG000|Overall Study|Lost to Follow-up|26|||
33362781|NCT00600483|62741476|FG001|Overall Study|Lost to Follow-up|47|||
33362782|NCT00600483|62741475|FG000|Overall Study|Randomized but not treated|10|||
33362783|NCT00600483|62741476|FG001|Overall Study|Randomized but not treated|0|||
33362784|NCT00600171|62741488|FG000|Overall Study|Adverse Event|0|||
33362785|NCT00600171|62741489|FG001|Overall Study|Adverse Event|1|||
33362786|NCT00600171|62741490|FG002|Overall Study|Adverse Event|0|||
33362787|NCT00600171|62741491|FG003|Overall Study|Adverse Event|0|||
33362788|NCT00600171|62741492|FG004|Overall Study|Adverse Event|1|||
33362789|NCT00600171|62741493|FG005|Overall Study|Adverse Event|0|||
33362790|NCT00600171|62741488|FG000|Overall Study|Lack of Efficacy|9|||
33362791|NCT00600171|62741489|FG001|Overall Study|Lack of Efficacy|12|||
33475363|NCT04386902|62849932|FG000|Overall Study|Technical problems in the recording|5|||
33655693|NCT04604184|63072702|FG001|Overall Study|Death|1|||
33362792|NCT00600171|62741490|FG002|Overall Study|Lack of Efficacy|3|||
33362793|NCT00600171|62741491|FG003|Overall Study|Lack of Efficacy|5|||
33362794|NCT00600171|62741492|FG004|Overall Study|Lack of Efficacy|4|||
33362795|NCT00600171|62741493|FG005|Overall Study|Lack of Efficacy|0|||
33362796|NCT00600171|62741488|FG000|Overall Study|Protocol Violation|1|||
33362797|NCT00600171|62741489|FG001|Overall Study|Protocol Violation|2|||
33362798|NCT00600171|62741490|FG002|Overall Study|Protocol Violation|0|||
33362799|NCT00600171|62741491|FG003|Overall Study|Protocol Violation|1|||
33362800|NCT00600171|62741492|FG004|Overall Study|Protocol Violation|0|||
33362801|NCT00600171|62741493|FG005|Overall Study|Protocol Violation|0|||
33362802|NCT00600171|62741488|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
33362803|NCT00600171|62741489|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33362804|NCT00600171|62741490|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
33362805|NCT00600171|62741491|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
33362806|NCT00600171|62741492|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
33362807|NCT00600171|62741493|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
33362808|NCT00600171|62741488|FG000|Overall Study|Withdrawal by Subject|3|||
33362809|NCT00600171|62741489|FG001|Overall Study|Withdrawal by Subject|0|||
33362810|NCT00600171|62741490|FG002|Overall Study|Withdrawal by Subject|0|||
33362811|NCT00600171|62741491|FG003|Overall Study|Withdrawal by Subject|1|||
33362812|NCT00600171|62741492|FG004|Overall Study|Withdrawal by Subject|1|||
33362813|NCT00600171|62741493|FG005|Overall Study|Withdrawal by Subject|1|||
33362814|NCT00600171|62741488|FG000|Overall Study|Physician Decision|0|||
33362815|NCT00600171|62741489|FG001|Overall Study|Physician Decision|1|||
33362816|NCT00600171|62741490|FG002|Overall Study|Physician Decision|0|||
33362817|NCT00600171|62741491|FG003|Overall Study|Physician Decision|1|||
33475364|NCT04232540|62849938|FG000|Overall Study|Lost to Follow-up|1|||
33475365|NCT04232540|62849939|FG001|Overall Study|Lost to Follow-up|0|||
33475366|NCT04504032|62849947|FG000|Overall Study|Adverse Event|1|||
33475367|NCT04504032|62849948|FG001|Overall Study|Adverse Event|2|||
33475368|NCT04504032|62849947|FG000|Overall Study|Lost to Follow-up|6|||
33475369|NCT04504032|62849948|FG001|Overall Study|Lost to Follow-up|9|||
33475370|NCT04504032|62849947|FG000|Overall Study|Protocol Violation|2|||
33475371|NCT04504032|62849948|FG001|Overall Study|Protocol Violation|0|||
33475372|NCT04504032|62849947|FG000|Overall Study|Study terminated by sponsor|1|||
33475373|NCT04504032|62849948|FG001|Overall Study|Study terminated by sponsor|2|||
33549473|NCT01348139|62940599|FG001|Period 1|Adverse Event|0|||
33549474|NCT01348139|62940600|FG002|Period 1|Adverse Event|0|||
33549475|NCT01348139|62940601|FG003|Period 1|Adverse Event|0|||
33549476|NCT01348139|62940602|FG004|Period 1|Adverse Event|0|||
33549477|NCT01348139|62940603|FG005|Period 1|Adverse Event|0|||
33549478|NCT02868229|62940621|FG000|Overall Study|Adverse Event|1|||
33549479|NCT02868229|62940622|FG001|Overall Study|Adverse Event|0|||
33549480|NCT02868229|62940623|FG002|Overall Study|Adverse Event|0|||
33549481|NCT02868229|62940624|FG003|Overall Study|Adverse Event|1|||
33549482|NCT02868229|62940621|FG000|Overall Study|Death|0|||
33549483|NCT02868229|62940622|FG001|Overall Study|Death|0|||
33475374|NCT04504032|62849947|FG000|Overall Study|Withdrawal by Subject|9|||
33475375|NCT04504032|62849948|FG001|Overall Study|Withdrawal by Subject|11|||
33475376|NCT04504032|62849947|FG000|Overall Study|Disease progression prior to dosing|15|||
33475377|NCT04504032|62849948|FG001|Overall Study|Disease progression prior to dosing|3|||
33475378|NCT04504032|62849947|FG000|Overall Study|Drug supply issues|1|||
33475379|NCT04504032|62849948|FG001|Overall Study|Drug supply issues|1|||
33475380|NCT04504032|62849947|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
33475381|NCT04504032|62849948|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
33475382|NCT04439240|62849954|FG000|Overall Study|Ineligible|2|||
33475383|NCT04439240|62849954|FG000|Overall Study|Never started treatment|2|||
33475384|NCT04439240|62849954|FG000|Overall Study|Adverse Event|12|||
33475385|NCT04439240|62849954|FG000|Overall Study|Death|2|||
33475386|NCT04439240|62849954|FG000|Overall Study|Disease progression|25|||
33475387|NCT04439240|62849954|FG000|Overall Study|Other diseases|2|||
33475388|NCT04439240|62849954|FG000|Overall Study|Withdrawal by Subject|3|||
33475389|NCT04439240|62849954|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
33475390|NCT04439240|62849954|FG000|Overall Study|Symptomatic decline|1|||
33362818|NCT00600171|62741492|FG004|Overall Study|Physician Decision|0|||
33475391|NCT04439240|62849954|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
33475392|NCT04439240|62849954|FG000|Overall Study|Clinical progression|1|||
33475393|NCT04605588|62849960|FG000|Overall Study|Withdrawal by Subject|1|||
33475394|NCT04605588|62849961|FG001|Overall Study|Withdrawal by Subject|0|||
33475395|NCT04885296|62849967|FG000|Period 1|Covid-19 Related|1|||
33475396|NCT04885296|62849968|FG001|Period 1|Covid-19 Related|0|||
33475397|NCT04885296|62849967|FG000|Period 1|Adverse Event|0|||
33475398|NCT04885296|62849968|FG001|Period 1|Adverse Event|1|||
33549484|NCT02868229|62940623|FG002|Overall Study|Death|1|||
33549485|NCT02868229|62940624|FG003|Overall Study|Death|1|||
33362819|NCT00600171|62741493|FG005|Overall Study|Physician Decision|2|||
33362820|NCT00600171|62741488|FG000|Overall Study|Lost to Follow-up|0|||
33362821|NCT00600171|62741489|FG001|Overall Study|Lost to Follow-up|0|||
33362822|NCT00600171|62741490|FG002|Overall Study|Lost to Follow-up|0|||
33362823|NCT00600171|62741491|FG003|Overall Study|Lost to Follow-up|1|||
33362824|NCT00600171|62741492|FG004|Overall Study|Lost to Follow-up|0|||
33362825|NCT00600171|62741493|FG005|Overall Study|Lost to Follow-up|0|||
33362826|NCT04035668|62741512|FG000|Overall Study|Adverse Event|3|||
33362827|NCT04035668|62741513|FG001|Overall Study|Adverse Event|4|||
33362828|NCT04035668|62741514|FG002|Overall Study|Adverse Event|2|||
33362829|NCT04035668|62741512|FG000|Overall Study|Lost to Follow-up|0|||
33362830|NCT04035668|62741513|FG001|Overall Study|Lost to Follow-up|1|||
33362831|NCT04035668|62741514|FG002|Overall Study|Lost to Follow-up|0|||
33362832|NCT04035668|62741512|FG000|Overall Study|Physician Decision|2|||
33362833|NCT04035668|62741513|FG001|Overall Study|Physician Decision|1|||
33362834|NCT04035668|62741514|FG002|Overall Study|Physician Decision|1|||
33362835|NCT04035668|62741512|FG000|Overall Study|Subject Decision|2|||
33362836|NCT04035668|62741513|FG001|Overall Study|Subject Decision|2|||
33362837|NCT04035668|62741514|FG002|Overall Study|Subject Decision|0|||
33362838|NCT00885495|62741534|FG000|Overall Study|Adverse Event|1|||
33362839|NCT00885495|62741535|FG001|Overall Study|Adverse Event|2|||
33362840|NCT00885495|62741534|FG000|Overall Study|Protocol Violation|0|||
33362841|NCT00885495|62741535|FG001|Overall Study|Protocol Violation|1|||
33362842|NCT00885495|62741534|FG000|Overall Study|Withdrawal by Subject|1|||
33362843|NCT00885495|62741535|FG001|Overall Study|Withdrawal by Subject|0|||
33362844|NCT00885105|62741548|FG000|Overall Study|Withdrawal by Subject|0|||
33362845|NCT00885105|62741549|FG001|Overall Study|Withdrawal by Subject|8|||
33362846|NCT00885105|62741548|FG000|Overall Study|Adverse Event|1|||
33362847|NCT00885105|62741549|FG001|Overall Study|Adverse Event|0|||
33362848|NCT00885105|62741548|FG000|Overall Study|Protocol Violation|0|||
33362849|NCT00885105|62741549|FG001|Overall Study|Protocol Violation|2|||
33362850|NCT03945188|62741557|FG000|Overall Study|Protocol Violation|1|||
33362851|NCT03945188|62741558|FG001|Overall Study|Protocol Violation|0|||
33475399|NCT04885296|62849967|FG000|Period 1|Withdrawal by Subject|1|||
33475400|NCT04885296|62849968|FG001|Period 1|Withdrawal by Subject|1|||
33475401|NCT04885296|62849967|FG000|Period 1|Test Article No Longer Available|1|||
33475402|NCT04885296|62849968|FG001|Period 1|Test Article No Longer Available|0|||
33475403|NCT04885296|62849967|FG000|Period 1|Dispensed Study lens in Error|1|||
33475404|NCT04885296|62849968|FG001|Period 1|Dispensed Study lens in Error|0|||
33475405|NCT04885296|62849967|FG000|Period 1|Lost to Follow-up|1|||
33475406|NCT04885296|62849968|FG001|Period 1|Lost to Follow-up|0|||
33475407|NCT04885296|62849967|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
33475408|NCT04885296|62849968|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
33549486|NCT02868229|62940621|FG000|Overall Study|Missed dose|0|||
33549487|NCT02868229|62940622|FG001|Overall Study|Missed dose|0|||
33549488|NCT02868229|62940623|FG002|Overall Study|Missed dose|0|||
33362852|NCT03945188|62741557|FG000|Overall Study|Disease worsening|79|||
33362853|NCT03945188|62741558|FG001|Overall Study|Disease worsening|73|||
33362854|NCT03945188|62741557|FG000|Overall Study|Physician Decision|2|||
33362855|NCT03945188|62741558|FG001|Overall Study|Physician Decision|2|||
33362856|NCT03945188|62741557|FG000|Overall Study|Lack of Efficacy|7|||
33362857|NCT03945188|62741558|FG001|Overall Study|Lack of Efficacy|4|||
33362858|NCT03945188|62741557|FG000|Overall Study|Pregnancy|2|||
33362859|NCT03945188|62741558|FG001|Overall Study|Pregnancy|0|||
33362860|NCT03945188|62741557|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
33362861|NCT03945188|62741558|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
33362862|NCT03945188|62741557|FG000|Overall Study|Adverse Event|10|||
33362863|NCT03945188|62741558|FG001|Overall Study|Adverse Event|5|||
33362864|NCT03945188|62741557|FG000|Overall Study|Other|2|||
33362865|NCT03945188|62741558|FG001|Overall Study|Other|2|||
33362866|NCT03945188|62741557|FG000|Overall Study|Lost to Follow-up|1|||
33362867|NCT03945188|62741558|FG001|Overall Study|Lost to Follow-up|2|||
33362868|NCT00884949|62741564|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
33362869|NCT00884949|62741564|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
33362870|NCT00884793|62741577|FG000|Overall Study|Withdrawal by Subject|1|||
33362871|NCT00884325|62741583|FG000|Overall Study|Lost to Follow-up|1|||
33362872|NCT00884325|62741584|FG001|Overall Study|Lost to Follow-up|2|||
33362873|NCT00884325|62741583|FG000|Overall Study|Lack of Efficacy|0|||
33362874|NCT00884325|62741584|FG001|Overall Study|Lack of Efficacy|1|||
33362875|NCT00884325|62741583|FG000|Overall Study|Withdrawal by Subject|1|||
33362876|NCT00884325|62741584|FG001|Overall Study|Withdrawal by Subject|1|||
33362877|NCT00884325|62741583|FG000|Overall Study|Not provided|1|||
33475409|NCT04602000|62849979|FG000|Overall Study|Withdrawal by Subject|3|||
33475410|NCT04602000|62849980|FG001|Overall Study|Withdrawal by Subject|6|||
33362878|NCT00884325|62741584|FG001|Overall Study|Not provided|0|||
33475411|NCT04602000|62849981|FG002|Overall Study|Withdrawal by Subject|3|||
33362879|NCT00883779|62741592|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
33362880|NCT00883779|62741593|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
33549489|NCT02868229|62940624|FG003|Overall Study|Missed dose|3|||
33362881|NCT00883779|62741592|FG000|Primary Study Treatment Phase|Disease progression|75|||
33362882|NCT00883779|62741593|FG001|Primary Study Treatment Phase|Disease progression|59|||
33362883|NCT00883779|62741592|FG000|Primary Study Treatment Phase|Adverse Event|16|||
33475412|NCT04602000|62849982|FG003|Overall Study|Withdrawal by Subject|27|||
33475413|NCT04602000|62849983|FG004|Overall Study|Withdrawal by Subject|39|||
33475414|NCT04602000|62849979|FG000|Overall Study|Physician Decision|1|||
33655694|NCT04604184|63072701|FG000|Overall Study|Withdrawal by Subject|1|||
33655695|NCT04604184|63072702|FG001|Overall Study|Withdrawal by Subject|3|||
33655696|NCT04604184|63072701|FG000|Overall Study|Not treated|2|||
33362884|NCT00883779|62741593|FG001|Primary Study Treatment Phase|Adverse Event|16|||
33362885|NCT00883779|62741592|FG000|Primary Study Treatment Phase|Death|2|||
33362886|NCT00883779|62741593|FG001|Primary Study Treatment Phase|Death|3|||
33362887|NCT00883779|62741592|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
33362888|NCT00883779|62741593|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
33362889|NCT00883779|62741592|FG000|Primary Study Treatment Phase|Other|3|||
33362890|NCT00883779|62741593|FG001|Primary Study Treatment Phase|Other|0|||
33362891|NCT00883779|62741592|FG000|Post-Study Treatment Phase|Adverse Event|2|||
33362892|NCT00883779|62741593|FG001|Post-Study Treatment Phase|Adverse Event|3|||
33362893|NCT00883779|62741592|FG000|Post-Study Treatment Phase|Death|1|||
33362894|NCT00883779|62741593|FG001|Post-Study Treatment Phase|Death|3|||
33362895|NCT00883779|62741592|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
33362896|NCT00883779|62741593|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
33362897|NCT00883779|62741592|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
33362898|NCT00883779|62741593|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
33362899|NCT00883779|62741592|FG000|Post-Study Treatment Phase|Disease progression|103|||
33362900|NCT00883779|62741593|FG001|Post-Study Treatment Phase|Disease progression|122|||
33362901|NCT00883779|62741592|FG000|Post-Study Treatment Phase|Other|3|||
33362902|NCT00883779|62741593|FG001|Post-Study Treatment Phase|Other|0|||
33362903|NCT00883779|62741592|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
33362904|NCT00883779|62741593|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
33362905|NCT00883779|62741592|FG000|Off-study Phase|Death|185|||
33362906|NCT00883779|62741593|FG001|Off-study Phase|Death|174|||
33362907|NCT00883779|62741592|FG000|Off-study Phase|Refused treatment|1|||
33362908|NCT00883779|62741593|FG001|Off-study Phase|Refused treatment|1|||
33362909|NCT00883779|62741592|FG000|Off-study Phase|Failure to return|5|||
33362910|NCT00883779|62741593|FG001|Off-study Phase|Failure to return|6|||
33362911|NCT00883779|62741592|FG000|Off-study Phase|Other|18|||
33362912|NCT00883779|62741593|FG001|Off-study Phase|Other|21|||
33362913|NCT04159701|62741601|FG000|Period 1: Treatment Period|Pregnancy|1|||
33362914|NCT04159701|62741602|FG001|Period 1: Treatment Period|Pregnancy|0|||
33362915|NCT04159701|62741601|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
33362916|NCT04159701|62741602|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
33362917|NCT04159701|62741601|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
33362918|NCT04159701|62741602|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
33362919|NCT04159701|62741601|FG000|Washout Period|site terminated by sponsor|0|||
33362920|NCT04159701|62741602|FG001|Washout Period|site terminated by sponsor|1|||
33362921|NCT04159701|62741601|FG000|Washout Period|study terminated by sponsor|10|||
33362922|NCT04159701|62741602|FG001|Washout Period|study terminated by sponsor|3|||
33362923|NCT04159701|62741601|FG000|Washout Period|Withdrawal by Subject|1|||
33362924|NCT04159701|62741602|FG001|Washout Period|Withdrawal by Subject|0|||
33362925|NCT04159701|62741601|FG000|Washout Period|Inadvertent Enrollment|1|||
33362926|NCT04159701|62741602|FG001|Washout Period|Inadvertent Enrollment|0|||
33362927|NCT04159701|62741601|FG000|Washout Period|Miscellaneous|1|||
33362928|NCT04159701|62741602|FG001|Washout Period|Miscellaneous|0|||
33362929|NCT04159701|62741601|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
33362930|NCT04159701|62741602|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
33362931|NCT04159701|62741601|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
33362932|NCT04159701|62741602|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
33362933|NCT04159701|62741601|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
33362934|NCT04159701|62741602|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
33362935|NCT04159701|62741601|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
33362936|NCT04159701|62741602|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
33362937|NCT04159701|62741601|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
33362938|NCT04159701|62741602|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
33362939|NCT00880269|62741614|FG000|Overall Study|Protocol Violation|1|||
33475415|NCT04602000|62849980|FG001|Overall Study|Physician Decision|0|||
33475416|NCT04602000|62849981|FG002|Overall Study|Physician Decision|0|||
33475417|NCT04602000|62849982|FG003|Overall Study|Physician Decision|2|||
33362940|NCT00880269|62741615|FG001|Overall Study|Protocol Violation|0|||
33362941|NCT00880269|62741614|FG000|Overall Study|Disease Progression|13|||
33362942|NCT00880269|62741615|FG001|Overall Study|Disease Progression|11|||
33362943|NCT00880269|62741614|FG000|Overall Study|New Cancer Therapy|1|||
33362944|NCT00880269|62741615|FG001|Overall Study|New Cancer Therapy|0|||
33475418|NCT04602000|62849983|FG004|Overall Study|Physician Decision|2|||
33475419|NCT04602000|62849979|FG000|Overall Study|Death|0|||
33475420|NCT04602000|62849980|FG001|Overall Study|Death|1|||
33475421|NCT04602000|62849981|FG002|Overall Study|Death|0|||
33475422|NCT04602000|62849982|FG003|Overall Study|Death|1|||
33475423|NCT04602000|62849983|FG004|Overall Study|Death|2|||
33475424|NCT04602000|62849979|FG000|Overall Study|Lost to Follow-up|0|||
33475425|NCT04602000|62849980|FG001|Overall Study|Lost to Follow-up|0|||
33475426|NCT04602000|62849981|FG002|Overall Study|Lost to Follow-up|0|||
33475427|NCT04602000|62849982|FG003|Overall Study|Lost to Follow-up|3|||
33475428|NCT04602000|62849983|FG004|Overall Study|Lost to Follow-up|4|||
33475429|NCT04602000|62849979|FG000|Overall Study|Other|4|||
33475430|NCT04602000|62849980|FG001|Overall Study|Other|1|||
33475431|NCT04602000|62849981|FG002|Overall Study|Other|2|||
33475432|NCT04602000|62849982|FG003|Overall Study|Other|5|||
33362945|NCT00880269|62741614|FG000|Overall Study|Death|4|||
33362946|NCT00880269|62741615|FG001|Overall Study|Death|2|||
33362947|NCT00880269|62741614|FG000|Overall Study|Lost to Follow-up|0|||
33362948|NCT00880269|62741615|FG001|Overall Study|Lost to Follow-up|1|||
33362949|NCT00880269|62741614|FG000|Overall Study|Withdrawal by Subject|3|||
33362950|NCT00880269|62741615|FG001|Overall Study|Withdrawal by Subject|4|||
33362951|NCT00880269|62741614|FG000|Overall Study|Adverse Event|10|||
33362952|NCT00880269|62741615|FG001|Overall Study|Adverse Event|9|||
33362953|NCT00880191|62741623|FG000|Overall Study|Refused further treatment|4|||
33362954|NCT00880191|62741624|FG001|Overall Study|Refused further treatment|1|||
33362955|NCT00880191|62741623|FG000|Overall Study|Adverse Event|8|||
33362956|NCT00880191|62741624|FG001|Overall Study|Adverse Event|6|||
33362957|NCT00880191|62741623|FG000|Overall Study|Hospitalization/efficacy|1|||
33362958|NCT00880191|62741624|FG001|Overall Study|Hospitalization/efficacy|1|||
33362959|NCT00597519|62741630|FG000|Overall Study|Death|1|||
33362960|NCT00879333|62741636|FG000|Overall Study|Adverse Event|94|||
33362961|NCT00879333|62741637|FG001|Overall Study|Adverse Event|34|||
33362962|NCT00879333|62741636|FG000|Overall Study|Abnormal Laboratory Value|1|||
33362963|NCT00879333|62741637|FG001|Overall Study|Abnormal Laboratory Value|0|||
33362964|NCT00879333|62741636|FG000|Overall Study|Withdrawal by Subject|20|||
33362965|NCT00879333|62741637|FG001|Overall Study|Withdrawal by Subject|7|||
33362966|NCT00879333|62741636|FG000|Overall Study|Lost to Follow-up|2|||
33362967|NCT00879333|62741637|FG001|Overall Study|Lost to Follow-up|1|||
33362968|NCT00879333|62741636|FG000|Overall Study|Administrative Problems|2|||
33362969|NCT00879333|62741637|FG001|Overall Study|Administrative Problems|0|||
33362970|NCT00879333|62741636|FG000|Overall Study|Death|16|||
33362971|NCT00879333|62741637|FG001|Overall Study|Death|5|||
33362972|NCT00879333|62741636|FG000|Overall Study|Disease Progression|292|||
33362973|NCT00879333|62741637|FG001|Overall Study|Disease Progression|169|||
33362974|NCT00879333|62741636|FG000|Overall Study|Protocol Violation|1|||
33362975|NCT00879333|62741637|FG001|Overall Study|Protocol Violation|1|||
33362976|NCT03481556|62741649|FG000|Overall Study|Adverse Event|1|||
33362977|NCT03481556|62741650|FG001|Overall Study|Adverse Event|0|||
33362978|NCT03481556|62741651|FG002|Overall Study|Adverse Event|0|||
33362979|NCT03481556|62741652|FG003|Overall Study|Adverse Event|0|||
33362980|NCT03481556|62741649|FG000|Overall Study|Death|4|||
33362981|NCT03481556|62741650|FG001|Overall Study|Death|2|||
33362982|NCT03481556|62741651|FG002|Overall Study|Death|3|||
33362983|NCT03481556|62741652|FG003|Overall Study|Death|16|||
33362984|NCT03481556|62741649|FG000|Overall Study|Study Terminated by Sponsor|10|||
33362985|NCT03481556|62741650|FG001|Overall Study|Study Terminated by Sponsor|5|||
33362986|NCT03481556|62741651|FG002|Overall Study|Study Terminated by Sponsor|2|||
33362987|NCT03481556|62741652|FG003|Overall Study|Study Terminated by Sponsor|9|||
33362988|NCT00596427|62741670|FG000|Overall Study|Withdrawal by Subject|2|||
33362989|NCT00596427|62741671|FG001|Overall Study|Withdrawal by Subject|2|||
33362990|NCT00596427|62741670|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
33362991|NCT00596427|62741671|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
33362992|NCT00596427|62741670|FG000|Overall Study|Protocol Violation|1|||
33362993|NCT00596427|62741671|FG001|Overall Study|Protocol Violation|0|||
33362994|NCT02732210|62741680|FG000|Overall Study|Site Closed|0|||
33362995|NCT02732210|62741681|FG001|Overall Study|Site Closed|11|||
33362996|NCT02732210|62741680|FG000|Overall Study|Study Ended|13|||
33475433|NCT04602000|62849983|FG004|Overall Study|Other|4|||
33362997|NCT02732210|62741681|FG001|Overall Study|Study Ended|13|||
33362998|NCT02732210|62741680|FG000|Overall Study|Withdrawal by Subject|28|||
33362999|NCT02732210|62741681|FG001|Overall Study|Withdrawal by Subject|87|||
33363000|NCT02732210|62741680|FG000|Overall Study|Lost to Follow-up|5|||
33475434|NCT04602000|62849979|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
33363001|NCT02732210|62741681|FG001|Overall Study|Lost to Follow-up|57|||
33363002|NCT02732210|62741680|FG000|Overall Study|Death|4|||
33363003|NCT02732210|62741681|FG001|Overall Study|Death|15|||
33475435|NCT04602000|62849980|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
33475436|NCT04602000|62849981|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
33549490|NCT02956967|62940639|FG000|Overall Study|Adverse Event|3|||
33363004|NCT02732210|62741680|FG000|Overall Study|Other|35|||
33363005|NCT02732210|62741681|FG001|Overall Study|Other|103|||
33475437|NCT04602000|62849982|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
33475438|NCT04602000|62849983|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
33475439|NCT03041116|62849999|FG000|Double-blind|Death|0|||
33475440|NCT03041116|62850000|FG001|Double-blind|Death|2|||
33475441|NCT03041116|62849999|FG000|Double-blind|Withdrawal by Subject|0|||
33475442|NCT03041116|62850000|FG001|Double-blind|Withdrawal by Subject|4|||
33475443|NCT03041116|62849999|FG000|Open-label|Death|1|||
33475444|NCT03041116|62850000|FG001|Open-label|Death|0|||
33475445|NCT03041116|62849999|FG000|Open-label|Termination of the study by Sponsor|39|||
33475446|NCT03041116|62850000|FG001|Open-label|Termination of the study by Sponsor|37|||
33475447|NCT03041116|62849999|FG000|Open-label|Withdrawal by Subject|1|||
33475448|NCT03041116|62850000|FG001|Open-label|Withdrawal by Subject|0|||
33475449|NCT04860258|62850017|FG000|Overall Study|Withdrawal by Subject|0|||
33475450|NCT04860258|62850018|FG001|Overall Study|Withdrawal by Subject|0|||
33475451|NCT04860258|62850019|FG002|Overall Study|Withdrawal by Subject|4|||
33475452|NCT04860258|62850020|FG003|Overall Study|Withdrawal by Subject|1|||
33475453|NCT04860258|62850021|FG004|Overall Study|Withdrawal by Subject|4|||
33475454|NCT04860258|62850022|FG005|Overall Study|Withdrawal by Subject|1|||
33475455|NCT04860258|62850023|FG006|Overall Study|Withdrawal by Subject|0|||
33475456|NCT03041038|62850041|FG000|Overall Study|Withdrawal by Subject|4|||
33475457|NCT03041038|62850042|FG001|Overall Study|Withdrawal by Subject|0|||
33475458|NCT03041038|62850041|FG000|Overall Study|Lost to Follow-up|1|||
33475459|NCT03041038|62850042|FG001|Overall Study|Lost to Follow-up|1|||
33475460|NCT03041038|62850041|FG000|Overall Study|Protocol Violation|1|||
33475461|NCT03041038|62850042|FG001|Overall Study|Protocol Violation|1|||
33475462|NCT04382066|62850053|FG000|Overall Study|Adverse Event|1|||
33475463|NCT04382066|62850054|FG001|Overall Study|Adverse Event|0|||
33475464|NCT04382066|62850055|FG002|Overall Study|Adverse Event|0|||
33475465|NCT04382066|62850053|FG000|Overall Study|Death|1|||
33475466|NCT04382066|62850054|FG001|Overall Study|Death|0|||
33475467|NCT04382066|62850055|FG002|Overall Study|Death|1|||
33475468|NCT04435184|62850071|FG000|Overall Study|follow-up blood draws missing|3|||
33475469|NCT04435184|62850072|FG001|Overall Study|follow-up blood draws missing|5|||
33475470|NCT04432376|62850081|FG000|Double-blind Treatment Period|Adverse Event|2|||
33475471|NCT04432376|62850082|FG001|Double-blind Treatment Period|Adverse Event|6|||
33475472|NCT04432376|62850083|FG002|Double-blind Treatment Period|Adverse Event|0|||
33475473|NCT04432376|62850081|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
33475474|NCT04432376|62850082|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
33475475|NCT04432376|62850083|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
33475476|NCT04432376|62850081|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
33475477|NCT04432376|62850082|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
33475478|NCT04432376|62850083|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33475479|NCT04432376|62850081|FG000|Double-blind Treatment Period|Protocol Violation|0|||
33475480|NCT04432376|62850082|FG001|Double-blind Treatment Period|Protocol Violation|1|||
33475481|NCT04432376|62850083|FG002|Double-blind Treatment Period|Protocol Violation|0|||
33475482|NCT04432376|62850081|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
33475483|NCT04432376|62850082|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
33475484|NCT04432376|62850083|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
33549491|NCT02956967|62940639|FG000|Overall Study|Reason non-related to neutropenia|10|||
33549492|NCT02956967|62940639|FG000|Overall Study|Lost to Follow-up|5|||
33549493|NCT02956967|62940639|FG000|Overall Study|Missing|1|||
33549494|NCT02956967|62940639|FG000|Overall Study|Termination of Nivestim administration|29|||
33549495|NCT02867995|62940663|FG000|Overall Study|Withdrawal by Subject|0|||
33549496|NCT02867995|62940664|FG001|Overall Study|Withdrawal by Subject|1|||
33549497|NCT02867995|62940663|FG000|Overall Study|Lost to Follow-up|0|||
33549498|NCT02867995|62940664|FG001|Overall Study|Lost to Follow-up|2|||
33475485|NCT03693404|62850092|FG000|Overall Study|Withdrawal by Subject|1|||
33363006|NCT02732210|62741680|FG000|Overall Study|Missing|0|||
33475486|NCT03693404|62850093|FG001|Overall Study|Withdrawal by Subject|0|||
33475487|NCT03693404|62850092|FG000|Overall Study|Lost to Follow-up|0|||
33549499|NCT03392883|62940677|FG000|Overall Study|Lost to Follow-up|122|||
33363007|NCT02732210|62741681|FG001|Overall Study|Missing|8|||
33475488|NCT03693404|62850093|FG001|Overall Study|Lost to Follow-up|5|||
33475489|NCT03693404|62850092|FG000|Overall Study|Excluded from Analysis|0|||
33475490|NCT03693404|62850093|FG001|Overall Study|Excluded from Analysis|1|||
33363008|NCT00595959|62741687|FG000|Overall Study|Withdrawal by Subject|1|||
33363009|NCT00595959|62741687|FG000|Overall Study|Lost to Follow-up|1|||
33363010|NCT00436748|62741725|FG000|Overall Study|Ineligibility Determined|1|||
33363011|NCT00436748|62741726|FG001|Overall Study|Ineligibility Determined|1|||
33363012|NCT00436748|62741725|FG000|Overall Study|Adverse Event|0|||
33363013|NCT00436748|62741726|FG001|Overall Study|Adverse Event|2|||
33363014|NCT00436748|62741725|FG000|Overall Study|Consent Withdrawn|1|||
33363015|NCT00436748|62741726|FG001|Overall Study|Consent Withdrawn|4|||
33363016|NCT00436748|62741725|FG000|Overall Study|Administrative Decision|1|||
33363017|NCT00436748|62741726|FG001|Overall Study|Administrative Decision|0|||
33363018|NCT00436748|62741725|FG000|Overall Study|Lost to Follow-up|0|||
33363019|NCT00436748|62741726|FG001|Overall Study|Lost to Follow-up|1|||
33363020|NCT00436748|62741725|FG000|Overall Study|Protocol-specified Criteria|5|||
33363021|NCT00436748|62741726|FG001|Overall Study|Protocol-specified Criteria|4|||
33363022|NCT00436748|62741725|FG000|Overall Study|Other|3|||
33363023|NCT00436748|62741726|FG001|Overall Study|Other|0|||
33363024|NCT03342404|62741734|FG000|Overall Study|Withdrawal by Subject|9|||
33363025|NCT03342404|62741735|FG001|Overall Study|Withdrawal by Subject|10|||
33363026|NCT03342404|62741734|FG000|Overall Study|Lack of Efficacy|1|||
33363027|NCT03342404|62741735|FG001|Overall Study|Lack of Efficacy|17|||
33363028|NCT03342404|62741734|FG000|Overall Study|Adverse Event|3|||
33363029|NCT03342404|62741735|FG001|Overall Study|Adverse Event|4|||
33363030|NCT03342404|62741734|FG000|Overall Study|Noncompliance with study drug|1|||
33363031|NCT03342404|62741735|FG001|Overall Study|Noncompliance with study drug|0|||
33363032|NCT03342404|62741734|FG000|Overall Study|Other reasons|1|||
33363033|NCT03342404|62741735|FG001|Overall Study|Other reasons|0|||
33363034|NCT02703272|62741745|FG000|Overall Study|Death|4|||
33363035|NCT02703272|62741746|FG001|Overall Study|Death|9|||
33363036|NCT02703272|62741747|FG002|Overall Study|Death|19|||
33363037|NCT02703272|62741748|FG003|Overall Study|Death|10|||
33363038|NCT02703272|62741745|FG000|Overall Study|Withdrawal by Subject|0|||
33363039|NCT02703272|62741746|FG001|Overall Study|Withdrawal by Subject|0|||
33363040|NCT02703272|62741747|FG002|Overall Study|Withdrawal by Subject|4|||
33363041|NCT02703272|62741748|FG003|Overall Study|Withdrawal by Subject|2|||
33363042|NCT02703272|62741745|FG000|Overall Study|Study Terminated by Sponsor|6|||
33363043|NCT02703272|62741746|FG001|Overall Study|Study Terminated by Sponsor|1|||
33363044|NCT02703272|62741747|FG002|Overall Study|Study Terminated by Sponsor|12|||
33363045|NCT02703272|62741748|FG003|Overall Study|Study Terminated by Sponsor|4|||
33363046|NCT02703272|62741745|FG000|Overall Study|Other|1|||
33363047|NCT02703272|62741746|FG001|Overall Study|Other|0|||
33363048|NCT02703272|62741747|FG002|Overall Study|Other|0|||
33363049|NCT02703272|62741748|FG003|Overall Study|Other|0|||
33363050|NCT02568215|62741788|FG000|Overall Study|Death|1|||
33363051|NCT02568215|62741789|FG001|Overall Study|Death|2|||
33363052|NCT02568215|62741790|FG002|Overall Study|Death|0|||
33363053|NCT02568215|62741788|FG000|Overall Study|Physician Decision|2|||
33363054|NCT02568215|62741789|FG001|Overall Study|Physician Decision|2|||
33363055|NCT02568215|62741790|FG002|Overall Study|Physician Decision|2|||
33363056|NCT02568215|62741788|FG000|Overall Study|Lost to Follow-up|29|||
33363057|NCT02568215|62741789|FG001|Overall Study|Lost to Follow-up|32|||
33363058|NCT02568215|62741790|FG002|Overall Study|Lost to Follow-up|41|||
33363059|NCT02568215|62741788|FG000|Overall Study|Withdrawal by Subject|21|||
33363060|NCT02568215|62741789|FG001|Overall Study|Withdrawal by Subject|19|||
33363061|NCT02568215|62741790|FG002|Overall Study|Withdrawal by Subject|22|||
33363062|NCT02568215|62741788|FG000|Overall Study|Protocol Violation|1|||
33363063|NCT02568215|62741789|FG001|Overall Study|Protocol Violation|1|||
33363064|NCT02568215|62741790|FG002|Overall Study|Protocol Violation|0|||
33363065|NCT02568215|62741788|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
33363066|NCT02568215|62741789|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
33363067|NCT02568215|62741790|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
33363068|NCT02568215|62741788|FG000|Overall Study|Other|0|||
33363069|NCT02568215|62741789|FG001|Overall Study|Other|1|||
33475491|NCT03696108|62850101|FG000|Overall Study|Physician Decision|1|||
33475492|NCT03696108|62850102|FG001|Overall Study|Physician Decision|0|||
33475493|NCT03696108|62850101|FG000|Overall Study|Withdrawal by Subject|3|||
33475494|NCT03696108|62850102|FG001|Overall Study|Withdrawal by Subject|6|||
33475495|NCT04218110|62850112|FG000|Overall Study|Withdrawal by Subject|0|||
33475496|NCT04218110|62850113|FG001|Overall Study|Withdrawal by Subject|0|||
33475497|NCT04218110|62850114|FG002|Overall Study|Withdrawal by Subject|0|||
33475498|NCT04218110|62850115|FG003|Overall Study|Withdrawal by Subject|1|||
33475499|NCT04214600|62850127|FG000|Overall Study|Lost to Follow-up|9|||
33475500|NCT04214600|62850128|FG001|Overall Study|Lost to Follow-up|14|||
33363070|NCT02568215|62741790|FG002|Overall Study|Other|4|||
33363071|NCT00908141|62741827|FG000|Overall Study|Withdrawal by Subject|0|||
33363072|NCT00908141|62741828|FG001|Overall Study|Withdrawal by Subject|1|||
33475501|NCT04210310|62850137|FG000|Overall Study|Lost to Follow-up|32|||
33475502|NCT04210310|62850138|FG001|Overall Study|Lost to Follow-up|1|||
33549500|NCT03392883|62940678|FG001|Overall Study|Lost to Follow-up|13|||
33549501|NCT03392883|62940679|FG002|Overall Study|Lost to Follow-up|9|||
33549502|NCT03392883|62940677|FG000|Overall Study|Death|4|||
33549503|NCT03392883|62940678|FG001|Overall Study|Death|0|||
33549504|NCT03392883|62940679|FG002|Overall Study|Death|0|||
33549505|NCT03392883|62940677|FG000|Overall Study|Lack of Efficacy|29|||
33549506|NCT03392883|62940678|FG001|Overall Study|Lack of Efficacy|0|||
33549507|NCT03392883|62940679|FG002|Overall Study|Lack of Efficacy|0|||
33549508|NCT03392883|62940677|FG000|Overall Study|Withdrawal by Subject|180|||
33549509|NCT03392883|62940678|FG001|Overall Study|Withdrawal by Subject|0|||
33549510|NCT03392883|62940679|FG002|Overall Study|Withdrawal by Subject|0|||
33549511|NCT03392883|62940677|FG000|Overall Study|Adverse Event|1|||
33549512|NCT03392883|62940678|FG001|Overall Study|Adverse Event|0|||
33549513|NCT03392883|62940679|FG002|Overall Study|Adverse Event|0|||
33549514|NCT02748863|62940690|FG000|Treatment Period 1|Adverse Event|0|||
33549515|NCT02748863|62940691|FG001|Treatment Period 1|Adverse Event|1|||
33549516|NCT02748863|62940692|FG002|Treatment Period 1|Adverse Event|0|||
33549517|NCT02748863|62940693|FG003|Treatment Period 1|Adverse Event|0|||
33549518|NCT02748863|62940694|FG004|Treatment Period 1|Adverse Event|0|||
33549519|NCT02748863|62940690|FG000|Treatment Period 1|Lack of Efficacy|0|||
33549520|NCT02748863|62940691|FG001|Treatment Period 1|Lack of Efficacy|0|||
33549521|NCT02748863|62940692|FG002|Treatment Period 1|Lack of Efficacy|1|||
33549522|NCT02748863|62940693|FG003|Treatment Period 1|Lack of Efficacy|0|||
33549523|NCT02748863|62940694|FG004|Treatment Period 1|Lack of Efficacy|0|||
33363073|NCT00906347|62741836|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
33549524|NCT02748863|62940690|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33549525|NCT02748863|62940691|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33363074|NCT00906347|62741837|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
33363075|NCT00906347|62741836|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
33363076|NCT00906347|62741837|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
33475503|NCT04209530|62850146|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
33549526|NCT02748863|62940692|FG002|Treatment Period 1|Withdrawal by Subject|1|||
33549527|NCT02748863|62940693|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33549528|NCT02748863|62940694|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33549529|NCT02748863|62940690|FG000|Treatment Period 2|Lost to Follow-up|2|||
33549530|NCT02748863|62940691|FG001|Treatment Period 2|Lost to Follow-up|0|||
33549531|NCT02748863|62940692|FG002|Treatment Period 2|Lost to Follow-up|0|||
33475504|NCT04209530|62850147|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
33475505|NCT04209530|62850146|FG000|Overall Study|Withdrawal by Subject|0|||
33475506|NCT04209530|62850147|FG001|Overall Study|Withdrawal by Subject|1|||
33363077|NCT00906347|62741836|FG000|Received Study Drug|Refused study drug|1|||
33363078|NCT00906347|62741837|FG001|Received Study Drug|Refused study drug|0|||
33363079|NCT00906347|62741836|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
33363080|NCT00906347|62741837|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
33363081|NCT00906035|62741846|FG000|Overall Study|Withdrawal by Subject|2|||
33363082|NCT00906035|62741847|FG001|Overall Study|Withdrawal by Subject|3|||
33363083|NCT00906035|62741848|FG002|Overall Study|Withdrawal by Subject|0|||
33363084|NCT00905489|62741856|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
33363085|NCT00905489|62741856|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
33363086|NCT00905489|62741856|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
33363087|NCT02704754|62741867|FG000|Overall Study|Lost to Follow-up|1|||
33363088|NCT02704754|62741868|FG001|Overall Study|Lost to Follow-up|1|||
33363089|NCT02704754|62741867|FG000|Overall Study|Lack of Efficacy|1|||
33363090|NCT02704754|62741868|FG001|Overall Study|Lack of Efficacy|0|||
33363091|NCT02704754|62741867|FG000|Overall Study|Withdrawal by Subject|1|||
33363092|NCT02704754|62741868|FG001|Overall Study|Withdrawal by Subject|0|||
33363093|NCT03170882|62741876|FG000|Overall Study|Death|17|||
33363094|NCT03170882|62741877|FG001|Overall Study|Death|29|||
33363095|NCT03170882|62741876|FG000|Overall Study|Lost to Follow-up|0|||
33363096|NCT03170882|62741877|FG001|Overall Study|Lost to Follow-up|1|||
33363097|NCT03170882|62741876|FG000|Overall Study|Withdrawal by Subject|4|||
33363098|NCT03170882|62741877|FG001|Overall Study|Withdrawal by Subject|7|||
33363099|NCT03170882|62741876|FG000|Overall Study|Reason not Specified|28|||
33363100|NCT03170882|62741877|FG001|Overall Study|Reason not Specified|36|||
33363101|NCT00907517|62741888|FG000|Overall Study|Progressive Disease|3|||
33363102|NCT00907517|62741889|FG001|Overall Study|Progressive Disease|3|||
33363103|NCT00907517|62741890|FG002|Overall Study|Progressive Disease|4|||
33363104|NCT00907517|62741891|FG003|Overall Study|Progressive Disease|4|||
33475507|NCT04349098|62850155|FG000|Overall Study|Death|16|||
33475508|NCT04349098|62850156|FG001|Overall Study|Death|8|||
33363105|NCT00907517|62741892|FG004|Overall Study|Progressive Disease|4|||
33363106|NCT00907517|62741888|FG000|Overall Study|Symptomatic Deterioration|0|||
33363107|NCT00907517|62741889|FG001|Overall Study|Symptomatic Deterioration|0|||
33475509|NCT04349098|62850155|FG000|Overall Study|Lost to Follow-up|11|||
33475510|NCT04349098|62850156|FG001|Overall Study|Lost to Follow-up|8|||
33363108|NCT00907517|62741890|FG002|Overall Study|Symptomatic Deterioration|0|||
33363109|NCT00907517|62741891|FG003|Overall Study|Symptomatic Deterioration|0|||
33475511|NCT04349098|62850155|FG000|Overall Study|Withdrawal by Subject|8|||
33475512|NCT04349098|62850156|FG001|Overall Study|Withdrawal by Subject|5|||
33475513|NCT04349098|62850155|FG000|Overall Study|Other|3|||
33475514|NCT04349098|62850156|FG001|Overall Study|Other|5|||
33475515|NCT04208750|62850164|FG000|Overall Study|Lost to Follow-up|16|||
33475516|NCT04208750|62850165|FG001|Overall Study|Lost to Follow-up|15|||
33475517|NCT04381988|62850173|FG000|Overall Study|The study was terminated|4|||
33475518|NCT04381988|62850174|FG001|Overall Study|The study was terminated|0|||
33475519|NCT04333498|62850182|FG000|Overall Study|Lost to Follow-up|1|||
33475520|NCT04333498|62850183|FG001|Overall Study|Lost to Follow-up|0|||
33475521|NCT04333498|62850182|FG000|Overall Study|Lost to Follow-up|0|||
33475522|NCT04333498|62850183|FG001|Overall Study|Lost to Follow-up|1|||
33475523|NCT03355664|62850191|FG000|Overall Study|Adverse Event|1|||
33475524|NCT03355664|62850192|FG001|Overall Study|Adverse Event|2|||
33475525|NCT03355664|62850191|FG000|Overall Study|Lost to Follow-up|11|||
33475526|NCT03355664|62850192|FG001|Overall Study|Lost to Follow-up|7|||
33475527|NCT03355664|62850191|FG000|Overall Study|Protocol Violation|1|||
33475528|NCT03355664|62850192|FG001|Overall Study|Protocol Violation|2|||
33363110|NCT00907517|62741892|FG004|Overall Study|Symptomatic Deterioration|1|||
33363111|NCT00905255|62741906|FG000|Overall Study|Adverse Event|7|||
33363112|NCT00905255|62741907|FG001|Overall Study|Adverse Event|5|||
33475529|NCT03355664|62850191|FG000|Overall Study|Withdrawal by Subject|2|||
33549532|NCT02748863|62940693|FG003|Treatment Period 2|Lost to Follow-up|0|||
33363113|NCT00905255|62741906|FG000|Overall Study|Withdrawal by Subject|5|||
33363114|NCT00905255|62741907|FG001|Overall Study|Withdrawal by Subject|4|||
33363115|NCT00905255|62741906|FG000|Overall Study|Familial and Personal Reasons|1|||
33363116|NCT00905255|62741907|FG001|Overall Study|Familial and Personal Reasons|0|||
33475530|NCT03355664|62850192|FG001|Overall Study|Withdrawal by Subject|1|||
33475531|NCT04170686|62850200|FG000|Screening|Physician Decision|12|||
33475532|NCT04170686|62850201|FG001|Screening|Physician Decision|13|||
33363117|NCT00905021|62741914|FG000|Overall Study|Adverse Event|2|||
33363118|NCT00906971|62741921|FG000|Overall Study|Withdrawal by Subject|8|||
33363119|NCT00906971|62741922|FG001|Overall Study|Withdrawal by Subject|2|||
33363120|NCT00906971|62741921|FG000|Overall Study|Lost to Follow-up|0|||
33363121|NCT00906971|62741922|FG001|Overall Study|Lost to Follow-up|1|||
33363122|NCT00903929|62741928|FG000|Overall Study|Withdrawal by Subject|0|||
33363123|NCT00903929|62741929|FG001|Overall Study|Withdrawal by Subject|0|||
33363124|NCT00903929|62741930|FG002|Overall Study|Withdrawal by Subject|1|||
33363125|NCT00903929|62741931|FG003|Overall Study|Withdrawal by Subject|2|||
33363126|NCT00903929|62741928|FG000|Overall Study|Adverse Event|0|||
33363127|NCT00903929|62741929|FG001|Overall Study|Adverse Event|0|||
33363128|NCT00903929|62741930|FG002|Overall Study|Adverse Event|0|||
33363129|NCT00903929|62741931|FG003|Overall Study|Adverse Event|1|||
33363130|NCT00903695|62741938|FG000|Overall Study|medical exclusion after 1st testing|1|||
33363131|NCT00903695|62741939|FG001|Overall Study|medical exclusion after 1st testing|0|||
33363132|NCT00903695|62741938|FG000|Overall Study|lung cancer|1|||
33363133|NCT00903695|62741939|FG001|Overall Study|lung cancer|0|||
33363134|NCT00903617|62741951|FG000|Overall Study|Adverse Event|0|||
33363135|NCT00903617|62741952|FG001|Overall Study|Adverse Event|1|||
33363136|NCT00903617|62741953|FG002|Overall Study|Adverse Event|1|||
33363137|NCT00903617|62741954|FG003|Overall Study|Adverse Event|0|||
33363138|NCT00903617|62741951|FG000|Overall Study|Protocol-defined stopping criteria|0|||
33363139|NCT00903617|62741952|FG001|Overall Study|Protocol-defined stopping criteria|2|||
33363140|NCT00903617|62741953|FG002|Overall Study|Protocol-defined stopping criteria|0|||
33363141|NCT00903617|62741954|FG003|Overall Study|Protocol-defined stopping criteria|0|||
33363142|NCT00903617|62741951|FG000|Overall Study|Lost to Follow-up|2|||
33363143|NCT00903617|62741952|FG001|Overall Study|Lost to Follow-up|0|||
33363144|NCT00903617|62741953|FG002|Overall Study|Lost to Follow-up|1|||
33363145|NCT00903617|62741954|FG003|Overall Study|Lost to Follow-up|1|||
33363146|NCT00903617|62741951|FG000|Overall Study|Withdrawal by Subject|1|||
33363147|NCT00903617|62741952|FG001|Overall Study|Withdrawal by Subject|2|||
33363148|NCT00903617|62741953|FG002|Overall Study|Withdrawal by Subject|3|||
33363149|NCT00903617|62741954|FG003|Overall Study|Withdrawal by Subject|0|||
33363150|NCT00903383|62741969|FG000|Overall Study|Adverse Event|1|||
33363151|NCT00903383|62741970|FG001|Overall Study|Adverse Event|2|||
33363152|NCT00903383|62741971|FG002|Overall Study|Adverse Event|3|||
33363153|NCT00903383|62741972|FG003|Overall Study|Adverse Event|1|||
33363154|NCT00903383|62741969|FG000|Overall Study|Physician Decision|1|||
33363155|NCT00903383|62741970|FG001|Overall Study|Physician Decision|2|||
33363156|NCT00903383|62741971|FG002|Overall Study|Physician Decision|0|||
33363157|NCT00903383|62741972|FG003|Overall Study|Physician Decision|0|||
33363158|NCT00903383|62741969|FG000|Overall Study|Lost to Follow-up|0|||
33363159|NCT00903383|62741970|FG001|Overall Study|Lost to Follow-up|0|||
33363160|NCT00903383|62741971|FG002|Overall Study|Lost to Follow-up|0|||
33363161|NCT00903383|62741972|FG003|Overall Study|Lost to Follow-up|1|||
33363162|NCT00903383|62741969|FG000|Overall Study|Decision of Sponsor|1|||
33363163|NCT00903383|62741970|FG001|Overall Study|Decision of Sponsor|0|||
33475533|NCT04170686|62850200|FG000|Randomization and Treatment|Lost to Follow-up|26|||
33475534|NCT04170686|62850201|FG001|Randomization and Treatment|Lost to Follow-up|15|||
33475535|NCT03695094|62850209|FG000|Overall Study|Adverse Event|1|||
33475536|NCT03695094|62850210|FG001|Overall Study|Adverse Event|1|||
33475537|NCT03695094|62850209|FG000|Overall Study|Withdrawal by Subject|1|||
33475538|NCT03695094|62850210|FG001|Overall Study|Withdrawal by Subject|0|||
33475539|NCT04497948|62850218|FG000|Overall Study|Death|2|||
33475540|NCT04495374|62850228|FG000|Overall Study|Protocol Violation|2|||
33475541|NCT04495374|62850229|FG001|Overall Study|Protocol Violation|1|||
33655697|NCT04604184|63072702|FG001|Overall Study|Not treated|2|||
33655698|NCT04604184|63072701|FG000|Overall Study|Due to sponsor decision|9|||
33655699|NCT04604184|63072702|FG001|Overall Study|Due to sponsor decision|7|||
33655700|NCT04604184|63072701|FG000|Overall Study|Physician Decision|0|||
33655701|NCT04604184|63072702|FG001|Overall Study|Physician Decision|1|||
33655702|NCT04604184|63072701|FG000|Overall Study|Transfer to healthcare|1|||
33363164|NCT00903383|62741971|FG002|Overall Study|Decision of Sponsor|0|||
33363165|NCT00903383|62741972|FG003|Overall Study|Decision of Sponsor|0|||
33363166|NCT00903383|62741969|FG000|Overall Study|Withdrawal by Subject|4|||
33363167|NCT00903383|62741970|FG001|Overall Study|Withdrawal by Subject|1|||
33475542|NCT04794270|62850235|FG000|Period 1|Non Compliance|1|||
33475543|NCT04794270|62850236|FG001|Period 1|Non Compliance|0|||
33475544|NCT04794270|62850235|FG000|Period 1|Adverse Event|1|||
33655703|NCT04604184|63072702|FG001|Overall Study|Transfer to healthcare|0|||
33363168|NCT00903383|62741971|FG002|Overall Study|Withdrawal by Subject|0|||
33363169|NCT00903383|62741972|FG003|Overall Study|Withdrawal by Subject|2|||
33363170|NCT00903383|62741969|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
33363171|NCT00903383|62741970|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
33363172|NCT00903383|62741971|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
33363173|NCT00903383|62741972|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
33475545|NCT04794270|62850236|FG001|Period 1|Adverse Event|0|||
33475546|NCT04794270|62850235|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
33363174|NCT00903383|62741969|FG000|Overall Study|Patient Decision|0|||
33363175|NCT00903383|62741970|FG001|Overall Study|Patient Decision|0|||
33363176|NCT00903383|62741971|FG002|Overall Study|Patient Decision|0|||
33363177|NCT00903383|62741972|FG003|Overall Study|Patient Decision|1|||
33363178|NCT02314026|62741982|FG000|Overall Study|Protocol Violation|28|||
33363179|NCT01617096|62741992|FG000|Overall Study|Withdrawal by Subject|96|||
33363180|NCT01617096|62741993|FG001|Overall Study|Withdrawal by Subject|81|||
33363181|NCT01617096|62741992|FG000|Overall Study|Lost to Follow-up|37|||
33475547|NCT04794270|62850236|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
33475548|NCT04567186|62850242|FG000|Period 1|COVID-19 related|1|||
33363182|NCT01617096|62741993|FG001|Overall Study|Lost to Follow-up|32|||
33363183|NCT01617096|62741992|FG000|Overall Study|Physician Decision|10|||
33363184|NCT01617096|62741993|FG001|Overall Study|Physician Decision|18|||
33363185|NCT01617096|62741992|FG000|Overall Study|Death|4|||
33363186|NCT01617096|62741993|FG001|Overall Study|Death|3|||
33363187|NCT01617096|62741992|FG000|Overall Study|Other|1|||
33363188|NCT01617096|62741993|FG001|Overall Study|Other|3|||
33363189|NCT00900731|62742022|FG000|Overall Study|Adverse Event|31|||
33475549|NCT04567186|62850243|FG001|Period 1|COVID-19 related|0|||
33475550|NCT04567186|62850242|FG000|Period 1|Protocol Violation|0|||
33475551|NCT04567186|62850243|FG001|Period 1|Protocol Violation|1|||
33475552|NCT04567186|62850242|FG000|Period 1|Adverse Event|0|||
33475553|NCT04567186|62850243|FG001|Period 1|Adverse Event|2|||
33475554|NCT04567186|62850242|FG000|Period 2|COVID-19 Related|0|||
33475555|NCT04567186|62850243|FG001|Period 2|COVID-19 Related|1|||
33475556|NCT04567186|62850242|FG000|Period 2|Protocol Violation|0|||
33475557|NCT04567186|62850243|FG001|Period 2|Protocol Violation|1|||
33475558|NCT04567186|62850242|FG000|Period 2|Lost to Follow-up|0|||
33475559|NCT04567186|62850243|FG001|Period 2|Lost to Follow-up|1|||
33475560|NCT04567186|62850242|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
33475561|NCT04567186|62850243|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
33475562|NCT04168190|62850254|FG000|Overall Study|Lost to Follow-up|0|||
33475563|NCT04168190|62850255|FG001|Overall Study|Lost to Follow-up|1|||
33475564|NCT04168190|62850256|FG002|Overall Study|Lost to Follow-up|0|||
33475565|NCT04168190|62850257|FG003|Overall Study|Lost to Follow-up|7|||
33475566|NCT04168190|62850258|FG004|Overall Study|Lost to Follow-up|5|||
33475567|NCT04168190|62850254|FG000|Overall Study|Withdrawal by Subject|1|||
33475568|NCT04168190|62850255|FG001|Overall Study|Withdrawal by Subject|0|||
33475569|NCT04168190|62850256|FG002|Overall Study|Withdrawal by Subject|0|||
33475570|NCT04168190|62850257|FG003|Overall Study|Withdrawal by Subject|2|||
33475571|NCT04168190|62850258|FG004|Overall Study|Withdrawal by Subject|4|||
33655704|NCT01859741|63072873|FG000|Overall Study|Death|3|||
33363190|NCT00900731|62742023|FG001|Overall Study|Adverse Event|27|||
33363191|NCT00900731|62742022|FG000|Overall Study|Withdrawal by Subject|8|||
33363192|NCT00900731|62742023|FG001|Overall Study|Withdrawal by Subject|7|||
33363193|NCT00900731|62742022|FG000|Overall Study|Protocol Deviation|8|||
33363194|NCT00900731|62742023|FG001|Overall Study|Protocol Deviation|11|||
33363195|NCT00900731|62742022|FG000|Overall Study|Administrative Problems|5|||
33363196|NCT00900731|62742023|FG001|Overall Study|Administrative Problems|4|||
33363197|NCT00900731|62742022|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
33363198|NCT00900731|62742023|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
33363199|NCT00900731|62742022|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
33363200|NCT00900731|62742023|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
33363201|NCT00900731|62742022|FG000|Overall Study|Lost to Follow-up|2|||
33363202|NCT00900731|62742023|FG001|Overall Study|Lost to Follow-up|3|||
33363203|NCT00900731|62742022|FG000|Overall Study|Lack of Efficacy|1|||
33363204|NCT00900731|62742023|FG001|Overall Study|Lack of Efficacy|3|||
33363205|NCT00900731|62742022|FG000|Overall Study|Death|0|||
33363206|NCT00900731|62742023|FG001|Overall Study|Death|2|||
33363207|NCT03842436|62742029|FG000|Overall Study|Lost to Follow-up|1|||
33475572|NCT04168190|62850254|FG000|Overall Study|Death|0|||
33475573|NCT04168190|62850255|FG001|Overall Study|Death|0|||
33475574|NCT04168190|62850256|FG002|Overall Study|Death|0|||
33475575|NCT04168190|62850257|FG003|Overall Study|Death|1|||
33475576|NCT04168190|62850258|FG004|Overall Study|Death|0|||
33475577|NCT04476108|62850272|FG000|Overall Study|Adverse Event|4|||
33475578|NCT04476108|62850273|FG001|Overall Study|Adverse Event|1|||
33363208|NCT00602472|62742069|FG000|Overall Study|Adverse Event|5|||
33363209|NCT00602472|62742070|FG001|Overall Study|Adverse Event|23|||
33363210|NCT00602472|62742069|FG000|Overall Study|Protocol Violation|4|||
33363211|NCT00602472|62742070|FG001|Overall Study|Protocol Violation|19|||
33363212|NCT00602472|62742069|FG000|Overall Study|Withdrawal by Subject|8|||
33363213|NCT00602472|62742070|FG001|Overall Study|Withdrawal by Subject|14|||
33475579|NCT04476108|62850272|FG000|Overall Study|Lost to Follow-up|1|||
33475580|NCT04476108|62850273|FG001|Overall Study|Lost to Follow-up|0|||
33363214|NCT00602472|62742069|FG000|Overall Study|Other incl. lack of efficacy|4|||
33363215|NCT00602472|62742070|FG001|Overall Study|Other incl. lack of efficacy|2|||
33363216|NCT00901901|62742105|FG000|Treatment Period|Adverse Event|120|||
33363217|NCT00901901|62742106|FG001|Treatment Period|Adverse Event|128|||
33475581|NCT04476108|62850272|FG000|Overall Study|Inadvertent Enrollment|1|||
33363218|NCT00901901|62742105|FG000|Treatment Period|Withdrawal by Subject|26|||
33363219|NCT00901901|62742106|FG001|Treatment Period|Withdrawal by Subject|24|||
33363220|NCT00901901|62742105|FG000|Treatment Period|Physician Decision|2|||
33363221|NCT00901901|62742106|FG001|Treatment Period|Physician Decision|2|||
33363222|NCT00901901|62742105|FG000|Treatment Period|Lost to Follow-up|3|||
33363223|NCT00901901|62742106|FG001|Treatment Period|Lost to Follow-up|5|||
33363224|NCT00901901|62742105|FG000|Treatment Period|Noncompliance with study medication|4|||
33363225|NCT00901901|62742106|FG001|Treatment Period|Noncompliance with study medication|1|||
33363226|NCT00901901|62742105|FG000|Treatment Period|Missing|1|||
33363227|NCT00901901|62742106|FG001|Treatment Period|Missing|0|||
33363228|NCT00901901|62742105|FG000|Treatment Period|Never treated|0|||
33363229|NCT00901901|62742106|FG001|Treatment Period|Never treated|3|||
33363230|NCT00901901|62742105|FG000|Treatment Period|Protocol driven decision point|0|||
33363231|NCT00901901|62742106|FG001|Treatment Period|Protocol driven decision point|2|||
33363232|NCT00901901|62742105|FG000|Treatment Period|Study terminated by sponsor|2|||
33363233|NCT00901901|62742106|FG001|Treatment Period|Study terminated by sponsor|0|||
33363234|NCT00901901|62742105|FG000|Treatment Period|Protocol Violation|5|||
33363235|NCT00901901|62742106|FG001|Treatment Period|Protocol Violation|9|||
33363236|NCT00901901|62742105|FG000|Treatment Period|Switch to commercial drug|1|||
33363237|NCT00901901|62742106|FG001|Treatment Period|Switch to commercial drug|1|||
33363238|NCT00901901|62742105|FG000|Treatment Period|Transfer to treatment continuation study|5|||
33363239|NCT00901901|62742106|FG001|Treatment Period|Transfer to treatment continuation study|2|||
33363240|NCT00901901|62742105|FG000|Follow-up Period|Death|181|||
33363241|NCT00901901|62742106|FG001|Follow-up Period|Death|208|||
33363242|NCT00901901|62742105|FG000|Follow-up Period|Protocol driven decision point|47|||
33363243|NCT00901901|62742106|FG001|Follow-up Period|Protocol driven decision point|36|||
33363244|NCT00901901|62742105|FG000|Follow-up Period|Withdrawal by Subject|6|||
33363245|NCT00901901|62742106|FG001|Follow-up Period|Withdrawal by Subject|9|||
33363246|NCT00901901|62742105|FG000|Follow-up Period|Lost to Follow-up|12|||
33363247|NCT00901901|62742106|FG001|Follow-up Period|Lost to Follow-up|8|||
33363248|NCT00901901|62742105|FG000|Follow-up Period|Missing|94|||
33363249|NCT00901901|62742106|FG001|Follow-up Period|Missing|80|||
33363250|NCT02143778|62742114|FG000|Overall Study|Withdrawal by Subject|2|||
33363251|NCT02143778|62742114|FG000|Overall Study|Device malfunction|1|||
33363252|NCT00896363|62742158|FG000|Overall Study|Adverse Event|3|||
33363253|NCT00896363|62742159|FG001|Overall Study|Adverse Event|4|||
33363254|NCT00896363|62742160|FG002|Overall Study|Adverse Event|2|||
33363255|NCT00896363|62742158|FG000|Overall Study|Lack of Efficacy|0|||
33363256|NCT00896363|62742159|FG001|Overall Study|Lack of Efficacy|2|||
33363257|NCT00896363|62742160|FG002|Overall Study|Lack of Efficacy|1|||
33363258|NCT00896363|62742158|FG000|Overall Study|Withdrawal by Subject|3|||
33363259|NCT00896363|62742159|FG001|Overall Study|Withdrawal by Subject|5|||
33363260|NCT00896363|62742160|FG002|Overall Study|Withdrawal by Subject|5|||
33363261|NCT00900029|62742176|FG000|Overall Study|Lost to Follow-up|0|||
33363262|NCT00900029|62742177|FG001|Overall Study|Lost to Follow-up|2|||
33363263|NCT00900029|62742178|FG002|Overall Study|Lost to Follow-up|1|||
33363264|NCT00900029|62742179|FG003|Overall Study|Lost to Follow-up|4|||
33363265|NCT00900029|62742180|FG004|Overall Study|Lost to Follow-up|4|||
33363266|NCT00900029|62742176|FG000|Overall Study|Withdrawal by Subject|2|||
33363267|NCT00900029|62742177|FG001|Overall Study|Withdrawal by Subject|2|||
33363268|NCT00900029|62742178|FG002|Overall Study|Withdrawal by Subject|1|||
33363269|NCT00900029|62742179|FG003|Overall Study|Withdrawal by Subject|1|||
33363270|NCT00900029|62742180|FG004|Overall Study|Withdrawal by Subject|1|||
33363271|NCT00900029|62742176|FG000|Overall Study|Adverse Event|0|||
33363272|NCT00900029|62742177|FG001|Overall Study|Adverse Event|0|||
33363273|NCT00900029|62742178|FG002|Overall Study|Adverse Event|1|||
33363274|NCT00900029|62742179|FG003|Overall Study|Adverse Event|1|||
33363275|NCT00900029|62742180|FG004|Overall Study|Adverse Event|1|||
33363276|NCT00900029|62742176|FG000|Overall Study|Death|1|||
33363277|NCT00900029|62742177|FG001|Overall Study|Death|0|||
33363278|NCT00900029|62742178|FG002|Overall Study|Death|0|||
33363279|NCT00900029|62742179|FG003|Overall Study|Death|1|||
33363280|NCT00900029|62742180|FG004|Overall Study|Death|0|||
33363281|NCT00896051|62742198|FG000|Overall Study|Adverse Event|2|||
33363282|NCT00896051|62742199|FG001|Overall Study|Adverse Event|1|||
33363283|NCT00896051|62742198|FG000|Overall Study|Lost to Follow-up|3|||
33363284|NCT00896051|62742199|FG001|Overall Study|Lost to Follow-up|2|||
33363285|NCT00896051|62742198|FG000|Overall Study|Withdrawal by Subject|3|||
33363286|NCT00896051|62742199|FG001|Overall Study|Withdrawal by Subject|2|||
33363287|NCT00896051|62742198|FG000|Overall Study|Subject noncompliant|1|||
33363288|NCT00896051|62742199|FG001|Overall Study|Subject noncompliant|3|||
33363289|NCT00896051|62742198|FG000|Overall Study|Other|1|||
33363290|NCT00896051|62742199|FG001|Overall Study|Other|1|||
33363291|NCT00894647|62742216|FG000|Overall Study|Adverse Event|5|||
33363292|NCT00894647|62742217|FG001|Overall Study|Adverse Event|4|||
33363293|NCT00894647|62742216|FG000|Overall Study|Withdrawal by Subject|4|||
33363294|NCT00894647|62742217|FG001|Overall Study|Withdrawal by Subject|4|||
33363295|NCT00894647|62742216|FG000|Overall Study|Lost to Follow-up|0|||
33363296|NCT00894647|62742217|FG001|Overall Study|Lost to Follow-up|2|||
33363297|NCT00894647|62742216|FG000|Overall Study|Non-compliance with study procedures|0|||
33363298|NCT00894647|62742217|FG001|Overall Study|Non-compliance with study procedures|2|||
33363299|NCT00894647|62742216|FG000|Overall Study|Other, not due to AE|1|||
33363300|NCT00894647|62742217|FG001|Overall Study|Other, not due to AE|2|||
33363301|NCT00892775|62742225|FG000|Overall Study|Protocol Violation|1|||
33363302|NCT00892775|62742226|FG001|Overall Study|Protocol Violation|0|||
33363303|NCT00892775|62742225|FG000|Overall Study|Subject difficulties with blood drawing|1|||
33363304|NCT00892775|62742226|FG001|Overall Study|Subject difficulties with blood drawing|0|||
33363305|NCT00892775|62742225|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
33363306|NCT00892775|62742226|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
33363307|NCT00892775|62742225|FG000|Overall Study|Migrated/ moved from study area|1|||
33363308|NCT00892775|62742226|FG001|Overall Study|Migrated/ moved from study area|0|||
33363309|NCT00892775|62742225|FG000|Overall Study|Withdrawal by Subject|0|||
33363310|NCT00892775|62742226|FG001|Overall Study|Withdrawal by Subject|1|||
33363311|NCT00892775|62742225|FG000|Overall Study|Lost to Follow-up|1|||
33363312|NCT00892775|62742226|FG001|Overall Study|Lost to Follow-up|0|||
33363313|NCT00895895|62742237|FG000|Period 1|Adverse Event|7|||
33363314|NCT00895895|62742238|FG001|Period 1|Adverse Event|6|||
33363315|NCT00895895|62742239|FG002|Period 1|Adverse Event|4|||
33363316|NCT00895895|62742240|FG003|Period 1|Adverse Event|6|||
33363317|NCT00895895|62742241|FG004|Period 1|Adverse Event|7|||
33363318|NCT00895895|62742237|FG000|Period 1|Death|0|||
33363319|NCT00895895|62742238|FG001|Period 1|Death|0|||
33363320|NCT00895895|62742239|FG002|Period 1|Death|0|||
33363321|NCT00895895|62742240|FG003|Period 1|Death|0|||
33363322|NCT00895895|62742241|FG004|Period 1|Death|1|||
33363323|NCT00895895|62742237|FG000|Period 1|discontinued by sponsor|2|||
33363324|NCT00895895|62742238|FG001|Period 1|discontinued by sponsor|1|||
33363325|NCT00895895|62742239|FG002|Period 1|discontinued by sponsor|2|||
33363326|NCT00895895|62742240|FG003|Period 1|discontinued by sponsor|1|||
33363327|NCT00895895|62742241|FG004|Period 1|discontinued by sponsor|1|||
33363328|NCT00895895|62742237|FG000|Period 1|failed to return|0|||
33363329|NCT00895895|62742238|FG001|Period 1|failed to return|0|||
33363330|NCT00895895|62742239|FG002|Period 1|failed to return|1|||
33363331|NCT00895895|62742240|FG003|Period 1|failed to return|0|||
33475582|NCT04476108|62850273|FG001|Overall Study|Inadvertent Enrollment|0|||
33475583|NCT04476108|62850272|FG000|Overall Study|Protocol Violation|1|||
33475584|NCT04476108|62850273|FG001|Overall Study|Protocol Violation|1|||
33475585|NCT04476108|62850272|FG000|Overall Study|Withdrawal by Subject|1|||
33475586|NCT04476108|62850273|FG001|Overall Study|Withdrawal by Subject|1|||
33475587|NCT03529942|62850279|FG000|Overall Study|Withdrawal by Subject|13|||
33475588|NCT03529942|62850279|FG000|Overall Study|Physician Decision|1|||
33363332|NCT00895895|62742241|FG004|Period 1|failed to return|1|||
33363333|NCT00895895|62742237|FG000|Period 1|investigator request|0|||
33363334|NCT00895895|62742238|FG001|Period 1|investigator request|1|||
33363335|NCT00895895|62742239|FG002|Period 1|investigator request|0|||
33363336|NCT00895895|62742240|FG003|Period 1|investigator request|0|||
33363337|NCT00895895|62742241|FG004|Period 1|investigator request|0|||
33475589|NCT03529942|62850279|FG000|Overall Study|Lost to Follow-up|7|||
33475590|NCT03529942|62850279|FG000|Overall Study|Needle inserted but no drug administered|1|||
33363338|NCT00895895|62742237|FG000|Period 1|Lost to Follow-up|2|||
33363339|NCT00895895|62742238|FG001|Period 1|Lost to Follow-up|1|||
33363340|NCT00895895|62742239|FG002|Period 1|Lost to Follow-up|3|||
33363341|NCT00895895|62742240|FG003|Period 1|Lost to Follow-up|2|||
33363342|NCT00895895|62742241|FG004|Period 1|Lost to Follow-up|3|||
33363343|NCT00895895|62742237|FG000|Period 1|Other|1|||
33363344|NCT00895895|62742238|FG001|Period 1|Other|2|||
33363345|NCT00895895|62742239|FG002|Period 1|Other|1|||
33363346|NCT00895895|62742240|FG003|Period 1|Other|1|||
33363347|NCT00895895|62742241|FG004|Period 1|Other|1|||
33363348|NCT00895895|62742237|FG000|Period 1|Protocol Violation|0|||
33363349|NCT00895895|62742238|FG001|Period 1|Protocol Violation|1|||
33363350|NCT00895895|62742239|FG002|Period 1|Protocol Violation|0|||
33363351|NCT00895895|62742240|FG003|Period 1|Protocol Violation|0|||
33363352|NCT00895895|62742241|FG004|Period 1|Protocol Violation|0|||
33363353|NCT00895895|62742237|FG000|Period 1|Withdrawal by Subject|6|||
33363354|NCT00895895|62742238|FG001|Period 1|Withdrawal by Subject|6|||
33363355|NCT00895895|62742239|FG002|Period 1|Withdrawal by Subject|8|||
33363356|NCT00895895|62742240|FG003|Period 1|Withdrawal by Subject|2|||
33363357|NCT00895895|62742241|FG004|Period 1|Withdrawal by Subject|4|||
33363358|NCT00895895|62742237|FG000|Period 1|unsatisfactory response-efficacy|2|||
33363359|NCT00895895|62742238|FG001|Period 1|unsatisfactory response-efficacy|0|||
33363360|NCT00895895|62742239|FG002|Period 1|unsatisfactory response-efficacy|0|||
33363361|NCT00895895|62742240|FG003|Period 1|unsatisfactory response-efficacy|0|||
33363362|NCT00895895|62742241|FG004|Period 1|unsatisfactory response-efficacy|0|||
33363363|NCT00895895|62742237|FG000|Period 1|randomized and not treated|1|||
33363364|NCT00895895|62742238|FG001|Period 1|randomized and not treated|3|||
33363365|NCT00895895|62742239|FG002|Period 1|randomized and not treated|1|||
33363366|NCT00895895|62742240|FG003|Period 1|randomized and not treated|1|||
33363367|NCT00895895|62742241|FG004|Period 1|randomized and not treated|2|||
33363368|NCT00895895|62742237|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
33363369|NCT00895895|62742238|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
33363370|NCT00895895|62742239|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
33363371|NCT00895895|62742240|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
33363372|NCT00895895|62742241|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
33363373|NCT00895895|62742237|FG000|After Period 1, Prior to Period 2|Other|0|||
33363374|NCT00895895|62742238|FG001|After Period 1, Prior to Period 2|Other|0|||
33363375|NCT00895895|62742239|FG002|After Period 1, Prior to Period 2|Other|1|||
33363376|NCT00895895|62742240|FG003|After Period 1, Prior to Period 2|Other|0|||
33363377|NCT00895895|62742241|FG004|After Period 1, Prior to Period 2|Other|0|||
33363378|NCT00895895|62742237|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
33363379|NCT00895895|62742238|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
33363380|NCT00895895|62742239|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
33363381|NCT00895895|62742240|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
33363382|NCT00895895|62742241|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
33363383|NCT00895895|62742237|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
33363384|NCT00895895|62742238|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
33363385|NCT00895895|62742239|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
33363386|NCT00895895|62742240|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
33363387|NCT00895895|62742241|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
33363388|NCT00895895|62742237|FG000|Period 2|Adverse Event|3|||
33363389|NCT00895895|62742238|FG001|Period 2|Adverse Event|3|||
33363390|NCT00895895|62742239|FG002|Period 2|Adverse Event|5|||
33363391|NCT00895895|62742240|FG003|Period 2|Adverse Event|2|||
33363392|NCT00895895|62742241|FG004|Period 2|Adverse Event|5|||
33363393|NCT00895895|62742237|FG000|Period 2|Death|0|||
33363394|NCT00895895|62742238|FG001|Period 2|Death|0|||
33363395|NCT00895895|62742239|FG002|Period 2|Death|1|||
33363396|NCT00895895|62742240|FG003|Period 2|Death|0|||
33363397|NCT00895895|62742241|FG004|Period 2|Death|0|||
33363398|NCT00895895|62742237|FG000|Period 2|discontinued by sponsor|44|||
33363399|NCT00895895|62742238|FG001|Period 2|discontinued by sponsor|44|||
33363400|NCT00895895|62742239|FG002|Period 2|discontinued by sponsor|38|||
33363401|NCT00895895|62742240|FG003|Period 2|discontinued by sponsor|46|||
33363402|NCT00895895|62742241|FG004|Period 2|discontinued by sponsor|37|||
33363403|NCT00895895|62742237|FG000|Period 2|failed to return|2|||
33363404|NCT00895895|62742238|FG001|Period 2|failed to return|0|||
33363405|NCT00895895|62742239|FG002|Period 2|failed to return|0|||
33363406|NCT00895895|62742240|FG003|Period 2|failed to return|0|||
33363407|NCT00895895|62742241|FG004|Period 2|failed to return|0|||
33475591|NCT03529942|62850279|FG000|Overall Study|Personal reasons|1|||
33475592|NCT04732338|62850288|FG000|Overall Study|Lost to Follow-up|3|||
33475593|NCT04732338|62850289|FG001|Overall Study|Lost to Follow-up|3|||
33475594|NCT04194008|62850295|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
33475595|NCT04194008|62850295|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
33363408|NCT00895895|62742237|FG000|Period 2|investigator request|2|||
33363409|NCT00895895|62742238|FG001|Period 2|investigator request|0|||
33363410|NCT00895895|62742239|FG002|Period 2|investigator request|0|||
33363411|NCT00895895|62742240|FG003|Period 2|investigator request|0|||
33363412|NCT00895895|62742241|FG004|Period 2|investigator request|0|||
33363413|NCT00895895|62742237|FG000|Period 2|Lost to Follow-up|1|||
33363414|NCT00895895|62742238|FG001|Period 2|Lost to Follow-up|2|||
33363415|NCT00895895|62742239|FG002|Period 2|Lost to Follow-up|1|||
33363416|NCT00895895|62742240|FG003|Period 2|Lost to Follow-up|1|||
33363417|NCT00895895|62742241|FG004|Period 2|Lost to Follow-up|0|||
33363418|NCT00895895|62742237|FG000|Period 2|Other|1|||
33363419|NCT00895895|62742238|FG001|Period 2|Other|1|||
33363420|NCT00895895|62742239|FG002|Period 2|Other|3|||
33363421|NCT00895895|62742240|FG003|Period 2|Other|1|||
33363422|NCT00895895|62742241|FG004|Period 2|Other|1|||
33363423|NCT00895895|62742237|FG000|Period 2|Protocol Violation|1|||
33363424|NCT00895895|62742238|FG001|Period 2|Protocol Violation|0|||
33363425|NCT00895895|62742239|FG002|Period 2|Protocol Violation|1|||
33363426|NCT00895895|62742240|FG003|Period 2|Protocol Violation|1|||
33363427|NCT00895895|62742241|FG004|Period 2|Protocol Violation|1|||
33363428|NCT00895895|62742237|FG000|Period 2|Withdrawal by Subject|0|||
33363429|NCT00895895|62742238|FG001|Period 2|Withdrawal by Subject|2|||
33363430|NCT00895895|62742239|FG002|Period 2|Withdrawal by Subject|0|||
33363431|NCT00895895|62742240|FG003|Period 2|Withdrawal by Subject|3|||
33363432|NCT00895895|62742241|FG004|Period 2|Withdrawal by Subject|5|||
33363433|NCT00895895|62742237|FG000|Period 2|unsatisfactory response-efficacy|2|||
33363434|NCT00895895|62742238|FG001|Period 2|unsatisfactory response-efficacy|1|||
33363435|NCT00895895|62742239|FG002|Period 2|unsatisfactory response-efficacy|0|||
33363436|NCT00895895|62742240|FG003|Period 2|unsatisfactory response-efficacy|0|||
33363437|NCT00895895|62742241|FG004|Period 2|unsatisfactory response-efficacy|0|||
33363438|NCT00895661|62742259|FG000|Overall Study|Death|1|||
33363439|NCT00895661|62742259|FG000|Overall Study|reason unknown|2|||
33363440|NCT00895583|62742265|FG000|Overall Study|Adverse Event|28|||
33363441|NCT00895583|62742266|FG001|Overall Study|Adverse Event|4|||
33363442|NCT00895583|62742265|FG000|Overall Study|Death|2|||
33363443|NCT00895583|62742266|FG001|Overall Study|Death|1|||
33363444|NCT00895583|62742265|FG000|Overall Study|Physician Decision|3|||
33363445|NCT00895583|62742266|FG001|Overall Study|Physician Decision|1|||
33363446|NCT00895583|62742265|FG000|Overall Study|Lost to Follow-up|1|||
33363447|NCT00895583|62742266|FG001|Overall Study|Lost to Follow-up|3|||
33363448|NCT00895583|62742265|FG000|Overall Study|Protocol Violation|1|||
33363449|NCT00895583|62742266|FG001|Overall Study|Protocol Violation|0|||
33363450|NCT00895583|62742265|FG000|Overall Study|Withdrawal by Subject|4|||
33363451|NCT00895583|62742266|FG001|Overall Study|Withdrawal by Subject|2|||
33363452|NCT00895583|62742265|FG000|Overall Study|Lack of Efficacy|5|||
33363453|NCT00895583|62742266|FG001|Overall Study|Lack of Efficacy|0|||
33363454|NCT00895583|62742265|FG000|Overall Study|Other|0|||
33363455|NCT00895583|62742266|FG001|Overall Study|Other|1|||
33363456|NCT00894413|62742283|FG000|Overall Study|Physician Decision|0|||
33363457|NCT00894413|62742284|FG001|Overall Study|Physician Decision|2|||
33363458|NCT00894413|62742283|FG000|Overall Study|Adverse Event|0|||
33363459|NCT00894413|62742284|FG001|Overall Study|Adverse Event|2|||
33363460|NCT00894413|62742283|FG000|Overall Study|Withdrawal by Subject|0|||
33363461|NCT00894413|62742284|FG001|Overall Study|Withdrawal by Subject|4|||
33363462|NCT00895037|62742293|FG000|Overall Study|Death|0|||
33363463|NCT00895037|62742294|FG001|Overall Study|Death|2|||
33363464|NCT00895037|62742295|FG002|Overall Study|Death|1|||
33363465|NCT00892151|62742303|FG000|Overall Study|Protocol Violation|1|||
33363466|NCT01706705|62742307|FG000|Overall Study|Death|1|||
33363467|NCT01706705|62742307|FG000|Overall Study|Lack of Efficacy|13|||
33363468|NCT01706705|62742307|FG000|Overall Study|Non-clinical|6|||
33363469|NCT00894803|62742323|FG000|Overall Study|Death|20|||
33363470|NCT00894803|62742324|FG001|Overall Study|Death|4|||
33363471|NCT00894803|62742323|FG000|Overall Study|Lost to Follow-up|0|||
33363472|NCT00894803|62742324|FG001|Overall Study|Lost to Follow-up|1|||
33363473|NCT00601458|62742333|FG000|Overall Study|Dosing Error|1|||
33363474|NCT00601458|62742334|FG001|Overall Study|Dosing Error|0|||
33363475|NCT00601458|62742335|FG002|Overall Study|Dosing Error|0|||
33363476|NCT00601458|62742333|FG000|Overall Study|Incomplete Data|0|||
33363477|NCT00601458|62742334|FG001|Overall Study|Incomplete Data|2|||
33363478|NCT00601458|62742335|FG002|Overall Study|Incomplete Data|0|||
33475596|NCT04194008|62850295|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
33475597|NCT04194008|62850295|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
33475598|NCT04194008|62850295|FG000|Treatment Phase With Nerivio|Missing data|4|||
33475599|NCT04194008|62850295|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
33475600|NCT04189952|62850308|FG000|Follow-up Period|Death|1|||
33363479|NCT00601458|62742333|FG000|Overall Study|Protocol Violation|3|||
33363480|NCT00601458|62742334|FG001|Overall Study|Protocol Violation|2|||
33363481|NCT00601458|62742335|FG002|Overall Study|Protocol Violation|1|||
33363482|NCT00601458|62742333|FG000|Overall Study|Early Termination|0|||
33475601|NCT04189952|62850308|FG000|Follow-up Period|Withdrawal by Subject|1|||
33475602|NCT04716426|62850314|FG000|Overall Study|Vaccination|1|||
33363483|NCT00601458|62742334|FG001|Overall Study|Early Termination|1|||
33363484|NCT00601458|62742335|FG002|Overall Study|Early Termination|1|||
33363485|NCT02141282|62742347|FG000|Overall Study|Adverse event, not related to progression|8|||
33363486|NCT02141282|62742348|FG001|Overall Study|Adverse event, not related to progression|1|||
33363487|NCT02141282|62742349|FG002|Overall Study|Adverse event, not related to progression|3|||
33363488|NCT02141282|62742350|FG003|Overall Study|Adverse event, not related to progression|1|||
33363489|NCT02141282|62742347|FG000|Overall Study|Adverse event, related to progression|1|||
33363490|NCT02141282|62742348|FG001|Overall Study|Adverse event, related to progression|0|||
33363491|NCT02141282|62742349|FG002|Overall Study|Adverse event, related to progression|2|||
33363492|NCT02141282|62742350|FG003|Overall Study|Adverse event, related to progression|0|||
33363493|NCT02141282|62742347|FG000|Overall Study|COVID-19 infection|1|||
33363494|NCT02141282|62742348|FG001|Overall Study|COVID-19 infection|0|||
33363495|NCT02141282|62742349|FG002|Overall Study|COVID-19 infection|0|||
33363496|NCT02141282|62742350|FG003|Overall Study|COVID-19 infection|0|||
33363497|NCT02141282|62742347|FG000|Overall Study|Lost to Follow-up|0|||
33363498|NCT02141282|62742348|FG001|Overall Study|Lost to Follow-up|0|||
33363499|NCT02141282|62742349|FG002|Overall Study|Lost to Follow-up|4|||
33363500|NCT02141282|62742350|FG003|Overall Study|Lost to Follow-up|2|||
33363501|NCT02141282|62742347|FG000|Overall Study|Other, not specified|14|||
33363502|NCT02141282|62742348|FG001|Overall Study|Other, not specified|11|||
33363503|NCT02141282|62742349|FG002|Overall Study|Other, not specified|23|||
33363504|NCT02141282|62742350|FG003|Overall Study|Other, not specified|9|||
33363505|NCT02141282|62742347|FG000|Overall Study|Progressive disease, Richter's|4|||
33363506|NCT02141282|62742348|FG001|Overall Study|Progressive disease, Richter's|1|||
33363507|NCT02141282|62742349|FG002|Overall Study|Progressive disease, Richter's|1|||
33363508|NCT02141282|62742350|FG003|Overall Study|Progressive disease, Richter's|1|||
33363509|NCT02141282|62742347|FG000|Overall Study|Progressive disease per protocol|12|||
33363510|NCT02141282|62742348|FG001|Overall Study|Progressive disease per protocol|7|||
33363511|NCT02141282|62742349|FG002|Overall Study|Progressive disease per protocol|9|||
33363512|NCT02141282|62742350|FG003|Overall Study|Progressive disease per protocol|2|||
33363513|NCT02141282|62742347|FG000|Overall Study|Stem cell transplant|1|||
33363514|NCT02141282|62742348|FG001|Overall Study|Stem cell transplant|0|||
33363515|NCT02141282|62742349|FG002|Overall Study|Stem cell transplant|1|||
33363516|NCT02141282|62742350|FG003|Overall Study|Stem cell transplant|0|||
33363517|NCT02141282|62742347|FG000|Overall Study|Study terminated by Sponsor|0|||
33363518|NCT02141282|62742348|FG001|Overall Study|Study terminated by Sponsor|1|||
33363519|NCT02141282|62742349|FG002|Overall Study|Study terminated by Sponsor|0|||
33363520|NCT02141282|62742350|FG003|Overall Study|Study terminated by Sponsor|0|||
33363521|NCT02141282|62742347|FG000|Overall Study|Subject non-compliance|0|||
33363522|NCT02141282|62742348|FG001|Overall Study|Subject non-compliance|0|||
33363523|NCT02141282|62742349|FG002|Overall Study|Subject non-compliance|1|||
33363524|NCT02141282|62742350|FG003|Overall Study|Subject non-compliance|0|||
33363525|NCT02141282|62742347|FG000|Overall Study|Withdrew consent|2|||
33363526|NCT02141282|62742348|FG001|Overall Study|Withdrew consent|0|||
33363527|NCT02141282|62742349|FG002|Overall Study|Withdrew consent|4|||
33363528|NCT02141282|62742350|FG003|Overall Study|Withdrew consent|0|||
33363529|NCT00003479|62742363|FG000|Overall Study|Not evaluable|3|||
33363530|NCT00891839|62742367|FG000|Overall Study|Adverse Event|2|||
33363531|NCT00891839|62742367|FG000|Overall Study|Withdrawal by Subject|2|||
33363532|NCT00891839|62742367|FG000|Overall Study|Disease progression|3|||
33363533|NCT00600756|62742373|FG000|Analysis After 6 Months|Adverse Event|43|||
33363534|NCT00600756|62742374|FG001|Analysis After 6 Months|Adverse Event|33|||
33363535|NCT00600756|62742373|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
33363536|NCT00600756|62742374|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
33363537|NCT00600756|62742373|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
33363538|NCT00600756|62742374|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
33363539|NCT00600756|62742373|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
33363540|NCT00600756|62742374|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
33363541|NCT00600756|62742373|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
33363542|NCT00600756|62742374|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
33363543|NCT00600756|62742373|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
33363544|NCT00600756|62742374|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
33363545|NCT00600756|62742373|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
33363546|NCT00600756|62742374|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
33363547|NCT00600756|62742373|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
33363548|NCT00600756|62742374|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
33363549|NCT00600756|62742373|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
33363550|NCT00600756|62742374|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
33363551|NCT00600756|62742373|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
33363552|NCT00600756|62742374|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
33363553|NCT00600756|62742373|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
33363554|NCT00600756|62742374|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
33363555|NCT00600756|62742373|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
33363556|NCT00600756|62742374|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
33363557|NCT00600756|62742373|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
33363558|NCT00600756|62742374|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
33363559|NCT00600756|62742373|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
33475603|NCT04716426|62850315|FG001|Overall Study|Vaccination|1|||
33363560|NCT00600756|62742374|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
33363561|NCT00890825|62742386|FG000|Overall Study|Withdrawal by Subject|1|||
33363562|NCT00890825|62742387|FG001|Overall Study|Withdrawal by Subject|0|||
33363563|NCT00890825|62742386|FG000|Overall Study|Alive at data cut off (DCO)|13|||
33363564|NCT00890825|62742387|FG001|Overall Study|Alive at data cut off (DCO)|14|||
33363565|NCT00890201|62742395|FG000|Overall Study|Protocol Violation|5|||
33363566|NCT00890201|62742396|FG001|Overall Study|Protocol Violation|56|||
33363567|NCT00891527|62742402|FG000|Overall Study|Withdrawal by Subject|2|||
33363568|NCT03861078|62742407|FG000|Overall Study|COVID-19 shut down|4|||
33363569|NCT03861078|62742407|FG000|Overall Study|Lost to Follow-up|1|||
33363570|NCT03861078|62742407|FG000|Overall Study|Protocol Violation|2|||
33363571|NCT03861078|62742407|FG000|Overall Study|lack of venous access|1|||
33363572|NCT00891371|62742415|FG000|Pre-assignment|Inclusion/exclusion|5|||
33363573|NCT00891371|62742415|FG000|Pre-assignment|Consent withdrawal|1|||
33363574|NCT00891371|62742415|FG000|Treatment|Lack of Efficacy|5|||
33363575|NCT00891371|62742415|FG000|Treatment|Adverse Event|2|||
33363576|NCT00891371|62742415|FG000|Treatment|Death|1|||
33363577|NCT00891371|62742415|FG000|Treatment|Lost to Follow-up|1|||
33363578|NCT00890045|62742421|FG000|Overall Study|Death|0|||
33363579|NCT00890045|62742422|FG001|Overall Study|Death|1|||
33363580|NCT00890045|62742421|FG000|Overall Study|Did not receive HeRO Graft|0|||
33363581|NCT00890045|62742422|FG001|Overall Study|Did not receive HeRO Graft|2|||
33363582|NCT00890045|62742421|FG000|Overall Study|Lost to Follow-up|5|||
33363583|NCT00890045|62742422|FG001|Overall Study|Lost to Follow-up|7|||
33363584|NCT00891293|62742428|FG000|Overall Study|Adverse Event|2|||
33363585|NCT00891293|62742428|FG000|Overall Study|Protocol Violation|2|||
33363586|NCT00891293|62742428|FG000|Overall Study|Laboratory abnormality|4|||
33363587|NCT00891293|62742428|FG000|Overall Study|Lost to Follow-up|7|||
33363588|NCT00891293|62742428|FG000|Overall Study|Subject withdrew consent|7|||
33363589|NCT00891293|62742428|FG000|Overall Study|Sponsor termination|62|||
33363590|NCT00889421|62742432|FG000|Overall Study|Lack of Efficacy|3|||
33363591|NCT00889265|62742436|FG000|Overall Study|Adverse Event|1|||
33363592|NCT00889265|62742436|FG000|Overall Study|Lost to Follow-up|5|||
33363593|NCT00889265|62742436|FG000|Overall Study|Protocol Violation|1|||
33363594|NCT00603746|62742446|FG000|Overall Study|Adverse Event|2|||
33363595|NCT00603746|62742447|FG001|Overall Study|Adverse Event|3|||
33363596|NCT00603746|62742448|FG002|Overall Study|Adverse Event|0|||
33363597|NCT00603746|62742449|FG003|Overall Study|Adverse Event|1|||
33363598|NCT00603746|62742450|FG004|Overall Study|Adverse Event|0|||
33363599|NCT00603746|62742451|FG005|Overall Study|Adverse Event|4|||
33363600|NCT00603746|62742446|FG000|Overall Study|Lack of Efficacy|34|||
33363601|NCT00603746|62742447|FG001|Overall Study|Lack of Efficacy|11|||
33363602|NCT00603746|62742448|FG002|Overall Study|Lack of Efficacy|6|||
33363603|NCT00603746|62742449|FG003|Overall Study|Lack of Efficacy|11|||
33363604|NCT00603746|62742450|FG004|Overall Study|Lack of Efficacy|12|||
33363605|NCT00603746|62742451|FG005|Overall Study|Lack of Efficacy|8|||
33363606|NCT00603746|62742446|FG000|Overall Study|Protocol Violation|0|||
33363607|NCT00603746|62742447|FG001|Overall Study|Protocol Violation|3|||
33363608|NCT00603746|62742448|FG002|Overall Study|Protocol Violation|1|||
33363609|NCT00603746|62742449|FG003|Overall Study|Protocol Violation|0|||
33363610|NCT00603746|62742450|FG004|Overall Study|Protocol Violation|1|||
33363611|NCT00603746|62742451|FG005|Overall Study|Protocol Violation|0|||
33363612|NCT00603746|62742446|FG000|Overall Study|Lost to Follow-up|0|||
33363613|NCT00603746|62742447|FG001|Overall Study|Lost to Follow-up|1|||
33363614|NCT00603746|62742448|FG002|Overall Study|Lost to Follow-up|1|||
33363615|NCT00603746|62742449|FG003|Overall Study|Lost to Follow-up|0|||
33363616|NCT00603746|62742450|FG004|Overall Study|Lost to Follow-up|0|||
33363617|NCT00603746|62742451|FG005|Overall Study|Lost to Follow-up|0|||
33363618|NCT00603746|62742446|FG000|Overall Study|Physician Decision|1|||
33363619|NCT00603746|62742447|FG001|Overall Study|Physician Decision|0|||
33363620|NCT00603746|62742448|FG002|Overall Study|Physician Decision|0|||
33363621|NCT00603746|62742449|FG003|Overall Study|Physician Decision|0|||
33655705|NCT01859741|63072874|FG001|Overall Study|Death|2|||
33655706|NCT01859741|63072875|FG002|Overall Study|Death|4|||
33363622|NCT00603746|62742450|FG004|Overall Study|Physician Decision|1|||
33363623|NCT00603746|62742451|FG005|Overall Study|Physician Decision|0|||
33363624|NCT00603746|62742446|FG000|Overall Study|Withdrawal by Subject|1|||
33363625|NCT00603746|62742447|FG001|Overall Study|Withdrawal by Subject|0|||
33363626|NCT00603746|62742448|FG002|Overall Study|Withdrawal by Subject|0|||
33363627|NCT00603746|62742449|FG003|Overall Study|Withdrawal by Subject|1|||
33363628|NCT00603746|62742450|FG004|Overall Study|Withdrawal by Subject|3|||
33363629|NCT00603746|62742451|FG005|Overall Study|Withdrawal by Subject|1|||
33363630|NCT00888329|62742467|FG000|Overall Study|Physician Decision|6|||
33363631|NCT00888329|62742468|FG001|Overall Study|Physician Decision|9|||
33363632|NCT00603590|62742476|FG000|Overall Study|Did not attend study clinic|39|||
33363633|NCT00603590|62742477|FG001|Overall Study|Did not attend study clinic|30|||
33363634|NCT00603590|62742476|FG000|Overall Study|Refused blood test|5|||
33363635|NCT00603590|62742477|FG001|Overall Study|Refused blood test|1|||
33475604|NCT04716426|62850314|FG000|Overall Study|Contamination|1|||
33655707|NCT01859741|63072876|FG003|Overall Study|Death|3|||
33363636|NCT00603590|62742476|FG000|Overall Study|Patient discontinued study drug|22|||
33363637|NCT00603590|62742477|FG001|Overall Study|Patient discontinued study drug|15|||
33363638|NCT00603590|62742476|FG000|Overall Study|Adverse Event|2|||
33363639|NCT00603590|62742477|FG001|Overall Study|Adverse Event|0|||
33363640|NCT00603590|62742476|FG000|Overall Study|Lost to Follow-up|8|||
33363641|NCT00603590|62742477|FG001|Overall Study|Lost to Follow-up|4|||
33363642|NCT00603590|62742476|FG000|Overall Study|Cardiovascular event|0|||
33363643|NCT00603590|62742477|FG001|Overall Study|Cardiovascular event|1|||
33363644|NCT00888173|62742483|FG000|Overall Study|Wrong Primary|1|||
33363645|NCT00888173|62742483|FG000|Overall Study|Ineligible: required test not done|1|||
33363646|NCT00887549|62742496|FG000|Induction Therapy|Adverse Event|8|||
33363647|NCT00887549|62742496|FG000|Induction Therapy|Physician Decision|1|||
33363648|NCT00887549|62742496|FG000|Induction Therapy|Progressive Disease|13|||
33363649|NCT00887549|62742496|FG000|Induction Therapy|Death due to Study Disease|4|||
33363650|NCT00887549|62742496|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
33363651|NCT00887549|62742496|FG000|Maintenance Therapy|Adverse Event|16|||
33363652|NCT00887549|62742496|FG000|Maintenance Therapy|Physician Decision|1|||
33363653|NCT00887549|62742496|FG000|Maintenance Therapy|Progressive Disease|25|||
33363654|NCT00887549|62742496|FG000|Maintenance Therapy|Death due to adverse event|1|||
33363655|NCT00887315|62742502|FG000|Overall Study|Study termination|7|||
33363656|NCT00887315|62742503|FG001|Overall Study|Study termination|4|||
33363657|NCT03608826|62742509|FG000|Overall Study|Death|3|||
33475605|NCT04716426|62850315|FG001|Overall Study|Contamination|0|||
33475606|NCT03694548|62850323|FG000|Part A Survey|Protocol Violation|3|||
33475607|NCT03694548|62850324|FG001|Part A Survey|Protocol Violation|3|||
33475608|NCT03694548|62850325|FG002|Part A Survey|Protocol Violation|0|||
33475609|NCT03694548|62850323|FG000|Part B Yoga Program|Protocol Violation|0|||
33475610|NCT03694548|62850324|FG001|Part B Yoga Program|Protocol Violation|0|||
33475611|NCT03694548|62850325|FG002|Part B Yoga Program|Protocol Violation|3|||
33475612|NCT03694548|62850323|FG000|Part B Yoga Program|Did not attend intervention|0|||
33475613|NCT03694548|62850324|FG001|Part B Yoga Program|Did not attend intervention|0|||
33475614|NCT03694548|62850325|FG002|Part B Yoga Program|Did not attend intervention|8|||
33363658|NCT03608826|62742509|FG000|Overall Study|Heart Transplant|3|||
33363659|NCT03608826|62742509|FG000|Overall Study|Physician Decision|4|||
33363660|NCT00887159|62742516|FG000|Overall Study|Disease progression|6|||
33363661|NCT00887159|62742517|FG001|Overall Study|Disease progression|39|||
33363662|NCT00887159|62742518|FG002|Overall Study|Disease progression|33|||
33363663|NCT00887159|62742516|FG000|Overall Study|Adverse Event|3|||
33363664|NCT00887159|62742517|FG001|Overall Study|Adverse Event|4|||
33363665|NCT00887159|62742518|FG002|Overall Study|Adverse Event|17|||
33363666|NCT00887159|62742516|FG000|Overall Study|Death|2|||
33363667|NCT00887159|62742517|FG001|Overall Study|Death|2|||
33363668|NCT00887159|62742518|FG002|Overall Study|Death|0|||
33363669|NCT00887159|62742516|FG000|Overall Study|Withdrawal by Subject|4|||
33363670|NCT00887159|62742517|FG001|Overall Study|Withdrawal by Subject|4|||
33363671|NCT00887159|62742518|FG002|Overall Study|Withdrawal by Subject|2|||
33363672|NCT00887159|62742516|FG000|Overall Study|Alternative therapy|2|||
33363673|NCT00887159|62742517|FG001|Overall Study|Alternative therapy|0|||
33363674|NCT00887159|62742518|FG002|Overall Study|Alternative therapy|0|||
33363675|NCT00887159|62742516|FG000|Overall Study|Physician Decision|1|||
33363676|NCT00887159|62742517|FG001|Overall Study|Physician Decision|1|||
33363677|NCT00887159|62742518|FG002|Overall Study|Physician Decision|0|||
33363678|NCT00887159|62742516|FG000|Overall Study|Sympomatic deterioration|1|||
33363679|NCT00887159|62742517|FG001|Overall Study|Sympomatic deterioration|0|||
33475615|NCT04166630|62850337|FG000|Overall Study|Withdrawal by Subject|0|||
33475616|NCT04166630|62850338|FG001|Overall Study|Withdrawal by Subject|1|||
33475617|NCT04164758|62850347|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
33475618|NCT04164758|62850348|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
33475619|NCT04164758|62850349|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
33475620|NCT04164758|62850347|FG000|Overall Study|Adverse Event|0|||
33475621|NCT04164758|62850348|FG001|Overall Study|Adverse Event|1|||
33475622|NCT04164758|62850349|FG002|Overall Study|Adverse Event|0|||
33549533|NCT02748863|62940694|FG004|Treatment Period 2|Lost to Follow-up|0|||
33549534|NCT02748863|62940690|FG000|Treatment Period 2|Adverse Event|3|||
33475623|NCT04178720|62850359|FG000|Overall Study|Withdrawal by Subject|2|||
33549535|NCT02748863|62940691|FG001|Treatment Period 2|Adverse Event|2|||
33549536|NCT02748863|62940692|FG002|Treatment Period 2|Adverse Event|0|||
33363680|NCT00887159|62742518|FG002|Overall Study|Sympomatic deterioration|0|||
33363681|NCT00887159|62742516|FG000|Overall Study|Treatment delayed|1|||
33363682|NCT00887159|62742517|FG001|Overall Study|Treatment delayed|1|||
33363683|NCT00887159|62742518|FG002|Overall Study|Treatment delayed|0|||
33363684|NCT00887159|62742516|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
33363685|NCT00887159|62742517|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
33363686|NCT00887159|62742518|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
33363687|NCT00887159|62742516|FG000|Overall Study|Received more tx instead of observation|1|||
33363688|NCT00887159|62742517|FG001|Overall Study|Received more tx instead of observation|0|||
33363689|NCT00887159|62742518|FG002|Overall Study|Received more tx instead of observation|0|||
33363690|NCT00887159|62742516|FG000|Overall Study|Ineligible|5|||
33475624|NCT04178720|62850360|FG001|Overall Study|Withdrawal by Subject|0|||
33475625|NCT04178720|62850359|FG000|Overall Study|Relocation|0|||
33475626|NCT04178720|62850360|FG001|Overall Study|Relocation|1|||
33475627|NCT04177862|62850371|FG000|Overall Study|Protocol Violation|2|||
33475628|NCT04177862|62850372|FG001|Overall Study|Protocol Violation|7|||
33475629|NCT04173572|62850381|FG000|Overall Study|Withdrawal by Subject|1|||
33475630|NCT04173572|62850382|FG001|Overall Study|Withdrawal by Subject|5|||
33475631|NCT04173572|62850381|FG000|Overall Study|Lost to Follow-up|3|||
33475632|NCT04173572|62850382|FG001|Overall Study|Lost to Follow-up|1|||
33475633|NCT04157738|62850390|FG000|Overall Study|Moved out of state|0|||
33475634|NCT04157738|62850391|FG001|Overall Study|Moved out of state|2|||
33475635|NCT04157738|62850390|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
33475636|NCT04157738|62850391|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
33475637|NCT04156646|62850399|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
33475638|NCT04156646|62850400|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
33475639|NCT04676412|62850411|FG000|Overall Study|Death|17|||
33475640|NCT04676412|62850412|FG001|Overall Study|Death|23|||
33363691|NCT00887159|62742517|FG001|Overall Study|Ineligible|1|||
33475641|NCT04676412|62850411|FG000|Overall Study|Withdrawal by Subject|0|||
33475642|NCT04676412|62850412|FG001|Overall Study|Withdrawal by Subject|2|||
33363692|NCT00887159|62742518|FG002|Overall Study|Ineligible|0|||
33475643|NCT04676412|62850411|FG000|Overall Study|Participants ongoing|32|||
33475644|NCT04676412|62850412|FG001|Overall Study|Participants ongoing|33|||
33475645|NCT04150250|62850420|FG000|Overall Study|Lost to Follow-up|0|||
33475646|NCT04150250|62850421|FG001|Overall Study|Lost to Follow-up|2|||
33549537|NCT02748863|62940693|FG003|Treatment Period 2|Adverse Event|2|||
33363693|NCT00887159|62742516|FG000|Overall Study|Never started assigned therapy|3|||
33363694|NCT00887159|62742517|FG001|Overall Study|Never started assigned therapy|3|||
33363695|NCT00887159|62742518|FG002|Overall Study|Never started assigned therapy|4|||
33363696|NCT00886769|62742530|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
33363697|NCT00886769|62742531|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
33363698|NCT00886613|62742540|FG000|Overall Study|Protocol deviation (Part B)|1|||
33363699|NCT00886613|62742541|FG001|Overall Study|Protocol deviation (Part B)|0|||
33363700|NCT00886613|62742542|FG002|Overall Study|Protocol deviation (Part B)|0|||
33363701|NCT00886613|62742540|FG000|Overall Study|Lost to follow-up (Part B)|1|||
33363702|NCT00886613|62742541|FG001|Overall Study|Lost to follow-up (Part B)|0|||
33363703|NCT00886613|62742542|FG002|Overall Study|Lost to follow-up (Part B)|1|||
33363704|NCT00886613|62742540|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
33363705|NCT00886613|62742541|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
33363706|NCT00886613|62742542|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
33363707|NCT00886379|62742558|FG000|Overall Study|Transferred Schools|0|||
33363708|NCT00886379|62742559|FG001|Overall Study|Transferred Schools|0|||
33363709|NCT00886379|62742560|FG002|Overall Study|Transferred Schools|2|||
33363710|NCT00886379|62742561|FG003|Overall Study|Transferred Schools|1|||
33363711|NCT00886379|62742562|FG004|Overall Study|Transferred Schools|1|||
33363712|NCT00886379|62742558|FG000|Overall Study|Final blood draw not obtained|3|||
33363713|NCT00886379|62742559|FG001|Overall Study|Final blood draw not obtained|3|||
33363714|NCT00886379|62742560|FG002|Overall Study|Final blood draw not obtained|4|||
33363715|NCT00886379|62742561|FG003|Overall Study|Final blood draw not obtained|2|||
33363716|NCT00886379|62742562|FG004|Overall Study|Final blood draw not obtained|2|||
33363717|NCT00599196|62742574|FG000|Overall Study|Lack of Efficacy|22|||
33363718|NCT00599196|62742574|FG000|Overall Study|Adverse Event|93|||
33363719|NCT00599196|62742574|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
33363720|NCT00599196|62742574|FG000|Overall Study|Subject withdrew consent|43|||
33363721|NCT00599196|62742574|FG000|Overall Study|Study ended per sponsor|197|||
33363722|NCT00599196|62742574|FG000|Overall Study|Lost to Follow-up|17|||
33363723|NCT00599196|62742574|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
33363724|NCT00599196|62742574|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
33363725|NCT00599196|62742574|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
33363726|NCT00599196|62742574|FG000|Overall Study|Other: Pt Moved To Australia|1|||
33363727|NCT00599196|62742574|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
33363728|NCT00599196|62742574|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
33363729|NCT00603512|62742583|FG000|Overall Study|Adverse Event|0|||
33363730|NCT00603512|62742584|FG001|Overall Study|Adverse Event|2|||
33363731|NCT00603512|62742585|FG002|Overall Study|Adverse Event|4|||
33363732|NCT00603512|62742586|FG003|Overall Study|Adverse Event|4|||
33363733|NCT00603512|62742587|FG004|Overall Study|Adverse Event|2|||
33363734|NCT00603512|62742583|FG000|Overall Study|Lack of Efficacy|0|||
33363735|NCT00603512|62742584|FG001|Overall Study|Lack of Efficacy|1|||
33363736|NCT00603512|62742585|FG002|Overall Study|Lack of Efficacy|0|||
33363737|NCT00603512|62742586|FG003|Overall Study|Lack of Efficacy|0|||
33363738|NCT00603512|62742587|FG004|Overall Study|Lack of Efficacy|1|||
33363739|NCT00603512|62742583|FG000|Overall Study|Other|2|||
33363740|NCT00603512|62742584|FG001|Overall Study|Other|1|||
33363741|NCT00603512|62742585|FG002|Overall Study|Other|0|||
33363742|NCT00603512|62742586|FG003|Overall Study|Other|1|||
33363743|NCT00603512|62742587|FG004|Overall Study|Other|1|||
33363744|NCT00603512|62742583|FG000|Overall Study|Withdrawal by Subject|0|||
33363745|NCT00603512|62742584|FG001|Overall Study|Withdrawal by Subject|0|||
33363746|NCT00603512|62742585|FG002|Overall Study|Withdrawal by Subject|0|||
33363747|NCT00603512|62742586|FG003|Overall Study|Withdrawal by Subject|0|||
33363748|NCT00603512|62742587|FG004|Overall Study|Withdrawal by Subject|1|||
33363749|NCT00603512|62742583|FG000|Overall Study|Randomized but not treated|0|||
33363750|NCT00603512|62742584|FG001|Overall Study|Randomized but not treated|1|||
33363751|NCT00603512|62742585|FG002|Overall Study|Randomized but not treated|1|||
33363752|NCT00603512|62742586|FG003|Overall Study|Randomized but not treated|2|||
33655708|NCT01859741|63072877|FG004|Overall Study|Death|5|||
33363753|NCT00603512|62742587|FG004|Overall Study|Randomized but not treated|0|||
33363754|NCT04242875|62742599|FG000|Overall Study|Adverse Event|2|||
33363755|NCT00603278|62742613|FG000|Overall Study|Lack of Efficacy|35|||
33363756|NCT00603278|62742614|FG001|Overall Study|Lack of Efficacy|10|||
33363757|NCT00603278|62742615|FG002|Overall Study|Lack of Efficacy|11|||
33363758|NCT00603278|62742616|FG003|Overall Study|Lack of Efficacy|8|||
33363759|NCT00603278|62742617|FG004|Overall Study|Lack of Efficacy|7|||
33363760|NCT00603278|62742618|FG005|Overall Study|Lack of Efficacy|14|||
33363761|NCT00603278|62742613|FG000|Overall Study|Adverse Event|0|||
33363762|NCT00603278|62742614|FG001|Overall Study|Adverse Event|3|||
33363763|NCT00603278|62742615|FG002|Overall Study|Adverse Event|1|||
33363764|NCT00603278|62742616|FG003|Overall Study|Adverse Event|0|||
33363765|NCT00603278|62742617|FG004|Overall Study|Adverse Event|2|||
33363766|NCT00603278|62742618|FG005|Overall Study|Adverse Event|1|||
33363767|NCT00603278|62742613|FG000|Overall Study|Withdrawal by Subject|2|||
33363768|NCT00603278|62742614|FG001|Overall Study|Withdrawal by Subject|3|||
33363769|NCT00603278|62742615|FG002|Overall Study|Withdrawal by Subject|1|||
33363770|NCT00603278|62742616|FG003|Overall Study|Withdrawal by Subject|2|||
33363771|NCT00603278|62742617|FG004|Overall Study|Withdrawal by Subject|1|||
33363772|NCT00603278|62742618|FG005|Overall Study|Withdrawal by Subject|2|||
33363773|NCT00603278|62742613|FG000|Overall Study|Protocol Violation|3|||
33363774|NCT00603278|62742614|FG001|Overall Study|Protocol Violation|0|||
33363775|NCT00603278|62742615|FG002|Overall Study|Protocol Violation|1|||
33363776|NCT00603278|62742616|FG003|Overall Study|Protocol Violation|1|||
33363777|NCT00603278|62742617|FG004|Overall Study|Protocol Violation|0|||
33363778|NCT00603278|62742618|FG005|Overall Study|Protocol Violation|1|||
33363779|NCT00603278|62742613|FG000|Overall Study|Physician Decision|0|||
33363780|NCT00603278|62742614|FG001|Overall Study|Physician Decision|1|||
33363781|NCT00603278|62742615|FG002|Overall Study|Physician Decision|0|||
33363782|NCT00603278|62742616|FG003|Overall Study|Physician Decision|0|||
33363783|NCT00603278|62742617|FG004|Overall Study|Physician Decision|2|||
33363784|NCT00603278|62742618|FG005|Overall Study|Physician Decision|1|||
33363785|NCT00603278|62742613|FG000|Overall Study|Lost to Follow-up|1|||
33363786|NCT00603278|62742614|FG001|Overall Study|Lost to Follow-up|0|||
33363787|NCT00603278|62742615|FG002|Overall Study|Lost to Follow-up|0|||
33363788|NCT00603278|62742616|FG003|Overall Study|Lost to Follow-up|0|||
33363789|NCT00603278|62742617|FG004|Overall Study|Lost to Follow-up|1|||
33363790|NCT00603278|62742618|FG005|Overall Study|Lost to Follow-up|0|||
33363791|NCT00876447|62742634|FG000|Overall Study|Other miscellaneous reasons|3|||
33363792|NCT00876447|62742635|FG001|Overall Study|Other miscellaneous reasons|8|||
33363793|NCT00876447|62742634|FG000|Overall Study|Site closure|19|||
33363794|NCT00876447|62742635|FG001|Overall Study|Site closure|14|||
33363795|NCT00876447|62742634|FG000|Overall Study|Protocol Violation|9|||
33363796|NCT00876447|62742635|FG001|Overall Study|Protocol Violation|3|||
33363797|NCT00876447|62742634|FG000|Overall Study|Personal reasons|30|||
33363798|NCT00876447|62742635|FG001|Overall Study|Personal reasons|28|||
33363799|NCT00876447|62742634|FG000|Overall Study|Lost to Follow-up|6|||
33363800|NCT00876447|62742635|FG001|Overall Study|Lost to Follow-up|15|||
33363801|NCT00876447|62742634|FG000|Overall Study|Pregnancy|4|||
33363802|NCT00876447|62742635|FG001|Overall Study|Pregnancy|2|||
33475647|NCT04537806|62850429|FG000|Overall Study|Randomized but not treated|1|||
33475648|NCT04537806|62850430|FG001|Overall Study|Randomized but not treated|0|||
33475649|NCT04537806|62850429|FG000|Overall Study|Adverse Event|1|||
33475650|NCT04537806|62850430|FG001|Overall Study|Adverse Event|1|||
33475651|NCT04015232|62850438|FG000|Overall Study|Withdrawal by Subject|7|||
33475652|NCT04015232|62850439|FG001|Overall Study|Withdrawal by Subject|4|||
33475653|NCT04015232|62850438|FG000|Overall Study|Protocol Violation|1|||
33475654|NCT04015232|62850439|FG001|Overall Study|Protocol Violation|0|||
33475655|NCT04015232|62850438|FG000|Overall Study|Medical Grounds|3|||
33475656|NCT04015232|62850439|FG001|Overall Study|Medical Grounds|3|||
33475657|NCT04533204|62850451|FG000|Overall Study|Unable to understand training instructions|1|||
33475658|NCT04533204|62850452|FG001|Overall Study|Unable to understand training instructions|1|||
33475659|NCT04465422|62850460|FG000|Overall Study|Lost to Follow-up|0|||
33475660|NCT04465422|62850461|FG001|Overall Study|Lost to Follow-up|2|||
33475661|NCT04014062|62850471|FG000|Period I: Dosing|Medical Grounds|4|||
33475662|NCT04014062|62850472|FG001|Period I: Dosing|Medical Grounds|5|||
33475663|NCT04014062|62850471|FG000|Period I: Dosing|Withdrawal by Subject|3|||
33475664|NCT04014062|62850472|FG001|Period I: Dosing|Withdrawal by Subject|1|||
33475665|NCT04531098|62850486|FG000|Stage I|Adverse Event|0|||
33475666|NCT04531098|62850487|FG001|Stage I|Adverse Event|0|||
33475667|NCT04531098|62850488|FG002|Stage I|Adverse Event|3|||
33475668|NCT04531098|62850486|FG000|Stage I|Protocol Violation|0|||
33363803|NCT00876447|62742634|FG000|Overall Study|Lack of Efficacy|5|||
33363804|NCT00876447|62742635|FG001|Overall Study|Lack of Efficacy|3|||
33363805|NCT00876447|62742634|FG000|Overall Study|Adverse Event|4|||
33363806|NCT00876447|62742635|FG001|Overall Study|Adverse Event|8|||
33363807|NCT00598650|62742665|FG000|Overall Study|Withdrawal by Subject|3|||
33363808|NCT00598650|62742665|FG000|Overall Study|Adverse Event|18|||
33363809|NCT00598650|62742665|FG000|Overall Study|No treatment for 3 weeks|1|||
33475669|NCT04531098|62850487|FG001|Stage I|Protocol Violation|0|||
33475670|NCT04531098|62850488|FG002|Stage I|Protocol Violation|5|||
33363810|NCT00598650|62742665|FG000|Overall Study|Not eligible|1|||
33363811|NCT00598650|62742665|FG000|Overall Study|Prohibited Concomitant Medication|2|||
33363812|NCT00598650|62742665|FG000|Overall Study|Physician Decision|2|||
33475671|NCT04531098|62850486|FG000|Stage I|Withdrawal by Subject|0|||
33475672|NCT04531098|62850487|FG001|Stage I|Withdrawal by Subject|5|||
33475673|NCT04531098|62850488|FG002|Stage I|Withdrawal by Subject|10|||
33363813|NCT04249076|62742672|FG000|Overall Study|Adverse Event|1|||
33475674|NCT04531098|62850486|FG000|Stage II|Adverse Event|1|||
33363814|NCT04249076|62742673|FG001|Overall Study|Adverse Event|1|||
33475675|NCT04531098|62850487|FG001|Stage II|Adverse Event|2|||
33475676|NCT04531098|62850488|FG002|Stage II|Adverse Event|0|||
33475677|NCT04531098|62850486|FG000|Stage II|Protocol Violation|1|||
33475678|NCT04531098|62850487|FG001|Stage II|Protocol Violation|2|||
33475679|NCT04531098|62850488|FG002|Stage II|Protocol Violation|0|||
33363815|NCT04249076|62742672|FG000|Overall Study|Protocol Violation|1|||
33363816|NCT04249076|62742673|FG001|Overall Study|Protocol Violation|2|||
33363817|NCT04249076|62742672|FG000|Overall Study|Lack of Efficacy|0|||
33363818|NCT04249076|62742673|FG001|Overall Study|Lack of Efficacy|1|||
33363819|NCT04249076|62742672|FG000|Overall Study|Withdrawal by Subject|0|||
33363820|NCT04249076|62742673|FG001|Overall Study|Withdrawal by Subject|1|||
33363821|NCT04150107|62742681|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
33363822|NCT04150107|62742682|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
33363823|NCT04150107|62742681|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
33363824|NCT04150107|62742682|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
33363825|NCT04173494|62742692|FG000|Randomized Double-Blind Treatment Period|Adverse Event|16|||
33363826|NCT04173494|62742693|FG001|Randomized Double-Blind Treatment Period|Adverse Event|11|||
33363827|NCT04173494|62742692|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|6|||
33363828|NCT04173494|62742693|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|5|||
33363829|NCT04173494|62742692|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|6|||
33363830|NCT04173494|62742693|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|3|||
33363831|NCT04173494|62742692|FG000|Randomized Double-Blind Treatment Period|Death|4|||
33363832|NCT04173494|62742693|FG001|Randomized Double-Blind Treatment Period|Death|3|||
33363833|NCT04173494|62742692|FG000|Randomized Double-Blind Treatment Period|Leukemic Transformation|2|||
33363834|NCT04173494|62742693|FG001|Randomized Double-Blind Treatment Period|Leukemic Transformation|2|||
33363835|NCT04173494|62742692|FG000|Randomized Double-Blind Treatment Period|Disease Progression|1|||
33363836|NCT04173494|62742693|FG001|Randomized Double-Blind Treatment Period|Disease Progression|2|||
33363837|NCT04173494|62742692|FG000|Randomized Double-Blind Treatment Period|Lost to Follow-up|1|||
33363838|NCT04173494|62742693|FG001|Randomized Double-Blind Treatment Period|Lost to Follow-up|0|||
33363839|NCT04173494|62742692|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
33363840|NCT04173494|62742693|FG001|Randomized Double-Blind Treatment Period|Physician Decision|1|||
33363841|NCT04173494|62742692|FG000|Open-Label Extended Treatment Period|Open-label treatment ongoing|52|||
33363842|NCT04173494|62742693|FG001|Open-Label Extended Treatment Period|Open-label treatment ongoing|22|||
33363843|NCT04173494|62742692|FG000|Open-Label Extended Treatment Period|Continuing in MMB extension study|24|||
33363844|NCT04173494|62742693|FG001|Open-Label Extended Treatment Period|Continuing in MMB extension study|9|||
33363845|NCT04173494|62742692|FG000|Open-Label Extended Treatment Period|Adverse Event|8|||
33363846|NCT04173494|62742693|FG001|Open-Label Extended Treatment Period|Adverse Event|1|||
33363847|NCT04173494|62742692|FG000|Open-Label Extended Treatment Period|Withdrawal by Subject|2|||
33363848|NCT04173494|62742693|FG001|Open-Label Extended Treatment Period|Withdrawal by Subject|3|||
33363849|NCT04173494|62742692|FG000|Open-Label Extended Treatment Period|Death|3|||
33363850|NCT04173494|62742693|FG001|Open-Label Extended Treatment Period|Death|1|||
33363851|NCT04173494|62742692|FG000|Open-Label Extended Treatment Period|Physician Decision|2|||
33363852|NCT04173494|62742693|FG001|Open-Label Extended Treatment Period|Physician Decision|2|||
33363853|NCT04173494|62742692|FG000|Open-Label Extended Treatment Period|Lack of Efficacy|1|||
33363854|NCT04173494|62742693|FG001|Open-Label Extended Treatment Period|Lack of Efficacy|1|||
33363855|NCT04173494|62742692|FG000|Open-Label Extended Treatment Period|Leukemic transformation|0|||
33363856|NCT04173494|62742693|FG001|Open-Label Extended Treatment Period|Leukemic transformation|1|||
33363857|NCT00875979|62742701|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
33363858|NCT00875979|62742702|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
33363859|NCT00875979|62742701|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
33363860|NCT00875979|62742702|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
33363861|NCT00875979|62742701|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
33363862|NCT00875979|62742702|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
33363863|NCT00875979|62742701|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
33363864|NCT00875979|62742702|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
33363865|NCT00875979|62742701|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
33363866|NCT00875979|62742702|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
33363867|NCT00875979|62742701|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
33475680|NCT04531098|62850486|FG000|Stage II|Withdrawal by Subject|3|||
33475681|NCT04531098|62850487|FG001|Stage II|Withdrawal by Subject|1|||
33475682|NCT04531098|62850488|FG002|Stage II|Withdrawal by Subject|0|||
33475683|NCT04531098|62850486|FG000|Stage II|Moved from study area|8|||
33475684|NCT04531098|62850487|FG001|Stage II|Moved from study area|5|||
33475685|NCT04531098|62850488|FG002|Stage II|Moved from study area|0|||
33655709|NCT01859741|63072878|FG005|Overall Study|Death|4|||
33655710|NCT01859741|63072879|FG006|Overall Study|Death|51|||
33655711|NCT01859741|63072880|FG007|Overall Study|Death|51|||
33655712|NCT01859741|63072873|FG000|Overall Study|Lost to Follow-up|0|||
33655713|NCT01859741|63072874|FG001|Overall Study|Lost to Follow-up|0|||
33655714|NCT01859741|63072875|FG002|Overall Study|Lost to Follow-up|0|||
33655715|NCT01859741|63072876|FG003|Overall Study|Lost to Follow-up|0|||
33655716|NCT01859741|63072877|FG004|Overall Study|Lost to Follow-up|0|||
33363868|NCT00875979|62742702|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
33363869|NCT00875979|62742701|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
33363870|NCT00875979|62742702|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
33363871|NCT00875979|62742701|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
33363872|NCT00875979|62742702|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
33363873|NCT00875979|62742701|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
33363874|NCT00875979|62742702|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
33363875|NCT00602420|62742710|FG000|Overall Study|Death|1|||
33655717|NCT01859741|63072878|FG005|Overall Study|Lost to Follow-up|1|||
33655718|NCT01859741|63072879|FG006|Overall Study|Lost to Follow-up|0|||
33363876|NCT00602420|62742711|FG001|Overall Study|Death|4|||
33363877|NCT00602420|62742710|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
33363878|NCT00602420|62742711|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
33363879|NCT00602420|62742710|FG000|Overall Study|Withdrawal by Subject|18|||
33363880|NCT00602420|62742711|FG001|Overall Study|Withdrawal by Subject|17|||
33363881|NCT00602420|62742710|FG000|Overall Study|Adverse Event|1|||
33363882|NCT00602420|62742711|FG001|Overall Study|Adverse Event|0|||
33363883|NCT00875667|62742725|FG000|Overall Study|Adverse Event|29|||
33363884|NCT00875667|62742726|FG001|Overall Study|Adverse Event|10|||
33363885|NCT00875667|62742725|FG000|Overall Study|Withdrawal by Subject|17|||
33363886|NCT00875667|62742726|FG001|Overall Study|Withdrawal by Subject|5|||
33363887|NCT00875667|62742725|FG000|Overall Study|Death|7|||
33363888|NCT00875667|62742726|FG001|Overall Study|Death|2|||
33363889|NCT00875667|62742725|FG000|Overall Study|Protocol Violation|2|||
33363890|NCT00875667|62742726|FG001|Overall Study|Protocol Violation|0|||
33363891|NCT00875667|62742725|FG000|Overall Study|Disease Progression|100|||
33363892|NCT00875667|62742726|FG001|Overall Study|Disease Progression|49|||
33363893|NCT00875667|62742725|FG000|Overall Study|Miscellaneous|12|||
33363894|NCT00875667|62742726|FG001|Overall Study|Miscellaneous|6|||
33363895|NCT00875667|62742725|FG000|Overall Study|Randomized but no Study Drug Given|3|||
33363896|NCT00875667|62742726|FG001|Overall Study|Randomized but no Study Drug Given|1|||
33363897|NCT00602030|62742736|FG000|Lead-in Phase|Disease Progression|2|||
33363898|NCT00602030|62742737|FG001|Lead-in Phase|Disease Progression|3|||
33363899|NCT00602030|62742738|FG002|Lead-in Phase|Disease Progression|0|||
33363900|NCT00602030|62742739|FG003|Lead-in Phase|Disease Progression|0|||
33363901|NCT00602030|62742740|FG004|Lead-in Phase|Disease Progression|0|||
33363902|NCT00602030|62742736|FG000|Lead-in Phase|Adverse Event|0|||
33363903|NCT00602030|62742737|FG001|Lead-in Phase|Adverse Event|2|||
33363904|NCT00602030|62742738|FG002|Lead-in Phase|Adverse Event|0|||
33363905|NCT00602030|62742739|FG003|Lead-in Phase|Adverse Event|0|||
33363906|NCT00602030|62742740|FG004|Lead-in Phase|Adverse Event|0|||
33363907|NCT00602030|62742736|FG000|Double-blind Phase|Disease progression|0|||
33363908|NCT00602030|62742737|FG001|Double-blind Phase|Disease progression|0|||
33363909|NCT00602030|62742738|FG002|Double-blind Phase|Disease progression|33|||
33363910|NCT00602030|62742739|FG003|Double-blind Phase|Disease progression|30|||
33363911|NCT00602030|62742740|FG004|Double-blind Phase|Disease progression|0|||
33363912|NCT00602030|62742736|FG000|Double-blind Phase|Adverse Event|0|||
33363913|NCT00602030|62742737|FG001|Double-blind Phase|Adverse Event|0|||
33363914|NCT00602030|62742738|FG002|Double-blind Phase|Adverse Event|9|||
33363915|NCT00602030|62742739|FG003|Double-blind Phase|Adverse Event|18|||
33363916|NCT00602030|62742740|FG004|Double-blind Phase|Adverse Event|0|||
33363917|NCT00602030|62742736|FG000|Double-blind Phase|Consent withdrawal|0|||
33363918|NCT00602030|62742737|FG001|Double-blind Phase|Consent withdrawal|0|||
33363919|NCT00602030|62742738|FG002|Double-blind Phase|Consent withdrawal|4|||
33363920|NCT00602030|62742739|FG003|Double-blind Phase|Consent withdrawal|3|||
33363921|NCT00602030|62742740|FG004|Double-blind Phase|Consent withdrawal|0|||
33363922|NCT00602030|62742736|FG000|Double-blind Phase|Death|0|||
33363923|NCT00602030|62742737|FG001|Double-blind Phase|Death|0|||
33363924|NCT00602030|62742738|FG002|Double-blind Phase|Death|3|||
33363925|NCT00602030|62742739|FG003|Double-blind Phase|Death|3|||
33363926|NCT00602030|62742740|FG004|Double-blind Phase|Death|0|||
33363927|NCT00602030|62742736|FG000|Double-blind Phase|Administrative decision|0|||
33363928|NCT00602030|62742737|FG001|Double-blind Phase|Administrative decision|0|||
33363929|NCT00602030|62742738|FG002|Double-blind Phase|Administrative decision|0|||
33363930|NCT00602030|62742739|FG003|Double-blind Phase|Administrative decision|2|||
33363931|NCT00602030|62742740|FG004|Double-blind Phase|Administrative decision|0|||
33363932|NCT00602030|62742736|FG000|Double-blind Phase|Ineligibility|0|||
33363933|NCT00602030|62742737|FG001|Double-blind Phase|Ineligibility|0|||
33363934|NCT00602030|62742738|FG002|Double-blind Phase|Ineligibility|0|||
33363935|NCT00602030|62742739|FG003|Double-blind Phase|Ineligibility|1|||
33363936|NCT00602030|62742740|FG004|Double-blind Phase|Ineligibility|0|||
33363937|NCT00602030|62742736|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
33363938|NCT00602030|62742737|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
33655719|NCT01859741|63072880|FG007|Overall Study|Lost to Follow-up|4|||
33363939|NCT00602030|62742738|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
33363940|NCT00602030|62742739|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
33363941|NCT00602030|62742740|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
33363942|NCT00602030|62742736|FG000|Double-blind Phase|Reason not specified|0|||
33363943|NCT00602030|62742737|FG001|Double-blind Phase|Reason not specified|0|||
33363944|NCT00602030|62742738|FG002|Double-blind Phase|Reason not specified|4|||
33363945|NCT00602030|62742739|FG003|Double-blind Phase|Reason not specified|2|||
33363946|NCT00602030|62742740|FG004|Double-blind Phase|Reason not specified|0|||
33363947|NCT00602030|62742736|FG000|Crossover Phase|Disease Progression|0|||
33363948|NCT00602030|62742737|FG001|Crossover Phase|Disease Progression|0|||
33363949|NCT00602030|62742738|FG002|Crossover Phase|Disease Progression|0|||
33363950|NCT00602030|62742739|FG003|Crossover Phase|Disease Progression|0|||
33475686|NCT04144166|62850496|FG000|Overall Study|Discharged before study start|1|||
33475687|NCT04144166|62850496|FG000|Overall Study|Pregnancy|1|||
33475688|NCT04144166|62850496|FG000|Overall Study|Nail polish could not be removed from finger|1|||
33475689|NCT04142450|62850505|FG000|Overall Study|Screen Failure|1|||
33475690|NCT04142450|62850505|FG000|Overall Study|Lost to Follow-up|1|||
33475691|NCT04529850|62850509|FG000|Overall Study|Death|2|||
33475692|NCT04529850|62850509|FG000|Overall Study|Physician Decision|1|||
33475693|NCT04529850|62850509|FG000|Overall Study|Withdrawal by Subject|2|||
33475694|NCT04225676|62850513|FG000|Overall Study|Physician Decision|1|||
33475695|NCT04225676|62850513|FG000|Overall Study|Lack of Efficacy|1|||
33475696|NCT04225676|62850513|FG000|Overall Study|Study terminated by sponsor|3|||
33475697|NCT04142216|62850521|FG000|Overall Study|Hospitalization|0|||
33475698|NCT04142216|62850522|FG001|Overall Study|Hospitalization|2|||
33475699|NCT04142216|62850521|FG000|Overall Study|Death|3|||
33475700|NCT04142216|62850522|FG001|Overall Study|Death|1|||
33475701|NCT04142216|62850521|FG000|Overall Study|Referral to another hemodialysis unit|3|||
33475702|NCT04142216|62850522|FG001|Overall Study|Referral to another hemodialysis unit|2|||
33475703|NCT04142216|62850521|FG000|Overall Study|Use of clove|0|||
33475704|NCT04142216|62850522|FG001|Overall Study|Use of clove|1|||
33475705|NCT04140890|62850530|FG000|Overall Study|Withdrawal by Subject|0|||
33475706|NCT04140890|62850531|FG001|Overall Study|Withdrawal by Subject|1|||
33549538|NCT02748863|62940694|FG004|Treatment Period 2|Adverse Event|0|||
33549539|NCT02748863|62940690|FG000|Treatment Period 2|Lack of Efficacy|0|||
33549540|NCT02748863|62940691|FG001|Treatment Period 2|Lack of Efficacy|1|||
33549541|NCT02748863|62940692|FG002|Treatment Period 2|Lack of Efficacy|0|||
33549542|NCT02748863|62940693|FG003|Treatment Period 2|Lack of Efficacy|0|||
33549543|NCT02748863|62940694|FG004|Treatment Period 2|Lack of Efficacy|0|||
33549544|NCT02748863|62940690|FG000|Treatment Period 2|Pregnancy|0|||
33549545|NCT02748863|62940691|FG001|Treatment Period 2|Pregnancy|0|||
33549546|NCT02748863|62940692|FG002|Treatment Period 2|Pregnancy|0|||
33549547|NCT02748863|62940693|FG003|Treatment Period 2|Pregnancy|0|||
33549548|NCT02748863|62940694|FG004|Treatment Period 2|Pregnancy|1|||
33549549|NCT02865499|62940715|FG000|Baseline|Adverse Event|1|||
33549550|NCT02865499|62940715|FG000|Baseline|Withdrawal by Subject|1|||
33549551|NCT02870933|62940721|FG000|Overall Study|Death|2|||
33549552|NCT02870933|62940722|FG001|Overall Study|Death|1|||
33549553|NCT02870933|62940721|FG000|Overall Study|Withdrawal by Subject|0|||
33549554|NCT02870933|62940722|FG001|Overall Study|Withdrawal by Subject|1|||
33549555|NCT02864407|62940729|FG000|Overall Study|Protocol Violation|3|||
33549556|NCT02864407|62940729|FG000|Overall Study|Lost to Follow-up|115|||
33549557|NCT02864407|62940729|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
33549558|NCT02864407|62940729|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
33549559|NCT02864407|62940729|FG000|Overall Study|Consent prior to the contract date|1|||
33549560|NCT02873429|62940735|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
33549561|NCT02873429|62940736|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
33549562|NCT02873429|62940735|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
33549563|NCT02873429|62940736|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
33549564|NCT02873429|62940735|FG000|16 Weeks|Lost to Follow-up|3|||
33549565|NCT02873429|62940736|FG001|16 Weeks|Lost to Follow-up|0|||
33363951|NCT00602030|62742740|FG004|Crossover Phase|Disease Progression|11|||
33363952|NCT00602030|62742736|FG000|Crossover Phase|Adverse Event|0|||
33363953|NCT00602030|62742737|FG001|Crossover Phase|Adverse Event|0|||
33363954|NCT00602030|62742738|FG002|Crossover Phase|Adverse Event|0|||
33363955|NCT00602030|62742739|FG003|Crossover Phase|Adverse Event|0|||
33475707|NCT03700320|62850542|FG000|Overall Study|Adverse Event|5|||
33549566|NCT02486302|62940742|FG000|Overall Study|Discontinued prematurely|410|||
33549567|NCT02486302|62940742|FG000|Overall Study|Documentation not completed|255|||
33475708|NCT03700320|62850543|FG001|Overall Study|Adverse Event|31|||
33475709|NCT03700320|62850542|FG000|Overall Study|Lack of Efficacy|2|||
33475710|NCT03700320|62850543|FG001|Overall Study|Lack of Efficacy|5|||
33475711|NCT03700320|62850542|FG000|Overall Study|Withdrawal by Subject|29|||
33549568|NCT02486302|62940742|FG000|Overall Study|Excluded due to legal reasons|8|||
33549569|NCT02486302|62940742|FG000|Overall Study|Not treated|3|||
33549570|NCT02747875|62940757|FG000|Overall Study|Physician Decision|1|||
33549571|NCT02747875|62940758|FG001|Overall Study|Physician Decision|0|||
33363956|NCT00602030|62742740|FG004|Crossover Phase|Adverse Event|3|||
33363957|NCT00602030|62742736|FG000|Crossover Phase|Consent withdrawal|0|||
33363958|NCT00602030|62742737|FG001|Crossover Phase|Consent withdrawal|0|||
33363959|NCT00602030|62742738|FG002|Crossover Phase|Consent withdrawal|0|||
33363960|NCT00602030|62742739|FG003|Crossover Phase|Consent withdrawal|0|||
33363961|NCT00602030|62742740|FG004|Crossover Phase|Consent withdrawal|2|||
33363962|NCT00549757|62742754|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
33549572|NCT02747875|62940757|FG000|Overall Study|Adverse Event|0|||
33363963|NCT00549757|62742755|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
33363964|NCT00549757|62742754|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
33363965|NCT00549757|62742755|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
33363966|NCT00549757|62742754|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
33363967|NCT00549757|62742755|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
33363968|NCT00549757|62742754|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
33363969|NCT00549757|62742755|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
33363970|NCT00549757|62742754|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
33363971|NCT00549757|62742755|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
33363972|NCT00549757|62742754|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
33363973|NCT00549757|62742755|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
33363974|NCT00549757|62742754|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
33363975|NCT00549757|62742755|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
33363976|NCT00549757|62742754|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
33363977|NCT00549757|62742755|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
33363978|NCT00549757|62742754|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
33363979|NCT00549757|62742755|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
33363980|NCT00549757|62742754|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
33363981|NCT00549757|62742755|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
33363982|NCT00549757|62742754|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
33363983|NCT00549757|62742755|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
33363984|NCT00549757|62742754|FG000|Extension Period (in Average 9 Months)|Death|143|||
33363985|NCT00549757|62742755|FG001|Extension Period (in Average 9 Months)|Death|136|||
33363986|NCT00549757|62742754|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
33363987|NCT00549757|62742755|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
33363988|NCT00549757|62742754|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
33363989|NCT00549757|62742755|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
33363990|NCT00549757|62742754|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
33363991|NCT00549757|62742755|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
33363992|NCT00549601|62742770|FG000|Randomized|Protocol Violation|0|||
33363993|NCT00549601|62742771|FG001|Randomized|Protocol Violation|0|||
33363994|NCT00549601|62742772|FG002|Randomized|Protocol Violation|1|||
33363995|NCT00549601|62742770|FG000|Randomized|Withdrawal by Subject|0|||
33363996|NCT00549601|62742771|FG001|Randomized|Withdrawal by Subject|1|||
33363997|NCT00549601|62742772|FG002|Randomized|Withdrawal by Subject|1|||
33363998|NCT00549601|62742770|FG000|Received Study Drug|Adverse Event|2|||
33363999|NCT00549601|62742771|FG001|Received Study Drug|Adverse Event|5|||
33364000|NCT00549601|62742772|FG002|Received Study Drug|Adverse Event|1|||
33364001|NCT00549601|62742770|FG000|Received Study Drug|Death|0|||
33364002|NCT00549601|62742771|FG001|Received Study Drug|Death|1|||
33364003|NCT00549601|62742772|FG002|Received Study Drug|Death|0|||
33364004|NCT00549601|62742770|FG000|Received Study Drug|Lost to Follow-up|0|||
33364005|NCT00549601|62742771|FG001|Received Study Drug|Lost to Follow-up|1|||
33364006|NCT00549601|62742772|FG002|Received Study Drug|Lost to Follow-up|1|||
33364007|NCT00549601|62742770|FG000|Received Study Drug|Protocol Violation|3|||
33364008|NCT00549601|62742771|FG001|Received Study Drug|Protocol Violation|4|||
33364009|NCT00549601|62742772|FG002|Received Study Drug|Protocol Violation|1|||
33364010|NCT00549601|62742770|FG000|Received Study Drug|Withdrawal by Subject|2|||
33364011|NCT00549601|62742771|FG001|Received Study Drug|Withdrawal by Subject|0|||
33364012|NCT00549601|62742772|FG002|Received Study Drug|Withdrawal by Subject|1|||
33364013|NCT00601640|62742798|FG000|Overall Study|Withdrawal by Subject|3|||
33364014|NCT00601640|62742799|FG001|Overall Study|Withdrawal by Subject|0|||
33364015|NCT00601640|62742800|FG002|Overall Study|Withdrawal by Subject|7|||
33364016|NCT00601640|62742798|FG000|Overall Study|Death|1|||
33364017|NCT00601640|62742799|FG001|Overall Study|Death|0|||
33364018|NCT00601640|62742800|FG002|Overall Study|Death|0|||
33364019|NCT00601640|62742798|FG000|Overall Study|Adverse Event|0|||
33364020|NCT00601640|62742799|FG001|Overall Study|Adverse Event|4|||
33364021|NCT00601640|62742800|FG002|Overall Study|Adverse Event|2|||
33549573|NCT02747875|62940758|FG001|Overall Study|Adverse Event|1|||
33549574|NCT02451124|62940784|FG000|Overall Study|Withdrawal by Subject|1|||
33364022|NCT00601640|62742798|FG000|Overall Study|intercurrent illness|1|||
33364023|NCT00601640|62742799|FG001|Overall Study|intercurrent illness|0|||
33364024|NCT00601640|62742800|FG002|Overall Study|intercurrent illness|0|||
33364025|NCT00601640|62742798|FG000|Overall Study|change in eligibility status|0|||
33364026|NCT00601640|62742799|FG001|Overall Study|change in eligibility status|1|||
33364027|NCT00601640|62742800|FG002|Overall Study|change in eligibility status|1|||
33364028|NCT02805725|62742815|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
33364029|NCT02805725|62742816|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
33364030|NCT02805725|62742817|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
33364031|NCT02805725|62742818|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
33364032|NCT02805725|62742819|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
33364033|NCT02805725|62742815|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
33364034|NCT02805725|62742816|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
33364035|NCT02805725|62742817|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
33364036|NCT02805725|62742818|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
33364037|NCT02805725|62742819|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
33364038|NCT02805725|62742815|FG000|Phase II|Protocol Violation|0|||
33364039|NCT02805725|62742816|FG001|Phase II|Protocol Violation|0|||
33364040|NCT02805725|62742817|FG002|Phase II|Protocol Violation|0|||
33364041|NCT02805725|62742818|FG003|Phase II|Protocol Violation|0|||
33364042|NCT02805725|62742819|FG004|Phase II|Protocol Violation|6|||
33364043|NCT00546871|62742836|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
33364044|NCT00546871|62742837|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
33364045|NCT00546871|62742836|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
33364046|NCT00546871|62742837|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
33364047|NCT00546871|62742836|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
33364048|NCT00546871|62742837|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
33364049|NCT00546871|62742836|FG000|Study Extension Period|Protocol Violation|1|||
33364050|NCT00546871|62742837|FG001|Study Extension Period|Protocol Violation|0|||
33364051|NCT00546871|62742836|FG000|Study Extension Period|Withdrawal by Subject|0|||
33364052|NCT00546871|62742837|FG001|Study Extension Period|Withdrawal by Subject|1|||
33364053|NCT03951805|62742870|FG000|Overall Study|Adverse Event|1|||
33364054|NCT03951805|62742871|FG001|Overall Study|Adverse Event|0|||
33364055|NCT03951805|62742872|FG002|Overall Study|Adverse Event|0|||
33364056|NCT03951805|62742873|FG003|Overall Study|Adverse Event|0|||
33364057|NCT03944707|62742885|FG000|Overall Study|Adverse Event|0|||
33364058|NCT03944707|62742886|FG001|Overall Study|Adverse Event|2|||
33364059|NCT03944707|62742885|FG000|Overall Study|Study terminated by sponsor|12|||
33364060|NCT03944707|62742886|FG001|Overall Study|Study terminated by sponsor|7|||
33364061|NCT03944707|62742885|FG000|Overall Study|Subject decision|0|||
33364062|NCT03944707|62742886|FG001|Overall Study|Subject decision|1|||
33364063|NCT00549055|62742892|FG000|Overall Study|Adverse Event|4|||
33364064|NCT00549055|62742892|FG000|Overall Study|Lack of Efficacy|18|||
33364065|NCT00549055|62742892|FG000|Overall Study|Stabilization|5|||
33364066|NCT00549055|62742892|FG000|Overall Study|Progression to fibrosis|2|||
33364067|NCT00549055|62742892|FG000|Overall Study|Decrease of size|1|||
33364068|NCT00549055|62742892|FG000|Overall Study|Active choroidal neovascula increased|1|||
33364069|NCT00549055|62742892|FG000|Overall Study|Vitreous hemorrhage|1|||
33364070|NCT00549055|62742892|FG000|Overall Study|Growth choroidal neovascularisation|1|||
33364071|NCT00549055|62742892|FG000|Overall Study|Choroidal neovascularization|1|||
33364072|NCT00549055|62742892|FG000|Overall Study|Very low visual acuity (VA)|1|||
33364073|NCT00883116|62742898|FG000|Overall Study|Adverse event unrelated to study drug|5|||
33364074|NCT00883116|62742899|FG001|Overall Study|Adverse event unrelated to study drug|10|||
33364075|NCT00883116|62742898|FG000|Overall Study|Death|6|||
33364076|NCT00883116|62742899|FG001|Overall Study|Death|2|||
33364077|NCT00883116|62742898|FG000|Overall Study|Disease progression|130|||
33364078|NCT00883116|62742899|FG001|Overall Study|Disease progression|128|||
33364079|NCT00883116|62742898|FG000|Overall Study|Lost to Follow-up|0|||
33364080|NCT00883116|62742899|FG001|Overall Study|Lost to Follow-up|1|||
33364081|NCT00883116|62742898|FG000|Overall Study|Maximum clinical benefit|13|||
33364082|NCT00883116|62742899|FG001|Overall Study|Maximum clinical benefit|46|||
33364083|NCT00883116|62742898|FG000|Overall Study|Not identified|3|||
33364084|NCT00883116|62742899|FG001|Overall Study|Not identified|6|||
33364085|NCT00883116|62742898|FG000|Overall Study|Study drug toxicity|36|||
33364086|NCT00883116|62742899|FG001|Overall Study|Study drug toxicity|16|||
33364087|NCT00883116|62742898|FG000|Overall Study|Withdrawal by Subject|14|||
33364088|NCT00883116|62742899|FG001|Overall Study|Withdrawal by Subject|8|||
33364089|NCT00883116|62742898|FG000|Overall Study|No longer meets study criteria|2|||
33364090|NCT00883116|62742899|FG001|Overall Study|No longer meets study criteria|2|||
33364091|NCT00594399|62742918|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
33364092|NCT00594399|62742919|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
33364093|NCT00594399|62742920|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
33364094|NCT00594399|62742918|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
33364095|NCT00594399|62742919|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
33364096|NCT00594399|62742920|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
33364097|NCT00594399|62742918|FG000|Initial 3 Month Counseling|Personal issues|2|||
33364098|NCT00594399|62742919|FG001|Initial 3 Month Counseling|Personal issues|0|||
33364099|NCT00594399|62742920|FG002|Initial 3 Month Counseling|Personal issues|0|||
33364100|NCT00594399|62742918|FG000|Initial 3 Month Counseling|Too busy|7|||
33364101|NCT00594399|62742919|FG001|Initial 3 Month Counseling|Too busy|1|||
33364102|NCT00594399|62742920|FG002|Initial 3 Month Counseling|Too busy|0|||
33364103|NCT00594399|62742918|FG000|Initial 3 Month Counseling|Pain|2|||
33364104|NCT00594399|62742919|FG001|Initial 3 Month Counseling|Pain|0|||
33364105|NCT00594399|62742920|FG002|Initial 3 Month Counseling|Pain|0|||
33364106|NCT00594399|62742918|FG000|Initial 3 Month Counseling|Moved|1|||
33364107|NCT00594399|62742919|FG001|Initial 3 Month Counseling|Moved|0|||
33364108|NCT00594399|62742920|FG002|Initial 3 Month Counseling|Moved|0|||
33364109|NCT00594399|62742918|FG000|Initial 3 Month Counseling|Family illness|1|||
33364110|NCT00594399|62742919|FG001|Initial 3 Month Counseling|Family illness|0|||
33364111|NCT00594399|62742920|FG002|Initial 3 Month Counseling|Family illness|0|||
33364112|NCT00594399|62742918|FG000|Rerandomization Arm 1 Only|Death|2|||
33364113|NCT00594399|62742919|FG001|Rerandomization Arm 1 Only|Death|1|||
33364114|NCT00594399|62742920|FG002|Rerandomization Arm 1 Only|Death|0|||
33364115|NCT00594399|62742918|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
33364116|NCT00594399|62742919|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
33364117|NCT00594399|62742920|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
33364118|NCT00546715|62742930|FG000|Overall Study|Withdrawal by Subject|0|||
33364119|NCT00546715|62742931|FG001|Overall Study|Withdrawal by Subject|1|||
33364120|NCT00546715|62742932|FG002|Overall Study|Withdrawal by Subject|0|||
33364121|NCT00546715|62742933|FG003|Overall Study|Withdrawal by Subject|0|||
33364122|NCT00874029|62742943|FG000|Overall Study|Withdrawal by Subject|10|||
33364123|NCT00874029|62742943|FG000|Overall Study|Pregnancy|4|||
33364124|NCT00874029|62742943|FG000|Overall Study|Physician Decision|1|||
33364125|NCT00874029|62742943|FG000|Overall Study|Adverse Event|1|||
33364126|NCT00874029|62742943|FG000|Overall Study|Lost to Follow-up|5|||
33364127|NCT00546637|62742959|FG000|Overall Study|Adverse Event|46|||
33364128|NCT00546637|62742960|FG001|Overall Study|Adverse Event|20|||
33364129|NCT00546637|62742959|FG000|Overall Study|Lack of Efficacy|5|||
33364130|NCT00546637|62742960|FG001|Overall Study|Lack of Efficacy|5|||
33364131|NCT00546637|62742959|FG000|Overall Study|Lost to Follow-up|2|||
33364132|NCT00546637|62742960|FG001|Overall Study|Lost to Follow-up|2|||
33364133|NCT00546637|62742959|FG000|Overall Study|Other|10|||
33364134|NCT00546637|62742960|FG001|Overall Study|Other|12|||
33364135|NCT00546637|62742959|FG000|Overall Study|Withdrawal by Subject|7|||
33475712|NCT03700320|62850543|FG001|Overall Study|Withdrawal by Subject|75|||
33475713|NCT03700320|62850542|FG000|Overall Study|Lost to Follow-up|16|||
33475714|NCT03700320|62850543|FG001|Overall Study|Lost to Follow-up|23|||
33475715|NCT03700320|62850542|FG000|Overall Study|Pregnancy|2|||
33475716|NCT03700320|62850543|FG001|Overall Study|Pregnancy|4|||
33475717|NCT03700320|62850542|FG000|Overall Study|Protocol Deviation|7|||
33475718|NCT03700320|62850543|FG001|Overall Study|Protocol Deviation|31|||
33475719|NCT03700320|62850542|FG000|Overall Study|Non-compliance with Study Drug|1|||
33475720|NCT03700320|62850543|FG001|Overall Study|Non-compliance with Study Drug|3|||
33475721|NCT03700320|62850542|FG000|Overall Study|Reason not Specified|0|||
33475722|NCT03700320|62850543|FG001|Overall Study|Reason not Specified|1|||
33475723|NCT04139018|62850551|FG000|Overall Study|Screen fail|1|||
33475724|NCT04139018|62850552|FG001|Overall Study|Screen fail|0|||
33475725|NCT04139018|62850551|FG000|Overall Study|Withdrawal by Subject|2|||
33475726|NCT04139018|62850552|FG001|Overall Study|Withdrawal by Subject|0|||
33475727|NCT04139018|62850551|FG000|Overall Study|Lost to Follow-up|0|||
33475728|NCT04139018|62850552|FG001|Overall Study|Lost to Follow-up|1|||
33549575|NCT02450578|62940796|FG000|Overall Study|ECG abnormality so not treated|1|||
33549576|NCT02450578|62940797|FG001|Overall Study|ECG abnormality so not treated|0|||
33549577|NCT02450578|62940798|FG002|Overall Study|ECG abnormality so not treated|0|||
33549578|NCT02450578|62940799|FG003|Overall Study|ECG abnormality so not treated|0|||
33364136|NCT00546637|62742960|FG001|Overall Study|Withdrawal by Subject|9|||
33364137|NCT00546637|62742959|FG000|Overall Study|Randomized, but not treated|3|||
33364138|NCT00546637|62742960|FG001|Overall Study|Randomized, but not treated|1|||
33364139|NCT00546481|62742968|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
33364140|NCT00546481|62742969|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
33475729|NCT04456686|62850560|FG000|Overall Study|Adverse Event|2|||
33475730|NCT04456686|62850561|FG001|Overall Study|Adverse Event|1|||
33475731|NCT04456686|62850560|FG000|Overall Study|Lack of Efficacy|3|||
33475732|NCT04456686|62850561|FG001|Overall Study|Lack of Efficacy|1|||
33475733|NCT04456686|62850560|FG000|Overall Study|Withdrew consent|3|||
33475734|NCT04456686|62850561|FG001|Overall Study|Withdrew consent|1|||
33475735|NCT04456686|62850560|FG000|Overall Study|Physician Decision|2|||
33475736|NCT04456686|62850561|FG001|Overall Study|Physician Decision|2|||
33364141|NCT00546481|62742970|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
33364142|NCT00546481|62742968|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
33475737|NCT04456686|62850560|FG000|Overall Study|Withdrawal by Subject|5|||
33475738|NCT04456686|62850561|FG001|Overall Study|Withdrawal by Subject|1|||
33475739|NCT04456686|62850560|FG000|Overall Study|Protocol Violation|0|||
33475740|NCT04456686|62850561|FG001|Overall Study|Protocol Violation|1|||
33475741|NCT04527978|62850569|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
33475742|NCT04527978|62850570|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
33475743|NCT04136444|62850581|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
33475744|NCT04136444|62850582|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
33475745|NCT04425252|62850596|FG000|Overall Study|Withdrawal by Subject|2|||
33475746|NCT04425252|62850597|FG001|Overall Study|Withdrawal by Subject|1|||
33475747|NCT04425252|62850596|FG000|Overall Study|Lost to Follow-up|1|||
33475748|NCT04425252|62850597|FG001|Overall Study|Lost to Follow-up|0|||
33475749|NCT04425252|62850596|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
33475750|NCT04425252|62850597|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
33475751|NCT03696576|62850608|FG000|Overall Study|Soreness of throat after therapy|1|||
33475752|NCT03696576|62850609|FG001|Overall Study|Soreness of throat after therapy|1|||
33475753|NCT03696576|62850608|FG000|Overall Study|Lost to Follow-up|2|||
33549579|NCT02449018|62940826|FG000|Overall Study|Abnormal laboratory value|0|||
33549580|NCT02449018|62940827|FG001|Overall Study|Abnormal laboratory value|1|||
33475754|NCT03696576|62850609|FG001|Overall Study|Lost to Follow-up|4|||
33364143|NCT00546481|62742969|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
33364144|NCT00546481|62742970|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
33364145|NCT00546481|62742968|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
33364146|NCT00546481|62742969|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
33364147|NCT00546481|62742970|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
33364148|NCT00546481|62742968|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
33364149|NCT00546481|62742969|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
33364150|NCT00546481|62742970|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
33364151|NCT00546481|62742968|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
33364152|NCT00546481|62742969|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
33364153|NCT00546481|62742970|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
33364154|NCT00546481|62742968|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
33364155|NCT00546481|62742969|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
33364156|NCT00546481|62742970|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
33364157|NCT00546481|62742968|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
33364158|NCT00546481|62742969|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
33364159|NCT00546481|62742970|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
33364160|NCT00546481|62742968|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
33364161|NCT00546481|62742969|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
33475755|NCT04003610|62850618|FG000|Overall Study|Lost to Follow-up|0|||
33475756|NCT04003610|62850619|FG001|Overall Study|Lost to Follow-up|1|||
33549581|NCT02449018|62940826|FG000|Overall Study|Administrative problems|1|||
33549582|NCT02449018|62940827|FG001|Overall Study|Administrative problems|0|||
33549583|NCT02449018|62940826|FG000|Overall Study|Adverse Event|5|||
33549584|NCT02449018|62940827|FG001|Overall Study|Adverse Event|1|||
33549585|NCT02449018|62940826|FG000|Overall Study|Protocol deviation|4|||
33549586|NCT02449018|62940827|FG001|Overall Study|Protocol deviation|0|||
33549587|NCT02449018|62940826|FG000|Overall Study|Patient decision|2|||
33549588|NCT02449018|62940827|FG001|Overall Study|Patient decision|0|||
33549589|NCT02859415|62940835|FG000|Overall Study|Physician Decision|1|||
33549590|NCT02859415|62940836|FG001|Overall Study|Physician Decision|0|||
33549591|NCT02859415|62940835|FG000|Overall Study|Off treatment due to cardiac event|0|||
33549592|NCT02859415|62940836|FG001|Overall Study|Off treatment due to cardiac event|1|||
33549593|NCT02871791|62940846|FG000|Phase 1b|Death|0|||
33549594|NCT02871791|62940847|FG001|Phase 1b|Death|1|||
33549595|NCT02871791|62940846|FG000|Phase 1b|progressive disease|6|||
33549596|NCT02871791|62940847|FG001|Phase 1b|progressive disease|2|||
33475757|NCT04003610|62850620|FG002|Overall Study|Lost to Follow-up|0|||
33475758|NCT04003610|62850618|FG000|Overall Study|Death|0|||
33475759|NCT04003610|62850619|FG001|Overall Study|Death|0|||
33475760|NCT04003610|62850620|FG002|Overall Study|Death|3|||
33475761|NCT04003610|62850618|FG000|Overall Study|Study Terminated by Sponsor|0|||
33549597|NCT02871791|62940846|FG000|Phase 2|Death|1|||
33549598|NCT02871791|62940847|FG001|Phase 2|Death|0|||
33549599|NCT02871791|62940846|FG000|Phase 2|Lost to Follow-up|2|||
33549600|NCT02871791|62940847|FG001|Phase 2|Lost to Follow-up|0|||
33549601|NCT02871635|62940855|FG000|Overall Study|Primary lack of efficacy|4|||
33475762|NCT04003610|62850619|FG001|Overall Study|Study Terminated by Sponsor|0|||
33475763|NCT04003610|62850620|FG002|Overall Study|Study Terminated by Sponsor|3|||
33475764|NCT03999554|62850634|FG000|Overall Study|Lost to Follow-up|4|||
33475765|NCT03999554|62850635|FG001|Overall Study|Lost to Follow-up|5|||
33475766|NCT03999554|62850636|FG002|Overall Study|Lost to Follow-up|4|||
33549602|NCT02871635|62940856|FG001|Overall Study|Primary lack of efficacy|4|||
33549603|NCT02871635|62940855|FG000|Overall Study|Protocol Violation|3|||
33549604|NCT02871635|62940856|FG001|Overall Study|Protocol Violation|1|||
33549605|NCT02871635|62940855|FG000|Overall Study|Lost to Follow-up|1|||
33549606|NCT02871635|62940856|FG001|Overall Study|Lost to Follow-up|2|||
33549607|NCT02871635|62940855|FG000|Overall Study|Pregnancy|0|||
33549608|NCT02871635|62940856|FG001|Overall Study|Pregnancy|2|||
33549609|NCT02871635|62940855|FG000|Overall Study|Physician Decision|1|||
33549610|NCT02871635|62940856|FG001|Overall Study|Physician Decision|1|||
33549611|NCT02871635|62940855|FG000|Overall Study|Withdrawal by Subject|3|||
33475767|NCT03999554|62850637|FG003|Overall Study|Lost to Follow-up|5|||
33475768|NCT03999554|62850638|FG004|Overall Study|Lost to Follow-up|8|||
33475769|NCT03999554|62850634|FG000|Overall Study|Protocol Violation|0|||
33475770|NCT03999554|62850635|FG001|Overall Study|Protocol Violation|0|||
33475771|NCT03999554|62850636|FG002|Overall Study|Protocol Violation|5|||
33549612|NCT02871635|62940856|FG001|Overall Study|Withdrawal by Subject|4|||
33549613|NCT02871635|62940855|FG000|Overall Study|Adverse Event|4|||
33549614|NCT02871635|62940856|FG001|Overall Study|Adverse Event|4|||
33549615|NCT02871635|62940855|FG000|Overall Study|Secondary lack of efficacy|2|||
33475772|NCT03999554|62850637|FG003|Overall Study|Protocol Violation|0|||
33475773|NCT03999554|62850638|FG004|Overall Study|Protocol Violation|0|||
33475774|NCT03999554|62850634|FG000|Overall Study|Pregnancy|0|||
33475775|NCT03999554|62850635|FG001|Overall Study|Pregnancy|0|||
33475776|NCT03999554|62850636|FG002|Overall Study|Pregnancy|1|||
33475777|NCT03999554|62850637|FG003|Overall Study|Pregnancy|0|||
33475778|NCT03999554|62850638|FG004|Overall Study|Pregnancy|0|||
33475779|NCT03999554|62850634|FG000|Overall Study|Withdrawal by Subject|2|||
33475780|NCT03999554|62850635|FG001|Overall Study|Withdrawal by Subject|2|||
33475781|NCT03999554|62850636|FG002|Overall Study|Withdrawal by Subject|2|||
33475782|NCT03999554|62850637|FG003|Overall Study|Withdrawal by Subject|1|||
33475783|NCT03999554|62850638|FG004|Overall Study|Withdrawal by Subject|1|||
33475784|NCT03999554|62850634|FG000|Overall Study|failure to comply with protocol requirements|0|||
33475785|NCT03999554|62850635|FG001|Overall Study|failure to comply with protocol requirements|0|||
33549616|NCT02871635|62940856|FG001|Overall Study|Secondary lack of efficacy|1|||
33549617|NCT02477332|62940870|FG000|Overall Study|Adverse Event|0|||
33549618|NCT02477332|62940871|FG001|Overall Study|Adverse Event|1|||
33549619|NCT02477332|62940872|FG002|Overall Study|Adverse Event|1|||
33549620|NCT02477332|62940873|FG003|Overall Study|Adverse Event|2|||
33549621|NCT02477332|62940874|FG004|Overall Study|Adverse Event|1|||
33549622|NCT02477332|62940875|FG005|Overall Study|Adverse Event|2|||
33655720|NCT01859741|63072873|FG000|Overall Study|Withdrawal by Subject|0|||
33475786|NCT03999554|62850636|FG002|Overall Study|failure to comply with protocol requirements|0|||
33475787|NCT03999554|62850637|FG003|Overall Study|failure to comply with protocol requirements|1|||
33475788|NCT03999554|62850638|FG004|Overall Study|failure to comply with protocol requirements|0|||
33475789|NCT04129346|62850653|FG000|Overall Study|Death|1|||
33475790|NCT04129346|62850654|FG001|Overall Study|Death|0|||
33475791|NCT04526574|62850662|FG000|Overall Study|Protocol Violation|3|||
33475792|NCT04526574|62850663|FG001|Overall Study|Protocol Violation|1|||
33475793|NCT04526574|62850662|FG000|Overall Study|Withdrawal by Subject|12|||
33475794|NCT04526574|62850663|FG001|Overall Study|Withdrawal by Subject|9|||
33475795|NCT04526574|62850662|FG000|Overall Study|Other|1|||
33475796|NCT04526574|62850663|FG001|Overall Study|Other|2|||
33475797|NCT04526574|62850662|FG000|Overall Study|Adverse Event|1|||
33475798|NCT04526574|62850663|FG001|Overall Study|Adverse Event|1|||
33475799|NCT04526574|62850662|FG000|Overall Study|Death|2|||
33475800|NCT04526574|62850663|FG001|Overall Study|Death|3|||
33475801|NCT04526574|62850662|FG000|Overall Study|Lost to Follow-up|9|||
33475802|NCT04526574|62850663|FG001|Overall Study|Lost to Follow-up|9|||
33475803|NCT04526574|62850662|FG000|Overall Study|No longer meets eligibility criteria|8|||
33475804|NCT04526574|62850663|FG001|Overall Study|No longer meets eligibility criteria|8|||
33475805|NCT03993392|62850673|FG000|Overall Study|Withdrawal by Subject|3|||
33655721|NCT01859741|63072874|FG001|Overall Study|Withdrawal by Subject|1|||
33475806|NCT03993392|62850673|FG000|Overall Study|Lost to Follow-up|2|||
33475807|NCT03993392|62850673|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
33475808|NCT04422990|62850680|FG000|Overall Study|Withdrawal by Subject|0|||
33475809|NCT04422990|62850681|FG001|Overall Study|Withdrawal by Subject|1|||
33475810|NCT04422990|62850680|FG000|Overall Study|Travel|3|||
33549623|NCT02477332|62940870|FG000|Overall Study|Lack of Efficacy|1|||
33549624|NCT02477332|62940871|FG001|Overall Study|Lack of Efficacy|2|||
33549625|NCT02477332|62940872|FG002|Overall Study|Lack of Efficacy|1|||
33475811|NCT04422990|62850681|FG001|Overall Study|Travel|0|||
33549626|NCT02477332|62940873|FG003|Overall Study|Lack of Efficacy|2|||
33549627|NCT02477332|62940874|FG004|Overall Study|Lack of Efficacy|1|||
33475812|NCT04377308|62850692|FG000|Overall Study|Withdrawal by Subject|0|||
33475813|NCT04377308|62850693|FG001|Overall Study|Withdrawal by Subject|1|||
33475814|NCT04447404|62850701|FG000|Overall Study|Death|2|||
33475815|NCT04447404|62850702|FG001|Overall Study|Death|0|||
33475816|NCT03988166|62850708|FG000|Overall Study|Lost to Follow-up|2|||
33475817|NCT03988166|62850708|FG000|Overall Study|Death|1|||
33475818|NCT03988088|62850717|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
33475819|NCT03988088|62850718|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
33475820|NCT03988088|62850719|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
33475821|NCT03988088|62850720|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
33475822|NCT03988088|62850717|FG000|Open-Label Addendum|Lost to Follow-up|0|||
33475823|NCT03988088|62850718|FG001|Open-Label Addendum|Lost to Follow-up|0|||
33475824|NCT03988088|62850719|FG002|Open-Label Addendum|Lost to Follow-up|1|||
33475825|NCT03988088|62850720|FG003|Open-Label Addendum|Lost to Follow-up|0|||
33475826|NCT03987932|62850731|FG000|Overall Study|Lost to Follow-up|2|||
33475827|NCT03987932|62850732|FG001|Overall Study|Lost to Follow-up|1|||
33475828|NCT03987932|62850733|FG002|Overall Study|Lost to Follow-up|1|||
33475829|NCT03987932|62850731|FG000|Overall Study|Non-study related elective surgery|0|||
33475830|NCT03987932|62850732|FG001|Overall Study|Non-study related elective surgery|0|||
33475831|NCT03987932|62850733|FG002|Overall Study|Non-study related elective surgery|1|||
33475832|NCT03987620|62850743|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
33475833|NCT03987620|62850744|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
33475834|NCT03987620|62850743|FG000|Overall Study|Adverse Event|3|||
33475835|NCT03987620|62850744|FG001|Overall Study|Adverse Event|0|||
33475836|NCT03987620|62850743|FG000|Overall Study|Lost to Follow-up|1|||
33475837|NCT03987620|62850744|FG001|Overall Study|Lost to Follow-up|2|||
33475838|NCT03987620|62850743|FG000|Overall Study|Physician Decision|0|||
33475839|NCT03987620|62850744|FG001|Overall Study|Physician Decision|1|||
33475840|NCT03987620|62850743|FG000|Overall Study|Pregnancy|1|||
33475841|NCT03987620|62850744|FG001|Overall Study|Pregnancy|0|||
33475842|NCT03987620|62850743|FG000|Overall Study|Withdrawal by Subject|7|||
33475843|NCT03987620|62850744|FG001|Overall Study|Withdrawal by Subject|1|||
33475844|NCT03987620|62850743|FG000|Overall Study|Other|2|||
33475845|NCT03987620|62850744|FG001|Overall Study|Other|5|||
33475846|NCT04376060|62850750|FG000|Overall Study|Physician Decision|1|||
33475847|NCT04413552|62850764|FG000|Overall Study|Adverse Event|0|||
33475848|NCT04413552|62850765|FG001|Overall Study|Adverse Event|0|||
33475849|NCT04413552|62850766|FG002|Overall Study|Adverse Event|0|||
33475850|NCT04413552|62850767|FG003|Overall Study|Adverse Event|0|||
33475851|NCT04413552|62850768|FG004|Overall Study|Adverse Event|0|||
33475852|NCT04413552|62850769|FG005|Overall Study|Adverse Event|0|||
33475853|NCT04413552|62850770|FG006|Overall Study|Adverse Event|1|||
33475854|NCT04413552|62850771|FG007|Overall Study|Adverse Event|0|||
33475855|NCT04413552|62850772|FG008|Overall Study|Adverse Event|0|||
33475856|NCT04413552|62850773|FG009|Overall Study|Adverse Event|0|||
33475857|NCT03987074|62850804|FG000|Overall Study|Withdrew Consent|1|||
33475858|NCT03987074|62850805|FG001|Overall Study|Withdrew Consent|1|||
33475859|NCT03987074|62850806|FG002|Overall Study|Withdrew Consent|0|||
33475860|NCT03987074|62850807|FG003|Overall Study|Withdrew Consent|2|||
33475861|NCT03987074|62850808|FG004|Overall Study|Withdrew Consent|1|||
33475862|NCT03987074|62850804|FG000|Overall Study|Adverse Event|2|||
33475863|NCT03987074|62850805|FG001|Overall Study|Adverse Event|1|||
33475864|NCT03987074|62850806|FG002|Overall Study|Adverse Event|0|||
33475865|NCT03987074|62850807|FG003|Overall Study|Adverse Event|0|||
33475866|NCT03987074|62850808|FG004|Overall Study|Adverse Event|1|||
33475867|NCT03987074|62850804|FG000|Overall Study|Lost to Follow-up|0|||
33475868|NCT03987074|62850805|FG001|Overall Study|Lost to Follow-up|0|||
33475869|NCT03987074|62850806|FG002|Overall Study|Lost to Follow-up|1|||
33475870|NCT03987074|62850807|FG003|Overall Study|Lost to Follow-up|1|||
33475871|NCT03987074|62850808|FG004|Overall Study|Lost to Follow-up|0|||
33475872|NCT03987074|62850804|FG000|Overall Study|Investigator's Discretion|0|||
33475873|NCT03987074|62850805|FG001|Overall Study|Investigator's Discretion|0|||
33475874|NCT03987074|62850806|FG002|Overall Study|Investigator's Discretion|0|||
33475875|NCT03987074|62850807|FG003|Overall Study|Investigator's Discretion|1|||
33475876|NCT03987074|62850808|FG004|Overall Study|Investigator's Discretion|0|||
33475877|NCT04439214|62850820|FG000|Overall Study|Adverse Event|13|||
33475878|NCT04439214|62850820|FG000|Overall Study|Disease progression|16|||
33475879|NCT04439214|62850820|FG000|Overall Study|Death|1|||
33475880|NCT04439214|62850820|FG000|Overall Study|Withdrawal by Subject|2|||
33475881|NCT04439214|62850820|FG000|Overall Study|Declining health|1|||
33475882|NCT04439214|62850820|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
33475883|NCT04439214|62850820|FG000|Overall Study|Ineligible|5|||
33475884|NCT03696342|62850826|FG000|Overall Study|Lost to Follow-up|1|||
33475885|NCT03696342|62850827|FG001|Overall Study|Lost to Follow-up|0|||
33475886|NCT04411680|62850835|FG000|Treatment Period|Adverse Event|3|||
33549628|NCT02477332|62940875|FG005|Overall Study|Lack of Efficacy|1|||
33475887|NCT04411680|62850836|FG001|Treatment Period|Adverse Event|0|||
33475888|NCT04411680|62850835|FG000|Treatment Period|Discharged from hospital|18|||
33475889|NCT04411680|62850836|FG001|Treatment Period|Discharged from hospital|7|||
33475890|NCT04411680|62850835|FG000|Treatment Period|Missed 1 or more doses|8|||
33475891|NCT04411680|62850836|FG001|Treatment Period|Missed 1 or more doses|0|||
33475892|NCT04411680|62850835|FG000|Treatment Period|Transferred to another hospital|0|||
33475893|NCT04411680|62850836|FG001|Treatment Period|Transferred to another hospital|1|||
33475894|NCT04411680|62850835|FG000|Follow up Period|Withdrawal by Subject|2|||
33475895|NCT04411680|62850836|FG001|Follow up Period|Withdrawal by Subject|0|||
33475896|NCT04411680|62850835|FG000|Follow up Period|Lost to Follow-up|5|||
33475897|NCT04411680|62850836|FG001|Follow up Period|Lost to Follow-up|6|||
33475898|NCT04411680|62850835|FG000|Follow up Period|Death|11|||
33475899|NCT04411680|62850836|FG001|Follow up Period|Death|8|||
33475900|NCT04410198|62850842|FG000|Overall Study|Death|10|||
33475901|NCT04410198|62850842|FG000|Overall Study|Withdrawal by Subject|7|||
33475902|NCT04410198|62850842|FG000|Overall Study|Transferred/Relocation|4|||
33475903|NCT04410198|62850842|FG000|Overall Study|Kidney Transplant|9|||
33475904|NCT04410198|62850842|FG000|Overall Study|Adverse Event|4|||
33475905|NCT04410198|62850842|FG000|Overall Study|Physician Decision|2|||
33475906|NCT04410198|62850842|FG000|Overall Study|Other than specified|1|||
33475907|NCT04161144|62850848|FG000|Overall Study|Withdrawal by Subject|0|||
33475908|NCT04161144|62850849|FG001|Overall Study|Withdrawal by Subject|1|||
33475909|NCT04161144|62850848|FG000|Overall Study|Protocol Violation|1|||
33475910|NCT04161144|62850849|FG001|Overall Study|Protocol Violation|0|||
33475911|NCT03984812|62850866|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33475912|NCT03984812|62850867|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33475913|NCT03984812|62850868|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
33475914|NCT03984812|62850869|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33475915|NCT03984812|62850870|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33475916|NCT03984812|62850871|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33475917|NCT03984812|62850872|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33475918|NCT03984812|62850873|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33475919|NCT03984812|62850874|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33475920|NCT03984812|62850875|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33475921|NCT03984812|62850876|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33475922|NCT04160988|62850903|FG000|Overall Study|poor image quality|28|||
33475923|NCT04153188|62850924|FG000|Overall Study|Lost to Follow-up|1|||
33475924|NCT04153188|62850925|FG001|Overall Study|Lost to Follow-up|1|||
33475925|NCT04153188|62850924|FG000|Overall Study|Withdrawal by Subject|2|||
33475926|NCT04153188|62850925|FG001|Overall Study|Withdrawal by Subject|0|||
33475927|NCT04153188|62850924|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
33475928|NCT04153188|62850925|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
33475929|NCT04113746|62850933|FG000|Overall Study|Lost to Follow-up|4|||
33475930|NCT04113746|62850934|FG001|Overall Study|Lost to Follow-up|4|||
33475931|NCT03611010|62850944|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
33475932|NCT03611010|62850945|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
33475933|NCT03611010|62850946|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
33475934|NCT03611010|62850947|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
33475935|NCT04357782|62850962|FG000|Overall Study|Discharged from hospital|1|||
33475936|NCT04357782|62850963|FG001|Overall Study|Discharged from hospital|0|||
33549629|NCT02477332|62940870|FG000|Overall Study|Non-compliance with study treatment|0|||
33655722|NCT01859741|63072875|FG002|Overall Study|Withdrawal by Subject|2|||
33475937|NCT04357782|62850962|FG000|Overall Study|Death|0|||
33475938|NCT04357782|62850963|FG001|Overall Study|Death|2|||
33475939|NCT03980522|62850974|FG000|Treatment Period|Adverse Event|1|||
33475940|NCT03980522|62850975|FG001|Treatment Period|Adverse Event|0|||
33475941|NCT03980522|62850976|FG002|Treatment Period|Adverse Event|0|||
33475942|NCT03980522|62850977|FG003|Treatment Period|Adverse Event|0|||
33475943|NCT03980522|62850978|FG004|Treatment Period|Adverse Event|0|||
33475944|NCT04402866|62850996|FG000|Overall Study|Discontinued Prior to Treatment|0|||
33475945|NCT04402866|62850997|FG001|Overall Study|Discontinued Prior to Treatment|0|||
33475946|NCT04402866|62850998|FG002|Overall Study|Discontinued Prior to Treatment|0|||
33475947|NCT04402866|62850999|FG003|Overall Study|Discontinued Prior to Treatment|0|||
33475948|NCT04402866|62851000|FG004|Overall Study|Discontinued Prior to Treatment|2|||
33475949|NCT04402866|62851001|FG005|Overall Study|Discontinued Prior to Treatment|3|||
33475950|NCT04402866|62850996|FG000|Overall Study|Adverse Event|2|||
33475951|NCT04402866|62850997|FG001|Overall Study|Adverse Event|1|||
33475952|NCT04402866|62850998|FG002|Overall Study|Adverse Event|0|||
33475953|NCT04402866|62850999|FG003|Overall Study|Adverse Event|0|||
33655723|NCT01859741|63072876|FG003|Overall Study|Withdrawal by Subject|0|||
33475954|NCT04402866|62851000|FG004|Overall Study|Adverse Event|13|||
33475955|NCT04402866|62851001|FG005|Overall Study|Adverse Event|8|||
33475956|NCT04402866|62850996|FG000|Overall Study|Miscellaneous|0|||
33475957|NCT04402866|62850997|FG001|Overall Study|Miscellaneous|0|||
33655724|NCT01859741|63072877|FG004|Overall Study|Withdrawal by Subject|0|||
33475958|NCT04402866|62850998|FG002|Overall Study|Miscellaneous|1|||
33475959|NCT04402866|62850999|FG003|Overall Study|Miscellaneous|0|||
33475960|NCT04402866|62851000|FG004|Overall Study|Miscellaneous|0|||
33475961|NCT04402866|62851001|FG005|Overall Study|Miscellaneous|0|||
33475962|NCT04402866|62850996|FG000|Overall Study|Lost to Follow-up|0|||
33475963|NCT04402866|62850997|FG001|Overall Study|Lost to Follow-up|0|||
33475964|NCT04402866|62850998|FG002|Overall Study|Lost to Follow-up|0|||
33475965|NCT04402866|62850999|FG003|Overall Study|Lost to Follow-up|0|||
33475966|NCT04402866|62851000|FG004|Overall Study|Lost to Follow-up|0|||
33475967|NCT04402866|62851001|FG005|Overall Study|Lost to Follow-up|1|||
33475968|NCT04402866|62850996|FG000|Overall Study|Withdrawal by Subject|0|||
33549630|NCT02477332|62940871|FG001|Overall Study|Non-compliance with study treatment|1|||
33549631|NCT02477332|62940872|FG002|Overall Study|Non-compliance with study treatment|2|||
33549632|NCT02477332|62940873|FG003|Overall Study|Non-compliance with study treatment|0|||
33549633|NCT02477332|62940874|FG004|Overall Study|Non-compliance with study treatment|0|||
33549634|NCT02477332|62940875|FG005|Overall Study|Non-compliance with study treatment|0|||
33475969|NCT04402866|62850997|FG001|Overall Study|Withdrawal by Subject|0|||
33475970|NCT04402866|62850998|FG002|Overall Study|Withdrawal by Subject|0|||
33475971|NCT04402866|62850999|FG003|Overall Study|Withdrawal by Subject|0|||
33475972|NCT04402866|62851000|FG004|Overall Study|Withdrawal by Subject|0|||
33475973|NCT04402866|62851001|FG005|Overall Study|Withdrawal by Subject|2|||
33475974|NCT04400682|62851013|FG000|Period 1|Withdrawal by Subject|1|||
33475975|NCT04400682|62851014|FG001|Period 1|Withdrawal by Subject|4|||
33475976|NCT03066778|62851022|FG000|Overall Study|Death|195|||
33475977|NCT03066778|62851023|FG001|Overall Study|Death|205|||
33475978|NCT03066778|62851022|FG000|Overall Study|Withdrawal by Subject|5|||
33475979|NCT03066778|62851023|FG001|Overall Study|Withdrawal by Subject|7|||
33475980|NCT04348656|62851032|FG000|Overall Study|Withdrawal by Subject|2|||
33475981|NCT04348656|62851033|FG001|Overall Study|Withdrawal by Subject|0|||
33475982|NCT04348656|62851032|FG000|Overall Study|Lost to Follow-up|11|||
33475983|NCT04348656|62851033|FG001|Overall Study|Lost to Follow-up|6|||
33475984|NCT04348500|62851048|FG000|Overall Study|Death|2|||
33475985|NCT04348500|62851049|FG001|Overall Study|Death|2|||
33475986|NCT04348500|62851048|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
33475987|NCT04348500|62851049|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
33549635|NCT02477332|62940870|FG000|Overall Study|Pregnancy|0|||
33549636|NCT02477332|62940871|FG001|Overall Study|Pregnancy|0|||
33549637|NCT02477332|62940872|FG002|Overall Study|Pregnancy|0|||
33549638|NCT02477332|62940873|FG003|Overall Study|Pregnancy|1|||
33549639|NCT02477332|62940874|FG004|Overall Study|Pregnancy|0|||
33549640|NCT02477332|62940875|FG005|Overall Study|Pregnancy|0|||
33549641|NCT02477332|62940870|FG000|Overall Study|Protocol Violation|2|||
33549642|NCT02477332|62940871|FG001|Overall Study|Protocol Violation|0|||
33549643|NCT02477332|62940872|FG002|Overall Study|Protocol Violation|3|||
33549644|NCT02477332|62940873|FG003|Overall Study|Protocol Violation|3|||
33549645|NCT02477332|62940874|FG004|Overall Study|Protocol Violation|1|||
33475988|NCT04347954|62851058|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
33475989|NCT04347954|62851059|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
33475990|NCT04347954|62851060|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
33475991|NCT04347954|62851058|FG000|Overall Study|Lost to Follow-up|0|||
33475992|NCT04347954|62851059|FG001|Overall Study|Lost to Follow-up|1|||
33475993|NCT04347954|62851060|FG002|Overall Study|Lost to Follow-up|0|||
33475994|NCT03065530|62851072|FG000|Overall Study|Lack of Efficacy|1|||
33475995|NCT03065530|62851073|FG001|Overall Study|Lack of Efficacy|1|||
33475996|NCT03065530|62851074|FG002|Overall Study|Lack of Efficacy|0|||
33475997|NCT03065530|62851075|FG003|Overall Study|Lack of Efficacy|1|||
33475998|NCT03065530|62851072|FG000|Overall Study|Protocol Violation|1|||
33475999|NCT03065530|62851073|FG001|Overall Study|Protocol Violation|0|||
33476000|NCT03065530|62851074|FG002|Overall Study|Protocol Violation|1|||
33476001|NCT03065530|62851075|FG003|Overall Study|Protocol Violation|1|||
33476002|NCT03979820|62851097|FG000|Overall Study|Protocol Violation|1|||
33476003|NCT03979820|62851098|FG001|Overall Study|Protocol Violation|0|||
33476004|NCT03979820|62851099|FG002|Overall Study|Protocol Violation|0|||
33549646|NCT02477332|62940875|FG005|Overall Study|Protocol Violation|1|||
33549647|NCT02477332|62940870|FG000|Overall Study|Technical problems|0|||
33549648|NCT02477332|62940871|FG001|Overall Study|Technical problems|0|||
33476005|NCT03979820|62851100|FG003|Overall Study|Protocol Violation|0|||
33549649|NCT02477332|62940872|FG002|Overall Study|Technical problems|1|||
33549650|NCT02477332|62940873|FG003|Overall Study|Technical problems|0|||
33549651|NCT02477332|62940874|FG004|Overall Study|Technical problems|0|||
33549652|NCT02477332|62940875|FG005|Overall Study|Technical problems|0|||
33476006|NCT03979820|62851097|FG000|Overall Study|Withdrawal by Subject|0|||
33476007|NCT03979820|62851098|FG001|Overall Study|Withdrawal by Subject|0|||
33476008|NCT03979820|62851099|FG002|Overall Study|Withdrawal by Subject|1|||
33476009|NCT03979820|62851100|FG003|Overall Study|Withdrawal by Subject|0|||
33476010|NCT03979820|62851097|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
33549653|NCT02477332|62940870|FG000|Overall Study|Lost to Follow-up|0|||
33549654|NCT02477332|62940871|FG001|Overall Study|Lost to Follow-up|0|||
33549655|NCT02477332|62940872|FG002|Overall Study|Lost to Follow-up|2|||
33549656|NCT02477332|62940873|FG003|Overall Study|Lost to Follow-up|0|||
33549657|NCT02477332|62940874|FG004|Overall Study|Lost to Follow-up|0|||
33549658|NCT02477332|62940875|FG005|Overall Study|Lost to Follow-up|0|||
33549659|NCT02477332|62940870|FG000|Overall Study|Physician Decision|0|||
33549660|NCT02477332|62940871|FG001|Overall Study|Physician Decision|0|||
33549661|NCT02477332|62940872|FG002|Overall Study|Physician Decision|1|||
33549662|NCT02477332|62940873|FG003|Overall Study|Physician Decision|3|||
33549663|NCT02477332|62940874|FG004|Overall Study|Physician Decision|0|||
33549664|NCT02477332|62940875|FG005|Overall Study|Physician Decision|1|||
33549665|NCT02477332|62940870|FG000|Overall Study|Withdrawal by Subject|0|||
33549666|NCT02477332|62940871|FG001|Overall Study|Withdrawal by Subject|3|||
33549667|NCT02477332|62940872|FG002|Overall Study|Withdrawal by Subject|1|||
33549668|NCT02477332|62940873|FG003|Overall Study|Withdrawal by Subject|2|||
33549669|NCT02477332|62940874|FG004|Overall Study|Withdrawal by Subject|1|||
33549670|NCT02477332|62940875|FG005|Overall Study|Withdrawal by Subject|0|||
33549671|NCT02477020|62940893|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
33549672|NCT02477020|62940894|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
33549673|NCT02477020|62940893|FG000|Overall Study|Voluntary Withdrawal|7|||
33549674|NCT02477020|62940894|FG001|Overall Study|Voluntary Withdrawal|16|||
33364162|NCT00546481|62742970|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
33364163|NCT00546481|62742968|FG000|Maintenance Phase (CERA)|Other Reason|0|||
33476011|NCT03979820|62851098|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
33476012|NCT03979820|62851099|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
33476013|NCT03979820|62851100|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
33476014|NCT03647488|62851117|FG000|Overall Study|Progressive disease|10|||
33476015|NCT03647488|62851118|FG001|Overall Study|Progressive disease|0|||
33476016|NCT03647488|62851119|FG002|Overall Study|Progressive disease|0|||
33476017|NCT03647488|62851117|FG000|Overall Study|Adverse Event|5|||
33476018|NCT03647488|62851118|FG001|Overall Study|Adverse Event|0|||
33476019|NCT03647488|62851119|FG002|Overall Study|Adverse Event|0|||
33476020|NCT03647488|62851117|FG000|Overall Study|Clinical progression|2|||
33476021|NCT03647488|62851118|FG001|Overall Study|Clinical progression|0|||
33476022|NCT03647488|62851119|FG002|Overall Study|Clinical progression|0|||
33476023|NCT03647488|62851117|FG000|Overall Study|Participant refused to take investigational product|1|||
33476024|NCT03647488|62851118|FG001|Overall Study|Participant refused to take investigational product|0|||
33549675|NCT02477020|62940893|FG000|Overall Study|Reason not Specified|3|||
33364164|NCT00546481|62742969|FG001|Maintenance Phase (CERA)|Other Reason|0|||
33364165|NCT00546481|62742970|FG002|Maintenance Phase (CERA)|Other Reason|1|||
33364166|NCT00880698|62742982|FG000|Overall Study|Death|0|||
33364167|NCT00880698|62742983|FG001|Overall Study|Death|0|||
33364168|NCT00880698|62742984|FG002|Overall Study|Death|1|||
33364169|NCT00880698|62742985|FG003|Overall Study|Death|2|||
33364170|NCT00880698|62742982|FG000|Overall Study|Lost to Follow-up|1|||
33364171|NCT00880698|62742983|FG001|Overall Study|Lost to Follow-up|3|||
33364172|NCT00880698|62742984|FG002|Overall Study|Lost to Follow-up|0|||
33364173|NCT00880698|62742985|FG003|Overall Study|Lost to Follow-up|1|||
33364174|NCT00880620|62743001|FG000|Overall Study|Adverse Event|4|||
33364175|NCT00880620|62743002|FG001|Overall Study|Adverse Event|5|||
33364176|NCT00880620|62743003|FG002|Overall Study|Adverse Event|15|||
33364177|NCT00880620|62743004|FG003|Overall Study|Adverse Event|15|||
33364178|NCT00880620|62743001|FG000|Overall Study|Death|0|||
33364179|NCT00880620|62743002|FG001|Overall Study|Death|0|||
33364180|NCT00880620|62743003|FG002|Overall Study|Death|1|||
33364181|NCT00880620|62743004|FG003|Overall Study|Death|0|||
33364182|NCT00880620|62743001|FG000|Overall Study|Lack of Efficacy|12|||
33364183|NCT00880620|62743002|FG001|Overall Study|Lack of Efficacy|4|||
33364184|NCT00880620|62743003|FG002|Overall Study|Lack of Efficacy|0|||
33364185|NCT00880620|62743004|FG003|Overall Study|Lack of Efficacy|1|||
33364186|NCT00880620|62743001|FG000|Overall Study|Lost to Follow-up|0|||
33364187|NCT00880620|62743002|FG001|Overall Study|Lost to Follow-up|1|||
33364188|NCT00880620|62743003|FG002|Overall Study|Lost to Follow-up|1|||
33364189|NCT00880620|62743004|FG003|Overall Study|Lost to Follow-up|0|||
33364190|NCT00880620|62743001|FG000|Overall Study|Protocol Violation|0|||
33364191|NCT00880620|62743002|FG001|Overall Study|Protocol Violation|1|||
33364192|NCT00880620|62743003|FG002|Overall Study|Protocol Violation|0|||
33364193|NCT00880620|62743004|FG003|Overall Study|Protocol Violation|2|||
33364194|NCT00880620|62743001|FG000|Overall Study|Withdrawal by Subject|4|||
33549676|NCT02477020|62940894|FG001|Overall Study|Reason not Specified|1|||
33549677|NCT02477020|62940893|FG000|Overall Study|Lack of Efficacy|14|||
33549678|NCT02477020|62940894|FG001|Overall Study|Lack of Efficacy|5|||
33364195|NCT00880620|62743002|FG001|Overall Study|Withdrawal by Subject|3|||
33364196|NCT00880620|62743003|FG002|Overall Study|Withdrawal by Subject|1|||
33364197|NCT00880620|62743004|FG003|Overall Study|Withdrawal by Subject|3|||
33364198|NCT00880620|62743001|FG000|Overall Study|Noncompliance|0|||
33364199|NCT00880620|62743002|FG001|Overall Study|Noncompliance|0|||
33364200|NCT00880620|62743003|FG002|Overall Study|Noncompliance|1|||
33364201|NCT00880620|62743004|FG003|Overall Study|Noncompliance|1|||
33364202|NCT00880620|62743001|FG000|Overall Study|Other|1|||
33476025|NCT03647488|62851119|FG002|Overall Study|Participant refused to take investigational product|0|||
33476026|NCT03693950|62851127|FG000|Overall Study|Withdrawal by Subject|1|||
33476027|NCT03693950|62851128|FG001|Overall Study|Withdrawal by Subject|0|||
33476028|NCT04110314|62851140|FG000|Overall Study|Did not meet inclusion criteria|35255|||
33476029|NCT04110314|62851141|FG001|Overall Study|Did not meet inclusion criteria|35104|||
33476030|NCT04110314|62851142|FG002|Overall Study|Did not meet inclusion criteria|35636|||
33476031|NCT04110314|62851143|FG003|Overall Study|Did not meet inclusion criteria|35135|||
33476032|NCT04110314|62851144|FG004|Overall Study|Did not meet inclusion criteria|35247|||
33476033|NCT04110314|62851145|FG005|Overall Study|Did not meet inclusion criteria|35727|||
33476037|NCT04098458|62851170|FG000|Overall Study|Death|1|||
33476038|NCT04098458|62851170|FG000|Overall Study|did not meet study inclusion criteria|3|||
33476039|NCT03447262|62851175|FG000|Overall Study|Adverse Event|7|||
33476040|NCT03447262|62851175|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
33476041|NCT03447262|62851175|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
33476042|NCT03447262|62851175|FG000|Overall Study|Death|2|||
33476043|NCT03447262|62851175|FG000|Overall Study|Study Termination by Sponsor|455|||
33476044|NCT03447262|62851175|FG000|Overall Study|Other|4|||
33476045|NCT04094870|62851184|FG000|Overall Study|Lost to Follow-up|1|||
33476046|NCT04094870|62851185|FG001|Overall Study|Lost to Follow-up|1|||
33476047|NCT04399356|62851200|FG000|Overall Study|Lost to Follow-up|1|||
33476048|NCT04399356|62851201|FG001|Overall Study|Lost to Follow-up|1|||
33476049|NCT04399356|62851200|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
33476050|NCT04399356|62851201|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
33476051|NCT04399356|62851200|FG000|Overall Study|Withdrawal by Subject|1|||
33476052|NCT04399356|62851201|FG001|Overall Study|Withdrawal by Subject|0|||
33476053|NCT03692676|62851211|FG000|Overall Study|exclude patients with prior use|4424|||
33476054|NCT03692676|62851212|FG001|Overall Study|exclude patients with prior use|24726|||
33476055|NCT03692676|62851213|FG002|Overall Study|exclude patients with prior use|0|||
33476056|NCT03692676|62851214|FG003|Overall Study|exclude patients with prior use|0|||
33476057|NCT03692676|62851211|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
33476058|NCT03692676|62851212|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
33476059|NCT03692676|62851213|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
33476060|NCT03692676|62851214|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
33476061|NCT03692676|62851211|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
33476062|NCT03692676|62851212|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
33476063|NCT03692676|62851213|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
33476064|NCT03692676|62851214|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
33476065|NCT03692676|62851211|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
33476066|NCT03692676|62851212|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
33476067|NCT03692676|62851213|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
33476068|NCT03692676|62851214|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
33476069|NCT03692676|62851211|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
33476070|NCT03692676|62851212|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
33476071|NCT03692676|62851213|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
33476072|NCT03692676|62851214|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
33476073|NCT03692676|62851211|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
33476074|NCT03692676|62851212|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
33476075|NCT03692676|62851213|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
33476076|NCT03692676|62851214|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
33476077|NCT03692676|62851211|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
33476078|NCT03692676|62851212|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
33476079|NCT03692676|62851213|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
33476080|NCT03692676|62851214|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
33476081|NCT03692676|62851211|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
33476082|NCT03692676|62851212|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
33476083|NCT03692676|62851213|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
33549679|NCT02862535|62940904|FG000|Overall Study|Death|7|||
33549680|NCT02862535|62940905|FG001|Overall Study|Death|3|||
33549681|NCT02862535|62940906|FG002|Overall Study|Death|2|||
33549682|NCT02862535|62940907|FG003|Overall Study|Death|5|||
33364203|NCT00880620|62743002|FG001|Overall Study|Other|1|||
33476084|NCT03692676|62851214|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
33476085|NCT03692676|62851211|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
33476086|NCT03692676|62851212|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
33476087|NCT03692676|62851213|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
33476088|NCT03692676|62851214|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
33476089|NCT03692676|62851211|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
33476090|NCT03692676|62851212|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
33476091|NCT03692676|62851213|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
33476092|NCT03692676|62851214|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
33476093|NCT03692676|62851211|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
33476094|NCT03692676|62851212|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
33476095|NCT03692676|62851213|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
33476096|NCT03692676|62851214|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
33476097|NCT03692676|62851211|FG000|Overall Study|Other|0|||
33476098|NCT03692676|62851212|FG001|Overall Study|Other|805|||
33476099|NCT03692676|62851213|FG002|Overall Study|Other|758|||
33476100|NCT03692676|62851214|FG003|Overall Study|Other|277|||
33476101|NCT03692676|62851211|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
33476102|NCT03692676|62851212|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
33476103|NCT03692676|62851213|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
33476104|NCT03692676|62851214|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
33476105|NCT03691428|62851226|FG000|Overall Study|Withdrawal by Subject|6|||
33549683|NCT02862535|62940904|FG000|Overall Study|Study Terminated by Sponsor|1|||
33549684|NCT02862535|62940905|FG001|Overall Study|Study Terminated by Sponsor|3|||
33549685|NCT02862535|62940906|FG002|Overall Study|Study Terminated by Sponsor|8|||
33549686|NCT02862535|62940907|FG003|Overall Study|Study Terminated by Sponsor|5|||
33549687|NCT02862535|62940904|FG000|Overall Study|Enrolled, not Treated|1|||
33549688|NCT02862535|62940905|FG001|Overall Study|Enrolled, not Treated|0|||
33549689|NCT02862535|62940906|FG002|Overall Study|Enrolled, not Treated|0|||
33549690|NCT02862535|62940907|FG003|Overall Study|Enrolled, not Treated|1|||
33549691|NCT02448706|62940917|FG000|Overall Study|Withdrawal by Subject|4|||
33549692|NCT02448706|62940918|FG001|Overall Study|Withdrawal by Subject|3|||
33549693|NCT02448706|62940917|FG000|Overall Study|Protocol Violation|1|||
33549694|NCT02448706|62940918|FG001|Overall Study|Protocol Violation|1|||
33549695|NCT02868281|62940928|FG000|Overall Study|Adverse Event|2|||
33549696|NCT02868281|62940929|FG001|Overall Study|Adverse Event|2|||
33549697|NCT02868281|62940928|FG000|Overall Study|Protocol Violation|13|||
33549698|NCT02868281|62940929|FG001|Overall Study|Protocol Violation|10|||
33549699|NCT02868281|62940928|FG000|Overall Study|Lost to Follow-up|3|||
33549700|NCT02868281|62940929|FG001|Overall Study|Lost to Follow-up|6|||
33549701|NCT02868281|62940928|FG000|Overall Study|Withdrawal by Subject|11|||
33549702|NCT02868281|62940929|FG001|Overall Study|Withdrawal by Subject|15|||
33549703|NCT02868281|62940928|FG000|Overall Study|Physician Decision|2|||
33549704|NCT02868281|62940929|FG001|Overall Study|Physician Decision|0|||
33549705|NCT02868281|62940928|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
33549706|NCT02868281|62940929|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
33549707|NCT02868281|62940928|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
33549708|NCT02868281|62940929|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
33549709|NCT02868281|62940928|FG000|Overall Study|Long journey/moving away|1|||
33549710|NCT02868281|62940929|FG001|Overall Study|Long journey/moving away|1|||
33549711|NCT02476006|62940935|FG000|Overall Study|Death|4|||
33549712|NCT02476006|62940935|FG000|Overall Study|Lack of treatment efficacy|2|||
33549713|NCT02476006|62940935|FG000|Overall Study|Pregnancy|1|||
33549714|NCT02476006|62940935|FG000|Overall Study|Participant did not wish to continue|39|||
33549715|NCT02476006|62940935|FG000|Overall Study|Adverse Event|41|||
33549716|NCT02476006|62940935|FG000|Overall Study|Poor compliance to study protocol|3|||
33549717|NCT02476006|62940935|FG000|Overall Study|Sponsor decision|6|||
33549718|NCT02476006|62940935|FG000|Overall Study|Lost to Follow-up|5|||
33549719|NCT02476006|62940935|FG000|Overall Study|Physician Decision|5|||
33549720|NCT02476006|62940935|FG000|Overall Study|Study ended treatment not available|4|||
33549721|NCT02476006|62940935|FG000|Overall Study|Switched to commercial drug|4|||
33549722|NCT02476006|62940935|FG000|Overall Study|Excluded from study|1|||
33549723|NCT02476006|62940935|FG000|Overall Study|Protocol Violation|1|||
33549724|NCT02476006|62940935|FG000|Overall Study|Enrolled but not treated|4|||
33549725|NCT02475850|62940941|FG000|Overall Study|Death|155|||
33549726|NCT02475850|62940942|FG001|Overall Study|Death|141|||
33549727|NCT02475850|62940941|FG000|Overall Study|Lost to Follow-up|217|||
33549728|NCT02475850|62940942|FG001|Overall Study|Lost to Follow-up|188|||
33476106|NCT03691428|62851227|FG001|Overall Study|Withdrawal by Subject|8|||
33476107|NCT04124952|62851233|FG000|Overall Study|Lost to Follow-up|1|||
33476108|NCT04122534|62851237|FG000|Overall Study|Lost to Follow-up|4|||
33476109|NCT04091360|62851247|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33476110|NCT04091360|62851248|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33476111|NCT04091360|62851249|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33476112|NCT04091360|62851250|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33476113|NCT04091360|62851251|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33655725|NCT01859741|63072878|FG005|Overall Study|Withdrawal by Subject|1|||
33549729|NCT02475850|62940941|FG000|Overall Study|Withdrawal by Subject|221|||
33549730|NCT02475850|62940942|FG001|Overall Study|Withdrawal by Subject|155|||
33549731|NCT02419612|62940951|FG000|Short-term Treatment Period|Adverse Event|1|||
33549732|NCT02419612|62940952|FG001|Short-term Treatment Period|Adverse Event|1|||
33549733|NCT02419612|62940951|FG000|Short-term Treatment Period|Death|0|||
33549734|NCT02419612|62940952|FG001|Short-term Treatment Period|Death|2|||
33655726|NCT01859741|63072879|FG006|Overall Study|Withdrawal by Subject|1|||
33655727|NCT01859741|63072880|FG007|Overall Study|Withdrawal by Subject|1|||
33655728|NCT01859741|63072873|FG000|Overall Study|Study Terminated by Sponsor|0|||
33655729|NCT01859741|63072874|FG001|Overall Study|Study Terminated by Sponsor|0|||
33655730|NCT01859741|63072875|FG002|Overall Study|Study Terminated by Sponsor|0|||
33655731|NCT01859741|63072876|FG003|Overall Study|Study Terminated by Sponsor|0|||
33655732|NCT01859741|63072877|FG004|Overall Study|Study Terminated by Sponsor|1|||
33655733|NCT01859741|63072878|FG005|Overall Study|Study Terminated by Sponsor|0|||
33655734|NCT01859741|63072879|FG006|Overall Study|Study Terminated by Sponsor|16|||
33655735|NCT01859741|63072880|FG007|Overall Study|Study Terminated by Sponsor|14|||
33655736|NCT01859741|63072873|FG000|Overall Study|Other|0|||
33655737|NCT01859741|63072874|FG001|Overall Study|Other|0|||
33655738|NCT01859741|63072875|FG002|Overall Study|Other|0|||
33655739|NCT01859741|63072876|FG003|Overall Study|Other|0|||
33655740|NCT01859741|63072877|FG004|Overall Study|Other|0|||
33655741|NCT01859741|63072878|FG005|Overall Study|Other|0|||
33655742|NCT01859741|63072879|FG006|Overall Study|Other|2|||
33655743|NCT01859741|63072880|FG007|Overall Study|Other|0|||
33655744|NCT01859507|63072926|FG000|Overall Study|left the country|4|||
33655745|NCT01876043|63072931|FG000|Overall Study|Death|1|||
33655746|NCT01876043|63072931|FG000|Overall Study|Withdrawal by Subject|1|||
33655747|NCT01875731|63072937|FG000|Overall Study|Fail to obtain lab sample|1|||
33655748|NCT01875731|63072938|FG001|Overall Study|Fail to obtain lab sample|0|||
33655749|NCT01873859|63072946|FG000|Overall Study|Withdrawal by Subject|0|||
33655750|NCT01873859|63072947|FG001|Overall Study|Withdrawal by Subject|4|||
33655751|NCT01857869|63072964|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
33655752|NCT01857869|63072965|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
33655753|NCT01857869|63072966|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
33655754|NCT01857869|63072967|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
33655755|NCT01857869|63072968|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
33655756|NCT01857869|63072969|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
33655757|NCT01857869|63072970|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
33655758|NCT01857869|63072971|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
33655759|NCT01857869|63072972|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
33655760|NCT01857869|63072973|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
33655761|NCT01857869|63072964|FG000|Primary/Challenge Phase|Pregnancy|1|||
33655762|NCT01857869|63072965|FG001|Primary/Challenge Phase|Pregnancy|0|||
33549735|NCT02419612|62940951|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
33549736|NCT02419612|62940952|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
33549737|NCT02419612|62940951|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
33549738|NCT02419612|62940952|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
33549739|NCT02419612|62940951|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
33549740|NCT02419612|62940952|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
33655763|NCT01857869|63072966|FG002|Primary/Challenge Phase|Pregnancy|0|||
33655764|NCT01857869|63072967|FG003|Primary/Challenge Phase|Pregnancy|0|||
33549741|NCT02419612|62940951|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
33549742|NCT02419612|62940952|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
33655765|NCT01857869|63072968|FG004|Primary/Challenge Phase|Pregnancy|0|||
33655766|NCT01857869|63072969|FG005|Primary/Challenge Phase|Pregnancy|0|||
33655767|NCT01857869|63072970|FG006|Primary/Challenge Phase|Pregnancy|0|||
33655768|NCT01857869|63072971|FG007|Primary/Challenge Phase|Pregnancy|0|||
33655769|NCT01857869|63072972|FG008|Primary/Challenge Phase|Pregnancy|0|||
33655770|NCT01857869|63072973|FG009|Primary/Challenge Phase|Pregnancy|0|||
33655771|NCT01857869|63072964|FG000|Primary/Challenge Phase|Protocol Violation|1|||
33655772|NCT01857869|63072965|FG001|Primary/Challenge Phase|Protocol Violation|0|||
33655773|NCT01857869|63072966|FG002|Primary/Challenge Phase|Protocol Violation|0|||
33476114|NCT04091360|62851252|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33549743|NCT02419612|62940951|FG000|Short-term Treatment Period|Worsening of liver function|0|||
33655774|NCT01857869|63072967|FG003|Primary/Challenge Phase|Protocol Violation|0|||
33655775|NCT01857869|63072968|FG004|Primary/Challenge Phase|Protocol Violation|0|||
33476115|NCT04091360|62851253|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33476116|NCT04091360|62851254|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33476117|NCT04091360|62851255|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
33476118|NCT04091360|62851256|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
33476119|NCT04091360|62851247|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33476120|NCT04091360|62851248|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33476121|NCT04091360|62851249|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33476122|NCT04091360|62851250|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33476123|NCT04091360|62851251|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33476124|NCT04091360|62851252|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33476125|NCT04091360|62851253|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
33476126|NCT04091360|62851254|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
33476127|NCT04091360|62851255|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33476128|NCT04091360|62851256|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33476129|NCT04091360|62851247|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33476130|NCT04091360|62851248|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33476131|NCT04091360|62851249|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33476132|NCT04091360|62851250|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33476133|NCT04091360|62851251|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33476134|NCT04091360|62851252|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33476135|NCT04091360|62851253|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
33476136|NCT04091360|62851254|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33476137|NCT04091360|62851255|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33476138|NCT04091360|62851256|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
33476139|NCT04118166|62851278|FG000|Overall Study|Adverse Event|1|||
33476140|NCT04346628|62851285|FG000|Overall Study|Lost to Follow-up|4|||
33476141|NCT04346628|62851286|FG001|Overall Study|Lost to Follow-up|4|||
33476142|NCT04346628|62851285|FG000|Overall Study|Withdrew (had personal reasons)|2|||
33476143|NCT04346628|62851286|FG001|Overall Study|Withdrew (had personal reasons)|5|||
33476144|NCT04346628|62851285|FG000|Overall Study|Withdrew (medication intolerant)|0|||
33476145|NCT04346628|62851286|FG001|Overall Study|Withdrew (medication intolerant)|3|||
33476146|NCT04346628|62851285|FG000|Overall Study|Withdrew (declined intervention)|0|||
33476147|NCT04346628|62851286|FG001|Overall Study|Withdrew (declined intervention)|1|||
33476148|NCT03681470|62851292|FG000|Overall Study|Lack of Efficacy|3|||
33476149|NCT03681470|62851292|FG000|Overall Study|Lost to Follow-up|1|||
33476150|NCT03681470|62851292|FG000|Overall Study|Protocol Violation|3|||
33476151|NCT03681470|62851292|FG000|Overall Study|Withdrawal by Subject|1|||
33476152|NCT04343976|62851298|FG000|Overall Study|Withdrawal by Subject|0|||
33476153|NCT04343976|62851299|FG001|Overall Study|Withdrawal by Subject|1|||
33476154|NCT03322540|62851307|FG000|Overall Study|Death|21|||
33476155|NCT03322540|62851308|FG001|Overall Study|Death|28|||
33476156|NCT03322540|62851307|FG000|Overall Study|Lost to Follow-up|0|||
33476157|NCT03322540|62851308|FG001|Overall Study|Lost to Follow-up|1|||
33476158|NCT03322540|62851307|FG000|Overall Study|Physician Decision|7|||
33476159|NCT03322540|62851308|FG001|Overall Study|Physician Decision|6|||
33476160|NCT03322540|62851307|FG000|Overall Study|Withdrawal by Subject|3|||
33476161|NCT03322540|62851308|FG001|Overall Study|Withdrawal by Subject|1|||
33476162|NCT03322540|62851307|FG000|Overall Study|Study terminated by sponsor|0|||
33476163|NCT03322540|62851308|FG001|Overall Study|Study terminated by sponsor|1|||
33476164|NCT04339296|62851318|FG000|Overall Study|Refuse to participate after allocation|1|||
33476165|NCT04339296|62851319|FG001|Overall Study|Refuse to participate after allocation|1|||
33476166|NCT04339296|62851318|FG000|Overall Study|Withdrew after completion of baseline|2|||
33476167|NCT04339296|62851319|FG001|Overall Study|Withdrew after completion of baseline|1|||
33476168|NCT04339296|62851318|FG000|Overall Study|Lost to Follow-up|0|||
33476169|NCT04339296|62851319|FG001|Overall Study|Lost to Follow-up|4|||
33476170|NCT04339296|62851318|FG000|Overall Study|Discontinued intervention|5|||
33476171|NCT04339296|62851319|FG001|Overall Study|Discontinued intervention|3|||
33476172|NCT02025556|62851328|FG000|Overall Study|Adverse Event|0|||
33476173|NCT02025556|62851329|FG001|Overall Study|Adverse Event|4|||
33476174|NCT02025556|62851330|FG002|Overall Study|Adverse Event|2|||
33476175|NCT02025556|62851328|FG000|Overall Study|Lack of Efficacy|2|||
33476176|NCT02025556|62851329|FG001|Overall Study|Lack of Efficacy|1|||
33476177|NCT02025556|62851330|FG002|Overall Study|Lack of Efficacy|0|||
33476178|NCT02025556|62851328|FG000|Overall Study|Protocol Violation|2|||
33476179|NCT02025556|62851329|FG001|Overall Study|Protocol Violation|1|||
33476180|NCT02025556|62851330|FG002|Overall Study|Protocol Violation|0|||
33476181|NCT02025556|62851328|FG000|Overall Study|Withdrawal by Subject|0|||
33476182|NCT02025556|62851329|FG001|Overall Study|Withdrawal by Subject|3|||
33476183|NCT02025556|62851330|FG002|Overall Study|Withdrawal by Subject|6|||
33476184|NCT02025556|62851328|FG000|Overall Study|Lost to Follow-up|2|||
33476185|NCT02025556|62851329|FG001|Overall Study|Lost to Follow-up|4|||
33476186|NCT02025556|62851330|FG002|Overall Study|Lost to Follow-up|0|||
33364204|NCT00880620|62743003|FG002|Overall Study|Other|2|||
33364205|NCT00880620|62743004|FG003|Overall Study|Other|2|||
33364206|NCT00881868|62743030|FG000|Overall Study|Adverse Event|0|||
33364207|NCT00881868|62743031|FG001|Overall Study|Adverse Event|1|||
33364208|NCT00881868|62743030|FG000|Overall Study|Lost to Follow-up|2|||
33364209|NCT00881868|62743031|FG001|Overall Study|Lost to Follow-up|1|||
33364210|NCT00881868|62743030|FG000|Overall Study|Physician Decision|4|||
33364211|NCT00881868|62743031|FG001|Overall Study|Physician Decision|0|||
33364212|NCT00881868|62743030|FG000|Overall Study|Protocol Violation|2|||
33364213|NCT00881868|62743031|FG001|Overall Study|Protocol Violation|0|||
33364214|NCT00881712|62743040|FG000|Overall Study|Death|1|||
33364215|NCT00881712|62743041|FG001|Overall Study|Death|0|||
33364216|NCT00881712|62743042|FG002|Overall Study|Death|0|||
33476187|NCT02025556|62851328|FG000|Overall Study|Reason not reported|0|||
33476188|NCT02025556|62851329|FG001|Overall Study|Reason not reported|0|||
33476189|NCT02025556|62851330|FG002|Overall Study|Reason not reported|1|||
33476190|NCT04334460|62851340|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
33476191|NCT04334460|62851341|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
33476192|NCT04334460|62851340|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
33476193|NCT04334460|62851341|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
33476194|NCT04334148|62851350|FG000|Overall Study|positive nasal swab at baseline|0|||
33476195|NCT04334148|62851351|FG001|Overall Study|positive nasal swab at baseline|1|||
33476196|NCT04399122|62851359|FG000|Overall Study|Lost to Follow-up|2|||
33476197|NCT04399122|62851360|FG001|Overall Study|Lost to Follow-up|0|||
33476198|NCT04399122|62851359|FG000|Overall Study|Withdrawal by Subject|1|||
33476199|NCT04399122|62851360|FG001|Overall Study|Withdrawal by Subject|0|||
33476200|NCT04398732|62851381|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
33476201|NCT04398030|62851387|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
33476202|NCT04398030|62851388|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
33476203|NCT04398030|62851387|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
33476204|NCT04398030|62851388|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
33476205|NCT03064438|62851396|FG000|Overall Study|Lost to Follow-up|1|||
33476206|NCT03064438|62851397|FG001|Overall Study|Lost to Follow-up|0|||
33476207|NCT03064438|62851396|FG000|Overall Study|Withdrawal by Subject|0|||
33476208|NCT03064438|62851397|FG001|Overall Study|Withdrawal by Subject|1|||
33476209|NCT04327986|62851403|FG000|Overall Study|Physician Decision|2|||
33476210|NCT04327986|62851404|FG001|Overall Study|Physician Decision|0|||
33476211|NCT04327986|62851405|FG002|Overall Study|Physician Decision|0|||
33476212|NCT04327986|62851403|FG000|Overall Study|Death|1|||
33476213|NCT04327986|62851404|FG001|Overall Study|Death|0|||
33549744|NCT02419612|62940952|FG001|Short-term Treatment Period|Worsening of liver function|1|||
33549745|NCT02419612|62940951|FG000|Short-term Treatment Period|Subject moved out of state|0|||
33549746|NCT02419612|62940952|FG001|Short-term Treatment Period|Subject moved out of state|1|||
33549747|NCT02419612|62940951|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
33549748|NCT02419612|62940952|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
33549749|NCT02419612|62940951|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
33549750|NCT02419612|62940952|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
33549751|NCT02419612|62940951|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
33549752|NCT02419612|62940952|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
33549753|NCT02419612|62940951|FG000|Long-term Treatment Period|Death|0|||
33549754|NCT02419612|62940952|FG001|Long-term Treatment Period|Death|1|||
33549755|NCT02419612|62940951|FG000|Long-term Treatment Period|Adverse Event|0|||
33549756|NCT02419612|62940952|FG001|Long-term Treatment Period|Adverse Event|5|||
33549757|NCT02419612|62940951|FG000|Long-term Treatment Period|Other|4|||
33549758|NCT02419612|62940952|FG001|Long-term Treatment Period|Other|4|||
33549759|NCT02419612|62940951|FG000|Long-term Treatment Period|Subject Decision|2|||
33476214|NCT04327986|62851405|FG002|Overall Study|Death|0|||
33476215|NCT04322682|62851411|FG000|Overall Study|Withdrawal by Subject|33|||
33476216|NCT04322682|62851412|FG001|Overall Study|Withdrawal by Subject|47|||
33476217|NCT04322682|62851411|FG000|Overall Study|Death|5|||
33476218|NCT04322682|62851412|FG001|Overall Study|Death|9|||
33476219|NCT04322682|62851411|FG000|Overall Study|Lost to Follow-up|4|||
33476220|NCT04322682|62851412|FG001|Overall Study|Lost to Follow-up|8|||
33476221|NCT04322682|62851411|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
33476222|NCT04322682|62851412|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
33476223|NCT04322526|62851420|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
33476224|NCT04322526|62851421|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
33476225|NCT04322526|62851420|FG000|Washout (1 Week)|Lost to Follow-up|1|||
33549760|NCT02419612|62940952|FG001|Long-term Treatment Period|Subject Decision|4|||
33364217|NCT00881712|62743040|FG000|Overall Study|Withdrawal by Subject|1|||
33364218|NCT00881712|62743041|FG001|Overall Study|Withdrawal by Subject|0|||
33364219|NCT00881712|62743042|FG002|Overall Study|Withdrawal by Subject|0|||
33549761|NCT02419612|62940951|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
33549762|NCT02419612|62940952|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
33549763|NCT02447848|62940958|FG000|Overall Study|Patient discharged|3|||
33549764|NCT02447848|62940958|FG000|Overall Study|Lack of Efficacy|4|||
33549765|NCT02447848|62940958|FG000|Overall Study|Withdrawal by Subject|4|||
33549766|NCT02418910|62940962|FG000|Overall Study|Lost to Follow-up|3|||
33549767|NCT02418910|62940962|FG000|Overall Study|Withdrawal by Subject|4|||
33549768|NCT02418754|62940978|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
33549769|NCT02418754|62940979|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
33549770|NCT02418754|62940980|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
33549771|NCT02418754|62940981|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
33549772|NCT02418754|62940982|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
33549773|NCT02418754|62940978|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
33549774|NCT02418754|62940979|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
33549775|NCT02418754|62940980|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
33549776|NCT02418754|62940981|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
33549777|NCT02418754|62940982|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
33549778|NCT02418754|62940978|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
33549779|NCT02418754|62940979|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
33549780|NCT02418754|62940980|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
33549781|NCT02418754|62940981|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
33549782|NCT02418754|62940982|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
33549783|NCT02418754|62940978|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
33549784|NCT02418754|62940979|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
33549785|NCT02418754|62940980|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
33549786|NCT02418754|62940981|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
33549787|NCT02418754|62940982|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
33549788|NCT02418754|62940978|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
33549789|NCT02418754|62940979|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
33549790|NCT02418754|62940980|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
33549791|NCT02418754|62940981|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
33549792|NCT02418754|62940982|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
33364220|NCT03955471|62743050|FG000|Overall Study|Death|22|||
33364221|NCT03955471|62743050|FG000|Overall Study|Lost to Follow-up|1|||
33364222|NCT03955471|62743050|FG000|Overall Study|Withdrawal by Subject|6|||
33364223|NCT03955471|62743050|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
33364224|NCT00880542|62743054|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
33364225|NCT00880542|62743054|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
33364226|NCT00880542|62743054|FG000|REP: Surgical Resection|progressive disease|1|||
33364227|NCT00885534|62743058|FG000|Overall Study|Patient deemed ineligible|1|||
33364228|NCT00885378|62743064|FG000|Overall Study|Lack of Efficacy|2|||
33364229|NCT00885378|62743065|FG001|Overall Study|Lack of Efficacy|2|||
33364230|NCT00885378|62743064|FG000|Overall Study|Withdrawal by Subject|1|||
33364231|NCT00885378|62743065|FG001|Overall Study|Withdrawal by Subject|2|||
33364232|NCT00885378|62743064|FG000|Overall Study|Lost to Follow-up|1|||
33364233|NCT00885378|62743065|FG001|Overall Study|Lost to Follow-up|2|||
33364234|NCT00885378|62743064|FG000|Overall Study|Poor/Noncompliance|2|||
33364235|NCT00885378|62743065|FG001|Overall Study|Poor/Noncompliance|2|||
33364236|NCT00885378|62743064|FG000|Overall Study|Protocol Violation|2|||
33364237|NCT00885378|62743065|FG001|Overall Study|Protocol Violation|0|||
33364238|NCT00545779|62743071|FG000|Overall Study|Violation of selection criteria at entry|8|||
33364239|NCT00545779|62743071|FG000|Overall Study|Other protocol violation|1|||
33364240|NCT00545779|62743071|FG000|Overall Study|Did not cooperate|7|||
33364241|NCT00545779|62743071|FG000|Overall Study|Withdrawal by Subject|20|||
33364242|NCT00545779|62743071|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
33364243|NCT00545779|62743071|FG000|Overall Study|Failure to return|3|||
33364244|NCT00597714|62743081|FG000|Overall Study|Death|56|||
33655776|NCT01857869|63072969|FG005|Primary/Challenge Phase|Protocol Violation|0|||
33364245|NCT00597714|62743082|FG001|Overall Study|Death|46|||
33364246|NCT00597714|62743083|FG002|Overall Study|Death|0|||
33364247|NCT00597714|62743081|FG000|Overall Study|Recipient death|0|||
33364248|NCT00597714|62743082|FG001|Overall Study|Recipient death|0|||
33364249|NCT00597714|62743083|FG002|Overall Study|Recipient death|10|||
33549793|NCT02418754|62940978|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
33549794|NCT02418754|62940979|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
33549795|NCT02418754|62940980|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
33549796|NCT02418754|62940981|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
33549797|NCT02418754|62940982|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
33549798|NCT02418754|62940978|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
33549799|NCT02418754|62940979|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
33549800|NCT02418754|62940980|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
33549801|NCT02418754|62940981|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
33549802|NCT02418754|62940982|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
33549803|NCT02418754|62940978|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
33549804|NCT02418754|62940979|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
33549805|NCT02418754|62940980|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
33549806|NCT02418754|62940981|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
33549807|NCT02418754|62940982|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
33549808|NCT02418754|62940978|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
33549809|NCT02418754|62940979|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
33549810|NCT02418754|62940980|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
33549811|NCT02418754|62940981|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
33549812|NCT02418754|62940982|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
33549813|NCT02418754|62940978|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
33549814|NCT02418754|62940979|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
33549815|NCT02418754|62940980|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
33549816|NCT02418754|62940981|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
33549817|NCT02418754|62940982|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
33549818|NCT02418754|62940978|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
33549819|NCT02418754|62940979|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
33549820|NCT02418754|62940980|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
33549821|NCT02418754|62940981|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
33549822|NCT02418754|62940982|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
33549823|NCT02447458|62940998|FG000|Overall Study|Other|0|||
33549824|NCT02447458|62940999|FG001|Overall Study|Other|0|||
33549825|NCT02447458|62941000|FG002|Overall Study|Other|1|||
33549826|NCT02447458|62941001|FG003|Overall Study|Other|0|||
33549827|NCT02447458|62941002|FG004|Overall Study|Other|0|||
33549828|NCT02447458|62941003|FG005|Overall Study|Other|0|||
33549829|NCT02862457|62941029|FG000|Overall Study|Death|1|||
33549830|NCT02862457|62941030|FG001|Overall Study|Death|3|||
33549831|NCT02862457|62941031|FG002|Overall Study|Death|2|||
33549832|NCT02862457|62941032|FG003|Overall Study|Death|3|||
33549833|NCT02862457|62941033|FG004|Overall Study|Death|0|||
33549834|NCT02862457|62941034|FG005|Overall Study|Death|2|||
33549835|NCT02862457|62941035|FG006|Overall Study|Death|1|||
33549836|NCT02862457|62941029|FG000|Overall Study|Lost to Follow-up|1|||
33549837|NCT02862457|62941030|FG001|Overall Study|Lost to Follow-up|0|||
33549838|NCT02862457|62941031|FG002|Overall Study|Lost to Follow-up|0|||
33549839|NCT02862457|62941032|FG003|Overall Study|Lost to Follow-up|1|||
33549840|NCT02862457|62941033|FG004|Overall Study|Lost to Follow-up|0|||
33549841|NCT02862457|62941034|FG005|Overall Study|Lost to Follow-up|0|||
33364250|NCT03938857|62743096|FG000|Overall Study|Physician Decision|1|||
33364251|NCT03938857|62743097|FG001|Overall Study|Physician Decision|0|||
33364252|NCT03938857|62743098|FG002|Overall Study|Physician Decision|0|||
33364253|NCT03938857|62743099|FG003|Overall Study|Physician Decision|0|||
33364254|NCT00884832|62743111|FG000|Overall Study|Withdrawal by Subject|0|||
33364255|NCT00884832|62743112|FG001|Overall Study|Withdrawal by Subject|1|||
33364256|NCT03938545|62743122|FG000|Overall Study|Lost to Follow-up|0|||
33364257|NCT03938545|62743123|FG001|Overall Study|Lost to Follow-up|0|||
33364258|NCT03938545|62743124|FG002|Overall Study|Lost to Follow-up|0|||
33364259|NCT03938545|62743125|FG003|Overall Study|Lost to Follow-up|1|||
33364260|NCT03938545|62743122|FG000|Overall Study|Non-compliance with study drug|0|||
33364261|NCT03938545|62743123|FG001|Overall Study|Non-compliance with study drug|0|||
33364262|NCT03938545|62743124|FG002|Overall Study|Non-compliance with study drug|1|||
33364263|NCT03938545|62743125|FG003|Overall Study|Non-compliance with study drug|0|||
33364264|NCT03938545|62743122|FG000|Overall Study|Pregnancy|1|||
33364265|NCT03938545|62743123|FG001|Overall Study|Pregnancy|0|||
33549842|NCT02862457|62941035|FG006|Overall Study|Lost to Follow-up|0|||
33549843|NCT02862457|62941029|FG000|Overall Study|Withdrawal by Subject|0|||
33364266|NCT03938545|62743124|FG002|Overall Study|Pregnancy|0|||
33364267|NCT03938545|62743125|FG003|Overall Study|Pregnancy|0|||
33364268|NCT03938545|62743122|FG000|Overall Study|Study terminated by sponsor|6|||
33364269|NCT03938545|62743123|FG001|Overall Study|Study terminated by sponsor|4|||
33364270|NCT03938545|62743124|FG002|Overall Study|Study terminated by sponsor|2|||
33549844|NCT02862457|62941030|FG001|Overall Study|Withdrawal by Subject|0|||
33549845|NCT02862457|62941031|FG002|Overall Study|Withdrawal by Subject|1|||
33549846|NCT02862457|62941032|FG003|Overall Study|Withdrawal by Subject|0|||
33549847|NCT02862457|62941033|FG004|Overall Study|Withdrawal by Subject|0|||
33549848|NCT02862457|62941034|FG005|Overall Study|Withdrawal by Subject|1|||
33549849|NCT02862457|62941035|FG006|Overall Study|Withdrawal by Subject|0|||
33549850|NCT02447302|62941062|FG000|Overall Study|Physician Decision|1|||
33549851|NCT02447302|62941063|FG001|Overall Study|Physician Decision|0|||
33549852|NCT02447302|62941064|FG002|Overall Study|Physician Decision|0|||
33549853|NCT02447302|62941062|FG000|Overall Study|Adverse Event|4|||
33549854|NCT02447302|62941063|FG001|Overall Study|Adverse Event|3|||
33549855|NCT02447302|62941064|FG002|Overall Study|Adverse Event|0|||
33549856|NCT02447302|62941062|FG000|Overall Study|Withdrawal by Subject|0|||
33549857|NCT02447302|62941063|FG001|Overall Study|Withdrawal by Subject|1|||
33549858|NCT02447302|62941064|FG002|Overall Study|Withdrawal by Subject|5|||
33549859|NCT02447302|62941062|FG000|Overall Study|Sponsor Decision|0|||
33549860|NCT02447302|62941063|FG001|Overall Study|Sponsor Decision|0|||
33549861|NCT02447302|62941064|FG002|Overall Study|Sponsor Decision|1|||
33549862|NCT02454517|62941074|FG000|Overall Study|Withdrawal by Subject|3|||
33549863|NCT02454517|62941075|FG001|Overall Study|Withdrawal by Subject|0|||
33549864|NCT02454517|62941074|FG000|Overall Study|Lost to Follow-up|4|||
33549865|NCT02454517|62941075|FG001|Overall Study|Lost to Follow-up|7|||
33549866|NCT02454517|62941074|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
33549867|NCT02454517|62941075|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
33549868|NCT03861039|62941086|FG000|Overall Study|Adverse Event|2|||
33549869|NCT03861039|62941087|FG001|Overall Study|Adverse Event|5|||
33549870|NCT03861039|62941088|FG002|Overall Study|Adverse Event|11|||
33549871|NCT03861039|62941086|FG000|Overall Study|Withdrawal by Subject|1|||
33549872|NCT03861039|62941087|FG001|Overall Study|Withdrawal by Subject|3|||
33549873|NCT03861039|62941088|FG002|Overall Study|Withdrawal by Subject|4|||
33549874|NCT02731755|62941098|FG000|First Intervention|Withdrawal by Subject|0|||
33549875|NCT02731755|62941099|FG001|First Intervention|Withdrawal by Subject|2|||
33549876|NCT02866175|62941128|FG000|Overall Study|Adverse Event|56|||
33549877|NCT02866175|62941129|FG001|Overall Study|Adverse Event|54|||
33549878|NCT02866175|62941128|FG000|Overall Study|Withdrawal by Subject|31|||
33549879|NCT02866175|62941129|FG001|Overall Study|Withdrawal by Subject|52|||
33549880|NCT02866175|62941128|FG000|Overall Study|Death|30|||
33549881|NCT02866175|62941129|FG001|Overall Study|Death|23|||
33549882|NCT02866175|62941128|FG000|Overall Study|Other|7|||
33549883|NCT02866175|62941129|FG001|Overall Study|Other|14|||
33549884|NCT02866175|62941128|FG000|Overall Study|Progressive disease|1|||
33549885|NCT02866175|62941129|FG001|Overall Study|Progressive disease|1|||
33549886|NCT02866175|62941128|FG000|Overall Study|Lost to Follow-up|2|||
33549887|NCT02866175|62941129|FG001|Overall Study|Lost to Follow-up|0|||
33549888|NCT02866175|62941128|FG000|Overall Study|Lack of Efficacy|0|||
33549889|NCT02866175|62941129|FG001|Overall Study|Lack of Efficacy|1|||
33549890|NCT02866175|62941128|FG000|Overall Study|Physician Decision|3|||
33549891|NCT02866175|62941129|FG001|Overall Study|Physician Decision|15|||
33549892|NCT02866175|62941128|FG000|Overall Study|Did not receive treatment|5|||
33549893|NCT02866175|62941129|FG001|Overall Study|Did not receive treatment|15|||
33549894|NCT01336205|62941142|FG000|Overall Study|Other|22|||
33549895|NCT01336205|62941143|FG001|Overall Study|Other|9|||
33549896|NCT01336205|62941142|FG000|Overall Study|Lost to Follow-up|40|||
33549897|NCT01336205|62941143|FG001|Overall Study|Lost to Follow-up|20|||
33549898|NCT01336205|62941142|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
33549899|NCT01336205|62941143|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
33549900|NCT01336205|62941142|FG000|Overall Study|Lack of Efficacy|4|||
33549901|NCT01336205|62941143|FG001|Overall Study|Lack of Efficacy|0|||
33549902|NCT01336205|62941142|FG000|Overall Study|Severe noncompliance with protocol|9|||
33549903|NCT01336205|62941143|FG001|Overall Study|Severe noncompliance with protocol|2|||
33549904|NCT01336205|62941142|FG000|Overall Study|Adverse Event|56|||
33549905|NCT01336205|62941143|FG001|Overall Study|Adverse Event|6|||
33549906|NCT01336205|62941142|FG000|Overall Study|Death|1|||
33549907|NCT01336205|62941143|FG001|Overall Study|Death|1|||
33549908|NCT01336205|62941142|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
33655777|NCT01857869|63072970|FG006|Primary/Challenge Phase|Protocol Violation|0|||
33549909|NCT01336205|62941143|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
33549910|NCT01336205|62941142|FG000|Overall Study|Withdrawal by Subject|72|||
33549911|NCT01336205|62941143|FG001|Overall Study|Withdrawal by Subject|38|||
33549912|NCT01336205|62941142|FG000|Overall Study|Did not receive treatment|4|||
33549913|NCT01336205|62941143|FG001|Overall Study|Did not receive treatment|0|||
33549914|NCT02865395|62941152|FG000|Overall Study|Physician Decision|6|||
33549915|NCT02865395|62941153|FG001|Overall Study|Physician Decision|10|||
33549916|NCT02865395|62941154|FG002|Overall Study|Physician Decision|7|||
33549917|NCT01123707|62941166|FG000|Overall Study|Lost to Follow-up|3|||
33549918|NCT01123707|62941167|FG001|Overall Study|Lost to Follow-up|1|||
33549919|NCT01123707|62941168|FG002|Overall Study|Lost to Follow-up|3|||
33549920|NCT01123707|62941169|FG003|Overall Study|Lost to Follow-up|2|||
33549921|NCT01123707|62941166|FG000|Overall Study|Adverse Event|5|||
33549922|NCT01123707|62941167|FG001|Overall Study|Adverse Event|7|||
33549923|NCT01123707|62941168|FG002|Overall Study|Adverse Event|5|||
33549924|NCT01123707|62941169|FG003|Overall Study|Adverse Event|3|||
33549925|NCT01123707|62941166|FG000|Overall Study|Sponsor Discontinued Study|30|||
33549926|NCT01123707|62941167|FG001|Overall Study|Sponsor Discontinued Study|24|||
33549927|NCT01123707|62941168|FG002|Overall Study|Sponsor Discontinued Study|25|||
33549928|NCT01123707|62941169|FG003|Overall Study|Sponsor Discontinued Study|40|||
33549929|NCT01123707|62941166|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
33549930|NCT01123707|62941167|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
33549931|NCT01123707|62941168|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
33549932|NCT01123707|62941169|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
33549933|NCT01123707|62941166|FG000|Overall Study|Investigator Withdrew Participant|0|||
33549934|NCT01123707|62941167|FG001|Overall Study|Investigator Withdrew Participant|1|||
33549935|NCT01123707|62941168|FG002|Overall Study|Investigator Withdrew Participant|1|||
33549936|NCT01123707|62941169|FG003|Overall Study|Investigator Withdrew Participant|1|||
33549937|NCT01123707|62941166|FG000|Overall Study|Subject Withdrew Consent|4|||
33549938|NCT01123707|62941167|FG001|Overall Study|Subject Withdrew Consent|5|||
33549939|NCT01123707|62941168|FG002|Overall Study|Subject Withdrew Consent|1|||
33549940|NCT01123707|62941169|FG003|Overall Study|Subject Withdrew Consent|2|||
33549941|NCT01123707|62941166|FG000|Overall Study|Lack of Efficacy|1|||
33549942|NCT01123707|62941167|FG001|Overall Study|Lack of Efficacy|2|||
33549943|NCT01123707|62941168|FG002|Overall Study|Lack of Efficacy|1|||
33549944|NCT01123707|62941169|FG003|Overall Study|Lack of Efficacy|0|||
33549945|NCT01123707|62941166|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
33549946|NCT01123707|62941167|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
33549947|NCT01123707|62941168|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
33549948|NCT01123707|62941169|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
33549949|NCT02755103|62941181|FG000|Overall Study|Lost to Follow-up|17|||
33549950|NCT02755103|62941182|FG001|Overall Study|Lost to Follow-up|15|||
33549951|NCT02755103|62941181|FG000|Overall Study|Death|0|||
33549952|NCT02755103|62941182|FG001|Overall Study|Death|1|||
33549953|NCT02755103|62941181|FG000|Overall Study|Physician Decision|0|||
33549954|NCT02755103|62941182|FG001|Overall Study|Physician Decision|1|||
33549955|NCT02755103|62941181|FG000|Overall Study|Pregnancy|0|||
33549956|NCT02755103|62941182|FG001|Overall Study|Pregnancy|1|||
33549957|NCT02755103|62941181|FG000|Overall Study|Withdrawal by Subject|3|||
33549958|NCT02755103|62941182|FG001|Overall Study|Withdrawal by Subject|0|||
33549959|NCT01258803|62941192|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
33549960|NCT01258803|62941193|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
33549961|NCT01258803|62941194|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
33549962|NCT01258803|62941195|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
33549963|NCT01258803|62941196|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
33655778|NCT01857869|63072971|FG007|Primary/Challenge Phase|Protocol Violation|0|||
33655779|NCT01857869|63072972|FG008|Primary/Challenge Phase|Protocol Violation|0|||
33476226|NCT04322526|62851421|FG001|Washout (1 Week)|Lost to Follow-up|2|||
33476227|NCT04115358|62851430|FG000|Overall Study|exfoliation|0|||
33476228|NCT04115358|62851431|FG001|Overall Study|exfoliation|0|||
33476229|NCT04115358|62851432|FG002|Overall Study|exfoliation|1|||
33476230|NCT04109118|62851441|FG000|Overall Study|Lost to Follow-up|3|||
33476231|NCT04105998|62851448|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
33476232|NCT04105998|62851449|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
33476233|NCT04397718|62851457|FG000|Overall Study|Death|7|||
33476234|NCT04397718|62851458|FG001|Overall Study|Death|11|||
33476235|NCT04397718|62851457|FG000|Overall Study|Lost to Follow-up|0|||
33476236|NCT04397718|62851458|FG001|Overall Study|Lost to Follow-up|4|||
33476237|NCT04105218|62851466|FG000|Overall Study|Withdrawal by Subject|3|||
33476238|NCT04105218|62851467|FG001|Overall Study|Withdrawal by Subject|2|||
33476239|NCT04105218|62851466|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
33476240|NCT04105218|62851467|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
33476241|NCT04105218|62851466|FG000|Overall Study|Failed screening tests|2|||
33476242|NCT04105218|62851467|FG001|Overall Study|Failed screening tests|1|||
33476243|NCT04317690|62851478|FG000|Overall Study|did not have complete information for primary outcome|0|||
33549964|NCT01258803|62941197|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
33549965|NCT01258803|62941192|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
33549966|NCT01258803|62941193|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
33549967|NCT01258803|62941194|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
33549968|NCT01258803|62941195|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
33549969|NCT01258803|62941196|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
33549970|NCT01258803|62941197|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
33549971|NCT01258803|62941192|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
33549972|NCT01258803|62941193|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
33549973|NCT01258803|62941194|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
33549974|NCT01258803|62941195|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
33549975|NCT01258803|62941196|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
33549976|NCT01258803|62941197|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
33549977|NCT02865083|62941213|FG000|Overall Study|Early Termination|3|||
33549978|NCT02865083|62941214|FG001|Overall Study|Early Termination|1|||
33549979|NCT00862251|62941223|FG000|Overall Study|Adverse Event|8|||
33549980|NCT00862251|62941224|FG001|Overall Study|Adverse Event|3|||
33549981|NCT00862251|62941225|FG002|Overall Study|Adverse Event|1|||
33549982|NCT00862251|62941223|FG000|Overall Study|Lost to Follow-up|0|||
33549983|NCT00862251|62941224|FG001|Overall Study|Lost to Follow-up|0|||
33549984|NCT00862251|62941225|FG002|Overall Study|Lost to Follow-up|1|||
33549985|NCT00862251|62941223|FG000|Overall Study|Protocol Violation|2|||
33549986|NCT00862251|62941224|FG001|Overall Study|Protocol Violation|0|||
33549987|NCT00862251|62941225|FG002|Overall Study|Protocol Violation|1|||
33549988|NCT00862251|62941223|FG000|Overall Study|Withdrawal by Subject|9|||
33364271|NCT03938545|62743125|FG003|Overall Study|Study terminated by sponsor|4|||
33364272|NCT03938545|62743122|FG000|Overall Study|Withdrawal by Subject|0|||
33364273|NCT03938545|62743123|FG001|Overall Study|Withdrawal by Subject|1|||
33364274|NCT03938545|62743124|FG002|Overall Study|Withdrawal by Subject|0|||
33364275|NCT03938545|62743125|FG003|Overall Study|Withdrawal by Subject|0|||
33364276|NCT03938545|62743122|FG000|Overall Study|Adverse Event|1|||
33364277|NCT03938545|62743123|FG001|Overall Study|Adverse Event|0|||
33364278|NCT03938545|62743124|FG002|Overall Study|Adverse Event|0|||
33364279|NCT03938545|62743125|FG003|Overall Study|Adverse Event|0|||
33364280|NCT00879996|62743137|FG000|Overall Study|Lost to Follow-up|7|||
33549989|NCT00862251|62941224|FG001|Overall Study|Withdrawal by Subject|2|||
33549990|NCT00862251|62941225|FG002|Overall Study|Withdrawal by Subject|6|||
33549991|NCT02864381|62941254|FG000|Overall Study|Death|58|||
33549992|NCT02864381|62941255|FG001|Overall Study|Death|61|||
33364281|NCT00879996|62743138|FG001|Overall Study|Lost to Follow-up|6|||
33364282|NCT00879996|62743137|FG000|Overall Study|non-compliance|6|||
33364283|NCT00879996|62743138|FG001|Overall Study|non-compliance|4|||
33364284|NCT00879996|62743137|FG000|Overall Study|Physician Decision|1|||
33364285|NCT00879996|62743138|FG001|Overall Study|Physician Decision|2|||
33364286|NCT00879996|62743137|FG000|Overall Study|psychiatric problem|0|||
33364287|NCT00879996|62743138|FG001|Overall Study|psychiatric problem|1|||
33364288|NCT00879996|62743137|FG000|Overall Study|put on parole|1|||
33364289|NCT00879996|62743138|FG001|Overall Study|put on parole|0|||
33364290|NCT00873093|62743151|FG000|Overall Study|Adverse Event|0|||
33549993|NCT02864381|62941254|FG000|Overall Study|Withdrew Consent|5|||
33655780|NCT01857869|63072973|FG009|Primary/Challenge Phase|Protocol Violation|0|||
33655781|NCT01857869|63072964|FG000|Primary/Challenge Phase|Other|1|||
33655782|NCT01857869|63072965|FG001|Primary/Challenge Phase|Other|1|||
33655783|NCT01857869|63072966|FG002|Primary/Challenge Phase|Other|0|||
33655784|NCT01857869|63072967|FG003|Primary/Challenge Phase|Other|0|||
33655785|NCT01857869|63072968|FG004|Primary/Challenge Phase|Other|0|||
33655786|NCT01857869|63072969|FG005|Primary/Challenge Phase|Other|0|||
33655787|NCT01857869|63072970|FG006|Primary/Challenge Phase|Other|0|||
33655788|NCT01857869|63072971|FG007|Primary/Challenge Phase|Other|0|||
33655789|NCT01857869|63072972|FG008|Primary/Challenge Phase|Other|0|||
33655790|NCT01857869|63072973|FG009|Primary/Challenge Phase|Other|0|||
33655791|NCT01857869|63072964|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33655792|NCT01857869|63072965|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33655793|NCT01857869|63072966|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33655794|NCT01857869|63072967|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
33655795|NCT01857869|63072968|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33655796|NCT01857869|63072969|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33364291|NCT00873093|62743152|FG001|Overall Study|Adverse Event|2|||
33364292|NCT00873093|62743153|FG002|Overall Study|Adverse Event|0|||
33364293|NCT00873093|62743154|FG003|Overall Study|Adverse Event|0|||
33549994|NCT02864381|62941255|FG001|Overall Study|Withdrew Consent|6|||
33655797|NCT01857869|63072970|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33655798|NCT01857869|63072971|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33655799|NCT01857869|63072972|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33655800|NCT01857869|63072973|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33364294|NCT00873093|62743155|FG004|Overall Study|Adverse Event|0|||
33364295|NCT00873093|62743151|FG000|Overall Study|Death|0|||
33364296|NCT00873093|62743152|FG001|Overall Study|Death|3|||
33364297|NCT00873093|62743153|FG002|Overall Study|Death|2|||
33364298|NCT00873093|62743154|FG003|Overall Study|Death|0|||
33549995|NCT02864381|62941254|FG000|Overall Study|Reason Unknown|7|||
33549996|NCT02864381|62941255|FG001|Overall Study|Reason Unknown|3|||
33549997|NCT02864381|62941254|FG000|Overall Study|Lost to Follow-up|1|||
33549998|NCT02864381|62941255|FG001|Overall Study|Lost to Follow-up|1|||
33364299|NCT00873093|62743155|FG004|Overall Study|Death|0|||
33364300|NCT00873093|62743151|FG000|Overall Study|Physician Decision|0|||
33364301|NCT00873093|62743152|FG001|Overall Study|Physician Decision|17|||
33364302|NCT00873093|62743153|FG002|Overall Study|Physician Decision|10|||
33364303|NCT00873093|62743154|FG003|Overall Study|Physician Decision|10|||
33364304|NCT00873093|62743155|FG004|Overall Study|Physician Decision|2|||
33364305|NCT00873093|62743151|FG000|Overall Study|Withdrawal by Subject|1|||
33364306|NCT00873093|62743152|FG001|Overall Study|Withdrawal by Subject|4|||
33364307|NCT00873093|62743153|FG002|Overall Study|Withdrawal by Subject|4|||
33364308|NCT00873093|62743154|FG003|Overall Study|Withdrawal by Subject|0|||
33364309|NCT00873093|62743155|FG004|Overall Study|Withdrawal by Subject|0|||
33549999|NCT02864381|62941254|FG000|Overall Study|Investigator's Discretion|1|||
33550000|NCT02864381|62941255|FG001|Overall Study|Investigator's Discretion|0|||
33550001|NCT02864381|62941254|FG000|Overall Study|Protocol Violation|0|||
33550002|NCT02864381|62941255|FG001|Overall Study|Protocol Violation|1|||
33550003|NCT02860169|62941263|FG000|Part A|Withdrawal by Subject|1|||
33550004|NCT02860169|62941263|FG000|Part A|Other (Screening failure)|6|||
33550005|NCT02860169|62941263|FG000|Part A|Other (Survey not completed)|3|||
33550006|NCT02860169|62941263|FG000|Part A|Other (did not completed consent)|1|||
33550007|NCT02860169|62941263|FG000|Part B|Other (Screening failure)|10|||
33364310|NCT00873093|62743151|FG000|Overall Study|Ineligible|0|||
33364311|NCT00873093|62743152|FG001|Overall Study|Ineligible|1|||
33364312|NCT00873093|62743153|FG002|Overall Study|Ineligible|0|||
33364313|NCT00873093|62743154|FG003|Overall Study|Ineligible|1|||
33364314|NCT00873093|62743155|FG004|Overall Study|Ineligible|0|||
33364315|NCT00884286|62743179|FG000|Overall Study|Progressive disease|21|||
33364316|NCT00884286|62743180|FG001|Overall Study|Progressive disease|28|||
33364317|NCT00884286|62743179|FG000|Overall Study|Toxicity|4|||
33364318|NCT00884286|62743180|FG001|Overall Study|Toxicity|1|||
33364319|NCT00884286|62743179|FG000|Overall Study|Death|2|||
33364320|NCT00884286|62743180|FG001|Overall Study|Death|2|||
33364321|NCT00884286|62743179|FG000|Overall Study|Physician Decision|1|||
33364322|NCT00884286|62743180|FG001|Overall Study|Physician Decision|0|||
33364323|NCT00884286|62743179|FG000|Overall Study|Septic shock|1|||
33364324|NCT00884286|62743180|FG001|Overall Study|Septic shock|0|||
33364325|NCT00884286|62743179|FG000|Overall Study|Thrombus in right auricle|1|||
33364326|NCT00884286|62743180|FG001|Overall Study|Thrombus in right auricle|0|||
33364327|NCT00884286|62743179|FG000|Overall Study|Not treated|2|||
33364328|NCT00884286|62743180|FG001|Overall Study|Not treated|1|||
33364329|NCT00884286|62743179|FG000|Overall Study|Comprised lung carcinoma|0|||
33364330|NCT00884286|62743180|FG001|Overall Study|Comprised lung carcinoma|1|||
33364331|NCT00873015|62743191|FG000|Overall Study|Withdrawal by Subject|0|||
33364332|NCT00873015|62743192|FG001|Overall Study|Withdrawal by Subject|1|||
33364333|NCT00873015|62743193|FG002|Overall Study|Withdrawal by Subject|0|||
33364334|NCT00873015|62743194|FG003|Overall Study|Withdrawal by Subject|0|||
33364335|NCT03921151|62743209|FG000|Overall Study|Withdrawal by Subject|11|||
33364336|NCT03921151|62743210|FG001|Overall Study|Withdrawal by Subject|16|||
33364337|NCT00872001|62743222|FG000|Overall Study|Adverse Event|34|||
33364338|NCT00872001|62743223|FG001|Overall Study|Adverse Event|23|||
33364339|NCT00872001|62743222|FG000|Overall Study|Protocol Defined Clinical Event|5|||
33364340|NCT00872001|62743223|FG001|Overall Study|Protocol Defined Clinical Event|7|||
33364341|NCT00872001|62743222|FG000|Overall Study|Lost to Follow-up|13|||
33364342|NCT00872001|62743223|FG001|Overall Study|Lost to Follow-up|12|||
33364343|NCT00872001|62743222|FG000|Overall Study|Withdrawal by Subject|18|||
33364344|NCT00872001|62743223|FG001|Overall Study|Withdrawal by Subject|30|||
33364345|NCT00872001|62743222|FG000|Overall Study|Protocol Violation|5|||
33364346|NCT00872001|62743223|FG001|Overall Study|Protocol Violation|8|||
33364347|NCT00872001|62743222|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
33364348|NCT00872001|62743223|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
33364349|NCT00872001|62743222|FG000|Overall Study|Administrative|23|||
33364350|NCT00872001|62743223|FG001|Overall Study|Administrative|15|||
33364351|NCT00871923|62743231|FG000|Overall Study|Death|1|||
33364352|NCT00871923|62743231|FG000|Overall Study|Withdrawal by Subject|1|||
33364353|NCT03922945|62743238|FG000|Overall Study|Adverse Event|1|||
33364354|NCT03922945|62743239|FG001|Overall Study|Adverse Event|1|||
33364355|NCT03922945|62743240|FG002|Overall Study|Adverse Event|2|||
33364356|NCT03922945|62743238|FG000|Overall Study|Lost to Follow-up|13|||
33364357|NCT03922945|62743239|FG001|Overall Study|Lost to Follow-up|9|||
33364358|NCT03922945|62743240|FG002|Overall Study|Lost to Follow-up|20|||
33364359|NCT03922945|62743238|FG000|Overall Study|Lack of Efficacy|2|||
33364360|NCT03922945|62743239|FG001|Overall Study|Lack of Efficacy|0|||
33476244|NCT04317690|62851479|FG001|Overall Study|did not have complete information for primary outcome|4|||
33476245|NCT04317690|62851480|FG002|Overall Study|did not have complete information for primary outcome|0|||
33476246|NCT04317690|62851481|FG003|Overall Study|did not have complete information for primary outcome|2|||
33476247|NCT04317690|62851482|FG004|Overall Study|did not have complete information for primary outcome|0|||
33476248|NCT03721276|62851509|FG000|Overall Study|Lost to Follow-up|5|||
33476249|NCT03721276|62851510|FG001|Overall Study|Lost to Follow-up|3|||
33476250|NCT03721276|62851509|FG000|Overall Study|Adverse Event|0|||
33476251|NCT03721276|62851510|FG001|Overall Study|Adverse Event|1|||
33550008|NCT02860169|62941263|FG000|Part B|Withdrawal by Subject|1|||
33364361|NCT03922945|62743240|FG002|Overall Study|Lack of Efficacy|1|||
33364362|NCT03922945|62743238|FG000|Overall Study|Protocol Non-Compliance|0|||
33364363|NCT03922945|62743239|FG001|Overall Study|Protocol Non-Compliance|0|||
33364364|NCT03922945|62743240|FG002|Overall Study|Protocol Non-Compliance|1|||
33364365|NCT03922945|62743238|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
33364366|NCT03922945|62743239|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
33364367|NCT03922945|62743240|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
33364368|NCT03922945|62743238|FG000|Overall Study|All Other Personal Reasons|1|||
33364369|NCT03922945|62743239|FG001|Overall Study|All Other Personal Reasons|1|||
33364370|NCT03922945|62743240|FG002|Overall Study|All Other Personal Reasons|2|||
33364371|NCT03922477|62743251|FG000|Overall Study|Death|9|||
33364372|NCT03922477|62743251|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
33364373|NCT03922477|62743251|FG000|Overall Study|Physician Decision|1|||
33364374|NCT03922477|62743251|FG000|Overall Study|Withdrawal by Subject|2|||
33364375|NCT00867165|62743257|FG000|Overall Study|Adverse Event|3|||
33364376|NCT00867165|62743258|FG001|Overall Study|Adverse Event|0|||
33364377|NCT00867165|62743257|FG000|Overall Study|Withdrawal by Subject|1|||
33364378|NCT00867165|62743258|FG001|Overall Study|Withdrawal by Subject|0|||
33364379|NCT00867087|62743264|FG000|Overall Study|Other|1|||
33364380|NCT00867087|62743264|FG000|Overall Study|Withdrawal by Subject|4|||
33364381|NCT00867087|62743264|FG000|Overall Study|Death|37|||
33364382|NCT00545233|62743270|FG000|Overall Study|Adverse Event|10|||
33364383|NCT00545233|62743271|FG001|Overall Study|Adverse Event|5|||
33364384|NCT00545233|62743270|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
33364385|NCT00545233|62743271|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
33364386|NCT00545233|62743270|FG000|Overall Study|Protocol Violation|2|||
33364387|NCT00545233|62743271|FG001|Overall Study|Protocol Violation|0|||
33364388|NCT00545233|62743270|FG000|Overall Study|Refused Treatment|9|||
33364389|NCT00545233|62743271|FG001|Overall Study|Refused Treatment|7|||
33364390|NCT00545233|62743270|FG000|Overall Study|Failure to Return|4|||
33364391|NCT00545233|62743271|FG001|Overall Study|Failure to Return|6|||
33364392|NCT00545233|62743270|FG000|Overall Study|Insufficient response|14|||
33364393|NCT00545233|62743271|FG001|Overall Study|Insufficient response|15|||
33364394|NCT00545233|62743270|FG000|Overall Study|Physician Decision|2|||
33364395|NCT00545233|62743271|FG001|Overall Study|Physician Decision|1|||
33364396|NCT02393248|62743303|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364397|NCT02393248|62743304|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
33364398|NCT02393248|62743305|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364399|NCT02393248|62743306|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364400|NCT02393248|62743307|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364401|NCT02393248|62743308|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
33364402|NCT02393248|62743309|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
33364403|NCT02393248|62743310|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364404|NCT02393248|62743311|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364405|NCT02393248|62743312|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364406|NCT02393248|62743313|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364407|NCT02393248|62743314|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33476252|NCT03269344|62851525|FG000|Overall Study|Protocol Violation|4|||
33476253|NCT03269344|62851526|FG001|Overall Study|Protocol Violation|3|||
33476254|NCT04389840|62851538|FG000|Overall Study|Adverse Event|0|||
33476255|NCT04389840|62851539|FG001|Overall Study|Adverse Event|0|||
33476256|NCT04389840|62851540|FG002|Overall Study|Adverse Event|0|||
33476257|NCT04389840|62851541|FG003|Overall Study|Adverse Event|1|||
33550009|NCT02860169|62941263|FG000|Part C|Other (Screening failure)|1|||
33550010|NCT00409773|62941274|FG000|Overall Study|Adverse Event|3|||
33550011|NCT00409773|62941275|FG001|Overall Study|Adverse Event|4|||
33550012|NCT00409773|62941276|FG002|Overall Study|Adverse Event|4|||
33364408|NCT02393248|62743315|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364409|NCT02393248|62743316|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364410|NCT02393248|62743317|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364411|NCT02393248|62743318|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364412|NCT02393248|62743319|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364413|NCT02393248|62743320|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364414|NCT02393248|62743321|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364415|NCT02393248|62743322|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33476258|NCT04389840|62851542|FG004|Overall Study|Adverse Event|0|||
33476259|NCT04389840|62851543|FG005|Overall Study|Adverse Event|0|||
33476260|NCT04389840|62851538|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
33476261|NCT04389840|62851539|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
33550013|NCT00409773|62941277|FG003|Overall Study|Adverse Event|2|||
33364416|NCT02393248|62743323|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33550014|NCT00409773|62941278|FG004|Overall Study|Adverse Event|6|||
33476262|NCT04389840|62851540|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
33476263|NCT04389840|62851541|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
33476264|NCT04389840|62851542|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
33476265|NCT04389840|62851543|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
33476266|NCT04389840|62851538|FG000|Overall Study|Death|0|||
33476267|NCT04389840|62851539|FG001|Overall Study|Death|1|||
33476268|NCT04389840|62851540|FG002|Overall Study|Death|0|||
33476269|NCT04389840|62851541|FG003|Overall Study|Death|0|||
33476270|NCT04389840|62851542|FG004|Overall Study|Death|0|||
33476271|NCT04389840|62851543|FG005|Overall Study|Death|0|||
33476272|NCT04307940|62851566|FG000|Overall Study|Adverse Event|1|||
33476273|NCT04307940|62851567|FG001|Overall Study|Adverse Event|0|||
33476274|NCT04307940|62851568|FG002|Overall Study|Adverse Event|0|||
33476275|NCT04307940|62851566|FG000|Overall Study|Withdrawal by Subject|2|||
33476276|NCT04307940|62851567|FG001|Overall Study|Withdrawal by Subject|3|||
33476277|NCT04307940|62851568|FG002|Overall Study|Withdrawal by Subject|1|||
33476278|NCT04307940|62851566|FG000|Overall Study|Lost to Follow-up|2|||
33476279|NCT04307940|62851567|FG001|Overall Study|Lost to Follow-up|0|||
33476280|NCT04307940|62851568|FG002|Overall Study|Lost to Follow-up|1|||
33476281|NCT02054104|62851578|FG000|Overall Study|Did not want to continue due to college classes|1|||
33476282|NCT02054104|62851579|FG001|Overall Study|Did not want to continue due to college classes|0|||
33476283|NCT02054104|62851578|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
33476284|NCT02054104|62851579|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
33476285|NCT02054104|62851578|FG000|Overall Study|No evidence of immunologic response|2|||
33550015|NCT00409773|62941274|FG000|Overall Study|Lost to Follow-up|6|||
33550016|NCT00409773|62941275|FG001|Overall Study|Lost to Follow-up|1|||
33550017|NCT00409773|62941276|FG002|Overall Study|Lost to Follow-up|2|||
33364417|NCT02393248|62743324|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364418|NCT02393248|62743325|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33550018|NCT00409773|62941277|FG003|Overall Study|Lost to Follow-up|3|||
33550019|NCT00409773|62941278|FG004|Overall Study|Lost to Follow-up|1|||
33550020|NCT00409773|62941274|FG000|Overall Study|Physician Decision|0|||
33550021|NCT00409773|62941275|FG001|Overall Study|Physician Decision|0|||
33655801|NCT01857869|63072964|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33655802|NCT01857869|63072965|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33655803|NCT01857869|63072966|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33655804|NCT01857869|63072967|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
33655805|NCT01857869|63072968|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33655806|NCT01857869|63072969|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33655807|NCT01857869|63072970|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33655808|NCT01857869|63072971|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33655809|NCT01857869|63072972|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33655810|NCT01857869|63072973|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33655811|NCT04452318|63073061|FG000|Overall Study|Physician Decision|1|||
33655812|NCT04452318|63073062|FG001|Overall Study|Physician Decision|2|||
33655813|NCT04452318|63073063|FG002|Overall Study|Physician Decision|0|||
33364419|NCT02393248|62743326|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33364420|NCT02393248|62743327|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33550022|NCT00409773|62941276|FG002|Overall Study|Physician Decision|0|||
33550023|NCT00409773|62941277|FG003|Overall Study|Physician Decision|2|||
33550024|NCT00409773|62941278|FG004|Overall Study|Physician Decision|0|||
33550025|NCT00409773|62941274|FG000|Overall Study|Protocol Violation|0|||
33550026|NCT00409773|62941275|FG001|Overall Study|Protocol Violation|2|||
33550027|NCT00409773|62941276|FG002|Overall Study|Protocol Violation|3|||
33550028|NCT00409773|62941277|FG003|Overall Study|Protocol Violation|3|||
33550029|NCT00409773|62941278|FG004|Overall Study|Protocol Violation|1|||
33550030|NCT00409773|62941274|FG000|Overall Study|Withdrawal by Subject|0|||
33550031|NCT00409773|62941275|FG001|Overall Study|Withdrawal by Subject|0|||
33550032|NCT00409773|62941276|FG002|Overall Study|Withdrawal by Subject|0|||
33550033|NCT00409773|62941277|FG003|Overall Study|Withdrawal by Subject|2|||
33550034|NCT00409773|62941278|FG004|Overall Study|Withdrawal by Subject|1|||
33655814|NCT04452318|63073064|FG003|Overall Study|Physician Decision|2|||
33655815|NCT04452318|63073065|FG004|Overall Study|Physician Decision|0|||
33655816|NCT04452318|63073066|FG005|Overall Study|Physician Decision|2|||
33655817|NCT04452318|63073067|FG006|Overall Study|Physician Decision|5|||
33476286|NCT02054104|62851579|FG001|Overall Study|No evidence of immunologic response|2|||
33655818|NCT04452318|63073061|FG000|Overall Study|Death|2|||
33476287|NCT02054104|62851578|FG000|Overall Study|Disease Progression On Study|4|||
33476288|NCT02054104|62851579|FG001|Overall Study|Disease Progression On Study|5|||
33550035|NCT00409773|62941274|FG000|Overall Study|Lack of Eligibility|0|||
33550036|NCT00409773|62941275|FG001|Overall Study|Lack of Eligibility|0|||
33550037|NCT00409773|62941276|FG002|Overall Study|Lack of Eligibility|0|||
33550038|NCT00409773|62941277|FG003|Overall Study|Lack of Eligibility|0|||
33476289|NCT02054104|62851578|FG000|Overall Study|Diagnosis of lymphoma|0|||
33476290|NCT02054104|62851579|FG001|Overall Study|Diagnosis of lymphoma|1|||
33476291|NCT02054104|62851578|FG000|Overall Study|Inconclusive response|0|||
33476292|NCT02054104|62851579|FG001|Overall Study|Inconclusive response|1|||
33476293|NCT04090242|62851587|FG000|Overall Study|Withdrawal by Subject|1|||
33476294|NCT04090242|62851588|FG001|Overall Study|Withdrawal by Subject|0|||
33476295|NCT04090164|62851597|FG000|Overall Study|incomplete data on file|245|||
33476296|NCT04090164|62851598|FG001|Overall Study|incomplete data on file|0|||
33476297|NCT04292730|62851618|FG000|Overall Study|Lost to Follow-up|8|||
33476298|NCT04292730|62851619|FG001|Overall Study|Lost to Follow-up|12|||
33476299|NCT04292730|62851620|FG002|Overall Study|Lost to Follow-up|12|||
33476300|NCT04292730|62851621|FG003|Overall Study|Lost to Follow-up|48|||
33476301|NCT04292730|62851618|FG000|Overall Study|Death|2|||
33476302|NCT04292730|62851619|FG001|Overall Study|Death|2|||
33476303|NCT04292730|62851620|FG002|Overall Study|Death|4|||
33476304|NCT04292730|62851621|FG003|Overall Study|Death|12|||
33476305|NCT04292730|62851618|FG000|Overall Study|Withdrew Consent|2|||
33476306|NCT04292730|62851619|FG001|Overall Study|Withdrew Consent|2|||
33476307|NCT04292730|62851620|FG002|Overall Study|Withdrew Consent|5|||
33476308|NCT04292730|62851621|FG003|Overall Study|Withdrew Consent|6|||
33476309|NCT04292730|62851618|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33476310|NCT04292730|62851619|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33476311|NCT04292730|62851620|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33476312|NCT04292730|62851621|FG003|Overall Study|Non-Compliance with Study Drug|0|||
33476313|NCT04292730|62851618|FG000|Overall Study|Protocol Violation|0|||
33476314|NCT04292730|62851619|FG001|Overall Study|Protocol Violation|0|||
33476315|NCT04292730|62851620|FG002|Overall Study|Protocol Violation|1|||
33476316|NCT04292730|62851621|FG003|Overall Study|Protocol Violation|0|||
33476317|NCT04292730|62851618|FG000|Overall Study|Randomized but not Treated|8|||
33476318|NCT04292730|62851619|FG001|Overall Study|Randomized but not Treated|4|||
33476319|NCT04292730|62851620|FG002|Overall Study|Randomized but not Treated|0|||
33476320|NCT04292730|62851621|FG003|Overall Study|Randomized but not Treated|14|||
33476321|NCT02861014|62851630|FG000|Primary Analysis|Adverse Event|7|||
33476322|NCT02861014|62851630|FG000|Primary Analysis|Death|1|||
33476323|NCT02861014|62851630|FG000|Primary Analysis|Lack of Efficacy|3|||
33476324|NCT02861014|62851630|FG000|Primary Analysis|Physician Decision|2|||
33476325|NCT02861014|62851630|FG000|Primary Analysis|Pregnancy|4|||
33476326|NCT02861014|62851630|FG000|Primary Analysis|Protocol Violation|2|||
33476327|NCT02861014|62851630|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
33476328|NCT02861014|62851630|FG000|Primary Analysis|Withdrawal by Subject|14|||
33476329|NCT02861014|62851630|FG000|Primary Analysis|Commercial ocrelizumab|3|||
33476330|NCT02861014|62851630|FG000|Safety Follow-up|Adverse Event|1|||
33476331|NCT02861014|62851630|FG000|Safety Follow-up|Pregnancy|1|||
33476332|NCT02861014|62851630|FG000|Safety Follow-up|Withdrawal by Subject|9|||
33476333|NCT02861014|62851630|FG000|Safety Follow-up|Study terminated by sponsor|1|||
33476334|NCT02861014|62851630|FG000|Safety Follow-up|Physician Decision|1|||
33476335|NCT02861014|62851630|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
33476336|NCT02861014|62851630|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
33476337|NCT04382586|62851638|FG000|Overall Study|Death|3|||
33476338|NCT04382586|62851639|FG001|Overall Study|Death|4|||
33476339|NCT04382586|62851638|FG000|Overall Study|Lost to Follow-up|11|||
33550039|NCT00409773|62941278|FG004|Overall Study|Lack of Eligibility|1|||
33550040|NCT02861807|62941292|FG000|Overall Study|Lost to Follow-up|7|||
33550041|NCT02861807|62941293|FG001|Overall Study|Lost to Follow-up|6|||
33550042|NCT02861807|62941292|FG000|Overall Study|Withdrawal by Subject|5|||
33476340|NCT04382586|62851639|FG001|Overall Study|Lost to Follow-up|8|||
33476341|NCT04382586|62851638|FG000|Overall Study|Withdrawal by Subject|3|||
33476342|NCT04382586|62851639|FG001|Overall Study|Withdrawal by Subject|1|||
33476343|NCT04382586|62851638|FG000|Overall Study|Physician Decision|0|||
33476344|NCT04382586|62851639|FG001|Overall Study|Physician Decision|3|||
33476345|NCT04480710|62851649|FG000|Overall Study|Adverse Event|0|||
33476346|NCT04480710|62851650|FG001|Overall Study|Adverse Event|2|||
33550043|NCT02861807|62941293|FG001|Overall Study|Withdrawal by Subject|8|||
33476347|NCT04480710|62851651|FG002|Overall Study|Adverse Event|0|||
33476348|NCT04480710|62851652|FG003|Overall Study|Adverse Event|0|||
33476349|NCT04480710|62851649|FG000|Overall Study|Withdrawal by Subject|0|||
33476350|NCT04480710|62851650|FG001|Overall Study|Withdrawal by Subject|1|||
33476351|NCT04480710|62851651|FG002|Overall Study|Withdrawal by Subject|0|||
33550044|NCT02858401|62941306|FG000|Overall Study|Withdrew Consent|0|||
33476352|NCT04480710|62851652|FG003|Overall Study|Withdrawal by Subject|0|||
33476353|NCT04480710|62851649|FG000|Overall Study|Physician Decision|0|||
33476354|NCT04480710|62851650|FG001|Overall Study|Physician Decision|0|||
33476355|NCT04480710|62851651|FG002|Overall Study|Physician Decision|1|||
33476356|NCT04480710|62851652|FG003|Overall Study|Physician Decision|0|||
33476357|NCT04268316|62851671|FG000|Overall Study|Withdrawal by Subject|2|||
33476358|NCT04268316|62851672|FG001|Overall Study|Withdrawal by Subject|1|||
33476359|NCT04268316|62851673|FG002|Overall Study|Withdrawal by Subject|0|||
33476360|NCT01971970|62851683|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
33476361|NCT01971970|62851684|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
33476362|NCT01971970|62851683|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
33476363|NCT01971970|62851684|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
33476364|NCT01971970|62851683|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
33476365|NCT01971970|62851684|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
33476366|NCT01971970|62851683|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
33476367|NCT01971970|62851684|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
33476368|NCT01971970|62851683|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
33476369|NCT01971970|62851684|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
33476370|NCT01971970|62851683|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
33476371|NCT01971970|62851684|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
33476372|NCT01971970|62851683|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
33476373|NCT01971970|62851684|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
33476374|NCT04079790|62851699|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
33476375|NCT04079790|62851700|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
33476376|NCT04079790|62851701|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
33476377|NCT04079790|62851702|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
33476378|NCT04079790|62851699|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
33476379|NCT04079790|62851700|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
33476380|NCT04079790|62851701|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
33476381|NCT04079790|62851702|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
33476382|NCT04079790|62851699|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
33476383|NCT04079790|62851700|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
33476384|NCT04079790|62851701|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
33476385|NCT04079790|62851702|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
33476386|NCT04259346|62851730|FG000|Overall Study|Lost to Follow-up|1|||
33476387|NCT04259346|62851731|FG001|Overall Study|Lost to Follow-up|3|||
33476388|NCT04259346|62851730|FG000|Overall Study|Protocol Violation|1|||
33476389|NCT04259346|62851731|FG001|Overall Study|Protocol Violation|0|||
33476390|NCT04259346|62851730|FG000|Overall Study|Withdrawal by Subject|1|||
33476391|NCT04259346|62851731|FG001|Overall Study|Withdrawal by Subject|0|||
33476392|NCT04259346|62851730|FG000|Overall Study|Adverse Event|1|||
33476393|NCT04259346|62851731|FG001|Overall Study|Adverse Event|1|||
33476394|NCT04230876|62851739|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
33476395|NCT04230876|62851740|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
33476396|NCT04228302|62851752|FG000|Overall Study|Adverse Event|0|||
33476397|NCT04228302|62851753|FG001|Overall Study|Adverse Event|0|||
33476398|NCT04228302|62851754|FG002|Overall Study|Adverse Event|0|||
33476399|NCT04228302|62851755|FG003|Overall Study|Adverse Event|0|||
33476400|NCT04228302|62851756|FG004|Overall Study|Adverse Event|1|||
33476401|NCT04228302|62851757|FG005|Overall Study|Adverse Event|0|||
33476402|NCT01348100|62851778|FG000|Overall Study|Subject Withdrew Consent|0|||
33476403|NCT01348100|62851779|FG001|Overall Study|Subject Withdrew Consent|0|||
33476404|NCT01348100|62851780|FG002|Overall Study|Subject Withdrew Consent|2|||
33476405|NCT01348100|62851781|FG003|Overall Study|Subject Withdrew Consent|0|||
33476406|NCT01348100|62851782|FG004|Overall Study|Subject Withdrew Consent|1|||
33476407|NCT01348100|62851783|FG005|Overall Study|Subject Withdrew Consent|0|||
33476408|NCT01348100|62851784|FG006|Overall Study|Subject Withdrew Consent|1|||
33476409|NCT01348100|62851778|FG000|Overall Study|Protocol Deviation|0|||
33476410|NCT01348100|62851779|FG001|Overall Study|Protocol Deviation|0|||
33476411|NCT01348100|62851780|FG002|Overall Study|Protocol Deviation|0|||
33476412|NCT01348100|62851781|FG003|Overall Study|Protocol Deviation|1|||
33476413|NCT01348100|62851782|FG004|Overall Study|Protocol Deviation|0|||
33476414|NCT01348100|62851783|FG005|Overall Study|Protocol Deviation|0|||
33476415|NCT01348100|62851784|FG006|Overall Study|Protocol Deviation|0|||
33476416|NCT01348100|62851778|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33476417|NCT01348100|62851779|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33476418|NCT01348100|62851780|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33476419|NCT01348100|62851781|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33476420|NCT01348100|62851782|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33476421|NCT01348100|62851783|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
33476422|NCT01348100|62851784|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33476423|NCT01348100|62851778|FG000|Overall Study|Lost to Follow-up|0|||
33476424|NCT01348100|62851779|FG001|Overall Study|Lost to Follow-up|0|||
33476425|NCT01348100|62851780|FG002|Overall Study|Lost to Follow-up|0|||
33476426|NCT01348100|62851781|FG003|Overall Study|Lost to Follow-up|0|||
33364421|NCT02393248|62743303|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364422|NCT02393248|62743304|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
33364423|NCT02393248|62743305|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33476427|NCT01348100|62851782|FG004|Overall Study|Lost to Follow-up|0|||
33476428|NCT01348100|62851783|FG005|Overall Study|Lost to Follow-up|0|||
33476429|NCT01348100|62851784|FG006|Overall Study|Lost to Follow-up|1|||
33476430|NCT01348100|62851778|FG000|Overall Study|Administrative Problems|0|||
33476431|NCT01348100|62851779|FG001|Overall Study|Administrative Problems|0|||
33476432|NCT01348100|62851780|FG002|Overall Study|Administrative Problems|0|||
33476433|NCT01348100|62851781|FG003|Overall Study|Administrative Problems|0|||
33476434|NCT01348100|62851782|FG004|Overall Study|Administrative Problems|0|||
33476435|NCT01348100|62851783|FG005|Overall Study|Administrative Problems|1|||
33476436|NCT01348100|62851784|FG006|Overall Study|Administrative Problems|1|||
33476437|NCT03676634|62851805|FG000|Overall Study|Red blood cell loss|1|||
33476438|NCT03676634|62851805|FG000|Overall Study|Out-of-limit pulse|2|||
33476439|NCT03675776|62851812|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
33476440|NCT03675776|62851813|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
33476441|NCT03675776|62851814|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
33476442|NCT03675776|62851812|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
33476443|NCT03675776|62851813|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
33476444|NCT03675776|62851814|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
33476445|NCT03673670|62851828|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
33476446|NCT03673670|62851829|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
33476447|NCT03673670|62851830|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
33476448|NCT03673670|62851831|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
33476449|NCT03673670|62851832|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
33476450|NCT03673670|62851833|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
33476451|NCT03673670|62851828|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
33476452|NCT03673670|62851829|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
33476453|NCT03673670|62851830|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
33476454|NCT03673670|62851831|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
33476455|NCT03673670|62851832|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
33476456|NCT03673670|62851833|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
33476457|NCT03673670|62851828|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
33476458|NCT03673670|62851829|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
33476459|NCT03673670|62851830|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
33476460|NCT03673670|62851831|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
33476461|NCT03673670|62851832|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
33476462|NCT03673670|62851833|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
33476463|NCT03673670|62851828|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
33476464|NCT03673670|62851829|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
33476465|NCT03673670|62851830|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
33476466|NCT03673670|62851831|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
33476467|NCT03673670|62851832|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
33364424|NCT02393248|62743306|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364425|NCT02393248|62743307|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364426|NCT02393248|62743308|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364427|NCT02393248|62743309|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364428|NCT02393248|62743310|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364429|NCT02393248|62743311|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364430|NCT02393248|62743312|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364431|NCT02393248|62743313|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364432|NCT02393248|62743314|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364433|NCT02393248|62743315|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364434|NCT02393248|62743316|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364435|NCT02393248|62743317|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364436|NCT02393248|62743318|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364437|NCT02393248|62743319|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33476468|NCT03673670|62851833|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
33476469|NCT03673670|62851828|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
33476470|NCT03673670|62851829|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
33476471|NCT03673670|62851830|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
33364438|NCT02393248|62743320|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364439|NCT02393248|62743321|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33476472|NCT03673670|62851831|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
33476473|NCT03673670|62851832|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
33476474|NCT03673670|62851833|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
33476475|NCT03673670|62851828|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
33476476|NCT03673670|62851829|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
33476477|NCT03673670|62851830|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
33476478|NCT03673670|62851831|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
33476479|NCT03673670|62851832|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
33476480|NCT03673670|62851833|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
33476481|NCT03673670|62851828|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
33476482|NCT03673670|62851829|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
33476483|NCT03673670|62851830|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
33476484|NCT03673670|62851831|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
33476485|NCT03673670|62851832|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
33476486|NCT03673670|62851833|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
33476487|NCT04369742|62851852|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
33476488|NCT04369742|62851853|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
33476489|NCT04369742|62851852|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
33476490|NCT04369742|62851853|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
33476491|NCT04369430|62851861|FG000|Overall Study|Adverse Event|2|||
33476492|NCT04369430|62851862|FG001|Overall Study|Adverse Event|3|||
33476493|NCT04369430|62851861|FG000|Overall Study|Death|1|||
33476494|NCT04369430|62851862|FG001|Overall Study|Death|0|||
33476495|NCT04369430|62851861|FG000|Overall Study|Withdrawal by Subject|4|||
33476496|NCT04369430|62851862|FG001|Overall Study|Withdrawal by Subject|3|||
33476497|NCT04369430|62851861|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
33476498|NCT04369430|62851862|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
33476499|NCT04369430|62851861|FG000|Overall Study|Lost to Follow-up|0|||
33476500|NCT04369430|62851862|FG001|Overall Study|Lost to Follow-up|1|||
33476501|NCT04363736|62851870|FG000|Overall Study|Withdrawal by Subject|1|||
33476502|NCT04363736|62851871|FG001|Overall Study|Withdrawal by Subject|0|||
33476503|NCT04363736|62851870|FG000|Overall Study|Lost to Follow-up|10|||
33476504|NCT04363736|62851871|FG001|Overall Study|Lost to Follow-up|7|||
33476505|NCT04363736|62851870|FG000|Overall Study|Death|8|||
33476506|NCT04363736|62851871|FG001|Overall Study|Death|6|||
33476507|NCT04362176|62851879|FG000|Overall Study|Lost to Follow-up|5|||
33476508|NCT04362176|62851880|FG001|Overall Study|Lost to Follow-up|8|||
33476509|NCT04362176|62851879|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
33476510|NCT04362176|62851880|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
33476511|NCT04079816|62851886|FG000|Overall Study|Request of Subject|2|||
33476512|NCT04079816|62851886|FG000|Overall Study|Unable to draw samples|1|||
33476513|NCT04079114|62851890|FG000|Overall Study|Study prematuely terminated.|166|||
33476514|NCT03055936|62851898|FG000|Overall Study|Adverse Event|0|||
33476515|NCT03055936|62851899|FG001|Overall Study|Adverse Event|1|||
33476516|NCT03055936|62851900|FG002|Overall Study|Adverse Event|1|||
33476517|NCT03055936|62851901|FG003|Overall Study|Adverse Event|1|||
33476518|NCT03055936|62851898|FG000|Overall Study|Personal reason|2|||
33476519|NCT03055936|62851899|FG001|Overall Study|Personal reason|0|||
33476520|NCT03055936|62851900|FG002|Overall Study|Personal reason|1|||
33476521|NCT03055936|62851901|FG003|Overall Study|Personal reason|0|||
33476522|NCT03891524|62851943|FG000|Overall Study|Death|0|||
33476523|NCT03891524|62851944|FG001|Overall Study|Death|0|||
33476524|NCT03891524|62851945|FG002|Overall Study|Death|0|||
33476525|NCT03891524|62851946|FG003|Overall Study|Death|0|||
33476526|NCT03891524|62851947|FG004|Overall Study|Death|0|||
33476527|NCT03891524|62851948|FG005|Overall Study|Death|0|||
33476528|NCT03891524|62851949|FG006|Overall Study|Death|0|||
33476529|NCT03891524|62851950|FG007|Overall Study|Death|1|||
33476530|NCT03891524|62851943|FG000|Overall Study|Withdrawal by Subject|0|||
33476531|NCT03891524|62851944|FG001|Overall Study|Withdrawal by Subject|1|||
33476532|NCT03891524|62851945|FG002|Overall Study|Withdrawal by Subject|2|||
33476533|NCT03891524|62851946|FG003|Overall Study|Withdrawal by Subject|1|||
33476534|NCT03891524|62851947|FG004|Overall Study|Withdrawal by Subject|2|||
33476535|NCT03891524|62851948|FG005|Overall Study|Withdrawal by Subject|2|||
33476536|NCT03891524|62851949|FG006|Overall Study|Withdrawal by Subject|2|||
33476537|NCT03891524|62851950|FG007|Overall Study|Withdrawal by Subject|1|||
33476538|NCT03055624|62851985|FG000|Overall Study|Study closed|9|||
33476539|NCT01346176|62851992|FG000|Recruited|Protocol Violation|1|||
33476540|NCT01346176|62851993|FG001|Recruited|Protocol Violation|0|||
33550045|NCT02858401|62941307|FG001|Overall Study|Withdrew Consent|0|||
33476541|NCT01346176|62851994|FG002|Recruited|Protocol Violation|0|||
33476542|NCT01346176|62851992|FG000|Completed Advance Directive|Death|3|||
33476543|NCT01346176|62851993|FG001|Completed Advance Directive|Death|2|||
33476544|NCT01346176|62851994|FG002|Completed Advance Directive|Death|2|||
33476545|NCT01346176|62851992|FG000|Completed Advance Directive|Became Ineligible|3|||
33476546|NCT01346176|62851993|FG001|Completed Advance Directive|Became Ineligible|0|||
33550046|NCT02858401|62941308|FG002|Overall Study|Withdrew Consent|0|||
33476547|NCT01346176|62851994|FG002|Completed Advance Directive|Became Ineligible|1|||
33476548|NCT01346176|62851992|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
33476549|NCT01346176|62851993|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
33476550|NCT01346176|62851994|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
33476551|NCT01346176|62851992|FG000|Completed Satisfaction Survey|Death|3|||
33476552|NCT01346176|62851993|FG001|Completed Satisfaction Survey|Death|0|||
33476553|NCT01346176|62851994|FG002|Completed Satisfaction Survey|Death|2|||
33476554|NCT01346176|62851992|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
33476555|NCT01346176|62851993|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
33476556|NCT01346176|62851994|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
33476557|NCT04075604|62852005|FG000|Overall Study|Adverse Event|0|||
33476558|NCT04075604|62852006|FG001|Overall Study|Adverse Event|0|||
33476559|NCT04075604|62852007|FG002|Overall Study|Adverse Event|3|||
33476560|NCT04075604|62852005|FG000|Overall Study|Participant request to discontinue study treatment|0|||
33476561|NCT04075604|62852006|FG001|Overall Study|Participant request to discontinue study treatment|0|||
33476562|NCT04075604|62852007|FG002|Overall Study|Participant request to discontinue study treatment|1|||
33476563|NCT04075604|62852005|FG000|Overall Study|Participant withdrew consent|0|||
33476564|NCT04075604|62852006|FG001|Overall Study|Participant withdrew consent|0|||
33476565|NCT04075604|62852007|FG002|Overall Study|Participant withdrew consent|1|||
33476566|NCT04075604|62852005|FG000|Overall Study|Other reasons|1|||
33476567|NCT04075604|62852006|FG001|Overall Study|Other reasons|0|||
33476568|NCT04075604|62852007|FG002|Overall Study|Other reasons|0|||
33476569|NCT04075604|62852005|FG000|Overall Study|Disease progression|0|||
33476570|NCT04075604|62852006|FG001|Overall Study|Disease progression|1|||
33476571|NCT04075604|62852007|FG002|Overall Study|Disease progression|0|||
33476572|NCT04075604|62852005|FG000|Overall Study|Study drug toxicity|0|||
33476573|NCT04075604|62852006|FG001|Overall Study|Study drug toxicity|5|||
33476574|NCT04075604|62852007|FG002|Overall Study|Study drug toxicity|1|||
33476575|NCT03796208|62852026|FG000|Overall Study|Withdrawal by Subject|3|||
33476576|NCT03796208|62852027|FG001|Overall Study|Withdrawal by Subject|0|||
33476577|NCT03796208|62852026|FG000|Overall Study|Loss of pregnancy|1|||
33476578|NCT03796208|62852027|FG001|Overall Study|Loss of pregnancy|1|||
33476579|NCT03796208|62852026|FG000|Overall Study|Changed prenatal clinics|0|||
33476580|NCT03796208|62852027|FG001|Overall Study|Changed prenatal clinics|5|||
33476581|NCT03796208|62852026|FG000|Overall Study|Lost to Follow-up|20|||
33476582|NCT03796208|62852027|FG001|Overall Study|Lost to Follow-up|16|||
33476583|NCT01318876|62852033|FG000|Day 8 Survey|email address invalid|96|||
33476584|NCT01318876|62852033|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
33476585|NCT01318876|62852033|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
33476586|NCT03668600|62852037|FG000|Overall Study|Study Terminated by the Sponsor|157|||
33476587|NCT03668600|62852037|FG000|Overall Study|Protocol Violation|1|||
33476588|NCT03668600|62852037|FG000|Overall Study|Pregnancy|1|||
33476589|NCT03668600|62852037|FG000|Overall Study|Lost to Follow-up|7|||
33476590|NCT03668600|62852037|FG000|Overall Study|Withdrawal by Subject|56|||
33476591|NCT03668600|62852037|FG000|Overall Study|Lack of Efficacy|7|||
33476592|NCT03668600|62852037|FG000|Overall Study|Adverse Event|1|||
33655819|NCT04452318|63073062|FG001|Overall Study|Death|3|||
33655820|NCT04452318|63073063|FG002|Overall Study|Death|0|||
33655821|NCT04452318|63073064|FG003|Overall Study|Death|0|||
33655822|NCT04452318|63073065|FG004|Overall Study|Death|0|||
33655823|NCT04452318|63073066|FG005|Overall Study|Death|0|||
33655824|NCT04452318|63073067|FG006|Overall Study|Death|0|||
33655825|NCT04452318|63073061|FG000|Overall Study|Lost to Follow-up|38|||
33655826|NCT04452318|63073062|FG001|Overall Study|Lost to Follow-up|28|||
33655827|NCT04452318|63073063|FG002|Overall Study|Lost to Follow-up|0|||
33655828|NCT04452318|63073064|FG003|Overall Study|Lost to Follow-up|3|||
33655829|NCT04452318|63073065|FG004|Overall Study|Lost to Follow-up|3|||
33655830|NCT04452318|63073066|FG005|Overall Study|Lost to Follow-up|2|||
33655831|NCT04452318|63073067|FG006|Overall Study|Lost to Follow-up|1|||
33655832|NCT04452318|63073061|FG000|Overall Study|Withdrawal by Subject|46|||
33476593|NCT04073186|62852041|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
33476594|NCT04073186|62852041|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
33476595|NCT04073186|62852041|FG000|First Wearing Cycle|Protocol Violation|1|||
33476596|NCT04073186|62852041|FG000|First Wearing Cycle|Lens Discomfort|2|||
33550047|NCT02858401|62941309|FG003|Overall Study|Withdrew Consent|0|||
33655833|NCT04452318|63073062|FG001|Overall Study|Withdrawal by Subject|40|||
33655834|NCT04452318|63073063|FG002|Overall Study|Withdrawal by Subject|0|||
33655835|NCT04452318|63073064|FG003|Overall Study|Withdrawal by Subject|18|||
33655836|NCT04452318|63073065|FG004|Overall Study|Withdrawal by Subject|6|||
33655837|NCT04452318|63073066|FG005|Overall Study|Withdrawal by Subject|8|||
33655838|NCT04452318|63073067|FG006|Overall Study|Withdrawal by Subject|6|||
33655839|NCT00634101|63073244|FG000|Overall Study|Study Terminated|3|||
33476597|NCT04073186|62852041|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
33476598|NCT04073186|62852041|FG000|Second Wearing Cycle|Adverse Event|1|||
33655840|NCT00634101|63073245|FG001|Overall Study|Study Terminated|3|||
33655841|NCT00634101|63073244|FG000|Overall Study|Lost to Follow-up|2|||
33476599|NCT03054064|62852046|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
33476600|NCT03054064|62852046|FG000|Overall Study|Investigator Decision|2|||
33476601|NCT03054064|62852046|FG000|Overall Study|Bladder Issue|1|||
33476602|NCT03054064|62852046|FG000|Overall Study|High Blood Pressure|1|||
33476603|NCT03054064|62852046|FG000|Overall Study|Change in Status|1|||
33476604|NCT03053518|62852050|FG000|Overall Study|Withdrawal by Subject|3|||
33476605|NCT03053518|62852050|FG000|Overall Study|Lost to Follow-up|2|||
33476606|NCT03053518|62852050|FG000|Overall Study|Ineligible|5|||
33476607|NCT04015336|62852054|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
33476608|NCT04071158|62852077|FG000|Overall Study|Lost to Follow-up|1|||
33476609|NCT04071158|62852078|FG001|Overall Study|Lost to Follow-up|2|||
33476610|NCT04071158|62852079|FG002|Overall Study|Lost to Follow-up|3|||
33476611|NCT04071158|62852080|FG003|Overall Study|Lost to Follow-up|3|||
33476612|NCT04071158|62852081|FG004|Overall Study|Lost to Follow-up|5|||
33476613|NCT04071158|62852077|FG000|Overall Study|Randomized but not treated|2|||
33476614|NCT04071158|62852078|FG001|Overall Study|Randomized but not treated|2|||
33476615|NCT04071158|62852079|FG002|Overall Study|Randomized but not treated|0|||
33476616|NCT04071158|62852080|FG003|Overall Study|Randomized but not treated|0|||
33476617|NCT04071158|62852081|FG004|Overall Study|Randomized but not treated|0|||
33476618|NCT01317940|62852105|FG000|Overall Study|Death|1|||
33476619|NCT01317940|62852106|FG001|Overall Study|Death|0|||
33476620|NCT01317940|62852107|FG002|Overall Study|Death|1|||
33476621|NCT01317940|62852108|FG003|Overall Study|Death|0|||
33476622|NCT01317940|62852109|FG004|Overall Study|Death|0|||
33476623|NCT01317940|62852110|FG005|Overall Study|Death|0|||
33476624|NCT01317940|62852105|FG000|Overall Study|Lost to Follow-up|0|||
33476625|NCT01317940|62852106|FG001|Overall Study|Lost to Follow-up|0|||
33476626|NCT01317940|62852107|FG002|Overall Study|Lost to Follow-up|1|||
33364440|NCT02393248|62743322|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364441|NCT02393248|62743323|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364442|NCT02393248|62743324|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364443|NCT02393248|62743325|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364444|NCT02393248|62743326|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364445|NCT02393248|62743327|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33364446|NCT02393248|62743303|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
33364447|NCT02393248|62743304|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
33364448|NCT02393248|62743305|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
33476627|NCT01317940|62852108|FG003|Overall Study|Lost to Follow-up|1|||
33476628|NCT01317940|62852109|FG004|Overall Study|Lost to Follow-up|1|||
33476629|NCT01317940|62852110|FG005|Overall Study|Lost to Follow-up|0|||
33476630|NCT01317940|62852105|FG000|Overall Study|Change in therapy plan|0|||
33476631|NCT01317940|62852106|FG001|Overall Study|Change in therapy plan|0|||
33476632|NCT01317940|62852107|FG002|Overall Study|Change in therapy plan|3|||
33476633|NCT01317940|62852108|FG003|Overall Study|Change in therapy plan|0|||
33476634|NCT01317940|62852109|FG004|Overall Study|Change in therapy plan|0|||
33476635|NCT01317940|62852110|FG005|Overall Study|Change in therapy plan|0|||
33476636|NCT01345786|62852129|FG000|Overall Study|Adverse Event|0|||
33476637|NCT01345786|62852130|FG001|Overall Study|Adverse Event|1|||
33476638|NCT01345786|62852131|FG002|Overall Study|Adverse Event|3|||
33476639|NCT01345786|62852132|FG003|Overall Study|Adverse Event|1|||
33476640|NCT01345786|62852129|FG000|Overall Study|Subject withdrew consent|2|||
33476641|NCT01345786|62852130|FG001|Overall Study|Subject withdrew consent|2|||
33364449|NCT02393248|62743306|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
33364450|NCT02393248|62743307|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
33476642|NCT01345786|62852131|FG002|Overall Study|Subject withdrew consent|1|||
33476643|NCT01345786|62852132|FG003|Overall Study|Subject withdrew consent|0|||
33476644|NCT01345786|62852129|FG000|Overall Study|Noncompliance with protocol|1|||
33476645|NCT01345786|62852130|FG001|Overall Study|Noncompliance with protocol|0|||
33476646|NCT01345786|62852131|FG002|Overall Study|Noncompliance with protocol|1|||
33476647|NCT01345786|62852132|FG003|Overall Study|Noncompliance with protocol|0|||
33476648|NCT01345786|62852129|FG000|Overall Study|Administrative|3|||
33476649|NCT01345786|62852130|FG001|Overall Study|Administrative|5|||
33476650|NCT01345786|62852131|FG002|Overall Study|Administrative|0|||
33476651|NCT01345786|62852132|FG003|Overall Study|Administrative|0|||
33476652|NCT01345786|62852129|FG000|Overall Study|Lost to Follow-up|0|||
33476653|NCT01345786|62852130|FG001|Overall Study|Lost to Follow-up|0|||
33476654|NCT01345786|62852131|FG002|Overall Study|Lost to Follow-up|0|||
33476655|NCT01345786|62852132|FG003|Overall Study|Lost to Follow-up|2|||
33476656|NCT01317550|62852146|FG000|Overall Study|Withdrawal by Subject|1|||
33476657|NCT01317550|62852147|FG001|Overall Study|Withdrawal by Subject|0|||
33476658|NCT01317550|62852148|FG002|Overall Study|Withdrawal by Subject|0|||
33364451|NCT02393248|62743308|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
33476659|NCT01317550|62852149|FG003|Overall Study|Withdrawal by Subject|0|||
33476660|NCT01317550|62852146|FG000|Overall Study|Lack of compliance study med|1|||
33476661|NCT01317550|62852147|FG001|Overall Study|Lack of compliance study med|0|||
33476662|NCT01317550|62852148|FG002|Overall Study|Lack of compliance study med|0|||
33476663|NCT01317550|62852149|FG003|Overall Study|Lack of compliance study med|0|||
33476664|NCT01317472|62852161|FG000|Overall Study|Withdrawal by Subject|1|||
33476665|NCT01317472|62852162|FG001|Overall Study|Withdrawal by Subject|0|||
33476666|NCT01317472|62852161|FG000|Overall Study|Unrelated hospitalization|1|||
33476667|NCT01317472|62852162|FG001|Overall Study|Unrelated hospitalization|0|||
33476668|NCT01345630|62852170|FG000|Overall Study|Adverse Event|22|||
33476669|NCT01345630|62852171|FG001|Overall Study|Adverse Event|23|||
33476670|NCT01345630|62852170|FG000|Overall Study|Lost to Follow-up|17|||
33655842|NCT00634101|63073245|FG001|Overall Study|Lost to Follow-up|0|||
33655843|NCT00633477|63073262|FG000|Overall Study|Death|1|||
33655844|NCT00633477|63073263|FG001|Overall Study|Death|0|||
33655845|NCT00633477|63073262|FG000|Overall Study|Randomized but not treated|1|||
33655846|NCT00633477|63073263|FG001|Overall Study|Randomized but not treated|0|||
33364452|NCT02393248|62743309|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
33476671|NCT01345630|62852171|FG001|Overall Study|Lost to Follow-up|16|||
33476672|NCT01345630|62852170|FG000|Overall Study|Protocol Violation|4|||
33476673|NCT01345630|62852171|FG001|Overall Study|Protocol Violation|1|||
33476674|NCT01345630|62852170|FG000|Overall Study|Medication error without associated AE|0|||
33476675|NCT01345630|62852171|FG001|Overall Study|Medication error without associated AE|1|||
33476676|NCT01345630|62852170|FG000|Overall Study|Study terminated by sponsor|254|||
33476677|NCT01345630|62852171|FG001|Overall Study|Study terminated by sponsor|285|||
33476678|NCT01345630|62852170|FG000|Overall Study|Other reasons|6|||
33476679|NCT01345630|62852171|FG001|Overall Study|Other reasons|8|||
33476680|NCT01345630|62852170|FG000|Overall Study|Withdrawn due to pregnancy|1|||
33476681|NCT01345630|62852171|FG001|Overall Study|Withdrawn due to pregnancy|2|||
33476682|NCT01345630|62852170|FG000|Overall Study|No longer willing to participate|9|||
33476683|NCT01345630|62852171|FG001|Overall Study|No longer willing to participate|12|||
33476684|NCT01345630|62852170|FG000|Overall Study|Insufficient clinical response|48|||
33476685|NCT01345630|62852171|FG001|Overall Study|Insufficient clinical response|11|||
33476686|NCT03693612|62852188|FG000|Overall Study|Lost to Follow-up|0|||
33476687|NCT03693612|62852189|FG001|Overall Study|Lost to Follow-up|0|||
33476688|NCT03693612|62852190|FG002|Overall Study|Lost to Follow-up|0|||
33476689|NCT03693612|62852191|FG003|Overall Study|Lost to Follow-up|0|||
33476690|NCT03693612|62852192|FG004|Overall Study|Lost to Follow-up|1|||
33476691|NCT03693612|62852193|FG005|Overall Study|Lost to Follow-up|0|||
33476692|NCT03693612|62852194|FG006|Overall Study|Lost to Follow-up|0|||
33655847|NCT00331773|63073288|FG000|Overall Study|Withdrawal by Subject|6|||
33364453|NCT02393248|62743310|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
33364454|NCT02393248|62743311|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
33364455|NCT02393248|62743312|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
33364456|NCT02393248|62743313|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
33364457|NCT02393248|62743314|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
33364458|NCT02393248|62743315|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
33364459|NCT02393248|62743316|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
33364460|NCT02393248|62743317|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
33364461|NCT02393248|62743318|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
33364462|NCT02393248|62743319|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
33364463|NCT02393248|62743320|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
33364464|NCT02393248|62743321|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
33364465|NCT02393248|62743322|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
33364466|NCT02393248|62743323|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
33364467|NCT02393248|62743324|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
33364468|NCT02393248|62743325|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
33364469|NCT02393248|62743326|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
33364470|NCT02393248|62743327|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
33364471|NCT02393248|62743303|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
33364472|NCT02393248|62743304|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364473|NCT02393248|62743305|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364474|NCT02393248|62743306|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364475|NCT02393248|62743307|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364476|NCT02393248|62743308|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364477|NCT02393248|62743309|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364478|NCT02393248|62743310|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364479|NCT02393248|62743311|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364480|NCT02393248|62743312|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33476693|NCT03693612|62852188|FG000|Overall Study|Withdrawal by Subject|0|||
33476694|NCT03693612|62852189|FG001|Overall Study|Withdrawal by Subject|0|||
33655848|NCT00331773|63073289|FG001|Overall Study|Withdrawal by Subject|4|||
33364481|NCT02393248|62743313|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364482|NCT02393248|62743314|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33476695|NCT03693612|62852190|FG002|Overall Study|Withdrawal by Subject|1|||
33364483|NCT02393248|62743315|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364484|NCT02393248|62743316|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364485|NCT02393248|62743317|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364486|NCT02393248|62743318|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364487|NCT02393248|62743319|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364488|NCT02393248|62743320|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364489|NCT02393248|62743321|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364490|NCT02393248|62743322|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33476696|NCT03693612|62852191|FG003|Overall Study|Withdrawal by Subject|0|||
33476697|NCT03693612|62852192|FG004|Overall Study|Withdrawal by Subject|2|||
33476698|NCT03693612|62852193|FG005|Overall Study|Withdrawal by Subject|0|||
33476699|NCT03693612|62852194|FG006|Overall Study|Withdrawal by Subject|0|||
33476700|NCT03693612|62852188|FG000|Overall Study|Study Terminated by Sponsor|0|||
33476701|NCT03693612|62852189|FG001|Overall Study|Study Terminated by Sponsor|1|||
33476702|NCT03693612|62852190|FG002|Overall Study|Study Terminated by Sponsor|0|||
33476703|NCT03693612|62852191|FG003|Overall Study|Study Terminated by Sponsor|0|||
33476704|NCT03693612|62852192|FG004|Overall Study|Study Terminated by Sponsor|3|||
33476705|NCT03693612|62852193|FG005|Overall Study|Study Terminated by Sponsor|0|||
33476706|NCT03693612|62852194|FG006|Overall Study|Study Terminated by Sponsor|0|||
33476707|NCT03692910|62852210|FG000|Overall Study|Lost to Follow-up|4|||
33476708|NCT03692910|62852211|FG001|Overall Study|Lost to Follow-up|0|||
33476709|NCT03692910|62852212|FG002|Overall Study|Lost to Follow-up|0|||
33476710|NCT03692910|62852210|FG000|Overall Study|Withdrawal by Subject|2|||
33476711|NCT03692910|62852211|FG001|Overall Study|Withdrawal by Subject|0|||
33476712|NCT03692910|62852212|FG002|Overall Study|Withdrawal by Subject|0|||
33476713|NCT04223232|62852218|FG000|Overall Study|Withdrawal by Subject|1|||
33476714|NCT04206384|62852222|FG000|Overall Study|Withdrawal by Subject|8|||
33476715|NCT04206384|62852222|FG000|Overall Study|Adverse Event|2|||
33476716|NCT04051944|62852228|FG000|Overall Study|Study ending|1|||
33476717|NCT04051944|62852229|FG001|Overall Study|Study ending|1|||
33476718|NCT04051944|62852228|FG000|Overall Study|Early study termination by participant|1|||
33476719|NCT04051944|62852229|FG001|Overall Study|Early study termination by participant|0|||
33476720|NCT04051944|62852228|FG000|Overall Study|Withdrawal by Subject|2|||
33476721|NCT04051944|62852229|FG001|Overall Study|Withdrawal by Subject|2|||
33476722|NCT04051944|62852228|FG000|Overall Study|Lack of Efficacy|3|||
33476723|NCT04051944|62852229|FG001|Overall Study|Lack of Efficacy|0|||
33476724|NCT04051944|62852228|FG000|Overall Study|Adverse event, non- fatal|1|||
33476725|NCT04051944|62852229|FG001|Overall Study|Adverse event, non- fatal|1|||
33476726|NCT04050618|62852237|FG000|First Intervention|Withdrawal by Subject|2|||
33476727|NCT04050618|62852238|FG001|First Intervention|Withdrawal by Subject|0|||
33476728|NCT04050618|62852237|FG000|Second Intervention|Withdrawal by Subject|1|||
33476729|NCT04050618|62852238|FG001|Second Intervention|Withdrawal by Subject|0|||
33476730|NCT04067492|62852255|FG000|Overall Study|Lost to Follow-up|0|||
33476731|NCT04067492|62852256|FG001|Overall Study|Lost to Follow-up|0|||
33476732|NCT04067492|62852257|FG002|Overall Study|Lost to Follow-up|0|||
33476733|NCT04067492|62852258|FG003|Overall Study|Lost to Follow-up|0|||
33476734|NCT04067492|62852259|FG004|Overall Study|Lost to Follow-up|0|||
33476735|NCT04067492|62852260|FG005|Overall Study|Lost to Follow-up|1|||
33476736|NCT04067492|62852255|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
33476737|NCT04067492|62852256|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
33476738|NCT04067492|62852257|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
33476739|NCT04067492|62852258|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
33476740|NCT04067492|62852259|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
33476741|NCT04067492|62852260|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
33476742|NCT04067492|62852255|FG000|Overall Study|COVID-19 epidemiological situation|0|||
33476743|NCT04067492|62852256|FG001|Overall Study|COVID-19 epidemiological situation|0|||
33476744|NCT04067492|62852257|FG002|Overall Study|COVID-19 epidemiological situation|0|||
33476745|NCT04067492|62852258|FG003|Overall Study|COVID-19 epidemiological situation|1|||
33476746|NCT04067492|62852259|FG004|Overall Study|COVID-19 epidemiological situation|0|||
33476747|NCT04067492|62852260|FG005|Overall Study|COVID-19 epidemiological situation|0|||
33476748|NCT04375878|62852278|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
33476749|NCT04375878|62852279|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
33476750|NCT04375878|62852280|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
33476751|NCT04375878|62852281|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
33476752|NCT04375878|62852282|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
33476753|NCT04375878|62852283|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
33476754|NCT04375878|62852278|FG000|Crossover First and Second Interventions|Adverse Event|0|||
33476755|NCT04375878|62852279|FG001|Crossover First and Second Interventions|Adverse Event|0|||
33476756|NCT04375878|62852280|FG002|Crossover First and Second Interventions|Adverse Event|1|||
33476757|NCT04375878|62852281|FG003|Crossover First and Second Interventions|Adverse Event|0|||
33364491|NCT02393248|62743323|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364492|NCT02393248|62743324|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364493|NCT02393248|62743325|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364494|NCT02393248|62743326|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364495|NCT02393248|62743327|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33364496|NCT02393248|62743303|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33364497|NCT02393248|62743304|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33364498|NCT02393248|62743305|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33364499|NCT02393248|62743306|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33364500|NCT02393248|62743307|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33364501|NCT02393248|62743308|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
33364502|NCT02393248|62743309|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
33364503|NCT02393248|62743310|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33364504|NCT02393248|62743311|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33364505|NCT02393248|62743312|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
33364506|NCT02393248|62743313|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33364507|NCT02393248|62743314|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33476758|NCT04375878|62852282|FG004|Crossover First and Second Interventions|Adverse Event|0|||
33550048|NCT02858401|62941310|FG004|Overall Study|Withdrew Consent|0|||
33550049|NCT02858401|62941311|FG005|Overall Study|Withdrew Consent|1|||
33550050|NCT02858401|62941312|FG006|Overall Study|Withdrew Consent|0|||
33550051|NCT02858401|62941306|FG000|Overall Study|Lost to Follow-up|0|||
33476759|NCT04375878|62852283|FG005|Crossover First and Second Interventions|Adverse Event|0|||
33476760|NCT04375878|62852278|FG000|Extension Phase|Withdrawal by Subject|0|||
33364508|NCT02393248|62743315|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33364509|NCT02393248|62743316|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33364510|NCT02393248|62743317|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33364511|NCT02393248|62743318|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33550052|NCT02858401|62941307|FG001|Overall Study|Lost to Follow-up|1|||
33550053|NCT02858401|62941308|FG002|Overall Study|Lost to Follow-up|0|||
33550054|NCT02858401|62941309|FG003|Overall Study|Lost to Follow-up|0|||
33655849|NCT00331773|63073288|FG000|Overall Study|Protocol Violation|10|||
33655850|NCT00331773|63073289|FG001|Overall Study|Protocol Violation|3|||
33655851|NCT00633243|63073322|FG000|Overall Study|Withdrawal by Subject|0|||
33655852|NCT00633243|63073323|FG001|Overall Study|Withdrawal by Subject|1|||
33655853|NCT00633243|63073322|FG000|Overall Study|incarceration|0|||
33655854|NCT00633243|63073323|FG001|Overall Study|incarceration|2|||
33655855|NCT00633243|63073322|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
33655856|NCT00633243|63073323|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
33655857|NCT00633243|63073322|FG000|Overall Study|Not comfortable with self-injecting|0|||
33655858|NCT00633243|63073323|FG001|Overall Study|Not comfortable with self-injecting|1|||
33655859|NCT00633243|63073322|FG000|Overall Study|Mental Health--Depression|0|||
33655860|NCT00633243|63073323|FG001|Overall Study|Mental Health--Depression|1|||
33655861|NCT00633243|63073322|FG000|Overall Study|Couldn't tolerate side-effects|1|||
33655862|NCT00633243|63073323|FG001|Overall Study|Couldn't tolerate side-effects|1|||
33655863|NCT01872689|63073333|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
33655864|NCT01872689|63073334|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
33655865|NCT01872689|63073335|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
33655866|NCT01872689|63073336|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
33655867|NCT01872689|63073333|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
33655868|NCT01872689|63073334|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
33655869|NCT01872689|63073335|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
33655870|NCT01872689|63073336|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
33655871|NCT01872689|63073333|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
33655872|NCT01872689|63073334|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
33655873|NCT01872689|63073335|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
33655874|NCT01872689|63073336|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
33655875|NCT01872689|63073333|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
33655876|NCT01872689|63073334|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
33655877|NCT01872689|63073335|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
33655878|NCT01872689|63073336|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
33655879|NCT01872689|63073333|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
33655880|NCT01872689|63073334|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
33655881|NCT01872689|63073335|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
33655882|NCT01872689|63073336|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
33655883|NCT01872689|63073333|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
33655884|NCT01872689|63073334|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
33550055|NCT02858401|62941310|FG004|Overall Study|Lost to Follow-up|0|||
33550056|NCT02858401|62941311|FG005|Overall Study|Lost to Follow-up|0|||
33550057|NCT02858401|62941312|FG006|Overall Study|Lost to Follow-up|0|||
33655885|NCT01872689|63073335|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
33655886|NCT01872689|63073336|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
33655887|NCT01872689|63073333|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
33364512|NCT02393248|62743319|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33550058|NCT02857283|62941339|FG000|First Exposure|Withdrawal by Subject|1|||
33550059|NCT02857283|62941340|FG001|First Exposure|Withdrawal by Subject|0|||
33655888|NCT01872689|63073334|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
33550060|NCT02746679|62941358|FG000|Overall Study|Lost to Follow-up|4|||
33476761|NCT04375878|62852279|FG001|Extension Phase|Withdrawal by Subject|0|||
33476762|NCT04375878|62852280|FG002|Extension Phase|Withdrawal by Subject|0|||
33476763|NCT04375878|62852281|FG003|Extension Phase|Withdrawal by Subject|0|||
33476764|NCT04375878|62852282|FG004|Extension Phase|Withdrawal by Subject|1|||
33476765|NCT04375878|62852283|FG005|Extension Phase|Withdrawal by Subject|0|||
33476766|NCT04189224|62852303|FG000|Period 2|Adverse Event|0|||
33476767|NCT04189224|62852304|FG001|Period 2|Adverse Event|1|||
33550061|NCT02746679|62941359|FG001|Overall Study|Lost to Follow-up|6|||
33550062|NCT02731131|62941367|FG000|Overall Study|Psychiatric Disorder|0|||
33550063|NCT02731131|62941368|FG001|Overall Study|Psychiatric Disorder|1|||
33550064|NCT02731131|62941367|FG000|Overall Study|Refused Therapy|0|||
33550065|NCT02731131|62941368|FG001|Overall Study|Refused Therapy|1|||
33550066|NCT02746705|62941376|FG000|Overall Study|Physician Decision|1|||
33550067|NCT02746705|62941377|FG001|Overall Study|Physician Decision|1|||
33550068|NCT02746705|62941376|FG000|Overall Study|Lost to Follow-up|1|||
33655889|NCT01872689|63073335|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
33655890|NCT01872689|63073336|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
33655891|NCT01872689|63073333|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
33655892|NCT01872689|63073334|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
33655893|NCT01872689|63073335|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
33655894|NCT01872689|63073336|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
33655895|NCT01872689|63073333|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
33655896|NCT01872689|63073334|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
33655897|NCT01872689|63073335|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
33655898|NCT01872689|63073336|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
33655899|NCT01872689|63073333|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
33655900|NCT01872689|63073334|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
33655901|NCT01872689|63073335|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
33655902|NCT01872689|63073336|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
33655903|NCT01872689|63073333|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
33655904|NCT01872689|63073334|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
33655905|NCT01872689|63073335|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
33655906|NCT01872689|63073336|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
33655907|NCT01872689|63073333|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
33655908|NCT01872689|63073334|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
33655909|NCT01872689|63073335|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
33655910|NCT01872689|63073336|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
33655911|NCT01872689|63073333|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
33655912|NCT01872689|63073334|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
33655913|NCT01872689|63073335|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
33655914|NCT01872689|63073336|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
33655915|NCT01872689|63073333|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
33655916|NCT01872689|63073334|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
33655917|NCT01872689|63073335|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
33655918|NCT01872689|63073336|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
33655919|NCT00632931|63073349|FG000|Part 1, Period 1|Protocol Violation|1|||
33655920|NCT00632931|63073350|FG001|Part 1, Period 1|Protocol Violation|0|||
33655921|NCT00632931|63073351|FG002|Part 1, Period 1|Protocol Violation|0|||
33655922|NCT00632931|63073349|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
33655923|NCT00632931|63073350|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
33655924|NCT00632931|63073351|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
33655925|NCT00632931|63073349|FG000|Part 2|Adverse Event|0|||
33655926|NCT00632931|63073350|FG001|Part 2|Adverse Event|0|||
33655927|NCT00632931|63073351|FG002|Part 2|Adverse Event|3|||
33655928|NCT00632931|63073349|FG000|Part 2|Death|0|||
33655929|NCT00632931|63073350|FG001|Part 2|Death|0|||
33655930|NCT00632931|63073351|FG002|Part 2|Death|1|||
33655931|NCT00632931|63073349|FG000|Part 2|Lack of Efficacy|0|||
33655932|NCT00632931|63073350|FG001|Part 2|Lack of Efficacy|0|||
33655933|NCT00632931|63073351|FG002|Part 2|Lack of Efficacy|17|||
33655934|NCT00632931|63073349|FG000|Part 2|Withdrawal by Subject|0|||
33655935|NCT00632931|63073350|FG001|Part 2|Withdrawal by Subject|0|||
33476768|NCT04186806|62852312|FG000|Period 1: 7 Days|Adverse Event|1|||
33476769|NCT04186806|62852313|FG001|Period 1: 7 Days|Adverse Event|0|||
33550069|NCT02746705|62941377|FG001|Overall Study|Lost to Follow-up|0|||
33550070|NCT02746705|62941376|FG000|Overall Study|outlier scores deemed not valid|0|||
33655936|NCT00632931|63073351|FG002|Part 2|Withdrawal by Subject|3|||
33476770|NCT04041414|62852322|FG000|Overall Study|Lost to Follow-up|1|||
33476771|NCT04041414|62852323|FG001|Overall Study|Lost to Follow-up|2|||
33476772|NCT04370028|62852332|FG000|Overall Study|Withdrawal by Subject|695|||
33550071|NCT02746705|62941377|FG001|Overall Study|outlier scores deemed not valid|1|||
33550072|NCT02746627|62941386|FG000|Overall Study|Withdrawal by Subject|1|||
33550073|NCT02746627|62941387|FG001|Overall Study|Withdrawal by Subject|1|||
33476773|NCT04370028|62852332|FG000|Overall Study|Protocol Violation|9|||
33476774|NCT04370028|62852332|FG000|Overall Study|Adverse Event|3|||
33476775|NCT04037748|62852345|FG000|Treatment Period 1|Withdrawal by Subject|3|||
33476776|NCT04037748|62852346|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33476777|NCT04037748|62852345|FG000|Treatment Period 1|Adverse Event|1|||
33476778|NCT04037748|62852346|FG001|Treatment Period 1|Adverse Event|1|||
33476779|NCT04037748|62852345|FG000|Treatment Period 1|Protocol Violation|4|||
33476780|NCT04037748|62852346|FG001|Treatment Period 1|Protocol Violation|5|||
33476781|NCT04037748|62852345|FG000|Treatment Period 2|Adverse Event|0|||
33476782|NCT04037748|62852346|FG001|Treatment Period 2|Adverse Event|1|||
33476783|NCT04037748|62852345|FG000|Treatment Period 2|Protocol Violation|2|||
33476784|NCT04037748|62852346|FG001|Treatment Period 2|Protocol Violation|0|||
33476785|NCT04036110|62852355|FG000|Overall Study|Lost to Follow-up|3|||
33476786|NCT04036110|62852356|FG001|Overall Study|Lost to Follow-up|2|||
33476787|NCT04036110|62852357|FG002|Overall Study|Lost to Follow-up|1|||
33476788|NCT04036110|62852355|FG000|Overall Study|Study Suspended|4|||
33476789|NCT04036110|62852356|FG001|Overall Study|Study Suspended|5|||
33476790|NCT04036110|62852357|FG002|Overall Study|Study Suspended|1|||
33476791|NCT03053050|62852368|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
33476792|NCT03053050|62852369|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
33476793|NCT03053050|62852370|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
33476794|NCT03053050|62852371|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
33476795|NCT03053050|62852368|FG000|Randomized Phase|Withdrew Consent|16|||
33476796|NCT03053050|62852369|FG001|Randomized Phase|Withdrew Consent|8|||
33476797|NCT03053050|62852370|FG002|Randomized Phase|Withdrew Consent|9|||
33476798|NCT03053050|62852371|FG003|Randomized Phase|Withdrew Consent|0|||
33476799|NCT03053050|62852368|FG000|Randomized Phase|Investigator's Discretion|6|||
33476800|NCT03053050|62852369|FG001|Randomized Phase|Investigator's Discretion|6|||
33476801|NCT03053050|62852370|FG002|Randomized Phase|Investigator's Discretion|3|||
33476802|NCT03053050|62852371|FG003|Randomized Phase|Investigator's Discretion|0|||
33550074|NCT02746627|62941388|FG002|Overall Study|Withdrawal by Subject|1|||
33550075|NCT02856113|62941398|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
33550076|NCT02856113|62941399|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
33550077|NCT02856113|62941398|FG000|Overall Study|Significant Protocol Deviation|1|||
33476803|NCT03053050|62852368|FG000|Randomized Phase|Lost to Follow-up|5|||
33476804|NCT03053050|62852369|FG001|Randomized Phase|Lost to Follow-up|1|||
33476805|NCT03053050|62852370|FG002|Randomized Phase|Lost to Follow-up|1|||
33476806|NCT03053050|62852371|FG003|Randomized Phase|Lost to Follow-up|0|||
33476807|NCT03053050|62852368|FG000|Randomized Phase|Adverse Event|0|||
33476808|NCT03053050|62852369|FG001|Randomized Phase|Adverse Event|1|||
33476809|NCT03053050|62852370|FG002|Randomized Phase|Adverse Event|0|||
33476810|NCT03053050|62852371|FG003|Randomized Phase|Adverse Event|0|||
33476811|NCT03053050|62852368|FG000|Randomized Phase|Randomized but Never Treated|2|||
33476812|NCT03053050|62852369|FG001|Randomized Phase|Randomized but Never Treated|2|||
33476813|NCT03053050|62852370|FG002|Randomized Phase|Randomized but Never Treated|2|||
33476814|NCT03053050|62852371|FG003|Randomized Phase|Randomized but Never Treated|0|||
33476815|NCT03053050|62852368|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
33476816|NCT03053050|62852369|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
33476817|NCT03053050|62852370|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
33476818|NCT03053050|62852371|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
33550078|NCT02856113|62941399|FG001|Overall Study|Significant Protocol Deviation|0|||
33550079|NCT02856113|62941398|FG000|Overall Study|Lost to Follow-up|3|||
33550080|NCT02856113|62941399|FG001|Overall Study|Lost to Follow-up|5|||
33550081|NCT02856113|62941398|FG000|Overall Study|Voluntary Withdrawal|3|||
33550082|NCT02856113|62941399|FG001|Overall Study|Voluntary Withdrawal|5|||
33550083|NCT02856113|62941398|FG000|Overall Study|Pregnancy|0|||
33550084|NCT02856113|62941399|FG001|Overall Study|Pregnancy|1|||
33550085|NCT02856113|62941398|FG000|Overall Study|Principal Investigator Discretion|2|||
33550086|NCT02856113|62941399|FG001|Overall Study|Principal Investigator Discretion|1|||
33550087|NCT02856113|62941398|FG000|Overall Study|Randomized but not Treated|1|||
33550088|NCT02856113|62941399|FG001|Overall Study|Randomized but not Treated|0|||
33550089|NCT02856113|62941398|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
33550090|NCT02856113|62941399|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
33550091|NCT02855411|62941406|FG000|Overall Study|Study terminated by sponsor|21|||
33550092|NCT02855411|62941406|FG000|Overall Study|Does not meet entrance criteria|14|||
33550093|NCT02745145|62941413|FG000|Overall Study|Adverse Event|1|||
33550094|NCT02745145|62941414|FG001|Overall Study|Adverse Event|0|||
33550095|NCT02745145|62941415|FG002|Overall Study|Adverse Event|0|||
33550096|NCT02745145|62941413|FG000|Overall Study|Death|0|||
33550097|NCT02745145|62941414|FG001|Overall Study|Death|1|||
33550098|NCT02745145|62941415|FG002|Overall Study|Death|0|||
33550099|NCT02745145|62941413|FG000|Overall Study|Progressive disease|0|||
33550100|NCT02745145|62941414|FG001|Overall Study|Progressive disease|0|||
33550101|NCT02745145|62941415|FG002|Overall Study|Progressive disease|1|||
33550102|NCT02745145|62941413|FG000|Overall Study|Withdrew consent|1|||
33550103|NCT02745145|62941414|FG001|Overall Study|Withdrew consent|1|||
33476819|NCT03053050|62852368|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
33476820|NCT03053050|62852369|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
33476821|NCT03053050|62852370|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
33476822|NCT03053050|62852371|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
33476823|NCT03053050|62852368|FG000|Open-label Phase|Withdrew Consent|0|||
33476824|NCT03053050|62852369|FG001|Open-label Phase|Withdrew Consent|0|||
33476825|NCT03053050|62852370|FG002|Open-label Phase|Withdrew Consent|0|||
33476826|NCT03053050|62852371|FG003|Open-label Phase|Withdrew Consent|6|||
33476827|NCT03053050|62852368|FG000|Open-label Phase|Investigator's Discretion|0|||
33476828|NCT03053050|62852369|FG001|Open-label Phase|Investigator's Discretion|0|||
33476829|NCT03053050|62852370|FG002|Open-label Phase|Investigator's Discretion|0|||
33476830|NCT03053050|62852371|FG003|Open-label Phase|Investigator's Discretion|4|||
33476831|NCT04369950|62852382|FG000|Overall Study|Protocol Violation|2|||
33476832|NCT04369950|62852383|FG001|Overall Study|Protocol Violation|2|||
33476833|NCT04035564|62852391|FG000|Overall Study|Protocol Violation|1|||
33476834|NCT04035564|62852392|FG001|Overall Study|Protocol Violation|2|||
33476835|NCT04035564|62852391|FG000|Overall Study|No laboratory available|2|||
33476836|NCT04035564|62852392|FG001|Overall Study|No laboratory available|2|||
33476837|NCT04035564|62852391|FG000|Overall Study|Guardian declined consent|1|||
33476838|NCT04035564|62852392|FG001|Overall Study|Guardian declined consent|2|||
33476839|NCT02955602|62852401|FG000|Overall Study|Adverse Event|0|||
33476840|NCT02955602|62852402|FG001|Overall Study|Adverse Event|3|||
33476841|NCT02955602|62852403|FG002|Overall Study|Adverse Event|0|||
33476842|NCT02955602|62852401|FG000|Overall Study|Withdrawal of informed consent|1|||
33476843|NCT02955602|62852402|FG001|Overall Study|Withdrawal of informed consent|3|||
33476844|NCT02955602|62852403|FG002|Overall Study|Withdrawal of informed consent|2|||
33476845|NCT02955602|62852401|FG000|Overall Study|Lost to Follow-up|0|||
33476846|NCT02955602|62852402|FG001|Overall Study|Lost to Follow-up|0|||
33476847|NCT02955602|62852403|FG002|Overall Study|Lost to Follow-up|1|||
33476848|NCT02955602|62852401|FG000|Overall Study|Other|0|||
33476849|NCT02955602|62852402|FG001|Overall Study|Other|1|||
33476850|NCT02955602|62852403|FG002|Overall Study|Other|3|||
33476851|NCT04179786|62852411|FG000|Overall Study|Withdrawal by Subject|8|||
33476852|NCT04175808|62852415|FG000|Part A|Miscellaneous|2|||
33476853|NCT04175808|62852416|FG001|Part A|Miscellaneous|0|||
33476854|NCT04175808|62852417|FG002|Part A|Miscellaneous|0|||
33476855|NCT04175808|62852418|FG003|Part A|Miscellaneous|0|||
33476856|NCT04175808|62852419|FG004|Part A|Miscellaneous|0|||
33476857|NCT04175808|62852420|FG005|Part A|Miscellaneous|0|||
33476858|NCT04175808|62852421|FG006|Part A|Miscellaneous|0|||
33476859|NCT04057196|62852437|FG000|Overall Study|Withdrawal by Subject|3|||
33476860|NCT04057196|62852437|FG000|Overall Study|Death|3|||
33476861|NCT04027686|62852443|FG000|Overall Study|Lost to Follow-up|2|||
33476862|NCT04027686|62852444|FG001|Overall Study|Lost to Follow-up|0|||
33476863|NCT04027686|62852443|FG000|Overall Study|Withdrawal by Subject|0|||
33476864|NCT04027686|62852444|FG001|Overall Study|Withdrawal by Subject|1|||
33476865|NCT03052426|62852457|FG000|Overall Study|Withdrawal by Subject|0|||
33476866|NCT03052426|62852458|FG001|Overall Study|Withdrawal by Subject|1|||
33476867|NCT03052426|62852459|FG002|Overall Study|Withdrawal by Subject|0|||
33476868|NCT03052426|62852457|FG000|Overall Study|Lost to Follow-up|2|||
33476869|NCT03052426|62852458|FG001|Overall Study|Lost to Follow-up|0|||
33476870|NCT03052426|62852459|FG002|Overall Study|Lost to Follow-up|1|||
33476871|NCT03688880|62852474|FG000|Overall Study|Withdrawal by Subject|0|||
33476872|NCT03688880|62852475|FG001|Overall Study|Withdrawal by Subject|2|||
33476873|NCT03688880|62852474|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
33476874|NCT03688880|62852475|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
33476875|NCT03688880|62852474|FG000|Overall Study|Lost to Follow-up|4|||
33476876|NCT03688880|62852475|FG001|Overall Study|Lost to Follow-up|7|||
33476877|NCT03688880|62852474|FG000|Overall Study|Adverse Event|0|||
33476878|NCT03688880|62852475|FG001|Overall Study|Adverse Event|2|||
33476879|NCT03688880|62852474|FG000|Overall Study|Device deficiencies|0|||
33476880|NCT03688880|62852475|FG001|Overall Study|Device deficiencies|2|||
33476881|NCT03688880|62852474|FG000|Overall Study|Other|10|||
33364513|NCT02393248|62743320|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33476882|NCT03688880|62852475|FG001|Overall Study|Other|16|||
33476883|NCT03051178|62852481|FG000|Overall Study|Withdrawal by Subject|5|||
33550104|NCT02745145|62941415|FG002|Overall Study|Withdrew consent|1|||
33364514|NCT02393248|62743321|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33476884|NCT03051100|62852487|FG000|Overall Study|Withdrawal by Subject|1|||
33476885|NCT03051100|62852488|FG001|Overall Study|Withdrawal by Subject|0|||
33476886|NCT01343368|62852496|FG000|Overall Study|Death|1|||
33476887|NCT01343368|62852497|FG001|Overall Study|Death|0|||
33476888|NCT01343368|62852496|FG000|Overall Study|Lost to Follow-up|1|||
33476889|NCT01343368|62852497|FG001|Overall Study|Lost to Follow-up|0|||
33476890|NCT02955212|62852505|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
33476891|NCT02955212|62852506|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
33476892|NCT02955212|62852505|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
33476893|NCT02955212|62852506|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
33476894|NCT02955212|62852505|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
33476895|NCT02955212|62852506|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
33476896|NCT02955212|62852505|FG000|Period 1: Double-blind Treatment Period|Other|3|||
33476897|NCT02955212|62852506|FG001|Period 1: Double-blind Treatment Period|Other|2|||
33476898|NCT02955212|62852505|FG000|Period 2: Open-label Extension|Adverse Event|11|||
33476899|NCT02955212|62852506|FG001|Period 2: Open-label Extension|Adverse Event|7|||
33476900|NCT02955212|62852505|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
33476901|NCT02955212|62852506|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
33476902|NCT02955212|62852505|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
33476903|NCT02955212|62852506|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
33476904|NCT02955212|62852505|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
33476905|NCT02955212|62852506|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
33476906|NCT02955212|62852505|FG000|Period 2: Open-label Extension|Other|2|||
33476907|NCT02955212|62852506|FG001|Period 2: Open-label Extension|Other|4|||
33476908|NCT03050398|62852513|FG000|Overall Study|Study terminated by sponsor|8|||
33476909|NCT03662750|62852517|FG000|Overall Study|Withdrawal by Subject|1|||
33476910|NCT04052204|62852521|FG000|Overall Study|Death|1|||
33476911|NCT04052204|62852522|FG001|Overall Study|Death|0|||
33476912|NCT04052204|62852523|FG002|Overall Study|Death|0|||
33476913|NCT04052204|62852521|FG000|Overall Study|Progressive disease|1|||
33476914|NCT04052204|62852522|FG001|Overall Study|Progressive disease|0|||
33476915|NCT04052204|62852523|FG002|Overall Study|Progressive disease|0|||
33476916|NCT04052204|62852521|FG000|Overall Study|Other|1|||
33476917|NCT04052204|62852522|FG001|Overall Study|Other|0|||
33476918|NCT04052204|62852523|FG002|Overall Study|Other|0|||
33476919|NCT04050722|62852529|FG000|Overall Study|Withdrawal by Subject|1|||
33476920|NCT04050722|62852530|FG001|Overall Study|Withdrawal by Subject|0|||
33476921|NCT04049552|62852536|FG000|Overall Study|Lost to Follow-up|1|||
33476922|NCT03048058|62852544|FG000|Overall Study|Lost to Follow-up|4|||
33476923|NCT03048058|62852545|FG001|Overall Study|Lost to Follow-up|0|||
33476924|NCT03048058|62852544|FG000|Overall Study|Withdrawal by Subject|0|||
33476925|NCT03048058|62852545|FG001|Overall Study|Withdrawal by Subject|4|||
33476926|NCT03047980|62852551|FG000|Overall Study|Adverse Event|1|||
33476927|NCT04048382|62852557|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
33476928|NCT04048382|62852558|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
33476929|NCT04048382|62852557|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
33476930|NCT04048382|62852558|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
33476931|NCT04048382|62852557|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
33476932|NCT04048382|62852558|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
33476933|NCT04047446|62852566|FG000|Overall Study|Physician Decision|1|||
33476934|NCT04047446|62852567|FG001|Overall Study|Physician Decision|0|||
33476935|NCT03655106|62852575|FG000|Overall Study|Withdrawal by Subject|3|||
33476936|NCT03655106|62852576|FG001|Overall Study|Withdrawal by Subject|2|||
33476937|NCT03655106|62852575|FG000|Overall Study|Lost to Follow-up|2|||
33476938|NCT03655106|62852576|FG001|Overall Study|Lost to Follow-up|1|||
33476939|NCT03655106|62852575|FG000|Overall Study|Duplicate Enrollment|1|||
33476940|NCT03655106|62852576|FG001|Overall Study|Duplicate Enrollment|1|||
33476941|NCT03655106|62852575|FG000|Overall Study|Protocol Violation|3|||
33476942|NCT03655106|62852576|FG001|Overall Study|Protocol Violation|0|||
33476943|NCT03630302|62852582|FG000|Surgery|hardware issue prevented LFP recordings|1|||
33476944|NCT03630302|62852582|FG000|3 Month Visit|Adverse Event|2|||
33476945|NCT03630302|62852582|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
33476946|NCT04041440|62852588|FG000|Overall Study|Withdrawal by Subject|0|||
33476947|NCT04041440|62852589|FG001|Overall Study|Withdrawal by Subject|1|||
33476948|NCT04041440|62852588|FG000|Overall Study|Lost to Follow-up|0|||
33476949|NCT04041440|62852589|FG001|Overall Study|Lost to Follow-up|1|||
33476950|NCT03654560|62852598|FG000|Overall Study|Death|3|||
33476951|NCT03654560|62852599|FG001|Overall Study|Death|1|||
33476952|NCT03654560|62852598|FG000|Overall Study|Lost to Follow-up|1|||
33476953|NCT03654560|62852599|FG001|Overall Study|Lost to Follow-up|0|||
33476954|NCT03629054|62852607|FG000|Period 2 (4 Days)|Not treated|0|||
33476955|NCT03629054|62852608|FG001|Period 2 (4 Days)|Not treated|1|||
33550105|NCT02745145|62941413|FG000|Overall Study|Study Termination|8|||
33476956|NCT03628898|62852614|FG000|Overall Study|Device deficiency|1|||
33476957|NCT03628508|62852618|FG000|Overall Study|Lost to Follow-up|1|||
33476958|NCT03045328|62852622|FG000|Overall Study|Withdrawal by Subject|2|||
33476959|NCT02154490|62852628|FG000|Overall Study|No tissue submitted|23|||
33550106|NCT02745145|62941414|FG001|Overall Study|Study Termination|3|||
33476960|NCT02154490|62852628|FG000|Overall Study|No biomarker results|167|||
33476961|NCT02154490|62852628|FG000|Overall Study|Not assigned to a sub-study|270|||
33476962|NCT02154490|62852628|FG000|Overall Study|Did not register to a sub-study|749|||
33476963|NCT03627494|62852644|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
33476964|NCT03627494|62852645|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
33476965|NCT03627494|62852646|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
33476966|NCT03627494|62852647|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
33476967|NCT03627494|62852648|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
33476968|NCT03627494|62852649|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
33476969|NCT03627494|62852650|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
33476970|NCT03627494|62852651|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
33476971|NCT03627494|62852652|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
33476972|NCT03627494|62852653|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
33476973|NCT03627494|62852654|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
33476974|NCT03627494|62852655|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
33476975|NCT03627494|62852644|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
33476976|NCT03627494|62852645|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
33476977|NCT03627494|62852646|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
33476978|NCT03627494|62852647|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
33476979|NCT03627494|62852648|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
33476980|NCT03627494|62852649|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
33476981|NCT03627494|62852650|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
33476982|NCT03627494|62852651|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
33476983|NCT03627494|62852652|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
33476984|NCT03627494|62852653|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
33476985|NCT03627494|62852654|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
33476986|NCT03627494|62852655|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
33476987|NCT03627494|62852644|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
33476988|NCT03627494|62852645|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
33476989|NCT03627494|62852646|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
33476990|NCT03627494|62852647|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
33476991|NCT03627494|62852648|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
33476992|NCT03627494|62852649|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
33476993|NCT03627494|62852650|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
33476994|NCT03627494|62852651|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
33476995|NCT03627494|62852652|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
33476996|NCT03627494|62852653|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
33476997|NCT03627494|62852654|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
33476998|NCT03627494|62852655|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
33476999|NCT03627416|62852696|FG000|Overall Study|Adverse Event|0|||
33477000|NCT03627416|62852697|FG001|Overall Study|Adverse Event|1|||
33477001|NCT00972478|62852705|FG000|Overall Study|Adverse Event|3|||
33477002|NCT00972478|62852706|FG001|Overall Study|Adverse Event|16|||
33477003|NCT00972478|62852705|FG000|Overall Study|Withdrawal by Subject|1|||
33477004|NCT00972478|62852706|FG001|Overall Study|Withdrawal by Subject|8|||
33477005|NCT00972478|62852705|FG000|Overall Study|Progression/Relapse|0|||
33477006|NCT00972478|62852706|FG001|Overall Study|Progression/Relapse|2|||
33477007|NCT00972478|62852705|FG000|Overall Study|Death|0|||
33477008|NCT00972478|62852706|FG001|Overall Study|Death|2|||
33477009|NCT00972478|62852705|FG000|Overall Study|Not protocol specified|1|||
33477010|NCT00972478|62852706|FG001|Overall Study|Not protocol specified|1|||
33477011|NCT00972478|62852705|FG000|Overall Study|Ineligible|1|||
33477012|NCT00972478|62852706|FG001|Overall Study|Ineligible|7|||
33477013|NCT00972478|62852705|FG000|Overall Study|Not start protocol treatment|1|||
33477014|NCT00972478|62852706|FG001|Overall Study|Not start protocol treatment|2|||
33477015|NCT00097539|62852720|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
33477016|NCT00097539|62852721|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
33477017|NCT00097539|62852722|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
33477018|NCT00097539|62852723|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
33477019|NCT00097539|62852724|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
33477020|NCT00097539|62852725|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
33477021|NCT00097539|62852726|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
33477022|NCT00097539|62852720|FG000|Overall Study|Withdrawal by Subject|925|||
33477023|NCT00097539|62852721|FG001|Overall Study|Withdrawal by Subject|323|||
33477024|NCT00097539|62852722|FG002|Overall Study|Withdrawal by Subject|346|||
33477025|NCT00097539|62852723|FG003|Overall Study|Withdrawal by Subject|217|||
33477026|NCT00097539|62852724|FG004|Overall Study|Withdrawal by Subject|68|||
33477027|NCT00097539|62852725|FG005|Overall Study|Withdrawal by Subject|229|||
33477028|NCT00097539|62852726|FG006|Overall Study|Withdrawal by Subject|3|||
33477029|NCT00097539|62852720|FG000|Overall Study|Participant Non-compliant|2140|||
33477030|NCT00097539|62852721|FG001|Overall Study|Participant Non-compliant|567|||
33477031|NCT00097539|62852722|FG002|Overall Study|Participant Non-compliant|1067|||
33477032|NCT00097539|62852723|FG003|Overall Study|Participant Non-compliant|353|||
33477033|NCT00097539|62852724|FG004|Overall Study|Participant Non-compliant|136|||
33477034|NCT00097539|62852725|FG005|Overall Study|Participant Non-compliant|543|||
33477035|NCT00097539|62852726|FG006|Overall Study|Participant Non-compliant|18|||
33477036|NCT00097539|62852720|FG000|Overall Study|Lack of Efficacy|249|||
33477037|NCT00097539|62852721|FG001|Overall Study|Lack of Efficacy|122|||
33477038|NCT00097539|62852722|FG002|Overall Study|Lack of Efficacy|202|||
33477039|NCT00097539|62852723|FG003|Overall Study|Lack of Efficacy|105|||
33477040|NCT00097539|62852724|FG004|Overall Study|Lack of Efficacy|45|||
33477041|NCT00097539|62852725|FG005|Overall Study|Lack of Efficacy|228|||
33477042|NCT00097539|62852726|FG006|Overall Study|Lack of Efficacy|5|||
33477043|NCT00097539|62852720|FG000|Overall Study|Adverse Event|78|||
33477044|NCT00097539|62852721|FG001|Overall Study|Adverse Event|133|||
33477045|NCT00097539|62852722|FG002|Overall Study|Adverse Event|37|||
33477046|NCT00097539|62852723|FG003|Overall Study|Adverse Event|27|||
33477047|NCT00097539|62852724|FG004|Overall Study|Adverse Event|30|||
33477048|NCT00097539|62852725|FG005|Overall Study|Adverse Event|59|||
33477049|NCT00097539|62852726|FG006|Overall Study|Adverse Event|1|||
33477050|NCT00097539|62852720|FG000|Overall Study|Death|2|||
33477051|NCT00097539|62852721|FG001|Overall Study|Death|7|||
33477052|NCT00097539|62852722|FG002|Overall Study|Death|0|||
33477053|NCT00097539|62852723|FG003|Overall Study|Death|0|||
33477054|NCT00097539|62852724|FG004|Overall Study|Death|1|||
33477055|NCT00097539|62852725|FG005|Overall Study|Death|3|||
33477056|NCT00097539|62852726|FG006|Overall Study|Death|0|||
33477057|NCT00097539|62852720|FG000|Overall Study|Reasons Other Than Above|3602|||
33477058|NCT00097539|62852721|FG001|Overall Study|Reasons Other Than Above|1382|||
33477059|NCT00097539|62852722|FG002|Overall Study|Reasons Other Than Above|1757|||
33477060|NCT00097539|62852723|FG003|Overall Study|Reasons Other Than Above|692|||
33477061|NCT00097539|62852724|FG004|Overall Study|Reasons Other Than Above|361|||
33477062|NCT00097539|62852725|FG005|Overall Study|Reasons Other Than Above|1244|||
33477063|NCT00097539|62852726|FG006|Overall Study|Reasons Other Than Above|34|||
33477064|NCT00097539|62852720|FG000|Overall Study|Reason not Specified|111|||
33477065|NCT00097539|62852721|FG001|Overall Study|Reason not Specified|49|||
33477066|NCT00097539|62852722|FG002|Overall Study|Reason not Specified|53|||
33477067|NCT00097539|62852723|FG003|Overall Study|Reason not Specified|21|||
33477068|NCT00097539|62852724|FG004|Overall Study|Reason not Specified|11|||
33477069|NCT00097539|62852725|FG005|Overall Study|Reason not Specified|40|||
33477070|NCT00097539|62852726|FG006|Overall Study|Reason not Specified|2|||
33477071|NCT03925324|62852744|FG000|Overall Study|Death|1|||
33477072|NCT03925324|62852745|FG001|Overall Study|Death|1|||
33477073|NCT03042910|62852751|FG000|Overall Study|Adverse Event|1|||
33477074|NCT03042910|62852751|FG000|Overall Study|Disease Progression|2|||
33477075|NCT03042910|62852751|FG000|Overall Study|Withdrawal by Subject|3|||
33477076|NCT03042910|62852751|FG000|Overall Study|Enrolled but not treated|1|||
33477077|NCT03059446|62852755|FG000|Overall Study|Adverse Event|11|||
33477078|NCT03059446|62852755|FG000|Overall Study|Withdrawal of Consent|16|||
33477079|NCT03059446|62852755|FG000|Overall Study|Lost to Follow-up|3|||
33477080|NCT03059446|62852755|FG000|Overall Study|Protocol Violation|1|||
33477081|NCT03059446|62852755|FG000|Overall Study|Study Terminated by Sponsor|131|||
33477082|NCT03059446|62852755|FG000|Overall Study|Reason not Specified|5|||
33477083|NCT00090519|62852761|FG000|Overall Study|Adverse Event|5|||
33477084|NCT00090519|62852762|FG001|Overall Study|Adverse Event|4|||
33477085|NCT00090519|62852761|FG000|Overall Study|Death|9|||
33550107|NCT02745145|62941415|FG002|Overall Study|Study Termination|7|||
33550108|NCT02854631|62941434|FG000|Overall Study|Adverse Event|1|||
33550109|NCT02854631|62941435|FG001|Overall Study|Adverse Event|2|||
33550110|NCT02854631|62941434|FG000|Overall Study|Withdrew Consent|3|||
33550111|NCT02854631|62941435|FG001|Overall Study|Withdrew Consent|2|||
33550112|NCT02854631|62941434|FG000|Overall Study|Investigator's Discretion|2|||
33550113|NCT02854631|62941435|FG001|Overall Study|Investigator's Discretion|0|||
33550114|NCT02854631|62941434|FG000|Overall Study|Death|12|||
33550115|NCT02854631|62941435|FG001|Overall Study|Death|8|||
33550116|NCT02854631|62941434|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
33550117|NCT02854631|62941435|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
33550118|NCT02854631|62941434|FG000|Overall Study|Protocol Violation|0|||
33477086|NCT00090519|62852762|FG001|Overall Study|Death|9|||
33477087|NCT00090519|62852761|FG000|Overall Study|Lost to Follow-up|26|||
33477088|NCT00090519|62852762|FG001|Overall Study|Lost to Follow-up|29|||
33477089|NCT00090519|62852761|FG000|Overall Study|Withdrawal by Subject|28|||
33477090|NCT00090519|62852762|FG001|Overall Study|Withdrawal by Subject|29|||
33550119|NCT02854631|62941435|FG001|Overall Study|Protocol Violation|1|||
33550120|NCT02854631|62941434|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
33364515|NCT02393248|62743322|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33477091|NCT00090519|62852761|FG000|Overall Study|Physician Decision|2|||
33550121|NCT02854631|62941435|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
33550122|NCT02854631|62941434|FG000|Overall Study|Lost to Follow-up|4|||
33364516|NCT02393248|62743323|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33477092|NCT00090519|62852762|FG001|Overall Study|Physician Decision|3|||
33477093|NCT00090519|62852761|FG000|Overall Study|Sponsor Decision|3|||
33477094|NCT00090519|62852762|FG001|Overall Study|Sponsor Decision|1|||
33477095|NCT00096993|62852792|FG000|Overall Study|Death|1|||
33477096|NCT00096993|62852793|FG001|Overall Study|Death|0|||
33477097|NCT00096993|62852792|FG000|Overall Study|Disease progression|56|||
33477098|NCT00096993|62852793|FG001|Overall Study|Disease progression|53|||
33477099|NCT00096993|62852792|FG000|Overall Study|Adverse Event|2|||
33550123|NCT02854631|62941435|FG001|Overall Study|Lost to Follow-up|2|||
33477100|NCT00096993|62852793|FG001|Overall Study|Adverse Event|8|||
33477101|NCT00096993|62852792|FG000|Overall Study|Subject's decision|3|||
33477102|NCT00096993|62852793|FG001|Overall Study|Subject's decision|1|||
33477103|NCT00096993|62852792|FG000|Overall Study|Physician Decision|2|||
33477104|NCT00096993|62852793|FG001|Overall Study|Physician Decision|1|||
33477105|NCT00096993|62852792|FG000|Overall Study|Non-compliance|0|||
33477106|NCT00096993|62852793|FG001|Overall Study|Non-compliance|1|||
33477107|NCT00096993|62852792|FG000|Overall Study|Other unspecified|1|||
33477108|NCT00096993|62852793|FG001|Overall Study|Other unspecified|1|||
33477109|NCT03040336|62852801|FG000|Overall Study|Death|1|||
33477110|NCT03040336|62852802|FG001|Overall Study|Death|0|||
33477111|NCT03040336|62852801|FG000|Overall Study|Withdrawal by Subject|2|||
33477112|NCT03040336|62852802|FG001|Overall Study|Withdrawal by Subject|3|||
33477113|NCT00072189|62852809|FG000|Overall Study|Withdrawal by Subject|1|||
33477114|NCT03040024|62852816|FG000|Overall Study|Adverse Event|0|||
33477115|NCT03040024|62852817|FG001|Overall Study|Adverse Event|1|||
33477116|NCT03040024|62852818|FG002|Overall Study|Adverse Event|0|||
33477117|NCT03040024|62852816|FG000|Overall Study|Death|0|||
33477118|NCT03040024|62852817|FG001|Overall Study|Death|1|||
33477119|NCT03040024|62852818|FG002|Overall Study|Death|0|||
33477120|NCT03040024|62852816|FG000|Overall Study|Physician Decision|0|||
33477121|NCT03040024|62852817|FG001|Overall Study|Physician Decision|0|||
33477122|NCT03040024|62852818|FG002|Overall Study|Physician Decision|1|||
33477123|NCT03039790|62852846|FG000|Overall Study|Lost to Follow-up|2|||
33477124|NCT03039790|62852847|FG001|Overall Study|Lost to Follow-up|0|||
33477125|NCT03039790|62852848|FG002|Overall Study|Lost to Follow-up|1|||
33477126|NCT03039790|62852849|FG003|Overall Study|Lost to Follow-up|1|||
33477127|NCT03039790|62852850|FG004|Overall Study|Lost to Follow-up|0|||
33477128|NCT03039790|62852851|FG005|Overall Study|Lost to Follow-up|1|||
33477129|NCT03039790|62852852|FG006|Overall Study|Lost to Follow-up|1|||
33477130|NCT03039790|62852853|FG007|Overall Study|Lost to Follow-up|1|||
33477131|NCT03039790|62852854|FG008|Overall Study|Lost to Follow-up|0|||
33477132|NCT03039790|62852855|FG009|Overall Study|Lost to Follow-up|1|||
33477133|NCT03039790|62852856|FG010|Overall Study|Lost to Follow-up|1|||
33477134|NCT03039790|62852857|FG011|Overall Study|Lost to Follow-up|0|||
33477135|NCT03039790|62852858|FG012|Overall Study|Lost to Follow-up|1|||
33477136|NCT03039790|62852859|FG013|Overall Study|Lost to Follow-up|0|||
33477137|NCT03039790|62852860|FG014|Overall Study|Lost to Follow-up|3|||
33477138|NCT03039790|62852861|FG015|Overall Study|Lost to Follow-up|1|||
33477139|NCT03039790|62852862|FG016|Overall Study|Lost to Follow-up|2|||
33477140|NCT03039790|62852863|FG017|Overall Study|Lost to Follow-up|2|||
33477141|NCT03039790|62852864|FG018|Overall Study|Lost to Follow-up|1|||
33477142|NCT03039790|62852865|FG019|Overall Study|Lost to Follow-up|3|||
33477143|NCT03039790|62852846|FG000|Overall Study|Withdrawal of Consent|1|||
33477144|NCT03039790|62852847|FG001|Overall Study|Withdrawal of Consent|0|||
33477145|NCT03039790|62852848|FG002|Overall Study|Withdrawal of Consent|0|||
33477146|NCT03039790|62852849|FG003|Overall Study|Withdrawal of Consent|1|||
33477147|NCT03039790|62852850|FG004|Overall Study|Withdrawal of Consent|0|||
33477148|NCT03039790|62852851|FG005|Overall Study|Withdrawal of Consent|0|||
33477149|NCT03039790|62852852|FG006|Overall Study|Withdrawal of Consent|0|||
33477150|NCT03039790|62852853|FG007|Overall Study|Withdrawal of Consent|0|||
33477151|NCT03039790|62852854|FG008|Overall Study|Withdrawal of Consent|0|||
33477152|NCT03039790|62852855|FG009|Overall Study|Withdrawal of Consent|1|||
33477153|NCT03039790|62852856|FG010|Overall Study|Withdrawal of Consent|0|||
33477154|NCT03039790|62852857|FG011|Overall Study|Withdrawal of Consent|0|||
33477155|NCT03039790|62852858|FG012|Overall Study|Withdrawal of Consent|2|||
33477156|NCT03039790|62852859|FG013|Overall Study|Withdrawal of Consent|0|||
33477157|NCT03039790|62852860|FG014|Overall Study|Withdrawal of Consent|1|||
33477158|NCT03039790|62852861|FG015|Overall Study|Withdrawal of Consent|5|||
33477159|NCT03039790|62852862|FG016|Overall Study|Withdrawal of Consent|3|||
33477160|NCT03039790|62852863|FG017|Overall Study|Withdrawal of Consent|0|||
33477161|NCT03039790|62852864|FG018|Overall Study|Withdrawal of Consent|2|||
33477162|NCT03039790|62852865|FG019|Overall Study|Withdrawal of Consent|5|||
33477163|NCT03039790|62852846|FG000|Overall Study|Death|0|||
33477164|NCT03039790|62852847|FG001|Overall Study|Death|0|||
33477165|NCT03039790|62852848|FG002|Overall Study|Death|0|||
33477166|NCT03039790|62852849|FG003|Overall Study|Death|0|||
33477167|NCT03039790|62852850|FG004|Overall Study|Death|0|||
33477168|NCT03039790|62852851|FG005|Overall Study|Death|0|||
33477169|NCT03039790|62852852|FG006|Overall Study|Death|0|||
33477170|NCT03039790|62852853|FG007|Overall Study|Death|0|||
33477171|NCT03039790|62852854|FG008|Overall Study|Death|0|||
33477172|NCT03039790|62852855|FG009|Overall Study|Death|0|||
33477173|NCT03039790|62852856|FG010|Overall Study|Death|0|||
33477174|NCT03039790|62852857|FG011|Overall Study|Death|0|||
33477175|NCT03039790|62852858|FG012|Overall Study|Death|0|||
33477176|NCT03039790|62852859|FG013|Overall Study|Death|0|||
33477177|NCT03039790|62852860|FG014|Overall Study|Death|0|||
33477178|NCT03039790|62852861|FG015|Overall Study|Death|1|||
33477179|NCT03039790|62852862|FG016|Overall Study|Death|3|||
33477180|NCT03039790|62852863|FG017|Overall Study|Death|0|||
33477181|NCT03039790|62852864|FG018|Overall Study|Death|2|||
33477182|NCT03039790|62852865|FG019|Overall Study|Death|0|||
33477183|NCT03039790|62852846|FG000|Overall Study|Reason, not Specified|1|||
33477184|NCT03039790|62852847|FG001|Overall Study|Reason, not Specified|0|||
33477185|NCT03039790|62852848|FG002|Overall Study|Reason, not Specified|0|||
33477186|NCT03039790|62852849|FG003|Overall Study|Reason, not Specified|0|||
33477187|NCT03039790|62852850|FG004|Overall Study|Reason, not Specified|0|||
33477188|NCT03039790|62852851|FG005|Overall Study|Reason, not Specified|0|||
33364517|NCT02393248|62743324|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33364518|NCT02393248|62743325|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33364519|NCT02393248|62743326|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33364520|NCT02393248|62743327|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33364521|NCT02393248|62743303|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364522|NCT02393248|62743304|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33477189|NCT03039790|62852852|FG006|Overall Study|Reason, not Specified|0|||
33477190|NCT03039790|62852853|FG007|Overall Study|Reason, not Specified|0|||
33477191|NCT03039790|62852854|FG008|Overall Study|Reason, not Specified|0|||
33477192|NCT03039790|62852855|FG009|Overall Study|Reason, not Specified|0|||
33477193|NCT03039790|62852856|FG010|Overall Study|Reason, not Specified|0|||
33477194|NCT03039790|62852857|FG011|Overall Study|Reason, not Specified|0|||
33477195|NCT03039790|62852858|FG012|Overall Study|Reason, not Specified|0|||
33477196|NCT03039790|62852859|FG013|Overall Study|Reason, not Specified|0|||
33477197|NCT03039790|62852860|FG014|Overall Study|Reason, not Specified|0|||
33477198|NCT03039790|62852861|FG015|Overall Study|Reason, not Specified|0|||
33477199|NCT03039790|62852862|FG016|Overall Study|Reason, not Specified|2|||
33477200|NCT03039790|62852863|FG017|Overall Study|Reason, not Specified|0|||
33477201|NCT03039790|62852864|FG018|Overall Study|Reason, not Specified|1|||
33477202|NCT03039790|62852865|FG019|Overall Study|Reason, not Specified|0|||
33477203|NCT03038620|62852938|FG000|Overall Study|Lost to Follow-up|18|||
33477204|NCT03038620|62852939|FG001|Overall Study|Lost to Follow-up|23|||
33477205|NCT03038620|62852938|FG000|Overall Study|Withdrawal by Subject|0|||
33477206|NCT03038620|62852939|FG001|Overall Study|Withdrawal by Subject|15|||
33477207|NCT03038620|62852938|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
33477208|NCT03038620|62852939|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
33477209|NCT01350934|62852960|FG000|Base Study|Adverse Event|6|||
33477210|NCT01350934|62852961|FG001|Base Study|Adverse Event|0|||
33477211|NCT01350934|62852960|FG000|Base Study|Lost to Follow-up|1|||
33477212|NCT01350934|62852961|FG001|Base Study|Lost to Follow-up|0|||
33477213|NCT01350934|62852960|FG000|Base Study|Protocol Violation|1|||
33477214|NCT01350934|62852961|FG001|Base Study|Protocol Violation|1|||
33477215|NCT01350934|62852960|FG000|Base Study|Withdrawal by Subject|1|||
33477216|NCT01350934|62852961|FG001|Base Study|Withdrawal by Subject|2|||
33477217|NCT01350934|62852960|FG000|Base Study|Non-Compliance With Study Drug|2|||
33477218|NCT01350934|62852961|FG001|Base Study|Non-Compliance With Study Drug|0|||
33477219|NCT01350934|62852960|FG000|Extension Study|Adverse Event|2|||
33477220|NCT01350934|62852961|FG001|Extension Study|Adverse Event|1|||
33477221|NCT01350934|62852960|FG000|Extension Study|Lost to Follow-up|2|||
33477222|NCT01350934|62852961|FG001|Extension Study|Lost to Follow-up|0|||
33477223|NCT01350934|62852960|FG000|Extension Study|Protocol Violation|1|||
33477224|NCT01350934|62852961|FG001|Extension Study|Protocol Violation|1|||
33477225|NCT01350934|62852960|FG000|Extension Study|Lack of Efficacy|0|||
33477226|NCT01350934|62852961|FG001|Extension Study|Lack of Efficacy|1|||
33477227|NCT01350934|62852960|FG000|Extension Study|Withdrawal by Subject|0|||
33477228|NCT01350934|62852961|FG001|Extension Study|Withdrawal by Subject|1|||
33477229|NCT03622580|62852985|FG000|Overall Study|Death|16|||
33477230|NCT03622580|62852986|FG001|Overall Study|Death|21|||
33477231|NCT03622580|62852987|FG002|Overall Study|Death|13|||
33477232|NCT03622580|62852985|FG000|Overall Study|Adverse Event|6|||
33477233|NCT03622580|62852986|FG001|Overall Study|Adverse Event|6|||
33477234|NCT03622580|62852987|FG002|Overall Study|Adverse Event|5|||
33477235|NCT03622580|62852985|FG000|Overall Study|Withdrawal by Subject|12|||
33477236|NCT03622580|62852986|FG001|Overall Study|Withdrawal by Subject|7|||
33477237|NCT03622580|62852987|FG002|Overall Study|Withdrawal by Subject|19|||
33477238|NCT03622580|62852985|FG000|Overall Study|Lost to Follow-up|12|||
33364523|NCT02393248|62743305|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33477239|NCT03622580|62852986|FG001|Overall Study|Lost to Follow-up|9|||
33477240|NCT03622580|62852987|FG002|Overall Study|Lost to Follow-up|9|||
33477241|NCT03622580|62852985|FG000|Overall Study|Protocol Violation|1|||
33477242|NCT03622580|62852986|FG001|Overall Study|Protocol Violation|0|||
33477243|NCT03622580|62852987|FG002|Overall Study|Protocol Violation|1|||
33477244|NCT03622580|62852985|FG000|Overall Study|Physician Decision|3|||
33477245|NCT03622580|62852986|FG001|Overall Study|Physician Decision|0|||
33550124|NCT02855359|62941443|FG000|Overall Study|Death|2|||
33477246|NCT03622580|62852987|FG002|Overall Study|Physician Decision|1|||
33477247|NCT03622580|62852985|FG000|Overall Study|Pregnancy|0|||
33477248|NCT03622580|62852986|FG001|Overall Study|Pregnancy|1|||
33550125|NCT02855359|62941444|FG001|Overall Study|Death|2|||
33477249|NCT03622580|62852987|FG002|Overall Study|Pregnancy|0|||
33477250|NCT03622580|62852985|FG000|Overall Study|Lack of Efficacy|0|||
33477251|NCT03622580|62852986|FG001|Overall Study|Lack of Efficacy|0|||
33477252|NCT03622580|62852987|FG002|Overall Study|Lack of Efficacy|1|||
33477253|NCT03622580|62852985|FG000|Overall Study|Other|2|||
33477254|NCT03622580|62852986|FG001|Overall Study|Other|0|||
33477255|NCT03622580|62852987|FG002|Overall Study|Other|3|||
33477256|NCT00461032|62852998|FG000|Overall Study|Adverse Event|5|||
33477257|NCT00461032|62852999|FG001|Overall Study|Adverse Event|6|||
33477258|NCT00461032|62852998|FG000|Overall Study|Lack of Efficacy|5|||
33477259|NCT00461032|62852999|FG001|Overall Study|Lack of Efficacy|1|||
33477260|NCT00461032|62852998|FG000|Overall Study|Lost to Follow-up|7|||
33477261|NCT00461032|62852999|FG001|Overall Study|Lost to Follow-up|12|||
33477262|NCT00461032|62852998|FG000|Overall Study|Protocol Violation|4|||
33477263|NCT00461032|62852999|FG001|Overall Study|Protocol Violation|4|||
33477264|NCT00461032|62852998|FG000|Overall Study|Withdrawal by Subject|7|||
33477265|NCT00461032|62852999|FG001|Overall Study|Withdrawal by Subject|15|||
33477266|NCT00461032|62852998|FG000|Overall Study|Patient Moved or Relocated|2|||
33477267|NCT00461032|62852999|FG001|Overall Study|Patient Moved or Relocated|1|||
33477268|NCT00461032|62852998|FG000|Overall Study|Other|7|||
33477269|NCT00461032|62852999|FG001|Overall Study|Other|5|||
33477270|NCT00090142|62853005|FG000|Treatment Period I|Lost to Follow-up|1|||
33477271|NCT00090142|62853006|FG001|Treatment Period I|Lost to Follow-up|2|||
33477272|NCT00090142|62853005|FG000|Treatment Period I|Protocol Violation|2|||
33477273|NCT00090142|62853006|FG001|Treatment Period I|Protocol Violation|0|||
33477274|NCT00090142|62853005|FG000|Treatment Period I|Withdrawal by Subject|2|||
33477275|NCT00090142|62853006|FG001|Treatment Period I|Withdrawal by Subject|0|||
33477276|NCT00090142|62853005|FG000|Treatment Period I|Other|0|||
33477277|NCT00090142|62853006|FG001|Treatment Period I|Other|1|||
33477278|NCT00090142|62853005|FG000|Treatment Period II|Other|1|||
33477279|NCT00090142|62853006|FG001|Treatment Period II|Other|0|||
33477280|NCT03622112|62853023|FG000|Overall Study|Withdrawal by Subject|6|||
33477281|NCT03622112|62853024|FG001|Overall Study|Withdrawal by Subject|2|||
33477282|NCT03622112|62853025|FG002|Overall Study|Withdrawal by Subject|4|||
33477283|NCT03622112|62853026|FG003|Overall Study|Withdrawal by Subject|2|||
33477284|NCT03622112|62853027|FG004|Overall Study|Withdrawal by Subject|1|||
33477285|NCT03622112|62853028|FG005|Overall Study|Withdrawal by Subject|2|||
33477286|NCT03622112|62853029|FG006|Overall Study|Withdrawal by Subject|2|||
33477287|NCT03622112|62853023|FG000|Overall Study|Death|0|||
33477288|NCT03622112|62853024|FG001|Overall Study|Death|0|||
33477289|NCT03622112|62853025|FG002|Overall Study|Death|0|||
33477290|NCT03622112|62853026|FG003|Overall Study|Death|1|||
33477291|NCT03622112|62853027|FG004|Overall Study|Death|0|||
33477292|NCT03622112|62853028|FG005|Overall Study|Death|0|||
33477293|NCT03622112|62853029|FG006|Overall Study|Death|0|||
33477294|NCT03622112|62853023|FG000|Overall Study|Lost to Follow-up|1|||
33477295|NCT03622112|62853024|FG001|Overall Study|Lost to Follow-up|1|||
33477296|NCT03622112|62853025|FG002|Overall Study|Lost to Follow-up|0|||
33364524|NCT02393248|62743306|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364525|NCT02393248|62743307|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364526|NCT02393248|62743308|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364527|NCT02393248|62743309|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
33364528|NCT02393248|62743310|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364529|NCT02393248|62743311|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364530|NCT02393248|62743312|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364531|NCT02393248|62743313|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364532|NCT02393248|62743314|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364533|NCT02393248|62743315|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364534|NCT02393248|62743316|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364535|NCT02393248|62743317|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364536|NCT02393248|62743318|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364537|NCT02393248|62743319|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33477297|NCT03622112|62853026|FG003|Overall Study|Lost to Follow-up|0|||
33477298|NCT03622112|62853027|FG004|Overall Study|Lost to Follow-up|0|||
33477299|NCT03622112|62853028|FG005|Overall Study|Lost to Follow-up|0|||
33477300|NCT03622112|62853029|FG006|Overall Study|Lost to Follow-up|0|||
33477301|NCT03622112|62853023|FG000|Overall Study|Study-specific withdrawal criteria|10|||
33477302|NCT03622112|62853024|FG001|Overall Study|Study-specific withdrawal criteria|8|||
33477303|NCT03622112|62853025|FG002|Overall Study|Study-specific withdrawal criteria|7|||
33477304|NCT03622112|62853026|FG003|Overall Study|Study-specific withdrawal criteria|6|||
33477305|NCT03622112|62853027|FG004|Overall Study|Study-specific withdrawal criteria|4|||
33477306|NCT03622112|62853028|FG005|Overall Study|Study-specific withdrawal criteria|18|||
33477307|NCT03622112|62853029|FG006|Overall Study|Study-specific withdrawal criteria|4|||
33477308|NCT03622112|62853023|FG000|Overall Study|Protocol Violation|2|||
33477309|NCT03622112|62853024|FG001|Overall Study|Protocol Violation|0|||
33477310|NCT03622112|62853025|FG002|Overall Study|Protocol Violation|1|||
33477311|NCT03622112|62853026|FG003|Overall Study|Protocol Violation|1|||
33477312|NCT03622112|62853027|FG004|Overall Study|Protocol Violation|0|||
33477313|NCT03622112|62853028|FG005|Overall Study|Protocol Violation|0|||
33477314|NCT03622112|62853029|FG006|Overall Study|Protocol Violation|0|||
33477315|NCT03622112|62853023|FG000|Overall Study|Adverse Event|6|||
33477316|NCT03622112|62853024|FG001|Overall Study|Adverse Event|8|||
33477317|NCT03622112|62853025|FG002|Overall Study|Adverse Event|4|||
33477318|NCT03622112|62853026|FG003|Overall Study|Adverse Event|11|||
33477319|NCT03622112|62853027|FG004|Overall Study|Adverse Event|4|||
33477320|NCT03622112|62853028|FG005|Overall Study|Adverse Event|20|||
33477321|NCT03622112|62853029|FG006|Overall Study|Adverse Event|2|||
33477322|NCT03622112|62853023|FG000|Overall Study|Reason not specified|0|||
33477323|NCT03622112|62853024|FG001|Overall Study|Reason not specified|1|||
33477324|NCT03622112|62853025|FG002|Overall Study|Reason not specified|0|||
33477325|NCT03622112|62853026|FG003|Overall Study|Reason not specified|1|||
33477326|NCT03622112|62853027|FG004|Overall Study|Reason not specified|1|||
33477327|NCT03622112|62853028|FG005|Overall Study|Reason not specified|2|||
33477328|NCT03622112|62853029|FG006|Overall Study|Reason not specified|1|||
33477329|NCT04032158|62853047|FG000|Overall Study|Study Termination|2|||
33655937|NCT01857323|63073356|FG000|Overall Study|Adverse Event|1|||
33655938|NCT01857323|63073356|FG000|Overall Study|Withdrawal by Subject|3|||
33655939|NCT01857323|63073356|FG000|Overall Study|Non-compliance|1|||
33655940|NCT01857323|63073356|FG000|Overall Study|Protocol Violation|6|||
33655941|NCT01857323|63073356|FG000|Overall Study|Lost to Follow-up|1|||
33655942|NCT01857323|63073356|FG000|Overall Study|Other|4|||
33655943|NCT01857323|63073356|FG000|Overall Study|Did not complete 180 doses|48|||
33655944|NCT00632541|63073360|FG000|Overall Study|Adverse Event|7|||
33655945|NCT01872611|63073366|FG000|Overall Study|Adverse Event|3|||
33655946|NCT01872611|63073367|FG001|Overall Study|Adverse Event|1|||
33655947|NCT01872611|63073366|FG000|Overall Study|Adverse Event, prior to treatment|0|||
33655948|NCT01872611|63073367|FG001|Overall Study|Adverse Event, prior to treatment|1|||
33655949|NCT01872611|63073366|FG000|Overall Study|Death|0|||
33655950|NCT01872611|63073367|FG001|Overall Study|Death|1|||
33655951|NCT01872611|63073366|FG000|Overall Study|Death, prior to treatment|0|||
33655952|NCT01872611|63073367|FG001|Overall Study|Death, prior to treatment|1|||
33655953|NCT01872611|63073366|FG000|Overall Study|Lost to Follow-up|8|||
33655954|NCT01872611|63073367|FG001|Overall Study|Lost to Follow-up|1|||
33655955|NCT01872611|63073366|FG000|Overall Study|Physician Decision|1|||
33655956|NCT01872611|63073367|FG001|Overall Study|Physician Decision|0|||
33655957|NCT01872611|63073366|FG000|Overall Study|Withdrawal by Subject|6|||
33655958|NCT01872611|63073367|FG001|Overall Study|Withdrawal by Subject|1|||
33364538|NCT02393248|62743320|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364539|NCT02393248|62743321|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364540|NCT02393248|62743322|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364541|NCT02393248|62743323|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364542|NCT02393248|62743324|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364543|NCT02393248|62743325|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364544|NCT02393248|62743326|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364545|NCT02393248|62743327|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33364546|NCT02393248|62743303|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364547|NCT02393248|62743304|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364548|NCT02393248|62743305|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364549|NCT02393248|62743306|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364550|NCT02393248|62743307|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364551|NCT02393248|62743308|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364552|NCT02393248|62743309|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364553|NCT02393248|62743310|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33477330|NCT04032158|62853048|FG001|Overall Study|Study Termination|1|||
33477331|NCT03620708|62853057|FG000|Overall Study|Lost to Follow-up|1|||
33477332|NCT03620708|62853058|FG001|Overall Study|Lost to Follow-up|1|||
33477333|NCT03620708|62853059|FG002|Overall Study|Lost to Follow-up|2|||
33477334|NCT03620708|62853057|FG000|Overall Study|Withdrawal by Subject|0|||
33655959|NCT01872611|63073366|FG000|Overall Study|Reason not provided|6|||
33655960|NCT01872611|63073367|FG001|Overall Study|Reason not provided|6|||
33655961|NCT03089853|63073377|FG000|Overall Study|Lost to Follow-up|2|||
33655962|NCT03089853|63073378|FG001|Overall Study|Lost to Follow-up|1|||
33477335|NCT03620708|62853058|FG001|Overall Study|Withdrawal by Subject|0|||
33477336|NCT03620708|62853059|FG002|Overall Study|Withdrawal by Subject|1|||
33655963|NCT03086967|63073386|FG000|Overall Study|Screen Failure|2|||
33655964|NCT03086967|63073387|FG001|Overall Study|Screen Failure|2|||
33655965|NCT01856543|63073395|FG000|Overall Study|Treatment discontinued|6|||
33477337|NCT03654326|62853069|FG000|Overall Study|Withdrawal by Subject|5|||
33477338|NCT03654326|62853070|FG001|Overall Study|Withdrawal by Subject|3|||
33477339|NCT03654326|62853069|FG000|Overall Study|Physician Decision|0|||
33477340|NCT03654326|62853070|FG001|Overall Study|Physician Decision|1|||
33477341|NCT03654326|62853069|FG000|Overall Study|Unable to adhere to study schedule|0|||
33477342|NCT03654326|62853070|FG001|Overall Study|Unable to adhere to study schedule|1|||
33477343|NCT03654326|62853069|FG000|Overall Study|Lost to Follow-up|1|||
33477344|NCT03654326|62853070|FG001|Overall Study|Lost to Follow-up|1|||
33477345|NCT04025684|62853080|FG000|Overall Study|Withdrawal by Subject|1|||
33655966|NCT01856543|63073396|FG001|Overall Study|Treatment discontinued|3|||
33655967|NCT01856543|63073395|FG000|Overall Study|Withdrawn before start|7|||
33655968|NCT01856543|63073396|FG001|Overall Study|Withdrawn before start|3|||
33655969|NCT00632463|63073406|FG000|Overall Study|Adverse Event|0|||
33655970|NCT00632463|63073407|FG001|Overall Study|Adverse Event|1|||
33655971|NCT00632463|63073408|FG002|Overall Study|Adverse Event|0|||
33655972|NCT00632229|63073418|FG000|Overall Study|Adverse Event|6|||
33655973|NCT00632229|63073419|FG001|Overall Study|Adverse Event|0|||
33655974|NCT00632229|63073418|FG000|Overall Study|Lost to Follow-up|0|||
33655975|NCT00632229|63073419|FG001|Overall Study|Lost to Follow-up|3|||
33655976|NCT00632229|63073418|FG000|Overall Study|Lack of Efficacy|0|||
33477346|NCT04025684|62853081|FG001|Overall Study|Withdrawal by Subject|1|||
33477347|NCT04025684|62853082|FG002|Overall Study|Withdrawal by Subject|0|||
33477348|NCT04025684|62853083|FG003|Overall Study|Withdrawal by Subject|0|||
33477349|NCT04025684|62853080|FG000|Overall Study|Multiple reasons|1|||
33477350|NCT04025684|62853081|FG001|Overall Study|Multiple reasons|3|||
33477351|NCT04025684|62853082|FG002|Overall Study|Multiple reasons|0|||
33477352|NCT04025684|62853083|FG003|Overall Study|Multiple reasons|1|||
33477353|NCT03617588|62853095|FG000|Overall Study|Withdrawal by Subject|1|||
33477354|NCT03617588|62853096|FG001|Overall Study|Withdrawal by Subject|0|||
33477355|NCT03616106|62853108|FG000|Overall Study|Removed by PI|6|||
33477356|NCT03616106|62853109|FG001|Overall Study|Removed by PI|0|||
33477357|NCT03616106|62853108|FG000|Overall Study|Withdrawal by Subject|1|||
33477358|NCT03616106|62853109|FG001|Overall Study|Withdrawal by Subject|1|||
33477359|NCT03616106|62853108|FG000|Overall Study|Lost to Follow-up|7|||
33477360|NCT03616106|62853109|FG001|Overall Study|Lost to Follow-up|0|||
33477361|NCT04019054|62853116|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
33477362|NCT04019054|62853117|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
33477363|NCT04019054|62853116|FG000|Overall Study|Withdrawal by Subject|3|||
33477364|NCT04019054|62853117|FG001|Overall Study|Withdrawal by Subject|1|||
33477365|NCT00071799|62853125|FG000|Overall Study|Adverse Event|19|||
33477366|NCT00071799|62853126|FG001|Overall Study|Adverse Event|10|||
33477367|NCT00071799|62853125|FG000|Overall Study|Protocol Violation|1|||
33477368|NCT00071799|62853126|FG001|Overall Study|Protocol Violation|7|||
33477369|NCT00071799|62853125|FG000|Overall Study|Lost to Follow-up|1|||
33477370|NCT00071799|62853126|FG001|Overall Study|Lost to Follow-up|1|||
33477371|NCT00071799|62853125|FG000|Overall Study|Withdrawal by Subject|15|||
33477372|NCT00071799|62853126|FG001|Overall Study|Withdrawal by Subject|37|||
33477373|NCT00071799|62853125|FG000|Overall Study|Physician Decision|0|||
33477374|NCT00071799|62853126|FG001|Overall Study|Physician Decision|2|||
33550126|NCT02855359|62941445|FG002|Overall Study|Death|0|||
33550127|NCT02855359|62941446|FG003|Overall Study|Death|0|||
33550128|NCT02855359|62941443|FG000|Overall Study|Study Termination by Sponsor|9|||
33550129|NCT02855359|62941444|FG001|Overall Study|Study Termination by Sponsor|11|||
33550130|NCT02855359|62941445|FG002|Overall Study|Study Termination by Sponsor|0|||
33550131|NCT02855359|62941446|FG003|Overall Study|Study Termination by Sponsor|0|||
33655977|NCT00632229|63073419|FG001|Overall Study|Lack of Efficacy|2|||
33655978|NCT00632229|63073418|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
33655979|NCT00632229|63073419|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
33655980|NCT00631137|63073427|FG000|Overall Study|Withdrawal by Subject|1|||
33655981|NCT00631137|63073428|FG001|Overall Study|Withdrawal by Subject|0|||
33655982|NCT00630825|63073447|FG000|Overall Study|Adverse Event|4|||
33655983|NCT00630825|63073448|FG001|Overall Study|Adverse Event|4|||
33364554|NCT02393248|62743311|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364555|NCT02393248|62743312|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33477375|NCT00071799|62853125|FG000|Overall Study|Lack of Efficacy|11|||
33477376|NCT00071799|62853126|FG001|Overall Study|Lack of Efficacy|18|||
33477377|NCT00071799|62853125|FG000|Overall Study|Disease Progression|23|||
33477378|NCT00071799|62853126|FG001|Overall Study|Disease Progression|20|||
33477379|NCT00071799|62853125|FG000|Overall Study|Different Central+Local Pathology Review|0|||
33477380|NCT00071799|62853126|FG001|Overall Study|Different Central+Local Pathology Review|1|||
33477381|NCT00071799|62853125|FG000|Overall Study|Not Documented|0|||
33477382|NCT00071799|62853126|FG001|Overall Study|Not Documented|2|||
33477383|NCT03615482|62853140|FG000|Overall Study|Death|1|||
33550132|NCT02853929|62941460|FG000|Overall Study|Lost to Follow-up|3|||
33655984|NCT00630825|63073449|FG002|Overall Study|Adverse Event|3|||
33655985|NCT00630825|63073450|FG003|Overall Study|Adverse Event|1|||
33477384|NCT03615482|62853141|FG001|Overall Study|Death|0|||
33477385|NCT03615482|62853140|FG000|Overall Study|Lost to Follow-up|7|||
33477386|NCT03615482|62853141|FG001|Overall Study|Lost to Follow-up|7|||
33477387|NCT03615482|62853140|FG000|Overall Study|Physician Decision|2|||
33477388|NCT03615482|62853141|FG001|Overall Study|Physician Decision|3|||
33477389|NCT03615482|62853140|FG000|Overall Study|Withdrawal by Subject|7|||
33477390|NCT03615482|62853141|FG001|Overall Study|Withdrawal by Subject|7|||
33477391|NCT03688620|62853150|FG000|Overall Study|Other|0|||
33477392|NCT03688620|62853151|FG001|Overall Study|Other|0|||
33477393|NCT03688620|62853152|FG002|Overall Study|Other|1|||
33477394|NCT03688620|62853150|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
33477395|NCT03688620|62853151|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
33477396|NCT03688620|62853152|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
33477397|NCT03688620|62853150|FG000|Overall Study|Lost to Follow-up|16|||
33477398|NCT03688620|62853151|FG001|Overall Study|Lost to Follow-up|0|||
33477399|NCT03688620|62853152|FG002|Overall Study|Lost to Follow-up|1|||
33477400|NCT03688620|62853150|FG000|Overall Study|Withdrawal by Subject|0|||
33477401|NCT03688620|62853151|FG001|Overall Study|Withdrawal by Subject|0|||
33477402|NCT03688620|62853152|FG002|Overall Study|Withdrawal by Subject|6|||
33477403|NCT00090363|62853165|FG000|Overall Study|Lost to Follow-up|1|||
33477404|NCT00090363|62853166|FG001|Overall Study|Lost to Follow-up|2|||
33477405|NCT00090363|62853167|FG002|Overall Study|Lost to Follow-up|1|||
33477406|NCT00090363|62853165|FG000|Overall Study|Withdrawal by Subject|7|||
33477407|NCT00090363|62853166|FG001|Overall Study|Withdrawal by Subject|7|||
33550133|NCT02853929|62941461|FG001|Overall Study|Lost to Follow-up|0|||
33550134|NCT02853929|62941460|FG000|Overall Study|Withdrawal by Subject|1|||
33550135|NCT02853929|62941461|FG001|Overall Study|Withdrawal by Subject|0|||
33550136|NCT02853929|62941460|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
33550137|NCT02853929|62941461|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
33550138|NCT02730819|62941497|FG000|Overall Study|Lost to Follow-up|9|||
33550139|NCT02038946|62941501|FG000|Overall Study|Death|5|||
33550140|NCT02038946|62941501|FG000|Overall Study|Withdrawal by Subject|3|||
33550141|NCT02038946|62941501|FG000|Overall Study|Lost to Follow-up|2|||
33550142|NCT02038946|62941501|FG000|Overall Study|Other reasons|2|||
33550143|NCT03143829|62941507|FG000|Overall Study|Withdrawal by Subject|2|||
33550144|NCT03143829|62941508|FG001|Overall Study|Withdrawal by Subject|5|||
33550145|NCT03143829|62941507|FG000|Overall Study|Lost to Follow-up|0|||
33550146|NCT03143829|62941508|FG001|Overall Study|Lost to Follow-up|2|||
33550147|NCT03143829|62941507|FG000|Overall Study|Death|1|||
33550148|NCT03143829|62941508|FG001|Overall Study|Death|1|||
33550149|NCT03143829|62941507|FG000|Overall Study|changed treatment, no longer eligible|2|||
33550150|NCT03143829|62941508|FG001|Overall Study|changed treatment, no longer eligible|2|||
33550151|NCT02853331|62941516|FG000|Overall Study|Death|59|||
33550152|NCT02853331|62941517|FG001|Overall Study|Death|95|||
33550153|NCT02853331|62941516|FG000|Overall Study|Withdrawal by Subject|5|||
33550154|NCT02853331|62941517|FG001|Overall Study|Withdrawal by Subject|9|||
33550155|NCT02853331|62941516|FG000|Overall Study|Ongoing in study|368|||
33550156|NCT02853331|62941517|FG001|Overall Study|Ongoing in study|325|||
33550157|NCT05896761|62941525|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
33550158|NCT05896761|62941526|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
33550159|NCT05896761|62941525|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
33550160|NCT05896761|62941526|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
33550161|NCT05048784|62941551|FG000|Period 1|Adverse Event|3|||
33477408|NCT00090363|62853167|FG002|Overall Study|Withdrawal by Subject|6|||
33477409|NCT00090363|62853165|FG000|Overall Study|Study-specific discontinuation criteria|75|||
33477410|NCT00090363|62853166|FG001|Overall Study|Study-specific discontinuation criteria|74|||
33477411|NCT00090363|62853167|FG002|Overall Study|Study-specific discontinuation criteria|62|||
33477412|NCT00090363|62853165|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33477413|NCT00090363|62853166|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33550162|NCT05048784|62941552|FG001|Period 1|Adverse Event|1|||
33477414|NCT00090363|62853167|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
33477415|NCT00090363|62853165|FG000|Overall Study|Consent expired|7|||
33550163|NCT05048784|62941553|FG002|Period 1|Adverse Event|0|||
33550164|NCT05048784|62941554|FG003|Period 1|Adverse Event|0|||
33550165|NCT05048784|62941551|FG000|Period 2|Lost to Follow-up|0|||
33550166|NCT05048784|62941552|FG001|Period 2|Lost to Follow-up|1|||
33550167|NCT05048784|62941553|FG002|Period 2|Lost to Follow-up|0|||
33550168|NCT05048784|62941554|FG003|Period 2|Lost to Follow-up|0|||
33477416|NCT00090363|62853166|FG001|Overall Study|Consent expired|10|||
33477417|NCT00090363|62853167|FG002|Overall Study|Consent expired|9|||
33477418|NCT00090363|62853165|FG000|Overall Study|Reasons not specified|2|||
33477419|NCT00090363|62853166|FG001|Overall Study|Reasons not specified|1|||
33477420|NCT00090363|62853167|FG002|Overall Study|Reasons not specified|1|||
33550169|NCT04700280|62941583|FG000|Overall Study|Adverse Event|4|||
33477421|NCT00090363|62853165|FG000|Overall Study|Continuing on study off treatment|14|||
33477422|NCT00090363|62853166|FG001|Overall Study|Continuing on study off treatment|13|||
33477423|NCT00090363|62853167|FG002|Overall Study|Continuing on study off treatment|16|||
33477424|NCT03652610|62853177|FG000|Overall Study|Lost to Follow-up|1|||
33477425|NCT03652610|62853178|FG001|Overall Study|Lost to Follow-up|0|||
33477426|NCT03652610|62853177|FG000|Overall Study|Withdrawal by Subject|3|||
33477427|NCT03652610|62853178|FG001|Overall Study|Withdrawal by Subject|5|||
33477428|NCT03615404|62853184|FG000|Overall Study|Death|1|||
33477429|NCT03615404|62853184|FG000|Overall Study|vaccine did not pass quality assurance|1|||
33477430|NCT03614156|62853191|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
33477431|NCT03614156|62853192|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
33477432|NCT03614156|62853193|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
33477433|NCT03614156|62853194|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
33477434|NCT03614156|62853191|FG000|Open-Label Treatment Period|Adverse Event|7|||
33477435|NCT03614156|62853192|FG001|Open-Label Treatment Period|Adverse Event|0|||
33477436|NCT03614156|62853193|FG002|Open-Label Treatment Period|Adverse Event|0|||
33477437|NCT03614156|62853194|FG003|Open-Label Treatment Period|Adverse Event|0|||
33477438|NCT03614156|62853191|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
33477439|NCT03614156|62853192|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
33477440|NCT03614156|62853193|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
33477441|NCT03614156|62853194|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
33477442|NCT03614156|62853191|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
33477443|NCT03614156|62853192|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
33477444|NCT03614156|62853193|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
33477445|NCT03614156|62853194|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
33477446|NCT03614156|62853191|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
33477447|NCT03614156|62853192|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
33477448|NCT03614156|62853193|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
33477449|NCT03614156|62853194|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
33477450|NCT03614156|62853191|FG000|Open-Label Treatment Period|Protocol Violation|2|||
33477451|NCT03614156|62853192|FG001|Open-Label Treatment Period|Protocol Violation|0|||
33477452|NCT03614156|62853193|FG002|Open-Label Treatment Period|Protocol Violation|0|||
33477453|NCT03614156|62853194|FG003|Open-Label Treatment Period|Protocol Violation|0|||
33477454|NCT03614156|62853191|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
33477455|NCT03614156|62853192|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
33477456|NCT03614156|62853193|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
33477457|NCT03614156|62853194|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
33477458|NCT03614156|62853191|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
33477459|NCT03614156|62853192|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
33477460|NCT03614156|62853193|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
33477461|NCT03614156|62853194|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
33477462|NCT03614156|62853191|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
33477463|NCT03614156|62853192|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
33477464|NCT03614156|62853193|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
33477465|NCT03614156|62853194|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
33477466|NCT03614156|62853191|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
33477467|NCT03614156|62853192|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
33477468|NCT03614156|62853193|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
33477469|NCT03614156|62853194|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
33477470|NCT03614156|62853191|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33477471|NCT03614156|62853192|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33477472|NCT03614156|62853193|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
33477473|NCT03614156|62853194|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
33477474|NCT03614156|62853191|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
33364556|NCT02393248|62743313|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364557|NCT02393248|62743314|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
33364558|NCT02393248|62743315|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
33364559|NCT02393248|62743316|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
33364560|NCT02393248|62743317|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
33364561|NCT02393248|62743318|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364562|NCT02393248|62743319|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364563|NCT02393248|62743320|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364564|NCT02393248|62743321|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364565|NCT02393248|62743322|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33477475|NCT03614156|62853192|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
33477476|NCT03614156|62853193|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
33477477|NCT03614156|62853194|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
33477478|NCT03614156|62853191|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
33477479|NCT03614156|62853192|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
33477480|NCT03614156|62853193|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
33477481|NCT03614156|62853194|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
33477482|NCT03614156|62853191|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
33477483|NCT03614156|62853192|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
33477484|NCT03614156|62853193|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
33477485|NCT03614156|62853194|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
33477486|NCT03614156|62853191|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
33477487|NCT03614156|62853192|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
33477488|NCT03614156|62853193|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
33477489|NCT03614156|62853194|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
33477490|NCT03614156|62853191|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
33477491|NCT03614156|62853192|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
33477492|NCT03614156|62853193|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
33477493|NCT03614156|62853194|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
33477494|NCT03614156|62853191|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
33477495|NCT03614156|62853192|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
33477496|NCT03614156|62853193|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
33477497|NCT03614156|62853194|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
33477498|NCT03614078|62853206|FG000|Overall Study|Withdrawal by Subject|2|||
33477499|NCT03614078|62853207|FG001|Overall Study|Withdrawal by Subject|2|||
33477500|NCT03614078|62853208|FG002|Overall Study|Withdrawal by Subject|3|||
33477501|NCT03614078|62853206|FG000|Overall Study|Participant Did Not Return for Visit|0|||
33477502|NCT03614078|62853207|FG001|Overall Study|Participant Did Not Return for Visit|1|||
33477503|NCT03614078|62853208|FG002|Overall Study|Participant Did Not Return for Visit|0|||
33477504|NCT03614078|62853206|FG000|Overall Study|High Neutrophils|0|||
33477505|NCT03614078|62853207|FG001|Overall Study|High Neutrophils|0|||
33477506|NCT03614078|62853208|FG002|Overall Study|High Neutrophils|2|||
33477507|NCT03614078|62853206|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
33477508|NCT03614078|62853207|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
33477509|NCT03614078|62853208|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
33477510|NCT03614078|62853206|FG000|Overall Study|Exacerbation of Psoriasis|0|||
33477511|NCT03614078|62853207|FG001|Overall Study|Exacerbation of Psoriasis|1|||
33477512|NCT03614078|62853208|FG002|Overall Study|Exacerbation of Psoriasis|0|||
33477513|NCT03614078|62853206|FG000|Overall Study|Adverse Event|0|||
33477514|NCT03614078|62853207|FG001|Overall Study|Adverse Event|2|||
33477515|NCT03614078|62853208|FG002|Overall Study|Adverse Event|0|||
33477516|NCT03614078|62853206|FG000|Overall Study|Dizziness and Rash|0|||
33477517|NCT03614078|62853207|FG001|Overall Study|Dizziness and Rash|1|||
33477518|NCT03614078|62853208|FG002|Overall Study|Dizziness and Rash|0|||
33477519|NCT03613454|62853218|FG000|Overall Study|Protocol Violation|1|||
33477520|NCT03613454|62853219|FG001|Overall Study|Protocol Violation|0|||
33477521|NCT03613454|62853218|FG000|Overall Study|Protocol Violation|0|||
33477522|NCT03613454|62853219|FG001|Overall Study|Protocol Violation|1|||
33477523|NCT03581786|62853227|FG000|Overall Study|Death|17|||
33477524|NCT03581786|62853228|FG001|Overall Study|Death|12|||
33477525|NCT03581786|62853227|FG000|Overall Study|Withdrawal by Subject|2|||
33477526|NCT03581786|62853228|FG001|Overall Study|Withdrawal by Subject|4|||
33477527|NCT03581786|62853227|FG000|Overall Study|Lost to Follow-up|1|||
33477528|NCT03581786|62853228|FG001|Overall Study|Lost to Follow-up|0|||
33477529|NCT03581786|62853227|FG000|Overall Study|reason other than specified above|0|||
33477530|NCT03581786|62853228|FG001|Overall Study|reason other than specified above|1|||
33477531|NCT03581786|62853227|FG000|Overall Study|Ongoing in the study|123|||
33477532|NCT03581786|62853228|FG001|Overall Study|Ongoing in the study|129|||
33477533|NCT03580382|62853236|FG000|Overall Study|Early Termination of Study|0|||
33477534|NCT03580382|62853237|FG001|Overall Study|Early Termination of Study|3|||
33477535|NCT03579290|62853242|FG000|Overall Study|Lost to Follow-up|9|||
33477536|NCT03611582|62853248|FG000|Overall Study|Adverse Event|26|||
33477537|NCT03611582|62853249|FG001|Overall Study|Adverse Event|6|||
33477538|NCT03611582|62853248|FG000|Overall Study|Protocol Violation|0|||
33550170|NCT04700280|62941584|FG001|Overall Study|Adverse Event|0|||
33550171|NCT04700280|62941583|FG000|Overall Study|Lack of Efficacy|1|||
33655986|NCT00630825|63073447|FG000|Overall Study|Entry Criteria Not Met|1|||
33655987|NCT00630825|63073448|FG001|Overall Study|Entry Criteria Not Met|0|||
33655988|NCT00630825|63073449|FG002|Overall Study|Entry Criteria Not Met|2|||
33477539|NCT03611582|62853249|FG001|Overall Study|Protocol Violation|1|||
33477540|NCT03611582|62853248|FG000|Overall Study|Pregnancy|1|||
33477541|NCT03611582|62853249|FG001|Overall Study|Pregnancy|2|||
33477542|NCT03611582|62853248|FG000|Overall Study|Lack of Efficacy|0|||
33477543|NCT03611582|62853249|FG001|Overall Study|Lack of Efficacy|1|||
33477544|NCT03611582|62853248|FG000|Overall Study|At the discretion of the investigator|1|||
33477545|NCT03611582|62853249|FG001|Overall Study|At the discretion of the investigator|0|||
33477546|NCT03611582|62853248|FG000|Overall Study|Safety concern as judged by the investigator|1|||
33550172|NCT04700280|62941584|FG001|Overall Study|Lack of Efficacy|0|||
33655989|NCT00630825|63073450|FG003|Overall Study|Entry Criteria Not Met|1|||
33477547|NCT03611582|62853249|FG001|Overall Study|Safety concern as judged by the investigator|2|||
33477548|NCT03611582|62853248|FG000|Overall Study|Withdrawal by Subject|4|||
33477549|NCT03611582|62853249|FG001|Overall Study|Withdrawal by Subject|3|||
33477550|NCT03611582|62853248|FG000|Overall Study|Lost to Follow-up|18|||
33477551|NCT03611582|62853249|FG001|Overall Study|Lost to Follow-up|7|||
33477552|NCT03611582|62853248|FG000|Overall Study|other|17|||
33477553|NCT03611582|62853249|FG001|Overall Study|other|16|||
33477554|NCT04015518|62853260|FG000|Overall Study|Adverse Event|6|||
33477555|NCT04015518|62853261|FG001|Overall Study|Adverse Event|1|||
33477556|NCT04015518|62853262|FG002|Overall Study|Adverse Event|1|||
33477557|NCT04015518|62853263|FG003|Overall Study|Adverse Event|3|||
33477558|NCT04015518|62853264|FG004|Overall Study|Adverse Event|3|||
33477559|NCT04015518|62853260|FG000|Overall Study|Lack of Efficacy|1|||
33477560|NCT04015518|62853261|FG001|Overall Study|Lack of Efficacy|0|||
33477561|NCT04015518|62853262|FG002|Overall Study|Lack of Efficacy|1|||
33477562|NCT04015518|62853263|FG003|Overall Study|Lack of Efficacy|0|||
33477563|NCT04015518|62853264|FG004|Overall Study|Lack of Efficacy|4|||
33477564|NCT04015518|62853260|FG000|Overall Study|Lost to Follow-up|0|||
33364566|NCT02393248|62743323|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364567|NCT02393248|62743324|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364568|NCT02393248|62743325|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33477565|NCT04015518|62853261|FG001|Overall Study|Lost to Follow-up|0|||
33477566|NCT04015518|62853262|FG002|Overall Study|Lost to Follow-up|0|||
33477567|NCT04015518|62853263|FG003|Overall Study|Lost to Follow-up|0|||
33477568|NCT04015518|62853264|FG004|Overall Study|Lost to Follow-up|1|||
33477569|NCT04015518|62853260|FG000|Overall Study|Withdrawal by Subject|0|||
33477570|NCT04015518|62853261|FG001|Overall Study|Withdrawal by Subject|1|||
33477571|NCT04015518|62853262|FG002|Overall Study|Withdrawal by Subject|0|||
33477572|NCT04015518|62853263|FG003|Overall Study|Withdrawal by Subject|1|||
33477573|NCT04015518|62853264|FG004|Overall Study|Withdrawal by Subject|1|||
33477574|NCT04015518|62853260|FG000|Overall Study|Patient did not come for consecutive visits|0|||
33477575|NCT04015518|62853261|FG001|Overall Study|Patient did not come for consecutive visits|1|||
33477576|NCT04015518|62853262|FG002|Overall Study|Patient did not come for consecutive visits|0|||
33477577|NCT04015518|62853263|FG003|Overall Study|Patient did not come for consecutive visits|0|||
33477578|NCT04015518|62853264|FG004|Overall Study|Patient did not come for consecutive visits|0|||
33477579|NCT04015518|62853260|FG000|Overall Study|not willing to travel due to Covid-19|0|||
33477580|NCT04015518|62853261|FG001|Overall Study|not willing to travel due to Covid-19|0|||
33477581|NCT04015518|62853262|FG002|Overall Study|not willing to travel due to Covid-19|1|||
33477582|NCT04015518|62853263|FG003|Overall Study|not willing to travel due to Covid-19|0|||
33477583|NCT04015518|62853264|FG004|Overall Study|not willing to travel due to Covid-19|0|||
33550173|NCT04700280|62941583|FG000|Overall Study|Study terminated by sponsor|5|||
33550174|NCT04700280|62941584|FG001|Overall Study|Study terminated by sponsor|3|||
33550175|NCT04700280|62941583|FG000|Overall Study|Other than specified|1|||
33550176|NCT04700280|62941584|FG001|Overall Study|Other than specified|0|||
33550177|NCT04679675|62941594|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
33550178|NCT04679675|62941595|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
33550179|NCT04679675|62941596|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
33550180|NCT04679675|62941597|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
33550181|NCT04679675|62941594|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
33550182|NCT04679675|62941595|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
33550183|NCT04679675|62941596|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
33550184|NCT04679675|62941597|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
33550185|NCT04626128|62941611|FG000|Overall Study|Withdrawal by Subject|0|||
33550186|NCT04626128|62941612|FG001|Overall Study|Withdrawal by Subject|1|||
33550187|NCT04626128|62941613|FG002|Overall Study|Withdrawal by Subject|0|||
33550188|NCT04626128|62941614|FG003|Overall Study|Withdrawal by Subject|0|||
33550189|NCT04581824|62941626|FG000|Overall Study|Ongoing|75|||
33550190|NCT04581824|62941627|FG001|Overall Study|Ongoing|69|||
33550191|NCT04581824|62941626|FG000|Overall Study|Withdrawal by Subject|3|||
33550192|NCT04581824|62941627|FG001|Overall Study|Withdrawal by Subject|5|||
33477584|NCT04015518|62853260|FG000|Overall Study|Patient wants to discontinue treatment|0|||
33550193|NCT04581824|62941626|FG000|Overall Study|Lost to Follow-up|1|||
33477585|NCT04015518|62853261|FG001|Overall Study|Patient wants to discontinue treatment|0|||
33477586|NCT04015518|62853262|FG002|Overall Study|Patient wants to discontinue treatment|0|||
33477587|NCT04015518|62853263|FG003|Overall Study|Patient wants to discontinue treatment|1|||
33477588|NCT04015518|62853264|FG004|Overall Study|Patient wants to discontinue treatment|0|||
33477589|NCT04015518|62853260|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
33477590|NCT04015518|62853261|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
33477591|NCT04015518|62853262|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
33477592|NCT04015518|62853263|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
33477593|NCT04015518|62853264|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
33477594|NCT04015518|62853260|FG000|Overall Study|Pregnancy|0|||
33477595|NCT04015518|62853261|FG001|Overall Study|Pregnancy|0|||
33477596|NCT04015518|62853262|FG002|Overall Study|Pregnancy|0|||
33477597|NCT04015518|62853263|FG003|Overall Study|Pregnancy|0|||
33477598|NCT04015518|62853264|FG004|Overall Study|Pregnancy|1|||
33477599|NCT04015518|62853260|FG000|Overall Study|Personal reasons|1|||
33477600|NCT04015518|62853261|FG001|Overall Study|Personal reasons|0|||
33477601|NCT04015518|62853262|FG002|Overall Study|Personal reasons|0|||
33477602|NCT04015518|62853263|FG003|Overall Study|Personal reasons|0|||
33477603|NCT04015518|62853264|FG004|Overall Study|Personal reasons|1|||
33477604|NCT04015518|62853260|FG000|Overall Study|Withdrew consent|1|||
33477605|NCT04015518|62853261|FG001|Overall Study|Withdrew consent|0|||
33477606|NCT04015518|62853262|FG002|Overall Study|Withdrew consent|0|||
33477607|NCT04015518|62853263|FG003|Overall Study|Withdrew consent|0|||
33477608|NCT04015518|62853264|FG004|Overall Study|Withdrew consent|0|||
33477609|NCT04015518|62853260|FG000|Overall Study|Prostate carcinoma|1|||
33477610|NCT04015518|62853261|FG001|Overall Study|Prostate carcinoma|0|||
33477611|NCT04015518|62853262|FG002|Overall Study|Prostate carcinoma|0|||
33477612|NCT04015518|62853263|FG003|Overall Study|Prostate carcinoma|0|||
33477613|NCT04015518|62853264|FG004|Overall Study|Prostate carcinoma|0|||
33477614|NCT04015518|62853260|FG000|Overall Study|Could not keep appointments due to work|1|||
33477615|NCT04015518|62853261|FG001|Overall Study|Could not keep appointments due to work|0|||
33477616|NCT04015518|62853262|FG002|Overall Study|Could not keep appointments due to work|0|||
33477617|NCT04015518|62853263|FG003|Overall Study|Could not keep appointments due to work|0|||
33477618|NCT04015518|62853264|FG004|Overall Study|Could not keep appointments due to work|0|||
33477619|NCT03577730|62853281|FG000|Overall Study|Physician Decision|3|||
33477620|NCT03577730|62853282|FG001|Overall Study|Physician Decision|1|||
33477621|NCT03577730|62853281|FG000|Overall Study|Did not receive allocated intervention|1|||
33477622|NCT03577730|62853282|FG001|Overall Study|Did not receive allocated intervention|0|||
33477623|NCT03608774|62853290|FG000|Overall Study|Lost to Follow-up|5|||
33477624|NCT03608774|62853291|FG001|Overall Study|Lost to Follow-up|5|||
33477625|NCT03608774|62853290|FG000|Overall Study|Withdrawal by Subject|1|||
33477626|NCT03608774|62853291|FG001|Overall Study|Withdrawal by Subject|0|||
33477627|NCT03608774|62853290|FG000|Overall Study|Protocol Violation|1|||
33477628|NCT03608774|62853291|FG001|Overall Study|Protocol Violation|0|||
33477629|NCT03608774|62853290|FG000|Overall Study|Not eligible at enrollment|0|||
33477630|NCT03608774|62853291|FG001|Overall Study|Not eligible at enrollment|1|||
33477631|NCT03608774|62853290|FG000|Overall Study|Health related event|0|||
33477632|NCT03608774|62853291|FG001|Overall Study|Health related event|1|||
33477633|NCT04021524|62853299|FG000|Overall Study|Change in surgical intervention|0|||
33477634|NCT04021524|62853300|FG001|Overall Study|Change in surgical intervention|1|||
33477635|NCT03607682|62853306|FG000|Overall Study|Withdrawal by Subject|1|||
33477636|NCT03607682|62853306|FG000|Overall Study|Disease progression|1|||
33477637|NCT03606668|62853310|FG000|Overall Study|Screen Failure|1|||
33477638|NCT03606668|62853310|FG000|Overall Study|Lost to Follow-up|1|||
33477639|NCT03601052|62853314|FG000|Overall Study|Lost to Follow-up|2|||
33477640|NCT03600740|62853323|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
33477641|NCT03600428|62853329|FG000|Overall Study|Not eligible|0|||
33477642|NCT03600428|62853330|FG001|Overall Study|Not eligible|1|||
33477643|NCT03600428|62853329|FG000|Overall Study|Lost to Follow-up|5|||
33477644|NCT03600428|62853330|FG001|Overall Study|Lost to Follow-up|4|||
33477645|NCT03575702|62853338|FG000|Overall Study|Withdrawal by Subject|1|||
33477646|NCT03575702|62853339|FG001|Overall Study|Withdrawal by Subject|1|||
33477647|NCT03575702|62853338|FG000|Overall Study|Lost to Follow-up|1|||
33550194|NCT04581824|62941627|FG001|Overall Study|Lost to Follow-up|0|||
33550195|NCT04523571|62941639|FG000|Received 2 Doses|Withdrawal by Subject|0|||
33550196|NCT04523571|62941640|FG001|Received 2 Doses|Withdrawal by Subject|0|||
33550197|NCT04523571|62941641|FG002|Received 2 Doses|Withdrawal by Subject|0|||
33550198|NCT04523571|62941642|FG003|Received 2 Doses|Withdrawal by Subject|1|||
33550199|NCT04523571|62941643|FG004|Received 2 Doses|Withdrawal by Subject|1|||
33477648|NCT03575702|62853339|FG001|Overall Study|Lost to Follow-up|2|||
33477649|NCT03575702|62853338|FG000|Overall Study|Protocol Violation|0|||
33477650|NCT03575702|62853339|FG001|Overall Study|Protocol Violation|1|||
33477651|NCT03575702|62853338|FG000|Overall Study|Patient non compliance|4|||
33477652|NCT03575702|62853339|FG001|Overall Study|Patient non compliance|0|||
33477653|NCT03575468|62853347|FG000|Overall Study|Withdrawal by Subject|3|||
33477654|NCT03575468|62853348|FG001|Overall Study|Withdrawal by Subject|0|||
33477655|NCT03575468|62853347|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
33477656|NCT03575468|62853348|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
33477657|NCT03575468|62853347|FG000|Overall Study|Lost to Follow-up|13|||
33477658|NCT03575468|62853348|FG001|Overall Study|Lost to Follow-up|17|||
33477659|NCT03573908|62853356|FG000|Treatment Period|Adverse Event|4|||
33477660|NCT03573908|62853357|FG001|Treatment Period|Adverse Event|9|||
33477661|NCT03573908|62853358|FG002|Treatment Period|Adverse Event|0|||
33477662|NCT03573908|62853359|FG003|Treatment Period|Adverse Event|0|||
33477663|NCT03573908|62853360|FG004|Treatment Period|Adverse Event|0|||
33477664|NCT03573908|62853356|FG000|Treatment Period|Protocol Violation|1|||
33477665|NCT03573908|62853357|FG001|Treatment Period|Protocol Violation|0|||
33477666|NCT03573908|62853358|FG002|Treatment Period|Protocol Violation|0|||
33477667|NCT03573908|62853359|FG003|Treatment Period|Protocol Violation|0|||
33477668|NCT03573908|62853360|FG004|Treatment Period|Protocol Violation|0|||
33477669|NCT03573908|62853356|FG000|Treatment Period|Withdrawal by Subject|7|||
33477670|NCT03573908|62853357|FG001|Treatment Period|Withdrawal by Subject|5|||
33477671|NCT03573908|62853358|FG002|Treatment Period|Withdrawal by Subject|0|||
33477672|NCT03573908|62853359|FG003|Treatment Period|Withdrawal by Subject|0|||
33477673|NCT03573908|62853360|FG004|Treatment Period|Withdrawal by Subject|0|||
33477674|NCT03573908|62853356|FG000|Treatment Period|Lost to Follow-up|7|||
33477675|NCT03573908|62853357|FG001|Treatment Period|Lost to Follow-up|6|||
33477676|NCT03573908|62853358|FG002|Treatment Period|Lost to Follow-up|0|||
33477677|NCT03573908|62853359|FG003|Treatment Period|Lost to Follow-up|0|||
33477678|NCT03573908|62853360|FG004|Treatment Period|Lost to Follow-up|0|||
33477679|NCT03573908|62853356|FG000|Treatment Period|Pregnancy|1|||
33477680|NCT03573908|62853357|FG001|Treatment Period|Pregnancy|0|||
33477681|NCT03573908|62853358|FG002|Treatment Period|Pregnancy|0|||
33477682|NCT03573908|62853359|FG003|Treatment Period|Pregnancy|0|||
33477683|NCT03573908|62853360|FG004|Treatment Period|Pregnancy|0|||
33477684|NCT03573908|62853356|FG000|Treatment Period|Other, Not Specified|4|||
33477685|NCT03573908|62853357|FG001|Treatment Period|Other, Not Specified|6|||
33477686|NCT03573908|62853358|FG002|Treatment Period|Other, Not Specified|0|||
33477687|NCT03573908|62853359|FG003|Treatment Period|Other, Not Specified|0|||
33477688|NCT03573908|62853360|FG004|Treatment Period|Other, Not Specified|0|||
33477689|NCT03573908|62853356|FG000|Randomized Withdrawal Period|Adverse Event|0|||
33477690|NCT03573908|62853357|FG001|Randomized Withdrawal Period|Adverse Event|0|||
33477691|NCT03573908|62853358|FG002|Randomized Withdrawal Period|Adverse Event|3|||
33477692|NCT03573908|62853359|FG003|Randomized Withdrawal Period|Adverse Event|0|||
33477693|NCT03573908|62853360|FG004|Randomized Withdrawal Period|Adverse Event|0|||
33477694|NCT03573908|62853356|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33477695|NCT03573908|62853357|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33477696|NCT03573908|62853358|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33477697|NCT03573908|62853359|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33477698|NCT03573908|62853360|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
33477699|NCT03573908|62853356|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
33477700|NCT03573908|62853357|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
33477701|NCT03573908|62853358|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
33477702|NCT03573908|62853359|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
33477703|NCT03573908|62853360|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
33477704|NCT03573908|62853356|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
33477705|NCT03573908|62853357|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
33477706|NCT03573908|62853358|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
33477707|NCT03573908|62853359|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
33477708|NCT03573908|62853360|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
33477709|NCT03573830|62853371|FG000|Overall Study|Dropped without completing treatment|0|||
33477710|NCT03573830|62853372|FG001|Overall Study|Dropped without completing treatment|7|||
33477711|NCT03573830|62853371|FG000|Overall Study|Lost to Follow-up|4|||
33477712|NCT03573830|62853372|FG001|Overall Study|Lost to Follow-up|0|||
33477713|NCT03595904|62853379|FG000|Overall Study|Protocol Violation|3|||
33477714|NCT03595904|62853380|FG001|Overall Study|Protocol Violation|1|||
33477715|NCT03595904|62853379|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
33477716|NCT03595904|62853380|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
33477717|NCT03595904|62853379|FG000|Overall Study|Insurance complications|1|||
33477718|NCT03595904|62853380|FG001|Overall Study|Insurance complications|0|||
33477719|NCT03595904|62853379|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
33477720|NCT03595904|62853380|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
33477721|NCT03595280|62853389|FG000|Overall Study|Lost to Follow-up|6|||
33477722|NCT03595280|62853390|FG001|Overall Study|Lost to Follow-up|9|||
33477723|NCT03595280|62853391|FG002|Overall Study|Lost to Follow-up|15|||
33477724|NCT03593876|62853399|FG000|Overall Study|Withdrawal by Subject|1|||
33477725|NCT03593876|62853399|FG000|Overall Study|Discharged home before intervention completion|2|||
33477726|NCT00071487|62853407|FG000|52-Week Double-Blind Period|Adverse Event|5|||
33477727|NCT00071487|62853408|FG001|52-Week Double-Blind Period|Adverse Event|8|||
33477728|NCT00071487|62853409|FG002|52-Week Double-Blind Period|Adverse Event|4|||
33477729|NCT00071487|62853410|FG003|52-Week Double-Blind Period|Adverse Event|8|||
33477730|NCT00071487|62853407|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
33655990|NCT00630825|63073447|FG000|Overall Study|Lost to Follow-up|1|||
33477731|NCT00071487|62853408|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
33477732|NCT00071487|62853409|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
33477733|NCT00071487|62853410|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
33477734|NCT00071487|62853407|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
33477735|NCT00071487|62853408|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
33477736|NCT00071487|62853409|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
33477737|NCT00071487|62853410|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
33477738|NCT00071487|62853407|FG000|52-Week Double-Blind Period|Physician Decision|1|||
33477739|NCT00071487|62853408|FG001|52-Week Double-Blind Period|Physician Decision|0|||
33477740|NCT00071487|62853409|FG002|52-Week Double-Blind Period|Physician Decision|0|||
33477741|NCT00071487|62853410|FG003|52-Week Double-Blind Period|Physician Decision|0|||
33477742|NCT00071487|62853407|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
33477743|NCT00071487|62853408|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
33477744|NCT00071487|62853409|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
33477745|NCT00071487|62853410|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
33477746|NCT00071487|62853407|FG000|52-Week Double-Blind Period|Pregnancy|0|||
33477747|NCT00071487|62853408|FG001|52-Week Double-Blind Period|Pregnancy|1|||
33477748|NCT00071487|62853409|FG002|52-Week Double-Blind Period|Pregnancy|0|||
33477749|NCT00071487|62853410|FG003|52-Week Double-Blind Period|Pregnancy|0|||
33477750|NCT00071487|62853407|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
33477751|NCT00071487|62853408|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
33477752|NCT00071487|62853409|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
33477753|NCT00071487|62853410|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
33477754|NCT00071487|62853407|FG000|52-Week Double-Blind Period|Death|0|||
33477755|NCT00071487|62853408|FG001|52-Week Double-Blind Period|Death|1|||
33477756|NCT00071487|62853409|FG002|52-Week Double-Blind Period|Death|0|||
33477757|NCT00071487|62853410|FG003|52-Week Double-Blind Period|Death|0|||
33477758|NCT00071487|62853407|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
33477759|NCT00071487|62853408|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
33477760|NCT00071487|62853409|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
33477761|NCT00071487|62853410|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
33477762|NCT00071487|62853407|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
33477763|NCT00071487|62853408|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
33477764|NCT00071487|62853409|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
33477765|NCT00071487|62853410|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
33477766|NCT00071487|62853407|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
33477767|NCT00071487|62853408|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
33477768|NCT00071487|62853409|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
33477769|NCT00071487|62853410|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
33477770|NCT00071487|62853407|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
33477771|NCT00071487|62853408|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
33477772|NCT00071487|62853409|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
33477773|NCT00071487|62853410|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
33477774|NCT00071487|62853407|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
33477775|NCT00071487|62853408|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
33477776|NCT00071487|62853409|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
33477777|NCT00071487|62853410|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
33477778|NCT00071487|62853407|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
33477779|NCT00071487|62853408|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
33477780|NCT00071487|62853409|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
33477781|NCT00071487|62853410|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
33477782|NCT00071487|62853407|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
33477783|NCT00071487|62853408|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
33477784|NCT00071487|62853409|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
33477785|NCT00071487|62853410|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
33477786|NCT03591146|62853427|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
33477787|NCT03591146|62853428|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
33477788|NCT03591146|62853429|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
33477789|NCT03591146|62853430|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
33477790|NCT03591146|62853431|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
33477791|NCT03591146|62853427|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
33477792|NCT03591146|62853428|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
33477793|NCT03591146|62853429|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
33477794|NCT03591146|62853430|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
33477795|NCT03591146|62853431|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
33477796|NCT03591146|62853427|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
33655991|NCT00630825|63073448|FG001|Overall Study|Lost to Follow-up|1|||
33364569|NCT02393248|62743326|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33364570|NCT02393248|62743327|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33477797|NCT03591146|62853428|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
33477798|NCT03591146|62853429|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
33477799|NCT03591146|62853430|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
33477800|NCT03591146|62853431|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
33477801|NCT03591146|62853427|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
33477802|NCT03591146|62853428|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
33477803|NCT03591146|62853429|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
33477804|NCT03591146|62853430|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
33477805|NCT03591146|62853431|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
33477806|NCT00096447|62853443|FG000|Overall Study|Never treated|1|||
33477807|NCT03590366|62853454|FG000|Overall Study|Adverse Event|0|||
33477808|NCT03590366|62853455|FG001|Overall Study|Adverse Event|3|||
33477809|NCT03590366|62853454|FG000|Overall Study|Lost to Follow-up|3|||
33477810|NCT03590366|62853455|FG001|Overall Study|Lost to Follow-up|3|||
33550200|NCT04523571|62941644|FG005|Received 2 Doses|Withdrawal by Subject|0|||
33550201|NCT04523571|62941639|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
33550202|NCT04523571|62941640|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
33550203|NCT04523571|62941641|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
33550204|NCT04523571|62941642|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
33550205|NCT04523571|62941643|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
33550206|NCT04523571|62941644|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
33550207|NCT04523571|62941639|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
33550208|NCT04523571|62941640|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
33550209|NCT04523571|62941641|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
33550210|NCT04523571|62941642|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
33550211|NCT04523571|62941643|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
33550212|NCT04523571|62941644|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
33550213|NCT04523571|62941639|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
33550214|NCT04523571|62941640|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
33550215|NCT04523571|62941641|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
33550216|NCT04523571|62941642|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
33550217|NCT04523571|62941643|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
33550218|NCT04523571|62941644|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
33550219|NCT04361617|62941660|FG000|Overall Study|Withdrawal by Subject|0|||
33550220|NCT04361617|62941661|FG001|Overall Study|Withdrawal by Subject|1|||
33550221|NCT04021914|62941667|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
33550222|NCT03850444|62941693|FG000|Overall Study|Adverse Event|16|||
33550223|NCT03850444|62941694|FG001|Overall Study|Adverse Event|10|||
33550224|NCT03850444|62941693|FG000|Overall Study|Death|87|||
33550225|NCT03850444|62941694|FG001|Overall Study|Death|107|||
33550226|NCT03850444|62941693|FG000|Overall Study|Lost to Follow-up|1|||
33550227|NCT03850444|62941694|FG001|Overall Study|Lost to Follow-up|1|||
33550228|NCT03850444|62941693|FG000|Overall Study|Withdrawal by Subject|1|||
33550229|NCT03850444|62941694|FG001|Overall Study|Withdrawal by Subject|5|||
33550230|NCT03850444|62941693|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
33550231|NCT03850444|62941694|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
33550232|NCT03781804|62941704|FG000|Overall Study|Adverse Event|2|||
33550233|NCT03781804|62941705|FG001|Overall Study|Adverse Event|2|||
33550234|NCT03781804|62941706|FG002|Overall Study|Adverse Event|3|||
33550235|NCT03781804|62941704|FG000|Overall Study|Lost to Follow-up|1|||
33550236|NCT03781804|62941705|FG001|Overall Study|Lost to Follow-up|1|||
33550237|NCT03781804|62941706|FG002|Overall Study|Lost to Follow-up|2|||
33550238|NCT03781804|62941704|FG000|Overall Study|Lack of Efficacy|4|||
33550239|NCT03781804|62941705|FG001|Overall Study|Lack of Efficacy|2|||
33550240|NCT03781804|62941706|FG002|Overall Study|Lack of Efficacy|9|||
33550241|NCT03781804|62941704|FG000|Overall Study|Protocol Violation|0|||
33550242|NCT03781804|62941705|FG001|Overall Study|Protocol Violation|0|||
33550243|NCT03781804|62941706|FG002|Overall Study|Protocol Violation|1|||
33550244|NCT03781804|62941704|FG000|Overall Study|Withdrawal by Subject|0|||
33655992|NCT00630825|63073449|FG002|Overall Study|Lost to Follow-up|1|||
33655993|NCT00630825|63073450|FG003|Overall Study|Lost to Follow-up|1|||
33550245|NCT03781804|62941705|FG001|Overall Study|Withdrawal by Subject|1|||
33550246|NCT03781804|62941706|FG002|Overall Study|Withdrawal by Subject|1|||
33550247|NCT03781804|62941704|FG000|Overall Study|Reason not provided|2|||
33550248|NCT03781804|62941705|FG001|Overall Study|Reason not provided|2|||
33550249|NCT03781804|62941706|FG002|Overall Study|Reason not provided|0|||
33477811|NCT03590366|62853454|FG000|Overall Study|Withdrawal by Subject|0|||
33477812|NCT03590366|62853455|FG001|Overall Study|Withdrawal by Subject|2|||
33477813|NCT03588572|62853463|FG000|Visitation 1|Lack of Efficacy|1|||
33655994|NCT00630825|63073447|FG000|Overall Study|Physician Decision|1|||
33477814|NCT03588572|62853464|FG001|Visitation 1|Lack of Efficacy|1|||
33477815|NCT03588572|62853463|FG000|Visitation 2|Lost to Follow-up|1|||
33477816|NCT03588572|62853464|FG001|Visitation 2|Lost to Follow-up|1|||
33477817|NCT03588572|62853463|FG000|Visitation 2|Lack of Efficacy|0|||
33477818|NCT03588572|62853464|FG001|Visitation 2|Lack of Efficacy|1|||
33477819|NCT03588572|62853463|FG000|Visitation 2|Withdrawal by Subject|1|||
33477820|NCT03588572|62853464|FG001|Visitation 2|Withdrawal by Subject|0|||
33477821|NCT03588572|62853463|FG000|Visitation 3|Lost to Follow-up|1|||
33477822|NCT03588572|62853464|FG001|Visitation 3|Lost to Follow-up|1|||
33477823|NCT03588572|62853463|FG000|Visitation 3|Physician Decision|1|||
33477824|NCT03588572|62853464|FG001|Visitation 3|Physician Decision|1|||
33477825|NCT03588572|62853463|FG000|Visitation 3|Withdrawal by Subject|1|||
33477826|NCT03588572|62853464|FG001|Visitation 3|Withdrawal by Subject|0|||
33477827|NCT00090285|62853472|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
33477828|NCT00090285|62853473|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
33477829|NCT00090285|62853474|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
33550250|NCT03662659|62941725|FG000|Pre-treatment|Participant no longer met study criteria|1|||
33550251|NCT03662659|62941726|FG001|Pre-treatment|Participant no longer met study criteria|1|||
33550252|NCT03662659|62941725|FG000|Pre-treatment|Other reasons|1|||
33550253|NCT03662659|62941726|FG001|Pre-treatment|Other reasons|0|||
33550254|NCT03662659|62941725|FG000|Treatment|Completed Treatment|0|||
33550255|NCT03662659|62941726|FG001|Treatment|Completed Treatment|3|||
33550256|NCT03662659|62941725|FG000|Treatment|Disease Progression|69|||
33550257|NCT03662659|62941726|FG001|Treatment|Disease Progression|78|||
33550258|NCT03662659|62941725|FG000|Treatment|Study Drug Toxicity|18|||
33550259|NCT03662659|62941726|FG001|Treatment|Study Drug Toxicity|8|||
33550260|NCT03662659|62941725|FG000|Treatment|Death|12|||
33550261|NCT03662659|62941726|FG001|Treatment|Death|7|||
33550262|NCT03662659|62941725|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
33550263|NCT03662659|62941726|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
33550264|NCT03662659|62941725|FG000|Treatment|Withdrawal by Subject|1|||
33550265|NCT03662659|62941726|FG001|Treatment|Withdrawal by Subject|1|||
33550266|NCT03662659|62941725|FG000|Treatment|Poor/Non-compliance|1|||
33550267|NCT03662659|62941726|FG001|Treatment|Poor/Non-compliance|0|||
33550268|NCT03662659|62941725|FG000|Treatment|Participant no longer meets study criteria|1|||
33550269|NCT03662659|62941726|FG001|Treatment|Participant no longer meets study criteria|0|||
33550270|NCT03662659|62941725|FG000|Treatment|Other reasons|6|||
33550271|NCT03662659|62941726|FG001|Treatment|Other reasons|5|||
33550272|NCT03623386|62941735|FG000|Overall Study|Protocol Violation|3|||
33550273|NCT03623386|62941736|FG001|Overall Study|Protocol Violation|2|||
33550274|NCT03623386|62941737|FG002|Overall Study|Protocol Violation|0|||
33550275|NCT03623386|62941735|FG000|Overall Study|Physician Decision|1|||
33550276|NCT03623386|62941736|FG001|Overall Study|Physician Decision|1|||
33550277|NCT03623386|62941737|FG002|Overall Study|Physician Decision|0|||
33550278|NCT03623386|62941735|FG000|Overall Study|Lost to Follow-up|0|||
33550279|NCT03623386|62941736|FG001|Overall Study|Lost to Follow-up|2|||
33550280|NCT03623386|62941737|FG002|Overall Study|Lost to Follow-up|0|||
33550281|NCT03623386|62941735|FG000|Overall Study|COVID-19|0|||
33550282|NCT03623386|62941736|FG001|Overall Study|COVID-19|1|||
33550283|NCT03623386|62941737|FG002|Overall Study|COVID-19|0|||
33550284|NCT03507686|62941748|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
33550285|NCT03507686|62941749|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
33550286|NCT03507686|62941748|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
33550287|NCT03507686|62941749|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
33550288|NCT03507686|62941748|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
33550289|NCT03507686|62941749|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
33550290|NCT03507686|62941748|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
33550291|NCT03507686|62941749|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
33550292|NCT03507686|62941748|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
33550293|NCT03507686|62941749|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
33550294|NCT03507686|62941748|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
33550295|NCT03507686|62941749|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
33550296|NCT03471507|62941757|FG000|Overall Study|Lost to Follow-up|1|||
33550297|NCT03471507|62941758|FG001|Overall Study|Lost to Follow-up|3|||
33550298|NCT03471507|62941757|FG000|Overall Study|Physician Decision|0|||
33550299|NCT03471507|62941758|FG001|Overall Study|Physician Decision|1|||
33550300|NCT03471507|62941757|FG000|Overall Study|Withdrawal by Subject|2|||
33550301|NCT03471507|62941758|FG001|Overall Study|Withdrawal by Subject|1|||
33477830|NCT00090285|62853475|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
33477831|NCT00090285|62853476|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
33477832|NCT00090285|62853477|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
33550302|NCT03338894|62941764|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
33550303|NCT03215706|62941770|FG000|Randomization|Adverse Event unrelated to study drug|1|||
33550304|NCT03215706|62941771|FG001|Randomization|Adverse Event unrelated to study drug|0|||
33477833|NCT00090285|62853472|FG000|Base Study Vaccination Period|Adverse Event|2|||
33477834|NCT00090285|62853473|FG001|Base Study Vaccination Period|Adverse Event|4|||
33477835|NCT00090285|62853474|FG002|Base Study Vaccination Period|Adverse Event|0|||
33477836|NCT00090285|62853475|FG003|Base Study Vaccination Period|Adverse Event|0|||
33477837|NCT00090285|62853476|FG004|Base Study Vaccination Period|Adverse Event|0|||
33477838|NCT00090285|62853477|FG005|Base Study Vaccination Period|Adverse Event|0|||
33477839|NCT00090285|62853472|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
33477840|NCT00090285|62853473|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
33477841|NCT00090285|62853474|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
33477842|NCT00090285|62853475|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
33477843|NCT00090285|62853476|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
33477844|NCT00090285|62853477|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
33477845|NCT00090285|62853472|FG000|Base Study Vaccination Period|Protocol Violation|2|||
33477846|NCT00090285|62853473|FG001|Base Study Vaccination Period|Protocol Violation|3|||
33477847|NCT00090285|62853474|FG002|Base Study Vaccination Period|Protocol Violation|0|||
33477848|NCT00090285|62853475|FG003|Base Study Vaccination Period|Protocol Violation|0|||
33477849|NCT00090285|62853476|FG004|Base Study Vaccination Period|Protocol Violation|0|||
33477850|NCT00090285|62853477|FG005|Base Study Vaccination Period|Protocol Violation|0|||
33477851|NCT00090285|62853472|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
33477852|NCT00090285|62853473|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
33477853|NCT00090285|62853474|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
33477854|NCT00090285|62853475|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
33477855|NCT00090285|62853476|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
33477856|NCT00090285|62853477|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
33477857|NCT00090285|62853472|FG000|Base Study Vaccination Period|Uncooperative|2|||
33477858|NCT00090285|62853473|FG001|Base Study Vaccination Period|Uncooperative|2|||
33477859|NCT00090285|62853474|FG002|Base Study Vaccination Period|Uncooperative|0|||
33477860|NCT00090285|62853475|FG003|Base Study Vaccination Period|Uncooperative|0|||
33477861|NCT00090285|62853476|FG004|Base Study Vaccination Period|Uncooperative|0|||
33477862|NCT00090285|62853477|FG005|Base Study Vaccination Period|Uncooperative|0|||
33477863|NCT00090285|62853472|FG000|Base Study Vaccination Period|Moved|20|||
33477864|NCT00090285|62853473|FG001|Base Study Vaccination Period|Moved|21|||
33477865|NCT00090285|62853474|FG002|Base Study Vaccination Period|Moved|0|||
33477866|NCT00090285|62853475|FG003|Base Study Vaccination Period|Moved|0|||
33477867|NCT00090285|62853476|FG004|Base Study Vaccination Period|Moved|0|||
33477868|NCT00090285|62853477|FG005|Base Study Vaccination Period|Moved|0|||
33477869|NCT00090285|62853472|FG000|Base Study Vaccination Period|Site Terminated|1|||
33477870|NCT00090285|62853473|FG001|Base Study Vaccination Period|Site Terminated|0|||
33477871|NCT00090285|62853474|FG002|Base Study Vaccination Period|Site Terminated|0|||
33477872|NCT00090285|62853475|FG003|Base Study Vaccination Period|Site Terminated|0|||
33477873|NCT00090285|62853476|FG004|Base Study Vaccination Period|Site Terminated|0|||
33477874|NCT00090285|62853477|FG005|Base Study Vaccination Period|Site Terminated|0|||
33477875|NCT00090285|62853472|FG000|Base Study Vaccination Period|Other|2|||
33477876|NCT00090285|62853473|FG001|Base Study Vaccination Period|Other|2|||
33477877|NCT00090285|62853474|FG002|Base Study Vaccination Period|Other|0|||
33477878|NCT00090285|62853475|FG003|Base Study Vaccination Period|Other|0|||
33477879|NCT00090285|62853476|FG004|Base Study Vaccination Period|Other|0|||
33477880|NCT00090285|62853477|FG005|Base Study Vaccination Period|Other|0|||
33477881|NCT00090285|62853472|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
33477882|NCT00090285|62853473|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
33477883|NCT00090285|62853474|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
33477884|NCT00090285|62853475|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
33477885|NCT00090285|62853476|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
33477886|NCT00090285|62853477|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
33477887|NCT00090285|62853472|FG000|Base Study Vaccination Period|HIV positive|1|||
33477888|NCT00090285|62853473|FG001|Base Study Vaccination Period|HIV positive|1|||
33477889|NCT00090285|62853474|FG002|Base Study Vaccination Period|HIV positive|0|||
33477890|NCT00090285|62853475|FG003|Base Study Vaccination Period|HIV positive|0|||
33477891|NCT00090285|62853476|FG004|Base Study Vaccination Period|HIV positive|0|||
33477892|NCT00090285|62853477|FG005|Base Study Vaccination Period|HIV positive|0|||
33477893|NCT00090285|62853472|FG000|Base Study Follow-up Period|Adverse Event|3|||
33550305|NCT03215706|62941770|FG000|Randomization|participant withdrew consent|1|||
33550306|NCT03215706|62941771|FG001|Randomization|participant withdrew consent|3|||
33364571|NCT02393248|62743303|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364572|NCT02393248|62743304|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364573|NCT02393248|62743305|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33477894|NCT00090285|62853473|FG001|Base Study Follow-up Period|Adverse Event|10|||
33477895|NCT00090285|62853474|FG002|Base Study Follow-up Period|Adverse Event|0|||
33477896|NCT00090285|62853475|FG003|Base Study Follow-up Period|Adverse Event|0|||
33550307|NCT03215706|62941770|FG000|Randomization|no longer meets study criteria|1|||
33477897|NCT00090285|62853476|FG004|Base Study Follow-up Period|Adverse Event|0|||
33477898|NCT00090285|62853477|FG005|Base Study Follow-up Period|Adverse Event|0|||
33477899|NCT00090285|62853472|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
33477900|NCT00090285|62853473|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
33477901|NCT00090285|62853474|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
33477902|NCT00090285|62853475|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
33477903|NCT00090285|62853476|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
33477904|NCT00090285|62853477|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
33477905|NCT00090285|62853472|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
33477906|NCT00090285|62853473|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
33477907|NCT00090285|62853474|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
33477908|NCT00090285|62853475|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
33477909|NCT00090285|62853476|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
33477910|NCT00090285|62853477|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
33477911|NCT00090285|62853472|FG000|Base Study Follow-up Period|Moved|41|||
33477912|NCT00090285|62853473|FG001|Base Study Follow-up Period|Moved|36|||
33477913|NCT00090285|62853474|FG002|Base Study Follow-up Period|Moved|0|||
33477914|NCT00090285|62853475|FG003|Base Study Follow-up Period|Moved|0|||
33477915|NCT00090285|62853476|FG004|Base Study Follow-up Period|Moved|0|||
33477916|NCT00090285|62853477|FG005|Base Study Follow-up Period|Moved|0|||
33477917|NCT00090285|62853472|FG000|Base Study Follow-up Period|Other|2|||
33477918|NCT00090285|62853473|FG001|Base Study Follow-up Period|Other|0|||
33477919|NCT00090285|62853474|FG002|Base Study Follow-up Period|Other|0|||
33477920|NCT00090285|62853475|FG003|Base Study Follow-up Period|Other|0|||
33477921|NCT00090285|62853476|FG004|Base Study Follow-up Period|Other|0|||
33477922|NCT00090285|62853477|FG005|Base Study Follow-up Period|Other|0|||
33477923|NCT00090285|62853472|FG000|Base Study Follow-up Period|Protocol Violation|1|||
33477924|NCT00090285|62853473|FG001|Base Study Follow-up Period|Protocol Violation|0|||
33477925|NCT00090285|62853474|FG002|Base Study Follow-up Period|Protocol Violation|0|||
33477926|NCT00090285|62853475|FG003|Base Study Follow-up Period|Protocol Violation|0|||
33477927|NCT00090285|62853476|FG004|Base Study Follow-up Period|Protocol Violation|0|||
33477928|NCT00090285|62853477|FG005|Base Study Follow-up Period|Protocol Violation|0|||
33477929|NCT00090285|62853472|FG000|Base Study Follow-up Period|Uncooperative|3|||
33477930|NCT00090285|62853473|FG001|Base Study Follow-up Period|Uncooperative|4|||
33477931|NCT00090285|62853474|FG002|Base Study Follow-up Period|Uncooperative|0|||
33477932|NCT00090285|62853475|FG003|Base Study Follow-up Period|Uncooperative|0|||
33477933|NCT00090285|62853476|FG004|Base Study Follow-up Period|Uncooperative|0|||
33477934|NCT00090285|62853477|FG005|Base Study Follow-up Period|Uncooperative|0|||
33477935|NCT00090285|62853472|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
33477936|NCT00090285|62853473|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
33477937|NCT00090285|62853474|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
33477938|NCT00090285|62853475|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
33477939|NCT00090285|62853476|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
33477940|NCT00090285|62853477|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
33477941|NCT00090285|62853472|FG000|Extension 1|Adverse Event|0|||
33477942|NCT00090285|62853473|FG001|Extension 1|Adverse Event|0|||
33477943|NCT00090285|62853474|FG002|Extension 1|Adverse Event|2|||
33477944|NCT00090285|62853475|FG003|Extension 1|Adverse Event|0|||
33477945|NCT00090285|62853476|FG004|Extension 1|Adverse Event|0|||
33477946|NCT00090285|62853477|FG005|Extension 1|Adverse Event|0|||
33477947|NCT00090285|62853472|FG000|Extension 1|Lost to Follow-up|0|||
33477948|NCT00090285|62853473|FG001|Extension 1|Lost to Follow-up|0|||
33477949|NCT00090285|62853474|FG002|Extension 1|Lost to Follow-up|35|||
33477950|NCT00090285|62853475|FG003|Extension 1|Lost to Follow-up|0|||
33477951|NCT00090285|62853476|FG004|Extension 1|Lost to Follow-up|0|||
33477952|NCT00090285|62853477|FG005|Extension 1|Lost to Follow-up|0|||
33477953|NCT00090285|62853472|FG000|Extension 1|Withdrawal by Subject|0|||
33477954|NCT00090285|62853473|FG001|Extension 1|Withdrawal by Subject|0|||
33477955|NCT00090285|62853474|FG002|Extension 1|Withdrawal by Subject|13|||
33477956|NCT00090285|62853475|FG003|Extension 1|Withdrawal by Subject|1|||
33477957|NCT00090285|62853476|FG004|Extension 1|Withdrawal by Subject|0|||
33477958|NCT00090285|62853477|FG005|Extension 1|Withdrawal by Subject|0|||
33477959|NCT00090285|62853472|FG000|Extension 1|Other|0|||
33477960|NCT00090285|62853473|FG001|Extension 1|Other|0|||
33477961|NCT00090285|62853474|FG002|Extension 1|Other|4|||
33655995|NCT00630825|63073448|FG001|Overall Study|Physician Decision|0|||
33477962|NCT00090285|62853475|FG003|Extension 1|Other|0|||
33477963|NCT00090285|62853476|FG004|Extension 1|Other|0|||
33477964|NCT00090285|62853477|FG005|Extension 1|Other|0|||
33477965|NCT00090285|62853472|FG000|Extension 1|Moved|0|||
33477966|NCT00090285|62853473|FG001|Extension 1|Moved|0|||
33477967|NCT00090285|62853474|FG002|Extension 1|Moved|3|||
33477968|NCT00090285|62853475|FG003|Extension 1|Moved|0|||
33477969|NCT00090285|62853476|FG004|Extension 1|Moved|0|||
33477970|NCT00090285|62853477|FG005|Extension 1|Moved|0|||
33477971|NCT00090285|62853472|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
33477972|NCT00090285|62853473|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
33477973|NCT00090285|62853474|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
33477974|NCT00090285|62853475|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
33477975|NCT00090285|62853476|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
33477976|NCT00090285|62853477|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
33477977|NCT00090285|62853472|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33477978|NCT00090285|62853473|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33477979|NCT00090285|62853474|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33477980|NCT00090285|62853475|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33477981|NCT00090285|62853476|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
33477982|NCT00090285|62853477|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
33550308|NCT03215706|62941771|FG001|Randomization|no longer meets study criteria|4|||
33550309|NCT03215706|62941770|FG000|Randomization|other reasons|0|||
33550310|NCT03215706|62941771|FG001|Randomization|other reasons|2|||
33550311|NCT03215706|62941770|FG000|Treatment Period|Disease Progression|150|||
33550312|NCT03215706|62941771|FG001|Treatment Period|Disease Progression|142|||
33477983|NCT00090285|62853472|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33477984|NCT00090285|62853473|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33477985|NCT00090285|62853474|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33477986|NCT00090285|62853475|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33477987|NCT00090285|62853476|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
33477988|NCT00090285|62853477|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
33477989|NCT00090285|62853472|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
33477990|NCT00090285|62853473|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
33477991|NCT00090285|62853474|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
33477992|NCT00090285|62853475|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
33477993|NCT00090285|62853476|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
33477994|NCT00090285|62853477|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
33477995|NCT00070941|62853495|FG000|Overall Study|Adverse Event|10|||
33477996|NCT00070941|62853496|FG001|Overall Study|Adverse Event|8|||
33477997|NCT00070941|62853497|FG002|Overall Study|Adverse Event|4|||
33477998|NCT00070707|62853507|FG000|Overall Study|Adverse Event|1|||
33477999|NCT00070707|62853508|FG001|Overall Study|Adverse Event|2|||
33478000|NCT00070707|62853507|FG000|Overall Study|Lack of Efficacy|4|||
33478001|NCT00070707|62853508|FG001|Overall Study|Lack of Efficacy|1|||
33478002|NCT00070707|62853507|FG000|Overall Study|Protocol Violation|8|||
33478003|NCT00070707|62853508|FG001|Overall Study|Protocol Violation|4|||
33478004|NCT00070707|62853507|FG000|Overall Study|Unrelated to Study Medication|1|||
33478005|NCT00070707|62853508|FG001|Overall Study|Unrelated to Study Medication|0|||
33478006|NCT03036124|62853516|FG000|Overall Study|Lost to Follow-up|0|||
33478007|NCT03036124|62853517|FG001|Overall Study|Lost to Follow-up|2|||
33478008|NCT03036124|62853516|FG000|Overall Study|Withdrawal by Subject|5|||
33478009|NCT03036124|62853517|FG001|Overall Study|Withdrawal by Subject|4|||
33478010|NCT00070317|62853523|FG000|Overall Study|Inevaluable (Never Treated)|1|||
33478011|NCT00070317|62853523|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
33478012|NCT00070317|62853523|FG000|Overall Study|Ineligible required test not done|1|||
33478013|NCT00070317|62853523|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
33478014|NCT00070317|62853523|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
33478015|NCT03649412|62853529|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
33478016|NCT03649412|62853530|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
33478017|NCT03649412|62853529|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
33478018|NCT03649412|62853530|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
33478019|NCT03649412|62853529|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
33478020|NCT03649412|62853530|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33478021|NCT03649412|62853529|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
33550313|NCT03215706|62941770|FG000|Treatment Period|Study Drug Toxicity|53|||
33550314|NCT03215706|62941771|FG001|Treatment Period|Study Drug Toxicity|21|||
33550315|NCT03215706|62941770|FG000|Treatment Period|Death|2|||
33478022|NCT03649412|62853530|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
33478023|NCT03649412|62853529|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
33478024|NCT03649412|62853530|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
33478025|NCT03649412|62853529|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
33478026|NCT03649412|62853530|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
33478027|NCT03587636|62853575|FG000|Overall Study|Lost to Follow-up|2|||
33478028|NCT03587636|62853576|FG001|Overall Study|Lost to Follow-up|5|||
33478029|NCT03586544|62853594|FG000|First Intervention|Adverse Event|0|||
33478030|NCT03586544|62853595|FG001|First Intervention|Adverse Event|1|||
33478031|NCT03586544|62853594|FG000|Second Intervention|Withdrawal by Subject|0|||
33478032|NCT03586544|62853595|FG001|Second Intervention|Withdrawal by Subject|1|||
33478033|NCT03585296|62853601|FG000|Overall Study|Adverse Event|1|||
33478034|NCT03585296|62853601|FG000|Overall Study|Lost to Follow-up|2|||
33478035|NCT03585296|62853601|FG000|Overall Study|Withdrawal by Subject|2|||
33478036|NCT03589768|62853609|FG000|Overall Study|Death|1|||
33478037|NCT03589768|62853610|FG001|Overall Study|Death|0|||
33478038|NCT03589768|62853611|FG002|Overall Study|Death|8|||
33478039|NCT03589768|62853612|FG003|Overall Study|Death|3|||
33478040|NCT03589768|62853609|FG000|Overall Study|Withdrawal by Subject|2|||
33478041|NCT03589768|62853610|FG001|Overall Study|Withdrawal by Subject|0|||
33478042|NCT03589768|62853611|FG002|Overall Study|Withdrawal by Subject|0|||
33478043|NCT03589768|62853612|FG003|Overall Study|Withdrawal by Subject|0|||
33478044|NCT03589768|62853609|FG000|Overall Study|Protocol Violation|1|||
33478045|NCT03589768|62853610|FG001|Overall Study|Protocol Violation|0|||
33478046|NCT03589768|62853611|FG002|Overall Study|Protocol Violation|0|||
33478047|NCT03589768|62853612|FG003|Overall Study|Protocol Violation|0|||
33478048|NCT02892422|62853622|FG000|Overall Study|Enrolled not treated|4|||
33478049|NCT02892422|62853622|FG000|Overall Study|Adverse Event|38|||
33478050|NCT02892422|62853622|FG000|Overall Study|Lack of Efficacy|32|||
33478051|NCT02892422|62853622|FG000|Overall Study|Non-compliance with study drug|11|||
33478052|NCT02892422|62853622|FG000|Overall Study|Protocol Violation|4|||
33478053|NCT02892422|62853622|FG000|Overall Study|Withdrawal by Subject|56|||
33478054|NCT02892422|62853622|FG000|Overall Study|Lost to Follow-up|5|||
33478055|NCT02892422|62853622|FG000|Overall Study|sponsor information 16159A results|21|||
33478056|NCT02892422|62853622|FG000|Overall Study|withdrawal of consent|13|||
33478057|NCT02892422|62853622|FG000|Overall Study|exclusion criteria met|3|||
33478058|NCT02892422|62853622|FG000|Overall Study|moving elsewhere|4|||
33478059|NCT02892422|62853622|FG000|Overall Study|non-compliance|10|||
33478060|NCT02892422|62853622|FG000|Overall Study|patient legally incapable|1|||
33478061|NCT02892422|62853622|FG000|Overall Study|patient decision|7|||
33478062|NCT02892422|62853622|FG000|Overall Study|Investigator decision|1|||
33478063|NCT03571646|62853628|FG000|Overall Study|Adverse Event|1|||
33478064|NCT03571646|62853629|FG001|Overall Study|Adverse Event|0|||
33478065|NCT03571646|62853628|FG000|Overall Study|Withdrawal by Subject|1|||
33478066|NCT03571646|62853629|FG001|Overall Study|Withdrawal by Subject|1|||
33478067|NCT03645434|62853635|FG000|Period 1|Adverse Event|0|||
33478068|NCT03645434|62853636|FG001|Period 1|Adverse Event|0|||
33478069|NCT03645434|62853637|FG002|Period 1|Adverse Event|0|||
33478070|NCT03645434|62853638|FG003|Period 1|Adverse Event|1|||
33478071|NCT03645434|62853639|FG004|Period 1|Adverse Event|0|||
33550316|NCT03215706|62941771|FG001|Treatment Period|Death|1|||
33550317|NCT03215706|62941770|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
33550318|NCT03215706|62941771|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
33550319|NCT03215706|62941770|FG000|Treatment Period|Request to D/C treatment|1|||
33550320|NCT03215706|62941771|FG001|Treatment Period|Request to D/C treatment|6|||
33550321|NCT03215706|62941770|FG000|Treatment Period|Participant withdrew consent|3|||
33550322|NCT03215706|62941771|FG001|Treatment Period|Participant withdrew consent|4|||
33550323|NCT03215706|62941770|FG000|Treatment Period|Lost to Follow-up|0|||
33550324|NCT03215706|62941771|FG001|Treatment Period|Lost to Follow-up|1|||
33550325|NCT03215706|62941770|FG000|Treatment Period|Other Reasons|4|||
33478072|NCT03645434|62853640|FG005|Period 1|Adverse Event|0|||
33478073|NCT03645434|62853635|FG000|Period 1|COPD exacerbation|0|||
33478074|NCT03645434|62853636|FG001|Period 1|COPD exacerbation|0|||
33478075|NCT03645434|62853637|FG002|Period 1|COPD exacerbation|0|||
33478076|NCT03645434|62853638|FG003|Period 1|COPD exacerbation|0|||
33478077|NCT03645434|62853639|FG004|Period 1|COPD exacerbation|1|||
33478078|NCT03645434|62853640|FG005|Period 1|COPD exacerbation|0|||
33478079|NCT00089505|62853652|FG000|Overall Study|Death|4|||
33478080|NCT00089505|62853653|FG001|Overall Study|Death|1|||
33478081|NCT00089505|62853654|FG002|Overall Study|Death|5|||
33478082|NCT00089505|62853655|FG003|Overall Study|Death|8|||
33478083|NCT00089505|62853652|FG000|Overall Study|Withdrawal by Subject|3|||
33478084|NCT00089505|62853653|FG001|Overall Study|Withdrawal by Subject|0|||
33478085|NCT00089505|62853654|FG002|Overall Study|Withdrawal by Subject|6|||
33478086|NCT00089505|62853655|FG003|Overall Study|Withdrawal by Subject|6|||
33478087|NCT00089505|62853652|FG000|Overall Study|Lost to Follow-up|1|||
33478088|NCT00089505|62853653|FG001|Overall Study|Lost to Follow-up|1|||
33478089|NCT00089505|62853654|FG002|Overall Study|Lost to Follow-up|9|||
33478090|NCT00089505|62853655|FG003|Overall Study|Lost to Follow-up|7|||
33478091|NCT00089505|62853652|FG000|Overall Study|Physician Decision|1|||
33478092|NCT00089505|62853653|FG001|Overall Study|Physician Decision|0|||
33478093|NCT00089505|62853654|FG002|Overall Study|Physician Decision|0|||
33550326|NCT03215706|62941771|FG001|Treatment Period|Other Reasons|5|||
33364574|NCT02393248|62743306|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364575|NCT02393248|62743307|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364576|NCT02393248|62743308|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364577|NCT02393248|62743309|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478094|NCT00089505|62853655|FG003|Overall Study|Physician Decision|0|||
33550327|NCT03215706|62941770|FG000|Treatment Period|Ongoing in the treatment period|105|||
33550328|NCT03215706|62941771|FG001|Treatment Period|Ongoing in the treatment period|43|||
33550329|NCT03138564|62941781|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
33550330|NCT03138564|62941782|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
33550331|NCT03138564|62941781|FG000|Overall Study|Lost to Follow-up|16|||
33550332|NCT03138564|62941782|FG001|Overall Study|Lost to Follow-up|2|||
33550333|NCT03138564|62941781|FG000|Overall Study|Withdrawal by Subject|48|||
33550334|NCT03138564|62941782|FG001|Overall Study|Withdrawal by Subject|4|||
33550335|NCT03138564|62941781|FG000|Overall Study|No longer met eligibility criteria|2|||
33550336|NCT03138564|62941782|FG001|Overall Study|No longer met eligibility criteria|0|||
33550337|NCT03138564|62941781|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
33550338|NCT03138564|62941782|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
33550339|NCT03138564|62941781|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
33550340|NCT03138564|62941782|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
33550341|NCT03138564|62941781|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
33550342|NCT03138564|62941782|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
33655996|NCT00630825|63073449|FG002|Overall Study|Physician Decision|0|||
33655997|NCT00630825|63073450|FG003|Overall Study|Physician Decision|0|||
33655998|NCT00630825|63073447|FG000|Overall Study|Withdrawal by Subject|2|||
33655999|NCT00630825|63073448|FG001|Overall Study|Withdrawal by Subject|2|||
33656000|NCT00630825|63073449|FG002|Overall Study|Withdrawal by Subject|2|||
33656001|NCT00630825|63073450|FG003|Overall Study|Withdrawal by Subject|3|||
33656002|NCT04075734|63073747|FG000|Overall Study|Lost to Follow-up|1|||
33656003|NCT04075734|63073748|FG001|Overall Study|Lost to Follow-up|1|||
33656004|NCT04075734|63073749|FG002|Overall Study|Lost to Follow-up|0|||
33656005|NCT04075734|63073747|FG000|Overall Study|Withdrawal by Subject|3|||
33656006|NCT04075734|63073748|FG001|Overall Study|Withdrawal by Subject|0|||
33656007|NCT04075734|63073749|FG002|Overall Study|Withdrawal by Subject|0|||
33656008|NCT00989781|63073794|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
33656009|NCT00989781|63073795|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
33656010|NCT00989235|63073836|FG000|Overall Study|Death|0|||
33656011|NCT00989235|63073837|FG001|Overall Study|Death|1|||
33656012|NCT00989235|63073836|FG000|Overall Study|Adverse Event|0|||
33656013|NCT00989235|63073837|FG001|Overall Study|Adverse Event|1|||
33656014|NCT00989235|63073836|FG000|Overall Study|Lack of Efficacy|1|||
33656015|NCT00989235|63073837|FG001|Overall Study|Lack of Efficacy|0|||
33656016|NCT00989235|63073836|FG000|Overall Study|Withdrawal of Consent|1|||
33656017|NCT00989235|63073837|FG001|Overall Study|Withdrawal of Consent|1|||
33478095|NCT00089505|62853652|FG000|Overall Study|Protocol Violation|0|||
33478096|NCT00089505|62853653|FG001|Overall Study|Protocol Violation|0|||
33478097|NCT00089505|62853654|FG002|Overall Study|Protocol Violation|1|||
33478098|NCT00089505|62853655|FG003|Overall Study|Protocol Violation|0|||
33478099|NCT04009824|62853670|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
33478100|NCT04009824|62853671|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
33478101|NCT04009824|62853672|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
33478102|NCT04009824|62853673|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
33550343|NCT03138564|62941781|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
33550344|NCT03138564|62941782|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
33478103|NCT04009824|62853674|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
33550345|NCT02923180|62941805|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
33550346|NCT02923180|62941805|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
33656018|NCT00989235|63073836|FG000|Overall Study|Desire to Become Pregnant|1|||
33656019|NCT00989235|63073837|FG001|Overall Study|Desire to Become Pregnant|0|||
33656020|NCT00989235|63073836|FG000|Overall Study|Randomized by Mistake|0|||
33656021|NCT00989235|63073837|FG001|Overall Study|Randomized by Mistake|2|||
33656022|NCT00989235|63073836|FG000|Overall Study|Lost to Follow-up|0|||
33656023|NCT00989235|63073837|FG001|Overall Study|Lost to Follow-up|1|||
33656024|NCT00988533|63073877|FG000|Overall Study|Lost to Follow-up|3|||
33478104|NCT03555890|62853690|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33478105|NCT03555890|62853691|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33550347|NCT02900976|62941811|FG000|Overall Study|Adverse Event|0|||
33550348|NCT02900976|62941812|FG001|Overall Study|Adverse Event|1|||
33550349|NCT02900976|62941811|FG000|Overall Study|Physician Decision|0|||
33550350|NCT02900976|62941812|FG001|Overall Study|Physician Decision|2|||
33550351|NCT02900976|62941811|FG000|Overall Study|Progressive disease|0|||
33550352|NCT02900976|62941812|FG001|Overall Study|Progressive disease|6|||
33550353|NCT02836717|62941822|FG000|Test Phase|Lack of Efficacy|14|||
33550354|NCT02836717|62941823|FG001|Test Phase|Lack of Efficacy|8|||
33550355|NCT02836717|62941824|FG002|Test Phase|Lack of Efficacy|0|||
33550356|NCT02836717|62941822|FG000|Study Phase|Adverse Event|2|||
33550357|NCT02836717|62941823|FG001|Study Phase|Adverse Event|0|||
33550358|NCT02836717|62941824|FG002|Study Phase|Adverse Event|0|||
33550359|NCT02836717|62941822|FG000|Study Phase|Lack of Efficacy|8|||
33550360|NCT02836717|62941823|FG001|Study Phase|Lack of Efficacy|6|||
33550361|NCT02836717|62941824|FG002|Study Phase|Lack of Efficacy|1|||
33478106|NCT03555890|62853692|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33364578|NCT02393248|62743310|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364579|NCT02393248|62743311|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364580|NCT02393248|62743312|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364581|NCT02393248|62743313|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
33478107|NCT03555890|62853693|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
33478108|NCT03688074|62853705|FG000|Overall Study|Adverse Event|0|||
33478109|NCT03688074|62853706|FG001|Overall Study|Adverse Event|1|||
33478110|NCT03688074|62853705|FG000|Overall Study|Other|1|||
33478111|NCT03688074|62853706|FG001|Overall Study|Other|0|||
33478112|NCT03630120|62853716|FG000|Overall Study|Disease progression|0|||
33478113|NCT03630120|62853717|FG001|Overall Study|Disease progression|1|||
33478114|NCT03630120|62853718|FG002|Overall Study|Disease progression|1|||
33478115|NCT03630120|62853719|FG003|Overall Study|Disease progression|1|||
33478116|NCT03555266|62853731|FG000|Overall Study|Protocol Violation|6|||
33478117|NCT03555266|62853732|FG001|Overall Study|Protocol Violation|4|||
33478118|NCT03629886|62853740|FG000|Overall Study|Migrated / moved from the study area|0|||
33478119|NCT03629886|62853741|FG001|Overall Study|Migrated / moved from the study area|55|||
33478120|NCT03629886|62853740|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
33478121|NCT03629886|62853741|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
33478122|NCT03629886|62853740|FG000|Overall Study|Study vaccine not administrated|0|||
33478123|NCT03629886|62853741|FG001|Overall Study|Study vaccine not administrated|3|||
33478124|NCT03629886|62853740|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
33478125|NCT03629886|62853741|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
33478126|NCT03629886|62853740|FG000|Overall Study|Refused vaccination step of the study|0|||
33478127|NCT03629886|62853741|FG001|Overall Study|Refused vaccination step of the study|44|||
33478128|NCT03656874|62853750|FG000|Overall Study|Lost to Follow-up|3|||
33478129|NCT03656874|62853751|FG001|Overall Study|Lost to Follow-up|17|||
33478130|NCT03554486|62853759|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
33478131|NCT03554486|62853760|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
33478132|NCT03554486|62853761|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
33478133|NCT03554486|62853759|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
33478134|NCT03554486|62853760|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
33478135|NCT03554486|62853761|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
33478136|NCT03554486|62853759|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
33478137|NCT03554486|62853760|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
33478138|NCT03554486|62853761|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
33478139|NCT03554018|62853770|FG000|Overall Study|Lost to Follow-up|3|||
33478140|NCT03554018|62853771|FG001|Overall Study|Lost to Follow-up|7|||
33478141|NCT03571256|62853780|FG000|Overall Study|Adverse Event|3|||
33478142|NCT03571256|62853781|FG001|Overall Study|Adverse Event|0|||
33478143|NCT03571256|62853782|FG002|Overall Study|Adverse Event|1|||
33550362|NCT02836717|62941822|FG000|Study Phase|Withdrawal by Subject|1|||
33550363|NCT02836717|62941823|FG001|Study Phase|Withdrawal by Subject|0|||
33478144|NCT03571256|62853780|FG000|Overall Study|Withdrawal by Subject|3|||
33478145|NCT03571256|62853781|FG001|Overall Study|Withdrawal by Subject|1|||
33478146|NCT03571256|62853782|FG002|Overall Study|Withdrawal by Subject|1|||
33478147|NCT03571256|62853780|FG000|Overall Study|Other than specified|0|||
33550364|NCT02836717|62941824|FG002|Study Phase|Withdrawal by Subject|0|||
33550365|NCT02836717|62941822|FG000|Study Phase|Death|1|||
33550366|NCT02836717|62941823|FG001|Study Phase|Death|0|||
33478148|NCT03571256|62853781|FG001|Overall Study|Other than specified|1|||
33478149|NCT03571256|62853782|FG002|Overall Study|Other than specified|1|||
33478150|NCT03571256|62853780|FG000|Overall Study|Protocol Violation|0|||
33478151|NCT03571256|62853781|FG001|Overall Study|Protocol Violation|1|||
33478152|NCT03571256|62853782|FG002|Overall Study|Protocol Violation|1|||
33478153|NCT03570554|62853796|FG000|Overall Study|Non-compliance with study drug|0|||
33478154|NCT03570554|62853797|FG001|Overall Study|Non-compliance with study drug|0|||
33550367|NCT02836717|62941824|FG002|Study Phase|Death|0|||
33550368|NCT02836717|62941822|FG000|Study Phase|abdominal surgeries|2|||
33478155|NCT03570554|62853798|FG002|Overall Study|Non-compliance with study drug|1|||
33478156|NCT03570554|62853799|FG003|Overall Study|Non-compliance with study drug|0|||
33478157|NCT03570554|62853796|FG000|Overall Study|Adverse Event|0|||
33478158|NCT03570554|62853797|FG001|Overall Study|Adverse Event|0|||
33478159|NCT03570554|62853798|FG002|Overall Study|Adverse Event|0|||
33478160|NCT03570554|62853799|FG003|Overall Study|Adverse Event|1|||
33478161|NCT04004208|62853811|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33478162|NCT04004208|62853812|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33478163|NCT04004208|62853811|FG000|Overall Study|Death|3|||
33478164|NCT04004208|62853812|FG001|Overall Study|Death|0|||
33478165|NCT04004208|62853811|FG000|Overall Study|COVID-19 pandemic|1|||
33550369|NCT02836717|62941823|FG001|Study Phase|abdominal surgeries|1|||
33550370|NCT02836717|62941824|FG002|Study Phase|abdominal surgeries|0|||
33550371|NCT02743494|62941835|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
33550372|NCT02743494|62941836|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
33550373|NCT02743494|62941835|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
33550374|NCT02743494|62941836|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
33550375|NCT02743494|62941835|FG000|Treatment Period|Completed treatment|229|||
33550376|NCT02743494|62941836|FG001|Treatment Period|Completed treatment|99|||
33550377|NCT02743494|62941835|FG000|Treatment Period|Disease recurrence|149|||
33550378|NCT02743494|62941836|FG001|Treatment Period|Disease recurrence|113|||
33550379|NCT02743494|62941835|FG000|Treatment Period|Study drug toxicity|57|||
33550380|NCT02743494|62941836|FG001|Treatment Period|Study drug toxicity|8|||
33550381|NCT02743494|62941835|FG000|Treatment Period|Death|1|||
33550382|NCT02743494|62941836|FG001|Treatment Period|Death|0|||
33550383|NCT02743494|62941835|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
33550384|NCT02743494|62941836|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
33550385|NCT02743494|62941835|FG000|Treatment Period|Participant request to discontinue treatment|30|||
33550386|NCT02743494|62941836|FG001|Treatment Period|Participant request to discontinue treatment|5|||
33550387|NCT02743494|62941835|FG000|Treatment Period|Participant withdrew consent|12|||
33550388|NCT02743494|62941836|FG001|Treatment Period|Participant withdrew consent|4|||
33550389|NCT02743494|62941835|FG000|Treatment Period|Lost to Follow-up|0|||
33550390|NCT02743494|62941836|FG001|Treatment Period|Lost to Follow-up|1|||
33550391|NCT02743494|62941835|FG000|Treatment Period|Poor/Non-compliance|1|||
33550392|NCT02743494|62941836|FG001|Treatment Period|Poor/Non-compliance|0|||
33550393|NCT02743494|62941835|FG000|Treatment Period|Other reasons|7|||
33550394|NCT02743494|62941836|FG001|Treatment Period|Other reasons|2|||
33550395|NCT02336282|62941842|FG000|Overall Study|Unrelated illness|1|||
33550396|NCT02336282|62941842|FG000|Overall Study|Uncomfortable with technology|1|||
33550397|NCT02336282|62941842|FG000|Overall Study|Lost to Follow-up|1|||
33550398|NCT02336282|62941842|FG000|Overall Study|Not enough time to complete sessions|2|||
33550399|NCT02272842|62941869|FG000|Overall Study|Lost to Follow-up|8|||
33550400|NCT02272842|62941870|FG001|Overall Study|Lost to Follow-up|8|||
33550401|NCT02272842|62941869|FG000|Overall Study|Withdrawal by Subject|8|||
33550402|NCT02272842|62941870|FG001|Overall Study|Withdrawal by Subject|2|||
33550403|NCT02258659|62941877|FG000|Overall Study|Withdrawal by Subject|1|||
33550404|NCT01990300|62941890|FG000|Overall Study|Case Report Forms Uncollected|89|||
33550405|NCT01990300|62941890|FG000|Overall Study|Protocol Deviation|53|||
33550406|NCT01909934|62941894|FG000|Overall Study|Ongoing|23|||
33550407|NCT01909934|62941894|FG000|Overall Study|Withdrawal by Subject|3|||
33550408|NCT01909934|62941894|FG000|Overall Study|Lost to Follow-up|1|||
33550409|NCT01909934|62941894|FG000|Overall Study|Withdrawal of Informed Consent|1|||
33550410|NCT01909934|62941894|FG000|Overall Study|Death|22|||
33550411|NCT01076400|62941923|FG000|Overall Study|Adverse Event|2|||
33550412|NCT01076400|62941924|FG001|Overall Study|Adverse Event|0|||
33550413|NCT01076400|62941925|FG002|Overall Study|Adverse Event|0|||
33550414|NCT01076400|62941923|FG000|Overall Study|Progressive Disease|5|||
33550415|NCT01076400|62941924|FG001|Overall Study|Progressive Disease|0|||
33550416|NCT01076400|62941925|FG002|Overall Study|Progressive Disease|0|||
33550417|NCT01000051|62941931|FG000|Overall Study|Withdrawal by Subject|1|||
33550418|NCT01000051|62941932|FG001|Overall Study|Withdrawal by Subject|1|||
33550419|NCT01000051|62941931|FG000|Overall Study|Disease Progression|1|||
33550420|NCT01000051|62941932|FG001|Overall Study|Disease Progression|0|||
33550421|NCT01000051|62941931|FG000|Overall Study|Serious noncompliance|1|||
33550422|NCT01000051|62941932|FG001|Overall Study|Serious noncompliance|0|||
33550423|NCT00953160|62941938|FG000|Overall Study|Lost to Follow-up|23|||
33550424|NCT00953160|62941938|FG000|Overall Study|Withdrawal by Subject|4|||
33550425|NCT00913497|62941965|FG000|Overall Study|Adverse Event|1|||
33550426|NCT00913497|62941965|FG000|Overall Study|Withdrawal by Subject|2|||
33550427|NCT00874822|62941971|FG000|Overall Study|excluded by criteria|8|||
33550428|NCT00736450|62941975|FG000|Overall Study|Not ABC gene eligible|19|||
33550429|NCT00736450|62941975|FG000|Overall Study|Withdrawal by Subject|5|||
33550430|NCT00736450|62941975|FG000|Overall Study|Physician Decision|1|||
33550431|NCT00556933|62941992|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
33478166|NCT04004208|62853812|FG001|Overall Study|COVID-19 pandemic|0|||
33478167|NCT04004208|62853811|FG000|Overall Study|Physician Decision|1|||
33478168|NCT04004208|62853812|FG001|Overall Study|Physician Decision|0|||
33478169|NCT04004208|62853811|FG000|Overall Study|Adverse Event|1|||
33478170|NCT04004208|62853812|FG001|Overall Study|Adverse Event|1|||
33478171|NCT03643952|62853818|FG000|Overall Study|Lack of Efficacy|1|||
33478172|NCT03035032|62853830|FG000|Overall Study|Adverse Event|2|||
33478173|NCT03035032|62853830|FG000|Overall Study|Death|9|||
33478174|NCT03035032|62853830|FG000|Overall Study|Lost to Follow-up|1|||
33478175|NCT03035032|62853830|FG000|Overall Study|Progressive Disease|22|||
33478176|NCT03035032|62853830|FG000|Overall Study|Protocol Violation|2|||
33478177|NCT03035032|62853830|FG000|Overall Study|Withdrawal by Subject|2|||
33478178|NCT03035032|62853830|FG000|Overall Study|Physician Decision|5|||
33478179|NCT03629184|62853836|FG000|Overall Study|Withdrawal by Subject|2|||
33478180|NCT03629184|62853837|FG001|Overall Study|Withdrawal by Subject|1|||
33550432|NCT00556933|62941993|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
33550433|NCT00556933|62941994|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
33550434|NCT00556933|62941995|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
33550435|NCT00556933|62941992|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
33550436|NCT00556933|62941993|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
33550437|NCT00556933|62941994|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
33550438|NCT00556933|62941995|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
33550439|NCT00556933|62941992|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
33478181|NCT03629184|62853836|FG000|Overall Study|Physician Decision|1|||
33478182|NCT03629184|62853837|FG001|Overall Study|Physician Decision|0|||
33478183|NCT03549338|62853855|FG000|Overall Study|Progressive Disease|1|||
33478184|NCT03549338|62853856|FG001|Overall Study|Progressive Disease|0|||
33478185|NCT03549338|62853857|FG002|Overall Study|Progressive Disease|0|||
33478186|NCT03549338|62853855|FG000|Overall Study|Clinical Progression|0|||
33478187|NCT03549338|62853856|FG001|Overall Study|Clinical Progression|1|||
33478188|NCT03549338|62853857|FG002|Overall Study|Clinical Progression|0|||
33478189|NCT03629028|62853865|FG000|Overall Study|Lost to Follow-up|26|||
33478190|NCT03629028|62853866|FG001|Overall Study|Lost to Follow-up|23|||
33478191|NCT03629028|62853865|FG000|Overall Study|Pregnancy|4|||
33550440|NCT00556933|62941993|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
33550441|NCT00556933|62941994|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
33478192|NCT03629028|62853866|FG001|Overall Study|Pregnancy|2|||
33478193|NCT03629028|62853865|FG000|Overall Study|intolerance to examination|2|||
33478194|NCT03629028|62853866|FG001|Overall Study|intolerance to examination|0|||
33478195|NCT03549104|62853884|FG000|Overall Study|Physician Decision|2|||
33478196|NCT03549104|62853885|FG001|Overall Study|Physician Decision|0|||
33478197|NCT03549104|62853884|FG000|Overall Study|Withdrawal by Subject|5|||
33478198|NCT03549104|62853885|FG001|Overall Study|Withdrawal by Subject|2|||
33478199|NCT03549104|62853884|FG000|Overall Study|Covid shelter in place|1|||
33478200|NCT03549104|62853885|FG001|Overall Study|Covid shelter in place|2|||
33478201|NCT02892344|62853893|FG000|Overall Study|Protocol deviation|3|||
33478202|NCT02892344|62853894|FG001|Overall Study|Protocol deviation|4|||
33478203|NCT02892344|62853893|FG000|Overall Study|Adverse Event|1|||
33550442|NCT00556933|62941995|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
33550443|NCT00556933|62941992|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
33550444|NCT00556933|62941993|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
33550445|NCT00556933|62941994|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
33550446|NCT00556933|62941995|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
33550447|NCT00556933|62941992|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
33656025|NCT03633396|63073909|FG000|Overall Study|Withdrawal by Subject|4|||
33656026|NCT03633396|63073910|FG001|Overall Study|Withdrawal by Subject|4|||
33364582|NCT02393248|62743314|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
33364583|NCT02393248|62743315|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364584|NCT02393248|62743316|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364585|NCT02393248|62743317|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364586|NCT02393248|62743318|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478204|NCT02892344|62853894|FG001|Overall Study|Adverse Event|8|||
33478205|NCT02892344|62853893|FG000|Overall Study|Lost to Follow-up|0|||
33478206|NCT02892344|62853894|FG001|Overall Study|Lost to Follow-up|1|||
33478207|NCT02892344|62853893|FG000|Overall Study|Non-compliance with study treatment|0|||
33478208|NCT02892344|62853894|FG001|Overall Study|Non-compliance with study treatment|1|||
33364587|NCT02393248|62743319|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478209|NCT02892344|62853893|FG000|Overall Study|Physician Decision|0|||
33478210|NCT02892344|62853894|FG001|Overall Study|Physician Decision|2|||
33478211|NCT02892344|62853893|FG000|Overall Study|Subject/guardian decision|0|||
33478212|NCT02892344|62853894|FG001|Overall Study|Subject/guardian decision|4|||
33478213|NCT02892344|62853893|FG000|Overall Study|Technical problems|0|||
33478214|NCT02892344|62853894|FG001|Overall Study|Technical problems|1|||
33478215|NCT03567980|62853900|FG000|Overall Study|Adverse Event|1|||
33364588|NCT02393248|62743320|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364589|NCT02393248|62743321|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364590|NCT02393248|62743322|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364591|NCT02393248|62743323|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364592|NCT02393248|62743324|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364593|NCT02393248|62743325|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364594|NCT02393248|62743326|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364595|NCT02393248|62743327|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33364596|NCT02393248|62743303|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
33478216|NCT02894840|62853908|FG000|Overall Study|Lost to Follow-up|1|||
33478217|NCT02894840|62853909|FG001|Overall Study|Lost to Follow-up|0|||
33478218|NCT02894840|62853910|FG002|Overall Study|Lost to Follow-up|3|||
33478219|NCT02894840|62853911|FG003|Overall Study|Lost to Follow-up|0|||
33478220|NCT03358030|62853930|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
33550448|NCT00556933|62941993|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
33550449|NCT00556933|62941994|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
33550450|NCT00556933|62941995|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
33550451|NCT00556933|62941992|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
33550452|NCT00556933|62941993|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
33550453|NCT00556933|62941994|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
33550454|NCT00556933|62941995|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
33550455|NCT00556933|62941992|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
33550456|NCT00556933|62941993|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
33550457|NCT00556933|62941994|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
33550458|NCT00556933|62941995|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
33550459|NCT00556933|62941992|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
33550460|NCT00556933|62941993|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
33550461|NCT00556933|62941994|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
33550462|NCT00556933|62941995|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
33550463|NCT00556933|62941992|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
33550464|NCT00556933|62941993|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
33550465|NCT00556933|62941994|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
33550466|NCT00556933|62941995|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
33550467|NCT00556933|62941992|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
33550468|NCT00556933|62941993|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
33550469|NCT00556933|62941994|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
33550470|NCT00556933|62941995|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
33550471|NCT00556933|62941992|FG000|CNI Withdrawal vs. Minimization|Death|0|||
33478221|NCT03358030|62853931|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
33478222|NCT03358030|62853932|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
33550472|NCT00556933|62941993|FG001|CNI Withdrawal vs. Minimization|Death|0|||
33550473|NCT00556933|62941994|FG002|CNI Withdrawal vs. Minimization|Death|0|||
33550474|NCT00556933|62941995|FG003|CNI Withdrawal vs. Minimization|Death|1|||
33550475|NCT00280917|62942034|FG000|Overall Study|Adverse Event|1|||
33550476|NCT00280917|62942035|FG001|Overall Study|Adverse Event|1|||
33550477|NCT00280917|62942036|FG002|Overall Study|Adverse Event|4|||
33550478|NCT00280917|62942037|FG003|Overall Study|Adverse Event|1|||
33550479|NCT00280917|62942034|FG000|Overall Study|Change Therapy|1|||
33550480|NCT00280917|62942035|FG001|Overall Study|Change Therapy|2|||
33550481|NCT00280917|62942036|FG002|Overall Study|Change Therapy|0|||
33550482|NCT00280917|62942037|FG003|Overall Study|Change Therapy|0|||
33550483|NCT00280917|62942034|FG000|Overall Study|Withdrawal by Subject|0|||
33550484|NCT00280917|62942035|FG001|Overall Study|Withdrawal by Subject|2|||
33550485|NCT00280917|62942036|FG002|Overall Study|Withdrawal by Subject|0|||
33364597|NCT02393248|62743304|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
33478223|NCT03358030|62853933|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
33478224|NCT03358030|62853930|FG000|Overall Study|Ineligibility|0|||
33478225|NCT03358030|62853931|FG001|Overall Study|Ineligibility|0|||
33478226|NCT03358030|62853932|FG002|Overall Study|Ineligibility|0|||
33478227|NCT03358030|62853933|FG003|Overall Study|Ineligibility|2|||
33478228|NCT03358030|62853930|FG000|Overall Study|Voluntary Withdrawal|1|||
33478229|NCT03358030|62853931|FG001|Overall Study|Voluntary Withdrawal|1|||
33478230|NCT03358030|62853932|FG002|Overall Study|Voluntary Withdrawal|3|||
33478231|NCT03358030|62853933|FG003|Overall Study|Voluntary Withdrawal|1|||
33550486|NCT00280917|62942037|FG003|Overall Study|Withdrawal by Subject|1|||
33550487|NCT00280917|62942034|FG000|Overall Study|Noncompliance|0|||
33550488|NCT00280917|62942035|FG001|Overall Study|Noncompliance|1|||
33550489|NCT00280917|62942036|FG002|Overall Study|Noncompliance|2|||
33550490|NCT00280917|62942037|FG003|Overall Study|Noncompliance|0|||
33478232|NCT03358030|62853930|FG000|Overall Study|Other|0|||
33478233|NCT03358030|62853931|FG001|Overall Study|Other|0|||
33478234|NCT03358030|62853932|FG002|Overall Study|Other|1|||
33478235|NCT03358030|62853933|FG003|Overall Study|Other|0|||
33478236|NCT03566810|62853947|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
33478237|NCT03566810|62853948|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
33478238|NCT03566810|62853949|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
33478239|NCT03566810|62853950|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
33478240|NCT03628716|62853973|FG000|Overall Study|Adverse Event|1|||
33478241|NCT03628716|62853974|FG001|Overall Study|Adverse Event|1|||
33478242|NCT03628716|62853973|FG000|Overall Study|Death|1|||
33478243|NCT03628716|62853974|FG001|Overall Study|Death|0|||
33478244|NCT03628716|62853973|FG000|Overall Study|Lack of Efficacy|15|||
33478245|NCT03628716|62853974|FG001|Overall Study|Lack of Efficacy|20|||
33478246|NCT03628716|62853973|FG000|Overall Study|Withdrawal by Subject|1|||
33478247|NCT03628716|62853974|FG001|Overall Study|Withdrawal by Subject|2|||
33478248|NCT03628716|62853973|FG000|Overall Study|Study Terminated by Sponsor|1|||
33478249|NCT03628716|62853974|FG001|Overall Study|Study Terminated by Sponsor|0|||
33478250|NCT04002960|62853982|FG000|Overall Study|Withdrawn prior to Completion|2|||
33478251|NCT04002648|62853988|FG000|Overall Study|Lost to Follow-up|2|||
33478252|NCT04002648|62853989|FG001|Overall Study|Lost to Follow-up|0|||
33478253|NCT00088413|62854010|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
33478254|NCT00088413|62854011|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
33478255|NCT00088413|62854012|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
33478256|NCT00088413|62854013|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
33478257|NCT00088413|62854010|FG000|Overall Study|Adverse Events/Side Effects|0|||
33478258|NCT00088413|62854011|FG001|Overall Study|Adverse Events/Side Effects|1|||
33478259|NCT00088413|62854012|FG002|Overall Study|Adverse Events/Side Effects|1|||
33478260|NCT00088413|62854013|FG003|Overall Study|Adverse Events/Side Effects|0|||
33478261|NCT00088413|62854010|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
33478262|NCT00088413|62854011|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
33478263|NCT00088413|62854012|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
33478264|NCT00088413|62854013|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
33478265|NCT00088413|62854010|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
33478266|NCT00088413|62854011|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
33478267|NCT00088413|62854012|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
33478268|NCT00088413|62854013|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
33478269|NCT00088413|62854010|FG000|Overall Study|Death|0|||
33478270|NCT00088413|62854011|FG001|Overall Study|Death|1|||
33478271|NCT00088413|62854012|FG002|Overall Study|Death|0|||
33478272|NCT00088413|62854013|FG003|Overall Study|Death|0|||
33478273|NCT00088413|62854010|FG000|Overall Study|Progressive disease|9|||
33478274|NCT00088413|62854011|FG001|Overall Study|Progressive disease|11|||
33478275|NCT00088413|62854012|FG002|Overall Study|Progressive disease|8|||
33478276|NCT00088413|62854013|FG003|Overall Study|Progressive disease|14|||
33478277|NCT00088413|62854010|FG000|Overall Study|Other|0|||
33478278|NCT00088413|62854011|FG001|Overall Study|Other|1|||
33478279|NCT00088413|62854012|FG002|Overall Study|Other|0|||
33478280|NCT00088413|62854013|FG003|Overall Study|Other|0|||
33478281|NCT00088413|62854010|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
33478282|NCT00088413|62854011|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
33478283|NCT00088413|62854012|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
33478284|NCT00088413|62854013|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
33478285|NCT03995784|62854025|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
33478286|NCT00086385|62854040|FG000|Overall Study|Death|2|||
33478287|NCT00086385|62854041|FG001|Overall Study|Death|2|||
33478288|NCT00086385|62854042|FG002|Overall Study|Death|1|||
33478289|NCT00086385|62854043|FG003|Overall Study|Death|1|||
33478290|NCT03993288|62854055|FG000|Overall Study|Lost to Follow-up|2|||
33478291|NCT03993288|62854056|FG001|Overall Study|Lost to Follow-up|1|||
33550491|NCT00006478|62942056|FG000|Overall Study|Vaccine could not be produced|1|||
33478292|NCT03993288|62854055|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
33478293|NCT03993288|62854056|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
33478294|NCT03993288|62854055|FG000|Overall Study|wrong randomization|0|||
33478295|NCT03993288|62854056|FG001|Overall Study|wrong randomization|1|||
33478296|NCT03993288|62854055|FG000|Overall Study|improper enrollment|0|||
33478297|NCT03993288|62854056|FG001|Overall Study|improper enrollment|1|||
33478298|NCT03993288|62854055|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
33478299|NCT03993288|62854056|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
33478300|NCT03993288|62854055|FG000|Overall Study|developed SAE|2|||
33478301|NCT03993288|62854056|FG001|Overall Study|developed SAE|0|||
33478302|NCT03993288|62854055|FG000|Overall Study|consent withdrawal|1|||
33478303|NCT03993288|62854056|FG001|Overall Study|consent withdrawal|0|||
33478304|NCT03993288|62854055|FG000|Overall Study|did not follow the treatment schedule|1|||
33478305|NCT03993288|62854056|FG001|Overall Study|did not follow the treatment schedule|0|||
33478306|NCT03993288|62854055|FG000|Overall Study|did not follow the treatment regimen|1|||
33478307|NCT03993288|62854056|FG001|Overall Study|did not follow the treatment regimen|0|||
33478308|NCT03993288|62854055|FG000|Overall Study|Adverse Event|1|||
33478309|NCT03993288|62854056|FG001|Overall Study|Adverse Event|0|||
33550492|NCT00006478|62942056|FG000|Overall Study|Physician Decision|6|||
33550493|NCT05718466|62942062|FG000|Overall Study|Withdrawal by Subject|1|||
33550494|NCT05718466|62942063|FG001|Overall Study|Withdrawal by Subject|2|||
33550495|NCT05718466|62942062|FG000|Overall Study|Death|0|||
33550496|NCT05718466|62942063|FG001|Overall Study|Death|1|||
33550497|NCT04938453|62942071|FG000|Washout Period 1|Adverse Event|1|||
33550498|NCT04938453|62942072|FG001|Washout Period 1|Adverse Event|0|||
33550499|NCT04938453|62942071|FG000|Washout Period 1|Physician Decision|0|||
33550500|NCT04938453|62942072|FG001|Washout Period 1|Physician Decision|1|||
33550501|NCT04147260|62942117|FG000|Overall Study|Adverse Event|1|||
33550502|NCT04147260|62942118|FG001|Overall Study|Adverse Event|0|||
33550503|NCT04147260|62942119|FG002|Overall Study|Adverse Event|1|||
33550504|NCT04147260|62942120|FG003|Overall Study|Adverse Event|2|||
33550505|NCT04147260|62942121|FG004|Overall Study|Adverse Event|0|||
33550506|NCT04147260|62942117|FG000|Overall Study|Withdrawal by Subject|0|||
33550507|NCT04147260|62942118|FG001|Overall Study|Withdrawal by Subject|0|||
33550508|NCT04147260|62942119|FG002|Overall Study|Withdrawal by Subject|1|||
33550509|NCT04147260|62942120|FG003|Overall Study|Withdrawal by Subject|1|||
33550510|NCT04147260|62942121|FG004|Overall Study|Withdrawal by Subject|0|||
33550511|NCT04134728|62942138|FG000|Overall Study|Adverse Event|3|||
33550512|NCT04134728|62942139|FG001|Overall Study|Adverse Event|2|||
33550513|NCT04134728|62942140|FG002|Overall Study|Adverse Event|9|||
33550514|NCT04134728|62942141|FG003|Overall Study|Adverse Event|0|||
33656027|NCT03633396|63073909|FG000|Overall Study|Adverse Event|1|||
33656028|NCT03633396|63073910|FG001|Overall Study|Adverse Event|1|||
33656029|NCT03633396|63073909|FG000|Overall Study|Lack of Efficacy|1|||
33656030|NCT03633396|63073910|FG001|Overall Study|Lack of Efficacy|0|||
33656031|NCT03633396|63073909|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
33656032|NCT03633396|63073910|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
33656033|NCT00988065|63073923|FG000|Overall Study|Adverse Event|4|||
33656034|NCT00988065|63073924|FG001|Overall Study|Adverse Event|10|||
33656035|NCT00988065|63073925|FG002|Overall Study|Adverse Event|2|||
33656036|NCT00988065|63073923|FG000|Overall Study|Lost to Follow-up|1|||
33656037|NCT00988065|63073924|FG001|Overall Study|Lost to Follow-up|2|||
33656038|NCT00988065|63073925|FG002|Overall Study|Lost to Follow-up|2|||
33656039|NCT00988065|63073923|FG000|Overall Study|Subject withdrew consent|3|||
33656040|NCT00988065|63073924|FG001|Overall Study|Subject withdrew consent|5|||
33656041|NCT00988065|63073925|FG002|Overall Study|Subject withdrew consent|2|||
33656042|NCT00988065|63073923|FG000|Overall Study|Noncompliance with protocol|5|||
33656043|NCT00988065|63073924|FG001|Overall Study|Noncompliance with protocol|6|||
33656044|NCT00988065|63073925|FG002|Overall Study|Noncompliance with protocol|9|||
33656045|NCT00987831|63073949|FG000|Overall Study|Never flared in 12 months|1|||
33656046|NCT00987831|63073950|FG001|Overall Study|Never flared in 12 months|0|||
33656047|NCT00987831|63073951|FG002|Overall Study|Never flared in 12 months|0|||
33656048|NCT00987831|63073949|FG000|Overall Study|Lost to Follow-up|0|||
33656049|NCT00987831|63073950|FG001|Overall Study|Lost to Follow-up|3|||
33656050|NCT00987831|63073951|FG002|Overall Study|Lost to Follow-up|0|||
33656051|NCT00986973|63073982|FG000|Overall Study|Withdrawn by study team|1|||
33656052|NCT00986427|63073989|FG000|Overall Study|Lost to Follow-up|2|||
33656053|NCT00986427|63073990|FG001|Overall Study|Lost to Follow-up|0|||
33656054|NCT00986427|63073989|FG000|Overall Study|Lack of Efficacy|1|||
33478310|NCT03993288|62854055|FG000|Overall Study|Withdrawal by Subject|1|||
33550515|NCT04134728|62942142|FG004|Overall Study|Adverse Event|0|||
33550516|NCT04134728|62942143|FG005|Overall Study|Adverse Event|0|||
33550517|NCT04134728|62942138|FG000|Overall Study|Lack of Efficacy|3|||
33550518|NCT04134728|62942139|FG001|Overall Study|Lack of Efficacy|3|||
33550519|NCT04134728|62942140|FG002|Overall Study|Lack of Efficacy|1|||
33656055|NCT00986427|63073990|FG001|Overall Study|Lack of Efficacy|0|||
33478311|NCT03993288|62854056|FG001|Overall Study|Withdrawal by Subject|1|||
33550520|NCT04134728|62942141|FG003|Overall Study|Lack of Efficacy|2|||
33656056|NCT00986427|63073989|FG000|Overall Study|Withdrawal by Subject|1|||
33656057|NCT00986427|63073990|FG001|Overall Study|Withdrawal by Subject|0|||
33656058|NCT00986349|63074000|FG000|Overall Study|Unsuccessful implant procedure|3|||
33656059|NCT00986349|63074000|FG000|Overall Study|Adverse Event|2|||
33656060|NCT00986349|63074000|FG000|Overall Study|Physician Decision|1|||
33478312|NCT03991494|62854062|FG000|Overall Study|Progressive Disease|4|||
33550521|NCT04134728|62942142|FG004|Overall Study|Lack of Efficacy|0|||
33550522|NCT04134728|62942143|FG005|Overall Study|Lack of Efficacy|0|||
33478313|NCT00086307|62854071|FG000|Overall Study|Lack of Efficacy|1|||
33478314|NCT00086307|62854072|FG001|Overall Study|Lack of Efficacy|1|||
33478315|NCT00086307|62854073|FG002|Overall Study|Lack of Efficacy|2|||
33478316|NCT00086307|62854071|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
33478317|NCT00086307|62854072|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
33478318|NCT00086307|62854073|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
33478319|NCT00086307|62854071|FG000|Overall Study|Nausea and headaches|0|||
33478320|NCT00086307|62854072|FG001|Overall Study|Nausea and headaches|0|||
33478321|NCT00086307|62854073|FG002|Overall Study|Nausea and headaches|1|||
33478322|NCT00086307|62854071|FG000|Overall Study|Constipation and sleepiness|0|||
33478323|NCT00086307|62854072|FG001|Overall Study|Constipation and sleepiness|0|||
33478324|NCT00086307|62854073|FG002|Overall Study|Constipation and sleepiness|1|||
33478325|NCT00086307|62854071|FG000|Overall Study|Suicidal ideation|0|||
33478326|NCT00086307|62854072|FG001|Overall Study|Suicidal ideation|0|||
33478327|NCT00086307|62854073|FG002|Overall Study|Suicidal ideation|1|||
33478328|NCT00086307|62854071|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
33478329|NCT00086307|62854072|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
33478330|NCT00086307|62854073|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
33478331|NCT00086307|62854071|FG000|Overall Study|Withdrawal by Subject|0|||
33478332|NCT00086307|62854072|FG001|Overall Study|Withdrawal by Subject|0|||
33478333|NCT00086307|62854073|FG002|Overall Study|Withdrawal by Subject|2|||
33478334|NCT03624972|62854084|FG000|Overall Study|Lost to Follow-up|2|||
33478335|NCT03624972|62854085|FG001|Overall Study|Lost to Follow-up|0|||
33478336|NCT03624972|62854086|FG002|Overall Study|Lost to Follow-up|0|||
33478337|NCT03624972|62854084|FG000|Overall Study|Withdrawal by Subject|0|||
33478338|NCT03624972|62854085|FG001|Overall Study|Withdrawal by Subject|2|||
33478339|NCT03624972|62854086|FG002|Overall Study|Withdrawal by Subject|0|||
33478340|NCT03988842|62854095|FG000|Overall Study|Death|1|||
33478341|NCT02668822|62854102|FG000|Overall Study|Protocol Violation|2|||
33478342|NCT02668822|62854103|FG001|Overall Study|Protocol Violation|0|||
33478343|NCT02668822|62854102|FG000|Overall Study|Study Terminated by Sponsor|7|||
33478344|NCT02668822|62854103|FG001|Overall Study|Study Terminated by Sponsor|9|||
33478345|NCT02524288|62854109|FG000|Overall Study|Adverse Event|115|||
33478346|NCT02524288|62854109|FG000|Overall Study|Lost to Follow-up|216|||
33478347|NCT02524288|62854109|FG000|Overall Study|Non-Compliance With Protocol|32|||
33478348|NCT02524288|62854109|FG000|Overall Study|Non-Compliance With Study Drug|14|||
33478349|NCT02524288|62854109|FG000|Overall Study|Pregnancy Wish|6|||
33478350|NCT02524288|62854109|FG000|Overall Study|Protocol Violation|6|||
33478351|NCT02524288|62854109|FG000|Overall Study|Screen Failure|2|||
33478352|NCT02524288|62854109|FG000|Overall Study|Site Discontinued Study Participation|1|||
33478353|NCT02524288|62854109|FG000|Overall Study|Study Terminated By Sponsor|1417|||
33478354|NCT02524288|62854109|FG000|Overall Study|Subject Moved|32|||
33478355|NCT02524288|62854109|FG000|Overall Study|Withdrawal by Subject|76|||
33478356|NCT02524288|62854109|FG000|Overall Study|Pregnancy|22|||
33478357|NCT02524288|62854109|FG000|Overall Study|Physician Decision|2|||
33478358|NCT03624504|62854113|FG000|Overall Study|Unsuccessful Implant|1|||
33478359|NCT02954952|62854120|FG000|Overall Study|Withdrawal by Subject|1|||
33478360|NCT02954952|62854121|FG001|Overall Study|Withdrawal by Subject|0|||
33478361|NCT02954952|62854122|FG002|Overall Study|Withdrawal by Subject|0|||
33478362|NCT02954952|62854120|FG000|Overall Study|No data collected|0|||
33478363|NCT02954952|62854121|FG001|Overall Study|No data collected|1|||
33478364|NCT02954952|62854122|FG002|Overall Study|No data collected|0|||
33478365|NCT03547154|62854132|FG000|Overall Study|Disease Progression/Recurrence|6|||
33478366|NCT03547154|62854133|FG001|Overall Study|Disease Progression/Recurrence|14|||
33478367|NCT03547154|62854132|FG000|Overall Study|Adverse Event|26|||
33478368|NCT03547154|62854133|FG001|Overall Study|Adverse Event|31|||
33478369|NCT03547154|62854132|FG000|Overall Study|Protocol Violation|6|||
33478370|NCT03547154|62854133|FG001|Overall Study|Protocol Violation|1|||
33478371|NCT03547154|62854132|FG000|Overall Study|Physician Decision|4|||
33478372|NCT03547154|62854133|FG001|Overall Study|Physician Decision|3|||
33478373|NCT03547154|62854132|FG000|Overall Study|Insufficient Therapeutic Response|13|||
33656061|NCT00986349|63074000|FG000|Overall Study|device migration|1|||
33656062|NCT00985959|63074023|FG000|Overall Study|Adverse Event|0|||
33478374|NCT03547154|62854133|FG001|Overall Study|Insufficient Therapeutic Response|10|||
33478375|NCT03547154|62854132|FG000|Overall Study|Withdrawal by Subject|10|||
33478376|NCT03547154|62854133|FG001|Overall Study|Withdrawal by Subject|6|||
33478377|NCT03547154|62854132|FG000|Overall Study|Not Selected|0|||
33478378|NCT03547154|62854133|FG001|Overall Study|Not Selected|1|||
33478379|NCT03547154|62854132|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
33478380|NCT03547154|62854133|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
33478381|NCT02275546|62854139|FG000|Treatment Period 2|Withdrawal by Subject|2|||
33478382|NCT02275546|62854140|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33478383|NCT02275546|62854139|FG000|Treatment Period 2|Protocol Violation|0|||
33478384|NCT02275546|62854140|FG001|Treatment Period 2|Protocol Violation|1|||
33478385|NCT03624192|62854146|FG000|Overall Study|Lost to Follow-up|1|||
33478386|NCT03624192|62854147|FG001|Overall Study|Lost to Follow-up|1|||
33478387|NCT03034954|62854157|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
33478388|NCT03034954|62854158|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
33478389|NCT03546842|62854164|FG000|Overall Study|Protocol Violation|1|||
33478390|NCT03546842|62854164|FG000|Overall Study|Withdrawal by Subject|2|||
33478391|NCT03640052|62854168|FG000|Overall Study|Lost to Follow-up|0|||
33478392|NCT03640052|62854169|FG001|Overall Study|Lost to Follow-up|1|||
33478393|NCT03640052|62854170|FG002|Overall Study|Lost to Follow-up|0|||
33478394|NCT03640052|62854171|FG003|Overall Study|Lost to Follow-up|0|||
33478395|NCT03640052|62854172|FG004|Overall Study|Lost to Follow-up|0|||
33478396|NCT00068601|62854186|FG000|Overall Study|Ineligible|11|||
33478397|NCT00068601|62854187|FG001|Overall Study|Ineligible|13|||
33478398|NCT00068601|62854186|FG000|Overall Study|Not evaluable: withdrew consent|5|||
33478399|NCT00068601|62854187|FG001|Overall Study|Not evaluable: withdrew consent|4|||
33478400|NCT00068601|62854186|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
33478401|NCT00068601|62854187|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
33478402|NCT00068601|62854186|FG000|Overall Study|Death|11|||
33478403|NCT00068601|62854187|FG001|Overall Study|Death|3|||
33478404|NCT00068601|62854186|FG000|Overall Study|Lost to Follow-up|3|||
33478405|NCT00068601|62854187|FG001|Overall Study|Lost to Follow-up|2|||
33478406|NCT00068601|62854186|FG000|Overall Study|Missing primary outcome data|30|||
33478407|NCT00068601|62854187|FG001|Overall Study|Missing primary outcome data|34|||
33478408|NCT03638258|62854196|FG000|Overall Study|Adverse Event|1|||
33478409|NCT03638258|62854197|FG001|Overall Study|Adverse Event|0|||
33478410|NCT03638258|62854198|FG002|Overall Study|Adverse Event|2|||
33478411|NCT03638258|62854196|FG000|Overall Study|Lost to Follow-up|2|||
33478412|NCT03638258|62854197|FG001|Overall Study|Lost to Follow-up|4|||
33478413|NCT03638258|62854198|FG002|Overall Study|Lost to Follow-up|5|||
33478414|NCT03638258|62854196|FG000|Overall Study|Pregnancy|0|||
33478415|NCT03638258|62854197|FG001|Overall Study|Pregnancy|0|||
33478416|NCT03638258|62854198|FG002|Overall Study|Pregnancy|1|||
33478417|NCT03638258|62854196|FG000|Overall Study|Protocol Violation|0|||
33478418|NCT03638258|62854197|FG001|Overall Study|Protocol Violation|0|||
33478419|NCT03638258|62854198|FG002|Overall Study|Protocol Violation|1|||
33478420|NCT03638258|62854196|FG000|Overall Study|Withdrawal by Subject|4|||
33478421|NCT03638258|62854197|FG001|Overall Study|Withdrawal by Subject|5|||
33478422|NCT03638258|62854198|FG002|Overall Study|Withdrawal by Subject|12|||
33478423|NCT03638258|62854196|FG000|Overall Study|Lack of Efficacy|0|||
33478424|NCT03638258|62854197|FG001|Overall Study|Lack of Efficacy|0|||
33478425|NCT03638258|62854198|FG002|Overall Study|Lack of Efficacy|2|||
33478426|NCT01670656|62854212|FG000|Overall Study|Non-compliance with study drug|0|||
33478427|NCT01670656|62854213|FG001|Overall Study|Non-compliance with study drug|0|||
33478428|NCT01670656|62854214|FG002|Overall Study|Non-compliance with study drug|3|||
33478429|NCT01670656|62854215|FG003|Overall Study|Non-compliance with study drug|0|||
33478430|NCT01670656|62854216|FG004|Overall Study|Non-compliance with study drug|1|||
33478431|NCT01670656|62854212|FG000|Overall Study|Pregnancy|0|||
33478432|NCT01670656|62854213|FG001|Overall Study|Pregnancy|0|||
33478433|NCT01670656|62854214|FG002|Overall Study|Pregnancy|0|||
33478434|NCT01670656|62854215|FG003|Overall Study|Pregnancy|0|||
33478435|NCT01670656|62854216|FG004|Overall Study|Pregnancy|1|||
33478436|NCT01670656|62854212|FG000|Overall Study|Withdrawal by Subject|1|||
33478437|NCT01670656|62854213|FG001|Overall Study|Withdrawal by Subject|1|||
33478438|NCT01670656|62854214|FG002|Overall Study|Withdrawal by Subject|0|||
33478439|NCT01670656|62854215|FG003|Overall Study|Withdrawal by Subject|0|||
33478440|NCT01670656|62854216|FG004|Overall Study|Withdrawal by Subject|0|||
33364598|NCT02393248|62743305|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
33478441|NCT01670656|62854212|FG000|Overall Study|Non-compliance with protocol|0|||
33478442|NCT01670656|62854213|FG001|Overall Study|Non-compliance with protocol|3|||
33478443|NCT01670656|62854214|FG002|Overall Study|Non-compliance with protocol|1|||
33478444|NCT01670656|62854215|FG003|Overall Study|Non-compliance with protocol|1|||
33478445|NCT01670656|62854216|FG004|Overall Study|Non-compliance with protocol|2|||
33478446|NCT01670656|62854212|FG000|Overall Study|Adverse Event|2|||
33364599|NCT02393248|62743306|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
33478447|NCT01670656|62854213|FG001|Overall Study|Adverse Event|2|||
33478448|NCT01670656|62854214|FG002|Overall Study|Adverse Event|2|||
33478449|NCT01670656|62854215|FG003|Overall Study|Adverse Event|3|||
33478450|NCT01670656|62854216|FG004|Overall Study|Adverse Event|3|||
33364600|NCT02393248|62743307|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
33478451|NCT01670656|62854212|FG000|Overall Study|Subject withdrew consent|0|||
33478452|NCT01670656|62854213|FG001|Overall Study|Subject withdrew consent|1|||
33478453|NCT01670656|62854214|FG002|Overall Study|Subject withdrew consent|2|||
33478454|NCT01670656|62854215|FG003|Overall Study|Subject withdrew consent|1|||
33478455|NCT01670656|62854216|FG004|Overall Study|Subject withdrew consent|1|||
33364601|NCT02393248|62743308|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
33478456|NCT01670656|62854212|FG000|Overall Study|Lost to Follow-up|0|||
33478457|NCT01670656|62854213|FG001|Overall Study|Lost to Follow-up|0|||
33478458|NCT01670656|62854214|FG002|Overall Study|Lost to Follow-up|0|||
33478459|NCT01670656|62854215|FG003|Overall Study|Lost to Follow-up|0|||
33478460|NCT01670656|62854216|FG004|Overall Study|Lost to Follow-up|3|||
33478461|NCT01670656|62854212|FG000|Overall Study|Subject moved|0|||
33478462|NCT01670656|62854213|FG001|Overall Study|Subject moved|0|||
33478463|NCT01670656|62854214|FG002|Overall Study|Subject moved|0|||
33478464|NCT01670656|62854215|FG003|Overall Study|Subject moved|1|||
33478465|NCT01670656|62854216|FG004|Overall Study|Subject moved|0|||
33478466|NCT03621696|62854232|FG000|Overall Study|Not eligible|0|||
33478467|NCT03621696|62854233|FG001|Overall Study|Not eligible|0|||
33478468|NCT03621696|62854234|FG002|Overall Study|Not eligible|0|||
33478469|NCT03621696|62854235|FG003|Overall Study|Not eligible|5|||
33478470|NCT03621696|62854232|FG000|Overall Study|Withdrawal by Subject|1|||
33478471|NCT03621696|62854233|FG001|Overall Study|Withdrawal by Subject|1|||
33478472|NCT03621696|62854234|FG002|Overall Study|Withdrawal by Subject|1|||
33478473|NCT03621696|62854235|FG003|Overall Study|Withdrawal by Subject|0|||
33478474|NCT03621696|62854232|FG000|Overall Study|Physician Decision|0|||
33478475|NCT03621696|62854233|FG001|Overall Study|Physician Decision|0|||
33478476|NCT03621696|62854234|FG002|Overall Study|Physician Decision|1|||
33478477|NCT03621696|62854235|FG003|Overall Study|Physician Decision|0|||
33478478|NCT00068445|62854245|FG000|Randomization|Cancel|1|||
33478479|NCT00068445|62854246|FG001|Randomization|Cancel|3|||
33478480|NCT00068445|62854245|FG000|Randomization|Ineligible|1|||
33478481|NCT00068445|62854246|FG001|Randomization|Ineligible|1|||
33478482|NCT00068445|62854245|FG000|Treatment|Refused Further Treatment|13|||
33478483|NCT00068445|62854246|FG001|Treatment|Refused Further Treatment|10|||
33478484|NCT00068445|62854245|FG000|Treatment|Adverse Event|7|||
33478485|NCT00068445|62854246|FG001|Treatment|Adverse Event|1|||
33478486|NCT00068445|62854245|FG000|Treatment|Other (Specifics not available)|9|||
33478487|NCT00068445|62854246|FG001|Treatment|Other (Specifics not available)|5|||
33478488|NCT03653208|62854261|FG000|Overall Study|Withdrawal by Subject|0|||
33478489|NCT03653208|62854262|FG001|Overall Study|Withdrawal by Subject|0|||
33478490|NCT03653208|62854263|FG002|Overall Study|Withdrawal by Subject|0|||
33478491|NCT03653208|62854264|FG003|Overall Study|Withdrawal by Subject|0|||
33478492|NCT03653208|62854265|FG004|Overall Study|Withdrawal by Subject|1|||
33478493|NCT03653208|62854266|FG005|Overall Study|Withdrawal by Subject|0|||
33478494|NCT03653208|62854267|FG006|Overall Study|Withdrawal by Subject|0|||
33478495|NCT03653208|62854268|FG007|Overall Study|Withdrawal by Subject|1|||
33478496|NCT03653208|62854269|FG008|Overall Study|Withdrawal by Subject|1|||
33478497|NCT03545984|62854291|FG000|Overall Study|CSF cases not present during rotation|11|||
33478498|NCT03545984|62854292|FG001|Overall Study|CSF cases not present during rotation|9|||
33478499|NCT03033784|62854300|FG000|Overall Study|Anxiety related to MRI scanner|0|||
33478500|NCT03033784|62854301|FG001|Overall Study|Anxiety related to MRI scanner|1|||
33478501|NCT03033784|62854302|FG002|Overall Study|Anxiety related to MRI scanner|0|||
33478502|NCT03033784|62854303|FG003|Overall Study|Anxiety related to MRI scanner|0|||
33478503|NCT03033784|62854304|FG004|Overall Study|Anxiety related to MRI scanner|0|||
33478504|NCT03033784|62854305|FG005|Overall Study|Anxiety related to MRI scanner|0|||
33478505|NCT03033784|62854306|FG006|Overall Study|Anxiety related to MRI scanner|0|||
33478506|NCT03033784|62854307|FG007|Overall Study|Anxiety related to MRI scanner|0|||
33478507|NCT03033784|62854308|FG008|Overall Study|Anxiety related to MRI scanner|0|||
33478508|NCT03033784|62854309|FG009|Overall Study|Anxiety related to MRI scanner|0|||
33478509|NCT03033784|62854310|FG010|Overall Study|Anxiety related to MRI scanner|0|||
33478510|NCT03033784|62854311|FG011|Overall Study|Anxiety related to MRI scanner|0|||
33478511|NCT03033784|62854312|FG012|Overall Study|Anxiety related to MRI scanner|0|||
33478512|NCT03033784|62854300|FG000|Overall Study|Withdrawal by Subject|0|||
33478513|NCT03033784|62854301|FG001|Overall Study|Withdrawal by Subject|0|||
33478514|NCT03033784|62854302|FG002|Overall Study|Withdrawal by Subject|0|||
33478515|NCT03033784|62854303|FG003|Overall Study|Withdrawal by Subject|0|||
33478516|NCT03033784|62854304|FG004|Overall Study|Withdrawal by Subject|0|||
33478517|NCT03033784|62854305|FG005|Overall Study|Withdrawal by Subject|0|||
33478518|NCT03033784|62854306|FG006|Overall Study|Withdrawal by Subject|0|||
33478519|NCT03033784|62854307|FG007|Overall Study|Withdrawal by Subject|0|||
33478520|NCT03033784|62854308|FG008|Overall Study|Withdrawal by Subject|0|||
33478521|NCT03033784|62854309|FG009|Overall Study|Withdrawal by Subject|0|||
33478522|NCT03033784|62854310|FG010|Overall Study|Withdrawal by Subject|0|||
33478523|NCT03033784|62854311|FG011|Overall Study|Withdrawal by Subject|0|||
33478524|NCT03033784|62854312|FG012|Overall Study|Withdrawal by Subject|2|||
33478525|NCT00038649|62854323|FG000|Overall Study|Adverse Event|9|||
33478526|NCT03544268|62854329|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
33656063|NCT00985959|63074024|FG001|Overall Study|Adverse Event|0|||
33656064|NCT00985959|63074025|FG002|Overall Study|Adverse Event|19|||
33656065|NCT00985959|63074023|FG000|Overall Study|Withdrawal by Subject|0|||
33478527|NCT03544268|62854330|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
33478528|NCT03652818|62854341|FG000|Overall Study|Adverse Event|1|||
33478529|NCT03652818|62854342|FG001|Overall Study|Adverse Event|0|||
33478530|NCT03652818|62854343|FG002|Overall Study|Adverse Event|0|||
33478531|NCT03652818|62854344|FG003|Overall Study|Adverse Event|0|||
33478532|NCT03652818|62854345|FG004|Overall Study|Adverse Event|0|||
33478533|NCT03652818|62854341|FG000|Overall Study|Physician Decision|1|||
33478534|NCT03652818|62854342|FG001|Overall Study|Physician Decision|0|||
33478535|NCT03652818|62854343|FG002|Overall Study|Physician Decision|0|||
33478536|NCT03652818|62854344|FG003|Overall Study|Physician Decision|0|||
33478537|NCT03652818|62854345|FG004|Overall Study|Physician Decision|0|||
33478538|NCT03652818|62854341|FG000|Overall Study|Lost to Follow-up|0|||
33478539|NCT03652818|62854342|FG001|Overall Study|Lost to Follow-up|1|||
33478540|NCT03652818|62854343|FG002|Overall Study|Lost to Follow-up|2|||
33478541|NCT03652818|62854344|FG003|Overall Study|Lost to Follow-up|1|||
33478542|NCT03652818|62854345|FG004|Overall Study|Lost to Follow-up|1|||
33478543|NCT03619902|62854357|FG000|Overall Study|Termination of Study by Investigator|1|||
33478544|NCT03619902|62854357|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
33478545|NCT00620464|62854363|FG000|Overall Study|Adverse Event|15|||
33478546|NCT00620464|62854364|FG001|Overall Study|Adverse Event|17|||
33478547|NCT00620464|62854363|FG000|Overall Study|Lost to Follow-up|1|||
33478548|NCT00620464|62854364|FG001|Overall Study|Lost to Follow-up|1|||
33478549|NCT00620464|62854363|FG000|Overall Study|Planning Pregnancy|1|||
33478550|NCT00620464|62854364|FG001|Overall Study|Planning Pregnancy|4|||
33478551|NCT00620464|62854363|FG000|Overall Study|Personal|2|||
33478552|NCT00620464|62854364|FG001|Overall Study|Personal|2|||
33478553|NCT00620464|62854363|FG000|Overall Study|Used prohibited medication|1|||
33478554|NCT00620464|62854364|FG001|Overall Study|Used prohibited medication|0|||
33478555|NCT03652662|62854372|FG000|Overall Study|Withdrawal by Subject|2|||
33478556|NCT03652662|62854373|FG001|Overall Study|Withdrawal by Subject|1|||
33478557|NCT03652662|62854372|FG000|Overall Study|Lost to Follow-up|1|||
33478558|NCT03652662|62854373|FG001|Overall Study|Lost to Follow-up|0|||
33478559|NCT03560258|62854382|FG000|Overall Study|Lost to Follow-up|3|||
33478560|NCT03560258|62854383|FG001|Overall Study|Lost to Follow-up|0|||
33478561|NCT03560258|62854384|FG002|Overall Study|Lost to Follow-up|0|||
33478562|NCT03560258|62854382|FG000|Overall Study|Protocol Violation|0|||
33478563|NCT03560258|62854383|FG001|Overall Study|Protocol Violation|1|||
33478564|NCT03560258|62854384|FG002|Overall Study|Protocol Violation|0|||
33478565|NCT03560258|62854382|FG000|Overall Study|Withdrawal by Subject|0|||
33478566|NCT03560258|62854383|FG001|Overall Study|Withdrawal by Subject|0|||
33478567|NCT03560258|62854384|FG002|Overall Study|Withdrawal by Subject|1|||
33478568|NCT02768662|62854392|FG000|Overall Study|Adverse Event|1|||
33478569|NCT02768662|62854392|FG000|Overall Study|Lost to Follow-up|4|||
33478570|NCT02768662|62854392|FG000|Overall Study|Withdrawal by Subject|3|||
33478571|NCT02768662|62854392|FG000|Overall Study|Study terminated by Sponsor|78|||
33478572|NCT03539432|62854398|FG000|Overall Study|Lost to Follow-up|0|||
33478573|NCT03539432|62854399|FG001|Overall Study|Lost to Follow-up|1|||
33478574|NCT03615924|62854407|FG000|Overall Study|Withdrawal by Subject|2|||
33478575|NCT03615924|62854408|FG001|Overall Study|Withdrawal by Subject|5|||
33478576|NCT03615924|62854407|FG000|Overall Study|Death|3|||
33478577|NCT03615924|62854408|FG001|Overall Study|Death|1|||
33478578|NCT03615924|62854407|FG000|Overall Study|Lost to Follow-up|1|||
33478579|NCT03615924|62854408|FG001|Overall Study|Lost to Follow-up|0|||
33478580|NCT03615924|62854407|FG000|Overall Study|Randomized in error|1|||
33478581|NCT03615924|62854408|FG001|Overall Study|Randomized in error|0|||
33478582|NCT03615924|62854407|FG000|Overall Study|Study termination by Sponsor|94|||
33478583|NCT03615924|62854408|FG001|Overall Study|Study termination by Sponsor|86|||
33478584|NCT03535844|62854416|FG000|Overall Study|Withdrawal by Subject|0|||
33478585|NCT03535844|62854417|FG001|Overall Study|Withdrawal by Subject|1|||
33478586|NCT03533114|62854434|FG000|Overall|Adverse Event|16|||
33478587|NCT03533114|62854435|FG001|Overall|Adverse Event|11|||
33550523|NCT04134728|62942138|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
33550524|NCT04134728|62942139|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33550525|NCT04134728|62942140|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
33550526|NCT04134728|62942141|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33478588|NCT03533114|62854434|FG000|Overall|Consent Withdrawal by Participant|7|||
33478589|NCT03533114|62854435|FG001|Overall|Consent Withdrawal by Participant|6|||
33550527|NCT04134728|62942142|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33478590|NCT03533114|62854434|FG000|Overall|Lack of Efficacy|5|||
33478591|NCT03533114|62854435|FG001|Overall|Lack of Efficacy|3|||
33478592|NCT03533114|62854434|FG000|Overall|Lost to Follow-up|1|||
33478593|NCT03533114|62854435|FG001|Overall|Lost to Follow-up|1|||
33478594|NCT03533114|62854434|FG000|Overall|Physician Decision|0|||
33478595|NCT03533114|62854435|FG001|Overall|Physician Decision|2|||
33478596|NCT03533114|62854434|FG000|Overall|Protocol deviation|1|||
33550528|NCT04134728|62942143|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33478597|NCT03533114|62854435|FG001|Overall|Protocol deviation|1|||
33478598|NCT03533114|62854434|FG000|Overall|Failure to meet randomization criteria|1|||
33478599|NCT03533114|62854435|FG001|Overall|Failure to meet randomization criteria|2|||
33478600|NCT03533114|62854434|FG000|Overall|Non-Compliance with study drug|0|||
33550529|NCT04134728|62942138|FG000|Overall Study|Protocol Deviation|0|||
33478601|NCT03533114|62854435|FG001|Overall|Non-Compliance with study drug|1|||
33478602|NCT03533114|62854434|FG000|Overall|Other|0|||
33478603|NCT03533114|62854435|FG001|Overall|Other|1|||
33478604|NCT03533114|62854434|FG000|Open Label Titration and Optimization|Adverse Event|11|||
33478605|NCT03533114|62854435|FG001|Open Label Titration and Optimization|Adverse Event|8|||
33478606|NCT03533114|62854434|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
33478607|NCT03533114|62854435|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
33478608|NCT03533114|62854434|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
33478609|NCT03533114|62854435|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
33478610|NCT03533114|62854434|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
33478611|NCT03533114|62854435|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
33550530|NCT04134728|62942139|FG001|Overall Study|Protocol Deviation|0|||
33478612|NCT03533114|62854434|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
33478613|NCT03533114|62854435|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
33478614|NCT03533114|62854434|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
33478615|NCT03533114|62854435|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
33478616|NCT03533114|62854434|FG000|Stable Dose|Adverse Event|0|||
33478617|NCT03533114|62854435|FG001|Stable Dose|Adverse Event|2|||
33478618|NCT03533114|62854434|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
33478619|NCT03533114|62854435|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
33550531|NCT04134728|62942140|FG002|Overall Study|Protocol Deviation|1|||
33550532|NCT04134728|62942141|FG003|Overall Study|Protocol Deviation|0|||
33550533|NCT04134728|62942142|FG004|Overall Study|Protocol Deviation|0|||
33550534|NCT04134728|62942143|FG005|Overall Study|Protocol Deviation|0|||
33550535|NCT04134728|62942138|FG000|Overall Study|Informed Consent Withdrawn|3|||
33478620|NCT03533114|62854434|FG000|Stable Dose|Lack of Efficacy|1|||
33478621|NCT03533114|62854435|FG001|Stable Dose|Lack of Efficacy|0|||
33478622|NCT03533114|62854434|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
33478623|NCT03533114|62854435|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
33478624|NCT03533114|62854434|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
33478625|NCT03533114|62854435|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
33550536|NCT04134728|62942139|FG001|Overall Study|Informed Consent Withdrawn|6|||
33550537|NCT04134728|62942140|FG002|Overall Study|Informed Consent Withdrawn|8|||
33550538|NCT04134728|62942141|FG003|Overall Study|Informed Consent Withdrawn|1|||
33656066|NCT00985959|63074024|FG001|Overall Study|Withdrawal by Subject|0|||
33478626|NCT03533114|62854434|FG000|Open-Label Safety Extension|Adverse Event|3|||
33478627|NCT03533114|62854435|FG001|Open-Label Safety Extension|Adverse Event|0|||
33478628|NCT03533114|62854434|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
33478629|NCT03533114|62854435|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
33478630|NCT03533114|62854434|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
33478631|NCT03533114|62854435|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
33478632|NCT03533114|62854434|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
33478633|NCT03533114|62854435|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
33478634|NCT03533114|62854434|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
33478635|NCT03533114|62854435|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
33478636|NCT03033394|62854443|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
33656067|NCT00985959|63074025|FG002|Overall Study|Withdrawal by Subject|8|||
33656068|NCT00985959|63074023|FG000|Overall Study|Progressive disease|1|||
33364602|NCT02393248|62743309|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
33364603|NCT02393248|62743310|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
33364604|NCT02393248|62743311|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
33478637|NCT03033394|62854443|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
33478638|NCT03033394|62854443|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
33478639|NCT03033394|62854443|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
33656069|NCT00985959|63074024|FG001|Overall Study|Progressive disease|2|||
33656070|NCT00985959|63074025|FG002|Overall Study|Progressive disease|8|||
33656071|NCT00985959|63074023|FG000|Overall Study|Unrecovered toxicity|0|||
33550539|NCT04134728|62942142|FG004|Overall Study|Informed Consent Withdrawn|1|||
33550540|NCT04134728|62942143|FG005|Overall Study|Informed Consent Withdrawn|0|||
33550541|NCT04134728|62942138|FG000|Overall Study|Physician Decision|2|||
33656072|NCT00985959|63074024|FG001|Overall Study|Unrecovered toxicity|0|||
33656073|NCT00985959|63074025|FG002|Overall Study|Unrecovered toxicity|7|||
33550542|NCT04134728|62942139|FG001|Overall Study|Physician Decision|0|||
33656074|NCT00985959|63074023|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
33478640|NCT03033394|62854443|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
33478641|NCT03981822|62854460|FG000|Overall Study|Lost to Follow-up|0|||
33478642|NCT03981822|62854461|FG001|Overall Study|Lost to Follow-up|1|||
33478643|NCT03981822|62854462|FG002|Overall Study|Lost to Follow-up|1|||
33478644|NCT03981822|62854463|FG003|Overall Study|Lost to Follow-up|0|||
33478645|NCT03981822|62854464|FG004|Overall Study|Lost to Follow-up|6|||
33478646|NCT03981822|62854465|FG005|Overall Study|Lost to Follow-up|4|||
33478647|NCT03981822|62854466|FG006|Overall Study|Lost to Follow-up|4|||
33478648|NCT03981822|62854467|FG007|Overall Study|Lost to Follow-up|2|||
33478649|NCT03981822|62854460|FG000|Overall Study|Withdrawal by Subject|0|||
33478650|NCT03981822|62854461|FG001|Overall Study|Withdrawal by Subject|1|||
33478651|NCT03981822|62854462|FG002|Overall Study|Withdrawal by Subject|0|||
33478652|NCT03981822|62854463|FG003|Overall Study|Withdrawal by Subject|0|||
33478653|NCT03981822|62854464|FG004|Overall Study|Withdrawal by Subject|0|||
33478654|NCT03981822|62854465|FG005|Overall Study|Withdrawal by Subject|1|||
33478655|NCT03981822|62854466|FG006|Overall Study|Withdrawal by Subject|0|||
33478656|NCT03981822|62854467|FG007|Overall Study|Withdrawal by Subject|2|||
33478657|NCT03981822|62854460|FG000|Overall Study|COVID-19 Related|0|||
33478658|NCT03981822|62854461|FG001|Overall Study|COVID-19 Related|0|||
33478659|NCT03981822|62854462|FG002|Overall Study|COVID-19 Related|0|||
33478660|NCT03981822|62854463|FG003|Overall Study|COVID-19 Related|0|||
33478661|NCT03981822|62854464|FG004|Overall Study|COVID-19 Related|2|||
33550543|NCT04134728|62942140|FG002|Overall Study|Physician Decision|0|||
33550544|NCT04134728|62942141|FG003|Overall Study|Physician Decision|0|||
33550545|NCT04134728|62942142|FG004|Overall Study|Physician Decision|0|||
33550546|NCT04134728|62942143|FG005|Overall Study|Physician Decision|0|||
33550547|NCT04134728|62942138|FG000|Overall Study|Lost to Follow-up|1|||
33550548|NCT04134728|62942139|FG001|Overall Study|Lost to Follow-up|2|||
33550549|NCT04134728|62942140|FG002|Overall Study|Lost to Follow-up|1|||
33478662|NCT03981822|62854465|FG005|Overall Study|COVID-19 Related|1|||
33478663|NCT03981822|62854466|FG006|Overall Study|COVID-19 Related|2|||
33478664|NCT03981822|62854467|FG007|Overall Study|COVID-19 Related|1|||
33478665|NCT03650556|62854479|FG000|Overall Study|Death|2|||
33478666|NCT03650556|62854479|FG000|Overall Study|Withdrawal by Subject|20|||
33478667|NCT03650556|62854479|FG000|Overall Study|Physician Decision|2|||
33478668|NCT03650556|62854479|FG000|Overall Study|Lost to Follow-up|8|||
33478669|NCT03650556|62854479|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
33478670|NCT03650556|62854479|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
33478671|NCT03531632|62854487|FG000|Overall Study|Adverse Event|0|||
33478672|NCT03531632|62854488|FG001|Overall Study|Adverse Event|0|||
33478673|NCT03531632|62854489|FG002|Overall Study|Adverse Event|1|||
33478674|NCT03531632|62854487|FG000|Overall Study|Death|4|||
33478675|NCT03531632|62854488|FG001|Overall Study|Death|0|||
33478676|NCT03531632|62854489|FG002|Overall Study|Death|14|||
33478677|NCT03531632|62854487|FG000|Overall Study|Study Terminated|1|||
33478678|NCT03531632|62854488|FG001|Overall Study|Study Terminated|3|||
33478679|NCT03531632|62854489|FG002|Overall Study|Study Terminated|11|||
33478680|NCT03979638|62854500|FG000|Period 1|Physician Decision|1|||
33550550|NCT04134728|62942141|FG003|Overall Study|Lost to Follow-up|0|||
33550551|NCT04134728|62942142|FG004|Overall Study|Lost to Follow-up|0|||
33550552|NCT04134728|62942143|FG005|Overall Study|Lost to Follow-up|1|||
33550553|NCT04134728|62942138|FG000|Overall Study|Investigator Site Closed|0|||
33550554|NCT04134728|62942139|FG001|Overall Study|Investigator Site Closed|1|||
33550555|NCT04134728|62942140|FG002|Overall Study|Investigator Site Closed|1|||
33550556|NCT04134728|62942141|FG003|Overall Study|Investigator Site Closed|0|||
33550557|NCT04134728|62942142|FG004|Overall Study|Investigator Site Closed|0|||
33550558|NCT04134728|62942143|FG005|Overall Study|Investigator Site Closed|0|||
33550559|NCT03886272|62942177|FG000|Period 1|Withdrawal by Subject|0|||
33550560|NCT03886272|62942178|FG001|Period 1|Withdrawal by Subject|0|||
33550561|NCT03886272|62942179|FG002|Period 1|Withdrawal by Subject|0|||
33550562|NCT03886272|62942180|FG003|Period 1|Withdrawal by Subject|0|||
33550563|NCT03886272|62942181|FG004|Period 1|Withdrawal by Subject|0|||
33550564|NCT03886272|62942182|FG005|Period 1|Withdrawal by Subject|1|||
33550565|NCT03886272|62942183|FG006|Period 1|Withdrawal by Subject|0|||
33550566|NCT03732833|62942202|FG000|Overall Study|Adverse Event|0|||
33656075|NCT00985959|63074024|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
33656076|NCT00985959|63074025|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
33550567|NCT03732833|62942203|FG001|Overall Study|Adverse Event|3|||
33550568|NCT03732833|62942204|FG002|Overall Study|Adverse Event|1|||
33550569|NCT03732833|62942202|FG000|Overall Study|Withdrawal by Subject|11|||
33478681|NCT03979638|62854501|FG001|Period 1|Physician Decision|1|||
33478682|NCT03979638|62854500|FG000|Period 1|Withdrawal by Subject|4|||
33478683|NCT03979638|62854501|FG001|Period 1|Withdrawal by Subject|3|||
33478684|NCT03979638|62854500|FG000|Period 1|Study terminated by Sponsor|1|||
33478685|NCT03979638|62854501|FG001|Period 1|Study terminated by Sponsor|3|||
33550570|NCT03732833|62942203|FG001|Overall Study|Withdrawal by Subject|13|||
33550571|NCT03732833|62942204|FG002|Overall Study|Withdrawal by Subject|8|||
33478686|NCT03979638|62854500|FG000|Period 1|Protocol Violation|1|||
33478687|NCT03979638|62854501|FG001|Period 1|Protocol Violation|0|||
33478688|NCT03979638|62854500|FG000|Period 2|Study terminated by Sponsor|1|||
33478689|NCT03979638|62854501|FG001|Period 2|Study terminated by Sponsor|1|||
33478690|NCT03655054|62854516|FG000|Overall Study|Lost to Follow-up|1|||
33478691|NCT03615144|62854522|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
33478692|NCT03615144|62854523|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
33478693|NCT03682302|62854533|FG000|Overall Study|Lost to Follow-up|1|||
33478694|NCT03682302|62854534|FG001|Overall Study|Lost to Follow-up|2|||
33478695|NCT03682302|62854535|FG002|Overall Study|Lost to Follow-up|0|||
33478696|NCT03682302|62854536|FG003|Overall Study|Lost to Follow-up|1|||
33478697|NCT03682302|62854533|FG000|Overall Study|Study drug was not administered|0|||
33478698|NCT03682302|62854534|FG001|Overall Study|Study drug was not administered|0|||
33478699|NCT03682302|62854535|FG002|Overall Study|Study drug was not administered|1|||
33478700|NCT03682302|62854536|FG003|Overall Study|Study drug was not administered|1|||
33478701|NCT03522506|62854550|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33478702|NCT03522506|62854551|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33478703|NCT03522506|62854552|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33478704|NCT03522506|62854553|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
33478705|NCT03522506|62854550|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
33478706|NCT03522506|62854551|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
33478707|NCT03522506|62854552|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
33478708|NCT03522506|62854553|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
33478709|NCT02892734|62854584|FG000|Treatment on Study|Progressive Disease|2|||
33478710|NCT02892734|62854584|FG000|Follow up for 2 Years|Death|2|||
33478711|NCT02892734|62854584|FG000|Follow up for 2 Years|Study closed early|1|||
33478712|NCT00055497|62854592|FG000|Overall Study|Adverse Event|1|||
33478713|NCT00055497|62854593|FG001|Overall Study|Adverse Event|1|||
33478714|NCT00055497|62854594|FG002|Overall Study|Adverse Event|1|||
33478715|NCT00055497|62854595|FG003|Overall Study|Adverse Event|28|||
33478716|NCT00055497|62854592|FG000|Overall Study|Withdrawal by Subject|3|||
33478717|NCT00055497|62854593|FG001|Overall Study|Withdrawal by Subject|1|||
33478718|NCT00055497|62854594|FG002|Overall Study|Withdrawal by Subject|1|||
33478719|NCT00055497|62854595|FG003|Overall Study|Withdrawal by Subject|15|||
33478720|NCT00055497|62854592|FG000|Overall Study|Lost to Follow-up|0|||
33478721|NCT00055497|62854593|FG001|Overall Study|Lost to Follow-up|1|||
33478722|NCT00055497|62854594|FG002|Overall Study|Lost to Follow-up|0|||
33478723|NCT00055497|62854595|FG003|Overall Study|Lost to Follow-up|5|||
33478724|NCT00055497|62854592|FG000|Overall Study|Protocol Violation|0|||
33478725|NCT00055497|62854593|FG001|Overall Study|Protocol Violation|0|||
33478726|NCT00055497|62854594|FG002|Overall Study|Protocol Violation|0|||
33478727|NCT00055497|62854595|FG003|Overall Study|Protocol Violation|3|||
33478728|NCT00055497|62854592|FG000|Overall Study|Lack of Efficacy|1|||
33478729|NCT00055497|62854593|FG001|Overall Study|Lack of Efficacy|0|||
33478730|NCT00055497|62854594|FG002|Overall Study|Lack of Efficacy|0|||
33478731|NCT00055497|62854595|FG003|Overall Study|Lack of Efficacy|27|||
33478732|NCT00055497|62854592|FG000|Overall Study|Administrative Reasons|0|||
33478733|NCT00055497|62854593|FG001|Overall Study|Administrative Reasons|0|||
33478734|NCT00055497|62854594|FG002|Overall Study|Administrative Reasons|0|||
33478735|NCT00055497|62854595|FG003|Overall Study|Administrative Reasons|1|||
33478736|NCT00055497|62854592|FG000|Overall Study|Other|0|||
33656077|NCT00985959|63074023|FG000|Overall Study|Complete response observed over 2 cycles|0|||
33656078|NCT00985959|63074024|FG001|Overall Study|Complete response observed over 2 cycles|1|||
33656079|NCT00985959|63074025|FG002|Overall Study|Complete response observed over 2 cycles|4|||
33656080|NCT00985959|63074023|FG000|Overall Study|Other|0|||
33656081|NCT00985959|63074024|FG001|Overall Study|Other|0|||
33656082|NCT00985959|63074025|FG002|Overall Study|Other|11|||
33656083|NCT00985725|63074041|FG000|Overall Study|Adverse Event|4|||
33656084|NCT00985725|63074042|FG001|Overall Study|Adverse Event|1|||
33478737|NCT00055497|62854593|FG001|Overall Study|Other|0|||
33478738|NCT00055497|62854594|FG002|Overall Study|Other|0|||
33478739|NCT00055497|62854595|FG003|Overall Study|Other|11|||
33478740|NCT03520400|62854612|FG000|Overall Study|Physician Decision|15|||
33656085|NCT00985725|63074041|FG000|Overall Study|Protocol Violation|1|||
33478741|NCT03520400|62854613|FG001|Overall Study|Physician Decision|7|||
33478742|NCT03615066|62854622|FG000|Main Study|Withdrew Consent|0|||
33656086|NCT00985725|63074042|FG001|Overall Study|Protocol Violation|3|||
33656087|NCT00985725|63074041|FG000|Overall Study|Withdrawal by Subject|4|||
33656088|NCT00985725|63074042|FG001|Overall Study|Withdrawal by Subject|4|||
33478743|NCT03615066|62854623|FG001|Main Study|Withdrew Consent|1|||
33478744|NCT03615066|62854624|FG002|Main Study|Withdrew Consent|1|||
33478745|NCT03615066|62854622|FG000|Main Study|Lost to Follow-up|0|||
33478746|NCT03615066|62854623|FG001|Main Study|Lost to Follow-up|0|||
33478747|NCT03615066|62854624|FG002|Main Study|Lost to Follow-up|1|||
33478748|NCT03615066|62854622|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
33478749|NCT03615066|62854623|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
33550572|NCT03732833|62942202|FG000|Overall Study|Lost to Follow-up|3|||
33478750|NCT03615066|62854624|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
33478751|NCT03615066|62854622|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
33478752|NCT03615066|62854623|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
33478753|NCT03615066|62854624|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
33478754|NCT03615066|62854622|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
33478755|NCT03615066|62854623|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
33478756|NCT03615066|62854624|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
33478757|NCT03527966|62854638|FG000|Overall Study|Lost to Follow-up|3|||
33478758|NCT03527966|62854639|FG001|Overall Study|Lost to Follow-up|0|||
33478759|NCT03808545|62854647|FG000|Overall Study|Withdrawal by Subject|1|||
33478760|NCT03808545|62854648|FG001|Overall Study|Withdrawal by Subject|1|||
33478761|NCT03807843|62854657|FG000|Overall Study|Lost to Follow-up|1|||
33478762|NCT03807843|62854658|FG001|Overall Study|Lost to Follow-up|0|||
33478763|NCT03519932|62854664|FG000|First Intervention|Adverse Event|1|||
33478764|NCT03519932|62854665|FG001|First Intervention|Adverse Event|3|||
33478765|NCT03806127|62854678|FG000|Overall Study|Withdrawal by Subject|4|||
33478766|NCT03806127|62854679|FG001|Overall Study|Withdrawal by Subject|5|||
33478767|NCT03806127|62854678|FG000|Overall Study|Protocol Violation|3|||
33478768|NCT03806127|62854679|FG001|Overall Study|Protocol Violation|1|||
33478769|NCT03806127|62854678|FG000|Overall Study|Adverse Event|3|||
33478770|NCT03806127|62854679|FG001|Overall Study|Adverse Event|0|||
33478771|NCT03806127|62854678|FG000|Overall Study|Unable to Complete Procedures|0|||
33478772|NCT03806127|62854679|FG001|Overall Study|Unable to Complete Procedures|1|||
33478773|NCT03806127|62854678|FG000|Overall Study|Pregnancy|0|||
33478774|NCT03806127|62854679|FG001|Overall Study|Pregnancy|1|||
33478775|NCT03806127|62854678|FG000|Overall Study|Lost to Follow-up|5|||
33478776|NCT03806127|62854679|FG001|Overall Study|Lost to Follow-up|1|||
33478777|NCT03806127|62854678|FG000|Overall Study|Physician Decision|1|||
33478778|NCT03806127|62854679|FG001|Overall Study|Physician Decision|1|||
33478779|NCT03806127|62854678|FG000|Overall Study|Could Not Come Due to Covid|1|||
33478780|NCT03806127|62854679|FG001|Overall Study|Could Not Come Due to Covid|0|||
33478781|NCT03806127|62854678|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
33478782|NCT03806127|62854679|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
33478783|NCT03806127|62854678|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
33478784|NCT03806127|62854679|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
33478785|NCT03806127|62854678|FG000|Overall Study|Covid 19 Restrictions|2|||
33478786|NCT03806127|62854679|FG001|Overall Study|Covid 19 Restrictions|0|||
33478787|NCT03806127|62854678|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
33478788|NCT03806127|62854679|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
33478789|NCT03806127|62854678|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
33478790|NCT03806127|62854679|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
33478791|NCT02843074|62854685|FG000|Overall Study|Withdrawal by Subject|5|||
33478792|NCT02843074|62854685|FG000|Overall Study|Progressive disease|1|||
33478793|NCT02843074|62854685|FG000|Overall Study|Physician Decision|1|||
33478794|NCT02843074|62854685|FG000|Overall Study|Lost to Follow-up|1|||
33478795|NCT02843074|62854685|FG000|Overall Study|Death|9|||
33478796|NCT03650400|62854691|FG000|Overall Study|Study terminated by sponsor|0|||
33478797|NCT03650400|62854692|FG001|Overall Study|Study terminated by sponsor|5|||
33478798|NCT00038103|62854700|FG000|Overall Study|Adverse Event|5|||
33478799|NCT00038103|62854701|FG001|Overall Study|Adverse Event|6|||
33478800|NCT00038103|62854700|FG000|Overall Study|Lack of Efficacy|48|||
33478801|NCT00038103|62854701|FG001|Overall Study|Lack of Efficacy|41|||
33478802|NCT00038103|62854700|FG000|Overall Study|Withdrawal by Subject|0|||
33478803|NCT00038103|62854701|FG001|Overall Study|Withdrawal by Subject|3|||
33478804|NCT00038103|62854700|FG000|Overall Study|Lost to Follow-up|0|||
33478805|NCT00038103|62854701|FG001|Overall Study|Lost to Follow-up|3|||
33478806|NCT00038103|62854700|FG000|Overall Study|Protocol Violation|0|||
33478807|NCT00038103|62854701|FG001|Overall Study|Protocol Violation|2|||
33478808|NCT00038103|62854700|FG000|Overall Study|Sponsor Decision|0|||
33478809|NCT00038103|62854701|FG001|Overall Study|Sponsor Decision|1|||
33478810|NCT00038103|62854700|FG000|Overall Study|Randomized/never treated|2|||
33478811|NCT00038103|62854701|FG001|Overall Study|Randomized/never treated|0|||
33478812|NCT03680742|62854707|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
33478813|NCT03678870|62854713|FG000|Overall Study|prescribed non- protocol medications|10|||
33478814|NCT03678870|62854714|FG001|Overall Study|prescribed non- protocol medications|6|||
33478815|NCT03678870|62854713|FG000|Overall Study|Lost to Follow-up|3|||
33550573|NCT03732833|62942203|FG001|Overall Study|Lost to Follow-up|5|||
33478816|NCT03678870|62854714|FG001|Overall Study|Lost to Follow-up|2|||
33478817|NCT03805971|62854720|FG000|Overall Study|Withdrawal by Subject|1|||
33478818|NCT03805971|62854720|FG000|Overall Study|Protocol Violation|2|||
33478819|NCT03032380|62854727|FG000|Overall Study|Adverse Event|0|||
33478820|NCT03032380|62854728|FG001|Overall Study|Adverse Event|1|||
33478821|NCT03032380|62854727|FG000|Overall Study|Lack of Efficacy|1|||
33478822|NCT03032380|62854728|FG001|Overall Study|Lack of Efficacy|0|||
33478823|NCT03032380|62854727|FG000|Overall Study|Withdrawal by Subject|2|||
33478824|NCT03032380|62854728|FG001|Overall Study|Withdrawal by Subject|3|||
33478825|NCT03032380|62854727|FG000|Overall Study|Recovery|0|||
33478826|NCT03032380|62854728|FG001|Overall Study|Recovery|1|||
33478827|NCT03032380|62854727|FG000|Overall Study|Death|39|||
33478828|NCT03032380|62854728|FG001|Overall Study|Death|34|||
33478829|NCT03032380|62854727|FG000|Overall Study|Other - Miscellaneous|0|||
33478830|NCT03032380|62854728|FG001|Overall Study|Other - Miscellaneous|1|||
33478831|NCT03519854|62854752|FG000|Overall Study|Technical Error|0|||
33478832|NCT03519854|62854753|FG001|Overall Study|Technical Error|0|||
33478833|NCT03519854|62854754|FG002|Overall Study|Technical Error|1|||
33478834|NCT03519854|62854755|FG003|Overall Study|Technical Error|0|||
33478835|NCT03519854|62854756|FG004|Overall Study|Technical Error|0|||
33478836|NCT03519854|62854757|FG005|Overall Study|Technical Error|0|||
33478837|NCT03519854|62854758|FG006|Overall Study|Technical Error|0|||
33478838|NCT03519854|62854759|FG007|Overall Study|Technical Error|0|||
33478839|NCT03519854|62854760|FG008|Overall Study|Technical Error|0|||
33478840|NCT03519854|62854761|FG009|Overall Study|Technical Error|0|||
33478841|NCT03519854|62854762|FG010|Overall Study|Technical Error|0|||
33478842|NCT03519854|62854763|FG011|Overall Study|Technical Error|0|||
33478843|NCT03519854|62854764|FG012|Overall Study|Technical Error|0|||
33478844|NCT03519854|62854765|FG013|Overall Study|Technical Error|0|||
33478845|NCT03519854|62854766|FG014|Overall Study|Technical Error|0|||
33478846|NCT03519854|62854767|FG015|Overall Study|Technical Error|0|||
33478847|NCT03519854|62854768|FG016|Overall Study|Technical Error|0|||
33478848|NCT03519854|62854769|FG017|Overall Study|Technical Error|0|||
33478849|NCT03479216|62854809|FG000|Overall Study|Withdrawal by Subject|3|||
33478850|NCT03479216|62854810|FG001|Overall Study|Withdrawal by Subject|2|||
33478851|NCT03479216|62854809|FG000|Overall Study|Physician Decision|2|||
33478852|NCT03479216|62854810|FG001|Overall Study|Physician Decision|3|||
33478853|NCT03518840|62854816|FG000|Overall Study|Lost to Follow-up|6|||
33478854|NCT03436082|62854825|FG000|Overall Study|Did not undergo procedure|1|||
33478855|NCT03436082|62854826|FG001|Overall Study|Did not undergo procedure|0|||
33478856|NCT03677934|62854834|FG000|Overall Study|Adverse Event|1|||
33478857|NCT03677934|62854835|FG001|Overall Study|Adverse Event|1|||
33478858|NCT03677934|62854834|FG000|Overall Study|Death|8|||
33478859|NCT03677934|62854835|FG001|Overall Study|Death|4|||
33478860|NCT03677934|62854834|FG000|Overall Study|Lost to Follow-up|3|||
33478861|NCT03677934|62854835|FG001|Overall Study|Lost to Follow-up|0|||
33478862|NCT03677934|62854834|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33478863|NCT03677934|62854835|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33478864|NCT03677934|62854834|FG000|Overall Study|Physician Decision|0|||
33478865|NCT03677934|62854835|FG001|Overall Study|Physician Decision|1|||
33478866|NCT03677934|62854834|FG000|Overall Study|Withdrawal by Subject|1|||
33478867|NCT03677934|62854835|FG001|Overall Study|Withdrawal by Subject|7|||
33478868|NCT03435692|62854847|FG000|Overall Study|Lack of Efficacy|2|||
33478869|NCT03435692|62854848|FG001|Overall Study|Lack of Efficacy|2|||
33478870|NCT03435692|62854849|FG002|Overall Study|Lack of Efficacy|0|||
33478871|NCT03475316|62854863|FG000|6 Month Intervention|Adverse Event|2|||
33478872|NCT03475316|62854864|FG001|6 Month Intervention|Adverse Event|1|||
33550574|NCT03732833|62942204|FG002|Overall Study|Lost to Follow-up|4|||
33550575|NCT03732833|62942202|FG000|Overall Study|Pregnancy|0|||
33478873|NCT03475316|62854863|FG000|6 Month Intervention|Withdrawal by Subject|2|||
33478874|NCT03475316|62854864|FG001|6 Month Intervention|Withdrawal by Subject|0|||
33478875|NCT03475316|62854863|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
33478876|NCT03475316|62854864|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
33478877|NCT03475316|62854863|FG000|9 Months|Study stopped due to COVID pandemic|3|||
33478878|NCT03475316|62854864|FG001|9 Months|Study stopped due to COVID pandemic|4|||
33478879|NCT03673956|62854874|FG000|Overall Study|Lost to Follow-up|1|||
33478880|NCT03673956|62854875|FG001|Overall Study|Lost to Follow-up|0|||
33478881|NCT03673956|62854876|FG002|Overall Study|Lost to Follow-up|0|||
33478882|NCT03673956|62854877|FG003|Overall Study|Lost to Follow-up|0|||
33478883|NCT03673956|62854874|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
33478884|NCT03673956|62854875|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
33478885|NCT03673956|62854876|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
33478886|NCT03673956|62854877|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
33478887|NCT03517436|62854887|FG000|Overall Study|Death|3|||
33478888|NCT03517436|62854887|FG000|Overall Study|Withdrawal by Subject|4|||
33478889|NCT03517436|62854887|FG000|Overall Study|Did not receive study valve.|1|||
33550576|NCT03732833|62942203|FG001|Overall Study|Pregnancy|2|||
33478890|NCT03673098|62854893|FG000|Overall Study|Lost to Follow-up|2|||
33478891|NCT03673098|62854894|FG001|Overall Study|Lost to Follow-up|3|||
33478892|NCT03673098|62854893|FG000|Overall Study|Withdrawal by Subject|6|||
33478893|NCT03673098|62854894|FG001|Overall Study|Withdrawal by Subject|1|||
33478894|NCT03673098|62854893|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
33550577|NCT03732833|62942204|FG002|Overall Study|Pregnancy|0|||
33550578|NCT03732833|62942202|FG000|Overall Study|Physician Decision|2|||
33550579|NCT03732833|62942203|FG001|Overall Study|Physician Decision|3|||
33550580|NCT03732833|62942204|FG002|Overall Study|Physician Decision|1|||
33550581|NCT03732833|62942202|FG000|Overall Study|Covid-19 related and other reasons|2|||
33550582|NCT03732833|62942203|FG001|Overall Study|Covid-19 related and other reasons|7|||
33550583|NCT03732833|62942204|FG002|Overall Study|Covid-19 related and other reasons|3|||
33550584|NCT03493919|62942221|FG000|Overall Study|Other|2|||
33550585|NCT03493919|62942222|FG001|Overall Study|Other|0|||
33550586|NCT03493919|62942223|FG002|Overall Study|Other|1|||
33478895|NCT03673098|62854894|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
33478896|NCT03435224|62854907|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
33478897|NCT03672396|62854911|FG000|Overall Study|Withdrawal by Subject|4|||
33478898|NCT03672396|62854911|FG000|Overall Study|Physician Decision|1|||
33478899|NCT03672396|62854911|FG000|Overall Study|Adverse Event|1|||
33478900|NCT03434834|62854915|FG000|Overall Study|unable to swallow OCT probe|16|||
33478901|NCT03605862|62854921|FG000|Overall Study|Withdrawal by Subject|12|||
33478902|NCT03605862|62854922|FG001|Overall Study|Withdrawal by Subject|9|||
33478903|NCT03605862|62854921|FG000|Overall Study|Adverse Event|2|||
33478904|NCT03605862|62854922|FG001|Overall Study|Adverse Event|1|||
33478905|NCT03605862|62854921|FG000|Overall Study|Physician Decision|3|||
33478906|NCT03605862|62854922|FG001|Overall Study|Physician Decision|1|||
33478907|NCT03605862|62854921|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
33478908|NCT03605862|62854922|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
33478909|NCT03672006|62854931|FG000|Overall Study|exclusion criteria met|0|||
33478910|NCT03672006|62854932|FG001|Overall Study|exclusion criteria met|1|||
33478911|NCT03512288|62854942|FG000|Overall Study|Adverse Event|1|||
33478912|NCT03512288|62854943|FG001|Overall Study|Adverse Event|0|||
33478913|NCT03512288|62854942|FG000|Overall Study|Lost to Follow-up|12|||
33478914|NCT03512288|62854943|FG001|Overall Study|Lost to Follow-up|15|||
33478915|NCT03512288|62854942|FG000|Overall Study|Physician Decision|0|||
33478916|NCT03512288|62854943|FG001|Overall Study|Physician Decision|2|||
33478917|NCT03512288|62854942|FG000|Overall Study|Protocol Violation|6|||
33478918|NCT03512288|62854943|FG001|Overall Study|Protocol Violation|4|||
33478919|NCT03512288|62854942|FG000|Overall Study|Medication error without associated adverse event|1|||
33478920|NCT03512288|62854943|FG001|Overall Study|Medication error without associated adverse event|0|||
33478921|NCT03512288|62854942|FG000|Overall Study|No longer met eligibility criteria|5|||
33478922|NCT03512288|62854943|FG001|Overall Study|No longer met eligibility criteria|2|||
33478923|NCT03512288|62854942|FG000|Overall Study|Withdrawal by parent/guardian|14|||
33478924|NCT03512288|62854943|FG001|Overall Study|Withdrawal by parent/guardian|18|||
33478925|NCT03512288|62854942|FG000|Overall Study|Other|1|||
33478926|NCT03512288|62854943|FG001|Overall Study|Other|1|||
33478927|NCT03512288|62854942|FG000|Overall Study|Randomized but not treated|1|||
33550587|NCT03493919|62942224|FG003|Overall Study|Other|0|||
33550588|NCT03493919|62942221|FG000|Overall Study|Withdrawal by Subject|9|||
33550589|NCT03493919|62942222|FG001|Overall Study|Withdrawal by Subject|3|||
33550590|NCT03493919|62942223|FG002|Overall Study|Withdrawal by Subject|1|||
33550591|NCT03493919|62942224|FG003|Overall Study|Withdrawal by Subject|1|||
33550592|NCT03493919|62942221|FG000|Overall Study|Lost to Follow-up|5|||
33550593|NCT03493919|62942222|FG001|Overall Study|Lost to Follow-up|0|||
33550594|NCT03493919|62942223|FG002|Overall Study|Lost to Follow-up|0|||
33550595|NCT03493919|62942224|FG003|Overall Study|Lost to Follow-up|3|||
33550596|NCT03493919|62942221|FG000|Overall Study|Adverse Event|0|||
33550597|NCT03493919|62942222|FG001|Overall Study|Adverse Event|1|||
33550598|NCT03493919|62942223|FG002|Overall Study|Adverse Event|0|||
33550599|NCT03493919|62942224|FG003|Overall Study|Adverse Event|0|||
33550600|NCT03280628|62942242|FG000|Overall Study|Lost to Follow-up|8|||
33550601|NCT03280628|62942243|FG001|Overall Study|Lost to Follow-up|6|||
33550602|NCT03280628|62942244|FG002|Overall Study|Lost to Follow-up|11|||
33550603|NCT03058146|62942271|FG000|Overall Study|Withdrawal by Subject|4|||
33550604|NCT03058146|62942272|FG001|Overall Study|Withdrawal by Subject|1|||
33550605|NCT03058146|62942271|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
33550606|NCT03058146|62942272|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
33550607|NCT03004443|62942282|FG000|Overall Study|Pregnancy|0|||
33550608|NCT03004443|62942283|FG001|Overall Study|Pregnancy|1|||
33550609|NCT02851511|62942293|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
33656089|NCT00985725|63074041|FG000|Overall Study|Lost to Follow-up|1|||
33550610|NCT02851511|62942294|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
33550611|NCT02851511|62942295|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
33550612|NCT02851511|62942296|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
33550613|NCT02851511|62942293|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
33478928|NCT03512288|62854943|FG001|Overall Study|Randomized but not treated|1|||
33550614|NCT02851511|62942294|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
33550615|NCT02851511|62942295|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
33550616|NCT02851511|62942296|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
33478929|NCT03031678|62854949|FG000|Overall Study|Study closed prior to completion|1|||
33478930|NCT03669588|62854959|FG000|Overall Study|Adverse Event|1|||
33478931|NCT03669588|62854960|FG001|Overall Study|Adverse Event|0|||
33478932|NCT03669588|62854959|FG000|Overall Study|Physician Decision|0|||
33478933|NCT03669588|62854960|FG001|Overall Study|Physician Decision|1|||
33478934|NCT03669588|62854959|FG000|Overall Study|Protocol Violation|1|||
33478935|NCT03669588|62854960|FG001|Overall Study|Protocol Violation|0|||
33478936|NCT03669588|62854959|FG000|Overall Study|Sponsor Decision|1|||
33478937|NCT03669588|62854960|FG001|Overall Study|Sponsor Decision|1|||
33478938|NCT03669588|62854959|FG000|Overall Study|Withdrawal by Subject|1|||
33478939|NCT03669588|62854960|FG001|Overall Study|Withdrawal by Subject|4|||
33478940|NCT03669588|62854959|FG000|Overall Study|Rescue Therapy Needed|0|||
33478941|NCT03669588|62854960|FG001|Overall Study|Rescue Therapy Needed|1|||
33478942|NCT03598140|62854968|FG000|Overall Study|enrolled but didn't start|1|||
33478943|NCT03598140|62854969|FG001|Overall Study|enrolled but didn't start|0|||
33478944|NCT03644550|62854975|FG000|Overall Study|Withdrawal by Subject|3|||
33478945|NCT03644550|62854975|FG000|Overall Study|Progressive disease|15|||
33478946|NCT00054717|62854982|FG000|Overall Study|Randomized but not treated|2|||
33478947|NCT00054717|62854983|FG001|Overall Study|Randomized but not treated|8|||
33478948|NCT00054717|62854982|FG000|Overall Study|Adverse Event|70|||
33478949|NCT00054717|62854983|FG001|Overall Study|Adverse Event|22|||
33478950|NCT00054717|62854982|FG000|Overall Study|Protocol Violation|18|||
33478951|NCT00054717|62854983|FG001|Overall Study|Protocol Violation|19|||
33478952|NCT00054717|62854982|FG000|Overall Study|Lost to Follow-up|23|||
33478953|NCT00054717|62854983|FG001|Overall Study|Lost to Follow-up|13|||
33478954|NCT00054717|62854982|FG000|Overall Study|Withdrawal by Subject|32|||
33478955|NCT00054717|62854983|FG001|Overall Study|Withdrawal by Subject|20|||
33478956|NCT00054717|62854982|FG000|Overall Study|Other reason not defined above|117|||
33478957|NCT00054717|62854983|FG001|Overall Study|Other reason not defined above|217|||
33478958|NCT03430856|62854992|FG000|Overall Study|Adverse Event|0|||
33478959|NCT03430856|62854993|FG001|Overall Study|Adverse Event|1|||
33478960|NCT03430856|62854994|FG002|Overall Study|Adverse Event|0|||
33478961|NCT03430856|62854992|FG000|Overall Study|Rescue criteria|1|||
33478962|NCT03430856|62854993|FG001|Overall Study|Rescue criteria|1|||
33478963|NCT03430856|62854994|FG002|Overall Study|Rescue criteria|0|||
33478964|NCT03430856|62854992|FG000|Overall Study|Voluntary withdrawal of consent|1|||
33478965|NCT03430856|62854993|FG001|Overall Study|Voluntary withdrawal of consent|1|||
33550617|NCT02851511|62942293|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
33550618|NCT02851511|62942294|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
33478966|NCT03430856|62854994|FG002|Overall Study|Voluntary withdrawal of consent|1|||
33478967|NCT03731364|62855010|FG000|Overall Study|Adverse Event|0|||
33478968|NCT03731364|62855011|FG001|Overall Study|Adverse Event|0|||
33478969|NCT03731364|62855012|FG002|Overall Study|Adverse Event|1|||
33478970|NCT03731364|62855013|FG003|Overall Study|Adverse Event|2|||
33478971|NCT03731364|62855014|FG004|Overall Study|Adverse Event|1|||
33478972|NCT03510182|62855026|FG000|Overall Study|Withdrawal by Subject|2|||
33478973|NCT00066807|62855032|FG000|Overall Study|Study was terminated early|14|||
33478974|NCT00066807|62855033|FG001|Overall Study|Study was terminated early|15|||
33478975|NCT03428750|62855041|FG000|Overall Study|Withdrawal by Subject|11|||
33478976|NCT03428750|62855042|FG001|Overall Study|Withdrawal by Subject|10|||
33478977|NCT03428750|62855041|FG000|Overall Study|Lost to Follow-up|3|||
33478978|NCT03428750|62855042|FG001|Overall Study|Lost to Follow-up|9|||
33478979|NCT03428750|62855041|FG000|Overall Study|Adverse Event|9|||
33478980|NCT03428750|62855042|FG001|Overall Study|Adverse Event|1|||
33478981|NCT03428750|62855041|FG000|Overall Study|Protocol Violation|1|||
33478982|NCT03428750|62855042|FG001|Overall Study|Protocol Violation|0|||
33478983|NCT03428750|62855041|FG000|Overall Study|Administrative|0|||
33478984|NCT03428750|62855042|FG001|Overall Study|Administrative|1|||
33478985|NCT03666858|62855071|FG000|Cohort 1|Adverse Event|1|||
33478986|NCT03666858|62855072|FG001|Cohort 1|Adverse Event|0|||
33478987|NCT03666858|62855071|FG000|Cohort 2|Adverse Event|0|||
33478988|NCT03666858|62855072|FG001|Cohort 2|Adverse Event|1|||
33478989|NCT00054639|62855078|FG000|Overall Study|Lack of Efficacy|1|||
33478990|NCT00054639|62855078|FG000|Overall Study|Physician Decision|1|||
33478991|NCT03428360|62855082|FG000|Overall Study|Informed consent withdrawn|5|||
33478992|NCT03428360|62855082|FG000|Overall Study|Withdrawal by Subject|4|||
33478993|NCT03428360|62855082|FG000|Overall Study|Lost to Follow-up|5|||
33550619|NCT02851511|62942295|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
33478994|NCT03428360|62855082|FG000|Overall Study|Physician Decision|2|||
33478995|NCT03428360|62855082|FG000|Overall Study|Informed consent withdrawn|5|||
33478996|NCT03428360|62855082|FG000|Overall Study|Study terminated by sponsor|10|||
33478997|NCT03428360|62855082|FG000|Overall Study|Non-compliant with study|1|||
33550620|NCT02851511|62942296|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
33550621|NCT02851511|62942293|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
33550622|NCT02851511|62942294|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
33478998|NCT03428360|62855082|FG000|Overall Study|Non-compliant with study drug|3|||
33478999|NCT03428360|62855082|FG000|Overall Study|Death|3|||
33479000|NCT03428360|62855082|FG000|Overall Study|Adverse Event|1|||
33479001|NCT03428360|62855082|FG000|Overall Study|Not on antiepileptic drug|1|||
33479002|NCT03427892|62855090|FG000|Overall Study|Lost to Follow-up|2|||
33479003|NCT03595332|62855096|FG000|Overall Study|Lost to Follow-up|16|||
33479004|NCT03595332|62855097|FG001|Overall Study|Lost to Follow-up|22|||
33479005|NCT03595332|62855096|FG000|Overall Study|Unable to retrieve ID from school|0|||
33479006|NCT03595332|62855097|FG001|Overall Study|Unable to retrieve ID from school|2|||
33479007|NCT03427268|62855106|FG000|Overall Study|Progressive disease|25|||
33479008|NCT03427268|62855106|FG000|Overall Study|Never treated|2|||
33479009|NCT03427268|62855106|FG000|Overall Study|Compassionate use|1|||
33479010|NCT03427268|62855106|FG000|Overall Study|Withdrawal by Subject|1|||
33479011|NCT03427268|62855106|FG000|Overall Study|Adverse Event|3|||
33479012|NCT03509948|62855110|FG000|Overall Study|Protocol Violation|0|||
33479013|NCT03509948|62855111|FG001|Overall Study|Protocol Violation|1|||
33479014|NCT03466658|62855117|FG000|Overall Study|Withdrawal by Subject|3|||
33479015|NCT03425396|62855128|FG000|Overall Study|Lost to Follow-up|2|||
33479016|NCT03425396|62855129|FG001|Overall Study|Lost to Follow-up|5|||
33479017|NCT03425396|62855130|FG002|Overall Study|Lost to Follow-up|2|||
33479018|NCT03425396|62855131|FG003|Overall Study|Lost to Follow-up|0|||
33479019|NCT03425396|62855132|FG004|Overall Study|Lost to Follow-up|0|||
33479020|NCT03425396|62855128|FG000|Overall Study|Withdrawal by Subject|0|||
33479021|NCT03425396|62855129|FG001|Overall Study|Withdrawal by Subject|1|||
33479022|NCT03425396|62855130|FG002|Overall Study|Withdrawal by Subject|0|||
33479023|NCT03425396|62855131|FG003|Overall Study|Withdrawal by Subject|1|||
33479024|NCT03425396|62855132|FG004|Overall Study|Withdrawal by Subject|0|||
33479025|NCT03425396|62855128|FG000|Overall Study|Other|0|||
33479026|NCT03425396|62855129|FG001|Overall Study|Other|1|||
33479027|NCT03425396|62855130|FG002|Overall Study|Other|1|||
33479028|NCT03425396|62855131|FG003|Overall Study|Other|0|||
33479029|NCT03425396|62855132|FG004|Overall Study|Other|1|||
33479030|NCT00066729|62855144|FG000|Overall Study|Lost to Follow-up|1|||
33479031|NCT00066729|62855144|FG000|Overall Study|Disease progression|1|||
33479032|NCT00032487|62855150|FG000|Overall Study|Withdrawal by Subject|67|||
33479033|NCT00032487|62855151|FG001|Overall Study|Withdrawal by Subject|43|||
33479034|NCT00032487|62855150|FG000|Overall Study|Adverse Event|3|||
33550623|NCT02851511|62942295|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
33550624|NCT02851511|62942296|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
33550625|NCT02851511|62942293|FG000|Phase I|Physician Decision|0|||
33550626|NCT02851511|62942294|FG001|Phase I|Physician Decision|0|||
33550627|NCT02851511|62942295|FG002|Phase I|Physician Decision|0|||
33550628|NCT02851511|62942296|FG003|Phase I|Physician Decision|1|||
33550629|NCT02851511|62942293|FG000|Phase I|Withdrawal by Subject|2|||
33550630|NCT02851511|62942294|FG001|Phase I|Withdrawal by Subject|1|||
33550631|NCT02851511|62942295|FG002|Phase I|Withdrawal by Subject|0|||
33550632|NCT02851511|62942296|FG003|Phase I|Withdrawal by Subject|3|||
33550633|NCT02851511|62942293|FG000|Phase II|Physician Decision|18|||
33550634|NCT02851511|62942294|FG001|Phase II|Physician Decision|16|||
33550635|NCT02851511|62942295|FG002|Phase II|Physician Decision|0|||
33550636|NCT02851511|62942296|FG003|Phase II|Physician Decision|0|||
33550637|NCT02851511|62942293|FG000|Phase II|Withdrawal by Subject|18|||
33550638|NCT02851511|62942294|FG001|Phase II|Withdrawal by Subject|16|||
33550639|NCT02851511|62942295|FG002|Phase II|Withdrawal by Subject|0|||
33550640|NCT02851511|62942296|FG003|Phase II|Withdrawal by Subject|0|||
33550641|NCT02851511|62942293|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
33550642|NCT02851511|62942294|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
33656090|NCT00985725|63074042|FG001|Overall Study|Lost to Follow-up|1|||
33656091|NCT00985725|63074041|FG000|Overall Study|Lack of Efficacy|0|||
33656092|NCT00985725|63074042|FG001|Overall Study|Lack of Efficacy|1|||
33656093|NCT00985725|63074041|FG000|Overall Study|Non-compliance|1|||
33656094|NCT00985725|63074042|FG001|Overall Study|Non-compliance|2|||
33656095|NCT00985725|63074041|FG000|Overall Study|Out-of-window visits|0|||
33656096|NCT00985725|63074042|FG001|Overall Study|Out-of-window visits|1|||
33656097|NCT00985491|63074057|FG000|Overall Study|Adverse Event|8|||
33656098|NCT00985491|63074057|FG000|Overall Study|device migration|7|||
33656099|NCT00985491|63074057|FG000|Overall Study|Withdrawal by Subject|1|||
33656100|NCT00985491|63074057|FG000|Overall Study|implant failure|3|||
33656101|NCT00984867|63074092|FG000|Overall Study|Adverse Event|3|||
33364605|NCT02393248|62743312|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
33550643|NCT02851511|62942295|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
33550644|NCT02851511|62942296|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
33550645|NCT02851511|62942293|FG000|Phase II|Lost to Follow-up|0|||
33550646|NCT02851511|62942294|FG001|Phase II|Lost to Follow-up|1|||
33656102|NCT00984867|63074093|FG001|Overall Study|Adverse Event|7|||
33479035|NCT00032487|62855151|FG001|Overall Study|Adverse Event|7|||
33479036|NCT00032487|62855150|FG000|Overall Study|Lost to Follow-up|57|||
33479037|NCT00032487|62855151|FG001|Overall Study|Lost to Follow-up|58|||
33479038|NCT00032487|62855150|FG000|Overall Study|Had other reason|12|||
33479039|NCT00032487|62855151|FG001|Overall Study|Had other reason|12|||
33479040|NCT03641508|62855159|FG000|First Injection|Lost to Follow-up|2|||
33479041|NCT03641508|62855160|FG001|First Injection|Lost to Follow-up|0|||
33479042|NCT03465878|62855168|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
33364606|NCT02393248|62743313|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
33364607|NCT02393248|62743314|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
33364608|NCT02393248|62743315|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
33364609|NCT02393248|62743316|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
33364610|NCT02393248|62743317|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
33479043|NCT03465878|62855169|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
33550647|NCT02851511|62942295|FG002|Phase II|Lost to Follow-up|0|||
33550648|NCT02851511|62942296|FG003|Phase II|Lost to Follow-up|0|||
33550649|NCT02478320|62942317|FG000|Overall Study|Adverse Event|2|||
33550650|NCT02478320|62942318|FG001|Overall Study|Adverse Event|0|||
33550651|NCT02478320|62942317|FG000|Overall Study|Death|1|||
33550652|NCT02478320|62942318|FG001|Overall Study|Death|0|||
33550653|NCT02478320|62942317|FG000|Overall Study|Lack of Efficacy|4|||
33550654|NCT02478320|62942318|FG001|Overall Study|Lack of Efficacy|0|||
33550655|NCT02478320|62942317|FG000|Overall Study|Withdrawal by Subject|2|||
33550656|NCT02478320|62942318|FG001|Overall Study|Withdrawal by Subject|0|||
33550657|NCT02478320|62942317|FG000|Overall Study|Screen Failure|3|||
33550658|NCT02478320|62942318|FG001|Overall Study|Screen Failure|0|||
33550659|NCT02252042|62942343|FG000|Overall Study|Adverse Event|9|||
33550660|NCT02252042|62942344|FG001|Overall Study|Adverse Event|6|||
33550661|NCT02252042|62942343|FG000|Overall Study|Death|209|||
33656103|NCT00984867|63074092|FG000|Overall Study|Death|1|||
33656104|NCT00984867|63074093|FG001|Overall Study|Death|0|||
33656105|NCT00984867|63074092|FG000|Overall Study|Withdrawal by Subject|13|||
33656106|NCT00984867|63074093|FG001|Overall Study|Withdrawal by Subject|4|||
33656107|NCT00984867|63074092|FG000|Overall Study|Lost to Follow-up|3|||
33656108|NCT00984867|63074093|FG001|Overall Study|Lost to Follow-up|4|||
33656109|NCT00984867|63074092|FG000|Overall Study|Poor/non-compliance|0|||
33656110|NCT00984867|63074093|FG001|Overall Study|Poor/non-compliance|1|||
33656111|NCT00984867|63074092|FG000|Overall Study|Subject no longer meets study criteria|1|||
33479044|NCT03465878|62855170|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
33479045|NCT03465878|62855171|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
33479046|NCT03465878|62855168|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
33479047|NCT03465878|62855169|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
33479048|NCT03465878|62855170|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
33479049|NCT03465878|62855171|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
33656112|NCT00984867|63074093|FG001|Overall Study|Subject no longer meets study criteria|1|||
33656113|NCT00984867|63074092|FG000|Overall Study|site closing|1|||
33656114|NCT00984867|63074093|FG001|Overall Study|site closing|0|||
33656115|NCT00984867|63074092|FG000|Overall Study|lack of efficacy and subject compliance|1|||
33656116|NCT00984867|63074093|FG001|Overall Study|lack of efficacy and subject compliance|0|||
33656117|NCT00984009|63074133|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
33656118|NCT00983931|63074140|FG000|14 Day Washout Period|Physician Decision|1|||
33656119|NCT00983853|63074152|FG000|Overall Study|Lost to Follow-up|1|||
33656120|NCT00983853|63074153|FG001|Overall Study|Lost to Follow-up|1|||
33656121|NCT00983853|63074154|FG002|Overall Study|Lost to Follow-up|2|||
33656122|NCT00983853|63074155|FG003|Overall Study|Lost to Follow-up|2|||
33656123|NCT00983853|63074156|FG004|Overall Study|Lost to Follow-up|2|||
33656124|NCT00983853|63074157|FG005|Overall Study|Lost to Follow-up|1|||
33656125|NCT00983853|63074152|FG000|Overall Study|Withdrawal by Subject|0|||
33656126|NCT00983853|63074153|FG001|Overall Study|Withdrawal by Subject|0|||
33656127|NCT00983853|63074154|FG002|Overall Study|Withdrawal by Subject|1|||
33656128|NCT00983853|63074155|FG003|Overall Study|Withdrawal by Subject|0|||
33656129|NCT00983853|63074156|FG004|Overall Study|Withdrawal by Subject|1|||
33656130|NCT00983853|63074157|FG005|Overall Study|Withdrawal by Subject|0|||
33656131|NCT00983853|63074152|FG000|Overall Study|Unable to come to study follow-up visits|0|||
33656132|NCT00983853|63074153|FG001|Overall Study|Unable to come to study follow-up visits|1|||
33656133|NCT00983853|63074154|FG002|Overall Study|Unable to come to study follow-up visits|0|||
33656134|NCT00983853|63074155|FG003|Overall Study|Unable to come to study follow-up visits|0|||
33479050|NCT03465878|62855168|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
33479051|NCT03465878|62855169|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
33479052|NCT03465878|62855170|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
33479053|NCT03465878|62855171|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
33550662|NCT02252042|62942344|FG001|Overall Study|Death|217|||
33656135|NCT00983853|63074156|FG004|Overall Study|Unable to come to study follow-up visits|0|||
33364611|NCT02393248|62743318|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
33550663|NCT02252042|62942343|FG000|Overall Study|Physician Decision|0|||
33656136|NCT00983853|63074157|FG005|Overall Study|Unable to come to study follow-up visits|0|||
33656137|NCT00983073|63074173|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
33550664|NCT02252042|62942344|FG001|Overall Study|Physician Decision|2|||
33550665|NCT02252042|62942343|FG000|Overall Study|Transferred to Extension Study|7|||
33550666|NCT02252042|62942344|FG001|Overall Study|Transferred to Extension Study|1|||
33550667|NCT02252042|62942343|FG000|Overall Study|Did Not Continue on Extension Study|7|||
33550668|NCT02252042|62942344|FG001|Overall Study|Did Not Continue on Extension Study|2|||
33550669|NCT02252042|62942343|FG000|Overall Study|Withdrawal by Subject|15|||
33550670|NCT02252042|62942344|FG001|Overall Study|Withdrawal by Subject|20|||
33550671|NCT00378482|62942371|FG000|Overall Study|Lost to Follow-up|1|||
33550672|NCT00378482|62942371|FG000|Overall Study|Lack of Efficacy|8|||
33550673|NCT00378482|62942371|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
33550674|NCT00378482|62942371|FG000|Overall Study|Withdrawal by Subject|4|||
33550675|NCT00378482|62942371|FG000|Overall Study|Adverse Event|9|||
33550676|NCT05288673|62942378|FG000|Overall Study|Consent withdrawn by subject|0|||
33550677|NCT05288673|62942379|FG001|Overall Study|Consent withdrawn by subject|0|||
33550678|NCT05288673|62942380|FG002|Overall Study|Consent withdrawn by subject|1|||
33550679|NCT04604795|62942426|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
33550680|NCT04604795|62942427|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
33550681|NCT04604795|62942428|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33550682|NCT04604795|62942429|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33550683|NCT04604795|62942430|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33550684|NCT04604795|62942431|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33550685|NCT04604795|62942432|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33550686|NCT04604795|62942433|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33550687|NCT04604795|62942434|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33550688|NCT04604795|62942435|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33550689|NCT04604795|62942426|FG000|Part B: Up to Day 14|Adverse Event|0|||
33550690|NCT04604795|62942427|FG001|Part B: Up to Day 14|Adverse Event|0|||
33550691|NCT04604795|62942428|FG002|Part B: Up to Day 14|Adverse Event|0|||
33550692|NCT04604795|62942429|FG003|Part B: Up to Day 14|Adverse Event|0|||
33550693|NCT04604795|62942430|FG004|Part B: Up to Day 14|Adverse Event|2|||
33550694|NCT04604795|62942431|FG005|Part B: Up to Day 14|Adverse Event|1|||
33550695|NCT04604795|62942432|FG006|Part B: Up to Day 14|Adverse Event|0|||
33550696|NCT04604795|62942433|FG007|Part B: Up to Day 14|Adverse Event|0|||
33550697|NCT04604795|62942434|FG008|Part B: Up to Day 14|Adverse Event|0|||
33550698|NCT04604795|62942435|FG009|Part B: Up to Day 14|Adverse Event|0|||
33550699|NCT04604795|62942426|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33550700|NCT04604795|62942427|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33550701|NCT04604795|62942428|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33550702|NCT04604795|62942429|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33550703|NCT04604795|62942430|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33550704|NCT04604795|62942431|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33550705|NCT04604795|62942432|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33550706|NCT04604795|62942433|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33550707|NCT04604795|62942434|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33550708|NCT04604795|62942435|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
33550709|NCT04604795|62942426|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33550710|NCT04604795|62942427|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33550711|NCT04604795|62942428|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33550712|NCT04604795|62942429|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33550713|NCT04604795|62942430|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33550714|NCT04604795|62942431|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33550715|NCT04604795|62942432|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33550716|NCT04604795|62942433|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33550717|NCT04604795|62942434|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
33550718|NCT04604795|62942435|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33550719|NCT04604795|62942426|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33550720|NCT04604795|62942427|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33550721|NCT04604795|62942428|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33550722|NCT04604795|62942429|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33550723|NCT04604795|62942430|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33550724|NCT04604795|62942431|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33550725|NCT04604795|62942432|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33550726|NCT04604795|62942433|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33550727|NCT04604795|62942434|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
33550728|NCT04604795|62942435|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33550729|NCT04604795|62942426|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
33550730|NCT04604795|62942427|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
33550731|NCT04604795|62942428|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
33550732|NCT04604795|62942429|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
33550733|NCT04604795|62942430|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
33550734|NCT04604795|62942431|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
33550735|NCT04604795|62942432|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
33550736|NCT04604795|62942433|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
33550737|NCT04604795|62942434|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
33550738|NCT04604795|62942435|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
33550739|NCT04314284|62942531|FG000|Overall Study|Withdrawal by Subject|4|||
33550740|NCT04314284|62942532|FG001|Overall Study|Withdrawal by Subject|7|||
33550741|NCT04314284|62942531|FG000|Overall Study|Consented but did not complete survey|0|||
33550742|NCT04314284|62942532|FG001|Overall Study|Consented but did not complete survey|6|||
33550743|NCT04246489|62942538|FG000|Overall Study|Ongoing at cut-off date|6|||
33550744|NCT04203823|62942544|FG000|Overall Study|Withdrawal by Subject|2|||
33550745|NCT04203823|62942545|FG001|Overall Study|Withdrawal by Subject|2|||
33550746|NCT04203823|62942544|FG000|Overall Study|Adverse Event|1|||
33550747|NCT04203823|62942545|FG001|Overall Study|Adverse Event|1|||
33550748|NCT04203823|62942544|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33550749|NCT04203823|62942545|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
33550750|NCT03703466|62942598|FG000|Overall Study|Death|2|||
33550751|NCT03703466|62942599|FG001|Overall Study|Death|1|||
33550752|NCT03703466|62942600|FG002|Overall Study|Death|0|||
33550753|NCT03703466|62942598|FG000|Overall Study|Protocol Violation|1|||
33550754|NCT03703466|62942599|FG001|Overall Study|Protocol Violation|0|||
33550755|NCT03703466|62942600|FG002|Overall Study|Protocol Violation|0|||
33550756|NCT03703466|62942598|FG000|Overall Study|Withdrawal by Subject|0|||
33550757|NCT03703466|62942599|FG001|Overall Study|Withdrawal by Subject|3|||
33550758|NCT03703466|62942600|FG002|Overall Study|Withdrawal by Subject|0|||
33550759|NCT03703466|62942598|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1|||
33550760|NCT03703466|62942599|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
33550761|NCT03703466|62942600|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
33550762|NCT03248128|62942659|FG000|Overall Study|Lost to Follow-up|1|||
33550763|NCT03248128|62942660|FG001|Overall Study|Lost to Follow-up|0|||
33550764|NCT03248128|62942659|FG000|Overall Study|Withdrawal by Subject|16|||
33550765|NCT03248128|62942660|FG001|Overall Study|Withdrawal by Subject|14|||
33550766|NCT03248128|62942659|FG000|Overall Study|Site Closed|4|||
33550767|NCT03248128|62942660|FG001|Overall Study|Site Closed|3|||
33550768|NCT03248128|62942659|FG000|Overall Study|Randomized, but did not receive treatment|1|||
33550769|NCT03248128|62942660|FG001|Overall Study|Randomized, but did not receive treatment|3|||
33550770|NCT02802631|62942703|FG000|Overall Study|Withdrawal by Subject|1|||
33550771|NCT02802631|62942704|FG001|Overall Study|Withdrawal by Subject|0|||
33550772|NCT02802631|62942705|FG002|Overall Study|Withdrawal by Subject|0|||
33550773|NCT02802631|62942706|FG003|Overall Study|Withdrawal by Subject|0|||
33550774|NCT02802631|62942707|FG004|Overall Study|Withdrawal by Subject|0|||
33550775|NCT02802631|62942708|FG005|Overall Study|Withdrawal by Subject|0|||
33550776|NCT02802631|62942709|FG006|Overall Study|Withdrawal by Subject|0|||
33550777|NCT02802631|62942710|FG007|Overall Study|Withdrawal by Subject|0|||
33550778|NCT02802631|62942703|FG000|Overall Study|Physician Decision|1|||
33550779|NCT02802631|62942704|FG001|Overall Study|Physician Decision|0|||
33550780|NCT02802631|62942705|FG002|Overall Study|Physician Decision|0|||
33550781|NCT02802631|62942706|FG003|Overall Study|Physician Decision|0|||
33550782|NCT02802631|62942707|FG004|Overall Study|Physician Decision|0|||
33550783|NCT02802631|62942708|FG005|Overall Study|Physician Decision|0|||
33550784|NCT02802631|62942709|FG006|Overall Study|Physician Decision|1|||
33550785|NCT02802631|62942710|FG007|Overall Study|Physician Decision|0|||
33550786|NCT02802631|62942703|FG000|Overall Study|Adverse Event|0|||
33550787|NCT02802631|62942704|FG001|Overall Study|Adverse Event|2|||
33550788|NCT02802631|62942705|FG002|Overall Study|Adverse Event|0|||
33550789|NCT02802631|62942706|FG003|Overall Study|Adverse Event|1|||
33550790|NCT02802631|62942707|FG004|Overall Study|Adverse Event|6|||
33550791|NCT02802631|62942708|FG005|Overall Study|Adverse Event|1|||
33550792|NCT02802631|62942709|FG006|Overall Study|Adverse Event|4|||
33550793|NCT02802631|62942710|FG007|Overall Study|Adverse Event|0|||
33550794|NCT02802631|62942703|FG000|Overall Study|Sponsor Decision|0|||
33550795|NCT02802631|62942704|FG001|Overall Study|Sponsor Decision|0|||
33550796|NCT02802631|62942705|FG002|Overall Study|Sponsor Decision|6|||
33550797|NCT02802631|62942706|FG003|Overall Study|Sponsor Decision|0|||
33550798|NCT02802631|62942707|FG004|Overall Study|Sponsor Decision|2|||
33550799|NCT02802631|62942708|FG005|Overall Study|Sponsor Decision|0|||
33550800|NCT02802631|62942709|FG006|Overall Study|Sponsor Decision|0|||
33550801|NCT02802631|62942710|FG007|Overall Study|Sponsor Decision|4|||
33550802|NCT02754479|62942742|FG000|Overall Study|Lost to Follow-up|1|||
33550803|NCT02036476|62942755|FG000|Overall Study|Withdrawal by Subject|2|||
33550804|NCT02036476|62942755|FG000|Overall Study|Progressive Disease|4|||
33550805|NCT02036476|62942755|FG000|Overall Study|Unacceptable Toxicity|2|||
33550806|NCT00643994|62942805|FG000|Overall Study|Death|24|||
33550807|NCT00643994|62942805|FG000|Overall Study|Lost to Follow-up|72|||
33550808|NCT00643617|62942811|FG000|Overall Study|Death|6|||
33550809|NCT00643617|62942812|FG001|Overall Study|Death|9|||
33550810|NCT00643617|62942811|FG000|Overall Study|Lost to Follow-up|42|||
33550811|NCT00643617|62942812|FG001|Overall Study|Lost to Follow-up|51|||
33550812|NCT00504582|62942839|FG000|Overall Study|Lost to Follow-up|1|||
33550813|NCT00504582|62942840|FG001|Overall Study|Lost to Follow-up|0|||
33550814|NCT00504582|62942841|FG002|Overall Study|Lost to Follow-up|0|||
33550815|NCT00314366|62942864|FG000|Overall Study|not treated due to patient medical condi|1|||
33550816|NCT00314366|62942865|FG001|Overall Study|not treated due to patient medical condi|0|||
33550817|NCT01595061|62942874|FG000|Overall Study|Never Treated|3|||
33550818|NCT01595061|62942874|FG000|Overall Study|Inadequate Pathology|1|||
33550819|NCT02852005|62942895|FG000|Overall Study|Lost to Follow-up|0|||
33550820|NCT02852005|62942896|FG001|Overall Study|Lost to Follow-up|0|||
33550821|NCT02852005|62942897|FG002|Overall Study|Lost to Follow-up|0|||
33550822|NCT02852005|62942898|FG003|Overall Study|Lost to Follow-up|0|||
33550823|NCT02852005|62942899|FG004|Overall Study|Lost to Follow-up|1|||
33550824|NCT02852005|62942895|FG000|Overall Study|Withdrawal by Subject|1|||
33550825|NCT02852005|62942896|FG001|Overall Study|Withdrawal by Subject|0|||
33550826|NCT02852005|62942897|FG002|Overall Study|Withdrawal by Subject|0|||
33550827|NCT02852005|62942898|FG003|Overall Study|Withdrawal by Subject|0|||
33550828|NCT02852005|62942899|FG004|Overall Study|Withdrawal by Subject|0|||
33550829|NCT02851615|62942915|FG000|Overall Study|Cognitive Issue|1|||
33550830|NCT02851615|62942916|FG001|Overall Study|Cognitive Issue|0|||
33550831|NCT02851615|62942915|FG000|Overall Study|Lost to Follow-up|0|||
33550832|NCT02851615|62942916|FG001|Overall Study|Lost to Follow-up|4|||
33550833|NCT02849743|62942925|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
33550834|NCT02849743|62942926|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
33550835|NCT02849743|62942925|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
33550836|NCT02849743|62942926|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
33550837|NCT02851069|62942961|FG000|Overall Study|Failure to Return|3|||
33550838|NCT02851069|62942961|FG000|Overall Study|Other|3|||
33550839|NCT02849509|62942969|FG000|Overall Study|Worsening of disease under study|1|||
33550840|NCT02849509|62942970|FG001|Overall Study|Worsening of disease under study|1|||
33550841|NCT02849509|62942971|FG002|Overall Study|Worsening of disease under study|1|||
33550842|NCT02849509|62942969|FG000|Overall Study|Worsening of other pre-existing disease|0|||
33550843|NCT02849509|62942970|FG001|Overall Study|Worsening of other pre-existing disease|1|||
33550844|NCT02849509|62942971|FG002|Overall Study|Worsening of other pre-existing disease|2|||
33550845|NCT02849509|62942969|FG000|Overall Study|Other adverse event|36|||
33550846|NCT02849509|62942970|FG001|Overall Study|Other adverse event|41|||
33550847|NCT02849509|62942971|FG002|Overall Study|Other adverse event|8|||
33550848|NCT02849509|62942969|FG000|Overall Study|Withdrawal by Subject|6|||
33550849|NCT02849509|62942970|FG001|Overall Study|Withdrawal by Subject|17|||
33550850|NCT02849509|62942971|FG002|Overall Study|Withdrawal by Subject|12|||
33550851|NCT02849509|62942969|FG000|Overall Study|Lost to Follow-up|27|||
33550852|NCT02849509|62942970|FG001|Overall Study|Lost to Follow-up|67|||
33479054|NCT03637374|62855199|FG000|Overall Study|Death|2|||
33479055|NCT03637374|62855200|FG001|Overall Study|Death|0|||
33479056|NCT03421730|62855206|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33479057|NCT03421730|62855207|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
33479058|NCT03421730|62855208|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33479059|NCT03421730|62855209|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33479060|NCT03421730|62855210|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33479061|NCT03421730|62855211|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33479062|NCT03421730|62855212|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33479063|NCT03421730|62855213|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33479064|NCT03421730|62855214|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33479065|NCT03421730|62855215|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33479066|NCT03421730|62855216|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33550853|NCT02849509|62942971|FG002|Overall Study|Lost to Follow-up|36|||
33550854|NCT02849509|62942969|FG000|Overall Study|Other, reason not specified|14|||
33550855|NCT02849509|62942970|FG001|Overall Study|Other, reason not specified|29|||
33550856|NCT02849509|62942971|FG002|Overall Study|Other, reason not specified|25|||
33550857|NCT02849509|62942969|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
33550858|NCT02849509|62942970|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
33550859|NCT02849509|62942971|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
33550860|NCT02848729|62942983|FG000|Overall Study|Withdrawal by Subject|1|||
33550861|NCT02848729|62942984|FG001|Overall Study|Withdrawal by Subject|0|||
33550862|NCT02848729|62942983|FG000|Overall Study|Emesis|15|||
33550863|NCT02848729|62942984|FG001|Overall Study|Emesis|11|||
33550864|NCT00158756|62943002|FG000|Overall Study|Withdrawal by Subject|5|||
33550865|NCT00158756|62943003|FG001|Overall Study|Withdrawal by Subject|0|||
33550866|NCT00158756|62943004|FG002|Overall Study|Withdrawal by Subject|6|||
33550867|NCT00158756|62943005|FG003|Overall Study|Withdrawal by Subject|1|||
33550868|NCT00158756|62943006|FG004|Overall Study|Withdrawal by Subject|3|||
33550869|NCT00158756|62943002|FG000|Overall Study|Adverse Event|0|||
33550870|NCT00158756|62943003|FG001|Overall Study|Adverse Event|0|||
33550871|NCT00158756|62943004|FG002|Overall Study|Adverse Event|1|||
33550872|NCT00158756|62943005|FG003|Overall Study|Adverse Event|0|||
33550873|NCT00158756|62943006|FG004|Overall Study|Adverse Event|0|||
33550874|NCT00158756|62943002|FG000|Overall Study|Serious adverse event|0|||
33550875|NCT00158756|62943003|FG001|Overall Study|Serious adverse event|0|||
33550876|NCT00158756|62943004|FG002|Overall Study|Serious adverse event|1|||
33550877|NCT00158756|62943005|FG003|Overall Study|Serious adverse event|0|||
33550878|NCT00158756|62943006|FG004|Overall Study|Serious adverse event|0|||
33550879|NCT02730195|62943018|FG000|Overall Study|Withdrawal by Subject|1|||
33550880|NCT02730351|62943026|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
33550881|NCT02730351|62943027|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
33550882|NCT02730351|62943026|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
33550883|NCT02730351|62943027|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
33550884|NCT02730351|62943026|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
33479067|NCT03421730|62855217|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33479068|NCT03421730|62855206|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33479069|NCT03421730|62855207|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33479070|NCT03421730|62855208|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33479071|NCT03421730|62855209|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33479072|NCT03421730|62855210|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
33479073|NCT03421730|62855211|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33479074|NCT03421730|62855212|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33479075|NCT03421730|62855213|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33479076|NCT03421730|62855214|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33479077|NCT03421730|62855215|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33479078|NCT03421730|62855216|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33479079|NCT03421730|62855217|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33479080|NCT00054327|62855237|FG000|Overall Study|Engraftment failure|1|||
33479081|NCT00054327|62855238|FG001|Overall Study|Engraftment failure|0|||
33479082|NCT00054327|62855239|FG002|Overall Study|Engraftment failure|0|||
33479083|NCT00054327|62855240|FG003|Overall Study|Engraftment failure|0|||
33479084|NCT00054327|62855241|FG004|Overall Study|Engraftment failure|0|||
33479085|NCT00054327|62855242|FG005|Overall Study|Engraftment failure|0|||
33479086|NCT03503162|62855256|FG000|Overall Study|did not meet eligibility|1|||
33479087|NCT03029650|62855260|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
33479088|NCT03029650|62855261|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
33479089|NCT03029650|62855260|FG000|Washout (1 Week)|Physician Decision|0|||
33479090|NCT03029650|62855261|FG001|Washout (1 Week)|Physician Decision|1|||
33479091|NCT03462680|62855273|FG000|Overall Study|Withdrawal by Subject|3|||
33479092|NCT03462680|62855274|FG001|Overall Study|Withdrawal by Subject|5|||
33479093|NCT03636906|62855283|FG000|Overall Study|Adverse Event|0|||
33479094|NCT03636906|62855284|FG001|Overall Study|Adverse Event|0|||
33479095|NCT03636906|62855285|FG002|Overall Study|Adverse Event|1|||
33479096|NCT03636906|62855283|FG000|Overall Study|Lost to Follow-up|1|||
33479097|NCT03636906|62855284|FG001|Overall Study|Lost to Follow-up|0|||
33479098|NCT03636906|62855285|FG002|Overall Study|Lost to Follow-up|0|||
33479099|NCT03636906|62855283|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
33479100|NCT03636906|62855284|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
33479101|NCT03636906|62855285|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
33550885|NCT02730351|62943027|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
33550886|NCT02730351|62943026|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
33550887|NCT02730351|62943027|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
33550888|NCT02730351|62943026|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
33550889|NCT02730351|62943027|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
33550890|NCT01376349|62943036|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
33550891|NCT01376349|62943037|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
33550892|NCT01376349|62943038|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
33550893|NCT01376349|62943036|FG000|Raondomized Treatment|Adverse Event|13|||
33550894|NCT01376349|62943037|FG001|Raondomized Treatment|Adverse Event|17|||
33479102|NCT03636906|62855283|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
33479103|NCT03636906|62855284|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33479104|NCT03636906|62855285|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
33479105|NCT03636906|62855283|FG000|Overall Study|Other|0|||
33479106|NCT03636906|62855284|FG001|Overall Study|Other|0|||
33479107|NCT03636906|62855285|FG002|Overall Study|Other|1|||
33479108|NCT03028870|62855303|FG000|Overall Study|Adverse Event|7|||
33479109|NCT03028870|62855304|FG001|Overall Study|Adverse Event|4|||
33479110|NCT03028870|62855305|FG002|Overall Study|Adverse Event|3|||
33479111|NCT03028870|62855306|FG003|Overall Study|Adverse Event|3|||
33479112|NCT03028870|62855303|FG000|Overall Study|Withdrawal by Subject|1|||
33479113|NCT03028870|62855304|FG001|Overall Study|Withdrawal by Subject|1|||
33479114|NCT03028870|62855305|FG002|Overall Study|Withdrawal by Subject|1|||
33479115|NCT03028870|62855306|FG003|Overall Study|Withdrawal by Subject|2|||
33479116|NCT03028870|62855303|FG000|Overall Study|Lost to Follow-up|1|||
33479117|NCT03028870|62855304|FG001|Overall Study|Lost to Follow-up|0|||
33479118|NCT03028870|62855305|FG002|Overall Study|Lost to Follow-up|0|||
33479119|NCT03028870|62855306|FG003|Overall Study|Lost to Follow-up|0|||
33479120|NCT03028870|62855303|FG000|Overall Study|Lack of Efficacy|3|||
33479121|NCT03028870|62855304|FG001|Overall Study|Lack of Efficacy|0|||
33479122|NCT03028870|62855305|FG002|Overall Study|Lack of Efficacy|0|||
33479123|NCT03028870|62855306|FG003|Overall Study|Lack of Efficacy|0|||
33479124|NCT03028870|62855303|FG000|Overall Study|Administrative|5|||
33479125|NCT03028870|62855304|FG001|Overall Study|Administrative|5|||
33479126|NCT03028870|62855305|FG002|Overall Study|Administrative|12|||
33479127|NCT03028870|62855306|FG003|Overall Study|Administrative|4|||
33479128|NCT03663582|62855316|FG000|Overall Study|Physician Decision|1|||
33479129|NCT03502616|62855322|FG000|Up to Week 16|Withdrawal by Subject|1|||
33479130|NCT03502616|62855323|FG001|Up to Week 16|Withdrawal by Subject|2|||
33479131|NCT03502616|62855322|FG000|Up to Week 16|Lost to Follow-up|0|||
33479132|NCT03502616|62855323|FG001|Up to Week 16|Lost to Follow-up|1|||
33479133|NCT03502616|62855322|FG000|Up to Week 16|Randomized, but not treated|1|||
33479134|NCT03502616|62855323|FG001|Up to Week 16|Randomized, but not treated|0|||
33479135|NCT03502616|62855322|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
33479136|NCT03502616|62855323|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
33479137|NCT03502616|62855322|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
33479138|NCT03502616|62855323|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
33479139|NCT03028012|62855344|FG000|Overall Study|Lost to Follow-up|2|||
33479140|NCT03028012|62855345|FG001|Overall Study|Lost to Follow-up|3|||
33479141|NCT03028012|62855346|FG002|Overall Study|Lost to Follow-up|3|||
33364612|NCT02393248|62743319|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
33364613|NCT02393248|62743320|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
33364614|NCT02393248|62743321|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
33364615|NCT02393248|62743322|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
33364616|NCT02393248|62743323|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
33364617|NCT02393248|62743324|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
33364618|NCT02393248|62743325|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
33364619|NCT02393248|62743326|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
33364620|NCT02393248|62743327|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
33364621|NCT02393248|62743303|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364622|NCT02393248|62743304|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364623|NCT02393248|62743305|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364624|NCT02393248|62743306|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364625|NCT02393248|62743307|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33479142|NCT03635190|62855355|FG000|Overall Study|Lost to Follow-up|4|||
33479143|NCT03635190|62855355|FG000|Overall Study|Death|3|||
33479144|NCT03635190|62855355|FG000|Overall Study|Withdrawal by Subject|1|||
33479145|NCT03635190|62855355|FG000|Overall Study|Patient moved and did not return for follow up|1|||
33479146|NCT03634800|62855362|FG000|Overall Study|Adverse Event|1|||
33479147|NCT03634800|62855362|FG000|Overall Study|Disease Progression|4|||
33550895|NCT01376349|62943038|FG002|Raondomized Treatment|Adverse Event|14|||
33364626|NCT02393248|62743308|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364627|NCT02393248|62743309|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33479148|NCT03634800|62855362|FG000|Overall Study|Withdrawal by Subject|1|||
33479149|NCT03027466|62855370|FG000|Overall Study|Opting out of the app|1869|||
33479150|NCT03027466|62855371|FG001|Overall Study|Opting out of the app|1819|||
33479151|NCT03027466|62855372|FG002|Overall Study|Opting out of the app|1743|||
33479152|NCT03027466|62855373|FG003|Overall Study|Opting out of the app|1821|||
33479153|NCT03662334|62855385|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
33479154|NCT03662334|62855386|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
33479155|NCT02955186|62855394|FG000|Overall Study|Withdrawal by Subject|6|||
33479156|NCT02955186|62855395|FG001|Overall Study|Withdrawal by Subject|2|||
33479157|NCT02955186|62855394|FG000|Overall Study|Protocol Violation|1|||
33479158|NCT02955186|62855395|FG001|Overall Study|Protocol Violation|0|||
33479159|NCT03502070|62855401|FG000|Overall Study|Withdrawal by Subject|1|||
33479160|NCT03502070|62855401|FG000|Overall Study|Screen Failure|1|||
33479161|NCT03586830|62855409|FG000|Overall Study|Site terminated by Sponsor|1|||
33479162|NCT03586830|62855410|FG001|Overall Study|Site terminated by Sponsor|4|||
33479163|NCT03586830|62855411|FG002|Overall Study|Site terminated by Sponsor|3|||
33479164|NCT03586830|62855412|FG003|Overall Study|Site terminated by Sponsor|3|||
33479165|NCT03586830|62855409|FG000|Overall Study|Lost to Follow-up|0|||
33479166|NCT03586830|62855410|FG001|Overall Study|Lost to Follow-up|2|||
33479167|NCT03586830|62855411|FG002|Overall Study|Lost to Follow-up|2|||
33479168|NCT03586830|62855412|FG003|Overall Study|Lost to Follow-up|1|||
33479169|NCT03586830|62855409|FG000|Overall Study|Withdrawal by Subject|1|||
33479170|NCT03586830|62855410|FG001|Overall Study|Withdrawal by Subject|0|||
33550896|NCT01376349|62943036|FG000|Raondomized Treatment|Unkown|1|||
33550897|NCT01376349|62943037|FG001|Raondomized Treatment|Unkown|2|||
33550898|NCT01376349|62943038|FG002|Raondomized Treatment|Unkown|1|||
33550899|NCT01376349|62943036|FG000|Raondomized Treatment|Alternative Treatment|0|||
33550900|NCT01376349|62943037|FG001|Raondomized Treatment|Alternative Treatment|0|||
33550901|NCT01376349|62943038|FG002|Raondomized Treatment|Alternative Treatment|1|||
33550902|NCT00158600|62943076|FG000|Overall Study|unable to commit time to study|0|||
33550903|NCT00158600|62943077|FG001|Overall Study|unable to commit time to study|1|||
33479171|NCT03586830|62855411|FG002|Overall Study|Withdrawal by Subject|3|||
33479172|NCT03586830|62855412|FG003|Overall Study|Withdrawal by Subject|1|||
33479173|NCT03026530|62855424|FG000|Overall Study|Lost to Follow-up|19|||
33479174|NCT03026530|62855425|FG001|Overall Study|Lost to Follow-up|24|||
33479175|NCT03026530|62855424|FG000|Overall Study|Protocol Violation|2|||
33479176|NCT03026530|62855425|FG001|Overall Study|Protocol Violation|5|||
33479177|NCT03418376|62855435|FG000|Overall Study|Musculoskeletal injury|1|||
33479178|NCT03418376|62855436|FG001|Overall Study|Musculoskeletal injury|2|||
33479179|NCT03418376|62855437|FG002|Overall Study|Musculoskeletal injury|1|||
33479180|NCT03418376|62855438|FG003|Overall Study|Musculoskeletal injury|0|||
33479181|NCT03418376|62855435|FG000|Overall Study|Personal reasons|0|||
33479182|NCT03418376|62855436|FG001|Overall Study|Personal reasons|2|||
33479183|NCT03418376|62855437|FG002|Overall Study|Personal reasons|2|||
33479184|NCT03418376|62855438|FG003|Overall Study|Personal reasons|1|||
33479185|NCT03418376|62855435|FG000|Overall Study|Exacerbation|0|||
33479186|NCT03418376|62855436|FG001|Overall Study|Exacerbation|1|||
33479187|NCT03418376|62855437|FG002|Overall Study|Exacerbation|0|||
33479188|NCT03418376|62855438|FG003|Overall Study|Exacerbation|0|||
33479189|NCT03585504|62855450|FG000|Overall Study|Lost to Follow-up|26|||
33479190|NCT03585504|62855451|FG001|Overall Study|Lost to Follow-up|29|||
33479191|NCT03417830|62855459|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
33479192|NCT03417830|62855460|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
33479193|NCT03576768|62855471|FG000|Overall Study|Lost to Follow-up|3|||
33479194|NCT03576768|62855472|FG001|Overall Study|Lost to Follow-up|3|||
33479195|NCT03576768|62855473|FG002|Overall Study|Lost to Follow-up|0|||
33479196|NCT03576768|62855474|FG003|Overall Study|Lost to Follow-up|0|||
33479197|NCT03576066|62855486|FG000|Overall Study|Noncompliance with study drug|0|||
33479198|NCT03576066|62855487|FG001|Overall Study|Noncompliance with study drug|1|||
33479199|NCT03557034|62855499|FG000|Overall Study|Withdrawal by Subject|1|||
33479200|NCT03557034|62855500|FG001|Overall Study|Withdrawal by Subject|0|||
33479201|NCT03583554|62855506|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
33479202|NCT03583554|62855507|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
33479203|NCT03583554|62855508|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
33479204|NCT03948178|62855519|FG000|Overall Study|Protocol Violation|1|||
33479205|NCT03948178|62855519|FG000|Overall Study|Lost to Follow-up|2|||
33550904|NCT00158600|62943076|FG000|Overall Study|Adverse Event|2|||
33550905|NCT00158600|62943077|FG001|Overall Study|Adverse Event|1|||
33550906|NCT00158600|62943076|FG000|Overall Study|Death|1|||
33550907|NCT00158600|62943077|FG001|Overall Study|Death|0|||
33550908|NCT00158600|62943076|FG000|Overall Study|Withdrawal by Subject|2|||
33550909|NCT00158600|62943077|FG001|Overall Study|Withdrawal by Subject|2|||
33550910|NCT01680458|62943084|FG000|Overall Study|Protocol Violation|3|||
33479206|NCT03948178|62855519|FG000|Overall Study|Withdrawal by Subject|2|||
33479207|NCT03948178|62855519|FG000|Overall Study|Reason not known|2|||
33479208|NCT03948178|62855519|FG000|Overall Study|Personal reason|14|||
33479209|NCT03948178|62855519|FG000|Overall Study|Disease progression|30|||
33550911|NCT04543136|62943088|FG000|Overall Study|Withdrawal by Subject|0|||
33550912|NCT04543136|62943089|FG001|Overall Study|Withdrawal by Subject|1|||
33550913|NCT04543136|62943090|FG002|Overall Study|Withdrawal by Subject|0|||
33550914|NCT04543136|62943091|FG003|Overall Study|Withdrawal by Subject|1|||
33550915|NCT04543136|62943092|FG004|Overall Study|Withdrawal by Subject|0|||
33550916|NCT04543136|62943093|FG005|Overall Study|Withdrawal by Subject|0|||
33550917|NCT00709761|62943101|FG000|Overall Study|Withdrawal by Subject|8|||
33479210|NCT03948178|62855519|FG000|Overall Study|Adverse Event|12|||
33479211|NCT03948178|62855519|FG000|Overall Study|Sponsor terminated study|164|||
33479212|NCT03520920|62855526|FG000|Overall Study|Death|13|||
33550918|NCT00709761|62943101|FG000|Overall Study|study closed/terminated|17|||
33550919|NCT00709761|62943101|FG000|Overall Study|Lost to Follow-up|2|||
33479213|NCT03520920|62855527|FG001|Overall Study|Death|1|||
33479214|NCT03520920|62855528|FG002|Overall Study|Death|0|||
33479215|NCT03520920|62855526|FG000|Overall Study|Withdrawal by Subject|2|||
33479216|NCT03520920|62855527|FG001|Overall Study|Withdrawal by Subject|1|||
33479217|NCT03520920|62855528|FG002|Overall Study|Withdrawal by Subject|0|||
33550920|NCT02848651|62943111|FG000|Overall Study|Death|85|||
33550921|NCT02848651|62943111|FG000|Overall Study|Lost to Follow-up|1|||
33550922|NCT02848651|62943111|FG000|Overall Study|Non-Compliance|1|||
33550923|NCT02848651|62943111|FG000|Overall Study|Symptomatic Deterioration|1|||
33550924|NCT02848651|62943111|FG000|Overall Study|Physician Decision|4|||
33550925|NCT02848651|62943111|FG000|Overall Study|Withdrawal by Subject|14|||
33550926|NCT00709059|62943131|FG000|Overall Study|Lost to Follow-up|34|||
33550927|NCT00709059|62943131|FG000|Overall Study|Withdrawal by Subject|19|||
33550928|NCT00709059|62943131|FG000|Overall Study|Physician Decision|7|||
33550929|NCT00709059|62943131|FG000|Overall Study|Disease complication|3|||
33550930|NCT00709059|62943131|FG000|Overall Study|Side effects|20|||
33550931|NCT00709059|62943131|FG000|Overall Study|Serious side effects|11|||
33550932|NCT01678820|62943138|FG000|Overall Study|Study Terminated by Sponsor|45|||
33550933|NCT01678820|62943139|FG001|Overall Study|Study Terminated by Sponsor|43|||
33550934|NCT01678820|62943140|FG002|Overall Study|Study Terminated by Sponsor|43|||
33550935|NCT01678820|62943138|FG000|Overall Study|Withdrawal by Subject|2|||
33550936|NCT01678820|62943139|FG001|Overall Study|Withdrawal by Subject|5|||
33550937|NCT01678820|62943140|FG002|Overall Study|Withdrawal by Subject|2|||
33550938|NCT01678820|62943138|FG000|Overall Study|Protocol Specified Criteria|2|||
33550939|NCT01678820|62943139|FG001|Overall Study|Protocol Specified Criteria|3|||
33550940|NCT01678820|62943140|FG002|Overall Study|Protocol Specified Criteria|1|||
33550941|NCT01678820|62943138|FG000|Overall Study|Adverse Event|2|||
33550942|NCT01678820|62943139|FG001|Overall Study|Adverse Event|2|||
33550943|NCT01678820|62943140|FG002|Overall Study|Adverse Event|2|||
33550944|NCT01678820|62943138|FG000|Overall Study|Lost to Follow-up|7|||
33550945|NCT01678820|62943139|FG001|Overall Study|Lost to Follow-up|2|||
33550946|NCT01678820|62943140|FG002|Overall Study|Lost to Follow-up|2|||
33550947|NCT01678820|62943138|FG000|Overall Study|Non-compliance with study drug|0|||
33550948|NCT01678820|62943139|FG001|Overall Study|Non-compliance with study drug|1|||
33550949|NCT01678820|62943140|FG002|Overall Study|Non-compliance with study drug|0|||
33550950|NCT01678820|62943138|FG000|Overall Study|Physician Decision|0|||
33550951|NCT01678820|62943139|FG001|Overall Study|Physician Decision|0|||
33550952|NCT01678820|62943140|FG002|Overall Study|Physician Decision|1|||
33550953|NCT01678820|62943138|FG000|Overall Study|Protocol Violation|4|||
33550954|NCT01678820|62943139|FG001|Overall Study|Protocol Violation|5|||
33550955|NCT01678820|62943140|FG002|Overall Study|Protocol Violation|4|||
33550956|NCT01678820|62943138|FG000|Overall Study|Not treated with double-blind study drug|0|||
33550957|NCT01678820|62943139|FG001|Overall Study|Not treated with double-blind study drug|2|||
33550958|NCT01678820|62943140|FG002|Overall Study|Not treated with double-blind study drug|2|||
33550959|NCT02660138|62943152|FG000|Overall Study|Adverse Event|0|||
33550960|NCT02660138|62943153|FG001|Overall Study|Adverse Event|3|||
33550961|NCT02660138|62943154|FG002|Overall Study|Adverse Event|2|||
33550962|NCT02660138|62943152|FG000|Overall Study|Lack of Efficacy|1|||
33550963|NCT02660138|62943153|FG001|Overall Study|Lack of Efficacy|2|||
33550964|NCT02660138|62943154|FG002|Overall Study|Lack of Efficacy|1|||
33479218|NCT03520920|62855526|FG000|Overall Study|Study Terminated by the Sponsor|5|||
33479219|NCT03520920|62855527|FG001|Overall Study|Study Terminated by the Sponsor|14|||
33479220|NCT03520920|62855528|FG002|Overall Study|Study Terminated by the Sponsor|5|||
33479221|NCT02953340|62855544|FG000|Overall Study|Death|0|||
33479222|NCT02953340|62855545|FG001|Overall Study|Death|1|||
33479223|NCT02953340|62855544|FG000|Overall Study|Investigator Decision|3|||
33479224|NCT02953340|62855545|FG001|Overall Study|Investigator Decision|3|||
33479225|NCT02953340|62855544|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
33479226|NCT02953340|62855545|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
33479227|NCT02953340|62855544|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
33479228|NCT02953340|62855545|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
33479229|NCT02953340|62855544|FG000|Overall Study|Withdrawal by Subject|9|||
33479230|NCT02953340|62855545|FG001|Overall Study|Withdrawal by Subject|9|||
33479231|NCT02953340|62855544|FG000|Overall Study|Sponsor decision|0|||
33479232|NCT02953340|62855545|FG001|Overall Study|Sponsor decision|2|||
33479233|NCT02953340|62855544|FG000|Overall Study|Lost to Follow-up|3|||
33550965|NCT02660138|62943152|FG000|Overall Study|Withdrawal by Subject|7|||
33550966|NCT02660138|62943153|FG001|Overall Study|Withdrawal by Subject|6|||
33550967|NCT02660138|62943154|FG002|Overall Study|Withdrawal by Subject|6|||
33550968|NCT02660138|62943152|FG000|Overall Study|Lost to Follow-up|4|||
33550969|NCT02660138|62943153|FG001|Overall Study|Lost to Follow-up|4|||
33479234|NCT02953340|62855545|FG001|Overall Study|Lost to Follow-up|2|||
33479235|NCT02953340|62855544|FG000|Overall Study|Reason not specified|2|||
33550970|NCT02660138|62943154|FG002|Overall Study|Lost to Follow-up|1|||
33479236|NCT02953340|62855545|FG001|Overall Study|Reason not specified|2|||
33479237|NCT03554772|62855561|FG000|Overall Study|Lost to Follow-up|0|||
33479238|NCT03554772|62855562|FG001|Overall Study|Lost to Follow-up|0|||
33479239|NCT03554772|62855563|FG002|Overall Study|Lost to Follow-up|0|||
33479240|NCT03554772|62855564|FG003|Overall Study|Lost to Follow-up|2|||
33479241|NCT03573804|62855574|FG000|Overall Study|claustrophobia or MRI table problems|10|||
33479242|NCT03417440|62855592|FG000|Overall Study|Lost to Follow-up|0|||
33479243|NCT03417440|62855593|FG001|Overall Study|Lost to Follow-up|1|||
33479244|NCT03417440|62855594|FG002|Overall Study|Lost to Follow-up|0|||
33479245|NCT03417440|62855595|FG003|Overall Study|Lost to Follow-up|0|||
33479246|NCT03417440|62855596|FG004|Overall Study|Lost to Follow-up|1|||
33479247|NCT03417440|62855597|FG005|Overall Study|Lost to Follow-up|0|||
33479248|NCT03417440|62855598|FG006|Overall Study|Lost to Follow-up|0|||
33479249|NCT03417440|62855599|FG007|Overall Study|Lost to Follow-up|0|||
33479250|NCT03417440|62855592|FG000|Overall Study|Withdrawal by Subject|2|||
33479251|NCT03417440|62855593|FG001|Overall Study|Withdrawal by Subject|0|||
33479252|NCT03417440|62855594|FG002|Overall Study|Withdrawal by Subject|2|||
33479253|NCT03417440|62855595|FG003|Overall Study|Withdrawal by Subject|1|||
33479254|NCT03417440|62855596|FG004|Overall Study|Withdrawal by Subject|1|||
33479255|NCT03417440|62855597|FG005|Overall Study|Withdrawal by Subject|0|||
33479256|NCT03417440|62855598|FG006|Overall Study|Withdrawal by Subject|0|||
33479257|NCT03417440|62855599|FG007|Overall Study|Withdrawal by Subject|1|||
33479258|NCT03458702|62855622|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
33479259|NCT03458702|62855623|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
33479260|NCT03458702|62855622|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
33479261|NCT03458702|62855623|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
33479262|NCT03454412|62855629|FG000|Baseline Assesment|Physician Decision|12|||
33479263|NCT03452540|62855633|FG000|Overall Study|Adverse Event|1|||
33479264|NCT03452540|62855633|FG000|Overall Study|Withdrawal by Subject|1|||
33479265|NCT03452540|62855633|FG000|Overall Study|Other SAE and AE|2|||
33479266|NCT03573336|62855640|FG000|Overall Study|Study terminated|2|||
33479267|NCT03573336|62855641|FG001|Overall Study|Study terminated|4|||
33479268|NCT03573336|62855642|FG002|Overall Study|Study terminated|2|||
33479269|NCT03500198|62855652|FG000|Overall Study|Lost to Follow-up|0|||
33479270|NCT03500198|62855653|FG001|Overall Study|Lost to Follow-up|1|||
33479271|NCT03553758|62855661|FG000|Overall Study|Lost to Follow-up|1|||
33479272|NCT03552198|62855671|FG000|Overall Study|Lost to Follow-up|42|||
33479273|NCT03552198|62855672|FG001|Overall Study|Lost to Follow-up|48|||
33479274|NCT03552198|62855673|FG002|Overall Study|Lost to Follow-up|15|||
33479275|NCT03552198|62855674|FG003|Overall Study|Lost to Follow-up|19|||
33479276|NCT03552198|62855671|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
33479277|NCT03552198|62855672|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
33479278|NCT03552198|62855673|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
33479279|NCT03552198|62855674|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
33479280|NCT03552198|62855671|FG000|Overall Study|Did not receive air alerts|1|||
33479281|NCT03552198|62855672|FG001|Overall Study|Did not receive air alerts|0|||
33479282|NCT03552198|62855673|FG002|Overall Study|Did not receive air alerts|0|||
33479283|NCT03552198|62855674|FG003|Overall Study|Did not receive air alerts|1|||
33479284|NCT02954354|62855687|FG000|Overall Study|Adverse Event|2|||
33479285|NCT02954354|62855688|FG001|Overall Study|Adverse Event|2|||
33479286|NCT02954354|62855689|FG002|Overall Study|Adverse Event|4|||
33479287|NCT02954354|62855687|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
33479288|NCT02954354|62855688|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
33479289|NCT02954354|62855689|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
33479290|NCT02954354|62855687|FG000|Overall Study|Lack of Efficacy|0|||
33479291|NCT02954354|62855688|FG001|Overall Study|Lack of Efficacy|2|||
33479292|NCT02954354|62855689|FG002|Overall Study|Lack of Efficacy|0|||
33479293|NCT02954354|62855687|FG000|Overall Study|Withdrawal by Subject|17|||
33479294|NCT02954354|62855688|FG001|Overall Study|Withdrawal by Subject|9|||
33479295|NCT02954354|62855689|FG002|Overall Study|Withdrawal by Subject|11|||
33479296|NCT02954354|62855687|FG000|Overall Study|Lost to Follow-up|12|||
33479297|NCT02954354|62855688|FG001|Overall Study|Lost to Follow-up|5|||
33479298|NCT02954354|62855689|FG002|Overall Study|Lost to Follow-up|0|||
33479299|NCT02954354|62855687|FG000|Overall Study|Miscellaneous|2|||
33479300|NCT02954354|62855688|FG001|Overall Study|Miscellaneous|2|||
33479301|NCT02954354|62855689|FG002|Overall Study|Miscellaneous|1|||
33479302|NCT03519516|62855701|FG000|Overall Study|Adverse Event|0|||
33479303|NCT03519516|62855702|FG001|Overall Study|Adverse Event|1|||
33479304|NCT03519204|62855710|FG000|Overall Study|Lost to Follow-up|3|||
33479305|NCT03519204|62855711|FG001|Overall Study|Lost to Follow-up|8|||
33479306|NCT03519204|62855710|FG000|Overall Study|Withdrawal by Subject|9|||
33550971|NCT02660138|62943152|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
33479307|NCT03519204|62855711|FG001|Overall Study|Withdrawal by Subject|7|||
33479308|NCT03519204|62855710|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33479309|NCT03519204|62855711|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33479310|NCT03518658|62855723|FG000|Overall Study|Other|51|||
33479311|NCT03518658|62855724|FG001|Overall Study|Other|0|||
33479312|NCT03518112|62855732|FG000|Overall Study|Withdrawal by Subject|1|||
33479313|NCT03706456|62855736|FG000|Overall Study|Lack of Efficacy|1|||
33479314|NCT03706456|62855736|FG000|Overall Study|Ongoing|21|||
33479315|NCT03517566|62855745|FG000|Overall Study|Adverse Event|5|||
33479316|NCT03517566|62855746|FG001|Overall Study|Adverse Event|2|||
33479317|NCT03517566|62855747|FG002|Overall Study|Adverse Event|2|||
33479318|NCT03517566|62855748|FG003|Overall Study|Adverse Event|8|||
33479319|NCT03517566|62855749|FG004|Overall Study|Adverse Event|7|||
33479320|NCT03517566|62855745|FG000|Overall Study|Lack of Efficacy|3|||
33479321|NCT03517566|62855746|FG001|Overall Study|Lack of Efficacy|2|||
33479322|NCT03517566|62855747|FG002|Overall Study|Lack of Efficacy|1|||
33479323|NCT03517566|62855748|FG003|Overall Study|Lack of Efficacy|1|||
33479324|NCT03517566|62855749|FG004|Overall Study|Lack of Efficacy|4|||
33550972|NCT02660138|62943153|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
33550973|NCT02660138|62943154|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
33550974|NCT02660138|62943152|FG000|Overall Study|Other|1|||
33550975|NCT02660138|62943153|FG001|Overall Study|Other|1|||
33550976|NCT02660138|62943154|FG002|Overall Study|Other|0|||
33550977|NCT02660138|62943152|FG000|Overall Study|Not treated|0|||
33479325|NCT03517566|62855745|FG000|Overall Study|Lost to Follow-up|3|||
33479326|NCT03517566|62855746|FG001|Overall Study|Lost to Follow-up|1|||
33479327|NCT03517566|62855747|FG002|Overall Study|Lost to Follow-up|1|||
33479328|NCT03517566|62855748|FG003|Overall Study|Lost to Follow-up|1|||
33479329|NCT03517566|62855749|FG004|Overall Study|Lost to Follow-up|0|||
33479330|NCT03517566|62855745|FG000|Overall Study|Physician Decision|1|||
33479331|NCT03517566|62855746|FG001|Overall Study|Physician Decision|1|||
33479332|NCT03517566|62855747|FG002|Overall Study|Physician Decision|0|||
33479333|NCT03517566|62855748|FG003|Overall Study|Physician Decision|1|||
33479334|NCT03517566|62855749|FG004|Overall Study|Physician Decision|0|||
33479335|NCT03517566|62855745|FG000|Overall Study|Pregnancy|0|||
33479336|NCT03517566|62855746|FG001|Overall Study|Pregnancy|1|||
33479337|NCT03517566|62855747|FG002|Overall Study|Pregnancy|0|||
33550978|NCT02660138|62943153|FG001|Overall Study|Not treated|1|||
33550979|NCT02660138|62943154|FG002|Overall Study|Not treated|0|||
33550980|NCT01603394|62943165|FG000|Overall Study|Adverse Event|1|||
33550981|NCT02729025|62943171|FG000|Overall Study|Sponsor Decision|0|||
33550982|NCT02729025|62943172|FG001|Overall Study|Sponsor Decision|1|||
33550983|NCT01603082|62943180|FG000|Overall Study|Adverse Event|0|||
33550984|NCT01603082|62943181|FG001|Overall Study|Adverse Event|1|||
33550985|NCT01603082|62943180|FG000|Overall Study|Withdrawal by Subject|1|||
33550986|NCT01603082|62943181|FG001|Overall Study|Withdrawal by Subject|0|||
33550987|NCT01603082|62943180|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
33479338|NCT03517566|62855748|FG003|Overall Study|Pregnancy|0|||
33479339|NCT03517566|62855749|FG004|Overall Study|Pregnancy|0|||
33479340|NCT03517566|62855745|FG000|Overall Study|Protocol Deviation|0|||
33479341|NCT03517566|62855746|FG001|Overall Study|Protocol Deviation|1|||
33479342|NCT03517566|62855747|FG002|Overall Study|Protocol Deviation|0|||
33479343|NCT03517566|62855748|FG003|Overall Study|Protocol Deviation|1|||
33479344|NCT03517566|62855749|FG004|Overall Study|Protocol Deviation|1|||
33479345|NCT03517566|62855745|FG000|Overall Study|Study terminated by Sponsor|11|||
33479346|NCT03517566|62855746|FG001|Overall Study|Study terminated by Sponsor|5|||
33479347|NCT03517566|62855747|FG002|Overall Study|Study terminated by Sponsor|6|||
33479348|NCT03517566|62855748|FG003|Overall Study|Study terminated by Sponsor|14|||
33479349|NCT03517566|62855749|FG004|Overall Study|Study terminated by Sponsor|12|||
33479350|NCT03517566|62855745|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
33479351|NCT03517566|62855746|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
33479352|NCT03517566|62855747|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
33550988|NCT01603082|62943181|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
33550989|NCT02846779|62943194|FG000|Overall Study|Lost Enrollment|83|||
33479353|NCT03517566|62855748|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
33479354|NCT03517566|62855749|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
33479355|NCT03916744|62855765|FG000|Overall Study|Withdrawal by Subject|0|||
33479356|NCT03916744|62855766|FG001|Overall Study|Withdrawal by Subject|1|||
33550990|NCT02846779|62943195|FG001|Overall Study|Lost Enrollment|82|||
33479357|NCT03916744|62855767|FG002|Overall Study|Withdrawal by Subject|2|||
33479358|NCT03639610|62855782|FG000|Overall Study|Adverse Event|7|||
33479359|NCT03639610|62855783|FG001|Overall Study|Adverse Event|1|||
33479360|NCT03639610|62855784|FG002|Overall Study|Adverse Event|0|||
33479361|NCT03639610|62855782|FG000|Overall Study|Physician Decision|3|||
33479362|NCT03639610|62855783|FG001|Overall Study|Physician Decision|1|||
33479363|NCT03639610|62855784|FG002|Overall Study|Physician Decision|0|||
33479364|NCT03639610|62855782|FG000|Overall Study|Disease progression|8|||
33550991|NCT02846779|62943196|FG002|Overall Study|Lost Enrollment|86|||
33550992|NCT02846779|62943194|FG000|Overall Study|Less than 31 days of follow-up|56|||
33479365|NCT03639610|62855783|FG001|Overall Study|Disease progression|5|||
33479366|NCT03639610|62855784|FG002|Overall Study|Disease progression|3|||
33479367|NCT03639610|62855782|FG000|Overall Study|Study terminated by sponsor|2|||
33479368|NCT03639610|62855783|FG001|Overall Study|Study terminated by sponsor|1|||
33479369|NCT03639610|62855784|FG002|Overall Study|Study terminated by sponsor|1|||
33479370|NCT03639610|62855782|FG000|Overall Study|Patient request to stop treatment|1|||
33479371|NCT03639610|62855783|FG001|Overall Study|Patient request to stop treatment|2|||
33479372|NCT03639610|62855784|FG002|Overall Study|Patient request to stop treatment|0|||
33479373|NCT02954406|62855802|FG000|Overall Study|Adverse Event|0|||
33479374|NCT02954406|62855803|FG001|Overall Study|Adverse Event|1|||
33479375|NCT02954406|62855804|FG002|Overall Study|Adverse Event|0|||
33479376|NCT02954406|62855805|FG003|Overall Study|Adverse Event|0|||
33479377|NCT02954406|62855806|FG004|Overall Study|Adverse Event|1|||
33479378|NCT02954406|62855807|FG005|Overall Study|Adverse Event|0|||
33479379|NCT02954406|62855808|FG006|Overall Study|Adverse Event|0|||
33479380|NCT02954406|62855809|FG007|Overall Study|Adverse Event|0|||
33479381|NCT02954406|62855810|FG008|Overall Study|Adverse Event|1|||
33479382|NCT02954406|62855811|FG009|Overall Study|Adverse Event|1|||
33479383|NCT02954406|62855812|FG010|Overall Study|Adverse Event|0|||
33479384|NCT02954406|62855802|FG000|Overall Study|Progressive Disease|3|||
33550993|NCT02846779|62943195|FG001|Overall Study|Less than 31 days of follow-up|45|||
33550994|NCT02846779|62943196|FG002|Overall Study|Less than 31 days of follow-up|52|||
33550995|NCT00406393|62943206|FG000|Overall Study|Did not undergo transplantation|2|||
33550996|NCT00406393|62943207|FG001|Overall Study|Did not undergo transplantation|1|||
33550997|NCT02845375|62943216|FG000|Overall Study|upper airway obstruction|1|||
33550998|NCT02845375|62943217|FG001|Overall Study|upper airway obstruction|2|||
33550999|NCT02845375|62943218|FG002|Overall Study|upper airway obstruction|1|||
33551000|NCT02658734|62943226|FG000|Overall Study|Adverse Event|2|||
33551001|NCT02658734|62943226|FG000|Overall Study|Death|4|||
33551002|NCT02658734|62943226|FG000|Overall Study|Lost to Follow-up|7|||
33551003|NCT02658734|62943226|FG000|Overall Study|Withdrawal of Consent|16|||
33551004|NCT02658734|62943226|FG000|Overall Study|Disease Progression|28|||
33551005|NCT02844439|62943230|FG000|Overall Study|Withdrawal by Subject|1|||
33551006|NCT02844439|62943230|FG000|Overall Study|Lost to Follow-up|2|||
33551007|NCT02844439|62943230|FG000|Overall Study|Termination by Sponsor|4|||
33551008|NCT02844439|62943230|FG000|Overall Study|Death|28|||
33551009|NCT02844439|62943230|FG000|Overall Study|Other|5|||
33551010|NCT01677182|62943244|FG000|Overall Study|Adverse Event|2|||
33551011|NCT01677182|62943245|FG001|Overall Study|Adverse Event|1|||
33551012|NCT01677182|62943246|FG002|Overall Study|Adverse Event|8|||
33551013|NCT01677182|62943244|FG000|Overall Study|Protocol Violation|5|||
33551014|NCT01677182|62943245|FG001|Overall Study|Protocol Violation|1|||
33551015|NCT01677182|62943246|FG002|Overall Study|Protocol Violation|4|||
33551016|NCT01677182|62943244|FG000|Overall Study|Lost to Follow-up|4|||
33551017|NCT01677182|62943245|FG001|Overall Study|Lost to Follow-up|0|||
33551018|NCT01677182|62943246|FG002|Overall Study|Lost to Follow-up|3|||
33551019|NCT01677182|62943244|FG000|Overall Study|Withdrawal by Subject|7|||
33551020|NCT01677182|62943245|FG001|Overall Study|Withdrawal by Subject|12|||
33551021|NCT01677182|62943246|FG002|Overall Study|Withdrawal by Subject|10|||
33551022|NCT01677182|62943244|FG000|Overall Study|Study termination|12|||
33551023|NCT01677182|62943245|FG001|Overall Study|Study termination|9|||
33551024|NCT01677182|62943246|FG002|Overall Study|Study termination|11|||
33551025|NCT01677182|62943244|FG000|Overall Study|Lack of Efficacy|3|||
33551026|NCT01677182|62943245|FG001|Overall Study|Lack of Efficacy|0|||
33551027|NCT01677182|62943246|FG002|Overall Study|Lack of Efficacy|1|||
33551028|NCT01677182|62943244|FG000|Overall Study|Other reasons|1|||
33551029|NCT01677182|62943245|FG001|Overall Study|Other reasons|5|||
33551030|NCT01677182|62943246|FG002|Overall Study|Other reasons|2|||
33551031|NCT02843659|62943257|FG000|Overall Study|Subject Withdrew Consent|0|||
33551032|NCT02843659|62943258|FG001|Overall Study|Subject Withdrew Consent|0|||
33551033|NCT02843659|62943259|FG002|Overall Study|Subject Withdrew Consent|1|||
33551034|NCT02843659|62943257|FG000|Overall Study|Administrative Reason by Sponsor|4|||
33551035|NCT02843659|62943258|FG001|Overall Study|Administrative Reason by Sponsor|5|||
33364628|NCT02393248|62743310|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33551036|NCT02843659|62943259|FG002|Overall Study|Administrative Reason by Sponsor|4|||
33551037|NCT02843659|62943257|FG000|Overall Study|Adverse Event|0|||
33551038|NCT02843659|62943258|FG001|Overall Study|Adverse Event|1|||
33551039|NCT02843659|62943259|FG002|Overall Study|Adverse Event|0|||
33551040|NCT00708435|62943269|FG000|Overall Study|Death / Serious Adverse Event|10|||
33551041|NCT00708435|62943270|FG001|Overall Study|Death / Serious Adverse Event|5|||
33551042|NCT00708435|62943269|FG000|Overall Study|Lost to Follow-up|9|||
33551043|NCT00708435|62943270|FG001|Overall Study|Lost to Follow-up|4|||
33479385|NCT02954406|62855803|FG001|Overall Study|Progressive Disease|4|||
33479386|NCT02954406|62855804|FG002|Overall Study|Progressive Disease|3|||
33479387|NCT02954406|62855805|FG003|Overall Study|Progressive Disease|4|||
33479388|NCT02954406|62855806|FG004|Overall Study|Progressive Disease|3|||
33551044|NCT00708435|62943269|FG000|Overall Study|Withdrawal by Subject|3|||
33551045|NCT00708435|62943270|FG001|Overall Study|Withdrawal by Subject|7|||
33479389|NCT02954406|62855807|FG005|Overall Study|Progressive Disease|3|||
33479390|NCT02954406|62855808|FG006|Overall Study|Progressive Disease|2|||
33479391|NCT02954406|62855809|FG007|Overall Study|Progressive Disease|2|||
33479392|NCT02954406|62855810|FG008|Overall Study|Progressive Disease|1|||
33479393|NCT02954406|62855811|FG009|Overall Study|Progressive Disease|1|||
33479394|NCT02954406|62855812|FG010|Overall Study|Progressive Disease|0|||
33479395|NCT02954406|62855802|FG000|Overall Study|Symptomatic Deterioration|0|||
33479396|NCT02954406|62855803|FG001|Overall Study|Symptomatic Deterioration|1|||
33479397|NCT02954406|62855804|FG002|Overall Study|Symptomatic Deterioration|0|||
33479398|NCT02954406|62855805|FG003|Overall Study|Symptomatic Deterioration|0|||
33479399|NCT02954406|62855806|FG004|Overall Study|Symptomatic Deterioration|0|||
33479400|NCT02954406|62855807|FG005|Overall Study|Symptomatic Deterioration|0|||
33479401|NCT02954406|62855808|FG006|Overall Study|Symptomatic Deterioration|0|||
33479402|NCT02954406|62855809|FG007|Overall Study|Symptomatic Deterioration|0|||
33479403|NCT02954406|62855810|FG008|Overall Study|Symptomatic Deterioration|0|||
33479404|NCT02954406|62855811|FG009|Overall Study|Symptomatic Deterioration|0|||
33479405|NCT02954406|62855812|FG010|Overall Study|Symptomatic Deterioration|0|||
33479406|NCT02954406|62855802|FG000|Overall Study|Death|0|||
33479407|NCT02954406|62855803|FG001|Overall Study|Death|0|||
33479408|NCT02954406|62855804|FG002|Overall Study|Death|0|||
33479409|NCT02954406|62855805|FG003|Overall Study|Death|0|||
33479410|NCT02954406|62855806|FG004|Overall Study|Death|1|||
33479411|NCT02954406|62855807|FG005|Overall Study|Death|0|||
33364629|NCT02393248|62743311|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364630|NCT02393248|62743312|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364631|NCT02393248|62743313|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364632|NCT02393248|62743314|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
33479412|NCT02954406|62855808|FG006|Overall Study|Death|0|||
33479413|NCT02954406|62855809|FG007|Overall Study|Death|0|||
33479414|NCT02954406|62855810|FG008|Overall Study|Death|1|||
33479415|NCT02954406|62855811|FG009|Overall Study|Death|1|||
33479416|NCT02954406|62855812|FG010|Overall Study|Death|0|||
33479417|NCT02954406|62855802|FG000|Overall Study|Reason Not Specified|0|||
33479418|NCT02954406|62855803|FG001|Overall Study|Reason Not Specified|0|||
33479419|NCT02954406|62855804|FG002|Overall Study|Reason Not Specified|3|||
33479420|NCT02954406|62855805|FG003|Overall Study|Reason Not Specified|2|||
33479421|NCT02954406|62855806|FG004|Overall Study|Reason Not Specified|2|||
33479422|NCT02954406|62855807|FG005|Overall Study|Reason Not Specified|0|||
33479423|NCT02954406|62855808|FG006|Overall Study|Reason Not Specified|1|||
33479424|NCT02954406|62855809|FG007|Overall Study|Reason Not Specified|0|||
33479425|NCT02954406|62855810|FG008|Overall Study|Reason Not Specified|1|||
33479426|NCT02954406|62855811|FG009|Overall Study|Reason Not Specified|0|||
33479427|NCT02954406|62855812|FG010|Overall Study|Reason Not Specified|0|||
33479428|NCT03514914|62855842|FG000|Overall Study|Death|3|||
33479429|NCT03514914|62855843|FG001|Overall Study|Death|3|||
33479430|NCT03514914|62855842|FG000|Overall Study|Lost to Follow-up|117|||
33479431|NCT03514914|62855843|FG001|Overall Study|Lost to Follow-up|89|||
33479432|NCT03513588|62855852|FG000|Overall Study|Lost to Follow-up|0|||
33479433|NCT03513588|62855853|FG001|Overall Study|Lost to Follow-up|1|||
33479434|NCT03513588|62855854|FG002|Overall Study|Lost to Follow-up|1|||
33479435|NCT03513588|62855852|FG000|Overall Study|Study dosing paused by sponsor|1|||
33479436|NCT03513588|62855853|FG001|Overall Study|Study dosing paused by sponsor|1|||
33479437|NCT03513588|62855854|FG002|Overall Study|Study dosing paused by sponsor|0|||
33479438|NCT03513588|62855852|FG000|Overall Study|Death|0|||
33479439|NCT03513588|62855853|FG001|Overall Study|Death|0|||
33479440|NCT03513588|62855854|FG002|Overall Study|Death|1|||
33479441|NCT03512028|62855866|FG000|Overall Study|Withdrawal by Subject|2|||
33479442|NCT03512028|62855867|FG001|Overall Study|Withdrawal by Subject|0|||
33479443|NCT03512028|62855866|FG000|Overall Study|Protocol Violation|2|||
33479444|NCT03512028|62855867|FG001|Overall Study|Protocol Violation|0|||
33479445|NCT03511326|62855873|FG000|Overall Study|Withdrawal by Subject|1|||
33479446|NCT03508830|62855879|FG000|Overall Study|Withdrawal by Subject|3|||
33479447|NCT03508830|62855880|FG001|Overall Study|Withdrawal by Subject|4|||
33479448|NCT03508830|62855879|FG000|Overall Study|Physician Decision|2|||
33479449|NCT03508830|62855880|FG001|Overall Study|Physician Decision|2|||
33364633|NCT02393248|62743315|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364634|NCT02393248|62743316|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
33479450|NCT03508050|62855888|FG000|Overall Study|Pleural adhesions|1|||
33479451|NCT03508050|62855889|FG001|Overall Study|Pleural adhesions|0|||
33479452|NCT03508050|62855888|FG000|Overall Study|Mucus plug|1|||
33479453|NCT03508050|62855889|FG001|Overall Study|Mucus plug|0|||
33479454|NCT03508050|62855888|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
33479455|NCT03508050|62855889|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
33479456|NCT03508050|62855888|FG000|Overall Study|Sustained desaturation|0|||
33479457|NCT03508050|62855889|FG001|Overall Study|Sustained desaturation|1|||
33479458|NCT03569202|62855898|FG000|Part 3|Physician Decision|1|||
33479459|NCT03569202|62855899|FG001|Part 3|Physician Decision|0|||
33479460|NCT03569202|62855898|FG000|Part 3|Other|1|||
33479461|NCT03569202|62855899|FG001|Part 3|Other|1|||
33479462|NCT03568500|62855908|FG000|Overall Study|Lost to Follow-up|1|||
33479463|NCT03568500|62855909|FG001|Overall Study|Lost to Follow-up|1|||
33479464|NCT03568500|62855910|FG002|Overall Study|Lost to Follow-up|2|||
33479465|NCT03568500|62855908|FG000|Overall Study|Adverse Event|1|||
33364635|NCT02393248|62743317|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364636|NCT02393248|62743318|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364637|NCT02393248|62743319|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364638|NCT02393248|62743320|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364639|NCT02393248|62743321|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364640|NCT02393248|62743322|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364641|NCT02393248|62743323|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364642|NCT02393248|62743324|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33479466|NCT03568500|62855909|FG001|Overall Study|Adverse Event|1|||
33479467|NCT03568500|62855910|FG002|Overall Study|Adverse Event|2|||
33479468|NCT03568500|62855908|FG000|Overall Study|Physician Decision|1|||
33479469|NCT03568500|62855909|FG001|Overall Study|Physician Decision|0|||
33479470|NCT03568500|62855910|FG002|Overall Study|Physician Decision|0|||
33479471|NCT03568500|62855908|FG000|Overall Study|Withdrawal by Subject|4|||
33656138|NCT00983073|63074173|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
33656139|NCT00983073|63074173|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
33656140|NCT00983073|63074173|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
33656141|NCT00983073|63074173|FG000|Titration and Optimal Dose Period|Other reason|4|||
33656142|NCT00983073|63074173|FG000|Maintenance Period|Adverse Event|5|||
33656143|NCT00983073|63074173|FG000|Maintenance Period|Withdrawal by Subject|2|||
33656144|NCT00983073|63074173|FG000|Maintenance Period|Lack of Efficacy|2|||
33656145|NCT00983073|63074173|FG000|Maintenance Period|Other Reason|7|||
33656146|NCT00982137|63074182|FG000|Overall Study|Lost to Follow-up|0|||
33479472|NCT03568500|62855909|FG001|Overall Study|Withdrawal by Subject|2|||
33479473|NCT03568500|62855910|FG002|Overall Study|Withdrawal by Subject|0|||
33479474|NCT03568500|62855908|FG000|Overall Study|Technical Problems|2|||
33479475|NCT03568500|62855909|FG001|Overall Study|Technical Problems|1|||
33479476|NCT03568500|62855910|FG002|Overall Study|Technical Problems|0|||
33479477|NCT03568500|62855908|FG000|Overall Study|Participant Noncompliance|1|||
33479478|NCT03568500|62855909|FG001|Overall Study|Participant Noncompliance|1|||
33479479|NCT03568500|62855910|FG002|Overall Study|Participant Noncompliance|0|||
33479480|NCT03504852|62855935|FG000|Overall Study|Withdrawal of informed consent|2|||
33479481|NCT03504852|62855936|FG001|Overall Study|Withdrawal of informed consent|1|||
33479482|NCT03504852|62855937|FG002|Overall Study|Withdrawal of informed consent|0|||
33479483|NCT03504852|62855935|FG000|Overall Study|Withdrawal by Subject|5|||
33479484|NCT03504852|62855936|FG001|Overall Study|Withdrawal by Subject|5|||
33479485|NCT03504852|62855937|FG002|Overall Study|Withdrawal by Subject|1|||
33551046|NCT00708435|62943269|FG000|Overall Study|Adverse Event|1|||
33551047|NCT00708435|62943270|FG001|Overall Study|Adverse Event|0|||
33551048|NCT00708435|62943269|FG000|Overall Study|Protocol Violation|0|||
33551049|NCT00708435|62943270|FG001|Overall Study|Protocol Violation|1|||
33551050|NCT00708435|62943269|FG000|Overall Study|Intervention by primary care physician|1|||
33551051|NCT00708435|62943270|FG001|Overall Study|Intervention by primary care physician|0|||
33551052|NCT00708435|62943269|FG000|Overall Study|Refused hospitalization|1|||
33551053|NCT00708435|62943270|FG001|Overall Study|Refused hospitalization|0|||
33551054|NCT02841787|62943281|FG000|Overall Study|Lost to Follow-up|1|||
33364643|NCT02393248|62743325|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33479486|NCT03504852|62855935|FG000|Overall Study|Lost to Follow-up|4|||
33479487|NCT03504852|62855936|FG001|Overall Study|Lost to Follow-up|1|||
33479488|NCT03504852|62855937|FG002|Overall Study|Lost to Follow-up|0|||
33479489|NCT03504852|62855935|FG000|Overall Study|New therapy for study indication|1|||
33479490|NCT03504852|62855936|FG001|Overall Study|New therapy for study indication|0|||
33479491|NCT03504852|62855937|FG002|Overall Study|New therapy for study indication|0|||
33479492|NCT03504852|62855935|FG000|Overall Study|Lack of Efficacy|1|||
33551055|NCT02841787|62943282|FG001|Overall Study|Lost to Follow-up|0|||
33551056|NCT02841787|62943283|FG002|Overall Study|Lost to Follow-up|0|||
33656147|NCT00982137|63074183|FG001|Overall Study|Lost to Follow-up|0|||
33479493|NCT03504852|62855936|FG001|Overall Study|Lack of Efficacy|2|||
33479494|NCT03504852|62855937|FG002|Overall Study|Lack of Efficacy|0|||
33479495|NCT03504852|62855935|FG000|Overall Study|Death|0|||
33479496|NCT03504852|62855936|FG001|Overall Study|Death|1|||
33479497|NCT03504852|62855937|FG002|Overall Study|Death|0|||
33479498|NCT03504852|62855935|FG000|Overall Study|Adverse Event|4|||
33479499|NCT03504852|62855936|FG001|Overall Study|Adverse Event|8|||
33479500|NCT03504852|62855937|FG002|Overall Study|Adverse Event|2|||
33479501|NCT03025828|62855947|FG000|Overall Study|Lost to Follow-up|1|||
33479502|NCT03546816|62855953|FG000|Overall Study|Adverse Event|5|||
33479503|NCT03546816|62855954|FG001|Overall Study|Adverse Event|3|||
33479504|NCT03546816|62855953|FG000|Overall Study|Lack of Efficacy|2|||
33479505|NCT03546816|62855954|FG001|Overall Study|Lack of Efficacy|4|||
33479506|NCT03546816|62855953|FG000|Overall Study|Pregnancy|1|||
33479507|NCT03546816|62855954|FG001|Overall Study|Pregnancy|0|||
33479508|NCT03546816|62855953|FG000|Overall Study|Physician Decision|2|||
33479509|NCT03546816|62855954|FG001|Overall Study|Physician Decision|0|||
33479510|NCT03546816|62855953|FG000|Overall Study|Withdrawal by Subject|8|||
33479511|NCT03546816|62855954|FG001|Overall Study|Withdrawal by Subject|10|||
33479512|NCT03546816|62855953|FG000|Overall Study|Lost to Follow-up|3|||
33479513|NCT03546816|62855954|FG001|Overall Study|Lost to Follow-up|2|||
33551057|NCT02841787|62943281|FG000|Overall Study|Symptoms dropped below threshold|1|||
33551058|NCT02841787|62943282|FG001|Overall Study|Symptoms dropped below threshold|0|||
33551059|NCT02841787|62943283|FG002|Overall Study|Symptoms dropped below threshold|0|||
33551060|NCT02841787|62943281|FG000|Overall Study|Withdrawal by Subject|1|||
33551061|NCT02841787|62943282|FG001|Overall Study|Withdrawal by Subject|4|||
33551062|NCT02841787|62943283|FG002|Overall Study|Withdrawal by Subject|0|||
33551063|NCT01376037|62943293|FG000|Overall Study|Lost to Follow-up|0|||
33551064|NCT01376037|62943294|FG001|Overall Study|Lost to Follow-up|2|||
33551065|NCT02657408|62943302|FG000|Overall Study|Adverse Event|3|||
33551066|NCT02657408|62943303|FG001|Overall Study|Adverse Event|7|||
33551067|NCT02841709|62943309|FG000|5th Intervention|Adverse Event|2|||
33551068|NCT02841709|62943310|FG001|5th Intervention|Adverse Event|0|||
33551069|NCT02841709|62943311|FG002|5th Intervention|Adverse Event|0|||
33551070|NCT02841709|62943312|FG003|5th Intervention|Adverse Event|0|||
33551071|NCT02841709|62943313|FG004|5th Intervention|Adverse Event|2|||
33551072|NCT01353859|62943326|FG000|Overall Study|Adverse Event|3|||
33551073|NCT01353859|62943326|FG000|Overall Study|Lack of Efficacy|1|||
33551074|NCT02850965|62943332|FG000|Overall Study|Other than listed|3|||
33551075|NCT02850965|62943333|FG001|Overall Study|Other than listed|4|||
33551076|NCT02850965|62943332|FG000|Overall Study|Protocol Violation|0|||
33551077|NCT02850965|62943333|FG001|Overall Study|Protocol Violation|2|||
33551078|NCT02850965|62943332|FG000|Overall Study|Lost to Follow-up|5|||
33551079|NCT02850965|62943333|FG001|Overall Study|Lost to Follow-up|3|||
33551080|NCT02850965|62943332|FG000|Overall Study|Lack of Efficacy|4|||
33551081|NCT02850965|62943333|FG001|Overall Study|Lack of Efficacy|8|||
33551082|NCT02850965|62943332|FG000|Overall Study|Adverse Event|3|||
33551083|NCT02850965|62943333|FG001|Overall Study|Adverse Event|2|||
33551084|NCT02850965|62943332|FG000|Overall Study|Withdrawal by Subject|3|||
33551085|NCT02850965|62943333|FG001|Overall Study|Withdrawal by Subject|4|||
33551086|NCT02850965|62943332|FG000|Overall Study|Physician Decision|0|||
33551087|NCT02850965|62943333|FG001|Overall Study|Physician Decision|1|||
33551088|NCT02850965|62943332|FG000|Overall Study|Randomized but not treated|0|||
33551089|NCT02850965|62943333|FG001|Overall Study|Randomized but not treated|1|||
33551090|NCT01375959|62943341|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
33551091|NCT01375959|62943342|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
33551092|NCT01375959|62943341|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
33551093|NCT01375959|62943342|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
33551094|NCT01375959|62943341|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
33551095|NCT01375959|62943342|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
33551096|NCT00708201|62943352|FG000|Overall Study|Adverse Event|4|||
33551097|NCT00708201|62943353|FG001|Overall Study|Adverse Event|4|||
33551098|NCT00708201|62943352|FG000|Overall Study|Withdrawal by Subject|1|||
33551099|NCT00708201|62943353|FG001|Overall Study|Withdrawal by Subject|1|||
33656148|NCT00982137|63074184|FG002|Overall Study|Lost to Follow-up|0|||
33656149|NCT00982137|63074185|FG003|Overall Study|Lost to Follow-up|1|||
33479514|NCT03024970|62855962|FG000|First Intervention|Adverse Event|1|||
33479515|NCT03024970|62855963|FG001|First Intervention|Adverse Event|0|||
33479516|NCT03024970|62855962|FG000|Second Intervention|Lost to Follow-up|1|||
33479517|NCT03024970|62855963|FG001|Second Intervention|Lost to Follow-up|0|||
33479518|NCT03500094|62855969|FG000|Overall Study|Withdrawal by Subject|1|||
33479519|NCT03500094|62855969|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
33551100|NCT00708201|62943352|FG000|Overall Study|Lost to Follow-up|2|||
33551101|NCT00708201|62943353|FG001|Overall Study|Lost to Follow-up|0|||
33551102|NCT00708201|62943352|FG000|Overall Study|Protocol Violation|0|||
33551103|NCT00708201|62943353|FG001|Overall Study|Protocol Violation|1|||
33551104|NCT02848313|62943361|FG000|Overall Study|Adverse Event|1|||
33551105|NCT02848313|62943362|FG001|Overall Study|Adverse Event|2|||
33479520|NCT03500094|62855969|FG000|Overall Study|Lost to Follow-up|1|||
33479521|NCT03566550|62855977|FG000|Overall Study|Withdrawal by Subject|0|||
33479522|NCT03566550|62855978|FG001|Overall Study|Withdrawal by Subject|1|||
33479523|NCT03566238|62855987|FG000|Overall Study|Adverse Event|0|||
33479524|NCT03566238|62855988|FG001|Overall Study|Adverse Event|1|||
33479525|NCT03566238|62855989|FG002|Overall Study|Adverse Event|0|||
33479526|NCT03566238|62855987|FG000|Overall Study|Lack of Efficacy|4|||
33479527|NCT03566238|62855988|FG001|Overall Study|Lack of Efficacy|2|||
33479528|NCT03566238|62855989|FG002|Overall Study|Lack of Efficacy|5|||
33479529|NCT03566238|62855987|FG000|Overall Study|Other|1|||
33479530|NCT03566238|62855988|FG001|Overall Study|Other|0|||
33479531|NCT03566238|62855989|FG002|Overall Study|Other|0|||
33479532|NCT02894502|62856000|FG000|Baseline|Withdrawal by Subject|24|||
33479533|NCT02894502|62856001|FG001|Baseline|Withdrawal by Subject|31|||
33479534|NCT02894502|62856002|FG002|Baseline|Withdrawal by Subject|36|||
33479535|NCT02894502|62856000|FG000|Baseline|Death|3|||
33479536|NCT02894502|62856001|FG001|Baseline|Death|1|||
33479537|NCT02894502|62856002|FG002|Baseline|Death|9|||
33479538|NCT02894502|62856000|FG000|First Follow up|Withdrawal by Subject|32|||
33479539|NCT02894502|62856001|FG001|First Follow up|Withdrawal by Subject|29|||
33479540|NCT02894502|62856002|FG002|First Follow up|Withdrawal by Subject|37|||
33479541|NCT02894502|62856000|FG000|First Follow up|Death|2|||
33479542|NCT02894502|62856001|FG001|First Follow up|Death|2|||
33479543|NCT02894502|62856002|FG002|First Follow up|Death|3|||
33479544|NCT02894502|62856000|FG000|Second Follow up|Withdrawal by Subject|13|||
33479545|NCT02894502|62856001|FG001|Second Follow up|Withdrawal by Subject|15|||
33479546|NCT02894502|62856002|FG002|Second Follow up|Withdrawal by Subject|13|||
33479547|NCT02894502|62856000|FG000|Second Follow up|Death|2|||
33479548|NCT02894502|62856001|FG001|Second Follow up|Death|3|||
33479549|NCT02894502|62856002|FG002|Second Follow up|Death|1|||
33479550|NCT02894502|62856000|FG000|Third Follow up|Withdrawal by Subject|5|||
33479551|NCT02894502|62856001|FG001|Third Follow up|Withdrawal by Subject|6|||
33479552|NCT02894502|62856002|FG002|Third Follow up|Withdrawal by Subject|3|||
33479553|NCT02894502|62856000|FG000|Third Follow up|Death|1|||
33479554|NCT02894502|62856001|FG001|Third Follow up|Death|1|||
33479555|NCT02894502|62856002|FG002|Third Follow up|Death|0|||
33479556|NCT03449030|62856023|FG000|Overall Study|Withdrawal by Subject|0|||
33479557|NCT03449030|62856024|FG001|Overall Study|Withdrawal by Subject|0|||
33479558|NCT03449030|62856025|FG002|Overall Study|Withdrawal by Subject|0|||
33479559|NCT03449030|62856026|FG003|Overall Study|Withdrawal by Subject|1|||
33479560|NCT03449030|62856027|FG004|Overall Study|Withdrawal by Subject|1|||
33479561|NCT03449030|62856028|FG005|Overall Study|Withdrawal by Subject|1|||
33479562|NCT03449030|62856029|FG006|Overall Study|Withdrawal by Subject|1|||
33479563|NCT03449030|62856030|FG007|Overall Study|Withdrawal by Subject|2|||
33479564|NCT03449030|62856031|FG008|Overall Study|Withdrawal by Subject|0|||
33479565|NCT03449030|62856032|FG009|Overall Study|Withdrawal by Subject|0|||
33479566|NCT03449030|62856023|FG000|Overall Study|Symptomatic Deterioration|0|||
33479567|NCT03449030|62856024|FG001|Overall Study|Symptomatic Deterioration|1|||
33479568|NCT03449030|62856025|FG002|Overall Study|Symptomatic Deterioration|0|||
33479569|NCT03449030|62856026|FG003|Overall Study|Symptomatic Deterioration|0|||
33479570|NCT03449030|62856027|FG004|Overall Study|Symptomatic Deterioration|0|||
33479571|NCT03449030|62856028|FG005|Overall Study|Symptomatic Deterioration|1|||
33479572|NCT03449030|62856029|FG006|Overall Study|Symptomatic Deterioration|1|||
33479573|NCT03449030|62856030|FG007|Overall Study|Symptomatic Deterioration|0|||
33479574|NCT03449030|62856031|FG008|Overall Study|Symptomatic Deterioration|2|||
33479575|NCT03449030|62856032|FG009|Overall Study|Symptomatic Deterioration|0|||
33479576|NCT03449030|62856023|FG000|Overall Study|Progressive Disease|1|||
33479577|NCT03449030|62856024|FG001|Overall Study|Progressive Disease|0|||
33479578|NCT03449030|62856025|FG002|Overall Study|Progressive Disease|1|||
33479579|NCT03449030|62856026|FG003|Overall Study|Progressive Disease|4|||
33479580|NCT03449030|62856027|FG004|Overall Study|Progressive Disease|5|||
33479581|NCT03449030|62856028|FG005|Overall Study|Progressive Disease|3|||
33479582|NCT03449030|62856029|FG006|Overall Study|Progressive Disease|0|||
33479583|NCT03449030|62856030|FG007|Overall Study|Progressive Disease|1|||
33479584|NCT03449030|62856031|FG008|Overall Study|Progressive Disease|1|||
33479585|NCT03449030|62856032|FG009|Overall Study|Progressive Disease|1|||
33479586|NCT03449030|62856023|FG000|Overall Study|Adverse Event|0|||
33479587|NCT03449030|62856024|FG001|Overall Study|Adverse Event|0|||
33656150|NCT00982137|63074182|FG000|Overall Study|Withdrawal by Subject|0|||
33479588|NCT03449030|62856025|FG002|Overall Study|Adverse Event|0|||
33479589|NCT03449030|62856026|FG003|Overall Study|Adverse Event|0|||
33479590|NCT03449030|62856027|FG004|Overall Study|Adverse Event|0|||
33479591|NCT03449030|62856028|FG005|Overall Study|Adverse Event|2|||
33656151|NCT00982137|63074183|FG001|Overall Study|Withdrawal by Subject|1|||
33479592|NCT03449030|62856029|FG006|Overall Study|Adverse Event|0|||
33479593|NCT03449030|62856030|FG007|Overall Study|Adverse Event|0|||
33479594|NCT03449030|62856031|FG008|Overall Study|Adverse Event|0|||
33479595|NCT03449030|62856032|FG009|Overall Study|Adverse Event|0|||
33479596|NCT03449030|62856023|FG000|Overall Study|Death|0|||
33479597|NCT03449030|62856024|FG001|Overall Study|Death|0|||
33479598|NCT03449030|62856025|FG002|Overall Study|Death|0|||
33479599|NCT03449030|62856026|FG003|Overall Study|Death|0|||
33479600|NCT03449030|62856027|FG004|Overall Study|Death|1|||
33479601|NCT03449030|62856028|FG005|Overall Study|Death|0|||
33479602|NCT03449030|62856029|FG006|Overall Study|Death|0|||
33479603|NCT03449030|62856030|FG007|Overall Study|Death|0|||
33479604|NCT03449030|62856031|FG008|Overall Study|Death|0|||
33479605|NCT03449030|62856032|FG009|Overall Study|Death|0|||
33479606|NCT03448406|62856057|FG000|Overall Study|Noncompliance of scheduled visits|1|||
33479607|NCT03448406|62856058|FG001|Overall Study|Noncompliance of scheduled visits|2|||
33479608|NCT03448406|62856057|FG000|Overall Study|Withdrawal by Subject|1|||
33479609|NCT03448406|62856058|FG001|Overall Study|Withdrawal by Subject|2|||
33479610|NCT03448406|62856057|FG000|Overall Study|Protocol Violation|1|||
33479611|NCT03448406|62856058|FG001|Overall Study|Protocol Violation|0|||
33479612|NCT03448406|62856057|FG000|Overall Study|Adverse Event|8|||
33479613|NCT03448406|62856058|FG001|Overall Study|Adverse Event|9|||
33479614|NCT03499028|62856066|FG000|Overall Study|Lost to Follow-up|12|||
33479615|NCT03499028|62856067|FG001|Overall Study|Lost to Follow-up|9|||
33479616|NCT03499028|62856066|FG000|Overall Study|Withdrawal by Subject|5|||
33479617|NCT03499028|62856067|FG001|Overall Study|Withdrawal by Subject|8|||
33479618|NCT03499028|62856066|FG000|Overall Study|Unplanned SNF discharge|5|||
33479619|NCT03499028|62856067|FG001|Overall Study|Unplanned SNF discharge|8|||
33479620|NCT03498560|62856075|FG000|Overall Study|Found Ineligible|2|||
33479621|NCT03498560|62856075|FG000|Overall Study|Withdrawal by Subject|14|||
33479622|NCT03498560|62856075|FG000|Overall Study|Lost to Follow-up|4|||
33479623|NCT03498560|62856075|FG000|Overall Study|Death|1|||
33479624|NCT00064701|62856083|FG000|One Year Post-transplant|Did not receive study drug|7|||
33479625|NCT00064701|62856084|FG001|One Year Post-transplant|Did not receive study drug|12|||
33479626|NCT00064701|62856085|FG002|One Year Post-transplant|Did not receive study drug|11|||
33479627|NCT00064701|62856083|FG000|One Year Post-transplant|Adverse Event|23|||
33479628|NCT00064701|62856084|FG001|One Year Post-transplant|Adverse Event|19|||
33479629|NCT00064701|62856085|FG002|One Year Post-transplant|Adverse Event|37|||
33479630|NCT00064701|62856083|FG000|One Year Post-transplant|Rejection|0|||
33479631|NCT00064701|62856084|FG001|One Year Post-transplant|Rejection|1|||
33479632|NCT00064701|62856085|FG002|One Year Post-transplant|Rejection|16|||
33479633|NCT00064701|62856083|FG000|One Year Post-transplant|Non-compliance|4|||
33551106|NCT02848313|62943361|FG000|Overall Study|Lack of Efficacy|0|||
33551107|NCT02848313|62943362|FG001|Overall Study|Lack of Efficacy|1|||
33551108|NCT02848313|62943361|FG000|Overall Study|Withdrawal by Subject|1|||
33551109|NCT02848313|62943362|FG001|Overall Study|Withdrawal by Subject|1|||
33551110|NCT02848313|62943361|FG000|Overall Study|Lost to follow up|1|||
33551111|NCT02848313|62943362|FG001|Overall Study|Lost to follow up|0|||
33551112|NCT02728089|62943368|FG000|Overall Study|Physician Decision|2|||
33551113|NCT02728089|62943368|FG000|Overall Study|Withdrawal by Subject|1|||
33551114|NCT02840461|62943375|FG000|Overall Study|Adverse Event|1|||
33551115|NCT02840461|62943376|FG001|Overall Study|Adverse Event|5|||
33551116|NCT02840461|62943377|FG002|Overall Study|Adverse Event|3|||
33551117|NCT02840461|62943375|FG000|Overall Study|Lost to Follow-up|10|||
33551118|NCT02840461|62943376|FG001|Overall Study|Lost to Follow-up|7|||
33551119|NCT02840461|62943377|FG002|Overall Study|Lost to Follow-up|6|||
33551120|NCT02840461|62943375|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
33551121|NCT02840461|62943376|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
33551122|NCT02840461|62943377|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
33551123|NCT02840461|62943375|FG000|Overall Study|Protocol Violation|2|||
33551124|NCT02840461|62943376|FG001|Overall Study|Protocol Violation|3|||
33551125|NCT02840461|62943377|FG002|Overall Study|Protocol Violation|1|||
33551126|NCT02840461|62943375|FG000|Overall Study|Withdrawal by Subject|10|||
33551127|NCT02840461|62943376|FG001|Overall Study|Withdrawal by Subject|6|||
33551128|NCT02840461|62943377|FG002|Overall Study|Withdrawal by Subject|2|||
33479634|NCT00064701|62856084|FG001|One Year Post-transplant|Non-compliance|2|||
33479635|NCT00064701|62856085|FG002|One Year Post-transplant|Non-compliance|5|||
33479636|NCT00064701|62856083|FG000|One Year Post-transplant|Graft Failure|3|||
33479637|NCT00064701|62856084|FG001|One Year Post-transplant|Graft Failure|2|||
33479638|NCT00064701|62856085|FG002|One Year Post-transplant|Graft Failure|1|||
33551129|NCT02840461|62943375|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
33479639|NCT00064701|62856083|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
33479640|NCT00064701|62856084|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
33479641|NCT00064701|62856085|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
33479642|NCT00064701|62856083|FG000|One Year Post-transplant|Lost to Follow-up|1|||
33479643|NCT00064701|62856084|FG001|One Year Post-transplant|Lost to Follow-up|0|||
33479644|NCT00064701|62856085|FG002|One Year Post-transplant|Lost to Follow-up|0|||
33479645|NCT00064701|62856083|FG000|One Year Post-transplant|Converted to rapamycin|1|||
33551130|NCT02840461|62943376|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
33551131|NCT02840461|62943377|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
33551132|NCT02839681|62943386|FG000|Overall Study|Death|2|||
33551133|NCT01676012|62943390|FG000|Overall Study|Adverse Event|2|||
33479646|NCT00064701|62856084|FG001|One Year Post-transplant|Converted to rapamycin|0|||
33479647|NCT00064701|62856085|FG002|One Year Post-transplant|Converted to rapamycin|0|||
33479648|NCT00064701|62856083|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
33479649|NCT00064701|62856084|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
33479650|NCT00064701|62856085|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
33479651|NCT00064701|62856083|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
33479652|NCT00064701|62856084|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
33479653|NCT00064701|62856085|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
33479654|NCT00064701|62856083|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
33479655|NCT00064701|62856084|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
33479656|NCT00064701|62856085|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
33479657|NCT00064701|62856083|FG000|One Year Post-transplant|Poor absorption|0|||
33479658|NCT00064701|62856084|FG001|One Year Post-transplant|Poor absorption|1|||
33479659|NCT00064701|62856085|FG002|One Year Post-transplant|Poor absorption|0|||
33479660|NCT00064701|62856083|FG000|One Year Post-transplant|Pancreas transplant|0|||
33479661|NCT00064701|62856084|FG001|One Year Post-transplant|Pancreas transplant|0|||
33479662|NCT00064701|62856085|FG002|One Year Post-transplant|Pancreas transplant|1|||
33479663|NCT00064701|62856083|FG000|Clinical Continuation Phase|Adverse Event|12|||
33479664|NCT00064701|62856084|FG001|Clinical Continuation Phase|Adverse Event|21|||
33479665|NCT00064701|62856085|FG002|Clinical Continuation Phase|Adverse Event|14|||
33479666|NCT00064701|62856083|FG000|Clinical Continuation Phase|Non-compliance|8|||
33479667|NCT00064701|62856084|FG001|Clinical Continuation Phase|Non-compliance|6|||
33479668|NCT00064701|62856085|FG002|Clinical Continuation Phase|Non-compliance|7|||
33479669|NCT00064701|62856083|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
33479670|NCT00064701|62856084|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
33479671|NCT00064701|62856085|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
33479672|NCT00064701|62856083|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
33479673|NCT00064701|62856084|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
33479674|NCT00064701|62856085|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
33479675|NCT00064701|62856083|FG000|Clinical Continuation Phase|Graft Failure|5|||
33479676|NCT00064701|62856084|FG001|Clinical Continuation Phase|Graft Failure|5|||
33479677|NCT00064701|62856085|FG002|Clinical Continuation Phase|Graft Failure|2|||
33479678|NCT00064701|62856083|FG000|Clinical Continuation Phase|Rejection|1|||
33479679|NCT00064701|62856084|FG001|Clinical Continuation Phase|Rejection|2|||
33479680|NCT00064701|62856085|FG002|Clinical Continuation Phase|Rejection|2|||
33479681|NCT00064701|62856083|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
33479682|NCT00064701|62856084|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
33479683|NCT00064701|62856085|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
33479684|NCT00064701|62856083|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
33479685|NCT00064701|62856084|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
33479686|NCT00064701|62856085|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
33479687|NCT00064701|62856083|FG000|Clinical Continuation Phase|Physician Decision|1|||
33479688|NCT00064701|62856084|FG001|Clinical Continuation Phase|Physician Decision|3|||
33479689|NCT00064701|62856085|FG002|Clinical Continuation Phase|Physician Decision|0|||
33479690|NCT00064701|62856083|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
33479691|NCT00064701|62856084|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
33479692|NCT00064701|62856085|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
33479693|NCT00064701|62856083|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
33479694|NCT00064701|62856084|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
33479695|NCT00064701|62856085|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
33479696|NCT00064701|62856083|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
33479697|NCT00064701|62856084|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
33479698|NCT00064701|62856085|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
33479699|NCT00064701|62856083|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
33479700|NCT00064701|62856084|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
33479701|NCT00064701|62856085|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
33479702|NCT00064701|62856083|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
33479703|NCT00064701|62856084|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
33479704|NCT00064701|62856085|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
33479705|NCT00064701|62856083|FG000|Clinical Continuation Phase|Patient opted out|0|||
33479706|NCT00064701|62856084|FG001|Clinical Continuation Phase|Patient opted out|0|||
33479707|NCT00064701|62856085|FG002|Clinical Continuation Phase|Patient opted out|1|||
33479708|NCT00064077|62856097|FG000|Overall Study|Improper prior treatment|1|||
33479709|NCT00064077|62856098|FG001|Overall Study|Improper prior treatment|0|||
33479710|NCT00064077|62856099|FG002|Overall Study|Improper prior treatment|0|||
33479711|NCT00064077|62856100|FG003|Overall Study|Improper prior treatment|0|||
33479712|NCT00064077|62856097|FG000|Overall Study|Poor risk|2|||
33479713|NCT00064077|62856098|FG001|Overall Study|Poor risk|0|||
33479714|NCT00064077|62856099|FG002|Overall Study|Poor risk|1|||
33479715|NCT00064077|62856100|FG003|Overall Study|Poor risk|1|||
33479716|NCT00064077|62856097|FG000|Overall Study|Pathology|10|||
33479717|NCT00064077|62856098|FG001|Overall Study|Pathology|7|||
33479718|NCT00064077|62856099|FG002|Overall Study|Pathology|3|||
33479719|NCT00064077|62856100|FG003|Overall Study|Pathology|4|||
33479720|NCT00064077|62856097|FG000|Overall Study|No surgery|0|||
33479721|NCT00064077|62856098|FG001|Overall Study|No surgery|0|||
33479722|NCT00064077|62856099|FG002|Overall Study|No surgery|1|||
33479723|NCT00064077|62856100|FG003|Overall Study|No surgery|0|||
33364644|NCT02393248|62743326|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364645|NCT02393248|62743327|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33364646|NCT02393248|62743303|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33364647|NCT02393248|62743304|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33364648|NCT02393248|62743305|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33364649|NCT02393248|62743306|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33364650|NCT02393248|62743307|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33364651|NCT02393248|62743308|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33364652|NCT02393248|62743309|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33364653|NCT02393248|62743310|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33364654|NCT02393248|62743311|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33479724|NCT00064077|62856097|FG000|Overall Study|No tumor|0|||
33479725|NCT00064077|62856098|FG001|Overall Study|No tumor|0|||
33479726|NCT00064077|62856099|FG002|Overall Study|No tumor|1|||
33479727|NCT00064077|62856100|FG003|Overall Study|No tumor|0|||
33479728|NCT00064077|62856097|FG000|Overall Study|Other reasons|2|||
33479729|NCT00064077|62856098|FG001|Overall Study|Other reasons|2|||
33479730|NCT00064077|62856099|FG002|Overall Study|Other reasons|1|||
33479731|NCT00064077|62856100|FG003|Overall Study|Other reasons|2|||
33479732|NCT00063999|62856112|FG000|Overall Study|Withdrawal by Subject|1|||
33479733|NCT00063999|62856113|FG001|Overall Study|Withdrawal by Subject|0|||
33479734|NCT00063999|62856112|FG000|Overall Study|Ineligible|44|||
33479735|NCT00063999|62856113|FG001|Overall Study|Ineligible|24|||
33479736|NCT03131440|62856158|FG000|Overall Study|Withdrawal by Subject|1|||
33479737|NCT03131440|62856159|FG001|Overall Study|Withdrawal by Subject|3|||
33479738|NCT03131440|62856160|FG002|Overall Study|Withdrawal by Subject|0|||
33551134|NCT01676012|62943390|FG000|Overall Study|incomplete set of videos|1|||
33551135|NCT02727777|62943406|FG000|Overall Study|Screen Failure|2|||
33551136|NCT02727777|62943407|FG001|Overall Study|Screen Failure|0|||
33551137|NCT02727777|62943408|FG002|Overall Study|Screen Failure|0|||
33551138|NCT02727777|62943406|FG000|Overall Study|Progressive disease|2|||
33551139|NCT02727777|62943407|FG001|Overall Study|Progressive disease|0|||
33551140|NCT02727777|62943408|FG002|Overall Study|Progressive disease|0|||
33551141|NCT00707577|62943418|FG000|Overall Study|Withdrawal by Subject|3|||
33551142|NCT00707577|62943419|FG001|Overall Study|Withdrawal by Subject|2|||
33551143|NCT00707577|62943418|FG000|Overall Study|Lost to Follow-up|34|||
33551144|NCT00707577|62943419|FG001|Overall Study|Lost to Follow-up|25|||
33551145|NCT00707577|62943418|FG000|Overall Study|Left employment|13|||
33551146|NCT00707577|62943419|FG001|Overall Study|Left employment|10|||
33551147|NCT00707577|62943418|FG000|Overall Study|Pregnancy|4|||
33551148|NCT00707577|62943419|FG001|Overall Study|Pregnancy|1|||
33551149|NCT01675622|62943427|FG000|Overall Study|Withdrawal by Subject|2|||
33551150|NCT01675622|62943428|FG001|Overall Study|Withdrawal by Subject|2|||
33551151|NCT01675622|62943427|FG000|Overall Study|Adverse Event|12|||
33551152|NCT01675622|62943428|FG001|Overall Study|Adverse Event|10|||
33551153|NCT01675622|62943427|FG000|Overall Study|Protocol Violation|4|||
33551154|NCT01675622|62943428|FG001|Overall Study|Protocol Violation|1|||
33551155|NCT01675622|62943427|FG000|Overall Study|Lack of Efficacy|2|||
33551156|NCT01675622|62943428|FG001|Overall Study|Lack of Efficacy|4|||
33551157|NCT01675622|62943427|FG000|Overall Study|Lost to Follow-up|1|||
33551158|NCT01675622|62943428|FG001|Overall Study|Lost to Follow-up|3|||
33551159|NCT01675622|62943427|FG000|Overall Study|Other|5|||
33551160|NCT01675622|62943428|FG001|Overall Study|Other|4|||
33656152|NCT00982137|63074184|FG002|Overall Study|Withdrawal by Subject|0|||
33656153|NCT00982137|63074185|FG003|Overall Study|Withdrawal by Subject|0|||
33479739|NCT03131440|62856161|FG003|Overall Study|Withdrawal by Subject|0|||
33364655|NCT02393248|62743312|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33479740|NCT03131440|62856162|FG004|Overall Study|Withdrawal by Subject|1|||
33479741|NCT03131440|62856163|FG005|Overall Study|Withdrawal by Subject|0|||
33479742|NCT03131440|62856164|FG006|Overall Study|Withdrawal by Subject|0|||
33479743|NCT03131440|62856165|FG007|Overall Study|Withdrawal by Subject|1|||
33479744|NCT03131440|62856166|FG008|Overall Study|Withdrawal by Subject|1|||
33479745|NCT03131440|62856167|FG009|Overall Study|Withdrawal by Subject|1|||
33479746|NCT03131440|62856168|FG010|Overall Study|Withdrawal by Subject|0|||
33479747|NCT03131440|62856169|FG011|Overall Study|Withdrawal by Subject|1|||
33551161|NCT02655224|62943436|FG000|Overall Study|Adverse Event|1|||
33551162|NCT02655224|62943437|FG001|Overall Study|Adverse Event|1|||
33551163|NCT01675544|62943443|FG000|Overall Study|Withdrawal by Subject|2|||
33551164|NCT02838901|62943486|FG000|Overall Study|Withdrawal by Subject|1|||
33656154|NCT00981747|63074202|FG000|Losartan|Withdrawal by Subject|1|||
33479748|NCT03131440|62856170|FG012|Overall Study|Withdrawal by Subject|1|||
33479749|NCT03131440|62856171|FG013|Overall Study|Withdrawal by Subject|0|||
33479750|NCT03131440|62856172|FG014|Overall Study|Withdrawal by Subject|1|||
33479751|NCT03131440|62856173|FG015|Overall Study|Withdrawal by Subject|0|||
33479752|NCT03131440|62856174|FG016|Overall Study|Withdrawal by Subject|0|||
33479753|NCT03131440|62856175|FG017|Overall Study|Withdrawal by Subject|0|||
33479754|NCT03131440|62856176|FG018|Overall Study|Withdrawal by Subject|1|||
33479755|NCT03131440|62856177|FG019|Overall Study|Withdrawal by Subject|0|||
33479756|NCT03131440|62856178|FG020|Overall Study|Withdrawal by Subject|1|||
33479757|NCT03131440|62856179|FG021|Overall Study|Withdrawal by Subject|1|||
33479758|NCT03131440|62856180|FG022|Overall Study|Withdrawal by Subject|1|||
33479759|NCT03131440|62856181|FG023|Overall Study|Withdrawal by Subject|0|||
33479760|NCT03131440|62856182|FG024|Overall Study|Withdrawal by Subject|0|||
33479761|NCT03131440|62856183|FG025|Overall Study|Withdrawal by Subject|0|||
33479762|NCT03131440|62856184|FG026|Overall Study|Withdrawal by Subject|0|||
33479763|NCT03131440|62856185|FG027|Overall Study|Withdrawal by Subject|0|||
33479764|NCT03131440|62856186|FG028|Overall Study|Withdrawal by Subject|0|||
33479765|NCT03131440|62856187|FG029|Overall Study|Withdrawal by Subject|0|||
33479766|NCT03131440|62856188|FG030|Overall Study|Withdrawal by Subject|1|||
33479767|NCT03131440|62856189|FG031|Overall Study|Withdrawal by Subject|0|||
33479768|NCT03131440|62856158|FG000|Overall Study|Lost to Follow-up|0|||
33479769|NCT03131440|62856159|FG001|Overall Study|Lost to Follow-up|0|||
33479770|NCT03131440|62856160|FG002|Overall Study|Lost to Follow-up|0|||
33479771|NCT03131440|62856161|FG003|Overall Study|Lost to Follow-up|0|||
33479772|NCT03131440|62856162|FG004|Overall Study|Lost to Follow-up|0|||
33479773|NCT03131440|62856163|FG005|Overall Study|Lost to Follow-up|1|||
33479774|NCT03131440|62856164|FG006|Overall Study|Lost to Follow-up|0|||
33479775|NCT03131440|62856165|FG007|Overall Study|Lost to Follow-up|0|||
33479776|NCT03131440|62856166|FG008|Overall Study|Lost to Follow-up|0|||
33479777|NCT03131440|62856167|FG009|Overall Study|Lost to Follow-up|0|||
33479778|NCT03131440|62856168|FG010|Overall Study|Lost to Follow-up|0|||
33479779|NCT03131440|62856169|FG011|Overall Study|Lost to Follow-up|0|||
33479780|NCT03131440|62856170|FG012|Overall Study|Lost to Follow-up|0|||
33479781|NCT03131440|62856171|FG013|Overall Study|Lost to Follow-up|0|||
33479782|NCT03131440|62856172|FG014|Overall Study|Lost to Follow-up|0|||
33479783|NCT03131440|62856173|FG015|Overall Study|Lost to Follow-up|0|||
33479784|NCT03131440|62856174|FG016|Overall Study|Lost to Follow-up|0|||
33479785|NCT03131440|62856175|FG017|Overall Study|Lost to Follow-up|0|||
33479786|NCT03131440|62856176|FG018|Overall Study|Lost to Follow-up|0|||
33479787|NCT03131440|62856177|FG019|Overall Study|Lost to Follow-up|2|||
33479788|NCT03131440|62856178|FG020|Overall Study|Lost to Follow-up|1|||
33479789|NCT03131440|62856179|FG021|Overall Study|Lost to Follow-up|0|||
33479790|NCT03131440|62856180|FG022|Overall Study|Lost to Follow-up|1|||
33479791|NCT03131440|62856181|FG023|Overall Study|Lost to Follow-up|0|||
33479792|NCT03131440|62856182|FG024|Overall Study|Lost to Follow-up|1|||
33479793|NCT03131440|62856183|FG025|Overall Study|Lost to Follow-up|0|||
33479794|NCT03131440|62856184|FG026|Overall Study|Lost to Follow-up|0|||
33479795|NCT03131440|62856185|FG027|Overall Study|Lost to Follow-up|2|||
33479796|NCT03131440|62856186|FG028|Overall Study|Lost to Follow-up|0|||
33479797|NCT03131440|62856187|FG029|Overall Study|Lost to Follow-up|2|||
33479798|NCT03131440|62856188|FG030|Overall Study|Lost to Follow-up|0|||
33479799|NCT03131440|62856189|FG031|Overall Study|Lost to Follow-up|0|||
33479800|NCT03131440|62856158|FG000|Overall Study|Death|0|||
33479801|NCT03131440|62856159|FG001|Overall Study|Death|0|||
33479802|NCT03131440|62856160|FG002|Overall Study|Death|0|||
33479803|NCT03131440|62856161|FG003|Overall Study|Death|0|||
33479804|NCT03131440|62856162|FG004|Overall Study|Death|0|||
33479805|NCT03131440|62856163|FG005|Overall Study|Death|0|||
33479806|NCT03131440|62856164|FG006|Overall Study|Death|0|||
33479807|NCT03131440|62856165|FG007|Overall Study|Death|0|||
33479808|NCT03131440|62856166|FG008|Overall Study|Death|0|||
33479809|NCT03131440|62856167|FG009|Overall Study|Death|0|||
33479810|NCT03131440|62856168|FG010|Overall Study|Death|0|||
33479811|NCT03131440|62856169|FG011|Overall Study|Death|0|||
33479812|NCT03131440|62856170|FG012|Overall Study|Death|0|||
33479813|NCT03131440|62856171|FG013|Overall Study|Death|0|||
33479814|NCT03131440|62856172|FG014|Overall Study|Death|0|||
33479815|NCT03131440|62856173|FG015|Overall Study|Death|0|||
33479816|NCT03131440|62856174|FG016|Overall Study|Death|0|||
33479817|NCT03131440|62856175|FG017|Overall Study|Death|0|||
33479818|NCT03131440|62856176|FG018|Overall Study|Death|0|||
33479819|NCT03131440|62856177|FG019|Overall Study|Death|0|||
33479820|NCT03131440|62856178|FG020|Overall Study|Death|0|||
33479821|NCT03131440|62856179|FG021|Overall Study|Death|0|||
33479822|NCT03131440|62856180|FG022|Overall Study|Death|0|||
33479823|NCT03131440|62856181|FG023|Overall Study|Death|0|||
33479824|NCT03131440|62856182|FG024|Overall Study|Death|0|||
33479825|NCT03131440|62856183|FG025|Overall Study|Death|1|||
33479826|NCT03131440|62856184|FG026|Overall Study|Death|0|||
33479827|NCT03131440|62856185|FG027|Overall Study|Death|0|||
33479828|NCT03131440|62856186|FG028|Overall Study|Death|0|||
33479829|NCT03131440|62856187|FG029|Overall Study|Death|0|||
33479830|NCT03131440|62856188|FG030|Overall Study|Death|0|||
33479831|NCT03131440|62856189|FG031|Overall Study|Death|0|||
33479832|NCT02915302|62856234|FG000|Overall Study|Adverse Event|3|||
33479833|NCT02915302|62856235|FG001|Overall Study|Adverse Event|0|||
33479834|NCT02915302|62856234|FG000|Overall Study|Protocol Violation|20|||
33479835|NCT02915302|62856235|FG001|Overall Study|Protocol Violation|27|||
33479836|NCT02915302|62856234|FG000|Overall Study|Lost to Follow-up|19|||
33479837|NCT02915302|62856235|FG001|Overall Study|Lost to Follow-up|22|||
33479838|NCT02915302|62856234|FG000|Overall Study|Withdrawal by Subject|22|||
33479839|NCT02915302|62856235|FG001|Overall Study|Withdrawal by Subject|29|||
33479840|NCT02915302|62856234|FG000|Overall Study|Other|1|||
33479841|NCT02915302|62856235|FG001|Overall Study|Other|0|||
33479842|NCT03023878|62856241|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
33479843|NCT03023878|62856241|FG000|Pre-Study Run-In Period|Death|1|||
33479844|NCT03023878|62856241|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
33479845|NCT03023878|62856241|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
33479846|NCT03023878|62856241|FG000|Treatment Period|Disease Progression|1|||
33479847|NCT03023878|62856241|FG000|Treatment Period|Withdrawal by Subject|1|||
33479848|NCT03023878|62856241|FG000|Treatment Period|Adverse Event|1|||
33479849|NCT03023878|62856241|FG000|Long Term Follow-Up Period|Death|2|||
33479850|NCT03022630|62856247|FG000|Overall Study|Death|9|||
33479851|NCT03022630|62856248|FG001|Overall Study|Death|7|||
33479852|NCT03022630|62856247|FG000|Overall Study|Withdrawal by Subject|0|||
33479853|NCT03022630|62856248|FG001|Overall Study|Withdrawal by Subject|5|||
33479854|NCT03023722|62856259|FG000|Overall Study|No follow-up assessment|4|||
33479855|NCT03022084|62856265|FG000|Overall Study|Lost to Follow-up|2|||
33479856|NCT03022084|62856266|FG001|Overall Study|Lost to Follow-up|3|||
33479857|NCT03021304|62856272|FG000|Overall Study|Lack of Efficacy|1|||
33479858|NCT01979536|62856278|FG000|Overall Study|Physician Decision|2|||
33479859|NCT01979536|62856279|FG001|Overall Study|Physician Decision|3|||
33479860|NCT01979536|62856278|FG000|Overall Study|Withdrawal by Subject|0|||
33479861|NCT01979536|62856279|FG001|Overall Study|Withdrawal by Subject|1|||
33479862|NCT01979536|62856278|FG000|Overall Study|Refusal|0|||
33479863|NCT01979536|62856279|FG001|Overall Study|Refusal|1|||
33479864|NCT01979536|62856278|FG000|Overall Study|Relapse|0|||
33479865|NCT01979536|62856279|FG001|Overall Study|Relapse|1|||
33479866|NCT01979536|62856278|FG000|Overall Study|Study terminated by Sponsor|0|||
33479867|NCT01979536|62856279|FG001|Overall Study|Study terminated by Sponsor|1|||
33479868|NCT01979536|62856278|FG000|Overall Study|Did not start treatment|0|||
33479869|NCT01979536|62856279|FG001|Overall Study|Did not start treatment|1|||
33479870|NCT03496298|62856296|FG000|Overall Study|Adverse Event|49|||
33479871|NCT03496298|62856297|FG001|Overall Study|Adverse Event|68|||
33479872|NCT03496298|62856298|FG002|Overall Study|Adverse Event|79|||
33479873|NCT03496298|62856296|FG000|Overall Study|Study terminated by Sponsor|1050|||
33479874|NCT03496298|62856297|FG001|Overall Study|Study terminated by Sponsor|1063|||
33479875|NCT03496298|62856298|FG002|Overall Study|Study terminated by Sponsor|1071|||
33479876|NCT03496298|62856296|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
33479877|NCT03496298|62856297|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
33479878|NCT03496298|62856298|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
33479879|NCT03496298|62856296|FG000|Overall Study|Withdrawal by Subject|176|||
33479880|NCT03496298|62856297|FG001|Overall Study|Withdrawal by Subject|154|||
33479881|NCT03496298|62856298|FG002|Overall Study|Withdrawal by Subject|151|||
33479882|NCT03496298|62856296|FG000|Overall Study|Other|29|||
33479883|NCT03496298|62856297|FG001|Overall Study|Other|20|||
33479884|NCT03496298|62856298|FG002|Overall Study|Other|23|||
33479885|NCT03496298|62856296|FG000|Overall Study|Randomized and not treated|1|||
33479886|NCT03496298|62856297|FG001|Overall Study|Randomized and not treated|1|||
33479887|NCT03496298|62856298|FG002|Overall Study|Randomized and not treated|1|||
33479888|NCT02914522|62856311|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
33479889|NCT02914522|62856312|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
33479890|NCT02914522|62856313|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
33479891|NCT02914522|62856314|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
33479892|NCT02914522|62856315|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
33479893|NCT02914522|62856316|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
33551165|NCT02838901|62943487|FG001|Overall Study|Withdrawal by Subject|1|||
33656155|NCT00981747|63074202|FG000|Losartan|Death|1|||
33479894|NCT02914522|62856317|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
33479895|NCT02914522|62856318|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
33479896|NCT02914522|62856319|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
33479897|NCT02914522|62856320|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
33479898|NCT02914522|62856321|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
33479899|NCT02914522|62856311|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
33479900|NCT02914522|62856312|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
33479901|NCT02914522|62856313|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
33479902|NCT02914522|62856314|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
33479903|NCT02914522|62856315|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
33479904|NCT02914522|62856316|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
33479905|NCT02914522|62856317|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
33479906|NCT02914522|62856318|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
33479907|NCT02914522|62856319|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
33479908|NCT02914522|62856320|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
33479909|NCT02914522|62856321|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
33479910|NCT02914522|62856311|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
33479911|NCT02914522|62856312|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
33479912|NCT02914522|62856313|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
33479913|NCT02914522|62856314|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
33479914|NCT02914522|62856315|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
33479915|NCT02914522|62856316|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
33479916|NCT02914522|62856317|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
33479917|NCT02914522|62856318|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
33479918|NCT02914522|62856319|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
33479919|NCT02914522|62856320|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
33479920|NCT02914522|62856321|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
33479921|NCT02914522|62856311|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33479922|NCT02914522|62856312|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
33479923|NCT02914522|62856313|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
33479924|NCT02914522|62856314|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
33479925|NCT02914522|62856315|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33479926|NCT02914522|62856316|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33479927|NCT02914522|62856317|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33479928|NCT02914522|62856318|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33479929|NCT02914522|62856319|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33479930|NCT02914522|62856320|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33479931|NCT02914522|62856321|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33479932|NCT02914522|62856311|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33479933|NCT02914522|62856312|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33479934|NCT02914522|62856313|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33479935|NCT02914522|62856314|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33479936|NCT02914522|62856315|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
33479937|NCT02914522|62856316|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33479938|NCT02914522|62856317|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33479939|NCT02914522|62856318|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33479940|NCT02914522|62856319|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33479941|NCT02914522|62856320|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33479942|NCT02914522|62856321|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33479943|NCT02914522|62856311|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
33479944|NCT02914522|62856312|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33479945|NCT02914522|62856313|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33479946|NCT02914522|62856314|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33479947|NCT02914522|62856315|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33479948|NCT02914522|62856316|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33479949|NCT02914522|62856317|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33479950|NCT02914522|62856318|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33479951|NCT02914522|62856319|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33479952|NCT02914522|62856320|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33551166|NCT02838901|62943486|FG000|Overall Study|Lost to Follow-up|1|||
33551167|NCT02838901|62943487|FG001|Overall Study|Lost to Follow-up|1|||
33551168|NCT00706797|62943515|FG000|Overall Study|Lack of Efficacy|3|||
33479953|NCT02914522|62856321|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33479954|NCT02914522|62856311|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
33479955|NCT02914522|62856312|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
33479956|NCT02914522|62856313|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
33479957|NCT02914522|62856314|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
33551169|NCT00706797|62943516|FG001|Overall Study|Lack of Efficacy|0|||
33551170|NCT00706797|62943515|FG000|Overall Study|Adverse Event|0|||
33551171|NCT00706797|62943516|FG001|Overall Study|Adverse Event|3|||
33551172|NCT00706797|62943515|FG000|Overall Study|Withdrawal by Subject|8|||
33551173|NCT00706797|62943516|FG001|Overall Study|Withdrawal by Subject|1|||
33551174|NCT00706797|62943515|FG000|Overall Study|Death|1|||
33551175|NCT00706797|62943516|FG001|Overall Study|Death|0|||
33551176|NCT00706797|62943515|FG000|Overall Study|Discontinuation of study by sponsor|52|||
33551177|NCT00706797|62943516|FG001|Overall Study|Discontinuation of study by sponsor|63|||
33551178|NCT00706797|62943515|FG000|Overall Study|Protocol Violation|3|||
33551179|NCT00706797|62943516|FG001|Overall Study|Protocol Violation|2|||
33551180|NCT00706797|62943515|FG000|Overall Study|Lost to Follow-up|1|||
33479958|NCT02914522|62856315|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
33479959|NCT02914522|62856316|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
33479960|NCT02914522|62856317|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
33479961|NCT02914522|62856318|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
33479962|NCT02914522|62856319|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
33479963|NCT02914522|62856320|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
33479964|NCT02914522|62856321|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
33551181|NCT00706797|62943516|FG001|Overall Study|Lost to Follow-up|2|||
33551182|NCT00706797|62943515|FG000|Overall Study|Other|1|||
33551183|NCT00706797|62943516|FG001|Overall Study|Other|0|||
33551184|NCT00706641|62943522|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
33551185|NCT00706641|62943522|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
33551186|NCT00706641|62943522|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
33551187|NCT01362530|62943528|FG000|Base Study (Cycle 1)|Adverse Event|2|||
33551188|NCT01362530|62943529|FG001|Base Study (Cycle 1)|Adverse Event|0|||
33551189|NCT01362530|62943528|FG000|Base Study (Cycle 1)|Physician Decision|0|||
33551190|NCT01362530|62943529|FG001|Base Study (Cycle 1)|Physician Decision|1|||
33551191|NCT01362530|62943528|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
33551192|NCT01362530|62943529|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
33551193|NCT01362530|62943528|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
33551194|NCT01362530|62943529|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
33551195|NCT01362530|62943528|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
33551196|NCT01362530|62943529|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
33551197|NCT01362530|62943528|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
33551198|NCT01362530|62943529|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
33656156|NCT00981747|63074202|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
33656157|NCT01856309|63074357|FG000|Overall Study|Death|4|||
33656158|NCT01856309|63074358|FG001|Overall Study|Death|6|||
33656159|NCT01856309|63074359|FG002|Overall Study|Death|11|||
33656160|NCT01856309|63074360|FG003|Overall Study|Death|6|||
33656161|NCT01856309|63074357|FG000|Overall Study|Lost to Follow-up|6|||
33656162|NCT01856309|63074358|FG001|Overall Study|Lost to Follow-up|2|||
33656163|NCT01856309|63074359|FG002|Overall Study|Lost to Follow-up|4|||
33656164|NCT01856309|63074360|FG003|Overall Study|Lost to Follow-up|8|||
33656165|NCT01856309|63074357|FG000|Overall Study|Withdrawal by Subject|11|||
33656166|NCT01856309|63074358|FG001|Overall Study|Withdrawal by Subject|13|||
33656167|NCT01856309|63074359|FG002|Overall Study|Withdrawal by Subject|28|||
33656168|NCT01856309|63074360|FG003|Overall Study|Withdrawal by Subject|26|||
33656169|NCT01856309|63074357|FG000|Overall Study|Other|227|||
33656170|NCT01856309|63074358|FG001|Overall Study|Other|225|||
33656171|NCT01856309|63074359|FG002|Overall Study|Other|447|||
33656172|NCT01856309|63074360|FG003|Overall Study|Other|469|||
33656173|NCT01856309|63074357|FG000|Overall Study|Lack of Efficacy|14|||
33656174|NCT01856309|63074358|FG001|Overall Study|Lack of Efficacy|9|||
33656175|NCT01856309|63074359|FG002|Overall Study|Lack of Efficacy|40|||
33656176|NCT01856309|63074360|FG003|Overall Study|Lack of Efficacy|25|||
33656177|NCT01856309|63074357|FG000|Overall Study|Adverse Event|31|||
33656178|NCT01856309|63074358|FG001|Overall Study|Adverse Event|31|||
33656179|NCT01856309|63074359|FG002|Overall Study|Adverse Event|55|||
33656180|NCT01856309|63074360|FG003|Overall Study|Adverse Event|65|||
33656181|NCT01856309|63074357|FG000|Overall Study|Pregnancy|0|||
33656182|NCT01856309|63074358|FG001|Overall Study|Pregnancy|0|||
33656183|NCT01856309|63074359|FG002|Overall Study|Pregnancy|0|||
33656184|NCT01856309|63074360|FG003|Overall Study|Pregnancy|1|||
33656185|NCT01856309|63074357|FG000|Overall Study|Physician Decision|6|||
33656186|NCT01856309|63074358|FG001|Overall Study|Physician Decision|1|||
33656187|NCT01856309|63074359|FG002|Overall Study|Physician Decision|6|||
33656188|NCT01856309|63074360|FG003|Overall Study|Physician Decision|8|||
33656189|NCT01856309|63074357|FG000|Overall Study|Noncompliance With Study Drug|0|||
33656190|NCT01856309|63074358|FG001|Overall Study|Noncompliance With Study Drug|1|||
33479965|NCT02914522|62856311|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33479966|NCT02914522|62856312|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
33479967|NCT02914522|62856313|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33479968|NCT02914522|62856314|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33551199|NCT01362530|62943528|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
33656191|NCT01856309|63074359|FG002|Overall Study|Noncompliance With Study Drug|4|||
33656192|NCT01856309|63074360|FG003|Overall Study|Noncompliance With Study Drug|1|||
33656193|NCT01855919|63074558|FG000|Overall Study|Adverse Event|16|||
33656194|NCT01855919|63074559|FG001|Overall Study|Adverse Event|8|||
33656195|NCT01855919|63074558|FG000|Overall Study|Lack of Efficacy|1|||
33656196|NCT01855919|63074559|FG001|Overall Study|Lack of Efficacy|3|||
33656197|NCT01855919|63074558|FG000|Overall Study|Withdrawal by Subject|4|||
33656198|NCT01855919|63074559|FG001|Overall Study|Withdrawal by Subject|10|||
33656199|NCT01855919|63074558|FG000|Overall Study|Entry Criteria Not Met|1|||
33656200|NCT01855919|63074559|FG001|Overall Study|Entry Criteria Not Met|1|||
33656201|NCT01855919|63074558|FG000|Overall Study|Protocol Violation|1|||
33479969|NCT02914522|62856315|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
33479970|NCT02914522|62856316|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
33479971|NCT02914522|62856317|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33479972|NCT02914522|62856318|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33479973|NCT02914522|62856319|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33479974|NCT02914522|62856320|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33479975|NCT02914522|62856321|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33479976|NCT02914522|62856311|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
33479977|NCT02914522|62856312|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
33479978|NCT02914522|62856313|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
33479979|NCT02914522|62856314|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
33479980|NCT02914522|62856315|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
33479981|NCT02914522|62856316|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
33479982|NCT02914522|62856317|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
33479983|NCT02914522|62856318|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
33479984|NCT02914522|62856319|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
33479985|NCT02914522|62856320|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
33479986|NCT02914522|62856321|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
33479987|NCT02914522|62856311|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
33479988|NCT02914522|62856312|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
33479989|NCT02914522|62856313|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
33479990|NCT02914522|62856314|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
33479991|NCT02914522|62856315|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
33479992|NCT02914522|62856316|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
33479993|NCT02914522|62856317|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
33479994|NCT02914522|62856318|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
33479995|NCT02914522|62856319|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
33479996|NCT02914522|62856320|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
33479997|NCT02914522|62856321|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
33479998|NCT02914522|62856311|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
33479999|NCT02914522|62856312|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
33480000|NCT02914522|62856313|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
33480001|NCT02914522|62856314|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
33480002|NCT02914522|62856315|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
33480003|NCT02914522|62856316|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
33480004|NCT02914522|62856317|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
33480005|NCT02914522|62856318|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
33480006|NCT02914522|62856319|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
33480007|NCT02914522|62856320|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
33480008|NCT02914522|62856321|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
33480009|NCT02914522|62856311|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
33480010|NCT02914522|62856312|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
33480011|NCT02914522|62856313|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
33480012|NCT02914522|62856314|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
33480013|NCT02914522|62856315|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
33480014|NCT02914522|62856316|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
33480015|NCT02914522|62856317|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
33480016|NCT02914522|62856318|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
33480017|NCT02914522|62856319|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
33480018|NCT02914522|62856320|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
33480019|NCT02914522|62856321|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
33480020|NCT02914522|62856311|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
33480021|NCT02914522|62856312|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
33480022|NCT02914522|62856313|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
33480023|NCT02914522|62856314|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
33480024|NCT02914522|62856315|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
33480025|NCT02914522|62856316|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
33480026|NCT02914522|62856317|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
33480027|NCT02914522|62856318|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
33551200|NCT01362530|62943529|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
33551201|NCT01362530|62943528|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
33656202|NCT01855919|63074559|FG001|Overall Study|Protocol Violation|4|||
33480028|NCT02914522|62856319|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
33480029|NCT02914522|62856320|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
33480030|NCT02914522|62856321|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
33480031|NCT02914522|62856311|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33480032|NCT02914522|62856312|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33480033|NCT02914522|62856313|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33480034|NCT02914522|62856314|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33480035|NCT02914522|62856315|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33656203|NCT01871519|63074575|FG000|Overall Study|Death|26|||
33656204|NCT01871519|63074575|FG000|Overall Study|Lost to Follow-up|15|||
33656205|NCT01871519|63074575|FG000|Overall Study|Withdrawal by Subject|49|||
33656206|NCT01871285|63074582|FG000|First Intervention (1 Day)|Adverse Event|1|||
33656207|NCT01871285|63074583|FG001|First Intervention (1 Day)|Adverse Event|0|||
33656208|NCT01871285|63074584|FG002|First Intervention (1 Day)|Adverse Event|0|||
33656209|NCT01871285|63074585|FG003|First Intervention (1 Day)|Adverse Event|0|||
33656210|NCT01871285|63074582|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
33656211|NCT01871285|63074583|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
33656212|NCT01871285|63074584|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
33656213|NCT01871285|63074585|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
33656214|NCT01870973|63074611|FG000|Overall Study|Lost to Follow-up|10|||
33656215|NCT01870973|63074612|FG001|Overall Study|Lost to Follow-up|3|||
33656216|NCT01854827|63074631|FG000|Overall Study|Death|1|||
33656217|NCT01854047|63074774|FG000|Overall Study|Lack of Efficacy|1|||
33656218|NCT01854047|63074775|FG001|Overall Study|Lack of Efficacy|0|||
33656219|NCT01854047|63074776|FG002|Overall Study|Lack of Efficacy|0|||
33656220|NCT01854047|63074777|FG003|Overall Study|Lack of Efficacy|0|||
33656221|NCT01854047|63074778|FG004|Overall Study|Lack of Efficacy|0|||
33656222|NCT01854047|63074774|FG000|Overall Study|Poor compliance to protocol|3|||
33656223|NCT01854047|63074775|FG001|Overall Study|Poor compliance to protocol|0|||
33656224|NCT01854047|63074776|FG002|Overall Study|Poor compliance to protocol|2|||
33656225|NCT01854047|63074777|FG003|Overall Study|Poor compliance to protocol|0|||
33656226|NCT01854047|63074778|FG004|Overall Study|Poor compliance to protocol|0|||
33656227|NCT01854047|63074774|FG000|Overall Study|Adverse Event|5|||
33656228|NCT01854047|63074775|FG001|Overall Study|Adverse Event|4|||
33656229|NCT01854047|63074776|FG002|Overall Study|Adverse Event|6|||
33656230|NCT01854047|63074777|FG003|Overall Study|Adverse Event|10|||
33656231|NCT01854047|63074778|FG004|Overall Study|Adverse Event|7|||
33656232|NCT01854047|63074774|FG000|Overall Study|Randomized but not treated|0|||
33656233|NCT01854047|63074775|FG001|Overall Study|Randomized but not treated|1|||
33656234|NCT01854047|63074776|FG002|Overall Study|Randomized but not treated|2|||
33656235|NCT01854047|63074777|FG003|Overall Study|Randomized but not treated|0|||
33656236|NCT01854047|63074778|FG004|Overall Study|Randomized but not treated|4|||
33656237|NCT01854047|63074774|FG000|Overall Study|Other than specified above|3|||
33656238|NCT01854047|63074775|FG001|Overall Study|Other than specified above|3|||
33656239|NCT01854047|63074776|FG002|Overall Study|Other than specified above|3|||
33656240|NCT01854047|63074777|FG003|Overall Study|Other than specified above|5|||
33656241|NCT01854047|63074778|FG004|Overall Study|Other than specified above|8|||
33656242|NCT01870739|63074824|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
33656243|NCT01870739|63074825|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
33656244|NCT01870739|63074824|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
33656245|NCT01870739|63074825|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
33656246|NCT01870739|63074824|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
33656247|NCT01870739|63074825|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
33656248|NCT01870739|63074824|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
33656249|NCT01870739|63074825|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
33656250|NCT01870739|63074824|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
33656251|NCT01870739|63074825|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
33656252|NCT01870739|63074824|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
33656253|NCT01870739|63074825|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
33656254|NCT01870739|63074824|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
33656255|NCT01870739|63074825|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
33656256|NCT01613417|63074852|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
33656257|NCT01613417|63074853|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
33656258|NCT01870583|63074881|FG000|Overall Study|Protocol Violation|0|||
33656259|NCT01870583|63074882|FG001|Overall Study|Protocol Violation|5|||
33656260|NCT01870583|63074883|FG002|Overall Study|Protocol Violation|3|||
33656261|NCT01870583|63074881|FG000|Overall Study|Lost to Follow-up|11|||
33656262|NCT01870583|63074882|FG001|Overall Study|Lost to Follow-up|13|||
33656263|NCT01870583|63074883|FG002|Overall Study|Lost to Follow-up|5|||
33480036|NCT02914522|62856316|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33656264|NCT01869959|63074941|FG000|Randomization Period|Physician Decision|0|||
33656265|NCT01869959|63074942|FG001|Randomization Period|Physician Decision|0|||
33656266|NCT01869959|63074943|FG002|Randomization Period|Physician Decision|0|||
33480037|NCT02914522|62856317|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33480038|NCT02914522|62856318|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
33480039|NCT02914522|62856319|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
33480040|NCT02914522|62856320|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33480041|NCT02914522|62856321|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33480042|NCT02914522|62856311|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33480043|NCT02914522|62856312|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33480044|NCT02914522|62856313|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33480045|NCT02914522|62856314|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33480046|NCT02914522|62856315|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33480047|NCT02914522|62856316|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33480048|NCT02914522|62856317|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33480049|NCT02914522|62856318|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33480050|NCT02914522|62856319|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
33480051|NCT02914522|62856320|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
33480052|NCT02914522|62856321|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33480053|NCT02914522|62856311|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33480054|NCT02914522|62856312|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33480055|NCT02914522|62856313|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33480056|NCT02914522|62856314|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33480057|NCT02914522|62856315|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33480058|NCT02914522|62856316|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33480059|NCT02914522|62856317|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33480060|NCT02914522|62856318|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33480061|NCT02914522|62856319|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33480062|NCT02914522|62856320|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
33480063|NCT02914522|62856321|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33480064|NCT02924428|62856350|FG000|Overall Study|Adverse Event|1|||
33480065|NCT02924428|62856351|FG001|Overall Study|Adverse Event|0|||
33480066|NCT02924428|62856350|FG000|Overall Study|Physician Decision|1|||
33480067|NCT02924428|62856351|FG001|Overall Study|Physician Decision|0|||
33480068|NCT02924428|62856350|FG000|Overall Study|Lost to Follow-up|2|||
33480069|NCT02924428|62856351|FG001|Overall Study|Lost to Follow-up|4|||
33480070|NCT02924428|62856350|FG000|Overall Study|Pregnancy|0|||
33551202|NCT01362530|62943529|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
33551203|NCT01362530|62943528|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
33551204|NCT01362530|62943529|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
33551205|NCT01362530|62943528|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
33551206|NCT01362530|62943529|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
33551207|NCT01362530|62943528|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
33551208|NCT01362530|62943529|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
33551209|NCT01362530|62943528|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
33551210|NCT01362530|62943529|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
33551211|NCT01362530|62943528|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
33551212|NCT01362530|62943529|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
33551213|NCT02654054|62943539|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
33551214|NCT02654054|62943540|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
33551215|NCT02654054|62943541|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
33656267|NCT01869959|63074944|FG003|Randomization Period|Physician Decision|0|||
33656268|NCT01869959|63074945|FG004|Randomization Period|Physician Decision|1|||
33656269|NCT01869959|63074941|FG000|Treatment Period|Adverse Event|1|||
33656270|NCT01869959|63074942|FG001|Treatment Period|Adverse Event|0|||
33656271|NCT01869959|63074943|FG002|Treatment Period|Adverse Event|3|||
33656272|NCT01869959|63074944|FG003|Treatment Period|Adverse Event|1|||
33656273|NCT01869959|63074945|FG004|Treatment Period|Adverse Event|0|||
33656274|NCT01869959|63074941|FG000|Treatment Period|Sponsor decision|0|||
33656275|NCT01869959|63074942|FG001|Treatment Period|Sponsor decision|1|||
33656276|NCT01869959|63074943|FG002|Treatment Period|Sponsor decision|0|||
33656277|NCT01869959|63074944|FG003|Treatment Period|Sponsor decision|1|||
33656278|NCT01869959|63074945|FG004|Treatment Period|Sponsor decision|0|||
33656279|NCT01869959|63074941|FG000|Treatment Period|Withdrawal by Subject|0|||
33480071|NCT02924428|62856351|FG001|Overall Study|Pregnancy|1|||
33480072|NCT00062751|62856362|FG000|Overall Study|Disease progression|24|||
33480073|NCT00062751|62856363|FG001|Overall Study|Disease progression|17|||
33480074|NCT00062751|62856364|FG002|Overall Study|Disease progression|24|||
33480075|NCT00062751|62856365|FG003|Overall Study|Disease progression|2|||
33551216|NCT02654054|62943539|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
33656280|NCT01869959|63074942|FG001|Treatment Period|Withdrawal by Subject|1|||
33480076|NCT00062751|62856366|FG004|Overall Study|Disease progression|2|||
33480077|NCT00062751|62856362|FG000|Overall Study|Adverse Event|4|||
33480078|NCT00062751|62856363|FG001|Overall Study|Adverse Event|7|||
33480079|NCT00062751|62856364|FG002|Overall Study|Adverse Event|2|||
33480080|NCT00062751|62856365|FG003|Overall Study|Adverse Event|2|||
33480081|NCT00062751|62856366|FG004|Overall Study|Adverse Event|2|||
33480082|NCT00062751|62856362|FG000|Overall Study|Other|2|||
33480083|NCT00062751|62856363|FG001|Overall Study|Other|3|||
33480084|NCT00062751|62856364|FG002|Overall Study|Other|1|||
33480085|NCT00062751|62856365|FG003|Overall Study|Other|0|||
33480086|NCT00062751|62856366|FG004|Overall Study|Other|1|||
33480087|NCT00062751|62856362|FG000|Overall Study|Withdrawal by Subject|1|||
33480088|NCT00062751|62856363|FG001|Overall Study|Withdrawal by Subject|2|||
33480089|NCT00062751|62856364|FG002|Overall Study|Withdrawal by Subject|2|||
33480090|NCT00062751|62856365|FG003|Overall Study|Withdrawal by Subject|1|||
33480091|NCT00062751|62856366|FG004|Overall Study|Withdrawal by Subject|0|||
33480092|NCT00062751|62856362|FG000|Overall Study|Symptomatic deterioration|1|||
33480093|NCT00062751|62856363|FG001|Overall Study|Symptomatic deterioration|1|||
33480094|NCT00062751|62856364|FG002|Overall Study|Symptomatic deterioration|0|||
33480095|NCT00062751|62856365|FG003|Overall Study|Symptomatic deterioration|0|||
33480096|NCT00062751|62856366|FG004|Overall Study|Symptomatic deterioration|1|||
33480097|NCT00062751|62856362|FG000|Overall Study|Death|1|||
33480098|NCT00062751|62856363|FG001|Overall Study|Death|0|||
33480099|NCT00062751|62856364|FG002|Overall Study|Death|1|||
33480100|NCT00062751|62856365|FG003|Overall Study|Death|0|||
33480101|NCT00062751|62856366|FG004|Overall Study|Death|0|||
33480102|NCT00062439|62856383|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
33480103|NCT00062439|62856383|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
33480104|NCT00062439|62856383|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
33480105|NCT00062439|62856383|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
33480106|NCT00062439|62856383|FG000|Post Chemoradiation Assessment|Death|1|||
33480107|NCT00062439|62856383|FG000|Post Chemoradiation Assessment|Disease progression|2|||
33480108|NCT00062439|62856383|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
33480109|NCT00062439|62856383|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
33480110|NCT00062439|62856383|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
33480111|NCT00062439|62856383|FG000|Surgery|Physician Decision|4|||
33480112|NCT00062439|62856383|FG000|Surgery|Death|1|||
33480113|NCT00062439|62856383|FG000|Surgery|Adverse Event|2|||
33480114|NCT00062439|62856383|FG000|Consolidation Chemotherapy|Adverse Event|2|||
33480115|NCT00051363|62856394|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
33480116|NCT00051363|62856395|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
33480117|NCT00051363|62856394|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
33480118|NCT00051363|62856395|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
33480119|NCT00051363|62856394|FG000|Overall Study|Death|2|||
33480120|NCT00051363|62856395|FG001|Overall Study|Death|2|||
33480121|NCT00051363|62856394|FG000|Overall Study|Excluded Pre-Randomization|2|||
33480122|NCT00051363|62856395|FG001|Overall Study|Excluded Pre-Randomization|5|||
33480123|NCT00031551|62856403|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
33480124|NCT00031551|62856404|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
33480125|NCT00049257|62856414|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
33480126|NCT00049257|62856414|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
33480127|NCT00049257|62856414|FG000|Carboplatin, Paclitaxel|Death|2|||
33480128|NCT00049257|62856414|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
33480129|NCT03020992|62856418|FG000|Overall Study|Adverse Event|5|||
33480130|NCT03020992|62856418|FG000|Overall Study|Withdrawal by Subject|1|||
33480131|NCT03020914|62856425|FG000|Overall Study|Surgery Cancelled|1|||
33480132|NCT03020914|62856426|FG001|Overall Study|Surgery Cancelled|0|||
33480133|NCT03018340|62856434|FG000|Overall Study|Adverse Event|1|||
33480134|NCT03018340|62856435|FG001|Overall Study|Adverse Event|2|||
33480135|NCT03018340|62856434|FG000|Overall Study|Withdrawal by Subject|0|||
33656281|NCT01869959|63074943|FG002|Treatment Period|Withdrawal by Subject|0|||
33480136|NCT03018340|62856435|FG001|Overall Study|Withdrawal by Subject|8|||
33480137|NCT03018340|62856434|FG000|Overall Study|Lack of Efficacy|0|||
33480138|NCT03018340|62856435|FG001|Overall Study|Lack of Efficacy|1|||
33480139|NCT03018340|62856434|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
33480140|NCT03018340|62856435|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
33480141|NCT03018340|62856434|FG000|Overall Study|Lost to Follow-up|1|||
33656282|NCT01869959|63074944|FG003|Treatment Period|Withdrawal by Subject|0|||
33480142|NCT03018340|62856435|FG001|Overall Study|Lost to Follow-up|7|||
33480143|NCT03018340|62856434|FG000|Overall Study|Protocol Violation|3|||
33480144|NCT03018340|62856435|FG001|Overall Study|Protocol Violation|7|||
33480145|NCT03018340|62856434|FG000|Overall Study|Not further specified|0|||
33480146|NCT03018340|62856435|FG001|Overall Study|Not further specified|1|||
33480147|NCT03016078|62856445|FG000|Overall Study|Protocol Violation|1|||
33480148|NCT03016078|62856445|FG000|Overall Study|Protocol Violation|1|||
33480149|NCT00048165|62856451|FG000|Completed 6 Months Study|Administration/Other|8|||
33480150|NCT00048165|62856452|FG001|Completed 6 Months Study|Administration/Other|8|||
33480151|NCT00048165|62856451|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
33480152|NCT00048165|62856452|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
33480153|NCT00048165|62856451|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
33480154|NCT00048165|62856452|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
33480155|NCT00048165|62856451|FG000|Completed 6 Months Study|Death|12|||
33551217|NCT02654054|62943540|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33551218|NCT02654054|62943541|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
33551219|NCT02654054|62943539|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
33551220|NCT02654054|62943540|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
33580910|NCT01454934|62978057|FG000|Overall Study|Withdrawal by Subject|11|||
33656283|NCT01869959|63074945|FG004|Treatment Period|Withdrawal by Subject|0|||
33656284|NCT01613027|63075006|FG000|Overall Study|Lost to Follow-up|5|||
33656285|NCT01613027|63075006|FG000|Overall Study|Switched Physician|1|||
33656286|NCT01613027|63075006|FG000|Overall Study|Lack of Efficacy|1|||
33656287|NCT01613027|63075006|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
33656288|NCT01869725|63075024|FG000|Overall Study|ineligible after registration|1|||
33656289|NCT01869725|63075024|FG000|Overall Study|Death|1|||
33656290|NCT01869725|63075024|FG000|Overall Study|Lost to Follow-up|2|||
33656291|NCT01851863|63075045|FG000|Overall Study|Did not receive study medication|2|||
33656292|NCT01851863|63075046|FG001|Overall Study|Did not receive study medication|5|||
33656293|NCT01851863|63075047|FG002|Overall Study|Did not receive study medication|3|||
33656294|NCT01851863|63075048|FG003|Overall Study|Did not receive study medication|0|||
33656295|NCT01851863|63075045|FG000|Overall Study|Lost to Follow-up|3|||
33656296|NCT01851863|63075046|FG001|Overall Study|Lost to Follow-up|4|||
33656297|NCT01851863|63075047|FG002|Overall Study|Lost to Follow-up|2|||
33656298|NCT01851863|63075048|FG003|Overall Study|Lost to Follow-up|3|||
33656299|NCT01850615|63075076|FG000|Overall Study|Protocol Violation|4|||
33656300|NCT01850615|63075077|FG001|Overall Study|Protocol Violation|1|||
33656301|NCT01850615|63075076|FG000|Overall Study|Adverse Event|2|||
33656302|NCT01850615|63075077|FG001|Overall Study|Adverse Event|1|||
33656303|NCT01850615|63075076|FG000|Overall Study|Withdrawal by Subject|3|||
33656304|NCT01850615|63075077|FG001|Overall Study|Withdrawal by Subject|1|||
33656305|NCT01850615|63075076|FG000|Overall Study|Lost to Follow-up|0|||
33656306|NCT01850615|63075077|FG001|Overall Study|Lost to Follow-up|1|||
33656307|NCT01850615|63075076|FG000|Overall Study|Unclassified|0|||
33656308|NCT01850615|63075077|FG001|Overall Study|Unclassified|1|||
33656309|NCT01868477|63075162|FG000|Overall Study|Adverse Event|2|||
33656310|NCT01868477|63075163|FG001|Overall Study|Adverse Event|4|||
33656311|NCT01868477|63075162|FG000|Overall Study|Disease progression|1|||
33656312|NCT01868477|63075163|FG001|Overall Study|Disease progression|1|||
33656313|NCT01868477|63075162|FG000|Overall Study|Withdrawal by Subject|1|||
33656314|NCT01868477|63075163|FG001|Overall Study|Withdrawal by Subject|0|||
33480156|NCT00048165|62856452|FG001|Completed 6 Months Study|Death|6|||
33480157|NCT00048165|62856451|FG000|Completed 6 Months Study|Insufficient therapy|1|||
33480158|NCT00048165|62856452|FG001|Completed 6 Months Study|Insufficient therapy|4|||
33480159|NCT00048165|62856451|FG000|Completed 6 Months Study|Other violation|4|||
33480160|NCT00048165|62856452|FG001|Completed 6 Months Study|Other violation|6|||
33480161|NCT00048165|62856451|FG000|Completed 6 Months Study|Refused treatment|5|||
33480162|NCT00048165|62856452|FG001|Completed 6 Months Study|Refused treatment|5|||
33480163|NCT00048165|62856451|FG000|Completed 6 Months Study|Violation criteria|0|||
33480164|NCT00048165|62856452|FG001|Completed 6 Months Study|Violation criteria|2|||
33480165|NCT00048165|62856451|FG000|Completed 6 Months Study|Did not receive study drug|6|||
33480166|NCT00048165|62856452|FG001|Completed 6 Months Study|Did not receive study drug|6|||
33480167|NCT00048165|62856451|FG000|Completed 12 Months Study|Administration/Other|0|||
33480168|NCT00048165|62856452|FG001|Completed 12 Months Study|Administration/Other|2|||
33480169|NCT00048165|62856451|FG000|Completed 12 Months Study|Death|2|||
33480170|NCT00048165|62856452|FG001|Completed 12 Months Study|Death|1|||
33480171|NCT00048165|62856451|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
33580911|NCT01454934|62978058|FG001|Overall Study|Withdrawal by Subject|15|||
33580912|NCT01454934|62978057|FG000|Overall Study|Disease progression|194|||
33580913|NCT01454934|62978058|FG001|Overall Study|Disease progression|181|||
33580914|NCT01454934|62978057|FG000|Overall Study|Lost to Follow-up|0|||
33580915|NCT01454934|62978058|FG001|Overall Study|Lost to Follow-up|1|||
33580916|NCT01454934|62978057|FG000|Overall Study|Not treated|1|||
33580917|NCT01454934|62978058|FG001|Overall Study|Not treated|2|||
33580918|NCT01439282|62978066|FG000|Overall Study|Adverse Event|5|||
33580919|NCT01439282|62978067|FG001|Overall Study|Adverse Event|0|||
33480172|NCT00048165|62856452|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
33480173|NCT00059787|62856460|FG000|Overall Study|Adverse Event|13|||
33480174|NCT00059787|62856460|FG000|Overall Study|disease progression|2|||
33480175|NCT00059787|62856460|FG000|Overall Study|ineligible|1|||
33480176|NCT00059787|62856460|FG000|Overall Study|Other|4|||
33656315|NCT01849289|63075178|FG000|Overall Study|Adverse Event|3|||
33656316|NCT01849289|63075179|FG001|Overall Study|Adverse Event|3|||
33656317|NCT01849289|63075178|FG000|Overall Study|Protocol Violation|3|||
33656318|NCT01849289|63075179|FG001|Overall Study|Protocol Violation|3|||
33656319|NCT01849289|63075178|FG000|Overall Study|Withdrawal criteria|1|||
33656320|NCT01849289|63075179|FG001|Overall Study|Withdrawal criteria|0|||
33656321|NCT01849289|63075178|FG000|Overall Study|Unclassified|25|||
33656322|NCT01849289|63075179|FG001|Overall Study|Unclassified|18|||
33656323|NCT01868243|63075187|FG000|Overall Study|Death|0|||
33656324|NCT01868243|63075188|FG001|Overall Study|Death|1|||
33656325|NCT01611935|63075196|FG000|Overall Study|Family Declined Participation|1|||
33656326|NCT01611935|63075197|FG001|Overall Study|Family Declined Participation|0|||
33656327|NCT01868165|63075203|FG000|Overall Study|Withdrawal by Subject|36|||
33656328|NCT01868165|63075203|FG000|Overall Study|Physician Decision|2|||
33656329|NCT01868165|63075203|FG000|Overall Study|Lost to Follow-up|3|||
33656330|NCT01868165|63075203|FG000|Overall Study|Death|4|||
33656331|NCT01868009|63075242|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
33656332|NCT01868009|63075243|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
33656333|NCT01868009|63075242|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
33551221|NCT02654054|62943541|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
33551222|NCT02654054|62943539|FG000|Post-Treatment Follow-Up Period|Other|1|||
33551223|NCT02654054|62943540|FG001|Post-Treatment Follow-Up Period|Other|0|||
33551224|NCT02654054|62943541|FG002|Post-Treatment Follow-Up Period|Other|4|||
33551225|NCT02654054|62943539|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
33551226|NCT02654054|62943540|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
33656334|NCT01868009|63075243|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
33656335|NCT01868009|63075242|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
33364656|NCT02393248|62743313|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33551227|NCT02654054|62943541|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
33551228|NCT02653664|62943562|FG000|Post-Treatment|Withdrawal by Subject|6|||
33551229|NCT02653664|62943563|FG001|Post-Treatment|Withdrawal by Subject|5|||
33551230|NCT02653664|62943564|FG002|Post-Treatment|Withdrawal by Subject|7|||
33551231|NCT02653664|62943562|FG000|Post-Treatment|Lost to Follow-up|8|||
33551232|NCT02653664|62943563|FG001|Post-Treatment|Lost to Follow-up|1|||
33551233|NCT02653664|62943564|FG002|Post-Treatment|Lost to Follow-up|7|||
33551234|NCT02653664|62943562|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
33551235|NCT02653664|62943563|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
33551236|NCT02653664|62943564|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
33551237|NCT02653664|62943562|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
33551238|NCT02653664|62943563|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
33551239|NCT02653664|62943564|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
33551240|NCT02653664|62943562|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
33480177|NCT00058539|62856465|FG000|Overall Study|Disease progression|24|||
33480178|NCT00058539|62856465|FG000|Overall Study|Adverse Event|3|||
33480179|NCT00058539|62856465|FG000|Overall Study|Withdrawal by Subject|5|||
33480180|NCT00058539|62856465|FG000|Overall Study|Physician Decision|9|||
33480181|NCT00058539|62856465|FG000|Overall Study|Death|1|||
33480182|NCT03015532|62856477|FG000|Overall Study|Adverse Event|0|||
33480183|NCT03015532|62856478|FG001|Overall Study|Adverse Event|0|||
33480184|NCT03015532|62856479|FG002|Overall Study|Adverse Event|0|||
33480185|NCT03015532|62856480|FG003|Overall Study|Adverse Event|0|||
33551241|NCT02653664|62943563|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
33551242|NCT02653664|62943564|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
33551243|NCT02653664|62943562|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
33551244|NCT02653664|62943563|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
33551245|NCT02653664|62943564|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
33551246|NCT02653664|62943562|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
33551247|NCT02653664|62943563|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
33551248|NCT02653664|62943564|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
33551249|NCT02653664|62943562|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
33551250|NCT02653664|62943563|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
33364657|NCT02393248|62743314|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33480186|NCT03015532|62856481|FG004|Overall Study|Adverse Event|0|||
33480187|NCT03015532|62856482|FG005|Overall Study|Adverse Event|2|||
33480188|NCT03015532|62856483|FG006|Overall Study|Adverse Event|1|||
33551251|NCT02653664|62943564|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
33551252|NCT02653664|62943562|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
33551253|NCT02653664|62943563|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
33480189|NCT03015532|62856484|FG007|Overall Study|Adverse Event|0|||
33480190|NCT03015532|62856477|FG000|Overall Study|Withdrawal by Subject|0|||
33480191|NCT03015532|62856478|FG001|Overall Study|Withdrawal by Subject|0|||
33480192|NCT03015532|62856479|FG002|Overall Study|Withdrawal by Subject|0|||
33480193|NCT03015532|62856480|FG003|Overall Study|Withdrawal by Subject|0|||
33480194|NCT03015532|62856481|FG004|Overall Study|Withdrawal by Subject|0|||
33480195|NCT03015532|62856482|FG005|Overall Study|Withdrawal by Subject|0|||
33480196|NCT03015532|62856483|FG006|Overall Study|Withdrawal by Subject|1|||
33480197|NCT03015532|62856484|FG007|Overall Study|Withdrawal by Subject|0|||
33480198|NCT00047463|62856506|FG000|Overall Study|Withdrawal by Subject|0|||
33551254|NCT02653664|62943564|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
33551255|NCT02653664|62943562|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
33551256|NCT02653664|62943563|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
33551257|NCT02653664|62943564|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
33551258|NCT02488629|62943582|FG000|Overall Study|Lack of Efficacy|3|||
33551259|NCT02488629|62943583|FG001|Overall Study|Lack of Efficacy|1|||
33551260|NCT02488629|62943584|FG002|Overall Study|Lack of Efficacy|0|||
33551261|NCT02488629|62943585|FG003|Overall Study|Lack of Efficacy|0|||
33551262|NCT02488629|62943582|FG000|Overall Study|Withdrawal by Subject|0|||
33551263|NCT02488629|62943583|FG001|Overall Study|Withdrawal by Subject|1|||
33551264|NCT02488629|62943584|FG002|Overall Study|Withdrawal by Subject|0|||
33551265|NCT02488629|62943585|FG003|Overall Study|Withdrawal by Subject|0|||
33551266|NCT02727699|62943596|FG000|Overall Study|Adverse Event|2|||
33551267|NCT02727699|62943597|FG001|Overall Study|Adverse Event|0|||
33551268|NCT02727699|62943596|FG000|Overall Study|Withdrawal by Subject|5|||
33551269|NCT02727699|62943597|FG001|Overall Study|Withdrawal by Subject|3|||
33551270|NCT02727699|62943596|FG000|Overall Study|Protocol Violation|0|||
33551271|NCT02727699|62943597|FG001|Overall Study|Protocol Violation|1|||
33551272|NCT02727699|62943596|FG000|Overall Study|Physician Decision|0|||
33551273|NCT02727699|62943597|FG001|Overall Study|Physician Decision|1|||
33551274|NCT02727699|62943596|FG000|Overall Study|Lost to Follow-up|1|||
33551275|NCT02727699|62943597|FG001|Overall Study|Lost to Follow-up|0|||
33551276|NCT02727699|62943596|FG000|Overall Study|Sponsor Decision|1|||
33551277|NCT02727699|62943597|FG001|Overall Study|Sponsor Decision|0|||
33551278|NCT03576716|62943605|FG000|Overall Study|Withdrawal by Subject|0|||
33551279|NCT03576716|62943606|FG001|Overall Study|Withdrawal by Subject|1|||
33551280|NCT02847637|62943625|FG000|Overall Study|Withdrawal by Subject|0|||
33551281|NCT02847637|62943626|FG001|Overall Study|Withdrawal by Subject|1|||
33551282|NCT02847637|62943627|FG002|Overall Study|Withdrawal by Subject|1|||
33551283|NCT02847637|62943628|FG003|Overall Study|Withdrawal by Subject|0|||
33551284|NCT02847637|62943625|FG000|Overall Study|Lost to Follow-up|1|||
33551285|NCT02847637|62943626|FG001|Overall Study|Lost to Follow-up|1|||
33551286|NCT02847637|62943627|FG002|Overall Study|Lost to Follow-up|0|||
33551287|NCT02847637|62943628|FG003|Overall Study|Lost to Follow-up|0|||
33551288|NCT02652260|62943654|FG000|Overall Study|Pregnancy|0|||
33551289|NCT02652260|62943655|FG001|Overall Study|Pregnancy|1|||
33551290|NCT02652260|62943654|FG000|Overall Study|Withdrawal by Subject|0|||
33551291|NCT02652260|62943655|FG001|Overall Study|Withdrawal by Subject|1|||
33551292|NCT00706095|62943667|FG000|Overall Study|Progressive Disease|4|||
33551293|NCT00706095|62943668|FG001|Overall Study|Progressive Disease|5|||
33551294|NCT00706095|62943669|FG002|Overall Study|Progressive Disease|3|||
33551295|NCT00706095|62943667|FG000|Overall Study|Clinical Progression|1|||
33551296|NCT00706095|62943668|FG001|Overall Study|Clinical Progression|2|||
33551297|NCT00706095|62943669|FG002|Overall Study|Clinical Progression|2|||
33551298|NCT00706095|62943667|FG000|Overall Study|Withdrawal by Subject|1|||
33551299|NCT00706095|62943668|FG001|Overall Study|Withdrawal by Subject|0|||
33551300|NCT00706095|62943669|FG002|Overall Study|Withdrawal by Subject|0|||
33551301|NCT02837731|62943679|FG000|Allocation|Admitted to General Floor|3|||
33551302|NCT02837731|62943680|FG001|Allocation|Admitted to General Floor|4|||
33551303|NCT02837731|62943679|FG000|Allocation|Immediate surgery/withdrew|2|||
33551304|NCT02837731|62943680|FG001|Allocation|Immediate surgery/withdrew|0|||
33551305|NCT02837731|62943679|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
33551306|NCT02837731|62943680|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
33551307|NCT02837731|62943679|FG000|Allocation|Withdrawal by Subject|2|||
33551308|NCT02837731|62943680|FG001|Allocation|Withdrawal by Subject|0|||
33551309|NCT02837731|62943679|FG000|Allocation|Device not available|1|||
33551310|NCT02837731|62943680|FG001|Allocation|Device not available|0|||
33551311|NCT02837731|62943679|FG000|Allocation|Protocol not implemented|7|||
33551312|NCT02837731|62943680|FG001|Allocation|Protocol not implemented|0|||
33551313|NCT02837731|62943679|FG000|Allocation|Moribund/Do not resuscitate|2|||
33551314|NCT02837731|62943680|FG001|Allocation|Moribund/Do not resuscitate|0|||
33551315|NCT02837731|62943679|FG000|Allocation|Did not meet sepsis criteria|1|||
33480199|NCT00047463|62856507|FG001|Overall Study|Withdrawal by Subject|3|||
33551316|NCT02837731|62943680|FG001|Allocation|Did not meet sepsis criteria|2|||
33551317|NCT02837731|62943679|FG000|Allocation|Known aortic abnormalities|0|||
33551318|NCT02837731|62943680|FG001|Allocation|Known aortic abnormalities|1|||
33551319|NCT02836873|62943688|FG000|Overall Study|Protocol Violation|0|||
33480200|NCT03015220|62856520|FG000|Overall Study|Withdrawal by Subject|3|||
33480201|NCT03015220|62856521|FG001|Overall Study|Withdrawal by Subject|2|||
33480202|NCT03015220|62856522|FG002|Overall Study|Withdrawal by Subject|2|||
33480203|NCT03015220|62856523|FG003|Overall Study|Withdrawal by Subject|2|||
33480204|NCT03015220|62856520|FG000|Overall Study|Lost to Follow-up|0|||
33480205|NCT03015220|62856521|FG001|Overall Study|Lost to Follow-up|0|||
33480206|NCT03015220|62856522|FG002|Overall Study|Lost to Follow-up|1|||
33480207|NCT03015220|62856523|FG003|Overall Study|Lost to Follow-up|0|||
33480208|NCT00022659|62856533|FG000|Overall Study|Ineligible: wrong primary|1|||
33480209|NCT00022659|62856533|FG000|Overall Study|Never treated|1|||
33480210|NCT03014674|62856544|FG000|Overall Study|Withdrawal by Subject|1|||
33480211|NCT03014674|62856545|FG001|Overall Study|Withdrawal by Subject|0|||
33480212|NCT03014674|62856546|FG002|Overall Study|Withdrawal by Subject|0|||
33480213|NCT03018106|62856556|FG000|Overall Study|Lost to Follow-up|0|||
33480214|NCT03018106|62856557|FG001|Overall Study|Lost to Follow-up|1|||
33480215|NCT03018028|62856566|FG000|Overall Study|Withdrawal by Subject|3|||
33480216|NCT03018028|62856567|FG001|Overall Study|Withdrawal by Subject|0|||
33480217|NCT03018028|62856568|FG002|Overall Study|Withdrawal by Subject|1|||
33480218|NCT03018028|62856569|FG003|Overall Study|Withdrawal by Subject|2|||
33480219|NCT03018028|62856570|FG004|Overall Study|Withdrawal by Subject|0|||
33480220|NCT03010462|62856584|FG000|Overall Study|Withdrawal by Subject|3|||
33480221|NCT03010462|62856585|FG001|Overall Study|Withdrawal by Subject|1|||
33480222|NCT00021255|62856594|FG000|Overall Study|Death|1|||
33480223|NCT00021255|62856595|FG001|Overall Study|Death|0|||
33480224|NCT00021255|62856596|FG002|Overall Study|Death|2|||
33480225|NCT00021255|62856594|FG000|Overall Study|Breast cancer relapse|5|||
33480226|NCT00021255|62856595|FG001|Overall Study|Breast cancer relapse|18|||
33480227|NCT00021255|62856596|FG002|Overall Study|Breast cancer relapse|11|||
33480228|NCT00021255|62856594|FG000|Overall Study|Second primary malignancy|0|||
33480229|NCT00021255|62856595|FG001|Overall Study|Second primary malignancy|4|||
33480230|NCT00021255|62856596|FG002|Overall Study|Second primary malignancy|1|||
33480231|NCT00021255|62856594|FG000|Overall Study|Withdrawal by Subject|41|||
33480232|NCT00021255|62856595|FG001|Overall Study|Withdrawal by Subject|64|||
33480233|NCT00021255|62856596|FG002|Overall Study|Withdrawal by Subject|26|||
33480234|NCT00021255|62856594|FG000|Overall Study|Lost to Follow-up|0|||
33480235|NCT00021255|62856595|FG001|Overall Study|Lost to Follow-up|2|||
33480236|NCT00021255|62856596|FG002|Overall Study|Lost to Follow-up|3|||
33480237|NCT00021255|62856594|FG000|Overall Study|Cardiac toxicity|0|||
33480238|NCT00021255|62856595|FG001|Overall Study|Cardiac toxicity|61|||
33480239|NCT00021255|62856596|FG002|Overall Study|Cardiac toxicity|32|||
33480240|NCT00021255|62856594|FG000|Overall Study|Herceptin toxicity|0|||
33480241|NCT00021255|62856595|FG001|Overall Study|Herceptin toxicity|22|||
33480242|NCT00021255|62856596|FG002|Overall Study|Herceptin toxicity|6|||
33480243|NCT00021255|62856594|FG000|Overall Study|Adverse Event|46|||
33480244|NCT00021255|62856595|FG001|Overall Study|Adverse Event|30|||
33480245|NCT00021255|62856596|FG002|Overall Study|Adverse Event|18|||
33480246|NCT00021255|62856594|FG000|Overall Study|Protocol Violation|0|||
33480247|NCT00021255|62856595|FG001|Overall Study|Protocol Violation|2|||
33480248|NCT00021255|62856596|FG002|Overall Study|Protocol Violation|0|||
33480249|NCT00021255|62856594|FG000|Overall Study|Other than specified above|0|||
33480250|NCT00021255|62856595|FG001|Overall Study|Other than specified above|38|||
33480251|NCT00021255|62856596|FG002|Overall Study|Other than specified above|19|||
33480252|NCT00021255|62856594|FG000|Overall Study|Missing|0|||
33480253|NCT00021255|62856595|FG001|Overall Study|Missing|27|||
33480254|NCT00021255|62856596|FG002|Overall Study|Missing|13|||
33480255|NCT00021255|62856594|FG000|Overall Study|Randomized but not treated|28|||
33480256|NCT00021255|62856595|FG001|Overall Study|Randomized but not treated|2|||
33480257|NCT00021255|62856596|FG002|Overall Study|Randomized but not treated|18|||
33480258|NCT03012334|62856614|FG000|Period 1|Withdrawal by Subject|0|||
33480259|NCT03012334|62856615|FG001|Period 1|Withdrawal by Subject|0|||
33480260|NCT03012334|62856616|FG002|Period 1|Withdrawal by Subject|0|||
33480261|NCT03012334|62856617|FG003|Period 1|Withdrawal by Subject|0|||
33480262|NCT03012334|62856618|FG004|Period 1|Withdrawal by Subject|0|||
33480263|NCT03012334|62856619|FG005|Period 1|Withdrawal by Subject|0|||
33480264|NCT03012334|62856620|FG006|Period 1|Withdrawal by Subject|0|||
33480265|NCT03012334|62856621|FG007|Period 1|Withdrawal by Subject|0|||
33480266|NCT03012334|62856622|FG008|Period 1|Withdrawal by Subject|0|||
33480267|NCT03012334|62856623|FG009|Period 1|Withdrawal by Subject|1|||
33480268|NCT03012334|62856614|FG000|Period 2|Withdrawal by Subject|0|||
33480269|NCT03012334|62856615|FG001|Period 2|Withdrawal by Subject|1|||
33480270|NCT03012334|62856616|FG002|Period 2|Withdrawal by Subject|0|||
33480271|NCT03012334|62856617|FG003|Period 2|Withdrawal by Subject|0|||
33480272|NCT03012334|62856618|FG004|Period 2|Withdrawal by Subject|0|||
33551320|NCT02836873|62943689|FG001|Overall Study|Protocol Violation|1|||
33551321|NCT02836873|62943688|FG000|Overall Study|Adverse Event|1|||
33551322|NCT02836873|62943689|FG001|Overall Study|Adverse Event|4|||
33551323|NCT02836873|62943688|FG000|Overall Study|Withdrawal by Subject|2|||
33551324|NCT02836873|62943689|FG001|Overall Study|Withdrawal by Subject|2|||
33480273|NCT03012334|62856619|FG005|Period 2|Withdrawal by Subject|0|||
33551325|NCT02836873|62943688|FG000|Overall Study|Lost to Follow-up|1|||
33551326|NCT02836873|62943689|FG001|Overall Study|Lost to Follow-up|3|||
33551327|NCT02836873|62943688|FG000|Overall Study|Physician Decision|0|||
33364658|NCT02393248|62743315|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33480274|NCT03012334|62856620|FG006|Period 2|Withdrawal by Subject|0|||
33480275|NCT03012334|62856621|FG007|Period 2|Withdrawal by Subject|0|||
33480276|NCT03012334|62856622|FG008|Period 2|Withdrawal by Subject|0|||
33480277|NCT03012334|62856623|FG009|Period 2|Withdrawal by Subject|0|||
33480278|NCT03012334|62856614|FG000|Period 2|Protocol Violation|0|||
33480279|NCT03012334|62856615|FG001|Period 2|Protocol Violation|0|||
33480280|NCT03012334|62856616|FG002|Period 2|Protocol Violation|1|||
33480281|NCT03012334|62856617|FG003|Period 2|Protocol Violation|0|||
33480282|NCT03012334|62856618|FG004|Period 2|Protocol Violation|0|||
33480283|NCT03012334|62856619|FG005|Period 2|Protocol Violation|0|||
33480284|NCT03012334|62856620|FG006|Period 2|Protocol Violation|0|||
33480285|NCT03012334|62856621|FG007|Period 2|Protocol Violation|1|||
33480286|NCT03012334|62856622|FG008|Period 2|Protocol Violation|0|||
33480287|NCT03012334|62856623|FG009|Period 2|Protocol Violation|0|||
33480288|NCT03012334|62856614|FG000|Period 4|Non-Compliance|0|||
33480289|NCT03012334|62856615|FG001|Period 4|Non-Compliance|0|||
33480290|NCT03012334|62856616|FG002|Period 4|Non-Compliance|0|||
33480291|NCT03012334|62856617|FG003|Period 4|Non-Compliance|0|||
33480292|NCT03012334|62856618|FG004|Period 4|Non-Compliance|0|||
33480293|NCT03012334|62856619|FG005|Period 4|Non-Compliance|0|||
33480294|NCT03012334|62856620|FG006|Period 4|Non-Compliance|1|||
33480295|NCT03012334|62856621|FG007|Period 4|Non-Compliance|0|||
33480296|NCT03012334|62856622|FG008|Period 4|Non-Compliance|0|||
33480297|NCT03012334|62856623|FG009|Period 4|Non-Compliance|0|||
33480298|NCT03012334|62856614|FG000|Period 4|Adverse Event|0|||
33480299|NCT03012334|62856615|FG001|Period 4|Adverse Event|0|||
33480300|NCT03012334|62856616|FG002|Period 4|Adverse Event|0|||
33480301|NCT03012334|62856617|FG003|Period 4|Adverse Event|0|||
33480302|NCT03012334|62856618|FG004|Period 4|Adverse Event|0|||
33480303|NCT03012334|62856619|FG005|Period 4|Adverse Event|0|||
33480304|NCT03012334|62856620|FG006|Period 4|Adverse Event|0|||
33480305|NCT03012334|62856621|FG007|Period 4|Adverse Event|0|||
33480306|NCT03012334|62856622|FG008|Period 4|Adverse Event|1|||
33480307|NCT03012334|62856623|FG009|Period 4|Adverse Event|0|||
33480308|NCT03565068|62856645|FG000|Overall Study|Protocol Violation|0|||
33480309|NCT03565068|62856646|FG001|Overall Study|Protocol Violation|0|||
33480310|NCT03565068|62856647|FG002|Overall Study|Protocol Violation|0|||
33480311|NCT03565068|62856648|FG003|Overall Study|Protocol Violation|0|||
33480312|NCT03565068|62856649|FG004|Overall Study|Protocol Violation|1|||
33480313|NCT03565068|62856650|FG005|Overall Study|Protocol Violation|0|||
33480314|NCT03565068|62856651|FG006|Overall Study|Protocol Violation|0|||
33480315|NCT03565068|62856652|FG007|Overall Study|Protocol Violation|1|||
33480316|NCT03565068|62856653|FG008|Overall Study|Protocol Violation|0|||
33480317|NCT03565068|62856645|FG000|Overall Study|Sponsor decision|0|||
33480318|NCT03565068|62856646|FG001|Overall Study|Sponsor decision|0|||
33480319|NCT03565068|62856647|FG002|Overall Study|Sponsor decision|0|||
33480320|NCT03565068|62856648|FG003|Overall Study|Sponsor decision|0|||
33480321|NCT03565068|62856649|FG004|Overall Study|Sponsor decision|1|||
33480322|NCT03565068|62856650|FG005|Overall Study|Sponsor decision|1|||
33480323|NCT03565068|62856651|FG006|Overall Study|Sponsor decision|0|||
33480324|NCT03565068|62856652|FG007|Overall Study|Sponsor decision|0|||
33480325|NCT03565068|62856653|FG008|Overall Study|Sponsor decision|0|||
33480326|NCT03565068|62856645|FG000|Overall Study|Withdrawal by Subject|0|||
33480327|NCT03565068|62856646|FG001|Overall Study|Withdrawal by Subject|0|||
33480328|NCT03565068|62856647|FG002|Overall Study|Withdrawal by Subject|1|||
33480329|NCT03565068|62856648|FG003|Overall Study|Withdrawal by Subject|0|||
33480330|NCT03565068|62856649|FG004|Overall Study|Withdrawal by Subject|2|||
33480331|NCT03565068|62856650|FG005|Overall Study|Withdrawal by Subject|0|||
33480332|NCT03565068|62856651|FG006|Overall Study|Withdrawal by Subject|1|||
33480333|NCT03565068|62856652|FG007|Overall Study|Withdrawal by Subject|5|||
33480334|NCT03565068|62856653|FG008|Overall Study|Withdrawal by Subject|1|||
33480335|NCT03565068|62856645|FG000|Overall Study|Physician Decision|0|||
33480336|NCT03565068|62856646|FG001|Overall Study|Physician Decision|0|||
33480337|NCT03565068|62856647|FG002|Overall Study|Physician Decision|0|||
33480338|NCT03565068|62856648|FG003|Overall Study|Physician Decision|0|||
33551328|NCT02836873|62943689|FG001|Overall Study|Physician Decision|1|||
33551329|NCT02836873|62943688|FG000|Overall Study|Other|1|||
33551330|NCT02836873|62943689|FG001|Overall Study|Other|0|||
33551331|NCT01342081|62943707|FG000|Overall Study|Did not receive allocated intervention|0|||
33551332|NCT01342081|62943708|FG001|Overall Study|Did not receive allocated intervention|0|||
33551333|NCT01342081|62943709|FG002|Overall Study|Did not receive allocated intervention|1|||
33551334|NCT01342081|62943707|FG000|Overall Study|Adverse Event|1|||
33551335|NCT01342081|62943708|FG001|Overall Study|Adverse Event|0|||
33551336|NCT01342081|62943709|FG002|Overall Study|Adverse Event|0|||
33551337|NCT01342081|62943707|FG000|Overall Study|Physician Decision|0|||
33480339|NCT03565068|62856649|FG004|Overall Study|Physician Decision|0|||
33480340|NCT03565068|62856650|FG005|Overall Study|Physician Decision|0|||
33480341|NCT03565068|62856651|FG006|Overall Study|Physician Decision|0|||
33480342|NCT03565068|62856652|FG007|Overall Study|Physician Decision|1|||
33480343|NCT03565068|62856653|FG008|Overall Study|Physician Decision|0|||
33480344|NCT03565068|62856645|FG000|Overall Study|Lost to Follow-up|0|||
33480345|NCT03565068|62856646|FG001|Overall Study|Lost to Follow-up|0|||
33480346|NCT03565068|62856647|FG002|Overall Study|Lost to Follow-up|0|||
33480347|NCT03565068|62856648|FG003|Overall Study|Lost to Follow-up|0|||
33480348|NCT03565068|62856649|FG004|Overall Study|Lost to Follow-up|0|||
33480349|NCT03565068|62856650|FG005|Overall Study|Lost to Follow-up|0|||
33480350|NCT03565068|62856651|FG006|Overall Study|Lost to Follow-up|0|||
33480351|NCT03565068|62856652|FG007|Overall Study|Lost to Follow-up|1|||
33480352|NCT03565068|62856653|FG008|Overall Study|Lost to Follow-up|0|||
33480353|NCT00010803|62856712|FG000|Overall Study|Withdrawal by Subject|97|||
33480354|NCT00010803|62856713|FG001|Overall Study|Withdrawal by Subject|98|||
33480355|NCT02914834|62856721|FG000|Overall Study|Study halted due to COVID|1|||
33480356|NCT02914834|62856722|FG001|Overall Study|Study halted due to COVID|1|||
33480357|NCT02914834|62856721|FG000|Overall Study|1 subject withdrew|0|||
33480358|NCT02914834|62856722|FG001|Overall Study|1 subject withdrew|1|||
33480359|NCT03497130|62856730|FG000|Overall Study|Lost to Follow-up|1|||
33480360|NCT03497130|62856731|FG001|Overall Study|Lost to Follow-up|1|||
33480361|NCT03006562|62856739|FG000|Overall Study|Lost to Follow-up|0|||
33480362|NCT03006562|62856740|FG001|Overall Study|Lost to Follow-up|1|||
33480363|NCT03007966|62856748|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
33480364|NCT03007966|62856749|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
33480365|NCT03007888|62856756|FG000|First Intervention (14 Days)|Adverse Event|1|||
33480366|NCT03007888|62856757|FG001|First Intervention (14 Days)|Adverse Event|0|||
33480367|NCT03541044|62856766|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
33480368|NCT03541044|62856767|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
33480369|NCT03541044|62856766|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
33480370|NCT03541044|62856767|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
33480371|NCT00009945|62856777|FG000|Overall Study|no follow up data|7|||
33480372|NCT00009945|62856778|FG001|Overall Study|no follow up data|5|||
33480373|NCT03540030|62856786|FG000|Overall Study|Withdrawal by Subject|2|||
33480374|NCT03540030|62856787|FG001|Overall Study|Withdrawal by Subject|1|||
33480375|NCT03540030|62856786|FG000|Overall Study|screen fail|7|||
33480376|NCT03540030|62856787|FG001|Overall Study|screen fail|1|||
33480377|NCT03540030|62856786|FG000|Overall Study|never had surgery after signing consent|9|||
33480378|NCT03540030|62856787|FG001|Overall Study|never had surgery after signing consent|1|||
33480379|NCT03003676|62856795|FG000|Overall Study|Lack of Efficacy|5|||
33480380|NCT03003676|62856796|FG001|Overall Study|Lack of Efficacy|7|||
33480381|NCT03003676|62856795|FG000|Overall Study|Withdrawal by Subject|0|||
33480382|NCT03003676|62856796|FG001|Overall Study|Withdrawal by Subject|1|||
33480383|NCT03003676|62856795|FG000|Overall Study|Hepatitis B infection|1|||
33480384|NCT03003676|62856796|FG001|Overall Study|Hepatitis B infection|0|||
33480385|NCT00047385|62856806|FG000|Overall Study|Death before any screening|2|||
33480386|NCT00047385|62856807|FG001|Overall Study|Death before any screening|5|||
33480387|NCT00047385|62856806|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
33480388|NCT00047385|62856807|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
33480389|NCT00047385|62856806|FG000|Overall Study|Eligible for screening but had no screen|260|||
33480390|NCT00047385|62856807|FG001|Overall Study|Eligible for screening but had no screen|492|||
33480391|NCT03002818|62856813|FG000|Overall Study|Decision of the investigator|1|||
33480392|NCT03002194|62856817|FG000|Overall Study|Lost to Follow-up|6|||
33480393|NCT03002194|62856817|FG000|Overall Study|Adverse Event|1|||
33480394|NCT03002194|62856817|FG000|Overall Study|Lack of Efficacy|1|||
33480395|NCT03002194|62856817|FG000|Overall Study|Withdrawal by Subject|2|||
33480396|NCT02912650|62856825|FG000|Overall Study|Withdrawal by Subject|1|||
33480397|NCT02912650|62856826|FG001|Overall Study|Withdrawal by Subject|0|||
33480398|NCT02912650|62856827|FG002|Overall Study|Withdrawal by Subject|1|||
33480399|NCT02912650|62856828|FG003|Overall Study|Withdrawal by Subject|5|||
33480400|NCT02912650|62856825|FG000|Overall Study|Adverse Event|0|||
33480401|NCT02912650|62856826|FG001|Overall Study|Adverse Event|0|||
33480402|NCT02912650|62856827|FG002|Overall Study|Adverse Event|1|||
33480403|NCT02912650|62856828|FG003|Overall Study|Adverse Event|0|||
33480404|NCT03004924|62856841|FG000|Overall Study|Adverse Event|6|||
33480405|NCT03004924|62856842|FG001|Overall Study|Adverse Event|5|||
33480406|NCT03004924|62856843|FG002|Overall Study|Adverse Event|10|||
33480407|NCT03004924|62856841|FG000|Overall Study|Protocol Violation|4|||
33551338|NCT01342081|62943708|FG001|Overall Study|Physician Decision|1|||
33551339|NCT01342081|62943709|FG002|Overall Study|Physician Decision|0|||
33551340|NCT01342081|62943707|FG000|Overall Study|Withdrawal by Subject|1|||
33551341|NCT01342081|62943708|FG001|Overall Study|Withdrawal by Subject|1|||
33551342|NCT01342081|62943709|FG002|Overall Study|Withdrawal by Subject|0|||
33551343|NCT01341457|62943719|FG000|Overall Study|Adverse Event|2|||
33551344|NCT01341457|62943720|FG001|Overall Study|Adverse Event|0|||
33656336|NCT01868009|63075243|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
33480408|NCT03004924|62856842|FG001|Overall Study|Protocol Violation|0|||
33480409|NCT03004924|62856843|FG002|Overall Study|Protocol Violation|1|||
33480410|NCT03004924|62856841|FG000|Overall Study|Withdrawal by Subject|5|||
33551345|NCT02832037|62943732|FG000|Overall Study|Administrative reasons|0|||
33656337|NCT01849055|63075297|FG000|Overall Study|Withdrawal by Subject|0|||
33656338|NCT01849055|63075298|FG001|Overall Study|Withdrawal by Subject|0|||
33480411|NCT03004924|62856842|FG001|Overall Study|Withdrawal by Subject|3|||
33480412|NCT03004924|62856843|FG002|Overall Study|Withdrawal by Subject|5|||
33551346|NCT02832037|62943733|FG001|Overall Study|Administrative reasons|0|||
33480413|NCT03004924|62856841|FG000|Overall Study|Lost to Follow-up|6|||
33480414|NCT03004924|62856842|FG001|Overall Study|Lost to Follow-up|1|||
33480415|NCT03004924|62856843|FG002|Overall Study|Lost to Follow-up|4|||
33480416|NCT03004924|62856841|FG000|Overall Study|Lack of Efficacy|2|||
33480417|NCT03004924|62856842|FG001|Overall Study|Lack of Efficacy|4|||
33480418|NCT03004924|62856843|FG002|Overall Study|Lack of Efficacy|2|||
33480419|NCT03004924|62856841|FG000|Overall Study|Physician Decision|1|||
33480420|NCT03004924|62856842|FG001|Overall Study|Physician Decision|0|||
33480421|NCT03004924|62856843|FG002|Overall Study|Physician Decision|1|||
33480422|NCT03004924|62856841|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33480423|NCT03004924|62856842|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33480424|NCT03004924|62856843|FG002|Overall Study|Withdrawal by parent/guardian|2|||
33480425|NCT03004924|62856841|FG000|Overall Study|Screen Failure|1|||
33480426|NCT03004924|62856842|FG001|Overall Study|Screen Failure|0|||
33480427|NCT03004924|62856843|FG002|Overall Study|Screen Failure|0|||
33480428|NCT03004924|62856841|FG000|Overall Study|Pregnancy|0|||
33480429|NCT03004924|62856842|FG001|Overall Study|Pregnancy|1|||
33480430|NCT03004924|62856843|FG002|Overall Study|Pregnancy|0|||
33480431|NCT03004924|62856841|FG000|Overall Study|Terminated by Sponsor|0|||
33480432|NCT03004924|62856842|FG001|Overall Study|Terminated by Sponsor|0|||
33480433|NCT03004924|62856843|FG002|Overall Study|Terminated by Sponsor|1|||
33480434|NCT03004924|62856841|FG000|Overall Study|Missed Study Visit|0|||
33480435|NCT03004924|62856842|FG001|Overall Study|Missed Study Visit|0|||
33480436|NCT03004924|62856843|FG002|Overall Study|Missed Study Visit|2|||
33480437|NCT03004924|62856841|FG000|Overall Study|HSV1 Positive|1|||
33551347|NCT02832037|62943734|FG002|Overall Study|Administrative reasons|1|||
33551348|NCT02832037|62943735|FG003|Overall Study|Administrative reasons|0|||
33551349|NCT02832037|62943736|FG004|Overall Study|Administrative reasons|0|||
33551350|NCT02832037|62943732|FG000|Overall Study|Protocol Violation|3|||
33551351|NCT02832037|62943733|FG001|Overall Study|Protocol Violation|0|||
33551352|NCT02832037|62943734|FG002|Overall Study|Protocol Violation|4|||
33551353|NCT02832037|62943735|FG003|Overall Study|Protocol Violation|1|||
33551354|NCT02832037|62943736|FG004|Overall Study|Protocol Violation|2|||
33551355|NCT02832037|62943732|FG000|Overall Study|Lost to Follow-up|2|||
33551356|NCT02832037|62943733|FG001|Overall Study|Lost to Follow-up|0|||
33551357|NCT02832037|62943734|FG002|Overall Study|Lost to Follow-up|3|||
33551358|NCT02832037|62943735|FG003|Overall Study|Lost to Follow-up|0|||
33551359|NCT02832037|62943736|FG004|Overall Study|Lost to Follow-up|5|||
33551360|NCT02832037|62943732|FG000|Overall Study|Withdrawal by Subject|9|||
33551361|NCT02832037|62943733|FG001|Overall Study|Withdrawal by Subject|8|||
33551362|NCT02832037|62943734|FG002|Overall Study|Withdrawal by Subject|0|||
33551363|NCT02832037|62943735|FG003|Overall Study|Withdrawal by Subject|4|||
33551364|NCT02832037|62943736|FG004|Overall Study|Withdrawal by Subject|8|||
33551365|NCT02832037|62943732|FG000|Overall Study|Adverse Event|5|||
33551366|NCT02832037|62943733|FG001|Overall Study|Adverse Event|4|||
33480438|NCT03004924|62856842|FG001|Overall Study|HSV1 Positive|0|||
33480439|NCT03004924|62856843|FG002|Overall Study|HSV1 Positive|0|||
33480440|NCT03002038|62856854|FG000|Overall Study|Adverse Event|3|||
33480441|NCT03002038|62856855|FG001|Overall Study|Adverse Event|1|||
33480442|NCT03002038|62856854|FG000|Overall Study|Withdrawal by Subject|8|||
33480443|NCT03002038|62856855|FG001|Overall Study|Withdrawal by Subject|4|||
33480444|NCT03002038|62856854|FG000|Overall Study|Immigration to another region|0|||
33480445|NCT03002038|62856855|FG001|Overall Study|Immigration to another region|2|||
33480446|NCT02911948|62856863|FG000|Overall Study|Protocol Violation|0|||
33551367|NCT02832037|62943734|FG002|Overall Study|Adverse Event|0|||
33551368|NCT02832037|62943735|FG003|Overall Study|Adverse Event|2|||
33551369|NCT02832037|62943736|FG004|Overall Study|Adverse Event|4|||
33551370|NCT01675154|62943752|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
33551371|NCT01675154|62943753|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
33551372|NCT01675154|62943754|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
33551373|NCT01675154|62943755|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
33551374|NCT02744755|62943779|FG000|Study Period 1|Protocol Violation|2|||
33656339|NCT01849055|63075299|FG002|Overall Study|Withdrawal by Subject|1|||
33480447|NCT02911948|62856864|FG001|Overall Study|Protocol Violation|1|||
33480448|NCT02911948|62856863|FG000|Overall Study|Withdrawal by Subject|0|||
33480449|NCT02911948|62856864|FG001|Overall Study|Withdrawal by Subject|2|||
33480450|NCT02911948|62856863|FG000|Overall Study|Lack of Efficacy|0|||
33551375|NCT02744755|62943780|FG001|Study Period 1|Protocol Violation|1|||
33551376|NCT02744755|62943779|FG000|Study Period 1|not defined|0|||
33551377|NCT02744755|62943780|FG001|Study Period 1|not defined|1|||
33551378|NCT02744755|62943779|FG000|Study Period 1|Pregnancy|1|||
33551379|NCT02744755|62943780|FG001|Study Period 1|Pregnancy|0|||
33551380|NCT02744755|62943779|FG000|Study Period 1|Adverse Event|1|||
33480451|NCT02911948|62856864|FG001|Overall Study|Lack of Efficacy|1|||
33551381|NCT02744755|62943780|FG001|Study Period 1|Adverse Event|1|||
33551382|NCT02744755|62943779|FG000|Study Period 1|Lost to Follow-up|1|||
33480452|NCT02911948|62856863|FG000|Overall Study|Unclassified|0|||
33480453|NCT02911948|62856864|FG001|Overall Study|Unclassified|3|||
33480454|NCT02996968|62856872|FG000|Overall Study|Withdrawal by Subject|1|||
33551383|NCT02744755|62943780|FG001|Study Period 1|Lost to Follow-up|1|||
33551384|NCT02744755|62943779|FG000|Study Period 1|Lack of Efficacy|1|||
33551385|NCT02744755|62943780|FG001|Study Period 1|Lack of Efficacy|0|||
33551386|NCT02744755|62943779|FG000|Study Period 1|Withdrawal by Subject|8|||
33551387|NCT02744755|62943780|FG001|Study Period 1|Withdrawal by Subject|4|||
33551388|NCT02744755|62943779|FG000|Study Period 2|Adverse Event|5|||
33551389|NCT02744755|62943780|FG001|Study Period 2|Adverse Event|0|||
33364659|NCT02393248|62743316|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33364660|NCT02393248|62743317|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33364661|NCT02393248|62743318|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33364662|NCT02393248|62743319|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33364663|NCT02393248|62743320|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33364664|NCT02393248|62743321|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
33364665|NCT02393248|62743322|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33364666|NCT02393248|62743323|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
33364667|NCT02393248|62743324|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
33364668|NCT02393248|62743325|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33480455|NCT02996968|62856873|FG001|Overall Study|Withdrawal by Subject|0|||
33480456|NCT00027027|62856884|FG000|Overall Study|Adverse Event|0|||
33551390|NCT02744755|62943779|FG000|Study Period 2|Protocol Violation|1|||
33551391|NCT02744755|62943780|FG001|Study Period 2|Protocol Violation|0|||
33551392|NCT02744755|62943779|FG000|Study Period 2|not defined|3|||
33551393|NCT02744755|62943780|FG001|Study Period 2|not defined|2|||
33551394|NCT02744755|62943779|FG000|Study Period 2|Lost to Follow-up|0|||
33480457|NCT00027027|62856885|FG001|Overall Study|Adverse Event|0|||
33480458|NCT00027027|62856886|FG002|Overall Study|Adverse Event|1|||
33480459|NCT00027027|62856887|FG003|Overall Study|Adverse Event|0|||
33480460|NCT00027027|62856888|FG004|Overall Study|Adverse Event|1|||
33480461|NCT00027027|62856884|FG000|Overall Study|Admitted for Signs of PD|0|||
33480462|NCT00027027|62856885|FG001|Overall Study|Admitted for Signs of PD|0|||
33480463|NCT00027027|62856886|FG002|Overall Study|Admitted for Signs of PD|0|||
33480464|NCT00027027|62856887|FG003|Overall Study|Admitted for Signs of PD|0|||
33480465|NCT00027027|62856888|FG004|Overall Study|Admitted for Signs of PD|1|||
33480466|NCT00027027|62856884|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
33480467|NCT00027027|62856885|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
33551395|NCT02744755|62943780|FG001|Study Period 2|Lost to Follow-up|2|||
33551396|NCT02744755|62943779|FG000|Study Period 2|Withdrawal by Subject|2|||
33551397|NCT02744755|62943780|FG001|Study Period 2|Withdrawal by Subject|2|||
33551398|NCT02744755|62943779|FG000|Study Period 2|Lack of Efficacy|3|||
33551399|NCT02744755|62943780|FG001|Study Period 2|Lack of Efficacy|2|||
33551400|NCT01356589|62943798|FG000|Overall Study|Enrolled, but not treated|3|||
33551401|NCT01356589|62943798|FG000|Overall Study|Dose data not recorded|2|||
33551402|NCT02830087|62943808|FG000|Overall Study|No study staff to follow-up patients|4|||
33551403|NCT02830087|62943809|FG001|Overall Study|No study staff to follow-up patients|4|||
33551404|NCT02830087|62943810|FG002|Overall Study|No study staff to follow-up patients|4|||
33551405|NCT02830087|62943811|FG003|Overall Study|No study staff to follow-up patients|3|||
33551406|NCT02830087|62943812|FG004|Overall Study|No study staff to follow-up patients|3|||
33551407|NCT02830087|62943813|FG005|Overall Study|No study staff to follow-up patients|3|||
33551408|NCT02829775|62943827|FG000|Overall Study|Death|1|||
33551409|NCT02829775|62943827|FG000|Overall Study|Withdrawal by Subject|3|||
33551410|NCT02829775|62943827|FG000|Overall Study|Disease remission|1|||
33551411|NCT01355497|62943848|FG000|Overall Study|Death|19|||
33551412|NCT01355497|62943849|FG001|Overall Study|Death|18|||
33551413|NCT01355497|62943848|FG000|Overall Study|Lost to Follow-up|3|||
33551414|NCT01355497|62943849|FG001|Overall Study|Lost to Follow-up|0|||
33551415|NCT01355497|62943848|FG000|Overall Study|Protocol Violation|0|||
33551416|NCT01355497|62943849|FG001|Overall Study|Protocol Violation|1|||
33551417|NCT01355497|62943848|FG000|Overall Study|other-not provided|9|||
33551418|NCT01355497|62943849|FG001|Overall Study|other-not provided|4|||
33551419|NCT01355497|62943848|FG000|Overall Study|Withdrawal by Subject|12|||
33551420|NCT01355497|62943849|FG001|Overall Study|Withdrawal by Subject|20|||
33656340|NCT01849055|63075300|FG003|Overall Study|Withdrawal by Subject|0|||
33656341|NCT01849055|63075301|FG004|Overall Study|Withdrawal by Subject|0|||
33656342|NCT01849055|63075302|FG005|Overall Study|Withdrawal by Subject|0|||
33656343|NCT01848353|63075328|FG000|Phase 1|Withdrawal by Subject|3|||
33551421|NCT01355497|62943848|FG000|Overall Study|noncompliance|1|||
33551422|NCT01355497|62943849|FG001|Overall Study|noncompliance|2|||
33656344|NCT01848353|63075329|FG001|Phase 1|Withdrawal by Subject|1|||
33656345|NCT01848353|63075330|FG002|Phase 1|Withdrawal by Subject|0|||
33480468|NCT00027027|62856886|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
33551423|NCT01355497|62943848|FG000|Overall Study|progressive disease|11|||
33551424|NCT01355497|62943849|FG001|Overall Study|progressive disease|8|||
33551425|NCT01355497|62943848|FG000|Overall Study|Adverse Event|11|||
33551426|NCT01355497|62943849|FG001|Overall Study|Adverse Event|10|||
33551427|NCT01355575|62943855|FG000|Overall Study|Withdrawal by Subject|2|||
33364669|NCT02393248|62743326|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
33551428|NCT02826421|62943867|FG000|Overall Study|Adverse Event|1|||
33656346|NCT01848353|63075331|FG003|Phase 1|Withdrawal by Subject|0|||
33551429|NCT02826421|62943868|FG001|Overall Study|Adverse Event|0|||
33551430|NCT02826421|62943869|FG002|Overall Study|Adverse Event|0|||
33551431|NCT02826421|62943870|FG003|Overall Study|Adverse Event|1|||
33551432|NCT02826421|62943867|FG000|Overall Study|Withdrawal by Subject|1|||
33551433|NCT02826421|62943868|FG001|Overall Study|Withdrawal by Subject|3|||
33551434|NCT02826421|62943869|FG002|Overall Study|Withdrawal by Subject|1|||
33551435|NCT02826421|62943870|FG003|Overall Study|Withdrawal by Subject|1|||
33551436|NCT02826421|62943867|FG000|Overall Study|Reason not given|1|||
33551437|NCT02826421|62943868|FG001|Overall Study|Reason not given|0|||
33551438|NCT02826421|62943869|FG002|Overall Study|Reason not given|1|||
33551439|NCT02826421|62943870|FG003|Overall Study|Reason not given|0|||
33551440|NCT02825251|62943883|FG000|Overall Study|Adverse Event|0|||
33551441|NCT02825251|62943884|FG001|Overall Study|Adverse Event|1|||
33551442|NCT02825251|62943883|FG000|Overall Study|Lost to Follow-up|0|||
33551443|NCT02825251|62943884|FG001|Overall Study|Lost to Follow-up|1|||
33551444|NCT02825251|62943883|FG000|Overall Study|Withdrawal by Subject|1|||
33551445|NCT02825251|62943884|FG001|Overall Study|Withdrawal by Subject|4|||
33551446|NCT02825251|62943883|FG000|Overall Study|Unclassified|2|||
33551447|NCT02825251|62943884|FG001|Overall Study|Unclassified|0|||
33551448|NCT02824627|62943892|FG000|Overall Study|Adverse Event|1|||
33551449|NCT02824627|62943893|FG001|Overall Study|Adverse Event|2|||
33480469|NCT00027027|62856887|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
33480470|NCT00027027|62856888|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
33480471|NCT00027027|62856884|FG000|Overall Study|PD Requiring Surgery|0|||
33480472|NCT00027027|62856885|FG001|Overall Study|PD Requiring Surgery|0|||
33480473|NCT00027027|62856886|FG002|Overall Study|PD Requiring Surgery|1|||
33480474|NCT00027027|62856887|FG003|Overall Study|PD Requiring Surgery|0|||
33480475|NCT00027027|62856888|FG004|Overall Study|PD Requiring Surgery|0|||
33480476|NCT00027027|62856884|FG000|Overall Study|Physician Decision Due To PD|2|||
33480477|NCT00027027|62856885|FG001|Overall Study|Physician Decision Due To PD|3|||
33480478|NCT00027027|62856886|FG002|Overall Study|Physician Decision Due To PD|2|||
33480479|NCT00027027|62856887|FG003|Overall Study|Physician Decision Due To PD|3|||
33480480|NCT00027027|62856888|FG004|Overall Study|Physician Decision Due To PD|5|||
33480481|NCT00027027|62856884|FG000|Overall Study|Withdrawal by Subject|0|||
33480482|NCT00027027|62856885|FG001|Overall Study|Withdrawal by Subject|0|||
33480483|NCT00027027|62856886|FG002|Overall Study|Withdrawal by Subject|0|||
33551450|NCT02824627|62943892|FG000|Overall Study|Lost to Follow-up|2|||
33551451|NCT02824627|62943893|FG001|Overall Study|Lost to Follow-up|1|||
33551452|NCT04860505|62943899|FG000|Overall Study|Lost to Follow-up|2|||
33551453|NCT04063865|62943905|FG000|Overall Study|Physician Decision|1|||
33551454|NCT04063865|62943906|FG001|Overall Study|Physician Decision|3|||
33551455|NCT04063865|62943905|FG000|Overall Study|Study Closed Prior to Completion|4|||
33551456|NCT04063865|62943906|FG001|Overall Study|Study Closed Prior to Completion|4|||
33551457|NCT04063865|62943905|FG000|Overall Study|Withdrawal by Subject|1|||
33551458|NCT04063865|62943906|FG001|Overall Study|Withdrawal by Subject|1|||
33551459|NCT03994211|62943914|FG000|Core Phase|Adverse Event|0|||
33551460|NCT03994211|62943915|FG001|Core Phase|Adverse Event|1|||
33551461|NCT03994211|62943916|FG002|Core Phase|Adverse Event|0|||
33551462|NCT03994211|62943914|FG000|Extension Phase|Adverse Event|0|||
33551463|NCT03994211|62943915|FG001|Extension Phase|Adverse Event|0|||
33551464|NCT03994211|62943916|FG002|Extension Phase|Adverse Event|1|||
33551465|NCT03994211|62943914|FG000|Extension Phase|Physician Decision|0|||
33551466|NCT03994211|62943915|FG001|Extension Phase|Physician Decision|0|||
33551467|NCT03994211|62943916|FG002|Extension Phase|Physician Decision|1|||
33551468|NCT03994211|62943914|FG000|Extension Phase|Progressive Disease|0|||
33551469|NCT03994211|62943915|FG001|Extension Phase|Progressive Disease|0|||
33551470|NCT03994211|62943916|FG002|Extension Phase|Progressive Disease|20|||
33551471|NCT03994211|62943914|FG000|Extension Phase|Withdrawal by Subject|0|||
33551472|NCT03994211|62943915|FG001|Extension Phase|Withdrawal by Subject|0|||
33551473|NCT03994211|62943916|FG002|Extension Phase|Withdrawal by Subject|2|||
33551474|NCT03818607|62943931|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
33551475|NCT03818607|62943932|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
33480484|NCT00027027|62856887|FG003|Overall Study|Withdrawal by Subject|0|||
33480485|NCT00027027|62856888|FG004|Overall Study|Withdrawal by Subject|1|||
33551476|NCT03818607|62943931|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
33480486|NCT00046839|62856906|FG000|Overall Study|Ineligible / No protocol treatment|0|||
33551477|NCT03818607|62943932|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
33551478|NCT03818607|62943931|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
33551479|NCT03818607|62943932|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
33551480|NCT03300817|62943970|FG000|Overall Study|Withdrawal by Subject|1|||
33551481|NCT03300817|62943970|FG000|Overall Study|Adverse Event|1|||
33551482|NCT03300817|62943970|FG000|Overall Study|Subject Found to be Ineligible|2|||
33656347|NCT01848353|63075328|FG000|Phase 2|Withdrawal by Subject|3|||
33480487|NCT00046839|62856907|FG001|Overall Study|Ineligible / No protocol treatment|2|||
33480488|NCT00046839|62856906|FG000|Overall Study|Withdrawal of consent|1|||
33480489|NCT00046839|62856907|FG001|Overall Study|Withdrawal of consent|0|||
33480490|NCT00006903|62856916|FG000|Overall Study|Still receiving treatment|0|||
33480491|NCT00006903|62856917|FG001|Overall Study|Still receiving treatment|0|||
33551483|NCT03144674|62943982|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
33551484|NCT03144674|62943983|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
33551485|NCT03144674|62943984|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
33551486|NCT03144674|62943985|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
33480492|NCT00006903|62856918|FG002|Overall Study|Still receiving treatment|1|||
33480493|NCT00006903|62856916|FG000|Overall Study|Refused further treatment|0|||
33480494|NCT00006903|62856917|FG001|Overall Study|Refused further treatment|2|||
33480495|NCT00006903|62856918|FG002|Overall Study|Refused further treatment|1|||
33480496|NCT00006903|62856916|FG000|Overall Study|Adverse Event|0|||
33480497|NCT00006903|62856917|FG001|Overall Study|Adverse Event|0|||
33480498|NCT00006903|62856918|FG002|Overall Study|Adverse Event|1|||
33480499|NCT00006903|62856916|FG000|Overall Study|Death|0|||
33480500|NCT00006903|62856917|FG001|Overall Study|Death|1|||
33480501|NCT00006903|62856918|FG002|Overall Study|Death|0|||
33480502|NCT00006903|62856916|FG000|Overall Study|Patient never treated|0|||
33480503|NCT00006903|62856917|FG001|Overall Study|Patient never treated|0|||
33480504|NCT00006903|62856918|FG002|Overall Study|Patient never treated|1|||
33551487|NCT03144674|62943982|FG000|Overall Study|Death|3|||
33551488|NCT03144674|62943983|FG001|Overall Study|Death|1|||
33551489|NCT03144674|62943984|FG002|Overall Study|Death|1|||
33551490|NCT03144674|62943985|FG003|Overall Study|Death|10|||
33551491|NCT03144674|62943982|FG000|Overall Study|Lost to Follow-up|0|||
33551492|NCT03144674|62943983|FG001|Overall Study|Lost to Follow-up|1|||
33551493|NCT03144674|62943984|FG002|Overall Study|Lost to Follow-up|1|||
33551494|NCT03144674|62943985|FG003|Overall Study|Lost to Follow-up|1|||
33551495|NCT03144674|62943982|FG000|Overall Study|Withdrawal by Participant|0|||
33551496|NCT03144674|62943983|FG001|Overall Study|Withdrawal by Participant|0|||
33551497|NCT03144674|62943984|FG002|Overall Study|Withdrawal by Participant|0|||
33551498|NCT03144674|62943985|FG003|Overall Study|Withdrawal by Participant|3|||
33551499|NCT03144674|62943982|FG000|Overall Study|Reason not Specified|0|||
33551500|NCT03144674|62943983|FG001|Overall Study|Reason not Specified|0|||
33551501|NCT03144674|62943984|FG002|Overall Study|Reason not Specified|2|||
33551502|NCT03144674|62943985|FG003|Overall Study|Reason not Specified|4|||
33551503|NCT02422615|62944002|FG000|Overall Study|Progressive disease|193|||
33551504|NCT02422615|62944003|FG001|Overall Study|Progressive disease|142|||
33551505|NCT02422615|62944002|FG000|Overall Study|Adverse Event|41|||
33551506|NCT02422615|62944003|FG001|Overall Study|Adverse Event|10|||
33551507|NCT02422615|62944002|FG000|Overall Study|Physician Decision|22|||
33551508|NCT02422615|62944003|FG001|Overall Study|Physician Decision|7|||
33551509|NCT02422615|62944002|FG000|Overall Study|Subject/guardian decision|21|||
33551510|NCT02422615|62944003|FG001|Overall Study|Subject/guardian decision|5|||
33551511|NCT02422615|62944002|FG000|Overall Study|Death|2|||
33551512|NCT02422615|62944003|FG001|Overall Study|Death|0|||
33551513|NCT02422615|62944002|FG000|Overall Study|Protocol Violation|1|||
33551514|NCT02422615|62944003|FG001|Overall Study|Protocol Violation|1|||
33480505|NCT00006903|62856916|FG000|Overall Study|Ineligible|10|||
33480506|NCT00006903|62856917|FG001|Overall Study|Ineligible|1|||
33480507|NCT00006903|62856918|FG002|Overall Study|Ineligible|2|||
33480508|NCT00026793|62856926|FG000|Overall Study|Death on study due to underlying disease|4|||
33480509|NCT00026793|62856926|FG000|Overall Study|Physician Decision|2|||
33480510|NCT00026793|62856926|FG000|Overall Study|Off study|2|||
33480511|NCT03539484|62856937|FG000|Overall Study|Death|1|||
33480512|NCT03539484|62856938|FG001|Overall Study|Death|0|||
33480513|NCT03539484|62856939|FG002|Overall Study|Death|0|||
33551515|NCT02422615|62944002|FG000|Overall Study|Technical problems|0|||
33480514|NCT03539484|62856940|FG003|Overall Study|Death|2|||
33480515|NCT03539484|62856941|FG004|Overall Study|Death|8|||
33480516|NCT03539484|62856942|FG005|Overall Study|Death|3|||
33480517|NCT03539484|62856943|FG006|Overall Study|Death|0|||
33480518|NCT03539484|62856937|FG000|Overall Study|Lost to Follow-up|0|||
33480519|NCT03539484|62856938|FG001|Overall Study|Lost to Follow-up|1|||
33480520|NCT03539484|62856939|FG002|Overall Study|Lost to Follow-up|0|||
33480521|NCT03539484|62856940|FG003|Overall Study|Lost to Follow-up|0|||
33480522|NCT03539484|62856941|FG004|Overall Study|Lost to Follow-up|1|||
33480523|NCT03539484|62856942|FG005|Overall Study|Lost to Follow-up|0|||
33551516|NCT02422615|62944003|FG001|Overall Study|Technical problems|1|||
33551517|NCT02382406|62944012|FG000|Study Treatment|Disease Progression|8|||
33551518|NCT02382406|62944013|FG001|Study Treatment|Disease Progression|0|||
33551519|NCT02382406|62944014|FG002|Study Treatment|Disease Progression|20|||
33551520|NCT02382406|62944012|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
33551521|NCT02382406|62944013|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
33551522|NCT02382406|62944014|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
33551523|NCT02382406|62944012|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
33551524|NCT02382406|62944013|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
33480524|NCT03539484|62856943|FG006|Overall Study|Lost to Follow-up|0|||
33480525|NCT03539484|62856937|FG000|Overall Study|Withdrawal by Subject|0|||
33656348|NCT01848353|63075329|FG001|Phase 2|Withdrawal by Subject|2|||
33656349|NCT01848353|63075330|FG002|Phase 2|Withdrawal by Subject|0|||
33656350|NCT01848353|63075331|FG003|Phase 2|Withdrawal by Subject|0|||
33656351|NCT01848353|63075328|FG000|Phase 3|Withdrawal by Subject|1|||
33656352|NCT01848353|63075329|FG001|Phase 3|Withdrawal by Subject|1|||
33551525|NCT02382406|62944014|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
33551526|NCT02382406|62944012|FG000|Study Treatment|symptomatic deterioration|1|||
33656353|NCT01848353|63075330|FG002|Phase 3|Withdrawal by Subject|0|||
33656354|NCT01848353|63075331|FG003|Phase 3|Withdrawal by Subject|0|||
33656355|NCT01847885|63075360|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
33656356|NCT01847885|63075361|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
33656357|NCT01847885|63075362|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
33656358|NCT01847885|63075360|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
33656359|NCT01847885|63075361|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
33656360|NCT01847885|63075362|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
33656361|NCT01847885|63075360|FG000|Initial Enrollment (Consented)|Screen failure|39|||
33656362|NCT01847885|63075361|FG001|Initial Enrollment (Consented)|Screen failure|0|||
33656363|NCT01847885|63075362|FG002|Initial Enrollment (Consented)|Screen failure|0|||
33656364|NCT01847885|63075360|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
33656365|NCT01847885|63075361|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
33656366|NCT01847885|63075362|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
33656367|NCT01847885|63075360|FG000|Randomization|Protocol Violation|0|||
33656368|NCT01847885|63075361|FG001|Randomization|Protocol Violation|1|||
33656369|NCT01847885|63075362|FG002|Randomization|Protocol Violation|0|||
33656370|NCT01847885|63075360|FG000|Randomization|Withdrawal by Subject|0|||
33656371|NCT01847885|63075361|FG001|Randomization|Withdrawal by Subject|0|||
33656372|NCT01847885|63075362|FG002|Randomization|Withdrawal by Subject|2|||
33656373|NCT01847885|63075360|FG000|Randomization|Screen Failure|0|||
33656374|NCT01847885|63075361|FG001|Randomization|Screen Failure|3|||
33656375|NCT01847885|63075362|FG002|Randomization|Screen Failure|0|||
33656376|NCT01867307|63075400|FG000|Overall Study|Protocol Violation|2|||
33551527|NCT02382406|62944013|FG001|Study Treatment|symptomatic deterioration|0|||
33551528|NCT02382406|62944014|FG002|Study Treatment|symptomatic deterioration|1|||
33551529|NCT02382406|62944012|FG000|Study Treatment|Death|0|||
33551530|NCT02382406|62944013|FG001|Study Treatment|Death|0|||
33656377|NCT01867307|63075401|FG001|Overall Study|Protocol Violation|0|||
33656378|NCT01867307|63075400|FG000|Overall Study|Other Adverse Event|1|||
33656379|NCT01867307|63075401|FG001|Overall Study|Other Adverse Event|3|||
33656380|NCT01845077|63075410|FG000|Washout Period|Lost to Follow-up|0|||
33656381|NCT01845077|63075411|FG001|Washout Period|Lost to Follow-up|1|||
33656382|NCT01845077|63075412|FG002|Washout Period|Lost to Follow-up|0|||
33656383|NCT01845077|63075413|FG003|Washout Period|Lost to Follow-up|1|||
33656384|NCT01845077|63075414|FG004|Washout Period|Lost to Follow-up|0|||
33656385|NCT01845077|63075415|FG005|Washout Period|Lost to Follow-up|1|||
33656386|NCT01845077|63075410|FG000|Washout Period|Adverse Event|1|||
33656387|NCT01845077|63075411|FG001|Washout Period|Adverse Event|0|||
33656388|NCT01845077|63075412|FG002|Washout Period|Adverse Event|0|||
33656389|NCT01845077|63075413|FG003|Washout Period|Adverse Event|0|||
33656390|NCT01845077|63075414|FG004|Washout Period|Adverse Event|0|||
33364670|NCT02393248|62743327|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33480526|NCT03539484|62856938|FG001|Overall Study|Withdrawal by Subject|0|||
33480527|NCT03539484|62856939|FG002|Overall Study|Withdrawal by Subject|0|||
33480528|NCT03539484|62856940|FG003|Overall Study|Withdrawal by Subject|0|||
33480529|NCT03539484|62856941|FG004|Overall Study|Withdrawal by Subject|2|||
33480530|NCT03539484|62856942|FG005|Overall Study|Withdrawal by Subject|0|||
33480531|NCT03539484|62856943|FG006|Overall Study|Withdrawal by Subject|1|||
33551531|NCT02382406|62944014|FG002|Study Treatment|Death|2|||
33551532|NCT02382406|62944012|FG000|Follow up|Death|11|||
33656391|NCT01845077|63075415|FG005|Washout Period|Adverse Event|0|||
33656392|NCT01845077|63075410|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
33656393|NCT01845077|63075411|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
33656394|NCT01845077|63075412|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
33656395|NCT01845077|63075413|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
33656396|NCT01845077|63075414|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
33656397|NCT01845077|63075415|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
33656398|NCT01845077|63075410|FG000|Washout Period|Protocol Violation|0|||
33656399|NCT01845077|63075411|FG001|Washout Period|Protocol Violation|0|||
33480532|NCT03539484|62856937|FG000|Overall Study|Study Terminated by Sponsor|0|||
33480533|NCT03539484|62856938|FG001|Overall Study|Study Terminated by Sponsor|0|||
33480534|NCT03539484|62856939|FG002|Overall Study|Study Terminated by Sponsor|1|||
33551533|NCT02382406|62944013|FG001|Follow up|Death|0|||
33656400|NCT01845077|63075412|FG002|Washout Period|Protocol Violation|0|||
33656401|NCT01845077|63075413|FG003|Washout Period|Protocol Violation|1|||
33551534|NCT02382406|62944014|FG002|Follow up|Death|19|||
33480535|NCT03539484|62856940|FG003|Overall Study|Study Terminated by Sponsor|1|||
33480536|NCT03539484|62856941|FG004|Overall Study|Study Terminated by Sponsor|2|||
33480537|NCT03539484|62856942|FG005|Overall Study|Study Terminated by Sponsor|2|||
33480538|NCT03539484|62856943|FG006|Overall Study|Study Terminated by Sponsor|1|||
33480539|NCT03561090|62856966|FG000|Overall Study|Adverse Event|11|||
33480540|NCT03561090|62856967|FG001|Overall Study|Adverse Event|7|||
33480541|NCT03561090|62856966|FG000|Overall Study|Non-Compliance With Study Drug|2|||
33551535|NCT02382406|62944012|FG000|Follow up|Symptomatic deterioration|1|||
33551536|NCT02382406|62944013|FG001|Follow up|Symptomatic deterioration|0|||
33551537|NCT02382406|62944014|FG002|Follow up|Symptomatic deterioration|1|||
33551538|NCT02382406|62944012|FG000|Follow up|Patient Refused Follow-up|1|||
33551539|NCT02382406|62944013|FG001|Follow up|Patient Refused Follow-up|0|||
33551540|NCT02382406|62944014|FG002|Follow up|Patient Refused Follow-up|0|||
33551541|NCT02382406|62944012|FG000|Follow up|Study Terminated|1|||
33551542|NCT02382406|62944013|FG001|Follow up|Study Terminated|0|||
33551543|NCT02382406|62944014|FG002|Follow up|Study Terminated|8|||
33551544|NCT02382406|62944012|FG000|Follow up|Withdrawal by Subject|0|||
33551545|NCT02382406|62944013|FG001|Follow up|Withdrawal by Subject|0|||
33551546|NCT02382406|62944014|FG002|Follow up|Withdrawal by Subject|2|||
33551547|NCT02101268|62944034|FG000|Randomized Treatment Phase|Subject Decision|8|||
33551548|NCT02101268|62944035|FG001|Randomized Treatment Phase|Subject Decision|4|||
33551549|NCT02101268|62944036|FG002|Randomized Treatment Phase|Subject Decision|0|||
33551550|NCT02101268|62944037|FG003|Randomized Treatment Phase|Subject Decision|0|||
33551551|NCT02101268|62944034|FG000|Randomized Treatment Phase|Physician Decision|4|||
33551552|NCT02101268|62944035|FG001|Randomized Treatment Phase|Physician Decision|1|||
33480542|NCT03561090|62856967|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33480543|NCT03561090|62856966|FG000|Overall Study|Protocol Violation|2|||
33480544|NCT03561090|62856967|FG001|Overall Study|Protocol Violation|2|||
33480545|NCT03561090|62856966|FG000|Overall Study|Withdrawal by Subject|7|||
33480546|NCT03561090|62856967|FG001|Overall Study|Withdrawal by Subject|7|||
33480547|NCT03561090|62856966|FG000|Overall Study|Lost to Follow-up|7|||
33480548|NCT03561090|62856967|FG001|Overall Study|Lost to Follow-up|2|||
33480549|NCT03561090|62856966|FG000|Overall Study|Study Terminated by Sponsor|10|||
33480550|NCT03561090|62856967|FG001|Overall Study|Study Terminated by Sponsor|15|||
33480551|NCT03561090|62856966|FG000|Overall Study|Randomized by Mistake|1|||
33480552|NCT03561090|62856967|FG001|Overall Study|Randomized by Mistake|1|||
33480553|NCT03561090|62856966|FG000|Overall Study|Other Not Specified|0|||
33480554|NCT03561090|62856967|FG001|Overall Study|Other Not Specified|2|||
33480555|NCT02996500|62856981|FG000|Overall Study|Adverse Event|1|||
33480556|NCT02996500|62856982|FG001|Overall Study|Adverse Event|1|||
33480557|NCT02996500|62856983|FG002|Overall Study|Adverse Event|4|||
33480558|NCT02996500|62856984|FG003|Overall Study|Adverse Event|3|||
33480559|NCT02996500|62856985|FG004|Overall Study|Adverse Event|1|||
33480560|NCT02996500|62856986|FG005|Overall Study|Adverse Event|2|||
33480561|NCT02996500|62856981|FG000|Overall Study|Lack of Efficacy|0|||
33480562|NCT02996500|62856982|FG001|Overall Study|Lack of Efficacy|0|||
33480563|NCT02996500|62856983|FG002|Overall Study|Lack of Efficacy|0|||
33480564|NCT02996500|62856984|FG003|Overall Study|Lack of Efficacy|0|||
33480565|NCT02996500|62856985|FG004|Overall Study|Lack of Efficacy|2|||
33551553|NCT02101268|62944036|FG002|Randomized Treatment Phase|Physician Decision|0|||
33551554|NCT02101268|62944037|FG003|Randomized Treatment Phase|Physician Decision|0|||
33480566|NCT02996500|62856986|FG005|Overall Study|Lack of Efficacy|0|||
33480567|NCT02996500|62856981|FG000|Overall Study|Lost to Follow-up|1|||
33480568|NCT02996500|62856982|FG001|Overall Study|Lost to Follow-up|0|||
33480569|NCT02996500|62856983|FG002|Overall Study|Lost to Follow-up|0|||
33480570|NCT02996500|62856984|FG003|Overall Study|Lost to Follow-up|0|||
33480571|NCT02996500|62856985|FG004|Overall Study|Lost to Follow-up|0|||
33480572|NCT02996500|62856986|FG005|Overall Study|Lost to Follow-up|1|||
33480573|NCT02996500|62856981|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33480574|NCT02996500|62856982|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33480575|NCT02996500|62856983|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
33480576|NCT02996500|62856984|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
33480577|NCT02996500|62856985|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
33480578|NCT02996500|62856986|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
33551555|NCT02101268|62944034|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
33551556|NCT02101268|62944035|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
33480579|NCT02996500|62856981|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33480580|NCT02996500|62856982|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33480581|NCT02996500|62856983|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33480582|NCT02996500|62856984|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33480583|NCT02996500|62856985|FG004|Overall Study|Non-Compliance With Study Drug|0|||
33480584|NCT02996500|62856986|FG005|Overall Study|Non-Compliance With Study Drug|1|||
33551557|NCT02101268|62944036|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
33551558|NCT02101268|62944037|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
33480585|NCT02996500|62856981|FG000|Overall Study|Progressive Disease|1|||
33480586|NCT02996500|62856982|FG001|Overall Study|Progressive Disease|0|||
33480587|NCT02996500|62856983|FG002|Overall Study|Progressive Disease|0|||
33480588|NCT02996500|62856984|FG003|Overall Study|Progressive Disease|0|||
33480589|NCT02996500|62856985|FG004|Overall Study|Progressive Disease|0|||
33480590|NCT02996500|62856986|FG005|Overall Study|Progressive Disease|0|||
33480591|NCT02996500|62856981|FG000|Overall Study|Other|2|||
33551559|NCT02101268|62944034|FG000|Randomized Treatment Phase|Adverse Event|6|||
33551560|NCT02101268|62944035|FG001|Randomized Treatment Phase|Adverse Event|0|||
33551561|NCT02101268|62944036|FG002|Randomized Treatment Phase|Adverse Event|0|||
33551562|NCT02101268|62944037|FG003|Randomized Treatment Phase|Adverse Event|0|||
33551563|NCT02101268|62944034|FG000|Randomized Treatment Phase|Death|5|||
33551564|NCT02101268|62944035|FG001|Randomized Treatment Phase|Death|4|||
33551565|NCT02101268|62944036|FG002|Randomized Treatment Phase|Death|0|||
33551566|NCT02101268|62944037|FG003|Randomized Treatment Phase|Death|0|||
33551567|NCT02101268|62944034|FG000|Randomized Treatment Phase|Disease Progression|4|||
33551568|NCT02101268|62944035|FG001|Randomized Treatment Phase|Disease Progression|1|||
33551569|NCT02101268|62944036|FG002|Randomized Treatment Phase|Disease Progression|0|||
33551570|NCT02101268|62944037|FG003|Randomized Treatment Phase|Disease Progression|0|||
33551571|NCT02101268|62944034|FG000|Extended Treatment Phase|Subject Decision|0|||
33551572|NCT02101268|62944035|FG001|Extended Treatment Phase|Subject Decision|0|||
33551573|NCT02101268|62944036|FG002|Extended Treatment Phase|Subject Decision|3|||
33551574|NCT02101268|62944037|FG003|Extended Treatment Phase|Subject Decision|2|||
33551575|NCT02101268|62944034|FG000|Extended Treatment Phase|Physician Decision|0|||
33480592|NCT02996500|62856982|FG001|Overall Study|Other|0|||
33480593|NCT02996500|62856983|FG002|Overall Study|Other|2|||
33480594|NCT02996500|62856984|FG003|Overall Study|Other|0|||
33656402|NCT01845077|63075414|FG004|Washout Period|Protocol Violation|1|||
33656403|NCT01845077|63075415|FG005|Washout Period|Protocol Violation|0|||
33656404|NCT01866917|63075432|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
33656405|NCT01866917|63075433|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
33656406|NCT01844765|63075568|FG000|Overall Study|Adverse Event|6|||
33656407|NCT01844765|63075569|FG001|Overall Study|Adverse Event|8|||
33656408|NCT01844765|63075568|FG000|Overall Study|Withdrawal by Subject|2|||
33656409|NCT01844765|63075569|FG001|Overall Study|Withdrawal by Subject|3|||
33656410|NCT01844765|63075568|FG000|Overall Study|Disease progression|1|||
33656411|NCT01844765|63075569|FG001|Overall Study|Disease progression|0|||
33656412|NCT01844765|63075568|FG000|Overall Study|Administrative problems|3|||
33656413|NCT01844765|63075569|FG001|Overall Study|Administrative problems|4|||
33656414|NCT01844765|63075568|FG000|Overall Study|Protocol deviation|2|||
33656415|NCT01844765|63075569|FG001|Overall Study|Protocol deviation|0|||
33656416|NCT01844765|63075568|FG000|Overall Study|Untreated|1|||
33656417|NCT01844765|63075569|FG001|Overall Study|Untreated|0|||
33656418|NCT01866293|63075584|FG000|Overall Study|Adverse Event|2|||
33656419|NCT01844687|63075588|FG000|Visit 1|Protocol Violation|3|||
33656420|NCT01844687|63075588|FG000|Visit 1|Lost to Follow-up|5|||
33656421|NCT01844687|63075588|FG000|Visit 2|Withdrawal by Subject|1|||
33656422|NCT01844687|63075588|FG000|Visit 2|Protocol Violation|1|||
33364671|NCT02393248|62743303|FG000|Part 3: Combination Therapy|Death|0|||
33364672|NCT02393248|62743304|FG001|Part 3: Combination Therapy|Death|0|||
33551576|NCT02101268|62944035|FG001|Extended Treatment Phase|Physician Decision|0|||
33551577|NCT02101268|62944036|FG002|Extended Treatment Phase|Physician Decision|5|||
33551578|NCT02101268|62944037|FG003|Extended Treatment Phase|Physician Decision|2|||
33551579|NCT02101268|62944034|FG000|Extended Treatment Phase|Adverse Event|0|||
33551580|NCT02101268|62944035|FG001|Extended Treatment Phase|Adverse Event|0|||
33551581|NCT02101268|62944036|FG002|Extended Treatment Phase|Adverse Event|14|||
33551582|NCT02101268|62944037|FG003|Extended Treatment Phase|Adverse Event|18|||
33551583|NCT02101268|62944034|FG000|Extended Treatment Phase|Death|0|||
33551584|NCT02101268|62944035|FG001|Extended Treatment Phase|Death|0|||
33551585|NCT02101268|62944036|FG002|Extended Treatment Phase|Death|5|||
33551586|NCT02101268|62944037|FG003|Extended Treatment Phase|Death|1|||
33551587|NCT02101268|62944034|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
33551588|NCT02101268|62944035|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
33480595|NCT02996500|62856985|FG004|Overall Study|Other|0|||
33551589|NCT02101268|62944036|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
33551590|NCT02101268|62944037|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
33551591|NCT02101268|62944034|FG000|Extended Treatment Phase|Disease Progression|0|||
33551592|NCT02101268|62944035|FG001|Extended Treatment Phase|Disease Progression|0|||
33551593|NCT02101268|62944036|FG002|Extended Treatment Phase|Disease Progression|13|||
33551594|NCT02101268|62944037|FG003|Extended Treatment Phase|Disease Progression|6|||
33656423|NCT01844687|63075588|FG000|Visit 3|Lost to Follow-up|1|||
33656424|NCT01844687|63075588|FG000|Visit 3|Withdrawal by Subject|3|||
33656425|NCT01844687|63075588|FG000|Visit 3|child care problems|1|||
33480596|NCT02996500|62856986|FG005|Overall Study|Other|0|||
33656426|NCT01844687|63075588|FG000|Visit 4|Pregnancy|1|||
33656427|NCT01844687|63075588|FG000|Visit 4|Lost to Follow-up|1|||
33364673|NCT02393248|62743305|FG002|Part 3: Combination Therapy|Death|0|||
33480597|NCT02996500|62856981|FG000|Overall Study|Protocol Violation|0|||
33480598|NCT02996500|62856982|FG001|Overall Study|Protocol Violation|0|||
33480599|NCT02996500|62856983|FG002|Overall Study|Protocol Violation|0|||
33480600|NCT02996500|62856984|FG003|Overall Study|Protocol Violation|1|||
33480601|NCT02996500|62856985|FG004|Overall Study|Protocol Violation|0|||
33480602|NCT02996500|62856986|FG005|Overall Study|Protocol Violation|0|||
33480603|NCT02996500|62856981|FG000|Overall Study|Withdrawal by Subject|3|||
33551595|NCT02101268|62944034|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
33551596|NCT02101268|62944035|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
33551597|NCT02101268|62944036|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
33551598|NCT02101268|62944037|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
33551599|NCT01898650|62944054|FG000|Overall Study|the subject would not lie still for imaging|1|||
33551600|NCT01880515|62944060|FG000|Overall Study|Lost to Follow-up|3|||
33551601|NCT01880515|62944061|FG001|Overall Study|Lost to Follow-up|2|||
33551602|NCT01880515|62944060|FG000|Overall Study|Disease Progression|5|||
33551603|NCT01880515|62944061|FG001|Overall Study|Disease Progression|7|||
33551604|NCT01668719|62944071|FG000|Phase I|On treatment|1|||
33551605|NCT01668719|62944072|FG001|Phase I|On treatment|0|||
33551606|NCT01668719|62944073|FG002|Phase I|On treatment|0|||
33551607|NCT01668719|62944071|FG000|Phase I|Adverse Event|2|||
33551608|NCT01668719|62944072|FG001|Phase I|Adverse Event|0|||
33656428|NCT01844687|63075588|FG000|Visit 4|Withdrawal by Subject|2|||
33656429|NCT01844531|63075614|FG000|Overall Study|Withdrawal by Subject|0|||
33656430|NCT01844531|63075615|FG001|Overall Study|Withdrawal by Subject|1|||
33656431|NCT01844531|63075616|FG002|Overall Study|Withdrawal by Subject|0|||
33656432|NCT01844531|63075617|FG003|Overall Study|Withdrawal by Subject|0|||
33551609|NCT01668719|62944073|FG002|Phase I|Adverse Event|0|||
33551610|NCT01668719|62944071|FG000|Phase I|Progression/relapse|1|||
33551611|NCT01668719|62944072|FG001|Phase I|Progression/relapse|0|||
33551612|NCT01668719|62944073|FG002|Phase I|Progression/relapse|0|||
33551613|NCT01668719|62944071|FG000|Phase I|not protocol specified|2|||
33551614|NCT01668719|62944072|FG001|Phase I|not protocol specified|0|||
33656433|NCT01844375|63075629|FG000|Overall Study|Protocol Violation|1|||
33656434|NCT01844375|63075630|FG001|Overall Study|Protocol Violation|1|||
33656435|NCT02367456|63075639|FG000|Overall Study|Death|8|||
33656436|NCT02367456|63075640|FG001|Overall Study|Death|21|||
33656437|NCT02367456|63075641|FG002|Overall Study|Death|14|||
33656438|NCT02367456|63075639|FG000|Overall Study|Lost to Follow-up|1|||
33656439|NCT02367456|63075640|FG001|Overall Study|Lost to Follow-up|3|||
33656440|NCT02367456|63075641|FG002|Overall Study|Lost to Follow-up|1|||
33656441|NCT02367456|63075639|FG000|Overall Study|Ongoing|0|||
33656442|NCT02367456|63075640|FG001|Overall Study|Ongoing|6|||
33656443|NCT02367456|63075641|FG002|Overall Study|Ongoing|15|||
33656444|NCT02367456|63075639|FG000|Overall Study|Other reason|3|||
33656445|NCT02367456|63075640|FG001|Overall Study|Other reason|0|||
33656446|NCT02367456|63075641|FG002|Overall Study|Other reason|0|||
33656447|NCT01865747|63075672|FG000|Overall Study (ITT)|Adverse Event|32|||
33656448|NCT01865747|63075673|FG001|Overall Study (ITT)|Adverse Event|31|||
33656449|NCT01865747|63075672|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
33656450|NCT01865747|63075673|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
33656451|NCT01865747|63075672|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
33656452|NCT01865747|63075673|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
33656453|NCT01865747|63075672|FG000|Overall Study (ITT)|Protocol Violation|1|||
33480604|NCT02996500|62856982|FG001|Overall Study|Withdrawal by Subject|0|||
33551615|NCT01668719|62944073|FG002|Phase I|not protocol specified|0|||
33551616|NCT01668719|62944071|FG000|Phase II|On treatment|0|||
33480605|NCT02996500|62856983|FG002|Overall Study|Withdrawal by Subject|3|||
33480606|NCT02996500|62856984|FG003|Overall Study|Withdrawal by Subject|0|||
33480607|NCT02996500|62856985|FG004|Overall Study|Withdrawal by Subject|2|||
33480608|NCT02996500|62856986|FG005|Overall Study|Withdrawal by Subject|0|||
33480609|NCT00006489|62857008|FG000|Overall Study|Adverse Event|3|||
33551617|NCT01668719|62944072|FG001|Phase II|On treatment|4|||
33551618|NCT01668719|62944073|FG002|Phase II|On treatment|3|||
33551619|NCT01668719|62944071|FG000|Phase II|Adverse Event|0|||
33551620|NCT01668719|62944072|FG001|Phase II|Adverse Event|18|||
33551621|NCT01668719|62944073|FG002|Phase II|Adverse Event|18|||
33551622|NCT01668719|62944071|FG000|Phase II|Refusal unrelated to adverse event|0|||
33551623|NCT01668719|62944072|FG001|Phase II|Refusal unrelated to adverse event|4|||
33480610|NCT00006489|62857009|FG001|Overall Study|Adverse Event|2|||
33551624|NCT01668719|62944073|FG002|Phase II|Refusal unrelated to adverse event|1|||
33551625|NCT01668719|62944071|FG000|Phase II|Progression/relapse|0|||
33551626|NCT01668719|62944072|FG001|Phase II|Progression/relapse|13|||
33551627|NCT01668719|62944073|FG002|Phase II|Progression/relapse|17|||
33656454|NCT01865747|63075673|FG001|Overall Study (ITT)|Protocol Violation|1|||
33656455|NCT01865747|63075672|FG000|Overall Study (ITT)|Physician Decision|5|||
33656456|NCT01865747|63075673|FG001|Overall Study (ITT)|Physician Decision|2|||
33656457|NCT01865747|63075672|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
33656458|NCT01865747|63075673|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
33656459|NCT01865747|63075672|FG000|Overall Study (ITT)|Sponsor Decision|0|||
33656460|NCT01865747|63075673|FG001|Overall Study (ITT)|Sponsor Decision|1|||
33480611|NCT00006489|62857010|FG002|Overall Study|Adverse Event|4|||
33480612|NCT00006489|62857011|FG003|Overall Study|Adverse Event|3|||
33480613|NCT00006489|62857008|FG000|Overall Study|Withdrawal by Subject|10|||
33480614|NCT00006489|62857009|FG001|Overall Study|Withdrawal by Subject|9|||
33480615|NCT00006489|62857010|FG002|Overall Study|Withdrawal by Subject|9|||
33480616|NCT00006489|62857011|FG003|Overall Study|Withdrawal by Subject|6|||
33480617|NCT00006489|62857008|FG000|Overall Study|Scheduling Conflict|0|||
33480618|NCT00006489|62857009|FG001|Overall Study|Scheduling Conflict|3|||
33480619|NCT00006489|62857010|FG002|Overall Study|Scheduling Conflict|2|||
33480620|NCT00006489|62857011|FG003|Overall Study|Scheduling Conflict|1|||
33480621|NCT00006489|62857008|FG000|Overall Study|Death|0|||
33480622|NCT00006489|62857009|FG001|Overall Study|Death|0|||
33480623|NCT00006489|62857010|FG002|Overall Study|Death|0|||
33480624|NCT00006489|62857011|FG003|Overall Study|Death|1|||
33480625|NCT03535974|62857024|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
33480626|NCT03535974|62857025|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
33480627|NCT03535974|62857026|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
33480628|NCT03535974|62857024|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
33480629|NCT03535974|62857025|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
33480630|NCT03535974|62857026|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
33480631|NCT00025233|62857034|FG000|Overall Study|Ineligible: wrong cell type|1|||
33480632|NCT00025233|62857034|FG000|Overall Study|Ineligible: wrong primary|1|||
33480633|NCT00025233|62857034|FG000|Overall Study|Ineligible: improper prior treatment|1|||
33480634|NCT00025233|62857034|FG000|Overall Study|Never treated|1|||
33480635|NCT00025155|62857044|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
33480636|NCT00025155|62857044|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
33480637|NCT02998996|62857059|FG000|Overall Study|Lost to Follow-up|0|||
33480638|NCT02998996|62857060|FG001|Overall Study|Lost to Follow-up|0|||
33480639|NCT02998996|62857061|FG002|Overall Study|Lost to Follow-up|1|||
33480640|NCT02998996|62857062|FG003|Overall Study|Lost to Follow-up|0|||
33480641|NCT02998996|62857063|FG004|Overall Study|Lost to Follow-up|0|||
33480642|NCT02998996|62857064|FG005|Overall Study|Lost to Follow-up|0|||
33480643|NCT02998996|62857059|FG000|Overall Study|Pregnancy|0|||
33480644|NCT02998996|62857060|FG001|Overall Study|Pregnancy|1|||
33480645|NCT02998996|62857061|FG002|Overall Study|Pregnancy|0|||
33480646|NCT02998996|62857062|FG003|Overall Study|Pregnancy|0|||
33480647|NCT02998996|62857063|FG004|Overall Study|Pregnancy|0|||
33480648|NCT02998996|62857064|FG005|Overall Study|Pregnancy|0|||
33480649|NCT02998996|62857059|FG000|Overall Study|Family reasons|0|||
33480650|NCT02998996|62857060|FG001|Overall Study|Family reasons|0|||
33480651|NCT02998996|62857061|FG002|Overall Study|Family reasons|0|||
33480652|NCT02998996|62857062|FG003|Overall Study|Family reasons|0|||
33480653|NCT02998996|62857063|FG004|Overall Study|Family reasons|1|||
33480654|NCT02998996|62857064|FG005|Overall Study|Family reasons|0|||
33480655|NCT02994940|62857080|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
33480656|NCT02994940|62857081|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
33480657|NCT02994940|62857080|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
33480658|NCT02994940|62857081|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
33480659|NCT02994940|62857080|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
33480660|NCT02994940|62857081|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
33480661|NCT02994394|62857089|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
33480662|NCT02994394|62857090|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
33480663|NCT02994394|62857091|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
33480664|NCT02994394|62857092|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
33480665|NCT02994394|62857093|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
33480666|NCT02994394|62857094|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
33480667|NCT02994394|62857089|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
33480668|NCT02994394|62857090|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
33480669|NCT02994394|62857091|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
33480670|NCT02994394|62857092|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
33480671|NCT02994394|62857093|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
33480672|NCT02994394|62857094|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
33480673|NCT02998840|62857112|FG000|Overall Study|Lost to Follow-up|1|||
33480674|NCT02998840|62857113|FG001|Overall Study|Lost to Follow-up|1|||
33480675|NCT02998840|62857114|FG002|Overall Study|Lost to Follow-up|2|||
33480676|NCT02998840|62857115|FG003|Overall Study|Lost to Follow-up|3|||
33480677|NCT02998840|62857112|FG000|Overall Study|Withdrawal by Subject|1|||
33480678|NCT02998840|62857113|FG001|Overall Study|Withdrawal by Subject|1|||
33480679|NCT02998840|62857114|FG002|Overall Study|Withdrawal by Subject|0|||
33480680|NCT02998840|62857115|FG003|Overall Study|Withdrawal by Subject|1|||
33480681|NCT02998840|62857112|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
33480682|NCT02998840|62857113|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
33551628|NCT01668719|62944071|FG000|Phase II|Death|0|||
33480683|NCT02998840|62857114|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
33480684|NCT02998840|62857115|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
33480685|NCT00023673|62857126|FG000|Overall Study|Ineligible / no protocol treatment|0|||
33480686|NCT00023673|62857127|FG001|Overall Study|Ineligible / no protocol treatment|0|||
33480687|NCT00023673|62857128|FG002|Overall Study|Ineligible / no protocol treatment|0|||
33480688|NCT00023673|62857129|FG003|Overall Study|Ineligible / no protocol treatment|1|||
33480689|NCT00023673|62857126|FG000|Overall Study|Patient withdrew consent|0|||
33480690|NCT00023673|62857127|FG001|Overall Study|Patient withdrew consent|0|||
33480691|NCT00023673|62857128|FG002|Overall Study|Patient withdrew consent|0|||
33480692|NCT00023673|62857129|FG003|Overall Study|Patient withdrew consent|1|||
33480693|NCT01069900|62857141|FG000|Overall Study|Technical problems|0|||
33480694|NCT01069900|62857142|FG001|Overall Study|Technical problems|1|||
33480695|NCT01069900|62857141|FG000|Overall Study|Lost to Follow-up|7|||
33551629|NCT01668719|62944072|FG001|Phase II|Death|0|||
33551630|NCT01668719|62944073|FG002|Phase II|Death|2|||
33551631|NCT01668719|62944071|FG000|Phase II|not protocol specified|0|||
33551632|NCT01668719|62944072|FG001|Phase II|not protocol specified|13|||
33551633|NCT01668719|62944073|FG002|Phase II|not protocol specified|7|||
33551634|NCT01642901|62944085|FG000|12-month Follow-up|Withdrawal by Subject|1|||
33551635|NCT01642901|62944086|FG001|12-month Follow-up|Withdrawal by Subject|0|||
33551636|NCT01488045|62944094|FG000|Overall Study|Withdrawal by Subject|6|||
33551637|NCT01488045|62944095|FG001|Overall Study|Withdrawal by Subject|11|||
33551638|NCT01488045|62944094|FG000|Overall Study|Failure to present for colonoscopy|3|||
33551639|NCT01488045|62944095|FG001|Overall Study|Failure to present for colonoscopy|6|||
33551640|NCT01488045|62944094|FG000|Overall Study|Failure to report exclusion criteria|0|||
33551641|NCT01488045|62944095|FG001|Overall Study|Failure to report exclusion criteria|1|||
33551642|NCT00946712|62944114|FG000|Overall Study|Adverse Event|118|||
33551643|NCT00946712|62944115|FG001|Overall Study|Adverse Event|124|||
33551644|NCT00946712|62944114|FG000|Overall Study|Disease progression|308|||
33551645|NCT00946712|62944115|FG001|Overall Study|Disease progression|404|||
33551646|NCT00946712|62944114|FG000|Overall Study|Death|21|||
33551647|NCT00946712|62944115|FG001|Overall Study|Death|22|||
33551648|NCT00946712|62944114|FG000|Overall Study|No treatment given|25|||
33551649|NCT00946712|62944115|FG001|Overall Study|No treatment given|29|||
33551650|NCT00946712|62944114|FG000|Overall Study|Other reasons|61|||
33551651|NCT00946712|62944115|FG001|Overall Study|Other reasons|73|||
33551652|NCT00946712|62944114|FG000|Overall Study|On Treatment|0|||
33551653|NCT00946712|62944115|FG001|Overall Study|On Treatment|4|||
33551654|NCT00946712|62944114|FG000|Overall Study|Ineligible|14|||
33480696|NCT01069900|62857142|FG001|Overall Study|Lost to Follow-up|1|||
33480697|NCT01069900|62857141|FG000|Overall Study|Withdrawal by Subject|6|||
33480698|NCT01069900|62857142|FG001|Overall Study|Withdrawal by Subject|1|||
33480699|NCT01069900|62857141|FG000|Overall Study|Protocol Violation|4|||
33480700|NCT01069900|62857142|FG001|Overall Study|Protocol Violation|1|||
33480701|NCT01069900|62857141|FG000|Overall Study|Insufficient Therapeutic effect|1|||
33480702|NCT01069900|62857142|FG001|Overall Study|Insufficient Therapeutic effect|0|||
33480703|NCT01069120|62857150|FG000|Overall Study|Study prematurely terminated|27|||
33480704|NCT00006237|62857158|FG000|Overall Study|Adverse Event|39|||
33480705|NCT00006237|62857159|FG001|Overall Study|Adverse Event|29|||
33480706|NCT00006237|62857158|FG000|Overall Study|Death|1|||
33480707|NCT00006237|62857159|FG001|Overall Study|Death|0|||
33480708|NCT00006237|62857158|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
33480709|NCT00006237|62857159|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
33480710|NCT00006237|62857158|FG000|Overall Study|Progression/relapse|54|||
33480711|NCT00006237|62857159|FG001|Overall Study|Progression/relapse|2|||
33480712|NCT00006237|62857158|FG000|Overall Study|Not eligible|9|||
33480713|NCT00006237|62857159|FG001|Overall Study|Not eligible|20|||
33480714|NCT00006237|62857158|FG000|Overall Study|Withdrawal by Subject|0|||
33480715|NCT00006237|62857159|FG001|Overall Study|Withdrawal by Subject|1|||
33480716|NCT00006237|62857158|FG000|Overall Study|Not protocol specified|14|||
33480717|NCT00006237|62857159|FG001|Overall Study|Not protocol specified|5|||
33480718|NCT02993926|62857168|FG000|Enantone Treatment Phase|Adverse Event|1|||
33551655|NCT00946712|62944115|FG001|Overall Study|Ineligible|6|||
33551656|NCT00656669|62944122|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
33551657|NCT00656669|62944122|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
33551658|NCT00656669|62944122|FG000|AC (Cycles 6-9)|Adverse Event|1|||
33551659|NCT00656669|62944122|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
33480719|NCT02993926|62857169|FG001|Enantone Treatment Phase|Adverse Event|0|||
33480720|NCT02993926|62857170|FG002|Enantone Treatment Phase|Adverse Event|0|||
33480721|NCT02993926|62857168|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
33551660|NCT00470704|62944133|FG000|Overall Study|Withdrawal by Subject|4|||
33551661|NCT00470704|62944134|FG001|Overall Study|Withdrawal by Subject|3|||
33551662|NCT00470704|62944133|FG000|Overall Study|Relapse/Progression|37|||
33551663|NCT00470704|62944134|FG001|Overall Study|Relapse/Progression|42|||
33551664|NCT00470704|62944133|FG000|Overall Study|toxicity|0|||
33551665|NCT00470704|62944134|FG001|Overall Study|toxicity|1|||
33480722|NCT02993926|62857169|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
33480723|NCT02993926|62857170|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
33480724|NCT02993926|62857168|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
33480725|NCT02993926|62857169|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
33480726|NCT02993926|62857170|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
33551666|NCT01338493|62944140|FG000|Enrolled|Withdrawal by Subject|1|||
33551667|NCT01338493|62944140|FG000|Enrolled|Patient not implanted|4|||
33551668|NCT01338493|62944140|FG000|Discharge|Death|1|||
33551669|NCT01338493|62944140|FG000|Discharge|Missed visit|1|||
33551670|NCT01338493|62944140|FG000|6 Months Follow up|Lost to Follow-up|11|||
33551671|NCT01338493|62944140|FG000|6 Months Follow up|Missed visit|8|||
33551672|NCT01338493|62944140|FG000|12 Months Follow up|Lost to Follow-up|9|||
33551673|NCT01362296|62944146|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
33551674|NCT01362296|62944147|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
33551675|NCT01362296|62944148|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
33551676|NCT01362296|62944149|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
33551677|NCT01362296|62944146|FG000|Randomized Phase (RP)|Physician Decision|1|||
33551678|NCT01362296|62944147|FG001|Randomized Phase (RP)|Physician Decision|9|||
33551679|NCT01362296|62944148|FG002|Randomized Phase (RP)|Physician Decision|0|||
33551680|NCT01362296|62944149|FG003|Randomized Phase (RP)|Physician Decision|0|||
33551681|NCT01362296|62944146|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
33551682|NCT01362296|62944147|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
33551683|NCT01362296|62944148|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
33551684|NCT01362296|62944149|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
33551685|NCT01362296|62944146|FG000|Randomized Phase (RP)|Adverse Event|20|||
33656461|NCT01865747|63075672|FG000|Overall Study (ITT)|Progressive Disease|122|||
33656462|NCT01865747|63075673|FG001|Overall Study (ITT)|Progressive Disease|158|||
33656463|NCT01865747|63075672|FG000|Overall Study (ITT)|Reason Not Provided|0|||
33656464|NCT01865747|63075673|FG001|Overall Study (ITT)|Reason Not Provided|1|||
33656465|NCT01865747|63075672|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
33656466|NCT01865747|63075673|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
33656467|NCT01865747|63075672|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
33656468|NCT01865747|63075673|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
33656469|NCT01865747|63075672|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
33656470|NCT01865747|63075673|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
33656471|NCT01865747|63075672|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
33656472|NCT01865747|63075673|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
33480727|NCT02993926|62857168|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
33656473|NCT01865747|63075672|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
33656474|NCT01865747|63075673|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
33656475|NCT01865747|63075672|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
33656476|NCT01865747|63075673|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
33656477|NCT01865747|63075672|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
33656478|NCT01865747|63075673|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
33656479|NCT01865747|63075672|FG000|Primary Intent to Treat (PITT)|Other|0|||
33656480|NCT01865747|63075673|FG001|Primary Intent to Treat (PITT)|Other|1|||
33656481|NCT01843673|63075714|FG000|Overall Study|Lack of Efficacy|2|||
33656482|NCT01843673|63075714|FG000|Overall Study|Withdrawal by Subject|4|||
33656483|NCT01843205|63075733|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
33656484|NCT01843205|63075734|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
33656485|NCT01835015|63075821|FG000|Overall Study|Adverse Event|0|||
33656486|NCT01835015|63075822|FG001|Overall Study|Adverse Event|0|||
33656487|NCT01835015|63075823|FG002|Overall Study|Adverse Event|1|||
33656488|NCT01835015|63075824|FG003|Overall Study|Adverse Event|0|||
33656489|NCT01835015|63075825|FG004|Overall Study|Adverse Event|0|||
33656490|NCT01842581|63075853|FG000|Overall Study|Adverse Event|6|||
33656491|NCT01842581|63075854|FG001|Overall Study|Adverse Event|4|||
33656492|NCT01842581|63075853|FG000|Overall Study|HE breakthrough|26|||
33656493|NCT01842581|63075854|FG001|Overall Study|HE breakthrough|13|||
33656494|NCT01842581|63075853|FG000|Overall Study|Liver transplant|2|||
33656495|NCT01842581|63075854|FG001|Overall Study|Liver transplant|0|||
33656496|NCT01842581|63075853|FG000|Overall Study|Lost to Follow-up|2|||
33656497|NCT01842581|63075854|FG001|Overall Study|Lost to Follow-up|5|||
33480728|NCT02993926|62857169|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
33480729|NCT02993926|62857170|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
33551686|NCT01362296|62944147|FG001|Randomized Phase (RP)|Adverse Event|4|||
33551687|NCT01362296|62944148|FG002|Randomized Phase (RP)|Adverse Event|0|||
33480730|NCT02993224|62857180|FG000|Core Phase - Period 1|Adverse Event|4|||
33551688|NCT01362296|62944149|FG003|Randomized Phase (RP)|Adverse Event|0|||
33551689|NCT01362296|62944146|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
33656498|NCT01842581|63075853|FG000|Overall Study|Withdrawal by Subject|5|||
33656499|NCT01842581|63075854|FG001|Overall Study|Withdrawal by Subject|7|||
33656500|NCT01842581|63075853|FG000|Overall Study|Other than specified|3|||
33480731|NCT02993224|62857180|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
33480732|NCT02993224|62857180|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
33480733|NCT02993224|62857180|FG000|Core Phase- Period 2|Adverse Event|1|||
33480734|NCT02993224|62857180|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
33480735|NCT02993224|62857180|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
33480736|NCT02993224|62857180|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
33480737|NCT02993224|62857180|FG000|Extension Phase|Adverse Event|3|||
33480738|NCT02993224|62857180|FG000|Extension Phase|Withdrawal by Subject|3|||
33480739|NCT02993224|62857180|FG000|Extension Phase|Lost to Follow-up|2|||
33480740|NCT02993224|62857180|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
33480741|NCT03495908|62857188|FG000|Overall Study|Withdrawal by Subject|3|||
33480742|NCT03495908|62857189|FG001|Overall Study|Withdrawal by Subject|1|||
33480743|NCT03495908|62857188|FG000|Overall Study|Lost to Follow-up|1|||
33480744|NCT03495908|62857189|FG001|Overall Study|Lost to Follow-up|4|||
33480745|NCT03495908|62857188|FG000|Overall Study|Adverse Event|0|||
33551690|NCT01362296|62944147|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
33551691|NCT01362296|62944148|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
33551692|NCT01362296|62944149|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
33551693|NCT01362296|62944146|FG000|Crossover Phase|PD including Death due to PD|0|||
33551694|NCT01362296|62944147|FG001|Crossover Phase|PD including Death due to PD|0|||
33551695|NCT01362296|62944148|FG002|Crossover Phase|PD including Death due to PD|16|||
33551696|NCT01362296|62944149|FG003|Crossover Phase|PD including Death due to PD|1|||
33480746|NCT03495908|62857189|FG001|Overall Study|Adverse Event|2|||
33480747|NCT03495908|62857188|FG000|Overall Study|Death|1|||
33480748|NCT03495908|62857189|FG001|Overall Study|Death|0|||
33480749|NCT03495908|62857188|FG000|Overall Study|Physician Decision|5|||
33480750|NCT03495908|62857189|FG001|Overall Study|Physician Decision|4|||
33480751|NCT03495908|62857188|FG000|Overall Study|No documented reason|0|||
33480752|NCT03495908|62857189|FG001|Overall Study|No documented reason|2|||
33480753|NCT02992288|62857201|FG000|Overall Study|Adverse Event|8|||
33480754|NCT02992288|62857202|FG001|Overall Study|Adverse Event|2|||
33480755|NCT02992288|62857203|FG002|Overall Study|Adverse Event|2|||
33480756|NCT02992288|62857204|FG003|Overall Study|Adverse Event|2|||
33551697|NCT01362296|62944146|FG000|Crossover Phase|Withdrawal by Subject|0|||
33551698|NCT01362296|62944147|FG001|Crossover Phase|Withdrawal by Subject|0|||
33656501|NCT01842581|63075854|FG001|Overall Study|Other than specified|1|||
33480757|NCT02992288|62857205|FG004|Overall Study|Adverse Event|2|||
33480758|NCT02992288|62857206|FG005|Overall Study|Adverse Event|7|||
33480759|NCT02992288|62857201|FG000|Overall Study|Non-compliance with study drug|0|||
33480760|NCT02992288|62857202|FG001|Overall Study|Non-compliance with study drug|1|||
33480761|NCT02992288|62857203|FG002|Overall Study|Non-compliance with study drug|1|||
33480762|NCT02992288|62857204|FG003|Overall Study|Non-compliance with study drug|0|||
33480763|NCT02992288|62857205|FG004|Overall Study|Non-compliance with study drug|1|||
33480764|NCT02992288|62857206|FG005|Overall Study|Non-compliance with study drug|0|||
33480765|NCT02992288|62857201|FG000|Overall Study|Physician Decision|3|||
33480766|NCT02992288|62857202|FG001|Overall Study|Physician Decision|0|||
33480767|NCT02992288|62857203|FG002|Overall Study|Physician Decision|1|||
33480768|NCT02992288|62857204|FG003|Overall Study|Physician Decision|0|||
33480769|NCT02992288|62857205|FG004|Overall Study|Physician Decision|0|||
33480770|NCT02992288|62857206|FG005|Overall Study|Physician Decision|1|||
33480771|NCT02992288|62857201|FG000|Overall Study|Death|2|||
33480772|NCT02992288|62857202|FG001|Overall Study|Death|0|||
33480773|NCT02992288|62857203|FG002|Overall Study|Death|2|||
33480774|NCT02992288|62857204|FG003|Overall Study|Death|1|||
33480775|NCT02992288|62857205|FG004|Overall Study|Death|2|||
33480776|NCT02992288|62857206|FG005|Overall Study|Death|0|||
33480777|NCT02992288|62857201|FG000|Overall Study|Lost to Follow-up|0|||
33480778|NCT02992288|62857202|FG001|Overall Study|Lost to Follow-up|0|||
33480779|NCT02992288|62857203|FG002|Overall Study|Lost to Follow-up|0|||
33656502|NCT01833533|63075862|FG000|Overall Study|Adverse Event|0|||
33480780|NCT02992288|62857204|FG003|Overall Study|Lost to Follow-up|1|||
33480781|NCT02992288|62857205|FG004|Overall Study|Lost to Follow-up|0|||
33480782|NCT02992288|62857206|FG005|Overall Study|Lost to Follow-up|0|||
33480783|NCT02992288|62857201|FG000|Overall Study|Protocol Violation|0|||
33480784|NCT02992288|62857202|FG001|Overall Study|Protocol Violation|0|||
33480785|NCT02992288|62857203|FG002|Overall Study|Protocol Violation|0|||
33480786|NCT02992288|62857204|FG003|Overall Study|Protocol Violation|0|||
33480787|NCT02992288|62857205|FG004|Overall Study|Protocol Violation|0|||
33551699|NCT01362296|62944148|FG002|Crossover Phase|Withdrawal by Subject|2|||
33551700|NCT01362296|62944149|FG003|Crossover Phase|Withdrawal by Subject|1|||
33551701|NCT01362296|62944146|FG000|Crossover Phase|Adverse Event|0|||
33480788|NCT02992288|62857206|FG005|Overall Study|Protocol Violation|1|||
33480789|NCT02992288|62857201|FG000|Overall Study|Withdrawal by Subject|4|||
33480790|NCT02992288|62857202|FG001|Overall Study|Withdrawal by Subject|2|||
33480791|NCT02992288|62857203|FG002|Overall Study|Withdrawal by Subject|1|||
33480792|NCT02992288|62857204|FG003|Overall Study|Withdrawal by Subject|5|||
33480793|NCT02992288|62857205|FG004|Overall Study|Withdrawal by Subject|3|||
33480794|NCT02992288|62857206|FG005|Overall Study|Withdrawal by Subject|4|||
33480795|NCT02992132|62857223|FG000|Overall Study|Adverse Event|4|||
33480796|NCT02992132|62857224|FG001|Overall Study|Adverse Event|1|||
33480797|NCT02992132|62857225|FG002|Overall Study|Adverse Event|3|||
33480798|NCT02992132|62857223|FG000|Overall Study|Lack of Efficacy|2|||
33480799|NCT02992132|62857224|FG001|Overall Study|Lack of Efficacy|0|||
33480800|NCT02992132|62857225|FG002|Overall Study|Lack of Efficacy|0|||
33480801|NCT02992132|62857223|FG000|Overall Study|Non-compliance with study drug|2|||
33480802|NCT02992132|62857224|FG001|Overall Study|Non-compliance with study drug|0|||
33480803|NCT02992132|62857225|FG002|Overall Study|Non-compliance with study drug|0|||
33480804|NCT02992132|62857223|FG000|Overall Study|Progressive disease|1|||
33480805|NCT02992132|62857224|FG001|Overall Study|Progressive disease|0|||
33480806|NCT02992132|62857225|FG002|Overall Study|Progressive disease|0|||
33480807|NCT02992132|62857223|FG000|Overall Study|Protocol Violation|2|||
33480808|NCT02992132|62857224|FG001|Overall Study|Protocol Violation|2|||
33480809|NCT02992132|62857225|FG002|Overall Study|Protocol Violation|0|||
33480810|NCT02992132|62857223|FG000|Overall Study|Caregiver withdrew consent|2|||
33480811|NCT02992132|62857224|FG001|Overall Study|Caregiver withdrew consent|3|||
33480812|NCT02992132|62857225|FG002|Overall Study|Caregiver withdrew consent|2|||
33480813|NCT02992132|62857223|FG000|Overall Study|Withdrawal by Subject|0|||
33480814|NCT02992132|62857224|FG001|Overall Study|Withdrawal by Subject|2|||
33480815|NCT02992132|62857225|FG002|Overall Study|Withdrawal by Subject|1|||
33480816|NCT02992132|62857223|FG000|Overall Study|Physician Decision|0|||
33480817|NCT02992132|62857224|FG001|Overall Study|Physician Decision|0|||
33551702|NCT01362296|62944147|FG001|Crossover Phase|Adverse Event|0|||
33551703|NCT01362296|62944148|FG002|Crossover Phase|Adverse Event|4|||
33551704|NCT01362296|62944149|FG003|Crossover Phase|Adverse Event|0|||
33551705|NCT01362296|62944146|FG000|Crossover Phase|Study Closed/Terminated|0|||
33551706|NCT01362296|62944147|FG001|Crossover Phase|Study Closed/Terminated|0|||
33551707|NCT01362296|62944148|FG002|Crossover Phase|Study Closed/Terminated|1|||
33551708|NCT01362296|62944149|FG003|Crossover Phase|Study Closed/Terminated|0|||
33551709|NCT01338415|62944161|FG000|Core + Extension|Adverse Event|8|||
33551710|NCT01338415|62944162|FG001|Core + Extension|Adverse Event|6|||
33551711|NCT01338415|62944163|FG002|Core + Extension|Adverse Event|0|||
33551712|NCT01338415|62944161|FG000|Core + Extension|Withdrawal by Subject|1|||
33551713|NCT01338415|62944162|FG001|Core + Extension|Withdrawal by Subject|1|||
33551714|NCT01338415|62944163|FG002|Core + Extension|Withdrawal by Subject|0|||
33480818|NCT02992132|62857225|FG002|Overall Study|Physician Decision|1|||
33480819|NCT03444584|62857235|FG000|Overall Study|Withdrawal by Subject|0|||
33480820|NCT03444584|62857236|FG001|Overall Study|Withdrawal by Subject|1|||
33480821|NCT03444584|62857235|FG000|Overall Study|Other|0|||
33480822|NCT03444584|62857236|FG001|Overall Study|Other|1|||
33480823|NCT02989168|62857245|FG000|Overall Study|Withdrawal by Subject|2|||
33480824|NCT02989168|62857246|FG001|Overall Study|Withdrawal by Subject|0|||
33480825|NCT02989168|62857245|FG000|Overall Study|Physician Decision|0|||
33551715|NCT01338415|62944161|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
33551716|NCT01338415|62944162|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
33551717|NCT01338415|62944163|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
33364674|NCT02393248|62743306|FG003|Part 3: Combination Therapy|Death|0|||
33364675|NCT02393248|62743307|FG004|Part 3: Combination Therapy|Death|0|||
33364676|NCT02393248|62743308|FG005|Part 3: Combination Therapy|Death|0|||
33364677|NCT02393248|62743309|FG006|Part 3: Combination Therapy|Death|0|||
33364678|NCT02393248|62743310|FG007|Part 3: Combination Therapy|Death|0|||
33480826|NCT02989168|62857246|FG001|Overall Study|Physician Decision|1|||
33480827|NCT02989168|62857245|FG000|Overall Study|Adverse Event|1|||
33480828|NCT02989168|62857246|FG001|Overall Study|Adverse Event|2|||
33480829|NCT02989168|62857245|FG000|Overall Study|Sponsor stopped study.|1|||
33480830|NCT02989168|62857246|FG001|Overall Study|Sponsor stopped study.|0|||
33480831|NCT02988622|62857254|FG000|Overall Study|Lost to Follow-up|17|||
33480832|NCT03412604|62857260|FG000|Overall Study|Withdrawal by Subject|1|||
33480833|NCT02991430|62857267|FG000|Treatment Period 1|Adverse Event|1|||
33480834|NCT02991430|62857268|FG001|Treatment Period 1|Adverse Event|0|||
33480835|NCT02991430|62857269|FG002|Treatment Period 1|Adverse Event|2|||
33480836|NCT02991430|62857267|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33480837|NCT02991430|62857268|FG001|Treatment Period 1|Withdrawal by Subject|4|||
33480838|NCT02991430|62857269|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33480839|NCT02991430|62857267|FG000|Treatment Period 2|Study Termination|6|||
33480840|NCT02991430|62857268|FG001|Treatment Period 2|Study Termination|3|||
33480841|NCT02991430|62857269|FG002|Treatment Period 2|Study Termination|3|||
33480842|NCT02991430|62857267|FG000|Treatment Period 2|Lost to Follow-up|0|||
33551718|NCT01338415|62944161|FG000|Core + Extension|Other (administrative reason)|1|||
33551719|NCT01338415|62944162|FG001|Core + Extension|Other (administrative reason)|0|||
33551720|NCT01338415|62944163|FG002|Core + Extension|Other (administrative reason)|0|||
33364679|NCT02393248|62743311|FG008|Part 3: Combination Therapy|Death|0|||
33480843|NCT02991430|62857268|FG001|Treatment Period 2|Lost to Follow-up|0|||
33480844|NCT02991430|62857269|FG002|Treatment Period 2|Lost to Follow-up|1|||
33364680|NCT02393248|62743312|FG009|Part 3: Combination Therapy|Death|0|||
33480845|NCT02991430|62857267|FG000|Post-treatment Observation Period|Study Termination|3|||
33480846|NCT02991430|62857268|FG001|Post-treatment Observation Period|Study Termination|6|||
33480847|NCT02991430|62857269|FG002|Post-treatment Observation Period|Study Termination|5|||
33480848|NCT03411902|62857279|FG000|Overall Study|Lost to Follow-up|3|||
33480849|NCT03411902|62857280|FG001|Overall Study|Lost to Follow-up|0|||
33480850|NCT03494816|62857286|FG000|Overall Study|Protocol Violation|2|||
33480851|NCT03494816|62857286|FG000|Overall Study|Physician Decision|2|||
33480852|NCT03494816|62857286|FG000|Overall Study|Did not start trial treatment|1|||
33480853|NCT03494816|62857286|FG000|Overall Study|Adverse Event|1|||
33480854|NCT03492554|62857296|FG000|Overall Study|Protocol Violation|0|||
33480855|NCT03492554|62857297|FG001|Overall Study|Protocol Violation|14|||
33480856|NCT04936334|62857342|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
33480857|NCT04822597|62857352|FG000|Overall Study|Withdrawal by Subject|0|||
33480858|NCT04822597|62857353|FG001|Overall Study|Withdrawal by Subject|1|||
33480859|NCT04822597|62857354|FG002|Overall Study|Withdrawal by Subject|1|||
33480860|NCT04822597|62857355|FG003|Overall Study|Withdrawal by Subject|0|||
33480861|NCT04822597|62857352|FG000|Overall Study|Physician Decision|0|||
33480862|NCT04822597|62857353|FG001|Overall Study|Physician Decision|0|||
33480863|NCT04822597|62857354|FG002|Overall Study|Physician Decision|1|||
33480864|NCT04822597|62857355|FG003|Overall Study|Physician Decision|1|||
33551721|NCT01338415|62944161|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
33551722|NCT01338415|62944162|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
33551723|NCT01338415|62944163|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
33551724|NCT01338415|62944161|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
33551725|NCT01338415|62944162|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
33551726|NCT01338415|62944163|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
33551727|NCT01338415|62944161|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
33551728|NCT01338415|62944162|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
33551729|NCT01338415|62944163|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
33551730|NCT01338415|62944161|FG000|Exceptional Use Treatment Period|Death|0|||
33656503|NCT01833533|63075863|FG001|Overall Study|Adverse Event|1|||
33364681|NCT02393248|62743313|FG010|Part 3: Combination Therapy|Death|0|||
33364682|NCT02393248|62743314|FG011|Part 3: Combination Therapy|Death|0|||
33364683|NCT02393248|62743315|FG012|Part 3: Combination Therapy|Death|0|||
33364684|NCT02393248|62743316|FG013|Part 3: Combination Therapy|Death|0|||
33364685|NCT02393248|62743317|FG014|Part 3: Combination Therapy|Death|0|||
33480865|NCT04822597|62857352|FG000|Overall Study|Subject withdrawn after enrollment|0|||
33480866|NCT04822597|62857353|FG001|Overall Study|Subject withdrawn after enrollment|1|||
33480867|NCT04822597|62857354|FG002|Overall Study|Subject withdrawn after enrollment|0|||
33480868|NCT04822597|62857355|FG003|Overall Study|Subject withdrawn after enrollment|1|||
33364686|NCT02393248|62743318|FG015|Part 3: Combination Therapy|Death|1|||
33364687|NCT02393248|62743319|FG016|Part 3: Combination Therapy|Death|7|||
33364688|NCT02393248|62743320|FG017|Part 3: Combination Therapy|Death|5|||
33364689|NCT02393248|62743321|FG018|Part 3: Combination Therapy|Death|5|||
33364690|NCT02393248|62743322|FG019|Part 3: Combination Therapy|Death|3|||
33364691|NCT02393248|62743323|FG020|Part 3: Combination Therapy|Death|7|||
33364692|NCT02393248|62743324|FG021|Part 3: Combination Therapy|Death|5|||
33364693|NCT02393248|62743325|FG022|Part 3: Combination Therapy|Death|6|||
33364694|NCT02393248|62743326|FG023|Part 3: Combination Therapy|Death|3|||
33364695|NCT02393248|62743327|FG024|Part 3: Combination Therapy|Death|0|||
33364696|NCT02393248|62743303|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33480869|NCT04822597|62857352|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
33480870|NCT04822597|62857353|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
33480871|NCT04822597|62857354|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
33480872|NCT04822597|62857355|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
33480873|NCT04639245|62857365|FG000|Overall Study|Death|1|||
33480874|NCT04599465|62857369|FG000|Overall Study|Physician Decision|1|||
33480875|NCT04599465|62857369|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
33364697|NCT02393248|62743304|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33364698|NCT02393248|62743305|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33480876|NCT04104646|62857416|FG000|Overall Study|Withdrawal by Subject|1|||
33480877|NCT04104646|62857417|FG001|Overall Study|Withdrawal by Subject|1|||
33480878|NCT04104646|62857416|FG000|Overall Study|Lost to Follow-up|1|||
33480879|NCT04104646|62857417|FG001|Overall Study|Lost to Follow-up|0|||
33480880|NCT04104646|62857416|FG000|Overall Study|Physician Decision|2|||
33480881|NCT04104646|62857417|FG001|Overall Study|Physician Decision|0|||
33480882|NCT03919669|62857428|FG000|Overall Study|Withdrawal by Subject|1|||
33480883|NCT03919669|62857429|FG001|Overall Study|Withdrawal by Subject|0|||
33480884|NCT03919669|62857430|FG002|Overall Study|Withdrawal by Subject|0|||
33480885|NCT03772665|62857441|FG000|Overall Study|Protocol Violation|1|||
33480886|NCT03772665|62857442|FG001|Overall Study|Protocol Violation|0|||
33480887|NCT03594110|62857459|FG000|Overall Study|Participant concerned about study treatment|23|||
33480888|NCT03594110|62857460|FG001|Overall Study|Participant concerned about study treatment|28|||
33364699|NCT02393248|62743306|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33364700|NCT02393248|62743307|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33364701|NCT02393248|62743308|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33364702|NCT02393248|62743309|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33364703|NCT02393248|62743310|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33364704|NCT02393248|62743311|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33364705|NCT02393248|62743312|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33364706|NCT02393248|62743313|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33364707|NCT02393248|62743314|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33364708|NCT02393248|62743315|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33364709|NCT02393248|62743316|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33480889|NCT03594110|62857459|FG000|Overall Study|Doctor advice|38|||
33551731|NCT01338415|62944162|FG001|Exceptional Use Treatment Period|Death|0|||
33551732|NCT01338415|62944163|FG002|Exceptional Use Treatment Period|Death|1|||
33551733|NCT05258149|62944173|FG000|Period 1|Protocol Deviation|1|||
33551734|NCT05258149|62944174|FG001|Period 1|Protocol Deviation|0|||
33551735|NCT05258149|62944173|FG000|Period 1|Adverse Event|0|||
33551736|NCT05258149|62944174|FG001|Period 1|Adverse Event|1|||
33551737|NCT05258149|62944173|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
33551738|NCT05258149|62944174|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
33551739|NCT05258149|62944173|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
33551740|NCT05258149|62944174|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
33551741|NCT05258149|62944173|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
33551742|NCT05258149|62944174|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
33551743|NCT01371643|62944182|FG000|Overall Study|Withdrawal by Subject|3|||
33551744|NCT01371643|62944183|FG001|Overall Study|Withdrawal by Subject|0|||
33551745|NCT01371565|62944189|FG000|Overall Study|Withdrawal by Subject|1|||
33551746|NCT01371565|62944189|FG000|Overall Study|Death|1|||
33551747|NCT01371565|62944189|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
33551748|NCT02821819|62944197|FG000|Overall Study|Protocol Violation|1|||
33580920|NCT01439282|62978066|FG000|Overall Study|Withdrawal by Subject|2|||
33580921|NCT01439282|62978067|FG001|Overall Study|Withdrawal by Subject|0|||
33580922|NCT01439282|62978066|FG000|Overall Study|Other|1|||
33364710|NCT02393248|62743317|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33364711|NCT02393248|62743318|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33364712|NCT02393248|62743319|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33364713|NCT02393248|62743320|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
33364714|NCT02393248|62743321|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
33364715|NCT02393248|62743322|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33364716|NCT02393248|62743323|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
33480890|NCT03594110|62857460|FG001|Overall Study|Doctor advice|40|||
33480891|NCT03594110|62857459|FG000|Overall Study|Participants' wish|89|||
33480892|NCT03594110|62857460|FG001|Overall Study|Participants' wish|68|||
33480893|NCT03594110|62857459|FG000|Overall Study|Adverse Event|119|||
33480894|NCT03594110|62857460|FG001|Overall Study|Adverse Event|116|||
33480895|NCT03594110|62857459|FG000|Overall Study|Study drug stopped, reason missing|337|||
33480896|NCT03594110|62857460|FG001|Overall Study|Study drug stopped, reason missing|295|||
33480897|NCT03594110|62857459|FG000|Overall Study|Cannot attend clinic because of personal problems|8|||
33480898|NCT03594110|62857460|FG001|Overall Study|Cannot attend clinic because of personal problems|16|||
33480899|NCT03594110|62857459|FG000|Overall Study|Cannot attend clinic because moving out of the area|15|||
33480900|NCT03594110|62857460|FG001|Overall Study|Cannot attend clinic because moving out of the area|9|||
33480901|NCT03594110|62857459|FG000|Overall Study|Contraindicated drug started|32|||
33480902|NCT03594110|62857460|FG001|Overall Study|Contraindicated drug started|18|||
33480903|NCT03594110|62857459|FG000|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|58|||
33480904|NCT03594110|62857460|FG001|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|45|||
33480905|NCT03594110|62857459|FG000|Overall Study|Death|129|||
33480906|NCT03594110|62857460|FG001|Overall Study|Death|120|||
33480907|NCT03057054|62857489|FG000|Overall Study|Death|4|||
33480908|NCT03057054|62857490|FG001|Overall Study|Death|4|||
33480909|NCT03057054|62857489|FG000|Overall Study|Withdrawal by Subject|6|||
33480910|NCT03057054|62857490|FG001|Overall Study|Withdrawal by Subject|3|||
33480911|NCT03057054|62857489|FG000|Overall Study|Ineligible|1|||
33480912|NCT03057054|62857490|FG001|Overall Study|Ineligible|1|||
33480913|NCT03024996|62857498|FG000|Overall Study|Death|57|||
33480914|NCT03024996|62857499|FG001|Overall Study|Death|55|||
33480915|NCT03024996|62857498|FG000|Overall Study|Disease relapse|1|||
33480916|NCT03024996|62857499|FG001|Overall Study|Disease relapse|0|||
33480917|NCT03024996|62857498|FG000|Overall Study|Lost to Follow-up|5|||
33480918|NCT03024996|62857499|FG001|Overall Study|Lost to Follow-up|10|||
33480919|NCT03024996|62857498|FG000|Overall Study|Other|3|||
33480920|NCT03024996|62857499|FG001|Overall Study|Other|3|||
33480921|NCT03024996|62857498|FG000|Overall Study|Physician Decision|0|||
33480922|NCT03024996|62857499|FG001|Overall Study|Physician Decision|1|||
33480923|NCT03024996|62857498|FG000|Overall Study|Study terminated by sponsor|303|||
33480924|NCT03024996|62857499|FG001|Overall Study|Study terminated by sponsor|283|||
33480925|NCT03024996|62857498|FG000|Overall Study|Withdrawal by Subject|21|||
33480926|NCT03024996|62857499|FG001|Overall Study|Withdrawal by Subject|36|||
33480927|NCT02967692|62857509|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
33480928|NCT02967692|62857510|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
33480929|NCT02967692|62857511|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
33480930|NCT02967692|62857512|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
33480931|NCT02967692|62857509|FG000|Overall Study|Progressive disease|3|||
33480932|NCT02967692|62857510|FG001|Overall Study|Progressive disease|15|||
33480933|NCT02967692|62857511|FG002|Overall Study|Progressive disease|99|||
33480934|NCT02967692|62857512|FG003|Overall Study|Progressive disease|128|||
33480935|NCT02967692|62857509|FG000|Overall Study|Subject/guardian decision|1|||
33480936|NCT02967692|62857510|FG001|Overall Study|Subject/guardian decision|1|||
33480937|NCT02967692|62857511|FG002|Overall Study|Subject/guardian decision|6|||
33480938|NCT02967692|62857512|FG003|Overall Study|Subject/guardian decision|13|||
33480939|NCT02967692|62857509|FG000|Overall Study|Death|0|||
33480940|NCT02967692|62857510|FG001|Overall Study|Death|1|||
33480941|NCT02967692|62857511|FG002|Overall Study|Death|10|||
33480942|NCT02967692|62857512|FG003|Overall Study|Death|9|||
33551749|NCT03926611|62944208|FG000|Overall Study|Adverse Event|0|||
33551750|NCT03926611|62944209|FG001|Overall Study|Adverse Event|0|||
33551751|NCT03926611|62944210|FG002|Overall Study|Adverse Event|0|||
33551752|NCT03926611|62944211|FG003|Overall Study|Adverse Event|3|||
33551753|NCT03926611|62944212|FG004|Overall Study|Adverse Event|1|||
33551754|NCT03926611|62944213|FG005|Overall Study|Adverse Event|3|||
33551755|NCT03926611|62944214|FG006|Overall Study|Adverse Event|0|||
33551756|NCT03926611|62944208|FG000|Overall Study|Lack of Efficacy|1|||
33656504|NCT01833533|63075862|FG000|Overall Study|Lost to Follow-up|4|||
33656505|NCT01833533|63075863|FG001|Overall Study|Lost to Follow-up|9|||
33656506|NCT01833533|63075862|FG000|Overall Study|To Enter an Extension Study|0|||
33480943|NCT02967692|62857509|FG000|Overall Study|Protocol deviation|1|||
33480944|NCT02967692|62857510|FG001|Overall Study|Protocol deviation|0|||
33480945|NCT02967692|62857511|FG002|Overall Study|Protocol deviation|1|||
33480946|NCT02967692|62857512|FG003|Overall Study|Protocol deviation|1|||
33480947|NCT02967692|62857509|FG000|Overall Study|Lost to Follow-up|0|||
33480948|NCT02967692|62857510|FG001|Overall Study|Lost to Follow-up|0|||
33480949|NCT02967692|62857511|FG002|Overall Study|Lost to Follow-up|1|||
33480950|NCT02967692|62857512|FG003|Overall Study|Lost to Follow-up|0|||
33480951|NCT02967692|62857509|FG000|Overall Study|Physician Decision|0|||
33480952|NCT02967692|62857510|FG001|Overall Study|Physician Decision|0|||
33480953|NCT02967692|62857511|FG002|Overall Study|Physician Decision|13|||
33480954|NCT02967692|62857512|FG003|Overall Study|Physician Decision|9|||
33480955|NCT02967692|62857509|FG000|Overall Study|Adverse Event|1|||
33480956|NCT02967692|62857510|FG001|Overall Study|Adverse Event|9|||
33480957|NCT02967692|62857511|FG002|Overall Study|Adverse Event|51|||
33480958|NCT02967692|62857512|FG003|Overall Study|Adverse Event|23|||
33480959|NCT02642965|62857548|FG000|Overall Study|Lack of Efficacy|4|||
33480960|NCT02642965|62857548|FG000|Overall Study|Physician Decision|9|||
33656507|NCT01833533|63075863|FG001|Overall Study|To Enter an Extension Study|4|||
33656508|NCT01833533|63075862|FG000|Overall Study|Other|2|||
33480963|NCT01320085|62857586|FG000|Overall Study|Treatment Ongoing|0|||
33480964|NCT01320085|62857587|FG001|Overall Study|Treatment Ongoing|13|||
33480965|NCT01320085|62857588|FG002|Overall Study|Treatment Ongoing|2|||
33480966|NCT01320085|62857586|FG000|Overall Study|Disease Progression|26|||
33551757|NCT03926611|62944209|FG001|Overall Study|Lack of Efficacy|2|||
33480967|NCT01320085|62857587|FG001|Overall Study|Disease Progression|86|||
33480968|NCT01320085|62857588|FG002|Overall Study|Disease Progression|16|||
33480969|NCT01320085|62857586|FG000|Overall Study|Adverse Event|12|||
33480970|NCT01320085|62857587|FG001|Overall Study|Adverse Event|14|||
33480971|NCT01320085|62857588|FG002|Overall Study|Adverse Event|5|||
33480972|NCT01320085|62857586|FG000|Overall Study|Withdrawal by Subject|2|||
33551758|NCT03926611|62944210|FG002|Overall Study|Lack of Efficacy|0|||
33551759|NCT03926611|62944211|FG003|Overall Study|Lack of Efficacy|0|||
33551760|NCT03926611|62944212|FG004|Overall Study|Lack of Efficacy|1|||
33480973|NCT01320085|62857587|FG001|Overall Study|Withdrawal by Subject|4|||
33480974|NCT01320085|62857588|FG002|Overall Study|Withdrawal by Subject|1|||
33480975|NCT01320085|62857586|FG000|Overall Study|Protocol Deviation|1|||
33480976|NCT01320085|62857587|FG001|Overall Study|Protocol Deviation|0|||
33480977|NCT01320085|62857588|FG002|Overall Study|Protocol Deviation|1|||
33480978|NCT01038778|62857611|FG000|Overall Study|Withdrawal by Subject|0|||
33480979|NCT01038778|62857612|FG001|Overall Study|Withdrawal by Subject|2|||
33480980|NCT01038778|62857613|FG002|Overall Study|Withdrawal by Subject|3|||
33480981|NCT03443414|62857640|FG000|Overall Study|Adverse Event|6|||
33480982|NCT03443414|62857641|FG001|Overall Study|Adverse Event|0|||
33551761|NCT03926611|62944213|FG005|Overall Study|Lack of Efficacy|0|||
33551762|NCT03926611|62944214|FG006|Overall Study|Lack of Efficacy|1|||
33551763|NCT03926611|62944208|FG000|Overall Study|Physician Decision|0|||
33551764|NCT03926611|62944209|FG001|Overall Study|Physician Decision|0|||
33551765|NCT03926611|62944210|FG002|Overall Study|Physician Decision|0|||
33551766|NCT03926611|62944211|FG003|Overall Study|Physician Decision|0|||
33480983|NCT03443414|62857642|FG002|Overall Study|Adverse Event|4|||
33480984|NCT03443414|62857643|FG003|Overall Study|Adverse Event|2|||
33480985|NCT03443414|62857644|FG004|Overall Study|Adverse Event|3|||
33480986|NCT03443414|62857640|FG000|Overall Study|Withdrawal by Subject|3|||
33480987|NCT03443414|62857641|FG001|Overall Study|Withdrawal by Subject|2|||
33480988|NCT03443414|62857642|FG002|Overall Study|Withdrawal by Subject|2|||
33480989|NCT03443414|62857643|FG003|Overall Study|Withdrawal by Subject|2|||
33480990|NCT03443414|62857644|FG004|Overall Study|Withdrawal by Subject|1|||
33480991|NCT03443414|62857640|FG000|Overall Study|Death|0|||
33480992|NCT03443414|62857641|FG001|Overall Study|Death|1|||
33480993|NCT03443414|62857642|FG002|Overall Study|Death|0|||
33480994|NCT03443414|62857643|FG003|Overall Study|Death|1|||
33480995|NCT03443414|62857644|FG004|Overall Study|Death|0|||
33480996|NCT03443414|62857640|FG000|Overall Study|Reason not specified|2|||
33480997|NCT03443414|62857641|FG001|Overall Study|Reason not specified|0|||
33480998|NCT03443414|62857642|FG002|Overall Study|Reason not specified|0|||
33480999|NCT03443414|62857643|FG003|Overall Study|Reason not specified|0|||
33481000|NCT03443414|62857644|FG004|Overall Study|Reason not specified|1|||
33551767|NCT03926611|62944212|FG004|Overall Study|Physician Decision|0|||
33551768|NCT03926611|62944213|FG005|Overall Study|Physician Decision|1|||
33551769|NCT03926611|62944214|FG006|Overall Study|Physician Decision|0|||
33551770|NCT03926611|62944208|FG000|Overall Study|Protocol Violation|1|||
33551771|NCT03926611|62944209|FG001|Overall Study|Protocol Violation|0|||
33551772|NCT03926611|62944210|FG002|Overall Study|Protocol Violation|0|||
33481001|NCT02991118|62857658|FG000|Overall Study|Death|3|||
33551773|NCT03926611|62944211|FG003|Overall Study|Protocol Violation|1|||
33551774|NCT03926611|62944212|FG004|Overall Study|Protocol Violation|1|||
33551775|NCT03926611|62944213|FG005|Overall Study|Protocol Violation|1|||
33551776|NCT03926611|62944214|FG006|Overall Study|Protocol Violation|1|||
33481002|NCT02991118|62857659|FG001|Overall Study|Death|8|||
33481003|NCT02991118|62857658|FG000|Overall Study|Protocol Violation|0|||
33481004|NCT02991118|62857659|FG001|Overall Study|Protocol Violation|3|||
33481005|NCT02991118|62857658|FG000|Overall Study|Physician Decision|0|||
33481006|NCT02991118|62857659|FG001|Overall Study|Physician Decision|1|||
33481007|NCT02991118|62857658|FG000|Overall Study|Moved out of the country|0|||
33481008|NCT02991118|62857659|FG001|Overall Study|Moved out of the country|1|||
33481009|NCT02991118|62857658|FG000|Overall Study|Adverse Event|2|||
33481010|NCT02991118|62857659|FG001|Overall Study|Adverse Event|2|||
33481011|NCT02991118|62857658|FG000|Overall Study|Withdrawal by Subject|1|||
33481012|NCT02991118|62857659|FG001|Overall Study|Withdrawal by Subject|7|||
33481013|NCT02991118|62857658|FG000|Overall Study|Could not attend study visits|0|||
33481014|NCT02991118|62857659|FG001|Overall Study|Could not attend study visits|1|||
33481015|NCT02991118|62857658|FG000|Overall Study|Lost to Follow-up|1|||
33481016|NCT02991118|62857659|FG001|Overall Study|Lost to Follow-up|9|||
33481017|NCT03491150|62857667|FG000|Overall Study|Adverse Event|1|||
33481018|NCT03491150|62857668|FG001|Overall Study|Adverse Event|0|||
33481019|NCT03491150|62857667|FG000|Overall Study|Study Terminated by Sponsor|74|||
33551777|NCT03926611|62944208|FG000|Overall Study|Technical problems|0|||
33481020|NCT03491150|62857668|FG001|Overall Study|Study Terminated by Sponsor|70|||
33481021|NCT03491150|62857667|FG000|Overall Study|Other|0|||
33481022|NCT03491150|62857668|FG001|Overall Study|Other|1|||
33481023|NCT03491150|62857667|FG000|Overall Study|Withdrawal by Subject|1|||
33481024|NCT03491150|62857668|FG001|Overall Study|Withdrawal by Subject|2|||
33551778|NCT03926611|62944209|FG001|Overall Study|Technical problems|0|||
33481025|NCT02991040|62857674|FG000|Overall Study|Withdrawal by Subject|2|||
33481026|NCT02991040|62857674|FG000|Overall Study|Lost to Follow-up|2|||
33481027|NCT02910466|62857680|FG000|Overall Study|Adverse Event|1|||
33551779|NCT03926611|62944210|FG002|Overall Study|Technical problems|0|||
33551780|NCT03926611|62944211|FG003|Overall Study|Technical problems|0|||
33481028|NCT02910466|62857680|FG000|Overall Study|Withdrawal by Subject|3|||
33481029|NCT02910466|62857680|FG000|Overall Study|Lost to Follow-up|5|||
33481030|NCT02910466|62857680|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
33551781|NCT03926611|62944212|FG004|Overall Study|Technical problems|0|||
33481031|NCT02910466|62857680|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
33481032|NCT03415178|62857686|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
33481033|NCT03415178|62857687|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
33481034|NCT03415178|62857686|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
33481035|NCT03415178|62857687|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
33481036|NCT01068730|62857697|FG000|Period 3|Personal reason|1|||
33481037|NCT01068730|62857698|FG001|Period 3|Personal reason|0|||
33481038|NCT01068730|62857699|FG002|Period 3|Personal reason|0|||
33481039|NCT01068730|62857700|FG003|Period 3|Personal reason|0|||
33481040|NCT01068730|62857697|FG000|Period 4|Family emergency|0|||
33481041|NCT01068730|62857698|FG001|Period 4|Family emergency|1|||
33481042|NCT01068730|62857699|FG002|Period 4|Family emergency|0|||
33481043|NCT01068730|62857700|FG003|Period 4|Family emergency|0|||
33481044|NCT01068652|62857719|FG000|Overall Study|Adverse Event|4|||
33481045|NCT01068652|62857720|FG001|Overall Study|Adverse Event|0|||
33481046|NCT01068652|62857719|FG000|Overall Study|Lack of Efficacy|0|||
33481047|NCT01068652|62857720|FG001|Overall Study|Lack of Efficacy|2|||
33481048|NCT01068652|62857719|FG000|Overall Study|Lost to Follow-up|2|||
33481049|NCT01068652|62857720|FG001|Overall Study|Lost to Follow-up|1|||
33481050|NCT01068652|62857719|FG000|Overall Study|Protocol Violation|3|||
33481051|NCT01068652|62857720|FG001|Overall Study|Protocol Violation|6|||
33481052|NCT01068652|62857719|FG000|Overall Study|Withdrawal criteria|1|||
33481053|NCT01068652|62857720|FG001|Overall Study|Withdrawal criteria|2|||
33481054|NCT01068652|62857719|FG000|Overall Study|Patient was not eligible|1|||
33481055|NCT01068652|62857720|FG001|Overall Study|Patient was not eligible|0|||
33481056|NCT01068652|62857719|FG000|Overall Study|Unclassified|7|||
33481057|NCT01068652|62857720|FG001|Overall Study|Unclassified|4|||
33481058|NCT02921776|62857732|FG000|Overall Study|patient deterioration, fatigue|2|||
33481059|NCT02921776|62857733|FG001|Overall Study|patient deterioration, fatigue|6|||
33481060|NCT02921776|62857734|FG002|Overall Study|patient deterioration, fatigue|0|||
33481061|NCT02921776|62857735|FG003|Overall Study|patient deterioration, fatigue|0|||
33551782|NCT03926611|62944213|FG005|Overall Study|Technical problems|1|||
33551783|NCT03926611|62944214|FG006|Overall Study|Technical problems|0|||
33551784|NCT03926611|62944208|FG000|Overall Study|Withdrawal by Subject|1|||
33551785|NCT03926611|62944209|FG001|Overall Study|Withdrawal by Subject|1|||
33551786|NCT03926611|62944210|FG002|Overall Study|Withdrawal by Subject|1|||
33551787|NCT03926611|62944211|FG003|Overall Study|Withdrawal by Subject|0|||
33551788|NCT03926611|62944212|FG004|Overall Study|Withdrawal by Subject|0|||
33551789|NCT03926611|62944213|FG005|Overall Study|Withdrawal by Subject|1|||
33551790|NCT03926611|62944214|FG006|Overall Study|Withdrawal by Subject|3|||
33551791|NCT03926611|62944208|FG000|Overall Study|Covid-19 pandemic|0|||
33551792|NCT03926611|62944209|FG001|Overall Study|Covid-19 pandemic|0|||
33551793|NCT03926611|62944210|FG002|Overall Study|Covid-19 pandemic|1|||
33551794|NCT03926611|62944211|FG003|Overall Study|Covid-19 pandemic|0|||
33551795|NCT03926611|62944212|FG004|Overall Study|Covid-19 pandemic|1|||
33551796|NCT03926611|62944213|FG005|Overall Study|Covid-19 pandemic|2|||
33551797|NCT03926611|62944214|FG006|Overall Study|Covid-19 pandemic|0|||
33551798|NCT02818777|62944243|FG000|Overall Study|Adverse Event|3|||
33551799|NCT02817841|62944257|FG000|Overall Study|Lost to Follow-up|287|||
33551800|NCT02817841|62944257|FG000|Overall Study|Withdrawal by Subject|183|||
33551801|NCT02817841|62944257|FG000|Overall Study|Adverse event not related to bleeding|131|||
33551802|NCT02817841|62944257|FG000|Overall Study|Adverse event related to bleeding|51|||
33551803|NCT02817841|62944257|FG000|Overall Study|Pregnancy|32|||
33551804|NCT02817841|62944257|FG000|Overall Study|Pregnancy wish|17|||
33551805|NCT02817841|62944257|FG000|Overall Study|Other reasons|53|||
33551806|NCT02817841|62944257|FG000|Overall Study|Protocol Violation|94|||
33551807|NCT02814565|62944267|FG000|Overall Study|Lack of Efficacy|0|||
33656509|NCT01833533|63075863|FG001|Overall Study|Other|7|||
33481062|NCT02921776|62857736|FG004|Overall Study|patient deterioration, fatigue|0|||
33481063|NCT02921776|62857737|FG005|Overall Study|patient deterioration, fatigue|0|||
33551808|NCT02814565|62944268|FG001|Overall Study|Lack of Efficacy|1|||
33551809|NCT02814565|62944267|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
33656510|NCT01833455|63075871|FG000|Overall Study|Withdrawal by Subject|1|||
33481064|NCT02921776|62857738|FG006|Overall Study|patient deterioration, fatigue|0|||
33481065|NCT02921776|62857739|FG007|Overall Study|patient deterioration, fatigue|0|||
33481066|NCT02921776|62857732|FG000|Overall Study|Withdrawal by Subject|0|||
33481067|NCT02921776|62857733|FG001|Overall Study|Withdrawal by Subject|2|||
33481068|NCT02921776|62857734|FG002|Overall Study|Withdrawal by Subject|0|||
33551810|NCT02814565|62944268|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
33551811|NCT02650466|62944274|FG000|Overall Study|Physician Decision|1|||
33551812|NCT02650466|62944274|FG000|Overall Study|Withdrawal by Subject|5|||
33656511|NCT01833455|63075872|FG001|Overall Study|Withdrawal by Subject|0|||
33481069|NCT02921776|62857735|FG003|Overall Study|Withdrawal by Subject|1|||
33481070|NCT02921776|62857736|FG004|Overall Study|Withdrawal by Subject|1|||
33481071|NCT02921776|62857737|FG005|Overall Study|Withdrawal by Subject|0|||
33481072|NCT02921776|62857738|FG006|Overall Study|Withdrawal by Subject|8|||
33481073|NCT02921776|62857739|FG007|Overall Study|Withdrawal by Subject|1|||
33481074|NCT02921776|62857732|FG000|Overall Study|Death|0|||
33481075|NCT02921776|62857733|FG001|Overall Study|Death|0|||
33481076|NCT02921776|62857734|FG002|Overall Study|Death|0|||
33481077|NCT02921776|62857735|FG003|Overall Study|Death|2|||
33481078|NCT02921776|62857736|FG004|Overall Study|Death|0|||
33481079|NCT02921776|62857737|FG005|Overall Study|Death|0|||
33481080|NCT02921776|62857738|FG006|Overall Study|Death|0|||
33481081|NCT02921776|62857739|FG007|Overall Study|Death|0|||
33481082|NCT02921776|62857732|FG000|Overall Study|extubation or early discharge|0|||
33481083|NCT02921776|62857733|FG001|Overall Study|extubation or early discharge|0|||
33551813|NCT02650466|62944274|FG000|Overall Study|Lost to Follow-up|1|||
33551814|NCT02815735|62944280|FG000|First Intervention (4 Weeks)|Discomfort|1|||
33481084|NCT02921776|62857734|FG002|Overall Study|extubation or early discharge|0|||
33481085|NCT02921776|62857735|FG003|Overall Study|extubation or early discharge|5|||
33481086|NCT02921776|62857736|FG004|Overall Study|extubation or early discharge|5|||
33481087|NCT02921776|62857737|FG005|Overall Study|extubation or early discharge|0|||
33481088|NCT02921776|62857738|FG006|Overall Study|extubation or early discharge|0|||
33481089|NCT02921776|62857739|FG007|Overall Study|extubation or early discharge|0|||
33481090|NCT02921776|62857732|FG000|Overall Study|Lost to Follow-up|0|||
33551815|NCT02815735|62944281|FG001|First Intervention (4 Weeks)|Discomfort|0|||
33551816|NCT02815735|62944280|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
33551817|NCT02815735|62944281|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
33551818|NCT02815735|62944280|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
33551819|NCT02815735|62944281|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
33551820|NCT02815735|62944280|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
33551821|NCT02815735|62944281|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
33551822|NCT02814643|62944298|FG000|Overall Study|Lost to Follow-up|0|||
33551823|NCT02814643|62944299|FG001|Overall Study|Lost to Follow-up|1|||
33551824|NCT02814643|62944298|FG000|Overall Study|Withdrawal by Subject|1|||
33551825|NCT02814643|62944299|FG001|Overall Study|Withdrawal by Subject|2|||
33551826|NCT02724111|62944307|FG000|Overall Study|Protocol Violation|2|||
33551827|NCT02724111|62944308|FG001|Overall Study|Protocol Violation|5|||
33551828|NCT02649218|62944314|FG000|Overall Study|Adverse Event|8|||
33551829|NCT02649218|62944314|FG000|Overall Study|Lack of Efficacy|8|||
33551830|NCT02649218|62944314|FG000|Overall Study|Pregnancy|3|||
33481091|NCT02921776|62857733|FG001|Overall Study|Lost to Follow-up|0|||
33481092|NCT02921776|62857734|FG002|Overall Study|Lost to Follow-up|0|||
33481093|NCT02921776|62857735|FG003|Overall Study|Lost to Follow-up|0|||
33481094|NCT02921776|62857736|FG004|Overall Study|Lost to Follow-up|0|||
33481095|NCT02921776|62857737|FG005|Overall Study|Lost to Follow-up|2|||
33481096|NCT02921776|62857738|FG006|Overall Study|Lost to Follow-up|3|||
33656512|NCT01833143|63075890|FG000|Overall Study|Not Treated|1|||
33656513|NCT01841567|63075894|FG000|Overall Study|Adverse Event|3|||
33656514|NCT01833065|63075901|FG000|Overall Study|Adverse Event|6|||
33656515|NCT01833065|63075902|FG001|Overall Study|Adverse Event|1|||
33481097|NCT02921776|62857739|FG007|Overall Study|Lost to Follow-up|6|||
33481098|NCT02922634|62857763|FG000|Overall Study|Withdrawal by Subject|5|||
33481099|NCT02922634|62857763|FG000|Overall Study|Did not have their surgery|5|||
33481100|NCT00023595|62857779|FG000|5 Year Follow up|Lost to Follow-up|2|||
33481101|NCT00023595|62857780|FG001|5 Year Follow up|Lost to Follow-up|2|||
33481102|NCT00023595|62857781|FG002|5 Year Follow up|Lost to Follow-up|1|||
33481103|NCT00023595|62857782|FG003|5 Year Follow up|Lost to Follow-up|7|||
33481104|NCT00023595|62857783|FG004|5 Year Follow up|Lost to Follow-up|3|||
33656516|NCT01833065|63075903|FG002|Overall Study|Adverse Event|0|||
33656517|NCT01833065|63075904|FG003|Overall Study|Adverse Event|2|||
33481105|NCT00023595|62857779|FG000|10 Year Follow up|Lost to Follow-up|12|||
33656518|NCT01833065|63075905|FG004|Overall Study|Adverse Event|3|||
33656519|NCT01833065|63075901|FG000|Overall Study|Protocol Violation|1|||
33656520|NCT01833065|63075902|FG001|Overall Study|Protocol Violation|0|||
33481106|NCT00023595|62857780|FG001|10 Year Follow up|Lost to Follow-up|10|||
33481107|NCT00023595|62857781|FG002|10 Year Follow up|Lost to Follow-up|3|||
33551831|NCT02649218|62944314|FG000|Overall Study|Protocol Violation|3|||
33481108|NCT00023595|62857782|FG003|10 Year Follow up|Lost to Follow-up|0|||
33481109|NCT00023595|62857783|FG004|10 Year Follow up|Lost to Follow-up|0|||
33481110|NCT02920528|62857809|FG000|Overall Study|Incomplete Data|1|||
33481111|NCT02920528|62857810|FG001|Overall Study|Incomplete Data|1|||
33551832|NCT02649218|62944314|FG000|Overall Study|Physician Decision|1|||
33551833|NCT02649218|62944314|FG000|Overall Study|Withdrawal by Subject|2|||
33551834|NCT02814175|62944321|FG000|Part 1|Adverse Event|2|||
33551835|NCT02814175|62944322|FG001|Part 1|Adverse Event|3|||
33656521|NCT01833065|63075903|FG002|Overall Study|Protocol Violation|0|||
33551836|NCT02814175|62944323|FG002|Part 1|Adverse Event|0|||
33551837|NCT02814175|62944324|FG003|Part 1|Adverse Event|0|||
33551838|NCT02814175|62944325|FG004|Part 1|Adverse Event|0|||
33551839|NCT02814175|62944326|FG005|Part 1|Adverse Event|0|||
33551840|NCT02814175|62944321|FG000|Part 1|Withdrawal Consent|8|||
33551841|NCT02814175|62944322|FG001|Part 1|Withdrawal Consent|1|||
33551842|NCT02814175|62944323|FG002|Part 1|Withdrawal Consent|0|||
33551843|NCT02814175|62944324|FG003|Part 1|Withdrawal Consent|0|||
33551844|NCT02814175|62944325|FG004|Part 1|Withdrawal Consent|0|||
33551845|NCT02814175|62944326|FG005|Part 1|Withdrawal Consent|0|||
33551846|NCT02814175|62944321|FG000|Part 1|Lost to Follow-up|1|||
33656522|NCT01833065|63075904|FG003|Overall Study|Protocol Violation|0|||
33656523|NCT01833065|63075905|FG004|Overall Study|Protocol Violation|2|||
33656524|NCT01833065|63075901|FG000|Overall Study|Lost to Follow-up|1|||
33656525|NCT01833065|63075902|FG001|Overall Study|Lost to Follow-up|0|||
33656526|NCT01833065|63075903|FG002|Overall Study|Lost to Follow-up|0|||
33656527|NCT01833065|63075904|FG003|Overall Study|Lost to Follow-up|0|||
33656528|NCT01833065|63075905|FG004|Overall Study|Lost to Follow-up|3|||
33656529|NCT01833065|63075901|FG000|Overall Study|Withdrawal by Subject|6|||
33656530|NCT01833065|63075902|FG001|Overall Study|Withdrawal by Subject|2|||
33656531|NCT01833065|63075903|FG002|Overall Study|Withdrawal by Subject|4|||
33481112|NCT02920528|62857811|FG002|Overall Study|Incomplete Data|1|||
33656532|NCT01833065|63075904|FG003|Overall Study|Withdrawal by Subject|3|||
33656533|NCT01833065|63075905|FG004|Overall Study|Withdrawal by Subject|11|||
33656534|NCT01833065|63075901|FG000|Overall Study|Subject's substantial non-compliance|0|||
33656535|NCT01833065|63075902|FG001|Overall Study|Subject's substantial non-compliance|1|||
33656536|NCT01833065|63075903|FG002|Overall Study|Subject's substantial non-compliance|0|||
33656537|NCT01833065|63075904|FG003|Overall Study|Subject's substantial non-compliance|0|||
33656538|NCT01833065|63075905|FG004|Overall Study|Subject's substantial non-compliance|0|||
33656539|NCT01833065|63075901|FG000|Overall Study|Trial terminated by sponsor|8|||
33656540|NCT01833065|63075902|FG001|Overall Study|Trial terminated by sponsor|8|||
33656541|NCT01833065|63075903|FG002|Overall Study|Trial terminated by sponsor|7|||
33656542|NCT01833065|63075904|FG003|Overall Study|Trial terminated by sponsor|3|||
33656543|NCT01833065|63075905|FG004|Overall Study|Trial terminated by sponsor|13|||
33656544|NCT01833065|63075901|FG000|Overall Study|Others|2|||
33656545|NCT01833065|63075902|FG001|Overall Study|Others|1|||
33656546|NCT01833065|63075903|FG002|Overall Study|Others|1|||
33656547|NCT01833065|63075904|FG003|Overall Study|Others|1|||
33656548|NCT01833065|63075905|FG004|Overall Study|Others|4|||
33656549|NCT01831817|63075919|FG000|Overall Study|Lost to Follow-up|1|||
33656550|NCT01831817|63075920|FG001|Overall Study|Lost to Follow-up|0|||
33656551|NCT01831817|63075921|FG002|Overall Study|Lost to Follow-up|0|||
33481113|NCT02920528|62857809|FG000|Overall Study|Adverse Event|0|||
33481114|NCT02920528|62857810|FG001|Overall Study|Adverse Event|0|||
33481115|NCT02920528|62857811|FG002|Overall Study|Adverse Event|3|||
33481116|NCT02920528|62857809|FG000|Overall Study|Did not meet inclusion criteria|2|||
33481117|NCT02920528|62857810|FG001|Overall Study|Did not meet inclusion criteria|0|||
33481118|NCT02920528|62857811|FG002|Overall Study|Did not meet inclusion criteria|1|||
33481119|NCT01068418|62857819|FG000|Overall Study|Physician Decision|12|||
33481120|NCT01068262|62857827|FG000|Overall Study|Adverse Event|2|||
33481121|NCT01068262|62857828|FG001|Overall Study|Adverse Event|0|||
33481122|NCT01068262|62857829|FG002|Overall Study|Adverse Event|1|||
33481123|NCT01068262|62857830|FG003|Overall Study|Adverse Event|0|||
33481124|NCT01068262|62857827|FG000|Overall Study|Protocol Violation|1|||
33481125|NCT01068262|62857828|FG001|Overall Study|Protocol Violation|0|||
33481126|NCT01068262|62857829|FG002|Overall Study|Protocol Violation|0|||
33481127|NCT01068262|62857830|FG003|Overall Study|Protocol Violation|0|||
33481128|NCT01068262|62857827|FG000|Overall Study|Withdrawal by Subject|0|||
33481129|NCT01068262|62857828|FG001|Overall Study|Withdrawal by Subject|1|||
33481130|NCT01068262|62857829|FG002|Overall Study|Withdrawal by Subject|0|||
33551847|NCT02814175|62944322|FG001|Part 1|Lost to Follow-up|0|||
33551848|NCT02814175|62944323|FG002|Part 1|Lost to Follow-up|0|||
33551849|NCT02814175|62944324|FG003|Part 1|Lost to Follow-up|0|||
33656552|NCT01831817|63075922|FG003|Overall Study|Lost to Follow-up|0|||
33656553|NCT01831817|63075919|FG000|Overall Study|Withdrawl of Consent|3|||
33481131|NCT01068262|62857830|FG003|Overall Study|Withdrawal by Subject|0|||
33481132|NCT02920450|62857843|FG000|Overall Study|Death|1|||
33481133|NCT02920450|62857844|FG001|Overall Study|Death|0|||
33551850|NCT02814175|62944325|FG004|Part 1|Lost to Follow-up|0|||
33551851|NCT02814175|62944326|FG005|Part 1|Lost to Follow-up|0|||
33551852|NCT02814175|62944321|FG000|Part 1|Lack of Efficacy|1|||
33656554|NCT01831817|63075920|FG001|Overall Study|Withdrawl of Consent|0|||
33656555|NCT01831817|63075921|FG002|Overall Study|Withdrawl of Consent|0|||
33656556|NCT01831817|63075922|FG003|Overall Study|Withdrawl of Consent|0|||
33481134|NCT02920450|62857845|FG002|Overall Study|Death|0|||
33551853|NCT02814175|62944322|FG001|Part 1|Lack of Efficacy|2|||
33551854|NCT02814175|62944323|FG002|Part 1|Lack of Efficacy|0|||
33551855|NCT02814175|62944324|FG003|Part 1|Lack of Efficacy|0|||
33551856|NCT02814175|62944325|FG004|Part 1|Lack of Efficacy|0|||
33481135|NCT02920450|62857846|FG003|Overall Study|Death|0|||
33481136|NCT02920450|62857843|FG000|Overall Study|Withdrawal by Subject|1|||
33481137|NCT02920450|62857844|FG001|Overall Study|Withdrawal by Subject|0|||
33481138|NCT02920450|62857845|FG002|Overall Study|Withdrawal by Subject|0|||
33481139|NCT02920450|62857846|FG003|Overall Study|Withdrawal by Subject|0|||
33481140|NCT01066936|62857857|FG000|Overall Study|Death|2|||
33481141|NCT01066936|62857857|FG000|Overall Study|Device revised/removed|1|||
33481142|NCT01066936|62857857|FG000|Overall Study|Lost to Follow-up|3|||
33481143|NCT01066936|62857857|FG000|Overall Study|Withdrawal by Subject|4|||
33481144|NCT02919436|62857865|FG000|Overall Study|Did not undergo surgery|16|||
33481145|NCT02919436|62857866|FG001|Overall Study|Did not undergo surgery|20|||
33481146|NCT02919436|62857865|FG000|Overall Study|Enrolled before trial registration|44|||
33481147|NCT02919436|62857866|FG001|Overall Study|Enrolled before trial registration|33|||
33481148|NCT03804879|62857876|FG000|Overall Study|Adverse Event|3|||
33481149|NCT03804879|62857877|FG001|Overall Study|Adverse Event|0|||
33481150|NCT03804879|62857876|FG000|Overall Study|Study Terminated By Sponsor|10|||
33481151|NCT03804879|62857877|FG001|Overall Study|Study Terminated By Sponsor|12|||
33481152|NCT03804879|62857876|FG000|Overall Study|Withdrawal by Subject|3|||
33481153|NCT03804879|62857877|FG001|Overall Study|Withdrawal by Subject|1|||
33481154|NCT03803475|62857884|FG000|Overall Study|Physician Decision|1|||
33481155|NCT00005937|62857888|FG000|Overall Study|Lack of Efficacy|5|||
33481156|NCT03443024|62857896|FG000|Overall Study|Adverse Event|2|||
33481157|NCT03443024|62857897|FG001|Overall Study|Adverse Event|4|||
33481158|NCT03443024|62857898|FG002|Overall Study|Adverse Event|3|||
33481159|NCT03443024|62857899|FG003|Overall Study|Adverse Event|1|||
33551857|NCT02814175|62944326|FG005|Part 1|Lack of Efficacy|0|||
33551858|NCT02814175|62944321|FG000|Part 2|Adverse Event|0|||
33551859|NCT02814175|62944322|FG001|Part 2|Adverse Event|0|||
33551860|NCT02814175|62944323|FG002|Part 2|Adverse Event|0|||
33481160|NCT03443024|62857896|FG000|Overall Study|Lost to Follow-up|9|||
33481161|NCT03443024|62857897|FG001|Overall Study|Lost to Follow-up|9|||
33481162|NCT03443024|62857898|FG002|Overall Study|Lost to Follow-up|7|||
33551861|NCT02814175|62944324|FG003|Part 2|Adverse Event|1|||
33551862|NCT02814175|62944325|FG004|Part 2|Adverse Event|1|||
33551863|NCT02814175|62944326|FG005|Part 2|Adverse Event|2|||
33551864|NCT02814175|62944321|FG000|Part 2|Withdrawal Consent|0|||
33551865|NCT02814175|62944322|FG001|Part 2|Withdrawal Consent|0|||
33656557|NCT01840943|63075947|FG000|Overall Study|Withdrawal by Subject|5|||
33481163|NCT03443024|62857899|FG003|Overall Study|Lost to Follow-up|5|||
33481164|NCT03443024|62857896|FG000|Overall Study|Withdrawal by Subject|8|||
33481165|NCT03443024|62857897|FG001|Overall Study|Withdrawal by Subject|15|||
33481166|NCT03443024|62857898|FG002|Overall Study|Withdrawal by Subject|9|||
33481167|NCT03443024|62857899|FG003|Overall Study|Withdrawal by Subject|23|||
33481168|NCT03443024|62857896|FG000|Overall Study|Physician Decision|1|||
33481169|NCT03443024|62857897|FG001|Overall Study|Physician Decision|2|||
33481170|NCT03443024|62857898|FG002|Overall Study|Physician Decision|0|||
33481171|NCT03443024|62857899|FG003|Overall Study|Physician Decision|1|||
33481172|NCT03443024|62857896|FG000|Overall Study|Sponsor Decision|1|||
33481173|NCT03443024|62857897|FG001|Overall Study|Sponsor Decision|1|||
33481174|NCT03443024|62857898|FG002|Overall Study|Sponsor Decision|0|||
33656558|NCT01840943|63075948|FG001|Overall Study|Withdrawal by Subject|6|||
33656559|NCT01840943|63075947|FG000|Overall Study|Physician Decision|4|||
33656560|NCT01840943|63075948|FG001|Overall Study|Physician Decision|2|||
33656561|NCT01840943|63075947|FG000|Overall Study|Lost to Follow-up|4|||
33656562|NCT01840943|63075948|FG001|Overall Study|Lost to Follow-up|4|||
33656563|NCT01840163|63075956|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
33656564|NCT01840163|63075957|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
33656565|NCT01840163|63075956|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
33656566|NCT01840163|63075957|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
33481175|NCT03443024|62857899|FG003|Overall Study|Sponsor Decision|0|||
33481176|NCT03443024|62857896|FG000|Overall Study|Protocol Deviation|0|||
33481177|NCT03443024|62857897|FG001|Overall Study|Protocol Deviation|0|||
33481178|NCT03443024|62857898|FG002|Overall Study|Protocol Deviation|0|||
33551866|NCT02814175|62944323|FG002|Part 2|Withdrawal Consent|0|||
33551867|NCT02814175|62944324|FG003|Part 2|Withdrawal Consent|2|||
33551868|NCT02814175|62944325|FG004|Part 2|Withdrawal Consent|1|||
33551869|NCT02814175|62944326|FG005|Part 2|Withdrawal Consent|1|||
33481179|NCT03443024|62857899|FG003|Overall Study|Protocol Deviation|2|||
33481180|NCT02908516|62857911|FG000|Overall Study|Study Terminated|3|||
33481181|NCT02908516|62857912|FG001|Overall Study|Study Terminated|3|||
33481182|NCT02907892|62857920|FG000|Overall Study|Lost to Follow-up|27|||
33481183|NCT02907892|62857921|FG001|Overall Study|Lost to Follow-up|40|||
33481184|NCT02906644|62857929|FG000|First 2 Weeks|Withdrawal by Subject|0|||
33481185|NCT02906644|62857930|FG001|First 2 Weeks|Withdrawal by Subject|2|||
33481186|NCT02906644|62857929|FG000|First 2 Weeks|Physician Decision|1|||
33551870|NCT02814175|62944321|FG000|Part 2|Lost to Follow-up|0|||
33551871|NCT02814175|62944322|FG001|Part 2|Lost to Follow-up|0|||
33551872|NCT02814175|62944323|FG002|Part 2|Lost to Follow-up|0|||
33551873|NCT02814175|62944324|FG003|Part 2|Lost to Follow-up|1|||
33481187|NCT02906644|62857930|FG001|First 2 Weeks|Physician Decision|1|||
33481188|NCT02906644|62857929|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
33656567|NCT01840163|63075956|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
33656568|NCT01840163|63075957|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
33656569|NCT01831427|63076110|FG000|Overall Study|Adverse Event|0|||
33656570|NCT01831427|63076111|FG001|Overall Study|Adverse Event|1|||
33551874|NCT02814175|62944325|FG004|Part 2|Lost to Follow-up|0|||
33656571|NCT01831427|63076112|FG002|Overall Study|Adverse Event|0|||
33656572|NCT01831427|63076113|FG003|Overall Study|Adverse Event|0|||
33656573|NCT01831427|63076114|FG004|Overall Study|Adverse Event|0|||
33656574|NCT01831427|63076115|FG005|Overall Study|Adverse Event|1|||
33656575|NCT01831427|63076116|FG006|Overall Study|Adverse Event|0|||
33656576|NCT01831427|63076117|FG007|Overall Study|Adverse Event|1|||
33656577|NCT01831427|63076118|FG008|Overall Study|Adverse Event|0|||
33656578|NCT01831427|63076119|FG009|Overall Study|Adverse Event|0|||
33656579|NCT01831427|63076120|FG010|Overall Study|Adverse Event|2|||
33656580|NCT01831427|63076110|FG000|Overall Study|Investigator's Discretion|0|||
33656581|NCT01831427|63076111|FG001|Overall Study|Investigator's Discretion|0|||
33656582|NCT01831427|63076112|FG002|Overall Study|Investigator's Discretion|0|||
33551875|NCT02814175|62944326|FG005|Part 2|Lost to Follow-up|0|||
33551876|NCT02814175|62944321|FG000|Part 2|Lack of Efficacy|0|||
33656583|NCT01831427|63076113|FG003|Overall Study|Investigator's Discretion|1|||
33656584|NCT01831427|63076114|FG004|Overall Study|Investigator's Discretion|0|||
33656585|NCT01831427|63076115|FG005|Overall Study|Investigator's Discretion|0|||
33656586|NCT01831427|63076116|FG006|Overall Study|Investigator's Discretion|0|||
33656587|NCT01831427|63076117|FG007|Overall Study|Investigator's Discretion|0|||
33656588|NCT01831427|63076118|FG008|Overall Study|Investigator's Discretion|0|||
33656589|NCT01831427|63076119|FG009|Overall Study|Investigator's Discretion|0|||
33656590|NCT01831427|63076120|FG010|Overall Study|Investigator's Discretion|0|||
33656591|NCT01831427|63076110|FG000|Overall Study|Withdrew Consent|0|||
33656592|NCT01831427|63076111|FG001|Overall Study|Withdrew Consent|0|||
33656593|NCT01831427|63076112|FG002|Overall Study|Withdrew Consent|0|||
33656594|NCT01831427|63076113|FG003|Overall Study|Withdrew Consent|0|||
33656595|NCT01831427|63076114|FG004|Overall Study|Withdrew Consent|0|||
33656596|NCT01831427|63076115|FG005|Overall Study|Withdrew Consent|0|||
33656597|NCT01831427|63076116|FG006|Overall Study|Withdrew Consent|2|||
33656598|NCT01831427|63076117|FG007|Overall Study|Withdrew Consent|0|||
33656599|NCT01831427|63076118|FG008|Overall Study|Withdrew Consent|0|||
33656600|NCT01831427|63076119|FG009|Overall Study|Withdrew Consent|1|||
33656601|NCT01831427|63076120|FG010|Overall Study|Withdrew Consent|1|||
33656602|NCT01830881|63076166|FG000|Overall Study|Changed decision to have an abortion|0|||
33656603|NCT01830881|63076167|FG001|Overall Study|Changed decision to have an abortion|1|||
33656604|NCT01838681|63076203|FG000|Period A|Adverse Event|39|||
33656605|NCT01838681|63076204|FG001|Period A|Adverse Event|0|||
33656606|NCT01838681|63076205|FG002|Period A|Adverse Event|0|||
33656607|NCT01838681|63076206|FG003|Period A|Adverse Event|0|||
33656608|NCT01838681|63076203|FG000|Period A|Lack of Efficacy|21|||
33656609|NCT01838681|63076204|FG001|Period A|Lack of Efficacy|0|||
33656610|NCT01838681|63076205|FG002|Period A|Lack of Efficacy|0|||
33481189|NCT02906644|62857930|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
33481190|NCT02906644|62857929|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
33481191|NCT02906644|62857930|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
33481192|NCT03410108|62857937|FG000|Overall Study|Ongoing|41|||
33481193|NCT03410108|62857937|FG000|Overall Study|Adverse Event|4|||
33481194|NCT03410108|62857937|FG000|Overall Study|Progressive Disease|58|||
33551877|NCT02814175|62944322|FG001|Part 2|Lack of Efficacy|0|||
33551878|NCT02814175|62944323|FG002|Part 2|Lack of Efficacy|0|||
33551879|NCT02814175|62944324|FG003|Part 2|Lack of Efficacy|0|||
33551880|NCT02814175|62944325|FG004|Part 2|Lack of Efficacy|0|||
33551881|NCT02814175|62944326|FG005|Part 2|Lack of Efficacy|3|||
33551882|NCT01335997|62944342|FG000|Period I and II|Adverse Event|63|||
33551883|NCT01335997|62944343|FG001|Period I and II|Adverse Event|43|||
33551884|NCT01335997|62944342|FG000|Period I and II|Noncompliance with Study Drug|1|||
33551885|NCT01335997|62944343|FG001|Period I and II|Noncompliance with Study Drug|1|||
33551886|NCT01335997|62944342|FG000|Period I and II|Lost to Follow-up|3|||
33656611|NCT01838681|63076206|FG003|Period A|Lack of Efficacy|0|||
33656612|NCT01838681|63076203|FG000|Period A|Early response|148|||
33656613|NCT01838681|63076204|FG001|Period A|Early response|0|||
33656614|NCT01838681|63076205|FG002|Period A|Early response|0|||
33656615|NCT01838681|63076206|FG003|Period A|Early response|0|||
33656616|NCT01838681|63076203|FG000|Period A|Withdrawal by Subject|70|||
33656617|NCT01838681|63076204|FG001|Period A|Withdrawal by Subject|0|||
33656618|NCT01838681|63076205|FG002|Period A|Withdrawal by Subject|0|||
33656619|NCT01838681|63076206|FG003|Period A|Withdrawal by Subject|0|||
33656620|NCT01838681|63076203|FG000|Period A|Protocol Violation|16|||
33481195|NCT03410108|62857937|FG000|Overall Study|Withdrawal by Subject|1|||
33481196|NCT02982772|62857946|FG000|Intervention|Lost to Follow-up|19|||
33551887|NCT01335997|62944343|FG001|Period I and II|Lost to Follow-up|5|||
33656621|NCT01838681|63076204|FG001|Period A|Protocol Violation|0|||
33656622|NCT01838681|63076205|FG002|Period A|Protocol Violation|0|||
33481197|NCT02982772|62857947|FG001|Intervention|Lost to Follow-up|13|||
33481198|NCT02982772|62857946|FG000|1M Follow-Up|Lost to Follow-up|21|||
33481199|NCT02982772|62857947|FG001|1M Follow-Up|Lost to Follow-up|18|||
33481200|NCT02982772|62857946|FG000|3M Follow-Up|Lost to Follow-up|17|||
33481201|NCT02982772|62857947|FG001|3M Follow-Up|Lost to Follow-up|11|||
33481202|NCT02982772|62857946|FG000|6M Follow-Up|Lost to Follow-up|11|||
33481203|NCT02982772|62857947|FG001|6M Follow-Up|Lost to Follow-up|9|||
33481204|NCT02982772|62857946|FG000|12M Follow-Up|Lost to Follow-up|11|||
33481205|NCT02982772|62857947|FG001|12M Follow-Up|Lost to Follow-up|5|||
33481206|NCT03488108|62857957|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
33481207|NCT03488108|62857958|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
33481208|NCT03488108|62857957|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
33481209|NCT03488108|62857958|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
33481210|NCT03440918|62857968|FG000|Overall Study|Protocol Violation|0|||
33481211|NCT03440918|62857969|FG001|Overall Study|Protocol Violation|16|||
33481212|NCT03486392|62857980|FG000|Overall Study|Lost to Follow-up|0|||
33481213|NCT03486392|62857981|FG001|Overall Study|Lost to Follow-up|0|||
33481214|NCT03486392|62857982|FG002|Overall Study|Lost to Follow-up|8|||
33481215|NCT03486392|62857983|FG003|Overall Study|Lost to Follow-up|5|||
33481216|NCT03486392|62857984|FG004|Overall Study|Lost to Follow-up|2|||
33481217|NCT03486392|62857980|FG000|Overall Study|Withdrawal by Subject|3|||
33551888|NCT01335997|62944342|FG000|Period I and II|Withdrawal by Subject|9|||
33551889|NCT01335997|62944343|FG001|Period I and II|Withdrawal by Subject|4|||
33551890|NCT01335997|62944342|FG000|Period I and II|Study Terminated by Sponsor|406|||
33551891|NCT01335997|62944343|FG001|Period I and II|Study Terminated by Sponsor|415|||
33551892|NCT01335997|62944342|FG000|Period I and II|Protocol Violation|9|||
33551893|NCT01335997|62944343|FG001|Period I and II|Protocol Violation|10|||
33551894|NCT01335997|62944342|FG000|Period I and II|Physician Decision|2|||
33551895|NCT01335997|62944343|FG001|Period I and II|Physician Decision|1|||
33481218|NCT03486392|62857981|FG001|Overall Study|Withdrawal by Subject|0|||
33481219|NCT03486392|62857982|FG002|Overall Study|Withdrawal by Subject|6|||
33481220|NCT03486392|62857983|FG003|Overall Study|Withdrawal by Subject|4|||
33481221|NCT03486392|62857984|FG004|Overall Study|Withdrawal by Subject|1|||
33481222|NCT03486392|62857980|FG000|Overall Study|Death|0|||
33481223|NCT03486392|62857981|FG001|Overall Study|Death|0|||
33481224|NCT03486392|62857982|FG002|Overall Study|Death|0|||
33481225|NCT03486392|62857983|FG003|Overall Study|Death|0|||
33481226|NCT03486392|62857984|FG004|Overall Study|Death|1|||
33481227|NCT02981602|62858001|FG000|Overall Study|Adverse Event|0|||
33481228|NCT02981602|62858002|FG001|Overall Study|Adverse Event|0|||
33481229|NCT02981602|62858003|FG002|Overall Study|Adverse Event|0|||
33481230|NCT02981602|62858004|FG003|Overall Study|Adverse Event|1|||
33481231|NCT02981602|62858005|FG004|Overall Study|Adverse Event|0|||
33481232|NCT02981524|62858018|FG000|Overall Study|Progressive Disease|14|||
33481233|NCT02981524|62858018|FG000|Overall Study|Death (unrelated)|1|||
33481234|NCT02981524|62858018|FG000|Overall Study|Treatment Related Toxicity|1|||
33481235|NCT02981524|62858018|FG000|Overall Study|Withdrawal by Subject|1|||
33551896|NCT01335997|62944342|FG000|Period III|Adverse Event|0|||
33551897|NCT01335997|62944343|FG001|Period III|Adverse Event|2|||
33551898|NCT01335997|62944342|FG000|Period III|Study Terminated by Sponsor|77|||
33481236|NCT03486314|62858022|FG000|Part A|Adverse Event|1|||
33481237|NCT03486314|62858023|FG001|Part A|Adverse Event|0|||
33481238|NCT03486314|62858024|FG002|Part A|Adverse Event|0|||
33481239|NCT03486314|62858022|FG000|Part A|Symptomatic Deterioration|2|||
33481240|NCT03486314|62858023|FG001|Part A|Symptomatic Deterioration|0|||
33481241|NCT03486314|62858024|FG002|Part A|Symptomatic Deterioration|0|||
33481242|NCT02905006|62858038|FG000|Overall Study|Adverse Event|1|||
33481243|NCT02905006|62858039|FG001|Overall Study|Adverse Event|1|||
33481244|NCT02905006|62858040|FG002|Overall Study|Adverse Event|1|||
33551899|NCT01335997|62944343|FG001|Period III|Study Terminated by Sponsor|76|||
33551900|NCT01335997|62944342|FG000|Period III|Protocol Violation|0|||
33551901|NCT01335997|62944343|FG001|Period III|Protocol Violation|1|||
33481245|NCT02905006|62858041|FG003|Overall Study|Adverse Event|1|||
33481246|NCT02905006|62858042|FG004|Overall Study|Adverse Event|0|||
33481247|NCT02905006|62858043|FG005|Overall Study|Adverse Event|1|||
33481248|NCT02905006|62858038|FG000|Overall Study|Lack of Efficacy|1|||
33481249|NCT02905006|62858039|FG001|Overall Study|Lack of Efficacy|0|||
33481250|NCT02905006|62858040|FG002|Overall Study|Lack of Efficacy|0|||
33481251|NCT02905006|62858041|FG003|Overall Study|Lack of Efficacy|0|||
33481252|NCT02905006|62858042|FG004|Overall Study|Lack of Efficacy|0|||
33481253|NCT02905006|62858043|FG005|Overall Study|Lack of Efficacy|0|||
33551902|NCT01335997|62944342|FG000|Period III|Lost to Follow-up|1|||
33481254|NCT02905006|62858038|FG000|Overall Study|Protocol Violation|2|||
33481255|NCT02905006|62858039|FG001|Overall Study|Protocol Violation|0|||
33656623|NCT01838681|63076206|FG003|Period A|Protocol Violation|0|||
33656624|NCT01838681|63076203|FG000|Period A|Non-compliance with IMP|6|||
33656625|NCT01838681|63076204|FG001|Period A|Non-compliance with IMP|0|||
33656626|NCT01838681|63076205|FG002|Period A|Non-compliance with IMP|0|||
33656627|NCT01838681|63076206|FG003|Period A|Non-compliance with IMP|0|||
33656628|NCT01838681|63076203|FG000|Period A|Lost to Follow-up|4|||
33656629|NCT01838681|63076204|FG001|Period A|Lost to Follow-up|0|||
33656630|NCT01838681|63076205|FG002|Period A|Lost to Follow-up|0|||
33656631|NCT01838681|63076206|FG003|Period A|Lost to Follow-up|0|||
33656632|NCT01838681|63076203|FG000|Period A|Withdrawal before treatment|4|||
33656633|NCT01838681|63076204|FG001|Period A|Withdrawal before treatment|0|||
33656634|NCT01838681|63076205|FG002|Period A|Withdrawal before treatment|0|||
33656635|NCT01838681|63076206|FG003|Period A|Withdrawal before treatment|0|||
33656636|NCT01838681|63076203|FG000|Period A|Administrative or other reasons|17|||
33656637|NCT01838681|63076204|FG001|Period A|Administrative or other reasons|0|||
33656638|NCT01838681|63076205|FG002|Period A|Administrative or other reasons|0|||
33656639|NCT01838681|63076206|FG003|Period A|Administrative or other reasons|0|||
33656640|NCT01838681|63076203|FG000|Period B/A+|Adverse Event|0|||
33656641|NCT01838681|63076204|FG001|Period B/A+|Adverse Event|13|||
33656642|NCT01838681|63076205|FG002|Period B/A+|Adverse Event|27|||
33656643|NCT01838681|63076206|FG003|Period B/A+|Adverse Event|16|||
33656644|NCT01838681|63076203|FG000|Period B/A+|Lack of Efficacy|0|||
33656645|NCT01838681|63076204|FG001|Period B/A+|Lack of Efficacy|9|||
33656646|NCT01838681|63076205|FG002|Period B/A+|Lack of Efficacy|11|||
33656647|NCT01838681|63076206|FG003|Period B/A+|Lack of Efficacy|6|||
33656648|NCT01838681|63076203|FG000|Period B/A+|Withdrawal by Subject|0|||
33656649|NCT01838681|63076204|FG001|Period B/A+|Withdrawal by Subject|28|||
33656650|NCT01838681|63076205|FG002|Period B/A+|Withdrawal by Subject|35|||
33656651|NCT01838681|63076206|FG003|Period B/A+|Withdrawal by Subject|47|||
33656652|NCT01838681|63076203|FG000|Period B/A+|Protocol Violation|0|||
33656653|NCT01838681|63076204|FG001|Period B/A+|Protocol Violation|1|||
33656654|NCT01838681|63076205|FG002|Period B/A+|Protocol Violation|4|||
33656655|NCT01838681|63076206|FG003|Period B/A+|Protocol Violation|6|||
33656656|NCT01838681|63076203|FG000|Period B/A+|Non-compliance with IMP|0|||
33656657|NCT01838681|63076204|FG001|Period B/A+|Non-compliance with IMP|2|||
33656658|NCT01838681|63076205|FG002|Period B/A+|Non-compliance with IMP|3|||
33656659|NCT01838681|63076206|FG003|Period B/A+|Non-compliance with IMP|3|||
33656660|NCT01838681|63076203|FG000|Period B/A+|Lost to Follow-up|0|||
33656661|NCT01838681|63076204|FG001|Period B/A+|Lost to Follow-up|2|||
33656662|NCT01838681|63076205|FG002|Period B/A+|Lost to Follow-up|5|||
33656663|NCT01838681|63076206|FG003|Period B/A+|Lost to Follow-up|11|||
33656664|NCT01838681|63076203|FG000|Period B/A+|Withdrawal before treatment|0|||
33656665|NCT01838681|63076204|FG001|Period B/A+|Withdrawal before treatment|1|||
33656666|NCT01838681|63076205|FG002|Period B/A+|Withdrawal before treatment|0|||
33656667|NCT01838681|63076206|FG003|Period B/A+|Withdrawal before treatment|0|||
33656668|NCT01838681|63076203|FG000|Period B/A+|Administrative or other reasons|0|||
33656669|NCT01838681|63076204|FG001|Period B/A+|Administrative or other reasons|6|||
33656670|NCT01838681|63076205|FG002|Period B/A+|Administrative or other reasons|10|||
33656671|NCT01838681|63076206|FG003|Period B/A+|Administrative or other reasons|28|||
33656672|NCT01611857|63076264|FG000|Overall Study|Withdrawal by Subject|0|||
33656673|NCT01611857|63076265|FG001|Overall Study|Withdrawal by Subject|2|||
33656674|NCT01829477|63076288|FG000|Overall Study|Study Terminated by Sponsor|15|||
33656675|NCT01829477|63076289|FG001|Overall Study|Study Terminated by Sponsor|15|||
33656676|NCT01829477|63076288|FG000|Overall Study|Withdrawal by Subject|1|||
33656677|NCT01829477|63076289|FG001|Overall Study|Withdrawal by Subject|0|||
33656678|NCT01611155|63076305|FG000|Overall Study|Adverse Event|1|||
33656679|NCT01611155|63076306|FG001|Overall Study|Adverse Event|1|||
33656680|NCT01611155|63076305|FG000|Overall Study|Refused further treatment|6|||
33656681|NCT01611155|63076306|FG001|Overall Study|Refused further treatment|4|||
33656682|NCT01611155|63076305|FG000|Overall Study|Disease progression|1|||
33656683|NCT01611155|63076306|FG001|Overall Study|Disease progression|0|||
33656684|NCT01611155|63076305|FG000|Overall Study|Withdrawal by Subject|1|||
33656685|NCT01611155|63076306|FG001|Overall Study|Withdrawal by Subject|0|||
33656686|NCT01611155|63076305|FG000|Overall Study|Alternative treatment|0|||
33656687|NCT01611155|63076306|FG001|Overall Study|Alternative treatment|1|||
33656688|NCT01611155|63076305|FG000|Overall Study|Ineligible patient|0|||
33656689|NCT01611155|63076306|FG001|Overall Study|Ineligible patient|1|||
33656690|NCT01829243|63076321|FG000|First Intervention|Screen Failure|4|||
33656691|NCT01829243|63076322|FG001|First Intervention|Screen Failure|2|||
33656692|NCT01838447|63076332|FG000|Overall Study|Change in surgical plan|1|||
33656693|NCT01838447|63076333|FG001|Overall Study|Change in surgical plan|2|||
33656694|NCT01838447|63076332|FG000|Overall Study|Withdrawal by Subject|1|||
33656695|NCT01838447|63076333|FG001|Overall Study|Withdrawal by Subject|1|||
33656696|NCT01829165|63076341|FG000|Overall Study|Did not complete intervention|2|||
33656697|NCT01829165|63076342|FG001|Overall Study|Did not complete intervention|0|||
33656698|NCT01838213|63076350|FG000|Overall Study|Ineligible|166|||
33481256|NCT02905006|62858040|FG002|Overall Study|Protocol Violation|0|||
33481257|NCT02905006|62858041|FG003|Overall Study|Protocol Violation|0|||
33481258|NCT02905006|62858042|FG004|Overall Study|Protocol Violation|0|||
33481259|NCT02905006|62858043|FG005|Overall Study|Protocol Violation|0|||
33481260|NCT02905006|62858038|FG000|Overall Study|Lost to Follow-up|0|||
33551903|NCT01335997|62944343|FG001|Period III|Lost to Follow-up|0|||
33551904|NCT02725671|62944351|FG000|Overall Study|Lost to Follow-up|1|||
33551905|NCT02446990|62944359|FG000|Overall Study|Death|485|||
33481261|NCT02905006|62858039|FG001|Overall Study|Lost to Follow-up|0|||
33481262|NCT02905006|62858040|FG002|Overall Study|Lost to Follow-up|0|||
33481263|NCT02905006|62858041|FG003|Overall Study|Lost to Follow-up|1|||
33481264|NCT02905006|62858042|FG004|Overall Study|Lost to Follow-up|1|||
33481265|NCT02905006|62858043|FG005|Overall Study|Lost to Follow-up|0|||
33481266|NCT02905006|62858038|FG000|Overall Study|Withdrawal by Subject|0|||
33481267|NCT02905006|62858039|FG001|Overall Study|Withdrawal by Subject|0|||
33481268|NCT02905006|62858040|FG002|Overall Study|Withdrawal by Subject|1|||
33481269|NCT02905006|62858041|FG003|Overall Study|Withdrawal by Subject|1|||
33551906|NCT02446990|62944360|FG001|Overall Study|Death|458|||
33551907|NCT02446990|62944359|FG000|Overall Study|Lost to Follow-up|3|||
33551908|NCT02446990|62944360|FG001|Overall Study|Lost to Follow-up|1|||
33551909|NCT02446990|62944359|FG000|Overall Study|Physician Decision|1|||
33551910|NCT02446990|62944360|FG001|Overall Study|Physician Decision|0|||
33551911|NCT02446990|62944359|FG000|Overall Study|Withdrawal by Subject|231|||
33551912|NCT02446990|62944360|FG001|Overall Study|Withdrawal by Subject|199|||
33551913|NCT02725515|62944368|FG000|Overall Study|Refused infusion (no study treatment)|1|||
33551914|NCT02725515|62944369|FG001|Overall Study|Refused infusion (no study treatment)|0|||
33551915|NCT02725515|62944368|FG000|Overall Study|Loss of Improvement per Protocol|14|||
33551916|NCT02725515|62944369|FG001|Overall Study|Loss of Improvement per Protocol|25|||
33551917|NCT02725515|62944368|FG000|Overall Study|Withdrawal by Subject|2|||
33551918|NCT02725515|62944369|FG001|Overall Study|Withdrawal by Subject|1|||
33551919|NCT02725515|62944368|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33481270|NCT02905006|62858042|FG004|Overall Study|Withdrawal by Subject|0|||
33481271|NCT02905006|62858043|FG005|Overall Study|Withdrawal by Subject|1|||
33481272|NCT02905006|62858038|FG000|Overall Study|Screening exclusion criteria met|1|||
33481273|NCT02905006|62858039|FG001|Overall Study|Screening exclusion criteria met|0|||
33481274|NCT02905006|62858040|FG002|Overall Study|Screening exclusion criteria met|0|||
33481275|NCT02905006|62858041|FG003|Overall Study|Screening exclusion criteria met|0|||
33481276|NCT02905006|62858042|FG004|Overall Study|Screening exclusion criteria met|0|||
33481277|NCT02905006|62858043|FG005|Overall Study|Screening exclusion criteria met|0|||
33481278|NCT02905006|62858038|FG000|Overall Study|Lab withdrawal criterion met|0|||
33481279|NCT02905006|62858039|FG001|Overall Study|Lab withdrawal criterion met|1|||
33481280|NCT02905006|62858040|FG002|Overall Study|Lab withdrawal criterion met|2|||
33551920|NCT02725515|62944369|FG001|Overall Study|Non-Compliance With Study Drug|3|||
33656699|NCT01838213|63076351|FG001|Overall Study|Ineligible|191|||
33656700|NCT01837823|63076357|FG000|Overall Study|Lost to Follow-up|6|||
33656701|NCT01828073|63076367|FG000|Overall Study|Lost to Follow-up|1|||
33656702|NCT01828073|63076368|FG001|Overall Study|Lost to Follow-up|2|||
33656703|NCT03819114|63076388|FG000|Overall Study|Protocol Violation|0|||
33656704|NCT03819114|63076389|FG001|Overall Study|Protocol Violation|1|||
33656705|NCT03819114|63076390|FG002|Overall Study|Protocol Violation|1|||
33656706|NCT03819114|63076391|FG003|Overall Study|Protocol Violation|0|||
33656707|NCT03819114|63076388|FG000|Overall Study|Lost to Follow-up|0|||
33656708|NCT03819114|63076389|FG001|Overall Study|Lost to Follow-up|0|||
33656709|NCT03819114|63076390|FG002|Overall Study|Lost to Follow-up|1|||
33656710|NCT03819114|63076391|FG003|Overall Study|Lost to Follow-up|0|||
33656711|NCT01827839|63076403|FG000|Overall Study|Adverse Event|1|||
33656712|NCT01827839|63076403|FG000|Overall Study|Consent Withdrawal|2|||
33656713|NCT01827371|63076418|FG000|Overall Study|Adverse Event|0|||
33656714|NCT01827371|63076419|FG001|Overall Study|Adverse Event|0|||
33656715|NCT01827371|63076420|FG002|Overall Study|Adverse Event|4|||
33656716|NCT01827371|63076421|FG003|Overall Study|Adverse Event|2|||
33656717|NCT01827371|63076418|FG000|Overall Study|Lost to Follow-up|0|||
33481281|NCT02905006|62858041|FG003|Overall Study|Lab withdrawal criterion met|2|||
33481282|NCT02905006|62858042|FG004|Overall Study|Lab withdrawal criterion met|2|||
33656718|NCT01827371|63076419|FG001|Overall Study|Lost to Follow-up|2|||
33656719|NCT01827371|63076420|FG002|Overall Study|Lost to Follow-up|0|||
33656720|NCT01827371|63076421|FG003|Overall Study|Lost to Follow-up|4|||
33481283|NCT02905006|62858043|FG005|Overall Study|Lab withdrawal criterion met|1|||
33481284|NCT02905006|62858038|FG000|Overall Study|Positive for Tuberculosis|0|||
33481285|NCT02905006|62858039|FG001|Overall Study|Positive for Tuberculosis|1|||
33481286|NCT02905006|62858040|FG002|Overall Study|Positive for Tuberculosis|0|||
33551921|NCT02725515|62944368|FG000|Overall Study|Lost to Follow-up|1|||
33551922|NCT02725515|62944369|FG001|Overall Study|Lost to Follow-up|1|||
33551923|NCT02725515|62944368|FG000|Overall Study|Adverse Event|7|||
33551924|NCT02725515|62944369|FG001|Overall Study|Adverse Event|2|||
33656721|NCT01827371|63076418|FG000|Overall Study|Protocol Violation|1|||
33656722|NCT01827371|63076419|FG001|Overall Study|Protocol Violation|0|||
33551925|NCT02725515|62944368|FG000|Overall Study|No Documented Disease Improvement|0|||
33551926|NCT02725515|62944369|FG001|Overall Study|No Documented Disease Improvement|1|||
33551927|NCT02725515|62944368|FG000|Overall Study|Completed Study Under Original Protocol|0|||
33551928|NCT02725515|62944369|FG001|Overall Study|Completed Study Under Original Protocol|1|||
33551929|NCT02725515|62944368|FG000|Overall Study|Lack of Response|0|||
33551930|NCT02725515|62944369|FG001|Overall Study|Lack of Response|1|||
33551931|NCT02416180|62944375|FG000|Overall Study|Withdrawal by Subject|1|||
33551932|NCT02473510|62944381|FG000|Overall Study|Lost to Follow-up|1|||
33481287|NCT02905006|62858041|FG003|Overall Study|Positive for Tuberculosis|0|||
33481288|NCT02905006|62858042|FG004|Overall Study|Positive for Tuberculosis|0|||
33481289|NCT02905006|62858043|FG005|Overall Study|Positive for Tuberculosis|0|||
33481290|NCT02905006|62858038|FG000|Overall Study|Subject positive for Hep B|0|||
33481291|NCT02905006|62858039|FG001|Overall Study|Subject positive for Hep B|0|||
33481292|NCT02905006|62858040|FG002|Overall Study|Subject positive for Hep B|1|||
33481293|NCT02905006|62858041|FG003|Overall Study|Subject positive for Hep B|0|||
33551933|NCT02473510|62944382|FG001|Overall Study|Lost to Follow-up|2|||
33551934|NCT02445586|62944388|FG000|Overall Study|Death|14|||
33551935|NCT02445586|62944388|FG000|Overall Study|Withdrawal by Subject|13|||
33551936|NCT02445586|62944388|FG000|Overall Study|Disease Progression|10|||
33551937|NCT02445586|62944388|FG000|Overall Study|Protocol Violation|1|||
33551938|NCT02445586|62944388|FG000|Overall Study|Medical Condition|1|||
33551939|NCT01674062|62944394|FG000|Overall Study|Insufficient Therapeutic Response|56|||
33551940|NCT01674062|62944395|FG001|Overall Study|Insufficient Therapeutic Response|26|||
33551941|NCT01674062|62944394|FG000|Overall Study|Other|8|||
33551942|NCT01674062|62944395|FG001|Overall Study|Other|1|||
33551943|NCT01674062|62944394|FG000|Overall Study|Adverse Event|1|||
33551944|NCT01674062|62944395|FG001|Overall Study|Adverse Event|1|||
33551945|NCT01674062|62944394|FG000|Overall Study|Death|0|||
33551946|NCT01674062|62944395|FG001|Overall Study|Death|1|||
33551947|NCT01674062|62944394|FG000|Overall Study|Programming Error|1|||
33551948|NCT01674062|62944395|FG001|Overall Study|Programming Error|0|||
33551949|NCT02472886|62944404|FG000|Overall Study|Lack of Efficacy|0|||
33481294|NCT02905006|62858042|FG004|Overall Study|Subject positive for Hep B|0|||
33481295|NCT02905006|62858043|FG005|Overall Study|Subject positive for Hep B|0|||
33481296|NCT02905006|62858038|FG000|Overall Study|Patient moved abroad|0|||
33481297|NCT02905006|62858039|FG001|Overall Study|Patient moved abroad|0|||
33481298|NCT02905006|62858040|FG002|Overall Study|Patient moved abroad|0|||
33656723|NCT01827371|63076420|FG002|Overall Study|Protocol Violation|0|||
33551950|NCT02472886|62944405|FG001|Overall Study|Lack of Efficacy|2|||
33656724|NCT01827371|63076421|FG003|Overall Study|Protocol Violation|0|||
33656725|NCT01827371|63076418|FG000|Overall Study|Withdrawal by Subject|1|||
33656726|NCT01827371|63076419|FG001|Overall Study|Withdrawal by Subject|2|||
33656727|NCT01827371|63076420|FG002|Overall Study|Withdrawal by Subject|2|||
33656728|NCT01827371|63076421|FG003|Overall Study|Withdrawal by Subject|3|||
33656729|NCT01827371|63076418|FG000|Overall Study|Physician Decision|0|||
33656730|NCT01827371|63076419|FG001|Overall Study|Physician Decision|1|||
33656731|NCT01827371|63076420|FG002|Overall Study|Physician Decision|0|||
33656732|NCT01827371|63076421|FG003|Overall Study|Physician Decision|1|||
33656733|NCT01827371|63076418|FG000|Overall Study|Temporary study halt to vaccinations|11|||
33656734|NCT01827371|63076419|FG001|Overall Study|Temporary study halt to vaccinations|2|||
33656735|NCT01827371|63076420|FG002|Overall Study|Temporary study halt to vaccinations|5|||
33656736|NCT01827371|63076421|FG003|Overall Study|Temporary study halt to vaccinations|13|||
33656737|NCT04409262|63076600|FG000|Overall Study|Adverse Event|0|||
33656738|NCT04409262|63076601|FG001|Overall Study|Adverse Event|2|||
33656739|NCT04409262|63076600|FG000|Overall Study|Death|55|||
33656740|NCT04409262|63076601|FG001|Overall Study|Death|97|||
33656741|NCT04409262|63076600|FG000|Overall Study|Lost to Follow-up|12|||
33656742|NCT04409262|63076601|FG001|Overall Study|Lost to Follow-up|23|||
33656743|NCT04409262|63076600|FG000|Overall Study|Lack of Staff|0|||
33656744|NCT04409262|63076601|FG001|Overall Study|Lack of Staff|1|||
33551951|NCT02472886|62944406|FG002|Overall Study|Lack of Efficacy|1|||
33551952|NCT02472652|62944419|FG000|Overall Study|Lost to Follow-up|1|||
33551953|NCT02807857|62944423|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
33551954|NCT02807857|62944423|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
33656745|NCT04409262|63076600|FG000|Overall Study|Protocol Violation|3|||
33481299|NCT02905006|62858041|FG003|Overall Study|Patient moved abroad|1|||
33551955|NCT02807857|62944423|FG000|Follow-Up Set|Withdrawal by Subject|8|||
33551956|NCT02807857|62944423|FG000|Follow-Up Set|Lost to Follow-up|7|||
33551957|NCT02807857|62944423|FG000|Follow-Up Set|Physician Decision|6|||
33551958|NCT02807857|62944423|FG000|Follow-Up Set|Adverse Event|3|||
33551959|NCT02807857|62944423|FG000|Follow-Up Set|Death|27|||
33551960|NCT02807857|62944423|FG000|Follow-Up Set|Relocation|2|||
33656746|NCT04409262|63076601|FG001|Overall Study|Protocol Violation|1|||
33656747|NCT04409262|63076600|FG000|Overall Study|Withdrawal by Subject|5|||
33551961|NCT02648438|62944436|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33481300|NCT02905006|62858042|FG004|Overall Study|Patient moved abroad|0|||
33481301|NCT02905006|62858043|FG005|Overall Study|Patient moved abroad|0|||
33481302|NCT02905006|62858038|FG000|Overall Study|Patient randomized by mistake|0|||
33481303|NCT02905006|62858039|FG001|Overall Study|Patient randomized by mistake|0|||
33481304|NCT02905006|62858040|FG002|Overall Study|Patient randomized by mistake|0|||
33481305|NCT02905006|62858041|FG003|Overall Study|Patient randomized by mistake|0|||
33481306|NCT02905006|62858042|FG004|Overall Study|Patient randomized by mistake|0|||
33656748|NCT04409262|63076601|FG001|Overall Study|Withdrawal by Subject|10|||
33656749|NCT04305912|63076645|FG000|First Intervention|COVID-19 Suspension|2|||
33656750|NCT04305912|63076646|FG001|First Intervention|COVID-19 Suspension|0|||
33656751|NCT04305912|63076645|FG000|First Intervention|Withdrawal by Subject|0|||
33656752|NCT04305912|63076646|FG001|First Intervention|Withdrawal by Subject|1|||
33656753|NCT04305912|63076645|FG000|Second Intervention|Adverse Event|0|||
33656754|NCT04305912|63076646|FG001|Second Intervention|Adverse Event|1|||
33656755|NCT00782184|63076875|FG000|Overall Study|Adverse Event|1|||
33656756|NCT00782184|63076876|FG001|Overall Study|Adverse Event|2|||
33656757|NCT00782184|63076875|FG000|Overall Study|Protocol Violation|0|||
33656758|NCT00782184|63076876|FG001|Overall Study|Protocol Violation|1|||
33656759|NCT00782184|63076875|FG000|Overall Study|Withdrawal by Subject|3|||
33656760|NCT00782184|63076876|FG001|Overall Study|Withdrawal by Subject|2|||
33656761|NCT02731638|63076912|FG000|Overall Study|Lost to Follow-up|6|||
33656762|NCT02731638|63076913|FG001|Overall Study|Lost to Follow-up|9|||
33656763|NCT03730662|63077360|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
33656764|NCT03730662|63077361|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
33656765|NCT03730662|63077362|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
33656766|NCT03730662|63077363|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
33656767|NCT03730662|63077360|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
33656768|NCT03730662|63077361|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
33656769|NCT03730662|63077362|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
33656770|NCT03730662|63077363|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
33656771|NCT03730662|63077360|FG000|Treatment Period (52 Weeks)|Death|6|||
33656772|NCT03730662|63077361|FG001|Treatment Period (52 Weeks)|Death|2|||
33656773|NCT03730662|63077362|FG002|Treatment Period (52 Weeks)|Death|2|||
33656774|NCT03730662|63077363|FG003|Treatment Period (52 Weeks)|Death|9|||
33656775|NCT03730662|63077360|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
33656776|NCT03730662|63077361|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
33656777|NCT03730662|63077362|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
33656778|NCT03730662|63077363|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
33656779|NCT03730662|63077360|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
33656780|NCT03730662|63077361|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
33656781|NCT03730662|63077362|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
33656782|NCT03730662|63077363|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
33656783|NCT03730662|63077360|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
33656784|NCT03730662|63077361|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
33656785|NCT03730662|63077362|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
33656786|NCT03730662|63077363|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
33656787|NCT03730662|63077360|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
33656788|NCT03730662|63077361|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
33656789|NCT03730662|63077362|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
33656790|NCT03730662|63077363|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
33656791|NCT03730662|63077360|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
33656792|NCT03730662|63077361|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
33656793|NCT03730662|63077362|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
33656794|NCT03730662|63077363|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
33656795|NCT03730662|63077360|FG000|Variable Treatment Period|Adverse Event|1|||
33656796|NCT03730662|63077361|FG001|Variable Treatment Period|Adverse Event|2|||
33656797|NCT03730662|63077362|FG002|Variable Treatment Period|Adverse Event|0|||
33656798|NCT03730662|63077363|FG003|Variable Treatment Period|Adverse Event|7|||
33656799|NCT03730662|63077360|FG000|Variable Treatment Period|Death|9|||
33656800|NCT03730662|63077361|FG001|Variable Treatment Period|Death|0|||
33656801|NCT03730662|63077362|FG002|Variable Treatment Period|Death|6|||
33481307|NCT02905006|62858043|FG005|Overall Study|Patient randomized by mistake|1|||
33656802|NCT03730662|63077363|FG003|Variable Treatment Period|Death|26|||
33656803|NCT03730662|63077360|FG000|Variable Treatment Period|Lost to Follow-up|2|||
33656804|NCT03730662|63077361|FG001|Variable Treatment Period|Lost to Follow-up|1|||
33656805|NCT03730662|63077362|FG002|Variable Treatment Period|Lost to Follow-up|4|||
33656806|NCT03730662|63077363|FG003|Variable Treatment Period|Lost to Follow-up|11|||
33656807|NCT03730662|63077360|FG000|Variable Treatment Period|Personal Reason|0|||
33656808|NCT03730662|63077361|FG001|Variable Treatment Period|Personal Reason|2|||
33656809|NCT03730662|63077362|FG002|Variable Treatment Period|Personal Reason|1|||
33656810|NCT03730662|63077363|FG003|Variable Treatment Period|Personal Reason|6|||
33656811|NCT03730662|63077360|FG000|Variable Treatment Period|Physician Decision|0|||
33656812|NCT03730662|63077361|FG001|Variable Treatment Period|Physician Decision|0|||
33551962|NCT02648438|62944437|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
33656813|NCT03730662|63077362|FG002|Variable Treatment Period|Physician Decision|0|||
33656814|NCT03730662|63077363|FG003|Variable Treatment Period|Physician Decision|3|||
33656815|NCT03730662|63077360|FG000|Variable Treatment Period|Protocol Violation|0|||
33656816|NCT03730662|63077361|FG001|Variable Treatment Period|Protocol Violation|1|||
33656817|NCT03730662|63077362|FG002|Variable Treatment Period|Protocol Violation|1|||
33656818|NCT03730662|63077363|FG003|Variable Treatment Period|Protocol Violation|1|||
33656819|NCT03730662|63077360|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
33656820|NCT03730662|63077361|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
33656821|NCT03730662|63077362|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
33656822|NCT03730662|63077363|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
33656823|NCT03185832|63077465|FG000|Overall Study|Death|9|||
33656824|NCT03185832|63077466|FG001|Overall Study|Death|14|||
33656825|NCT03185832|63077467|FG002|Overall Study|Death|9|||
33656826|NCT03185832|63077468|FG003|Overall Study|Death|7|||
33656827|NCT03185832|63077465|FG000|Overall Study|Withdrawn - vital status available|0|||
33656828|NCT03185832|63077466|FG001|Overall Study|Withdrawn - vital status available|1|||
33656829|NCT03185832|63077467|FG002|Overall Study|Withdrawn - vital status available|1|||
33656830|NCT03185832|63077468|FG003|Overall Study|Withdrawn - vital status available|4|||
33656831|NCT04569786|63077520|FG000|Overall Study|Lost to Follow-up|1|||
33656832|NCT04569786|63077521|FG001|Overall Study|Lost to Follow-up|0|||
33656833|NCT04569786|63077522|FG002|Overall Study|Lost to Follow-up|4|||
33656834|NCT04569786|63077523|FG003|Overall Study|Lost to Follow-up|1|||
33656835|NCT04569786|63077524|FG004|Overall Study|Lost to Follow-up|0|||
33656836|NCT04569786|63077520|FG000|Overall Study|Withdrawal by Subject|0|||
33656837|NCT04569786|63077521|FG001|Overall Study|Withdrawal by Subject|0|||
33656838|NCT04569786|63077522|FG002|Overall Study|Withdrawal by Subject|0|||
33656839|NCT04569786|63077523|FG003|Overall Study|Withdrawal by Subject|5|||
33656840|NCT04569786|63077524|FG004|Overall Study|Withdrawal by Subject|1|||
33656841|NCT04569786|63077520|FG000|Overall Study|Physician Decision|0|||
33656842|NCT04569786|63077521|FG001|Overall Study|Physician Decision|0|||
33656843|NCT04569786|63077522|FG002|Overall Study|Physician Decision|0|||
33656844|NCT04569786|63077523|FG003|Overall Study|Physician Decision|1|||
33656845|NCT04569786|63077524|FG004|Overall Study|Physician Decision|0|||
33656846|NCT01826981|63077700|FG000|Overall Study|Lack of Efficacy|0|||
33656847|NCT01826981|63077701|FG001|Overall Study|Lack of Efficacy|1|||
33656848|NCT01826981|63077702|FG002|Overall Study|Lack of Efficacy|0|||
33656849|NCT01826981|63077703|FG003|Overall Study|Lack of Efficacy|0|||
33656850|NCT01826981|63077704|FG004|Overall Study|Lack of Efficacy|5|||
33656851|NCT01826981|63077705|FG005|Overall Study|Lack of Efficacy|0|||
33656852|NCT01826981|63077706|FG006|Overall Study|Lack of Efficacy|0|||
33656853|NCT01826981|63077707|FG007|Overall Study|Lack of Efficacy|8|||
33656854|NCT01826981|63077708|FG008|Overall Study|Lack of Efficacy|7|||
33656855|NCT01826981|63077709|FG009|Overall Study|Lack of Efficacy|0|||
33656856|NCT01826981|63077710|FG010|Overall Study|Lack of Efficacy|1|||
33481308|NCT01066780|62858081|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
33481309|NCT01066780|62858082|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
33481310|NCT02975206|62858089|FG000|Overall Study|Withdrawal by Subject|14|||
33481311|NCT02975206|62858090|FG001|Overall Study|Withdrawal by Subject|11|||
33481312|NCT02975206|62858091|FG002|Overall Study|Withdrawal by Subject|11|||
33481313|NCT02975206|62858089|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
33481314|NCT02975206|62858090|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
33481315|NCT02975206|62858091|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
33481316|NCT01066156|62858099|FG000|Overall Study|ineligible|2|||
33481317|NCT01066156|62858099|FG000|Overall Study|Lost to Follow-up|7|||
33481318|NCT01066156|62858099|FG000|Overall Study|Withdrawal by Subject|1|||
33481319|NCT02980042|62858105|FG000|Overall Study|Lost to Follow-up|5|||
33551963|NCT02648438|62944438|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
33656857|NCT01826981|63077711|FG011|Overall Study|Lack of Efficacy|0|||
33656858|NCT01826981|63077712|FG012|Overall Study|Lack of Efficacy|0|||
33656859|NCT01826981|63077713|FG013|Overall Study|Lack of Efficacy|3|||
33656860|NCT01826981|63077714|FG014|Overall Study|Lack of Efficacy|0|||
33656861|NCT01826981|63077700|FG000|Overall Study|Lost to Follow-up|0|||
33656862|NCT01826981|63077701|FG001|Overall Study|Lost to Follow-up|0|||
33656863|NCT01826981|63077702|FG002|Overall Study|Lost to Follow-up|0|||
33656864|NCT01826981|63077703|FG003|Overall Study|Lost to Follow-up|0|||
33656865|NCT01826981|63077704|FG004|Overall Study|Lost to Follow-up|1|||
33656866|NCT01826981|63077705|FG005|Overall Study|Lost to Follow-up|1|||
33656867|NCT01826981|63077706|FG006|Overall Study|Lost to Follow-up|0|||
33656868|NCT01826981|63077707|FG007|Overall Study|Lost to Follow-up|1|||
33481320|NCT02980042|62858106|FG001|Overall Study|Lost to Follow-up|0|||
33481321|NCT02980042|62858105|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
33481322|NCT02980042|62858106|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
33481323|NCT01066000|62858124|FG000|Overall Study|Protocol Violation|4|||
33481324|NCT01066000|62858124|FG000|Overall Study|Death|3|||
33551964|NCT02648438|62944436|FG000|Overall Study|Protocol Violation|2|||
33481325|NCT01066000|62858124|FG000|Overall Study|Withdrawal by Subject|1|||
33481326|NCT01066000|62858124|FG000|Overall Study|Adverse Event|1|||
33481327|NCT01065844|62858128|FG000|Overall Study|Adverse Event|5|||
33481328|NCT00004635|62858134|FG000|Period One|refused|2|||
33481329|NCT00004635|62858135|FG001|Period One|refused|1|||
33481330|NCT00004635|62858134|FG000|Period One|Withdrawal by Subject|1|||
33481331|NCT00004635|62858135|FG001|Period One|Withdrawal by Subject|1|||
33481332|NCT00004635|62858134|FG000|Period One|Protocol Violation|1|||
33481333|NCT00004635|62858135|FG001|Period One|Protocol Violation|0|||
33481334|NCT00004635|62858134|FG000|Period One|PSA did not go <5 ng/mL|1|||
33481335|NCT00004635|62858135|FG001|Period One|PSA did not go <5 ng/mL|0|||
33481336|NCT00004635|62858134|FG000|Period One|second malignancy|1|||
33481337|NCT00004635|62858135|FG001|Period One|second malignancy|0|||
33481338|NCT00004635|62858134|FG000|Period One|progressed|0|||
33551965|NCT02648438|62944437|FG001|Overall Study|Protocol Violation|0|||
33551966|NCT02648438|62944438|FG002|Overall Study|Protocol Violation|0|||
33551967|NCT02648438|62944436|FG000|Overall Study|Withdrawal by Subject|1|||
33551968|NCT02648438|62944437|FG001|Overall Study|Withdrawal by Subject|1|||
33551969|NCT02648438|62944438|FG002|Overall Study|Withdrawal by Subject|0|||
33551970|NCT02415556|62944458|FG000|Overall Study|Adverse Event|3|||
33551971|NCT02415556|62944459|FG001|Overall Study|Adverse Event|4|||
33656869|NCT01826981|63077708|FG008|Overall Study|Lost to Follow-up|0|||
33656870|NCT01826981|63077709|FG009|Overall Study|Lost to Follow-up|1|||
33656871|NCT01826981|63077710|FG010|Overall Study|Lost to Follow-up|1|||
33481339|NCT00004635|62858135|FG001|Period One|progressed|2|||
33481340|NCT00004635|62858134|FG000|Period One|health problem|0|||
33481341|NCT00004635|62858135|FG001|Period One|health problem|1|||
33551972|NCT02415556|62944460|FG002|Overall Study|Adverse Event|2|||
33551973|NCT02415556|62944461|FG003|Overall Study|Adverse Event|4|||
33551974|NCT02415556|62944458|FG000|Overall Study|Lost to Follow-up|4|||
33551975|NCT02415556|62944459|FG001|Overall Study|Lost to Follow-up|5|||
33551976|NCT02415556|62944460|FG002|Overall Study|Lost to Follow-up|4|||
33551977|NCT02415556|62944461|FG003|Overall Study|Lost to Follow-up|1|||
33551978|NCT02415556|62944458|FG000|Overall Study|Withdrawal by Subject|13|||
33551979|NCT02415556|62944459|FG001|Overall Study|Withdrawal by Subject|4|||
33551980|NCT02415556|62944460|FG002|Overall Study|Withdrawal by Subject|14|||
33551981|NCT02415556|62944461|FG003|Overall Study|Withdrawal by Subject|12|||
33551982|NCT02415556|62944458|FG000|Overall Study|Physician Decision|1|||
33551983|NCT02415556|62944459|FG001|Overall Study|Physician Decision|3|||
33551984|NCT02415556|62944460|FG002|Overall Study|Physician Decision|1|||
33551985|NCT02415556|62944461|FG003|Overall Study|Physician Decision|2|||
33551986|NCT02415556|62944458|FG000|Overall Study|Censored - study completion|4|||
33551987|NCT02415556|62944459|FG001|Overall Study|Censored - study completion|5|||
33551988|NCT02415556|62944460|FG002|Overall Study|Censored - study completion|1|||
33551989|NCT02415556|62944461|FG003|Overall Study|Censored - study completion|0|||
33551990|NCT02415556|62944458|FG000|Overall Study|Family-related issues|0|||
33551991|NCT02415556|62944459|FG001|Overall Study|Family-related issues|0|||
33551992|NCT02415556|62944460|FG002|Overall Study|Family-related issues|0|||
33551993|NCT02415556|62944461|FG003|Overall Study|Family-related issues|1|||
33551994|NCT02807623|62944474|FG000|Overall Study|Lost to Follow-up|23|||
33551995|NCT02807623|62944475|FG001|Overall Study|Lost to Follow-up|18|||
33551996|NCT02807623|62944476|FG002|Overall Study|Lost to Follow-up|22|||
33551997|NCT02807623|62944474|FG000|Overall Study|Drug intolerance|0|||
33551998|NCT02807623|62944475|FG001|Overall Study|Drug intolerance|1|||
33551999|NCT02807623|62944476|FG002|Overall Study|Drug intolerance|0|||
33552000|NCT02807623|62944474|FG000|Overall Study|incomplete blood draw|0|||
33552001|NCT02807623|62944475|FG001|Overall Study|incomplete blood draw|2|||
33552002|NCT02807623|62944476|FG002|Overall Study|incomplete blood draw|1|||
33552003|NCT02805907|62944495|FG000|Overall Study|Lost to Follow-up|3|||
33552004|NCT02805907|62944496|FG001|Overall Study|Lost to Follow-up|3|||
33552005|NCT02723175|62944504|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
33552006|NCT02723175|62944505|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
33481342|NCT00004635|62858134|FG000|Period One|discrepancy in data entry|0|||
33552007|NCT02723175|62944504|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
33552008|NCT02723175|62944505|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
33552009|NCT02801617|62944513|FG000|Overall Study|Protocol Violation|2|||
33552010|NCT02801617|62944514|FG001|Overall Study|Protocol Violation|6|||
33552011|NCT01334515|62944526|FG000|Overall Study|Adverse Event|1|||
33552012|NCT01334515|62944527|FG001|Overall Study|Adverse Event|6|||
33552013|NCT01334515|62944526|FG000|Overall Study|Death|1|||
33552014|NCT01334515|62944527|FG001|Overall Study|Death|0|||
33481343|NCT00004635|62858135|FG001|Period One|discrepancy in data entry|1|||
33552015|NCT01334515|62944526|FG000|Overall Study|Lack of Efficacy|8|||
33481344|NCT00004635|62858134|FG000|Period Two|progression|2|||
33481345|NCT00004635|62858135|FG001|Period Two|progression|3|||
33481346|NCT00004635|62858134|FG000|Period Two|Adverse Event|1|||
33481347|NCT00004635|62858135|FG001|Period Two|Adverse Event|0|||
33481348|NCT00004635|62858134|FG000|Period Two|refused|0|||
33481349|NCT00004635|62858135|FG001|Period Two|refused|2|||
33481350|NCT00004635|62858134|FG000|Period Two|health problem|1|||
33481351|NCT00004635|62858135|FG001|Period Two|health problem|1|||
33481352|NCT00004635|62858134|FG000|Period Two|travel issues|0|||
33481353|NCT00004635|62858135|FG001|Period Two|travel issues|1|||
33481354|NCT00004635|62858134|FG000|Period Two|secondary malignancy|1|||
33481355|NCT00004635|62858135|FG001|Period Two|secondary malignancy|1|||
33481356|NCT00004635|62858134|FG000|Period Two|Lost to Follow-up|1|||
33481357|NCT00004635|62858135|FG001|Period Two|Lost to Follow-up|0|||
33481358|NCT00004635|62858134|FG000|Period Two|discrepancy in data entry|0|||
33481359|NCT00004635|62858135|FG001|Period Two|discrepancy in data entry|1|||
33481360|NCT00004563|62858146|FG000|Overall Study|Withdrawal by Subject|20|||
33481361|NCT00004563|62858147|FG001|Overall Study|Withdrawal by Subject|16|||
33481362|NCT00004563|62858146|FG000|Overall Study|Lack of Efficacy|3|||
33481363|NCT00004563|62858147|FG001|Overall Study|Lack of Efficacy|5|||
33481364|NCT00004563|62858146|FG000|Overall Study|Death|2|||
33481365|NCT00004563|62858147|FG001|Overall Study|Death|3|||
33481366|NCT00003645|62858155|FG000|Overall Study|Death|4|||
33481367|NCT00003645|62858156|FG001|Overall Study|Death|1|||
33481368|NCT00003645|62858155|FG000|Overall Study|Lost to Follow-up|7|||
33481369|NCT00003645|62858156|FG001|Overall Study|Lost to Follow-up|8|||
33481370|NCT00003645|62858155|FG000|Overall Study|Withdrawal by Subject|1|||
33481371|NCT00003645|62858156|FG001|Overall Study|Withdrawal by Subject|3|||
33481372|NCT00003537|62858164|FG000|Overall Study|Not evalauable|1|||
33481373|NCT00003531|62858168|FG000|Overall Study|Not evaluable|10|||
33481374|NCT02918968|62858174|FG000|1st Line AAT|Progressive disease|9|||
33552016|NCT01334515|62944527|FG001|Overall Study|Lack of Efficacy|21|||
33552017|NCT01334515|62944526|FG000|Overall Study|Physician Decision|1|||
33552018|NCT01334515|62944527|FG001|Overall Study|Physician Decision|1|||
33552019|NCT01334515|62944526|FG000|Overall Study|Withdrawal by Subject|1|||
33481375|NCT02918968|62858175|FG001|1st Line AAT|Progressive disease|4|||
33481376|NCT02918968|62858174|FG000|1st Line AAT|Adverse Event|12|||
33481377|NCT02918968|62858175|FG001|1st Line AAT|Adverse Event|3|||
33481378|NCT02918968|62858174|FG000|1st Line AAT|Physician Decision|4|||
33481379|NCT02918968|62858175|FG001|1st Line AAT|Physician Decision|2|||
33481380|NCT02918968|62858174|FG000|1st Line AAT|Withdrawal by Subject|2|||
33481381|NCT02918968|62858175|FG001|1st Line AAT|Withdrawal by Subject|1|||
33481382|NCT02918968|62858174|FG000|1st Line AAT|Lost to Follow-up|0|||
33481383|NCT02918968|62858175|FG001|1st Line AAT|Lost to Follow-up|1|||
33481384|NCT02918968|62858174|FG000|1st Line AAT|Death|1|||
33481385|NCT02918968|62858175|FG001|1st Line AAT|Death|0|||
33481386|NCT02918968|62858174|FG000|1st Line AAT|Miscellaneous|1|||
33481387|NCT02918968|62858175|FG001|1st Line AAT|Miscellaneous|0|||
33481388|NCT02918968|62858174|FG000|2nd Line AAT|Progressive disease|21|||
33481389|NCT02918968|62858175|FG001|2nd Line AAT|Progressive disease|3|||
33481390|NCT02918968|62858174|FG000|2nd Line AAT|Adverse Event|2|||
33481391|NCT02918968|62858175|FG001|2nd Line AAT|Adverse Event|5|||
33552020|NCT01334515|62944527|FG001|Overall Study|Withdrawal by Subject|1|||
33552021|NCT02802319|62944535|FG000|Overall Study|Physician Decision|2|||
33552022|NCT02802319|62944536|FG001|Overall Study|Physician Decision|1|||
33552023|NCT02802319|62944535|FG000|Overall Study|Lost to Follow-up|0|||
33552024|NCT02802319|62944536|FG001|Overall Study|Lost to Follow-up|4|||
33552025|NCT02415400|62944546|FG000|Overall Study|Adverse Event|0|||
33552026|NCT02415400|62944547|FG001|Overall Study|Adverse Event|1|||
33552027|NCT02415400|62944548|FG002|Overall Study|Adverse Event|1|||
33552028|NCT02415400|62944549|FG003|Overall Study|Adverse Event|2|||
33552029|NCT02415400|62944546|FG000|Overall Study|Participant request to stop therapy|4|||
33552030|NCT02415400|62944547|FG001|Overall Study|Participant request to stop therapy|3|||
33552031|NCT02415400|62944548|FG002|Overall Study|Participant request to stop therapy|8|||
33656872|NCT01826981|63077711|FG011|Overall Study|Lost to Follow-up|1|||
33481392|NCT02918968|62858174|FG000|2nd Line AAT|Physician Decision|0|||
33481393|NCT02918968|62858175|FG001|2nd Line AAT|Physician Decision|1|||
33481394|NCT02918968|62858174|FG000|2nd Line AAT|Withdrawal by Subject|2|||
33481395|NCT02918968|62858175|FG001|2nd Line AAT|Withdrawal by Subject|2|||
33481396|NCT02918968|62858174|FG000|2nd Line AAT|Death|0|||
33481397|NCT02918968|62858175|FG001|2nd Line AAT|Death|1|||
33481398|NCT01065766|62858183|FG000|Overall Study|Assessed before the contracted date|1|||
33481399|NCT01065766|62858183|FG000|Overall Study|Contraindication to administration|6|||
33481400|NCT01065766|62858183|FG000|Overall Study|Violated dosage/administration|25|||
33481401|NCT01063972|62858189|FG000|Overall Study|Death|12|||
33552032|NCT02415400|62944549|FG003|Overall Study|Participant request to stop therapy|6|||
33552033|NCT02415400|62944546|FG000|Overall Study|Participant withdrew consent|14|||
33552034|NCT02415400|62944547|FG001|Overall Study|Participant withdrew consent|12|||
33481402|NCT01063972|62858190|FG001|Overall Study|Death|11|||
33481403|NCT01063972|62858189|FG000|Overall Study|Incarcerated|2|||
33552035|NCT02415400|62944548|FG002|Overall Study|Participant withdrew consent|30|||
33552036|NCT02415400|62944549|FG003|Overall Study|Participant withdrew consent|21|||
33552037|NCT02415400|62944546|FG000|Overall Study|Death|39|||
33552038|NCT02415400|62944547|FG001|Overall Study|Death|41|||
33552039|NCT02415400|62944548|FG002|Overall Study|Death|35|||
33481404|NCT01063972|62858190|FG001|Overall Study|Incarcerated|1|||
33552040|NCT02415400|62944549|FG003|Overall Study|Death|42|||
33552041|NCT02415400|62944546|FG000|Overall Study|Lost to Follow-up|3|||
33552042|NCT02415400|62944547|FG001|Overall Study|Lost to Follow-up|3|||
33552043|NCT02415400|62944548|FG002|Overall Study|Lost to Follow-up|2|||
33552044|NCT02415400|62944549|FG003|Overall Study|Lost to Follow-up|5|||
33552045|NCT02415400|62944546|FG000|Overall Study|Poor/Non-Compliance|0|||
33552046|NCT02415400|62944547|FG001|Overall Study|Poor/Non-Compliance|1|||
33552047|NCT02415400|62944548|FG002|Overall Study|Poor/Non-Compliance|3|||
33552048|NCT02415400|62944549|FG003|Overall Study|Poor/Non-Compliance|4|||
33552049|NCT02415400|62944546|FG000|Overall Study|Participant no longer meets criteria|2|||
33656873|NCT01826981|63077712|FG012|Overall Study|Lost to Follow-up|1|||
33656874|NCT01826981|63077713|FG013|Overall Study|Lost to Follow-up|0|||
33656875|NCT01826981|63077714|FG014|Overall Study|Lost to Follow-up|0|||
33656876|NCT01826981|63077700|FG000|Overall Study|Withdrew Consent|0|||
33656877|NCT01826981|63077701|FG001|Overall Study|Withdrew Consent|0|||
33656878|NCT01826981|63077702|FG002|Overall Study|Withdrew Consent|0|||
33656879|NCT01826981|63077703|FG003|Overall Study|Withdrew Consent|0|||
33481405|NCT00003483|62858196|FG000|Overall Study|Not evaluable|1|||
33481406|NCT00003477|62858200|FG000|Overall Study|Not evalauable|4|||
33656880|NCT01826981|63077704|FG004|Overall Study|Withdrew Consent|0|||
33656881|NCT01826981|63077705|FG005|Overall Study|Withdrew Consent|0|||
33656882|NCT01826981|63077706|FG006|Overall Study|Withdrew Consent|1|||
33656883|NCT01826981|63077707|FG007|Overall Study|Withdrew Consent|1|||
33656884|NCT01826981|63077708|FG008|Overall Study|Withdrew Consent|0|||
33656885|NCT01826981|63077709|FG009|Overall Study|Withdrew Consent|0|||
33656886|NCT01826981|63077710|FG010|Overall Study|Withdrew Consent|0|||
33656887|NCT01826981|63077711|FG011|Overall Study|Withdrew Consent|1|||
33656888|NCT01826981|63077712|FG012|Overall Study|Withdrew Consent|0|||
33656889|NCT01826981|63077713|FG013|Overall Study|Withdrew Consent|1|||
33656890|NCT01826981|63077714|FG014|Overall Study|Withdrew Consent|0|||
33656891|NCT01826981|63077700|FG000|Overall Study|Adverse Event|0|||
33656892|NCT01826981|63077701|FG001|Overall Study|Adverse Event|0|||
33656893|NCT01826981|63077702|FG002|Overall Study|Adverse Event|0|||
33656894|NCT01826981|63077703|FG003|Overall Study|Adverse Event|0|||
33656895|NCT01826981|63077704|FG004|Overall Study|Adverse Event|1|||
33656896|NCT01826981|63077705|FG005|Overall Study|Adverse Event|0|||
33656897|NCT01826981|63077706|FG006|Overall Study|Adverse Event|0|||
33656898|NCT01826981|63077707|FG007|Overall Study|Adverse Event|0|||
33656899|NCT01826981|63077708|FG008|Overall Study|Adverse Event|0|||
33656900|NCT01826981|63077709|FG009|Overall Study|Adverse Event|0|||
33656901|NCT01826981|63077710|FG010|Overall Study|Adverse Event|0|||
33656902|NCT01826981|63077711|FG011|Overall Study|Adverse Event|0|||
33656903|NCT01826981|63077712|FG012|Overall Study|Adverse Event|0|||
33656904|NCT01826981|63077713|FG013|Overall Study|Adverse Event|0|||
33656905|NCT01826981|63077714|FG014|Overall Study|Adverse Event|0|||
33656906|NCT01826981|63077700|FG000|Overall Study|Upper G-I Haemorrhage|0|||
33656907|NCT01826981|63077701|FG001|Overall Study|Upper G-I Haemorrhage|0|||
33656908|NCT01826981|63077702|FG002|Overall Study|Upper G-I Haemorrhage|0|||
33364717|NCT02393248|62743324|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
33481407|NCT00003471|62858204|FG000|Overall Study|Not evaluable|4|||
33481408|NCT04185220|62858210|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
33481409|NCT04185220|62858211|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
33481410|NCT04185220|62858210|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
33481411|NCT04185220|62858211|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
33481412|NCT00002931|62858218|FG000|Overall Study|rapidly progressing disease during|2|||
33552050|NCT02415400|62944547|FG001|Overall Study|Participant no longer meets criteria|0|||
33656909|NCT01826981|63077703|FG003|Overall Study|Upper G-I Haemorrhage|0|||
33656910|NCT01826981|63077704|FG004|Overall Study|Upper G-I Haemorrhage|0|||
33656911|NCT01826981|63077705|FG005|Overall Study|Upper G-I Haemorrhage|0|||
33656912|NCT01826981|63077706|FG006|Overall Study|Upper G-I Haemorrhage|0|||
33656913|NCT01826981|63077707|FG007|Overall Study|Upper G-I Haemorrhage|0|||
33552051|NCT02415400|62944548|FG002|Overall Study|Participant no longer meets criteria|0|||
33552052|NCT02415400|62944549|FG003|Overall Study|Participant no longer meets criteria|1|||
33552053|NCT02415400|62944546|FG000|Overall Study|Participant doesn't answer phone|1|||
33656914|NCT01826981|63077708|FG008|Overall Study|Upper G-I Haemorrhage|0|||
33656915|NCT01826981|63077709|FG009|Overall Study|Upper G-I Haemorrhage|0|||
33656916|NCT01826981|63077710|FG010|Overall Study|Upper G-I Haemorrhage|0|||
33552054|NCT02415400|62944547|FG001|Overall Study|Participant doesn't answer phone|0|||
33656917|NCT01826981|63077711|FG011|Overall Study|Upper G-I Haemorrhage|0|||
33481413|NCT02918266|62858233|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
33481414|NCT02918266|62858234|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33481415|NCT02918266|62858235|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33552055|NCT02415400|62944548|FG002|Overall Study|Participant doesn't answer phone|0|||
33552056|NCT02415400|62944549|FG003|Overall Study|Participant doesn't answer phone|0|||
33552057|NCT02415400|62944546|FG000|Overall Study|Participant wanted home visits|1|||
33552058|NCT02415400|62944547|FG001|Overall Study|Participant wanted home visits|0|||
33552059|NCT02415400|62944548|FG002|Overall Study|Participant wanted home visits|0|||
33552060|NCT02415400|62944549|FG003|Overall Study|Participant wanted home visits|0|||
33481416|NCT02918266|62858236|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33481417|NCT02918266|62858237|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33481418|NCT02918266|62858238|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33481419|NCT02918266|62858239|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
33552061|NCT02415400|62944546|FG000|Overall Study|Randomized in error|2|||
33552062|NCT02415400|62944547|FG001|Overall Study|Randomized in error|0|||
33552063|NCT02415400|62944548|FG002|Overall Study|Randomized in error|0|||
33552064|NCT02415400|62944549|FG003|Overall Study|Randomized in error|0|||
33552065|NCT02415400|62944546|FG000|Overall Study|No study drug on site|0|||
33552066|NCT02415400|62944547|FG001|Overall Study|No study drug on site|1|||
33552067|NCT02415400|62944548|FG002|Overall Study|No study drug on site|0|||
33552068|NCT02415400|62944549|FG003|Overall Study|No study drug on site|0|||
33552069|NCT02415400|62944546|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
33552070|NCT02415400|62944547|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
33481420|NCT02918266|62858240|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33481421|NCT02918266|62858241|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
33481422|NCT02918266|62858242|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33552071|NCT02415400|62944548|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
33552072|NCT02415400|62944549|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
33552073|NCT02415400|62944546|FG000|Overall Study|Coagulation values cannot be set|0|||
33552074|NCT02415400|62944547|FG001|Overall Study|Coagulation values cannot be set|0|||
33552075|NCT02415400|62944548|FG002|Overall Study|Coagulation values cannot be set|1|||
33552076|NCT02415400|62944549|FG003|Overall Study|Coagulation values cannot be set|0|||
33552077|NCT02415400|62944546|FG000|Overall Study|State regulations prevent participation|0|||
33552078|NCT02415400|62944547|FG001|Overall Study|State regulations prevent participation|0|||
33552079|NCT02415400|62944548|FG002|Overall Study|State regulations prevent participation|1|||
33552080|NCT02415400|62944549|FG003|Overall Study|State regulations prevent participation|0|||
33552081|NCT02415400|62944546|FG000|Overall Study|Poor treatment monitoring|0|||
33552082|NCT02415400|62944547|FG001|Overall Study|Poor treatment monitoring|0|||
33552083|NCT02415400|62944548|FG002|Overall Study|Poor treatment monitoring|1|||
33552084|NCT02415400|62944549|FG003|Overall Study|Poor treatment monitoring|0|||
33656918|NCT01826981|63077712|FG012|Overall Study|Upper G-I Haemorrhage|0|||
33656919|NCT01826981|63077713|FG013|Overall Study|Upper G-I Haemorrhage|1|||
33656920|NCT01826981|63077714|FG014|Overall Study|Upper G-I Haemorrhage|0|||
33656921|NCT01826981|63077700|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
33656922|NCT01826981|63077701|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
33656923|NCT01826981|63077702|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
33656924|NCT01826981|63077703|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
33656925|NCT01826981|63077704|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
33656926|NCT01826981|63077705|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
33656927|NCT01826981|63077706|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
33656928|NCT01826981|63077707|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
33656929|NCT01826981|63077708|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
33656930|NCT01826981|63077709|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
33656931|NCT01826981|63077710|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
33656932|NCT01826981|63077711|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
33656933|NCT01826981|63077712|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
33656934|NCT01826981|63077713|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
33656935|NCT01826981|63077714|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
33656936|NCT01804049|63077786|FG000|Overall Study|Adverse Event|2|||
33656937|NCT01804049|63077787|FG001|Overall Study|Adverse Event|10|||
33656938|NCT01804049|63077786|FG000|Overall Study|Lost to Follow-up|2|||
33656939|NCT01804049|63077787|FG001|Overall Study|Lost to Follow-up|1|||
33656940|NCT01804049|63077786|FG000|Overall Study|Decreased interest/personal|4|||
33656941|NCT01804049|63077787|FG001|Overall Study|Decreased interest/personal|5|||
33552085|NCT02415400|62944546|FG000|Overall Study|Participant in jail|0|||
33552086|NCT02415400|62944547|FG001|Overall Study|Participant in jail|0|||
33552087|NCT02415400|62944548|FG002|Overall Study|Participant in jail|1|||
33552088|NCT02415400|62944549|FG003|Overall Study|Participant in jail|0|||
33552089|NCT02415400|62944546|FG000|Overall Study|Investigator decision|0|||
33552090|NCT02415400|62944547|FG001|Overall Study|Investigator decision|0|||
33552091|NCT02415400|62944548|FG002|Overall Study|Investigator decision|1|||
33656942|NCT01804049|63077786|FG000|Overall Study|Other health concerns|2|||
33481423|NCT02918266|62858243|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33481424|NCT00041067|62858263|FG000|Overall Study|Adverse Event|20|||
33481425|NCT00041067|62858263|FG000|Overall Study|Progression|19|||
33481426|NCT00041067|62858263|FG000|Overall Study|Patient refusal|12|||
33481427|NCT00041067|62858263|FG000|Overall Study|Other reasons|23|||
33481428|NCT00041067|62858263|FG000|Overall Study|Ineligible|2|||
33481429|NCT01063036|62858268|FG000|Participants Treated With Study Drug|Adverse Event|1|||
33481430|NCT01063036|62858268|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
33656943|NCT01804049|63077787|FG001|Overall Study|Other health concerns|7|||
33656944|NCT01804049|63077786|FG000|Overall Study|Moved out of area|0|||
33656945|NCT01804049|63077787|FG001|Overall Study|Moved out of area|7|||
33656946|NCT01804049|63077786|FG000|Overall Study|other MD recommended|1|||
33656947|NCT01804049|63077787|FG001|Overall Study|other MD recommended|1|||
33656948|NCT01804049|63077786|FG000|Overall Study|Enrollment in dual studies|0|||
33656949|NCT01804049|63077787|FG001|Overall Study|Enrollment in dual studies|1|||
33656950|NCT01826825|63077797|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
33656951|NCT01826825|63077798|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
33656952|NCT01803737|63077808|FG000|Overall Study|Lack of Time|1|||
33656953|NCT01803737|63077809|FG001|Overall Study|Lack of Time|0|||
33656954|NCT01803737|63077808|FG000|Overall Study|Medical Reason|0|||
33656955|NCT01803737|63077809|FG001|Overall Study|Medical Reason|1|||
33656956|NCT01803737|63077808|FG000|Overall Study|Lost to Follow-up|0|||
33656957|NCT01803737|63077809|FG001|Overall Study|Lost to Follow-up|2|||
33656958|NCT01826201|63077815|FG000|Overall Study|Non compliance with protocol|4|||
33656959|NCT01803269|63077846|FG000|Overall Study|Withdrawal by Subject|3|||
33656960|NCT01803269|63077847|FG001|Overall Study|Withdrawal by Subject|0|||
33656961|NCT01803269|63077848|FG002|Overall Study|Withdrawal by Subject|0|||
33656962|NCT01802879|63077856|FG000|Overall Study|Administrative problems|2|||
33656963|NCT01802879|63077856|FG000|Overall Study|Disease progression|6|||
33656964|NCT01825577|63077860|FG000|Overall Study|Physician Decision|2|||
33656965|NCT01825577|63077860|FG000|Overall Study|Withdrawal by Subject|1|||
33656966|NCT01825577|63077860|FG000|Overall Study|Withdrawn by family members|2|||
33656967|NCT01825577|63077860|FG000|Overall Study|Lack of Efficacy|3|||
33656968|NCT01802411|63077866|FG000|Overall Study|Death|2|||
33656969|NCT01802411|63077867|FG001|Overall Study|Death|1|||
33656970|NCT01802411|63077866|FG000|Overall Study|Adverse Event|2|||
33656971|NCT01802411|63077867|FG001|Overall Study|Adverse Event|7|||
33481431|NCT01063036|62858268|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
33481432|NCT01063036|62858268|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
33481433|NCT01063036|62858268|FG000|Participants Treated With Study Drug|Pregnancy|1|||
33481434|NCT01063036|62858268|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
33481435|NCT01063036|62858268|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
33481436|NCT01063036|62858268|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
33481437|NCT00040365|62858272|FG000|Overall Study|Death|1|||
33481438|NCT00040365|62858272|FG000|Overall Study|Progressive disease|7|||
33481439|NCT00040365|62858272|FG000|Overall Study|Lost to Follow-up|3|||
33481440|NCT02974114|62858279|FG000|Overall Study|Other (Not specified)|0|||
33481441|NCT02974114|62858280|FG001|Overall Study|Other (Not specified)|1|||
33481442|NCT02974114|62858281|FG002|Overall Study|Other (Not specified)|2|||
33481443|NCT00001959|62858291|FG000|Overall Study|newly diagnosed colon cancer|1|||
33481444|NCT00001959|62858291|FG000|Overall Study|disabling sedation|1|||
33552092|NCT02415400|62944549|FG003|Overall Study|Investigator decision|1|||
33552093|NCT02415400|62944546|FG000|Overall Study|Site closure; participant won't transfer|0|||
33552094|NCT02415400|62944547|FG001|Overall Study|Site closure; participant won't transfer|0|||
33552095|NCT02415400|62944548|FG002|Overall Study|Site closure; participant won't transfer|0|||
33552096|NCT02415400|62944549|FG003|Overall Study|Site closure; participant won't transfer|1|||
33552097|NCT04194801|62944566|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
33552098|NCT04194801|62944567|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
33552099|NCT04194801|62944568|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
33552100|NCT04194801|62944566|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
33656972|NCT01802411|63077866|FG000|Overall Study|Lack of Efficacy|8|||
33481445|NCT00001959|62858291|FG000|Overall Study|non-compliance|1|||
33481446|NCT00001941|62858295|FG000|Overall Study|not treated- rapidly progressing disease|0|||
33481447|NCT00001941|62858296|FG001|Overall Study|not treated- rapidly progressing disease|0|||
33552101|NCT04194801|62944567|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
33552102|NCT04194801|62944568|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
33552103|NCT04194801|62944566|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
33552104|NCT04194801|62944567|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
33656973|NCT01802411|63077867|FG001|Overall Study|Lack of Efficacy|10|||
33656974|NCT01802411|63077866|FG000|Overall Study|Withdrawal by Subject|0|||
33481448|NCT00001941|62858297|FG002|Overall Study|not treated- rapidly progressing disease|0|||
33656975|NCT01802411|63077867|FG001|Overall Study|Withdrawal by Subject|2|||
33552105|NCT04194801|62944568|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
33481449|NCT00001941|62858298|FG003|Overall Study|not treated- rapidly progressing disease|0|||
33481450|NCT00001941|62858299|FG004|Overall Study|not treated- rapidly progressing disease|1|||
33481451|NCT02978326|62858307|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
33481452|NCT02978326|62858308|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
33481453|NCT02978326|62858309|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
33552106|NCT04194801|62944566|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
33552107|NCT04194801|62944567|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
33552108|NCT04194801|62944568|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
33552109|NCT04194801|62944566|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
33552110|NCT04194801|62944567|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
33552111|NCT04194801|62944568|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
33552112|NCT04194801|62944566|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
33552113|NCT04194801|62944567|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
33552114|NCT04194801|62944568|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
33364718|NCT02393248|62743325|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
33364719|NCT02393248|62743326|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
33364720|NCT02393248|62743327|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
33364721|NCT02393248|62743303|FG000|Part 3: Combination Therapy|Disease Progression|0|||
33364722|NCT02393248|62743304|FG001|Part 3: Combination Therapy|Disease Progression|0|||
33481454|NCT02978326|62858307|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
33481455|NCT02978326|62858308|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
33481456|NCT02978326|62858309|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
33552115|NCT04194801|62944566|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
33552116|NCT04194801|62944567|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
33552117|NCT04194801|62944568|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
33552118|NCT04194801|62944566|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
33552119|NCT04194801|62944567|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
33552120|NCT04194801|62944568|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
33552121|NCT04194801|62944566|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
33552122|NCT04194801|62944567|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
33552123|NCT04194801|62944568|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
33552124|NCT04194801|62944566|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
33552125|NCT04194801|62944567|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
33552126|NCT04194801|62944568|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
33552127|NCT04194801|62944566|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
33552128|NCT04194801|62944567|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
33552129|NCT04194801|62944568|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
33552130|NCT04194801|62944566|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
33552131|NCT04194801|62944567|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
33552132|NCT04194801|62944568|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
33552133|NCT04194801|62944566|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
33552134|NCT04194801|62944567|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
33552135|NCT04194801|62944568|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
33552136|NCT04194801|62944566|FG000|Part Ib/II End of Study|Death|2|||
33552137|NCT04194801|62944567|FG001|Part Ib/II End of Study|Death|3|||
33552138|NCT04194801|62944568|FG002|Part Ib/II End of Study|Death|3|||
33552139|NCT04194801|62944566|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
33552140|NCT04194801|62944567|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
33552141|NCT04194801|62944568|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
33656976|NCT01802411|63077866|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
33656977|NCT01802411|63077867|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
33656978|NCT01802411|63077866|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
33656979|NCT01802411|63077867|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
33656980|NCT01802411|63077866|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
33481457|NCT02978326|62858307|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
33481458|NCT02978326|62858308|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
33481459|NCT02978326|62858309|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
33481460|NCT02978326|62858307|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
33481461|NCT02978326|62858308|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
33481462|NCT02978326|62858309|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
33481463|NCT01061866|62858319|FG000|Overall Study|Adverse Event|2|||
33481464|NCT01061008|62858325|FG000|Overall Study|Badiocephalic fistula failed|3|||
33656981|NCT01802411|63077867|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
33552142|NCT04194801|62944566|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
33481465|NCT01061008|62858326|FG001|Overall Study|Badiocephalic fistula failed|2|||
33481466|NCT01061008|62858325|FG000|Overall Study|Death|1|||
33481467|NCT01061008|62858326|FG001|Overall Study|Death|0|||
33481468|NCT01061008|62858325|FG000|Overall Study|Withdrawal by Subject|1|||
33481469|NCT01061008|62858326|FG001|Overall Study|Withdrawal by Subject|3|||
33481470|NCT01061008|62858325|FG000|Overall Study|Unable to exercise following surgery|1|||
33481471|NCT01061008|62858326|FG001|Overall Study|Unable to exercise following surgery|0|||
33481472|NCT01061008|62858325|FG000|Overall Study|Adverse Event|0|||
33481473|NCT01061008|62858326|FG001|Overall Study|Adverse Event|1|||
33481474|NCT00039741|62858336|FG000|Overall Study|Death|0|||
33481475|NCT00039741|62858337|FG001|Overall Study|Death|1|||
33481476|NCT00039741|62858338|FG002|Overall Study|Death|0|||
33481477|NCT00039741|62858339|FG003|Overall Study|Death|0|||
33481478|NCT00039741|62858336|FG000|Overall Study|Lost to Follow-up|3|||
33481479|NCT00039741|62858337|FG001|Overall Study|Lost to Follow-up|1|||
33481480|NCT00039741|62858338|FG002|Overall Study|Lost to Follow-up|5|||
33481481|NCT00039741|62858339|FG003|Overall Study|Lost to Follow-up|2|||
33481482|NCT00039741|62858336|FG000|Overall Study|Confounding medical condition|1|||
33481483|NCT00039741|62858337|FG001|Overall Study|Confounding medical condition|0|||
33481484|NCT00039741|62858338|FG002|Overall Study|Confounding medical condition|0|||
33481485|NCT00039741|62858339|FG003|Overall Study|Confounding medical condition|0|||
33481486|NCT00039741|62858336|FG000|Overall Study|Not able to get to clinic|5|||
33481487|NCT00039741|62858337|FG001|Overall Study|Not able to get to clinic|2|||
33481488|NCT00039741|62858338|FG002|Overall Study|Not able to get to clinic|0|||
33481489|NCT00039741|62858339|FG003|Overall Study|Not able to get to clinic|3|||
33481490|NCT00039741|62858336|FG000|Overall Study|Moved|3|||
33481491|NCT00039741|62858337|FG001|Overall Study|Moved|2|||
33481492|NCT00039741|62858338|FG002|Overall Study|Moved|3|||
33481493|NCT00039741|62858339|FG003|Overall Study|Moved|6|||
33481494|NCT00039741|62858336|FG000|Overall Study|Non-compliance with protocol|1|||
33481495|NCT00039741|62858337|FG001|Overall Study|Non-compliance with protocol|0|||
33481496|NCT00039741|62858338|FG002|Overall Study|Non-compliance with protocol|1|||
33552143|NCT04194801|62944567|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
33552144|NCT04194801|62944568|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
33552145|NCT04194801|62944566|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
33656982|NCT02963610|63077908|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
33656983|NCT02606136|63077990|FG000|Overall Study|Participant/Legal Guardian Decision|5|||
33656984|NCT02606136|63077990|FG000|Overall Study|Withdrawal by Subject|1|||
33656985|NCT01802333|63078133|FG000|Overall Study|Ineligible|2|||
33656986|NCT01802333|63078134|FG001|Overall Study|Ineligible|6|||
33656987|NCT01802333|63078135|FG002|Overall Study|Ineligible|8|||
33656988|NCT01802333|63078133|FG000|Overall Study|Adverse Event|1|||
33656989|NCT01802333|63078134|FG001|Overall Study|Adverse Event|8|||
33656990|NCT01802333|63078135|FG002|Overall Study|Adverse Event|8|||
33656991|NCT01802333|63078133|FG000|Overall Study|Withdrawal by Subject|6|||
33656992|NCT01802333|63078134|FG001|Overall Study|Withdrawal by Subject|6|||
33656993|NCT01802333|63078135|FG002|Overall Study|Withdrawal by Subject|5|||
33656994|NCT01802333|63078133|FG000|Overall Study|Progression/relapse|1|||
33656995|NCT01802333|63078134|FG001|Overall Study|Progression/relapse|3|||
33656996|NCT01802333|63078135|FG002|Overall Study|Progression/relapse|0|||
33656997|NCT01802333|63078133|FG000|Overall Study|Death|7|||
33656998|NCT01802333|63078134|FG001|Overall Study|Death|14|||
33656999|NCT01802333|63078135|FG002|Overall Study|Death|13|||
33657000|NCT01802333|63078133|FG000|Overall Study|Other - not protocol specified|32|||
33657001|NCT01802333|63078134|FG001|Overall Study|Other - not protocol specified|22|||
33657002|NCT01802333|63078135|FG002|Overall Study|Other - not protocol specified|24|||
33657003|NCT01802333|63078133|FG000|Overall Study|Did not start treatment|0|||
33657004|NCT01802333|63078134|FG001|Overall Study|Did not start treatment|2|||
33552146|NCT04194801|62944567|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
33552147|NCT04194801|62944568|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
33552148|NCT04194801|62944566|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
33552149|NCT04194801|62944567|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
33657005|NCT01802333|63078135|FG002|Overall Study|Did not start treatment|5|||
33657006|NCT00980655|63078180|FG000|Overall Study|Adverse Event|13|||
33657007|NCT00980655|63078181|FG001|Overall Study|Adverse Event|31|||
33481497|NCT00039741|62858339|FG003|Overall Study|Non-compliance with protocol|0|||
33481498|NCT00039741|62858336|FG000|Overall Study|Withdrew consent|0|||
33481499|NCT00039741|62858337|FG001|Overall Study|Withdrew consent|5|||
33481500|NCT00039741|62858338|FG002|Overall Study|Withdrew consent|0|||
33481501|NCT00039741|62858339|FG003|Overall Study|Withdrew consent|1|||
33481502|NCT00039741|62858336|FG000|Overall Study|Missed final visit|2|||
33552150|NCT04194801|62944568|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
33657008|NCT00980655|63078180|FG000|Overall Study|Death|0|||
33657009|NCT00980655|63078181|FG001|Overall Study|Death|7|||
33657010|NCT00980655|63078180|FG000|Overall Study|Protocol Violation|2|||
33657011|NCT00980655|63078181|FG001|Overall Study|Protocol Violation|7|||
33481503|NCT00039741|62858337|FG001|Overall Study|Missed final visit|1|||
33481504|NCT00039741|62858338|FG002|Overall Study|Missed final visit|2|||
33481505|NCT00039741|62858339|FG003|Overall Study|Missed final visit|2|||
33481506|NCT02973802|62858349|FG000|Overall Study|Lost to Follow-up|1|||
33481507|NCT02973802|62858349|FG000|Overall Study|Withdrawal by Subject|1|||
33481508|NCT02973100|62858358|FG000|Overall Study|Adverse Event|1|||
33481509|NCT02973100|62858359|FG001|Overall Study|Adverse Event|2|||
33552151|NCT02802865|62944592|FG000|Overall Study|Pregnancy|1|||
33657012|NCT00980655|63078180|FG000|Overall Study|Withdrawal by Subject|0|||
33657013|NCT00980655|63078181|FG001|Overall Study|Withdrawal by Subject|4|||
33657014|NCT00980655|63078180|FG000|Overall Study|Lost to Follow-up|0|||
33657015|NCT00980655|63078181|FG001|Overall Study|Lost to Follow-up|1|||
33657016|NCT00980655|63078180|FG000|Overall Study|Parent/legal guardian request|1|||
33657017|NCT00980655|63078181|FG001|Overall Study|Parent/legal guardian request|0|||
33657018|NCT00980655|63078180|FG000|Overall Study|Other|0|||
33657019|NCT00980655|63078181|FG001|Overall Study|Other|1|||
33657020|NCT01801865|63078223|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
33657021|NCT01801865|63078223|FG000|Overall Study|Physician Decision|7|||
33657022|NCT00980343|63078233|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
33657023|NCT00980343|63078234|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
33657024|NCT01801475|63078244|FG000|Overall Study|Withdrawal by Subject|0|||
33657025|NCT01801475|63078245|FG001|Overall Study|Withdrawal by Subject|0|||
33657026|NCT01801475|63078246|FG002|Overall Study|Withdrawal by Subject|0|||
33657027|NCT01801475|63078247|FG003|Overall Study|Withdrawal by Subject|0|||
33657028|NCT01801475|63078248|FG004|Overall Study|Withdrawal by Subject|1|||
33657029|NCT01822925|63078307|FG000|Overall Study|Adverse Event|1|||
33657030|NCT01822925|63078308|FG001|Overall Study|Adverse Event|1|||
33657031|NCT01822925|63078309|FG002|Overall Study|Adverse Event|1|||
33657032|NCT01822925|63078310|FG003|Overall Study|Adverse Event|1|||
33657033|NCT01822925|63078307|FG000|Overall Study|Lost to Follow-up|0|||
33657034|NCT01822925|63078308|FG001|Overall Study|Lost to Follow-up|1|||
33657035|NCT01822925|63078309|FG002|Overall Study|Lost to Follow-up|0|||
33657036|NCT01822925|63078310|FG003|Overall Study|Lost to Follow-up|0|||
33657037|NCT01822925|63078307|FG000|Overall Study|Protocol Violation|1|||
33657038|NCT01822925|63078308|FG001|Overall Study|Protocol Violation|0|||
33657039|NCT01822925|63078309|FG002|Overall Study|Protocol Violation|0|||
33657040|NCT01822925|63078310|FG003|Overall Study|Protocol Violation|1|||
33657041|NCT01822925|63078307|FG000|Overall Study|Withdrawal by Subject|2|||
33657042|NCT01822925|63078308|FG001|Overall Study|Withdrawal by Subject|0|||
33657043|NCT01822925|63078309|FG002|Overall Study|Withdrawal by Subject|2|||
33657044|NCT01822925|63078310|FG003|Overall Study|Withdrawal by Subject|2|||
33657045|NCT01822925|63078307|FG000|Overall Study|Taking prohibited medication|2|||
33657046|NCT01822925|63078308|FG001|Overall Study|Taking prohibited medication|0|||
33657047|NCT01822925|63078309|FG002|Overall Study|Taking prohibited medication|0|||
33657048|NCT01822925|63078310|FG003|Overall Study|Taking prohibited medication|1|||
33657049|NCT01801007|63078343|FG000|Overall Study|Adverse Event|2|||
33657050|NCT01801007|63078343|FG000|Overall Study|Lost to Follow-up|4|||
33657051|NCT01801007|63078343|FG000|Overall Study|Withdrawal by Subject|5|||
33657052|NCT01822691|63078347|FG000|Overall Study|Withdrawal by Subject|2|||
33657053|NCT01822535|63078353|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
33657054|NCT01822535|63078354|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
33657055|NCT01822535|63078353|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
33657056|NCT01822535|63078354|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
33657057|NCT01822535|63078353|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
33657058|NCT01822535|63078354|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
33657059|NCT01799993|63078440|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
33481510|NCT02973100|62858360|FG002|Overall Study|Adverse Event|1|||
33481511|NCT02973100|62858361|FG003|Overall Study|Adverse Event|2|||
33481512|NCT02973100|62858358|FG000|Overall Study|Lost to Follow-up|3|||
33481513|NCT02973100|62858359|FG001|Overall Study|Lost to Follow-up|1|||
33481514|NCT02973100|62858360|FG002|Overall Study|Lost to Follow-up|1|||
33481515|NCT02973100|62858361|FG003|Overall Study|Lost to Follow-up|0|||
33481516|NCT02973100|62858358|FG000|Overall Study|Withdrawal by Subject|3|||
33481517|NCT02973100|62858359|FG001|Overall Study|Withdrawal by Subject|5|||
33481518|NCT02973100|62858360|FG002|Overall Study|Withdrawal by Subject|1|||
33481519|NCT02973100|62858361|FG003|Overall Study|Withdrawal by Subject|4|||
33481520|NCT02973100|62858358|FG000|Overall Study|Notification of change in address|0|||
33481521|NCT02973100|62858359|FG001|Overall Study|Notification of change in address|0|||
33481522|NCT02973100|62858360|FG002|Overall Study|Notification of change in address|0|||
33657060|NCT01799993|63078441|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
33657061|NCT01799993|63078440|FG000|Overall Study|Death|61|||
33657062|NCT01799993|63078441|FG001|Overall Study|Death|45|||
33657063|NCT01799993|63078440|FG000|Overall Study|Withdrawal by Subject|23|||
33657064|NCT01799993|63078441|FG001|Overall Study|Withdrawal by Subject|24|||
33481523|NCT02973100|62858361|FG003|Overall Study|Notification of change in address|1|||
33481524|NCT02973100|62858358|FG000|Overall Study|Failed to attend Safety followup period|0|||
33657065|NCT01799993|63078440|FG000|Overall Study|Lost to Follow-up|5|||
33552152|NCT02802865|62944593|FG001|Overall Study|Pregnancy|1|||
33552153|NCT02802865|62944592|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
33552154|NCT02802865|62944593|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
33552155|NCT02414932|62944601|FG000|Overall Study|Withdrawal by Subject|2|||
33552156|NCT02414932|62944602|FG001|Overall Study|Withdrawal by Subject|3|||
33552157|NCT02414932|62944601|FG000|Overall Study|Adverse Event|1|||
33552158|NCT02414932|62944602|FG001|Overall Study|Adverse Event|0|||
33552159|NCT00704535|62944608|FG000|Overall Study|Adverse Event|2|||
33552160|NCT00704535|62944608|FG000|Overall Study|Death|2|||
33552161|NCT00704535|62944608|FG000|Overall Study|Lost to Follow-up|8|||
33552162|NCT00704535|62944608|FG000|Overall Study|Protocol Violation|10|||
33552163|NCT00704535|62944608|FG000|Overall Study|Completed status not on Case Report Form|124|||
33657066|NCT01799993|63078441|FG001|Overall Study|Lost to Follow-up|8|||
33657067|NCT01799993|63078440|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
33657068|NCT01799993|63078441|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
33657069|NCT01799993|63078440|FG000|Overall Study|Protocol driven decision point|0|||
33657070|NCT01799993|63078441|FG001|Overall Study|Protocol driven decision point|3|||
33657071|NCT01799993|63078440|FG000|Overall Study|Protocol Violation|1|||
33657072|NCT01799993|63078441|FG001|Overall Study|Protocol Violation|1|||
33657073|NCT01799993|63078440|FG000|Overall Study|Deterioration of general conditions|2|||
33657074|NCT01799993|63078441|FG001|Overall Study|Deterioration of general conditions|0|||
33657075|NCT01799993|63078440|FG000|Overall Study|Screen failure|0|||
33657076|NCT01799993|63078441|FG001|Overall Study|Screen failure|1|||
33657077|NCT01799993|63078440|FG000|Overall Study|Adverse Event|1|||
33657078|NCT01799993|63078441|FG001|Overall Study|Adverse Event|0|||
33657079|NCT01799993|63078440|FG000|Overall Study|Lack of Efficacy|1|||
33657080|NCT01799993|63078441|FG001|Overall Study|Lack of Efficacy|0|||
33657081|NCT01799993|63078440|FG000|Overall Study|Recovery|0|||
33657082|NCT01799993|63078441|FG001|Overall Study|Recovery|1|||
33657083|NCT01799993|63078440|FG000|Overall Study|Logistical difficulties|1|||
33657084|NCT01799993|63078441|FG001|Overall Study|Logistical difficulties|0|||
33657085|NCT01799993|63078440|FG000|Overall Study|Protocol deviation|1|||
33657086|NCT01799993|63078441|FG001|Overall Study|Protocol deviation|0|||
33657087|NCT01799993|63078440|FG000|Overall Study|Non-compliance with medical device|1|||
33657088|NCT01799993|63078441|FG001|Overall Study|Non-compliance with medical device|0|||
33657089|NCT01799993|63078440|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33657090|NCT01799993|63078441|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33657091|NCT01799993|63078440|FG000|Overall Study|Other|1|||
33657092|NCT01799993|63078441|FG001|Overall Study|Other|0|||
33657093|NCT01799993|63078440|FG000|Overall Study|Subject didn't return for follow-up|0|||
33657094|NCT01799993|63078441|FG001|Overall Study|Subject didn't return for follow-up|1|||
33657095|NCT01822223|63078458|FG000|Overall Study|Death|0|||
33657096|NCT01822223|63078459|FG001|Overall Study|Death|1|||
33657097|NCT02228382|63078545|FG000|Overall Study|Death|5|||
33657098|NCT02228382|63078546|FG001|Overall Study|Death|7|||
33657099|NCT02228382|63078547|FG002|Overall Study|Death|5|||
33657100|NCT02228382|63078548|FG003|Overall Study|Death|0|||
33657101|NCT02228382|63078549|FG004|Overall Study|Death|2|||
33481525|NCT02973100|62858359|FG001|Overall Study|Failed to attend Safety followup period|0|||
33481526|NCT02973100|62858360|FG002|Overall Study|Failed to attend Safety followup period|1|||
33481527|NCT02973100|62858361|FG003|Overall Study|Failed to attend Safety followup period|0|||
33481528|NCT01060540|62858376|FG000|Overall Study|Withdrawal by Subject|10|||
33481529|NCT01060540|62858377|FG001|Overall Study|Withdrawal by Subject|20|||
33481530|NCT01060540|62858376|FG000|Overall Study|Lost to Follow-up|52|||
33481531|NCT01060540|62858377|FG001|Overall Study|Lost to Follow-up|43|||
33481532|NCT01060540|62858376|FG000|Overall Study|Death|2|||
33481533|NCT01060540|62858377|FG001|Overall Study|Death|1|||
33481534|NCT01060540|62858376|FG000|Overall Study|Physician Decision|0|||
33552164|NCT01740687|62944612|FG000|Overall Study|Lost to Follow-up|11|||
33657102|NCT02228382|63078545|FG000|Overall Study|Participant refused further follow-up|0|||
33657103|NCT02228382|63078546|FG001|Overall Study|Participant refused further follow-up|0|||
33657104|NCT02228382|63078547|FG002|Overall Study|Participant refused further follow-up|1|||
33657105|NCT02228382|63078548|FG003|Overall Study|Participant refused further follow-up|0|||
33657106|NCT02228382|63078549|FG004|Overall Study|Participant refused further follow-up|0|||
33657107|NCT02228382|63078545|FG000|Overall Study|Study terminated by sponsor|3|||
33657108|NCT02228382|63078546|FG001|Overall Study|Study terminated by sponsor|5|||
33657109|NCT02228382|63078547|FG002|Overall Study|Study terminated by sponsor|7|||
33552165|NCT01740687|62944612|FG000|Overall Study|Withdrawal by Subject|2|||
33552166|NCT01740687|62944612|FG000|Overall Study|other reason|22|||
33552167|NCT01740687|62944612|FG000|Overall Study|treatment not received|2|||
33552168|NCT02648204|62944620|FG000|Overall Study|Withdrawal by Subject|12|||
33657110|NCT02228382|63078548|FG003|Overall Study|Study terminated by sponsor|0|||
33657111|NCT02228382|63078549|FG004|Overall Study|Study terminated by sponsor|0|||
33657112|NCT02228382|63078545|FG000|Overall Study|Lost to Follow-up|0|||
33552169|NCT02648204|62944621|FG001|Overall Study|Withdrawal by Subject|8|||
33552170|NCT02648204|62944622|FG002|Overall Study|Withdrawal by Subject|2|||
33552171|NCT02648204|62944623|FG003|Overall Study|Withdrawal by Subject|6|||
33552172|NCT02648204|62944620|FG000|Overall Study|Lost to Follow-up|5|||
33552173|NCT02648204|62944621|FG001|Overall Study|Lost to Follow-up|8|||
33552174|NCT02648204|62944622|FG002|Overall Study|Lost to Follow-up|4|||
33552175|NCT02648204|62944623|FG003|Overall Study|Lost to Follow-up|6|||
33552176|NCT02648204|62944620|FG000|Overall Study|Missing follow-up information|4|||
33552177|NCT02648204|62944621|FG001|Overall Study|Missing follow-up information|4|||
33364723|NCT02393248|62743305|FG002|Part 3: Combination Therapy|Disease Progression|0|||
33364724|NCT02393248|62743306|FG003|Part 3: Combination Therapy|Disease Progression|0|||
33364725|NCT02393248|62743307|FG004|Part 3: Combination Therapy|Disease Progression|0|||
33364726|NCT02393248|62743308|FG005|Part 3: Combination Therapy|Disease Progression|0|||
33364727|NCT02393248|62743309|FG006|Part 3: Combination Therapy|Disease Progression|0|||
33364728|NCT02393248|62743310|FG007|Part 3: Combination Therapy|Disease Progression|0|||
33364729|NCT02393248|62743311|FG008|Part 3: Combination Therapy|Disease Progression|0|||
33364730|NCT02393248|62743312|FG009|Part 3: Combination Therapy|Disease Progression|0|||
33364731|NCT02393248|62743313|FG010|Part 3: Combination Therapy|Disease Progression|0|||
33364732|NCT02393248|62743314|FG011|Part 3: Combination Therapy|Disease Progression|0|||
33481535|NCT01060540|62858377|FG001|Overall Study|Physician Decision|1|||
33481536|NCT02972632|62858402|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
33481537|NCT02972632|62858402|FG000|Overall Study|Lost to Follow-up|4|||
33481538|NCT02972632|62858402|FG000|Overall Study|Voluntary Withdrawal|10|||
33481539|NCT01060384|62858406|FG000|Overall Study|Withdrawal by Subject|0|||
33481540|NCT01060384|62858407|FG001|Overall Study|Withdrawal by Subject|1|||
33481541|NCT01060384|62858408|FG002|Overall Study|Withdrawal by Subject|0|||
33481542|NCT01060384|62858409|FG003|Overall Study|Withdrawal by Subject|0|||
33481543|NCT01060384|62858410|FG004|Overall Study|Withdrawal by Subject|0|||
33481544|NCT01060384|62858406|FG000|Overall Study|Death|0|||
33481545|NCT01060384|62858407|FG001|Overall Study|Death|0|||
33481546|NCT01060384|62858408|FG002|Overall Study|Death|0|||
33481547|NCT01060384|62858409|FG003|Overall Study|Death|0|||
33481548|NCT01060384|62858410|FG004|Overall Study|Death|1|||
33481549|NCT01060384|62858406|FG000|Overall Study|Intercurrent illness|0|||
33481550|NCT01060384|62858407|FG001|Overall Study|Intercurrent illness|0|||
33481551|NCT01060384|62858408|FG002|Overall Study|Intercurrent illness|0|||
33481552|NCT01060384|62858409|FG003|Overall Study|Intercurrent illness|0|||
33481553|NCT01060384|62858410|FG004|Overall Study|Intercurrent illness|1|||
33481554|NCT01060150|62858419|FG000|Overall Study|Adverse Event|6|||
33481555|NCT01060150|62858419|FG000|Overall Study|Lost to Follow-up|1|||
33481556|NCT01060150|62858419|FG000|Overall Study|Protocol Violation|6|||
33481557|NCT01060150|62858419|FG000|Overall Study|Withdrawal by Subject|8|||
33481558|NCT01060150|62858419|FG000|Overall Study|Enrolled, but not treated|2|||
33481559|NCT02972242|62858425|FG000|Overall Study|Withdrawal by Subject|1|||
33481560|NCT02972242|62858426|FG001|Overall Study|Withdrawal by Subject|0|||
33481561|NCT02970292|62858434|FG000|Overall Study|Physician Decision|1|||
33481562|NCT02970292|62858435|FG001|Overall Study|Physician Decision|1|||
33481563|NCT02970292|62858434|FG000|Overall Study|Withdrawal by Subject|11|||
33481564|NCT02970292|62858435|FG001|Overall Study|Withdrawal by Subject|5|||
33481565|NCT02970292|62858434|FG000|Overall Study|Noncompliance with study drug|2|||
33481566|NCT02970292|62858435|FG001|Overall Study|Noncompliance with study drug|2|||
33481567|NCT02970292|62858434|FG000|Overall Study|Adverse Event|5|||
33481568|NCT02970292|62858435|FG001|Overall Study|Adverse Event|0|||
33481569|NCT02970292|62858434|FG000|Overall Study|Lack of Efficacy|1|||
33481570|NCT02970292|62858435|FG001|Overall Study|Lack of Efficacy|0|||
33481571|NCT02970292|62858434|FG000|Overall Study|Lost to Follow-up|1|||
33481572|NCT02970292|62858435|FG001|Overall Study|Lost to Follow-up|0|||
33481573|NCT02970292|62858434|FG000|Overall Study|Protocol Violation|2|||
33481574|NCT02970292|62858435|FG001|Overall Study|Protocol Violation|0|||
33481575|NCT02970292|62858434|FG000|Overall Study|Other|1|||
33481576|NCT02970292|62858435|FG001|Overall Study|Other|0|||
33481577|NCT02971228|62858441|FG000|Overall Study|Withdrawal by Subject|1|||
33481578|NCT02971228|62858442|FG001|Overall Study|Withdrawal by Subject|1|||
33552178|NCT02648204|62944622|FG002|Overall Study|Missing follow-up information|4|||
33552179|NCT02648204|62944623|FG003|Overall Study|Missing follow-up information|2|||
33552180|NCT02648204|62944620|FG000|Overall Study|Death|1|||
33552181|NCT02648204|62944621|FG001|Overall Study|Death|1|||
33552182|NCT02648204|62944622|FG002|Overall Study|Death|2|||
33552183|NCT02648204|62944623|FG003|Overall Study|Death|2|||
33552184|NCT02648204|62944620|FG000|Overall Study|Adverse Event|0|||
33364733|NCT02393248|62743315|FG012|Part 3: Combination Therapy|Disease Progression|0|||
33364734|NCT02393248|62743316|FG013|Part 3: Combination Therapy|Disease Progression|0|||
33481579|NCT02971228|62858443|FG002|Overall Study|Withdrawal by Subject|0|||
33481580|NCT02971228|62858444|FG003|Overall Study|Withdrawal by Subject|0|||
33481581|NCT02971228|62858445|FG004|Overall Study|Withdrawal by Subject|0|||
33481582|NCT02971228|62858441|FG000|Overall Study|Logistical challenges|0|||
33481583|NCT02971228|62858442|FG001|Overall Study|Logistical challenges|1|||
33552185|NCT02648204|62944621|FG001|Overall Study|Adverse Event|0|||
33552186|NCT02648204|62944622|FG002|Overall Study|Adverse Event|1|||
33552187|NCT02648204|62944623|FG003|Overall Study|Adverse Event|0|||
33552188|NCT02799745|62944635|FG000|Overall Study|Participant moved out of state|1|||
33552189|NCT02799745|62944636|FG001|Overall Study|Participant moved out of state|0|||
33552190|NCT02799745|62944635|FG000|Overall Study|Discontinued due to planned surgery|1|||
33552191|NCT02799745|62944636|FG001|Overall Study|Discontinued due to planned surgery|0|||
33552192|NCT02799745|62944635|FG000|Overall Study|Withdrawal by Subject|16|||
33481584|NCT02971228|62858443|FG002|Overall Study|Logistical challenges|0|||
33481585|NCT02971228|62858444|FG003|Overall Study|Logistical challenges|0|||
33481586|NCT02971228|62858445|FG004|Overall Study|Logistical challenges|0|||
33481587|NCT01060072|62858458|FG000|Overall Study|Adverse Event|1|||
33481588|NCT01060072|62858459|FG001|Overall Study|Adverse Event|1|||
33481589|NCT01060072|62858458|FG000|Overall Study|Physician Decision|0|||
33481590|NCT01060072|62858459|FG001|Overall Study|Physician Decision|2|||
33481591|NCT01060072|62858458|FG000|Overall Study|Protocol Violation|0|||
33481592|NCT01060072|62858459|FG001|Overall Study|Protocol Violation|1|||
33481593|NCT01060072|62858458|FG000|Overall Study|Acute cholecystitis|1|||
33481594|NCT01060072|62858459|FG001|Overall Study|Acute cholecystitis|0|||
33481595|NCT01060072|62858458|FG000|Overall Study|Excluded Medications|0|||
33481596|NCT01060072|62858459|FG001|Overall Study|Excluded Medications|1|||
33481597|NCT02969590|62858467|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
33481598|NCT02969590|62858468|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
33481599|NCT02969590|62858469|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
33481600|NCT03345849|62858481|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
33552193|NCT02799745|62944636|FG001|Overall Study|Withdrawal by Subject|25|||
33552194|NCT02799745|62944635|FG000|Overall Study|Protocol Deviation|4|||
33552195|NCT02799745|62944636|FG001|Overall Study|Protocol Deviation|5|||
33552196|NCT02799745|62944635|FG000|Overall Study|Progressive Disease|28|||
33552197|NCT02799745|62944636|FG001|Overall Study|Progressive Disease|38|||
33552198|NCT02799745|62944635|FG000|Overall Study|Lost to Follow-up|3|||
33552199|NCT02799745|62944636|FG001|Overall Study|Lost to Follow-up|2|||
33552200|NCT02799745|62944635|FG000|Overall Study|Death|3|||
33552201|NCT02799745|62944636|FG001|Overall Study|Death|0|||
33552202|NCT02799745|62944635|FG000|Overall Study|Adverse Event|0|||
33552203|NCT02799745|62944636|FG001|Overall Study|Adverse Event|1|||
33552204|NCT00705159|62944646|FG000|Overall Study|Withdrawal by Subject|0|||
33552205|NCT00705159|62944647|FG001|Overall Study|Withdrawal by Subject|1|||
33552206|NCT00705159|62944648|FG002|Overall Study|Withdrawal by Subject|1|||
33552207|NCT00705159|62944649|FG003|Overall Study|Withdrawal by Subject|1|||
33552208|NCT00705159|62944646|FG000|Overall Study|Protocol Violation|0|||
33552209|NCT00705159|62944647|FG001|Overall Study|Protocol Violation|1|||
33552210|NCT00705159|62944648|FG002|Overall Study|Protocol Violation|0|||
33657113|NCT02228382|63078546|FG001|Overall Study|Lost to Follow-up|0|||
33657114|NCT02228382|63078547|FG002|Overall Study|Lost to Follow-up|3|||
33657115|NCT02228382|63078548|FG003|Overall Study|Lost to Follow-up|1|||
33657116|NCT02228382|63078549|FG004|Overall Study|Lost to Follow-up|0|||
33657117|NCT02228382|63078545|FG000|Overall Study|Withdrawal by Subject|0|||
33657118|NCT02228382|63078546|FG001|Overall Study|Withdrawal by Subject|3|||
33657119|NCT02228382|63078547|FG002|Overall Study|Withdrawal by Subject|2|||
33657120|NCT02228382|63078548|FG003|Overall Study|Withdrawal by Subject|1|||
33657121|NCT02228382|63078549|FG004|Overall Study|Withdrawal by Subject|0|||
33657122|NCT02228382|63078545|FG000|Overall Study|Other|2|||
33657123|NCT02228382|63078546|FG001|Overall Study|Other|3|||
33657124|NCT02228382|63078547|FG002|Overall Study|Other|3|||
33657125|NCT02228382|63078548|FG003|Overall Study|Other|0|||
33657126|NCT02228382|63078549|FG004|Overall Study|Other|0|||
33657127|NCT01900002|63078593|FG000|Overall Study|Withdrawal by Subject|2|||
33657128|NCT01900002|63078593|FG000|Overall Study|ineligible for Y-90|4|||
33657129|NCT01377012|63078623|FG000|Core Study|Study terminated by Sponsor|47|||
33481601|NCT03345849|62858482|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
33481602|NCT03345849|62858483|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
33481603|NCT03345849|62858484|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
33657130|NCT01377012|63078624|FG001|Core Study|Study terminated by Sponsor|54|||
33552211|NCT00705159|62944649|FG003|Overall Study|Protocol Violation|0|||
33552212|NCT00705159|62944646|FG000|Overall Study|Adverse Event|0|||
33657131|NCT01377012|63078625|FG002|Core Study|Study terminated by Sponsor|46|||
33657132|NCT01377012|63078623|FG000|Core Study|Technical problems|1|||
33481604|NCT03345849|62858481|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
33481605|NCT03345849|62858482|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
33552213|NCT00705159|62944647|FG001|Overall Study|Adverse Event|0|||
33552214|NCT00705159|62944648|FG002|Overall Study|Adverse Event|1|||
33552215|NCT00705159|62944649|FG003|Overall Study|Adverse Event|0|||
33552216|NCT00705159|62944646|FG000|Overall Study|Lost to Follow-up|0|||
33552217|NCT00705159|62944647|FG001|Overall Study|Lost to Follow-up|0|||
33552218|NCT00705159|62944648|FG002|Overall Study|Lost to Follow-up|3|||
33657133|NCT01377012|63078624|FG001|Core Study|Technical problems|0|||
33481606|NCT03345849|62858483|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
33481607|NCT03345849|62858484|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
33481608|NCT03345849|62858481|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
33481609|NCT03345849|62858482|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
33481610|NCT03345849|62858483|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
33481611|NCT03345849|62858484|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
33481612|NCT03345849|62858481|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
33481613|NCT03345849|62858482|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
33481614|NCT03345849|62858483|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
33552219|NCT00705159|62944649|FG003|Overall Study|Lost to Follow-up|2|||
33552220|NCT00705159|62944646|FG000|Overall Study|Screen Failure|0|||
33552221|NCT00705159|62944647|FG001|Overall Study|Screen Failure|0|||
33552222|NCT00705159|62944648|FG002|Overall Study|Screen Failure|0|||
33481615|NCT03345849|62858484|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
33481616|NCT03345849|62858481|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
33481617|NCT03345849|62858482|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
33481618|NCT03345849|62858483|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
33481619|NCT03345849|62858484|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
33481620|NCT03345849|62858481|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
33481621|NCT03345849|62858482|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
33481622|NCT03345849|62858483|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
33481623|NCT03345849|62858484|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
33481624|NCT03345849|62858481|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
33552223|NCT00705159|62944649|FG003|Overall Study|Screen Failure|1|||
33552224|NCT01673984|62944661|FG000|Overall Study|Adverse Event|1|||
33552225|NCT01673984|62944662|FG001|Overall Study|Adverse Event|0|||
33552226|NCT01673984|62944661|FG000|Overall Study|Study termination|9|||
33552227|NCT01673984|62944662|FG001|Overall Study|Study termination|6|||
33552228|NCT02332928|62944681|FG000|Overall Study|Withdrawal by Subject|0|||
33481625|NCT03345849|62858482|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
33481626|NCT03345849|62858483|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
33481627|NCT03345849|62858484|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
33481628|NCT03345849|62858481|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
33481629|NCT03345849|62858482|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
33552229|NCT02332928|62944682|FG001|Overall Study|Withdrawal by Subject|2|||
33552230|NCT02332928|62944681|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
33552231|NCT02332928|62944682|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
33552232|NCT02647658|62944690|FG000|Overall Study|Consent refusal|15|||
33552233|NCT02647658|62944691|FG001|Overall Study|Consent refusal|24|||
33657134|NCT01377012|63078625|FG002|Core Study|Technical problems|0|||
33657135|NCT01377012|63078623|FG000|Core Study|Withdrawal by Subject|15|||
33657136|NCT01377012|63078624|FG001|Core Study|Withdrawal by Subject|23|||
33657137|NCT01377012|63078625|FG002|Core Study|Withdrawal by Subject|18|||
33657138|NCT01377012|63078623|FG000|Core Study|Protocol Violation|7|||
33657139|NCT01377012|63078624|FG001|Core Study|Protocol Violation|3|||
33657140|NCT01377012|63078625|FG002|Core Study|Protocol Violation|2|||
33657141|NCT01377012|63078623|FG000|Core Study|Pregnancy|0|||
33657142|NCT01377012|63078624|FG001|Core Study|Pregnancy|0|||
33657143|NCT01377012|63078625|FG002|Core Study|Pregnancy|1|||
33657144|NCT01377012|63078623|FG000|Core Study|Physician Decision|5|||
33657145|NCT01377012|63078624|FG001|Core Study|Physician Decision|4|||
33657146|NCT01377012|63078625|FG002|Core Study|Physician Decision|10|||
33657147|NCT01377012|63078623|FG000|Core Study|Non-Compliant with study treatment|0|||
33657148|NCT01377012|63078624|FG001|Core Study|Non-Compliant with study treatment|0|||
33657149|NCT01377012|63078625|FG002|Core Study|Non-Compliant with study treatment|1|||
33657150|NCT01377012|63078623|FG000|Core Study|No Longer require treatment|0|||
33657151|NCT01377012|63078624|FG001|Core Study|No Longer require treatment|0|||
33657152|NCT01377012|63078625|FG002|Core Study|No Longer require treatment|1|||
33657153|NCT01377012|63078623|FG000|Core Study|Lost to Follow-up|7|||
33657154|NCT01377012|63078624|FG001|Core Study|Lost to Follow-up|5|||
33657155|NCT01377012|63078625|FG002|Core Study|Lost to Follow-up|4|||
33657156|NCT01377012|63078623|FG000|Core Study|Lack of Efficacy|41|||
33657157|NCT01377012|63078624|FG001|Core Study|Lack of Efficacy|28|||
33657158|NCT01377012|63078625|FG002|Core Study|Lack of Efficacy|37|||
33657159|NCT01377012|63078623|FG000|Core Study|Death|1|||
33657160|NCT01377012|63078624|FG001|Core Study|Death|1|||
33552234|NCT00703677|62944697|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
33552235|NCT00703911|62944705|FG000|Overall Study|Death|1|||
33552236|NCT00703911|62944705|FG000|Overall Study|Physician Decision|6|||
33657161|NCT01377012|63078625|FG002|Core Study|Death|1|||
33657162|NCT01377012|63078623|FG000|Core Study|Adverse Event|10|||
33657163|NCT01377012|63078624|FG001|Core Study|Adverse Event|14|||
33657164|NCT01377012|63078625|FG002|Core Study|Adverse Event|13|||
33657165|NCT01377012|63078623|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
33481630|NCT03345849|62858483|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
33481631|NCT03345849|62858484|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
33481632|NCT03345849|62858481|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
33481633|NCT03345849|62858482|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
33481634|NCT03345849|62858483|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
33481635|NCT03345849|62858484|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
33481636|NCT03345849|62858481|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
33481637|NCT03345849|62858482|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
33481638|NCT03345849|62858483|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
33552237|NCT00703911|62944705|FG000|Overall Study|Lost to Follow-up|1|||
33552238|NCT00703911|62944705|FG000|Overall Study|Withdrawal by Subject|2|||
33552239|NCT02055547|62944709|FG000|Overall Study|Protocol Violation|0|||
33481639|NCT03345849|62858484|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
33481640|NCT03345849|62858481|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
33481641|NCT03345849|62858482|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
33481642|NCT03345849|62858483|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
33481643|NCT03345849|62858484|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
33481644|NCT03011307|62858494|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
33481645|NCT03011307|62858495|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
33481646|NCT03011307|62858494|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
33481647|NCT03011307|62858495|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
33481648|NCT03011307|62858494|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
33481649|NCT03011307|62858495|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
33481650|NCT03798717|62858507|FG000|Overall Study|Failed Screening|0|||
33481651|NCT03798717|62858508|FG001|Overall Study|Failed Screening|0|||
33481652|NCT03798717|62858509|FG002|Overall Study|Failed Screening|0|||
33481653|NCT03798717|62858510|FG003|Overall Study|Failed Screening|0|||
33481654|NCT03798717|62858511|FG004|Overall Study|Failed Screening|0|||
33481655|NCT03798717|62858512|FG005|Overall Study|Failed Screening|1|||
33481656|NCT03798717|62858507|FG000|Overall Study|Physician Decision|1|||
33481657|NCT03798717|62858508|FG001|Overall Study|Physician Decision|0|||
33552240|NCT02055547|62944710|FG001|Overall Study|Protocol Violation|0|||
33552241|NCT02055547|62944711|FG002|Overall Study|Protocol Violation|1|||
33552242|NCT02055547|62944712|FG003|Overall Study|Protocol Violation|0|||
33552243|NCT02055547|62944713|FG004|Overall Study|Protocol Violation|0|||
33552244|NCT02055547|62944714|FG005|Overall Study|Protocol Violation|0|||
33552245|NCT02055547|62944715|FG006|Overall Study|Protocol Violation|1|||
33552246|NCT02055547|62944716|FG007|Overall Study|Protocol Violation|0|||
33552247|NCT02055547|62944717|FG008|Overall Study|Protocol Violation|0|||
33552248|NCT02055547|62944718|FG009|Overall Study|Protocol Violation|0|||
33552249|NCT02055547|62944719|FG010|Overall Study|Protocol Violation|0|||
33552250|NCT02055547|62944720|FG011|Overall Study|Protocol Violation|0|||
33552251|NCT02055547|62944721|FG012|Overall Study|Protocol Violation|0|||
33657166|NCT01377012|63078624|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
33657167|NCT01377012|63078625|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
33657168|NCT01377012|63078623|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
33657169|NCT01377012|63078624|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
33657170|NCT01377012|63078625|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
33657171|NCT01377012|63078623|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
33657172|NCT01377012|63078624|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
33657173|NCT01377012|63078625|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
33657174|NCT01377012|63078623|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
33657175|NCT01377012|63078624|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
33657176|NCT01377012|63078625|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
33657177|NCT01377012|63078623|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
33657178|NCT01377012|63078624|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
33657179|NCT01377012|63078625|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
33657180|NCT01377012|63078623|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
33657181|NCT01377012|63078624|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
33657182|NCT01377012|63078625|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
33657183|NCT01376310|63078874|FG000|Overall Study|Study closed/terminated|1|||
33657184|NCT01376310|63078875|FG001|Overall Study|Study closed/terminated|2|||
33552252|NCT02055547|62944722|FG013|Overall Study|Protocol Violation|0|||
33552253|NCT02055547|62944723|FG014|Overall Study|Protocol Violation|0|||
33552254|NCT02055547|62944724|FG015|Overall Study|Protocol Violation|0|||
33657185|NCT01376310|63078874|FG000|Overall Study|Withdrawal by Subject|8|||
33657186|NCT01376310|63078875|FG001|Overall Study|Withdrawal by Subject|2|||
33657187|NCT01376310|63078874|FG000|Overall Study|Physician Decision|26|||
33657188|NCT01376310|63078875|FG001|Overall Study|Physician Decision|7|||
33481658|NCT03798717|62858509|FG002|Overall Study|Physician Decision|1|||
33481659|NCT03798717|62858510|FG003|Overall Study|Physician Decision|0|||
33481660|NCT03798717|62858511|FG004|Overall Study|Physician Decision|0|||
33481661|NCT03798717|62858512|FG005|Overall Study|Physician Decision|0|||
33657189|NCT01376310|63078874|FG000|Overall Study|Lost to Follow-up|1|||
33657190|NCT01376310|63078875|FG001|Overall Study|Lost to Follow-up|0|||
33657191|NCT01949506|63078881|FG000|Overall Study|Physician Decision|1|||
33552255|NCT02055547|62944725|FG016|Overall Study|Protocol Violation|0|||
33552256|NCT02055547|62944726|FG017|Overall Study|Protocol Violation|0|||
33552257|NCT02055547|62944727|FG018|Overall Study|Protocol Violation|0|||
33552258|NCT02055547|62944709|FG000|Overall Study|Physician Decision|0|||
33552259|NCT02055547|62944710|FG001|Overall Study|Physician Decision|1|||
33552260|NCT02055547|62944711|FG002|Overall Study|Physician Decision|1|||
33552261|NCT02055547|62944712|FG003|Overall Study|Physician Decision|0|||
33552262|NCT02055547|62944713|FG004|Overall Study|Physician Decision|1|||
33552263|NCT02055547|62944714|FG005|Overall Study|Physician Decision|0|||
33657192|NCT00709098|63078978|FG000|Double-blind Period|Withdrawal of consent|3|||
33657193|NCT00709098|63078979|FG001|Double-blind Period|Withdrawal of consent|3|||
33657194|NCT00709098|63078980|FG002|Double-blind Period|Withdrawal of consent|0|||
33657195|NCT00709098|63078978|FG000|Double-blind Period|Administrative reason|1|||
33657196|NCT00709098|63078979|FG001|Double-blind Period|Administrative reason|3|||
33657197|NCT00709098|63078980|FG002|Double-blind Period|Administrative reason|0|||
33657198|NCT00709098|63078978|FG000|Double-blind Period|Death|1|||
33657199|NCT00709098|63078979|FG001|Double-blind Period|Death|1|||
33481662|NCT03798717|62858507|FG000|Overall Study|Withdrawal by Subject|0|||
33481663|NCT03798717|62858508|FG001|Overall Study|Withdrawal by Subject|0|||
33481664|NCT03798717|62858509|FG002|Overall Study|Withdrawal by Subject|0|||
33481665|NCT03798717|62858510|FG003|Overall Study|Withdrawal by Subject|1|||
33481666|NCT03798717|62858511|FG004|Overall Study|Withdrawal by Subject|0|||
33481667|NCT03798717|62858512|FG005|Overall Study|Withdrawal by Subject|0|||
33481668|NCT03798717|62858507|FG000|Overall Study|Lost to Follow-up|1|||
33481669|NCT03798717|62858508|FG001|Overall Study|Lost to Follow-up|0|||
33481670|NCT03798717|62858509|FG002|Overall Study|Lost to Follow-up|0|||
33481671|NCT03798717|62858510|FG003|Overall Study|Lost to Follow-up|1|||
33552264|NCT02055547|62944715|FG006|Overall Study|Physician Decision|0|||
33552265|NCT02055547|62944716|FG007|Overall Study|Physician Decision|0|||
33552266|NCT02055547|62944717|FG008|Overall Study|Physician Decision|0|||
33552267|NCT02055547|62944718|FG009|Overall Study|Physician Decision|1|||
33552268|NCT02055547|62944719|FG010|Overall Study|Physician Decision|1|||
33552269|NCT02055547|62944720|FG011|Overall Study|Physician Decision|0|||
33552270|NCT02055547|62944721|FG012|Overall Study|Physician Decision|0|||
33552271|NCT02055547|62944722|FG013|Overall Study|Physician Decision|0|||
33552272|NCT02055547|62944723|FG014|Overall Study|Physician Decision|0|||
33552273|NCT02055547|62944724|FG015|Overall Study|Physician Decision|0|||
33552274|NCT02055547|62944725|FG016|Overall Study|Physician Decision|0|||
33552275|NCT02055547|62944726|FG017|Overall Study|Physician Decision|0|||
33552276|NCT02055547|62944727|FG018|Overall Study|Physician Decision|0|||
33552277|NCT02055547|62944709|FG000|Overall Study|Adverse Event|0|||
33552278|NCT02055547|62944710|FG001|Overall Study|Adverse Event|0|||
33552279|NCT02055547|62944711|FG002|Overall Study|Adverse Event|0|||
33552280|NCT02055547|62944712|FG003|Overall Study|Adverse Event|0|||
33552281|NCT02055547|62944713|FG004|Overall Study|Adverse Event|0|||
33552282|NCT02055547|62944714|FG005|Overall Study|Adverse Event|0|||
33552283|NCT02055547|62944715|FG006|Overall Study|Adverse Event|1|||
33552284|NCT02055547|62944716|FG007|Overall Study|Adverse Event|0|||
33552285|NCT02055547|62944717|FG008|Overall Study|Adverse Event|1|||
33552286|NCT02055547|62944718|FG009|Overall Study|Adverse Event|0|||
33552287|NCT02055547|62944719|FG010|Overall Study|Adverse Event|0|||
33552288|NCT02055547|62944720|FG011|Overall Study|Adverse Event|0|||
33552289|NCT02055547|62944721|FG012|Overall Study|Adverse Event|0|||
33552290|NCT02055547|62944722|FG013|Overall Study|Adverse Event|0|||
33552291|NCT02055547|62944723|FG014|Overall Study|Adverse Event|0|||
33552292|NCT02055547|62944724|FG015|Overall Study|Adverse Event|0|||
33552293|NCT02055547|62944725|FG016|Overall Study|Adverse Event|0|||
33364735|NCT02393248|62743317|FG014|Part 3: Combination Therapy|Disease Progression|0|||
33364736|NCT02393248|62743318|FG015|Part 3: Combination Therapy|Disease Progression|0|||
33481672|NCT03798717|62858511|FG004|Overall Study|Lost to Follow-up|0|||
33552294|NCT02055547|62944726|FG017|Overall Study|Adverse Event|0|||
33552295|NCT02055547|62944727|FG018|Overall Study|Adverse Event|0|||
33552296|NCT02055547|62944709|FG000|Overall Study|Withdrawal by Subject|0|||
33552297|NCT02055547|62944710|FG001|Overall Study|Withdrawal by Subject|0|||
33552298|NCT02055547|62944711|FG002|Overall Study|Withdrawal by Subject|0|||
33481673|NCT03798717|62858512|FG005|Overall Study|Lost to Follow-up|0|||
33552299|NCT02055547|62944712|FG003|Overall Study|Withdrawal by Subject|0|||
33552300|NCT02055547|62944713|FG004|Overall Study|Withdrawal by Subject|0|||
33552301|NCT02055547|62944714|FG005|Overall Study|Withdrawal by Subject|1|||
33552302|NCT02055547|62944715|FG006|Overall Study|Withdrawal by Subject|0|||
33552303|NCT02055547|62944716|FG007|Overall Study|Withdrawal by Subject|0|||
33657200|NCT00709098|63078980|FG002|Double-blind Period|Death|0|||
33481674|NCT03798717|62858507|FG000|Overall Study|Adverse Event|0|||
33481675|NCT03798717|62858508|FG001|Overall Study|Adverse Event|1|||
33481676|NCT03798717|62858509|FG002|Overall Study|Adverse Event|0|||
33481677|NCT03798717|62858510|FG003|Overall Study|Adverse Event|0|||
33481678|NCT03798717|62858511|FG004|Overall Study|Adverse Event|0|||
33481679|NCT03798717|62858512|FG005|Overall Study|Adverse Event|0|||
33481680|NCT03798717|62858507|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
33481681|NCT03798717|62858508|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
33481682|NCT03798717|62858509|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
33481683|NCT03798717|62858510|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
33481684|NCT03798717|62858511|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
33481685|NCT03798717|62858512|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
33481686|NCT03798483|62858521|FG000|Overall Study|Lost to Follow-up|2|||
33481687|NCT03792477|62858534|FG000|Overall Study|Adverse Event|0|||
33481688|NCT03792477|62858535|FG001|Overall Study|Adverse Event|0|||
33481689|NCT03792477|62858536|FG002|Overall Study|Adverse Event|0|||
33481690|NCT03792477|62858537|FG003|Overall Study|Adverse Event|1|||
33481691|NCT03792477|62858538|FG004|Overall Study|Adverse Event|0|||
33481692|NCT03792477|62858534|FG000|Overall Study|Lost to Follow-up|0|||
33481693|NCT03792477|62858535|FG001|Overall Study|Lost to Follow-up|0|||
33481694|NCT03792477|62858536|FG002|Overall Study|Lost to Follow-up|2|||
33481695|NCT03792477|62858537|FG003|Overall Study|Lost to Follow-up|0|||
33481696|NCT03792477|62858538|FG004|Overall Study|Lost to Follow-up|0|||
33481697|NCT03792477|62858534|FG000|Overall Study|Other|0|||
33481698|NCT03792477|62858535|FG001|Overall Study|Other|0|||
33481699|NCT03792477|62858536|FG002|Overall Study|Other|0|||
33481700|NCT03792477|62858537|FG003|Overall Study|Other|0|||
33481701|NCT03792477|62858538|FG004|Overall Study|Other|1|||
33481702|NCT03790917|62858544|FG000|Overall Study|Death|1|||
33481703|NCT03788967|62858551|FG000|Overall Study|Lost to Follow-up|14|||
33481704|NCT03788967|62858552|FG001|Overall Study|Lost to Follow-up|10|||
33481705|NCT03788967|62858551|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
33481706|NCT03788967|62858552|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
33481707|NCT03788967|62858551|FG000|Overall Study|Participant Withdrawal of Consent|13|||
33481708|NCT03788967|62858552|FG001|Overall Study|Participant Withdrawal of Consent|5|||
33481709|NCT03788967|62858551|FG000|Overall Study|Adverse Event|1|||
33481710|NCT03788967|62858552|FG001|Overall Study|Adverse Event|1|||
33481711|NCT03788967|62858551|FG000|Overall Study|COVID-19|1|||
33481712|NCT03788967|62858552|FG001|Overall Study|COVID-19|2|||
33481713|NCT03782571|62858560|FG000|Period 1|Withdrawal by Subject|1|||
33481714|NCT03782571|62858561|FG001|Period 1|Withdrawal by Subject|0|||
33481715|NCT03782571|62858562|FG002|Period 1|Withdrawal by Subject|0|||
33481716|NCT03782571|62858563|FG003|Period 1|Withdrawal by Subject|0|||
33481717|NCT03782571|62858560|FG000|Period 3|Subject Unable to Attend V5|1|||
33481718|NCT03782571|62858561|FG001|Period 3|Subject Unable to Attend V5|0|||
33481719|NCT03782571|62858562|FG002|Period 3|Subject Unable to Attend V5|0|||
33481720|NCT03782571|62858563|FG003|Period 3|Subject Unable to Attend V5|0|||
33481721|NCT03782571|62858560|FG000|Period 3|Adverse Event|1|||
33481722|NCT03782571|62858561|FG001|Period 3|Adverse Event|0|||
33481723|NCT03782571|62858562|FG002|Period 3|Adverse Event|0|||
33481724|NCT03782571|62858563|FG003|Period 3|Adverse Event|0|||
33481725|NCT03783039|62858577|FG000|Overall Study|Death|2|||
33481726|NCT03783039|62858578|FG001|Overall Study|Death|1|||
33552304|NCT02055547|62944717|FG008|Overall Study|Withdrawal by Subject|1|||
33552305|NCT02055547|62944718|FG009|Overall Study|Withdrawal by Subject|0|||
33552306|NCT02055547|62944719|FG010|Overall Study|Withdrawal by Subject|0|||
33552307|NCT02055547|62944720|FG011|Overall Study|Withdrawal by Subject|0|||
33552308|NCT02055547|62944721|FG012|Overall Study|Withdrawal by Subject|0|||
33552309|NCT02055547|62944722|FG013|Overall Study|Withdrawal by Subject|1|||
33552310|NCT02055547|62944723|FG014|Overall Study|Withdrawal by Subject|0|||
33552311|NCT02055547|62944724|FG015|Overall Study|Withdrawal by Subject|1|||
33552312|NCT02055547|62944725|FG016|Overall Study|Withdrawal by Subject|0|||
33552313|NCT02055547|62944726|FG017|Overall Study|Withdrawal by Subject|0|||
33552314|NCT02055547|62944727|FG018|Overall Study|Withdrawal by Subject|0|||
33552315|NCT02055547|62944709|FG000|Overall Study|Lost to Follow-up|0|||
33657201|NCT00709098|63078978|FG000|Double-blind Period|Lost to Follow-up|1|||
33657202|NCT00709098|63078979|FG001|Double-blind Period|Lost to Follow-up|1|||
33481727|NCT03776175|62858597|FG000|Treatment Period (42 Days)|Adverse Event|0|||
33481728|NCT03776175|62858598|FG001|Treatment Period (42 Days)|Adverse Event|1|||
33481729|NCT03776175|62858599|FG002|Treatment Period (42 Days)|Adverse Event|1|||
33481730|NCT03776175|62858600|FG003|Treatment Period (42 Days)|Adverse Event|0|||
33481731|NCT03776175|62858597|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
33481732|NCT03776175|62858598|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
33481733|NCT03776175|62858599|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
33481734|NCT03776175|62858600|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
33552316|NCT02055547|62944710|FG001|Overall Study|Lost to Follow-up|0|||
33552317|NCT02055547|62944711|FG002|Overall Study|Lost to Follow-up|1|||
33657203|NCT00709098|63078980|FG002|Double-blind Period|Lost to Follow-up|0|||
33481735|NCT03776175|62858597|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
33481736|NCT03776175|62858598|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
33481737|NCT03776175|62858599|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
33481738|NCT03776175|62858600|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
33481739|NCT03776175|62858597|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
33481740|NCT03776175|62858598|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
33481741|NCT03776175|62858599|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
33481742|NCT03776175|62858600|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
33481743|NCT03776175|62858597|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
33481744|NCT03776175|62858598|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
33481745|NCT03776175|62858599|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
33657204|NCT00709098|63078978|FG000|Open-label Period|Withdrawal of consent|0|||
33657205|NCT00709098|63078979|FG001|Open-label Period|Withdrawal of consent|0|||
33657206|NCT00709098|63078980|FG002|Open-label Period|Withdrawal of consent|7|||
33657207|NCT00709098|63078978|FG000|Open-label Period|Administrative reason|0|||
33657208|NCT00709098|63078979|FG001|Open-label Period|Administrative reason|0|||
33657209|NCT00709098|63078980|FG002|Open-label Period|Administrative reason|5|||
33657210|NCT00709098|63078978|FG000|Open-label Period|Death|0|||
33657211|NCT00709098|63078979|FG001|Open-label Period|Death|0|||
33657212|NCT00709098|63078980|FG002|Open-label Period|Death|1|||
33657213|NCT00709098|63078978|FG000|Open-label Period|Lost to Follow-up|0|||
33657214|NCT00709098|63078979|FG001|Open-label Period|Lost to Follow-up|0|||
33657215|NCT00709098|63078980|FG002|Open-label Period|Lost to Follow-up|1|||
33657216|NCT01376700|63078989|FG000|Overall Study|Sponsor terminated study early|8|||
33657217|NCT01376700|63078989|FG000|Overall Study|Low or high titer inhibitor|8|||
33657218|NCT01797965|63079000|FG000|Overall Study|Adverse Event|104|||
33657219|NCT01797965|63079001|FG001|Overall Study|Adverse Event|129|||
33657220|NCT01797965|63079002|FG002|Overall Study|Adverse Event|4|||
33657221|NCT01797965|63079003|FG003|Overall Study|Adverse Event|21|||
33657222|NCT01797965|63079000|FG000|Overall Study|Lost to Follow-up|9|||
33657223|NCT01797965|63079001|FG001|Overall Study|Lost to Follow-up|8|||
33657224|NCT01797965|63079002|FG002|Overall Study|Lost to Follow-up|1|||
33657225|NCT01797965|63079003|FG003|Overall Study|Lost to Follow-up|2|||
33657226|NCT01797965|63079000|FG000|Overall Study|Consent withdrawn|130|||
33657227|NCT01797965|63079001|FG001|Overall Study|Consent withdrawn|117|||
33657228|NCT01797965|63079002|FG002|Overall Study|Consent withdrawn|3|||
33657229|NCT01797965|63079003|FG003|Overall Study|Consent withdrawn|35|||
33657230|NCT01797965|63079000|FG000|Overall Study|Investigator decision|21|||
33657231|NCT01797965|63079001|FG001|Overall Study|Investigator decision|15|||
33657232|NCT01797965|63079002|FG002|Overall Study|Investigator decision|0|||
33657233|NCT01797965|63079003|FG003|Overall Study|Investigator decision|0|||
33657234|NCT01797965|63079000|FG000|Overall Study|Death|2|||
33657235|NCT01797965|63079001|FG001|Overall Study|Death|4|||
33657236|NCT01797965|63079002|FG002|Overall Study|Death|0|||
33657237|NCT01797965|63079003|FG003|Overall Study|Death|0|||
33657238|NCT01797965|63079000|FG000|Overall Study|Disease progression, defined by protocol|3|||
33657239|NCT01797965|63079001|FG001|Overall Study|Disease progression, defined by protocol|1|||
33657240|NCT01797965|63079002|FG002|Overall Study|Disease progression, defined by protocol|0|||
33657241|NCT01797965|63079003|FG003|Overall Study|Disease progression, defined by protocol|0|||
33657242|NCT01797965|63079000|FG000|Overall Study|Reason Not Specified|280|||
33657243|NCT01797965|63079001|FG001|Overall Study|Reason Not Specified|295|||
33657244|NCT01797965|63079002|FG002|Overall Study|Reason Not Specified|0|||
33657245|NCT01797965|63079003|FG003|Overall Study|Reason Not Specified|15|||
33657246|NCT01376388|63079048|FG000|Overall Study|Adverse Event|13|||
33657247|NCT01376388|63079048|FG000|Overall Study|Lack of Efficacy|2|||
33657248|NCT01376388|63079048|FG000|Overall Study|Withdrawal by Subject|3|||
33657249|NCT01821677|63079069|FG000|Overall Study|Adverse Event|4|||
33657250|NCT01821677|63079070|FG001|Overall Study|Adverse Event|6|||
33657251|NCT01821677|63079071|FG002|Overall Study|Adverse Event|5|||
33657252|NCT01821677|63079069|FG000|Overall Study|Physician Decision|1|||
33657253|NCT01821677|63079070|FG001|Overall Study|Physician Decision|4|||
33657254|NCT01821677|63079071|FG002|Overall Study|Physician Decision|1|||
33657255|NCT01821677|63079069|FG000|Overall Study|Non-compliance|0|||
33481746|NCT03776175|62858600|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
33657256|NCT01821677|63079070|FG001|Overall Study|Non-compliance|1|||
33657257|NCT01821677|63079071|FG002|Overall Study|Non-compliance|2|||
33657258|NCT01821677|63079069|FG000|Overall Study|Lost to Follow-up|2|||
33657259|NCT01821677|63079070|FG001|Overall Study|Lost to Follow-up|1|||
33657260|NCT01821677|63079071|FG002|Overall Study|Lost to Follow-up|3|||
33657261|NCT01821677|63079069|FG000|Overall Study|Protocol Violation|0|||
33657262|NCT01821677|63079070|FG001|Overall Study|Protocol Violation|0|||
33657263|NCT01821677|63079071|FG002|Overall Study|Protocol Violation|2|||
33657264|NCT01821677|63079069|FG000|Overall Study|Withdrawal by Subject|7|||
33657265|NCT01821677|63079070|FG001|Overall Study|Withdrawal by Subject|3|||
33657266|NCT01821677|63079071|FG002|Overall Study|Withdrawal by Subject|2|||
33657267|NCT01821677|63079069|FG000|Overall Study|Other|9|||
33481747|NCT03776175|62858597|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
33481748|NCT03776175|62858598|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
33552318|NCT02055547|62944712|FG003|Overall Study|Lost to Follow-up|0|||
33552319|NCT02055547|62944713|FG004|Overall Study|Lost to Follow-up|0|||
33552320|NCT02055547|62944714|FG005|Overall Study|Lost to Follow-up|0|||
33552321|NCT02055547|62944715|FG006|Overall Study|Lost to Follow-up|0|||
33552322|NCT02055547|62944716|FG007|Overall Study|Lost to Follow-up|0|||
33552323|NCT02055547|62944717|FG008|Overall Study|Lost to Follow-up|0|||
33552324|NCT02055547|62944718|FG009|Overall Study|Lost to Follow-up|0|||
33552325|NCT02055547|62944719|FG010|Overall Study|Lost to Follow-up|0|||
33481749|NCT03776175|62858599|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
33552326|NCT02055547|62944720|FG011|Overall Study|Lost to Follow-up|0|||
33552327|NCT02055547|62944721|FG012|Overall Study|Lost to Follow-up|0|||
33552328|NCT02055547|62944722|FG013|Overall Study|Lost to Follow-up|0|||
33552329|NCT02055547|62944723|FG014|Overall Study|Lost to Follow-up|0|||
33481750|NCT03776175|62858600|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
33481751|NCT02903914|62858618|FG000|Overall Study|Adverse Event|0|||
33481752|NCT02903914|62858619|FG001|Overall Study|Adverse Event|0|||
33481753|NCT02903914|62858620|FG002|Overall Study|Adverse Event|1|||
33481754|NCT02903914|62858621|FG003|Overall Study|Adverse Event|0|||
33481755|NCT02903914|62858622|FG004|Overall Study|Adverse Event|0|||
33481756|NCT02903914|62858623|FG005|Overall Study|Adverse Event|1|||
33481757|NCT02903914|62858624|FG006|Overall Study|Adverse Event|2|||
33481758|NCT02903914|62858625|FG007|Overall Study|Adverse Event|1|||
33481759|NCT02903914|62858618|FG000|Overall Study|Withdrawal by Subject|3|||
33481760|NCT02903914|62858619|FG001|Overall Study|Withdrawal by Subject|1|||
33481761|NCT02903914|62858620|FG002|Overall Study|Withdrawal by Subject|28|||
33481762|NCT02903914|62858621|FG003|Overall Study|Withdrawal by Subject|0|||
33481763|NCT02903914|62858622|FG004|Overall Study|Withdrawal by Subject|1|||
33481764|NCT02903914|62858623|FG005|Overall Study|Withdrawal by Subject|1|||
33481765|NCT02903914|62858624|FG006|Overall Study|Withdrawal by Subject|12|||
33481766|NCT02903914|62858625|FG007|Overall Study|Withdrawal by Subject|0|||
33481767|NCT02903914|62858618|FG000|Overall Study|Progressive Disease|1|||
33481768|NCT02903914|62858619|FG001|Overall Study|Progressive Disease|0|||
33481769|NCT02903914|62858620|FG002|Overall Study|Progressive Disease|4|||
33481770|NCT02903914|62858621|FG003|Overall Study|Progressive Disease|0|||
33481771|NCT02903914|62858622|FG004|Overall Study|Progressive Disease|0|||
33481772|NCT02903914|62858623|FG005|Overall Study|Progressive Disease|0|||
33481773|NCT02903914|62858624|FG006|Overall Study|Progressive Disease|2|||
33481774|NCT02903914|62858625|FG007|Overall Study|Progressive Disease|4|||
33481775|NCT02903914|62858618|FG000|Overall Study|Death|0|||
33481776|NCT02903914|62858619|FG001|Overall Study|Death|0|||
33481777|NCT02903914|62858620|FG002|Overall Study|Death|9|||
33481778|NCT02903914|62858621|FG003|Overall Study|Death|0|||
33481779|NCT02903914|62858622|FG004|Overall Study|Death|1|||
33481780|NCT02903914|62858623|FG005|Overall Study|Death|3|||
33481781|NCT02903914|62858624|FG006|Overall Study|Death|24|||
33481782|NCT02903914|62858625|FG007|Overall Study|Death|0|||
33481783|NCT02903914|62858618|FG000|Overall Study|Lost to Follow-up|0|||
33481784|NCT02903914|62858619|FG001|Overall Study|Lost to Follow-up|1|||
33657268|NCT01821677|63079070|FG001|Overall Study|Other|0|||
33552330|NCT02055547|62944724|FG015|Overall Study|Lost to Follow-up|0|||
33552331|NCT02055547|62944725|FG016|Overall Study|Lost to Follow-up|0|||
33657269|NCT01821677|63079071|FG002|Overall Study|Other|0|||
33657270|NCT01797731|63079082|FG000|Overall Study|Didn't have proper radiographs required|3|||
33657271|NCT01797731|63079083|FG001|Overall Study|Didn't have proper radiographs required|3|||
33657272|NCT00709722|63079089|FG000|Overall Study|Adverse Event|1|||
33657273|NCT01820585|63079110|FG000|Overall Study|Adverse Event|9|||
33657274|NCT01820585|63079111|FG001|Overall Study|Adverse Event|13|||
33364737|NCT02393248|62743319|FG016|Part 3: Combination Therapy|Disease Progression|0|||
33481785|NCT02903914|62858620|FG002|Overall Study|Lost to Follow-up|0|||
33481786|NCT02903914|62858621|FG003|Overall Study|Lost to Follow-up|0|||
33481787|NCT02903914|62858622|FG004|Overall Study|Lost to Follow-up|2|||
33481788|NCT02903914|62858623|FG005|Overall Study|Lost to Follow-up|0|||
33481789|NCT02903914|62858624|FG006|Overall Study|Lost to Follow-up|1|||
33481790|NCT02903914|62858625|FG007|Overall Study|Lost to Follow-up|0|||
33481791|NCT02903914|62858618|FG000|Overall Study|Physician Decision|0|||
33481792|NCT02903914|62858619|FG001|Overall Study|Physician Decision|0|||
33481793|NCT02903914|62858620|FG002|Overall Study|Physician Decision|1|||
33552332|NCT02055547|62944726|FG017|Overall Study|Lost to Follow-up|0|||
33552333|NCT02055547|62944727|FG018|Overall Study|Lost to Follow-up|0|||
33552334|NCT02414854|62944765|FG000|Overall Study|Adverse Event|9|||
33552335|NCT02414854|62944766|FG001|Overall Study|Adverse Event|7|||
33552336|NCT02414854|62944767|FG002|Overall Study|Adverse Event|1|||
33657275|NCT01820585|63079112|FG002|Overall Study|Adverse Event|23|||
33552337|NCT02414854|62944768|FG003|Overall Study|Adverse Event|12|||
33481794|NCT02903914|62858621|FG003|Overall Study|Physician Decision|0|||
33481795|NCT02903914|62858622|FG004|Overall Study|Physician Decision|0|||
33552338|NCT02414854|62944765|FG000|Overall Study|Poor compliance to protocol|1|||
33481796|NCT02903914|62858623|FG005|Overall Study|Physician Decision|0|||
33481797|NCT02903914|62858624|FG006|Overall Study|Physician Decision|1|||
33481798|NCT02903914|62858625|FG007|Overall Study|Physician Decision|0|||
33481799|NCT02903914|62858618|FG000|Overall Study|Symptomatic Deterioration|0|||
33481800|NCT02903914|62858619|FG001|Overall Study|Symptomatic Deterioration|0|||
33481801|NCT02903914|62858620|FG002|Overall Study|Symptomatic Deterioration|1|||
33481802|NCT02903914|62858621|FG003|Overall Study|Symptomatic Deterioration|0|||
33481803|NCT02903914|62858622|FG004|Overall Study|Symptomatic Deterioration|0|||
33481804|NCT02903914|62858623|FG005|Overall Study|Symptomatic Deterioration|0|||
33481805|NCT02903914|62858624|FG006|Overall Study|Symptomatic Deterioration|0|||
33481806|NCT02903914|62858625|FG007|Overall Study|Symptomatic Deterioration|0|||
33481807|NCT02903914|62858618|FG000|Overall Study|New Cancer Therapy|2|||
33481808|NCT02903914|62858619|FG001|Overall Study|New Cancer Therapy|2|||
33481809|NCT02903914|62858620|FG002|Overall Study|New Cancer Therapy|21|||
33481810|NCT02903914|62858621|FG003|Overall Study|New Cancer Therapy|4|||
33481811|NCT02903914|62858622|FG004|Overall Study|New Cancer Therapy|3|||
33481812|NCT02903914|62858623|FG005|Overall Study|New Cancer Therapy|6|||
33481813|NCT02903914|62858624|FG006|Overall Study|New Cancer Therapy|55|||
33481814|NCT02903914|62858625|FG007|Overall Study|New Cancer Therapy|0|||
33481815|NCT02903914|62858618|FG000|Overall Study|Reasoning not specified|2|||
33481816|NCT02903914|62858619|FG001|Overall Study|Reasoning not specified|3|||
33481817|NCT02903914|62858620|FG002|Overall Study|Reasoning not specified|20|||
33481818|NCT02903914|62858621|FG003|Overall Study|Reasoning not specified|3|||
33481819|NCT02903914|62858622|FG004|Overall Study|Reasoning not specified|3|||
33481820|NCT02903914|62858623|FG005|Overall Study|Reasoning not specified|3|||
33481821|NCT02903914|62858624|FG006|Overall Study|Reasoning not specified|20|||
33481822|NCT02903914|62858625|FG007|Overall Study|Reasoning not specified|0|||
33481823|NCT02969044|62858647|FG000|Overall Study|Withdrawal by Subject|2|||
33481824|NCT02969044|62858648|FG001|Overall Study|Withdrawal by Subject|6|||
33481825|NCT02969044|62858647|FG000|Overall Study|Adverse Event|3|||
33481826|NCT02969044|62858648|FG001|Overall Study|Adverse Event|0|||
33481827|NCT02967562|62858656|FG000|Overall Study|Consent not obtained|1|||
33481828|NCT02967562|62858657|FG001|Overall Study|Consent not obtained|0|||
33481829|NCT02967562|62858656|FG000|Overall Study|High leak precluding analysis|1|||
33481830|NCT02967562|62858657|FG001|Overall Study|High leak precluding analysis|1|||
33481831|NCT02968576|62858663|FG000|Overall Study|Pregnancy|0|||
33481832|NCT02968576|62858664|FG001|Overall Study|Pregnancy|1|||
33481833|NCT02966002|62858668|FG000|Overall Study|Withdrawal by Subject|2|||
33481834|NCT02966002|62858668|FG000|Overall Study|Adverse Event|1|||
33481835|NCT02966002|62858668|FG000|Overall Study|Lost to Follow-up|1|||
33481836|NCT02965846|62858675|FG000|Overall Study|Lost to Follow-up|1|||
33481837|NCT02965846|62858676|FG001|Overall Study|Lost to Follow-up|0|||
33481838|NCT02965846|62858677|FG002|Overall Study|Lost to Follow-up|0|||
33481839|NCT02965846|62858675|FG000|Overall Study|Withdrawal by Subject|0|||
33481840|NCT02965846|62858676|FG001|Overall Study|Withdrawal by Subject|1|||
33481841|NCT02965846|62858677|FG002|Overall Study|Withdrawal by Subject|0|||
33481842|NCT02965846|62858675|FG000|Overall Study|Study Terminated By Sponsor|4|||
33481843|NCT02965846|62858676|FG001|Overall Study|Study Terminated By Sponsor|4|||
33481844|NCT02965846|62858677|FG002|Overall Study|Study Terminated By Sponsor|0|||
33481845|NCT02965846|62858675|FG000|Overall Study|Participants not randomized|0|||
33481846|NCT02965846|62858676|FG001|Overall Study|Participants not randomized|0|||
33481847|NCT02965846|62858677|FG002|Overall Study|Participants not randomized|33|||
33481848|NCT02900170|62858683|FG000|Overall Study|Lost to Follow-up|8|||
33481849|NCT02900092|62858687|FG000|Overall Study|Adverse Event|1|||
33481850|NCT02902120|62858695|FG000|Overall Study|Lack of Efficacy|1|||
33481851|NCT02965456|62858701|FG000|Overall Study|Lost to Follow-up|40|||
33552339|NCT02414854|62944766|FG001|Overall Study|Poor compliance to protocol|1|||
33552340|NCT02414854|62944767|FG002|Overall Study|Poor compliance to protocol|2|||
33552341|NCT02414854|62944768|FG003|Overall Study|Poor compliance to protocol|2|||
33552342|NCT02414854|62944765|FG000|Overall Study|Other than specified above|12|||
33552343|NCT02414854|62944766|FG001|Overall Study|Other than specified above|37|||
33552344|NCT02414854|62944767|FG002|Overall Study|Other than specified above|17|||
33552345|NCT02414854|62944768|FG003|Overall Study|Other than specified above|37|||
33552346|NCT03332498|62944781|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
33657276|NCT01820585|63079113|FG003|Overall Study|Adverse Event|34|||
33481852|NCT02965456|62858702|FG001|Overall Study|Lost to Follow-up|18|||
33481853|NCT02965456|62858701|FG000|Overall Study|Subject Request|22|||
33481854|NCT02965456|62858702|FG001|Overall Study|Subject Request|13|||
33552347|NCT03332498|62944782|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
33481855|NCT02965456|62858701|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
33481856|NCT02965456|62858702|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
33481857|NCT02965456|62858701|FG000|Overall Study|Adverse Event|3|||
33481858|NCT02965456|62858702|FG001|Overall Study|Adverse Event|0|||
33481859|NCT02965456|62858701|FG000|Overall Study|Noncompliance with Study Drug|1|||
33481860|NCT02965456|62858702|FG001|Overall Study|Noncompliance with Study Drug|1|||
33481861|NCT02965456|62858701|FG000|Overall Study|Worsening Condition|0|||
33481862|NCT02965456|62858702|FG001|Overall Study|Worsening Condition|2|||
33481863|NCT02965456|62858701|FG000|Overall Study|Lack of Efficacy|1|||
33481864|NCT02965456|62858702|FG001|Overall Study|Lack of Efficacy|0|||
33481865|NCT02965456|62858701|FG000|Overall Study|Physician Decision|0|||
33481866|NCT02965456|62858702|FG001|Overall Study|Physician Decision|1|||
33481867|NCT02965456|62858701|FG000|Overall Study|Pregnancy|1|||
33481868|NCT02965456|62858702|FG001|Overall Study|Pregnancy|0|||
33481869|NCT02965456|62858701|FG000|Overall Study|Protocol Violation|0|||
33481870|NCT02965456|62858702|FG001|Overall Study|Protocol Violation|1|||
33481871|NCT02965456|62858701|FG000|Overall Study|Participant ran out of study drug|0|||
33481872|NCT02965456|62858702|FG001|Overall Study|Participant ran out of study drug|1|||
33481873|NCT02965378|62858710|FG000|Overall Study|Progression|16|||
33481874|NCT02965378|62858711|FG001|Overall Study|Progression|4|||
33481875|NCT02965378|62858710|FG000|Overall Study|Adverse Event|5|||
33481876|NCT02965378|62858711|FG001|Overall Study|Adverse Event|2|||
33481877|NCT02965378|62858710|FG000|Overall Study|Death|2|||
33481878|NCT02965378|62858711|FG001|Overall Study|Death|0|||
33481879|NCT02965378|62858710|FG000|Overall Study|Refusal|2|||
33552348|NCT03332498|62944783|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
33552349|NCT01334125|62944792|FG000|Overall Study|Lost to Follow-up|3|||
33552350|NCT01334125|62944793|FG001|Overall Study|Lost to Follow-up|3|||
33552351|NCT02414152|62944800|FG000|Overall Study|Withdrawal by Subject|1|||
33657277|NCT01820585|63079110|FG000|Overall Study|Lack of Efficacy|9|||
33657278|NCT01820585|63079111|FG001|Overall Study|Lack of Efficacy|7|||
33657279|NCT01820585|63079112|FG002|Overall Study|Lack of Efficacy|5|||
33657280|NCT01820585|63079113|FG003|Overall Study|Lack of Efficacy|1|||
33657281|NCT01820585|63079110|FG000|Overall Study|Withdrawal by Subject|3|||
33657282|NCT01820585|63079111|FG001|Overall Study|Withdrawal by Subject|7|||
33657283|NCT01820585|63079112|FG002|Overall Study|Withdrawal by Subject|3|||
33552352|NCT02414152|62944800|FG000|Overall Study|Lack of Efficacy|1|||
33552353|NCT02413996|62944806|FG000|Overall Study|not comfortable with the intervention|9|||
33552354|NCT02413996|62944807|FG001|Overall Study|not comfortable with the intervention|2|||
33552355|NCT01333501|62944815|FG000|Overall Study|Adverse Event|3|||
33552356|NCT01333501|62944816|FG001|Overall Study|Adverse Event|1|||
33552357|NCT01333501|62944815|FG000|Overall Study|Abnormal laboratory value|2|||
33552358|NCT01333501|62944816|FG001|Overall Study|Abnormal laboratory value|1|||
33552359|NCT01333501|62944815|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33552360|NCT01333501|62944816|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
33552361|NCT01333501|62944815|FG000|Overall Study|Withdrawn consent|3|||
33552362|NCT01333501|62944816|FG001|Overall Study|Withdrawn consent|12|||
33552363|NCT01362140|62944824|FG000|Overall Study|Noncompliance|1|||
33552364|NCT01362140|62944825|FG001|Overall Study|Noncompliance|0|||
33552365|NCT01362140|62944824|FG000|Overall Study|Adverse Event|2|||
33552366|NCT01362140|62944825|FG001|Overall Study|Adverse Event|2|||
33552367|NCT01362140|62944824|FG000|Overall Study|Withdrawal by Subject|3|||
33657284|NCT01820585|63079113|FG003|Overall Study|Withdrawal by Subject|8|||
33657285|NCT01820585|63079110|FG000|Overall Study|Lost to Follow-up|3|||
33657286|NCT01820585|63079111|FG001|Overall Study|Lost to Follow-up|3|||
33657287|NCT01820585|63079112|FG002|Overall Study|Lost to Follow-up|0|||
33657288|NCT01820585|63079113|FG003|Overall Study|Lost to Follow-up|3|||
33657289|NCT01820585|63079110|FG000|Overall Study|Protocol Violation|3|||
33657290|NCT01820585|63079111|FG001|Overall Study|Protocol Violation|1|||
33657291|NCT01820585|63079112|FG002|Overall Study|Protocol Violation|1|||
33657292|NCT01820585|63079113|FG003|Overall Study|Protocol Violation|1|||
33657293|NCT01820585|63079110|FG000|Overall Study|Subject non-compliance|0|||
33657294|NCT01820585|63079111|FG001|Overall Study|Subject non-compliance|0|||
33657295|NCT01820585|63079112|FG002|Overall Study|Subject non-compliance|1|||
33657296|NCT01820585|63079113|FG003|Overall Study|Subject non-compliance|2|||
33364738|NCT02393248|62743320|FG017|Part 3: Combination Therapy|Disease Progression|0|||
33481880|NCT02965378|62858711|FG001|Overall Study|Refusal|1|||
33481881|NCT02965378|62858710|FG000|Overall Study|Not protocol specified|0|||
33481882|NCT02965378|62858711|FG001|Overall Study|Not protocol specified|2|||
33481883|NCT03772041|62858719|FG000|Overall Study|Adverse Event|8|||
33552368|NCT01362140|62944825|FG001|Overall Study|Withdrawal by Subject|3|||
33552369|NCT01362140|62944824|FG000|Overall Study|Administrative Decision|0|||
33552370|NCT01362140|62944825|FG001|Overall Study|Administrative Decision|1|||
33552371|NCT01362140|62944824|FG000|Overall Study|Death|2|||
33552372|NCT01362140|62944825|FG001|Overall Study|Death|1|||
33552373|NCT01362140|62944824|FG000|Overall Study|Other|1|||
33657297|NCT01820585|63079110|FG000|Overall Study|at sponsor request|0|||
33657298|NCT01820585|63079111|FG001|Overall Study|at sponsor request|0|||
33657299|NCT01820585|63079112|FG002|Overall Study|at sponsor request|1|||
33481884|NCT03772041|62858720|FG001|Overall Study|Adverse Event|3|||
33481885|NCT03772041|62858719|FG000|Overall Study|Withdrawal by Subject|0|||
33481886|NCT03772041|62858720|FG001|Overall Study|Withdrawal by Subject|2|||
33481887|NCT03772041|62858719|FG000|Overall Study|Protocol Violation|4|||
33481888|NCT03772041|62858720|FG001|Overall Study|Protocol Violation|2|||
33481889|NCT03772041|62858719|FG000|Overall Study|Physician Decision|2|||
33481890|NCT03772041|62858720|FG001|Overall Study|Physician Decision|3|||
33481891|NCT02899156|62858728|FG000|Overall Study|Death|1|||
33481892|NCT02899156|62858729|FG001|Overall Study|Death|0|||
33481893|NCT02899156|62858728|FG000|Overall Study|Physician Decision|0|||
33481894|NCT02899156|62858729|FG001|Overall Study|Physician Decision|1|||
33481895|NCT03773133|62858735|FG000|Overall Study|Screen Failure|8|||
33552374|NCT01362140|62944825|FG001|Overall Study|Other|1|||
33552375|NCT01362140|62944824|FG000|Overall Study|Protocol-specified Criteria|1|||
33552376|NCT01362140|62944825|FG001|Overall Study|Protocol-specified Criteria|2|||
33552377|NCT01362140|62944824|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
33552378|NCT01362140|62944825|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
33552379|NCT01333189|62944833|FG000|Overall Study|Time constraints|1|||
33552380|NCT01333189|62944834|FG001|Overall Study|Time constraints|0|||
33552381|NCT01333189|62944833|FG000|Overall Study|Adverse Event|1|||
33552382|NCT01333189|62944834|FG001|Overall Study|Adverse Event|0|||
33552383|NCT01333189|62944833|FG000|Overall Study|Transportation difficulties|0|||
33552384|NCT01333189|62944834|FG001|Overall Study|Transportation difficulties|1|||
33552385|NCT01333189|62944833|FG000|Overall Study|Moved from region|0|||
33552386|NCT01333189|62944834|FG001|Overall Study|Moved from region|1|||
33552387|NCT01333111|62944843|FG000|Overall Study|patient undergoing major surgery|0|||
33552388|NCT01333111|62944844|FG001|Overall Study|patient undergoing major surgery|2|||
33552389|NCT01333111|62944845|FG002|Overall Study|patient undergoing major surgery|0|||
33552390|NCT01333111|62944843|FG000|Overall Study|personal reasons|0|||
33552391|NCT01333111|62944844|FG001|Overall Study|personal reasons|0|||
33552392|NCT01333111|62944845|FG002|Overall Study|personal reasons|1|||
33552393|NCT01333111|62944843|FG000|Overall Study|unclassified|1|||
33552394|NCT01333111|62944844|FG001|Overall Study|unclassified|0|||
33552395|NCT01333111|62944845|FG002|Overall Study|unclassified|0|||
33552396|NCT01333111|62944843|FG000|Overall Study|withdrawal criteria|0|||
33552397|NCT01333111|62944844|FG001|Overall Study|withdrawal criteria|1|||
33552398|NCT01333111|62944845|FG002|Overall Study|withdrawal criteria|0|||
33552399|NCT01333111|62944843|FG000|Overall Study|Non-compliance|1|||
33552400|NCT01333111|62944844|FG001|Overall Study|Non-compliance|0|||
33552401|NCT01333111|62944845|FG002|Overall Study|Non-compliance|0|||
33552402|NCT01333111|62944843|FG000|Overall Study|Ineffective therapy|0|||
33552403|NCT01333111|62944844|FG001|Overall Study|Ineffective therapy|0|||
33552404|NCT01333111|62944845|FG002|Overall Study|Ineffective therapy|1|||
33552405|NCT00702507|62944853|FG000|Initial Treatment Phase|Adverse Event|2|||
33552406|NCT00702507|62944853|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
33552407|NCT00702507|62944853|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
33552408|NCT00702507|62944853|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
33552409|NCT00702507|62944853|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
33552410|NCT00702507|62944853|FG000|Follow-up Phase|Protocol Violation|2|||
33552411|NCT00702507|62944853|FG000|Follow-up Phase|Lost to Follow-up|23|||
33552412|NCT00702507|62944853|FG000|Follow-up Phase|Late Enrollment|1|||
33552413|NCT01673594|62944869|FG000|Overall Study|Adverse Event|3|||
33552414|NCT01673594|62944870|FG001|Overall Study|Adverse Event|1|||
33552415|NCT01673594|62944869|FG000|Overall Study|Lost to Follow-up|1|||
33552416|NCT01673594|62944870|FG001|Overall Study|Lost to Follow-up|0|||
33481896|NCT02969356|62858740|FG000|Overall Study|Adverse Event|7|||
33552417|NCT01673594|62944869|FG000|Overall Study|Physician Decision|2|||
33552418|NCT01673594|62944870|FG001|Overall Study|Physician Decision|4|||
33552419|NCT01673594|62944869|FG000|Overall Study|Withdrawal by Subject|0|||
33364739|NCT02393248|62743321|FG018|Part 3: Combination Therapy|Disease Progression|0|||
33552420|NCT01673594|62944870|FG001|Overall Study|Withdrawal by Subject|1|||
33552421|NCT02721147|62944879|FG000|Overall Study|Lost to Follow-up|2|||
33364740|NCT02393248|62743322|FG019|Part 3: Combination Therapy|Disease Progression|0|||
33552422|NCT02721147|62944880|FG001|Overall Study|Lost to Follow-up|0|||
33481897|NCT02969356|62858740|FG000|Overall Study|Consent withdrawn|2|||
33481898|NCT02969356|62858740|FG000|Overall Study|Lost to Follow-up|3|||
33481899|NCT02969356|62858740|FG000|Overall Study|Did not need to be reinjected|6|||
33481900|NCT02969356|62858740|FG000|Overall Study|Personal reasons|5|||
33481901|NCT02898454|62858747|FG000|Overall Study|Adverse Event|4|||
33481902|NCT02898454|62858748|FG001|Overall Study|Adverse Event|1|||
33481903|NCT02898454|62858749|FG002|Overall Study|Adverse Event|2|||
33481904|NCT02898454|62858747|FG000|Overall Study|Protocol Violation|1|||
33481905|NCT02898454|62858748|FG001|Overall Study|Protocol Violation|0|||
33481906|NCT02898454|62858749|FG002|Overall Study|Protocol Violation|1|||
33657300|NCT01820585|63079113|FG003|Overall Study|at sponsor request|0|||
33657301|NCT01820585|63079110|FG000|Overall Study|Pregnancy|0|||
33657302|NCT01820585|63079111|FG001|Overall Study|Pregnancy|1|||
33657303|NCT01820585|63079112|FG002|Overall Study|Pregnancy|0|||
33657304|NCT01820585|63079113|FG003|Overall Study|Pregnancy|0|||
33657305|NCT01797263|63079125|FG000|Overall Study|Withdrawal by Subject|21|||
33657306|NCT01797263|63079126|FG001|Overall Study|Withdrawal by Subject|25|||
33657307|NCT01797263|63079125|FG000|Overall Study|Death|1|||
33657308|NCT01797263|63079126|FG001|Overall Study|Death|0|||
33657309|NCT01797263|63079125|FG000|Overall Study|Lost to Follow-up|15|||
33657310|NCT01797263|63079126|FG001|Overall Study|Lost to Follow-up|15|||
33657311|NCT01797185|63079181|FG000|Overall Study|Adverse Event|5|||
33657312|NCT01797185|63079182|FG001|Overall Study|Adverse Event|15|||
33657313|NCT01797185|63079183|FG002|Overall Study|Adverse Event|6|||
33657314|NCT01797185|63079181|FG000|Overall Study|Withdrawal by Subject|6|||
33552423|NCT02721147|62944881|FG002|Overall Study|Lost to Follow-up|0|||
33552424|NCT02720757|62944889|FG000|Overall Study|Other reason|5|||
33552425|NCT02720757|62944889|FG000|Overall Study|Loss of contact|4|||
33552426|NCT02720757|62944889|FG000|Overall Study|Informed consent withdrawal|1|||
33552427|NCT02720757|62944889|FG000|Overall Study|Patients wish to withdraw|2|||
33552428|NCT02720757|62944889|FG000|Overall Study|Missing|3|||
33552429|NCT02720757|62944889|FG000|Overall Study|General exclusion|3|||
33552430|NCT02646566|62944919|FG000|Overall Study|Lost to Follow-up|5|||
33552431|NCT02646566|62944920|FG001|Overall Study|Lost to Follow-up|4|||
33552432|NCT02646566|62944921|FG002|Overall Study|Lost to Follow-up|5|||
33552433|NCT02646566|62944919|FG000|Overall Study|Treatment failure|1|||
33552434|NCT02646566|62944920|FG001|Overall Study|Treatment failure|0|||
33657315|NCT01797185|63079182|FG001|Overall Study|Withdrawal by Subject|9|||
33657316|NCT01797185|63079183|FG002|Overall Study|Withdrawal by Subject|5|||
33552435|NCT02646566|62944921|FG002|Overall Study|Treatment failure|0|||
33552436|NCT02720523|62944937|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
33552437|NCT02720523|62944938|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
33552438|NCT02720523|62944939|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
33552439|NCT02720523|62944940|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
33552440|NCT02720523|62944941|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
33552441|NCT02720523|62944942|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
33552442|NCT02720523|62944943|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
33552443|NCT02720523|62944937|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
33552444|NCT02720523|62944938|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33552445|NCT02720523|62944939|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33552446|NCT02720523|62944940|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33552447|NCT02720523|62944941|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33552448|NCT02720523|62944942|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33552449|NCT02720523|62944943|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33552450|NCT02720523|62944937|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
33552451|NCT02720523|62944938|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
33552452|NCT02720523|62944939|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
33552453|NCT02720523|62944940|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
33552454|NCT02720523|62944941|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
33552455|NCT02720523|62944942|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
33552456|NCT02720523|62944943|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
33657317|NCT01797185|63079181|FG000|Overall Study|Site terminated|8|||
33481907|NCT02898454|62858747|FG000|Overall Study|Lack of Efficacy|4|||
33481908|NCT02898454|62858748|FG001|Overall Study|Lack of Efficacy|1|||
33481909|NCT02898454|62858749|FG002|Overall Study|Lack of Efficacy|0|||
33481910|NCT02898454|62858747|FG000|Overall Study|Withdrawal by Subject|6|||
33552457|NCT02720523|62944937|FG000|Period 1: Placebo-controlled Period|Other|0|||
33657318|NCT01797185|63079182|FG001|Overall Study|Site terminated|4|||
33657319|NCT01797185|63079183|FG002|Overall Study|Site terminated|0|||
33657320|NCT01797185|63079181|FG000|Overall Study|Lost to Follow-up|2|||
33552458|NCT02720523|62944938|FG001|Period 1: Placebo-controlled Period|Other|0|||
33481911|NCT02898454|62858748|FG001|Overall Study|Withdrawal by Subject|3|||
33481912|NCT02898454|62858749|FG002|Overall Study|Withdrawal by Subject|3|||
33481913|NCT02898454|62858747|FG000|Overall Study|Lost to Follow-up|1|||
33481914|NCT02898454|62858748|FG001|Overall Study|Lost to Follow-up|0|||
33552459|NCT02720523|62944939|FG002|Period 1: Placebo-controlled Period|Other|1|||
33552460|NCT02720523|62944940|FG003|Period 1: Placebo-controlled Period|Other|1|||
33552461|NCT02720523|62944941|FG004|Period 1: Placebo-controlled Period|Other|0|||
33552462|NCT02720523|62944942|FG005|Period 1: Placebo-controlled Period|Other|0|||
33552463|NCT02720523|62944943|FG006|Period 1: Placebo-controlled Period|Other|0|||
33552464|NCT02720523|62944937|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
33552465|NCT02720523|62944938|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
33552466|NCT02720523|62944939|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
33552467|NCT02720523|62944940|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
33552468|NCT02720523|62944941|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
33552469|NCT02720523|62944942|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
33552470|NCT02720523|62944943|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
33481915|NCT02898454|62858749|FG002|Overall Study|Lost to Follow-up|0|||
33481916|NCT02898454|62858747|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
33481917|NCT02898454|62858748|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
33481918|NCT02898454|62858749|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
33481919|NCT03772587|62858767|FG000|Overall Study|COVID-19|0|||
33481920|NCT03772587|62858768|FG001|Overall Study|COVID-19|0|||
33481921|NCT03772587|62858769|FG002|Overall Study|COVID-19|1|||
33552471|NCT02720523|62944937|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
33481922|NCT03772587|62858770|FG003|Overall Study|COVID-19|1|||
33481923|NCT03772587|62858771|FG004|Overall Study|COVID-19|0|||
33552472|NCT02720523|62944938|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
33552473|NCT02720523|62944939|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
33552474|NCT02720523|62944940|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
33552475|NCT02720523|62944941|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
33552476|NCT02720523|62944942|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
33552477|NCT02720523|62944943|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
33552478|NCT02720523|62944937|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
33552479|NCT02720523|62944938|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
33552480|NCT02720523|62944939|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
33481924|NCT03772587|62858767|FG000|Overall Study|Withdrawal by Subject|1|||
33481925|NCT03772587|62858768|FG001|Overall Study|Withdrawal by Subject|0|||
33481926|NCT03772587|62858769|FG002|Overall Study|Withdrawal by Subject|0|||
33481927|NCT03772587|62858770|FG003|Overall Study|Withdrawal by Subject|0|||
33481928|NCT03772587|62858771|FG004|Overall Study|Withdrawal by Subject|0|||
33481929|NCT02963506|62858798|FG000|Double-Blind Period|Adverse Event|0|||
33481930|NCT02963506|62858799|FG001|Double-Blind Period|Adverse Event|0|||
33481931|NCT02963506|62858800|FG002|Double-Blind Period|Adverse Event|1|||
33481932|NCT02963506|62858801|FG003|Double-Blind Period|Adverse Event|0|||
33481933|NCT02963506|62858802|FG004|Double-Blind Period|Adverse Event|0|||
33481934|NCT02963506|62858803|FG005|Double-Blind Period|Adverse Event|0|||
33481935|NCT02963506|62858804|FG006|Double-Blind Period|Adverse Event|0|||
33481936|NCT02963506|62858805|FG007|Double-Blind Period|Adverse Event|0|||
33481937|NCT02963506|62858806|FG008|Double-Blind Period|Adverse Event|0|||
33481938|NCT02963506|62858807|FG009|Double-Blind Period|Adverse Event|0|||
33481939|NCT02963506|62858808|FG010|Double-Blind Period|Adverse Event|0|||
33481940|NCT02963506|62858809|FG011|Double-Blind Period|Adverse Event|0|||
33481941|NCT02963506|62858810|FG012|Double-Blind Period|Adverse Event|0|||
33481942|NCT02963506|62858798|FG000|Double-Blind Period|Death|0|||
33481943|NCT02963506|62858799|FG001|Double-Blind Period|Death|0|||
33552481|NCT02720523|62944940|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
33552482|NCT02720523|62944941|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
33552483|NCT02720523|62944942|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
33552484|NCT02720523|62944943|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
33552485|NCT02720523|62944937|FG000|Period 2: Long-term Extension Period|Other|0|||
33657321|NCT01797185|63079182|FG001|Overall Study|Lost to Follow-up|6|||
33657322|NCT01797185|63079183|FG002|Overall Study|Lost to Follow-up|1|||
33657323|NCT01797185|63079181|FG000|Overall Study|Withdrawn per sponsor|5|||
33657324|NCT01797185|63079182|FG001|Overall Study|Withdrawn per sponsor|0|||
33657325|NCT01797185|63079183|FG002|Overall Study|Withdrawn per sponsor|0|||
33657326|NCT01797185|63079181|FG000|Overall Study|Physician Decision|1|||
33657327|NCT01797185|63079182|FG001|Overall Study|Physician Decision|3|||
33657328|NCT01797185|63079183|FG002|Overall Study|Physician Decision|0|||
33657329|NCT01797185|63079181|FG000|Overall Study|Protocol Violation|1|||
33657330|NCT01797185|63079182|FG001|Overall Study|Protocol Violation|1|||
33657331|NCT01797185|63079183|FG002|Overall Study|Protocol Violation|0|||
33657332|NCT01819727|63079239|FG000|Overall Study|Adverse Event|8|||
33657333|NCT01819727|63079240|FG001|Overall Study|Adverse Event|9|||
33657334|NCT01819727|63079239|FG000|Overall Study|Death|1|||
33657335|NCT01819727|63079240|FG001|Overall Study|Death|0|||
33657336|NCT01819727|63079239|FG000|Overall Study|Lost to Follow-up|1|||
33657337|NCT01819727|63079240|FG001|Overall Study|Lost to Follow-up|1|||
33657338|NCT01819727|63079239|FG000|Overall Study|Physician Decision|3|||
33657339|NCT01819727|63079240|FG001|Overall Study|Physician Decision|2|||
33657340|NCT01819727|63079239|FG000|Overall Study|Pregnancy|1|||
33657341|NCT01819727|63079240|FG001|Overall Study|Pregnancy|0|||
33657342|NCT01819727|63079239|FG000|Overall Study|Protocol Violation|0|||
33657343|NCT01819727|63079240|FG001|Overall Study|Protocol Violation|2|||
33552486|NCT02720523|62944938|FG001|Period 2: Long-term Extension Period|Other|0|||
33657344|NCT01819727|63079239|FG000|Overall Study|Study Terminated by Sponsor|0|||
33657345|NCT01819727|63079240|FG001|Overall Study|Study Terminated by Sponsor|1|||
33657346|NCT01819727|63079239|FG000|Overall Study|Withdrawal by Subject|6|||
33657347|NCT01819727|63079240|FG001|Overall Study|Withdrawal by Subject|11|||
33657348|NCT01819727|63079239|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
33481944|NCT02963506|62858800|FG002|Double-Blind Period|Death|0|||
33481945|NCT02963506|62858801|FG003|Double-Blind Period|Death|1|||
33657349|NCT01819727|63079240|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
33657350|NCT01819727|63079239|FG000|Overall Study|Quit due to lack of health benifits|0|||
33657351|NCT01819727|63079240|FG001|Overall Study|Quit due to lack of health benifits|1|||
33657352|NCT01795937|63079299|FG000|Overall Study|Withdrawal by Subject|1|||
33481946|NCT02963506|62858802|FG004|Double-Blind Period|Death|0|||
33481947|NCT02963506|62858803|FG005|Double-Blind Period|Death|0|||
33552487|NCT02720523|62944939|FG002|Period 2: Long-term Extension Period|Other|0|||
33552488|NCT02720523|62944940|FG003|Period 2: Long-term Extension Period|Other|0|||
33552489|NCT02720523|62944941|FG004|Period 2: Long-term Extension Period|Other|2|||
33552490|NCT02720523|62944942|FG005|Period 2: Long-term Extension Period|Other|0|||
33552491|NCT02720523|62944943|FG006|Period 2: Long-term Extension Period|Other|3|||
33552492|NCT02646332|62944958|FG000|Overall Study|Lost to Follow-up|0|||
33552493|NCT02646332|62944959|FG001|Overall Study|Lost to Follow-up|3|||
33552494|NCT02471716|62944970|FG000|Overall Study|Withdrawal by Subject|0|||
33481948|NCT02963506|62858804|FG006|Double-Blind Period|Death|0|||
33481949|NCT02963506|62858805|FG007|Double-Blind Period|Death|0|||
33552495|NCT02471716|62944971|FG001|Overall Study|Withdrawal by Subject|1|||
33481950|NCT02963506|62858806|FG008|Double-Blind Period|Death|0|||
33481951|NCT02963506|62858807|FG009|Double-Blind Period|Death|0|||
33481952|NCT02963506|62858808|FG010|Double-Blind Period|Death|0|||
33481953|NCT02963506|62858809|FG011|Double-Blind Period|Death|0|||
33481954|NCT02963506|62858810|FG012|Double-Blind Period|Death|0|||
33481955|NCT02963506|62858798|FG000|Double-Blind Period|Lost to Follow-up|0|||
33481956|NCT02963506|62858799|FG001|Double-Blind Period|Lost to Follow-up|1|||
33481957|NCT02963506|62858800|FG002|Double-Blind Period|Lost to Follow-up|0|||
33552496|NCT02471716|62944972|FG002|Overall Study|Withdrawal by Subject|0|||
33552497|NCT02471716|62944973|FG003|Overall Study|Withdrawal by Subject|2|||
33552498|NCT02471716|62944974|FG004|Overall Study|Withdrawal by Subject|5|||
33552499|NCT02471716|62944970|FG000|Overall Study|Study Terminiated by sponsor|0|||
33552500|NCT02471716|62944971|FG001|Overall Study|Study Terminiated by sponsor|0|||
33552501|NCT02471716|62944972|FG002|Overall Study|Study Terminiated by sponsor|0|||
33552502|NCT02471716|62944973|FG003|Overall Study|Study Terminiated by sponsor|1|||
33552503|NCT02471716|62944974|FG004|Overall Study|Study Terminiated by sponsor|0|||
33552504|NCT02471716|62944970|FG000|Overall Study|Lost to Follow-up|0|||
33552505|NCT02471716|62944971|FG001|Overall Study|Lost to Follow-up|0|||
33552506|NCT02471716|62944972|FG002|Overall Study|Lost to Follow-up|0|||
33552507|NCT02471716|62944973|FG003|Overall Study|Lost to Follow-up|3|||
33552508|NCT02471716|62944974|FG004|Overall Study|Lost to Follow-up|2|||
33552509|NCT02471716|62944970|FG000|Overall Study|Death|0|||
33552510|NCT02471716|62944971|FG001|Overall Study|Death|0|||
33552511|NCT02471716|62944972|FG002|Overall Study|Death|0|||
33552512|NCT02471716|62944973|FG003|Overall Study|Death|1|||
33552513|NCT02471716|62944974|FG004|Overall Study|Death|0|||
33552514|NCT02471716|62944970|FG000|Overall Study|Other|0|||
33552515|NCT02471716|62944971|FG001|Overall Study|Other|0|||
33552516|NCT02471716|62944972|FG002|Overall Study|Other|0|||
33552517|NCT02471716|62944973|FG003|Overall Study|Other|8|||
33552518|NCT02471716|62944974|FG004|Overall Study|Other|9|||
33552519|NCT01370863|62944990|FG000|Overall Study|Adverse Event|1|||
33552520|NCT01370863|62944991|FG001|Overall Study|Adverse Event|1|||
33552521|NCT01370863|62944990|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
33481958|NCT02963506|62858801|FG003|Double-Blind Period|Lost to Follow-up|0|||
33481959|NCT02963506|62858802|FG004|Double-Blind Period|Lost to Follow-up|0|||
33552522|NCT01370863|62944991|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
33552523|NCT01370863|62944990|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
33552524|NCT01370863|62944991|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
33552525|NCT02444182|62944999|FG000|Overall Study|non-compliance|2|||
33552526|NCT02444182|62945000|FG001|Overall Study|non-compliance|1|||
33552527|NCT02444182|62944999|FG000|Overall Study|Lost to Follow-up|0|||
33552528|NCT02444182|62945000|FG001|Overall Study|Lost to Follow-up|4|||
33552529|NCT02471404|62945009|FG000|Overall Study|Adverse Event|7|||
33552530|NCT02471404|62945010|FG001|Overall Study|Adverse Event|1|||
33552531|NCT02471404|62945011|FG002|Overall Study|Adverse Event|2|||
33552532|NCT02471404|62945009|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
33552533|NCT02471404|62945010|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
33552534|NCT02471404|62945011|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
33552535|NCT02471404|62945009|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
33552536|NCT02471404|62945010|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
33552537|NCT02471404|62945011|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
33552538|NCT02471404|62945009|FG000|Overall Study|Lost to Follow-up|1|||
33552539|NCT02471404|62945010|FG001|Overall Study|Lost to Follow-up|1|||
33552540|NCT02471404|62945011|FG002|Overall Study|Lost to Follow-up|3|||
33481960|NCT02963506|62858803|FG005|Double-Blind Period|Lost to Follow-up|0|||
33481961|NCT02963506|62858804|FG006|Double-Blind Period|Lost to Follow-up|0|||
33552541|NCT02471404|62945009|FG000|Overall Study|Protocol Violation|1|||
33481962|NCT02963506|62858805|FG007|Double-Blind Period|Lost to Follow-up|0|||
33552542|NCT02471404|62945010|FG001|Overall Study|Protocol Violation|0|||
33552543|NCT02471404|62945011|FG002|Overall Study|Protocol Violation|0|||
33552544|NCT02471404|62945009|FG000|Overall Study|Withdrawal by Subject|8|||
33481963|NCT02963506|62858806|FG008|Double-Blind Period|Lost to Follow-up|0|||
33481964|NCT02963506|62858807|FG009|Double-Blind Period|Lost to Follow-up|0|||
33552545|NCT02471404|62945010|FG001|Overall Study|Withdrawal by Subject|4|||
33580923|NCT01439282|62978067|FG001|Overall Study|Other|1|||
33481965|NCT02963506|62858808|FG010|Double-Blind Period|Lost to Follow-up|0|||
33481966|NCT02963506|62858809|FG011|Double-Blind Period|Lost to Follow-up|0|||
33481967|NCT02963506|62858810|FG012|Double-Blind Period|Lost to Follow-up|0|||
33481968|NCT02963506|62858798|FG000|Double-Blind Period|Withdrawal by Subject|0|||
33481969|NCT02963506|62858799|FG001|Double-Blind Period|Withdrawal by Subject|0|||
33481970|NCT02963506|62858800|FG002|Double-Blind Period|Withdrawal by Subject|1|||
33481971|NCT02963506|62858801|FG003|Double-Blind Period|Withdrawal by Subject|1|||
33481972|NCT02963506|62858802|FG004|Double-Blind Period|Withdrawal by Subject|0|||
33552546|NCT02471404|62945011|FG002|Overall Study|Withdrawal by Subject|5|||
33481973|NCT02963506|62858803|FG005|Double-Blind Period|Withdrawal by Subject|0|||
33481974|NCT02963506|62858804|FG006|Double-Blind Period|Withdrawal by Subject|0|||
33481975|NCT02963506|62858805|FG007|Double-Blind Period|Withdrawal by Subject|0|||
33481976|NCT02963506|62858806|FG008|Double-Blind Period|Withdrawal by Subject|0|||
33552547|NCT02471404|62945009|FG000|Overall Study|Other reasons not specified|10|||
33552548|NCT02471404|62945010|FG001|Overall Study|Other reasons not specified|7|||
33552549|NCT02471404|62945011|FG002|Overall Study|Other reasons not specified|12|||
33552550|NCT02471014|62945021|FG000|Overall Study|Lost to Follow-up|2|||
33552551|NCT02471014|62945022|FG001|Overall Study|Lost to Follow-up|2|||
33552552|NCT02413372|62945031|FG000|Treatment|Lost to Follow-up|0|||
33481977|NCT02963506|62858807|FG009|Double-Blind Period|Withdrawal by Subject|0|||
33481978|NCT02963506|62858808|FG010|Double-Blind Period|Withdrawal by Subject|0|||
33481979|NCT02963506|62858809|FG011|Double-Blind Period|Withdrawal by Subject|0|||
33481980|NCT02963506|62858810|FG012|Double-Blind Period|Withdrawal by Subject|0|||
33481981|NCT02963506|62858798|FG000|Double-Blind Period|No compliance|0|||
33481982|NCT02963506|62858799|FG001|Double-Blind Period|No compliance|1|||
33481983|NCT02963506|62858800|FG002|Double-Blind Period|No compliance|0|||
33481984|NCT02963506|62858801|FG003|Double-Blind Period|No compliance|0|||
33481985|NCT02963506|62858802|FG004|Double-Blind Period|No compliance|0|||
33481986|NCT02963506|62858803|FG005|Double-Blind Period|No compliance|0|||
33481987|NCT02963506|62858804|FG006|Double-Blind Period|No compliance|0|||
33481988|NCT02963506|62858805|FG007|Double-Blind Period|No compliance|0|||
33481989|NCT02963506|62858806|FG008|Double-Blind Period|No compliance|0|||
33481990|NCT02963506|62858807|FG009|Double-Blind Period|No compliance|0|||
33552553|NCT02413372|62945032|FG001|Treatment|Lost to Follow-up|2|||
33552554|NCT02413372|62945033|FG002|Treatment|Lost to Follow-up|1|||
33552555|NCT02413372|62945031|FG000|Treatment|Withdrawal by Subject|1|||
33552556|NCT02413372|62945032|FG001|Treatment|Withdrawal by Subject|0|||
33552557|NCT02413372|62945033|FG002|Treatment|Withdrawal by Subject|0|||
33552558|NCT02413372|62945031|FG000|Follow-up|Lost to Follow-up|1|||
33552559|NCT02413372|62945032|FG001|Follow-up|Lost to Follow-up|1|||
33552560|NCT02413372|62945033|FG002|Follow-up|Lost to Follow-up|0|||
33552561|NCT02413372|62945031|FG000|Follow-up|Subject Withdrew Consent|1|||
33552562|NCT02413372|62945032|FG001|Follow-up|Subject Withdrew Consent|0|||
33657353|NCT01795937|63079300|FG001|Overall Study|Withdrawal by Subject|0|||
33657354|NCT01795937|63079301|FG002|Overall Study|Withdrawal by Subject|0|||
33657355|NCT01795937|63079299|FG000|Overall Study|Physician Decision|0|||
33657356|NCT01795937|63079300|FG001|Overall Study|Physician Decision|1|||
33657357|NCT01795937|63079301|FG002|Overall Study|Physician Decision|0|||
33657358|NCT01817777|63079343|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
33657359|NCT01817777|63079344|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
33657360|NCT01817777|63079345|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
33657361|NCT01817777|63079343|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
33657362|NCT01817777|63079344|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
33657363|NCT01817777|63079345|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
33657364|NCT01817777|63079343|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
33657365|NCT01817777|63079344|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
33657366|NCT01817777|63079345|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
33481991|NCT02963506|62858808|FG010|Double-Blind Period|No compliance|0|||
33481992|NCT02963506|62858809|FG011|Double-Blind Period|No compliance|0|||
33481993|NCT02963506|62858810|FG012|Double-Blind Period|No compliance|0|||
33657367|NCT01817777|63079343|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
33481994|NCT02963506|62858798|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33481995|NCT02963506|62858799|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
33481996|NCT02963506|62858800|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33481997|NCT02963506|62858801|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33481998|NCT02963506|62858802|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33552563|NCT02413372|62945033|FG002|Follow-up|Subject Withdrew Consent|1|||
33552564|NCT02413372|62945031|FG000|Follow-up|Subject unable to return for visit|0|||
33552565|NCT02413372|62945032|FG001|Follow-up|Subject unable to return for visit|0|||
33552566|NCT02413372|62945033|FG002|Follow-up|Subject unable to return for visit|1|||
33552567|NCT02413294|62945041|FG000|Overall Study|Withdrawal by Subject|1|||
33481999|NCT02963506|62858803|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33482000|NCT02963506|62858804|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33552568|NCT02719353|62945054|FG000|First Intervention|Physician Decision|0|||
33657368|NCT01817777|63079344|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
33657369|NCT01817777|63079345|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
33657370|NCT01817777|63079343|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
33657371|NCT01817777|63079344|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
33657372|NCT01817777|63079345|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
33657373|NCT01795547|63079371|FG000|Overall Study|Adverse Event|16|||
33657374|NCT01795547|63079372|FG001|Overall Study|Adverse Event|27|||
33657375|NCT01795547|63079371|FG000|Overall Study|Lack of Efficacy|8|||
33657376|NCT01795547|63079372|FG001|Overall Study|Lack of Efficacy|3|||
33657377|NCT01795547|63079371|FG000|Overall Study|Protocol Violation|6|||
33657378|NCT01795547|63079372|FG001|Overall Study|Protocol Violation|4|||
33657379|NCT01795547|63079371|FG000|Overall Study|Lost to Follow-up|2|||
33657380|NCT01795547|63079372|FG001|Overall Study|Lost to Follow-up|5|||
33657381|NCT01795547|63079371|FG000|Overall Study|Withdrawal of consent|7|||
33657382|NCT01795547|63079372|FG001|Overall Study|Withdrawal of consent|12|||
33657383|NCT01795547|63079371|FG000|Overall Study|Not Treated|4|||
33657384|NCT01795547|63079372|FG001|Overall Study|Not Treated|10|||
33657385|NCT01795547|63079371|FG000|Overall Study|Non-compliance with IMP|1|||
33657386|NCT01795547|63079372|FG001|Overall Study|Non-compliance with IMP|1|||
33657387|NCT01795547|63079371|FG000|Overall Study|Others|4|||
33657388|NCT01795547|63079372|FG001|Overall Study|Others|1|||
33657389|NCT01795547|63079371|FG000|Overall Study|Not stated|0|||
33364741|NCT02393248|62743323|FG020|Part 3: Combination Therapy|Disease Progression|2|||
33482001|NCT02963506|62858805|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33482002|NCT02963506|62858806|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33482003|NCT02963506|62858807|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33482004|NCT02963506|62858808|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33482005|NCT02963506|62858809|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33552569|NCT02719353|62945055|FG001|First Intervention|Physician Decision|1|||
33552570|NCT01362062|62945064|FG000|Overall Study|Adverse Event|1|||
33552571|NCT01362062|62945065|FG001|Overall Study|Adverse Event|0|||
33552572|NCT01362062|62945064|FG000|Overall Study|Lost to Follow-up|11|||
33552573|NCT01362062|62945065|FG001|Overall Study|Lost to Follow-up|0|||
33552574|NCT01362062|62945064|FG000|Overall Study|Withdrawal by Subject|2|||
33552575|NCT01362062|62945065|FG001|Overall Study|Withdrawal by Subject|0|||
33552576|NCT01362062|62945064|FG000|Overall Study|Non-compliant participant|2|||
33552577|NCT01362062|62945065|FG001|Overall Study|Non-compliant participant|0|||
33552578|NCT01362062|62945064|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
33552579|NCT01362062|62945065|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
33482006|NCT02963506|62858810|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33482007|NCT02963506|62858798|FG000|Dose-Blind Period|Adverse Event|0|||
33552580|NCT01362062|62945064|FG000|Overall Study|Had significant improvement|9|||
33552581|NCT01362062|62945065|FG001|Overall Study|Had significant improvement|0|||
33552582|NCT01361594|62945072|FG000|Overall Study|Withdrawal by Subject|1|||
33657390|NCT01795547|63079372|FG001|Overall Study|Not stated|1|||
33364742|NCT02393248|62743324|FG021|Part 3: Combination Therapy|Disease Progression|1|||
33364743|NCT02393248|62743325|FG022|Part 3: Combination Therapy|Disease Progression|0|||
33482008|NCT02963506|62858799|FG001|Dose-Blind Period|Adverse Event|0|||
33482009|NCT02963506|62858800|FG002|Dose-Blind Period|Adverse Event|0|||
33482010|NCT02963506|62858801|FG003|Dose-Blind Period|Adverse Event|0|||
33482011|NCT02963506|62858802|FG004|Dose-Blind Period|Adverse Event|0|||
33482012|NCT02963506|62858803|FG005|Dose-Blind Period|Adverse Event|1|||
33482013|NCT02963506|62858804|FG006|Dose-Blind Period|Adverse Event|3|||
33482014|NCT02963506|62858805|FG007|Dose-Blind Period|Adverse Event|2|||
33482015|NCT02963506|62858806|FG008|Dose-Blind Period|Adverse Event|2|||
33482016|NCT02963506|62858807|FG009|Dose-Blind Period|Adverse Event|2|||
33482017|NCT02963506|62858808|FG010|Dose-Blind Period|Adverse Event|1|||
33482018|NCT02963506|62858809|FG011|Dose-Blind Period|Adverse Event|1|||
33482019|NCT02963506|62858810|FG012|Dose-Blind Period|Adverse Event|6|||
33482020|NCT02963506|62858798|FG000|Dose-Blind Period|Lack of Efficacy|0|||
33552583|NCT01361594|62945073|FG001|Overall Study|Withdrawal by Subject|2|||
33552584|NCT02642432|62945079|FG000|Overall Study|Adverse Event|2|||
33552585|NCT02642432|62945079|FG000|Overall Study|Withdrew Consent|1|||
33552586|NCT02642432|62945079|FG000|Overall Study|Lost to Follow-up|2|||
33657391|NCT01794923|63079398|FG000|Overall Study|Adverse Event|0|||
33657392|NCT01794923|63079399|FG001|Overall Study|Adverse Event|0|||
33657393|NCT01794923|63079400|FG002|Overall Study|Adverse Event|1|||
33657394|NCT01794845|63079408|FG000|Overall Study|Withdrawal by Subject|1|||
33657395|NCT01794689|63079416|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
33657396|NCT01794689|63079417|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
33657397|NCT01794689|63079418|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
33657398|NCT01794689|63079419|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
33657399|NCT01794689|63079416|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
33657400|NCT01794689|63079417|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
33657401|NCT01794689|63079418|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
33657402|NCT01794689|63079419|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
33657403|NCT01794689|63079416|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
33657404|NCT01794689|63079417|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
33552587|NCT02642432|62945079|FG000|Overall Study|Other|3|||
33552588|NCT02640482|62945085|FG000|Overall Study|Lost to Follow-up|3|||
33552589|NCT02640482|62945086|FG001|Overall Study|Lost to Follow-up|0|||
33552590|NCT02719743|62945097|FG000|Overall Study|Consent withdrawal|0|||
33552591|NCT02719743|62945098|FG001|Overall Study|Consent withdrawal|2|||
33552592|NCT02719743|62945099|FG002|Overall Study|Consent withdrawal|0|||
33552593|NCT02719743|62945100|FG003|Overall Study|Consent withdrawal|1|||
33552594|NCT02719743|62945101|FG004|Overall Study|Consent withdrawal|0|||
33552595|NCT02719743|62945097|FG000|Overall Study|Migrated/moved from study area|0|||
33552596|NCT02719743|62945098|FG001|Overall Study|Migrated/moved from study area|0|||
33552597|NCT02719743|62945099|FG002|Overall Study|Migrated/moved from study area|0|||
33552598|NCT02719743|62945100|FG003|Overall Study|Migrated/moved from study area|0|||
33552599|NCT02719743|62945101|FG004|Overall Study|Migrated/moved from study area|2|||
33552600|NCT02719743|62945097|FG000|Overall Study|Lost to Follow-up|1|||
33552601|NCT02719743|62945098|FG001|Overall Study|Lost to Follow-up|1|||
33552602|NCT02719743|62945099|FG002|Overall Study|Lost to Follow-up|0|||
33552603|NCT02719743|62945100|FG003|Overall Study|Lost to Follow-up|0|||
33552604|NCT02719743|62945101|FG004|Overall Study|Lost to Follow-up|0|||
33552605|NCT02641730|62945116|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
33552606|NCT02641730|62945117|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33552607|NCT02641730|62945118|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33552608|NCT02641730|62945119|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
33552609|NCT02641730|62945120|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
33552610|NCT02641730|62945116|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
33552611|NCT02641730|62945117|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
33552612|NCT02641730|62945118|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
33552613|NCT02641730|62945119|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
33552614|NCT02641730|62945120|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
33552615|NCT02641730|62945116|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
33552616|NCT02641730|62945117|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
33657405|NCT01794689|63079418|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
33482021|NCT02963506|62858799|FG001|Dose-Blind Period|Lack of Efficacy|0|||
33552617|NCT02641730|62945118|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
33552618|NCT02641730|62945119|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
33552619|NCT02641730|62945120|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
33552620|NCT02641730|62945116|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
33482022|NCT02963506|62858800|FG002|Dose-Blind Period|Lack of Efficacy|0|||
33482023|NCT02963506|62858801|FG003|Dose-Blind Period|Lack of Efficacy|0|||
33482024|NCT02963506|62858802|FG004|Dose-Blind Period|Lack of Efficacy|0|||
33482025|NCT02963506|62858803|FG005|Dose-Blind Period|Lack of Efficacy|0|||
33482026|NCT02963506|62858804|FG006|Dose-Blind Period|Lack of Efficacy|0|||
33482027|NCT02963506|62858805|FG007|Dose-Blind Period|Lack of Efficacy|1|||
33482028|NCT02963506|62858806|FG008|Dose-Blind Period|Lack of Efficacy|0|||
33482029|NCT02963506|62858807|FG009|Dose-Blind Period|Lack of Efficacy|1|||
33482030|NCT02963506|62858808|FG010|Dose-Blind Period|Lack of Efficacy|0|||
33482031|NCT02963506|62858809|FG011|Dose-Blind Period|Lack of Efficacy|0|||
33482032|NCT02963506|62858810|FG012|Dose-Blind Period|Lack of Efficacy|0|||
33482033|NCT02963506|62858798|FG000|Dose-Blind Period|Lost to Follow-up|0|||
33482034|NCT02963506|62858799|FG001|Dose-Blind Period|Lost to Follow-up|0|||
33482035|NCT02963506|62858800|FG002|Dose-Blind Period|Lost to Follow-up|0|||
33482036|NCT02963506|62858801|FG003|Dose-Blind Period|Lost to Follow-up|0|||
33482037|NCT02963506|62858802|FG004|Dose-Blind Period|Lost to Follow-up|0|||
33482038|NCT02963506|62858803|FG005|Dose-Blind Period|Lost to Follow-up|1|||
33482039|NCT02963506|62858804|FG006|Dose-Blind Period|Lost to Follow-up|0|||
33482040|NCT02963506|62858805|FG007|Dose-Blind Period|Lost to Follow-up|0|||
33482041|NCT02963506|62858806|FG008|Dose-Blind Period|Lost to Follow-up|1|||
33482042|NCT02963506|62858807|FG009|Dose-Blind Period|Lost to Follow-up|0|||
33482043|NCT02963506|62858808|FG010|Dose-Blind Period|Lost to Follow-up|0|||
33482044|NCT02963506|62858809|FG011|Dose-Blind Period|Lost to Follow-up|1|||
33482045|NCT02963506|62858810|FG012|Dose-Blind Period|Lost to Follow-up|0|||
33482046|NCT02963506|62858798|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
33482047|NCT02963506|62858799|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
33482048|NCT02963506|62858800|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
33552621|NCT02641730|62945117|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
33552622|NCT02641730|62945118|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
33552623|NCT02641730|62945119|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
33552624|NCT02641730|62945120|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
33552625|NCT02641730|62945116|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
33552626|NCT02641730|62945117|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
33552627|NCT02641730|62945118|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
33552628|NCT02641730|62945119|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
33552629|NCT02641730|62945120|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
33552630|NCT02641730|62945116|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
33552631|NCT02641730|62945117|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
33552632|NCT02641730|62945118|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
33552633|NCT02641730|62945119|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
33552634|NCT02641730|62945120|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
33552635|NCT02797171|62945140|FG000|Overall Study|Lost to Follow-up|2|||
33552636|NCT02797171|62945141|FG001|Overall Study|Lost to Follow-up|0|||
33552637|NCT02797171|62945142|FG002|Overall Study|Lost to Follow-up|2|||
33552638|NCT02797171|62945143|FG003|Overall Study|Lost to Follow-up|1|||
33552639|NCT02797171|62945144|FG004|Overall Study|Lost to Follow-up|2|||
33552640|NCT02797171|62945145|FG005|Overall Study|Lost to Follow-up|0|||
33552641|NCT02797171|62945140|FG000|Overall Study|Withdrawal by Subject|1|||
33552642|NCT02797171|62945141|FG001|Overall Study|Withdrawal by Subject|1|||
33552643|NCT02797171|62945142|FG002|Overall Study|Withdrawal by Subject|0|||
33552644|NCT02797171|62945143|FG003|Overall Study|Withdrawal by Subject|0|||
33552645|NCT02797171|62945144|FG004|Overall Study|Withdrawal by Subject|0|||
33552646|NCT02797171|62945145|FG005|Overall Study|Withdrawal by Subject|0|||
33552647|NCT02797171|62945140|FG000|Overall Study|Protocol Violation|1|||
33552648|NCT02797171|62945141|FG001|Overall Study|Protocol Violation|0|||
33552649|NCT02797171|62945142|FG002|Overall Study|Protocol Violation|0|||
33552650|NCT02797171|62945143|FG003|Overall Study|Protocol Violation|0|||
33552651|NCT02797171|62945144|FG004|Overall Study|Protocol Violation|0|||
33552652|NCT02797171|62945145|FG005|Overall Study|Protocol Violation|0|||
33552653|NCT02797171|62945140|FG000|Overall Study|Participant unable to adhere|0|||
33552654|NCT02797171|62945141|FG001|Overall Study|Participant unable to adhere|1|||
33552655|NCT02797171|62945142|FG002|Overall Study|Participant unable to adhere|0|||
33552656|NCT02797171|62945143|FG003|Overall Study|Participant unable to adhere|0|||
33552657|NCT02797171|62945144|FG004|Overall Study|Participant unable to adhere|0|||
33552658|NCT02797171|62945145|FG005|Overall Study|Participant unable to adhere|0|||
33552659|NCT02797171|62945140|FG000|Overall Study|Not Randomized|0|||
33552660|NCT02797171|62945141|FG001|Overall Study|Not Randomized|0|||
33552661|NCT02797171|62945142|FG002|Overall Study|Not Randomized|0|||
33552662|NCT02797171|62945143|FG003|Overall Study|Not Randomized|0|||
33552663|NCT02797171|62945144|FG004|Overall Study|Not Randomized|0|||
33552664|NCT02797171|62945145|FG005|Overall Study|Not Randomized|1|||
33552665|NCT02797951|62945159|FG000|Overall Study|Adverse Event|4|||
33552666|NCT02797951|62945159|FG000|Overall Study|Death|1|||
33482049|NCT02963506|62858801|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
33482050|NCT02963506|62858802|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
33482051|NCT02963506|62858803|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
33482052|NCT02963506|62858804|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
33482053|NCT02963506|62858805|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
33482054|NCT02963506|62858806|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
33482055|NCT02963506|62858807|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
33482056|NCT02963506|62858808|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
33364744|NCT02393248|62743326|FG023|Part 3: Combination Therapy|Disease Progression|0|||
33364745|NCT02393248|62743327|FG024|Part 3: Combination Therapy|Disease Progression|0|||
33657406|NCT01794689|63079419|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
33657407|NCT01794689|63079416|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
33657408|NCT01794689|63079417|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
33657409|NCT01794689|63079418|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
33657410|NCT01794689|63079419|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
33657411|NCT01794299|63079435|FG000|Overall Study|ATIR manufacturing not possible|1|||
33657412|NCT01794299|63079435|FG000|Overall Study|Death|14|||
33657413|NCT01794299|63079435|FG000|Overall Study|Graft failure|1|||
33657414|NCT01794299|63079435|FG000|Overall Study|ATIR batch rejected|2|||
33657415|NCT01794299|63079435|FG000|Overall Study|Relapse|2|||
33657416|NCT01794299|63079435|FG000|Overall Study|Discontinued from active follow-up|1|||
33657417|NCT01794299|63079435|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
33657418|NCT01817075|63079441|FG000|Overall Study|Adverse Event|7|||
33657419|NCT01817075|63079442|FG001|Overall Study|Adverse Event|5|||
33657420|NCT01817075|63079441|FG000|Overall Study|Physician Decision|9|||
33657421|NCT01817075|63079442|FG001|Overall Study|Physician Decision|12|||
33657422|NCT01817075|63079441|FG000|Overall Study|Withdrawal by Subject|31|||
33657423|NCT01817075|63079442|FG001|Overall Study|Withdrawal by Subject|15|||
33657424|NCT01817075|63079441|FG000|Overall Study|Received Sorafenib after enrollment|0|||
33657425|NCT01817075|63079442|FG001|Overall Study|Received Sorafenib after enrollment|1|||
33657426|NCT01817075|63079441|FG000|Overall Study|Ineligible|0|||
33657427|NCT01817075|63079442|FG001|Overall Study|Ineligible|2|||
33657428|NCT01816763|63079451|FG000|Overall Study|The main reason for an incomplete survey|4|||
33657429|NCT01816763|63079452|FG001|Overall Study|The main reason for an incomplete survey|15|||
33657430|NCT01816763|63079453|FG002|Overall Study|The main reason for an incomplete survey|11|||
33657431|NCT01816685|63079466|FG000|Overall Study|Lost to Follow-up|7|||
33657432|NCT01816685|63079467|FG001|Overall Study|Lost to Follow-up|9|||
33657433|NCT01816685|63079466|FG000|Overall Study|Surgery Cancelled|3|||
33657434|NCT01816685|63079467|FG001|Overall Study|Surgery Cancelled|2|||
33657435|NCT00708552|63079498|FG000|Overall Study|Adverse Event|10|||
33657436|NCT00708552|63079499|FG001|Overall Study|Adverse Event|3|||
33657437|NCT00708552|63079500|FG002|Overall Study|Adverse Event|4|||
33657438|NCT00708552|63079501|FG003|Overall Study|Adverse Event|6|||
33657439|NCT00708552|63079498|FG000|Overall Study|Lack of Efficacy|0|||
33657440|NCT00708552|63079499|FG001|Overall Study|Lack of Efficacy|4|||
33657441|NCT00708552|63079500|FG002|Overall Study|Lack of Efficacy|1|||
33657442|NCT00708552|63079501|FG003|Overall Study|Lack of Efficacy|0|||
33657443|NCT00708552|63079498|FG000|Overall Study|Protocol Violation|0|||
33657444|NCT00708552|63079499|FG001|Overall Study|Protocol Violation|0|||
33657445|NCT00708552|63079500|FG002|Overall Study|Protocol Violation|2|||
33657446|NCT00708552|63079501|FG003|Overall Study|Protocol Violation|4|||
33657447|NCT00708552|63079498|FG000|Overall Study|Lost to Follow-up|4|||
33657448|NCT00708552|63079499|FG001|Overall Study|Lost to Follow-up|2|||
33657449|NCT00708552|63079500|FG002|Overall Study|Lost to Follow-up|0|||
33657450|NCT00708552|63079501|FG003|Overall Study|Lost to Follow-up|1|||
33657451|NCT00708552|63079498|FG000|Overall Study|Physician Decision|1|||
33657452|NCT00708552|63079499|FG001|Overall Study|Physician Decision|2|||
33657453|NCT00708552|63079500|FG002|Overall Study|Physician Decision|0|||
33657454|NCT00708552|63079501|FG003|Overall Study|Physician Decision|0|||
33657455|NCT00708552|63079498|FG000|Overall Study|Withdrawal by Subject|12|||
33657456|NCT00708552|63079499|FG001|Overall Study|Withdrawal by Subject|7|||
33657457|NCT00708552|63079500|FG002|Overall Study|Withdrawal by Subject|8|||
33657458|NCT00708552|63079501|FG003|Overall Study|Withdrawal by Subject|10|||
33482057|NCT02963506|62858809|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
33482058|NCT02963506|62858810|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
33482059|NCT02963506|62858798|FG000|Dose-Blind Period|Sponsor decision|0|||
33482060|NCT02963506|62858799|FG001|Dose-Blind Period|Sponsor decision|0|||
33657459|NCT01816295|63079631|FG000|Double Blind Phase|Adverse Event|11|||
33482061|NCT02963506|62858800|FG002|Dose-Blind Period|Sponsor decision|0|||
33657460|NCT01816295|63079632|FG001|Double Blind Phase|Adverse Event|8|||
33657461|NCT01816295|63079631|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
33657462|NCT01816295|63079632|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
33657463|NCT01816295|63079631|FG000|Double Blind Phase|Lost to Follow-up|3|||
33657464|NCT01816295|63079632|FG001|Double Blind Phase|Lost to Follow-up|5|||
33657465|NCT01816295|63079631|FG000|Double Blind Phase|Physician Decision|2|||
33482062|NCT02963506|62858801|FG003|Dose-Blind Period|Sponsor decision|0|||
33552667|NCT02797951|62945159|FG000|Overall Study|Lack of Efficacy|19|||
33552668|NCT02797951|62945159|FG000|Overall Study|Lost to Follow-up|4|||
33552669|NCT02797951|62945159|FG000|Overall Study|Physician Decision|6|||
33552670|NCT02797951|62945159|FG000|Overall Study|Withdrawal by Subject|15|||
33552671|NCT00701805|62945167|FG000|Overall Study|Withdrawal by Subject|3|||
33552672|NCT00701805|62945168|FG001|Overall Study|Withdrawal by Subject|1|||
33552673|NCT00701805|62945169|FG002|Overall Study|Withdrawal by Subject|4|||
33552674|NCT00701805|62945170|FG003|Overall Study|Withdrawal by Subject|3|||
33552675|NCT00701805|62945167|FG000|Overall Study|Adverse Event|0|||
33552676|NCT00701805|62945168|FG001|Overall Study|Adverse Event|1|||
33552677|NCT00701805|62945169|FG002|Overall Study|Adverse Event|1|||
33552678|NCT00701805|62945170|FG003|Overall Study|Adverse Event|0|||
33552679|NCT00701805|62945167|FG000|Overall Study|Missed 7 consecutive doses|0|||
33552680|NCT00701805|62945168|FG001|Overall Study|Missed 7 consecutive doses|1|||
33552681|NCT00701805|62945169|FG002|Overall Study|Missed 7 consecutive doses|0|||
33552682|NCT00701805|62945170|FG003|Overall Study|Missed 7 consecutive doses|0|||
33552683|NCT00701805|62945167|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
33552684|NCT00701805|62945168|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
33552685|NCT00701805|62945169|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
33657466|NCT01816295|63079632|FG001|Double Blind Phase|Physician Decision|2|||
33552686|NCT00701805|62945170|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
33657467|NCT01816295|63079631|FG000|Double Blind Phase|Protocol Violation|17|||
33552687|NCT00701805|62945167|FG000|Overall Study|Physician decision, change of therapy|0|||
33552688|NCT00701805|62945168|FG001|Overall Study|Physician decision, change of therapy|0|||
33657468|NCT01816295|63079632|FG001|Double Blind Phase|Protocol Violation|11|||
33482063|NCT02963506|62858802|FG004|Dose-Blind Period|Sponsor decision|0|||
33482064|NCT02963506|62858803|FG005|Dose-Blind Period|Sponsor decision|1|||
33482065|NCT02963506|62858804|FG006|Dose-Blind Period|Sponsor decision|0|||
33482066|NCT02963506|62858805|FG007|Dose-Blind Period|Sponsor decision|0|||
33482067|NCT02963506|62858806|FG008|Dose-Blind Period|Sponsor decision|0|||
33482068|NCT02963506|62858807|FG009|Dose-Blind Period|Sponsor decision|0|||
33482069|NCT02963506|62858808|FG010|Dose-Blind Period|Sponsor decision|0|||
33482070|NCT02963506|62858809|FG011|Dose-Blind Period|Sponsor decision|0|||
33482071|NCT02963506|62858810|FG012|Dose-Blind Period|Sponsor decision|0|||
33482072|NCT02963506|62858798|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33657469|NCT01816295|63079631|FG000|Double Blind Phase|Sponsor Decision|8|||
33657470|NCT01816295|63079632|FG001|Double Blind Phase|Sponsor Decision|8|||
33657471|NCT01816295|63079631|FG000|Double Blind Phase|Withdrawal by Subject|22|||
33657472|NCT01816295|63079632|FG001|Double Blind Phase|Withdrawal by Subject|20|||
33657473|NCT01816295|63079631|FG000|OLE Phase|Adverse Event|17|||
33657474|NCT01816295|63079632|FG001|OLE Phase|Adverse Event|15|||
33657475|NCT01816295|63079631|FG000|OLE Phase|Death|1|||
33657476|NCT01816295|63079632|FG001|OLE Phase|Death|0|||
33657477|NCT01816295|63079631|FG000|OLE Phase|Entry Criteria Not Met|3|||
33657478|NCT01816295|63079632|FG001|OLE Phase|Entry Criteria Not Met|5|||
33657479|NCT01816295|63079631|FG000|OLE Phase|Lost to Follow-up|5|||
33657480|NCT01816295|63079632|FG001|OLE Phase|Lost to Follow-up|5|||
33657481|NCT01816295|63079631|FG000|OLE Phase|Physician Decision|3|||
33657482|NCT01816295|63079632|FG001|OLE Phase|Physician Decision|1|||
33657483|NCT01816295|63079631|FG000|OLE Phase|Protocol Violation|4|||
33657484|NCT01816295|63079632|FG001|OLE Phase|Protocol Violation|4|||
33657485|NCT01816295|63079631|FG000|OLE Phase|Sponsor Decision|7|||
33657486|NCT01816295|63079632|FG001|OLE Phase|Sponsor Decision|9|||
33657487|NCT01816295|63079631|FG000|OLE Phase|Withdrawal by Subject|10|||
33657488|NCT01816295|63079632|FG001|OLE Phase|Withdrawal by Subject|10|||
33657489|NCT01816295|63079631|FG000|OLE Phase|Lack of Efficacy|3|||
33657490|NCT01816295|63079632|FG001|OLE Phase|Lack of Efficacy|7|||
33657491|NCT01610297|63079657|FG000|Overall Study|Lost to Follow-up|1|||
33657492|NCT01793051|63079668|FG000|Overall Study|Withdrawal by Subject|6|||
33657493|NCT01793051|63079669|FG001|Overall Study|Withdrawal by Subject|4|||
33657494|NCT01793051|63079668|FG000|Overall Study|Adverse Event|0|||
33657495|NCT01793051|63079669|FG001|Overall Study|Adverse Event|2|||
33657496|NCT01793051|63079668|FG000|Overall Study|Too ill to continue|1|||
33657497|NCT01793051|63079669|FG001|Overall Study|Too ill to continue|0|||
33657498|NCT01793051|63079668|FG000|Overall Study|Switched chemo|1|||
33657499|NCT01793051|63079669|FG001|Overall Study|Switched chemo|1|||
33482073|NCT02963506|62858799|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33482074|NCT02963506|62858800|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33482075|NCT02963506|62858801|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33482076|NCT02963506|62858802|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33657500|NCT01793051|63079668|FG000|Overall Study|Lack of compliance|1|||
33657501|NCT01793051|63079669|FG001|Overall Study|Lack of compliance|0|||
33482077|NCT02963506|62858803|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33482078|NCT02963506|62858804|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33657502|NCT01793051|63079668|FG000|Overall Study|Requested to be removed from the study|1|||
33657503|NCT01793051|63079669|FG001|Overall Study|Requested to be removed from the study|1|||
33657504|NCT01816061|63079702|FG000|Overall Study|Lost to Follow-up|13|||
33657505|NCT01816061|63079703|FG001|Overall Study|Lost to Follow-up|24|||
33657506|NCT01792115|63079729|FG000|Overall Study|Lost to Follow-up|0|||
33657507|NCT01792115|63079730|FG001|Overall Study|Lost to Follow-up|1|||
33657508|NCT01792115|63079731|FG002|Overall Study|Lost to Follow-up|0|||
33657509|NCT01791803|63079743|FG000|Overall Study|Withdrawal by Subject|0|||
33657510|NCT01791803|63079744|FG001|Overall Study|Withdrawal by Subject|0|||
33552689|NCT00701805|62945169|FG002|Overall Study|Physician decision, change of therapy|0|||
33552690|NCT00701805|62945170|FG003|Overall Study|Physician decision, change of therapy|1|||
33552691|NCT00701805|62945167|FG000|Overall Study|Difficult to travel to dialysis site|0|||
33657511|NCT01791803|63079745|FG002|Overall Study|Withdrawal by Subject|0|||
33657512|NCT01791803|63079746|FG003|Overall Study|Withdrawal by Subject|2|||
33657513|NCT01791803|63079743|FG000|Overall Study|Physician Decision|0|||
33657514|NCT01791803|63079744|FG001|Overall Study|Physician Decision|2|||
33552692|NCT00701805|62945168|FG001|Overall Study|Difficult to travel to dialysis site|0|||
33552693|NCT00701805|62945169|FG002|Overall Study|Difficult to travel to dialysis site|1|||
33552694|NCT00701805|62945170|FG003|Overall Study|Difficult to travel to dialysis site|0|||
33552695|NCT00701805|62945167|FG000|Overall Study|Resumption criteria were not met|0|||
33552696|NCT00701805|62945168|FG001|Overall Study|Resumption criteria were not met|1|||
33552697|NCT00701805|62945169|FG002|Overall Study|Resumption criteria were not met|0|||
33657515|NCT01791803|63079745|FG002|Overall Study|Physician Decision|0|||
33657516|NCT01791803|63079746|FG003|Overall Study|Physician Decision|1|||
33657517|NCT01791803|63079743|FG000|Overall Study|Death|0|||
33657518|NCT01791803|63079744|FG001|Overall Study|Death|0|||
33657519|NCT01791803|63079745|FG002|Overall Study|Death|2|||
33657520|NCT01791803|63079746|FG003|Overall Study|Death|2|||
33657521|NCT01791725|63079771|FG000|Overall Study|Withdrawal by Subject|0|||
33657522|NCT01791725|63079772|FG001|Overall Study|Withdrawal by Subject|1|||
33657523|NCT01791725|63079773|FG002|Overall Study|Withdrawal by Subject|0|||
33657524|NCT01791413|63079783|FG000|Overall Study|Lost to Follow-up|5|||
33657525|NCT01791413|63079784|FG001|Overall Study|Lost to Follow-up|1|||
33657526|NCT01610063|63079797|FG000|Overall Study|Lost to Follow-up|42|||
33657527|NCT01610063|63079798|FG001|Overall Study|Lost to Follow-up|20|||
33657528|NCT01813721|63079804|FG000|Overall Study|Ineligibility determined|63|||
33657529|NCT01813721|63079804|FG000|Overall Study|Withdrawal by Subject|1|||
33657530|NCT01790633|63079828|FG000|Overall Study|Protocol Violation|1|||
33657531|NCT01790633|63079829|FG001|Overall Study|Protocol Violation|2|||
33657532|NCT01790633|63079828|FG000|Overall Study|Did not have serology performed|47|||
33657533|NCT01790633|63079829|FG001|Overall Study|Did not have serology performed|0|||
33657534|NCT01790633|63079828|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
33657535|NCT01790633|63079829|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
33657536|NCT01788215|63079838|FG000|Overall Study|Withdrawal by Subject|0|||
33657537|NCT01788215|63079839|FG001|Overall Study|Withdrawal by Subject|1|||
33657538|NCT01788215|63079838|FG000|Overall Study|Lost to Follow-up|2|||
33657539|NCT01788215|63079839|FG001|Overall Study|Lost to Follow-up|0|||
33657540|NCT01787825|63079845|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
33657541|NCT01787825|63079846|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
33657542|NCT01787825|63079845|FG000|Overall Study|Data Not Analyzable|5|||
33657543|NCT01787825|63079846|FG001|Overall Study|Data Not Analyzable|1|||
33657544|NCT01813019|63079855|FG000|Overall Study|Adverse Event|0|||
33657545|NCT01813019|63079856|FG001|Overall Study|Adverse Event|3|||
33657546|NCT01813019|63079855|FG000|Overall Study|Withdrawal by Subject|3|||
33657547|NCT01813019|63079856|FG001|Overall Study|Withdrawal by Subject|2|||
33657548|NCT01813019|63079855|FG000|Overall Study|administrative problems|2|||
33657549|NCT01813019|63079856|FG001|Overall Study|administrative problems|0|||
33657550|NCT01813019|63079855|FG000|Overall Study|Protocol Deviation|2|||
33657551|NCT01813019|63079856|FG001|Overall Study|Protocol Deviation|1|||
33657552|NCT01787591|63079864|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
33657553|NCT01787591|63079865|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
33657554|NCT01787591|63079866|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
33657555|NCT01787591|63079867|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
33657556|NCT01812707|63079882|FG000|Overall Study|Adverse Event|0|||
33657557|NCT01812707|63079883|FG001|Overall Study|Adverse Event|0|||
33657558|NCT01812707|63079884|FG002|Overall Study|Adverse Event|0|||
33364746|NCT02393248|62743303|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
33552698|NCT00701805|62945170|FG003|Overall Study|Resumption criteria were not met|0|||
33657559|NCT01812707|63079885|FG003|Overall Study|Adverse Event|2|||
33657560|NCT01812707|63079882|FG000|Overall Study|Poor compliance to protocol|1|||
33657561|NCT01812707|63079883|FG001|Overall Study|Poor compliance to protocol|0|||
33657562|NCT01812707|63079884|FG002|Overall Study|Poor compliance to protocol|0|||
33657563|NCT01812707|63079885|FG003|Overall Study|Poor compliance to protocol|0|||
33657564|NCT01812707|63079882|FG000|Overall Study|Consent withdrawn by participant|1|||
33657565|NCT01812707|63079883|FG001|Overall Study|Consent withdrawn by participant|0|||
33657566|NCT01812707|63079884|FG002|Overall Study|Consent withdrawn by participant|0|||
33657567|NCT01812707|63079885|FG003|Overall Study|Consent withdrawn by participant|0|||
33657568|NCT01787279|63079896|FG000|Overall Study|Lost to Follow-up|2|||
33657569|NCT01787279|63079896|FG000|Overall Study|Lack of Efficacy|1|||
33657570|NCT02728206|63079900|FG000|Overall Study|Death|1|||
33657571|NCT01811225|63079904|FG000|Treatment Period 1|Adverse Event|2|||
33657572|NCT01811225|63079905|FG001|Treatment Period 1|Adverse Event|3|||
33657573|NCT01811225|63079904|FG000|Treatment Period 1|Lost to Follow-up|12|||
33657574|NCT01811225|63079905|FG001|Treatment Period 1|Lost to Follow-up|8|||
33657575|NCT01811225|63079904|FG000|Treatment Period 1|transporation|1|||
33657576|NCT01811225|63079905|FG001|Treatment Period 1|transporation|0|||
33364747|NCT02393248|62743304|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
33482079|NCT02963506|62858805|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33482080|NCT02963506|62858806|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33482081|NCT02963506|62858807|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33482082|NCT02963506|62858808|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33482083|NCT02963506|62858809|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33482084|NCT02963506|62858810|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
33482085|NCT01345162|62858829|FG000|Overall Study|Protocol Violation|2|||
33482086|NCT01345162|62858830|FG001|Overall Study|Protocol Violation|4|||
33482087|NCT01345318|62858836|FG000|Overall Study|Adverse Event|16|||
33482088|NCT01345318|62858836|FG000|Overall Study|Lack of Efficacy|17|||
33482089|NCT01345318|62858836|FG000|Overall Study|Lost to Follow-up|2|||
33482090|NCT01345318|62858836|FG000|Overall Study|Protocol Violation|1|||
33552699|NCT02715765|62945183|FG000|Overall Study|Study Termination|3|||
33552700|NCT02715765|62945184|FG001|Overall Study|Study Termination|0|||
33552701|NCT02715765|62945185|FG002|Overall Study|Study Termination|0|||
33552702|NCT04542291|62945193|FG000|Overall Study|Adverse Event|1|||
33552703|NCT04542291|62945193|FG000|Overall Study|Physician Decision|2|||
33552704|NCT02795767|62945200|FG000|Overall Study|Received Commercial Emicizumab|1|||
33552705|NCT02795767|62945201|FG001|Overall Study|Received Commercial Emicizumab|0|||
33552706|NCT02795767|62945202|FG002|Overall Study|Received Commercial Emicizumab|0|||
33552707|NCT02639559|62945216|FG000|Overall Study|Mobilization failure|0|||
33552708|NCT02639559|62945217|FG001|Overall Study|Mobilization failure|3|||
33552709|NCT02639559|62945216|FG000|Overall Study|Issues with vascular acess|1|||
33552710|NCT02639559|62945217|FG001|Overall Study|Issues with vascular acess|0|||
33552711|NCT02796391|62945238|FG000|Overall Study|Lost to Follow-up|2|||
33552712|NCT02796391|62945239|FG001|Overall Study|Lost to Follow-up|2|||
33552713|NCT02796391|62945240|FG002|Overall Study|Lost to Follow-up|13|||
33552714|NCT02796391|62945241|FG003|Overall Study|Lost to Follow-up|8|||
33552715|NCT02796391|62945242|FG004|Overall Study|Lost to Follow-up|14|||
33552716|NCT02796391|62945243|FG005|Overall Study|Lost to Follow-up|13|||
33552717|NCT02796391|62945238|FG000|Overall Study|COVID|0|||
33552718|NCT02796391|62945239|FG001|Overall Study|COVID|0|||
33552719|NCT02796391|62945240|FG002|Overall Study|COVID|5|||
33552720|NCT02796391|62945241|FG003|Overall Study|COVID|5|||
33552721|NCT02796391|62945242|FG004|Overall Study|COVID|2|||
33552722|NCT02796391|62945243|FG005|Overall Study|COVID|4|||
33552723|NCT02796391|62945238|FG000|Overall Study|Participant did not like study cigarettes|0|||
33552724|NCT02796391|62945239|FG001|Overall Study|Participant did not like study cigarettes|0|||
33552725|NCT02796391|62945240|FG002|Overall Study|Participant did not like study cigarettes|3|||
33552726|NCT02796391|62945241|FG003|Overall Study|Participant did not like study cigarettes|0|||
33552727|NCT02796391|62945242|FG004|Overall Study|Participant did not like study cigarettes|0|||
33552728|NCT02796391|62945243|FG005|Overall Study|Participant did not like study cigarettes|0|||
33552729|NCT02796391|62945238|FG000|Overall Study|Withdrawal by Subject|1|||
33552730|NCT02796391|62945239|FG001|Overall Study|Withdrawal by Subject|1|||
33482091|NCT01345318|62858836|FG000|Overall Study|Withdrawal by Subject|41|||
33552731|NCT02796391|62945240|FG002|Overall Study|Withdrawal by Subject|4|||
33552732|NCT02796391|62945241|FG003|Overall Study|Withdrawal by Subject|3|||
33364748|NCT02393248|62743305|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
33364749|NCT02393248|62743306|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
33482092|NCT01345318|62858836|FG000|Overall Study|Other|3|||
33552733|NCT02796391|62945242|FG004|Overall Study|Withdrawal by Subject|4|||
33552734|NCT02796391|62945243|FG005|Overall Study|Withdrawal by Subject|3|||
33552735|NCT02796391|62945238|FG000|Overall Study|Adverse Event|0|||
33482093|NCT02961244|62858843|FG000|Overall Study|Protocol Violation|0|||
33552736|NCT02796391|62945239|FG001|Overall Study|Adverse Event|0|||
33657577|NCT01811225|63079904|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
33364750|NCT02393248|62743307|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
33552737|NCT02796391|62945240|FG002|Overall Study|Adverse Event|0|||
33657578|NCT01811225|63079905|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
33657579|NCT01811225|63079904|FG000|Treatment Period 2|Lost to Follow-up|1|||
33657580|NCT01811225|63079905|FG001|Treatment Period 2|Lost to Follow-up|2|||
33657581|NCT01811225|63079904|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
33657582|NCT01811225|63079905|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
33657583|NCT01809197|63079913|FG000|Overall Study|Lost to Follow-up|4|||
33657584|NCT01809197|63079914|FG001|Overall Study|Lost to Follow-up|2|||
33657585|NCT01809197|63079913|FG000|Overall Study|Adverse Event|2|||
33657586|NCT01809197|63079914|FG001|Overall Study|Adverse Event|3|||
33657587|NCT01809197|63079913|FG000|Overall Study|Failed slit lamp exam|1|||
33657588|NCT01809197|63079914|FG001|Overall Study|Failed slit lamp exam|0|||
33657589|NCT01809197|63079913|FG000|Overall Study|Non-Compliance|1|||
33657590|NCT01809197|63079914|FG001|Overall Study|Non-Compliance|1|||
33657591|NCT01809197|63079913|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
33657592|NCT01809197|63079914|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
33657593|NCT01809197|63079913|FG000|Overall Study|Withdrawal by Subject|1|||
33657594|NCT01809197|63079914|FG001|Overall Study|Withdrawal by Subject|1|||
33657595|NCT01809197|63079913|FG000|Overall Study|Product not available|0|||
33657596|NCT01809197|63079914|FG001|Overall Study|Product not available|1|||
33657597|NCT01786109|63079923|FG000|Overall Study|fail manometry barostat tube placement|1|||
33657598|NCT01786109|63079924|FG001|Overall Study|fail manometry barostat tube placement|0|||
33657599|NCT01786109|63079925|FG002|Overall Study|fail manometry barostat tube placement|0|||
33657600|NCT01786109|63079923|FG000|Overall Study|unrelated illness|0|||
33657601|NCT01786109|63079924|FG001|Overall Study|unrelated illness|0|||
33657602|NCT01786109|63079925|FG002|Overall Study|unrelated illness|1|||
33657603|NCT01786109|63079923|FG000|Overall Study|adverse effects colon preparation|0|||
33657604|NCT01786109|63079924|FG001|Overall Study|adverse effects colon preparation|0|||
33657605|NCT01786109|63079925|FG002|Overall Study|adverse effects colon preparation|1|||
33657606|NCT02728830|63080009|FG000|Overall Study|Exclusionary Surgery|9|||
33552738|NCT02796391|62945241|FG003|Overall Study|Adverse Event|1|||
33552739|NCT02796391|62945242|FG004|Overall Study|Adverse Event|0|||
33552740|NCT02796391|62945243|FG005|Overall Study|Adverse Event|0|||
33552741|NCT02796391|62945238|FG000|Overall Study|Protocol Violation|0|||
33552742|NCT02796391|62945239|FG001|Overall Study|Protocol Violation|0|||
33552743|NCT02796391|62945240|FG002|Overall Study|Protocol Violation|0|||
33552744|NCT02796391|62945241|FG003|Overall Study|Protocol Violation|1|||
33552745|NCT02796391|62945242|FG004|Overall Study|Protocol Violation|0|||
33552746|NCT02796391|62945243|FG005|Overall Study|Protocol Violation|0|||
33552747|NCT01370317|62945259|FG000|Overall Study|Participant withdrew consent|1|||
33552748|NCT01370317|62945260|FG001|Overall Study|Participant withdrew consent|0|||
33552749|NCT01370317|62945259|FG000|Overall Study|Protocol deviation|0|||
33552750|NCT01370317|62945260|FG001|Overall Study|Protocol deviation|1|||
33552751|NCT01370083|62945268|FG000|Overall Study|Lost to Follow-up|2|||
33552752|NCT01370083|62945269|FG001|Overall Study|Lost to Follow-up|0|||
33552753|NCT01370083|62945268|FG000|Overall Study|Adverse Event|0|||
33552754|NCT01370083|62945269|FG001|Overall Study|Adverse Event|1|||
33552755|NCT03350815|62945275|FG000|Period 1|Adverse Event|10|||
33552756|NCT03350815|62945276|FG001|Period 1|Adverse Event|0|||
33552757|NCT03350815|62945277|FG002|Period 1|Adverse Event|0|||
33552758|NCT03350815|62945278|FG003|Period 1|Adverse Event|0|||
33552759|NCT03350815|62945275|FG000|Period 1|Technical problems|1|||
33552760|NCT03350815|62945276|FG001|Period 1|Technical problems|0|||
33552761|NCT03350815|62945277|FG002|Period 1|Technical problems|0|||
33552762|NCT03350815|62945278|FG003|Period 1|Technical problems|0|||
33552763|NCT03350815|62945275|FG000|Period 1|Lost to Follow-up|3|||
33552764|NCT03350815|62945276|FG001|Period 1|Lost to Follow-up|0|||
33552765|NCT03350815|62945277|FG002|Period 1|Lost to Follow-up|0|||
33552766|NCT03350815|62945278|FG003|Period 1|Lost to Follow-up|0|||
33552767|NCT03350815|62945275|FG000|Period 1|Physician Decision|1|||
33552768|NCT03350815|62945276|FG001|Period 1|Physician Decision|0|||
33552769|NCT03350815|62945277|FG002|Period 1|Physician Decision|0|||
33552770|NCT03350815|62945278|FG003|Period 1|Physician Decision|0|||
33552771|NCT03350815|62945275|FG000|Period 1|Withdrawal by Subject|8|||
33657607|NCT02728830|63080009|FG000|Overall Study|Exclusionary Pathology|6|||
33657608|NCT02728830|63080009|FG000|Overall Study|Physician Decision|3|||
33552772|NCT03350815|62945276|FG001|Period 1|Withdrawal by Subject|0|||
33552773|NCT03350815|62945277|FG002|Period 1|Withdrawal by Subject|0|||
33657609|NCT02728830|63080009|FG000|Overall Study|Withdrawal by Subject|2|||
33657610|NCT02728830|63080009|FG000|Overall Study|Lost to Follow-up|1|||
33657611|NCT02728830|63080009|FG000|Overall Study|Exclusionary Lab Values|1|||
33552774|NCT03350815|62945278|FG003|Period 1|Withdrawal by Subject|0|||
33552775|NCT03350815|62945275|FG000|Period 1|Lack of Efficacy|15|||
33552776|NCT03350815|62945276|FG001|Period 1|Lack of Efficacy|0|||
33552777|NCT03350815|62945277|FG002|Period 1|Lack of Efficacy|0|||
33552778|NCT03350815|62945278|FG003|Period 1|Lack of Efficacy|0|||
33657612|NCT02728830|63080009|FG000|Overall Study|Contraindicated Illness|1|||
33657613|NCT02728830|63080009|FG000|Overall Study|Language Barrier|1|||
33657614|NCT02728596|63080063|FG000|Overall Study|Refusal unrelated to adverse event|3|||
33657615|NCT02728596|63080064|FG001|Overall Study|Refusal unrelated to adverse event|6|||
33657616|NCT02728596|63080065|FG002|Overall Study|Refusal unrelated to adverse event|7|||
33657617|NCT02728596|63080066|FG003|Overall Study|Refusal unrelated to adverse event|7|||
33657618|NCT02728596|63080063|FG000|Overall Study|Death|44|||
33657619|NCT02728596|63080064|FG001|Overall Study|Death|42|||
33657620|NCT02728596|63080065|FG002|Overall Study|Death|123|||
33657621|NCT02728596|63080066|FG003|Overall Study|Death|68|||
33657622|NCT00708162|63080440|FG000|Randomized Phase|Randomized but Not Treated|7|||
33657623|NCT00708162|63080441|FG001|Randomized Phase|Randomized but Not Treated|5|||
33657624|NCT00708162|63080440|FG000|Randomized Phase|Participant Noncompliance|40|||
33657625|NCT00708162|63080441|FG001|Randomized Phase|Participant Noncompliance|32|||
33657626|NCT00708162|63080440|FG000|Randomized Phase|Lost to Follow-up|34|||
33657627|NCT00708162|63080441|FG001|Randomized Phase|Lost to Follow-up|34|||
33657628|NCT00708162|63080440|FG000|Randomized Phase|Withdrew Consent|31|||
33657629|NCT00708162|63080441|FG001|Randomized Phase|Withdrew Consent|22|||
33657630|NCT00708162|63080440|FG000|Randomized Phase|Lack of Efficacy|14|||
33657631|NCT00708162|63080441|FG001|Randomized Phase|Lack of Efficacy|19|||
33657632|NCT00708162|63080440|FG000|Randomized Phase|Protocol Violation|10|||
33657633|NCT00708162|63080441|FG001|Randomized Phase|Protocol Violation|11|||
33657634|NCT00708162|63080440|FG000|Randomized Phase|Adverse Event|8|||
33657635|NCT00708162|63080441|FG001|Randomized Phase|Adverse Event|12|||
33552779|NCT03350815|62945275|FG000|Period 1|Non-compliance with study treatment|2|||
33552780|NCT03350815|62945276|FG001|Period 1|Non-compliance with study treatment|0|||
33552781|NCT03350815|62945277|FG002|Period 1|Non-compliance with study treatment|0|||
33552782|NCT03350815|62945278|FG003|Period 1|Non-compliance with study treatment|0|||
33552783|NCT03350815|62945275|FG000|Period 1|Protocol Violation|3|||
33552784|NCT03350815|62945276|FG001|Period 1|Protocol Violation|0|||
33552785|NCT03350815|62945277|FG002|Period 1|Protocol Violation|0|||
33552786|NCT03350815|62945278|FG003|Period 1|Protocol Violation|0|||
33552787|NCT03350815|62945275|FG000|Period 2|Adverse Event|0|||
33657636|NCT00708162|63080440|FG000|Randomized Phase|Investigator's Discretion|7|||
33657637|NCT00708162|63080441|FG001|Randomized Phase|Investigator's Discretion|10|||
33657638|NCT00708162|63080440|FG000|Randomized Phase|Death|2|||
33657639|NCT00708162|63080441|FG001|Randomized Phase|Death|9|||
33657640|NCT00708162|63080440|FG000|Randomized Phase|Pregnancy|3|||
33657641|NCT00708162|63080441|FG001|Randomized Phase|Pregnancy|0|||
33657642|NCT00708162|63080440|FG000|Open-Label Phase|Lost to Follow-up|10|||
33657643|NCT00708162|63080441|FG001|Open-Label Phase|Lost to Follow-up|8|||
33657644|NCT00708162|63080440|FG000|Open-Label Phase|Withdrew Consent|12|||
33657645|NCT00708162|63080441|FG001|Open-Label Phase|Withdrew Consent|6|||
33657646|NCT00708162|63080440|FG000|Open-Label Phase|Participant Noncompliance|7|||
33657647|NCT00708162|63080441|FG001|Open-Label Phase|Participant Noncompliance|7|||
33657648|NCT00708162|63080440|FG000|Open-Label Phase|Lack of Efficacy|7|||
33657649|NCT00708162|63080441|FG001|Open-Label Phase|Lack of Efficacy|4|||
33657650|NCT00708162|63080440|FG000|Open-Label Phase|Investigator's Discretion|3|||
33657651|NCT00708162|63080441|FG001|Open-Label Phase|Investigator's Discretion|2|||
33657652|NCT00708162|63080440|FG000|Open-Label Phase|Death|3|||
33657653|NCT00708162|63080441|FG001|Open-Label Phase|Death|1|||
33657654|NCT00708162|63080440|FG000|Open-Label Phase|Adverse Event|1|||
33657655|NCT00708162|63080441|FG001|Open-Label Phase|Adverse Event|2|||
33657656|NCT00708162|63080440|FG000|Open-Label Phase|Other|1|||
33657657|NCT00708162|63080441|FG001|Open-Label Phase|Other|0|||
33657658|NCT02245672|63080526|FG000|Overall Study|Adverse Event|4|||
33657659|NCT02245672|63080527|FG001|Overall Study|Adverse Event|4|||
33657660|NCT02245672|63080528|FG002|Overall Study|Adverse Event|4|||
33657661|NCT02245672|63080526|FG000|Overall Study|Lost to Follow-up|3|||
33657662|NCT02245672|63080527|FG001|Overall Study|Lost to Follow-up|5|||
33657663|NCT02245672|63080528|FG002|Overall Study|Lost to Follow-up|1|||
33657664|NCT02245672|63080526|FG000|Overall Study|Withdrawal by Subject|6|||
33657665|NCT02245672|63080527|FG001|Overall Study|Withdrawal by Subject|3|||
33657666|NCT02245672|63080528|FG002|Overall Study|Withdrawal by Subject|0|||
33482094|NCT02961244|62858844|FG001|Overall Study|Protocol Violation|1|||
33552788|NCT03350815|62945276|FG001|Period 2|Adverse Event|3|||
33552789|NCT03350815|62945277|FG002|Period 2|Adverse Event|5|||
33657667|NCT02245672|63080526|FG000|Overall Study|Randomized in error (not treated)|0|||
33657668|NCT02245672|63080527|FG001|Overall Study|Randomized in error (not treated)|1|||
33657669|NCT02245672|63080528|FG002|Overall Study|Randomized in error (not treated)|0|||
33657670|NCT00706992|63080673|FG000|Overall Study|Study termination|5|||
33657671|NCT00706992|63080674|FG001|Overall Study|Study termination|5|||
33657672|NCT00706992|63080675|FG002|Overall Study|Study termination|6|||
33657673|NCT00706992|63080676|FG003|Overall Study|Study termination|2|||
33657674|NCT00706992|63080677|FG004|Overall Study|Study termination|3|||
33657675|NCT00706992|63080678|FG005|Overall Study|Study termination|2|||
33657676|NCT00706992|63080679|FG006|Overall Study|Study termination|3|||
33657677|NCT00706992|63080673|FG000|Overall Study|Disease progression before treatment|0|||
33657678|NCT00706992|63080674|FG001|Overall Study|Disease progression before treatment|0|||
33657679|NCT00706992|63080675|FG002|Overall Study|Disease progression before treatment|0|||
33657680|NCT00706992|63080676|FG003|Overall Study|Disease progression before treatment|0|||
33657681|NCT00706992|63080677|FG004|Overall Study|Disease progression before treatment|1|||
33657682|NCT00706992|63080678|FG005|Overall Study|Disease progression before treatment|0|||
33657683|NCT00706992|63080679|FG006|Overall Study|Disease progression before treatment|0|||
33657684|NCT01785875|63080732|FG000|Overall Study|Withdrawal by Subject|41|||
33657685|NCT01785875|63080733|FG001|Overall Study|Withdrawal by Subject|34|||
33657686|NCT01785875|63080734|FG002|Overall Study|Withdrawal by Subject|36|||
33657687|NCT01785875|63080732|FG000|Overall Study|Lost to Follow-up|19|||
33657688|NCT01785875|63080733|FG001|Overall Study|Lost to Follow-up|22|||
33657689|NCT01785875|63080734|FG002|Overall Study|Lost to Follow-up|6|||
33657690|NCT01785875|63080732|FG000|Overall Study|Death|27|||
33657691|NCT01785875|63080733|FG001|Overall Study|Death|16|||
33657692|NCT01785875|63080734|FG002|Overall Study|Death|7|||
33657693|NCT01785875|63080732|FG000|Overall Study|Sponsor Decision|0|||
33657694|NCT01785875|63080733|FG001|Overall Study|Sponsor Decision|2|||
33657695|NCT01785875|63080734|FG002|Overall Study|Sponsor Decision|0|||
33657696|NCT01785875|63080732|FG000|Overall Study|Protocol Specified Criteria|207|||
33657697|NCT01785875|63080733|FG001|Overall Study|Protocol Specified Criteria|214|||
33657698|NCT01785875|63080734|FG002|Overall Study|Protocol Specified Criteria|55|||
33657699|NCT01785875|63080732|FG000|Overall Study|Missing|0|||
33657700|NCT01785875|63080733|FG001|Overall Study|Missing|1|||
33657701|NCT01785875|63080734|FG002|Overall Study|Missing|3|||
33657702|NCT05567393|63080763|FG000|Overall Study|Voluntary Withdrawal|0|||
33657703|NCT05567393|63080764|FG001|Overall Study|Voluntary Withdrawal|0|||
33657704|NCT05567393|63080765|FG002|Overall Study|Voluntary Withdrawal|0|||
33657705|NCT05567393|63080766|FG003|Overall Study|Voluntary Withdrawal|0|||
33657706|NCT05567393|63080767|FG004|Overall Study|Voluntary Withdrawal|0|||
33657707|NCT05567393|63080768|FG005|Overall Study|Voluntary Withdrawal|0|||
33657708|NCT05567393|63080769|FG006|Overall Study|Voluntary Withdrawal|0|||
33657709|NCT05567393|63080770|FG007|Overall Study|Voluntary Withdrawal|0|||
33657710|NCT05567393|63080771|FG008|Overall Study|Voluntary Withdrawal|0|||
33657711|NCT05567393|63080772|FG009|Overall Study|Voluntary Withdrawal|0|||
33657712|NCT05567393|63080773|FG010|Overall Study|Voluntary Withdrawal|0|||
33552790|NCT03350815|62945278|FG003|Period 2|Adverse Event|0|||
33552791|NCT03350815|62945275|FG000|Period 2|Technical problem|0|||
33552792|NCT03350815|62945276|FG001|Period 2|Technical problem|1|||
33552793|NCT03350815|62945277|FG002|Period 2|Technical problem|0|||
33552794|NCT03350815|62945278|FG003|Period 2|Technical problem|0|||
33552795|NCT03350815|62945275|FG000|Period 2|Lost to Follow-up|0|||
33552796|NCT03350815|62945276|FG001|Period 2|Lost to Follow-up|3|||
33552797|NCT03350815|62945277|FG002|Period 2|Lost to Follow-up|3|||
33552798|NCT03350815|62945278|FG003|Period 2|Lost to Follow-up|0|||
33552799|NCT03350815|62945275|FG000|Period 2|Physician Decision|0|||
33552800|NCT03350815|62945276|FG001|Period 2|Physician Decision|0|||
33657713|NCT05567393|63080774|FG011|Overall Study|Voluntary Withdrawal|0|||
33657714|NCT05567393|63080775|FG012|Overall Study|Voluntary Withdrawal|0|||
33657715|NCT05567393|63080776|FG013|Overall Study|Voluntary Withdrawal|1|||
33657716|NCT05567393|63080777|FG014|Overall Study|Voluntary Withdrawal|0|||
33657717|NCT05567393|63080778|FG015|Overall Study|Voluntary Withdrawal|0|||
33657718|NCT05567393|63080779|FG016|Overall Study|Voluntary Withdrawal|0|||
33657719|NCT05567393|63080780|FG017|Overall Study|Voluntary Withdrawal|0|||
33657720|NCT05071313|63080853|FG000|Overall Study|Lost to Follow-up|17|||
33657721|NCT05071313|63080854|FG001|Overall Study|Lost to Follow-up|10|||
33657722|NCT05071313|63080853|FG000|Overall Study|Physician Decision|1|||
33657723|NCT05071313|63080854|FG001|Overall Study|Physician Decision|6|||
33657724|NCT05071313|63080853|FG000|Overall Study|Death|1|||
33657725|NCT05071313|63080854|FG001|Overall Study|Death|0|||
33364751|NCT02393248|62743308|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
33552801|NCT03350815|62945277|FG002|Period 2|Physician Decision|1|||
33552802|NCT03350815|62945278|FG003|Period 2|Physician Decision|0|||
33657726|NCT05071313|63080853|FG000|Overall Study|Withdrawal by Subject|10|||
33657727|NCT05071313|63080854|FG001|Overall Study|Withdrawal by Subject|15|||
33657728|NCT05071313|63080853|FG000|Overall Study|Other|1|||
33657729|NCT05071313|63080854|FG001|Overall Study|Other|0|||
33657730|NCT05071313|63080853|FG000|Overall Study|Randomized but not vaccinated|4|||
33657731|NCT05071313|63080854|FG001|Overall Study|Randomized but not vaccinated|2|||
33657732|NCT04973085|63080878|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
33657733|NCT04973085|63080879|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
33657734|NCT04676152|63080926|FG000|Overall Study|screen fail|9|||
33657735|NCT04542070|63080933|FG000|Overall Study|Adverse Event|10|||
33657736|NCT04542070|63080934|FG001|Overall Study|Adverse Event|3|||
33657737|NCT04542070|63080935|FG002|Overall Study|Adverse Event|1|||
33657738|NCT04542070|63080933|FG000|Overall Study|Lack of Efficacy|1|||
33657739|NCT04542070|63080934|FG001|Overall Study|Lack of Efficacy|2|||
33657740|NCT04542070|63080935|FG002|Overall Study|Lack of Efficacy|0|||
33657741|NCT04542070|63080933|FG000|Overall Study|Lost to Follow-up|3|||
33657742|NCT04542070|63080934|FG001|Overall Study|Lost to Follow-up|4|||
33657743|NCT04542070|63080935|FG002|Overall Study|Lost to Follow-up|2|||
33657744|NCT04542070|63080933|FG000|Overall Study|Physician Decision|1|||
33657745|NCT04542070|63080934|FG001|Overall Study|Physician Decision|0|||
33657746|NCT04542070|63080935|FG002|Overall Study|Physician Decision|1|||
33657747|NCT04542070|63080933|FG000|Overall Study|Withdrawal by Subject|5|||
33657748|NCT04542070|63080934|FG001|Overall Study|Withdrawal by Subject|8|||
33657749|NCT04542070|63080935|FG002|Overall Study|Withdrawal by Subject|9|||
33657750|NCT04542070|63080933|FG000|Overall Study|Protocol Deviation|2|||
33657751|NCT04542070|63080934|FG001|Overall Study|Protocol Deviation|6|||
33657752|NCT04542070|63080935|FG002|Overall Study|Protocol Deviation|1|||
33657753|NCT04542070|63080933|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
33657754|NCT04542070|63080934|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
33657755|NCT04542070|63080935|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33657756|NCT04538950|63080944|FG000|Overall Study|Pulmonary Issues|2|||
33657757|NCT04538950|63080944|FG000|Overall Study|illness|2|||
33657758|NCT04445688|63080957|FG000|Washout (One Week)|Adverse Event|2|||
33657759|NCT04445688|63080957|FG000|Washout (One Week)|Withdrawal by Subject|1|||
33552803|NCT03350815|62945275|FG000|Period 2|Withdrawal by Subject|0|||
33552804|NCT03350815|62945276|FG001|Period 2|Withdrawal by Subject|3|||
33552805|NCT03350815|62945277|FG002|Period 2|Withdrawal by Subject|4|||
33552806|NCT03350815|62945278|FG003|Period 2|Withdrawal by Subject|0|||
33552807|NCT03350815|62945275|FG000|Period 2|Lack of Efficacy|0|||
33552808|NCT03350815|62945276|FG001|Period 2|Lack of Efficacy|6|||
33552809|NCT03350815|62945277|FG002|Period 2|Lack of Efficacy|2|||
33552810|NCT03350815|62945278|FG003|Period 2|Lack of Efficacy|0|||
33552811|NCT03350815|62945275|FG000|Period 2|Protocol Violation|0|||
33552812|NCT03350815|62945276|FG001|Period 2|Protocol Violation|0|||
33552813|NCT03350815|62945277|FG002|Period 2|Protocol Violation|1|||
33552814|NCT03350815|62945278|FG003|Period 2|Protocol Violation|0|||
33552815|NCT03350815|62945275|FG000|Period 2|New therapy for study indication|0|||
33552816|NCT03350815|62945276|FG001|Period 2|New therapy for study indication|0|||
33552817|NCT03350815|62945277|FG002|Period 2|New therapy for study indication|1|||
33552818|NCT03350815|62945278|FG003|Period 2|New therapy for study indication|0|||
33552819|NCT00854295|62945293|FG000|Overall Study|Death|7|||
33552820|NCT00854295|62945294|FG001|Overall Study|Death|0|||
33552821|NCT00854295|62945295|FG002|Overall Study|Death|1|||
33552822|NCT00854295|62945296|FG003|Overall Study|Death|1|||
33552823|NCT00854295|62945293|FG000|Overall Study|Adverse Event|6|||
33552824|NCT00854295|62945294|FG001|Overall Study|Adverse Event|1|||
33552825|NCT00854295|62945295|FG002|Overall Study|Adverse Event|1|||
33552826|NCT00854295|62945296|FG003|Overall Study|Adverse Event|3|||
33552827|NCT00854295|62945293|FG000|Overall Study|Lost to Follow-up|18|||
33552828|NCT00854295|62945294|FG001|Overall Study|Lost to Follow-up|5|||
33552829|NCT00854295|62945295|FG002|Overall Study|Lost to Follow-up|21|||
33552830|NCT00854295|62945296|FG003|Overall Study|Lost to Follow-up|21|||
33552831|NCT00854295|62945293|FG000|Overall Study|Physician Decision|10|||
33552832|NCT00854295|62945294|FG001|Overall Study|Physician Decision|0|||
33552833|NCT00854295|62945295|FG002|Overall Study|Physician Decision|0|||
33552834|NCT00854295|62945296|FG003|Overall Study|Physician Decision|0|||
33552835|NCT02792959|62945307|FG000|Overall Study|Protocol Violation|1|||
33657760|NCT04382755|63080967|FG000|Overall Study|Withdrawal by Subject|1|||
33657761|NCT04382755|63080968|FG001|Overall Study|Withdrawal by Subject|0|||
33657762|NCT04382755|63080967|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
33482095|NCT02961244|62858843|FG000|Overall Study|Withdrawal by Subject|1|||
33482096|NCT02961244|62858844|FG001|Overall Study|Withdrawal by Subject|2|||
33482097|NCT02961244|62858843|FG000|Overall Study|Surgery plan change after study approval|0|||
33482098|NCT02961244|62858844|FG001|Overall Study|Surgery plan change after study approval|2|||
33482099|NCT02961244|62858843|FG000|Overall Study|Lost to Follow-up|0|||
33482100|NCT02961244|62858844|FG001|Overall Study|Lost to Follow-up|2|||
33482101|NCT02961244|62858843|FG000|Overall Study|İnadequate data|0|||
33482102|NCT02961244|62858844|FG001|Overall Study|İnadequate data|2|||
33482103|NCT03771963|62858850|FG000|Overall Study|Lost to Follow-up|22|||
33482104|NCT03771963|62858850|FG000|Overall Study|Withdrawal of Consent|10|||
33482105|NCT02962648|62858854|FG000|Overall Study|Withdrawal by Subject|3|||
33482106|NCT02962648|62858854|FG000|Overall Study|Lost to Follow-up|3|||
33482107|NCT02962648|62858854|FG000|Overall Study|Physician Decision|1|||
33482108|NCT02962648|62858854|FG000|Overall Study|Subject had problems with transportation|2|||
33482109|NCT02962882|62858858|FG000|Overall Study|Adverse Event|2|||
33482110|NCT02962882|62858858|FG000|Overall Study|Withdrawal by Subject|2|||
33482111|NCT02962882|62858858|FG000|Overall Study|Transfer from ICU|32|||
33482112|NCT02961790|62858867|FG000|Overall Study|Canceled|4|||
33552836|NCT01652872|62945313|FG000|Overall Study|Death|36|||
33657763|NCT04382755|63080968|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
33657764|NCT04382755|63080967|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
33552837|NCT01652872|62945314|FG001|Overall Study|Death|39|||
33657765|NCT04382755|63080968|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
33657766|NCT04322539|63080977|FG000|Overall Study|Withdrawal of consent|14|||
33657767|NCT04322539|63080978|FG001|Overall Study|Withdrawal of consent|8|||
33657768|NCT04322539|63080977|FG000|Overall Study|Death|317|||
33657769|NCT04322539|63080978|FG001|Overall Study|Death|173|||
33657770|NCT04322539|63080977|FG000|Overall Study|Adverse Event|1|||
33657771|NCT04322539|63080978|FG001|Overall Study|Adverse Event|0|||
33657772|NCT04322539|63080977|FG000|Overall Study|Lost to Follow-up|3|||
33657773|NCT04322539|63080978|FG001|Overall Study|Lost to Follow-up|0|||
33657774|NCT04322539|63080977|FG000|Overall Study|Other|2|||
33657775|NCT04322539|63080978|FG001|Overall Study|Other|3|||
33657776|NCT04322539|63080977|FG000|Overall Study|Ongoing|124|||
33657777|NCT04322539|63080978|FG001|Overall Study|Ongoing|46|||
33657778|NCT03928418|63081022|FG000|Overall Study|Lost to Follow-up|5|||
33657779|NCT03928418|63081023|FG001|Overall Study|Lost to Follow-up|3|||
33657780|NCT03928418|63081024|FG002|Overall Study|Lost to Follow-up|5|||
33657781|NCT03928418|63081022|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
33657782|NCT03928418|63081023|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
33657783|NCT03928418|63081024|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
33657784|NCT03818035|63081062|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
33657785|NCT03818035|63081063|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
33657786|NCT03818035|63081064|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
33482113|NCT02961790|62858868|FG001|Overall Study|Canceled|5|||
33482114|NCT02961790|62858869|FG002|Overall Study|Canceled|1|||
33482115|NCT02961790|62858870|FG003|Overall Study|Canceled|4|||
33482116|NCT02961790|62858867|FG000|Overall Study|without baseline data|4|||
33657787|NCT03818035|63081065|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
33657788|NCT03818035|63081062|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
33657789|NCT03818035|63081063|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
33657790|NCT03818035|63081064|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
33657791|NCT03818035|63081065|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
33657792|NCT03818035|63081062|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
33657793|NCT03818035|63081063|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
33657794|NCT03818035|63081064|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
33657795|NCT03818035|63081065|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
33657796|NCT03818035|63081062|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
33657797|NCT03818035|63081063|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
33657798|NCT03818035|63081064|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
33657799|NCT03818035|63081065|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
33657800|NCT03818035|63081062|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
33657801|NCT03818035|63081063|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
33657802|NCT03818035|63081064|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
33657803|NCT03818035|63081065|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
33657804|NCT03818035|63081062|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
33657805|NCT03818035|63081063|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
33657806|NCT03818035|63081064|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
33657807|NCT03818035|63081065|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
33657808|NCT03818035|63081062|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
33657809|NCT03818035|63081063|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
33657810|NCT03818035|63081064|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
33657811|NCT03818035|63081065|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
33657812|NCT03818035|63081062|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
33657813|NCT03818035|63081063|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
33657814|NCT03818035|63081064|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
33657815|NCT03818035|63081065|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
33657816|NCT03818035|63081062|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
33657817|NCT03818035|63081063|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
33657818|NCT03818035|63081064|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
33482117|NCT02961790|62858868|FG001|Overall Study|without baseline data|0|||
33482118|NCT02961790|62858869|FG002|Overall Study|without baseline data|1|||
33482119|NCT02961790|62858870|FG003|Overall Study|without baseline data|0|||
33482120|NCT02961790|62858867|FG000|Overall Study|without post baseline data|7|||
33482121|NCT02961790|62858868|FG001|Overall Study|without post baseline data|6|||
33657819|NCT03818035|63081065|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
33482122|NCT02961790|62858869|FG002|Overall Study|without post baseline data|4|||
33552838|NCT01652872|62945313|FG000|Overall Study|Lost to Follow-up|28|||
33552839|NCT01652872|62945314|FG001|Overall Study|Lost to Follow-up|23|||
33657820|NCT03818035|63081062|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
33657821|NCT03818035|63081063|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
33482123|NCT02961790|62858870|FG003|Overall Study|without post baseline data|1|||
33657822|NCT03818035|63081064|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
33657823|NCT03818035|63081065|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
33657824|NCT03818035|63081062|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
33657825|NCT03818035|63081063|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
33657826|NCT03818035|63081064|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
33657827|NCT03818035|63081065|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
33657828|NCT03818035|63081062|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
33657829|NCT03818035|63081063|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
33657830|NCT03818035|63081064|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
33657831|NCT03818035|63081065|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
33657832|NCT03818035|63081062|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
33657833|NCT03818035|63081063|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
33657834|NCT03818035|63081064|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
33657835|NCT03818035|63081065|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
33657836|NCT03818035|63081062|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
33657837|NCT03818035|63081063|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
33657838|NCT03818035|63081064|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
33657839|NCT03818035|63081065|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
33657840|NCT03818035|63081062|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
33657841|NCT03818035|63081063|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
33657842|NCT03818035|63081064|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
33657843|NCT03818035|63081065|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
33657844|NCT03782376|63081080|FG000|Overall Study|Lost to Follow-up|2|||
33657845|NCT03782376|63081081|FG001|Overall Study|Lost to Follow-up|2|||
33657846|NCT03782376|63081080|FG000|Overall Study|Withdrawal by Subject|7|||
33657847|NCT03782376|63081081|FG001|Overall Study|Withdrawal by Subject|11|||
33657848|NCT03782376|63081080|FG000|Overall Study|Death|1|||
33657849|NCT03782376|63081081|FG001|Overall Study|Death|0|||
33657850|NCT03782376|63081080|FG000|Overall Study|Other|16|||
33657851|NCT03782376|63081081|FG001|Overall Study|Other|17|||
33657852|NCT03757130|63081095|FG000|Overall Study|Lost to Follow-up|0|||
33657853|NCT03757130|63081096|FG001|Overall Study|Lost to Follow-up|0|||
33657854|NCT03757130|63081097|FG002|Overall Study|Lost to Follow-up|0|||
33657855|NCT03757130|63081098|FG003|Overall Study|Lost to Follow-up|1|||
33657856|NCT03757130|63081099|FG004|Overall Study|Lost to Follow-up|0|||
33657857|NCT03757130|63081100|FG005|Overall Study|Lost to Follow-up|0|||
33657858|NCT03757130|63081101|FG006|Overall Study|Lost to Follow-up|0|||
33657859|NCT03757130|63081102|FG007|Overall Study|Lost to Follow-up|1|||
33657860|NCT03757130|63081095|FG000|Overall Study|Withdrawal by Subject|0|||
33657861|NCT03757130|63081096|FG001|Overall Study|Withdrawal by Subject|0|||
33657862|NCT03757130|63081097|FG002|Overall Study|Withdrawal by Subject|0|||
33657863|NCT03757130|63081098|FG003|Overall Study|Withdrawal by Subject|0|||
33657864|NCT03757130|63081099|FG004|Overall Study|Withdrawal by Subject|0|||
33657865|NCT03757130|63081100|FG005|Overall Study|Withdrawal by Subject|0|||
33657866|NCT03757130|63081101|FG006|Overall Study|Withdrawal by Subject|1|||
33657867|NCT03757130|63081102|FG007|Overall Study|Withdrawal by Subject|0|||
33657868|NCT03555565|63081143|FG000|Overall Study|Case Report Forms Uncollected|2|||
33657869|NCT03555565|63081143|FG000|Overall Study|Protocol Deviation|13|||
33657870|NCT03553836|63081149|FG000|Overall Study|Ongoing in Study|460|||
33657871|NCT03553836|63081150|FG001|Overall Study|Ongoing in Study|459|||
33657872|NCT03553836|63081149|FG000|Overall Study|Withdrawal by Subject|9|||
33657873|NCT03553836|63081150|FG001|Overall Study|Withdrawal by Subject|10|||
33657874|NCT03553836|63081149|FG000|Overall Study|Lost to Follow-up|1|||
33657875|NCT03553836|63081150|FG001|Overall Study|Lost to Follow-up|3|||
33657876|NCT03553836|63081149|FG000|Overall Study|Death|17|||
33657877|NCT03553836|63081150|FG001|Overall Study|Death|17|||
33657878|NCT03519386|63081160|FG000|Overall Study|Withdrawal by Subject|4|||
33657879|NCT03519386|63081161|FG001|Overall Study|Withdrawal by Subject|1|||
33657880|NCT03519386|63081162|FG002|Overall Study|Withdrawal by Subject|2|||
33657881|NCT03519386|63081160|FG000|Overall Study|Physician Decision|1|||
33657882|NCT03519386|63081161|FG001|Overall Study|Physician Decision|1|||
33657883|NCT03519386|63081162|FG002|Overall Study|Physician Decision|1|||
33657884|NCT03519386|63081160|FG000|Overall Study|Lost to Follow-up|0|||
33657885|NCT03519386|63081161|FG001|Overall Study|Lost to Follow-up|1|||
33657886|NCT03519386|63081162|FG002|Overall Study|Lost to Follow-up|1|||
33364752|NCT02393248|62743309|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
33364753|NCT02393248|62743310|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
33364754|NCT02393248|62743311|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
33364755|NCT02393248|62743312|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
33657887|NCT03519386|63081160|FG000|Overall Study|Death|1|||
33657888|NCT03519386|63081161|FG001|Overall Study|Death|0|||
33657889|NCT03519386|63081162|FG002|Overall Study|Death|4|||
33657890|NCT03519386|63081160|FG000|Overall Study|Adverse Event|2|||
33657891|NCT03519386|63081161|FG001|Overall Study|Adverse Event|1|||
33657892|NCT03519386|63081162|FG002|Overall Study|Adverse Event|2|||
33657893|NCT03519386|63081160|FG000|Overall Study|Explanted|2|||
33657894|NCT03519386|63081161|FG001|Overall Study|Explanted|1|||
33657895|NCT03519386|63081162|FG002|Overall Study|Explanted|0|||
33657896|NCT03519386|63081160|FG000|Overall Study|Ongoing in study|190|||
33657897|NCT03519386|63081161|FG001|Overall Study|Ongoing in study|192|||
33657898|NCT03519386|63081162|FG002|Overall Study|Ongoing in study|183|||
33657899|NCT03492177|63081173|FG000|Overall Study|Adverse Event|1|||
33657900|NCT03492177|63081174|FG001|Overall Study|Adverse Event|0|||
33657901|NCT03492177|63081175|FG002|Overall Study|Adverse Event|0|||
33657902|NCT03492177|63081173|FG000|Overall Study|Death|3|||
33657903|NCT03492177|63081174|FG001|Overall Study|Death|0|||
33657904|NCT03492177|63081175|FG002|Overall Study|Death|3|||
33657905|NCT03492177|63081173|FG000|Overall Study|Lack of Efficacy|1|||
33657906|NCT03492177|63081174|FG001|Overall Study|Lack of Efficacy|2|||
33657907|NCT03492177|63081175|FG002|Overall Study|Lack of Efficacy|0|||
33657908|NCT03492177|63081173|FG000|Overall Study|Other|1|||
33657909|NCT03492177|63081174|FG001|Overall Study|Other|0|||
33657910|NCT03492177|63081175|FG002|Overall Study|Other|0|||
33657911|NCT03492177|63081173|FG000|Overall Study|Ongoing|16|||
33657912|NCT03492177|63081174|FG001|Overall Study|Ongoing|19|||
33657913|NCT03492177|63081175|FG002|Overall Study|Ongoing|17|||
33657914|NCT03412565|63081200|FG000|Overall Study|Other|0|||
33657915|NCT03412565|63081201|FG001|Overall Study|Other|0|||
33657916|NCT03412565|63081202|FG002|Overall Study|Other|0|||
33657917|NCT03412565|63081203|FG003|Overall Study|Other|3|||
33657918|NCT03412565|63081200|FG000|Overall Study|Withdrawal by Subject|0|||
33657919|NCT03412565|63081201|FG001|Overall Study|Withdrawal by Subject|0|||
33657920|NCT03412565|63081202|FG002|Overall Study|Withdrawal by Subject|1|||
33657921|NCT03412565|63081203|FG003|Overall Study|Withdrawal by Subject|5|||
33657922|NCT03412565|63081200|FG000|Overall Study|Physician Decision|0|||
33657923|NCT03412565|63081201|FG001|Overall Study|Physician Decision|1|||
33657924|NCT03412565|63081202|FG002|Overall Study|Physician Decision|0|||
33657925|NCT03412565|63081203|FG003|Overall Study|Physician Decision|1|||
33657926|NCT03412565|63081200|FG000|Overall Study|Death|1|||
33657927|NCT03412565|63081201|FG001|Overall Study|Death|2|||
33657928|NCT03412565|63081202|FG002|Overall Study|Death|2|||
33657929|NCT03412565|63081203|FG003|Overall Study|Death|4|||
33657930|NCT03412565|63081200|FG000|Overall Study|Still ongoing|0|||
33657931|NCT03412565|63081201|FG001|Overall Study|Still ongoing|62|||
33657932|NCT03412565|63081202|FG002|Overall Study|Still ongoing|59|||
33552840|NCT01652872|62945313|FG000|Overall Study|Decision by sponsor|5|||
33552841|NCT01652872|62945314|FG001|Overall Study|Decision by sponsor|7|||
33657933|NCT03412565|63081203|FG003|Overall Study|Still ongoing|41|||
33657934|NCT03382561|63081225|FG000|Overall Study|Disease progression|47|||
33657935|NCT03382561|63081226|FG001|Overall Study|Disease progression|6|||
33657936|NCT03382561|63081225|FG000|Overall Study|Adverse Event|10|||
33657937|NCT03382561|63081226|FG001|Overall Study|Adverse Event|2|||
33657938|NCT03382561|63081225|FG000|Overall Study|Death|8|||
33657939|NCT03382561|63081226|FG001|Overall Study|Death|3|||
33552842|NCT01652872|62945313|FG000|Overall Study|Withdrawal by Subject|76|||
33552843|NCT01652872|62945314|FG001|Overall Study|Withdrawal by Subject|84|||
33552844|NCT04251273|62945322|FG000|Overall Study|Lost to Follow-up|331|||
33552845|NCT04251273|62945323|FG001|Overall Study|Lost to Follow-up|290|||
33552846|NCT02443402|62945331|FG000|Overall Study|Withdrawal by Subject|3|||
33552847|NCT02443402|62945332|FG001|Overall Study|Withdrawal by Subject|1|||
33552848|NCT02443402|62945331|FG000|Overall Study|Screen Failure|1|||
33657940|NCT03382561|63081225|FG000|Overall Study|Withdrawal by Subject|6|||
33657941|NCT03382561|63081226|FG001|Overall Study|Withdrawal by Subject|5|||
33657942|NCT03382561|63081225|FG000|Overall Study|Alternative therapy|2|||
33657943|NCT03382561|63081226|FG001|Overall Study|Alternative therapy|8|||
33657944|NCT03382561|63081225|FG000|Overall Study|Never started treatment|3|||
33657945|NCT03382561|63081226|FG001|Overall Study|Never started treatment|6|||
33482124|NCT02960854|62858892|FG000|Overall Study|Not Disclosed|2|||
33482125|NCT02960854|62858893|FG001|Overall Study|Not Disclosed|2|||
33482126|NCT02960854|62858892|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
33482127|NCT02960854|62858893|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
33482128|NCT02960854|62858892|FG000|Overall Study|Subject Withdrew Consent|0|||
33482129|NCT02960854|62858893|FG001|Overall Study|Subject Withdrew Consent|1|||
33482130|NCT02960854|62858892|FG000|Overall Study|Death|4|||
33482131|NCT02960854|62858893|FG001|Overall Study|Death|6|||
33482132|NCT01344538|62858901|FG000|Overall Study|Adverse Event|1|||
33482133|NCT01344538|62858902|FG001|Overall Study|Adverse Event|1|||
33482134|NCT01344538|62858901|FG000|Overall Study|Lost to Follow-up|1|||
33482135|NCT01344538|62858902|FG001|Overall Study|Lost to Follow-up|0|||
33552849|NCT02443402|62945332|FG001|Overall Study|Screen Failure|2|||
33657946|NCT03382561|63081225|FG000|Overall Study|Lack of Efficacy|0|||
33657947|NCT03382561|63081226|FG001|Overall Study|Lack of Efficacy|1|||
33657948|NCT03382561|63081225|FG000|Overall Study|Physician Decision|0|||
33657949|NCT03382561|63081226|FG001|Overall Study|Physician Decision|1|||
33657950|NCT03382561|63081225|FG000|Overall Study|Other complicating disease|0|||
33657951|NCT03382561|63081226|FG001|Overall Study|Other complicating disease|1|||
33657952|NCT03369665|63081232|FG000|Overall Study|Adverse Event|3|||
33657953|NCT03369665|63081232|FG000|Overall Study|Lost to Follow-up|7|||
33657954|NCT03369665|63081232|FG000|Overall Study|Withdrawal by Subject|15|||
33657955|NCT03369665|63081232|FG000|Overall Study|Progression Disease|2|||
33657956|NCT03369665|63081232|FG000|Overall Study|Not classified|3|||
33657957|NCT03345784|63081238|FG000|Overall Study|Withdrawal by Subject|2|||
33657958|NCT03345784|63081239|FG001|Overall Study|Withdrawal by Subject|1|||
33657959|NCT03317405|63081259|FG000|Overall Study|Withdrawal by Subject|1|||
33657960|NCT03317405|63081260|FG001|Overall Study|Withdrawal by Subject|0|||
33657961|NCT03317405|63081261|FG002|Overall Study|Withdrawal by Subject|0|||
33657962|NCT03317405|63081259|FG000|Overall Study|Physician Decision|0|||
33657963|NCT03317405|63081260|FG001|Overall Study|Physician Decision|0|||
33657964|NCT03317405|63081261|FG002|Overall Study|Physician Decision|1|||
33657965|NCT03317405|63081259|FG000|Overall Study|Surgery Rescheduled|0|||
33657966|NCT03317405|63081260|FG001|Overall Study|Surgery Rescheduled|1|||
33657967|NCT03317405|63081261|FG002|Overall Study|Surgery Rescheduled|0|||
33482136|NCT01344460|62858908|FG000|Overall Study|Withdrawal by Subject|1|||
33482137|NCT01344460|62858908|FG000|Overall Study|Lost to Follow-up|2|||
33482138|NCT03764631|62858918|FG000|Overall Study|Personal Reasons|3|||
33482139|NCT03764631|62858919|FG001|Overall Study|Personal Reasons|2|||
33482140|NCT03764631|62858918|FG000|Overall Study|Switching Therapy|3|||
33482141|NCT03764631|62858919|FG001|Overall Study|Switching Therapy|3|||
33482142|NCT03764631|62858918|FG000|Overall Study|Adverse Event|0|||
33482143|NCT03764631|62858919|FG001|Overall Study|Adverse Event|1|||
33482144|NCT03764631|62858918|FG000|Overall Study|Lost to Follow-up|33|||
33657968|NCT03304249|63081275|FG000|Overall Study|Lost to Follow-up|8|||
33657969|NCT03304249|63081276|FG001|Overall Study|Lost to Follow-up|10|||
33657970|NCT03304249|63081275|FG000|Overall Study|Withdrawal by Subject|12|||
33657971|NCT03304249|63081276|FG001|Overall Study|Withdrawal by Subject|2|||
33657972|NCT03304249|63081275|FG000|Overall Study|Moved Out of District|4|||
33657973|NCT03304249|63081276|FG001|Overall Study|Moved Out of District|2|||
33657974|NCT03277105|63081301|FG000|Overall Study|Death|77|||
33657975|NCT03277105|63081302|FG001|Overall Study|Death|73|||
33657976|NCT03277105|63081301|FG000|Overall Study|Lost to Follow-up|0|||
33657977|NCT03277105|63081302|FG001|Overall Study|Lost to Follow-up|3|||
33657978|NCT03277105|63081301|FG000|Overall Study|Withdrawal by Subject|10|||
33657979|NCT03277105|63081302|FG001|Overall Study|Withdrawal by Subject|9|||
33657980|NCT03277105|63081301|FG000|Overall Study|Other|1|||
33657981|NCT03277105|63081302|FG001|Overall Study|Other|3|||
33657982|NCT03277105|63081301|FG000|Overall Study|Ongoing|171|||
33657983|NCT03277105|63081302|FG001|Overall Study|Ongoing|175|||
33657984|NCT03206203|63081333|FG000|Treatment|Death|38|||
33657985|NCT03206203|63081334|FG001|Treatment|Death|26|||
33657986|NCT03206203|63081335|FG002|Treatment|Death|0|||
33657987|NCT03206203|63081333|FG000|Treatment|Withdrawal by Subject|1|||
33657988|NCT03206203|63081334|FG001|Treatment|Withdrawal by Subject|0|||
33657989|NCT03206203|63081335|FG002|Treatment|Withdrawal by Subject|0|||
33657990|NCT03206203|63081333|FG000|Treatment|Lost to Follow-up|4|||
33657991|NCT03206203|63081334|FG001|Treatment|Lost to Follow-up|0|||
33657992|NCT03206203|63081335|FG002|Treatment|Lost to Follow-up|0|||
33657993|NCT03206203|63081333|FG000|Treatment|N/A in Follow-Up|8|||
33657994|NCT03206203|63081334|FG001|Treatment|N/A in Follow-Up|1|||
33657995|NCT03206203|63081335|FG002|Treatment|N/A in Follow-Up|0|||
33657996|NCT03206203|63081333|FG000|Treatment|Disease progression|0|||
33657997|NCT03206203|63081334|FG001|Treatment|Disease progression|1|||
33657998|NCT03206203|63081335|FG002|Treatment|Disease progression|0|||
33657999|NCT03206203|63081333|FG000|Treatment|Refused follow-up|0|||
33658000|NCT03206203|63081334|FG001|Treatment|Refused follow-up|1|||
33658001|NCT03206203|63081335|FG002|Treatment|Refused follow-up|0|||
33658002|NCT03206203|63081333|FG000|Treatment|Cross over to Arm 1|0|||
33658003|NCT03206203|63081334|FG001|Treatment|Cross over to Arm 1|19|||
33658004|NCT03206203|63081335|FG002|Treatment|Cross over to Arm 1|0|||
33482145|NCT03764631|62858919|FG001|Overall Study|Lost to Follow-up|41|||
33658005|NCT03206203|63081333|FG000|Optional Cross-Over|Death|0|||
33364756|NCT02393248|62743313|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
33364757|NCT02393248|62743314|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
33658006|NCT03206203|63081334|FG001|Optional Cross-Over|Death|0|||
33658007|NCT03206203|63081335|FG002|Optional Cross-Over|Death|14|||
33658008|NCT03206203|63081333|FG000|Optional Cross-Over|Refused follow-up|0|||
33658009|NCT03206203|63081334|FG001|Optional Cross-Over|Refused follow-up|0|||
33658010|NCT03206203|63081335|FG002|Optional Cross-Over|Refused follow-up|2|||
33658011|NCT03201965|63081345|FG000|Overall Study|Death|5|||
33364758|NCT02393248|62743315|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
33482146|NCT03764631|62858918|FG000|Overall Study|No data as study site was closed|2|||
33482147|NCT03764631|62858919|FG001|Overall Study|No data as study site was closed|6|||
33658012|NCT03201965|63081346|FG001|Overall Study|Death|27|||
33658013|NCT03201965|63081347|FG002|Overall Study|Death|27|||
33658014|NCT03201965|63081345|FG000|Overall Study|Lost to Follow-up|0|||
33658015|NCT03201965|63081346|FG001|Overall Study|Lost to Follow-up|1|||
33658016|NCT03201965|63081347|FG002|Overall Study|Lost to Follow-up|0|||
33658017|NCT03201965|63081345|FG000|Overall Study|Withdrawal by Subject|3|||
33658018|NCT03201965|63081346|FG001|Overall Study|Withdrawal by Subject|13|||
33658019|NCT03201965|63081347|FG002|Overall Study|Withdrawal by Subject|4|||
33658020|NCT03201965|63081345|FG000|Overall Study|Ongoing|20|||
33658021|NCT03201965|63081346|FG001|Overall Study|Ongoing|152|||
33658022|NCT03201965|63081347|FG002|Overall Study|Ongoing|164|||
33658023|NCT03201458|63081356|FG000|Overall Study|No longer eligible|2|||
33658024|NCT03201458|63081357|FG001|Overall Study|No longer eligible|5|||
33658025|NCT03201458|63081356|FG000|Overall Study|Health event before starting|1|||
33658026|NCT03201458|63081357|FG001|Overall Study|Health event before starting|0|||
33658027|NCT03201458|63081356|FG000|Overall Study|Physician Decision|1|||
33552850|NCT01370005|62945341|FG000|Overall Study|Not treated|1|||
33552851|NCT01370005|62945342|FG001|Overall Study|Not treated|0|||
33552852|NCT01370005|62945343|FG002|Overall Study|Not treated|0|||
33552853|NCT01370005|62945341|FG000|Overall Study|Adverse Event|5|||
33658028|NCT03201458|63081357|FG001|Overall Study|Physician Decision|0|||
33658029|NCT03181893|63081374|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33658030|NCT03181893|63081375|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
33658031|NCT03181893|63081376|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33552854|NCT01370005|62945342|FG001|Overall Study|Adverse Event|5|||
33552855|NCT01370005|62945343|FG002|Overall Study|Adverse Event|6|||
33552856|NCT01370005|62945341|FG000|Overall Study|Lack of Efficacy|1|||
33552857|NCT01370005|62945342|FG001|Overall Study|Lack of Efficacy|0|||
33552858|NCT01370005|62945343|FG002|Overall Study|Lack of Efficacy|0|||
33552859|NCT01370005|62945341|FG000|Overall Study|Non compliant with protocol|0|||
33658032|NCT03181893|63081377|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33658033|NCT03181893|63081378|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33658034|NCT03181893|63081379|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33658035|NCT03181893|63081380|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33658036|NCT03181893|63081381|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33658037|NCT03181893|63081382|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33658038|NCT03181893|63081383|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33658039|NCT03181893|63081384|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33658040|NCT03181893|63081374|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
33658041|NCT03181893|63081375|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
33658042|NCT03181893|63081376|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33658043|NCT03181893|63081377|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33658044|NCT03181893|63081378|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33658045|NCT03181893|63081379|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33658046|NCT03181893|63081380|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33658047|NCT03181893|63081381|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33658048|NCT03181893|63081382|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33658049|NCT03181893|63081383|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33658050|NCT03181893|63081384|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33552860|NCT01370005|62945342|FG001|Overall Study|Non compliant with protocol|1|||
33658051|NCT03181893|63081374|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33658052|NCT03181893|63081375|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33658053|NCT03181893|63081376|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33658054|NCT03181893|63081377|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33658055|NCT03181893|63081378|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33658056|NCT03181893|63081379|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33658057|NCT03181893|63081380|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33658058|NCT03181893|63081381|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
33658059|NCT03181893|63081382|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
33658060|NCT03181893|63081383|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33658061|NCT03181893|63081384|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33658062|NCT03181893|63081374|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33658063|NCT03181893|63081375|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33658064|NCT03181893|63081376|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33658065|NCT03181893|63081377|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33658066|NCT03181893|63081378|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33658067|NCT03181893|63081379|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33658068|NCT03181893|63081380|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33658069|NCT03181893|63081381|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33552861|NCT01370005|62945343|FG002|Overall Study|Non compliant with protocol|2|||
33658070|NCT03181893|63081382|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33658071|NCT03181893|63081383|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
33658072|NCT03181893|63081384|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33552862|NCT01370005|62945341|FG000|Overall Study|Lost to Follow-up|1|||
33658073|NCT03181893|63081374|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33658074|NCT03181893|63081375|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33658075|NCT03181893|63081376|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33658076|NCT03181893|63081377|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33658077|NCT03181893|63081378|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33658078|NCT03181893|63081379|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33658079|NCT03181893|63081380|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33482148|NCT02956486|62858938|FG000|Core Phase|Adverse Event|51|||
33482149|NCT02956486|62858939|FG001|Core Phase|Adverse Event|88|||
33552863|NCT01370005|62945342|FG001|Overall Study|Lost to Follow-up|1|||
33552864|NCT01370005|62945343|FG002|Overall Study|Lost to Follow-up|1|||
33552865|NCT01370005|62945341|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
33552866|NCT01370005|62945342|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
33552867|NCT01370005|62945343|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
33552868|NCT01370005|62945341|FG000|Overall Study|Other reason not defined above|3|||
33552869|NCT01370005|62945342|FG001|Overall Study|Other reason not defined above|0|||
33552870|NCT01370005|62945343|FG002|Overall Study|Other reason not defined above|2|||
33552871|NCT02442778|62945354|FG000|Overall Study|Adverse Event|2|||
33552872|NCT02442778|62945355|FG001|Overall Study|Adverse Event|6|||
33552873|NCT02442778|62945356|FG002|Overall Study|Adverse Event|6|||
33552874|NCT02442778|62945354|FG000|Overall Study|Death|0|||
33552875|NCT02442778|62945355|FG001|Overall Study|Death|2|||
33552876|NCT02442778|62945356|FG002|Overall Study|Death|0|||
33552877|NCT02442778|62945354|FG000|Overall Study|Lack of Efficacy|1|||
33552878|NCT02442778|62945355|FG001|Overall Study|Lack of Efficacy|0|||
33552879|NCT02442778|62945356|FG002|Overall Study|Lack of Efficacy|0|||
33552880|NCT02442778|62945354|FG000|Overall Study|Lost to Follow-up|1|||
33552881|NCT02442778|62945355|FG001|Overall Study|Lost to Follow-up|1|||
33552882|NCT02442778|62945356|FG002|Overall Study|Lost to Follow-up|1|||
33552883|NCT02442778|62945354|FG000|Overall Study|Non-compliance with study drug|2|||
33552884|NCT02442778|62945355|FG001|Overall Study|Non-compliance with study drug|0|||
33552885|NCT02442778|62945356|FG002|Overall Study|Non-compliance with study drug|1|||
33552886|NCT02442778|62945354|FG000|Overall Study|Physician Decision|1|||
33552887|NCT02442778|62945355|FG001|Overall Study|Physician Decision|1|||
33552888|NCT02442778|62945356|FG002|Overall Study|Physician Decision|1|||
33552889|NCT02442778|62945354|FG000|Overall Study|Protocol Deviation|3|||
33552890|NCT02442778|62945355|FG001|Overall Study|Protocol Deviation|0|||
33552891|NCT02442778|62945356|FG002|Overall Study|Protocol Deviation|1|||
33552892|NCT02442778|62945354|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
33552893|NCT02442778|62945355|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
33552894|NCT02442778|62945356|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
33552895|NCT02442778|62945354|FG000|Overall Study|Withdrawal by Subject|4|||
33552896|NCT02442778|62945355|FG001|Overall Study|Withdrawal by Subject|4|||
33552897|NCT02442778|62945356|FG002|Overall Study|Withdrawal by Subject|3|||
33552898|NCT02442778|62945354|FG000|Overall Study|Reason not specified|1|||
33552899|NCT02442778|62945355|FG001|Overall Study|Reason not specified|4|||
33552900|NCT02442778|62945356|FG002|Overall Study|Reason not specified|0|||
33552901|NCT02412436|62945364|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
33482150|NCT02956486|62858940|FG002|Core Phase|Adverse Event|0|||
33482151|NCT02956486|62858938|FG000|Core Phase|Lost to Follow-up|8|||
33482152|NCT02956486|62858939|FG001|Core Phase|Lost to Follow-up|6|||
33482153|NCT02956486|62858940|FG002|Core Phase|Lost to Follow-up|0|||
33482154|NCT02956486|62858938|FG000|Core Phase|Inadequate therapeutic effect|4|||
33552902|NCT02412436|62945364|FG000|Overall Study|Lost to Follow-up|6|||
33552903|NCT02412436|62945364|FG000|Overall Study|Unable to get to clinic|3|||
33552904|NCT02412436|62945364|FG000|Overall Study|Death|1|||
33552905|NCT02412436|62945364|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
33482155|NCT02956486|62858939|FG001|Core Phase|Inadequate therapeutic effect|5|||
33482156|NCT02956486|62858940|FG002|Core Phase|Inadequate therapeutic effect|0|||
33552906|NCT01651000|62945370|FG000|Overall Study|Adverse Event|2|||
33552907|NCT01651000|62945371|FG001|Overall Study|Adverse Event|8|||
33552908|NCT01651000|62945370|FG000|Overall Study|Lost to Follow-up|3|||
33552909|NCT01651000|62945371|FG001|Overall Study|Lost to Follow-up|2|||
33552910|NCT01651000|62945370|FG000|Overall Study|Protocol Violation|0|||
33552911|NCT01651000|62945371|FG001|Overall Study|Protocol Violation|3|||
33552912|NCT01651000|62945370|FG000|Overall Study|Withdrawal by Subject|2|||
33552913|NCT01651000|62945371|FG001|Overall Study|Withdrawal by Subject|10|||
33552914|NCT01651000|62945370|FG000|Overall Study|Subject noncompliance|0|||
33482157|NCT02956486|62858938|FG000|Core Phase|Withdrawal by Subject|101|||
33482158|NCT02956486|62858939|FG001|Core Phase|Withdrawal by Subject|104|||
33658080|NCT03181893|63081381|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33658081|NCT03181893|63081382|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33658082|NCT03181893|63081383|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33658083|NCT03181893|63081384|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
33658084|NCT03180840|63081409|FG000|Overall Study|Withdrawal by Subject|1|||
33658085|NCT03072238|63081420|FG000|Overall Study|Withdrawal by Subject|30|||
33658086|NCT03072238|63081421|FG001|Overall Study|Withdrawal by Subject|51|||
33658087|NCT03072238|63081420|FG000|Overall Study|Lost to Follow-up|7|||
33658088|NCT03072238|63081421|FG001|Overall Study|Lost to Follow-up|4|||
33658089|NCT03072238|63081420|FG000|Overall Study|Physician Decision|1|||
33658090|NCT03072238|63081421|FG001|Overall Study|Physician Decision|3|||
33658091|NCT03072238|63081420|FG000|Overall Study|Death|139|||
33658092|NCT03072238|63081421|FG001|Overall Study|Death|121|||
33658093|NCT03072238|63081420|FG000|Overall Study|Other|0|||
33658094|NCT03072238|63081421|FG001|Overall Study|Other|1|||
33658095|NCT03072238|63081420|FG000|Overall Study|Ongoing on study|377|||
33658096|NCT03072238|63081421|FG001|Overall Study|Ongoing on study|367|||
33658097|NCT03064035|63081430|FG000|Overall Study|Did not receive allocated intervention|4|||
33658098|NCT03064035|63081431|FG001|Overall Study|Did not receive allocated intervention|2|||
33658099|NCT03064035|63081430|FG000|Overall Study|Lost to Follow-up|1|||
33658100|NCT03064035|63081431|FG001|Overall Study|Lost to Follow-up|1|||
33658101|NCT03014206|63081444|FG000|Overall Study|Registration Violation|12|||
33658102|NCT02921256|63081461|FG000|Arm 1a v. Arm II|Adverse Event|6|||
33658103|NCT02921256|63081462|FG001|Arm 1a v. Arm II|Adverse Event|15|||
33658104|NCT02921256|63081463|FG002|Arm 1a v. Arm II|Adverse Event|0|||
33658105|NCT02921256|63081461|FG000|Arm 1a v. Arm II|Death|0|||
33658106|NCT02921256|63081462|FG001|Arm 1a v. Arm II|Death|2|||
33658107|NCT02921256|63081463|FG002|Arm 1a v. Arm II|Death|0|||
33658108|NCT02921256|63081461|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
33658109|NCT02921256|63081462|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
33658110|NCT02921256|63081463|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
33658111|NCT02921256|63081461|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
33658112|NCT02921256|63081462|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
33658113|NCT02921256|63081463|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
33482159|NCT02956486|62858940|FG002|Core Phase|Withdrawal by Subject|0|||
33482160|NCT02956486|62858938|FG000|Core Phase|Study terminated by sponsor|888|||
33482161|NCT02956486|62858939|FG001|Core Phase|Study terminated by sponsor|848|||
33482162|NCT02956486|62858940|FG002|Core Phase|Study terminated by sponsor|0|||
33482163|NCT02956486|62858938|FG000|Core Phase|Other|27|||
33482164|NCT02956486|62858939|FG001|Core Phase|Other|18|||
33482165|NCT02956486|62858940|FG002|Core Phase|Other|0|||
33482166|NCT02956486|62858938|FG000|Core Phase|Not treated|0|||
33482167|NCT02956486|62858939|FG001|Core Phase|Not treated|3|||
33482168|NCT02956486|62858940|FG002|Core Phase|Not treated|0|||
33482169|NCT02956486|62858938|FG000|Extension Phase|Adverse Event|0|||
33482170|NCT02956486|62858939|FG001|Extension Phase|Adverse Event|0|||
33482171|NCT02956486|62858940|FG002|Extension Phase|Adverse Event|2|||
33482172|NCT02956486|62858938|FG000|Extension Phase|Study terminated by sponsor|0|||
33482173|NCT02956486|62858939|FG001|Extension Phase|Study terminated by sponsor|0|||
33482174|NCT02956486|62858940|FG002|Extension Phase|Study terminated by sponsor|16|||
33482175|NCT02956486|62858938|FG000|Extension Phase|Not Treated|0|||
33482176|NCT02956486|62858939|FG001|Extension Phase|Not Treated|0|||
33482177|NCT02956486|62858940|FG002|Extension Phase|Not Treated|1|||
33482178|NCT03445533|62858955|FG000|Overall Study|Progressive Disease|48|||
33482179|NCT03445533|62858956|FG001|Overall Study|Progressive Disease|81|||
33482180|NCT03445533|62858955|FG000|Overall Study|Adverse Event|60|||
33482181|NCT03445533|62858956|FG001|Overall Study|Adverse Event|64|||
33482182|NCT03445533|62858955|FG000|Overall Study|Death|9|||
33482183|NCT03445533|62858956|FG001|Overall Study|Death|19|||
33482184|NCT03445533|62858955|FG000|Overall Study|Miscellaneous|0|||
33482185|NCT03445533|62858956|FG001|Overall Study|Miscellaneous|16|||
33482186|NCT03445533|62858955|FG000|Overall Study|Withdrawal by Subject|3|||
33482187|NCT03445533|62858956|FG001|Overall Study|Withdrawal by Subject|4|||
33482188|NCT03445533|62858955|FG000|Overall Study|Physician Decision|1|||
33482189|NCT03445533|62858956|FG001|Overall Study|Physician Decision|3|||
33482190|NCT03445533|62858955|FG000|Overall Study|Sponsor Decision|0|||
33658114|NCT02921256|63081461|FG000|Arm 1a v. Arm II|Physician Decision|1|||
33658115|NCT02921256|63081462|FG001|Arm 1a v. Arm II|Physician Decision|1|||
33658116|NCT02921256|63081463|FG002|Arm 1a v. Arm II|Physician Decision|0|||
33658117|NCT02921256|63081461|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
33482191|NCT03445533|62858956|FG001|Overall Study|Sponsor Decision|1|||
33482192|NCT03445533|62858955|FG000|Overall Study|Lost to Follow-up|0|||
33482193|NCT03445533|62858956|FG001|Overall Study|Lost to Follow-up|1|||
33482194|NCT03445533|62858955|FG000|Overall Study|Never Received any Study Treatment|7|||
33658118|NCT02921256|63081462|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
33658119|NCT02921256|63081463|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
33658120|NCT02921256|63081461|FG000|Arm Ib v Arm III|Adverse Event|9|||
33658121|NCT02921256|63081462|FG001|Arm Ib v Arm III|Adverse Event|0|||
33658122|NCT02921256|63081463|FG002|Arm Ib v Arm III|Adverse Event|4|||
33552915|NCT01651000|62945371|FG001|Overall Study|Subject noncompliance|3|||
33552916|NCT01651000|62945370|FG000|Overall Study|Lack of Efficacy|1|||
33552917|NCT01651000|62945371|FG001|Overall Study|Lack of Efficacy|1|||
33552918|NCT01651000|62945370|FG000|Overall Study|Physician Decision|1|||
33364759|NCT02393248|62743316|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
33364760|NCT02393248|62743317|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
33364761|NCT02393248|62743318|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
33364762|NCT02393248|62743319|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
33364763|NCT02393248|62743320|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
33364764|NCT02393248|62743321|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
33364765|NCT02393248|62743322|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
33364766|NCT02393248|62743323|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
33658123|NCT02921256|63081461|FG000|Arm Ib v Arm III|Death|1|||
33658124|NCT02921256|63081462|FG001|Arm Ib v Arm III|Death|0|||
33658125|NCT02921256|63081463|FG002|Arm Ib v Arm III|Death|1|||
33658126|NCT02921256|63081461|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
33658127|NCT02921256|63081462|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
33658128|NCT02921256|63081463|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
33658129|NCT02921256|63081461|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
33658130|NCT02921256|63081462|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
33658131|NCT02921256|63081463|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
33658132|NCT02921256|63081461|FG000|Arm Ib v Arm III|Physician Decision|4|||
33658133|NCT02921256|63081462|FG001|Arm Ib v Arm III|Physician Decision|0|||
33658134|NCT02921256|63081463|FG002|Arm Ib v Arm III|Physician Decision|1|||
33552919|NCT01651000|62945371|FG001|Overall Study|Physician Decision|0|||
33552920|NCT01651000|62945370|FG000|Overall Study|Administrative reason|1|||
33552921|NCT01651000|62945371|FG001|Overall Study|Administrative reason|0|||
33658135|NCT02921256|63081461|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
33658136|NCT02921256|63081462|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
33658137|NCT02921256|63081463|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
33658138|NCT02890355|63081479|FG000|Overall Study|Adverse Event|5|||
33658139|NCT02890355|63081480|FG001|Overall Study|Adverse Event|5|||
33658140|NCT02890355|63081479|FG000|Overall Study|Refusal unrelated to adverse event|5|||
33658141|NCT02890355|63081480|FG001|Overall Study|Refusal unrelated to adverse event|10|||
33658142|NCT02890355|63081479|FG000|Overall Study|Progression/relapse|46|||
33658143|NCT02890355|63081480|FG001|Overall Study|Progression/relapse|39|||
33658144|NCT02890355|63081479|FG000|Overall Study|Not protocol specified|3|||
33658145|NCT02890355|63081480|FG001|Overall Study|Not protocol specified|4|||
33658146|NCT02854436|63081488|FG000|Overall Study|Adverse Event|1|||
33658147|NCT02854436|63081488|FG000|Overall Study|Death|208|||
33658148|NCT02854436|63081488|FG000|Overall Study|Lost to Follow-up|5|||
33658149|NCT02854436|63081488|FG000|Overall Study|Withdrawal by Subject|12|||
33658150|NCT02854436|63081488|FG000|Overall Study|Other|45|||
33658151|NCT02854436|63081488|FG000|Overall Study|Ongoing|18|||
33658152|NCT02822573|63081494|FG000|Overall Study|Lost to Follow-up|5|||
33658153|NCT02822573|63081495|FG001|Overall Study|Lost to Follow-up|3|||
33658154|NCT02822573|63081494|FG000|Overall Study|Physician Decision|1|||
33658155|NCT02822573|63081495|FG001|Overall Study|Physician Decision|1|||
33658156|NCT02822573|63081494|FG000|Overall Study|Withdrawal by Subject|9|||
33658157|NCT02822573|63081495|FG001|Overall Study|Withdrawal by Subject|5|||
33658158|NCT02822573|63081494|FG000|Overall Study|Protocol Violation|6|||
33658159|NCT02822573|63081495|FG001|Overall Study|Protocol Violation|4|||
33482195|NCT03445533|62858956|FG001|Overall Study|Never Received any Study Treatment|4|||
33482196|NCT01337050|62858965|FG000|Overall Study|Death|0|||
33482197|NCT01337050|62858966|FG001|Overall Study|Death|0|||
33482198|NCT01337050|62858967|FG002|Overall Study|Death|4|||
33482199|NCT01337050|62858965|FG000|Overall Study|Other|4|||
33482200|NCT01337050|62858966|FG001|Overall Study|Other|6|||
33482201|NCT01337050|62858967|FG002|Overall Study|Other|8|||
33482202|NCT01337050|62858965|FG000|Overall Study|Participants refused further follow-up|0|||
33482203|NCT01337050|62858966|FG001|Overall Study|Participants refused further follow-up|7|||
33552922|NCT01651000|62945370|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
33658160|NCT02822573|63081494|FG000|Overall Study|Too sick or ill|2|||
33658161|NCT02822573|63081495|FG001|Overall Study|Too sick or ill|1|||
33482204|NCT01337050|62858967|FG002|Overall Study|Participants refused further follow-up|7|||
33658162|NCT02822573|63081494|FG000|Overall Study|Disease Progression|1|||
33658163|NCT02822573|63081495|FG001|Overall Study|Disease Progression|1|||
33658164|NCT02822573|63081494|FG000|Overall Study|No reason given|6|||
33552923|NCT01651000|62945371|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
33552924|NCT02469610|62945379|FG000|Overall Study|Death|1|||
33658165|NCT02822573|63081495|FG001|Overall Study|No reason given|4|||
33658166|NCT02795676|63081503|FG000|Overall Study|Adverse Event|2|||
33482205|NCT01336972|62858979|FG000|Overall Study|Adverse Event|1|||
33552925|NCT02469610|62945380|FG001|Overall Study|Death|0|||
33552926|NCT02469610|62945379|FG000|Overall Study|Lost to Follow-up|1|||
33552927|NCT02469610|62945380|FG001|Overall Study|Lost to Follow-up|0|||
33552928|NCT02469610|62945379|FG000|Overall Study|exclusion criteria|2|||
33552929|NCT02469610|62945380|FG001|Overall Study|exclusion criteria|1|||
33552930|NCT02469298|62945390|FG000|Overall Study|Protocol Violation|0|||
33552931|NCT02469298|62945391|FG001|Overall Study|Protocol Violation|1|||
33552932|NCT02469298|62945392|FG002|Overall Study|Protocol Violation|1|||
33552933|NCT02469298|62945393|FG003|Overall Study|Protocol Violation|0|||
33552934|NCT02469298|62945390|FG000|Overall Study|Lost to Follow-up|1|||
33552935|NCT02469298|62945391|FG001|Overall Study|Lost to Follow-up|0|||
33552936|NCT02469298|62945392|FG002|Overall Study|Lost to Follow-up|1|||
33552937|NCT02469298|62945393|FG003|Overall Study|Lost to Follow-up|0|||
33552938|NCT02469298|62945390|FG000|Overall Study|Physician Decision|0|||
33552939|NCT02469298|62945391|FG001|Overall Study|Physician Decision|0|||
33552940|NCT02469298|62945392|FG002|Overall Study|Physician Decision|0|||
33552941|NCT02469298|62945393|FG003|Overall Study|Physician Decision|1|||
33552942|NCT02469298|62945390|FG000|Overall Study|Withdrawal by Subject|0|||
33552943|NCT02469298|62945391|FG001|Overall Study|Withdrawal by Subject|0|||
33552944|NCT02469298|62945392|FG002|Overall Study|Withdrawal by Subject|0|||
33552945|NCT02469298|62945393|FG003|Overall Study|Withdrawal by Subject|1|||
33552946|NCT04163991|62945415|FG000|Overall Study|Adverse Event|0|||
33552947|NCT04163991|62945416|FG001|Overall Study|Adverse Event|0|||
33552948|NCT04163991|62945417|FG002|Overall Study|Adverse Event|0|||
33552949|NCT04163991|62945418|FG003|Overall Study|Adverse Event|1|||
33552950|NCT04163991|62945419|FG004|Overall Study|Adverse Event|0|||
33552951|NCT04163991|62945415|FG000|Overall Study|Death|0|||
33552952|NCT04163991|62945416|FG001|Overall Study|Death|0|||
33552953|NCT04163991|62945417|FG002|Overall Study|Death|1|||
33552954|NCT04163991|62945418|FG003|Overall Study|Death|0|||
33552955|NCT04163991|62945419|FG004|Overall Study|Death|0|||
33552956|NCT04163991|62945415|FG000|Overall Study|Lost to Follow-up|0|||
33552957|NCT04163991|62945416|FG001|Overall Study|Lost to Follow-up|1|||
33552958|NCT04163991|62945417|FG002|Overall Study|Lost to Follow-up|0|||
33552959|NCT04163991|62945418|FG003|Overall Study|Lost to Follow-up|0|||
33552960|NCT04163991|62945419|FG004|Overall Study|Lost to Follow-up|0|||
33552961|NCT04163991|62945415|FG000|Overall Study|Withdrawal by Subject|1|||
33552962|NCT04163991|62945416|FG001|Overall Study|Withdrawal by Subject|1|||
33552963|NCT04163991|62945417|FG002|Overall Study|Withdrawal by Subject|3|||
33552964|NCT04163991|62945418|FG003|Overall Study|Withdrawal by Subject|1|||
33552965|NCT04163991|62945419|FG004|Overall Study|Withdrawal by Subject|1|||
33552966|NCT04163991|62945415|FG000|Overall Study|Other, Not Specified|0|||
33552967|NCT04163991|62945416|FG001|Overall Study|Other, Not Specified|1|||
33552968|NCT04163991|62945417|FG002|Overall Study|Other, Not Specified|1|||
33482206|NCT01336972|62858980|FG001|Overall Study|Adverse Event|1|||
33482207|NCT01336972|62858981|FG002|Overall Study|Adverse Event|0|||
33482208|NCT03762681|62858998|FG000|Part 1|Withdrawal by Subject|0|||
33482209|NCT03762681|62858999|FG001|Part 1|Withdrawal by Subject|0|||
33482210|NCT03762681|62859000|FG002|Part 1|Withdrawal by Subject|0|||
33482211|NCT03762681|62859001|FG003|Part 1|Withdrawal by Subject|1|||
33482212|NCT03762681|62859002|FG004|Part 1|Withdrawal by Subject|0|||
33482213|NCT03762681|62859003|FG005|Part 1|Withdrawal by Subject|0|||
33482214|NCT03762681|62859004|FG006|Part 1|Withdrawal by Subject|0|||
33482215|NCT03762681|62859005|FG007|Part 1|Withdrawal by Subject|0|||
33482216|NCT03762681|62858998|FG000|Part 2a|Pandemic Travel Restrictions|0|||
33482217|NCT03762681|62858999|FG001|Part 2a|Pandemic Travel Restrictions|0|||
33482218|NCT03762681|62859000|FG002|Part 2a|Pandemic Travel Restrictions|0|||
33482219|NCT03762681|62859001|FG003|Part 2a|Pandemic Travel Restrictions|0|||
33482220|NCT03762681|62859002|FG004|Part 2a|Pandemic Travel Restrictions|0|||
33482221|NCT03762681|62859003|FG005|Part 2a|Pandemic Travel Restrictions|0|||
33552969|NCT04163991|62945418|FG003|Overall Study|Other, Not Specified|1|||
33552970|NCT04163991|62945419|FG004|Overall Study|Other, Not Specified|0|||
33552971|NCT02442622|62945437|FG000|Overall Study|Withdrawal by Subject|3|||
33552972|NCT02442622|62945438|FG001|Overall Study|Withdrawal by Subject|1|||
33552973|NCT02411578|62945446|FG000|Crossover Trial Phase|Pregnancy|0|||
33552974|NCT02411578|62945447|FG001|Crossover Trial Phase|Pregnancy|1|||
33552975|NCT02442310|62945455|FG000|Overall Study|Adverse Event|2|||
33552976|NCT02442310|62945455|FG000|Overall Study|Withdrawal by Subject|1|||
33552977|NCT02411110|62945467|FG000|Treatment Period 1|Adverse Event|4|||
33552978|NCT02411110|62945468|FG001|Treatment Period 1|Adverse Event|2|||
33552979|NCT02411110|62945467|FG000|Treatment Period 1|Lost to Follow-up|1|||
33552980|NCT02411110|62945468|FG001|Treatment Period 1|Lost to Follow-up|0|||
33482222|NCT03762681|62859004|FG006|Part 2a|Pandemic Travel Restrictions|0|||
33552981|NCT02411110|62945467|FG000|Treatment Period 1|Personal Reasons|2|||
33552982|NCT02411110|62945468|FG001|Treatment Period 1|Personal Reasons|5|||
33552983|NCT02411110|62945467|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
33552984|NCT02411110|62945468|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
33552985|NCT02411110|62945467|FG000|Treatment Period 2|Adverse Event|1|||
33552986|NCT02411110|62945468|FG001|Treatment Period 2|Adverse Event|0|||
33552987|NCT02411110|62945467|FG000|Treatment Period 2|Lost to Follow-up|0|||
33658167|NCT02795676|63081504|FG001|Overall Study|Adverse Event|0|||
33658168|NCT02795676|63081503|FG000|Overall Study|Withdrawal by Subject|3|||
33658169|NCT02795676|63081504|FG001|Overall Study|Withdrawal by Subject|1|||
33658170|NCT02784535|63081510|FG000|Overall Study|Adverse Event|1|||
33658171|NCT02784535|63081511|FG001|Overall Study|Adverse Event|0|||
33658172|NCT02784535|63081510|FG000|Overall Study|Withdrawal by Subject|0|||
33658173|NCT02784535|63081511|FG001|Overall Study|Withdrawal by Subject|1|||
33658174|NCT02784535|63081510|FG000|Overall Study|Physician Decision|0|||
33658175|NCT02784535|63081511|FG001|Overall Study|Physician Decision|1|||
33658176|NCT02617511|63081522|FG000|Overall Study|Withdrawal by Subject|1|||
33658177|NCT02617511|63081523|FG001|Overall Study|Withdrawal by Subject|0|||
33482223|NCT03762681|62859005|FG007|Part 2a|Pandemic Travel Restrictions|1|||
33482224|NCT03764475|62859034|FG000|Overall Study|Adverse Event|11|||
33482225|NCT03764475|62859035|FG001|Overall Study|Adverse Event|2|||
33482226|NCT03764475|62859034|FG000|Overall Study|Lost to Follow-up|24|||
33482227|NCT03764475|62859035|FG001|Overall Study|Lost to Follow-up|10|||
33658178|NCT02587234|63081531|FG000|Overall Study|Withdrawal by Subject|1|||
33658179|NCT02587234|63081532|FG001|Overall Study|Withdrawal by Subject|1|||
33658180|NCT02587234|63081531|FG000|Overall Study|Lost to Follow-up|0|||
33658181|NCT02587234|63081532|FG001|Overall Study|Lost to Follow-up|2|||
33658182|NCT02581930|63081538|FG000|Overall Study|Withdrawal by Subject|1|||
33658183|NCT02581930|63081538|FG000|Overall Study|patient declined further treatment|1|||
33658184|NCT02521285|63081544|FG000|Overall Study|Lost to Follow-up|1|||
33658185|NCT02521285|63081545|FG001|Overall Study|Lost to Follow-up|1|||
33658186|NCT02521285|63081544|FG000|Overall Study|Withdrawal by Subject|1|||
33552988|NCT02411110|62945468|FG001|Treatment Period 2|Lost to Follow-up|2|||
33552989|NCT02411110|62945467|FG000|Treatment Period 2|Personal Reasons|0|||
33552990|NCT02411110|62945468|FG001|Treatment Period 2|Personal Reasons|2|||
33552991|NCT01369849|62945479|FG000|Overall Study|Ineligible prior to treatment|0|||
33658187|NCT02521285|63081545|FG001|Overall Study|Withdrawal by Subject|1|||
33658188|NCT02521285|63081544|FG000|Overall Study|Adverse Event|0|||
33658189|NCT02521285|63081545|FG001|Overall Study|Adverse Event|1|||
33658190|NCT02516241|63081554|FG000|Overall Study|Death|255|||
33658191|NCT02516241|63081555|FG001|Overall Study|Death|262|||
33658192|NCT02516241|63081556|FG002|Overall Study|Death|270|||
33658193|NCT02516241|63081554|FG000|Overall Study|Lost to Follow-up|1|||
33658194|NCT02516241|63081555|FG001|Overall Study|Lost to Follow-up|1|||
33658195|NCT02516241|63081556|FG002|Overall Study|Lost to Follow-up|3|||
33658196|NCT02516241|63081554|FG000|Overall Study|Withdrawal by Subject|2|||
33658197|NCT02516241|63081555|FG001|Overall Study|Withdrawal by Subject|7|||
33658198|NCT02516241|63081556|FG002|Overall Study|Withdrawal by Subject|12|||
33658199|NCT02516241|63081554|FG000|Overall Study|participants ongoing at data cut-off|84|||
33658200|NCT02516241|63081555|FG001|Overall Study|participants ongoing at data cut-off|76|||
33658201|NCT02516241|63081556|FG002|Overall Study|participants ongoing at data cut-off|59|||
33658202|NCT02489318|63081571|FG000|Randomized|Withdrawal by Subject|0|||
33658203|NCT02489318|63081572|FG001|Randomized|Withdrawal by Subject|1|||
33658204|NCT02489318|63081571|FG000|Treated|Adverse Event|19|||
33552992|NCT01369849|62945480|FG001|Overall Study|Ineligible prior to treatment|0|||
33552993|NCT01369849|62945481|FG002|Overall Study|Ineligible prior to treatment|1|||
33552994|NCT01369849|62945479|FG000|Overall Study|Ineligible after receiving treatment|0|||
33552995|NCT01369849|62945480|FG001|Overall Study|Ineligible after receiving treatment|1|||
33552996|NCT01369849|62945481|FG002|Overall Study|Ineligible after receiving treatment|0|||
33552997|NCT02716779|62945494|FG000|Monotherapy|Adverse Event|0|||
33552998|NCT02716779|62945495|FG001|Monotherapy|Adverse Event|1|||
33658205|NCT02489318|63081572|FG001|Treated|Adverse Event|62|||
33658206|NCT02489318|63081571|FG000|Treated|Death|13|||
33658207|NCT02489318|63081572|FG001|Treated|Death|11|||
33658208|NCT02489318|63081571|FG000|Treated|Physician Decision|4|||
33658209|NCT02489318|63081572|FG001|Treated|Physician Decision|6|||
33658210|NCT02489318|63081571|FG000|Treated|Protocol Violation|1|||
33658211|NCT02489318|63081572|FG001|Treated|Protocol Violation|2|||
33482228|NCT03764475|62859034|FG000|Overall Study|Withdrawal by Subject|26|||
33482229|NCT03764475|62859035|FG001|Overall Study|Withdrawal by Subject|10|||
33482230|NCT03764475|62859034|FG000|Overall Study|Lack of Efficacy|3|||
33552999|NCT02716779|62945496|FG002|Monotherapy|Adverse Event|1|||
33553000|NCT02716779|62945494|FG000|Combination Therapy|Adverse Event|0|||
33553001|NCT02716779|62945495|FG001|Combination Therapy|Adverse Event|2|||
33658212|NCT02489318|63081571|FG000|Treated|Withdrawal by Subject|37|||
33658213|NCT02489318|63081572|FG001|Treated|Withdrawal by Subject|36|||
33482231|NCT03764475|62859035|FG001|Overall Study|Lack of Efficacy|0|||
33553002|NCT02716779|62945496|FG002|Combination Therapy|Adverse Event|1|||
33658214|NCT02489318|63081571|FG000|Treated|Other: Progressive Disease|245|||
33658215|NCT02489318|63081572|FG001|Treated|Other: Progressive Disease|138|||
33658216|NCT02489318|63081571|FG000|Treated|Other|0|||
33658217|NCT02489318|63081572|FG001|Treated|Other|2|||
33658218|NCT02489318|63081571|FG000|Treated|Ongoing|0|||
33658219|NCT02489318|63081572|FG001|Treated|Ongoing|267|||
33658220|NCT02277444|63081579|FG000|Overall Study|Adverse Event|10|||
33658221|NCT02277444|63081579|FG000|Overall Study|Withdrawal by Subject|3|||
33658222|NCT02277444|63081579|FG000|Overall Study|Other|1|||
33658223|NCT02277444|63081579|FG000|Overall Study|Enrolled and not Treated|3|||
33658224|NCT02277444|63081579|FG000|Overall Study|Ongoing|113|||
33658225|NCT02195479|63081585|FG000|Overall Study|Lost to Follow-up|3|||
33658226|NCT02195479|63081586|FG001|Overall Study|Lost to Follow-up|0|||
33658227|NCT02195479|63081585|FG000|Overall Study|Death|48|||
33658228|NCT02195479|63081586|FG001|Overall Study|Death|45|||
33658229|NCT02195479|63081585|FG000|Overall Study|Physician Decision|1|||
33658230|NCT02195479|63081586|FG001|Overall Study|Physician Decision|0|||
33658231|NCT02195479|63081585|FG000|Overall Study|Withdrawal by Subject|11|||
33658232|NCT02195479|63081586|FG001|Overall Study|Withdrawal by Subject|6|||
33658233|NCT02195479|63081585|FG000|Overall Study|Other|2|||
33658234|NCT02195479|63081586|FG001|Overall Study|Other|2|||
33658235|NCT02195479|63081585|FG000|Overall Study|Ongoing|291|||
33658236|NCT02195479|63081586|FG001|Overall Study|Ongoing|297|||
33658237|NCT02184195|63081594|FG000|Overall Study|Patient decision|5|||
33658238|NCT02184195|63081595|FG001|Overall Study|Patient decision|2|||
33658239|NCT02184195|63081594|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33658240|NCT02184195|63081595|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33658241|NCT02184195|63081594|FG000|Overall Study|Death|67|||
33658242|NCT02184195|63081595|FG001|Overall Study|Death|44|||
33658243|NCT02184195|63081594|FG000|Overall Study|Lost to Follow-up|1|||
33658244|NCT02184195|63081595|FG001|Overall Study|Lost to Follow-up|5|||
33658245|NCT02184195|63081594|FG000|Overall Study|Other|0|||
33658246|NCT02184195|63081595|FG001|Overall Study|Other|3|||
33658247|NCT02181413|63081603|FG000|Overall Study|Adverse Event|7|||
33658248|NCT02181413|63081604|FG001|Overall Study|Adverse Event|24|||
33658249|NCT02181413|63081603|FG000|Overall Study|Progressive Disease|121|||
33658250|NCT02181413|63081604|FG001|Overall Study|Progressive Disease|143|||
33658251|NCT02181413|63081603|FG000|Overall Study|Withdrawal by Subject|5|||
33658252|NCT02181413|63081604|FG001|Overall Study|Withdrawal by Subject|8|||
33658253|NCT02181413|63081603|FG000|Overall Study|Reason Not Specified|19|||
33658254|NCT02181413|63081604|FG001|Overall Study|Reason Not Specified|20|||
33658255|NCT02181413|63081603|FG000|Overall Study|Ongoing Study Treatment|0|||
33658256|NCT02181413|63081604|FG001|Overall Study|Ongoing Study Treatment|1|||
33658257|NCT02181413|63081603|FG000|Overall Study|Lost to Follow-up|0|||
33658258|NCT02181413|63081604|FG001|Overall Study|Lost to Follow-up|1|||
33658259|NCT02180867|63081617|FG000|Overall Study|Adverse Event|3|||
33658260|NCT02180867|63081618|FG001|Overall Study|Adverse Event|4|||
33658261|NCT02180867|63081619|FG002|Overall Study|Adverse Event|1|||
33658262|NCT02180867|63081620|FG003|Overall Study|Adverse Event|5|||
33658263|NCT02180867|63081621|FG004|Overall Study|Adverse Event|0|||
33658264|NCT02180867|63081622|FG005|Overall Study|Adverse Event|0|||
33658265|NCT02180867|63081623|FG006|Overall Study|Adverse Event|0|||
33658266|NCT02180867|63081617|FG000|Overall Study|Death|0|||
33658267|NCT02180867|63081618|FG001|Overall Study|Death|0|||
33658268|NCT02180867|63081619|FG002|Overall Study|Death|0|||
33658269|NCT02180867|63081620|FG003|Overall Study|Death|0|||
33658270|NCT02180867|63081621|FG004|Overall Study|Death|1|||
33658271|NCT02180867|63081622|FG005|Overall Study|Death|0|||
33658272|NCT02180867|63081623|FG006|Overall Study|Death|0|||
33658273|NCT02180867|63081617|FG000|Overall Study|Lack of Efficacy|0|||
33658274|NCT02180867|63081618|FG001|Overall Study|Lack of Efficacy|2|||
33658275|NCT02180867|63081619|FG002|Overall Study|Lack of Efficacy|0|||
33658276|NCT02180867|63081620|FG003|Overall Study|Lack of Efficacy|1|||
33658277|NCT02180867|63081621|FG004|Overall Study|Lack of Efficacy|6|||
33658278|NCT02180867|63081622|FG005|Overall Study|Lack of Efficacy|0|||
33658279|NCT02180867|63081623|FG006|Overall Study|Lack of Efficacy|1|||
33658280|NCT02180867|63081617|FG000|Overall Study|Physician Decision|1|||
33658281|NCT02180867|63081618|FG001|Overall Study|Physician Decision|3|||
33658282|NCT02180867|63081619|FG002|Overall Study|Physician Decision|1|||
33658283|NCT02180867|63081620|FG003|Overall Study|Physician Decision|10|||
33658284|NCT02180867|63081621|FG004|Overall Study|Physician Decision|9|||
33658285|NCT02180867|63081622|FG005|Overall Study|Physician Decision|3|||
33658286|NCT02180867|63081623|FG006|Overall Study|Physician Decision|4|||
33658287|NCT02180867|63081617|FG000|Overall Study|Withdrawal by Subject|0|||
33658288|NCT02180867|63081618|FG001|Overall Study|Withdrawal by Subject|0|||
33658289|NCT02180867|63081619|FG002|Overall Study|Withdrawal by Subject|0|||
33658290|NCT02180867|63081620|FG003|Overall Study|Withdrawal by Subject|1|||
33658291|NCT02180867|63081621|FG004|Overall Study|Withdrawal by Subject|1|||
33658292|NCT02180867|63081622|FG005|Overall Study|Withdrawal by Subject|0|||
33658293|NCT02180867|63081623|FG006|Overall Study|Withdrawal by Subject|0|||
33658294|NCT02180867|63081617|FG000|Overall Study|Ineligible|1|||
33658295|NCT02180867|63081618|FG001|Overall Study|Ineligible|2|||
33658296|NCT02180867|63081619|FG002|Overall Study|Ineligible|0|||
33658297|NCT02180867|63081620|FG003|Overall Study|Ineligible|3|||
33658298|NCT02180867|63081621|FG004|Overall Study|Ineligible|5|||
33658299|NCT02180867|63081622|FG005|Overall Study|Ineligible|0|||
33658300|NCT02180867|63081623|FG006|Overall Study|Ineligible|0|||
33658301|NCT02180867|63081617|FG000|Overall Study|Repeat Eligibility Studies|0|||
33658302|NCT02180867|63081618|FG001|Overall Study|Repeat Eligibility Studies|0|||
33658303|NCT02180867|63081619|FG002|Overall Study|Repeat Eligibility Studies|0|||
33658304|NCT02180867|63081620|FG003|Overall Study|Repeat Eligibility Studies|0|||
33658305|NCT02180867|63081621|FG004|Overall Study|Repeat Eligibility Studies|1|||
33658306|NCT02180867|63081622|FG005|Overall Study|Repeat Eligibility Studies|0|||
33658307|NCT02180867|63081623|FG006|Overall Study|Repeat Eligibility Studies|0|||
33658308|NCT02180867|63081617|FG000|Overall Study|Refusal of further protocol therapy|1|||
33658309|NCT02180867|63081618|FG001|Overall Study|Refusal of further protocol therapy|0|||
33658310|NCT02180867|63081619|FG002|Overall Study|Refusal of further protocol therapy|2|||
33658311|NCT02180867|63081620|FG003|Overall Study|Refusal of further protocol therapy|6|||
33658312|NCT02180867|63081621|FG004|Overall Study|Refusal of further protocol therapy|4|||
33658313|NCT02180867|63081622|FG005|Overall Study|Refusal of further protocol therapy|0|||
33658314|NCT02180867|63081623|FG006|Overall Study|Refusal of further protocol therapy|0|||
33658315|NCT02152982|63081653|FG000|Overall Study|Ineligible|4|||
33658316|NCT02152982|63081654|FG001|Overall Study|Ineligible|4|||
33658317|NCT02152982|63081653|FG000|Overall Study|Did not start treatment|12|||
33658318|NCT02152982|63081654|FG001|Overall Study|Did not start treatment|6|||
33658319|NCT02152631|63081668|FG000|Overall Study|Adverse Event|32|||
33658320|NCT02152631|63081669|FG001|Overall Study|Adverse Event|4|||
33658321|NCT02152631|63081668|FG000|Overall Study|Withdrawal by Subject|13|||
33658322|NCT02152631|63081669|FG001|Overall Study|Withdrawal by Subject|16|||
33658323|NCT02152631|63081668|FG000|Overall Study|Noncompliance with study drug|1|||
33658324|NCT02152631|63081669|FG001|Overall Study|Noncompliance with study drug|0|||
33658325|NCT02152631|63081668|FG000|Overall Study|Physician Decision|1|||
33658326|NCT02152631|63081669|FG001|Overall Study|Physician Decision|2|||
33658327|NCT02152631|63081668|FG000|Overall Study|Lost to Follow-up|0|||
33658328|NCT02152631|63081669|FG001|Overall Study|Lost to Follow-up|1|||
33658329|NCT02152631|63081668|FG000|Overall Study|On Treatment|19|||
33658330|NCT02152631|63081669|FG001|Overall Study|On Treatment|3|||
33658331|NCT02151981|63081677|FG000|Overall Study|Death|184|||
33658332|NCT02151981|63081678|FG001|Overall Study|Death|88|||
33658333|NCT02151981|63081677|FG000|Overall Study|Lost to Follow-up|7|||
33658334|NCT02151981|63081678|FG001|Overall Study|Lost to Follow-up|1|||
33658335|NCT02151981|63081677|FG000|Overall Study|Withdrawal by Subject|27|||
33658336|NCT02151981|63081678|FG001|Overall Study|Withdrawal by Subject|21|||
33658337|NCT02151981|63081677|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
33658338|NCT02151981|63081678|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
33658339|NCT02151981|63081677|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33658340|NCT02151981|63081678|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33658341|NCT02151981|63081677|FG000|Overall Study|Patient had no clinical benefit|1|||
33658342|NCT02151981|63081678|FG001|Overall Study|Patient had no clinical benefit|0|||
33658343|NCT02151981|63081677|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
33364767|NCT02393248|62743324|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
33364768|NCT02393248|62743325|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
33364769|NCT02393248|62743326|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
33658344|NCT02151981|63081678|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
33658345|NCT02151981|63081677|FG000|Overall Study|Study terminated|0|||
33658346|NCT02151981|63081678|FG001|Overall Study|Study terminated|1|||
33364770|NCT02393248|62743327|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
33482232|NCT03764475|62859034|FG000|Overall Study|COVID-19 Disruption|2|||
33658347|NCT02136134|63081686|FG000|Overall Study|Death|35|||
33658348|NCT02136134|63081687|FG001|Overall Study|Death|29|||
33658349|NCT02136134|63081686|FG000|Overall Study|Withdrawal by Subject|14|||
33658350|NCT02136134|63081687|FG001|Overall Study|Withdrawal by Subject|4|||
33658351|NCT02136134|63081686|FG000|Overall Study|Other|3|||
33658352|NCT02136134|63081687|FG001|Overall Study|Other|3|||
33658353|NCT02136134|63081686|FG000|Overall Study|Ongoing|185|||
33658354|NCT02136134|63081687|FG001|Overall Study|Ongoing|207|||
33658355|NCT02136134|63081686|FG000|Overall Study|Subjects randomized but not treated|10|||
33658356|NCT02136134|63081687|FG001|Overall Study|Subjects randomized but not treated|8|||
33658357|NCT02076009|63081695|FG000|Overall Study|Death|44|||
33658358|NCT02076009|63081696|FG001|Overall Study|Death|30|||
33658359|NCT02076009|63081695|FG000|Overall Study|Withdrawal by Subject|9|||
33658360|NCT02076009|63081696|FG001|Overall Study|Withdrawal by Subject|3|||
33658361|NCT02076009|63081695|FG000|Overall Study|Lost to Follow-up|1|||
33658362|NCT02076009|63081696|FG001|Overall Study|Lost to Follow-up|1|||
33658363|NCT02076009|63081695|FG000|Overall Study|Progressive disease|1|||
33658364|NCT02076009|63081696|FG001|Overall Study|Progressive disease|0|||
33658365|NCT02076009|63081695|FG000|Overall Study|Ongoing|226|||
33658366|NCT02076009|63081696|FG001|Overall Study|Ongoing|249|||
33658367|NCT02076009|63081695|FG000|Overall Study|Subjects randomized but not treated|2|||
33658368|NCT02076009|63081696|FG001|Overall Study|Subjects randomized but not treated|3|||
33658369|NCT02003209|63081704|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
33658370|NCT02003209|63081705|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
33658371|NCT01981720|63081724|FG000|Overall Study|Adverse Event|1|||
33658372|NCT01981720|63081724|FG000|Overall Study|Withdrawal by Subject|3|||
33658373|NCT01981720|63081724|FG000|Overall Study|Pregnancy|1|||
33658374|NCT01974440|63081734|FG000|Overall Study|Lost to Follow-up|8|||
33658375|NCT01974440|63081735|FG001|Overall Study|Lost to Follow-up|7|||
33658376|NCT01974440|63081734|FG000|Overall Study|Withdrawal by Subject|20|||
33658377|NCT01974440|63081735|FG001|Overall Study|Withdrawal by Subject|19|||
33658378|NCT01974440|63081734|FG000|Overall Study|Ongoing|112|||
33658379|NCT01974440|63081735|FG001|Overall Study|Ongoing|116|||
33658380|NCT01902173|63081756|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
33658381|NCT01902173|63081757|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
33658382|NCT01902173|63081758|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
33658383|NCT01902173|63081759|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
33658384|NCT01902173|63081760|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
33658385|NCT01902173|63081761|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
33658386|NCT01902173|63081756|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
33658387|NCT01902173|63081757|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
33658388|NCT01902173|63081758|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
33658389|NCT01902173|63081759|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
33658390|NCT01902173|63081760|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
33658391|NCT01902173|63081761|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
33658392|NCT01902173|63081756|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
33658393|NCT01902173|63081757|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
33553003|NCT01369615|62945512|FG000|Overall Study|Withdrawal by Subject|0|||
33553004|NCT01369615|62945513|FG001|Overall Study|Withdrawal by Subject|1|||
33553005|NCT01369615|62945512|FG000|Overall Study|Lost to Follow-up|0|||
33553006|NCT01369615|62945513|FG001|Overall Study|Lost to Follow-up|1|||
33553007|NCT02468674|62945537|FG000|Overall Study|Adverse Event|0|||
33553008|NCT02468674|62945538|FG001|Overall Study|Adverse Event|0|||
33553009|NCT02468674|62945539|FG002|Overall Study|Adverse Event|0|||
33553010|NCT02468674|62945540|FG003|Overall Study|Adverse Event|1|||
33553011|NCT02468674|62945541|FG004|Overall Study|Adverse Event|0|||
33553012|NCT02468674|62945542|FG005|Overall Study|Adverse Event|1|||
33553013|NCT02468674|62945543|FG006|Overall Study|Adverse Event|0|||
33553014|NCT02468674|62945544|FG007|Overall Study|Adverse Event|0|||
33553015|NCT02468674|62945545|FG008|Overall Study|Adverse Event|0|||
33553016|NCT02468674|62945537|FG000|Overall Study|Lost to Follow-up|1|||
33553017|NCT02468674|62945538|FG001|Overall Study|Lost to Follow-up|0|||
33658394|NCT01902173|63081758|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
33658395|NCT01902173|63081759|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
33658396|NCT01902173|63081760|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
33658397|NCT01902173|63081761|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
33658398|NCT01902173|63081756|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
33364771|NCT02393248|62743303|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364772|NCT02393248|62743304|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33553018|NCT02468674|62945539|FG002|Overall Study|Lost to Follow-up|0|||
33658399|NCT01902173|63081757|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
33553019|NCT02468674|62945540|FG003|Overall Study|Lost to Follow-up|0|||
33553020|NCT02468674|62945541|FG004|Overall Study|Lost to Follow-up|0|||
33553021|NCT02468674|62945542|FG005|Overall Study|Lost to Follow-up|0|||
33658400|NCT01902173|63081758|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
33658401|NCT01902173|63081759|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
33658402|NCT01902173|63081760|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
33658403|NCT01902173|63081761|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
33658404|NCT01902173|63081756|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
33658405|NCT01902173|63081757|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
33553022|NCT02468674|62945543|FG006|Overall Study|Lost to Follow-up|0|||
33553023|NCT02468674|62945544|FG007|Overall Study|Lost to Follow-up|1|||
33553024|NCT02468674|62945545|FG008|Overall Study|Lost to Follow-up|1|||
33553025|NCT02468674|62945537|FG000|Overall Study|Physician Decision|0|||
33553026|NCT02468674|62945538|FG001|Overall Study|Physician Decision|0|||
33553027|NCT02468674|62945539|FG002|Overall Study|Physician Decision|0|||
33553028|NCT02468674|62945540|FG003|Overall Study|Physician Decision|0|||
33553029|NCT02468674|62945541|FG004|Overall Study|Physician Decision|0|||
33553030|NCT02468674|62945542|FG005|Overall Study|Physician Decision|0|||
33553031|NCT02468674|62945543|FG006|Overall Study|Physician Decision|1|||
33553032|NCT02468674|62945544|FG007|Overall Study|Physician Decision|0|||
33553033|NCT02468674|62945545|FG008|Overall Study|Physician Decision|0|||
33553034|NCT02468674|62945537|FG000|Overall Study|Patient/Guardian Decision|0|||
33553035|NCT02468674|62945538|FG001|Overall Study|Patient/Guardian Decision|0|||
33364773|NCT02393248|62743305|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364774|NCT02393248|62743306|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33553036|NCT02468674|62945539|FG002|Overall Study|Patient/Guardian Decision|0|||
33658406|NCT01902173|63081758|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
33553037|NCT02468674|62945540|FG003|Overall Study|Patient/Guardian Decision|0|||
33553038|NCT02468674|62945541|FG004|Overall Study|Patient/Guardian Decision|1|||
33553039|NCT02468674|62945542|FG005|Overall Study|Patient/Guardian Decision|0|||
33553040|NCT02468674|62945543|FG006|Overall Study|Patient/Guardian Decision|0|||
33553041|NCT02468674|62945544|FG007|Overall Study|Patient/Guardian Decision|2|||
33553042|NCT02468674|62945545|FG008|Overall Study|Patient/Guardian Decision|1|||
33553043|NCT02468674|62945537|FG000|Overall Study|Protocol Deviation|0|||
33553044|NCT02468674|62945538|FG001|Overall Study|Protocol Deviation|0|||
33553045|NCT02468674|62945539|FG002|Overall Study|Protocol Deviation|0|||
33553046|NCT02468674|62945540|FG003|Overall Study|Protocol Deviation|0|||
33553047|NCT02468674|62945541|FG004|Overall Study|Protocol Deviation|0|||
33553048|NCT02468674|62945542|FG005|Overall Study|Protocol Deviation|0|||
33553049|NCT02468674|62945543|FG006|Overall Study|Protocol Deviation|0|||
33553050|NCT02468674|62945544|FG007|Overall Study|Protocol Deviation|1|||
33553051|NCT02468674|62945545|FG008|Overall Study|Protocol Deviation|1|||
33553052|NCT02467192|62945565|FG000|Overall Study|Death|1|||
33553053|NCT02467192|62945565|FG000|Overall Study|revealed to have pneumonia before|2|||
33553054|NCT02410954|62945575|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
33553055|NCT02410954|62945576|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
33553056|NCT02410954|62945575|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
33553057|NCT02410954|62945576|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
33553058|NCT02689453|62945585|FG000|Overall Study|Progressive disease|0|||
33553059|NCT02689453|62945586|FG001|Overall Study|Progressive disease|1|||
33553060|NCT02689453|62945587|FG002|Overall Study|Progressive disease|1|||
33658407|NCT01902173|63081759|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
33658408|NCT01902173|63081760|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
33658409|NCT01902173|63081761|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
33658410|NCT01902173|63081756|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
33658411|NCT01902173|63081757|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
33658412|NCT01902173|63081758|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
33658413|NCT01902173|63081759|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
33658414|NCT01902173|63081760|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
33658415|NCT01902173|63081761|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
33658416|NCT01902173|63081756|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
33658417|NCT01902173|63081757|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
33658418|NCT01902173|63081758|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
33658419|NCT01902173|63081759|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
33658420|NCT01902173|63081760|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
33658421|NCT01902173|63081761|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
33658422|NCT01902173|63081756|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
33658423|NCT01902173|63081757|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
33658424|NCT01902173|63081758|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
33658425|NCT01902173|63081759|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
33658426|NCT01902173|63081760|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
33658427|NCT01902173|63081761|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
33553061|NCT00701103|62945622|FG000|Overall Study|Adverse Event|0|||
33553062|NCT00701103|62945623|FG001|Overall Study|Adverse Event|0|||
33553063|NCT00701103|62945624|FG002|Overall Study|Adverse Event|1|||
33553064|NCT00701103|62945625|FG003|Overall Study|Adverse Event|1|||
33553065|NCT00701103|62945626|FG004|Overall Study|Adverse Event|0|||
33553066|NCT00701103|62945627|FG005|Overall Study|Adverse Event|1|||
33658428|NCT01902173|63081756|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
33658429|NCT01902173|63081757|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
33658430|NCT01902173|63081758|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
33658431|NCT01902173|63081759|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
33658432|NCT01902173|63081760|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
33658433|NCT01902173|63081761|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
33658434|NCT01902173|63081756|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
33658435|NCT01902173|63081757|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
33658436|NCT01902173|63081758|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
33658437|NCT01902173|63081759|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
33658438|NCT01902173|63081760|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
33658439|NCT01902173|63081761|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
33553067|NCT00701103|62945628|FG006|Overall Study|Adverse Event|1|||
33553068|NCT00701103|62945629|FG007|Overall Study|Adverse Event|0|||
33553069|NCT00701103|62945630|FG008|Overall Study|Adverse Event|0|||
33553070|NCT00701103|62945631|FG009|Overall Study|Adverse Event|2|||
33553071|NCT00701103|62945632|FG010|Overall Study|Adverse Event|0|||
33482233|NCT03764475|62859035|FG001|Overall Study|COVID-19 Disruption|0|||
33482234|NCT02872012|62859050|FG000|Overall Study|Withdrawal by Subject|1|||
33482235|NCT02872012|62859051|FG001|Overall Study|Withdrawal by Subject|0|||
33482236|NCT02872012|62859052|FG002|Overall Study|Withdrawal by Subject|0|||
33482237|NCT02872012|62859053|FG003|Overall Study|Withdrawal by Subject|0|||
33482238|NCT02872012|62859054|FG004|Overall Study|Withdrawal by Subject|0|||
33553072|NCT00701103|62945622|FG000|Overall Study|Progressive Disease|5|||
33553073|NCT00701103|62945623|FG001|Overall Study|Progressive Disease|2|||
33553074|NCT00701103|62945624|FG002|Overall Study|Progressive Disease|6|||
33553075|NCT00701103|62945625|FG003|Overall Study|Progressive Disease|5|||
33553076|NCT00701103|62945626|FG004|Overall Study|Progressive Disease|6|||
33482239|NCT02959138|62859071|FG000|Overall Study|Enrolled but Never Treated|0|||
33482240|NCT02959138|62859072|FG001|Overall Study|Enrolled but Never Treated|1|||
33482241|NCT02959138|62859073|FG002|Overall Study|Enrolled but Never Treated|0|||
33482242|NCT01344226|62859085|FG000|Overall Study|Protocol Violation|2|||
33553077|NCT00701103|62945627|FG005|Overall Study|Progressive Disease|5|||
33553078|NCT00701103|62945628|FG006|Overall Study|Progressive Disease|7|||
33553079|NCT00701103|62945629|FG007|Overall Study|Progressive Disease|7|||
33658440|NCT01902173|63081756|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
33658441|NCT01902173|63081757|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
33658442|NCT01902173|63081758|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
33658443|NCT01902173|63081759|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
33658444|NCT01902173|63081760|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
33658445|NCT01902173|63081761|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
33658446|NCT01902173|63081756|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
33658447|NCT01902173|63081757|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
33658448|NCT01902173|63081758|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
33658449|NCT01902173|63081759|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
33658450|NCT01902173|63081760|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
33658451|NCT01902173|63081761|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
33658452|NCT01902173|63081756|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
33658453|NCT01902173|63081757|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
33658454|NCT01902173|63081758|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
33658455|NCT01902173|63081759|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
33658456|NCT01902173|63081760|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
33658457|NCT01902173|63081761|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
33658458|NCT01902173|63081756|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
33658459|NCT01902173|63081757|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
33658460|NCT01902173|63081758|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
33658461|NCT01902173|63081759|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
33658462|NCT01902173|63081760|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
33658463|NCT01902173|63081761|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
33658464|NCT01802281|63081780|FG000|Overall Study|Death|1|||
33658465|NCT01802281|63081781|FG001|Overall Study|Death|2|||
33658466|NCT01802281|63081780|FG000|Overall Study|Withdrawal by Subject|2|||
33658467|NCT01802281|63081781|FG001|Overall Study|Withdrawal by Subject|1|||
33658468|NCT01802281|63081780|FG000|Overall Study|Ineligible|5|||
33658469|NCT01802281|63081781|FG001|Overall Study|Ineligible|3|||
33658470|NCT01776840|63081789|FG000|Overall Study|Lost to Follow-up|4|||
33658471|NCT01776840|63081790|FG001|Overall Study|Lost to Follow-up|4|||
33658472|NCT01776840|63081789|FG000|Overall Study|Withdrawal by Subject|42|||
33658473|NCT01776840|63081790|FG001|Overall Study|Withdrawal by Subject|22|||
33658474|NCT01776840|63081789|FG000|Overall Study|Ongoing|112|||
33658475|NCT01776840|63081790|FG001|Overall Study|Ongoing|129|||
33658476|NCT01678898|63081813|FG000|PB-102-F01|Adverse Event|0|||
33658477|NCT01678898|63081814|FG001|PB-102-F01|Adverse Event|1|||
33658478|NCT01678898|63081815|FG002|PB-102-F01|Adverse Event|0|||
33658479|NCT01678898|63081813|FG000|PB-102-F01|Physician Decision|0|||
33658480|NCT01678898|63081814|FG001|PB-102-F01|Physician Decision|1|||
33658481|NCT01678898|63081815|FG002|PB-102-F01|Physician Decision|0|||
33658482|NCT01615029|63081837|FG000|Overall Study|Adverse Event|0|||
33658483|NCT01615029|63081838|FG001|Overall Study|Adverse Event|0|||
33364775|NCT02393248|62743307|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33482243|NCT01344226|62859085|FG000|Overall Study|Withdrawal by Subject|3|||
33482244|NCT01344226|62859085|FG000|Overall Study|Lack of Efficacy|3|||
33482245|NCT02869438|62859091|FG000|Overall Study|Lost to Follow-up|1|||
33482246|NCT02869438|62859092|FG001|Overall Study|Lost to Follow-up|0|||
33482247|NCT02869438|62859091|FG000|Overall Study|Adverse Event|1|||
33553080|NCT00701103|62945630|FG008|Overall Study|Progressive Disease|8|||
33553081|NCT00701103|62945631|FG009|Overall Study|Progressive Disease|8|||
33553082|NCT00701103|62945632|FG010|Overall Study|Progressive Disease|11|||
33553083|NCT00701103|62945622|FG000|Overall Study|Withdrawal by Subject|0|||
33553084|NCT00701103|62945623|FG001|Overall Study|Withdrawal by Subject|1|||
33553085|NCT00701103|62945624|FG002|Overall Study|Withdrawal by Subject|1|||
33553086|NCT00701103|62945625|FG003|Overall Study|Withdrawal by Subject|0|||
33553087|NCT00701103|62945626|FG004|Overall Study|Withdrawal by Subject|0|||
33553088|NCT00701103|62945627|FG005|Overall Study|Withdrawal by Subject|0|||
33553089|NCT00701103|62945628|FG006|Overall Study|Withdrawal by Subject|0|||
33553090|NCT00701103|62945629|FG007|Overall Study|Withdrawal by Subject|0|||
33553091|NCT00701103|62945630|FG008|Overall Study|Withdrawal by Subject|0|||
33553092|NCT00701103|62945631|FG009|Overall Study|Withdrawal by Subject|0|||
33553093|NCT00701103|62945632|FG010|Overall Study|Withdrawal by Subject|0|||
33553094|NCT00701103|62945622|FG000|Overall Study|Other|0|||
33553095|NCT00701103|62945623|FG001|Overall Study|Other|0|||
33553096|NCT00701103|62945624|FG002|Overall Study|Other|0|||
33553097|NCT00701103|62945625|FG003|Overall Study|Other|0|||
33553098|NCT00701103|62945626|FG004|Overall Study|Other|0|||
33553099|NCT00701103|62945627|FG005|Overall Study|Other|0|||
33553100|NCT00701103|62945628|FG006|Overall Study|Other|0|||
33553101|NCT00701103|62945629|FG007|Overall Study|Other|0|||
33553102|NCT00701103|62945630|FG008|Overall Study|Other|1|||
33553103|NCT00701103|62945631|FG009|Overall Study|Other|1|||
33553104|NCT00701103|62945632|FG010|Overall Study|Other|0|||
33553105|NCT01369225|62945666|FG000|Overall Study|Withdrawal by Subject|1|||
33553106|NCT01369225|62945667|FG001|Overall Study|Withdrawal by Subject|0|||
33553107|NCT01369225|62945668|FG002|Overall Study|Withdrawal by Subject|2|||
33553108|NCT01369225|62945669|FG003|Overall Study|Withdrawal by Subject|1|||
33553109|NCT01369225|62945670|FG004|Overall Study|Withdrawal by Subject|0|||
33553110|NCT01369225|62945671|FG005|Overall Study|Withdrawal by Subject|0|||
33553111|NCT01369225|62945666|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
33553112|NCT01369225|62945667|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
33553113|NCT01369225|62945668|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
33553114|NCT01369225|62945669|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
33553115|NCT01369225|62945670|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
33553116|NCT01369225|62945671|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
33553117|NCT01369225|62945666|FG000|Overall Study|Other|1|||
33553118|NCT01369225|62945667|FG001|Overall Study|Other|0|||
33553119|NCT01369225|62945668|FG002|Overall Study|Other|0|||
33553120|NCT01369225|62945669|FG003|Overall Study|Other|0|||
33553121|NCT01369225|62945670|FG004|Overall Study|Other|1|||
33553122|NCT01369225|62945671|FG005|Overall Study|Other|0|||
33553123|NCT01369225|62945666|FG000|Overall Study|Adverse Event|0|||
33553124|NCT01369225|62945667|FG001|Overall Study|Adverse Event|0|||
33553125|NCT01369225|62945668|FG002|Overall Study|Adverse Event|0|||
33553126|NCT01369225|62945669|FG003|Overall Study|Adverse Event|1|||
33553127|NCT01369225|62945670|FG004|Overall Study|Adverse Event|1|||
33553128|NCT01369225|62945671|FG005|Overall Study|Adverse Event|0|||
33482248|NCT02869438|62859092|FG001|Overall Study|Adverse Event|0|||
33482249|NCT02869438|62859091|FG000|Overall Study|Withdrawal by Subject|1|||
33553129|NCT02639546|62945693|FG000|Overall Study|Death|2|||
33482250|NCT02869438|62859092|FG001|Overall Study|Withdrawal by Subject|2|||
33482251|NCT02868892|62859098|FG000|Overall Study|Investigator left site and no follow-up|6|||
33553130|NCT02639546|62945694|FG001|Overall Study|Death|2|||
33553131|NCT02639546|62945695|FG002|Overall Study|Death|1|||
33553132|NCT02639546|62945696|FG003|Overall Study|Death|2|||
33553133|NCT02639546|62945697|FG004|Overall Study|Death|2|||
33553134|NCT02639546|62945698|FG005|Overall Study|Death|2|||
33553135|NCT02639546|62945699|FG006|Overall Study|Death|0|||
33553136|NCT02639546|62945700|FG007|Overall Study|Death|0|||
33553137|NCT02639546|62945693|FG000|Overall Study|Lost to Follow-up|0|||
33553138|NCT02639546|62945694|FG001|Overall Study|Lost to Follow-up|0|||
33658484|NCT01615029|63081839|FG002|Overall Study|Adverse Event|0|||
33658485|NCT01615029|63081840|FG003|Overall Study|Adverse Event|0|||
33658486|NCT01615029|63081841|FG004|Overall Study|Adverse Event|1|||
33658487|NCT01615029|63081837|FG000|Overall Study|Death|0|||
33658488|NCT01615029|63081838|FG001|Overall Study|Death|0|||
33658489|NCT01615029|63081839|FG002|Overall Study|Death|0|||
33658490|NCT01615029|63081840|FG003|Overall Study|Death|0|||
33658491|NCT01615029|63081841|FG004|Overall Study|Death|1|||
33658492|NCT01615029|63081837|FG000|Overall Study|Lost to Follow-up|0|||
33658493|NCT01615029|63081838|FG001|Overall Study|Lost to Follow-up|0|||
33658494|NCT01615029|63081839|FG002|Overall Study|Lost to Follow-up|0|||
33658495|NCT01615029|63081840|FG003|Overall Study|Lost to Follow-up|0|||
33658496|NCT01615029|63081841|FG004|Overall Study|Lost to Follow-up|1|||
33658497|NCT01615029|63081837|FG000|Overall Study|Progressive disease|2|||
33658498|NCT01615029|63081838|FG001|Overall Study|Progressive disease|1|||
33658499|NCT01615029|63081839|FG002|Overall Study|Progressive disease|1|||
33658500|NCT01615029|63081840|FG003|Overall Study|Progressive disease|1|||
33658501|NCT01615029|63081841|FG004|Overall Study|Progressive disease|5|||
33658502|NCT01615029|63081837|FG000|Overall Study|Physician Decision|0|||
33658503|NCT01615029|63081838|FG001|Overall Study|Physician Decision|0|||
33658504|NCT01615029|63081839|FG002|Overall Study|Physician Decision|0|||
33658505|NCT01615029|63081840|FG003|Overall Study|Physician Decision|0|||
33658506|NCT01615029|63081841|FG004|Overall Study|Physician Decision|1|||
33658507|NCT01615029|63081837|FG000|Overall Study|Ongoing|1|||
33658508|NCT01615029|63081838|FG001|Overall Study|Ongoing|2|||
33658509|NCT01615029|63081839|FG002|Overall Study|Ongoing|3|||
33658510|NCT01615029|63081840|FG003|Overall Study|Ongoing|2|||
33658511|NCT01615029|63081841|FG004|Overall Study|Ongoing|23|||
33658512|NCT01522976|63081856|FG000|Overall Study|Ineligible|4|||
33658513|NCT01522976|63081857|FG001|Overall Study|Ineligible|0|||
33658514|NCT01522976|63081858|FG002|Overall Study|Ineligible|1|||
33658515|NCT01522976|63081856|FG000|Overall Study|Death|7|||
33658516|NCT01522976|63081857|FG001|Overall Study|Death|6|||
33658517|NCT01522976|63081858|FG002|Overall Study|Death|2|||
33658518|NCT01522976|63081856|FG000|Overall Study|Still on treatment|9|||
33658519|NCT01522976|63081857|FG001|Overall Study|Still on treatment|9|||
33658520|NCT01522976|63081858|FG002|Overall Study|Still on treatment|6|||
33658521|NCT01522976|63081856|FG000|Overall Study|Disease progression|28|||
33658522|NCT01522976|63081857|FG001|Overall Study|Disease progression|30|||
33658523|NCT01522976|63081858|FG002|Overall Study|Disease progression|25|||
33658524|NCT01522976|63081856|FG000|Overall Study|Adverse Event|17|||
33658525|NCT01522976|63081857|FG001|Overall Study|Adverse Event|7|||
33658526|NCT01522976|63081858|FG002|Overall Study|Adverse Event|18|||
33658527|NCT01522976|63081856|FG000|Overall Study|Refusal unrelated to adverse event|10|||
33658528|NCT01522976|63081857|FG001|Overall Study|Refusal unrelated to adverse event|13|||
33658529|NCT01522976|63081858|FG002|Overall Study|Refusal unrelated to adverse event|14|||
33658530|NCT01522976|63081856|FG000|Overall Study|Not protocol specified|22|||
33658531|NCT01522976|63081857|FG001|Overall Study|Not protocol specified|27|||
33658532|NCT01522976|63081858|FG002|Overall Study|Not protocol specified|27|||
33658533|NCT01485861|63081879|FG000|Phase Ib|Death|1|||
33658534|NCT01485861|63081880|FG001|Phase Ib|Death|0|||
33658535|NCT01485861|63081881|FG002|Phase Ib|Death|0|||
33658536|NCT01485861|63081882|FG003|Phase Ib|Death|0|||
33658537|NCT01485861|63081883|FG004|Phase Ib|Death|0|||
33658538|NCT01485861|63081884|FG005|Phase Ib|Death|0|||
33658539|NCT01485861|63081879|FG000|Phase Ib|Physician Decision|1|||
33658540|NCT01485861|63081880|FG001|Phase Ib|Physician Decision|1|||
33658541|NCT01485861|63081881|FG002|Phase Ib|Physician Decision|0|||
33658542|NCT01485861|63081882|FG003|Phase Ib|Physician Decision|0|||
33364776|NCT02393248|62743308|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33658543|NCT01485861|63081883|FG004|Phase Ib|Physician Decision|0|||
33658544|NCT01485861|63081884|FG005|Phase Ib|Physician Decision|0|||
33658545|NCT01485861|63081879|FG000|Phase Ib|Adverse Event|0|||
33658546|NCT01485861|63081880|FG001|Phase Ib|Adverse Event|4|||
33658547|NCT01485861|63081881|FG002|Phase Ib|Adverse Event|0|||
33658548|NCT01485861|63081882|FG003|Phase Ib|Adverse Event|0|||
33658549|NCT01485861|63081883|FG004|Phase Ib|Adverse Event|0|||
33658550|NCT01485861|63081884|FG005|Phase Ib|Adverse Event|0|||
33658551|NCT01485861|63081879|FG000|Phase Ib|Progression of disease|5|||
33658552|NCT01485861|63081880|FG001|Phase Ib|Progression of disease|0|||
33482252|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Death|1|||
33658553|NCT01485861|63081881|FG002|Phase Ib|Progression of disease|0|||
33658554|NCT01485861|63081882|FG003|Phase Ib|Progression of disease|0|||
33658555|NCT01485861|63081883|FG004|Phase Ib|Progression of disease|0|||
33658556|NCT01485861|63081884|FG005|Phase Ib|Progression of disease|0|||
33658557|NCT01485861|63081879|FG000|Phase Ib|Other|3|||
33658558|NCT01485861|63081880|FG001|Phase Ib|Other|0|||
33658559|NCT01485861|63081881|FG002|Phase Ib|Other|0|||
33658560|NCT01485861|63081882|FG003|Phase Ib|Other|0|||
33658561|NCT01485861|63081883|FG004|Phase Ib|Other|0|||
33658562|NCT01485861|63081884|FG005|Phase Ib|Other|0|||
33658563|NCT01485861|63081879|FG000|Phase Ib|Withdrawal by Subject|4|||
33658564|NCT01485861|63081880|FG001|Phase Ib|Withdrawal by Subject|1|||
33658565|NCT01485861|63081881|FG002|Phase Ib|Withdrawal by Subject|0|||
33658566|NCT01485861|63081882|FG003|Phase Ib|Withdrawal by Subject|0|||
33658567|NCT01485861|63081883|FG004|Phase Ib|Withdrawal by Subject|0|||
33658568|NCT01485861|63081884|FG005|Phase Ib|Withdrawal by Subject|0|||
33658569|NCT01485861|63081879|FG000|Phase II|Death|0|||
33658570|NCT01485861|63081880|FG001|Phase II|Death|0|||
33658571|NCT01485861|63081881|FG002|Phase II|Death|67|||
33658572|NCT01485861|63081882|FG003|Phase II|Death|71|||
33658573|NCT01485861|63081883|FG004|Phase II|Death|68|||
33658574|NCT01485861|63081884|FG005|Phase II|Death|0|||
33658575|NCT01485861|63081879|FG000|Phase II|Progression of Disease|0|||
33658576|NCT01485861|63081880|FG001|Phase II|Progression of Disease|0|||
33658577|NCT01485861|63081881|FG002|Phase II|Progression of Disease|1|||
33658578|NCT01485861|63081882|FG003|Phase II|Progression of Disease|0|||
33658579|NCT01485861|63081883|FG004|Phase II|Progression of Disease|0|||
33658580|NCT01485861|63081884|FG005|Phase II|Progression of Disease|0|||
33658581|NCT01485861|63081879|FG000|Phase II|Other|0|||
33658582|NCT01485861|63081880|FG001|Phase II|Other|0|||
33658583|NCT01485861|63081881|FG002|Phase II|Other|0|||
33658584|NCT01485861|63081882|FG003|Phase II|Other|1|||
33658585|NCT01485861|63081883|FG004|Phase II|Other|0|||
33658586|NCT01485861|63081884|FG005|Phase II|Other|0|||
33658587|NCT01485861|63081879|FG000|Phase II|Withdrawal by Subject|0|||
33658588|NCT01485861|63081880|FG001|Phase II|Withdrawal by Subject|0|||
33658589|NCT01485861|63081881|FG002|Phase II|Withdrawal by Subject|6|||
33658590|NCT01485861|63081882|FG003|Phase II|Withdrawal by Subject|3|||
33658591|NCT01485861|63081883|FG004|Phase II|Withdrawal by Subject|4|||
33658592|NCT01485861|63081884|FG005|Phase II|Withdrawal by Subject|0|||
33658593|NCT01485861|63081879|FG000|Phase II|Lost to Follow-up|0|||
33658594|NCT01485861|63081880|FG001|Phase II|Lost to Follow-up|0|||
33658595|NCT01485861|63081881|FG002|Phase II|Lost to Follow-up|2|||
33658596|NCT01485861|63081882|FG003|Phase II|Lost to Follow-up|3|||
33658597|NCT01485861|63081883|FG004|Phase II|Lost to Follow-up|5|||
33658598|NCT01485861|63081884|FG005|Phase II|Lost to Follow-up|0|||
33658599|NCT01485861|63081879|FG000|Phase II|Study Ended|0|||
33658600|NCT01485861|63081880|FG001|Phase II|Study Ended|0|||
33658601|NCT01485861|63081881|FG002|Phase II|Study Ended|7|||
33658602|NCT01485861|63081882|FG003|Phase II|Study Ended|8|||
33658603|NCT01485861|63081883|FG004|Phase II|Study Ended|6|||
33658604|NCT01485861|63081884|FG005|Phase II|Study Ended|0|||
33658605|NCT01485861|63081879|FG000|Safety Phase|Death|0|||
33658606|NCT01485861|63081880|FG001|Safety Phase|Death|0|||
33658607|NCT01485861|63081881|FG002|Safety Phase|Death|0|||
33658608|NCT01485861|63081882|FG003|Safety Phase|Death|0|||
33658609|NCT01485861|63081883|FG004|Safety Phase|Death|0|||
33658610|NCT01485861|63081884|FG005|Safety Phase|Death|2|||
33658611|NCT01485861|63081879|FG000|Safety Phase|Adverse Event|0|||
33658612|NCT01485861|63081880|FG001|Safety Phase|Adverse Event|0|||
33658613|NCT01485861|63081881|FG002|Safety Phase|Adverse Event|0|||
33658614|NCT01485861|63081882|FG003|Safety Phase|Adverse Event|0|||
33658615|NCT01485861|63081883|FG004|Safety Phase|Adverse Event|0|||
33658616|NCT01485861|63081884|FG005|Safety Phase|Adverse Event|1|||
33658617|NCT01485861|63081879|FG000|Safety Phase|Other|0|||
33658618|NCT01485861|63081880|FG001|Safety Phase|Other|0|||
33482253|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Death|1|||
33482254|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Death|0|||
33482255|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Death|0|||
33482256|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Death|1|||
33482257|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Death|0|||
33482258|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Death|0|||
33482259|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Death|0|||
33482260|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Death|0|||
33658619|NCT01485861|63081881|FG002|Safety Phase|Other|0|||
33658620|NCT01485861|63081882|FG003|Safety Phase|Other|0|||
33658621|NCT01485861|63081883|FG004|Safety Phase|Other|0|||
33658622|NCT01485861|63081884|FG005|Safety Phase|Other|5|||
33658623|NCT01485861|63081879|FG000|Safety Phase|Progression of Disease|0|||
33658624|NCT01485861|63081880|FG001|Safety Phase|Progression of Disease|0|||
33658625|NCT01485861|63081881|FG002|Safety Phase|Progression of Disease|0|||
33658626|NCT01485861|63081882|FG003|Safety Phase|Progression of Disease|0|||
33658627|NCT01485861|63081883|FG004|Safety Phase|Progression of Disease|0|||
33658628|NCT01485861|63081884|FG005|Safety Phase|Progression of Disease|9|||
33658629|NCT01485861|63081879|FG000|Safety Phase|Withdrawal by Subject|0|||
33658630|NCT01485861|63081880|FG001|Safety Phase|Withdrawal by Subject|0|||
33482261|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Death|0|||
33658631|NCT01485861|63081881|FG002|Safety Phase|Withdrawal by Subject|0|||
33658632|NCT01485861|63081882|FG003|Safety Phase|Withdrawal by Subject|0|||
33658633|NCT01485861|63081883|FG004|Safety Phase|Withdrawal by Subject|0|||
33658634|NCT01485861|63081884|FG005|Safety Phase|Withdrawal by Subject|6|||
33658635|NCT01485861|63081879|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
33658636|NCT01485861|63081880|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
33658637|NCT01485861|63081881|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
33658638|NCT01485861|63081882|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
33658639|NCT01485861|63081883|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
33658640|NCT01485861|63081884|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
33658641|NCT01386385|63081903|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
33658642|NCT01386385|63081904|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
33658643|NCT01386385|63081905|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
33658644|NCT01386385|63081906|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
33658645|NCT01386385|63081907|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
33658646|NCT01386385|63081908|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
33658647|NCT01386385|63081909|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
33658648|NCT01386385|63081910|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
33658649|NCT01386385|63081903|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
33658650|NCT01386385|63081904|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
33658651|NCT01386385|63081905|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
33658652|NCT01386385|63081906|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
33658653|NCT01386385|63081907|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
33658654|NCT01386385|63081908|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
33658655|NCT01386385|63081909|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
33658656|NCT01386385|63081910|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
33658657|NCT01386385|63081903|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
33658658|NCT01386385|63081904|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
33658659|NCT01386385|63081905|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
33658660|NCT01386385|63081906|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
33658661|NCT01386385|63081907|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
33658662|NCT01386385|63081908|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
33658663|NCT01386385|63081909|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
33482262|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
33482263|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
33482264|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
33482265|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
33482266|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
33482267|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
33482268|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
33482269|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
33658664|NCT01386385|63081910|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
33658665|NCT01386385|63081903|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
33658666|NCT01386385|63081904|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
33658667|NCT01386385|63081905|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
33658668|NCT01386385|63081906|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
33658669|NCT01386385|63081907|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
33482270|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
33482271|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
33482272|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33658670|NCT01386385|63081908|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
33658671|NCT01386385|63081909|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
33658672|NCT01386385|63081910|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
33658673|NCT01386385|63081903|FG000|Phase II Concurrent CRT|Adverse Event|0|||
33658674|NCT01386385|63081904|FG001|Phase II Concurrent CRT|Adverse Event|0|||
33658675|NCT01386385|63081905|FG002|Phase II Concurrent CRT|Adverse Event|0|||
33364777|NCT02393248|62743309|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364778|NCT02393248|62743310|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33658676|NCT01386385|63081906|FG003|Phase II Concurrent CRT|Adverse Event|0|||
33658677|NCT01386385|63081907|FG004|Phase II Concurrent CRT|Adverse Event|0|||
33658678|NCT01386385|63081908|FG005|Phase II Concurrent CRT|Adverse Event|0|||
33658679|NCT01386385|63081909|FG006|Phase II Concurrent CRT|Adverse Event|3|||
33658680|NCT01386385|63081910|FG007|Phase II Concurrent CRT|Adverse Event|3|||
33658681|NCT01386385|63081903|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
33658682|NCT01386385|63081904|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
33658683|NCT01386385|63081905|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
33658684|NCT01386385|63081906|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
33658685|NCT01386385|63081907|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
33658686|NCT01386385|63081908|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
33658687|NCT01386385|63081909|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
33658688|NCT01386385|63081910|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
33658689|NCT01386385|63081903|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
33658690|NCT01386385|63081904|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
33658691|NCT01386385|63081905|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
33658692|NCT01386385|63081906|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
33364779|NCT02393248|62743311|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33553139|NCT02639546|62945695|FG002|Overall Study|Lost to Follow-up|1|||
33658693|NCT01386385|63081907|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
33658694|NCT01386385|63081908|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
33658695|NCT01386385|63081909|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
33658696|NCT01386385|63081910|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
33658697|NCT01386385|63081903|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
33658698|NCT01386385|63081904|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
33658699|NCT01386385|63081905|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
33658700|NCT01386385|63081906|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
33658701|NCT01386385|63081907|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
33658702|NCT01386385|63081908|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
33658703|NCT01386385|63081909|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
33658704|NCT01386385|63081910|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
33658705|NCT01386385|63081903|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
33658706|NCT01386385|63081904|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
33658707|NCT01386385|63081905|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
33658708|NCT01386385|63081906|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
33658709|NCT01386385|63081907|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
33658710|NCT01386385|63081908|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
33553140|NCT02639546|62945696|FG003|Overall Study|Lost to Follow-up|0|||
33553141|NCT02639546|62945697|FG004|Overall Study|Lost to Follow-up|1|||
33553142|NCT02639546|62945698|FG005|Overall Study|Lost to Follow-up|1|||
33553143|NCT02639546|62945699|FG006|Overall Study|Lost to Follow-up|0|||
33553144|NCT02639546|62945700|FG007|Overall Study|Lost to Follow-up|1|||
33553145|NCT02639546|62945693|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
33553146|NCT02639546|62945694|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
33553147|NCT02639546|62945695|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
33553148|NCT02639546|62945696|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
33553149|NCT02639546|62945697|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
33553150|NCT02639546|62945698|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
33553151|NCT02639546|62945699|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
33553152|NCT02639546|62945700|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
33553153|NCT02639546|62945693|FG000|Overall Study|Study Terminated By Sponsor|0|||
33553154|NCT02639546|62945694|FG001|Overall Study|Study Terminated By Sponsor|2|||
33553155|NCT02639546|62945695|FG002|Overall Study|Study Terminated By Sponsor|3|||
33553156|NCT02639546|62945696|FG003|Overall Study|Study Terminated By Sponsor|4|||
33553157|NCT02639546|62945697|FG004|Overall Study|Study Terminated By Sponsor|4|||
33658711|NCT01386385|63081909|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
33658712|NCT01386385|63081910|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
33658713|NCT01314118|63081931|FG000|Overall Study|Adverse Event|9|||
33658714|NCT01314118|63081931|FG000|Overall Study|Progressive disease|27|||
33658715|NCT01314118|63081931|FG000|Overall Study|Physician Decision|11|||
33658716|NCT01314118|63081931|FG000|Overall Study|Death|4|||
33658717|NCT01314118|63081931|FG000|Overall Study|Protocol Violation|5|||
33658718|NCT01314118|63081931|FG000|Overall Study|Withdrawal by Subject|11|||
33553158|NCT02639546|62945698|FG005|Overall Study|Study Terminated By Sponsor|3|||
33553159|NCT02639546|62945699|FG006|Overall Study|Study Terminated By Sponsor|3|||
33553160|NCT02639546|62945700|FG007|Overall Study|Study Terminated By Sponsor|9|||
33553161|NCT02639546|62945693|FG000|Overall Study|Withdrawal by Subject|2|||
33553162|NCT02639546|62945694|FG001|Overall Study|Withdrawal by Subject|2|||
33553163|NCT02639546|62945695|FG002|Overall Study|Withdrawal by Subject|1|||
33553164|NCT02639546|62945696|FG003|Overall Study|Withdrawal by Subject|0|||
33553165|NCT02639546|62945697|FG004|Overall Study|Withdrawal by Subject|0|||
33553166|NCT02639546|62945698|FG005|Overall Study|Withdrawal by Subject|1|||
33553167|NCT02639546|62945699|FG006|Overall Study|Withdrawal by Subject|2|||
33658719|NCT01314118|63081931|FG000|Overall Study|Other|2|||
33658720|NCT01314118|63081931|FG000|Overall Study|Ongoing|62|||
33658721|NCT01275677|63081937|FG000|Overall Study|Not at risk for recurrence.|1|||
33658722|NCT01275677|63081938|FG001|Overall Study|Not at risk for recurrence.|1|||
33553168|NCT02639546|62945700|FG007|Overall Study|Withdrawal by Subject|1|||
33553169|NCT02639390|62945734|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
33658723|NCT01275677|63081937|FG000|Overall Study|No follow-up|26|||
33658724|NCT01275677|63081938|FG001|Overall Study|No follow-up|37|||
33658725|NCT01275677|63081937|FG000|Overall Study|No clinical follow up.|1|||
33658726|NCT01275677|63081938|FG001|Overall Study|No clinical follow up.|4|||
33553170|NCT02639390|62945735|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
33553171|NCT02718417|62945744|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
33553172|NCT02718417|62945745|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
33553173|NCT02718417|62945746|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
33553174|NCT02718417|62945744|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
33553175|NCT02718417|62945745|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
33553176|NCT02718417|62945746|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
33658727|NCT01274338|63081950|FG000|Overall Study|Lack of Efficacy|72|||
33658728|NCT01274338|63081951|FG001|Overall Study|Lack of Efficacy|108|||
33658729|NCT01274338|63081952|FG002|Overall Study|Lack of Efficacy|116|||
33658730|NCT01274338|63081953|FG003|Overall Study|Lack of Efficacy|0|||
33658731|NCT01274338|63081954|FG004|Overall Study|Lack of Efficacy|0|||
33658732|NCT01274338|63081955|FG005|Overall Study|Lack of Efficacy|0|||
33658733|NCT01274338|63081950|FG000|Overall Study|Adverse Event|272|||
33658734|NCT01274338|63081951|FG001|Overall Study|Adverse Event|105|||
33658735|NCT01274338|63081952|FG002|Overall Study|Adverse Event|180|||
33482273|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33482274|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33482275|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33482276|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
33482277|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33482278|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33482279|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33482280|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33482281|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33482282|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
33482283|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33482284|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33482285|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33553177|NCT02718417|62945744|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
33553178|NCT02718417|62945745|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
33553179|NCT02718417|62945746|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
33658736|NCT01274338|63081953|FG003|Overall Study|Adverse Event|1|||
33658737|NCT01274338|63081954|FG004|Overall Study|Adverse Event|0|||
33658738|NCT01274338|63081955|FG005|Overall Study|Adverse Event|0|||
33658739|NCT01274338|63081950|FG000|Overall Study|Death|8|||
33658740|NCT01274338|63081951|FG001|Overall Study|Death|1|||
33658741|NCT01274338|63081952|FG002|Overall Study|Death|0|||
33658742|NCT01274338|63081953|FG003|Overall Study|Death|0|||
33658743|NCT01274338|63081954|FG004|Overall Study|Death|0|||
33658744|NCT01274338|63081955|FG005|Overall Study|Death|0|||
33658745|NCT01274338|63081950|FG000|Overall Study|Withdrawal by Subject|27|||
33482286|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33482287|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33482288|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33553180|NCT02718417|62945744|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
33553181|NCT02718417|62945745|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
33658746|NCT01274338|63081951|FG001|Overall Study|Withdrawal by Subject|99|||
33658747|NCT01274338|63081952|FG002|Overall Study|Withdrawal by Subject|17|||
33658748|NCT01274338|63081953|FG003|Overall Study|Withdrawal by Subject|0|||
33658749|NCT01274338|63081954|FG004|Overall Study|Withdrawal by Subject|0|||
33658750|NCT01274338|63081955|FG005|Overall Study|Withdrawal by Subject|0|||
33658751|NCT01274338|63081950|FG000|Overall Study|Did not start treatment|8|||
33553182|NCT02718417|62945746|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
33553183|NCT02718417|62945744|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
33553184|NCT02718417|62945745|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
33553185|NCT02718417|62945746|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
33553186|NCT02718417|62945744|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
33553187|NCT02718417|62945745|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
33553188|NCT02718417|62945746|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
33658752|NCT01274338|63081951|FG001|Overall Study|Did not start treatment|116|||
33482289|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33482290|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33482291|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33482292|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
33553189|NCT02718417|62945744|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
33553190|NCT02718417|62945745|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
33553191|NCT02718417|62945746|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
33553192|NCT02718417|62945744|FG000|Chemotherapy Phase (CP)|Other|2|||
33553193|NCT02718417|62945745|FG001|Chemotherapy Phase (CP)|Other|0|||
33553194|NCT02718417|62945746|FG002|Chemotherapy Phase (CP)|Other|1|||
33658753|NCT01274338|63081952|FG002|Overall Study|Did not start treatment|7|||
33658754|NCT01274338|63081953|FG003|Overall Study|Did not start treatment|0|||
33658755|NCT01274338|63081954|FG004|Overall Study|Did not start treatment|0|||
33658756|NCT01274338|63081955|FG005|Overall Study|Did not start treatment|0|||
33658757|NCT01274338|63081950|FG000|Overall Study|Alternative therapy|0|||
33658758|NCT01274338|63081951|FG001|Overall Study|Alternative therapy|1|||
33658759|NCT01274338|63081952|FG002|Overall Study|Alternative therapy|0|||
33658760|NCT01274338|63081953|FG003|Overall Study|Alternative therapy|0|||
33658761|NCT01274338|63081954|FG004|Overall Study|Alternative therapy|0|||
33658762|NCT01274338|63081955|FG005|Overall Study|Alternative therapy|0|||
33658763|NCT01274338|63081950|FG000|Overall Study|Other complicating diseases|0|||
33658764|NCT01274338|63081951|FG001|Overall Study|Other complicating diseases|3|||
33658765|NCT01274338|63081952|FG002|Overall Study|Other complicating diseases|1|||
33658766|NCT01274338|63081953|FG003|Overall Study|Other complicating diseases|0|||
33658767|NCT01274338|63081954|FG004|Overall Study|Other complicating diseases|0|||
33658768|NCT01274338|63081955|FG005|Overall Study|Other complicating diseases|0|||
33658769|NCT01274338|63081950|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
33553195|NCT02718417|62945744|FG000|Maintenance Phase (MP)|Adverse Event|21|||
33553196|NCT02718417|62945745|FG001|Maintenance Phase (MP)|Adverse Event|26|||
33553197|NCT02718417|62945746|FG002|Maintenance Phase (MP)|Adverse Event|0|||
33553198|NCT02718417|62945744|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
33658770|NCT01274338|63081951|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
33658771|NCT01274338|63081952|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
33658772|NCT01274338|63081953|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
33658773|NCT01274338|63081954|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
33658774|NCT01274338|63081955|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
33658775|NCT01274338|63081950|FG000|Overall Study|Pregnancy|0|||
33658776|NCT01274338|63081951|FG001|Overall Study|Pregnancy|0|||
33658777|NCT01274338|63081952|FG002|Overall Study|Pregnancy|1|||
33658778|NCT01274338|63081953|FG003|Overall Study|Pregnancy|0|||
33658779|NCT01274338|63081954|FG004|Overall Study|Pregnancy|0|||
33658780|NCT01274338|63081955|FG005|Overall Study|Pregnancy|0|||
33658781|NCT01274338|63081950|FG000|Overall Study|Reason not reported|12|||
33658782|NCT01274338|63081951|FG001|Overall Study|Reason not reported|21|||
33658783|NCT01274338|63081952|FG002|Overall Study|Reason not reported|3|||
33658784|NCT01274338|63081953|FG003|Overall Study|Reason not reported|0|||
33658785|NCT01274338|63081954|FG004|Overall Study|Reason not reported|1|||
33658786|NCT01274338|63081955|FG005|Overall Study|Reason not reported|0|||
33658787|NCT01171898|63081990|FG000|Overall Study|Death|0|||
33658788|NCT01171898|63081991|FG001|Overall Study|Death|0|||
33553199|NCT02718417|62945745|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
33553200|NCT02718417|62945746|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
33553201|NCT02718417|62945744|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
33553202|NCT02718417|62945745|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
33658789|NCT01171898|63081992|FG002|Overall Study|Death|2|||
33658790|NCT01171898|63081993|FG003|Overall Study|Death|0|||
33658791|NCT01171898|63081990|FG000|Overall Study|Lost to Follow-up|0|||
33658792|NCT01171898|63081991|FG001|Overall Study|Lost to Follow-up|1|||
33658793|NCT01171898|63081992|FG002|Overall Study|Lost to Follow-up|1|||
33658794|NCT01171898|63081993|FG003|Overall Study|Lost to Follow-up|1|||
33658795|NCT01171898|63081990|FG000|Overall Study|Withdrawal by Subject|1|||
33658796|NCT01171898|63081991|FG001|Overall Study|Withdrawal by Subject|4|||
33658797|NCT01171898|63081992|FG002|Overall Study|Withdrawal by Subject|6|||
33482293|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
33482294|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
33482295|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
33482296|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
33482297|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
33482298|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
33482299|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
33482300|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
33482301|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
33482302|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
33482303|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33482304|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33482305|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
33482306|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33658798|NCT01171898|63081993|FG003|Overall Study|Withdrawal by Subject|3|||
33658799|NCT01171898|63081990|FG000|Overall Study|Terminated by Sponsor|1|||
33658800|NCT01171898|63081991|FG001|Overall Study|Terminated by Sponsor|0|||
33658801|NCT01171898|63081992|FG002|Overall Study|Terminated by Sponsor|0|||
33658802|NCT01171898|63081993|FG003|Overall Study|Terminated by Sponsor|0|||
33658803|NCT01171898|63081990|FG000|Overall Study|Ongoing|1|||
33658804|NCT01171898|63081991|FG001|Overall Study|Ongoing|9|||
33658805|NCT01171898|63081992|FG002|Overall Study|Ongoing|3|||
33553203|NCT02718417|62945746|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
33658806|NCT01171898|63081993|FG003|Overall Study|Ongoing|0|||
33658807|NCT01171898|63081990|FG000|Overall Study|Other|1|||
33553204|NCT02718417|62945744|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
33553205|NCT02718417|62945745|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
33553206|NCT02718417|62945746|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
33553207|NCT02718417|62945744|FG000|Maintenance Phase (MP)|Physician's decision|6|||
33553208|NCT02718417|62945745|FG001|Maintenance Phase (MP)|Physician's decision|7|||
33553209|NCT02718417|62945746|FG002|Maintenance Phase (MP)|Physician's decision|0|||
33553210|NCT02718417|62945744|FG000|Maintenance Phase (MP)|Progressive disease|100|||
33553211|NCT02718417|62945745|FG001|Maintenance Phase (MP)|Progressive disease|88|||
33553212|NCT02718417|62945746|FG002|Maintenance Phase (MP)|Progressive disease|0|||
33553213|NCT02718417|62945744|FG000|Maintenance Phase (MP)|Other|2|||
33553214|NCT02718417|62945745|FG001|Maintenance Phase (MP)|Other|1|||
33553215|NCT02718417|62945746|FG002|Maintenance Phase (MP)|Other|0|||
33553216|NCT02718417|62945744|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
33553217|NCT02718417|62945745|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
33553218|NCT02718417|62945746|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
33553219|NCT02718417|62945744|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
33553220|NCT02718417|62945745|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
33553221|NCT02718417|62945746|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
33553222|NCT02718417|62945744|FG000|Observation Phase (OP)|Adverse Event|0|||
33553223|NCT02718417|62945745|FG001|Observation Phase (OP)|Adverse Event|0|||
33553224|NCT02718417|62945746|FG002|Observation Phase (OP)|Adverse Event|1|||
33553225|NCT02718417|62945744|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
33553226|NCT02718417|62945745|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
33553227|NCT02718417|62945746|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
33658808|NCT01171898|63081991|FG001|Overall Study|Other|5|||
33658809|NCT01171898|63081992|FG002|Overall Study|Other|0|||
33658810|NCT01171898|63081993|FG003|Overall Study|Other|2|||
33482307|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33482308|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33482309|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33482310|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33482311|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33482312|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
33482313|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
33658811|NCT01169337|63082009|FG000|Overall Study|Lack of Efficacy|5|||
33658812|NCT01169337|63082010|FG001|Overall Study|Lack of Efficacy|7|||
33658813|NCT01169337|63082011|FG002|Overall Study|Lack of Efficacy|0|||
33658814|NCT01169337|63082009|FG000|Overall Study|Adverse Event|12|||
33658815|NCT01169337|63082010|FG001|Overall Study|Adverse Event|18|||
33658816|NCT01169337|63082011|FG002|Overall Study|Adverse Event|0|||
33658817|NCT01169337|63082009|FG000|Overall Study|Death|2|||
33658818|NCT01169337|63082010|FG001|Overall Study|Death|0|||
33658819|NCT01169337|63082011|FG002|Overall Study|Death|0|||
33658820|NCT01169337|63082009|FG000|Overall Study|Withdrawal by Subject|11|||
33658821|NCT01169337|63082010|FG001|Overall Study|Withdrawal by Subject|11|||
33658822|NCT01169337|63082011|FG002|Overall Study|Withdrawal by Subject|6|||
33658823|NCT01169337|63082009|FG000|Overall Study|Noncompliance|2|||
33658824|NCT01169337|63082010|FG001|Overall Study|Noncompliance|0|||
33658825|NCT01169337|63082011|FG002|Overall Study|Noncompliance|0|||
33658826|NCT01169337|63082009|FG000|Overall Study|Other complicating disease|1|||
33658827|NCT01169337|63082010|FG001|Overall Study|Other complicating disease|1|||
33658828|NCT01169337|63082011|FG002|Overall Study|Other complicating disease|0|||
33658829|NCT01169337|63082009|FG000|Overall Study|Physician Decision|1|||
33658830|NCT01169337|63082010|FG001|Overall Study|Physician Decision|5|||
33658831|NCT01169337|63082011|FG002|Overall Study|Physician Decision|0|||
33658832|NCT01169337|63082009|FG000|Overall Study|Alternative therapy|0|||
33658833|NCT01169337|63082010|FG001|Overall Study|Alternative therapy|2|||
33658834|NCT01169337|63082011|FG002|Overall Study|Alternative therapy|0|||
33553228|NCT02718417|62945744|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
33553229|NCT02718417|62945745|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
33364780|NCT02393248|62743312|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33482314|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
33482315|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
33482316|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
33482317|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
33482318|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
33482319|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
33482320|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
33482321|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
33553230|NCT02718417|62945746|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
33553231|NCT02718417|62945744|FG000|Observation Phase (OP)|Physician Decision|0|||
33580924|NCT01326312|62978077|FG000|Overall Study|Adverse Event|11|||
33580925|NCT01326312|62978078|FG001|Overall Study|Adverse Event|11|||
33580926|NCT01326312|62978079|FG002|Overall Study|Adverse Event|1|||
33580927|NCT01326312|62978077|FG000|Overall Study|Withdrawal by Subject|1|||
33580928|NCT01326312|62978078|FG001|Overall Study|Withdrawal by Subject|2|||
33580929|NCT01326312|62978079|FG002|Overall Study|Withdrawal by Subject|1|||
33580930|NCT01326312|62978077|FG000|Overall Study|Protocol Violation|0|||
33580931|NCT01326312|62978078|FG001|Overall Study|Protocol Violation|1|||
33580932|NCT01326312|62978079|FG002|Overall Study|Protocol Violation|0|||
33580933|NCT01326312|62978077|FG000|Overall Study|Lack of Efficacy|13|||
33580934|NCT01326312|62978078|FG001|Overall Study|Lack of Efficacy|7|||
33580935|NCT01326312|62978079|FG002|Overall Study|Lack of Efficacy|1|||
33580936|NCT01326312|62978077|FG000|Overall Study|Death|1|||
33580937|NCT01326312|62978078|FG001|Overall Study|Death|0|||
33580938|NCT01326312|62978079|FG002|Overall Study|Death|1|||
33580939|NCT01326312|62978077|FG000|Overall Study|progressive disease|0|||
33580940|NCT01326312|62978078|FG001|Overall Study|progressive disease|1|||
33580941|NCT01326312|62978079|FG002|Overall Study|progressive disease|1|||
33580942|NCT01326312|62978077|FG000|Overall Study|Study terminated by Sponsor|8|||
33580943|NCT01326312|62978078|FG001|Overall Study|Study terminated by Sponsor|32|||
33580944|NCT01326312|62978079|FG002|Overall Study|Study terminated by Sponsor|46|||
33580945|NCT01326312|62978077|FG000|Overall Study|Treatment arm terminated|19|||
33580946|NCT01326312|62978078|FG001|Overall Study|Treatment arm terminated|0|||
33580947|NCT01326312|62978079|FG002|Overall Study|Treatment arm terminated|0|||
33580948|NCT01326312|62978077|FG000|Overall Study|QTc > 500|0|||
33580949|NCT01326312|62978078|FG001|Overall Study|QTc > 500|1|||
33580950|NCT01326312|62978079|FG002|Overall Study|QTc > 500|0|||
33580951|NCT01269346|62978101|FG000|Treatment Phase|Disease progression|3|||
33580952|NCT01269346|62978101|FG000|Treatment Phase|Adverse Event|3|||
33580953|NCT01269346|62978101|FG000|Treatment Phase|Withdrawal by Subject|1|||
33580954|NCT01269346|62978101|FG000|Treatment Phase|Other|2|||
33580955|NCT01269346|62978101|FG000|Extension Phase|Adverse Event|6|||
33580956|NCT01269346|62978101|FG000|Extension Phase|Withdrawal by Subject|4|||
33580957|NCT01269346|62978101|FG000|Extension Phase|Disease progression|22|||
33580958|NCT01269346|62978101|FG000|Extension Phase|Physician decision or participant choice|9|||
33580959|NCT01269346|62978101|FG000|Extension Phase|Clinical progression|1|||
33580960|NCT01269346|62978101|FG000|Extension Phase|Started a prohibited con med|1|||
33482322|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
33482323|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
33482324|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
33482325|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33482326|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
33482327|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33482328|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33482329|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33553232|NCT02718417|62945745|FG001|Observation Phase (OP)|Physician Decision|0|||
33553233|NCT02718417|62945746|FG002|Observation Phase (OP)|Physician Decision|9|||
33553234|NCT02718417|62945744|FG000|Observation Phase (OP)|Progressive disease|0|||
33553235|NCT02718417|62945745|FG001|Observation Phase (OP)|Progressive disease|0|||
33553236|NCT02718417|62945746|FG002|Observation Phase (OP)|Progressive disease|92|||
33553237|NCT02718417|62945744|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
33553238|NCT02718417|62945745|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
33553239|NCT02718417|62945746|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
33553240|NCT02718417|62945744|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
33553241|NCT02718417|62945745|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
33553242|NCT02718417|62945746|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
33553243|NCT02718417|62945744|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
33553244|NCT02718417|62945745|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
33553245|NCT02718417|62945746|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
33553246|NCT02718417|62945744|FG000|Observation Phase (OP)|Other|0|||
33553247|NCT02718417|62945745|FG001|Observation Phase (OP)|Other|0|||
33553248|NCT02718417|62945746|FG002|Observation Phase (OP)|Other|7|||
33658835|NCT01169337|63082009|FG000|Overall Study|Changed hospital|0|||
33658836|NCT01169337|63082010|FG001|Overall Study|Changed hospital|1|||
33658837|NCT01169337|63082011|FG002|Overall Study|Changed hospital|0|||
33658838|NCT01169337|63082009|FG000|Overall Study|Never started treatment|0|||
33658839|NCT01169337|63082010|FG001|Overall Study|Never started treatment|2|||
33658840|NCT01169337|63082011|FG002|Overall Study|Never started treatment|0|||
33658841|NCT01169337|63082009|FG000|Overall Study|Reason not reported|1|||
33658842|NCT01169337|63082010|FG001|Overall Study|Reason not reported|0|||
33658843|NCT01169337|63082011|FG002|Overall Study|Reason not reported|0|||
33658844|NCT01169337|63082009|FG000|Overall Study|Continuing lenalidomide|9|||
33658845|NCT01169337|63082010|FG001|Overall Study|Continuing lenalidomide|43|||
33658846|NCT01169337|63082011|FG002|Overall Study|Continuing lenalidomide|0|||
33658847|NCT01101438|63082030|FG000|Overall Study|Withdrawal by Subject|8|||
33658848|NCT01101438|63082031|FG001|Overall Study|Withdrawal by Subject|9|||
33658849|NCT00980538|63082058|FG000|Overall Study|Lost to Follow-up|20|||
33658850|NCT00980538|63082058|FG000|Overall Study|Sponsor's Decision|4|||
33658851|NCT00980538|63082058|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
33658852|NCT00980538|63082058|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
33658853|NCT00980538|63082058|FG000|Overall Study|Switch to Commercially Available Medication|25|||
33658854|NCT00980538|63082058|FG000|Overall Study|Participant Non-Compliant|9|||
33658855|NCT00980538|63082058|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
33658856|NCT00980538|63082058|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
33658857|NCT00980538|63082058|FG000|Overall Study|Other|60|||
33658858|NCT00980538|63082058|FG000|Overall Study|Other|1|||
33658859|NCT00977574|63082065|FG000|Overall Study|Never Treated|4|||
33658860|NCT00977574|63082066|FG001|Overall Study|Never Treated|2|||
33658861|NCT00977574|63082067|FG002|Overall Study|Never Treated|4|||
33658862|NCT00966979|63082075|FG000|Overall Study|Death|1|||
33658863|NCT00966979|63082075|FG000|Overall Study|Lost to Follow-up|6|||
33658864|NCT00966979|63082075|FG000|Overall Study|Withdrawal by Subject|14|||
33658865|NCT00966979|63082075|FG000|Overall Study|Adverse Event|5|||
33658866|NCT00966979|63082075|FG000|Overall Study|Sponsor terminated early|49|||
33553249|NCT02718417|62945744|FG000|Follow-up Phase|Adverse Event|3|||
33553250|NCT02718417|62945745|FG001|Follow-up Phase|Adverse Event|1|||
33553251|NCT02718417|62945746|FG002|Follow-up Phase|Adverse Event|1|||
33553252|NCT02718417|62945744|FG000|Follow-up Phase|Other|4|||
33553253|NCT02718417|62945745|FG001|Follow-up Phase|Other|6|||
33553254|NCT02718417|62945746|FG002|Follow-up Phase|Other|4|||
33658867|NCT00966979|63082075|FG000|Overall Study|Censored because surgery not done|2|||
33658868|NCT00966979|63082075|FG000|Overall Study|Censored because study device was not implanted|14|||
33658869|NCT00966979|63082075|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
33658870|NCT00931606|63082093|FG000|Overall Study|Death|1|||
33658871|NCT00931606|63082094|FG001|Overall Study|Death|3|||
33658872|NCT00931606|63082095|FG002|Overall Study|Death|2|||
33658873|NCT00931606|63082096|FG003|Overall Study|Death|0|||
33658874|NCT00931606|63082093|FG000|Overall Study|Lost to Follow-up|0|||
33658875|NCT00931606|63082094|FG001|Overall Study|Lost to Follow-up|1|||
33658876|NCT00931606|63082095|FG002|Overall Study|Lost to Follow-up|0|||
33658877|NCT00931606|63082096|FG003|Overall Study|Lost to Follow-up|0|||
33658878|NCT00931606|63082093|FG000|Overall Study|Physician Decision|0|||
33658879|NCT00931606|63082094|FG001|Overall Study|Physician Decision|0|||
33658880|NCT00931606|63082095|FG002|Overall Study|Physician Decision|3|||
33658881|NCT00931606|63082096|FG003|Overall Study|Physician Decision|0|||
33658882|NCT00931606|63082093|FG000|Overall Study|Sponsor Decision|1|||
33658883|NCT00931606|63082094|FG001|Overall Study|Sponsor Decision|4|||
33658884|NCT00931606|63082095|FG002|Overall Study|Sponsor Decision|0|||
33658885|NCT00931606|63082096|FG003|Overall Study|Sponsor Decision|2|||
33658886|NCT00931606|63082093|FG000|Overall Study|Withdrawal by Subject|3|||
33658887|NCT00931606|63082094|FG001|Overall Study|Withdrawal by Subject|1|||
33658888|NCT00931606|63082095|FG002|Overall Study|Withdrawal by Subject|1|||
33658889|NCT00931606|63082096|FG003|Overall Study|Withdrawal by Subject|1|||
33658890|NCT00769379|63082110|FG000|Overall Study|No follow up data mapped to Other.|3|||
33658891|NCT00769379|63082111|FG001|Overall Study|No follow up data mapped to Other.|13|||
33658892|NCT00644228|63082123|FG000|Randomization & Eligibility|Ineligible|31|||
33658893|NCT00644228|63082124|FG001|Randomization & Eligibility|Ineligible|21|||
33658894|NCT00644228|63082123|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
33658895|NCT00644228|63082124|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
33658896|NCT00644228|63082123|FG000|Randomization & Eligibility|Invalid Consent|0|||
33658897|NCT00644228|63082124|FG001|Randomization & Eligibility|Invalid Consent|1|||
33658898|NCT00644228|63082123|FG000|Induction Therapy|Adverse Event|22|||
33364781|NCT02393248|62743313|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33553255|NCT02718417|62945744|FG000|Follow-up Phase|Withdrawal by Subject|19|||
33658899|NCT00644228|63082124|FG001|Induction Therapy|Adverse Event|55|||
33658900|NCT00644228|63082123|FG000|Induction Therapy|Withdrawal by Subject|10|||
33658901|NCT00644228|63082124|FG001|Induction Therapy|Withdrawal by Subject|3|||
33658902|NCT00644228|63082123|FG000|Induction Therapy|Progression/Relapse|24|||
33658903|NCT00644228|63082124|FG001|Induction Therapy|Progression/Relapse|12|||
33553256|NCT02718417|62945745|FG001|Follow-up Phase|Withdrawal by Subject|17|||
33553257|NCT02718417|62945746|FG002|Follow-up Phase|Withdrawal by Subject|5|||
33553258|NCT02718417|62945744|FG000|Follow-up Phase|Study terminated by sponsor|100|||
33658904|NCT00644228|63082123|FG000|Induction Therapy|Death|3|||
33658905|NCT00644228|63082124|FG001|Induction Therapy|Death|7|||
33658906|NCT00644228|63082123|FG000|Induction Therapy|Not Protocol-Specified|24|||
33658907|NCT00644228|63082124|FG001|Induction Therapy|Not Protocol-Specified|28|||
33553259|NCT02718417|62945745|FG001|Follow-up Phase|Study terminated by sponsor|138|||
33658908|NCT00644228|63082123|FG000|Maintenance|Adverse Event|27|||
33658909|NCT00644228|63082124|FG001|Maintenance|Adverse Event|31|||
33658910|NCT00644228|63082123|FG000|Maintenance|Withdrawal by Subject|6|||
33658911|NCT00644228|63082124|FG001|Maintenance|Withdrawal by Subject|4|||
33658912|NCT00644228|63082123|FG000|Maintenance|Progression/Relapse|67|||
33658913|NCT00644228|63082124|FG001|Maintenance|Progression/Relapse|42|||
33658914|NCT00644228|63082123|FG000|Maintenance|Death|3|||
33658915|NCT00644228|63082124|FG001|Maintenance|Death|3|||
33658916|NCT00644228|63082123|FG000|Maintenance|Not Protocol-Specified|14|||
33658917|NCT00644228|63082124|FG001|Maintenance|Not Protocol-Specified|15|||
33658918|NCT00644228|63082123|FG000|Maintenance|On Treatment|26|||
33658919|NCT00644228|63082124|FG001|Maintenance|On Treatment|40|||
33658920|NCT00569127|63082137|FG000|Overall Study|Adverse Event|57|||
33658921|NCT00569127|63082138|FG001|Overall Study|Adverse Event|47|||
33658922|NCT00569127|63082137|FG000|Overall Study|Withdrawal by Subject|13|||
33658923|NCT00569127|63082138|FG001|Overall Study|Withdrawal by Subject|27|||
33658924|NCT00569127|63082137|FG000|Overall Study|Progression|99|||
33658925|NCT00569127|63082138|FG001|Overall Study|Progression|100|||
33658926|NCT00569127|63082137|FG000|Overall Study|Death|4|||
33658927|NCT00569127|63082138|FG001|Overall Study|Death|3|||
33658928|NCT00569127|63082137|FG000|Overall Study|Other|20|||
33658929|NCT00569127|63082138|FG001|Overall Study|Other|19|||
33658930|NCT00569127|63082137|FG000|Overall Study|Lost to Follow-up|0|||
33658931|NCT00569127|63082138|FG001|Overall Study|Lost to Follow-up|3|||
33658932|NCT00569127|63082137|FG000|Overall Study|Not Eligible|14|||
33658933|NCT00569127|63082138|FG001|Overall Study|Not Eligible|11|||
33658934|NCT00569127|63082137|FG000|Overall Study|Still on Treatment|7|||
33658935|NCT00569127|63082138|FG001|Overall Study|Still on Treatment|3|||
33658936|NCT00324805|63082154|FG000|Overall Study|Adverse Event|62|||
33658937|NCT00324805|63082155|FG001|Overall Study|Adverse Event|203|||
33658938|NCT00324805|63082154|FG000|Overall Study|Progression|7|||
33658939|NCT00324805|63082155|FG001|Overall Study|Progression|35|||
33658940|NCT00324805|63082154|FG000|Overall Study|Withdrawal by Subject|51|||
33658941|NCT00324805|63082155|FG001|Overall Study|Withdrawal by Subject|174|||
33658942|NCT00324805|63082154|FG000|Overall Study|Death|6|||
33658943|NCT00324805|63082155|FG001|Overall Study|Death|9|||
33658944|NCT00324805|63082154|FG000|Overall Study|Alternative therapy|4|||
33658945|NCT00324805|63082155|FG001|Overall Study|Alternative therapy|8|||
33658946|NCT00324805|63082154|FG000|Overall Study|Other complicating disease|1|||
33658947|NCT00324805|63082155|FG001|Overall Study|Other complicating disease|9|||
33658948|NCT00324805|63082154|FG000|Overall Study|Other reasons|7|||
33658949|NCT00324805|63082155|FG001|Overall Study|Other reasons|26|||
33658950|NCT00324805|63082154|FG000|Overall Study|Other|0|||
33658951|NCT00324805|63082155|FG001|Overall Study|Other|2|||
33658952|NCT00324805|63082154|FG000|Overall Study|Did not start therapy|12|||
33658953|NCT00324805|63082155|FG001|Overall Study|Did not start therapy|17|||
33658954|NCT00706914|63082220|FG000|Overall Study|Lack of Efficacy|0|||
33658955|NCT00706914|63082221|FG001|Overall Study|Lack of Efficacy|1|||
33658956|NCT00706914|63082222|FG002|Overall Study|Lack of Efficacy|0|||
33658957|NCT00706914|63082220|FG000|Overall Study|Lost to Follow-up|1|||
33658958|NCT00706914|63082221|FG001|Overall Study|Lost to Follow-up|0|||
33482330|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33482331|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33482332|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
33482333|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
33482334|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
33553260|NCT02718417|62945746|FG002|Follow-up Phase|Study terminated by sponsor|6|||
33658959|NCT00706914|63082222|FG002|Overall Study|Lost to Follow-up|0|||
33658960|NCT00706914|63082220|FG000|Overall Study|Adverse Event|2|||
33658961|NCT00706914|63082221|FG001|Overall Study|Adverse Event|2|||
33658962|NCT00706914|63082222|FG002|Overall Study|Adverse Event|0|||
33658963|NCT00706914|63082220|FG000|Overall Study|Protocol Violation|3|||
33658964|NCT00706914|63082221|FG001|Overall Study|Protocol Violation|1|||
33658965|NCT00706914|63082222|FG002|Overall Study|Protocol Violation|1|||
33658966|NCT01808651|63082329|FG000|Study Period 1|Lost to Follow-up|1|||
33658967|NCT01808651|63082330|FG001|Study Period 1|Lost to Follow-up|3|||
33658968|NCT01808651|63082331|FG002|Study Period 1|Lost to Follow-up|0|||
33658969|NCT01808651|63082329|FG000|Study Period 1|Protocol Violation|1|||
33658970|NCT01808651|63082330|FG001|Study Period 1|Protocol Violation|0|||
33658971|NCT01808651|63082331|FG002|Study Period 1|Protocol Violation|1|||
33658972|NCT01808651|63082329|FG000|Study Period 1|Physician Decision|3|||
33658973|NCT01808651|63082330|FG001|Study Period 1|Physician Decision|2|||
33658974|NCT01808651|63082331|FG002|Study Period 1|Physician Decision|0|||
33658975|NCT01808651|63082329|FG000|Study Period 1|Lack of Efficacy|2|||
33658976|NCT01808651|63082330|FG001|Study Period 1|Lack of Efficacy|1|||
33658977|NCT01808651|63082331|FG002|Study Period 1|Lack of Efficacy|0|||
33658978|NCT01808651|63082329|FG000|Study Period 1|Adverse Event|10|||
33658979|NCT01808651|63082330|FG001|Study Period 1|Adverse Event|4|||
33658980|NCT01808651|63082331|FG002|Study Period 1|Adverse Event|1|||
33553261|NCT02718417|62945744|FG000|Follow-up Phase|Lost to Follow-up|2|||
33364782|NCT02393248|62743314|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364783|NCT02393248|62743315|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364784|NCT02393248|62743316|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364785|NCT02393248|62743317|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364786|NCT02393248|62743318|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364787|NCT02393248|62743319|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364788|NCT02393248|62743320|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364789|NCT02393248|62743321|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364790|NCT02393248|62743322|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364791|NCT02393248|62743323|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
33364792|NCT02393248|62743324|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364793|NCT02393248|62743325|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364794|NCT02393248|62743326|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364795|NCT02393248|62743327|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33364796|NCT02393248|62743303|FG000|Part 3: Combination Therapy|Adverse Event|0|||
33364797|NCT02393248|62743304|FG001|Part 3: Combination Therapy|Adverse Event|0|||
33364798|NCT02393248|62743305|FG002|Part 3: Combination Therapy|Adverse Event|0|||
33482335|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
33482336|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
33482337|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
33482338|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
33482339|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
33482340|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
33482341|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
33482342|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
33553262|NCT02718417|62945745|FG001|Follow-up Phase|Lost to Follow-up|3|||
33553263|NCT02718417|62945746|FG002|Follow-up Phase|Lost to Follow-up|0|||
33553264|NCT02718417|62945744|FG000|Follow-up Phase|Death leading to discontinuation|7|||
33658981|NCT01808651|63082329|FG000|Study Period 1|Participant Decision|9|||
33658982|NCT01808651|63082330|FG001|Study Period 1|Participant Decision|7|||
33658983|NCT01808651|63082331|FG002|Study Period 1|Participant Decision|3|||
33658984|NCT00706134|63082396|FG000|Overall Study|Adverse Event|8|||
33658985|NCT00706134|63082397|FG001|Overall Study|Adverse Event|7|||
33658986|NCT00706134|63082398|FG002|Overall Study|Adverse Event|2|||
33553265|NCT02718417|62945745|FG001|Follow-up Phase|Death leading to discontinuation|7|||
33553266|NCT02718417|62945746|FG002|Follow-up Phase|Death leading to discontinuation|3|||
33553267|NCT02718417|62945744|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
33553268|NCT02718417|62945745|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
33553269|NCT02718417|62945746|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
33553270|NCT02718417|62945744|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
33553271|NCT02718417|62945745|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
33553272|NCT02718417|62945746|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
33553273|NCT02718417|62945744|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
33553274|NCT02718417|62945745|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
33553275|NCT02718417|62945746|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
33553276|NCT02718417|62945744|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
33553277|NCT02718417|62945745|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
33553278|NCT02718417|62945746|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
33658987|NCT00706134|63082399|FG003|Overall Study|Adverse Event|3|||
33553279|NCT02718417|62945744|FG000|Long-term Follow-up Phase|Other|0|||
33553280|NCT02718417|62945745|FG001|Long-term Follow-up Phase|Other|2|||
33553281|NCT02718417|62945746|FG002|Long-term Follow-up Phase|Other|0|||
33553282|NCT02640404|62945763|FG000|Overall Study|Protocol Violation|1|||
33553283|NCT02640404|62945764|FG001|Overall Study|Protocol Violation|0|||
33553284|NCT02640404|62945763|FG000|Overall Study|Withdrawal by Subject|1|||
33553285|NCT02640404|62945764|FG001|Overall Study|Withdrawal by Subject|0|||
33553286|NCT00701727|62945770|FG000|First Treatment Period|Adverse Event|0|||
33553287|NCT00701727|62945771|FG001|First Treatment Period|Adverse Event|0|||
33553288|NCT00701727|62945770|FG000|First Treatment Period|Withdrawal by Subject|1|||
33553289|NCT00701727|62945771|FG001|First Treatment Period|Withdrawal by Subject|0|||
33553290|NCT00701727|62945770|FG000|First Treatment Period|sponsor decision|0|||
33553291|NCT00701727|62945771|FG001|First Treatment Period|sponsor decision|1|||
33553292|NCT00701727|62945770|FG000|First Treatment Period|Lost to Follow-up|0|||
33553293|NCT00701727|62945771|FG001|First Treatment Period|Lost to Follow-up|1|||
33553294|NCT00701727|62945770|FG000|Second Treatment Period|Withdrawal by Subject|2|||
33553295|NCT00701727|62945771|FG001|Second Treatment Period|Withdrawal by Subject|0|||
33553296|NCT01369069|62945788|FG000|Overall Study|Lost to Follow-up|8|||
33553297|NCT01369069|62945789|FG001|Overall Study|Lost to Follow-up|9|||
33553298|NCT01369069|62945788|FG000|Overall Study|Withdrawal by Subject|9|||
33553299|NCT01369069|62945789|FG001|Overall Study|Withdrawal by Subject|7|||
33553300|NCT02441218|62945797|FG000|Overall Study|Death|503|||
33658988|NCT00706134|63082396|FG000|Overall Study|Lost to Follow-up|0|||
33658989|NCT00706134|63082397|FG001|Overall Study|Lost to Follow-up|1|||
33658990|NCT00706134|63082398|FG002|Overall Study|Lost to Follow-up|0|||
33364799|NCT02393248|62743306|FG003|Part 3: Combination Therapy|Adverse Event|0|||
33364800|NCT02393248|62743307|FG004|Part 3: Combination Therapy|Adverse Event|0|||
33482343|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
33482344|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33482345|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
33482346|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
33482347|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33482348|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33482349|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33482350|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33482351|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33553301|NCT02441218|62945798|FG001|Overall Study|Death|553|||
33553302|NCT02441218|62945797|FG000|Overall Study|Withdrawal by Subject|73|||
33553303|NCT02441218|62945798|FG001|Overall Study|Withdrawal by Subject|58|||
33553304|NCT02441218|62945797|FG000|Overall Study|Lost to Follow-up|2|||
33553305|NCT02441218|62945798|FG001|Overall Study|Lost to Follow-up|1|||
33553306|NCT02410252|62945804|FG000|Overall Study|Withdrawal by Subject|4|||
33553307|NCT02410252|62945804|FG000|Overall Study|Physician Decision|2|||
33553308|NCT02440594|62945818|FG000|Overall Study|Lost to Follow-up|34|||
33553309|NCT02440594|62945819|FG001|Overall Study|Lost to Follow-up|33|||
33658991|NCT00706134|63082399|FG003|Overall Study|Lost to Follow-up|0|||
33658992|NCT00706134|63082396|FG000|Overall Study|Protocol Violation|0|||
33658993|NCT00706134|63082397|FG001|Overall Study|Protocol Violation|6|||
33658994|NCT00706134|63082398|FG002|Overall Study|Protocol Violation|0|||
33658995|NCT00706134|63082399|FG003|Overall Study|Protocol Violation|3|||
33658996|NCT00706134|63082396|FG000|Overall Study|Withdrawal by Subject|1|||
33658997|NCT00706134|63082397|FG001|Overall Study|Withdrawal by Subject|2|||
33553310|NCT02440594|62945820|FG002|Overall Study|Lost to Follow-up|54|||
33553311|NCT02440594|62945821|FG003|Overall Study|Lost to Follow-up|47|||
33553312|NCT02440594|62945822|FG004|Overall Study|Lost to Follow-up|5|||
33553313|NCT02440594|62945823|FG005|Overall Study|Lost to Follow-up|4|||
33553314|NCT02440594|62945824|FG006|Overall Study|Lost to Follow-up|28|||
33553315|NCT02440594|62945825|FG007|Overall Study|Lost to Follow-up|48|||
33553316|NCT02440594|62945818|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
33553317|NCT02440594|62945819|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
33553318|NCT02440594|62945820|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
33553319|NCT02440594|62945821|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
33553320|NCT02440594|62945822|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
33553321|NCT02440594|62945823|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
33553322|NCT02440594|62945824|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
33553323|NCT02440594|62945825|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
33553324|NCT02440594|62945818|FG000|Overall Study|Withdrawal by Subject|81|||
33553325|NCT02440594|62945819|FG001|Overall Study|Withdrawal by Subject|67|||
33553326|NCT02440594|62945820|FG002|Overall Study|Withdrawal by Subject|59|||
33553327|NCT02440594|62945821|FG003|Overall Study|Withdrawal by Subject|38|||
33553328|NCT02440594|62945822|FG004|Overall Study|Withdrawal by Subject|2|||
33553329|NCT02440594|62945823|FG005|Overall Study|Withdrawal by Subject|2|||
33553330|NCT02440594|62945824|FG006|Overall Study|Withdrawal by Subject|7|||
33658998|NCT00706134|63082398|FG002|Overall Study|Withdrawal by Subject|1|||
33658999|NCT00706134|63082399|FG003|Overall Study|Withdrawal by Subject|0|||
33659000|NCT00706134|63082396|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
33659001|NCT00706134|63082397|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33659002|NCT00706134|63082398|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
33659003|NCT00706134|63082399|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
33659004|NCT00706134|63082396|FG000|Overall Study|Did not meet study criteria|2|||
33482352|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482353|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482354|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
33482355|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482356|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
33482357|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482358|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482359|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482360|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482361|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482362|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
33482363|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
33553331|NCT02440594|62945825|FG007|Overall Study|Withdrawal by Subject|7|||
33553332|NCT02440594|62945818|FG000|Overall Study|Administratively w/drawn|3|||
33553333|NCT02440594|62945819|FG001|Overall Study|Administratively w/drawn|2|||
33553334|NCT02440594|62945820|FG002|Overall Study|Administratively w/drawn|0|||
33553335|NCT02440594|62945821|FG003|Overall Study|Administratively w/drawn|0|||
33553336|NCT02440594|62945822|FG004|Overall Study|Administratively w/drawn|0|||
33553337|NCT02440594|62945823|FG005|Overall Study|Administratively w/drawn|0|||
33553338|NCT02440594|62945824|FG006|Overall Study|Administratively w/drawn|2|||
33553339|NCT02440594|62945825|FG007|Overall Study|Administratively w/drawn|1|||
33553340|NCT03836001|62945852|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
33553341|NCT03836001|62945853|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
33553342|NCT03836001|62945854|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
33553343|NCT03836001|62945852|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
33482364|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
33553344|NCT03836001|62945853|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
33553345|NCT03836001|62945854|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
33553346|NCT03836001|62945852|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
33553347|NCT03836001|62945853|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
33553348|NCT03836001|62945854|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
33553349|NCT03836001|62945852|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
33659005|NCT00706134|63082397|FG001|Overall Study|Did not meet study criteria|0|||
33659006|NCT00706134|63082398|FG002|Overall Study|Did not meet study criteria|0|||
33659007|NCT00706134|63082399|FG003|Overall Study|Did not meet study criteria|0|||
33659008|NCT01808573|63082411|FG000|Overall Study|Death|212|||
33659009|NCT01808573|63082412|FG001|Overall Study|Death|240|||
33659010|NCT01808573|63082411|FG000|Overall Study|Withdrawal by Subject|12|||
33659011|NCT01808573|63082412|FG001|Overall Study|Withdrawal by Subject|10|||
33659012|NCT01808573|63082411|FG000|Overall Study|Lost to Follow-up|3|||
33659013|NCT01808573|63082412|FG001|Overall Study|Lost to Follow-up|0|||
33659014|NCT01808573|63082411|FG000|Overall Study|Discontinuation of study by sponsor|79|||
33659015|NCT01808573|63082412|FG001|Overall Study|Discontinuation of study by sponsor|64|||
33659016|NCT01808573|63082411|FG000|Overall Study|Randomized in Error|1|||
33553350|NCT03836001|62945853|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
33553351|NCT03836001|62945854|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
33553352|NCT02465866|62945861|FG000|Period 3|Withdrawal by Subject|0|||
33553353|NCT02465866|62945862|FG001|Period 3|Withdrawal by Subject|1|||
33553354|NCT02465866|62945863|FG002|Period 3|Withdrawal by Subject|0|||
33553355|NCT02465866|62945864|FG003|Period 3|Withdrawal by Subject|0|||
33553356|NCT02439970|62945876|FG000|Overall Study|Study Terminated|2|||
33553357|NCT02439970|62945877|FG001|Overall Study|Study Terminated|3|||
33553358|NCT02437864|62945885|FG000|Overall Study|Protocol Violation|4|||
33553359|NCT02437864|62945886|FG001|Overall Study|Protocol Violation|0|||
33553360|NCT02408068|62945892|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
33553361|NCT02408068|62945893|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
33553362|NCT02408068|62945894|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
33553363|NCT02408068|62945895|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
33553364|NCT02408068|62945896|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
33553365|NCT02408068|62945897|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
33553366|NCT01361126|62945910|FG000|Overall Study|Sponsor decision|0|||
33553367|NCT01361126|62945911|FG001|Overall Study|Sponsor decision|2|||
33659017|NCT01808573|63082412|FG001|Overall Study|Randomized in Error|0|||
33659018|NCT02246530|63082439|FG000|Overall Study|Lost to Follow-up|4|||
33659019|NCT02246530|63082440|FG001|Overall Study|Lost to Follow-up|0|||
33659020|NCT01808339|63082446|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33659021|NCT01808339|63082447|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33659022|NCT01808339|63082448|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33659023|NCT01808339|63082449|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
33659024|NCT01808339|63082450|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
33659025|NCT01808339|63082451|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
33659026|NCT01808339|63082446|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33659027|NCT01808339|63082447|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33659028|NCT01808339|63082448|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33659029|NCT01808339|63082449|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33659030|NCT01808339|63082450|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33659031|NCT01808339|63082451|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33659032|NCT01808339|63082446|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33659033|NCT01808339|63082447|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33659034|NCT01808339|63082448|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
33659035|NCT01808339|63082449|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33659036|NCT01808339|63082450|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33659037|NCT01808339|63082451|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33659038|NCT02727660|63082501|FG000|Overall Study|Lack of Efficacy|40|||
33659039|NCT02727660|63082502|FG001|Overall Study|Lack of Efficacy|40|||
33659040|NCT02727660|63082503|FG002|Overall Study|Lack of Efficacy|70|||
33659041|NCT02727660|63082501|FG000|Overall Study|Adverse Event|28|||
33659042|NCT02727660|63082502|FG001|Overall Study|Adverse Event|21|||
33659043|NCT02727660|63082503|FG002|Overall Study|Adverse Event|32|||
33659044|NCT02727660|63082501|FG000|Overall Study|Withdrawal by Subject|26|||
33482365|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
33482366|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
33482367|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
33482368|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
33482369|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
33482370|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
33482371|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
33482372|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33482373|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33553368|NCT04428645|62945918|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
33553369|NCT01368835|62945922|FG000|Overall Study|Inclusion criteria/photography quality|22|||
33659045|NCT02727660|63082502|FG001|Overall Study|Withdrawal by Subject|25|||
33659046|NCT02727660|63082503|FG002|Overall Study|Withdrawal by Subject|30|||
33659047|NCT02727660|63082501|FG000|Overall Study|Physician Decision|3|||
33659048|NCT02727660|63082502|FG001|Overall Study|Physician Decision|8|||
33553370|NCT01368835|62945922|FG000|Overall Study|Lost to Follow-up|11|||
33553371|NCT02407990|62945941|FG000|Overall Study|Death|2|||
33659049|NCT02727660|63082503|FG002|Overall Study|Physician Decision|14|||
33659050|NCT02727660|63082501|FG000|Overall Study|Lost to Follow-up|5|||
33659051|NCT02727660|63082502|FG001|Overall Study|Lost to Follow-up|9|||
33659052|NCT02727660|63082503|FG002|Overall Study|Lost to Follow-up|8|||
33659053|NCT02727660|63082501|FG000|Overall Study|Protocol Violation|7|||
33659054|NCT02727660|63082502|FG001|Overall Study|Protocol Violation|5|||
33659055|NCT02727660|63082503|FG002|Overall Study|Protocol Violation|5|||
33659056|NCT02727660|63082501|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
33659057|NCT02727660|63082502|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
33659058|NCT02727660|63082503|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
33659059|NCT02727660|63082501|FG000|Overall Study|Administrative Reasons|2|||
33659060|NCT02727660|63082502|FG001|Overall Study|Administrative Reasons|3|||
33659061|NCT02727660|63082503|FG002|Overall Study|Administrative Reasons|4|||
33659062|NCT01784861|63082517|FG000|Overall Study|Adverse Event|0|||
33482374|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33482375|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
33659063|NCT01784861|63082518|FG001|Overall Study|Adverse Event|0|||
33659064|NCT01784861|63082519|FG002|Overall Study|Adverse Event|1|||
33659065|NCT01784861|63082520|FG003|Overall Study|Adverse Event|2|||
33659066|NCT01784861|63082521|FG004|Overall Study|Adverse Event|1|||
33659067|NCT01784861|63082522|FG005|Overall Study|Adverse Event|0|||
33659068|NCT01784861|63082517|FG000|Overall Study|Withdrawal by Subject|0|||
33659069|NCT01784861|63082518|FG001|Overall Study|Withdrawal by Subject|0|||
33659070|NCT01784861|63082519|FG002|Overall Study|Withdrawal by Subject|0|||
33659071|NCT01784861|63082520|FG003|Overall Study|Withdrawal by Subject|1|||
33659072|NCT01784861|63082521|FG004|Overall Study|Withdrawal by Subject|0|||
33659073|NCT01784861|63082522|FG005|Overall Study|Withdrawal by Subject|0|||
33659074|NCT01784861|63082517|FG000|Overall Study|Physician Decision|0|||
33659075|NCT01784861|63082518|FG001|Overall Study|Physician Decision|0|||
33482376|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
33482377|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33482378|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33482379|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33482380|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33482381|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33482382|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
33482383|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33482384|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
33482385|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
33482386|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
33482387|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33482388|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33482389|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33482390|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33482391|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33482392|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
33553372|NCT02407990|62945942|FG001|Overall Study|Death|22|||
33553373|NCT02407990|62945943|FG002|Overall Study|Death|23|||
33659076|NCT01784861|63082519|FG002|Overall Study|Physician Decision|0|||
33659077|NCT01784861|63082520|FG003|Overall Study|Physician Decision|2|||
33659078|NCT01784861|63082521|FG004|Overall Study|Physician Decision|0|||
33659079|NCT01784861|63082522|FG005|Overall Study|Physician Decision|1|||
33659080|NCT02727192|63082596|FG000|Overall Study|Lost to Follow-up|1|||
33659081|NCT02727192|63082597|FG001|Overall Study|Lost to Follow-up|0|||
33659082|NCT02727192|63082598|FG002|Overall Study|Lost to Follow-up|0|||
33659083|NCT00705666|63082618|FG000|Overall Study|No post-treatment questionnaire|279|||
33659084|NCT00705666|63082618|FG000|Overall Study|Withdrawal by Subject|21|||
33659085|NCT00705666|63082618|FG000|Overall Study|Physician Decision|7|||
33659086|NCT00705666|63082618|FG000|Overall Study|Lost to Follow-up|5|||
33659087|NCT00705666|63082618|FG000|Overall Study|Death|1|||
33659088|NCT00705666|63082618|FG000|Overall Study|Adverse Event|4|||
33659089|NCT00705666|63082618|FG000|Overall Study|Other|12|||
33659090|NCT00705666|63082618|FG000|Overall Study|Other|2|||
33659091|NCT00705666|63082618|FG000|Overall Study|Lack of data|3|||
33659092|NCT00705666|63082618|FG000|Overall Study|Untreated|5|||
33659093|NCT02725866|63082777|FG000|Overall Study|Failure to return|6|||
33659094|NCT02725866|63082777|FG000|Overall Study|Withdrew consent|3|||
33659095|NCT02725866|63082777|FG000|Overall Study|Insufficient virological response|1|||
33659096|NCT02725866|63082777|FG000|Overall Study|Other, not specified|4|||
33659097|NCT02726022|63082813|FG000|Overall Study|Adverse Event|14|||
33553374|NCT02407990|62945944|FG003|Overall Study|Death|7|||
33553375|NCT02407990|62945945|FG004|Overall Study|Death|17|||
33553376|NCT02407990|62945946|FG005|Overall Study|Death|16|||
33659098|NCT02726022|63082813|FG000|Overall Study|Treatment Failure|8|||
33659099|NCT02726022|63082813|FG000|Overall Study|Poor Compliance|13|||
33659100|NCT02726022|63082813|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
33659101|NCT02725788|63082828|FG000|Overall Study|Lost to Follow-up|1|||
33659102|NCT02725788|63082829|FG001|Overall Study|Lost to Follow-up|1|||
33659103|NCT02725788|63082828|FG000|Overall Study|Protocol Violation|0|||
33659104|NCT02725788|63082829|FG001|Overall Study|Protocol Violation|1|||
33659105|NCT02725710|63082968|FG000|Overall Study|Lost to Follow-up|1|||
33553377|NCT02407990|62945947|FG006|Overall Study|Death|10|||
33553378|NCT02407990|62945948|FG007|Overall Study|Death|248|||
33553379|NCT02407990|62945941|FG000|Overall Study|Lost to Follow-up|0|||
33553380|NCT02407990|62945942|FG001|Overall Study|Lost to Follow-up|1|||
33659106|NCT02725710|63082969|FG001|Overall Study|Lost to Follow-up|0|||
33659107|NCT02724462|63083000|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
33659108|NCT02724462|63083001|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
33659109|NCT02724462|63083000|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
33659110|NCT02724462|63083001|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
33659111|NCT02724462|63083000|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
33659112|NCT02724462|63083001|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
33659113|NCT02724462|63083000|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
33659114|NCT02724462|63083001|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
33659115|NCT02724462|63083000|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
33659116|NCT02724462|63083001|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
33659117|NCT02724462|63083000|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
33659118|NCT02724462|63083001|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
33659119|NCT02725476|63083058|FG000|Overall Study|Physician Decision|2|||
33659120|NCT02725476|63083059|FG001|Overall Study|Physician Decision|0|||
33659121|NCT02725476|63083058|FG000|Overall Study|Adverse Event|1|||
33659122|NCT02725476|63083059|FG001|Overall Study|Adverse Event|1|||
33659123|NCT02725008|63083164|FG000|Overall Study|Lost to Follow-up|7|||
33659124|NCT02725008|63083165|FG001|Overall Study|Lost to Follow-up|9|||
33659125|NCT02725008|63083164|FG000|Overall Study|Withdrawal by Subject|2|||
33659126|NCT02725008|63083165|FG001|Overall Study|Withdrawal by Subject|2|||
33553381|NCT02407990|62945943|FG002|Overall Study|Lost to Follow-up|0|||
33659127|NCT02725008|63083164|FG000|Overall Study|Admitted to hospital|0|||
33659128|NCT02725008|63083165|FG001|Overall Study|Admitted to hospital|1|||
33659129|NCT01807949|63083437|FG000|Overall Study|Adverse Event|1|||
33659130|NCT01807949|63083438|FG001|Overall Study|Adverse Event|2|||
33659131|NCT01807949|63083439|FG002|Overall Study|Adverse Event|2|||
33659132|NCT01807949|63083437|FG000|Overall Study|Withdrawal by Subject|1|||
33659133|NCT01807949|63083438|FG001|Overall Study|Withdrawal by Subject|2|||
33659134|NCT01807949|63083439|FG002|Overall Study|Withdrawal by Subject|2|||
33659135|NCT01807949|63083437|FG000|Overall Study|Non-Compliance|0|||
33659136|NCT01807949|63083438|FG001|Overall Study|Non-Compliance|0|||
33659137|NCT01807949|63083439|FG002|Overall Study|Non-Compliance|1|||
33659138|NCT01807949|63083437|FG000|Overall Study|Undefined|0|||
33659139|NCT01807949|63083438|FG001|Overall Study|Undefined|1|||
33659140|NCT01807949|63083439|FG002|Overall Study|Undefined|2|||
33659141|NCT01807949|63083437|FG000|Overall Study|Randomized But Not Treated|0|||
33553382|NCT02407990|62945944|FG003|Overall Study|Lost to Follow-up|0|||
33659142|NCT01807949|63083438|FG001|Overall Study|Randomized But Not Treated|2|||
33659143|NCT01807949|63083439|FG002|Overall Study|Randomized But Not Treated|2|||
33659144|NCT01806779|63083451|FG000|Overall Study|Physician Decision|2|||
33659145|NCT01806779|63083452|FG001|Overall Study|Physician Decision|0|||
33553383|NCT02407990|62945945|FG004|Overall Study|Lost to Follow-up|0|||
33553384|NCT02407990|62945946|FG005|Overall Study|Lost to Follow-up|0|||
33553385|NCT02407990|62945947|FG006|Overall Study|Lost to Follow-up|0|||
33659146|NCT01806779|63083453|FG002|Overall Study|Physician Decision|1|||
33553386|NCT02407990|62945948|FG007|Overall Study|Lost to Follow-up|17|||
33659147|NCT01806779|63083451|FG000|Overall Study|Lack of Efficacy|1|||
33659148|NCT01806779|63083452|FG001|Overall Study|Lack of Efficacy|1|||
33553387|NCT02407990|62945941|FG000|Overall Study|Progressive Disease|0|||
33553388|NCT02407990|62945942|FG001|Overall Study|Progressive Disease|0|||
33553389|NCT02407990|62945943|FG002|Overall Study|Progressive Disease|0|||
33553390|NCT02407990|62945944|FG003|Overall Study|Progressive Disease|0|||
33553391|NCT02407990|62945945|FG004|Overall Study|Progressive Disease|0|||
33553392|NCT02407990|62945946|FG005|Overall Study|Progressive Disease|0|||
33553393|NCT02407990|62945947|FG006|Overall Study|Progressive Disease|0|||
33553394|NCT02407990|62945948|FG007|Overall Study|Progressive Disease|1|||
33553395|NCT02407990|62945941|FG000|Overall Study|Withdrawal by Subject|0|||
33553396|NCT02407990|62945942|FG001|Overall Study|Withdrawal by Subject|0|||
33553397|NCT02407990|62945943|FG002|Overall Study|Withdrawal by Subject|0|||
33553398|NCT02407990|62945944|FG003|Overall Study|Withdrawal by Subject|0|||
33553399|NCT02407990|62945945|FG004|Overall Study|Withdrawal by Subject|1|||
33553400|NCT02407990|62945946|FG005|Overall Study|Withdrawal by Subject|0|||
33553401|NCT02407990|62945947|FG006|Overall Study|Withdrawal by Subject|0|||
33553402|NCT02407990|62945948|FG007|Overall Study|Withdrawal by Subject|30|||
33553403|NCT02407990|62945941|FG000|Overall Study|Study Terminated by Sponsor|1|||
33553404|NCT02407990|62945942|FG001|Overall Study|Study Terminated by Sponsor|3|||
33553405|NCT02407990|62945943|FG002|Overall Study|Study Terminated by Sponsor|3|||
33553406|NCT02407990|62945944|FG003|Overall Study|Study Terminated by Sponsor|0|||
33553407|NCT02407990|62945945|FG004|Overall Study|Study Terminated by Sponsor|3|||
33553408|NCT02407990|62945946|FG005|Overall Study|Study Terminated by Sponsor|4|||
33553409|NCT02407990|62945947|FG006|Overall Study|Study Terminated by Sponsor|3|||
33553410|NCT02407990|62945948|FG007|Overall Study|Study Terminated by Sponsor|37|||
33553411|NCT02407990|62945941|FG000|Overall Study|Logistics|0|||
33553412|NCT02407990|62945942|FG001|Overall Study|Logistics|0|||
33553413|NCT02407990|62945943|FG002|Overall Study|Logistics|0|||
33553414|NCT02407990|62945944|FG003|Overall Study|Logistics|0|||
33553415|NCT02407990|62945945|FG004|Overall Study|Logistics|0|||
33553416|NCT02407990|62945946|FG005|Overall Study|Logistics|0|||
33553417|NCT02407990|62945947|FG006|Overall Study|Logistics|0|||
33553418|NCT02407990|62945948|FG007|Overall Study|Logistics|1|||
33553419|NCT02407990|62945941|FG000|Overall Study|Rolled into long-term extension study|0|||
33553420|NCT02407990|62945942|FG001|Overall Study|Rolled into long-term extension study|0|||
33553421|NCT02407990|62945943|FG002|Overall Study|Rolled into long-term extension study|0|||
33553422|NCT02407990|62945944|FG003|Overall Study|Rolled into long-term extension study|0|||
33659149|NCT01806779|63083453|FG002|Overall Study|Lack of Efficacy|0|||
33659150|NCT01806779|63083451|FG000|Overall Study|Lost to Follow-up|19|||
33659151|NCT01806779|63083452|FG001|Overall Study|Lost to Follow-up|20|||
33659152|NCT01806779|63083453|FG002|Overall Study|Lost to Follow-up|0|||
33659153|NCT01806779|63083451|FG000|Overall Study|Withdrawal by Subject|20|||
33659154|NCT01806779|63083452|FG001|Overall Study|Withdrawal by Subject|23|||
33659155|NCT01806779|63083453|FG002|Overall Study|Withdrawal by Subject|22|||
33659156|NCT01607957|63083527|FG000|Overall Study|Not treated|1|||
33659157|NCT01607957|63083528|FG001|Overall Study|Not treated|1|||
33659158|NCT01607957|63083527|FG000|Overall Study|Death|367|||
33659159|NCT01607957|63083528|FG001|Overall Study|Death|211|||
33659160|NCT01607957|63083527|FG000|Overall Study|Lost to Follow-up|3|||
33659161|NCT01607957|63083528|FG001|Overall Study|Lost to Follow-up|3|||
33659162|NCT01607957|63083527|FG000|Overall Study|Participant refusal|1|||
33553423|NCT02407990|62945945|FG004|Overall Study|Rolled into long-term extension study|0|||
33553424|NCT02407990|62945946|FG005|Overall Study|Rolled into long-term extension study|0|||
33553425|NCT02407990|62945947|FG006|Overall Study|Rolled into long-term extension study|0|||
33553426|NCT02407990|62945948|FG007|Overall Study|Rolled into long-term extension study|1|||
33553427|NCT03288129|62945972|FG000|Overall Study|Adverse Event|10|||
33553428|NCT03288129|62945972|FG000|Overall Study|Lost to Follow-up|3|||
33553429|NCT03288129|62945972|FG000|Overall Study|Withdrawal by Subject|3|||
33553430|NCT03288129|62945972|FG000|Overall Study|Withdrawal of consent/assent|1|||
33553431|NCT03288129|62945972|FG000|Overall Study|Other|5|||
33659163|NCT01607957|63083528|FG001|Overall Study|Participant refusal|0|||
33553432|NCT01673282|62945978|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
33553433|NCT01673282|62945979|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
33553434|NCT01673282|62945978|FG000|Overall Study|Lack of Efficacy|9|||
33553435|NCT01673282|62945979|FG001|Overall Study|Lack of Efficacy|2|||
33553436|NCT01673282|62945978|FG000|Overall Study|Lost to Follow-up|11|||
33553437|NCT01673282|62945979|FG001|Overall Study|Lost to Follow-up|10|||
33553438|NCT01673282|62945978|FG000|Overall Study|Withdrawal by Subject|3|||
33553439|NCT01673282|62945979|FG001|Overall Study|Withdrawal by Subject|3|||
33553440|NCT01673282|62945978|FG000|Overall Study|Other|1|||
33553441|NCT01673282|62945979|FG001|Overall Study|Other|6|||
33553442|NCT04157751|62945987|FG000|Overall Study|Withdrawal by Subject|12|||
33553443|NCT04157751|62945988|FG001|Overall Study|Withdrawal by Subject|17|||
33553444|NCT04157751|62945987|FG000|Overall Study|Lost to Follow-up|6|||
33553445|NCT04157751|62945988|FG001|Overall Study|Lost to Follow-up|2|||
33553446|NCT04157751|62945987|FG000|Overall Study|Adverse Event|34|||
33553447|NCT04157751|62945988|FG001|Overall Study|Adverse Event|23|||
33553448|NCT04157751|62945987|FG000|Overall Study|Not treated|1|||
33659164|NCT01806623|63083548|FG000|Overall Study|Withdrawal by Subject|1|||
33659165|NCT01806623|63083548|FG000|Overall Study|Adverse Event|1|||
33659166|NCT01806623|63083548|FG000|Overall Study|Did not meet the inclusion criteria|56|||
33659167|NCT01806545|63083554|FG000|Overall Study|Adverse Event|2|||
33659168|NCT01806545|63083555|FG001|Overall Study|Adverse Event|3|||
33659169|NCT01806545|63083554|FG000|Overall Study|Lost to Follow-up|1|||
33659170|NCT01806545|63083555|FG001|Overall Study|Lost to Follow-up|0|||
33659171|NCT01806545|63083554|FG000|Overall Study|Withdrawal by Subject|3|||
33659172|NCT01806545|63083555|FG001|Overall Study|Withdrawal by Subject|2|||
33659173|NCT01806389|63083561|FG000|Overall Study|Withdrawal by Subject|4|||
33659174|NCT01782131|63083817|FG000|Overall Study|Death|93|||
33553449|NCT04157751|62945988|FG001|Overall Study|Not treated|5|||
33553450|NCT04157751|62945987|FG000|Overall Study|Other reason not stated above|10|||
33553451|NCT04157751|62945988|FG001|Overall Study|Other reason not stated above|10|||
33553452|NCT01673126|62945996|FG000|Overall Study|change of diagnosis|4|||
33553453|NCT01673126|62945997|FG001|Overall Study|change of diagnosis|3|||
33553454|NCT02407054|62946006|FG000|Overall Study|Adverse Event|1|||
33553455|NCT02407054|62946007|FG001|Overall Study|Adverse Event|4|||
33553456|NCT02407054|62946008|FG002|Overall Study|Adverse Event|1|||
33364801|NCT02393248|62743308|FG005|Part 3: Combination Therapy|Adverse Event|0|||
33364802|NCT02393248|62743309|FG006|Part 3: Combination Therapy|Adverse Event|0|||
33364803|NCT02393248|62743310|FG007|Part 3: Combination Therapy|Adverse Event|0|||
33364804|NCT02393248|62743311|FG008|Part 3: Combination Therapy|Adverse Event|0|||
33364805|NCT02393248|62743312|FG009|Part 3: Combination Therapy|Adverse Event|0|||
33364806|NCT02393248|62743313|FG010|Part 3: Combination Therapy|Adverse Event|0|||
33364807|NCT02393248|62743314|FG011|Part 3: Combination Therapy|Adverse Event|0|||
33364808|NCT02393248|62743315|FG012|Part 3: Combination Therapy|Adverse Event|0|||
33364809|NCT02393248|62743316|FG013|Part 3: Combination Therapy|Adverse Event|0|||
33364810|NCT02393248|62743317|FG014|Part 3: Combination Therapy|Adverse Event|0|||
33364811|NCT02393248|62743318|FG015|Part 3: Combination Therapy|Adverse Event|0|||
33553457|NCT02407054|62946006|FG000|Overall Study|Non-compliance with Study|0|||
33553458|NCT02407054|62946007|FG001|Overall Study|Non-compliance with Study|2|||
33553459|NCT02407054|62946008|FG002|Overall Study|Non-compliance with Study|1|||
33553460|NCT02407054|62946006|FG000|Overall Study|Physician Decision|1|||
33553461|NCT02407054|62946007|FG001|Overall Study|Physician Decision|3|||
33553462|NCT02407054|62946008|FG002|Overall Study|Physician Decision|3|||
33553463|NCT02407054|62946006|FG000|Overall Study|Withdrawal by Subject|5|||
33553464|NCT02407054|62946007|FG001|Overall Study|Withdrawal by Subject|9|||
33553465|NCT02407054|62946008|FG002|Overall Study|Withdrawal by Subject|2|||
33553466|NCT01652716|62946019|FG000|Overall Study|Loss of glucose control|1|||
33553467|NCT01652716|62946020|FG001|Overall Study|Loss of glucose control|0|||
33553468|NCT01652716|62946019|FG000|Overall Study|Administrative|0|||
33553469|NCT01652716|62946020|FG001|Overall Study|Administrative|2|||
33553470|NCT01652716|62946019|FG000|Overall Study|Investigator decision|1|||
33553471|NCT01652716|62946020|FG001|Overall Study|Investigator decision|4|||
33659175|NCT01782131|63083818|FG001|Overall Study|Death|96|||
33553472|NCT01652716|62946019|FG000|Overall Study|Lost to Follow-up|12|||
33553473|NCT01652716|62946020|FG001|Overall Study|Lost to Follow-up|11|||
33553474|NCT01652716|62946019|FG000|Overall Study|Protocol Violation|2|||
33553475|NCT01652716|62946020|FG001|Overall Study|Protocol Violation|1|||
33364812|NCT02393248|62743319|FG016|Part 3: Combination Therapy|Adverse Event|0|||
33553476|NCT01652716|62946019|FG000|Overall Study|Adverse Event|7|||
33553477|NCT01652716|62946020|FG001|Overall Study|Adverse Event|10|||
33553478|NCT01652716|62946019|FG000|Overall Study|Withdrawal by Subject|33|||
33553479|NCT01652716|62946020|FG001|Overall Study|Withdrawal by Subject|18|||
33553480|NCT02790073|62946026|FG000|Overall Study|Death|1|||
33553481|NCT02790073|62946026|FG000|Overall Study|Withdrawal from HD|1|||
33553482|NCT02790073|62946026|FG000|Overall Study|Withdrawal by Subject|1|||
33659176|NCT01782131|63083817|FG000|Overall Study|Lost to Follow-up|1|||
33659177|NCT01782131|63083818|FG001|Overall Study|Lost to Follow-up|3|||
33659178|NCT01782131|63083817|FG000|Overall Study|Withdrawal by Subject|10|||
33659179|NCT01782131|63083818|FG001|Overall Study|Withdrawal by Subject|10|||
33659180|NCT01782131|63083817|FG000|Overall Study|Randomized but not treated|5|||
33659181|NCT01782131|63083818|FG001|Overall Study|Randomized but not treated|5|||
33659182|NCT01782131|63083817|FG000|Overall Study|Reason not provided|0|||
33659183|NCT01782131|63083818|FG001|Overall Study|Reason not provided|1|||
33659184|NCT01781975|63083839|FG000|Overall Study|Death|1|||
33659185|NCT01781975|63083840|FG001|Overall Study|Death|0|||
33659186|NCT01781975|63083839|FG000|Overall Study|Withdrawal by Subject|1|||
33659187|NCT01781975|63083840|FG001|Overall Study|Withdrawal by Subject|1|||
33659188|NCT01804673|63083861|FG000|Overall Study|Adverse Event|4|||
33659189|NCT01804673|63083861|FG000|Overall Study|Withdrawal by Subject|1|||
33659190|NCT01804673|63083861|FG000|Overall Study|Lack of Efficacy|9|||
33659191|NCT01804673|63083861|FG000|Overall Study|Change to Oral Therapy|37|||
33659192|NCT01804673|63083861|FG000|Overall Study|No Further Therapy Required|84|||
33659193|NCT01804673|63083861|FG000|Overall Study|Use of Prohibited Medication|1|||
33659194|NCT01804673|63083861|FG000|Overall Study|Other|4|||
33659195|NCT01774097|63083871|FG000|Overall Study|Withdrawal by Subject|1|||
33659196|NCT01774097|63083872|FG001|Overall Study|Withdrawal by Subject|1|||
33659197|NCT01774097|63083871|FG000|Overall Study|Adverse Event|1|||
33659198|NCT01774097|63083872|FG001|Overall Study|Adverse Event|1|||
33659199|NCT02859558|63083946|FG000|Step 1|Not Eligible|0|||
33659200|NCT02859558|63083947|FG001|Step 1|Not Eligible|0|||
33659201|NCT02859558|63083948|FG002|Step 1|Not Eligible|0|||
33659202|NCT02859558|63083949|FG003|Step 1|Not Eligible|0|||
33659203|NCT02859558|63083950|FG004|Step 1|Not Eligible|3|||
33659204|NCT02859558|63083946|FG000|Step 1|Lost to Follow-up|1|||
33659205|NCT02859558|63083947|FG001|Step 1|Lost to Follow-up|3|||
33659206|NCT02859558|63083948|FG002|Step 1|Lost to Follow-up|3|||
33659207|NCT02859558|63083949|FG003|Step 1|Lost to Follow-up|0|||
33659208|NCT02859558|63083950|FG004|Step 1|Lost to Follow-up|0|||
33659209|NCT02859558|63083946|FG000|Step 1|Did Not Return to Clinic|2|||
33659210|NCT02859558|63083947|FG001|Step 1|Did Not Return to Clinic|3|||
33659211|NCT02859558|63083948|FG002|Step 1|Did Not Return to Clinic|4|||
33659212|NCT02859558|63083949|FG003|Step 1|Did Not Return to Clinic|0|||
33659213|NCT02859558|63083950|FG004|Step 1|Did Not Return to Clinic|0|||
33482393|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482394|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482395|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482396|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
33482397|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482398|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482399|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482400|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482401|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33482402|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482403|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33553483|NCT02789137|62946030|FG000|Overall Study|Dropped out/Died|58|||
33659214|NCT02859558|63083946|FG000|Step 1|Moved|0|||
33659215|NCT02859558|63083947|FG001|Step 1|Moved|1|||
33659216|NCT02859558|63083948|FG002|Step 1|Moved|1|||
33659217|NCT02859558|63083949|FG003|Step 1|Moved|0|||
33659218|NCT02859558|63083950|FG004|Step 1|Moved|0|||
33659219|NCT02859558|63083946|FG000|Step 1|Withdrawal By Participant|1|||
33659220|NCT02859558|63083947|FG001|Step 1|Withdrawal By Participant|2|||
33659221|NCT02859558|63083948|FG002|Step 1|Withdrawal By Participant|1|||
33659222|NCT02859558|63083949|FG003|Step 1|Withdrawal By Participant|0|||
33659223|NCT02859558|63083950|FG004|Step 1|Withdrawal By Participant|0|||
33659224|NCT02859558|63083946|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
33659225|NCT02859558|63083947|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
33659226|NCT02859558|63083948|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
33659227|NCT02859558|63083949|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
33659228|NCT02859558|63083950|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
33659229|NCT02859558|63083946|FG000|Step 1|Incarceration|0|||
33364813|NCT02393248|62743320|FG017|Part 3: Combination Therapy|Adverse Event|0|||
33364814|NCT02393248|62743321|FG018|Part 3: Combination Therapy|Adverse Event|0|||
33364815|NCT02393248|62743322|FG019|Part 3: Combination Therapy|Adverse Event|0|||
33482404|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482405|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482406|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
33482407|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482408|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482409|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482410|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482411|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482412|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33482413|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
33482414|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33482415|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33364816|NCT02393248|62743323|FG020|Part 3: Combination Therapy|Adverse Event|0|||
33364817|NCT02393248|62743324|FG021|Part 3: Combination Therapy|Adverse Event|0|||
33364818|NCT02393248|62743325|FG022|Part 3: Combination Therapy|Adverse Event|0|||
33364819|NCT02393248|62743326|FG023|Part 3: Combination Therapy|Adverse Event|1|||
33364820|NCT02393248|62743327|FG024|Part 3: Combination Therapy|Adverse Event|0|||
33364821|NCT02393248|62743303|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364822|NCT02393248|62743304|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364823|NCT02393248|62743305|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364824|NCT02393248|62743306|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364825|NCT02393248|62743307|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364826|NCT02393248|62743308|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364827|NCT02393248|62743309|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364828|NCT02393248|62743310|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364829|NCT02393248|62743311|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364830|NCT02393248|62743312|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364831|NCT02393248|62743313|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364832|NCT02393248|62743314|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364833|NCT02393248|62743315|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364834|NCT02393248|62743316|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364835|NCT02393248|62743317|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364836|NCT02393248|62743318|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364837|NCT02393248|62743319|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364838|NCT02393248|62743320|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364839|NCT02393248|62743321|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364840|NCT02393248|62743322|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364841|NCT02393248|62743323|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364842|NCT02393248|62743324|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364843|NCT02393248|62743325|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364844|NCT02393248|62743326|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
33364845|NCT02393248|62743327|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33364846|NCT00601484|62743390|FG000|Overall Study|Adverse Event|0|||
33364847|NCT00601484|62743391|FG001|Overall Study|Adverse Event|1|||
33364848|NCT00601484|62743390|FG000|Overall Study|Lost to Follow-up|4|||
33364849|NCT00601484|62743391|FG001|Overall Study|Lost to Follow-up|3|||
33364850|NCT00601484|62743390|FG000|Overall Study|Lack of Efficacy|0|||
33364851|NCT00601484|62743391|FG001|Overall Study|Lack of Efficacy|2|||
33364852|NCT00601484|62743390|FG000|Overall Study|Withdrawal by Subject|1|||
33364853|NCT00601484|62743391|FG001|Overall Study|Withdrawal by Subject|1|||
33364854|NCT00601484|62743390|FG000|Overall Study|Randomized, but not treated|0|||
33364855|NCT00601484|62743391|FG001|Overall Study|Randomized, but not treated|1|||
33659230|NCT02859558|63083947|FG001|Step 1|Incarceration|1|||
33659231|NCT02859558|63083948|FG002|Step 1|Incarceration|0|||
33364856|NCT00883896|62743401|FG000|Overall Study|Lost to Follow-up|0|||
33659232|NCT02859558|63083949|FG003|Step 1|Incarceration|0|||
33659233|NCT02859558|63083950|FG004|Step 1|Incarceration|0|||
33659234|NCT02859558|63083946|FG000|Step 1|Non-Adherence to Study Drug|2|||
33659235|NCT02859558|63083947|FG001|Step 1|Non-Adherence to Study Drug|0|||
33659236|NCT02859558|63083948|FG002|Step 1|Non-Adherence to Study Drug|1|||
33659237|NCT02859558|63083949|FG003|Step 1|Non-Adherence to Study Drug|0|||
33659238|NCT02859558|63083950|FG004|Step 1|Non-Adherence to Study Drug|0|||
33659239|NCT02859558|63083946|FG000|Step 1|Non-Adherence to Study Requirements|3|||
33659240|NCT02859558|63083947|FG001|Step 1|Non-Adherence to Study Requirements|1|||
33659241|NCT02859558|63083948|FG002|Step 1|Non-Adherence to Study Requirements|0|||
33659242|NCT02859558|63083949|FG003|Step 1|Non-Adherence to Study Requirements|0|||
33659243|NCT02859558|63083950|FG004|Step 1|Non-Adherence to Study Requirements|0|||
33659244|NCT02859558|63083946|FG000|Step 1|Virologic Failure|2|||
33659245|NCT02859558|63083947|FG001|Step 1|Virologic Failure|1|||
33659246|NCT02859558|63083948|FG002|Step 1|Virologic Failure|1|||
33659247|NCT02859558|63083949|FG003|Step 1|Virologic Failure|0|||
33659248|NCT02859558|63083950|FG004|Step 1|Virologic Failure|0|||
33659249|NCT02859558|63083946|FG000|Step 2|Active On Study|23|||
33659250|NCT02859558|63083947|FG001|Step 2|Active On Study|38|||
33659251|NCT02859558|63083948|FG002|Step 2|Active On Study|20|||
33659252|NCT02859558|63083949|FG003|Step 2|Active On Study|0|||
33659253|NCT02859558|63083950|FG004|Step 2|Active On Study|0|||
33659254|NCT02859558|63083946|FG000|Step 2|Did Not Return to Clinic|2|||
33659255|NCT02859558|63083947|FG001|Step 2|Did Not Return to Clinic|0|||
33659256|NCT02859558|63083948|FG002|Step 2|Did Not Return to Clinic|0|||
33659257|NCT02859558|63083949|FG003|Step 2|Did Not Return to Clinic|0|||
33659258|NCT02859558|63083950|FG004|Step 2|Did Not Return to Clinic|0|||
33659259|NCT02859558|63083946|FG000|Step 2|Unexpected Closure of Site|0|||
33659260|NCT02859558|63083947|FG001|Step 2|Unexpected Closure of Site|1|||
33659261|NCT02859558|63083948|FG002|Step 2|Unexpected Closure of Site|1|||
33659262|NCT02859558|63083949|FG003|Step 2|Unexpected Closure of Site|0|||
33659263|NCT02859558|63083950|FG004|Step 2|Unexpected Closure of Site|0|||
33659264|NCT00705432|63084001|FG000|Treatment Period|Adverse Event|45|||
33659265|NCT00705432|63084002|FG001|Treatment Period|Adverse Event|37|||
33659266|NCT00705432|63084003|FG002|Treatment Period|Adverse Event|51|||
33659267|NCT00705432|63084004|FG003|Treatment Period|Adverse Event|12|||
33659268|NCT00705432|63084005|FG004|Treatment Period|Adverse Event|8|||
33659269|NCT00705432|63084006|FG005|Treatment Period|Adverse Event|9|||
33659270|NCT00705432|63084001|FG000|Treatment Period|Treatment failure|92|||
33659271|NCT00705432|63084002|FG001|Treatment Period|Treatment failure|42|||
33659272|NCT00705432|63084003|FG002|Treatment Period|Treatment failure|33|||
33659273|NCT00705432|63084004|FG003|Treatment Period|Treatment failure|25|||
33659274|NCT00705432|63084005|FG004|Treatment Period|Treatment failure|13|||
33659275|NCT00705432|63084006|FG005|Treatment Period|Treatment failure|14|||
33659276|NCT00705432|63084001|FG000|Treatment Period|Non medical reason|26|||
33659277|NCT00705432|63084002|FG001|Treatment Period|Non medical reason|32|||
33659278|NCT00705432|63084003|FG002|Treatment Period|Non medical reason|37|||
33659279|NCT00705432|63084004|FG003|Treatment Period|Non medical reason|4|||
33659280|NCT00705432|63084005|FG004|Treatment Period|Non medical reason|7|||
33659281|NCT00705432|63084006|FG005|Treatment Period|Non medical reason|7|||
33659282|NCT00705432|63084001|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
33659283|NCT00705432|63084002|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
33659284|NCT00705432|63084003|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
33659285|NCT00705432|63084004|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
33659286|NCT00705432|63084005|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
33659287|NCT00705432|63084006|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
33659288|NCT00705432|63084001|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
33659289|NCT00705432|63084002|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
33659290|NCT00705432|63084003|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
33659291|NCT00705432|63084004|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
33659292|NCT00705432|63084005|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
33659293|NCT00705432|63084006|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
33659294|NCT00704964|63084017|FG000|Overall Study|Not completed on time|328|||
33659295|NCT00704808|63084033|FG000|Overall Study|Discontinued prior to starting treatment|14|||
33659296|NCT00704808|63084033|FG000|Overall Study|Death|7|||
33659297|NCT00704808|63084033|FG000|Overall Study|Tumor progression|80|||
33659298|NCT00704808|63084033|FG000|Overall Study|Patient's decision|11|||
33659299|NCT00704808|63084033|FG000|Overall Study|Early therapy discontinuation|16|||
33659300|NCT00704808|63084033|FG000|Overall Study|Adverse Event|1|||
33659301|NCT00704808|63084033|FG000|Overall Study|Lost to Follow-up|1|||
33659302|NCT00704808|63084033|FG000|Overall Study|Treatment change|1|||
33659303|NCT05166876|63084067|FG000|Overall Study|Withdrawal by Subject|1|||
33659304|NCT05166876|63084068|FG001|Overall Study|Withdrawal by Subject|0|||
33659305|NCT05166876|63084069|FG002|Overall Study|Withdrawal by Subject|0|||
33659306|NCT01375608|63084081|FG000|Overall Study|Withdrawal by Subject|2|||
33659307|NCT00704418|63084096|FG000|Overall Study|Withdrawal by Subject|2|||
33659308|NCT00704418|63084097|FG001|Overall Study|Withdrawal by Subject|0|||
33659309|NCT00704418|63084096|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
33659310|NCT00704418|63084097|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
33659311|NCT00704340|63084166|FG000|Overall Study|Lost to Follow-up|2|||
33659312|NCT00704340|63084167|FG001|Overall Study|Lost to Follow-up|1|||
33659313|NCT00704340|63084166|FG000|Overall Study|Death|0|||
33659314|NCT00704340|63084167|FG001|Overall Study|Death|1|||
33659315|NCT00552058|63084175|FG000|Overall Study|Adverse Event|8|||
33659316|NCT00552058|63084176|FG001|Overall Study|Adverse Event|7|||
33659317|NCT00552058|63084175|FG000|Overall Study|Lack of Efficacy|1|||
33659318|NCT00552058|63084176|FG001|Overall Study|Lack of Efficacy|5|||
33659319|NCT00552058|63084175|FG000|Overall Study|Lost to Follow-up|1|||
33659320|NCT00552058|63084176|FG001|Overall Study|Lost to Follow-up|0|||
33659321|NCT00552058|63084175|FG000|Overall Study|Withdrawal by Subject|4|||
33659322|NCT00552058|63084176|FG001|Overall Study|Withdrawal by Subject|4|||
33659323|NCT00552058|63084175|FG000|Overall Study|Other: Protocol Violation|0|||
33482416|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
33482417|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33482418|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33482419|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33482420|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33553484|NCT01672970|62946035|FG000|Overall Study|Lack of Efficacy|12|||
33553485|NCT01672970|62946035|FG000|Overall Study|Adverse Event|18|||
33553486|NCT01672970|62946035|FG000|Overall Study|Withdrawal by Subject|2|||
33553487|NCT01672970|62946035|FG000|Overall Study|Lost to Follow-up|5|||
33553488|NCT01672970|62946035|FG000|Overall Study|Other|9|||
33553489|NCT01672970|62946035|FG000|Overall Study|Enrolled but not treated|1|||
33553490|NCT02788747|62946059|FG000|Overall Study|Adverse Event|1|||
33553491|NCT02788747|62946060|FG001|Overall Study|Adverse Event|0|||
33553492|NCT02788747|62946061|FG002|Overall Study|Adverse Event|0|||
33553493|NCT02406742|62946075|FG000|Overall Study|Progression of Disease|5|||
33553494|NCT02406742|62946076|FG001|Overall Study|Progression of Disease|1|||
33553495|NCT02406742|62946077|FG002|Overall Study|Progression of Disease|6|||
33553496|NCT02406742|62946075|FG000|Overall Study|Adverse Event|3|||
33553497|NCT02406742|62946076|FG001|Overall Study|Adverse Event|0|||
33553498|NCT02406742|62946077|FG002|Overall Study|Adverse Event|2|||
33553499|NCT02406742|62946075|FG000|Overall Study|Death|1|||
33553500|NCT02406742|62946076|FG001|Overall Study|Death|0|||
33553501|NCT02406742|62946077|FG002|Overall Study|Death|0|||
33553502|NCT02406742|62946075|FG000|Overall Study|Lack of Efficacy|0|||
33553503|NCT02406742|62946076|FG001|Overall Study|Lack of Efficacy|0|||
33553504|NCT02406742|62946077|FG002|Overall Study|Lack of Efficacy|1|||
33553505|NCT02406742|62946075|FG000|Overall Study|Withdrawal by Participant|1|||
33553506|NCT02406742|62946076|FG001|Overall Study|Withdrawal by Participant|2|||
33553507|NCT02406742|62946077|FG002|Overall Study|Withdrawal by Participant|0|||
33553508|NCT02406742|62946075|FG000|Overall Study|Physician Decision|1|||
33553509|NCT02406742|62946076|FG001|Overall Study|Physician Decision|2|||
33553510|NCT02406742|62946077|FG002|Overall Study|Physician Decision|1|||
33553511|NCT02406742|62946075|FG000|Overall Study|Transition to other treatment|2|||
33553512|NCT02406742|62946076|FG001|Overall Study|Transition to other treatment|0|||
33553513|NCT02406742|62946077|FG002|Overall Study|Transition to other treatment|1|||
33553514|NCT02406742|62946075|FG000|Overall Study|Other Reasons|1|||
33553515|NCT02406742|62946076|FG001|Overall Study|Other Reasons|11|||
33553516|NCT02406742|62946077|FG002|Overall Study|Other Reasons|5|||
33553517|NCT02714595|62946087|FG000|Overall Study|Lost to Follow-up|1|||
33553518|NCT02714595|62946088|FG001|Overall Study|Lost to Follow-up|0|||
33553519|NCT02714595|62946087|FG000|Overall Study|Withdrawal by Subject|1|||
33482421|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33482422|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
33482423|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33482424|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33553520|NCT02714595|62946088|FG001|Overall Study|Withdrawal by Subject|2|||
33553521|NCT02714595|62946087|FG000|Overall Study|Lack of Efficacy|0|||
33553522|NCT02714595|62946088|FG001|Overall Study|Lack of Efficacy|1|||
33553523|NCT02714595|62946087|FG000|Overall Study|Death|30|||
33553524|NCT02714595|62946088|FG001|Overall Study|Death|9|||
33553525|NCT02714595|62946087|FG000|Overall Study|Other-Miscellaneous|0|||
33659324|NCT00552058|63084176|FG001|Overall Study|Other: Protocol Violation|1|||
33364857|NCT00883896|62743402|FG001|Overall Study|Lost to Follow-up|0|||
33553526|NCT02714595|62946088|FG001|Overall Study|Other-Miscellaneous|1|||
33553527|NCT02437162|62946115|FG000|Overall Study|Protocol Violation|0|||
33553528|NCT02437162|62946116|FG001|Overall Study|Protocol Violation|1|||
33553529|NCT02437162|62946117|FG002|Overall Study|Protocol Violation|0|||
33553530|NCT02437162|62946115|FG000|Overall Study|Randomized but not treated|0|||
33580961|NCT01268293|62978106|FG000|Overall Study|Disease progression|7|||
33659325|NCT00552058|63084175|FG000|Overall Study|Other: Non Compliance|1|||
33659326|NCT00552058|63084176|FG001|Overall Study|Other: Non Compliance|2|||
33553531|NCT02437162|62946116|FG001|Overall Study|Randomized but not treated|0|||
33482425|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33482426|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
33482427|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33553532|NCT02437162|62946117|FG002|Overall Study|Randomized but not treated|1|||
33553533|NCT02437162|62946115|FG000|Overall Study|Study discontinued by Sponsor|93|||
33553534|NCT02437162|62946116|FG001|Overall Study|Study discontinued by Sponsor|98|||
33553535|NCT02437162|62946117|FG002|Overall Study|Study discontinued by Sponsor|97|||
33553536|NCT02437162|62946115|FG000|Overall Study|Withdrawal by Subject|13|||
33553537|NCT02437162|62946116|FG001|Overall Study|Withdrawal by Subject|7|||
33553538|NCT02437162|62946117|FG002|Overall Study|Withdrawal by Subject|9|||
33553539|NCT02437162|62946115|FG000|Overall Study|Adverse Event|0|||
33553540|NCT02437162|62946116|FG001|Overall Study|Adverse Event|1|||
33553541|NCT02437162|62946117|FG002|Overall Study|Adverse Event|0|||
33553542|NCT02437162|62946115|FG000|Overall Study|Lost to Follow-up|1|||
33553543|NCT02437162|62946116|FG001|Overall Study|Lost to Follow-up|0|||
33553544|NCT02437162|62946117|FG002|Overall Study|Lost to Follow-up|1|||
33553545|NCT02437162|62946115|FG000|Overall Study|Death|0|||
33553546|NCT02437162|62946116|FG001|Overall Study|Death|1|||
33553547|NCT02437162|62946117|FG002|Overall Study|Death|0|||
33553548|NCT02437162|62946115|FG000|Overall Study|Other|0|||
33553549|NCT02437162|62946116|FG001|Overall Study|Other|0|||
33553550|NCT02437162|62946117|FG002|Overall Study|Other|1|||
33553551|NCT01368211|62946132|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
33553552|NCT01368211|62946133|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
33553553|NCT02437084|62946139|FG000|Overall Study|Withdrawal by Subject|2|||
33553554|NCT02437084|62946139|FG000|Overall Study|Physician Decision|1|||
33553555|NCT02406586|62946146|FG000|Overall Study|Lost to Follow-up|0|||
33553556|NCT02406586|62946147|FG001|Overall Study|Lost to Follow-up|4|||
33553557|NCT02406586|62946148|FG002|Overall Study|Lost to Follow-up|2|||
33553558|NCT02406586|62946146|FG000|Overall Study|Withdrawal by Subject|1|||
33553559|NCT02406586|62946147|FG001|Overall Study|Withdrawal by Subject|0|||
33659327|NCT00552058|63084175|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
33659328|NCT00552058|63084176|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
33482428|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33482429|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33482430|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33482431|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33482432|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
33482433|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
33482434|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
33482435|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
33482436|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
33482437|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
33482438|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
33482439|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
33482440|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
33482441|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
33482442|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Other|5|||
33482443|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Other|1|||
33553560|NCT02406586|62946148|FG002|Overall Study|Withdrawal by Subject|0|||
33553561|NCT02460562|62946161|FG000|Overall Study|Lost to Follow-up|15|||
33553562|NCT02460562|62946162|FG001|Overall Study|Lost to Follow-up|16|||
33659329|NCT00552058|63084175|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
33364858|NCT00883896|62743403|FG002|Overall Study|Lost to Follow-up|0|||
33553563|NCT02788357|62946170|FG000|Overall Study|Lost to Follow-up|3|||
33553564|NCT02788357|62946171|FG001|Overall Study|Lost to Follow-up|0|||
33553565|NCT02457910|62946183|FG000|Overall Study|Withdrawal by Subject|0|||
33659330|NCT00552058|63084176|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
33659331|NCT00552058|63084175|FG000|Overall Study|Other: Positive Stool Result|0|||
33659332|NCT00552058|63084176|FG001|Overall Study|Other: Positive Stool Result|1|||
33659333|NCT00552058|63084175|FG000|Overall Study|Other: Randomized in error|0|||
33659334|NCT00552058|63084176|FG001|Overall Study|Other: Randomized in error|1|||
33659335|NCT00552058|63084175|FG000|Overall Study|Other: Sponsors Decision|0|||
33659336|NCT00552058|63084176|FG001|Overall Study|Other: Sponsors Decision|1|||
33659337|NCT00552058|63084175|FG000|Overall Study|Other: Early Roll Over|1|||
33659338|NCT00552058|63084176|FG001|Overall Study|Other: Early Roll Over|0|||
33659339|NCT00550732|63084205|FG000|Overall Study|Death|4|||
33659340|NCT00550732|63084205|FG000|Overall Study|Withdrawal by Subject|2|||
33659341|NCT00550732|63084205|FG000|Overall Study|Physician Decision|2|||
33659342|NCT00550732|63084205|FG000|Overall Study|Lost to Follow-up|1|||
33482444|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Other|0|||
33482445|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Other|3|||
33482446|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Other|0|||
33482447|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Other|0|||
33482448|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Other|0|||
33482449|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Other|0|||
33482450|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Other|0|||
33482451|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Other|0|||
33482452|NCT03352557|62859107|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
33482453|NCT03352557|62859108|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
33482454|NCT03352557|62859109|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
33482455|NCT03352557|62859110|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
33482456|NCT03352557|62859111|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
33482457|NCT03352557|62859112|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
33482458|NCT03352557|62859113|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
33482459|NCT03352557|62859114|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
33482460|NCT03352557|62859115|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
33482461|NCT03352557|62859116|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
33482462|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|Death|0|||
33482463|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|Death|0|||
33482464|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|Death|0|||
33482465|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|Death|0|||
33482466|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|Death|0|||
33482467|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|Death|1|||
33482468|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|Death|0|||
33482469|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|Death|1|||
33482470|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|Death|1|||
33482471|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|Death|1|||
33482472|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33482473|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33482474|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33482475|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33482476|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33482477|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
33482478|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33482479|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33482480|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33482481|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33659343|NCT00550732|63084205|FG000|Overall Study|Palliative care|1|||
33659344|NCT00550732|63084205|FG000|Overall Study|Adverse Event|1|||
33659345|NCT00550420|63084219|FG000|Overall Study|Adverse Event|28|||
33659346|NCT00550420|63084219|FG000|Overall Study|Lost to Follow-up|8|||
33659347|NCT00550420|63084219|FG000|Overall Study|Protocol Violation|11|||
33482482|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33659348|NCT00550420|63084219|FG000|Overall Study|Withdrawal by Subject|30|||
33659349|NCT00550420|63084219|FG000|Overall Study|Still in study at termination|206|||
33482483|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33482484|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33482485|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33659350|NCT00550420|63084219|FG000|Overall Study|Missing|2|||
33659351|NCT00550420|63084219|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
33659352|NCT00550420|63084219|FG000|Overall Study|Investigators opinion|1|||
33659353|NCT00550420|63084219|FG000|Overall Study|Lack of curative effect|1|||
33659354|NCT00550420|63084219|FG000|Overall Study|Unethical stop of enrollment|2|||
33659355|NCT00550420|63084219|FG000|Overall Study|Caregiver's decision to withdraw|1|||
33659356|NCT00550420|63084219|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
33659357|NCT00550420|63084219|FG000|Overall Study|Exclusion criteria|1|||
33659358|NCT00550420|63084219|FG000|Overall Study|Prohibited medicine|1|||
33659359|NCT00558064|63084231|FG000|Overall Study|Adverse Event|3|||
33659360|NCT00558064|63084232|FG001|Overall Study|Adverse Event|2|||
33659361|NCT00558064|63084231|FG000|Overall Study|Lack of Efficacy|0|||
33659362|NCT00558064|63084232|FG001|Overall Study|Lack of Efficacy|1|||
33659363|NCT00558064|63084231|FG000|Overall Study|Protocol Violation|1|||
33659364|NCT00558064|63084232|FG001|Overall Study|Protocol Violation|0|||
33553566|NCT02457910|62946184|FG001|Overall Study|Withdrawal by Subject|0|||
33553567|NCT02457910|62946185|FG002|Overall Study|Withdrawal by Subject|0|||
33553568|NCT02457910|62946186|FG003|Overall Study|Withdrawal by Subject|0|||
33553569|NCT02457910|62946187|FG004|Overall Study|Withdrawal by Subject|0|||
33553570|NCT02457910|62946188|FG005|Overall Study|Withdrawal by Subject|1|||
33553571|NCT02457910|62946183|FG000|Overall Study|Adverse Event|0|||
33553572|NCT02457910|62946184|FG001|Overall Study|Adverse Event|2|||
33553573|NCT02457910|62946185|FG002|Overall Study|Adverse Event|1|||
33553574|NCT02457910|62946186|FG003|Overall Study|Adverse Event|1|||
33553575|NCT02457910|62946187|FG004|Overall Study|Adverse Event|1|||
33553576|NCT02457910|62946188|FG005|Overall Study|Adverse Event|3|||
33553577|NCT02457910|62946183|FG000|Overall Study|Disease progression|3|||
33553578|NCT02457910|62946184|FG001|Overall Study|Disease progression|3|||
33553579|NCT02457910|62946185|FG002|Overall Study|Disease progression|1|||
33553580|NCT02457910|62946186|FG003|Overall Study|Disease progression|1|||
33553581|NCT02457910|62946187|FG004|Overall Study|Disease progression|4|||
33553582|NCT02457910|62946188|FG005|Overall Study|Disease progression|6|||
33553583|NCT02457910|62946183|FG000|Overall Study|Other complicating illness|0|||
33553584|NCT02457910|62946184|FG001|Overall Study|Other complicating illness|0|||
33553585|NCT02457910|62946185|FG002|Overall Study|Other complicating illness|0|||
33553586|NCT02457910|62946186|FG003|Overall Study|Other complicating illness|0|||
33553587|NCT02457910|62946187|FG004|Overall Study|Other complicating illness|0|||
33553588|NCT02457910|62946188|FG005|Overall Study|Other complicating illness|1|||
33553589|NCT02457910|62946183|FG000|Overall Study|Death|0|||
33659365|NCT00558064|63084231|FG000|Overall Study|Lost to Follow-up|0|||
33659366|NCT00558064|63084232|FG001|Overall Study|Lost to Follow-up|1|||
33659367|NCT00558064|63084231|FG000|Overall Study|Withdrawal by Subject|0|||
33659368|NCT00558064|63084232|FG001|Overall Study|Withdrawal by Subject|1|||
33659369|NCT00558064|63084231|FG000|Overall Study|No visit within allowance period|1|||
33364859|NCT00883896|62743404|FG003|Overall Study|Lost to Follow-up|2|||
33364860|NCT00883896|62743401|FG000|Overall Study|Withdrawal by Subject|5|||
33364861|NCT00883896|62743402|FG001|Overall Study|Withdrawal by Subject|0|||
33364862|NCT00883896|62743403|FG002|Overall Study|Withdrawal by Subject|1|||
33659370|NCT00558064|63084232|FG001|Overall Study|No visit within allowance period|0|||
33659371|NCT00557830|63084241|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
33659372|NCT00557830|63084242|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
33659373|NCT00557830|63084243|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
33364863|NCT00883896|62743404|FG003|Overall Study|Withdrawal by Subject|3|||
33364864|NCT00883896|62743401|FG000|Overall Study|Lack of Efficacy|0|||
33364865|NCT00883896|62743402|FG001|Overall Study|Lack of Efficacy|0|||
33553590|NCT02457910|62946184|FG001|Overall Study|Death|0|||
33553591|NCT02457910|62946185|FG002|Overall Study|Death|1|||
33553592|NCT02457910|62946186|FG003|Overall Study|Death|0|||
33553593|NCT02457910|62946187|FG004|Overall Study|Death|0|||
33659374|NCT00557830|63084241|FG000|Screening Treatment Phase|Adverse Event|2|||
33659375|NCT00557830|63084242|FG001|Screening Treatment Phase|Adverse Event|0|||
33659376|NCT00557830|63084243|FG002|Screening Treatment Phase|Adverse Event|0|||
33659377|NCT00557830|63084241|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
33659378|NCT00557830|63084242|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
33659379|NCT00557830|63084243|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
33659380|NCT00557440|63084254|FG000|Treatment Period 1|Adverse Event|0|||
33659381|NCT00557440|63084255|FG001|Treatment Period 1|Adverse Event|0|||
33659382|NCT00557440|63084256|FG002|Treatment Period 1|Adverse Event|1|||
33659383|NCT00556894|63084267|FG000|Overall Study|Adverse Event|2|||
33659384|NCT00556894|63084268|FG001|Overall Study|Adverse Event|3|||
33659385|NCT00556894|63084269|FG002|Overall Study|Adverse Event|3|||
33659386|NCT00556894|63084267|FG000|Overall Study|Death|1|||
33659387|NCT00556894|63084268|FG001|Overall Study|Death|0|||
33659388|NCT00556894|63084269|FG002|Overall Study|Death|0|||
33659389|NCT00556894|63084267|FG000|Overall Study|regulatory decision in Bulgaria|10|||
33659390|NCT00556894|63084268|FG001|Overall Study|regulatory decision in Bulgaria|14|||
33659391|NCT00556894|63084269|FG002|Overall Study|regulatory decision in Bulgaria|13|||
33659392|NCT00556894|63084267|FG000|Overall Study|Change in therapy|2|||
33659393|NCT00556894|63084268|FG001|Overall Study|Change in therapy|1|||
33553594|NCT02457910|62946188|FG005|Overall Study|Death|0|||
33553595|NCT02405962|62946207|FG000|Overall Study|Lost to Follow-up|1|||
33553596|NCT02405962|62946208|FG001|Overall Study|Lost to Follow-up|4|||
33553597|NCT02405962|62946207|FG000|Overall Study|A participant has moved to another place|0|||
33553598|NCT02405962|62946208|FG001|Overall Study|A participant has moved to another place|1|||
33553599|NCT02436304|62946217|FG000|Overall Study|Lost to Follow-up|0|||
33553600|NCT02436304|62946218|FG001|Overall Study|Lost to Follow-up|1|||
33553601|NCT02436304|62946219|FG002|Overall Study|Lost to Follow-up|0|||
33553602|NCT02436304|62946217|FG000|Overall Study|Withdrawal by Subject|0|||
33553603|NCT02436304|62946218|FG001|Overall Study|Withdrawal by Subject|1|||
33553604|NCT02436304|62946219|FG002|Overall Study|Withdrawal by Subject|0|||
33553605|NCT02436304|62946217|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
33553606|NCT02436304|62946218|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
33553607|NCT02436304|62946219|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
33553608|NCT02402218|62946231|FG000|Overall Study|Did not pickup study medication|12|||
33553609|NCT02402218|62946232|FG001|Overall Study|Did not pickup study medication|9|||
33553610|NCT02402218|62946233|FG002|Overall Study|Did not pickup study medication|13|||
33553611|NCT02402218|62946231|FG000|Overall Study|Lack of Efficacy|0|||
33553612|NCT02402218|62946232|FG001|Overall Study|Lack of Efficacy|1|||
33553613|NCT02402218|62946233|FG002|Overall Study|Lack of Efficacy|1|||
33659394|NCT00556894|63084269|FG002|Overall Study|Change in therapy|2|||
33659395|NCT00556894|63084267|FG000|Overall Study|Withdrawal by Subject|1|||
33659396|NCT00556894|63084268|FG001|Overall Study|Withdrawal by Subject|1|||
33659397|NCT00556894|63084269|FG002|Overall Study|Withdrawal by Subject|1|||
33659398|NCT02722044|63084277|FG000|Overall Study|Adverse Event|2|||
33659399|NCT02722044|63084277|FG000|Overall Study|Physician Decision|1|||
33659400|NCT02722044|63084277|FG000|Overall Study|Withdrawal by Subject|1|||
33659401|NCT02722044|63084277|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
33659402|NCT00556426|63084282|FG000|Overall Study|Withdrawal by Subject|3|||
33659403|NCT00556426|63084282|FG000|Overall Study|Death|6|||
33659404|NCT00555568|63084290|FG000|Overall Study|Lost to Follow-up|26|||
33659405|NCT00555568|63084291|FG001|Overall Study|Lost to Follow-up|16|||
33659406|NCT00555568|63084292|FG002|Overall Study|Lost to Follow-up|16|||
33659407|NCT00702702|63084303|FG000|Overall Study|Study prematurely terminated|56|||
33659408|NCT02721966|63084314|FG000|Overall Study|Protocol Violation|1|||
33659409|NCT02721966|63084315|FG001|Overall Study|Protocol Violation|0|||
33482486|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33482487|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33482488|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33482489|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33482490|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
33482491|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33482492|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
33482493|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
33553614|NCT02402218|62946231|FG000|Overall Study|Death|1|||
33553615|NCT02402218|62946232|FG001|Overall Study|Death|0|||
33659410|NCT02721966|63084316|FG002|Overall Study|Protocol Violation|0|||
33659411|NCT02721966|63084317|FG003|Overall Study|Protocol Violation|0|||
33659412|NCT02721966|63084318|FG004|Overall Study|Protocol Violation|0|||
33659413|NCT02721966|63084314|FG000|Overall Study|Withdrawal by Subject|9|||
33553616|NCT02402218|62946233|FG002|Overall Study|Death|0|||
33659414|NCT02721966|63084315|FG001|Overall Study|Withdrawal by Subject|2|||
33659415|NCT02721966|63084316|FG002|Overall Study|Withdrawal by Subject|3|||
33659416|NCT02721966|63084317|FG003|Overall Study|Withdrawal by Subject|7|||
33659417|NCT02721966|63084318|FG004|Overall Study|Withdrawal by Subject|0|||
33659418|NCT02721966|63084314|FG000|Overall Study|Adverse Event|4|||
33659419|NCT02721966|63084315|FG001|Overall Study|Adverse Event|4|||
33659420|NCT02721966|63084316|FG002|Overall Study|Adverse Event|3|||
33659421|NCT02721966|63084317|FG003|Overall Study|Adverse Event|0|||
33659422|NCT02721966|63084318|FG004|Overall Study|Adverse Event|0|||
33553617|NCT02402218|62946231|FG000|Overall Study|Reinfection|0|||
33553618|NCT02402218|62946232|FG001|Overall Study|Reinfection|0|||
33553619|NCT02402218|62946233|FG002|Overall Study|Reinfection|1|||
33553620|NCT02402218|62946231|FG000|Overall Study|Adverse Event|0|||
33553621|NCT02402218|62946232|FG001|Overall Study|Adverse Event|2|||
33553622|NCT02402218|62946233|FG002|Overall Study|Adverse Event|1|||
33553623|NCT02402218|62946231|FG000|Overall Study|Withdrawal by Subject|1|||
33553624|NCT02402218|62946232|FG001|Overall Study|Withdrawal by Subject|1|||
33553625|NCT02402218|62946233|FG002|Overall Study|Withdrawal by Subject|1|||
33659423|NCT02721966|63084314|FG000|Overall Study|Death|1|||
33659424|NCT02721966|63084315|FG001|Overall Study|Death|0|||
33659425|NCT02721966|63084316|FG002|Overall Study|Death|0|||
33659426|NCT02721966|63084317|FG003|Overall Study|Death|0|||
33659427|NCT02721966|63084318|FG004|Overall Study|Death|0|||
33659428|NCT02721966|63084314|FG000|Overall Study|Lack of Efficacy|7|||
33659429|NCT02721966|63084315|FG001|Overall Study|Lack of Efficacy|4|||
33659430|NCT02721966|63084316|FG002|Overall Study|Lack of Efficacy|0|||
33659431|NCT02721966|63084317|FG003|Overall Study|Lack of Efficacy|0|||
33659432|NCT02721966|63084318|FG004|Overall Study|Lack of Efficacy|0|||
33659433|NCT02721966|63084314|FG000|Overall Study|Lost to Follow-up|0|||
33659434|NCT02721966|63084315|FG001|Overall Study|Lost to Follow-up|0|||
33659435|NCT02721966|63084316|FG002|Overall Study|Lost to Follow-up|3|||
33659436|NCT02721966|63084317|FG003|Overall Study|Lost to Follow-up|0|||
33659437|NCT02721966|63084318|FG004|Overall Study|Lost to Follow-up|0|||
33659438|NCT02721966|63084314|FG000|Overall Study|Physician Decision|1|||
33659439|NCT02721966|63084315|FG001|Overall Study|Physician Decision|1|||
33659440|NCT02721966|63084316|FG002|Overall Study|Physician Decision|0|||
33659441|NCT02721966|63084317|FG003|Overall Study|Physician Decision|0|||
33659442|NCT02721966|63084318|FG004|Overall Study|Physician Decision|0|||
33659443|NCT02721966|63084314|FG000|Overall Study|Pregnancy|1|||
33659444|NCT02721966|63084315|FG001|Overall Study|Pregnancy|0|||
33659445|NCT02721966|63084316|FG002|Overall Study|Pregnancy|0|||
33659446|NCT02721966|63084317|FG003|Overall Study|Pregnancy|0|||
33659447|NCT02721966|63084318|FG004|Overall Study|Pregnancy|0|||
33659448|NCT02721966|63084314|FG000|Overall Study|Did not continue to period 2|5|||
33659449|NCT02721966|63084315|FG001|Overall Study|Did not continue to period 2|12|||
33659450|NCT02721966|63084316|FG002|Overall Study|Did not continue to period 2|0|||
33659451|NCT02721966|63084317|FG003|Overall Study|Did not continue to period 2|0|||
33659452|NCT02721966|63084318|FG004|Overall Study|Did not continue to period 2|5|||
33659453|NCT00553462|63084326|FG000|Overall Study|Adverse Event|4|||
33659454|NCT00553462|63084326|FG000|Overall Study|Progression|4|||
33659455|NCT00553462|63084326|FG000|Overall Study|Withdrawal by Subject|5|||
33659456|NCT00553462|63084326|FG000|Overall Study|Physician Decision|1|||
33482494|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
33482495|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
33482496|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
33482497|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
33482498|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
33482499|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
33482500|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
33482501|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
33482502|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33553626|NCT02457520|62946241|FG000|Active Treatment Phase|Adverse Event|10|||
33553627|NCT02457520|62946241|FG000|Active Treatment Phase|Lost to Follow-up|8|||
33553628|NCT02457520|62946241|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
33553629|NCT02457520|62946241|FG000|Active Treatment Phase|other|4|||
33553630|NCT02457520|62946241|FG000|Active Treatment Phase|Physician Decision|1|||
33659457|NCT00553150|63084332|FG000|Overall Study|Withdrawal by Subject|0|||
33659458|NCT00553150|63084333|FG001|Overall Study|Withdrawal by Subject|0|||
33659459|NCT00553150|63084334|FG002|Overall Study|Withdrawal by Subject|0|||
33659460|NCT00553150|63084335|FG003|Overall Study|Withdrawal by Subject|2|||
33659461|NCT00553150|63084332|FG000|Overall Study|Protocol Violation|0|||
33659462|NCT00553150|63084333|FG001|Overall Study|Protocol Violation|0|||
33553631|NCT02457520|62946241|FG000|Active Treatment Phase|Protocol Violation|1|||
33553632|NCT02457520|62946241|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
33659463|NCT00553150|63084334|FG002|Overall Study|Protocol Violation|0|||
33659464|NCT00553150|63084335|FG003|Overall Study|Protocol Violation|1|||
33659465|NCT00553150|63084332|FG000|Overall Study|Ineligible|0|||
33659466|NCT00553150|63084333|FG001|Overall Study|Ineligible|0|||
33659467|NCT00553150|63084334|FG002|Overall Study|Ineligible|0|||
33553633|NCT02457520|62946241|FG000|Post-treatment Period|Other: Retreatment Required|7|||
33553634|NCT02457520|62946241|FG000|Post-treatment Period|Lost to Follow-up|23|||
33553635|NCT02457520|62946241|FG000|Post-treatment Period|Other|3|||
33553636|NCT02457520|62946241|FG000|Post-treatment Period|Physician Decision|1|||
33553637|NCT02457520|62946241|FG000|Post-treatment Period|Withdrawal by Subject|14|||
33553638|NCT02788279|62946274|FG000|Overall Study|Death|62|||
33553639|NCT02788279|62946275|FG001|Overall Study|Death|136|||
33553640|NCT02788279|62946276|FG002|Overall Study|Death|72|||
33553641|NCT02788279|62946274|FG000|Overall Study|Withdrawal by Subject|10|||
33553642|NCT02788279|62946275|FG001|Overall Study|Withdrawal by Subject|15|||
33553643|NCT02788279|62946276|FG002|Overall Study|Withdrawal by Subject|5|||
33553644|NCT02788279|62946274|FG000|Overall Study|Lost to Follow-up|0|||
33553645|NCT02788279|62946275|FG001|Overall Study|Lost to Follow-up|3|||
33553646|NCT02788279|62946276|FG002|Overall Study|Lost to Follow-up|2|||
33553647|NCT02788279|62946274|FG000|Overall Study|Sponsor decision|18|||
33553648|NCT02788279|62946275|FG001|Overall Study|Sponsor decision|29|||
33553649|NCT02788279|62946276|FG002|Overall Study|Sponsor decision|11|||
33553650|NCT02435992|62946292|FG000|Overall Study|non compliance with protocol|2|||
33553651|NCT02435992|62946293|FG001|Overall Study|non compliance with protocol|0|||
33553652|NCT02435992|62946294|FG002|Overall Study|non compliance with protocol|1|||
33553653|NCT02435992|62946295|FG003|Overall Study|non compliance with protocol|0|||
33553654|NCT02435992|62946296|FG004|Overall Study|non compliance with protocol|0|||
33553655|NCT02435992|62946292|FG000|Overall Study|Adverse Event|11|||
33553656|NCT02435992|62946293|FG001|Overall Study|Adverse Event|6|||
33553657|NCT02435992|62946294|FG002|Overall Study|Adverse Event|12|||
33553658|NCT02435992|62946295|FG003|Overall Study|Adverse Event|0|||
33553659|NCT02435992|62946296|FG004|Overall Study|Adverse Event|0|||
33553660|NCT02435992|62946292|FG000|Overall Study|Lack of Efficacy|4|||
33553661|NCT02435992|62946293|FG001|Overall Study|Lack of Efficacy|10|||
33553662|NCT02435992|62946294|FG002|Overall Study|Lack of Efficacy|9|||
33553663|NCT02435992|62946295|FG003|Overall Study|Lack of Efficacy|0|||
33553664|NCT02435992|62946296|FG004|Overall Study|Lack of Efficacy|0|||
33553665|NCT02435992|62946292|FG000|Overall Study|Withdrawal by Subject|10|||
33553666|NCT02435992|62946293|FG001|Overall Study|Withdrawal by Subject|8|||
33553667|NCT02435992|62946294|FG002|Overall Study|Withdrawal by Subject|20|||
33553668|NCT02435992|62946295|FG003|Overall Study|Withdrawal by Subject|0|||
33553669|NCT02435992|62946296|FG004|Overall Study|Withdrawal by Subject|0|||
33553670|NCT02435992|62946292|FG000|Overall Study|Other Reason|1|||
33553671|NCT02435992|62946293|FG001|Overall Study|Other Reason|0|||
33553672|NCT02435992|62946294|FG002|Overall Study|Other Reason|0|||
33553673|NCT02435992|62946295|FG003|Overall Study|Other Reason|0|||
33553674|NCT02435992|62946296|FG004|Overall Study|Other Reason|0|||
33553675|NCT02435992|62946292|FG000|Overall Study|Physician Decision|0|||
33553676|NCT02435992|62946293|FG001|Overall Study|Physician Decision|0|||
33553677|NCT02435992|62946294|FG002|Overall Study|Physician Decision|1|||
33553678|NCT02435992|62946295|FG003|Overall Study|Physician Decision|0|||
33553679|NCT02435992|62946296|FG004|Overall Study|Physician Decision|0|||
33553680|NCT02788513|62946313|FG000|Overall Study|Withdrawal by Subject|3|||
33553681|NCT02788513|62946314|FG001|Overall Study|Withdrawal by Subject|0|||
33553682|NCT02788513|62946315|FG002|Overall Study|Withdrawal by Subject|2|||
33553683|NCT02788513|62946316|FG003|Overall Study|Withdrawal by Subject|3|||
33364866|NCT00883896|62743403|FG002|Overall Study|Lack of Efficacy|0|||
33364867|NCT00883896|62743404|FG003|Overall Study|Lack of Efficacy|2|||
33364868|NCT00883896|62743401|FG000|Overall Study|Other|1|||
33364869|NCT00883896|62743402|FG001|Overall Study|Other|0|||
33482503|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33482504|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33482505|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33482506|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33482507|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
33482508|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33482509|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
33553684|NCT02788513|62946317|FG004|Overall Study|Withdrawal by Subject|1|||
33553685|NCT02788513|62946313|FG000|Overall Study|Lost to Follow-up|1|||
33553686|NCT02788513|62946314|FG001|Overall Study|Lost to Follow-up|0|||
33553687|NCT02788513|62946315|FG002|Overall Study|Lost to Follow-up|0|||
33553688|NCT02788513|62946316|FG003|Overall Study|Lost to Follow-up|0|||
33553689|NCT02788513|62946317|FG004|Overall Study|Lost to Follow-up|1|||
33364870|NCT00883896|62743403|FG002|Overall Study|Other|0|||
33364871|NCT00883896|62743404|FG003|Overall Study|Other|0|||
33553690|NCT02788513|62946313|FG000|Overall Study|Adverse Event|5|||
33553691|NCT02788513|62946314|FG001|Overall Study|Adverse Event|8|||
33553692|NCT02788513|62946315|FG002|Overall Study|Adverse Event|4|||
33553693|NCT02788513|62946316|FG003|Overall Study|Adverse Event|2|||
33659468|NCT00553150|63084335|FG003|Overall Study|Ineligible|1|||
33659469|NCT03301350|63084343|FG000|Overall Study|Withdrawal by Subject|4|||
33659470|NCT03301350|63084343|FG000|Overall Study|Adverse Event|1|||
33659471|NCT03301350|63084343|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
33659472|NCT03301350|63084343|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
33659473|NCT03301350|63084343|FG000|Overall Study|no detail provided|1|||
33659474|NCT04735432|63084350|FG000|Overall Study|Other - due to personal reason|1|||
33659475|NCT04735432|63084351|FG001|Overall Study|Other - due to personal reason|0|||
33659476|NCT04735432|63084350|FG000|Overall Study|Adverse Event|2|||
33659477|NCT04735432|63084351|FG001|Overall Study|Adverse Event|0|||
33659478|NCT02722278|63084360|FG000|Overall Study|Withdrawal by Subject|5|||
33659479|NCT02722278|63084361|FG001|Overall Study|Withdrawal by Subject|3|||
33659480|NCT02722278|63084360|FG000|Overall Study|Adverse Event|4|||
33659481|NCT02722278|63084361|FG001|Overall Study|Adverse Event|1|||
33659482|NCT02722278|63084360|FG000|Overall Study|Lost to Follow-up|2|||
33659483|NCT02722278|63084361|FG001|Overall Study|Lost to Follow-up|0|||
33659484|NCT02722278|63084360|FG000|Overall Study|Protocol Violation|1|||
33659485|NCT02722278|63084361|FG001|Overall Study|Protocol Violation|0|||
33659486|NCT02722278|63084360|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
33659487|NCT02722278|63084361|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
33659488|NCT02722278|63084360|FG000|Overall Study|Subject declined after tx assignment|0|||
33659489|NCT02722278|63084361|FG001|Overall Study|Subject declined after tx assignment|1|||
33659490|NCT02722278|63084360|FG000|Overall Study|Site closure not study related|0|||
33659491|NCT02722278|63084361|FG001|Overall Study|Site closure not study related|1|||
33659492|NCT00703092|63084369|FG000|Overall Study|Withdrawal by Subject|2|||
33659493|NCT02720484|63084373|FG000|Treatment on Study|Adverse Event|1|||
33659494|NCT02720484|63084373|FG000|Treatment on Study|Withdrawal by Subject|1|||
33659495|NCT02720484|63084373|FG000|Treatment on Study|Progressive Disease|4|||
33659496|NCT02720484|63084373|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
33659497|NCT02720484|63084373|FG000|Follow Up for 2 Years|Death|3|||
33659498|NCT02720484|63084373|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
33659499|NCT02715804|63084379|FG000|Overall Study|Death|222|||
33659500|NCT02715804|63084380|FG001|Overall Study|Death|106|||
33659501|NCT02715804|63084379|FG000|Overall Study|Withdrawal by Subject|5|||
33659502|NCT02715804|63084380|FG001|Overall Study|Withdrawal by Subject|4|||
33659503|NCT02715804|63084379|FG000|Overall Study|Other than specified|2|||
33659504|NCT02715804|63084380|FG001|Overall Study|Other than specified|3|||
33659505|NCT02717832|63084386|FG000|Overall Study|Inability to place IV|3|||
33659506|NCT02717754|63084397|FG000|Overall Study|Incorrect Infusion Duration|0|||
33659507|NCT02717754|63084398|FG001|Overall Study|Incorrect Infusion Duration|0|||
33659508|NCT02717754|63084399|FG002|Overall Study|Incorrect Infusion Duration|0|||
33659509|NCT02717754|63084400|FG003|Overall Study|Incorrect Infusion Duration|10|||
33659510|NCT02717754|63084401|FG004|Overall Study|Incorrect Infusion Duration|20|||
33659511|NCT02717754|63084402|FG005|Overall Study|Incorrect Infusion Duration|20|||
33659512|NCT02717130|63084412|FG000|Overall Study|Withdrawal by Subject|1|||
33659513|NCT02717130|63084412|FG000|Overall Study|Adverse Event|1|||
33659514|NCT02717130|63084412|FG000|Overall Study|Physician Decision|1|||
33659515|NCT02717130|63084412|FG000|Overall Study|Study Closure|4|||
33659516|NCT02192502|63084432|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
33659517|NCT02192502|63084433|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
33659518|NCT02192502|63084432|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
33659519|NCT02192502|63084433|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
33659520|NCT02192502|63084432|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
33659521|NCT02192502|63084433|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
33659522|NCT01781429|63084454|FG000|Overall Study|Death|0|||
33659523|NCT01781429|63084455|FG001|Overall Study|Death|0|||
33659524|NCT01781429|63084456|FG002|Overall Study|Death|0|||
33659525|NCT01781429|63084457|FG003|Overall Study|Death|0|||
33659526|NCT01781429|63084458|FG004|Overall Study|Death|0|||
33659527|NCT01781429|63084459|FG005|Overall Study|Death|0|||
33659528|NCT01781429|63084460|FG006|Overall Study|Death|0|||
33659529|NCT01781429|63084461|FG007|Overall Study|Death|0|||
33659530|NCT01781429|63084462|FG008|Overall Study|Death|0|||
33659531|NCT01781429|63084463|FG009|Overall Study|Death|1|||
33659532|NCT01781429|63084464|FG010|Overall Study|Death|0|||
33659533|NCT01781429|63084465|FG011|Overall Study|Death|0|||
33659534|NCT01781429|63084466|FG012|Overall Study|Death|1|||
33659535|NCT01781429|63084467|FG013|Overall Study|Death|0|||
33659536|NCT01781429|63084468|FG014|Overall Study|Death|1|||
33659537|NCT01781429|63084469|FG015|Overall Study|Death|0|||
33659538|NCT01781429|63084454|FG000|Overall Study|Withdrawal by Subject|0|||
33659539|NCT01781429|63084455|FG001|Overall Study|Withdrawal by Subject|0|||
33659540|NCT01781429|63084456|FG002|Overall Study|Withdrawal by Subject|0|||
33659541|NCT01781429|63084457|FG003|Overall Study|Withdrawal by Subject|0|||
33659542|NCT01781429|63084458|FG004|Overall Study|Withdrawal by Subject|0|||
33659543|NCT01781429|63084459|FG005|Overall Study|Withdrawal by Subject|0|||
33659544|NCT01781429|63084460|FG006|Overall Study|Withdrawal by Subject|0|||
33659545|NCT01781429|63084461|FG007|Overall Study|Withdrawal by Subject|0|||
33659546|NCT01781429|63084462|FG008|Overall Study|Withdrawal by Subject|1|||
33659547|NCT01781429|63084463|FG009|Overall Study|Withdrawal by Subject|3|||
33659548|NCT01781429|63084464|FG010|Overall Study|Withdrawal by Subject|1|||
33659549|NCT01781429|63084465|FG011|Overall Study|Withdrawal by Subject|1|||
33659550|NCT01781429|63084466|FG012|Overall Study|Withdrawal by Subject|5|||
33659551|NCT01781429|63084467|FG013|Overall Study|Withdrawal by Subject|2|||
33659552|NCT01781429|63084468|FG014|Overall Study|Withdrawal by Subject|3|||
33659553|NCT01781429|63084469|FG015|Overall Study|Withdrawal by Subject|0|||
33659554|NCT01781429|63084454|FG000|Overall Study|Disease Progression|1|||
33659555|NCT01781429|63084455|FG001|Overall Study|Disease Progression|0|||
33659556|NCT01781429|63084456|FG002|Overall Study|Disease Progression|1|||
33659557|NCT01781429|63084457|FG003|Overall Study|Disease Progression|1|||
33659558|NCT01781429|63084458|FG004|Overall Study|Disease Progression|1|||
33659559|NCT01781429|63084459|FG005|Overall Study|Disease Progression|4|||
33659560|NCT01781429|63084460|FG006|Overall Study|Disease Progression|7|||
33659561|NCT01781429|63084461|FG007|Overall Study|Disease Progression|4|||
33659562|NCT01781429|63084462|FG008|Overall Study|Disease Progression|6|||
33659563|NCT01781429|63084463|FG009|Overall Study|Disease Progression|15|||
33659564|NCT01781429|63084464|FG010|Overall Study|Disease Progression|15|||
33659565|NCT01781429|63084465|FG011|Overall Study|Disease Progression|15|||
33659566|NCT01781429|63084466|FG012|Overall Study|Disease Progression|15|||
33659567|NCT01781429|63084467|FG013|Overall Study|Disease Progression|4|||
33659568|NCT01781429|63084468|FG014|Overall Study|Disease Progression|11|||
33659569|NCT01781429|63084469|FG015|Overall Study|Disease Progression|0|||
33659570|NCT01781429|63084454|FG000|Overall Study|Unacceptable Toxicity|0|||
33659571|NCT01781429|63084455|FG001|Overall Study|Unacceptable Toxicity|0|||
33659572|NCT01781429|63084456|FG002|Overall Study|Unacceptable Toxicity|0|||
33659573|NCT01781429|63084457|FG003|Overall Study|Unacceptable Toxicity|0|||
33659574|NCT01781429|63084458|FG004|Overall Study|Unacceptable Toxicity|0|||
33659575|NCT01781429|63084459|FG005|Overall Study|Unacceptable Toxicity|0|||
33659576|NCT01781429|63084460|FG006|Overall Study|Unacceptable Toxicity|0|||
33659577|NCT01781429|63084461|FG007|Overall Study|Unacceptable Toxicity|0|||
33364872|NCT00867009|62743414|FG000|Induction Period|Nonserious Adverse Event|5|||
33482510|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
33482511|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
33482512|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33482513|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33482514|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33482515|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33482516|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33659578|NCT01781429|63084462|FG008|Overall Study|Unacceptable Toxicity|0|||
33659579|NCT01781429|63084463|FG009|Overall Study|Unacceptable Toxicity|0|||
33659580|NCT01781429|63084464|FG010|Overall Study|Unacceptable Toxicity|0|||
33659581|NCT01781429|63084465|FG011|Overall Study|Unacceptable Toxicity|2|||
33659582|NCT01781429|63084466|FG012|Overall Study|Unacceptable Toxicity|0|||
33659583|NCT01781429|63084467|FG013|Overall Study|Unacceptable Toxicity|0|||
33659584|NCT01781429|63084468|FG014|Overall Study|Unacceptable Toxicity|0|||
33659585|NCT01781429|63084469|FG015|Overall Study|Unacceptable Toxicity|0|||
33659586|NCT01781429|63084454|FG000|Overall Study|Patient Condition Changed|0|||
33659587|NCT01781429|63084455|FG001|Overall Study|Patient Condition Changed|0|||
33659588|NCT01781429|63084456|FG002|Overall Study|Patient Condition Changed|0|||
33659589|NCT01781429|63084457|FG003|Overall Study|Patient Condition Changed|0|||
33659590|NCT01781429|63084458|FG004|Overall Study|Patient Condition Changed|0|||
33659591|NCT01781429|63084459|FG005|Overall Study|Patient Condition Changed|0|||
33659592|NCT01781429|63084460|FG006|Overall Study|Patient Condition Changed|0|||
33659593|NCT01781429|63084461|FG007|Overall Study|Patient Condition Changed|0|||
33659594|NCT01781429|63084462|FG008|Overall Study|Patient Condition Changed|0|||
33659595|NCT01781429|63084463|FG009|Overall Study|Patient Condition Changed|4|||
33659596|NCT01781429|63084464|FG010|Overall Study|Patient Condition Changed|0|||
33659597|NCT01781429|63084465|FG011|Overall Study|Patient Condition Changed|1|||
33659598|NCT01781429|63084466|FG012|Overall Study|Patient Condition Changed|0|||
33659599|NCT01781429|63084467|FG013|Overall Study|Patient Condition Changed|1|||
33659600|NCT01781429|63084468|FG014|Overall Study|Patient Condition Changed|0|||
33659601|NCT01781429|63084469|FG015|Overall Study|Patient Condition Changed|0|||
33659602|NCT01781429|63084454|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
33659603|NCT01781429|63084455|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
33659604|NCT01781429|63084456|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
33659605|NCT01781429|63084457|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
33659606|NCT01781429|63084458|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
33659607|NCT01781429|63084459|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
33659608|NCT01781429|63084460|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
33659609|NCT01781429|63084461|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
33659610|NCT01781429|63084462|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
33659611|NCT01781429|63084463|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
33659612|NCT01781429|63084464|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
33482517|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
33482518|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33482519|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
33482520|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
33482521|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33482522|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
33482523|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
33482524|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
33482525|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
33482526|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
33482527|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
33482528|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
33482529|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
33482530|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
33482531|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
33482532|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33482533|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33482534|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33482535|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33482536|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33482537|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33482538|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33482539|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33482540|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
33482541|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
33482542|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33482543|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33482544|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33482545|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33482546|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33482547|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33482548|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33482549|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
33482550|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33553694|NCT02788513|62946317|FG004|Overall Study|Adverse Event|2|||
33659613|NCT01781429|63084465|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
33659614|NCT01781429|63084466|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
33659615|NCT01781429|63084467|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
33659616|NCT01781429|63084468|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
33659617|NCT01781429|63084469|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
33659618|NCT01781429|63084454|FG000|Overall Study|Enrolled, but not treated|0|||
33659619|NCT01781429|63084455|FG001|Overall Study|Enrolled, but not treated|0|||
33659620|NCT01781429|63084456|FG002|Overall Study|Enrolled, but not treated|0|||
33659621|NCT01781429|63084457|FG003|Overall Study|Enrolled, but not treated|0|||
33659622|NCT01781429|63084458|FG004|Overall Study|Enrolled, but not treated|0|||
33659623|NCT01781429|63084459|FG005|Overall Study|Enrolled, but not treated|0|||
33659624|NCT01781429|63084460|FG006|Overall Study|Enrolled, but not treated|0|||
33659625|NCT01781429|63084461|FG007|Overall Study|Enrolled, but not treated|0|||
33659626|NCT01781429|63084462|FG008|Overall Study|Enrolled, but not treated|0|||
33659627|NCT01781429|63084463|FG009|Overall Study|Enrolled, but not treated|0|||
33659628|NCT01781429|63084464|FG010|Overall Study|Enrolled, but not treated|1|||
33659629|NCT01781429|63084465|FG011|Overall Study|Enrolled, but not treated|0|||
33659630|NCT01781429|63084466|FG012|Overall Study|Enrolled, but not treated|0|||
33659631|NCT01781429|63084467|FG013|Overall Study|Enrolled, but not treated|0|||
33659632|NCT01781429|63084468|FG014|Overall Study|Enrolled, but not treated|0|||
33659633|NCT01781429|63084469|FG015|Overall Study|Enrolled, but not treated|0|||
33659634|NCT01773473|63084504|FG000|Overall Study|Adverse Event|3|||
33659635|NCT01773473|63084505|FG001|Overall Study|Adverse Event|2|||
33659636|NCT01773473|63084504|FG000|Overall Study|Protocol Violation|0|||
33659637|NCT01773473|63084505|FG001|Overall Study|Protocol Violation|4|||
33659638|NCT01773473|63084504|FG000|Overall Study|Physician Decision|3|||
33659639|NCT01773473|63084505|FG001|Overall Study|Physician Decision|5|||
33659640|NCT01773473|63084504|FG000|Overall Study|Sponsor Decision|2|||
33659641|NCT01773473|63084505|FG001|Overall Study|Sponsor Decision|0|||
33659642|NCT01773473|63084504|FG000|Overall Study|Lack of Efficacy|0|||
33659643|NCT01773473|63084505|FG001|Overall Study|Lack of Efficacy|1|||
33659644|NCT01773473|63084504|FG000|Overall Study|Non-Compliance with study drug|1|||
33659645|NCT01773473|63084505|FG001|Overall Study|Non-Compliance with study drug|4|||
33659646|NCT01773473|63084504|FG000|Overall Study|Withdrawal by Subject|5|||
33659647|NCT01773473|63084505|FG001|Overall Study|Withdrawal by Subject|3|||
33659648|NCT01773473|63084504|FG000|Overall Study|Lost to Follow-up|2|||
33659649|NCT01773473|63084505|FG001|Overall Study|Lost to Follow-up|0|||
33659650|NCT01772693|63084513|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
33659651|NCT01772693|63084514|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
33659652|NCT01772693|63084513|FG000|Overall Study|Withdrawal by Subject|2|||
33659653|NCT01772693|63084514|FG001|Overall Study|Withdrawal by Subject|0|||
33659654|NCT01772693|63084513|FG000|Overall Study|Alternative Treatment|2|||
33659655|NCT01772693|63084514|FG001|Overall Study|Alternative Treatment|0|||
33659656|NCT01779869|63084520|FG000|Overall Study|Physician Decision|2|||
33659657|NCT01772537|63084527|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
33659658|NCT01772537|63084528|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
33482551|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33482552|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33482553|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33482554|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33482555|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33482556|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33482557|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33482558|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33482559|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
33482560|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33482561|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33482562|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482563|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482564|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482565|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482566|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482567|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482568|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482569|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
33482570|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
33482571|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33482572|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33553695|NCT02788513|62946313|FG000|Overall Study|Protocol Violation|0|||
33659659|NCT01772537|63084529|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
33659660|NCT01772147|63084542|FG000|Overall Study|Adverse Event|13|||
33659661|NCT01772147|63084543|FG001|Overall Study|Adverse Event|10|||
33659662|NCT01772147|63084544|FG002|Overall Study|Adverse Event|6|||
33659663|NCT01772147|63084542|FG000|Overall Study|Withdrew Consent|7|||
33659664|NCT01772147|63084543|FG001|Overall Study|Withdrew Consent|8|||
33659665|NCT01772147|63084544|FG002|Overall Study|Withdrew Consent|4|||
33659666|NCT01772147|63084542|FG000|Overall Study|Lost to Follow-up|1|||
33659667|NCT01772147|63084543|FG001|Overall Study|Lost to Follow-up|0|||
33659668|NCT01772147|63084544|FG002|Overall Study|Lost to Follow-up|1|||
33482573|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33482574|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33482575|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33482576|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33482577|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
33482578|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33482579|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33482580|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
33482581|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33482582|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33482583|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33482584|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33482585|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33482586|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33482587|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33482588|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33482589|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33482590|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33482591|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
33482592|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33482593|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33482594|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33482595|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33482596|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33482597|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33482598|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33482599|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33482600|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
33553696|NCT02788513|62946314|FG001|Overall Study|Protocol Violation|0|||
33553697|NCT02788513|62946315|FG002|Overall Study|Protocol Violation|1|||
33553698|NCT02788513|62946316|FG003|Overall Study|Protocol Violation|1|||
33659669|NCT01772147|63084542|FG000|Overall Study|Protocol Deviation|2|||
33659670|NCT01772147|63084543|FG001|Overall Study|Protocol Deviation|1|||
33659671|NCT01772147|63084544|FG002|Overall Study|Protocol Deviation|1|||
33553699|NCT02788513|62946317|FG004|Overall Study|Protocol Violation|0|||
33364873|NCT00867009|62743414|FG000|Induction Period|Serious Adverse Event|10|||
33482601|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
33482602|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33553700|NCT02788513|62946313|FG000|Overall Study|Subject decided to stop taking treatment|0|||
33553701|NCT02788513|62946314|FG001|Overall Study|Subject decided to stop taking treatment|0|||
33553702|NCT02788513|62946315|FG002|Overall Study|Subject decided to stop taking treatment|1|||
33659672|NCT01772147|63084542|FG000|Overall Study|Lack of Efficacy|8|||
33482603|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33553703|NCT02788513|62946316|FG003|Overall Study|Subject decided to stop taking treatment|0|||
33553704|NCT02788513|62946317|FG004|Overall Study|Subject decided to stop taking treatment|0|||
33553705|NCT02788513|62946313|FG000|Overall Study|Decision by the study team|0|||
33659673|NCT01772147|63084543|FG001|Overall Study|Lack of Efficacy|6|||
33553706|NCT02788513|62946314|FG001|Overall Study|Decision by the study team|0|||
33553707|NCT02788513|62946315|FG002|Overall Study|Decision by the study team|0|||
33553708|NCT02788513|62946316|FG003|Overall Study|Decision by the study team|0|||
33553709|NCT02788513|62946317|FG004|Overall Study|Decision by the study team|1|||
33553710|NCT03077828|62946329|FG000|Treatment Cycles|Death|1|||
33659674|NCT01772147|63084544|FG002|Overall Study|Lack of Efficacy|6|||
33659675|NCT01771913|63084554|FG000|Overall Study|Withdrawal by Subject|1|||
33659676|NCT01771913|63084555|FG001|Overall Study|Withdrawal by Subject|0|||
33659677|NCT01606787|63084563|FG000|Overall Study|Withdrawal by Subject|4|||
33659678|NCT01606787|63084564|FG001|Overall Study|Withdrawal by Subject|5|||
33659679|NCT01606787|63084563|FG000|Overall Study|Surgery canceled|0|||
33659680|NCT01606787|63084564|FG001|Overall Study|Surgery canceled|2|||
33659681|NCT01778855|63084572|FG000|Overall Study|Death|0|||
33659682|NCT01778855|63084573|FG001|Overall Study|Death|1|||
33659683|NCT01777997|63084579|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
33659684|NCT01777997|63084579|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
33659685|NCT01777997|63084579|FG000|Weeks 48 to 72/96 on ART|Death|1|||
33659686|NCT01777997|63084579|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
33364874|NCT00867009|62743414|FG000|Induction Period|Death due to serious adverse event|6|||
33364875|NCT00867009|62743414|FG000|Induction Period|Death due to Study Disease|4|||
33659687|NCT01770509|63084585|FG000|Overall Study|Injury|0|||
33659688|NCT01770509|63084586|FG001|Overall Study|Injury|1|||
33659689|NCT01770509|63084585|FG000|Overall Study|Lost to Follow-up|1|||
33659690|NCT01770509|63084586|FG001|Overall Study|Lost to Follow-up|2|||
33659691|NCT01770353|63084594|FG000|Overall Study|Progressive disease|2|||
33659692|NCT01770353|63084595|FG001|Overall Study|Progressive disease|1|||
33659693|NCT01770353|63084594|FG000|Overall Study|Adverse Event|0|||
33659694|NCT01770353|63084595|FG001|Overall Study|Adverse Event|1|||
33659695|NCT01770353|63084594|FG000|Overall Study|Protocol Violation|1|||
33659696|NCT01770353|63084595|FG001|Overall Study|Protocol Violation|0|||
33659697|NCT01770353|63084594|FG000|Overall Study|Physician Decision|0|||
33659698|NCT01770353|63084595|FG001|Overall Study|Physician Decision|3|||
33659699|NCT01770353|63084594|FG000|Overall Study|Clinical deterioration|3|||
33659700|NCT01770353|63084595|FG001|Overall Study|Clinical deterioration|6|||
33659701|NCT01770353|63084594|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
33659702|NCT01770353|63084595|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
33659703|NCT01777763|63084611|FG000|Overall Study|Adverse Event|2|||
33659704|NCT01777763|63084612|FG001|Overall Study|Adverse Event|32|||
33364876|NCT00867009|62743414|FG000|Induction Period|Protocol Violation|1|||
33364877|NCT00867009|62743414|FG000|Induction Period|Withdrawal by Subject|8|||
33364878|NCT00867009|62743414|FG000|Induction Period|Physician Decision|3|||
33364879|NCT00867009|62743414|FG000|Induction Period|Progressive Disease (PD)|25|||
33659705|NCT01777763|63084611|FG000|Overall Study|Protocol Violation|1|||
33659706|NCT01777763|63084612|FG001|Overall Study|Protocol Violation|7|||
33659707|NCT01777763|63084611|FG000|Overall Study|Withdrawal by Subject|0|||
33659708|NCT01777763|63084612|FG001|Overall Study|Withdrawal by Subject|2|||
33659709|NCT01777763|63084611|FG000|Overall Study|Treatment Failure|1|||
33659710|NCT01777763|63084612|FG001|Overall Study|Treatment Failure|6|||
33659711|NCT01769339|63084618|FG000|Overall Study|Lost to Follow-up|42|||
33659712|NCT01769339|63084618|FG000|Overall Study|Adverse Event|1|||
33659713|NCT01769105|63084624|FG000|First Intervention|Protocol Violation|2|||
33364880|NCT00867009|62743414|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
33364881|NCT00601250|62743420|FG000|Overall Study|Adverse Event|3|||
33364882|NCT00601250|62743421|FG001|Overall Study|Adverse Event|9|||
33364883|NCT00601250|62743420|FG000|Overall Study|Protocol Violation|3|||
33659714|NCT01769105|63084625|FG001|First Intervention|Protocol Violation|2|||
33659715|NCT01769105|63084624|FG000|Cross-over|Lost to Follow-up|5|||
33659716|NCT01769105|63084625|FG001|Cross-over|Lost to Follow-up|0|||
33659717|NCT01777139|63084633|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
33659718|NCT01777139|63084634|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
33659719|NCT01777139|63084633|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
33659720|NCT01777139|63084634|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
33364884|NCT00601250|62743421|FG001|Overall Study|Protocol Violation|2|||
33364885|NCT00601250|62743420|FG000|Overall Study|Lost to Follow-up|2|||
33364886|NCT00601250|62743421|FG001|Overall Study|Lost to Follow-up|6|||
33659721|NCT01777139|63084633|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
33659722|NCT01777139|63084634|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
33659723|NCT01777139|63084633|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
33659724|NCT01777139|63084634|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
33659725|NCT01777139|63084633|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
33364887|NCT00601250|62743420|FG000|Overall Study|Withdrawal by Subject|4|||
33364888|NCT00601250|62743421|FG001|Overall Study|Withdrawal by Subject|13|||
33364889|NCT00601250|62743420|FG000|Overall Study|Other incl. lack of efficacy|2|||
33553711|NCT03077828|62946329|FG000|Treatment Cycles|Withdrawal by Subject|1|||
33553712|NCT03077828|62946329|FG000|Treatment Cycles|Screen Fail|2|||
33364890|NCT00601250|62743421|FG001|Overall Study|Other incl. lack of efficacy|9|||
33364891|NCT00866775|62743429|FG000|Overall Study|Adverse Event|5|||
33364892|NCT00866775|62743430|FG001|Overall Study|Adverse Event|19|||
33364893|NCT00866775|62743429|FG000|Overall Study|Death|1|||
33364894|NCT00866775|62743430|FG001|Overall Study|Death|0|||
33364895|NCT00866775|62743429|FG000|Overall Study|Lost to Follow-up|0|||
33364896|NCT00866775|62743430|FG001|Overall Study|Lost to Follow-up|4|||
33364897|NCT00866775|62743429|FG000|Overall Study|Physician Decision|0|||
33364898|NCT00866775|62743430|FG001|Overall Study|Physician Decision|3|||
33364899|NCT00866775|62743429|FG000|Overall Study|Protocol Violation|3|||
33364900|NCT00866775|62743430|FG001|Overall Study|Protocol Violation|4|||
33364901|NCT00866775|62743429|FG000|Overall Study|Withdrawal by Subject|4|||
33364902|NCT00866775|62743430|FG001|Overall Study|Withdrawal by Subject|4|||
33364903|NCT00866775|62743429|FG000|Overall Study|met exit criteria|23|||
33659726|NCT01777139|63084634|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
33659727|NCT01777139|63084633|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
33659728|NCT01777139|63084634|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
33659729|NCT01777139|63084633|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
33659730|NCT01777139|63084634|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
33659731|NCT01777139|63084633|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
33659732|NCT01777139|63084634|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
33659733|NCT01768637|63084643|FG000|Overall Study|Lost to Follow-up|2|||
33659734|NCT01768637|63084644|FG001|Overall Study|Lost to Follow-up|7|||
33659735|NCT01768637|63084643|FG000|Overall Study|Difficult blood draw|1|||
33659736|NCT01768637|63084644|FG001|Overall Study|Difficult blood draw|0|||
33659737|NCT01768559|63084653|FG000|Overall Study|Randomized but not treated|0|||
33659738|NCT01768559|63084654|FG001|Overall Study|Randomized but not treated|0|||
33659739|NCT01768559|63084655|FG002|Overall Study|Randomized but not treated|1|||
33659740|NCT01768559|63084653|FG000|Overall Study|Adverse Event|15|||
33659741|NCT01768559|63084654|FG001|Overall Study|Adverse Event|2|||
33659742|NCT01768559|63084655|FG002|Overall Study|Adverse Event|5|||
33659743|NCT01768559|63084653|FG000|Overall Study|Lack of Efficacy|6|||
33659744|NCT01768559|63084654|FG001|Overall Study|Lack of Efficacy|4|||
33659745|NCT01768559|63084655|FG002|Overall Study|Lack of Efficacy|0|||
33659746|NCT01768559|63084653|FG000|Overall Study|Poor compliance to protocol|0|||
33659747|NCT01768559|63084654|FG001|Overall Study|Poor compliance to protocol|3|||
33659748|NCT01768559|63084655|FG002|Overall Study|Poor compliance to protocol|2|||
33364904|NCT00866775|62743430|FG001|Overall Study|met exit criteria|17|||
33364905|NCT00866775|62743429|FG000|Overall Study|discontinued due to communication error|0|||
33364906|NCT00866775|62743430|FG001|Overall Study|discontinued due to communication error|1|||
33364907|NCT03265210|62743440|FG000|Overall Study|Withdrawal by Subject|7|||
33482604|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33553713|NCT03077828|62946329|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
33553714|NCT03077828|62946329|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
33659749|NCT01768559|63084653|FG000|Overall Study|Other than specified|9|||
33659750|NCT01768559|63084654|FG001|Overall Study|Other than specified|8|||
33482605|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33482606|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33482607|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33482608|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33659751|NCT01768559|63084655|FG002|Overall Study|Other than specified|5|||
33659752|NCT00983619|63084679|FG000|Overall Study|Lost to Follow-up|0|||
33482609|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
33482610|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
33482611|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33482612|NCT03352557|62859107|FG000|LTE Period: Week 80 to Week 173|Other|0|||
33482613|NCT03352557|62859108|FG001|LTE Period: Week 80 to Week 173|Other|0|||
33482614|NCT03352557|62859109|FG002|LTE Period: Week 80 to Week 173|Other|0|||
33553715|NCT03077828|62946329|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
33553716|NCT03077828|62946329|FG000|Follow-up|Patients still in follow-up|15|||
33659753|NCT00983619|63084680|FG001|Overall Study|Lost to Follow-up|1|||
33659754|NCT00983619|63084681|FG002|Overall Study|Lost to Follow-up|0|||
33659755|NCT00983619|63084682|FG003|Overall Study|Lost to Follow-up|0|||
33364908|NCT03265210|62743441|FG001|Overall Study|Withdrawal by Subject|9|||
33553717|NCT02401672|62946335|FG000|Overall Study|Withdrawal by Subject|1|||
33553718|NCT02401672|62946336|FG001|Overall Study|Withdrawal by Subject|3|||
33659756|NCT00983619|63084683|FG004|Overall Study|Lost to Follow-up|0|||
33364909|NCT03265210|62743440|FG000|Overall Study|Lost to Follow-up|2|||
33482615|NCT03352557|62859110|FG003|LTE Period: Week 80 to Week 173|Other|0|||
33659757|NCT00983619|63084684|FG005|Overall Study|Lost to Follow-up|2|||
33553719|NCT02435914|62946346|FG000|Overall Study|Ocular Adverse Event|1|||
33553720|NCT02435914|62946347|FG001|Overall Study|Ocular Adverse Event|0|||
33659758|NCT00983619|63084685|FG006|Overall Study|Lost to Follow-up|0|||
33659759|NCT00983619|63084686|FG007|Overall Study|Lost to Follow-up|0|||
33659760|NCT00983619|63084687|FG008|Overall Study|Lost to Follow-up|0|||
33659761|NCT00983619|63084688|FG009|Overall Study|Lost to Follow-up|0|||
33659762|NCT00983619|63084689|FG010|Overall Study|Lost to Follow-up|0|||
33659763|NCT00983619|63084690|FG011|Overall Study|Lost to Follow-up|2|||
33659764|NCT00983619|63084679|FG000|Overall Study|Withdrawal by Subject|2|||
33553721|NCT02435914|62946348|FG002|Overall Study|Ocular Adverse Event|0|||
33553722|NCT02435914|62946349|FG003|Overall Study|Ocular Adverse Event|0|||
33553723|NCT02435914|62946346|FG000|Overall Study|Withdrawal by Subject|0|||
33553724|NCT02435914|62946347|FG001|Overall Study|Withdrawal by Subject|1|||
33553725|NCT02435914|62946348|FG002|Overall Study|Withdrawal by Subject|0|||
33553726|NCT02435914|62946349|FG003|Overall Study|Withdrawal by Subject|0|||
33553727|NCT02435914|62946346|FG000|Overall Study|Other Miscellaneous Reason|0|||
33553728|NCT02435914|62946347|FG001|Overall Study|Other Miscellaneous Reason|0|||
33553729|NCT02435914|62946348|FG002|Overall Study|Other Miscellaneous Reason|1|||
33553730|NCT02435914|62946349|FG003|Overall Study|Other Miscellaneous Reason|0|||
33553731|NCT02786953|62946361|FG000|Overall Study|Withdrawal by Subject|3|||
33553732|NCT02786953|62946362|FG001|Overall Study|Withdrawal by Subject|0|||
33553733|NCT02786953|62946361|FG000|Overall Study|Physician Decision|0|||
33553734|NCT02786953|62946362|FG001|Overall Study|Physician Decision|1|||
33553735|NCT02435836|62946368|FG000|Overall Study|Lost to Follow-up|21|||
33553736|NCT02435836|62946368|FG000|Overall Study|Lack of Efficacy|1|||
33553737|NCT02435836|62946368|FG000|Overall Study|Withdrawal by Subject|236|||
33553738|NCT02435836|62946368|FG000|Overall Study|Insufficient Clinical Response|26|||
33659765|NCT00983619|63084680|FG001|Overall Study|Withdrawal by Subject|1|||
33659766|NCT00983619|63084681|FG002|Overall Study|Withdrawal by Subject|1|||
33659767|NCT00983619|63084682|FG003|Overall Study|Withdrawal by Subject|3|||
33659768|NCT00983619|63084683|FG004|Overall Study|Withdrawal by Subject|1|||
33659769|NCT00983619|63084684|FG005|Overall Study|Withdrawal by Subject|23|||
33659770|NCT00983619|63084685|FG006|Overall Study|Withdrawal by Subject|0|||
33659771|NCT00983619|63084686|FG007|Overall Study|Withdrawal by Subject|0|||
33659772|NCT00983619|63084687|FG008|Overall Study|Withdrawal by Subject|0|||
33659773|NCT00983619|63084688|FG009|Overall Study|Withdrawal by Subject|0|||
33659774|NCT00983619|63084689|FG010|Overall Study|Withdrawal by Subject|1|||
33659775|NCT00983619|63084690|FG011|Overall Study|Withdrawal by Subject|1|||
33659776|NCT00983619|63084679|FG000|Overall Study|Death|0|||
33659777|NCT00983619|63084680|FG001|Overall Study|Death|2|||
33659778|NCT00983619|63084681|FG002|Overall Study|Death|2|||
33659779|NCT00983619|63084682|FG003|Overall Study|Death|1|||
33659780|NCT00983619|63084683|FG004|Overall Study|Death|2|||
33659781|NCT00983619|63084684|FG005|Overall Study|Death|30|||
33659782|NCT00983619|63084685|FG006|Overall Study|Death|1|||
33659783|NCT00983619|63084686|FG007|Overall Study|Death|0|||
33659784|NCT00983619|63084687|FG008|Overall Study|Death|1|||
33659785|NCT00983619|63084688|FG009|Overall Study|Death|2|||
33659786|NCT00983619|63084689|FG010|Overall Study|Death|9|||
33659787|NCT00983619|63084690|FG011|Overall Study|Death|8|||
33553739|NCT02435836|62946368|FG000|Overall Study|Adverse Event|44|||
33553740|NCT02435836|62946368|FG000|Overall Study|Sponsor discontinued trial|167|||
33553741|NCT02435836|62946368|FG000|Overall Study|Noncompliance|27|||
33553742|NCT02435836|62946368|FG000|Overall Study|Protocol Violation|6|||
33659788|NCT00983619|63084679|FG000|Overall Study|Other|1|||
33659789|NCT00983619|63084680|FG001|Overall Study|Other|0|||
33659790|NCT00983619|63084681|FG002|Overall Study|Other|0|||
33659791|NCT00983619|63084682|FG003|Overall Study|Other|1|||
33659792|NCT00983619|63084683|FG004|Overall Study|Other|0|||
33659793|NCT00983619|63084684|FG005|Overall Study|Other|12|||
33659794|NCT00983619|63084685|FG006|Overall Study|Other|2|||
33659795|NCT00983619|63084686|FG007|Overall Study|Other|2|||
33482616|NCT03352557|62859111|FG004|LTE Period: Week 80 to Week 173|Other|0|||
33482617|NCT03352557|62859112|FG005|LTE Period: Week 80 to Week 173|Other|0|||
33482618|NCT03352557|62859113|FG006|LTE Period: Week 80 to Week 173|Other|0|||
33482619|NCT03352557|62859114|FG007|LTE Period: Week 80 to Week 173|Other|1|||
33482620|NCT03352557|62859115|FG008|LTE Period: Week 80 to Week 173|Other|0|||
33482621|NCT03352557|62859116|FG009|LTE Period: Week 80 to Week 173|Other|0|||
33482622|NCT02866942|62859141|FG000|Overall Study|Invalid consent|1|||
33482623|NCT02908672|62859195|FG000|Overall Study|Death|112|||
33482624|NCT02908672|62859196|FG001|Overall Study|Death|93|||
33482625|NCT02908672|62859195|FG000|Overall Study|Lost to Follow-up|3|||
33482626|NCT02908672|62859196|FG001|Overall Study|Lost to Follow-up|3|||
33482627|NCT02908672|62859195|FG000|Overall Study|Other|2|||
33482628|NCT02908672|62859196|FG001|Overall Study|Other|0|||
33482629|NCT02908672|62859195|FG000|Overall Study|Protocol Violation|1|||
33482630|NCT02908672|62859196|FG001|Overall Study|Protocol Violation|1|||
33482631|NCT02908672|62859195|FG000|Overall Study|Withdrawal by Subject|13|||
33482632|NCT02908672|62859196|FG001|Overall Study|Withdrawal by Subject|18|||
33553743|NCT02435836|62946368|FG000|Overall Study|Met Withdrawal Criteria|7|||
33553744|NCT02435836|62946368|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
33553745|NCT02788201|62946378|FG000|Overall Study|Death|1|||
33553746|NCT02788201|62946379|FG001|Overall Study|Death|1|||
33553747|NCT02788201|62946380|FG002|Overall Study|Death|1|||
33659796|NCT00983619|63084687|FG008|Overall Study|Other|0|||
33659797|NCT00983619|63084688|FG009|Overall Study|Other|1|||
33659798|NCT00983619|63084689|FG010|Overall Study|Other|1|||
33659799|NCT00983619|63084690|FG011|Overall Study|Other|0|||
33659800|NCT00653068|63084740|FG000|Overall Study|Death|9|||
33659801|NCT00653068|63084740|FG000|Overall Study|Lack of Efficacy|34|||
33659802|NCT00653068|63084740|FG000|Overall Study|Physician Decision|4|||
33659803|NCT00653068|63084740|FG000|Overall Study|Withdrawal by Subject|1|||
33553748|NCT02788201|62946381|FG003|Overall Study|Death|1|||
33553749|NCT02788201|62946382|FG004|Overall Study|Death|0|||
33553750|NCT02788201|62946383|FG005|Overall Study|Death|1|||
33553751|NCT02788201|62946378|FG000|Overall Study|Ineligible|0|||
33659804|NCT00653068|63084740|FG000|Overall Study|Ineligible|2|||
33659805|NCT01767857|63084749|FG000|Overall Study|Adverse Event|27|||
33659806|NCT01767857|63084750|FG001|Overall Study|Adverse Event|7|||
33659807|NCT01767857|63084749|FG000|Overall Study|Death|28|||
33482633|NCT02908672|62859195|FG000|Overall Study|Study is ongoing|124|||
33553752|NCT02788201|62946379|FG001|Overall Study|Ineligible|0|||
33553753|NCT02788201|62946380|FG002|Overall Study|Ineligible|0|||
33553754|NCT02788201|62946381|FG003|Overall Study|Ineligible|0|||
33553755|NCT02788201|62946382|FG004|Overall Study|Ineligible|0|||
33553756|NCT02788201|62946383|FG005|Overall Study|Ineligible|1|||
33553757|NCT02788201|62946378|FG000|Overall Study|Withdrawal by Subject|0|||
33553758|NCT02788201|62946379|FG001|Overall Study|Withdrawal by Subject|0|||
33659808|NCT01767857|63084750|FG001|Overall Study|Death|13|||
33659809|NCT01767857|63084749|FG000|Overall Study|Lack of Efficacy|299|||
33659810|NCT01767857|63084750|FG001|Overall Study|Lack of Efficacy|151|||
33659811|NCT01767857|63084749|FG000|Overall Study|Lost to Follow-up|1|||
33482634|NCT02908672|62859196|FG001|Overall Study|Study is ongoing|141|||
33482635|NCT02908672|62859195|FG000|Overall Study|Discontinued the study during run-in|3|||
33482636|NCT02908672|62859196|FG001|Overall Study|Discontinued the study during run-in|0|||
33482637|NCT01336894|62859204|FG000|Follow-up|Study terminated prematurely|2|||
33659812|NCT01767857|63084750|FG001|Overall Study|Lost to Follow-up|1|||
33364910|NCT03265210|62743441|FG001|Overall Study|Lost to Follow-up|0|||
33364911|NCT03265210|62743440|FG000|Overall Study|Physician Decision|2|||
33364912|NCT03265210|62743441|FG001|Overall Study|Physician Decision|0|||
33364913|NCT03265210|62743440|FG000|Overall Study|Adverse Event|1|||
33364914|NCT03265210|62743441|FG001|Overall Study|Adverse Event|0|||
33364915|NCT00543985|62743447|FG000|Overall Study|Withdrawal by Subject|4|||
33364916|NCT00582556|62743462|FG000|Overall Study|Withdrawal by Subject|0|||
33364917|NCT00582556|62743463|FG001|Overall Study|Withdrawal by Subject|1|||
33364918|NCT00582556|62743464|FG002|Overall Study|Withdrawal by Subject|1|||
33364919|NCT00582556|62743462|FG000|Overall Study|Physician Decision|0|||
33364920|NCT00582556|62743463|FG001|Overall Study|Physician Decision|0|||
33364921|NCT00582556|62743464|FG002|Overall Study|Physician Decision|1|||
33364922|NCT00542269|62743476|FG000|Overall Study|Adverse Event|10|||
33364923|NCT00542269|62743477|FG001|Overall Study|Adverse Event|4|||
33364924|NCT00542269|62743478|FG002|Overall Study|Adverse Event|5|||
33364925|NCT00542269|62743476|FG000|Overall Study|Protocol Violation|1|||
33364926|NCT00542269|62743477|FG001|Overall Study|Protocol Violation|1|||
33364927|NCT00542269|62743478|FG002|Overall Study|Protocol Violation|0|||
33364928|NCT00542269|62743476|FG000|Overall Study|Withdrawal by Subject|1|||
33364929|NCT00542269|62743477|FG001|Overall Study|Withdrawal by Subject|0|||
33364930|NCT00542269|62743478|FG002|Overall Study|Withdrawal by Subject|0|||
33364931|NCT00542269|62743476|FG000|Overall Study|Administrative problems|1|||
33364932|NCT00542269|62743477|FG001|Overall Study|Administrative problems|1|||
33364933|NCT00542269|62743478|FG002|Overall Study|Administrative problems|1|||
33364934|NCT00866697|62743490|FG000|Overall Study|Study closed/terminated|156|||
33364935|NCT00866697|62743491|FG001|Overall Study|Study closed/terminated|138|||
33364936|NCT00866697|62743490|FG000|Overall Study|Lost to Follow-up|22|||
33364937|NCT00866697|62743491|FG001|Overall Study|Lost to Follow-up|28|||
33364938|NCT00866697|62743490|FG000|Overall Study|Physician Decision|3|||
33364939|NCT00866697|62743491|FG001|Overall Study|Physician Decision|5|||
33482638|NCT01336894|62859205|FG001|Follow-up|Study terminated prematurely|7|||
33482639|NCT02572167|62859214|FG000|Overall Study|Withdrawal by Subject|0|||
33482640|NCT02572167|62859215|FG001|Overall Study|Withdrawal by Subject|3|||
33482641|NCT02572167|62859216|FG002|Overall Study|Withdrawal by Subject|0|||
33482642|NCT02572167|62859214|FG000|Overall Study|Lost to Follow-up|2|||
33482643|NCT02572167|62859215|FG001|Overall Study|Lost to Follow-up|5|||
33482644|NCT02572167|62859216|FG002|Overall Study|Lost to Follow-up|3|||
33482645|NCT02572167|62859214|FG000|Overall Study|Death|0|||
33482646|NCT02572167|62859215|FG001|Overall Study|Death|8|||
33482647|NCT02572167|62859216|FG002|Overall Study|Death|3|||
33659813|NCT01767857|63084749|FG000|Overall Study|Withdrawal by Subject|38|||
33659814|NCT01767857|63084750|FG001|Overall Study|Withdrawal by Subject|18|||
33659815|NCT01767857|63084749|FG000|Overall Study|Physician Decision|17|||
33659816|NCT01767857|63084750|FG001|Overall Study|Physician Decision|10|||
33659817|NCT01767857|63084749|FG000|Overall Study|Protocol Terminated|1|||
33659818|NCT01767857|63084750|FG001|Overall Study|Protocol Terminated|0|||
33659819|NCT01767857|63084749|FG000|Overall Study|Randomized But Never Treated|19|||
33364940|NCT00866697|62743490|FG000|Overall Study|Withdrawal by Subject|33|||
33364941|NCT00866697|62743491|FG001|Overall Study|Withdrawal by Subject|57|||
33364942|NCT00542191|62743497|FG000|Overall Study|Death|3|||
33364943|NCT00600938|62743503|FG000|Core Study|Abnormal test procedure result(s)|3|||
33364944|NCT00600938|62743504|FG001|Core Study|Abnormal test procedure result(s)|2|||
33364945|NCT00600938|62743505|FG002|Core Study|Abnormal test procedure result(s)|0|||
33364946|NCT00600938|62743506|FG003|Core Study|Abnormal test procedure result(s)|0|||
33364947|NCT00600938|62743503|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
33553759|NCT02788201|62946380|FG002|Overall Study|Withdrawal by Subject|0|||
33553760|NCT02788201|62946381|FG003|Overall Study|Withdrawal by Subject|0|||
33553761|NCT02788201|62946382|FG004|Overall Study|Withdrawal by Subject|0|||
33553762|NCT02788201|62946383|FG005|Overall Study|Withdrawal by Subject|1|||
33553763|NCT02456740|62946402|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
33553764|NCT02456740|62946403|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
33553765|NCT02456740|62946404|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
33553766|NCT02456740|62946405|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
33553767|NCT02456740|62946406|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
33553768|NCT02456740|62946407|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
33553769|NCT02456740|62946408|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
33364948|NCT00600938|62743504|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
33553770|NCT02456740|62946409|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
33553771|NCT02456740|62946410|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
33553772|NCT02456740|62946402|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
33553773|NCT02456740|62946403|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
33553774|NCT02456740|62946404|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
33553775|NCT02456740|62946405|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
33364949|NCT00600938|62743505|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
33364950|NCT00600938|62743506|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
33364951|NCT00600938|62743503|FG000|Core Study|Patient withdrew consent|7|||
33364952|NCT00600938|62743504|FG001|Core Study|Patient withdrew consent|12|||
33364953|NCT00600938|62743505|FG002|Core Study|Patient withdrew consent|0|||
33364954|NCT00600938|62743506|FG003|Core Study|Patient withdrew consent|0|||
33364955|NCT00600938|62743503|FG000|Core Study|Lost to Follow-up|3|||
33364956|NCT00600938|62743504|FG001|Core Study|Lost to Follow-up|2|||
33364957|NCT00600938|62743505|FG002|Core Study|Lost to Follow-up|0|||
33364958|NCT00600938|62743506|FG003|Core Study|Lost to Follow-up|0|||
33364959|NCT00600938|62743503|FG000|Core Study|Death|1|||
33364960|NCT00600938|62743504|FG001|Core Study|Death|1|||
33364961|NCT00600938|62743505|FG002|Core Study|Death|0|||
33364962|NCT00600938|62743506|FG003|Core Study|Death|0|||
33364963|NCT00600938|62743503|FG000|Core Study|Protocol Violation|1|||
33364964|NCT00600938|62743504|FG001|Core Study|Protocol Violation|2|||
33364965|NCT00600938|62743505|FG002|Core Study|Protocol Violation|0|||
33364966|NCT00600938|62743506|FG003|Core Study|Protocol Violation|0|||
33364967|NCT00600938|62743503|FG000|Extension Study|Adverse Event|1|||
33364968|NCT00600938|62743504|FG001|Extension Study|Adverse Event|0|||
33364969|NCT00600938|62743505|FG002|Extension Study|Adverse Event|2|||
33364970|NCT00600938|62743506|FG003|Extension Study|Adverse Event|0|||
33364971|NCT00600938|62743503|FG000|Extension Study|Abnormal test procedure results|0|||
33553776|NCT02456740|62946406|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
33553777|NCT02456740|62946407|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
33553778|NCT02456740|62946408|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
33553779|NCT02456740|62946409|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
33553780|NCT02456740|62946410|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
33553781|NCT02456740|62946402|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
33553782|NCT02456740|62946403|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
33364972|NCT00600938|62743504|FG001|Extension Study|Abnormal test procedure results|1|||
33364973|NCT00600938|62743505|FG002|Extension Study|Abnormal test procedure results|1|||
33659820|NCT01767857|63084750|FG001|Overall Study|Randomized But Never Treated|13|||
33659821|NCT01775501|63084757|FG000|Overall Study|Discontinued prior to treatment|1|||
33364974|NCT00600938|62743506|FG003|Extension Study|Abnormal test procedure results|1|||
33364975|NCT00600938|62743503|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
33364976|NCT00600938|62743504|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
33482648|NCT02572167|62859214|FG000|Overall Study|Did not meet inclusion criteria|0|||
33482649|NCT02572167|62859215|FG001|Overall Study|Did not meet inclusion criteria|0|||
33482650|NCT02572167|62859216|FG002|Overall Study|Did not meet inclusion criteria|1|||
33482651|NCT02572167|62859214|FG000|Overall Study|Study closure by Sponsor|4|||
33482652|NCT02572167|62859215|FG001|Overall Study|Study closure by Sponsor|40|||
33482653|NCT02572167|62859216|FG002|Overall Study|Study closure by Sponsor|24|||
33482654|NCT01336738|62859230|FG000|Overall Study|Adverse Event|0|||
33482655|NCT01336738|62859231|FG001|Overall Study|Adverse Event|3|||
33482656|NCT01336738|62859232|FG002|Overall Study|Adverse Event|2|||
33553783|NCT02456740|62946404|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
33553784|NCT02456740|62946405|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
33553785|NCT02456740|62946406|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
33553786|NCT02456740|62946407|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
33553787|NCT02456740|62946408|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
33553788|NCT02456740|62946409|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
33553789|NCT02456740|62946410|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
33553790|NCT02456740|62946402|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
33553791|NCT02456740|62946403|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
33553792|NCT02456740|62946404|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
33553793|NCT02456740|62946405|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
33553794|NCT02456740|62946406|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
33553795|NCT02456740|62946407|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
33553796|NCT02456740|62946408|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
33553797|NCT02456740|62946409|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
33553798|NCT02456740|62946410|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
33553799|NCT02456740|62946402|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
33553800|NCT02456740|62946403|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
33553801|NCT02456740|62946404|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
33553802|NCT02456740|62946405|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
33553803|NCT02456740|62946406|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
33553804|NCT02456740|62946407|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
33553805|NCT02456740|62946408|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
33553806|NCT02456740|62946409|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
33553807|NCT02456740|62946410|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
33553808|NCT02456740|62946402|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33553809|NCT02456740|62946403|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33553810|NCT02456740|62946404|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33553811|NCT02456740|62946405|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33553812|NCT02456740|62946406|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33553813|NCT02456740|62946407|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33553814|NCT02456740|62946408|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33553815|NCT02456740|62946409|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
33553816|NCT02456740|62946410|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33553817|NCT02456740|62946402|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33553818|NCT02456740|62946403|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33553819|NCT02456740|62946404|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33553820|NCT02456740|62946405|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
33659822|NCT01775189|63084786|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33659823|NCT01775189|63084787|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
33659824|NCT01775189|63084788|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33659825|NCT01775189|63084789|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33659826|NCT01775189|63084790|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33659827|NCT01775189|63084791|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33659828|NCT01775189|63084792|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33659829|NCT01775189|63084786|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33659830|NCT01775189|63084787|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
33482657|NCT01336738|62859233|FG003|Overall Study|Adverse Event|1|||
33482658|NCT01336738|62859234|FG004|Overall Study|Adverse Event|3|||
33482659|NCT01336738|62859230|FG000|Overall Study|Lost to Follow-up|2|||
33482660|NCT01336738|62859231|FG001|Overall Study|Lost to Follow-up|1|||
33482661|NCT01336738|62859232|FG002|Overall Study|Lost to Follow-up|2|||
33553821|NCT02456740|62946406|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
33659831|NCT01775189|63084788|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33482662|NCT01336738|62859233|FG003|Overall Study|Lost to Follow-up|2|||
33482663|NCT01336738|62859234|FG004|Overall Study|Lost to Follow-up|2|||
33482664|NCT01336738|62859230|FG000|Overall Study|Did not meet entrance criteria|0|||
33482665|NCT01336738|62859231|FG001|Overall Study|Did not meet entrance criteria|1|||
33553822|NCT02456740|62946407|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
33553823|NCT02456740|62946408|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
33553824|NCT02456740|62946409|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
33553825|NCT02456740|62946410|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
33659832|NCT01775189|63084789|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33659833|NCT01775189|63084790|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33659834|NCT01775189|63084791|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33659835|NCT01775189|63084792|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33659836|NCT01775189|63084786|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
33659837|NCT01775189|63084787|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
33659838|NCT01775189|63084788|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
33659839|NCT01775189|63084789|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
33659840|NCT01775189|63084790|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
33659841|NCT01775189|63084791|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
33659842|NCT01775189|63084792|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
33659843|NCT01775189|63084786|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
33659844|NCT01775189|63084787|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
33659845|NCT01775189|63084788|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
33659846|NCT01775189|63084789|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
33659847|NCT01775189|63084790|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
33659848|NCT01775189|63084791|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
33659849|NCT01775189|63084792|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
33659850|NCT01775189|63084786|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
33659851|NCT01775189|63084787|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
33659852|NCT01775189|63084788|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
33659853|NCT01775189|63084789|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
33659854|NCT01775189|63084790|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
33659855|NCT01775189|63084791|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
33659856|NCT01775189|63084792|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
33659857|NCT01775189|63084786|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
33659858|NCT01775189|63084787|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
33659859|NCT01775189|63084788|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
33659860|NCT01775189|63084789|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
33659861|NCT01775189|63084790|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
33659862|NCT01775189|63084791|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
33659863|NCT01775189|63084792|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
33659864|NCT01770743|63084858|FG000|Overall Study|Adverse Event|1|||
33364977|NCT00600938|62743505|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
33364978|NCT00600938|62743506|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
33364979|NCT00600938|62743503|FG000|Extension Study|Withdrawal by Subject|2|||
33482666|NCT01336738|62859232|FG002|Overall Study|Did not meet entrance criteria|0|||
33659865|NCT01770743|63084859|FG001|Overall Study|Adverse Event|0|||
33659866|NCT01770743|63084860|FG002|Overall Study|Adverse Event|0|||
33659867|NCT01770743|63084861|FG003|Overall Study|Adverse Event|0|||
33659868|NCT01770743|63084862|FG004|Overall Study|Adverse Event|0|||
33659869|NCT01770743|63084858|FG000|Overall Study|Withdrawal by Subject|0|||
33659870|NCT01770743|63084859|FG001|Overall Study|Withdrawal by Subject|0|||
33659871|NCT01770743|63084860|FG002|Overall Study|Withdrawal by Subject|1|||
33659872|NCT01770743|63084861|FG003|Overall Study|Withdrawal by Subject|1|||
33659873|NCT01770743|63084862|FG004|Overall Study|Withdrawal by Subject|1|||
33659874|NCT01770743|63084858|FG000|Overall Study|Lost to Follow-up|0|||
33659875|NCT01770743|63084859|FG001|Overall Study|Lost to Follow-up|2|||
33659876|NCT01770743|63084860|FG002|Overall Study|Lost to Follow-up|0|||
33659877|NCT01770743|63084861|FG003|Overall Study|Lost to Follow-up|0|||
33659878|NCT01770743|63084862|FG004|Overall Study|Lost to Follow-up|1|||
33482667|NCT01336738|62859233|FG003|Overall Study|Did not meet entrance criteria|0|||
33482668|NCT01336738|62859234|FG004|Overall Study|Did not meet entrance criteria|0|||
33482669|NCT01336738|62859230|FG000|Overall Study|Protocol Violation|0|||
33482670|NCT01336738|62859231|FG001|Overall Study|Protocol Violation|1|||
33482671|NCT01336738|62859232|FG002|Overall Study|Protocol Violation|0|||
33482672|NCT01336738|62859233|FG003|Overall Study|Protocol Violation|0|||
33482673|NCT01336738|62859234|FG004|Overall Study|Protocol Violation|0|||
33482674|NCT01336738|62859230|FG000|Overall Study|Withdrawal by Subject|2|||
33553826|NCT02400580|62946422|FG000|Overall Study|Withdrawal by Subject|1|||
33553827|NCT02400580|62946423|FG001|Overall Study|Withdrawal by Subject|1|||
33482675|NCT01336738|62859231|FG001|Overall Study|Withdrawal by Subject|0|||
33364980|NCT00600938|62743504|FG001|Extension Study|Withdrawal by Subject|2|||
33482676|NCT01336738|62859232|FG002|Overall Study|Withdrawal by Subject|2|||
33482677|NCT01336738|62859233|FG003|Overall Study|Withdrawal by Subject|1|||
33553828|NCT02400580|62946422|FG000|Overall Study|Adverse Event|1|||
33553829|NCT02400580|62946423|FG001|Overall Study|Adverse Event|0|||
33553830|NCT01367119|62946431|FG000|Overall Study|Adverse Event|1|||
33553831|NCT01367119|62946432|FG001|Overall Study|Adverse Event|0|||
33553832|NCT01367119|62946431|FG000|Overall Study|Withdrawal by Subject|1|||
33553833|NCT01367119|62946432|FG001|Overall Study|Withdrawal by Subject|1|||
33553834|NCT02635724|62946441|FG000|Overall Study|Withdrawal by Subject|0|||
33482678|NCT01336738|62859234|FG004|Overall Study|Withdrawal by Subject|1|||
33482679|NCT01336738|62859230|FG000|Overall Study|Other|3|||
33482680|NCT01336738|62859231|FG001|Overall Study|Other|3|||
33482681|NCT01336738|62859232|FG002|Overall Study|Other|2|||
33482682|NCT01336738|62859233|FG003|Overall Study|Other|3|||
33482683|NCT01336738|62859234|FG004|Overall Study|Other|4|||
33482684|NCT02865538|62859251|FG000|Overall Study|Withdrawal by Subject|0|||
33364981|NCT00600938|62743505|FG002|Extension Study|Withdrawal by Subject|3|||
33364982|NCT00600938|62743506|FG003|Extension Study|Withdrawal by Subject|0|||
33364983|NCT00600938|62743503|FG000|Extension Study|Lost to Follow-up|1|||
33364984|NCT00600938|62743504|FG001|Extension Study|Lost to Follow-up|1|||
33482685|NCT02865538|62859252|FG001|Overall Study|Withdrawal by Subject|0|||
33482686|NCT02865538|62859253|FG002|Overall Study|Withdrawal by Subject|1|||
33482687|NCT02865538|62859254|FG003|Overall Study|Withdrawal by Subject|0|||
33482688|NCT02865538|62859255|FG004|Overall Study|Withdrawal by Subject|0|||
33482689|NCT02865538|62859251|FG000|Overall Study|Lost to Follow-up|1|||
33482690|NCT02865538|62859252|FG001|Overall Study|Lost to Follow-up|0|||
33482691|NCT02865538|62859253|FG002|Overall Study|Lost to Follow-up|0|||
33482692|NCT02865538|62859254|FG003|Overall Study|Lost to Follow-up|0|||
33482693|NCT02865538|62859255|FG004|Overall Study|Lost to Follow-up|0|||
33482694|NCT02860546|62859267|FG000|Overall Study|Clinical Progression|6|||
33482695|NCT02860546|62859267|FG000|Overall Study|Radiological Progression|12|||
33482696|NCT01982955|62859276|FG000|Overall Study|Randomized but not treated|0|||
33482697|NCT01982955|62859277|FG001|Overall Study|Randomized but not treated|0|||
33482698|NCT01982955|62859278|FG002|Overall Study|Randomized but not treated|0|||
33482699|NCT01982955|62859279|FG003|Overall Study|Randomized but not treated|1|||
33482700|NCT01982955|62859280|FG004|Overall Study|Randomized but not treated|0|||
33553835|NCT02635724|62946442|FG001|Overall Study|Withdrawal by Subject|1|||
33482701|NCT00396279|62859293|FG000|Overall Study|Ongoing in study|26|||
33553836|NCT02635724|62946443|FG002|Overall Study|Withdrawal by Subject|0|||
33553837|NCT02635646|62946453|FG000|Overall Study|Lost to Follow-up|24|||
33553838|NCT02635646|62946454|FG001|Overall Study|Lost to Follow-up|25|||
33553839|NCT02635646|62946453|FG000|Overall Study|Pregnancy|1|||
33659879|NCT01770743|63084858|FG000|Overall Study|Sponsor Terminated Subject|1|||
33553840|NCT02635646|62946454|FG001|Overall Study|Pregnancy|1|||
33553841|NCT02634788|62946470|FG000|Overall Study|Adverse Event|0|||
33553842|NCT02634788|62946471|FG001|Overall Study|Adverse Event|8|||
33553843|NCT02634788|62946472|FG002|Overall Study|Adverse Event|3|||
33553844|NCT02634788|62946473|FG003|Overall Study|Adverse Event|1|||
33553845|NCT02634788|62946470|FG000|Overall Study|Lack of Efficacy|4|||
33553846|NCT02634788|62946471|FG001|Overall Study|Lack of Efficacy|0|||
33553847|NCT02634788|62946472|FG002|Overall Study|Lack of Efficacy|1|||
33553848|NCT02634788|62946473|FG003|Overall Study|Lack of Efficacy|4|||
33553849|NCT02634788|62946470|FG000|Overall Study|Lost to Follow-up|0|||
33553850|NCT02634788|62946471|FG001|Overall Study|Lost to Follow-up|1|||
33553851|NCT02634788|62946472|FG002|Overall Study|Lost to Follow-up|0|||
33553852|NCT02634788|62946473|FG003|Overall Study|Lost to Follow-up|0|||
33553853|NCT02634788|62946470|FG000|Overall Study|Withdrawal by Subject|0|||
33553854|NCT02634788|62946471|FG001|Overall Study|Withdrawal by Subject|1|||
33553855|NCT02634788|62946472|FG002|Overall Study|Withdrawal by Subject|1|||
33553856|NCT02634788|62946473|FG003|Overall Study|Withdrawal by Subject|0|||
33553857|NCT02785939|62946485|FG000|Overall Study|Progression|25|||
33553858|NCT02785939|62946486|FG001|Overall Study|Progression|8|||
33553859|NCT02785939|62946485|FG000|Overall Study|Adverse Event|3|||
33659880|NCT01770743|63084859|FG001|Overall Study|Sponsor Terminated Subject|0|||
33659881|NCT01770743|63084860|FG002|Overall Study|Sponsor Terminated Subject|0|||
33659882|NCT01770743|63084861|FG003|Overall Study|Sponsor Terminated Subject|1|||
33659883|NCT01770743|63084862|FG004|Overall Study|Sponsor Terminated Subject|0|||
33659884|NCT01770743|63084858|FG000|Overall Study|Moving Out of State|0|||
33659885|NCT01770743|63084859|FG001|Overall Study|Moving Out of State|1|||
33659886|NCT01770743|63084860|FG002|Overall Study|Moving Out of State|0|||
33659887|NCT01770743|63084861|FG003|Overall Study|Moving Out of State|0|||
33659888|NCT01770743|63084862|FG004|Overall Study|Moving Out of State|0|||
33659889|NCT01767467|63084958|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
33659890|NCT01767467|63084959|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
33659891|NCT01767467|63084958|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
33659892|NCT01767467|63084959|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
33553860|NCT02785939|62946486|FG001|Overall Study|Adverse Event|1|||
33553861|NCT02785939|62946485|FG000|Overall Study|Death|1|||
33553862|NCT02785939|62946486|FG001|Overall Study|Death|0|||
33553863|NCT02785939|62946485|FG000|Overall Study|Refusal|1|||
33553864|NCT02785939|62946486|FG001|Overall Study|Refusal|0|||
33364985|NCT00600938|62743505|FG002|Extension Study|Lost to Follow-up|2|||
33482702|NCT00396279|62859293|FG000|Overall Study|Disease progression|2|||
33482703|NCT00396279|62859293|FG000|Overall Study|Withdrawal by Subject|1|||
33482704|NCT00396279|62859293|FG000|Overall Study|Physician Decision|1|||
33482705|NCT01347866|62859314|FG000|Overall Study|Death|0|||
33482706|NCT01347866|62859315|FG001|Overall Study|Death|0|||
33482707|NCT01347866|62859316|FG002|Overall Study|Death|0|||
33482708|NCT01347866|62859317|FG003|Overall Study|Death|1|||
33482709|NCT01347866|62859318|FG004|Overall Study|Death|2|||
33482710|NCT01347866|62859319|FG005|Overall Study|Death|2|||
33482711|NCT01347866|62859320|FG006|Overall Study|Death|1|||
33482712|NCT01347866|62859321|FG007|Overall Study|Death|0|||
33482713|NCT01347866|62859322|FG008|Overall Study|Death|4|||
33553865|NCT02785939|62946485|FG000|Overall Study|Deteriorating health|1|||
33553866|NCT02785939|62946486|FG001|Overall Study|Deteriorating health|0|||
33553867|NCT02785939|62946485|FG000|Overall Study|Not protocol specified|0|||
33553868|NCT02785939|62946486|FG001|Overall Study|Not protocol specified|1|||
33659893|NCT01767467|63084958|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
33482714|NCT01347866|62859323|FG009|Overall Study|Death|1|||
33553869|NCT02634320|62946500|FG000|Overall Study|Adverse Event|2|||
33553870|NCT02634320|62946500|FG000|Overall Study|Lost to Follow-up|3|||
33553871|NCT02634320|62946500|FG000|Overall Study|Moved out of area|2|||
33553872|NCT02634320|62946500|FG000|Overall Study|Out of window for study visits|1|||
33553873|NCT02634320|62946500|FG000|Overall Study|Protocol Violation|1|||
33553874|NCT02634320|62946500|FG000|Overall Study|Withdrawal by Subject|5|||
33659894|NCT01767467|63084959|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
33553875|NCT02634320|62946500|FG000|Overall Study|Lack of Efficacy|2|||
33659895|NCT01767467|63084958|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
33659896|NCT01767467|63084959|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
33659897|NCT01767467|63084958|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
33659898|NCT01767467|63084959|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
33659899|NCT01767467|63084958|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
33659900|NCT01767467|63084959|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
33659901|NCT01767467|63084958|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
33659902|NCT01767467|63084959|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
33659903|NCT01767467|63084958|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
33659904|NCT01767467|63084959|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
33659905|NCT01767467|63084958|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
33659906|NCT01767467|63084959|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
33659907|NCT01767467|63084958|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
33659908|NCT01767467|63084959|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
33659909|NCT01767467|63084958|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
33659910|NCT01767467|63084959|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
33659911|NCT01767467|63084958|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
33659912|NCT01767467|63084959|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
33659913|NCT01767467|63084958|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
33659914|NCT01767467|63084959|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
33659915|NCT01767467|63084958|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
33659916|NCT01767467|63084959|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
33659917|NCT04126083|63085032|FG000|Overall Study|Withdrawal by Subject|1|||
33659918|NCT01766921|63085072|FG000|Overall Study|Administrative Reason|5|||
33659919|NCT01766921|63085073|FG001|Overall Study|Administrative Reason|5|||
33659920|NCT01766921|63085072|FG000|Overall Study|Death|1|||
33659921|NCT01766921|63085073|FG001|Overall Study|Death|1|||
33659922|NCT01766921|63085072|FG000|Overall Study|Lost to Follow-up|1|||
33659923|NCT01766921|63085073|FG001|Overall Study|Lost to Follow-up|3|||
33659924|NCT01766921|63085072|FG000|Overall Study|Unclassified|2|||
33659925|NCT01766921|63085073|FG001|Overall Study|Unclassified|2|||
33659926|NCT01766921|63085072|FG000|Overall Study|Protocol Violation|1|||
33659927|NCT01766921|63085073|FG001|Overall Study|Protocol Violation|1|||
33659928|NCT01766921|63085072|FG000|Overall Study|Withdrawal by Subject|14|||
33659929|NCT01766921|63085073|FG001|Overall Study|Withdrawal by Subject|5|||
33659930|NCT01774799|63085091|FG000|Overall Study|Lost to Follow-up|1|||
33659931|NCT01774799|63085092|FG001|Overall Study|Lost to Follow-up|1|||
33659932|NCT01774799|63085093|FG002|Overall Study|Lost to Follow-up|0|||
33659933|NCT01774799|63085094|FG003|Overall Study|Lost to Follow-up|0|||
33659934|NCT01765751|63085136|FG000|Overall Study|Lost to Follow-up|0|||
33659935|NCT01765751|63085137|FG001|Overall Study|Lost to Follow-up|2|||
33659936|NCT01765751|63085138|FG002|Overall Study|Lost to Follow-up|1|||
33659937|NCT01736657|63085158|FG000|Overall Study|insufficient vascular access|1|||
33659938|NCT01736579|63085173|FG000|Overall Study|Termination of Study by Sponsor|2|||
33659939|NCT01736579|63085174|FG001|Overall Study|Termination of Study by Sponsor|2|||
33659940|NCT01765673|63085205|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
33659941|NCT01764659|63085212|FG000|Overall Study|Death|1|||
33659942|NCT01764659|63085212|FG000|Overall Study|Physician Decision|1|||
33659943|NCT01736189|63085218|FG000|Overall Study|Violation of registration criteria|41|||
33659944|NCT01736189|63085218|FG000|Overall Study|Protocol Violation|4|||
33659945|NCT01736189|63085218|FG000|Overall Study|Criteria and protocol violations|1|||
33659946|NCT01735175|63085250|FG000|Overall Study|Withdrawal by Subject|9|||
33659947|NCT01735175|63085251|FG001|Overall Study|Withdrawal by Subject|2|||
33482715|NCT01347866|62859324|FG010|Overall Study|Death|3|||
33482716|NCT01347866|62859325|FG011|Overall Study|Death|1|||
33482717|NCT01347866|62859326|FG012|Overall Study|Death|2|||
33482718|NCT01347866|62859327|FG013|Overall Study|Death|0|||
33482719|NCT01347866|62859328|FG014|Overall Study|Death|0|||
33482720|NCT01347866|62859329|FG015|Overall Study|Death|1|||
33482721|NCT01347866|62859330|FG016|Overall Study|Death|0|||
33482722|NCT01347866|62859314|FG000|Overall Study|Lost to Follow-up|0|||
33482723|NCT01347866|62859315|FG001|Overall Study|Lost to Follow-up|0|||
33482724|NCT01347866|62859316|FG002|Overall Study|Lost to Follow-up|0|||
33482725|NCT01347866|62859317|FG003|Overall Study|Lost to Follow-up|0|||
33482726|NCT01347866|62859318|FG004|Overall Study|Lost to Follow-up|0|||
33482727|NCT01347866|62859319|FG005|Overall Study|Lost to Follow-up|0|||
33553876|NCT02435680|62946507|FG000|Overall Study|Physician Decision|3|||
33482728|NCT01347866|62859320|FG006|Overall Study|Lost to Follow-up|0|||
33482729|NCT01347866|62859321|FG007|Overall Study|Lost to Follow-up|1|||
33482730|NCT01347866|62859322|FG008|Overall Study|Lost to Follow-up|1|||
33482731|NCT01347866|62859323|FG009|Overall Study|Lost to Follow-up|0|||
33553877|NCT02435680|62946508|FG001|Overall Study|Physician Decision|0|||
33659948|NCT01735175|63085250|FG000|Overall Study|Lost to Follow-up|4|||
33659949|NCT01735175|63085251|FG001|Overall Study|Lost to Follow-up|2|||
33659950|NCT01735175|63085250|FG000|Overall Study|Death|3|||
33659951|NCT01735175|63085251|FG001|Overall Study|Death|2|||
33659952|NCT01735175|63085250|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
33659953|NCT01735175|63085251|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
33659954|NCT01762943|63085263|FG000|Overall Study|Physician Decision|1|||
33659955|NCT01762943|63085264|FG001|Overall Study|Physician Decision|1|||
33659956|NCT01762943|63085263|FG000|Overall Study|Protocol Violation|1|||
33659957|NCT01762943|63085264|FG001|Overall Study|Protocol Violation|0|||
33659958|NCT01762943|63085263|FG000|Overall Study|Withdrawal by Subject|2|||
33659959|NCT01762943|63085264|FG001|Overall Study|Withdrawal by Subject|1|||
33659960|NCT01734785|63085327|FG000|Open-Label Period|Adverse Event|0|||
33482732|NCT01347866|62859324|FG010|Overall Study|Lost to Follow-up|0|||
33482733|NCT01347866|62859325|FG011|Overall Study|Lost to Follow-up|0|||
33482734|NCT01347866|62859326|FG012|Overall Study|Lost to Follow-up|0|||
33482735|NCT01347866|62859327|FG013|Overall Study|Lost to Follow-up|0|||
33482736|NCT01347866|62859328|FG014|Overall Study|Lost to Follow-up|0|||
33482737|NCT01347866|62859329|FG015|Overall Study|Lost to Follow-up|0|||
33482738|NCT01347866|62859330|FG016|Overall Study|Lost to Follow-up|0|||
33482739|NCT01347866|62859314|FG000|Overall Study|Other|3|||
33482740|NCT01347866|62859315|FG001|Overall Study|Other|1|||
33482741|NCT01347866|62859316|FG002|Overall Study|Other|1|||
33482742|NCT01347866|62859317|FG003|Overall Study|Other|4|||
33482743|NCT01347866|62859318|FG004|Overall Study|Other|5|||
33482744|NCT01347866|62859319|FG005|Overall Study|Other|0|||
33482745|NCT01347866|62859320|FG006|Overall Study|Other|5|||
33482746|NCT01347866|62859321|FG007|Overall Study|Other|3|||
33482747|NCT01347866|62859322|FG008|Overall Study|Other|22|||
33482748|NCT01347866|62859323|FG009|Overall Study|Other|5|||
33482749|NCT01347866|62859324|FG010|Overall Study|Other|0|||
33482750|NCT01347866|62859325|FG011|Overall Study|Other|3|||
33482751|NCT01347866|62859326|FG012|Overall Study|Other|4|||
33482752|NCT01347866|62859327|FG013|Overall Study|Other|4|||
33482753|NCT01347866|62859328|FG014|Overall Study|Other|2|||
33482754|NCT01347866|62859329|FG015|Overall Study|Other|3|||
33482755|NCT01347866|62859330|FG016|Overall Study|Other|0|||
33482756|NCT01347866|62859314|FG000|Overall Study|Subject refused further follow-up|2|||
33482757|NCT01347866|62859315|FG001|Overall Study|Subject refused further follow-up|0|||
33482758|NCT01347866|62859316|FG002|Overall Study|Subject refused further follow-up|0|||
33482759|NCT01347866|62859317|FG003|Overall Study|Subject refused further follow-up|2|||
33482760|NCT01347866|62859318|FG004|Overall Study|Subject refused further follow-up|0|||
33482761|NCT01347866|62859319|FG005|Overall Study|Subject refused further follow-up|1|||
33482762|NCT01347866|62859320|FG006|Overall Study|Subject refused further follow-up|0|||
33482763|NCT01347866|62859321|FG007|Overall Study|Subject refused further follow-up|0|||
33482764|NCT01347866|62859322|FG008|Overall Study|Subject refused further follow-up|4|||
33482765|NCT01347866|62859323|FG009|Overall Study|Subject refused further follow-up|1|||
33482766|NCT01347866|62859324|FG010|Overall Study|Subject refused further follow-up|0|||
33482767|NCT01347866|62859325|FG011|Overall Study|Subject refused further follow-up|0|||
33482768|NCT01347866|62859326|FG012|Overall Study|Subject refused further follow-up|1|||
33482769|NCT01347866|62859327|FG013|Overall Study|Subject refused further follow-up|3|||
33482770|NCT01347866|62859328|FG014|Overall Study|Subject refused further follow-up|1|||
33482771|NCT01347866|62859329|FG015|Overall Study|Subject refused further follow-up|0|||
33482772|NCT01347866|62859330|FG016|Overall Study|Subject refused further follow-up|2|||
33482773|NCT01347710|62859401|FG000|Overall Study|Withdrawal by Subject|2|||
33482774|NCT01347710|62859401|FG000|Overall Study|Adverse Event|4|||
33482775|NCT01347710|62859401|FG000|Overall Study|Angio or SPECT not completed|18|||
33482776|NCT01347710|62859401|FG000|Overall Study|issue with vitals prior to dosing|1|||
33553878|NCT02435680|62946509|FG002|Overall Study|Physician Decision|0|||
33659961|NCT01734785|63085328|FG001|Open-Label Period|Adverse Event|0|||
33482777|NCT01347710|62859401|FG000|Overall Study|Lost to Follow-up|1|||
33482778|NCT01347710|62859401|FG000|Overall Study|Physician Decision|2|||
33659962|NCT01734785|63085329|FG002|Open-Label Period|Adverse Event|0|||
33482779|NCT01347710|62859401|FG000|Overall Study|Other|3|||
33482780|NCT03485222|62859411|FG000|Overall Study|Death|0|||
33482781|NCT03485222|62859412|FG001|Overall Study|Death|1|||
33482782|NCT03485222|62859411|FG000|Overall Study|Lost to Follow-up|2|||
33482783|NCT03485222|62859412|FG001|Overall Study|Lost to Follow-up|1|||
33482784|NCT01347554|62859420|FG000|Overall Study|Lack of Efficacy|7|||
33482785|NCT01347554|62859421|FG001|Overall Study|Lack of Efficacy|11|||
33482786|NCT03482882|62859427|FG000|Overall Study|Adverse Event|3|||
33553879|NCT02435680|62946507|FG000|Overall Study|subject / guardian decision|0|||
33659963|NCT01734785|63085330|FG003|Open-Label Period|Adverse Event|9|||
33659964|NCT01734785|63085327|FG000|Open-Label Period|Lack of Efficacy|0|||
33659965|NCT01734785|63085328|FG001|Open-Label Period|Lack of Efficacy|0|||
33659966|NCT01734785|63085329|FG002|Open-Label Period|Lack of Efficacy|0|||
33659967|NCT01734785|63085330|FG003|Open-Label Period|Lack of Efficacy|1|||
33659968|NCT01734785|63085327|FG000|Open-Label Period|Protocol Violation|0|||
33659969|NCT01734785|63085328|FG001|Open-Label Period|Protocol Violation|0|||
33659970|NCT01734785|63085329|FG002|Open-Label Period|Protocol Violation|0|||
33659971|NCT01734785|63085330|FG003|Open-Label Period|Protocol Violation|13|||
33659972|NCT01734785|63085327|FG000|Open-Label Period|Lost to Follow-up|0|||
33659973|NCT01734785|63085328|FG001|Open-Label Period|Lost to Follow-up|0|||
33659974|NCT01734785|63085329|FG002|Open-Label Period|Lost to Follow-up|0|||
33659975|NCT01734785|63085330|FG003|Open-Label Period|Lost to Follow-up|14|||
33659976|NCT01734785|63085327|FG000|Open-Label Period|Withdrawal by Subject|0|||
33659977|NCT01734785|63085328|FG001|Open-Label Period|Withdrawal by Subject|0|||
33659978|NCT01734785|63085329|FG002|Open-Label Period|Withdrawal by Subject|0|||
33659979|NCT01734785|63085330|FG003|Open-Label Period|Withdrawal by Subject|12|||
33659980|NCT01734785|63085327|FG000|Open-Label Period|Other Reasons|0|||
33659981|NCT01734785|63085328|FG001|Open-Label Period|Other Reasons|0|||
33659982|NCT01734785|63085329|FG002|Open-Label Period|Other Reasons|0|||
33659983|NCT01734785|63085330|FG003|Open-Label Period|Other Reasons|224|||
33659984|NCT01734785|63085327|FG000|Double-Blind Period|Adverse Event|0|||
33659985|NCT01734785|63085328|FG001|Double-Blind Period|Adverse Event|3|||
33659986|NCT01734785|63085329|FG002|Double-Blind Period|Adverse Event|2|||
33659987|NCT01734785|63085330|FG003|Double-Blind Period|Adverse Event|0|||
33659988|NCT01734785|63085327|FG000|Double-Blind Period|Lack of Efficacy|0|||
33659989|NCT01734785|63085328|FG001|Double-Blind Period|Lack of Efficacy|1|||
33659990|NCT01734785|63085329|FG002|Double-Blind Period|Lack of Efficacy|0|||
33659991|NCT01734785|63085330|FG003|Double-Blind Period|Lack of Efficacy|0|||
33659992|NCT01734785|63085327|FG000|Double-Blind Period|Protocol Violation|0|||
33659993|NCT01734785|63085328|FG001|Double-Blind Period|Protocol Violation|1|||
33659994|NCT01734785|63085329|FG002|Double-Blind Period|Protocol Violation|1|||
33659995|NCT01734785|63085330|FG003|Double-Blind Period|Protocol Violation|0|||
33659996|NCT01734785|63085327|FG000|Double-Blind Period|Lost to Follow-up|2|||
33659997|NCT01734785|63085328|FG001|Double-Blind Period|Lost to Follow-up|4|||
33659998|NCT01734785|63085329|FG002|Double-Blind Period|Lost to Follow-up|2|||
33659999|NCT01734785|63085330|FG003|Double-Blind Period|Lost to Follow-up|0|||
33660000|NCT01734785|63085327|FG000|Double-Blind Period|Withdrawal by Subject|2|||
33660001|NCT01734785|63085328|FG001|Double-Blind Period|Withdrawal by Subject|0|||
33660002|NCT01734785|63085329|FG002|Double-Blind Period|Withdrawal by Subject|0|||
33660003|NCT01734785|63085330|FG003|Double-Blind Period|Withdrawal by Subject|0|||
33660004|NCT01734785|63085327|FG000|Double-Blind Period|Not treated|1|||
33660005|NCT01734785|63085328|FG001|Double-Blind Period|Not treated|0|||
33660006|NCT01734785|63085329|FG002|Double-Blind Period|Not treated|0|||
33660007|NCT01734785|63085330|FG003|Double-Blind Period|Not treated|0|||
33660008|NCT01734395|63085339|FG000|Overall Study|Other|65|||
33660009|NCT01734395|63085339|FG000|Overall Study|Lost to Follow-up|287|||
33660010|NCT01734395|63085339|FG000|Overall Study|Lack of Efficacy|5|||
33660011|NCT01734395|63085339|FG000|Overall Study|Adverse Event|40|||
33660012|NCT01734395|63085339|FG000|Overall Study|Withdrawal by Subject|10|||
33660013|NCT01734395|63085339|FG000|Overall Study|Missing the reasons for not completed|3|||
33660014|NCT01597505|63085373|FG000|Overall Study|Physician Decision|5|||
33660015|NCT01597505|63085374|FG001|Overall Study|Physician Decision|0|||
33660016|NCT01597505|63085373|FG000|Overall Study|Adverse Event|19|||
33660017|NCT01597505|63085374|FG001|Overall Study|Adverse Event|7|||
33660018|NCT01597505|63085373|FG000|Overall Study|Lost to Follow-up|4|||
33660019|NCT01597505|63085374|FG001|Overall Study|Lost to Follow-up|2|||
33660020|NCT01597505|63085373|FG000|Overall Study|Withdrawal by Subject|10|||
33660021|NCT01597505|63085374|FG001|Overall Study|Withdrawal by Subject|18|||
33660022|NCT01597505|63085373|FG000|Overall Study|Other|5|||
33660023|NCT01597505|63085374|FG001|Overall Study|Other|6|||
33660024|NCT01597505|63085373|FG000|Overall Study|Missing|1|||
33660025|NCT01597505|63085374|FG001|Overall Study|Missing|0|||
33660026|NCT01760447|63085413|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
33660027|NCT01760447|63085414|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
33660028|NCT01760447|63085415|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
33660029|NCT01760447|63085416|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
33660030|NCT01760447|63085413|FG000|Weeks 0-20|Withdrawal by Subject|2|||
33660031|NCT01760447|63085414|FG001|Weeks 0-20|Withdrawal by Subject|0|||
33364986|NCT00600938|62743506|FG003|Extension Study|Lost to Follow-up|0|||
33660032|NCT01760447|63085415|FG002|Weeks 0-20|Withdrawal by Subject|1|||
33660033|NCT01760447|63085416|FG003|Weeks 0-20|Withdrawal by Subject|0|||
33660034|NCT01760447|63085413|FG000|Weeks 0-20|Lost to Follow-up|1|||
33660035|NCT01760447|63085414|FG001|Weeks 0-20|Lost to Follow-up|0|||
33660036|NCT01760447|63085415|FG002|Weeks 0-20|Lost to Follow-up|1|||
33660037|NCT01760447|63085416|FG003|Weeks 0-20|Lost to Follow-up|1|||
33660038|NCT01760447|63085413|FG000|Weeks 0-20|Randomized but not treated|0|||
33660039|NCT01760447|63085414|FG001|Weeks 0-20|Randomized but not treated|0|||
33660040|NCT01760447|63085415|FG002|Weeks 0-20|Randomized but not treated|2|||
33553880|NCT02435680|62946508|FG001|Overall Study|subject / guardian decision|3|||
33660041|NCT01760447|63085416|FG003|Weeks 0-20|Randomized but not treated|0|||
33660042|NCT01760447|63085413|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
33660043|NCT01760447|63085414|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
33660044|NCT01760447|63085415|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
33660045|NCT01760447|63085416|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
33660046|NCT01760447|63085413|FG000|Weeks 20-54|Withdrawal by Subject|2|||
33660047|NCT01760447|63085414|FG001|Weeks 20-54|Withdrawal by Subject|1|||
33482787|NCT03482882|62859427|FG000|Overall Study|Lost to Follow-up|1|||
33482788|NCT03482882|62859427|FG000|Overall Study|Protocol Violation|2|||
33482789|NCT03482882|62859427|FG000|Overall Study|Not further specified|1|||
33482790|NCT03480932|62859434|FG000|Overall Study|Death|1|||
33482791|NCT03480932|62859435|FG001|Overall Study|Death|1|||
33482792|NCT03480932|62859436|FG002|Overall Study|Death|0|||
33482793|NCT03480932|62859434|FG000|Overall Study|Lost to Follow-up|0|||
33482794|NCT03480932|62859435|FG001|Overall Study|Lost to Follow-up|2|||
33482795|NCT03480932|62859436|FG002|Overall Study|Lost to Follow-up|3|||
33482796|NCT03480932|62859434|FG000|Overall Study|Incarcerated|2|||
33482797|NCT03480932|62859435|FG001|Overall Study|Incarcerated|2|||
33482798|NCT03480932|62859436|FG002|Overall Study|Incarcerated|2|||
33482799|NCT03387020|62859447|FG000|Overall Study|Adverse Event|0|||
33482800|NCT03387020|62859448|FG001|Overall Study|Adverse Event|2|||
33482801|NCT03387020|62859449|FG002|Overall Study|Adverse Event|0|||
33553881|NCT02435680|62946509|FG002|Overall Study|subject / guardian decision|2|||
33553882|NCT02435680|62946507|FG000|Overall Study|Adverse Event|8|||
33553883|NCT02435680|62946508|FG001|Overall Study|Adverse Event|3|||
33553884|NCT02435680|62946509|FG002|Overall Study|Adverse Event|2|||
33553885|NCT02435680|62946507|FG000|Overall Study|progressive disease|10|||
33553886|NCT02435680|62946508|FG001|Overall Study|progressive disease|7|||
33553887|NCT02435680|62946509|FG002|Overall Study|progressive disease|11|||
33553888|NCT02435680|62946507|FG000|Overall Study|not treated|0|||
33553889|NCT02435680|62946508|FG001|Overall Study|not treated|0|||
33553890|NCT02435680|62946509|FG002|Overall Study|not treated|1|||
33553891|NCT03371732|62946523|FG000|Overall Study|Withdrawal by Subject|9|||
33553892|NCT03371732|62946524|FG001|Overall Study|Withdrawal by Subject|3|||
33553893|NCT03371732|62946523|FG000|Overall Study|Refusal to continue|3|||
33553894|NCT03371732|62946524|FG001|Overall Study|Refusal to continue|4|||
33553895|NCT02745119|62946536|FG000|Overall Study|Adverse Event|1|||
33553896|NCT02745119|62946537|FG001|Overall Study|Adverse Event|0|||
33553897|NCT02745119|62946538|FG002|Overall Study|Adverse Event|1|||
33553898|NCT02745119|62946539|FG003|Overall Study|Adverse Event|3|||
33553899|NCT02745119|62946536|FG000|Overall Study|Death|3|||
33553900|NCT02745119|62946537|FG001|Overall Study|Death|3|||
33553901|NCT02745119|62946538|FG002|Overall Study|Death|0|||
33553902|NCT02745119|62946539|FG003|Overall Study|Death|4|||
33553903|NCT02745119|62946536|FG000|Overall Study|Lost to Follow-up|0|||
33553904|NCT02745119|62946537|FG001|Overall Study|Lost to Follow-up|0|||
33553905|NCT02745119|62946538|FG002|Overall Study|Lost to Follow-up|0|||
33553906|NCT02745119|62946539|FG003|Overall Study|Lost to Follow-up|1|||
33553907|NCT02745119|62946536|FG000|Overall Study|Protocol Deviation|0|||
33553908|NCT02745119|62946537|FG001|Overall Study|Protocol Deviation|0|||
33553909|NCT02745119|62946538|FG002|Overall Study|Protocol Deviation|0|||
33660048|NCT01760447|63085415|FG002|Weeks 20-54|Withdrawal by Subject|1|||
33553910|NCT02745119|62946539|FG003|Overall Study|Protocol Deviation|1|||
33553911|NCT02745119|62946536|FG000|Overall Study|Withdrawal by Subject|7|||
33553912|NCT02745119|62946537|FG001|Overall Study|Withdrawal by Subject|15|||
33660049|NCT01760447|63085416|FG003|Weeks 20-54|Withdrawal by Subject|2|||
33660050|NCT01760447|63085413|FG000|Weeks 20-54|Lost to Follow-up|0|||
33553913|NCT02745119|62946538|FG002|Overall Study|Withdrawal by Subject|8|||
33553914|NCT02745119|62946539|FG003|Overall Study|Withdrawal by Subject|14|||
33553915|NCT02745119|62946536|FG000|Overall Study|Study Terminated by Sponsor|134|||
33553916|NCT02745119|62946537|FG001|Overall Study|Study Terminated by Sponsor|252|||
33553917|NCT02745119|62946538|FG002|Overall Study|Study Terminated by Sponsor|135|||
33553918|NCT02745119|62946539|FG003|Overall Study|Study Terminated by Sponsor|251|||
33660051|NCT01760447|63085414|FG001|Weeks 20-54|Lost to Follow-up|0|||
33660052|NCT01760447|63085415|FG002|Weeks 20-54|Lost to Follow-up|1|||
33364987|NCT00600938|62743503|FG000|Extension Study|Death|1|||
33482802|NCT03387020|62859447|FG000|Overall Study|Withdrawal by Subject|2|||
33482803|NCT03387020|62859448|FG001|Overall Study|Withdrawal by Subject|0|||
33482804|NCT03387020|62859449|FG002|Overall Study|Withdrawal by Subject|0|||
33482805|NCT03386474|62859469|FG000|Overall Study|Death|1|||
33553919|NCT02745119|62946536|FG000|Overall Study|Physician Decision|0|||
33553920|NCT02745119|62946537|FG001|Overall Study|Physician Decision|2|||
33553921|NCT02745119|62946538|FG002|Overall Study|Physician Decision|2|||
33553922|NCT02745119|62946539|FG003|Overall Study|Physician Decision|2|||
33553923|NCT02745119|62946536|FG000|Overall Study|Reason Not Specified|0|||
33553924|NCT02745119|62946537|FG001|Overall Study|Reason Not Specified|2|||
33553925|NCT02745119|62946538|FG002|Overall Study|Reason Not Specified|0|||
33553926|NCT02745119|62946539|FG003|Overall Study|Reason Not Specified|1|||
33660053|NCT01760447|63085416|FG003|Weeks 20-54|Lost to Follow-up|2|||
33660054|NCT01732913|63085505|FG000|Overall Study|Study Terminated by Sponsor|105|||
33553927|NCT01367665|62946553|FG000|Overall Study|Death|102|||
33553928|NCT01367665|62946554|FG001|Overall Study|Death|19|||
33553929|NCT01367665|62946553|FG000|Overall Study|Lost to Follow-up|222|||
33553930|NCT01367665|62946554|FG001|Overall Study|Lost to Follow-up|22|||
33553931|NCT01367665|62946553|FG000|Overall Study|Not Done|118|||
33553932|NCT01367665|62946554|FG001|Overall Study|Not Done|14|||
33660055|NCT01732913|63085506|FG001|Overall Study|Study Terminated by Sponsor|55|||
33660056|NCT01732913|63085505|FG000|Overall Study|Withdrawal by Subject|27|||
33660057|NCT01732913|63085506|FG001|Overall Study|Withdrawal by Subject|4|||
33660058|NCT01732913|63085505|FG000|Overall Study|Physician Decision|14|||
33660059|NCT01732913|63085506|FG001|Overall Study|Physician Decision|7|||
33660060|NCT01732913|63085505|FG000|Overall Study|Other|7|||
33660061|NCT01732913|63085506|FG001|Overall Study|Other|1|||
33660062|NCT01732913|63085505|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
33660063|NCT01732913|63085506|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
33660064|NCT01732835|63085537|FG000|6-month Primary Endpoint|Did not receive device|19|||
33660065|NCT01732835|63085537|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
33660066|NCT01732835|63085537|FG000|6-month Primary Endpoint|Adverse Event|3|||
33660067|NCT01732835|63085537|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
33660068|NCT01732835|63085537|FG000|2-year Extended Follow-up|Adverse Event|3|||
33553933|NCT02576847|62946561|FG000|Overall Study|Adverse Event|27|||
33553934|NCT02576847|62946561|FG000|Overall Study|Lost to Follow-up|22|||
33553935|NCT02576847|62946561|FG000|Overall Study|Physician Decision|1|||
33553936|NCT02576847|62946561|FG000|Overall Study|Pregnancy|1|||
33553937|NCT02576847|62946561|FG000|Overall Study|Protocol Violation|3|||
33553938|NCT02576847|62946561|FG000|Overall Study|Withdrawal by Subject|78|||
33660069|NCT01732835|63085537|FG000|2-year Extended Follow-up|Death|1|||
33660070|NCT01759511|63085591|FG000|Overall Study|Adverse Event|4|||
33660071|NCT01759511|63085591|FG000|Overall Study|Death|2|||
33660072|NCT01759511|63085591|FG000|Overall Study|Lack of Efficacy|2|||
33553939|NCT02576847|62946561|FG000|Overall Study|Other|5|||
33660073|NCT01759511|63085591|FG000|Overall Study|Physician Decision|1|||
33660074|NCT01759511|63085591|FG000|Overall Study|Progressive Disease|5|||
33660075|NCT01759511|63085591|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
33660076|NCT01759511|63085591|FG000|Overall Study|Study Terminated by Sponsor|13|||
33660077|NCT01759511|63085591|FG000|Overall Study|Withdrawal by Subject|3|||
33660078|NCT01732757|63085609|FG000|Overall Study|Lost to Follow-up|1|||
33482806|NCT03386474|62859470|FG001|Overall Study|Death|0|||
33482807|NCT03386474|62859469|FG000|Overall Study|Adverse Event|0|||
33482808|NCT03386474|62859470|FG001|Overall Study|Adverse Event|1|||
33482809|NCT03405818|62859481|FG000|Overall Study|Withdrawal by Subject|4|||
33482810|NCT03405818|62859481|FG000|Overall Study|Lost to Follow-up|4|||
33482811|NCT03403634|62859485|FG000|Overall Study|Disease progression|3|||
33482812|NCT03403634|62859485|FG000|Overall Study|Did not meet eligibility criteria|4|||
33482813|NCT03403400|62859492|FG000|Overall Study|Lost to Follow-up|1|||
33482814|NCT03403400|62859493|FG001|Overall Study|Lost to Follow-up|0|||
33482815|NCT03403400|62859494|FG002|Overall Study|Lost to Follow-up|1|||
33482816|NCT03403400|62859492|FG000|Overall Study|Hospitalization|1|||
33482817|NCT03403400|62859493|FG001|Overall Study|Hospitalization|0|||
33482818|NCT03403400|62859494|FG002|Overall Study|Hospitalization|0|||
33482819|NCT03403400|62859492|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
33482820|NCT03403400|62859493|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
33482821|NCT03403400|62859494|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
33482822|NCT02863354|62859519|FG000|Year 1|Lost to Follow-up|1|||
33482823|NCT02863354|62859520|FG001|Year 1|Lost to Follow-up|1|||
33482824|NCT02863354|62859519|FG000|Year 1|Withdrawal by Subject|3|||
33482825|NCT02863354|62859520|FG001|Year 1|Withdrawal by Subject|0|||
33482826|NCT02863354|62859519|FG000|Year 1|Death|0|||
33482827|NCT02863354|62859520|FG001|Year 1|Death|1|||
33482828|NCT02863354|62859519|FG000|Year 2|Lost to Follow-up|2|||
33553940|NCT02135029|62946577|FG000|Overall Study|Adverse Event|2|||
33553941|NCT02135029|62946578|FG001|Overall Study|Adverse Event|2|||
33553942|NCT02135029|62946579|FG002|Overall Study|Adverse Event|2|||
33660079|NCT01732757|63085610|FG001|Overall Study|Lost to Follow-up|0|||
33660080|NCT01732757|63085611|FG002|Overall Study|Lost to Follow-up|0|||
33482829|NCT02863354|62859520|FG001|Year 2|Lost to Follow-up|2|||
33482830|NCT03480152|62859528|FG000|Phase I|Signed consent. Died before treatment.|1|||
33482831|NCT03480152|62859529|FG001|Phase I|Signed consent. Died before treatment.|0|||
33482832|NCT03480152|62859530|FG002|Phase I|Signed consent. Died before treatment.|0|||
33553943|NCT02135029|62946577|FG000|Overall Study|Lost to Follow-up|0|||
33553944|NCT02135029|62946578|FG001|Overall Study|Lost to Follow-up|1|||
33553945|NCT02135029|62946579|FG002|Overall Study|Lost to Follow-up|0|||
33660081|NCT01758731|63085619|FG000|Overall Study|Physician Decision|1|||
33660082|NCT01606319|63085629|FG000|Overall Study|Lost to Follow-up|17|||
33660083|NCT01606319|63085630|FG001|Overall Study|Lost to Follow-up|14|||
33660084|NCT01606319|63085629|FG000|Overall Study|Withdrawal by Subject|9|||
33660085|NCT01606319|63085630|FG001|Overall Study|Withdrawal by Subject|12|||
33660086|NCT01606319|63085629|FG000|Overall Study|Physician Decision|1|||
33660087|NCT01606319|63085630|FG001|Overall Study|Physician Decision|2|||
33660088|NCT01606319|63085629|FG000|Overall Study|Lack of Efficacy|6|||
33553946|NCT02135029|62946577|FG000|Overall Study|Withdrawal by Subject|2|||
33553947|NCT02135029|62946578|FG001|Overall Study|Withdrawal by Subject|0|||
33553948|NCT02135029|62946579|FG002|Overall Study|Withdrawal by Subject|1|||
33553949|NCT02135029|62946577|FG000|Overall Study|Other|0|||
33553950|NCT02135029|62946578|FG001|Overall Study|Other|1|||
33553951|NCT02135029|62946579|FG002|Overall Study|Other|0|||
33660089|NCT01606319|63085630|FG001|Overall Study|Lack of Efficacy|8|||
33660090|NCT01606319|63085629|FG000|Overall Study|Adverse Event|1|||
33660091|NCT01606319|63085630|FG001|Overall Study|Adverse Event|4|||
33660092|NCT01757405|63085638|FG000|Overall Study|Lost to Follow-up|1|||
33660093|NCT01757405|63085639|FG001|Overall Study|Lost to Follow-up|1|||
33660094|NCT01757405|63085638|FG000|Overall Study|Withdrawal by Subject|0|||
33660095|NCT01757405|63085639|FG001|Overall Study|Withdrawal by Subject|1|||
33660096|NCT01455597|63085645|FG000|Overall Study|Adverse Event|7|||
33660097|NCT01455597|63085646|FG001|Overall Study|Adverse Event|0|||
33660098|NCT01455597|63085647|FG002|Overall Study|Adverse Event|5|||
33660099|NCT01455597|63085648|FG003|Overall Study|Adverse Event|1|||
33660100|NCT01455597|63085645|FG000|Overall Study|Lack of Efficacy|0|||
33660101|NCT01455597|63085646|FG001|Overall Study|Lack of Efficacy|1|||
33660102|NCT01455597|63085647|FG002|Overall Study|Lack of Efficacy|2|||
33660103|NCT01455597|63085648|FG003|Overall Study|Lack of Efficacy|0|||
33660104|NCT01455597|63085645|FG000|Overall Study|Lost to Follow-up|3|||
33660105|NCT01455597|63085646|FG001|Overall Study|Lost to Follow-up|0|||
33660106|NCT01455597|63085647|FG002|Overall Study|Lost to Follow-up|2|||
33660107|NCT01455597|63085648|FG003|Overall Study|Lost to Follow-up|1|||
33660108|NCT01455597|63085645|FG000|Overall Study|Withdrew Consent|6|||
33660109|NCT01455597|63085646|FG001|Overall Study|Withdrew Consent|5|||
33660110|NCT01455597|63085647|FG002|Overall Study|Withdrew Consent|8|||
33660111|NCT01455597|63085648|FG003|Overall Study|Withdrew Consent|5|||
33660112|NCT01455597|63085645|FG000|Overall Study|Reason not Specified|1|||
33660113|NCT01455597|63085646|FG001|Overall Study|Reason not Specified|2|||
33660114|NCT01455597|63085647|FG002|Overall Study|Reason not Specified|3|||
33660115|NCT01455597|63085648|FG003|Overall Study|Reason not Specified|3|||
33660116|NCT01757171|63085671|FG000|Overall Study|Adverse Event|5|||
33660117|NCT01757171|63085672|FG001|Overall Study|Adverse Event|1|||
33364988|NCT00600938|62743504|FG001|Extension Study|Death|0|||
33482833|NCT02859454|62859538|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
33482834|NCT02862730|62859545|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
33482835|NCT02862730|62859546|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
33553952|NCT02135029|62946577|FG000|Overall Study|Death|0|||
33553953|NCT02135029|62946578|FG001|Overall Study|Death|1|||
33553954|NCT02135029|62946579|FG002|Overall Study|Death|0|||
33553955|NCT02842151|62946588|FG000|Overall Study|Adverse Event|1|||
33553956|NCT02842151|62946588|FG000|Overall Study|Subject moved too far away|1|||
33553957|NCT02842073|62946594|FG000|Overall Study|Withdrawal by Subject|1|||
33553958|NCT01367275|62946598|FG000|Overall Study|Ineligible|1|||
33553959|NCT01367275|62946598|FG000|Overall Study|Disease Progression|2|||
33553960|NCT02842853|62946606|FG000|Overall Study|Non-compliance with the protocol|3|||
33553961|NCT02842853|62946607|FG001|Overall Study|Non-compliance with the protocol|7|||
33553962|NCT02842853|62946608|FG002|Overall Study|Non-compliance with the protocol|2|||
33553963|NCT02842853|62946609|FG003|Overall Study|Non-compliance with the protocol|5|||
33553964|NCT02842853|62946606|FG000|Overall Study|Subject met exclusion criteria|0|||
33553965|NCT02842853|62946607|FG001|Overall Study|Subject met exclusion criteria|1|||
33553966|NCT02842853|62946608|FG002|Overall Study|Subject met exclusion criteria|0|||
33553967|NCT02842853|62946609|FG003|Overall Study|Subject met exclusion criteria|0|||
33482836|NCT02862730|62859547|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
33482837|NCT02862730|62859548|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
33482838|NCT02862730|62859549|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
33482839|NCT02862730|62859550|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
33482840|NCT02862730|62859551|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
33553968|NCT02842853|62946606|FG000|Overall Study|Withdrawal by Subject|11|||
33660118|NCT01757171|63085671|FG000|Overall Study|Disease Progression|1|||
33660119|NCT01757171|63085672|FG001|Overall Study|Disease Progression|0|||
33660120|NCT01757171|63085671|FG000|Overall Study|Hospitalization|1|||
33660121|NCT01757171|63085672|FG001|Overall Study|Hospitalization|0|||
33660122|NCT01757171|63085671|FG000|Overall Study|ECOG decline|1|||
33660123|NCT01757171|63085672|FG001|Overall Study|ECOG decline|0|||
33660124|NCT01756235|63085678|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
33660125|NCT01730729|63085682|FG000|Overall Study|Adverse Event|1|||
33660126|NCT01730729|63085682|FG000|Overall Study|Death|1|||
33660127|NCT01730729|63085682|FG000|Overall Study|Progressive Disease|12|||
33660128|NCT01756157|63085686|FG000|First Intervention Period|Withdrawal by Subject|1|||
33660129|NCT01756157|63085687|FG001|First Intervention Period|Withdrawal by Subject|0|||
33660130|NCT01756157|63085686|FG000|First Intervention Period|Lost to Follow-up|0|||
33660131|NCT01756157|63085687|FG001|First Intervention Period|Lost to Follow-up|2|||
33660132|NCT01756079|63085693|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
33660133|NCT01756079|63085693|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
33660134|NCT01756079|63085693|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
33660135|NCT01756079|63085693|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
33660136|NCT01756079|63085693|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
33660137|NCT04967885|63085700|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
33660138|NCT04967885|63085701|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
33364989|NCT00600938|62743505|FG002|Extension Study|Death|0|||
33364990|NCT00600938|62743506|FG003|Extension Study|Death|0|||
33364991|NCT00543439|62743547|FG000|Period 1|Adverse Event|0|||
33364992|NCT00543439|62743548|FG001|Period 1|Adverse Event|2|||
33364993|NCT00543439|62743549|FG002|Period 1|Adverse Event|1|||
33364994|NCT00543439|62743547|FG000|Period 1|Withdrawal by Subject|1|||
33364995|NCT00543439|62743548|FG001|Period 1|Withdrawal by Subject|1|||
33482841|NCT02862730|62859545|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
33482842|NCT02862730|62859546|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
33364996|NCT00543439|62743549|FG002|Period 1|Withdrawal by Subject|0|||
33364997|NCT00543439|62743547|FG000|Period 1|Physician Decision|0|||
33364998|NCT00543439|62743548|FG001|Period 1|Physician Decision|0|||
33482843|NCT02862730|62859547|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
33482844|NCT02862730|62859548|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
33482845|NCT02862730|62859549|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
33482846|NCT02862730|62859550|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
33482847|NCT02862730|62859551|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
33482848|NCT02862730|62859545|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
33482849|NCT02862730|62859546|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
33482850|NCT02862730|62859547|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
33660139|NCT04967885|63085700|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
33364999|NCT00543439|62743549|FG002|Period 1|Physician Decision|1|||
33660140|NCT04967885|63085701|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
33660141|NCT04967885|63085700|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
33660142|NCT04967885|63085701|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
33660143|NCT04967885|63085700|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
33553969|NCT02842853|62946607|FG001|Overall Study|Withdrawal by Subject|13|||
33553970|NCT02842853|62946608|FG002|Overall Study|Withdrawal by Subject|9|||
33553971|NCT02842853|62946609|FG003|Overall Study|Withdrawal by Subject|8|||
33553972|NCT02842853|62946606|FG000|Overall Study|Lost to Follow-up|9|||
33553973|NCT02842853|62946607|FG001|Overall Study|Lost to Follow-up|13|||
33553974|NCT02842853|62946608|FG002|Overall Study|Lost to Follow-up|10|||
33553975|NCT02842853|62946609|FG003|Overall Study|Lost to Follow-up|11|||
33482851|NCT02862730|62859548|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
33482852|NCT02862730|62859549|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
33553976|NCT02433340|62946625|FG000|Overall Study|Adverse Event|0|||
33553977|NCT02433340|62946626|FG001|Overall Study|Adverse Event|0|||
33553978|NCT02433340|62946627|FG002|Overall Study|Adverse Event|1|||
33553979|NCT02433340|62946628|FG003|Overall Study|Adverse Event|0|||
33553980|NCT02433340|62946625|FG000|Overall Study|Withdrawal by Subject|1|||
33553981|NCT02433340|62946626|FG001|Overall Study|Withdrawal by Subject|0|||
33553982|NCT02433340|62946627|FG002|Overall Study|Withdrawal by Subject|1|||
33553983|NCT02433340|62946628|FG003|Overall Study|Withdrawal by Subject|2|||
33482853|NCT02862730|62859550|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
33482854|NCT02862730|62859551|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
33482855|NCT02862730|62859545|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
33482856|NCT02862730|62859546|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
33482857|NCT02862730|62859547|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
33482858|NCT02862730|62859548|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
33482859|NCT02862730|62859549|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
33482860|NCT02862730|62859550|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
33482861|NCT02862730|62859551|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
33482862|NCT03402386|62859566|FG000|Overall Study|Adverse Event|3|||
33482863|NCT03402386|62859566|FG000|Overall Study|Physician Decision|1|||
33482864|NCT03402386|62859566|FG000|Overall Study|Difficult to control Hb|2|||
33482865|NCT03353792|62859572|FG000|Overall Study|Lost to Follow-up|1|||
33482866|NCT03353792|62859573|FG001|Overall Study|Lost to Follow-up|0|||
33482867|NCT03353792|62859572|FG000|Overall Study|Participant Unable to Manage Device|1|||
33482868|NCT03353792|62859573|FG001|Overall Study|Participant Unable to Manage Device|0|||
33482869|NCT02862574|62859582|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33482870|NCT02862574|62859583|FG001|Double-Blind Treatment Period|Adverse Event|1|||
33482871|NCT02862574|62859584|FG002|Double-Blind Treatment Period|Adverse Event|0|||
33482872|NCT02862574|62859582|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
33482873|NCT02862574|62859583|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
33482874|NCT02862574|62859584|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
33482875|NCT02862574|62859582|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
33482876|NCT02862574|62859583|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
33482877|NCT02862574|62859584|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
33482878|NCT02862106|62859599|FG000|Overall Study|Adverse Event|4|||
33482879|NCT02862106|62859600|FG001|Overall Study|Adverse Event|0|||
33482880|NCT02862106|62859599|FG000|Overall Study|Protocol Violation|16|||
33482881|NCT02862106|62859600|FG001|Overall Study|Protocol Violation|1|||
33482882|NCT02862106|62859599|FG000|Overall Study|Lost to Follow-up|15|||
33482883|NCT02862106|62859600|FG001|Overall Study|Lost to Follow-up|5|||
33482884|NCT02862106|62859599|FG000|Overall Study|Withdrawal by Subject|2|||
33660144|NCT04967885|63085701|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
33660145|NCT04967885|63085700|FG000|EMI-II Intervention|Lost to Follow-up|14|||
33482885|NCT02862106|62859600|FG001|Overall Study|Withdrawal by Subject|0|||
33482886|NCT02862106|62859599|FG000|Overall Study|Subjects moved to other city|1|||
33482887|NCT02862106|62859600|FG001|Overall Study|Subjects moved to other city|0|||
33482888|NCT04157296|62859615|FG000|Overall Study|Withdrawal by Subject|0|||
33482889|NCT04157296|62859616|FG001|Overall Study|Withdrawal by Subject|1|||
33553984|NCT02433340|62946625|FG000|Overall Study|Lost to Follow-up|0|||
33553985|NCT02433340|62946626|FG001|Overall Study|Lost to Follow-up|1|||
33553986|NCT02433340|62946627|FG002|Overall Study|Lost to Follow-up|0|||
33553987|NCT02433340|62946628|FG003|Overall Study|Lost to Follow-up|0|||
33553988|NCT02433340|62946625|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
33553989|NCT02433340|62946626|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
33553990|NCT02433340|62946627|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
33553991|NCT02433340|62946628|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
33553992|NCT02433340|62946625|FG000|Overall Study|Other|0|||
33553993|NCT02433340|62946626|FG001|Overall Study|Other|1|||
33553994|NCT02433340|62946627|FG002|Overall Study|Other|0|||
33553995|NCT02433340|62946628|FG003|Overall Study|Other|0|||
33553996|NCT02400346|62946640|FG000|Overall Study|Adverse Event|24|||
33553997|NCT02400346|62946640|FG000|Overall Study|Lack of Efficacy|9|||
33553998|NCT02400346|62946640|FG000|Overall Study|Non-compliance with IMP|1|||
33553999|NCT02400346|62946640|FG000|Overall Study|Withdrawal by Subject|7|||
33554000|NCT02400346|62946640|FG000|Overall Study|Administrative or other reason(s)|2|||
33554001|NCT02400346|62946640|FG000|Overall Study|Lost to Follow-up|1|||
33554002|NCT02399254|62946644|FG000|Overall Study|Physician Decision|2|||
33554003|NCT02456662|62946651|FG000|Overall Study|Lost to Follow-up|2|||
33554004|NCT02456662|62946652|FG001|Overall Study|Lost to Follow-up|1|||
33554005|NCT01653262|62946658|FG000|Overall Study|Lack of Efficacy|1|||
33554006|NCT01653262|62946658|FG000|Overall Study|SAE, non-fatal|1|||
33554007|NCT01653262|62946658|FG000|Overall Study|AE, non-serious non-fatal|1|||
33554008|NCT02455336|62946664|FG000|Overall Study|Withdrawal by Subject|0|||
33554009|NCT02455336|62946665|FG001|Overall Study|Withdrawal by Subject|2|||
33554010|NCT02455336|62946664|FG000|Overall Study|Adverse Event|3|||
33554011|NCT02455336|62946665|FG001|Overall Study|Adverse Event|0|||
33554012|NCT02455336|62946664|FG000|Overall Study|Non-responder to treatment|2|||
33554013|NCT02455336|62946665|FG001|Overall Study|Non-responder to treatment|0|||
33554014|NCT04525703|62946692|FG000|Overall Study|Lost to Follow-up|6|||
33554015|NCT04525703|62946693|FG001|Overall Study|Lost to Follow-up|15|||
33554016|NCT04525703|62946694|FG002|Overall Study|Lost to Follow-up|8|||
33554017|NCT04509076|62946707|FG000|Overall Study|Withdrawal by Subject|1|||
33554018|NCT04509076|62946708|FG001|Overall Study|Withdrawal by Subject|2|||
33554019|NCT04509076|62946707|FG000|Overall Study|Lost to Follow-up|1|||
33554020|NCT04509076|62946708|FG001|Overall Study|Lost to Follow-up|2|||
33554021|NCT04267614|62946722|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
33554022|NCT04267614|62946722|FG000|Overall Study|Lost to Follow-up|115|||
33554023|NCT03735680|62946733|FG000|Overall Study|Withdrawal by Subject|0|||
33554024|NCT03735680|62946734|FG001|Overall Study|Withdrawal by Subject|1|||
33554025|NCT03735680|62946735|FG002|Overall Study|Withdrawal by Subject|0|||
33554026|NCT03735680|62946736|FG003|Overall Study|Withdrawal by Subject|0|||
33554027|NCT03735680|62946737|FG004|Overall Study|Withdrawal by Subject|0|||
33660146|NCT04967885|63085701|FG001|EMI-II Intervention|Lost to Follow-up|10|||
33660147|NCT04571060|63085718|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
33660148|NCT04571060|63085719|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
33660149|NCT04571060|63085718|FG000|Overall Study|Never treated migraine|47|||
33660150|NCT04571060|63085719|FG001|Overall Study|Never treated migraine|36|||
33660151|NCT04571060|63085718|FG000|Overall Study|Protocol Violation|4|||
33660152|NCT04571060|63085719|FG001|Overall Study|Protocol Violation|2|||
33482890|NCT04157296|62859615|FG000|Overall Study|Did not obtain second fMRI.|0|||
33482891|NCT04157296|62859616|FG001|Overall Study|Did not obtain second fMRI.|1|||
33482892|NCT04157296|62859615|FG000|Overall Study|MRI failed/no second fMRI|0|||
33482893|NCT04157296|62859616|FG001|Overall Study|MRI failed/no second fMRI|1|||
33482894|NCT02859142|62859624|FG000|Overall Study|Adverse Event|1|||
33482895|NCT02859142|62859625|FG001|Overall Study|Adverse Event|2|||
33482896|NCT02859142|62859624|FG000|Overall Study|Lost to Follow-up|1|||
33482897|NCT02859142|62859625|FG001|Overall Study|Lost to Follow-up|4|||
33482898|NCT02859142|62859624|FG000|Overall Study|Withdrawal by Subject|2|||
33482899|NCT02859142|62859625|FG001|Overall Study|Withdrawal by Subject|0|||
33482900|NCT02859142|62859624|FG000|Overall Study|Scheduling difficulties|0|||
33482901|NCT02859142|62859625|FG001|Overall Study|Scheduling difficulties|3|||
33554028|NCT03735680|62946738|FG005|Overall Study|Withdrawal by Subject|1|||
33554029|NCT03735680|62946733|FG000|Overall Study|Patient unable or unwilling to continue|0|||
33554030|NCT03735680|62946734|FG001|Overall Study|Patient unable or unwilling to continue|0|||
33554031|NCT03735680|62946735|FG002|Overall Study|Patient unable or unwilling to continue|1|||
33554032|NCT03735680|62946736|FG003|Overall Study|Patient unable or unwilling to continue|0|||
33482902|NCT03351608|62859636|FG000|Overall Study|Lost to Follow-up|0|||
33554033|NCT03735680|62946737|FG004|Overall Study|Patient unable or unwilling to continue|0|||
33554034|NCT03735680|62946738|FG005|Overall Study|Patient unable or unwilling to continue|0|||
33554035|NCT03726658|62946774|FG000|Overall Study|Lost to Follow-up|0|||
33554036|NCT03726658|62946775|FG001|Overall Study|Lost to Follow-up|0|||
33554037|NCT03726658|62946776|FG002|Overall Study|Lost to Follow-up|2|||
33554038|NCT03726658|62946777|FG003|Overall Study|Lost to Follow-up|0|||
33554039|NCT03726658|62946778|FG004|Overall Study|Lost to Follow-up|0|||
33554040|NCT03726658|62946779|FG005|Overall Study|Lost to Follow-up|1|||
33660153|NCT04571060|63085718|FG000|Overall Study|Withdrawal by Subject|6|||
33660154|NCT04571060|63085719|FG001|Overall Study|Withdrawal by Subject|2|||
33660155|NCT04571060|63085718|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
33660156|NCT04571060|63085719|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
33660157|NCT04426318|63085727|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
33660158|NCT04426318|63085728|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
33554041|NCT03726658|62946780|FG006|Overall Study|Lost to Follow-up|1|||
33554042|NCT03726658|62946774|FG000|Overall Study|Withdrawal by Subject|1|||
33554043|NCT03726658|62946775|FG001|Overall Study|Withdrawal by Subject|0|||
33554044|NCT03726658|62946776|FG002|Overall Study|Withdrawal by Subject|0|||
33554045|NCT03726658|62946777|FG003|Overall Study|Withdrawal by Subject|0|||
33554046|NCT03726658|62946778|FG004|Overall Study|Withdrawal by Subject|6|||
33554047|NCT03726658|62946779|FG005|Overall Study|Withdrawal by Subject|4|||
33554048|NCT03726658|62946780|FG006|Overall Study|Withdrawal by Subject|2|||
33554049|NCT03726658|62946774|FG000|Overall Study|Pregnancy|0|||
33554050|NCT03726658|62946775|FG001|Overall Study|Pregnancy|0|||
33554051|NCT03726658|62946776|FG002|Overall Study|Pregnancy|0|||
33554052|NCT03726658|62946777|FG003|Overall Study|Pregnancy|0|||
33660159|NCT04356963|63085743|FG000|First Session|Withdrawal by Subject|1|||
33660160|NCT04356963|63085743|FG000|Second Session|Withdrawal by Subject|3|||
33660161|NCT04356963|63085743|FG000|Second Session|Lost to Follow-up|1|||
33660162|NCT04356963|63085743|FG000|Third Session|Lost to Follow-up|6|||
33660163|NCT04356963|63085743|FG000|Third Session|Withdrawal by Subject|1|||
33660164|NCT03941483|63085756|FG000|Overall Study|Miscellaneous|2|||
33660165|NCT03941483|63085757|FG001|Overall Study|Miscellaneous|3|||
33660166|NCT03941483|63085758|FG002|Overall Study|Miscellaneous|0|||
33660167|NCT03941483|63085756|FG000|Overall Study|Study Terminated by Sponsor|1|||
33660168|NCT03941483|63085757|FG001|Overall Study|Study Terminated by Sponsor|0|||
33660169|NCT03941483|63085758|FG002|Overall Study|Study Terminated by Sponsor|0|||
33660170|NCT03941483|63085756|FG000|Overall Study|Withdrawal by Subject|1|||
33660171|NCT03941483|63085757|FG001|Overall Study|Withdrawal by Subject|4|||
33660172|NCT03941483|63085758|FG002|Overall Study|Withdrawal by Subject|1|||
33660173|NCT03941483|63085756|FG000|Overall Study|Lost to Follow-up|2|||
33660174|NCT03941483|63085757|FG001|Overall Study|Lost to Follow-up|1|||
33660175|NCT03941483|63085758|FG002|Overall Study|Lost to Follow-up|8|||
33660176|NCT03941483|63085756|FG000|Overall Study|Death|3|||
33660177|NCT03941483|63085757|FG001|Overall Study|Death|2|||
33660178|NCT03941483|63085758|FG002|Overall Study|Death|6|||
33660179|NCT03689855|63085794|FG000|Overall Study|Adverse Event|3|||
33660180|NCT03689855|63085794|FG000|Overall Study|Withdrawal by Subject|1|||
33660181|NCT03635996|63085798|FG000|Overall Study|Study terminated by Sponsor|94|||
33660182|NCT03635996|63085798|FG000|Overall Study|Withdrawal by Subject|20|||
33660183|NCT03635996|63085798|FG000|Overall Study|Ablation|26|||
33660184|NCT03635996|63085798|FG000|Overall Study|Adverse Event|7|||
33660185|NCT03635996|63085798|FG000|Overall Study|Physician Decision|3|||
33660186|NCT03635996|63085798|FG000|Overall Study|Prohibited medication|5|||
33660187|NCT03635996|63085798|FG000|Overall Study|Did not meet eligibility criteria|5|||
33660188|NCT03635996|63085798|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
33660189|NCT03635996|63085798|FG000|Overall Study|Protocol Violation|1|||
33660190|NCT03635996|63085798|FG000|Overall Study|Lost to Follow-up|1|||
33660191|NCT03595878|63085805|FG000|Overall Study|Death|2|||
33660192|NCT03595878|63085806|FG001|Overall Study|Death|1|||
33660193|NCT03595878|63085807|FG002|Overall Study|Death|0|||
33660194|NCT03595878|63085805|FG000|Overall Study|Disease progression|2|||
33660195|NCT03595878|63085806|FG001|Overall Study|Disease progression|1|||
33482903|NCT03351608|62859637|FG001|Overall Study|Lost to Follow-up|1|||
33482904|NCT03351608|62859638|FG002|Overall Study|Lost to Follow-up|1|||
33482905|NCT03351608|62859639|FG003|Overall Study|Lost to Follow-up|1|||
33482906|NCT03351608|62859640|FG004|Overall Study|Lost to Follow-up|1|||
33482907|NCT03351608|62859636|FG000|Overall Study|Physician Decision|1|||
33482908|NCT03351608|62859637|FG001|Overall Study|Physician Decision|0|||
33482909|NCT03351608|62859638|FG002|Overall Study|Physician Decision|0|||
33482910|NCT03351608|62859639|FG003|Overall Study|Physician Decision|2|||
33482911|NCT03351608|62859640|FG004|Overall Study|Physician Decision|1|||
33482912|NCT03351608|62859636|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
33482913|NCT03351608|62859637|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
33482914|NCT03351608|62859638|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
33554053|NCT03726658|62946778|FG004|Overall Study|Pregnancy|0|||
33660196|NCT03595878|63085807|FG002|Overall Study|Disease progression|2|||
33660197|NCT03168464|63085853|FG000|Overall Study|Death|9|||
33660198|NCT03168464|63085853|FG000|Overall Study|Progression of disease|6|||
33482915|NCT03351608|62859639|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
33554054|NCT03726658|62946779|FG005|Overall Study|Pregnancy|0|||
33554055|NCT03726658|62946780|FG006|Overall Study|Pregnancy|1|||
33660199|NCT02818920|63085857|FG000|Overall Study|Unresectable|4|||
33660200|NCT02818920|63085857|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
33660201|NCT02818920|63085857|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
33660202|NCT02818920|63085857|FG000|Overall Study|Adverse Event|3|||
33660203|NCT02818920|63085857|FG000|Overall Study|Developed Other Disease|1|||
33660204|NCT02818920|63085857|FG000|Overall Study|Refused Further Treatment|1|||
33660205|NCT01454401|63085883|FG000|Overall Study|Death|1|||
33660206|NCT01454401|63085883|FG000|Overall Study|hospitalised|1|||
33660207|NCT01454401|63085883|FG000|Overall Study|osteomyelitis|2|||
33660208|NCT01454401|63085883|FG000|Overall Study|non-adherence|1|||
33660209|NCT01344018|63085889|FG000|Overall Study|Death|22|||
33660210|NCT01344018|63085890|FG001|Overall Study|Death|25|||
33660211|NCT01344018|63085889|FG000|Overall Study|Lost to Follow-up|4|||
33660212|NCT01344018|63085890|FG001|Overall Study|Lost to Follow-up|7|||
33660213|NCT01755767|63085923|FG000|Overall Study|Progressive Disease|8|||
33660214|NCT01755767|63085924|FG001|Overall Study|Progressive Disease|7|||
33660215|NCT01755767|63085925|FG002|Overall Study|Progressive Disease|91|||
33660216|NCT01755767|63085926|FG003|Overall Study|Progressive Disease|43|||
33660217|NCT01755767|63085923|FG000|Overall Study|Clinical Disease Progression|4|||
33660218|NCT01755767|63085924|FG001|Overall Study|Clinical Disease Progression|2|||
33660219|NCT01755767|63085925|FG002|Overall Study|Clinical Disease Progression|29|||
33660220|NCT01755767|63085926|FG003|Overall Study|Clinical Disease Progression|20|||
33660221|NCT01755767|63085923|FG000|Overall Study|Radiographic Disease Progression|9|||
33660222|NCT01755767|63085924|FG001|Overall Study|Radiographic Disease Progression|4|||
33660223|NCT01755767|63085925|FG002|Overall Study|Radiographic Disease Progression|44|||
33660224|NCT01755767|63085926|FG003|Overall Study|Radiographic Disease Progression|27|||
33660225|NCT01755767|63085923|FG000|Overall Study|Adverse Event|6|||
33660226|NCT01755767|63085924|FG001|Overall Study|Adverse Event|0|||
33660227|NCT01755767|63085925|FG002|Overall Study|Adverse Event|28|||
33660228|NCT01755767|63085926|FG003|Overall Study|Adverse Event|11|||
33554056|NCT03726658|62946774|FG000|Overall Study|Not Reported|0|||
33554057|NCT03726658|62946775|FG001|Overall Study|Not Reported|0|||
33554058|NCT03726658|62946776|FG002|Overall Study|Not Reported|0|||
33554059|NCT03726658|62946777|FG003|Overall Study|Not Reported|0|||
33660229|NCT01755767|63085923|FG000|Overall Study|Death|1|||
33365000|NCT00543439|62743547|FG000|Period 2|Protocol Violation|1|||
33365001|NCT00543439|62743548|FG001|Period 2|Protocol Violation|0|||
33365002|NCT00543439|62743549|FG002|Period 2|Protocol Violation|1|||
33365003|NCT00543439|62743547|FG000|Period 2|Adverse Event|0|||
33365004|NCT00543439|62743548|FG001|Period 2|Adverse Event|1|||
33365005|NCT00543439|62743549|FG002|Period 2|Adverse Event|1|||
33365006|NCT00582166|62743566|FG000|Overall Study|Death|1|||
33365007|NCT00582166|62743566|FG000|Overall Study|Ineligible pathology|1|||
33660230|NCT01755767|63085924|FG001|Overall Study|Death|2|||
33660231|NCT01755767|63085925|FG002|Overall Study|Death|15|||
33482916|NCT03351608|62859640|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
33482917|NCT03351608|62859636|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33482918|NCT03351608|62859637|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33482919|NCT03351608|62859638|FG002|Overall Study|Withdrawal by parent/guardian|1|||
33482920|NCT03351608|62859639|FG003|Overall Study|Withdrawal by parent/guardian|1|||
33482921|NCT03351608|62859640|FG004|Overall Study|Withdrawal by parent/guardian|0|||
33482922|NCT03351608|62859636|FG000|Overall Study|Other|0|||
33554060|NCT03726658|62946778|FG004|Overall Study|Not Reported|0|||
33554061|NCT03726658|62946779|FG005|Overall Study|Not Reported|0|||
33554062|NCT03726658|62946780|FG006|Overall Study|Not Reported|1|||
33554063|NCT03106779|62946840|FG000|Overall Study|Lack of Efficacy|33|||
33554064|NCT03106779|62946841|FG001|Overall Study|Lack of Efficacy|24|||
33554065|NCT03106779|62946840|FG000|Overall Study|Adverse Event|8|||
33554066|NCT03106779|62946841|FG001|Overall Study|Adverse Event|16|||
33554067|NCT03106779|62946840|FG000|Overall Study|Physician Decision|10|||
33554068|NCT03106779|62946841|FG001|Overall Study|Physician Decision|6|||
33660232|NCT01755767|63085926|FG003|Overall Study|Death|4|||
33660233|NCT01755767|63085923|FG000|Overall Study|Subject Decision|0|||
33660234|NCT01755767|63085924|FG001|Overall Study|Subject Decision|0|||
33660235|NCT01755767|63085925|FG002|Overall Study|Subject Decision|10|||
33660236|NCT01755767|63085926|FG003|Overall Study|Subject Decision|3|||
33365008|NCT00601172|62743572|FG000|Overall Study|Adverse Event|43|||
33365009|NCT00601172|62743573|FG001|Overall Study|Adverse Event|32|||
33482923|NCT03351608|62859637|FG001|Overall Study|Other|1|||
33482924|NCT03351608|62859638|FG002|Overall Study|Other|1|||
33482925|NCT03351608|62859639|FG003|Overall Study|Other|3|||
33554069|NCT03106779|62946840|FG000|Overall Study|Patient/guardian decision|4|||
33554070|NCT03106779|62946841|FG001|Overall Study|Patient/guardian decision|3|||
33554071|NCT03106779|62946840|FG000|Overall Study|Progressive disease|1|||
33554072|NCT03106779|62946841|FG001|Overall Study|Progressive disease|3|||
33660237|NCT01755767|63085923|FG000|Overall Study|Withdrawal by Subject|0|||
33660238|NCT01755767|63085924|FG001|Overall Study|Withdrawal by Subject|0|||
33660239|NCT01755767|63085925|FG002|Overall Study|Withdrawal by Subject|2|||
33660240|NCT01755767|63085926|FG003|Overall Study|Withdrawal by Subject|1|||
33660241|NCT01755767|63085923|FG000|Overall Study|Other|0|||
33660242|NCT01755767|63085924|FG001|Overall Study|Other|0|||
33660243|NCT01755767|63085925|FG002|Overall Study|Other|2|||
33660244|NCT01755767|63085926|FG003|Overall Study|Other|3|||
33554073|NCT03106779|62946840|FG000|Overall Study|Lost to Follow-up|1|||
33554074|NCT03106779|62946841|FG001|Overall Study|Lost to Follow-up|2|||
33554075|NCT03106779|62946840|FG000|Overall Study|Death|1|||
33554076|NCT03106779|62946841|FG001|Overall Study|Death|0|||
33554077|NCT03106779|62946840|FG000|Overall Study|Protocol Violation|1|||
33554078|NCT03106779|62946841|FG001|Overall Study|Protocol Violation|0|||
33554079|NCT03106779|62946840|FG000|Overall Study|Not treated|1|||
33554080|NCT03106779|62946841|FG001|Overall Study|Not treated|0|||
33554081|NCT03062358|62946858|FG000|Overall Study|Death|220|||
33554082|NCT03062358|62946859|FG001|Overall Study|Death|127|||
33554083|NCT03062358|62946858|FG000|Overall Study|Withdrawal by Subject|2|||
33554084|NCT03062358|62946859|FG001|Overall Study|Withdrawal by Subject|1|||
33554085|NCT03062358|62946858|FG000|Overall Study|Ongoing in Trial|78|||
33554086|NCT03062358|62946859|FG001|Overall Study|Ongoing in Trial|25|||
33554087|NCT02706873|62946870|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
33554088|NCT02706873|62946871|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
33554089|NCT02706873|62946872|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
33554090|NCT02706873|62946873|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
33554091|NCT02706873|62946870|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
33554092|NCT02706873|62946871|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
33554093|NCT02706873|62946872|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
33554094|NCT02706873|62946873|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
33554095|NCT02706873|62946870|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
33554096|NCT02706873|62946871|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
33554097|NCT02706873|62946872|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
33482926|NCT03351608|62859640|FG004|Overall Study|Other|0|||
33482927|NCT02857816|62859663|FG000|Overall Study|Screen Failure|33|||
33482928|NCT02857816|62859663|FG000|Overall Study|Withdrawal by Subject|4|||
33482929|NCT02857816|62859663|FG000|Overall Study|Lost to Follow-up|1|||
33482930|NCT02858440|62859668|FG000|Overall Study|Lost to Follow-up|3|||
33554098|NCT02706873|62946873|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
33365010|NCT00601172|62743572|FG000|Overall Study|Lack of Efficacy|11|||
33482931|NCT02858440|62859668|FG000|Overall Study|Protocol Violation|2|||
33482932|NCT02858440|62859668|FG000|Overall Study|Consent withdrawal|3|||
33482933|NCT02858440|62859668|FG000|Overall Study|Migrated/moved from study area|4|||
33482934|NCT03382418|62859675|FG000|Overall Study|Withdrawal by Subject|1|||
33482935|NCT03382418|62859676|FG001|Overall Study|Withdrawal by Subject|0|||
33482936|NCT03382418|62859677|FG002|Overall Study|Withdrawal by Subject|0|||
33482937|NCT03382418|62859675|FG000|Overall Study|Lost to Follow-up|2|||
33482938|NCT03382418|62859676|FG001|Overall Study|Lost to Follow-up|3|||
33482939|NCT03382418|62859677|FG002|Overall Study|Lost to Follow-up|0|||
33482940|NCT02858362|62859689|FG000|Overall Study|Protocol Violation|0|||
33482941|NCT02858362|62859690|FG001|Overall Study|Protocol Violation|1|||
33482942|NCT02858362|62859691|FG002|Overall Study|Protocol Violation|0|||
33482943|NCT02858362|62859689|FG000|Overall Study|Withdrawal by Subject|1|||
33482944|NCT02858362|62859690|FG001|Overall Study|Withdrawal by Subject|0|||
33482945|NCT02858362|62859691|FG002|Overall Study|Withdrawal by Subject|0|||
33482946|NCT02858362|62859689|FG000|Overall Study|Early Study Termination|0|||
33482947|NCT02858362|62859690|FG001|Overall Study|Early Study Termination|0|||
33482948|NCT02858362|62859691|FG002|Overall Study|Early Study Termination|3|||
33482949|NCT02858362|62859689|FG000|Overall Study|Lost to Follow-up|1|||
33482950|NCT02858362|62859690|FG001|Overall Study|Lost to Follow-up|0|||
33482951|NCT02858362|62859691|FG002|Overall Study|Lost to Follow-up|0|||
33482952|NCT03382262|62859708|FG000|Overall Study|Physician Decision|0|||
33482953|NCT03382262|62859709|FG001|Overall Study|Physician Decision|0|||
33482954|NCT03382262|62859710|FG002|Overall Study|Physician Decision|1|||
33482955|NCT03382262|62859711|FG003|Overall Study|Physician Decision|0|||
33482956|NCT03382262|62859708|FG000|Overall Study|Withdrawal by Subject|0|||
33482957|NCT03382262|62859709|FG001|Overall Study|Withdrawal by Subject|0|||
33482958|NCT03382262|62859710|FG002|Overall Study|Withdrawal by Subject|0|||
33482959|NCT03382262|62859711|FG003|Overall Study|Withdrawal by Subject|1|||
33554099|NCT02706873|62946870|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
33554100|NCT02706873|62946871|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
33554101|NCT02706873|62946872|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
33554102|NCT02706873|62946873|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
33554103|NCT02706873|62946870|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
33365011|NCT00601172|62743573|FG001|Overall Study|Lack of Efficacy|12|||
33365012|NCT00601172|62743572|FG000|Overall Study|Protocol Violation|2|||
33365013|NCT00601172|62743573|FG001|Overall Study|Protocol Violation|5|||
33482960|NCT03350750|62859723|FG000|Overall Study|Death|1|||
33482961|NCT03350750|62859724|FG001|Overall Study|Death|1|||
33482962|NCT03394508|62859734|FG000|Overall Study|Protocol Violation|0|||
33482963|NCT03394508|62859735|FG001|Overall Study|Protocol Violation|3|||
33482964|NCT03394508|62859734|FG000|Overall Study|Lost to Follow-up|1|||
33482965|NCT03394508|62859735|FG001|Overall Study|Lost to Follow-up|0|||
33482966|NCT02856880|62859745|FG000|Overall Study|Withdrawal of consent|1|||
33482967|NCT03393806|62859766|FG000|Overall Study|Physician Decision|1|||
33554104|NCT02706873|62946871|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
33554105|NCT02706873|62946872|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
33554106|NCT02706873|62946873|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
33554107|NCT02706873|62946870|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
33554108|NCT02706873|62946871|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
33554109|NCT02706873|62946872|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
33482968|NCT03393806|62859767|FG001|Overall Study|Physician Decision|0|||
33482969|NCT02856802|62859776|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
33482970|NCT02856802|62859777|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
33482971|NCT02856802|62859776|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
33482972|NCT02856802|62859777|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
33482973|NCT02856802|62859776|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
33482974|NCT02856802|62859777|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
33482975|NCT02856802|62859776|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
33482976|NCT02856802|62859777|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
33482977|NCT02856802|62859776|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
33482978|NCT02856802|62859777|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
33482979|NCT02856802|62859776|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
33482980|NCT02856802|62859777|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
33482981|NCT03381248|62859789|FG000|Overall Study|Withdrawal by Subject|5|||
33482982|NCT03381248|62859790|FG001|Overall Study|Withdrawal by Subject|3|||
33482983|NCT03381248|62859789|FG000|Overall Study|Lost to Follow-up|3|||
33482984|NCT03381248|62859790|FG001|Overall Study|Lost to Follow-up|2|||
33482985|NCT03381248|62859789|FG000|Overall Study|Lack of Efficacy|1|||
33482986|NCT03381248|62859790|FG001|Overall Study|Lack of Efficacy|0|||
33482987|NCT03381248|62859789|FG000|Overall Study|Adverse Event|2|||
33482988|NCT03381248|62859790|FG001|Overall Study|Adverse Event|0|||
33482989|NCT03381248|62859789|FG000|Overall Study|Protocol Violation|2|||
33482990|NCT03381248|62859790|FG001|Overall Study|Protocol Violation|1|||
33482991|NCT03380390|62859796|FG000|Overall Study|Adverse Event|3|||
33482992|NCT03350672|62859803|FG000|Overall Study|Withdrawal by Subject|7|||
33482993|NCT03350672|62859804|FG001|Overall Study|Withdrawal by Subject|0|||
33482994|NCT03350672|62859805|FG002|Overall Study|Withdrawal by Subject|0|||
33482995|NCT03392168|62859817|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
33482996|NCT03392168|62859818|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
33482997|NCT03392168|62859819|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
33482998|NCT03392168|62859820|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
33482999|NCT03392168|62859817|FG000|Period 2: Cohort 2|Other|0|||
33483000|NCT03392168|62859818|FG001|Period 2: Cohort 2|Other|1|||
33483001|NCT03392168|62859819|FG002|Period 2: Cohort 2|Other|0|||
33483002|NCT03392168|62859820|FG003|Period 2: Cohort 2|Other|0|||
33483003|NCT03391232|62859831|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
33483004|NCT03391232|62859832|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
33483005|NCT03391232|62859831|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
33483006|NCT03391232|62859832|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
33483007|NCT03379376|62859840|FG000|Overall Study|Lost to Follow-up|2|||
33483008|NCT03379376|62859840|FG000|Overall Study|Did not wish to complete follow up|1|||
33483009|NCT03379376|62859840|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
33483010|NCT03379376|62859840|FG000|Overall Study|Death|1|||
33483011|NCT03349034|62859846|FG000|Overall Study|catheters dislodged during transport|2|||
33483012|NCT03349034|62859847|FG001|Overall Study|catheters dislodged during transport|0|||
33483013|NCT03349034|62859846|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
33554110|NCT02706873|62946873|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
33554111|NCT02706873|62946870|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
33483014|NCT03349034|62859847|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
33483015|NCT03349034|62859846|FG000|Overall Study|soft tissue flap used|1|||
33483016|NCT03349034|62859847|FG001|Overall Study|soft tissue flap used|0|||
33483017|NCT03349034|62859846|FG000|Overall Study|Other|0|||
33554112|NCT02706873|62946871|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
33554113|NCT02706873|62946872|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
33554114|NCT02706873|62946873|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
33554115|NCT02706873|62946870|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
33554116|NCT02706873|62946871|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
33554117|NCT02706873|62946872|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
33483018|NCT03349034|62859847|FG001|Overall Study|Other|1|||
33483019|NCT00358215|62859857|FG000|Overall Study|Ineligibility determined|4|||
33483020|NCT00358215|62859858|FG001|Overall Study|Ineligibility determined|3|||
33483021|NCT00358215|62859857|FG000|Overall Study|Adverse Event|83|||
33483022|NCT00358215|62859858|FG001|Overall Study|Adverse Event|65|||
33483023|NCT00358215|62859857|FG000|Overall Study|Withdrawal by Subject|111|||
33483024|NCT00358215|62859858|FG001|Overall Study|Withdrawal by Subject|102|||
33483025|NCT00358215|62859857|FG000|Overall Study|Participant request|65|||
33483026|NCT00358215|62859858|FG001|Overall Study|Participant request|64|||
33554118|NCT02706873|62946873|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
33554119|NCT02706873|62946870|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
33554120|NCT02706873|62946871|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
33554121|NCT02706873|62946872|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
33554122|NCT02706873|62946873|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
33554123|NCT02706873|62946870|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
33554124|NCT02706873|62946871|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
33554125|NCT02706873|62946872|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
33554126|NCT02706873|62946873|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
33554127|NCT02706873|62946870|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
33554128|NCT02706873|62946871|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
33554129|NCT02706873|62946872|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
33554130|NCT02706873|62946873|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
33554131|NCT02706873|62946870|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
33554132|NCT02706873|62946871|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
33554133|NCT02706873|62946872|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
33554134|NCT02706873|62946873|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
33554135|NCT02706873|62946870|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
33554136|NCT02706873|62946871|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
33554137|NCT02706873|62946872|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
33554138|NCT02706873|62946873|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
33554139|NCT02584634|62946896|FG000|Overall Study|Adverse Event|3|||
33554140|NCT02584634|62946897|FG001|Overall Study|Adverse Event|5|||
33554141|NCT02584634|62946896|FG000|Overall Study|Death|0|||
33554142|NCT02584634|62946897|FG001|Overall Study|Death|1|||
33554143|NCT02584634|62946896|FG000|Overall Study|Lost to Follow-up|0|||
33554144|NCT02584634|62946897|FG001|Overall Study|Lost to Follow-up|1|||
33554145|NCT02584634|62946896|FG000|Overall Study|Physician Decision|1|||
33554146|NCT02584634|62946897|FG001|Overall Study|Physician Decision|2|||
33554147|NCT02584634|62946896|FG000|Overall Study|Progressive disease|7|||
33554148|NCT02584634|62946897|FG001|Overall Study|Progressive disease|15|||
33554149|NCT02584634|62946896|FG000|Overall Study|Withdrawal by Subject|1|||
33554150|NCT02584634|62946897|FG001|Overall Study|Withdrawal by Subject|1|||
33554151|NCT02584634|62946896|FG000|Overall Study|Other|0|||
33554152|NCT02584634|62946897|FG001|Overall Study|Other|6|||
33554153|NCT02000622|62946907|FG000|Overall Study|Withdrawal by Subject|5|||
33554154|NCT02000622|62946908|FG001|Overall Study|Withdrawal by Subject|7|||
33554155|NCT02000622|62946907|FG000|Overall Study|Lost to Follow-up|4|||
33554156|NCT02000622|62946908|FG001|Overall Study|Lost to Follow-up|0|||
33554157|NCT02000622|62946907|FG000|Overall Study|Death|159|||
33554158|NCT02000622|62946908|FG001|Overall Study|Death|73|||
33483027|NCT00358215|62859857|FG000|Overall Study|Physician Decision|47|||
33483028|NCT00358215|62859858|FG001|Overall Study|Physician Decision|39|||
33483029|NCT00358215|62859857|FG000|Overall Study|Lost to Follow-up|16|||
33483030|NCT00358215|62859858|FG001|Overall Study|Lost to Follow-up|22|||
33483031|NCT00358215|62859857|FG000|Overall Study|Death|265|||
33483032|NCT00358215|62859858|FG001|Overall Study|Death|281|||
33483033|NCT00358215|62859857|FG000|Overall Study|Protocol Violation|64|||
33483034|NCT00358215|62859858|FG001|Overall Study|Protocol Violation|59|||
33483035|NCT00358215|62859857|FG000|Overall Study|Pregnancy|1|||
33483036|NCT00358215|62859858|FG001|Overall Study|Pregnancy|0|||
33483037|NCT00358215|62859857|FG000|Overall Study|Other|21|||
33483038|NCT00358215|62859858|FG001|Overall Study|Other|14|||
33483039|NCT00358215|62859857|FG000|Overall Study|Did not receive investigational product|2|||
33483040|NCT00358215|62859858|FG001|Overall Study|Did not receive investigational product|3|||
33483041|NCT02855164|62859872|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
33483042|NCT02855164|62859873|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
33483043|NCT02855164|62859874|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
33483044|NCT02855164|62859875|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
33483045|NCT02855164|62859876|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
33554159|NCT02000622|62946907|FG000|Overall Study|Withdrawn due to site closure|1|||
33554160|NCT02000622|62946908|FG001|Overall Study|Withdrawn due to site closure|0|||
33483046|NCT02855164|62859877|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
33554161|NCT01275729|62946920|FG000|Overall Study|Death|3|||
33554162|NCT01275729|62946920|FG000|Overall Study|Withdrawal by Subject|1|||
33554163|NCT01107626|62946928|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
33554164|NCT01107626|62946929|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
33554165|NCT01107626|62946930|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
33483047|NCT02855164|62859878|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
33483048|NCT02855164|62859879|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
33483049|NCT02855164|62859872|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
33660245|NCT01755767|63085923|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
33554166|NCT01107626|62946931|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
33554167|NCT01107626|62946928|FG000|Step 1: Induction Therapy|Adverse Event|198|||
33554168|NCT01107626|62946929|FG001|Step 1: Induction Therapy|Adverse Event|0|||
33554169|NCT01107626|62946930|FG002|Step 1: Induction Therapy|Adverse Event|0|||
33554170|NCT01107626|62946931|FG003|Step 1: Induction Therapy|Adverse Event|0|||
33554171|NCT01107626|62946928|FG000|Step 1: Induction Therapy|Death|62|||
33554172|NCT01107626|62946929|FG001|Step 1: Induction Therapy|Death|0|||
33554173|NCT01107626|62946930|FG002|Step 1: Induction Therapy|Death|0|||
33554174|NCT01107626|62946931|FG003|Step 1: Induction Therapy|Death|0|||
33554175|NCT01107626|62946928|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
33660246|NCT01755767|63085924|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
33660247|NCT01755767|63085925|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
33554176|NCT01107626|62946929|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
33554177|NCT01107626|62946930|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
33554178|NCT01107626|62946931|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
33554179|NCT01107626|62946928|FG000|Step 1: Induction Therapy|Complicating disease|13|||
33554180|NCT01107626|62946929|FG001|Step 1: Induction Therapy|Complicating disease|0|||
33365014|NCT00601172|62743572|FG000|Overall Study|Lost to Follow-up|4|||
33365015|NCT00601172|62743573|FG001|Overall Study|Lost to Follow-up|3|||
33365016|NCT00601172|62743572|FG000|Overall Study|Physician Decision|27|||
33660248|NCT01755767|63085926|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
33660249|NCT01730339|63086022|FG000|Overall Study|Withdrawal by Subject|3|||
33660250|NCT01730339|63086023|FG001|Overall Study|Withdrawal by Subject|2|||
33660251|NCT01730339|63086022|FG000|Overall Study|Lost to Follow-up|1|||
33660252|NCT01730339|63086023|FG001|Overall Study|Lost to Follow-up|1|||
33660253|NCT01730339|63086022|FG000|Overall Study|Un-specified|1|||
33660254|NCT01730339|63086023|FG001|Overall Study|Un-specified|0|||
33660255|NCT01754753|63086080|FG000|Overall Study|Study close|43|||
33660256|NCT01754753|63086081|FG001|Overall Study|Study close|44|||
33660257|NCT01754753|63086080|FG000|Overall Study|Lost to Follow-up|9|||
33660258|NCT01754753|63086081|FG001|Overall Study|Lost to Follow-up|5|||
33554181|NCT01107626|62946930|FG002|Step 1: Induction Therapy|Complicating disease|0|||
33660259|NCT01729871|63086089|FG000|Overall Study|Adverse Event|7|||
33660260|NCT01729871|63086090|FG001|Overall Study|Adverse Event|7|||
33660261|NCT01729871|63086089|FG000|Overall Study|Death|0|||
33660262|NCT01729871|63086090|FG001|Overall Study|Death|1|||
33660263|NCT01729871|63086089|FG000|Overall Study|Lack of Efficacy|0|||
33660264|NCT01729871|63086090|FG001|Overall Study|Lack of Efficacy|1|||
33660265|NCT01729871|63086089|FG000|Overall Study|Physician Decision|0|||
33660266|NCT01729871|63086090|FG001|Overall Study|Physician Decision|2|||
33554182|NCT01107626|62946931|FG003|Step 1: Induction Therapy|Complicating disease|0|||
33554183|NCT01107626|62946928|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
33554184|NCT01107626|62946929|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
33554185|NCT01107626|62946930|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
33554186|NCT01107626|62946931|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
33554187|NCT01107626|62946928|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
33554188|NCT01107626|62946929|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
33554189|NCT01107626|62946930|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
33660267|NCT01729871|63086089|FG000|Overall Study|Protocol Violation|1|||
33660268|NCT01729871|63086090|FG001|Overall Study|Protocol Violation|0|||
33365017|NCT00601172|62743573|FG001|Overall Study|Physician Decision|28|||
33365018|NCT00601172|62743572|FG000|Overall Study|Withdrawal by Subject|35|||
33660269|NCT01729871|63086089|FG000|Overall Study|Withdrawal by Subject|0|||
33660270|NCT01729871|63086090|FG001|Overall Study|Withdrawal by Subject|3|||
33660271|NCT01729871|63086089|FG000|Overall Study|Other|4|||
33660272|NCT01729871|63086090|FG001|Overall Study|Other|9|||
33660273|NCT01729559|63086098|FG000|Overall Study|Protocol Violation|31|||
33660274|NCT01729559|63086099|FG001|Overall Study|Protocol Violation|28|||
33660275|NCT01728779|63086118|FG000|Overall Study|Withdrawal by Subject|1|||
33365019|NCT00601172|62743573|FG001|Overall Study|Withdrawal by Subject|27|||
33365020|NCT00601172|62743572|FG000|Overall Study|Did not meet continuation criteria|19|||
33365021|NCT00601172|62743573|FG001|Overall Study|Did not meet continuation criteria|20|||
33365022|NCT00582010|62743582|FG000|Overall Study|Death|0|||
33554190|NCT01107626|62946931|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
33554191|NCT01107626|62946928|FG000|Step 1: Induction Therapy|Non-compliance|4|||
33554192|NCT01107626|62946929|FG001|Step 1: Induction Therapy|Non-compliance|0|||
33554193|NCT01107626|62946930|FG002|Step 1: Induction Therapy|Non-compliance|0|||
33660276|NCT01728623|63086129|FG000|Overall Study|Disease progression|26|||
33660277|NCT01728623|63086129|FG000|Overall Study|Adverse Event|1|||
33660278|NCT01728623|63086129|FG000|Overall Study|Withdrawal by Subject|1|||
33660279|NCT01754129|63086136|FG000|Overall Study|Death|13|||
33660280|NCT01754129|63086136|FG000|Overall Study|Duodopa discontinuation|9|||
33660281|NCT01754129|63086136|FG000|Overall Study|Lost to Follow-up|7|||
33660282|NCT01754129|63086136|FG000|Overall Study|Withdrew consent|1|||
33660283|NCT01754129|63086136|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
33660284|NCT01728077|63086149|FG000|Overall Study|Lack of Efficacy|3|||
33660285|NCT01728077|63086150|FG001|Overall Study|Lack of Efficacy|1|||
33660286|NCT01728077|63086149|FG000|Overall Study|Lost to Follow-up|1|||
33660287|NCT01728077|63086150|FG001|Overall Study|Lost to Follow-up|0|||
33660288|NCT01728077|63086149|FG000|Overall Study|Subject choice|2|||
33660289|NCT01728077|63086150|FG001|Overall Study|Subject choice|3|||
33660290|NCT01728077|63086149|FG000|Overall Study|Death|0|||
33660291|NCT01728077|63086150|FG001|Overall Study|Death|1|||
33660292|NCT01728077|63086149|FG000|Overall Study|Patient moving|1|||
33660293|NCT01728077|63086150|FG001|Overall Study|Patient moving|0|||
33660294|NCT01728077|63086149|FG000|Overall Study|Non compliance|1|||
33660295|NCT01728077|63086150|FG001|Overall Study|Non compliance|0|||
33660296|NCT01606007|63086169|FG000|Overall Study|Reason 'Other' in the protocol|0|||
33660297|NCT01606007|63086170|FG001|Overall Study|Reason 'Other' in the protocol|1|||
33660298|NCT01606007|63086171|FG002|Overall Study|Reason 'Other' in the protocol|1|||
33660299|NCT01606007|63086169|FG000|Overall Study|Pregnancy|0|||
33483050|NCT02855164|62859873|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
33483051|NCT02855164|62859874|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
33483052|NCT02855164|62859875|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
33483053|NCT02855164|62859876|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
33483054|NCT02855164|62859877|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
33660300|NCT01606007|63086170|FG001|Overall Study|Pregnancy|1|||
33660301|NCT01606007|63086171|FG002|Overall Study|Pregnancy|1|||
33660302|NCT01606007|63086169|FG000|Overall Study|Withdrawal by Subject|8|||
33660303|NCT01606007|63086170|FG001|Overall Study|Withdrawal by Subject|6|||
33660304|NCT01606007|63086171|FG002|Overall Study|Withdrawal by Subject|1|||
33660305|NCT01606007|63086169|FG000|Overall Study|Adverse Event|0|||
33660306|NCT01606007|63086170|FG001|Overall Study|Adverse Event|1|||
33660307|NCT01606007|63086171|FG002|Overall Study|Adverse Event|1|||
33660308|NCT01606007|63086169|FG000|Overall Study|discontinue study treatment|0|||
33660309|NCT01606007|63086170|FG001|Overall Study|discontinue study treatment|2|||
33660310|NCT01606007|63086171|FG002|Overall Study|discontinue study treatment|1|||
33660311|NCT01606007|63086169|FG000|Overall Study|Lost to Follow-up|6|||
33660312|NCT01606007|63086170|FG001|Overall Study|Lost to Follow-up|8|||
33660313|NCT01606007|63086171|FG002|Overall Study|Lost to Follow-up|5|||
33660314|NCT01606007|63086169|FG000|Overall Study|Poor/Non-compliance|1|||
33660315|NCT01606007|63086170|FG001|Overall Study|Poor/Non-compliance|0|||
33660316|NCT01606007|63086171|FG002|Overall Study|Poor/Non-compliance|0|||
33660317|NCT01753193|63086250|FG000|Overall Study|Withdrawal by Subject|23|||
33660318|NCT01753193|63086250|FG000|Overall Study|Lost to Follow-up|6|||
33660319|NCT01753193|63086250|FG000|Overall Study|Death|1|||
33660320|NCT01753193|63086250|FG000|Overall Study|Other|16|||
33660321|NCT01727297|63086297|FG000|Overall Study|Death|13|||
33660322|NCT01727297|63086298|FG001|Overall Study|Death|0|||
33660323|NCT01727297|63086297|FG000|Overall Study|Protocol Violation|1|||
33660324|NCT01727297|63086298|FG001|Overall Study|Protocol Violation|10|||
33660325|NCT01727297|63086297|FG000|Overall Study|Adverse Event|3|||
33660326|NCT01727297|63086298|FG001|Overall Study|Adverse Event|1|||
33660327|NCT01727297|63086297|FG000|Overall Study|Lost to Follow-up|11|||
33660328|NCT01727297|63086298|FG001|Overall Study|Lost to Follow-up|0|||
33365023|NCT00582010|62743583|FG001|Overall Study|Death|1|||
33365024|NCT03920215|62743597|FG000|Overall Study|Lost to Follow-up|1|||
33365025|NCT03920215|62743598|FG001|Overall Study|Lost to Follow-up|2|||
33483055|NCT02855164|62859878|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
33483056|NCT02855164|62859879|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
33483057|NCT02855164|62859872|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
33483058|NCT02855164|62859873|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
33660329|NCT01727297|63086297|FG000|Overall Study|Withdrawal by Subject|26|||
33365026|NCT03920215|62743599|FG002|Overall Study|Lost to Follow-up|0|||
33365027|NCT03920215|62743600|FG003|Overall Study|Lost to Follow-up|0|||
33660330|NCT01727297|63086298|FG001|Overall Study|Withdrawal by Subject|27|||
33365028|NCT03920215|62743597|FG000|Overall Study|Death|0|||
33483059|NCT02855164|62859874|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
33483060|NCT02855164|62859875|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
33483061|NCT02855164|62859876|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
33483062|NCT02855164|62859877|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
33483063|NCT02855164|62859878|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
33483064|NCT02855164|62859879|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
33483065|NCT02855164|62859872|FG000|Part C (Randomized Set)|Adverse Event|0|||
33483066|NCT02855164|62859873|FG001|Part C (Randomized Set)|Adverse Event|0|||
33483067|NCT02855164|62859874|FG002|Part C (Randomized Set)|Adverse Event|0|||
33483068|NCT02855164|62859875|FG003|Part C (Randomized Set)|Adverse Event|0|||
33483069|NCT02855164|62859876|FG004|Part C (Randomized Set)|Adverse Event|0|||
33660331|NCT01727297|63086297|FG000|Overall Study|Physician Decision|19|||
33554194|NCT01107626|62946931|FG003|Step 1: Induction Therapy|Non-compliance|0|||
33660332|NCT01727297|63086298|FG001|Overall Study|Physician Decision|5|||
33660333|NCT01727297|63086297|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
33660334|NCT01727297|63086298|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
33660335|NCT01753115|63086314|FG000|Overall Study|Lost to Follow-up|3|||
33660336|NCT01753115|63086315|FG001|Overall Study|Lost to Follow-up|6|||
33660337|NCT01753115|63086316|FG002|Overall Study|Lost to Follow-up|8|||
33660338|NCT01753115|63086314|FG000|Overall Study|Withdrawal by Subject|6|||
33660339|NCT01753115|63086315|FG001|Overall Study|Withdrawal by Subject|5|||
33660340|NCT01753115|63086316|FG002|Overall Study|Withdrawal by Subject|6|||
33660341|NCT01753115|63086314|FG000|Overall Study|Subject non-compliant|3|||
33660342|NCT01753115|63086315|FG001|Overall Study|Subject non-compliant|3|||
33660343|NCT01753115|63086316|FG002|Overall Study|Subject non-compliant|0|||
33660344|NCT01753115|63086314|FG000|Overall Study|Used excluded drug|0|||
33660345|NCT01753115|63086315|FG001|Overall Study|Used excluded drug|1|||
33660346|NCT01753115|63086316|FG002|Overall Study|Used excluded drug|0|||
33660347|NCT01727141|63086337|FG000|Overall Study|Physician Decision|0|||
33660348|NCT01727141|63086338|FG001|Overall Study|Physician Decision|1|||
33660349|NCT01727141|63086339|FG002|Overall Study|Physician Decision|0|||
33660350|NCT01727141|63086340|FG003|Overall Study|Physician Decision|2|||
33660351|NCT01727141|63086337|FG000|Overall Study|Lost to Follow-up|0|||
33660352|NCT01727141|63086338|FG001|Overall Study|Lost to Follow-up|2|||
33660353|NCT01727141|63086339|FG002|Overall Study|Lost to Follow-up|0|||
33660354|NCT01727141|63086340|FG003|Overall Study|Lost to Follow-up|0|||
33660355|NCT01727141|63086337|FG000|Overall Study|Death|0|||
33660356|NCT01727141|63086338|FG001|Overall Study|Death|1|||
33660357|NCT01727141|63086339|FG002|Overall Study|Death|1|||
33660358|NCT01727141|63086340|FG003|Overall Study|Death|1|||
33660359|NCT01727141|63086337|FG000|Overall Study|Protocol deviation|1|||
33660360|NCT01727141|63086338|FG001|Overall Study|Protocol deviation|1|||
33660361|NCT01727141|63086339|FG002|Overall Study|Protocol deviation|0|||
33660362|NCT01727141|63086340|FG003|Overall Study|Protocol deviation|1|||
33660363|NCT01727141|63086337|FG000|Overall Study|Withdrawal by Subject|4|||
33660364|NCT01727141|63086338|FG001|Overall Study|Withdrawal by Subject|4|||
33660365|NCT01727141|63086339|FG002|Overall Study|Withdrawal by Subject|2|||
33660366|NCT01727141|63086340|FG003|Overall Study|Withdrawal by Subject|11|||
33660367|NCT01726517|63086364|FG000|Overall Study|Withdrawal by Subject|0|||
33660368|NCT01726517|63086365|FG001|Overall Study|Withdrawal by Subject|0|||
33660369|NCT01726517|63086366|FG002|Overall Study|Withdrawal by Subject|1|||
33660370|NCT01726517|63086367|FG003|Overall Study|Withdrawal by Subject|0|||
33660371|NCT01726517|63086368|FG004|Overall Study|Withdrawal by Subject|0|||
33660372|NCT01752023|63086382|FG000|Overall Study|Physician Decision|2|||
33660373|NCT01752023|63086383|FG001|Overall Study|Physician Decision|1|||
33660374|NCT01726049|63086395|FG000|Overall Study|Death|1|||
33660375|NCT01726049|63086396|FG001|Overall Study|Death|1|||
33660376|NCT01726049|63086395|FG000|Overall Study|Adverse Event|4|||
33660377|NCT01726049|63086396|FG001|Overall Study|Adverse Event|1|||
33660378|NCT01726049|63086395|FG000|Overall Study|refused second HC|0|||
33660379|NCT01726049|63086396|FG001|Overall Study|refused second HC|2|||
33660380|NCT01605617|63086417|FG000|First Intervention|Adverse Event|0|||
33660381|NCT01605617|63086418|FG001|First Intervention|Adverse Event|1|||
33660382|NCT01605617|63086417|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
33660383|NCT01605617|63086418|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
33660384|NCT01751867|63086435|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
33660385|NCT01751867|63086436|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
33660386|NCT01751867|63086435|FG000|Overall Study|Diease Progression|4|||
33660387|NCT01751867|63086436|FG001|Overall Study|Diease Progression|18|||
33660388|NCT01751867|63086435|FG000|Overall Study|Adverse Event|8|||
33660389|NCT01751867|63086436|FG001|Overall Study|Adverse Event|15|||
33660390|NCT01751867|63086435|FG000|Overall Study|Poor Compliance|0|||
33554195|NCT01107626|62946928|FG000|Step 1: Induction Therapy|Pain|4|||
33554196|NCT01107626|62946929|FG001|Step 1: Induction Therapy|Pain|0|||
33554197|NCT01107626|62946930|FG002|Step 1: Induction Therapy|Pain|0|||
33554198|NCT01107626|62946931|FG003|Step 1: Induction Therapy|Pain|0|||
33554199|NCT01107626|62946928|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
33554200|NCT01107626|62946929|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
33554201|NCT01107626|62946930|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
33554202|NCT01107626|62946931|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
33554203|NCT01107626|62946928|FG000|Step 1: Induction Therapy|Hospice care|1|||
33660391|NCT01751867|63086436|FG001|Overall Study|Poor Compliance|5|||
33660392|NCT01751867|63086435|FG000|Overall Study|Withdrawal by Subject|3|||
33660393|NCT01751867|63086436|FG001|Overall Study|Withdrawal by Subject|1|||
33660394|NCT01751867|63086435|FG000|Overall Study|Physician Decision|4|||
33365029|NCT03920215|62743598|FG001|Overall Study|Death|0|||
33365030|NCT03920215|62743599|FG002|Overall Study|Death|0|||
33554204|NCT01107626|62946929|FG001|Step 1: Induction Therapy|Hospice care|0|||
33660395|NCT01751867|63086436|FG001|Overall Study|Physician Decision|7|||
33660396|NCT01751867|63086435|FG000|Overall Study|Protocol Violation|0|||
33660397|NCT01751867|63086436|FG001|Overall Study|Protocol Violation|2|||
33660398|NCT01751867|63086435|FG000|Overall Study|Death|0|||
33660399|NCT01751867|63086436|FG001|Overall Study|Death|5|||
33660400|NCT01751867|63086435|FG000|Overall Study|Other|11|||
33660401|NCT01751867|63086436|FG001|Overall Study|Other|37|||
33660402|NCT01751867|63086435|FG000|Overall Study|Randomized but not treated.|2|||
33660403|NCT01751867|63086436|FG001|Overall Study|Randomized but not treated.|1|||
33660404|NCT01751165|63086462|FG000|Overall Study|Adverse event, serious fatal|1|||
33660405|NCT01751165|63086463|FG001|Overall Study|Adverse event, serious fatal|0|||
33660406|NCT01751165|63086464|FG002|Overall Study|Adverse event, serious fatal|1|||
33660407|NCT01751165|63086462|FG000|Overall Study|Withdrawal by Subject|0|||
33660408|NCT01751165|63086463|FG001|Overall Study|Withdrawal by Subject|0|||
33660409|NCT01751165|63086464|FG002|Overall Study|Withdrawal by Subject|1|||
33660410|NCT01751165|63086462|FG000|Overall Study|Serious adverse event|0|||
33660411|NCT01751165|63086463|FG001|Overall Study|Serious adverse event|2|||
33660412|NCT01751165|63086464|FG002|Overall Study|Serious adverse event|0|||
33660413|NCT01751165|63086462|FG000|Overall Study|Lost to Follow-up|1|||
33660414|NCT01751165|63086463|FG001|Overall Study|Lost to Follow-up|1|||
33660415|NCT01751165|63086464|FG002|Overall Study|Lost to Follow-up|1|||
33660416|NCT01751087|63086489|FG000|Overall Study|Withdrawal by Subject|1|||
33660417|NCT01751087|63086490|FG001|Overall Study|Withdrawal by Subject|0|||
33660418|NCT01751087|63086491|FG002|Overall Study|Withdrawal by Subject|0|||
33483070|NCT02855164|62859877|FG005|Part C (Randomized Set)|Adverse Event|5|||
33483071|NCT02855164|62859878|FG006|Part C (Randomized Set)|Adverse Event|9|||
33483072|NCT02855164|62859879|FG007|Part C (Randomized Set)|Adverse Event|2|||
33483073|NCT02855164|62859872|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
33660419|NCT01751087|63086489|FG000|Overall Study|Physician Decision|0|||
33483074|NCT02855164|62859873|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
33483075|NCT02855164|62859874|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
33483076|NCT02855164|62859875|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
33554205|NCT01107626|62946930|FG002|Step 1: Induction Therapy|Hospice care|0|||
33483077|NCT02855164|62859876|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
33483078|NCT02855164|62859877|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
33660420|NCT01751087|63086490|FG001|Overall Study|Physician Decision|0|||
33660421|NCT01751087|63086491|FG002|Overall Study|Physician Decision|1|||
33660422|NCT01750697|63086499|FG000|Overall Study|Transferred Back to Local Hospital|1|||
33660423|NCT01750697|63086499|FG000|Overall Study|Physician and Family Decision|1|||
33660424|NCT01750697|63086499|FG000|Overall Study|Transferred to Adult Services|5|||
33554206|NCT01107626|62946931|FG003|Step 1: Induction Therapy|Hospice care|0|||
33554207|NCT01107626|62946928|FG000|Step 1: Induction Therapy|Physician Decision|1|||
33554208|NCT01107626|62946929|FG001|Step 1: Induction Therapy|Physician Decision|0|||
33554209|NCT01107626|62946930|FG002|Step 1: Induction Therapy|Physician Decision|0|||
33554210|NCT01107626|62946931|FG003|Step 1: Induction Therapy|Physician Decision|0|||
33554211|NCT01107626|62946928|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
33554212|NCT01107626|62946929|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
33554213|NCT01107626|62946930|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
33554214|NCT01107626|62946931|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
33554215|NCT01107626|62946928|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
33554216|NCT01107626|62946929|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
33554217|NCT01107626|62946930|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
33554218|NCT01107626|62946931|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
33554219|NCT01107626|62946928|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
33554220|NCT01107626|62946929|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
33554221|NCT01107626|62946930|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
33554222|NCT01107626|62946931|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
33660425|NCT01750697|63086499|FG000|Overall Study|Physician Decision|1|||
33554223|NCT01107626|62946928|FG000|Step 2: Maintenance Therapy|Death|0|||
33554224|NCT01107626|62946929|FG001|Step 2: Maintenance Therapy|Death|8|||
33660426|NCT01750697|63086499|FG000|Overall Study|Withdrawal by Subject|1|||
33660427|NCT01750229|63086510|FG000|Randomized Crossover Phase|Adverse Event|1|||
33660428|NCT01750229|63086510|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
33660429|NCT01750229|63086510|FG000|Long-term Follow-up Phase|Adverse Event|2|||
33660430|NCT01750229|63086510|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
33660431|NCT01724489|63086522|FG000|Overall Study|Adverse Event|8|||
33660432|NCT01724489|63086523|FG001|Overall Study|Adverse Event|3|||
33660433|NCT01724489|63086522|FG000|Overall Study|Surgery, medication|1|||
33660434|NCT01724489|63086523|FG001|Overall Study|Surgery, medication|1|||
33660435|NCT01724489|63086522|FG000|Overall Study|Lost to Follow-up|1|||
33660436|NCT01724489|63086523|FG001|Overall Study|Lost to Follow-up|2|||
33660437|NCT01724489|63086522|FG000|Overall Study|Withdrawal by Subject|6|||
33660438|NCT01724489|63086523|FG001|Overall Study|Withdrawal by Subject|6|||
33554225|NCT01107626|62946930|FG002|Step 2: Maintenance Therapy|Death|2|||
33554226|NCT01107626|62946931|FG003|Step 2: Maintenance Therapy|Death|13|||
33554227|NCT01107626|62946928|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
33554228|NCT01107626|62946929|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
33554229|NCT01107626|62946930|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
33554230|NCT01107626|62946931|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
33554231|NCT01107626|62946928|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
33554232|NCT01107626|62946929|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
33554233|NCT01107626|62946930|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
33554234|NCT01107626|62946931|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
33554235|NCT01107626|62946928|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
33554236|NCT01107626|62946929|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
33554237|NCT01107626|62946930|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
33554238|NCT01107626|62946931|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
33554239|NCT01107626|62946928|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
33554240|NCT01107626|62946929|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
33554241|NCT01107626|62946930|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
33554242|NCT01107626|62946931|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
33554243|NCT01107626|62946928|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
33554244|NCT01107626|62946929|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
33554245|NCT01107626|62946930|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
33554246|NCT01107626|62946931|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
33554247|NCT01107626|62946928|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
33554248|NCT01107626|62946929|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
33554249|NCT01107626|62946930|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
33554250|NCT01107626|62946931|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
33554251|NCT01107626|62946928|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
33554252|NCT01107626|62946929|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
33554253|NCT01107626|62946930|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
33554254|NCT01107626|62946931|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
33554255|NCT01107626|62946928|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
33554256|NCT01107626|62946929|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
33554257|NCT01107626|62946930|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
33554258|NCT01107626|62946931|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
33554259|NCT01107626|62946928|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
33554260|NCT01107626|62946929|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
33554261|NCT01107626|62946930|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
33554262|NCT01107626|62946931|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
33554263|NCT01107626|62946928|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
33554264|NCT01107626|62946929|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
33554265|NCT01107626|62946930|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
33554266|NCT01107626|62946931|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
33554267|NCT01107626|62946928|FG000|Step 2: Maintenance Therapy|Pain|0|||
33554268|NCT01107626|62946929|FG001|Step 2: Maintenance Therapy|Pain|0|||
33554269|NCT01107626|62946930|FG002|Step 2: Maintenance Therapy|Pain|0|||
33554270|NCT01107626|62946931|FG003|Step 2: Maintenance Therapy|Pain|1|||
33554271|NCT01107626|62946928|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
33554272|NCT01107626|62946929|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
33554273|NCT01107626|62946930|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
33554274|NCT01107626|62946931|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
33554275|NCT00828009|62946940|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
33554276|NCT00828009|62946940|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
33554277|NCT00828009|62946940|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
33554278|NCT00828009|62946940|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
33580962|NCT01268293|62978106|FG000|Overall Study|Adverse Event|1|||
33660439|NCT01724177|63086538|FG000|Overall Study|Adverse Event|8|||
33660440|NCT01724177|63086538|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
33660441|NCT01724177|63086538|FG000|Overall Study|Nervous participant|1|||
33554279|NCT00828009|62946940|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
33554280|NCT00828009|62946940|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
33660442|NCT01724177|63086538|FG000|Overall Study|Serious Adverse Event Related|1|||
33660443|NCT04378270|63086557|FG000|Overall Study|Lack of Efficacy|1|||
33660444|NCT04378270|63086557|FG000|Overall Study|Withdrawal by Subject|1|||
33660445|NCT04378270|63086557|FG000|Overall Study|Screen Failure|1|||
33660446|NCT04378270|63086557|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
33660447|NCT01724021|63086563|FG000|Overall Study|Adverse Event|11|||
33660448|NCT01724021|63086564|FG001|Overall Study|Adverse Event|6|||
33660449|NCT01724021|63086563|FG000|Overall Study|Death|46|||
33660450|NCT01724021|63086564|FG001|Overall Study|Death|58|||
33660451|NCT01724021|63086563|FG000|Overall Study|Participant request/ Withdrew consent|18|||
33660452|NCT01724021|63086564|FG001|Overall Study|Participant request/ Withdrew consent|14|||
33660453|NCT01724021|63086563|FG000|Overall Study|Lost to Follow-up|15|||
33660454|NCT01724021|63086564|FG001|Overall Study|Lost to Follow-up|15|||
33660455|NCT01724021|63086563|FG000|Overall Study|Reason Not Specified|36|||
33660456|NCT01724021|63086564|FG001|Overall Study|Reason Not Specified|39|||
33660457|NCT01724021|63086563|FG000|Overall Study|Missing|1|||
33660458|NCT01724021|63086564|FG001|Overall Study|Missing|1|||
33660459|NCT01723397|63086578|FG000|Study Period 1|Protocol Violation|0|||
33660460|NCT01723397|63086579|FG001|Study Period 1|Protocol Violation|1|||
33660461|NCT01723397|63086578|FG000|Study Period 2|Protocol Violation|0|||
33660462|NCT01723397|63086579|FG001|Study Period 2|Protocol Violation|1|||
33660463|NCT01723163|63086587|FG000|Treatment Phase|Withdrawal by Subject|14|||
33660464|NCT01723163|63086588|FG001|Treatment Phase|Withdrawal by Subject|6|||
33660465|NCT01723163|63086587|FG000|Treatment Phase|Withdrawal by PI|5|||
33660466|NCT01723163|63086588|FG001|Treatment Phase|Withdrawal by PI|1|||
33660467|NCT01723163|63086587|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
33660468|NCT01723163|63086588|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
33660469|NCT01723163|63086587|FG000|3-Month Follow-up|Unable to Contact|12|||
33660470|NCT01723163|63086588|FG001|3-Month Follow-up|Unable to Contact|19|||
33660471|NCT01723163|63086587|FG000|6-Month Follow-up|Death|1|||
33660472|NCT01723163|63086588|FG001|6-Month Follow-up|Death|0|||
33660473|NCT01723163|63086587|FG000|6-Month Follow-up|Unable to Contact|17|||
33660474|NCT01723163|63086588|FG001|6-Month Follow-up|Unable to Contact|15|||
33660475|NCT01723163|63086587|FG000|12-Month Follow-up|Death|1|||
33660476|NCT01723163|63086588|FG001|12-Month Follow-up|Death|0|||
33483079|NCT02855164|62859878|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
33483080|NCT02855164|62859879|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
33483081|NCT02855164|62859872|FG000|Part C (Randomized Set)|Physician Decision|0|||
33483082|NCT02855164|62859873|FG001|Part C (Randomized Set)|Physician Decision|0|||
33483083|NCT02855164|62859874|FG002|Part C (Randomized Set)|Physician Decision|0|||
33483084|NCT02855164|62859875|FG003|Part C (Randomized Set)|Physician Decision|0|||
33554281|NCT00828009|62946940|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
33554282|NCT00828009|62946940|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
33554283|NCT00828009|62946940|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
33554284|NCT00828009|62946940|FG000|Step 2 - Maintenance Therapy|Death|1|||
33554285|NCT00828009|62946940|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
33554286|NCT00828009|62946940|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
33554287|NCT00828009|62946940|FG000|Step 2 - Maintenance Therapy|Other|1|||
33554288|NCT00068393|62946960|FG000|Overall Study|Adverse Event|2|||
33554289|NCT00068393|62946960|FG000|Overall Study|Death|3|||
33554290|NCT00068393|62946960|FG000|Overall Study|Withdrawal by Subject|3|||
33554291|NCT00068393|62946960|FG000|Overall Study|Alternative treatment|1|||
33554292|NCT00068393|62946960|FG000|Overall Study|Quality of life worsening|1|||
33554293|NCT00062010|62946964|FG000|Overall Study|Ineligible|3|||
33483085|NCT02855164|62859876|FG004|Part C (Randomized Set)|Physician Decision|0|||
33483086|NCT02855164|62859877|FG005|Part C (Randomized Set)|Physician Decision|1|||
33554294|NCT00047008|62946970|FG000|Overall Study|Withdrawn consent|2|||
33554295|NCT00047008|62946971|FG001|Overall Study|Withdrawn consent|3|||
33660477|NCT01723163|63086587|FG000|12-Month Follow-up|Unable to Contact|23|||
33660478|NCT01723163|63086588|FG001|12-Month Follow-up|Unable to Contact|28|||
33660479|NCT01722071|63086598|FG000|Overall Study|Protocol Violation|1|||
33660480|NCT01722071|63086599|FG001|Overall Study|Protocol Violation|0|||
33660481|NCT01721759|63086605|FG000|Treatment Period|Disease Progression|85|||
33660482|NCT01721759|63086605|FG000|Treatment Period|Study drug toxicity|14|||
33660483|NCT01721759|63086605|FG000|Treatment Period|Death|1|||
33660484|NCT01721759|63086605|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
33660485|NCT01721759|63086605|FG000|Treatment Period|Participant request to withdraw|3|||
33660486|NCT01721759|63086605|FG000|Treatment Period|Other Reasons|3|||
33660487|NCT01721759|63086605|FG000|End of Study Period|Participant Withdrew Consent|5|||
33660488|NCT01721759|63086605|FG000|End of Study Period|Death|101|||
33660489|NCT01721759|63086605|FG000|End of Study Period|Lost to Follow-up|1|||
33660490|NCT01721759|63086605|FG000|End of Study Period|Other Reasons|10|||
33365031|NCT03920215|62743600|FG003|Overall Study|Death|1|||
33554296|NCT00047008|62946970|FG000|Overall Study|Ineligible|9|||
33554297|NCT00047008|62946971|FG001|Overall Study|Ineligible|8|||
33554298|NCT02397694|62946979|FG000|Double-Blinded Phase|Adverse Event|1|||
33554299|NCT02397694|62946980|FG001|Double-Blinded Phase|Adverse Event|0|||
33554300|NCT02397694|62946979|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
33660491|NCT01721369|63086614|FG000|Overall Study|Not initial etiological diagnosis|12|||
33660492|NCT01721057|63086676|FG000|Treatment Period|Withdrawal by Subject|11|||
33660493|NCT01721057|63086677|FG001|Treatment Period|Withdrawal by Subject|5|||
33660494|NCT01721057|63086678|FG002|Treatment Period|Withdrawal by Subject|8|||
33660495|NCT01721057|63086679|FG003|Treatment Period|Withdrawal by Subject|0|||
33660496|NCT01721057|63086680|FG004|Treatment Period|Withdrawal by Subject|0|||
33660497|NCT01721057|63086681|FG005|Treatment Period|Withdrawal by Subject|0|||
33660498|NCT01721057|63086682|FG006|Treatment Period|Withdrawal by Subject|0|||
33660499|NCT01721057|63086676|FG000|Treatment Period|Adverse Event|7|||
33660500|NCT01721057|63086677|FG001|Treatment Period|Adverse Event|10|||
33660501|NCT01721057|63086678|FG002|Treatment Period|Adverse Event|12|||
33660502|NCT01721057|63086679|FG003|Treatment Period|Adverse Event|0|||
33660503|NCT01721057|63086680|FG004|Treatment Period|Adverse Event|0|||
33660504|NCT01721057|63086681|FG005|Treatment Period|Adverse Event|0|||
33660505|NCT01721057|63086682|FG006|Treatment Period|Adverse Event|0|||
33660506|NCT01721057|63086676|FG000|Treatment Period|Lack of Efficacy|7|||
33660507|NCT01721057|63086677|FG001|Treatment Period|Lack of Efficacy|3|||
33660508|NCT01721057|63086678|FG002|Treatment Period|Lack of Efficacy|0|||
33660509|NCT01721057|63086679|FG003|Treatment Period|Lack of Efficacy|0|||
33660510|NCT01721057|63086680|FG004|Treatment Period|Lack of Efficacy|0|||
33660511|NCT01721057|63086681|FG005|Treatment Period|Lack of Efficacy|0|||
33660512|NCT01721057|63086682|FG006|Treatment Period|Lack of Efficacy|0|||
33660513|NCT01721057|63086676|FG000|Treatment Period|Lost to Follow-up|1|||
33660514|NCT01721057|63086677|FG001|Treatment Period|Lost to Follow-up|0|||
33660515|NCT01721057|63086678|FG002|Treatment Period|Lost to Follow-up|0|||
33660516|NCT01721057|63086679|FG003|Treatment Period|Lost to Follow-up|0|||
33660517|NCT01721057|63086680|FG004|Treatment Period|Lost to Follow-up|0|||
33660518|NCT01721057|63086681|FG005|Treatment Period|Lost to Follow-up|0|||
33660519|NCT01721057|63086682|FG006|Treatment Period|Lost to Follow-up|0|||
33660520|NCT01721057|63086676|FG000|Treatment Period|Physician Decision|0|||
33660521|NCT01721057|63086677|FG001|Treatment Period|Physician Decision|1|||
33660522|NCT01721057|63086678|FG002|Treatment Period|Physician Decision|3|||
33660523|NCT01721057|63086679|FG003|Treatment Period|Physician Decision|0|||
33660524|NCT01721057|63086680|FG004|Treatment Period|Physician Decision|0|||
33660525|NCT01721057|63086681|FG005|Treatment Period|Physician Decision|0|||
33660526|NCT01721057|63086682|FG006|Treatment Period|Physician Decision|0|||
33660527|NCT01721057|63086676|FG000|Treatment Period|Death|2|||
33660528|NCT01721057|63086677|FG001|Treatment Period|Death|0|||
33660529|NCT01721057|63086678|FG002|Treatment Period|Death|0|||
33660530|NCT01721057|63086679|FG003|Treatment Period|Death|0|||
33365032|NCT00580840|62743610|FG000|Run-in|Adverse Event|17|||
33554301|NCT02397694|62946980|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
33660531|NCT01721057|63086680|FG004|Treatment Period|Death|0|||
33660532|NCT01721057|63086681|FG005|Treatment Period|Death|0|||
33660533|NCT01721057|63086682|FG006|Treatment Period|Death|0|||
33660534|NCT01721057|63086676|FG000|Rescue Period|Adverse Event|0|||
33660535|NCT01721057|63086677|FG001|Rescue Period|Adverse Event|0|||
33660536|NCT01721057|63086678|FG002|Rescue Period|Adverse Event|0|||
33660537|NCT01721057|63086679|FG003|Rescue Period|Adverse Event|1|||
33660538|NCT01721057|63086680|FG004|Rescue Period|Adverse Event|0|||
33660539|NCT01721057|63086681|FG005|Rescue Period|Adverse Event|0|||
33660540|NCT01721057|63086682|FG006|Rescue Period|Adverse Event|0|||
33660541|NCT01721057|63086676|FG000|Rescue Period|Lack of Efficacy|0|||
33660542|NCT01721057|63086677|FG001|Rescue Period|Lack of Efficacy|0|||
33660543|NCT01721057|63086678|FG002|Rescue Period|Lack of Efficacy|0|||
33660544|NCT01721057|63086679|FG003|Rescue Period|Lack of Efficacy|2|||
33660545|NCT01721057|63086680|FG004|Rescue Period|Lack of Efficacy|0|||
33660546|NCT01721057|63086681|FG005|Rescue Period|Lack of Efficacy|0|||
33660547|NCT01721057|63086682|FG006|Rescue Period|Lack of Efficacy|0|||
33660548|NCT04570384|63086711|FG000|Overall Study|Adverse Event|2|||
33660549|NCT04570384|63086712|FG001|Overall Study|Adverse Event|1|||
33660550|NCT04570384|63086711|FG000|Overall Study|Death|2|||
33660551|NCT04570384|63086712|FG001|Overall Study|Death|5|||
33660552|NCT04570384|63086711|FG000|Overall Study|Lost to Follow-up|1|||
33660553|NCT04570384|63086712|FG001|Overall Study|Lost to Follow-up|0|||
33660554|NCT04570384|63086711|FG000|Overall Study|Other|1|||
33660555|NCT04570384|63086712|FG001|Overall Study|Other|0|||
33660556|NCT04570384|63086711|FG000|Overall Study|Protocol Violation|0|||
33660557|NCT04570384|63086712|FG001|Overall Study|Protocol Violation|1|||
33660558|NCT04570384|63086711|FG000|Overall Study|Sponsor Decision|1|||
33660559|NCT04570384|63086712|FG001|Overall Study|Sponsor Decision|0|||
33660560|NCT04570384|63086711|FG000|Overall Study|Withdrawal by Subject|4|||
33660561|NCT04570384|63086712|FG001|Overall Study|Withdrawal by Subject|2|||
33660562|NCT02563522|63086765|FG000|Overall Study|Adverse Event|2|||
33660563|NCT02563522|63086766|FG001|Overall Study|Adverse Event|3|||
33660564|NCT02563522|63086765|FG000|Overall Study|Lost to Follow-up|1|||
33660565|NCT02563522|63086766|FG001|Overall Study|Lost to Follow-up|0|||
33660566|NCT02563522|63086765|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
33660567|NCT02563522|63086766|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
33660568|NCT03578146|63086778|FG000|Overall Study|Did Not Receive Treatment|1|||
33660569|NCT03578146|63086779|FG001|Overall Study|Did Not Receive Treatment|0|||
33660570|NCT03578146|63086780|FG002|Overall Study|Did Not Receive Treatment|0|||
33660571|NCT03578146|63086781|FG003|Overall Study|Did Not Receive Treatment|0|||
33660572|NCT03578146|63086782|FG004|Overall Study|Did Not Receive Treatment|0|||
33660573|NCT03578146|63086783|FG005|Overall Study|Did Not Receive Treatment|2|||
33660574|NCT03578146|63086778|FG000|Overall Study|Lost to Follow-up|0|||
33660575|NCT03578146|63086779|FG001|Overall Study|Lost to Follow-up|1|||
33660576|NCT03578146|63086780|FG002|Overall Study|Lost to Follow-up|1|||
33660577|NCT03578146|63086781|FG003|Overall Study|Lost to Follow-up|0|||
33660578|NCT03578146|63086782|FG004|Overall Study|Lost to Follow-up|0|||
33660579|NCT03578146|63086783|FG005|Overall Study|Lost to Follow-up|1|||
33660580|NCT02716896|63086799|FG000|Overall Study|Physician Decision|0|||
33660581|NCT02716896|63086800|FG001|Overall Study|Physician Decision|1|||
33660582|NCT02715726|63086855|FG000|Overall Study|Adverse Event|2|||
33660583|NCT02715726|63086856|FG001|Overall Study|Adverse Event|6|||
33660584|NCT02715726|63086855|FG000|Overall Study|Protocol Violation|1|||
33660585|NCT02715726|63086856|FG001|Overall Study|Protocol Violation|0|||
33660586|NCT02715726|63086855|FG000|Overall Study|Death|2|||
33660587|NCT02715726|63086856|FG001|Overall Study|Death|1|||
33660588|NCT02715726|63086855|FG000|Overall Study|Participant moved|1|||
33660589|NCT02715726|63086856|FG001|Overall Study|Participant moved|3|||
33660590|NCT02715726|63086855|FG000|Overall Study|Other than specified above|11|||
33365033|NCT00580840|62743611|FG001|Run-in|Adverse Event|0|||
33483087|NCT02855164|62859878|FG006|Part C (Randomized Set)|Physician Decision|0|||
33483088|NCT02855164|62859879|FG007|Part C (Randomized Set)|Physician Decision|1|||
33483089|NCT02855164|62859872|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
33483090|NCT02855164|62859873|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
33483091|NCT02855164|62859874|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
33483092|NCT02855164|62859875|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
33483093|NCT02855164|62859876|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
33483094|NCT02855164|62859877|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
33660591|NCT02715726|63086856|FG001|Overall Study|Other than specified above|15|||
33660592|NCT02715726|63086855|FG000|Overall Study|Randomized but not treated|1|||
33660593|NCT02715726|63086856|FG001|Overall Study|Randomized but not treated|2|||
33660594|NCT04248816|63086869|FG000|Overall Study|Ineligible post-randomization|7|||
33660595|NCT04248816|63086870|FG001|Overall Study|Ineligible post-randomization|21|||
33660596|NCT04248816|63086871|FG002|Overall Study|Ineligible post-randomization|25|||
33660597|NCT02314156|63086908|FG000|Overall Study|Adverse Event|1|||
33660598|NCT02314156|63086909|FG001|Overall Study|Adverse Event|0|||
33660599|NCT02314156|63086908|FG000|Overall Study|Withdrawal by Subject|1|||
33660600|NCT02314156|63086909|FG001|Overall Study|Withdrawal by Subject|0|||
33365034|NCT00580840|62743612|FG002|Run-in|Adverse Event|0|||
33660601|NCT02716584|63087129|FG000|Overall Study|Lost to Follow-up|8|||
33660602|NCT02716584|63087130|FG001|Overall Study|Lost to Follow-up|5|||
33660603|NCT02716194|63087211|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
33554302|NCT02397694|62946979|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
33554303|NCT02397694|62946980|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
33554304|NCT02397694|62946979|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
33554305|NCT02397694|62946980|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
33554306|NCT02397694|62946979|FG000|Open Label Extension Phase|Protocol Violation|1|||
33554307|NCT02397694|62946980|FG001|Open Label Extension Phase|Protocol Violation|0|||
33554308|NCT02397694|62946979|FG000|Open Label Extension Phase|Withdrew Consent|3|||
33554309|NCT02397694|62946980|FG001|Open Label Extension Phase|Withdrew Consent|1|||
33554310|NCT02397694|62946979|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
33554311|NCT02397694|62946980|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
33554312|NCT02783599|62946990|FG000|Overall Study|Progressive disease|23|||
33554313|NCT02783599|62946990|FG000|Overall Study|Surgical Resection|10|||
33660604|NCT02716194|63087212|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
33660605|NCT02716194|63087213|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
33660606|NCT03773484|63087283|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
33660607|NCT02715258|63087466|FG000|Overall Study|Withdrawal by Subject|6|||
33660608|NCT02715258|63087467|FG001|Overall Study|Withdrawal by Subject|1|||
33660609|NCT02715258|63087466|FG000|Overall Study|Lost to Follow-up|7|||
33660610|NCT02715258|63087467|FG001|Overall Study|Lost to Follow-up|1|||
33660611|NCT02715258|63087466|FG000|Overall Study|Terminated by Sponsor|0|||
33660612|NCT02715258|63087467|FG001|Overall Study|Terminated by Sponsor|1|||
33660613|NCT02715258|63087466|FG000|Overall Study|Death|0|||
33660614|NCT02715258|63087467|FG001|Overall Study|Death|1|||
33660615|NCT02715258|63087466|FG000|Overall Study|Subject non-compliant|1|||
33660616|NCT02715258|63087467|FG001|Overall Study|Subject non-compliant|1|||
33660617|NCT02715258|63087466|FG000|Overall Study|GCP violation|2|||
33660618|NCT02715258|63087467|FG001|Overall Study|GCP violation|1|||
33660619|NCT02714868|63087492|FG000|Overall Study|Withdrawal by Subject|3|||
33660620|NCT02714868|63087493|FG001|Overall Study|Withdrawal by Subject|0|||
33660621|NCT02714868|63087492|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
33660622|NCT02714868|63087493|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
33660623|NCT02714868|63087492|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
33660624|NCT02714868|63087493|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
33660625|NCT02713542|63087808|FG000|Overall Study|Use of prohibited medication|14|||
33660626|NCT02713542|63087809|FG001|Overall Study|Use of prohibited medication|5|||
33660627|NCT02713542|63087808|FG000|Overall Study|Withdrawal by Subject|4|||
33660628|NCT02713542|63087809|FG001|Overall Study|Withdrawal by Subject|1|||
33660629|NCT03548220|63087893|FG000|Overall Study|Lost to Follow-up|1|||
33660630|NCT03548220|63087894|FG001|Overall Study|Lost to Follow-up|0|||
33660631|NCT03548220|63087895|FG002|Overall Study|Lost to Follow-up|0|||
33660632|NCT03548220|63087896|FG003|Overall Study|Lost to Follow-up|0|||
33660633|NCT02712996|63087931|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
33660634|NCT02712996|63087932|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
33660635|NCT00701064|63088039|FG000|Overall Study|Protocol Violation|1|||
33660636|NCT00701064|63088040|FG001|Overall Study|Protocol Violation|1|||
33660637|NCT00701064|63088039|FG000|Overall Study|Withdrawal by Subject|1|||
33660638|NCT00701064|63088040|FG001|Overall Study|Withdrawal by Subject|1|||
33660639|NCT00701064|63088039|FG000|Overall Study|initiated other PTSD treatment|2|||
33660640|NCT00701064|63088040|FG001|Overall Study|initiated other PTSD treatment|2|||
33660641|NCT01748825|63088179|FG000|Dose Escalation|Refused further treatment|2|||
33365035|NCT00580840|62743613|FG003|Run-in|Adverse Event|0|||
33554314|NCT02783599|62946990|FG000|Overall Study|Adverse Event|4|||
33554315|NCT02783599|62946990|FG000|Overall Study|Physician Decision|2|||
33554316|NCT02783599|62946990|FG000|Overall Study|Death|1|||
33554317|NCT02838017|62947003|FG000|Overall Study|Lost to Follow-up|14|||
33660642|NCT01748825|63088180|FG001|Dose Escalation|Refused further treatment|2|||
33660643|NCT01748825|63088181|FG002|Dose Escalation|Refused further treatment|0|||
33660644|NCT01748825|63088182|FG003|Dose Escalation|Refused further treatment|0|||
33660645|NCT01748825|63088183|FG004|Dose Escalation|Refused further treatment|1|||
33660646|NCT01748825|63088184|FG005|Dose Escalation|Refused further treatment|2|||
33660647|NCT01748825|63088185|FG006|Dose Escalation|Refused further treatment|0|||
33660648|NCT01748825|63088186|FG007|Dose Escalation|Refused further treatment|0|||
33660649|NCT01748825|63088187|FG008|Dose Escalation|Refused further treatment|0|||
33660650|NCT01748825|63088188|FG009|Dose Escalation|Refused further treatment|0|||
33660651|NCT01748825|63088179|FG000|Dose Escalation|Switched to alternative treatment|0|||
33660652|NCT01748825|63088180|FG001|Dose Escalation|Switched to alternative treatment|0|||
33660653|NCT01748825|63088181|FG002|Dose Escalation|Switched to alternative treatment|0|||
33660654|NCT01748825|63088182|FG003|Dose Escalation|Switched to alternative treatment|1|||
33660655|NCT01748825|63088183|FG004|Dose Escalation|Switched to alternative treatment|0|||
33660656|NCT01748825|63088184|FG005|Dose Escalation|Switched to alternative treatment|0|||
33660657|NCT01748825|63088185|FG006|Dose Escalation|Switched to alternative treatment|0|||
33660658|NCT01748825|63088186|FG007|Dose Escalation|Switched to alternative treatment|0|||
33660659|NCT01748825|63088187|FG008|Dose Escalation|Switched to alternative treatment|0|||
33660660|NCT01748825|63088188|FG009|Dose Escalation|Switched to alternative treatment|0|||
33660661|NCT01748825|63088179|FG000|Dose Escalation|Adverse Event|0|||
33660662|NCT01748825|63088180|FG001|Dose Escalation|Adverse Event|0|||
33660663|NCT01748825|63088181|FG002|Dose Escalation|Adverse Event|0|||
33660664|NCT01748825|63088182|FG003|Dose Escalation|Adverse Event|0|||
33660665|NCT01748825|63088183|FG004|Dose Escalation|Adverse Event|0|||
33660666|NCT01748825|63088184|FG005|Dose Escalation|Adverse Event|0|||
33660667|NCT01748825|63088185|FG006|Dose Escalation|Adverse Event|1|||
33660668|NCT01748825|63088186|FG007|Dose Escalation|Adverse Event|0|||
33660669|NCT01748825|63088187|FG008|Dose Escalation|Adverse Event|0|||
33660670|NCT01748825|63088188|FG009|Dose Escalation|Adverse Event|0|||
33660671|NCT01748825|63088179|FG000|Dose Expansion|Refused further treatment|0|||
33660672|NCT01748825|63088180|FG001|Dose Expansion|Refused further treatment|0|||
33660673|NCT01748825|63088181|FG002|Dose Expansion|Refused further treatment|0|||
33660674|NCT01748825|63088182|FG003|Dose Expansion|Refused further treatment|0|||
33660675|NCT01748825|63088183|FG004|Dose Expansion|Refused further treatment|0|||
33660676|NCT01748825|63088184|FG005|Dose Expansion|Refused further treatment|0|||
33660677|NCT01748825|63088185|FG006|Dose Expansion|Refused further treatment|0|||
33554318|NCT02838017|62947004|FG001|Overall Study|Lost to Follow-up|11|||
33660678|NCT01748825|63088186|FG007|Dose Expansion|Refused further treatment|0|||
33660679|NCT01748825|63088187|FG008|Dose Expansion|Refused further treatment|1|||
33580963|NCT01268293|62978106|FG000|Overall Study|Subject choice|1|||
33660680|NCT01748825|63088188|FG009|Dose Expansion|Refused further treatment|1|||
33660681|NCT01748825|63088179|FG000|Dose Expansion|Switched to alternative treatment|0|||
33660682|NCT01748825|63088180|FG001|Dose Expansion|Switched to alternative treatment|0|||
33660683|NCT01748825|63088181|FG002|Dose Expansion|Switched to alternative treatment|0|||
33660684|NCT01748825|63088182|FG003|Dose Expansion|Switched to alternative treatment|0|||
33660685|NCT01748825|63088183|FG004|Dose Expansion|Switched to alternative treatment|0|||
33660686|NCT01748825|63088184|FG005|Dose Expansion|Switched to alternative treatment|0|||
33365036|NCT00580840|62743610|FG000|Run-in|Lack of Efficacy|93|||
33365037|NCT00580840|62743611|FG001|Run-in|Lack of Efficacy|0|||
33365038|NCT00580840|62743612|FG002|Run-in|Lack of Efficacy|0|||
33483095|NCT02855164|62859878|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
33483096|NCT02855164|62859879|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
33483097|NCT01002742|62859919|FG000|Overall Study|Determined to be ineligible|0|||
33483098|NCT01002742|62859920|FG001|Overall Study|Determined to be ineligible|1|||
33483099|NCT02853760|62859926|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
33483100|NCT02853760|62859927|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
33483101|NCT02853760|62859928|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
33483102|NCT02853760|62859929|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
33483103|NCT02853760|62859930|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
33483104|NCT02853760|62859931|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
33483105|NCT02852434|62859941|FG000|Overall Study|Withdrawal by Subject|0|||
33483106|NCT02852434|62859942|FG001|Overall Study|Withdrawal by Subject|1|||
33483107|NCT02852434|62859941|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
33483108|NCT02852434|62859942|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
33483109|NCT02850016|62859950|FG000|Overall Study|Withdrawal by Subject|1|||
33483110|NCT02850016|62859951|FG001|Overall Study|Withdrawal by Subject|2|||
33483111|NCT02849704|62859959|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
33483112|NCT02849704|62859960|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
33660687|NCT01748825|63088185|FG006|Dose Expansion|Switched to alternative treatment|0|||
33660688|NCT01748825|63088186|FG007|Dose Expansion|Switched to alternative treatment|0|||
33660689|NCT01748825|63088187|FG008|Dose Expansion|Switched to alternative treatment|0|||
33660690|NCT01748825|63088188|FG009|Dose Expansion|Switched to alternative treatment|1|||
33660691|NCT01748825|63088179|FG000|Dose Expansion|Adverse Event|0|||
33660692|NCT01748825|63088180|FG001|Dose Expansion|Adverse Event|0|||
33660693|NCT01748825|63088181|FG002|Dose Expansion|Adverse Event|0|||
33660694|NCT01748825|63088182|FG003|Dose Expansion|Adverse Event|0|||
33660695|NCT01748825|63088183|FG004|Dose Expansion|Adverse Event|0|||
33660696|NCT01748825|63088184|FG005|Dose Expansion|Adverse Event|0|||
33660697|NCT01748825|63088185|FG006|Dose Expansion|Adverse Event|0|||
33660698|NCT01748825|63088186|FG007|Dose Expansion|Adverse Event|0|||
33660699|NCT01748825|63088187|FG008|Dose Expansion|Adverse Event|0|||
33660700|NCT01748825|63088188|FG009|Dose Expansion|Adverse Event|3|||
33660701|NCT01748825|63088179|FG000|Dose Expansion|Physician Decision|0|||
33660702|NCT01748825|63088180|FG001|Dose Expansion|Physician Decision|0|||
33660703|NCT01748825|63088181|FG002|Dose Expansion|Physician Decision|0|||
33660704|NCT01748825|63088182|FG003|Dose Expansion|Physician Decision|0|||
33660705|NCT01748825|63088183|FG004|Dose Expansion|Physician Decision|0|||
33660706|NCT01748825|63088184|FG005|Dose Expansion|Physician Decision|0|||
33660707|NCT01748825|63088185|FG006|Dose Expansion|Physician Decision|0|||
33660708|NCT01748825|63088186|FG007|Dose Expansion|Physician Decision|0|||
33660709|NCT01748825|63088187|FG008|Dose Expansion|Physician Decision|1|||
33660710|NCT01748825|63088188|FG009|Dose Expansion|Physician Decision|0|||
33660711|NCT01720667|63088250|FG000|Overall Study|Adverse Event|1|||
33660712|NCT01720667|63088251|FG001|Overall Study|Adverse Event|1|||
33660713|NCT01720667|63088250|FG000|Overall Study|Withdrawal by Subject|3|||
33660714|NCT01720667|63088251|FG001|Overall Study|Withdrawal by Subject|0|||
33660715|NCT01720043|63088259|FG000|Overall Study|Withdrawal by Subject|1|||
33660716|NCT00700752|63088263|FG000|First Intervention|Withdrawal by Subject|0|||
33483113|NCT02849704|62859959|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
33483114|NCT02849704|62859960|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
33554319|NCT03188666|62947012|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
33554320|NCT03188666|62947013|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
33554321|NCT03188666|62947014|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
33554322|NCT03188666|62947015|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
33554323|NCT03188666|62947012|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
33554324|NCT03188666|62947013|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
33554325|NCT03188666|62947014|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
33554326|NCT03188666|62947015|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
33554327|NCT03188666|62947012|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
33554328|NCT03188666|62947013|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
33554329|NCT03188666|62947014|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
33554330|NCT03188666|62947015|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
33554331|NCT03188666|62947012|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
33554332|NCT03188666|62947013|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
33483115|NCT02849704|62859959|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
33483116|NCT02849704|62859960|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
33483117|NCT03347396|62859981|FG000|Part A (26 Weeks)|Adverse Event|1|||
33483118|NCT03347396|62859982|FG001|Part A (26 Weeks)|Adverse Event|0|||
33483119|NCT03347396|62859981|FG000|Part A (26 Weeks)|Death|0|||
33483120|NCT03347396|62859982|FG001|Part A (26 Weeks)|Death|1|||
33483121|NCT03347396|62859981|FG000|Part B (149 Weeks)|Adverse Event|1|||
33483122|NCT03347396|62859982|FG001|Part B (149 Weeks)|Adverse Event|1|||
33483123|NCT03347396|62859981|FG000|Part B (149 Weeks)|Death|1|||
33483124|NCT03347396|62859982|FG001|Part B (149 Weeks)|Death|0|||
33483125|NCT03335150|62859993|FG000|Overall Study|Withdrawal by Subject|10|||
33483126|NCT03335150|62859994|FG001|Overall Study|Withdrawal by Subject|4|||
33483127|NCT03335150|62859993|FG000|Overall Study|Adverse Event|0|||
33483128|NCT03335150|62859994|FG001|Overall Study|Adverse Event|1|||
33483129|NCT03334448|62860000|FG000|Washout|Personal Reason|0|||
33483130|NCT03334448|62860001|FG001|Washout|Personal Reason|1|||
33483131|NCT03334448|62860002|FG002|Washout|Personal Reason|0|||
33483132|NCT03334448|62860003|FG003|Washout|Personal Reason|0|||
33483133|NCT03334448|62860000|FG000|Washout|Protocol Violation|0|||
33660717|NCT00700752|63088264|FG001|First Intervention|Withdrawal by Subject|2|||
33483134|NCT03334448|62860001|FG001|Washout|Protocol Violation|0|||
33483135|NCT03334448|62860002|FG002|Washout|Protocol Violation|0|||
33483136|NCT03334448|62860003|FG003|Washout|Protocol Violation|1|||
33554333|NCT03188666|62947014|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
33660718|NCT01747811|63088281|FG000|Overall Study|Lack of Efficacy|2|||
33660719|NCT01747811|63088282|FG001|Overall Study|Lack of Efficacy|4|||
33660720|NCT01747655|63088290|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
33660721|NCT01747655|63088291|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
33660722|NCT01747655|63088290|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
33660723|NCT01747655|63088291|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
33554334|NCT03188666|62947015|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
33554335|NCT02836769|62947029|FG000|Overall Study|Lost to Follow-up|10|||
33554336|NCT02836769|62947029|FG000|Overall Study|Medical withdrawal|2|||
33554337|NCT02836769|62947029|FG000|Overall Study|Withdrawal by Subject|3|||
33554338|NCT02836613|62947035|FG000|Overall Study|Accidental drowning|1|||
33554339|NCT02836613|62947036|FG001|Overall Study|Accidental drowning|0|||
33554340|NCT02836613|62947035|FG000|Overall Study|Lost to Follow-up|0|||
33554341|NCT02836613|62947036|FG001|Overall Study|Lost to Follow-up|1|||
33554342|NCT02836613|62947035|FG000|Overall Study|Withdrawal by Subject|0|||
33554343|NCT02836613|62947036|FG001|Overall Study|Withdrawal by Subject|2|||
33554344|NCT02397460|62947050|FG000|Treatment Period 2|Adverse Event|0|||
33554345|NCT02397460|62947051|FG001|Treatment Period 2|Adverse Event|0|||
33554346|NCT02397460|62947052|FG002|Treatment Period 2|Adverse Event|0|||
33554347|NCT02397460|62947053|FG003|Treatment Period 2|Adverse Event|0|||
33554348|NCT02397460|62947054|FG004|Treatment Period 2|Adverse Event|0|||
33554349|NCT02397460|62947055|FG005|Treatment Period 2|Adverse Event|0|||
33554350|NCT02397460|62947056|FG006|Treatment Period 2|Adverse Event|0|||
33554351|NCT02397460|62947057|FG007|Treatment Period 2|Adverse Event|1|||
33554352|NCT02397460|62947050|FG000|Treatment Period 4|Adverse Event|0|||
33554353|NCT02397460|62947051|FG001|Treatment Period 4|Adverse Event|1|||
33554354|NCT02397460|62947052|FG002|Treatment Period 4|Adverse Event|0|||
33554355|NCT02397460|62947053|FG003|Treatment Period 4|Adverse Event|0|||
33554356|NCT02397460|62947054|FG004|Treatment Period 4|Adverse Event|0|||
33483137|NCT02849080|62860011|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
33483138|NCT02849080|62860012|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
33483139|NCT02849080|62860013|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
33483140|NCT02849080|62860014|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
33483141|NCT02849080|62860011|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
33483142|NCT02849080|62860012|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
33483143|NCT02849080|62860013|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
33483144|NCT02849080|62860014|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
33483145|NCT02849080|62860011|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
33483146|NCT02849080|62860012|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
33483147|NCT02849080|62860013|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
33483148|NCT02849080|62860014|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
33483149|NCT02849080|62860011|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
33483150|NCT02849080|62860012|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
33483151|NCT02849080|62860013|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
33483152|NCT02849080|62860014|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
33483153|NCT02849080|62860011|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
33483154|NCT02849080|62860012|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
33483155|NCT02849080|62860013|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
33483156|NCT02849080|62860014|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
33483157|NCT02849080|62860011|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
33483158|NCT02849080|62860012|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
33483159|NCT02849080|62860013|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
33483160|NCT02849080|62860014|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
33483161|NCT03346070|62860031|FG000|Overall Study|Death|0|||
33483162|NCT03346070|62860032|FG001|Overall Study|Death|0|||
33483163|NCT03346070|62860033|FG002|Overall Study|Death|0|||
33483164|NCT03346070|62860034|FG003|Overall Study|Death|0|||
33483165|NCT03346070|62860035|FG004|Overall Study|Death|1|||
33483166|NCT03346070|62860031|FG000|Overall Study|Lost to Follow-up|0|||
33483167|NCT03346070|62860032|FG001|Overall Study|Lost to Follow-up|1|||
33483168|NCT03346070|62860033|FG002|Overall Study|Lost to Follow-up|2|||
33483169|NCT03346070|62860034|FG003|Overall Study|Lost to Follow-up|0|||
33483170|NCT03346070|62860035|FG004|Overall Study|Lost to Follow-up|0|||
33483171|NCT03346070|62860031|FG000|Overall Study|Physician Decision|0|||
33483172|NCT03346070|62860032|FG001|Overall Study|Physician Decision|0|||
33483173|NCT03346070|62860033|FG002|Overall Study|Physician Decision|0|||
33483174|NCT03346070|62860034|FG003|Overall Study|Physician Decision|1|||
33483175|NCT03346070|62860035|FG004|Overall Study|Physician Decision|1|||
33483176|NCT03346070|62860031|FG000|Overall Study|Withdrawal by Subject|1|||
33483177|NCT03346070|62860032|FG001|Overall Study|Withdrawal by Subject|0|||
33483178|NCT03346070|62860033|FG002|Overall Study|Withdrawal by Subject|0|||
33483179|NCT03346070|62860034|FG003|Overall Study|Withdrawal by Subject|1|||
33483180|NCT03346070|62860035|FG004|Overall Study|Withdrawal by Subject|0|||
33483181|NCT03346070|62860031|FG000|Overall Study|Study medication not received as planned|2|||
33554357|NCT02397460|62947055|FG005|Treatment Period 4|Adverse Event|0|||
33554358|NCT02397460|62947056|FG006|Treatment Period 4|Adverse Event|0|||
33554359|NCT02397460|62947057|FG007|Treatment Period 4|Adverse Event|0|||
33554360|NCT02397460|62947050|FG000|Treatment Period 4|Physician Decision|0|||
33554361|NCT02397460|62947051|FG001|Treatment Period 4|Physician Decision|0|||
33554362|NCT02397460|62947052|FG002|Treatment Period 4|Physician Decision|0|||
33554363|NCT02397460|62947053|FG003|Treatment Period 4|Physician Decision|0|||
33554364|NCT02397460|62947054|FG004|Treatment Period 4|Physician Decision|1|||
33554365|NCT02397460|62947055|FG005|Treatment Period 4|Physician Decision|0|||
33554366|NCT02397460|62947056|FG006|Treatment Period 4|Physician Decision|0|||
33554367|NCT02397460|62947057|FG007|Treatment Period 4|Physician Decision|0|||
33554368|NCT02834819|62947133|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
33554369|NCT02834819|62947134|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
33554370|NCT02454478|62947140|FG000|Overall Study|Incomplete DLT Evaluation|1|||
33554371|NCT01341587|62947146|FG000|Overall Study|Lost to Follow-up|2|||
33554372|NCT01341587|62947147|FG001|Overall Study|Lost to Follow-up|0|||
33660724|NCT01747655|63088290|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
33660725|NCT01747655|63088291|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
33660726|NCT01718483|63088299|FG000|Overall Study|Withdrawal by Subject|14|||
33554373|NCT01341587|62947146|FG000|Overall Study|stopped using the meters|2|||
33660727|NCT01718483|63088300|FG001|Overall Study|Withdrawal by Subject|12|||
33660728|NCT01718483|63088299|FG000|Overall Study|Adverse Event|5|||
33554374|NCT01341587|62947147|FG001|Overall Study|stopped using the meters|10|||
33554375|NCT01358825|62947155|FG000|Overall Study|Blood sample not drawn|0|||
33660729|NCT01718483|63088300|FG001|Overall Study|Adverse Event|12|||
33660730|NCT01718483|63088299|FG000|Overall Study|Lost to Follow-up|8|||
33660731|NCT01718483|63088300|FG001|Overall Study|Lost to Follow-up|3|||
33660732|NCT01718483|63088299|FG000|Overall Study|Protocol Violation|4|||
33660733|NCT01718483|63088300|FG001|Overall Study|Protocol Violation|2|||
33660734|NCT01718483|63088299|FG000|Overall Study|Other|1|||
33660735|NCT01718483|63088300|FG001|Overall Study|Other|4|||
33660736|NCT01718483|63088299|FG000|Overall Study|Pregnancy|1|||
33660737|NCT01718483|63088300|FG001|Overall Study|Pregnancy|1|||
33660738|NCT01718483|63088299|FG000|Overall Study|Lack of Efficacy|1|||
33660739|NCT01718483|63088300|FG001|Overall Study|Lack of Efficacy|0|||
33660740|NCT01717859|63088306|FG000|Overall Study|Adverse Event|5|||
33660741|NCT01717859|63088306|FG000|Overall Study|Moved out of state|1|||
33660742|NCT01717859|63088306|FG000|Overall Study|Patient concerned about mental health|1|||
33660743|NCT01717859|63088306|FG000|Overall Study|Lost to Follow-up|1|||
33660744|NCT01717859|63088306|FG000|Overall Study|Withdrawal by Subject|2|||
33660745|NCT01747499|63088599|FG000|Overall Study|Steroid refractory aGvHD|1|||
33660746|NCT01747499|63088600|FG001|Overall Study|Steroid refractory aGvHD|0|||
33660747|NCT01747499|63088601|FG002|Overall Study|Steroid refractory aGvHD|0|||
33660748|NCT01747499|63088602|FG003|Overall Study|Steroid refractory aGvHD|1|||
33660749|NCT01747499|63088603|FG004|Overall Study|Steroid refractory aGvHD|4|||
33660750|NCT01747499|63088599|FG000|Overall Study|Physician Decision|0|||
33660751|NCT01747499|63088600|FG001|Overall Study|Physician Decision|1|||
33660752|NCT01747499|63088601|FG002|Overall Study|Physician Decision|0|||
33660753|NCT01747499|63088602|FG003|Overall Study|Physician Decision|0|||
33660754|NCT01747499|63088603|FG004|Overall Study|Physician Decision|2|||
33660755|NCT01747499|63088599|FG000|Overall Study|Death|0|||
33554376|NCT01358825|62947156|FG001|Overall Study|Blood sample not drawn|1|||
33554377|NCT02453386|62947165|FG000|Overall Study|Adverse Event|22|||
33554378|NCT02453386|62947166|FG001|Overall Study|Adverse Event|30|||
33554379|NCT02453386|62947167|FG002|Overall Study|Adverse Event|15|||
33554380|NCT02453386|62947165|FG000|Overall Study|Protocol Violation|1|||
33554381|NCT02453386|62947166|FG001|Overall Study|Protocol Violation|0|||
33554382|NCT02453386|62947167|FG002|Overall Study|Protocol Violation|1|||
33554383|NCT02453386|62947165|FG000|Overall Study|Withdrawal by Subject|10|||
33554384|NCT02453386|62947166|FG001|Overall Study|Withdrawal by Subject|9|||
33554385|NCT02453386|62947167|FG002|Overall Study|Withdrawal by Subject|9|||
33554386|NCT02453386|62947165|FG000|Overall Study|Sponsor Terminated Study|14|||
33554387|NCT02453386|62947166|FG001|Overall Study|Sponsor Terminated Study|8|||
33554388|NCT02453386|62947167|FG002|Overall Study|Sponsor Terminated Study|11|||
33554389|NCT02453386|62947165|FG000|Overall Study|Subject Terminated by Sponsor|1|||
33554390|NCT02453386|62947166|FG001|Overall Study|Subject Terminated by Sponsor|1|||
33554391|NCT02453386|62947167|FG002|Overall Study|Subject Terminated by Sponsor|1|||
33554392|NCT02453386|62947165|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
33554393|NCT02453386|62947166|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
33554394|NCT02453386|62947167|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
33554395|NCT02453386|62947165|FG000|Overall Study|Lost to Follow-up|0|||
33554396|NCT02453386|62947166|FG001|Overall Study|Lost to Follow-up|0|||
33554397|NCT02453386|62947167|FG002|Overall Study|Lost to Follow-up|1|||
33554398|NCT02453386|62947165|FG000|Overall Study|Other|1|||
33554399|NCT02453386|62947166|FG001|Overall Study|Other|0|||
33554400|NCT02453386|62947167|FG002|Overall Study|Other|1|||
33554401|NCT02431468|62947185|FG000|Overall Study|Adverse Event|2|||
33554402|NCT02431468|62947186|FG001|Overall Study|Adverse Event|4|||
33660756|NCT01747499|63088600|FG001|Overall Study|Death|0|||
33660757|NCT01747499|63088601|FG002|Overall Study|Death|0|||
33660758|NCT01747499|63088602|FG003|Overall Study|Death|1|||
33660759|NCT01747499|63088603|FG004|Overall Study|Death|1|||
33660760|NCT01747499|63088599|FG000|Overall Study|Withdrawal by Subject|0|||
33660761|NCT01747499|63088600|FG001|Overall Study|Withdrawal by Subject|0|||
33660762|NCT01747499|63088601|FG002|Overall Study|Withdrawal by Subject|0|||
33554403|NCT02431468|62947187|FG002|Overall Study|Adverse Event|5|||
33554404|NCT02431468|62947185|FG000|Overall Study|Withdrawal by Subject|4|||
33554405|NCT02431468|62947186|FG001|Overall Study|Withdrawal by Subject|12|||
33554406|NCT02431468|62947187|FG002|Overall Study|Withdrawal by Subject|2|||
33554407|NCT02431468|62947185|FG000|Overall Study|noncompliance, investigator termination,|2|||
33554408|NCT02431468|62947186|FG001|Overall Study|noncompliance, investigator termination,|2|||
33554409|NCT02431468|62947187|FG002|Overall Study|noncompliance, investigator termination,|2|||
33483182|NCT03346070|62860032|FG001|Overall Study|Study medication not received as planned|3|||
33483183|NCT03346070|62860033|FG002|Overall Study|Study medication not received as planned|2|||
33483184|NCT03346070|62860034|FG003|Overall Study|Study medication not received as planned|3|||
33483185|NCT03346070|62860035|FG004|Overall Study|Study medication not received as planned|2|||
33483186|NCT03346070|62860031|FG000|Overall Study|Screen Failure|0|||
33483187|NCT03346070|62860032|FG001|Overall Study|Screen Failure|0|||
33483188|NCT03346070|62860033|FG002|Overall Study|Screen Failure|0|||
33483189|NCT03346070|62860034|FG003|Overall Study|Screen Failure|1|||
33483190|NCT03346070|62860035|FG004|Overall Study|Screen Failure|1|||
33483191|NCT02951780|62860058|FG000|Period 1|Adverse Event|0|||
33483192|NCT02951780|62860059|FG001|Period 1|Adverse Event|0|||
33554410|NCT02452762|62947203|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
33554411|NCT02452762|62947204|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
33554412|NCT02452762|62947203|FG000|Overall Study|Withdrawal by Subject|1|||
33554413|NCT02452762|62947204|FG001|Overall Study|Withdrawal by Subject|0|||
33554414|NCT02631746|62947211|FG000|Overall Study|Lack of Efficacy|3|||
33554415|NCT02633306|62947215|FG000|Overall Study|Withdrawal by Subject|3|||
33554416|NCT02396758|62947224|FG000|Overall Study|Withdrawal by Subject|2|||
33554417|NCT02396758|62947225|FG001|Overall Study|Withdrawal by Subject|0|||
33554418|NCT02396758|62947226|FG002|Overall Study|Withdrawal by Subject|0|||
33554419|NCT02396758|62947227|FG003|Overall Study|Withdrawal by Subject|1|||
33554420|NCT02396758|62947224|FG000|Overall Study|Lost to Follow-up|8|||
33554421|NCT02396758|62947225|FG001|Overall Study|Lost to Follow-up|5|||
33554422|NCT02396758|62947226|FG002|Overall Study|Lost to Follow-up|3|||
33554423|NCT02396758|62947227|FG003|Overall Study|Lost to Follow-up|3|||
33554424|NCT02396758|62947224|FG000|Overall Study|Death|1|||
33554425|NCT02396758|62947225|FG001|Overall Study|Death|1|||
33554426|NCT02396758|62947226|FG002|Overall Study|Death|0|||
33554427|NCT02396758|62947227|FG003|Overall Study|Death|1|||
33554428|NCT02396758|62947224|FG000|Overall Study|Randomized but not treated|1|||
33554429|NCT02396758|62947225|FG001|Overall Study|Randomized but not treated|0|||
33554430|NCT02396758|62947226|FG002|Overall Study|Randomized but not treated|1|||
33554431|NCT02396758|62947227|FG003|Overall Study|Randomized but not treated|0|||
33554432|NCT02632838|62947239|FG000|Overall Study|Withdrawal by Subject|3|||
33554433|NCT02632838|62947240|FG001|Overall Study|Withdrawal by Subject|0|||
33554434|NCT02632838|62947239|FG000|Overall Study|Lost to Follow-up|0|||
33554435|NCT02632838|62947240|FG001|Overall Study|Lost to Follow-up|2|||
33554436|NCT02396212|62947250|FG000|Overall Study|Adverse Event|1|||
33554437|NCT02396212|62947250|FG000|Overall Study|Lack of Efficacy|2|||
33554438|NCT02395822|62947254|FG000|Overall Study|Withdrawal by Subject|1|||
33554439|NCT02395822|62947254|FG000|Overall Study|Death|1|||
33554440|NCT01651936|62947260|FG000|Base Study|Adverse Event|3|||
33483193|NCT02951780|62860060|FG002|Period 1|Adverse Event|0|||
33483194|NCT02951780|62860061|FG003|Period 1|Adverse Event|1|||
33483195|NCT02951780|62860062|FG004|Period 1|Adverse Event|0|||
33483196|NCT02951780|62860063|FG005|Period 1|Adverse Event|0|||
33483197|NCT02951780|62860064|FG006|Period 1|Adverse Event|0|||
33554441|NCT01651936|62947261|FG001|Base Study|Adverse Event|0|||
33554442|NCT01651936|62947262|FG002|Base Study|Adverse Event|0|||
33483198|NCT02951780|62860065|FG007|Period 1|Adverse Event|0|||
33483199|NCT02951780|62860066|FG008|Period 1|Adverse Event|0|||
33483200|NCT02951780|62860058|FG000|Period 1|Scheduling Conflicts|0|||
33554443|NCT01651936|62947260|FG000|Base Study|Withdrawal by Subject|1|||
33554444|NCT01651936|62947261|FG001|Base Study|Withdrawal by Subject|1|||
33483201|NCT02951780|62860059|FG001|Period 1|Scheduling Conflicts|0|||
33483202|NCT02951780|62860060|FG002|Period 1|Scheduling Conflicts|0|||
33483203|NCT02951780|62860061|FG003|Period 1|Scheduling Conflicts|0|||
33554445|NCT01651936|62947262|FG002|Base Study|Withdrawal by Subject|0|||
33554446|NCT01651936|62947260|FG000|Base Study|Early Escape|2|||
33554447|NCT01651936|62947261|FG001|Base Study|Early Escape|8|||
33483204|NCT02951780|62860062|FG004|Period 1|Scheduling Conflicts|0|||
33483205|NCT02951780|62860063|FG005|Period 1|Scheduling Conflicts|0|||
33554448|NCT01651936|62947262|FG002|Base Study|Early Escape|0|||
33554449|NCT01651936|62947260|FG000|Base Study|Study terminated by sponsor|21|||
33554450|NCT01651936|62947261|FG001|Base Study|Study terminated by sponsor|16|||
33554451|NCT01651936|62947262|FG002|Base Study|Study terminated by sponsor|0|||
33554452|NCT01651936|62947260|FG000|Extension Study|Lack of Efficacy|0|||
33554453|NCT01651936|62947261|FG001|Extension Study|Lack of Efficacy|0|||
33554454|NCT01651936|62947262|FG002|Extension Study|Lack of Efficacy|1|||
33554455|NCT01651936|62947260|FG000|Extension Study|Study terminated by sponsor|0|||
33554456|NCT01651936|62947261|FG001|Extension Study|Study terminated by sponsor|0|||
33554457|NCT01651936|62947262|FG002|Extension Study|Study terminated by sponsor|13|||
33554458|NCT02395042|62947272|FG000|Treatment 1 Period|Adverse Event|1|||
33365039|NCT00580840|62743613|FG003|Run-in|Lack of Efficacy|0|||
33365040|NCT00580840|62743610|FG000|Run-in|Loss of Efficacy|1|||
33365041|NCT00580840|62743611|FG001|Run-in|Loss of Efficacy|0|||
33365042|NCT00580840|62743612|FG002|Run-in|Loss of Efficacy|0|||
33365043|NCT00580840|62743613|FG003|Run-in|Loss of Efficacy|0|||
33365044|NCT00580840|62743610|FG000|Run-in|Lost to Follow-up|4|||
33365045|NCT00580840|62743611|FG001|Run-in|Lost to Follow-up|0|||
33365046|NCT00580840|62743612|FG002|Run-in|Lost to Follow-up|0|||
33365047|NCT00580840|62743613|FG003|Run-in|Lost to Follow-up|0|||
33365048|NCT00580840|62743610|FG000|Run-in|Withdrawal by Subject|5|||
33365049|NCT00580840|62743611|FG001|Run-in|Withdrawal by Subject|0|||
33365050|NCT00580840|62743612|FG002|Run-in|Withdrawal by Subject|0|||
33365051|NCT00580840|62743613|FG003|Run-in|Withdrawal by Subject|0|||
33365052|NCT00580840|62743610|FG000|Run-in|Other: Per Sponsor Request|2|||
33365053|NCT00580840|62743611|FG001|Run-in|Other: Per Sponsor Request|0|||
33483206|NCT02951780|62860064|FG006|Period 1|Scheduling Conflicts|0|||
33483207|NCT02951780|62860065|FG007|Period 1|Scheduling Conflicts|1|||
33483208|NCT02951780|62860066|FG008|Period 1|Scheduling Conflicts|0|||
33483209|NCT02951780|62860058|FG000|Period 2|Scheduling Conflicts|0|||
33483210|NCT02951780|62860059|FG001|Period 2|Scheduling Conflicts|0|||
33483211|NCT02951780|62860060|FG002|Period 2|Scheduling Conflicts|0|||
33483212|NCT02951780|62860061|FG003|Period 2|Scheduling Conflicts|0|||
33483213|NCT02951780|62860062|FG004|Period 2|Scheduling Conflicts|0|||
33483214|NCT02951780|62860063|FG005|Period 2|Scheduling Conflicts|0|||
33483215|NCT02951780|62860064|FG006|Period 2|Scheduling Conflicts|0|||
33483216|NCT02951780|62860065|FG007|Period 2|Scheduling Conflicts|1|||
33483217|NCT02951780|62860066|FG008|Period 2|Scheduling Conflicts|0|||
33483218|NCT03334214|62860088|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
33483219|NCT03334214|62860089|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
33483220|NCT03334214|62860088|FG000|Overall Study|Withdrawal by Subject|0|||
33483221|NCT03334214|62860089|FG001|Overall Study|Withdrawal by Subject|1|||
33483222|NCT03334214|62860088|FG000|Overall Study|Other|1|||
33483223|NCT03334214|62860089|FG001|Overall Study|Other|0|||
33483224|NCT02250664|62860099|FG000|Overall Study|Lost to Follow-up|18|||
33483225|NCT02250664|62860100|FG001|Overall Study|Lost to Follow-up|28|||
33483226|NCT02250664|62860101|FG002|Overall Study|Lost to Follow-up|33|||
33483227|NCT02250664|62860099|FG000|Overall Study|Personal Reasons|7|||
33483228|NCT02250664|62860100|FG001|Overall Study|Personal Reasons|8|||
33483229|NCT02250664|62860101|FG002|Overall Study|Personal Reasons|14|||
33483230|NCT02250664|62860099|FG000|Overall Study|Adverse Event|6|||
33483231|NCT02250664|62860100|FG001|Overall Study|Adverse Event|3|||
33483232|NCT02250664|62860101|FG002|Overall Study|Adverse Event|8|||
33483233|NCT02250664|62860099|FG000|Overall Study|Incarcerated|2|||
33483234|NCT02250664|62860100|FG001|Overall Study|Incarcerated|1|||
33483235|NCT02250664|62860101|FG002|Overall Study|Incarcerated|2|||
33483236|NCT02250664|62860099|FG000|Overall Study|Withdrawal by Subject|0|||
33483237|NCT02250664|62860100|FG001|Overall Study|Withdrawal by Subject|1|||
33483238|NCT02250664|62860101|FG002|Overall Study|Withdrawal by Subject|2|||
33483239|NCT02250664|62860099|FG000|Overall Study|Death|0|||
33483240|NCT02250664|62860100|FG001|Overall Study|Death|1|||
33483241|NCT02250664|62860101|FG002|Overall Study|Death|1|||
33365054|NCT00580840|62743612|FG002|Run-in|Other: Per Sponsor Request|0|||
33365055|NCT00580840|62743613|FG003|Run-in|Other: Per Sponsor Request|0|||
33365056|NCT00580840|62743610|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
33365057|NCT00580840|62743611|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
33365058|NCT00580840|62743612|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
33365059|NCT00580840|62743613|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
33365060|NCT00580840|62743610|FG000|Run-in|Other: Exclusionary Lab Value|1|||
33365061|NCT00580840|62743611|FG001|Run-in|Other: Exclusionary Lab Value|0|||
33483242|NCT02250664|62860099|FG000|Overall Study|Physician Decision|1|||
33483243|NCT02250664|62860100|FG001|Overall Study|Physician Decision|3|||
33554459|NCT02395042|62947273|FG001|Treatment 1 Period|Adverse Event|3|||
33483244|NCT02250664|62860101|FG002|Overall Study|Physician Decision|1|||
33483245|NCT02250664|62860099|FG000|Overall Study|Protocol Violation|1|||
33483246|NCT02250664|62860100|FG001|Overall Study|Protocol Violation|0|||
33554460|NCT02395042|62947274|FG002|Treatment 1 Period|Adverse Event|1|||
33554461|NCT02395042|62947272|FG000|Treatment 1 Period|Lack of Efficacy|1|||
33554462|NCT02395042|62947273|FG001|Treatment 1 Period|Lack of Efficacy|1|||
33554463|NCT02395042|62947274|FG002|Treatment 1 Period|Lack of Efficacy|0|||
33554464|NCT02395042|62947272|FG000|Treatment 1 Period|Lost to Follow-up|1|||
33554465|NCT02395042|62947273|FG001|Treatment 1 Period|Lost to Follow-up|0|||
33554466|NCT02395042|62947274|FG002|Treatment 1 Period|Lost to Follow-up|0|||
33554467|NCT02395042|62947272|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
33554468|NCT02395042|62947273|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
33554469|NCT02395042|62947274|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
33483247|NCT02250664|62860101|FG002|Overall Study|Protocol Violation|1|||
33483248|NCT02250664|62860099|FG000|Overall Study|Reason unknown|1|||
33483249|NCT02250664|62860100|FG001|Overall Study|Reason unknown|0|||
33483250|NCT02250664|62860101|FG002|Overall Study|Reason unknown|0|||
33483251|NCT02646982|62860111|FG000|Overall Study|Adverse Event|1|||
33483252|NCT02646982|62860112|FG001|Overall Study|Adverse Event|1|||
33483253|NCT02646982|62860111|FG000|Overall Study|Withdrawal by Subject|2|||
33483254|NCT02646982|62860112|FG001|Overall Study|Withdrawal by Subject|1|||
33483255|NCT02845336|62860120|FG000|Overall Study|Lost to Follow-up|3|||
33483256|NCT02845336|62860121|FG001|Overall Study|Lost to Follow-up|1|||
33483257|NCT02845336|62860120|FG000|Overall Study|Inability to get medication|2|||
33483258|NCT02845336|62860121|FG001|Overall Study|Inability to get medication|0|||
33483259|NCT02844946|62860129|FG000|Overall Study|Lost to Follow-up|7|||
33483260|NCT02844946|62860130|FG001|Overall Study|Lost to Follow-up|0|||
33483261|NCT02951156|62860139|FG000|Overall Study|Death|3|||
33483262|NCT02951156|62860140|FG001|Overall Study|Death|8|||
33483263|NCT02951156|62860141|FG002|Overall Study|Death|5|||
33483264|NCT02951156|62860139|FG000|Overall Study|Progressive disease|1|||
33483265|NCT02951156|62860140|FG001|Overall Study|Progressive disease|0|||
33483266|NCT02951156|62860141|FG002|Overall Study|Progressive disease|1|||
33483267|NCT02951156|62860139|FG000|Overall Study|Withdrawal by Subject|0|||
33483268|NCT02951156|62860140|FG001|Overall Study|Withdrawal by Subject|0|||
33483269|NCT02951156|62860141|FG002|Overall Study|Withdrawal by Subject|1|||
33483270|NCT02951156|62860139|FG000|Overall Study|Study terminated by sponsor|0|||
33554470|NCT02395042|62947272|FG000|Treatment 2 Period|Lack of Efficacy|1|||
33554471|NCT02395042|62947273|FG001|Treatment 2 Period|Lack of Efficacy|1|||
33483271|NCT02951156|62860140|FG001|Overall Study|Study terminated by sponsor|0|||
33483272|NCT02951156|62860141|FG002|Overall Study|Study terminated by sponsor|1|||
33483273|NCT02951156|62860139|FG000|Overall Study|Other|5|||
33483274|NCT02951156|62860140|FG001|Overall Study|Other|1|||
33554472|NCT02395042|62947274|FG002|Treatment 2 Period|Lack of Efficacy|0|||
33554473|NCT02394808|62947285|FG000|Period 1|Unsatisfactory lens fitting|0|||
33554474|NCT02394808|62947286|FG001|Period 1|Unsatisfactory lens fitting|1|||
33554475|NCT02394808|62947285|FG000|Period 2|Lost to Follow-up|1|||
33554476|NCT02394808|62947286|FG001|Period 2|Lost to Follow-up|0|||
33365062|NCT00580840|62743612|FG002|Run-in|Other: Exclusionary Lab Value|0|||
33365063|NCT00580840|62743613|FG003|Run-in|Other: Exclusionary Lab Value|0|||
33365064|NCT00580840|62743610|FG000|Double-Blind|Adverse Event|0|||
33365065|NCT00580840|62743611|FG001|Double-Blind|Adverse Event|3|||
33365066|NCT00580840|62743612|FG002|Double-Blind|Adverse Event|4|||
33365067|NCT00580840|62743613|FG003|Double-Blind|Adverse Event|1|||
33554477|NCT02630966|62947294|FG000|Overall Study|Adverse Event|1|||
33554478|NCT02630966|62947295|FG001|Overall Study|Adverse Event|3|||
33554479|NCT02630966|62947294|FG000|Overall Study|Significant Protocol Deviation|0|||
33365068|NCT00580840|62743610|FG000|Double-Blind|Loss of Efficacy|0|||
33365069|NCT00580840|62743611|FG001|Double-Blind|Loss of Efficacy|1|||
33365070|NCT00580840|62743612|FG002|Double-Blind|Loss of Efficacy|2|||
33483275|NCT02951156|62860141|FG002|Overall Study|Other|2|||
33483276|NCT03345914|62860153|FG000|Overall Study|Transition to another study at week 16|80|||
33483277|NCT03345914|62860154|FG001|Overall Study|Transition to another study at week 16|86|||
33483278|NCT03345914|62860155|FG002|Overall Study|Transition to another study at week 16|78|||
33483279|NCT03345914|62860153|FG000|Overall Study|Transition to OLE during follow-up|37|||
33483280|NCT03345914|62860154|FG001|Overall Study|Transition to OLE during follow-up|33|||
33554480|NCT02630966|62947295|FG001|Overall Study|Significant Protocol Deviation|2|||
33554481|NCT02630966|62947294|FG000|Overall Study|Voluntary Withdrawal|1|||
33554482|NCT02630966|62947295|FG001|Overall Study|Voluntary Withdrawal|1|||
33554483|NCT02630966|62947294|FG000|Overall Study|Lack of Efficacy|0|||
33554484|NCT02630966|62947295|FG001|Overall Study|Lack of Efficacy|2|||
33554485|NCT01651780|62947303|FG000|Overall Study|Physician decision: No 30-day visit|2|||
33554486|NCT01651780|62947304|FG001|Overall Study|Physician decision: No 30-day visit|1|||
33554487|NCT01651780|62947303|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
33554488|NCT01651780|62947304|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
33554489|NCT01651780|62947303|FG000|Overall Study|Withdrawal by Subject|2|||
33554490|NCT01651780|62947304|FG001|Overall Study|Withdrawal by Subject|0|||
33554491|NCT01651780|62947303|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
33554492|NCT01651780|62947304|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33554493|NCT01651780|62947303|FG000|Overall Study|Lost to Follow-up|1|||
33554494|NCT01651780|62947304|FG001|Overall Study|Lost to Follow-up|2|||
33554495|NCT01651780|62947303|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
33554496|NCT01651780|62947304|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
33554497|NCT02394730|62947316|FG000|Overall Study|Lost to Follow-up|1|||
33554498|NCT02394730|62947317|FG001|Overall Study|Lost to Follow-up|0|||
33483281|NCT03345914|62860155|FG002|Overall Study|Transition to OLE during follow-up|39|||
33483282|NCT03345914|62860153|FG000|Overall Study|Physician Decision|0|||
33483283|NCT03345914|62860154|FG001|Overall Study|Physician Decision|1|||
33483284|NCT03345914|62860155|FG002|Overall Study|Physician Decision|1|||
33483285|NCT03345914|62860153|FG000|Overall Study|Withdrawal by Subject|5|||
33483286|NCT03345914|62860154|FG001|Overall Study|Withdrawal by Subject|1|||
33483287|NCT03345914|62860155|FG002|Overall Study|Withdrawal by Subject|2|||
33483288|NCT03345914|62860153|FG000|Overall Study|Other|1|||
33483289|NCT03345914|62860154|FG001|Overall Study|Other|1|||
33483290|NCT03345914|62860155|FG002|Overall Study|Other|1|||
33483291|NCT03345914|62860153|FG000|Overall Study|Ongoing|0|||
33483292|NCT03345914|62860154|FG001|Overall Study|Ongoing|0|||
33483293|NCT03345914|62860155|FG002|Overall Study|Ongoing|1|||
33483294|NCT03369704|62860165|FG000|Treatment Epoch|technical problems|1|||
33483295|NCT03369704|62860166|FG001|Treatment Epoch|technical problems|0|||
33483296|NCT03369704|62860165|FG000|Treatment Epoch|Protocol Violation|1|||
33483297|NCT03369704|62860166|FG001|Treatment Epoch|Protocol Violation|0|||
33483298|NCT03369704|62860165|FG000|Treatment Epoch|Lost to Follow-up|0|||
33483299|NCT03369704|62860166|FG001|Treatment Epoch|Lost to Follow-up|1|||
33483300|NCT03369704|62860165|FG000|Treatment Epoch|Lack of Efficacy|0|||
33483301|NCT03369704|62860166|FG001|Treatment Epoch|Lack of Efficacy|2|||
33483302|NCT03369704|62860165|FG000|Treatment Epoch|Adverse Event|2|||
33483303|NCT03369704|62860166|FG001|Treatment Epoch|Adverse Event|0|||
33483304|NCT03369704|62860165|FG000|Follow-up Epoch|Lost to Follow-up|1|||
33483305|NCT03369704|62860166|FG001|Follow-up Epoch|Lost to Follow-up|0|||
33483306|NCT03366428|62860172|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
33483307|NCT03366428|62860172|FG000|Overall Study|Adverse Event|12|||
33483308|NCT03366428|62860172|FG000|Overall Study|Clinical progression|2|||
33554499|NCT02394730|62947316|FG000|Overall Study|Withdrawal by Subject|0|||
33483309|NCT03366428|62860172|FG000|Overall Study|Withdrawal by Subject|4|||
33483310|NCT02839876|62860180|FG000|Overall Study|Protocol Violation|10|||
33483311|NCT02839876|62860181|FG001|Overall Study|Protocol Violation|11|||
33483312|NCT03366194|62860187|FG000|Overall Study|Lost to Follow-up|2|||
33660763|NCT01747499|63088602|FG003|Overall Study|Withdrawal by Subject|0|||
33660764|NCT01747499|63088603|FG004|Overall Study|Withdrawal by Subject|6|||
33660765|NCT01747499|63088599|FG000|Overall Study|Developed AML and death|0|||
33660766|NCT01747499|63088600|FG001|Overall Study|Developed AML and death|0|||
33660767|NCT01747499|63088601|FG002|Overall Study|Developed AML and death|0|||
33483313|NCT02839798|62860192|FG000|Overall Study|Withdrawal by Subject|2|||
33483314|NCT03345836|62860199|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
33483315|NCT03345836|62860200|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
33483316|NCT03345836|62860201|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
33483317|NCT03345836|62860202|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
33483318|NCT03345836|62860203|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
33483319|NCT03345836|62860204|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
33483320|NCT03345836|62860199|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
33483321|NCT03345836|62860200|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
33483322|NCT03345836|62860201|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
33483323|NCT03345836|62860202|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
33483324|NCT03345836|62860203|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
33483325|NCT03345836|62860204|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
33483326|NCT03345836|62860199|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
33483327|NCT03345836|62860200|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
33483328|NCT03345836|62860201|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
33483329|NCT03345836|62860202|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
33483330|NCT03345836|62860203|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
33483331|NCT03345836|62860204|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
33483332|NCT03345836|62860199|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
33483333|NCT03345836|62860200|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
33483334|NCT03345836|62860201|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
33483335|NCT03345836|62860202|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
33483336|NCT03345836|62860203|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
33483337|NCT03345836|62860204|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
33483338|NCT03345836|62860199|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
33483339|NCT03345836|62860200|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
33483340|NCT03345836|62860201|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
33483341|NCT03345836|62860202|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
33483342|NCT03345836|62860203|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
33483343|NCT03345836|62860204|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
33483344|NCT03345836|62860199|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
33483345|NCT03345836|62860200|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
33483346|NCT03345836|62860201|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
33483347|NCT03345836|62860202|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
33483348|NCT03345836|62860203|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
33483349|NCT03345836|62860204|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
33483350|NCT03345836|62860199|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
33483351|NCT03345836|62860200|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
33483352|NCT03345836|62860201|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
33483353|NCT03345836|62860202|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
33483354|NCT03345836|62860203|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
33483355|NCT03345836|62860204|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
33483356|NCT03345836|62860199|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
33483357|NCT03345836|62860200|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
33483358|NCT03345836|62860201|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
33660768|NCT01747499|63088602|FG003|Overall Study|Developed AML and death|0|||
33483359|NCT03345836|62860202|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
33483360|NCT03345836|62860203|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
33660769|NCT01747499|63088603|FG004|Overall Study|Developed AML and death|1|||
33660770|NCT01747499|63088599|FG000|Overall Study|Determined not to be eligible|0|||
33660771|NCT01747499|63088600|FG001|Overall Study|Determined not to be eligible|0|||
33660772|NCT01747499|63088601|FG002|Overall Study|Determined not to be eligible|0|||
33660773|NCT01747499|63088602|FG003|Overall Study|Determined not to be eligible|0|||
33660774|NCT01747499|63088603|FG004|Overall Study|Determined not to be eligible|1|||
33660775|NCT01717391|63088635|FG000|Overall Study|Withdrawal by Subject|5|||
33660776|NCT01717391|63088635|FG000|Overall Study|Physician Decision|1|||
33660777|NCT01717391|63088635|FG000|Overall Study|FLT technical failure|3|||
33660778|NCT01746017|63088778|FG000|Period 1|Withdrawal by Subject|0|||
33660779|NCT01746017|63088779|FG001|Period 1|Withdrawal by Subject|0|||
33660780|NCT01746017|63088780|FG002|Period 1|Withdrawal by Subject|0|||
33660781|NCT01746017|63088781|FG003|Period 1|Withdrawal by Subject|0|||
33660782|NCT01746017|63088782|FG004|Period 1|Withdrawal by Subject|0|||
33660783|NCT01746017|63088783|FG005|Period 1|Withdrawal by Subject|0|||
33483361|NCT03345836|62860204|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
33483362|NCT03345836|62860199|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
33483363|NCT03345836|62860200|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
33554500|NCT02394730|62947317|FG001|Overall Study|Withdrawal by Subject|1|||
33554501|NCT02430532|62947325|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
33660784|NCT01746017|63088784|FG006|Period 1|Withdrawal by Subject|1|||
33660785|NCT01746017|63088785|FG007|Period 1|Withdrawal by Subject|0|||
33660786|NCT01746017|63088786|FG008|Period 1|Withdrawal by Subject|0|||
33660787|NCT01746017|63088787|FG009|Period 1|Withdrawal by Subject|0|||
33660788|NCT01746017|63088788|FG010|Period 1|Withdrawal by Subject|0|||
33660789|NCT01746017|63088778|FG000|Period 3|Withdrawal by Subject|0|||
33660790|NCT01746017|63088779|FG001|Period 3|Withdrawal by Subject|0|||
33660791|NCT01746017|63088780|FG002|Period 3|Withdrawal by Subject|0|||
33660792|NCT01746017|63088781|FG003|Period 3|Withdrawal by Subject|0|||
33660793|NCT01746017|63088782|FG004|Period 3|Withdrawal by Subject|0|||
33660794|NCT01746017|63088783|FG005|Period 3|Withdrawal by Subject|1|||
33660795|NCT01746017|63088784|FG006|Period 3|Withdrawal by Subject|0|||
33660796|NCT01746017|63088785|FG007|Period 3|Withdrawal by Subject|0|||
33660797|NCT01746017|63088786|FG008|Period 3|Withdrawal by Subject|0|||
33660798|NCT01746017|63088787|FG009|Period 3|Withdrawal by Subject|0|||
33660799|NCT01746017|63088788|FG010|Period 3|Withdrawal by Subject|0|||
33660800|NCT01717313|63088850|FG000|Phase A (Weeks 0 to 24)|Death|0|||
33660801|NCT01717313|63088851|FG001|Phase A (Weeks 0 to 24)|Death|1|||
33365071|NCT00580840|62743613|FG003|Double-Blind|Loss of Efficacy|10|||
33483364|NCT03345836|62860201|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
33483365|NCT03345836|62860202|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
33483366|NCT03345836|62860203|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
33483367|NCT03345836|62860204|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
33554502|NCT02430532|62947326|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
33554503|NCT02430532|62947325|FG000|Overall Study|Consent Withdrawn|0|||
33554504|NCT02430532|62947326|FG001|Overall Study|Consent Withdrawn|2|||
33554505|NCT02430532|62947325|FG000|Overall Study|Adverse Event|0|||
33554506|NCT02430532|62947326|FG001|Overall Study|Adverse Event|1|||
33554507|NCT02394340|62947334|FG000|Overall Study|Failed drug screen test|1|||
33554508|NCT02394340|62947334|FG000|Overall Study|Adverse Event|1|||
33660802|NCT01717313|63088850|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
33660803|NCT01717313|63088851|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
33660804|NCT01717313|63088850|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
33660805|NCT01717313|63088851|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
33660806|NCT01717313|63088850|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
33660807|NCT01717313|63088851|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
33660808|NCT01717313|63088850|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
33660809|NCT01717313|63088851|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
33554509|NCT01672736|62947338|FG000|Overall Study|Available drug expired on 31 May 16|3|||
33660810|NCT01717313|63088850|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
33660811|NCT01717313|63088851|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
33660812|NCT01717313|63088850|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
33660813|NCT01717313|63088851|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
33660814|NCT01717313|63088850|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
33660815|NCT01717313|63088851|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
33660816|NCT01717313|63088850|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
33660817|NCT01717313|63088851|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
33660818|NCT01745393|63088863|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
33660819|NCT01745393|63088864|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
33660820|NCT01745393|63088863|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
33660821|NCT01745393|63088864|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
33660822|NCT01745393|63088863|FG000|12-month Follow-up|Lost to Follow-up|6|||
33483368|NCT03345836|62860199|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
33483369|NCT03345836|62860200|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
33483370|NCT03345836|62860201|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
33483371|NCT03345836|62860202|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
33483372|NCT03345836|62860203|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
33483373|NCT03345836|62860204|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
33483374|NCT03345836|62860199|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
33483375|NCT03345836|62860200|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
33483376|NCT03345836|62860201|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
33483377|NCT03345836|62860202|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
33483378|NCT03345836|62860203|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
33483379|NCT03345836|62860204|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
33483380|NCT02839330|62860224|FG000|Overall Study|Adverse Event|0|||
33483381|NCT02839330|62860225|FG001|Overall Study|Adverse Event|1|||
33483382|NCT02839330|62860226|FG002|Overall Study|Adverse Event|2|||
33483383|NCT02839330|62860227|FG003|Overall Study|Adverse Event|2|||
33483384|NCT02839330|62860224|FG000|Overall Study|Death|4|||
33483385|NCT02839330|62860225|FG001|Overall Study|Death|6|||
33483386|NCT02839330|62860226|FG002|Overall Study|Death|1|||
33483387|NCT02839330|62860227|FG003|Overall Study|Death|1|||
33483388|NCT02839330|62860224|FG000|Overall Study|Withdrawal by Subject|27|||
33554510|NCT01560637|62947342|FG000|Overall Study|Adverse Event|63|||
33554511|NCT01560637|62947342|FG000|Overall Study|Death|69|||
33554512|NCT01560637|62947342|FG000|Overall Study|Lost to Follow-up|8|||
33554513|NCT01560637|62947342|FG000|Overall Study|Protocol Violation|8|||
33554514|NCT01560637|62947342|FG000|Overall Study|Withdrawal by Subject|24|||
33554515|NCT01560637|62947342|FG000|Overall Study|Progressive Disease|20|||
33554516|NCT01560637|62947342|FG000|Overall Study|Other Reason Not Specified|6|||
33554517|NCT01353911|62947354|FG000|Overall Study|Lost to Follow-up|2|||
33554518|NCT01353911|62947355|FG001|Overall Study|Lost to Follow-up|6|||
33554519|NCT01353911|62947356|FG002|Overall Study|Lost to Follow-up|4|||
33554520|NCT01353911|62947357|FG003|Overall Study|Lost to Follow-up|0|||
33554521|NCT01353911|62947358|FG004|Overall Study|Lost to Follow-up|4|||
33554522|NCT01353911|62947359|FG005|Overall Study|Lost to Follow-up|4|||
33554523|NCT01353911|62947360|FG006|Overall Study|Lost to Follow-up|3|||
33554524|NCT01353911|62947361|FG007|Overall Study|Lost to Follow-up|6|||
33554525|NCT01353911|62947354|FG000|Overall Study|Withdrawal by Subject|2|||
33483389|NCT02839330|62860225|FG001|Overall Study|Withdrawal by Subject|19|||
33483390|NCT02839330|62860226|FG002|Overall Study|Withdrawal by Subject|11|||
33483391|NCT02839330|62860227|FG003|Overall Study|Withdrawal by Subject|13|||
33483392|NCT02839330|62860224|FG000|Overall Study|Lost to Follow-up|22|||
33483393|NCT02839330|62860225|FG001|Overall Study|Lost to Follow-up|27|||
33483394|NCT02839330|62860226|FG002|Overall Study|Lost to Follow-up|29|||
33483395|NCT02839330|62860227|FG003|Overall Study|Lost to Follow-up|25|||
33483396|NCT02839330|62860224|FG000|Overall Study|Administrative Reason|0|||
33483397|NCT02839330|62860225|FG001|Overall Study|Administrative Reason|0|||
33554526|NCT01353911|62947355|FG001|Overall Study|Withdrawal by Subject|3|||
33554527|NCT01353911|62947356|FG002|Overall Study|Withdrawal by Subject|4|||
33554528|NCT01353911|62947357|FG003|Overall Study|Withdrawal by Subject|2|||
33554529|NCT01353911|62947358|FG004|Overall Study|Withdrawal by Subject|2|||
33660823|NCT01745393|63088864|FG001|12-month Follow-up|Lost to Follow-up|5|||
33660824|NCT01744691|63088895|FG000|Overall Study|Progressive Disease|18|||
33483398|NCT02839330|62860226|FG002|Overall Study|Administrative Reason|0|||
33554530|NCT01353911|62947359|FG005|Overall Study|Withdrawal by Subject|3|||
33483399|NCT02839330|62860227|FG003|Overall Study|Administrative Reason|1|||
33554531|NCT01353911|62947360|FG006|Overall Study|Withdrawal by Subject|3|||
33554532|NCT01353911|62947361|FG007|Overall Study|Withdrawal by Subject|9|||
33660825|NCT01744691|63088895|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
33554533|NCT01353911|62947354|FG000|Overall Study|Status Not Recorded|4|||
33554534|NCT01353911|62947355|FG001|Overall Study|Status Not Recorded|0|||
33554535|NCT01353911|62947356|FG002|Overall Study|Status Not Recorded|1|||
33554536|NCT01353911|62947357|FG003|Overall Study|Status Not Recorded|0|||
33554537|NCT01353911|62947358|FG004|Overall Study|Status Not Recorded|0|||
33554538|NCT01353911|62947359|FG005|Overall Study|Status Not Recorded|0|||
33554539|NCT01353911|62947360|FG006|Overall Study|Status Not Recorded|0|||
33554540|NCT01353911|62947361|FG007|Overall Study|Status Not Recorded|0|||
33554541|NCT01671488|62947379|FG000|Overall Study|Withdrawal by Subject|1|||
33554542|NCT02783911|62947385|FG000|Overall Study|Lost to Follow-up|3|||
33554543|NCT02783911|62947386|FG001|Overall Study|Lost to Follow-up|32|||
33554544|NCT01358357|62947394|FG000|Open Label Phase|Adverse Event|0|||
33554545|NCT01358357|62947395|FG001|Open Label Phase|Adverse Event|0|||
33554546|NCT01358357|62947396|FG002|Open Label Phase|Adverse Event|59|||
33554547|NCT01358357|62947394|FG000|Open Label Phase|Lack of Efficacy|0|||
33554548|NCT01358357|62947395|FG001|Open Label Phase|Lack of Efficacy|0|||
33554549|NCT01358357|62947396|FG002|Open Label Phase|Lack of Efficacy|107|||
33554550|NCT01358357|62947394|FG000|Open Label Phase|Lost to Follow-up|0|||
33554551|NCT01358357|62947395|FG001|Open Label Phase|Lost to Follow-up|0|||
33554552|NCT01358357|62947396|FG002|Open Label Phase|Lost to Follow-up|76|||
33660826|NCT01744691|63088895|FG000|Overall Study|Withdrawal of consent for treatment|3|||
33660827|NCT01744691|63088895|FG000|Overall Study|Physician Decision|4|||
33660828|NCT01716533|63088930|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
33660829|NCT01716533|63088931|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
33660830|NCT01716533|63088932|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
33660831|NCT01716533|63088933|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
33554553|NCT01358357|62947394|FG000|Open Label Phase|Protocol Violation|0|||
33554554|NCT01358357|62947395|FG001|Open Label Phase|Protocol Violation|0|||
33554555|NCT01358357|62947396|FG002|Open Label Phase|Protocol Violation|45|||
33660832|NCT01716533|63088930|FG000|Overall Study|Withdrawal by Subject|0|||
33660833|NCT01716533|63088931|FG001|Overall Study|Withdrawal by Subject|0|||
33660834|NCT01716533|63088932|FG002|Overall Study|Withdrawal by Subject|0|||
33660835|NCT01716533|63088933|FG003|Overall Study|Withdrawal by Subject|5|||
33660836|NCT01716533|63088930|FG000|Overall Study|Death|0|||
33660837|NCT01716533|63088931|FG001|Overall Study|Death|0|||
33660838|NCT01716533|63088932|FG002|Overall Study|Death|0|||
33660839|NCT01716533|63088933|FG003|Overall Study|Death|2|||
33660840|NCT01716533|63088930|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
33660841|NCT01716533|63088931|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
33660842|NCT01716533|63088932|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
33660843|NCT01716533|63088933|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
33660844|NCT01375374|63088947|FG000|Overall Study|Adverse Event|1|||
33660845|NCT01743989|63089545|FG000|Treatment Phase|Unstable MR4.0|0|||
33660846|NCT01743989|63089546|FG001|Treatment Phase|Unstable MR4.0|6|||
33660847|NCT01743989|63089547|FG002|Treatment Phase|Unstable MR4.0|263|||
33660848|NCT01743989|63089545|FG000|Treatment Phase|Adverse Event|0|||
33660849|NCT01743989|63089546|FG001|Treatment Phase|Adverse Event|4|||
33660850|NCT01743989|63089547|FG002|Treatment Phase|Adverse Event|67|||
33660851|NCT01743989|63089545|FG000|Treatment Phase|Withdrawal by Subject|1|||
33660852|NCT01743989|63089546|FG001|Treatment Phase|Withdrawal by Subject|3|||
33660853|NCT01743989|63089547|FG002|Treatment Phase|Withdrawal by Subject|28|||
33660854|NCT01743989|63089545|FG000|Treatment Phase|Death|0|||
33660855|NCT01743989|63089546|FG001|Treatment Phase|Death|1|||
33660856|NCT01743989|63089547|FG002|Treatment Phase|Death|3|||
33660857|NCT01743989|63089545|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
33660858|NCT01743989|63089546|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
33660859|NCT01743989|63089547|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
33660860|NCT01743989|63089545|FG000|Treatment Phase|Protocol deviation|0|||
33660861|NCT01743989|63089546|FG001|Treatment Phase|Protocol deviation|0|||
33660862|NCT01743989|63089547|FG002|Treatment Phase|Protocol deviation|3|||
33660863|NCT01743989|63089545|FG000|Treatment Phase|Pregnancy|0|||
33660864|NCT01743989|63089546|FG001|Treatment Phase|Pregnancy|0|||
33554556|NCT01358357|62947394|FG000|Open Label Phase|Withdrawal by Subject|0|||
33554557|NCT01358357|62947395|FG001|Open Label Phase|Withdrawal by Subject|0|||
33554558|NCT01358357|62947396|FG002|Open Label Phase|Withdrawal by Subject|112|||
33554559|NCT01358357|62947394|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
33554560|NCT01358357|62947395|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
33554561|NCT01358357|62947396|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
33660865|NCT01743989|63089547|FG002|Treatment Phase|Pregnancy|2|||
33660866|NCT01743989|63089545|FG000|Treatment Phase|Lost to Follow-up|0|||
33660867|NCT01743989|63089546|FG001|Treatment Phase|Lost to Follow-up|0|||
33660868|NCT01743989|63089547|FG002|Treatment Phase|Lost to Follow-up|2|||
33660869|NCT01743989|63089545|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
33660870|NCT01743989|63089546|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
33660871|NCT01743989|63089547|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
33660872|NCT01743989|63089545|FG000|Treatment Phase|Administrative problems|0|||
33660873|NCT01743989|63089546|FG001|Treatment Phase|Administrative problems|0|||
33660874|NCT01743989|63089547|FG002|Treatment Phase|Administrative problems|1|||
33660875|NCT01743989|63089545|FG000|Treatment Phase|New cancer (CML) therapy|0|||
33660876|NCT01743989|63089546|FG001|Treatment Phase|New cancer (CML) therapy|1|||
33660877|NCT01743989|63089547|FG002|Treatment Phase|New cancer (CML) therapy|0|||
33660878|NCT01743989|63089545|FG000|Treatment Phase|Physician Decision|0|||
33660879|NCT01743989|63089546|FG001|Treatment Phase|Physician Decision|0|||
33660880|NCT01743989|63089547|FG002|Treatment Phase|Physician Decision|3|||
33660881|NCT01743989|63089545|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
33660882|NCT01743989|63089546|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
33660883|NCT01743989|63089547|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
33660884|NCT01743989|63089545|FG000|Treatment Phase|Not randomized by mistake|0|||
33660885|NCT01743989|63089546|FG001|Treatment Phase|Not randomized by mistake|0|||
33660886|NCT01743989|63089547|FG002|Treatment Phase|Not randomized by mistake|1|||
33660887|NCT01743989|63089545|FG000|Treatment Phase|Included by mistake|0|||
33660888|NCT01743989|63089546|FG001|Treatment Phase|Included by mistake|0|||
33660889|NCT01743989|63089547|FG002|Treatment Phase|Included by mistake|1|||
33483400|NCT02839330|62860224|FG000|Overall Study|Protocol Violation|1|||
33483401|NCT02839330|62860225|FG001|Overall Study|Protocol Violation|2|||
33483402|NCT02839330|62860226|FG002|Overall Study|Protocol Violation|2|||
33483403|NCT02839330|62860227|FG003|Overall Study|Protocol Violation|3|||
33483404|NCT02839330|62860224|FG000|Overall Study|Other reason, not specified|4|||
33483405|NCT02839330|62860225|FG001|Overall Study|Other reason, not specified|3|||
33483406|NCT02839330|62860226|FG002|Overall Study|Other reason, not specified|3|||
33483407|NCT02839330|62860227|FG003|Overall Study|Other reason, not specified|6|||
33483408|NCT03363776|62860241|FG000|Overall Study|Progressive disease|2|||
33483409|NCT03363776|62860242|FG001|Overall Study|Progressive disease|3|||
33483410|NCT03363776|62860243|FG002|Overall Study|Progressive disease|1|||
33483411|NCT03363776|62860241|FG000|Overall Study|Study drug toxicity|0|||
33483412|NCT03363776|62860242|FG001|Overall Study|Study drug toxicity|0|||
33554562|NCT01358357|62947394|FG000|Open Label Phase|Terminated at study completion|0|||
33554563|NCT01358357|62947395|FG001|Open Label Phase|Terminated at study completion|0|||
33554564|NCT01358357|62947396|FG002|Open Label Phase|Terminated at study completion|5|||
33554565|NCT01358357|62947394|FG000|Open Label Phase|Mood episode|0|||
33554566|NCT01358357|62947395|FG001|Open Label Phase|Mood episode|0|||
33554567|NCT01358357|62947396|FG002|Open Label Phase|Mood episode|42|||
33554568|NCT01358357|62947394|FG000|Double-Blind Phase|Adverse Event|8|||
33554569|NCT01358357|62947395|FG001|Double-Blind Phase|Adverse Event|5|||
33554570|NCT01358357|62947396|FG002|Double-Blind Phase|Adverse Event|0|||
33554571|NCT01358357|62947394|FG000|Double-Blind Phase|Lost to Follow-up|5|||
33554572|NCT01358357|62947395|FG001|Double-Blind Phase|Lost to Follow-up|7|||
33554573|NCT01358357|62947396|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33554574|NCT01358357|62947394|FG000|Double-Blind Phase|Protocol Violation|1|||
33554575|NCT01358357|62947395|FG001|Double-Blind Phase|Protocol Violation|11|||
33554576|NCT01358357|62947396|FG002|Double-Blind Phase|Protocol Violation|0|||
33554577|NCT01358357|62947394|FG000|Double-Blind Phase|Protocol Violation|16|||
33554578|NCT01358357|62947395|FG001|Double-Blind Phase|Protocol Violation|12|||
33660890|NCT01743989|63089545|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
33483413|NCT03363776|62860243|FG002|Overall Study|Study drug toxicity|1|||
33483414|NCT03363776|62860241|FG000|Overall Study|Death|1|||
33483415|NCT03363776|62860242|FG001|Overall Study|Death|0|||
33483416|NCT03363776|62860243|FG002|Overall Study|Death|0|||
33483417|NCT03360344|62860254|FG000|Overall Study|Withdrawal by Subject|0|||
33483418|NCT03360344|62860255|FG001|Overall Study|Withdrawal by Subject|1|||
33483419|NCT03360344|62860256|FG002|Overall Study|Withdrawal by Subject|1|||
33483420|NCT02838628|62860266|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
33554579|NCT01358357|62947396|FG002|Double-Blind Phase|Protocol Violation|0|||
33554580|NCT01358357|62947394|FG000|Double-Blind Phase|Terminated at study completion|2|||
33483421|NCT02838628|62860267|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
33483422|NCT02838628|62860266|FG000|Recurrence Follow-up Period|Adverse Event|1|||
33483423|NCT02838628|62860267|FG001|Recurrence Follow-up Period|Adverse Event|0|||
33483424|NCT02838628|62860266|FG000|Recurrence Follow-up Period|Non-compliance|0|||
33483425|NCT02838628|62860267|FG001|Recurrence Follow-up Period|Non-compliance|1|||
33660891|NCT01743989|63089546|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
33660892|NCT01743989|63089547|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
33660893|NCT01743989|63089545|FG000|TFR Phase|Adverse Event|0|||
33660894|NCT01743989|63089546|FG001|TFR Phase|Adverse Event|1|||
33660895|NCT01743989|63089547|FG002|TFR Phase|Adverse Event|0|||
33660896|NCT01743989|63089545|FG000|TFR Phase|Lost to Follow-up|0|||
33660897|NCT01743989|63089546|FG001|TFR Phase|Lost to Follow-up|2|||
33660898|NCT01743989|63089547|FG002|TFR Phase|Lost to Follow-up|0|||
33554581|NCT01358357|62947395|FG001|Double-Blind Phase|Terminated at study completion|0|||
33660899|NCT01743989|63089545|FG000|TFR Phase|Physician Decision|0|||
33660900|NCT01743989|63089546|FG001|TFR Phase|Physician Decision|1|||
33660901|NCT01743989|63089547|FG002|TFR Phase|Physician Decision|0|||
33660902|NCT01743989|63089545|FG000|TFR Phase|Logistical problems|0|||
33660903|NCT01743989|63089546|FG001|TFR Phase|Logistical problems|2|||
33660904|NCT01743989|63089547|FG002|TFR Phase|Logistical problems|0|||
33660905|NCT01743989|63089545|FG000|TFR Phase|Protocol deviation|0|||
33660906|NCT01743989|63089546|FG001|TFR Phase|Protocol deviation|1|||
33660907|NCT01743989|63089547|FG002|TFR Phase|Protocol deviation|0|||
33660908|NCT01743989|63089545|FG000|TFR Phase|Withdrawal by Subject|0|||
33660909|NCT01743989|63089546|FG001|TFR Phase|Withdrawal by Subject|2|||
33660910|NCT01743989|63089547|FG002|TFR Phase|Withdrawal by Subject|0|||
33660911|NCT01743989|63089545|FG000|Re-treatment Phase|Adverse Event|8|||
33660912|NCT01743989|63089546|FG001|Re-treatment Phase|Adverse Event|4|||
33660913|NCT01743989|63089547|FG002|Re-treatment Phase|Adverse Event|0|||
33660914|NCT01743989|63089545|FG000|Re-treatment Phase|Death|1|||
33554582|NCT01358357|62947396|FG002|Double-Blind Phase|Terminated at study completion|0|||
33554583|NCT01358357|62947394|FG000|Double-Blind Phase|Recurrence of mood event|48|||
33554584|NCT01358357|62947395|FG001|Double-Blind Phase|Recurrence of mood event|64|||
33554585|NCT01358357|62947396|FG002|Double-Blind Phase|Recurrence of mood event|0|||
33554586|NCT01358357|62947394|FG000|Double-Blind Phase|Administrative|0|||
33554587|NCT01358357|62947395|FG001|Double-Blind Phase|Administrative|1|||
33554588|NCT01358357|62947396|FG002|Double-Blind Phase|Administrative|0|||
33660915|NCT01743989|63089546|FG001|Re-treatment Phase|Death|1|||
33660916|NCT01743989|63089547|FG002|Re-treatment Phase|Death|0|||
33660917|NCT01743989|63089545|FG000|Re-treatment Phase|Administrative problems|1|||
33660918|NCT01743989|63089546|FG001|Re-treatment Phase|Administrative problems|1|||
33660919|NCT01743989|63089547|FG002|Re-treatment Phase|Administrative problems|0|||
33660920|NCT01743989|63089545|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
33660921|NCT01743989|63089546|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
33660922|NCT01743989|63089547|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
33660923|NCT01743989|63089545|FG000|Re-treatment Phase|Unstable MR|1|||
33660924|NCT01743989|63089546|FG001|Re-treatment Phase|Unstable MR|0|||
33660925|NCT01743989|63089547|FG002|Re-treatment Phase|Unstable MR|0|||
33660926|NCT01743989|63089545|FG000|Re-treatment Phase|Physician Decision|0|||
33660927|NCT01743989|63089546|FG001|Re-treatment Phase|Physician Decision|1|||
33660928|NCT01743989|63089547|FG002|Re-treatment Phase|Physician Decision|0|||
33660929|NCT01743989|63089545|FG000|Re-treatment Phase|Lost to Follow-up|0|||
33660930|NCT01743989|63089546|FG001|Re-treatment Phase|Lost to Follow-up|1|||
33660931|NCT01743989|63089547|FG002|Re-treatment Phase|Lost to Follow-up|0|||
33660932|NCT01605461|63089580|FG000|Overall Study|Lost to Follow-up|3|||
33660933|NCT01605461|63089580|FG000|Overall Study|Withdrawal by Subject|1|||
33660934|NCT01742897|63089584|FG000|Overall Study|Adverse Event|3|||
33660935|NCT01742897|63089584|FG000|Overall Study|Withdrawal by Subject|1|||
33660936|NCT01742897|63089584|FG000|Overall Study|Other|1|||
33660937|NCT01715831|63089588|FG000|Overall Study|Adverse Event|1|||
33660938|NCT01741259|63089594|FG000|Overall Study|Protocol Violation|6|||
33660939|NCT01741259|63089595|FG001|Overall Study|Protocol Violation|4|||
33660940|NCT01741259|63089594|FG000|Overall Study|Withdrawal by Subject|0|||
33660941|NCT01741259|63089595|FG001|Overall Study|Withdrawal by Subject|2|||
33660942|NCT01715129|63089601|FG000|Overall Study|Adverse Event, fatal|1|||
33554589|NCT02831387|62947405|FG000|Overall Study|Withdrawal by Subject|1|||
33554590|NCT02831387|62947406|FG001|Overall Study|Withdrawal by Subject|1|||
33660943|NCT01715129|63089601|FG000|Overall Study|Lack of Efficacy|3|||
33660944|NCT01715129|63089601|FG000|Overall Study|Protocol Violation|1|||
33660945|NCT01715129|63089601|FG000|Overall Study|Consent Withdrawn|2|||
33660946|NCT01715129|63089601|FG000|Overall Study|Lost to Follow-up|1|||
33660947|NCT01715129|63089601|FG000|Overall Study|Other|1|||
33660948|NCT01740791|63089694|FG000|Overall Study|Randomized but never treated|5|||
33660949|NCT01740791|63089695|FG001|Overall Study|Randomized but never treated|3|||
33660950|NCT01740791|63089696|FG002|Overall Study|Randomized but never treated|2|||
33660951|NCT01740791|63089697|FG003|Overall Study|Randomized but never treated|2|||
33660952|NCT01740791|63089698|FG004|Overall Study|Randomized but never treated|1|||
33660953|NCT01740791|63089699|FG005|Overall Study|Randomized but never treated|3|||
33554591|NCT02831387|62947405|FG000|Overall Study|Discontinued due to stock recovery|0|||
33554592|NCT02831387|62947406|FG001|Overall Study|Discontinued due to stock recovery|1|||
33554593|NCT02831855|62947412|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
33554594|NCT02831855|62947413|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
33554595|NCT02831855|62947414|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
33554596|NCT02831855|62947412|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
33554597|NCT02831855|62947413|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
33554598|NCT02831855|62947414|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
33365072|NCT00580840|62743610|FG000|Double-Blind|Lost to Follow-up|0|||
33365073|NCT00580840|62743611|FG001|Double-Blind|Lost to Follow-up|1|||
33554599|NCT02831855|62947412|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
33554600|NCT02831855|62947413|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
33554601|NCT02831855|62947414|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
33554602|NCT02831855|62947412|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
33554603|NCT02831855|62947413|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
33554604|NCT02831855|62947414|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
33554605|NCT02831855|62947412|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
33554606|NCT02831855|62947413|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
33554607|NCT02831855|62947414|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
33554608|NCT02831855|62947412|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
33554609|NCT02831855|62947413|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
33554610|NCT02831855|62947414|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
33554611|NCT02831855|62947412|FG000|Open Label Phase (24 Weeks)|Other|4|||
33554612|NCT02831855|62947413|FG001|Open Label Phase (24 Weeks)|Other|0|||
33660954|NCT01740791|63089694|FG000|Overall Study|Lost to Follow-up|2|||
33660955|NCT01740791|63089695|FG001|Overall Study|Lost to Follow-up|0|||
33660956|NCT01740791|63089696|FG002|Overall Study|Lost to Follow-up|2|||
33660957|NCT01740791|63089697|FG003|Overall Study|Lost to Follow-up|3|||
33660958|NCT01740791|63089698|FG004|Overall Study|Lost to Follow-up|2|||
33660959|NCT01740791|63089699|FG005|Overall Study|Lost to Follow-up|3|||
33660960|NCT01740791|63089694|FG000|Overall Study|Withdrew Consent|4|||
33660961|NCT01740791|63089695|FG001|Overall Study|Withdrew Consent|0|||
33660962|NCT01740791|63089696|FG002|Overall Study|Withdrew Consent|1|||
33660963|NCT01740791|63089697|FG003|Overall Study|Withdrew Consent|2|||
33660964|NCT01740791|63089698|FG004|Overall Study|Withdrew Consent|0|||
33660965|NCT01740791|63089699|FG005|Overall Study|Withdrew Consent|3|||
33660966|NCT01740791|63089694|FG000|Overall Study|Investigator's discretion|1|||
33660967|NCT01740791|63089695|FG001|Overall Study|Investigator's discretion|0|||
33660968|NCT01740791|63089696|FG002|Overall Study|Investigator's discretion|1|||
33660969|NCT01740791|63089697|FG003|Overall Study|Investigator's discretion|0|||
33660970|NCT01740791|63089698|FG004|Overall Study|Investigator's discretion|0|||
33660971|NCT01740791|63089699|FG005|Overall Study|Investigator's discretion|1|||
33660972|NCT01740791|63089694|FG000|Overall Study|Adverse Event|0|||
33660973|NCT01740791|63089695|FG001|Overall Study|Adverse Event|0|||
33660974|NCT01740791|63089696|FG002|Overall Study|Adverse Event|0|||
33660975|NCT01740791|63089697|FG003|Overall Study|Adverse Event|0|||
33660976|NCT01740791|63089698|FG004|Overall Study|Adverse Event|0|||
33660977|NCT01740791|63089699|FG005|Overall Study|Adverse Event|1|||
33554613|NCT02831855|62947414|FG002|Open Label Phase (24 Weeks)|Other|0|||
33554614|NCT02831855|62947412|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
33660978|NCT01740323|63089756|FG000|Overall Study|Adverse Event|1|||
33660979|NCT01740323|63089757|FG001|Overall Study|Adverse Event|0|||
33660980|NCT01740323|63089756|FG000|Overall Study|Randomized but did not take study drug|1|||
33660981|NCT01740323|63089757|FG001|Overall Study|Randomized but did not take study drug|0|||
33660982|NCT01740089|63089775|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
33660983|NCT01740089|63089776|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
33660984|NCT01740089|63089777|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
33660985|NCT01740089|63089775|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
33660986|NCT01740089|63089776|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
33660987|NCT01740089|63089777|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
33660988|NCT01740089|63089775|FG000|After 12 Weeks|Lack of Efficacy|3|||
33660989|NCT01740089|63089776|FG001|After 12 Weeks|Lack of Efficacy|1|||
33660990|NCT01740089|63089777|FG002|After 12 Weeks|Lack of Efficacy|4|||
33660991|NCT01740089|63089775|FG000|After 12 Weeks|Adverse Event|2|||
33660992|NCT01740089|63089776|FG001|After 12 Weeks|Adverse Event|0|||
33660993|NCT01740089|63089777|FG002|After 12 Weeks|Adverse Event|5|||
33660994|NCT01740089|63089775|FG000|After 12 Weeks|Protocol Violation|1|||
33660995|NCT01740089|63089776|FG001|After 12 Weeks|Protocol Violation|1|||
33660996|NCT01740089|63089777|FG002|After 12 Weeks|Protocol Violation|1|||
33660997|NCT01740089|63089775|FG000|After 12 Weeks|Withdrawal by Subject|1|||
33660998|NCT01740089|63089776|FG001|After 12 Weeks|Withdrawal by Subject|1|||
33554615|NCT02831855|62947413|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
33554616|NCT02831855|62947414|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
33660999|NCT01740089|63089777|FG002|After 12 Weeks|Withdrawal by Subject|1|||
33661000|NCT01739933|63089788|FG000|Overall Study|Death|89|||
33661001|NCT01739933|63089789|FG001|Overall Study|Death|86|||
33554617|NCT02831855|62947412|FG000|Double Blind Phase (24 Weeks)|Death|0|||
33554618|NCT02831855|62947413|FG001|Double Blind Phase (24 Weeks)|Death|0|||
33554619|NCT02831855|62947414|FG002|Double Blind Phase (24 Weeks)|Death|2|||
33661002|NCT01739933|63089788|FG000|Overall Study|Withdrawal by Subject|10|||
33661003|NCT01739933|63089789|FG001|Overall Study|Withdrawal by Subject|8|||
33661004|NCT01739933|63089788|FG000|Overall Study|Lost to Follow-up|3|||
33554620|NCT02831855|62947412|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
33554621|NCT02831855|62947413|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
33554622|NCT02831855|62947414|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
33554623|NCT02831855|62947412|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
33661005|NCT01739933|63089789|FG001|Overall Study|Lost to Follow-up|10|||
33661006|NCT01739933|63089788|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
33661007|NCT01739933|63089789|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
33661008|NCT01738919|63089806|FG000|Overall Study|Lost to Follow-up|1|||
33661009|NCT01738919|63089807|FG001|Overall Study|Lost to Follow-up|0|||
33661010|NCT01738919|63089806|FG000|Overall Study|Immigrated|0|||
33661011|NCT01738919|63089807|FG001|Overall Study|Immigrated|1|||
33661012|NCT01738919|63089806|FG000|Overall Study|Withdrawal by Subject|0|||
33661013|NCT01738919|63089807|FG001|Overall Study|Withdrawal by Subject|1|||
33661014|NCT01738919|63089806|FG000|Overall Study|Not treated in accordance to guidelines|0|||
33554624|NCT02831855|62947413|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
33554625|NCT02831855|62947414|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
33554626|NCT02831855|62947412|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
33554627|NCT02831855|62947413|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
33661015|NCT01738919|63089807|FG001|Overall Study|Not treated in accordance to guidelines|1|||
33661016|NCT01712399|63089828|FG000|Overall Study|Lost to Follow-up|1|||
33661017|NCT01712399|63089828|FG000|Overall Study|Withdrawal by Subject|39|||
33661018|NCT01712399|63089828|FG000|Overall Study|Death|1|||
33483426|NCT02838628|62860266|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
33483427|NCT02838628|62860267|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
33483428|NCT02838628|62860266|FG000|Recurrence Follow-up Period|Other un-specified|1|||
33483429|NCT02838628|62860267|FG001|Recurrence Follow-up Period|Other un-specified|1|||
33483430|NCT02835820|62860276|FG000|Overall Study|Baseline Screen Failure|0|||
33483431|NCT02835820|62860277|FG001|Overall Study|Baseline Screen Failure|3|||
33483432|NCT03359174|62860283|FG000|Overall Study|Adverse Event|1|||
33483433|NCT02832622|62860287|FG000|Overall Study|MPP not programmed|1259|||
33483434|NCT02832622|62860287|FG000|Overall Study|Withdrawal by Subject|123|||
33483435|NCT02832622|62860287|FG000|Overall Study|Death|119|||
33661019|NCT01712399|63089828|FG000|Overall Study|Adverse Event|11|||
33661020|NCT01712399|63089828|FG000|Overall Study|Study closure|345|||
33661021|NCT03225846|63089935|FG000|Overall Study|Adverse Event|0|||
33554628|NCT02831855|62947414|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
33661022|NCT03225846|63089936|FG001|Overall Study|Adverse Event|0|||
33483436|NCT02832622|62860287|FG000|Overall Study|Unsuccessful CRT implant|93|||
33483437|NCT02832622|62860287|FG000|Overall Study|Lost to Follow-up|45|||
33483438|NCT02832622|62860287|FG000|Overall Study|Patient non-compliance|42|||
33483439|NCT02832622|62860287|FG000|Overall Study|Withdrawal by other reasons|25|||
33483440|NCT02832622|62860287|FG000|Overall Study|System explant|24|||
33483441|NCT02832622|62860287|FG000|Overall Study|Physician Decision|6|||
33483442|NCT00093015|62860294|FG000|Overall Study|Withdrawal by Subject|194|||
33483443|NCT00093015|62860295|FG001|Overall Study|Withdrawal by Subject|171|||
33483444|NCT00093015|62860294|FG000|Overall Study|Lost to Follow-up|96|||
33483445|NCT00093015|62860295|FG001|Overall Study|Lost to Follow-up|108|||
33483446|NCT00093015|62860294|FG000|Overall Study|Death|375|||
33483447|NCT00093015|62860295|FG001|Overall Study|Death|385|||
33661023|NCT03225846|63089937|FG002|Overall Study|Adverse Event|0|||
33661024|NCT03225846|63089938|FG003|Overall Study|Adverse Event|0|||
33661025|NCT03225846|63089939|FG004|Overall Study|Adverse Event|0|||
33661026|NCT03225846|63089940|FG005|Overall Study|Adverse Event|0|||
33661027|NCT03225846|63089941|FG006|Overall Study|Adverse Event|6|||
33661028|NCT03225846|63089935|FG000|Overall Study|Withdrawal by Subject|0|||
33661029|NCT03225846|63089936|FG001|Overall Study|Withdrawal by Subject|1|||
33661030|NCT03225846|63089937|FG002|Overall Study|Withdrawal by Subject|0|||
33661031|NCT03225846|63089938|FG003|Overall Study|Withdrawal by Subject|0|||
33483448|NCT03358238|62860303|FG000|Overall Study|Withdrawal by Subject|0|||
33483449|NCT03358238|62860304|FG001|Overall Study|Withdrawal by Subject|1|||
33483450|NCT03342638|62860316|FG000|Overall Study|Withdrawal by Subject|1|||
33483451|NCT03342638|62860317|FG001|Overall Study|Withdrawal by Subject|0|||
33554629|NCT02831855|62947412|FG000|Double Blind Phase (24 Weeks)|Other|0|||
33554630|NCT02831855|62947413|FG001|Double Blind Phase (24 Weeks)|Other|2|||
33554631|NCT02831855|62947414|FG002|Double Blind Phase (24 Weeks)|Other|5|||
33554632|NCT02831855|62947412|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
33554633|NCT02831855|62947413|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
33554634|NCT02831855|62947414|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
33554635|NCT02831855|62947412|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
33554636|NCT02831855|62947413|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
33554637|NCT02831855|62947414|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
33483452|NCT03342638|62860316|FG000|Overall Study|Physician Decision|0|||
33483453|NCT03342638|62860317|FG001|Overall Study|Physician Decision|1|||
33483454|NCT03342560|62860323|FG000|Overall Study|Lost to Follow-up|2|||
33483455|NCT03355742|62860340|FG000|Overall Study|Lost to Follow-up|4|||
33483456|NCT03355742|62860340|FG000|Overall Study|Withdrawal by Subject|29|||
33554638|NCT02831855|62947412|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
33554639|NCT02831855|62947413|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
33661032|NCT03225846|63089939|FG004|Overall Study|Withdrawal by Subject|0|||
33483457|NCT03355742|62860340|FG000|Overall Study|Physician Decision|6|||
33483458|NCT03355742|62860340|FG000|Overall Study|Death|55|||
33483459|NCT03355742|62860340|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
33483460|NCT03341312|62860344|FG000|Period 1|Withdrawal by Subject|0|||
33661033|NCT03225846|63089940|FG005|Overall Study|Withdrawal by Subject|0|||
33661034|NCT03225846|63089941|FG006|Overall Study|Withdrawal by Subject|0|||
33661035|NCT03225846|63089935|FG000|Overall Study|Death|0|||
33661036|NCT03225846|63089936|FG001|Overall Study|Death|1|||
33661037|NCT03225846|63089937|FG002|Overall Study|Death|0|||
33661038|NCT03225846|63089938|FG003|Overall Study|Death|0|||
33661039|NCT03225846|63089939|FG004|Overall Study|Death|0|||
33661040|NCT03225846|63089940|FG005|Overall Study|Death|0|||
33661041|NCT03225846|63089941|FG006|Overall Study|Death|0|||
33661042|NCT03225846|63089935|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
33661043|NCT03225846|63089936|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
33661044|NCT03225846|63089937|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
33661045|NCT03225846|63089938|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
33661046|NCT03225846|63089939|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
33661047|NCT03225846|63089940|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
33661048|NCT03225846|63089941|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
33661049|NCT03225846|63089935|FG000|Overall Study|Patient decision|0|||
33661050|NCT03225846|63089936|FG001|Overall Study|Patient decision|0|||
33661051|NCT03225846|63089937|FG002|Overall Study|Patient decision|0|||
33661052|NCT03225846|63089938|FG003|Overall Study|Patient decision|0|||
33554640|NCT02831855|62947414|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
33554641|NCT02628938|62947427|FG000|Overall Study|Did not attend the follow up recall|2|||
33554642|NCT02628938|62947428|FG001|Overall Study|Did not attend the follow up recall|2|||
33554643|NCT02628938|62947429|FG002|Overall Study|Did not attend the follow up recall|1|||
33554644|NCT02628938|62947427|FG000|Overall Study|Failure to comply with the instructions|3|||
33554645|NCT02628938|62947428|FG001|Overall Study|Failure to comply with the instructions|0|||
33554646|NCT02628938|62947429|FG002|Overall Study|Failure to comply with the instructions|3|||
33554647|NCT01356407|62947443|FG000|Overall Study|Lost to Follow-up|2|||
33554648|NCT01356407|62947444|FG001|Overall Study|Lost to Follow-up|0|||
33554649|NCT01356407|62947443|FG000|Overall Study|Patient Withdrew Consent|2|||
33554650|NCT01356407|62947444|FG001|Overall Study|Patient Withdrew Consent|1|||
33554651|NCT01356407|62947443|FG000|Overall Study|Could not afford IMP administration|0|||
33554652|NCT01356407|62947444|FG001|Overall Study|Could not afford IMP administration|1|||
33554653|NCT01356407|62947443|FG000|Overall Study|Not complete Endoscopy|2|||
33554654|NCT01356407|62947444|FG001|Overall Study|Not complete Endoscopy|2|||
33554655|NCT00109837|62947450|FG000|Overall Study|Adverse Event|2|||
33554656|NCT00109837|62947450|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
33554657|NCT00109837|62947450|FG000|Overall Study|Death|1|||
33554658|NCT00109837|62947450|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
33554659|NCT00109837|62947450|FG000|Overall Study|Not treated|1|||
33554660|NCT00109837|62947450|FG000|Overall Study|Ineligible|1|||
33661053|NCT03225846|63089939|FG004|Overall Study|Patient decision|0|||
33554661|NCT02828111|62947463|FG000|Overall Study|Withdrawal by Subject|0|||
33554662|NCT02828111|62947464|FG001|Overall Study|Withdrawal by Subject|0|||
33661054|NCT03225846|63089940|FG005|Overall Study|Patient decision|0|||
33554663|NCT02828111|62947465|FG002|Overall Study|Withdrawal by Subject|2|||
33554664|NCT02828111|62947466|FG003|Overall Study|Withdrawal by Subject|0|||
33661055|NCT03225846|63089941|FG006|Overall Study|Patient decision|1|||
33661056|NCT01712009|63090006|FG000|Overall Study|Withdrawal by Subject|24|||
33483461|NCT03341312|62860345|FG001|Period 1|Withdrawal by Subject|1|||
33483462|NCT03341312|62860346|FG002|Period 1|Withdrawal by Subject|0|||
33483463|NCT03341312|62860347|FG003|Period 1|Withdrawal by Subject|0|||
33554665|NCT02828111|62947467|FG004|Overall Study|Withdrawal by Subject|0|||
33554666|NCT02828111|62947463|FG000|Overall Study|Lost to Follow-up|0|||
33554667|NCT02828111|62947464|FG001|Overall Study|Lost to Follow-up|0|||
33554668|NCT02828111|62947465|FG002|Overall Study|Lost to Follow-up|0|||
33554669|NCT02828111|62947466|FG003|Overall Study|Lost to Follow-up|1|||
33554670|NCT02828111|62947467|FG004|Overall Study|Lost to Follow-up|1|||
33554671|NCT01671332|62947490|FG000|Overall Study|Withdrawal by Subject|1|||
33661057|NCT01712009|63090007|FG001|Overall Study|Withdrawal by Subject|15|||
33661058|NCT01712009|63090008|FG002|Overall Study|Withdrawal by Subject|8|||
33661059|NCT01712009|63090006|FG000|Overall Study|Lost to Follow-up|2|||
33661060|NCT01712009|63090007|FG001|Overall Study|Lost to Follow-up|0|||
33661061|NCT01712009|63090008|FG002|Overall Study|Lost to Follow-up|1|||
33661062|NCT01712009|63090006|FG000|Overall Study|Decision by Sponsor|12|||
33661063|NCT01712009|63090007|FG001|Overall Study|Decision by Sponsor|14|||
33661064|NCT01712009|63090008|FG002|Overall Study|Decision by Sponsor|12|||
33661065|NCT01711853|63090037|FG000|Overall Study|Not treated|3|||
33661066|NCT01708187|63090043|FG000|Overall Study|Lost to Follow-up|0|||
33661067|NCT01708187|63090044|FG001|Overall Study|Lost to Follow-up|1|||
33661068|NCT01740401|63090120|FG000|Overall Study|Progression of disease|6|||
33661069|NCT01740401|63090120|FG000|Overall Study|Adverse Event|2|||
33661070|NCT01740401|63090120|FG000|Overall Study|Did not reach primary endpoint|2|||
33661071|NCT01711619|63090141|FG000|Overall Study|Early study termination|10|||
33661072|NCT01711619|63090142|FG001|Overall Study|Early study termination|14|||
33661073|NCT01711619|63090141|FG000|Overall Study|Withdrawal by Subject|3|||
33661074|NCT01711619|63090142|FG001|Overall Study|Withdrawal by Subject|7|||
33661075|NCT01711619|63090141|FG000|Overall Study|Protocol Violation|2|||
33661076|NCT01711619|63090142|FG001|Overall Study|Protocol Violation|3|||
33661077|NCT01711619|63090141|FG000|Overall Study|Adverse Event|2|||
33661078|NCT01711619|63090142|FG001|Overall Study|Adverse Event|0|||
33661079|NCT01711619|63090141|FG000|Overall Study|Lost to Follow-up|1|||
33661080|NCT01711619|63090142|FG001|Overall Study|Lost to Follow-up|0|||
33661081|NCT01710527|63090157|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
33661082|NCT01710527|63090158|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
33661083|NCT01706939|63090166|FG000|Pre Randomization|Screen Failure|1|||
33661084|NCT01706939|63090167|FG001|Pre Randomization|Screen Failure|0|||
33661085|NCT01706939|63090168|FG002|Pre Randomization|Screen Failure|0|||
33661086|NCT01706939|63090166|FG000|Pre Randomization|Ineligible for Randomization|1|||
33661087|NCT01706939|63090167|FG001|Pre Randomization|Ineligible for Randomization|0|||
33661088|NCT01706939|63090168|FG002|Pre Randomization|Ineligible for Randomization|0|||
33661089|NCT01706939|63090166|FG000|Pre Randomization|Withdrawal by Subject|1|||
33661090|NCT01706939|63090167|FG001|Pre Randomization|Withdrawal by Subject|0|||
33483464|NCT02949908|62860359|FG000|Overall Study|Study termination|2|||
33483465|NCT01358734|62860366|FG000|Overall Study|Adverse Event|4|||
33483466|NCT01358734|62860367|FG001|Overall Study|Adverse Event|7|||
33483467|NCT01358734|62860368|FG002|Overall Study|Adverse Event|3|||
33483468|NCT01358734|62860366|FG000|Overall Study|Lack of Efficacy|0|||
33483469|NCT01358734|62860367|FG001|Overall Study|Lack of Efficacy|1|||
33483470|NCT01358734|62860368|FG002|Overall Study|Lack of Efficacy|3|||
33483471|NCT01358734|62860366|FG000|Overall Study|Withdrawal by Subject|1|||
33483472|NCT01358734|62860367|FG001|Overall Study|Withdrawal by Subject|6|||
33483473|NCT01358734|62860368|FG002|Overall Study|Withdrawal by Subject|3|||
33661091|NCT01706939|63090168|FG002|Pre Randomization|Withdrawal by Subject|0|||
33661092|NCT01706939|63090166|FG000|Randomization|Insufficient QoL survey compliance|0|||
33661093|NCT01706939|63090167|FG001|Randomization|Insufficient QoL survey compliance|1|||
33661094|NCT01706939|63090168|FG002|Randomization|Insufficient QoL survey compliance|1|||
33483474|NCT01358734|62860366|FG000|Overall Study|Death|3|||
33483475|NCT01358734|62860367|FG001|Overall Study|Death|7|||
33483476|NCT01358734|62860368|FG002|Overall Study|Death|2|||
33661095|NCT01706939|63090166|FG000|Randomization|Progression of disease|0|||
33661096|NCT01706939|63090167|FG001|Randomization|Progression of disease|2|||
33661097|NCT01706939|63090168|FG002|Randomization|Progression of disease|1|||
33661098|NCT01709903|63090177|FG000|Overall Study|administrative problems|2|||
33661099|NCT01709903|63090178|FG001|Overall Study|administrative problems|6|||
33483477|NCT01358734|62860366|FG000|Overall Study|Progressive Disease|5|||
33483478|NCT01358734|62860367|FG001|Overall Study|Progressive Disease|13|||
33365074|NCT00580840|62743612|FG002|Double-Blind|Lost to Follow-up|0|||
33365075|NCT00580840|62743613|FG003|Double-Blind|Lost to Follow-up|2|||
33365076|NCT00580840|62743610|FG000|Double-Blind|Withdrawal by Subject|0|||
33365077|NCT00580840|62743611|FG001|Double-Blind|Withdrawal by Subject|1|||
33483479|NCT01358734|62860368|FG002|Overall Study|Progressive Disease|16|||
33483480|NCT01358734|62860366|FG000|Overall Study|Non-compliance with study drug|0|||
33483481|NCT01358734|62860367|FG001|Overall Study|Non-compliance with study drug|0|||
33554672|NCT01671332|62947491|FG001|Overall Study|Withdrawal by Subject|1|||
33554673|NCT01355627|62947499|FG000|Overall Study|Request By the Patient to Discontinue|5|||
33554674|NCT01355627|62947500|FG001|Overall Study|Request By the Patient to Discontinue|7|||
33554675|NCT01355627|62947499|FG000|Overall Study|Lost to Follow-up|8|||
33554676|NCT01355627|62947500|FG001|Overall Study|Lost to Follow-up|7|||
33554677|NCT01355627|62947499|FG000|Overall Study|Fatal Adverse Event|19|||
33554678|NCT01355627|62947500|FG001|Overall Study|Fatal Adverse Event|23|||
33554679|NCT01355627|62947499|FG000|Overall Study|Other|1|||
33554680|NCT01355627|62947500|FG001|Overall Study|Other|1|||
33554681|NCT00100802|62947506|FG000|Overall Study|Adverse Event|9|||
33554682|NCT00100802|62947506|FG000|Overall Study|Death|1|||
33554683|NCT00100802|62947506|FG000|Overall Study|Lack of Efficacy|47|||
33554684|NCT00100802|62947506|FG000|Overall Study|Physician Decision|5|||
33554685|NCT00100802|62947506|FG000|Overall Study|Protocol Violation|1|||
33554686|NCT00100802|62947506|FG000|Overall Study|Withdrawal by Subject|5|||
33554687|NCT00100802|62947506|FG000|Overall Study|Ineligible|12|||
33554688|NCT01355159|62947512|FG000|Overall Study|Withdrew consent|39|||
33554689|NCT01355159|62947513|FG001|Overall Study|Withdrew consent|47|||
33554690|NCT01355159|62947512|FG000|Overall Study|No primary outcome data|17|||
33554691|NCT01355159|62947513|FG001|Overall Study|No primary outcome data|11|||
33554692|NCT01355159|62947512|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
33554693|NCT01355159|62947513|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
33554694|NCT01355159|62947512|FG000|Overall Study|Early intrauterine fetal death|6|||
33554695|NCT01355159|62947513|FG001|Overall Study|Early intrauterine fetal death|6|||
33554696|NCT02630186|62947519|FG000|Overall Study|Withdrawal by Subject|1|||
33554697|NCT01669928|62947525|FG000|First Intervention|Withdrawal by Subject|3|||
33554698|NCT01669928|62947526|FG001|First Intervention|Withdrawal by Subject|5|||
33554699|NCT01355081|62947537|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
33554700|NCT01355081|62947538|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
33554701|NCT01355081|62947539|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
33554702|NCT01355081|62947537|FG000|Overall Study|Major Protocol Deviation|0|||
33554703|NCT01355081|62947538|FG001|Overall Study|Major Protocol Deviation|1|||
33554704|NCT01355081|62947539|FG002|Overall Study|Major Protocol Deviation|0|||
33554705|NCT01355081|62947537|FG000|Overall Study|Lost to Follow-up|0|||
33554706|NCT01355081|62947538|FG001|Overall Study|Lost to Follow-up|0|||
33554707|NCT01355081|62947539|FG002|Overall Study|Lost to Follow-up|1|||
33554708|NCT01355081|62947537|FG000|Overall Study|Withdrawal of Consent|2|||
33554709|NCT01355081|62947538|FG001|Overall Study|Withdrawal of Consent|3|||
33554710|NCT01355081|62947539|FG002|Overall Study|Withdrawal of Consent|3|||
33483482|NCT01358734|62860368|FG002|Overall Study|Non-compliance with study drug|1|||
33483483|NCT01358734|62860366|FG000|Overall Study|Other|2|||
33483484|NCT01358734|62860367|FG001|Overall Study|Other|5|||
33483485|NCT01358734|62860368|FG002|Overall Study|Other|4|||
33483486|NCT01358734|62860366|FG000|Overall Study|Protocol Violation|0|||
33483487|NCT01358734|62860367|FG001|Overall Study|Protocol Violation|0|||
33554711|NCT01355081|62947537|FG000|Overall Study|Lack of Efficacy|2|||
33554712|NCT01355081|62947538|FG001|Overall Study|Lack of Efficacy|1|||
33554713|NCT01355081|62947539|FG002|Overall Study|Lack of Efficacy|1|||
33554714|NCT01355081|62947537|FG000|Overall Study|Non Compliance with Study Medication|0|||
33554715|NCT01355081|62947538|FG001|Overall Study|Non Compliance with Study Medication|1|||
33554716|NCT01355081|62947539|FG002|Overall Study|Non Compliance with Study Medication|0|||
33554717|NCT01354223|62947549|FG000|Overall Study|Withdrawal by Subject|3|||
33554718|NCT01354223|62947550|FG001|Overall Study|Withdrawal by Subject|1|||
33554719|NCT04043455|62947560|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
33554720|NCT04043455|62947561|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
33554721|NCT04043455|62947562|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
33554722|NCT04043455|62947563|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
33661100|NCT01709903|63090177|FG000|Overall Study|Abnormal test procedure results|1|||
33661101|NCT01709903|63090178|FG001|Overall Study|Abnormal test procedure results|0|||
33554723|NCT04043455|62947564|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
33554724|NCT04043455|62947565|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
33554725|NCT04043455|62947560|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
33554726|NCT04043455|62947561|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
33365078|NCT00580840|62743612|FG002|Double-Blind|Withdrawal by Subject|2|||
33483488|NCT01358734|62860368|FG002|Overall Study|Protocol Violation|2|||
33483489|NCT01341652|62860378|FG000|Overall Study|Incorrect Random Assignment|0|||
33483490|NCT01341652|62860379|FG001|Overall Study|Incorrect Random Assignment|1|||
33365079|NCT00580840|62743613|FG003|Double-Blind|Withdrawal by Subject|2|||
33554727|NCT04043455|62947562|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
33554728|NCT04043455|62947563|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
33554729|NCT04043455|62947564|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
33554730|NCT04043455|62947565|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
33554731|NCT04043455|62947560|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
33554732|NCT04043455|62947561|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
33554733|NCT04043455|62947562|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
33554734|NCT04043455|62947563|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
33554735|NCT04043455|62947564|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
33554736|NCT04043455|62947565|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
33554737|NCT04043455|62947560|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
33554738|NCT04043455|62947561|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
33554739|NCT04043455|62947562|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
33365080|NCT00580840|62743610|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
33365081|NCT00580840|62743611|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
33365082|NCT00580840|62743612|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
33365083|NCT00580840|62743613|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
33365084|NCT00580840|62743610|FG000|Double-Blind|Other: Forbidden Medication|0|||
33365085|NCT00580840|62743611|FG001|Double-Blind|Other: Forbidden Medication|0|||
33554740|NCT04043455|62947563|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
33554741|NCT04043455|62947564|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
33554742|NCT04043455|62947565|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
33554743|NCT04043455|62947560|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
33554744|NCT04043455|62947561|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
33554745|NCT04043455|62947562|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
33554746|NCT04043455|62947563|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
33661102|NCT01709903|63090177|FG000|Overall Study|In ability to use device|1|||
33661103|NCT01709903|63090178|FG001|Overall Study|In ability to use device|1|||
33661104|NCT01709903|63090177|FG000|Overall Study|no longer needed study drug|0|||
33661105|NCT01709903|63090178|FG001|Overall Study|no longer needed study drug|1|||
33365086|NCT00580840|62743612|FG002|Double-Blind|Other: Forbidden Medication|1|||
33365087|NCT00580840|62743613|FG003|Double-Blind|Other: Forbidden Medication|0|||
33365088|NCT00879684|62743623|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
33365089|NCT00879684|62743624|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
33365090|NCT00879684|62743625|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
33365091|NCT00879684|62743626|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
33365092|NCT00879684|62743627|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
33365093|NCT00879684|62743628|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
33365094|NCT00879684|62743629|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
33483491|NCT01341652|62860378|FG000|Overall Study|ineligible; presence metastatic disease|0|||
33483492|NCT01341652|62860379|FG001|Overall Study|ineligible; presence metastatic disease|1|||
33483493|NCT02828644|62860387|FG000|Overall Study|Lost to Follow-up|23|||
33483494|NCT02828644|62860388|FG001|Overall Study|Lost to Follow-up|22|||
33483495|NCT02949362|62860397|FG000|Retrospective Period|Inform consent not signed by participant|4|||
33483496|NCT02949362|62860398|FG001|Retrospective Period|Inform consent not signed by participant|1|||
33483497|NCT02949362|62860399|FG002|Retrospective Period|Inform consent not signed by participant|0|||
33483498|NCT02949362|62860400|FG003|Retrospective Period|Inform consent not signed by participant|0|||
33661106|NCT01709903|63090177|FG000|Overall Study|Lost to Follow-up|0|||
33661107|NCT01709903|63090178|FG001|Overall Study|Lost to Follow-up|2|||
33661108|NCT01709903|63090177|FG000|Overall Study|Death|2|||
33661109|NCT01709903|63090178|FG001|Overall Study|Death|0|||
33661110|NCT01709903|63090177|FG000|Overall Study|Protocol Violation|3|||
33661111|NCT01709903|63090178|FG001|Overall Study|Protocol Violation|2|||
33483499|NCT02949362|62860397|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
33483500|NCT02949362|62860398|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
33483501|NCT02949362|62860399|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
33483502|NCT02949362|62860400|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
33483503|NCT02949362|62860397|FG000|Prospective Period|Other|0|||
33483504|NCT02949362|62860398|FG001|Prospective Period|Other|0|||
33483505|NCT02949362|62860399|FG002|Prospective Period|Other|0|||
33483506|NCT02949362|62860400|FG003|Prospective Period|Other|4|||
33483507|NCT02947022|62860412|FG000|Overall Study|Study Stopped|1|||
33483508|NCT03338972|62860423|FG000|Overall Study|Death|1|||
33483509|NCT03338972|62860424|FG001|Overall Study|Death|1|||
33483510|NCT03338972|62860425|FG002|Overall Study|Death|0|||
33483511|NCT03338972|62860426|FG003|Overall Study|Death|0|||
33483512|NCT03338972|62860423|FG000|Overall Study|Withdrawal by Subject|1|||
33483513|NCT03338972|62860424|FG001|Overall Study|Withdrawal by Subject|0|||
33554747|NCT04043455|62947564|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
33554748|NCT04043455|62947565|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
33554749|NCT04043455|62947560|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
33554750|NCT04043455|62947561|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
33554751|NCT04043455|62947562|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
33554752|NCT04043455|62947563|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
33554753|NCT04043455|62947564|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
33554754|NCT04043455|62947565|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
33554755|NCT04043455|62947560|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
33554756|NCT04043455|62947561|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
33554757|NCT04043455|62947562|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
33554758|NCT04043455|62947563|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
33554759|NCT04043455|62947564|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
33554760|NCT04043455|62947565|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
33554761|NCT04043455|62947560|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
33554762|NCT04043455|62947561|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
33554763|NCT04043455|62947562|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
33554764|NCT04043455|62947563|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
33554765|NCT04043455|62947564|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
33554766|NCT04043455|62947565|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
33554767|NCT04043455|62947560|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
33554768|NCT04043455|62947561|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
33554769|NCT04043455|62947562|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
33554770|NCT04043455|62947563|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
33554771|NCT04043455|62947564|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
33554772|NCT04043455|62947565|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
33554773|NCT04043455|62947560|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
33661112|NCT01709903|63090177|FG000|Overall Study|Lack of Efficacy|3|||
33661113|NCT01709903|63090178|FG001|Overall Study|Lack of Efficacy|3|||
33661114|NCT01709903|63090177|FG000|Overall Study|Withdrawal by Subject|6|||
33661115|NCT01709903|63090178|FG001|Overall Study|Withdrawal by Subject|6|||
33661116|NCT01709903|63090177|FG000|Overall Study|Adverse Event|11|||
33661117|NCT01709903|63090178|FG001|Overall Study|Adverse Event|18|||
33661118|NCT04492618|63090184|FG000|Overall Study|Withdrawal by Subject|1|||
33661119|NCT01605227|63090190|FG000|Overall Study|Did not receive study treatment|2|||
33661120|NCT01605227|63090191|FG001|Overall Study|Did not receive study treatment|3|||
33661121|NCT01605227|63090190|FG000|Overall Study|Adverse Event|228|||
33661122|NCT01605227|63090191|FG001|Overall Study|Adverse Event|42|||
33661123|NCT01605227|63090190|FG000|Overall Study|Progressive Disease|132|||
33365095|NCT00879684|62743623|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
33483514|NCT03338972|62860425|FG002|Overall Study|Withdrawal by Subject|0|||
33483515|NCT03338972|62860426|FG003|Overall Study|Withdrawal by Subject|0|||
33483516|NCT03338816|62860442|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
33483517|NCT03338816|62860443|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
33483518|NCT03338816|62860444|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
33483519|NCT03338816|62860445|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
33483520|NCT03338816|62860442|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
33483521|NCT03338816|62860443|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
33483522|NCT03338816|62860444|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
33483523|NCT03338816|62860445|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
33483524|NCT03338816|62860442|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
33483525|NCT03338816|62860443|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
33483526|NCT03338816|62860444|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
33483527|NCT03338816|62860445|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
33483528|NCT03338816|62860442|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
33483529|NCT03338816|62860443|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
33483530|NCT03338816|62860444|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
33483531|NCT03338816|62860445|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
33483532|NCT03338816|62860442|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
33483533|NCT03338816|62860443|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
33483534|NCT03338816|62860444|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
33483535|NCT03338816|62860445|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
33483536|NCT03338816|62860442|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
33483537|NCT03338816|62860443|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
33483538|NCT03338816|62860444|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
33483539|NCT03338816|62860445|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
33483540|NCT03338816|62860442|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
33483541|NCT03338816|62860443|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
33483542|NCT03338816|62860444|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
33661124|NCT01605227|63090191|FG001|Overall Study|Progressive Disease|128|||
33661125|NCT01605227|63090190|FG000|Overall Study|Clinical Deterioration|227|||
33661126|NCT01605227|63090191|FG001|Overall Study|Clinical Deterioration|133|||
33661127|NCT01605227|63090190|FG000|Overall Study|Lost to Follow-up|1|||
33661128|NCT01605227|63090191|FG001|Overall Study|Lost to Follow-up|0|||
33661129|NCT01605227|63090190|FG000|Overall Study|Protocol Violation|1|||
33661130|NCT01605227|63090191|FG001|Overall Study|Protocol Violation|0|||
33661131|NCT01605227|63090190|FG000|Overall Study|Physician Decision|9|||
33661132|NCT01605227|63090191|FG001|Overall Study|Physician Decision|7|||
33661133|NCT01605227|63090190|FG000|Overall Study|Withdrawal by Subject|18|||
33661134|NCT01605227|63090191|FG001|Overall Study|Withdrawal by Subject|14|||
33661135|NCT01605227|63090190|FG000|Overall Study|Sponsor Decision|2|||
33661136|NCT01605227|63090191|FG001|Overall Study|Sponsor Decision|0|||
33661137|NCT01605227|63090190|FG000|Overall Study|Started New Therapy|1|||
33661138|NCT01605227|63090191|FG001|Overall Study|Started New Therapy|0|||
33661139|NCT01605227|63090190|FG000|Overall Study|Subject Decision|0|||
33661140|NCT01605227|63090191|FG001|Overall Study|Subject Decision|1|||
33661141|NCT01605227|63090190|FG000|Overall Study|Dose Held >6 weeks|0|||
33661142|NCT01605227|63090191|FG001|Overall Study|Dose Held >6 weeks|1|||
33661143|NCT01709513|63090200|FG000|Overall Study|Randomized but not treated|0|||
33661144|NCT01709513|63090201|FG001|Overall Study|Randomized but not treated|1|||
33661145|NCT01709513|63090202|FG002|Overall Study|Randomized but not treated|0|||
33365096|NCT00879684|62743624|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
33483543|NCT03338816|62860445|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
33483544|NCT03337490|62860457|FG000|Overall Study|Withdrawal by Subject|1|||
33483545|NCT03337490|62860458|FG001|Overall Study|Withdrawal by Subject|0|||
33483546|NCT03337490|62860459|FG002|Overall Study|Withdrawal by Subject|0|||
33483547|NCT03337490|62860457|FG000|Overall Study|Lack of Efficacy|10|||
33483548|NCT03337490|62860458|FG001|Overall Study|Lack of Efficacy|12|||
33483549|NCT03337490|62860459|FG002|Overall Study|Lack of Efficacy|35|||
33483550|NCT03337490|62860457|FG000|Overall Study|Physician Decision|0|||
33483551|NCT03337490|62860458|FG001|Overall Study|Physician Decision|1|||
33483552|NCT03337490|62860459|FG002|Overall Study|Physician Decision|0|||
33483553|NCT03337490|62860457|FG000|Overall Study|Lost to Follow-up|0|||
33661146|NCT01709513|63090200|FG000|Overall Study|Adverse Event|16|||
33661147|NCT01709513|63090201|FG001|Overall Study|Adverse Event|31|||
33661148|NCT01709513|63090202|FG002|Overall Study|Adverse Event|23|||
33661149|NCT01709513|63090200|FG000|Overall Study|Poor compliance to protocol|2|||
33661150|NCT01709513|63090201|FG001|Overall Study|Poor compliance to protocol|0|||
33661151|NCT01709513|63090202|FG002|Overall Study|Poor compliance to protocol|0|||
33661152|NCT01709513|63090200|FG000|Overall Study|Other|3|||
33365097|NCT00879684|62743625|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
33365098|NCT00879684|62743626|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
33365099|NCT00879684|62743627|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
33365100|NCT00879684|62743628|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
33365101|NCT00879684|62743629|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
33365102|NCT00879684|62743623|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
33365103|NCT00879684|62743624|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
33365104|NCT00879684|62743625|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
33365105|NCT00879684|62743626|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
33365106|NCT00879684|62743627|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
33483554|NCT03337490|62860458|FG001|Overall Study|Lost to Follow-up|1|||
33483555|NCT03337490|62860459|FG002|Overall Study|Lost to Follow-up|0|||
33483556|NCT02944448|62860469|FG000|Overall Study|Adverse Event|37|||
33483557|NCT02944448|62860470|FG001|Overall Study|Adverse Event|6|||
33483558|NCT02944448|62860469|FG000|Overall Study|Lack of Efficacy|8|||
33483559|NCT02944448|62860470|FG001|Overall Study|Lack of Efficacy|5|||
33483560|NCT02944448|62860469|FG000|Overall Study|Lost to Follow-up|3|||
33483561|NCT02944448|62860470|FG001|Overall Study|Lost to Follow-up|1|||
33483562|NCT02944448|62860469|FG000|Overall Study|Protocol Violation|25|||
33483563|NCT02944448|62860470|FG001|Overall Study|Protocol Violation|7|||
33483564|NCT02944448|62860469|FG000|Overall Study|Withdrawal by Subject|14|||
33483565|NCT02944448|62860470|FG001|Overall Study|Withdrawal by Subject|4|||
33483566|NCT02944448|62860469|FG000|Overall Study|Sponsor did not supply drug in time|0|||
33483567|NCT02944448|62860470|FG001|Overall Study|Sponsor did not supply drug in time|1|||
33554774|NCT04043455|62947561|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
33554775|NCT04043455|62947562|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
33554776|NCT04043455|62947563|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
33554777|NCT04043455|62947564|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
33554778|NCT04043455|62947565|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
33554779|NCT04043455|62947560|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
33554780|NCT04043455|62947561|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
33554781|NCT04043455|62947562|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
33483568|NCT02944448|62860469|FG000|Overall Study|Noncompliant with dosing|1|||
33483569|NCT02944448|62860470|FG001|Overall Study|Noncompliant with dosing|0|||
33483570|NCT02944448|62860469|FG000|Overall Study|Abnormal laboratory values|1|||
33483571|NCT02944448|62860470|FG001|Overall Study|Abnormal laboratory values|0|||
33554782|NCT04043455|62947563|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
33554783|NCT04043455|62947564|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
33554784|NCT04043455|62947565|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
33554785|NCT02627144|62947583|FG000|Overall Study|Serious adverse event|32|||
33554786|NCT02627144|62947583|FG000|Overall Study|Cancer progression|171|||
33554787|NCT02627144|62947583|FG000|Overall Study|Death from cancer|20|||
33554788|NCT02627144|62947583|FG000|Overall Study|Death from other cause|8|||
33554789|NCT02627144|62947583|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
33554790|NCT02627144|62947583|FG000|Overall Study|Administrative reasons|65|||
33554791|NCT02627144|62947583|FG000|Overall Study|Lost to Follow-up|8|||
33554792|NCT02627144|62947583|FG000|Overall Study|Enrolled, not treated|6|||
33554793|NCT02627144|62947583|FG000|Overall Study|Other|17|||
33554794|NCT02626520|62947589|FG000|Overall Study|Physician Decision|1|||
33554795|NCT02626520|62947590|FG001|Overall Study|Physician Decision|1|||
33554796|NCT02626520|62947589|FG000|Overall Study|Adverse Event|0|||
33554797|NCT02626520|62947590|FG001|Overall Study|Adverse Event|4|||
33554798|NCT02626520|62947589|FG000|Overall Study|Lack of Efficacy|0|||
33554799|NCT02626520|62947590|FG001|Overall Study|Lack of Efficacy|2|||
33554800|NCT02626520|62947589|FG000|Overall Study|Did not start protocol therapy|0|||
33554801|NCT02626520|62947590|FG001|Overall Study|Did not start protocol therapy|2|||
33554802|NCT02626520|62947589|FG000|Overall Study|Study terminated|0|||
33554803|NCT02626520|62947590|FG001|Overall Study|Study terminated|1|||
33554804|NCT04522141|62947598|FG000|Overall Study|Withdrawal by Subject|1|||
33554805|NCT04522141|62947599|FG001|Overall Study|Withdrawal by Subject|0|||
33661153|NCT01709513|63090201|FG001|Overall Study|Other|11|||
33661154|NCT01709513|63090202|FG002|Overall Study|Other|7|||
33661155|NCT01605071|63090215|FG000|Overall Study|Withdrawal by Subject|3|||
33661156|NCT01605071|63090216|FG001|Overall Study|Withdrawal by Subject|2|||
33661157|NCT02710422|63090226|FG000|Overall Study|Termination of study|9|||
33661158|NCT02710422|63090227|FG001|Overall Study|Termination of study|9|||
33661159|NCT01706159|63090237|FG000|Overall Study|Withdrawal Criteria|2|||
33661160|NCT01706159|63090238|FG001|Overall Study|Withdrawal Criteria|1|||
33661161|NCT01706159|63090237|FG000|Overall Study|Unclassified|6|||
33661162|NCT01706159|63090238|FG001|Overall Study|Unclassified|1|||
33661163|NCT01706003|63090246|FG000|Overall Study|Withdrawal by Subject|2|||
33661164|NCT01706003|63090247|FG001|Overall Study|Withdrawal by Subject|0|||
33661165|NCT01706003|63090246|FG000|Overall Study|Not scheduled|3|||
33661166|NCT01706003|63090247|FG001|Overall Study|Not scheduled|0|||
33661167|NCT01706003|63090246|FG000|Overall Study|Lost to Follow-up|6|||
33483572|NCT02943668|62860477|FG000|Overall Study|Disease Progression|1|||
33483573|NCT02891408|62860512|FG000|Overall Study|Lost to Follow-up|0|||
33554806|NCT01329029|62947622|FG000|Overall Study|Withdrawal by Subject|117|||
33554807|NCT01329029|62947623|FG001|Overall Study|Withdrawal by Subject|87|||
33554808|NCT01329029|62947622|FG000|Overall Study|Adverse Event|82|||
33661168|NCT01706003|63090247|FG001|Overall Study|Lost to Follow-up|4|||
33483574|NCT02891408|62860513|FG001|Overall Study|Lost to Follow-up|0|||
33554809|NCT01329029|62947623|FG001|Overall Study|Adverse Event|29|||
33554810|NCT01329029|62947622|FG000|Overall Study|Death|16|||
33554811|NCT01329029|62947623|FG001|Overall Study|Death|19|||
33554812|NCT01329029|62947622|FG000|Overall Study|Other|14|||
33661169|NCT01705691|63090255|FG000|Overall Study|Death|1|||
33483575|NCT02891408|62860514|FG002|Overall Study|Lost to Follow-up|1|||
33483576|NCT02891408|62860515|FG003|Overall Study|Lost to Follow-up|0|||
33661170|NCT01705691|63090256|FG001|Overall Study|Death|2|||
33661171|NCT01705691|63090255|FG000|Overall Study|Withdrawal by Subject|1|||
33483577|NCT02891408|62860516|FG004|Overall Study|Lost to Follow-up|0|||
33483578|NCT02891408|62860517|FG005|Overall Study|Lost to Follow-up|0|||
33483579|NCT02891408|62860518|FG006|Overall Study|Lost to Follow-up|0|||
33483580|NCT03283670|62860544|FG000|Placebo Gas|Withdrawal by Subject|2|||
33483581|NCT03283670|62860544|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
33554813|NCT01329029|62947623|FG001|Overall Study|Other|20|||
33554814|NCT01329029|62947622|FG000|Overall Study|COPD Exacerbation|11|||
33483582|NCT03283670|62860544|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
33483583|NCT01358578|62860565|FG000|Induction Period|Adverse Event|2|||
33483584|NCT01358578|62860566|FG001|Induction Period|Adverse Event|4|||
33483585|NCT01358578|62860567|FG002|Induction Period|Adverse Event|2|||
33483586|NCT01358578|62860568|FG003|Induction Period|Adverse Event|6|||
33483587|NCT01358578|62860569|FG004|Induction Period|Adverse Event|0|||
33483588|NCT01358578|62860570|FG005|Induction Period|Adverse Event|0|||
33483589|NCT01358578|62860565|FG000|Induction Period|Lack of Efficacy|0|||
33483590|NCT01358578|62860566|FG001|Induction Period|Lack of Efficacy|0|||
33483591|NCT01358578|62860567|FG002|Induction Period|Lack of Efficacy|9|||
33483592|NCT01358578|62860568|FG003|Induction Period|Lack of Efficacy|1|||
33483593|NCT01358578|62860569|FG004|Induction Period|Lack of Efficacy|0|||
33483594|NCT01358578|62860570|FG005|Induction Period|Lack of Efficacy|0|||
33483595|NCT01358578|62860565|FG000|Induction Period|Lost to Follow-up|0|||
33483596|NCT01358578|62860566|FG001|Induction Period|Lost to Follow-up|0|||
33483597|NCT01358578|62860567|FG002|Induction Period|Lost to Follow-up|1|||
33483598|NCT01358578|62860568|FG003|Induction Period|Lost to Follow-up|4|||
33483599|NCT01358578|62860569|FG004|Induction Period|Lost to Follow-up|0|||
33483600|NCT01358578|62860570|FG005|Induction Period|Lost to Follow-up|0|||
33483601|NCT01358578|62860565|FG000|Induction Period|Physician Decision|2|||
33483602|NCT01358578|62860566|FG001|Induction Period|Physician Decision|1|||
33483603|NCT01358578|62860567|FG002|Induction Period|Physician Decision|2|||
33483604|NCT01358578|62860568|FG003|Induction Period|Physician Decision|0|||
33483605|NCT01358578|62860569|FG004|Induction Period|Physician Decision|0|||
33483606|NCT01358578|62860570|FG005|Induction Period|Physician Decision|0|||
33483607|NCT01358578|62860565|FG000|Induction Period|Protocol Deviation|3|||
33483608|NCT01358578|62860566|FG001|Induction Period|Protocol Deviation|5|||
33483609|NCT01358578|62860567|FG002|Induction Period|Protocol Deviation|0|||
33554815|NCT01329029|62947623|FG001|Overall Study|COPD Exacerbation|18|||
33483610|NCT01358578|62860568|FG003|Induction Period|Protocol Deviation|3|||
33483611|NCT01358578|62860569|FG004|Induction Period|Protocol Deviation|0|||
33483612|NCT01358578|62860570|FG005|Induction Period|Protocol Deviation|0|||
33483613|NCT01358578|62860565|FG000|Induction Period|technical problems|0|||
33483614|NCT01358578|62860566|FG001|Induction Period|technical problems|0|||
33483615|NCT01358578|62860567|FG002|Induction Period|technical problems|1|||
33483616|NCT01358578|62860568|FG003|Induction Period|technical problems|1|||
33483617|NCT01358578|62860569|FG004|Induction Period|technical problems|0|||
33483618|NCT01358578|62860570|FG005|Induction Period|technical problems|0|||
33483619|NCT01358578|62860565|FG000|Induction Period|Withdrawal by Subject|5|||
33483620|NCT01358578|62860566|FG001|Induction Period|Withdrawal by Subject|5|||
33483621|NCT01358578|62860567|FG002|Induction Period|Withdrawal by Subject|10|||
33483622|NCT01358578|62860568|FG003|Induction Period|Withdrawal by Subject|6|||
33483623|NCT01358578|62860569|FG004|Induction Period|Withdrawal by Subject|0|||
33483624|NCT01358578|62860570|FG005|Induction Period|Withdrawal by Subject|0|||
33483625|NCT01358578|62860565|FG000|Maintenance Period|Adverse Event|2|||
33483626|NCT01358578|62860566|FG001|Maintenance Period|Adverse Event|7|||
33483627|NCT01358578|62860567|FG002|Maintenance Period|Adverse Event|0|||
33483628|NCT01358578|62860568|FG003|Maintenance Period|Adverse Event|6|||
33483629|NCT01358578|62860569|FG004|Maintenance Period|Adverse Event|4|||
33483630|NCT01358578|62860570|FG005|Maintenance Period|Adverse Event|3|||
33483631|NCT01358578|62860565|FG000|Maintenance Period|Lack of Efficacy|10|||
33483632|NCT01358578|62860566|FG001|Maintenance Period|Lack of Efficacy|2|||
33483633|NCT01358578|62860567|FG002|Maintenance Period|Lack of Efficacy|0|||
33483634|NCT01358578|62860568|FG003|Maintenance Period|Lack of Efficacy|11|||
33483635|NCT01358578|62860569|FG004|Maintenance Period|Lack of Efficacy|3|||
33483636|NCT01358578|62860570|FG005|Maintenance Period|Lack of Efficacy|0|||
33483637|NCT01358578|62860565|FG000|Maintenance Period|Lost to Follow-up|4|||
33483638|NCT01358578|62860566|FG001|Maintenance Period|Lost to Follow-up|0|||
33483639|NCT01358578|62860567|FG002|Maintenance Period|Lost to Follow-up|0|||
33483640|NCT01358578|62860568|FG003|Maintenance Period|Lost to Follow-up|5|||
33483641|NCT01358578|62860569|FG004|Maintenance Period|Lost to Follow-up|1|||
33483642|NCT01358578|62860570|FG005|Maintenance Period|Lost to Follow-up|1|||
33483643|NCT01358578|62860565|FG000|Maintenance Period|Non-compliance with study treatment|3|||
33483644|NCT01358578|62860566|FG001|Maintenance Period|Non-compliance with study treatment|1|||
33483645|NCT01358578|62860567|FG002|Maintenance Period|Non-compliance with study treatment|0|||
33483646|NCT01358578|62860568|FG003|Maintenance Period|Non-compliance with study treatment|2|||
33483647|NCT01358578|62860569|FG004|Maintenance Period|Non-compliance with study treatment|1|||
33483648|NCT01358578|62860570|FG005|Maintenance Period|Non-compliance with study treatment|2|||
33483649|NCT01358578|62860565|FG000|Maintenance Period|Physician Decision|0|||
33483650|NCT01358578|62860566|FG001|Maintenance Period|Physician Decision|1|||
33483651|NCT01358578|62860567|FG002|Maintenance Period|Physician Decision|0|||
33483652|NCT01358578|62860568|FG003|Maintenance Period|Physician Decision|1|||
33483653|NCT01358578|62860569|FG004|Maintenance Period|Physician Decision|0|||
33483654|NCT01358578|62860570|FG005|Maintenance Period|Physician Decision|0|||
33483655|NCT01358578|62860565|FG000|Maintenance Period|Pregnancy|1|||
33483656|NCT01358578|62860566|FG001|Maintenance Period|Pregnancy|0|||
33483657|NCT01358578|62860567|FG002|Maintenance Period|Pregnancy|0|||
33483658|NCT01358578|62860568|FG003|Maintenance Period|Pregnancy|0|||
33483659|NCT01358578|62860569|FG004|Maintenance Period|Pregnancy|0|||
33483660|NCT01358578|62860570|FG005|Maintenance Period|Pregnancy|0|||
33554816|NCT01329029|62947622|FG000|Overall Study|Physician Decision|16|||
33554817|NCT01329029|62947623|FG001|Overall Study|Physician Decision|13|||
33554818|NCT01329029|62947622|FG000|Overall Study|Lost to Follow-up|8|||
33554819|NCT01329029|62947623|FG001|Overall Study|Lost to Follow-up|5|||
33554820|NCT01329029|62947622|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
33554821|NCT01329029|62947623|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
33554822|NCT01372085|62947639|FG000|Washout Period 2|Physician Decision|0|||
33554823|NCT01372085|62947640|FG001|Washout Period 2|Physician Decision|0|||
33554824|NCT01372085|62947641|FG002|Washout Period 2|Physician Decision|0|||
33554825|NCT01372085|62947642|FG003|Washout Period 2|Physician Decision|0|||
33554826|NCT01372085|62947643|FG004|Washout Period 2|Physician Decision|1|||
33554827|NCT01372085|62947644|FG005|Washout Period 2|Physician Decision|0|||
33554828|NCT01372085|62947645|FG006|Washout Period 2|Physician Decision|0|||
33554829|NCT01372085|62947646|FG007|Washout Period 2|Physician Decision|0|||
33554830|NCT01372085|62947647|FG008|Washout Period 2|Physician Decision|0|||
33554831|NCT01372085|62947648|FG009|Washout Period 2|Physician Decision|0|||
33554832|NCT01372085|62947639|FG000|Washout Period 3|Withdrawal by Subject|0|||
33554833|NCT01372085|62947640|FG001|Washout Period 3|Withdrawal by Subject|0|||
33365107|NCT00879684|62743628|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
33483661|NCT01358578|62860565|FG000|Maintenance Period|Protocol deviation|7|||
33483662|NCT01358578|62860566|FG001|Maintenance Period|Protocol deviation|4|||
33483663|NCT01358578|62860567|FG002|Maintenance Period|Protocol deviation|0|||
33483664|NCT01358578|62860568|FG003|Maintenance Period|Protocol deviation|2|||
33483665|NCT01358578|62860569|FG004|Maintenance Period|Protocol deviation|2|||
33483666|NCT01358578|62860570|FG005|Maintenance Period|Protocol deviation|2|||
33483667|NCT01358578|62860565|FG000|Maintenance Period|Withdrawal by Subject|12|||
33483668|NCT01358578|62860566|FG001|Maintenance Period|Withdrawal by Subject|7|||
33483669|NCT01358578|62860567|FG002|Maintenance Period|Withdrawal by Subject|2|||
33554834|NCT01372085|62947641|FG002|Washout Period 3|Withdrawal by Subject|0|||
33554835|NCT01372085|62947642|FG003|Washout Period 3|Withdrawal by Subject|0|||
33554836|NCT01372085|62947643|FG004|Washout Period 3|Withdrawal by Subject|0|||
33554837|NCT01372085|62947644|FG005|Washout Period 3|Withdrawal by Subject|2|||
33554838|NCT01372085|62947645|FG006|Washout Period 3|Withdrawal by Subject|0|||
33554839|NCT01372085|62947646|FG007|Washout Period 3|Withdrawal by Subject|0|||
33554840|NCT01372085|62947647|FG008|Washout Period 3|Withdrawal by Subject|0|||
33554841|NCT01372085|62947648|FG009|Washout Period 3|Withdrawal by Subject|0|||
33554842|NCT04012853|62947674|FG000|Overall Study|Withdrawal by Subject|1|||
33554843|NCT04012853|62947675|FG001|Overall Study|Withdrawal by Subject|1|||
33554844|NCT04012853|62947674|FG000|Overall Study|Protocol Violation|1|||
33554845|NCT04012853|62947675|FG001|Overall Study|Protocol Violation|0|||
33554846|NCT04012853|62947674|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
33554847|NCT04012853|62947675|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
33661172|NCT01705691|63090256|FG001|Overall Study|Withdrawal by Subject|2|||
33661173|NCT01705691|63090255|FG000|Overall Study|Lost to Follow-up|1|||
33483670|NCT01358578|62860568|FG003|Maintenance Period|Withdrawal by Subject|15|||
33483671|NCT01358578|62860569|FG004|Maintenance Period|Withdrawal by Subject|6|||
33483672|NCT01358578|62860570|FG005|Maintenance Period|Withdrawal by Subject|3|||
33483673|NCT01358578|62860565|FG000|Follow-up Period|Adverse Event|1|||
33483674|NCT01358578|62860566|FG001|Follow-up Period|Adverse Event|1|||
33483675|NCT01358578|62860567|FG002|Follow-up Period|Adverse Event|0|||
33661174|NCT01705691|63090256|FG001|Overall Study|Lost to Follow-up|1|||
33483676|NCT01358578|62860568|FG003|Follow-up Period|Adverse Event|0|||
33483677|NCT01358578|62860569|FG004|Follow-up Period|Adverse Event|0|||
33483678|NCT01358578|62860570|FG005|Follow-up Period|Adverse Event|0|||
33483679|NCT01358578|62860565|FG000|Follow-up Period|Lack of Efficacy|3|||
33483680|NCT01358578|62860566|FG001|Follow-up Period|Lack of Efficacy|0|||
33483681|NCT01358578|62860567|FG002|Follow-up Period|Lack of Efficacy|4|||
33483682|NCT01358578|62860568|FG003|Follow-up Period|Lack of Efficacy|1|||
33483683|NCT01358578|62860569|FG004|Follow-up Period|Lack of Efficacy|0|||
33483684|NCT01358578|62860570|FG005|Follow-up Period|Lack of Efficacy|0|||
33483685|NCT01358578|62860565|FG000|Follow-up Period|Lost to Follow-up|0|||
33483686|NCT01358578|62860566|FG001|Follow-up Period|Lost to Follow-up|1|||
33483687|NCT01358578|62860567|FG002|Follow-up Period|Lost to Follow-up|0|||
33483688|NCT01358578|62860568|FG003|Follow-up Period|Lost to Follow-up|4|||
33483689|NCT01358578|62860569|FG004|Follow-up Period|Lost to Follow-up|0|||
33483690|NCT01358578|62860570|FG005|Follow-up Period|Lost to Follow-up|0|||
33483691|NCT01358578|62860565|FG000|Follow-up Period|non- compliance with study treatment|1|||
33483692|NCT01358578|62860566|FG001|Follow-up Period|non- compliance with study treatment|0|||
33483693|NCT01358578|62860567|FG002|Follow-up Period|non- compliance with study treatment|0|||
33483694|NCT01358578|62860568|FG003|Follow-up Period|non- compliance with study treatment|0|||
33483695|NCT01358578|62860569|FG004|Follow-up Period|non- compliance with study treatment|0|||
33483696|NCT01358578|62860570|FG005|Follow-up Period|non- compliance with study treatment|0|||
33483697|NCT01358578|62860565|FG000|Follow-up Period|Pregnancy|1|||
33483698|NCT01358578|62860566|FG001|Follow-up Period|Pregnancy|0|||
33483699|NCT01358578|62860567|FG002|Follow-up Period|Pregnancy|0|||
33483700|NCT01358578|62860568|FG003|Follow-up Period|Pregnancy|0|||
33483701|NCT01358578|62860569|FG004|Follow-up Period|Pregnancy|0|||
33483702|NCT01358578|62860570|FG005|Follow-up Period|Pregnancy|0|||
33483703|NCT01358578|62860565|FG000|Follow-up Period|Withdrawal by Subject|3|||
33483704|NCT01358578|62860566|FG001|Follow-up Period|Withdrawal by Subject|3|||
33483705|NCT01358578|62860567|FG002|Follow-up Period|Withdrawal by Subject|1|||
33483706|NCT01358578|62860568|FG003|Follow-up Period|Withdrawal by Subject|12|||
33483707|NCT01358578|62860569|FG004|Follow-up Period|Withdrawal by Subject|0|||
33483708|NCT01358578|62860570|FG005|Follow-up Period|Withdrawal by Subject|0|||
33483709|NCT01358578|62860565|FG000|Follow-up Period|Physician Decision|1|||
33483710|NCT01358578|62860566|FG001|Follow-up Period|Physician Decision|1|||
33483711|NCT01358578|62860567|FG002|Follow-up Period|Physician Decision|0|||
33483712|NCT01358578|62860568|FG003|Follow-up Period|Physician Decision|2|||
33483713|NCT01358578|62860569|FG004|Follow-up Period|Physician Decision|0|||
33483714|NCT01358578|62860570|FG005|Follow-up Period|Physician Decision|0|||
33483715|NCT02833948|62860600|FG000|Overall Study|Death|2|||
33483716|NCT02833948|62860601|FG001|Overall Study|Death|3|||
33554848|NCT02941549|62947684|FG000|Overall Study|Adverse Event|1|||
33483717|NCT02833948|62860600|FG000|Overall Study|were not scanned|8|||
33554849|NCT02941549|62947685|FG001|Overall Study|Adverse Event|0|||
33554850|NCT02941549|62947686|FG002|Overall Study|Adverse Event|0|||
33661175|NCT01705691|63090255|FG000|Overall Study|Other|0|||
33661176|NCT01705691|63090256|FG001|Overall Study|Other|1|||
33483718|NCT02833948|62860601|FG001|Overall Study|were not scanned|13|||
33483719|NCT02833948|62860600|FG000|Overall Study|scans could not be evaluated|5|||
33483720|NCT02833948|62860601|FG001|Overall Study|scans could not be evaluated|2|||
33483721|NCT02828020|62860614|FG000|Treatment Period|Adverse Event|3|||
33483722|NCT02828020|62860615|FG001|Treatment Period|Adverse Event|1|||
33483723|NCT02828020|62860616|FG002|Treatment Period|Adverse Event|1|||
33483724|NCT02828020|62860614|FG000|Treatment Period|Withdrawal of Consent|10|||
33483725|NCT02828020|62860615|FG001|Treatment Period|Withdrawal of Consent|14|||
33483726|NCT02828020|62860616|FG002|Treatment Period|Withdrawal of Consent|9|||
33483727|NCT02828020|62860614|FG000|Treatment Period|Lost to Follow-up|21|||
33483728|NCT02828020|62860615|FG001|Treatment Period|Lost to Follow-up|24|||
33483729|NCT02828020|62860616|FG002|Treatment Period|Lost to Follow-up|18|||
33483730|NCT02828020|62860614|FG000|Treatment Period|Lack of Qualifying Event|44|||
33483731|NCT02828020|62860615|FG001|Treatment Period|Lack of Qualifying Event|53|||
33483732|NCT02828020|62860616|FG002|Treatment Period|Lack of Qualifying Event|43|||
33483733|NCT02828020|62860614|FG000|Treatment Period|Pregnancy|0|||
33483734|NCT02828020|62860615|FG001|Treatment Period|Pregnancy|2|||
33483735|NCT02828020|62860616|FG002|Treatment Period|Pregnancy|0|||
33483736|NCT02828020|62860614|FG000|Treatment Period|Protocol Violation|2|||
33483737|NCT02828020|62860615|FG001|Treatment Period|Protocol Violation|4|||
33483738|NCT02828020|62860616|FG002|Treatment Period|Protocol Violation|7|||
33483739|NCT02828020|62860614|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
33483740|NCT02828020|62860615|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
33483741|NCT02828020|62860616|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
33483742|NCT02828020|62860614|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
33483743|NCT02828020|62860615|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
33483744|NCT02828020|62860616|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
33483745|NCT02828020|62860614|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
33483746|NCT02828020|62860615|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
33483747|NCT02828020|62860616|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
33483748|NCT02828020|62860614|FG000|Safety Follow-up Period|Protocol Violation|0|||
33483749|NCT02828020|62860615|FG001|Safety Follow-up Period|Protocol Violation|2|||
33483750|NCT02828020|62860616|FG002|Safety Follow-up Period|Protocol Violation|1|||
33483751|NCT02828020|62860614|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
33483752|NCT02828020|62860615|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
33483753|NCT02828020|62860616|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
33483754|NCT02827708|62860635|FG000|Overall Study|Lost to Follow-up|3|||
33483755|NCT02827708|62860636|FG001|Overall Study|Lost to Follow-up|1|||
33483756|NCT02827708|62860635|FG000|Overall Study|Withdrawal by Subject|1|||
33483757|NCT02827708|62860636|FG001|Overall Study|Withdrawal by Subject|2|||
33483758|NCT02827708|62860635|FG000|Overall Study|Death|1|||
33483759|NCT02827708|62860636|FG001|Overall Study|Death|2|||
33483760|NCT03760185|62860642|FG000|Overall Study|Lost to Follow-up|1|||
33483761|NCT03760185|62860643|FG001|Overall Study|Lost to Follow-up|1|||
33483762|NCT02891174|62860653|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
33483763|NCT02891174|62860654|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
33483764|NCT02891174|62860653|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
33483765|NCT02891174|62860654|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
33483766|NCT02891174|62860653|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
33483767|NCT02891174|62860654|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
33483768|NCT02891174|62860653|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
33554851|NCT02941549|62947684|FG000|Overall Study|Withdrawal by Subject|2|||
33554852|NCT02941549|62947685|FG001|Overall Study|Withdrawal by Subject|1|||
33554853|NCT02941549|62947686|FG002|Overall Study|Withdrawal by Subject|2|||
33554854|NCT02394028|62947708|FG000|Induction Phase|Adverse Event|2|||
33554855|NCT02394028|62947709|FG001|Induction Phase|Adverse Event|4|||
33554856|NCT02394028|62947710|FG002|Induction Phase|Adverse Event|1|||
33554857|NCT02394028|62947711|FG003|Induction Phase|Adverse Event|2|||
33554858|NCT02394028|62947712|FG004|Induction Phase|Adverse Event|5|||
33554859|NCT02394028|62947713|FG005|Induction Phase|Adverse Event|2|||
33554860|NCT02394028|62947714|FG006|Induction Phase|Adverse Event|0|||
33554861|NCT02394028|62947715|FG007|Induction Phase|Adverse Event|0|||
33554862|NCT02394028|62947716|FG008|Induction Phase|Adverse Event|0|||
33554863|NCT02394028|62947717|FG009|Induction Phase|Adverse Event|0|||
33554864|NCT02394028|62947718|FG010|Induction Phase|Adverse Event|0|||
33554865|NCT02394028|62947708|FG000|Induction Phase|Lack of Efficacy|3|||
33554866|NCT02394028|62947709|FG001|Induction Phase|Lack of Efficacy|6|||
33483769|NCT02891174|62860654|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
33483770|NCT02891174|62860653|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
33483771|NCT02891174|62860654|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
33483772|NCT02891174|62860653|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
33483773|NCT02891174|62860654|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
33554867|NCT02394028|62947710|FG002|Induction Phase|Lack of Efficacy|2|||
33483774|NCT02891174|62860653|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
33554868|NCT02394028|62947711|FG003|Induction Phase|Lack of Efficacy|17|||
33554869|NCT02394028|62947712|FG004|Induction Phase|Lack of Efficacy|14|||
33554870|NCT02394028|62947713|FG005|Induction Phase|Lack of Efficacy|8|||
33554871|NCT02394028|62947714|FG006|Induction Phase|Lack of Efficacy|17|||
33554872|NCT02394028|62947715|FG007|Induction Phase|Lack of Efficacy|23|||
33661177|NCT03766906|63090262|FG000|Overall Study|Withdrawal by Subject|6|||
33483775|NCT02891174|62860654|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
33483776|NCT01751984|62860675|FG000|Overall Study|Adverse Event|5|||
33483777|NCT01751984|62860676|FG001|Overall Study|Adverse Event|3|||
33483778|NCT01751984|62860675|FG000|Overall Study|Withdrawal by Subject|0|||
33483779|NCT01751984|62860676|FG001|Overall Study|Withdrawal by Subject|1|||
33483780|NCT01751984|62860675|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
33483781|NCT01751984|62860676|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
33483782|NCT03330236|62860684|FG000|Overall Study|Death|2|||
33483783|NCT03330236|62860685|FG001|Overall Study|Death|1|||
33483784|NCT03330236|62860684|FG000|Overall Study|Withdrawal by Subject|2|||
33483785|NCT03330236|62860685|FG001|Overall Study|Withdrawal by Subject|4|||
33483786|NCT03330236|62860684|FG000|Overall Study|Lost to Follow-up|0|||
33483787|NCT03330236|62860685|FG001|Overall Study|Lost to Follow-up|2|||
33483788|NCT03330236|62860684|FG000|Overall Study|Physician Decision|2|||
33483789|NCT03330236|62860685|FG001|Overall Study|Physician Decision|0|||
33483790|NCT03330236|62860684|FG000|Overall Study|Protocol Violation|4|||
33483791|NCT03330236|62860685|FG001|Overall Study|Protocol Violation|3|||
33483792|NCT03330236|62860684|FG000|Overall Study|SedLine malfunction/blinding|19|||
33483793|NCT03330236|62860685|FG001|Overall Study|SedLine malfunction/blinding|14|||
33483794|NCT03330236|62860684|FG000|Overall Study|Volatile anesthetics used|11|||
33483795|NCT03330236|62860685|FG001|Overall Study|Volatile anesthetics used|8|||
33483796|NCT03330236|62860684|FG000|Overall Study|Surgery aborted/converted to open|60|||
33483797|NCT03330236|62860685|FG001|Overall Study|Surgery aborted/converted to open|52|||
33483798|NCT03330002|62860691|FG000|Overall Study|Lost to Follow-up|15|||
33483799|NCT03330002|62860691|FG000|Overall Study|Death|7|||
33483800|NCT02948582|62860695|FG000|Washout Period 1|Adverse Event|0|||
33483801|NCT02948582|62860696|FG001|Washout Period 1|Adverse Event|2|||
33483802|NCT02948582|62860697|FG002|Washout Period 1|Adverse Event|0|||
33483803|NCT02948582|62860698|FG003|Washout Period 1|Adverse Event|0|||
33483804|NCT02948582|62860699|FG004|Washout Period 1|Adverse Event|0|||
33483805|NCT02948582|62860700|FG005|Washout Period 1|Adverse Event|0|||
33483806|NCT02948582|62860695|FG000|Washout Period 1|Protocol Violation|0|||
33483807|NCT02948582|62860696|FG001|Washout Period 1|Protocol Violation|0|||
33483808|NCT02948582|62860697|FG002|Washout Period 1|Protocol Violation|0|||
33483809|NCT02948582|62860698|FG003|Washout Period 1|Protocol Violation|0|||
33483810|NCT02948582|62860699|FG004|Washout Period 1|Protocol Violation|0|||
33483811|NCT02948582|62860700|FG005|Washout Period 1|Protocol Violation|1|||
33483812|NCT02948582|62860695|FG000|Washout Period 2|Adverse Event|0|||
33483813|NCT02948582|62860696|FG001|Washout Period 2|Adverse Event|1|||
33483814|NCT02948582|62860697|FG002|Washout Period 2|Adverse Event|0|||
33483815|NCT02948582|62860698|FG003|Washout Period 2|Adverse Event|0|||
33483816|NCT02948582|62860699|FG004|Washout Period 2|Adverse Event|0|||
33483817|NCT02948582|62860700|FG005|Washout Period 2|Adverse Event|0|||
33483818|NCT02948582|62860695|FG000|Washout Period 2|personal reasons|0|||
33554873|NCT02394028|62947716|FG008|Induction Phase|Lack of Efficacy|0|||
33554874|NCT02394028|62947717|FG009|Induction Phase|Lack of Efficacy|0|||
33483819|NCT02948582|62860696|FG001|Washout Period 2|personal reasons|0|||
33554875|NCT02394028|62947718|FG010|Induction Phase|Lack of Efficacy|0|||
33554876|NCT02394028|62947708|FG000|Induction Phase|Lost to Follow-up|1|||
33554877|NCT02394028|62947709|FG001|Induction Phase|Lost to Follow-up|0|||
33554878|NCT02394028|62947710|FG002|Induction Phase|Lost to Follow-up|0|||
33554879|NCT02394028|62947711|FG003|Induction Phase|Lost to Follow-up|1|||
33554880|NCT02394028|62947712|FG004|Induction Phase|Lost to Follow-up|0|||
33554881|NCT02394028|62947713|FG005|Induction Phase|Lost to Follow-up|0|||
33483820|NCT02948582|62860697|FG002|Washout Period 2|personal reasons|0|||
33483821|NCT02948582|62860698|FG003|Washout Period 2|personal reasons|1|||
33483822|NCT02948582|62860699|FG004|Washout Period 2|personal reasons|0|||
33661178|NCT01705145|63090266|FG000|Part B|Adverse Event|1|||
33661179|NCT01704755|63090284|FG000|Overall Study|Adverse Event|4|||
33483823|NCT02948582|62860700|FG005|Washout Period 2|personal reasons|0|||
33483824|NCT02948582|62860695|FG000|Washout Period 4|Adverse Event|1|||
33483825|NCT02948582|62860696|FG001|Washout Period 4|Adverse Event|0|||
33483826|NCT02948582|62860697|FG002|Washout Period 4|Adverse Event|1|||
33483827|NCT02948582|62860698|FG003|Washout Period 4|Adverse Event|0|||
33483828|NCT02948582|62860699|FG004|Washout Period 4|Adverse Event|0|||
33483829|NCT02948582|62860700|FG005|Washout Period 4|Adverse Event|0|||
33483830|NCT03756285|62860716|FG000|Overall Study|Lost to Follow-up|0|||
33483831|NCT03756285|62860717|FG001|Overall Study|Lost to Follow-up|1|||
33483832|NCT03756285|62860716|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
33483833|NCT03756285|62860717|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
33483834|NCT03756285|62860716|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
33554882|NCT02394028|62947714|FG006|Induction Phase|Lost to Follow-up|1|||
33554883|NCT02394028|62947715|FG007|Induction Phase|Lost to Follow-up|0|||
33554884|NCT02394028|62947716|FG008|Induction Phase|Lost to Follow-up|0|||
33554885|NCT02394028|62947717|FG009|Induction Phase|Lost to Follow-up|0|||
33554886|NCT02394028|62947718|FG010|Induction Phase|Lost to Follow-up|0|||
33554887|NCT02394028|62947708|FG000|Induction Phase|Non-compliance|0|||
33554888|NCT02394028|62947709|FG001|Induction Phase|Non-compliance|1|||
33554889|NCT02394028|62947710|FG002|Induction Phase|Non-compliance|3|||
33554890|NCT02394028|62947711|FG003|Induction Phase|Non-compliance|1|||
33661180|NCT01704755|63090285|FG001|Overall Study|Adverse Event|1|||
33661181|NCT01704755|63090284|FG000|Overall Study|Lost to Follow-up|3|||
33483835|NCT03756285|62860717|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
33483836|NCT02825992|62860743|FG000|Overall Study|Withdrawal by Subject|4|||
33483837|NCT02825992|62860743|FG000|Overall Study|Lost to Follow-up|2|||
33483838|NCT02825992|62860743|FG000|Overall Study|Procedure terminated|2|||
33483839|NCT01339000|62860755|FG000|Overall Study|study closed due to lack of drug supply|1|||
33483840|NCT01339000|62860756|FG001|Overall Study|study closed due to lack of drug supply|0|||
33483841|NCT03755661|62860767|FG000|Overall Study|Lost to Follow-up|1|||
33483842|NCT03755661|62860768|FG001|Overall Study|Lost to Follow-up|0|||
33483843|NCT03752151|62860774|FG000|Overall Study|Withdrawal by Subject|1|||
33483844|NCT03752151|62860774|FG000|Overall Study|Protocol Violation|1|||
33483845|NCT01336634|62860782|FG000|Overall Study|Study closed/terminated|5|||
33483846|NCT01336634|62860783|FG001|Overall Study|Study closed/terminated|6|||
33483847|NCT01336634|62860784|FG002|Overall Study|Study closed/terminated|6|||
33483848|NCT01336634|62860782|FG000|Overall Study|Lost to Follow-up|2|||
33483849|NCT01336634|62860783|FG001|Overall Study|Lost to Follow-up|1|||
33483850|NCT01336634|62860784|FG002|Overall Study|Lost to Follow-up|1|||
33483851|NCT01336634|62860782|FG000|Overall Study|Physician Decision|1|||
33483852|NCT01336634|62860783|FG001|Overall Study|Physician Decision|1|||
33483853|NCT01336634|62860784|FG002|Overall Study|Physician Decision|0|||
33661182|NCT01704755|63090285|FG001|Overall Study|Lost to Follow-up|4|||
33661183|NCT01704755|63090284|FG000|Overall Study|Withdrew consent|1|||
33661184|NCT01704755|63090285|FG001|Overall Study|Withdrew consent|1|||
33661185|NCT01704755|63090284|FG000|Overall Study|Other (not specified)|3|||
33661186|NCT01704755|63090285|FG001|Overall Study|Other (not specified)|1|||
33661187|NCT01704755|63090284|FG000|Overall Study|Withdrew consent and personal issues|1|||
33661188|NCT01704755|63090285|FG001|Overall Study|Withdrew consent and personal issues|0|||
33661189|NCT01704599|63090291|FG000|Overall Study|Adverse Event|1|||
33661190|NCT03599518|63090323|FG000|Overall Study|Clinical progression|0|||
33661191|NCT03599518|63090324|FG001|Overall Study|Clinical progression|0|||
33661192|NCT03599518|63090325|FG002|Overall Study|Clinical progression|0|||
33483854|NCT01336634|62860782|FG000|Overall Study|Withdrawal by Subject|6|||
33483855|NCT01336634|62860783|FG001|Overall Study|Withdrawal by Subject|0|||
33483856|NCT01336634|62860784|FG002|Overall Study|Withdrawal by Subject|2|||
33661193|NCT03599518|63090326|FG003|Overall Study|Clinical progression|0|||
33661194|NCT03599518|63090327|FG004|Overall Study|Clinical progression|1|||
33483857|NCT02947100|62860799|FG000|Overall Study|study terminated early|3|||
33483858|NCT02947100|62860799|FG000|Overall Study|did not meet inclusion criteria|1|||
33554891|NCT02394028|62947712|FG004|Induction Phase|Non-compliance|3|||
33661195|NCT03599518|63090323|FG000|Overall Study|Adverse Event|0|||
33554892|NCT02394028|62947713|FG005|Induction Phase|Non-compliance|0|||
33554893|NCT02394028|62947714|FG006|Induction Phase|Non-compliance|1|||
33661196|NCT03599518|63090324|FG001|Overall Study|Adverse Event|0|||
33365108|NCT00879684|62743629|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
33365109|NCT00879684|62743623|FG000|Stage 1: Dose Escalation|Death|0|||
33365110|NCT00879684|62743624|FG001|Stage 1: Dose Escalation|Death|0|||
33365111|NCT00879684|62743625|FG002|Stage 1: Dose Escalation|Death|1|||
33365112|NCT00879684|62743626|FG003|Stage 1: Dose Escalation|Death|0|||
33365113|NCT00879684|62743627|FG004|Stage 1: Dose Escalation|Death|0|||
33365114|NCT00879684|62743628|FG005|Stage 1: Dose Escalation|Death|0|||
33483859|NCT03329846|62860805|FG000|Overall Study|Disease progression|4|||
33483860|NCT03329846|62860806|FG001|Overall Study|Disease progression|6|||
33483861|NCT03329846|62860805|FG000|Overall Study|Study drug toxicity|1|||
33483862|NCT03329846|62860806|FG001|Overall Study|Study drug toxicity|0|||
33483863|NCT03329846|62860805|FG000|Overall Study|Participant request to discontinue treatment|0|||
33483864|NCT03329846|62860806|FG001|Overall Study|Participant request to discontinue treatment|1|||
33483865|NCT03329846|62860805|FG000|Overall Study|Participant withdrew consent|1|||
33661197|NCT03599518|63090325|FG002|Overall Study|Adverse Event|0|||
33661198|NCT03599518|63090326|FG003|Overall Study|Adverse Event|0|||
33661199|NCT03599518|63090327|FG004|Overall Study|Adverse Event|1|||
33661200|NCT03599518|63090323|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
33661201|NCT03599518|63090324|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
33661202|NCT03599518|63090325|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
33661203|NCT03599518|63090326|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
33661204|NCT03599518|63090327|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
33365115|NCT00879684|62743629|FG006|Stage 1: Dose Escalation|Death|0|||
33365116|NCT00879684|62743623|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
33365117|NCT00879684|62743624|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
33365118|NCT00879684|62743625|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
33365119|NCT00879684|62743626|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
33365120|NCT00879684|62743627|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
33365121|NCT00879684|62743628|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
33365122|NCT00879684|62743629|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
33365123|NCT00879684|62743623|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
33365124|NCT00879684|62743624|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
33365125|NCT00879684|62743625|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
33365126|NCT00879684|62743626|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
33365127|NCT00879684|62743627|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
33365128|NCT00879684|62743628|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
33365129|NCT00879684|62743629|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
33365130|NCT00879684|62743623|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
33365131|NCT00879684|62743624|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
33365132|NCT00879684|62743625|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
33365133|NCT00879684|62743626|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
33661205|NCT03599518|63090323|FG000|Overall Study|Participant withdrawal from study treatment|0|||
33661206|NCT03599518|63090324|FG001|Overall Study|Participant withdrawal from study treatment|0|||
33661207|NCT03599518|63090325|FG002|Overall Study|Participant withdrawal from study treatment|1|||
33365134|NCT00879684|62743627|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
33554894|NCT02394028|62947715|FG007|Induction Phase|Non-compliance|1|||
33365135|NCT00879684|62743628|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
33365136|NCT00879684|62743629|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
33365137|NCT00581776|62743648|FG000|Overall Study|Disease progression or no response|3|||
33365138|NCT00883740|62743652|FG000|First Intervention|Lost to Follow-up|1|||
33554895|NCT02394028|62947716|FG008|Induction Phase|Non-compliance|0|||
33554896|NCT02394028|62947717|FG009|Induction Phase|Non-compliance|0|||
33554897|NCT02394028|62947718|FG010|Induction Phase|Non-compliance|0|||
33661208|NCT03599518|63090326|FG003|Overall Study|Participant withdrawal from study treatment|0|||
33365139|NCT00883740|62743653|FG001|First Intervention|Lost to Follow-up|0|||
33554898|NCT02394028|62947708|FG000|Induction Phase|Physician Decision|0|||
33365140|NCT00883740|62743652|FG000|First Intervention|No longer willing to participate|2|||
33365141|NCT00883740|62743653|FG001|First Intervention|No longer willing to participate|0|||
33365142|NCT00883740|62743652|FG000|First Intervention|Protocol Violation|3|||
33365143|NCT00883740|62743653|FG001|First Intervention|Protocol Violation|6|||
33365144|NCT00883740|62743652|FG000|First Intervention|Adverse Event|1|||
33365145|NCT00883740|62743653|FG001|First Intervention|Adverse Event|2|||
33483866|NCT03329846|62860806|FG001|Overall Study|Participant withdrew consent|0|||
33483867|NCT03329846|62860805|FG000|Overall Study|Other reasons|2|||
33483868|NCT03329846|62860806|FG001|Overall Study|Other reasons|2|||
33483869|NCT03325010|62860814|FG000|Overall Study|Adverse Event|3|||
33554899|NCT02394028|62947709|FG001|Induction Phase|Physician Decision|0|||
33554900|NCT02394028|62947710|FG002|Induction Phase|Physician Decision|1|||
33554901|NCT02394028|62947711|FG003|Induction Phase|Physician Decision|4|||
33365146|NCT00883740|62743652|FG000|Second Intervention|Protocol Violation|1|||
33365147|NCT00883740|62743653|FG001|Second Intervention|Protocol Violation|0|||
33365148|NCT00883740|62743652|FG000|Second Intervention|No longer willing to participate|0|||
33365149|NCT00883740|62743653|FG001|Second Intervention|No longer willing to participate|1|||
33365150|NCT00597012|62743661|FG000|Overall Study|Death|1|||
33365151|NCT00597012|62743662|FG001|Overall Study|Death|1|||
33554902|NCT02394028|62947712|FG004|Induction Phase|Physician Decision|0|||
33554903|NCT02394028|62947713|FG005|Induction Phase|Physician Decision|2|||
33365152|NCT00597012|62743661|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
33365153|NCT00597012|62743662|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
33365154|NCT00597012|62743661|FG000|Overall Study|Withdrawal by Subject|7|||
33365155|NCT00597012|62743662|FG001|Overall Study|Withdrawal by Subject|4|||
33365156|NCT00597012|62743661|FG000|Overall Study|Ineligible|2|||
33365157|NCT00597012|62743662|FG001|Overall Study|Ineligible|0|||
33365158|NCT00597012|62743661|FG000|Overall Study|Lost to Follow-up|0|||
33365159|NCT00597012|62743662|FG001|Overall Study|Lost to Follow-up|2|||
33554904|NCT02394028|62947714|FG006|Induction Phase|Physician Decision|1|||
33554905|NCT02394028|62947715|FG007|Induction Phase|Physician Decision|0|||
33554906|NCT02394028|62947716|FG008|Induction Phase|Physician Decision|0|||
33554907|NCT02394028|62947717|FG009|Induction Phase|Physician Decision|0|||
33554908|NCT02394028|62947718|FG010|Induction Phase|Physician Decision|0|||
33554909|NCT02394028|62947708|FG000|Induction Phase|Protocol Violation|0|||
33554910|NCT02394028|62947709|FG001|Induction Phase|Protocol Violation|2|||
33554911|NCT02394028|62947710|FG002|Induction Phase|Protocol Violation|0|||
33554912|NCT02394028|62947711|FG003|Induction Phase|Protocol Violation|3|||
33554913|NCT02394028|62947712|FG004|Induction Phase|Protocol Violation|0|||
33554914|NCT02394028|62947713|FG005|Induction Phase|Protocol Violation|1|||
33554915|NCT02394028|62947714|FG006|Induction Phase|Protocol Violation|1|||
33554916|NCT02394028|62947715|FG007|Induction Phase|Protocol Violation|0|||
33554917|NCT02394028|62947716|FG008|Induction Phase|Protocol Violation|0|||
33554918|NCT02394028|62947717|FG009|Induction Phase|Protocol Violation|0|||
33554919|NCT02394028|62947718|FG010|Induction Phase|Protocol Violation|0|||
33554920|NCT02394028|62947708|FG000|Induction Phase|Withdrawal by Subject|1|||
33554921|NCT02394028|62947709|FG001|Induction Phase|Withdrawal by Subject|2|||
33554922|NCT02394028|62947710|FG002|Induction Phase|Withdrawal by Subject|4|||
33554923|NCT02394028|62947711|FG003|Induction Phase|Withdrawal by Subject|6|||
33554924|NCT02394028|62947712|FG004|Induction Phase|Withdrawal by Subject|7|||
33661209|NCT03599518|63090327|FG004|Overall Study|Participant withdrawal from study treatment|0|||
33661210|NCT02709486|63090404|FG000|Overall Study|Adverse Event|2|||
33365160|NCT00542815|62743673|FG000|Overall Study|Adverse Event|19|||
33483870|NCT03325010|62860815|FG001|Overall Study|Adverse Event|8|||
33483871|NCT03325010|62860814|FG000|Overall Study|Protocol Violation|1|||
33483872|NCT03325010|62860815|FG001|Overall Study|Protocol Violation|8|||
33483873|NCT03325010|62860814|FG000|Overall Study|Withdrawal by Subject|1|||
33483874|NCT03325010|62860815|FG001|Overall Study|Withdrawal by Subject|3|||
33483875|NCT03325010|62860814|FG000|Overall Study|Lost to Follow-up|1|||
33483876|NCT03325010|62860815|FG001|Overall Study|Lost to Follow-up|0|||
33483877|NCT03325010|62860814|FG000|Overall Study|Physician Decision|1|||
33483878|NCT03325010|62860815|FG001|Overall Study|Physician Decision|1|||
33483879|NCT03325010|62860814|FG000|Overall Study|Lack of Efficacy|2|||
33483880|NCT03325010|62860815|FG001|Overall Study|Lack of Efficacy|0|||
33483881|NCT02824432|62860823|FG000|Overall Study|Major Protocol Deviation|1|||
33483882|NCT02824432|62860824|FG001|Overall Study|Major Protocol Deviation|0|||
33483883|NCT02823964|62860830|FG000|Overall Study|Adverse Event|2|||
33554925|NCT02394028|62947713|FG005|Induction Phase|Withdrawal by Subject|4|||
33661211|NCT02709486|63090405|FG001|Overall Study|Adverse Event|5|||
33661212|NCT02709486|63090406|FG002|Overall Study|Adverse Event|3|||
33661213|NCT02709486|63090404|FG000|Overall Study|Death|0|||
33554926|NCT02394028|62947714|FG006|Induction Phase|Withdrawal by Subject|3|||
33554927|NCT02394028|62947715|FG007|Induction Phase|Withdrawal by Subject|6|||
33554928|NCT02394028|62947716|FG008|Induction Phase|Withdrawal by Subject|0|||
33554929|NCT02394028|62947717|FG009|Induction Phase|Withdrawal by Subject|0|||
33554930|NCT02394028|62947718|FG010|Induction Phase|Withdrawal by Subject|0|||
33554931|NCT02394028|62947708|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
33554932|NCT02394028|62947709|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
33554933|NCT02394028|62947710|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
33554934|NCT02394028|62947711|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
33554935|NCT02394028|62947712|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
33554936|NCT02394028|62947713|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
33554937|NCT02394028|62947714|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
33554938|NCT02394028|62947715|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
33554939|NCT02394028|62947716|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
33554940|NCT02394028|62947717|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
33554941|NCT02394028|62947718|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
33483884|NCT02823964|62860830|FG000|Overall Study|Physician Decision|1|||
33483885|NCT02823964|62860830|FG000|Overall Study|Lack of Efficacy|1|||
33483886|NCT02823964|62860830|FG000|Overall Study|Withdrawal by Subject|1|||
33483887|NCT01338610|62860837|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
33483888|NCT01338610|62860838|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
33483889|NCT01338610|62860839|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
33483890|NCT01338610|62860837|FG000|Overall Study|Protocol Violation|1|||
33483891|NCT01338610|62860838|FG001|Overall Study|Protocol Violation|0|||
33483892|NCT01338610|62860839|FG002|Overall Study|Protocol Violation|1|||
33483893|NCT01338610|62860837|FG000|Overall Study|Adverse Event|3|||
33483894|NCT01338610|62860838|FG001|Overall Study|Adverse Event|0|||
33554942|NCT02394028|62947708|FG000|Induction Phase|Sponsor decision|0|||
33365161|NCT00542815|62743674|FG001|Overall Study|Adverse Event|6|||
33365162|NCT00542815|62743675|FG002|Overall Study|Adverse Event|9|||
33365163|NCT00542815|62743673|FG000|Overall Study|Death|10|||
33661214|NCT02709486|63090405|FG001|Overall Study|Death|0|||
33661215|NCT02709486|63090406|FG002|Overall Study|Death|2|||
33661216|NCT02709486|63090404|FG000|Overall Study|Insufficient clinical response|7|||
33365164|NCT00542815|62743674|FG001|Overall Study|Death|7|||
33365165|NCT00542815|62743675|FG002|Overall Study|Death|3|||
33483895|NCT01338610|62860839|FG002|Overall Study|Adverse Event|0|||
33483896|NCT01355302|62860846|FG000|Phase 1b|Death|4|||
33483897|NCT01355302|62860847|FG001|Phase 1b|Death|0|||
33483898|NCT01355302|62860848|FG002|Phase 1b|Death|0|||
33483899|NCT01355302|62860846|FG000|Phase 1b|Study terminated by sponsor|2|||
33483900|NCT01355302|62860847|FG001|Phase 1b|Study terminated by sponsor|0|||
33483901|NCT01355302|62860848|FG002|Phase 1b|Study terminated by sponsor|0|||
33365166|NCT00542815|62743673|FG000|Overall Study|Lack of Efficacy|9|||
33365167|NCT00542815|62743674|FG001|Overall Study|Lack of Efficacy|2|||
33365168|NCT00542815|62743675|FG002|Overall Study|Lack of Efficacy|0|||
33483902|NCT01355068|62860856|FG000|First Intervention Period|Adverse Event|0|||
33365169|NCT00542815|62743673|FG000|Overall Study|Physician Decision|2|||
33365170|NCT00542815|62743674|FG001|Overall Study|Physician Decision|1|||
33483903|NCT01355068|62860857|FG001|First Intervention Period|Adverse Event|1|||
33483904|NCT01355068|62860856|FG000|First Intervention Period|Withdrawal by Subject|0|||
33483905|NCT01355068|62860857|FG001|First Intervention Period|Withdrawal by Subject|1|||
33554943|NCT02394028|62947709|FG001|Induction Phase|Sponsor decision|1|||
33554944|NCT02394028|62947710|FG002|Induction Phase|Sponsor decision|2|||
33365171|NCT00542815|62743675|FG002|Overall Study|Physician Decision|0|||
33365172|NCT00542815|62743673|FG000|Overall Study|Protocol Violation|1|||
33483906|NCT03756129|62860869|FG000|Overall Study|Adverse Event|1|||
33483907|NCT03756129|62860870|FG001|Overall Study|Adverse Event|1|||
33483908|NCT03756129|62860871|FG002|Overall Study|Adverse Event|0|||
33483909|NCT03756129|62860872|FG003|Overall Study|Adverse Event|2|||
33483910|NCT03756129|62860873|FG004|Overall Study|Adverse Event|0|||
33554945|NCT02394028|62947711|FG003|Induction Phase|Sponsor decision|0|||
33365173|NCT00542815|62743674|FG001|Overall Study|Protocol Violation|1|||
33365174|NCT00542815|62743675|FG002|Overall Study|Protocol Violation|2|||
33554946|NCT02394028|62947712|FG004|Induction Phase|Sponsor decision|0|||
33483911|NCT03756129|62860874|FG005|Overall Study|Adverse Event|0|||
33554947|NCT02394028|62947713|FG005|Induction Phase|Sponsor decision|0|||
33554948|NCT02394028|62947714|FG006|Induction Phase|Sponsor decision|0|||
33365175|NCT00542815|62743673|FG000|Overall Study|Withdrawal by Subject|41|||
33365176|NCT00542815|62743674|FG001|Overall Study|Withdrawal by Subject|5|||
33554949|NCT02394028|62947715|FG007|Induction Phase|Sponsor decision|0|||
33365177|NCT00542815|62743675|FG002|Overall Study|Withdrawal by Subject|8|||
33365178|NCT00542815|62743673|FG000|Overall Study|Other reasons|24|||
33365179|NCT00542815|62743674|FG001|Overall Study|Other reasons|10|||
33365180|NCT00542815|62743675|FG002|Overall Study|Other reasons|10|||
33365181|NCT00542425|62743688|FG000|Initial 24 Weeks|Administrative reasons|0|||
33365182|NCT00542425|62743689|FG001|Initial 24 Weeks|Administrative reasons|0|||
33365183|NCT00542425|62743690|FG002|Initial 24 Weeks|Administrative reasons|1|||
33365184|NCT00542425|62743691|FG003|Initial 24 Weeks|Administrative reasons|1|||
33365185|NCT00542425|62743692|FG004|Initial 24 Weeks|Administrative reasons|0|||
33365186|NCT00542425|62743688|FG000|Initial 24 Weeks|Adverse Event|0|||
33365187|NCT00542425|62743689|FG001|Initial 24 Weeks|Adverse Event|1|||
33365188|NCT00542425|62743690|FG002|Initial 24 Weeks|Adverse Event|1|||
33365189|NCT00542425|62743691|FG003|Initial 24 Weeks|Adverse Event|3|||
33365190|NCT00542425|62743692|FG004|Initial 24 Weeks|Adverse Event|2|||
33365191|NCT00542425|62743688|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
33365192|NCT00542425|62743689|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
33365193|NCT00542425|62743690|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
33365194|NCT00542425|62743691|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
33365195|NCT00542425|62743692|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
33365196|NCT00542425|62743688|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
33365197|NCT00542425|62743689|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
33365198|NCT00542425|62743690|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
33365199|NCT00542425|62743691|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
33661217|NCT02709486|63090405|FG001|Overall Study|Insufficient clinical response|3|||
33661218|NCT02709486|63090406|FG002|Overall Study|Insufficient clinical response|3|||
33661219|NCT02709486|63090404|FG000|Overall Study|Lost to Follow-up|3|||
33365200|NCT00542425|62743692|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
33365201|NCT00542425|62743688|FG000|Initial 24 Weeks|Non-compliance|0|||
33365202|NCT00542425|62743689|FG001|Initial 24 Weeks|Non-compliance|0|||
33661220|NCT02709486|63090405|FG001|Overall Study|Lost to Follow-up|2|||
33365203|NCT00542425|62743690|FG002|Initial 24 Weeks|Non-compliance|0|||
33365204|NCT00542425|62743691|FG003|Initial 24 Weeks|Non-compliance|1|||
33365205|NCT00542425|62743692|FG004|Initial 24 Weeks|Non-compliance|1|||
33365206|NCT00542425|62743688|FG000|Initial 24 Weeks|Protocol Violation|0|||
33365207|NCT00542425|62743689|FG001|Initial 24 Weeks|Protocol Violation|0|||
33365208|NCT00542425|62743690|FG002|Initial 24 Weeks|Protocol Violation|0|||
33365209|NCT00542425|62743691|FG003|Initial 24 Weeks|Protocol Violation|1|||
33365210|NCT00542425|62743692|FG004|Initial 24 Weeks|Protocol Violation|0|||
33365211|NCT00542425|62743688|FG000|Initial 24 Weeks|Refusal of treatment|2|||
33365212|NCT00542425|62743689|FG001|Initial 24 Weeks|Refusal of treatment|2|||
33365213|NCT00542425|62743690|FG002|Initial 24 Weeks|Refusal of treatment|1|||
33365214|NCT00542425|62743691|FG003|Initial 24 Weeks|Refusal of treatment|4|||
33365215|NCT00542425|62743692|FG004|Initial 24 Weeks|Refusal of treatment|1|||
33365216|NCT00542425|62743688|FG000|Initial 24 Weeks|Other|0|||
33365217|NCT00542425|62743689|FG001|Initial 24 Weeks|Other|2|||
33365218|NCT00542425|62743690|FG002|Initial 24 Weeks|Other|1|||
33365219|NCT00542425|62743691|FG003|Initial 24 Weeks|Other|0|||
33365220|NCT00542425|62743692|FG004|Initial 24 Weeks|Other|0|||
33365221|NCT00542425|62743688|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
33365222|NCT00542425|62743689|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
33365223|NCT00542425|62743690|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
33365224|NCT00542425|62743691|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
33365225|NCT00542425|62743692|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
33365226|NCT00542425|62743688|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
33365227|NCT00542425|62743689|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
33365228|NCT00542425|62743690|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
33365229|NCT00542425|62743691|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
33365230|NCT00542425|62743692|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
33365231|NCT00542425|62743688|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
33365232|NCT00542425|62743689|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
33365233|NCT00542425|62743690|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
33365234|NCT00542425|62743691|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
33365235|NCT00542425|62743692|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
33365236|NCT00542425|62743688|FG000|Extended 24 Weeks of Treatment|Other|1|||
33365237|NCT00542425|62743689|FG001|Extended 24 Weeks of Treatment|Other|1|||
33661221|NCT02709486|63090406|FG002|Overall Study|Lost to Follow-up|2|||
33661222|NCT02709486|63090404|FG000|Overall Study|Other|0|||
33554950|NCT02394028|62947716|FG008|Induction Phase|Sponsor decision|0|||
33365238|NCT00542425|62743690|FG002|Extended 24 Weeks of Treatment|Other|0|||
33365239|NCT00542425|62743691|FG003|Extended 24 Weeks of Treatment|Other|0|||
33365240|NCT00542425|62743692|FG004|Extended 24 Weeks of Treatment|Other|1|||
33365241|NCT00541099|62743704|FG000|Overall Study|Ineligible|3|||
33483912|NCT03756129|62860869|FG000|Overall Study|Withdrawal by Subject|2|||
33483913|NCT03756129|62860870|FG001|Overall Study|Withdrawal by Subject|1|||
33483914|NCT03756129|62860871|FG002|Overall Study|Withdrawal by Subject|3|||
33483915|NCT03756129|62860872|FG003|Overall Study|Withdrawal by Subject|1|||
33365242|NCT00580606|62743710|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
33365243|NCT00580606|62743711|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
33365244|NCT00580606|62743710|FG000|Open Label (OL)|Withdrawal by Subject|4|||
33365245|NCT00580606|62743711|FG001|Open Label (OL)|Withdrawal by Subject|6|||
33365246|NCT00580606|62743710|FG000|Open Label (OL)|Dosing Symptoms|0|||
33365247|NCT00580606|62743711|FG001|Open Label (OL)|Dosing Symptoms|1|||
33365248|NCT00580606|62743710|FG000|Open Label (OL)|Lost to Follow-up|0|||
33365249|NCT00580606|62743711|FG001|Open Label (OL)|Lost to Follow-up|1|||
33365250|NCT00580606|62743710|FG000|Open Label (OL)|Pregnancy|0|||
33365251|NCT00580606|62743711|FG001|Open Label (OL)|Pregnancy|1|||
33365252|NCT00580606|62743710|FG000|Open Label (OL)|Non-compliance|2|||
33365253|NCT00580606|62743711|FG001|Open Label (OL)|Non-compliance|0|||
33365254|NCT00580606|62743710|FG000|Open Label (OL)|Physician Decision|1|||
33365255|NCT00580606|62743711|FG001|Open Label (OL)|Physician Decision|1|||
33365256|NCT00580606|62743710|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
33661223|NCT02709486|63090405|FG001|Overall Study|Other|2|||
33365257|NCT00580606|62743711|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
33365258|NCT00579982|62743725|FG000|Overall Study|Adverse Event|4|||
33365259|NCT00579982|62743725|FG000|Overall Study|Protocol Violation|4|||
33365260|NCT00596466|62743729|FG000|Overall Study|Lack of Efficacy|5|||
33365261|NCT00596466|62743729|FG000|Overall Study|Adverse Event|4|||
33365262|NCT00596466|62743729|FG000|Overall Study|Withdrawal by Subject|2|||
33365263|NCT00596466|62743729|FG000|Overall Study|Protocol Violation|2|||
33365264|NCT00596466|62743729|FG000|Overall Study|Unpecified|2|||
33365265|NCT00596466|62743729|FG000|Overall Study|Enrolled, not treated|2|||
33365266|NCT00596934|62743733|FG000|Overall Study|Protocol Violation|1|||
33365267|NCT00596934|62743733|FG000|Overall Study|Withdrawal by Subject|1|||
33483916|NCT03756129|62860873|FG004|Overall Study|Withdrawal by Subject|1|||
33483917|NCT03756129|62860874|FG005|Overall Study|Withdrawal by Subject|3|||
33483918|NCT03756129|62860869|FG000|Overall Study|Lost to Follow-up|0|||
33483919|NCT03756129|62860870|FG001|Overall Study|Lost to Follow-up|0|||
33483920|NCT03756129|62860871|FG002|Overall Study|Lost to Follow-up|0|||
33483921|NCT03756129|62860872|FG003|Overall Study|Lost to Follow-up|0|||
33483922|NCT03756129|62860873|FG004|Overall Study|Lost to Follow-up|0|||
33483923|NCT03756129|62860874|FG005|Overall Study|Lost to Follow-up|1|||
33483924|NCT03756129|62860869|FG000|Overall Study|Physician Decision|0|||
33483925|NCT03756129|62860870|FG001|Overall Study|Physician Decision|0|||
33483926|NCT03756129|62860871|FG002|Overall Study|Physician Decision|0|||
33483927|NCT03756129|62860872|FG003|Overall Study|Physician Decision|0|||
33483928|NCT03756129|62860873|FG004|Overall Study|Physician Decision|0|||
33483929|NCT03756129|62860874|FG005|Overall Study|Physician Decision|1|||
33483930|NCT02822794|62860900|FG000|Overall Study|Withdrew Consent|1|||
33483931|NCT02822794|62860901|FG001|Overall Study|Withdrew Consent|0|||
33483932|NCT01338298|62860916|FG000|Overall Study|Withdrawal by Subject|1|||
33483933|NCT01338298|62860917|FG001|Overall Study|Withdrawal by Subject|1|||
33483934|NCT01338298|62860916|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
33483935|NCT01338298|62860917|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
33483936|NCT01338298|62860916|FG000|Overall Study|Administrative error|0|||
33483937|NCT01338298|62860917|FG001|Overall Study|Administrative error|1|||
33483938|NCT01338298|62860916|FG000|Overall Study|Positive symptom worsening|1|||
33483939|NCT01338298|62860917|FG001|Overall Study|Positive symptom worsening|0|||
33483940|NCT01338298|62860916|FG000|Overall Study|Depressive symptoms and nausea|1|||
33483941|NCT01338298|62860917|FG001|Overall Study|Depressive symptoms and nausea|0|||
33483942|NCT01338298|62860916|FG000|Overall Study|Non-adherence|1|||
33661224|NCT02709486|63090406|FG002|Overall Study|Other|3|||
33483943|NCT01338298|62860917|FG001|Overall Study|Non-adherence|0|||
33483944|NCT01354132|62860925|FG000|Randomization|Physician Decision|1|||
33483945|NCT01354132|62860926|FG001|Randomization|Physician Decision|0|||
33483946|NCT01354132|62860925|FG000|Randomization|Withdrawal by Subject|0|||
33483947|NCT01354132|62860926|FG001|Randomization|Withdrawal by Subject|1|||
33483948|NCT01354132|62860925|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
33661225|NCT02709486|63090404|FG000|Overall Study|Withdrawal by Subject|32|||
33365268|NCT03911401|62743742|FG000|Overall Study|Adverse Event|1|||
33365269|NCT03911401|62743743|FG001|Overall Study|Adverse Event|2|||
33365270|NCT03911401|62743744|FG002|Overall Study|Adverse Event|5|||
33483949|NCT01354132|62860926|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
33554951|NCT02394028|62947717|FG009|Induction Phase|Sponsor decision|0|||
33365271|NCT03911401|62743742|FG000|Overall Study|Lack of Efficacy|1|||
33554952|NCT02394028|62947718|FG010|Induction Phase|Sponsor decision|0|||
33554953|NCT02394028|62947708|FG000|Induction Phase|Technical reason|0|||
33554954|NCT02394028|62947709|FG001|Induction Phase|Technical reason|0|||
33554955|NCT02394028|62947710|FG002|Induction Phase|Technical reason|0|||
33554956|NCT02394028|62947711|FG003|Induction Phase|Technical reason|1|||
33661226|NCT02709486|63090405|FG001|Overall Study|Withdrawal by Subject|22|||
33554957|NCT02394028|62947712|FG004|Induction Phase|Technical reason|0|||
33483950|NCT01354132|62860925|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
33483951|NCT01354132|62860926|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
33483952|NCT01354132|62860925|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
33483953|NCT01354132|62860926|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
33554958|NCT02394028|62947713|FG005|Induction Phase|Technical reason|0|||
33554959|NCT02394028|62947714|FG006|Induction Phase|Technical reason|0|||
33554960|NCT02394028|62947715|FG007|Induction Phase|Technical reason|0|||
33554961|NCT02394028|62947716|FG008|Induction Phase|Technical reason|0|||
33365272|NCT03911401|62743743|FG001|Overall Study|Lack of Efficacy|1|||
33365273|NCT03911401|62743744|FG002|Overall Study|Lack of Efficacy|8|||
33365274|NCT03911401|62743742|FG000|Overall Study|Physician Decision|0|||
33365275|NCT03911401|62743743|FG001|Overall Study|Physician Decision|0|||
33365276|NCT03911401|62743744|FG002|Overall Study|Physician Decision|1|||
33483954|NCT01353898|62860941|FG000|Overall Study|Study site terminated|0|||
33483955|NCT01353898|62860942|FG001|Overall Study|Study site terminated|0|||
33365277|NCT03911401|62743742|FG000|Overall Study|Withdrawal by Subject|1|||
33483956|NCT01353898|62860943|FG002|Overall Study|Study site terminated|0|||
33554962|NCT02394028|62947717|FG009|Induction Phase|Technical reason|0|||
33365278|NCT03911401|62743743|FG001|Overall Study|Withdrawal by Subject|2|||
33365279|NCT03911401|62743744|FG002|Overall Study|Withdrawal by Subject|0|||
33365280|NCT03911401|62743742|FG000|Overall Study|Withdrawal by parent/guardian|4|||
33365281|NCT03911401|62743743|FG001|Overall Study|Withdrawal by parent/guardian|4|||
33365282|NCT03911401|62743744|FG002|Overall Study|Withdrawal by parent/guardian|11|||
33365283|NCT00579670|62743757|FG000|Overall Study|Death|1|||
33365284|NCT00579670|62743758|FG001|Overall Study|Death|0|||
33483957|NCT01353898|62860944|FG003|Overall Study|Study site terminated|0|||
33483958|NCT01353898|62860945|FG004|Overall Study|Study site terminated|0|||
33483959|NCT01353898|62860946|FG005|Overall Study|Study site terminated|1|||
33554963|NCT02394028|62947718|FG010|Induction Phase|Technical reason|0|||
33483960|NCT01372150|62860963|FG000|Overall Study|Lack of Efficacy|3|||
33365285|NCT00579670|62743759|FG002|Overall Study|Death|0|||
33365286|NCT00579670|62743760|FG003|Overall Study|Death|0|||
33483961|NCT01372150|62860964|FG001|Overall Study|Lack of Efficacy|0|||
33365287|NCT00579670|62743761|FG004|Overall Study|Death|0|||
33365288|NCT00579670|62743757|FG000|Overall Study|Adverse Event|1|||
33483962|NCT01372150|62860965|FG002|Overall Study|Lack of Efficacy|1|||
33483963|NCT01372150|62860963|FG000|Overall Study|Lost to Follow-up|4|||
33483964|NCT01372150|62860964|FG001|Overall Study|Lost to Follow-up|5|||
33483965|NCT01372150|62860965|FG002|Overall Study|Lost to Follow-up|6|||
33483966|NCT01372150|62860963|FG000|Overall Study|Protocol Violation|1|||
33483967|NCT01372150|62860964|FG001|Overall Study|Protocol Violation|0|||
33483968|NCT01372150|62860965|FG002|Overall Study|Protocol Violation|3|||
33483969|NCT01372150|62860963|FG000|Overall Study|Withdrawal by Subject|2|||
33483970|NCT01372150|62860964|FG001|Overall Study|Withdrawal by Subject|7|||
33483971|NCT01372150|62860965|FG002|Overall Study|Withdrawal by Subject|2|||
33483972|NCT01372150|62860963|FG000|Overall Study|Other|1|||
33483973|NCT01372150|62860964|FG001|Overall Study|Other|0|||
33483974|NCT01372150|62860965|FG002|Overall Study|Other|2|||
33483975|NCT01372150|62860963|FG000|Overall Study|Adverse Event|2|||
33483976|NCT01372150|62860964|FG001|Overall Study|Adverse Event|1|||
33483977|NCT01372150|62860965|FG002|Overall Study|Adverse Event|2|||
33483978|NCT01372150|62860963|FG000|Overall Study|Randomized but not treated|0|||
33483979|NCT01372150|62860964|FG001|Overall Study|Randomized but not treated|1|||
33483980|NCT01372150|62860965|FG002|Overall Study|Randomized but not treated|0|||
33483981|NCT03329690|62860978|FG000|Overall Study|Progressive disease per RECIST|85|||
33483982|NCT03329690|62860979|FG001|Overall Study|Progressive disease per RECIST|44|||
33483983|NCT03329690|62860980|FG002|Overall Study|Progressive disease per RECIST|6|||
33365289|NCT00579670|62743758|FG001|Overall Study|Adverse Event|0|||
33365290|NCT00579670|62743759|FG002|Overall Study|Adverse Event|1|||
33365291|NCT00579670|62743760|FG003|Overall Study|Adverse Event|2|||
33365292|NCT00579670|62743761|FG004|Overall Study|Adverse Event|0|||
33365293|NCT00579670|62743757|FG000|Overall Study|Lack of Efficacy|0|||
33365294|NCT00579670|62743758|FG001|Overall Study|Lack of Efficacy|0|||
33365295|NCT00579670|62743759|FG002|Overall Study|Lack of Efficacy|1|||
33365296|NCT00579670|62743760|FG003|Overall Study|Lack of Efficacy|14|||
33365297|NCT00579670|62743761|FG004|Overall Study|Lack of Efficacy|0|||
33483984|NCT03329690|62860981|FG003|Overall Study|Progressive disease per RECIST|16|||
33483985|NCT03329690|62860982|FG004|Overall Study|Progressive disease per RECIST|20|||
33483986|NCT03329690|62860978|FG000|Overall Study|Clinical progression|7|||
33483987|NCT03329690|62860979|FG001|Overall Study|Clinical progression|4|||
33483988|NCT03329690|62860980|FG002|Overall Study|Clinical progression|1|||
33483989|NCT03329690|62860981|FG003|Overall Study|Clinical progression|1|||
33365298|NCT00579670|62743757|FG000|Overall Study|Lost to Follow-up|0|||
33365299|NCT00579670|62743758|FG001|Overall Study|Lost to Follow-up|1|||
33661227|NCT02709486|63090406|FG002|Overall Study|Withdrawal by Subject|32|||
33661228|NCT03110770|63090423|FG000|Overall Study|Death|1|||
33661229|NCT03110770|63090424|FG001|Overall Study|Death|0|||
33661230|NCT03110770|63090425|FG002|Overall Study|Death|0|||
33661231|NCT03110770|63090426|FG003|Overall Study|Death|1|||
33661232|NCT03110770|63090427|FG004|Overall Study|Death|0|||
33661233|NCT03110770|63090423|FG000|Overall Study|Enrolled but did not receive product|0|||
33661234|NCT03110770|63090424|FG001|Overall Study|Enrolled but did not receive product|0|||
33661235|NCT03110770|63090425|FG002|Overall Study|Enrolled but did not receive product|0|||
33661236|NCT03110770|63090426|FG003|Overall Study|Enrolled but did not receive product|8|||
33661237|NCT03110770|63090427|FG004|Overall Study|Enrolled but did not receive product|7|||
33661238|NCT03110770|63090423|FG000|Overall Study|Lost to Follow-up|0|||
33365300|NCT00579670|62743759|FG002|Overall Study|Lost to Follow-up|0|||
33365301|NCT00579670|62743760|FG003|Overall Study|Lost to Follow-up|4|||
33365302|NCT00579670|62743761|FG004|Overall Study|Lost to Follow-up|0|||
33661239|NCT03110770|63090424|FG001|Overall Study|Lost to Follow-up|0|||
33365303|NCT00579670|62743757|FG000|Overall Study|Other|0|||
33365304|NCT00579670|62743758|FG001|Overall Study|Other|0|||
33483990|NCT03329690|62860982|FG004|Overall Study|Clinical progression|1|||
33483991|NCT03329690|62860978|FG000|Overall Study|Adverse Event|22|||
33483992|NCT03329690|62860979|FG001|Overall Study|Adverse Event|4|||
33661240|NCT03110770|63090425|FG002|Overall Study|Lost to Follow-up|0|||
33365305|NCT00579670|62743759|FG002|Overall Study|Other|1|||
33365306|NCT00579670|62743760|FG003|Overall Study|Other|2|||
33365307|NCT00579670|62743761|FG004|Overall Study|Other|0|||
33365308|NCT00579670|62743757|FG000|Overall Study|Withdrawal by Subject|0|||
33365309|NCT00579670|62743758|FG001|Overall Study|Withdrawal by Subject|0|||
33365310|NCT00579670|62743759|FG002|Overall Study|Withdrawal by Subject|1|||
33365311|NCT00579670|62743760|FG003|Overall Study|Withdrawal by Subject|0|||
33483993|NCT03329690|62860980|FG002|Overall Study|Adverse Event|0|||
33483994|NCT03329690|62860981|FG003|Overall Study|Adverse Event|1|||
33483995|NCT03329690|62860982|FG004|Overall Study|Adverse Event|2|||
33483996|NCT03329690|62860978|FG000|Overall Study|Death|2|||
33483997|NCT03329690|62860979|FG001|Overall Study|Death|0|||
33483998|NCT03329690|62860980|FG002|Overall Study|Death|0|||
33483999|NCT03329690|62860981|FG003|Overall Study|Death|1|||
33484000|NCT03329690|62860982|FG004|Overall Study|Death|0|||
33484001|NCT03329690|62860978|FG000|Overall Study|Withdrawal by Subject|2|||
33484002|NCT03329690|62860979|FG001|Overall Study|Withdrawal by Subject|3|||
33484003|NCT03329690|62860980|FG002|Overall Study|Withdrawal by Subject|0|||
33484004|NCT03329690|62860981|FG003|Overall Study|Withdrawal by Subject|1|||
33484005|NCT03329690|62860982|FG004|Overall Study|Withdrawal by Subject|0|||
33484006|NCT03329690|62860978|FG000|Overall Study|Physician Decision|1|||
33484007|NCT03329690|62860979|FG001|Overall Study|Physician Decision|0|||
33484008|NCT03329690|62860980|FG002|Overall Study|Physician Decision|0|||
33484009|NCT03329690|62860981|FG003|Overall Study|Physician Decision|0|||
33484010|NCT03329690|62860982|FG004|Overall Study|Physician Decision|1|||
33484011|NCT03329690|62860978|FG000|Overall Study|Miscellaneous|6|||
33484012|NCT03329690|62860979|FG001|Overall Study|Miscellaneous|0|||
33365312|NCT00579670|62743761|FG004|Overall Study|Withdrawal by Subject|0|||
33365313|NCT03909295|62743785|FG000|Overall Study|Adverse Event|2|||
33365314|NCT03909295|62743785|FG000|Overall Study|Study terminated by sponsor|50|||
33365315|NCT00599924|62743796|FG000|Overall Study|Lack of Efficacy|3|||
33365316|NCT00599924|62743797|FG001|Overall Study|Lack of Efficacy|5|||
33365317|NCT00599924|62743798|FG002|Overall Study|Lack of Efficacy|1|||
33365318|NCT00599924|62743799|FG003|Overall Study|Lack of Efficacy|2|||
33484013|NCT03329690|62860980|FG002|Overall Study|Miscellaneous|0|||
33554964|NCT02394028|62947708|FG000|Induction Phase|:ack of calculation|0|||
33365319|NCT00599924|62743800|FG004|Overall Study|Lack of Efficacy|3|||
33365320|NCT00599924|62743801|FG005|Overall Study|Lack of Efficacy|2|||
33484014|NCT03329690|62860981|FG003|Overall Study|Miscellaneous|0|||
33484015|NCT03329690|62860982|FG004|Overall Study|Miscellaneous|0|||
33484016|NCT03329690|62860978|FG000|Overall Study|Did not receive treatment|1|||
33484017|NCT03329690|62860979|FG001|Overall Study|Did not receive treatment|0|||
33484018|NCT03329690|62860980|FG002|Overall Study|Did not receive treatment|0|||
33484019|NCT03329690|62860981|FG003|Overall Study|Did not receive treatment|1|||
33484020|NCT03329690|62860982|FG004|Overall Study|Did not receive treatment|0|||
33484021|NCT03328832|62861002|FG000|Overall Study|Lost to Follow-up|0|||
33484022|NCT03328832|62861003|FG001|Overall Study|Lost to Follow-up|1|||
33484023|NCT02820844|62861011|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
33484024|NCT02820844|62861012|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
33484025|NCT02820844|62861013|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
33484026|NCT02820844|62861014|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
33484027|NCT02820844|62861015|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
33484028|NCT02820844|62861016|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
33484029|NCT02820844|62861011|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
33661241|NCT03110770|63090426|FG003|Overall Study|Lost to Follow-up|53|||
33365321|NCT00599924|62743802|FG006|Overall Study|Lack of Efficacy|0|||
33484030|NCT02820844|62861012|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
33484031|NCT02820844|62861013|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
33484032|NCT02820844|62861014|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
33484033|NCT02820844|62861015|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
33484034|NCT02820844|62861016|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
33484035|NCT02820844|62861011|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
33484036|NCT02820844|62861012|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
33484037|NCT02820844|62861013|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
33484038|NCT02820844|62861014|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
33484039|NCT02820844|62861015|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
33484040|NCT02820844|62861016|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
33484041|NCT02820844|62861011|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
33484042|NCT02820844|62861012|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
33484043|NCT02820844|62861013|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
33484044|NCT02820844|62861014|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
33484045|NCT02820844|62861015|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
33484046|NCT02820844|62861016|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
33484047|NCT02820844|62861011|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
33484048|NCT02820844|62861012|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
33365322|NCT00599924|62743796|FG000|Overall Study|Adverse Event|0|||
33484049|NCT02820844|62861013|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
33484050|NCT02820844|62861014|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
33484051|NCT02820844|62861015|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
33484052|NCT02820844|62861016|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
33484053|NCT02820844|62861011|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
33484054|NCT02820844|62861012|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
33554965|NCT02394028|62947709|FG001|Induction Phase|:ack of calculation|0|||
33554966|NCT02394028|62947710|FG002|Induction Phase|:ack of calculation|0|||
33554967|NCT02394028|62947711|FG003|Induction Phase|:ack of calculation|0|||
33661242|NCT03110770|63090427|FG004|Overall Study|Lost to Follow-up|45|||
33661243|NCT03110770|63090423|FG000|Overall Study|Investigator Decision|0|||
33661244|NCT03110770|63090424|FG001|Overall Study|Investigator Decision|0|||
33661245|NCT03110770|63090425|FG002|Overall Study|Investigator Decision|0|||
33661246|NCT03110770|63090426|FG003|Overall Study|Investigator Decision|5|||
33661247|NCT03110770|63090427|FG004|Overall Study|Investigator Decision|3|||
33661248|NCT03110770|63090423|FG000|Overall Study|Withdrawal by Subject|0|||
33661249|NCT03110770|63090424|FG001|Overall Study|Withdrawal by Subject|0|||
33365323|NCT00599924|62743797|FG001|Overall Study|Adverse Event|0|||
33661250|NCT03110770|63090425|FG002|Overall Study|Withdrawal by Subject|0|||
33365324|NCT00599924|62743798|FG002|Overall Study|Adverse Event|0|||
33365325|NCT00599924|62743799|FG003|Overall Study|Adverse Event|2|||
33365326|NCT00599924|62743800|FG004|Overall Study|Adverse Event|0|||
33554968|NCT02394028|62947712|FG004|Induction Phase|:ack of calculation|0|||
33365327|NCT00599924|62743801|FG005|Overall Study|Adverse Event|0|||
33365328|NCT00599924|62743802|FG006|Overall Study|Adverse Event|2|||
33365329|NCT00599924|62743796|FG000|Overall Study|Death|0|||
33661251|NCT03110770|63090426|FG003|Overall Study|Withdrawal by Subject|24|||
33365330|NCT00599924|62743797|FG001|Overall Study|Death|0|||
33365331|NCT00599924|62743798|FG002|Overall Study|Death|0|||
33365332|NCT00599924|62743799|FG003|Overall Study|Death|2|||
33365333|NCT00599924|62743800|FG004|Overall Study|Death|0|||
33365334|NCT00599924|62743801|FG005|Overall Study|Death|2|||
33365335|NCT00599924|62743802|FG006|Overall Study|Death|1|||
33365336|NCT00599924|62743796|FG000|Overall Study|Protocol Violation|0|||
33365337|NCT00599924|62743797|FG001|Overall Study|Protocol Violation|0|||
33365338|NCT00599924|62743798|FG002|Overall Study|Protocol Violation|0|||
33365339|NCT00599924|62743799|FG003|Overall Study|Protocol Violation|1|||
33365340|NCT00599924|62743800|FG004|Overall Study|Protocol Violation|0|||
33365341|NCT00599924|62743801|FG005|Overall Study|Protocol Violation|0|||
33365342|NCT00599924|62743802|FG006|Overall Study|Protocol Violation|0|||
33365343|NCT00599924|62743796|FG000|Overall Study|Withdrawal by Subject|0|||
33365344|NCT00599924|62743797|FG001|Overall Study|Withdrawal by Subject|0|||
33365345|NCT00599924|62743798|FG002|Overall Study|Withdrawal by Subject|1|||
33365346|NCT00599924|62743799|FG003|Overall Study|Withdrawal by Subject|0|||
33365347|NCT00599924|62743800|FG004|Overall Study|Withdrawal by Subject|1|||
33365348|NCT00599924|62743801|FG005|Overall Study|Withdrawal by Subject|0|||
33365349|NCT00599924|62743802|FG006|Overall Study|Withdrawal by Subject|0|||
33365350|NCT00599924|62743796|FG000|Overall Study|Other|0|||
33554969|NCT02394028|62947713|FG005|Induction Phase|:ack of calculation|0|||
33365351|NCT00599924|62743797|FG001|Overall Study|Other|0|||
33365352|NCT00599924|62743798|FG002|Overall Study|Other|0|||
33365353|NCT00599924|62743799|FG003|Overall Study|Other|1|||
33365354|NCT00599924|62743800|FG004|Overall Study|Other|2|||
33365355|NCT00599924|62743801|FG005|Overall Study|Other|0|||
33365356|NCT00599924|62743802|FG006|Overall Study|Other|2|||
33365357|NCT00581542|62743825|FG000|Overall Study|they met an exclusion criteria|2|||
33365358|NCT00581542|62743826|FG001|Overall Study|they met an exclusion criteria|2|||
33365359|NCT00581542|62743825|FG000|Overall Study|Lost to Follow-up|9|||
33365360|NCT00581542|62743826|FG001|Overall Study|Lost to Follow-up|21|||
33365361|NCT03912337|62743836|FG000|Overall Study|Withdrawal of Consent From Study|1|||
33365362|NCT03912337|62743837|FG001|Overall Study|Withdrawal of Consent From Study|0|||
33365363|NCT03912337|62743836|FG000|Overall Study|Lost to Follow-up|1|||
33365364|NCT03912337|62743837|FG001|Overall Study|Lost to Follow-up|1|||
33365365|NCT03912259|62743845|FG000|Overall Study|Adverse Event (AE)|2|||
33365366|NCT03912259|62743846|FG001|Overall Study|Adverse Event (AE)|4|||
33365367|NCT03912259|62743845|FG000|Overall Study|Lack of Efficacy|4|||
33365368|NCT03912259|62743846|FG001|Overall Study|Lack of Efficacy|1|||
33365369|NCT03912259|62743845|FG000|Overall Study|Withdrawal by Subject|11|||
33365370|NCT03912259|62743846|FG001|Overall Study|Withdrawal by Subject|1|||
33365371|NCT02121652|62743855|FG000|Overall Study|Lost to Follow-up|2|||
33484055|NCT02820844|62861013|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
33661252|NCT03110770|63090427|FG004|Overall Study|Withdrawal by Subject|24|||
33661253|NCT03110770|63090423|FG000|Overall Study|Moved from area|5|||
33661254|NCT03110770|63090424|FG001|Overall Study|Moved from area|0|||
33661255|NCT03110770|63090425|FG002|Overall Study|Moved from area|2|||
33661256|NCT03110770|63090426|FG003|Overall Study|Moved from area|42|||
33661257|NCT03110770|63090427|FG004|Overall Study|Moved from area|43|||
33661258|NCT03110770|63090423|FG000|Overall Study|Illness/Injury unrelated to product|0|||
33661259|NCT03110770|63090424|FG001|Overall Study|Illness/Injury unrelated to product|0|||
33365372|NCT02121652|62743856|FG001|Overall Study|Lost to Follow-up|1|||
33661260|NCT03110770|63090425|FG002|Overall Study|Illness/Injury unrelated to product|0|||
33365373|NCT02121652|62743855|FG000|Overall Study|Death|1|||
33661261|NCT03110770|63090426|FG003|Overall Study|Illness/Injury unrelated to product|0|||
33661262|NCT03110770|63090427|FG004|Overall Study|Illness/Injury unrelated to product|1|||
33661263|NCT00703326|63090633|FG000|Overall Study|Lost to Follow-up|47|||
33661264|NCT00703326|63090634|FG001|Overall Study|Lost to Follow-up|18|||
33661265|NCT00703326|63090633|FG000|Overall Study|Withdrawal by Subject|54|||
33661266|NCT00703326|63090634|FG001|Overall Study|Withdrawal by Subject|20|||
33661267|NCT00703326|63090633|FG000|Overall Study|Adverse Event|1|||
33661268|NCT00703326|63090634|FG001|Overall Study|Adverse Event|0|||
33365374|NCT02121652|62743856|FG001|Overall Study|Death|0|||
33365375|NCT02121652|62743855|FG000|Overall Study|Withdrawal by Subject|3|||
33365376|NCT02121652|62743856|FG001|Overall Study|Withdrawal by Subject|3|||
33365377|NCT00595920|62743875|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
33661269|NCT04868500|63090687|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
33661270|NCT04868500|63090688|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
33365378|NCT00595764|62743881|FG000|Overall Study|Protocol Violation|24|||
33365379|NCT00595764|62743882|FG001|Overall Study|Protocol Violation|19|||
33365380|NCT00595764|62743881|FG000|Overall Study|Missed Medication >1 week|10|||
33365381|NCT00595764|62743882|FG001|Overall Study|Missed Medication >1 week|17|||
33365382|NCT00595764|62743881|FG000|Overall Study|Missed 3 PM visits|1|||
33365383|NCT00595764|62743882|FG001|Overall Study|Missed 3 PM visits|7|||
33365384|NCT00595764|62743881|FG000|Overall Study|Withdrawal by Subject|4|||
33365385|NCT00595764|62743882|FG001|Overall Study|Withdrawal by Subject|0|||
33365386|NCT00581308|62743902|FG000|Pre Discharge|Lost to Follow-up|1|||
33365387|NCT00581308|62743902|FG000|Pre Discharge|Device Removed|1|||
33365388|NCT00581308|62743902|FG000|Month 1|Lost to Follow-up|3|||
33365389|NCT00581308|62743902|FG000|Month 1|Withdrawal by Subject|2|||
33365390|NCT00581308|62743902|FG000|Month 1|Device Removed|2|||
33365391|NCT00581308|62743902|FG000|Month 1|Uknown|1|||
33365392|NCT00581308|62743902|FG000|Month 6|Lost to Follow-up|1|||
33365393|NCT00581308|62743902|FG000|Month 6|Withdrawal by Subject|2|||
33365394|NCT00581308|62743902|FG000|Month 12|Death|1|||
33365395|NCT00581308|62743902|FG000|Month 12|Lost to Follow-up|14|||
33365396|NCT00581308|62743902|FG000|Month 12|Withdrawal by Subject|3|||
33365397|NCT00581308|62743902|FG000|Month 12|Device Removed|1|||
33365398|NCT00581308|62743902|FG000|Month 12|Other|1|||
33365399|NCT00877890|62743911|FG000|Overall Study|Adverse Event|6|||
33365400|NCT00877890|62743912|FG001|Overall Study|Adverse Event|6|||
33365401|NCT00877890|62743911|FG000|Overall Study|Lost to Follow-up|5|||
33365402|NCT00877890|62743912|FG001|Overall Study|Lost to Follow-up|5|||
33365403|NCT00877890|62743911|FG000|Overall Study|Protocol Violation|0|||
33365404|NCT00877890|62743912|FG001|Overall Study|Protocol Violation|1|||
33365405|NCT00877890|62743911|FG000|Overall Study|Withdrawal of Consent|6|||
33365406|NCT00877890|62743912|FG001|Overall Study|Withdrawal of Consent|12|||
33365407|NCT00877890|62743911|FG000|Overall Study|Investigator Decision|0|||
33365408|NCT00877890|62743912|FG001|Overall Study|Investigator Decision|2|||
33365409|NCT00877890|62743911|FG000|Overall Study|Loss of Glucose Control|3|||
33365410|NCT00877890|62743912|FG001|Overall Study|Loss of Glucose Control|4|||
33365411|NCT03474679|62743922|FG000|Overall Study|Death|7|||
33365412|NCT03474679|62743922|FG000|Overall Study|Withdrawal by Subject|1|||
33365413|NCT03472885|62743926|FG000|Overall Study|Adverse Event|1|||
33365414|NCT03905863|62743932|FG000|Overall Study|Adverse Event|2|||
33365415|NCT03905863|62743933|FG001|Overall Study|Adverse Event|4|||
33365416|NCT03905863|62743932|FG000|Overall Study|Withdrawal by Subject|2|||
33365417|NCT03905863|62743933|FG001|Overall Study|Withdrawal by Subject|2|||
33365418|NCT03905863|62743932|FG000|Overall Study|Physician Decision|0|||
33365419|NCT03905863|62743933|FG001|Overall Study|Physician Decision|3|||
33365420|NCT03905863|62743932|FG000|Overall Study|Lost to Follow-up|1|||
33365421|NCT03905863|62743933|FG001|Overall Study|Lost to Follow-up|0|||
33365422|NCT03905863|62743932|FG000|Overall Study|Protocol Violation|0|||
33365423|NCT03905863|62743933|FG001|Overall Study|Protocol Violation|2|||
33365424|NCT03905863|62743932|FG000|Overall Study|Death|0|||
33365425|NCT03905863|62743933|FG001|Overall Study|Death|1|||
33365426|NCT04067011|62743942|FG000|Overall Study|Not Treated|8|||
33365427|NCT04067011|62743943|FG001|Overall Study|Not Treated|7|||
33365428|NCT04067011|62743944|FG002|Overall Study|Not Treated|5|||
33365429|NCT04067011|62743942|FG000|Overall Study|Adverse Event|2|||
33365430|NCT04067011|62743943|FG001|Overall Study|Adverse Event|1|||
33365431|NCT04067011|62743944|FG002|Overall Study|Adverse Event|0|||
33365432|NCT04067011|62743942|FG000|Overall Study|Withdrawal by Subject|6|||
33365433|NCT04067011|62743943|FG001|Overall Study|Withdrawal by Subject|2|||
33365434|NCT04067011|62743944|FG002|Overall Study|Withdrawal by Subject|1|||
33365435|NCT04067011|62743942|FG000|Overall Study|Lost to Follow-up|0|||
33365436|NCT04067011|62743943|FG001|Overall Study|Lost to Follow-up|0|||
33365437|NCT04067011|62743944|FG002|Overall Study|Lost to Follow-up|1|||
33365438|NCT04067011|62743942|FG000|Overall Study|Physician Decision|1|||
33365439|NCT04067011|62743943|FG001|Overall Study|Physician Decision|1|||
33365440|NCT04067011|62743944|FG002|Overall Study|Physician Decision|0|||
33365441|NCT04067011|62743942|FG000|Overall Study|Other Reasons|2|||
33365442|NCT04067011|62743943|FG001|Overall Study|Other Reasons|0|||
33365443|NCT04067011|62743944|FG002|Overall Study|Other Reasons|1|||
33365444|NCT04067011|62743942|FG000|Overall Study|Missing|0|||
33365445|NCT04067011|62743943|FG001|Overall Study|Missing|2|||
33365446|NCT04067011|62743944|FG002|Overall Study|Missing|0|||
33365447|NCT00539305|62743988|FG000|Overall Study|Adverse Event|1|||
33365448|NCT00539305|62743989|FG001|Overall Study|Adverse Event|0|||
33365449|NCT00539305|62743988|FG000|Overall Study|Substance Use|0|||
33365450|NCT00539305|62743989|FG001|Overall Study|Substance Use|1|||
33365451|NCT00539305|62743988|FG000|Overall Study|Withdrawal by Subject|0|||
33365452|NCT00539305|62743989|FG001|Overall Study|Withdrawal by Subject|1|||
33365453|NCT04469465|62744016|FG000|Overall Study|Adverse Event|2|||
33365454|NCT04469465|62744017|FG001|Overall Study|Adverse Event|1|||
33365455|NCT04469465|62744016|FG000|Overall Study|Ongoing treatment|7|||
33365456|NCT04469465|62744017|FG001|Overall Study|Ongoing treatment|4|||
33365457|NCT04469465|62744016|FG000|Overall Study|Withdrawal by Subject|0|||
33365458|NCT04469465|62744017|FG001|Overall Study|Withdrawal by Subject|1|||
33365459|NCT00877032|62744030|FG000|Overall Study|Did not meet entrance criteria|0|||
33365460|NCT00877032|62744031|FG001|Overall Study|Did not meet entrance criteria|0|||
33365461|NCT00877032|62744032|FG002|Overall Study|Did not meet entrance criteria|0|||
33365462|NCT00877032|62744033|FG003|Overall Study|Did not meet entrance criteria|1|||
33365463|NCT00877032|62744034|FG004|Overall Study|Did not meet entrance criteria|0|||
33365464|NCT00877032|62744035|FG005|Overall Study|Did not meet entrance criteria|0|||
33365465|NCT00877032|62744036|FG006|Overall Study|Did not meet entrance criteria|2|||
33365466|NCT00538681|62744075|FG000|Overall Study|Progressive Disease|7|||
33365467|NCT00538681|62744076|FG001|Overall Study|Progressive Disease|0|||
33365468|NCT00538681|62744077|FG002|Overall Study|Progressive Disease|1|||
33365469|NCT00538681|62744078|FG003|Overall Study|Progressive Disease|0|||
33661271|NCT04868500|63090687|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
33365470|NCT00538681|62744075|FG000|Overall Study|Sponsor Decision|1|||
33365471|NCT00538681|62744076|FG001|Overall Study|Sponsor Decision|3|||
33365472|NCT00538681|62744077|FG002|Overall Study|Sponsor Decision|8|||
33365473|NCT00538681|62744078|FG003|Overall Study|Sponsor Decision|9|||
33365474|NCT00538681|62744075|FG000|Overall Study|Adverse Event|1|||
33365475|NCT00538681|62744076|FG001|Overall Study|Adverse Event|1|||
33661272|NCT04868500|63090688|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
33661273|NCT04372186|63090696|FG000|Overall Study|Death|24|||
33661274|NCT04372186|63090697|FG001|Overall Study|Death|11|||
33661275|NCT04372186|63090696|FG000|Overall Study|Transferred to a different facility for care|0|||
33661276|NCT04372186|63090697|FG001|Overall Study|Transferred to a different facility for care|2|||
33365476|NCT00538681|62744077|FG002|Overall Study|Adverse Event|1|||
33554970|NCT02394028|62947714|FG006|Induction Phase|:ack of calculation|0|||
33554971|NCT02394028|62947715|FG007|Induction Phase|:ack of calculation|1|||
33365477|NCT00538681|62744078|FG003|Overall Study|Adverse Event|0|||
33365478|NCT00538681|62744075|FG000|Overall Study|Death|0|||
33365479|NCT00538681|62744076|FG001|Overall Study|Death|0|||
33365480|NCT00538681|62744077|FG002|Overall Study|Death|1|||
33365481|NCT00538681|62744078|FG003|Overall Study|Death|1|||
33365482|NCT00538681|62744075|FG000|Overall Study|Investigator Decision|0|||
33365483|NCT00538681|62744076|FG001|Overall Study|Investigator Decision|0|||
33365484|NCT00538681|62744077|FG002|Overall Study|Investigator Decision|0|||
33365485|NCT00538681|62744078|FG003|Overall Study|Investigator Decision|1|||
33365486|NCT00876018|62744092|FG000|Overall Study|Lost to Follow-up|0|||
33365487|NCT00876018|62744093|FG001|Overall Study|Lost to Follow-up|1|||
33365488|NCT00876018|62744094|FG002|Overall Study|Lost to Follow-up|1|||
33365489|NCT00876018|62744092|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
33365490|NCT00876018|62744093|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
33365491|NCT00876018|62744094|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
33365492|NCT03885934|62744119|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
33365493|NCT03885934|62744120|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
33365494|NCT03885934|62744121|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
33365495|NCT03885934|62744122|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
33365496|NCT03885934|62744123|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
33365497|NCT03885934|62744124|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
33365498|NCT00875706|62744141|FG000|Overall Study|Withdrawal by Subject|1|||
33365499|NCT00875706|62744142|FG001|Overall Study|Withdrawal by Subject|0|||
33365500|NCT00875706|62744143|FG002|Overall Study|Withdrawal by Subject|0|||
33365501|NCT04399889|62744154|FG000|Overall Study|Death|5|||
33365502|NCT04399889|62744155|FG001|Overall Study|Death|1|||
33365503|NCT04399889|62744156|FG002|Overall Study|Death|1|||
33365504|NCT00837265|62744171|FG000|Pilot Phase|Withdrawal by Subject|0|||
33365505|NCT00837265|62744172|FG001|Pilot Phase|Withdrawal by Subject|2|||
33365506|NCT00837265|62744173|FG002|Pilot Phase|Withdrawal by Subject|3|||
33365507|NCT00837265|62744174|FG003|Pilot Phase|Withdrawal by Subject|2|||
33365508|NCT00837265|62744175|FG004|Pilot Phase|Withdrawal by Subject|0|||
33365509|NCT00837265|62744176|FG005|Pilot Phase|Withdrawal by Subject|0|||
33365510|NCT00837265|62744177|FG006|Pilot Phase|Withdrawal by Subject|0|||
33365511|NCT00837265|62744171|FG000|Pilot Phase|Decision of the investigator|2|||
33365512|NCT00837265|62744172|FG001|Pilot Phase|Decision of the investigator|1|||
33365513|NCT00837265|62744173|FG002|Pilot Phase|Decision of the investigator|0|||
33365514|NCT00837265|62744174|FG003|Pilot Phase|Decision of the investigator|0|||
33365515|NCT00837265|62744175|FG004|Pilot Phase|Decision of the investigator|0|||
33365516|NCT00837265|62744176|FG005|Pilot Phase|Decision of the investigator|0|||
33365517|NCT00837265|62744177|FG006|Pilot Phase|Decision of the investigator|0|||
33365518|NCT00837265|62744171|FG000|Pilot Phase|Adverse Event|1|||
33365519|NCT00837265|62744172|FG001|Pilot Phase|Adverse Event|0|||
33365520|NCT00837265|62744173|FG002|Pilot Phase|Adverse Event|0|||
33365521|NCT00837265|62744174|FG003|Pilot Phase|Adverse Event|0|||
33365522|NCT00837265|62744175|FG004|Pilot Phase|Adverse Event|0|||
33365523|NCT00837265|62744176|FG005|Pilot Phase|Adverse Event|0|||
33365524|NCT00837265|62744177|FG006|Pilot Phase|Adverse Event|0|||
33365525|NCT00837265|62744171|FG000|Pilot Phase|Disease progression|0|||
33365526|NCT00837265|62744172|FG001|Pilot Phase|Disease progression|0|||
33365527|NCT00837265|62744173|FG002|Pilot Phase|Disease progression|0|||
33365528|NCT00837265|62744174|FG003|Pilot Phase|Disease progression|1|||
33365529|NCT00837265|62744175|FG004|Pilot Phase|Disease progression|0|||
33365530|NCT00837265|62744176|FG005|Pilot Phase|Disease progression|0|||
33365531|NCT00837265|62744177|FG006|Pilot Phase|Disease progression|0|||
33365532|NCT00837265|62744171|FG000|Pilot Phase|Participant left the city|0|||
33365533|NCT00837265|62744172|FG001|Pilot Phase|Participant left the city|0|||
33365534|NCT00837265|62744173|FG002|Pilot Phase|Participant left the city|0|||
33365535|NCT00837265|62744174|FG003|Pilot Phase|Participant left the city|1|||
33365536|NCT00837265|62744175|FG004|Pilot Phase|Participant left the city|0|||
33365537|NCT00837265|62744176|FG005|Pilot Phase|Participant left the city|0|||
33365538|NCT00837265|62744177|FG006|Pilot Phase|Participant left the city|0|||
33365539|NCT00837265|62744171|FG000|Main Phase|Withdrawal by Subject|0|||
33365540|NCT00837265|62744172|FG001|Main Phase|Withdrawal by Subject|0|||
33365541|NCT00837265|62744173|FG002|Main Phase|Withdrawal by Subject|0|||
33365542|NCT00837265|62744174|FG003|Main Phase|Withdrawal by Subject|0|||
33365543|NCT00837265|62744175|FG004|Main Phase|Withdrawal by Subject|4|||
33365544|NCT00837265|62744176|FG005|Main Phase|Withdrawal by Subject|2|||
33365545|NCT00837265|62744177|FG006|Main Phase|Withdrawal by Subject|1|||
33365546|NCT00837265|62744171|FG000|Main Phase|Decision of the investigator|0|||
33365547|NCT00837265|62744172|FG001|Main Phase|Decision of the investigator|0|||
33365548|NCT00837265|62744173|FG002|Main Phase|Decision of the investigator|0|||
33365549|NCT00837265|62744174|FG003|Main Phase|Decision of the investigator|0|||
33365550|NCT00837265|62744175|FG004|Main Phase|Decision of the investigator|0|||
33365551|NCT00837265|62744176|FG005|Main Phase|Decision of the investigator|2|||
33365552|NCT00837265|62744177|FG006|Main Phase|Decision of the investigator|1|||
33365553|NCT00837265|62744171|FG000|Main Phase|Adverse Event|0|||
33365554|NCT00837265|62744172|FG001|Main Phase|Adverse Event|0|||
33365555|NCT00837265|62744173|FG002|Main Phase|Adverse Event|0|||
33554972|NCT02394028|62947716|FG008|Induction Phase|:ack of calculation|0|||
33554973|NCT02394028|62947717|FG009|Induction Phase|:ack of calculation|0|||
33365556|NCT00837265|62744174|FG003|Main Phase|Adverse Event|0|||
33365557|NCT00837265|62744175|FG004|Main Phase|Adverse Event|0|||
33365558|NCT00837265|62744176|FG005|Main Phase|Adverse Event|1|||
33484056|NCT02820844|62861014|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
33661277|NCT04317040|63090727|FG000|Overall Study|Lost to Follow-up|2|||
33661278|NCT04317040|63090728|FG001|Overall Study|Lost to Follow-up|0|||
33661279|NCT04317040|63090727|FG000|Overall Study|Death|16|||
33661280|NCT04317040|63090728|FG001|Overall Study|Death|18|||
33661281|NCT04317040|63090727|FG000|Overall Study|Withdrawal by Subject|0|||
33661282|NCT04317040|63090728|FG001|Overall Study|Withdrawal by Subject|1|||
33365559|NCT00837265|62744177|FG006|Main Phase|Adverse Event|0|||
33365560|NCT00837265|62744171|FG000|Main Phase|Death|0|||
33365561|NCT00837265|62744172|FG001|Main Phase|Death|0|||
33365562|NCT00837265|62744173|FG002|Main Phase|Death|0|||
33661283|NCT04317040|63090727|FG000|Overall Study|Incomplete assessments|0|||
33661284|NCT04317040|63090728|FG001|Overall Study|Incomplete assessments|1|||
33661285|NCT00703014|63090808|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
33661286|NCT00703014|63090809|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
33661287|NCT00703014|63090810|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
33661288|NCT00703014|63090811|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
33661289|NCT00703014|63090808|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
33661290|NCT00703014|63090809|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
33661291|NCT00703014|63090810|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
33661292|NCT00703014|63090811|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
33661293|NCT03915496|63090859|FG000|Overall Study|Adverse Event|2|||
33661294|NCT03915496|63090860|FG001|Overall Study|Adverse Event|1|||
33661295|NCT03915496|63090861|FG002|Overall Study|Adverse Event|2|||
33365563|NCT00837265|62744174|FG003|Main Phase|Death|0|||
33365564|NCT00837265|62744175|FG004|Main Phase|Death|2|||
33365565|NCT00837265|62744176|FG005|Main Phase|Death|0|||
33365566|NCT00837265|62744177|FG006|Main Phase|Death|1|||
33365567|NCT00837265|62744171|FG000|Main Phase|Lost to Follow-up|0|||
33554974|NCT02394028|62947718|FG010|Induction Phase|:ack of calculation|0|||
33554975|NCT02394028|62947708|FG000|Maintenance Phase|Protocol Violation|0|||
33661296|NCT02709330|63090878|FG000|Overall Study|Death|5|||
33365568|NCT00837265|62744172|FG001|Main Phase|Lost to Follow-up|0|||
33365569|NCT00837265|62744173|FG002|Main Phase|Lost to Follow-up|0|||
33365570|NCT00837265|62744174|FG003|Main Phase|Lost to Follow-up|0|||
33365571|NCT00837265|62744175|FG004|Main Phase|Lost to Follow-up|1|||
33365572|NCT00837265|62744176|FG005|Main Phase|Lost to Follow-up|0|||
33365573|NCT00837265|62744177|FG006|Main Phase|Lost to Follow-up|0|||
33365574|NCT00837265|62744171|FG000|Main Phase|Principal investigator resignation|0|||
33365575|NCT00837265|62744172|FG001|Main Phase|Principal investigator resignation|0|||
33365576|NCT00837265|62744173|FG002|Main Phase|Principal investigator resignation|0|||
33365577|NCT00837265|62744174|FG003|Main Phase|Principal investigator resignation|0|||
33365578|NCT00837265|62744175|FG004|Main Phase|Principal investigator resignation|2|||
33365579|NCT00837265|62744176|FG005|Main Phase|Principal investigator resignation|0|||
33365580|NCT00837265|62744177|FG006|Main Phase|Principal investigator resignation|0|||
33365581|NCT00837265|62744171|FG000|Main Phase|Participant's personal reason|0|||
33365582|NCT00837265|62744172|FG001|Main Phase|Participant's personal reason|0|||
33365583|NCT00837265|62744173|FG002|Main Phase|Participant's personal reason|0|||
33365584|NCT00837265|62744174|FG003|Main Phase|Participant's personal reason|0|||
33365585|NCT00837265|62744175|FG004|Main Phase|Participant's personal reason|1|||
33365586|NCT00837265|62744176|FG005|Main Phase|Participant's personal reason|0|||
33365587|NCT00837265|62744177|FG006|Main Phase|Participant's personal reason|0|||
33365588|NCT00594516|62744190|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
33365589|NCT00594516|62744191|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
33365590|NCT00594516|62744192|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
33365591|NCT00594516|62744190|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
33365592|NCT00594516|62744191|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
33365593|NCT00594516|62744192|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
33365594|NCT00594516|62744190|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
33365595|NCT00594516|62744191|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
33661297|NCT02709330|63090879|FG001|Overall Study|Death|0|||
33661298|NCT02709330|63090878|FG000|Overall Study|Lost to Follow-up|2|||
33365596|NCT00594516|62744192|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
33365597|NCT00594516|62744190|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
33365598|NCT00594516|62744191|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
33365599|NCT00594516|62744192|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
33365600|NCT00594516|62744190|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
33661299|NCT02709330|63090879|FG001|Overall Study|Lost to Follow-up|0|||
33365601|NCT00594516|62744191|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
33365602|NCT00594516|62744192|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
33365603|NCT00594516|62744190|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
33365604|NCT00594516|62744191|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
33365605|NCT00594516|62744192|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
33365606|NCT00594516|62744190|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
33365607|NCT00594516|62744191|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
33365608|NCT00594516|62744192|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
33365609|NCT00594516|62744190|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
33365610|NCT00594516|62744191|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
33365611|NCT00594516|62744192|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
33365612|NCT00594516|62744190|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
33365613|NCT00594516|62744191|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
33365614|NCT00594516|62744192|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
33365615|NCT00538291|62744196|FG000|Overall Study|Adverse Event|2|||
33365616|NCT00538291|62744196|FG000|Overall Study|Withdrawal by Subject|1|||
33365617|NCT00594906|62744202|FG000|Overall Study|Physician Decision|1|||
33365618|NCT00594906|62744203|FG001|Overall Study|Physician Decision|0|||
33365619|NCT00594906|62744202|FG000|Overall Study|Physician Decision|0|||
33365620|NCT00594906|62744203|FG001|Overall Study|Physician Decision|1|||
33365621|NCT00594906|62744202|FG000|Overall Study|Death|0|||
33365622|NCT00594906|62744203|FG001|Overall Study|Death|1|||
33365623|NCT00537979|62744211|FG000|Overall Study|Adverse Event|2|||
33365624|NCT00537979|62744212|FG001|Overall Study|Adverse Event|2|||
33365625|NCT00537979|62744211|FG000|Overall Study|Withdrawal by Subject|1|||
33365626|NCT00537979|62744212|FG001|Overall Study|Withdrawal by Subject|4|||
33365627|NCT00537979|62744211|FG000|Overall Study|Lost to Follow-up|1|||
33365628|NCT00537979|62744212|FG001|Overall Study|Lost to Follow-up|4|||
33365629|NCT00537979|62744211|FG000|Overall Study|Lack of Efficacy|0|||
33365630|NCT00537979|62744212|FG001|Overall Study|Lack of Efficacy|1|||
33365631|NCT00537979|62744211|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
33365632|NCT00537979|62744212|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
33365633|NCT00537979|62744211|FG000|Overall Study|Death|0|||
33484057|NCT02820844|62861015|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
33484058|NCT02820844|62861016|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
33484059|NCT02820844|62861011|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
33484060|NCT02820844|62861012|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
33484061|NCT02820844|62861013|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
33484062|NCT02820844|62861014|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
33484063|NCT02820844|62861015|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
33554976|NCT02394028|62947709|FG001|Maintenance Phase|Protocol Violation|0|||
33554977|NCT02394028|62947710|FG002|Maintenance Phase|Protocol Violation|0|||
33661300|NCT02709330|63090878|FG000|Overall Study|Physician Decision|2|||
33365634|NCT00537979|62744212|FG001|Overall Study|Death|3|||
33365635|NCT00537979|62744211|FG000|Overall Study|Kidney transplant|0|||
33365636|NCT00537979|62744212|FG001|Overall Study|Kidney transplant|3|||
33365637|NCT00537979|62744211|FG000|Overall Study|Heart failure|0|||
33365638|NCT00537979|62744212|FG001|Overall Study|Heart failure|1|||
33365639|NCT00537823|62744221|FG000|Overall Study|Adverse Event|2|||
33365640|NCT00537823|62744222|FG001|Overall Study|Adverse Event|0|||
33365641|NCT00537277|62744229|FG000|Overall Study|Adverse Event|1|||
33365642|NCT00537277|62744229|FG000|Overall Study|Lack of Efficacy|2|||
33365643|NCT00537277|62744229|FG000|Overall Study|Lost to Follow-up|12|||
33365644|NCT00537277|62744229|FG000|Overall Study|Protocol Violation|11|||
33484064|NCT02820844|62861016|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
33484065|NCT02820844|62861011|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33484066|NCT02820844|62861012|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33484067|NCT02820844|62861013|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
33484068|NCT02820844|62861014|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
33484069|NCT02820844|62861015|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33661301|NCT02709330|63090879|FG001|Overall Study|Physician Decision|0|||
33661302|NCT02709330|63090878|FG000|Overall Study|Withdrawal by Subject|4|||
33484070|NCT02820844|62861016|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33554978|NCT02394028|62947711|FG003|Maintenance Phase|Protocol Violation|0|||
33661303|NCT02709330|63090879|FG001|Overall Study|Withdrawal by Subject|0|||
33661304|NCT02709096|63090887|FG000|Overall Study|non-compliance|1|||
33661305|NCT02709096|63090888|FG001|Overall Study|non-compliance|1|||
33661306|NCT01372410|63090894|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
33661307|NCT01372410|63090895|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
33484071|NCT02820844|62861011|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
33365645|NCT00537277|62744229|FG000|Overall Study|Unclassified|4|||
33365646|NCT00537277|62744229|FG000|Overall Study|Inability to tolerate trial medication|4|||
33661308|NCT01372410|63090896|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
33661309|NCT01372410|63090897|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
33661310|NCT01372410|63090898|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
33661311|NCT01372410|63090899|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
33661312|NCT01372410|63090900|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
33661313|NCT01372410|63090901|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
33661314|NCT01372410|63090894|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
33661315|NCT01372410|63090895|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
33365647|NCT00537277|62744229|FG000|Overall Study|Non-compliance with trial procedures|15|||
33365648|NCT00537199|62744233|FG000|Overall Study|Study Terminated|1|||
33661316|NCT01372410|63090896|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
33365649|NCT03898063|62744239|FG000|Overall Study|Withdrawal by Subject|10|||
33365650|NCT03898063|62744240|FG001|Overall Study|Withdrawal by Subject|8|||
33365651|NCT00873912|62744248|FG000|Overall Study|Withdrawal by Subject|1|||
33365652|NCT00873912|62744249|FG001|Overall Study|Withdrawal by Subject|0|||
33365653|NCT00873912|62744248|FG000|Overall Study|Lost to Follow-up|2|||
33365654|NCT00873912|62744249|FG001|Overall Study|Lost to Follow-up|0|||
33365655|NCT03823300|62744261|FG000|Overall Study|Withdrawal by Subject|16|||
33365656|NCT03823300|62744262|FG001|Overall Study|Withdrawal by Subject|22|||
33365657|NCT03823300|62744261|FG000|Overall Study|Death|10|||
33365658|NCT03823300|62744262|FG001|Overall Study|Death|14|||
33365659|NCT03823300|62744261|FG000|Overall Study|Adverse Event|3|||
33365660|NCT03823300|62744262|FG001|Overall Study|Adverse Event|5|||
33365661|NCT03823300|62744261|FG000|Overall Study|Physician Decision|1|||
33365662|NCT03823300|62744262|FG001|Overall Study|Physician Decision|7|||
33365663|NCT03823300|62744261|FG000|Overall Study|Lost to Follow-up|1|||
33365664|NCT03823300|62744262|FG001|Overall Study|Lost to Follow-up|3|||
33365665|NCT03823300|62744261|FG000|Overall Study|Protocol Violation|1|||
33365666|NCT03823300|62744262|FG001|Overall Study|Protocol Violation|1|||
33484072|NCT02820844|62861012|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
33661317|NCT01372410|63090897|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
33661318|NCT01372410|63090898|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
33365667|NCT03823300|62744261|FG000|Overall Study|Lack of Efficacy|1|||
33365668|NCT03823300|62744262|FG001|Overall Study|Lack of Efficacy|1|||
33365669|NCT03823300|62744261|FG000|Overall Study|Not Eligible|0|||
33365670|NCT03823300|62744262|FG001|Overall Study|Not Eligible|1|||
33365671|NCT03823300|62744261|FG000|Overall Study|Other|1|||
33365672|NCT03823300|62744262|FG001|Overall Study|Other|0|||
33365673|NCT00537745|62744268|FG000|Overall Study|Did not meet eligibility criteria|2|||
33365674|NCT00537745|62744268|FG000|Overall Study|Withdrawal by Subject|2|||
33365675|NCT00537745|62744268|FG000|Overall Study|Subject unable to provide Interlock info|1|||
33365676|NCT00874848|62744275|FG000|Overall Study|Adverse Event|13|||
33365677|NCT00874848|62744276|FG001|Overall Study|Adverse Event|2|||
33365678|NCT00874848|62744275|FG000|Overall Study|Progressive neoplastic disease|38|||
33365679|NCT00874848|62744276|FG001|Overall Study|Progressive neoplastic disease|18|||
33365680|NCT00874848|62744275|FG000|Overall Study|Withdrawal by Subject|7|||
33365681|NCT00874848|62744276|FG001|Overall Study|Withdrawal by Subject|4|||
33365682|NCT00874848|62744275|FG000|Overall Study|Noncompliance|1|||
33365683|NCT00874848|62744276|FG001|Overall Study|Noncompliance|1|||
33365684|NCT00874848|62744275|FG000|Overall Study|Failure to comply with protocol|0|||
33365685|NCT00874848|62744276|FG001|Overall Study|Failure to comply with protocol|1|||
33365686|NCT00874848|62744275|FG000|Overall Study|Physician Decision|0|||
33365687|NCT00874848|62744276|FG001|Overall Study|Physician Decision|2|||
33365688|NCT00578812|62744284|FG000|Overall Study|Not treated|6|||
33365689|NCT00578812|62744285|FG001|Overall Study|Not treated|7|||
33365690|NCT04043806|62744292|FG000|Overall Study|Commercial drug is available for participants|13|||
33365691|NCT04043806|62744292|FG000|Overall Study|Physician Decision|2|||
33365692|NCT04043806|62744292|FG000|Overall Study|Other|12|||
33365693|NCT04043806|62744292|FG000|Overall Study|Adverse Event|2|||
33365694|NCT04043806|62744292|FG000|Overall Study|Lost to Follow-up|6|||
33365695|NCT04043806|62744292|FG000|Overall Study|Other non-compliance|2|||
33365696|NCT04043806|62744292|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
33365697|NCT04043806|62744292|FG000|Overall Study|Never Dosed|1|||
33365698|NCT00536809|62744297|FG000|Phase II|Adverse Event|1|||
33365699|NCT00536809|62744297|FG000|Phase II|Referred for surgical resection|1|||
33365700|NCT00536731|62744308|FG000|Overall Study|Adverse Event|3|||
33365701|NCT00536731|62744309|FG001|Overall Study|Adverse Event|2|||
33365702|NCT00536731|62744310|FG002|Overall Study|Adverse Event|3|||
33365703|NCT00536731|62744308|FG000|Overall Study|Withdrawal by Subject|0|||
33365704|NCT00536731|62744309|FG001|Overall Study|Withdrawal by Subject|2|||
33365705|NCT00536731|62744310|FG002|Overall Study|Withdrawal by Subject|0|||
33365706|NCT00536731|62744308|FG000|Overall Study|Intake of prohibited conc. medication|0|||
33365707|NCT00536731|62744309|FG001|Overall Study|Intake of prohibited conc. medication|0|||
33365708|NCT00536731|62744310|FG002|Overall Study|Intake of prohibited conc. medication|1|||
33365709|NCT00536731|62744308|FG000|Overall Study|Safety reasons|0|||
33365710|NCT00536731|62744309|FG001|Overall Study|Safety reasons|0|||
33365711|NCT00536731|62744310|FG002|Overall Study|Safety reasons|1|||
33365712|NCT00536731|62744308|FG000|Overall Study|Other|1|||
33365713|NCT00536731|62744309|FG001|Overall Study|Other|1|||
33365714|NCT00536731|62744310|FG002|Overall Study|Other|0|||
33365715|NCT00536575|62744318|FG000|Overall Study|Withdrawal by Subject|1|||
33484073|NCT02820844|62861013|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
33365716|NCT00536575|62744318|FG000|Overall Study|Death|1|||
33365717|NCT03214250|62744329|FG000|Overall Study|Death|5|||
33365718|NCT03214250|62744330|FG001|Overall Study|Death|5|||
33365719|NCT03214250|62744331|FG002|Overall Study|Death|7|||
33365720|NCT03214250|62744332|FG003|Overall Study|Death|4|||
33365721|NCT03214250|62744333|FG004|Overall Study|Death|23|||
33365722|NCT03214250|62744334|FG005|Overall Study|Death|23|||
33365723|NCT03214250|62744335|FG006|Overall Study|Death|24|||
33365724|NCT03214250|62744329|FG000|Overall Study|Lost to Follow-up|0|||
33365725|NCT03214250|62744330|FG001|Overall Study|Lost to Follow-up|0|||
33365726|NCT03214250|62744331|FG002|Overall Study|Lost to Follow-up|0|||
33365727|NCT03214250|62744332|FG003|Overall Study|Lost to Follow-up|1|||
33365728|NCT03214250|62744333|FG004|Overall Study|Lost to Follow-up|1|||
33365729|NCT03214250|62744334|FG005|Overall Study|Lost to Follow-up|2|||
33365730|NCT03214250|62744335|FG006|Overall Study|Lost to Follow-up|0|||
33365731|NCT03214250|62744329|FG000|Overall Study|Other|0|||
33365732|NCT03214250|62744330|FG001|Overall Study|Other|0|||
33365733|NCT03214250|62744331|FG002|Overall Study|Other|0|||
33365734|NCT03214250|62744332|FG003|Overall Study|Other|0|||
33365735|NCT03214250|62744333|FG004|Overall Study|Other|1|||
33365736|NCT03214250|62744334|FG005|Overall Study|Other|1|||
33365737|NCT03214250|62744335|FG006|Overall Study|Other|2|||
33365738|NCT03214250|62744329|FG000|Overall Study|Remains on Study|2|||
33365739|NCT03214250|62744330|FG001|Overall Study|Remains on Study|2|||
33365740|NCT03214250|62744331|FG002|Overall Study|Remains on Study|0|||
33365741|NCT03214250|62744332|FG003|Overall Study|Remains on Study|1|||
33365742|NCT03214250|62744333|FG004|Overall Study|Remains on Study|7|||
33365743|NCT03214250|62744334|FG005|Overall Study|Remains on Study|5|||
33365744|NCT03214250|62744335|FG006|Overall Study|Remains on Study|3|||
33365745|NCT03214250|62744329|FG000|Overall Study|Withdrawal by Subject|0|||
33365746|NCT03214250|62744330|FG001|Overall Study|Withdrawal by Subject|0|||
33484074|NCT02820844|62861014|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
33484075|NCT02820844|62861015|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
33484076|NCT02820844|62861016|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
33484077|NCT02820844|62861011|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33484078|NCT02820844|62861012|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33484079|NCT02820844|62861013|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33554979|NCT02394028|62947712|FG004|Maintenance Phase|Protocol Violation|0|||
33554980|NCT02394028|62947713|FG005|Maintenance Phase|Protocol Violation|0|||
33484080|NCT02820844|62861014|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33484081|NCT02820844|62861015|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33484082|NCT02820844|62861016|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
33484083|NCT02942576|62861035|FG000|Overall Study|Adverse Event|28|||
33554981|NCT02394028|62947714|FG006|Maintenance Phase|Protocol Violation|0|||
33554982|NCT02394028|62947715|FG007|Maintenance Phase|Protocol Violation|0|||
33661319|NCT01372410|63090899|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
33661320|NCT01372410|63090900|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
33661321|NCT01372410|63090901|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
33661322|NCT01372410|63090894|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33661323|NCT01372410|63090895|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33661324|NCT01372410|63090896|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33661325|NCT01372410|63090897|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33661326|NCT01372410|63090898|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
33661327|NCT01372410|63090899|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33661328|NCT01372410|63090900|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33661329|NCT01372410|63090901|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33661330|NCT01372410|63090894|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
33661331|NCT01372410|63090895|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
33661332|NCT01372410|63090896|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
33661333|NCT01372410|63090897|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
33661334|NCT01372410|63090898|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
33661335|NCT01372410|63090899|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
33661336|NCT01372410|63090900|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
33661337|NCT01372410|63090901|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
33661338|NCT01372410|63090894|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
33365747|NCT03214250|62744331|FG002|Overall Study|Withdrawal by Subject|1|||
33554983|NCT02394028|62947716|FG008|Maintenance Phase|Protocol Violation|0|||
33554984|NCT02394028|62947717|FG009|Maintenance Phase|Protocol Violation|0|||
33554985|NCT02394028|62947718|FG010|Maintenance Phase|Protocol Violation|1|||
33554986|NCT02394028|62947708|FG000|Maintenance Phase|Physician Decision|0|||
33554987|NCT02394028|62947709|FG001|Maintenance Phase|Physician Decision|0|||
33661339|NCT01372410|63090895|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
33661340|NCT01372410|63090896|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
33365748|NCT03214250|62744332|FG003|Overall Study|Withdrawal by Subject|2|||
33365749|NCT03214250|62744333|FG004|Overall Study|Withdrawal by Subject|5|||
33365750|NCT03214250|62744334|FG005|Overall Study|Withdrawal by Subject|0|||
33365751|NCT03214250|62744335|FG006|Overall Study|Withdrawal by Subject|2|||
33365752|NCT00874770|62744359|FG000|Overall Study|Lack of Efficacy|2|||
33365753|NCT00874770|62744360|FG001|Overall Study|Lack of Efficacy|0|||
33365754|NCT00874770|62744361|FG002|Overall Study|Lack of Efficacy|0|||
33484084|NCT02942576|62861036|FG001|Overall Study|Adverse Event|6|||
33554988|NCT02394028|62947710|FG002|Maintenance Phase|Physician Decision|0|||
33365755|NCT00874770|62744362|FG003|Overall Study|Lack of Efficacy|2|||
33365756|NCT00874770|62744359|FG000|Overall Study|Adverse Event|1|||
33365757|NCT00874770|62744360|FG001|Overall Study|Adverse Event|1|||
33365758|NCT00874770|62744361|FG002|Overall Study|Adverse Event|4|||
33365759|NCT00874770|62744362|FG003|Overall Study|Adverse Event|2|||
33365760|NCT00874770|62744359|FG000|Overall Study|Lost to Follow-up|1|||
33365761|NCT00874770|62744360|FG001|Overall Study|Lost to Follow-up|0|||
33365762|NCT00874770|62744361|FG002|Overall Study|Lost to Follow-up|0|||
33365763|NCT00874770|62744362|FG003|Overall Study|Lost to Follow-up|1|||
33365764|NCT00874770|62744359|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
33365765|NCT00874770|62744360|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
33365766|NCT00874770|62744361|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
33365767|NCT00874770|62744362|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
33365768|NCT00536263|62744385|FG000|Overall Study|Adverse Event|5|||
33365769|NCT00536263|62744386|FG001|Overall Study|Adverse Event|5|||
33365770|NCT00536263|62744387|FG002|Overall Study|Adverse Event|7|||
33365771|NCT00536263|62744385|FG000|Overall Study|Lost to Follow-up|3|||
33365772|NCT00536263|62744386|FG001|Overall Study|Lost to Follow-up|4|||
33365773|NCT00536263|62744387|FG002|Overall Study|Lost to Follow-up|4|||
33365774|NCT00536263|62744385|FG000|Overall Study|Subject withdrew - not treatment related|2|||
33365775|NCT00536263|62744386|FG001|Overall Study|Subject withdrew - not treatment related|0|||
33365776|NCT00536263|62744387|FG002|Overall Study|Subject withdrew - not treatment related|5|||
33365777|NCT00536263|62744385|FG000|Overall Study|Subject withdrew - treatment related|0|||
33365778|NCT00536263|62744386|FG001|Overall Study|Subject withdrew - treatment related|3|||
33365779|NCT00536263|62744387|FG002|Overall Study|Subject withdrew - treatment related|2|||
33365780|NCT00536263|62744385|FG000|Overall Study|Noncompliance with protocol|0|||
33365781|NCT00536263|62744386|FG001|Overall Study|Noncompliance with protocol|0|||
33365782|NCT00536263|62744387|FG002|Overall Study|Noncompliance with protocol|1|||
33365783|NCT00536263|62744385|FG000|Overall Study|Did not meet protocol eligibility|1|||
33365784|NCT00536263|62744386|FG001|Overall Study|Did not meet protocol eligibility|2|||
33365785|NCT00536263|62744387|FG002|Overall Study|Did not meet protocol eligibility|2|||
33365786|NCT00578344|62744395|FG000|Overall Study|Insurance problems|1|||
33365787|NCT00578344|62744395|FG000|Overall Study|Graft failure|1|||
33365788|NCT00873366|62744399|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
33365789|NCT00873366|62744399|FG000|Overall Study|Off tamoxifen due to side effects|2|||
33365790|NCT00873366|62744399|FG000|Overall Study|Refused to continue DM-BT testing|3|||
33365791|NCT00536107|62744405|FG000|Overall Study|Death|5|||
33365792|NCT00536107|62744406|FG001|Overall Study|Death|1|||
33365793|NCT00536107|62744405|FG000|Overall Study|Incorrect enrolment|1|||
33365794|NCT00536107|62744406|FG001|Overall Study|Incorrect enrolment|0|||
33365795|NCT00536107|62744405|FG000|Overall Study|Withdrawal by Subject|0|||
33365796|NCT00536107|62744406|FG001|Overall Study|Withdrawal by Subject|1|||
33365797|NCT00536107|62744405|FG000|Overall Study|Study Termination|2|||
33365798|NCT00536107|62744406|FG001|Overall Study|Study Termination|4|||
33365799|NCT00885482|62744426|FG000|Overall Study|Pregnancy|1|||
33365800|NCT00885482|62744426|FG000|Overall Study|Lack of Efficacy|1|||
33365801|NCT00885482|62744426|FG000|Overall Study|Death|1|||
33365802|NCT00885482|62744426|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
33365803|NCT00885170|62744450|FG000|Overall Study|Adverse Event|12|||
33365804|NCT00885170|62744451|FG001|Overall Study|Adverse Event|4|||
33365805|NCT00885170|62744450|FG000|Overall Study|Excessive bone loss|6|||
33365806|NCT00885170|62744451|FG001|Overall Study|Excessive bone loss|3|||
33365807|NCT00885170|62744450|FG000|Overall Study|Lost to Follow-up|2|||
33365808|NCT00885170|62744451|FG001|Overall Study|Lost to Follow-up|1|||
33365809|NCT00885170|62744450|FG000|Overall Study|Physician Decision|2|||
33365810|NCT00885170|62744451|FG001|Overall Study|Physician Decision|1|||
33365811|NCT00885170|62744450|FG000|Overall Study|Protocol Violation|3|||
33365812|NCT00885170|62744451|FG001|Overall Study|Protocol Violation|1|||
33365813|NCT00885170|62744450|FG000|Overall Study|Withdrawal by Subject|13|||
33661341|NCT01372410|63090897|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
33661342|NCT01372410|63090898|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
33661343|NCT01372410|63090899|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
33365814|NCT00885170|62744451|FG001|Overall Study|Withdrawal by Subject|13|||
33365815|NCT00866619|62744478|FG000|Overall Study|Adverse Event|112|||
33365816|NCT00866619|62744479|FG001|Overall Study|Adverse Event|106|||
33365817|NCT00866619|62744480|FG002|Overall Study|Adverse Event|47|||
33661344|NCT01372410|63090900|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
33365818|NCT00866619|62744481|FG003|Overall Study|Adverse Event|44|||
33365819|NCT00866619|62744478|FG000|Overall Study|Protocol Violation|2|||
33365820|NCT00866619|62744479|FG001|Overall Study|Protocol Violation|39|||
33365821|NCT00866619|62744480|FG002|Overall Study|Protocol Violation|2|||
33661345|NCT01372410|63090901|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
33661346|NCT01372410|63090894|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
33365822|NCT00866619|62744481|FG003|Overall Study|Protocol Violation|17|||
33365823|NCT00866619|62744478|FG000|Overall Study|Withdrawal by Subject|587|||
33554989|NCT02394028|62947711|FG003|Maintenance Phase|Physician Decision|0|||
33484085|NCT02942576|62861035|FG000|Overall Study|Withdrawal by Subject|7|||
33484086|NCT02942576|62861036|FG001|Overall Study|Withdrawal by Subject|5|||
33484087|NCT02942576|62861035|FG000|Overall Study|Physician Decision|1|||
33484088|NCT02942576|62861036|FG001|Overall Study|Physician Decision|4|||
33484089|NCT02942576|62861035|FG000|Overall Study|Other|10|||
33554990|NCT02394028|62947712|FG004|Maintenance Phase|Physician Decision|0|||
33554991|NCT02394028|62947713|FG005|Maintenance Phase|Physician Decision|0|||
33554992|NCT02394028|62947714|FG006|Maintenance Phase|Physician Decision|0|||
33554993|NCT02394028|62947715|FG007|Maintenance Phase|Physician Decision|0|||
33554994|NCT02394028|62947716|FG008|Maintenance Phase|Physician Decision|1|||
33365824|NCT00866619|62744479|FG001|Overall Study|Withdrawal by Subject|295|||
33484090|NCT02942576|62861036|FG001|Overall Study|Other|8|||
33484091|NCT02820298|62861044|FG000|Overall Study|Withdrawal by Subject|0|||
33484092|NCT02820298|62861045|FG001|Overall Study|Withdrawal by Subject|1|||
33484093|NCT02820298|62861044|FG000|Overall Study|Physician Decision|1|||
33484094|NCT02820298|62861045|FG001|Overall Study|Physician Decision|0|||
33484095|NCT02820298|62861044|FG000|Overall Study|Protocol Violation|0|||
33484096|NCT02820298|62861045|FG001|Overall Study|Protocol Violation|1|||
33484097|NCT02819440|62861059|FG000|Overall Study|Adverse Event|3|||
33484098|NCT02819440|62861060|FG001|Overall Study|Adverse Event|1|||
33484099|NCT02819440|62861059|FG000|Overall Study|Lost to Follow-up|1|||
33484100|NCT02819440|62861060|FG001|Overall Study|Lost to Follow-up|3|||
33484101|NCT02819440|62861059|FG000|Overall Study|Withdrawal by Subject|9|||
33484102|NCT02819440|62861060|FG001|Overall Study|Withdrawal by Subject|8|||
33554995|NCT02394028|62947717|FG009|Maintenance Phase|Physician Decision|3|||
33554996|NCT02394028|62947718|FG010|Maintenance Phase|Physician Decision|2|||
33661347|NCT01372410|63090895|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
33661348|NCT01372410|63090896|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
33484103|NCT03814720|62861071|FG000|Overall Study|Lost to Follow-up|0|||
33484104|NCT03814720|62861072|FG001|Overall Study|Lost to Follow-up|1|||
33484105|NCT03814720|62861073|FG002|Overall Study|Lost to Follow-up|0|||
33554997|NCT02394028|62947708|FG000|Maintenance Phase|Lack of Efficacy|0|||
33365825|NCT00866619|62744480|FG002|Overall Study|Withdrawal by Subject|272|||
33484106|NCT03814720|62861074|FG003|Overall Study|Lost to Follow-up|0|||
33484107|NCT03814720|62861075|FG004|Overall Study|Lost to Follow-up|0|||
33484108|NCT02818036|62861091|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
33484109|NCT02818036|62861092|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
33554998|NCT02394028|62947709|FG001|Maintenance Phase|Lack of Efficacy|0|||
33554999|NCT02394028|62947710|FG002|Maintenance Phase|Lack of Efficacy|0|||
33365826|NCT00866619|62744481|FG003|Overall Study|Withdrawal by Subject|144|||
33365827|NCT00866619|62744478|FG000|Overall Study|Lost to Follow-up|1145|||
33365828|NCT00866619|62744479|FG001|Overall Study|Lost to Follow-up|830|||
33365829|NCT00866619|62744480|FG002|Overall Study|Lost to Follow-up|568|||
33365830|NCT00866619|62744481|FG003|Overall Study|Lost to Follow-up|425|||
33365831|NCT00884390|62744528|FG000|Overall Study|Adverse Event|0|||
33365832|NCT00884390|62744529|FG001|Overall Study|Adverse Event|1|||
33365833|NCT00884390|62744528|FG000|Overall Study|Lost to Follow-up|0|||
33365834|NCT00884390|62744529|FG001|Overall Study|Lost to Follow-up|1|||
33365835|NCT00884390|62744528|FG000|Overall Study|Physician Decision|2|||
33365836|NCT00884390|62744529|FG001|Overall Study|Physician Decision|1|||
33484110|NCT02818036|62861091|FG000|Overall Study|Withdrawal by Subject|1|||
33484111|NCT02818036|62861092|FG001|Overall Study|Withdrawal by Subject|0|||
33365837|NCT00884390|62744528|FG000|Overall Study|Protocol Violation|4|||
33365838|NCT00884390|62744529|FG001|Overall Study|Protocol Violation|1|||
33365839|NCT00884390|62744528|FG000|Overall Study|Withdrawal by Subject|4|||
33365840|NCT00884390|62744529|FG001|Overall Study|Withdrawal by Subject|1|||
33484112|NCT01287741|62861100|FG000|Overall Study|Withdrawal by Subject|35|||
33484113|NCT01287741|62861101|FG001|Overall Study|Withdrawal by Subject|38|||
33555000|NCT02394028|62947711|FG003|Maintenance Phase|Lack of Efficacy|0|||
33555001|NCT02394028|62947712|FG004|Maintenance Phase|Lack of Efficacy|0|||
33365841|NCT00884390|62744528|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
33365842|NCT00884390|62744529|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
33365843|NCT00884390|62744528|FG000|Overall Study|Other|11|||
33365844|NCT00884390|62744529|FG001|Overall Study|Other|1|||
33365845|NCT00872898|62744566|FG000|Part Two - Double Blind|Adverse Event|4|||
33365846|NCT00872898|62744567|FG001|Part Two - Double Blind|Adverse Event|3|||
33365847|NCT00872898|62744566|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
33365848|NCT00872898|62744567|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
33484114|NCT01287741|62861100|FG000|Overall Study|Protocol Violation|2|||
33484115|NCT01287741|62861101|FG001|Overall Study|Protocol Violation|0|||
33484116|NCT01287741|62861100|FG000|Overall Study|Physician Decision|15|||
33365849|NCT00872898|62744566|FG000|Part Two - Double Blind|Protocol Violation|1|||
33365850|NCT00872898|62744567|FG001|Part Two - Double Blind|Protocol Violation|0|||
33365851|NCT00872898|62744566|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
33365852|NCT00872898|62744567|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
33555002|NCT02394028|62947713|FG005|Maintenance Phase|Lack of Efficacy|0|||
33555003|NCT02394028|62947714|FG006|Maintenance Phase|Lack of Efficacy|0|||
33555004|NCT02394028|62947715|FG007|Maintenance Phase|Lack of Efficacy|0|||
33555005|NCT02394028|62947716|FG008|Maintenance Phase|Lack of Efficacy|7|||
33555006|NCT02394028|62947717|FG009|Maintenance Phase|Lack of Efficacy|25|||
33555007|NCT02394028|62947718|FG010|Maintenance Phase|Lack of Efficacy|33|||
33555008|NCT02394028|62947708|FG000|Maintenance Phase|Death|0|||
33555009|NCT02394028|62947709|FG001|Maintenance Phase|Death|0|||
33555010|NCT02394028|62947710|FG002|Maintenance Phase|Death|0|||
33365853|NCT00872898|62744566|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
33365854|NCT00872898|62744567|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
33484117|NCT01287741|62861101|FG001|Overall Study|Physician Decision|23|||
33484118|NCT01287741|62861100|FG000|Overall Study|Non-compliance|8|||
33484119|NCT01287741|62861101|FG001|Overall Study|Non-compliance|6|||
33484120|NCT01287741|62861100|FG000|Overall Study|Lost to Follow-up|10|||
33484121|NCT01287741|62861101|FG001|Overall Study|Lost to Follow-up|8|||
33484122|NCT01287741|62861100|FG000|Overall Study|Death|32|||
33484123|NCT01287741|62861101|FG001|Overall Study|Death|44|||
33484124|NCT01287741|62861100|FG000|Overall Study|Adverse Event|4|||
33555011|NCT02394028|62947711|FG003|Maintenance Phase|Death|0|||
33555012|NCT02394028|62947712|FG004|Maintenance Phase|Death|0|||
33365855|NCT00872898|62744566|FG000|Part Two - Double Blind|Other reasons|2|||
33484125|NCT01287741|62861101|FG001|Overall Study|Adverse Event|6|||
33484126|NCT01287741|62861100|FG000|Overall Study|Study terminated by Sponsor|307|||
33484127|NCT01287741|62861101|FG001|Overall Study|Study terminated by Sponsor|315|||
33365856|NCT00872898|62744567|FG001|Part Two - Double Blind|Other reasons|0|||
33555013|NCT02394028|62947713|FG005|Maintenance Phase|Death|0|||
33365857|NCT00884312|62744578|FG000|Overall Study|Non-fatal Progressive Disease|0|||
33365858|NCT00884312|62744579|FG001|Overall Study|Non-fatal Progressive Disease|8|||
33365859|NCT00884312|62744578|FG000|Overall Study|Fatal Progressive Disease|0|||
33365860|NCT00884312|62744579|FG001|Overall Study|Fatal Progressive Disease|1|||
33365861|NCT00884312|62744578|FG000|Overall Study|Non-fatal Adverse Event|1|||
33365862|NCT00884312|62744579|FG001|Overall Study|Non-fatal Adverse Event|0|||
33365863|NCT00884312|62744578|FG000|Overall Study|Fatal Adverse Event|1|||
33365864|NCT00884312|62744579|FG001|Overall Study|Fatal Adverse Event|4|||
33365865|NCT00884312|62744578|FG000|Overall Study|Withdrawal by Subject|0|||
33365866|NCT00884312|62744579|FG001|Overall Study|Withdrawal by Subject|6|||
33365867|NCT00884312|62744578|FG000|Overall Study|Physician Decision|0|||
33365868|NCT00884312|62744579|FG001|Overall Study|Physician Decision|1|||
33365869|NCT00884312|62744578|FG000|Overall Study|Other|0|||
33365870|NCT00884312|62744579|FG001|Overall Study|Other|4|||
33365871|NCT00884312|62744578|FG000|Overall Study|Did Not Receive Study Drug|0|||
33365872|NCT00884312|62744579|FG001|Overall Study|Did Not Receive Study Drug|1|||
33365873|NCT00534313|62744589|FG000|Short-term Period|Adverse Event|1|||
33365874|NCT00534313|62744590|FG001|Short-term Period|Adverse Event|2|||
33365875|NCT00534313|62744591|FG002|Short-term Period|Adverse Event|1|||
33365876|NCT00534313|62744592|FG003|Short-term Period|Adverse Event|3|||
33365877|NCT00534313|62744589|FG000|Short-term Period|Lack of Efficacy|3|||
33365878|NCT00534313|62744590|FG001|Short-term Period|Lack of Efficacy|4|||
33365879|NCT00534313|62744591|FG002|Short-term Period|Lack of Efficacy|0|||
33365880|NCT00534313|62744592|FG003|Short-term Period|Lack of Efficacy|3|||
33365881|NCT00534313|62744589|FG000|Short-term Period|Participant not meeting study criteria|0|||
33365882|NCT00534313|62744590|FG001|Short-term Period|Participant not meeting study criteria|0|||
33365883|NCT00534313|62744591|FG002|Short-term Period|Participant not meeting study criteria|0|||
33365884|NCT00534313|62744592|FG003|Short-term Period|Participant not meeting study criteria|1|||
33365885|NCT00534313|62744589|FG000|Short-term Period|Participant withdrew consent|2|||
33365886|NCT00534313|62744590|FG001|Short-term Period|Participant withdrew consent|0|||
33365887|NCT00534313|62744591|FG002|Short-term Period|Participant withdrew consent|0|||
33365888|NCT00534313|62744592|FG003|Short-term Period|Participant withdrew consent|2|||
33365889|NCT00534313|62744589|FG000|Short-term Period|Pregnancy|0|||
33365890|NCT00534313|62744590|FG001|Short-term Period|Pregnancy|0|||
33365891|NCT00534313|62744591|FG002|Short-term Period|Pregnancy|1|||
33365892|NCT00534313|62744592|FG003|Short-term Period|Pregnancy|0|||
33365893|NCT00534313|62744589|FG000|Long-term Period|Adverse Event|2|||
33365894|NCT00534313|62744590|FG001|Long-term Period|Adverse Event|1|||
33365895|NCT00534313|62744591|FG002|Long-term Period|Adverse Event|0|||
33365896|NCT00534313|62744592|FG003|Long-term Period|Adverse Event|1|||
33365897|NCT00534313|62744589|FG000|Long-term Period|Lack of Efficacy|14|||
33365898|NCT00534313|62744590|FG001|Long-term Period|Lack of Efficacy|10|||
33365899|NCT00534313|62744591|FG002|Long-term Period|Lack of Efficacy|14|||
33365900|NCT00534313|62744592|FG003|Long-term Period|Lack of Efficacy|12|||
33484128|NCT01287741|62861100|FG000|Overall Study|Progressive disease|190|||
33484129|NCT01287741|62861101|FG001|Overall Study|Progressive disease|166|||
33661349|NCT01372410|63090897|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
33661350|NCT01372410|63090898|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
33365901|NCT00534313|62744589|FG000|Long-term Period|Lost to Follow-up|1|||
33365902|NCT00534313|62744590|FG001|Long-term Period|Lost to Follow-up|2|||
33365903|NCT00534313|62744591|FG002|Long-term Period|Lost to Follow-up|0|||
33365904|NCT00534313|62744592|FG003|Long-term Period|Lost to Follow-up|0|||
33365905|NCT00534313|62744589|FG000|Long-term Period|Withdrawal by Subject|2|||
33365906|NCT00534313|62744590|FG001|Long-term Period|Withdrawal by Subject|2|||
33365907|NCT00534313|62744591|FG002|Long-term Period|Withdrawal by Subject|0|||
33365908|NCT00534313|62744592|FG003|Long-term Period|Withdrawal by Subject|0|||
33365909|NCT00534313|62744589|FG000|Long-term Period|No longer meets study criteria|0|||
33365910|NCT00534313|62744590|FG001|Long-term Period|No longer meets study criteria|1|||
33365911|NCT00534313|62744591|FG002|Long-term Period|No longer meets study criteria|0|||
33365912|NCT00534313|62744592|FG003|Long-term Period|No longer meets study criteria|0|||
33365913|NCT00534313|62744589|FG000|Long-term Period|Poor compliance/noncompliance|0|||
33365914|NCT00534313|62744590|FG001|Long-term Period|Poor compliance/noncompliance|1|||
33365915|NCT00534313|62744591|FG002|Long-term Period|Poor compliance/noncompliance|1|||
33365916|NCT00534313|62744592|FG003|Long-term Period|Poor compliance/noncompliance|0|||
33365917|NCT00534313|62744589|FG000|Long-term Period|Administrative reason by sponsor|17|||
33365918|NCT00534313|62744590|FG001|Long-term Period|Administrative reason by sponsor|15|||
33365919|NCT00534313|62744591|FG002|Long-term Period|Administrative reason by sponsor|26|||
33365920|NCT00534313|62744592|FG003|Long-term Period|Administrative reason by sponsor|18|||
33365921|NCT00534313|62744589|FG000|Long-term Period|Other|1|||
33365922|NCT00534313|62744590|FG001|Long-term Period|Other|2|||
33365923|NCT00534313|62744591|FG002|Long-term Period|Other|2|||
33365924|NCT00534313|62744592|FG003|Long-term Period|Other|2|||
33365925|NCT03888391|62744637|FG000|Overall Study|Lost to Follow-up|15|||
33365926|NCT00594204|62744643|FG000|Overall Study|Adverse Event|15|||
33365927|NCT00594204|62744644|FG001|Overall Study|Adverse Event|3|||
33365928|NCT00594204|62744643|FG000|Overall Study|Lost to Follow-up|9|||
33365929|NCT00594204|62744644|FG001|Overall Study|Lost to Follow-up|5|||
33661351|NCT01372410|63090899|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
33365930|NCT00594204|62744643|FG000|Overall Study|Withdrawal by Subject|23|||
33365931|NCT00594204|62744644|FG001|Overall Study|Withdrawal by Subject|29|||
33365932|NCT00594204|62744643|FG000|Overall Study|Other|4|||
33365933|NCT00594204|62744644|FG001|Overall Study|Other|3|||
33365934|NCT00594204|62744643|FG000|Overall Study|Lack of Efficacy|3|||
33365935|NCT00594204|62744644|FG001|Overall Study|Lack of Efficacy|4|||
33365936|NCT00594204|62744643|FG000|Overall Study|Randomized but not treated|4|||
33484130|NCT01287741|62861100|FG000|Overall Study|Reason not specified|23|||
33484131|NCT01287741|62861101|FG001|Overall Study|Reason not specified|9|||
33484132|NCT05372315|62861114|FG000|Overall Study|Withdrawal by Subject|1|||
33484133|NCT05372315|62861115|FG001|Overall Study|Withdrawal by Subject|0|||
33484134|NCT04913675|62861135|FG000|Main Study (Up to Week 36)|Death|0|||
33484135|NCT04913675|62861136|FG001|Main Study (Up to Week 36)|Death|2|||
33484136|NCT04913675|62861137|FG002|Main Study (Up to Week 36)|Death|2|||
33484137|NCT04913675|62861138|FG003|Main Study (Up to Week 36)|Death|0|||
33484138|NCT04913675|62861135|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
33484139|NCT04913675|62861136|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
33484140|NCT04913675|62861137|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
33484141|NCT04913675|62861138|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
33555014|NCT02394028|62947714|FG006|Maintenance Phase|Death|0|||
33365937|NCT00594204|62744644|FG001|Overall Study|Randomized but not treated|1|||
33365938|NCT03888235|62744662|FG000|Overall Study|Lost to Follow-up|1|||
33365939|NCT03888235|62744663|FG001|Overall Study|Lost to Follow-up|1|||
33365940|NCT03888235|62744664|FG002|Overall Study|Lost to Follow-up|0|||
33365941|NCT00866307|62744695|FG000|Induction|Adverse Event|5|||
33365942|NCT00866307|62744696|FG001|Induction|Adverse Event|0|||
33365943|NCT00866307|62744697|FG002|Induction|Adverse Event|0|||
33365944|NCT00866307|62744695|FG000|Induction|Death|2|||
33365945|NCT00866307|62744696|FG001|Induction|Death|0|||
33365946|NCT00866307|62744697|FG002|Induction|Death|0|||
33365947|NCT00866307|62744695|FG000|Induction|Physician Decision|5|||
33365948|NCT00866307|62744696|FG001|Induction|Physician Decision|0|||
33484142|NCT04913675|62861135|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
33555015|NCT02394028|62947715|FG007|Maintenance Phase|Death|0|||
33555016|NCT02394028|62947716|FG008|Maintenance Phase|Death|0|||
33555017|NCT02394028|62947717|FG009|Maintenance Phase|Death|0|||
33555018|NCT02394028|62947718|FG010|Maintenance Phase|Death|1|||
33555019|NCT02394028|62947708|FG000|Maintenance Phase|Adverse Event|0|||
33555020|NCT02394028|62947709|FG001|Maintenance Phase|Adverse Event|0|||
33555021|NCT02394028|62947710|FG002|Maintenance Phase|Adverse Event|0|||
33484143|NCT04913675|62861136|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
33484144|NCT04913675|62861137|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
33484145|NCT04913675|62861138|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
33484146|NCT04913675|62861135|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
33484147|NCT04913675|62861136|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
33484148|NCT04913675|62861137|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
33484149|NCT04913675|62861138|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
33484150|NCT04913675|62861135|FG000|Safety Sub-study (Up to Day 29)|Ongoing in this study|0|||
33484151|NCT04913675|62861136|FG001|Safety Sub-study (Up to Day 29)|Ongoing in this study|0|||
33484152|NCT04913675|62861137|FG002|Safety Sub-study (Up to Day 29)|Ongoing in this study|0|||
33484153|NCT04913675|62861138|FG003|Safety Sub-study (Up to Day 29)|Ongoing in this study|80|||
33484154|NCT04913675|62861135|FG000|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|0|||
33484155|NCT04913675|62861136|FG001|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|0|||
33484156|NCT04913675|62861137|FG002|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|0|||
33484157|NCT04913675|62861138|FG003|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|1|||
33484158|NCT04760314|62861155|FG000|Induction Period|Withdrawal by Subject|0|||
33484159|NCT04760314|62861156|FG001|Induction Period|Withdrawal by Subject|1|||
33484160|NCT04760314|62861157|FG002|Induction Period|Withdrawal by Subject|1|||
33484161|NCT04760314|62861158|FG003|Induction Period|Withdrawal by Subject|0|||
33484162|NCT04760314|62861159|FG004|Induction Period|Withdrawal by Subject|0|||
33484163|NCT04760314|62861160|FG005|Induction Period|Withdrawal by Subject|0|||
33484164|NCT04760314|62861161|FG006|Induction Period|Withdrawal by Subject|0|||
33484165|NCT04760314|62861162|FG007|Induction Period|Withdrawal by Subject|0|||
33484166|NCT04760314|62861163|FG008|Induction Period|Withdrawal by Subject|0|||
33484167|NCT04760314|62861164|FG009|Induction Period|Withdrawal by Subject|0|||
33484168|NCT04760314|62861165|FG010|Induction Period|Withdrawal by Subject|0|||
33484169|NCT04760314|62861155|FG000|Induction Period|Adverse Event|0|||
33555022|NCT02394028|62947711|FG003|Maintenance Phase|Adverse Event|0|||
33555023|NCT02394028|62947712|FG004|Maintenance Phase|Adverse Event|0|||
33365949|NCT00866307|62744697|FG002|Induction|Physician Decision|0|||
33365950|NCT00866307|62744695|FG000|Induction|Progressive Disease|1|||
33365951|NCT00866307|62744696|FG001|Induction|Progressive Disease|0|||
33365952|NCT00866307|62744697|FG002|Induction|Progressive Disease|0|||
33365953|NCT00866307|62744695|FG000|Induction|Identification of Patients with Day 29 M|3|||
33365954|NCT00866307|62744696|FG001|Induction|Identification of Patients with Day 29 M|0|||
33365955|NCT00866307|62744697|FG002|Induction|Identification of Patients with Day 29 M|0|||
33365956|NCT00866307|62744695|FG000|Induction|Inadequate cytognetic samples th|1|||
33365957|NCT00866307|62744696|FG001|Induction|Inadequate cytognetic samples th|0|||
33365958|NCT00866307|62744697|FG002|Induction|Inadequate cytognetic samples th|0|||
33365959|NCT00866307|62744695|FG000|Induction|Improper post-induction consent|2|||
33365960|NCT00866307|62744696|FG001|Induction|Improper post-induction consent|0|||
33365961|NCT00866307|62744697|FG002|Induction|Improper post-induction consent|0|||
33365962|NCT00866307|62744695|FG000|Induction|Study was closed at the time|1|||
33365963|NCT00866307|62744696|FG001|Induction|Study was closed at the time|0|||
33365964|NCT00866307|62744697|FG002|Induction|Study was closed at the time|0|||
33365965|NCT00866307|62744695|FG000|Consolidation/Maintenance|Adverse Event|0|||
33365966|NCT00866307|62744696|FG001|Consolidation/Maintenance|Adverse Event|0|||
33365967|NCT00866307|62744697|FG002|Consolidation/Maintenance|Adverse Event|8|||
33365968|NCT00866307|62744695|FG000|Consolidation/Maintenance|Death|0|||
33365969|NCT00866307|62744696|FG001|Consolidation/Maintenance|Death|0|||
33365970|NCT00866307|62744697|FG002|Consolidation/Maintenance|Death|1|||
33365971|NCT00866307|62744695|FG000|Consolidation/Maintenance|Physician Decision|0|||
33365972|NCT00866307|62744696|FG001|Consolidation/Maintenance|Physician Decision|3|||
33365973|NCT00866307|62744697|FG002|Consolidation/Maintenance|Physician Decision|2|||
33365974|NCT00866307|62744695|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
33365975|NCT00866307|62744696|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
33365976|NCT00866307|62744697|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
33365977|NCT00866307|62744695|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
33365978|NCT00866307|62744696|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
33365979|NCT00866307|62744697|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
33365980|NCT00866307|62744695|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
33365981|NCT00866307|62744696|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
33365982|NCT00866307|62744697|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
33365983|NCT00866307|62744695|FG000|Consolidation/Maintenance|Therapy error|0|||
33365984|NCT00866307|62744696|FG001|Consolidation/Maintenance|Therapy error|1|||
33365985|NCT00866307|62744697|FG002|Consolidation/Maintenance|Therapy error|0|||
33365986|NCT00866307|62744695|FG000|Consolidation/Maintenance|Non-compliance|0|||
33365987|NCT00866307|62744696|FG001|Consolidation/Maintenance|Non-compliance|0|||
33365988|NCT00866307|62744697|FG002|Consolidation/Maintenance|Non-compliance|1|||
33365989|NCT00866307|62744695|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
33365990|NCT00866307|62744696|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
33365991|NCT00866307|62744697|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
33365992|NCT00531427|62744705|FG000|Overall Study|Withdrawal by Subject|7|||
33365993|NCT00531427|62744706|FG001|Overall Study|Withdrawal by Subject|13|||
33365994|NCT00531427|62744705|FG000|Overall Study|Adverse Event|44|||
33365995|NCT00531427|62744706|FG001|Overall Study|Adverse Event|30|||
33365996|NCT00531427|62744705|FG000|Overall Study|Lost to Follow-up|4|||
33365997|NCT00531427|62744706|FG001|Overall Study|Lost to Follow-up|3|||
33365998|NCT00531427|62744705|FG000|Overall Study|Lack of Efficacy|14|||
33365999|NCT00531427|62744706|FG001|Overall Study|Lack of Efficacy|39|||
33366000|NCT00531427|62744705|FG000|Overall Study|Administrative|4|||
33484170|NCT04760314|62861156|FG001|Induction Period|Adverse Event|0|||
33484171|NCT04760314|62861157|FG002|Induction Period|Adverse Event|2|||
33484172|NCT04760314|62861158|FG003|Induction Period|Adverse Event|0|||
33484173|NCT04760314|62861159|FG004|Induction Period|Adverse Event|0|||
33484174|NCT04760314|62861160|FG005|Induction Period|Adverse Event|0|||
33484175|NCT04760314|62861161|FG006|Induction Period|Adverse Event|0|||
33484176|NCT04760314|62861162|FG007|Induction Period|Adverse Event|0|||
33484177|NCT04760314|62861163|FG008|Induction Period|Adverse Event|0|||
33484178|NCT04760314|62861164|FG009|Induction Period|Adverse Event|0|||
33366001|NCT00531427|62744706|FG001|Overall Study|Administrative|9|||
33366002|NCT00871728|62744713|FG000|Overall Study|Adverse Event|1|||
33366003|NCT00871728|62744713|FG000|Overall Study|Protocol Violation|7|||
33366004|NCT00871728|62744713|FG000|Overall Study|Lost to Follow-up|2|||
33366005|NCT00871728|62744713|FG000|Overall Study|Failed to Visit Hospital|4|||
33484179|NCT04760314|62861165|FG010|Induction Period|Adverse Event|0|||
33366006|NCT00871728|62744713|FG000|Overall Study|Participant Non-compliance|1|||
33366007|NCT00871728|62744713|FG000|Overall Study|Withdrawal of Informed Consent|5|||
33366008|NCT00868998|62744717|FG000|Overall Study|Screen Failure|1|||
33366009|NCT00868998|62744717|FG000|Overall Study|Withdrawal by Subject|1|||
33484180|NCT04760314|62861155|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
33484181|NCT04760314|62861156|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
33484182|NCT04760314|62861157|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
33484183|NCT04760314|62861158|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
33484184|NCT04760314|62861159|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
33484185|NCT04760314|62861160|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
33484186|NCT04760314|62861161|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
33484187|NCT04760314|62861162|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
33484188|NCT04760314|62861163|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
33484189|NCT04760314|62861164|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
33484190|NCT04760314|62861165|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
33484191|NCT04760314|62861155|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33484192|NCT04760314|62861156|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33484193|NCT04760314|62861157|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33555024|NCT02394028|62947713|FG005|Maintenance Phase|Adverse Event|0|||
33366010|NCT00868998|62744717|FG000|Overall Study|Progression of disease|2|||
33366011|NCT00868998|62744717|FG000|Overall Study|Death|1|||
33366012|NCT00533845|62744732|FG000|Overall Study|Physician Decision|1|||
33366013|NCT00533845|62744733|FG001|Overall Study|Physician Decision|0|||
33366014|NCT00857649|62744741|FG000|Overall Study|Adverse Event|15|||
33366015|NCT00857649|62744742|FG001|Overall Study|Adverse Event|10|||
33366016|NCT00857649|62744741|FG000|Overall Study|Non-compliance|1|||
33366017|NCT00857649|62744742|FG001|Overall Study|Non-compliance|1|||
33366018|NCT00857649|62744741|FG000|Overall Study|Protocol Violation|2|||
33555025|NCT02394028|62947714|FG006|Maintenance Phase|Adverse Event|0|||
33366019|NCT00857649|62744742|FG001|Overall Study|Protocol Violation|2|||
33366020|NCT00857649|62744741|FG000|Overall Study|Withdrawal of Consent|10|||
33366021|NCT00857649|62744742|FG001|Overall Study|Withdrawal of Consent|7|||
33366022|NCT00857649|62744741|FG000|Overall Study|Nursing Home Placement|2|||
33366023|NCT00857649|62744742|FG001|Overall Study|Nursing Home Placement|9|||
33366024|NCT00857649|62744741|FG000|Overall Study|Other Reasons|1|||
33366025|NCT00857649|62744742|FG001|Overall Study|Other Reasons|3|||
33366026|NCT00857415|62744750|FG000|Overall Study|Image acquisition failure|2|||
33366027|NCT00857415|62744751|FG001|Overall Study|Image acquisition failure|0|||
33366028|NCT00857415|62744750|FG000|Overall Study|Invalid image or not imaged|3|||
33366029|NCT00857415|62744751|FG001|Overall Study|Invalid image or not imaged|0|||
33366030|NCT00857415|62744750|FG000|Overall Study|Subject still living at end of study|110|||
33366031|NCT00857415|62744751|FG001|Overall Study|Subject still living at end of study|0|||
33366032|NCT00857415|62744750|FG000|Overall Study|Deceased with no autopsy|2|||
33366033|NCT00857415|62744751|FG001|Overall Study|Deceased with no autopsy|0|||
33366034|NCT00532441|62744757|FG000|Overall Study|Death|1|||
33366035|NCT00532441|62744758|FG001|Overall Study|Death|0|||
33366036|NCT00857259|62744779|FG000|Overall Study|Protocol Violation|1|||
33366037|NCT00857259|62744780|FG001|Overall Study|Protocol Violation|0|||
33366038|NCT00857259|62744781|FG002|Overall Study|Protocol Violation|1|||
33366039|NCT00868608|62744794|FG000|Overall Study|Withdrawal by Subject|3|||
33366040|NCT00868608|62744795|FG001|Overall Study|Withdrawal by Subject|1|||
33366041|NCT00868608|62744796|FG002|Overall Study|Withdrawal by Subject|0|||
33366042|NCT00868608|62744794|FG000|Overall Study|Lost to Follow-up|3|||
33366043|NCT00868608|62744795|FG001|Overall Study|Lost to Follow-up|0|||
33366044|NCT00868608|62744796|FG002|Overall Study|Lost to Follow-up|1|||
33484194|NCT04760314|62861158|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
33484195|NCT04760314|62861159|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33366045|NCT00868608|62744794|FG000|Overall Study|Death|16|||
33366046|NCT00868608|62744795|FG001|Overall Study|Death|2|||
33366047|NCT00868608|62744796|FG002|Overall Study|Death|4|||
33366048|NCT00868608|62744794|FG000|Overall Study|Other - Unspecified|1|||
33366049|NCT00868608|62744795|FG001|Overall Study|Other - Unspecified|0|||
33366050|NCT00868608|62744796|FG002|Overall Study|Other - Unspecified|0|||
33366051|NCT00856635|62744806|FG000|Overall Study|Lost to Follow-up|2|||
33366052|NCT00856635|62744807|FG001|Overall Study|Lost to Follow-up|5|||
33366053|NCT00856635|62744806|FG000|Overall Study|Pregnancy|1|||
33366054|NCT00856635|62744807|FG001|Overall Study|Pregnancy|0|||
33366055|NCT00856635|62744806|FG000|Overall Study|Withdrawal by Subject|3|||
33366056|NCT00856635|62744807|FG001|Overall Study|Withdrawal by Subject|1|||
33366057|NCT00856635|62744806|FG000|Overall Study|Serious Adverse Event|1|||
33661352|NCT01372410|63090900|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
33661353|NCT01372410|63090901|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
33661354|NCT01372410|63090894|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
33366058|NCT00856635|62744807|FG001|Overall Study|Serious Adverse Event|0|||
33366059|NCT00856635|62744806|FG000|Overall Study|Other|1|||
33366060|NCT00856635|62744807|FG001|Overall Study|Other|0|||
33366061|NCT00856635|62744806|FG000|Overall Study|Discontinued at Randomization|2|||
33366062|NCT00856635|62744807|FG001|Overall Study|Discontinued at Randomization|2|||
33366063|NCT00856557|62744817|FG000|Overall Study|No patients with contextual flags|12|||
33366064|NCT00856557|62744818|FG001|Overall Study|No patients with contextual flags|16|||
33366065|NCT00856323|62744824|FG000|Overall Study|Withdrawal by Subject|2|||
33366066|NCT00856245|62744832|FG000|Overall Study|Was not transplanted|5|||
33366067|NCT00855933|62744838|FG000|Overall Study|Withdrawal by Subject|0|||
33366068|NCT00855933|62744839|FG001|Overall Study|Withdrawal by Subject|1|||
33366069|NCT00871572|62744849|FG000|Overall Study|Adverse Event|0|||
33366070|NCT00871572|62744850|FG001|Overall Study|Adverse Event|2|||
33366071|NCT00871572|62744851|FG002|Overall Study|Adverse Event|0|||
33366072|NCT00871572|62744852|FG003|Overall Study|Adverse Event|3|||
33366073|NCT00871572|62744849|FG000|Overall Study|Investigator Decision|0|||
33366074|NCT00871572|62744850|FG001|Overall Study|Investigator Decision|1|||
33366075|NCT00871572|62744851|FG002|Overall Study|Investigator Decision|0|||
33366076|NCT00871572|62744852|FG003|Overall Study|Investigator Decision|1|||
33366077|NCT00871572|62744849|FG000|Overall Study|Lost to Follow-up|0|||
33366078|NCT00871572|62744850|FG001|Overall Study|Lost to Follow-up|1|||
33366079|NCT00871572|62744851|FG002|Overall Study|Lost to Follow-up|0|||
33366080|NCT00871572|62744852|FG003|Overall Study|Lost to Follow-up|1|||
33366081|NCT00871572|62744849|FG000|Overall Study|Protocol Violation|0|||
33366082|NCT00871572|62744850|FG001|Overall Study|Protocol Violation|0|||
33366083|NCT00871572|62744851|FG002|Overall Study|Protocol Violation|1|||
33366084|NCT00871572|62744852|FG003|Overall Study|Protocol Violation|1|||
33366085|NCT00871572|62744849|FG000|Overall Study|Sponsor Decision|1|||
33555026|NCT02394028|62947715|FG007|Maintenance Phase|Adverse Event|0|||
33366086|NCT00871572|62744850|FG001|Overall Study|Sponsor Decision|0|||
33366087|NCT00871572|62744851|FG002|Overall Study|Sponsor Decision|0|||
33366088|NCT00871572|62744852|FG003|Overall Study|Sponsor Decision|0|||
33366089|NCT00871572|62744849|FG000|Overall Study|Withdrawal by Subject|1|||
33366090|NCT00871572|62744850|FG001|Overall Study|Withdrawal by Subject|2|||
33366091|NCT00871572|62744851|FG002|Overall Study|Withdrawal by Subject|3|||
33366092|NCT00871572|62744852|FG003|Overall Study|Withdrawal by Subject|1|||
33366093|NCT03885661|62744864|FG000|Overall Study|Withdrawal by Subject|0|||
33366094|NCT03885661|62744865|FG001|Overall Study|Withdrawal by Subject|1|||
33366095|NCT03885661|62744864|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
33366096|NCT03885661|62744865|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
33366097|NCT00868530|62744871|FG000|Overall Study|Adverse Event|3|||
33366098|NCT00868530|62744871|FG000|Overall Study|Lost to Follow-up|1|||
33366099|NCT00855465|62744877|FG000|Treatment Period|Adverse Event|4|||
33366100|NCT00855465|62744878|FG001|Treatment Period|Adverse Event|2|||
33366101|NCT00855465|62744877|FG000|Treatment Period|Death|2|||
33366102|NCT00855465|62744878|FG001|Treatment Period|Death|2|||
33366103|NCT00855465|62744877|FG000|Treatment Period|Lack of Efficacy|2|||
33366104|NCT00855465|62744878|FG001|Treatment Period|Lack of Efficacy|1|||
33366105|NCT00855465|62744877|FG000|Treatment Period|Non-compliance|1|||
33366106|NCT00855465|62744878|FG001|Treatment Period|Non-compliance|0|||
33366107|NCT00855465|62744877|FG000|Treatment Period|Protocol Violation|2|||
33366108|NCT00855465|62744878|FG001|Treatment Period|Protocol Violation|0|||
33366109|NCT00855465|62744877|FG000|Treatment Period|Withdrawal by Subject|2|||
33366110|NCT00855465|62744878|FG001|Treatment Period|Withdrawal by Subject|0|||
33366111|NCT00855465|62744877|FG000|Treatment Period|Not treated|1|||
33661355|NCT01372410|63090895|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
33661356|NCT01372410|63090896|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
33661357|NCT01372410|63090897|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
33661358|NCT01372410|63090898|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
33661359|NCT01372410|63090899|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
33661360|NCT01372410|63090900|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
33661361|NCT01372410|63090901|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
33661362|NCT01372410|63090894|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
33661363|NCT01372410|63090895|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
33661364|NCT01372410|63090896|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
33661365|NCT01372410|63090897|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
33661366|NCT01372410|63090898|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
33661367|NCT01372410|63090899|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
33661368|NCT01372410|63090900|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
33661369|NCT01372410|63090901|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
33661370|NCT01372410|63090894|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
33366112|NCT00855465|62744878|FG001|Treatment Period|Not treated|0|||
33366113|NCT00855465|62744877|FG000|Follow-up Period (FUP)|Adverse Event|0|||
33366114|NCT00855465|62744878|FG001|Follow-up Period (FUP)|Adverse Event|1|||
33366115|NCT00855465|62744877|FG000|Follow-up Period (FUP)|Death|0|||
33366116|NCT00855465|62744878|FG001|Follow-up Period (FUP)|Death|1|||
33366117|NCT00855465|62744877|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
33366118|NCT00855465|62744878|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
33366119|NCT00855465|62744877|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
33366120|NCT00855465|62744878|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
33366121|NCT00855465|62744877|FG000|Follow-up Period (FUP)|Missing|1|||
33366122|NCT00855465|62744878|FG001|Follow-up Period (FUP)|Missing|0|||
33366123|NCT00598442|62744887|FG000|Overall Study|Adverse Event|3|||
33366124|NCT00598442|62744888|FG001|Overall Study|Adverse Event|0|||
33366125|NCT00598442|62744889|FG002|Overall Study|Adverse Event|0|||
33366126|NCT00598442|62744887|FG000|Overall Study|Death|19|||
33366127|NCT00598442|62744888|FG001|Overall Study|Death|11|||
33366128|NCT00598442|62744889|FG002|Overall Study|Death|11|||
33366129|NCT00598442|62744887|FG000|Overall Study|Lost to Follow-up|4|||
33366130|NCT00598442|62744888|FG001|Overall Study|Lost to Follow-up|3|||
33366131|NCT00598442|62744889|FG002|Overall Study|Lost to Follow-up|3|||
33366132|NCT00598442|62744887|FG000|Overall Study|Physician Decision|2|||
33366133|NCT00598442|62744888|FG001|Overall Study|Physician Decision|1|||
33366134|NCT00598442|62744889|FG002|Overall Study|Physician Decision|1|||
33366135|NCT00598442|62744887|FG000|Overall Study|Withdrawal by Subject|8|||
33366136|NCT00598442|62744888|FG001|Overall Study|Withdrawal by Subject|16|||
33366137|NCT00598442|62744889|FG002|Overall Study|Withdrawal by Subject|6|||
33366138|NCT00598442|62744887|FG000|Overall Study|Noncompliance|0|||
33366139|NCT00598442|62744888|FG001|Overall Study|Noncompliance|2|||
33366140|NCT00598442|62744889|FG002|Overall Study|Noncompliance|1|||
33366141|NCT00598442|62744887|FG000|Overall Study|Relocation|1|||
33366142|NCT00598442|62744888|FG001|Overall Study|Relocation|4|||
33366143|NCT00598442|62744889|FG002|Overall Study|Relocation|0|||
33366144|NCT00598442|62744887|FG000|Overall Study|Renal transplant|0|||
33366145|NCT00598442|62744888|FG001|Overall Study|Renal transplant|0|||
33366146|NCT00598442|62744889|FG002|Overall Study|Renal transplant|1|||
33366147|NCT00598442|62744887|FG000|Overall Study|Site closed by sponsor|5|||
33366148|NCT00598442|62744888|FG001|Overall Study|Site closed by sponsor|2|||
33366149|NCT00598442|62744889|FG002|Overall Study|Site closed by sponsor|1|||
33366150|NCT00598442|62744887|FG000|Overall Study|Started dialysis|1|||
33366151|NCT00598442|62744888|FG001|Overall Study|Started dialysis|0|||
33366152|NCT00598442|62744889|FG002|Overall Study|Started dialysis|0|||
33366153|NCT00593814|62744899|FG000|Overall Study|Death|7|||
33366154|NCT00593814|62744900|FG001|Overall Study|Death|0|||
33366155|NCT00593814|62744899|FG000|Overall Study|Withdrawal by Subject|7|||
33366156|NCT00593814|62744900|FG001|Overall Study|Withdrawal by Subject|0|||
33366157|NCT00593814|62744899|FG000|Overall Study|Lost to Follow-up|7|||
33366158|NCT00593814|62744900|FG001|Overall Study|Lost to Follow-up|0|||
33366159|NCT00593814|62744899|FG000|Overall Study|Physician Decision|3|||
33484196|NCT04760314|62861160|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
33484197|NCT04760314|62861161|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
33484198|NCT04760314|62861162|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33484199|NCT04760314|62861163|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33484200|NCT04760314|62861164|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33366160|NCT00593814|62744900|FG001|Overall Study|Physician Decision|0|||
33366161|NCT00855309|62744908|FG000|Overall Study|patient never recieved drug|1|||
33366162|NCT00855309|62744909|FG001|Overall Study|patient never recieved drug|0|||
33366163|NCT00532129|62744915|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
33366164|NCT00532129|62744915|FG000|Treatment Period|Physician Decision|15|||
33366165|NCT00532129|62744915|FG000|Treatment Period|Disease progression|3|||
33366166|NCT00532129|62744915|FG000|Treatment Period|Protocol Violation|1|||
33366167|NCT00532129|62744915|FG000|Treatment Period|Other|5|||
33366168|NCT00532129|62744915|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
33366169|NCT00532129|62744915|FG000|Follow-up Period|Disease progression|57|||
33366170|NCT00532129|62744915|FG000|Follow-up Period|Lost to Follow-up|1|||
33366171|NCT00532129|62744915|FG000|Follow-up Period|Other|6|||
33366172|NCT00854607|62744919|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
33366173|NCT00854373|62744932|FG000|Overall Study|Withdrawal by Subject|1|||
33366174|NCT00854373|62744933|FG001|Overall Study|Withdrawal by Subject|3|||
33366175|NCT00854373|62744932|FG000|Overall Study|Forgot to take study drug|1|||
33366176|NCT00854373|62744933|FG001|Overall Study|Forgot to take study drug|1|||
33366177|NCT00853905|62744941|FG000|Overall Study|Lost to Follow-up|1|||
33366178|NCT00853905|62744942|FG001|Overall Study|Lost to Follow-up|3|||
33366179|NCT00853905|62744941|FG000|Overall Study|Withdrawal by Subject|0|||
33366180|NCT00853905|62744942|FG001|Overall Study|Withdrawal by Subject|1|||
33366181|NCT00853905|62744941|FG000|Overall Study|never had surgery|1|||
33484201|NCT04760314|62861165|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33484202|NCT04760314|62861155|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33366182|NCT00853905|62744942|FG001|Overall Study|never had surgery|0|||
33366183|NCT00868296|62744953|FG000|Overall Study|Adverse Event|0|||
33366184|NCT00868296|62744954|FG001|Overall Study|Adverse Event|2|||
33366185|NCT00868296|62744953|FG000|Overall Study|Withdrawal by Subject|0|||
33366186|NCT00868296|62744954|FG001|Overall Study|Withdrawal by Subject|1|||
33366187|NCT00867360|62744962|FG000|Overall Study|Withdrawal by Subject|1|||
33366188|NCT00867360|62744963|FG001|Overall Study|Withdrawal by Subject|0|||
33366189|NCT00867360|62744962|FG000|Overall Study|Physician Decision|0|||
33366190|NCT00867360|62744963|FG001|Overall Study|Physician Decision|1|||
33366191|NCT00593736|62744974|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
33366192|NCT00593736|62744975|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
33484203|NCT04760314|62861156|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33484204|NCT04760314|62861157|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33484205|NCT04760314|62861158|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33484206|NCT04760314|62861159|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
33484207|NCT04760314|62861160|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33484208|NCT04760314|62861161|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33484209|NCT04760314|62861162|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33661371|NCT01372410|63090895|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
33366193|NCT00593736|62744976|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
33661372|NCT01372410|63090896|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
33366194|NCT00593736|62744977|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
33366195|NCT00593736|62744974|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
33366196|NCT00593736|62744975|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
33366197|NCT00593736|62744976|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
33366198|NCT00593736|62744977|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
33366199|NCT00593736|62744974|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
33366200|NCT00593736|62744975|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
33366201|NCT00593736|62744976|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
33366202|NCT00593736|62744977|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
33366203|NCT00593736|62744974|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
33366204|NCT00593736|62744975|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
33366205|NCT00593736|62744976|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
33366206|NCT00593736|62744977|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
33366207|NCT00593736|62744974|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
33366208|NCT00593736|62744975|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
33366209|NCT00593736|62744976|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
33366210|NCT00593736|62744977|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
33366211|NCT00593736|62744974|FG000|Screening Period and Placebo Run-in|Various|0|||
33366212|NCT00593736|62744975|FG001|Screening Period and Placebo Run-in|Various|0|||
33366213|NCT00593736|62744976|FG002|Screening Period and Placebo Run-in|Various|0|||
33366214|NCT00593736|62744977|FG003|Screening Period and Placebo Run-in|Various|25|||
33366215|NCT00593736|62744974|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
33366216|NCT00593736|62744975|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
33366217|NCT00593736|62744976|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
33366218|NCT00593736|62744977|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
33366219|NCT00593736|62744974|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
33366220|NCT00593736|62744975|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
33366221|NCT00593736|62744976|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
33366222|NCT00593736|62744977|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
33366223|NCT00593736|62744974|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
33366224|NCT00593736|62744975|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
33366225|NCT00593736|62744976|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
33366226|NCT00593736|62744977|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
33366227|NCT00593736|62744974|FG000|Treatment Period and Placebo Run-out|Various|1|||
33366228|NCT00593736|62744975|FG001|Treatment Period and Placebo Run-out|Various|1|||
33366229|NCT00593736|62744976|FG002|Treatment Period and Placebo Run-out|Various|1|||
33366230|NCT00593736|62744977|FG003|Treatment Period and Placebo Run-out|Various|0|||
33366231|NCT00883688|62744987|FG000|Overall Study|Ineligible|2|||
33366232|NCT03883477|62744993|FG000|Overall Study|Death|1|||
33366233|NCT03883477|62744994|FG001|Overall Study|Death|0|||
33366234|NCT03883477|62744993|FG000|Overall Study|Protocol Violation|0|||
33366235|NCT03883477|62744994|FG001|Overall Study|Protocol Violation|1|||
33366236|NCT00853827|62745002|FG000|Single Blind Period (1 Week)|Other|4|||
33366237|NCT00853827|62745003|FG001|Single Blind Period (1 Week)|Other|0|||
33366238|NCT00853827|62745002|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
33366239|NCT00853827|62745003|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
33366240|NCT00853827|62745002|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
33661373|NCT01372410|63090897|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
33661374|NCT01372410|63090898|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
33661375|NCT01372410|63090899|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
33661376|NCT01372410|63090900|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
33661377|NCT01372410|63090901|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
33661378|NCT01372410|63090894|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
33661379|NCT01372410|63090895|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
33661380|NCT01372410|63090896|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
33484210|NCT04760314|62861163|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33484211|NCT04760314|62861164|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33484212|NCT04760314|62861165|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33484213|NCT04760314|62861155|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
33484214|NCT04760314|62861156|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
33484215|NCT04760314|62861157|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
33484216|NCT04760314|62861158|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
33484217|NCT04760314|62861159|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
33484218|NCT04760314|62861160|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
33484219|NCT04760314|62861161|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
33484220|NCT04760314|62861162|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
33661381|NCT01372410|63090897|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
33661382|NCT01372410|63090898|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
33661383|NCT01372410|63090899|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
33661384|NCT01372410|63090900|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
33555027|NCT02394028|62947716|FG008|Maintenance Phase|Adverse Event|1|||
33555028|NCT02394028|62947717|FG009|Maintenance Phase|Adverse Event|1|||
33555029|NCT02394028|62947718|FG010|Maintenance Phase|Adverse Event|3|||
33555030|NCT02394028|62947708|FG000|Maintenance Phase|Site closure|0|||
33555031|NCT02394028|62947709|FG001|Maintenance Phase|Site closure|0|||
33555032|NCT02394028|62947710|FG002|Maintenance Phase|Site closure|0|||
33366241|NCT00853827|62745003|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
33555033|NCT02394028|62947711|FG003|Maintenance Phase|Site closure|0|||
33555034|NCT02394028|62947712|FG004|Maintenance Phase|Site closure|0|||
33484221|NCT04760314|62861163|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
33661385|NCT01372410|63090901|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
33366242|NCT00853827|62745002|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
33366243|NCT00853827|62745003|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
33366244|NCT00853827|62745002|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
33366245|NCT00853827|62745003|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
33366246|NCT00853827|62745002|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
33366247|NCT00853827|62745003|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
33366248|NCT00853827|62745002|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
33366249|NCT00853827|62745003|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
33366250|NCT00853827|62745002|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
33366251|NCT00853827|62745003|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
33366252|NCT00853827|62745002|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
33366253|NCT00853827|62745003|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
33366254|NCT00853827|62745002|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
33366255|NCT00853827|62745003|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
33366256|NCT00853827|62745002|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
33366257|NCT00853827|62745003|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
33366258|NCT00853827|62745002|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
33366259|NCT00853827|62745003|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
33366260|NCT00853827|62745002|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
33366261|NCT00853827|62745003|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
33484222|NCT04760314|62861164|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
33661386|NCT04624672|63090922|FG000|Overall Study|Early Study Closure|2|||
33661387|NCT04624672|63090923|FG001|Overall Study|Early Study Closure|1|||
33484223|NCT04760314|62861165|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
33484224|NCT04760314|62861155|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33484225|NCT04760314|62861156|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33484226|NCT04760314|62861157|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33484227|NCT04760314|62861158|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33484228|NCT04760314|62861159|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33484229|NCT04760314|62861160|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33484230|NCT04760314|62861161|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33484231|NCT04760314|62861162|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
33484232|NCT04760314|62861163|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33484233|NCT04760314|62861164|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
33484234|NCT04760314|62861165|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
33484235|NCT04760314|62861155|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33484236|NCT04760314|62861156|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33555035|NCT02394028|62947713|FG005|Maintenance Phase|Site closure|0|||
33555036|NCT02394028|62947714|FG006|Maintenance Phase|Site closure|0|||
33366262|NCT00853827|62745002|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
33484237|NCT04760314|62861157|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33484238|NCT04760314|62861158|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33484239|NCT04760314|62861159|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33484240|NCT04760314|62861160|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33484241|NCT04760314|62861161|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33484242|NCT04760314|62861162|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
33484243|NCT04760314|62861163|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
33484244|NCT04760314|62861164|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
33484245|NCT04760314|62861165|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33366263|NCT00853827|62745003|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
33484246|NCT04760314|62861155|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33484247|NCT04760314|62861156|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33484248|NCT04760314|62861157|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33366264|NCT00853827|62745002|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
33366265|NCT00853827|62745003|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
33366266|NCT00853827|62745002|FG000|Double Blind Period (103 Weeks)|Death|1|||
33366267|NCT00853827|62745003|FG001|Double Blind Period (103 Weeks)|Death|6|||
33484249|NCT04760314|62861158|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33484250|NCT04760314|62861159|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33366268|NCT00853749|62745011|FG000|Overall Study|Lost to Follow-up|0|||
33555037|NCT02394028|62947715|FG007|Maintenance Phase|Site closure|0|||
33366269|NCT00853749|62745012|FG001|Overall Study|Lost to Follow-up|1|||
33484251|NCT04760314|62861160|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33484252|NCT04760314|62861161|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33484253|NCT04760314|62861162|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
33484254|NCT04760314|62861163|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33555038|NCT02394028|62947716|FG008|Maintenance Phase|Site closure|0|||
33484255|NCT04760314|62861164|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33366270|NCT00592839|62745021|FG000|Overall Study|Withdrawal by Subject|1|||
33366271|NCT00592839|62745022|FG001|Overall Study|Withdrawal by Subject|1|||
33366272|NCT00592839|62745023|FG002|Overall Study|Withdrawal by Subject|3|||
33366273|NCT00592839|62745021|FG000|Overall Study|Protocol Violation|1|||
33366274|NCT00592839|62745022|FG001|Overall Study|Protocol Violation|1|||
33366275|NCT00592839|62745023|FG002|Overall Study|Protocol Violation|2|||
33366276|NCT00592839|62745021|FG000|Overall Study|Adverse Event|0|||
33366277|NCT00592839|62745022|FG001|Overall Study|Adverse Event|1|||
33366278|NCT00592839|62745023|FG002|Overall Study|Adverse Event|0|||
33366279|NCT00592839|62745021|FG000|Overall Study|Lost to Follow-up|0|||
33366280|NCT00592839|62745022|FG001|Overall Study|Lost to Follow-up|1|||
33366281|NCT00592839|62745023|FG002|Overall Study|Lost to Follow-up|1|||
33366282|NCT00598832|62745033|FG000|Overall Study|Lack of Efficacy|3|||
33366283|NCT00598832|62745034|FG001|Overall Study|Lack of Efficacy|7|||
33366284|NCT00598832|62745033|FG000|Overall Study|Adverse Event|6|||
33366285|NCT00598832|62745034|FG001|Overall Study|Adverse Event|2|||
33366286|NCT00598832|62745033|FG000|Overall Study|Withdrawal by Subject|25|||
33366287|NCT00598832|62745034|FG001|Overall Study|Withdrawal by Subject|36|||
33366288|NCT00598832|62745033|FG000|Overall Study|Protocol Violation|0|||
33366289|NCT00598832|62745034|FG001|Overall Study|Protocol Violation|2|||
33366290|NCT00598832|62745033|FG000|Overall Study|Lost to Follow-up|24|||
33366291|NCT00598832|62745034|FG001|Overall Study|Lost to Follow-up|29|||
33366292|NCT00598832|62745033|FG000|Overall Study|Pregnancy|2|||
33366293|NCT00598832|62745034|FG001|Overall Study|Pregnancy|2|||
33366294|NCT00598832|62745033|FG000|Overall Study|Physician Decision|1|||
33366295|NCT00598832|62745034|FG001|Overall Study|Physician Decision|4|||
33366296|NCT00598832|62745033|FG000|Overall Study|Non compliance|1|||
33366297|NCT00598832|62745034|FG001|Overall Study|Non compliance|0|||
33661388|NCT01704287|63090948|FG000|Initial Treatment Period|Death|139|||
33366298|NCT00853593|62745040|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
33366299|NCT00853593|62745040|FG000|Overall Study|Model 4396 lead not attempted|29|||
33366300|NCT00853593|62745040|FG000|Overall Study|Implant not attempted|4|||
33366301|NCT00853125|62745061|FG000|Overall Study|Study participant's donor was CMV +|1|||
33366302|NCT00530023|62745068|FG000|Overall Study|Withdrawal by Subject|0|||
33366303|NCT00530023|62745069|FG001|Overall Study|Withdrawal by Subject|1|||
33366304|NCT00529087|62745078|FG000|Overall Study|Adverse Event|10|||
33366305|NCT00529087|62745079|FG001|Overall Study|Adverse Event|13|||
33366306|NCT00529087|62745080|FG002|Overall Study|Adverse Event|4|||
33366307|NCT00529087|62745078|FG000|Overall Study|Lost to Follow-up|6|||
33366308|NCT00529087|62745079|FG001|Overall Study|Lost to Follow-up|4|||
33366309|NCT00529087|62745080|FG002|Overall Study|Lost to Follow-up|1|||
33366310|NCT00529087|62745078|FG000|Overall Study|Protocol Violation|8|||
33366311|NCT00529087|62745079|FG001|Overall Study|Protocol Violation|7|||
33366312|NCT00529087|62745080|FG002|Overall Study|Protocol Violation|6|||
33366313|NCT00529087|62745078|FG000|Overall Study|Withdrawal by Subject|3|||
33366314|NCT00529087|62745079|FG001|Overall Study|Withdrawal by Subject|3|||
33366315|NCT00529087|62745080|FG002|Overall Study|Withdrawal by Subject|3|||
33366316|NCT00529087|62745078|FG000|Overall Study|Protocol deviation|1|||
33366317|NCT00529087|62745079|FG001|Overall Study|Protocol deviation|1|||
33366318|NCT00529087|62745080|FG002|Overall Study|Protocol deviation|2|||
33366319|NCT00870870|62745115|FG000|Overall Study|Withdrawal by Subject|0|||
33366320|NCT00870870|62745116|FG001|Overall Study|Withdrawal by Subject|1|||
33366321|NCT00870870|62745117|FG002|Overall Study|Withdrawal by Subject|1|||
33366322|NCT00870870|62745118|FG003|Overall Study|Withdrawal by Subject|3|||
33366323|NCT00870870|62745115|FG000|Overall Study|Adverse Event|0|||
33366324|NCT00870870|62745116|FG001|Overall Study|Adverse Event|0|||
33366325|NCT00870870|62745117|FG002|Overall Study|Adverse Event|2|||
33366326|NCT00870870|62745118|FG003|Overall Study|Adverse Event|2|||
33366327|NCT03877237|62745135|FG000|Overall Study|Adverse Event|1|||
33366328|NCT03877237|62745136|FG001|Overall Study|Adverse Event|2|||
33366329|NCT03877237|62745135|FG000|Overall Study|Death|3|||
33366330|NCT03877237|62745136|FG001|Overall Study|Death|2|||
33366331|NCT03877237|62745135|FG000|Overall Study|Physician Decision|1|||
33366332|NCT03877237|62745136|FG001|Overall Study|Physician Decision|0|||
33366333|NCT03877237|62745135|FG000|Overall Study|Withdrawal by Subject|0|||
33366334|NCT03877237|62745136|FG001|Overall Study|Withdrawal by Subject|2|||
33366335|NCT00528931|62745142|FG000|Overall Study|Lost to Follow-up|1|||
33366336|NCT00866814|62745147|FG000|Overall Study|Lost to Follow-up|12|||
33366337|NCT00866814|62745147|FG000|Overall Study|Adverse Event|2|||
33366338|NCT00866814|62745147|FG000|Overall Study|Physician Decision|1|||
33366339|NCT00866814|62745147|FG000|Overall Study|Death|1|||
33366340|NCT00866814|62745147|FG000|Overall Study|No longer wished to participate|1|||
33366341|NCT00866814|62745147|FG000|Overall Study|Unable to meet follow-up requirements|2|||
33366342|NCT00866814|62745147|FG000|Overall Study|Moved to area without study site|1|||
33366343|NCT00871494|62745151|FG000|Overall Study|Protocol Violation|5|||
33366344|NCT00871494|62745151|FG000|Overall Study|Lack of Efficacy|4|||
33366345|NCT00871494|62745151|FG000|Overall Study|Adverse Event|4|||
33366346|NCT00871494|62745151|FG000|Overall Study|Lost to Follow-up|1|||
33366347|NCT00529789|62745155|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
33366348|NCT00529789|62745155|FG000|Study Period II/III|Adverse Event|3|||
33366349|NCT00529789|62745155|FG000|Study Period II/III|Lack of Efficacy|2|||
33366350|NCT00529789|62745155|FG000|Study Period II/III|Withdrawal by Subject|1|||
33366351|NCT00529789|62745155|FG000|Study Period II/III|Protocol Violation|3|||
33366352|NCT00529789|62745155|FG000|Study Period II/III|Physician Decision|3|||
33366353|NCT00529789|62745155|FG000|Study Period II/III|Lost to Follow-up|3|||
33366354|NCT00529789|62745155|FG000|Study Period IV|Parent/Caregiver Decision|1|||
33366355|NCT00529789|62745155|FG000|Study Period IV|Adverse Event|1|||
33366356|NCT00529789|62745155|FG000|Study Period IV|Lack of Efficacy|1|||
33366357|NCT00529789|62745155|FG000|Study Period IV|Lost to Follow-up|3|||
33366358|NCT00577642|62745165|FG000|Overall Study|Clinical Disease Progression|1|||
33366359|NCT00866658|62745171|FG000|Overall Study|Adverse Event|5|||
33366360|NCT00866658|62745172|FG001|Overall Study|Adverse Event|14|||
33366361|NCT00866658|62745171|FG000|Overall Study|Lack of Efficacy|2|||
33366362|NCT00866658|62745172|FG001|Overall Study|Lack of Efficacy|1|||
33366363|NCT00866658|62745171|FG000|Overall Study|Withdrawal by Subject|1|||
33366364|NCT00866658|62745172|FG001|Overall Study|Withdrawal by Subject|0|||
33366365|NCT00866658|62745171|FG000|Overall Study|Protocol Violation|1|||
33366366|NCT00866658|62745172|FG001|Overall Study|Protocol Violation|1|||
33366367|NCT00866658|62745171|FG000|Overall Study|Familial and Personal Reasons|4|||
33366368|NCT00866658|62745172|FG001|Overall Study|Familial and Personal Reasons|5|||
33366369|NCT00597584|62745180|FG000|Overall Study|Adverse Event|4|||
33366370|NCT00597584|62745181|FG001|Overall Study|Adverse Event|2|||
33366371|NCT00597584|62745180|FG000|Overall Study|Death|53|||
33366372|NCT00597584|62745181|FG001|Overall Study|Death|30|||
33366373|NCT00597584|62745180|FG000|Overall Study|Lack of Efficacy|1|||
33366374|NCT00597584|62745181|FG001|Overall Study|Lack of Efficacy|0|||
33366375|NCT00597584|62745180|FG000|Overall Study|Lost to Follow-up|2|||
33484256|NCT04760314|62861165|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33484257|NCT04760314|62861155|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
33484258|NCT04760314|62861156|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
33366376|NCT00597584|62745181|FG001|Overall Study|Lost to Follow-up|4|||
33366377|NCT00597584|62745180|FG000|Overall Study|Physician Decision|3|||
33366378|NCT00597584|62745181|FG001|Overall Study|Physician Decision|0|||
33366379|NCT00597584|62745180|FG000|Overall Study|Pregnancy|2|||
33366380|NCT00597584|62745181|FG001|Overall Study|Pregnancy|0|||
33366381|NCT00597584|62745180|FG000|Overall Study|Withdrawal by Subject|44|||
33366382|NCT00597584|62745181|FG001|Overall Study|Withdrawal by Subject|12|||
33366383|NCT00597584|62745180|FG000|Overall Study|Discontinued Dialysis|0|||
33366384|NCT00597584|62745181|FG001|Overall Study|Discontinued Dialysis|1|||
33366385|NCT00597584|62745180|FG000|Overall Study|Lost ability to consent|1|||
33366386|NCT00597584|62745181|FG001|Overall Study|Lost ability to consent|1|||
33366387|NCT00597584|62745180|FG000|Overall Study|Never dosed|1|||
33366388|NCT00597584|62745181|FG001|Overall Study|Never dosed|0|||
33366389|NCT00597584|62745180|FG000|Overall Study|Relocation|8|||
33366390|NCT00597584|62745181|FG001|Overall Study|Relocation|6|||
33366391|NCT00597584|62745180|FG000|Overall Study|Renal transplant|9|||
33366392|NCT00597584|62745181|FG001|Overall Study|Renal transplant|7|||
33366393|NCT00529633|62745189|FG000|Overall Study|Withdrawal by Subject|1|||
33366394|NCT00529633|62745190|FG001|Overall Study|Withdrawal by Subject|1|||
33366395|NCT00530335|62745196|FG000|Overall Study|Adverse Event|3|||
33366396|NCT00530335|62745196|FG000|Overall Study|Protocol Violation|1|||
33366397|NCT00530335|62745196|FG000|Overall Study|Withdrawal by Subject|1|||
33366398|NCT00530335|62745196|FG000|Overall Study|Physician Decision|1|||
33366399|NCT00712270|62745203|FG000|Overall Study|Withdrawal by Subject|11|||
33366400|NCT00712270|62745203|FG000|Overall Study|Screen Failure|3|||
33366401|NCT00530257|62745229|FG000|Overall Study|Lost to Follow-up|1|||
33366402|NCT00869778|62745239|FG000|Overall Study|Adverse Event|2|||
33366403|NCT00869778|62745240|FG001|Overall Study|Adverse Event|0|||
33484259|NCT04760314|62861157|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
33484260|NCT04760314|62861158|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
33484261|NCT04760314|62861159|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
33484262|NCT04760314|62861160|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
33484263|NCT04760314|62861161|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
33484264|NCT04760314|62861162|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
33484265|NCT04760314|62861163|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
33484266|NCT04760314|62861164|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
33484267|NCT04760314|62861165|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
33484268|NCT04576455|62861193|FG000|Overall Study|Ongoing in the Study|122|||
33484269|NCT04576455|62861194|FG001|Overall Study|Ongoing in the Study|135|||
33484270|NCT04576455|62861193|FG000|Overall Study|Death|18|||
33484271|NCT04576455|62861194|FG001|Overall Study|Death|12|||
33484272|NCT04576455|62861193|FG000|Overall Study|Lost to Follow-up|1|||
33484273|NCT04576455|62861194|FG001|Overall Study|Lost to Follow-up|0|||
33484274|NCT04576455|62861193|FG000|Overall Study|Withdrawal by Subject|10|||
33484275|NCT04576455|62861194|FG001|Overall Study|Withdrawal by Subject|5|||
33484276|NCT04493684|62861218|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
33366404|NCT00869778|62745241|FG002|Overall Study|Adverse Event|0|||
33484277|NCT04493684|62861219|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33484278|NCT04493684|62861220|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
33484279|NCT04493684|62861221|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33484280|NCT04493684|62861222|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33484281|NCT04493684|62861223|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
33484282|NCT04493684|62861224|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33484283|NCT04493684|62861225|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33366405|NCT00869778|62745239|FG000|Overall Study|Withdrawal by Subject|3|||
33366406|NCT00869778|62745240|FG001|Overall Study|Withdrawal by Subject|4|||
33366407|NCT00869778|62745241|FG002|Overall Study|Withdrawal by Subject|5|||
33366408|NCT00869778|62745239|FG000|Overall Study|Pregnancy|1|||
33366409|NCT00869778|62745240|FG001|Overall Study|Pregnancy|0|||
33366410|NCT00869778|62745241|FG002|Overall Study|Pregnancy|0|||
33366411|NCT00869778|62745239|FG000|Overall Study|Protocol Violation|5|||
33484284|NCT04493684|62861226|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33366412|NCT00869778|62745240|FG001|Overall Study|Protocol Violation|3|||
33366413|NCT00869778|62745241|FG002|Overall Study|Protocol Violation|5|||
33366414|NCT00869778|62745239|FG000|Overall Study|Unblinding|1|||
33484285|NCT04493684|62861227|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33484286|NCT04493684|62861228|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33484287|NCT04493684|62861229|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33484288|NCT04493684|62861230|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33366415|NCT00869778|62745240|FG001|Overall Study|Unblinding|0|||
33366416|NCT00869778|62745241|FG002|Overall Study|Unblinding|0|||
33366417|NCT00711958|62745272|FG000|Overall Study|Withdrawal by Subject|6|||
33484289|NCT04493684|62861231|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33484290|NCT04493684|62861232|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33484291|NCT04493684|62861233|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33661389|NCT01704287|63090949|FG001|Initial Treatment Period|Death|129|||
33661390|NCT01704287|63090950|FG002|Initial Treatment Period|Death|71|||
33555039|NCT02394028|62947717|FG009|Maintenance Phase|Site closure|1|||
33555040|NCT02394028|62947718|FG010|Maintenance Phase|Site closure|0|||
33661391|NCT01704287|63090951|FG003|Initial Treatment Period|Death|0|||
33484292|NCT04493684|62861234|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33484293|NCT04493684|62861218|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
33484294|NCT04493684|62861219|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33484295|NCT04493684|62861220|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33484296|NCT04493684|62861221|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33555041|NCT02394028|62947708|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33555042|NCT02394028|62947709|FG001|Maintenance Phase|Withdrawal by Subject|0|||
33555043|NCT02394028|62947710|FG002|Maintenance Phase|Withdrawal by Subject|0|||
33661392|NCT01704287|63090952|FG004|Initial Treatment Period|Death|0|||
33661393|NCT01704287|63090948|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
33661394|NCT01704287|63090949|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
33661395|NCT01704287|63090950|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
33661396|NCT01704287|63090951|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
33555044|NCT02394028|62947711|FG003|Maintenance Phase|Withdrawal by Subject|0|||
33555045|NCT02394028|62947712|FG004|Maintenance Phase|Withdrawal by Subject|0|||
33661397|NCT01704287|63090952|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
33484297|NCT04493684|62861222|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33484298|NCT04493684|62861223|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33484299|NCT04493684|62861224|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33484300|NCT04493684|62861225|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33484301|NCT04493684|62861226|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33484302|NCT04493684|62861227|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33366418|NCT00711958|62745273|FG001|Overall Study|Withdrawal by Subject|8|||
33366419|NCT00711958|62745272|FG000|Overall Study|Lack of Efficacy|3|||
33366420|NCT00711958|62745273|FG001|Overall Study|Lack of Efficacy|1|||
33366421|NCT00711958|62745272|FG000|Overall Study|Clinical deterioration|1|||
33555046|NCT02394028|62947713|FG005|Maintenance Phase|Withdrawal by Subject|0|||
33366422|NCT00711958|62745273|FG001|Overall Study|Clinical deterioration|0|||
33366423|NCT00711958|62745272|FG000|Overall Study|Adverse Event|9|||
33366424|NCT00711958|62745273|FG001|Overall Study|Adverse Event|7|||
33366425|NCT00711958|62745272|FG000|Overall Study|Protocol Violation|1|||
33366426|NCT00711958|62745273|FG001|Overall Study|Protocol Violation|0|||
33366427|NCT00711958|62745272|FG000|Overall Study|Lost to Follow-up|2|||
33366428|NCT00711958|62745273|FG001|Overall Study|Lost to Follow-up|2|||
33366429|NCT00711958|62745272|FG000|Overall Study|Death|10|||
33366430|NCT00711958|62745273|FG001|Overall Study|Death|5|||
33366431|NCT00711958|62745272|FG000|Overall Study|Progression of disease|1|||
33366432|NCT00711958|62745273|FG001|Overall Study|Progression of disease|0|||
33366433|NCT00711880|62745281|FG000|Overall Study|Adverse Event|11|||
33366434|NCT00711880|62745282|FG001|Overall Study|Adverse Event|2|||
33366435|NCT00711880|62745281|FG000|Overall Study|Patient non-compliance|1|||
33366436|NCT00711880|62745282|FG001|Overall Study|Patient non-compliance|0|||
33366437|NCT00711880|62745281|FG000|Overall Study|Lack of Efficacy|1|||
33366438|NCT00711880|62745282|FG001|Overall Study|Lack of Efficacy|5|||
33366439|NCT00528775|62745288|FG000|Overall Study|Other not specified|1|||
33366440|NCT00529399|62745295|FG000|Overall Study|Lost to Follow-up|1|||
33366441|NCT00529399|62745296|FG001|Overall Study|Lost to Follow-up|0|||
33366442|NCT00529399|62745297|FG002|Overall Study|Lost to Follow-up|1|||
33366443|NCT00529399|62745295|FG000|Overall Study|Withdrawal by Subject|1|||
33366444|NCT00529399|62745296|FG001|Overall Study|Withdrawal by Subject|0|||
33366445|NCT00529399|62745297|FG002|Overall Study|Withdrawal by Subject|1|||
33366446|NCT00529399|62745295|FG000|Overall Study|Non-compliant|0|||
33366447|NCT00529399|62745296|FG001|Overall Study|Non-compliant|1|||
33366448|NCT00529399|62745297|FG002|Overall Study|Non-compliant|0|||
33661398|NCT01704287|63090948|FG000|Initial Treatment Period|Lost to Follow-up|5|||
33661399|NCT01704287|63090949|FG001|Initial Treatment Period|Lost to Follow-up|3|||
33661400|NCT01704287|63090950|FG002|Initial Treatment Period|Lost to Follow-up|0|||
33661401|NCT01704287|63090951|FG003|Initial Treatment Period|Lost to Follow-up|0|||
33661402|NCT01704287|63090952|FG004|Initial Treatment Period|Lost to Follow-up|0|||
33366449|NCT00852969|62745307|FG000|Overall Study|Adverse Event|0|||
33366450|NCT00852969|62745308|FG001|Overall Study|Adverse Event|1|||
33366451|NCT00852969|62745307|FG000|Overall Study|Lost to Follow-up|0|||
33366452|NCT00852969|62745308|FG001|Overall Study|Lost to Follow-up|1|||
33484303|NCT04493684|62861228|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33484304|NCT04493684|62861229|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33366453|NCT03870997|62745320|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
33366454|NCT03870997|62745321|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
33484305|NCT04493684|62861230|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33484306|NCT04493684|62861231|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33366455|NCT03870997|62745322|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
33366456|NCT03870997|62745323|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
33366457|NCT03870997|62745324|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
33366458|NCT03870997|62745325|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
33366459|NCT00521365|62745334|FG000|Overall Study|Adverse Event|3|||
33366460|NCT00521365|62745334|FG000|Overall Study|Lost to Follow-up|6|||
33366461|NCT00521365|62745334|FG000|Overall Study|Protocol deviation|2|||
33366462|NCT00521365|62745334|FG000|Overall Study|Drug compliance|3|||
33661403|NCT01704287|63090948|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
33661404|NCT01704287|63090949|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
33661405|NCT01704287|63090950|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
33366463|NCT00521365|62745334|FG000|Overall Study|Usage of not allowed drugs|6|||
33366464|NCT00711802|62745346|FG000|Overall Study|Not treated (no further detail)|2|||
33366465|NCT00711802|62745347|FG001|Overall Study|Not treated (no further detail)|1|||
33366466|NCT00711802|62745348|FG002|Overall Study|Not treated (no further detail)|2|||
33366467|NCT00711802|62745349|FG003|Overall Study|Not treated (no further detail)|0|||
33366468|NCT00711802|62745350|FG004|Overall Study|Not treated (no further detail)|2|||
33366469|NCT00711802|62745351|FG005|Overall Study|Not treated (no further detail)|0|||
33366470|NCT00711802|62745352|FG006|Overall Study|Not treated (no further detail)|0|||
33366471|NCT00711802|62745353|FG007|Overall Study|Not treated (no further detail)|0|||
33366472|NCT00711802|62745346|FG000|Overall Study|Adverse Event|0|||
33366473|NCT00711802|62745347|FG001|Overall Study|Adverse Event|0|||
33366474|NCT00711802|62745348|FG002|Overall Study|Adverse Event|0|||
33366475|NCT00711802|62745349|FG003|Overall Study|Adverse Event|0|||
33366476|NCT00711802|62745350|FG004|Overall Study|Adverse Event|1|||
33366477|NCT00711802|62745351|FG005|Overall Study|Adverse Event|1|||
33366478|NCT00711802|62745352|FG006|Overall Study|Adverse Event|0|||
33366479|NCT00711802|62745353|FG007|Overall Study|Adverse Event|0|||
33366480|NCT00711802|62745346|FG000|Overall Study|Microbiological failure|0|||
33366481|NCT00711802|62745347|FG001|Overall Study|Microbiological failure|1|||
33366482|NCT00711802|62745348|FG002|Overall Study|Microbiological failure|0|||
33366483|NCT00711802|62745349|FG003|Overall Study|Microbiological failure|0|||
33366484|NCT00711802|62745350|FG004|Overall Study|Microbiological failure|0|||
33366485|NCT00711802|62745351|FG005|Overall Study|Microbiological failure|1|||
33366486|NCT00711802|62745352|FG006|Overall Study|Microbiological failure|0|||
33366487|NCT00711802|62745353|FG007|Overall Study|Microbiological failure|0|||
33366488|NCT00711802|62745346|FG000|Overall Study|Protocol Violation|0|||
33484307|NCT04493684|62861232|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33366489|NCT00711802|62745347|FG001|Overall Study|Protocol Violation|0|||
33366490|NCT00711802|62745348|FG002|Overall Study|Protocol Violation|0|||
33366491|NCT00711802|62745349|FG003|Overall Study|Protocol Violation|1|||
33366492|NCT00711802|62745350|FG004|Overall Study|Protocol Violation|0|||
33366493|NCT00711802|62745351|FG005|Overall Study|Protocol Violation|0|||
33484308|NCT04493684|62861233|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33484309|NCT04493684|62861234|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33484310|NCT04493684|62861218|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33484311|NCT04493684|62861219|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33366494|NCT00711802|62745352|FG006|Overall Study|Protocol Violation|0|||
33484312|NCT04493684|62861220|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33484313|NCT04493684|62861221|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33484314|NCT04493684|62861222|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33555047|NCT02394028|62947714|FG006|Maintenance Phase|Withdrawal by Subject|0|||
33366495|NCT00711802|62745353|FG007|Overall Study|Protocol Violation|0|||
33366496|NCT00711802|62745346|FG000|Overall Study|Physician Decision|0|||
33366497|NCT00711802|62745347|FG001|Overall Study|Physician Decision|2|||
33484315|NCT04493684|62861223|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33484316|NCT04493684|62861224|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
33484317|NCT04493684|62861225|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33484318|NCT04493684|62861226|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33484319|NCT04493684|62861227|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33484320|NCT04493684|62861228|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33484321|NCT04493684|62861229|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33484322|NCT04493684|62861230|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33366498|NCT00711802|62745348|FG002|Overall Study|Physician Decision|0|||
33484323|NCT04493684|62861231|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33484324|NCT04493684|62861232|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33484325|NCT04493684|62861233|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33484326|NCT04493684|62861234|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33661406|NCT01704287|63090951|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
33484327|NCT04493684|62861218|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
33366499|NCT00711802|62745349|FG003|Overall Study|Physician Decision|0|||
33366500|NCT00711802|62745350|FG004|Overall Study|Physician Decision|0|||
33366501|NCT00711802|62745351|FG005|Overall Study|Physician Decision|0|||
33555048|NCT02394028|62947715|FG007|Maintenance Phase|Withdrawal by Subject|0|||
33555049|NCT02394028|62947716|FG008|Maintenance Phase|Withdrawal by Subject|3|||
33366502|NCT00711802|62745352|FG006|Overall Study|Physician Decision|0|||
33366503|NCT00711802|62745353|FG007|Overall Study|Physician Decision|0|||
33366504|NCT00711802|62745346|FG000|Overall Study|Withdrawal by Subject|0|||
33366505|NCT00711802|62745347|FG001|Overall Study|Withdrawal by Subject|1|||
33366506|NCT00711802|62745348|FG002|Overall Study|Withdrawal by Subject|0|||
33366507|NCT00711802|62745349|FG003|Overall Study|Withdrawal by Subject|1|||
33366508|NCT00711802|62745350|FG004|Overall Study|Withdrawal by Subject|0|||
33366509|NCT00711802|62745351|FG005|Overall Study|Withdrawal by Subject|0|||
33366510|NCT00711802|62745352|FG006|Overall Study|Withdrawal by Subject|0|||
33366511|NCT00711802|62745353|FG007|Overall Study|Withdrawal by Subject|0|||
33366512|NCT00711802|62745346|FG000|Overall Study|Lost to Follow-up|0|||
33366513|NCT00711802|62745347|FG001|Overall Study|Lost to Follow-up|0|||
33366514|NCT00711802|62745348|FG002|Overall Study|Lost to Follow-up|3|||
33366515|NCT00711802|62745349|FG003|Overall Study|Lost to Follow-up|1|||
33366516|NCT00711802|62745350|FG004|Overall Study|Lost to Follow-up|10|||
33366517|NCT00711802|62745351|FG005|Overall Study|Lost to Follow-up|6|||
33366518|NCT00711802|62745352|FG006|Overall Study|Lost to Follow-up|4|||
33366519|NCT00711802|62745353|FG007|Overall Study|Lost to Follow-up|2|||
33366520|NCT00711802|62745346|FG000|Overall Study|Reason not reported|0|||
33366521|NCT00711802|62745347|FG001|Overall Study|Reason not reported|1|||
33366522|NCT00711802|62745348|FG002|Overall Study|Reason not reported|1|||
33366523|NCT00711802|62745349|FG003|Overall Study|Reason not reported|0|||
33366524|NCT00711802|62745350|FG004|Overall Study|Reason not reported|1|||
33366525|NCT00711802|62745351|FG005|Overall Study|Reason not reported|0|||
33366526|NCT00711802|62745352|FG006|Overall Study|Reason not reported|1|||
33366527|NCT00711802|62745353|FG007|Overall Study|Reason not reported|0|||
33366528|NCT00851877|62745374|FG000|Phase I-1|Death|1|||
33366529|NCT00851877|62745375|FG001|Phase I-1|Death|0|||
33366530|NCT00851877|62745376|FG002|Phase I-1|Death|0|||
33366531|NCT00851877|62745374|FG000|Phase II|Withdrawal by Subject|0|||
33366532|NCT00851877|62745375|FG001|Phase II|Withdrawal by Subject|0|||
33366533|NCT00851877|62745376|FG002|Phase II|Withdrawal by Subject|3|||
33366534|NCT00882908|62745387|FG000|Overall Study|Adverse Event|0|||
33366535|NCT00882908|62745388|FG001|Overall Study|Adverse Event|0|||
33366536|NCT00882908|62745389|FG002|Overall Study|Adverse Event|1|||
33366537|NCT00882908|62745390|FG003|Overall Study|Adverse Event|0|||
33366538|NCT00882908|62745391|FG004|Overall Study|Adverse Event|1|||
33366539|NCT00882908|62745387|FG000|Overall Study|Lost to Follow-up|3|||
33366540|NCT00882908|62745388|FG001|Overall Study|Lost to Follow-up|5|||
33366541|NCT00882908|62745389|FG002|Overall Study|Lost to Follow-up|3|||
33366542|NCT00882908|62745390|FG003|Overall Study|Lost to Follow-up|1|||
33366543|NCT00882908|62745391|FG004|Overall Study|Lost to Follow-up|2|||
33366544|NCT00882908|62745387|FG000|Overall Study|Protocol Violation|0|||
33366545|NCT00882908|62745388|FG001|Overall Study|Protocol Violation|1|||
33366546|NCT00882908|62745389|FG002|Overall Study|Protocol Violation|0|||
33366547|NCT00882908|62745390|FG003|Overall Study|Protocol Violation|0|||
33366548|NCT00882908|62745391|FG004|Overall Study|Protocol Violation|0|||
33366549|NCT00882908|62745387|FG000|Overall Study|Withdrawal by Subject|0|||
33366550|NCT00882908|62745388|FG001|Overall Study|Withdrawal by Subject|0|||
33366551|NCT00882908|62745389|FG002|Overall Study|Withdrawal by Subject|3|||
33366552|NCT00882908|62745390|FG003|Overall Study|Withdrawal by Subject|5|||
33366553|NCT00882908|62745391|FG004|Overall Study|Withdrawal by Subject|2|||
33366554|NCT00882908|62745387|FG000|Overall Study|Subject reached a virologic endpoint|0|||
33366555|NCT00882908|62745388|FG001|Overall Study|Subject reached a virologic endpoint|0|||
33366556|NCT00882908|62745389|FG002|Overall Study|Subject reached a virologic endpoint|0|||
33366557|NCT00882908|62745390|FG003|Overall Study|Subject reached a virologic endpoint|0|||
33366558|NCT00882908|62745391|FG004|Overall Study|Subject reached a virologic endpoint|1|||
33366559|NCT00882908|62745387|FG000|Overall Study|Study terminated in error|0|||
33366560|NCT00882908|62745388|FG001|Overall Study|Study terminated in error|0|||
33366561|NCT00882908|62745389|FG002|Overall Study|Study terminated in error|0|||
33366562|NCT00882908|62745390|FG003|Overall Study|Study terminated in error|1|||
33366563|NCT00882908|62745391|FG004|Overall Study|Study terminated in error|0|||
33366564|NCT00851799|62745407|FG000|Overall Study|Death|1|||
33366565|NCT00851799|62745408|FG001|Overall Study|Death|0|||
33366566|NCT00851799|62745409|FG002|Overall Study|Death|1|||
33661407|NCT01704287|63090952|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
33661408|NCT01704287|63090948|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
33366567|NCT00851799|62745407|FG000|Overall Study|Lost to Follow-up|5|||
33366568|NCT00851799|62745408|FG001|Overall Study|Lost to Follow-up|3|||
33366569|NCT00851799|62745409|FG002|Overall Study|Lost to Follow-up|10|||
33366570|NCT00851799|62745407|FG000|Overall Study|Not able to get to clinic|8|||
33366571|NCT00851799|62745408|FG001|Overall Study|Not able to get to clinic|5|||
33366572|NCT00851799|62745409|FG002|Overall Study|Not able to get to clinic|9|||
33366573|NCT00851799|62745407|FG000|Overall Study|Not willing to adhere to requirements|1|||
33366574|NCT00851799|62745408|FG001|Overall Study|Not willing to adhere to requirements|2|||
33555050|NCT02394028|62947717|FG009|Maintenance Phase|Withdrawal by Subject|12|||
33555051|NCT02394028|62947718|FG010|Maintenance Phase|Withdrawal by Subject|12|||
33555052|NCT01371539|62947772|FG000|Period One: One Week|Lost to Follow-up|0|||
33366575|NCT00851799|62745409|FG002|Overall Study|Not willing to adhere to requirements|2|||
33366576|NCT00851799|62745407|FG000|Overall Study|Withdrew consent prior study completion|1|||
33366577|NCT00851799|62745408|FG001|Overall Study|Withdrew consent prior study completion|2|||
33366578|NCT00851799|62745409|FG002|Overall Study|Withdrew consent prior study completion|1|||
33366579|NCT00851799|62745407|FG000|Overall Study|Severe Debilitation|0|||
33661409|NCT01704287|63090949|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
33661410|NCT01704287|63090950|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
33661411|NCT01704287|63090951|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
33661412|NCT01704287|63090952|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
33661413|NCT01704287|63090948|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
33661414|NCT01704287|63090949|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
33661415|NCT01704287|63090950|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
33661416|NCT01704287|63090951|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
33661417|NCT01704287|63090952|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
33661418|NCT01704287|63090948|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
33661419|NCT01704287|63090949|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
33555053|NCT01371539|62947773|FG001|Period One: One Week|Lost to Follow-up|1|||
33484328|NCT04493684|62861219|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33484329|NCT04493684|62861220|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33484330|NCT04493684|62861221|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33484331|NCT04493684|62861222|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33484332|NCT04493684|62861223|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33484333|NCT04493684|62861224|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33484334|NCT04493684|62861225|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33555054|NCT01371539|62947772|FG000|Period Two: One Week|Lost to Follow-up|0|||
33555055|NCT01371539|62947773|FG001|Period Two: One Week|Lost to Follow-up|1|||
33555056|NCT01371539|62947772|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
33366580|NCT00851799|62745408|FG001|Overall Study|Severe Debilitation|1|||
33555057|NCT01371539|62947773|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
33555058|NCT01371539|62947772|FG000|Period Two: One Week|Time/job conflict|0|||
33555059|NCT01371539|62947773|FG001|Period Two: One Week|Time/job conflict|1|||
33555060|NCT03320330|62947782|FG000|Overall Study|Lack of Efficacy|5|||
33555061|NCT03320330|62947783|FG001|Overall Study|Lack of Efficacy|5|||
33555062|NCT03320330|62947784|FG002|Overall Study|Lack of Efficacy|14|||
33555063|NCT03320330|62947782|FG000|Overall Study|Physician Decision|1|||
33555064|NCT03320330|62947783|FG001|Overall Study|Physician Decision|0|||
33555065|NCT03320330|62947784|FG002|Overall Study|Physician Decision|0|||
33555066|NCT02819297|62947795|FG000|Overall Study|Withdrawal by Subject|25|||
33555067|NCT02819297|62947796|FG001|Overall Study|Withdrawal by Subject|13|||
33661420|NCT01704287|63090950|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
33484335|NCT04493684|62861226|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33484336|NCT04493684|62861227|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33661421|NCT01704287|63090951|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
33661422|NCT01704287|63090952|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
33661423|NCT01682837|63090980|FG000|Baseline|Withdrawal by Subject|5|||
33661424|NCT01703819|63091017|FG000|Overall Study|Adverse Event|0|||
33661425|NCT01703819|63091018|FG001|Overall Study|Adverse Event|1|||
33661426|NCT01703819|63091017|FG000|Overall Study|Withdrawal by Subject|0|||
33661427|NCT01703819|63091018|FG001|Overall Study|Withdrawal by Subject|1|||
33661428|NCT01682759|63091030|FG000|Overall Study|Death|2|||
33661429|NCT01682759|63091031|FG001|Overall Study|Death|1|||
33661430|NCT01682759|63091030|FG000|Overall Study|Lost to Follow-up|10|||
33661431|NCT01682759|63091031|FG001|Overall Study|Lost to Follow-up|13|||
33661432|NCT01682759|63091030|FG000|Overall Study|Physician Decision|1|||
33661433|NCT01682759|63091031|FG001|Overall Study|Physician Decision|1|||
33661434|NCT01682759|63091030|FG000|Overall Study|Withdrawal by Subject|56|||
33661435|NCT01682759|63091031|FG001|Overall Study|Withdrawal by Subject|55|||
33661436|NCT01682681|63091041|FG000|Overall Study|Lack of Efficacy|62|||
33661437|NCT01682681|63091041|FG000|Overall Study|Withdrawal by Subject|1|||
33661438|NCT01682681|63091041|FG000|Overall Study|Moved to other hospital|10|||
33661439|NCT01682681|63091041|FG000|Overall Study|Lost to Follow-up|174|||
33661440|NCT01682681|63091041|FG000|Overall Study|Adverse Event|46|||
33661441|NCT01682681|63091041|FG000|Overall Study|tapering of topiramate|5|||
33661442|NCT01682681|63091041|FG000|Overall Study|Other|21|||
33661443|NCT01682681|63091041|FG000|Overall Study|Low compliance|13|||
33661444|NCT01682603|63091045|FG000|Overall Study|Lost to Follow-up|3|||
33661445|NCT01682213|63091061|FG000|Overall Study|Withdrawal by Subject|2|||
33661446|NCT01703741|63091070|FG000|Overall Study|Withdrawal by Subject|6|||
33661447|NCT01703741|63091070|FG000|Overall Study|Adverse Event|2|||
33661448|NCT01703741|63091070|FG000|Overall Study|Physician Decision|2|||
33661449|NCT01703741|63091070|FG000|Overall Study|Protocol Violation|1|||
33661450|NCT01703741|63091070|FG000|Overall Study|Lost to Follow-up|3|||
33661451|NCT01703741|63091070|FG000|Overall Study|Subject did not want to continue|2|||
33661452|NCT01703741|63091070|FG000|Overall Study|Subject cannot comply with study visits|1|||
33661453|NCT01703741|63091070|FG000|Overall Study|Subject started testosterone injections|1|||
33661454|NCT01681511|63091076|FG000|Overall Study|No Treatment Received|1|||
33661455|NCT01681511|63091077|FG001|Overall Study|No Treatment Received|3|||
33661456|NCT01681511|63091076|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
33661457|NCT01681511|63091077|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
33661458|NCT01681511|63091076|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
33661459|NCT01681511|63091077|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
33661460|NCT01681511|63091076|FG000|Overall Study|No Daily Urine Sample Collected|0|||
33661461|NCT01681511|63091077|FG001|Overall Study|No Daily Urine Sample Collected|1|||
33661462|NCT01681511|63091076|FG000|Overall Study|No post-catheter sample collected|11|||
33661463|NCT01681511|63091077|FG001|Overall Study|No post-catheter sample collected|4|||
33661464|NCT02175004|63091085|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
33661465|NCT02175004|63091086|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
33661466|NCT02175004|63091085|FG000|Overall Study|Investigator Judgment|1|||
33661467|NCT02175004|63091086|FG001|Overall Study|Investigator Judgment|4|||
33661468|NCT02175004|63091085|FG000|Overall Study|Voluntary Withdrawal|6|||
33661469|NCT02175004|63091086|FG001|Overall Study|Voluntary Withdrawal|19|||
33661470|NCT02175004|63091085|FG000|Overall Study|Liver Transplant|1|||
33661471|NCT02175004|63091086|FG001|Overall Study|Liver Transplant|0|||
33661472|NCT02175004|63091085|FG000|Overall Study|Disease Progression|1|||
33661473|NCT02175004|63091086|FG001|Overall Study|Disease Progression|0|||
33661474|NCT02175004|63091085|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
33661475|NCT02175004|63091086|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
33661476|NCT01681433|63091094|FG000|Overall Study|Lack of Efficacy|23|||
33661477|NCT01681433|63091095|FG001|Overall Study|Lack of Efficacy|23|||
33661478|NCT01681433|63091094|FG000|Overall Study|Withdrawal by Subject|5|||
33661479|NCT01681433|63091095|FG001|Overall Study|Withdrawal by Subject|5|||
33661480|NCT01681433|63091094|FG000|Overall Study|Protocol Violation|2|||
33661481|NCT01681433|63091095|FG001|Overall Study|Protocol Violation|0|||
33661482|NCT01681433|63091094|FG000|Overall Study|Adverse Event|2|||
33661483|NCT01681433|63091095|FG001|Overall Study|Adverse Event|4|||
33661484|NCT01681433|63091094|FG000|Overall Study|Lost to Follow-up|0|||
33661485|NCT01681433|63091095|FG001|Overall Study|Lost to Follow-up|1|||
33661486|NCT01681277|63091106|FG000|Overall Study|Adverse Event|1|||
33661487|NCT01681277|63091107|FG001|Overall Study|Adverse Event|0|||
33661488|NCT01681277|63091108|FG002|Overall Study|Adverse Event|0|||
33661489|NCT01681277|63091109|FG003|Overall Study|Adverse Event|0|||
33484337|NCT04493684|62861228|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33484338|NCT04493684|62861229|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33484339|NCT04493684|62861230|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33484340|NCT04493684|62861231|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33661490|NCT01681277|63091110|FG004|Overall Study|Adverse Event|0|||
33661491|NCT01703117|63091128|FG000|Overall Study|Adverse Event|4|||
33661492|NCT01703117|63091129|FG001|Overall Study|Adverse Event|3|||
33661493|NCT01703117|63091128|FG000|Overall Study|Withdrawal by Subject|0|||
33484341|NCT04493684|62861232|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33484342|NCT04493684|62861233|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33484343|NCT04493684|62861234|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33484344|NCT04493684|62861218|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33484345|NCT04493684|62861219|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33555068|NCT02819297|62947795|FG000|Overall Study|Lost to Follow-up|12|||
33366581|NCT00851799|62745409|FG002|Overall Study|Severe Debilitation|0|||
33366582|NCT00851799|62745407|FG000|Overall Study|Completed protocol due to pregnancy|0|||
33366583|NCT00851799|62745408|FG001|Overall Study|Completed protocol due to pregnancy|0|||
33366584|NCT00851799|62745409|FG002|Overall Study|Completed protocol due to pregnancy|1|||
33366585|NCT00521053|62745417|FG000|Observation Phase|Disease Progression|55|||
33366586|NCT00521053|62745417|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
33366587|NCT00521053|62745417|FG000|Observation Phase|Death|2|||
33366588|NCT00521053|62745417|FG000|Observation Phase|Adverse Event|1|||
33366589|NCT00521053|62745417|FG000|Observation Phase|Other non-study melanoma treatment|1|||
33366590|NCT00521053|62745417|FG000|Observation Phase|Physician Decision|1|||
33366591|NCT00853047|62745429|FG000|Core Phase|Participant Request|0|||
33366592|NCT00853047|62745430|FG001|Core Phase|Participant Request|0|||
33366593|NCT00853047|62745431|FG002|Core Phase|Participant Request|0|||
33366594|NCT00853047|62745432|FG003|Core Phase|Participant Request|1|||
33366595|NCT00853047|62745433|FG004|Core Phase|Participant Request|0|||
33366596|NCT00853047|62745434|FG005|Core Phase|Participant Request|0|||
33366597|NCT00853047|62745429|FG000|Open-Label Extension Phase|Participant Request|0|||
33366598|NCT00853047|62745430|FG001|Open-Label Extension Phase|Participant Request|0|||
33366599|NCT00853047|62745431|FG002|Open-Label Extension Phase|Participant Request|0|||
33366600|NCT00853047|62745432|FG003|Open-Label Extension Phase|Participant Request|0|||
33366601|NCT00853047|62745433|FG004|Open-Label Extension Phase|Participant Request|0|||
33366602|NCT00853047|62745434|FG005|Open-Label Extension Phase|Participant Request|7|||
33366603|NCT00853047|62745429|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
33366604|NCT00853047|62745430|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
33366605|NCT00853047|62745431|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
33366606|NCT00853047|62745432|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
33366607|NCT00853047|62745433|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
33366608|NCT00853047|62745434|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
33366609|NCT00853047|62745429|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
33366610|NCT00853047|62745430|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
33366611|NCT00853047|62745431|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
33366612|NCT00853047|62745432|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
33366613|NCT00853047|62745433|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
33366614|NCT00853047|62745434|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
33366615|NCT00853047|62745429|FG000|Open-Label Extension Phase|Investigator Decision|0|||
33366616|NCT00853047|62745430|FG001|Open-Label Extension Phase|Investigator Decision|0|||
33366617|NCT00853047|62745431|FG002|Open-Label Extension Phase|Investigator Decision|0|||
33366618|NCT00853047|62745432|FG003|Open-Label Extension Phase|Investigator Decision|0|||
33366619|NCT00853047|62745433|FG004|Open-Label Extension Phase|Investigator Decision|0|||
33366620|NCT00853047|62745434|FG005|Open-Label Extension Phase|Investigator Decision|1|||
33366621|NCT00853047|62745429|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
33366622|NCT00853047|62745430|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
33366623|NCT00853047|62745431|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
33366624|NCT00853047|62745432|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
33366625|NCT00853047|62745433|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
33366626|NCT00853047|62745434|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
33366627|NCT00520975|62745451|FG000|Overall Study|Disease progression|31|||
33366628|NCT00520975|62745452|FG001|Overall Study|Disease progression|23|||
33366629|NCT00520975|62745451|FG000|Overall Study|Adverse Event|7|||
33366630|NCT00520975|62745452|FG001|Overall Study|Adverse Event|10|||
33366631|NCT00520975|62745451|FG000|Overall Study|Death|0|||
33484346|NCT04493684|62861220|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33484347|NCT04493684|62861221|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33484348|NCT04493684|62861222|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33555069|NCT02819297|62947796|FG001|Overall Study|Lost to Follow-up|14|||
33555070|NCT02819297|62947795|FG000|Overall Study|Adverse Event|12|||
33555071|NCT02819297|62947796|FG001|Overall Study|Adverse Event|10|||
33555072|NCT02819297|62947795|FG000|Overall Study|Physician Decision|5|||
33366632|NCT00520975|62745452|FG001|Overall Study|Death|2|||
33555073|NCT02819297|62947796|FG001|Overall Study|Physician Decision|5|||
33484349|NCT04493684|62861223|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
33484350|NCT04493684|62861224|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33555074|NCT02819297|62947795|FG000|Overall Study|Lack of Efficacy|5|||
33555075|NCT02819297|62947796|FG001|Overall Study|Lack of Efficacy|8|||
33555076|NCT02819297|62947795|FG000|Overall Study|Protocol Violation|1|||
33555077|NCT02819297|62947796|FG001|Overall Study|Protocol Violation|2|||
33555078|NCT02429830|62947802|FG000|Overall Study|Lost to Follow-up|1|||
33555079|NCT02429830|62947802|FG000|Overall Study|Device Explant|2|||
33555080|NCT02821715|62947806|FG000|Overall Study|Protocol Violation|1|||
33555081|NCT02821715|62947807|FG001|Overall Study|Protocol Violation|0|||
33484351|NCT04493684|62861225|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33484352|NCT04493684|62861226|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33484353|NCT04493684|62861227|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33484354|NCT04493684|62861228|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33484355|NCT04493684|62861229|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33484356|NCT04493684|62861230|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33555082|NCT02821715|62947808|FG002|Overall Study|Protocol Violation|0|||
33555083|NCT02821715|62947809|FG003|Overall Study|Protocol Violation|0|||
33555084|NCT02821715|62947810|FG004|Overall Study|Protocol Violation|0|||
33555085|NCT02821715|62947811|FG005|Overall Study|Protocol Violation|0|||
33555086|NCT02813681|62947822|FG000|Overall Study|Physician Decision|5|||
33555087|NCT02813681|62947823|FG001|Overall Study|Physician Decision|5|||
33555088|NCT02813681|62947824|FG002|Overall Study|Physician Decision|0|||
33555089|NCT02813681|62947822|FG000|Overall Study|Lost to Follow-up|0|||
33555090|NCT02813681|62947823|FG001|Overall Study|Lost to Follow-up|1|||
33484357|NCT04493684|62861231|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33366633|NCT00520975|62745451|FG000|Overall Study|Withdrawal by Subject|3|||
33366634|NCT00520975|62745452|FG001|Overall Study|Withdrawal by Subject|5|||
33366635|NCT00520975|62745451|FG000|Overall Study|Other therapy|2|||
33661494|NCT01703117|63091129|FG001|Overall Study|Withdrawal by Subject|1|||
33366636|NCT00520975|62745452|FG001|Overall Study|Other therapy|4|||
33484358|NCT04493684|62861232|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33484359|NCT04493684|62861233|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33484360|NCT04493684|62861234|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33484361|NCT04493684|62861218|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33484362|NCT04493684|62861219|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33484363|NCT04493684|62861220|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33484364|NCT04493684|62861221|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33555091|NCT02813681|62947824|FG002|Overall Study|Lost to Follow-up|0|||
33366637|NCT00520975|62745451|FG000|Overall Study|Other reasons|4|||
33366638|NCT00520975|62745452|FG001|Overall Study|Other reasons|2|||
33484365|NCT04493684|62861222|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33366639|NCT00520975|62745451|FG000|Overall Study|Not start protocol therapy|1|||
33366640|NCT00520975|62745452|FG001|Overall Study|Not start protocol therapy|2|||
33366641|NCT00851721|62745460|FG000|Overall Study|planned surgery|1|||
33366642|NCT00851721|62745461|FG001|Overall Study|planned surgery|0|||
33555092|NCT02393950|62947836|FG000|Overall Study|Adverse Event|1|||
33366643|NCT00851721|62745460|FG000|Overall Study|Death|1|||
33484366|NCT04493684|62861223|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33484367|NCT04493684|62861224|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33484368|NCT04493684|62861225|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33484369|NCT04493684|62861226|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33484370|NCT04493684|62861227|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33484371|NCT04493684|62861228|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33555093|NCT02393950|62947837|FG001|Overall Study|Adverse Event|0|||
33555094|NCT02393950|62947836|FG000|Overall Study|Withdrawal by Subject|0|||
33366644|NCT00851721|62745461|FG001|Overall Study|Death|0|||
33366645|NCT00851721|62745460|FG000|Overall Study|Adverse Event|0|||
33366646|NCT00851721|62745461|FG001|Overall Study|Adverse Event|1|||
33366647|NCT00520741|62745475|FG000|Overall Study|Adverse Event|16|||
33366648|NCT00520741|62745476|FG001|Overall Study|Adverse Event|56|||
33366649|NCT00520741|62745475|FG000|Overall Study|Lack of Efficacy|11|||
33366650|NCT00520741|62745476|FG001|Overall Study|Lack of Efficacy|30|||
33366651|NCT00520741|62745475|FG000|Overall Study|Withdrawal by Subject|0|||
33366652|NCT00520741|62745476|FG001|Overall Study|Withdrawal by Subject|11|||
33366653|NCT00520741|62745475|FG000|Overall Study|Protocol Violation|2|||
33366654|NCT00520741|62745476|FG001|Overall Study|Protocol Violation|15|||
33366655|NCT00520741|62745475|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
33366656|NCT00520741|62745476|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
33366657|NCT00520741|62745475|FG000|Overall Study|Lost to Follow-up|4|||
33366658|NCT00520741|62745476|FG001|Overall Study|Lost to Follow-up|4|||
33366659|NCT00520741|62745475|FG000|Overall Study|Other reasons for premature termination|0|||
33366660|NCT00520741|62745476|FG001|Overall Study|Other reasons for premature termination|6|||
33366661|NCT00882518|62745486|FG000|Overall Study|Adverse Event|9|||
33366662|NCT00882518|62745487|FG001|Overall Study|Adverse Event|18|||
33366663|NCT00882518|62745486|FG000|Overall Study|Withdrawal by Subject|9|||
33366664|NCT00882518|62745487|FG001|Overall Study|Withdrawal by Subject|13|||
33366665|NCT00882518|62745486|FG000|Overall Study|Lack of Efficacy|12|||
33366666|NCT00882518|62745487|FG001|Overall Study|Lack of Efficacy|9|||
33366667|NCT00882518|62745486|FG000|Overall Study|Severe non-compliance to protocol|3|||
33366668|NCT00882518|62745487|FG001|Overall Study|Severe non-compliance to protocol|1|||
33366669|NCT00882518|62745486|FG000|Overall Study|Incorrect enrolment|4|||
33366670|NCT00882518|62745487|FG001|Overall Study|Incorrect enrolment|2|||
33366671|NCT00882518|62745486|FG000|Overall Study|Central lab closure for National day|1|||
33366672|NCT00882518|62745487|FG001|Overall Study|Central lab closure for National day|0|||
33366673|NCT00882518|62745486|FG000|Overall Study|Allocating random number by mistake|0|||
33366674|NCT00882518|62745487|FG001|Overall Study|Allocating random number by mistake|1|||
33366675|NCT00882362|62745504|FG000|Overall Study|Adverse Event|13|||
33366676|NCT00882362|62745505|FG001|Overall Study|Adverse Event|10|||
33366677|NCT00882362|62745504|FG000|Overall Study|Withdrawal by Subject|13|||
33366678|NCT00882362|62745505|FG001|Overall Study|Withdrawal by Subject|10|||
33366679|NCT00882362|62745504|FG000|Overall Study|Lack of Efficacy|3|||
33366680|NCT00882362|62745505|FG001|Overall Study|Lack of Efficacy|0|||
33366681|NCT00882362|62745504|FG000|Overall Study|Protocol Violation|7|||
33366682|NCT00882362|62745505|FG001|Overall Study|Protocol Violation|2|||
33555095|NCT02393950|62947837|FG001|Overall Study|Withdrawal by Subject|1|||
33555096|NCT02815397|62947872|FG000|Overall Study|Physician Decision|2|||
33555097|NCT02427958|62947876|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
33555098|NCT02427958|62947876|FG000|Overall Study|Lost to Follow-up|6|||
33366683|NCT00882362|62745504|FG000|Overall Study|Pregnancy|1|||
33366684|NCT00882362|62745505|FG001|Overall Study|Pregnancy|0|||
33366685|NCT00882362|62745504|FG000|Overall Study|Physician Decision|5|||
33661495|NCT01702961|63091137|FG000|Overall Study|Additional treatment|3|||
33661496|NCT01702961|63091137|FG000|Overall Study|Progressive disease|5|||
33661497|NCT01702961|63091137|FG000|Overall Study|Relapse|20|||
33661498|NCT01702961|63091137|FG000|Overall Study|Death|6|||
33661499|NCT01702961|63091137|FG000|Overall Study|Lost to Follow-up|2|||
33661500|NCT01702961|63091137|FG000|Overall Study|Ongoing|11|||
33661501|NCT01593917|63091141|FG000|Overall Study|Death|67|||
33661502|NCT01593917|63091141|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
33661503|NCT01593917|63091141|FG000|Overall Study|Withdrawal by Subject|23|||
33661504|NCT01593917|63091141|FG000|Overall Study|Lost to Follow-up|12|||
33661505|NCT01593917|63091141|FG000|Overall Study|Protocol Violation|5|||
33661506|NCT01593917|63091141|FG000|Overall Study|Physician Decision|3|||
33661507|NCT01593761|63091145|FG000|Overall Study|Lost to Follow-up|1|||
33661508|NCT01593761|63091145|FG000|Overall Study|culture negative for MRSA at baseline|5|||
33661509|NCT01593761|63091145|FG000|Overall Study|positive for hepatitis C virus|1|||
33661510|NCT01593761|63091145|FG000|Overall Study|secondary cellulitis|1|||
33661511|NCT02706834|63091166|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33661512|NCT02706834|63091167|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
33661513|NCT02706834|63091168|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
33661514|NCT02706834|63091169|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
33661515|NCT02706834|63091170|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
33661516|NCT02706834|63091171|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
33661517|NCT02706834|63091172|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
33661518|NCT02706834|63091173|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
33661519|NCT02706834|63091174|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
33661520|NCT02706834|63091175|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
33661521|NCT02706834|63091176|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
33661522|NCT02706834|63091166|FG000|Overall Study|Lost to Follow-up|0|||
33661523|NCT02706834|63091167|FG001|Overall Study|Lost to Follow-up|0|||
33661524|NCT02706834|63091168|FG002|Overall Study|Lost to Follow-up|1|||
33366686|NCT00882362|62745505|FG001|Overall Study|Physician Decision|1|||
33366687|NCT00882362|62745504|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
33366688|NCT00882362|62745505|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
33366689|NCT00882362|62745504|FG000|Overall Study|change of residence or other commitments|5|||
33366690|NCT00882362|62745505|FG001|Overall Study|change of residence or other commitments|0|||
33366691|NCT00851643|62745517|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
33366692|NCT00851643|62745518|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
33366693|NCT00851643|62745519|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
33366694|NCT00851643|62745520|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
33366695|NCT00851643|62745521|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
33366696|NCT00851643|62745522|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
33366697|NCT00851643|62745517|FG000|Base Study (Up to 12 Months)|Other|0|||
33366698|NCT00851643|62745518|FG001|Base Study (Up to 12 Months)|Other|0|||
33366699|NCT00851643|62745519|FG002|Base Study (Up to 12 Months)|Other|0|||
33366700|NCT00851643|62745520|FG003|Base Study (Up to 12 Months)|Other|0|||
33366701|NCT00851643|62745521|FG004|Base Study (Up to 12 Months)|Other|0|||
33366702|NCT00851643|62745522|FG005|Base Study (Up to 12 Months)|Other|1|||
33484372|NCT04493684|62861229|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
33484373|NCT04493684|62861230|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33484374|NCT04493684|62861231|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33366703|NCT00851643|62745517|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
33484375|NCT04493684|62861232|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33555099|NCT02427958|62947876|FG000|Overall Study|Withdrawal by Subject|14|||
33366704|NCT00851643|62745518|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
33366705|NCT00851643|62745519|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
33661525|NCT02706834|63091169|FG003|Overall Study|Lost to Follow-up|0|||
33661526|NCT02706834|63091170|FG004|Overall Study|Lost to Follow-up|0|||
33661527|NCT02706834|63091171|FG005|Overall Study|Lost to Follow-up|0|||
33555100|NCT02427958|62947876|FG000|Overall Study|Lack of Efficacy|1|||
33555101|NCT02392624|62947883|FG000|Overall Study|Withdrawal by Subject|15|||
33555102|NCT02392624|62947884|FG001|Overall Study|Withdrawal by Subject|12|||
33661528|NCT02706834|63091172|FG006|Overall Study|Lost to Follow-up|0|||
33555103|NCT02392624|62947885|FG002|Overall Study|Withdrawal by Subject|9|||
33661529|NCT02706834|63091173|FG007|Overall Study|Lost to Follow-up|0|||
33555104|NCT02392624|62947883|FG000|Overall Study|Adverse Event|4|||
33555105|NCT02392624|62947884|FG001|Overall Study|Adverse Event|1|||
33555106|NCT02392624|62947885|FG002|Overall Study|Adverse Event|2|||
33366706|NCT00851643|62745520|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
33366707|NCT00851643|62745521|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
33366708|NCT00851643|62745522|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
33366709|NCT00851643|62745517|FG000|Extension Study (Up to 36 Months)|Moved|0|||
33366710|NCT00851643|62745518|FG001|Extension Study (Up to 36 Months)|Moved|2|||
33366711|NCT00851643|62745519|FG002|Extension Study (Up to 36 Months)|Moved|1|||
33366712|NCT00851643|62745520|FG003|Extension Study (Up to 36 Months)|Moved|1|||
33366713|NCT00851643|62745521|FG004|Extension Study (Up to 36 Months)|Moved|0|||
33366714|NCT00851643|62745522|FG005|Extension Study (Up to 36 Months)|Moved|1|||
33366715|NCT00529243|62745535|FG000|Overall Study|Adverse Event|1|||
33661530|NCT02706834|63091174|FG008|Overall Study|Lost to Follow-up|0|||
33661531|NCT02706834|63091175|FG009|Overall Study|Lost to Follow-up|0|||
33661532|NCT02706834|63091176|FG010|Overall Study|Lost to Follow-up|0|||
33661533|NCT02706834|63091166|FG000|Overall Study|Voluntary Withdrawal|1|||
33661534|NCT02706834|63091167|FG001|Overall Study|Voluntary Withdrawal|0|||
33366716|NCT00529243|62745535|FG000|Overall Study|Death|1|||
33366717|NCT00529243|62745535|FG000|Overall Study|Relocated|1|||
33366718|NCT03728309|62745541|FG000|Overall Study|Randomized but not Treated|0|||
33366719|NCT03728309|62745542|FG001|Overall Study|Randomized but not Treated|1|||
33366720|NCT03728309|62745541|FG000|Overall Study|Adverse Event|0|||
33366721|NCT03728309|62745542|FG001|Overall Study|Adverse Event|1|||
33366722|NCT03728309|62745541|FG000|Overall Study|Withdrawal by Subject|2|||
33366723|NCT03728309|62745542|FG001|Overall Study|Withdrawal by Subject|8|||
33366724|NCT03728309|62745541|FG000|Overall Study|Lost to Follow-up|9|||
33366725|NCT03728309|62745542|FG001|Overall Study|Lost to Follow-up|10|||
33366726|NCT03728309|62745541|FG000|Overall Study|Protocol Deviation|0|||
33366727|NCT03728309|62745542|FG001|Overall Study|Protocol Deviation|1|||
33366728|NCT03728309|62745541|FG000|Overall Study|Due to COVID|1|||
33366729|NCT03728309|62745542|FG001|Overall Study|Due to COVID|3|||
33366730|NCT03683719|62745559|FG000|Overall Study|Lack of Efficacy|1|||
33366731|NCT03683719|62745560|FG001|Overall Study|Lack of Efficacy|3|||
33366732|NCT03683719|62745561|FG002|Overall Study|Lack of Efficacy|4|||
33366733|NCT03683719|62745562|FG003|Overall Study|Lack of Efficacy|0|||
33366734|NCT03683719|62745563|FG004|Overall Study|Lack of Efficacy|4|||
33366735|NCT03683719|62745559|FG000|Overall Study|Adverse Event|6|||
33366736|NCT03683719|62745560|FG001|Overall Study|Adverse Event|6|||
33366737|NCT03683719|62745561|FG002|Overall Study|Adverse Event|0|||
33366738|NCT03683719|62745562|FG003|Overall Study|Adverse Event|1|||
33366739|NCT03683719|62745563|FG004|Overall Study|Adverse Event|3|||
33661535|NCT02706834|63091168|FG002|Overall Study|Voluntary Withdrawal|0|||
33366740|NCT03683719|62745559|FG000|Overall Study|Withdrawal by Subject|4|||
33366741|NCT03683719|62745560|FG001|Overall Study|Withdrawal by Subject|4|||
33366742|NCT03683719|62745561|FG002|Overall Study|Withdrawal by Subject|3|||
33366743|NCT03683719|62745562|FG003|Overall Study|Withdrawal by Subject|5|||
33366744|NCT03683719|62745563|FG004|Overall Study|Withdrawal by Subject|5|||
33366745|NCT03683719|62745559|FG000|Overall Study|Lost to Follow-up|1|||
33366746|NCT03683719|62745560|FG001|Overall Study|Lost to Follow-up|0|||
33366747|NCT03683719|62745561|FG002|Overall Study|Lost to Follow-up|0|||
33366748|NCT03683719|62745562|FG003|Overall Study|Lost to Follow-up|1|||
33366749|NCT03683719|62745563|FG004|Overall Study|Lost to Follow-up|1|||
33366750|NCT03683719|62745559|FG000|Overall Study|Other personal reasons|0|||
33661536|NCT02706834|63091169|FG003|Overall Study|Voluntary Withdrawal|0|||
33661537|NCT02706834|63091170|FG004|Overall Study|Voluntary Withdrawal|0|||
33366751|NCT03683719|62745560|FG001|Overall Study|Other personal reasons|0|||
33366752|NCT03683719|62745561|FG002|Overall Study|Other personal reasons|1|||
33366753|NCT03683719|62745562|FG003|Overall Study|Other personal reasons|0|||
33366754|NCT03683719|62745563|FG004|Overall Study|Other personal reasons|1|||
33366755|NCT00851253|62745577|FG000|Overall Study|Disease Progression|1|||
33366756|NCT00851253|62745578|FG001|Overall Study|Disease Progression|0|||
33366757|NCT00520351|62745586|FG000|First Intervention|Withdrawal by Subject|1|||
33366758|NCT00520351|62745587|FG001|First Intervention|Withdrawal by Subject|1|||
33366759|NCT00850395|62745597|FG000|Overall Study|Death|1|||
33366760|NCT00850395|62745597|FG000|Overall Study|Adverse Event|1|||
33366761|NCT00850395|62745597|FG000|Overall Study|Insufficient clinical response|3|||
33366762|NCT00850395|62745597|FG000|Overall Study|Other|5|||
33366763|NCT00520039|62745603|FG000|Overall Study|Exclusion criteria met at first visit|7|||
33366764|NCT00520039|62745604|FG001|Overall Study|Exclusion criteria met at first visit|5|||
33366765|NCT00577720|62745616|FG000|Overall Study|Adverse Event|2|||
33366766|NCT00577720|62745617|FG001|Overall Study|Adverse Event|1|||
33366767|NCT00577720|62745618|FG002|Overall Study|Adverse Event|0|||
33366768|NCT00577720|62745619|FG003|Overall Study|Adverse Event|4|||
33366769|NCT00577720|62745616|FG000|Overall Study|Lost to Follow-up|0|||
33366770|NCT00577720|62745617|FG001|Overall Study|Lost to Follow-up|0|||
33366771|NCT00577720|62745618|FG002|Overall Study|Lost to Follow-up|1|||
33366772|NCT00577720|62745619|FG003|Overall Study|Lost to Follow-up|0|||
33366773|NCT00577720|62745616|FG000|Overall Study|Protocol Violation|0|||
33366774|NCT00577720|62745617|FG001|Overall Study|Protocol Violation|0|||
33366775|NCT00577720|62745618|FG002|Overall Study|Protocol Violation|0|||
33366776|NCT00577720|62745619|FG003|Overall Study|Protocol Violation|1|||
33366777|NCT00577720|62745616|FG000|Overall Study|Withdrawal by Subject|2|||
33366778|NCT00577720|62745617|FG001|Overall Study|Withdrawal by Subject|0|||
33366779|NCT00577720|62745618|FG002|Overall Study|Withdrawal by Subject|0|||
33366780|NCT00577720|62745619|FG003|Overall Study|Withdrawal by Subject|2|||
33366781|NCT00519649|62745629|FG000|Overall Study|Withdrawal by Subject|1|||
33366782|NCT00512707|62745647|FG000|Overall Study|Lost to Follow-up|5|||
33366783|NCT00512707|62745648|FG001|Overall Study|Lost to Follow-up|11|||
33366784|NCT00512707|62745647|FG000|Overall Study|Developed skin irritation|2|||
33366785|NCT00512707|62745648|FG001|Overall Study|Developed skin irritation|1|||
33366786|NCT00512707|62745647|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
33366787|NCT00512707|62745648|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
33366788|NCT00512707|62745647|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
33366789|NCT00512707|62745648|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
33366790|NCT03471767|62745656|FG000|Overall Study|Withdrawal by Subject|3|||
33366791|NCT03471767|62745657|FG001|Overall Study|Withdrawal by Subject|1|||
33366792|NCT03471767|62745656|FG000|Overall Study|Adverse Event|1|||
33366793|NCT03471767|62745657|FG001|Overall Study|Adverse Event|0|||
33366794|NCT03471767|62745656|FG000|Overall Study|Lost to Follow-up|1|||
33366795|NCT03471767|62745657|FG001|Overall Study|Lost to Follow-up|0|||
33366796|NCT03471767|62745656|FG000|Overall Study|PI Withdrawal|1|||
33366797|NCT03471767|62745657|FG001|Overall Study|PI Withdrawal|3|||
33366798|NCT00849693|62745667|FG000|Acute Treatment Phase|Adverse Event|12|||
33366799|NCT00849693|62745668|FG001|Acute Treatment Phase|Adverse Event|7|||
33366800|NCT00849693|62745669|FG002|Acute Treatment Phase|Adverse Event|6|||
33366801|NCT00849693|62745670|FG003|Acute Treatment Phase|Adverse Event|4|||
33366802|NCT00849693|62745667|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
33366803|NCT00849693|62745668|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
33366804|NCT00849693|62745669|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
33366805|NCT00849693|62745670|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
33366806|NCT00849693|62745667|FG000|Acute Treatment Phase|Protocol Violation|1|||
33366807|NCT00849693|62745668|FG001|Acute Treatment Phase|Protocol Violation|5|||
33366808|NCT00849693|62745669|FG002|Acute Treatment Phase|Protocol Violation|2|||
33366809|NCT00849693|62745670|FG003|Acute Treatment Phase|Protocol Violation|6|||
33366810|NCT00849693|62745667|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
33366811|NCT00849693|62745668|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
33366812|NCT00849693|62745669|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
33366813|NCT00849693|62745670|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
33366814|NCT00849693|62745667|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
33366815|NCT00849693|62745668|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
33484376|NCT04493684|62861233|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33484377|NCT04493684|62861234|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33484378|NCT04493684|62861218|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33484379|NCT04493684|62861219|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33555107|NCT02392624|62947883|FG000|Overall Study|Pregnancy|1|||
33555108|NCT02392624|62947884|FG001|Overall Study|Pregnancy|0|||
33366816|NCT00849693|62745669|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
33366817|NCT00849693|62745670|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
33366818|NCT00849693|62745667|FG000|Acute Treatment Phase|Physician Decision|2|||
33366819|NCT00849693|62745668|FG001|Acute Treatment Phase|Physician Decision|1|||
33366820|NCT00849693|62745669|FG002|Acute Treatment Phase|Physician Decision|2|||
33366821|NCT00849693|62745670|FG003|Acute Treatment Phase|Physician Decision|1|||
33366822|NCT00849693|62745667|FG000|Acute Treatment Phase|Sponsor decision|0|||
33366823|NCT00849693|62745668|FG001|Acute Treatment Phase|Sponsor decision|0|||
33366824|NCT00849693|62745669|FG002|Acute Treatment Phase|Sponsor decision|1|||
33366825|NCT00849693|62745670|FG003|Acute Treatment Phase|Sponsor decision|0|||
33366826|NCT00849693|62745667|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
33366827|NCT00849693|62745668|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
33366828|NCT00849693|62745669|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
33366829|NCT00849693|62745670|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
33366830|NCT00849693|62745667|FG000|Extension Phase|Adverse Event|4|||
33366831|NCT00849693|62745668|FG001|Extension Phase|Adverse Event|6|||
33366832|NCT00849693|62745669|FG002|Extension Phase|Adverse Event|3|||
33366833|NCT00849693|62745670|FG003|Extension Phase|Adverse Event|7|||
33366834|NCT00849693|62745667|FG000|Extension Phase|Lost to Follow-up|7|||
33366835|NCT00849693|62745668|FG001|Extension Phase|Lost to Follow-up|5|||
33366836|NCT00849693|62745669|FG002|Extension Phase|Lost to Follow-up|6|||
33366837|NCT00849693|62745670|FG003|Extension Phase|Lost to Follow-up|6|||
33366838|NCT00849693|62745667|FG000|Extension Phase|Protocol Violation|0|||
33366839|NCT00849693|62745668|FG001|Extension Phase|Protocol Violation|3|||
33366840|NCT00849693|62745669|FG002|Extension Phase|Protocol Violation|2|||
33366841|NCT00849693|62745670|FG003|Extension Phase|Protocol Violation|3|||
33366842|NCT00849693|62745667|FG000|Extension Phase|Withdrawal by Subject|6|||
33366843|NCT00849693|62745668|FG001|Extension Phase|Withdrawal by Subject|9|||
33366844|NCT00849693|62745669|FG002|Extension Phase|Withdrawal by Subject|10|||
33366845|NCT00849693|62745670|FG003|Extension Phase|Withdrawal by Subject|15|||
33366846|NCT00849693|62745667|FG000|Extension Phase|Parent or caregiver decision|9|||
33366847|NCT00849693|62745668|FG001|Extension Phase|Parent or caregiver decision|4|||
33366848|NCT00849693|62745669|FG002|Extension Phase|Parent or caregiver decision|10|||
33366849|NCT00849693|62745670|FG003|Extension Phase|Parent or caregiver decision|5|||
33366850|NCT00849693|62745667|FG000|Extension Phase|Physician Decision|1|||
33366851|NCT00849693|62745668|FG001|Extension Phase|Physician Decision|1|||
33366852|NCT00849693|62745669|FG002|Extension Phase|Physician Decision|2|||
33661538|NCT02706834|63091171|FG005|Overall Study|Voluntary Withdrawal|0|||
33661539|NCT02706834|63091172|FG006|Overall Study|Voluntary Withdrawal|0|||
33661540|NCT02706834|63091173|FG007|Overall Study|Voluntary Withdrawal|0|||
33661541|NCT02706834|63091174|FG008|Overall Study|Voluntary Withdrawal|0|||
33661542|NCT02706834|63091175|FG009|Overall Study|Voluntary Withdrawal|1|||
33661543|NCT02706834|63091176|FG010|Overall Study|Voluntary Withdrawal|0|||
33661544|NCT02706834|63091166|FG000|Overall Study|Other Reason Not Specified|1|||
33661545|NCT02706834|63091167|FG001|Overall Study|Other Reason Not Specified|0|||
33661546|NCT02706834|63091168|FG002|Overall Study|Other Reason Not Specified|0|||
33661547|NCT02706834|63091169|FG003|Overall Study|Other Reason Not Specified|0|||
33661548|NCT02706834|63091170|FG004|Overall Study|Other Reason Not Specified|1|||
33661549|NCT02706834|63091171|FG005|Overall Study|Other Reason Not Specified|0|||
33661550|NCT02706834|63091172|FG006|Overall Study|Other Reason Not Specified|0|||
33661551|NCT02706834|63091173|FG007|Overall Study|Other Reason Not Specified|0|||
33661552|NCT02706834|63091174|FG008|Overall Study|Other Reason Not Specified|0|||
33661553|NCT02706834|63091175|FG009|Overall Study|Other Reason Not Specified|0|||
33661554|NCT02706834|63091176|FG010|Overall Study|Other Reason Not Specified|0|||
33661555|NCT01702025|63091225|FG000|Overall Study|Equipment failure|1|||
33661556|NCT01702025|63091226|FG001|Overall Study|Equipment failure|0|||
33661557|NCT01702025|63091227|FG002|Overall Study|Equipment failure|0|||
33661558|NCT01702025|63091228|FG003|Overall Study|Equipment failure|0|||
33661559|NCT01702025|63091225|FG000|Overall Study|Adverse Event|1|||
33661560|NCT01702025|63091226|FG001|Overall Study|Adverse Event|1|||
33661561|NCT01702025|63091227|FG002|Overall Study|Adverse Event|1|||
33366853|NCT00849693|62745670|FG003|Extension Phase|Physician Decision|0|||
33366854|NCT00849693|62745667|FG000|Extension Phase|Sponsor decision|1|||
33366855|NCT00849693|62745668|FG001|Extension Phase|Sponsor decision|0|||
33366856|NCT00849693|62745669|FG002|Extension Phase|Sponsor decision|0|||
33366857|NCT00849693|62745670|FG003|Extension Phase|Sponsor decision|1|||
33366858|NCT00849693|62745667|FG000|Extension Phase|Lack of Efficacy|2|||
33366859|NCT00849693|62745668|FG001|Extension Phase|Lack of Efficacy|2|||
33366860|NCT00849693|62745669|FG002|Extension Phase|Lack of Efficacy|2|||
33366861|NCT00849693|62745670|FG003|Extension Phase|Lack of Efficacy|1|||
33366862|NCT00527605|62745694|FG000|Overall Study|Adverse Event|3|||
33366863|NCT00527605|62745695|FG001|Overall Study|Adverse Event|0|||
33366864|NCT00527605|62745694|FG000|Overall Study|Withdrawal by Subject|3|||
33366865|NCT00527605|62745695|FG001|Overall Study|Withdrawal by Subject|7|||
33366866|NCT00527605|62745694|FG000|Overall Study|Lost to Follow-up|6|||
33366867|NCT00527605|62745695|FG001|Overall Study|Lost to Follow-up|2|||
33366868|NCT00527605|62745694|FG000|Overall Study|Protocol Violation|1|||
33366869|NCT00527605|62745695|FG001|Overall Study|Protocol Violation|2|||
33366870|NCT00849381|62745701|FG000|Overall Study|Adverse Event|1|||
33366871|NCT00849381|62745701|FG000|Overall Study|Lost to Follow-up|129|||
33366872|NCT00849381|62745701|FG000|Overall Study|Protocol Violation|5|||
33366873|NCT00849381|62745701|FG000|Overall Study|Withdrawal by Subject|6|||
33366874|NCT00849381|62745701|FG000|Overall Study|Other|4|||
33366875|NCT00711412|62745705|FG000|Induction Treatment|Death|2|||
33366876|NCT00711412|62745705|FG000|Induction Treatment|Adverse Event|1|||
33366877|NCT00711412|62745705|FG000|Induction Treatment|Other|1|||
33366878|NCT00711412|62745705|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
33366879|NCT00711412|62745705|FG000|Evaluated for Combination Treatment|Death|1|||
33366880|NCT00711412|62745705|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
33366881|NCT00711412|62745705|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
33366882|NCT00711412|62745705|FG000|Combination Treatment|Progressive Disease|1|||
33366883|NCT00711412|62745705|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
33366884|NCT00711412|62745705|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
33366885|NCT00711412|62745705|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
33366886|NCT00711412|62745705|FG000|Evaluation for Response and Surgery|Death|1|||
33366887|NCT00711412|62745705|FG000|Survival Follow up Until Death|Other|12|||
33366888|NCT00577408|62745721|FG000|Overall Study|Stopped attending study visits|9|||
33366889|NCT00577408|62745722|FG001|Overall Study|Stopped attending study visits|11|||
33366890|NCT00577408|62745721|FG000|Overall Study|Continued opioid use|3|||
33366891|NCT00577408|62745722|FG001|Overall Study|Continued opioid use|2|||
33366892|NCT00577408|62745721|FG000|Overall Study|Non-compliance with study meds|0|||
33366893|NCT00577408|62745722|FG001|Overall Study|Non-compliance with study meds|3|||
33366894|NCT00577408|62745721|FG000|Overall Study|Refused Oral Naltrexone|0|||
33366895|NCT00577408|62745722|FG001|Overall Study|Refused Oral Naltrexone|1|||
33366896|NCT00577408|62745721|FG000|Overall Study|Moved out of state|0|||
33366897|NCT00577408|62745722|FG001|Overall Study|Moved out of state|1|||
33366898|NCT00577408|62745721|FG000|Overall Study|Scheduling Issues|0|||
33366899|NCT00577408|62745722|FG001|Overall Study|Scheduling Issues|3|||
33366900|NCT00577408|62745721|FG000|Overall Study|Death|0|||
33366901|NCT00577408|62745722|FG001|Overall Study|Death|1|||
33366902|NCT00577408|62745721|FG000|Overall Study|Psychiatric hospitalization|0|||
33366903|NCT00577408|62745722|FG001|Overall Study|Psychiatric hospitalization|1|||
33366904|NCT00713596|62745731|FG000|Overall Study|Study was terminated|2|||
33366905|NCT00713596|62745732|FG001|Overall Study|Study was terminated|3|||
33366906|NCT00713596|62745733|FG002|Overall Study|Study was terminated|2|||
33366907|NCT00880568|62745750|FG000|Overall Study|Disease progression|3|||
33366908|NCT00880568|62745751|FG001|Overall Study|Disease progression|3|||
33366909|NCT00880568|62745752|FG002|Overall Study|Disease progression|3|||
33366910|NCT00880568|62745753|FG003|Overall Study|Disease progression|1|||
33366911|NCT00880568|62745754|FG004|Overall Study|Disease progression|3|||
33366912|NCT00880568|62745755|FG005|Overall Study|Disease progression|3|||
33366913|NCT00880568|62745756|FG006|Overall Study|Disease progression|5|||
33366914|NCT00880568|62745757|FG007|Overall Study|Disease progression|0|||
33366915|NCT00880568|62745758|FG008|Overall Study|Disease progression|3|||
33366916|NCT00880568|62745750|FG000|Overall Study|Adverse Event|0|||
33366917|NCT00880568|62745751|FG001|Overall Study|Adverse Event|0|||
33366918|NCT00880568|62745752|FG002|Overall Study|Adverse Event|0|||
33366919|NCT00880568|62745753|FG003|Overall Study|Adverse Event|0|||
33366920|NCT00880568|62745754|FG004|Overall Study|Adverse Event|0|||
33366921|NCT00880568|62745755|FG005|Overall Study|Adverse Event|0|||
33366922|NCT00880568|62745756|FG006|Overall Study|Adverse Event|1|||
33366923|NCT00880568|62745757|FG007|Overall Study|Adverse Event|1|||
33366924|NCT00880568|62745758|FG008|Overall Study|Adverse Event|0|||
33366925|NCT00880568|62745750|FG000|Overall Study|Withdrawal by Subject|0|||
33366926|NCT00880568|62745751|FG001|Overall Study|Withdrawal by Subject|0|||
33661562|NCT01702025|63091228|FG003|Overall Study|Adverse Event|0|||
33555109|NCT02392624|62947885|FG002|Overall Study|Pregnancy|0|||
33555110|NCT02392624|62947883|FG000|Overall Study|Protocol Violation|0|||
33555111|NCT02392624|62947884|FG001|Overall Study|Protocol Violation|0|||
33555112|NCT02392624|62947885|FG002|Overall Study|Protocol Violation|1|||
33555113|NCT02392624|62947883|FG000|Overall Study|Sponsor/Investigator Decision|2|||
33366927|NCT00880568|62745752|FG002|Overall Study|Withdrawal by Subject|0|||
33366928|NCT00880568|62745753|FG003|Overall Study|Withdrawal by Subject|0|||
33366929|NCT00880568|62745754|FG004|Overall Study|Withdrawal by Subject|0|||
33366930|NCT00880568|62745755|FG005|Overall Study|Withdrawal by Subject|0|||
33366931|NCT00880568|62745756|FG006|Overall Study|Withdrawal by Subject|0|||
33366932|NCT00880568|62745757|FG007|Overall Study|Withdrawal by Subject|1|||
33366933|NCT00880568|62745758|FG008|Overall Study|Withdrawal by Subject|0|||
33366934|NCT00881894|62745785|FG000|Overall Study|Consent withdrawn|0|||
33366935|NCT00881894|62745786|FG001|Overall Study|Consent withdrawn|1|||
33366936|NCT00881894|62745785|FG000|Overall Study|Other reasons for premature termination|1|||
33366937|NCT00881894|62745786|FG001|Overall Study|Other reasons for premature termination|2|||
33366938|NCT00711100|62745792|FG000|Overall Study|Lack of Efficacy|5|||
33366939|NCT00711100|62745792|FG000|Overall Study|Withdrawal by Subject|8|||
33366940|NCT00827931|62745810|FG000|Overall Study|Death|3|||
33366941|NCT00827931|62745811|FG001|Overall Study|Death|5|||
33366942|NCT00827931|62745810|FG000|Overall Study|Adverse Event|1|||
33366943|NCT00827931|62745811|FG001|Overall Study|Adverse Event|0|||
33366944|NCT00827931|62745810|FG000|Overall Study|Lost to Follow-up|1|||
33366945|NCT00827931|62745811|FG001|Overall Study|Lost to Follow-up|0|||
33366946|NCT00827931|62745810|FG000|Overall Study|Withdrawal by Subject|0|||
33366947|NCT00827931|62745811|FG001|Overall Study|Withdrawal by Subject|1|||
33366948|NCT00827931|62745810|FG000|Overall Study|Other|1|||
33366949|NCT00827931|62745811|FG001|Overall Study|Other|0|||
33366950|NCT00526669|62745817|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
33366951|NCT00526669|62745818|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
33366952|NCT00526669|62745817|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
33366953|NCT00526669|62745818|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
33366954|NCT00526669|62745817|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
33366955|NCT00526669|62745818|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
33661563|NCT01592747|63091245|FG000|Overall Study|Loss of Therapeutic Response|107|||
33661564|NCT01592747|63091246|FG001|Overall Study|Loss of Therapeutic Response|108|||
33484380|NCT04493684|62861220|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33366956|NCT00526669|62745817|FG000|Combined Treatment Phase|Death|0|||
33366957|NCT00526669|62745818|FG001|Combined Treatment Phase|Death|2|||
33366958|NCT00710866|62745830|FG000|Overall Study|Protocol Violation|5|||
33661565|NCT01592747|63091247|FG002|Overall Study|Loss of Therapeutic Response|100|||
33366959|NCT00710866|62745831|FG001|Overall Study|Protocol Violation|4|||
33366960|NCT00710866|62745830|FG000|Overall Study|Withdrawal by Subject|2|||
33555114|NCT02392624|62947884|FG001|Overall Study|Sponsor/Investigator Decision|1|||
33555115|NCT02392624|62947885|FG002|Overall Study|Sponsor/Investigator Decision|0|||
33555116|NCT02392624|62947883|FG000|Overall Study|Other|49|||
33555117|NCT02392624|62947884|FG001|Overall Study|Other|1|||
33366961|NCT00710866|62745831|FG001|Overall Study|Withdrawal by Subject|1|||
33661566|NCT01592747|63091245|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
33661567|NCT01592747|63091246|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
33661568|NCT01592747|63091247|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
33366962|NCT00710866|62745830|FG000|Overall Study|Lost to Follow-up|1|||
33366963|NCT00710866|62745831|FG001|Overall Study|Lost to Follow-up|0|||
33366964|NCT00710866|62745830|FG000|Overall Study|Failed to meet eligibility|1|||
33366965|NCT00710866|62745831|FG001|Overall Study|Failed to meet eligibility|1|||
33366966|NCT00827775|62745848|FG000|Overall Study|Withdrawal by Subject|0|||
33366967|NCT00827775|62745849|FG001|Overall Study|Withdrawal by Subject|5|||
33366968|NCT00827541|62745857|FG000|Overall Study|Exitus|1|||
33366969|NCT00827541|62745858|FG001|Overall Study|Exitus|8|||
33366970|NCT00827541|62745857|FG000|Overall Study|Other|1|||
33366971|NCT00827541|62745858|FG001|Overall Study|Other|3|||
33366972|NCT00827541|62745857|FG000|Overall Study|Pathogen not susceptible|1|||
33366973|NCT00827541|62745858|FG001|Overall Study|Pathogen not susceptible|0|||
33366974|NCT00827541|62745857|FG000|Overall Study|Lack of effectiveness|1|||
33366975|NCT00827541|62745858|FG001|Overall Study|Lack of effectiveness|0|||
33366976|NCT00518323|62745868|FG000|Overall Study|Lack of Efficacy|14|||
33366977|NCT00518323|62745869|FG001|Overall Study|Lack of Efficacy|2|||
33366978|NCT00518323|62745870|FG002|Overall Study|Lack of Efficacy|4|||
33366979|NCT00518323|62745871|FG003|Overall Study|Lack of Efficacy|20|||
33366980|NCT00518323|62745868|FG000|Overall Study|Withdrawal by Subject|1|||
33366981|NCT00518323|62745869|FG001|Overall Study|Withdrawal by Subject|2|||
33366982|NCT00518323|62745870|FG002|Overall Study|Withdrawal by Subject|4|||
33366983|NCT00518323|62745871|FG003|Overall Study|Withdrawal by Subject|2|||
33366984|NCT00518323|62745868|FG000|Overall Study|Lost to Follow-up|0|||
33366985|NCT00518323|62745869|FG001|Overall Study|Lost to Follow-up|2|||
33366986|NCT00518323|62745870|FG002|Overall Study|Lost to Follow-up|1|||
33366987|NCT00518323|62745871|FG003|Overall Study|Lost to Follow-up|3|||
33366988|NCT00518323|62745868|FG000|Overall Study|Adverse Event|1|||
33366989|NCT00518323|62745869|FG001|Overall Study|Adverse Event|1|||
33366990|NCT00518323|62745870|FG002|Overall Study|Adverse Event|1|||
33366991|NCT00518323|62745871|FG003|Overall Study|Adverse Event|0|||
33366992|NCT00518323|62745868|FG000|Overall Study|Prohibited medication and others|3|||
33366993|NCT00518323|62745869|FG001|Overall Study|Prohibited medication and others|1|||
33366994|NCT00518323|62745870|FG002|Overall Study|Prohibited medication and others|1|||
33366995|NCT00518323|62745871|FG003|Overall Study|Prohibited medication and others|0|||
33366996|NCT00826449|62745883|FG000|Overall Study|Disease Progression|4|||
33366997|NCT00826449|62745883|FG000|Overall Study|Withdrawal by Subject|1|||
33366998|NCT00825825|62745888|FG000|First Medication Period (14 Days)|Adverse Event|1|||
33366999|NCT00825825|62745889|FG001|First Medication Period (14 Days)|Adverse Event|0|||
33367000|NCT00825825|62745890|FG002|First Medication Period (14 Days)|Adverse Event|0|||
33367001|NCT00825825|62745891|FG003|First Medication Period (14 Days)|Adverse Event|0|||
33367002|NCT00825825|62745892|FG004|First Medication Period (14 Days)|Adverse Event|0|||
33367003|NCT00825825|62745893|FG005|First Medication Period (14 Days)|Adverse Event|1|||
33367004|NCT00825825|62745888|FG000|First Medication Period (14 Days)|Physician Decision|2|||
33367005|NCT00825825|62745889|FG001|First Medication Period (14 Days)|Physician Decision|0|||
33367006|NCT00825825|62745890|FG002|First Medication Period (14 Days)|Physician Decision|1|||
33367007|NCT00825825|62745891|FG003|First Medication Period (14 Days)|Physician Decision|0|||
33484381|NCT04493684|62861221|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33367008|NCT00825825|62745892|FG004|First Medication Period (14 Days)|Physician Decision|0|||
33367009|NCT00825825|62745893|FG005|First Medication Period (14 Days)|Physician Decision|1|||
33367010|NCT00825825|62745888|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
33367011|NCT00825825|62745889|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
33367012|NCT00825825|62745890|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
33367013|NCT00825825|62745891|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
33367014|NCT00825825|62745892|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
33367015|NCT00825825|62745893|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
33367016|NCT00825825|62745888|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
33367017|NCT00825825|62745889|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
33367018|NCT00825825|62745890|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
33367019|NCT00825825|62745891|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
33484382|NCT04493684|62861222|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33367020|NCT00825825|62745892|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
33367021|NCT00825825|62745893|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
33484383|NCT04493684|62861223|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33555118|NCT02392624|62947885|FG002|Overall Study|Other|1|||
33555119|NCT02387164|62947895|FG000|Overall Study|Lost to Follow-up|2|||
33555120|NCT02387164|62947896|FG001|Overall Study|Lost to Follow-up|0|||
33555121|NCT02387164|62947895|FG000|Overall Study|Diagnosed|1|||
33555122|NCT02387164|62947896|FG001|Overall Study|Diagnosed|2|||
33555123|NCT02392234|62947914|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
33555124|NCT02392234|62947915|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
33555125|NCT02392234|62947916|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
33555126|NCT02392234|62947917|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
33555127|NCT02392234|62947918|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
33555128|NCT02392234|62947919|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
33555129|NCT02392234|62947914|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
33555130|NCT02392234|62947915|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
33555131|NCT02392234|62947916|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
33555132|NCT02392234|62947917|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
33555133|NCT02392234|62947918|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
33555134|NCT02392234|62947919|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
33555135|NCT02392234|62947914|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
33555136|NCT02392234|62947915|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
33555137|NCT02392234|62947916|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
33555138|NCT02392234|62947917|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
33555139|NCT02392234|62947918|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
33555140|NCT02392234|62947919|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
33555141|NCT02392234|62947914|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
33555142|NCT02392234|62947915|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
33555143|NCT02392234|62947916|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
33555144|NCT02392234|62947917|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
33555145|NCT02392234|62947918|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
33555146|NCT02392234|62947919|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
33555147|NCT02392234|62947914|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
33555148|NCT02392234|62947915|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
33555149|NCT02392234|62947916|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
33555150|NCT02392234|62947917|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
33555151|NCT02392234|62947918|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
33555152|NCT02392234|62947919|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
33555153|NCT02392234|62947914|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
33555154|NCT02392234|62947915|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
33555155|NCT02392234|62947916|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
33555156|NCT02392234|62947917|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
33555157|NCT02392234|62947918|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
33555158|NCT02392234|62947919|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
33555159|NCT02392234|62947914|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
33555160|NCT02392234|62947915|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
33555161|NCT02392234|62947916|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
33555162|NCT02392234|62947917|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
33555163|NCT02392234|62947918|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
33555164|NCT02392234|62947919|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
33555165|NCT02392234|62947914|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
33661569|NCT01592747|63091245|FG000|Overall Study|Adverse Event|1|||
33661570|NCT01592747|63091246|FG001|Overall Study|Adverse Event|0|||
33555166|NCT02392234|62947915|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
33555167|NCT02392234|62947916|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
33555168|NCT02392234|62947917|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
33555169|NCT02392234|62947918|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
33555170|NCT02392234|62947919|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
33555171|NCT02963090|62947933|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
33555172|NCT02963090|62947934|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
33555173|NCT02427802|62947946|FG000|Overall Study|Adverse Event|11|||
33661571|NCT01592747|63091247|FG002|Overall Study|Adverse Event|0|||
33555174|NCT02427802|62947947|FG001|Overall Study|Adverse Event|3|||
33555175|NCT02427802|62947948|FG002|Overall Study|Adverse Event|7|||
33555176|NCT02427802|62947946|FG000|Overall Study|Death|0|||
33555177|NCT02427802|62947947|FG001|Overall Study|Death|4|||
33555178|NCT02427802|62947948|FG002|Overall Study|Death|1|||
33555179|NCT02427802|62947946|FG000|Overall Study|Lost to Follow-up|13|||
33555180|NCT02427802|62947947|FG001|Overall Study|Lost to Follow-up|8|||
33555181|NCT02427802|62947948|FG002|Overall Study|Lost to Follow-up|8|||
33555182|NCT02427802|62947946|FG000|Overall Study|Physician Decision|4|||
33555183|NCT02427802|62947947|FG001|Overall Study|Physician Decision|2|||
33555184|NCT02427802|62947948|FG002|Overall Study|Physician Decision|4|||
33555185|NCT02427802|62947946|FG000|Overall Study|Withdrawal by Subject|10|||
33555186|NCT02427802|62947947|FG001|Overall Study|Withdrawal by Subject|5|||
33555187|NCT02427802|62947948|FG002|Overall Study|Withdrawal by Subject|11|||
33555188|NCT02427802|62947946|FG000|Overall Study|Protocol Violation|3|||
33555189|NCT02427802|62947947|FG001|Overall Study|Protocol Violation|1|||
33555190|NCT02427802|62947948|FG002|Overall Study|Protocol Violation|1|||
33555191|NCT02427802|62947946|FG000|Overall Study|protocol specific treatment unrelated|18|||
33555192|NCT02427802|62947947|FG001|Overall Study|protocol specific treatment unrelated|11|||
33555193|NCT02427802|62947948|FG002|Overall Study|protocol specific treatment unrelated|11|||
33555194|NCT02427646|62947958|FG000|Overall Study|Lack of Efficacy|2|||
33555195|NCT02427646|62947959|FG001|Overall Study|Lack of Efficacy|3|||
33555196|NCT02427646|62947958|FG000|Overall Study|Physician Decision|1|||
33555197|NCT02427646|62947959|FG001|Overall Study|Physician Decision|4|||
33555198|NCT02427646|62947958|FG000|Overall Study|Protocol Violation|3|||
33555199|NCT02427646|62947959|FG001|Overall Study|Protocol Violation|3|||
33555200|NCT02427646|62947958|FG000|Overall Study|Bothersome hand weakness|2|||
33555201|NCT02427646|62947959|FG001|Overall Study|Bothersome hand weakness|4|||
33555202|NCT02392000|62947967|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
33555203|NCT02392000|62947967|FG000|Overall Study|Withdrawal by Subject|1|||
33555204|NCT02392000|62947967|FG000|Overall Study|Lost to Follow-up|8|||
33555205|NCT02385526|62947975|FG000|Overall Study|Withdrawal by Subject|0|||
33555206|NCT02385526|62947976|FG001|Overall Study|Withdrawal by Subject|2|||
33555207|NCT02385526|62947977|FG002|Overall Study|Withdrawal by Subject|0|||
33555208|NCT02385526|62947975|FG000|Overall Study|Lost to Follow-up|0|||
33555209|NCT02385526|62947976|FG001|Overall Study|Lost to Follow-up|1|||
33555210|NCT02385526|62947977|FG002|Overall Study|Lost to Follow-up|0|||
33555211|NCT02385526|62947975|FG000|Overall Study|Physician Decision|1|||
33555212|NCT02385526|62947976|FG001|Overall Study|Physician Decision|0|||
33555213|NCT02385526|62947977|FG002|Overall Study|Physician Decision|0|||
33555214|NCT02385526|62947975|FG000|Overall Study|Protocol Violation|1|||
33555215|NCT02385526|62947976|FG001|Overall Study|Protocol Violation|0|||
33555216|NCT02385526|62947977|FG002|Overall Study|Protocol Violation|0|||
33555217|NCT02808143|62947987|FG000|Maintenance Phase|Disease recurrence|1|||
33555218|NCT02808143|62947988|FG001|Maintenance Phase|Disease recurrence|3|||
33484384|NCT04493684|62861224|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33484385|NCT04493684|62861225|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33484386|NCT04493684|62861226|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33484387|NCT04493684|62861227|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33484388|NCT04493684|62861228|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33484389|NCT04493684|62861229|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33484390|NCT04493684|62861230|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33484391|NCT04493684|62861231|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33484392|NCT04493684|62861232|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33484393|NCT04493684|62861233|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
33555219|NCT02808143|62947987|FG000|Maintenance Phase|Disease progression|1|||
33661572|NCT01592747|63091245|FG000|Overall Study|Protocol Violation|4|||
33661573|NCT01592747|63091246|FG001|Overall Study|Protocol Violation|0|||
33661574|NCT01592747|63091247|FG002|Overall Study|Protocol Violation|4|||
33555220|NCT02808143|62947988|FG001|Maintenance Phase|Disease progression|2|||
33555221|NCT02808143|62947987|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
33555222|NCT02808143|62947988|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
33367022|NCT00825825|62745888|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
33555223|NCT02808143|62947987|FG000|Survival Follow-Up|Disease recurrence|0|||
33555224|NCT02808143|62947988|FG001|Survival Follow-Up|Disease recurrence|2|||
33555225|NCT02808143|62947987|FG000|Survival Follow-Up|Adverse Event|0|||
33555226|NCT02808143|62947988|FG001|Survival Follow-Up|Adverse Event|1|||
33555227|NCT02808143|62947987|FG000|Survival Follow-Up|Death|1|||
33555228|NCT02808143|62947988|FG001|Survival Follow-Up|Death|0|||
33555229|NCT02427100|62947998|FG000|Overall Study|Lost to Follow-up|0|||
33555230|NCT02427100|62947999|FG001|Overall Study|Lost to Follow-up|2|||
33555231|NCT02806973|62948005|FG000|Period 1|Withdrawal by Subject|0|||
33555232|NCT02806973|62948006|FG001|Period 1|Withdrawal by Subject|2|||
33555233|NCT02806973|62948007|FG002|Period 1|Withdrawal by Subject|1|||
33555234|NCT02806973|62948008|FG003|Period 1|Withdrawal by Subject|1|||
33555235|NCT02806973|62948005|FG000|Period 1|Adverse Event|0|||
33367023|NCT00825825|62745889|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
33367024|NCT00825825|62745890|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
33555236|NCT02806973|62948006|FG001|Period 1|Adverse Event|0|||
33555237|NCT02806973|62948007|FG002|Period 1|Adverse Event|0|||
33555238|NCT02806973|62948008|FG003|Period 1|Adverse Event|1|||
33555239|NCT02806973|62948005|FG000|Period 3|Withdrawal by Subject|0|||
33555240|NCT02806973|62948006|FG001|Period 3|Withdrawal by Subject|0|||
33555241|NCT02806973|62948007|FG002|Period 3|Withdrawal by Subject|0|||
33555242|NCT02806973|62948008|FG003|Period 3|Withdrawal by Subject|3|||
33484394|NCT04493684|62861234|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33484395|NCT04493684|62861218|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33484396|NCT04493684|62861219|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33484397|NCT04493684|62861220|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33484398|NCT04493684|62861221|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33484399|NCT04493684|62861222|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33484400|NCT04493684|62861223|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33484401|NCT04493684|62861224|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33555243|NCT02806973|62948005|FG000|Period 3|Adverse Event|0|||
33555244|NCT02806973|62948006|FG001|Period 3|Adverse Event|0|||
33367025|NCT00825825|62745891|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
33367026|NCT00825825|62745892|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
33367027|NCT00825825|62745893|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
33367028|NCT00825825|62745888|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
33367029|NCT00825825|62745889|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
33367030|NCT00825825|62745890|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
33367031|NCT00825825|62745891|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
33367032|NCT00825825|62745892|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
33367033|NCT00825825|62745893|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
33367034|NCT00825825|62745888|FG000|Third Medication Period (14 Days)|poor data quality|0|||
33367035|NCT00825825|62745889|FG001|Third Medication Period (14 Days)|poor data quality|1|||
33367036|NCT00825825|62745890|FG002|Third Medication Period (14 Days)|poor data quality|0|||
33367037|NCT00825825|62745891|FG003|Third Medication Period (14 Days)|poor data quality|0|||
33367038|NCT00825825|62745892|FG004|Third Medication Period (14 Days)|poor data quality|0|||
33367039|NCT00825825|62745893|FG005|Third Medication Period (14 Days)|poor data quality|0|||
33367040|NCT00710710|62745902|FG000|Overall Study|Consent withdrawn|2|||
33367041|NCT00710710|62745903|FG001|Overall Study|Consent withdrawn|2|||
33367042|NCT00710710|62745902|FG000|Overall Study|Protocol Violation|0|||
33367043|NCT00710710|62745903|FG001|Overall Study|Protocol Violation|1|||
33367044|NCT00710710|62745902|FG000|Overall Study|Adverse Event|3|||
33367045|NCT00710710|62745903|FG001|Overall Study|Adverse Event|3|||
33367046|NCT00710710|62745902|FG000|Overall Study|Progressive disease|40|||
33367047|NCT00710710|62745903|FG001|Overall Study|Progressive disease|38|||
33367048|NCT00880334|62745911|FG000|Randomized Phase|Physician Decision|1|||
33367049|NCT00880334|62745912|FG001|Randomized Phase|Physician Decision|0|||
33367050|NCT00880334|62745911|FG000|Randomized Phase|Withdrawal by Subject|2|||
33367051|NCT00880334|62745912|FG001|Randomized Phase|Withdrawal by Subject|1|||
33367052|NCT00880334|62745911|FG000|Randomized Phase|Inadequate Labs|1|||
33367053|NCT00880334|62745912|FG001|Randomized Phase|Inadequate Labs|1|||
33367054|NCT00880334|62745911|FG000|Randomized Phase|Brain Metastasis|0|||
33367055|NCT00880334|62745912|FG001|Randomized Phase|Brain Metastasis|1|||
33367056|NCT00880334|62745911|FG000|Randomized Phase|Crossover Participants|0|||
33367057|NCT00880334|62745912|FG001|Randomized Phase|Crossover Participants|37|||
33367058|NCT00865566|62745924|FG000|Overall Study|Death|1|||
33367059|NCT00865566|62745925|FG001|Overall Study|Death|11|||
33367060|NCT00865566|62745924|FG000|Overall Study|Lost to Follow-up|314|||
33367061|NCT00865566|62745925|FG001|Overall Study|Lost to Follow-up|315|||
33367062|NCT00865566|62745924|FG000|Overall Study|Withdrawal by Subject|45|||
33367063|NCT00865566|62745925|FG001|Overall Study|Withdrawal by Subject|65|||
33367064|NCT00865566|62745924|FG000|Overall Study|Physician Decision|0|||
33367065|NCT00865566|62745925|FG001|Overall Study|Physician Decision|1|||
33367066|NCT00865566|62745924|FG000|Overall Study|Participant relocated|78|||
33367067|NCT00865566|62745925|FG001|Overall Study|Participant relocated|107|||
33367068|NCT00865566|62745924|FG000|Overall Study|Participant unable to adhere|27|||
33367069|NCT00865566|62745925|FG001|Overall Study|Participant unable to adhere|42|||
33367070|NCT00865566|62745924|FG000|Overall Study|Other; N=245 due to early study closure|154|||
33367071|NCT00865566|62745925|FG001|Overall Study|Other; N=245 due to early study closure|139|||
33367072|NCT00865566|62745924|FG000|Overall Study|HIV infection|5|||
33367073|NCT00865566|62745925|FG001|Overall Study|HIV infection|7|||
33367074|NCT03866473|62745933|FG000|Phase 1|Death|1|||
33367075|NCT03866473|62745934|FG001|Phase 1|Death|0|||
33367076|NCT03866473|62745933|FG000|Phase 2|Death|0|||
33367077|NCT03866473|62745934|FG001|Phase 2|Death|2|||
33367078|NCT03866473|62745933|FG000|Phase 2|Dropped|1|||
33367079|NCT03866473|62745934|FG001|Phase 2|Dropped|1|||
33367080|NCT03866473|62745933|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
33367081|NCT03866473|62745934|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
33367082|NCT00525499|62745948|FG000|Overall Study|Lost to Follow-up|2|||
33367083|NCT00525499|62745949|FG001|Overall Study|Lost to Follow-up|4|||
33367084|NCT00525499|62745950|FG002|Overall Study|Lost to Follow-up|1|||
33367085|NCT00525499|62745951|FG003|Overall Study|Lost to Follow-up|4|||
33367086|NCT00525499|62745948|FG000|Overall Study|Adverse Event|0|||
33367087|NCT00525499|62745949|FG001|Overall Study|Adverse Event|1|||
33367088|NCT00525499|62745950|FG002|Overall Study|Adverse Event|0|||
33367089|NCT00525499|62745951|FG003|Overall Study|Adverse Event|1|||
33367090|NCT00525499|62745948|FG000|Overall Study|Withdrawal by Subject|5|||
33555245|NCT02806973|62948007|FG002|Period 3|Adverse Event|1|||
33555246|NCT02806973|62948008|FG003|Period 3|Adverse Event|0|||
33367091|NCT00525499|62745949|FG001|Overall Study|Withdrawal by Subject|1|||
33367092|NCT00525499|62745950|FG002|Overall Study|Withdrawal by Subject|5|||
33367093|NCT00525499|62745951|FG003|Overall Study|Withdrawal by Subject|2|||
33367094|NCT00525499|62745948|FG000|Overall Study|Protocol Violation|0|||
33367095|NCT00525499|62745949|FG001|Overall Study|Protocol Violation|1|||
33367096|NCT00525499|62745950|FG002|Overall Study|Protocol Violation|1|||
33367097|NCT00525499|62745951|FG003|Overall Study|Protocol Violation|0|||
33367098|NCT00824655|62745963|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
33367099|NCT00824655|62745964|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
33367100|NCT00824655|62745963|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
33367101|NCT00824655|62745964|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
33367102|NCT00525265|62745974|FG000|Overall Study|Protocol Violation|1|||
33367103|NCT00525265|62745975|FG001|Overall Study|Protocol Violation|0|||
33367104|NCT00880256|62745981|FG000|Overall Study|Lost to Follow-up|28|||
33367105|NCT03865381|62745990|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
33367106|NCT03865381|62745990|FG000|Overall Study|Withdrawal by Subject|2|||
33367107|NCT00865098|62745994|FG000|Overall Study|Progressive disease|1|||
33367108|NCT00880100|62745998|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
33367109|NCT00880100|62745998|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
33367110|NCT00880100|62745998|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
33367111|NCT00518011|62746004|FG000|Overall Study|Death|1|||
33367112|NCT00518011|62746005|FG001|Overall Study|Death|1|||
33367113|NCT00518011|62746004|FG000|Overall Study|Adverse Event|2|||
33367114|NCT00518011|62746005|FG001|Overall Study|Adverse Event|3|||
33367115|NCT00518011|62746004|FG000|Overall Study|Disease Progression|2|||
33367116|NCT00518011|62746005|FG001|Overall Study|Disease Progression|2|||
33367117|NCT00518011|62746004|FG000|Overall Study|Other Reasons|3|||
33367118|NCT00518011|62746005|FG001|Overall Study|Other Reasons|2|||
33367119|NCT00518011|62746004|FG000|Overall Study|Withdrawal by Subject|1|||
33367120|NCT00518011|62746005|FG001|Overall Study|Withdrawal by Subject|0|||
33555247|NCT02806505|62948020|FG000|Overall Study|Adverse event/intercurrent illness|1|||
33555248|NCT02806505|62948021|FG001|Overall Study|Adverse event/intercurrent illness|3|||
33367121|NCT00865020|62746014|FG000|Overall Study|Withdrawal by Subject|22|||
33367122|NCT00865020|62746015|FG001|Overall Study|Withdrawal by Subject|16|||
33367123|NCT00865020|62746014|FG000|Overall Study|Adverse Event|9|||
33367124|NCT00865020|62746015|FG001|Overall Study|Adverse Event|14|||
33367125|NCT00865020|62746014|FG000|Overall Study|Abnormal test procedure result(s)|6|||
33367126|NCT00865020|62746015|FG001|Overall Study|Abnormal test procedure result(s)|8|||
33367127|NCT00865020|62746014|FG000|Overall Study|Lost to Follow-up|6|||
33367128|NCT00865020|62746015|FG001|Overall Study|Lost to Follow-up|4|||
33367129|NCT00865020|62746014|FG000|Overall Study|Protocol deviation|4|||
33367130|NCT00865020|62746015|FG001|Overall Study|Protocol deviation|1|||
33555249|NCT02806505|62948020|FG000|Overall Study|Death|4|||
33555250|NCT02806505|62948021|FG001|Overall Study|Death|0|||
33555251|NCT02806505|62948020|FG000|Overall Study|Did not cooperate/refused treatment|3|||
33555252|NCT02806505|62948021|FG001|Overall Study|Did not cooperate/refused treatment|3|||
33555253|NCT02806505|62948020|FG000|Overall Study|Failure to return|0|||
33555254|NCT02806505|62948021|FG001|Overall Study|Failure to return|1|||
33555255|NCT02806505|62948020|FG000|Overall Study|Insufficient therapeutic response|2|||
33555256|NCT02806505|62948021|FG001|Overall Study|Insufficient therapeutic response|4|||
33555257|NCT02807363|62948031|FG000|Dosing Period|Adverse Event|0|||
33555258|NCT02807363|62948032|FG001|Dosing Period|Adverse Event|1|||
33555259|NCT02807363|62948033|FG002|Dosing Period|Adverse Event|0|||
33555260|NCT02807363|62948034|FG003|Dosing Period|Adverse Event|0|||
33555261|NCT02383966|62948048|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
33555262|NCT02383966|62948049|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
33555263|NCT02383966|62948048|FG000|Overall Study|Randomized, but not treated|1|||
33555264|NCT02383966|62948049|FG001|Overall Study|Randomized, but not treated|3|||
33367131|NCT00865020|62746014|FG000|Overall Study|Administrative problems|0|||
33367132|NCT00865020|62746015|FG001|Overall Study|Administrative problems|2|||
33555265|NCT02383576|62948057|FG000|Overall Study|Death|53|||
33555266|NCT02383576|62948058|FG001|Overall Study|Death|33|||
33555267|NCT02383576|62948057|FG000|Overall Study|Lost to Follow-up|7|||
33555268|NCT02383576|62948058|FG001|Overall Study|Lost to Follow-up|1|||
33367133|NCT00865020|62746014|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33367134|NCT00865020|62746015|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33555269|NCT02383576|62948057|FG000|Overall Study|Withdrew Consent|1|||
33367135|NCT00865020|62746014|FG000|Overall Study|Death|0|||
33555270|NCT02383576|62948058|FG001|Overall Study|Withdrew Consent|6|||
33555271|NCT02383576|62948057|FG000|Overall Study|Investigator's Decision|0|||
33367136|NCT00865020|62746015|FG001|Overall Study|Death|1|||
33367137|NCT00865020|62746014|FG000|Overall Study|Randomized but discontinued|2|||
33484402|NCT04493684|62861225|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33367138|NCT00865020|62746015|FG001|Overall Study|Randomized but discontinued|4|||
33367139|NCT00517933|62746023|FG000|Period 1|Death|2|||
33367140|NCT00517933|62746024|FG001|Period 1|Death|1|||
33367141|NCT00517933|62746023|FG000|Period 1|Adverse Event|4|||
33484403|NCT04493684|62861226|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33484404|NCT04493684|62861227|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33661575|NCT01592747|63091245|FG000|Overall Study|Lack of Efficacy|0|||
33661576|NCT01592747|63091246|FG001|Overall Study|Lack of Efficacy|1|||
33367142|NCT00517933|62746024|FG001|Period 1|Adverse Event|4|||
33484405|NCT04493684|62861228|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33661577|NCT01592747|63091247|FG002|Overall Study|Lack of Efficacy|0|||
33367143|NCT00517933|62746023|FG000|Period 1|Lost to Follow-up|2|||
33484406|NCT04493684|62861229|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33484407|NCT04493684|62861230|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33661578|NCT01592747|63091245|FG000|Overall Study|Withdrawal by Subject|2|||
33555272|NCT02383576|62948058|FG001|Overall Study|Investigator's Decision|1|||
33555273|NCT02383576|62948057|FG000|Overall Study|Administrative/Other|2|||
33661579|NCT01592747|63091246|FG001|Overall Study|Withdrawal by Subject|0|||
33661580|NCT01592747|63091247|FG002|Overall Study|Withdrawal by Subject|2|||
33661581|NCT01592747|63091245|FG000|Overall Study|Lost to Follow-up|1|||
33661582|NCT01592747|63091246|FG001|Overall Study|Lost to Follow-up|0|||
33661583|NCT01592747|63091247|FG002|Overall Study|Lost to Follow-up|1|||
33661584|NCT01592747|63091245|FG000|Overall Study|Other Reasons|1|||
33661585|NCT01592747|63091246|FG001|Overall Study|Other Reasons|1|||
33661586|NCT01592747|63091247|FG002|Overall Study|Other Reasons|0|||
33661587|NCT02051608|63091260|FG000|Part 1: Double Blind Treatment|Death|3|||
33661588|NCT02051608|63091261|FG001|Part 1: Double Blind Treatment|Death|3|||
33661589|NCT02051608|63091262|FG002|Part 1: Double Blind Treatment|Death|0|||
33661590|NCT02051608|63091263|FG003|Part 1: Double Blind Treatment|Death|0|||
33661591|NCT02051608|63091260|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
33661592|NCT02051608|63091261|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
33661593|NCT02051608|63091262|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
33661594|NCT02051608|63091263|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
33661595|NCT02051608|63091260|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
33661596|NCT02051608|63091261|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
33661597|NCT02051608|63091262|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
33661598|NCT02051608|63091263|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
33661599|NCT02051608|63091260|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
33661600|NCT02051608|63091261|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
33661601|NCT02051608|63091262|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
33661602|NCT02051608|63091263|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
33661603|NCT02051608|63091260|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
33661604|NCT02051608|63091261|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
33661605|NCT02051608|63091262|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
33661606|NCT02051608|63091263|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
33661607|NCT02051608|63091260|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
33661608|NCT02051608|63091261|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
33661609|NCT02051608|63091262|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
33661610|NCT02051608|63091263|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
33661611|NCT02051608|63091260|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
33661612|NCT02051608|63091261|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
33661613|NCT02051608|63091262|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
33661614|NCT02051608|63091263|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
33661615|NCT02051608|63091260|FG000|Part 1: Double Blind Treatment|Other|6|||
33661616|NCT02051608|63091261|FG001|Part 1: Double Blind Treatment|Other|3|||
33661617|NCT02051608|63091262|FG002|Part 1: Double Blind Treatment|Other|0|||
33661618|NCT02051608|63091263|FG003|Part 1: Double Blind Treatment|Other|0|||
33661619|NCT02051608|63091260|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
33661620|NCT02051608|63091261|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
33661621|NCT02051608|63091262|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
33661622|NCT02051608|63091263|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
33661623|NCT02051608|63091260|FG000|Part 2: Open-label Extension|Adverse Event|0|||
33367144|NCT00517933|62746024|FG001|Period 1|Lost to Follow-up|0|||
33555274|NCT02383576|62948058|FG001|Overall Study|Administrative/Other|4|||
33555275|NCT02748317|62948064|FG000|Overall Study|Withdrawal by Subject|14|||
33555276|NCT02748317|62948064|FG000|Overall Study|Lost to Follow-up|8|||
33555277|NCT02748317|62948064|FG000|Overall Study|Death|1|||
33555278|NCT02426086|62948070|FG000|Overall Study|Death|33|||
33555279|NCT02426086|62948071|FG001|Overall Study|Death|36|||
33555280|NCT02426086|62948070|FG000|Overall Study|Lost to Follow-up|2|||
33555281|NCT02426086|62948071|FG001|Overall Study|Lost to Follow-up|0|||
33555282|NCT02426086|62948070|FG000|Overall Study|Study Terminated by Sponsor|5|||
33555283|NCT02426086|62948071|FG001|Overall Study|Study Terminated by Sponsor|14|||
33661624|NCT02051608|63091261|FG001|Part 2: Open-label Extension|Adverse Event|0|||
33661625|NCT02051608|63091262|FG002|Part 2: Open-label Extension|Adverse Event|6|||
33661626|NCT02051608|63091263|FG003|Part 2: Open-label Extension|Adverse Event|8|||
33661627|NCT02051608|63091260|FG000|Part 2: Open-label Extension|Death|0|||
33661628|NCT02051608|63091261|FG001|Part 2: Open-label Extension|Death|0|||
33661629|NCT02051608|63091262|FG002|Part 2: Open-label Extension|Death|7|||
33661630|NCT02051608|63091263|FG003|Part 2: Open-label Extension|Death|4|||
33661631|NCT02051608|63091260|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
33661632|NCT02051608|63091261|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
33661633|NCT02051608|63091262|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
33661634|NCT02051608|63091263|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
33661635|NCT02051608|63091260|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
33661636|NCT02051608|63091261|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
33661637|NCT02051608|63091262|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
33661638|NCT02051608|63091263|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
33661639|NCT02051608|63091260|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
33661640|NCT02051608|63091261|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
33661641|NCT02051608|63091262|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
33661642|NCT02051608|63091263|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
33661643|NCT02051608|63091260|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
33661644|NCT02051608|63091261|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
33661645|NCT02051608|63091262|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
33661646|NCT02051608|63091263|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
33661647|NCT02051608|63091260|FG000|Part 2: Open-label Extension|Physician Decision|0|||
33661648|NCT02051608|63091261|FG001|Part 2: Open-label Extension|Physician Decision|0|||
33661649|NCT02051608|63091262|FG002|Part 2: Open-label Extension|Physician Decision|8|||
33661650|NCT02051608|63091263|FG003|Part 2: Open-label Extension|Physician Decision|5|||
33661651|NCT02051608|63091260|FG000|Part 2: Open-label Extension|Other|0|||
33661652|NCT02051608|63091261|FG001|Part 2: Open-label Extension|Other|0|||
33661653|NCT02051608|63091262|FG002|Part 2: Open-label Extension|Other|9|||
33661654|NCT02051608|63091263|FG003|Part 2: Open-label Extension|Other|9|||
33661655|NCT02705586|63091276|FG000|Overall Study|Health Issues|2|||
33661656|NCT02705586|63091276|FG000|Overall Study|Transportation Difficulties|5|||
33661657|NCT02705586|63091276|FG000|Overall Study|Vacation/Planned Absence|1|||
33661658|NCT01592045|63091282|FG000|Overall Study|Disease Progression|1|||
33661659|NCT01592045|63091283|FG001|Overall Study|Disease Progression|1|||
33661660|NCT01592045|63091282|FG000|Overall Study|Adverse Event|1|||
33661661|NCT01592045|63091283|FG001|Overall Study|Adverse Event|1|||
33661662|NCT01592045|63091282|FG000|Overall Study|Withdrawal by Subject|1|||
33661663|NCT01592045|63091283|FG001|Overall Study|Withdrawal by Subject|0|||
33661664|NCT01592045|63091282|FG000|Overall Study|Moved out of country|2|||
33661665|NCT01592045|63091283|FG001|Overall Study|Moved out of country|0|||
33661666|NCT01591499|63091291|FG000|Baseline Visit|Withdrawal by Subject|0|||
33661667|NCT01591499|63091292|FG001|Baseline Visit|Withdrawal by Subject|2|||
33661668|NCT01591499|63091293|FG002|Baseline Visit|Withdrawal by Subject|0|||
33661669|NCT01591499|63091294|FG003|Baseline Visit|Withdrawal by Subject|2|||
33661670|NCT01591499|63091291|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
33661671|NCT01591499|63091292|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
33661672|NCT01591499|63091293|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
33661673|NCT01591499|63091294|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
33661674|NCT01591499|63091291|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
33661675|NCT01591499|63091292|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
33661676|NCT01591499|63091293|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
33661677|NCT01591499|63091294|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
33484408|NCT04493684|62861231|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33484409|NCT04493684|62861232|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33484410|NCT04493684|62861233|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
33661678|NCT01590797|63091320|FG000|Overall Study|Adverse Event|4|||
33661679|NCT01590797|63091321|FG001|Overall Study|Adverse Event|3|||
33661680|NCT01590797|63091320|FG000|Overall Study|Lack of Efficacy|0|||
33661681|NCT01590797|63091321|FG001|Overall Study|Lack of Efficacy|2|||
33661682|NCT01590797|63091320|FG000|Overall Study|Lost to Follow-up|0|||
33661683|NCT01590797|63091321|FG001|Overall Study|Lost to Follow-up|1|||
33661684|NCT01590797|63091320|FG000|Overall Study|Protocol Violation|4|||
33661685|NCT01590797|63091321|FG001|Overall Study|Protocol Violation|1|||
33367145|NCT00517933|62746023|FG000|Period 1|Underwent lung transplant|0|||
33484411|NCT04493684|62861234|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33484412|NCT04289298|62861299|FG000|Overall Study|Lost to Follow-up|5|||
33484413|NCT04289298|62861300|FG001|Overall Study|Lost to Follow-up|0|||
33661686|NCT01590797|63091320|FG000|Overall Study|Withdrawal by Subject|7|||
33661687|NCT01590797|63091321|FG001|Overall Study|Withdrawal by Subject|5|||
33661688|NCT01590797|63091320|FG000|Overall Study|Other Protocol Specified Criteria|2|||
33661689|NCT01590797|63091321|FG001|Overall Study|Other Protocol Specified Criteria|4|||
33661690|NCT01590563|63091327|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
33661691|NCT01701401|63091336|FG000|Overall Study|Randomized But Not Treated|3|||
33661692|NCT01701401|63091337|FG001|Overall Study|Randomized But Not Treated|1|||
33661693|NCT01701401|63091338|FG002|Overall Study|Randomized But Not Treated|0|||
33661694|NCT01701401|63091339|FG003|Overall Study|Randomized But Not Treated|1|||
33661695|NCT01701401|63091336|FG000|Overall Study|Lost to Follow-up|5|||
33661696|NCT01701401|63091337|FG001|Overall Study|Lost to Follow-up|5|||
33661697|NCT01701401|63091338|FG002|Overall Study|Lost to Follow-up|1|||
33661698|NCT01701401|63091339|FG003|Overall Study|Lost to Follow-up|3|||
33661699|NCT01701401|63091336|FG000|Overall Study|Withdrew Consent|0|||
33661700|NCT01701401|63091337|FG001|Overall Study|Withdrew Consent|3|||
33661701|NCT01701401|63091338|FG002|Overall Study|Withdrew Consent|1|||
33661702|NCT01701401|63091339|FG003|Overall Study|Withdrew Consent|2|||
33661703|NCT01701401|63091336|FG000|Overall Study|Lack of Efficacy|1|||
33661704|NCT01701401|63091337|FG001|Overall Study|Lack of Efficacy|0|||
33661705|NCT01701401|63091338|FG002|Overall Study|Lack of Efficacy|2|||
33661706|NCT01701401|63091339|FG003|Overall Study|Lack of Efficacy|0|||
33661707|NCT01701401|63091336|FG000|Overall Study|Adverse Event|1|||
33661708|NCT01701401|63091337|FG001|Overall Study|Adverse Event|0|||
33661709|NCT01701401|63091338|FG002|Overall Study|Adverse Event|0|||
33661710|NCT01701401|63091339|FG003|Overall Study|Adverse Event|0|||
33661711|NCT01701401|63091336|FG000|Overall Study|Protocol Violation|0|||
33661712|NCT01701401|63091337|FG001|Overall Study|Protocol Violation|0|||
33661713|NCT01701401|63091338|FG002|Overall Study|Protocol Violation|1|||
33367146|NCT00517933|62746024|FG001|Period 1|Underwent lung transplant|1|||
33367147|NCT00517933|62746023|FG000|Period 2|Death|2|||
33367148|NCT00517933|62746024|FG001|Period 2|Death|4|||
33367149|NCT00517933|62746023|FG000|Period 2|Adverse Event|2|||
33661714|NCT01701401|63091339|FG003|Overall Study|Protocol Violation|0|||
33661715|NCT01701245|63091351|FG000|Overall Study|Protocol Violation|1|||
33661716|NCT01701245|63091352|FG001|Overall Study|Protocol Violation|3|||
33661717|NCT01701245|63091351|FG000|Overall Study|Did not complete the open label period|11|||
33661718|NCT01701245|63091352|FG001|Overall Study|Did not complete the open label period|12|||
33661719|NCT01590017|63091358|FG000|Overall Study|Adverse Event|1|||
33661720|NCT01590017|63091358|FG000|Overall Study|Withdrawal by Subject|1|||
33661721|NCT01590017|63091358|FG000|Overall Study|Lack of Efficacy|1|||
33661722|NCT01590017|63091358|FG000|Overall Study|Physician Decision|1|||
33661723|NCT01700621|63091364|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
33661724|NCT01700621|63091365|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
33661725|NCT01700621|63091364|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
33661726|NCT01700621|63091365|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
33661727|NCT01700621|63091364|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
33661728|NCT01700621|63091365|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
33661729|NCT01589237|63091376|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
33367150|NCT00517933|62746024|FG001|Period 2|Adverse Event|4|||
33367151|NCT00517933|62746023|FG000|Period 2|Physician Decision|1|||
33661730|NCT01589237|63091377|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
33661731|NCT01589237|63091378|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
33484414|NCT04289298|62861299|FG000|Overall Study|Withdrawal by Subject|2|||
33484415|NCT04289298|62861300|FG001|Overall Study|Withdrawal by Subject|0|||
33484416|NCT04116710|62861311|FG000|Overall Study|Death|4|||
33484417|NCT04116710|62861312|FG001|Overall Study|Death|6|||
33484418|NCT04116710|62861313|FG002|Overall Study|Death|3|||
33484419|NCT04116710|62861314|FG003|Overall Study|Death|1|||
33484420|NCT04116710|62861311|FG000|Overall Study|Withdrawal by Subject|0|||
33484421|NCT04116710|62861312|FG001|Overall Study|Withdrawal by Subject|0|||
33484422|NCT04116710|62861313|FG002|Overall Study|Withdrawal by Subject|0|||
33484423|NCT04116710|62861314|FG003|Overall Study|Withdrawal by Subject|1|||
33484424|NCT03476798|62861347|FG000|Overall Study|Death|1|||
33484425|NCT03476798|62861347|FG000|Overall Study|Withdrawal by Subject|2|||
33484426|NCT03476798|62861347|FG000|Overall Study|Protocol Violation|2|||
33484427|NCT02946515|62861357|FG000|Overall Study|Lost to Follow-up|2|||
33484428|NCT02946515|62861358|FG001|Overall Study|Lost to Follow-up|1|||
33484429|NCT02677896|62861370|FG000|Double Blind Period (up to 35 Months)|Death|113|||
33484430|NCT02677896|62861371|FG001|Double Blind Period (up to 35 Months)|Death|189|||
33484431|NCT02677896|62861370|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
33484432|NCT02677896|62861371|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
33661732|NCT01589237|63091379|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
33367152|NCT00517933|62746024|FG001|Period 2|Physician Decision|0|||
33367153|NCT00517933|62746023|FG000|Period 2|Withdrawal by Subject|1|||
33367154|NCT00517933|62746024|FG001|Period 2|Withdrawal by Subject|3|||
33661733|NCT01589237|63091376|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
33367155|NCT00517933|62746023|FG000|Period 2|Underwent lung transplant|0|||
33661734|NCT01589237|63091377|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
33367156|NCT00517933|62746024|FG001|Period 2|Underwent lung transplant|2|||
33555284|NCT02426086|62948070|FG000|Overall Study|Withdrawal by Subject|8|||
33555285|NCT02426086|62948071|FG001|Overall Study|Withdrawal by Subject|9|||
33661735|NCT01589237|63091378|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
33661736|NCT01589237|63091379|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
33661737|NCT01589237|63091376|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
33484433|NCT02677896|62861370|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
33484434|NCT02677896|62861371|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
33555286|NCT02422264|62948084|FG000|Overall Study|Serious Adverse Event|1|||
33367157|NCT00701038|62746035|FG000|Overall Study|study amended pilot group of patients|4|||
33367158|NCT00701038|62746036|FG001|Overall Study|study amended pilot group of patients|4|||
33367159|NCT00857766|62746044|FG000|Overall Study|Adverse Event|13|||
33367160|NCT00857766|62746045|FG001|Overall Study|Adverse Event|12|||
33367161|NCT00857766|62746044|FG000|Overall Study|Protocol Violation|11|||
33367162|NCT00857766|62746045|FG001|Overall Study|Protocol Violation|11|||
33367163|NCT00857766|62746044|FG000|Overall Study|Lost to Follow-up|1|||
33367164|NCT00857766|62746045|FG001|Overall Study|Lost to Follow-up|0|||
33367165|NCT00857766|62746044|FG000|Overall Study|Investigator Discretion|2|||
33367166|NCT00857766|62746045|FG001|Overall Study|Investigator Discretion|3|||
33367167|NCT00857766|62746044|FG000|Overall Study|Participant Withdrew Consent|4|||
33367168|NCT00857766|62746045|FG001|Overall Study|Participant Withdrew Consent|4|||
33367169|NCT00517699|62746051|FG000|Overall Study|Withdrawal by Subject|1|||
33367170|NCT00517699|62746051|FG000|Overall Study|Lack of Efficacy|1|||
33367171|NCT00517699|62746051|FG000|Overall Study|Administrative error|1|||
33367172|NCT00517699|62746051|FG000|Overall Study|Study terminated by Sponsor|2|||
33367173|NCT00857454|62746055|FG000|Overall Study|Withdrawal by Subject|2|||
33367174|NCT00857454|62746055|FG000|Overall Study|Lost to Follow-up|1|||
33367175|NCT00857454|62746055|FG000|Overall Study|Adverse Event|2|||
33367176|NCT00857454|62746055|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
33367177|NCT00857454|62746055|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
33367178|NCT00857454|62746055|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
33367179|NCT00525031|62746061|FG000|Overall Study|Disease Progression|1|||
33367180|NCT00525031|62746062|FG001|Overall Study|Disease Progression|1|||
33367181|NCT00524485|62746069|FG000|Overall Study|Withdrawal by Subject|5|||
33367182|NCT00857220|62746073|FG000|Overall Study|Adverse Event|35|||
33555287|NCT02422264|62948085|FG001|Overall Study|Serious Adverse Event|0|||
33367183|NCT00857220|62746073|FG000|Overall Study|Death|1|||
33367184|NCT00857220|62746073|FG000|Overall Study|Lack of Efficacy|11|||
33367185|NCT00857220|62746073|FG000|Overall Study|Lost to Follow-up|30|||
33484435|NCT02677896|62861370|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
33484436|NCT02677896|62861371|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
33555288|NCT02422264|62948084|FG000|Overall Study|Withdrawal by Subject|1|||
33555289|NCT02422264|62948085|FG001|Overall Study|Withdrawal by Subject|2|||
33555290|NCT02422264|62948084|FG000|Overall Study|Migrated/moved from study area|3|||
33367186|NCT00857220|62746073|FG000|Overall Study|Physician Decision|4|||
33367187|NCT00857220|62746073|FG000|Overall Study|Protocol Violation|16|||
33367188|NCT00857220|62746073|FG000|Overall Study|Withdrawal by Subject|67|||
33367189|NCT00857220|62746073|FG000|Overall Study|Clinical Hold|6|||
33367190|NCT00857220|62746073|FG000|Overall Study|Site Closed|5|||
33367191|NCT00857220|62746073|FG000|Overall Study|Miscellaneous|8|||
33367192|NCT00524173|62746079|FG000|Overall Study|Lost to Follow-up|0|||
33367193|NCT00524173|62746080|FG001|Overall Study|Lost to Follow-up|1|||
33367194|NCT00524173|62746079|FG000|Overall Study|Death|1|||
33367195|NCT00524173|62746080|FG001|Overall Study|Death|0|||
33367196|NCT00524173|62746079|FG000|Overall Study|Had not reached endpoint at study close|4|||
33367197|NCT00524173|62746080|FG001|Overall Study|Had not reached endpoint at study close|1|||
33367198|NCT00879710|62746088|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
33367199|NCT00879710|62746089|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
33367200|NCT00879710|62746090|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
33367201|NCT00879710|62746091|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
33367202|NCT00879710|62746088|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
33367203|NCT00879710|62746089|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
33367204|NCT00879710|62746090|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
33367205|NCT00879710|62746091|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
33367206|NCT00597506|62746099|FG000|Overall Study|Subject is being followed for survival|1|||
33367207|NCT00708682|62746112|FG000|Infant Series|Adverse Event|1|||
33367208|NCT00708682|62746112|FG000|Infant Series|Lost to Follow-up|4|||
33367209|NCT00708682|62746112|FG000|Infant Series|Protocol Violation|1|||
33367210|NCT00708682|62746112|FG000|Infant Series|Parent/legal guardian request|6|||
33367211|NCT00708682|62746112|FG000|Infant Series|Failed to return|2|||
33367212|NCT00708682|62746112|FG000|Infant Series|Other|19|||
33367213|NCT00708682|62746112|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
33367214|NCT00708682|62746112|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
33367215|NCT00708682|62746112|FG000|Toddler Dose|Lost to Follow-up|3|||
33367216|NCT00708682|62746112|FG000|Toddler Dose|Failed to Return|4|||
33367217|NCT00712348|62746118|FG000|Overall Study|Withdrawal by Subject|1|||
33367218|NCT00881504|62746122|FG000|Overall Study|Withdrawal by Subject|1|||
33367219|NCT01936831|62746135|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33367220|NCT01936831|62746136|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33367221|NCT01936831|62746137|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33367222|NCT01936831|62746138|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33367223|NCT01936831|62746139|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33367224|NCT01936831|62746140|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
33367225|NCT01936831|62746141|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33367226|NCT01936831|62746142|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33367227|NCT01936831|62746143|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33367228|NCT03863353|62746160|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
33367229|NCT03863353|62746161|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
33367230|NCT00523705|62746169|FG000|Overall Study|No time for study.|0|||
33367231|NCT00523705|62746170|FG001|Overall Study|No time for study.|1|||
33367232|NCT00523549|62746183|FG000|Overall Study|Adverse Event|6|||
33367233|NCT00523549|62746184|FG001|Overall Study|Adverse Event|3|||
33367234|NCT00523549|62746183|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33367235|NCT00523549|62746184|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33367236|NCT00523549|62746183|FG000|Overall Study|Protocol Deviation|3|||
33367237|NCT00523549|62746184|FG001|Overall Study|Protocol Deviation|1|||
33367238|NCT00523549|62746183|FG000|Overall Study|Patient withdrew consent|7|||
33367239|NCT00523549|62746184|FG001|Overall Study|Patient withdrew consent|6|||
33367240|NCT00523549|62746183|FG000|Overall Study|Lost to Follow-up|3|||
33367241|NCT00523549|62746184|FG001|Overall Study|Lost to Follow-up|5|||
33367242|NCT03504085|62746192|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
33367243|NCT03504085|62746193|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
33367244|NCT03504085|62746192|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
33367245|NCT03504085|62746193|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
33484437|NCT02677896|62861370|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
33367246|NCT00700102|62746201|FG000|Overall Study|Died|394|||
33484438|NCT02677896|62861371|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
33367247|NCT00700102|62746202|FG001|Overall Study|Died|385|||
33367248|NCT00700102|62746201|FG000|Overall Study|Lost to Follow-up|8|||
33367249|NCT00700102|62746202|FG001|Overall Study|Lost to Follow-up|10|||
33367250|NCT00595478|62746210|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
33484439|NCT02677896|62861370|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
33484440|NCT02677896|62861371|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
33484441|NCT02677896|62861370|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
33484442|NCT02677896|62861371|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
33484443|NCT02677896|62861370|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
33484444|NCT02677896|62861371|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
33367251|NCT00595478|62746211|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
33367252|NCT00595478|62746210|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
33367253|NCT00595478|62746211|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
33367254|NCT00516295|62746220|FG000|Overall Study|Lack of Efficacy|2|||
33367255|NCT00516295|62746221|FG001|Overall Study|Lack of Efficacy|0|||
33367256|NCT00516295|62746222|FG002|Overall Study|Lack of Efficacy|0|||
33367257|NCT00516295|62746220|FG000|Overall Study|Ineligible|1|||
33367258|NCT00516295|62746221|FG001|Overall Study|Ineligible|0|||
33367259|NCT00516295|62746222|FG002|Overall Study|Ineligible|0|||
33367260|NCT03861559|62746232|FG000|Overall Study|Adverse Event|0|||
33367261|NCT03861559|62746233|FG001|Overall Study|Adverse Event|2|||
33367262|NCT03861559|62746232|FG000|Overall Study|Treatment failure|0|||
33367263|NCT03861559|62746233|FG001|Overall Study|Treatment failure|2|||
33367264|NCT03861559|62746232|FG000|Overall Study|Noncompliance|1|||
33367265|NCT03861559|62746233|FG001|Overall Study|Noncompliance|1|||
33484445|NCT02677896|62861370|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
33661738|NCT01589237|63091377|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
33661739|NCT01589237|63091378|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
33367266|NCT03861559|62746232|FG000|Overall Study|Did not meet eligibility requirements|1|||
33367267|NCT03861559|62746233|FG001|Overall Study|Did not meet eligibility requirements|0|||
33367268|NCT00516139|62746239|FG000|Overall Study|Adverse Event|27|||
33367269|NCT00516139|62746239|FG000|Overall Study|Lost to Follow-up|1|||
33367270|NCT00516139|62746239|FG000|Overall Study|Protocol Violation|1|||
33367271|NCT00516139|62746239|FG000|Overall Study|Withdrawal by Subject|8|||
33367272|NCT00516139|62746239|FG000|Overall Study|Lack of Efficacy|1|||
33484446|NCT02677896|62861371|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
33484447|NCT02677896|62861370|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
33484448|NCT02677896|62861371|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
33484449|NCT02677896|62861370|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
33367273|NCT00515827|62746249|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
33367274|NCT00515827|62746250|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
33367275|NCT00515827|62746249|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
33367276|NCT00515827|62746250|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
33367277|NCT00522457|62746258|FG000|Overall Study|Due to disease progression|16|||
33367278|NCT00522457|62746258|FG000|Overall Study|Adverse Event|2|||
33367279|NCT00856986|62746267|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
33367280|NCT00856986|62746268|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
33367281|NCT00856986|62746269|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
33367282|NCT00856986|62746270|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
33367283|NCT00856986|62746271|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
33367284|NCT00856986|62746267|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
33367285|NCT00856986|62746268|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
33367286|NCT00856986|62746269|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
33367287|NCT00856986|62746270|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
33367288|NCT00856986|62746271|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
33367289|NCT00856986|62746267|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
33367290|NCT00856986|62746268|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
33367291|NCT00856986|62746269|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
33367292|NCT00856986|62746270|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
33367293|NCT00856986|62746271|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
33484450|NCT02677896|62861371|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
33484451|NCT02677896|62861370|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
33484452|NCT02677896|62861371|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
33484453|NCT02677896|62861370|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
33661740|NCT01589237|63091379|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
33367294|NCT00856986|62746267|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
33367295|NCT00856986|62746268|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
33367296|NCT00856986|62746269|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
33367297|NCT00856986|62746270|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
33367298|NCT00856986|62746271|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
33367299|NCT00856986|62746267|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
33367300|NCT00856986|62746268|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
33367301|NCT00856986|62746269|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
33367302|NCT00856986|62746270|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
33367303|NCT00856986|62746271|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
33367304|NCT00856986|62746267|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
33367305|NCT00856986|62746268|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
33367306|NCT00856986|62746269|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
33367307|NCT00856986|62746270|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
33367308|NCT00856986|62746271|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
33367309|NCT00856986|62746267|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
33367310|NCT00856986|62746268|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
33367311|NCT00856986|62746269|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
33367312|NCT00856986|62746270|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
33367313|NCT00856986|62746271|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
33367314|NCT00856986|62746267|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
33367315|NCT00856986|62746268|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
33367316|NCT00856986|62746269|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
33367317|NCT00856986|62746270|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
33367318|NCT00856986|62746271|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
33367319|NCT00856986|62746267|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
33367320|NCT00856986|62746268|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
33367321|NCT00856986|62746269|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
33367322|NCT00856986|62746270|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
33367323|NCT00856986|62746271|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
33367324|NCT00856986|62746267|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
33367325|NCT00856986|62746268|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
33367326|NCT00856986|62746269|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
33367327|NCT00856986|62746270|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
33367328|NCT00856986|62746271|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
33367329|NCT00856986|62746267|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
33367330|NCT00856986|62746268|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
33367331|NCT00856986|62746269|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
33367332|NCT00856986|62746270|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
33367333|NCT00856986|62746271|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
33367334|NCT00856986|62746267|FG000|Main Period, Weeks 0-26|Unclassified|7|||
33367335|NCT00856986|62746268|FG001|Main Period, Weeks 0-26|Unclassified|6|||
33367336|NCT00856986|62746269|FG002|Main Period, Weeks 0-26|Unclassified|7|||
33367337|NCT00856986|62746270|FG003|Main Period, Weeks 0-26|Unclassified|0|||
33367338|NCT00856986|62746271|FG004|Main Period, Weeks 0-26|Unclassified|0|||
33367339|NCT00856986|62746267|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
33367340|NCT00856986|62746268|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
33367341|NCT00856986|62746269|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
33367342|NCT00856986|62746270|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
33367343|NCT00856986|62746271|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
33367344|NCT00856986|62746267|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
33484454|NCT02677896|62861371|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
33555291|NCT02422264|62948085|FG001|Overall Study|Migrated/moved from study area|1|||
33555292|NCT02422264|62948084|FG000|Overall Study|Subject vaccinated outside of the study|0|||
33484455|NCT02677896|62861370|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
33484456|NCT02677896|62861371|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
33484457|NCT02586623|62861381|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
33661741|NCT01589237|63091376|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
33661742|NCT01589237|63091377|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
33661743|NCT01589237|63091378|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
33661744|NCT01589237|63091379|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
33661745|NCT01700387|63091395|FG000|Overall Study|Withdrawal by Subject|1|||
33661746|NCT01700387|63091396|FG001|Overall Study|Withdrawal by Subject|2|||
33661747|NCT01700387|63091395|FG000|Overall Study|Adverse Event|1|||
33661748|NCT01700387|63091396|FG001|Overall Study|Adverse Event|1|||
33661749|NCT01700387|63091395|FG000|Overall Study|Lost to Follow-up|2|||
33661750|NCT01700387|63091396|FG001|Overall Study|Lost to Follow-up|1|||
33367345|NCT00856986|62746268|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
33367346|NCT00856986|62746269|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
33367347|NCT00856986|62746270|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
33367348|NCT00856986|62746271|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
33367349|NCT00856986|62746267|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
33367350|NCT00856986|62746268|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
33367351|NCT00856986|62746269|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
33367352|NCT00856986|62746270|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
33661751|NCT01699685|63091408|FG000|Period 1|Adverse Event|1|||
33484458|NCT02586623|62861382|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
33484459|NCT02586623|62861383|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
33484460|NCT02586623|62861381|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
33484461|NCT02586623|62861382|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
33484462|NCT02586623|62861383|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
33661752|NCT01699685|63091409|FG001|Period 1|Adverse Event|1|||
33661753|NCT01699685|63091408|FG000|Period 1|Medical or ethical, noncompliance|2|||
33367353|NCT00856986|62746271|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
33555293|NCT02422264|62948085|FG001|Overall Study|Subject vaccinated outside of the study|1|||
33555294|NCT02390362|62948093|FG000|Overall Study|Withdrawal by Subject|0|||
33555295|NCT02390362|62948094|FG001|Overall Study|Withdrawal by Subject|1|||
33555296|NCT02389894|62948103|FG000|Overall Study|Death|4|||
33555297|NCT02389894|62948104|FG001|Overall Study|Death|5|||
33555298|NCT02389894|62948105|FG002|Overall Study|Death|3|||
33555299|NCT02389894|62948103|FG000|Overall Study|Withdrawal by Subject|2|||
33555300|NCT02389894|62948104|FG001|Overall Study|Withdrawal by Subject|4|||
33555301|NCT02389894|62948105|FG002|Overall Study|Withdrawal by Subject|5|||
33555302|NCT02389894|62948103|FG000|Overall Study|Lost to Follow-up|2|||
33661754|NCT01699685|63091409|FG001|Period 1|Medical or ethical, noncompliance|0|||
33484463|NCT02586623|62861381|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
33484464|NCT02586623|62861382|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
33484465|NCT02586623|62861383|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
33484466|NCT02586623|62861381|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
33484467|NCT02586623|62861382|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
33484468|NCT02586623|62861383|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
33484469|NCT02586623|62861381|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
33484470|NCT02586623|62861382|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
33484471|NCT02586623|62861383|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
33484472|NCT02586623|62861381|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
33484473|NCT02586623|62861382|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
33484474|NCT02586623|62861383|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
33484475|NCT02586623|62861381|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
33484476|NCT02586623|62861382|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
33484477|NCT02586623|62861383|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
33555303|NCT02389894|62948104|FG001|Overall Study|Lost to Follow-up|1|||
33555304|NCT02389894|62948105|FG002|Overall Study|Lost to Follow-up|1|||
33367354|NCT00856986|62746267|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
33555305|NCT02389816|62948116|FG000|Overall Study|Randomized but Not Treated|1|||
33555306|NCT02389816|62948117|FG001|Overall Study|Randomized but Not Treated|0|||
33367355|NCT00856986|62746268|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
33367356|NCT00856986|62746269|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
33367357|NCT00856986|62746270|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
33367358|NCT00856986|62746271|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
33367359|NCT00856986|62746267|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
33367360|NCT00856986|62746268|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
33367361|NCT00856986|62746269|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
33367362|NCT00856986|62746270|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
33367363|NCT00856986|62746271|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
33367364|NCT00856986|62746267|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
33367365|NCT00856986|62746268|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
33367366|NCT00856986|62746269|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
33367367|NCT00856986|62746270|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
33367368|NCT00856986|62746271|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
33367369|NCT00707746|62746285|FG000|Treatment Period|Adverse Event|2|||
33367370|NCT00707746|62746286|FG001|Treatment Period|Adverse Event|4|||
33367371|NCT00707746|62746285|FG000|Treatment Period|Ineligibility|0|||
33367372|NCT00707746|62746286|FG001|Treatment Period|Ineligibility|1|||
33367373|NCT00856908|62746294|FG000|Overall Study|Lost to Follow-up|1|||
33367374|NCT00856908|62746295|FG001|Overall Study|Lost to Follow-up|0|||
33367375|NCT00522379|62746306|FG000|Overall Study|Adverse Event|12|||
33367376|NCT00522379|62746307|FG001|Overall Study|Adverse Event|15|||
33367377|NCT00522379|62746308|FG002|Overall Study|Adverse Event|12|||
33367378|NCT00522379|62746309|FG003|Overall Study|Adverse Event|5|||
33367379|NCT00522379|62746310|FG004|Overall Study|Adverse Event|17|||
33367380|NCT00522379|62746306|FG000|Overall Study|Lack of Efficacy|3|||
33367381|NCT00522379|62746307|FG001|Overall Study|Lack of Efficacy|0|||
33367382|NCT00522379|62746308|FG002|Overall Study|Lack of Efficacy|2|||
33367383|NCT00522379|62746309|FG003|Overall Study|Lack of Efficacy|2|||
33367384|NCT00522379|62746310|FG004|Overall Study|Lack of Efficacy|7|||
33367385|NCT00522379|62746306|FG000|Overall Study|Withdrawal by Subject|2|||
33367386|NCT00522379|62746307|FG001|Overall Study|Withdrawal by Subject|3|||
33367387|NCT00522379|62746308|FG002|Overall Study|Withdrawal by Subject|1|||
33367388|NCT00522379|62746309|FG003|Overall Study|Withdrawal by Subject|2|||
33367389|NCT00522379|62746310|FG004|Overall Study|Withdrawal by Subject|0|||
33367390|NCT00522379|62746306|FG000|Overall Study|Protocol Violation|1|||
33367391|NCT00522379|62746307|FG001|Overall Study|Protocol Violation|1|||
33367392|NCT00522379|62746308|FG002|Overall Study|Protocol Violation|2|||
33367393|NCT00522379|62746309|FG003|Overall Study|Protocol Violation|0|||
33367394|NCT00522379|62746310|FG004|Overall Study|Protocol Violation|0|||
33367395|NCT00522379|62746306|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
33367396|NCT00522379|62746307|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
33367397|NCT00522379|62746308|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
33367398|NCT00522379|62746309|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
33367399|NCT00522379|62746310|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
33555307|NCT02389816|62948118|FG002|Overall Study|Randomized but Not Treated|0|||
33555308|NCT02389816|62948116|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
33555309|NCT02389816|62948117|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
33555310|NCT02389816|62948118|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
33555311|NCT02389816|62948116|FG000|Overall Study|Major Protocol Deviation|1|||
33555312|NCT02389816|62948117|FG001|Overall Study|Major Protocol Deviation|0|||
33555313|NCT02389816|62948118|FG002|Overall Study|Major Protocol Deviation|0|||
33555314|NCT02389816|62948116|FG000|Overall Study|Lost to Follow-up|1|||
33555315|NCT02389816|62948117|FG001|Overall Study|Lost to Follow-up|0|||
33555316|NCT02389816|62948118|FG002|Overall Study|Lost to Follow-up|0|||
33555317|NCT02389816|62948116|FG000|Overall Study|Withdrawal of Consent|6|||
33555318|NCT02389816|62948117|FG001|Overall Study|Withdrawal of Consent|4|||
33367400|NCT00522379|62746306|FG000|Overall Study|Lost to Follow-up|1|||
33367401|NCT00522379|62746307|FG001|Overall Study|Lost to Follow-up|0|||
33555319|NCT02389816|62948118|FG002|Overall Study|Withdrawal of Consent|4|||
33661755|NCT01699685|63091408|FG000|Period 1|Other|0|||
33661756|NCT01699685|63091409|FG001|Period 1|Other|1|||
33367402|NCT00522379|62746308|FG002|Overall Study|Lost to Follow-up|4|||
33367403|NCT00522379|62746309|FG003|Overall Study|Lost to Follow-up|2|||
33367404|NCT00522379|62746310|FG004|Overall Study|Lost to Follow-up|2|||
33367405|NCT00522379|62746306|FG000|Overall Study|Randomization error|0|||
33367406|NCT00522379|62746307|FG001|Overall Study|Randomization error|0|||
33367407|NCT00522379|62746308|FG002|Overall Study|Randomization error|0|||
33367408|NCT00522379|62746309|FG003|Overall Study|Randomization error|0|||
33367409|NCT00522379|62746310|FG004|Overall Study|Randomization error|1|||
33367410|NCT00522379|62746306|FG000|Overall Study|Dispensing error|1|||
33367411|NCT00522379|62746307|FG001|Overall Study|Dispensing error|0|||
33367412|NCT00522379|62746308|FG002|Overall Study|Dispensing error|0|||
33367413|NCT00522379|62746309|FG003|Overall Study|Dispensing error|1|||
33367414|NCT00522379|62746310|FG004|Overall Study|Dispensing error|0|||
33367415|NCT00522379|62746306|FG000|Overall Study|Subject Moved|1|||
33367416|NCT00522379|62746307|FG001|Overall Study|Subject Moved|1|||
33367417|NCT00522379|62746308|FG002|Overall Study|Subject Moved|0|||
33367418|NCT00522379|62746309|FG003|Overall Study|Subject Moved|0|||
33367419|NCT00522379|62746310|FG004|Overall Study|Subject Moved|0|||
33367420|NCT00522379|62746306|FG000|Overall Study|Sponsor Request|0|||
33367421|NCT00522379|62746307|FG001|Overall Study|Sponsor Request|1|||
33367422|NCT00522379|62746308|FG002|Overall Study|Sponsor Request|0|||
33367423|NCT00522379|62746309|FG003|Overall Study|Sponsor Request|0|||
33367424|NCT00522379|62746310|FG004|Overall Study|Sponsor Request|0|||
33367425|NCT00522379|62746306|FG000|Overall Study|Family Problem|0|||
33367426|NCT00522379|62746307|FG001|Overall Study|Family Problem|0|||
33367427|NCT00522379|62746308|FG002|Overall Study|Family Problem|1|||
33367428|NCT00522379|62746309|FG003|Overall Study|Family Problem|0|||
33367429|NCT00522379|62746310|FG004|Overall Study|Family Problem|0|||
33367430|NCT00522379|62746306|FG000|Overall Study|Site Closed|0|||
33367431|NCT00522379|62746307|FG001|Overall Study|Site Closed|0|||
33367432|NCT00522379|62746308|FG002|Overall Study|Site Closed|0|||
33367433|NCT00522379|62746309|FG003|Overall Study|Site Closed|1|||
33367434|NCT00522379|62746310|FG004|Overall Study|Site Closed|0|||
33367435|NCT00522379|62746306|FG000|Overall Study|Subject Withdrawal|0|||
33367436|NCT00522379|62746307|FG001|Overall Study|Subject Withdrawal|0|||
33367437|NCT00522379|62746308|FG002|Overall Study|Subject Withdrawal|0|||
33367438|NCT00522379|62746309|FG003|Overall Study|Subject Withdrawal|1|||
33367439|NCT00522379|62746310|FG004|Overall Study|Subject Withdrawal|0|||
33367440|NCT00856830|62746326|FG000|Irinotecan & Bendamustine|Death|0|||
33367441|NCT00856830|62746327|FG001|Irinotecan & Bendamustine|Death|0|||
33367442|NCT00856830|62746328|FG002|Irinotecan & Bendamustine|Death|0|||
33367443|NCT00856830|62746329|FG003|Irinotecan & Bendamustine|Death|2|||
33367444|NCT00856830|62746326|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
33367445|NCT00856830|62746327|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
33367446|NCT00856830|62746328|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
33367447|NCT00856830|62746329|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
33367448|NCT00522301|62746334|FG000|Overall Study|Withdrawal by Subject|1|||
33367449|NCT00522301|62746334|FG000|Overall Study|Adverse Event|5|||
33367450|NCT00863928|62746340|FG000|Overall Study|Protocol Violation|26|||
33367451|NCT00863928|62746341|FG001|Overall Study|Protocol Violation|0|||
33367452|NCT00863928|62746340|FG000|Overall Study|Withdrawal by Subject|3|||
33367453|NCT00863928|62746341|FG001|Overall Study|Withdrawal by Subject|0|||
33367454|NCT00863928|62746340|FG000|Overall Study|surgery cancellation|4|||
33367455|NCT00863928|62746341|FG001|Overall Study|surgery cancellation|0|||
33367456|NCT00863928|62746340|FG000|Overall Study|medication allergy|3|||
33367457|NCT00863928|62746341|FG001|Overall Study|medication allergy|0|||
33367458|NCT00856518|62746349|FG000|Overall Study|Lost to Follow-up|4|||
33661757|NCT01699685|63091408|FG000|Period 1|Patient request|0|||
33367459|NCT00856518|62746350|FG001|Overall Study|Lost to Follow-up|2|||
33367460|NCT00506389|62746361|FG000|In-treatment Period|Other|3|||
33367461|NCT00506389|62746362|FG001|In-treatment Period|Other|3|||
33367462|NCT00506389|62746363|FG002|In-treatment Period|Other|4|||
33367463|NCT00506389|62746361|FG000|In-treatment Period|Lost to Follow-up|0|||
33367464|NCT00506389|62746362|FG001|In-treatment Period|Lost to Follow-up|0|||
33367465|NCT00506389|62746363|FG002|In-treatment Period|Lost to Follow-up|1|||
33367466|NCT00506389|62746361|FG000|In-treatment Period|Lack of compliance|1|||
33367467|NCT00506389|62746362|FG001|In-treatment Period|Lack of compliance|0|||
33367468|NCT00506389|62746363|FG002|In-treatment Period|Lack of compliance|0|||
33367469|NCT00506389|62746361|FG000|In-treatment Period|Reasons not related to trial|4|||
33367470|NCT00506389|62746362|FG001|In-treatment Period|Reasons not related to trial|1|||
33367471|NCT00506389|62746363|FG002|In-treatment Period|Reasons not related to trial|0|||
33367472|NCT00506389|62746361|FG000|In-treatment Period|Withdrawal by Subject|3|||
33367473|NCT00506389|62746362|FG001|In-treatment Period|Withdrawal by Subject|3|||
33367474|NCT00506389|62746363|FG002|In-treatment Period|Withdrawal by Subject|4|||
33367475|NCT00506389|62746361|FG000|In-treatment Period|Lack of Efficacy|0|||
33367476|NCT00506389|62746362|FG001|In-treatment Period|Lack of Efficacy|2|||
33367477|NCT00506389|62746363|FG002|In-treatment Period|Lack of Efficacy|0|||
33367478|NCT00506389|62746361|FG000|In-treatment Period|Adverse Event|11|||
33367479|NCT00506389|62746362|FG001|In-treatment Period|Adverse Event|5|||
33367480|NCT00506389|62746363|FG002|In-treatment Period|Adverse Event|2|||
33367481|NCT00506389|62746361|FG000|In-treatment Period|Randomized but not treated|4|||
33367482|NCT00506389|62746362|FG001|In-treatment Period|Randomized but not treated|1|||
33367483|NCT00506389|62746363|FG002|In-treatment Period|Randomized but not treated|1|||
33367484|NCT00871338|62746376|FG000|Prior to Booster|Withdrawal by Subject|1|||
33367485|NCT00871338|62746377|FG001|Prior to Booster|Withdrawal by Subject|3|||
33367486|NCT00871338|62746376|FG000|Prior to Booster|Lost to Follow-up|1|||
33367487|NCT00871338|62746377|FG001|Prior to Booster|Lost to Follow-up|0|||
33367488|NCT00824421|62746386|FG000|Overall Study|Adverse Event|6|||
33367489|NCT00824421|62746387|FG001|Overall Study|Adverse Event|6|||
33367490|NCT00824421|62746388|FG002|Overall Study|Adverse Event|6|||
33367491|NCT00824421|62746386|FG000|Overall Study|Death|0|||
33367492|NCT00824421|62746387|FG001|Overall Study|Death|1|||
33367493|NCT00824421|62746388|FG002|Overall Study|Death|0|||
33367494|NCT00824421|62746386|FG000|Overall Study|Lack of Efficacy|5|||
33367495|NCT00824421|62746387|FG001|Overall Study|Lack of Efficacy|7|||
33367496|NCT00824421|62746388|FG002|Overall Study|Lack of Efficacy|4|||
33367497|NCT00824421|62746386|FG000|Overall Study|Lost to Follow-up|2|||
33367498|NCT00824421|62746387|FG001|Overall Study|Lost to Follow-up|3|||
33367499|NCT00824421|62746388|FG002|Overall Study|Lost to Follow-up|0|||
33367500|NCT00824421|62746386|FG000|Overall Study|Pregnancy|1|||
33367501|NCT00824421|62746387|FG001|Overall Study|Pregnancy|0|||
33367502|NCT00824421|62746388|FG002|Overall Study|Pregnancy|1|||
33367503|NCT00824421|62746386|FG000|Overall Study|Withdrawal by Subject|2|||
33367504|NCT00824421|62746387|FG001|Overall Study|Withdrawal by Subject|3|||
33367505|NCT00824421|62746388|FG002|Overall Study|Withdrawal by Subject|3|||
33367506|NCT00824421|62746386|FG000|Overall Study|Randomized but not Treated|1|||
33367507|NCT00824421|62746387|FG001|Overall Study|Randomized but not Treated|1|||
33367508|NCT00824421|62746388|FG002|Overall Study|Randomized but not Treated|0|||
33367509|NCT00824421|62746386|FG000|Overall Study|Other|0|||
33367510|NCT00824421|62746387|FG001|Overall Study|Other|1|||
33367511|NCT00824421|62746388|FG002|Overall Study|Other|0|||
33367512|NCT00514813|62746402|FG000|Overall Study|Study terminated|14|||
33367513|NCT00514813|62746403|FG001|Overall Study|Study terminated|74|||
33367514|NCT00514813|62746404|FG002|Overall Study|Study terminated|40|||
33367515|NCT00514813|62746405|FG003|Overall Study|Study terminated|2|||
33661758|NCT01699685|63091409|FG001|Period 1|Patient request|1|||
33661759|NCT01699685|63091408|FG000|Period 2|Lost to Follow-up|1|||
33367516|NCT00514813|62746402|FG000|Overall Study|Adverse Event|0|||
33367517|NCT00514813|62746403|FG001|Overall Study|Adverse Event|2|||
33367518|NCT00514813|62746404|FG002|Overall Study|Adverse Event|2|||
33367519|NCT00514813|62746405|FG003|Overall Study|Adverse Event|0|||
33367520|NCT00514813|62746402|FG000|Overall Study|Protocol Violation|1|||
33367521|NCT00514813|62746403|FG001|Overall Study|Protocol Violation|0|||
33367522|NCT00514813|62746404|FG002|Overall Study|Protocol Violation|0|||
33367523|NCT00514813|62746405|FG003|Overall Study|Protocol Violation|0|||
33367524|NCT00514813|62746402|FG000|Overall Study|Withdrawal by Subject|0|||
33661760|NCT01699685|63091409|FG001|Period 2|Lost to Follow-up|0|||
33367525|NCT00514813|62746403|FG001|Overall Study|Withdrawal by Subject|1|||
33367526|NCT00514813|62746404|FG002|Overall Study|Withdrawal by Subject|0|||
33367527|NCT00514813|62746405|FG003|Overall Study|Withdrawal by Subject|0|||
33367528|NCT00514813|62746402|FG000|Overall Study|Lack of Efficacy|0|||
33367529|NCT00514813|62746403|FG001|Overall Study|Lack of Efficacy|1|||
33367530|NCT00514813|62746404|FG002|Overall Study|Lack of Efficacy|0|||
33367531|NCT00514813|62746405|FG003|Overall Study|Lack of Efficacy|0|||
33367532|NCT00514813|62746402|FG000|Overall Study|Kidney transplant|0|||
33484478|NCT02586623|62861381|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
33484479|NCT02586623|62861382|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
33484480|NCT02586623|62861383|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
33555320|NCT02389816|62948116|FG000|Overall Study|Lack of Efficacy|1|||
33555321|NCT02389816|62948117|FG001|Overall Study|Lack of Efficacy|0|||
33555322|NCT02389816|62948118|FG002|Overall Study|Lack of Efficacy|0|||
33555323|NCT02389816|62948116|FG000|Overall Study|Non Compliance with Study Drug|1|||
33555324|NCT02389816|62948117|FG001|Overall Study|Non Compliance with Study Drug|1|||
33555325|NCT02389816|62948118|FG002|Overall Study|Non Compliance with Study Drug|1|||
33555326|NCT02389816|62948116|FG000|Overall Study|Reason not Specified|0|||
33555327|NCT02389816|62948117|FG001|Overall Study|Reason not Specified|2|||
33555328|NCT02389816|62948118|FG002|Overall Study|Reason not Specified|0|||
33555329|NCT02388724|62948128|FG000|Overall Study|Reason not Specified|0|||
33555330|NCT02388724|62948129|FG001|Overall Study|Reason not Specified|1|||
33555331|NCT02388724|62948128|FG000|Overall Study|Major Protocol Deviation|3|||
33555332|NCT02388724|62948129|FG001|Overall Study|Major Protocol Deviation|3|||
33555333|NCT02388724|62948128|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
33555334|NCT02388724|62948129|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
33555335|NCT02388724|62948128|FG000|Overall Study|Voluntary Withdrawal|6|||
33661761|NCT01587989|63091417|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
33661762|NCT01587989|63091418|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
33661763|NCT01587989|63091419|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
33661764|NCT01587989|63091417|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
33661765|NCT01587989|63091418|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
33661766|NCT01587989|63091419|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
33484481|NCT02586623|62861381|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
33484482|NCT02586623|62861382|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
33367533|NCT00514813|62746403|FG001|Overall Study|Kidney transplant|6|||
33484483|NCT02586623|62861383|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
33484484|NCT02586623|62861381|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
33484485|NCT02586623|62861382|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
33484486|NCT02586623|62861383|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
33555336|NCT02388724|62948129|FG001|Overall Study|Voluntary Withdrawal|5|||
33367534|NCT00514813|62746404|FG002|Overall Study|Kidney transplant|2|||
33367535|NCT00514813|62746405|FG003|Overall Study|Kidney transplant|0|||
33367536|NCT00514813|62746402|FG000|Overall Study|Death|0|||
33367537|NCT00514813|62746403|FG001|Overall Study|Death|2|||
33367538|NCT00514813|62746404|FG002|Overall Study|Death|3|||
33367539|NCT00514813|62746405|FG003|Overall Study|Death|2|||
33367540|NCT00597116|62746417|FG000|Overall Study|Adverse Event|2|||
33367541|NCT00597116|62746418|FG001|Overall Study|Adverse Event|1|||
33367542|NCT00597116|62746417|FG000|Overall Study|Withdrawal by Subject|0|||
33367543|NCT00597116|62746418|FG001|Overall Study|Withdrawal by Subject|2|||
33367544|NCT00597116|62746417|FG000|Overall Study|Physician Decision|0|||
33367545|NCT00597116|62746418|FG001|Overall Study|Physician Decision|1|||
33367546|NCT00597116|62746417|FG000|Overall Study|Death|0|||
33367547|NCT00597116|62746418|FG001|Overall Study|Death|1|||
33367548|NCT00597116|62746417|FG000|Overall Study|Lost to Follow-up|1|||
33367549|NCT00597116|62746418|FG001|Overall Study|Lost to Follow-up|0|||
33367550|NCT00597116|62746417|FG000|Overall Study|Progressive disease|11|||
33367551|NCT00597116|62746418|FG001|Overall Study|Progressive disease|6|||
33367552|NCT00514735|62746426|FG000|Overall Study|Withdrawal by Subject|13|||
33367553|NCT00514735|62746427|FG001|Overall Study|Withdrawal by Subject|5|||
33367554|NCT00514735|62746426|FG000|Overall Study|Death|1|||
33367555|NCT00514735|62746427|FG001|Overall Study|Death|0|||
33367556|NCT00514735|62746426|FG000|Overall Study|Lost to Follow-up|0|||
33367557|NCT00514735|62746427|FG001|Overall Study|Lost to Follow-up|1|||
33367558|NCT03252587|62746439|FG000|Overall Study|Adverse Event|3|||
33367559|NCT03252587|62746440|FG001|Overall Study|Adverse Event|8|||
33367560|NCT03252587|62746441|FG002|Overall Study|Adverse Event|6|||
33367561|NCT03252587|62746442|FG003|Overall Study|Adverse Event|12|||
33367562|NCT03252587|62746439|FG000|Overall Study|Lack of Efficacy|7|||
33367563|NCT03252587|62746440|FG001|Overall Study|Lack of Efficacy|2|||
33367564|NCT03252587|62746441|FG002|Overall Study|Lack of Efficacy|2|||
33367565|NCT03252587|62746442|FG003|Overall Study|Lack of Efficacy|4|||
33367566|NCT03252587|62746439|FG000|Overall Study|Lost to Follow-up|2|||
33367567|NCT03252587|62746440|FG001|Overall Study|Lost to Follow-up|0|||
33367568|NCT03252587|62746441|FG002|Overall Study|Lost to Follow-up|0|||
33367569|NCT03252587|62746442|FG003|Overall Study|Lost to Follow-up|2|||
33367570|NCT03252587|62746439|FG000|Overall Study|Pregnancy|2|||
33367571|NCT03252587|62746440|FG001|Overall Study|Pregnancy|1|||
33367572|NCT03252587|62746441|FG002|Overall Study|Pregnancy|0|||
33484487|NCT02586623|62861381|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
33484488|NCT02586623|62861382|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
33484489|NCT02586623|62861383|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
33484490|NCT02586623|62861381|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
33484491|NCT02586623|62861382|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
33484492|NCT02586623|62861383|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
33484493|NCT02586623|62861381|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
33484494|NCT02586623|62861382|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
33484495|NCT02586623|62861383|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
33484496|NCT02586623|62861381|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
33484497|NCT02586623|62861382|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
33484498|NCT02586623|62861383|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
33484499|NCT02586623|62861381|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
33484500|NCT02586623|62861382|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
33484501|NCT02586623|62861383|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
33484502|NCT02586623|62861381|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
33484503|NCT02586623|62861382|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
33484504|NCT02586623|62861383|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
33484505|NCT02586623|62861381|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
33484506|NCT02586623|62861382|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
33484507|NCT02586623|62861383|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
33484508|NCT02586623|62861381|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
33484509|NCT02586623|62861382|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
33484510|NCT02586623|62861383|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
33484511|NCT02586623|62861381|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
33484512|NCT02586623|62861382|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
33484513|NCT02586623|62861383|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
33484514|NCT02586623|62861381|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
33484515|NCT02586623|62861382|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
33484516|NCT02586623|62861383|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
33484517|NCT02586623|62861381|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
33484518|NCT02586623|62861382|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
33484519|NCT02586623|62861383|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
33484520|NCT01819831|62861390|FG000|Overall Study|Withdrawal by Subject|1|||
33484521|NCT00078949|62861407|FG000|Overall Study|No treated|4|||
33484522|NCT00078949|62861408|FG001|Overall Study|No treated|5|||
33484523|NCT00078949|62861409|FG002|Overall Study|No treated|3|||
33484524|NCT00078949|62861410|FG003|Overall Study|No treated|3|||
33484525|NCT03739203|62861425|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
33484526|NCT03739203|62861426|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
33484527|NCT03739203|62861427|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
33484528|NCT03739203|62861425|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
33484529|NCT03739203|62861426|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33484530|NCT03739203|62861427|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
33484531|NCT03739203|62861425|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
33484532|NCT03739203|62861426|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
33484533|NCT03739203|62861427|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
33484534|NCT03739203|62861425|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
33367573|NCT03252587|62746442|FG003|Overall Study|Pregnancy|1|||
33367574|NCT03252587|62746439|FG000|Overall Study|Withdrawal by Subject|8|||
33367575|NCT03252587|62746440|FG001|Overall Study|Withdrawal by Subject|4|||
33367576|NCT03252587|62746441|FG002|Overall Study|Withdrawal by Subject|4|||
33367577|NCT03252587|62746442|FG003|Overall Study|Withdrawal by Subject|4|||
33367578|NCT03252587|62746439|FG000|Overall Study|Other Reasons|2|||
33367579|NCT03252587|62746440|FG001|Overall Study|Other Reasons|5|||
33367580|NCT03252587|62746441|FG002|Overall Study|Other Reasons|5|||
33367581|NCT03252587|62746442|FG003|Overall Study|Other Reasons|4|||
33367582|NCT00511147|62746455|FG000|Overall Study|Withdrawal by Subject|1|||
33367583|NCT00511147|62746455|FG000|Overall Study|Disease progression|5|||
33367584|NCT00511147|62746455|FG000|Overall Study|Required platelet transfusion|1|||
33367585|NCT00510835|62746462|FG000|Overall Study|Withdrawal by Subject|6|||
33367586|NCT00510835|62746463|FG001|Overall Study|Withdrawal by Subject|2|||
33367587|NCT00510835|62746464|FG002|Overall Study|Withdrawal by Subject|2|||
33367588|NCT00506077|62746474|FG000|Treatment Period 1|Adverse Event|2|||
33367589|NCT00506077|62746475|FG001|Treatment Period 1|Adverse Event|1|||
33367590|NCT00506077|62746474|FG000|Treatment Period 1|Lost to Follow-up|0|||
33367591|NCT00506077|62746475|FG001|Treatment Period 1|Lost to Follow-up|2|||
33367592|NCT00506077|62746474|FG000|Treatment Period 1|Withdrawal by Subject|2|||
33367593|NCT00506077|62746475|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33367594|NCT00506077|62746474|FG000|Treatment Period 2|Adverse Event|0|||
33367595|NCT00506077|62746475|FG001|Treatment Period 2|Adverse Event|1|||
33367596|NCT00506077|62746474|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33367597|NCT00506077|62746475|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33367598|NCT00505921|62746481|FG000|Overall Study|Ineligible|1|||
33367599|NCT00505921|62746481|FG000|Overall Study|Failed to Mobilize|8|||
33367600|NCT00596960|62746487|FG000|Overall Study|Death|1|||
33367601|NCT00596960|62746488|FG001|Overall Study|Death|2|||
33367602|NCT00596960|62746487|FG000|Overall Study|Lost to Follow-up|6|||
33367603|NCT00596960|62746488|FG001|Overall Study|Lost to Follow-up|5|||
33484535|NCT03739203|62861426|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
33367604|NCT00596960|62746487|FG000|Overall Study|Withdrawal by Subject|1|||
33367605|NCT00596960|62746488|FG001|Overall Study|Withdrawal by Subject|0|||
33484536|NCT03739203|62861427|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
33484537|NCT03739203|62861425|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
33555337|NCT02388724|62948128|FG000|Overall Study|Randomized but not Treated|0|||
33555338|NCT02388724|62948129|FG001|Overall Study|Randomized but not Treated|2|||
33555339|NCT02382796|62948135|FG000|Overall Study|Global deterioration of health status|1|||
33555340|NCT02382796|62948135|FG000|Overall Study|Objective progression or relapse|3|||
33555341|NCT02382796|62948135|FG000|Overall Study|Commercial dacomitinib became available|3|||
33555342|NCT02382640|62948143|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
33555343|NCT02382640|62948144|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
33555344|NCT02382640|62948145|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
33555345|NCT02382640|62948146|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
33555346|NCT02801669|62948158|FG000|Overall Study|Death|66|||
33555347|NCT02801669|62948159|FG001|Overall Study|Death|69|||
33555348|NCT02801669|62948158|FG000|Overall Study|Withdrawal by Subject|81|||
33555349|NCT02801669|62948159|FG001|Overall Study|Withdrawal by Subject|77|||
33555350|NCT02801669|62948158|FG000|Overall Study|Other|4|||
33555351|NCT02801669|62948159|FG001|Overall Study|Other|6|||
33555352|NCT02804399|62948165|FG000|Period 2|Adverse Event|0|||
33555353|NCT02804399|62948166|FG001|Period 2|Adverse Event|1|||
33555354|NCT01333943|62948177|FG000|Overall Study|Known neuropathy|1|||
33555355|NCT01333943|62948178|FG001|Overall Study|Known neuropathy|0|||
33555356|NCT01333865|62948184|FG000|Overall Study|Adverse Event|2|||
33555357|NCT01333475|62948190|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
33555358|NCT01333475|62948191|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
33555359|NCT01333475|62948190|FG000|Overall Study|Toxicity|1|||
33555360|NCT01333475|62948191|FG001|Overall Study|Toxicity|3|||
33555361|NCT01333397|62948203|FG000|Overall Study|Lost to Follow-up|1|||
33555362|NCT01333397|62948204|FG001|Overall Study|Lost to Follow-up|0|||
33555363|NCT01333397|62948205|FG002|Overall Study|Lost to Follow-up|0|||
33555364|NCT01333397|62948206|FG003|Overall Study|Lost to Follow-up|1|||
33555365|NCT01333397|62948207|FG004|Overall Study|Lost to Follow-up|0|||
33555366|NCT02798861|62948228|FG000|Overall Study|Lost to Follow-up|22|||
33555367|NCT02798861|62948228|FG000|Overall Study|Withdrawal by Subject|1|||
33555368|NCT02798315|62948232|FG000|Overall Study|Failure to return|1|||
33555369|NCT02796755|62948238|FG000|Overall Study|Adverse Event|2|||
33555370|NCT02796755|62948239|FG001|Overall Study|Adverse Event|0|||
33555371|NCT02382016|62948247|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
33555372|NCT02382016|62948248|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
33555373|NCT02382016|62948247|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
33555374|NCT02382016|62948248|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
33555375|NCT02382016|62948247|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
33555376|NCT02382016|62948248|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
33555377|NCT02382016|62948247|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
33555378|NCT02382016|62948248|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
33555379|NCT02382016|62948247|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
33555380|NCT02382016|62948248|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
33555381|NCT02382016|62948247|FG000|Open-label (OL) Treatment Period|Death|4|||
33555382|NCT02382016|62948248|FG001|Open-label (OL) Treatment Period|Death|0|||
33555383|NCT02382016|62948247|FG000|OL Extension Period|Physician Decision|3|||
33555384|NCT02382016|62948248|FG001|OL Extension Period|Physician Decision|0|||
33555385|NCT02382016|62948247|FG000|OL Extension Period|Death|2|||
33555386|NCT02382016|62948248|FG001|OL Extension Period|Death|0|||
33555387|NCT02382016|62948247|FG000|OL Extension Period|Withdrawal by Subject|1|||
33555388|NCT02382016|62948248|FG001|OL Extension Period|Withdrawal by Subject|0|||
33555389|NCT02422186|62948258|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
33555390|NCT02422186|62948259|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
33555391|NCT02422186|62948258|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
33367606|NCT00596960|62746487|FG000|Overall Study|Incarcerated|2|||
33367607|NCT00596960|62746488|FG001|Overall Study|Incarcerated|0|||
33367608|NCT00596960|62746487|FG000|Overall Study|Physician Decision|1|||
33367609|NCT00596960|62746488|FG001|Overall Study|Physician Decision|0|||
33367610|NCT00596960|62746487|FG000|Overall Study|Protocol Violation|0|||
33367611|NCT00596960|62746488|FG001|Overall Study|Protocol Violation|1|||
33367612|NCT00596960|62746487|FG000|Overall Study|No alcohol use data|0|||
33367613|NCT00596960|62746488|FG001|Overall Study|No alcohol use data|1|||
33484538|NCT03739203|62861426|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
33484539|NCT03739203|62861427|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
33484540|NCT03739203|62861425|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
33484541|NCT03739203|62861426|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
33484542|NCT03739203|62861427|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
33484543|NCT03739203|62861425|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
33484544|NCT03739203|62861426|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
33484545|NCT03739203|62861427|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
33555392|NCT02422186|62948259|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
33555393|NCT02422186|62948258|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
33555394|NCT02422186|62948259|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
33555395|NCT02422186|62948258|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
33555396|NCT02422186|62948259|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
33555397|NCT02422186|62948258|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
33555398|NCT02422186|62948259|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
33555399|NCT02422186|62948258|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
33555400|NCT02422186|62948259|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
33555401|NCT02422186|62948258|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
33555402|NCT02422186|62948259|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
33555403|NCT02422186|62948258|FG000|Follow-up Phase (2 Weeks)|Other|3|||
33555404|NCT02422186|62948259|FG001|Follow-up Phase (2 Weeks)|Other|0|||
33555405|NCT02421952|62948267|FG000|Overall Study|Diary Not Returned|93|||
33555406|NCT02421952|62948267|FG000|Overall Study|Failed seriation task|13|||
33555407|NCT02421952|62948267|FG000|Overall Study|Subject uncooperative for baseline test|2|||
33555408|NCT02421952|62948267|FG000|Overall Study|Surgery cancelled|1|||
33555409|NCT02796677|62948278|FG000|Overall Study|Adverse Event|11|||
33555410|NCT02796677|62948279|FG001|Overall Study|Adverse Event|22|||
33555411|NCT02796677|62948280|FG002|Overall Study|Adverse Event|14|||
33555412|NCT02796677|62948281|FG003|Overall Study|Adverse Event|14|||
33555413|NCT02796677|62948278|FG000|Overall Study|Protocol Violation|7|||
33555414|NCT02796677|62948279|FG001|Overall Study|Protocol Violation|5|||
33555415|NCT02796677|62948280|FG002|Overall Study|Protocol Violation|4|||
33555416|NCT02796677|62948281|FG003|Overall Study|Protocol Violation|8|||
33555417|NCT02796677|62948278|FG000|Overall Study|Lost to Follow-up|1|||
33555418|NCT02796677|62948279|FG001|Overall Study|Lost to Follow-up|5|||
33555419|NCT02796677|62948280|FG002|Overall Study|Lost to Follow-up|2|||
33555420|NCT02796677|62948281|FG003|Overall Study|Lost to Follow-up|2|||
33555421|NCT02796677|62948278|FG000|Overall Study|Lack of Efficacy|7|||
33555422|NCT02796677|62948279|FG001|Overall Study|Lack of Efficacy|9|||
33555423|NCT02796677|62948280|FG002|Overall Study|Lack of Efficacy|14|||
33555424|NCT02796677|62948281|FG003|Overall Study|Lack of Efficacy|20|||
33555425|NCT02796677|62948278|FG000|Overall Study|Withdrawal by Subject|4|||
33555426|NCT02796677|62948279|FG001|Overall Study|Withdrawal by Subject|14|||
33555427|NCT02796677|62948280|FG002|Overall Study|Withdrawal by Subject|6|||
33555428|NCT02796677|62948281|FG003|Overall Study|Withdrawal by Subject|7|||
33555429|NCT02796677|62948278|FG000|Overall Study|Progressive disease|6|||
33555430|NCT02796677|62948279|FG001|Overall Study|Progressive disease|15|||
33555431|NCT02796677|62948280|FG002|Overall Study|Progressive disease|13|||
33555432|NCT02796677|62948281|FG003|Overall Study|Progressive disease|18|||
33555433|NCT02796677|62948278|FG000|Overall Study|Reason not mentioned|2|||
33555434|NCT02796677|62948279|FG001|Overall Study|Reason not mentioned|3|||
33555435|NCT02796677|62948280|FG002|Overall Study|Reason not mentioned|0|||
33555436|NCT02796677|62948281|FG003|Overall Study|Reason not mentioned|5|||
33555437|NCT02421172|62948295|FG000|Period 1|Adverse Event|1|||
33555438|NCT02421172|62948296|FG001|Period 1|Adverse Event|0|||
33555439|NCT02421172|62948297|FG002|Period 1|Adverse Event|0|||
33555440|NCT02421172|62948298|FG003|Period 1|Adverse Event|0|||
33555441|NCT02421172|62948299|FG004|Period 1|Adverse Event|0|||
33555442|NCT02421172|62948295|FG000|Period 1|Lost to Follow-up|3|||
33555443|NCT02421172|62948296|FG001|Period 1|Lost to Follow-up|1|||
33555444|NCT02421172|62948297|FG002|Period 1|Lost to Follow-up|0|||
33555445|NCT02421172|62948298|FG003|Period 1|Lost to Follow-up|0|||
33555446|NCT02421172|62948299|FG004|Period 1|Lost to Follow-up|0|||
33367614|NCT00505765|62746497|FG000|Overall Study|Withdrawal by Subject|1|||
33367615|NCT00505765|62746498|FG001|Overall Study|Withdrawal by Subject|0|||
33367616|NCT00505765|62746499|FG002|Overall Study|Withdrawal by Subject|0|||
33367617|NCT00505765|62746497|FG000|Overall Study|Adverse Event|1|||
33367618|NCT00505765|62746498|FG001|Overall Study|Adverse Event|2|||
33367619|NCT00505765|62746499|FG002|Overall Study|Adverse Event|0|||
33367620|NCT00505765|62746497|FG000|Overall Study|Noncompliance|0|||
33367621|NCT00505765|62746498|FG001|Overall Study|Noncompliance|1|||
33367622|NCT00505765|62746499|FG002|Overall Study|Noncompliance|3|||
33367623|NCT00505687|62746507|FG000|Overall Study|Important protocol violation|2|||
33555447|NCT02421172|62948295|FG000|Period 1|Patient/guardian decision|0|||
33555448|NCT02421172|62948296|FG001|Period 1|Patient/guardian decision|1|||
33555449|NCT02421172|62948297|FG002|Period 1|Patient/guardian decision|0|||
33555450|NCT02421172|62948298|FG003|Period 1|Patient/guardian decision|0|||
33555451|NCT02421172|62948299|FG004|Period 1|Patient/guardian decision|0|||
33555452|NCT02421172|62948295|FG000|Period 2|Adverse Event|0|||
33555453|NCT02421172|62948296|FG001|Period 2|Adverse Event|0|||
33367624|NCT00505687|62746507|FG000|Overall Study|Lack of Efficacy|15|||
33555454|NCT02421172|62948297|FG002|Period 2|Adverse Event|4|||
33555455|NCT02421172|62948298|FG003|Period 2|Adverse Event|0|||
33555456|NCT02421172|62948299|FG004|Period 2|Adverse Event|0|||
33555457|NCT02421172|62948295|FG000|Period 2|Lost to Follow-up|0|||
33555458|NCT02421172|62948296|FG001|Period 2|Lost to Follow-up|0|||
33555459|NCT02421172|62948297|FG002|Period 2|Lost to Follow-up|0|||
33367625|NCT00505687|62746507|FG000|Overall Study|Adverse Event|48|||
33555460|NCT02421172|62948298|FG003|Period 2|Lost to Follow-up|1|||
33555461|NCT02421172|62948299|FG004|Period 2|Lost to Follow-up|0|||
33555462|NCT02421172|62948295|FG000|Period 2|Patient/guardian decision|0|||
33555463|NCT02421172|62948296|FG001|Period 2|Patient/guardian decision|0|||
33555464|NCT02421172|62948297|FG002|Period 2|Patient/guardian decision|3|||
33661767|NCT01587989|63091417|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
33661768|NCT01587989|63091418|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
33555465|NCT02421172|62948298|FG003|Period 2|Patient/guardian decision|2|||
33484546|NCT03739203|62861425|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
33484547|NCT03739203|62861426|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
33484548|NCT03739203|62861427|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
33484549|NCT03739203|62861425|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
33484550|NCT03739203|62861426|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
33484551|NCT03739203|62861427|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
33661769|NCT01587989|63091419|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
33484552|NCT03739203|62861425|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
33661770|NCT01587989|63091417|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
33661771|NCT01587989|63091418|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
33484553|NCT03739203|62861426|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
33484554|NCT03739203|62861427|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
33484555|NCT03739203|62861425|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
33484556|NCT03739203|62861426|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
33484557|NCT03739203|62861427|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
33367626|NCT00505687|62746507|FG000|Overall Study|Subject withdrew consent|15|||
33367627|NCT00505687|62746507|FG000|Overall Study|Lost to Follow-up|1|||
33367628|NCT00505687|62746507|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
33367629|NCT00505687|62746507|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
33367630|NCT00505687|62746507|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
33367631|NCT00505687|62746507|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
33367632|NCT00505687|62746507|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
33367633|NCT00505687|62746507|FG000|Overall Study|Other: Disease Progression|1|||
33367634|NCT00505687|62746507|FG000|Overall Study|Other: As Per Sponsor|8|||
33367635|NCT00505375|62746513|FG000|Overall Study|Death|1|||
33367636|NCT00505375|62746514|FG001|Overall Study|Death|0|||
33367637|NCT00505375|62746513|FG000|Overall Study|Withdrawal by Subject|2|||
33367638|NCT00505375|62746514|FG001|Overall Study|Withdrawal by Subject|2|||
33367639|NCT00505375|62746513|FG000|Overall Study|Lost to Follow-up|0|||
33367640|NCT00505375|62746514|FG001|Overall Study|Lost to Follow-up|2|||
33367641|NCT00505375|62746513|FG000|Overall Study|Pregnancy|1|||
33367642|NCT00505375|62746514|FG001|Overall Study|Pregnancy|0|||
33367643|NCT00505375|62746513|FG000|Overall Study|Travel issues|0|||
33367644|NCT00505375|62746514|FG001|Overall Study|Travel issues|1|||
33367645|NCT00594932|62746522|FG000|First 3 Months|Withdrawal by Subject|1|||
33367646|NCT00594932|62746523|FG001|First 3 Months|Withdrawal by Subject|3|||
33367647|NCT00594932|62746522|FG000|Final 3 Months|Withdrawal by Subject|4|||
33367648|NCT00594932|62746523|FG001|Final 3 Months|Withdrawal by Subject|3|||
33367649|NCT00504829|62746532|FG000|Overall Study|Protocol Violation|6|||
33367650|NCT00504829|62746533|FG001|Overall Study|Protocol Violation|4|||
33367651|NCT00504829|62746534|FG002|Overall Study|Protocol Violation|10|||
33367652|NCT00504595|62746546|FG000|Overall Study|Lack of Efficacy|1|||
33367653|NCT00504595|62746547|FG001|Overall Study|Lack of Efficacy|0|||
33367654|NCT00504595|62746548|FG002|Overall Study|Lack of Efficacy|0|||
33367655|NCT00504595|62746549|FG003|Overall Study|Lack of Efficacy|0|||
33367656|NCT00504595|62746546|FG000|Overall Study|Other|0|||
33367657|NCT00504595|62746547|FG001|Overall Study|Other|0|||
33367658|NCT00504595|62746548|FG002|Overall Study|Other|2|||
33367659|NCT00504595|62746549|FG003|Overall Study|Other|0|||
33367660|NCT00513409|62746561|FG000|Overall Study|Adverse Event|0|||
33367661|NCT00513409|62746562|FG001|Overall Study|Adverse Event|1|||
33367662|NCT00513409|62746561|FG000|Overall Study|Withdrawal by Subject|0|||
33367663|NCT00513409|62746562|FG001|Overall Study|Withdrawal by Subject|2|||
33367664|NCT00513409|62746561|FG000|Overall Study|Lost to Follow-up|0|||
33367665|NCT00513409|62746562|FG001|Overall Study|Lost to Follow-up|1|||
33367666|NCT00513409|62746561|FG000|Overall Study|Physician Decision|1|||
33367667|NCT00513409|62746562|FG001|Overall Study|Physician Decision|0|||
33367668|NCT00513409|62746561|FG000|Overall Study|Visit 3 not done|1|||
33367669|NCT00513409|62746562|FG001|Overall Study|Visit 3 not done|2|||
33367670|NCT03150095|62746570|FG000|Overall Study|Death|0|||
33367671|NCT03150095|62746571|FG001|Overall Study|Death|1|||
33367672|NCT03150095|62746570|FG000|Overall Study|Lost to Follow-up|1|||
33367673|NCT03150095|62746571|FG001|Overall Study|Lost to Follow-up|1|||
33367674|NCT03150095|62746570|FG000|Overall Study|Withdrawal by Subject|4|||
33367675|NCT03150095|62746571|FG001|Overall Study|Withdrawal by Subject|0|||
33367676|NCT03150095|62746570|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
33367677|NCT03150095|62746571|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
33367678|NCT00705016|62746580|FG000|Overall Study|Adverse Event|6|||
33367679|NCT00705016|62746581|FG001|Overall Study|Adverse Event|11|||
33367680|NCT00705016|62746582|FG002|Overall Study|Adverse Event|10|||
33367681|NCT00705016|62746580|FG000|Overall Study|Death|5|||
33367682|NCT00705016|62746581|FG001|Overall Study|Death|7|||
33367683|NCT00705016|62746582|FG002|Overall Study|Death|5|||
33367684|NCT00705016|62746580|FG000|Overall Study|Protocol Violation|0|||
33367685|NCT00705016|62746581|FG001|Overall Study|Protocol Violation|1|||
33367686|NCT00705016|62746582|FG002|Overall Study|Protocol Violation|1|||
33367687|NCT00705016|62746580|FG000|Overall Study|Withdrawal by Subject|4|||
33367688|NCT00705016|62746581|FG001|Overall Study|Withdrawal by Subject|3|||
33367689|NCT00705016|62746582|FG002|Overall Study|Withdrawal by Subject|2|||
33367690|NCT00705016|62746580|FG000|Overall Study|Progressive Disease|33|||
33367691|NCT00705016|62746581|FG001|Overall Study|Progressive Disease|29|||
33661772|NCT01587989|63091419|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
33367692|NCT00705016|62746582|FG002|Overall Study|Progressive Disease|33|||
33367693|NCT00705016|62746580|FG000|Overall Study|Symptomatic Deterioration|3|||
33484558|NCT02942264|62861444|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
33367694|NCT00705016|62746581|FG001|Overall Study|Symptomatic Deterioration|1|||
33367695|NCT00705016|62746582|FG002|Overall Study|Symptomatic Deterioration|1|||
33367696|NCT00705016|62746580|FG000|Overall Study|Other|9|||
33367697|NCT00705016|62746581|FG001|Overall Study|Other|6|||
33367698|NCT00705016|62746582|FG002|Overall Study|Other|6|||
33367699|NCT00595868|62746592|FG000|Overall Study|Lost to Follow-up|45|||
33367700|NCT00595868|62746593|FG001|Overall Study|Lost to Follow-up|50|||
33661773|NCT01587989|63091417|FG000|Randomized Study Treatment|Screening failure|0|||
33661774|NCT01587989|63091418|FG001|Randomized Study Treatment|Screening failure|1|||
33661775|NCT01587989|63091419|FG002|Randomized Study Treatment|Screening failure|0|||
33661776|NCT01587989|63091417|FG000|Randomized Study Treatment|Physician Decision|0|||
33661777|NCT01587989|63091418|FG001|Randomized Study Treatment|Physician Decision|0|||
33661778|NCT01587989|63091419|FG002|Randomized Study Treatment|Physician Decision|1|||
33661779|NCT01697969|63091425|FG000|Overall Study|Did not meet inc/exc criteria|3|||
33661780|NCT01586819|63091432|FG000|Overall Study|Withdrawal by Subject|1|||
33555466|NCT02421172|62948299|FG004|Period 2|Patient/guardian decision|1|||
33555467|NCT02379052|62948312|FG000|Overall Study|Protocol Violation|0|||
33555468|NCT02379052|62948313|FG001|Overall Study|Protocol Violation|1|||
33367701|NCT00856284|62746623|FG000|Overall Study|Hyperglycemic rescue|231|||
33367702|NCT00856284|62746624|FG001|Overall Study|Hyperglycemic rescue|201|||
33367703|NCT00856284|62746625|FG002|Overall Study|Hyperglycemic rescue|235|||
33367704|NCT00856284|62746623|FG000|Overall Study|Adverse Event|60|||
33367705|NCT00856284|62746624|FG001|Overall Study|Adverse Event|74|||
33367706|NCT00856284|62746625|FG002|Overall Study|Adverse Event|82|||
33367707|NCT00856284|62746623|FG000|Overall Study|Major protocol deviation|24|||
33367708|NCT00856284|62746624|FG001|Overall Study|Major protocol deviation|16|||
33367709|NCT00856284|62746625|FG002|Overall Study|Major protocol deviation|15|||
33367710|NCT00856284|62746623|FG000|Overall Study|Lost to Follow-up|20|||
33367711|NCT00856284|62746624|FG001|Overall Study|Lost to Follow-up|22|||
33367712|NCT00856284|62746625|FG002|Overall Study|Lost to Follow-up|28|||
33367713|NCT00856284|62746623|FG000|Overall Study|Voluntary withdrawal|48|||
33367714|NCT00856284|62746624|FG001|Overall Study|Voluntary withdrawal|52|||
33367715|NCT00856284|62746625|FG002|Overall Study|Voluntary withdrawal|62|||
33367716|NCT00856284|62746623|FG000|Overall Study|Pregnancy|1|||
33367717|NCT00856284|62746624|FG001|Overall Study|Pregnancy|2|||
33367718|NCT00856284|62746625|FG002|Overall Study|Pregnancy|0|||
33367719|NCT00856284|62746623|FG000|Overall Study|Investigator discretion|9|||
33367720|NCT00856284|62746624|FG001|Overall Study|Investigator discretion|8|||
33367721|NCT00856284|62746625|FG002|Overall Study|Investigator discretion|10|||
33367722|NCT00856284|62746623|FG000|Overall Study|Other|15|||
33367723|NCT00856284|62746624|FG001|Overall Study|Other|17|||
33367724|NCT00856284|62746625|FG002|Overall Study|Other|14|||
33367725|NCT00856284|62746623|FG000|Overall Study|Randomized in error|0|||
33367726|NCT00856284|62746624|FG001|Overall Study|Randomized in error|0|||
33367727|NCT00856284|62746625|FG002|Overall Study|Randomized in error|1|||
33367728|NCT00510289|62746633|FG000|Overall Study|Withdrawal by Subject|7|||
33367729|NCT00510289|62746633|FG000|Overall Study|Refused bone marrow biopsy|2|||
33367730|NCT00510289|62746633|FG000|Overall Study|Lost to Follow-up|1|||
33367731|NCT00510289|62746633|FG000|Overall Study|Progressed prior to starting drug|2|||
33367732|NCT00492115|62746640|FG000|Overall Study|Withdrawal by Subject|3|||
33367733|NCT00492115|62746641|FG001|Overall Study|Withdrawal by Subject|4|||
33367734|NCT00856206|62746649|FG000|Overall Study|Protocol Violation|6|||
33367735|NCT00856206|62746650|FG001|Overall Study|Protocol Violation|18|||
33367736|NCT00856206|62746649|FG000|Overall Study|Adverse Event|10|||
33367737|NCT00856206|62746650|FG001|Overall Study|Adverse Event|46|||
33367738|NCT00856206|62746649|FG000|Overall Study|Lack of Efficacy|1|||
33367739|NCT00856206|62746650|FG001|Overall Study|Lack of Efficacy|2|||
33367740|NCT00856206|62746649|FG000|Overall Study|Withdrawal by Subject|15|||
33367741|NCT00856206|62746650|FG001|Overall Study|Withdrawal by Subject|36|||
33367742|NCT00856206|62746649|FG000|Overall Study|Lost to Follow-up|13|||
33367743|NCT00856206|62746650|FG001|Overall Study|Lost to Follow-up|39|||
33367744|NCT00856206|62746649|FG000|Overall Study|Death|2|||
33367745|NCT00856206|62746650|FG001|Overall Study|Death|2|||
33367746|NCT00856206|62746649|FG000|Overall Study|Decision by the Sponsor|4|||
33367747|NCT00856206|62746650|FG001|Overall Study|Decision by the Sponsor|8|||
33367748|NCT00856206|62746649|FG000|Overall Study|Other than specified above|3|||
33367749|NCT00856206|62746650|FG001|Overall Study|Other than specified above|10|||
33367750|NCT00593112|62746658|FG000|Overall Study|Scan Anxiety|3|||
33367751|NCT00593112|62746659|FG001|Overall Study|Scan Anxiety|0|||
33367752|NCT00593112|62746658|FG000|Overall Study|Abnormal Scan|1|||
33367753|NCT00593112|62746659|FG001|Overall Study|Abnormal Scan|0|||
33367754|NCT00593112|62746658|FG000|Overall Study|Unreadable Scan|1|||
33262665|NCT04521114|62633350|FG000|Overall Study|Lost to Follow-up|1|||
33262666|NCT04521114|62633351|FG001|Overall Study|Lost to Follow-up|2|||
33262667|NCT04521114|62633352|FG002|Overall Study|Lost to Follow-up|0|||
33262668|NCT04521114|62633350|FG000|Overall Study|Withdrawal by Subject|1|||
33262669|NCT04521114|62633351|FG001|Overall Study|Withdrawal by Subject|2|||
33262670|NCT04521114|62633352|FG002|Overall Study|Withdrawal by Subject|2|||
33262671|NCT04521114|62633350|FG000|Overall Study|Adverse Event|1|||
33262672|NCT04521114|62633351|FG001|Overall Study|Adverse Event|0|||
33262673|NCT04521114|62633352|FG002|Overall Study|Adverse Event|0|||
33262674|NCT04521114|62633350|FG000|Overall Study|Sponsor Wish|1|||
33262675|NCT04521114|62633351|FG001|Overall Study|Sponsor Wish|0|||
33262676|NCT04521114|62633352|FG002|Overall Study|Sponsor Wish|0|||
33262677|NCT04521114|62633350|FG000|Overall Study|Withdrawal of Consent|2|||
33262678|NCT04521114|62633351|FG001|Overall Study|Withdrawal of Consent|2|||
33262679|NCT04521114|62633352|FG002|Overall Study|Withdrawal of Consent|0|||
33262680|NCT04360824|62633374|FG000|Overall Study|Withdrawal by Subject|2|||
33262681|NCT04360824|62633375|FG001|Overall Study|Withdrawal by Subject|1|||
33262682|NCT04360824|62633374|FG000|Overall Study|Did not receive assigned treatment|1|||
33262683|NCT04360824|62633375|FG001|Overall Study|Did not receive assigned treatment|3|||
33262684|NCT03711786|62633384|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
33262685|NCT03711786|62633385|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
33262686|NCT03711786|62633384|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
33262687|NCT03711786|62633385|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
33262688|NCT03711786|62633384|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
33262689|NCT03711786|62633385|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
33262690|NCT03711786|62633384|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
33262691|NCT03711786|62633385|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
33262692|NCT03711786|62633384|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
33262693|NCT03711786|62633385|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
33262694|NCT03711786|62633384|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
33262695|NCT03711786|62633385|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
33262696|NCT03691974|62633395|FG000|Overall Study|Physician Decision|1|||
33262697|NCT03691974|62633396|FG001|Overall Study|Physician Decision|0|||
33262698|NCT03691974|62633395|FG000|Overall Study|Adverse Event|1|||
33262699|NCT03691974|62633396|FG001|Overall Study|Adverse Event|0|||
33262700|NCT03691974|62633395|FG000|Overall Study|Withdrawal by Subject|11|||
33262701|NCT03691974|62633396|FG001|Overall Study|Withdrawal by Subject|9|||
33262702|NCT03691974|62633395|FG000|Overall Study|Protocol Violation|1|||
33262703|NCT03691974|62633396|FG001|Overall Study|Protocol Violation|0|||
33262704|NCT03691974|62633395|FG000|Overall Study|Lost to Follow-up|8|||
33262705|NCT03691974|62633396|FG001|Overall Study|Lost to Follow-up|7|||
33262706|NCT03525678|62633417|FG000|Overall Study|Ongoing at the time of interim analysis|60|||
33262707|NCT03525678|62633418|FG001|Overall Study|Ongoing at the time of interim analysis|65|||
33262708|NCT03525678|62633419|FG002|Overall Study|Ongoing at the time of interim analysis|21|||
33262709|NCT03525678|62633417|FG000|Overall Study|Withdrawal by Subject|3|||
33262710|NCT03525678|62633418|FG001|Overall Study|Withdrawal by Subject|1|||
33262711|NCT03525678|62633419|FG002|Overall Study|Withdrawal by Subject|0|||
33262712|NCT03525678|62633417|FG000|Overall Study|Physician Decision|1|||
33262713|NCT03525678|62633418|FG001|Overall Study|Physician Decision|2|||
33262714|NCT03525678|62633419|FG002|Overall Study|Physician Decision|0|||
33262715|NCT03525678|62633417|FG000|Overall Study|Lost to Follow-up|1|||
33262716|NCT03525678|62633418|FG001|Overall Study|Lost to Follow-up|0|||
33262717|NCT03525678|62633419|FG002|Overall Study|Lost to Follow-up|0|||
33262718|NCT03525678|62633417|FG000|Overall Study|Death|32|||
33262719|NCT03525678|62633418|FG001|Overall Study|Death|31|||
33262720|NCT03525678|62633419|FG002|Overall Study|Death|4|||
33262721|NCT02454972|62633436|FG000|Overall Study|Progressive disease|17|||
33262722|NCT02454972|62633437|FG001|Overall Study|Progressive disease|16|||
33262723|NCT02454972|62633438|FG002|Overall Study|Progressive disease|59|||
33262724|NCT02454972|62633439|FG003|Overall Study|Progressive disease|23|||
33262725|NCT02454972|62633440|FG004|Overall Study|Progressive disease|16|||
33262726|NCT02454972|62633441|FG005|Overall Study|Progressive disease|12|||
33262727|NCT02454972|62633442|FG006|Overall Study|Progressive disease|19|||
33262728|NCT02454972|62633443|FG007|Overall Study|Progressive disease|27|||
33262729|NCT02454972|62633444|FG008|Overall Study|Progressive disease|0|||
33262730|NCT02454972|62633436|FG000|Overall Study|Death|0|||
33262731|NCT02454972|62633437|FG001|Overall Study|Death|0|||
33262732|NCT02454972|62633438|FG002|Overall Study|Death|5|||
33262733|NCT02454972|62633439|FG003|Overall Study|Death|1|||
33262734|NCT02454972|62633440|FG004|Overall Study|Death|0|||
33262735|NCT02454972|62633441|FG005|Overall Study|Death|0|||
33262736|NCT02454972|62633442|FG006|Overall Study|Death|0|||
33262737|NCT02454972|62633443|FG007|Overall Study|Death|0|||
33262738|NCT02454972|62633444|FG008|Overall Study|Death|95|||
33262739|NCT02454972|62633436|FG000|Overall Study|Physician Decision|0|||
33262740|NCT02454972|62633437|FG001|Overall Study|Physician Decision|1|||
33262741|NCT02454972|62633438|FG002|Overall Study|Physician Decision|2|||
33262742|NCT02454972|62633439|FG003|Overall Study|Physician Decision|1|||
33262743|NCT02454972|62633440|FG004|Overall Study|Physician Decision|2|||
33262744|NCT02454972|62633441|FG005|Overall Study|Physician Decision|0|||
33262745|NCT02454972|62633442|FG006|Overall Study|Physician Decision|0|||
33262746|NCT02454972|62633443|FG007|Overall Study|Physician Decision|1|||
33262747|NCT02454972|62633444|FG008|Overall Study|Physician Decision|0|||
33262748|NCT02454972|62633436|FG000|Overall Study|Non treatment-related adverse event|2|||
33262749|NCT02454972|62633437|FG001|Overall Study|Non treatment-related adverse event|0|||
33262750|NCT02454972|62633438|FG002|Overall Study|Non treatment-related adverse event|1|||
33262751|NCT02454972|62633439|FG003|Overall Study|Non treatment-related adverse event|0|||
33262752|NCT02454972|62633440|FG004|Overall Study|Non treatment-related adverse event|0|||
33262753|NCT02454972|62633441|FG005|Overall Study|Non treatment-related adverse event|1|||
33262754|NCT02454972|62633442|FG006|Overall Study|Non treatment-related adverse event|0|||
33262755|NCT02454972|62633443|FG007|Overall Study|Non treatment-related adverse event|1|||
33262756|NCT02454972|62633444|FG008|Overall Study|Non treatment-related adverse event|0|||
33262757|NCT02454972|62633436|FG000|Overall Study|Treatment-related adverse events|0|||
33262758|NCT02454972|62633437|FG001|Overall Study|Treatment-related adverse events|1|||
33262759|NCT02454972|62633438|FG002|Overall Study|Treatment-related adverse events|1|||
33262760|NCT02454972|62633439|FG003|Overall Study|Treatment-related adverse events|0|||
33262761|NCT02454972|62633440|FG004|Overall Study|Treatment-related adverse events|2|||
33262762|NCT02454972|62633441|FG005|Overall Study|Treatment-related adverse events|0|||
33262763|NCT02454972|62633442|FG006|Overall Study|Treatment-related adverse events|0|||
33262764|NCT02454972|62633443|FG007|Overall Study|Treatment-related adverse events|2|||
33262765|NCT02454972|62633444|FG008|Overall Study|Treatment-related adverse events|0|||
33262766|NCT02454972|62633436|FG000|Overall Study|Patient moves to compassionate use|0|||
33262767|NCT02454972|62633437|FG001|Overall Study|Patient moves to compassionate use|0|||
33262768|NCT02454972|62633438|FG002|Overall Study|Patient moves to compassionate use|0|||
33262769|NCT02454972|62633439|FG003|Overall Study|Patient moves to compassionate use|0|||
33484559|NCT02942264|62861445|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
33262770|NCT02454972|62633440|FG004|Overall Study|Patient moves to compassionate use|0|||
33262771|NCT02454972|62633441|FG005|Overall Study|Patient moves to compassionate use|0|||
33262772|NCT02454972|62633442|FG006|Overall Study|Patient moves to compassionate use|2|||
33555469|NCT02379052|62948312|FG000|Overall Study|Adverse Event|0|||
33262773|NCT02454972|62633443|FG007|Overall Study|Patient moves to compassionate use|0|||
33262774|NCT02454972|62633444|FG008|Overall Study|Patient moves to compassionate use|0|||
33262775|NCT02454972|62633436|FG000|Overall Study|Withdrawal by Subject|0|||
33262776|NCT02454972|62633437|FG001|Overall Study|Withdrawal by Subject|1|||
33262777|NCT02454972|62633438|FG002|Overall Study|Withdrawal by Subject|5|||
33262778|NCT02454972|62633439|FG003|Overall Study|Withdrawal by Subject|2|||
33262779|NCT02454972|62633440|FG004|Overall Study|Withdrawal by Subject|3|||
33262780|NCT02454972|62633441|FG005|Overall Study|Withdrawal by Subject|2|||
33262781|NCT02454972|62633442|FG006|Overall Study|Withdrawal by Subject|0|||
33262782|NCT02454972|62633443|FG007|Overall Study|Withdrawal by Subject|1|||
33262783|NCT02454972|62633444|FG008|Overall Study|Withdrawal by Subject|2|||
33262784|NCT02454972|62633436|FG000|Overall Study|Multiple delay/holds on treatment|0|||
33262785|NCT02454972|62633437|FG001|Overall Study|Multiple delay/holds on treatment|0|||
33262786|NCT02454972|62633438|FG002|Overall Study|Multiple delay/holds on treatment|0|||
33262787|NCT02454972|62633439|FG003|Overall Study|Multiple delay/holds on treatment|1|||
33262788|NCT02454972|62633440|FG004|Overall Study|Multiple delay/holds on treatment|0|||
33262789|NCT02454972|62633441|FG005|Overall Study|Multiple delay/holds on treatment|0|||
33262790|NCT02454972|62633442|FG006|Overall Study|Multiple delay/holds on treatment|0|||
33262791|NCT02454972|62633443|FG007|Overall Study|Multiple delay/holds on treatment|0|||
33262792|NCT02454972|62633444|FG008|Overall Study|Multiple delay/holds on treatment|0|||
33262793|NCT02454972|62633436|FG000|Overall Study|Never treated|0|||
33262794|NCT02454972|62633437|FG001|Overall Study|Never treated|0|||
33262795|NCT02454972|62633438|FG002|Overall Study|Never treated|3|||
33262796|NCT02454972|62633439|FG003|Overall Study|Never treated|1|||
33262797|NCT02454972|62633440|FG004|Overall Study|Never treated|1|||
33262798|NCT02454972|62633441|FG005|Overall Study|Never treated|0|||
33262799|NCT02454972|62633442|FG006|Overall Study|Never treated|0|||
33262800|NCT02454972|62633443|FG007|Overall Study|Never treated|0|||
33262801|NCT02454972|62633444|FG008|Overall Study|Never treated|5|||
33262802|NCT02454972|62633436|FG000|Overall Study|Lost to Follow-up|0|||
33262803|NCT02454972|62633437|FG001|Overall Study|Lost to Follow-up|0|||
33262804|NCT02454972|62633438|FG002|Overall Study|Lost to Follow-up|0|||
33262805|NCT02454972|62633439|FG003|Overall Study|Lost to Follow-up|0|||
33262806|NCT02454972|62633440|FG004|Overall Study|Lost to Follow-up|0|||
33262807|NCT02454972|62633441|FG005|Overall Study|Lost to Follow-up|0|||
33262808|NCT02454972|62633442|FG006|Overall Study|Lost to Follow-up|0|||
33262809|NCT02454972|62633443|FG007|Overall Study|Lost to Follow-up|0|||
33262810|NCT02454972|62633444|FG008|Overall Study|Lost to Follow-up|2|||
33262811|NCT02454972|62633436|FG000|Overall Study|Study termination|0|||
33262812|NCT02454972|62633437|FG001|Overall Study|Study termination|0|||
33262813|NCT02454972|62633438|FG002|Overall Study|Study termination|0|||
33262814|NCT02454972|62633439|FG003|Overall Study|Study termination|0|||
33262815|NCT02454972|62633440|FG004|Overall Study|Study termination|0|||
33262816|NCT02454972|62633441|FG005|Overall Study|Study termination|0|||
33262817|NCT02454972|62633442|FG006|Overall Study|Study termination|0|||
33262818|NCT02454972|62633443|FG007|Overall Study|Study termination|0|||
33262819|NCT02454972|62633444|FG008|Overall Study|Study termination|6|||
33262820|NCT01096368|62633461|FG000|Overall Study|Death|0|||
33262821|NCT01096368|62633462|FG001|Overall Study|Death|1|||
33262822|NCT01096368|62633463|FG002|Overall Study|Death|0|||
33262823|NCT01096368|62633464|FG003|Overall Study|Death|0|||
33262824|NCT01096368|62633465|FG004|Overall Study|Death|0|||
33262825|NCT01096368|62633461|FG000|Overall Study|Physician Decision|0|||
33262826|NCT01096368|62633462|FG001|Overall Study|Physician Decision|13|||
33262827|NCT01096368|62633463|FG002|Overall Study|Physician Decision|2|||
33262828|NCT01096368|62633464|FG003|Overall Study|Physician Decision|4|||
33262829|NCT01096368|62633465|FG004|Overall Study|Physician Decision|6|||
33262830|NCT01096368|62633461|FG000|Overall Study|Withdrawal by Subject|0|||
33262831|NCT01096368|62633462|FG001|Overall Study|Withdrawal by Subject|52|||
33661781|NCT01586819|63091433|FG001|Overall Study|Withdrawal by Subject|0|||
33661782|NCT01697579|63091444|FG000|Base Study-Cycle 1|Adverse Event|1|||
33661783|NCT01697579|63091445|FG001|Base Study-Cycle 1|Adverse Event|0|||
33661784|NCT01697579|63091446|FG002|Base Study-Cycle 1|Adverse Event|0|||
33661785|NCT01697579|63091447|FG003|Base Study-Cycle 1|Adverse Event|0|||
33661786|NCT01697579|63091448|FG004|Base Study-Cycle 1|Adverse Event|0|||
33262832|NCT01096368|62633463|FG002|Overall Study|Withdrawal by Subject|0|||
33262833|NCT01096368|62633464|FG003|Overall Study|Withdrawal by Subject|10|||
33262834|NCT01096368|62633465|FG004|Overall Study|Withdrawal by Subject|14|||
33262835|NCT01096368|62633461|FG000|Overall Study|Ineligible|0|||
33262836|NCT01096368|62633462|FG001|Overall Study|Ineligible|3|||
33262837|NCT01096368|62633463|FG002|Overall Study|Ineligible|2|||
33262838|NCT01096368|62633464|FG003|Overall Study|Ineligible|0|||
33262839|NCT01096368|62633465|FG004|Overall Study|Ineligible|25|||
33262840|NCT01096368|62633461|FG000|Overall Study|Did not start treatment|0|||
33262841|NCT01096368|62633462|FG001|Overall Study|Did not start treatment|4|||
33262842|NCT01096368|62633463|FG002|Overall Study|Did not start treatment|4|||
33262843|NCT01096368|62633464|FG003|Overall Study|Did not start treatment|0|||
33262844|NCT01096368|62633465|FG004|Overall Study|Did not start treatment|0|||
33262845|NCT01096368|62633461|FG000|Overall Study|Progressive disease|0|||
33661787|NCT01697579|63091449|FG005|Base Study-Cycle 1|Adverse Event|0|||
33262846|NCT01096368|62633462|FG001|Overall Study|Progressive disease|6|||
33262847|NCT01096368|62633463|FG002|Overall Study|Progressive disease|0|||
33262848|NCT01096368|62633464|FG003|Overall Study|Progressive disease|10|||
33262849|NCT01096368|62633465|FG004|Overall Study|Progressive disease|3|||
33262850|NCT01096368|62633461|FG000|Overall Study|Other|0|||
33262851|NCT01096368|62633462|FG001|Overall Study|Other|0|||
33262852|NCT01096368|62633463|FG002|Overall Study|Other|1|||
33262853|NCT01096368|62633464|FG003|Overall Study|Other|0|||
33262854|NCT01096368|62633465|FG004|Overall Study|Other|0|||
33262855|NCT01096368|62633461|FG000|Overall Study|Treated with institutional review|0|||
33262856|NCT01096368|62633462|FG001|Overall Study|Treated with institutional review|0|||
33262857|NCT01096368|62633463|FG002|Overall Study|Treated with institutional review|0|||
33262858|NCT01096368|62633464|FG003|Overall Study|Treated with institutional review|0|||
33262859|NCT01096368|62633465|FG004|Overall Study|Treated with institutional review|1|||
33262860|NCT00063882|62633486|FG000|Overall Study|Protocol Violation|3|||
33262861|NCT00063882|62633487|FG001|Overall Study|Protocol Violation|3|||
33262862|NCT00063882|62633486|FG000|Overall Study|Withdrawal by Subject|2|||
33262863|NCT00063882|62633487|FG001|Overall Study|Withdrawal by Subject|1|||
33262864|NCT01279044|62633496|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
33262865|NCT01279044|62633497|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
33262866|NCT01279044|62633498|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
33262867|NCT01279044|62633496|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
33262868|NCT01279044|62633497|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
33262869|NCT01279044|62633498|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
33262870|NCT01279044|62633496|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
33262871|NCT01279044|62633497|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
33262872|NCT01279044|62633498|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
33262873|NCT01278342|62633507|FG000|Overall Study|Physician Decision|0|||
33262874|NCT01278342|62633508|FG001|Overall Study|Physician Decision|1|||
33262875|NCT01278342|62633509|FG002|Overall Study|Physician Decision|0|||
33262876|NCT01278342|62633507|FG000|Overall Study|Lost to Follow-up|1|||
33262877|NCT01278342|62633508|FG001|Overall Study|Lost to Follow-up|0|||
33262878|NCT01278342|62633509|FG002|Overall Study|Lost to Follow-up|0|||
33262879|NCT01278342|62633507|FG000|Overall Study|Administrative problems|2|||
33262880|NCT01278342|62633508|FG001|Overall Study|Administrative problems|0|||
33262881|NCT01278342|62633509|FG002|Overall Study|Administrative problems|0|||
33262882|NCT01278342|62633507|FG000|Overall Study|Other|1|||
33262883|NCT01278342|62633508|FG001|Overall Study|Other|0|||
33262884|NCT01278342|62633509|FG002|Overall Study|Other|0|||
33262885|NCT01278030|62633519|FG000|Overall Study|Withdrawal by Subject|8|||
33262886|NCT01278030|62633520|FG001|Overall Study|Withdrawal by Subject|4|||
33262887|NCT01277718|62633526|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
33262888|NCT01277718|62633527|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
33262889|NCT01277718|62633526|FG000|Period 2 - Second Intervention|Physician Decision|0|||
33262890|NCT01277718|62633527|FG001|Period 2 - Second Intervention|Physician Decision|2|||
33262891|NCT01276236|62633535|FG000|Overall Study|Lack of Efficacy|2|||
33262892|NCT01276236|62633535|FG000|Overall Study|Withdrawal by Subject|4|||
33262893|NCT01275222|62633545|FG000|Phase l by Treatment|Adverse Event|1|||
33262894|NCT01275222|62633546|FG001|Phase l by Treatment|Adverse Event|4|||
33262895|NCT01275222|62633547|FG002|Phase l by Treatment|Adverse Event|2|||
33262896|NCT01275222|62633548|FG003|Phase l by Treatment|Adverse Event|3|||
33262897|NCT01275222|62633549|FG004|Phase l by Treatment|Adverse Event|0|||
33262898|NCT01275222|62633550|FG005|Phase l by Treatment|Adverse Event|0|||
33262899|NCT01275222|62633545|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
33262900|NCT01275222|62633546|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
33262901|NCT01275222|62633547|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
33262902|NCT01275222|62633548|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
33262903|NCT01275222|62633549|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
33262904|NCT01275222|62633550|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
33262905|NCT01275222|62633545|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
33262906|NCT01275222|62633546|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
33262907|NCT01275222|62633547|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
33262908|NCT01275222|62633548|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
33262909|NCT01275222|62633549|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
33262910|NCT01275222|62633550|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
33262911|NCT01275222|62633545|FG000|Phase l by Treatment|Disease progression|12|||
33262912|NCT01275222|62633546|FG001|Phase l by Treatment|Disease progression|8|||
33262913|NCT01275222|62633547|FG002|Phase l by Treatment|Disease progression|2|||
33262914|NCT01275222|62633548|FG003|Phase l by Treatment|Disease progression|5|||
33262915|NCT01275222|62633549|FG004|Phase l by Treatment|Disease progression|0|||
33262916|NCT01275222|62633550|FG005|Phase l by Treatment|Disease progression|0|||
33661788|NCT01697579|63091450|FG006|Base Study-Cycle 1|Adverse Event|0|||
33262917|NCT01275222|62633545|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
33262918|NCT01275222|62633546|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
33262919|NCT01275222|62633547|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
33262920|NCT01275222|62633548|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
33262921|NCT01275222|62633549|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
33262922|NCT01275222|62633550|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
33262923|NCT01275222|62633545|FG000|Phase l by Treatment|Death|0|||
33262924|NCT01275222|62633546|FG001|Phase l by Treatment|Death|1|||
33262925|NCT01275222|62633547|FG002|Phase l by Treatment|Death|0|||
33262926|NCT01275222|62633548|FG003|Phase l by Treatment|Death|1|||
33262927|NCT01275222|62633549|FG004|Phase l by Treatment|Death|0|||
33262928|NCT01275222|62633550|FG005|Phase l by Treatment|Death|0|||
33262929|NCT01275222|62633545|FG000|Phase ll by Stratum|Adverse Event|0|||
33262930|NCT01275222|62633546|FG001|Phase ll by Stratum|Adverse Event|0|||
33262931|NCT01275222|62633547|FG002|Phase ll by Stratum|Adverse Event|0|||
33262932|NCT01275222|62633548|FG003|Phase ll by Stratum|Adverse Event|0|||
33262933|NCT01275222|62633549|FG004|Phase ll by Stratum|Adverse Event|2|||
33262934|NCT01275222|62633550|FG005|Phase ll by Stratum|Adverse Event|10|||
33262935|NCT01275222|62633545|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
33262936|NCT01275222|62633546|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
33262937|NCT01275222|62633547|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
33262938|NCT01275222|62633548|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
33262939|NCT01275222|62633549|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
33262940|NCT01275222|62633550|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
33262941|NCT01275222|62633545|FG000|Phase ll by Stratum|Disease progression|0|||
33262942|NCT01275222|62633546|FG001|Phase ll by Stratum|Disease progression|0|||
33262943|NCT01275222|62633547|FG002|Phase ll by Stratum|Disease progression|0|||
33262944|NCT01275222|62633548|FG003|Phase ll by Stratum|Disease progression|0|||
33262945|NCT01275222|62633549|FG004|Phase ll by Stratum|Disease progression|23|||
33262946|NCT01275222|62633550|FG005|Phase ll by Stratum|Disease progression|31|||
33262947|NCT01275222|62633545|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
33262948|NCT01275222|62633546|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
33262949|NCT01275222|62633547|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
33262950|NCT01275222|62633548|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
33262951|NCT01275222|62633549|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
33262952|NCT01275222|62633550|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
33262953|NCT01275222|62633545|FG000|Phase ll by Stratum|Death|0|||
33262954|NCT01275222|62633546|FG001|Phase ll by Stratum|Death|0|||
33262955|NCT01275222|62633547|FG002|Phase ll by Stratum|Death|0|||
33262956|NCT01275222|62633548|FG003|Phase ll by Stratum|Death|0|||
33262957|NCT01275222|62633549|FG004|Phase ll by Stratum|Death|1|||
33262958|NCT01275222|62633550|FG005|Phase ll by Stratum|Death|1|||
33262959|NCT01275144|62633568|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
33262960|NCT01275144|62633569|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
33262961|NCT01275066|62633580|FG000|Overall Study|Withdrawal by Subject|0|||
33262962|NCT01275066|62633581|FG001|Overall Study|Withdrawal by Subject|0|||
33262963|NCT01275066|62633582|FG002|Overall Study|Withdrawal by Subject|1|||
33262964|NCT01275066|62633580|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
33262965|NCT01275066|62633581|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
33262966|NCT01275066|62633582|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
33262967|NCT01273038|62633592|FG000|Second Intervention (14 Days)|Adverse Event|0|||
33262968|NCT01273038|62633593|FG001|Second Intervention (14 Days)|Adverse Event|1|||
33262969|NCT01273038|62633592|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
33262970|NCT01273038|62633593|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
33262971|NCT01272180|62633603|FG000|Overall Study|Adverse Event|0|||
33262972|NCT01272180|62633604|FG001|Overall Study|Adverse Event|0|||
33262973|NCT01272180|62633605|FG002|Overall Study|Adverse Event|1|||
33262974|NCT01272180|62633606|FG003|Overall Study|Adverse Event|0|||
33262975|NCT01272180|62633603|FG000|Overall Study|Withdrawal by Subject|2|||
33262976|NCT01272180|62633604|FG001|Overall Study|Withdrawal by Subject|6|||
33262977|NCT01272180|62633605|FG002|Overall Study|Withdrawal by Subject|3|||
33262978|NCT01272180|62633606|FG003|Overall Study|Withdrawal by Subject|2|||
33367755|NCT00593112|62746659|FG001|Overall Study|Unreadable Scan|0|||
33367756|NCT00593112|62746658|FG000|Overall Study|Withdrawal by Subject|5|||
33367757|NCT00593112|62746659|FG001|Overall Study|Withdrawal by Subject|0|||
33367758|NCT00491179|62746667|FG000|Overall Study|Adverse Event|5|||
33262979|NCT01272180|62633603|FG000|Overall Study|Lost to Follow-up|15|||
33262980|NCT01272180|62633604|FG001|Overall Study|Lost to Follow-up|14|||
33262981|NCT01272180|62633605|FG002|Overall Study|Lost to Follow-up|8|||
33262982|NCT01272180|62633606|FG003|Overall Study|Lost to Follow-up|10|||
33262983|NCT01272180|62633603|FG000|Overall Study|Inappropriate enrollment|0|||
33262984|NCT01272180|62633604|FG001|Overall Study|Inappropriate enrollment|0|||
33262985|NCT01272180|62633605|FG002|Overall Study|Inappropriate enrollment|1|||
33262986|NCT01272180|62633606|FG003|Overall Study|Inappropriate enrollment|1|||
33262987|NCT01272180|62633603|FG000|Overall Study|Protocol Violation|0|||
33367759|NCT00491179|62746668|FG001|Overall Study|Adverse Event|1|||
33262988|NCT01272180|62633604|FG001|Overall Study|Protocol Violation|1|||
33262989|NCT01272180|62633605|FG002|Overall Study|Protocol Violation|0|||
33555470|NCT02379052|62948313|FG001|Overall Study|Adverse Event|1|||
33262990|NCT01272180|62633606|FG003|Overall Study|Protocol Violation|1|||
33262991|NCT01271712|62633622|FG000|Double Blind Treatment|Death|2|||
33262992|NCT01271712|62633623|FG001|Double Blind Treatment|Death|0|||
33262993|NCT01271712|62633622|FG000|Double Blind Treatment|Lack of Efficacy|1|||
33367760|NCT00491179|62746667|FG000|Overall Study|Withdrawal by Subject|2|||
33367761|NCT00491179|62746668|FG001|Overall Study|Withdrawal by Subject|1|||
33367762|NCT00503581|62746677|FG000|Overall Study|Study closed|3|||
33367763|NCT00503581|62746678|FG001|Overall Study|Study closed|4|||
33367764|NCT00503581|62746679|FG002|Overall Study|Study closed|2|||
33367765|NCT00703534|62746689|FG000|Overall Study|Adverse Event|14|||
33367766|NCT00703534|62746690|FG001|Overall Study|Adverse Event|3|||
33367767|NCT00703534|62746689|FG000|Overall Study|Withdrawal by Subject|8|||
33367768|NCT00703534|62746690|FG001|Overall Study|Withdrawal by Subject|7|||
33367769|NCT00703534|62746689|FG000|Overall Study|Incorrect Enrollment|6|||
33367770|NCT00703534|62746690|FG001|Overall Study|Incorrect Enrollment|6|||
33367771|NCT00703534|62746689|FG000|Overall Study|Lost to Follow-up|1|||
33367772|NCT00703534|62746690|FG001|Overall Study|Lost to Follow-up|4|||
33367773|NCT00703534|62746689|FG000|Overall Study|Severe Non Compliance|1|||
33367774|NCT00703534|62746690|FG001|Overall Study|Severe Non Compliance|5|||
33367775|NCT00503425|62746696|FG000|Overall Study|Participant files lost|6|||
33367776|NCT00503425|62746696|FG000|Overall Study|Adverse Event|5|||
33367777|NCT00503425|62746696|FG000|Overall Study|Lack of Efficacy|25|||
33367778|NCT00503425|62746696|FG000|Overall Study|Withdrawal by Subject|8|||
33367779|NCT00503425|62746696|FG000|Overall Study|Lost to Follow-up|3|||
33367780|NCT00503425|62746696|FG000|Overall Study|Death|3|||
33367781|NCT00503425|62746696|FG000|Overall Study|Missing Data/Unknown|4|||
33367782|NCT00863772|62746704|FG000|Overall Study|Adverse Event|1|||
33367783|NCT00863772|62746705|FG001|Overall Study|Adverse Event|4|||
33367784|NCT00863772|62746706|FG002|Overall Study|Adverse Event|0|||
33367785|NCT00863772|62746704|FG000|Overall Study|Lack of Efficacy|4|||
33367786|NCT00863772|62746705|FG001|Overall Study|Lack of Efficacy|2|||
33367787|NCT00863772|62746706|FG002|Overall Study|Lack of Efficacy|4|||
33367788|NCT00863772|62746704|FG000|Overall Study|Lost to Follow-up|5|||
33367789|NCT00863772|62746705|FG001|Overall Study|Lost to Follow-up|1|||
33367790|NCT00863772|62746706|FG002|Overall Study|Lost to Follow-up|1|||
33367791|NCT00863772|62746704|FG000|Overall Study|Protocol Violation|2|||
33367792|NCT00863772|62746705|FG001|Overall Study|Protocol Violation|0|||
33367793|NCT00863772|62746706|FG002|Overall Study|Protocol Violation|2|||
33367794|NCT00863772|62746704|FG000|Overall Study|Withdrawal by Subject|4|||
33367795|NCT00863772|62746705|FG001|Overall Study|Withdrawal by Subject|7|||
33367796|NCT00863772|62746706|FG002|Overall Study|Withdrawal by Subject|5|||
33367797|NCT00863772|62746704|FG000|Overall Study|Study terminated by sponsor|44|||
33367798|NCT00863772|62746705|FG001|Overall Study|Study terminated by sponsor|45|||
33367799|NCT00863772|62746706|FG002|Overall Study|Study terminated by sponsor|36|||
33367800|NCT00863772|62746704|FG000|Overall Study|Entered extension study|6|||
33367801|NCT00863772|62746705|FG001|Overall Study|Entered extension study|4|||
33367802|NCT00863772|62746706|FG002|Overall Study|Entered extension study|9|||
33367803|NCT00863772|62746704|FG000|Overall Study|Other|1|||
33367804|NCT00863772|62746705|FG001|Overall Study|Other|2|||
33367805|NCT00863772|62746706|FG002|Overall Study|Other|4|||
33367806|NCT00863772|62746704|FG000|Overall Study|Randomized but not Treated|1|||
33367807|NCT00863772|62746705|FG001|Overall Study|Randomized but not Treated|0|||
33367808|NCT00863772|62746706|FG002|Overall Study|Randomized but not Treated|0|||
33367809|NCT00502801|62746714|FG000|Treatment Period|Withdrawal by Subject|3|||
33367810|NCT00502801|62746714|FG000|Treatment Period|Adverse Event|7|||
33367811|NCT00502801|62746714|FG000|Treatment Period|Death|14|||
33367812|NCT00502801|62746714|FG000|Treatment Period|OTHER|30|||
33367813|NCT00502801|62746714|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
33367814|NCT00502801|62746714|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
33367815|NCT00502801|62746714|FG000|End of Therapy to Test of Cure|Death|3|||
33367816|NCT00502801|62746714|FG000|End of Therapy to Test of Cure|OTHER|2|||
33367817|NCT00824265|62746720|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
33367818|NCT00824265|62746721|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
33367819|NCT00824265|62746720|FG000|Treatment Phase|Protocol Violation|1|||
33367820|NCT00824265|62746721|FG001|Treatment Phase|Protocol Violation|0|||
33367821|NCT00824265|62746720|FG000|Treatment Phase|Lost to Follow-up|1|||
33367822|NCT00824265|62746721|FG001|Treatment Phase|Lost to Follow-up|1|||
33367823|NCT00824265|62746720|FG000|Treatment Phase|Physician Decision|6|||
33367824|NCT00824265|62746721|FG001|Treatment Phase|Physician Decision|12|||
33367825|NCT00824265|62746720|FG000|Treatment Phase|Withdrawal by Subject|6|||
33262994|NCT01271712|62633623|FG001|Double Blind Treatment|Lack of Efficacy|0|||
33367826|NCT00824265|62746721|FG001|Treatment Phase|Withdrawal by Subject|15|||
33367827|NCT00824265|62746720|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
33367828|NCT00824265|62746721|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
33367829|NCT00824265|62746720|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
33367830|NCT00824265|62746721|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
33367831|NCT00855894|62746731|FG000|Overall Study|Death|31|||
33262995|NCT01271712|62633622|FG000|Double Blind Treatment|Adverse Event|9|||
33262996|NCT01271712|62633623|FG001|Double Blind Treatment|Adverse Event|4|||
33262997|NCT01271712|62633622|FG000|Double Blind Treatment|Progressive disease|23|||
33262998|NCT01271712|62633623|FG001|Double Blind Treatment|Progressive disease|3|||
33262999|NCT01271712|62633622|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
33263000|NCT01271712|62633623|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
33263001|NCT01271712|62633622|FG000|Double Blind Treatment|Non compliance with study drug|2|||
33263002|NCT01271712|62633623|FG001|Double Blind Treatment|Non compliance with study drug|0|||
33263003|NCT01271712|62633622|FG000|Double Blind Treatment|receive no study drug|1|||
33263004|NCT01271712|62633623|FG001|Double Blind Treatment|receive no study drug|0|||
33263005|NCT01271712|62633622|FG000|Open Label Treatment|Death|6|||
33263006|NCT01271712|62633623|FG001|Open Label Treatment|Death|5|||
33263007|NCT01271712|62633622|FG000|Open Label Treatment|Withdrawal by Subject|6|||
33263008|NCT01271712|62633623|FG001|Open Label Treatment|Withdrawal by Subject|11|||
33263009|NCT01271712|62633622|FG000|Open Label Treatment|Physician Decision|2|||
33263010|NCT01271712|62633623|FG001|Open Label Treatment|Physician Decision|0|||
33263011|NCT01271712|62633622|FG000|Open Label Treatment|Adverse Event|14|||
33263012|NCT01271712|62633623|FG001|Open Label Treatment|Adverse Event|8|||
33263013|NCT01271712|62633622|FG000|Open Label Treatment|Progressive disease|59|||
33263014|NCT01271712|62633623|FG001|Open Label Treatment|Progressive disease|32|||
33555471|NCT02379052|62948312|FG000|Overall Study|Physician Decision|1|||
33555472|NCT02379052|62948313|FG001|Overall Study|Physician Decision|1|||
33555473|NCT02379052|62948312|FG000|Overall Study|Withdrawal by Subject|2|||
33555474|NCT02379052|62948313|FG001|Overall Study|Withdrawal by Subject|0|||
33555475|NCT02379052|62948312|FG000|Overall Study|Lost to Follow-up|2|||
33555476|NCT02379052|62948313|FG001|Overall Study|Lost to Follow-up|1|||
33555477|NCT02379052|62948312|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
33555478|NCT02379052|62948313|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
33555479|NCT02379052|62948312|FG000|Overall Study|Subject was Incarcerated|0|||
33555480|NCT02379052|62948313|FG001|Overall Study|Subject was Incarcerated|1|||
33555481|NCT02378662|62948321|FG000|Overall Study|Early Discontinuation|2|||
33555482|NCT02378662|62948322|FG001|Overall Study|Early Discontinuation|0|||
33555483|NCT02378506|62948328|FG000|Overall Study|Lack of Efficacy|3|||
33555484|NCT02378506|62948328|FG000|Overall Study|Withdrawal by Subject|4|||
33555485|NCT02378506|62948328|FG000|Overall Study|Protocol Violation|2|||
33555486|NCT02378506|62948328|FG000|Overall Study|Death|1|||
33555487|NCT02378506|62948328|FG000|Overall Study|Adverse Event|14|||
33555488|NCT02378506|62948328|FG000|Overall Study|Randomized But Not Treated|1|||
33555489|NCT02347774|62948335|FG000|Study Participation|Lost to Follow-up|3|||
33555490|NCT02347774|62948336|FG001|Study Participation|Lost to Follow-up|6|||
33555491|NCT02347774|62948337|FG002|Study Participation|Lost to Follow-up|2|||
33555492|NCT02347774|62948335|FG000|Study Participation|Withdrawal by Subject|8|||
33555493|NCT02347774|62948336|FG001|Study Participation|Withdrawal by Subject|9|||
33555494|NCT02347774|62948337|FG002|Study Participation|Withdrawal by Subject|15|||
33555495|NCT02347774|62948335|FG000|Study Participation|Adverse Event|1|||
33555496|NCT02347774|62948336|FG001|Study Participation|Adverse Event|4|||
33555497|NCT02347774|62948337|FG002|Study Participation|Adverse Event|6|||
33555498|NCT02347774|62948335|FG000|Study Participation|withdrew consent|1|||
33555499|NCT02347774|62948336|FG001|Study Participation|withdrew consent|1|||
33555500|NCT02347774|62948337|FG002|Study Participation|withdrew consent|1|||
33555501|NCT02347774|62948335|FG000|Study Participation|Met Prolonged QT criteria|1|||
33555502|NCT02347774|62948336|FG001|Study Participation|Met Prolonged QT criteria|0|||
33555503|NCT02347774|62948337|FG002|Study Participation|Met Prolonged QT criteria|0|||
33263015|NCT01271712|62633622|FG000|Open Label Treatment|transferred to rollover study|1|||
33263016|NCT01271712|62633623|FG001|Open Label Treatment|transferred to rollover study|0|||
33263017|NCT01271712|62633622|FG000|Open Label Treatment|Non-compliance with study drug|1|||
33263018|NCT01271712|62633623|FG001|Open Label Treatment|Non-compliance with study drug|0|||
33263019|NCT01271712|62633622|FG000|Open Label Treatment|Protocol Violation|0|||
33263020|NCT01271712|62633623|FG001|Open Label Treatment|Protocol Violation|1|||
33263021|NCT01271712|62633622|FG000|Open Label Treatment|Switching to other therapy|2|||
33263022|NCT01271712|62633623|FG001|Open Label Treatment|Switching to other therapy|1|||
33367832|NCT00855894|62746731|FG000|Overall Study|Patient's decision|1|||
33367833|NCT00855894|62746731|FG000|Overall Study|Disease progression|1|||
33263023|NCT01271712|62633622|FG000|Safety Follow-up|Death|11|||
33263024|NCT01271712|62633623|FG001|Safety Follow-up|Death|7|||
33367834|NCT00855816|62746737|FG000|Overall Study|Withdrawal by Subject|22|||
33555504|NCT02347774|62948335|FG000|Study Participation|non-compliance with study drug|0|||
33555505|NCT02347774|62948336|FG001|Study Participation|non-compliance with study drug|1|||
33555506|NCT02347774|62948337|FG002|Study Participation|non-compliance with study drug|0|||
33555507|NCT02347774|62948335|FG000|Study Participation|incarceration|1|||
33263025|NCT01271712|62633622|FG000|Safety Follow-up|Withdrawal by Subject|4|||
33263026|NCT01271712|62633623|FG001|Safety Follow-up|Withdrawal by Subject|2|||
33263027|NCT01271712|62633622|FG000|Safety Follow-up|Protocol Violation|1|||
33367835|NCT00855816|62746738|FG001|Overall Study|Withdrawal by Subject|15|||
33263028|NCT01271712|62633623|FG001|Safety Follow-up|Protocol Violation|1|||
33263029|NCT01271712|62633622|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
33263030|NCT01271712|62633623|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
33263031|NCT01271712|62633622|FG000|Safety Follow-up|No follow-up|1|||
33263032|NCT01271712|62633623|FG001|Safety Follow-up|No follow-up|1|||
33263033|NCT01271712|62633622|FG000|Safety Follow-up|Progressive disease|1|||
33263034|NCT01271712|62633623|FG001|Safety Follow-up|Progressive disease|0|||
33263035|NCT01271712|62633622|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
33263036|NCT01271712|62633623|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
33263037|NCT01271010|62633632|FG000|Overall Study|Reason not specified|11|||
33263038|NCT01271010|62633632|FG000|Overall Study|Start of new CLL therapy|1|||
33263039|NCT01271010|62633632|FG000|Overall Study|Protocol Violation|1|||
33263040|NCT01271010|62633632|FG000|Overall Study|Death|2|||
33263041|NCT01271010|62633632|FG000|Overall Study|Progression and relapse of disease|1|||
33263042|NCT01271010|62633632|FG000|Overall Study|Withdrawal by Subject|18|||
33263043|NCT01271010|62633632|FG000|Overall Study|Disease progression|27|||
33263044|NCT01270620|62633638|FG000|Overall Study|Withdrawal by Subject|1|||
33263045|NCT01270620|62633639|FG001|Overall Study|Withdrawal by Subject|3|||
33263046|NCT01270464|62633654|FG000|Overall Study|Protocol Violation|4|||
33263047|NCT01270464|62633655|FG001|Overall Study|Protocol Violation|3|||
33263048|NCT01270464|62633656|FG002|Overall Study|Protocol Violation|2|||
33263049|NCT01270464|62633654|FG000|Overall Study|Lack of Efficacy|2|||
33263050|NCT01270464|62633655|FG001|Overall Study|Lack of Efficacy|3|||
33263051|NCT01270464|62633656|FG002|Overall Study|Lack of Efficacy|1|||
33263052|NCT01270464|62633654|FG000|Overall Study|Adverse Event|9|||
33263053|NCT01270464|62633655|FG001|Overall Study|Adverse Event|1|||
33263054|NCT01270464|62633656|FG002|Overall Study|Adverse Event|7|||
33263055|NCT01270464|62633654|FG000|Overall Study|Withdrawal by Subject|2|||
33263056|NCT01270464|62633655|FG001|Overall Study|Withdrawal by Subject|1|||
33263057|NCT01270464|62633656|FG002|Overall Study|Withdrawal by Subject|4|||
33263058|NCT01270464|62633654|FG000|Overall Study|Lost to Follow-up|2|||
33263059|NCT01270464|62633655|FG001|Overall Study|Lost to Follow-up|3|||
33263060|NCT01270464|62633656|FG002|Overall Study|Lost to Follow-up|1|||
33263061|NCT01270464|62633654|FG000|Overall Study|Other|1|||
33263062|NCT01270464|62633655|FG001|Overall Study|Other|1|||
33263063|NCT01270464|62633656|FG002|Overall Study|Other|3|||
33263064|NCT00249834|62633672|FG000|Overall Study|Ovarian stimulation failed|1|||
33263065|NCT00249834|62633673|FG001|Overall Study|Ovarian stimulation failed|0|||
33263066|NCT00249834|62633674|FG002|Overall Study|Ovarian stimulation failed|0|||
33263067|NCT00249834|62633675|FG003|Overall Study|Ovarian stimulation failed|0|||
33263068|NCT00249834|62633676|FG004|Overall Study|Ovarian stimulation failed|0|||
33263069|NCT00249834|62633677|FG005|Overall Study|Ovarian stimulation failed|0|||
33263070|NCT00249834|62633678|FG006|Overall Study|Ovarian stimulation failed|0|||
33263071|NCT00249834|62633679|FG007|Overall Study|Ovarian stimulation failed|0|||
33263072|NCT00249834|62633672|FG000|Overall Study|Failure of down-regulation|0|||
33263073|NCT00249834|62633673|FG001|Overall Study|Failure of down-regulation|0|||
33263074|NCT00249834|62633674|FG002|Overall Study|Failure of down-regulation|0|||
33263075|NCT00249834|62633675|FG003|Overall Study|Failure of down-regulation|0|||
33263076|NCT00249834|62633676|FG004|Overall Study|Failure of down-regulation|0|||
33263077|NCT00249834|62633677|FG005|Overall Study|Failure of down-regulation|0|||
33263078|NCT00249834|62633678|FG006|Overall Study|Failure of down-regulation|1|||
33263079|NCT00249834|62633679|FG007|Overall Study|Failure of down-regulation|0|||
33263080|NCT00249834|62633672|FG000|Overall Study|Protocol Violation|0|||
33263081|NCT00249834|62633673|FG001|Overall Study|Protocol Violation|19|||
33263082|NCT00249834|62633674|FG002|Overall Study|Protocol Violation|14|||
33263083|NCT00249834|62633675|FG003|Overall Study|Protocol Violation|8|||
33263084|NCT00249834|62633676|FG004|Overall Study|Protocol Violation|5|||
33263085|NCT00249834|62633677|FG005|Overall Study|Protocol Violation|2|||
33263086|NCT00249834|62633678|FG006|Overall Study|Protocol Violation|0|||
33263087|NCT00249834|62633679|FG007|Overall Study|Protocol Violation|0|||
33263088|NCT00249444|62633693|FG000|Overall Study|Lost to Follow-up|2|||
33263089|NCT00249444|62633694|FG001|Overall Study|Lost to Follow-up|2|||
33263090|NCT00249444|62633693|FG000|Overall Study|non-compliant|9|||
33263091|NCT00249444|62633694|FG001|Overall Study|non-compliant|11|||
33263092|NCT00249444|62633693|FG000|Overall Study|Adverse Event|1|||
33263093|NCT00249444|62633694|FG001|Overall Study|Adverse Event|1|||
33263094|NCT00249444|62633693|FG000|Overall Study|life event|0|||
33263095|NCT00249444|62633694|FG001|Overall Study|life event|1|||
33263096|NCT00249288|62633702|FG000|Overall Study|Lost to Follow-up|3|||
33263097|NCT00249288|62633703|FG001|Overall Study|Lost to Follow-up|3|||
33263098|NCT00249288|62633702|FG000|Overall Study|Withdrawal by Subject|2|||
33263099|NCT00249288|62633703|FG001|Overall Study|Withdrawal by Subject|2|||
33263100|NCT00248040|62633720|FG000|Overall Study|transplantectomy|2|||
33263101|NCT00248040|62633721|FG001|Overall Study|transplantectomy|1|||
33263102|NCT00248040|62633722|FG002|Overall Study|transplantectomy|3|||
33263103|NCT00248040|62633720|FG000|Overall Study|transplant cancelled post treat start|1|||
33263104|NCT00248040|62633721|FG001|Overall Study|transplant cancelled post treat start|0|||
33263105|NCT00248040|62633722|FG002|Overall Study|transplant cancelled post treat start|0|||
33263106|NCT00248040|62633720|FG000|Overall Study|Death|0|||
33263107|NCT00248040|62633721|FG001|Overall Study|Death|0|||
33263108|NCT00248040|62633722|FG002|Overall Study|Death|1|||
33263109|NCT00247962|62633733|FG000|Overall Study|Adverse Event|15|||
33263110|NCT00247962|62633734|FG001|Overall Study|Adverse Event|12|||
33263111|NCT00247962|62633733|FG000|Overall Study|Lost to Follow-up|3|||
33263112|NCT00247962|62633734|FG001|Overall Study|Lost to Follow-up|1|||
33263113|NCT00247962|62633733|FG000|Overall Study|Physician Decision|0|||
33263114|NCT00247962|62633734|FG001|Overall Study|Physician Decision|1|||
33263115|NCT00247962|62633733|FG000|Overall Study|Protocol Violation|1|||
33263116|NCT00247962|62633734|FG001|Overall Study|Protocol Violation|1|||
33263117|NCT00247962|62633733|FG000|Overall Study|Withdrawal by Subject|3|||
33263118|NCT00247962|62633734|FG001|Overall Study|Withdrawal by Subject|2|||
33263119|NCT00247962|62633733|FG000|Overall Study|Lack of Efficacy|4|||
33263120|NCT00247962|62633734|FG001|Overall Study|Lack of Efficacy|2|||
33263121|NCT00247416|62633742|FG000|Overall Study|3 patients were found to be ineligible|1|||
33263122|NCT00247416|62633743|FG001|Overall Study|3 patients were found to be ineligible|2|||
33263123|NCT00246090|62633751|FG000|Overall Study|Adverse Event|25|||
33263124|NCT00246090|62633751|FG000|Overall Study|Withdrawal by Subject|7|||
33263125|NCT00246090|62633751|FG000|Overall Study|Progressive Disease|212|||
33263126|NCT00246090|62633751|FG000|Overall Study|Clinical Progression|30|||
33263127|NCT00246090|62633751|FG000|Overall Study|Physician Decision|11|||
33263128|NCT00246090|62633751|FG000|Overall Study|Not Otherwise Specified|10|||
33263129|NCT00246012|62633764|FG000|Overall Study|Adverse Event|0|||
33263130|NCT00246012|62633765|FG001|Overall Study|Adverse Event|0|||
33263131|NCT00246012|62633766|FG002|Overall Study|Adverse Event|0|||
33263132|NCT00246012|62633767|FG003|Overall Study|Adverse Event|0|||
33263133|NCT00246012|62633768|FG004|Overall Study|Adverse Event|0|||
33263134|NCT00246012|62633769|FG005|Overall Study|Adverse Event|1|||
33263135|NCT00246012|62633770|FG006|Overall Study|Adverse Event|0|||
33263136|NCT00246012|62633771|FG007|Overall Study|Adverse Event|0|||
33263137|NCT00246012|62633772|FG008|Overall Study|Adverse Event|2|||
33263138|NCT00246012|62633764|FG000|Overall Study|Withdrawal by Subject|0|||
33263139|NCT00246012|62633765|FG001|Overall Study|Withdrawal by Subject|0|||
33263140|NCT00246012|62633766|FG002|Overall Study|Withdrawal by Subject|0|||
33263141|NCT00246012|62633767|FG003|Overall Study|Withdrawal by Subject|0|||
33263142|NCT00246012|62633768|FG004|Overall Study|Withdrawal by Subject|0|||
33263143|NCT00246012|62633769|FG005|Overall Study|Withdrawal by Subject|1|||
33263144|NCT00246012|62633770|FG006|Overall Study|Withdrawal by Subject|0|||
33263145|NCT00246012|62633771|FG007|Overall Study|Withdrawal by Subject|0|||
33263146|NCT00246012|62633772|FG008|Overall Study|Withdrawal by Subject|0|||
33263147|NCT00246012|62633764|FG000|Overall Study|Disease progression|3|||
33263148|NCT00246012|62633765|FG001|Overall Study|Disease progression|1|||
33263149|NCT00246012|62633766|FG002|Overall Study|Disease progression|2|||
33263150|NCT00246012|62633767|FG003|Overall Study|Disease progression|3|||
33263151|NCT00246012|62633768|FG004|Overall Study|Disease progression|3|||
33263152|NCT00246012|62633769|FG005|Overall Study|Disease progression|25|||
33263153|NCT00246012|62633770|FG006|Overall Study|Disease progression|30|||
33263154|NCT00246012|62633771|FG007|Overall Study|Disease progression|27|||
33263155|NCT00246012|62633772|FG008|Overall Study|Disease progression|26|||
33263156|NCT00246012|62633764|FG000|Overall Study|Other|0|||
33263157|NCT00246012|62633765|FG001|Overall Study|Other|0|||
33263158|NCT00246012|62633766|FG002|Overall Study|Other|0|||
33263159|NCT00246012|62633767|FG003|Overall Study|Other|0|||
33263160|NCT00246012|62633768|FG004|Overall Study|Other|0|||
33263161|NCT00246012|62633769|FG005|Overall Study|Other|0|||
33263162|NCT00246012|62633770|FG006|Overall Study|Other|0|||
33263163|NCT00246012|62633771|FG007|Overall Study|Other|1|||
33263164|NCT00246012|62633772|FG008|Overall Study|Other|0|||
33263165|NCT00246012|62633764|FG000|Overall Study|Randomly assigned but not treated|0|||
33263166|NCT00246012|62633765|FG001|Overall Study|Randomly assigned but not treated|0|||
33263167|NCT00246012|62633766|FG002|Overall Study|Randomly assigned but not treated|0|||
33263168|NCT00246012|62633767|FG003|Overall Study|Randomly assigned but not treated|0|||
33661789|NCT01697579|63091444|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
33661790|NCT01697579|63091445|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
33263169|NCT00246012|62633768|FG004|Overall Study|Randomly assigned but not treated|0|||
33263170|NCT00246012|62633769|FG005|Overall Study|Randomly assigned but not treated|1|||
33263171|NCT00246012|62633770|FG006|Overall Study|Randomly assigned but not treated|1|||
33263172|NCT00246012|62633771|FG007|Overall Study|Randomly assigned but not treated|0|||
33263173|NCT00246012|62633772|FG008|Overall Study|Randomly assigned but not treated|0|||
33263174|NCT00245856|62633794|FG000|Period Two|Withdrawal by Subject|0|||
33263175|NCT00245856|62633795|FG001|Period Two|Withdrawal by Subject|1|||
33263176|NCT00245466|62633805|FG000|Overall Study|Adverse Event|2|||
33263177|NCT00245466|62633806|FG001|Overall Study|Adverse Event|8|||
33263178|NCT00245466|62633807|FG002|Overall Study|Adverse Event|4|||
33263179|NCT00245466|62633805|FG000|Overall Study|Low prostate specific antigen suppr|16|||
33263180|NCT00245466|62633806|FG001|Overall Study|Low prostate specific antigen suppr|14|||
33263181|NCT00245466|62633807|FG002|Overall Study|Low prostate specific antigen suppr|5|||
33263182|NCT00245466|62633805|FG000|Overall Study|Insufficient testosterone suppr|12|||
33263183|NCT00245466|62633806|FG001|Overall Study|Insufficient testosterone suppr|12|||
33263184|NCT00245466|62633807|FG002|Overall Study|Insufficient testosterone suppr|21|||
33263185|NCT00245466|62633805|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
33263186|NCT00245466|62633806|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
33263187|NCT00245466|62633807|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
33263188|NCT00245466|62633805|FG000|Overall Study|Withdrawal by Subject|2|||
33263189|NCT00245466|62633806|FG001|Overall Study|Withdrawal by Subject|2|||
33263190|NCT00245466|62633807|FG002|Overall Study|Withdrawal by Subject|1|||
33263191|NCT00245466|62633805|FG000|Overall Study|Lost to Follow-up|3|||
33263192|NCT00245466|62633806|FG001|Overall Study|Lost to Follow-up|0|||
33263193|NCT00245466|62633807|FG002|Overall Study|Lost to Follow-up|0|||
33263194|NCT00245466|62633805|FG000|Overall Study|Disease progression|0|||
33263195|NCT00245466|62633806|FG001|Overall Study|Disease progression|3|||
33263196|NCT00245466|62633807|FG002|Overall Study|Disease progression|1|||
33263197|NCT00245466|62633805|FG000|Overall Study|Protocol Violation|1|||
33263198|NCT00245466|62633806|FG001|Overall Study|Protocol Violation|2|||
33263199|NCT00245466|62633807|FG002|Overall Study|Protocol Violation|2|||
33263200|NCT00245466|62633805|FG000|Overall Study|Death|0|||
33263201|NCT00245466|62633806|FG001|Overall Study|Death|2|||
33263202|NCT00245466|62633807|FG002|Overall Study|Death|0|||
33263203|NCT00245466|62633805|FG000|Overall Study|Administrative reasons|0|||
33263204|NCT00245466|62633806|FG001|Overall Study|Administrative reasons|1|||
33367836|NCT00855816|62746737|FG000|Overall Study|Lost to Follow-up|3|||
33555508|NCT02347774|62948336|FG001|Study Participation|incarceration|0|||
33555509|NCT02347774|62948337|FG002|Study Participation|incarceration|0|||
33555510|NCT02347774|62948335|FG000|Study Participation|randomized in error|0|||
33263205|NCT00245466|62633807|FG002|Overall Study|Administrative reasons|0|||
33263206|NCT00244764|62633815|FG000|Overall Study|Adverse Event|37|||
33263207|NCT00244764|62633815|FG000|Overall Study|Lost to Follow-up|23|||
33263208|NCT00244764|62633815|FG000|Overall Study|Withdrawal by Subject|12|||
33263209|NCT00244764|62633815|FG000|Overall Study|Disease Progression|13|||
33263210|NCT00244764|62633815|FG000|Overall Study|Protocol Violation|2|||
33263211|NCT00244764|62633815|FG000|Overall Study|Death|1|||
33263212|NCT00244764|62633815|FG000|Overall Study|Off Study Medication for >21 Days|1|||
33263213|NCT00244764|62633815|FG000|Overall Study|Declining Performance Status|1|||
33263214|NCT00244764|62633815|FG000|Overall Study|Participant was Hospitalized until Death|1|||
33263215|NCT00244764|62633815|FG000|Overall Study|Primary Investigator Discretion|2|||
33263216|NCT00244764|62633815|FG000|Overall Study|Sponsor Terminated Study|2|||
33263217|NCT00244764|62633815|FG000|Overall Study|Developed Secondary Malignancy|1|||
33263218|NCT00244374|62633820|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
33263219|NCT00244374|62633821|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
33263220|NCT00244374|62633822|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
33263221|NCT00244374|62633823|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
33263222|NCT00244374|62633824|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
33263223|NCT00244374|62633820|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
33263224|NCT00244374|62633821|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
33263225|NCT00244374|62633822|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
33263226|NCT00244374|62633823|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
33263227|NCT00244374|62633824|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
33263228|NCT00244374|62633820|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
33263229|NCT00244374|62633821|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
33263230|NCT00244374|62633822|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
33263231|NCT00244374|62633823|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
33263232|NCT00244374|62633824|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
33263233|NCT00244374|62633820|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
33263234|NCT00244374|62633821|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
33263235|NCT00244374|62633822|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
33263236|NCT00244374|62633823|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
33263237|NCT00244374|62633824|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
33263238|NCT00244374|62633820|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
33263239|NCT00244374|62633821|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
33263240|NCT00244374|62633822|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
33263241|NCT00244374|62633823|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
33367837|NCT00855816|62746738|FG001|Overall Study|Lost to Follow-up|5|||
33555511|NCT02347774|62948336|FG001|Study Participation|randomized in error|0|||
33555512|NCT02347774|62948337|FG002|Study Participation|randomized in error|1|||
33263242|NCT00244374|62633824|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
33263243|NCT00244374|62633820|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
33263244|NCT00244374|62633821|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
33263245|NCT00244374|62633822|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
33263246|NCT00244374|62633823|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
33263247|NCT00244374|62633824|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
33263248|NCT00244374|62633820|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
33263249|NCT00244374|62633821|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
33263250|NCT00244374|62633822|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
33263251|NCT00244374|62633823|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
33263252|NCT00244374|62633824|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
33263253|NCT00244374|62633820|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
33263254|NCT00244374|62633821|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
33263255|NCT00244374|62633822|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
33263256|NCT00244374|62633823|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
33263257|NCT00244374|62633824|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
33263258|NCT00244374|62633820|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
33263259|NCT00244374|62633821|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
33263260|NCT00244374|62633822|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
33263261|NCT00244374|62633823|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
33263262|NCT00244374|62633824|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
33263263|NCT00242658|62633842|FG000|Overall Study|Lost to Follow-up|22|||
33263264|NCT00242658|62633843|FG001|Overall Study|Lost to Follow-up|19|||
33263265|NCT00242580|62633852|FG000|Overall Study|Adverse Event|3|||
33263266|NCT00242580|62633853|FG001|Overall Study|Adverse Event|0|||
33263267|NCT00242580|62633854|FG002|Overall Study|Adverse Event|2|||
33263268|NCT00242580|62633852|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33263269|NCT00242580|62633853|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
33263270|NCT00242580|62633854|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
33263271|NCT00242580|62633852|FG000|Overall Study|Protocol Violation|0|||
33263272|NCT00242580|62633853|FG001|Overall Study|Protocol Violation|0|||
33263273|NCT00242580|62633854|FG002|Overall Study|Protocol Violation|1|||
33263274|NCT00242580|62633852|FG000|Overall Study|Subject withdrew consent|2|||
33263275|NCT00242580|62633853|FG001|Overall Study|Subject withdrew consent|2|||
33263276|NCT00242580|62633854|FG002|Overall Study|Subject withdrew consent|5|||
33263277|NCT00242580|62633852|FG000|Overall Study|Lost to Follow-up|0|||
33263278|NCT00242580|62633853|FG001|Overall Study|Lost to Follow-up|3|||
33263279|NCT00242580|62633854|FG002|Overall Study|Lost to Follow-up|0|||
33263280|NCT00242580|62633852|FG000|Overall Study|Death|1|||
33263281|NCT00242580|62633853|FG001|Overall Study|Death|2|||
33263282|NCT00242580|62633854|FG002|Overall Study|Death|1|||
33263283|NCT00241644|62633866|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
33263284|NCT00241644|62633867|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
33263285|NCT00241644|62633868|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
33263286|NCT00241644|62633869|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
33263287|NCT00241644|62633866|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
33263288|NCT00241644|62633867|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
33263289|NCT00241644|62633868|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
33263290|NCT00241644|62633869|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
33263291|NCT00241644|62633866|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
33263292|NCT00241644|62633867|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
33263293|NCT00241644|62633868|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
33263294|NCT00241644|62633869|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
33263295|NCT00241644|62633866|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
33263296|NCT00241644|62633867|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
33263297|NCT00241644|62633868|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
33263298|NCT00241644|62633869|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
33263299|NCT00241644|62633866|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
33263300|NCT00241644|62633867|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
33263301|NCT00241644|62633868|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
33263302|NCT00241644|62633869|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
33263303|NCT00241644|62633866|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
33263304|NCT00241644|62633867|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
33263305|NCT00241644|62633868|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
33263306|NCT00241644|62633869|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
33263307|NCT00241644|62633866|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
33263308|NCT00241644|62633867|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
33263309|NCT00241644|62633868|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
33263310|NCT00241644|62633869|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
33263311|NCT00241644|62633866|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
33263312|NCT00241644|62633867|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
33263313|NCT00241644|62633868|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
33263314|NCT00241644|62633869|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
33263315|NCT00241644|62633866|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
33263316|NCT00241644|62633867|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
33263317|NCT00241644|62633868|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
33263318|NCT00241644|62633869|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
33263319|NCT00241644|62633866|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
33263320|NCT00241644|62633867|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
33263321|NCT00241644|62633868|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
33263322|NCT00241644|62633869|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
33263323|NCT00241644|62633866|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
33263324|NCT00241644|62633867|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
33263325|NCT00241644|62633868|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
33263326|NCT00241644|62633869|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
33263327|NCT00241644|62633866|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
33263328|NCT00241644|62633867|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
33263329|NCT00241644|62633868|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
33263330|NCT00241644|62633869|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
33263331|NCT00241644|62633866|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
33263332|NCT00241644|62633867|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
33263333|NCT00241644|62633868|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
33263334|NCT00241644|62633869|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
33263335|NCT03804684|62633890|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
33263336|NCT03804684|62633891|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
33263337|NCT04295772|62633906|FG000|Overall Study|Protocol Violation|1|||
33263338|NCT04295772|62633907|FG001|Overall Study|Protocol Violation|0|||
33263339|NCT04295772|62633906|FG000|Overall Study|Ongoing for safety monitoring|14|||
33263340|NCT04295772|62633907|FG001|Overall Study|Ongoing for safety monitoring|1|||
33263341|NCT04295772|62633906|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
33263342|NCT04295772|62633907|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
33263343|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criterion #1|24|||
33263344|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criterion #1|0|||
33263345|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
33263346|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
33263347|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
33263348|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33263349|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
33263350|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
33263351|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
33263352|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
33263353|NCT03888066|62633916|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
33263354|NCT03888066|62633917|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33263355|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
33263356|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33263357|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
33263358|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
33263359|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
33263360|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33263361|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
33263362|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33263363|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criterion #2|5|||
33263364|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criterion #2|0|||
33263365|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
33263366|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
33367838|NCT00855816|62746737|FG000|Overall Study|Death|1|||
33367839|NCT00855816|62746738|FG001|Overall Study|Death|0|||
33367840|NCT00855816|62746737|FG000|Overall Study|Became ineligible|0|||
33367841|NCT00855816|62746738|FG001|Overall Study|Became ineligible|1|||
33263367|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
33263368|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
33263369|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
33263370|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
33263371|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criterion #3|11|||
33263372|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criterion #3|0|||
33263373|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
33263374|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
33263375|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
33263376|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
33263377|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
33263378|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33263379|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criterion #4|3|||
33263380|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criterion #4|0|||
33263381|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
33263382|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
33263383|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
33263384|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
33263385|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
33263386|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
33263387|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
33263388|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
33263389|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
33263390|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33263391|NCT03888066|62633916|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
33263392|NCT03888066|62633917|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
33263393|NCT03888066|62633916|FG000|Run-in Phase|AE (Adverse Event)|17|||
33263394|NCT03888066|62633917|FG001|Run-in Phase|AE (Adverse Event)|0|||
33263395|NCT03888066|62633916|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
33263396|NCT03888066|62633917|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
33263397|NCT03888066|62633916|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
33263398|NCT03888066|62633917|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33263399|NCT03888066|62633916|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
33263400|NCT03888066|62633917|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33263401|NCT03888066|62633916|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
33367842|NCT00855738|62746744|FG000|Overall Study|Lost to Follow-up|2|||
33367843|NCT00855738|62746744|FG000|Overall Study|Adverse Event|1|||
33367844|NCT00855738|62746744|FG000|Overall Study|Subject Defaulted|1|||
33367845|NCT00855738|62746744|FG000|Overall Study|Death|1|||
33367846|NCT00490945|62746755|FG000|Overall Study|Adverse Event|0|||
33367847|NCT00490945|62746756|FG001|Overall Study|Adverse Event|1|||
33367848|NCT00490945|62746757|FG002|Overall Study|Adverse Event|0|||
33367849|NCT00490945|62746758|FG003|Overall Study|Adverse Event|0|||
33367850|NCT00490945|62746759|FG004|Overall Study|Adverse Event|0|||
33367851|NCT00879398|62746777|FG000|Overall Study|Visit Stop|399|||
33367852|NCT00879398|62746777|FG000|Overall Study|Lack of Efficacy|64|||
33367853|NCT00879398|62746777|FG000|Overall Study|Adverse Event|41|||
33367854|NCT00879398|62746777|FG000|Overall Study|Other Reasons|171|||
33367855|NCT00696436|62746786|FG000|Overall Study|Adverse Event|7|||
33367856|NCT00696436|62746787|FG001|Overall Study|Adverse Event|9|||
33367857|NCT00696436|62746788|FG002|Overall Study|Adverse Event|8|||
33367858|NCT00696436|62746789|FG003|Overall Study|Adverse Event|6|||
33367859|NCT00696436|62746790|FG004|Overall Study|Adverse Event|4|||
33367860|NCT00696436|62746786|FG000|Overall Study|Protocol Violation|3|||
33367861|NCT00696436|62746787|FG001|Overall Study|Protocol Violation|2|||
33367862|NCT00696436|62746788|FG002|Overall Study|Protocol Violation|2|||
33367863|NCT00696436|62746789|FG003|Overall Study|Protocol Violation|0|||
33367864|NCT00696436|62746790|FG004|Overall Study|Protocol Violation|1|||
33367865|NCT00696436|62746786|FG000|Overall Study|Lost to Follow-up|1|||
33367866|NCT00696436|62746787|FG001|Overall Study|Lost to Follow-up|6|||
33367867|NCT00696436|62746788|FG002|Overall Study|Lost to Follow-up|2|||
33367868|NCT00696436|62746789|FG003|Overall Study|Lost to Follow-up|4|||
33367869|NCT00696436|62746790|FG004|Overall Study|Lost to Follow-up|3|||
33367870|NCT00696436|62746786|FG000|Overall Study|Withdrawal by Subject|4|||
33367871|NCT00696436|62746787|FG001|Overall Study|Withdrawal by Subject|11|||
33484560|NCT02942264|62861446|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
33367872|NCT00696436|62746788|FG002|Overall Study|Withdrawal by Subject|5|||
33367873|NCT00696436|62746789|FG003|Overall Study|Withdrawal by Subject|7|||
33263402|NCT03888066|62633917|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
33263403|NCT03888066|62633916|FG000|Run-in Phase|Withdrawal by Subject|43|||
33263404|NCT03888066|62633917|FG001|Run-in Phase|Withdrawal by Subject|0|||
33263405|NCT03888066|62633916|FG000|Run-in Phase|AE; Physician Decision|1|||
33263406|NCT03888066|62633917|FG001|Run-in Phase|AE; Physician Decision|0|||
33263407|NCT03888066|62633916|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
33263408|NCT03888066|62633917|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33263409|NCT03888066|62633916|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
33263410|NCT03888066|62633917|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
33263411|NCT03888066|62633916|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
33263412|NCT03888066|62633917|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
33263413|NCT03888066|62633916|FG000|Run-in Phase|Death|1|||
33263414|NCT03888066|62633917|FG001|Run-in Phase|Death|0|||
33263415|NCT03888066|62633916|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
33263416|NCT03888066|62633917|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
33263417|NCT03888066|62633916|FG000|Run-in Phase|Physician Decision|1|||
33263418|NCT03888066|62633917|FG001|Run-in Phase|Physician Decision|0|||
33263419|NCT03888066|62633916|FG000|Run-in Phase|Protocol Violation|13|||
33263420|NCT03888066|62633917|FG001|Run-in Phase|Protocol Violation|0|||
33263421|NCT03888066|62633916|FG000|Run-in Phase|Sponsor Request|34|||
33263422|NCT03888066|62633917|FG001|Run-in Phase|Sponsor Request|0|||
33263423|NCT03888066|62633916|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
33263424|NCT03888066|62633917|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
33263425|NCT03888066|62633916|FG000|Run-in Phase|Withdrawal Of Consent|1|||
33263426|NCT03888066|62633917|FG001|Run-in Phase|Withdrawal Of Consent|0|||
33263427|NCT03888066|62633916|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
33263428|NCT03888066|62633917|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
33263429|NCT03888066|62633916|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
33263430|NCT03888066|62633917|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
33263431|NCT03888066|62633916|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
33263432|NCT03888066|62633917|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
33263433|NCT03888066|62633916|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
33263434|NCT03888066|62633917|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
33263435|NCT03888066|62633916|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
33263436|NCT03888066|62633917|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
33263437|NCT03888066|62633916|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
33263438|NCT03888066|62633917|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
33263439|NCT03888066|62633916|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
33263440|NCT03888066|62633917|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
33263441|NCT03888066|62633916|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
33263442|NCT03888066|62633917|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
33263443|NCT03888066|62633916|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
33263444|NCT03888066|62633917|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
33263445|NCT03888066|62633916|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
33263446|NCT03888066|62633917|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
33263447|NCT03888066|62633916|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
33263448|NCT03888066|62633917|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
33263449|NCT03888066|62633916|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
33263450|NCT03888066|62633917|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
33263451|NCT02017704|62633926|FG000|Overall Study|Withdrawal by Subject|2|||
33263452|NCT02017704|62633927|FG001|Overall Study|Withdrawal by Subject|0|||
33263453|NCT01049334|62633937|FG000|Overall Study|Withdrawal by Subject|5|||
33263454|NCT01049334|62633938|FG001|Overall Study|Withdrawal by Subject|3|||
33263455|NCT01049334|62633937|FG000|Overall Study|Adverse Event|2|||
33263456|NCT01049334|62633938|FG001|Overall Study|Adverse Event|3|||
33263457|NCT01049334|62633937|FG000|Overall Study|Physician Decision|2|||
33263458|NCT01049334|62633938|FG001|Overall Study|Physician Decision|0|||
33263459|NCT01049334|62633937|FG000|Overall Study|Protocol Violation|0|||
33263460|NCT01049334|62633938|FG001|Overall Study|Protocol Violation|1|||
33263461|NCT01048944|62633948|FG000|Overall Study|Protocol Violation|8|||
33263462|NCT01048944|62633949|FG001|Overall Study|Protocol Violation|10|||
33263463|NCT01048944|62633950|FG002|Overall Study|Protocol Violation|10|||
33263464|NCT01048944|62633951|FG003|Overall Study|Protocol Violation|2|||
33263465|NCT01048866|62633963|FG000|Overall Study|Adverse Event|1|||
33263466|NCT01048866|62633964|FG001|Overall Study|Adverse Event|0|||
33263467|NCT01048866|62633963|FG000|Overall Study|Protocol Violation|1|||
33263468|NCT01048866|62633964|FG001|Overall Study|Protocol Violation|0|||
33263469|NCT01048866|62633963|FG000|Overall Study|Physician Decision|1|||
33263470|NCT01048866|62633964|FG001|Overall Study|Physician Decision|0|||
33263471|NCT01048866|62633963|FG000|Overall Study|Withdrawal by Subject|0|||
33263472|NCT01048866|62633964|FG001|Overall Study|Withdrawal by Subject|2|||
33263473|NCT01048866|62633963|FG000|Overall Study|Lost to Follow-up|0|||
33263474|NCT01048866|62633964|FG001|Overall Study|Lost to Follow-up|2|||
33263475|NCT01048866|62633963|FG000|Overall Study|Other|1|||
33263476|NCT01048866|62633964|FG001|Overall Study|Other|1|||
33263477|NCT01048788|62633973|FG000|Overall Study|Adverse Event|5|||
33263478|NCT01048788|62633974|FG001|Overall Study|Adverse Event|1|||
33263479|NCT01048788|62633975|FG002|Overall Study|Adverse Event|1|||
33263480|NCT01048788|62633973|FG000|Overall Study|Lack of Efficacy|0|||
33263481|NCT01048788|62633974|FG001|Overall Study|Lack of Efficacy|0|||
33263482|NCT01048788|62633975|FG002|Overall Study|Lack of Efficacy|1|||
33263483|NCT01048788|62633973|FG000|Overall Study|Withdrawal by Subject|0|||
33263484|NCT01048788|62633974|FG001|Overall Study|Withdrawal by Subject|1|||
33263485|NCT01048788|62633975|FG002|Overall Study|Withdrawal by Subject|0|||
33263486|NCT01048242|62633985|FG000|Overall Study|See study flow chart|4|||
33263487|NCT01048242|62633986|FG001|Overall Study|See study flow chart|2|||
33263488|NCT01047306|62633994|FG000|Overall Study|Withdrawal by Subject|2|||
33263489|NCT01047306|62633995|FG001|Overall Study|Withdrawal by Subject|0|||
33263490|NCT01047306|62633994|FG000|Overall Study|Lost to Follow-up|1|||
33263491|NCT01047306|62633995|FG001|Overall Study|Lost to Follow-up|0|||
33263492|NCT01046682|62634005|FG000|Overall Study|Adverse Event|2|||
33263493|NCT01046682|62634006|FG001|Overall Study|Adverse Event|0|||
33263494|NCT01044732|62634014|FG000|Overall Study|Lost to Follow-up|2|||
33263495|NCT01044732|62634015|FG001|Overall Study|Lost to Follow-up|1|||
33263496|NCT01044732|62634014|FG000|Overall Study|Physician Decision|5|||
33263497|NCT01044732|62634015|FG001|Overall Study|Physician Decision|3|||
33263498|NCT01044732|62634014|FG000|Overall Study|Protocol Violation|11|||
33263499|NCT01044732|62634015|FG001|Overall Study|Protocol Violation|12|||
33263500|NCT01044732|62634014|FG000|Overall Study|Withdrawal by Subject|0|||
33263501|NCT01044732|62634015|FG001|Overall Study|Withdrawal by Subject|1|||
33263502|NCT01044732|62634014|FG000|Overall Study|Inadequate bowel preparation|11|||
33263503|NCT01044732|62634015|FG001|Overall Study|Inadequate bowel preparation|17|||
33263504|NCT01044732|62634014|FG000|Overall Study|Inability to reach cecum|5|||
33263505|NCT01044732|62634015|FG001|Overall Study|Inability to reach cecum|2|||
33263506|NCT01044732|62634014|FG000|Overall Study|Technical error or malfunction|15|||
33263507|NCT01044732|62634015|FG001|Overall Study|Technical error or malfunction|14|||
33263508|NCT01044498|62634025|FG000|Overall Study|Withdrew consent|1|||
33263509|NCT01044498|62634026|FG001|Overall Study|Withdrew consent|1|||
33263510|NCT01044498|62634025|FG000|Overall Study|Adverse Event|1|||
33263511|NCT01044498|62634026|FG001|Overall Study|Adverse Event|1|||
33263512|NCT01044498|62634025|FG000|Overall Study|Other|1|||
33263513|NCT01044498|62634026|FG001|Overall Study|Other|0|||
33263514|NCT01043874|62634032|FG000|Overall Study|Adverse Event|3|||
33263515|NCT01043874|62634032|FG000|Overall Study|Withdrawal by Subject|1|||
33263516|NCT01043874|62634032|FG000|Overall Study|Lack of Efficacy|1|||
33263517|NCT01043874|62634032|FG000|Overall Study|Administrative Problems|1|||
33263518|NCT01042938|62634038|FG000|Overall Study|Withdrawal by Subject|1|||
33263519|NCT01042938|62634039|FG001|Overall Study|Withdrawal by Subject|1|||
33263520|NCT01042938|62634038|FG000|Overall Study|Protocol Violation|1|||
33263521|NCT01042938|62634039|FG001|Overall Study|Protocol Violation|1|||
33263522|NCT01042938|62634038|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
33263523|NCT01042938|62634039|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
33263524|NCT01042158|62634047|FG000|Overall Study|Physician Decision|1|||
33263525|NCT03408444|62634055|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
33263526|NCT03408444|62634056|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
33263527|NCT03408444|62634057|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
33263528|NCT03408444|62634058|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
33263529|NCT03408444|62634055|FG000|Overall Study|Lens Discomfort|0|||
33263530|NCT03408444|62634056|FG001|Overall Study|Lens Discomfort|1|||
33263531|NCT03408444|62634057|FG002|Overall Study|Lens Discomfort|0|||
33263532|NCT03408444|62634058|FG003|Overall Study|Lens Discomfort|0|||
33263533|NCT03408444|62634055|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
33263534|NCT03408444|62634056|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
33263535|NCT03408444|62634057|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
33263536|NCT03408444|62634058|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
33263537|NCT03408444|62634055|FG000|Overall Study|Withdrawal by Subject|0|||
33263538|NCT03408444|62634056|FG001|Overall Study|Withdrawal by Subject|2|||
33263539|NCT03408444|62634057|FG002|Overall Study|Withdrawal by Subject|3|||
33263540|NCT03408444|62634058|FG003|Overall Study|Withdrawal by Subject|0|||
33263541|NCT03408444|62634055|FG000|Overall Study|Lost to Follow-up|0|||
33263542|NCT03408444|62634056|FG001|Overall Study|Lost to Follow-up|0|||
33263543|NCT03408444|62634057|FG002|Overall Study|Lost to Follow-up|1|||
33263544|NCT03408444|62634058|FG003|Overall Study|Lost to Follow-up|0|||
33263545|NCT03408444|62634055|FG000|Overall Study|Adverse Event|0|||
33263546|NCT03408444|62634056|FG001|Overall Study|Adverse Event|0|||
33263547|NCT03408444|62634057|FG002|Overall Study|Adverse Event|0|||
33263548|NCT03408444|62634058|FG003|Overall Study|Adverse Event|1|||
33263549|NCT03408444|62634055|FG000|Overall Study|Lens Handling Difficulties|0|||
33263550|NCT03408444|62634056|FG001|Overall Study|Lens Handling Difficulties|0|||
33263551|NCT03408444|62634057|FG002|Overall Study|Lens Handling Difficulties|1|||
33263552|NCT03408444|62634058|FG003|Overall Study|Lens Handling Difficulties|0|||
33263553|NCT03408444|62634055|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
33263554|NCT03408444|62634056|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
33263555|NCT03408444|62634057|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
33263556|NCT03408444|62634058|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
33263557|NCT03400956|62634088|FG000|Treatment Period 1|Adverse Event|0|||
33263558|NCT03400956|62634089|FG001|Treatment Period 1|Adverse Event|1|||
33263559|NCT03400956|62634090|FG002|Treatment Period 1|Adverse Event|0|||
33263560|NCT03400956|62634088|FG000|Treatment Period 1|Lost to Follow-up|0|||
33263561|NCT03400956|62634089|FG001|Treatment Period 1|Lost to Follow-up|0|||
33263562|NCT03400956|62634090|FG002|Treatment Period 1|Lost to Follow-up|1|||
33263563|NCT03400956|62634088|FG000|Treatment Period 1|Protocol Violation|0|||
33263564|NCT03400956|62634089|FG001|Treatment Period 1|Protocol Violation|2|||
33263565|NCT03400956|62634090|FG002|Treatment Period 1|Protocol Violation|0|||
33263566|NCT03400956|62634088|FG000|Treatment Period 1|Study terminated by sponsor|3|||
33263567|NCT03400956|62634089|FG001|Treatment Period 1|Study terminated by sponsor|1|||
33263568|NCT03400956|62634090|FG002|Treatment Period 1|Study terminated by sponsor|1|||
33263569|NCT03400956|62634088|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33263570|NCT03400956|62634089|FG001|Treatment Period 1|Withdrawal by Subject|2|||
33263571|NCT03400956|62634090|FG002|Treatment Period 1|Withdrawal by Subject|4|||
33263572|NCT03400956|62634088|FG000|Treatment Period 1|Other|1|||
33263573|NCT03400956|62634089|FG001|Treatment Period 1|Other|2|||
33263574|NCT03400956|62634090|FG002|Treatment Period 1|Other|3|||
33263575|NCT03400956|62634088|FG000|Post-treatment Period 1|Adverse Event|0|||
33263576|NCT03400956|62634089|FG001|Post-treatment Period 1|Adverse Event|0|||
33263577|NCT03400956|62634090|FG002|Post-treatment Period 1|Adverse Event|1|||
33263578|NCT03400956|62634088|FG000|Post-treatment Period 1|Physician Decision|2|||
33263579|NCT03400956|62634089|FG001|Post-treatment Period 1|Physician Decision|3|||
33263580|NCT03400956|62634090|FG002|Post-treatment Period 1|Physician Decision|0|||
33263581|NCT03400956|62634088|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
33263582|NCT03400956|62634089|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
33263583|NCT03400956|62634090|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
33263584|NCT03400956|62634088|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
33263585|NCT03400956|62634089|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
33263586|NCT03400956|62634090|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
33263587|NCT03400956|62634088|FG000|Post-treatment Period 1|Other|4|||
33263588|NCT03400956|62634089|FG001|Post-treatment Period 1|Other|3|||
33263589|NCT03400956|62634090|FG002|Post-treatment Period 1|Other|4|||
33263590|NCT03400956|62634088|FG000|Treatment Period 2|Adverse Event|2|||
33263591|NCT03400956|62634089|FG001|Treatment Period 2|Adverse Event|1|||
33263592|NCT03400956|62634090|FG002|Treatment Period 2|Adverse Event|1|||
33263593|NCT03400956|62634088|FG000|Treatment Period 2|Lost to Follow-up|1|||
33263594|NCT03400956|62634089|FG001|Treatment Period 2|Lost to Follow-up|1|||
33263595|NCT03400956|62634090|FG002|Treatment Period 2|Lost to Follow-up|0|||
33263596|NCT03400956|62634088|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33263597|NCT03400956|62634089|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33263598|NCT03400956|62634090|FG002|Treatment Period 2|Withdrawal by Subject|3|||
33263599|NCT03400956|62634088|FG000|Treatment Period 2|Other|1|||
33263600|NCT03400956|62634089|FG001|Treatment Period 2|Other|1|||
33263601|NCT03400956|62634090|FG002|Treatment Period 2|Other|0|||
33263602|NCT03400956|62634088|FG000|Follow-up Period|Withdrawal by Subject|0|||
33263603|NCT03400956|62634089|FG001|Follow-up Period|Withdrawal by Subject|0|||
33263604|NCT03400956|62634090|FG002|Follow-up Period|Withdrawal by Subject|1|||
33263605|NCT03400956|62634088|FG000|Follow-up Period|Other|0|||
33263606|NCT03400956|62634089|FG001|Follow-up Period|Other|0|||
33263607|NCT03400956|62634090|FG002|Follow-up Period|Other|1|||
33263608|NCT00012012|62634103|FG000|Overall Study|Protocol Violation|1|||
33263609|NCT00012012|62634104|FG001|Overall Study|Protocol Violation|1|||
33263610|NCT00012012|62634103|FG000|Overall Study|Withdrawal by Subject|0|||
33263611|NCT00012012|62634104|FG001|Overall Study|Withdrawal by Subject|2|||
33263612|NCT00010374|62634110|FG000|Overall Study|False positive phrenic nerve test|1|||
33263613|NCT00559962|62634132|FG000|Overall Study|Adverse Event|1|||
33263614|NCT00559962|62634133|FG001|Overall Study|Adverse Event|7|||
33263615|NCT00559962|62634134|FG002|Overall Study|Adverse Event|8|||
33263616|NCT00559962|62634135|FG003|Overall Study|Adverse Event|5|||
33263617|NCT00559962|62634136|FG004|Overall Study|Adverse Event|11|||
33263618|NCT00559962|62634137|FG005|Overall Study|Adverse Event|4|||
33263619|NCT00559962|62634138|FG006|Overall Study|Adverse Event|4|||
33484561|NCT02942264|62861447|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
33263620|NCT00559962|62634139|FG007|Overall Study|Adverse Event|2|||
33263621|NCT00559962|62634132|FG000|Overall Study|Lost to Follow-up|0|||
33263622|NCT00559962|62634133|FG001|Overall Study|Lost to Follow-up|1|||
33263623|NCT00559962|62634134|FG002|Overall Study|Lost to Follow-up|0|||
33263624|NCT00559962|62634135|FG003|Overall Study|Lost to Follow-up|0|||
33263625|NCT00559962|62634136|FG004|Overall Study|Lost to Follow-up|0|||
33263626|NCT00559962|62634137|FG005|Overall Study|Lost to Follow-up|0|||
33263627|NCT00559962|62634138|FG006|Overall Study|Lost to Follow-up|0|||
33263628|NCT00559962|62634139|FG007|Overall Study|Lost to Follow-up|0|||
33263629|NCT00559962|62634132|FG000|Overall Study|Withdrawal by Subject|1|||
33263630|NCT00559962|62634133|FG001|Overall Study|Withdrawal by Subject|1|||
33263631|NCT00559962|62634134|FG002|Overall Study|Withdrawal by Subject|2|||
33263632|NCT00559962|62634135|FG003|Overall Study|Withdrawal by Subject|0|||
33263633|NCT00559962|62634136|FG004|Overall Study|Withdrawal by Subject|3|||
33263634|NCT00559962|62634137|FG005|Overall Study|Withdrawal by Subject|1|||
33263635|NCT00559962|62634138|FG006|Overall Study|Withdrawal by Subject|0|||
33263636|NCT00559962|62634139|FG007|Overall Study|Withdrawal by Subject|2|||
33263637|NCT00559962|62634132|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
33263638|NCT00559962|62634133|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
33263639|NCT00559962|62634134|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
33263640|NCT00559962|62634135|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
33263641|NCT00559962|62634136|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
33263642|NCT00559962|62634137|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
33263643|NCT00559962|62634138|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
33263644|NCT00559962|62634139|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
33263645|NCT00559104|62634160|FG000|Overall Study|Lack of Efficacy|9|||
33263646|NCT00559104|62634161|FG001|Overall Study|Lack of Efficacy|0|||
33263647|NCT00558636|62634169|FG000|Treatment|Adverse Event|9|||
33263648|NCT00558636|62634170|FG001|Treatment|Adverse Event|2|||
33263649|NCT00558636|62634169|FG000|Treatment|Withdrawal by Subject|2|||
33263650|NCT00558636|62634170|FG001|Treatment|Withdrawal by Subject|0|||
33263651|NCT00558636|62634169|FG000|Treatment|Premature termination of the study|35|||
33263652|NCT00558636|62634170|FG001|Treatment|Premature termination of the study|37|||
33263653|NCT00558636|62634169|FG000|Treatment|Disease progression|1|||
33263654|NCT00558636|62634170|FG001|Treatment|Disease progression|5|||
33263655|NCT00558636|62634169|FG000|Follow-up|Premature termination of the study|12|||
33263656|NCT00558636|62634170|FG001|Follow-up|Premature termination of the study|7|||
33263657|NCT00558558|62634176|FG000|Overall Study|Unable to swallow|1|||
33263658|NCT00558558|62634176|FG000|Overall Study|Withdrawal by Subject|1|||
33263659|NCT00558558|62634176|FG000|Overall Study|Lack of Efficacy|4|||
33263660|NCT00557622|62634182|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
33263661|NCT00557622|62634183|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
33263662|NCT00557622|62634182|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
33263663|NCT00557622|62634183|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
33263664|NCT00557622|62634182|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
33263665|NCT00557622|62634183|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
33263666|NCT00557466|62634195|FG000|Overall Study|Adverse Event|3|||
33263667|NCT00557466|62634196|FG001|Overall Study|Adverse Event|1|||
33263668|NCT00557466|62634197|FG002|Overall Study|Adverse Event|4|||
33263669|NCT00557466|62634198|FG003|Overall Study|Adverse Event|1|||
33263670|NCT00557466|62634199|FG004|Overall Study|Adverse Event|2|||
33263671|NCT00557466|62634200|FG005|Overall Study|Adverse Event|4|||
33263672|NCT00557466|62634195|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33263673|NCT00557466|62634196|FG001|Overall Study|Abnormal laboratory value(s)|2|||
33263674|NCT00557466|62634197|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33263675|NCT00557466|62634198|FG003|Overall Study|Abnormal laboratory value(s)|0|||
33263676|NCT00557466|62634199|FG004|Overall Study|Abnormal laboratory value(s)|0|||
33263677|NCT00557466|62634200|FG005|Overall Study|Abnormal laboratory value(s)|0|||
33263678|NCT00557466|62634195|FG000|Overall Study|Protocol deviation|0|||
33263679|NCT00557466|62634196|FG001|Overall Study|Protocol deviation|1|||
33263680|NCT00557466|62634197|FG002|Overall Study|Protocol deviation|0|||
33263681|NCT00557466|62634198|FG003|Overall Study|Protocol deviation|2|||
33263682|NCT00557466|62634199|FG004|Overall Study|Protocol deviation|0|||
33263683|NCT00557466|62634200|FG005|Overall Study|Protocol deviation|0|||
33263684|NCT00557466|62634195|FG000|Overall Study|Subject withdrew consent|0|||
33263685|NCT00557466|62634196|FG001|Overall Study|Subject withdrew consent|0|||
33263686|NCT00557466|62634197|FG002|Overall Study|Subject withdrew consent|0|||
33263687|NCT00557466|62634198|FG003|Overall Study|Subject withdrew consent|0|||
33263688|NCT00557466|62634199|FG004|Overall Study|Subject withdrew consent|1|||
33263689|NCT00557466|62634200|FG005|Overall Study|Subject withdrew consent|2|||
33263690|NCT00557466|62634195|FG000|Overall Study|Administrative problems|0|||
33263691|NCT00557466|62634196|FG001|Overall Study|Administrative problems|1|||
33263692|NCT00557466|62634197|FG002|Overall Study|Administrative problems|1|||
33263693|NCT00557466|62634198|FG003|Overall Study|Administrative problems|0|||
33263694|NCT00557466|62634199|FG004|Overall Study|Administrative problems|0|||
33263695|NCT00557466|62634200|FG005|Overall Study|Administrative problems|0|||
33263696|NCT00557466|62634195|FG000|Overall Study|Abnormal test procedure results|0|||
33263697|NCT00557466|62634196|FG001|Overall Study|Abnormal test procedure results|0|||
33263698|NCT00557466|62634197|FG002|Overall Study|Abnormal test procedure results|1|||
33263699|NCT00557466|62634198|FG003|Overall Study|Abnormal test procedure results|0|||
33263700|NCT00557466|62634199|FG004|Overall Study|Abnormal test procedure results|0|||
33263701|NCT00557466|62634200|FG005|Overall Study|Abnormal test procedure results|0|||
33263702|NCT00557466|62634195|FG000|Overall Study|Lost to Follow-up|0|||
33263703|NCT00557466|62634196|FG001|Overall Study|Lost to Follow-up|0|||
33263704|NCT00557466|62634197|FG002|Overall Study|Lost to Follow-up|0|||
33263705|NCT00557466|62634198|FG003|Overall Study|Lost to Follow-up|1|||
33263706|NCT00557466|62634199|FG004|Overall Study|Lost to Follow-up|0|||
33263707|NCT00557466|62634200|FG005|Overall Study|Lost to Follow-up|0|||
33263708|NCT00557310|62634214|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
33263709|NCT00557310|62634214|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
33263710|NCT00557310|62634214|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
33263711|NCT00557310|62634214|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
33263712|NCT00557310|62634214|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
33263713|NCT00557310|62634214|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
33263714|NCT00555438|62634218|FG000|10 Days Post-operative|Death|4|||
33263715|NCT00555438|62634218|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
33263716|NCT00553644|62634222|FG000|Overall Study|Adverse Event|17|||
33263717|NCT00553644|62634222|FG000|Overall Study|Withdrawal by Subject|4|||
33263718|NCT00553644|62634222|FG000|Overall Study|Physician Decision|1|||
33263719|NCT00553644|62634222|FG000|Overall Study|Alternative therapy|6|||
33263720|NCT00553332|62634226|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
33263721|NCT00552396|62634237|FG000|Overall Study|protocol withdrawal criteria|3|||
33263722|NCT00552396|62634238|FG001|Overall Study|protocol withdrawal criteria|3|||
33263723|NCT00552396|62634239|FG002|Overall Study|protocol withdrawal criteria|3|||
33263724|NCT00552396|62634240|FG003|Overall Study|protocol withdrawal criteria|6|||
33263725|NCT00552396|62634241|FG004|Overall Study|protocol withdrawal criteria|3|||
33263726|NCT00552396|62634242|FG005|Overall Study|protocol withdrawal criteria|3|||
33263727|NCT00552396|62634243|FG006|Overall Study|protocol withdrawal criteria|9|||
33263728|NCT00552240|62634279|FG000|Overall Study|Adverse Event|9|||
33263729|NCT00552240|62634280|FG001|Overall Study|Adverse Event|9|||
33263730|NCT00552240|62634279|FG000|Overall Study|Protocol Violation|1|||
33263731|NCT00552240|62634280|FG001|Overall Study|Protocol Violation|1|||
33263732|NCT00552240|62634279|FG000|Overall Study|Lost to Follow-up|5|||
33263733|NCT00552240|62634280|FG001|Overall Study|Lost to Follow-up|6|||
33263734|NCT00552240|62634279|FG000|Overall Study|Withdrawal by Subject|2|||
33263735|NCT00552240|62634280|FG001|Overall Study|Withdrawal by Subject|2|||
33263736|NCT00552240|62634279|FG000|Overall Study|Lack of Efficacy|6|||
33263737|NCT00552240|62634280|FG001|Overall Study|Lack of Efficacy|0|||
33263738|NCT00552240|62634279|FG000|Overall Study|Other|1|||
33263739|NCT00552240|62634280|FG001|Overall Study|Other|0|||
33263740|NCT00552084|62634288|FG000|Overall Study|Adverse Event|2|||
33263741|NCT00552084|62634289|FG001|Overall Study|Adverse Event|3|||
33263742|NCT00552084|62634288|FG000|Overall Study|Withdrawal by Subject|4|||
33263743|NCT00552084|62634289|FG001|Overall Study|Withdrawal by Subject|5|||
33263744|NCT00552084|62634288|FG000|Overall Study|Protocol Violation|1|||
33263745|NCT00552084|62634289|FG001|Overall Study|Protocol Violation|0|||
33263746|NCT00552084|62634288|FG000|Overall Study|change in anti-arrythmic drug|1|||
33263747|NCT00552084|62634289|FG001|Overall Study|change in anti-arrythmic drug|1|||
33263748|NCT00550836|62634297|FG000|Overall Study|Withdrawal by Subject|3|||
33263749|NCT00550836|62634298|FG001|Overall Study|Withdrawal by Subject|9|||
33263750|NCT00550680|62634304|FG000|Overall Study|Administrative Reasons|1|||
33263751|NCT00550680|62634304|FG000|Overall Study|Adverse Event|5|||
33263752|NCT00550680|62634304|FG000|Overall Study|Death|3|||
33263753|NCT00550680|62634304|FG000|Overall Study|Early Improvement|1|||
33263754|NCT00550680|62634304|FG000|Overall Study|Lost to Follow-up|3|||
33263755|NCT00550680|62634304|FG000|Overall Study|Lack of Efficacy|1|||
33263756|NCT00550680|62634304|FG000|Overall Study|Other|10|||
33263757|NCT00550680|62634304|FG000|Overall Study|Protocol Violation|7|||
33263758|NCT00550680|62634304|FG000|Overall Study|Refused Treatment|19|||
33263759|NCT00550680|62634304|FG000|Overall Study|Screen Failure|6|||
33263760|NCT00554190|62634308|FG000|Overall Study|Termination forms not completed|10|||
33263761|NCT00556374|62634314|FG000|Overall Study|Withdrawal by Subject|235|||
33263762|NCT00556374|62634315|FG001|Overall Study|Withdrawal by Subject|205|||
33263763|NCT00556374|62634314|FG000|Overall Study|Death|158|||
33263764|NCT00556374|62634315|FG001|Overall Study|Death|127|||
33263765|NCT00556374|62634314|FG000|Overall Study|Lost to Follow-up|24|||
33263766|NCT00556374|62634315|FG001|Overall Study|Lost to Follow-up|17|||
33263767|NCT00556374|62634314|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
33263768|NCT00556374|62634315|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
33263769|NCT04677959|62634346|FG000|Overall Study|Adverse Event|1|||
33263770|NCT04677959|62634347|FG001|Overall Study|Adverse Event|9|||
33263771|NCT04677959|62634346|FG000|Overall Study|Withdrawal by Subject|2|||
33263772|NCT04677959|62634347|FG001|Overall Study|Withdrawal by Subject|15|||
33263773|NCT04677959|62634346|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33263774|NCT04677959|62634347|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33263775|NCT04677959|62634346|FG000|Overall Study|Non-compliance with study drug|0|||
33263776|NCT04677959|62634347|FG001|Overall Study|Non-compliance with study drug|2|||
33263777|NCT04677959|62634346|FG000|Overall Study|Protocol deviation|0|||
33263778|NCT04677959|62634347|FG001|Overall Study|Protocol deviation|11|||
33263779|NCT04677959|62634346|FG000|Overall Study|Lost to Follow-up|9|||
33263780|NCT04677959|62634347|FG001|Overall Study|Lost to Follow-up|13|||
33263781|NCT04677959|62634346|FG000|Overall Study|Other than specified|0|||
33263782|NCT04677959|62634347|FG001|Overall Study|Other than specified|8|||
33263783|NCT04330638|62634374|FG000|Overall Study|Adverse Event|9|||
33263784|NCT04330638|62634375|FG001|Overall Study|Adverse Event|10|||
33263785|NCT04330638|62634376|FG002|Overall Study|Adverse Event|15|||
33263786|NCT04330638|62634377|FG003|Overall Study|Adverse Event|6|||
33263787|NCT04330638|62634378|FG004|Overall Study|Adverse Event|10|||
33263788|NCT04330638|62634379|FG005|Overall Study|Adverse Event|5|||
33263789|NCT04330638|62634374|FG000|Overall Study|Other|2|||
33263790|NCT04330638|62634375|FG001|Overall Study|Other|2|||
33263791|NCT04330638|62634376|FG002|Overall Study|Other|5|||
33263792|NCT04330638|62634377|FG003|Overall Study|Other|1|||
33263793|NCT04330638|62634378|FG004|Overall Study|Other|3|||
33263794|NCT04330638|62634379|FG005|Overall Study|Other|2|||
33263795|NCT04330638|62634374|FG000|Overall Study|Withdrawal by Subject|4|||
33263796|NCT04330638|62634375|FG001|Overall Study|Withdrawal by Subject|0|||
33263797|NCT04330638|62634376|FG002|Overall Study|Withdrawal by Subject|0|||
33263798|NCT04330638|62634377|FG003|Overall Study|Withdrawal by Subject|0|||
33263799|NCT04330638|62634378|FG004|Overall Study|Withdrawal by Subject|0|||
33263800|NCT04330638|62634379|FG005|Overall Study|Withdrawal by Subject|0|||
33263801|NCT04330638|62634374|FG000|Overall Study|Lost to Follow-up|3|||
33263802|NCT04330638|62634375|FG001|Overall Study|Lost to Follow-up|2|||
33263803|NCT04330638|62634376|FG002|Overall Study|Lost to Follow-up|3|||
33263804|NCT04330638|62634377|FG003|Overall Study|Lost to Follow-up|2|||
33263805|NCT04330638|62634378|FG004|Overall Study|Lost to Follow-up|3|||
33263806|NCT04330638|62634379|FG005|Overall Study|Lost to Follow-up|0|||
33263807|NCT04194541|62634400|FG000|Day 1 Through 13|Lost to Follow-up|3|||
33263808|NCT04194541|62634400|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
33263809|NCT04194541|62634400|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
33263810|NCT04006392|62634418|FG000|Overall Study|Lost to Follow-up|0|||
33263811|NCT04006392|62634419|FG001|Overall Study|Lost to Follow-up|1|||
33263812|NCT03959423|62634427|FG000|Overall Study|Withdrawal by Subject|2|||
33263813|NCT03959423|62634428|FG001|Overall Study|Withdrawal by Subject|3|||
33263814|NCT03959423|62634427|FG000|Overall Study|Physician Decision|0|||
33263815|NCT03959423|62634428|FG001|Overall Study|Physician Decision|1|||
33263816|NCT03959423|62634427|FG000|Overall Study|Lost to Follow-up|1|||
33263817|NCT03959423|62634428|FG001|Overall Study|Lost to Follow-up|0|||
33263818|NCT03959423|62634427|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
33263819|NCT03959423|62634428|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33263820|NCT03786783|62634434|FG000|Overall Study|Death|1|||
33263821|NCT03786783|62634434|FG000|Overall Study|Physician Decision|6|||
33263822|NCT03786783|62634434|FG000|Overall Study|Withdrawal by Subject|2|||
33263823|NCT03786783|62634434|FG000|Overall Study|Disease Progression|7|||
33263824|NCT03786783|62634434|FG000|Overall Study|Patient/Parent Refusal|4|||
33263825|NCT03432494|62634448|FG000|Overall Study|Death|1|||
33263826|NCT03432494|62634448|FG000|Overall Study|Noncompliance|1|||
33263827|NCT03312634|62634454|FG000|Overall Study|Adverse Event|6|||
33263828|NCT03312634|62634455|FG001|Overall Study|Adverse Event|0|||
33263829|NCT03312634|62634454|FG000|Overall Study|Sponsor request|2|||
33263830|NCT03312634|62634455|FG001|Overall Study|Sponsor request|0|||
33263831|NCT03312634|62634454|FG000|Overall Study|Withdrawal by Subject|11|||
33263832|NCT03312634|62634455|FG001|Overall Study|Withdrawal by Subject|9|||
33263833|NCT03312634|62634454|FG000|Overall Study|Ongoing in study at DCO|88|||
33263834|NCT03312634|62634455|FG001|Overall Study|Ongoing in study at DCO|0|||
33263835|NCT03312634|62634454|FG000|Overall Study|Enrolled in an interventional study|0|||
33263836|NCT03312634|62634455|FG001|Overall Study|Enrolled in an interventional study|52|||
33263837|NCT03312634|62634454|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
33263838|NCT03312634|62634455|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
33263839|NCT03312634|62634454|FG000|Overall Study|Death|0|||
33263840|NCT03312634|62634455|FG001|Overall Study|Death|1|||
33263841|NCT03312634|62634454|FG000|Overall Study|Non-compliance|0|||
33263842|NCT03312634|62634455|FG001|Overall Study|Non-compliance|2|||
33263843|NCT03312634|62634454|FG000|Overall Study|Lost to Follow-up|0|||
33263844|NCT03312634|62634455|FG001|Overall Study|Lost to Follow-up|1|||
33263845|NCT03312634|62634454|FG000|Overall Study|Enrolled into non-interventional study|0|||
33661791|NCT01697579|63091446|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
33263846|NCT03312634|62634455|FG001|Overall Study|Enrolled into non-interventional study|5|||
33263847|NCT03312634|62634454|FG000|Overall Study|Worsening clinical condition|0|||
33263848|NCT03312634|62634455|FG001|Overall Study|Worsening clinical condition|1|||
33263849|NCT03312634|62634454|FG000|Overall Study|Participant did not want to travel|0|||
33263850|NCT03312634|62634455|FG001|Overall Study|Participant did not want to travel|1|||
33263851|NCT03287830|62634466|FG000|Overall Study|Withdrawal by Subject|1|||
33367874|NCT00696436|62746790|FG004|Overall Study|Withdrawal by Subject|1|||
33367875|NCT00696436|62746786|FG000|Overall Study|Lack of Efficacy|3|||
33367876|NCT00696436|62746787|FG001|Overall Study|Lack of Efficacy|1|||
33367877|NCT00696436|62746788|FG002|Overall Study|Lack of Efficacy|5|||
33367878|NCT00696436|62746789|FG003|Overall Study|Lack of Efficacy|2|||
33367879|NCT00696436|62746790|FG004|Overall Study|Lack of Efficacy|4|||
33367880|NCT00696436|62746786|FG000|Overall Study|Participant Unavailability|2|||
33367881|NCT00696436|62746787|FG001|Overall Study|Participant Unavailability|0|||
33367882|NCT00696436|62746788|FG002|Overall Study|Participant Unavailability|2|||
33367883|NCT00696436|62746789|FG003|Overall Study|Participant Unavailability|1|||
33367884|NCT00696436|62746790|FG004|Overall Study|Participant Unavailability|0|||
33367885|NCT00696436|62746786|FG000|Overall Study|Administrative Error|2|||
33484562|NCT02942264|62861448|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
33484563|NCT02942264|62861449|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
33484564|NCT02942264|62861450|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
33263852|NCT03287830|62634467|FG001|Overall Study|Withdrawal by Subject|1|||
33367886|NCT00696436|62746787|FG001|Overall Study|Administrative Error|0|||
33367887|NCT00696436|62746788|FG002|Overall Study|Administrative Error|2|||
33367888|NCT00696436|62746789|FG003|Overall Study|Administrative Error|0|||
33367889|NCT00696436|62746790|FG004|Overall Study|Administrative Error|0|||
33367890|NCT00696436|62746786|FG000|Overall Study|Participant Non-compliance|0|||
33367891|NCT00696436|62746787|FG001|Overall Study|Participant Non-compliance|0|||
33367892|NCT00696436|62746788|FG002|Overall Study|Participant Non-compliance|1|||
33367893|NCT00696436|62746789|FG003|Overall Study|Participant Non-compliance|2|||
33367894|NCT00696436|62746790|FG004|Overall Study|Participant Non-compliance|0|||
33367895|NCT00696436|62746786|FG000|Overall Study|Administrative Decision|1|||
33367896|NCT00696436|62746787|FG001|Overall Study|Administrative Decision|0|||
33367897|NCT00696436|62746788|FG002|Overall Study|Administrative Decision|0|||
33367898|NCT00696436|62746789|FG003|Overall Study|Administrative Decision|0|||
33367899|NCT00696436|62746790|FG004|Overall Study|Administrative Decision|0|||
33367900|NCT00696436|62746786|FG000|Overall Study|Missing|0|||
33367901|NCT00696436|62746787|FG001|Overall Study|Missing|1|||
33367902|NCT00696436|62746788|FG002|Overall Study|Missing|1|||
33367903|NCT00696436|62746789|FG003|Overall Study|Missing|0|||
33367904|NCT00696436|62746790|FG004|Overall Study|Missing|0|||
33367905|NCT00878072|62746802|FG000|Overall Study|Withdrew consent|2|||
33367906|NCT00594854|62746830|FG000|Overall Study|Study terminated|7|||
33367907|NCT00594854|62746831|FG001|Overall Study|Study terminated|10|||
33367908|NCT00855582|62746840|FG000|Overall Study|Adverse Event|2|||
33367909|NCT00855582|62746841|FG001|Overall Study|Adverse Event|6|||
33367910|NCT00855582|62746842|FG002|Overall Study|Adverse Event|3|||
33367911|NCT00855582|62746840|FG000|Overall Study|Death|1|||
33367912|NCT00855582|62746841|FG001|Overall Study|Death|0|||
33367913|NCT00855582|62746842|FG002|Overall Study|Death|0|||
33367914|NCT00855582|62746840|FG000|Overall Study|Lack of Efficacy|1|||
33367915|NCT00855582|62746841|FG001|Overall Study|Lack of Efficacy|3|||
33367916|NCT00855582|62746842|FG002|Overall Study|Lack of Efficacy|8|||
33367917|NCT00855582|62746840|FG000|Overall Study|Lost to Follow-up|1|||
33367918|NCT00855582|62746841|FG001|Overall Study|Lost to Follow-up|3|||
33367919|NCT00855582|62746842|FG002|Overall Study|Lost to Follow-up|1|||
33367920|NCT00855582|62746840|FG000|Overall Study|Physician Decision|0|||
33367921|NCT00855582|62746841|FG001|Overall Study|Physician Decision|0|||
33367922|NCT00855582|62746842|FG002|Overall Study|Physician Decision|1|||
33263853|NCT03287830|62634466|FG000|Overall Study|not meeting inclusion criteria|5|||
33263854|NCT03287830|62634467|FG001|Overall Study|not meeting inclusion criteria|12|||
33263855|NCT03181633|62634477|FG000|Overall Study|Withdrawal by Subject|1|||
33263856|NCT03181633|62634477|FG000|Overall Study|Missing follow-up visit|1|||
33263857|NCT03122223|62634494|FG000|Overall Study|Withdrawal by Subject|2|||
33263858|NCT03122223|62634495|FG001|Overall Study|Withdrawal by Subject|2|||
33263859|NCT03122223|62634496|FG002|Overall Study|Withdrawal by Subject|1|||
33263860|NCT03122223|62634497|FG003|Overall Study|Withdrawal by Subject|0|||
33263861|NCT03122223|62634494|FG000|Overall Study|Lost to Follow-up|0|||
33263862|NCT03122223|62634495|FG001|Overall Study|Lost to Follow-up|2|||
33367923|NCT00855582|62746840|FG000|Overall Study|Protocol Violation|6|||
33367924|NCT00855582|62746841|FG001|Overall Study|Protocol Violation|2|||
33367925|NCT00855582|62746842|FG002|Overall Study|Protocol Violation|6|||
33367926|NCT00855582|62746840|FG000|Overall Study|Entry Criteria Not Met|8|||
33367927|NCT00855582|62746841|FG001|Overall Study|Entry Criteria Not Met|6|||
33367928|NCT00855582|62746842|FG002|Overall Study|Entry Criteria Not Met|3|||
33484565|NCT02942264|62861451|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
33484566|NCT02942264|62861452|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
33263863|NCT03122223|62634496|FG002|Overall Study|Lost to Follow-up|2|||
33263864|NCT03122223|62634497|FG003|Overall Study|Lost to Follow-up|0|||
33263865|NCT03122223|62634494|FG000|Overall Study|Participant unable to adhere|1|||
33367929|NCT00855582|62746840|FG000|Overall Study|Withdrawal by Subject|7|||
33367930|NCT00855582|62746841|FG001|Overall Study|Withdrawal by Subject|4|||
33367931|NCT00855582|62746842|FG002|Overall Study|Withdrawal by Subject|8|||
33367932|NCT00854724|62746855|FG000|First Intervention|Withdrawal by Subject|1|||
33263866|NCT03122223|62634495|FG001|Overall Study|Participant unable to adhere|1|||
33555513|NCT02347774|62948335|FG000|On Study Treatment|Adverse Event|9|||
33555514|NCT02347774|62948336|FG001|On Study Treatment|Adverse Event|15|||
33555515|NCT02347774|62948337|FG002|On Study Treatment|Adverse Event|19|||
33555516|NCT02347774|62948335|FG000|On Study Treatment|Lack of Efficacy|3|||
33263867|NCT03122223|62634496|FG002|Overall Study|Participant unable to adhere|1|||
33263868|NCT03122223|62634497|FG003|Overall Study|Participant unable to adhere|0|||
33263869|NCT03077087|62634507|FG000|Overall Study|Physician Decision|2|||
33263870|NCT02853604|62634513|FG000|Overall Study|Withdrawal by Subject|12|||
33263871|NCT02853604|62634514|FG001|Overall Study|Withdrawal by Subject|35|||
33263872|NCT02853604|62634513|FG000|Overall Study|Lost to Follow-up|4|||
33263873|NCT02853604|62634514|FG001|Overall Study|Lost to Follow-up|8|||
33263874|NCT02853604|62634513|FG000|Overall Study|Death|1|||
33263875|NCT02853604|62634514|FG001|Overall Study|Death|5|||
33263876|NCT02853604|62634513|FG000|Overall Study|Miscellaneous|11|||
33263877|NCT02853604|62634514|FG001|Overall Study|Miscellaneous|2|||
33263878|NCT02853604|62634513|FG000|Overall Study|Progressive Disease|0|||
33263879|NCT02853604|62634514|FG001|Overall Study|Progressive Disease|2|||
33263880|NCT02632552|62634540|FG000|Overall Study|Lost to Follow-up|14|||
33263881|NCT02632552|62634541|FG001|Overall Study|Lost to Follow-up|8|||
33263882|NCT02632552|62634540|FG000|Overall Study|Withdrawal by Subject|2|||
33263883|NCT02632552|62634541|FG001|Overall Study|Withdrawal by Subject|0|||
33263884|NCT02632552|62634540|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
33367933|NCT00854724|62746856|FG001|First Intervention|Withdrawal by Subject|1|||
33367934|NCT00854724|62746855|FG000|Washout|Protocol Violation|1|||
33367935|NCT00854724|62746856|FG001|Washout|Protocol Violation|0|||
33367936|NCT00854724|62746855|FG000|Washout|Withdrawal by Subject|0|||
33367937|NCT00854724|62746856|FG001|Washout|Withdrawal by Subject|1|||
33367938|NCT00854724|62746855|FG000|Second Intervention|Protocol Violation|1|||
33367939|NCT00854724|62746856|FG001|Second Intervention|Protocol Violation|0|||
33367940|NCT00854724|62746855|FG000|Second Intervention|Physician Decision|0|||
33367941|NCT00854724|62746856|FG001|Second Intervention|Physician Decision|1|||
33367942|NCT00698932|62746894|FG000|Overall Study|Adverse Event|0|||
33367943|NCT00698932|62746895|FG001|Overall Study|Adverse Event|2|||
33367944|NCT00698932|62746894|FG000|Overall Study|Incorrect enrollment|0|||
33367945|NCT00698932|62746895|FG001|Overall Study|Incorrect enrollment|2|||
33367946|NCT00698932|62746894|FG000|Overall Study|Study specific discontinuation criteria|3|||
33367947|NCT00698932|62746895|FG001|Overall Study|Study specific discontinuation criteria|4|||
33367948|NCT00698932|62746894|FG000|Overall Study|Withdrawal by Subject|11|||
33367949|NCT00698932|62746895|FG001|Overall Study|Withdrawal by Subject|23|||
33367950|NCT00698932|62746894|FG000|Overall Study|Lost to Follow-up|6|||
33367951|NCT00698932|62746895|FG001|Overall Study|Lost to Follow-up|1|||
33367952|NCT00698932|62746894|FG000|Overall Study|Severe non-compliance to protocol|1|||
33367953|NCT00698932|62746895|FG001|Overall Study|Severe non-compliance to protocol|2|||
33367954|NCT00698932|62746894|FG000|Overall Study|Safety reasons|0|||
33367955|NCT00698932|62746895|FG001|Overall Study|Safety reasons|2|||
33367956|NCT00698932|62746894|FG000|Overall Study|Death|1|||
33367957|NCT00698932|62746895|FG001|Overall Study|Death|0|||
33367958|NCT00823719|62746903|FG000|Overall Study|Adverse Event|1|||
33367959|NCT00823719|62746904|FG001|Overall Study|Adverse Event|2|||
33367960|NCT00823719|62746903|FG000|Overall Study|Physician Decision|1|||
33367961|NCT00823719|62746904|FG001|Overall Study|Physician Decision|4|||
33367962|NCT00823719|62746903|FG000|Overall Study|Withdrawal by Subject|0|||
33367963|NCT00823719|62746904|FG001|Overall Study|Withdrawal by Subject|1|||
33367964|NCT00823719|62746903|FG000|Overall Study|Disease Progression|4|||
33367965|NCT00823719|62746904|FG001|Overall Study|Disease Progression|4|||
33367966|NCT00875420|62746917|FG000|Overall Study|Adverse Event|0|||
33367967|NCT00875420|62746918|FG001|Overall Study|Adverse Event|1|||
33367968|NCT00875420|62746919|FG002|Overall Study|Adverse Event|1|||
33367969|NCT00875420|62746920|FG003|Overall Study|Adverse Event|0|||
33367970|NCT00875420|62746921|FG004|Overall Study|Adverse Event|0|||
33367971|NCT00875420|62746917|FG000|Overall Study|Inability to complete study procedures|1|||
33367972|NCT00875420|62746918|FG001|Overall Study|Inability to complete study procedures|0|||
33367973|NCT00875420|62746919|FG002|Overall Study|Inability to complete study procedures|1|||
33367974|NCT00875420|62746920|FG003|Overall Study|Inability to complete study procedures|1|||
33367975|NCT00875420|62746921|FG004|Overall Study|Inability to complete study procedures|1|||
33367976|NCT00875420|62746917|FG000|Overall Study|Lost to Follow-up|1|||
33367977|NCT00875420|62746918|FG001|Overall Study|Lost to Follow-up|0|||
33367978|NCT00875420|62746919|FG002|Overall Study|Lost to Follow-up|0|||
33367979|NCT00875420|62746920|FG003|Overall Study|Lost to Follow-up|0|||
33555517|NCT02347774|62948336|FG001|On Study Treatment|Lack of Efficacy|0|||
33263885|NCT02632552|62634541|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
33263886|NCT02525562|62634579|FG000|Overall Study|Death|9|||
33263887|NCT02525562|62634580|FG001|Overall Study|Death|0|||
33367980|NCT00875420|62746921|FG004|Overall Study|Lost to Follow-up|0|||
33367981|NCT00875420|62746917|FG000|Overall Study|Personal reason|0|||
33555518|NCT02347774|62948337|FG002|On Study Treatment|Lack of Efficacy|2|||
33263888|NCT02525562|62634581|FG002|Overall Study|Death|0|||
33263889|NCT02525562|62634579|FG000|Overall Study|Lost to Follow-up|19|||
33263890|NCT02525562|62634580|FG001|Overall Study|Lost to Follow-up|0|||
33367982|NCT00875420|62746918|FG001|Overall Study|Personal reason|0|||
33367983|NCT00875420|62746919|FG002|Overall Study|Personal reason|0|||
33367984|NCT00875420|62746920|FG003|Overall Study|Personal reason|0|||
33367985|NCT00875420|62746921|FG004|Overall Study|Personal reason|1|||
33367986|NCT00875420|62746917|FG000|Overall Study|Prohibited medication|0|||
33367987|NCT00875420|62746918|FG001|Overall Study|Prohibited medication|0|||
33367988|NCT00875420|62746919|FG002|Overall Study|Prohibited medication|0|||
33367989|NCT00875420|62746920|FG003|Overall Study|Prohibited medication|1|||
33367990|NCT00875420|62746921|FG004|Overall Study|Prohibited medication|0|||
33367991|NCT00875420|62746917|FG000|Overall Study|Sponsor decision|0|||
33367992|NCT00875420|62746918|FG001|Overall Study|Sponsor decision|1|||
33367993|NCT00875420|62746919|FG002|Overall Study|Sponsor decision|0|||
33367994|NCT00875420|62746920|FG003|Overall Study|Sponsor decision|0|||
33367995|NCT00875420|62746921|FG004|Overall Study|Sponsor decision|0|||
33367996|NCT00875420|62746917|FG000|Overall Study|Withdrawal by Subject|0|||
33367997|NCT00875420|62746918|FG001|Overall Study|Withdrawal by Subject|0|||
33367998|NCT00875420|62746919|FG002|Overall Study|Withdrawal by Subject|1|||
33367999|NCT00875420|62746920|FG003|Overall Study|Withdrawal by Subject|0|||
33368000|NCT00875420|62746921|FG004|Overall Study|Withdrawal by Subject|0|||
33368001|NCT00822237|62746935|FG000|Dose 1 Vaccination|Not vaccinated|3|||
33368002|NCT00822237|62746936|FG001|Dose 1 Vaccination|Not vaccinated|0|||
33368003|NCT00822237|62746935|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
33368004|NCT00822237|62746936|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
33368005|NCT00822237|62746935|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
33368006|NCT00822237|62746936|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
33368007|NCT00822237|62746935|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
33368008|NCT00822237|62746936|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
33368009|NCT00822237|62746935|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
33368010|NCT00822237|62746936|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
33368011|NCT00577096|62746943|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
33368012|NCT00577096|62746944|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
33368013|NCT00577096|62746943|FG000|Short Term Participation|Withdrawal by Subject|3|||
33368014|NCT00577096|62746944|FG001|Short Term Participation|Withdrawal by Subject|5|||
33368015|NCT00577096|62746943|FG000|Short Term Participation|Death|1|||
33368016|NCT00577096|62746944|FG001|Short Term Participation|Death|1|||
33368017|NCT00863304|62746954|FG000|Overall Study|Adverse Event|10|||
33368018|NCT00863304|62746955|FG001|Overall Study|Adverse Event|4|||
33368019|NCT00863304|62746956|FG002|Overall Study|Adverse Event|14|||
33368020|NCT00863304|62746957|FG003|Overall Study|Adverse Event|16|||
33368021|NCT00863304|62746954|FG000|Overall Study|Lost to Follow-up|1|||
33368022|NCT00863304|62746955|FG001|Overall Study|Lost to Follow-up|5|||
33368023|NCT00863304|62746956|FG002|Overall Study|Lost to Follow-up|4|||
33368024|NCT00863304|62746957|FG003|Overall Study|Lost to Follow-up|2|||
33368025|NCT00863304|62746954|FG000|Overall Study|Lack of Efficacy|57|||
33368026|NCT00863304|62746955|FG001|Overall Study|Lack of Efficacy|26|||
33368027|NCT00863304|62746956|FG002|Overall Study|Lack of Efficacy|30|||
33368028|NCT00863304|62746957|FG003|Overall Study|Lack of Efficacy|28|||
33368029|NCT00863304|62746954|FG000|Overall Study|Withdrawal by Subject|19|||
33368030|NCT00863304|62746955|FG001|Overall Study|Withdrawal by Subject|14|||
33368031|NCT00863304|62746956|FG002|Overall Study|Withdrawal by Subject|20|||
33368032|NCT00863304|62746957|FG003|Overall Study|Withdrawal by Subject|18|||
33368033|NCT00863304|62746954|FG000|Overall Study|Other|1|||
33368034|NCT00863304|62746955|FG001|Overall Study|Other|0|||
33368035|NCT00863304|62746956|FG002|Overall Study|Other|0|||
33368036|NCT00863304|62746957|FG003|Overall Study|Other|1|||
33368037|NCT00863304|62746954|FG000|Overall Study|Protocol Violation|2|||
33263891|NCT02525562|62634581|FG002|Overall Study|Lost to Follow-up|0|||
33263892|NCT02525562|62634579|FG000|Overall Study|Withdrawal by Subject|37|||
33263893|NCT02525562|62634580|FG001|Overall Study|Withdrawal by Subject|0|||
33263894|NCT02525562|62634581|FG002|Overall Study|Withdrawal by Subject|0|||
33263895|NCT02525562|62634579|FG000|Overall Study|Revision/Removal of Study Device|4|||
33263896|NCT02525562|62634580|FG001|Overall Study|Revision/Removal of Study Device|0|||
33263897|NCT02525562|62634581|FG002|Overall Study|Revision/Removal of Study Device|0|||
33263898|NCT02525562|62634579|FG000|Overall Study|Study Closed by Sponsor|154|||
33263899|NCT02525562|62634580|FG001|Overall Study|Study Closed by Sponsor|0|||
33263900|NCT02525562|62634581|FG002|Overall Study|Study Closed by Sponsor|0|||
33368038|NCT00863304|62746955|FG001|Overall Study|Protocol Violation|6|||
33368039|NCT00863304|62746956|FG002|Overall Study|Protocol Violation|2|||
33368040|NCT00863304|62746957|FG003|Overall Study|Protocol Violation|0|||
33368041|NCT00863304|62746954|FG000|Overall Study|Randomized, but not Treated|3|||
33368042|NCT00863304|62746955|FG001|Overall Study|Randomized, but not Treated|1|||
33368043|NCT00863304|62746956|FG002|Overall Study|Randomized, but not Treated|4|||
33368044|NCT00863304|62746957|FG003|Overall Study|Randomized, but not Treated|1|||
33368045|NCT00863304|62746954|FG000|Overall Study|Entered extension study|101|||
33263901|NCT01992653|62634594|FG000|Overall Study|Death|0|||
33263902|NCT01992653|62634595|FG001|Overall Study|Death|0|||
33263903|NCT01992653|62634596|FG002|Overall Study|Death|1|||
33263904|NCT01992653|62634597|FG003|Overall Study|Death|0|||
33263905|NCT01992653|62634598|FG004|Overall Study|Death|1|||
33263906|NCT01992653|62634599|FG005|Overall Study|Death|0|||
33263907|NCT01992653|62634600|FG006|Overall Study|Death|4|||
33263908|NCT01992653|62634601|FG007|Overall Study|Death|2|||
33263909|NCT01992653|62634594|FG000|Overall Study|Lost to Follow-up|0|||
33263910|NCT01992653|62634595|FG001|Overall Study|Lost to Follow-up|0|||
33263911|NCT01992653|62634596|FG002|Overall Study|Lost to Follow-up|0|||
33263912|NCT01992653|62634597|FG003|Overall Study|Lost to Follow-up|0|||
33263913|NCT01992653|62634598|FG004|Overall Study|Lost to Follow-up|0|||
33263914|NCT01992653|62634599|FG005|Overall Study|Lost to Follow-up|0|||
33484567|NCT02942264|62861444|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33484568|NCT02942264|62861445|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33484569|NCT02942264|62861446|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33263915|NCT01992653|62634600|FG006|Overall Study|Lost to Follow-up|0|||
33263916|NCT01992653|62634601|FG007|Overall Study|Lost to Follow-up|1|||
33263917|NCT01992653|62634594|FG000|Overall Study|Study Completed|0|||
33263918|NCT01992653|62634595|FG001|Overall Study|Study Completed|0|||
33263919|NCT01992653|62634596|FG002|Overall Study|Study Completed|0|||
33263920|NCT01992653|62634597|FG003|Overall Study|Study Completed|0|||
33263921|NCT01992653|62634598|FG004|Overall Study|Study Completed|0|||
33263922|NCT01992653|62634599|FG005|Overall Study|Study Completed|0|||
33263923|NCT01992653|62634600|FG006|Overall Study|Study Completed|0|||
33263924|NCT01992653|62634601|FG007|Overall Study|Study Completed|1|||
33263925|NCT01992653|62634594|FG000|Overall Study|Disease Progression|0|||
33368046|NCT00863304|62746955|FG001|Overall Study|Entered extension study|129|||
33368047|NCT00863304|62746956|FG002|Overall Study|Entered extension study|113|||
33368048|NCT00863304|62746957|FG003|Overall Study|Entered extension study|125|||
33263926|NCT01992653|62634595|FG001|Overall Study|Disease Progression|0|||
33263927|NCT01992653|62634596|FG002|Overall Study|Disease Progression|0|||
33368049|NCT00695110|62746969|FG000|Treatment Period 1|Adverse Event|1|||
33368050|NCT00695110|62746969|FG000|Treatment Period 1|Withdrawal by Subject|2|||
33368051|NCT00695110|62746969|FG000|Treatment Period 3|Withdrawal by Subject|1|||
33368052|NCT00695110|62746969|FG000|Treatment Period 4|Adverse Event|1|||
33368053|NCT00594386|62746976|FG000|Overall Study|Major protocol violation|2|||
33368054|NCT00594386|62746976|FG000|Overall Study|Lack of Efficacy|12|||
33368055|NCT00594386|62746976|FG000|Overall Study|Adverse Event|68|||
33368056|NCT00594386|62746976|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
33368057|NCT00594386|62746976|FG000|Overall Study|Subject withdrew consent|35|||
33368058|NCT00594386|62746976|FG000|Overall Study|Study ended per sponsor|115|||
33368059|NCT00594386|62746976|FG000|Overall Study|Lost to Follow-up|6|||
33368060|NCT00594386|62746976|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
33368061|NCT00594386|62746976|FG000|Overall Study|Other: Subject moved to Seattle|1|||
33368062|NCT00594386|62746976|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
33368063|NCT00594386|62746976|FG000|Overall Study|Other: Study terminated per investigator|2|||
33368064|NCT00594386|62746976|FG000|Overall Study|Other: Sponsor closure of study|1|||
33368065|NCT00594386|62746976|FG000|Overall Study|Other: Site terminated participation|1|||
33368066|NCT00594386|62746976|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
33368067|NCT00594386|62746976|FG000|Overall Study|Other: Loss of drivers license|1|||
33368068|NCT00862992|62746983|FG000|Overall Study|Adverse Event|2|||
33368069|NCT00862992|62746984|FG001|Overall Study|Adverse Event|1|||
33368070|NCT00862992|62746985|FG002|Overall Study|Adverse Event|1|||
33368071|NCT00862992|62746983|FG000|Overall Study|Physician Decision|1|||
33368072|NCT00862992|62746984|FG001|Overall Study|Physician Decision|0|||
33368073|NCT00862992|62746985|FG002|Overall Study|Physician Decision|0|||
33484570|NCT02942264|62861447|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33484571|NCT02942264|62861448|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33484572|NCT02942264|62861449|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33484573|NCT02942264|62861450|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33484574|NCT02942264|62861451|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33484575|NCT02942264|62861452|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
33484576|NCT03322514|62861479|FG000|Overall Study|Withdrawal by Subject|1|||
33484577|NCT03322514|62861480|FG001|Overall Study|Withdrawal by Subject|1|||
33484578|NCT03325712|62861494|FG000|Overall Study|Protocol Violation|0|||
33263928|NCT01992653|62634597|FG003|Overall Study|Disease Progression|0|||
33263929|NCT01992653|62634598|FG004|Overall Study|Disease Progression|0|||
33263930|NCT01992653|62634599|FG005|Overall Study|Disease Progression|0|||
33263931|NCT01992653|62634600|FG006|Overall Study|Disease Progression|4|||
33263932|NCT01992653|62634601|FG007|Overall Study|Disease Progression|0|||
33263933|NCT01654276|62634636|FG000|Overall Study|Lack of Efficacy|1|||
33263934|NCT01654276|62634636|FG000|Overall Study|Lost to Follow-up|4|||
33263935|NCT01654276|62634636|FG000|Overall Study|Withdrawal by Subject|1|||
33368074|NCT00862992|62746983|FG000|Overall Study|Withdrawal by Subject|0|||
33368075|NCT00862992|62746984|FG001|Overall Study|Withdrawal by Subject|0|||
33263936|NCT01399658|62634640|FG000|Overall Study|Ineligible|1|||
33263937|NCT01399658|62634640|FG000|Overall Study|Machine Technical Issue|3|||
33263938|NCT01399658|62634640|FG000|Overall Study|Alternative therapy|1|||
33263939|NCT01399658|62634640|FG000|Overall Study|No reason given|1|||
33263940|NCT00590122|62634646|FG000|Overall Study|swallowed oral dissolving dose|1|||
33263941|NCT00590122|62634647|FG001|Overall Study|swallowed oral dissolving dose|0|||
33263942|NCT01386658|62634676|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
33263943|NCT01386658|62634677|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
33263944|NCT01386658|62634676|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
33263945|NCT01386658|62634677|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
33263946|NCT01386684|62634687|FG000|Overall Study|Lost to Follow-up|51|||
33263947|NCT01386684|62634687|FG000|Overall Study|Other|51|||
33263948|NCT01386684|62634687|FG000|Overall Study|Death|47|||
33263949|NCT01386684|62634687|FG000|Overall Study|Withdrawal of Consent|44|||
33263950|NCT01386684|62634687|FG000|Overall Study|Alternative Therapy Required|37|||
33263951|NCT01386684|62634687|FG000|Overall Study|Disease Progression|28|||
33263952|NCT01386684|62634687|FG000|Overall Study|Adverse Event|20|||
33263953|NCT01386684|62634687|FG000|Overall Study|Noncompliance|8|||
33263954|NCT01386684|62634687|FG000|Overall Study|Protocol Violation|4|||
33263955|NCT01386684|62634687|FG000|Overall Study|Missing|3|||
33263956|NCT04980014|62634704|FG000|Overall Study|Participants who are Duplicated|1|||
33263957|NCT04980014|62634704|FG000|Overall Study|Follow-up Failure|13|||
33263958|NCT04980014|62634704|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
33263959|NCT04980014|62634704|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
33263960|NCT04980014|62634704|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
33263961|NCT03735849|62634728|FG000|Overall Study|Lost to Follow-up|1|||
33263962|NCT03735849|62634729|FG001|Overall Study|Lost to Follow-up|0|||
33263963|NCT03735849|62634730|FG002|Overall Study|Lost to Follow-up|0|||
33263964|NCT03735849|62634728|FG000|Overall Study|Participant unable to adhere to visit|1|||
33263965|NCT03735849|62634729|FG001|Overall Study|Participant unable to adhere to visit|0|||
33263966|NCT03735849|62634730|FG002|Overall Study|Participant unable to adhere to visit|0|||
33263967|NCT03735849|62634728|FG000|Overall Study|Not Randomized|0|||
33263968|NCT03735849|62634729|FG001|Overall Study|Not Randomized|0|||
33263969|NCT03735849|62634730|FG002|Overall Study|Not Randomized|4|||
33263970|NCT03552393|62634737|FG000|Core Period|Kidney Transplant|1|||
33263971|NCT03552393|62634737|FG000|Core Period|Prohibited Medication|1|||
33263972|NCT03552393|62634737|FG000|Safety Extension Period|Kidney Transplant|4|||
33263973|NCT03333382|62634743|FG000|Overall Study|Lost to Follow-up|1|||
33263974|NCT03333382|62634744|FG001|Overall Study|Lost to Follow-up|0|||
33263975|NCT03107611|62634783|FG000|Overall Study|Adverse Event|1|||
33263976|NCT03107611|62634784|FG001|Overall Study|Adverse Event|0|||
33263977|NCT03107611|62634785|FG002|Overall Study|Adverse Event|2|||
33263978|NCT03107611|62634783|FG000|Overall Study|Lost to Follow-up|3|||
33263979|NCT03107611|62634784|FG001|Overall Study|Lost to Follow-up|3|||
33263980|NCT03107611|62634785|FG002|Overall Study|Lost to Follow-up|3|||
33263981|NCT03107611|62634783|FG000|Overall Study|Protocol Violation|0|||
33263982|NCT03107611|62634784|FG001|Overall Study|Protocol Violation|0|||
33263983|NCT03107611|62634785|FG002|Overall Study|Protocol Violation|1|||
33263984|NCT03107611|62634783|FG000|Overall Study|Withdrawal by Subject|1|||
33263985|NCT03107611|62634784|FG001|Overall Study|Withdrawal by Subject|0|||
33263986|NCT03107611|62634785|FG002|Overall Study|Withdrawal by Subject|1|||
33263987|NCT03107611|62634783|FG000|Overall Study|Worsening signs/symptoms|2|||
33263988|NCT03107611|62634784|FG001|Overall Study|Worsening signs/symptoms|1|||
33263989|NCT03107611|62634785|FG002|Overall Study|Worsening signs/symptoms|2|||
33263990|NCT02720016|62634796|FG000|Overall Study|Separation of couple|6|||
33263991|NCT02720016|62634797|FG001|Overall Study|Separation of couple|8|||
33263992|NCT02720016|62634798|FG002|Overall Study|Separation of couple|2|||
33263993|NCT02720016|62634796|FG000|Overall Study|Withdrawal by Subject|6|||
33484579|NCT03325712|62861495|FG001|Overall Study|Protocol Violation|0|||
33484580|NCT03325712|62861496|FG002|Overall Study|Protocol Violation|0|||
33484581|NCT03325712|62861497|FG003|Overall Study|Protocol Violation|0|||
33484582|NCT03325712|62861498|FG004|Overall Study|Protocol Violation|1|||
33484583|NCT03325712|62861499|FG005|Overall Study|Protocol Violation|0|||
33484584|NCT03325712|62861500|FG006|Overall Study|Protocol Violation|0|||
33263994|NCT02720016|62634797|FG001|Overall Study|Withdrawal by Subject|6|||
33263995|NCT02720016|62634798|FG002|Overall Study|Withdrawal by Subject|4|||
33263996|NCT02720016|62634796|FG000|Overall Study|Scheduling issues|2|||
33263997|NCT02720016|62634797|FG001|Overall Study|Scheduling issues|4|||
33263998|NCT02720016|62634798|FG002|Overall Study|Scheduling issues|7|||
33263999|NCT02720016|62634796|FG000|Overall Study|Childcare|2|||
33264000|NCT02720016|62634797|FG001|Overall Study|Childcare|0|||
33264001|NCT02720016|62634798|FG002|Overall Study|Childcare|2|||
33484585|NCT03325712|62861501|FG007|Overall Study|Protocol Violation|0|||
33264002|NCT02720016|62634796|FG000|Overall Study|Withdrawal by PI|2|||
33264003|NCT02720016|62634797|FG001|Overall Study|Withdrawal by PI|2|||
33264004|NCT02720016|62634798|FG002|Overall Study|Withdrawal by PI|0|||
33264005|NCT02720016|62634796|FG000|Overall Study|Moved away|2|||
33264006|NCT02720016|62634797|FG001|Overall Study|Moved away|0|||
33264007|NCT02720016|62634798|FG002|Overall Study|Moved away|0|||
33264008|NCT02720016|62634796|FG000|Overall Study|Not Primary Health Concern|0|||
33264009|NCT02720016|62634797|FG001|Overall Study|Not Primary Health Concern|0|||
33264010|NCT02720016|62634798|FG002|Overall Study|Not Primary Health Concern|2|||
33264011|NCT02720016|62634796|FG000|Overall Study|Transportation issues|0|||
33264012|NCT02720016|62634797|FG001|Overall Study|Transportation issues|0|||
33264013|NCT02720016|62634798|FG002|Overall Study|Transportation issues|1|||
33264014|NCT02720016|62634796|FG000|Overall Study|Other|0|||
33264015|NCT02720016|62634797|FG001|Overall Study|Other|0|||
33264016|NCT02720016|62634798|FG002|Overall Study|Other|2|||
33264017|NCT02607956|62634809|FG000|Double-Blinded Phase|Withdrew Consent|17|||
33264018|NCT02607956|62634810|FG001|Double-Blinded Phase|Withdrew Consent|19|||
33264019|NCT02607956|62634811|FG002|Double-Blinded Phase|Withdrew Consent|0|||
33264020|NCT02607956|62634812|FG003|Double-Blinded Phase|Withdrew Consent|0|||
33264021|NCT02607956|62634809|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
33264022|NCT02607956|62634810|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
33264023|NCT02607956|62634811|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
33264024|NCT02607956|62634812|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
33264025|NCT02607956|62634809|FG000|Double-Blinded Phase|Randomized but never treated|7|||
33264026|NCT02607956|62634810|FG001|Double-Blinded Phase|Randomized but never treated|5|||
33264027|NCT02607956|62634811|FG002|Double-Blinded Phase|Randomized but never treated|0|||
33264028|NCT02607956|62634812|FG003|Double-Blinded Phase|Randomized but never treated|0|||
33264029|NCT02607956|62634809|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
33264030|NCT02607956|62634810|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
33264031|NCT02607956|62634811|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
33264032|NCT02607956|62634812|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
33264033|NCT02607956|62634809|FG000|Double-Blinded Phase|Death|4|||
33264034|NCT02607956|62634810|FG001|Double-Blinded Phase|Death|4|||
33264035|NCT02607956|62634811|FG002|Double-Blinded Phase|Death|0|||
33264036|NCT02607956|62634812|FG003|Double-Blinded Phase|Death|0|||
33264037|NCT02607956|62634809|FG000|Double-Blinded Phase|Adverse Event|4|||
33264038|NCT02607956|62634810|FG001|Double-Blinded Phase|Adverse Event|3|||
33264039|NCT02607956|62634811|FG002|Double-Blinded Phase|Adverse Event|0|||
33264040|NCT02607956|62634812|FG003|Double-Blinded Phase|Adverse Event|0|||
33264041|NCT02607956|62634809|FG000|Double-Blinded Phase|Protocol Violation|3|||
33264042|NCT02607956|62634810|FG001|Double-Blinded Phase|Protocol Violation|1|||
33264043|NCT02607956|62634811|FG002|Double-Blinded Phase|Protocol Violation|0|||
33264044|NCT02607956|62634812|FG003|Double-Blinded Phase|Protocol Violation|0|||
33264045|NCT02607956|62634809|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
33264046|NCT02607956|62634810|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
33264047|NCT02607956|62634811|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
33264048|NCT02607956|62634812|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
33264049|NCT02607956|62634809|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
33264050|NCT02607956|62634810|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
33264051|NCT02607956|62634811|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
33264052|NCT02607956|62634812|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
33264053|NCT02607956|62634809|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
33264054|NCT02607956|62634810|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
33264055|NCT02607956|62634811|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
33264056|NCT02607956|62634812|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
33264057|NCT02607956|62634809|FG000|Open-Label Extension Phase|Death|0|||
33264058|NCT02607956|62634810|FG001|Open-Label Extension Phase|Death|0|||
33264059|NCT02607956|62634811|FG002|Open-Label Extension Phase|Death|1|||
33264060|NCT02607956|62634812|FG003|Open-Label Extension Phase|Death|3|||
33264061|NCT02607956|62634809|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
33264062|NCT02607956|62634810|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
33264063|NCT02607956|62634811|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
33264064|NCT02607956|62634812|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
33264065|NCT02607956|62634809|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
33264066|NCT02607956|62634810|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
33264067|NCT02607956|62634811|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
33264068|NCT02607956|62634812|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
33264069|NCT02607956|62634809|FG000|Open-Label Extension Phase|Protocol Violation|0|||
33264070|NCT02607956|62634810|FG001|Open-Label Extension Phase|Protocol Violation|0|||
33264071|NCT02607956|62634811|FG002|Open-Label Extension Phase|Protocol Violation|0|||
33264072|NCT02607956|62634812|FG003|Open-Label Extension Phase|Protocol Violation|2|||
33264073|NCT02607956|62634809|FG000|Open-Label Extension Phase|Pregnancy|0|||
33368076|NCT00862992|62746985|FG002|Overall Study|Withdrawal by Subject|2|||
33555519|NCT02347774|62948335|FG000|On Study Treatment|non-complicance with study medication|0|||
33264074|NCT02607956|62634810|FG001|Open-Label Extension Phase|Pregnancy|0|||
33264075|NCT02607956|62634811|FG002|Open-Label Extension Phase|Pregnancy|0|||
33264076|NCT02607956|62634812|FG003|Open-Label Extension Phase|Pregnancy|1|||
33264077|NCT02564523|62634842|FG000|Overall Study|Withdrawal by Subject|3|||
33264078|NCT02564523|62634843|FG001|Overall Study|Withdrawal by Subject|0|||
33264079|NCT02564523|62634844|FG002|Overall Study|Withdrawal by Subject|1|||
33264080|NCT02564523|62634845|FG003|Overall Study|Withdrawal by Subject|0|||
33264081|NCT02564523|62634846|FG004|Overall Study|Withdrawal by Subject|1|||
33264082|NCT02564523|62634847|FG005|Overall Study|Withdrawal by Subject|0|||
33264083|NCT02564523|62634848|FG006|Overall Study|Withdrawal by Subject|1|||
33264084|NCT02564523|62634849|FG007|Overall Study|Withdrawal by Subject|0|||
33264085|NCT02564523|62634850|FG008|Overall Study|Withdrawal by Subject|0|||
33264086|NCT02564523|62634851|FG009|Overall Study|Withdrawal by Subject|0|||
33264087|NCT02564523|62634852|FG010|Overall Study|Withdrawal by Subject|1|||
33368077|NCT00694096|62746993|FG000|Overall Study|Withdrawal by Subject|5|||
33368078|NCT00854100|62747000|FG000|Overall Study|Inability to complete the study visits|0|||
33368079|NCT00854100|62747001|FG001|Overall Study|Inability to complete the study visits|0|||
33368080|NCT00854100|62747002|FG002|Overall Study|Inability to complete the study visits|1|||
33368081|NCT00854100|62747000|FG000|Overall Study|Lost to Follow-up|2|||
33368082|NCT00854100|62747001|FG001|Overall Study|Lost to Follow-up|0|||
33368083|NCT00854100|62747002|FG002|Overall Study|Lost to Follow-up|3|||
33368084|NCT00854100|62747000|FG000|Overall Study|Withdrawal by Subject|3|||
33368085|NCT00854100|62747001|FG001|Overall Study|Withdrawal by Subject|1|||
33368086|NCT00854100|62747002|FG002|Overall Study|Withdrawal by Subject|2|||
33368087|NCT00854100|62747000|FG000|Overall Study|Protocol Violation|2|||
33368088|NCT00854100|62747001|FG001|Overall Study|Protocol Violation|4|||
33368089|NCT00854100|62747002|FG002|Overall Study|Protocol Violation|3|||
33368090|NCT00854100|62747000|FG000|Overall Study|Adverse Event|2|||
33264088|NCT02564523|62634853|FG011|Overall Study|Withdrawal by Subject|0|||
33264089|NCT02564523|62634854|FG012|Overall Study|Withdrawal by Subject|1|||
33264090|NCT02564523|62634855|FG013|Overall Study|Withdrawal by Subject|0|||
33264091|NCT02564523|62634856|FG014|Overall Study|Withdrawal by Subject|0|||
33264092|NCT02564523|62634857|FG015|Overall Study|Withdrawal by Subject|0|||
33264093|NCT02564523|62634858|FG016|Overall Study|Withdrawal by Subject|0|||
33264094|NCT02564523|62634859|FG017|Overall Study|Withdrawal by Subject|0|||
33264095|NCT02564523|62634842|FG000|Overall Study|Adverse Event|0|||
33264096|NCT02564523|62634843|FG001|Overall Study|Adverse Event|0|||
33264097|NCT02564523|62634844|FG002|Overall Study|Adverse Event|0|||
33264098|NCT02564523|62634845|FG003|Overall Study|Adverse Event|0|||
33264099|NCT02564523|62634846|FG004|Overall Study|Adverse Event|0|||
33264100|NCT02564523|62634847|FG005|Overall Study|Adverse Event|0|||
33264101|NCT02564523|62634848|FG006|Overall Study|Adverse Event|0|||
33264102|NCT02564523|62634849|FG007|Overall Study|Adverse Event|0|||
33264103|NCT02564523|62634850|FG008|Overall Study|Adverse Event|0|||
33264104|NCT02564523|62634851|FG009|Overall Study|Adverse Event|0|||
33264105|NCT02564523|62634852|FG010|Overall Study|Adverse Event|0|||
33264106|NCT02564523|62634853|FG011|Overall Study|Adverse Event|0|||
33264107|NCT02564523|62634854|FG012|Overall Study|Adverse Event|0|||
33264108|NCT02564523|62634855|FG013|Overall Study|Adverse Event|0|||
33264109|NCT02564523|62634856|FG014|Overall Study|Adverse Event|0|||
33264110|NCT02564523|62634857|FG015|Overall Study|Adverse Event|0|||
33264111|NCT02564523|62634858|FG016|Overall Study|Adverse Event|0|||
33264112|NCT02564523|62634859|FG017|Overall Study|Adverse Event|1|||
33264113|NCT02564523|62634842|FG000|Overall Study|Death|0|||
33264114|NCT02564523|62634843|FG001|Overall Study|Death|0|||
33264115|NCT02564523|62634844|FG002|Overall Study|Death|0|||
33264116|NCT02564523|62634845|FG003|Overall Study|Death|0|||
33264117|NCT02564523|62634846|FG004|Overall Study|Death|0|||
33264118|NCT02564523|62634847|FG005|Overall Study|Death|0|||
33264119|NCT02564523|62634848|FG006|Overall Study|Death|1|||
33264120|NCT02564523|62634849|FG007|Overall Study|Death|0|||
33264121|NCT02564523|62634850|FG008|Overall Study|Death|0|||
33661792|NCT01697579|63091447|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
33661793|NCT01697579|63091448|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
33661794|NCT01697579|63091449|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
33661795|NCT01697579|63091450|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
33661796|NCT01697579|63091444|FG000|Base Study-Cycle 1|Protocol Violation|0|||
33368091|NCT00854100|62747001|FG001|Overall Study|Adverse Event|1|||
33368092|NCT00854100|62747002|FG002|Overall Study|Adverse Event|2|||
33368093|NCT00509899|62747019|FG000|Overall Study|Progressive disease|1|||
33368094|NCT00509899|62747020|FG001|Overall Study|Progressive disease|3|||
33368095|NCT00509899|62747021|FG002|Overall Study|Progressive disease|5|||
33368096|NCT00509899|62747022|FG003|Overall Study|Progressive disease|1|||
33368097|NCT00509899|62747023|FG004|Overall Study|Progressive disease|0|||
33661797|NCT01697579|63091445|FG001|Base Study-Cycle 1|Protocol Violation|0|||
33661798|NCT01697579|63091446|FG002|Base Study-Cycle 1|Protocol Violation|0|||
33661799|NCT01697579|63091447|FG003|Base Study-Cycle 1|Protocol Violation|0|||
33661800|NCT01697579|63091448|FG004|Base Study-Cycle 1|Protocol Violation|3|||
33264122|NCT02564523|62634851|FG009|Overall Study|Death|0|||
33264123|NCT02564523|62634852|FG010|Overall Study|Death|1|||
33368098|NCT00509899|62747024|FG005|Overall Study|Progressive disease|1|||
33264124|NCT02564523|62634853|FG011|Overall Study|Death|0|||
33264125|NCT02564523|62634854|FG012|Overall Study|Death|0|||
33264126|NCT02564523|62634855|FG013|Overall Study|Death|0|||
33264127|NCT02564523|62634856|FG014|Overall Study|Death|0|||
33264128|NCT02564523|62634857|FG015|Overall Study|Death|0|||
33264129|NCT02564523|62634858|FG016|Overall Study|Death|0|||
33264130|NCT02564523|62634859|FG017|Overall Study|Death|0|||
33264131|NCT02564523|62634842|FG000|Overall Study|Lost to Follow-up|2|||
33264132|NCT02564523|62634843|FG001|Overall Study|Lost to Follow-up|1|||
33264133|NCT02564523|62634844|FG002|Overall Study|Lost to Follow-up|4|||
33264134|NCT02564523|62634845|FG003|Overall Study|Lost to Follow-up|0|||
33264135|NCT02564523|62634846|FG004|Overall Study|Lost to Follow-up|1|||
33264136|NCT02564523|62634847|FG005|Overall Study|Lost to Follow-up|0|||
33264137|NCT02564523|62634848|FG006|Overall Study|Lost to Follow-up|1|||
33264138|NCT02564523|62634849|FG007|Overall Study|Lost to Follow-up|0|||
33264139|NCT02564523|62634850|FG008|Overall Study|Lost to Follow-up|0|||
33264140|NCT02564523|62634851|FG009|Overall Study|Lost to Follow-up|0|||
33264141|NCT02564523|62634852|FG010|Overall Study|Lost to Follow-up|0|||
33264142|NCT02564523|62634853|FG011|Overall Study|Lost to Follow-up|1|||
33264143|NCT02564523|62634854|FG012|Overall Study|Lost to Follow-up|1|||
33264144|NCT02564523|62634855|FG013|Overall Study|Lost to Follow-up|0|||
33264145|NCT02564523|62634856|FG014|Overall Study|Lost to Follow-up|0|||
33264146|NCT02564523|62634857|FG015|Overall Study|Lost to Follow-up|0|||
33264147|NCT02564523|62634858|FG016|Overall Study|Lost to Follow-up|0|||
33264148|NCT02564523|62634859|FG017|Overall Study|Lost to Follow-up|0|||
33264149|NCT02564523|62634842|FG000|Overall Study|Physician Decision|0|||
33264150|NCT02564523|62634843|FG001|Overall Study|Physician Decision|0|||
33264151|NCT02564523|62634844|FG002|Overall Study|Physician Decision|0|||
33264152|NCT02564523|62634845|FG003|Overall Study|Physician Decision|0|||
33264153|NCT02564523|62634846|FG004|Overall Study|Physician Decision|1|||
33264154|NCT02564523|62634847|FG005|Overall Study|Physician Decision|0|||
33264155|NCT02564523|62634848|FG006|Overall Study|Physician Decision|0|||
33264156|NCT02564523|62634849|FG007|Overall Study|Physician Decision|0|||
33264157|NCT02564523|62634850|FG008|Overall Study|Physician Decision|0|||
33264158|NCT02564523|62634851|FG009|Overall Study|Physician Decision|0|||
33264159|NCT02564523|62634852|FG010|Overall Study|Physician Decision|1|||
33264160|NCT02564523|62634853|FG011|Overall Study|Physician Decision|0|||
33264161|NCT02564523|62634854|FG012|Overall Study|Physician Decision|0|||
33264162|NCT02564523|62634855|FG013|Overall Study|Physician Decision|0|||
33264163|NCT02564523|62634856|FG014|Overall Study|Physician Decision|0|||
33264164|NCT02564523|62634857|FG015|Overall Study|Physician Decision|0|||
33264165|NCT02564523|62634858|FG016|Overall Study|Physician Decision|0|||
33264166|NCT02564523|62634859|FG017|Overall Study|Physician Decision|0|||
33264167|NCT02564523|62634842|FG000|Overall Study|Protocol Violation|2|||
33264168|NCT02564523|62634843|FG001|Overall Study|Protocol Violation|2|||
33264169|NCT02564523|62634844|FG002|Overall Study|Protocol Violation|5|||
33264170|NCT02564523|62634845|FG003|Overall Study|Protocol Violation|0|||
33264171|NCT02564523|62634846|FG004|Overall Study|Protocol Violation|1|||
33264172|NCT02564523|62634847|FG005|Overall Study|Protocol Violation|0|||
33264173|NCT02564523|62634848|FG006|Overall Study|Protocol Violation|0|||
33264174|NCT02564523|62634849|FG007|Overall Study|Protocol Violation|0|||
33264175|NCT02564523|62634850|FG008|Overall Study|Protocol Violation|0|||
33264176|NCT02564523|62634851|FG009|Overall Study|Protocol Violation|0|||
33555520|NCT02347774|62948336|FG001|On Study Treatment|non-complicance with study medication|2|||
33264177|NCT02564523|62634852|FG010|Overall Study|Protocol Violation|0|||
33264178|NCT02564523|62634853|FG011|Overall Study|Protocol Violation|0|||
33264179|NCT02564523|62634854|FG012|Overall Study|Protocol Violation|0|||
33264180|NCT02564523|62634855|FG013|Overall Study|Protocol Violation|0|||
33264181|NCT02564523|62634856|FG014|Overall Study|Protocol Violation|0|||
33264182|NCT02564523|62634857|FG015|Overall Study|Protocol Violation|0|||
33368099|NCT00509899|62747025|FG006|Overall Study|Progressive disease|0|||
33484586|NCT03325712|62861494|FG000|Overall Study|Adverse Event|0|||
33484587|NCT03325712|62861495|FG001|Overall Study|Adverse Event|0|||
33484588|NCT03325712|62861496|FG002|Overall Study|Adverse Event|0|||
33484589|NCT03325712|62861497|FG003|Overall Study|Adverse Event|0|||
33484590|NCT03325712|62861498|FG004|Overall Study|Adverse Event|1|||
33484591|NCT03325712|62861499|FG005|Overall Study|Adverse Event|0|||
33264183|NCT02564523|62634858|FG016|Overall Study|Protocol Violation|0|||
33264184|NCT02564523|62634859|FG017|Overall Study|Protocol Violation|0|||
33264185|NCT02564523|62634842|FG000|Overall Study|Other|3|||
33264186|NCT02564523|62634843|FG001|Overall Study|Other|0|||
33368100|NCT00509899|62747026|FG007|Overall Study|Progressive disease|0|||
33555521|NCT02347774|62948337|FG002|On Study Treatment|non-complicance with study medication|0|||
33555522|NCT02347774|62948335|FG000|On Study Treatment|Protocol Violation|0|||
33555523|NCT02347774|62948336|FG001|On Study Treatment|Protocol Violation|0|||
33264187|NCT02564523|62634844|FG002|Overall Study|Other|0|||
33264188|NCT02564523|62634845|FG003|Overall Study|Other|1|||
33264189|NCT02564523|62634846|FG004|Overall Study|Other|0|||
33264190|NCT02564523|62634847|FG005|Overall Study|Other|0|||
33264191|NCT02564523|62634848|FG006|Overall Study|Other|0|||
33264192|NCT02564523|62634849|FG007|Overall Study|Other|0|||
33484592|NCT03325712|62861500|FG006|Overall Study|Adverse Event|0|||
33264193|NCT02564523|62634850|FG008|Overall Study|Other|0|||
33264194|NCT02564523|62634851|FG009|Overall Study|Other|0|||
33264195|NCT02564523|62634852|FG010|Overall Study|Other|0|||
33264196|NCT02564523|62634853|FG011|Overall Study|Other|0|||
33264197|NCT02564523|62634854|FG012|Overall Study|Other|0|||
33264198|NCT02564523|62634855|FG013|Overall Study|Other|0|||
33264199|NCT02564523|62634856|FG014|Overall Study|Other|0|||
33264200|NCT02564523|62634857|FG015|Overall Study|Other|0|||
33264201|NCT02564523|62634858|FG016|Overall Study|Other|0|||
33264202|NCT02564523|62634859|FG017|Overall Study|Other|0|||
33264203|NCT01447628|62634966|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
33264204|NCT01447628|62634967|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
33264205|NCT01447628|62634968|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
33264206|NCT01447628|62634969|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
33264207|NCT00515853|62634991|FG000|Overall Study|Lost to Follow-up|9|||
33264208|NCT00515853|62634992|FG001|Overall Study|Lost to Follow-up|13|||
33264209|NCT00515853|62634991|FG000|Overall Study|Withdrawal by Subject|6|||
33264210|NCT00515853|62634992|FG001|Overall Study|Withdrawal by Subject|4|||
33264211|NCT00003458|62634998|FG000|Overall Study|Not evaluable|4|||
33368101|NCT00509899|62747019|FG000|Overall Study|Unacceptable Toxicity|1|||
33368102|NCT00509899|62747020|FG001|Overall Study|Unacceptable Toxicity|0|||
33368103|NCT00509899|62747021|FG002|Overall Study|Unacceptable Toxicity|0|||
33368104|NCT00509899|62747022|FG003|Overall Study|Unacceptable Toxicity|2|||
33368105|NCT00509899|62747023|FG004|Overall Study|Unacceptable Toxicity|0|||
33368106|NCT00509899|62747024|FG005|Overall Study|Unacceptable Toxicity|0|||
33368107|NCT00509899|62747025|FG006|Overall Study|Unacceptable Toxicity|0|||
33368108|NCT00509899|62747026|FG007|Overall Study|Unacceptable Toxicity|0|||
33368109|NCT00509899|62747019|FG000|Overall Study|Withdrawal by Subject|6|||
33368110|NCT00509899|62747020|FG001|Overall Study|Withdrawal by Subject|2|||
33368111|NCT00509899|62747021|FG002|Overall Study|Withdrawal by Subject|3|||
33368112|NCT00509899|62747022|FG003|Overall Study|Withdrawal by Subject|0|||
33368113|NCT00509899|62747023|FG004|Overall Study|Withdrawal by Subject|3|||
33368114|NCT00509899|62747024|FG005|Overall Study|Withdrawal by Subject|2|||
33368115|NCT00509899|62747025|FG006|Overall Study|Withdrawal by Subject|0|||
33368116|NCT00509899|62747026|FG007|Overall Study|Withdrawal by Subject|0|||
33368117|NCT00509899|62747019|FG000|Overall Study|Physician Decision|4|||
33368118|NCT00509899|62747020|FG001|Overall Study|Physician Decision|2|||
33368119|NCT00509899|62747021|FG002|Overall Study|Physician Decision|7|||
33368120|NCT00509899|62747022|FG003|Overall Study|Physician Decision|0|||
33368121|NCT00509899|62747023|FG004|Overall Study|Physician Decision|1|||
33368122|NCT00509899|62747024|FG005|Overall Study|Physician Decision|4|||
33368123|NCT00509899|62747025|FG006|Overall Study|Physician Decision|0|||
33368124|NCT00509899|62747026|FG007|Overall Study|Physician Decision|0|||
33368125|NCT00509899|62747019|FG000|Overall Study|Intercurrent Illness|1|||
33368126|NCT00509899|62747020|FG001|Overall Study|Intercurrent Illness|0|||
33368127|NCT00509899|62747021|FG002|Overall Study|Intercurrent Illness|0|||
33368128|NCT00509899|62747022|FG003|Overall Study|Intercurrent Illness|1|||
33368129|NCT00509899|62747023|FG004|Overall Study|Intercurrent Illness|0|||
33368130|NCT00509899|62747024|FG005|Overall Study|Intercurrent Illness|1|||
33368131|NCT00509899|62747025|FG006|Overall Study|Intercurrent Illness|0|||
33368132|NCT00509899|62747026|FG007|Overall Study|Intercurrent Illness|0|||
33368133|NCT00509899|62747019|FG000|Overall Study|Death|2|||
33368134|NCT00509899|62747020|FG001|Overall Study|Death|2|||
33368135|NCT00509899|62747021|FG002|Overall Study|Death|3|||
33368136|NCT00509899|62747022|FG003|Overall Study|Death|0|||
33368137|NCT00509899|62747023|FG004|Overall Study|Death|1|||
33368138|NCT00509899|62747024|FG005|Overall Study|Death|1|||
33368139|NCT00509899|62747025|FG006|Overall Study|Death|1|||
33368140|NCT00509899|62747026|FG007|Overall Study|Death|1|||
33368141|NCT00509899|62747019|FG000|Overall Study|Lack of Efficacy|1|||
33484593|NCT03325712|62861501|FG007|Overall Study|Adverse Event|0|||
33484594|NCT03734679|62861529|FG000|Overall Study|Missed Visit|1|||
33264212|NCT05032872|62635005|FG000|Overall Study|Adverse Event|1|||
33484595|NCT03325556|62861533|FG000|Open-label Period|Lack of Response in OL period|70|||
33484596|NCT03325556|62861534|FG001|Open-label Period|Lack of Response in OL period|0|||
33484597|NCT03325556|62861535|FG002|Open-label Period|Lack of Response in OL period|0|||
33264213|NCT05032872|62635006|FG001|Overall Study|Adverse Event|0|||
33368142|NCT00509899|62747020|FG001|Overall Study|Lack of Efficacy|0|||
33368143|NCT00509899|62747021|FG002|Overall Study|Lack of Efficacy|2|||
33368144|NCT00509899|62747022|FG003|Overall Study|Lack of Efficacy|0|||
33368145|NCT00509899|62747023|FG004|Overall Study|Lack of Efficacy|0|||
33368146|NCT00509899|62747024|FG005|Overall Study|Lack of Efficacy|1|||
33484598|NCT03325556|62861533|FG000|Open-label Period|Adverse Event|27|||
33264214|NCT05032872|62635005|FG000|Overall Study|Lost to Follow-up|2|||
33264215|NCT05032872|62635006|FG001|Overall Study|Lost to Follow-up|4|||
33264216|NCT05032872|62635005|FG000|Overall Study|Withdrawal by Subject|4|||
33264217|NCT05032872|62635006|FG001|Overall Study|Withdrawal by Subject|3|||
33264218|NCT04613739|62635032|FG000|Overall Study|Lost to Follow-up|6|||
33264219|NCT04613739|62635033|FG001|Overall Study|Lost to Follow-up|9|||
33264220|NCT04613739|62635032|FG000|Overall Study|potentially duplicative/fraudulent|1|||
33264221|NCT04613739|62635033|FG001|Overall Study|potentially duplicative/fraudulent|3|||
33264222|NCT04407806|62635060|FG000|Overall Study|Withdrawal by Subject|1|||
33264223|NCT04407806|62635061|FG001|Overall Study|Withdrawal by Subject|2|||
33264224|NCT04324021|62635070|FG000|Overall Study|Adverse Event|1|||
33264225|NCT04324021|62635071|FG001|Overall Study|Adverse Event|0|||
33264226|NCT04324021|62635072|FG002|Overall Study|Adverse Event|0|||
33264227|NCT04324021|62635070|FG000|Overall Study|Lack of Efficacy|0|||
33264228|NCT04324021|62635071|FG001|Overall Study|Lack of Efficacy|0|||
33264229|NCT04324021|62635072|FG002|Overall Study|Lack of Efficacy|1|||
33264230|NCT04324021|62635070|FG000|Overall Study|Death|1|||
33264231|NCT04324021|62635071|FG001|Overall Study|Death|1|||
33264232|NCT04324021|62635072|FG002|Overall Study|Death|0|||
33264233|NCT04209621|62635083|FG000|Overall Study|Death|1|||
33264234|NCT04209621|62635083|FG000|Overall Study|Study Terminated Early|2|||
33264235|NCT04186663|62635088|FG000|Overall Study|Lost to Follow-up|1|||
33264236|NCT04186663|62635088|FG000|Overall Study|Unable to complete blood draw|3|||
33264237|NCT04158219|62635092|FG000|Overall Study|Lost to Follow-up|1|||
33264238|NCT03954743|62635125|FG000|Overall Study|Adverse Event|1|||
33264239|NCT03954743|62635126|FG001|Overall Study|Adverse Event|0|||
33264240|NCT03954743|62635125|FG000|Overall Study|Lost to Follow-up|6|||
33264241|NCT03954743|62635126|FG001|Overall Study|Lost to Follow-up|4|||
33264242|NCT03954743|62635125|FG000|Overall Study|Protocol Violation|1|||
33264243|NCT03954743|62635126|FG001|Overall Study|Protocol Violation|0|||
33264244|NCT03954743|62635125|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
33264245|NCT03954743|62635126|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
33264246|NCT03954743|62635125|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
33264247|NCT03954743|62635126|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33264248|NCT03880565|62635147|FG000|Overall Study|Withdrawal by Subject|1|||
33264249|NCT03880565|62635148|FG001|Overall Study|Withdrawal by Subject|0|||
33264250|NCT03782792|62635156|FG000|Overall Study|Patient left the country|0|||
33264251|NCT03782792|62635157|FG001|Overall Study|Patient left the country|1|||
33264252|NCT03782792|62635156|FG000|Overall Study|Withdrawal by Subject|1|||
33264253|NCT03782792|62635157|FG001|Overall Study|Withdrawal by Subject|2|||
33264254|NCT03733119|62635167|FG000|Overall Study|Physician Decision|2|||
33264255|NCT03733119|62635168|FG001|Overall Study|Physician Decision|1|||
33264256|NCT03733119|62635167|FG000|Overall Study|ineligible to treat per protocol|0|||
33264257|NCT03733119|62635168|FG001|Overall Study|ineligible to treat per protocol|1|||
33264258|NCT03661996|62635179|FG000|Overall Study|Adverse Event|0|||
33264259|NCT03661996|62635180|FG001|Overall Study|Adverse Event|0|||
33264260|NCT03661996|62635181|FG002|Overall Study|Adverse Event|1|||
33264261|NCT03661996|62635182|FG003|Overall Study|Adverse Event|1|||
33264262|NCT03661996|62635183|FG004|Overall Study|Adverse Event|0|||
33264263|NCT03661996|62635179|FG000|Overall Study|Lost to Follow-up|5|||
33264264|NCT03661996|62635180|FG001|Overall Study|Lost to Follow-up|1|||
33264265|NCT03661996|62635181|FG002|Overall Study|Lost to Follow-up|2|||
33264266|NCT03661996|62635182|FG003|Overall Study|Lost to Follow-up|2|||
33264267|NCT03661996|62635183|FG004|Overall Study|Lost to Follow-up|6|||
33264268|NCT03661996|62635179|FG000|Overall Study|Physician Decision|1|||
33264269|NCT03661996|62635180|FG001|Overall Study|Physician Decision|1|||
33264270|NCT03661996|62635181|FG002|Overall Study|Physician Decision|1|||
33264271|NCT03661996|62635182|FG003|Overall Study|Physician Decision|2|||
33264272|NCT03661996|62635183|FG004|Overall Study|Physician Decision|0|||
33264273|NCT03661996|62635179|FG000|Overall Study|Protocol Violation|0|||
33264274|NCT03661996|62635180|FG001|Overall Study|Protocol Violation|0|||
33264275|NCT03661996|62635181|FG002|Overall Study|Protocol Violation|0|||
33264276|NCT03661996|62635182|FG003|Overall Study|Protocol Violation|0|||
33264277|NCT03661996|62635183|FG004|Overall Study|Protocol Violation|1|||
33264278|NCT03661996|62635179|FG000|Overall Study|Withdrawal by Subject|3|||
33264279|NCT03661996|62635180|FG001|Overall Study|Withdrawal by Subject|5|||
33264280|NCT03661996|62635181|FG002|Overall Study|Withdrawal by Subject|1|||
33264281|NCT03661996|62635182|FG003|Overall Study|Withdrawal by Subject|7|||
33264282|NCT03661996|62635183|FG004|Overall Study|Withdrawal by Subject|7|||
33264283|NCT03661996|62635179|FG000|Overall Study|Sponsors Decision|2|||
33264284|NCT03661996|62635180|FG001|Overall Study|Sponsors Decision|0|||
33264285|NCT03661996|62635181|FG002|Overall Study|Sponsors Decision|0|||
33264286|NCT03661996|62635182|FG003|Overall Study|Sponsors Decision|0|||
33264287|NCT03661996|62635183|FG004|Overall Study|Sponsors Decision|0|||
33264288|NCT03661996|62635179|FG000|Overall Study|Other|1|||
33264289|NCT03661996|62635180|FG001|Overall Study|Other|1|||
33264290|NCT03661996|62635181|FG002|Overall Study|Other|1|||
33264291|NCT03661996|62635182|FG003|Overall Study|Other|1|||
33264292|NCT03661996|62635183|FG004|Overall Study|Other|0|||
33264293|NCT03633461|62635200|FG000|Overall Study|Lost to Follow-up|0|||
33264294|NCT03633461|62635201|FG001|Overall Study|Lost to Follow-up|1|||
33264295|NCT03499314|62635229|FG000|Overall Study|Time Commitment|1|||
33264296|NCT03499314|62635230|FG001|Overall Study|Time Commitment|2|||
33264297|NCT03499314|62635229|FG000|Overall Study|Medical issue unrelated to research study|1|||
33264298|NCT03499314|62635230|FG001|Overall Study|Medical issue unrelated to research study|1|||
33264299|NCT03369431|62635238|FG000|Overall Study|Lost to Follow-up|1|||
33264300|NCT03369431|62635239|FG001|Overall Study|Lost to Follow-up|3|||
33264301|NCT03369431|62635238|FG000|Overall Study|Withdrawal by Subject|2|||
33264302|NCT03369431|62635239|FG001|Overall Study|Withdrawal by Subject|3|||
33264303|NCT03369431|62635238|FG000|Overall Study|Protocol Violation|1|||
33264304|NCT03369431|62635239|FG001|Overall Study|Protocol Violation|1|||
33264305|NCT03336866|62635248|FG000|Overall Study|Lost to Follow-up|2|||
33264306|NCT03336866|62635249|FG001|Overall Study|Lost to Follow-up|0|||
33264307|NCT03336866|62635250|FG002|Overall Study|Lost to Follow-up|3|||
33264308|NCT03336866|62635248|FG000|Overall Study|Withdrawal by Subject|1|||
33264309|NCT03336866|62635249|FG001|Overall Study|Withdrawal by Subject|1|||
33264310|NCT03336866|62635250|FG002|Overall Study|Withdrawal by Subject|0|||
33264311|NCT03336866|62635248|FG000|Overall Study|Noncompliance with clinic house rules|0|||
33264312|NCT03336866|62635249|FG001|Overall Study|Noncompliance with clinic house rules|0|||
33264313|NCT03336866|62635250|FG002|Overall Study|Noncompliance with clinic house rules|1|||
33264314|NCT03332173|62635263|FG000|Overall Study|Death|7|||
33264315|NCT03332173|62635263|FG000|Overall Study|Withdrawal by Subject|6|||
33264316|NCT03332173|62635263|FG000|Overall Study|Lost to Follow-up|2|||
33264317|NCT03332173|62635263|FG000|Overall Study|Transferred to long-term extension study|29|||
33264318|NCT03322293|62635270|FG000|Overall Study|Lost to Follow-up|0|||
33264319|NCT03322293|62635271|FG001|Overall Study|Lost to Follow-up|0|||
33264320|NCT03322293|62635272|FG002|Overall Study|Lost to Follow-up|1|||
33264321|NCT03254394|62635294|FG000|Overall Study|Withdrawal by Subject|0|||
33264322|NCT03254394|62635295|FG001|Overall Study|Withdrawal by Subject|2|||
33264323|NCT03253809|62635301|FG000|Overall Study|Unable to obtain study related data|14|||
33264324|NCT02998476|62635380|FG000|Overall Study|Lost to Follow-up|1|||
33264325|NCT02998476|62635381|FG001|Overall Study|Lost to Follow-up|0|||
33264326|NCT02998476|62635380|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
33264327|NCT02998476|62635381|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
33264328|NCT02998476|62635380|FG000|Overall Study|Withdrawal by Subject|1|||
33484599|NCT03325556|62861534|FG001|Open-label Period|Adverse Event|0|||
33484600|NCT03325556|62861535|FG002|Open-label Period|Adverse Event|0|||
33484601|NCT03325556|62861533|FG000|Open-label Period|Death|1|||
33484602|NCT03325556|62861534|FG001|Open-label Period|Death|0|||
33484603|NCT03325556|62861535|FG002|Open-label Period|Death|0|||
33484604|NCT03325556|62861533|FG000|Open-label Period|Lost to Follow-up|1|||
33484605|NCT03325556|62861534|FG001|Open-label Period|Lost to Follow-up|0|||
33484606|NCT03325556|62861535|FG002|Open-label Period|Lost to Follow-up|0|||
33484607|NCT03325556|62861533|FG000|Open-label Period|Non-compliance with study drug|5|||
33264329|NCT02998476|62635381|FG001|Overall Study|Withdrawal by Subject|2|||
33264330|NCT02998476|62635380|FG000|Overall Study|Death|45|||
33264331|NCT02998476|62635381|FG001|Overall Study|Death|2|||
33264332|NCT02998476|62635380|FG000|Overall Study|Other|6|||
33264333|NCT02998476|62635381|FG001|Overall Study|Other|1|||
33264334|NCT02924064|62635399|FG000|Overall Study|Adverse Event|2|||
33264335|NCT02924064|62635400|FG001|Overall Study|Adverse Event|2|||
33264336|NCT02924064|62635399|FG000|Overall Study|Lost to Follow-up|0|||
33264337|NCT02924064|62635400|FG001|Overall Study|Lost to Follow-up|2|||
33264338|NCT02924064|62635399|FG000|Overall Study|Physician Decision|0|||
33264339|NCT02924064|62635400|FG001|Overall Study|Physician Decision|2|||
33264340|NCT02924064|62635399|FG000|Overall Study|Protocol Violation|1|||
33264341|NCT02924064|62635400|FG001|Overall Study|Protocol Violation|3|||
33264342|NCT02924064|62635399|FG000|Overall Study|Withdrawal by Subject|4|||
33264343|NCT02924064|62635400|FG001|Overall Study|Withdrawal by Subject|5|||
33264344|NCT02924064|62635399|FG000|Overall Study|Other|17|||
33264345|NCT02924064|62635400|FG001|Overall Study|Other|29|||
33264346|NCT02916706|62635408|FG000|Overall Study|Adverse Event|0|||
33264347|NCT02916706|62635409|FG001|Overall Study|Adverse Event|1|||
33264348|NCT02916706|62635408|FG000|Overall Study|Lost to Follow-up|0|||
33264349|NCT02916706|62635409|FG001|Overall Study|Lost to Follow-up|1|||
33368147|NCT00509899|62747025|FG006|Overall Study|Lack of Efficacy|0|||
33368148|NCT00509899|62747026|FG007|Overall Study|Lack of Efficacy|0|||
33264350|NCT02916706|62635408|FG000|Overall Study|Physician Decision|1|||
33368149|NCT00862836|62747040|FG000|Overall Study|Withdrawal by Subject|1|||
33264351|NCT02916706|62635409|FG001|Overall Study|Physician Decision|0|||
33264352|NCT02916706|62635408|FG000|Overall Study|Protocol Violation|3|||
33264353|NCT02916706|62635409|FG001|Overall Study|Protocol Violation|1|||
33264354|NCT02916706|62635408|FG000|Overall Study|Withdrawal by Subject|6|||
33264355|NCT02916706|62635409|FG001|Overall Study|Withdrawal by Subject|9|||
33264356|NCT02916706|62635408|FG000|Overall Study|Other|5|||
33264357|NCT02916706|62635409|FG001|Overall Study|Other|19|||
33264358|NCT02889900|62635415|FG000|Overall Study|Adverse Event|11|||
33264359|NCT02889900|62635415|FG000|Overall Study|Condition under investigation worsened|32|||
33264360|NCT02889900|62635415|FG000|Overall Study|Other|5|||
33264361|NCT02889900|62635415|FG000|Overall Study|Withdrawal by Subject|7|||
33264362|NCT02889900|62635415|FG000|Overall Study|Not treated|2|||
33484608|NCT03325556|62861534|FG001|Open-label Period|Non-compliance with study drug|0|||
33484609|NCT03325556|62861535|FG002|Open-label Period|Non-compliance with study drug|0|||
33264363|NCT02866695|62635419|FG000|Overall Study|Adverse Event|1|||
33264364|NCT02866695|62635419|FG000|Overall Study|Lost to Follow-up|1|||
33264365|NCT02834793|62635425|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
33264366|NCT02834793|62635426|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
33264367|NCT02834793|62635427|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
33264368|NCT02834793|62635428|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
33264369|NCT02834793|62635425|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
33264370|NCT02834793|62635426|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
33264371|NCT02834793|62635427|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
33264372|NCT02834793|62635428|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
33264373|NCT02834793|62635425|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
33264374|NCT02834793|62635426|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
33264375|NCT02834793|62635427|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
33264376|NCT02834793|62635428|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
33264377|NCT02834793|62635425|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
33264378|NCT02834793|62635426|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
33264379|NCT02834793|62635427|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
33264380|NCT02834793|62635428|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
33264381|NCT02834793|62635425|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
33264382|NCT02834793|62635426|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
33264383|NCT02834793|62635427|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
33264384|NCT02834793|62635428|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
33264385|NCT02834793|62635425|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
33264386|NCT02834793|62635426|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
33264387|NCT02834793|62635427|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
33264388|NCT02834793|62635428|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
33264389|NCT02834793|62635425|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
33264390|NCT02834793|62635426|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
33264391|NCT02834793|62635427|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
33264392|NCT02834793|62635428|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
33264393|NCT02834793|62635425|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
33264394|NCT02834793|62635426|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
33264395|NCT02834793|62635427|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
33264396|NCT02834793|62635428|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
33264397|NCT02834793|62635425|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
33264398|NCT02834793|62635426|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
33264399|NCT02834793|62635427|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
33264400|NCT02834793|62635428|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
33264401|NCT02834793|62635425|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
33264402|NCT02834793|62635426|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
33264403|NCT02834793|62635427|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
33264404|NCT02834793|62635428|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
33264405|NCT02834793|62635425|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
33264406|NCT02834793|62635426|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
33264407|NCT02834793|62635427|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
33264408|NCT02834793|62635428|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
33264409|NCT02834793|62635425|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
33264410|NCT02834793|62635426|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
33264411|NCT02834793|62635427|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
33264412|NCT02834793|62635428|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
33264413|NCT02834793|62635425|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
33264414|NCT02834793|62635426|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
33264415|NCT02834793|62635427|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
33264416|NCT02834793|62635428|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
33264417|NCT02834793|62635425|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
33264418|NCT02834793|62635426|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
33264419|NCT02834793|62635427|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
33264420|NCT02834793|62635428|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
33264421|NCT02834793|62635425|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
33264422|NCT02834793|62635426|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
33264423|NCT02834793|62635427|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
33368150|NCT00820755|62747044|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
33368151|NCT00820755|62747045|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
33368152|NCT00820755|62747046|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
33368153|NCT00820755|62747044|FG000|Period 1: Combination Therapy Phase|Death|28|||
33264424|NCT02834793|62635428|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
33264425|NCT02810457|62635438|FG000|Overall Study|Randomised but no treatment received|2|||
33368154|NCT00820755|62747045|FG001|Period 1: Combination Therapy Phase|Death|0|||
33264426|NCT02810457|62635439|FG001|Overall Study|Randomised but no treatment received|1|||
33264427|NCT02810457|62635438|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
33264428|NCT02810457|62635439|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
33264429|NCT02810457|62635438|FG000|Overall Study|Adverse Event|37|||
33264430|NCT02810457|62635439|FG001|Overall Study|Adverse Event|43|||
33264431|NCT02810457|62635438|FG000|Overall Study|Patient decision|31|||
33264432|NCT02810457|62635439|FG001|Overall Study|Patient decision|35|||
33264433|NCT02810457|62635438|FG000|Overall Study|Patient lost to follow-up|2|||
33264434|NCT02810457|62635439|FG001|Overall Study|Patient lost to follow-up|2|||
33264435|NCT02810457|62635438|FG000|Overall Study|Death|39|||
33264436|NCT02810457|62635439|FG001|Overall Study|Death|28|||
33264437|NCT02810457|62635438|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
33264438|NCT02810457|62635439|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
33264439|NCT02810457|62635438|FG000|Overall Study|Clinical progression|15|||
33264440|NCT02810457|62635439|FG001|Overall Study|Clinical progression|16|||
33264441|NCT02810457|62635438|FG000|Overall Study|Investigator decision|3|||
33264442|NCT02810457|62635439|FG001|Overall Study|Investigator decision|2|||
33264443|NCT02810457|62635438|FG000|Overall Study|Patient ineligibility|3|||
33264444|NCT02810457|62635439|FG001|Overall Study|Patient ineligibility|0|||
33264445|NCT02810457|62635438|FG000|Overall Study|Miscalculated PD|1|||
33264446|NCT02810457|62635439|FG001|Overall Study|Miscalculated PD|0|||
33264447|NCT02810457|62635438|FG000|Overall Study|Physician Decision|0|||
33264448|NCT02810457|62635439|FG001|Overall Study|Physician Decision|1|||
33264449|NCT02745535|62635445|FG000|Overall Study|Death|1|||
33264450|NCT02745535|62635445|FG000|Overall Study|Adverse Event|3|||
33264451|NCT02745535|62635445|FG000|Overall Study|Lost to Follow-up|2|||
33264452|NCT02625090|62635479|FG000|Overall Study|Participant wants to be pregnant|2|||
33264453|NCT02625090|62635479|FG000|Overall Study|For the Promoter|1|||
33264454|NCT02625090|62635479|FG000|Overall Study|Sponsor's Decision|9|||
33264455|NCT02625090|62635479|FG000|Overall Study|Somnolence|1|||
33264456|NCT02625090|62635479|FG000|Overall Study|Study terminated by Sponsor|7|||
33264457|NCT02625090|62635479|FG000|Overall Study|Negative Benefit/Risk|1|||
33264458|NCT02625090|62635479|FG000|Overall Study|Protocol Deviation|2|||
33264459|NCT02625090|62635479|FG000|Overall Study|Lack of Efficacy|16|||
33264460|NCT02625090|62635479|FG000|Overall Study|Adverse Event|3|||
33264461|NCT02539225|62635486|FG000|Part A|Adverse Event|13|||
33264462|NCT02539225|62635487|FG001|Part A|Adverse Event|4|||
33264463|NCT02539225|62635486|FG000|Part A|Withdrawal by Subject|2|||
33264464|NCT02539225|62635487|FG001|Part A|Withdrawal by Subject|4|||
33264465|NCT02539225|62635486|FG000|Part A|Physician Decision|4|||
33264466|NCT02539225|62635487|FG001|Part A|Physician Decision|7|||
33264467|NCT02539225|62635486|FG000|Part A|Did Not Receive study Drug|1|||
33264468|NCT02539225|62635487|FG001|Part A|Did Not Receive study Drug|1|||
33264469|NCT02539225|62635486|FG000|Pre Treatment for Part B|Progressive disease|1|||
33264470|NCT02539225|62635487|FG001|Pre Treatment for Part B|Progressive disease|1|||
33264471|NCT02539225|62635486|FG000|Pre Treatment for Part B|Adverse Event|1|||
33264472|NCT02539225|62635487|FG001|Pre Treatment for Part B|Adverse Event|1|||
33264473|NCT02539225|62635486|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
33264474|NCT02539225|62635487|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
33264475|NCT02539225|62635486|FG000|Pre Treatment for Part B|Physician Decision|2|||
33264476|NCT02539225|62635487|FG001|Pre Treatment for Part B|Physician Decision|0|||
33264477|NCT02539225|62635486|FG000|Part B|Adverse Event|4|||
33264478|NCT02539225|62635487|FG001|Part B|Adverse Event|4|||
33264479|NCT02539225|62635486|FG000|Part B|Withdrawal by Subject|0|||
33264480|NCT02539225|62635487|FG001|Part B|Withdrawal by Subject|3|||
33264481|NCT02539225|62635486|FG000|Part B|Physician Decision|0|||
33264482|NCT02539225|62635487|FG001|Part B|Physician Decision|9|||
33264483|NCT02526017|62635507|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33264484|NCT02526017|62635508|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33264485|NCT02526017|62635509|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33264486|NCT02526017|62635510|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33264487|NCT02526017|62635511|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
33264488|NCT02526017|62635512|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33264489|NCT02526017|62635513|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33368155|NCT00820755|62747046|FG002|Period 1: Combination Therapy Phase|Death|0|||
33264490|NCT02526017|62635514|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33264491|NCT02526017|62635515|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33368156|NCT00820755|62747044|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
33484610|NCT03325556|62861533|FG000|Open-label Period|Use of prohibited medication|1|||
33264492|NCT02369653|62635584|FG000|Overall Study|Lost to Follow-up|0|||
33264493|NCT02369653|62635585|FG001|Overall Study|Lost to Follow-up|1|||
33264494|NCT02369653|62635584|FG000|Overall Study|Administrative reason by sponsor|0|||
33264495|NCT02369653|62635585|FG001|Overall Study|Administrative reason by sponsor|1|||
33264496|NCT02369653|62635584|FG000|Overall Study|Death|1|||
33264497|NCT02369653|62635585|FG001|Overall Study|Death|2|||
33264498|NCT02369653|62635584|FG000|Overall Study|Participant withdrew consent|13|||
33264499|NCT02369653|62635585|FG001|Overall Study|Participant withdrew consent|3|||
33264500|NCT02284568|62635598|FG000|Overall Study|Adverse Event|2|||
33264501|NCT02284568|62635599|FG001|Overall Study|Adverse Event|9|||
33264502|NCT02284568|62635600|FG002|Overall Study|Adverse Event|4|||
33264503|NCT02284568|62635598|FG000|Overall Study|Withdrawal by Subject|22|||
33264504|NCT02284568|62635599|FG001|Overall Study|Withdrawal by Subject|21|||
33264505|NCT02284568|62635600|FG002|Overall Study|Withdrawal by Subject|1|||
33264506|NCT02284568|62635598|FG000|Overall Study|Noncompliance with study drug admin|1|||
33264507|NCT02284568|62635599|FG001|Overall Study|Noncompliance with study drug admin|2|||
33264508|NCT02284568|62635600|FG002|Overall Study|Noncompliance with study drug admin|0|||
33264509|NCT02284568|62635598|FG000|Overall Study|Noncompliance|1|||
33264510|NCT02284568|62635599|FG001|Overall Study|Noncompliance|0|||
33264511|NCT02284568|62635600|FG002|Overall Study|Noncompliance|0|||
33264512|NCT02284568|62635598|FG000|Overall Study|Protocol Violation|0|||
33264513|NCT02284568|62635599|FG001|Overall Study|Protocol Violation|1|||
33264514|NCT02284568|62635600|FG002|Overall Study|Protocol Violation|0|||
33264515|NCT02284568|62635598|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
33264516|NCT02284568|62635599|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
33264517|NCT02284568|62635600|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
33264518|NCT02284568|62635598|FG000|Overall Study|Lost to Follow-up|0|||
33264519|NCT02284568|62635599|FG001|Overall Study|Lost to Follow-up|3|||
33264520|NCT02284568|62635600|FG002|Overall Study|Lost to Follow-up|0|||
33264521|NCT02284568|62635598|FG000|Overall Study|Lack of Efficacy|4|||
33264522|NCT02284568|62635599|FG001|Overall Study|Lack of Efficacy|7|||
33264523|NCT02284568|62635600|FG002|Overall Study|Lack of Efficacy|0|||
33264524|NCT02284568|62635598|FG000|Overall Study|Other|1|||
33264525|NCT02284568|62635599|FG001|Overall Study|Other|2|||
33264526|NCT02284568|62635600|FG002|Overall Study|Other|0|||
33264527|NCT02284568|62635598|FG000|Overall Study|Withdrew before taking study drug|0|||
33264528|NCT02284568|62635599|FG001|Overall Study|Withdrew before taking study drug|1|||
33264529|NCT02284568|62635600|FG002|Overall Study|Withdrew before taking study drug|0|||
33264530|NCT02195986|62635615|FG000|Overall Study|Adverse Event|3|||
33264531|NCT02195986|62635616|FG001|Overall Study|Adverse Event|0|||
33264532|NCT02195986|62635617|FG002|Overall Study|Adverse Event|0|||
33264533|NCT02195986|62635615|FG000|Overall Study|Withdrawal by Subject|0|||
33264534|NCT02195986|62635616|FG001|Overall Study|Withdrawal by Subject|3|||
33264535|NCT02195986|62635617|FG002|Overall Study|Withdrawal by Subject|0|||
33264536|NCT02195986|62635615|FG000|Overall Study|Family Emergency|0|||
33264537|NCT02195986|62635616|FG001|Overall Study|Family Emergency|0|||
33264538|NCT02195986|62635617|FG002|Overall Study|Family Emergency|1|||
33264539|NCT02195986|62635615|FG000|Overall Study|Protocol Violation|0|||
33264540|NCT02195986|62635616|FG001|Overall Study|Protocol Violation|1|||
33264541|NCT02195986|62635617|FG002|Overall Study|Protocol Violation|1|||
33264542|NCT02195986|62635615|FG000|Overall Study|Non-compliance|0|||
33264543|NCT02195986|62635616|FG001|Overall Study|Non-compliance|1|||
33264544|NCT02195986|62635617|FG002|Overall Study|Non-compliance|0|||
33264545|NCT01982630|62635633|FG000|Overall Study|Adverse Event|2|||
33264546|NCT01982630|62635634|FG001|Overall Study|Adverse Event|0|||
33264547|NCT01982630|62635635|FG002|Overall Study|Adverse Event|1|||
33264548|NCT01982630|62635636|FG003|Overall Study|Adverse Event|0|||
33264549|NCT01982630|62635637|FG004|Overall Study|Adverse Event|1|||
33264550|NCT01982630|62635638|FG005|Overall Study|Adverse Event|2|||
33264551|NCT01982630|62635639|FG006|Overall Study|Adverse Event|1|||
33264552|NCT01982630|62635640|FG007|Overall Study|Adverse Event|0|||
33264553|NCT01982630|62635633|FG000|Overall Study|Physician Decision|1|||
33264554|NCT01982630|62635634|FG001|Overall Study|Physician Decision|0|||
33264555|NCT01982630|62635635|FG002|Overall Study|Physician Decision|2|||
33264556|NCT01982630|62635636|FG003|Overall Study|Physician Decision|1|||
33264557|NCT01982630|62635637|FG004|Overall Study|Physician Decision|2|||
33264558|NCT01982630|62635638|FG005|Overall Study|Physician Decision|0|||
33264559|NCT01982630|62635639|FG006|Overall Study|Physician Decision|0|||
33555524|NCT02347774|62948337|FG002|On Study Treatment|Protocol Violation|1|||
33555525|NCT02347774|62948335|FG000|On Study Treatment|withdrew consent|9|||
33264560|NCT01982630|62635640|FG007|Overall Study|Physician Decision|0|||
33264561|NCT01982630|62635633|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
33264562|NCT01982630|62635634|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
33264563|NCT01982630|62635635|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
33264564|NCT01982630|62635636|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
33264565|NCT01982630|62635637|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
33264566|NCT01982630|62635638|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
33264567|NCT01982630|62635639|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
33264568|NCT01982630|62635640|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
33264569|NCT01982630|62635633|FG000|Overall Study|Withdrawal by Subject|0|||
33264570|NCT01982630|62635634|FG001|Overall Study|Withdrawal by Subject|0|||
33264571|NCT01982630|62635635|FG002|Overall Study|Withdrawal by Subject|0|||
33264572|NCT01982630|62635636|FG003|Overall Study|Withdrawal by Subject|0|||
33264573|NCT01982630|62635637|FG004|Overall Study|Withdrawal by Subject|0|||
33264574|NCT01982630|62635638|FG005|Overall Study|Withdrawal by Subject|1|||
33264575|NCT01982630|62635639|FG006|Overall Study|Withdrawal by Subject|0|||
33264576|NCT01982630|62635640|FG007|Overall Study|Withdrawal by Subject|0|||
33264577|NCT01740297|62635705|FG000|Overall Study|Withdrawal by Subject|4|||
33264578|NCT01740297|62635706|FG001|Overall Study|Withdrawal by Subject|16|||
33264579|NCT01740297|62635707|FG002|Overall Study|Withdrawal by Subject|17|||
33264580|NCT01740297|62635705|FG000|Overall Study|Death|8|||
33264581|NCT01740297|62635706|FG001|Overall Study|Death|46|||
33264582|NCT01740297|62635707|FG002|Overall Study|Death|40|||
33264583|NCT01740297|62635705|FG000|Overall Study|Lost to Follow-up|1|||
33264584|NCT01740297|62635706|FG001|Overall Study|Lost to Follow-up|2|||
33264585|NCT01740297|62635707|FG002|Overall Study|Lost to Follow-up|4|||
33264586|NCT01729754|62635721|FG000|Part 1|Adverse Event|2|||
33264587|NCT01729754|62635722|FG001|Part 1|Adverse Event|0|||
33264588|NCT01729754|62635723|FG002|Part 1|Adverse Event|0|||
33264589|NCT01729754|62635724|FG003|Part 1|Adverse Event|1|||
33264590|NCT01729754|62635725|FG004|Part 1|Adverse Event|0|||
33264591|NCT01729754|62635726|FG005|Part 1|Adverse Event|0|||
33264592|NCT01729754|62635727|FG006|Part 1|Adverse Event|2|||
33264593|NCT01729754|62635728|FG007|Part 1|Adverse Event|0|||
33264594|NCT01729754|62635729|FG008|Part 1|Adverse Event|0|||
33264595|NCT01729754|62635730|FG009|Part 1|Adverse Event|5|||
33264596|NCT01729754|62635721|FG000|Part 1|Lack of Efficacy|1|||
33264597|NCT01729754|62635722|FG001|Part 1|Lack of Efficacy|0|||
33264598|NCT01729754|62635723|FG002|Part 1|Lack of Efficacy|0|||
33264599|NCT01729754|62635724|FG003|Part 1|Lack of Efficacy|0|||
33264600|NCT01729754|62635725|FG004|Part 1|Lack of Efficacy|0|||
33264601|NCT01729754|62635726|FG005|Part 1|Lack of Efficacy|0|||
33264602|NCT01729754|62635727|FG006|Part 1|Lack of Efficacy|2|||
33264603|NCT01729754|62635728|FG007|Part 1|Lack of Efficacy|0|||
33264604|NCT01729754|62635729|FG008|Part 1|Lack of Efficacy|0|||
33264605|NCT01729754|62635730|FG009|Part 1|Lack of Efficacy|0|||
33264606|NCT01729754|62635721|FG000|Part 1|Lost to Follow-up|1|||
33264607|NCT01729754|62635722|FG001|Part 1|Lost to Follow-up|0|||
33264608|NCT01729754|62635723|FG002|Part 1|Lost to Follow-up|0|||
33264609|NCT01729754|62635724|FG003|Part 1|Lost to Follow-up|2|||
33264610|NCT01729754|62635725|FG004|Part 1|Lost to Follow-up|0|||
33264611|NCT01729754|62635726|FG005|Part 1|Lost to Follow-up|0|||
33264612|NCT01729754|62635727|FG006|Part 1|Lost to Follow-up|3|||
33264613|NCT01729754|62635728|FG007|Part 1|Lost to Follow-up|0|||
33264614|NCT01729754|62635729|FG008|Part 1|Lost to Follow-up|0|||
33264615|NCT01729754|62635730|FG009|Part 1|Lost to Follow-up|3|||
33264616|NCT01729754|62635721|FG000|Part 1|Non-compliance with Study Drug|1|||
33264617|NCT01729754|62635722|FG001|Part 1|Non-compliance with Study Drug|0|||
33264618|NCT01729754|62635723|FG002|Part 1|Non-compliance with Study Drug|0|||
33264619|NCT01729754|62635724|FG003|Part 1|Non-compliance with Study Drug|0|||
33264620|NCT01729754|62635725|FG004|Part 1|Non-compliance with Study Drug|0|||
33264621|NCT01729754|62635726|FG005|Part 1|Non-compliance with Study Drug|0|||
33264622|NCT01729754|62635727|FG006|Part 1|Non-compliance with Study Drug|0|||
33264623|NCT01729754|62635728|FG007|Part 1|Non-compliance with Study Drug|0|||
33264624|NCT01729754|62635729|FG008|Part 1|Non-compliance with Study Drug|0|||
33264625|NCT01729754|62635730|FG009|Part 1|Non-compliance with Study Drug|0|||
33264626|NCT01729754|62635721|FG000|Part 1|Physician Decision|0|||
33264627|NCT01729754|62635722|FG001|Part 1|Physician Decision|0|||
33264628|NCT01729754|62635723|FG002|Part 1|Physician Decision|0|||
33264629|NCT01729754|62635724|FG003|Part 1|Physician Decision|0|||
33264630|NCT01729754|62635725|FG004|Part 1|Physician Decision|0|||
33264631|NCT01729754|62635726|FG005|Part 1|Physician Decision|0|||
33264632|NCT01729754|62635727|FG006|Part 1|Physician Decision|0|||
33264633|NCT01729754|62635728|FG007|Part 1|Physician Decision|0|||
33264634|NCT01729754|62635729|FG008|Part 1|Physician Decision|0|||
33264635|NCT01729754|62635730|FG009|Part 1|Physician Decision|4|||
33484611|NCT03325556|62861534|FG001|Open-label Period|Use of prohibited medication|0|||
33484612|NCT03325556|62861535|FG002|Open-label Period|Use of prohibited medication|0|||
33484613|NCT03325556|62861533|FG000|Open-label Period|Protocol Violation|4|||
33264636|NCT01729754|62635721|FG000|Part 1|Pregnancy|0|||
33264637|NCT01729754|62635722|FG001|Part 1|Pregnancy|0|||
33264638|NCT01729754|62635723|FG002|Part 1|Pregnancy|0|||
33264639|NCT01729754|62635724|FG003|Part 1|Pregnancy|1|||
33264640|NCT01729754|62635725|FG004|Part 1|Pregnancy|0|||
33264641|NCT01729754|62635726|FG005|Part 1|Pregnancy|0|||
33264642|NCT01729754|62635727|FG006|Part 1|Pregnancy|0|||
33264643|NCT01729754|62635728|FG007|Part 1|Pregnancy|0|||
33264644|NCT01729754|62635729|FG008|Part 1|Pregnancy|0|||
33264645|NCT01729754|62635730|FG009|Part 1|Pregnancy|1|||
33264646|NCT01729754|62635721|FG000|Part 1|Progressive Disease|0|||
33264647|NCT01729754|62635722|FG001|Part 1|Progressive Disease|0|||
33264648|NCT01729754|62635723|FG002|Part 1|Progressive Disease|0|||
33264649|NCT01729754|62635724|FG003|Part 1|Progressive Disease|0|||
33264650|NCT01729754|62635725|FG004|Part 1|Progressive Disease|0|||
33264651|NCT01729754|62635726|FG005|Part 1|Progressive Disease|0|||
33264652|NCT01729754|62635727|FG006|Part 1|Progressive Disease|0|||
33264653|NCT01729754|62635728|FG007|Part 1|Progressive Disease|0|||
33264654|NCT01729754|62635729|FG008|Part 1|Progressive Disease|0|||
33264655|NCT01729754|62635730|FG009|Part 1|Progressive Disease|1|||
33264656|NCT01729754|62635721|FG000|Part 1|Protocol Violation|2|||
33264657|NCT01729754|62635722|FG001|Part 1|Protocol Violation|0|||
33264658|NCT01729754|62635723|FG002|Part 1|Protocol Violation|0|||
33264659|NCT01729754|62635724|FG003|Part 1|Protocol Violation|1|||
33264660|NCT01729754|62635725|FG004|Part 1|Protocol Violation|0|||
33264661|NCT01729754|62635726|FG005|Part 1|Protocol Violation|0|||
33264662|NCT01729754|62635727|FG006|Part 1|Protocol Violation|1|||
33264663|NCT01729754|62635728|FG007|Part 1|Protocol Violation|0|||
33264664|NCT01729754|62635729|FG008|Part 1|Protocol Violation|0|||
33264665|NCT01729754|62635730|FG009|Part 1|Protocol Violation|0|||
33264666|NCT01729754|62635721|FG000|Part 1|Withdrawal by Subject|5|||
33264667|NCT01729754|62635722|FG001|Part 1|Withdrawal by Subject|0|||
33264668|NCT01729754|62635723|FG002|Part 1|Withdrawal by Subject|0|||
33264669|NCT01729754|62635724|FG003|Part 1|Withdrawal by Subject|7|||
33264670|NCT01729754|62635725|FG004|Part 1|Withdrawal by Subject|0|||
33264671|NCT01729754|62635726|FG005|Part 1|Withdrawal by Subject|0|||
33264672|NCT01729754|62635727|FG006|Part 1|Withdrawal by Subject|5|||
33264673|NCT01729754|62635728|FG007|Part 1|Withdrawal by Subject|0|||
33264674|NCT01729754|62635729|FG008|Part 1|Withdrawal by Subject|0|||
33264675|NCT01729754|62635730|FG009|Part 1|Withdrawal by Subject|6|||
33264676|NCT01729754|62635721|FG000|Part 1|Other Protocol Specified Criteria|2|||
33264677|NCT01729754|62635722|FG001|Part 1|Other Protocol Specified Criteria|0|||
33264678|NCT01729754|62635723|FG002|Part 1|Other Protocol Specified Criteria|0|||
33264679|NCT01729754|62635724|FG003|Part 1|Other Protocol Specified Criteria|0|||
33264680|NCT01729754|62635725|FG004|Part 1|Other Protocol Specified Criteria|0|||
33264681|NCT01729754|62635726|FG005|Part 1|Other Protocol Specified Criteria|0|||
33264682|NCT01729754|62635727|FG006|Part 1|Other Protocol Specified Criteria|1|||
33264683|NCT01729754|62635728|FG007|Part 1|Other Protocol Specified Criteria|0|||
33264684|NCT01729754|62635729|FG008|Part 1|Other Protocol Specified Criteria|0|||
33264685|NCT01729754|62635730|FG009|Part 1|Other Protocol Specified Criteria|4|||
33264686|NCT01729754|62635721|FG000|Part 2|Adverse Event|2|||
33264687|NCT01729754|62635722|FG001|Part 2|Adverse Event|0|||
33264688|NCT01729754|62635723|FG002|Part 2|Adverse Event|0|||
33264689|NCT01729754|62635724|FG003|Part 2|Adverse Event|0|||
33264690|NCT01729754|62635725|FG004|Part 2|Adverse Event|0|||
33264691|NCT01729754|62635726|FG005|Part 2|Adverse Event|0|||
33264692|NCT01729754|62635727|FG006|Part 2|Adverse Event|0|||
33264693|NCT01729754|62635728|FG007|Part 2|Adverse Event|0|||
33264694|NCT01729754|62635729|FG008|Part 2|Adverse Event|1|||
33264695|NCT01729754|62635730|FG009|Part 2|Adverse Event|2|||
33264696|NCT01729754|62635721|FG000|Part 2|Lack of Efficacy|0|||
33264697|NCT01729754|62635722|FG001|Part 2|Lack of Efficacy|0|||
33264698|NCT01729754|62635723|FG002|Part 2|Lack of Efficacy|0|||
33264699|NCT01729754|62635724|FG003|Part 2|Lack of Efficacy|0|||
33264700|NCT01729754|62635725|FG004|Part 2|Lack of Efficacy|0|||
33264701|NCT01729754|62635726|FG005|Part 2|Lack of Efficacy|0|||
33264702|NCT01729754|62635727|FG006|Part 2|Lack of Efficacy|0|||
33264703|NCT01729754|62635728|FG007|Part 2|Lack of Efficacy|0|||
33264704|NCT01729754|62635729|FG008|Part 2|Lack of Efficacy|2|||
33264705|NCT01729754|62635730|FG009|Part 2|Lack of Efficacy|2|||
33264706|NCT01729754|62635721|FG000|Part 2|Lost to Follow-up|0|||
33264707|NCT01729754|62635722|FG001|Part 2|Lost to Follow-up|0|||
33264708|NCT01729754|62635723|FG002|Part 2|Lost to Follow-up|0|||
33264709|NCT01729754|62635724|FG003|Part 2|Lost to Follow-up|2|||
33264710|NCT01729754|62635725|FG004|Part 2|Lost to Follow-up|0|||
33264711|NCT01729754|62635726|FG005|Part 2|Lost to Follow-up|0|||
33264712|NCT01729754|62635727|FG006|Part 2|Lost to Follow-up|0|||
33264713|NCT01729754|62635728|FG007|Part 2|Lost to Follow-up|1|||
33264714|NCT01729754|62635729|FG008|Part 2|Lost to Follow-up|0|||
33264715|NCT01729754|62635730|FG009|Part 2|Lost to Follow-up|2|||
33264716|NCT01729754|62635721|FG000|Part 2|Non-Compliance with Study Drug|0|||
33264717|NCT01729754|62635722|FG001|Part 2|Non-Compliance with Study Drug|0|||
33264718|NCT01729754|62635723|FG002|Part 2|Non-Compliance with Study Drug|0|||
33264719|NCT01729754|62635724|FG003|Part 2|Non-Compliance with Study Drug|0|||
33264720|NCT01729754|62635725|FG004|Part 2|Non-Compliance with Study Drug|0|||
33264721|NCT01729754|62635726|FG005|Part 2|Non-Compliance with Study Drug|0|||
33484614|NCT03325556|62861534|FG001|Open-label Period|Protocol Violation|0|||
33484615|NCT03325556|62861535|FG002|Open-label Period|Protocol Violation|0|||
33484616|NCT03325556|62861533|FG000|Open-label Period|Withdrawal by Subject|17|||
33264722|NCT01729754|62635727|FG006|Part 2|Non-Compliance with Study Drug|0|||
33264723|NCT01729754|62635728|FG007|Part 2|Non-Compliance with Study Drug|0|||
33264724|NCT01729754|62635729|FG008|Part 2|Non-Compliance with Study Drug|0|||
33264725|NCT01729754|62635730|FG009|Part 2|Non-Compliance with Study Drug|1|||
33264726|NCT01729754|62635721|FG000|Part 2|Pregnancy|0|||
33264727|NCT01729754|62635722|FG001|Part 2|Pregnancy|0|||
33264728|NCT01729754|62635723|FG002|Part 2|Pregnancy|0|||
33264729|NCT01729754|62635724|FG003|Part 2|Pregnancy|1|||
33484617|NCT03325556|62861534|FG001|Open-label Period|Withdrawal by Subject|0|||
33484618|NCT03325556|62861535|FG002|Open-label Period|Withdrawal by Subject|0|||
33264730|NCT01729754|62635725|FG004|Part 2|Pregnancy|0|||
33264731|NCT01729754|62635726|FG005|Part 2|Pregnancy|0|||
33264732|NCT01729754|62635727|FG006|Part 2|Pregnancy|0|||
33264733|NCT01729754|62635728|FG007|Part 2|Pregnancy|0|||
33264734|NCT01729754|62635729|FG008|Part 2|Pregnancy|0|||
33264735|NCT01729754|62635730|FG009|Part 2|Pregnancy|1|||
33264736|NCT01729754|62635721|FG000|Part 2|Withdrawal by Subject|3|||
33264737|NCT01729754|62635722|FG001|Part 2|Withdrawal by Subject|0|||
33264738|NCT01729754|62635723|FG002|Part 2|Withdrawal by Subject|0|||
33264739|NCT01729754|62635724|FG003|Part 2|Withdrawal by Subject|2|||
33264740|NCT01729754|62635725|FG004|Part 2|Withdrawal by Subject|0|||
33264741|NCT01729754|62635726|FG005|Part 2|Withdrawal by Subject|0|||
33264742|NCT01729754|62635727|FG006|Part 2|Withdrawal by Subject|0|||
33264743|NCT01729754|62635728|FG007|Part 2|Withdrawal by Subject|1|||
33264744|NCT01729754|62635729|FG008|Part 2|Withdrawal by Subject|1|||
33264745|NCT01729754|62635730|FG009|Part 2|Withdrawal by Subject|4|||
33264746|NCT01729754|62635721|FG000|Part 2|Other Protocol Specified Criteria|1|||
33264747|NCT01729754|62635722|FG001|Part 2|Other Protocol Specified Criteria|0|||
33264748|NCT01729754|62635723|FG002|Part 2|Other Protocol Specified Criteria|0|||
33264749|NCT01729754|62635724|FG003|Part 2|Other Protocol Specified Criteria|0|||
33264750|NCT01729754|62635725|FG004|Part 2|Other Protocol Specified Criteria|0|||
33264751|NCT01729754|62635726|FG005|Part 2|Other Protocol Specified Criteria|0|||
33264752|NCT01729754|62635727|FG006|Part 2|Other Protocol Specified Criteria|0|||
33264753|NCT01729754|62635728|FG007|Part 2|Other Protocol Specified Criteria|1|||
33264754|NCT01729754|62635729|FG008|Part 2|Other Protocol Specified Criteria|0|||
33264755|NCT01729754|62635730|FG009|Part 2|Other Protocol Specified Criteria|0|||
33264756|NCT01729754|62635721|FG000|Part 3|Adverse Event|0|||
33264757|NCT01729754|62635722|FG001|Part 3|Adverse Event|0|||
33264758|NCT01729754|62635723|FG002|Part 3|Adverse Event|1|||
33264759|NCT01729754|62635724|FG003|Part 3|Adverse Event|0|||
33264760|NCT01729754|62635725|FG004|Part 3|Adverse Event|0|||
33264761|NCT01729754|62635726|FG005|Part 3|Adverse Event|5|||
33264762|NCT01729754|62635727|FG006|Part 3|Adverse Event|0|||
33264763|NCT01729754|62635728|FG007|Part 3|Adverse Event|0|||
33264764|NCT01729754|62635729|FG008|Part 3|Adverse Event|0|||
33264765|NCT01729754|62635730|FG009|Part 3|Adverse Event|3|||
33264766|NCT01729754|62635721|FG000|Part 3|Death|0|||
33264767|NCT01729754|62635722|FG001|Part 3|Death|0|||
33264768|NCT01729754|62635723|FG002|Part 3|Death|0|||
33264769|NCT01729754|62635724|FG003|Part 3|Death|0|||
33264770|NCT01729754|62635725|FG004|Part 3|Death|0|||
33264771|NCT01729754|62635726|FG005|Part 3|Death|2|||
33264772|NCT01729754|62635727|FG006|Part 3|Death|0|||
33264773|NCT01729754|62635728|FG007|Part 3|Death|0|||
33264774|NCT01729754|62635729|FG008|Part 3|Death|0|||
33264775|NCT01729754|62635730|FG009|Part 3|Death|0|||
33264776|NCT01729754|62635721|FG000|Part 3|Lack of Efficacy|0|||
33264777|NCT01729754|62635722|FG001|Part 3|Lack of Efficacy|0|||
33264778|NCT01729754|62635723|FG002|Part 3|Lack of Efficacy|0|||
33264779|NCT01729754|62635724|FG003|Part 3|Lack of Efficacy|0|||
33264780|NCT01729754|62635725|FG004|Part 3|Lack of Efficacy|2|||
33264781|NCT01729754|62635726|FG005|Part 3|Lack of Efficacy|0|||
33264782|NCT01729754|62635727|FG006|Part 3|Lack of Efficacy|0|||
33264783|NCT01729754|62635728|FG007|Part 3|Lack of Efficacy|0|||
33264784|NCT01729754|62635729|FG008|Part 3|Lack of Efficacy|0|||
33264785|NCT01729754|62635730|FG009|Part 3|Lack of Efficacy|4|||
33264786|NCT01729754|62635721|FG000|Part 3|Lost to Follow-up|0|||
33264787|NCT01729754|62635722|FG001|Part 3|Lost to Follow-up|1|||
33264788|NCT01729754|62635723|FG002|Part 3|Lost to Follow-up|2|||
33264789|NCT01729754|62635724|FG003|Part 3|Lost to Follow-up|0|||
33264790|NCT01729754|62635725|FG004|Part 3|Lost to Follow-up|0|||
33264791|NCT01729754|62635726|FG005|Part 3|Lost to Follow-up|3|||
33264792|NCT01729754|62635727|FG006|Part 3|Lost to Follow-up|0|||
33264793|NCT01729754|62635728|FG007|Part 3|Lost to Follow-up|0|||
33264794|NCT01729754|62635729|FG008|Part 3|Lost to Follow-up|1|||
33264795|NCT01729754|62635730|FG009|Part 3|Lost to Follow-up|0|||
33264796|NCT01729754|62635721|FG000|Part 3|Physician Decision|0|||
33264797|NCT01729754|62635722|FG001|Part 3|Physician Decision|0|||
33264798|NCT01729754|62635723|FG002|Part 3|Physician Decision|1|||
33264799|NCT01729754|62635724|FG003|Part 3|Physician Decision|0|||
33264800|NCT01729754|62635725|FG004|Part 3|Physician Decision|0|||
33484619|NCT03325556|62861533|FG000|Open-label Period|Not otherwise specified|8|||
33484620|NCT03325556|62861534|FG001|Open-label Period|Not otherwise specified|0|||
33484621|NCT03325556|62861535|FG002|Open-label Period|Not otherwise specified|0|||
33484622|NCT03325556|62861533|FG000|Open-label Period|Administrative discont. at study termination|41|||
33484623|NCT03325556|62861534|FG001|Open-label Period|Administrative discont. at study termination|0|||
33555526|NCT02347774|62948336|FG001|On Study Treatment|withdrew consent|8|||
33484624|NCT03325556|62861535|FG002|Open-label Period|Administrative discont. at study termination|0|||
33484625|NCT03325556|62861533|FG000|Double-blind Period|Relapse|0|||
33484626|NCT03325556|62861534|FG001|Double-blind Period|Relapse|15|||
33264801|NCT01729754|62635726|FG005|Part 3|Physician Decision|0|||
33264802|NCT01729754|62635727|FG006|Part 3|Physician Decision|0|||
33264803|NCT01729754|62635728|FG007|Part 3|Physician Decision|0|||
33264804|NCT01729754|62635729|FG008|Part 3|Physician Decision|0|||
33264805|NCT01729754|62635730|FG009|Part 3|Physician Decision|0|||
33264806|NCT01729754|62635721|FG000|Part 3|Withdrawal by Subject|0|||
33264807|NCT01729754|62635722|FG001|Part 3|Withdrawal by Subject|4|||
33264808|NCT01729754|62635723|FG002|Part 3|Withdrawal by Subject|1|||
33484627|NCT03325556|62861535|FG002|Double-blind Period|Relapse|34|||
33484628|NCT03325556|62861533|FG000|Double-blind Period|Adverse Event|0|||
33484629|NCT03325556|62861534|FG001|Double-blind Period|Adverse Event|3|||
33484630|NCT03325556|62861535|FG002|Double-blind Period|Adverse Event|1|||
33484631|NCT03325556|62861533|FG000|Double-blind Period|Noncompliance with study drug|0|||
33484632|NCT03325556|62861534|FG001|Double-blind Period|Noncompliance with study drug|0|||
33484633|NCT03325556|62861535|FG002|Double-blind Period|Noncompliance with study drug|1|||
33484634|NCT03325556|62861533|FG000|Double-blind Period|Use of prohibited medication|0|||
33484635|NCT03325556|62861534|FG001|Double-blind Period|Use of prohibited medication|1|||
33484636|NCT03325556|62861535|FG002|Double-blind Period|Use of prohibited medication|0|||
33484637|NCT03325556|62861533|FG000|Double-blind Period|Physician Decision|0|||
33264809|NCT01729754|62635724|FG003|Part 3|Withdrawal by Subject|0|||
33264810|NCT01729754|62635725|FG004|Part 3|Withdrawal by Subject|2|||
33264811|NCT01729754|62635726|FG005|Part 3|Withdrawal by Subject|1|||
33264812|NCT01729754|62635727|FG006|Part 3|Withdrawal by Subject|0|||
33264813|NCT01729754|62635728|FG007|Part 3|Withdrawal by Subject|2|||
33264814|NCT01729754|62635729|FG008|Part 3|Withdrawal by Subject|0|||
33264815|NCT01729754|62635730|FG009|Part 3|Withdrawal by Subject|0|||
33264816|NCT01729754|62635721|FG000|Part 3|Other Protocol Specified Criteria|0|||
33264817|NCT01729754|62635722|FG001|Part 3|Other Protocol Specified Criteria|0|||
33264818|NCT01729754|62635723|FG002|Part 3|Other Protocol Specified Criteria|0|||
33264819|NCT01729754|62635724|FG003|Part 3|Other Protocol Specified Criteria|0|||
33264820|NCT01729754|62635725|FG004|Part 3|Other Protocol Specified Criteria|0|||
33264821|NCT01729754|62635726|FG005|Part 3|Other Protocol Specified Criteria|2|||
33264822|NCT01729754|62635727|FG006|Part 3|Other Protocol Specified Criteria|0|||
33264823|NCT01729754|62635728|FG007|Part 3|Other Protocol Specified Criteria|1|||
33264824|NCT01729754|62635729|FG008|Part 3|Other Protocol Specified Criteria|0|||
33264825|NCT01729754|62635730|FG009|Part 3|Other Protocol Specified Criteria|0|||
33264826|NCT01515306|62635775|FG000|Overall Study|Adverse Event|3|||
33264827|NCT01515306|62635776|FG001|Overall Study|Adverse Event|2|||
33264828|NCT01515306|62635775|FG000|Overall Study|Progressive Disease|19|||
33264829|NCT01515306|62635776|FG001|Overall Study|Progressive Disease|9|||
33264830|NCT01515306|62635775|FG000|Overall Study|Withdrawal by Subject|1|||
33264831|NCT01515306|62635776|FG001|Overall Study|Withdrawal by Subject|2|||
33264832|NCT01515306|62635775|FG000|Overall Study|Physician Decision|1|||
33264833|NCT01515306|62635776|FG001|Overall Study|Physician Decision|1|||
33264834|NCT01423851|62635797|FG000|Whole Study|Disease progression|2|||
33264835|NCT01423851|62635798|FG001|Whole Study|Disease progression|1|||
33264836|NCT01423851|62635799|FG002|Whole Study|Disease progression|1|||
33264837|NCT01423851|62635800|FG003|Whole Study|Disease progression|4|||
33264838|NCT01423851|62635801|FG004|Whole Study|Disease progression|1|||
33264839|NCT01423851|62635802|FG005|Whole Study|Disease progression|3|||
33264840|NCT01423851|62635803|FG006|Whole Study|Disease progression|1|||
33264841|NCT01423851|62635804|FG007|Whole Study|Disease progression|4|||
33264842|NCT01423851|62635805|FG008|Whole Study|Disease progression|0|||
33264843|NCT01423851|62635806|FG009|Whole Study|Disease progression|2|||
33264844|NCT01423851|62635807|FG010|Whole Study|Disease progression|10|||
33264845|NCT01423851|62635797|FG000|Whole Study|Physician Decision|0|||
33264846|NCT01423851|62635798|FG001|Whole Study|Physician Decision|1|||
33264847|NCT01423851|62635799|FG002|Whole Study|Physician Decision|2|||
33264848|NCT01423851|62635800|FG003|Whole Study|Physician Decision|0|||
33264849|NCT01423851|62635801|FG004|Whole Study|Physician Decision|2|||
33264850|NCT01423851|62635802|FG005|Whole Study|Physician Decision|0|||
33264851|NCT01423851|62635803|FG006|Whole Study|Physician Decision|2|||
33264852|NCT01423851|62635804|FG007|Whole Study|Physician Decision|1|||
33264853|NCT01423851|62635805|FG008|Whole Study|Physician Decision|3|||
33264854|NCT01423851|62635806|FG009|Whole Study|Physician Decision|4|||
33264855|NCT01423851|62635807|FG010|Whole Study|Physician Decision|12|||
33264856|NCT01423851|62635797|FG000|Whole Study|Withdrawal by Subject|1|||
33264857|NCT01423851|62635798|FG001|Whole Study|Withdrawal by Subject|1|||
33264858|NCT01423851|62635799|FG002|Whole Study|Withdrawal by Subject|0|||
33264859|NCT01423851|62635800|FG003|Whole Study|Withdrawal by Subject|0|||
33264860|NCT01423851|62635801|FG004|Whole Study|Withdrawal by Subject|0|||
33264861|NCT01423851|62635802|FG005|Whole Study|Withdrawal by Subject|0|||
33264862|NCT01423851|62635803|FG006|Whole Study|Withdrawal by Subject|0|||
33264863|NCT01423851|62635804|FG007|Whole Study|Withdrawal by Subject|0|||
33264864|NCT01423851|62635805|FG008|Whole Study|Withdrawal by Subject|2|||
33264865|NCT01423851|62635806|FG009|Whole Study|Withdrawal by Subject|0|||
33264866|NCT01423851|62635807|FG010|Whole Study|Withdrawal by Subject|4|||
33264867|NCT01423851|62635797|FG000|Whole Study|Adverse Event|0|||
33264868|NCT01423851|62635798|FG001|Whole Study|Adverse Event|0|||
33264869|NCT01423851|62635799|FG002|Whole Study|Adverse Event|0|||
33264870|NCT01423851|62635800|FG003|Whole Study|Adverse Event|2|||
33264871|NCT01423851|62635801|FG004|Whole Study|Adverse Event|0|||
33264872|NCT01423851|62635802|FG005|Whole Study|Adverse Event|0|||
33264873|NCT01423851|62635803|FG006|Whole Study|Adverse Event|0|||
33264874|NCT01423851|62635804|FG007|Whole Study|Adverse Event|3|||
33264875|NCT01423851|62635805|FG008|Whole Study|Adverse Event|3|||
33264876|NCT01423851|62635806|FG009|Whole Study|Adverse Event|2|||
33264877|NCT01423851|62635807|FG010|Whole Study|Adverse Event|3|||
33264878|NCT01334606|62635849|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
33264879|NCT01317875|62635865|FG000|Overall Study|Other|0|||
33264880|NCT01317875|62635866|FG001|Overall Study|Other|0|||
33264881|NCT01317875|62635867|FG002|Overall Study|Other|1|||
33264882|NCT01317875|62635868|FG003|Overall Study|Other|0|||
33264883|NCT01317875|62635869|FG004|Overall Study|Other|0|||
33264884|NCT01317875|62635870|FG005|Overall Study|Other|0|||
33264885|NCT01317875|62635871|FG006|Overall Study|Other|0|||
33264886|NCT01317875|62635872|FG007|Overall Study|Other|0|||
33264887|NCT01317875|62635873|FG008|Overall Study|Other|0|||
33264888|NCT01317875|62635874|FG009|Overall Study|Other|0|||
33264889|NCT01317875|62635865|FG000|Overall Study|Noncompliance with study drug|0|||
33264890|NCT01317875|62635866|FG001|Overall Study|Noncompliance with study drug|0|||
33264891|NCT01317875|62635867|FG002|Overall Study|Noncompliance with study drug|1|||
33264892|NCT01317875|62635868|FG003|Overall Study|Noncompliance with study drug|0|||
33264893|NCT01317875|62635869|FG004|Overall Study|Noncompliance with study drug|0|||
33264894|NCT01317875|62635870|FG005|Overall Study|Noncompliance with study drug|0|||
33264895|NCT01317875|62635871|FG006|Overall Study|Noncompliance with study drug|0|||
33264896|NCT01317875|62635872|FG007|Overall Study|Noncompliance with study drug|0|||
33264897|NCT01317875|62635873|FG008|Overall Study|Noncompliance with study drug|0|||
33264898|NCT01317875|62635874|FG009|Overall Study|Noncompliance with study drug|0|||
33264899|NCT01317875|62635865|FG000|Overall Study|Progressive Disease|1|||
33264900|NCT01317875|62635866|FG001|Overall Study|Progressive Disease|0|||
33264901|NCT01317875|62635867|FG002|Overall Study|Progressive Disease|2|||
33264902|NCT01317875|62635868|FG003|Overall Study|Progressive Disease|0|||
33264903|NCT01317875|62635869|FG004|Overall Study|Progressive Disease|1|||
33264904|NCT01317875|62635870|FG005|Overall Study|Progressive Disease|0|||
33264905|NCT01317875|62635871|FG006|Overall Study|Progressive Disease|0|||
33264906|NCT01317875|62635872|FG007|Overall Study|Progressive Disease|1|||
33264907|NCT01317875|62635873|FG008|Overall Study|Progressive Disease|0|||
33264908|NCT01317875|62635874|FG009|Overall Study|Progressive Disease|0|||
33264909|NCT01317875|62635865|FG000|Overall Study|Withdrawal by Subject|0|||
33264910|NCT01317875|62635866|FG001|Overall Study|Withdrawal by Subject|0|||
33264911|NCT01317875|62635867|FG002|Overall Study|Withdrawal by Subject|0|||
33264912|NCT01317875|62635868|FG003|Overall Study|Withdrawal by Subject|0|||
33264913|NCT01317875|62635869|FG004|Overall Study|Withdrawal by Subject|1|||
33264914|NCT01317875|62635870|FG005|Overall Study|Withdrawal by Subject|0|||
33264915|NCT01317875|62635871|FG006|Overall Study|Withdrawal by Subject|0|||
33264916|NCT01317875|62635872|FG007|Overall Study|Withdrawal by Subject|3|||
33264917|NCT01317875|62635873|FG008|Overall Study|Withdrawal by Subject|0|||
33264918|NCT01317875|62635874|FG009|Overall Study|Withdrawal by Subject|0|||
33264919|NCT01317875|62635865|FG000|Overall Study|Physician Decision|0|||
33264920|NCT01317875|62635866|FG001|Overall Study|Physician Decision|1|||
33264921|NCT01317875|62635867|FG002|Overall Study|Physician Decision|1|||
33264922|NCT01317875|62635868|FG003|Overall Study|Physician Decision|0|||
33264923|NCT01317875|62635869|FG004|Overall Study|Physician Decision|2|||
33264924|NCT01317875|62635870|FG005|Overall Study|Physician Decision|0|||
33264925|NCT01317875|62635871|FG006|Overall Study|Physician Decision|0|||
33264926|NCT01317875|62635872|FG007|Overall Study|Physician Decision|2|||
33264927|NCT01317875|62635873|FG008|Overall Study|Physician Decision|0|||
33264928|NCT01317875|62635874|FG009|Overall Study|Physician Decision|0|||
33264929|NCT01317875|62635865|FG000|Overall Study|Death|0|||
33264930|NCT01317875|62635866|FG001|Overall Study|Death|0|||
33264931|NCT01317875|62635867|FG002|Overall Study|Death|2|||
33264932|NCT01317875|62635868|FG003|Overall Study|Death|1|||
33264933|NCT01317875|62635869|FG004|Overall Study|Death|0|||
33264934|NCT01317875|62635870|FG005|Overall Study|Death|1|||
33264935|NCT01317875|62635871|FG006|Overall Study|Death|0|||
33264936|NCT01317875|62635872|FG007|Overall Study|Death|4|||
33555527|NCT02347774|62948337|FG002|On Study Treatment|withdrew consent|12|||
33555528|NCT02347774|62948335|FG000|On Study Treatment|Lost to Follow-up|2|||
33264937|NCT01317875|62635873|FG008|Overall Study|Death|0|||
33264938|NCT01317875|62635874|FG009|Overall Study|Death|0|||
33484638|NCT03325556|62861534|FG001|Double-blind Period|Physician Decision|0|||
33484639|NCT03325556|62861535|FG002|Double-blind Period|Physician Decision|1|||
33484640|NCT03325556|62861533|FG000|Double-blind Period|Withdrawal by Subject|0|||
33484641|NCT03325556|62861534|FG001|Double-blind Period|Withdrawal by Subject|6|||
33484642|NCT03325556|62861535|FG002|Double-blind Period|Withdrawal by Subject|4|||
33484643|NCT03325556|62861533|FG000|Double-blind Period|Not otherwise specified|0|||
33484644|NCT03325556|62861534|FG001|Double-blind Period|Not otherwise specified|1|||
33484645|NCT03325556|62861535|FG002|Double-blind Period|Not otherwise specified|5|||
33484646|NCT03325556|62861533|FG000|Double-blind Period|Administrative discont. at study termination|0|||
33484647|NCT03325556|62861534|FG001|Double-blind Period|Administrative discont. at study termination|35|||
33484648|NCT03325556|62861535|FG002|Double-blind Period|Administrative discont. at study termination|31|||
33484649|NCT03320564|62861542|FG000|Overall Study|Protocol Violation|1|||
33484650|NCT03325166|62861546|FG000|Overall Study|Adverse Event|1|||
33264939|NCT01317875|62635865|FG000|Overall Study|Adverse Event|2|||
33264940|NCT01317875|62635866|FG001|Overall Study|Adverse Event|1|||
33484651|NCT02888756|62861553|FG000|Analytical Treatment Interruption|Physician Decision|10|||
33484652|NCT02888756|62861554|FG001|Analytical Treatment Interruption|Physician Decision|6|||
33484653|NCT02888756|62861555|FG002|Analytical Treatment Interruption|Physician Decision|5|||
33484654|NCT03305666|62861565|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
33484655|NCT03305666|62861566|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
33484656|NCT03304184|62861574|FG000|Overall Study|Withdrawal by Subject|1|||
33484657|NCT03304184|62861575|FG001|Overall Study|Withdrawal by Subject|2|||
33484658|NCT03736785|62861585|FG000|Overall Study|Adverse Event|1|||
33484659|NCT03736785|62861586|FG001|Overall Study|Adverse Event|1|||
33484660|NCT03736785|62861587|FG002|Overall Study|Adverse Event|1|||
33484661|NCT03736785|62861585|FG000|Overall Study|Death|1|||
33484662|NCT03736785|62861586|FG001|Overall Study|Death|0|||
33484663|NCT03736785|62861587|FG002|Overall Study|Death|1|||
33484664|NCT03736785|62861585|FG000|Overall Study|Lost to Follow-up|0|||
33484665|NCT03736785|62861586|FG001|Overall Study|Lost to Follow-up|2|||
33484666|NCT03736785|62861587|FG002|Overall Study|Lost to Follow-up|3|||
33484667|NCT03736785|62861585|FG000|Overall Study|Non compliance with study drug|1|||
33484668|NCT03736785|62861586|FG001|Overall Study|Non compliance with study drug|1|||
33484669|NCT03736785|62861587|FG002|Overall Study|Non compliance with study drug|0|||
33484670|NCT03736785|62861585|FG000|Overall Study|Physician Decision|0|||
33484671|NCT03736785|62861586|FG001|Overall Study|Physician Decision|1|||
33264941|NCT01317875|62635867|FG002|Overall Study|Adverse Event|2|||
33264942|NCT01317875|62635868|FG003|Overall Study|Adverse Event|1|||
33264943|NCT01317875|62635869|FG004|Overall Study|Adverse Event|5|||
33368157|NCT00820755|62747045|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
33368158|NCT00820755|62747046|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
33368159|NCT00820755|62747044|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
33368160|NCT00820755|62747045|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
33368161|NCT00820755|62747046|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
33368162|NCT00820755|62747044|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
33368163|NCT00820755|62747045|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
33368164|NCT00820755|62747046|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
33368165|NCT00820755|62747044|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
33368166|NCT00820755|62747045|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
33368167|NCT00820755|62747046|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
33368168|NCT00820755|62747044|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
33368169|NCT00820755|62747045|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
33368170|NCT00820755|62747046|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
33368171|NCT00820755|62747044|FG000|Period 1: Combination Therapy Phase|Other|11|||
33368172|NCT00820755|62747045|FG001|Period 1: Combination Therapy Phase|Other|0|||
33368173|NCT00820755|62747046|FG002|Period 1: Combination Therapy Phase|Other|0|||
33368174|NCT00820755|62747044|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
33368175|NCT00820755|62747045|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
33368176|NCT00820755|62747046|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
33368177|NCT00820599|62747054|FG000|Overall Study|Death|129|||
33368178|NCT00820599|62747054|FG000|Overall Study|Withdrawal by Subject|2|||
33368179|NCT00819741|62747060|FG000|Overall Study|Adverse Event|5|||
33368180|NCT00819741|62747061|FG001|Overall Study|Adverse Event|2|||
33368181|NCT00819741|62747060|FG000|Overall Study|Lack of Efficacy|0|||
33368182|NCT00819741|62747061|FG001|Overall Study|Lack of Efficacy|2|||
33368183|NCT00819741|62747060|FG000|Overall Study|Lost to Follow-up|3|||
33368184|NCT00819741|62747061|FG001|Overall Study|Lost to Follow-up|1|||
33368185|NCT00819741|62747060|FG000|Overall Study|Protocol Violation|3|||
33368186|NCT00819741|62747061|FG001|Overall Study|Protocol Violation|4|||
33368187|NCT00819741|62747060|FG000|Overall Study|Withdrawal by Subject|2|||
33368188|NCT00819741|62747061|FG001|Overall Study|Withdrawal by Subject|2|||
33368189|NCT00819741|62747060|FG000|Overall Study|Unclassified|6|||
33368190|NCT00819741|62747061|FG001|Overall Study|Unclassified|0|||
33368191|NCT00819741|62747060|FG000|Overall Study|Reasons unknown|3|||
33368192|NCT00819741|62747061|FG001|Overall Study|Reasons unknown|3|||
33368193|NCT00862134|62747069|FG000|Overall Study|Death|1|||
33368194|NCT00862134|62747070|FG001|Overall Study|Death|0|||
33264944|NCT01317875|62635870|FG005|Overall Study|Adverse Event|1|||
33264945|NCT01317875|62635871|FG006|Overall Study|Adverse Event|2|||
33264946|NCT01317875|62635872|FG007|Overall Study|Adverse Event|5|||
33368195|NCT00862134|62747069|FG000|Overall Study|Physician Decision|0|||
33368196|NCT00862134|62747070|FG001|Overall Study|Physician Decision|1|||
33368197|NCT00862134|62747069|FG000|Overall Study|Withdrawal by Subject|1|||
33368198|NCT00862134|62747070|FG001|Overall Study|Withdrawal by Subject|2|||
33368199|NCT00862134|62747069|FG000|Overall Study|Sponsor terminated study|5|||
33368200|NCT00862134|62747070|FG001|Overall Study|Sponsor terminated study|7|||
33484672|NCT03736785|62861587|FG002|Overall Study|Physician Decision|1|||
33484673|NCT03736785|62861585|FG000|Overall Study|Protocol Violation|1|||
33264947|NCT01317875|62635873|FG008|Overall Study|Adverse Event|0|||
33264948|NCT01317875|62635874|FG009|Overall Study|Adverse Event|0|||
33264949|NCT00500071|62635950|FG000|Screening and Washout Phase|Protocol Violation|1|||
33264950|NCT00500071|62635950|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
33484674|NCT03736785|62861586|FG001|Overall Study|Protocol Violation|4|||
33484675|NCT03736785|62861587|FG002|Overall Study|Protocol Violation|3|||
33484676|NCT03736785|62861585|FG000|Overall Study|Sponsor Decision|1|||
33484677|NCT03736785|62861586|FG001|Overall Study|Sponsor Decision|0|||
33484678|NCT03736785|62861587|FG002|Overall Study|Sponsor Decision|0|||
33484679|NCT03736785|62861585|FG000|Overall Study|Unknown/Missing data|3|||
33484680|NCT03736785|62861586|FG001|Overall Study|Unknown/Missing data|2|||
33484681|NCT03736785|62861587|FG002|Overall Study|Unknown/Missing data|1|||
33484682|NCT03736785|62861585|FG000|Overall Study|Withdrawal by Subject|9|||
33484683|NCT03736785|62861586|FG001|Overall Study|Withdrawal by Subject|6|||
33484684|NCT03736785|62861587|FG002|Overall Study|Withdrawal by Subject|4|||
33484685|NCT03734991|62861598|FG000|Overall Study|Adverse Event|4|||
33264951|NCT00500071|62635950|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
33264952|NCT00500071|62635950|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
33264953|NCT00500071|62635950|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
33264954|NCT00500071|62635950|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
33264955|NCT00500071|62635950|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
33264956|NCT00447122|62635958|FG000|Overall Study|worsening medical condition -came off|0|||
33264957|NCT00447122|62635959|FG001|Overall Study|worsening medical condition -came off|1|||
33264958|NCT00447122|62635960|FG002|Overall Study|worsening medical condition -came off|0|||
33264959|NCT00447122|62635961|FG003|Overall Study|worsening medical condition -came off|0|||
33264960|NCT00382252|62635971|FG000|Overall Study|Death|4|||
33264961|NCT00382252|62635971|FG000|Overall Study|Protocol Violation|8|||
33264962|NCT00382252|62635971|FG000|Overall Study|Not treated by RFA|1|||
33264963|NCT00290251|62635978|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
33264964|NCT00290251|62635979|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
33264965|NCT00290251|62635980|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
33264966|NCT00290251|62635981|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
33264967|NCT00290251|62635982|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
33264968|NCT00290251|62635983|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
33264969|NCT00290251|62635978|FG000|Treatment 1 (Months 2-4)|headache|0|||
33264970|NCT00290251|62635979|FG001|Treatment 1 (Months 2-4)|headache|0|||
33264971|NCT00290251|62635980|FG002|Treatment 1 (Months 2-4)|headache|0|||
33264972|NCT00290251|62635981|FG003|Treatment 1 (Months 2-4)|headache|0|||
33264973|NCT00290251|62635982|FG004|Treatment 1 (Months 2-4)|headache|1|||
33264974|NCT00290251|62635983|FG005|Treatment 1 (Months 2-4)|headache|0|||
33264975|NCT00290251|62635978|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
33264976|NCT00290251|62635979|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
33264977|NCT00290251|62635980|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
33264978|NCT00290251|62635981|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
33264979|NCT00290251|62635982|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
33264980|NCT00290251|62635983|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
33264981|NCT01403948|62636019|FG000|Overall Study|Progressive disease|0|||
33264982|NCT01403948|62636020|FG001|Overall Study|Progressive disease|2|||
33264983|NCT01403948|62636021|FG002|Overall Study|Progressive disease|2|||
33264984|NCT01403948|62636022|FG003|Overall Study|Progressive disease|4|||
33264985|NCT01403948|62636023|FG004|Overall Study|Progressive disease|2|||
33264986|NCT01403948|62636024|FG005|Overall Study|Progressive disease|6|||
33264987|NCT01403948|62636025|FG006|Overall Study|Progressive disease|2|||
33264988|NCT01403948|62636026|FG007|Overall Study|Progressive disease|4|||
33264989|NCT01403948|62636027|FG008|Overall Study|Progressive disease|5|||
33264990|NCT01403948|62636028|FG009|Overall Study|Progressive disease|5|||
33264991|NCT01403948|62636019|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
33264992|NCT01403948|62636020|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
33264993|NCT01403948|62636021|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
33264994|NCT01403948|62636022|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
33264995|NCT01403948|62636023|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
33484686|NCT03734991|62861599|FG001|Overall Study|Adverse Event|0|||
33484687|NCT03734991|62861598|FG000|Overall Study|Lost to Follow-up|4|||
33264996|NCT01403948|62636024|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
33264997|NCT01403948|62636025|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
33264998|NCT01403948|62636026|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
33264999|NCT01403948|62636027|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
33265000|NCT01403948|62636028|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
33265001|NCT01403948|62636019|FG000|Overall Study|Lost to Follow-up|0|||
33265002|NCT01403948|62636020|FG001|Overall Study|Lost to Follow-up|0|||
33265003|NCT01403948|62636021|FG002|Overall Study|Lost to Follow-up|0|||
33265004|NCT01403948|62636022|FG003|Overall Study|Lost to Follow-up|0|||
33484688|NCT03734991|62861599|FG001|Overall Study|Lost to Follow-up|0|||
33484689|NCT03734991|62861598|FG000|Overall Study|Physician Decision|0|||
33265005|NCT01403948|62636023|FG004|Overall Study|Lost to Follow-up|0|||
33265006|NCT01403948|62636024|FG005|Overall Study|Lost to Follow-up|0|||
33265007|NCT01403948|62636025|FG006|Overall Study|Lost to Follow-up|0|||
33265008|NCT01403948|62636026|FG007|Overall Study|Lost to Follow-up|0|||
33265009|NCT01403948|62636027|FG008|Overall Study|Lost to Follow-up|0|||
33265010|NCT01403948|62636028|FG009|Overall Study|Lost to Follow-up|1|||
33265011|NCT01403948|62636019|FG000|Overall Study|Refused cont. medication|0|||
33265012|NCT01403948|62636020|FG001|Overall Study|Refused cont. medication|0|||
33265013|NCT01403948|62636021|FG002|Overall Study|Refused cont. medication|0|||
33265014|NCT01403948|62636022|FG003|Overall Study|Refused cont. medication|0|||
33265015|NCT01403948|62636023|FG004|Overall Study|Refused cont. medication|1|||
33265016|NCT01403948|62636024|FG005|Overall Study|Refused cont. medication|0|||
33265017|NCT01403948|62636025|FG006|Overall Study|Refused cont. medication|0|||
33265018|NCT01403948|62636026|FG007|Overall Study|Refused cont. medication|0|||
33265019|NCT01403948|62636027|FG008|Overall Study|Refused cont. medication|0|||
33265020|NCT01403948|62636028|FG009|Overall Study|Refused cont. medication|1|||
33265021|NCT01403948|62636019|FG000|Overall Study|other than above|1|||
33265022|NCT01403948|62636020|FG001|Overall Study|other than above|2|||
33265023|NCT01403948|62636021|FG002|Overall Study|other than above|1|||
33265024|NCT01403948|62636022|FG003|Overall Study|other than above|0|||
33265025|NCT01403948|62636023|FG004|Overall Study|other than above|1|||
33265026|NCT01403948|62636024|FG005|Overall Study|other than above|1|||
33265027|NCT01403948|62636025|FG006|Overall Study|other than above|2|||
33265028|NCT01403948|62636026|FG007|Overall Study|other than above|0|||
33265029|NCT01403948|62636027|FG008|Overall Study|other than above|0|||
33265030|NCT01403948|62636028|FG009|Overall Study|other than above|0|||
33265031|NCT01404312|62636056|FG000|Overall Study|Death|21|||
33265032|NCT01404312|62636057|FG001|Overall Study|Death|27|||
33265033|NCT01404312|62636056|FG000|Overall Study|Withdrawal by Subject|15|||
33265034|NCT01404312|62636057|FG001|Overall Study|Withdrawal by Subject|18|||
33265035|NCT01404312|62636056|FG000|Overall Study|Participant Unable to get to clinic|93|||
33265036|NCT01404312|62636057|FG001|Overall Study|Participant Unable to get to clinic|103|||
33265037|NCT01404312|62636056|FG000|Overall Study|Lost to Follow-up|115|||
33265038|NCT01404312|62636057|FG001|Overall Study|Lost to Follow-up|111|||
33265039|NCT01404312|62636056|FG000|Overall Study|Site closed|22|||
33265040|NCT01404312|62636057|FG001|Overall Study|Site closed|21|||
33265041|NCT01404312|62636056|FG000|Overall Study|Participant not willing to adhere to req|31|||
33265042|NCT01404312|62636057|FG001|Overall Study|Participant not willing to adhere to req|29|||
33265043|NCT01404312|62636056|FG000|Overall Study|Severe debilitation, unable to continue|1|||
33265044|NCT01404312|62636057|FG001|Overall Study|Severe debilitation, unable to continue|2|||
33265045|NCT01414608|62636066|FG000|Overall Study|Ineligible|5|||
33265046|NCT01414608|62636067|FG001|Overall Study|Ineligible|2|||
33265047|NCT01425008|62636096|FG000|Dose Escalation Phase|Progressive Disease|2|||
33265048|NCT01425008|62636097|FG001|Dose Escalation Phase|Progressive Disease|3|||
33265049|NCT01425008|62636098|FG002|Dose Escalation Phase|Progressive Disease|2|||
33265050|NCT01425008|62636099|FG003|Dose Escalation Phase|Progressive Disease|3|||
33265051|NCT01425008|62636100|FG004|Dose Escalation Phase|Progressive Disease|5|||
33265052|NCT01425008|62636101|FG005|Dose Escalation Phase|Progressive Disease|4|||
33265053|NCT01425008|62636102|FG006|Dose Escalation Phase|Progressive Disease|0|||
33265054|NCT01425008|62636103|FG007|Dose Escalation Phase|Progressive Disease|2|||
33265055|NCT01425008|62636104|FG008|Dose Escalation Phase|Progressive Disease|6|||
33265056|NCT01425008|62636105|FG009|Dose Escalation Phase|Progressive Disease|2|||
33265057|NCT01425008|62636106|FG010|Dose Escalation Phase|Progressive Disease|0|||
33265058|NCT01425008|62636107|FG011|Dose Escalation Phase|Progressive Disease|0|||
33265059|NCT01425008|62636108|FG012|Dose Escalation Phase|Progressive Disease|0|||
33265060|NCT01425008|62636109|FG013|Dose Escalation Phase|Progressive Disease|0|||
33265061|NCT01425008|62636110|FG014|Dose Escalation Phase|Progressive Disease|0|||
33265062|NCT01425008|62636111|FG015|Dose Escalation Phase|Progressive Disease|0|||
33265063|NCT01425008|62636112|FG016|Dose Escalation Phase|Progressive Disease|0|||
33265064|NCT01425008|62636113|FG017|Dose Escalation Phase|Progressive Disease|0|||
33265065|NCT01425008|62636114|FG018|Dose Escalation Phase|Progressive Disease|0|||
33265066|NCT01425008|62636096|FG000|Dose Escalation Phase|Adverse Event|2|||
33265067|NCT01425008|62636097|FG001|Dose Escalation Phase|Adverse Event|0|||
33265068|NCT01425008|62636098|FG002|Dose Escalation Phase|Adverse Event|0|||
33265069|NCT01425008|62636099|FG003|Dose Escalation Phase|Adverse Event|0|||
33265070|NCT01425008|62636100|FG004|Dose Escalation Phase|Adverse Event|0|||
33265071|NCT01425008|62636101|FG005|Dose Escalation Phase|Adverse Event|2|||
33265072|NCT01425008|62636102|FG006|Dose Escalation Phase|Adverse Event|0|||
33265073|NCT01425008|62636103|FG007|Dose Escalation Phase|Adverse Event|0|||
33265074|NCT01425008|62636104|FG008|Dose Escalation Phase|Adverse Event|2|||
33265075|NCT01425008|62636105|FG009|Dose Escalation Phase|Adverse Event|0|||
33265076|NCT01425008|62636106|FG010|Dose Escalation Phase|Adverse Event|0|||
33265077|NCT01425008|62636107|FG011|Dose Escalation Phase|Adverse Event|0|||
33265078|NCT01425008|62636108|FG012|Dose Escalation Phase|Adverse Event|0|||
33265079|NCT01425008|62636109|FG013|Dose Escalation Phase|Adverse Event|0|||
33265080|NCT01425008|62636110|FG014|Dose Escalation Phase|Adverse Event|0|||
33265081|NCT01425008|62636111|FG015|Dose Escalation Phase|Adverse Event|0|||
33265082|NCT01425008|62636112|FG016|Dose Escalation Phase|Adverse Event|0|||
33265083|NCT01425008|62636113|FG017|Dose Escalation Phase|Adverse Event|0|||
33265084|NCT01425008|62636114|FG018|Dose Escalation Phase|Adverse Event|0|||
33265085|NCT01425008|62636096|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33265086|NCT01425008|62636097|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33265087|NCT01425008|62636098|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33265088|NCT01425008|62636099|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33265089|NCT01425008|62636100|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
33265090|NCT01425008|62636101|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33265091|NCT01425008|62636102|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
33265092|NCT01425008|62636103|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
33265093|NCT01425008|62636104|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
33265094|NCT01425008|62636105|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33265095|NCT01425008|62636106|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33265096|NCT01425008|62636107|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33265097|NCT01425008|62636108|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33265098|NCT01425008|62636109|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33265099|NCT01425008|62636110|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33265100|NCT01425008|62636111|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33265101|NCT01425008|62636112|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33265102|NCT01425008|62636113|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33265103|NCT01425008|62636114|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33265104|NCT01425008|62636096|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
33265105|NCT01425008|62636097|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
33265106|NCT01425008|62636098|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
33265107|NCT01425008|62636099|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
33265108|NCT01425008|62636100|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
33265109|NCT01425008|62636101|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
33265110|NCT01425008|62636102|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
33265111|NCT01425008|62636103|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
33265112|NCT01425008|62636104|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
33265113|NCT01425008|62636105|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
33265114|NCT01425008|62636106|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
33265115|NCT01425008|62636107|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
33265116|NCT01425008|62636108|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
33265117|NCT01425008|62636109|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
33265118|NCT01425008|62636110|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
33265119|NCT01425008|62636111|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
33265120|NCT01425008|62636112|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
33265121|NCT01425008|62636113|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
33265122|NCT01425008|62636114|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
33265123|NCT01425008|62636096|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265124|NCT01425008|62636097|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265125|NCT01425008|62636098|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
33265126|NCT01425008|62636099|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265127|NCT01425008|62636100|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265128|NCT01425008|62636101|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265129|NCT01425008|62636102|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265130|NCT01425008|62636103|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265131|NCT01425008|62636104|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
33265132|NCT01425008|62636105|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
33265133|NCT01425008|62636106|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265134|NCT01425008|62636107|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265135|NCT01425008|62636108|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265136|NCT01425008|62636109|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265137|NCT01425008|62636110|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265138|NCT01425008|62636111|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265139|NCT01425008|62636112|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265140|NCT01425008|62636113|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265141|NCT01425008|62636114|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
33265142|NCT01425008|62636096|FG000|Dose Escalation Phase|Other|0|||
33555529|NCT02347774|62948336|FG001|On Study Treatment|Lost to Follow-up|6|||
33661801|NCT01697579|63091449|FG005|Base Study-Cycle 1|Protocol Violation|0|||
33265143|NCT01425008|62636097|FG001|Dose Escalation Phase|Other|0|||
33265144|NCT01425008|62636098|FG002|Dose Escalation Phase|Other|0|||
33265145|NCT01425008|62636099|FG003|Dose Escalation Phase|Other|0|||
33265146|NCT01425008|62636100|FG004|Dose Escalation Phase|Other|0|||
33265147|NCT01425008|62636101|FG005|Dose Escalation Phase|Other|0|||
33265148|NCT01425008|62636102|FG006|Dose Escalation Phase|Other|0|||
33555530|NCT02347774|62948337|FG002|On Study Treatment|Lost to Follow-up|1|||
33265149|NCT01425008|62636103|FG007|Dose Escalation Phase|Other|0|||
33265150|NCT01425008|62636104|FG008|Dose Escalation Phase|Other|1|||
33265151|NCT01425008|62636105|FG009|Dose Escalation Phase|Other|0|||
33265152|NCT01425008|62636106|FG010|Dose Escalation Phase|Other|0|||
33265153|NCT01425008|62636107|FG011|Dose Escalation Phase|Other|0|||
33265154|NCT01425008|62636108|FG012|Dose Escalation Phase|Other|0|||
33265155|NCT01425008|62636109|FG013|Dose Escalation Phase|Other|0|||
33265156|NCT01425008|62636110|FG014|Dose Escalation Phase|Other|0|||
33265157|NCT01425008|62636111|FG015|Dose Escalation Phase|Other|0|||
33265158|NCT01425008|62636112|FG016|Dose Escalation Phase|Other|0|||
33265159|NCT01425008|62636113|FG017|Dose Escalation Phase|Other|0|||
33265160|NCT01425008|62636114|FG018|Dose Escalation Phase|Other|0|||
33265161|NCT01425008|62636096|FG000|Dose Expansion Phase|Progressive Disease|0|||
33265162|NCT01425008|62636097|FG001|Dose Expansion Phase|Progressive Disease|0|||
33265163|NCT01425008|62636098|FG002|Dose Expansion Phase|Progressive Disease|0|||
33265164|NCT01425008|62636099|FG003|Dose Expansion Phase|Progressive Disease|0|||
33265165|NCT01425008|62636100|FG004|Dose Expansion Phase|Progressive Disease|0|||
33265166|NCT01425008|62636101|FG005|Dose Expansion Phase|Progressive Disease|0|||
33265167|NCT01425008|62636102|FG006|Dose Expansion Phase|Progressive Disease|0|||
33265168|NCT01425008|62636103|FG007|Dose Expansion Phase|Progressive Disease|0|||
33265169|NCT01425008|62636104|FG008|Dose Expansion Phase|Progressive Disease|0|||
33265170|NCT01425008|62636105|FG009|Dose Expansion Phase|Progressive Disease|0|||
33265171|NCT01425008|62636106|FG010|Dose Expansion Phase|Progressive Disease|10|||
33265172|NCT01425008|62636107|FG011|Dose Expansion Phase|Progressive Disease|4|||
33265173|NCT01425008|62636108|FG012|Dose Expansion Phase|Progressive Disease|12|||
33265174|NCT01425008|62636109|FG013|Dose Expansion Phase|Progressive Disease|1|||
33265175|NCT01425008|62636110|FG014|Dose Expansion Phase|Progressive Disease|5|||
33265176|NCT01425008|62636111|FG015|Dose Expansion Phase|Progressive Disease|8|||
33265177|NCT01425008|62636112|FG016|Dose Expansion Phase|Progressive Disease|9|||
33265178|NCT01425008|62636113|FG017|Dose Expansion Phase|Progressive Disease|2|||
33265179|NCT01425008|62636114|FG018|Dose Expansion Phase|Progressive Disease|10|||
33265180|NCT01425008|62636096|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
33265181|NCT01425008|62636097|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
33265182|NCT01425008|62636098|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
33265183|NCT01425008|62636099|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
33265184|NCT01425008|62636100|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
33265185|NCT01425008|62636101|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
33265186|NCT01425008|62636102|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
33265187|NCT01425008|62636103|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
33265188|NCT01425008|62636104|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
33265189|NCT01425008|62636105|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
33265190|NCT01425008|62636106|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
33265191|NCT01425008|62636107|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
33265192|NCT01425008|62636108|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
33265193|NCT01425008|62636109|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
33265194|NCT01425008|62636110|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
33265195|NCT01425008|62636111|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
33265196|NCT01425008|62636112|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
33265197|NCT01425008|62636113|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
33265198|NCT01425008|62636114|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
33265199|NCT01425008|62636096|FG000|Dose Expansion Phase|Other|0|||
33265200|NCT01425008|62636097|FG001|Dose Expansion Phase|Other|0|||
33265201|NCT01425008|62636098|FG002|Dose Expansion Phase|Other|0|||
33265202|NCT01425008|62636099|FG003|Dose Expansion Phase|Other|0|||
33265203|NCT01425008|62636100|FG004|Dose Expansion Phase|Other|0|||
33265204|NCT01425008|62636101|FG005|Dose Expansion Phase|Other|0|||
33265205|NCT01425008|62636102|FG006|Dose Expansion Phase|Other|0|||
33265206|NCT01425008|62636103|FG007|Dose Expansion Phase|Other|0|||
33265207|NCT01425008|62636104|FG008|Dose Expansion Phase|Other|0|||
33265208|NCT01425008|62636105|FG009|Dose Expansion Phase|Other|0|||
33265209|NCT01425008|62636106|FG010|Dose Expansion Phase|Other|0|||
33265210|NCT01425008|62636107|FG011|Dose Expansion Phase|Other|0|||
33265211|NCT01425008|62636108|FG012|Dose Expansion Phase|Other|1|||
33265212|NCT01425008|62636109|FG013|Dose Expansion Phase|Other|0|||
33265213|NCT01425008|62636110|FG014|Dose Expansion Phase|Other|0|||
33265214|NCT01425008|62636111|FG015|Dose Expansion Phase|Other|0|||
33265215|NCT01425008|62636112|FG016|Dose Expansion Phase|Other|2|||
33265216|NCT01425008|62636113|FG017|Dose Expansion Phase|Other|0|||
33265217|NCT01425008|62636114|FG018|Dose Expansion Phase|Other|4|||
33265218|NCT01425008|62636096|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
33265219|NCT01425008|62636097|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
33265220|NCT01425008|62636098|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
33265221|NCT01425008|62636099|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
33265222|NCT01425008|62636100|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
33265223|NCT01425008|62636101|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
33265224|NCT01425008|62636102|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
33265225|NCT01425008|62636103|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
33265226|NCT01425008|62636104|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
33265227|NCT01425008|62636105|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
33265228|NCT01425008|62636106|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
33265229|NCT01425008|62636107|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
33265230|NCT01425008|62636108|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
33265231|NCT01425008|62636109|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
33265232|NCT01425008|62636110|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
33265233|NCT01425008|62636111|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
33265234|NCT01425008|62636112|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
33265235|NCT01425008|62636113|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
33265236|NCT01425008|62636114|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
33265237|NCT01425008|62636096|FG000|Dose Expansion Phase|Adverse Event|0|||
33265238|NCT01425008|62636097|FG001|Dose Expansion Phase|Adverse Event|0|||
33265239|NCT01425008|62636098|FG002|Dose Expansion Phase|Adverse Event|0|||
33265240|NCT01425008|62636099|FG003|Dose Expansion Phase|Adverse Event|0|||
33265241|NCT01425008|62636100|FG004|Dose Expansion Phase|Adverse Event|0|||
33368201|NCT00862134|62747069|FG000|Overall Study|Adverse Event|2|||
33368202|NCT00862134|62747070|FG001|Overall Study|Adverse Event|2|||
33368203|NCT00862134|62747069|FG000|Overall Study|Withdrew prior to dosing|2|||
33368204|NCT00862134|62747070|FG001|Overall Study|Withdrew prior to dosing|0|||
33368205|NCT00848484|62747078|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
33368206|NCT00848484|62747079|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
33368207|NCT00848484|62747078|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
33368208|NCT00848484|62747079|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
33368209|NCT00848484|62747078|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
33368210|NCT00848484|62747079|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
33484690|NCT03734991|62861599|FG001|Overall Study|Physician Decision|1|||
33484691|NCT03734991|62861598|FG000|Overall Study|Pregnancy|1|||
33484692|NCT03734991|62861599|FG001|Overall Study|Pregnancy|0|||
33484693|NCT03734991|62861598|FG000|Overall Study|Withdrawal by Subject|6|||
33484694|NCT03734991|62861599|FG001|Overall Study|Withdrawal by Subject|3|||
33484695|NCT03734991|62861598|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
33484696|NCT03734991|62861599|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
33484697|NCT03734991|62861598|FG000|Overall Study|Other|2|||
33484698|NCT03734991|62861599|FG001|Overall Study|Other|2|||
33484699|NCT03303092|62861608|FG000|Overall Study|Adverse Event|1|||
33484700|NCT03303092|62861609|FG001|Overall Study|Adverse Event|0|||
33484701|NCT03303092|62861610|FG002|Overall Study|Adverse Event|1|||
33484702|NCT03303092|62861608|FG000|Overall Study|Protocol Violation|1|||
33484703|NCT03303092|62861609|FG001|Overall Study|Protocol Violation|5|||
33484704|NCT03303092|62861610|FG002|Overall Study|Protocol Violation|1|||
33484705|NCT03303092|62861608|FG000|Overall Study|Withdrawal by Subject|1|||
33484706|NCT03303092|62861609|FG001|Overall Study|Withdrawal by Subject|1|||
33484707|NCT03303092|62861610|FG002|Overall Study|Withdrawal by Subject|3|||
33484708|NCT03302936|62861620|FG000|Overall Study|Protocol Violation|3|||
33484709|NCT03302936|62861621|FG001|Overall Study|Protocol Violation|4|||
33484710|NCT03733899|62861631|FG000|Period 1|Protocol Violation|0|||
33484711|NCT03733899|62861632|FG001|Period 1|Protocol Violation|0|||
33484712|NCT03733899|62861633|FG002|Period 1|Protocol Violation|0|||
33484713|NCT03733899|62861634|FG003|Period 1|Protocol Violation|0|||
33484714|NCT03733899|62861635|FG004|Period 1|Protocol Violation|0|||
33484715|NCT03733899|62861636|FG005|Period 1|Protocol Violation|1|||
33484716|NCT03733899|62861631|FG000|Period 2|Unscuccessful Treatment|0|||
33484717|NCT03733899|62861632|FG001|Period 2|Unscuccessful Treatment|1|||
33484718|NCT03733899|62861633|FG002|Period 2|Unscuccessful Treatment|0|||
33484719|NCT03733899|62861634|FG003|Period 2|Unscuccessful Treatment|0|||
33484720|NCT03733899|62861635|FG004|Period 2|Unscuccessful Treatment|0|||
33484721|NCT03733899|62861636|FG005|Period 2|Unscuccessful Treatment|0|||
33484722|NCT03733899|62861631|FG000|Period 3|Withdrawal by Subject|1|||
33484723|NCT03733899|62861632|FG001|Period 3|Withdrawal by Subject|0|||
33484724|NCT03733899|62861633|FG002|Period 3|Withdrawal by Subject|0|||
33484725|NCT03733899|62861634|FG003|Period 3|Withdrawal by Subject|0|||
33484726|NCT03733899|62861635|FG004|Period 3|Withdrawal by Subject|0|||
33484727|NCT03733899|62861636|FG005|Period 3|Withdrawal by Subject|0|||
33484728|NCT03727347|62861649|FG000|Overall Study|Withdrawal by Subject|2|||
33484729|NCT03727347|62861649|FG000|Overall Study|Lost to Follow-up|1|||
33484730|NCT03915626|62861662|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
33484731|NCT03301844|62861674|FG000|Overall Study|suspected colon cancer|1|||
33265242|NCT01425008|62636101|FG005|Dose Expansion Phase|Adverse Event|0|||
33484732|NCT03301844|62861675|FG001|Overall Study|suspected colon cancer|1|||
33484733|NCT03313310|62861683|FG000|Phase 2|Lost to Follow-up|4|||
33484734|NCT03313310|62861684|FG001|Phase 2|Lost to Follow-up|0|||
33484735|NCT03313310|62861683|FG000|Phase 3|Lost to Follow-up|0|||
33484736|NCT03313310|62861684|FG001|Phase 3|Lost to Follow-up|1|||
33265243|NCT01425008|62636102|FG006|Dose Expansion Phase|Adverse Event|0|||
33265244|NCT01425008|62636103|FG007|Dose Expansion Phase|Adverse Event|0|||
33265245|NCT01425008|62636104|FG008|Dose Expansion Phase|Adverse Event|0|||
33265246|NCT01425008|62636105|FG009|Dose Expansion Phase|Adverse Event|0|||
33265247|NCT01425008|62636106|FG010|Dose Expansion Phase|Adverse Event|2|||
33265248|NCT01425008|62636107|FG011|Dose Expansion Phase|Adverse Event|3|||
33265249|NCT01425008|62636108|FG012|Dose Expansion Phase|Adverse Event|3|||
33265250|NCT01425008|62636109|FG013|Dose Expansion Phase|Adverse Event|0|||
33265251|NCT01425008|62636110|FG014|Dose Expansion Phase|Adverse Event|1|||
33265252|NCT01425008|62636111|FG015|Dose Expansion Phase|Adverse Event|1|||
33265253|NCT01425008|62636112|FG016|Dose Expansion Phase|Adverse Event|5|||
33265254|NCT01425008|62636113|FG017|Dose Expansion Phase|Adverse Event|0|||
33265255|NCT01425008|62636114|FG018|Dose Expansion Phase|Adverse Event|3|||
33265256|NCT01425008|62636096|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
33265257|NCT01425008|62636097|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
33265258|NCT01425008|62636098|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
33265259|NCT01425008|62636099|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
33265260|NCT01425008|62636100|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
33265261|NCT01425008|62636101|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
33265262|NCT01425008|62636102|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
33265263|NCT01425008|62636103|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
33265264|NCT01425008|62636104|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
33265265|NCT01425008|62636105|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
33265266|NCT01425008|62636106|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
33265267|NCT01425008|62636107|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
33265268|NCT01425008|62636108|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
33265269|NCT01425008|62636109|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
33265270|NCT01425008|62636110|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
33265271|NCT01425008|62636111|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
33265272|NCT01425008|62636112|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
33265273|NCT01425008|62636113|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
33265274|NCT01425008|62636114|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
33265275|NCT01425008|62636096|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265276|NCT01425008|62636097|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265277|NCT01425008|62636098|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265278|NCT01425008|62636099|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265279|NCT01425008|62636100|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265280|NCT01425008|62636101|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265281|NCT01425008|62636102|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265282|NCT01425008|62636103|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265283|NCT01425008|62636104|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265284|NCT01425008|62636105|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265285|NCT01425008|62636106|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265286|NCT01425008|62636107|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265287|NCT01425008|62636108|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265288|NCT01425008|62636109|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265289|NCT01425008|62636110|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265290|NCT01425008|62636111|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265291|NCT01425008|62636112|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265292|NCT01425008|62636113|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33265293|NCT01425008|62636114|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
33265294|NCT04425902|62636167|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
33265295|NCT04072146|62636180|FG000|Overall Study|Adverse Event|0|||
33265296|NCT04072146|62636181|FG001|Overall Study|Adverse Event|1|||
33265297|NCT03861481|62636195|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
33265298|NCT03861481|62636196|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
33265299|NCT03861481|62636195|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
33265300|NCT03861481|62636196|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
33265301|NCT03861481|62636195|FG000|Overall Study|Relapse|1|||
33265302|NCT03861481|62636196|FG001|Overall Study|Relapse|0|||
33265303|NCT03861481|62636195|FG000|Overall Study|Withdrawal by Subject|0|||
33265304|NCT03861481|62636196|FG001|Overall Study|Withdrawal by Subject|1|||
33265305|NCT03861481|62636195|FG000|Overall Study|Lack of Efficacy|4|||
33555531|NCT02347774|62948335|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
33265306|NCT03861481|62636196|FG001|Overall Study|Lack of Efficacy|5|||
33265307|NCT03648476|62636208|FG000|Overall Study|Withdrawal by Subject|2|||
33265308|NCT03648476|62636209|FG001|Overall Study|Withdrawal by Subject|1|||
33265309|NCT04660799|62636240|FG000|Overall Study|Ongoing in Study|9|||
33265310|NCT04660799|62636241|FG001|Overall Study|Ongoing in Study|13|||
33265311|NCT04660799|62636240|FG000|Overall Study|Progressive Disease|1|||
33265312|NCT04660799|62636241|FG001|Overall Study|Progressive Disease|1|||
33265313|NCT04660799|62636240|FG000|Overall Study|Death|2|||
33265314|NCT04660799|62636241|FG001|Overall Study|Death|1|||
33265315|NCT04660799|62636240|FG000|Overall Study|Adverse Event|2|||
33265316|NCT04660799|62636241|FG001|Overall Study|Adverse Event|1|||
33265317|NCT04660799|62636240|FG000|Overall Study|Withdrawal by Subject|2|||
33368211|NCT00848484|62747078|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
33368212|NCT00848484|62747079|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
33368213|NCT00848484|62747078|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
33368214|NCT00848484|62747079|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
33368215|NCT00509821|62747087|FG000|Study Period 1 (Induction)|Death|0|||
33368216|NCT00509821|62747088|FG001|Study Period 1 (Induction)|Death|1|||
33368217|NCT00509821|62747087|FG000|Study Period 1 (Induction)|Adverse Event|0|||
33368218|NCT00509821|62747088|FG001|Study Period 1 (Induction)|Adverse Event|2|||
33368219|NCT00509821|62747087|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
33368220|NCT00509821|62747088|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
33368221|NCT00508651|62747101|FG000|Overall Study|Lost to Follow-up|3|||
33368222|NCT00508651|62747102|FG001|Overall Study|Lost to Follow-up|1|||
33368223|NCT00508651|62747101|FG000|Overall Study|Withdrawal by Subject|1|||
33368224|NCT00508651|62747102|FG001|Overall Study|Withdrawal by Subject|1|||
33368225|NCT00490555|62747112|FG000|Overall Study|noncompliant with drug administration|0|||
33368226|NCT00490555|62747113|FG001|Overall Study|noncompliant with drug administration|0|||
33368227|NCT00490555|62747114|FG002|Overall Study|noncompliant with drug administration|2|||
33368228|NCT00490555|62747115|FG003|Overall Study|noncompliant with drug administration|0|||
33368229|NCT00501085|62747125|FG000|Overall Study|Lost to Follow-up|195|||
33368230|NCT00501085|62747125|FG000|Overall Study|Withdrawal by Subject|34|||
33368231|NCT00501085|62747125|FG000|Overall Study|Subject Decision|1|||
33368232|NCT00501085|62747125|FG000|Overall Study|Revision Surgery|7|||
33368233|NCT00501085|62747125|FG000|Overall Study|Explantation Surgery|26|||
33368234|NCT00501085|62747125|FG000|Overall Study|Adverse Event|4|||
33368235|NCT00501085|62747125|FG000|Overall Study|Non-Compliance|24|||
33368236|NCT00501085|62747125|FG000|Overall Study|Study closed by sponsor|109|||
33368237|NCT00501085|62747125|FG000|Overall Study|Other loss to follow-up|32|||
33368238|NCT00501007|62747129|FG000|Overall Study|Inclusion criteria not met.|29|||
33368239|NCT00501007|62747130|FG001|Overall Study|Inclusion criteria not met.|25|||
33368240|NCT00873860|62747140|FG000|Overall Study|Lost to Follow-up|1|||
33368241|NCT00873860|62747141|FG001|Overall Study|Lost to Follow-up|0|||
33368242|NCT00873860|62747142|FG002|Overall Study|Lost to Follow-up|0|||
33368243|NCT00873860|62747143|FG003|Overall Study|Lost to Follow-up|1|||
33368244|NCT00873860|62747140|FG000|Overall Study|Withdrawal by Subject|1|||
33368245|NCT00873860|62747141|FG001|Overall Study|Withdrawal by Subject|0|||
33368246|NCT00873860|62747142|FG002|Overall Study|Withdrawal by Subject|2|||
33368247|NCT00873860|62747143|FG003|Overall Study|Withdrawal by Subject|0|||
33368248|NCT00873860|62747140|FG000|Overall Study|Death|1|||
33368249|NCT00873860|62747141|FG001|Overall Study|Death|0|||
33368250|NCT00873860|62747142|FG002|Overall Study|Death|0|||
33368251|NCT00873860|62747143|FG003|Overall Study|Death|0|||
33368252|NCT00873860|62747140|FG000|Overall Study|Other|1|||
33368253|NCT00873860|62747141|FG001|Overall Study|Other|0|||
33368254|NCT00873860|62747142|FG002|Overall Study|Other|1|||
33368255|NCT00873860|62747143|FG003|Overall Study|Other|0|||
33368256|NCT03853291|62747166|FG000|Overall Study|Lost to Follow-up|1|||
33368257|NCT03853291|62747167|FG001|Overall Study|Lost to Follow-up|2|||
33368258|NCT03853291|62747168|FG002|Overall Study|Lost to Follow-up|0|||
33368259|NCT03853291|62747169|FG003|Overall Study|Lost to Follow-up|0|||
33368260|NCT03853291|62747170|FG004|Overall Study|Lost to Follow-up|0|||
33368261|NCT03853291|62747171|FG005|Overall Study|Lost to Follow-up|0|||
33368262|NCT03853291|62747166|FG000|Overall Study|Determined to be ineligible|1|||
33368263|NCT03853291|62747167|FG001|Overall Study|Determined to be ineligible|1|||
33368264|NCT03853291|62747168|FG002|Overall Study|Determined to be ineligible|0|||
33484737|NCT03313076|62861694|FG000|Overall Study|Withdrawal by Subject|2|||
33484738|NCT03313076|62861695|FG001|Overall Study|Withdrawal by Subject|0|||
33484739|NCT03313076|62861696|FG002|Overall Study|Withdrawal by Subject|0|||
33265318|NCT04660799|62636241|FG001|Overall Study|Withdrawal by Subject|4|||
33265319|NCT04545060|62636249|FG000|Overall Study|Adverse Event|0|||
33265320|NCT04545060|62636250|FG001|Overall Study|Adverse Event|1|||
33368265|NCT03853291|62747169|FG003|Overall Study|Determined to be ineligible|0|||
33368266|NCT03853291|62747170|FG004|Overall Study|Determined to be ineligible|0|||
33484740|NCT03313076|62861697|FG003|Overall Study|Withdrawal by Subject|0|||
33265321|NCT04545060|62636249|FG000|Overall Study|Death|0|||
33368267|NCT03853291|62747171|FG005|Overall Study|Determined to be ineligible|0|||
33368268|NCT03853213|62747184|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
33368269|NCT03853213|62747185|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
33368270|NCT03853213|62747184|FG000|Overall Study|Other (e.g., too busy)|0|||
33368271|NCT03853213|62747185|FG001|Overall Study|Other (e.g., too busy)|2|||
33265322|NCT04545060|62636250|FG001|Overall Study|Death|5|||
33368272|NCT02666105|62747211|FG000|Overall Study|Death|1|||
33368273|NCT00819585|62747230|FG000|Core Study|Adverse Event|2|||
33368274|NCT00819585|62747231|FG001|Core Study|Adverse Event|1|||
33265323|NCT04545060|62636249|FG000|Overall Study|Lost to Follow-up|10|||
33265324|NCT04545060|62636250|FG001|Overall Study|Lost to Follow-up|13|||
33265325|NCT04545060|62636249|FG000|Overall Study|Physician Decision|3|||
33265326|NCT04545060|62636250|FG001|Overall Study|Physician Decision|0|||
33265327|NCT04545060|62636249|FG000|Overall Study|Withdrawal by Subject|17|||
33265328|NCT04545060|62636250|FG001|Overall Study|Withdrawal by Subject|22|||
33265329|NCT03533660|62636306|FG000|Overall Study|Withdrawal by Subject|2|||
33265330|NCT03533660|62636307|FG001|Overall Study|Withdrawal by Subject|2|||
33265331|NCT03533660|62636306|FG000|Overall Study|Death|2|||
33265332|NCT03533660|62636307|FG001|Overall Study|Death|4|||
33265333|NCT03533660|62636306|FG000|Overall Study|Adverse Event|0|||
33265334|NCT03533660|62636307|FG001|Overall Study|Adverse Event|2|||
33265335|NCT03416127|62636321|FG000|Overall Study|Withdrawal by Subject|0|||
33265336|NCT03416127|62636322|FG001|Overall Study|Withdrawal by Subject|1|||
33265337|NCT03416127|62636323|FG002|Overall Study|Withdrawal by Subject|1|||
33265338|NCT02986334|62636357|FG000|Overall Study|Withdrawal by Subject|0|||
33265339|NCT02986334|62636358|FG001|Overall Study|Withdrawal by Subject|1|||
33265340|NCT02986334|62636359|FG002|Overall Study|Withdrawal by Subject|2|||
33265341|NCT02986334|62636357|FG000|Overall Study|Lost to Follow-up|1|||
33265342|NCT02986334|62636358|FG001|Overall Study|Lost to Follow-up|2|||
33265343|NCT02986334|62636359|FG002|Overall Study|Lost to Follow-up|1|||
33265344|NCT02986334|62636357|FG000|Overall Study|Adverse Event|0|||
33265345|NCT02986334|62636358|FG001|Overall Study|Adverse Event|2|||
33265346|NCT02986334|62636359|FG002|Overall Study|Adverse Event|1|||
33265347|NCT02986334|62636357|FG000|Overall Study|non compliance in phone ratings|2|||
33265348|NCT02986334|62636358|FG001|Overall Study|non compliance in phone ratings|1|||
33265349|NCT02986334|62636359|FG002|Overall Study|non compliance in phone ratings|2|||
33265350|NCT02986334|62636357|FG000|Overall Study|undisclosed comorbidities|0|||
33265351|NCT02986334|62636358|FG001|Overall Study|undisclosed comorbidities|1|||
33265352|NCT02986334|62636359|FG002|Overall Study|undisclosed comorbidities|1|||
33265353|NCT02210221|62636381|FG000|Overall Study|Lack of Efficacy|7|||
33265354|NCT02210221|62636381|FG000|Overall Study|Withdrawal by Subject|43|||
33265355|NCT02124902|62636394|FG000|Overall Study|Adverse Event|7|||
33265356|NCT02124902|62636395|FG001|Overall Study|Adverse Event|2|||
33265357|NCT02124902|62636394|FG000|Overall Study|Went to alternative treatment|4|||
33265358|NCT02124902|62636395|FG001|Overall Study|Went to alternative treatment|0|||
33265359|NCT02124902|62636394|FG000|Overall Study|Withdrawal by Subject|2|||
33265360|NCT02124902|62636395|FG001|Overall Study|Withdrawal by Subject|1|||
33265361|NCT02124902|62636394|FG000|Overall Study|Physician Decision|2|||
33265362|NCT02124902|62636395|FG001|Overall Study|Physician Decision|0|||
33265363|NCT02124902|62636394|FG000|Overall Study|Not eligible|1|||
33265364|NCT02124902|62636395|FG001|Overall Study|Not eligible|0|||
33265365|NCT02124902|62636394|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
33265366|NCT02124902|62636395|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
33265367|NCT01940341|62636403|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
33265368|NCT01940341|62636404|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
33265369|NCT01940341|62636405|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
33265370|NCT01940341|62636406|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
33265371|NCT01940341|62636403|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
33265372|NCT01940341|62636404|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
33265373|NCT01940341|62636405|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
33265374|NCT01940341|62636406|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
33265375|NCT01940341|62636403|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
33265376|NCT01940341|62636404|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
33265377|NCT01940341|62636405|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
33265378|NCT01940341|62636406|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
33265379|NCT01940341|62636403|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
33265380|NCT01940341|62636404|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
33265381|NCT01940341|62636405|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
33265382|NCT01940341|62636406|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
33265383|NCT01940341|62636403|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
33265384|NCT01940341|62636404|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
33265385|NCT01940341|62636405|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
33265386|NCT01940341|62636406|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
33265387|NCT01940341|62636403|FG000|Period 1: Double-blind Phase|Death|0|||
33265388|NCT01940341|62636404|FG001|Period 1: Double-blind Phase|Death|1|||
33265389|NCT01940341|62636405|FG002|Period 1: Double-blind Phase|Death|0|||
33265390|NCT01940341|62636406|FG003|Period 1: Double-blind Phase|Death|0|||
33265391|NCT01940341|62636403|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
33265392|NCT01940341|62636404|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
33265393|NCT01940341|62636405|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
33265394|NCT01940341|62636406|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
33265395|NCT01940341|62636403|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
33368275|NCT00819585|62747232|FG002|Core Study|Adverse Event|1|||
33265396|NCT01940341|62636404|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
33265397|NCT01940341|62636405|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
33265398|NCT01940341|62636406|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
33265399|NCT01940341|62636403|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
33265400|NCT01940341|62636404|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
33265401|NCT01940341|62636405|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
33265402|NCT01940341|62636406|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
33265403|NCT01940341|62636403|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
33265404|NCT01940341|62636404|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
33265405|NCT01940341|62636405|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
33265406|NCT01940341|62636406|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
33265407|NCT01940341|62636403|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
33265408|NCT01940341|62636404|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
33265409|NCT01940341|62636405|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
33265410|NCT01940341|62636406|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
33265411|NCT01940341|62636403|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
33265412|NCT01940341|62636404|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
33265413|NCT01940341|62636405|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
33265414|NCT01940341|62636406|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
33265415|NCT01940341|62636403|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
33265416|NCT01940341|62636404|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
33265417|NCT01940341|62636405|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
33265418|NCT01940341|62636406|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
33265419|NCT01940341|62636403|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
33265420|NCT01940341|62636404|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
33265421|NCT01940341|62636405|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
33265422|NCT01940341|62636406|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
33265423|NCT01940341|62636403|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
33265424|NCT01940341|62636404|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
33265425|NCT01940341|62636405|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
33265426|NCT01940341|62636406|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
33265427|NCT01940341|62636403|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
33265428|NCT01940341|62636404|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
33265429|NCT01940341|62636405|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
33368276|NCT00819585|62747233|FG003|Core Study|Adverse Event|4|||
33368277|NCT00819585|62747234|FG004|Core Study|Adverse Event|1|||
33368278|NCT00819585|62747235|FG005|Core Study|Adverse Event|0|||
33368279|NCT00819585|62747236|FG006|Core Study|Adverse Event|2|||
33368280|NCT00819585|62747237|FG007|Core Study|Adverse Event|0|||
33368281|NCT00819585|62747238|FG008|Core Study|Adverse Event|0|||
33368282|NCT00819585|62747239|FG009|Core Study|Adverse Event|0|||
33368283|NCT00819585|62747240|FG010|Core Study|Adverse Event|0|||
33368284|NCT00819585|62747230|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
33368285|NCT00819585|62747231|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
33368286|NCT00819585|62747232|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
33368287|NCT00819585|62747233|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
33368288|NCT00819585|62747234|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
33368289|NCT00819585|62747235|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
33368290|NCT00819585|62747236|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
33368291|NCT00819585|62747237|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
33368292|NCT00819585|62747238|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
33368293|NCT00819585|62747239|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
33368294|NCT00819585|62747240|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
33368295|NCT00819585|62747230|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
33368296|NCT00819585|62747231|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
33368297|NCT00819585|62747232|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
33368298|NCT00819585|62747233|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
33368299|NCT00819585|62747234|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
33368300|NCT00819585|62747235|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
33368301|NCT00819585|62747236|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
33368302|NCT00819585|62747237|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
33368303|NCT00819585|62747238|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
33368304|NCT00819585|62747239|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
33368305|NCT00819585|62747240|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
33484741|NCT03313076|62861694|FG000|Overall Study|Lost to Follow-up|0|||
33368306|NCT00819585|62747230|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
33368307|NCT00819585|62747231|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
33368308|NCT00819585|62747232|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
33265430|NCT01940341|62636406|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
33265431|NCT01940341|62636403|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
33265432|NCT01940341|62636404|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
33265433|NCT01940341|62636405|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
33265434|NCT01940341|62636406|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
33265435|NCT01940341|62636403|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
33265436|NCT01940341|62636404|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
33265437|NCT01940341|62636405|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
33265438|NCT01940341|62636406|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
33265439|NCT01940341|62636403|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
33265440|NCT01940341|62636404|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
33265441|NCT01940341|62636405|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
33265442|NCT01940341|62636406|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
33265443|NCT01877837|62636414|FG000|Overall Study|Lost to Follow-up|1|||
33265444|NCT01877837|62636414|FG000|Overall Study|Ineligible|4|||
33265445|NCT01624142|62636434|FG000|Overall Study|Withdrawal by Subject|14|||
33265446|NCT01624142|62636435|FG001|Overall Study|Withdrawal by Subject|4|||
33265447|NCT01624142|62636434|FG000|Overall Study|Death|3|||
33265448|NCT01624142|62636435|FG001|Overall Study|Death|6|||
33265449|NCT01624142|62636434|FG000|Overall Study|Study Closure|12|||
33265450|NCT01624142|62636435|FG001|Overall Study|Study Closure|6|||
33265451|NCT01624142|62636434|FG000|Overall Study|Lost to Follow-up|2|||
33265452|NCT01624142|62636435|FG001|Overall Study|Lost to Follow-up|0|||
33265453|NCT01624142|62636434|FG000|Overall Study|Other|1|||
33265454|NCT01624142|62636435|FG001|Overall Study|Other|0|||
33265455|NCT01535807|62636444|FG000|Overall Study|Withdrawal by Subject|1|||
33265456|NCT01535807|62636445|FG001|Overall Study|Withdrawal by Subject|1|||
33265457|NCT01535807|62636444|FG000|Overall Study|Data collection error|1|||
33265458|NCT01535807|62636445|FG001|Overall Study|Data collection error|1|||
33265459|NCT01375764|62636457|FG000|Overall Study|Lost to Follow-up|0|||
33265460|NCT01375764|62636458|FG001|Overall Study|Lost to Follow-up|1|||
33265461|NCT01375764|62636459|FG002|Overall Study|Lost to Follow-up|0|||
33265462|NCT01375764|62636460|FG003|Overall Study|Lost to Follow-up|0|||
33265463|NCT01375764|62636461|FG004|Overall Study|Lost to Follow-up|0|||
33265464|NCT01375764|62636457|FG000|Overall Study|Withdrawal by Subject|2|||
33265465|NCT01375764|62636458|FG001|Overall Study|Withdrawal by Subject|0|||
33265466|NCT01375764|62636459|FG002|Overall Study|Withdrawal by Subject|0|||
33265467|NCT01375764|62636460|FG003|Overall Study|Withdrawal by Subject|0|||
33265468|NCT01375764|62636461|FG004|Overall Study|Withdrawal by Subject|1|||
33265469|NCT01375764|62636457|FG000|Overall Study|Other|0|||
33265470|NCT01375764|62636458|FG001|Overall Study|Other|0|||
33265471|NCT01375764|62636459|FG002|Overall Study|Other|0|||
33265472|NCT01375764|62636460|FG003|Overall Study|Other|1|||
33265473|NCT01375764|62636461|FG004|Overall Study|Other|0|||
33265474|NCT00722046|62636480|FG000|Overall Study|Adverse Event|0|||
33265475|NCT00722046|62636481|FG001|Overall Study|Adverse Event|1|||
33265476|NCT00722046|62636482|FG002|Overall Study|Adverse Event|2|||
33265477|NCT00722046|62636483|FG003|Overall Study|Adverse Event|1|||
33265478|NCT00722046|62636484|FG004|Overall Study|Adverse Event|2|||
33265479|NCT00722046|62636485|FG005|Overall Study|Adverse Event|1|||
33265480|NCT00722046|62636486|FG006|Overall Study|Adverse Event|0|||
33265481|NCT00722046|62636480|FG000|Overall Study|Death|0|||
33265482|NCT00722046|62636481|FG001|Overall Study|Death|1|||
33265483|NCT00722046|62636482|FG002|Overall Study|Death|0|||
33265484|NCT00722046|62636483|FG003|Overall Study|Death|0|||
33265485|NCT00722046|62636484|FG004|Overall Study|Death|0|||
33265486|NCT00722046|62636485|FG005|Overall Study|Death|0|||
33265487|NCT00722046|62636486|FG006|Overall Study|Death|2|||
33368309|NCT00819585|62747233|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
33368310|NCT00819585|62747234|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
33368311|NCT00819585|62747235|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
33368312|NCT00819585|62747236|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
33661802|NCT01697579|63091450|FG006|Base Study-Cycle 1|Protocol Violation|0|||
33661803|NCT01697579|63091444|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
33661804|NCT01697579|63091445|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
33661805|NCT01697579|63091446|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
33661806|NCT01697579|63091447|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
33661807|NCT01697579|63091448|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
33265488|NCT00722046|62636480|FG000|Overall Study|Protocol Violation|1|||
33265489|NCT00722046|62636481|FG001|Overall Study|Protocol Violation|0|||
33265490|NCT00722046|62636482|FG002|Overall Study|Protocol Violation|0|||
33265491|NCT00722046|62636483|FG003|Overall Study|Protocol Violation|0|||
33265492|NCT00722046|62636484|FG004|Overall Study|Protocol Violation|0|||
33265493|NCT00722046|62636485|FG005|Overall Study|Protocol Violation|1|||
33265494|NCT00722046|62636486|FG006|Overall Study|Protocol Violation|0|||
33265495|NCT00722046|62636480|FG000|Overall Study|Withdrawal by Subject|3|||
33265496|NCT00722046|62636481|FG001|Overall Study|Withdrawal by Subject|3|||
33265497|NCT00722046|62636482|FG002|Overall Study|Withdrawal by Subject|4|||
33265498|NCT00722046|62636483|FG003|Overall Study|Withdrawal by Subject|4|||
33265499|NCT00722046|62636484|FG004|Overall Study|Withdrawal by Subject|4|||
33265500|NCT00722046|62636485|FG005|Overall Study|Withdrawal by Subject|7|||
33265501|NCT00722046|62636486|FG006|Overall Study|Withdrawal by Subject|3|||
33265502|NCT00722046|62636480|FG000|Overall Study|Randomized, but not treated|1|||
33265503|NCT00722046|62636481|FG001|Overall Study|Randomized, but not treated|1|||
33265504|NCT00722046|62636482|FG002|Overall Study|Randomized, but not treated|0|||
33265505|NCT00722046|62636483|FG003|Overall Study|Randomized, but not treated|2|||
33265506|NCT00722046|62636484|FG004|Overall Study|Randomized, but not treated|0|||
33265507|NCT00722046|62636485|FG005|Overall Study|Randomized, but not treated|0|||
33265508|NCT00722046|62636486|FG006|Overall Study|Randomized, but not treated|0|||
33265509|NCT00722046|62636480|FG000|Overall Study|Other|0|||
33265510|NCT00722046|62636481|FG001|Overall Study|Other|0|||
33265511|NCT00722046|62636482|FG002|Overall Study|Other|1|||
33265512|NCT00722046|62636483|FG003|Overall Study|Other|1|||
33265513|NCT00722046|62636484|FG004|Overall Study|Other|3|||
33265514|NCT00722046|62636485|FG005|Overall Study|Other|2|||
33265515|NCT00722046|62636486|FG006|Overall Study|Other|1|||
33265516|NCT00614523|62636506|FG000|Overall Study|Adverse Event|4|||
33265517|NCT00614523|62636507|FG001|Overall Study|Adverse Event|20|||
33265518|NCT00614523|62636506|FG000|Overall Study|Death|5|||
33265519|NCT00614523|62636507|FG001|Overall Study|Death|8|||
33265520|NCT00614523|62636506|FG000|Overall Study|Lack of Efficacy|9|||
33265521|NCT00614523|62636507|FG001|Overall Study|Lack of Efficacy|11|||
33265522|NCT00614523|62636506|FG000|Overall Study|Lost to Follow-up|0|||
33265523|NCT00614523|62636507|FG001|Overall Study|Lost to Follow-up|1|||
33265524|NCT00614523|62636506|FG000|Overall Study|Protocol Violation|3|||
33265525|NCT00614523|62636507|FG001|Overall Study|Protocol Violation|2|||
33265526|NCT00614523|62636506|FG000|Overall Study|Withdrawal by Subject|12|||
33265527|NCT00614523|62636507|FG001|Overall Study|Withdrawal by Subject|22|||
33265528|NCT00614523|62636506|FG000|Overall Study|Other|6|||
33265529|NCT00614523|62636507|FG001|Overall Study|Other|11|||
33265530|NCT00614523|62636506|FG000|Overall Study|Ineligibility Determined|1|||
33265531|NCT00614523|62636507|FG001|Overall Study|Ineligibility Determined|2|||
33265532|NCT00614523|62636506|FG000|Overall Study|Disease Progression|0|||
33265533|NCT00614523|62636507|FG001|Overall Study|Disease Progression|8|||
33265534|NCT00614523|62636506|FG000|Overall Study|Administrative Decision|23|||
33265535|NCT00614523|62636507|FG001|Overall Study|Administrative Decision|46|||
33265536|NCT00523341|62636515|FG000|Overall Study|Withdrawal by Subject|399|||
33265537|NCT00523341|62636516|FG001|Overall Study|Withdrawal by Subject|427|||
33265538|NCT00523341|62636515|FG000|Overall Study|Other|181|||
33265539|NCT00523341|62636516|FG001|Overall Study|Other|198|||
33265540|NCT00523341|62636515|FG000|Overall Study|Adverse Event|122|||
33265541|NCT00523341|62636516|FG001|Overall Study|Adverse Event|155|||
33265542|NCT00523341|62636515|FG000|Overall Study|Death|101|||
33265543|NCT00523341|62636516|FG001|Overall Study|Death|110|||
33265544|NCT00523341|62636515|FG000|Overall Study|Lost to Follow-up|73|||
33265545|NCT00523341|62636516|FG001|Overall Study|Lost to Follow-up|61|||
33265546|NCT00523341|62636515|FG000|Overall Study|Non-compliance|20|||
33265547|NCT00523341|62636516|FG001|Overall Study|Non-compliance|13|||
33265548|NCT00523341|62636515|FG000|Overall Study|Physician Decision|14|||
33265549|NCT00523341|62636516|FG001|Overall Study|Physician Decision|13|||
33265550|NCT00523341|62636515|FG000|Overall Study|Requirement for Alternative Therapy|4|||
33265551|NCT00523341|62636516|FG001|Overall Study|Requirement for Alternative Therapy|14|||
33265552|NCT00523341|62636515|FG000|Overall Study|Protocol Deviation|6|||
33265553|NCT00523341|62636516|FG001|Overall Study|Protocol Deviation|5|||
33265554|NCT00523341|62636515|FG000|Overall Study|Ineligibility Determined|3|||
33265555|NCT00523341|62636516|FG001|Overall Study|Ineligibility Determined|4|||
33265556|NCT00523341|62636515|FG000|Overall Study|Disease Progression|1|||
33265557|NCT00523341|62636516|FG001|Overall Study|Disease Progression|0|||
33265558|NCT00364013|62636524|FG000|Overall Study|Ineligibility determined|4|||
33265559|NCT00364013|62636525|FG001|Overall Study|Ineligibility determined|2|||
33265560|NCT00364013|62636524|FG000|Overall Study|Adverse Event|4|||
33265561|NCT00364013|62636525|FG001|Overall Study|Adverse Event|3|||
33265562|NCT00364013|62636524|FG000|Overall Study|Withdrawal by Subject|13|||
33265563|NCT00364013|62636525|FG001|Overall Study|Withdrawal by Subject|18|||
33265564|NCT00364013|62636524|FG000|Overall Study|Physician Decision|3|||
33265565|NCT00364013|62636525|FG001|Overall Study|Physician Decision|3|||
33368313|NCT00819585|62747237|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
33265566|NCT00364013|62636524|FG000|Overall Study|Lost to Follow-up|10|||
33265567|NCT00364013|62636525|FG001|Overall Study|Lost to Follow-up|3|||
33265568|NCT00364013|62636524|FG000|Overall Study|Protocol-specified criteria|6|||
33265569|NCT00364013|62636525|FG001|Overall Study|Protocol-specified criteria|6|||
33265570|NCT00364013|62636524|FG000|Overall Study|Other|41|||
33265571|NCT00364013|62636525|FG001|Overall Study|Other|47|||
33265572|NCT00364013|62636524|FG000|Overall Study|Ongoing|20|||
33265573|NCT00364013|62636525|FG001|Overall Study|Ongoing|13|||
33265574|NCT00345839|62636537|FG000|Overall Study|Withdrawal by Subject|91|||
33265575|NCT00345839|62636538|FG001|Overall Study|Withdrawal by Subject|98|||
33265576|NCT00345839|62636537|FG000|Overall Study|Lost to Follow-up|58|||
33265577|NCT00345839|62636538|FG001|Overall Study|Lost to Follow-up|61|||
33265578|NCT00330759|62636546|FG000|Overall Study|Death|316|||
33265579|NCT00330759|62636547|FG001|Overall Study|Death|310|||
33265580|NCT00330759|62636546|FG000|Overall Study|Disease progression|104|||
33265581|NCT00330759|62636547|FG001|Overall Study|Disease progression|126|||
33265582|NCT00330759|62636546|FG000|Overall Study|Withdrawal by Subject|143|||
33265583|NCT00330759|62636547|FG001|Overall Study|Withdrawal by Subject|124|||
33265584|NCT00330759|62636546|FG000|Overall Study|Adverse Event|48|||
33265585|NCT00330759|62636547|FG001|Overall Study|Adverse Event|36|||
33265586|NCT00330759|62636546|FG000|Overall Study|Participant request|31|||
33265587|NCT00330759|62636547|FG001|Overall Study|Participant request|22|||
33265588|NCT00330759|62636546|FG000|Overall Study|Lost to Follow-up|16|||
33265589|NCT00330759|62636547|FG001|Overall Study|Lost to Follow-up|22|||
33265590|NCT00330759|62636546|FG000|Overall Study|Noncompliance|15|||
33265591|NCT00330759|62636547|FG001|Overall Study|Noncompliance|17|||
33265592|NCT00330759|62636546|FG000|Overall Study|Physician Decision|1|||
33265593|NCT00330759|62636547|FG001|Overall Study|Physician Decision|2|||
33265594|NCT00330759|62636546|FG000|Overall Study|Protocol deviation|0|||
33265595|NCT00330759|62636547|FG001|Overall Study|Protocol deviation|2|||
33265596|NCT00330759|62636546|FG000|Overall Study|Ineligibility determined|2|||
33265597|NCT00330759|62636547|FG001|Overall Study|Ineligibility determined|1|||
33265598|NCT00330759|62636546|FG000|Overall Study|Other|36|||
33265599|NCT00330759|62636547|FG001|Overall Study|Other|44|||
33265600|NCT00113763|62636555|FG000|Overall Study|Adverse Event|5|||
33265601|NCT00113763|62636556|FG001|Overall Study|Adverse Event|2|||
33265602|NCT00113763|62636555|FG000|Overall Study|Disease Progression|28|||
33265603|NCT00113763|62636556|FG001|Overall Study|Disease Progression|14|||
33484742|NCT03313076|62861695|FG001|Overall Study|Lost to Follow-up|2|||
33484743|NCT03313076|62861696|FG002|Overall Study|Lost to Follow-up|2|||
33484744|NCT03313076|62861697|FG003|Overall Study|Lost to Follow-up|2|||
33484745|NCT02940626|62861715|FG000|Overall Study|Death|40|||
33484746|NCT02940626|62861716|FG001|Overall Study|Death|32|||
33484747|NCT02940626|62861715|FG000|Overall Study|Lost to Follow-up|5|||
33484748|NCT02940626|62861716|FG001|Overall Study|Lost to Follow-up|2|||
33484749|NCT02940626|62861715|FG000|Overall Study|Withdrawal by Subject|1|||
33484750|NCT02940626|62861716|FG001|Overall Study|Withdrawal by Subject|0|||
33484751|NCT02940626|62861715|FG000|Overall Study|Transfer to Hospice Care|1|||
33484752|NCT02940626|62861716|FG001|Overall Study|Transfer to Hospice Care|0|||
33484753|NCT02940626|62861715|FG000|Overall Study|Prohibited Concomitant Medication|0|||
33484754|NCT02940626|62861716|FG001|Overall Study|Prohibited Concomitant Medication|1|||
33484755|NCT03300050|62861729|FG000|Overall Study|Lost to Follow-up|2|||
33484756|NCT03300050|62861730|FG001|Overall Study|Lost to Follow-up|1|||
33484757|NCT03300050|62861731|FG002|Overall Study|Lost to Follow-up|0|||
33484758|NCT03300050|62861732|FG003|Overall Study|Lost to Follow-up|0|||
33484759|NCT03300050|62861733|FG004|Overall Study|Lost to Follow-up|1|||
33484760|NCT03300050|62861729|FG000|Overall Study|Withdrawal by Subject|1|||
33484761|NCT03300050|62861730|FG001|Overall Study|Withdrawal by Subject|1|||
33484762|NCT03300050|62861731|FG002|Overall Study|Withdrawal by Subject|1|||
33484763|NCT03300050|62861732|FG003|Overall Study|Withdrawal by Subject|0|||
33484764|NCT03300050|62861733|FG004|Overall Study|Withdrawal by Subject|0|||
33484765|NCT03300050|62861729|FG000|Overall Study|Death|0|||
33484766|NCT03300050|62861730|FG001|Overall Study|Death|0|||
33484767|NCT03300050|62861731|FG002|Overall Study|Death|1|||
33484768|NCT03300050|62861732|FG003|Overall Study|Death|0|||
33484769|NCT03300050|62861733|FG004|Overall Study|Death|0|||
33484770|NCT03300050|62861729|FG000|Overall Study|Not Eligible at Randomization|0|||
33484771|NCT03300050|62861730|FG001|Overall Study|Not Eligible at Randomization|0|||
33484772|NCT03300050|62861731|FG002|Overall Study|Not Eligible at Randomization|1|||
33484773|NCT03300050|62861732|FG003|Overall Study|Not Eligible at Randomization|1|||
33484774|NCT03300050|62861733|FG004|Overall Study|Not Eligible at Randomization|0|||
33484775|NCT03725085|62861745|FG000|Overall Study|Lost to Follow-up|2|||
33484776|NCT02940392|62861750|FG000|Overall Study|Lost to Follow-up|3|||
33484777|NCT02940392|62861750|FG000|Overall Study|Retreatment|3|||
33265604|NCT00113763|62636555|FG000|Overall Study|Lost to Follow-up|10|||
33265605|NCT00113763|62636556|FG001|Overall Study|Lost to Follow-up|0|||
33265606|NCT00113763|62636555|FG000|Overall Study|Withdrawal by Subject|1|||
33265607|NCT00113763|62636556|FG001|Overall Study|Withdrawal by Subject|4|||
33265608|NCT00113763|62636555|FG000|Overall Study|Other|27|||
33265609|NCT00113763|62636556|FG001|Overall Study|Other|6|||
33265610|NCT00113763|62636555|FG000|Overall Study|Non-compliance|1|||
33265611|NCT00113763|62636556|FG001|Overall Study|Non-compliance|0|||
33265612|NCT00113763|62636555|FG000|Overall Study|Ongoing|1|||
33484778|NCT02940392|62861750|FG000|Overall Study|Death|2|||
33484779|NCT03298412|62861763|FG000|Run-in Period|Other, Not Specified|1|||
33484780|NCT03298412|62861763|FG000|Run-in Period|Disease Progression|1|||
33484781|NCT03298412|62861763|FG000|Run-in Period|Ineligibility Determined|1|||
33484782|NCT03298412|62861763|FG000|Run-in Period|Decision by Sponsor|6|||
33265613|NCT00113763|62636556|FG001|Overall Study|Ongoing|0|||
33265614|NCT05166902|62636570|FG000|First Intervention|Lost to Follow-up|0|||
33265615|NCT05166902|62636571|FG001|First Intervention|Lost to Follow-up|1|||
33265616|NCT05142566|62636577|FG000|Overall Study|Protocol Violation|1|||
33265617|NCT05083949|62636583|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
33265618|NCT05083949|62636584|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
33265619|NCT05083949|62636583|FG000|Period 1|Adverse Event|1|||
33265620|NCT05083949|62636584|FG001|Period 1|Adverse Event|1|||
33265621|NCT05083949|62636583|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
33265622|NCT05083949|62636584|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
33265623|NCT05083949|62636583|FG000|Period 2|Adverse Event|0|||
33265624|NCT05083949|62636584|FG001|Period 2|Adverse Event|2|||
33265625|NCT04982575|62636596|FG000|Overall Study|Withdrawal by Subject|2|||
33265626|NCT04982575|62636597|FG001|Overall Study|Withdrawal by Subject|0|||
33265627|NCT04982575|62636598|FG002|Overall Study|Withdrawal by Subject|2|||
33265628|NCT05776901|62636629|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
33265629|NCT05513625|62636633|FG000|Overall Study|Withdrawal by Subject|1|||
33265630|NCT05344560|62636643|FG000|Period 1|Subject out of visit window|1|||
33265631|NCT05344560|62636644|FG001|Period 1|Subject out of visit window|1|||
33265632|NCT05344560|62636643|FG000|Period 2|Covid-19 Related|1|||
33265633|NCT05344560|62636644|FG001|Period 2|Covid-19 Related|0|||
33265634|NCT05344560|62636643|FG000|Period 2|Adverse Event|1|||
33265635|NCT05344560|62636644|FG001|Period 2|Adverse Event|0|||
33265636|NCT05344560|62636643|FG000|Period 2|Subject out of visit window|1|||
33265637|NCT05344560|62636644|FG001|Period 2|Subject out of visit window|1|||
33265638|NCT05344560|62636643|FG000|Period 3|Subject out of visit window|1|||
33265639|NCT05344560|62636644|FG001|Period 3|Subject out of visit window|0|||
33265640|NCT05024058|62636664|FG000|Treatment|Study terminated by sponsor|5|||
33265641|NCT05024058|62636665|FG001|Treatment|Study terminated by sponsor|6|||
33265642|NCT05024058|62636666|FG002|Treatment|Study terminated by sponsor|4|||
33265643|NCT05024058|62636667|FG003|Treatment|Study terminated by sponsor|2|||
33265644|NCT05024058|62636668|FG004|Treatment|Study terminated by sponsor|3|||
33265645|NCT05024058|62636669|FG005|Treatment|Study terminated by sponsor|3|||
33265646|NCT05024058|62636670|FG006|Treatment|Study terminated by sponsor|1|||
33265647|NCT05024058|62636671|FG007|Treatment|Study terminated by sponsor|3|||
33265648|NCT05024058|62636672|FG008|Treatment|Study terminated by sponsor|6|||
33265649|NCT05024058|62636673|FG009|Treatment|Study terminated by sponsor|6|||
33265650|NCT05024058|62636664|FG000|Follow-up|Withdrawal by Subject|1|||
33265651|NCT05024058|62636665|FG001|Follow-up|Withdrawal by Subject|0|||
33265652|NCT05024058|62636666|FG002|Follow-up|Withdrawal by Subject|1|||
33265653|NCT05024058|62636667|FG003|Follow-up|Withdrawal by Subject|0|||
33265654|NCT05024058|62636668|FG004|Follow-up|Withdrawal by Subject|0|||
33265655|NCT05024058|62636669|FG005|Follow-up|Withdrawal by Subject|0|||
33265656|NCT05024058|62636670|FG006|Follow-up|Withdrawal by Subject|0|||
33265657|NCT05024058|62636671|FG007|Follow-up|Withdrawal by Subject|1|||
33265658|NCT05024058|62636672|FG008|Follow-up|Withdrawal by Subject|0|||
33265659|NCT05024058|62636673|FG009|Follow-up|Withdrawal by Subject|1|||
33265660|NCT05013008|62636696|FG000|Overall Study|Exclusion from mBFAS|5|||
33265661|NCT05013008|62636697|FG001|Overall Study|Exclusion from mBFAS|25|||
33368314|NCT00819585|62747238|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
33368315|NCT00819585|62747239|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
33368316|NCT00819585|62747240|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
33484783|NCT03297398|62861770|FG000|Overall Study|Sponsor's decision|6|||
33484784|NCT03297398|62861771|FG001|Overall Study|Sponsor's decision|9|||
33484785|NCT03297398|62861772|FG002|Overall Study|Sponsor's decision|7|||
33484786|NCT03297398|62861770|FG000|Overall Study|Adverse Event|1|||
33265662|NCT04826900|62636705|FG000|Overall Study|Family factor|1|||
33265663|NCT04826900|62636706|FG001|Overall Study|Family factor|1|||
33265664|NCT04721158|62636712|FG000|Overall Study|Lost to Follow-up|4|||
33265665|NCT04721158|62636712|FG000|Overall Study|Device did not connect|1|||
33265666|NCT04696055|62636719|FG000|Overall Study|Adverse Event|10|||
33265667|NCT04696055|62636720|FG001|Overall Study|Adverse Event|0|||
33265668|NCT04696055|62636719|FG000|Overall Study|Death|2|||
33265669|NCT04696055|62636720|FG001|Overall Study|Death|1|||
33265670|NCT04696055|62636719|FG000|Overall Study|Other|4|||
33265671|NCT04696055|62636720|FG001|Overall Study|Other|0|||
33265672|NCT04696055|62636719|FG000|Overall Study|Physician Decision|1|||
33265673|NCT04696055|62636720|FG001|Overall Study|Physician Decision|0|||
33265674|NCT04696055|62636719|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
33265675|NCT04696055|62636720|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
33265676|NCT04696055|62636719|FG000|Overall Study|Progressive Disease - Radiological Progression|36|||
33265677|NCT04696055|62636720|FG001|Overall Study|Progressive Disease - Radiological Progression|13|||
33265678|NCT04696055|62636719|FG000|Overall Study|Subject Decision|1|||
33265679|NCT04696055|62636720|FG001|Overall Study|Subject Decision|2|||
33265680|NCT04696055|62636719|FG000|Overall Study|Ongoing with study treatment|13|||
33265681|NCT04696055|62636720|FG001|Overall Study|Ongoing with study treatment|10|||
33265682|NCT04263766|62636728|FG000|Overall Study|Withdrawal by Subject|6|||
33265683|NCT04263766|62636729|FG001|Overall Study|Withdrawal by Subject|4|||
33265684|NCT04263766|62636728|FG000|Overall Study|Lack of Efficacy|1|||
33265685|NCT04263766|62636729|FG001|Overall Study|Lack of Efficacy|3|||
33265686|NCT04225039|62636753|FG000|Overall Study|Withdrawal by Subject|1|||
33265687|NCT04225039|62636754|FG001|Overall Study|Withdrawal by Subject|0|||
33265688|NCT04225039|62636755|FG002|Overall Study|Withdrawal by Subject|0|||
33265689|NCT04225039|62636756|FG003|Overall Study|Withdrawal by Subject|1|||
33265690|NCT04225039|62636753|FG000|Overall Study|Currently active on study treatment|0|||
33265691|NCT04225039|62636754|FG001|Overall Study|Currently active on study treatment|1|||
33265692|NCT04225039|62636755|FG002|Overall Study|Currently active on study treatment|0|||
33265693|NCT04225039|62636756|FG003|Overall Study|Currently active on study treatment|0|||
33265694|NCT04225039|62636753|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
33265695|NCT04225039|62636754|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
33265696|NCT04225039|62636755|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
33265697|NCT04225039|62636756|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
33265698|NCT04225039|62636753|FG000|Overall Study|Ineligible for treatment|0|||
33265699|NCT04225039|62636754|FG001|Overall Study|Ineligible for treatment|0|||
33265700|NCT04225039|62636755|FG002|Overall Study|Ineligible for treatment|0|||
33265701|NCT04225039|62636756|FG003|Overall Study|Ineligible for treatment|4|||
33265702|NCT04203199|62636765|FG000|First Intervention Period|Lost to Follow-up|0|||
33265703|NCT04203199|62636766|FG001|First Intervention Period|Lost to Follow-up|1|||
33265704|NCT04203199|62636765|FG000|Second Intervention Period|Medication change|1|||
33265705|NCT04203199|62636766|FG001|Second Intervention Period|Medication change|0|||
33265706|NCT04191733|62636774|FG000|Overall Study|Withdrawn due to study closure|13|||
33265707|NCT04191733|62636775|FG001|Overall Study|Withdrawn due to study closure|14|||
33265708|NCT04191733|62636774|FG000|Overall Study|Withdrawal by Subject|2|||
33265709|NCT04191733|62636775|FG001|Overall Study|Withdrawal by Subject|4|||
33265710|NCT04191733|62636774|FG000|Overall Study|Physician Decision|1|||
33265711|NCT04191733|62636775|FG001|Overall Study|Physician Decision|1|||
33265712|NCT04191733|62636774|FG000|Overall Study|Lost to Follow-up|5|||
33265713|NCT04191733|62636775|FG001|Overall Study|Lost to Follow-up|6|||
33265714|NCT04191733|62636774|FG000|Overall Study|Death|0|||
33265715|NCT04191733|62636775|FG001|Overall Study|Death|1|||
33265716|NCT04049097|62636781|FG000|Overall Study|Adverse Event|18|||
33265717|NCT04049097|62636781|FG000|Overall Study|Death|2|||
33265718|NCT04049097|62636781|FG000|Overall Study|Lost to Follow-up|1|||
33265719|NCT04049097|62636781|FG000|Overall Study|Physician Decision|2|||
33265720|NCT04049097|62636781|FG000|Overall Study|Withdrawal by Subject|9|||
33265721|NCT04049097|62636781|FG000|Overall Study|Protocol Violation|2|||
33265722|NCT04049097|62636781|FG000|Overall Study|Other|1|||
33265723|NCT04049097|62636781|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
33265724|NCT04002310|62636790|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
33265725|NCT04002310|62636791|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
33265726|NCT04002310|62636792|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
33265727|NCT04002310|62636793|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
33265728|NCT04002310|62636794|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
33265729|NCT03887650|62636817|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
33265730|NCT03887650|62636818|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
33265731|NCT03887650|62636817|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
33265732|NCT03887650|62636818|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
33265733|NCT03887650|62636817|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
33265734|NCT03887650|62636818|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
33265735|NCT03692052|62636833|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
33265736|NCT03692052|62636833|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
33265737|NCT03692052|62636833|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
33265738|NCT03692052|62636833|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
33661808|NCT01697579|63091449|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
33661809|NCT01697579|63091450|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
33661810|NCT01697579|63091444|FG000|Base Study-Cycle 1|Technical Problems|0|||
33265743|NCT03661723|62636849|FG000|Overall Study|Disease Progression|4|||
33265744|NCT03661723|62636850|FG001|Overall Study|Disease Progression|24|||
33265745|NCT03661723|62636851|FG002|Overall Study|Disease Progression|4|||
33265746|NCT03661723|62636852|FG003|Overall Study|Disease Progression|19|||
33265747|NCT03661723|62636849|FG000|Overall Study|Withdrawal by Subject|1|||
33265748|NCT03661723|62636850|FG001|Overall Study|Withdrawal by Subject|0|||
33265749|NCT03661723|62636851|FG002|Overall Study|Withdrawal by Subject|2|||
33265750|NCT03661723|62636852|FG003|Overall Study|Withdrawal by Subject|4|||
33265751|NCT03661723|62636849|FG000|Overall Study|Physician Decision|1|||
33265752|NCT03661723|62636850|FG001|Overall Study|Physician Decision|0|||
33265753|NCT03661723|62636851|FG002|Overall Study|Physician Decision|0|||
33265754|NCT03661723|62636852|FG003|Overall Study|Physician Decision|0|||
33484787|NCT03297398|62861771|FG001|Overall Study|Adverse Event|4|||
33265755|NCT03661723|62636849|FG000|Overall Study|Clinical Deterioration|0|||
33265756|NCT03661723|62636850|FG001|Overall Study|Clinical Deterioration|0|||
33265757|NCT03661723|62636851|FG002|Overall Study|Clinical Deterioration|0|||
33265758|NCT03661723|62636852|FG003|Overall Study|Clinical Deterioration|1|||
33265759|NCT03345342|62636890|FG000|Open-Label Phase|Adverse Event|30|||
33265760|NCT03345342|62636891|FG001|Open-Label Phase|Adverse Event|0|||
33265761|NCT03345342|62636892|FG002|Open-Label Phase|Adverse Event|0|||
33265762|NCT03345342|62636893|FG003|Open-Label Phase|Adverse Event|0|||
33265763|NCT03345342|62636894|FG004|Open-Label Phase|Adverse Event|0|||
33265764|NCT03345342|62636890|FG000|Open-Label Phase|Death|1|||
33265765|NCT03345342|62636891|FG001|Open-Label Phase|Death|0|||
33265766|NCT03345342|62636892|FG002|Open-Label Phase|Death|0|||
33265767|NCT03345342|62636893|FG003|Open-Label Phase|Death|0|||
33265768|NCT03345342|62636894|FG004|Open-Label Phase|Death|0|||
33265769|NCT03345342|62636890|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
33265770|NCT03345342|62636891|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
33265771|NCT03345342|62636892|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
33265772|NCT03345342|62636893|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
33265773|NCT03345342|62636894|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
33265774|NCT03345342|62636890|FG000|Open-Label Phase|Lack of Efficacy|6|||
33265775|NCT03345342|62636891|FG001|Open-Label Phase|Lack of Efficacy|0|||
33265776|NCT03345342|62636892|FG002|Open-Label Phase|Lack of Efficacy|0|||
33265777|NCT03345342|62636893|FG003|Open-Label Phase|Lack of Efficacy|0|||
33265778|NCT03345342|62636894|FG004|Open-Label Phase|Lack of Efficacy|0|||
33265779|NCT03345342|62636890|FG000|Open-Label Phase|Lost to Follow-up|9|||
33265780|NCT03345342|62636891|FG001|Open-Label Phase|Lost to Follow-up|0|||
33265781|NCT03345342|62636892|FG002|Open-Label Phase|Lost to Follow-up|0|||
33265782|NCT03345342|62636893|FG003|Open-Label Phase|Lost to Follow-up|0|||
33265783|NCT03345342|62636894|FG004|Open-Label Phase|Lost to Follow-up|0|||
33265784|NCT03345342|62636890|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
33265785|NCT03345342|62636891|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
33265786|NCT03345342|62636892|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
33265787|NCT03345342|62636893|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
33265788|NCT03345342|62636894|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
33265789|NCT03345342|62636890|FG000|Open-Label Phase|Physician Decision|4|||
33265790|NCT03345342|62636891|FG001|Open-Label Phase|Physician Decision|0|||
33265791|NCT03345342|62636892|FG002|Open-Label Phase|Physician Decision|0|||
33265792|NCT03345342|62636893|FG003|Open-Label Phase|Physician Decision|0|||
33265793|NCT03345342|62636894|FG004|Open-Label Phase|Physician Decision|0|||
33265794|NCT03345342|62636890|FG000|Open-Label Phase|Protocol Violation|8|||
33265795|NCT03345342|62636891|FG001|Open-Label Phase|Protocol Violation|0|||
33265796|NCT03345342|62636892|FG002|Open-Label Phase|Protocol Violation|0|||
33265797|NCT03345342|62636893|FG003|Open-Label Phase|Protocol Violation|0|||
33265798|NCT03345342|62636894|FG004|Open-Label Phase|Protocol Violation|0|||
33265799|NCT03345342|62636890|FG000|Open-Label Phase|Withdrawal by Subject|57|||
33265800|NCT03345342|62636891|FG001|Open-Label Phase|Withdrawal by Subject|0|||
33265801|NCT03345342|62636892|FG002|Open-Label Phase|Withdrawal by Subject|0|||
33265802|NCT03345342|62636893|FG003|Open-Label Phase|Withdrawal by Subject|0|||
33265803|NCT03345342|62636894|FG004|Open-Label Phase|Withdrawal by Subject|0|||
33265804|NCT03345342|62636890|FG000|Open-Label Phase|Other|15|||
33265805|NCT03345342|62636891|FG001|Open-Label Phase|Other|0|||
33265806|NCT03345342|62636892|FG002|Open-Label Phase|Other|0|||
33265807|NCT03345342|62636893|FG003|Open-Label Phase|Other|0|||
33265808|NCT03345342|62636894|FG004|Open-Label Phase|Other|0|||
33265809|NCT03345342|62636890|FG000|Double-Blind Phase|Adverse Event|0|||
33265810|NCT03345342|62636891|FG001|Double-Blind Phase|Adverse Event|1|||
33265811|NCT03345342|62636892|FG002|Double-Blind Phase|Adverse Event|6|||
33265812|NCT03345342|62636893|FG003|Double-Blind Phase|Adverse Event|0|||
33265813|NCT03345342|62636894|FG004|Double-Blind Phase|Adverse Event|0|||
33368317|NCT00819585|62747230|FG000|Core Study|Subject Withdrew Consent|0|||
33368318|NCT00819585|62747231|FG001|Core Study|Subject Withdrew Consent|3|||
33368319|NCT00819585|62747232|FG002|Core Study|Subject Withdrew Consent|2|||
33265814|NCT03345342|62636890|FG000|Double-Blind Phase|Death|0|||
33265815|NCT03345342|62636891|FG001|Double-Blind Phase|Death|2|||
33265816|NCT03345342|62636892|FG002|Double-Blind Phase|Death|1|||
33265817|NCT03345342|62636893|FG003|Double-Blind Phase|Death|0|||
33265818|NCT03345342|62636894|FG004|Double-Blind Phase|Death|0|||
33265819|NCT03345342|62636890|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
33265820|NCT03345342|62636891|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
33265821|NCT03345342|62636892|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
33265822|NCT03345342|62636893|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
33265823|NCT03345342|62636894|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
33265824|NCT03345342|62636890|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33265825|NCT03345342|62636891|FG001|Double-Blind Phase|Lost to Follow-up|1|||
33265826|NCT03345342|62636892|FG002|Double-Blind Phase|Lost to Follow-up|7|||
33265827|NCT03345342|62636893|FG003|Double-Blind Phase|Lost to Follow-up|0|||
33265828|NCT03345342|62636894|FG004|Double-Blind Phase|Lost to Follow-up|0|||
33265829|NCT03345342|62636890|FG000|Double-Blind Phase|Physician Decision|0|||
33265830|NCT03345342|62636891|FG001|Double-Blind Phase|Physician Decision|1|||
33265831|NCT03345342|62636892|FG002|Double-Blind Phase|Physician Decision|4|||
33265832|NCT03345342|62636893|FG003|Double-Blind Phase|Physician Decision|0|||
33265833|NCT03345342|62636894|FG004|Double-Blind Phase|Physician Decision|0|||
33265834|NCT03345342|62636890|FG000|Double-Blind Phase|Protocol Violation|0|||
33265835|NCT03345342|62636891|FG001|Double-Blind Phase|Protocol Violation|0|||
33265836|NCT03345342|62636892|FG002|Double-Blind Phase|Protocol Violation|1|||
33265837|NCT03345342|62636893|FG003|Double-Blind Phase|Protocol Violation|0|||
33265838|NCT03345342|62636894|FG004|Double-Blind Phase|Protocol Violation|0|||
33265839|NCT03345342|62636890|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
33265840|NCT03345342|62636891|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
33368320|NCT00819585|62747233|FG003|Core Study|Subject Withdrew Consent|1|||
33368321|NCT00819585|62747234|FG004|Core Study|Subject Withdrew Consent|0|||
33368322|NCT00819585|62747235|FG005|Core Study|Subject Withdrew Consent|0|||
33368323|NCT00819585|62747236|FG006|Core Study|Subject Withdrew Consent|3|||
33368324|NCT00819585|62747237|FG007|Core Study|Subject Withdrew Consent|0|||
33368325|NCT00819585|62747238|FG008|Core Study|Subject Withdrew Consent|0|||
33368326|NCT00819585|62747239|FG009|Core Study|Subject Withdrew Consent|0|||
33368327|NCT00819585|62747240|FG010|Core Study|Subject Withdrew Consent|0|||
33265841|NCT03345342|62636892|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
33265842|NCT03345342|62636893|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
33265843|NCT03345342|62636894|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
33265844|NCT03345342|62636890|FG000|Double-Blind Phase|Other|0|||
33265845|NCT03345342|62636891|FG001|Double-Blind Phase|Other|1|||
33265846|NCT03345342|62636892|FG002|Double-Blind Phase|Other|3|||
33265847|NCT03345342|62636893|FG003|Double-Blind Phase|Other|0|||
33265848|NCT03345342|62636894|FG004|Double-Blind Phase|Other|0|||
33265849|NCT03345342|62636890|FG000|Follow-Up Phase|Adverse Event|0|||
33265850|NCT03345342|62636891|FG001|Follow-Up Phase|Adverse Event|0|||
33265851|NCT03345342|62636892|FG002|Follow-Up Phase|Adverse Event|0|||
33265852|NCT03345342|62636893|FG003|Follow-Up Phase|Adverse Event|0|||
33265853|NCT03345342|62636894|FG004|Follow-Up Phase|Adverse Event|4|||
33265854|NCT03345342|62636890|FG000|Follow-Up Phase|Lost to Follow-up|0|||
33265855|NCT03345342|62636891|FG001|Follow-Up Phase|Lost to Follow-up|0|||
33265856|NCT03345342|62636892|FG002|Follow-Up Phase|Lost to Follow-up|0|||
33265857|NCT03345342|62636893|FG003|Follow-Up Phase|Lost to Follow-up|0|||
33265858|NCT03345342|62636894|FG004|Follow-Up Phase|Lost to Follow-up|6|||
33265859|NCT03345342|62636890|FG000|Follow-Up Phase|Physician Decision|0|||
33265860|NCT03345342|62636891|FG001|Follow-Up Phase|Physician Decision|0|||
33265861|NCT03345342|62636892|FG002|Follow-Up Phase|Physician Decision|0|||
33265862|NCT03345342|62636893|FG003|Follow-Up Phase|Physician Decision|0|||
33265863|NCT03345342|62636894|FG004|Follow-Up Phase|Physician Decision|5|||
33265864|NCT03345342|62636890|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
33265865|NCT03345342|62636891|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
33265866|NCT03345342|62636892|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
33265867|NCT03345342|62636893|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
33265868|NCT03345342|62636894|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
33265869|NCT03345342|62636890|FG000|Follow-Up Phase|Other|0|||
33265870|NCT03345342|62636891|FG001|Follow-Up Phase|Other|0|||
33265871|NCT03345342|62636892|FG002|Follow-Up Phase|Other|0|||
33265872|NCT03345342|62636893|FG003|Follow-Up Phase|Other|3|||
33265873|NCT03345342|62636894|FG004|Follow-Up Phase|Other|1|||
33265874|NCT03220035|62636910|FG000|Overall Study|Adverse Event|1|||
33265875|NCT03220035|62636910|FG000|Overall Study|Protocol Violation|1|||
33265876|NCT03220035|62636910|FG000|Overall Study|Progressive Disease|2|||
33265877|NCT03192176|62636922|FG000|Overall Study|Adverse Event|1|||
33265878|NCT03192176|62636923|FG001|Overall Study|Adverse Event|0|||
33265879|NCT03192176|62636924|FG002|Overall Study|Adverse Event|4|||
33265880|NCT03192176|62636925|FG003|Overall Study|Adverse Event|5|||
33265881|NCT03192176|62636926|FG004|Overall Study|Adverse Event|3|||
33265882|NCT03192176|62636927|FG005|Overall Study|Adverse Event|2|||
33265883|NCT03192176|62636928|FG006|Overall Study|Adverse Event|3|||
33265884|NCT03192176|62636929|FG007|Overall Study|Adverse Event|3|||
33265885|NCT03192176|62636922|FG000|Overall Study|Lost to Follow-up|0|||
33265886|NCT03192176|62636923|FG001|Overall Study|Lost to Follow-up|0|||
33265887|NCT03192176|62636924|FG002|Overall Study|Lost to Follow-up|1|||
33368328|NCT00819585|62747230|FG000|Core Study|Lost to Follow-up|2|||
33484788|NCT03297398|62861772|FG002|Overall Study|Adverse Event|4|||
33484789|NCT03297398|62861770|FG000|Overall Study|Withdrawal by Subject|1|||
33265888|NCT03192176|62636925|FG003|Overall Study|Lost to Follow-up|2|||
33265889|NCT03192176|62636926|FG004|Overall Study|Lost to Follow-up|3|||
33265890|NCT03192176|62636927|FG005|Overall Study|Lost to Follow-up|1|||
33265891|NCT03192176|62636928|FG006|Overall Study|Lost to Follow-up|1|||
33265892|NCT03192176|62636929|FG007|Overall Study|Lost to Follow-up|1|||
33265893|NCT03192176|62636922|FG000|Overall Study|Physician Decision|1|||
33265894|NCT03192176|62636923|FG001|Overall Study|Physician Decision|0|||
33265895|NCT03192176|62636924|FG002|Overall Study|Physician Decision|0|||
33368329|NCT00819585|62747231|FG001|Core Study|Lost to Follow-up|1|||
33265896|NCT03192176|62636925|FG003|Overall Study|Physician Decision|0|||
33265897|NCT03192176|62636926|FG004|Overall Study|Physician Decision|0|||
33265898|NCT03192176|62636927|FG005|Overall Study|Physician Decision|2|||
33265899|NCT03192176|62636928|FG006|Overall Study|Physician Decision|1|||
33265900|NCT03192176|62636929|FG007|Overall Study|Physician Decision|0|||
33265901|NCT03192176|62636922|FG000|Overall Study|Protocol Deviation|1|||
33265902|NCT03192176|62636923|FG001|Overall Study|Protocol Deviation|1|||
33265903|NCT03192176|62636924|FG002|Overall Study|Protocol Deviation|0|||
33265904|NCT03192176|62636925|FG003|Overall Study|Protocol Deviation|0|||
33265905|NCT03192176|62636926|FG004|Overall Study|Protocol Deviation|2|||
33265906|NCT03192176|62636927|FG005|Overall Study|Protocol Deviation|0|||
33265907|NCT03192176|62636928|FG006|Overall Study|Protocol Deviation|0|||
33265908|NCT03192176|62636929|FG007|Overall Study|Protocol Deviation|0|||
33265909|NCT03192176|62636922|FG000|Overall Study|Withdrawal by Subject|3|||
33265910|NCT03192176|62636923|FG001|Overall Study|Withdrawal by Subject|4|||
33265911|NCT03192176|62636924|FG002|Overall Study|Withdrawal by Subject|0|||
33265912|NCT03192176|62636925|FG003|Overall Study|Withdrawal by Subject|4|||
33265913|NCT03192176|62636926|FG004|Overall Study|Withdrawal by Subject|3|||
33265914|NCT03192176|62636927|FG005|Overall Study|Withdrawal by Subject|4|||
33265915|NCT03192176|62636928|FG006|Overall Study|Withdrawal by Subject|4|||
33265916|NCT03192176|62636929|FG007|Overall Study|Withdrawal by Subject|2|||
33265917|NCT03192176|62636922|FG000|Overall Study|Miscellaneous|1|||
33265918|NCT03192176|62636923|FG001|Overall Study|Miscellaneous|0|||
33265919|NCT03192176|62636924|FG002|Overall Study|Miscellaneous|1|||
33265920|NCT03192176|62636925|FG003|Overall Study|Miscellaneous|1|||
33265921|NCT03192176|62636926|FG004|Overall Study|Miscellaneous|1|||
33265922|NCT03192176|62636927|FG005|Overall Study|Miscellaneous|2|||
33265923|NCT03192176|62636928|FG006|Overall Study|Miscellaneous|0|||
33265924|NCT03192176|62636929|FG007|Overall Study|Miscellaneous|1|||
33265925|NCT02795156|62636956|FG000|Overall Study|Progressive Disease|22|||
33265926|NCT02795156|62636957|FG001|Overall Study|Progressive Disease|7|||
33265927|NCT02795156|62636958|FG002|Overall Study|Progressive Disease|34|||
33265928|NCT02795156|62636959|FG003|Overall Study|Progressive Disease|7|||
33265929|NCT02795156|62636956|FG000|Overall Study|Adverse Event|13|||
33265930|NCT02795156|62636957|FG001|Overall Study|Adverse Event|2|||
33265931|NCT02795156|62636958|FG002|Overall Study|Adverse Event|3|||
33265932|NCT02795156|62636959|FG003|Overall Study|Adverse Event|2|||
33265933|NCT02795156|62636956|FG000|Overall Study|Death|1|||
33265934|NCT02795156|62636957|FG001|Overall Study|Death|1|||
33265935|NCT02795156|62636958|FG002|Overall Study|Death|1|||
33265936|NCT02795156|62636959|FG003|Overall Study|Death|0|||
33265937|NCT02795156|62636956|FG000|Overall Study|Physician Decision|1|||
33265938|NCT02795156|62636957|FG001|Overall Study|Physician Decision|0|||
33265939|NCT02795156|62636958|FG002|Overall Study|Physician Decision|1|||
33265940|NCT02795156|62636959|FG003|Overall Study|Physician Decision|0|||
33265941|NCT02795156|62636956|FG000|Overall Study|Withdrawal by Subject|2|||
33265942|NCT02795156|62636957|FG001|Overall Study|Withdrawal by Subject|0|||
33265943|NCT02795156|62636958|FG002|Overall Study|Withdrawal by Subject|3|||
33265944|NCT02795156|62636959|FG003|Overall Study|Withdrawal by Subject|0|||
33265945|NCT02609503|62636977|FG000|Overall Study|Adverse Event|1|||
33265946|NCT02609503|62636977|FG000|Overall Study|Death|1|||
33265947|NCT02609503|62636977|FG000|Overall Study|Withdrawal by Subject|1|||
33265948|NCT02609503|62636977|FG000|Overall Study|Disease progression|1|||
33265949|NCT02531594|62637001|FG000|Overall Study|Withdrawal by Subject|7|||
33265950|NCT02531594|62637002|FG001|Overall Study|Withdrawal by Subject|8|||
33265951|NCT02476916|62637010|FG000|Core Period|Adverse Event|2|||
33265952|NCT02476916|62637011|FG001|Core Period|Adverse Event|2|||
33265953|NCT02476916|62637010|FG000|Core Period|Investigator decision|1|||
33265954|NCT02476916|62637011|FG001|Core Period|Investigator decision|1|||
33265955|NCT02476916|62637010|FG000|Core Period|Withdrawal by Subject|3|||
33265956|NCT02476916|62637011|FG001|Core Period|Withdrawal by Subject|0|||
33265957|NCT02476916|62637010|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
33265958|NCT02476916|62637011|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
33265959|NCT02476916|62637010|FG000|Extension Period|On Treatment|12|||
33484790|NCT03297398|62861771|FG001|Overall Study|Withdrawal by Subject|2|||
33484791|NCT03297398|62861772|FG002|Overall Study|Withdrawal by Subject|2|||
33484792|NCT03297398|62861770|FG000|Overall Study|Protocol Violation|0|||
33265960|NCT02476916|62637011|FG001|Extension Period|On Treatment|17|||
33265961|NCT02365467|62637027|FG000|Overall Study|Death|3|||
33265962|NCT02043678|62637033|FG000|Overall Study|Never treated|11|||
33265963|NCT02043678|62637034|FG001|Overall Study|Never treated|9|||
33265964|NCT02043678|62637033|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
33265965|NCT02043678|62637034|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
33265966|NCT02043678|62637033|FG000|Overall Study|AE without clinical PD|51|||
33265967|NCT02043678|62637034|FG001|Overall Study|AE without clinical PD|34|||
33265968|NCT02043678|62637033|FG000|Overall Study|Lost to Follow-up|1|||
33265969|NCT02043678|62637034|FG001|Overall Study|Lost to Follow-up|1|||
33265970|NCT02043678|62637033|FG000|Overall Study|Other|19|||
33265971|NCT02043678|62637034|FG001|Overall Study|Other|16|||
33265972|NCT02043678|62637033|FG000|Overall Study|Clinical PD|108|||
33265973|NCT02043678|62637034|FG001|Overall Study|Clinical PD|138|||
33265974|NCT02043678|62637033|FG000|Overall Study|Radiological PD|91|||
33265975|NCT02043678|62637034|FG001|Overall Study|Radiological PD|80|||
33265976|NCT02043678|62637033|FG000|Overall Study|Protocol-driven decision point|56|||
33265977|NCT02043678|62637034|FG001|Overall Study|Protocol-driven decision point|56|||
33265978|NCT02043678|62637033|FG000|Overall Study|Withdrawal by Subject|12|||
33265979|NCT02043678|62637034|FG001|Overall Study|Withdrawal by Subject|15|||
33265980|NCT02043678|62637033|FG000|Overall Study|Ongoing with treatment|34|||
33265981|NCT02043678|62637034|FG001|Overall Study|Ongoing with treatment|38|||
33265982|NCT01256593|62637049|FG000|Overall Study|Protocol Violation|26|||
33265983|NCT01256593|62637049|FG000|Overall Study|No Drug Administration Information|2|||
33265984|NCT01256593|62637049|FG000|Overall Study|No Visit After Treatment|186|||
33368330|NCT00819585|62747232|FG002|Core Study|Lost to Follow-up|2|||
33368331|NCT00819585|62747233|FG003|Core Study|Lost to Follow-up|0|||
33368332|NCT00819585|62747234|FG004|Core Study|Lost to Follow-up|1|||
33368333|NCT00819585|62747235|FG005|Core Study|Lost to Follow-up|1|||
33368334|NCT00819585|62747236|FG006|Core Study|Lost to Follow-up|1|||
33265990|NCT00562640|62637071|FG000|Overall Study|Death|0|||
33265991|NCT00562640|62637072|FG001|Overall Study|Death|1|||
33265992|NCT00562640|62637073|FG002|Overall Study|Death|1|||
33265993|NCT00562640|62637074|FG003|Overall Study|Death|0|||
33265994|NCT04554394|62637107|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
33265995|NCT04554394|62637108|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
33265996|NCT04554394|62637107|FG000|Overall Study|Withdrawal by Subject|2|||
33265997|NCT04554394|62637108|FG001|Overall Study|Withdrawal by Subject|2|||
33265998|NCT04554394|62637107|FG000|Overall Study|Lost to Follow-up|2|||
33265999|NCT04554394|62637108|FG001|Overall Study|Lost to Follow-up|2|||
33266000|NCT04554394|62637107|FG000|Overall Study|Physician Decision|1|||
33266001|NCT04554394|62637108|FG001|Overall Study|Physician Decision|1|||
33266002|NCT04518410|62637138|FG000|Overall Study|Lost to Follow-up|1|||
33266003|NCT04518410|62637139|FG001|Overall Study|Lost to Follow-up|1|||
33266004|NCT04518410|62637140|FG002|Overall Study|Lost to Follow-up|8|||
33266005|NCT04518410|62637141|FG003|Overall Study|Lost to Follow-up|5|||
33266006|NCT04518410|62637142|FG004|Overall Study|Lost to Follow-up|92|||
33266007|NCT04518410|62637143|FG005|Overall Study|Lost to Follow-up|27|||
33266008|NCT04518410|62637144|FG006|Overall Study|Lost to Follow-up|26|||
33266009|NCT04518410|62637145|FG007|Overall Study|Lost to Follow-up|3|||
33266010|NCT04518410|62637146|FG008|Overall Study|Lost to Follow-up|2|||
33266011|NCT04518410|62637147|FG009|Overall Study|Lost to Follow-up|15|||
33266012|NCT04518410|62637148|FG010|Overall Study|Lost to Follow-up|9|||
33266013|NCT04518410|62637149|FG011|Overall Study|Lost to Follow-up|13|||
33266014|NCT04518410|62637150|FG012|Overall Study|Lost to Follow-up|9|||
33266015|NCT04518410|62637151|FG013|Overall Study|Lost to Follow-up|14|||
33266016|NCT04518410|62637152|FG014|Overall Study|Lost to Follow-up|8|||
33266017|NCT04518410|62637153|FG015|Overall Study|Lost to Follow-up|10|||
33266018|NCT04518410|62637154|FG016|Overall Study|Lost to Follow-up|6|||
33266019|NCT04518410|62637155|FG017|Overall Study|Lost to Follow-up|8|||
33266020|NCT04518410|62637156|FG018|Overall Study|Lost to Follow-up|20|||
33266021|NCT04518410|62637157|FG019|Overall Study|Lost to Follow-up|6|||
33266022|NCT04518410|62637158|FG020|Overall Study|Lost to Follow-up|4|||
33266023|NCT04518410|62637159|FG021|Overall Study|Lost to Follow-up|22|||
33266024|NCT04518410|62637160|FG022|Overall Study|Lost to Follow-up|1|||
33266025|NCT04518410|62637161|FG023|Overall Study|Lost to Follow-up|7|||
33266026|NCT04518410|62637162|FG024|Overall Study|Lost to Follow-up|6|||
33266027|NCT04518410|62637138|FG000|Overall Study|Withdrawal by Subject|1|||
33266028|NCT04518410|62637139|FG001|Overall Study|Withdrawal by Subject|2|||
33266029|NCT04518410|62637140|FG002|Overall Study|Withdrawal by Subject|2|||
33266030|NCT04518410|62637141|FG003|Overall Study|Withdrawal by Subject|3|||
33555532|NCT02347774|62948336|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
33266031|NCT04518410|62637142|FG004|Overall Study|Withdrawal by Subject|20|||
33266032|NCT04518410|62637143|FG005|Overall Study|Withdrawal by Subject|21|||
33266033|NCT04518410|62637144|FG006|Overall Study|Withdrawal by Subject|27|||
33266034|NCT04518410|62637145|FG007|Overall Study|Withdrawal by Subject|6|||
33266035|NCT04518410|62637146|FG008|Overall Study|Withdrawal by Subject|2|||
33266036|NCT04518410|62637147|FG009|Overall Study|Withdrawal by Subject|12|||
33266037|NCT04518410|62637148|FG010|Overall Study|Withdrawal by Subject|6|||
33266038|NCT04518410|62637149|FG011|Overall Study|Withdrawal by Subject|7|||
33266039|NCT04518410|62637150|FG012|Overall Study|Withdrawal by Subject|2|||
33555533|NCT02347774|62948337|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
33266040|NCT04518410|62637151|FG013|Overall Study|Withdrawal by Subject|13|||
33266041|NCT04518410|62637152|FG014|Overall Study|Withdrawal by Subject|4|||
33266042|NCT04518410|62637153|FG015|Overall Study|Withdrawal by Subject|9|||
33266043|NCT04518410|62637154|FG016|Overall Study|Withdrawal by Subject|0|||
33266044|NCT04518410|62637155|FG017|Overall Study|Withdrawal by Subject|14|||
33266045|NCT04518410|62637156|FG018|Overall Study|Withdrawal by Subject|13|||
33266046|NCT04518410|62637157|FG019|Overall Study|Withdrawal by Subject|9|||
33266047|NCT04518410|62637158|FG020|Overall Study|Withdrawal by Subject|13|||
33266048|NCT04518410|62637159|FG021|Overall Study|Withdrawal by Subject|3|||
33266049|NCT04518410|62637160|FG022|Overall Study|Withdrawal by Subject|2|||
33266050|NCT04518410|62637161|FG023|Overall Study|Withdrawal by Subject|9|||
33266051|NCT04518410|62637162|FG024|Overall Study|Withdrawal by Subject|8|||
33266052|NCT04518410|62637138|FG000|Overall Study|Other|1|||
33266053|NCT04518410|62637139|FG001|Overall Study|Other|0|||
33266054|NCT04518410|62637140|FG002|Overall Study|Other|0|||
33266055|NCT04518410|62637141|FG003|Overall Study|Other|1|||
33266056|NCT04518410|62637142|FG004|Overall Study|Other|6|||
33266057|NCT04518410|62637143|FG005|Overall Study|Other|6|||
33266058|NCT04518410|62637144|FG006|Overall Study|Other|5|||
33266059|NCT04518410|62637145|FG007|Overall Study|Other|2|||
33266060|NCT04518410|62637146|FG008|Overall Study|Other|0|||
33266061|NCT04518410|62637147|FG009|Overall Study|Other|1|||
33266062|NCT04518410|62637148|FG010|Overall Study|Other|0|||
33266063|NCT04518410|62637149|FG011|Overall Study|Other|2|||
33266064|NCT04518410|62637150|FG012|Overall Study|Other|0|||
33266065|NCT04518410|62637151|FG013|Overall Study|Other|0|||
33266066|NCT04518410|62637152|FG014|Overall Study|Other|0|||
33266067|NCT04518410|62637153|FG015|Overall Study|Other|3|||
33266068|NCT04518410|62637154|FG016|Overall Study|Other|1|||
33266069|NCT04518410|62637155|FG017|Overall Study|Other|1|||
33266070|NCT04518410|62637156|FG018|Overall Study|Other|1|||
33266071|NCT04518410|62637157|FG019|Overall Study|Other|0|||
33266072|NCT04518410|62637158|FG020|Overall Study|Other|0|||
33266073|NCT04518410|62637159|FG021|Overall Study|Other|0|||
33266074|NCT04518410|62637160|FG022|Overall Study|Other|1|||
33266075|NCT04518410|62637161|FG023|Overall Study|Other|2|||
33266076|NCT04518410|62637162|FG024|Overall Study|Other|2|||
33266077|NCT04518410|62637138|FG000|Overall Study|Protocol Violation|0|||
33266078|NCT04518410|62637139|FG001|Overall Study|Protocol Violation|0|||
33266079|NCT04518410|62637140|FG002|Overall Study|Protocol Violation|0|||
33266080|NCT04518410|62637141|FG003|Overall Study|Protocol Violation|2|||
33266081|NCT04518410|62637142|FG004|Overall Study|Protocol Violation|17|||
33266082|NCT04518410|62637143|FG005|Overall Study|Protocol Violation|1|||
33266083|NCT04518410|62637144|FG006|Overall Study|Protocol Violation|2|||
33266084|NCT04518410|62637145|FG007|Overall Study|Protocol Violation|1|||
33266085|NCT04518410|62637146|FG008|Overall Study|Protocol Violation|0|||
33266086|NCT04518410|62637147|FG009|Overall Study|Protocol Violation|0|||
33266087|NCT04518410|62637148|FG010|Overall Study|Protocol Violation|0|||
33266088|NCT04518410|62637149|FG011|Overall Study|Protocol Violation|0|||
33266089|NCT04518410|62637150|FG012|Overall Study|Protocol Violation|0|||
33266090|NCT04518410|62637151|FG013|Overall Study|Protocol Violation|0|||
33266091|NCT04518410|62637152|FG014|Overall Study|Protocol Violation|0|||
33266092|NCT04518410|62637153|FG015|Overall Study|Protocol Violation|0|||
33266093|NCT04518410|62637154|FG016|Overall Study|Protocol Violation|1|||
33266094|NCT04518410|62637155|FG017|Overall Study|Protocol Violation|1|||
33266095|NCT04518410|62637156|FG018|Overall Study|Protocol Violation|0|||
33266096|NCT04518410|62637157|FG019|Overall Study|Protocol Violation|0|||
33266097|NCT04518410|62637158|FG020|Overall Study|Protocol Violation|1|||
33266098|NCT04518410|62637159|FG021|Overall Study|Protocol Violation|2|||
33266099|NCT04518410|62637160|FG022|Overall Study|Protocol Violation|0|||
33266100|NCT04518410|62637161|FG023|Overall Study|Protocol Violation|3|||
33266101|NCT04518410|62637162|FG024|Overall Study|Protocol Violation|0|||
33266102|NCT04518410|62637138|FG000|Overall Study|Death|0|||
33266103|NCT04518410|62637139|FG001|Overall Study|Death|0|||
33266104|NCT04518410|62637140|FG002|Overall Study|Death|0|||
33266105|NCT04518410|62637141|FG003|Overall Study|Death|0|||
33266106|NCT04518410|62637142|FG004|Overall Study|Death|12|||
33266107|NCT04518410|62637143|FG005|Overall Study|Death|2|||
33266108|NCT04518410|62637144|FG006|Overall Study|Death|11|||
33266109|NCT04518410|62637145|FG007|Overall Study|Death|0|||
33266110|NCT04518410|62637146|FG008|Overall Study|Death|1|||
33266111|NCT04518410|62637147|FG009|Overall Study|Death|0|||
33266112|NCT04518410|62637148|FG010|Overall Study|Death|0|||
33266113|NCT04518410|62637149|FG011|Overall Study|Death|0|||
33266114|NCT04518410|62637150|FG012|Overall Study|Death|0|||
33266115|NCT04518410|62637151|FG013|Overall Study|Death|1|||
33266116|NCT04518410|62637152|FG014|Overall Study|Death|1|||
33266117|NCT04518410|62637153|FG015|Overall Study|Death|0|||
33266118|NCT04518410|62637154|FG016|Overall Study|Death|0|||
33266119|NCT04518410|62637155|FG017|Overall Study|Death|1|||
33266120|NCT04518410|62637156|FG018|Overall Study|Death|3|||
33266121|NCT04518410|62637157|FG019|Overall Study|Death|4|||
33266122|NCT04518410|62637158|FG020|Overall Study|Death|1|||
33266123|NCT04518410|62637159|FG021|Overall Study|Death|0|||
33266124|NCT04518410|62637160|FG022|Overall Study|Death|0|||
33266125|NCT04518410|62637161|FG023|Overall Study|Death|0|||
33266126|NCT04518410|62637162|FG024|Overall Study|Death|0|||
33266127|NCT04518410|62637138|FG000|Overall Study|Requirement to start alternative therapy|0|||
33266128|NCT04518410|62637139|FG001|Overall Study|Requirement to start alternative therapy|0|||
33266129|NCT04518410|62637140|FG002|Overall Study|Requirement to start alternative therapy|1|||
33266130|NCT04518410|62637141|FG003|Overall Study|Requirement to start alternative therapy|0|||
33266131|NCT04518410|62637142|FG004|Overall Study|Requirement to start alternative therapy|0|||
33266132|NCT04518410|62637143|FG005|Overall Study|Requirement to start alternative therapy|0|||
33266133|NCT04518410|62637144|FG006|Overall Study|Requirement to start alternative therapy|0|||
33266134|NCT04518410|62637145|FG007|Overall Study|Requirement to start alternative therapy|0|||
33266135|NCT04518410|62637146|FG008|Overall Study|Requirement to start alternative therapy|0|||
33266136|NCT04518410|62637147|FG009|Overall Study|Requirement to start alternative therapy|0|||
33266137|NCT04518410|62637148|FG010|Overall Study|Requirement to start alternative therapy|0|||
33266138|NCT04518410|62637149|FG011|Overall Study|Requirement to start alternative therapy|0|||
33266139|NCT04518410|62637150|FG012|Overall Study|Requirement to start alternative therapy|0|||
33266140|NCT04518410|62637151|FG013|Overall Study|Requirement to start alternative therapy|0|||
33266141|NCT04518410|62637152|FG014|Overall Study|Requirement to start alternative therapy|0|||
33266142|NCT04518410|62637153|FG015|Overall Study|Requirement to start alternative therapy|0|||
33266143|NCT04518410|62637154|FG016|Overall Study|Requirement to start alternative therapy|0|||
33266144|NCT04518410|62637155|FG017|Overall Study|Requirement to start alternative therapy|0|||
33266145|NCT04518410|62637156|FG018|Overall Study|Requirement to start alternative therapy|0|||
33266146|NCT04518410|62637157|FG019|Overall Study|Requirement to start alternative therapy|0|||
33266147|NCT04518410|62637158|FG020|Overall Study|Requirement to start alternative therapy|0|||
33266148|NCT04518410|62637159|FG021|Overall Study|Requirement to start alternative therapy|0|||
33266149|NCT04518410|62637160|FG022|Overall Study|Requirement to start alternative therapy|1|||
33266150|NCT04518410|62637161|FG023|Overall Study|Requirement to start alternative therapy|0|||
33266151|NCT04518410|62637162|FG024|Overall Study|Requirement to start alternative therapy|0|||
33266152|NCT04518410|62637138|FG000|Overall Study|Ongoing in study|0|||
33266153|NCT04518410|62637139|FG001|Overall Study|Ongoing in study|0|||
33266154|NCT04518410|62637140|FG002|Overall Study|Ongoing in study|0|||
33266155|NCT04518410|62637141|FG003|Overall Study|Ongoing in study|0|||
33266156|NCT04518410|62637142|FG004|Overall Study|Ongoing in study|0|||
33266157|NCT04518410|62637143|FG005|Overall Study|Ongoing in study|0|||
33266158|NCT04518410|62637144|FG006|Overall Study|Ongoing in study|0|||
33266159|NCT04518410|62637145|FG007|Overall Study|Ongoing in study|0|||
33266160|NCT04518410|62637146|FG008|Overall Study|Ongoing in study|0|||
33266161|NCT04518410|62637147|FG009|Overall Study|Ongoing in study|0|||
33266162|NCT04518410|62637148|FG010|Overall Study|Ongoing in study|0|||
33266163|NCT04518410|62637149|FG011|Overall Study|Ongoing in study|0|||
33266164|NCT04518410|62637150|FG012|Overall Study|Ongoing in study|0|||
33266165|NCT04518410|62637151|FG013|Overall Study|Ongoing in study|0|||
33266166|NCT04518410|62637152|FG014|Overall Study|Ongoing in study|0|||
33266167|NCT04518410|62637153|FG015|Overall Study|Ongoing in study|0|||
33266168|NCT04518410|62637154|FG016|Overall Study|Ongoing in study|0|||
33266169|NCT04518410|62637155|FG017|Overall Study|Ongoing in study|193|||
33266170|NCT04518410|62637156|FG018|Overall Study|Ongoing in study|173|||
33266171|NCT04518410|62637157|FG019|Overall Study|Ongoing in study|50|||
33266172|NCT04518410|62637158|FG020|Overall Study|Ongoing in study|65|||
33266173|NCT04518410|62637159|FG021|Overall Study|Ongoing in study|0|||
33266174|NCT04518410|62637160|FG022|Overall Study|Ongoing in study|0|||
33266175|NCT04518410|62637161|FG023|Overall Study|Ongoing in study|0|||
33266176|NCT04518410|62637162|FG024|Overall Study|Ongoing in study|0|||
33266177|NCT04518410|62637138|FG000|Overall Study|Randomized but not treated|0|||
33266178|NCT04518410|62637139|FG001|Overall Study|Randomized but not treated|0|||
33266179|NCT04518410|62637140|FG002|Overall Study|Randomized but not treated|0|||
33266180|NCT04518410|62637141|FG003|Overall Study|Randomized but not treated|2|||
33266181|NCT04518410|62637142|FG004|Overall Study|Randomized but not treated|6|||
33266182|NCT04518410|62637143|FG005|Overall Study|Randomized but not treated|6|||
33266183|NCT04518410|62637144|FG006|Overall Study|Randomized but not treated|3|||
33266184|NCT04518410|62637145|FG007|Overall Study|Randomized but not treated|3|||
33266185|NCT04518410|62637146|FG008|Overall Study|Randomized but not treated|0|||
33266186|NCT04518410|62637147|FG009|Overall Study|Randomized but not treated|4|||
33266187|NCT04518410|62637148|FG010|Overall Study|Randomized but not treated|0|||
33266188|NCT04518410|62637149|FG011|Overall Study|Randomized but not treated|0|||
33266189|NCT04518410|62637150|FG012|Overall Study|Randomized but not treated|1|||
33266190|NCT04518410|62637151|FG013|Overall Study|Randomized but not treated|4|||
33266191|NCT04518410|62637152|FG014|Overall Study|Randomized but not treated|3|||
33266192|NCT04518410|62637153|FG015|Overall Study|Randomized but not treated|3|||
33266193|NCT04518410|62637154|FG016|Overall Study|Randomized but not treated|4|||
33266194|NCT04518410|62637155|FG017|Overall Study|Randomized but not treated|6|||
33266195|NCT04518410|62637156|FG018|Overall Study|Randomized but not treated|4|||
33266196|NCT04518410|62637157|FG019|Overall Study|Randomized but not treated|0|||
33266197|NCT04518410|62637158|FG020|Overall Study|Randomized but not treated|0|||
33266198|NCT04518410|62637159|FG021|Overall Study|Randomized but not treated|5|||
33266199|NCT04518410|62637160|FG022|Overall Study|Randomized but not treated|0|||
33266200|NCT04518410|62637161|FG023|Overall Study|Randomized but not treated|3|||
33266201|NCT04518410|62637162|FG024|Overall Study|Randomized but not treated|1|||
33266202|NCT04518410|62637138|FG000|Overall Study|Screen Fail but Randomized|0|||
33266203|NCT04518410|62637139|FG001|Overall Study|Screen Fail but Randomized|0|||
33266204|NCT04518410|62637140|FG002|Overall Study|Screen Fail but Randomized|0|||
33266205|NCT04518410|62637141|FG003|Overall Study|Screen Fail but Randomized|0|||
33266206|NCT04518410|62637142|FG004|Overall Study|Screen Fail but Randomized|2|||
33266207|NCT04518410|62637143|FG005|Overall Study|Screen Fail but Randomized|0|||
33266208|NCT04518410|62637144|FG006|Overall Study|Screen Fail but Randomized|0|||
33266209|NCT04518410|62637145|FG007|Overall Study|Screen Fail but Randomized|0|||
33266210|NCT04518410|62637146|FG008|Overall Study|Screen Fail but Randomized|0|||
33266211|NCT04518410|62637147|FG009|Overall Study|Screen Fail but Randomized|0|||
33266212|NCT04518410|62637148|FG010|Overall Study|Screen Fail but Randomized|0|||
33266213|NCT04518410|62637149|FG011|Overall Study|Screen Fail but Randomized|0|||
33266214|NCT04518410|62637150|FG012|Overall Study|Screen Fail but Randomized|0|||
33266215|NCT04518410|62637151|FG013|Overall Study|Screen Fail but Randomized|0|||
33266216|NCT04518410|62637152|FG014|Overall Study|Screen Fail but Randomized|0|||
33266217|NCT04518410|62637153|FG015|Overall Study|Screen Fail but Randomized|0|||
33266218|NCT04518410|62637154|FG016|Overall Study|Screen Fail but Randomized|0|||
33266219|NCT04518410|62637155|FG017|Overall Study|Screen Fail but Randomized|0|||
33266220|NCT04518410|62637156|FG018|Overall Study|Screen Fail but Randomized|0|||
33266221|NCT04518410|62637157|FG019|Overall Study|Screen Fail but Randomized|0|||
33266222|NCT04518410|62637158|FG020|Overall Study|Screen Fail but Randomized|0|||
33266223|NCT04518410|62637159|FG021|Overall Study|Screen Fail but Randomized|0|||
33266224|NCT04518410|62637160|FG022|Overall Study|Screen Fail but Randomized|0|||
33266225|NCT04518410|62637161|FG023|Overall Study|Screen Fail but Randomized|0|||
33266226|NCT04518410|62637162|FG024|Overall Study|Screen Fail but Randomized|0|||
33266227|NCT04518410|62637138|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266228|NCT04518410|62637139|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266229|NCT04518410|62637140|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266230|NCT04518410|62637141|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266231|NCT04518410|62637142|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
33266232|NCT04518410|62637143|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
33266233|NCT04518410|62637144|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|9|||
33266234|NCT04518410|62637145|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266235|NCT04518410|62637146|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
33266236|NCT04518410|62637147|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266237|NCT04518410|62637148|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266238|NCT04518410|62637149|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266239|NCT04518410|62637150|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266240|NCT04518410|62637151|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266241|NCT04518410|62637152|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266242|NCT04518410|62637153|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266243|NCT04518410|62637154|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266244|NCT04518410|62637155|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266245|NCT04518410|62637156|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266246|NCT04518410|62637157|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266247|NCT04518410|62637158|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33368335|NCT00819585|62747237|FG007|Core Study|Lost to Follow-up|0|||
33368336|NCT00819585|62747238|FG008|Core Study|Lost to Follow-up|0|||
33368337|NCT00819585|62747239|FG009|Core Study|Lost to Follow-up|0|||
33368338|NCT00819585|62747240|FG010|Core Study|Lost to Follow-up|0|||
33368339|NCT00819585|62747230|FG000|Core Study|Administrative Problems|0|||
33368340|NCT00819585|62747231|FG001|Core Study|Administrative Problems|0|||
33368341|NCT00819585|62747232|FG002|Core Study|Administrative Problems|0|||
33368342|NCT00819585|62747233|FG003|Core Study|Administrative Problems|0|||
33368343|NCT00819585|62747234|FG004|Core Study|Administrative Problems|0|||
33368344|NCT00819585|62747235|FG005|Core Study|Administrative Problems|0|||
33368345|NCT00819585|62747236|FG006|Core Study|Administrative Problems|2|||
33368346|NCT00819585|62747237|FG007|Core Study|Administrative Problems|0|||
33368347|NCT00819585|62747238|FG008|Core Study|Administrative Problems|0|||
33368348|NCT00819585|62747239|FG009|Core Study|Administrative Problems|0|||
33484793|NCT03297398|62861771|FG001|Overall Study|Protocol Violation|2|||
33484794|NCT03297398|62861772|FG002|Overall Study|Protocol Violation|0|||
33484795|NCT03297398|62861770|FG000|Overall Study|Physician Decision|0|||
33484796|NCT03297398|62861771|FG001|Overall Study|Physician Decision|0|||
33484797|NCT03297398|62861772|FG002|Overall Study|Physician Decision|1|||
33661811|NCT01697579|63091445|FG001|Base Study-Cycle 1|Technical Problems|0|||
33266248|NCT04518410|62637159|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266249|NCT04518410|62637160|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33266250|NCT04518410|62637161|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
33266251|NCT04518410|62637162|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
33266252|NCT04518410|62637138|FG000|Overall Study|Dual Enrolled Subject|0|||
33266253|NCT04518410|62637139|FG001|Overall Study|Dual Enrolled Subject|0|||
33266254|NCT04518410|62637140|FG002|Overall Study|Dual Enrolled Subject|0|||
33266255|NCT04518410|62637141|FG003|Overall Study|Dual Enrolled Subject|0|||
33266256|NCT04518410|62637142|FG004|Overall Study|Dual Enrolled Subject|0|||
33266257|NCT04518410|62637143|FG005|Overall Study|Dual Enrolled Subject|0|||
33266258|NCT04518410|62637144|FG006|Overall Study|Dual Enrolled Subject|0|||
33266259|NCT04518410|62637145|FG007|Overall Study|Dual Enrolled Subject|0|||
33266260|NCT04518410|62637146|FG008|Overall Study|Dual Enrolled Subject|0|||
33266261|NCT04518410|62637147|FG009|Overall Study|Dual Enrolled Subject|0|||
33266262|NCT04518410|62637148|FG010|Overall Study|Dual Enrolled Subject|0|||
33266263|NCT04518410|62637149|FG011|Overall Study|Dual Enrolled Subject|0|||
33266264|NCT04518410|62637150|FG012|Overall Study|Dual Enrolled Subject|0|||
33266265|NCT04518410|62637151|FG013|Overall Study|Dual Enrolled Subject|0|||
33266266|NCT04518410|62637152|FG014|Overall Study|Dual Enrolled Subject|0|||
33266267|NCT04518410|62637153|FG015|Overall Study|Dual Enrolled Subject|0|||
33266268|NCT04518410|62637154|FG016|Overall Study|Dual Enrolled Subject|0|||
33266269|NCT04518410|62637155|FG017|Overall Study|Dual Enrolled Subject|1|||
33266270|NCT04518410|62637156|FG018|Overall Study|Dual Enrolled Subject|0|||
33266271|NCT04518410|62637157|FG019|Overall Study|Dual Enrolled Subject|0|||
33266272|NCT04518410|62637158|FG020|Overall Study|Dual Enrolled Subject|0|||
33266273|NCT04518410|62637159|FG021|Overall Study|Dual Enrolled Subject|0|||
33266274|NCT04518410|62637160|FG022|Overall Study|Dual Enrolled Subject|0|||
33266275|NCT04518410|62637161|FG023|Overall Study|Dual Enrolled Subject|0|||
33266276|NCT04518410|62637162|FG024|Overall Study|Dual Enrolled Subject|0|||
33266277|NCT04517864|62637222|FG000|Placebo-Controlled Phase|Adverse Event|1|||
33266278|NCT04517864|62637223|FG001|Placebo-Controlled Phase|Adverse Event|0|||
33266279|NCT04517864|62637222|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
33266280|NCT04517864|62637223|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
33266281|NCT04517864|62637222|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
33266282|NCT04517864|62637223|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
33266283|NCT04517864|62637222|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
33266284|NCT04517864|62637223|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
33266285|NCT04517864|62637222|FG000|Active Therapy Extension Phase|Adverse Event|1|||
33266286|NCT04517864|62637223|FG001|Active Therapy Extension Phase|Adverse Event|0|||
33266287|NCT04507204|62637244|FG000|Overall Study|Adverse Event|8|||
33266288|NCT04507204|62637245|FG001|Overall Study|Adverse Event|13|||
33266289|NCT04507204|62637244|FG000|Overall Study|Death|0|||
33266290|NCT04507204|62637245|FG001|Overall Study|Death|1|||
33266291|NCT04507204|62637244|FG000|Overall Study|Lost to Follow-up|15|||
33266292|NCT04507204|62637245|FG001|Overall Study|Lost to Follow-up|14|||
33266293|NCT04507204|62637244|FG000|Overall Study|Poor Compliance with Protocol|2|||
33266294|NCT04507204|62637245|FG001|Overall Study|Poor Compliance with Protocol|4|||
33266295|NCT04507204|62637244|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
33266296|NCT04507204|62637245|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
33266297|NCT04507204|62637244|FG000|Overall Study|Withdrawal of Patient Consent|21|||
33266298|NCT04507204|62637245|FG001|Overall Study|Withdrawal of Patient Consent|13|||
33266299|NCT04158648|62637269|FG000|Overall Study|Ongoing in the Study|69|||
33266300|NCT04158648|62637269|FG000|Overall Study|Withdrawal by Subject|4|||
33266301|NCT04135937|62637276|FG000|Overall Study|Lost to Follow-up|2|||
33266302|NCT04135937|62637276|FG000|Overall Study|Withdrawal by Subject|1|||
33266303|NCT04060147|62637280|FG000|Overall Study|Withdrew consent|1|||
33266304|NCT04045132|62637286|FG000|Overall Study|Lost to Follow-up|3|||
33266305|NCT04045132|62637287|FG001|Overall Study|Lost to Follow-up|6|||
33266306|NCT04019041|62637325|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
33266307|NCT04019041|62637326|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
33266308|NCT04019041|62637327|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
33266309|NCT04019041|62637328|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
33266310|NCT04019041|62637329|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
33266311|NCT04019041|62637330|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
33266312|NCT04019041|62637325|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
33266313|NCT04019041|62637326|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
33266314|NCT04019041|62637327|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
33266315|NCT04019041|62637328|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
33266316|NCT04019041|62637329|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
33266317|NCT04019041|62637330|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
33266318|NCT04019041|62637325|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
33266319|NCT04019041|62637326|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
33266320|NCT04019041|62637327|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
33266321|NCT04019041|62637328|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
33266322|NCT04019041|62637329|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
33266323|NCT04019041|62637330|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
33266324|NCT04019041|62637325|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
33266325|NCT04019041|62637326|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
33266326|NCT04019041|62637327|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
33266327|NCT04019041|62637328|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
33266328|NCT04019041|62637329|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
33266329|NCT04019041|62637330|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
33266330|NCT04019041|62637325|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
33266331|NCT04019041|62637326|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
33266332|NCT04019041|62637327|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
33266333|NCT04019041|62637328|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
33266334|NCT04019041|62637329|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
33266335|NCT04019041|62637330|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
33266336|NCT04019041|62637325|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
33266337|NCT04019041|62637326|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
33266338|NCT04019041|62637327|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
33266339|NCT04019041|62637328|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
33266340|NCT04019041|62637329|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
33266341|NCT04019041|62637330|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
33266342|NCT04019041|62637325|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
33266343|NCT04019041|62637326|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
33266344|NCT04019041|62637327|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
33266345|NCT04019041|62637328|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
33266346|NCT04019041|62637329|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
33266347|NCT04019041|62637330|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
33266348|NCT04019041|62637325|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
33266349|NCT04019041|62637326|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
33266350|NCT04019041|62637327|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
33266351|NCT04019041|62637328|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
33266352|NCT04019041|62637329|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
33266353|NCT04019041|62637330|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
33266354|NCT04019041|62637325|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
33266355|NCT04019041|62637326|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
33266356|NCT04019041|62637327|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
33266357|NCT04019041|62637328|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
33266358|NCT04019041|62637329|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
33266359|NCT04019041|62637330|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
33266360|NCT03919448|62637359|FG000|Overall Study|Withdrawal by Subject|1|||
33266361|NCT03919448|62637360|FG001|Overall Study|Withdrawal by Subject|0|||
33266362|NCT03919448|62637361|FG002|Overall Study|Withdrawal by Subject|0|||
33266363|NCT03795922|62637388|FG000|Overall Study|Adverse Event|2|||
33266364|NCT03795922|62637389|FG001|Overall Study|Adverse Event|1|||
33266365|NCT03795922|62637388|FG000|Overall Study|Withdrawal by Subject|5|||
33266366|NCT03795922|62637389|FG001|Overall Study|Withdrawal by Subject|13|||
33266367|NCT03795922|62637388|FG000|Overall Study|Lost to Follow-up|2|||
33266368|NCT03795922|62637389|FG001|Overall Study|Lost to Follow-up|3|||
33266369|NCT03795922|62637388|FG000|Overall Study|Pregnancy|0|||
33266370|NCT03795922|62637389|FG001|Overall Study|Pregnancy|1|||
33266371|NCT03795922|62637388|FG000|Overall Study|Physician Decision|1|||
33266372|NCT03795922|62637389|FG001|Overall Study|Physician Decision|2|||
33266373|NCT03795922|62637388|FG000|Overall Study|Protocol Violation|0|||
33266374|NCT03795922|62637389|FG001|Overall Study|Protocol Violation|1|||
33266375|NCT03795922|62637388|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
33266376|NCT03795922|62637389|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
33266377|NCT03794089|62637399|FG000|Overall Study|Lost to Follow-up|4|||
33266378|NCT03794089|62637400|FG001|Overall Study|Lost to Follow-up|1|||
33266379|NCT03794089|62637399|FG000|Overall Study|Withdrawal by Subject|2|||
33266380|NCT03794089|62637400|FG001|Overall Study|Withdrawal by Subject|0|||
33266381|NCT03769025|62637408|FG000|Overall Study|Withdrawal by Subject|1|||
33266382|NCT03769025|62637409|FG001|Overall Study|Withdrawal by Subject|1|||
33266383|NCT03769025|62637408|FG000|Overall Study|Lost to Follow-up|4|||
33266384|NCT03769025|62637409|FG001|Overall Study|Lost to Follow-up|3|||
33266385|NCT03762473|62637417|FG000|Overall Study|Death|1|||
33266386|NCT03762473|62637418|FG001|Overall Study|Death|0|||
33266387|NCT03761056|62637424|FG000|Overall Study|Still on Study|34|||
33266388|NCT03761056|62637424|FG000|Overall Study|Death|6|||
33266389|NCT03761056|62637424|FG000|Overall Study|Investigator Decision|1|||
33266390|NCT03761056|62637424|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1|||
33266391|NCT03759366|62637430|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1|||
33266392|NCT03759366|62637430|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10|||
33266393|NCT03745989|62637437|FG000|Overall Study|Death|3|||
33266394|NCT03745989|62637438|FG001|Overall Study|Death|7|||
33266395|NCT03745989|62637439|FG002|Overall Study|Death|4|||
33266396|NCT03745989|62637437|FG000|Overall Study|Lost to Follow-up|0|||
33266397|NCT03745989|62637438|FG001|Overall Study|Lost to Follow-up|2|||
33266398|NCT03745989|62637439|FG002|Overall Study|Lost to Follow-up|0|||
33266399|NCT03745989|62637437|FG000|Overall Study|Sponsor Decision|0|||
33266400|NCT03745989|62637438|FG001|Overall Study|Sponsor Decision|2|||
33266401|NCT03745989|62637439|FG002|Overall Study|Sponsor Decision|8|||
33266402|NCT03745989|62637437|FG000|Overall Study|Withdrawal by Subject|0|||
33266403|NCT03745989|62637438|FG001|Overall Study|Withdrawal by Subject|1|||
33266404|NCT03745989|62637439|FG002|Overall Study|Withdrawal by Subject|3|||
33266405|NCT03646656|62637469|FG000|Overall Study|Lost to Follow-up|1|||
33266406|NCT03646656|62637470|FG001|Overall Study|Lost to Follow-up|0|||
33266407|NCT03646656|62637469|FG000|Overall Study|Withdrawal by Subject|2|||
33266408|NCT03646656|62637470|FG001|Overall Study|Withdrawal by Subject|0|||
33266409|NCT03555435|62637483|FG000|Overall Study|Lost to Follow-up|17|||
33266410|NCT03555435|62637484|FG001|Overall Study|Lost to Follow-up|19|||
33266411|NCT03555435|62637485|FG002|Overall Study|Lost to Follow-up|8|||
33266412|NCT03521115|62637495|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
33266413|NCT03521115|62637496|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
33266414|NCT03521115|62637495|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
33266415|NCT03521115|62637496|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
33266416|NCT03520413|62637510|FG000|Overall Study|Lost to Follow-up|1|||
33266417|NCT03520413|62637511|FG001|Overall Study|Lost to Follow-up|1|||
33266418|NCT03520413|62637510|FG000|Overall Study|Withdrawal by Subject|1|||
33266419|NCT03520413|62637511|FG001|Overall Study|Withdrawal by Subject|2|||
33266420|NCT03520413|62637510|FG000|Overall Study|Death|0|||
33266421|NCT03520413|62637511|FG001|Overall Study|Death|1|||
33266422|NCT03520413|62637510|FG000|Overall Study|Physician Decision|3|||
33266423|NCT03520413|62637511|FG001|Overall Study|Physician Decision|3|||
33266424|NCT03520413|62637510|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
33266425|NCT03520413|62637511|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
33266426|NCT03419897|62637518|FG000|Overall Study|Death|180|||
33266427|NCT03419897|62637518|FG000|Overall Study|Lost to Follow-up|1|||
33266428|NCT03419897|62637518|FG000|Overall Study|Withdrawal by Subject|6|||
33266429|NCT03419897|62637518|FG000|Overall Study|Sponsor Decision|61|||
33266430|NCT03419897|62637518|FG000|Overall Study|Physician Decision|1|||
33266431|NCT03418129|62637525|FG000|Overall Study|Lost to Follow-up|11|||
33266432|NCT03418129|62637526|FG001|Overall Study|Lost to Follow-up|20|||
33266433|NCT03418129|62637527|FG002|Overall Study|Lost to Follow-up|15|||
33266434|NCT03418129|62637525|FG000|Overall Study|Withdrawal by Subject|3|||
33266435|NCT03418129|62637526|FG001|Overall Study|Withdrawal by Subject|6|||
33266436|NCT03418129|62637527|FG002|Overall Study|Withdrawal by Subject|4|||
33266437|NCT03344796|62637545|FG000|Overall Study|Lost to Follow-up|0|||
33266438|NCT03344796|62637546|FG001|Overall Study|Lost to Follow-up|0|||
33266439|NCT03344796|62637547|FG002|Overall Study|Lost to Follow-up|0|||
33266440|NCT03344796|62637548|FG003|Overall Study|Lost to Follow-up|0|||
33266441|NCT03344796|62637549|FG004|Overall Study|Lost to Follow-up|0|||
33266442|NCT03344796|62637550|FG005|Overall Study|Lost to Follow-up|2|||
33266443|NCT03335488|62637573|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
33266444|NCT03335488|62637574|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
33266445|NCT03335488|62637573|FG000|Safety Extension Period|Adverse Event|1|||
33266446|NCT03335488|62637574|FG001|Safety Extension Period|Adverse Event|0|||
33266447|NCT03335488|62637573|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
33266448|NCT03335488|62637574|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
33266449|NCT03261700|62637593|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
33266450|NCT03261700|62637594|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
33266451|NCT03238417|62637605|FG000|Overall|non-response|955|||
33266452|NCT03238417|62637606|FG001|Overall|non-response|1920|||
33266453|NCT03238417|62637605|FG000|Overall|partial completion|48|||
33266454|NCT03238417|62637606|FG001|Overall|partial completion|68|||
33266455|NCT03238417|62637605|FG000|Baseline|Partial completion|17|||
33266456|NCT03238417|62637606|FG001|Baseline|Partial completion|48|||
33266457|NCT03238417|62637605|FG000|Baseline|non-response|372|||
33266458|NCT03238417|62637606|FG001|Baseline|non-response|669|||
33266459|NCT03238417|62637605|FG000|12-month|non-response|296|||
33266460|NCT03238417|62637606|FG001|12-month|non-response|669|||
33266461|NCT03238417|62637605|FG000|12-month|partial completion|23|||
33266462|NCT03238417|62637606|FG001|12-month|partial completion|37|||
33266463|NCT03238417|62637605|FG000|24-month|non-response|287|||
33266464|NCT03238417|62637606|FG001|24-month|non-response|594|||
33266465|NCT03238417|62637605|FG000|24-month|partial completion|8|||
33266466|NCT03238417|62637606|FG001|24-month|partial completion|31|||
33266467|NCT03215277|62637614|FG000|Overall Study|Adverse Event|2|||
33266468|NCT03215277|62637615|FG001|Overall Study|Adverse Event|3|||
33266469|NCT03215277|62637614|FG000|Overall Study|Death|1|||
33266470|NCT03215277|62637615|FG001|Overall Study|Death|0|||
33266471|NCT03215277|62637614|FG000|Overall Study|Lost to Follow-up|0|||
33266472|NCT03215277|62637615|FG001|Overall Study|Lost to Follow-up|1|||
33266473|NCT03215277|62637614|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
33266474|NCT03215277|62637615|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
33266475|NCT03185013|62637625|FG000|Overall Study|Withdrawal by Subject|5|||
33266476|NCT03185013|62637626|FG001|Overall Study|Withdrawal by Subject|3|||
33266477|NCT03185013|62637625|FG000|Overall Study|Adverse Event|1|||
33266478|NCT03185013|62637626|FG001|Overall Study|Adverse Event|0|||
33266479|NCT03185013|62637625|FG000|Overall Study|Progressive Disease|1|||
33266480|NCT03185013|62637626|FG001|Overall Study|Progressive Disease|0|||
33266481|NCT03185013|62637625|FG000|Overall Study|Lost to Follow-up|8|||
33266482|NCT03185013|62637626|FG001|Overall Study|Lost to Follow-up|2|||
33266483|NCT03185013|62637625|FG000|Overall Study|Physician Decision|1|||
33266484|NCT03185013|62637626|FG001|Overall Study|Physician Decision|0|||
33266485|NCT03185013|62637625|FG000|Overall Study|Protocol Deviation|2|||
33266486|NCT03185013|62637626|FG001|Overall Study|Protocol Deviation|0|||
33266487|NCT03185013|62637625|FG000|Overall Study|Reason not Specified|3|||
33266488|NCT03185013|62637626|FG001|Overall Study|Reason not Specified|2|||
33266489|NCT03185013|62637625|FG000|Overall Study|Death|1|||
33266490|NCT03185013|62637626|FG001|Overall Study|Death|0|||
33266491|NCT03182907|62637634|FG000|Overall Study|Death|3|||
33266492|NCT03182907|62637635|FG001|Overall Study|Death|0|||
33266493|NCT03182907|62637634|FG000|Overall Study|Protocol Violation|4|||
33266494|NCT03182907|62637635|FG001|Overall Study|Protocol Violation|0|||
33266495|NCT03182907|62637634|FG000|Overall Study|Lost to Follow-up|1|||
33266496|NCT03182907|62637635|FG001|Overall Study|Lost to Follow-up|0|||
33266497|NCT03182907|62637634|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33266498|NCT03182907|62637635|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
33266499|NCT03126019|62637646|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
33266500|NCT03126019|62637647|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
33266501|NCT03126019|62637646|FG000|Overall Study|Death|2|||
33266502|NCT03126019|62637647|FG001|Overall Study|Death|7|||
33266503|NCT03126019|62637646|FG000|Overall Study|Lost to Follow-up|2|||
33266504|NCT03126019|62637647|FG001|Overall Study|Lost to Follow-up|3|||
33266505|NCT03126019|62637646|FG000|Overall Study|Withdrawal by Participant|1|||
33266506|NCT03126019|62637647|FG001|Overall Study|Withdrawal by Participant|3|||
33266507|NCT03126019|62637646|FG000|Overall Study|Reason not Specified|1|||
33266508|NCT03126019|62637647|FG001|Overall Study|Reason not Specified|3|||
33266509|NCT03036813|62637657|FG000|Overall Study|Adverse Event|6|||
33266510|NCT03036813|62637658|FG001|Overall Study|Adverse Event|11|||
33266511|NCT03036813|62637659|FG002|Overall Study|Adverse Event|6|||
33266512|NCT03036813|62637657|FG000|Overall Study|Withdrawal by Subject|12|||
33266513|NCT03036813|62637658|FG001|Overall Study|Withdrawal by Subject|6|||
33266514|NCT03036813|62637659|FG002|Overall Study|Withdrawal by Subject|10|||
33266515|NCT03036813|62637657|FG000|Overall Study|Lost to Follow-up|1|||
33266516|NCT03036813|62637658|FG001|Overall Study|Lost to Follow-up|1|||
33266517|NCT03036813|62637659|FG002|Overall Study|Lost to Follow-up|0|||
33266518|NCT03036813|62637657|FG000|Overall Study|Physician Decision|2|||
33266519|NCT03036813|62637658|FG001|Overall Study|Physician Decision|1|||
33266520|NCT03036813|62637659|FG002|Overall Study|Physician Decision|1|||
33266521|NCT03036813|62637657|FG000|Overall Study|Non-Compliance|1|||
33266522|NCT03036813|62637658|FG001|Overall Study|Non-Compliance|5|||
33266523|NCT03036813|62637659|FG002|Overall Study|Non-Compliance|3|||
33266524|NCT03036813|62637657|FG000|Overall Study|Pregnancy|0|||
33266525|NCT03036813|62637658|FG001|Overall Study|Pregnancy|0|||
33266526|NCT03036813|62637659|FG002|Overall Study|Pregnancy|1|||
33266527|NCT03036813|62637657|FG000|Overall Study|Other|0|||
33266528|NCT03036813|62637658|FG001|Overall Study|Other|3|||
33266529|NCT03036813|62637659|FG002|Overall Study|Other|5|||
33266530|NCT03007953|62637672|FG000|Overall Study|Withdrawal by Subject|5|||
33266531|NCT03007953|62637673|FG001|Overall Study|Withdrawal by Subject|2|||
33266532|NCT03007953|62637672|FG000|Overall Study|Death|5|||
33266533|NCT03007953|62637673|FG001|Overall Study|Death|7|||
33266534|NCT03007953|62637672|FG000|Overall Study|Lost to Follow-up|3|||
33266535|NCT03007953|62637673|FG001|Overall Study|Lost to Follow-up|2|||
33266536|NCT03007953|62637672|FG000|Overall Study|Enrolled in Hospice|3|||
33266537|NCT03007953|62637673|FG001|Overall Study|Enrolled in Hospice|2|||
33266538|NCT02919618|62637688|FG000|Overall Study|Death|1|||
33266539|NCT02911701|62637705|FG000|Overall Study|Withdrawal by Subject|2|||
33266540|NCT02911701|62637706|FG001|Overall Study|Withdrawal by Subject|4|||
33266541|NCT02911701|62637705|FG000|Overall Study|Adverse Event|1|||
33266542|NCT02911701|62637706|FG001|Overall Study|Adverse Event|0|||
33266543|NCT02903368|62637714|FG000|Overall Study|Adverse Event|3|||
33266544|NCT02903368|62637715|FG001|Overall Study|Adverse Event|0|||
33266545|NCT02903368|62637714|FG000|Overall Study|Withdrawal by Subject|1|||
33266546|NCT02903368|62637715|FG001|Overall Study|Withdrawal by Subject|0|||
33266547|NCT02896257|62637725|FG000|Providers|Without eligible patients|21|||
33266548|NCT02896257|62637726|FG001|Providers|Without eligible patients|28|||
33266549|NCT02896257|62637725|FG000|Patients|PFT entry criteria not met|43|||
33266550|NCT02896257|62637726|FG001|Patients|PFT entry criteria not met|50|||
33266551|NCT02896257|62637725|FG000|Patients|No capacity to review|8|||
33266552|NCT02896257|62637726|FG001|Patients|No capacity to review|11|||
33266553|NCT02896257|62637725|FG000|Patients|Appointment rescheduled/cancelled|5|||
33266554|NCT02896257|62637726|FG001|Patients|Appointment rescheduled/cancelled|7|||
33266555|NCT02896257|62637725|FG000|Patients|PCP not assigned a clinic|4|||
33266556|NCT02896257|62637726|FG001|Patients|PCP not assigned a clinic|0|||
33266557|NCT02896257|62637725|FG000|Patients|No history of COPD|0|||
33266558|NCT02896257|62637726|FG001|Patients|No history of COPD|1|||
33266559|NCT02896257|62637725|FG000|Patients|Deceased between review and index date|0|||
33266560|NCT02896257|62637726|FG001|Patients|Deceased between review and index date|1|||
33266561|NCT02896257|62637725|FG000|Patients|No ICS Rx upon review|1|||
33266562|NCT02896257|62637726|FG001|Patients|No ICS Rx upon review|1|||
33266563|NCT02896257|62637725|FG000|Patients|Protocol Violation|2|||
33266564|NCT02896257|62637726|FG001|Patients|Protocol Violation|1|||
33266565|NCT02896257|62637725|FG000|Patients|Hospice care|0|||
33266566|NCT02896257|62637726|FG001|Patients|Hospice care|1|||
33266567|NCT02874742|62637736|FG000|Overall Study|Death|0|||
33266568|NCT02874742|62637737|FG001|Overall Study|Death|1|||
33266569|NCT02874742|62637738|FG002|Overall Study|Death|0|||
33266570|NCT02874742|62637736|FG000|Overall Study|Lost to Follow-up|5|||
33266571|NCT02874742|62637737|FG001|Overall Study|Lost to Follow-up|4|||
33266572|NCT02874742|62637738|FG002|Overall Study|Lost to Follow-up|1|||
33266573|NCT02874742|62637736|FG000|Overall Study|Withdrawal by Subject|17|||
33266574|NCT02874742|62637737|FG001|Overall Study|Withdrawal by Subject|8|||
33266575|NCT02874742|62637738|FG002|Overall Study|Withdrawal by Subject|0|||
33266576|NCT02874742|62637736|FG000|Overall Study|Other|4|||
33266577|NCT02874742|62637737|FG001|Overall Study|Other|1|||
33266578|NCT02874742|62637738|FG002|Overall Study|Other|0|||
33266579|NCT02874742|62637736|FG000|Overall Study|Progressive Disease|1|||
33266580|NCT02874742|62637737|FG001|Overall Study|Progressive Disease|0|||
33266581|NCT02874742|62637738|FG002|Overall Study|Progressive Disease|0|||
33266582|NCT02874742|62637736|FG000|Overall Study|Screen Failure|0|||
33266583|NCT02874742|62637737|FG001|Overall Study|Screen Failure|2|||
33266584|NCT02874742|62637738|FG002|Overall Study|Screen Failure|0|||
33266585|NCT02749292|62637748|FG000|Overall Study|Physician Decision|1|||
33266586|NCT02749292|62637749|FG001|Overall Study|Physician Decision|0|||
33266587|NCT02749292|62637748|FG000|Overall Study|Withdrawal by Subject|5|||
33266588|NCT02749292|62637749|FG001|Overall Study|Withdrawal by Subject|7|||
33266589|NCT02749292|62637748|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
33266590|NCT02749292|62637749|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
33266591|NCT02749292|62637748|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
33266592|NCT02749292|62637749|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
33484798|NCT03297398|62861770|FG000|Overall Study|Lost to Follow-up|0|||
33484799|NCT03297398|62861771|FG001|Overall Study|Lost to Follow-up|0|||
33484800|NCT03297398|62861772|FG002|Overall Study|Lost to Follow-up|1|||
33484801|NCT03293654|62861783|FG000|Overall Study|Lost to Follow-up|0|||
33484802|NCT03293654|62861784|FG001|Overall Study|Lost to Follow-up|1|||
33484803|NCT03293654|62861785|FG002|Overall Study|Lost to Follow-up|0|||
33484804|NCT03312218|62861795|FG000|Overall Study|Never signed in to access the app|54|||
33484805|NCT03312218|62861796|FG001|Overall Study|Never signed in to access the app|58|||
33484806|NCT03930615|62861804|FG000|Overall Study|Death|9|||
33484807|NCT03930615|62861805|FG001|Overall Study|Death|3|||
33484808|NCT03930615|62861804|FG000|Overall Study|Lost to Follow-up|1|||
33484809|NCT03930615|62861805|FG001|Overall Study|Lost to Follow-up|2|||
33484810|NCT03930615|62861804|FG000|Overall Study|Physician Decision|3|||
33484811|NCT03930615|62861805|FG001|Overall Study|Physician Decision|4|||
33484812|NCT03930615|62861804|FG000|Overall Study|Withdrawal by Subject|13|||
33484813|NCT03930615|62861805|FG001|Overall Study|Withdrawal by Subject|2|||
33266593|NCT02749292|62637748|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
33266594|NCT02749292|62637749|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
33266595|NCT02749292|62637748|FG000|Overall Study|Adverse Event|4|||
33266596|NCT02749292|62637749|FG001|Overall Study|Adverse Event|1|||
33266597|NCT02749292|62637748|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
33484814|NCT03930615|62861804|FG000|Overall Study|Not treated|1|||
33266598|NCT02749292|62637749|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
33484815|NCT03930615|62861805|FG001|Overall Study|Not treated|1|||
33266599|NCT02749292|62637748|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
33266600|NCT02749292|62637749|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
33266601|NCT02749292|62637748|FG000|Overall Study|Requiring glucocorticoids|0|||
33484816|NCT03292640|62861813|FG000|Overall Study|Withdrawal by Subject|17|||
33484817|NCT03292640|62861814|FG001|Overall Study|Withdrawal by Subject|16|||
33484818|NCT03292640|62861813|FG000|Overall Study|Adverse Event|20|||
33484819|NCT03292640|62861814|FG001|Overall Study|Adverse Event|2|||
33484820|NCT03292640|62861813|FG000|Overall Study|Lost to Follow-up|24|||
33484821|NCT03292640|62861814|FG001|Overall Study|Lost to Follow-up|24|||
33484822|NCT03292406|62861827|FG000|Overall Study|Progressive Disease|6|||
33484823|NCT03292406|62861828|FG001|Overall Study|Progressive Disease|3|||
33484824|NCT03292406|62861829|FG002|Overall Study|Progressive Disease|4|||
33484825|NCT03292406|62861827|FG000|Overall Study|Adverse Event|7|||
33484826|NCT03292406|62861828|FG001|Overall Study|Adverse Event|1|||
33484827|NCT03292406|62861829|FG002|Overall Study|Adverse Event|4|||
33484828|NCT03292406|62861827|FG000|Overall Study|Withdrawal by Subject|0|||
33484829|NCT03292406|62861828|FG001|Overall Study|Withdrawal by Subject|7|||
33484830|NCT03292406|62861829|FG002|Overall Study|Withdrawal by Subject|2|||
33484831|NCT03292406|62861827|FG000|Overall Study|Protocol Violation|0|||
33484832|NCT03292406|62861828|FG001|Overall Study|Protocol Violation|1|||
33484833|NCT03292406|62861829|FG002|Overall Study|Protocol Violation|1|||
33266602|NCT02749292|62637749|FG001|Overall Study|Requiring glucocorticoids|3|||
33266603|NCT02749292|62637748|FG000|Overall Study|Cancer|1|||
33266604|NCT02749292|62637749|FG001|Overall Study|Cancer|0|||
33266605|NCT02689076|62637768|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
33266606|NCT02689076|62637769|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
33266607|NCT02689076|62637770|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
33266608|NCT02689076|62637768|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
33266609|NCT02689076|62637769|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
33266610|NCT02689076|62637770|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
33266611|NCT02689076|62637768|FG000|Overall Study|Did not have an HIE match|2|||
33266612|NCT02689076|62637769|FG001|Overall Study|Did not have an HIE match|0|||
33266613|NCT02689076|62637770|FG002|Overall Study|Did not have an HIE match|0|||
33266614|NCT02689076|62637768|FG000|Overall Study|Death during non-VA encounter|2|||
33266615|NCT02689076|62637769|FG001|Overall Study|Death during non-VA encounter|5|||
33266616|NCT02689076|62637770|FG002|Overall Study|Death during non-VA encounter|0|||
33266617|NCT02689076|62637768|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
33266618|NCT02689076|62637769|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
33266619|NCT02689076|62637770|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
33266620|NCT02689076|62637768|FG000|Overall Study|Participant no longer active in VA system|1|||
33266621|NCT02689076|62637769|FG001|Overall Study|Participant no longer active in VA system|0|||
33266622|NCT02689076|62637770|FG002|Overall Study|Participant no longer active in VA system|0|||
33266623|NCT02689076|62637768|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
33266624|NCT02689076|62637769|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
33266625|NCT02689076|62637770|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
33266626|NCT02670525|62637780|FG000|Overall Study|Death|94|||
33266627|NCT02670525|62637781|FG001|Overall Study|Death|14|||
33266628|NCT02670525|62637780|FG000|Overall Study|Lost to Follow-up|4|||
33266629|NCT02670525|62637781|FG001|Overall Study|Lost to Follow-up|1|||
33266630|NCT02670525|62637780|FG000|Overall Study|Subject withdrew consent|1|||
33266631|NCT02670525|62637781|FG001|Overall Study|Subject withdrew consent|0|||
33266632|NCT02670525|62637780|FG000|Overall Study|Unknown, data entry delayed|123|||
33266633|NCT02670525|62637781|FG001|Overall Study|Unknown, data entry delayed|78|||
33266634|NCT02576990|62637789|FG000|Overall Study|Death|29|||
33266635|NCT02576990|62637790|FG001|Overall Study|Death|18|||
33266636|NCT02576990|62637789|FG000|Overall Study|Physician Decision|1|||
33266637|NCT02576990|62637790|FG001|Overall Study|Physician Decision|0|||
33266638|NCT02576990|62637789|FG000|Overall Study|Screen failure|2|||
33266639|NCT02576990|62637790|FG001|Overall Study|Screen failure|0|||
33266640|NCT02576990|62637789|FG000|Overall Study|Sponsor's decision|24|||
33266641|NCT02576990|62637790|FG001|Overall Study|Sponsor's decision|4|||
33266642|NCT02576990|62637789|FG000|Overall Study|Withdrawal by Subject|0|||
33266643|NCT02576990|62637790|FG001|Overall Study|Withdrawal by Subject|2|||
33266644|NCT02550561|62637796|FG000|Overall Study|Lost to Follow-up|5|||
33266645|NCT02550561|62637796|FG000|Overall Study|Withdrawal by Subject|1|||
33484834|NCT03292406|62861827|FG000|Overall Study|Other|0|||
33266646|NCT02524171|62637806|FG000|6-month Follow-up|Lost to Follow-up|53|||
33266647|NCT02524171|62637807|FG001|6-month Follow-up|Lost to Follow-up|45|||
33266648|NCT02524171|62637806|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
33266649|NCT02524171|62637807|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
33266650|NCT02511106|62637815|FG000|Overall Study|Lost to Follow-up|1|||
33484835|NCT03292406|62861828|FG001|Overall Study|Other|1|||
33484836|NCT03292406|62861829|FG002|Overall Study|Other|2|||
33484837|NCT03292016|62861866|FG000|Second Washout|Adverse Event|0|||
33484838|NCT03292016|62861867|FG001|Second Washout|Adverse Event|1|||
33266651|NCT02511106|62637816|FG001|Overall Study|Lost to Follow-up|2|||
33266652|NCT02511106|62637815|FG000|Overall Study|Withdrawal by Subject|19|||
33368349|NCT00819585|62747240|FG010|Core Study|Administrative Problems|0|||
33368350|NCT00819585|62747230|FG000|Core Study|Death|0|||
33368351|NCT00819585|62747231|FG001|Core Study|Death|0|||
33368352|NCT00819585|62747232|FG002|Core Study|Death|0|||
33368353|NCT00819585|62747233|FG003|Core Study|Death|0|||
33368354|NCT00819585|62747234|FG004|Core Study|Death|0|||
33368355|NCT00819585|62747235|FG005|Core Study|Death|0|||
33368356|NCT00819585|62747236|FG006|Core Study|Death|1|||
33368357|NCT00819585|62747237|FG007|Core Study|Death|0|||
33368358|NCT00819585|62747238|FG008|Core Study|Death|0|||
33368359|NCT00819585|62747239|FG009|Core Study|Death|0|||
33368360|NCT00819585|62747240|FG010|Core Study|Death|0|||
33368361|NCT00819585|62747230|FG000|Core Study|Protocol Violation|0|||
33368362|NCT00819585|62747231|FG001|Core Study|Protocol Violation|0|||
33368363|NCT00819585|62747232|FG002|Core Study|Protocol Violation|1|||
33368364|NCT00819585|62747233|FG003|Core Study|Protocol Violation|0|||
33368365|NCT00819585|62747234|FG004|Core Study|Protocol Violation|0|||
33368366|NCT00819585|62747235|FG005|Core Study|Protocol Violation|1|||
33368367|NCT00819585|62747236|FG006|Core Study|Protocol Violation|3|||
33368368|NCT00819585|62747237|FG007|Core Study|Protocol Violation|0|||
33368369|NCT00819585|62747238|FG008|Core Study|Protocol Violation|0|||
33368370|NCT00819585|62747239|FG009|Core Study|Protocol Violation|0|||
33368371|NCT00819585|62747240|FG010|Core Study|Protocol Violation|0|||
33368372|NCT00819585|62747230|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
33368373|NCT00819585|62747231|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
33368374|NCT00819585|62747232|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
33368375|NCT00819585|62747233|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
33368376|NCT00819585|62747234|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
33368377|NCT00819585|62747235|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
33368378|NCT00819585|62747236|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
33368379|NCT00819585|62747237|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
33368380|NCT00819585|62747238|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
33368381|NCT00819585|62747239|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
33368382|NCT00819585|62747240|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
33368383|NCT00819585|62747230|FG000|Extension Study|Subject Withdrew Consent|0|||
33368384|NCT00819585|62747231|FG001|Extension Study|Subject Withdrew Consent|0|||
33368385|NCT00819585|62747232|FG002|Extension Study|Subject Withdrew Consent|0|||
33368386|NCT00819585|62747233|FG003|Extension Study|Subject Withdrew Consent|0|||
33368387|NCT00819585|62747234|FG004|Extension Study|Subject Withdrew Consent|0|||
33368388|NCT00819585|62747235|FG005|Extension Study|Subject Withdrew Consent|0|||
33368389|NCT00819585|62747236|FG006|Extension Study|Subject Withdrew Consent|0|||
33368390|NCT00819585|62747237|FG007|Extension Study|Subject Withdrew Consent|0|||
33368391|NCT00819585|62747238|FG008|Extension Study|Subject Withdrew Consent|3|||
33368392|NCT00819585|62747239|FG009|Extension Study|Subject Withdrew Consent|0|||
33368393|NCT00819585|62747240|FG010|Extension Study|Subject Withdrew Consent|1|||
33368394|NCT00819585|62747230|FG000|Extension Study|Lost to Follow-up|0|||
33368395|NCT00819585|62747231|FG001|Extension Study|Lost to Follow-up|0|||
33368396|NCT00819585|62747232|FG002|Extension Study|Lost to Follow-up|0|||
33368397|NCT00819585|62747233|FG003|Extension Study|Lost to Follow-up|0|||
33368398|NCT00819585|62747234|FG004|Extension Study|Lost to Follow-up|0|||
33368399|NCT00819585|62747235|FG005|Extension Study|Lost to Follow-up|0|||
33368400|NCT00819585|62747236|FG006|Extension Study|Lost to Follow-up|0|||
33368401|NCT00819585|62747237|FG007|Extension Study|Lost to Follow-up|0|||
33368402|NCT00819585|62747238|FG008|Extension Study|Lost to Follow-up|2|||
33368403|NCT00819585|62747239|FG009|Extension Study|Lost to Follow-up|1|||
33368404|NCT00819585|62747240|FG010|Extension Study|Lost to Follow-up|1|||
33368405|NCT00819585|62747230|FG000|Extension Study|Death|0|||
33368406|NCT00819585|62747231|FG001|Extension Study|Death|0|||
33368407|NCT00819585|62747232|FG002|Extension Study|Death|0|||
33368408|NCT00819585|62747233|FG003|Extension Study|Death|0|||
33368409|NCT00819585|62747234|FG004|Extension Study|Death|0|||
33484839|NCT03292016|62861868|FG002|Second Washout|Adverse Event|0|||
33368410|NCT00819585|62747235|FG005|Extension Study|Death|0|||
33368411|NCT00819585|62747236|FG006|Extension Study|Death|0|||
33368412|NCT00819585|62747237|FG007|Extension Study|Death|0|||
33368413|NCT00819585|62747238|FG008|Extension Study|Death|2|||
33484840|NCT03292016|62861869|FG003|Second Washout|Adverse Event|0|||
33368414|NCT00819585|62747239|FG009|Extension Study|Death|0|||
33368415|NCT00819585|62747240|FG010|Extension Study|Death|0|||
33368416|NCT00508261|62747272|FG000|Overall Study|Other|0|||
33368417|NCT00508261|62747273|FG001|Overall Study|Other|1|||
33368418|NCT00508261|62747274|FG002|Overall Study|Other|1|||
33266653|NCT02511106|62637816|FG001|Overall Study|Withdrawal by Subject|14|||
33368419|NCT00508261|62747275|FG003|Overall Study|Other|0|||
33368420|NCT00508261|62747272|FG000|Overall Study|Serious Adverse Event|0|||
33368421|NCT00508261|62747273|FG001|Overall Study|Serious Adverse Event|1|||
33368422|NCT00508261|62747274|FG002|Overall Study|Serious Adverse Event|0|||
33368423|NCT00508261|62747275|FG003|Overall Study|Serious Adverse Event|0|||
33368424|NCT00508261|62747272|FG000|Overall Study|Withdrawal by Subject|3|||
33266654|NCT02511106|62637815|FG000|Overall Study|Ongoing study at data cut-off|309|||
33266655|NCT02511106|62637816|FG001|Overall Study|Ongoing study at data cut-off|307|||
33266656|NCT02511106|62637815|FG000|Overall Study|Without specified reason|1|||
33266657|NCT02511106|62637816|FG001|Overall Study|Without specified reason|0|||
33266658|NCT02511106|62637815|FG000|Overall Study|Missing|1|||
33266659|NCT02511106|62637816|FG001|Overall Study|Missing|0|||
33266660|NCT02500589|62637826|FG000|Overall Study|Withdrawal by Subject|11|||
33266661|NCT02500589|62637827|FG001|Overall Study|Withdrawal by Subject|14|||
33266662|NCT02500589|62637826|FG000|Overall Study|Lost to Follow-up|10|||
33266663|NCT02500589|62637827|FG001|Overall Study|Lost to Follow-up|12|||
33266664|NCT02500589|62637826|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
33266665|NCT02500589|62637827|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
33266666|NCT02500589|62637826|FG000|Overall Study|Death|7|||
33266667|NCT02500589|62637827|FG001|Overall Study|Death|5|||
33266668|NCT02481830|62637839|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
33266669|NCT02481830|62637840|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
33266670|NCT02481830|62637839|FG000|Pre-treatment|Withdrawal by Subject|0|||
33266671|NCT02481830|62637840|FG001|Pre-treatment|Withdrawal by Subject|10|||
33266672|NCT02481830|62637839|FG000|Pre-treatment|Disease Progression|1|||
33266673|NCT02481830|62637840|FG001|Pre-treatment|Disease Progression|1|||
33266674|NCT02481830|62637839|FG000|Pre-treatment|Other reasons|0|||
33266675|NCT02481830|62637840|FG001|Pre-treatment|Other reasons|1|||
33266676|NCT02481830|62637839|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
33266677|NCT02481830|62637840|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
33266678|NCT02481830|62637839|FG000|Treatment|Disease Progression|233|||
33266679|NCT02481830|62637840|FG001|Treatment|Disease Progression|171|||
33266680|NCT02481830|62637839|FG000|Treatment|Study drug toxicity|18|||
33266681|NCT02481830|62637840|FG001|Treatment|Study drug toxicity|38|||
33266682|NCT02481830|62637839|FG000|Treatment|Death|1|||
33266683|NCT02481830|62637840|FG001|Treatment|Death|1|||
33266684|NCT02481830|62637839|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
33266685|NCT02481830|62637840|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
33266686|NCT02481830|62637839|FG000|Treatment|Participants request to discontinue Study treatment|6|||
33266687|NCT02481830|62637840|FG001|Treatment|Participants request to discontinue Study treatment|34|||
33266688|NCT02481830|62637839|FG000|Treatment|Withdrawal by Subject|2|||
33266689|NCT02481830|62637840|FG001|Treatment|Withdrawal by Subject|3|||
33266690|NCT02481830|62637839|FG000|Treatment|Lost to Follow-up|1|||
33266691|NCT02481830|62637840|FG001|Treatment|Lost to Follow-up|0|||
33266692|NCT02481830|62637839|FG000|Treatment|Maximum Clinical Benefit|0|||
33266693|NCT02481830|62637840|FG001|Treatment|Maximum Clinical Benefit|5|||
33266694|NCT02481830|62637839|FG000|Treatment|Administrative reason by sponsor|1|||
33266695|NCT02481830|62637840|FG001|Treatment|Administrative reason by sponsor|1|||
33266696|NCT02481830|62637839|FG000|Treatment|Other reasons|6|||
33266697|NCT02481830|62637840|FG001|Treatment|Other reasons|1|||
33368425|NCT00508261|62747273|FG001|Overall Study|Withdrawal by Subject|4|||
33368426|NCT00508261|62747274|FG002|Overall Study|Withdrawal by Subject|4|||
33368427|NCT00508261|62747275|FG003|Overall Study|Withdrawal by Subject|0|||
33368428|NCT00508261|62747272|FG000|Overall Study|Migrated/ moved from study area|0|||
33368429|NCT00508261|62747273|FG001|Overall Study|Migrated/ moved from study area|1|||
33368430|NCT00508261|62747274|FG002|Overall Study|Migrated/ moved from study area|0|||
33368431|NCT00508261|62747275|FG003|Overall Study|Migrated/ moved from study area|0|||
33368432|NCT00508261|62747272|FG000|Overall Study|Lost to Follow-up|0|||
33368433|NCT00508261|62747273|FG001|Overall Study|Lost to Follow-up|1|||
33368434|NCT00508261|62747274|FG002|Overall Study|Lost to Follow-up|1|||
33368435|NCT00508261|62747275|FG003|Overall Study|Lost to Follow-up|1|||
33368436|NCT00819039|62747314|FG000|Overall Study|Physician Decision|1|||
33368437|NCT00819039|62747315|FG001|Overall Study|Physician Decision|0|||
33368438|NCT00819039|62747316|FG002|Overall Study|Physician Decision|1|||
33368439|NCT00819039|62747314|FG000|Overall Study|Protocol Violation|1|||
33555534|NCT02347774|62948335|FG000|On Study Treatment|ranomized in error|0|||
33555535|NCT02347774|62948336|FG001|On Study Treatment|ranomized in error|0|||
33661812|NCT01697579|63091446|FG002|Base Study-Cycle 1|Technical Problems|1|||
33266698|NCT02477111|62637846|FG000|Overall Study|Death|5|||
33266699|NCT02477111|62637846|FG000|Overall Study|Withdrawal by Subject|2|||
33266700|NCT02477111|62637846|FG000|Overall Study|missed visit|4|||
33266701|NCT02425943|62637854|FG000|Overall Study|Adverse Event|3|||
33266702|NCT02425943|62637855|FG001|Overall Study|Adverse Event|1|||
33266703|NCT02425943|62637854|FG000|Overall Study|Lost to Follow-up|59|||
33266704|NCT02425943|62637855|FG001|Overall Study|Lost to Follow-up|37|||
33266705|NCT02425943|62637854|FG000|Overall Study|Protocol Violation|4|||
33266706|NCT02425943|62637855|FG001|Overall Study|Protocol Violation|1|||
33266707|NCT02425943|62637854|FG000|Overall Study|Withdrawal by Subject|64|||
33266708|NCT02425943|62637855|FG001|Overall Study|Withdrawal by Subject|31|||
33266709|NCT02425943|62637854|FG000|Overall Study|Other|6|||
33368440|NCT00819039|62747315|FG001|Overall Study|Protocol Violation|0|||
33368441|NCT00819039|62747316|FG002|Overall Study|Protocol Violation|0|||
33368442|NCT00500539|62747326|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
33266710|NCT02425943|62637855|FG001|Overall Study|Other|0|||
33266711|NCT02383173|62637865|FG000|Overall Study|Palliative Care Team withdrew|0|||
33266712|NCT02383173|62637866|FG001|Overall Study|Palliative Care Team withdrew|2|||
33266713|NCT02380690|62637874|FG000|Overall Study|Lost to Follow-up|14|||
33266714|NCT02380690|62637875|FG001|Overall Study|Lost to Follow-up|4|||
33266715|NCT02380690|62637874|FG000|Overall Study|Withdrawal by Subject|20|||
33266716|NCT02380690|62637875|FG001|Overall Study|Withdrawal by Subject|8|||
33266717|NCT02311673|62637917|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
33266718|NCT02311673|62637918|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
33266719|NCT02311673|62637919|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
33266720|NCT02311673|62637920|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
33266721|NCT02286089|62637956|FG000|Overall Study|Ongoing in Study|1|||
33266722|NCT02286089|62637957|FG001|Overall Study|Ongoing in Study|1|||
33266723|NCT02286089|62637958|FG002|Overall Study|Ongoing in Study|4|||
33266724|NCT02286089|62637959|FG003|Overall Study|Ongoing in Study|10|||
33266725|NCT02286089|62637956|FG000|Overall Study|Withdrawal by Subject|0|||
33266726|NCT02286089|62637957|FG001|Overall Study|Withdrawal by Subject|0|||
33266727|NCT02286089|62637958|FG002|Overall Study|Withdrawal by Subject|2|||
33266728|NCT02286089|62637959|FG003|Overall Study|Withdrawal by Subject|2|||
33266729|NCT02284113|62637971|FG000|Overall Study|Adverse Event|1|||
33266730|NCT02284113|62637972|FG001|Overall Study|Adverse Event|0|||
33266731|NCT02284113|62637971|FG000|Overall Study|non-compliance|0|||
33266732|NCT02284113|62637972|FG001|Overall Study|non-compliance|1|||
33266733|NCT02284113|62637971|FG000|Overall Study|Withdrawal by Subject|0|||
33266734|NCT02284113|62637972|FG001|Overall Study|Withdrawal by Subject|1|||
33266735|NCT02284113|62637971|FG000|Overall Study|not provided|0|||
33266736|NCT02284113|62637972|FG001|Overall Study|not provided|1|||
33368443|NCT00500539|62747326|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
33368444|NCT00500539|62747326|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
33368445|NCT00500539|62747326|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
33368446|NCT00500539|62747326|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
33368447|NCT00500539|62747326|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
33368448|NCT00500539|62747326|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
33368449|NCT00500539|62747326|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
33368450|NCT00500539|62747326|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
33368451|NCT00500539|62747326|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
33368452|NCT00500539|62747326|FG000|Follow-up Period (16 Weeks)|Death|1|||
33368453|NCT00500539|62747326|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
33368454|NCT00500539|62747326|FG000|Follow-up Period (16 Weeks)|Missing|3|||
33368455|NCT00818883|62747335|FG000|Overall Study|Adverse Event|28|||
33368456|NCT00818883|62747336|FG001|Overall Study|Adverse Event|19|||
33368457|NCT00818883|62747335|FG000|Overall Study|Protocol Violation|2|||
33368458|NCT00818883|62747336|FG001|Overall Study|Protocol Violation|2|||
33368459|NCT00818883|62747335|FG000|Overall Study|Lost to Follow-up|3|||
33368460|NCT00818883|62747336|FG001|Overall Study|Lost to Follow-up|2|||
33368461|NCT00818883|62747335|FG000|Overall Study|Withdrawal by Subject|16|||
33368462|NCT00818883|62747336|FG001|Overall Study|Withdrawal by Subject|14|||
33368463|NCT00818883|62747335|FG000|Overall Study|Lack of Efficacy|0|||
33368464|NCT00818883|62747336|FG001|Overall Study|Lack of Efficacy|2|||
33368465|NCT00818883|62747335|FG000|Overall Study|Other|2|||
33368466|NCT00818883|62747336|FG001|Overall Study|Other|7|||
33368467|NCT00508027|62747342|FG000|Dose Level 1|Lost to Follow-up|4|||
33368468|NCT00508027|62747342|FG000|Dose Level 1|Withdrawal by Subject|2|||
33368469|NCT00508027|62747342|FG000|Dose Level 1|Physician Decision|2|||
33368470|NCT00508027|62747342|FG000|Dose Level 2|Lost to Follow-up|2|||
33368471|NCT00508027|62747342|FG000|Dose Level 2|Withdrawal by Subject|2|||
33368472|NCT00500149|62747371|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
33368473|NCT00500149|62747372|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
33368474|NCT00500149|62747371|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
33368475|NCT00500149|62747372|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
33368476|NCT00500149|62747371|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
33368477|NCT00500149|62747372|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
33266737|NCT02284113|62637971|FG000|Overall Study|surgery cancelled|2|||
33368478|NCT00500149|62747371|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
33368479|NCT00500149|62747372|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
33368480|NCT00500149|62747371|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
33368481|NCT00500149|62747372|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
33368482|NCT00500149|62747371|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
33368483|NCT00500149|62747372|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
33266738|NCT02284113|62637972|FG001|Overall Study|surgery cancelled|0|||
33266739|NCT02233738|62637980|FG000|Overall Study|Lost to Follow-up|5|||
33266740|NCT02233738|62637981|FG001|Overall Study|Lost to Follow-up|12|||
33266741|NCT02233738|62637980|FG000|Overall Study|Death|0|||
33368484|NCT00500149|62747371|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
33368485|NCT00500149|62747372|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
33368486|NCT00489853|62747378|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
33368487|NCT00489853|62747379|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
33368488|NCT00489853|62747380|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
33368489|NCT00489853|62747378|FG000|Wash-out Period 1|Adverse Event|0|||
33368490|NCT00489853|62747379|FG001|Wash-out Period 1|Adverse Event|1|||
33368491|NCT00489853|62747380|FG002|Wash-out Period 1|Adverse Event|1|||
33368492|NCT00489853|62747378|FG000|Wash-out Period 1|Protocol Violation|0|||
33368493|NCT00489853|62747379|FG001|Wash-out Period 1|Protocol Violation|1|||
33368494|NCT00489853|62747380|FG002|Wash-out Period 1|Protocol Violation|1|||
33368495|NCT00489853|62747378|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
33368496|NCT00489853|62747379|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
33368497|NCT00489853|62747380|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
33368498|NCT00489853|62747378|FG000|Wash-out Period 2|Adverse Event|1|||
33368499|NCT00489853|62747379|FG001|Wash-out Period 2|Adverse Event|1|||
33368500|NCT00489853|62747380|FG002|Wash-out Period 2|Adverse Event|0|||
33368501|NCT00489853|62747378|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
33368502|NCT00489853|62747379|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
33484841|NCT03292016|62861870|FG004|Second Washout|Adverse Event|0|||
33484842|NCT03292016|62861871|FG005|Second Washout|Adverse Event|0|||
33484843|NCT03290300|62861879|FG000|Overall Study|Lost to Follow-up|3|||
33484844|NCT03289676|62861892|FG000|Overall Study|Withdrawal by Subject|2|||
33484845|NCT03289676|62861893|FG001|Overall Study|Withdrawal by Subject|0|||
33368503|NCT00489853|62747380|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
33368504|NCT00489853|62747378|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
33368505|NCT00489853|62747379|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
33368506|NCT00489853|62747380|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
33368507|NCT03686423|62747388|FG000|Overall Study|Withdrawal by Subject|9|||
33368508|NCT03686423|62747388|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
33368509|NCT00499681|62747394|FG000|Overall Study|toxicity|0|||
33368510|NCT00499681|62747395|FG001|Overall Study|toxicity|1|||
33368511|NCT00499681|62747394|FG000|Overall Study|disease progression|0|||
33368512|NCT00499681|62747395|FG001|Overall Study|disease progression|1|||
33368513|NCT00875810|62747406|FG000|Overall Study|Withdrawal by Subject|1|||
33368514|NCT00875810|62747406|FG000|Overall Study|Physician Decision|3|||
33368515|NCT00875810|62747406|FG000|Overall Study|Lost to Follow-up|39|||
33368516|NCT00875810|62747406|FG000|Overall Study|Patient enroled but not implanted|2|||
33368517|NCT00875810|62747406|FG000|Overall Study|Device explanted|1|||
33368518|NCT00499603|62747412|FG000|Overall Study|Adverse Event|0|||
33368519|NCT00499603|62747413|FG001|Overall Study|Adverse Event|1|||
33368520|NCT00810069|62747432|FG000|Lead-in Period I|Adverse Event|43|||
33368521|NCT00810069|62747433|FG001|Lead-in Period I|Adverse Event|0|||
33368522|NCT00810069|62747434|FG002|Lead-in Period I|Adverse Event|0|||
33368523|NCT00810069|62747432|FG000|Lead-in Period I|Lack of Efficacy|1|||
33368524|NCT00810069|62747433|FG001|Lead-in Period I|Lack of Efficacy|0|||
33368525|NCT00810069|62747434|FG002|Lead-in Period I|Lack of Efficacy|0|||
33368526|NCT00810069|62747432|FG000|Lead-in Period I|Lost to Follow-up|19|||
33368527|NCT00810069|62747433|FG001|Lead-in Period I|Lost to Follow-up|0|||
33368528|NCT00810069|62747434|FG002|Lead-in Period I|Lost to Follow-up|0|||
33368529|NCT00810069|62747432|FG000|Lead-in Period I|Physician Decision|1|||
33368530|NCT00810069|62747433|FG001|Lead-in Period I|Physician Decision|0|||
33368531|NCT00810069|62747434|FG002|Lead-in Period I|Physician Decision|0|||
33368532|NCT00810069|62747432|FG000|Lead-in Period I|Protocol Violation|1|||
33368533|NCT00810069|62747433|FG001|Lead-in Period I|Protocol Violation|0|||
33368534|NCT00810069|62747434|FG002|Lead-in Period I|Protocol Violation|0|||
33368535|NCT00810069|62747432|FG000|Lead-in Period I|Withdrawal by Subject|46|||
33368536|NCT00810069|62747433|FG001|Lead-in Period I|Withdrawal by Subject|0|||
33368537|NCT00810069|62747434|FG002|Lead-in Period I|Withdrawal by Subject|0|||
33368538|NCT00810069|62747432|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
33484846|NCT03289676|62861892|FG000|Overall Study|Protocol Violation|2|||
33484847|NCT03289676|62861893|FG001|Overall Study|Protocol Violation|0|||
33484848|NCT03289676|62861892|FG000|Overall Study|Lost to Follow-up|0|||
33484849|NCT03289676|62861893|FG001|Overall Study|Lost to Follow-up|1|||
33484850|NCT03287804|62861909|FG000|Overall Study|Death|1|||
33266742|NCT02233738|62637981|FG001|Overall Study|Death|1|||
33484851|NCT03287804|62861909|FG000|Overall Study|Physician Decision|2|||
33484852|NCT03287804|62861909|FG000|Overall Study|Progressive disease|8|||
33484853|NCT03286400|62861914|FG000|Overall Study|Death|10|||
33484854|NCT03286400|62861914|FG000|Overall Study|Lost to Follow-up|10|||
33368539|NCT00810069|62747433|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
33368540|NCT00810069|62747434|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
33484855|NCT03286400|62861914|FG000|Overall Study|Physician Decision|1|||
33368541|NCT00810069|62747432|FG000|Lead-in Period I|Randomization criteria not met|158|||
33484856|NCT03286400|62861914|FG000|Overall Study|Scheduling difficulty|4|||
33484857|NCT03310970|62861918|FG000|Overall Study|Withdrawal by Subject|0|||
33484858|NCT03310970|62861919|FG001|Overall Study|Withdrawal by Subject|1|||
33484859|NCT03285308|62861928|FG000|Overall Study|Adverse Event|3|||
33368542|NCT00810069|62747433|FG001|Lead-in Period I|Randomization criteria not met|0|||
33368543|NCT00810069|62747434|FG002|Lead-in Period I|Randomization criteria not met|0|||
33368544|NCT00810069|62747432|FG000|Double-Blind Period II|Adverse Event|0|||
33368545|NCT00810069|62747433|FG001|Double-Blind Period II|Adverse Event|9|||
33368546|NCT00810069|62747434|FG002|Double-Blind Period II|Adverse Event|8|||
33368547|NCT00810069|62747432|FG000|Double-Blind Period II|Lack of Efficacy|0|||
33368548|NCT00810069|62747433|FG001|Double-Blind Period II|Lack of Efficacy|7|||
33368549|NCT00810069|62747434|FG002|Double-Blind Period II|Lack of Efficacy|12|||
33368550|NCT00810069|62747432|FG000|Double-Blind Period II|Lost to Follow-up|0|||
33368551|NCT00810069|62747433|FG001|Double-Blind Period II|Lost to Follow-up|9|||
33368552|NCT00810069|62747434|FG002|Double-Blind Period II|Lost to Follow-up|9|||
33368553|NCT00810069|62747432|FG000|Double-Blind Period II|Physician Decision|0|||
33368554|NCT00810069|62747433|FG001|Double-Blind Period II|Physician Decision|0|||
33368555|NCT00810069|62747434|FG002|Double-Blind Period II|Physician Decision|1|||
33368556|NCT00810069|62747432|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
33368557|NCT00810069|62747433|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
33484860|NCT03285308|62861929|FG001|Overall Study|Adverse Event|7|||
33484861|NCT03285308|62861928|FG000|Overall Study|Withdrawal by Subject|8|||
33484862|NCT03285308|62861929|FG001|Overall Study|Withdrawal by Subject|9|||
33484863|NCT03285308|62861928|FG000|Overall Study|Lost to Follow-up|3|||
33484864|NCT03285308|62861929|FG001|Overall Study|Lost to Follow-up|1|||
33484865|NCT03285308|62861928|FG000|Overall Study|Protocol Deviation|6|||
33484866|NCT03285308|62861929|FG001|Overall Study|Protocol Deviation|5|||
33484867|NCT03285308|62861928|FG000|Overall Study|Reason not Specified|0|||
33484868|NCT03285308|62861929|FG001|Overall Study|Reason not Specified|1|||
33484869|NCT03537651|62861936|FG000|Overall Study|Adverse Event|2|||
33484870|NCT03537651|62861936|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
33484871|NCT03537651|62861936|FG000|Overall Study|Commercial Drug is Available for Participant|56|||
33484872|NCT03537651|62861936|FG000|Overall Study|Other|1|||
33555536|NCT02347774|62948337|FG002|On Study Treatment|ranomized in error|1|||
33555537|NCT02794883|62948348|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
33555538|NCT02794883|62948349|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
33555539|NCT02794883|62948350|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
33555540|NCT02794883|62948348|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
33555541|NCT02794883|62948349|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
33555542|NCT02794883|62948350|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
33555543|NCT02794883|62948348|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
33555544|NCT02794883|62948349|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
33555545|NCT02794883|62948350|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
33555546|NCT02794883|62948348|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
33555547|NCT02794883|62948349|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
33555548|NCT02794883|62948350|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
33266743|NCT02233738|62637980|FG000|Overall Study|Withdrawal by Subject|0|||
33266744|NCT02233738|62637981|FG001|Overall Study|Withdrawal by Subject|1|||
33266745|NCT02233738|62637980|FG000|Overall Study|Did not return after Baseline|3|||
33266746|NCT02233738|62637981|FG001|Overall Study|Did not return after Baseline|2|||
33266747|NCT01959698|62638169|FG000|Overall Study|Adverse Event|0|||
33266748|NCT01959698|62638170|FG001|Overall Study|Adverse Event|0|||
33266749|NCT01959698|62638171|FG002|Overall Study|Adverse Event|0|||
33266750|NCT01959698|62638172|FG003|Overall Study|Adverse Event|0|||
33266751|NCT01959698|62638173|FG004|Overall Study|Adverse Event|0|||
33266752|NCT01959698|62638174|FG005|Overall Study|Adverse Event|0|||
33266753|NCT01959698|62638175|FG006|Overall Study|Adverse Event|1|||
33266754|NCT01959698|62638169|FG000|Overall Study|Physician Decision|1|||
33266755|NCT01959698|62638170|FG001|Overall Study|Physician Decision|0|||
33266756|NCT01959698|62638171|FG002|Overall Study|Physician Decision|1|||
33266757|NCT01959698|62638172|FG003|Overall Study|Physician Decision|2|||
33266758|NCT01959698|62638173|FG004|Overall Study|Physician Decision|0|||
33266759|NCT01959698|62638174|FG005|Overall Study|Physician Decision|3|||
33266760|NCT01959698|62638175|FG006|Overall Study|Physician Decision|3|||
33266761|NCT01910402|62638194|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
33266762|NCT01910402|62638195|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
33266763|NCT01910402|62638196|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
33484873|NCT03723915|62861952|FG000|Screening|Failed to meet screening requirements.|2|||
33266764|NCT01910402|62638194|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
33266765|NCT01910402|62638195|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
33266766|NCT01910402|62638196|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
33266767|NCT01910402|62638194|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
33368558|NCT00810069|62747434|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
33368559|NCT00810069|62747432|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
33484874|NCT03723915|62861952|FG000|On Treatment|Failed to meet treatment requirements|2|||
33368560|NCT00810069|62747433|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
33368561|NCT00810069|62747434|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
33368562|NCT00810069|62747432|FG000|Double-Blind Period II|Clinical relapse|0|||
33368563|NCT00810069|62747433|FG001|Double-Blind Period II|Clinical relapse|3|||
33368564|NCT00810069|62747434|FG002|Double-Blind Period II|Clinical relapse|0|||
33368565|NCT00810069|62747432|FG000|Double-Blind Period II|Protocol Violation|0|||
33368566|NCT00810069|62747433|FG001|Double-Blind Period II|Protocol Violation|7|||
33368567|NCT00810069|62747434|FG002|Double-Blind Period II|Protocol Violation|6|||
33368568|NCT00489541|62747445|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
33368569|NCT00489541|62747446|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
33368570|NCT00489541|62747445|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
33368571|NCT00489541|62747446|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
33368572|NCT00489541|62747445|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
33368573|NCT00489541|62747446|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
33368574|NCT00489541|62747445|FG000|12-Month Clinical Follow-up|Death|3|||
33368575|NCT00489541|62747446|FG001|12-Month Clinical Follow-up|Death|2|||
33368576|NCT00489541|62747445|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
33368577|NCT00489541|62747446|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
33368578|NCT00489541|62747445|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
33368579|NCT00489541|62747446|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
33368580|NCT00809835|62747456|FG000|Overall Study|Lost to Follow-up|7|||
33368581|NCT00809835|62747457|FG001|Overall Study|Lost to Follow-up|6|||
33368582|NCT00809835|62747458|FG002|Overall Study|Lost to Follow-up|10|||
33368583|NCT00809835|62747459|FG003|Overall Study|Lost to Follow-up|2|||
33368584|NCT00809835|62747456|FG000|Overall Study|Withdrawal by Subject|1|||
33368585|NCT00809835|62747457|FG001|Overall Study|Withdrawal by Subject|1|||
33368586|NCT00809835|62747458|FG002|Overall Study|Withdrawal by Subject|1|||
33368587|NCT00809835|62747459|FG003|Overall Study|Withdrawal by Subject|0|||
33661813|NCT01697579|63091447|FG003|Base Study-Cycle 1|Technical Problems|1|||
33661814|NCT01697579|63091448|FG004|Base Study-Cycle 1|Technical Problems|0|||
33661815|NCT01697579|63091449|FG005|Base Study-Cycle 1|Technical Problems|0|||
33661816|NCT01697579|63091450|FG006|Base Study-Cycle 1|Technical Problems|0|||
33661817|NCT01697579|63091444|FG000|Optional Extension-Cycles 2-6|Death|0|||
33661818|NCT01697579|63091445|FG001|Optional Extension-Cycles 2-6|Death|0|||
33661819|NCT01697579|63091446|FG002|Optional Extension-Cycles 2-6|Death|0|||
33661820|NCT01697579|63091447|FG003|Optional Extension-Cycles 2-6|Death|0|||
33661821|NCT01697579|63091448|FG004|Optional Extension-Cycles 2-6|Death|0|||
33661822|NCT01697579|63091449|FG005|Optional Extension-Cycles 2-6|Death|0|||
33661823|NCT01697579|63091450|FG006|Optional Extension-Cycles 2-6|Death|2|||
33661824|NCT01697579|63091444|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
33661825|NCT01697579|63091445|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
33661826|NCT01697579|63091446|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
33661827|NCT01697579|63091447|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
33661828|NCT01697579|63091448|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
33661829|NCT01697579|63091449|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
33661830|NCT01697579|63091450|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
33661831|NCT01697579|63091444|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
33661832|NCT01697579|63091445|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
33661833|NCT01697579|63091446|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
33661834|NCT01697579|63091447|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
33661835|NCT01697579|63091448|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
33661836|NCT01697579|63091449|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
33661837|NCT01697579|63091450|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
33661838|NCT01697579|63091444|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
33661839|NCT01697579|63091445|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
33661840|NCT01697579|63091446|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
33661841|NCT01697579|63091447|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
33661842|NCT01697579|63091448|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
33661843|NCT01697579|63091449|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
33661844|NCT01697579|63091450|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
33661845|NCT01697579|63091444|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
33661846|NCT01697579|63091445|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
33661847|NCT01697579|63091446|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
33484875|NCT03281876|62861958|FG000|Overall Study|Adverse Event|4|||
33484876|NCT03281876|62861959|FG001|Overall Study|Adverse Event|15|||
33484877|NCT03281876|62861958|FG000|Overall Study|Lost to Follow-up|1|||
33661848|NCT01697579|63091447|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
33661849|NCT01697579|63091448|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
33661850|NCT01697579|63091449|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
33661851|NCT01697579|63091450|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
33661852|NCT01697579|63091444|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
33368588|NCT00853242|62747476|FG000|Overall Study|Adverse Event|0|||
33368589|NCT00853242|62747477|FG001|Overall Study|Adverse Event|1|||
33368590|NCT00853242|62747478|FG002|Overall Study|Adverse Event|1|||
33368591|NCT00853242|62747479|FG003|Overall Study|Adverse Event|0|||
33484878|NCT03281876|62861959|FG001|Overall Study|Lost to Follow-up|4|||
33484879|NCT03281876|62861958|FG000|Overall Study|Withdrawal by Subject|11|||
33484880|NCT03281876|62861959|FG001|Overall Study|Withdrawal by Subject|15|||
33484881|NCT03281876|62861958|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
33484882|NCT03281876|62861959|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33555549|NCT02794883|62948348|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
33555550|NCT02794883|62948349|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
33661853|NCT01697579|63091445|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
33661854|NCT01697579|63091446|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
33661855|NCT01697579|63091447|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
33661856|NCT01697579|63091448|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
33661857|NCT01697579|63091449|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
33661858|NCT01697579|63091450|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
33661859|NCT01697579|63091444|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
33661860|NCT01697579|63091445|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
33661861|NCT01697579|63091446|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
33661862|NCT01697579|63091447|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
33661863|NCT01697579|63091448|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
33661864|NCT01697579|63091449|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
33661865|NCT01697579|63091450|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
33661866|NCT01697579|63091444|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
33661867|NCT01697579|63091445|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
33661868|NCT01697579|63091446|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
33661869|NCT01697579|63091447|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
33661870|NCT01697579|63091448|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
33661871|NCT01697579|63091449|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
33661872|NCT01697579|63091450|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
33661873|NCT01697579|63091444|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
33661874|NCT01697579|63091445|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
33661875|NCT01697579|63091446|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
33368592|NCT00853242|62747480|FG004|Overall Study|Adverse Event|3|||
33368593|NCT00853242|62747481|FG005|Overall Study|Adverse Event|1|||
33368594|NCT00853242|62747482|FG006|Overall Study|Adverse Event|1|||
33368595|NCT00853242|62747476|FG000|Overall Study|Noncompliant|0|||
33368596|NCT00853242|62747477|FG001|Overall Study|Noncompliant|0|||
33555551|NCT02794883|62948350|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
33661876|NCT01697579|63091447|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
33661877|NCT01697579|63091448|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
33661878|NCT01697579|63091449|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
33661879|NCT01697579|63091450|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
33661880|NCT01697579|63091444|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
33661881|NCT01697579|63091445|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
33266768|NCT01910402|62638195|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
33266769|NCT01910402|62638196|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
33266770|NCT01910402|62638194|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
33266771|NCT01910402|62638195|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
33266772|NCT01910402|62638196|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
33266773|NCT01910402|62638194|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
33266774|NCT01910402|62638195|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
33266775|NCT01910402|62638196|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
33266776|NCT01910402|62638194|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
33266777|NCT01910402|62638195|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
33266778|NCT01910402|62638196|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
33266779|NCT01910402|62638194|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
33266780|NCT01910402|62638195|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
33266781|NCT01910402|62638196|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
33368597|NCT00853242|62747478|FG002|Overall Study|Noncompliant|0|||
33368598|NCT00853242|62747479|FG003|Overall Study|Noncompliant|0|||
33368599|NCT00853242|62747480|FG004|Overall Study|Noncompliant|1|||
33368600|NCT00853242|62747481|FG005|Overall Study|Noncompliant|0|||
33368601|NCT00853242|62747482|FG006|Overall Study|Noncompliant|0|||
33484883|NCT03281876|62861958|FG000|Overall Study|OTHER|5|||
33484884|NCT03281876|62861959|FG001|Overall Study|OTHER|5|||
33484885|NCT02819518|62861970|FG000|Overall Study|Death|9|||
33484886|NCT02819518|62861971|FG001|Overall Study|Death|11|||
33368602|NCT00853242|62747476|FG000|Overall Study|Withdrawal by Subject|1|||
33368603|NCT00853242|62747477|FG001|Overall Study|Withdrawal by Subject|2|||
33368604|NCT00853242|62747478|FG002|Overall Study|Withdrawal by Subject|0|||
33368605|NCT00853242|62747479|FG003|Overall Study|Withdrawal by Subject|4|||
33368606|NCT00853242|62747480|FG004|Overall Study|Withdrawal by Subject|0|||
33368607|NCT00853242|62747481|FG005|Overall Study|Withdrawal by Subject|0|||
33368608|NCT00853242|62747482|FG006|Overall Study|Withdrawal by Subject|2|||
33368609|NCT00853242|62747476|FG000|Overall Study|Other|2|||
33368610|NCT00853242|62747477|FG001|Overall Study|Other|0|||
33368611|NCT00853242|62747478|FG002|Overall Study|Other|2|||
33368612|NCT00853242|62747479|FG003|Overall Study|Other|0|||
33368613|NCT00853242|62747480|FG004|Overall Study|Other|0|||
33368614|NCT00853242|62747481|FG005|Overall Study|Other|1|||
33368615|NCT00853242|62747482|FG006|Overall Study|Other|2|||
33368616|NCT00848250|62747506|FG000|Overall Study|surgery was completed without cardiopulm|0|||
33368617|NCT00848250|62747507|FG001|Overall Study|surgery was completed without cardiopulm|1|||
33368618|NCT00809757|62747517|FG000|Overall Study|Adverse Event|2|||
33368619|NCT00809757|62747518|FG001|Overall Study|Adverse Event|3|||
33368620|NCT00809757|62747519|FG002|Overall Study|Adverse Event|3|||
33368621|NCT00809757|62747517|FG000|Overall Study|Lost to Follow-up|0|||
33368622|NCT00809757|62747518|FG001|Overall Study|Lost to Follow-up|0|||
33368623|NCT00809757|62747519|FG002|Overall Study|Lost to Follow-up|1|||
33368624|NCT00809757|62747517|FG000|Overall Study|Protocol Violation|1|||
33368625|NCT00809757|62747518|FG001|Overall Study|Protocol Violation|1|||
33368626|NCT00809757|62747519|FG002|Overall Study|Protocol Violation|1|||
33368627|NCT00809757|62747517|FG000|Overall Study|Withdrawal by Subject|2|||
33368628|NCT00809757|62747518|FG001|Overall Study|Withdrawal by Subject|1|||
33368629|NCT00809757|62747519|FG002|Overall Study|Withdrawal by Subject|3|||
33368630|NCT00809757|62747517|FG000|Overall Study|Subject Uncooperative|1|||
33368631|NCT00809757|62747518|FG001|Overall Study|Subject Uncooperative|0|||
33368632|NCT00809757|62747519|FG002|Overall Study|Subject Uncooperative|2|||
33368633|NCT00809757|62747517|FG000|Overall Study|Noncompliance with Medication|0|||
33368634|NCT00809757|62747518|FG001|Overall Study|Noncompliance with Medication|0|||
33368635|NCT00809757|62747519|FG002|Overall Study|Noncompliance with Medication|1|||
33368636|NCT00594464|62747533|FG000|Overall Study|Withdrawal by Subject|1|||
33368637|NCT00594464|62747533|FG000|Overall Study|Delay in operation|2|||
33484887|NCT02819518|62861972|FG002|Overall Study|Death|9|||
33555552|NCT02794883|62948348|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
33368638|NCT00809445|62747546|FG000|1 Month Follow-up|Lost contact|1|||
33368639|NCT00809445|62747547|FG001|1 Month Follow-up|Lost contact|2|||
33368640|NCT00809445|62747548|FG002|1 Month Follow-up|Lost contact|1|||
33368641|NCT00809445|62747546|FG000|1 Month Follow-up|Withdrew consent|1|||
33368642|NCT00809445|62747547|FG001|1 Month Follow-up|Withdrew consent|1|||
33368643|NCT00809445|62747548|FG002|1 Month Follow-up|Withdrew consent|1|||
33368644|NCT00809445|62747546|FG000|1 Month Follow-up|Death|0|||
33368645|NCT00809445|62747547|FG001|1 Month Follow-up|Death|1|||
33368646|NCT00809445|62747548|FG002|1 Month Follow-up|Death|1|||
33368647|NCT00809445|62747546|FG000|1 Month Follow-up|Incarcerated|0|||
33368648|NCT00809445|62747547|FG001|1 Month Follow-up|Incarcerated|0|||
33368649|NCT00809445|62747548|FG002|1 Month Follow-up|Incarcerated|1|||
33368650|NCT00809445|62747546|FG000|6 Month Follow-up|Lost contact|16|||
33368651|NCT00809445|62747547|FG001|6 Month Follow-up|Lost contact|14|||
33368652|NCT00809445|62747548|FG002|6 Month Follow-up|Lost contact|14|||
33368653|NCT00809445|62747546|FG000|6 Month Follow-up|Death|2|||
33368654|NCT00809445|62747547|FG001|6 Month Follow-up|Death|1|||
33368655|NCT00809445|62747548|FG002|6 Month Follow-up|Death|1|||
33368656|NCT00809445|62747546|FG000|6 Month Follow-up|Incarcerated|6|||
33368657|NCT00809445|62747547|FG001|6 Month Follow-up|Incarcerated|8|||
33368658|NCT00809445|62747548|FG002|6 Month Follow-up|Incarcerated|8|||
33484888|NCT02819518|62861973|FG003|Overall Study|Death|447|||
33484889|NCT02819518|62861974|FG004|Overall Study|Death|233|||
33484890|NCT02819518|62861970|FG000|Overall Study|Withdrawal by Subject|0|||
33484891|NCT02819518|62861971|FG001|Overall Study|Withdrawal by Subject|0|||
33484892|NCT02819518|62861972|FG002|Overall Study|Withdrawal by Subject|0|||
33484893|NCT02819518|62861973|FG003|Overall Study|Withdrawal by Subject|21|||
33368659|NCT00809445|62747546|FG000|6 Month Follow-up|Withdrew consent|0|||
33368660|NCT00809445|62747547|FG001|6 Month Follow-up|Withdrew consent|0|||
33368661|NCT00809445|62747548|FG002|6 Month Follow-up|Withdrew consent|1|||
33368662|NCT00593918|62747571|FG000|Overall Study|Withdrawal by Subject|5|||
33368663|NCT00593918|62747572|FG001|Overall Study|Withdrawal by Subject|24|||
33368664|NCT00499369|62747583|FG000|Overall Study|Adverse Event|2|||
33368665|NCT00499369|62747584|FG001|Overall Study|Adverse Event|2|||
33368666|NCT00499369|62747585|FG002|Overall Study|Adverse Event|3|||
33368667|NCT00499369|62747586|FG003|Overall Study|Adverse Event|1|||
33484894|NCT02819518|62861974|FG004|Overall Study|Withdrawal by Subject|6|||
33368668|NCT00499369|62747587|FG004|Overall Study|Adverse Event|2|||
33368669|NCT00499369|62747583|FG000|Overall Study|Withdrawal by Subject|0|||
33368670|NCT00499369|62747584|FG001|Overall Study|Withdrawal by Subject|1|||
33368671|NCT00499369|62747585|FG002|Overall Study|Withdrawal by Subject|1|||
33368672|NCT00499369|62747586|FG003|Overall Study|Withdrawal by Subject|0|||
33368673|NCT00499369|62747587|FG004|Overall Study|Withdrawal by Subject|0|||
33368674|NCT00499369|62747583|FG000|Overall Study|Progression|10|||
33266782|NCT01910402|62638194|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
33266783|NCT01910402|62638195|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
33266784|NCT01910402|62638196|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
33266785|NCT01910402|62638194|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
33368675|NCT00499369|62747584|FG001|Overall Study|Progression|12|||
33368676|NCT00499369|62747585|FG002|Overall Study|Progression|9|||
33368677|NCT00499369|62747586|FG003|Overall Study|Progression|6|||
33368678|NCT00499369|62747587|FG004|Overall Study|Progression|10|||
33368679|NCT00499369|62747583|FG000|Overall Study|Death|0|||
33368680|NCT00499369|62747584|FG001|Overall Study|Death|1|||
33368681|NCT00499369|62747585|FG002|Overall Study|Death|0|||
33368682|NCT00499369|62747586|FG003|Overall Study|Death|0|||
33368683|NCT00499369|62747587|FG004|Overall Study|Death|0|||
33368684|NCT00499369|62747583|FG000|Overall Study|Not protocol specified|2|||
33368685|NCT00499369|62747584|FG001|Overall Study|Not protocol specified|0|||
33368686|NCT00499369|62747585|FG002|Overall Study|Not protocol specified|3|||
33368687|NCT00499369|62747586|FG003|Overall Study|Not protocol specified|1|||
33368688|NCT00499369|62747587|FG004|Overall Study|Not protocol specified|0|||
33368689|NCT00499369|62747583|FG000|Overall Study|Ineligible|2|||
33368690|NCT00499369|62747584|FG001|Overall Study|Ineligible|2|||
33368691|NCT00499369|62747585|FG002|Overall Study|Ineligible|1|||
33368692|NCT00499369|62747586|FG003|Overall Study|Ineligible|1|||
33368693|NCT00499369|62747587|FG004|Overall Study|Ineligible|0|||
33368694|NCT00869258|62747599|FG000|Overall Study|Physician Decision|1|||
33368695|NCT00693784|62747603|FG000|Overall Study|Lost to Follow-up|2|||
33368696|NCT00693784|62747603|FG000|Overall Study|Withdrawal by Subject|2|||
33368697|NCT00693706|62747609|FG000|Overall Study|Protocol Violation|0|||
33368698|NCT00693706|62747610|FG001|Overall Study|Protocol Violation|1|||
33368699|NCT00488683|62747619|FG000|Overall Study|Withdrawal by Subject|1|||
33368700|NCT00488683|62747620|FG001|Overall Study|Withdrawal by Subject|2|||
33368701|NCT00488683|62747621|FG002|Overall Study|Withdrawal by Subject|2|||
33368702|NCT00488683|62747619|FG000|Overall Study|Lost to Follow-up|5|||
33368703|NCT00488683|62747620|FG001|Overall Study|Lost to Follow-up|3|||
33368704|NCT00488683|62747621|FG002|Overall Study|Lost to Follow-up|0|||
33368705|NCT00488683|62747619|FG000|Overall Study|Protocol Violation|5|||
33368706|NCT00488683|62747620|FG001|Overall Study|Protocol Violation|1|||
33368707|NCT00488683|62747621|FG002|Overall Study|Protocol Violation|0|||
33368708|NCT00488683|62747619|FG000|Overall Study|Unable to Classify|1|||
33368709|NCT00488683|62747620|FG001|Overall Study|Unable to Classify|0|||
33368710|NCT00488683|62747621|FG002|Overall Study|Unable to Classify|0|||
33368711|NCT00693472|62747655|FG000|Part 1|Adverse Event|1|||
33368712|NCT00693472|62747656|FG001|Part 1|Adverse Event|1|||
33368713|NCT00693472|62747657|FG002|Part 1|Adverse Event|0|||
33368714|NCT00693472|62747658|FG003|Part 1|Adverse Event|0|||
33368715|NCT00693472|62747655|FG000|Part 1|Lost to Follow-up|0|||
33368716|NCT00693472|62747656|FG001|Part 1|Lost to Follow-up|1|||
33368717|NCT00693472|62747657|FG002|Part 1|Lost to Follow-up|0|||
33368718|NCT00693472|62747658|FG003|Part 1|Lost to Follow-up|0|||
33368719|NCT00693472|62747655|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
33368720|NCT00693472|62747656|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
33368721|NCT00693472|62747657|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
33368722|NCT00693472|62747658|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
33368723|NCT00693472|62747655|FG000|Part 2|Adverse Event|0|||
33368724|NCT00693472|62747656|FG001|Part 2|Adverse Event|0|||
33368725|NCT00693472|62747657|FG002|Part 2|Adverse Event|1|||
33368726|NCT00693472|62747658|FG003|Part 2|Adverse Event|0|||
33368727|NCT00693472|62747655|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
33368728|NCT00693472|62747656|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
33368729|NCT00693472|62747657|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
33368730|NCT00693472|62747658|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
33368731|NCT00498433|62747671|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
33484895|NCT02819518|62861970|FG000|Overall Study|Ongoing in Study|2|||
33368732|NCT00498433|62747672|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
33368733|NCT00498433|62747673|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
33368734|NCT00498433|62747671|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
33368735|NCT00498433|62747672|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
33368736|NCT00498433|62747673|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
33368737|NCT00498433|62747671|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
33368738|NCT00498433|62747672|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
33368739|NCT00498433|62747673|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
33484896|NCT02819518|62861971|FG001|Overall Study|Ongoing in Study|3|||
33368740|NCT00498433|62747671|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
33368741|NCT00498433|62747672|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
33368742|NCT00498433|62747673|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
33368743|NCT00498355|62747690|FG000|Overall Study|Lost to Follow-up|1|||
33368744|NCT04327271|62747697|FG000|Overall Study|Death|1|||
33368745|NCT04327271|62747698|FG001|Overall Study|Death|0|||
33368746|NCT04327271|62747697|FG000|Overall Study|Withdrawal by Subject|1|||
33368747|NCT04327271|62747698|FG001|Overall Study|Withdrawal by Subject|0|||
33368748|NCT04327271|62747697|FG000|Overall Study|randomization error (data capture)|4|||
33368749|NCT04327271|62747698|FG001|Overall Study|randomization error (data capture)|3|||
33368750|NCT00688636|62747715|FG000|Overall Study|Adverse Event|2|||
33368751|NCT00688636|62747716|FG001|Overall Study|Adverse Event|1|||
33368752|NCT00870740|62747728|FG000|Overall Study|Adverse Event|2|||
33368753|NCT00870740|62747729|FG001|Overall Study|Adverse Event|1|||
33368754|NCT00870740|62747730|FG002|Overall Study|Adverse Event|3|||
33368755|NCT00870740|62747731|FG003|Overall Study|Adverse Event|2|||
33368756|NCT00870740|62747732|FG004|Overall Study|Adverse Event|1|||
33368757|NCT00870740|62747733|FG005|Overall Study|Adverse Event|6|||
33368758|NCT00870740|62747728|FG000|Overall Study|Consent Withdrawn|6|||
33368759|NCT00870740|62747729|FG001|Overall Study|Consent Withdrawn|3|||
33368760|NCT00870740|62747730|FG002|Overall Study|Consent Withdrawn|4|||
33368761|NCT00870740|62747731|FG003|Overall Study|Consent Withdrawn|6|||
33368762|NCT00870740|62747732|FG004|Overall Study|Consent Withdrawn|6|||
33368763|NCT00870740|62747733|FG005|Overall Study|Consent Withdrawn|5|||
33368764|NCT00870740|62747728|FG000|Overall Study|Investigator Decision|2|||
33368765|NCT00870740|62747729|FG001|Overall Study|Investigator Decision|0|||
33368766|NCT00870740|62747730|FG002|Overall Study|Investigator Decision|1|||
33368767|NCT00870740|62747731|FG003|Overall Study|Investigator Decision|0|||
33368768|NCT00870740|62747732|FG004|Overall Study|Investigator Decision|0|||
33368769|NCT00870740|62747733|FG005|Overall Study|Investigator Decision|0|||
33368770|NCT00870740|62747728|FG000|Overall Study|Subject Non-compliance|0|||
33368771|NCT00870740|62747729|FG001|Overall Study|Subject Non-compliance|0|||
33368772|NCT00870740|62747730|FG002|Overall Study|Subject Non-compliance|0|||
33368773|NCT00870740|62747731|FG003|Overall Study|Subject Non-compliance|0|||
33368774|NCT00870740|62747732|FG004|Overall Study|Subject Non-compliance|0|||
33368775|NCT00870740|62747733|FG005|Overall Study|Subject Non-compliance|1|||
33368776|NCT00870740|62747728|FG000|Overall Study|Death|0|||
33368777|NCT00870740|62747729|FG001|Overall Study|Death|0|||
33368778|NCT00870740|62747730|FG002|Overall Study|Death|0|||
33368779|NCT00870740|62747731|FG003|Overall Study|Death|0|||
33368780|NCT00870740|62747732|FG004|Overall Study|Death|1|||
33368781|NCT00870740|62747733|FG005|Overall Study|Death|0|||
33368782|NCT00870740|62747728|FG000|Overall Study|Other|2|||
33368783|NCT00870740|62747729|FG001|Overall Study|Other|5|||
33368784|NCT00870740|62747730|FG002|Overall Study|Other|2|||
33368785|NCT00870740|62747731|FG003|Overall Study|Other|4|||
33368786|NCT00870740|62747732|FG004|Overall Study|Other|3|||
33368787|NCT00870740|62747733|FG005|Overall Study|Other|5|||
33368788|NCT00869024|62747760|FG000|Overall Study|Death|2|||
33368789|NCT00869024|62747761|FG001|Overall Study|Death|3|||
33368790|NCT00869024|62747760|FG000|Overall Study|Lost to Follow-up|0|||
33368791|NCT00869024|62747761|FG001|Overall Study|Lost to Follow-up|1|||
33368792|NCT00869024|62747760|FG000|Overall Study|Protocol Violation|0|||
33368793|NCT00869024|62747761|FG001|Overall Study|Protocol Violation|1|||
33368794|NCT00506779|62747769|FG000|Overall Study|Withdrawal by Subject|1|||
33368795|NCT00506779|62747770|FG001|Overall Study|Withdrawal by Subject|0|||
33368796|NCT00506779|62747771|FG002|Overall Study|Withdrawal by Subject|1|||
33368797|NCT00506779|62747772|FG003|Overall Study|Withdrawal by Subject|0|||
33368798|NCT00506779|62747769|FG000|Overall Study|Adverse Event|0|||
33368799|NCT00506779|62747770|FG001|Overall Study|Adverse Event|1|||
33368800|NCT00506779|62747771|FG002|Overall Study|Adverse Event|1|||
33368801|NCT00506779|62747772|FG003|Overall Study|Adverse Event|1|||
33368802|NCT00488293|62747785|FG000|Overall Study|Lost to Follow-up|28|||
33368803|NCT00488293|62747786|FG001|Overall Study|Lost to Follow-up|25|||
33368804|NCT00488293|62747785|FG000|Overall Study|Withdrawal by Subject|5|||
33368805|NCT00488293|62747786|FG001|Overall Study|Withdrawal by Subject|3|||
33368806|NCT00488293|62747785|FG000|Overall Study|Death|2|||
33368807|NCT00488293|62747786|FG001|Overall Study|Death|1|||
33368808|NCT00488293|62747785|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
33368809|NCT00488293|62747786|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
33368810|NCT00868790|62747792|FG000|Period 1|Adverse Event|1|||
33368811|NCT00868790|62747793|FG001|Period 1|Adverse Event|0|||
33368812|NCT00868790|62747794|FG002|Period 1|Adverse Event|0|||
33368813|NCT00868790|62747795|FG003|Period 1|Adverse Event|0|||
33368814|NCT00868790|62747796|FG004|Period 1|Adverse Event|0|||
33368815|NCT00868790|62747797|FG005|Period 1|Adverse Event|0|||
33368816|NCT00868790|62747798|FG006|Period 1|Adverse Event|0|||
33368817|NCT00868790|62747799|FG007|Period 1|Adverse Event|3|||
33368818|NCT00868790|62747800|FG008|Period 1|Adverse Event|1|||
33368819|NCT00868790|62747801|FG009|Period 1|Adverse Event|0|||
33368820|NCT00868790|62747802|FG010|Period 1|Adverse Event|0|||
33368821|NCT00868790|62747803|FG011|Period 1|Adverse Event|0|||
33368822|NCT00868790|62747804|FG012|Period 1|Adverse Event|0|||
33368823|NCT00868790|62747805|FG013|Period 1|Adverse Event|1|||
33368824|NCT00868790|62747792|FG000|Period 1|Protocol Violation|1|||
33368825|NCT00868790|62747793|FG001|Period 1|Protocol Violation|0|||
33368826|NCT00868790|62747794|FG002|Period 1|Protocol Violation|0|||
33368827|NCT00868790|62747795|FG003|Period 1|Protocol Violation|0|||
33368828|NCT00868790|62747796|FG004|Period 1|Protocol Violation|0|||
33368829|NCT00868790|62747797|FG005|Period 1|Protocol Violation|0|||
33368830|NCT00868790|62747798|FG006|Period 1|Protocol Violation|0|||
33368831|NCT00868790|62747799|FG007|Period 1|Protocol Violation|0|||
33368832|NCT00868790|62747800|FG008|Period 1|Protocol Violation|0|||
33368833|NCT00868790|62747801|FG009|Period 1|Protocol Violation|0|||
33368834|NCT00868790|62747802|FG010|Period 1|Protocol Violation|0|||
33368835|NCT00868790|62747803|FG011|Period 1|Protocol Violation|0|||
33368836|NCT00868790|62747804|FG012|Period 1|Protocol Violation|0|||
33368837|NCT00868790|62747805|FG013|Period 1|Protocol Violation|0|||
33368838|NCT00868790|62747792|FG000|Period 1|Withdrawal by Subject|0|||
33368839|NCT00868790|62747793|FG001|Period 1|Withdrawal by Subject|1|||
33368840|NCT00868790|62747794|FG002|Period 1|Withdrawal by Subject|0|||
33368841|NCT00868790|62747795|FG003|Period 1|Withdrawal by Subject|0|||
33368842|NCT00868790|62747796|FG004|Period 1|Withdrawal by Subject|0|||
33368843|NCT00868790|62747797|FG005|Period 1|Withdrawal by Subject|0|||
33368844|NCT00868790|62747798|FG006|Period 1|Withdrawal by Subject|0|||
33368845|NCT00868790|62747799|FG007|Period 1|Withdrawal by Subject|0|||
33368846|NCT00868790|62747800|FG008|Period 1|Withdrawal by Subject|0|||
33368847|NCT00868790|62747801|FG009|Period 1|Withdrawal by Subject|0|||
33368848|NCT00868790|62747802|FG010|Period 1|Withdrawal by Subject|0|||
33368849|NCT00868790|62747803|FG011|Period 1|Withdrawal by Subject|0|||
33368850|NCT00868790|62747804|FG012|Period 1|Withdrawal by Subject|0|||
33368851|NCT00868790|62747805|FG013|Period 1|Withdrawal by Subject|1|||
33368852|NCT00868790|62747792|FG000|Period 1|Abnormal Triglycerides|0|||
33368853|NCT00868790|62747793|FG001|Period 1|Abnormal Triglycerides|0|||
33368854|NCT00868790|62747794|FG002|Period 1|Abnormal Triglycerides|0|||
33368855|NCT00868790|62747795|FG003|Period 1|Abnormal Triglycerides|0|||
33368856|NCT00868790|62747796|FG004|Period 1|Abnormal Triglycerides|1|||
33368857|NCT00868790|62747797|FG005|Period 1|Abnormal Triglycerides|0|||
33368858|NCT00868790|62747798|FG006|Period 1|Abnormal Triglycerides|0|||
33368859|NCT00868790|62747799|FG007|Period 1|Abnormal Triglycerides|0|||
33368860|NCT00868790|62747800|FG008|Period 1|Abnormal Triglycerides|0|||
33368861|NCT00868790|62747801|FG009|Period 1|Abnormal Triglycerides|0|||
33368862|NCT00868790|62747802|FG010|Period 1|Abnormal Triglycerides|0|||
33368863|NCT00868790|62747803|FG011|Period 1|Abnormal Triglycerides|0|||
33368864|NCT00868790|62747804|FG012|Period 1|Abnormal Triglycerides|0|||
33368865|NCT00868790|62747805|FG013|Period 1|Abnormal Triglycerides|0|||
33368866|NCT00868790|62747792|FG000|Period 1|Lost to Follow-up|0|||
33368867|NCT00868790|62747793|FG001|Period 1|Lost to Follow-up|0|||
33368868|NCT00868790|62747794|FG002|Period 1|Lost to Follow-up|0|||
33368869|NCT00868790|62747795|FG003|Period 1|Lost to Follow-up|0|||
33368870|NCT00868790|62747796|FG004|Period 1|Lost to Follow-up|0|||
33368871|NCT00868790|62747797|FG005|Period 1|Lost to Follow-up|1|||
33368872|NCT00868790|62747798|FG006|Period 1|Lost to Follow-up|0|||
33368873|NCT00868790|62747799|FG007|Period 1|Lost to Follow-up|0|||
33266786|NCT01910402|62638195|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
33368874|NCT00868790|62747800|FG008|Period 1|Lost to Follow-up|0|||
33484897|NCT02819518|62861972|FG002|Overall Study|Ongoing in Study|1|||
33555553|NCT02794883|62948349|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
33266787|NCT01910402|62638196|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
33266788|NCT01910402|62638194|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
33266789|NCT01910402|62638195|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
33266790|NCT01910402|62638196|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
33266791|NCT01910402|62638194|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
33266792|NCT01910402|62638195|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
33266793|NCT01910402|62638196|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
33266794|NCT01910402|62638194|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
33266795|NCT01910402|62638195|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
33266796|NCT01910402|62638196|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
33368875|NCT00868790|62747801|FG009|Period 1|Lost to Follow-up|0|||
33368876|NCT00868790|62747802|FG010|Period 1|Lost to Follow-up|0|||
33368877|NCT00868790|62747803|FG011|Period 1|Lost to Follow-up|0|||
33368878|NCT00868790|62747804|FG012|Period 1|Lost to Follow-up|0|||
33368879|NCT00868790|62747805|FG013|Period 1|Lost to Follow-up|0|||
33368880|NCT00868790|62747792|FG000|Period 2|Adverse Event|0|||
33368881|NCT00868790|62747793|FG001|Period 2|Adverse Event|0|||
33368882|NCT00868790|62747794|FG002|Period 2|Adverse Event|0|||
33368883|NCT00868790|62747795|FG003|Period 2|Adverse Event|0|||
33368884|NCT00868790|62747796|FG004|Period 2|Adverse Event|0|||
33368885|NCT00868790|62747797|FG005|Period 2|Adverse Event|0|||
33266797|NCT01910402|62638194|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
33266798|NCT01910402|62638195|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
33266799|NCT01910402|62638196|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
33266800|NCT01757535|62638223|FG000|Overall Study|Disease Relapse|143|||
33266801|NCT01757535|62638224|FG001|Overall Study|Disease Relapse|180|||
33266802|NCT01757535|62638223|FG000|Overall Study|Adverse Event|29|||
33266803|NCT01757535|62638224|FG001|Overall Study|Adverse Event|11|||
33266804|NCT01757535|62638223|FG000|Overall Study|Withdrawal by Subject|9|||
33266805|NCT01757535|62638224|FG001|Overall Study|Withdrawal by Subject|13|||
33266806|NCT01757535|62638223|FG000|Overall Study|Miscellaneous|5|||
33266807|NCT01757535|62638224|FG001|Overall Study|Miscellaneous|2|||
33266808|NCT01757535|62638223|FG000|Overall Study|Physician Decision|6|||
33266809|NCT01757535|62638224|FG001|Overall Study|Physician Decision|0|||
33266810|NCT01757535|62638223|FG000|Overall Study|Death|1|||
33266811|NCT01757535|62638224|FG001|Overall Study|Death|2|||
33266812|NCT01614197|62638238|FG000|Overall Study|Withdrawal by Subject|0|||
33266813|NCT01614197|62638239|FG001|Overall Study|Withdrawal by Subject|1|||
33266814|NCT01614197|62638240|FG002|Overall Study|Withdrawal by Subject|0|||
33266815|NCT01614197|62638241|FG003|Overall Study|Withdrawal by Subject|0|||
33266816|NCT01236521|62638275|FG000|Overall Study|Withdrawal by Subject|12|||
33266817|NCT01236521|62638276|FG001|Overall Study|Withdrawal by Subject|17|||
33266818|NCT01236521|62638275|FG000|Overall Study|Death|2|||
33266819|NCT01236521|62638276|FG001|Overall Study|Death|1|||
33266820|NCT01236521|62638275|FG000|Overall Study|Lost to Follow-up|9|||
33266821|NCT01236521|62638276|FG001|Overall Study|Lost to Follow-up|7|||
33266822|NCT01226797|62638284|FG000|Overall Study|Adverse Event|1|||
33266823|NCT01226797|62638285|FG001|Overall Study|Adverse Event|0|||
33266824|NCT01226797|62638284|FG000|Overall Study|No longer willing to participate|1|||
33266825|NCT01226797|62638285|FG001|Overall Study|No longer willing to participate|0|||
33266826|NCT01226797|62638284|FG000|Overall Study|Protocol Violation|0|||
33266827|NCT01226797|62638285|FG001|Overall Study|Protocol Violation|1|||
33266828|NCT01142908|62638293|FG000|Overall Study|Lost to Follow-up|19|||
33266829|NCT01142908|62638294|FG001|Overall Study|Lost to Follow-up|13|||
33266830|NCT01142908|62638293|FG000|Overall Study|Death|1|||
33266831|NCT01142908|62638294|FG001|Overall Study|Death|4|||
33266832|NCT01142908|62638293|FG000|Overall Study|Excluded - did not meet criteria|9|||
33266833|NCT01142908|62638294|FG001|Overall Study|Excluded - did not meet criteria|5|||
33266834|NCT01142908|62638293|FG000|Overall Study|Withdrawal by Subject|3|||
33266835|NCT01142908|62638294|FG001|Overall Study|Withdrawal by Subject|0|||
33266836|NCT01470326|62638330|FG000|Overall Study|Protocol Violation|32|||
33266837|NCT01470326|62638330|FG000|Overall Study|No Drug Administration Information|2|||
33266838|NCT01470326|62638330|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
33266839|NCT01480180|62638345|FG000|Main Phase|Withdrawal criteria|12|||
33266840|NCT01480180|62638346|FG001|Main Phase|Withdrawal criteria|1|||
33266841|NCT01480180|62638347|FG002|Main Phase|Withdrawal criteria|0|||
33266842|NCT01480180|62638348|FG003|Main Phase|Withdrawal criteria|0|||
33266843|NCT01480180|62638349|FG004|Main Phase|Withdrawal criteria|0|||
33266844|NCT01480180|62638350|FG005|Main Phase|Withdrawal criteria|0|||
33266845|NCT01480180|62638345|FG000|Main Phase|Lack of Efficacy|1|||
33266846|NCT01480180|62638346|FG001|Main Phase|Lack of Efficacy|0|||
33266847|NCT01480180|62638347|FG002|Main Phase|Lack of Efficacy|0|||
33266848|NCT01480180|62638348|FG003|Main Phase|Lack of Efficacy|0|||
33266849|NCT01480180|62638349|FG004|Main Phase|Lack of Efficacy|0|||
33266850|NCT01480180|62638350|FG005|Main Phase|Lack of Efficacy|0|||
33266851|NCT01480180|62638345|FG000|Main Phase|Non-compliance|3|||
33266852|NCT01480180|62638346|FG001|Main Phase|Non-compliance|0|||
33266853|NCT01480180|62638347|FG002|Main Phase|Non-compliance|0|||
33266854|NCT01480180|62638348|FG003|Main Phase|Non-compliance|0|||
33266855|NCT01480180|62638349|FG004|Main Phase|Non-compliance|0|||
33266856|NCT01480180|62638350|FG005|Main Phase|Non-compliance|0|||
33266857|NCT01480180|62638345|FG000|Main Phase|Unclassified|3|||
33266858|NCT01480180|62638346|FG001|Main Phase|Unclassified|0|||
33266859|NCT01480180|62638347|FG002|Main Phase|Unclassified|0|||
33266860|NCT01480180|62638348|FG003|Main Phase|Unclassified|0|||
33266861|NCT01480180|62638349|FG004|Main Phase|Unclassified|0|||
33266862|NCT01480180|62638350|FG005|Main Phase|Unclassified|0|||
33266863|NCT01480180|62638345|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
33266864|NCT01480180|62638346|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
33266865|NCT01480180|62638347|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
33484898|NCT02819518|62861973|FG003|Overall Study|Ongoing in Study|98|||
33484899|NCT02819518|62861974|FG004|Overall Study|Ongoing in Study|42|||
33484900|NCT03310580|62861991|FG000|Overall Study|Adverse Event|0|||
33266866|NCT01480180|62638348|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
33266867|NCT01480180|62638349|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
33266868|NCT01480180|62638350|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
33484901|NCT03310580|62861992|FG001|Overall Study|Adverse Event|1|||
33266869|NCT01480180|62638345|FG000|Extension Phase, Part 1|Unclassified|0|||
33266870|NCT01480180|62638346|FG001|Extension Phase, Part 1|Unclassified|0|||
33266871|NCT01480180|62638347|FG002|Extension Phase, Part 1|Unclassified|1|||
33266872|NCT01480180|62638348|FG003|Extension Phase, Part 1|Unclassified|0|||
33266873|NCT01480180|62638349|FG004|Extension Phase, Part 1|Unclassified|0|||
33266874|NCT01480180|62638350|FG005|Extension Phase, Part 1|Unclassified|0|||
33266875|NCT01480180|62638345|FG000|Extension Phase, Part 1|Adverse Event|0|||
33266876|NCT01480180|62638346|FG001|Extension Phase, Part 1|Adverse Event|0|||
33266877|NCT01480180|62638347|FG002|Extension Phase, Part 1|Adverse Event|4|||
33266878|NCT01480180|62638348|FG003|Extension Phase, Part 1|Adverse Event|1|||
33266879|NCT01480180|62638349|FG004|Extension Phase, Part 1|Adverse Event|0|||
33266880|NCT01480180|62638350|FG005|Extension Phase, Part 1|Adverse Event|0|||
33266881|NCT01480180|62638345|FG000|Extension Phase, Part 1|Change of treatment|0|||
33266882|NCT01480180|62638346|FG001|Extension Phase, Part 1|Change of treatment|0|||
33266883|NCT01480180|62638347|FG002|Extension Phase, Part 1|Change of treatment|0|||
33266884|NCT01480180|62638348|FG003|Extension Phase, Part 1|Change of treatment|9|||
33266885|NCT01480180|62638349|FG004|Extension Phase, Part 1|Change of treatment|0|||
33266886|NCT01480180|62638350|FG005|Extension Phase, Part 1|Change of treatment|0|||
33266887|NCT01480180|62638345|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
33266888|NCT01480180|62638346|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
33266889|NCT01480180|62638347|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
33266890|NCT01480180|62638348|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
33266891|NCT01480180|62638349|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
33266892|NCT01480180|62638350|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
33266893|NCT01480180|62638345|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
33266894|NCT01480180|62638346|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
33266895|NCT01480180|62638347|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
33266896|NCT01480180|62638348|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
33266897|NCT01480180|62638349|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
33266898|NCT01480180|62638350|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
33266899|NCT01480180|62638345|FG000|Extension Phase, Part 2|Unclassified|0|||
33266900|NCT01480180|62638346|FG001|Extension Phase, Part 2|Unclassified|0|||
33266901|NCT01480180|62638347|FG002|Extension Phase, Part 2|Unclassified|3|||
33266902|NCT01480180|62638348|FG003|Extension Phase, Part 2|Unclassified|1|||
33266903|NCT01480180|62638349|FG004|Extension Phase, Part 2|Unclassified|1|||
33266904|NCT01480180|62638350|FG005|Extension Phase, Part 2|Unclassified|0|||
33266905|NCT05300087|62638381|FG000|Overall Study|Withdrawal by Subject|0|||
33266906|NCT05300087|62638382|FG001|Overall Study|Withdrawal by Subject|1|||
33266907|NCT04803734|62638395|FG000|Overall Study|Withdrawal by Subject|0|||
33266908|NCT04803734|62638396|FG001|Overall Study|Withdrawal by Subject|1|||
33266909|NCT04803734|62638395|FG000|Overall Study|Protocol Violation|0|||
33266910|NCT04803734|62638396|FG001|Overall Study|Protocol Violation|1|||
33266911|NCT04112173|62638432|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
33266912|NCT03872453|62638440|FG000|Overall Study|Adverse Event|1|||
33266913|NCT03872453|62638441|FG001|Overall Study|Adverse Event|1|||
33266914|NCT03872453|62638442|FG002|Overall Study|Adverse Event|0|||
33266915|NCT03872453|62638443|FG003|Overall Study|Adverse Event|0|||
33266916|NCT03872453|62638440|FG000|Overall Study|Lost to Follow-up|8|||
33266917|NCT03872453|62638441|FG001|Overall Study|Lost to Follow-up|7|||
33266918|NCT03872453|62638442|FG002|Overall Study|Lost to Follow-up|4|||
33266919|NCT03872453|62638443|FG003|Overall Study|Lost to Follow-up|4|||
33266920|NCT03872453|62638440|FG000|Overall Study|Never Treated Migraine|19|||
33266921|NCT03872453|62638441|FG001|Overall Study|Never Treated Migraine|17|||
33266922|NCT03872453|62638442|FG002|Overall Study|Never Treated Migraine|13|||
33266923|NCT03872453|62638443|FG003|Overall Study|Never Treated Migraine|12|||
33266924|NCT03872453|62638440|FG000|Overall Study|Pregnancy|1|||
33266925|NCT03872453|62638441|FG001|Overall Study|Pregnancy|0|||
33266926|NCT03872453|62638442|FG002|Overall Study|Pregnancy|0|||
33266927|NCT03872453|62638443|FG003|Overall Study|Pregnancy|0|||
33266928|NCT03872453|62638440|FG000|Overall Study|Protocol Deviation|2|||
33266929|NCT03872453|62638441|FG001|Overall Study|Protocol Deviation|0|||
33266930|NCT03872453|62638442|FG002|Overall Study|Protocol Deviation|0|||
33266931|NCT03872453|62638443|FG003|Overall Study|Protocol Deviation|2|||
33266932|NCT03872453|62638440|FG000|Overall Study|Withdrawal by Subject|0|||
33266933|NCT03872453|62638441|FG001|Overall Study|Withdrawal by Subject|1|||
33266934|NCT03872453|62638442|FG002|Overall Study|Withdrawal by Subject|2|||
33266935|NCT03872453|62638443|FG003|Overall Study|Withdrawal by Subject|0|||
33266936|NCT03872453|62638440|FG000|Overall Study|Other Than Specified|1|||
33266937|NCT03872453|62638441|FG001|Overall Study|Other Than Specified|0|||
33266938|NCT03872453|62638442|FG002|Overall Study|Other Than Specified|0|||
33266939|NCT03872453|62638443|FG003|Overall Study|Other Than Specified|0|||
33266940|NCT03726879|62638455|FG000|Overall Study|Death|6|||
33266941|NCT03726879|62638456|FG001|Overall Study|Death|4|||
33266942|NCT03726879|62638455|FG000|Overall Study|Physician Decision|0|||
33266943|NCT03726879|62638456|FG001|Overall Study|Physician Decision|2|||
33266944|NCT03726879|62638455|FG000|Overall Study|Protocol Violation|0|||
33266945|NCT03726879|62638456|FG001|Overall Study|Protocol Violation|1|||
33266946|NCT03726879|62638455|FG000|Overall Study|Withdrawal by Subject|5|||
33266947|NCT03726879|62638456|FG001|Overall Study|Withdrawal by Subject|5|||
33266948|NCT03726879|62638455|FG000|Overall Study|TSH result is unstable|0|||
33266949|NCT03726879|62638456|FG001|Overall Study|TSH result is unstable|1|||
33266950|NCT03726879|62638455|FG000|Overall Study|Continuing on Study|215|||
33266951|NCT03726879|62638456|FG001|Overall Study|Continuing on Study|215|||
33266952|NCT03721835|62638462|FG000|Overall Study|Participant not able to return|1|||
33266953|NCT03721835|62638462|FG000|Overall Study|Lost to Follow-up|1|||
33266954|NCT03721835|62638462|FG000|Overall Study|Revision of the components of the study device|2|||
33266955|NCT03721835|62638462|FG000|Overall Study|Sponsor terminated study|6|||
33266956|NCT03721835|62638462|FG000|Overall Study|Death|1|||
33266957|NCT03721835|62638462|FG000|Overall Study|Sponsor decision|1|||
33266958|NCT03565991|62638468|FG000|Overall Study|Other|11|||
33266959|NCT03565991|62638469|FG001|Overall Study|Other|0|||
33266960|NCT03565991|62638468|FG000|Overall Study|Global deterioration of health status|14|||
33266961|NCT03565991|62638469|FG001|Overall Study|Global deterioration of health status|4|||
33266962|NCT03565991|62638468|FG000|Overall Study|Withdrawal by Subject|2|||
33266963|NCT03565991|62638469|FG001|Overall Study|Withdrawal by Subject|6|||
33266964|NCT03565991|62638468|FG000|Overall Study|Progressive disease|121|||
33266965|NCT03565991|62638469|FG001|Overall Study|Progressive disease|29|||
33266966|NCT03565991|62638468|FG000|Overall Study|Death|3|||
33266967|NCT03565991|62638469|FG001|Overall Study|Death|0|||
33266968|NCT03565991|62638468|FG000|Overall Study|Adverse Event|7|||
33266969|NCT03565991|62638469|FG001|Overall Study|Adverse Event|2|||
33266972|NCT03186638|62638483|FG000|Overall Study|Withdrawal by Subject|4|||
33266973|NCT03186638|62638484|FG001|Overall Study|Withdrawal by Subject|4|||
33266974|NCT03186638|62638483|FG000|Overall Study|Withdrawn due to medical problem|3|||
33266975|NCT03186638|62638484|FG001|Overall Study|Withdrawn due to medical problem|2|||
33266976|NCT03186638|62638483|FG000|Overall Study|Lost to Follow-up|1|||
33266977|NCT03186638|62638484|FG001|Overall Study|Lost to Follow-up|0|||
33266978|NCT02975934|62638492|FG000|Treatment Phase|Ongoing at data-analysis|33|||
33266979|NCT02975934|62638493|FG001|Treatment Phase|Ongoing at data-analysis|5|||
33266980|NCT02975934|62638492|FG000|Treatment Phase|Discontinued prior to study drug|0|||
33266981|NCT02975934|62638493|FG001|Treatment Phase|Discontinued prior to study drug|5|||
33266982|NCT02975934|62638492|FG000|Cross-Over Phase|Ongoing at data-analysis|0|||
33266983|NCT02975934|62638493|FG001|Cross-Over Phase|Ongoing at data-analysis|7|||
33266984|NCT02927301|62638508|FG000|Overall Study|Adverse Event|7|||
33266985|NCT02927301|62638508|FG000|Overall Study|Withdrawal by Subject|1|||
33266986|NCT02927301|62638508|FG000|Overall Study|Physician Decision|2|||
33266987|NCT02691663|62638514|FG000|Overall Study|Screen failure after baseline|2|||
33266988|NCT02691663|62638515|FG001|Overall Study|Screen failure after baseline|2|||
33266989|NCT02691663|62638514|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
33266990|NCT02691663|62638515|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
33266991|NCT02691663|62638514|FG000|Overall Study|Withdrawn after Follow up 2|1|||
33266992|NCT02691663|62638515|FG001|Overall Study|Withdrawn after Follow up 2|1|||
33266993|NCT02691663|62638514|FG000|Overall Study|Lost to Follow-up|3|||
33266994|NCT02691663|62638515|FG001|Overall Study|Lost to Follow-up|2|||
33266995|NCT02639065|62638522|FG000|Study Treatment|Disease Progression|13|||
33266996|NCT02639065|62638522|FG000|Study Treatment|Adverse Event|9|||
33266997|NCT02639065|62638522|FG000|Study Treatment|Withdrawal by Subject|1|||
33266998|NCT02639065|62638522|FG000|Follow up|Subject refused to follow up|1|||
33266999|NCT02639065|62638522|FG000|Follow up|Symptomatic Deterioration|2|||
33267000|NCT02639065|62638522|FG000|Follow up|Death|2|||
33267001|NCT02639065|62638522|FG000|Follow up|Study Terminated|1|||
33267002|NCT02639065|62638522|FG000|Follow up|Disease Progression|3|||
33267003|NCT02566785|62638528|FG000|Overall Study|Lost to Follow-up|0|||
33267004|NCT02566785|62638529|FG001|Overall Study|Lost to Follow-up|2|||
33555554|NCT02794883|62948350|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
33555555|NCT02794883|62948348|FG000|Follow-up Period (up to 2 Years)|Death|12|||
33267005|NCT02566785|62638528|FG000|Overall Study|Worsening condition|1|||
33267006|NCT02566785|62638529|FG001|Overall Study|Worsening condition|1|||
33267007|NCT02451943|62638537|FG000|Overall Study|On Treatment|4|||
33267008|NCT02451943|62638538|FG001|Overall Study|On Treatment|4|||
33267009|NCT02451943|62638537|FG000|Overall Study|Withdrawal by Subject|13|||
33267010|NCT02451943|62638538|FG001|Overall Study|Withdrawal by Subject|16|||
33267011|NCT02451943|62638537|FG000|Overall Study|Lost to Follow-up|3|||
33267012|NCT02451943|62638538|FG001|Overall Study|Lost to Follow-up|4|||
33267013|NCT02344537|62638546|FG000|Overall Study|Protocol Violation|1|||
33267014|NCT02344537|62638547|FG001|Overall Study|Protocol Violation|1|||
33267015|NCT02344537|62638546|FG000|Overall Study|Subject started another treatment after wk 6|1|||
33267016|NCT02344537|62638547|FG001|Overall Study|Subject started another treatment after wk 6|0|||
33267017|NCT02344537|62638546|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
33267018|NCT02344537|62638547|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
33368886|NCT00868790|62747798|FG006|Period 2|Adverse Event|0|||
33555556|NCT02794883|62948349|FG001|Follow-up Period (up to 2 Years)|Death|10|||
33555557|NCT02794883|62948350|FG002|Follow-up Period (up to 2 Years)|Death|10|||
33368887|NCT00868790|62747799|FG007|Period 2|Adverse Event|0|||
33484902|NCT03310580|62861993|FG002|Overall Study|Adverse Event|0|||
33555558|NCT01370603|62948360|FG000|Period 1|Adverse Event|5|||
33555559|NCT01370603|62948361|FG001|Period 1|Adverse Event|3|||
33555560|NCT01370603|62948360|FG000|Period 1|Lost to Follow-up|2|||
33555561|NCT01370603|62948361|FG001|Period 1|Lost to Follow-up|0|||
33555562|NCT01370603|62948360|FG000|Period 1|Protocol Violation|2|||
33555563|NCT01370603|62948361|FG001|Period 1|Protocol Violation|2|||
33555564|NCT01370603|62948360|FG000|Period 1|Withdrawal by Subject|5|||
33555565|NCT01370603|62948361|FG001|Period 1|Withdrawal by Subject|5|||
33555566|NCT01370603|62948360|FG000|Crossover Washout|Adverse Event|2|||
33555567|NCT01370603|62948361|FG001|Crossover Washout|Adverse Event|1|||
33555568|NCT01370603|62948360|FG000|Crossover Washout|Lost to Follow-up|2|||
33555569|NCT01370603|62948361|FG001|Crossover Washout|Lost to Follow-up|0|||
33555570|NCT01370603|62948360|FG000|Crossover Washout|Protocol Violation|1|||
33555571|NCT01370603|62948361|FG001|Crossover Washout|Protocol Violation|0|||
33555572|NCT01370603|62948360|FG000|Crossover Washout|Withdrawal by Subject|4|||
33555573|NCT01370603|62948361|FG001|Crossover Washout|Withdrawal by Subject|1|||
33555574|NCT01370603|62948360|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
33555575|NCT01370603|62948361|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
33555576|NCT01370603|62948360|FG000|Period 2|Adverse Event|1|||
33555577|NCT01370603|62948361|FG001|Period 2|Adverse Event|4|||
33555578|NCT01370603|62948360|FG000|Period 2|Lost to Follow-up|1|||
33555579|NCT01370603|62948361|FG001|Period 2|Lost to Follow-up|0|||
33555580|NCT01370603|62948360|FG000|Period 2|Withdrawal by Subject|1|||
33555581|NCT01370603|62948361|FG001|Period 2|Withdrawal by Subject|0|||
33555582|NCT02312206|62948369|FG000|Overall Study|Adverse Event|3|||
33555583|NCT02312206|62948370|FG001|Overall Study|Adverse Event|6|||
33555584|NCT02312206|62948369|FG000|Overall Study|Withdrawal by Subject|7|||
33555585|NCT02312206|62948370|FG001|Overall Study|Withdrawal by Subject|6|||
33555586|NCT02312206|62948369|FG000|Overall Study|Physician Decision|7|||
33555587|NCT02312206|62948370|FG001|Overall Study|Physician Decision|6|||
33555588|NCT02312206|62948369|FG000|Overall Study|Death|30|||
33555589|NCT02312206|62948370|FG001|Overall Study|Death|36|||
33555590|NCT02312206|62948369|FG000|Overall Study|Study Terminated by Sponsor|81|||
33555591|NCT02312206|62948370|FG001|Overall Study|Study Terminated by Sponsor|74|||
33555592|NCT02312206|62948369|FG000|Overall Study|Disease Progression|1|||
33555593|NCT02312206|62948370|FG001|Overall Study|Disease Progression|0|||
33555594|NCT02312206|62948369|FG000|Overall Study|Patient progression and new therapy|1|||
33555595|NCT02312206|62948370|FG001|Overall Study|Patient progression and new therapy|0|||
33555596|NCT02312206|62948369|FG000|Overall Study|Patient transferred to hospice|0|||
33555597|NCT02312206|62948370|FG001|Overall Study|Patient transferred to hospice|1|||
33555598|NCT02312206|62948369|FG000|Overall Study|Subject missed 3 consecutive tx visits|0|||
33555599|NCT02312206|62948370|FG001|Overall Study|Subject missed 3 consecutive tx visits|1|||
33555600|NCT02347072|62948376|FG000|Overall Study|Adverse Event|2|||
33555601|NCT02347072|62948376|FG000|Overall Study|Withdrawal by Subject|6|||
33555602|NCT02347072|62948376|FG000|Overall Study|Physician Decision|1|||
33555603|NCT02347072|62948376|FG000|Overall Study|Lost to Follow-up|2|||
33555604|NCT02347072|62948376|FG000|Overall Study|Protocol Violation|1|||
33555605|NCT02347072|62948376|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
33555606|NCT02794103|62948384|FG000|Overall Study|Loss to follow up due to high sedation|3|||
33555607|NCT02346370|62948391|FG000|Overall Study|Not treated|1|||
33555608|NCT02346370|62948392|FG001|Overall Study|Not treated|0|||
33555609|NCT02346370|62948393|FG002|Overall Study|Not treated|0|||
33555610|NCT02346370|62948391|FG000|Overall Study|Withdrawal of consent|1|||
33555611|NCT02346370|62948392|FG001|Overall Study|Withdrawal of consent|0|||
33555612|NCT02346370|62948393|FG002|Overall Study|Withdrawal of consent|0|||
33555613|NCT02346370|62948391|FG000|Overall Study|Death|1|||
33555614|NCT02346370|62948392|FG001|Overall Study|Death|3|||
33555615|NCT02346370|62948393|FG002|Overall Study|Death|1|||
33555616|NCT02346370|62948391|FG000|Overall Study|Sponsor discontinued study|5|||
33555617|NCT02346370|62948392|FG001|Overall Study|Sponsor discontinued study|0|||
33555618|NCT02346370|62948393|FG002|Overall Study|Sponsor discontinued study|2|||
33555619|NCT02346370|62948391|FG000|Overall Study|Radiologic progression|0|||
33555620|NCT02346370|62948392|FG001|Overall Study|Radiologic progression|0|||
33555621|NCT02346370|62948393|FG002|Overall Study|Radiologic progression|1|||
33555622|NCT02346370|62948391|FG000|Overall Study|Physician Decision|0|||
33555623|NCT02346370|62948392|FG001|Overall Study|Physician Decision|1|||
33555624|NCT02346370|62948393|FG002|Overall Study|Physician Decision|0|||
33555625|NCT02346136|62948405|FG000|Overall Study|Withdrawal by Subject|7|||
33555626|NCT02346136|62948406|FG001|Overall Study|Withdrawal by Subject|5|||
33555627|NCT02346136|62948405|FG000|Overall Study|Death|1|||
33555628|NCT02346136|62948406|FG001|Overall Study|Death|0|||
33555629|NCT02346136|62948405|FG000|Overall Study|Study termination|14|||
33555630|NCT02346136|62948406|FG001|Overall Study|Study termination|18|||
33555631|NCT02793947|62948414|FG000|Overall Study|Death|1|||
33661882|NCT01697579|63091446|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
33661883|NCT01697579|63091447|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
33661884|NCT01697579|63091448|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
33661885|NCT01697579|63091449|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
33661886|NCT01697579|63091450|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
33661887|NCT01697579|63091444|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
33661888|NCT01697579|63091445|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
33661889|NCT01697579|63091446|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
33661890|NCT01697579|63091447|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
33661891|NCT01697579|63091448|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
33661892|NCT01697579|63091449|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
33661893|NCT01697579|63091450|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
33661894|NCT01697579|63091444|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
33661895|NCT01697579|63091445|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
33661896|NCT01697579|63091446|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
33661897|NCT01697579|63091447|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
33661898|NCT01697579|63091448|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
33661899|NCT01697579|63091449|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
33661900|NCT01697579|63091450|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
33661901|NCT01697579|63091444|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
33661902|NCT01697579|63091445|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
33661903|NCT01697579|63091446|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
33661904|NCT01697579|63091447|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
33661905|NCT01697579|63091448|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
33661906|NCT01697579|63091449|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
33661907|NCT01697579|63091450|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
33661908|NCT01586195|63091478|FG000|Overall Study|Death|11|||
33661909|NCT01586195|63091478|FG000|Overall Study|Withdrawal of Consent|5|||
33661910|NCT01586195|63091478|FG000|Overall Study|Started new anti-melanoma therapy|1|||
33661911|NCT01586195|63091478|FG000|Overall Study|Reason not specified|9|||
33661912|NCT01585961|63091482|FG000|Overall Study|Death|6|||
33661913|NCT01585961|63091482|FG000|Overall Study|Physician Decision|1|||
33661914|NCT01585961|63091482|FG000|Overall Study|Decision to use non-study catheter|1|||
33661915|NCT01585961|63091482|FG000|Overall Study|Withdrawal by Subject|1|||
33661916|NCT01585961|63091482|FG000|Overall Study|Lost to Follow-up|23|||
33661917|NCT01585961|63091482|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
33661918|NCT01697501|63091486|FG000|Overall Study|Protocol Violation|2|||
33661919|NCT01697345|63091499|FG000|Overall Study|Withdrawal by Subject|1|||
33661920|NCT01697267|63091568|FG000|Overall Study|Death|3|||
33661921|NCT01697267|63091569|FG001|Overall Study|Death|1|||
33661922|NCT01697267|63091568|FG000|Overall Study|Withdrawal by Subject|5|||
33661923|NCT01697267|63091569|FG001|Overall Study|Withdrawal by Subject|5|||
33661924|NCT01697267|63091568|FG000|Overall Study|Adverse Event|2|||
33661925|NCT01697267|63091569|FG001|Overall Study|Adverse Event|1|||
33661926|NCT01697267|63091568|FG000|Overall Study|Lost to Follow-up|2|||
33661927|NCT01697267|63091569|FG001|Overall Study|Lost to Follow-up|4|||
33661928|NCT01697267|63091568|FG000|Overall Study|Physician Decision|2|||
33661929|NCT01697267|63091569|FG001|Overall Study|Physician Decision|4|||
33661930|NCT01696955|63091631|FG000|Main Study|Protocol Violation|1|||
33661931|NCT01696955|63091632|FG001|Main Study|Protocol Violation|0|||
33661932|NCT01696955|63091631|FG000|Main Study|Withdrawal by Subject|1|||
33661933|NCT01696955|63091632|FG001|Main Study|Withdrawal by Subject|1|||
33661934|NCT02702388|63091656|FG000|Overall Study|Disease Progression|18|||
33661935|NCT02702388|63091657|FG001|Overall Study|Disease Progression|25|||
33661936|NCT02702388|63091656|FG000|Overall Study|Withdrawal by Subject|9|||
33661937|NCT02702388|63091657|FG001|Overall Study|Withdrawal by Subject|7|||
33661938|NCT02702388|63091656|FG000|Overall Study|Adverse Event|11|||
33661939|NCT02702388|63091657|FG001|Overall Study|Adverse Event|15|||
33661940|NCT02702388|63091656|FG000|Overall Study|Other|2|||
33661941|NCT02702388|63091657|FG001|Overall Study|Other|4|||
33661942|NCT01696877|63091683|FG000|Overall Study|Adverse Event|0|||
33661943|NCT01696877|63091684|FG001|Overall Study|Adverse Event|1|||
33661944|NCT02703636|63091880|FG000|Overall Study|Adverse Event|14|||
33661945|NCT02703636|63091880|FG000|Overall Study|Study stopped by sponsor|1|||
33661946|NCT02703636|63091880|FG000|Overall Study|Withdrawal by Subject|1|||
33661947|NCT02703324|63092108|FG000|Period Two|Withdrawal by Subject|0|||
33661948|NCT02703324|63092109|FG001|Period Two|Withdrawal by Subject|0|||
33267154|NCT01092702|62638605|FG000|Overall Study|Withdrawal by Subject|7|||
33267155|NCT01092702|62638605|FG000|Overall Study|Lost to Follow-up|2|||
33267156|NCT00658879|62638634|FG000|Overall Study|Protocol Violation|1|||
33267157|NCT00591851|62638638|FG000|Overall Study|Withdrawal by Subject|3|||
33267158|NCT00591851|62638638|FG000|Overall Study|Adverse Event|2|||
33267159|NCT00591851|62638638|FG000|Overall Study|Progressive Disease|1|||
33661949|NCT02703324|63092110|FG002|Period Two|Withdrawal by Subject|1|||
33661950|NCT02703324|63092111|FG003|Period Two|Withdrawal by Subject|0|||
33267160|NCT00374595|62638642|FG000|Overall Study|Death|23|||
33267161|NCT00374595|62638642|FG000|Overall Study|Withdrawal by Subject|39|||
33267162|NCT00374595|62638642|FG000|Overall Study|Lost to Follow-up|3|||
33267163|NCT00374595|62638642|FG000|Overall Study|too much time commitment|1|||
33267164|NCT00374595|62638642|FG000|Overall Study|transfer care to other clinical site|1|||
33267165|NCT00374595|62638642|FG000|Overall Study|relocation|3|||
33267166|NCT00336024|62638648|FG000|Overall Study|Death|2|||
33267167|NCT00336024|62638649|FG001|Overall Study|Death|1|||
33267168|NCT00336024|62638648|FG000|Overall Study|Physician Decision|4|||
33267169|NCT00336024|62638649|FG001|Overall Study|Physician Decision|1|||
33267170|NCT00336024|62638648|FG000|Overall Study|Protocol Violation|1|||
33267171|NCT00336024|62638649|FG001|Overall Study|Protocol Violation|0|||
33267172|NCT00336024|62638648|FG000|Overall Study|Withdrawal by Subject|1|||
33267173|NCT00336024|62638649|FG001|Overall Study|Withdrawal by Subject|2|||
33267174|NCT00336024|62638648|FG000|Overall Study|Failure to fulfill consolidation|1|||
33267175|NCT00336024|62638649|FG001|Overall Study|Failure to fulfill consolidation|1|||
33267176|NCT00336024|62638648|FG000|Overall Study|Progressive Disease|4|||
33267177|NCT00336024|62638649|FG001|Overall Study|Progressive Disease|7|||
33267178|NCT00336024|62638648|FG000|Overall Study|Ineligible|7|||
33267179|NCT00336024|62638649|FG001|Overall Study|Ineligible|7|||
33267180|NCT00133705|62638657|FG000|Overall Study|Withdrawal by Subject|2|||
33267181|NCT00133705|62638658|FG001|Overall Study|Withdrawal by Subject|3|||
33368888|NCT00868790|62747800|FG008|Period 2|Adverse Event|1|||
33368889|NCT00868790|62747801|FG009|Period 2|Adverse Event|0|||
33368890|NCT00868790|62747802|FG010|Period 2|Adverse Event|0|||
33368891|NCT00868790|62747803|FG011|Period 2|Adverse Event|0|||
33368892|NCT00868790|62747804|FG012|Period 2|Adverse Event|0|||
33368893|NCT00868790|62747805|FG013|Period 2|Adverse Event|0|||
33368894|NCT00868790|62747792|FG000|Period 2|Lost to Follow-up|0|||
33368895|NCT00868790|62747793|FG001|Period 2|Lost to Follow-up|1|||
33368896|NCT00868790|62747794|FG002|Period 2|Lost to Follow-up|0|||
33368897|NCT00868790|62747795|FG003|Period 2|Lost to Follow-up|0|||
33368898|NCT00868790|62747796|FG004|Period 2|Lost to Follow-up|0|||
33368899|NCT00868790|62747797|FG005|Period 2|Lost to Follow-up|1|||
33368900|NCT00868790|62747798|FG006|Period 2|Lost to Follow-up|0|||
33368901|NCT00868790|62747799|FG007|Period 2|Lost to Follow-up|0|||
33368902|NCT00868790|62747800|FG008|Period 2|Lost to Follow-up|0|||
33368903|NCT00868790|62747801|FG009|Period 2|Lost to Follow-up|0|||
33368904|NCT00868790|62747802|FG010|Period 2|Lost to Follow-up|0|||
33368905|NCT00868790|62747803|FG011|Period 2|Lost to Follow-up|0|||
33368906|NCT00868790|62747804|FG012|Period 2|Lost to Follow-up|0|||
33368907|NCT00868790|62747805|FG013|Period 2|Lost to Follow-up|0|||
33368908|NCT00868790|62747792|FG000|Period 2|Withdrawal by Subject|0|||
33368909|NCT00868790|62747793|FG001|Period 2|Withdrawal by Subject|0|||
33368910|NCT00868790|62747794|FG002|Period 2|Withdrawal by Subject|0|||
33368911|NCT00868790|62747795|FG003|Period 2|Withdrawal by Subject|0|||
33368912|NCT00868790|62747796|FG004|Period 2|Withdrawal by Subject|0|||
33368913|NCT00868790|62747797|FG005|Period 2|Withdrawal by Subject|0|||
33368914|NCT00868790|62747798|FG006|Period 2|Withdrawal by Subject|0|||
33368915|NCT00868790|62747799|FG007|Period 2|Withdrawal by Subject|0|||
33368916|NCT00868790|62747800|FG008|Period 2|Withdrawal by Subject|1|||
33368917|NCT00868790|62747801|FG009|Period 2|Withdrawal by Subject|0|||
33368918|NCT00868790|62747802|FG010|Period 2|Withdrawal by Subject|0|||
33368919|NCT00868790|62747803|FG011|Period 2|Withdrawal by Subject|0|||
33368920|NCT00868790|62747804|FG012|Period 2|Withdrawal by Subject|0|||
33368921|NCT00868790|62747805|FG013|Period 2|Withdrawal by Subject|1|||
33368922|NCT00868790|62747792|FG000|Period 3|Adverse Event|0|||
33368923|NCT00868790|62747793|FG001|Period 3|Adverse Event|0|||
33368924|NCT00868790|62747794|FG002|Period 3|Adverse Event|0|||
33368925|NCT00868790|62747795|FG003|Period 3|Adverse Event|0|||
33368926|NCT00868790|62747796|FG004|Period 3|Adverse Event|0|||
33368927|NCT00868790|62747797|FG005|Period 3|Adverse Event|0|||
33368928|NCT00868790|62747798|FG006|Period 3|Adverse Event|0|||
33368929|NCT00868790|62747799|FG007|Period 3|Adverse Event|0|||
33368930|NCT00868790|62747800|FG008|Period 3|Adverse Event|0|||
33368931|NCT00868790|62747801|FG009|Period 3|Adverse Event|1|||
33368932|NCT00868790|62747802|FG010|Period 3|Adverse Event|0|||
33368933|NCT00868790|62747803|FG011|Period 3|Adverse Event|0|||
33368934|NCT00868790|62747804|FG012|Period 3|Adverse Event|0|||
33368935|NCT00868790|62747805|FG013|Period 3|Adverse Event|0|||
33368936|NCT00868790|62747792|FG000|Period 3|Protocol Violation|0|||
33368937|NCT00868790|62747793|FG001|Period 3|Protocol Violation|0|||
33368938|NCT00868790|62747794|FG002|Period 3|Protocol Violation|0|||
33368939|NCT00868790|62747795|FG003|Period 3|Protocol Violation|0|||
33368940|NCT00868790|62747796|FG004|Period 3|Protocol Violation|0|||
33368941|NCT00868790|62747797|FG005|Period 3|Protocol Violation|0|||
33368942|NCT00868790|62747798|FG006|Period 3|Protocol Violation|0|||
33368943|NCT00868790|62747799|FG007|Period 3|Protocol Violation|0|||
33368944|NCT00868790|62747800|FG008|Period 3|Protocol Violation|0|||
33368945|NCT00868790|62747801|FG009|Period 3|Protocol Violation|0|||
33368946|NCT00868790|62747802|FG010|Period 3|Protocol Violation|1|||
33368947|NCT00868790|62747803|FG011|Period 3|Protocol Violation|0|||
33267182|NCT01545050|62638669|FG000|Overall Study|Lack of Efficacy|0|||
33267183|NCT01545050|62638670|FG001|Overall Study|Lack of Efficacy|0|||
33267184|NCT01545050|62638671|FG002|Overall Study|Lack of Efficacy|0|||
33267185|NCT01545050|62638672|FG003|Overall Study|Lack of Efficacy|3|||
33267186|NCT01545050|62638673|FG004|Overall Study|Lack of Efficacy|2|||
33267187|NCT01545050|62638669|FG000|Overall Study|Adverse Event|1|||
33267188|NCT01545050|62638670|FG001|Overall Study|Adverse Event|1|||
33267189|NCT01545050|62638671|FG002|Overall Study|Adverse Event|2|||
33267190|NCT01545050|62638672|FG003|Overall Study|Adverse Event|2|||
33267191|NCT01545050|62638673|FG004|Overall Study|Adverse Event|0|||
33267192|NCT01545050|62638669|FG000|Overall Study|Discontinued study treatment|1|||
33267193|NCT01545050|62638670|FG001|Overall Study|Discontinued study treatment|0|||
33267194|NCT01545050|62638671|FG002|Overall Study|Discontinued study treatment|0|||
33267195|NCT01545050|62638672|FG003|Overall Study|Discontinued study treatment|0|||
33267196|NCT01545050|62638673|FG004|Overall Study|Discontinued study treatment|0|||
33267197|NCT01545050|62638669|FG000|Overall Study|Withdrawal by Subject|1|||
33267198|NCT01545050|62638670|FG001|Overall Study|Withdrawal by Subject|0|||
33267199|NCT01545050|62638671|FG002|Overall Study|Withdrawal by Subject|0|||
33267200|NCT01545050|62638672|FG003|Overall Study|Withdrawal by Subject|2|||
33267201|NCT01545050|62638673|FG004|Overall Study|Withdrawal by Subject|1|||
33267202|NCT01545050|62638669|FG000|Overall Study|Participant no longer meets study criteria|0|||
33267203|NCT01545050|62638670|FG001|Overall Study|Participant no longer meets study criteria|2|||
33267204|NCT01545050|62638671|FG002|Overall Study|Participant no longer meets study criteria|0|||
33267205|NCT01545050|62638672|FG003|Overall Study|Participant no longer meets study criteria|0|||
33267206|NCT01545050|62638673|FG004|Overall Study|Participant no longer meets study criteria|1|||
33267207|NCT01545050|62638669|FG000|Overall Study|Administrative reason by sponsor|4|||
33267208|NCT01545050|62638670|FG001|Overall Study|Administrative reason by sponsor|2|||
33267209|NCT01545050|62638671|FG002|Overall Study|Administrative reason by sponsor|3|||
33267210|NCT01545050|62638672|FG003|Overall Study|Administrative reason by sponsor|5|||
33267211|NCT01545050|62638673|FG004|Overall Study|Administrative reason by sponsor|5|||
33267212|NCT01555021|62638700|FG000|Overall Study|Lost to Follow-up|1|||
33267213|NCT01555021|62638701|FG001|Overall Study|Lost to Follow-up|2|||
33267214|NCT04721925|62638715|FG000|2-Month Assessment|Lost to Follow-up|5|||
33267215|NCT04721925|62638716|FG001|2-Month Assessment|Lost to Follow-up|3|||
33267216|NCT04721925|62638715|FG000|4-Month Assessment|Lost to Follow-up|3|||
33267217|NCT04721925|62638716|FG001|4-Month Assessment|Lost to Follow-up|6|||
33267218|NCT04710368|62638721|FG000|Overall Study|Withdrawal by Subject|9|||
33267219|NCT04710368|62638721|FG000|Overall Study|Lost to Follow-up|4|||
33267220|NCT04710368|62638721|FG000|Overall Study|Death|2|||
33368948|NCT00868790|62747804|FG012|Period 3|Protocol Violation|0|||
33368949|NCT00868790|62747805|FG013|Period 3|Protocol Violation|0|||
33368950|NCT00868790|62747792|FG000|Period 3|Study Terminated by Sponsor|0|||
33368951|NCT00868790|62747793|FG001|Period 3|Study Terminated by Sponsor|0|||
33368952|NCT00868790|62747794|FG002|Period 3|Study Terminated by Sponsor|0|||
33368953|NCT00868790|62747795|FG003|Period 3|Study Terminated by Sponsor|1|||
33368954|NCT00868790|62747796|FG004|Period 3|Study Terminated by Sponsor|0|||
33368955|NCT00868790|62747797|FG005|Period 3|Study Terminated by Sponsor|0|||
33368956|NCT00868790|62747798|FG006|Period 3|Study Terminated by Sponsor|0|||
33368957|NCT00868790|62747799|FG007|Period 3|Study Terminated by Sponsor|0|||
33368958|NCT00868790|62747800|FG008|Period 3|Study Terminated by Sponsor|0|||
33368959|NCT00868790|62747801|FG009|Period 3|Study Terminated by Sponsor|0|||
33368960|NCT00868790|62747802|FG010|Period 3|Study Terminated by Sponsor|0|||
33368961|NCT00868790|62747803|FG011|Period 3|Study Terminated by Sponsor|0|||
33368962|NCT00868790|62747804|FG012|Period 3|Study Terminated by Sponsor|0|||
33368963|NCT00868790|62747805|FG013|Period 3|Study Terminated by Sponsor|0|||
33368964|NCT00868790|62747792|FG000|Period 4|Adverse Event|0|||
33368965|NCT00868790|62747793|FG001|Period 4|Adverse Event|0|||
33368966|NCT00868790|62747794|FG002|Period 4|Adverse Event|0|||
33368967|NCT00868790|62747795|FG003|Period 4|Adverse Event|0|||
33368968|NCT00868790|62747796|FG004|Period 4|Adverse Event|0|||
33368969|NCT00868790|62747797|FG005|Period 4|Adverse Event|0|||
33267221|NCT04710368|62638721|FG000|Overall Study|Patient preference|11|||
33267222|NCT04710368|62638721|FG000|Overall Study|Treatment discontinuation|1|||
33267223|NCT04677660|62638727|FG000|Overall Study|Lost to Follow-up|0|||
33368970|NCT00868790|62747798|FG006|Period 4|Adverse Event|0|||
33368971|NCT00868790|62747799|FG007|Period 4|Adverse Event|1|||
33267224|NCT04677660|62638728|FG001|Overall Study|Lost to Follow-up|2|||
33368972|NCT00868790|62747800|FG008|Period 4|Adverse Event|0|||
33267225|NCT04677660|62638727|FG000|Overall Study|Withdrawal by Subject|0|||
33267226|NCT04677660|62638728|FG001|Overall Study|Withdrawal by Subject|1|||
33267227|NCT04677660|62638727|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
33267228|NCT04677660|62638728|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
33267229|NCT04518995|62638737|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
33368973|NCT00868790|62747801|FG009|Period 4|Adverse Event|0|||
33368974|NCT00868790|62747802|FG010|Period 4|Adverse Event|1|||
33267230|NCT04518995|62638738|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
33267231|NCT04518995|62638739|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
33267232|NCT04518995|62638737|FG000|Overall Study|Lack of Efficacy|2|||
33267233|NCT04518995|62638738|FG001|Overall Study|Lack of Efficacy|1|||
33267234|NCT04518995|62638739|FG002|Overall Study|Lack of Efficacy|0|||
33267235|NCT04518995|62638737|FG000|Overall Study|Non-compliance With Study Drug|0|||
33267236|NCT04518995|62638738|FG001|Overall Study|Non-compliance With Study Drug|3|||
33267237|NCT04518995|62638739|FG002|Overall Study|Non-compliance With Study Drug|2|||
33267238|NCT04518995|62638737|FG000|Overall Study|Pregnancy|0|||
33267239|NCT04518995|62638738|FG001|Overall Study|Pregnancy|0|||
33267240|NCT04518995|62638739|FG002|Overall Study|Pregnancy|1|||
33267241|NCT04518995|62638737|FG000|Overall Study|Protocol Violation|2|||
33267242|NCT04518995|62638738|FG001|Overall Study|Protocol Violation|0|||
33267243|NCT04518995|62638739|FG002|Overall Study|Protocol Violation|1|||
33267244|NCT04518995|62638737|FG000|Overall Study|Reason not Specified|4|||
33267245|NCT04518995|62638738|FG001|Overall Study|Reason not Specified|11|||
33267246|NCT04518995|62638739|FG002|Overall Study|Reason not Specified|2|||
33267247|NCT04518995|62638737|FG000|Overall Study|Lost to Follow-up|1|||
33267248|NCT04518995|62638738|FG001|Overall Study|Lost to Follow-up|10|||
33267249|NCT04518995|62638739|FG002|Overall Study|Lost to Follow-up|6|||
33267250|NCT04505722|62638749|FG000|Overall Study|Adverse Event|1|||
33267251|NCT04505722|62638750|FG001|Overall Study|Adverse Event|2|||
33267252|NCT04505722|62638749|FG000|Overall Study|Death|34|||
33267253|NCT04505722|62638750|FG001|Overall Study|Death|63|||
33267254|NCT04505722|62638749|FG000|Overall Study|Lost to Follow-up|271|||
33267255|NCT04505722|62638750|FG001|Overall Study|Lost to Follow-up|333|||
33267256|NCT04505722|62638749|FG000|Overall Study|Physician Decision|17|||
33267257|NCT04505722|62638750|FG001|Overall Study|Physician Decision|17|||
33267258|NCT04505722|62638749|FG000|Overall Study|Protocol Violation|0|||
33267259|NCT04505722|62638750|FG001|Overall Study|Protocol Violation|1|||
33267260|NCT04505722|62638749|FG000|Overall Study|Withdrawal by Subject|376|||
33267261|NCT04505722|62638750|FG001|Overall Study|Withdrawal by Subject|714|||
33267262|NCT04505722|62638749|FG000|Overall Study|Other|61|||
33267263|NCT04505722|62638750|FG001|Overall Study|Other|98|||
33267264|NCT04505722|62638749|FG000|Overall Study|Still ongoing|21138|||
33267265|NCT04505722|62638750|FG001|Overall Study|Still ongoing|20662|||
33267266|NCT04505722|62638749|FG000|Overall Study|Randomized not vaccinated|276|||
33267267|NCT04505722|62638750|FG001|Overall Study|Randomized not vaccinated|260|||
33267268|NCT04474691|62638756|FG000|Overall Study|Withdrawal by Subject|9|||
33267269|NCT04014075|62638788|FG000|Overall Study|Progressive Disease|48|||
33267270|NCT04014075|62638788|FG000|Overall Study|Adverse Event|11|||
33267271|NCT04014075|62638788|FG000|Overall Study|Clinical Progression|4|||
33267272|NCT04014075|62638788|FG000|Overall Study|Death|2|||
33267273|NCT04014075|62638788|FG000|Overall Study|Withdrawal by Subject|2|||
33267274|NCT04014075|62638788|FG000|Overall Study|Miscellaneous|1|||
33267275|NCT04014075|62638788|FG000|Overall Study|Physician Decision|1|||
33267276|NCT03840174|62638796|FG000|Overall Study|Withdrawal by Subject|1|||
33267277|NCT03840174|62638797|FG001|Overall Study|Withdrawal by Subject|0|||
33267278|NCT03840174|62638798|FG002|Overall Study|Withdrawal by Subject|0|||
33267279|NCT03840174|62638799|FG003|Overall Study|Withdrawal by Subject|0|||
33267280|NCT03786718|62638810|FG000|Overall Study|Lost to Follow-up|3|||
33267281|NCT03786718|62638810|FG000|Overall Study|Withdrawal by Subject|1|||
33267282|NCT03786718|62638810|FG000|Overall Study|Did not use the intervention|2|||
33267283|NCT03786718|62638810|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
33267284|NCT03400943|62638843|FG000|Treatment Period 1|Adverse Event|0|||
33267285|NCT03400943|62638844|FG001|Treatment Period 1|Adverse Event|0|||
33267286|NCT03400943|62638845|FG002|Treatment Period 1|Adverse Event|0|||
33267287|NCT03400943|62638846|FG003|Treatment Period 1|Adverse Event|1|||
33267288|NCT03400943|62638843|FG000|Treatment Period 1|Lost to Follow-up|1|||
33267289|NCT03400943|62638844|FG001|Treatment Period 1|Lost to Follow-up|0|||
33267290|NCT03400943|62638845|FG002|Treatment Period 1|Lost to Follow-up|0|||
33267291|NCT03400943|62638846|FG003|Treatment Period 1|Lost to Follow-up|0|||
33267292|NCT03400943|62638843|FG000|Treatment Period 1|Protocol Violation|0|||
33267293|NCT03400943|62638844|FG001|Treatment Period 1|Protocol Violation|1|||
33267294|NCT03400943|62638845|FG002|Treatment Period 1|Protocol Violation|1|||
33267295|NCT03400943|62638846|FG003|Treatment Period 1|Protocol Violation|0|||
33267296|NCT03400943|62638843|FG000|Treatment Period 1|Study terminated by sponsor|2|||
33267297|NCT03400943|62638844|FG001|Treatment Period 1|Study terminated by sponsor|0|||
33267298|NCT03400943|62638845|FG002|Treatment Period 1|Study terminated by sponsor|0|||
33267299|NCT03400943|62638846|FG003|Treatment Period 1|Study terminated by sponsor|1|||
33267300|NCT03400943|62638843|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33267301|NCT03400943|62638844|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33267302|NCT03400943|62638845|FG002|Treatment Period 1|Withdrawal by Subject|3|||
33267303|NCT03400943|62638846|FG003|Treatment Period 1|Withdrawal by Subject|1|||
33267304|NCT03400943|62638843|FG000|Treatment Period 1|Other|2|||
33267305|NCT03400943|62638844|FG001|Treatment Period 1|Other|1|||
33267306|NCT03400943|62638845|FG002|Treatment Period 1|Other|2|||
33267307|NCT03400943|62638846|FG003|Treatment Period 1|Other|2|||
33267308|NCT03400943|62638843|FG000|Post-treatment Period 1|Adverse Event|2|||
33267309|NCT03400943|62638844|FG001|Post-treatment Period 1|Adverse Event|0|||
33267310|NCT03400943|62638845|FG002|Post-treatment Period 1|Adverse Event|0|||
33267311|NCT03400943|62638846|FG003|Post-treatment Period 1|Adverse Event|0|||
33267312|NCT03400943|62638843|FG000|Post-treatment Period 1|Protocol Violation|1|||
33267313|NCT03400943|62638844|FG001|Post-treatment Period 1|Protocol Violation|0|||
33267314|NCT03400943|62638845|FG002|Post-treatment Period 1|Protocol Violation|0|||
33267315|NCT03400943|62638846|FG003|Post-treatment Period 1|Protocol Violation|0|||
33267316|NCT03400943|62638843|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
33267317|NCT03400943|62638844|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
33267318|NCT03400943|62638845|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
33267319|NCT03400943|62638846|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
33267320|NCT03400943|62638843|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
33267321|NCT03400943|62638844|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
33267322|NCT03400943|62638845|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
33267323|NCT03400943|62638846|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
33267324|NCT03400943|62638843|FG000|Post-treatment Period 1|Other|2|||
33267325|NCT03400943|62638844|FG001|Post-treatment Period 1|Other|0|||
33267326|NCT03400943|62638845|FG002|Post-treatment Period 1|Other|4|||
33267327|NCT03400943|62638846|FG003|Post-treatment Period 1|Other|5|||
33267328|NCT03400943|62638843|FG000|Treatment Period 2|Study terminated by sponsor|0|||
33267329|NCT03400943|62638844|FG001|Treatment Period 2|Study terminated by sponsor|1|||
33267330|NCT03400943|62638845|FG002|Treatment Period 2|Study terminated by sponsor|0|||
33267331|NCT03400943|62638846|FG003|Treatment Period 2|Study terminated by sponsor|0|||
33267332|NCT03400943|62638843|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33267333|NCT03400943|62638844|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33267334|NCT03400943|62638845|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33267335|NCT03400943|62638846|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33267336|NCT03400943|62638843|FG000|Treatment Period 2|Other|1|||
33267337|NCT03400943|62638844|FG001|Treatment Period 2|Other|6|||
33267338|NCT03400943|62638845|FG002|Treatment Period 2|Other|0|||
33267339|NCT03400943|62638846|FG003|Treatment Period 2|Other|0|||
33267340|NCT03400943|62638843|FG000|Follow-up Period|Withdrawal by Subject|1|||
33267341|NCT03400943|62638844|FG001|Follow-up Period|Withdrawal by Subject|0|||
33267342|NCT03400943|62638845|FG002|Follow-up Period|Withdrawal by Subject|0|||
33267343|NCT03400943|62638846|FG003|Follow-up Period|Withdrawal by Subject|0|||
33267344|NCT03366103|62638861|FG000|Overall Study|Disease Progression|3|||
33267345|NCT03366103|62638862|FG001|Overall Study|Disease Progression|1|||
33267346|NCT03366103|62638863|FG002|Overall Study|Disease Progression|0|||
33267347|NCT03366103|62638861|FG000|Overall Study|Adverse Event|0|||
33267348|NCT03366103|62638862|FG001|Overall Study|Adverse Event|1|||
33267349|NCT03366103|62638863|FG002|Overall Study|Adverse Event|0|||
33267350|NCT03321526|62638876|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
33267351|NCT03321526|62638877|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
33267352|NCT03321526|62638876|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
33267353|NCT03321526|62638877|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
33267354|NCT03321526|62638876|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
33267355|NCT03321526|62638877|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
33267356|NCT03321526|62638876|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
33267357|NCT03321526|62638877|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
33267358|NCT03321526|62638876|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
33267359|NCT03321526|62638877|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
33267360|NCT03321526|62638876|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
33267361|NCT03321526|62638877|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
33267362|NCT03321526|62638876|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
33267363|NCT03321526|62638877|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
33267364|NCT03321526|62638876|FG000|Follow-up Phase (2 Weeks)|Other|24|||
33267365|NCT03321526|62638877|FG001|Follow-up Phase (2 Weeks)|Other|24|||
33267366|NCT03153111|62638891|FG000|Overall Study|Death|2|||
33267367|NCT03153111|62638892|FG001|Overall Study|Death|5|||
33267368|NCT03153111|62638891|FG000|Overall Study|Lost to Follow-up|1|||
33267369|NCT03153111|62638892|FG001|Overall Study|Lost to Follow-up|0|||
33368975|NCT00868790|62747803|FG011|Period 4|Adverse Event|0|||
33267370|NCT03153111|62638891|FG000|Overall Study|Physician Decision|5|||
33267371|NCT03153111|62638892|FG001|Overall Study|Physician Decision|1|||
33267372|NCT03153111|62638891|FG000|Overall Study|Withdrawal by Subject|3|||
33267373|NCT03153111|62638892|FG001|Overall Study|Withdrawal by Subject|3|||
33267374|NCT03126435|62638900|FG000|Overall Study|Death|90|||
33267375|NCT03126435|62638901|FG001|Overall Study|Death|84|||
33267376|NCT03126435|62638900|FG000|Overall Study|Lost to Follow-up|4|||
33267377|NCT03126435|62638901|FG001|Overall Study|Lost to Follow-up|3|||
33267378|NCT03126435|62638900|FG000|Overall Study|Physician Decision|0|||
33267379|NCT03126435|62638901|FG001|Overall Study|Physician Decision|1|||
33267380|NCT03126435|62638900|FG000|Overall Study|Withdrawal by Subject|6|||
33267381|NCT03126435|62638901|FG001|Overall Study|Withdrawal by Subject|12|||
33267382|NCT03126435|62638900|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
33267383|NCT03126435|62638901|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
33267384|NCT02823574|62638922|FG000|Randomization|Disease Progression|0|||
33267385|NCT02823574|62638923|FG001|Randomization|Disease Progression|0|||
33267386|NCT02823574|62638924|FG002|Randomization|Disease Progression|1|||
33267387|NCT02823574|62638925|FG003|Randomization|Disease Progression|0|||
33267388|NCT02823574|62638922|FG000|Randomization|AE unrelated to Study Drug|1|||
33267389|NCT02823574|62638923|FG001|Randomization|AE unrelated to Study Drug|0|||
33267390|NCT02823574|62638924|FG002|Randomization|AE unrelated to Study Drug|0|||
33267391|NCT02823574|62638925|FG003|Randomization|AE unrelated to Study Drug|0|||
33267392|NCT02823574|62638922|FG000|Treatment Period|Poor/Non Compliance|1|||
33267393|NCT02823574|62638923|FG001|Treatment Period|Poor/Non Compliance|0|||
33267394|NCT02823574|62638924|FG002|Treatment Period|Poor/Non Compliance|0|||
33267395|NCT02823574|62638925|FG003|Treatment Period|Poor/Non Compliance|1|||
33267396|NCT02823574|62638922|FG000|Treatment Period|Maximum Clinical Benefit|8|||
33267397|NCT02823574|62638923|FG001|Treatment Period|Maximum Clinical Benefit|4|||
33267398|NCT02823574|62638924|FG002|Treatment Period|Maximum Clinical Benefit|7|||
33267399|NCT02823574|62638925|FG003|Treatment Period|Maximum Clinical Benefit|1|||
33267400|NCT02823574|62638922|FG000|Treatment Period|Lost to Follow-up|1|||
33267401|NCT02823574|62638923|FG001|Treatment Period|Lost to Follow-up|1|||
33267402|NCT02823574|62638924|FG002|Treatment Period|Lost to Follow-up|0|||
33267403|NCT02823574|62638925|FG003|Treatment Period|Lost to Follow-up|0|||
33267404|NCT02823574|62638922|FG000|Treatment Period|Participant withdrew consent|4|||
33267405|NCT02823574|62638923|FG001|Treatment Period|Participant withdrew consent|0|||
33267406|NCT02823574|62638924|FG002|Treatment Period|Participant withdrew consent|0|||
33267407|NCT02823574|62638925|FG003|Treatment Period|Participant withdrew consent|1|||
33267408|NCT02823574|62638922|FG000|Treatment Period|Participant request to discontinue|5|||
33267409|NCT02823574|62638923|FG001|Treatment Period|Participant request to discontinue|0|||
33267410|NCT02823574|62638924|FG002|Treatment Period|Participant request to discontinue|3|||
33267411|NCT02823574|62638925|FG003|Treatment Period|Participant request to discontinue|2|||
33267412|NCT02823574|62638922|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
33267413|NCT02823574|62638923|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
33267414|NCT02823574|62638924|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
33267415|NCT02823574|62638925|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
33267416|NCT02823574|62638922|FG000|Treatment Period|Study Drug Toxicity|11|||
33267417|NCT02823574|62638923|FG001|Treatment Period|Study Drug Toxicity|2|||
33267418|NCT02823574|62638924|FG002|Treatment Period|Study Drug Toxicity|14|||
33267419|NCT02823574|62638925|FG003|Treatment Period|Study Drug Toxicity|4|||
33267420|NCT02823574|62638922|FG000|Treatment Period|Disease Progression|113|||
33267421|NCT02823574|62638923|FG001|Treatment Period|Disease Progression|64|||
33267422|NCT02823574|62638924|FG002|Treatment Period|Disease Progression|82|||
33267423|NCT02823574|62638925|FG003|Treatment Period|Disease Progression|43|||
33267424|NCT02823574|62638922|FG000|Treatment Period|Other reasons|5|||
33267425|NCT02823574|62638923|FG001|Treatment Period|Other reasons|9|||
33267426|NCT02823574|62638924|FG002|Treatment Period|Other reasons|3|||
33267427|NCT02823574|62638925|FG003|Treatment Period|Other reasons|6|||
33267428|NCT02823574|62638922|FG000|Treatment Period|Participant no longer meets study criteria|0|||
33267429|NCT02823574|62638923|FG001|Treatment Period|Participant no longer meets study criteria|0|||
33267430|NCT02823574|62638924|FG002|Treatment Period|Participant no longer meets study criteria|1|||
33267431|NCT02823574|62638925|FG003|Treatment Period|Participant no longer meets study criteria|0|||
33267432|NCT02823574|62638922|FG000|Treatment Period|Death|0|||
33267433|NCT02823574|62638923|FG001|Treatment Period|Death|0|||
33267434|NCT02823574|62638924|FG002|Treatment Period|Death|3|||
33267435|NCT02823574|62638925|FG003|Treatment Period|Death|1|||
33267436|NCT02746809|62638938|FG000|Enrollment|Inclusion Exclusion not met|9|||
33267437|NCT02746809|62638938|FG000|Enrollment|Withdrawal by Subject|1|||
33267438|NCT02746809|62638938|FG000|Enrollment|Expected Enrollment Met|2|||
33267439|NCT02746809|62638938|FG000|Procedure|Death|1|||
33267440|NCT02746809|62638938|FG000|1-Month|Death|5|||
33267441|NCT02746809|62638938|FG000|6-Month|Death|2|||
33267442|NCT02746809|62638938|FG000|6-Month|Withdrawal by Subject|1|||
33267443|NCT02746809|62638938|FG000|12-Month|Death|3|||
33267444|NCT02746809|62638938|FG000|12-Month|Withdrawal by Subject|2|||
33368976|NCT00868790|62747804|FG012|Period 4|Adverse Event|1|||
33267445|NCT02746809|62638938|FG000|24-Month|Death|1|||
33267446|NCT02746809|62638938|FG000|24-Month|Withdrawal by Subject|1|||
33267447|NCT02746809|62638938|FG000|36-Month|Death|8|||
33267448|NCT02746809|62638938|FG000|36-Month|Withdrawal by Subject|1|||
33267449|NCT02746809|62638938|FG000|48-Month|Death|7|||
33267450|NCT02746809|62638938|FG000|48-Month|Withdrawal by Subject|1|||
33267451|NCT02746809|62638938|FG000|60-Month|Death|1|||
33267452|NCT02746809|62638938|FG000|60-Month|Lost to Follow-up|2|||
33267453|NCT02525796|62638947|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
33267454|NCT02525796|62638948|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
33267455|NCT02525796|62638949|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
33368977|NCT00868790|62747805|FG013|Period 4|Adverse Event|0|||
33267456|NCT02525796|62638947|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
33267457|NCT02525796|62638948|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
33267458|NCT02525796|62638949|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
33267459|NCT02525796|62638947|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
33267460|NCT02525796|62638948|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
33267461|NCT02525796|62638949|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
33267462|NCT02525796|62638947|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
33267463|NCT02525796|62638948|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
33267464|NCT02525796|62638949|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
33267465|NCT02525796|62638947|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
33267466|NCT02525796|62638948|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
33267467|NCT02525796|62638949|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
33267468|NCT02360280|62638965|FG000|Overall Study|Withdrawal by Subject|2|||
33267469|NCT02360280|62638966|FG001|Overall Study|Withdrawal by Subject|0|||
33267470|NCT02360280|62638965|FG000|Overall Study|Adverse Event|0|||
33267471|NCT02360280|62638966|FG001|Overall Study|Adverse Event|1|||
33267472|NCT02360280|62638965|FG000|Overall Study|Lost to Follow-up|1|||
33267473|NCT02360280|62638966|FG001|Overall Study|Lost to Follow-up|0|||
33267474|NCT02201251|62638974|FG000|Overall Study|Adverse Event|1|||
33267475|NCT02201251|62638975|FG001|Overall Study|Adverse Event|1|||
33267476|NCT02201251|62638974|FG000|Overall Study|Protocol Violation|1|||
33267477|NCT02201251|62638975|FG001|Overall Study|Protocol Violation|0|||
33267478|NCT02201251|62638974|FG000|Overall Study|Noncompliance with Study Drug|0|||
33267479|NCT02201251|62638975|FG001|Overall Study|Noncompliance with Study Drug|1|||
33267480|NCT02201251|62638974|FG000|Overall Study|Withdrawal by Subject|2|||
33267481|NCT02201251|62638975|FG001|Overall Study|Withdrawal by Subject|1|||
33267482|NCT02027545|62638983|FG000|Overall Study|Failed to sign HIPAA|0|||
33267483|NCT02027545|62638984|FG001|Overall Study|Failed to sign HIPAA|2|||
33267484|NCT02027545|62638983|FG000|Overall Study|Failed to attend study visit|2|||
33267485|NCT02027545|62638984|FG001|Overall Study|Failed to attend study visit|0|||
33267486|NCT02027545|62638983|FG000|Overall Study|Protocol Violation|1|||
33267487|NCT02027545|62638984|FG001|Overall Study|Protocol Violation|0|||
33267488|NCT01867242|62639014|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
33267489|NCT01867242|62639015|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
33267490|NCT01867242|62639016|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
33267491|NCT01858688|62639024|FG000|Overall Study|Withdrawal by Subject|8|||
33267492|NCT01858688|62639024|FG000|Overall Study|Participant began another therapy|3|||
33267493|NCT01858688|62639024|FG000|Overall Study|Physician Decision|2|||
33267494|NCT01858688|62639024|FG000|Overall Study|Progressive Disease|2|||
33267495|NCT01858688|62639024|FG000|Overall Study|Reason not reproted|5|||
33267496|NCT01599234|62639043|FG000|Overall Study|Adverse Event|9|||
33267497|NCT01599234|62639044|FG001|Overall Study|Adverse Event|5|||
33267498|NCT01599234|62639043|FG000|Overall Study|Withdrawal by Subject|2|||
33267499|NCT01599234|62639044|FG001|Overall Study|Withdrawal by Subject|1|||
33267500|NCT01599234|62639043|FG000|Overall Study|Lost to Follow-up|1|||
33267501|NCT01599234|62639044|FG001|Overall Study|Lost to Follow-up|2|||
33267502|NCT01599234|62639043|FG000|Overall Study|Lack of Efficacy|2|||
33267503|NCT01599234|62639044|FG001|Overall Study|Lack of Efficacy|4|||
33267504|NCT01599234|62639043|FG000|Overall Study|Unable to operate spray|1|||
33267505|NCT01599234|62639044|FG001|Overall Study|Unable to operate spray|0|||
33267506|NCT01599234|62639043|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
33267507|NCT01599234|62639044|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
33267508|NCT01599234|62639043|FG000|Overall Study|Death|1|||
33267509|NCT01599234|62639044|FG001|Overall Study|Death|0|||
33267510|NCT01599234|62639043|FG000|Overall Study|Patient would not stop driving|1|||
33267511|NCT01599234|62639044|FG001|Overall Study|Patient would not stop driving|0|||
33267512|NCT01599234|62639043|FG000|Overall Study|Contra-indication discovered|0|||
33267513|NCT01599234|62639044|FG001|Overall Study|Contra-indication discovered|1|||
33267514|NCT01599234|62639043|FG000|Overall Study|Pregnancy|0|||
33267515|NCT01599234|62639044|FG001|Overall Study|Pregnancy|1|||
33267516|NCT01586910|62639052|FG000|Overall Study|Death|4|||
33267517|NCT01586910|62639053|FG001|Overall Study|Death|4|||
33267518|NCT01586910|62639052|FG000|Overall Study|Withdrawal by Subject|6|||
33267519|NCT01586910|62639053|FG001|Overall Study|Withdrawal by Subject|43|||
33267520|NCT01586910|62639052|FG000|Overall Study|Physician withdrew Subject|5|||
33267521|NCT01586910|62639053|FG001|Overall Study|Physician withdrew Subject|24|||
33267522|NCT01393301|62639073|FG000|Overall Study|Lost to Follow-up|5|||
33267523|NCT01393301|62639074|FG001|Overall Study|Lost to Follow-up|3|||
33267524|NCT01393301|62639073|FG000|Overall Study|Withdrawal by Subject|2|||
33267525|NCT01393301|62639074|FG001|Overall Study|Withdrawal by Subject|0|||
33267526|NCT01393301|62639073|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
33267527|NCT01393301|62639074|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
33267528|NCT01251861|62639082|FG000|Overall Study|Disease progression|6|||
33267529|NCT01251861|62639083|FG001|Overall Study|Disease progression|6|||
33267530|NCT01251861|62639082|FG000|Overall Study|Adverse Event|2|||
33267531|NCT01251861|62639083|FG001|Overall Study|Adverse Event|17|||
33267532|NCT01251861|62639082|FG000|Overall Study|Withdrawal by Subject|2|||
33267533|NCT01251861|62639083|FG001|Overall Study|Withdrawal by Subject|2|||
33267534|NCT01251861|62639082|FG000|Overall Study|Alternative therapy|1|||
33267535|NCT01251861|62639083|FG001|Overall Study|Alternative therapy|0|||
33267536|NCT01251861|62639082|FG000|Overall Study|Other complicating disease|0|||
33267537|NCT01251861|62639083|FG001|Overall Study|Other complicating disease|1|||
33267538|NCT01251861|62639082|FG000|Overall Study|Physician Decision|1|||
33267539|NCT01251861|62639083|FG001|Overall Study|Physician Decision|0|||
33267540|NCT01251861|62639082|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
33267541|NCT01251861|62639083|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
33267542|NCT01251861|62639082|FG000|Overall Study|Other|1|||
33267543|NCT01251861|62639083|FG001|Overall Study|Other|0|||
33267544|NCT01251861|62639082|FG000|Overall Study|Never started therapy|4|||
33267545|NCT01251861|62639083|FG001|Overall Study|Never started therapy|1|||
33267546|NCT01251861|62639082|FG000|Overall Study|Potential interaction of drugs|0|||
33267547|NCT01251861|62639083|FG001|Overall Study|Potential interaction of drugs|1|||
33267548|NCT00843882|62639092|FG000|Step 1|Lack of Efficacy|14|||
33267549|NCT00843882|62639093|FG001|Step 1|Lack of Efficacy|10|||
33267550|NCT00843882|62639094|FG002|Step 1|Lack of Efficacy|21|||
33267551|NCT00843882|62639092|FG000|Step 1|Adverse Event|8|||
33267552|NCT00843882|62639093|FG001|Step 1|Adverse Event|17|||
33267553|NCT00843882|62639094|FG002|Step 1|Adverse Event|20|||
33267554|NCT00843882|62639092|FG000|Step 1|Death|1|||
33267555|NCT00843882|62639093|FG001|Step 1|Death|2|||
33267556|NCT00843882|62639094|FG002|Step 1|Death|4|||
33267557|NCT00843882|62639092|FG000|Step 1|Withdrawal by Subject|6|||
33267558|NCT00843882|62639093|FG001|Step 1|Withdrawal by Subject|12|||
33267559|NCT00843882|62639094|FG002|Step 1|Withdrawal by Subject|9|||
33267560|NCT00843882|62639092|FG000|Step 1|Physician Decision|0|||
33267561|NCT00843882|62639093|FG001|Step 1|Physician Decision|5|||
33267562|NCT00843882|62639094|FG002|Step 1|Physician Decision|1|||
33267563|NCT00843882|62639092|FG000|Step 1|Patient and physician's decision|0|||
33267564|NCT00843882|62639093|FG001|Step 1|Patient and physician's decision|0|||
33267565|NCT00843882|62639094|FG002|Step 1|Patient and physician's decision|1|||
33267566|NCT00843882|62639092|FG000|Step 1|Other complicating disease|1|||
33267567|NCT00843882|62639093|FG001|Step 1|Other complicating disease|3|||
33267568|NCT00843882|62639094|FG002|Step 1|Other complicating disease|4|||
33267569|NCT00843882|62639092|FG000|Step 1|Alternative therapy|0|||
33267570|NCT00843882|62639093|FG001|Step 1|Alternative therapy|1|||
33267571|NCT00843882|62639094|FG002|Step 1|Alternative therapy|1|||
33267572|NCT00843882|62639092|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
33267573|NCT00843882|62639093|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
33267574|NCT00843882|62639094|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
33267575|NCT00843882|62639092|FG000|Step 1|Off treatment reason unknown|0|||
33267576|NCT00843882|62639093|FG001|Step 1|Off treatment reason unknown|1|||
33267577|NCT00843882|62639094|FG002|Step 1|Off treatment reason unknown|4|||
33267578|NCT00843882|62639092|FG000|Step 1|Never started treatment|2|||
33267579|NCT00843882|62639093|FG001|Step 1|Never started treatment|0|||
33267580|NCT00843882|62639094|FG002|Step 1|Never started treatment|0|||
33267581|NCT00843882|62639092|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
33267582|NCT00843882|62639093|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
33267583|NCT00843882|62639094|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
33267584|NCT00843882|62639092|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
33267585|NCT00843882|62639093|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
33267586|NCT00843882|62639094|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
33267587|NCT00843882|62639092|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
33267588|NCT00843882|62639093|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
33267589|NCT00843882|62639094|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
33267590|NCT00843882|62639092|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
33267591|NCT00843882|62639093|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
33267592|NCT00843882|62639094|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
33267593|NCT00843882|62639092|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
33661951|NCT02703324|63092112|FG004|Period Two|Withdrawal by Subject|0|||
33267594|NCT00843882|62639093|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
33267595|NCT00843882|62639094|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
33267596|NCT00843882|62639092|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
33267597|NCT00843882|62639093|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
33267598|NCT00843882|62639094|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
33267599|NCT00843882|62639092|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
33267600|NCT00843882|62639093|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
33267601|NCT00843882|62639094|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
33267602|NCT00716625|62639107|FG000|Overall Study|Safety was not Assessable|1|||
33267603|NCT00713323|62639134|FG000|Overall Study|Adverse Event|75|||
33267604|NCT00713323|62639134|FG000|Overall Study|Withdrawal by Subject|15|||
33267605|NCT00713323|62639134|FG000|Overall Study|Lost to Follow-up|11|||
33267606|NCT00713323|62639134|FG000|Overall Study|Lack of Efficacy|36|||
33267607|NCT00713323|62639134|FG000|Overall Study|Low creatine clearance at screening|1|||
33267608|NCT00713323|62639134|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
33267609|NCT00713323|62639134|FG000|Overall Study|Surgery cured allodynic pain|1|||
33267610|NCT00713323|62639134|FG000|Overall Study|Pain free|1|||
33267611|NCT00713323|62639134|FG000|Overall Study|Non-compliance|1|||
33267612|NCT00713323|62639134|FG000|Overall Study|Pain resolved|1|||
33267613|NCT00713323|62639134|FG000|Overall Study|Subject travelling to USA|1|||
33267614|NCT00713323|62639134|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
33267615|NCT00713323|62639134|FG000|Overall Study|Treatment that may interact with Sativex|1|||
33267616|NCT00710554|62639151|FG000|Overall Study|Adverse Event|24|||
33267617|NCT00710554|62639152|FG001|Overall Study|Adverse Event|7|||
33267618|NCT00710554|62639151|FG000|Overall Study|Withdrawal by Subject|7|||
33267619|NCT00710554|62639152|FG001|Overall Study|Withdrawal by Subject|3|||
33267620|NCT00710554|62639151|FG000|Overall Study|Lost to Follow-up|7|||
33267621|NCT00710554|62639152|FG001|Overall Study|Lost to Follow-up|1|||
33267622|NCT00710554|62639151|FG000|Overall Study|Lack of Efficacy|11|||
33267623|NCT00710554|62639152|FG001|Overall Study|Lack of Efficacy|12|||
33267624|NCT00710554|62639151|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
33267625|NCT00710554|62639152|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
33267626|NCT00710424|62639160|FG000|Overall Study|Adverse Event|30|||
33267627|NCT00710424|62639161|FG001|Overall Study|Adverse Event|12|||
33267628|NCT00710424|62639160|FG000|Overall Study|Lack of Efficacy|4|||
33267629|NCT00710424|62639161|FG001|Overall Study|Lack of Efficacy|5|||
33267630|NCT00710424|62639160|FG000|Overall Study|Withdrawal by Subject|5|||
33267631|NCT00710424|62639161|FG001|Overall Study|Withdrawal by Subject|3|||
33267632|NCT00710424|62639160|FG000|Overall Study|Lost to Follow-up|0|||
33267633|NCT00710424|62639161|FG001|Overall Study|Lost to Follow-up|1|||
33267634|NCT00710424|62639160|FG000|Overall Study|Refused medication, no side effects|1|||
33267635|NCT00710424|62639161|FG001|Overall Study|Refused medication, no side effects|0|||
33267636|NCT00710424|62639160|FG000|Overall Study|Non-compliance with stable analgesia|1|||
33267637|NCT00710424|62639161|FG001|Overall Study|Non-compliance with stable analgesia|0|||
33267638|NCT00710424|62639160|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
33267639|NCT00710424|62639161|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
33267640|NCT00710424|62639160|FG000|Overall Study|Subject thought medication changed|1|||
33267641|NCT00710424|62639161|FG001|Overall Study|Subject thought medication changed|0|||
33267642|NCT00710424|62639160|FG000|Overall Study|Ceased treatment due to travel|1|||
33267643|NCT00710424|62639161|FG001|Overall Study|Ceased treatment due to travel|0|||
33267644|NCT00710424|62639160|FG000|Overall Study|Subject preferred paracetamol|0|||
33267645|NCT00710424|62639161|FG001|Overall Study|Subject preferred paracetamol|1|||
33267646|NCT00710424|62639160|FG000|Overall Study|Felt good so stopped treatment|0|||
33267647|NCT00710424|62639161|FG001|Overall Study|Felt good so stopped treatment|1|||
33267648|NCT00118846|62639191|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
33267649|NCT00118846|62639192|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
33368978|NCT00868790|62747792|FG000|Period 4|Lost to Follow-up|0|||
33368979|NCT00868790|62747793|FG001|Period 4|Lost to Follow-up|0|||
33368980|NCT00868790|62747794|FG002|Period 4|Lost to Follow-up|0|||
33368981|NCT00868790|62747795|FG003|Period 4|Lost to Follow-up|0|||
33368982|NCT00868790|62747796|FG004|Period 4|Lost to Follow-up|0|||
33368983|NCT00868790|62747797|FG005|Period 4|Lost to Follow-up|0|||
33368984|NCT00868790|62747798|FG006|Period 4|Lost to Follow-up|0|||
33368985|NCT00868790|62747799|FG007|Period 4|Lost to Follow-up|1|||
33368986|NCT00868790|62747800|FG008|Period 4|Lost to Follow-up|0|||
33368987|NCT00868790|62747801|FG009|Period 4|Lost to Follow-up|0|||
33368988|NCT00868790|62747802|FG010|Period 4|Lost to Follow-up|0|||
33368989|NCT00868790|62747803|FG011|Period 4|Lost to Follow-up|0|||
33368990|NCT00868790|62747804|FG012|Period 4|Lost to Follow-up|0|||
33368991|NCT00868790|62747805|FG013|Period 4|Lost to Follow-up|0|||
33368992|NCT00868790|62747792|FG000|Period 4|Study Terminated by Sponsor|2|||
33368993|NCT00868790|62747793|FG001|Period 4|Study Terminated by Sponsor|0|||
33368994|NCT00868790|62747794|FG002|Period 4|Study Terminated by Sponsor|0|||
33368995|NCT00868790|62747795|FG003|Period 4|Study Terminated by Sponsor|0|||
33368996|NCT00868790|62747796|FG004|Period 4|Study Terminated by Sponsor|0|||
33368997|NCT00868790|62747797|FG005|Period 4|Study Terminated by Sponsor|0|||
33368998|NCT00868790|62747798|FG006|Period 4|Study Terminated by Sponsor|0|||
33267650|NCT00118846|62639191|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
33267651|NCT00118846|62639192|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
33267652|NCT00118846|62639191|FG000|Overall Study|Physician Decision|1|||
33267653|NCT00118846|62639192|FG001|Overall Study|Physician Decision|0|||
33368999|NCT00868790|62747799|FG007|Period 4|Study Terminated by Sponsor|1|||
33484903|NCT03415022|62862016|FG000|Overall Study|Withdrawal by Subject|1|||
33484904|NCT03415022|62862017|FG001|Overall Study|Withdrawal by Subject|2|||
33267654|NCT00118846|62639191|FG000|Overall Study|Medical condition|2|||
33369000|NCT00868790|62747800|FG008|Period 4|Study Terminated by Sponsor|2|||
33267655|NCT00118846|62639192|FG001|Overall Study|Medical condition|2|||
33267656|NCT00118846|62639191|FG000|Overall Study|Lost to Follow-up|0|||
33267657|NCT00118846|62639192|FG001|Overall Study|Lost to Follow-up|2|||
33267658|NCT00118846|62639191|FG000|Overall Study|Personal reason|4|||
33267659|NCT00118846|62639192|FG001|Overall Study|Personal reason|5|||
33267660|NCT04705051|62639198|FG000|Overall Study|Enrolled but not treated|1|||
33267661|NCT04705051|62639198|FG000|Overall Study|Study terminated by sponsor|23|||
33267662|NCT04464421|62639205|FG000|Overall Study|Lost to Follow-up|2|||
33267663|NCT04464421|62639206|FG001|Overall Study|Lost to Follow-up|2|||
33267664|NCT04112784|62639224|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
33267665|NCT04112784|62639224|FG000|Overall Study|Screen Failures|4|||
33267666|NCT04049617|62639234|FG000|Overall Study|Adverse Event|0|||
33267667|NCT04049617|62639235|FG001|Overall Study|Adverse Event|0|||
33267668|NCT04049617|62639236|FG002|Overall Study|Adverse Event|0|||
33267669|NCT04049617|62639237|FG003|Overall Study|Adverse Event|1|||
33267670|NCT04049617|62639238|FG004|Overall Study|Adverse Event|0|||
33267671|NCT04049617|62639239|FG005|Overall Study|Adverse Event|0|||
33267672|NCT04049617|62639234|FG000|Overall Study|Death|0|||
33267673|NCT04049617|62639235|FG001|Overall Study|Death|0|||
33267674|NCT04049617|62639236|FG002|Overall Study|Death|0|||
33267675|NCT04049617|62639237|FG003|Overall Study|Death|0|||
33267676|NCT04049617|62639238|FG004|Overall Study|Death|0|||
33267677|NCT04049617|62639239|FG005|Overall Study|Death|1|||
33267678|NCT04049617|62639234|FG000|Overall Study|Lost to Follow-up|0|||
33267679|NCT04049617|62639235|FG001|Overall Study|Lost to Follow-up|0|||
33267680|NCT04049617|62639236|FG002|Overall Study|Lost to Follow-up|0|||
33267681|NCT04049617|62639237|FG003|Overall Study|Lost to Follow-up|1|||
33267682|NCT04049617|62639238|FG004|Overall Study|Lost to Follow-up|0|||
33267683|NCT04049617|62639239|FG005|Overall Study|Lost to Follow-up|0|||
33267684|NCT04049617|62639234|FG000|Overall Study|Withdrew consent|0|||
33267685|NCT04049617|62639235|FG001|Overall Study|Withdrew consent|0|||
33267686|NCT04049617|62639236|FG002|Overall Study|Withdrew consent|1|||
33267687|NCT04049617|62639237|FG003|Overall Study|Withdrew consent|0|||
33267688|NCT04049617|62639238|FG004|Overall Study|Withdrew consent|0|||
33267689|NCT04049617|62639239|FG005|Overall Study|Withdrew consent|0|||
33267690|NCT03911154|62639255|FG000|Overall Study|Withdrawal by Subject|1|||
33267691|NCT03781778|62639273|FG000|Overall Study|Withdrawal by Subject|2|||
33267692|NCT03781778|62639274|FG001|Overall Study|Withdrawal by Subject|2|||
33267693|NCT03710590|62639282|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
33267694|NCT03710590|62639283|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
33267695|NCT03465722|62639335|FG000|Overall Study|Withdrawal by Subject|21|||
33267696|NCT03465722|62639336|FG001|Overall Study|Withdrawal by Subject|14|||
33267697|NCT03465722|62639335|FG000|Overall Study|Death|89|||
33267698|NCT03465722|62639336|FG001|Overall Study|Death|87|||
33267699|NCT03465722|62639335|FG000|Overall Study|Lost to Follow-up|5|||
33267700|NCT03465722|62639336|FG001|Overall Study|Lost to Follow-up|3|||
33267701|NCT03465722|62639335|FG000|Overall Study|Administrative/Other|33|||
33267702|NCT03465722|62639336|FG001|Overall Study|Administrative/Other|32|||
33267703|NCT03465722|62639335|FG000|Overall Study|Not treated|1|||
33267704|NCT03465722|62639336|FG001|Overall Study|Not treated|2|||
33267705|NCT03465722|62639335|FG000|Overall Study|Sponsor decision|91|||
33267706|NCT03465722|62639336|FG001|Overall Study|Sponsor decision|98|||
33267707|NCT03205423|62639342|FG000|Overall Study|Personal|1|||
33267708|NCT03205423|62639343|FG001|Overall Study|Personal|1|||
33267709|NCT03205423|62639342|FG000|Overall Study|Physician Decision|0|||
33267710|NCT03205423|62639343|FG001|Overall Study|Physician Decision|2|||
33267711|NCT03104400|62639354|FG000|Overall Study|Adverse Event|5|||
33267712|NCT03104400|62639355|FG001|Overall Study|Adverse Event|7|||
33267713|NCT03104400|62639356|FG002|Overall Study|Adverse Event|11|||
33267714|NCT03104400|62639357|FG003|Overall Study|Adverse Event|9|||
33267715|NCT03104400|62639358|FG004|Overall Study|Adverse Event|21|||
33267716|NCT03104400|62639354|FG000|Overall Study|Withdrawal by Subject|17|||
33369001|NCT00868790|62747801|FG009|Period 4|Study Terminated by Sponsor|0|||
33369002|NCT00868790|62747802|FG010|Period 4|Study Terminated by Sponsor|2|||
33369003|NCT00868790|62747803|FG011|Period 4|Study Terminated by Sponsor|1|||
33369004|NCT00868790|62747804|FG012|Period 4|Study Terminated by Sponsor|0|||
33267717|NCT03104400|62639355|FG001|Overall Study|Withdrawal by Subject|19|||
33267718|NCT03104400|62639356|FG002|Overall Study|Withdrawal by Subject|29|||
33267719|NCT03104400|62639357|FG003|Overall Study|Withdrawal by Subject|25|||
33267720|NCT03104400|62639358|FG004|Overall Study|Withdrawal by Subject|24|||
33484905|NCT03415022|62862016|FG000|Overall Study|COVID-19 Suspension|2|||
33267721|NCT03104400|62639354|FG000|Overall Study|Lost to Follow-up|4|||
33267722|NCT03104400|62639355|FG001|Overall Study|Lost to Follow-up|1|||
33267723|NCT03104400|62639356|FG002|Overall Study|Lost to Follow-up|4|||
33267724|NCT03104400|62639357|FG003|Overall Study|Lost to Follow-up|8|||
33267725|NCT03104400|62639358|FG004|Overall Study|Lost to Follow-up|7|||
33267726|NCT03104400|62639354|FG000|Overall Study|Lack of Efficacy|6|||
33267727|NCT03104400|62639355|FG001|Overall Study|Lack of Efficacy|3|||
33267728|NCT03104400|62639356|FG002|Overall Study|Lack of Efficacy|8|||
33267729|NCT03104400|62639357|FG003|Overall Study|Lack of Efficacy|2|||
33267730|NCT03104400|62639358|FG004|Overall Study|Lack of Efficacy|1|||
33267731|NCT03104400|62639354|FG000|Overall Study|COVID Logistical Restrictions|0|||
33267732|NCT03104400|62639355|FG001|Overall Study|COVID Logistical Restrictions|0|||
33267733|NCT03104400|62639356|FG002|Overall Study|COVID Logistical Restrictions|0|||
33267734|NCT03104400|62639357|FG003|Overall Study|COVID Logistical Restrictions|1|||
33267735|NCT03104400|62639358|FG004|Overall Study|COVID Logistical Restrictions|0|||
33267736|NCT03104400|62639354|FG000|Overall Study|Other|2|||
33267737|NCT03104400|62639355|FG001|Overall Study|Other|3|||
33267738|NCT03104400|62639356|FG002|Overall Study|Other|7|||
33267739|NCT03104400|62639357|FG003|Overall Study|Other|6|||
33267740|NCT03104400|62639358|FG004|Overall Study|Other|4|||
33267741|NCT03104400|62639354|FG000|Overall Study|Other|0|||
33267742|NCT03104400|62639355|FG001|Overall Study|Other|1|||
33267743|NCT03104400|62639356|FG002|Overall Study|Other|0|||
33267744|NCT03104400|62639357|FG003|Overall Study|Other|0|||
33267745|NCT03104400|62639358|FG004|Overall Study|Other|0|||
33267746|NCT03104374|62639375|FG000|Overall Study|Adverse Event|7|||
33267747|NCT03104374|62639376|FG001|Overall Study|Adverse Event|6|||
33267748|NCT03104374|62639377|FG002|Overall Study|Adverse Event|12|||
33267749|NCT03104374|62639378|FG003|Overall Study|Adverse Event|15|||
33267750|NCT03104374|62639375|FG000|Overall Study|Withdrawal by Subject|18|||
33267751|NCT03104374|62639376|FG001|Overall Study|Withdrawal by Subject|10|||
33267752|NCT03104374|62639377|FG002|Overall Study|Withdrawal by Subject|10|||
33267753|NCT03104374|62639378|FG003|Overall Study|Withdrawal by Subject|17|||
33267754|NCT03104374|62639375|FG000|Overall Study|Lost to Follow-up|4|||
33267755|NCT03104374|62639376|FG001|Overall Study|Lost to Follow-up|4|||
33267756|NCT03104374|62639377|FG002|Overall Study|Lost to Follow-up|6|||
33267757|NCT03104374|62639378|FG003|Overall Study|Lost to Follow-up|8|||
33267758|NCT03104374|62639375|FG000|Overall Study|Lack of Efficacy|6|||
33484906|NCT03415022|62862017|FG001|Overall Study|COVID-19 Suspension|3|||
33484907|NCT03415022|62862016|FG000|Overall Study|Lost to Follow-up|2|||
33484908|NCT03415022|62862017|FG001|Overall Study|Lost to Follow-up|0|||
33484909|NCT02816398|62862023|FG000|Overall Study|Death|5|||
33267759|NCT03104374|62639376|FG001|Overall Study|Lack of Efficacy|7|||
33267760|NCT03104374|62639377|FG002|Overall Study|Lack of Efficacy|12|||
33267761|NCT03104374|62639378|FG003|Overall Study|Lack of Efficacy|6|||
33267762|NCT03104374|62639375|FG000|Overall Study|Other|2|||
33267763|NCT03104374|62639376|FG001|Overall Study|Other|2|||
33267764|NCT03104374|62639377|FG002|Overall Study|Other|4|||
33267765|NCT03104374|62639378|FG003|Overall Study|Other|7|||
33267766|NCT03073603|62639390|FG000|Overall Study|Noncompliance|3|||
33267767|NCT03073603|62639391|FG001|Overall Study|Noncompliance|1|||
33267768|NCT03073603|62639390|FG000|Overall Study|Adverse Event|5|||
33267769|NCT03073603|62639391|FG001|Overall Study|Adverse Event|3|||
33267770|NCT03073603|62639390|FG000|Overall Study|Physician Decision|1|||
33267771|NCT03073603|62639391|FG001|Overall Study|Physician Decision|2|||
33267772|NCT03073603|62639390|FG000|Overall Study|Required treatment not allowed by protocol|1|||
33267773|NCT03073603|62639391|FG001|Overall Study|Required treatment not allowed by protocol|0|||
33267774|NCT03073603|62639390|FG000|Overall Study|Financial or insurance-related|8|||
33267775|NCT03073603|62639391|FG001|Overall Study|Financial or insurance-related|0|||
33267776|NCT03073603|62639390|FG000|Overall Study|Withdrawal by Subject|0|||
33267777|NCT03073603|62639391|FG001|Overall Study|Withdrawal by Subject|1|||
33267778|NCT03073603|62639390|FG000|Overall Study|Discontinued DMT|4|||
33267779|NCT03073603|62639391|FG001|Overall Study|Discontinued DMT|0|||
33267780|NCT03073603|62639390|FG000|Overall Study|Restarted DMT|0|||
33267781|NCT03073603|62639391|FG001|Overall Study|Restarted DMT|1|||
33267782|NCT03002155|62639403|FG000|Overall Study|Lost to Follow-up|1|||
33267783|NCT03002155|62639404|FG001|Overall Study|Lost to Follow-up|2|||
33267784|NCT03002155|62639403|FG000|Overall Study|Withdrawal by Subject|1|||
33267785|NCT03002155|62639404|FG001|Overall Study|Withdrawal by Subject|0|||
33267786|NCT03002155|62639403|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
33267787|NCT03002155|62639404|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
33267788|NCT02918006|62639414|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
33267789|NCT02918006|62639415|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
33267790|NCT02918006|62639416|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
33267791|NCT02918006|62639414|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
33267792|NCT02918006|62639415|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
33267793|NCT02918006|62639416|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
33267794|NCT02918006|62639414|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
33267795|NCT02918006|62639415|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
33267796|NCT02918006|62639416|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
33267797|NCT02918006|62639414|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
33267798|NCT02918006|62639415|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
33369005|NCT00868790|62747805|FG013|Period 4|Study Terminated by Sponsor|1|||
33369006|NCT00868790|62747792|FG000|Period 4|Abnormal ALT/AST|0|||
33369007|NCT00868790|62747793|FG001|Period 4|Abnormal ALT/AST|0|||
33267799|NCT02918006|62639416|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
33267800|NCT02918006|62639414|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
33267801|NCT02918006|62639415|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
33267802|NCT02918006|62639416|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
33267803|NCT02918006|62639414|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
33267804|NCT02918006|62639415|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
33267805|NCT02918006|62639416|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
33267806|NCT02918006|62639414|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
33267807|NCT02918006|62639415|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
33267808|NCT02918006|62639416|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
33267809|NCT02918006|62639414|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
33267810|NCT02918006|62639415|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
33267811|NCT02918006|62639416|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
33267812|NCT02918006|62639414|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
33267813|NCT02918006|62639415|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
33267814|NCT02918006|62639416|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
33661952|NCT02703324|63092113|FG005|Period Two|Withdrawal by Subject|0|||
33661953|NCT02701764|63092124|FG000|Overall Study|Lost to Follow-up|0|||
33661954|NCT02701764|63092125|FG001|Overall Study|Lost to Follow-up|1|||
33661955|NCT01696643|63092306|FG000|Overall Study|Adverse Event|15|||
33661956|NCT01696643|63092307|FG001|Overall Study|Adverse Event|7|||
33661957|NCT01696643|63092306|FG000|Overall Study|Death|1|||
33267821|NCT02179749|62639470|FG000|Overall Study|Adverse Event|0|||
33267822|NCT02179749|62639471|FG001|Overall Study|Adverse Event|0|||
33267823|NCT02179749|62639472|FG002|Overall Study|Adverse Event|1|||
33267824|NCT02179749|62639470|FG000|Overall Study|Withdrawal by Subject|0|||
33267825|NCT02179749|62639471|FG001|Overall Study|Withdrawal by Subject|0|||
33267826|NCT02179749|62639472|FG002|Overall Study|Withdrawal by Subject|1|||
33267827|NCT02075593|62639483|FG000|Overall Study|Withdrawal by Subject|1|||
33267828|NCT00641186|62639516|FG000|Overall Study|Adverse Event|3|||
33267829|NCT01595009|62639522|FG000|Core|Patients completed per protocol|85|||
33267830|NCT01595009|62639523|FG001|Core|Patients completed per protocol|44|||
33267831|NCT01595009|62639524|FG002|Core|Patients completed per protocol|0|||
33267832|NCT01595009|62639525|FG003|Core|Patients completed per protocol|0|||
33267833|NCT01595009|62639522|FG000|Core|Adverse Event|19|||
33267834|NCT01595009|62639523|FG001|Core|Adverse Event|23|||
33267835|NCT01595009|62639524|FG002|Core|Adverse Event|0|||
33267836|NCT01595009|62639525|FG003|Core|Adverse Event|0|||
33267837|NCT01595009|62639522|FG000|Core|Disease progression|14|||
33267838|NCT01595009|62639523|FG001|Core|Disease progression|26|||
33267839|NCT01595009|62639524|FG002|Core|Disease progression|0|||
33267840|NCT01595009|62639525|FG003|Core|Disease progression|0|||
33267841|NCT01595009|62639522|FG000|Core|Withdrawal by Subject|4|||
33267842|NCT01595009|62639523|FG001|Core|Withdrawal by Subject|17|||
33267843|NCT01595009|62639524|FG002|Core|Withdrawal by Subject|0|||
33267844|NCT01595009|62639525|FG003|Core|Withdrawal by Subject|0|||
33267845|NCT01595009|62639522|FG000|Core|Death|3|||
33267846|NCT01595009|62639523|FG001|Core|Death|6|||
33267847|NCT01595009|62639524|FG002|Core|Death|0|||
33267848|NCT01595009|62639525|FG003|Core|Death|0|||
33267849|NCT01595009|62639522|FG000|Core|Lost to Follow-up|1|||
33267850|NCT01595009|62639523|FG001|Core|Lost to Follow-up|2|||
33267851|NCT01595009|62639524|FG002|Core|Lost to Follow-up|0|||
33267852|NCT01595009|62639525|FG003|Core|Lost to Follow-up|0|||
33267853|NCT01595009|62639522|FG000|Core|Protocol deviation|0|||
33267854|NCT01595009|62639523|FG001|Core|Protocol deviation|1|||
33267855|NCT01595009|62639524|FG002|Core|Protocol deviation|0|||
33267856|NCT01595009|62639525|FG003|Core|Protocol deviation|0|||
33267857|NCT01595009|62639522|FG000|Core|Administrative problems|0|||
33267858|NCT01595009|62639523|FG001|Core|Administrative problems|1|||
33267859|NCT01595009|62639524|FG002|Core|Administrative problems|0|||
33267860|NCT01595009|62639525|FG003|Core|Administrative problems|0|||
33267861|NCT01595009|62639522|FG000|Extension|Administrative problems|0|||
33267862|NCT01595009|62639523|FG001|Extension|Administrative problems|0|||
33267863|NCT01595009|62639524|FG002|Extension|Administrative problems|0|||
33267864|NCT01595009|62639525|FG003|Extension|Administrative problems|1|||
33267865|NCT01595009|62639522|FG000|Extension|Patients completed per protocol|0|||
33267866|NCT01595009|62639523|FG001|Extension|Patients completed per protocol|0|||
33267867|NCT01595009|62639524|FG002|Extension|Patients completed per protocol|0|||
33267868|NCT01595009|62639525|FG003|Extension|Patients completed per protocol|2|||
33267869|NCT01595009|62639522|FG000|Extension|Disease progression|0|||
33267870|NCT01595009|62639523|FG001|Extension|Disease progression|0|||
33267871|NCT01595009|62639524|FG002|Extension|Disease progression|4|||
33267872|NCT01595009|62639525|FG003|Extension|Disease progression|7|||
33267873|NCT01595009|62639522|FG000|Extension|Adverse Event|0|||
33267874|NCT01595009|62639523|FG001|Extension|Adverse Event|0|||
33267875|NCT01595009|62639524|FG002|Extension|Adverse Event|0|||
33267876|NCT01595009|62639525|FG003|Extension|Adverse Event|1|||
33267877|NCT05553808|62639542|FG000|Overall Study|Death|25|||
33267878|NCT05553808|62639543|FG001|Overall Study|Death|62|||
33267879|NCT05553808|62639542|FG000|Overall Study|Site Closed|6|||
33267880|NCT05553808|62639543|FG001|Overall Study|Site Closed|6|||
33267881|NCT05553808|62639542|FG000|Overall Study|Lost to Follow-up|1|||
33267882|NCT05553808|62639543|FG001|Overall Study|Lost to Follow-up|0|||
33267883|NCT05553808|62639542|FG000|Overall Study|Withdrawal by Subject|3|||
33267884|NCT05553808|62639543|FG001|Overall Study|Withdrawal by Subject|2|||
33267885|NCT04997161|62639559|FG000|Overall Study|Study terminated by sponsor|3|||
33267886|NCT04753216|62639563|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
33267887|NCT04753216|62639563|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
33267888|NCT04753216|62639563|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
33267889|NCT04530747|62639596|FG000|Overall Study|Withdrawal by Subject|1|||
33267890|NCT04530747|62639597|FG001|Overall Study|Withdrawal by Subject|0|||
33267891|NCT04493242|62639608|FG000|Overall Study|Death|10|||
33267892|NCT04493242|62639609|FG001|Overall Study|Death|14|||
33267893|NCT04493242|62639610|FG002|Overall Study|Death|16|||
33267894|NCT04493242|62639608|FG000|Overall Study|Lost to Follow-up|1|||
33267895|NCT04493242|62639609|FG001|Overall Study|Lost to Follow-up|1|||
33267896|NCT04493242|62639610|FG002|Overall Study|Lost to Follow-up|0|||
33267897|NCT04493242|62639608|FG000|Overall Study|Withdrawal by Subject|1|||
33267898|NCT04493242|62639609|FG001|Overall Study|Withdrawal by Subject|0|||
33267899|NCT04493242|62639610|FG002|Overall Study|Withdrawal by Subject|0|||
33267900|NCT04493242|62639608|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
33267901|NCT04493242|62639609|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
33267902|NCT04493242|62639610|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
33267903|NCT04493242|62639608|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
33267904|NCT04493242|62639609|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
33267905|NCT04493242|62639610|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
33267906|NCT04040751|62639631|FG000|Overall Study|Withdrawal by Subject|2|||
33267907|NCT04040751|62639632|FG001|Overall Study|Withdrawal by Subject|0|||
33267908|NCT04040751|62639633|FG002|Overall Study|Withdrawal by Subject|2|||
33267909|NCT04040751|62639634|FG003|Overall Study|Withdrawal by Subject|0|||
33267910|NCT03997916|62639644|FG000|Overall Study|Protocol Violation|35|||
33267911|NCT03596177|62639663|FG000|Single Blind Period|Withdrawal by Subject|1|||
33267912|NCT03596177|62639664|FG001|Single Blind Period|Withdrawal by Subject|1|||
33267913|NCT03596177|62639663|FG000|Single Blind Period|Other|1|||
33267914|NCT03596177|62639664|FG001|Single Blind Period|Other|0|||
33267915|NCT03596177|62639663|FG000|Double Blind Period|Withdrawal by Subject|0|||
33267916|NCT03596177|62639664|FG001|Double Blind Period|Withdrawal by Subject|1|||
33267917|NCT03596177|62639663|FG000|Double Blind Period|Other|0|||
33267918|NCT03596177|62639664|FG001|Double Blind Period|Other|4|||
33267919|NCT03596177|62639663|FG000|Double Blind Period|Death during safety follow-up|0|||
33267920|NCT03596177|62639664|FG001|Double Blind Period|Death during safety follow-up|1|||
33267921|NCT03579459|62639674|FG000|Overall Study|Adverse Event|7|||
33267922|NCT03579459|62639675|FG001|Overall Study|Adverse Event|6|||
33267923|NCT03579459|62639676|FG002|Overall Study|Adverse Event|2|||
33267924|NCT03579459|62639677|FG003|Overall Study|Adverse Event|6|||
33267925|NCT03579459|62639674|FG000|Overall Study|Death|1|||
33267926|NCT03579459|62639675|FG001|Overall Study|Death|0|||
33267927|NCT03579459|62639676|FG002|Overall Study|Death|1|||
33267928|NCT03579459|62639677|FG003|Overall Study|Death|2|||
33267929|NCT03579459|62639674|FG000|Overall Study|Lost to Follow-up|6|||
33267930|NCT03579459|62639675|FG001|Overall Study|Lost to Follow-up|2|||
33267931|NCT03579459|62639676|FG002|Overall Study|Lost to Follow-up|4|||
33267932|NCT03579459|62639677|FG003|Overall Study|Lost to Follow-up|1|||
33267933|NCT03579459|62639674|FG000|Overall Study|Physician Decision|0|||
33267934|NCT03579459|62639675|FG001|Overall Study|Physician Decision|1|||
33267935|NCT03579459|62639676|FG002|Overall Study|Physician Decision|0|||
33267936|NCT03579459|62639677|FG003|Overall Study|Physician Decision|1|||
33267937|NCT03579459|62639674|FG000|Overall Study|Protocol Violation|1|||
33267938|NCT03579459|62639675|FG001|Overall Study|Protocol Violation|2|||
33267939|NCT03579459|62639676|FG002|Overall Study|Protocol Violation|3|||
33267940|NCT03579459|62639677|FG003|Overall Study|Protocol Violation|5|||
33369008|NCT00868790|62747794|FG002|Period 4|Abnormal ALT/AST|1|||
33267941|NCT03579459|62639674|FG000|Overall Study|Withdrawal by Subject|12|||
33267942|NCT03579459|62639675|FG001|Overall Study|Withdrawal by Subject|8|||
33267943|NCT03579459|62639676|FG002|Overall Study|Withdrawal by Subject|11|||
33267944|NCT03579459|62639677|FG003|Overall Study|Withdrawal by Subject|8|||
33369009|NCT00868790|62747795|FG003|Period 4|Abnormal ALT/AST|0|||
33267945|NCT03579459|62639674|FG000|Overall Study|Medication error without associated adverse event|2|||
33267946|NCT03579459|62639675|FG001|Overall Study|Medication error without associated adverse event|1|||
33267947|NCT03579459|62639676|FG002|Overall Study|Medication error without associated adverse event|1|||
33267948|NCT03579459|62639677|FG003|Overall Study|Medication error without associated adverse event|0|||
33267949|NCT03579459|62639674|FG000|Overall Study|Other|0|||
33267950|NCT03579459|62639675|FG001|Overall Study|Other|1|||
33267951|NCT03579459|62639676|FG002|Overall Study|Other|1|||
33369010|NCT00868790|62747796|FG004|Period 4|Abnormal ALT/AST|0|||
33267952|NCT03579459|62639677|FG003|Overall Study|Other|0|||
33267953|NCT03579459|62639674|FG000|Overall Study|Randomized not vaccinated|0|||
33267954|NCT03579459|62639675|FG001|Overall Study|Randomized not vaccinated|2|||
33267955|NCT03579459|62639676|FG002|Overall Study|Randomized not vaccinated|0|||
33267956|NCT03579459|62639677|FG003|Overall Study|Randomized not vaccinated|1|||
33267957|NCT04449276|62639704|FG000|Overall Study|Adverse Event|1|||
33267958|NCT04449276|62639705|FG001|Overall Study|Adverse Event|2|||
33267959|NCT04449276|62639706|FG002|Overall Study|Adverse Event|0|||
33267960|NCT04449276|62639707|FG003|Overall Study|Adverse Event|0|||
33267961|NCT04449276|62639708|FG004|Overall Study|Adverse Event|2|||
33267962|NCT04449276|62639709|FG005|Overall Study|Adverse Event|0|||
33267963|NCT04449276|62639710|FG006|Overall Study|Adverse Event|0|||
33267964|NCT04449276|62639711|FG007|Overall Study|Adverse Event|1|||
33267965|NCT04449276|62639704|FG000|Overall Study|Withdrawal by Subject|2|||
33267966|NCT04449276|62639705|FG001|Overall Study|Withdrawal by Subject|0|||
33267967|NCT04449276|62639706|FG002|Overall Study|Withdrawal by Subject|0|||
33267968|NCT04449276|62639707|FG003|Overall Study|Withdrawal by Subject|1|||
33267969|NCT04449276|62639708|FG004|Overall Study|Withdrawal by Subject|0|||
33267970|NCT04449276|62639709|FG005|Overall Study|Withdrawal by Subject|0|||
33267971|NCT04449276|62639710|FG006|Overall Study|Withdrawal by Subject|0|||
33267972|NCT04449276|62639711|FG007|Overall Study|Withdrawal by Subject|0|||
33267973|NCT04449276|62639704|FG000|Overall Study|Other|0|||
33267974|NCT04449276|62639705|FG001|Overall Study|Other|2|||
33267975|NCT04449276|62639706|FG002|Overall Study|Other|3|||
33267976|NCT04449276|62639707|FG003|Overall Study|Other|2|||
33267977|NCT04449276|62639708|FG004|Overall Study|Other|0|||
33267978|NCT04449276|62639709|FG005|Overall Study|Other|0|||
33267979|NCT04449276|62639710|FG006|Overall Study|Other|0|||
33267980|NCT04449276|62639711|FG007|Overall Study|Other|1|||
33267981|NCT04391894|62639751|FG000|Overall Study|Adverse Event|1|||
33267982|NCT04391894|62639752|FG001|Overall Study|Adverse Event|1|||
33267983|NCT04391894|62639753|FG002|Overall Study|Adverse Event|1|||
33267984|NCT04391894|62639754|FG003|Overall Study|Adverse Event|1|||
33267985|NCT04391894|62639755|FG004|Overall Study|Adverse Event|1|||
33267986|NCT04391894|62639751|FG000|Overall Study|Lost to Follow-up|1|||
33267987|NCT04391894|62639752|FG001|Overall Study|Lost to Follow-up|0|||
33267988|NCT04391894|62639753|FG002|Overall Study|Lost to Follow-up|0|||
33267989|NCT04391894|62639754|FG003|Overall Study|Lost to Follow-up|0|||
33267990|NCT04391894|62639755|FG004|Overall Study|Lost to Follow-up|0|||
33267991|NCT04391894|62639751|FG000|Overall Study|Protocol Violation|0|||
33267992|NCT04391894|62639752|FG001|Overall Study|Protocol Violation|0|||
33267993|NCT04391894|62639753|FG002|Overall Study|Protocol Violation|0|||
33267994|NCT04391894|62639754|FG003|Overall Study|Protocol Violation|1|||
33267995|NCT04391894|62639755|FG004|Overall Study|Protocol Violation|0|||
33267996|NCT04391894|62639751|FG000|Overall Study|Withdrawal by Subject|2|||
33267997|NCT04391894|62639752|FG001|Overall Study|Withdrawal by Subject|0|||
33267998|NCT04391894|62639753|FG002|Overall Study|Withdrawal by Subject|3|||
33267999|NCT04391894|62639754|FG003|Overall Study|Withdrawal by Subject|0|||
33268000|NCT04391894|62639755|FG004|Overall Study|Withdrawal by Subject|1|||
33268001|NCT04391894|62639751|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
33268002|NCT04391894|62639752|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
33268003|NCT04391894|62639753|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
33268004|NCT04391894|62639754|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
33268005|NCT04391894|62639755|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
33268006|NCT03851705|62639773|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
33268007|NCT03851705|62639774|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
33268008|NCT03851705|62639775|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
33268009|NCT03851705|62639776|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
33268010|NCT03851705|62639773|FG000|Part 1: Double-Blind Period|Other reason|1|||
33268011|NCT03851705|62639774|FG001|Part 1: Double-Blind Period|Other reason|0|||
33268012|NCT03851705|62639775|FG002|Part 1: Double-Blind Period|Other reason|0|||
33268013|NCT03851705|62639776|FG003|Part 1: Double-Blind Period|Other reason|0|||
33268014|NCT03851705|62639773|FG000|Part 2: Open-Label Period|Other reason|0|||
33268015|NCT03851705|62639774|FG001|Part 2: Open-Label Period|Other reason|0|||
33268016|NCT03851705|62639775|FG002|Part 2: Open-Label Period|Other reason|0|||
33268017|NCT03851705|62639776|FG003|Part 2: Open-Label Period|Other reason|1|||
33268018|NCT03851705|62639773|FG000|Part 2: Open-Label Period|Death|0|||
33268019|NCT03851705|62639774|FG001|Part 2: Open-Label Period|Death|0|||
33268020|NCT03851705|62639775|FG002|Part 2: Open-Label Period|Death|3|||
33268021|NCT03851705|62639776|FG003|Part 2: Open-Label Period|Death|0|||
33268022|NCT03851705|62639773|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
33268023|NCT03851705|62639774|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
33268024|NCT03851705|62639775|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
33268025|NCT03851705|62639776|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
33268026|NCT03824366|62639789|FG000|Overall Study|Death|1|||
33268027|NCT03824366|62639789|FG000|Overall Study|Previously unidentified metal artifact|1|||
33268028|NCT03824366|62639789|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
33268029|NCT03824366|62639789|FG000|Overall Study|Withdrawal by Subject|1|||
33268030|NCT03810313|62639795|FG000|Overall Study|Study terminated by sponsor|164|||
33268031|NCT03810313|62639796|FG001|Overall Study|Study terminated by sponsor|159|||
33268032|NCT03810313|62639795|FG000|Overall Study|Subject decision|10|||
33268033|NCT03810313|62639796|FG001|Overall Study|Subject decision|11|||
33268034|NCT03810313|62639795|FG000|Overall Study|Lost to Follow-up|3|||
33268035|NCT03810313|62639796|FG001|Overall Study|Lost to Follow-up|3|||
33268036|NCT03810313|62639795|FG000|Overall Study|Adverse Event|2|||
33268037|NCT03810313|62639796|FG001|Overall Study|Adverse Event|1|||
33268038|NCT03810313|62639795|FG000|Overall Study|Death|2|||
33268039|NCT03810313|62639796|FG001|Overall Study|Death|1|||
33268040|NCT03810313|62639795|FG000|Overall Study|Physician Decision|0|||
33268041|NCT03810313|62639796|FG001|Overall Study|Physician Decision|1|||
33268042|NCT03802630|62639805|FG000|Overall Study|Study terminated by sponsor|130|||
33268043|NCT03802630|62639806|FG001|Overall Study|Study terminated by sponsor|134|||
33268044|NCT03802630|62639805|FG000|Overall Study|Subject decision|16|||
33268045|NCT03802630|62639806|FG001|Overall Study|Subject decision|9|||
33268046|NCT03802630|62639805|FG000|Overall Study|Adverse Event|3|||
33268047|NCT03802630|62639806|FG001|Overall Study|Adverse Event|1|||
33268048|NCT03802630|62639805|FG000|Overall Study|Lost to Follow-up|2|||
33268049|NCT03802630|62639806|FG001|Overall Study|Lost to Follow-up|2|||
33268050|NCT03802630|62639805|FG000|Overall Study|Physician Decision|2|||
33268051|NCT03802630|62639806|FG001|Overall Study|Physician Decision|0|||
33268052|NCT03802630|62639805|FG000|Overall Study|Death|0|||
33268053|NCT03802630|62639806|FG001|Overall Study|Death|2|||
33268054|NCT03775213|62639815|FG000|Overall Study|Withdrawal by Subject|51|||
33268055|NCT03775213|62639816|FG001|Overall Study|Withdrawal by Subject|53|||
33268056|NCT03775213|62639815|FG000|Overall Study|Incomplete Survey|7|||
33268057|NCT03775213|62639816|FG001|Overall Study|Incomplete Survey|7|||
33268058|NCT03710564|62639824|FG000|Overall Study|Study Terminated by Sponsor|104|||
33268059|NCT03710564|62639825|FG001|Overall Study|Study Terminated by Sponsor|55|||
33268060|NCT03710564|62639824|FG000|Overall Study|Withdrawal by Subject|57|||
33268061|NCT03710564|62639825|FG001|Overall Study|Withdrawal by Subject|25|||
33268062|NCT03710564|62639824|FG000|Overall Study|Death|10|||
33268063|NCT03710564|62639825|FG001|Overall Study|Death|4|||
33268064|NCT03710564|62639824|FG000|Overall Study|Lost to Follow-up|5|||
33268065|NCT03710564|62639825|FG001|Overall Study|Lost to Follow-up|4|||
33268066|NCT03710564|62639824|FG000|Overall Study|Protocol Violation|3|||
33268067|NCT03710564|62639825|FG001|Overall Study|Protocol Violation|2|||
33268068|NCT03710564|62639824|FG000|Overall Study|Adverse Event|3|||
33268069|NCT03710564|62639825|FG001|Overall Study|Adverse Event|0|||
33268070|NCT03710564|62639824|FG000|Overall Study|Physician Decision|2|||
33268071|NCT03710564|62639825|FG001|Overall Study|Physician Decision|3|||
33268072|NCT03624127|62639835|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
33268073|NCT03624127|62639836|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
33268074|NCT03624127|62639837|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
33268075|NCT03624127|62639835|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
33268076|NCT03624127|62639836|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
33268077|NCT03624127|62639837|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
33268078|NCT03624127|62639835|FG000|Treatment Week 0 - Week 16|Death|0|||
33268079|NCT03624127|62639836|FG001|Treatment Week 0 - Week 16|Death|1|||
33268080|NCT03624127|62639837|FG002|Treatment Week 0 - Week 16|Death|0|||
33268081|NCT03624127|62639835|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
33268082|NCT03624127|62639836|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
33268083|NCT03624127|62639837|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
33268084|NCT03624127|62639835|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
33268085|NCT03624127|62639836|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
33268086|NCT03624127|62639837|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
33268087|NCT03624127|62639835|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
33268088|NCT03624127|62639836|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
33268089|NCT03624127|62639837|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
33268090|NCT03624127|62639835|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
33268091|NCT03624127|62639836|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
33268092|NCT03624127|62639837|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
33268093|NCT03624127|62639835|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
33268094|NCT03624127|62639836|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
33268095|NCT03624127|62639837|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
33268096|NCT03624127|62639835|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
33268097|NCT03624127|62639836|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
33268098|NCT03624127|62639837|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
33268099|NCT03624127|62639835|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
33268100|NCT03624127|62639836|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
33268101|NCT03624127|62639837|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
33268102|NCT03624127|62639835|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
33268103|NCT03624127|62639836|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
33268104|NCT03624127|62639837|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
33268105|NCT03624127|62639835|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
33268106|NCT03624127|62639836|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
33268107|NCT03624127|62639837|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
33268108|NCT03624127|62639835|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
33268109|NCT03624127|62639836|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
33268110|NCT03624127|62639837|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
33268111|NCT03624127|62639835|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
33484910|NCT02816398|62862023|FG000|Overall Study|Lack of Efficacy|8|||
33484911|NCT02816398|62862023|FG000|Overall Study|Lost to Follow-up|1|||
33268112|NCT03624127|62639836|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
33268113|NCT03624127|62639837|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
33268114|NCT03624127|62639835|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
33268115|NCT03624127|62639836|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
33268116|NCT03624127|62639837|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
33268117|NCT03624127|62639835|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
33268118|NCT03624127|62639836|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
33268119|NCT03624127|62639837|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
33268120|NCT03624127|62639835|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
33268121|NCT03624127|62639836|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
33268122|NCT03624127|62639837|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
33268123|NCT03624127|62639835|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
33268124|NCT03624127|62639836|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
33268125|NCT03624127|62639837|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
33268126|NCT03624127|62639835|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
33268127|NCT03624127|62639836|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
33268128|NCT03624127|62639837|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
33268129|NCT03624127|62639835|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
33268130|NCT03624127|62639836|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
33268131|NCT03624127|62639837|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
33268132|NCT03624127|62639835|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
33268133|NCT03624127|62639836|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
33268134|NCT03624127|62639837|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
33268135|NCT03616912|62639855|FG000|Overall Study|Adverse Event|17|||
33268136|NCT03616912|62639856|FG001|Overall Study|Adverse Event|21|||
33268137|NCT03616912|62639857|FG002|Overall Study|Adverse Event|9|||
33268138|NCT03616912|62639858|FG003|Overall Study|Adverse Event|0|||
33268139|NCT03616912|62639859|FG004|Overall Study|Adverse Event|0|||
33268140|NCT03616912|62639860|FG005|Overall Study|Adverse Event|0|||
33268141|NCT03616912|62639855|FG000|Overall Study|Death|1|||
33268142|NCT03616912|62639856|FG001|Overall Study|Death|1|||
33268143|NCT03616912|62639857|FG002|Overall Study|Death|0|||
33268144|NCT03616912|62639858|FG003|Overall Study|Death|0|||
33268145|NCT03616912|62639859|FG004|Overall Study|Death|0|||
33268146|NCT03616912|62639860|FG005|Overall Study|Death|0|||
33268147|NCT03616912|62639855|FG000|Overall Study|Lack of Efficacy|13|||
33268148|NCT03616912|62639856|FG001|Overall Study|Lack of Efficacy|6|||
33268149|NCT03616912|62639857|FG002|Overall Study|Lack of Efficacy|8|||
33268150|NCT03616912|62639858|FG003|Overall Study|Lack of Efficacy|4|||
33268151|NCT03616912|62639859|FG004|Overall Study|Lack of Efficacy|5|||
33268152|NCT03616912|62639860|FG005|Overall Study|Lack of Efficacy|1|||
33268153|NCT03616912|62639855|FG000|Overall Study|Lost to Follow-up|1|||
33268154|NCT03616912|62639856|FG001|Overall Study|Lost to Follow-up|2|||
33268155|NCT03616912|62639857|FG002|Overall Study|Lost to Follow-up|3|||
33268156|NCT03616912|62639858|FG003|Overall Study|Lost to Follow-up|0|||
33268157|NCT03616912|62639859|FG004|Overall Study|Lost to Follow-up|0|||
33268158|NCT03616912|62639860|FG005|Overall Study|Lost to Follow-up|0|||
33268159|NCT03616912|62639855|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
33268160|NCT03616912|62639856|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
33268161|NCT03616912|62639857|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
33268162|NCT03616912|62639858|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
33268163|NCT03616912|62639859|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
33268164|NCT03616912|62639860|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
33555632|NCT02793947|62948415|FG001|Overall Study|Death|0|||
33268165|NCT03616912|62639855|FG000|Overall Study|Withdrawal by Subject|12|||
33268166|NCT03616912|62639856|FG001|Overall Study|Withdrawal by Subject|12|||
33268167|NCT03616912|62639857|FG002|Overall Study|Withdrawal by Subject|15|||
33268168|NCT03616912|62639858|FG003|Overall Study|Withdrawal by Subject|2|||
33268169|NCT03616912|62639859|FG004|Overall Study|Withdrawal by Subject|0|||
33268170|NCT03616912|62639860|FG005|Overall Study|Withdrawal by Subject|2|||
33268171|NCT03616912|62639855|FG000|Overall Study|Study Terminated by Sponsor|0|||
33268172|NCT03616912|62639856|FG001|Overall Study|Study Terminated by Sponsor|0|||
33268173|NCT03616912|62639857|FG002|Overall Study|Study Terminated by Sponsor|0|||
33268174|NCT03616912|62639858|FG003|Overall Study|Study Terminated by Sponsor|10|||
33268175|NCT03616912|62639859|FG004|Overall Study|Study Terminated by Sponsor|9|||
33268176|NCT03616912|62639860|FG005|Overall Study|Study Terminated by Sponsor|11|||
33484912|NCT02812186|62862029|FG000|Period 1|Post randomization screen failure|5|||
33484913|NCT02812186|62862030|FG001|Period 1|Post randomization screen failure|9|||
33268177|NCT03616912|62639855|FG000|Overall Study|Protocol Deviation|1|||
33268178|NCT03616912|62639856|FG001|Overall Study|Protocol Deviation|1|||
33268179|NCT03616912|62639857|FG002|Overall Study|Protocol Deviation|0|||
33268180|NCT03616912|62639858|FG003|Overall Study|Protocol Deviation|0|||
33268181|NCT03616912|62639859|FG004|Overall Study|Protocol Deviation|0|||
33268182|NCT03616912|62639860|FG005|Overall Study|Protocol Deviation|0|||
33268183|NCT03616912|62639855|FG000|Overall Study|Pregnancy|1|||
33268184|NCT03616912|62639856|FG001|Overall Study|Pregnancy|0|||
33268185|NCT03616912|62639857|FG002|Overall Study|Pregnancy|4|||
33268186|NCT03616912|62639858|FG003|Overall Study|Pregnancy|0|||
33268187|NCT03616912|62639859|FG004|Overall Study|Pregnancy|0|||
33268188|NCT03616912|62639860|FG005|Overall Study|Pregnancy|0|||
33268189|NCT03616912|62639855|FG000|Overall Study|Protocol Violation|1|||
33268190|NCT03616912|62639856|FG001|Overall Study|Protocol Violation|0|||
33268191|NCT03616912|62639857|FG002|Overall Study|Protocol Violation|2|||
33268192|NCT03616912|62639858|FG003|Overall Study|Protocol Violation|0|||
33268193|NCT03616912|62639859|FG004|Overall Study|Protocol Violation|0|||
33268194|NCT03616912|62639860|FG005|Overall Study|Protocol Violation|0|||
33268195|NCT03616912|62639855|FG000|Overall Study|Physician Decision|2|||
33268196|NCT03616912|62639856|FG001|Overall Study|Physician Decision|0|||
33268197|NCT03616912|62639857|FG002|Overall Study|Physician Decision|0|||
33268198|NCT03616912|62639858|FG003|Overall Study|Physician Decision|0|||
33268199|NCT03616912|62639859|FG004|Overall Study|Physician Decision|1|||
33268200|NCT03616912|62639860|FG005|Overall Study|Physician Decision|0|||
33268201|NCT03616912|62639855|FG000|Overall Study|Randomized But Never Treated|0|||
33268202|NCT03616912|62639856|FG001|Overall Study|Randomized But Never Treated|2|||
33268203|NCT03616912|62639857|FG002|Overall Study|Randomized But Never Treated|0|||
33268204|NCT03616912|62639858|FG003|Overall Study|Randomized But Never Treated|0|||
33268205|NCT03616912|62639859|FG004|Overall Study|Randomized But Never Treated|0|||
33268206|NCT03616912|62639860|FG005|Overall Study|Randomized But Never Treated|0|||
33268207|NCT03499899|62639877|FG000|Overall Study|Adverse Event|2|||
33268208|NCT03499899|62639878|FG001|Overall Study|Adverse Event|3|||
33268209|NCT03499899|62639879|FG002|Overall Study|Adverse Event|3|||
33268210|NCT03499899|62639877|FG000|Overall Study|Death|0|||
33268211|NCT03499899|62639878|FG001|Overall Study|Death|0|||
33268212|NCT03499899|62639879|FG002|Overall Study|Death|1|||
33268213|NCT03499899|62639877|FG000|Overall Study|Physician Decision|3|||
33268214|NCT03499899|62639878|FG001|Overall Study|Physician Decision|6|||
33268215|NCT03499899|62639879|FG002|Overall Study|Physician Decision|6|||
33268216|NCT03499899|62639877|FG000|Overall Study|Progressive disease|15|||
33268217|NCT03499899|62639878|FG001|Overall Study|Progressive disease|23|||
33268218|NCT03499899|62639879|FG002|Overall Study|Progressive disease|23|||
33268219|NCT03499899|62639877|FG000|Overall Study|Patient decision|0|||
33369011|NCT00868790|62747797|FG005|Period 4|Abnormal ALT/AST|0|||
33369012|NCT00868790|62747798|FG006|Period 4|Abnormal ALT/AST|0|||
33369013|NCT00868790|62747799|FG007|Period 4|Abnormal ALT/AST|0|||
33369014|NCT00868790|62747800|FG008|Period 4|Abnormal ALT/AST|0|||
33369015|NCT00868790|62747801|FG009|Period 4|Abnormal ALT/AST|0|||
33369016|NCT00868790|62747802|FG010|Period 4|Abnormal ALT/AST|0|||
33369017|NCT00868790|62747803|FG011|Period 4|Abnormal ALT/AST|0|||
33369018|NCT00868790|62747804|FG012|Period 4|Abnormal ALT/AST|0|||
33369019|NCT00868790|62747805|FG013|Period 4|Abnormal ALT/AST|0|||
33369020|NCT00868790|62747792|FG000|Post-study|Withdrawal by Subject|0|||
33369021|NCT00868790|62747793|FG001|Post-study|Withdrawal by Subject|0|||
33369022|NCT00868790|62747794|FG002|Post-study|Withdrawal by Subject|0|||
33369023|NCT00868790|62747795|FG003|Post-study|Withdrawal by Subject|0|||
33484914|NCT02812186|62862029|FG000|Period 1|nonevaluable data sets|6|||
33484915|NCT02812186|62862030|FG001|Period 1|nonevaluable data sets|6|||
33484916|NCT02811640|62862039|FG000|Overall Study|Technology malfunction|2|||
33484917|NCT03310268|62862046|FG000|Overall Study|(Not specified)|1|||
33484918|NCT03310268|62862047|FG001|Overall Study|(Not specified)|5|||
33484919|NCT03310268|62862048|FG002|Overall Study|(Not specified)|0|||
33484920|NCT02810392|62862058|FG000|Overall Study|Subject too ill to continue|1|||
33484921|NCT02810392|62862059|FG001|Overall Study|Subject too ill to continue|0|||
33268220|NCT03499899|62639878|FG001|Overall Study|Patient decision|1|||
33268221|NCT03499899|62639879|FG002|Overall Study|Patient decision|1|||
33268222|NCT03499899|62639877|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
33268223|NCT03499899|62639878|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
33268224|NCT03499899|62639879|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
33268225|NCT03481634|62639895|FG000|Overall Study|Withdrawal by Subject|16|||
33268226|NCT03481634|62639896|FG001|Overall Study|Withdrawal by Subject|19|||
33268227|NCT03481634|62639897|FG002|Overall Study|Withdrawal by Subject|14|||
33268228|NCT03481634|62639895|FG000|Overall Study|Protocol Violation|1|||
33268229|NCT03481634|62639896|FG001|Overall Study|Protocol Violation|0|||
33369024|NCT00868790|62747796|FG004|Post-study|Withdrawal by Subject|1|||
33369025|NCT00868790|62747797|FG005|Post-study|Withdrawal by Subject|0|||
33555633|NCT02793947|62948414|FG000|Overall Study|Physician Decision|1|||
33369026|NCT00868790|62747798|FG006|Post-study|Withdrawal by Subject|0|||
33268230|NCT03481634|62639897|FG002|Overall Study|Protocol Violation|1|||
33268231|NCT03481634|62639895|FG000|Overall Study|Progressive disease|0|||
33268232|NCT03481634|62639896|FG001|Overall Study|Progressive disease|1|||
33268233|NCT03481634|62639897|FG002|Overall Study|Progressive disease|0|||
33268234|NCT03481634|62639895|FG000|Overall Study|Physician Decision|3|||
33268235|NCT03481634|62639896|FG001|Overall Study|Physician Decision|0|||
33268236|NCT03481634|62639897|FG002|Overall Study|Physician Decision|1|||
33268237|NCT03481634|62639895|FG000|Overall Study|Lost to Follow-up|3|||
33268238|NCT03481634|62639896|FG001|Overall Study|Lost to Follow-up|4|||
33268239|NCT03481634|62639897|FG002|Overall Study|Lost to Follow-up|4|||
33268240|NCT03481634|62639895|FG000|Overall Study|Death|4|||
33268241|NCT03481634|62639896|FG001|Overall Study|Death|8|||
33268242|NCT03481634|62639897|FG002|Overall Study|Death|7|||
33268243|NCT03481634|62639895|FG000|Overall Study|Adverse Event|6|||
33268244|NCT03481634|62639896|FG001|Overall Study|Adverse Event|3|||
33268245|NCT03481634|62639897|FG002|Overall Study|Adverse Event|7|||
33268246|NCT03373461|62639911|FG000|Part 2|Adverse Event|0|||
33268247|NCT03373461|62639912|FG001|Part 2|Adverse Event|1|||
33268248|NCT03373461|62639913|FG002|Part 2|Adverse Event|0|||
33268249|NCT03373461|62639914|FG003|Part 2|Adverse Event|0|||
33268250|NCT03373461|62639915|FG004|Part 2|Adverse Event|1|||
33268251|NCT03364751|62639966|FG000|Overall Study|Withdrawal by Subject|1|||
33268252|NCT03364751|62639967|FG001|Overall Study|Withdrawal by Subject|0|||
33268253|NCT03364751|62639968|FG002|Overall Study|Withdrawal by Subject|0|||
33268254|NCT03364751|62639969|FG003|Overall Study|Withdrawal by Subject|0|||
33268255|NCT03364751|62639966|FG000|Overall Study|Lost to Follow-up|0|||
33268256|NCT03364751|62639967|FG001|Overall Study|Lost to Follow-up|1|||
33268257|NCT03364751|62639968|FG002|Overall Study|Lost to Follow-up|0|||
33268258|NCT03364751|62639969|FG003|Overall Study|Lost to Follow-up|0|||
33268259|NCT03149003|62639990|FG000|Overall Study|Randomized but not treated|0|||
33268260|NCT03149003|62639991|FG001|Overall Study|Randomized but not treated|1|||
33268261|NCT03149003|62639992|FG002|Overall Study|Randomized but not treated|18|||
33268262|NCT02990806|62640002|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
33268263|NCT02990806|62640003|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
33268264|NCT02990806|62640004|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
33268265|NCT02990806|62640005|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
33268266|NCT02990806|62640002|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
33268267|NCT02990806|62640003|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
33268268|NCT02990806|62640004|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
33268269|NCT02990806|62640005|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
33268270|NCT02990806|62640002|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
33268271|NCT02990806|62640003|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
33268272|NCT02990806|62640004|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
33268273|NCT02990806|62640005|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
33268274|NCT02990806|62640002|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
33268275|NCT02990806|62640003|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
33268276|NCT02990806|62640004|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
33268277|NCT02990806|62640005|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
33268278|NCT02990806|62640002|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
33268279|NCT02990806|62640003|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
33268280|NCT02990806|62640004|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
33268281|NCT02990806|62640005|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
33268282|NCT02990806|62640002|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
33268283|NCT02990806|62640003|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
33268284|NCT02990806|62640004|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
33268285|NCT02990806|62640005|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
33268286|NCT02990806|62640002|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
33268287|NCT02990806|62640003|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
33268288|NCT02990806|62640004|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
33268289|NCT02990806|62640005|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
33268290|NCT02990806|62640002|FG000|Stage 1 (22 Weeks)|Death|0|||
33268291|NCT02990806|62640003|FG001|Stage 1 (22 Weeks)|Death|1|||
33268292|NCT02990806|62640004|FG002|Stage 1 (22 Weeks)|Death|0|||
33268293|NCT02990806|62640005|FG003|Stage 1 (22 Weeks)|Death|0|||
33268294|NCT02990806|62640002|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
33268295|NCT02990806|62640003|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
33268296|NCT02990806|62640004|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
33268297|NCT02990806|62640005|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
33268298|NCT02990806|62640002|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
33268299|NCT02990806|62640003|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
33268300|NCT02990806|62640004|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
33268301|NCT02990806|62640005|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
33268302|NCT02990806|62640002|FG000|Stage 1 (22 Weeks)|Other|1|||
33268303|NCT02990806|62640003|FG001|Stage 1 (22 Weeks)|Other|3|||
33268304|NCT02990806|62640004|FG002|Stage 1 (22 Weeks)|Other|0|||
33268305|NCT02990806|62640005|FG003|Stage 1 (22 Weeks)|Other|0|||
33268306|NCT02990806|62640002|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
33268307|NCT02990806|62640003|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
33268308|NCT02990806|62640004|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
33268309|NCT02990806|62640005|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
33268310|NCT02990806|62640002|FG000|Stage 2 (32 Weeks)|Death|1|||
33268311|NCT02990806|62640003|FG001|Stage 2 (32 Weeks)|Death|0|||
33268312|NCT02990806|62640004|FG002|Stage 2 (32 Weeks)|Death|0|||
33268313|NCT02990806|62640005|FG003|Stage 2 (32 Weeks)|Death|0|||
33268314|NCT02990806|62640002|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
33268315|NCT02990806|62640003|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
33268316|NCT02990806|62640004|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
33268317|NCT02990806|62640005|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
33268318|NCT02990806|62640002|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
33268319|NCT02990806|62640003|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
33369027|NCT00868790|62747799|FG007|Post-study|Withdrawal by Subject|0|||
33369028|NCT00868790|62747800|FG008|Post-study|Withdrawal by Subject|0|||
33369029|NCT00868790|62747801|FG009|Post-study|Withdrawal by Subject|0|||
33369030|NCT00868790|62747802|FG010|Post-study|Withdrawal by Subject|0|||
33369031|NCT00868790|62747803|FG011|Post-study|Withdrawal by Subject|0|||
33369032|NCT00868790|62747804|FG012|Post-study|Withdrawal by Subject|0|||
33369033|NCT00868790|62747805|FG013|Post-study|Withdrawal by Subject|0|||
33369034|NCT00868790|62747792|FG000|Post-study|Excluded Medication|0|||
33369035|NCT00868790|62747793|FG001|Post-study|Excluded Medication|0|||
33369036|NCT00868790|62747794|FG002|Post-study|Excluded Medication|0|||
33369037|NCT00868790|62747795|FG003|Post-study|Excluded Medication|0|||
33369038|NCT00868790|62747796|FG004|Post-study|Excluded Medication|0|||
33369039|NCT00868790|62747797|FG005|Post-study|Excluded Medication|0|||
33268320|NCT02990806|62640004|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
33268321|NCT02990806|62640005|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
33369040|NCT00868790|62747798|FG006|Post-study|Excluded Medication|0|||
33369041|NCT00868790|62747799|FG007|Post-study|Excluded Medication|2|||
33369042|NCT00868790|62747800|FG008|Post-study|Excluded Medication|0|||
33369043|NCT00868790|62747801|FG009|Post-study|Excluded Medication|1|||
33369044|NCT00868790|62747802|FG010|Post-study|Excluded Medication|0|||
33369045|NCT00868790|62747803|FG011|Post-study|Excluded Medication|0|||
33369046|NCT00868790|62747804|FG012|Post-study|Excluded Medication|0|||
33268322|NCT02990806|62640002|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
33369047|NCT00868790|62747805|FG013|Post-study|Excluded Medication|0|||
33369048|NCT00496483|62747821|FG000|Overall Study|Not dosed|9|||
33369049|NCT00496483|62747821|FG000|Overall Study|Adverse Event|2|||
33369050|NCT00496483|62747821|FG000|Overall Study|Lack of Efficacy|1|||
33369051|NCT03528551|62747831|FG000|Overall Study|Lost to Follow-up|0|||
33369052|NCT03528551|62747832|FG001|Overall Study|Lost to Follow-up|1|||
33369053|NCT03528551|62747833|FG002|Overall Study|Lost to Follow-up|0|||
33369054|NCT03528551|62747831|FG000|Overall Study|Transferred to other arm/group|2|||
33369055|NCT03528551|62747832|FG001|Overall Study|Transferred to other arm/group|3|||
33369056|NCT03528551|62747833|FG002|Overall Study|Transferred to other arm/group|0|||
33369057|NCT03528551|62747831|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33369058|NCT03528551|62747832|FG001|Overall Study|Withdrawal by parent/guardian|5|||
33369059|NCT03528551|62747833|FG002|Overall Study|Withdrawal by parent/guardian|0|||
33369060|NCT03528551|62747831|FG000|Overall Study|Protocol Violation|0|||
33369061|NCT03528551|62747832|FG001|Overall Study|Protocol Violation|3|||
33369062|NCT03528551|62747833|FG002|Overall Study|Protocol Violation|0|||
33369063|NCT03528551|62747831|FG000|Overall Study|Withdrawal by Subject|0|||
33369064|NCT03528551|62747832|FG001|Overall Study|Withdrawal by Subject|7|||
33369065|NCT03528551|62747833|FG002|Overall Study|Withdrawal by Subject|0|||
33369066|NCT00487981|62747842|FG000|Overall Study|Hypothyroidism diagnosis|1|||
33369067|NCT00861744|62747850|FG000|Overall Study|Adverse Event|0|||
33369068|NCT00861744|62747851|FG001|Overall Study|Adverse Event|0|||
33369069|NCT00861744|62747852|FG002|Overall Study|Adverse Event|0|||
33369070|NCT00861744|62747853|FG003|Overall Study|Adverse Event|1|||
33268323|NCT02990806|62640003|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
33369071|NCT00861744|62747850|FG000|Overall Study|Lost to Follow-up|7|||
33369072|NCT00861744|62747851|FG001|Overall Study|Lost to Follow-up|19|||
33369073|NCT00861744|62747852|FG002|Overall Study|Lost to Follow-up|17|||
33369074|NCT00861744|62747853|FG003|Overall Study|Lost to Follow-up|12|||
33369075|NCT00861744|62747850|FG000|Overall Study|Withdrawal by Subject|10|||
33268324|NCT02990806|62640004|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
33369076|NCT00861744|62747851|FG001|Overall Study|Withdrawal by Subject|6|||
33369077|NCT00861744|62747852|FG002|Overall Study|Withdrawal by Subject|6|||
33369078|NCT00861744|62747853|FG003|Overall Study|Withdrawal by Subject|19|||
33369079|NCT00861744|62747850|FG000|Overall Study|Protocol Violation|0|||
33369080|NCT00861744|62747851|FG001|Overall Study|Protocol Violation|1|||
33369081|NCT00861744|62747852|FG002|Overall Study|Protocol Violation|0|||
33369082|NCT00861744|62747853|FG003|Overall Study|Protocol Violation|0|||
33369083|NCT00861744|62747850|FG000|Overall Study|Migration from study area|0|||
33369084|NCT00861744|62747851|FG001|Overall Study|Migration from study area|3|||
33369085|NCT00861744|62747852|FG002|Overall Study|Migration from study area|1|||
33268325|NCT02990806|62640005|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
33268326|NCT02990806|62640002|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
33268327|NCT02990806|62640003|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
33268328|NCT02990806|62640004|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
33268329|NCT02990806|62640005|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
33268330|NCT02990806|62640002|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
33268331|NCT02990806|62640003|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
33268332|NCT02990806|62640004|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
33268333|NCT02990806|62640005|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
33268334|NCT02990806|62640002|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
33268335|NCT02990806|62640003|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
33268336|NCT02990806|62640004|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
33268337|NCT02990806|62640005|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
33268338|NCT02990806|62640002|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
33268339|NCT02990806|62640003|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
33268340|NCT02990806|62640004|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
33268341|NCT02990806|62640005|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
33268342|NCT02990806|62640002|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
33268343|NCT02990806|62640003|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
33268344|NCT02990806|62640004|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
33268345|NCT02990806|62640005|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
33268346|NCT02990806|62640002|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
33268347|NCT02990806|62640003|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
33268348|NCT02990806|62640004|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
33268349|NCT02990806|62640005|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
33268350|NCT02990806|62640002|FG000|Stage 2 (32 Weeks)|Other|3|||
33268351|NCT02990806|62640003|FG001|Stage 2 (32 Weeks)|Other|0|||
33268352|NCT02990806|62640004|FG002|Stage 2 (32 Weeks)|Other|4|||
33268353|NCT02990806|62640005|FG003|Stage 2 (32 Weeks)|Other|1|||
33268354|NCT02990806|62640002|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
33268355|NCT02990806|62640003|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
33268356|NCT02990806|62640004|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
33268357|NCT02990806|62640005|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
33268358|NCT02990806|62640002|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
33268359|NCT02990806|62640003|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
33268360|NCT02990806|62640004|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
33268361|NCT02990806|62640005|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
33268362|NCT02990806|62640002|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
33268363|NCT02990806|62640003|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
33268364|NCT02990806|62640004|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
33268365|NCT02990806|62640005|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
33268366|NCT02990806|62640002|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
33268367|NCT02990806|62640003|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
33268368|NCT02990806|62640004|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
33268369|NCT02990806|62640005|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
33268370|NCT02990806|62640002|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
33268371|NCT02990806|62640003|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
33268372|NCT02990806|62640004|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
33268373|NCT02990806|62640005|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
33268374|NCT02990806|62640002|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
33268375|NCT02990806|62640003|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
33268376|NCT02990806|62640004|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
33268377|NCT02990806|62640005|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
33268378|NCT02990806|62640002|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
33268379|NCT02990806|62640003|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
33268380|NCT02990806|62640004|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
33268381|NCT02990806|62640005|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
33268382|NCT02990806|62640002|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
33268383|NCT02990806|62640003|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
33268384|NCT02990806|62640004|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
33268385|NCT02990806|62640005|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
33268386|NCT02990806|62640002|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
33268387|NCT02990806|62640003|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
33268388|NCT02990806|62640004|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
33369086|NCT00861744|62747853|FG003|Overall Study|Migration from study area|0|||
33661958|NCT01696643|63092307|FG001|Overall Study|Death|2|||
33268389|NCT02990806|62640005|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
33268390|NCT02420821|62640076|FG000|Overall Study|Lost to Follow-up|6|||
33268391|NCT02420821|62640077|FG001|Overall Study|Lost to Follow-up|6|||
33268392|NCT02420821|62640076|FG000|Overall Study|Non-compliance|0|||
33268393|NCT02420821|62640077|FG001|Overall Study|Non-compliance|2|||
33268394|NCT02420821|62640076|FG000|Overall Study|Physician Decision|6|||
33268395|NCT02420821|62640077|FG001|Overall Study|Physician Decision|2|||
33268396|NCT02420821|62640076|FG000|Overall Study|Withdrawal by Subject|32|||
33268397|NCT02420821|62640077|FG001|Overall Study|Withdrawal by Subject|25|||
33268398|NCT02420821|62640076|FG000|Overall Study|Death|270|||
33268399|NCT02420821|62640077|FG001|Overall Study|Death|263|||
33268400|NCT02420821|62640076|FG000|Overall Study|Study Terminated By Sponsor|145|||
33268401|NCT02420821|62640077|FG001|Overall Study|Study Terminated By Sponsor|149|||
33268402|NCT02420821|62640076|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
33268403|NCT02420821|62640077|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
33268404|NCT02420821|62640076|FG000|Overall Study|Adverse Event|0|||
33268405|NCT02420821|62640077|FG001|Overall Study|Adverse Event|1|||
33268406|NCT02420821|62640076|FG000|Overall Study|Protinuria|0|||
33268407|NCT02420821|62640077|FG001|Overall Study|Protinuria|1|||
33268408|NCT02420821|62640076|FG000|Overall Study|Progressive Disease|1|||
33268409|NCT02420821|62640077|FG001|Overall Study|Progressive Disease|1|||
33268410|NCT02420821|62640076|FG000|Overall Study|Disease Progression|0|||
33268411|NCT02420821|62640077|FG001|Overall Study|Disease Progression|1|||
33268412|NCT02420821|62640076|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
33268413|NCT02420821|62640077|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
33268414|NCT02039063|62640108|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
33268415|NCT02039063|62640109|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
33268416|NCT02039063|62640110|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
33268417|NCT02039063|62640111|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
33268418|NCT02039063|62640108|FG000|Treatment Phase|Progression of disease|0|||
33268419|NCT02039063|62640109|FG001|Treatment Phase|Progression of disease|0|||
33268420|NCT02039063|62640110|FG002|Treatment Phase|Progression of disease|1|||
33268421|NCT02039063|62640111|FG003|Treatment Phase|Progression of disease|1|||
33268422|NCT02039063|62640108|FG000|Extension Phase|Inadequate therapeutic effect|0|||
33268423|NCT02039063|62640109|FG001|Extension Phase|Inadequate therapeutic effect|1|||
33268424|NCT02039063|62640110|FG002|Extension Phase|Inadequate therapeutic effect|2|||
33268425|NCT02039063|62640111|FG003|Extension Phase|Inadequate therapeutic effect|0|||
33268426|NCT02039063|62640108|FG000|Extension Phase|Progression of disease|0|||
33268427|NCT02039063|62640109|FG001|Extension Phase|Progression of disease|0|||
33268428|NCT02039063|62640110|FG002|Extension Phase|Progression of disease|0|||
33268429|NCT02039063|62640111|FG003|Extension Phase|Progression of disease|1|||
33268430|NCT02039063|62640108|FG000|Extension Phase|Adverse Event|0|||
33268431|NCT02039063|62640109|FG001|Extension Phase|Adverse Event|0|||
33268432|NCT02039063|62640110|FG002|Extension Phase|Adverse Event|1|||
33268433|NCT02039063|62640111|FG003|Extension Phase|Adverse Event|0|||
33268434|NCT01746173|62640128|FG000|Overall Study|Disease Progression|2|||
33268435|NCT02995733|62640168|FG000|Overall Study|Study site closed|9|||
33268436|NCT02995733|62640169|FG001|Overall Study|Study site closed|10|||
33268437|NCT02995733|62640168|FG000|Overall Study|Death|3|||
33268438|NCT02995733|62640169|FG001|Overall Study|Death|4|||
33268439|NCT02995733|62640168|FG000|Overall Study|Withdrawal by Subject|6|||
33268440|NCT02995733|62640169|FG001|Overall Study|Withdrawal by Subject|2|||
33268441|NCT02995733|62640168|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
33268442|NCT02995733|62640169|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
33268443|NCT02995733|62640168|FG000|Overall Study|Lost to Follow-up|48|||
33268444|NCT02995733|62640169|FG001|Overall Study|Lost to Follow-up|37|||
33268445|NCT02995733|62640168|FG000|Overall Study|Other|0|||
33268446|NCT02995733|62640169|FG001|Overall Study|Other|1|||
33268447|NCT02815566|62640186|FG000|Overall Study|Adverse Event|1|||
33369087|NCT00861744|62747850|FG000|Overall Study|Blood draws|0|||
33369088|NCT00861744|62747851|FG001|Overall Study|Blood draws|0|||
33369089|NCT00861744|62747852|FG002|Overall Study|Blood draws|0|||
33369090|NCT00861744|62747853|FG003|Overall Study|Blood draws|1|||
33369091|NCT00603239|62747865|FG000|Overall Study|Adverse Event|4|||
33369092|NCT00603239|62747866|FG001|Overall Study|Adverse Event|1|||
33484922|NCT02810392|62862058|FG000|Overall Study|COVID 19 research restrictions|0|||
33484923|NCT02810392|62862059|FG001|Overall Study|COVID 19 research restrictions|1|||
33268448|NCT02815566|62640187|FG001|Overall Study|Adverse Event|1|||
33268449|NCT02815566|62640186|FG000|Overall Study|Withdrawal by Subject|1|||
33268450|NCT02815566|62640187|FG001|Overall Study|Withdrawal by Subject|0|||
33268451|NCT02815566|62640186|FG000|Overall Study|Lost to Follow-up|0|||
33268452|NCT02815566|62640187|FG001|Overall Study|Lost to Follow-up|1|||
33268453|NCT02525783|62640194|FG000|Overall Study|Lost to Follow-up|10|||
33369093|NCT00603239|62747865|FG000|Overall Study|Entry criteria not met|0|||
33369094|NCT00603239|62747866|FG001|Overall Study|Entry criteria not met|1|||
33369095|NCT00603239|62747865|FG000|Overall Study|Loss of glucose control|3|||
33268454|NCT02466243|62640210|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
33268455|NCT02466243|62640211|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
33268456|NCT02466243|62640210|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
33268457|NCT02466243|62640211|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
33268458|NCT02466243|62640210|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
33268459|NCT02466243|62640211|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
33268460|NCT02466243|62640210|FG000|Part B Open-label Treatment Period|Missing|2|||
33268461|NCT02466243|62640211|FG001|Part B Open-label Treatment Period|Missing|2|||
33268462|NCT02321098|62640224|FG000|12 Weeks Treament|Lost to Follow-up|1|||
33268463|NCT02321098|62640225|FG001|12 Weeks Treament|Lost to Follow-up|1|||
33268464|NCT02321098|62640226|FG002|12 Weeks Treament|Lost to Follow-up|0|||
33268465|NCT02321098|62640224|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
33268466|NCT02321098|62640225|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
33369096|NCT00603239|62747866|FG001|Overall Study|Loss of glucose control|0|||
33369097|NCT00603239|62747865|FG000|Overall Study|Lost to Follow-up|2|||
33369098|NCT00603239|62747866|FG001|Overall Study|Lost to Follow-up|1|||
33369099|NCT00603239|62747865|FG000|Overall Study|Physician Decision|2|||
33369100|NCT00603239|62747866|FG001|Overall Study|Physician Decision|0|||
33268467|NCT02321098|62640226|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
33268468|NCT02321098|62640224|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
33268469|NCT02321098|62640225|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
33268470|NCT02321098|62640226|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
33268471|NCT02321098|62640224|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
33268472|NCT02321098|62640225|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
33268473|NCT02321098|62640226|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
33268474|NCT01966731|62640235|FG000|Overall Study|Death|2|||
33268475|NCT01966731|62640235|FG000|Overall Study|Lost to Follow-up|1|||
33268476|NCT01966731|62640235|FG000|Overall Study|Physician Decision|2|||
33268477|NCT01966731|62640235|FG000|Overall Study|Follow up is not complete|600|||
33268478|NCT01966731|62640235|FG000|Overall Study|Screening Failure|29|||
33268479|NCT01966731|62640235|FG000|Overall Study|Found to be ineligible|1|||
33268480|NCT01843374|62640241|FG000|Overall Study|Death|155|||
33268481|NCT01843374|62640242|FG001|Overall Study|Death|313|||
33268482|NCT01843374|62640241|FG000|Overall Study|Withdrawal by Subject|14|||
33268483|NCT01843374|62640242|FG001|Overall Study|Withdrawal by Subject|20|||
33268484|NCT01843374|62640241|FG000|Overall Study|Withdrawing due to Other reason|20|||
33268485|NCT01843374|62640242|FG001|Overall Study|Withdrawing due to Other reason|46|||
33268486|NCT01620944|62640264|FG000|Overall Study|Early termination of Study|2|||
33268487|NCT01620944|62640265|FG001|Overall Study|Early termination of Study|1|||
33268488|NCT01627561|62640273|FG000|Overall Study|Lost to Follow-up|1|||
33268489|NCT01627561|62640274|FG001|Overall Study|Lost to Follow-up|0|||
33268490|NCT01627561|62640273|FG000|Overall Study|Withdrawal by Subject|0|||
33268491|NCT01627561|62640274|FG001|Overall Study|Withdrawal by Subject|1|||
33268492|NCT01627561|62640273|FG000|Overall Study|Migrated/moved from study area|0|||
33268493|NCT01627561|62640274|FG001|Overall Study|Migrated/moved from study area|2|||
33268494|NCT01652534|62640308|FG000|Overall Study|Lack of Efficacy|1|||
33268495|NCT01652534|62640309|FG001|Overall Study|Lack of Efficacy|0|||
33268496|NCT04709575|62640317|FG000|Overall Study|Withdrawal by Subject|6|||
33268497|NCT04709575|62640318|FG001|Overall Study|Withdrawal by Subject|2|||
33268498|NCT04709575|62640317|FG000|Overall Study|Lost to Follow-up|2|||
33268499|NCT04709575|62640318|FG001|Overall Study|Lost to Follow-up|2|||
33268500|NCT04709575|62640317|FG000|Overall Study|Adverse Event|1|||
33268501|NCT04709575|62640318|FG001|Overall Study|Adverse Event|0|||
33268502|NCT04709575|62640317|FG000|Overall Study|Protocol Violation|1|||
33268503|NCT04709575|62640318|FG001|Overall Study|Protocol Violation|1|||
33268504|NCT04450407|62640327|FG000|Overall Study|Withdrawal by Subject|10|||
33268505|NCT04450407|62640328|FG001|Overall Study|Withdrawal by Subject|1|||
33268506|NCT04450407|62640329|FG002|Overall Study|Withdrawal by Subject|4|||
33268507|NCT04450407|62640327|FG000|Overall Study|Adverse Event|0|||
33268508|NCT04450407|62640328|FG001|Overall Study|Adverse Event|0|||
33268509|NCT04450407|62640329|FG002|Overall Study|Adverse Event|1|||
33268510|NCT04450407|62640327|FG000|Overall Study|Lost to Follow-up|1|||
33268511|NCT04450407|62640328|FG001|Overall Study|Lost to Follow-up|0|||
33268512|NCT04450407|62640329|FG002|Overall Study|Lost to Follow-up|0|||
33369101|NCT00603239|62747865|FG000|Overall Study|Protocol Violation|2|||
33369102|NCT00603239|62747866|FG001|Overall Study|Protocol Violation|0|||
33369103|NCT00603239|62747865|FG000|Overall Study|Subject decision|2|||
33369104|NCT00603239|62747866|FG001|Overall Study|Subject decision|1|||
33268513|NCT04450407|62640327|FG000|Overall Study|Physician Decision|0|||
33268514|NCT04450407|62640328|FG001|Overall Study|Physician Decision|0|||
33268515|NCT04450407|62640329|FG002|Overall Study|Physician Decision|1|||
33369105|NCT00852930|62747875|FG000|Overall Study|Withdrawal by Subject|1|||
33268516|NCT04450407|62640327|FG000|Overall Study|Pregnancy|1|||
33268517|NCT04450407|62640328|FG001|Overall Study|Pregnancy|0|||
33369106|NCT00852930|62747876|FG001|Overall Study|Withdrawal by Subject|1|||
33369107|NCT00852930|62747877|FG002|Overall Study|Withdrawal by Subject|1|||
33268518|NCT04450407|62640329|FG002|Overall Study|Pregnancy|0|||
33268519|NCT04450407|62640327|FG000|Overall Study|Protocol Violation|2|||
33268520|NCT04450407|62640328|FG001|Overall Study|Protocol Violation|0|||
33268521|NCT04450407|62640329|FG002|Overall Study|Protocol Violation|0|||
33268522|NCT04450407|62640327|FG000|Overall Study|Investigational site terminated by sponsor|3|||
33268523|NCT04450407|62640328|FG001|Overall Study|Investigational site terminated by sponsor|0|||
33268524|NCT04450407|62640329|FG002|Overall Study|Investigational site terminated by sponsor|2|||
33268546|NCT04388826|62640351|FG000|Overall Study|Lost to Follow-up|3|||
33268547|NCT04388826|62640352|FG001|Overall Study|Lost to Follow-up|2|||
33268548|NCT04388826|62640351|FG000|Overall Study|Adverse Event|1|||
33268549|NCT04388826|62640352|FG001|Overall Study|Adverse Event|0|||
33268550|NCT04218266|62640374|FG000|Overall Study|Death|1|||
33268551|NCT04218266|62640375|FG001|Overall Study|Death|2|||
33268552|NCT04218266|62640376|FG002|Overall Study|Death|3|||
33268553|NCT04218266|62640374|FG000|Overall Study|Adverse Event|13|||
33268554|NCT04218266|62640375|FG001|Overall Study|Adverse Event|14|||
33268555|NCT04218266|62640376|FG002|Overall Study|Adverse Event|11|||
33268556|NCT04218266|62640374|FG000|Overall Study|Other|7|||
33268557|NCT04218266|62640375|FG001|Overall Study|Other|5|||
33268558|NCT04218266|62640376|FG002|Overall Study|Other|14|||
33268559|NCT04218266|62640374|FG000|Overall Study|Physician Decision|1|||
33268560|NCT04218266|62640375|FG001|Overall Study|Physician Decision|3|||
33268561|NCT04218266|62640376|FG002|Overall Study|Physician Decision|2|||
33268562|NCT04218266|62640374|FG000|Overall Study|Non-compliance with study drug|0|||
33268563|NCT04218266|62640375|FG001|Overall Study|Non-compliance with study drug|0|||
33268564|NCT04218266|62640376|FG002|Overall Study|Non-compliance with study drug|1|||
33268565|NCT04218266|62640374|FG000|Overall Study|Withdrawal by Subject|1|||
33268566|NCT04218266|62640375|FG001|Overall Study|Withdrawal by Subject|3|||
33268567|NCT04218266|62640376|FG002|Overall Study|Withdrawal by Subject|1|||
33268568|NCT04218266|62640374|FG000|Overall Study|Study drug never administered|2|||
33268569|NCT04218266|62640375|FG001|Overall Study|Study drug never administered|0|||
33268570|NCT04218266|62640376|FG002|Overall Study|Study drug never administered|0|||
33268571|NCT03894904|62640398|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
33268572|NCT03894904|62640399|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
33268573|NCT03894904|62640398|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
33268574|NCT03894904|62640399|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
33268575|NCT03518086|62640416|FG000|Overall Study|Adverse Event|23|||
33268576|NCT03518086|62640417|FG001|Overall Study|Adverse Event|15|||
33268577|NCT03518086|62640418|FG002|Overall Study|Adverse Event|0|||
33268578|NCT03518086|62640419|FG003|Overall Study|Adverse Event|0|||
33268579|NCT03518086|62640416|FG000|Overall Study|Withdrawal by Subject|8|||
33268580|NCT03518086|62640417|FG001|Overall Study|Withdrawal by Subject|5|||
33268581|NCT03518086|62640418|FG002|Overall Study|Withdrawal by Subject|0|||
33268582|NCT03518086|62640419|FG003|Overall Study|Withdrawal by Subject|0|||
33268583|NCT03518086|62640416|FG000|Overall Study|Lack of Efficacy|5|||
33268584|NCT03518086|62640417|FG001|Overall Study|Lack of Efficacy|5|||
33268585|NCT03518086|62640418|FG002|Overall Study|Lack of Efficacy|0|||
33661959|NCT01696643|63092306|FG000|Overall Study|Lack of Efficacy|3|||
33661960|NCT01696643|63092307|FG001|Overall Study|Lack of Efficacy|0|||
33661961|NCT01696643|63092306|FG000|Overall Study|Lost to Follow-up|67|||
33268586|NCT03518086|62640419|FG003|Overall Study|Lack of Efficacy|0|||
33268587|NCT03518086|62640416|FG000|Overall Study|Protocol Violation|1|||
33268588|NCT03518086|62640417|FG001|Overall Study|Protocol Violation|5|||
33661962|NCT01696643|63092307|FG001|Overall Study|Lost to Follow-up|67|||
33661963|NCT01696643|63092306|FG000|Overall Study|Physician Decision|3|||
33661964|NCT01696643|63092307|FG001|Overall Study|Physician Decision|2|||
33661965|NCT01696643|63092306|FG000|Overall Study|Pregnancy|0|||
33661966|NCT01696643|63092307|FG001|Overall Study|Pregnancy|1|||
33661967|NCT01696643|63092306|FG000|Overall Study|Protocol Violation|7|||
33661968|NCT01696643|63092307|FG001|Overall Study|Protocol Violation|7|||
33661969|NCT01696643|63092306|FG000|Overall Study|Study Terminated by Sponsor|286|||
33661970|NCT01696643|63092307|FG001|Overall Study|Study Terminated by Sponsor|294|||
33661971|NCT01696643|63092306|FG000|Overall Study|Withdrawal by Subject|142|||
33661972|NCT01696643|63092307|FG001|Overall Study|Withdrawal by Subject|149|||
33661973|NCT01696643|63092306|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
33661974|NCT01696643|63092307|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
33661975|NCT01696643|63092306|FG000|Overall Study|Site Error|2|||
33661976|NCT01696643|63092307|FG001|Overall Study|Site Error|1|||
33661977|NCT01696643|63092306|FG000|Overall Study|Participant Incarcerated|0|||
33661978|NCT01696643|63092307|FG001|Overall Study|Participant Incarcerated|1|||
33661979|NCT01696643|63092306|FG000|Overall Study|Medical Monitor Decision|0|||
33661980|NCT01696643|63092307|FG001|Overall Study|Medical Monitor Decision|2|||
33661981|NCT01696643|63092306|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
33661982|NCT01696643|63092307|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
33661983|NCT01695317|63092319|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
33268589|NCT03518086|62640418|FG002|Overall Study|Protocol Violation|0|||
33268590|NCT03518086|62640419|FG003|Overall Study|Protocol Violation|0|||
33268591|NCT03518086|62640416|FG000|Overall Study|Lost to Follow-up|0|||
33268592|NCT03518086|62640417|FG001|Overall Study|Lost to Follow-up|3|||
33268593|NCT03518086|62640418|FG002|Overall Study|Lost to Follow-up|0|||
33268594|NCT03518086|62640419|FG003|Overall Study|Lost to Follow-up|0|||
33268595|NCT03518086|62640416|FG000|Overall Study|Insufficient Diary Data|0|||
33268596|NCT03518086|62640417|FG001|Overall Study|Insufficient Diary Data|2|||
33268597|NCT03518086|62640418|FG002|Overall Study|Insufficient Diary Data|0|||
33268598|NCT03518086|62640419|FG003|Overall Study|Insufficient Diary Data|0|||
33268599|NCT03518086|62640416|FG000|Overall Study|Non- compliance to Protocol|0|||
33268600|NCT03518086|62640417|FG001|Overall Study|Non- compliance to Protocol|1|||
33268601|NCT03518086|62640418|FG002|Overall Study|Non- compliance to Protocol|0|||
33268602|NCT03518086|62640419|FG003|Overall Study|Non- compliance to Protocol|0|||
33268603|NCT03518086|62640416|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
33268604|NCT03518086|62640417|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
33268605|NCT03518086|62640418|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
33268606|NCT03518086|62640419|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
33268607|NCT03518086|62640416|FG000|Overall Study|Site Terminated by Sponsor|0|||
33268608|NCT03518086|62640417|FG001|Overall Study|Site Terminated by Sponsor|1|||
33268609|NCT03518086|62640418|FG002|Overall Study|Site Terminated by Sponsor|0|||
33268610|NCT03518086|62640419|FG003|Overall Study|Site Terminated by Sponsor|0|||
33661984|NCT01695317|63092320|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
33661985|NCT01695317|63092319|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
33661986|NCT01695317|63092320|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
33661987|NCT02701296|63092376|FG000|Overall Study|Incomplete Data|0|||
33661988|NCT02701296|63092377|FG001|Overall Study|Incomplete Data|2|||
33661989|NCT01582451|63092394|FG000|Overall Study|Adverse Event|1|||
33661990|NCT01582451|63092395|FG001|Overall Study|Adverse Event|3|||
33661991|NCT01582451|63092394|FG000|Overall Study|Death|3|||
33661992|NCT01582451|63092395|FG001|Overall Study|Death|3|||
33661993|NCT01582451|63092394|FG000|Overall Study|Lost to Follow-up|0|||
33661994|NCT01582451|63092395|FG001|Overall Study|Lost to Follow-up|2|||
33661995|NCT01582451|63092394|FG000|Overall Study|Protocol Violation|11|||
33661996|NCT01582451|63092395|FG001|Overall Study|Protocol Violation|3|||
33661997|NCT01582451|63092394|FG000|Overall Study|Withdrawal by Subject|13|||
33661998|NCT01582451|63092395|FG001|Overall Study|Withdrawal by Subject|9|||
33661999|NCT01582451|63092394|FG000|Overall Study|Physician Decision|3|||
33662000|NCT01582451|63092395|FG001|Overall Study|Physician Decision|0|||
33662001|NCT01582451|63092394|FG000|Overall Study|Sponsor Decision|1|||
33662002|NCT01582451|63092395|FG001|Overall Study|Sponsor Decision|0|||
33662003|NCT02700984|63092479|FG000|Overall Study|Death|2|||
33662004|NCT02700984|63092480|FG001|Overall Study|Death|1|||
33268632|NCT03099265|62640444|FG000|Overall Study|Adverse Event|1|||
33268633|NCT02658656|62640462|FG000|Screening|Failed eligibility criteria|0|||
33268634|NCT02658656|62640463|FG001|Screening|Failed eligibility criteria|0|||
33268635|NCT02658656|62640464|FG002|Screening|Failed eligibility criteria|263|||
33268636|NCT02658656|62640462|FG000|Randomization|Withdrawal by Subject|8|||
33268637|NCT02658656|62640463|FG001|Randomization|Withdrawal by Subject|7|||
33268638|NCT02658656|62640464|FG002|Randomization|Withdrawal by Subject|0|||
33268639|NCT02658656|62640462|FG000|Randomization|Lost to Follow-up|1|||
33268640|NCT02658656|62640463|FG001|Randomization|Lost to Follow-up|3|||
33268641|NCT02658656|62640464|FG002|Randomization|Lost to Follow-up|0|||
33268642|NCT02658656|62640462|FG000|Randomization|Adverse Event|4|||
33268643|NCT02658656|62640463|FG001|Randomization|Adverse Event|0|||
33268644|NCT02658656|62640464|FG002|Randomization|Adverse Event|0|||
33268645|NCT02658656|62640462|FG000|Randomization|Administrative Termination|3|||
33268646|NCT02658656|62640463|FG001|Randomization|Administrative Termination|1|||
33268647|NCT02658656|62640464|FG002|Randomization|Administrative Termination|0|||
33268648|NCT02658656|62640462|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
33268649|NCT02658656|62640463|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
33268650|NCT02658656|62640464|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
33268651|NCT02658656|62640462|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
33268652|NCT02658656|62640463|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
33268653|NCT02658656|62640464|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
33268654|NCT02658656|62640462|FG000|Randomization|Not eligible for Randomization|1|||
33268655|NCT02658656|62640463|FG001|Randomization|Not eligible for Randomization|0|||
33268656|NCT02658656|62640464|FG002|Randomization|Not eligible for Randomization|0|||
33268657|NCT02658656|62640462|FG000|Randomization|Protocol Violation|1|||
33268658|NCT02658656|62640463|FG001|Randomization|Protocol Violation|0|||
33268659|NCT02658656|62640464|FG002|Randomization|Protocol Violation|0|||
33268660|NCT05141175|62640522|FG000|Overall Study|Withdrawal by Subject|1|||
33268661|NCT04869345|62640528|FG000|Overall Study|Lost to Follow-up|8|||
33662005|NCT02700984|63092479|FG000|Overall Study|Lost to Follow-up|2|||
33662006|NCT02700984|63092480|FG001|Overall Study|Lost to Follow-up|1|||
33268662|NCT04869345|62640529|FG001|Overall Study|Lost to Follow-up|3|||
33268663|NCT03610737|62640601|FG000|Overall Study|Withdrawal by Subject|1|||
33268664|NCT03610737|62640602|FG001|Overall Study|Withdrawal by Subject|5|||
33268665|NCT03610737|62640601|FG000|Overall Study|Death|1|||
33268666|NCT03610737|62640602|FG001|Overall Study|Death|0|||
33268667|NCT03610737|62640601|FG000|Overall Study|Not treated|5|||
33268668|NCT03610737|62640602|FG001|Overall Study|Not treated|2|||
33268669|NCT03610737|62640601|FG000|Overall Study|Missed Visit|1|||
33268670|NCT03610737|62640602|FG001|Overall Study|Missed Visit|2|||
33268671|NCT03321929|62640612|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
33268672|NCT03250624|62640619|FG000|Overall Study|Lack of Efficacy|1|||
33268673|NCT03250624|62640620|FG001|Overall Study|Lack of Efficacy|4|||
33268674|NCT03250624|62640619|FG000|Overall Study|Adverse Event|0|||
33268675|NCT03250624|62640620|FG001|Overall Study|Adverse Event|1|||
33268676|NCT03250624|62640619|FG000|Overall Study|Other|1|||
33268677|NCT03250624|62640620|FG001|Overall Study|Other|2|||
33268678|NCT02507297|62640628|FG000|Overall Study|Withdrawal by Subject|1|||
33268679|NCT02507297|62640629|FG001|Overall Study|Withdrawal by Subject|0|||
33268680|NCT02507297|62640628|FG000|Overall Study|Lost to Follow-up|0|||
33268681|NCT02507297|62640629|FG001|Overall Study|Lost to Follow-up|1|||
33268682|NCT01333514|62640637|FG000|Overall Study|Withdrawal by Subject|1|||
33268683|NCT01333514|62640638|FG001|Overall Study|Withdrawal by Subject|0|||
33268684|NCT02066636|62640647|FG000|Overall Study|Disease progression|51|||
33268685|NCT02066636|62640648|FG001|Overall Study|Disease progression|60|||
33268686|NCT02066636|62640649|FG002|Overall Study|Disease progression|700|||
33268687|NCT02066636|62640647|FG000|Overall Study|Study drug toxicity|13|||
33268688|NCT02066636|62640648|FG001|Overall Study|Study drug toxicity|2|||
33268689|NCT02066636|62640649|FG002|Overall Study|Study drug toxicity|58|||
33268690|NCT02066636|62640647|FG000|Overall Study|Death|4|||
33268691|NCT02066636|62640648|FG001|Overall Study|Death|2|||
33268692|NCT02066636|62640649|FG002|Overall Study|Death|158|||
33268693|NCT02066636|62640647|FG000|Overall Study|Adverse event unrelated to study drug|6|||
33268694|NCT02066636|62640648|FG001|Overall Study|Adverse event unrelated to study drug|4|||
33268695|NCT02066636|62640649|FG002|Overall Study|Adverse event unrelated to study drug|45|||
33268696|NCT02066636|62640647|FG000|Overall Study|Participant request to discontinue treatment|12|||
33268697|NCT02066636|62640648|FG001|Overall Study|Participant request to discontinue treatment|12|||
33268698|NCT02066636|62640649|FG002|Overall Study|Participant request to discontinue treatment|70|||
33268699|NCT02066636|62640647|FG000|Overall Study|Participant withdrew consent|10|||
33268700|NCT02066636|62640648|FG001|Overall Study|Participant withdrew consent|18|||
33268701|NCT02066636|62640649|FG002|Overall Study|Participant withdrew consent|61|||
33268702|NCT02066636|62640647|FG000|Overall Study|Lost to Follow-up|0|||
33268703|NCT02066636|62640648|FG001|Overall Study|Lost to Follow-up|2|||
33268704|NCT02066636|62640649|FG002|Overall Study|Lost to Follow-up|2|||
33268705|NCT02066636|62640647|FG000|Overall Study|Maximum clinical benefit|2|||
33268706|NCT02066636|62640648|FG001|Overall Study|Maximum clinical benefit|2|||
33268707|NCT02066636|62640649|FG002|Overall Study|Maximum clinical benefit|3|||
33268708|NCT02066636|62640647|FG000|Overall Study|Poor/non-compliance|2|||
33268709|NCT02066636|62640648|FG001|Overall Study|Poor/non-compliance|1|||
33268710|NCT02066636|62640649|FG002|Overall Study|Poor/non-compliance|1|||
33268711|NCT02066636|62640647|FG000|Overall Study|Participant no loner meets study criteria|3|||
33268712|NCT02066636|62640648|FG001|Overall Study|Participant no loner meets study criteria|2|||
33268713|NCT02066636|62640649|FG002|Overall Study|Participant no loner meets study criteria|28|||
33268714|NCT02066636|62640647|FG000|Overall Study|Administrative reasons by sponsor|8|||
33268715|NCT02066636|62640648|FG001|Overall Study|Administrative reasons by sponsor|5|||
33268716|NCT02066636|62640649|FG002|Overall Study|Administrative reasons by sponsor|0|||
33268717|NCT02066636|62640647|FG000|Overall Study|Other reasons|16|||
33268718|NCT02066636|62640648|FG001|Overall Study|Other reasons|15|||
33268719|NCT02066636|62640649|FG002|Overall Study|Other reasons|50|||
33268720|NCT01486264|62640661|FG000|Overall Study|Death|1|||
33268721|NCT01486264|62640662|FG001|Overall Study|Death|1|||
33268722|NCT01486264|62640661|FG000|Overall Study|Adverse Event|3|||
33268723|NCT01486264|62640662|FG001|Overall Study|Adverse Event|3|||
33268724|NCT01486264|62640661|FG000|Overall Study|Lack of Efficacy|6|||
33268725|NCT01486264|62640662|FG001|Overall Study|Lack of Efficacy|10|||
33268726|NCT01486264|62640661|FG000|Overall Study|Withdrawal by Subject|7|||
33268727|NCT01486264|62640662|FG001|Overall Study|Withdrawal by Subject|18|||
33268728|NCT01486264|62640661|FG000|Overall Study|Physician Decision|1|||
33268729|NCT01486264|62640662|FG001|Overall Study|Physician Decision|1|||
33268730|NCT01486264|62640661|FG000|Overall Study|Protocol Violation|3|||
33268731|NCT01486264|62640662|FG001|Overall Study|Protocol Violation|0|||
33268732|NCT01486264|62640661|FG000|Overall Study|Lost to Follow-up|3|||
33268733|NCT01486264|62640662|FG001|Overall Study|Lost to Follow-up|2|||
33268734|NCT01486264|62640661|FG000|Overall Study|Other|5|||
33268735|NCT01486264|62640662|FG001|Overall Study|Other|11|||
33268736|NCT01486264|62640661|FG000|Overall Study|Not treated|0|||
33268737|NCT01486264|62640662|FG001|Overall Study|Not treated|1|||
33268738|NCT01323270|62640670|FG000|Overall Study|Withdrawal by Subject|19|||
33268739|NCT01323270|62640671|FG001|Overall Study|Withdrawal by Subject|10|||
33268740|NCT01323270|62640670|FG000|Overall Study|Protocol Violation|9|||
33268741|NCT01323270|62640671|FG001|Overall Study|Protocol Violation|7|||
33268742|NCT01323270|62640670|FG000|Overall Study|Lost to Follow-up|4|||
33268743|NCT01323270|62640671|FG001|Overall Study|Lost to Follow-up|6|||
33268744|NCT01323270|62640670|FG000|Overall Study|Adverse Event|8|||
33268745|NCT01323270|62640671|FG001|Overall Study|Adverse Event|0|||
33268746|NCT01323270|62640670|FG000|Overall Study|Other|0|||
33268747|NCT01323270|62640671|FG001|Overall Study|Other|3|||
33268748|NCT01323270|62640670|FG000|Overall Study|Physician Decision|0|||
33268749|NCT01323270|62640671|FG001|Overall Study|Physician Decision|2|||
33268750|NCT01323270|62640670|FG000|Overall Study|Not eligible|1|||
33268751|NCT01323270|62640671|FG001|Overall Study|Not eligible|1|||
33268752|NCT01323270|62640670|FG000|Overall Study|Death|1|||
33268753|NCT01323270|62640671|FG001|Overall Study|Death|0|||
33268754|NCT01323270|62640670|FG000|Overall Study|Randomized, but not vaccinated|1|||
33268755|NCT01323270|62640671|FG001|Overall Study|Randomized, but not vaccinated|0|||
33268756|NCT01300728|62640680|FG000|Overall Study|Withdrawal by Subject|1|||
33268757|NCT01300728|62640681|FG001|Overall Study|Withdrawal by Subject|1|||
33268758|NCT01300728|62640680|FG000|Overall Study|Physician Decision|1|||
33268759|NCT01300728|62640681|FG001|Overall Study|Physician Decision|0|||
33268760|NCT01299480|62640692|FG000|Overall Study|No longer willing to participate|19|||
33268761|NCT01299480|62640693|FG001|Overall Study|No longer willing to participate|17|||
33268762|NCT01299480|62640694|FG002|Overall Study|No longer willing to participate|14|||
33268763|NCT01299480|62640695|FG003|Overall Study|No longer willing to participate|13|||
33268764|NCT01299480|62640696|FG004|Overall Study|No longer willing to participate|10|||
33268765|NCT01299480|62640692|FG000|Overall Study|Protocol Violation|7|||
33268766|NCT01299480|62640693|FG001|Overall Study|Protocol Violation|5|||
33268767|NCT01299480|62640694|FG002|Overall Study|Protocol Violation|8|||
33268768|NCT01299480|62640695|FG003|Overall Study|Protocol Violation|1|||
33268769|NCT01299480|62640696|FG004|Overall Study|Protocol Violation|1|||
33268770|NCT01299480|62640692|FG000|Overall Study|Withdrawal by Subject|3|||
33268771|NCT01299480|62640693|FG001|Overall Study|Withdrawal by Subject|4|||
33268772|NCT01299480|62640694|FG002|Overall Study|Withdrawal by Subject|7|||
33268773|NCT01299480|62640695|FG003|Overall Study|Withdrawal by Subject|3|||
33268774|NCT01299480|62640696|FG004|Overall Study|Withdrawal by Subject|4|||
33268775|NCT01299480|62640692|FG000|Overall Study|Adverse Event|6|||
33268776|NCT01299480|62640693|FG001|Overall Study|Adverse Event|4|||
33268777|NCT01299480|62640694|FG002|Overall Study|Adverse Event|5|||
33268778|NCT01299480|62640695|FG003|Overall Study|Adverse Event|4|||
33268779|NCT01299480|62640696|FG004|Overall Study|Adverse Event|0|||
33268780|NCT01299480|62640692|FG000|Overall Study|Withdrawal due to pregnancy|0|||
33268781|NCT01299480|62640693|FG001|Overall Study|Withdrawal due to pregnancy|1|||
33268782|NCT01299480|62640694|FG002|Overall Study|Withdrawal due to pregnancy|1|||
33268783|NCT01299480|62640695|FG003|Overall Study|Withdrawal due to pregnancy|0|||
33268784|NCT01299480|62640696|FG004|Overall Study|Withdrawal due to pregnancy|0|||
33268785|NCT01299480|62640692|FG000|Overall Study|Physician Decision|1|||
33268786|NCT01299480|62640693|FG001|Overall Study|Physician Decision|1|||
33268787|NCT01299480|62640694|FG002|Overall Study|Physician Decision|0|||
33268788|NCT01299480|62640695|FG003|Overall Study|Physician Decision|2|||
33268789|NCT01299480|62640696|FG004|Overall Study|Physician Decision|0|||
33268790|NCT01299480|62640692|FG000|Overall Study|Lost to Follow-up|3|||
33268791|NCT01299480|62640693|FG001|Overall Study|Lost to Follow-up|1|||
33268792|NCT01299480|62640694|FG002|Overall Study|Lost to Follow-up|2|||
33268793|NCT01299480|62640695|FG003|Overall Study|Lost to Follow-up|1|||
33268794|NCT01299480|62640696|FG004|Overall Study|Lost to Follow-up|2|||
33268795|NCT01299480|62640692|FG000|Overall Study|Other|3|||
33268796|NCT01299480|62640693|FG001|Overall Study|Other|2|||
33268797|NCT01299480|62640694|FG002|Overall Study|Other|3|||
33268798|NCT01299480|62640695|FG003|Overall Study|Other|0|||
33268799|NCT01299480|62640696|FG004|Overall Study|Other|3|||
33268800|NCT01299480|62640692|FG000|Overall Study|Started, but not vaccinated|0|||
33268801|NCT01299480|62640693|FG001|Overall Study|Started, but not vaccinated|0|||
33268802|NCT01299480|62640694|FG002|Overall Study|Started, but not vaccinated|1|||
33268803|NCT01299480|62640695|FG003|Overall Study|Started, but not vaccinated|1|||
33268804|NCT01299480|62640696|FG004|Overall Study|Started, but not vaccinated|0|||
33268805|NCT04799405|62640718|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
33268806|NCT04688671|62640728|FG000|Overall Study|Adverse Event|3|||
33268807|NCT04688671|62640729|FG001|Overall Study|Adverse Event|1|||
33268808|NCT04688671|62640728|FG000|Overall Study|Withdrawal by Subject|3|||
33268809|NCT04688671|62640729|FG001|Overall Study|Withdrawal by Subject|1|||
33268810|NCT04688671|62640728|FG000|Overall Study|Lack of Efficacy|1|||
33268811|NCT04688671|62640729|FG001|Overall Study|Lack of Efficacy|1|||
33268812|NCT04688671|62640728|FG000|Overall Study|Protocol Violation|1|||
33268813|NCT04688671|62640729|FG001|Overall Study|Protocol Violation|0|||
33268814|NCT04688671|62640728|FG000|Overall Study|Lost to Follow-up|0|||
33268815|NCT04688671|62640729|FG001|Overall Study|Lost to Follow-up|1|||
33268816|NCT04529499|62640737|FG000|Overall Study|Withdrawal by Subject|9|||
33268817|NCT04529499|62640738|FG001|Overall Study|Withdrawal by Subject|11|||
33268818|NCT04529499|62640737|FG000|Overall Study|Physician Decision|1|||
33268819|NCT04529499|62640738|FG001|Overall Study|Physician Decision|2|||
33268820|NCT04529499|62640737|FG000|Overall Study|Adverse Event|4|||
33268821|NCT04529499|62640738|FG001|Overall Study|Adverse Event|4|||
33268822|NCT04529499|62640737|FG000|Overall Study|Death|14|||
33268823|NCT04529499|62640738|FG001|Overall Study|Death|11|||
33268824|NCT04529499|62640737|FG000|Overall Study|Lost to Follow-up|1|||
33268825|NCT04529499|62640738|FG001|Overall Study|Lost to Follow-up|1|||
33268826|NCT04529499|62640737|FG000|Overall Study|Others|7|||
33268827|NCT04529499|62640738|FG001|Overall Study|Others|11|||
33268828|NCT04501094|62640746|FG000|Overall Study|Death (unrelated to research)|1|||
33268829|NCT04501094|62640747|FG001|Overall Study|Death (unrelated to research)|0|||
33268830|NCT04414618|62640755|FG000|Overall Study|Death|3|||
33268831|NCT04414618|62640756|FG001|Overall Study|Death|3|||
33268832|NCT04414618|62640755|FG000|Overall Study|Withdrawal by Subject|2|||
33268833|NCT04414618|62640756|FG001|Overall Study|Withdrawal by Subject|1|||
33268834|NCT04414618|62640755|FG000|Overall Study|Lost to Follow-up|2|||
33268835|NCT04414618|62640756|FG001|Overall Study|Lost to Follow-up|3|||
33268836|NCT04414618|62640755|FG000|Overall Study|Physician Decision|1|||
33268837|NCT04414618|62640756|FG001|Overall Study|Physician Decision|0|||
33268838|NCT04412057|62640765|FG000|Overall Study|Death|3|||
33268839|NCT04412057|62640766|FG001|Overall Study|Death|7|||
33268840|NCT04412057|62640765|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
33268841|NCT04412057|62640766|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
33268842|NCT04402060|62640775|FG000|Overall Study|Death|1|||
33268843|NCT04402060|62640776|FG001|Overall Study|Death|12|||
33268844|NCT04402060|62640777|FG002|Overall Study|Death|7|||
33268845|NCT04402060|62640775|FG000|Overall Study|Adverse Event|0|||
33268846|NCT04402060|62640776|FG001|Overall Study|Adverse Event|0|||
33268847|NCT04402060|62640777|FG002|Overall Study|Adverse Event|1|||
33268848|NCT04402060|62640775|FG000|Overall Study|Withdrawal by Subject|0|||
33268849|NCT04402060|62640776|FG001|Overall Study|Withdrawal by Subject|1|||
33268850|NCT04402060|62640777|FG002|Overall Study|Withdrawal by Subject|2|||
33268851|NCT04402060|62640775|FG000|Overall Study|Sponsor Request|0|||
33268852|NCT04402060|62640776|FG001|Overall Study|Sponsor Request|2|||
33268853|NCT04402060|62640777|FG002|Overall Study|Sponsor Request|0|||
33268854|NCT04402060|62640775|FG000|Overall Study|Physician Decision|0|||
33268855|NCT04402060|62640776|FG001|Overall Study|Physician Decision|0|||
33268856|NCT04402060|62640777|FG002|Overall Study|Physician Decision|1|||
33268857|NCT04402060|62640775|FG000|Overall Study|Other|0|||
33268858|NCT04402060|62640776|FG001|Overall Study|Other|1|||
33268859|NCT04402060|62640777|FG002|Overall Study|Other|0|||
33268860|NCT04376684|62640812|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
33268861|NCT04376684|62640813|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
33268862|NCT04376684|62640814|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
33268863|NCT04376684|62640815|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
33268864|NCT04376684|62640812|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
33268865|NCT04376684|62640813|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
33268866|NCT04376684|62640814|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
33268867|NCT04376684|62640815|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
33268868|NCT04376684|62640812|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
33268869|NCT04376684|62640813|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
33268870|NCT04376684|62640814|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
33268871|NCT04376684|62640815|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
33268872|NCT04376684|62640812|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
33268873|NCT04376684|62640813|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
33268874|NCT04376684|62640814|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
33268875|NCT04376684|62640815|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
33268876|NCT04376684|62640812|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
33268877|NCT04376684|62640813|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
33268878|NCT04376684|62640814|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
33268879|NCT04376684|62640815|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
33268880|NCT04376684|62640812|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
33268881|NCT04376684|62640813|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
33268882|NCT04376684|62640814|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
33268883|NCT04376684|62640815|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
33268884|NCT04376684|62640812|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
33268885|NCT04376684|62640813|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
33268886|NCT04376684|62640814|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
33268887|NCT04376684|62640815|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
33268888|NCT04353284|62640827|FG000|Overall Study|Adverse Event|1|||
33268889|NCT04353284|62640828|FG001|Overall Study|Adverse Event|1|||
33268890|NCT04353284|62640827|FG000|Overall Study|Lost to Follow-up|1|||
33268891|NCT04353284|62640828|FG001|Overall Study|Lost to Follow-up|0|||
33268892|NCT04294147|62640836|FG000|Overall Study|Protocol Violation|2|||
33268893|NCT04294147|62640837|FG001|Overall Study|Protocol Violation|0|||
33268894|NCT04231825|62640849|FG000|Overall Study|Protocol Violation|3|||
33268895|NCT04231825|62640850|FG001|Overall Study|Protocol Violation|3|||
33268896|NCT04231825|62640849|FG000|Overall Study|Lost to Follow-up|0|||
33268897|NCT04231825|62640850|FG001|Overall Study|Lost to Follow-up|1|||
33268898|NCT04178772|62640856|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
33268899|NCT04178772|62640856|FG000|Overall Study|study terminated early due to COVID-19|7|||
33268900|NCT04148651|62640860|FG000|Overall Study|Lost to Follow-up|2|||
33268901|NCT03924427|62640873|FG000|Overall Study|Adverse Event|4|||
33268902|NCT03924427|62640873|FG000|Overall Study|Lack of Efficacy|1|||
33268903|NCT03924427|62640873|FG000|Overall Study|Withdrawal by Subject|1|||
33268904|NCT03642132|62640911|FG000|Chemotherapy Period|Adverse Event|1|||
33268905|NCT03642132|62640912|FG001|Chemotherapy Period|Adverse Event|1|||
33268906|NCT03642132|62640913|FG002|Chemotherapy Period|Adverse Event|0|||
33268907|NCT03642132|62640911|FG000|Chemotherapy Period|Physician's decision|4|||
33268908|NCT03642132|62640912|FG001|Chemotherapy Period|Physician's decision|1|||
33268909|NCT03642132|62640913|FG002|Chemotherapy Period|Physician's decision|0|||
33268910|NCT03642132|62640911|FG000|Chemotherapy Period|Progressive disease|0|||
33268911|NCT03642132|62640912|FG001|Chemotherapy Period|Progressive disease|0|||
33268912|NCT03642132|62640913|FG002|Chemotherapy Period|Progressive disease|1|||
33268913|NCT03642132|62640911|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
33268914|NCT03642132|62640912|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
33268915|NCT03642132|62640913|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
33268916|NCT03642132|62640911|FG000|Chemotherapy Period|Other|1|||
33268917|NCT03642132|62640912|FG001|Chemotherapy Period|Other|0|||
33268918|NCT03642132|62640913|FG002|Chemotherapy Period|Other|2|||
33268919|NCT03642132|62640911|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
33268920|NCT03642132|62640912|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
33268921|NCT03642132|62640913|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
33268922|NCT03642132|62640911|FG000|Maintenance Period|Adverse Event|1|||
33268923|NCT03642132|62640912|FG001|Maintenance Period|Adverse Event|2|||
33268924|NCT03642132|62640913|FG002|Maintenance Period|Adverse Event|0|||
33268925|NCT03642132|62640911|FG000|Maintenance Period|Non-compliance with study drug|0|||
33268926|NCT03642132|62640912|FG001|Maintenance Period|Non-compliance with study drug|0|||
33268927|NCT03642132|62640913|FG002|Maintenance Period|Non-compliance with study drug|1|||
33268928|NCT03642132|62640911|FG000|Maintenance Period|Physician's decision|2|||
33268929|NCT03642132|62640912|FG001|Maintenance Period|Physician's decision|2|||
33268930|NCT03642132|62640913|FG002|Maintenance Period|Physician's decision|2|||
33268931|NCT03642132|62640911|FG000|Maintenance Period|Progressive disease|9|||
33268932|NCT03642132|62640912|FG001|Maintenance Period|Progressive disease|3|||
33268933|NCT03642132|62640913|FG002|Maintenance Period|Progressive disease|6|||
33268934|NCT03642132|62640911|FG000|Maintenance Period|Other|0|||
33268935|NCT03642132|62640912|FG001|Maintenance Period|Other|0|||
33268936|NCT03642132|62640913|FG002|Maintenance Period|Other|3|||
33268937|NCT03642132|62640911|FG000|Maintenance Period|Withdrawal by Subject|1|||
33268938|NCT03642132|62640912|FG001|Maintenance Period|Withdrawal by Subject|1|||
33268939|NCT03642132|62640913|FG002|Maintenance Period|Withdrawal by Subject|2|||
33268940|NCT03642132|62640911|FG000|Follow-up Period|Other|0|||
33268941|NCT03642132|62640912|FG001|Follow-up Period|Other|0|||
33268942|NCT03642132|62640913|FG002|Follow-up Period|Other|1|||
33268943|NCT03642132|62640911|FG000|Follow-up Period|Withdrawal by Subject|1|||
33268944|NCT03642132|62640912|FG001|Follow-up Period|Withdrawal by Subject|2|||
33268945|NCT03642132|62640913|FG002|Follow-up Period|Withdrawal by Subject|0|||
33268946|NCT03642132|62640911|FG000|Follow-up Period|Study terminated by sponsor|1|||
33268947|NCT03642132|62640912|FG001|Follow-up Period|Study terminated by sponsor|0|||
33268948|NCT03642132|62640913|FG002|Follow-up Period|Study terminated by sponsor|1|||
33268949|NCT03642132|62640911|FG000|Follow-up Period|Lack of Efficacy|1|||
33268950|NCT03642132|62640912|FG001|Follow-up Period|Lack of Efficacy|0|||
33268951|NCT03642132|62640913|FG002|Follow-up Period|Lack of Efficacy|0|||
33268952|NCT03642132|62640911|FG000|Follow-up Period|Death|1|||
33268953|NCT03642132|62640912|FG001|Follow-up Period|Death|0|||
33268954|NCT03642132|62640913|FG002|Follow-up Period|Death|2|||
33268955|NCT03642132|62640911|FG000|Follow-up Period|Adverse Event|1|||
33268956|NCT03642132|62640912|FG001|Follow-up Period|Adverse Event|0|||
33268957|NCT03642132|62640913|FG002|Follow-up Period|Adverse Event|0|||
33268958|NCT03008122|62640928|FG000|Overall Study|Physician Decision|3|||
33268959|NCT03008122|62640929|FG001|Overall Study|Physician Decision|2|||
33268960|NCT03008122|62640930|FG002|Overall Study|Physician Decision|0|||
33555634|NCT02793947|62948415|FG001|Overall Study|Physician Decision|5|||
33555635|NCT02345512|62948421|FG000|Overall Study|Adverse Event|1|||
33555636|NCT02345512|62948421|FG000|Overall Study|Withdrawal by Subject|1|||
33268961|NCT03008122|62640928|FG000|Overall Study|Withdrawal by Subject|1|||
33268962|NCT03008122|62640929|FG001|Overall Study|Withdrawal by Subject|3|||
33268963|NCT03008122|62640930|FG002|Overall Study|Withdrawal by Subject|0|||
33268964|NCT03008122|62640928|FG000|Overall Study|Lost to Follow-up|4|||
33268965|NCT03008122|62640929|FG001|Overall Study|Lost to Follow-up|8|||
33268966|NCT03008122|62640930|FG002|Overall Study|Lost to Follow-up|3|||
33268967|NCT03008122|62640928|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
33268968|NCT03008122|62640929|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
33268969|NCT03008122|62640930|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
33268970|NCT03008122|62640928|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
33268971|NCT03008122|62640929|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
33268972|NCT03008122|62640930|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
33268973|NCT03008122|62640928|FG000|Overall Study|Death|0|||
33268974|NCT03008122|62640929|FG001|Overall Study|Death|0|||
33268975|NCT03008122|62640930|FG002|Overall Study|Death|1|||
33268976|NCT02003924|62640969|FG000|Double-blind Phase|Lost to Follow-up|2|||
33268977|NCT02003924|62640970|FG001|Double-blind Phase|Lost to Follow-up|1|||
33268978|NCT02003924|62640971|FG002|Double-blind Phase|Lost to Follow-up|0|||
33268979|NCT02003924|62640969|FG000|Double-blind Phase|Protocol Violation|1|||
33268980|NCT02003924|62640970|FG001|Double-blind Phase|Protocol Violation|2|||
33268981|NCT02003924|62640971|FG002|Double-blind Phase|Protocol Violation|0|||
33268982|NCT02003924|62640969|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
33268983|NCT02003924|62640970|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
33268984|NCT02003924|62640971|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
33268985|NCT02003924|62640969|FG000|Double-blind Phase|Disease Progression|229|||
33268986|NCT02003924|62640970|FG001|Double-blind Phase|Disease Progression|247|||
33268987|NCT02003924|62640971|FG002|Double-blind Phase|Disease Progression|0|||
33268988|NCT02003924|62640969|FG000|Double-blind Phase|Adverse Event|120|||
33268989|NCT02003924|62640970|FG001|Double-blind Phase|Adverse Event|31|||
33268990|NCT02003924|62640971|FG002|Double-blind Phase|Adverse Event|0|||
33268991|NCT02003924|62640969|FG000|Double-blind Phase|Randomized But not Treated|3|||
33268992|NCT02003924|62640970|FG001|Double-blind Phase|Randomized But not Treated|3|||
33268993|NCT02003924|62640971|FG002|Double-blind Phase|Randomized But not Treated|0|||
33268994|NCT02003924|62640969|FG000|Double-blind Phase|Other|29|||
33268995|NCT02003924|62640970|FG001|Double-blind Phase|Other|50|||
33268996|NCT02003924|62640971|FG002|Double-blind Phase|Other|0|||
33268997|NCT02003924|62640969|FG000|Open-label Phase|Lost to Follow-up|0|||
33268998|NCT02003924|62640970|FG001|Open-label Phase|Lost to Follow-up|0|||
33268999|NCT02003924|62640971|FG002|Open-label Phase|Lost to Follow-up|1|||
33269000|NCT02003924|62640969|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
33269001|NCT02003924|62640970|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
33269002|NCT02003924|62640971|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
33269003|NCT02003924|62640969|FG000|Open-label Phase|Disease Progression|59|||
33269004|NCT02003924|62640970|FG001|Open-label Phase|Disease Progression|0|||
33269005|NCT02003924|62640971|FG002|Open-label Phase|Disease Progression|5|||
33269006|NCT02003924|62640969|FG000|Open-label Phase|Adverse Event|25|||
33269007|NCT02003924|62640970|FG001|Open-label Phase|Adverse Event|0|||
33269008|NCT02003924|62640971|FG002|Open-label Phase|Adverse Event|10|||
33269009|NCT02003924|62640969|FG000|Open-label Phase|Other|7|||
33269010|NCT02003924|62640970|FG001|Open-label Phase|Other|0|||
33269011|NCT02003924|62640971|FG002|Open-label Phase|Other|0|||
33269012|NCT02003924|62640969|FG000|Long-term Follow-up Phase|Death|288|||
33269013|NCT02003924|62640970|FG001|Long-term Follow-up Phase|Death|174|||
33269014|NCT02003924|62640971|FG002|Long-term Follow-up Phase|Death|4|||
33269015|NCT02003924|62640969|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
33269016|NCT02003924|62640970|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
33269017|NCT02003924|62640971|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
33269018|NCT02003924|62640969|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
33269019|NCT02003924|62640970|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
33269020|NCT02003924|62640971|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
33269021|NCT02003924|62640969|FG000|Long-term Follow-up Phase|Other|5|||
33269022|NCT02003924|62640970|FG001|Long-term Follow-up Phase|Other|2|||
33269023|NCT02003924|62640971|FG002|Long-term Follow-up Phase|Other|1|||
33269024|NCT01817751|62640983|FG000|Overall Study|Physician Decision|1|||
33269025|NCT01349322|62640999|FG000|Overall Study|Protocol Violation|45|||
33269026|NCT01349322|62641000|FG001|Overall Study|Protocol Violation|47|||
33269027|NCT01182415|62641012|FG000|Overall Study|Lost to Follow-up|1|||
33269028|NCT01030523|62641018|FG000|Initial Study (5 Years)|Death|1|||
33269029|NCT01030523|62641019|FG001|Initial Study (5 Years)|Death|0|||
33269030|NCT01030523|62641018|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
33555637|NCT02345434|62948432|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
33269031|NCT01030523|62641019|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
33269032|NCT01030523|62641018|FG000|Initial Study (5 Years)|Implant failure|1|||
33269033|NCT01030523|62641019|FG001|Initial Study (5 Years)|Implant failure|0|||
33269034|NCT01030523|62641018|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
33555638|NCT02345434|62948433|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
33269035|NCT01030523|62641019|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
33269036|NCT01030523|62641018|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
33269037|NCT01030523|62641019|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
33269038|NCT01030523|62641018|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
33269039|NCT01030523|62641019|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
33269040|NCT03811574|62641058|FG000|Overall Study|Withdrawal by Subject|2|||
33269041|NCT03811574|62641059|FG001|Overall Study|Withdrawal by Subject|4|||
33269042|NCT03811574|62641060|FG002|Overall Study|Withdrawal by Subject|0|||
33269043|NCT03727750|62641083|FG000|Overall Study|Death|45|||
33269044|NCT03727750|62641083|FG000|Overall Study|Withdrawal by Subject|2|||
33269045|NCT03727750|62641083|FG000|Overall Study|Lost to Follow-up|1|||
33269046|NCT03727750|62641083|FG000|Overall Study|Other|1|||
33269047|NCT03715829|62641093|FG000|Dose Ranging Period|Adverse Event|2|||
33269048|NCT03715829|62641094|FG001|Dose Ranging Period|Adverse Event|4|||
33269049|NCT03715829|62641095|FG002|Dose Ranging Period|Adverse Event|5|||
33269050|NCT03715829|62641096|FG003|Dose Ranging Period|Adverse Event|2|||
33269051|NCT03715829|62641097|FG004|Dose Ranging Period|Adverse Event|3|||
33484924|NCT02815540|62862065|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
33484925|NCT03280550|62862071|FG000|Overall Study|Withdrawal by Subject|2|||
33484926|NCT03280550|62862072|FG001|Overall Study|Withdrawal by Subject|2|||
33484927|NCT03280550|62862071|FG000|Overall Study|Physician Decision|0|||
33484928|NCT03280550|62862072|FG001|Overall Study|Physician Decision|1|||
33484929|NCT03276026|62862080|FG000|Overall Study|Protocol Violation|1|||
33484930|NCT03276026|62862081|FG001|Overall Study|Protocol Violation|0|||
33484931|NCT01589523|62862087|FG000|Overall Study|Withdrawal by Subject|1|||
33484932|NCT03277352|62862093|FG000|Overall Study|Study Terminated By Sponsor|2|||
33484933|NCT03277352|62862093|FG000|Overall Study|Withdrawal by Subject|4|||
33484934|NCT03277352|62862093|FG000|Overall Study|Death|4|||
33484935|NCT02814838|62862100|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
33269052|NCT03715829|62641098|FG005|Dose Ranging Period|Adverse Event|3|||
33269053|NCT03715829|62641099|FG006|Dose Ranging Period|Adverse Event|0|||
33269054|NCT03715829|62641100|FG007|Dose Ranging Period|Adverse Event|0|||
33269055|NCT03715829|62641101|FG008|Dose Ranging Period|Adverse Event|0|||
33269056|NCT03715829|62641102|FG009|Dose Ranging Period|Adverse Event|0|||
33269057|NCT03715829|62641103|FG010|Dose Ranging Period|Adverse Event|0|||
33269058|NCT03715829|62641093|FG000|Dose Ranging Period|Lack of Efficacy|0|||
33269059|NCT03715829|62641094|FG001|Dose Ranging Period|Lack of Efficacy|1|||
33269060|NCT03715829|62641095|FG002|Dose Ranging Period|Lack of Efficacy|0|||
33269061|NCT03715829|62641096|FG003|Dose Ranging Period|Lack of Efficacy|1|||
33269062|NCT03715829|62641097|FG004|Dose Ranging Period|Lack of Efficacy|0|||
33269063|NCT03715829|62641098|FG005|Dose Ranging Period|Lack of Efficacy|0|||
33269064|NCT03715829|62641099|FG006|Dose Ranging Period|Lack of Efficacy|0|||
33269065|NCT03715829|62641100|FG007|Dose Ranging Period|Lack of Efficacy|0|||
33269066|NCT03715829|62641101|FG008|Dose Ranging Period|Lack of Efficacy|0|||
33269067|NCT03715829|62641102|FG009|Dose Ranging Period|Lack of Efficacy|0|||
33269068|NCT03715829|62641103|FG010|Dose Ranging Period|Lack of Efficacy|0|||
33269069|NCT03715829|62641093|FG000|Dose Ranging Period|Lost to Follow-up|2|||
33269070|NCT03715829|62641094|FG001|Dose Ranging Period|Lost to Follow-up|0|||
33269071|NCT03715829|62641095|FG002|Dose Ranging Period|Lost to Follow-up|1|||
33269072|NCT03715829|62641096|FG003|Dose Ranging Period|Lost to Follow-up|1|||
33269073|NCT03715829|62641097|FG004|Dose Ranging Period|Lost to Follow-up|1|||
33269074|NCT03715829|62641098|FG005|Dose Ranging Period|Lost to Follow-up|2|||
33269075|NCT03715829|62641099|FG006|Dose Ranging Period|Lost to Follow-up|0|||
33269076|NCT03715829|62641100|FG007|Dose Ranging Period|Lost to Follow-up|0|||
33269077|NCT03715829|62641101|FG008|Dose Ranging Period|Lost to Follow-up|0|||
33269078|NCT03715829|62641102|FG009|Dose Ranging Period|Lost to Follow-up|0|||
33269079|NCT03715829|62641103|FG010|Dose Ranging Period|Lost to Follow-up|0|||
33269080|NCT03715829|62641093|FG000|Dose Ranging Period|Protocol Violation|0|||
33269081|NCT03715829|62641094|FG001|Dose Ranging Period|Protocol Violation|0|||
33269082|NCT03715829|62641095|FG002|Dose Ranging Period|Protocol Violation|0|||
33269083|NCT03715829|62641096|FG003|Dose Ranging Period|Protocol Violation|1|||
33269084|NCT03715829|62641097|FG004|Dose Ranging Period|Protocol Violation|0|||
33269085|NCT03715829|62641098|FG005|Dose Ranging Period|Protocol Violation|0|||
33269086|NCT03715829|62641099|FG006|Dose Ranging Period|Protocol Violation|0|||
33269087|NCT03715829|62641100|FG007|Dose Ranging Period|Protocol Violation|0|||
33269088|NCT03715829|62641101|FG008|Dose Ranging Period|Protocol Violation|0|||
33269089|NCT03715829|62641102|FG009|Dose Ranging Period|Protocol Violation|0|||
33269090|NCT03715829|62641103|FG010|Dose Ranging Period|Protocol Violation|0|||
33269091|NCT03715829|62641093|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
33269092|NCT03715829|62641094|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
33369108|NCT00852930|62747875|FG000|Overall Study|Physician Decision|0|||
33369109|NCT00852930|62747876|FG001|Overall Study|Physician Decision|0|||
33369110|NCT00852930|62747877|FG002|Overall Study|Physician Decision|1|||
33269093|NCT03715829|62641095|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
33369111|NCT00852540|62747888|FG000|Overall Study|Adverse Event|10|||
33269094|NCT03715829|62641096|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
33269095|NCT03715829|62641097|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
33269096|NCT03715829|62641098|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
33269097|NCT03715829|62641099|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
33269098|NCT03715829|62641100|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
33369112|NCT00852540|62747889|FG001|Overall Study|Adverse Event|3|||
33269099|NCT03715829|62641101|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
33269100|NCT03715829|62641102|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
33269101|NCT03715829|62641103|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
33269102|NCT03715829|62641093|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33269103|NCT03715829|62641094|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33269104|NCT03715829|62641095|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
33269105|NCT03715829|62641096|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33269106|NCT03715829|62641097|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33269107|NCT03715829|62641098|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33269108|NCT03715829|62641099|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33269109|NCT03715829|62641100|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33269110|NCT03715829|62641101|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33369113|NCT00852540|62747888|FG000|Overall Study|Lack of Efficacy|15|||
33369114|NCT00852540|62747889|FG001|Overall Study|Lack of Efficacy|3|||
33369115|NCT00852540|62747888|FG000|Overall Study|Protocol Violation|1|||
33369116|NCT00852540|62747889|FG001|Overall Study|Protocol Violation|2|||
33369117|NCT00852540|62747888|FG000|Overall Study|Lost to Follow-up|2|||
33369118|NCT00852540|62747889|FG001|Overall Study|Lost to Follow-up|3|||
33369119|NCT00852540|62747888|FG000|Overall Study|Investigator Discretion|2|||
33369120|NCT00852540|62747889|FG001|Overall Study|Investigator Discretion|3|||
33369121|NCT00852540|62747888|FG000|Overall Study|Withdrawal by Subject|3|||
33369122|NCT00852540|62747889|FG001|Overall Study|Withdrawal by Subject|1|||
33369123|NCT00852540|62747888|FG000|Overall Study|Did Not Receive Study Drug|3|||
33369124|NCT00852540|62747889|FG001|Overall Study|Did Not Receive Study Drug|3|||
33369125|NCT00861198|62747896|FG000|Overall Study|SpyGlass Failed|5|||
33369126|NCT00847704|62747900|FG000|Overall Study|Withdrawal by Subject|1|||
33369127|NCT00860574|62747904|FG000|Overall Study|Death|2|||
33369128|NCT00860574|62747904|FG000|Overall Study|Relapse|1|||
33369129|NCT00496015|62747913|FG000|Overall Study|Other|1|||
33369130|NCT00496015|62747914|FG001|Overall Study|Other|0|||
33369131|NCT00496015|62747915|FG002|Overall Study|Other|0|||
33369132|NCT00496015|62747916|FG003|Overall Study|Other|1|||
33369133|NCT00496015|62747917|FG004|Overall Study|Other|0|||
33369134|NCT00487825|62747939|FG000|Overall Study|Adverse Event|2|||
33369135|NCT00487825|62747940|FG001|Overall Study|Adverse Event|2|||
33369136|NCT00487825|62747939|FG000|Overall Study|Lack of Efficacy|1|||
33369137|NCT00487825|62747940|FG001|Overall Study|Lack of Efficacy|1|||
33369138|NCT00487825|62747939|FG000|Overall Study|Other|3|||
33369139|NCT00487825|62747940|FG001|Overall Study|Other|2|||
33369140|NCT00487747|62747946|FG000|Overall Study|Adverse Event|1|||
33369141|NCT00487747|62747946|FG000|Overall Study|Lost to Follow-up|9|||
33369142|NCT00487747|62747946|FG000|Overall Study|Lack of Efficacy|1|||
33369143|NCT00487435|62747950|FG000|Overall Study|Adverse Event|146|||
33369144|NCT00487435|62747950|FG000|Overall Study|Death|2|||
33369145|NCT00487435|62747950|FG000|Overall Study|Lack of Efficacy|33|||
33369146|NCT00487435|62747950|FG000|Overall Study|Lost to Follow-up|54|||
33369147|NCT00487435|62747950|FG000|Overall Study|Pregnancy|2|||
33369148|NCT00487435|62747950|FG000|Overall Study|Withdrawal by Subject|132|||
33369149|NCT00487435|62747950|FG000|Overall Study|Resolution Of Pain|1|||
33369150|NCT00487435|62747950|FG000|Overall Study|Study Medication Non-Compliant|32|||
33369151|NCT00487435|62747950|FG000|Overall Study|Other|83|||
33369152|NCT00487279|62747956|FG000|Overall Study|Death|1|||
33369153|NCT00487279|62747957|FG001|Overall Study|Death|0|||
33369154|NCT00487279|62747956|FG000|Overall Study|Withdrawal by Subject|0|||
33369155|NCT00487279|62747957|FG001|Overall Study|Withdrawal by Subject|2|||
33369156|NCT00495625|62747963|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
33369157|NCT00847626|62747978|FG000|Overall Study|Adverse Event|10|||
33369158|NCT00847626|62747979|FG001|Overall Study|Adverse Event|10|||
33369159|NCT00847626|62747980|FG002|Overall Study|Adverse Event|6|||
33369160|NCT00847626|62747981|FG003|Overall Study|Adverse Event|19|||
33369161|NCT00847626|62747982|FG004|Overall Study|Adverse Event|11|||
33369162|NCT00847626|62747983|FG005|Overall Study|Adverse Event|22|||
33369163|NCT00847626|62747984|FG006|Overall Study|Adverse Event|4|||
33369164|NCT00847626|62747985|FG007|Overall Study|Adverse Event|6|||
33369165|NCT00847626|62747986|FG008|Overall Study|Adverse Event|3|||
33269111|NCT03715829|62641102|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33269112|NCT03715829|62641103|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33269113|NCT03715829|62641093|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33269114|NCT03715829|62641094|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33269115|NCT03715829|62641095|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
33269116|NCT03715829|62641096|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33269117|NCT03715829|62641097|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
33269118|NCT03715829|62641098|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33269119|NCT03715829|62641099|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33369166|NCT00847626|62747987|FG009|Overall Study|Adverse Event|6|||
33369167|NCT00847626|62747988|FG010|Overall Study|Adverse Event|6|||
33369168|NCT00847626|62747978|FG000|Overall Study|Protocol Violation|2|||
33369169|NCT00847626|62747979|FG001|Overall Study|Protocol Violation|1|||
33369170|NCT00847626|62747980|FG002|Overall Study|Protocol Violation|2|||
33269120|NCT03715829|62641100|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33269121|NCT03715829|62641101|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33269122|NCT03715829|62641102|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33269123|NCT03715829|62641103|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33269124|NCT03715829|62641093|FG000|Dose Ranging Period|Other|0|||
33269125|NCT03715829|62641094|FG001|Dose Ranging Period|Other|0|||
33484936|NCT02814838|62862101|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
33484937|NCT02814838|62862100|FG000|Overall Study|Consent withdrawal|1|||
33269126|NCT03715829|62641095|FG002|Dose Ranging Period|Other|2|||
33269127|NCT03715829|62641096|FG003|Dose Ranging Period|Other|0|||
33269128|NCT03715829|62641097|FG004|Dose Ranging Period|Other|0|||
33269129|NCT03715829|62641098|FG005|Dose Ranging Period|Other|3|||
33269130|NCT03715829|62641099|FG006|Dose Ranging Period|Other|0|||
33269131|NCT03715829|62641100|FG007|Dose Ranging Period|Other|0|||
33269132|NCT03715829|62641101|FG008|Dose Ranging Period|Other|0|||
33269133|NCT03715829|62641102|FG009|Dose Ranging Period|Other|0|||
33269134|NCT03715829|62641103|FG010|Dose Ranging Period|Other|0|||
33269135|NCT03715829|62641093|FG000|Extension Period|Adverse Event|0|||
33269136|NCT03715829|62641094|FG001|Extension Period|Adverse Event|0|||
33269137|NCT03715829|62641095|FG002|Extension Period|Adverse Event|0|||
33269138|NCT03715829|62641096|FG003|Extension Period|Adverse Event|0|||
33269139|NCT03715829|62641097|FG004|Extension Period|Adverse Event|0|||
33269140|NCT03715829|62641098|FG005|Extension Period|Adverse Event|0|||
33369171|NCT00847626|62747981|FG003|Overall Study|Protocol Violation|1|||
33369172|NCT00847626|62747982|FG004|Overall Study|Protocol Violation|1|||
33369173|NCT00847626|62747983|FG005|Overall Study|Protocol Violation|1|||
33369174|NCT00847626|62747984|FG006|Overall Study|Protocol Violation|1|||
33369175|NCT00847626|62747985|FG007|Overall Study|Protocol Violation|1|||
33369176|NCT00847626|62747986|FG008|Overall Study|Protocol Violation|0|||
33369177|NCT00847626|62747987|FG009|Overall Study|Protocol Violation|1|||
33369178|NCT00847626|62747988|FG010|Overall Study|Protocol Violation|1|||
33369179|NCT00847626|62747978|FG000|Overall Study|Lost to Follow-up|0|||
33369180|NCT00847626|62747979|FG001|Overall Study|Lost to Follow-up|1|||
33369181|NCT00847626|62747980|FG002|Overall Study|Lost to Follow-up|1|||
33369182|NCT00847626|62747981|FG003|Overall Study|Lost to Follow-up|1|||
33369183|NCT00847626|62747982|FG004|Overall Study|Lost to Follow-up|0|||
33369184|NCT00847626|62747983|FG005|Overall Study|Lost to Follow-up|3|||
33369185|NCT00847626|62747984|FG006|Overall Study|Lost to Follow-up|1|||
33369186|NCT00847626|62747985|FG007|Overall Study|Lost to Follow-up|3|||
33369187|NCT00847626|62747986|FG008|Overall Study|Lost to Follow-up|1|||
33369188|NCT00847626|62747987|FG009|Overall Study|Lost to Follow-up|0|||
33369189|NCT00847626|62747988|FG010|Overall Study|Lost to Follow-up|1|||
33369190|NCT00847626|62747978|FG000|Overall Study|Withdrawal by Subject|5|||
33369191|NCT00847626|62747979|FG001|Overall Study|Withdrawal by Subject|5|||
33369192|NCT00847626|62747980|FG002|Overall Study|Withdrawal by Subject|3|||
33369193|NCT00847626|62747981|FG003|Overall Study|Withdrawal by Subject|8|||
33369194|NCT00847626|62747982|FG004|Overall Study|Withdrawal by Subject|12|||
33369195|NCT00847626|62747983|FG005|Overall Study|Withdrawal by Subject|9|||
33369196|NCT00847626|62747984|FG006|Overall Study|Withdrawal by Subject|8|||
33369197|NCT00847626|62747985|FG007|Overall Study|Withdrawal by Subject|4|||
33369198|NCT00847626|62747986|FG008|Overall Study|Withdrawal by Subject|4|||
33369199|NCT00847626|62747987|FG009|Overall Study|Withdrawal by Subject|5|||
33369200|NCT00847626|62747988|FG010|Overall Study|Withdrawal by Subject|2|||
33369201|NCT00847626|62747978|FG000|Overall Study|Lack of Efficacy|3|||
33369202|NCT00847626|62747979|FG001|Overall Study|Lack of Efficacy|1|||
33369203|NCT00847626|62747980|FG002|Overall Study|Lack of Efficacy|0|||
33369204|NCT00847626|62747981|FG003|Overall Study|Lack of Efficacy|1|||
33369205|NCT00847626|62747982|FG004|Overall Study|Lack of Efficacy|2|||
33369206|NCT00847626|62747983|FG005|Overall Study|Lack of Efficacy|0|||
33369207|NCT00847626|62747984|FG006|Overall Study|Lack of Efficacy|6|||
33369208|NCT00847626|62747985|FG007|Overall Study|Lack of Efficacy|2|||
33369209|NCT00847626|62747986|FG008|Overall Study|Lack of Efficacy|5|||
33369210|NCT00847626|62747987|FG009|Overall Study|Lack of Efficacy|1|||
33369211|NCT00847626|62747988|FG010|Overall Study|Lack of Efficacy|7|||
33369212|NCT00847626|62747978|FG000|Overall Study|Other|1|||
33369213|NCT00847626|62747979|FG001|Overall Study|Other|5|||
33369214|NCT00847626|62747980|FG002|Overall Study|Other|4|||
33369215|NCT00847626|62747981|FG003|Overall Study|Other|1|||
33369216|NCT00847626|62747982|FG004|Overall Study|Other|2|||
33369217|NCT00847626|62747983|FG005|Overall Study|Other|2|||
33369218|NCT00847626|62747984|FG006|Overall Study|Other|2|||
33269141|NCT03715829|62641099|FG006|Extension Period|Adverse Event|3|||
33269142|NCT03715829|62641100|FG007|Extension Period|Adverse Event|1|||
33369219|NCT00847626|62747985|FG007|Overall Study|Other|3|||
33369220|NCT00847626|62747986|FG008|Overall Study|Other|1|||
33369221|NCT00847626|62747987|FG009|Overall Study|Other|1|||
33369222|NCT00847626|62747988|FG010|Overall Study|Other|3|||
33269143|NCT03715829|62641101|FG008|Extension Period|Adverse Event|6|||
33369223|NCT00851682|62748017|FG000|Overall Study|screen failure|5|||
33369224|NCT00851682|62748018|FG001|Overall Study|screen failure|0|||
33369225|NCT00860262|62748027|FG000|Overall Study|Adverse Event|9|||
33269144|NCT03715829|62641102|FG009|Extension Period|Adverse Event|0|||
33269145|NCT03715829|62641103|FG010|Extension Period|Adverse Event|0|||
33269146|NCT03715829|62641093|FG000|Extension Period|Lack of Efficacy|0|||
33269147|NCT03715829|62641094|FG001|Extension Period|Lack of Efficacy|0|||
33269148|NCT03715829|62641095|FG002|Extension Period|Lack of Efficacy|0|||
33269149|NCT03715829|62641096|FG003|Extension Period|Lack of Efficacy|0|||
33269150|NCT03715829|62641097|FG004|Extension Period|Lack of Efficacy|0|||
33269151|NCT03715829|62641098|FG005|Extension Period|Lack of Efficacy|0|||
33269152|NCT03715829|62641099|FG006|Extension Period|Lack of Efficacy|1|||
33269153|NCT03715829|62641100|FG007|Extension Period|Lack of Efficacy|9|||
33269154|NCT03715829|62641101|FG008|Extension Period|Lack of Efficacy|2|||
33269155|NCT03715829|62641102|FG009|Extension Period|Lack of Efficacy|0|||
33269156|NCT03715829|62641103|FG010|Extension Period|Lack of Efficacy|0|||
33269157|NCT03715829|62641093|FG000|Extension Period|Lost to Follow-up|0|||
33269158|NCT03715829|62641094|FG001|Extension Period|Lost to Follow-up|0|||
33269159|NCT03715829|62641095|FG002|Extension Period|Lost to Follow-up|0|||
33269160|NCT03715829|62641096|FG003|Extension Period|Lost to Follow-up|0|||
33269161|NCT03715829|62641097|FG004|Extension Period|Lost to Follow-up|0|||
33269162|NCT03715829|62641098|FG005|Extension Period|Lost to Follow-up|0|||
33269163|NCT03715829|62641099|FG006|Extension Period|Lost to Follow-up|0|||
33269164|NCT03715829|62641100|FG007|Extension Period|Lost to Follow-up|0|||
33269165|NCT03715829|62641101|FG008|Extension Period|Lost to Follow-up|2|||
33269166|NCT03715829|62641102|FG009|Extension Period|Lost to Follow-up|0|||
33269167|NCT03715829|62641103|FG010|Extension Period|Lost to Follow-up|0|||
33269168|NCT03715829|62641093|FG000|Extension Period|Protocol Violation|0|||
33269169|NCT03715829|62641094|FG001|Extension Period|Protocol Violation|0|||
33269170|NCT03715829|62641095|FG002|Extension Period|Protocol Violation|0|||
33269171|NCT03715829|62641096|FG003|Extension Period|Protocol Violation|0|||
33269172|NCT03715829|62641097|FG004|Extension Period|Protocol Violation|0|||
33269173|NCT03715829|62641098|FG005|Extension Period|Protocol Violation|0|||
33269174|NCT03715829|62641099|FG006|Extension Period|Protocol Violation|0|||
33269175|NCT03715829|62641100|FG007|Extension Period|Protocol Violation|0|||
33269176|NCT03715829|62641101|FG008|Extension Period|Protocol Violation|1|||
33269177|NCT03715829|62641102|FG009|Extension Period|Protocol Violation|0|||
33269178|NCT03715829|62641103|FG010|Extension Period|Protocol Violation|0|||
33269179|NCT03715829|62641093|FG000|Extension Period|Withdrawal by Subject|0|||
33269180|NCT03715829|62641094|FG001|Extension Period|Withdrawal by Subject|0|||
33269181|NCT03715829|62641095|FG002|Extension Period|Withdrawal by Subject|0|||
33269182|NCT03715829|62641096|FG003|Extension Period|Withdrawal by Subject|0|||
33484938|NCT02814838|62862101|FG001|Overall Study|Consent withdrawal|1|||
33269183|NCT03715829|62641097|FG004|Extension Period|Withdrawal by Subject|0|||
33269184|NCT03715829|62641098|FG005|Extension Period|Withdrawal by Subject|0|||
33269185|NCT03715829|62641099|FG006|Extension Period|Withdrawal by Subject|3|||
33269186|NCT03715829|62641100|FG007|Extension Period|Withdrawal by Subject|3|||
33269187|NCT03715829|62641101|FG008|Extension Period|Withdrawal by Subject|12|||
33269188|NCT03715829|62641102|FG009|Extension Period|Withdrawal by Subject|3|||
33269189|NCT03715829|62641103|FG010|Extension Period|Withdrawal by Subject|0|||
33269190|NCT03715829|62641093|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
33484939|NCT03276728|62862115|FG000|Overall Study|Lost to Follow-up|0|||
33484940|NCT03276728|62862116|FG001|Overall Study|Lost to Follow-up|0|||
33484941|NCT03276728|62862117|FG002|Overall Study|Lost to Follow-up|2|||
33484942|NCT03276728|62862118|FG003|Overall Study|Lost to Follow-up|2|||
33484943|NCT03276728|62862119|FG004|Overall Study|Lost to Follow-up|0|||
33484944|NCT03276728|62862120|FG005|Overall Study|Lost to Follow-up|0|||
33484945|NCT03276728|62862121|FG006|Overall Study|Lost to Follow-up|0|||
33484946|NCT03276728|62862122|FG007|Overall Study|Lost to Follow-up|0|||
33484947|NCT03276728|62862115|FG000|Overall Study|Withdrawal by Subject|0|||
33484948|NCT03276728|62862116|FG001|Overall Study|Withdrawal by Subject|0|||
33484949|NCT03276728|62862117|FG002|Overall Study|Withdrawal by Subject|0|||
33484950|NCT03276728|62862118|FG003|Overall Study|Withdrawal by Subject|3|||
33484951|NCT03276728|62862119|FG004|Overall Study|Withdrawal by Subject|0|||
33484952|NCT03276728|62862120|FG005|Overall Study|Withdrawal by Subject|0|||
33484953|NCT03276728|62862121|FG006|Overall Study|Withdrawal by Subject|0|||
33484954|NCT03276728|62862122|FG007|Overall Study|Withdrawal by Subject|0|||
33484955|NCT03276728|62862115|FG000|Overall Study|Decision by sponsor|0|||
33484956|NCT03276728|62862116|FG001|Overall Study|Decision by sponsor|0|||
33484957|NCT03276728|62862117|FG002|Overall Study|Decision by sponsor|0|||
33484958|NCT03276728|62862118|FG003|Overall Study|Decision by sponsor|0|||
33484959|NCT03276728|62862119|FG004|Overall Study|Decision by sponsor|1|||
33269191|NCT03715829|62641094|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
33269192|NCT03715829|62641095|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
33269193|NCT03715829|62641096|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
33269194|NCT03715829|62641097|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
33269195|NCT03715829|62641098|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
33484960|NCT03276728|62862120|FG005|Overall Study|Decision by sponsor|0|||
33484961|NCT03276728|62862121|FG006|Overall Study|Decision by sponsor|2|||
33269196|NCT03715829|62641099|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
33269197|NCT03715829|62641100|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
33484962|NCT03276728|62862122|FG007|Overall Study|Decision by sponsor|1|||
33484963|NCT03275246|62862142|FG000|Overall Study|Protocol Violation|5|||
33484964|NCT03275246|62862142|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
33484965|NCT02940860|62862148|FG000|Overall Study|Non-serious AE|1|||
33484966|NCT02940860|62862149|FG001|Overall Study|Non-serious AE|2|||
33484967|NCT02940860|62862148|FG000|Overall Study|Serious AE|7|||
33484968|NCT02940860|62862149|FG001|Overall Study|Serious AE|3|||
33484969|NCT02940860|62862148|FG000|Overall Study|Withdrawal by Subject|19|||
33484970|NCT02940860|62862149|FG001|Overall Study|Withdrawal by Subject|9|||
33484971|NCT02940860|62862148|FG000|Overall Study|Lost to Follow-up|13|||
33484972|NCT02940860|62862149|FG001|Overall Study|Lost to Follow-up|7|||
33484973|NCT02940860|62862148|FG000|Overall Study|Physician Decision|5|||
33484974|NCT02940860|62862149|FG001|Overall Study|Physician Decision|3|||
33484975|NCT02940860|62862148|FG000|Overall Study|Sponsor Decision|0|||
33484976|NCT02940860|62862149|FG001|Overall Study|Sponsor Decision|1|||
33484977|NCT02940860|62862148|FG000|Overall Study|Protocol Violation|0|||
33484978|NCT02940860|62862149|FG001|Overall Study|Protocol Violation|2|||
33484979|NCT02940860|62862148|FG000|Overall Study|Death|3|||
33269198|NCT03715829|62641101|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
33269199|NCT03715829|62641102|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
33269200|NCT03715829|62641103|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
33269201|NCT03715829|62641093|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
33269202|NCT03715829|62641094|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
33269203|NCT03715829|62641095|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
33269204|NCT03715829|62641096|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
33269205|NCT03715829|62641097|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
33269206|NCT03715829|62641098|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
33269207|NCT03715829|62641099|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
33269208|NCT03715829|62641100|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
33269209|NCT03715829|62641101|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
33269210|NCT03715829|62641102|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
33269211|NCT03715829|62641103|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
33269212|NCT03715829|62641093|FG000|Extension Period|Other|0|||
33269213|NCT03715829|62641094|FG001|Extension Period|Other|0|||
33269214|NCT03715829|62641095|FG002|Extension Period|Other|0|||
33269215|NCT03715829|62641096|FG003|Extension Period|Other|0|||
33269216|NCT03715829|62641097|FG004|Extension Period|Other|0|||
33269217|NCT03715829|62641098|FG005|Extension Period|Other|0|||
33269218|NCT03715829|62641099|FG006|Extension Period|Other|1|||
33269219|NCT03715829|62641100|FG007|Extension Period|Other|2|||
33269220|NCT03715829|62641101|FG008|Extension Period|Other|4|||
33269221|NCT03715829|62641102|FG009|Extension Period|Other|0|||
33269222|NCT03715829|62641103|FG010|Extension Period|Other|0|||
33269223|NCT03575104|62641165|FG000|Overall Study|Adverse Event|4|||
33269224|NCT03575104|62641166|FG001|Overall Study|Adverse Event|3|||
33269225|NCT03575104|62641167|FG002|Overall Study|Adverse Event|4|||
33269226|NCT03575104|62641165|FG000|Overall Study|Withdrawal by Subject|13|||
33269227|NCT03575104|62641166|FG001|Overall Study|Withdrawal by Subject|16|||
33269228|NCT03575104|62641167|FG002|Overall Study|Withdrawal by Subject|11|||
33269229|NCT03575104|62641165|FG000|Overall Study|Other reasons|6|||
33269230|NCT03575104|62641166|FG001|Overall Study|Other reasons|8|||
33269231|NCT03575104|62641167|FG002|Overall Study|Other reasons|6|||
33269232|NCT03575104|62641165|FG000|Overall Study|Lost to Follow-up|1|||
33269233|NCT03575104|62641166|FG001|Overall Study|Lost to Follow-up|2|||
33269234|NCT03575104|62641167|FG002|Overall Study|Lost to Follow-up|1|||
33269235|NCT03569475|62641178|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
33269236|NCT03569475|62641179|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
33269237|NCT03569475|62641180|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
33269238|NCT03569475|62641178|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
33369226|NCT00860262|62748028|FG001|Overall Study|Adverse Event|6|||
33369227|NCT00860262|62748029|FG002|Overall Study|Adverse Event|7|||
33369228|NCT00860262|62748027|FG000|Overall Study|Protocol Violation|0|||
33369229|NCT00860262|62748028|FG001|Overall Study|Protocol Violation|1|||
33484980|NCT02940860|62862149|FG001|Overall Study|Death|2|||
33484981|NCT02940860|62862148|FG000|Overall Study|Moved, poor venous access, transport|6|||
33484982|NCT02940860|62862149|FG001|Overall Study|Moved, poor venous access, transport|4|||
33484983|NCT02940860|62862148|FG000|Overall Study|Not treated|2|||
33484984|NCT02940860|62862149|FG001|Overall Study|Not treated|2|||
33484985|NCT03309020|62862159|FG000|Overall Study|Death|1|||
33484986|NCT03309020|62862160|FG001|Overall Study|Death|0|||
33484987|NCT03309020|62862159|FG000|Overall Study|Did not undergo surgery|2|||
33484988|NCT03309020|62862160|FG001|Overall Study|Did not undergo surgery|1|||
33369230|NCT00860262|62748029|FG002|Overall Study|Protocol Violation|0|||
33555639|NCT01370213|62948442|FG000|Overall Study|Early Death|1|||
33269239|NCT03569475|62641179|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
33269240|NCT03569475|62641180|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
33269241|NCT03569475|62641178|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
33269242|NCT03569475|62641179|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
33269243|NCT03569475|62641180|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
33269244|NCT03569475|62641178|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
33269245|NCT03569475|62641179|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
33269246|NCT03569475|62641180|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
33269247|NCT03569475|62641178|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
33269248|NCT03569475|62641179|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
33269249|NCT03569475|62641180|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
33269250|NCT03569475|62641178|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
33269251|NCT03569475|62641179|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
33269252|NCT03569475|62641180|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
33269253|NCT03569475|62641178|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
33269254|NCT03569475|62641179|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
33269255|NCT03569475|62641180|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
33269256|NCT03569475|62641178|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
33269257|NCT03569475|62641179|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
33269258|NCT03569475|62641180|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
33269259|NCT03569475|62641178|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
33269260|NCT03569475|62641179|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
33269261|NCT03569475|62641180|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
33269262|NCT03545191|62641234|FG000|Overall Study|Death|1|||
33269263|NCT03545191|62641235|FG001|Overall Study|Death|0|||
33269264|NCT03545191|62641236|FG002|Overall Study|Death|0|||
33269265|NCT03545191|62641234|FG000|Overall Study|Adverse Event|4|||
33269266|NCT03545191|62641235|FG001|Overall Study|Adverse Event|2|||
33269267|NCT03545191|62641236|FG002|Overall Study|Adverse Event|7|||
33269268|NCT03545191|62641234|FG000|Overall Study|Other reasons|3|||
33269269|NCT03545191|62641235|FG001|Overall Study|Other reasons|11|||
33269270|NCT03545191|62641236|FG002|Overall Study|Other reasons|8|||
33269271|NCT03545191|62641234|FG000|Overall Study|Withdrawal by Subject|13|||
33269272|NCT03545191|62641235|FG001|Overall Study|Withdrawal by Subject|10|||
33269273|NCT03545191|62641236|FG002|Overall Study|Withdrawal by Subject|12|||
33484989|NCT02806960|62862168|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
33484990|NCT02806960|62862169|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
33484991|NCT02806960|62862170|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
33484992|NCT02806960|62862171|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
33484993|NCT03718143|62862181|FG000|Overall Study|Death|1|||
33269274|NCT03545191|62641234|FG000|Overall Study|Lost to Follow-up|1|||
33269275|NCT03545191|62641235|FG001|Overall Study|Lost to Follow-up|2|||
33269276|NCT03545191|62641236|FG002|Overall Study|Lost to Follow-up|3|||
33269277|NCT03500549|62641246|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
33269278|NCT03500549|62641247|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
33269279|NCT03500549|62641246|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
33269280|NCT03500549|62641247|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
33269281|NCT03366792|62641267|FG000|Overall Study|Withdrawal by Subject|7|||
33269282|NCT03366792|62641267|FG000|Overall Study|Lost to Follow-up|2|||
33269283|NCT03366792|62641267|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
33269284|NCT03366792|62641267|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
33269285|NCT03366337|62641275|FG000|Overall Study|Lost to Follow-up|1|||
33269286|NCT03366337|62641276|FG001|Overall Study|Lost to Follow-up|0|||
33269287|NCT03366337|62641277|FG002|Overall Study|Lost to Follow-up|1|||
33269288|NCT03366337|62641278|FG003|Overall Study|Lost to Follow-up|0|||
33269289|NCT03366337|62641275|FG000|Overall Study|Withdrawal by Subject|2|||
33269290|NCT03366337|62641276|FG001|Overall Study|Withdrawal by Subject|0|||
33269291|NCT03366337|62641277|FG002|Overall Study|Withdrawal by Subject|1|||
33269292|NCT03366337|62641278|FG003|Overall Study|Withdrawal by Subject|1|||
33269293|NCT03342053|62641290|FG000|Overall Study|Adverse Event|2|||
33269294|NCT03342053|62641291|FG001|Overall Study|Adverse Event|0|||
33269295|NCT03342053|62641290|FG000|Overall Study|Withdrawal by Subject|0|||
33269296|NCT03342053|62641291|FG001|Overall Study|Withdrawal by Subject|1|||
33269297|NCT03325777|62641299|FG000|Overall Study|Lost to Follow-up|9|||
33269298|NCT03325777|62641300|FG001|Overall Study|Lost to Follow-up|12|||
33269299|NCT03283241|62641308|FG000|Overall Study|Adverse Event|4|||
33269300|NCT03283241|62641309|FG001|Overall Study|Adverse Event|1|||
33269301|NCT03283241|62641308|FG000|Overall Study|Withdrawal by Subject|0|||
33269302|NCT03283241|62641309|FG001|Overall Study|Withdrawal by Subject|1|||
33269303|NCT03283241|62641308|FG000|Overall Study|Subject relocated to Finland|0|||
33369231|NCT00860262|62748027|FG000|Overall Study|Lost to Follow-up|2|||
33269304|NCT03283241|62641309|FG001|Overall Study|Subject relocated to Finland|1|||
33269305|NCT03242772|62641317|FG000|Overall Study|Lost to Follow-up|2|||
33269306|NCT03242772|62641318|FG001|Overall Study|Lost to Follow-up|0|||
33269307|NCT03242772|62641317|FG000|Overall Study|Physician Decision|0|||
33269308|NCT03242772|62641318|FG001|Overall Study|Physician Decision|1|||
33269309|NCT03242772|62641317|FG000|Overall Study|Withdrawal by Subject|1|||
33269310|NCT03242772|62641318|FG001|Overall Study|Withdrawal by Subject|0|||
33269311|NCT03236311|62641326|FG000|Overall Study|Study terminated by sponsor|0|||
33269312|NCT03236311|62641327|FG001|Overall Study|Study terminated by sponsor|2|||
33269313|NCT03236311|62641326|FG000|Overall Study|Adverse Event|0|||
33269314|NCT03236311|62641327|FG001|Overall Study|Adverse Event|1|||
33269315|NCT03192046|62641335|FG000|Overall Study|Withdrawal by Subject|1|||
33269316|NCT03192046|62641336|FG001|Overall Study|Withdrawal by Subject|1|||
33269317|NCT03190369|62641344|FG000|Overall Study|Poor compliance to protocol|0|||
33269318|NCT03190369|62641345|FG001|Overall Study|Poor compliance to protocol|1|||
33269319|NCT03190369|62641344|FG000|Overall Study|Withdraw before treatment|1|||
33269320|NCT03190369|62641345|FG001|Overall Study|Withdraw before treatment|5|||
33484994|NCT03718143|62862182|FG001|Overall Study|Death|0|||
33484995|NCT03718143|62862183|FG002|Overall Study|Death|0|||
33484996|NCT03718143|62862181|FG000|Overall Study|Progression of Disease|1|||
33484997|NCT03718143|62862182|FG001|Overall Study|Progression of Disease|0|||
33484998|NCT03718143|62862183|FG002|Overall Study|Progression of Disease|0|||
33484999|NCT03718143|62862181|FG000|Overall Study|Withdrawal of Informed Consent|1|||
33485000|NCT03718143|62862182|FG001|Overall Study|Withdrawal of Informed Consent|2|||
33485001|NCT03718143|62862183|FG002|Overall Study|Withdrawal of Informed Consent|1|||
33269321|NCT03190369|62641344|FG000|Overall Study|Randomized but not treated|0|||
33269322|NCT03190369|62641345|FG001|Overall Study|Randomized but not treated|2|||
33269323|NCT04657198|62641354|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
33269324|NCT04657198|62641355|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
33269325|NCT04657198|62641356|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
33269326|NCT04590586|62641370|FG000|Overall Study|Death|7|||
33269327|NCT04590586|62641371|FG001|Overall Study|Death|1|||
33269328|NCT04590586|62641372|FG002|Overall Study|Death|37|||
33269329|NCT04590586|62641373|FG003|Overall Study|Death|34|||
33269330|NCT04590586|62641374|FG004|Overall Study|Death|19|||
33269331|NCT04590586|62641375|FG005|Overall Study|Death|3|||
33269332|NCT04590586|62641370|FG000|Overall Study|Lost to Follow-up|3|||
33269333|NCT04590586|62641371|FG001|Overall Study|Lost to Follow-up|0|||
33269334|NCT04590586|62641372|FG002|Overall Study|Lost to Follow-up|11|||
33269335|NCT04590586|62641373|FG003|Overall Study|Lost to Follow-up|11|||
33269336|NCT04590586|62641374|FG004|Overall Study|Lost to Follow-up|6|||
33269337|NCT04590586|62641375|FG005|Overall Study|Lost to Follow-up|0|||
33269338|NCT04590586|62641370|FG000|Overall Study|Withdrawal by Subject|0|||
33269339|NCT04590586|62641371|FG001|Overall Study|Withdrawal by Subject|0|||
33369232|NCT00860262|62748028|FG001|Overall Study|Lost to Follow-up|0|||
33369233|NCT00860262|62748029|FG002|Overall Study|Lost to Follow-up|1|||
33369234|NCT00860262|62748027|FG000|Overall Study|Withdrawal by Subject|4|||
33369235|NCT00860262|62748028|FG001|Overall Study|Withdrawal by Subject|8|||
33369236|NCT00860262|62748029|FG002|Overall Study|Withdrawal by Subject|6|||
33369237|NCT00860262|62748027|FG000|Overall Study|Lack of Efficacy|0|||
33369238|NCT00860262|62748028|FG001|Overall Study|Lack of Efficacy|4|||
33369239|NCT00860262|62748029|FG002|Overall Study|Lack of Efficacy|3|||
33369240|NCT00860262|62748027|FG000|Overall Study|Other|5|||
33369241|NCT00860262|62748028|FG001|Overall Study|Other|3|||
33369242|NCT00860262|62748029|FG002|Overall Study|Other|1|||
33369243|NCT00860028|62748041|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
33369244|NCT00860028|62748042|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
33369245|NCT00859638|62748052|FG000|Overall Study|Lost to Follow-up|6|||
33369246|NCT00859638|62748053|FG001|Overall Study|Lost to Follow-up|1|||
33369247|NCT00859638|62748052|FG000|Overall Study|Withdrawal by Subject|3|||
33369248|NCT00859638|62748053|FG001|Overall Study|Withdrawal by Subject|2|||
33369249|NCT00859638|62748052|FG000|Overall Study|Ill health|1|||
33369250|NCT00859638|62748053|FG001|Overall Study|Ill health|1|||
33369251|NCT00846846|62748059|FG000|Overall Study|Death|56|||
33369252|NCT00846846|62748059|FG000|Overall Study|Withdrawal by Subject|19|||
33369253|NCT00846768|62748063|FG000|Overall Study|Adverse Event|0|||
33369254|NCT00846768|62748064|FG001|Overall Study|Adverse Event|1|||
33369255|NCT00846768|62748065|FG002|Overall Study|Adverse Event|0|||
33369256|NCT00846768|62748066|FG003|Overall Study|Adverse Event|0|||
33269340|NCT04590586|62641372|FG002|Overall Study|Withdrawal by Subject|6|||
33269341|NCT04590586|62641373|FG003|Overall Study|Withdrawal by Subject|0|||
33269342|NCT04590586|62641374|FG004|Overall Study|Withdrawal by Subject|3|||
33269343|NCT04590586|62641375|FG005|Overall Study|Withdrawal by Subject|0|||
33369257|NCT00863798|62748079|FG000|Overall Study|Adverse Event|5|||
33369258|NCT00863798|62748080|FG001|Overall Study|Adverse Event|2|||
33369259|NCT00863798|62748081|FG002|Overall Study|Adverse Event|4|||
33369260|NCT00863798|62748079|FG000|Overall Study|Participant failed to return|2|||
33369261|NCT00863798|62748080|FG001|Overall Study|Participant failed to return|1|||
33269344|NCT04590586|62641370|FG000|Overall Study|Other|3|||
33269345|NCT04590586|62641371|FG001|Overall Study|Other|0|||
33269346|NCT04590586|62641372|FG002|Overall Study|Other|1|||
33269347|NCT04590586|62641373|FG003|Overall Study|Other|1|||
33269348|NCT04590586|62641374|FG004|Overall Study|Other|2|||
33269349|NCT04590586|62641375|FG005|Overall Study|Other|1|||
33269350|NCT04312009|62641401|FG000|Overall Study|Withdrawal by Subject|2|||
33269351|NCT04312009|62641402|FG001|Overall Study|Withdrawal by Subject|1|||
33269352|NCT03937466|62641417|FG000|Overall Study|not eligbile after the 2-week diary|9|||
33269353|NCT03937466|62641417|FG000|Overall Study|never returned their diary|6|||
33269354|NCT03937466|62641417|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
33269355|NCT03937466|62641417|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
33269356|NCT03850483|62641430|FG000|Treatment for Stage 1|Adverse Event|1|||
33269357|NCT03850483|62641431|FG001|Treatment for Stage 1|Adverse Event|1|||
33269358|NCT03850483|62641432|FG002|Treatment for Stage 1|Adverse Event|3|||
33269359|NCT03850483|62641433|FG003|Treatment for Stage 1|Adverse Event|0|||
33269360|NCT03850483|62641434|FG004|Treatment for Stage 1|Adverse Event|2|||
33269361|NCT03850483|62641435|FG005|Treatment for Stage 1|Adverse Event|0|||
33269362|NCT03850483|62641436|FG006|Treatment for Stage 1|Adverse Event|2|||
33269363|NCT03850483|62641437|FG007|Treatment for Stage 1|Adverse Event|2|||
33269364|NCT03850483|62641438|FG008|Treatment for Stage 1|Adverse Event|0|||
33269365|NCT03850483|62641439|FG009|Treatment for Stage 1|Adverse Event|0|||
33269366|NCT03850483|62641430|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
33269367|NCT03850483|62641431|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
33269368|NCT03850483|62641432|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
33269369|NCT03850483|62641433|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
33269370|NCT03850483|62641434|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
33269371|NCT03850483|62641435|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
33269372|NCT03850483|62641436|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
33269373|NCT03850483|62641437|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
33269374|NCT03850483|62641438|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
33269375|NCT03850483|62641439|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
33269376|NCT03850483|62641430|FG000|Treatment for Stage 1|Protocol Violation|1|||
33269377|NCT03850483|62641431|FG001|Treatment for Stage 1|Protocol Violation|0|||
33269378|NCT03850483|62641432|FG002|Treatment for Stage 1|Protocol Violation|0|||
33269379|NCT03850483|62641433|FG003|Treatment for Stage 1|Protocol Violation|0|||
33269380|NCT03850483|62641434|FG004|Treatment for Stage 1|Protocol Violation|0|||
33269381|NCT03850483|62641435|FG005|Treatment for Stage 1|Protocol Violation|0|||
33269382|NCT03850483|62641436|FG006|Treatment for Stage 1|Protocol Violation|1|||
33269383|NCT03850483|62641437|FG007|Treatment for Stage 1|Protocol Violation|0|||
33269384|NCT03850483|62641438|FG008|Treatment for Stage 1|Protocol Violation|0|||
33269385|NCT03850483|62641439|FG009|Treatment for Stage 1|Protocol Violation|0|||
33269386|NCT03850483|62641430|FG000|Treatment for Stage 1|Physician Decision|0|||
33269387|NCT03850483|62641431|FG001|Treatment for Stage 1|Physician Decision|0|||
33269388|NCT03850483|62641432|FG002|Treatment for Stage 1|Physician Decision|0|||
33269389|NCT03850483|62641433|FG003|Treatment for Stage 1|Physician Decision|0|||
33269390|NCT03850483|62641434|FG004|Treatment for Stage 1|Physician Decision|0|||
33269391|NCT03850483|62641435|FG005|Treatment for Stage 1|Physician Decision|1|||
33269392|NCT03850483|62641436|FG006|Treatment for Stage 1|Physician Decision|0|||
33269393|NCT03850483|62641437|FG007|Treatment for Stage 1|Physician Decision|0|||
33269394|NCT03850483|62641438|FG008|Treatment for Stage 1|Physician Decision|0|||
33269395|NCT03850483|62641439|FG009|Treatment for Stage 1|Physician Decision|0|||
33269396|NCT03850483|62641430|FG000|Treatment for Stage 1|Other|0|||
33269397|NCT03850483|62641431|FG001|Treatment for Stage 1|Other|0|||
33269398|NCT03850483|62641432|FG002|Treatment for Stage 1|Other|0|||
33269399|NCT03850483|62641433|FG003|Treatment for Stage 1|Other|0|||
33269400|NCT03850483|62641434|FG004|Treatment for Stage 1|Other|2|||
33269401|NCT03850483|62641435|FG005|Treatment for Stage 1|Other|1|||
33269402|NCT03850483|62641436|FG006|Treatment for Stage 1|Other|0|||
33269403|NCT03850483|62641437|FG007|Treatment for Stage 1|Other|0|||
33269404|NCT03850483|62641438|FG008|Treatment for Stage 1|Other|0|||
33269405|NCT03850483|62641439|FG009|Treatment for Stage 1|Other|0|||
33369262|NCT00863798|62748081|FG002|Overall Study|Participant failed to return|0|||
33369263|NCT00863798|62748079|FG000|Overall Study|Investigator request|1|||
33269406|NCT03850483|62641430|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33269407|NCT03850483|62641431|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33369264|NCT00863798|62748080|FG001|Overall Study|Investigator request|2|||
33269408|NCT03850483|62641432|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
33269409|NCT03850483|62641433|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33269410|NCT03850483|62641434|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33485002|NCT03274466|62862193|FG000|Overall Study|Withdrawal by Subject|7|||
33269411|NCT03850483|62641435|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33269412|NCT03850483|62641436|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33269413|NCT03850483|62641437|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33269414|NCT03850483|62641438|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33269415|NCT03850483|62641439|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33269416|NCT03850483|62641430|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33269417|NCT03850483|62641431|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33269418|NCT03850483|62641432|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33269419|NCT03850483|62641433|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33269420|NCT03850483|62641434|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33269421|NCT03850483|62641435|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
33269422|NCT03850483|62641436|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33269423|NCT03850483|62641437|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33269424|NCT03850483|62641438|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33269425|NCT03850483|62641439|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33269426|NCT03850483|62641430|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
33269427|NCT03850483|62641431|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
33269428|NCT03850483|62641432|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
33269429|NCT03850483|62641433|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
33269430|NCT03850483|62641434|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
33269431|NCT03850483|62641435|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
33269432|NCT03850483|62641436|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
33269433|NCT03850483|62641437|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
33269434|NCT03850483|62641438|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
33269435|NCT03850483|62641439|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
33269436|NCT03850483|62641430|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
33269437|NCT03850483|62641431|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
33369265|NCT00863798|62748081|FG002|Overall Study|Investigator request|1|||
33369266|NCT00863798|62748079|FG000|Overall Study|Lack of Efficacy|4|||
33369267|NCT00863798|62748080|FG001|Overall Study|Lack of Efficacy|3|||
33369268|NCT00863798|62748081|FG002|Overall Study|Lack of Efficacy|6|||
33369269|NCT00863798|62748079|FG000|Overall Study|Lost to Follow-up|6|||
33369270|NCT00863798|62748080|FG001|Overall Study|Lost to Follow-up|9|||
33369271|NCT00863798|62748081|FG002|Overall Study|Lost to Follow-up|5|||
33369272|NCT00863798|62748079|FG000|Overall Study|Other|2|||
33369273|NCT00863798|62748080|FG001|Overall Study|Other|3|||
33369274|NCT00863798|62748081|FG002|Overall Study|Other|1|||
33369275|NCT00863798|62748079|FG000|Overall Study|Protocol Violation|0|||
33369276|NCT00863798|62748080|FG001|Overall Study|Protocol Violation|1|||
33369277|NCT00863798|62748081|FG002|Overall Study|Protocol Violation|1|||
33369278|NCT00863798|62748079|FG000|Overall Study|Withdrawal by Subject|8|||
33369279|NCT00863798|62748080|FG001|Overall Study|Withdrawal by Subject|7|||
33369280|NCT00863798|62748081|FG002|Overall Study|Withdrawal by Subject|4|||
33369281|NCT00863798|62748079|FG000|Overall Study|Randomized not treated|4|||
33369282|NCT00863798|62748080|FG001|Overall Study|Randomized not treated|2|||
33369283|NCT00863798|62748081|FG002|Overall Study|Randomized not treated|3|||
33369284|NCT00859014|62748089|FG000|Overall Study|Death|4|||
33369285|NCT00859014|62748089|FG000|Overall Study|Lost to Follow-up|1|||
33369286|NCT00593606|62748093|FG000|Overall Study|Adverse Event|13|||
33369287|NCT00593606|62748093|FG000|Overall Study|Withdrawal by Subject|1|||
33369288|NCT00593606|62748093|FG000|Overall Study|Protocol Violation|3|||
33369289|NCT00593606|62748093|FG000|Overall Study|Lost to Follow-up|2|||
33369290|NCT00593606|62748093|FG000|Overall Study|Run-In Failure|5|||
33369291|NCT00593606|62748093|FG000|Overall Study|Screen Failure|3|||
33369292|NCT00870584|62748099|FG000|Overall Study|Adverse Event|3|||
33369293|NCT00870584|62748100|FG001|Overall Study|Adverse Event|3|||
33369294|NCT00870584|62748099|FG000|Overall Study|Withdrawal by Subject|6|||
33369295|NCT00870584|62748100|FG001|Overall Study|Withdrawal by Subject|7|||
33369296|NCT00870584|62748099|FG000|Overall Study|Lost to Follow-up|5|||
33369297|NCT00870584|62748100|FG001|Overall Study|Lost to Follow-up|1|||
33369298|NCT00870584|62748099|FG000|Overall Study|Protocol Deviation|2|||
33269438|NCT03850483|62641432|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
33269439|NCT03850483|62641433|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
33269440|NCT03850483|62641434|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
33269441|NCT03850483|62641435|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
33269442|NCT03850483|62641436|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
33269443|NCT03850483|62641437|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
33269444|NCT03850483|62641438|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
33369299|NCT00870584|62748100|FG001|Overall Study|Protocol Deviation|2|||
33369300|NCT00870194|62748108|FG000|Overall Study|Adverse Event|10|||
33369301|NCT00870194|62748109|FG001|Overall Study|Adverse Event|5|||
33269445|NCT03850483|62641439|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
33369302|NCT00870194|62748108|FG000|Overall Study|Lack of Efficacy|0|||
33369303|NCT00870194|62748109|FG001|Overall Study|Lack of Efficacy|1|||
33369304|NCT00870194|62748108|FG000|Overall Study|Lost to Follow-up|2|||
33369305|NCT00870194|62748109|FG001|Overall Study|Lost to Follow-up|0|||
33369306|NCT00870194|62748108|FG000|Overall Study|Physician Decision|3|||
33369307|NCT00870194|62748109|FG001|Overall Study|Physician Decision|1|||
33269446|NCT03850483|62641430|FG000|Treatment for Stage 1|Death|0|||
33269447|NCT03850483|62641431|FG001|Treatment for Stage 1|Death|0|||
33269448|NCT03850483|62641432|FG002|Treatment for Stage 1|Death|0|||
33269449|NCT03850483|62641433|FG003|Treatment for Stage 1|Death|0|||
33269450|NCT03850483|62641434|FG004|Treatment for Stage 1|Death|0|||
33269451|NCT03850483|62641435|FG005|Treatment for Stage 1|Death|1|||
33269452|NCT03850483|62641436|FG006|Treatment for Stage 1|Death|0|||
33269453|NCT03850483|62641437|FG007|Treatment for Stage 1|Death|0|||
33269454|NCT03850483|62641438|FG008|Treatment for Stage 1|Death|0|||
33269455|NCT03850483|62641439|FG009|Treatment for Stage 1|Death|0|||
33269456|NCT03850483|62641430|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
33269457|NCT03850483|62641431|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
33269458|NCT03850483|62641432|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
33269459|NCT03850483|62641433|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
33269460|NCT03850483|62641434|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
33269461|NCT03850483|62641435|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
33269462|NCT03850483|62641436|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
33269463|NCT03850483|62641437|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
33269464|NCT03850483|62641438|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
33269465|NCT03850483|62641439|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
33269466|NCT03850483|62641430|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
33269467|NCT03850483|62641431|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
33369308|NCT00870194|62748108|FG000|Overall Study|Protocol Violation|3|||
33369309|NCT00870194|62748109|FG001|Overall Study|Protocol Violation|3|||
33369310|NCT00870194|62748108|FG000|Overall Study|Entry Criteria Not Met|1|||
33369311|NCT00870194|62748109|FG001|Overall Study|Entry Criteria Not Met|2|||
33369312|NCT00870194|62748108|FG000|Overall Study|Subject Decision|7|||
33369313|NCT00870194|62748109|FG001|Overall Study|Subject Decision|2|||
33369314|NCT00690430|62748117|FG000|Core Phase|Abnormal Laboratory value|0|||
33369315|NCT00690430|62748118|FG001|Core Phase|Abnormal Laboratory value|1|||
33369316|NCT00690430|62748119|FG002|Core Phase|Abnormal Laboratory value|0|||
33369317|NCT00690430|62748117|FG000|Core Phase|Adverse Event|5|||
33369318|NCT00690430|62748118|FG001|Core Phase|Adverse Event|1|||
33369319|NCT00690430|62748119|FG002|Core Phase|Adverse Event|0|||
33369320|NCT00690430|62748117|FG000|Core Phase|Death|0|||
33369321|NCT00690430|62748118|FG001|Core Phase|Death|2|||
33269468|NCT03850483|62641432|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
33269469|NCT03850483|62641433|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
33269470|NCT03850483|62641434|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
33269471|NCT03850483|62641435|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
33269472|NCT03850483|62641436|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
33269473|NCT03850483|62641437|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
33269474|NCT03850483|62641438|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
33269475|NCT03850483|62641439|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
33369322|NCT00690430|62748119|FG002|Core Phase|Death|0|||
33369323|NCT00690430|62748117|FG000|Core Phase|Protocol Violation|1|||
33369324|NCT00690430|62748118|FG001|Core Phase|Protocol Violation|0|||
33485003|NCT03274466|62862194|FG001|Overall Study|Withdrawal by Subject|3|||
33485004|NCT03274466|62862193|FG000|Overall Study|Protocol Specified Withdrawal|5|||
33485005|NCT03274466|62862194|FG001|Overall Study|Protocol Specified Withdrawal|11|||
33485006|NCT03274466|62862193|FG000|Overall Study|Lost to Follow-up|5|||
33485007|NCT03274466|62862194|FG001|Overall Study|Lost to Follow-up|7|||
33485008|NCT03274466|62862193|FG000|Overall Study|Subject Non-compliance|0|||
33485009|NCT03274466|62862194|FG001|Overall Study|Subject Non-compliance|1|||
33555640|NCT01370213|62948443|FG001|Overall Study|Early Death|0|||
33555641|NCT01370213|62948444|FG002|Overall Study|Early Death|0|||
33555642|NCT01370213|62948442|FG000|Overall Study|Not evaluable|0|||
33555643|NCT01370213|62948443|FG001|Overall Study|Not evaluable|2|||
33555644|NCT01370213|62948444|FG002|Overall Study|Not evaluable|0|||
33555645|NCT01370525|62948453|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
33555646|NCT01370525|62948454|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
33555647|NCT01370525|62948453|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33555648|NCT01370525|62948454|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33485010|NCT03274466|62862193|FG000|Overall Study|Adverse Event|3|||
33485011|NCT03274466|62862194|FG001|Overall Study|Adverse Event|3|||
33555649|NCT01370525|62948453|FG000|Overall Study|Adverse Event|0|||
33555650|NCT01370525|62948454|FG001|Overall Study|Adverse Event|1|||
33269476|NCT03850483|62641430|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
33269477|NCT03850483|62641431|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
33269478|NCT03850483|62641432|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
33269479|NCT03850483|62641433|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
33269480|NCT03850483|62641434|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
33269481|NCT03850483|62641435|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
33369325|NCT00690430|62748119|FG002|Core Phase|Protocol Violation|0|||
33369326|NCT00690430|62748117|FG000|Core Phase|Withdrawal by Subject|3|||
33369327|NCT00690430|62748118|FG001|Core Phase|Withdrawal by Subject|3|||
33369328|NCT00690430|62748119|FG002|Core Phase|Withdrawal by Subject|0|||
33269482|NCT03850483|62641436|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
33269483|NCT03850483|62641437|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
33269484|NCT03850483|62641438|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
33269485|NCT03850483|62641439|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
33269486|NCT03850483|62641430|FG000|Follow-up for Stage 1|Physician Decision|0|||
33269487|NCT03850483|62641431|FG001|Follow-up for Stage 1|Physician Decision|0|||
33269488|NCT03850483|62641432|FG002|Follow-up for Stage 1|Physician Decision|0|||
33269489|NCT03850483|62641433|FG003|Follow-up for Stage 1|Physician Decision|0|||
33269490|NCT03850483|62641434|FG004|Follow-up for Stage 1|Physician Decision|1|||
33269491|NCT03850483|62641435|FG005|Follow-up for Stage 1|Physician Decision|0|||
33269492|NCT03850483|62641436|FG006|Follow-up for Stage 1|Physician Decision|1|||
33269493|NCT03850483|62641437|FG007|Follow-up for Stage 1|Physician Decision|0|||
33269494|NCT03850483|62641438|FG008|Follow-up for Stage 1|Physician Decision|0|||
33485012|NCT03274466|62862193|FG000|Overall Study|Physician Decision|0|||
33485013|NCT03274466|62862194|FG001|Overall Study|Physician Decision|1|||
33485014|NCT03274466|62862193|FG000|Overall Study|Protocol Violation|3|||
33485015|NCT03274466|62862194|FG001|Overall Study|Protocol Violation|3|||
33485016|NCT02806726|62862200|FG000|Overall Study|Lost to Follow-up|1|||
33485017|NCT02806414|62862205|FG000|Overall Study|Lost to Follow-up|2|||
33485018|NCT02806024|62862211|FG000|Overall Study|Night Delivery|1|||
33485019|NCT02806024|62862212|FG001|Overall Study|Night Delivery|1|||
33485020|NCT02806024|62862211|FG000|Overall Study|DVT during antepartum admission|0|||
33485021|NCT02806024|62862212|FG001|Overall Study|DVT during antepartum admission|1|||
33485022|NCT02805790|62862220|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
33485023|NCT02805790|62862221|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
33485024|NCT02802592|62862227|FG000|Overall Study|Study terminated due to loss of funding|4|||
33485025|NCT02803138|62862232|FG000|Overall Study|Failure to return|38|||
33485026|NCT02803138|62862232|FG000|Overall Study|Insufficient virological response|2|||
33485027|NCT02803138|62862232|FG000|Overall Study|Withdrawn consent|1|||
33485028|NCT02803138|62862232|FG000|Overall Study|Death|1|||
33485029|NCT02803138|62862232|FG000|Overall Study|Other, not specified|28|||
33485030|NCT02801578|62862238|FG000|Overall Study|Adverse Event|2|||
33485031|NCT02799472|62862244|FG000|Overall Study|Withdrawal by Subject|2|||
33485032|NCT02799472|62862245|FG001|Overall Study|Withdrawal by Subject|4|||
33485033|NCT02799472|62862244|FG000|Overall Study|Lack of Efficacy|2|||
33485034|NCT02799472|62862245|FG001|Overall Study|Lack of Efficacy|0|||
33485035|NCT02799472|62862244|FG000|Overall Study|Lost to Follow-up|0|||
33269495|NCT03850483|62641439|FG009|Follow-up for Stage 1|Physician Decision|0|||
33269496|NCT03850483|62641430|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
33269497|NCT03850483|62641431|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
33269498|NCT03850483|62641432|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
33269499|NCT03850483|62641433|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
33269500|NCT03850483|62641434|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
33269501|NCT03850483|62641435|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
33269502|NCT03850483|62641436|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
33269503|NCT03850483|62641437|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
33269504|NCT03850483|62641438|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
33269505|NCT03850483|62641439|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
33269506|NCT03850483|62641430|FG000|Follow-up for Stage 1|Adverse Event|0|||
33269507|NCT03850483|62641431|FG001|Follow-up for Stage 1|Adverse Event|0|||
33269508|NCT03850483|62641432|FG002|Follow-up for Stage 1|Adverse Event|1|||
33369329|NCT00690430|62748117|FG000|Core Phase|Subject no longer requires study drug|1|||
33369330|NCT00690430|62748118|FG001|Core Phase|Subject no longer requires study drug|0|||
33369331|NCT00690430|62748119|FG002|Core Phase|Subject no longer requires study drug|0|||
33555651|NCT01370525|62948453|FG000|Overall Study|Protocol Violation|2|||
33369332|NCT00690430|62748117|FG000|Core Phase|Lack of Efficacy|8|||
33369333|NCT00690430|62748118|FG001|Core Phase|Lack of Efficacy|10|||
33485036|NCT02799472|62862245|FG001|Overall Study|Lost to Follow-up|1|||
33485037|NCT03245450|62862258|FG000|Overall Study|Radiological disease progression|3|||
33485038|NCT03245450|62862259|FG001|Overall Study|Radiological disease progression|3|||
33485039|NCT03245450|62862260|FG002|Overall Study|Radiological disease progression|2|||
33485040|NCT03245450|62862261|FG003|Overall Study|Radiological disease progression|2|||
33555652|NCT01370525|62948454|FG001|Overall Study|Protocol Violation|1|||
33555653|NCT01370525|62948453|FG000|Overall Study|Lost to follow up|2|||
33485041|NCT03245450|62862262|FG004|Overall Study|Radiological disease progression|7|||
33485042|NCT03245450|62862263|FG005|Overall Study|Radiological disease progression|6|||
33485043|NCT03245450|62862264|FG006|Overall Study|Radiological disease progression|6|||
33485044|NCT03245450|62862258|FG000|Overall Study|Clinical disease progression|0|||
33485045|NCT03245450|62862259|FG001|Overall Study|Clinical disease progression|0|||
33485046|NCT03245450|62862260|FG002|Overall Study|Clinical disease progression|1|||
33485047|NCT03245450|62862261|FG003|Overall Study|Clinical disease progression|0|||
33485048|NCT03245450|62862262|FG004|Overall Study|Clinical disease progression|0|||
33555654|NCT01370525|62948454|FG001|Overall Study|Lost to follow up|6|||
33662007|NCT02700984|63092479|FG000|Overall Study|Physician Decision|0|||
33269509|NCT03850483|62641433|FG003|Follow-up for Stage 1|Adverse Event|0|||
33485049|NCT03245450|62862263|FG005|Overall Study|Clinical disease progression|2|||
33485050|NCT03245450|62862264|FG006|Overall Study|Clinical disease progression|0|||
33485051|NCT03245450|62862258|FG000|Overall Study|Other|0|||
33485052|NCT03245450|62862259|FG001|Overall Study|Other|0|||
33485053|NCT03245450|62862260|FG002|Overall Study|Other|0|||
33485054|NCT03245450|62862261|FG003|Overall Study|Other|1|||
33485055|NCT03245450|62862262|FG004|Overall Study|Other|1|||
33485056|NCT03245450|62862263|FG005|Overall Study|Other|1|||
33485057|NCT03245450|62862264|FG006|Overall Study|Other|1|||
33485058|NCT03245450|62862258|FG000|Overall Study|Withdrawal by Subject|0|||
33485059|NCT03245450|62862259|FG001|Overall Study|Withdrawal by Subject|1|||
33485060|NCT03245450|62862260|FG002|Overall Study|Withdrawal by Subject|0|||
33485061|NCT03245450|62862261|FG003|Overall Study|Withdrawal by Subject|0|||
33485062|NCT03245450|62862262|FG004|Overall Study|Withdrawal by Subject|0|||
33485063|NCT03245450|62862263|FG005|Overall Study|Withdrawal by Subject|0|||
33485064|NCT03245450|62862264|FG006|Overall Study|Withdrawal by Subject|0|||
33485065|NCT03245450|62862258|FG000|Overall Study|Adverse Event|0|||
33485066|NCT03245450|62862259|FG001|Overall Study|Adverse Event|0|||
33485067|NCT03245450|62862260|FG002|Overall Study|Adverse Event|0|||
33485068|NCT03245450|62862261|FG003|Overall Study|Adverse Event|0|||
33485069|NCT03245450|62862262|FG004|Overall Study|Adverse Event|1|||
33269510|NCT03850483|62641434|FG004|Follow-up for Stage 1|Adverse Event|0|||
33269511|NCT03850483|62641435|FG005|Follow-up for Stage 1|Adverse Event|1|||
33269512|NCT03850483|62641436|FG006|Follow-up for Stage 1|Adverse Event|0|||
33269513|NCT03850483|62641437|FG007|Follow-up for Stage 1|Adverse Event|0|||
33269514|NCT03850483|62641438|FG008|Follow-up for Stage 1|Adverse Event|0|||
33269515|NCT03850483|62641439|FG009|Follow-up for Stage 1|Adverse Event|0|||
33269516|NCT03850483|62641430|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
33269517|NCT03850483|62641431|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
33269518|NCT03850483|62641432|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
33369334|NCT00690430|62748119|FG002|Core Phase|Lack of Efficacy|0|||
33485070|NCT03245450|62862263|FG005|Overall Study|Adverse Event|0|||
33369335|NCT00690430|62748117|FG000|Core Phase|Administrative Problems|0|||
33369336|NCT00690430|62748118|FG001|Core Phase|Administrative Problems|1|||
33369337|NCT00690430|62748119|FG002|Core Phase|Administrative Problems|0|||
33369338|NCT00690430|62748117|FG000|Core Phase|Early Termination|0|||
33369339|NCT00690430|62748118|FG001|Core Phase|Early Termination|5|||
33369340|NCT00690430|62748119|FG002|Core Phase|Early Termination|0|||
33369341|NCT00690430|62748117|FG000|Extension Phase|Lack of Efficacy|3|||
33369342|NCT00690430|62748118|FG001|Extension Phase|Lack of Efficacy|1|||
33369343|NCT00690430|62748119|FG002|Extension Phase|Lack of Efficacy|4|||
33369344|NCT00690430|62748117|FG000|Extension Phase|Abnormal Lab Values|1|||
33369345|NCT00690430|62748118|FG001|Extension Phase|Abnormal Lab Values|0|||
33369346|NCT00690430|62748119|FG002|Extension Phase|Abnormal Lab Values|0|||
33369347|NCT00690430|62748117|FG000|Extension Phase|Abnormal test procedure results|1|||
33369348|NCT00690430|62748118|FG001|Extension Phase|Abnormal test procedure results|0|||
33369349|NCT00690430|62748119|FG002|Extension Phase|Abnormal test procedure results|0|||
33369350|NCT00690430|62748117|FG000|Extension Phase|Administrative Problems|0|||
33369351|NCT00690430|62748118|FG001|Extension Phase|Administrative Problems|1|||
33369352|NCT00690430|62748119|FG002|Extension Phase|Administrative Problems|1|||
33369353|NCT00690430|62748117|FG000|Extension Phase|Adverse Event|2|||
33369354|NCT00690430|62748118|FG001|Extension Phase|Adverse Event|1|||
33369355|NCT00690430|62748119|FG002|Extension Phase|Adverse Event|2|||
33369356|NCT00690430|62748117|FG000|Extension Phase|Death|1|||
33369357|NCT00690430|62748118|FG001|Extension Phase|Death|1|||
33369358|NCT00690430|62748119|FG002|Extension Phase|Death|1|||
33369359|NCT00690430|62748117|FG000|Extension Phase|Withdrawal by Subject|0|||
33369360|NCT00690430|62748118|FG001|Extension Phase|Withdrawal by Subject|0|||
33369361|NCT00690430|62748119|FG002|Extension Phase|Withdrawal by Subject|2|||
33369362|NCT00690430|62748117|FG000|Extension Phase|Early Termination|10|||
33369363|NCT00690430|62748118|FG001|Extension Phase|Early Termination|1|||
33369364|NCT00690430|62748119|FG002|Extension Phase|Early Termination|3|||
33369365|NCT00863330|62748128|FG000|Overall Study|study terminated early due to administra|6|||
33369366|NCT00688324|62748132|FG000|Overall Study|Withdrawal by Subject|2|||
33369367|NCT00688324|62748132|FG000|Overall Study|Physician Decision|5|||
33369368|NCT00688324|62748132|FG000|Overall Study|Lost to Follow-up|1|||
33369369|NCT00862940|62748139|FG000|Overall Study|Adverse Event|15|||
33485071|NCT03245450|62862264|FG006|Overall Study|Adverse Event|2|||
33485072|NCT03712917|62862289|FG000|Overall Study|Pregnancy|0|||
33269519|NCT03850483|62641433|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
33369370|NCT00862940|62748140|FG001|Overall Study|Adverse Event|12|||
33369371|NCT00862940|62748139|FG000|Overall Study|Lack of Efficacy|1|||
33369372|NCT00862940|62748140|FG001|Overall Study|Lack of Efficacy|3|||
33369373|NCT00862940|62748139|FG000|Overall Study|Protocol Violation|2|||
33485073|NCT03712917|62862290|FG001|Overall Study|Pregnancy|0|||
33485074|NCT03712917|62862291|FG002|Overall Study|Pregnancy|1|||
33485075|NCT03712917|62862289|FG000|Overall Study|Adverse Event|0|||
33485076|NCT03712917|62862290|FG001|Overall Study|Adverse Event|4|||
33485077|NCT03712917|62862291|FG002|Overall Study|Adverse Event|3|||
33485078|NCT03712917|62862289|FG000|Overall Study|Lost to Follow-up|9|||
33485079|NCT03712917|62862290|FG001|Overall Study|Lost to Follow-up|4|||
33485080|NCT03712917|62862291|FG002|Overall Study|Lost to Follow-up|5|||
33485081|NCT02748694|62862314|FG000|Overall Study|Voluntary Withdrawal|0|||
33485082|NCT02748694|62862315|FG001|Overall Study|Voluntary Withdrawal|0|||
33485083|NCT02748694|62862316|FG002|Overall Study|Voluntary Withdrawal|0|||
33485084|NCT02748694|62862317|FG003|Overall Study|Voluntary Withdrawal|0|||
33485085|NCT02748694|62862318|FG004|Overall Study|Voluntary Withdrawal|0|||
33485086|NCT02748694|62862319|FG005|Overall Study|Voluntary Withdrawal|0|||
33485087|NCT02748694|62862320|FG006|Overall Study|Voluntary Withdrawal|0|||
33485088|NCT02748694|62862321|FG007|Overall Study|Voluntary Withdrawal|0|||
33485089|NCT02748694|62862322|FG008|Overall Study|Voluntary Withdrawal|0|||
33485090|NCT02748694|62862323|FG009|Overall Study|Voluntary Withdrawal|0|||
33485091|NCT02748694|62862324|FG010|Overall Study|Voluntary Withdrawal|0|||
33485092|NCT02748694|62862325|FG011|Overall Study|Voluntary Withdrawal|0|||
33485093|NCT02748694|62862326|FG012|Overall Study|Voluntary Withdrawal|0|||
33485094|NCT02748694|62862327|FG013|Overall Study|Voluntary Withdrawal|0|||
33485095|NCT02748694|62862328|FG014|Overall Study|Voluntary Withdrawal|2|||
33485096|NCT02800642|62862384|FG000|Overall Study|Death|3|||
33485097|NCT02800642|62862384|FG000|Overall Study|Other|10|||
33485098|NCT02800642|62862384|FG000|Overall Study|Physician Decision|2|||
33485099|NCT02800642|62862384|FG000|Overall Study|Adverse Event|6|||
33485100|NCT02800642|62862384|FG000|Overall Study|Withdrawal by Subject|3|||
33485101|NCT02800642|62862384|FG000|Overall Study|Lost to Follow-up|1|||
33485102|NCT02799784|62862388|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
33485103|NCT02799784|62862389|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
33485104|NCT02799784|62862388|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
33485105|NCT02799784|62862389|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
33269520|NCT03850483|62641434|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
33269521|NCT03850483|62641435|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
33269522|NCT03850483|62641436|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
33269523|NCT03850483|62641437|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
33269524|NCT03850483|62641438|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
33269525|NCT03850483|62641439|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
33269526|NCT03850483|62641430|FG000|Follow-up for Stage 1|Other|0|||
33269527|NCT03850483|62641431|FG001|Follow-up for Stage 1|Other|2|||
33269528|NCT03850483|62641432|FG002|Follow-up for Stage 1|Other|0|||
33269529|NCT03850483|62641433|FG003|Follow-up for Stage 1|Other|2|||
33269530|NCT03850483|62641434|FG004|Follow-up for Stage 1|Other|0|||
33555655|NCT02792777|62948462|FG000|Overall Study|Withdrawal by Subject|2|||
33555656|NCT02792777|62948463|FG001|Overall Study|Withdrawal by Subject|0|||
33555657|NCT02792777|62948462|FG000|Overall Study|Recording malfunction|2|||
33555658|NCT02792777|62948463|FG001|Overall Study|Recording malfunction|0|||
33555659|NCT02792777|62948462|FG000|Overall Study|Later determined to be ineligible|2|||
33269531|NCT03850483|62641435|FG005|Follow-up for Stage 1|Other|1|||
33269532|NCT03850483|62641436|FG006|Follow-up for Stage 1|Other|0|||
33269533|NCT03850483|62641437|FG007|Follow-up for Stage 1|Other|0|||
33269534|NCT03850483|62641438|FG008|Follow-up for Stage 1|Other|0|||
33269535|NCT03850483|62641439|FG009|Follow-up for Stage 1|Other|0|||
33269536|NCT03850483|62641430|FG000|Treatment for Stage 2|Adverse Event|0|||
33269537|NCT03850483|62641431|FG001|Treatment for Stage 2|Adverse Event|0|||
33269538|NCT03850483|62641432|FG002|Treatment for Stage 2|Adverse Event|0|||
33269539|NCT03850483|62641433|FG003|Treatment for Stage 2|Adverse Event|0|||
33269540|NCT03850483|62641434|FG004|Treatment for Stage 2|Adverse Event|0|||
33269541|NCT03850483|62641435|FG005|Treatment for Stage 2|Adverse Event|0|||
33269542|NCT03850483|62641436|FG006|Treatment for Stage 2|Adverse Event|0|||
33269543|NCT03850483|62641437|FG007|Treatment for Stage 2|Adverse Event|0|||
33269544|NCT03850483|62641438|FG008|Treatment for Stage 2|Adverse Event|0|||
33269545|NCT03850483|62641439|FG009|Treatment for Stage 2|Adverse Event|1|||
33269546|NCT03850483|62641430|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
33269547|NCT03850483|62641431|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
33485106|NCT02799784|62862388|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
33485107|NCT02799784|62862389|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
33485108|NCT02799784|62862388|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
33485109|NCT02799784|62862389|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
33485110|NCT02799784|62862388|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
33485111|NCT02799784|62862389|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
33485112|NCT02799784|62862388|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
33555660|NCT02792777|62948463|FG001|Overall Study|Later determined to be ineligible|0|||
33269548|NCT03850483|62641432|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
33269549|NCT03850483|62641433|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
33269550|NCT03850483|62641434|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
33269551|NCT03850483|62641435|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
33485113|NCT02799784|62862389|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
33485114|NCT01333072|62862397|FG000|Overall Study|Lost to Follow-up|3|||
33485115|NCT01333072|62862398|FG001|Overall Study|Lost to Follow-up|0|||
33485116|NCT01333072|62862397|FG000|Overall Study|Adverse Event|2|||
33485117|NCT01333072|62862398|FG001|Overall Study|Adverse Event|4|||
33485118|NCT01333072|62862397|FG000|Overall Study|Physician Decision|1|||
33485119|NCT01333072|62862398|FG001|Overall Study|Physician Decision|0|||
33485120|NCT01315353|62862407|FG000|Overall Study|Death|2|||
33485121|NCT01315353|62862408|FG001|Overall Study|Death|1|||
33485122|NCT01315353|62862409|FG002|Overall Study|Death|0|||
33485123|NCT01315353|62862407|FG000|Overall Study|Withdrawal by Subject|2|||
33485124|NCT01315353|62862408|FG001|Overall Study|Withdrawal by Subject|6|||
33485125|NCT01315353|62862409|FG002|Overall Study|Withdrawal by Subject|1|||
33485126|NCT01315353|62862407|FG000|Overall Study|Lost to Follow-up|13|||
33485127|NCT01315353|62862408|FG001|Overall Study|Lost to Follow-up|6|||
33485128|NCT01315353|62862409|FG002|Overall Study|Lost to Follow-up|6|||
33269552|NCT03850483|62641436|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
33269553|NCT03850483|62641437|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
33269554|NCT03850483|62641438|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
33269555|NCT03850483|62641439|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
33269556|NCT03850483|62641430|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
33269557|NCT03850483|62641431|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
33269558|NCT03850483|62641432|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
33269559|NCT03850483|62641433|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
33269560|NCT03850483|62641434|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
33485129|NCT01315353|62862407|FG000|Overall Study|Unwilling to adhere to requirements|5|||
33485130|NCT01315353|62862408|FG001|Overall Study|Unwilling to adhere to requirements|5|||
33485131|NCT01315353|62862409|FG002|Overall Study|Unwilling to adhere to requirements|4|||
33485132|NCT01315353|62862407|FG000|Overall Study|Site closing|7|||
33485133|NCT01315353|62862408|FG001|Overall Study|Site closing|4|||
33485134|NCT01315353|62862409|FG002|Overall Study|Site closing|0|||
33485135|NCT01315353|62862407|FG000|Overall Study|Taken off study by site in error|0|||
33485136|NCT01315353|62862408|FG001|Overall Study|Taken off study by site in error|1|||
33485137|NCT01315353|62862409|FG002|Overall Study|Taken off study by site in error|0|||
33485138|NCT01315353|62862407|FG000|Overall Study|Inadvertent randomization/assignment|0|||
33485139|NCT01315353|62862408|FG001|Overall Study|Inadvertent randomization/assignment|0|||
33485140|NCT01315353|62862409|FG002|Overall Study|Inadvertent randomization/assignment|2|||
33485141|NCT03712449|62862419|FG000|Overall Study|Withdraw Consent|0|||
33485142|NCT03712449|62862420|FG001|Overall Study|Withdraw Consent|1|||
33485143|NCT03517540|62862430|FG000|Overall Study|Protocol Violation|2|||
33485144|NCT03517540|62862431|FG001|Overall Study|Protocol Violation|0|||
33485145|NCT03517540|62862432|FG002|Overall Study|Protocol Violation|0|||
33485146|NCT03517540|62862433|FG003|Overall Study|Protocol Violation|1|||
33485147|NCT03517540|62862430|FG000|Overall Study|Adverse Event|9|||
33485148|NCT03517540|62862431|FG001|Overall Study|Adverse Event|3|||
33485149|NCT03517540|62862432|FG002|Overall Study|Adverse Event|8|||
33485150|NCT03517540|62862433|FG003|Overall Study|Adverse Event|1|||
33485151|NCT03517540|62862430|FG000|Overall Study|Withdrawal by Subject|3|||
33485152|NCT03517540|62862431|FG001|Overall Study|Withdrawal by Subject|4|||
33485153|NCT03517540|62862432|FG002|Overall Study|Withdrawal by Subject|1|||
33485154|NCT03517540|62862433|FG003|Overall Study|Withdrawal by Subject|3|||
33485155|NCT02799082|62862445|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
33485156|NCT02799082|62862446|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
33485157|NCT02799082|62862445|FG000|Overall Study|Protocol Violation|0|||
33485158|NCT02799082|62862446|FG001|Overall Study|Protocol Violation|1|||
33485159|NCT03710889|62862452|FG000|Overall Study|Adverse Event|2|||
33485160|NCT03710889|62862452|FG000|Overall Study|Protocol Deviation|1|||
33485161|NCT02797678|62862456|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
33485162|NCT02797678|62862457|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
33485163|NCT02797678|62862458|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
33485164|NCT02797678|62862459|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
33485165|NCT02797678|62862456|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
33485166|NCT02797678|62862457|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
33485167|NCT02797678|62862458|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
33485168|NCT02797678|62862459|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
33485169|NCT02797678|62862456|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
33485170|NCT02797678|62862457|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
33485171|NCT02797678|62862458|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
33485172|NCT02797678|62862459|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
33485173|NCT03308942|62862477|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
33269561|NCT03850483|62641435|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
33269562|NCT03850483|62641436|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
33269563|NCT03850483|62641437|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
33485174|NCT03308942|62862478|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
33485175|NCT03308942|62862479|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
33485176|NCT03308942|62862480|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
33485177|NCT03308942|62862481|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
33485178|NCT03308942|62862477|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
33485179|NCT03308942|62862478|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
33485180|NCT03308942|62862479|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
33485181|NCT03308942|62862480|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
33485182|NCT03308942|62862481|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
33485183|NCT03308942|62862477|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
33485184|NCT03308942|62862478|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
33485185|NCT03308942|62862479|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
33485186|NCT03308942|62862480|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
33485187|NCT03308942|62862481|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
33485188|NCT03308942|62862477|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
33485189|NCT03308942|62862478|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
33485190|NCT03308942|62862479|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
33485191|NCT03308942|62862480|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
33485192|NCT03308942|62862481|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
33485193|NCT03308942|62862477|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
33485194|NCT03308942|62862478|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
33485195|NCT03308942|62862479|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
33485196|NCT03308942|62862480|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
33485197|NCT03308942|62862481|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
33485198|NCT03308942|62862477|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
33485199|NCT03308942|62862478|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
33485200|NCT03308942|62862479|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
33485201|NCT03308942|62862480|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
33485202|NCT03308942|62862481|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
33485203|NCT03308942|62862477|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
33485204|NCT03308942|62862478|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
33485205|NCT03308942|62862479|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
33485206|NCT03308942|62862480|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
33485207|NCT03308942|62862481|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
33485208|NCT03308786|62862494|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
33485209|NCT03274076|62862501|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
33485210|NCT03274076|62862502|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
33485211|NCT03274076|62862503|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
33485212|NCT03274076|62862504|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
33485213|NCT03274076|62862501|FG000|24 Weeks Open Label|Adverse Event|0|||
33485214|NCT03274076|62862502|FG001|24 Weeks Open Label|Adverse Event|0|||
33485215|NCT03274076|62862503|FG002|24 Weeks Open Label|Adverse Event|2|||
33485216|NCT03274076|62862504|FG003|24 Weeks Open Label|Adverse Event|0|||
33485217|NCT03274076|62862501|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
33485218|NCT03274076|62862502|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
33485219|NCT03274076|62862503|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
33485220|NCT03274076|62862504|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
33485221|NCT02797522|62862534|FG000|Overall Study|Study Terminated by Sponsor|0|||
33485222|NCT02797522|62862535|FG001|Overall Study|Study Terminated by Sponsor|0|||
33485223|NCT02797522|62862536|FG002|Overall Study|Study Terminated by Sponsor|0|||
33485224|NCT02797522|62862537|FG003|Overall Study|Study Terminated by Sponsor|0|||
33485225|NCT02797522|62862538|FG004|Overall Study|Study Terminated by Sponsor|0|||
33485226|NCT02797522|62862539|FG005|Overall Study|Study Terminated by Sponsor|0|||
33485227|NCT02797522|62862540|FG006|Overall Study|Study Terminated by Sponsor|0|||
33485228|NCT02797522|62862541|FG007|Overall Study|Study Terminated by Sponsor|4|||
33485229|NCT02797522|62862542|FG008|Overall Study|Study Terminated by Sponsor|2|||
33485230|NCT02797522|62862543|FG009|Overall Study|Study Terminated by Sponsor|4|||
33485231|NCT02797522|62862544|FG010|Overall Study|Study Terminated by Sponsor|1|||
33485232|NCT02659514|62862583|FG000|Overall Study|Adverse Event|3|||
33485233|NCT02659514|62862584|FG001|Overall Study|Adverse Event|12|||
33485234|NCT02659514|62862583|FG000|Overall Study|Disease Progression|23|||
33485235|NCT02659514|62862584|FG001|Overall Study|Disease Progression|13|||
33485236|NCT02659514|62862583|FG000|Overall Study|Withdrawal by Subject|0|||
33485237|NCT02659514|62862584|FG001|Overall Study|Withdrawal by Subject|4|||
33485238|NCT02659514|62862583|FG000|Overall Study|Lost to Follow-up|0|||
33485239|NCT02659514|62862584|FG001|Overall Study|Lost to Follow-up|1|||
33485240|NCT02659514|62862583|FG000|Overall Study|Death|6|||
33485241|NCT02659514|62862584|FG001|Overall Study|Death|1|||
33485242|NCT02659514|62862583|FG000|Overall Study|Reason Unspecified|0|||
33485243|NCT02659514|62862584|FG001|Overall Study|Reason Unspecified|3|||
33485244|NCT04570670|62862592|FG000|Overall Study|Withdrawal by Subject|1|||
33485245|NCT04570670|62862593|FG001|Overall Study|Withdrawal by Subject|0|||
33485246|NCT02797132|62862599|FG000|Part A (15 Days)|Adverse Event|1|||
33485247|NCT02797132|62862599|FG000|Part B (24 Weeks)|Adverse Event|3|||
33485248|NCT03270644|62862612|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
33485249|NCT03270644|62862612|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
33485250|NCT03269552|62862623|FG000|Overall Study|Adverse Event|2|||
33485251|NCT02796664|62862630|FG000|Overall Study|Withdrawal by Subject|0|||
33485252|NCT02796664|62862631|FG001|Overall Study|Withdrawal by Subject|3|||
33485253|NCT02796664|62862630|FG000|Overall Study|Noncompliance|1|||
33485254|NCT02796664|62862631|FG001|Overall Study|Noncompliance|1|||
33485255|NCT02796664|62862630|FG000|Overall Study|Death|0|||
33485256|NCT02796664|62862631|FG001|Overall Study|Death|1|||
33485257|NCT01370356|62862641|FG000|Overall Study|Death|1|||
33485258|NCT01370356|62862642|FG001|Overall Study|Death|0|||
33485259|NCT01370356|62862641|FG000|Overall Study|Lack of Efficacy|6|||
33485260|NCT01370356|62862642|FG001|Overall Study|Lack of Efficacy|28|||
33485261|NCT01370356|62862641|FG000|Overall Study|Lost to Follow-up|76|||
33485262|NCT01370356|62862642|FG001|Overall Study|Lost to Follow-up|81|||
33485263|NCT01370356|62862641|FG000|Overall Study|Withdrawal by Subject|54|||
33485264|NCT01370356|62862642|FG001|Overall Study|Withdrawal by Subject|59|||
33485265|NCT01370356|62862641|FG000|Overall Study|Reason not specified|39|||
33485266|NCT01370356|62862642|FG001|Overall Study|Reason not specified|43|||
33485267|NCT01370356|62862641|FG000|Overall Study|Protocol Violation|3|||
33485268|NCT01370356|62862642|FG001|Overall Study|Protocol Violation|3|||
33485269|NCT01370356|62862641|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
33485270|NCT01370356|62862642|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
33485271|NCT01370356|62862641|FG000|Overall Study|AE Not Related to Study Drug|1|||
33485272|NCT01370356|62862642|FG001|Overall Study|AE Not Related to Study Drug|4|||
33369374|NCT00862940|62748140|FG001|Overall Study|Protocol Violation|5|||
33369375|NCT00862940|62748139|FG000|Overall Study|Withdrawal by Subject|4|||
33369376|NCT00862940|62748140|FG001|Overall Study|Withdrawal by Subject|6|||
33369377|NCT00862940|62748139|FG000|Overall Study|Non-compliance|4|||
33369378|NCT00862940|62748140|FG001|Overall Study|Non-compliance|0|||
33369379|NCT00862940|62748139|FG000|Overall Study|Lost to Follow-up|0|||
33369380|NCT00862940|62748140|FG001|Overall Study|Lost to Follow-up|1|||
33369381|NCT00862940|62748139|FG000|Overall Study|Administrative or other reason(s)|4|||
33369382|NCT00862940|62748140|FG001|Overall Study|Administrative or other reason(s)|3|||
33369383|NCT00868166|62748148|FG000|Overall Study|Death|58|||
33369384|NCT00868166|62748149|FG001|Overall Study|Death|65|||
33369385|NCT00868166|62748148|FG000|Overall Study|Withdrawal by Subject|33|||
33369386|NCT00868166|62748149|FG001|Overall Study|Withdrawal by Subject|25|||
33369387|NCT00868166|62748148|FG000|Overall Study|Protocol Violation|1|||
33369388|NCT00868166|62748149|FG001|Overall Study|Protocol Violation|0|||
33369389|NCT00868166|62748148|FG000|Overall Study|Lost to Follow-up|1|||
33369390|NCT00868166|62748149|FG001|Overall Study|Lost to Follow-up|3|||
33369391|NCT00868166|62748148|FG000|Overall Study|Adverse Event|9|||
33369392|NCT00868166|62748149|FG001|Overall Study|Adverse Event|10|||
33369393|NCT00868166|62748148|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
33369394|NCT00868166|62748149|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
33369395|NCT00868166|62748148|FG000|Overall Study|Non-compliance with IMP|1|||
33369396|NCT00868166|62748149|FG001|Overall Study|Non-compliance with IMP|1|||
33369397|NCT00858780|62748155|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
33369398|NCT00858780|62748156|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
33369399|NCT00858780|62748157|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
33369400|NCT00858780|62748158|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
33369401|NCT00858780|62748159|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
33369402|NCT00858780|62748155|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
33369403|NCT00858780|62748156|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
33485273|NCT02794870|62862650|FG000|Overall Study|Withdrawal by Subject|2|||
33485274|NCT02794870|62862651|FG001|Overall Study|Withdrawal by Subject|0|||
33485275|NCT01370590|62862659|FG000|Period 1|Adverse Event|8|||
33485276|NCT01370590|62862660|FG001|Period 1|Adverse Event|4|||
33485277|NCT01370590|62862659|FG000|Period 1|Lost to Follow-up|2|||
33485278|NCT01370590|62862660|FG001|Period 1|Lost to Follow-up|2|||
33485279|NCT01370590|62862659|FG000|Period 1|Protocol Violation|2|||
33485280|NCT01370590|62862660|FG001|Period 1|Protocol Violation|2|||
33485281|NCT01370590|62862659|FG000|Period 1|Withdrawal by Subject|4|||
33485282|NCT01370590|62862660|FG001|Period 1|Withdrawal by Subject|2|||
33369404|NCT00858780|62748157|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
33369405|NCT00858780|62748158|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
33485283|NCT01370590|62862659|FG000|Period 1|Could not access randomization system|0|||
33485284|NCT01370590|62862660|FG001|Period 1|Could not access randomization system|1|||
33485285|NCT01370590|62862659|FG000|Crossover Washout Period|Adverse Event|1|||
33485286|NCT01370590|62862660|FG001|Crossover Washout Period|Adverse Event|4|||
33485287|NCT01370590|62862659|FG000|Crossover Washout Period|Lost to Follow-up|2|||
33369406|NCT00858780|62748159|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
33369407|NCT00858780|62748155|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
33369408|NCT00858780|62748156|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
33369409|NCT00858780|62748157|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
33369410|NCT00858780|62748158|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
33369411|NCT00858780|62748159|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
33485288|NCT01370590|62862660|FG001|Crossover Washout Period|Lost to Follow-up|0|||
33485289|NCT01370590|62862659|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
33485290|NCT01370590|62862660|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
33269564|NCT03850483|62641438|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
33269565|NCT03850483|62641439|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
33269566|NCT03850483|62641430|FG000|Treatment for Stage 2|Physician Decision|0|||
33269567|NCT03850483|62641431|FG001|Treatment for Stage 2|Physician Decision|0|||
33269568|NCT03850483|62641432|FG002|Treatment for Stage 2|Physician Decision|0|||
33269569|NCT03850483|62641433|FG003|Treatment for Stage 2|Physician Decision|0|||
33269570|NCT03850483|62641434|FG004|Treatment for Stage 2|Physician Decision|0|||
33269571|NCT03850483|62641435|FG005|Treatment for Stage 2|Physician Decision|0|||
33269572|NCT03850483|62641436|FG006|Treatment for Stage 2|Physician Decision|0|||
33269573|NCT03850483|62641437|FG007|Treatment for Stage 2|Physician Decision|0|||
33269574|NCT03850483|62641438|FG008|Treatment for Stage 2|Physician Decision|0|||
33269575|NCT03850483|62641439|FG009|Treatment for Stage 2|Physician Decision|1|||
33269576|NCT03850483|62641430|FG000|Treatment for Stage 2|Protocol Violation|0|||
33269577|NCT03850483|62641431|FG001|Treatment for Stage 2|Protocol Violation|0|||
33269578|NCT03850483|62641432|FG002|Treatment for Stage 2|Protocol Violation|0|||
33269579|NCT03850483|62641433|FG003|Treatment for Stage 2|Protocol Violation|0|||
33269580|NCT03850483|62641434|FG004|Treatment for Stage 2|Protocol Violation|0|||
33269581|NCT03850483|62641435|FG005|Treatment for Stage 2|Protocol Violation|0|||
33269582|NCT03850483|62641436|FG006|Treatment for Stage 2|Protocol Violation|0|||
33269583|NCT03850483|62641437|FG007|Treatment for Stage 2|Protocol Violation|0|||
33269584|NCT03850483|62641438|FG008|Treatment for Stage 2|Protocol Violation|1|||
33269585|NCT03850483|62641439|FG009|Treatment for Stage 2|Protocol Violation|0|||
33269586|NCT03850483|62641430|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
33269587|NCT03850483|62641431|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
33269588|NCT03850483|62641432|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
33269589|NCT03850483|62641433|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
33269590|NCT03850483|62641434|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
33269591|NCT03850483|62641435|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
33269592|NCT03850483|62641436|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
33269593|NCT03850483|62641437|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
33269594|NCT03850483|62641438|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
33269595|NCT03850483|62641439|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
33269596|NCT03850483|62641430|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33269597|NCT03850483|62641431|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33269598|NCT03850483|62641432|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33269599|NCT03850483|62641433|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33269600|NCT03850483|62641434|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33269601|NCT03850483|62641435|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33269602|NCT03850483|62641436|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33269603|NCT03850483|62641437|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33269604|NCT03850483|62641438|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33269605|NCT03850483|62641439|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
33269606|NCT03850483|62641430|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
33269607|NCT03850483|62641431|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
33269608|NCT03850483|62641432|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
33269609|NCT03850483|62641433|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
33369412|NCT00858780|62748155|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
33485291|NCT01370590|62862659|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
33485292|NCT01370590|62862660|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
33485293|NCT01370590|62862659|FG000|Period 2|Adverse Event|0|||
33485294|NCT01370590|62862660|FG001|Period 2|Adverse Event|1|||
33485295|NCT01370590|62862659|FG000|Period 2|Withdrawal by Subject|1|||
33485296|NCT01370590|62862660|FG001|Period 2|Withdrawal by Subject|1|||
33485297|NCT05200455|62862671|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
33485298|NCT04646109|62862678|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
33269610|NCT03850483|62641434|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
33269611|NCT03850483|62641435|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
33269612|NCT03850483|62641436|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
33269613|NCT03850483|62641437|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
33269614|NCT03850483|62641438|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
33485299|NCT04646109|62862679|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
33485300|NCT04502979|62862688|FG000|Overall Study|Lost to Follow-up|1|||
33485301|NCT04502979|62862689|FG001|Overall Study|Lost to Follow-up|3|||
33485302|NCT04502979|62862688|FG000|Overall Study|Withdrawal by Subject|2|||
33485303|NCT04502979|62862689|FG001|Overall Study|Withdrawal by Subject|1|||
33485304|NCT04590027|62862697|FG000|Overall Study|Lost to Follow-up|17|||
33485305|NCT04590027|62862698|FG001|Overall Study|Lost to Follow-up|14|||
33485306|NCT04590027|62862697|FG000|Overall Study|Protocol Violation|0|||
33485307|NCT04590027|62862698|FG001|Overall Study|Protocol Violation|3|||
33485308|NCT04587453|62862710|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
33485309|NCT04587453|62862711|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
33485310|NCT02793232|62862728|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
33485311|NCT02793232|62862729|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
33485312|NCT02793232|62862730|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
33485313|NCT02793232|62862731|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
33485314|NCT02793232|62862732|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
33485315|NCT02793232|62862733|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
33485316|NCT02793232|62862734|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
33485317|NCT02793232|62862735|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
33485318|NCT02793232|62862736|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
33485319|NCT04584645|62862772|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
33485320|NCT04584645|62862773|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
33485321|NCT03695367|62862799|FG000|Overall Study|Missed the Day 28 visit.|1|||
33485322|NCT03695367|62862800|FG001|Overall Study|Missed the Day 28 visit.|0|||
33485323|NCT03695367|62862799|FG000|Overall Study|Lost to Follow-up|0|||
33485324|NCT03695367|62862800|FG001|Overall Study|Lost to Follow-up|1|||
33485325|NCT03695367|62862799|FG000|Overall Study|Withdrawal by Subject|0|||
33485326|NCT03695367|62862800|FG001|Overall Study|Withdrawal by Subject|1|||
33485327|NCT03695367|62862799|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
33485328|NCT03695367|62862800|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
33485329|NCT02794480|62862808|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
33485330|NCT02794480|62862809|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
33485331|NCT02794480|62862810|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
33485332|NCT02794480|62862811|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
33485333|NCT02794480|62862808|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
33485334|NCT02794480|62862809|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
33485335|NCT02794480|62862810|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
33485336|NCT02794480|62862811|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
33485337|NCT02794480|62862808|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33485338|NCT02794480|62862809|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33485339|NCT02794480|62862810|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33485340|NCT02794480|62862811|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
33485341|NCT02794480|62862808|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33485342|NCT02794480|62862809|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
33485343|NCT02794480|62862810|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33485344|NCT02794480|62862811|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
33485345|NCT02794480|62862808|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
33485346|NCT02794480|62862809|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33485347|NCT02794480|62862810|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33485348|NCT02794480|62862811|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
33485349|NCT04558125|62862819|FG000|Overall Study|Death|1|||
33485350|NCT02793622|62862825|FG000|Overall Study|Lost to Follow-up|31|||
33485351|NCT02793622|62862826|FG001|Overall Study|Lost to Follow-up|19|||
33485352|NCT02793622|62862825|FG000|Overall Study|Withdrawal by Subject|21|||
33485353|NCT02793622|62862826|FG001|Overall Study|Withdrawal by Subject|17|||
33485354|NCT02793622|62862825|FG000|Overall Study|Adverse Event|0|||
33485355|NCT02793622|62862826|FG001|Overall Study|Adverse Event|1|||
33485356|NCT02793622|62862825|FG000|Overall Study|Protocol Violation|1|||
33485357|NCT02793622|62862826|FG001|Overall Study|Protocol Violation|5|||
33485358|NCT04493931|62862839|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
33485359|NCT04493931|62862840|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
33485360|NCT04493931|62862841|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
33485361|NCT04493931|62862842|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
33485362|NCT04493931|62862843|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
33485363|NCT04493931|62862844|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
33485364|NCT04493931|62862845|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
33662008|NCT02700984|63092480|FG001|Overall Study|Physician Decision|1|||
33485365|NCT04493931|62862839|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
33485366|NCT04493931|62862840|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
33485367|NCT04493931|62862841|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
33485368|NCT04493931|62862842|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
33485369|NCT04493931|62862843|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
33485370|NCT04493931|62862844|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
33485371|NCT04493931|62862845|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
33485372|NCT04493931|62862839|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
33485373|NCT04493931|62862840|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
33485374|NCT04493931|62862841|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
33485375|NCT04493931|62862842|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
33485376|NCT04493931|62862843|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
33485377|NCT04493931|62862844|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
33485378|NCT04493931|62862845|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
33485379|NCT04493931|62862839|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
33485380|NCT04493931|62862840|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
33485381|NCT04493931|62862841|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
33485382|NCT04493931|62862842|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
33485383|NCT04493931|62862843|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
33485384|NCT04493931|62862844|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
33485385|NCT04493931|62862845|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
33485386|NCT03437278|62862878|FG000|Overall Study|Adverse Event|0|||
33485387|NCT03437278|62862879|FG001|Overall Study|Adverse Event|0|||
33485388|NCT03437278|62862880|FG002|Overall Study|Adverse Event|1|||
33485389|NCT03437278|62862878|FG000|Overall Study|Progressive disease|1|||
33485390|NCT03437278|62862879|FG001|Overall Study|Progressive disease|0|||
33485391|NCT03437278|62862880|FG002|Overall Study|Progressive disease|0|||
33485392|NCT03437278|62862878|FG000|Overall Study|Physician Decision|1|||
33485393|NCT03437278|62862879|FG001|Overall Study|Physician Decision|0|||
33485394|NCT03437278|62862880|FG002|Overall Study|Physician Decision|1|||
33485395|NCT04553913|62862890|FG000|Overall Study|patient's block resolved prior to PACU|1|||
33485396|NCT04553913|62862890|FG000|Overall Study|did not use the device properly|5|||
33485397|NCT04490499|62862895|FG000|Overall Study|Withdrawal by Subject|2|||
33485398|NCT01332994|62862899|FG000|Overall Study|Adverse Event|34|||
33485399|NCT01332994|62862899|FG000|Overall Study|Death|1|||
33485400|NCT01332994|62862899|FG000|Overall Study|Lack of Efficacy|1|||
33485401|NCT01332994|62862899|FG000|Overall Study|Lost to Follow-up|4|||
33485402|NCT01332994|62862899|FG000|Overall Study|Protocol Violation|6|||
33485403|NCT01332994|62862899|FG000|Overall Study|Withdrawal by Subject|15|||
33485404|NCT01332994|62862899|FG000|Overall Study|Administrative Problem|2|||
33485405|NCT01332994|62862899|FG000|Overall Study|Other|8|||
33485406|NCT03698331|62862905|FG000|Overall Study|Adverse Event|2|||
33485407|NCT03698331|62862906|FG001|Overall Study|Adverse Event|3|||
33485408|NCT03698331|62862905|FG000|Overall Study|Withdrawal by Subject|1|||
33485409|NCT03698331|62862906|FG001|Overall Study|Withdrawal by Subject|1|||
33485410|NCT03698331|62862905|FG000|Overall Study|Lost to Follow-up|0|||
33485411|NCT03698331|62862906|FG001|Overall Study|Lost to Follow-up|2|||
33485412|NCT03698331|62862905|FG000|Overall Study|Non-compliance with study drug|1|||
33485413|NCT03698331|62862906|FG001|Overall Study|Non-compliance with study drug|0|||
33485414|NCT04889625|62862912|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
33485415|NCT04889625|62862913|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
33485416|NCT04889625|62862912|FG000|Period 1|Subject out of window|0|||
33485417|NCT04889625|62862913|FG001|Period 1|Subject out of window|1|||
33485418|NCT04889625|62862912|FG000|Period 1|Wrong add power dispensed|0|||
33485419|NCT04889625|62862913|FG001|Period 1|Wrong add power dispensed|1|||
33485420|NCT04889625|62862912|FG000|Period 1|Discontinued due to fitting guide error|1|||
33485421|NCT04889625|62862913|FG001|Period 1|Discontinued due to fitting guide error|1|||
33485422|NCT04889625|62862912|FG000|Period 2|Test article no longer available|1|||
33485423|NCT04889625|62862913|FG001|Period 2|Test article no longer available|0|||
33485424|NCT04889625|62862912|FG000|Period 2|Incorrect lens dispensed|1|||
33485425|NCT04889625|62862913|FG001|Period 2|Incorrect lens dispensed|0|||
33555661|NCT02792777|62948462|FG000|Overall Study|Participant interviewed twice|1|||
33485426|NCT04889625|62862912|FG000|Period 2|Wrong add power dispensed|0|||
33485427|NCT04889625|62862913|FG001|Period 2|Wrong add power dispensed|1|||
33485428|NCT04883541|62862921|FG000|Overall Study|Not attending regular yoga class|16|||
33485429|NCT04883541|62862922|FG001|Overall Study|Not attending regular yoga class|0|||
33485430|NCT04883541|62862921|FG000|Overall Study|Not attending the pregnancy school|0|||
33485431|NCT04883541|62862922|FG001|Overall Study|Not attending the pregnancy school|9|||
33485432|NCT04882995|62862930|FG000|Overall Study|Withdrawal by Subject|1|||
33485433|NCT04882995|62862931|FG001|Overall Study|Withdrawal by Subject|2|||
33485434|NCT04882995|62862930|FG000|Overall Study|Protocol Violation|4|||
33485435|NCT04882995|62862931|FG001|Overall Study|Protocol Violation|4|||
33485436|NCT04882995|62862930|FG000|Overall Study|Surgery postponed due to COVID|1|||
33485437|NCT04882995|62862931|FG001|Overall Study|Surgery postponed due to COVID|1|||
33485438|NCT04483011|62862939|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
33485439|NCT04483011|62862940|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
33485440|NCT04545567|62862950|FG000|Overall Study|tested positive for SARS-co-V2|1|||
33485441|NCT04545567|62862951|FG001|Overall Study|tested positive for SARS-co-V2|1|||
33485442|NCT04545567|62862950|FG000|Overall Study|Withdrawal by Subject|0|||
33485443|NCT04545567|62862951|FG001|Overall Study|Withdrawal by Subject|1|||
33485444|NCT04534491|62862957|FG000|Overall Study|Not completed end-of-study interview|24|||
33485445|NCT04534491|62862957|FG000|Overall Study|Non-users|70|||
33485446|NCT04534491|62862957|FG000|Overall Study|Non-verifiable users|58|||
33485447|NCT03694821|62862964|FG000|Overall Study|Study terminated|4|||
33485448|NCT03694821|62862965|FG001|Overall Study|Study terminated|8|||
33485449|NCT03694821|62862966|FG002|Overall Study|Study terminated|4|||
33485450|NCT04531527|62862974|FG000|Overall Study|Found to be Ineligible|3|||
33485451|NCT04474197|62862982|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
33485452|NCT04474197|62862983|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
33485453|NCT04474197|62862984|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
33485454|NCT04474197|62862985|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
33485455|NCT02079766|62863002|FG000|Overall Study|Physician Decision|1|||
33485456|NCT02079766|62863003|FG001|Overall Study|Physician Decision|0|||
33485457|NCT02079766|62863002|FG000|Overall Study|Withdrawal by Subject|1|||
33485458|NCT02079766|62863003|FG001|Overall Study|Withdrawal by Subject|0|||
33485459|NCT04841577|62863011|FG000|Overall Study|Adverse Event|5|||
33485460|NCT04841577|62863012|FG001|Overall Study|Adverse Event|10|||
33485461|NCT04841577|62863011|FG000|Overall Study|Lost to Follow-up|8|||
33485462|NCT04841577|62863012|FG001|Overall Study|Lost to Follow-up|7|||
33485463|NCT04841577|62863011|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
33485464|NCT04841577|62863012|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
33485465|NCT04841577|62863011|FG000|Overall Study|Other|0|||
33485466|NCT04841577|62863012|FG001|Overall Study|Other|1|||
33485467|NCT04529109|62863018|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
33485468|NCT04529109|62863019|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
33485469|NCT04528641|62863031|FG000|Overall Study|Withdrawal by Subject|0|||
33485470|NCT04528641|62863032|FG001|Overall Study|Withdrawal by Subject|0|||
33485471|NCT04528641|62863033|FG002|Overall Study|Withdrawal by Subject|0|||
33485472|NCT04528641|62863034|FG003|Overall Study|Withdrawal by Subject|1|||
33485473|NCT04528641|62863035|FG004|Overall Study|Withdrawal by Subject|0|||
33485474|NCT04528641|62863036|FG005|Overall Study|Withdrawal by Subject|1|||
33485475|NCT04527471|62863055|FG000|Overall Study|Adverse Event|1|||
33485476|NCT04527471|62863056|FG001|Overall Study|Adverse Event|0|||
33485477|NCT04527471|62863055|FG000|Overall Study|Lost to Follow-up|1|||
33485478|NCT04527471|62863056|FG001|Overall Study|Lost to Follow-up|0|||
33485479|NCT04471935|62863062|FG000|Overall Study|Withdrawal by Subject|1|||
33485480|NCT04471935|62863062|FG000|Overall Study|Deemed ineligible to participate|1|||
33485481|NCT04468347|62863070|FG000|Overall Study|Withdrawal by Subject|0|||
33485482|NCT04468347|62863071|FG001|Overall Study|Withdrawal by Subject|1|||
33485483|NCT04468347|62863072|FG002|Overall Study|Withdrawal by Subject|3|||
33485484|NCT04468347|62863073|FG003|Overall Study|Withdrawal by Subject|3|||
33485485|NCT04468347|62863070|FG000|Overall Study|Lost to Follow-up|0|||
33485486|NCT04468347|62863071|FG001|Overall Study|Lost to Follow-up|0|||
33485487|NCT04468347|62863072|FG002|Overall Study|Lost to Follow-up|1|||
33485488|NCT04468347|62863073|FG003|Overall Study|Lost to Follow-up|1|||
33485489|NCT04468347|62863070|FG000|Overall Study|Physician Decision|1|||
33485490|NCT04468347|62863071|FG001|Overall Study|Physician Decision|0|||
33485491|NCT04468347|62863072|FG002|Overall Study|Physician Decision|2|||
33485492|NCT04468347|62863073|FG003|Overall Study|Physician Decision|0|||
33485493|NCT04468347|62863070|FG000|Overall Study|Protocol Violation|1|||
33485494|NCT04468347|62863071|FG001|Overall Study|Protocol Violation|0|||
33485495|NCT04468347|62863072|FG002|Overall Study|Protocol Violation|0|||
33485496|NCT04468347|62863073|FG003|Overall Study|Protocol Violation|0|||
33485497|NCT04822701|62863089|FG000|Overall Study|Not treated|2|||
33485498|NCT04822701|62863090|FG001|Overall Study|Not treated|0|||
33485499|NCT04822701|62863089|FG000|Overall Study|Lost to Follow-up|1|||
33485500|NCT04822701|62863090|FG001|Overall Study|Lost to Follow-up|0|||
33555662|NCT02792777|62948463|FG001|Overall Study|Participant interviewed twice|0|||
33555663|NCT02625974|62948472|FG000|Overall Study|Adverse Event|12|||
33485501|NCT04822701|62863089|FG000|Overall Study|Withdrawal by Subject|1|||
33485502|NCT04822701|62863090|FG001|Overall Study|Withdrawal by Subject|0|||
33485503|NCT04461795|62863096|FG000|Overall Study|Lost to Follow-up|2|||
33485504|NCT04461795|62863096|FG000|Overall Study|Withdrawal by Subject|2|||
33555664|NCT02625974|62948473|FG001|Overall Study|Adverse Event|2|||
33269615|NCT03850483|62641439|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
33269616|NCT03850483|62641430|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
33269617|NCT03850483|62641431|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
33269618|NCT03850483|62641432|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
33269619|NCT03850483|62641433|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
33269620|NCT03850483|62641434|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
33269621|NCT03850483|62641435|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
33269622|NCT03850483|62641436|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
33269623|NCT03850483|62641437|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
33269624|NCT03850483|62641438|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
33269625|NCT03850483|62641439|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
33269626|NCT03850483|62641430|FG000|Follow-up For Stage 2|Other|0|||
33269627|NCT03850483|62641431|FG001|Follow-up For Stage 2|Other|0|||
33269628|NCT03850483|62641432|FG002|Follow-up For Stage 2|Other|0|||
33269629|NCT03850483|62641433|FG003|Follow-up For Stage 2|Other|0|||
33269630|NCT03850483|62641434|FG004|Follow-up For Stage 2|Other|0|||
33269631|NCT03850483|62641435|FG005|Follow-up For Stage 2|Other|0|||
33269632|NCT03850483|62641436|FG006|Follow-up For Stage 2|Other|0|||
33269633|NCT03850483|62641437|FG007|Follow-up For Stage 2|Other|0|||
33269634|NCT03850483|62641438|FG008|Follow-up For Stage 2|Other|0|||
33269635|NCT03850483|62641439|FG009|Follow-up For Stage 2|Other|1|||
33269636|NCT03473925|62641470|FG000|Overall Study|Death|48|||
33269637|NCT03473925|62641471|FG001|Overall Study|Death|44|||
33269638|NCT03473925|62641470|FG000|Overall Study|Sponsor Decision|2|||
33269639|NCT03473925|62641471|FG001|Overall Study|Sponsor Decision|7|||
33269640|NCT03473925|62641470|FG000|Overall Study|Withdrawal by Subject|1|||
33269641|NCT03473925|62641471|FG001|Overall Study|Withdrawal by Subject|3|||
33269642|NCT03473925|62641470|FG000|Overall Study|Not Treated|1|||
33269643|NCT03473925|62641471|FG001|Overall Study|Not Treated|1|||
33269644|NCT03230097|62641479|FG000|Overall Study|Adverse Event|2|||
33269645|NCT03230097|62641480|FG001|Overall Study|Adverse Event|1|||
33485505|NCT04461795|62863096|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
33485506|NCT04461015|62863103|FG000|Overall Study|IV access lost during the study|0|||
33485507|NCT04461015|62863104|FG001|Overall Study|IV access lost during the study|1|||
33485508|NCT04461015|62863103|FG000|Overall Study|Withdrawal by Subject|0|||
33485509|NCT04461015|62863104|FG001|Overall Study|Withdrawal by Subject|1|||
33485510|NCT04810221|62863110|FG000|Overall Study|Physician Decision|3|||
33485511|NCT03694353|62863114|FG000|Overall Study|Withdrawal by Subject|1|||
33485512|NCT03694353|62863114|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
33485513|NCT04521777|62863118|FG000|Overall Study|Death|2|||
33485514|NCT04521777|62863118|FG000|Overall Study|Withdrawal by Subject|2|||
33485515|NCT03700671|62863124|FG000|Overall Study|Lack of Efficacy|1|||
33485516|NCT03700671|62863125|FG001|Overall Study|Lack of Efficacy|2|||
33485517|NCT04764669|62863137|FG000|Overall Study|Adverse Event|1|||
33485518|NCT04764669|62863138|FG001|Overall Study|Adverse Event|0|||
33485519|NCT04764669|62863139|FG002|Overall Study|Adverse Event|1|||
33485520|NCT04764669|62863140|FG003|Overall Study|Adverse Event|0|||
33485521|NCT04764669|62863137|FG000|Overall Study|Subject Choice|0|||
33485522|NCT04764669|62863138|FG001|Overall Study|Subject Choice|0|||
33485523|NCT04764669|62863139|FG002|Overall Study|Subject Choice|1|||
33485524|NCT04764669|62863140|FG003|Overall Study|Subject Choice|0|||
33485525|NCT04764669|62863137|FG000|Overall Study|Withdrawal by Subject|2|||
33485526|NCT04764669|62863138|FG001|Overall Study|Withdrawal by Subject|0|||
33485527|NCT04764669|62863139|FG002|Overall Study|Withdrawal by Subject|0|||
33485528|NCT04764669|62863140|FG003|Overall Study|Withdrawal by Subject|0|||
33485529|NCT04439253|62863150|FG000|Overall Study|Adverse Event|1|||
33485530|NCT04439253|62863150|FG000|Overall Study|Disease progression|2|||
33485531|NCT04439253|62863150|FG000|Overall Study|Complicating disease|1|||
33485532|NCT04438785|62863156|FG000|Overall Study|change of weight, give up intervention|2|||
33485533|NCT04438785|62863157|FG001|Overall Study|change of weight, give up intervention|10|||
33485534|NCT04741503|62863165|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
33485535|NCT04741503|62863166|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
33485536|NCT04741503|62863167|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
33485537|NCT04741503|62863165|FG000|Initial Enrollment|Overquotas removed|0|||
33485538|NCT04741503|62863166|FG001|Initial Enrollment|Overquotas removed|0|||
33485539|NCT04741503|62863167|FG002|Initial Enrollment|Overquotas removed|186|||
33485540|NCT04741503|62863165|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
33485541|NCT04741503|62863166|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
33485542|NCT04741503|62863167|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
33485543|NCT04734873|62863176|FG000|Overall Study|Lost to Follow-up|1|||
33485544|NCT04734873|62863177|FG001|Overall Study|Lost to Follow-up|3|||
33662009|NCT02700984|63092479|FG000|Overall Study|Withdrawal by Subject|8|||
33269646|NCT03230097|62641479|FG000|Overall Study|non-compliance|0|||
33269647|NCT03230097|62641480|FG001|Overall Study|non-compliance|1|||
33269648|NCT03230097|62641479|FG000|Overall Study|Lost to Follow-up|2|||
33269649|NCT03230097|62641480|FG001|Overall Study|Lost to Follow-up|4|||
33269650|NCT03230097|62641479|FG000|Overall Study|Withdrawal by Subject|7|||
33485545|NCT04734873|62863178|FG002|Overall Study|Lost to Follow-up|2|||
33485546|NCT04734873|62863176|FG000|Overall Study|Randomized but not dosed|1|||
33485547|NCT04734873|62863177|FG001|Overall Study|Randomized but not dosed|0|||
33485548|NCT04734873|62863178|FG002|Overall Study|Randomized but not dosed|1|||
33485549|NCT04435665|62863190|FG000|Overall Study|Lost to Follow-up|0|||
33485550|NCT04435665|62863191|FG001|Overall Study|Lost to Follow-up|0|||
33485551|NCT04435665|62863192|FG002|Overall Study|Lost to Follow-up|0|||
33485552|NCT04435665|62863193|FG003|Overall Study|Lost to Follow-up|1|||
33485553|NCT04428411|62863203|FG000|Overall Study|Lost to Follow-up|114|||
33485554|NCT04422561|62863212|FG000|Overall Study|Lost to Follow-up|25|||
33485555|NCT04422561|62863213|FG001|Overall Study|Lost to Follow-up|11|||
33485556|NCT01369498|62863223|FG000|Overall Study|Lack of Efficacy|9|||
33485557|NCT01369498|62863224|FG001|Overall Study|Lack of Efficacy|9|||
33269651|NCT03230097|62641480|FG001|Overall Study|Withdrawal by Subject|3|||
33269652|NCT03230097|62641479|FG000|Overall Study|Trial termination|4|||
33269653|NCT03230097|62641480|FG001|Overall Study|Trial termination|5|||
33269654|NCT03230097|62641479|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
33269655|NCT03230097|62641480|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
33269656|NCT03230097|62641479|FG000|Overall Study|outcome event|0|||
33269657|NCT03230097|62641480|FG001|Overall Study|outcome event|1|||
33269658|NCT02803593|62641505|FG000|Overall Study|Lost to Follow-up|17|||
33269659|NCT02803593|62641506|FG001|Overall Study|Lost to Follow-up|35|||
33269660|NCT02663908|62641514|FG000|Overall Study|Withdrawal by Subject|8|||
33269661|NCT02663908|62641515|FG001|Overall Study|Withdrawal by Subject|5|||
33269662|NCT02663908|62641514|FG000|Overall Study|Lost to Follow-up|1|||
33269663|NCT02663908|62641515|FG001|Overall Study|Lost to Follow-up|5|||
33269664|NCT02663908|62641514|FG000|Overall Study|Adverse Event|13|||
33269665|NCT02663908|62641515|FG001|Overall Study|Adverse Event|11|||
33269666|NCT02663908|62641514|FG000|Overall Study|Protocol Violation|1|||
33269667|NCT02663908|62641515|FG001|Overall Study|Protocol Violation|2|||
33269668|NCT02663908|62641514|FG000|Overall Study|Lack of therapeutic response|2|||
33269669|NCT02663908|62641515|FG001|Overall Study|Lack of therapeutic response|0|||
33269670|NCT02663908|62641514|FG000|Overall Study|COVID-19|1|||
33269671|NCT02663908|62641515|FG001|Overall Study|COVID-19|0|||
33269672|NCT02663908|62641514|FG000|Overall Study|Site closed|1|||
33269673|NCT02663908|62641515|FG001|Overall Study|Site closed|0|||
33269674|NCT02663908|62641514|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
33269675|NCT02663908|62641515|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
33269676|NCT02663908|62641514|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
33269677|NCT02663908|62641515|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
33269678|NCT02663908|62641514|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
33269679|NCT02663908|62641515|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
33269680|NCT02663908|62641514|FG000|Overall Study|Death|1|||
33269681|NCT02663908|62641515|FG001|Overall Study|Death|0|||
33269682|NCT02663908|62641514|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
33269683|NCT02663908|62641515|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
33269684|NCT02663908|62641514|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
33269685|NCT02663908|62641515|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
33269686|NCT02650284|62641523|FG000|Overall Study|Lost to Follow-up|3|||
33269687|NCT02650284|62641524|FG001|Overall Study|Lost to Follow-up|3|||
33269688|NCT02650284|62641523|FG000|Overall Study|Consent incorrectly taken|0|||
33269689|NCT02650284|62641524|FG001|Overall Study|Consent incorrectly taken|1|||
33269690|NCT02175030|62641532|FG000|Overall Study|Failed screen after consent|7|||
33269691|NCT02175030|62641533|FG001|Overall Study|Failed screen after consent|6|||
33269692|NCT02175030|62641532|FG000|Overall Study|Failed IUD Insertion|20|||
33269693|NCT02175030|62641533|FG001|Overall Study|Failed IUD Insertion|21|||
33269694|NCT02175030|62641532|FG000|Overall Study|Physician Decision|1|||
33269695|NCT02175030|62641533|FG001|Overall Study|Physician Decision|1|||
33269696|NCT02175030|62641532|FG000|Overall Study|Lost to Follow-up|6|||
33269697|NCT02175030|62641533|FG001|Overall Study|Lost to Follow-up|6|||
33269698|NCT02175030|62641532|FG000|Overall Study|Withdrawal by Subject|1|||
33269699|NCT02175030|62641533|FG001|Overall Study|Withdrawal by Subject|4|||
33269700|NCT03096834|62641558|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
33269701|NCT03096834|62641559|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
33269702|NCT03096834|62641560|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
33269703|NCT03096834|62641561|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
33269704|NCT03096834|62641558|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
33269705|NCT03096834|62641559|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
33269706|NCT03096834|62641560|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
33269707|NCT03096834|62641561|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
33269708|NCT03096834|62641558|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
33485558|NCT01369498|62863225|FG002|Overall Study|Lack of Efficacy|1|||
33485559|NCT01369498|62863226|FG003|Overall Study|Lack of Efficacy|3|||
33485560|NCT01369498|62863223|FG000|Overall Study|Adverse Event|1|||
33269709|NCT03096834|62641559|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
33269710|NCT03096834|62641560|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
33269711|NCT03096834|62641561|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
33269712|NCT03096834|62641558|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
33269713|NCT03096834|62641559|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
33269714|NCT03096834|62641560|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
33269715|NCT03096834|62641561|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
33269716|NCT03096834|62641558|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
33269717|NCT03096834|62641559|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
33269718|NCT03096834|62641560|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
33269719|NCT03096834|62641561|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
33269720|NCT03096834|62641558|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
33269721|NCT03096834|62641559|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
33269722|NCT03096834|62641560|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
33269723|NCT03096834|62641561|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
33269724|NCT03096834|62641558|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
33269725|NCT03096834|62641559|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
33269726|NCT03096834|62641560|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
33269727|NCT03096834|62641561|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
33269728|NCT03096834|62641558|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
33269729|NCT03096834|62641559|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
33269730|NCT03096834|62641560|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
33269731|NCT03096834|62641561|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
33269732|NCT03096834|62641558|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
33269733|NCT03096834|62641559|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
33269734|NCT03096834|62641560|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
33269735|NCT03096834|62641561|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
33269736|NCT03096834|62641558|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
33269737|NCT03096834|62641559|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
33269738|NCT03096834|62641560|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
33269739|NCT03096834|62641561|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
33269740|NCT03096834|62641558|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
33269741|NCT03096834|62641559|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
33269742|NCT03096834|62641560|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
33269743|NCT03096834|62641561|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
33269744|NCT03096834|62641558|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
33269745|NCT03096834|62641559|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
33269746|NCT03096834|62641560|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
33269747|NCT03096834|62641561|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
33269748|NCT03012815|62641572|FG000|Overall Study|Lost to Follow-up|1|||
33269749|NCT03012815|62641573|FG001|Overall Study|Lost to Follow-up|0|||
33269750|NCT03012815|62641572|FG000|Overall Study|Physician Decision|3|||
33269751|NCT03012815|62641573|FG001|Overall Study|Physician Decision|2|||
33269752|NCT03012815|62641572|FG000|Overall Study|Adverse Event|1|||
33269753|NCT03012815|62641573|FG001|Overall Study|Adverse Event|0|||
33269754|NCT03001011|62641582|FG000|Overall Study|Adverse Event|9|||
33269755|NCT03001011|62641583|FG001|Overall Study|Adverse Event|3|||
33269756|NCT03001011|62641582|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
33269757|NCT03001011|62641583|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
33269758|NCT03001011|62641582|FG000|Overall Study|Other than specified above|3|||
33269759|NCT03001011|62641583|FG001|Overall Study|Other than specified above|8|||
33269760|NCT02993757|62641592|FG000|Overall Study|Non compliance with the protocol|155|||
33269761|NCT02993757|62641593|FG001|Overall Study|Non compliance with the protocol|170|||
33269762|NCT02993757|62641592|FG000|Overall Study|Lost to Follow-up|1|||
33269763|NCT02993757|62641593|FG001|Overall Study|Lost to Follow-up|0|||
33269764|NCT02993757|62641592|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
33269765|NCT02993757|62641593|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
33269766|NCT02979535|62641601|FG000|Overall Study|Non compliance with the protocol|78|||
33269767|NCT02979535|62641602|FG001|Overall Study|Non compliance with the protocol|82|||
33269768|NCT02979535|62641601|FG000|Overall Study|Consent withdrawn by participant|11|||
33269769|NCT02979535|62641602|FG001|Overall Study|Consent withdrawn by participant|18|||
33269770|NCT02979535|62641601|FG000|Overall Study|Lost to Follow-up|6|||
33269771|NCT02979535|62641602|FG001|Overall Study|Lost to Follow-up|1|||
33269772|NCT02978716|62641611|FG000|Overall Study|Death|25|||
33269773|NCT02978716|62641612|FG001|Overall Study|Death|13|||
33269774|NCT02978716|62641613|FG002|Overall Study|Death|20|||
33269775|NCT02978716|62641611|FG000|Overall Study|Lost to Follow-up|0|||
33269776|NCT02978716|62641612|FG001|Overall Study|Lost to Follow-up|0|||
33269777|NCT02978716|62641613|FG002|Overall Study|Lost to Follow-up|1|||
33269778|NCT02978716|62641611|FG000|Overall Study|Withdrawal by Subject|6|||
33269779|NCT02978716|62641612|FG001|Overall Study|Withdrawal by Subject|4|||
33269780|NCT02978716|62641613|FG002|Overall Study|Withdrawal by Subject|5|||
33269781|NCT02978716|62641611|FG000|Overall Study|Sponsor terminated|2|||
33269782|NCT02978716|62641612|FG001|Overall Study|Sponsor terminated|13|||
33269783|NCT02978716|62641613|FG002|Overall Study|Sponsor terminated|9|||
33269784|NCT02978716|62641611|FG000|Overall Study|Other|1|||
33269785|NCT02978716|62641612|FG001|Overall Study|Other|3|||
33269786|NCT02978716|62641613|FG002|Overall Study|Other|0|||
33269787|NCT02973321|62641628|FG000|Overall Study|Other than specified|0|||
33269788|NCT02973321|62641629|FG001|Overall Study|Other than specified|5|||
33269789|NCT02973321|62641630|FG002|Overall Study|Other than specified|3|||
33269790|NCT02973321|62641631|FG003|Overall Study|Other than specified|3|||
33269791|NCT02973321|62641632|FG004|Overall Study|Other than specified|1|||
33269792|NCT02973321|62641628|FG000|Overall Study|Lack of Efficacy|0|||
33269793|NCT02973321|62641629|FG001|Overall Study|Lack of Efficacy|0|||
33269794|NCT02973321|62641630|FG002|Overall Study|Lack of Efficacy|0|||
33269795|NCT02973321|62641631|FG003|Overall Study|Lack of Efficacy|0|||
33269796|NCT02973321|62641632|FG004|Overall Study|Lack of Efficacy|1|||
33269797|NCT02973321|62641628|FG000|Overall Study|Adverse Event|1|||
33269798|NCT02973321|62641629|FG001|Overall Study|Adverse Event|10|||
33269799|NCT02973321|62641630|FG002|Overall Study|Adverse Event|11|||
33269800|NCT02973321|62641631|FG003|Overall Study|Adverse Event|13|||
33269801|NCT02973321|62641632|FG004|Overall Study|Adverse Event|3|||
33269802|NCT02943785|62641647|FG000|Overall Study|Adverse Event|112|||
33269803|NCT02943785|62641648|FG001|Overall Study|Adverse Event|97|||
33269804|NCT02943785|62641647|FG000|Overall Study|Withdrawal by Subject|63|||
33269805|NCT02943785|62641648|FG001|Overall Study|Withdrawal by Subject|126|||
33269806|NCT02943785|62641647|FG000|Overall Study|Physician Decision|23|||
33269807|NCT02943785|62641648|FG001|Overall Study|Physician Decision|47|||
33269808|NCT02943785|62641647|FG000|Overall Study|Death|46|||
33269809|NCT02943785|62641648|FG001|Overall Study|Death|46|||
33269810|NCT02943785|62641647|FG000|Overall Study|Lost to Follow-up|1|||
33269811|NCT02943785|62641648|FG001|Overall Study|Lost to Follow-up|0|||
33269812|NCT02943785|62641647|FG000|Overall Study|Other|16|||
33269813|NCT02943785|62641648|FG001|Overall Study|Other|19|||
33269814|NCT02943785|62641647|FG000|Overall Study|Did not receive any study medication|21|||
33269815|NCT02943785|62641648|FG001|Overall Study|Did not receive any study medication|28|||
33269816|NCT02923674|62641657|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
33269817|NCT02923674|62641658|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
33269818|NCT02923674|62641659|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
33269819|NCT02923674|62641657|FG000|Overall Study|Lost to Follow-up|7|||
33269820|NCT02923674|62641658|FG001|Overall Study|Lost to Follow-up|12|||
33269821|NCT02923674|62641659|FG002|Overall Study|Lost to Follow-up|7|||
33269822|NCT02923674|62641657|FG000|Overall Study|Problem with intervention|2|||
33269823|NCT02923674|62641658|FG001|Overall Study|Problem with intervention|2|||
33269824|NCT02923674|62641659|FG002|Overall Study|Problem with intervention|1|||
33269825|NCT02923674|62641657|FG000|Overall Study|Adverse Event|3|||
33269826|NCT02923674|62641658|FG001|Overall Study|Adverse Event|1|||
33269827|NCT02923674|62641659|FG002|Overall Study|Adverse Event|1|||
33269828|NCT02923674|62641657|FG000|Overall Study|Withdrawal by Subject|2|||
33269829|NCT02923674|62641658|FG001|Overall Study|Withdrawal by Subject|2|||
33269830|NCT02923674|62641659|FG002|Overall Study|Withdrawal by Subject|2|||
33269831|NCT02921971|62641669|FG000|Overall Study|Adverse Event|1|||
33269832|NCT02921971|62641670|FG001|Overall Study|Adverse Event|2|||
33269833|NCT02921971|62641669|FG000|Overall Study|Lack of Efficacy|3|||
33269834|NCT02921971|62641670|FG001|Overall Study|Lack of Efficacy|1|||
33269835|NCT02921971|62641669|FG000|Overall Study|Other than specified above|2|||
33269836|NCT02921971|62641670|FG001|Overall Study|Other than specified above|1|||
33269837|NCT02886286|62641678|FG000|Overall Study|pump motor stall|0|||
33269838|NCT02886286|62641679|FG001|Overall Study|pump motor stall|1|||
33269839|NCT02865187|62641687|FG000|Overall Study|Lost to Follow-up|12|||
33269840|NCT02865187|62641688|FG001|Overall Study|Lost to Follow-up|7|||
33269841|NCT02865187|62641687|FG000|Overall Study|Adverse Event|1|||
33269842|NCT02865187|62641688|FG001|Overall Study|Adverse Event|0|||
33269843|NCT02824198|62641696|FG000|Overall Study|Non-compliance with the protocol|5|||
33269844|NCT02824198|62641697|FG001|Overall Study|Non-compliance with the protocol|1|||
33269845|NCT02824198|62641696|FG000|Overall Study|Lost to Follow-up|5|||
33269846|NCT02824198|62641697|FG001|Overall Study|Lost to Follow-up|2|||
33269847|NCT02824198|62641696|FG000|Overall Study|Withdrawal by Subject|5|||
33269848|NCT02824198|62641697|FG001|Overall Study|Withdrawal by Subject|0|||
33269849|NCT02787551|62641707|FG000|Core Period: 26 Weeks|Adverse Event|10|||
33269850|NCT02787551|62641708|FG001|Core Period: 26 Weeks|Adverse Event|0|||
33269851|NCT02787551|62641707|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
33269852|NCT02787551|62641708|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
33269853|NCT02787551|62641707|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
33269854|NCT02787551|62641708|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
33269855|NCT02787551|62641707|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
33269856|NCT02787551|62641708|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
33269857|NCT02787551|62641707|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
33269858|NCT02787551|62641708|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
33269859|NCT02787551|62641707|FG000|Core Period: 26 Weeks|Other than specified|3|||
33269860|NCT02787551|62641708|FG001|Core Period: 26 Weeks|Other than specified|1|||
33269861|NCT02787551|62641707|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
33269862|NCT02787551|62641708|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
33269863|NCT02787551|62641707|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
33269864|NCT02787551|62641708|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
33269865|NCT02787551|62641707|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
33269866|NCT02787551|62641708|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
33269867|NCT02735044|62641728|FG000|Overall Study|Adverse Event|3|||
33269868|NCT02735044|62641729|FG001|Overall Study|Adverse Event|3|||
33269869|NCT02735044|62641728|FG000|Overall Study|Lack of Efficacy|1|||
33269870|NCT02735044|62641729|FG001|Overall Study|Lack of Efficacy|0|||
33269871|NCT02735044|62641728|FG000|Overall Study|Poor compliance to protocol|7|||
33269872|NCT02735044|62641729|FG001|Overall Study|Poor compliance to protocol|7|||
33269873|NCT02735044|62641728|FG000|Overall Study|Randomized and not treated|0|||
33269874|NCT02735044|62641729|FG001|Overall Study|Randomized and not treated|2|||
33269875|NCT02735044|62641728|FG000|Overall Study|Other, not specified above|5|||
33269876|NCT02735044|62641729|FG001|Overall Study|Other, not specified above|11|||
33269877|NCT02720744|62641737|FG000|Overall Study|Protocol Violation|0|||
33269878|NCT02720744|62641738|FG001|Overall Study|Protocol Violation|2|||
33269879|NCT02720744|62641737|FG000|Overall Study|Pregnancy|2|||
33269880|NCT02720744|62641738|FG001|Overall Study|Pregnancy|0|||
33269881|NCT02720744|62641737|FG000|Overall Study|Lack of Efficacy|2|||
33269882|NCT02720744|62641738|FG001|Overall Study|Lack of Efficacy|8|||
33269883|NCT02720744|62641737|FG000|Overall Study|Adverse Event|21|||
33269884|NCT02720744|62641738|FG001|Overall Study|Adverse Event|3|||
33269885|NCT02720744|62641737|FG000|Overall Study|Withdrawal by Subject|11|||
33269886|NCT02720744|62641738|FG001|Overall Study|Withdrawal by Subject|11|||
33269887|NCT02720744|62641737|FG000|Overall Study|Lost to follow up|2|||
33269888|NCT02720744|62641738|FG001|Overall Study|Lost to follow up|0|||
33269889|NCT02720744|62641737|FG000|Overall Study|Non Compliance with Investigational Product|0|||
33269890|NCT02720744|62641738|FG001|Overall Study|Non Compliance with Investigational Product|1|||
33269891|NCT02720744|62641737|FG000|Overall Study|Excluded Concomitant Medication|0|||
33269892|NCT02720744|62641738|FG001|Overall Study|Excluded Concomitant Medication|1|||
33269893|NCT02694185|62641746|FG000|Overall Study|Withdrawal by Subject|45|||
33269894|NCT02694185|62641747|FG001|Overall Study|Withdrawal by Subject|0|||
33269895|NCT02692651|62641755|FG000|Study Treatment|Death|7|||
33269896|NCT02692651|62641756|FG001|Study Treatment|Death|3|||
33269897|NCT02692651|62641755|FG000|Study Treatment|comfort care|1|||
33269898|NCT02692651|62641756|FG001|Study Treatment|comfort care|1|||
33269899|NCT02692651|62641755|FG000|Study Treatment|Protocol violation per treating team preference|8|||
33269900|NCT02692651|62641756|FG001|Study Treatment|Protocol violation per treating team preference|6|||
33269901|NCT02692651|62641755|FG000|Post Study Treatment Follow-up|Death|4|||
33269902|NCT02692651|62641756|FG001|Post Study Treatment Follow-up|Death|4|||
33269903|NCT02686658|62641768|FG000|Overall Study|Adverse Event|0|||
33269904|NCT02686658|62641769|FG001|Overall Study|Adverse Event|0|||
33269905|NCT02686658|62641770|FG002|Overall Study|Adverse Event|1|||
33269906|NCT02686658|62641771|FG003|Overall Study|Adverse Event|1|||
33269907|NCT02686658|62641772|FG004|Overall Study|Adverse Event|2|||
33269908|NCT02686658|62641773|FG005|Overall Study|Adverse Event|1|||
33269909|NCT02686658|62641768|FG000|Overall Study|Investigator decision|0|||
33269910|NCT02686658|62641769|FG001|Overall Study|Investigator decision|0|||
33269911|NCT02686658|62641770|FG002|Overall Study|Investigator decision|0|||
33269912|NCT02686658|62641771|FG003|Overall Study|Investigator decision|1|||
33269913|NCT02686658|62641772|FG004|Overall Study|Investigator decision|2|||
33269914|NCT02686658|62641773|FG005|Overall Study|Investigator decision|1|||
33269915|NCT02686658|62641768|FG000|Overall Study|Sponsor decision|1|||
33269916|NCT02686658|62641769|FG001|Overall Study|Sponsor decision|2|||
33269917|NCT02686658|62641770|FG002|Overall Study|Sponsor decision|1|||
33269918|NCT02686658|62641771|FG003|Overall Study|Sponsor decision|5|||
33269919|NCT02686658|62641772|FG004|Overall Study|Sponsor decision|13|||
33555665|NCT02625974|62948472|FG000|Overall Study|Withdrawal by Subject|3|||
33555666|NCT02625974|62948473|FG001|Overall Study|Withdrawal by Subject|1|||
33269920|NCT02686658|62641773|FG005|Overall Study|Sponsor decision|2|||
33269921|NCT02686658|62641768|FG000|Overall Study|Lost to Follow-up|0|||
33269922|NCT02686658|62641769|FG001|Overall Study|Lost to Follow-up|0|||
33269923|NCT02686658|62641770|FG002|Overall Study|Lost to Follow-up|2|||
33269924|NCT02686658|62641771|FG003|Overall Study|Lost to Follow-up|0|||
33269925|NCT02686658|62641772|FG004|Overall Study|Lost to Follow-up|0|||
33269926|NCT02686658|62641773|FG005|Overall Study|Lost to Follow-up|1|||
33269927|NCT02686658|62641768|FG000|Overall Study|Death|1|||
33269928|NCT02686658|62641769|FG001|Overall Study|Death|0|||
33269929|NCT02686658|62641770|FG002|Overall Study|Death|0|||
33269930|NCT02686658|62641771|FG003|Overall Study|Death|1|||
33269931|NCT02686658|62641772|FG004|Overall Study|Death|1|||
33269932|NCT02686658|62641773|FG005|Overall Study|Death|1|||
33269933|NCT02686658|62641768|FG000|Overall Study|Withdrawal by Subject|2|||
33269934|NCT02686658|62641769|FG001|Overall Study|Withdrawal by Subject|5|||
33269935|NCT02686658|62641770|FG002|Overall Study|Withdrawal by Subject|4|||
33269936|NCT02686658|62641771|FG003|Overall Study|Withdrawal by Subject|4|||
33269937|NCT02686658|62641772|FG004|Overall Study|Withdrawal by Subject|17|||
33269938|NCT02686658|62641773|FG005|Overall Study|Withdrawal by Subject|8|||
33269939|NCT02686658|62641768|FG000|Overall Study|Placed in hospice care|0|||
33269940|NCT02686658|62641769|FG001|Overall Study|Placed in hospice care|0|||
33269941|NCT02686658|62641770|FG002|Overall Study|Placed in hospice care|1|||
33269942|NCT02686658|62641771|FG003|Overall Study|Placed in hospice care|0|||
33269943|NCT02686658|62641772|FG004|Overall Study|Placed in hospice care|0|||
33269944|NCT02686658|62641773|FG005|Overall Study|Placed in hospice care|0|||
33269945|NCT02686658|62641768|FG000|Overall Study|Participant non-compliance|0|||
33269946|NCT02686658|62641769|FG001|Overall Study|Participant non-compliance|0|||
33269947|NCT02686658|62641770|FG002|Overall Study|Participant non-compliance|0|||
33269948|NCT02686658|62641771|FG003|Overall Study|Participant non-compliance|0|||
33269949|NCT02686658|62641772|FG004|Overall Study|Participant non-compliance|0|||
33269950|NCT02686658|62641773|FG005|Overall Study|Participant non-compliance|1|||
33269951|NCT02686658|62641768|FG000|Overall Study|Concern over coronavirus disease care|0|||
33269952|NCT02686658|62641769|FG001|Overall Study|Concern over coronavirus disease care|0|||
33269953|NCT02686658|62641770|FG002|Overall Study|Concern over coronavirus disease care|0|||
33269954|NCT02686658|62641771|FG003|Overall Study|Concern over coronavirus disease care|0|||
33269955|NCT02686658|62641772|FG004|Overall Study|Concern over coronavirus disease care|2|||
33269956|NCT02686658|62641773|FG005|Overall Study|Concern over coronavirus disease care|1|||
33269957|NCT02674061|62641789|FG000|Overall Study|Death|229|||
33269958|NCT02674061|62641790|FG001|Overall Study|Death|77|||
33269959|NCT02674061|62641789|FG000|Overall Study|Lost to Follow-up|3|||
33269960|NCT02674061|62641790|FG001|Overall Study|Lost to Follow-up|3|||
33269961|NCT02674061|62641789|FG000|Overall Study|Withdrawal by Subject|9|||
33269962|NCT02674061|62641790|FG001|Overall Study|Withdrawal by Subject|1|||
33269963|NCT02674061|62641789|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
33269964|NCT02674061|62641790|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
33269965|NCT02628444|62641810|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
33269966|NCT02628444|62641811|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33269967|NCT02628444|62641812|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33269968|NCT02628444|62641813|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33269969|NCT02628444|62641814|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33269970|NCT02628444|62641815|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33269971|NCT02628444|62641816|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33269972|NCT02628444|62641817|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33269973|NCT02628444|62641818|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33269974|NCT02628444|62641810|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
33269975|NCT02628444|62641811|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
33269976|NCT02628444|62641812|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
33269977|NCT02628444|62641813|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
33269978|NCT02628444|62641814|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
33269979|NCT02628444|62641815|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
33269980|NCT02628444|62641816|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
33269981|NCT02628444|62641817|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
33269982|NCT02628444|62641818|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
33269983|NCT02628444|62641810|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
33269984|NCT02628444|62641811|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
33269985|NCT02628444|62641812|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
33269986|NCT02628444|62641813|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
33269987|NCT02628444|62641814|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
33269988|NCT02628444|62641815|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
33269989|NCT02628444|62641816|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
33269990|NCT02628444|62641817|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
33269991|NCT02628444|62641818|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
33269992|NCT02628444|62641810|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
33269993|NCT02628444|62641811|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
33269994|NCT02628444|62641812|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
33269995|NCT02628444|62641813|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
33369413|NCT00858780|62748156|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
33269996|NCT02628444|62641814|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
33269997|NCT02628444|62641815|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
33269998|NCT02628444|62641816|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
33269999|NCT02628444|62641817|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
33270000|NCT02628444|62641818|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
33270001|NCT02628444|62641810|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
33270002|NCT02628444|62641811|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
33270003|NCT02628444|62641812|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
33270004|NCT02628444|62641813|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
33369414|NCT00858780|62748157|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
33369415|NCT00858780|62748158|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
33369416|NCT00858780|62748159|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
33369417|NCT00858780|62748155|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
33369418|NCT00858780|62748156|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
33369419|NCT00858780|62748157|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
33369420|NCT00858780|62748158|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
33369421|NCT00858780|62748159|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
33369422|NCT00858780|62748155|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
33369423|NCT00858780|62748156|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
33369424|NCT00858780|62748157|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
33369425|NCT00858780|62748158|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
33369426|NCT00858780|62748159|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
33369427|NCT00850200|62748169|FG000|Overall Study|Physician Decision|2|||
33369428|NCT00850200|62748169|FG000|Overall Study|Did not recieve treatment|2|||
33369429|NCT00850200|62748169|FG000|Overall Study|Withdrawal by Subject|1|||
33369430|NCT00858234|62748176|FG000|Overall Study|Adverse Event|6|||
33369431|NCT00858234|62748176|FG000|Overall Study|Progressive disease|2|||
33369432|NCT00858234|62748176|FG000|Overall Study|Status unknown|1|||
33369433|NCT00862082|62748182|FG000|Overall Study|Sponsor decision to terminate the study|5|||
33369434|NCT00862082|62748183|FG001|Overall Study|Sponsor decision to terminate the study|0|||
33369435|NCT00862082|62748182|FG000|Overall Study|Withdrawal by Subject|0|||
33369436|NCT00862082|62748183|FG001|Overall Study|Withdrawal by Subject|1|||
33369437|NCT00849186|62748196|FG000|Overall Study|Adverse Event|2|||
33369438|NCT00849186|62748196|FG000|Overall Study|Withdrawal by Subject|1|||
33369439|NCT00849186|62748196|FG000|Overall Study|not treated|6|||
33369440|NCT00849186|62748196|FG000|Overall Study|Other|1|||
33369441|NCT00692770|62748203|FG000|Overall Study|Protocol Violation|2|||
33369442|NCT00692770|62748204|FG001|Overall Study|Protocol Violation|7|||
33369443|NCT00692770|62748203|FG000|Overall Study|Withdrawal by Subject|97|||
33369444|NCT00692770|62748204|FG001|Overall Study|Withdrawal by Subject|36|||
33369445|NCT00692770|62748203|FG000|Overall Study|Adverse Event|136|||
33369446|NCT00692770|62748204|FG001|Overall Study|Adverse Event|41|||
33369447|NCT00692770|62748203|FG000|Overall Study|Death|10|||
33369448|NCT00692770|62748204|FG001|Overall Study|Death|5|||
33369449|NCT00692770|62748203|FG000|Overall Study|Lost to Follow-up|7|||
33369450|NCT00692770|62748204|FG001|Overall Study|Lost to Follow-up|3|||
33369451|NCT00692770|62748203|FG000|Overall Study|Non-compliant with study medication|11|||
33369452|NCT00692770|62748204|FG001|Overall Study|Non-compliant with study medication|5|||
33369453|NCT00692770|62748203|FG000|Overall Study|Progression by clinical judgment|2|||
33369454|NCT00692770|62748204|FG001|Overall Study|Progression by clinical judgment|3|||
33369455|NCT00692770|62748203|FG000|Overall Study|Physician decision not protocol driven|10|||
33369456|NCT00692770|62748204|FG001|Overall Study|Physician decision not protocol driven|14|||
33369457|NCT00692770|62748203|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
33270005|NCT02628444|62641814|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
33270006|NCT02628444|62641815|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
33270007|NCT02628444|62641816|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
33270008|NCT02628444|62641817|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
33270009|NCT02628444|62641818|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
33270010|NCT02628444|62641810|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33270011|NCT02628444|62641811|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33270012|NCT02628444|62641812|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33270013|NCT02628444|62641813|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
33369458|NCT00692770|62748204|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
33369459|NCT00692770|62748203|FG000|Overall Study|Protocol driven decision point|3|||
33369460|NCT00692770|62748204|FG001|Overall Study|Protocol driven decision point|7|||
33369461|NCT00692770|62748203|FG000|Overall Study|Completed all planned assessments|79|||
33369462|NCT00692770|62748204|FG001|Overall Study|Completed all planned assessments|101|||
33369463|NCT00692770|62748203|FG000|Overall Study|Radiological and clinical progression|8|||
33369464|NCT00692770|62748204|FG001|Overall Study|Radiological and clinical progression|8|||
33369465|NCT00692770|62748203|FG000|Overall Study|Clinical endpoint reached|16|||
33369466|NCT00692770|62748204|FG001|Overall Study|Clinical endpoint reached|43|||
33369467|NCT00692770|62748203|FG000|Overall Study|Study terminated by sponsor|2|||
33369468|NCT00692770|62748204|FG001|Overall Study|Study terminated by sponsor|2|||
33369469|NCT00692770|62748203|FG000|Overall Study|Randomized but not treated|3|||
33369470|NCT00692770|62748204|FG001|Overall Study|Randomized but not treated|4|||
33270014|NCT02628444|62641814|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33270015|NCT02628444|62641815|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33270016|NCT02628444|62641816|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33270017|NCT02628444|62641817|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33270018|NCT02628444|62641818|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33270019|NCT02628444|62641810|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
33270020|NCT02628444|62641811|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
33270021|NCT02628444|62641812|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
33270022|NCT02628444|62641813|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
33270023|NCT02628444|62641814|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
33270024|NCT02628444|62641815|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
33270025|NCT02628444|62641816|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
33270026|NCT02628444|62641817|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
33369471|NCT00849108|62748219|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
33369472|NCT00849108|62748220|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
33369473|NCT00849108|62748219|FG000|Cohort 2 Efficacy|Adverse Event|0|||
33369474|NCT00849108|62748220|FG001|Cohort 2 Efficacy|Adverse Event|1|||
33369475|NCT00849108|62748219|FG000|Cohort 2 Efficacy|Other|0|||
33369476|NCT00849108|62748220|FG001|Cohort 2 Efficacy|Other|9|||
33369477|NCT00867308|62748230|FG000|Overall Study|Death|1|||
33369478|NCT00867308|62748231|FG001|Overall Study|Death|0|||
33369479|NCT00867308|62748230|FG000|Overall Study|Adverse Event|1|||
33369480|NCT00867308|62748231|FG001|Overall Study|Adverse Event|4|||
33369481|NCT00867308|62748230|FG000|Overall Study|Lack of Efficacy|6|||
33369482|NCT00867308|62748231|FG001|Overall Study|Lack of Efficacy|12|||
33369483|NCT00867308|62748230|FG000|Overall Study|Withdrawal by Subject|1|||
33369484|NCT00867308|62748231|FG001|Overall Study|Withdrawal by Subject|2|||
33270027|NCT02628444|62641818|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
33270028|NCT02628444|62641810|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
33270029|NCT02628444|62641811|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
33270030|NCT02628444|62641812|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
33270031|NCT02628444|62641813|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
33270032|NCT02628444|62641814|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
33369485|NCT00866918|62748239|FG000|Overall Study|Death|1|||
33369486|NCT00866918|62748240|FG001|Overall Study|Death|5|||
33369487|NCT00866918|62748239|FG000|Overall Study|Lack of Efficacy|1|||
33369488|NCT00866918|62748240|FG001|Overall Study|Lack of Efficacy|1|||
33369489|NCT00866918|62748239|FG000|Overall Study|Physician Decision|10|||
33369490|NCT00866918|62748240|FG001|Overall Study|Physician Decision|2|||
33369491|NCT00866918|62748239|FG000|Overall Study|Ineligible|2|||
33369492|NCT00866918|62748240|FG001|Overall Study|Ineligible|4|||
33369493|NCT00866918|62748239|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
33369494|NCT00866918|62748240|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
33369495|NCT00866918|62748239|FG000|Overall Study|Secondary malignancy|1|||
33270033|NCT02628444|62641815|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
33270034|NCT02628444|62641816|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
33270035|NCT02628444|62641817|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
33270036|NCT02628444|62641818|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
33270037|NCT02628444|62641810|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
33270038|NCT02628444|62641811|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
33270039|NCT02628444|62641812|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
33270040|NCT02628444|62641813|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
33270041|NCT02628444|62641814|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
33270042|NCT02628444|62641815|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
33270043|NCT02628444|62641816|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
33270044|NCT02628444|62641817|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
33270045|NCT02628444|62641818|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
33270046|NCT02628444|62641810|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
33369496|NCT00866918|62748240|FG001|Overall Study|Secondary malignancy|0|||
33369497|NCT03158285|62748249|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
33369498|NCT03158285|62748250|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
33369499|NCT03158285|62748251|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
33369500|NCT03158285|62748249|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
33369501|NCT03158285|62748250|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
33270047|NCT02628444|62641811|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
33270048|NCT02628444|62641812|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
33270049|NCT02628444|62641813|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
33270050|NCT02628444|62641814|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
33270051|NCT02628444|62641815|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
33270052|NCT02628444|62641816|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
33270053|NCT02628444|62641817|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
33270054|NCT02628444|62641818|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
33270055|NCT02623725|62641854|FG000|Overall Study|Non compliance with protocol|9|||
33270056|NCT02623725|62641855|FG001|Overall Study|Non compliance with protocol|3|||
33270057|NCT02623725|62641854|FG000|Overall Study|Serious adverse event|0|||
33270058|NCT02623725|62641855|FG001|Overall Study|Serious adverse event|2|||
33270059|NCT02623725|62641854|FG000|Overall Study|Withdrawal by Subject|7|||
33270060|NCT02623725|62641855|FG001|Overall Study|Withdrawal by Subject|1|||
33270061|NCT02608684|62641863|FG000|Overall Study|Physician Decision|2|||
33270062|NCT02608684|62641863|FG000|Overall Study|Withdrawal by Subject|1|||
33270063|NCT02587520|62641885|FG000|Overall Study|Protocol Violation|2|||
33270064|NCT02587520|62641886|FG001|Overall Study|Protocol Violation|0|||
33270065|NCT02587520|62641887|FG002|Overall Study|Protocol Violation|0|||
33270066|NCT02587520|62641888|FG003|Overall Study|Protocol Violation|2|||
33270067|NCT02587520|62641889|FG004|Overall Study|Protocol Violation|0|||
33270068|NCT02587520|62641890|FG005|Overall Study|Protocol Violation|1|||
33270069|NCT02587520|62641891|FG006|Overall Study|Protocol Violation|1|||
33369502|NCT03158285|62748251|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
33369503|NCT03158285|62748249|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
33369504|NCT03158285|62748250|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
33369505|NCT03158285|62748251|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
33270070|NCT02587520|62641892|FG007|Overall Study|Protocol Violation|1|||
33270071|NCT02587520|62641893|FG008|Overall Study|Protocol Violation|3|||
33270072|NCT02587520|62641894|FG009|Overall Study|Protocol Violation|3|||
33270073|NCT02587520|62641895|FG010|Overall Study|Protocol Violation|1|||
33270074|NCT02587520|62641896|FG011|Overall Study|Protocol Violation|2|||
33270075|NCT02587520|62641897|FG012|Overall Study|Protocol Violation|0|||
33369506|NCT03158285|62748249|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
33369507|NCT03158285|62748250|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
33369508|NCT03158285|62748251|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
33369509|NCT03158285|62748249|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
33369510|NCT03158285|62748250|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
33369511|NCT03158285|62748251|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
33555667|NCT02625974|62948472|FG000|Overall Study|positive parasitemia|1|||
33555668|NCT02625974|62948473|FG001|Overall Study|positive parasitemia|0|||
33270076|NCT02587520|62641898|FG013|Overall Study|Protocol Violation|0|||
33270077|NCT02587520|62641899|FG014|Overall Study|Protocol Violation|0|||
33270078|NCT02587520|62641900|FG015|Overall Study|Protocol Violation|0|||
33270079|NCT02587520|62641901|FG016|Overall Study|Protocol Violation|0|||
33270080|NCT02587520|62641902|FG017|Overall Study|Protocol Violation|0|||
33270081|NCT02587520|62641885|FG000|Overall Study|Adverse Event|0|||
33270082|NCT02587520|62641886|FG001|Overall Study|Adverse Event|0|||
33270083|NCT02587520|62641887|FG002|Overall Study|Adverse Event|0|||
33270084|NCT02587520|62641888|FG003|Overall Study|Adverse Event|0|||
33270085|NCT02587520|62641889|FG004|Overall Study|Adverse Event|0|||
33270086|NCT02587520|62641890|FG005|Overall Study|Adverse Event|0|||
33270087|NCT02587520|62641891|FG006|Overall Study|Adverse Event|0|||
33270088|NCT02587520|62641892|FG007|Overall Study|Adverse Event|0|||
33270089|NCT02587520|62641893|FG008|Overall Study|Adverse Event|0|||
33270090|NCT02587520|62641894|FG009|Overall Study|Adverse Event|0|||
33270091|NCT02587520|62641895|FG010|Overall Study|Adverse Event|0|||
33270092|NCT02587520|62641896|FG011|Overall Study|Adverse Event|1|||
33270093|NCT02587520|62641897|FG012|Overall Study|Adverse Event|0|||
33270094|NCT02587520|62641898|FG013|Overall Study|Adverse Event|0|||
33270095|NCT02587520|62641899|FG014|Overall Study|Adverse Event|0|||
33270096|NCT02587520|62641900|FG015|Overall Study|Adverse Event|0|||
33270097|NCT02587520|62641901|FG016|Overall Study|Adverse Event|0|||
33270098|NCT02587520|62641902|FG017|Overall Study|Adverse Event|0|||
33270099|NCT02587520|62641885|FG000|Overall Study|Withdrawal by Subject|0|||
33270100|NCT02587520|62641886|FG001|Overall Study|Withdrawal by Subject|0|||
33270101|NCT02587520|62641887|FG002|Overall Study|Withdrawal by Subject|1|||
33270102|NCT02587520|62641888|FG003|Overall Study|Withdrawal by Subject|1|||
33270103|NCT02587520|62641889|FG004|Overall Study|Withdrawal by Subject|0|||
33270104|NCT02587520|62641890|FG005|Overall Study|Withdrawal by Subject|1|||
33270105|NCT02587520|62641891|FG006|Overall Study|Withdrawal by Subject|1|||
33270106|NCT02587520|62641892|FG007|Overall Study|Withdrawal by Subject|0|||
33369512|NCT03158285|62748249|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
33369513|NCT03158285|62748250|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
33270107|NCT02587520|62641893|FG008|Overall Study|Withdrawal by Subject|0|||
33555669|NCT02625974|62948472|FG000|Overall Study|non-compliance with study drug|0|||
33270108|NCT02587520|62641894|FG009|Overall Study|Withdrawal by Subject|0|||
33270109|NCT02587520|62641895|FG010|Overall Study|Withdrawal by Subject|0|||
33270110|NCT02587520|62641896|FG011|Overall Study|Withdrawal by Subject|0|||
33270111|NCT02587520|62641897|FG012|Overall Study|Withdrawal by Subject|0|||
33270112|NCT02587520|62641898|FG013|Overall Study|Withdrawal by Subject|1|||
33270113|NCT02587520|62641899|FG014|Overall Study|Withdrawal by Subject|0|||
33270114|NCT02587520|62641900|FG015|Overall Study|Withdrawal by Subject|0|||
33270115|NCT02587520|62641901|FG016|Overall Study|Withdrawal by Subject|0|||
33270116|NCT02587520|62641902|FG017|Overall Study|Withdrawal by Subject|0|||
33270117|NCT02587520|62641885|FG000|Overall Study|Lost to Follow-up|0|||
33270118|NCT02587520|62641886|FG001|Overall Study|Lost to Follow-up|2|||
33270119|NCT02587520|62641887|FG002|Overall Study|Lost to Follow-up|0|||
33270120|NCT02587520|62641888|FG003|Overall Study|Lost to Follow-up|2|||
33270121|NCT02587520|62641889|FG004|Overall Study|Lost to Follow-up|0|||
33270122|NCT02587520|62641890|FG005|Overall Study|Lost to Follow-up|1|||
33270123|NCT02587520|62641891|FG006|Overall Study|Lost to Follow-up|1|||
33270124|NCT02587520|62641892|FG007|Overall Study|Lost to Follow-up|1|||
33270125|NCT02587520|62641893|FG008|Overall Study|Lost to Follow-up|0|||
33270126|NCT02587520|62641894|FG009|Overall Study|Lost to Follow-up|2|||
33270127|NCT02587520|62641895|FG010|Overall Study|Lost to Follow-up|2|||
33270128|NCT02587520|62641896|FG011|Overall Study|Lost to Follow-up|1|||
33270129|NCT02587520|62641897|FG012|Overall Study|Lost to Follow-up|0|||
33270130|NCT02587520|62641898|FG013|Overall Study|Lost to Follow-up|0|||
33270131|NCT02587520|62641899|FG014|Overall Study|Lost to Follow-up|0|||
33270132|NCT02587520|62641900|FG015|Overall Study|Lost to Follow-up|0|||
33270133|NCT02587520|62641901|FG016|Overall Study|Lost to Follow-up|0|||
33270134|NCT02587520|62641902|FG017|Overall Study|Lost to Follow-up|0|||
33270135|NCT02584829|62641942|FG000|Overall Study|Physician Decision|1|||
33270136|NCT02584829|62641943|FG001|Overall Study|Physician Decision|0|||
33270137|NCT02584829|62641942|FG000|Overall Study|Withdrawal by Subject|0|||
33270138|NCT02584829|62641943|FG001|Overall Study|Withdrawal by Subject|1|||
33270139|NCT02584829|62641942|FG000|Overall Study|Progressive Disease|0|||
33270140|NCT02584829|62641943|FG001|Overall Study|Progressive Disease|3|||
33270141|NCT02570308|62641956|FG000|Overall Study|Death|1|||
33270142|NCT02570308|62641957|FG001|Overall Study|Death|5|||
33270143|NCT02570308|62641958|FG002|Overall Study|Death|4|||
33270144|NCT02570308|62641959|FG003|Overall Study|Death|4|||
33270145|NCT02570308|62641960|FG004|Overall Study|Death|69|||
33270146|NCT02570308|62641956|FG000|Overall Study|Lost to Follow-up|0|||
33270147|NCT02570308|62641957|FG001|Overall Study|Lost to Follow-up|0|||
33270148|NCT02570308|62641958|FG002|Overall Study|Lost to Follow-up|0|||
33270149|NCT02570308|62641959|FG003|Overall Study|Lost to Follow-up|0|||
33270150|NCT02570308|62641960|FG004|Overall Study|Lost to Follow-up|2|||
33270151|NCT02570308|62641956|FG000|Overall Study|Withdrawal by Subject|0|||
33270152|NCT02570308|62641957|FG001|Overall Study|Withdrawal by Subject|0|||
33270153|NCT02570308|62641958|FG002|Overall Study|Withdrawal by Subject|0|||
33270154|NCT02570308|62641959|FG003|Overall Study|Withdrawal by Subject|0|||
33270155|NCT02570308|62641960|FG004|Overall Study|Withdrawal by Subject|1|||
33270156|NCT02570308|62641956|FG000|Overall Study|Other|0|||
33270157|NCT02570308|62641957|FG001|Overall Study|Other|0|||
33270158|NCT02570308|62641958|FG002|Overall Study|Other|0|||
33270159|NCT02570308|62641959|FG003|Overall Study|Other|0|||
33270160|NCT02570308|62641960|FG004|Overall Study|Other|2|||
33270161|NCT02497612|62641982|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
33270162|NCT02497612|62641983|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
33270163|NCT02497612|62641984|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
33270164|NCT02497612|62641985|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
33270165|NCT02497612|62641982|FG000|Overall Study|Participant's request|2|||
33270166|NCT02497612|62641983|FG001|Overall Study|Participant's request|3|||
33270167|NCT02497612|62641984|FG002|Overall Study|Participant's request|4|||
33270168|NCT02497612|62641985|FG003|Overall Study|Participant's request|1|||
33555670|NCT02625974|62948473|FG001|Overall Study|non-compliance with study drug|2|||
33555671|NCT02625974|62948472|FG000|Overall Study|Protocol Violation|0|||
33270169|NCT02497612|62641982|FG000|Overall Study|Investigator's judgement|1|||
33270170|NCT02497612|62641983|FG001|Overall Study|Investigator's judgement|0|||
33270171|NCT02497612|62641984|FG002|Overall Study|Investigator's judgement|0|||
33270172|NCT02497612|62641985|FG003|Overall Study|Investigator's judgement|2|||
33270173|NCT02497612|62641982|FG000|Overall Study|Adverse Event|3|||
33270174|NCT02497612|62641983|FG001|Overall Study|Adverse Event|1|||
33270175|NCT02497612|62641984|FG002|Overall Study|Adverse Event|4|||
33270176|NCT02497612|62641985|FG003|Overall Study|Adverse Event|1|||
33270177|NCT02497612|62641982|FG000|Overall Study|Lost to Follow-up|1|||
33270178|NCT02497612|62641983|FG001|Overall Study|Lost to Follow-up|1|||
33270179|NCT02497612|62641984|FG002|Overall Study|Lost to Follow-up|0|||
33270180|NCT02497612|62641985|FG003|Overall Study|Lost to Follow-up|1|||
33270181|NCT02497612|62641982|FG000|Overall Study|Other unspecified|1|||
33555672|NCT02625974|62948473|FG001|Overall Study|Protocol Violation|1|||
33270182|NCT02497612|62641983|FG001|Overall Study|Other unspecified|1|||
33270183|NCT02497612|62641984|FG002|Overall Study|Other unspecified|2|||
33270184|NCT02497612|62641985|FG003|Overall Study|Other unspecified|0|||
33270185|NCT02497612|62641982|FG000|Overall Study|Not eligible|1|||
33270186|NCT02497612|62641983|FG001|Overall Study|Not eligible|0|||
33270187|NCT02497612|62641984|FG002|Overall Study|Not eligible|0|||
33270188|NCT02497612|62641985|FG003|Overall Study|Not eligible|1|||
33270189|NCT02460458|62641995|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47|||
33270190|NCT02460458|62641995|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27|||
33270191|NCT02460458|62641995|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14|||
33270192|NCT02460458|62641995|FG000|First Prospective Phase|Lost to Follow-up|16|||
33270193|NCT02460458|62641995|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9|||
33270194|NCT02457559|62642010|FG000|Overall Study|Progressive Disease|1|||
33270195|NCT02457559|62642011|FG001|Overall Study|Progressive Disease|2|||
33270196|NCT02457559|62642012|FG002|Overall Study|Progressive Disease|3|||
33270197|NCT02457559|62642013|FG003|Overall Study|Progressive Disease|0|||
33270198|NCT02457559|62642014|FG004|Overall Study|Progressive Disease|0|||
33270199|NCT02457559|62642015|FG005|Overall Study|Progressive Disease|2|||
33270200|NCT02457559|62642016|FG006|Overall Study|Progressive Disease|1|||
33270201|NCT02457559|62642017|FG007|Overall Study|Progressive Disease|0|||
33270202|NCT02457559|62642018|FG008|Overall Study|Progressive Disease|1|||
33270203|NCT02457559|62642019|FG009|Overall Study|Progressive Disease|1|||
33270204|NCT02457559|62642020|FG010|Overall Study|Progressive Disease|1|||
33270205|NCT02457559|62642010|FG000|Overall Study|Investigator's Discretion|0|||
33270206|NCT02457559|62642011|FG001|Overall Study|Investigator's Discretion|0|||
33270207|NCT02457559|62642012|FG002|Overall Study|Investigator's Discretion|2|||
33270208|NCT02457559|62642013|FG003|Overall Study|Investigator's Discretion|0|||
33270209|NCT02457559|62642014|FG004|Overall Study|Investigator's Discretion|1|||
33270210|NCT02457559|62642015|FG005|Overall Study|Investigator's Discretion|0|||
33270211|NCT02457559|62642016|FG006|Overall Study|Investigator's Discretion|1|||
33270212|NCT02457559|62642017|FG007|Overall Study|Investigator's Discretion|0|||
33270213|NCT02457559|62642018|FG008|Overall Study|Investigator's Discretion|1|||
33270214|NCT02457559|62642019|FG009|Overall Study|Investigator's Discretion|0|||
33270215|NCT02457559|62642020|FG010|Overall Study|Investigator's Discretion|1|||
33270216|NCT02457559|62642010|FG000|Overall Study|Adverse Event|0|||
33270217|NCT02457559|62642011|FG001|Overall Study|Adverse Event|1|||
33270218|NCT02457559|62642012|FG002|Overall Study|Adverse Event|2|||
33270219|NCT02457559|62642013|FG003|Overall Study|Adverse Event|0|||
33270220|NCT02457559|62642014|FG004|Overall Study|Adverse Event|0|||
33270221|NCT02457559|62642015|FG005|Overall Study|Adverse Event|0|||
33555673|NCT02792699|62948518|FG000|Overall Study|Adverse Event|1|||
33369514|NCT03158285|62748251|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
33369515|NCT03158285|62748249|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
33369516|NCT03158285|62748250|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
33369517|NCT03158285|62748251|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
33369518|NCT03158285|62748249|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
33369519|NCT03158285|62748250|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
33369520|NCT03158285|62748251|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
33369521|NCT03158285|62748249|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
33369522|NCT03158285|62748250|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
33369523|NCT03158285|62748251|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
33369524|NCT03158285|62748249|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
33369525|NCT03158285|62748250|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
33555674|NCT02792699|62948519|FG001|Overall Study|Adverse Event|2|||
33555675|NCT02792699|62948520|FG002|Overall Study|Adverse Event|4|||
33555676|NCT02792699|62948518|FG000|Overall Study|Withdrawal by Subject|4|||
33555677|NCT02792699|62948519|FG001|Overall Study|Withdrawal by Subject|4|||
33270222|NCT02457559|62642016|FG006|Overall Study|Adverse Event|0|||
33270223|NCT02457559|62642017|FG007|Overall Study|Adverse Event|0|||
33270224|NCT02457559|62642018|FG008|Overall Study|Adverse Event|0|||
33270225|NCT02457559|62642019|FG009|Overall Study|Adverse Event|0|||
33270226|NCT02457559|62642020|FG010|Overall Study|Adverse Event|0|||
33369526|NCT03158285|62748251|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
33662010|NCT02700984|63092480|FG001|Overall Study|Withdrawal by Subject|9|||
33369527|NCT03158285|62748249|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
33662011|NCT02700984|63092479|FG000|Overall Study|Reason not specified|3|||
33270227|NCT02457559|62642010|FG000|Overall Study|Reason not Specified|1|||
33270228|NCT02457559|62642011|FG001|Overall Study|Reason not Specified|0|||
33270229|NCT02457559|62642012|FG002|Overall Study|Reason not Specified|0|||
33270230|NCT02457559|62642013|FG003|Overall Study|Reason not Specified|0|||
33270231|NCT02457559|62642014|FG004|Overall Study|Reason not Specified|0|||
33270232|NCT02457559|62642015|FG005|Overall Study|Reason not Specified|0|||
33270233|NCT02457559|62642016|FG006|Overall Study|Reason not Specified|0|||
33270234|NCT02457559|62642017|FG007|Overall Study|Reason not Specified|0|||
33369528|NCT03158285|62748250|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
33369529|NCT03158285|62748251|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
33369530|NCT03158285|62748249|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
33369531|NCT03158285|62748250|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
33369532|NCT03158285|62748251|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
33369533|NCT03158285|62748249|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
33369534|NCT03158285|62748250|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
33369535|NCT03158285|62748251|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
33369536|NCT03158285|62748249|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
33369537|NCT03158285|62748250|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
33369538|NCT03158285|62748251|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
33369539|NCT03158285|62748249|FG000|Active Treatment Period: Week 52-100|Death|1|||
33369540|NCT03158285|62748250|FG001|Active Treatment Period: Week 52-100|Death|0|||
33369541|NCT03158285|62748251|FG002|Active Treatment Period: Week 52-100|Death|0|||
33369542|NCT03158285|62748249|FG000|Active Treatment Period: Week 52-100|Other|4|||
33369543|NCT03158285|62748250|FG001|Active Treatment Period: Week 52-100|Other|1|||
33369544|NCT03158285|62748251|FG002|Active Treatment Period: Week 52-100|Other|0|||
33369545|NCT00861692|62748264|FG000|Overall Study|Death|6|||
33369546|NCT00602927|62748270|FG000|Period 1: 13 Days|Protocol Violation|2|||
33369547|NCT00602927|62748271|FG001|Period 1: 13 Days|Protocol Violation|4|||
33369548|NCT00602927|62748270|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
33369549|NCT00602927|62748271|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
33369550|NCT00602927|62748270|FG000|Period 1: 13 Days|Time|1|||
33369551|NCT00602927|62748271|FG001|Period 1: 13 Days|Time|0|||
33369552|NCT00602927|62748270|FG000|Period 1: 13 Days|Claustrophobia|0|||
33369553|NCT00602927|62748271|FG001|Period 1: 13 Days|Claustrophobia|1|||
33369554|NCT00602927|62748270|FG000|Period 2: 14 Days|Protocol Violation|0|||
33369555|NCT00602927|62748271|FG001|Period 2: 14 Days|Protocol Violation|2|||
33369556|NCT00602927|62748270|FG000|Period 3: 13 Days|Protocol Violation|0|||
33369557|NCT00602927|62748271|FG001|Period 3: 13 Days|Protocol Violation|1|||
33369558|NCT00602927|62748270|FG000|Period 3: 13 Days|MRI data quality|2|||
33369559|NCT00602927|62748271|FG001|Period 3: 13 Days|MRI data quality|2|||
33369560|NCT00602537|62748279|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
33369561|NCT00602537|62748280|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
33369562|NCT00602537|62748279|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
33369563|NCT00602537|62748280|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
33369564|NCT00602537|62748279|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
33369565|NCT00602537|62748280|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
33369566|NCT00602537|62748279|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
33369567|NCT00602537|62748280|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
33369568|NCT00602537|62748279|FG000|Follow Up Study Comparison|Adverse Event|1|||
33369569|NCT00602537|62748280|FG001|Follow Up Study Comparison|Adverse Event|0|||
33369570|NCT00602537|62748279|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
33369571|NCT00602537|62748280|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
33369572|NCT00602537|62748279|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
33369573|NCT00602537|62748280|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
33369574|NCT00861614|62748288|FG000|Overall Study|Disease Progression|182|||
33369575|NCT00861614|62748289|FG001|Overall Study|Disease Progression|263|||
33369576|NCT00861614|62748288|FG000|Overall Study|Study Drug Toxicity|79|||
33369577|NCT00861614|62748289|FG001|Overall Study|Study Drug Toxicity|6|||
33369578|NCT00861614|62748288|FG000|Overall Study|Death|32|||
33369579|NCT00861614|62748289|FG001|Overall Study|Death|19|||
33485561|NCT01369498|62863224|FG001|Overall Study|Adverse Event|2|||
33485562|NCT01369498|62863225|FG002|Overall Study|Adverse Event|0|||
33485563|NCT01369498|62863226|FG003|Overall Study|Adverse Event|1|||
33485564|NCT01369498|62863223|FG000|Overall Study|Withdrawal of Consent|0|||
33485565|NCT01369498|62863224|FG001|Overall Study|Withdrawal of Consent|1|||
33485566|NCT01369498|62863225|FG002|Overall Study|Withdrawal of Consent|1|||
33485567|NCT01369498|62863226|FG003|Overall Study|Withdrawal of Consent|1|||
33369580|NCT00861614|62748288|FG000|Overall Study|Adverse Event|27|||
33369581|NCT00861614|62748289|FG001|Overall Study|Adverse Event|23|||
33369582|NCT00861614|62748288|FG000|Overall Study|Withdrawal by Subject|34|||
33369583|NCT00861614|62748289|FG001|Overall Study|Withdrawal by Subject|35|||
33369584|NCT00861614|62748288|FG000|Overall Study|Other|17|||
33369585|NCT00861614|62748289|FG001|Overall Study|Other|22|||
33369586|NCT00485173|62748297|FG000|Overall Study|Death|4|||
33369587|NCT00485173|62748298|FG001|Overall Study|Death|3|||
33369588|NCT00485173|62748297|FG000|Overall Study|Lost to Follow-up|32|||
33369589|NCT00485173|62748298|FG001|Overall Study|Lost to Follow-up|61|||
33369590|NCT00495469|62748311|FG000|Overall Study|Adverse Event|0|||
33369591|NCT00495469|62748312|FG001|Overall Study|Adverse Event|1|||
33369592|NCT00495469|62748313|FG002|Overall Study|Adverse Event|3|||
33369593|NCT00495469|62748314|FG003|Overall Study|Adverse Event|0|||
33485568|NCT01369498|62863223|FG000|Overall Study|Death|0|||
33485569|NCT01369498|62863224|FG001|Overall Study|Death|0|||
33369594|NCT00495469|62748315|FG004|Overall Study|Adverse Event|1|||
33369595|NCT00495469|62748316|FG005|Overall Study|Adverse Event|1|||
33369596|NCT00495469|62748317|FG006|Overall Study|Adverse Event|1|||
33369597|NCT00495469|62748311|FG000|Overall Study|Lost to Follow-up|1|||
33369598|NCT00495469|62748312|FG001|Overall Study|Lost to Follow-up|1|||
33369599|NCT00495469|62748313|FG002|Overall Study|Lost to Follow-up|3|||
33369600|NCT00495469|62748314|FG003|Overall Study|Lost to Follow-up|1|||
33369601|NCT00495469|62748315|FG004|Overall Study|Lost to Follow-up|0|||
33369602|NCT00495469|62748316|FG005|Overall Study|Lost to Follow-up|0|||
33369603|NCT00495469|62748317|FG006|Overall Study|Lost to Follow-up|0|||
33369604|NCT00495469|62748311|FG000|Overall Study|Protocol Violation|0|||
33369605|NCT00495469|62748312|FG001|Overall Study|Protocol Violation|0|||
33369606|NCT00495469|62748313|FG002|Overall Study|Protocol Violation|0|||
33369607|NCT00495469|62748314|FG003|Overall Study|Protocol Violation|0|||
33369608|NCT00495469|62748315|FG004|Overall Study|Protocol Violation|1|||
33369609|NCT00495469|62748316|FG005|Overall Study|Protocol Violation|2|||
33369610|NCT00495469|62748317|FG006|Overall Study|Protocol Violation|0|||
33369611|NCT00495469|62748311|FG000|Overall Study|Withdrawal by Subject|5|||
33369612|NCT00495469|62748312|FG001|Overall Study|Withdrawal by Subject|3|||
33369613|NCT00495469|62748313|FG002|Overall Study|Withdrawal by Subject|1|||
33369614|NCT00495469|62748314|FG003|Overall Study|Withdrawal by Subject|3|||
33369615|NCT00495469|62748315|FG004|Overall Study|Withdrawal by Subject|3|||
33369616|NCT00495469|62748316|FG005|Overall Study|Withdrawal by Subject|2|||
33369617|NCT00495469|62748317|FG006|Overall Study|Withdrawal by Subject|3|||
33270235|NCT02457559|62642018|FG008|Overall Study|Reason not Specified|0|||
33270236|NCT02457559|62642019|FG009|Overall Study|Reason not Specified|2|||
33270237|NCT02457559|62642020|FG010|Overall Study|Reason not Specified|0|||
33270238|NCT02457559|62642010|FG000|Overall Study|Death|0|||
33270239|NCT02457559|62642011|FG001|Overall Study|Death|0|||
33270240|NCT02457559|62642012|FG002|Overall Study|Death|0|||
33270241|NCT02457559|62642013|FG003|Overall Study|Death|0|||
33270242|NCT02457559|62642014|FG004|Overall Study|Death|0|||
33270243|NCT02457559|62642015|FG005|Overall Study|Death|0|||
33270244|NCT02457559|62642016|FG006|Overall Study|Death|0|||
33270245|NCT02457559|62642017|FG007|Overall Study|Death|0|||
33270246|NCT02457559|62642018|FG008|Overall Study|Death|1|||
33270247|NCT02457559|62642019|FG009|Overall Study|Death|1|||
33270248|NCT02457559|62642020|FG010|Overall Study|Death|0|||
33270249|NCT02381652|62642070|FG000|Overall Study|Withdrawal by Subject|0|||
33270250|NCT02381652|62642071|FG001|Overall Study|Withdrawal by Subject|0|||
33270251|NCT02381652|62642072|FG002|Overall Study|Withdrawal by Subject|1|||
33270252|NCT02367794|62642081|FG000|Overall Study|Death|252|||
33270253|NCT02367794|62642082|FG001|Overall Study|Death|245|||
33270254|NCT02367794|62642083|FG002|Overall Study|Death|243|||
33270255|NCT02367794|62642081|FG000|Overall Study|Lost to Follow-up|1|||
33270256|NCT02367794|62642082|FG001|Overall Study|Lost to Follow-up|2|||
33270257|NCT02367794|62642083|FG002|Overall Study|Lost to Follow-up|2|||
33270258|NCT02367794|62642081|FG000|Overall Study|Physician Decision|0|||
33270259|NCT02367794|62642082|FG001|Overall Study|Physician Decision|5|||
33270260|NCT02367794|62642083|FG002|Overall Study|Physician Decision|3|||
33270261|NCT02367794|62642081|FG000|Overall Study|Protocol Violation|1|||
33270262|NCT02367794|62642082|FG001|Overall Study|Protocol Violation|0|||
33270263|NCT02367794|62642083|FG002|Overall Study|Protocol Violation|1|||
33270264|NCT02367794|62642081|FG000|Overall Study|Withdrawal by Subject|25|||
33270265|NCT02367794|62642082|FG001|Overall Study|Withdrawal by Subject|12|||
33270266|NCT02367794|62642083|FG002|Overall Study|Withdrawal by Subject|20|||
33270267|NCT02367794|62642081|FG000|Overall Study|Brain metastasis|1|||
33369618|NCT00495469|62748311|FG000|Overall Study|Lack of Efficacy|0|||
33369619|NCT00495469|62748312|FG001|Overall Study|Lack of Efficacy|0|||
33485570|NCT01369498|62863225|FG002|Overall Study|Death|1|||
33485571|NCT01369498|62863226|FG003|Overall Study|Death|0|||
33485572|NCT01369498|62863223|FG000|Overall Study|Investigator's Discretion|1|||
33485573|NCT01369498|62863224|FG001|Overall Study|Investigator's Discretion|0|||
33485574|NCT01369498|62863225|FG002|Overall Study|Investigator's Discretion|1|||
33369620|NCT00495469|62748313|FG002|Overall Study|Lack of Efficacy|0|||
33485575|NCT01369498|62863226|FG003|Overall Study|Investigator's Discretion|3|||
33270268|NCT02367794|62642082|FG001|Overall Study|Brain metastasis|0|||
33270269|NCT02367794|62642083|FG002|Overall Study|Brain metastasis|0|||
33270270|NCT02367794|62642081|FG000|Overall Study|Randomized in error|0|||
33270271|NCT02367794|62642082|FG001|Overall Study|Randomized in error|0|||
33270272|NCT02367794|62642083|FG002|Overall Study|Randomized in error|1|||
33270273|NCT02367794|62642081|FG000|Overall Study|Patient unable to receive carboplatin|0|||
33270274|NCT02367794|62642082|FG001|Overall Study|Patient unable to receive carboplatin|0|||
33369621|NCT00495469|62748314|FG003|Overall Study|Lack of Efficacy|0|||
33369622|NCT00495469|62748315|FG004|Overall Study|Lack of Efficacy|0|||
33369623|NCT00495469|62748316|FG005|Overall Study|Lack of Efficacy|0|||
33270275|NCT02367794|62642083|FG002|Overall Study|Patient unable to receive carboplatin|1|||
33270276|NCT02367794|62642081|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
33369624|NCT00495469|62748317|FG006|Overall Study|Lack of Efficacy|1|||
33369625|NCT00495469|62748311|FG000|Overall Study|Liver function test abnormality|0|||
33369626|NCT00495469|62748312|FG001|Overall Study|Liver function test abnormality|1|||
33369627|NCT00495469|62748313|FG002|Overall Study|Liver function test abnormality|0|||
33369628|NCT00495469|62748314|FG003|Overall Study|Liver function test abnormality|0|||
33369629|NCT00495469|62748315|FG004|Overall Study|Liver function test abnormality|0|||
33369630|NCT00495469|62748316|FG005|Overall Study|Liver function test abnormality|0|||
33369631|NCT00495469|62748317|FG006|Overall Study|Liver function test abnormality|0|||
33369632|NCT00495469|62748311|FG000|Overall Study|ST depression at randomisation in ECG|0|||
33369633|NCT00495469|62748312|FG001|Overall Study|ST depression at randomisation in ECG|1|||
33369634|NCT00495469|62748313|FG002|Overall Study|ST depression at randomisation in ECG|0|||
33369635|NCT00495469|62748314|FG003|Overall Study|ST depression at randomisation in ECG|0|||
33369636|NCT00495469|62748315|FG004|Overall Study|ST depression at randomisation in ECG|0|||
33369637|NCT00495469|62748316|FG005|Overall Study|ST depression at randomisation in ECG|0|||
33369638|NCT00495469|62748317|FG006|Overall Study|ST depression at randomisation in ECG|0|||
33369639|NCT00861380|62748347|FG000|Overall Study|Withdrawal Information not recorded|8427|||
33369640|NCT00861380|62748348|FG001|Overall Study|Withdrawal Information not recorded|9112|||
33369641|NCT00861380|62748349|FG002|Overall Study|Withdrawal Information not recorded|8872|||
33369642|NCT00861380|62748350|FG003|Overall Study|Withdrawal Information not recorded|3689|||
33369643|NCT00861380|62748351|FG004|Overall Study|Withdrawal Information not recorded|1812|||
33369644|NCT00861380|62748352|FG005|Overall Study|Withdrawal Information not recorded|6249|||
33369645|NCT00861380|62748353|FG006|Overall Study|Withdrawal Information not recorded|3020|||
33369646|NCT00495391|62748388|FG000|Overall Study|Lack of Efficacy|34|||
33369647|NCT00495391|62748389|FG001|Overall Study|Lack of Efficacy|18|||
33369648|NCT00495391|62748388|FG000|Overall Study|Withdrawal by Subject|2|||
33369649|NCT00495391|62748389|FG001|Overall Study|Withdrawal by Subject|3|||
33369650|NCT00869960|62748395|FG000|Overall Study|Lost to Follow-up|2|||
33369651|NCT00494299|62748401|FG000|Overall Study|Adverse Event|93|||
33369652|NCT00494299|62748402|FG001|Overall Study|Adverse Event|13|||
33369653|NCT00494299|62748401|FG000|Overall Study|Lost to Follow-up|1|||
33369654|NCT00494299|62748402|FG001|Overall Study|Lost to Follow-up|0|||
33369655|NCT00494299|62748401|FG000|Overall Study|Physician Decision|0|||
33369656|NCT00494299|62748402|FG001|Overall Study|Physician Decision|2|||
33369657|NCT00494299|62748401|FG000|Overall Study|Protocol Violation|1|||
33369658|NCT00494299|62748402|FG001|Overall Study|Protocol Violation|2|||
33369659|NCT00494299|62748401|FG000|Overall Study|Withdrawal by Subject|8|||
33369660|NCT00494299|62748402|FG001|Overall Study|Withdrawal by Subject|3|||
33270277|NCT02367794|62642082|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
33270278|NCT02367794|62642083|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
33270279|NCT02367794|62642081|FG000|Overall Study|Adverse Event|0|||
33270280|NCT02367794|62642082|FG001|Overall Study|Adverse Event|0|||
33270281|NCT02367794|62642083|FG002|Overall Study|Adverse Event|2|||
33270282|NCT02367794|62642081|FG000|Overall Study|Study Terminated By Sponsor|0|||
33270283|NCT02367794|62642082|FG001|Overall Study|Study Terminated By Sponsor|1|||
33270284|NCT02367794|62642083|FG002|Overall Study|Study Terminated By Sponsor|1|||
33270285|NCT02367794|62642081|FG000|Overall Study|Moved to Roll-Over Study|0|||
33270286|NCT02367794|62642082|FG001|Overall Study|Moved to Roll-Over Study|15|||
33270287|NCT02367794|62642083|FG002|Overall Study|Moved to Roll-Over Study|13|||
33270288|NCT02367794|62642081|FG000|Overall Study|Sponsor Request|60|||
33270289|NCT02367794|62642082|FG001|Overall Study|Sponsor Request|57|||
33270290|NCT02367794|62642083|FG002|Overall Study|Sponsor Request|45|||
33270291|NCT02367794|62642081|FG000|Overall Study|Moved into PTAP Study|0|||
33270292|NCT02367794|62642082|FG001|Overall Study|Moved into PTAP Study|2|||
33270293|NCT02367794|62642083|FG002|Overall Study|Moved into PTAP Study|3|||
33270294|NCT02367794|62642081|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
33270295|NCT02367794|62642082|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
33270296|NCT02367794|62642083|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
33270297|NCT02367794|62642081|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
33270298|NCT02367794|62642082|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
33270299|NCT02367794|62642083|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
33270300|NCT02367794|62642081|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
33270301|NCT02367794|62642082|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
33270302|NCT02367794|62642083|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
33270303|NCT02367794|62642081|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
33270304|NCT02367794|62642082|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
33270305|NCT02367794|62642083|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
33369661|NCT00494299|62748401|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
33369662|NCT00494299|62748402|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
33369663|NCT00494299|62748401|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
33369664|NCT00494299|62748402|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
33369665|NCT00494299|62748401|FG000|Overall Study|Site Closed by Sponsor|6|||
33369666|NCT00494299|62748402|FG001|Overall Study|Site Closed by Sponsor|0|||
33369667|NCT00494299|62748401|FG000|Overall Study|Protocol Driven Decision Point|11|||
33485576|NCT01369498|62863223|FG000|Overall Study|Unknown Reason|1|||
33270306|NCT02353832|62642116|FG000|Overall Study|Ineligible after enrollment|1|||
33270307|NCT02353832|62642116|FG000|Overall Study|Lost to Follow-up|1|||
33270308|NCT02353728|62642120|FG000|Overall Study|Subject non-compliance|1|||
33270309|NCT02345070|62642127|FG000|Overall Study|Adverse Event|12|||
33270310|NCT02345070|62642128|FG001|Overall Study|Adverse Event|8|||
33270311|NCT02345070|62642129|FG002|Overall Study|Adverse Event|16|||
33270312|NCT02345070|62642127|FG000|Overall Study|Poor compliance to protocol|2|||
33270313|NCT02345070|62642128|FG001|Overall Study|Poor compliance to protocol|0|||
33270314|NCT02345070|62642129|FG002|Overall Study|Poor compliance to protocol|0|||
33270315|NCT02345070|62642127|FG000|Overall Study|Other than specified above|6|||
33270316|NCT02345070|62642128|FG001|Overall Study|Other than specified above|3|||
33270317|NCT02345070|62642129|FG002|Overall Study|Other than specified above|7|||
33270318|NCT02325466|62642137|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
33270319|NCT02325466|62642138|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
33270320|NCT02325466|62642139|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
33270321|NCT02325466|62642137|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
33270322|NCT02325466|62642138|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
33270323|NCT02325466|62642139|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
33270324|NCT02325466|62642137|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
33270325|NCT02325466|62642138|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
33270326|NCT02325466|62642139|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
33270327|NCT02325466|62642137|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
33270328|NCT02325466|62642138|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
33270329|NCT02325466|62642139|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
33270330|NCT02325466|62642137|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
33270331|NCT02325466|62642138|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
33270332|NCT02325466|62642139|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
33270333|NCT02325466|62642137|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
33270334|NCT02325466|62642138|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
33270335|NCT02325466|62642139|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
33270336|NCT02325466|62642137|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
33270337|NCT02325466|62642138|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
33270338|NCT02325466|62642139|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
33270339|NCT02325466|62642137|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
33270340|NCT02325466|62642138|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
33270341|NCT02325466|62642139|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
33270342|NCT02325466|62642137|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
33270343|NCT02325466|62642138|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
33270344|NCT02325466|62642139|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
33270345|NCT02322710|62642150|FG000|Overall Study|No efficacy assessment post-baseline|0|||
33270346|NCT02322710|62642151|FG001|Overall Study|No efficacy assessment post-baseline|1|||
33270347|NCT02322710|62642150|FG000|Overall Study|Protocol Violation|20|||
33270348|NCT02322710|62642151|FG001|Overall Study|Protocol Violation|25|||
33270349|NCT02234310|62642194|FG000|Overall Study|Physician Decision|1|||
33270350|NCT02234310|62642194|FG000|Overall Study|Adverse Event|1|||
33270351|NCT02234310|62642194|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
33270352|NCT02234310|62642194|FG000|Overall Study|Withdrawal by Subject|2|||
33270353|NCT02106195|62642227|FG000|Overall Study|Adverse Event|2|||
33270354|NCT02106195|62642227|FG000|Overall Study|Protocol Violation|1|||
33270355|NCT02104180|62642239|FG000|Overall Study|Protocol Violation|1|||
33270356|NCT02104180|62642240|FG001|Overall Study|Protocol Violation|0|||
33270357|NCT02040857|62642250|FG000|Overall Study|Adverse Event|14|||
33270358|NCT02040857|62642250|FG000|Overall Study|Physician Decision|5|||
33270359|NCT02040857|62642250|FG000|Overall Study|Withdrawal by Subject|31|||
33270360|NCT02040857|62642250|FG000|Overall Study|patient non-compliance|3|||
33270361|NCT02040857|62642250|FG000|Overall Study|Lost to Follow-up|2|||
33270362|NCT02040857|62642250|FG000|Overall Study|recurrence|4|||
33270363|NCT02040857|62642250|FG000|Overall Study|ineligible|1|||
33270364|NCT01943825|62642270|FG000|Overall Study|Lost to Follow-up|9|||
33270365|NCT01943825|62642271|FG001|Overall Study|Lost to Follow-up|3|||
33270366|NCT01943825|62642272|FG002|Overall Study|Lost to Follow-up|12|||
33270367|NCT01943825|62642273|FG003|Overall Study|Lost to Follow-up|8|||
33270368|NCT01943825|62642270|FG000|Overall Study|Withdrawal by Subject|1|||
33270369|NCT01943825|62642271|FG001|Overall Study|Withdrawal by Subject|0|||
33270370|NCT01943825|62642272|FG002|Overall Study|Withdrawal by Subject|3|||
33270371|NCT01943825|62642273|FG003|Overall Study|Withdrawal by Subject|2|||
33270372|NCT01943825|62642270|FG000|Overall Study|Other than specified above|0|||
33270373|NCT01943825|62642271|FG001|Overall Study|Other than specified above|1|||
33270374|NCT01943825|62642272|FG002|Overall Study|Other than specified above|0|||
33662012|NCT02700984|63092480|FG001|Overall Study|Reason not specified|2|||
33662013|NCT02696850|63092554|FG000|Overall Study|Withdrawal by Subject|3|||
33270375|NCT01943825|62642273|FG003|Overall Study|Other than specified above|1|||
33270376|NCT01722331|62642305|FG000|Part 1|Adverse Event|5|||
33270377|NCT01722331|62642306|FG001|Part 1|Adverse Event|0|||
33270378|NCT01722331|62642307|FG002|Part 1|Adverse Event|0|||
33369668|NCT00494299|62748402|FG001|Overall Study|Protocol Driven Decision Point|22|||
33369669|NCT00593684|62748410|FG000|Overall Study|Death|2|||
33369670|NCT00593684|62748411|FG001|Overall Study|Death|1|||
33369671|NCT02963831|62748421|FG000|Overall Study|Progressive Disease|3|||
33369672|NCT02963831|62748422|FG001|Overall Study|Progressive Disease|3|||
33369673|NCT02963831|62748423|FG002|Overall Study|Progressive Disease|16|||
33270379|NCT01722331|62642308|FG003|Part 1|Adverse Event|0|||
33270380|NCT01722331|62642309|FG004|Part 1|Adverse Event|0|||
33270381|NCT01722331|62642310|FG005|Part 1|Adverse Event|0|||
33270382|NCT01722331|62642311|FG006|Part 1|Adverse Event|0|||
33270383|NCT01722331|62642305|FG000|Part 1|Lack of Efficacy|0|||
33270384|NCT01722331|62642306|FG001|Part 1|Lack of Efficacy|0|||
33270385|NCT01722331|62642307|FG002|Part 1|Lack of Efficacy|1|||
33270386|NCT01722331|62642308|FG003|Part 1|Lack of Efficacy|0|||
33270387|NCT01722331|62642309|FG004|Part 1|Lack of Efficacy|2|||
33270388|NCT01722331|62642310|FG005|Part 1|Lack of Efficacy|0|||
33270389|NCT01722331|62642311|FG006|Part 1|Lack of Efficacy|0|||
33270390|NCT01722331|62642305|FG000|Part 1|Lost to Follow-up|1|||
33369674|NCT02963831|62748424|FG003|Overall Study|Progressive Disease|27|||
33369675|NCT02963831|62748421|FG000|Overall Study|Withdrawal by Subject|1|||
33369676|NCT02963831|62748422|FG001|Overall Study|Withdrawal by Subject|0|||
33369677|NCT02963831|62748423|FG002|Overall Study|Withdrawal by Subject|2|||
33369678|NCT02963831|62748424|FG003|Overall Study|Withdrawal by Subject|4|||
33369679|NCT02963831|62748421|FG000|Overall Study|Adverse Event|0|||
33270391|NCT01722331|62642306|FG001|Part 1|Lost to Follow-up|0|||
33270392|NCT01722331|62642307|FG002|Part 1|Lost to Follow-up|2|||
33270393|NCT01722331|62642308|FG003|Part 1|Lost to Follow-up|0|||
33270394|NCT01722331|62642309|FG004|Part 1|Lost to Follow-up|1|||
33270395|NCT01722331|62642310|FG005|Part 1|Lost to Follow-up|0|||
33270396|NCT01722331|62642311|FG006|Part 1|Lost to Follow-up|0|||
33270397|NCT01722331|62642305|FG000|Part 1|Physician Decision|0|||
33270398|NCT01722331|62642306|FG001|Part 1|Physician Decision|0|||
33270399|NCT01722331|62642307|FG002|Part 1|Physician Decision|3|||
33270400|NCT01722331|62642308|FG003|Part 1|Physician Decision|0|||
33270401|NCT01722331|62642309|FG004|Part 1|Physician Decision|1|||
33270402|NCT01722331|62642310|FG005|Part 1|Physician Decision|0|||
33270403|NCT01722331|62642311|FG006|Part 1|Physician Decision|0|||
33270404|NCT01722331|62642305|FG000|Part 1|Pregnancy|1|||
33270405|NCT01722331|62642306|FG001|Part 1|Pregnancy|0|||
33270406|NCT01722331|62642307|FG002|Part 1|Pregnancy|0|||
33270407|NCT01722331|62642308|FG003|Part 1|Pregnancy|0|||
33270408|NCT01722331|62642309|FG004|Part 1|Pregnancy|0|||
33270409|NCT01722331|62642310|FG005|Part 1|Pregnancy|0|||
33270410|NCT01722331|62642311|FG006|Part 1|Pregnancy|0|||
33270411|NCT01722331|62642305|FG000|Part 1|Progressive Disease|0|||
33270412|NCT01722331|62642306|FG001|Part 1|Progressive Disease|0|||
33270413|NCT01722331|62642307|FG002|Part 1|Progressive Disease|0|||
33270414|NCT01722331|62642308|FG003|Part 1|Progressive Disease|0|||
33270415|NCT01722331|62642309|FG004|Part 1|Progressive Disease|1|||
33270416|NCT01722331|62642310|FG005|Part 1|Progressive Disease|0|||
33270417|NCT01722331|62642311|FG006|Part 1|Progressive Disease|0|||
33270418|NCT01722331|62642305|FG000|Part 1|Protocol Violation|1|||
33270419|NCT01722331|62642306|FG001|Part 1|Protocol Violation|0|||
33270420|NCT01722331|62642307|FG002|Part 1|Protocol Violation|0|||
33270421|NCT01722331|62642308|FG003|Part 1|Protocol Violation|0|||
33270422|NCT01722331|62642309|FG004|Part 1|Protocol Violation|1|||
33270423|NCT01722331|62642310|FG005|Part 1|Protocol Violation|0|||
33270424|NCT01722331|62642311|FG006|Part 1|Protocol Violation|0|||
33270425|NCT01722331|62642305|FG000|Part 1|Withdrawal by Subject|2|||
33270426|NCT01722331|62642306|FG001|Part 1|Withdrawal by Subject|0|||
33270427|NCT01722331|62642307|FG002|Part 1|Withdrawal by Subject|3|||
33270428|NCT01722331|62642308|FG003|Part 1|Withdrawal by Subject|0|||
33270429|NCT01722331|62642309|FG004|Part 1|Withdrawal by Subject|3|||
33369680|NCT02963831|62748422|FG001|Overall Study|Adverse Event|1|||
33369681|NCT02963831|62748423|FG002|Overall Study|Adverse Event|1|||
33369682|NCT02963831|62748424|FG003|Overall Study|Adverse Event|2|||
33270430|NCT01722331|62642310|FG005|Part 1|Withdrawal by Subject|0|||
33270431|NCT01722331|62642311|FG006|Part 1|Withdrawal by Subject|0|||
33270432|NCT01722331|62642305|FG000|Part 2|Adverse Event|3|||
33270433|NCT01722331|62642306|FG001|Part 2|Adverse Event|0|||
33369683|NCT02963831|62748421|FG000|Overall Study|Death|0|||
33369684|NCT02963831|62748422|FG001|Overall Study|Death|0|||
33270434|NCT01722331|62642307|FG002|Part 2|Adverse Event|0|||
33270435|NCT01722331|62642308|FG003|Part 2|Adverse Event|0|||
33270436|NCT01722331|62642309|FG004|Part 2|Adverse Event|0|||
33270437|NCT01722331|62642310|FG005|Part 2|Adverse Event|1|||
33270438|NCT01722331|62642311|FG006|Part 2|Adverse Event|0|||
33270439|NCT01722331|62642305|FG000|Part 2|Lack of Efficacy|3|||
33270440|NCT01722331|62642306|FG001|Part 2|Lack of Efficacy|0|||
33270441|NCT01722331|62642307|FG002|Part 2|Lack of Efficacy|11|||
33270442|NCT01722331|62642308|FG003|Part 2|Lack of Efficacy|0|||
33270443|NCT01722331|62642309|FG004|Part 2|Lack of Efficacy|0|||
33369685|NCT02963831|62748423|FG002|Overall Study|Death|0|||
33270444|NCT01722331|62642310|FG005|Part 2|Lack of Efficacy|3|||
33270445|NCT01722331|62642311|FG006|Part 2|Lack of Efficacy|3|||
33270446|NCT01722331|62642305|FG000|Part 2|Lost to Follow-up|0|||
33270447|NCT01722331|62642306|FG001|Part 2|Lost to Follow-up|0|||
33270448|NCT01722331|62642307|FG002|Part 2|Lost to Follow-up|3|||
33270449|NCT01722331|62642308|FG003|Part 2|Lost to Follow-up|0|||
33270450|NCT01722331|62642309|FG004|Part 2|Lost to Follow-up|0|||
33270451|NCT01722331|62642310|FG005|Part 2|Lost to Follow-up|1|||
33270452|NCT01722331|62642311|FG006|Part 2|Lost to Follow-up|1|||
33270453|NCT01722331|62642305|FG000|Part 2|Non-Compliance with Study Drug|1|||
33270454|NCT01722331|62642306|FG001|Part 2|Non-Compliance with Study Drug|0|||
33270455|NCT01722331|62642307|FG002|Part 2|Non-Compliance with Study Drug|1|||
33270456|NCT01722331|62642308|FG003|Part 2|Non-Compliance with Study Drug|0|||
33270457|NCT01722331|62642309|FG004|Part 2|Non-Compliance with Study Drug|0|||
33270458|NCT01722331|62642310|FG005|Part 2|Non-Compliance with Study Drug|0|||
33270459|NCT01722331|62642311|FG006|Part 2|Non-Compliance with Study Drug|0|||
33270460|NCT01722331|62642305|FG000|Part 2|Physician Decision|0|||
33270461|NCT01722331|62642306|FG001|Part 2|Physician Decision|0|||
33270462|NCT01722331|62642307|FG002|Part 2|Physician Decision|2|||
33270463|NCT01722331|62642308|FG003|Part 2|Physician Decision|0|||
33369686|NCT02963831|62748424|FG003|Overall Study|Death|2|||
33369687|NCT00859898|62748439|FG000|Overall Study|Lack of Efficacy|0|||
33369688|NCT00859898|62748440|FG001|Overall Study|Lack of Efficacy|1|||
33369689|NCT00859898|62748441|FG002|Overall Study|Lack of Efficacy|1|||
33369690|NCT00859898|62748439|FG000|Overall Study|Adverse Event|4|||
33369691|NCT00859898|62748440|FG001|Overall Study|Adverse Event|9|||
33369692|NCT00859898|62748441|FG002|Overall Study|Adverse Event|8|||
33369693|NCT00859898|62748439|FG000|Overall Study|Withdrawal by Subject|11|||
33369694|NCT00859898|62748440|FG001|Overall Study|Withdrawal by Subject|8|||
33369695|NCT00859898|62748441|FG002|Overall Study|Withdrawal by Subject|11|||
33369696|NCT00859898|62748439|FG000|Overall Study|Death|0|||
33369697|NCT00859898|62748440|FG001|Overall Study|Death|0|||
33369698|NCT00859898|62748441|FG002|Overall Study|Death|1|||
33369699|NCT00859898|62748439|FG000|Overall Study|Lost to Follow-up|10|||
33369700|NCT00859898|62748440|FG001|Overall Study|Lost to Follow-up|11|||
33369701|NCT00859898|62748441|FG002|Overall Study|Lost to Follow-up|5|||
33369702|NCT00859898|62748439|FG000|Overall Study|poor/non-compliance|2|||
33369703|NCT00859898|62748440|FG001|Overall Study|poor/non-compliance|0|||
33369704|NCT00859898|62748441|FG002|Overall Study|poor/non-compliance|0|||
33369705|NCT00859898|62748439|FG000|Overall Study|No longer meets criteria|0|||
33369706|NCT00859898|62748440|FG001|Overall Study|No longer meets criteria|1|||
33369707|NCT00859898|62748441|FG002|Overall Study|No longer meets criteria|0|||
33369708|NCT00859898|62748439|FG000|Overall Study|non-specified|1|||
33369709|NCT00859898|62748440|FG001|Overall Study|non-specified|1|||
33369710|NCT00859898|62748441|FG002|Overall Study|non-specified|1|||
33369711|NCT00859586|62748450|FG000|Overall Study|Donors|4|||
33369712|NCT00494221|62748457|FG000|Overall Study|Death|15|||
33369713|NCT00494221|62748458|FG001|Overall Study|Death|9|||
33369714|NCT00494221|62748459|FG002|Overall Study|Death|14|||
33369715|NCT00494221|62748457|FG000|Overall Study|Withdrawal by Subject|1|||
33369716|NCT00494221|62748458|FG001|Overall Study|Withdrawal by Subject|2|||
33369717|NCT00494221|62748459|FG002|Overall Study|Withdrawal by Subject|0|||
33369718|NCT00857948|62748471|FG000|Overall Study|Withdrawal by Subject|2|||
33369719|NCT00857948|62748472|FG001|Overall Study|Withdrawal by Subject|0|||
33369720|NCT00857948|62748473|FG002|Overall Study|Withdrawal by Subject|0|||
33369721|NCT00857948|62748474|FG003|Overall Study|Withdrawal by Subject|0|||
33369722|NCT00857948|62748471|FG000|Overall Study|Protocol Violation|1|||
33369723|NCT00857948|62748472|FG001|Overall Study|Protocol Violation|0|||
33369724|NCT00857948|62748473|FG002|Overall Study|Protocol Violation|1|||
33369725|NCT00857948|62748474|FG003|Overall Study|Protocol Violation|0|||
33369726|NCT00866606|62748484|FG000|Overall Study|Lost to Follow-up|3|||
33369727|NCT00866606|62748484|FG000|Overall Study|Adverse Event|1|||
33369728|NCT00857792|62748488|FG000|Overall Study|inadequate image quality for analysis|12|||
33369729|NCT00601835|62748494|FG000|Overall Study|Withdrawal by Subject|9|||
33369730|NCT00601835|62748495|FG001|Overall Study|Withdrawal by Subject|6|||
33369731|NCT00601835|62748494|FG000|Overall Study|Physician Decision|1|||
33369732|NCT00601835|62748495|FG001|Overall Study|Physician Decision|0|||
33369733|NCT00601835|62748494|FG000|Overall Study|Lost to Follow-up|37|||
33369734|NCT00601835|62748495|FG001|Overall Study|Lost to Follow-up|5|||
33369735|NCT00601835|62748494|FG000|Overall Study|Adverse Event|1|||
33369736|NCT00601835|62748495|FG001|Overall Study|Adverse Event|1|||
33369737|NCT00601835|62748494|FG000|Overall Study|Relocate|12|||
33270464|NCT01722331|62642309|FG004|Part 2|Physician Decision|0|||
33270465|NCT01722331|62642310|FG005|Part 2|Physician Decision|0|||
33270466|NCT01722331|62642311|FG006|Part 2|Physician Decision|0|||
33270467|NCT01722331|62642305|FG000|Part 2|Pregnancy|0|||
33270468|NCT01722331|62642306|FG001|Part 2|Pregnancy|0|||
33270469|NCT01722331|62642307|FG002|Part 2|Pregnancy|0|||
33369738|NCT00601835|62748495|FG001|Overall Study|Relocate|2|||
33369739|NCT00857246|62748501|FG000|Induction Regimen|Adverse Event|1|||
33369740|NCT00857246|62748501|FG000|Induction Regimen|disease-related complications|1|||
33369741|NCT00857246|62748501|FG000|Induction Regimen|Withdrawal by Subject|1|||
33369742|NCT00857246|62748501|FG000|Surgery (Curative)|disease progression|6|||
33369743|NCT00857246|62748501|FG000|ChemoRT|Withdrawal by Subject|1|||
33369744|NCT00857246|62748501|FG000|ChemoRT|Adverse Event|2|||
33369745|NCT00856856|62748508|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
33369746|NCT00856856|62748508|FG000|4-year Clinical Follow-up|Missed visit|1|||
33369747|NCT00493285|62748523|FG000|Overall Study|Lost to Follow-up|0|||
33369748|NCT00493285|62748524|FG001|Overall Study|Lost to Follow-up|0|||
33369749|NCT00493285|62748525|FG002|Overall Study|Lost to Follow-up|0|||
33369750|NCT00493285|62748526|FG003|Overall Study|Lost to Follow-up|0|||
33369751|NCT00493285|62748527|FG004|Overall Study|Lost to Follow-up|1|||
33369752|NCT00493285|62748528|FG005|Overall Study|Lost to Follow-up|0|||
33369753|NCT00856778|62748542|FG000|Overall Study|Adverse Event|7|||
33369754|NCT00856778|62748542|FG000|Overall Study|Withdrawal by Subject|10|||
33369755|NCT00856778|62748542|FG000|Overall Study|Study deviation|2|||
33369756|NCT00856778|62748542|FG000|Overall Study|Lost to Follow-up|5|||
33369757|NCT00603473|62748546|FG000|Overall Study|Adverse Event|4|||
33369758|NCT00603473|62748546|FG000|Overall Study|Lack of Efficacy|4|||
33369759|NCT00603473|62748546|FG000|Overall Study|Protocol Violation|1|||
33369760|NCT00486889|62748550|FG000|Overall Study|Death|3|||
33369761|NCT00486889|62748550|FG000|Overall Study|Non-compliant|2|||
33369762|NCT00486889|62748550|FG000|Overall Study|Withdrawal by Subject|6|||
33369763|NCT00486811|62748557|FG000|Overall Study|Adverse Event|28|||
33369764|NCT00486811|62748558|FG001|Overall Study|Adverse Event|60|||
33270470|NCT01722331|62642308|FG003|Part 2|Pregnancy|0|||
33270471|NCT01722331|62642309|FG004|Part 2|Pregnancy|0|||
33270472|NCT01722331|62642310|FG005|Part 2|Pregnancy|1|||
33270473|NCT01722331|62642311|FG006|Part 2|Pregnancy|0|||
33270474|NCT01722331|62642305|FG000|Part 2|Progressive Disease|0|||
33270475|NCT01722331|62642306|FG001|Part 2|Progressive Disease|0|||
33270476|NCT01722331|62642307|FG002|Part 2|Progressive Disease|1|||
33270477|NCT01722331|62642308|FG003|Part 2|Progressive Disease|0|||
33270478|NCT01722331|62642309|FG004|Part 2|Progressive Disease|0|||
33270479|NCT01722331|62642310|FG005|Part 2|Progressive Disease|0|||
33270480|NCT01722331|62642311|FG006|Part 2|Progressive Disease|0|||
33270481|NCT01722331|62642305|FG000|Part 2|Protocol Violation|1|||
33270482|NCT01722331|62642306|FG001|Part 2|Protocol Violation|0|||
33270483|NCT01722331|62642307|FG002|Part 2|Protocol Violation|0|||
33270484|NCT01722331|62642308|FG003|Part 2|Protocol Violation|0|||
33270485|NCT01722331|62642309|FG004|Part 2|Protocol Violation|0|||
33270486|NCT01722331|62642310|FG005|Part 2|Protocol Violation|0|||
33270487|NCT01722331|62642311|FG006|Part 2|Protocol Violation|0|||
33270488|NCT01722331|62642305|FG000|Part 2|Withdrawal by Subject|5|||
33270489|NCT01722331|62642306|FG001|Part 2|Withdrawal by Subject|0|||
33270490|NCT01722331|62642307|FG002|Part 2|Withdrawal by Subject|3|||
33270491|NCT01722331|62642308|FG003|Part 2|Withdrawal by Subject|0|||
33270492|NCT01722331|62642309|FG004|Part 2|Withdrawal by Subject|0|||
33270493|NCT01722331|62642310|FG005|Part 2|Withdrawal by Subject|2|||
33270494|NCT01722331|62642311|FG006|Part 2|Withdrawal by Subject|2|||
33270495|NCT01722331|62642305|FG000|Part 2|Other Protocol Specified Criteria|6|||
33270496|NCT01722331|62642306|FG001|Part 2|Other Protocol Specified Criteria|0|||
33270497|NCT01722331|62642307|FG002|Part 2|Other Protocol Specified Criteria|10|||
33270498|NCT01722331|62642308|FG003|Part 2|Other Protocol Specified Criteria|0|||
33270499|NCT01722331|62642309|FG004|Part 2|Other Protocol Specified Criteria|0|||
33270500|NCT01722331|62642310|FG005|Part 2|Other Protocol Specified Criteria|2|||
33270501|NCT01722331|62642311|FG006|Part 2|Other Protocol Specified Criteria|1|||
33270502|NCT01722331|62642305|FG000|Part 3|Adverse Event|2|||
33270503|NCT01722331|62642306|FG001|Part 3|Adverse Event|2|||
33270504|NCT01722331|62642307|FG002|Part 3|Adverse Event|0|||
33270505|NCT01722331|62642308|FG003|Part 3|Adverse Event|1|||
33270506|NCT01722331|62642309|FG004|Part 3|Adverse Event|0|||
33270507|NCT01722331|62642310|FG005|Part 3|Adverse Event|0|||
33270508|NCT01722331|62642311|FG006|Part 3|Adverse Event|0|||
33270509|NCT01722331|62642305|FG000|Part 3|Death|1|||
33270510|NCT01722331|62642306|FG001|Part 3|Death|0|||
33270511|NCT01722331|62642307|FG002|Part 3|Death|0|||
33270512|NCT01722331|62642308|FG003|Part 3|Death|0|||
33270513|NCT01722331|62642309|FG004|Part 3|Death|0|||
33270514|NCT01722331|62642310|FG005|Part 3|Death|0|||
33270515|NCT01722331|62642311|FG006|Part 3|Death|0|||
33270516|NCT01722331|62642305|FG000|Part 3|Lack of Efficacy|1|||
33369765|NCT00486811|62748559|FG002|Overall Study|Adverse Event|135|||
33270517|NCT01722331|62642306|FG001|Part 3|Lack of Efficacy|0|||
33369766|NCT00486811|62748557|FG000|Overall Study|Lack of Efficacy|34|||
33270518|NCT01722331|62642307|FG002|Part 3|Lack of Efficacy|0|||
33270519|NCT01722331|62642308|FG003|Part 3|Lack of Efficacy|0|||
33270520|NCT01722331|62642309|FG004|Part 3|Lack of Efficacy|0|||
33270521|NCT01722331|62642310|FG005|Part 3|Lack of Efficacy|0|||
33270522|NCT01722331|62642311|FG006|Part 3|Lack of Efficacy|0|||
33270523|NCT01722331|62642305|FG000|Part 3|Lost to Follow-up|3|||
33270524|NCT01722331|62642306|FG001|Part 3|Lost to Follow-up|4|||
33270525|NCT01722331|62642307|FG002|Part 3|Lost to Follow-up|0|||
33270526|NCT01722331|62642308|FG003|Part 3|Lost to Follow-up|0|||
33369767|NCT00486811|62748558|FG001|Overall Study|Lack of Efficacy|14|||
33369768|NCT00486811|62748559|FG002|Overall Study|Lack of Efficacy|7|||
33270527|NCT01722331|62642309|FG004|Part 3|Lost to Follow-up|0|||
33270528|NCT01722331|62642310|FG005|Part 3|Lost to Follow-up|1|||
33270529|NCT01722331|62642311|FG006|Part 3|Lost to Follow-up|0|||
33270530|NCT01722331|62642305|FG000|Part 3|Non-Compliance with Study Drug|0|||
33270531|NCT01722331|62642306|FG001|Part 3|Non-Compliance with Study Drug|1|||
33270532|NCT01722331|62642307|FG002|Part 3|Non-Compliance with Study Drug|0|||
33270533|NCT01722331|62642308|FG003|Part 3|Non-Compliance with Study Drug|0|||
33270534|NCT01722331|62642309|FG004|Part 3|Non-Compliance with Study Drug|0|||
33270535|NCT01722331|62642310|FG005|Part 3|Non-Compliance with Study Drug|0|||
33270536|NCT01722331|62642311|FG006|Part 3|Non-Compliance with Study Drug|0|||
33270537|NCT01722331|62642305|FG000|Part 3|Physician Decision|1|||
33270538|NCT01722331|62642306|FG001|Part 3|Physician Decision|1|||
33270539|NCT01722331|62642307|FG002|Part 3|Physician Decision|0|||
33270540|NCT01722331|62642308|FG003|Part 3|Physician Decision|0|||
33270541|NCT01722331|62642309|FG004|Part 3|Physician Decision|0|||
33270542|NCT01722331|62642310|FG005|Part 3|Physician Decision|0|||
33270543|NCT01722331|62642311|FG006|Part 3|Physician Decision|1|||
33369769|NCT00486811|62748557|FG000|Overall Study|Lost to Follow-up|4|||
33369770|NCT00486811|62748558|FG001|Overall Study|Lost to Follow-up|6|||
33369771|NCT00486811|62748559|FG002|Overall Study|Lost to Follow-up|4|||
33369772|NCT00486811|62748557|FG000|Overall Study|Withdrawal by Subject|33|||
33369773|NCT00486811|62748558|FG001|Overall Study|Withdrawal by Subject|44|||
33369774|NCT00486811|62748559|FG002|Overall Study|Withdrawal by Subject|58|||
33369775|NCT00486811|62748557|FG000|Overall Study|Study drug non-compliant|5|||
33369776|NCT00486811|62748558|FG001|Overall Study|Study drug non-compliant|6|||
33369777|NCT00486811|62748559|FG002|Overall Study|Study drug non-compliant|3|||
33369778|NCT00486811|62748557|FG000|Overall Study|All other|18|||
33369779|NCT00486811|62748558|FG001|Overall Study|All other|11|||
33369780|NCT00486811|62748559|FG002|Overall Study|All other|7|||
33369781|NCT00486265|62748567|FG000|Overall Study|Adverse Event|1|||
33369782|NCT00486265|62748567|FG000|Overall Study|Lack of Efficacy|8|||
33369783|NCT02151604|62748571|FG000|Overall Study|Lost to Follow-up|3|||
33369784|NCT02151604|62748571|FG000|Overall Study|Withdrawal by Subject|2|||
33369785|NCT02151604|62748571|FG000|Overall Study|Physician Decision|3|||
33369786|NCT02151604|62748571|FG000|Overall Study|Death|1|||
33369787|NCT00466921|62748576|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
33369788|NCT00466921|62748576|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
33369789|NCT00466921|62748576|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
33369790|NCT00466921|62748576|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
33369791|NCT00466921|62748576|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
33369792|NCT00466921|62748576|FG000|Follow up for a Minimum of 1 Year|Death|6|||
33369793|NCT00601523|62748582|FG000|Overall Study|Adverse Event|42|||
33369794|NCT00601523|62748583|FG001|Overall Study|Adverse Event|14|||
33369795|NCT00601523|62748582|FG000|Overall Study|Lack of Efficacy|3|||
33369796|NCT00601523|62748583|FG001|Overall Study|Lack of Efficacy|0|||
33369797|NCT00601523|62748582|FG000|Overall Study|Protocol Violation|5|||
33369798|NCT00601523|62748583|FG001|Overall Study|Protocol Violation|1|||
33270544|NCT01722331|62642305|FG000|Part 3|Protocol Violation|2|||
33270545|NCT01722331|62642306|FG001|Part 3|Protocol Violation|1|||
33270546|NCT01722331|62642307|FG002|Part 3|Protocol Violation|0|||
33270547|NCT01722331|62642308|FG003|Part 3|Protocol Violation|0|||
33270548|NCT01722331|62642309|FG004|Part 3|Protocol Violation|0|||
33270549|NCT01722331|62642310|FG005|Part 3|Protocol Violation|0|||
33270550|NCT01722331|62642311|FG006|Part 3|Protocol Violation|0|||
33369799|NCT00601523|62748582|FG000|Overall Study|Lost to Follow-up|0|||
33369800|NCT00601523|62748583|FG001|Overall Study|Lost to Follow-up|1|||
33369801|NCT00601523|62748582|FG000|Overall Study|Withdrawal by Subject|18|||
33369802|NCT00601523|62748583|FG001|Overall Study|Withdrawal by Subject|9|||
33369803|NCT00601523|62748582|FG000|Overall Study|Other|9|||
33369804|NCT00601523|62748583|FG001|Overall Study|Other|1|||
33369805|NCT00466687|62748589|FG000|Overall Study|Adverse Event|1|||
33369806|NCT00466687|62748589|FG000|Overall Study|Other complicating illness|3|||
33270551|NCT01722331|62642305|FG000|Part 3|Withdrawal by Subject|4|||
33369807|NCT00466687|62748589|FG000|Overall Study|Withdrawal by Subject|1|||
33369808|NCT00466687|62748589|FG000|Overall Study|Disease progression|29|||
33369809|NCT00465985|62748611|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
33369810|NCT00465985|62748612|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
33369811|NCT00465985|62748611|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
33369812|NCT00465985|62748612|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
33270552|NCT01722331|62642306|FG001|Part 3|Withdrawal by Subject|7|||
33270553|NCT01722331|62642307|FG002|Part 3|Withdrawal by Subject|0|||
33369813|NCT00465985|62748611|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
33270554|NCT01722331|62642308|FG003|Part 3|Withdrawal by Subject|0|||
33270555|NCT01722331|62642309|FG004|Part 3|Withdrawal by Subject|0|||
33270556|NCT01722331|62642310|FG005|Part 3|Withdrawal by Subject|2|||
33270557|NCT01722331|62642311|FG006|Part 3|Withdrawal by Subject|1|||
33369814|NCT00465985|62748612|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
33369815|NCT00465985|62748611|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
33369816|NCT00465985|62748612|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
33369817|NCT00454051|62748623|FG000|Overall Study|Adverse Event|1|||
33369818|NCT00454051|62748624|FG001|Overall Study|Adverse Event|2|||
33369819|NCT00454051|62748623|FG000|Overall Study|Withdrawal by Subject|1|||
33369820|NCT00454051|62748624|FG001|Overall Study|Withdrawal by Subject|0|||
33369821|NCT00454051|62748623|FG000|Overall Study|Protocol Violation|1|||
33369822|NCT00454051|62748624|FG001|Overall Study|Protocol Violation|1|||
33270558|NCT01722331|62642305|FG000|Part 3|Other Protocol Specified Criteria|1|||
33270559|NCT01722331|62642306|FG001|Part 3|Other Protocol Specified Criteria|1|||
33270560|NCT01722331|62642307|FG002|Part 3|Other Protocol Specified Criteria|0|||
33270561|NCT01722331|62642308|FG003|Part 3|Other Protocol Specified Criteria|0|||
33270562|NCT01722331|62642309|FG004|Part 3|Other Protocol Specified Criteria|0|||
33270563|NCT01722331|62642310|FG005|Part 3|Other Protocol Specified Criteria|0|||
33270564|NCT01722331|62642311|FG006|Part 3|Other Protocol Specified Criteria|0|||
33270565|NCT01630590|62642323|FG000|Overall Study|Adverse Event|9|||
33270566|NCT01630590|62642323|FG000|Overall Study|Lack of Efficacy|37|||
33270567|NCT01630590|62642323|FG000|Overall Study|Withdrawal by Subject|4|||
33270568|NCT01630590|62642323|FG000|Overall Study|2nd primary tumor|2|||
33270569|NCT01630590|62642323|FG000|Overall Study|Automobile accident|1|||
33270570|NCT01630590|62642323|FG000|Overall Study|Maximum benefit|4|||
33270571|NCT01619085|62642327|FG000|Overall Study|Adverse Event|231|||
33270572|NCT01619085|62642327|FG000|Overall Study|Protocol Violation|4|||
33270573|NCT01619085|62642327|FG000|Overall Study|Lost to Follow-up|3|||
33270574|NCT01619085|62642327|FG000|Overall Study|Withdrawal by Subject|45|||
33270575|NCT01619085|62642327|FG000|Overall Study|Other than specified|96|||
33270576|NCT01619085|62642327|FG000|Overall Study|Not treated|1|||
33270577|NCT01619085|62642327|FG000|Overall Study|Death|145|||
33270578|NCT01499095|62642340|FG000|Overall Study|Randomized But Not Treated|1|||
33270579|NCT01499095|62642341|FG001|Overall Study|Randomized But Not Treated|1|||
33270580|NCT01499095|62642340|FG000|Overall Study|Adverse Event|12|||
33270581|NCT01499095|62642341|FG001|Overall Study|Adverse Event|7|||
33270582|NCT01499095|62642340|FG000|Overall Study|Lack of Efficacy|2|||
33270583|NCT01499095|62642341|FG001|Overall Study|Lack of Efficacy|1|||
33270584|NCT01499095|62642340|FG000|Overall Study|Protocol Violation|6|||
33270585|NCT01499095|62642341|FG001|Overall Study|Protocol Violation|7|||
33270586|NCT01499095|62642340|FG000|Overall Study|Received Rescue Therapy|32|||
33270587|NCT01499095|62642341|FG001|Overall Study|Received Rescue Therapy|40|||
33270588|NCT01499095|62642340|FG000|Overall Study|Diverse Reasons|22|||
33270589|NCT01499095|62642341|FG001|Overall Study|Diverse Reasons|25|||
33270590|NCT01499095|62642340|FG000|Overall Study|Lost to Follow-up|6|||
33270591|NCT01499095|62642341|FG001|Overall Study|Lost to Follow-up|4|||
33270592|NCT01499095|62642340|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
33270593|NCT01499095|62642341|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
33270594|NCT01499095|62642340|FG000|Overall Study|Hypoglycemia|3|||
33270595|NCT01499095|62642341|FG001|Overall Study|Hypoglycemia|1|||
33270596|NCT01499095|62642340|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
33270597|NCT01499095|62642341|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
33270598|NCT01499095|62642340|FG000|Overall Study|Change in Injection Schedule|2|||
33270599|NCT01499095|62642341|FG001|Overall Study|Change in Injection Schedule|0|||
33270600|NCT01499095|62642340|FG000|Overall Study|Perceived Lack of Efficacy|1|||
33270601|NCT01499095|62642341|FG001|Overall Study|Perceived Lack of Efficacy|1|||
33270602|NCT01499082|62642352|FG000|Overall Study|Randomized but not Treated|0|||
33270603|NCT01499082|62642353|FG001|Overall Study|Randomized but not Treated|1|||
33270604|NCT01499082|62642352|FG000|Overall Study|Adverse Event|12|||
33270605|NCT01499082|62642353|FG001|Overall Study|Adverse Event|16|||
33270606|NCT01499082|62642352|FG000|Overall Study|Lack of Efficacy|1|||
33270607|NCT01499082|62642353|FG001|Overall Study|Lack of Efficacy|1|||
33270608|NCT01499082|62642352|FG000|Overall Study|Protocol Violation|6|||
33270609|NCT01499082|62642353|FG001|Overall Study|Protocol Violation|8|||
33270610|NCT01499082|62642352|FG000|Overall Study|Diverse Reasons|18|||
33270611|NCT01499082|62642353|FG001|Overall Study|Diverse Reasons|14|||
33270612|NCT01499082|62642352|FG000|Overall Study|Site Closure for Noncompliance|5|||
33270613|NCT01499082|62642353|FG001|Overall Study|Site Closure for Noncompliance|2|||
33270614|NCT01499082|62642352|FG000|Overall Study|Hypoglycemia|2|||
33270615|NCT01499082|62642353|FG001|Overall Study|Hypoglycemia|3|||
33270616|NCT01499082|62642352|FG000|Overall Study|Lost to Follow-up|1|||
33270617|NCT01499082|62642353|FG001|Overall Study|Lost to Follow-up|3|||
33270618|NCT01488890|62642365|FG000|Overall Study|Serious adverse event|2|||
33270619|NCT01488890|62642366|FG001|Overall Study|Serious adverse event|0|||
33270620|NCT01488890|62642367|FG002|Overall Study|Serious adverse event|0|||
33270621|NCT01488890|62642368|FG003|Overall Study|Serious adverse event|0|||
33270622|NCT01488890|62642365|FG000|Overall Study|Protocol Violation|3|||
33270623|NCT01488890|62642366|FG001|Overall Study|Protocol Violation|0|||
33270624|NCT01488890|62642367|FG002|Overall Study|Protocol Violation|4|||
33369823|NCT00484939|62748632|FG000|Overall Study|Death|9|||
33369824|NCT00484939|62748633|FG001|Overall Study|Death|13|||
33270625|NCT01488890|62642368|FG003|Overall Study|Protocol Violation|0|||
33270626|NCT01488890|62642365|FG000|Overall Study|Lost to Follow-up|13|||
33270627|NCT01488890|62642366|FG001|Overall Study|Lost to Follow-up|10|||
33270628|NCT01488890|62642367|FG002|Overall Study|Lost to Follow-up|20|||
33270629|NCT01488890|62642368|FG003|Overall Study|Lost to Follow-up|3|||
33270630|NCT01488890|62642365|FG000|Overall Study|Withdrawal by Subject|14|||
33270631|NCT01488890|62642366|FG001|Overall Study|Withdrawal by Subject|10|||
33270632|NCT01488890|62642367|FG002|Overall Study|Withdrawal by Subject|11|||
33270633|NCT01488890|62642368|FG003|Overall Study|Withdrawal by Subject|2|||
33270634|NCT01436396|62642384|FG000|Overall Study|Protocol Violation|7|||
33270635|NCT01436396|62642385|FG001|Overall Study|Protocol Violation|5|||
33270636|NCT01436396|62642384|FG000|Overall Study|Adverse Event|1|||
33270637|NCT01436396|62642385|FG001|Overall Study|Adverse Event|2|||
33270638|NCT01436396|62642384|FG000|Overall Study|Withdrawal by Subject|19|||
33270639|NCT01436396|62642385|FG001|Overall Study|Withdrawal by Subject|29|||
33270640|NCT01436396|62642384|FG000|Overall Study|Serious adverse event|2|||
33270641|NCT01436396|62642385|FG001|Overall Study|Serious adverse event|3|||
33270642|NCT01436396|62642384|FG000|Overall Study|Lost to Follow-up|3|||
33270643|NCT01436396|62642385|FG001|Overall Study|Lost to Follow-up|3|||
33270644|NCT01411241|62642393|FG000|Overall Study|Protocol Violation|0|||
33270645|NCT01411241|62642394|FG001|Overall Study|Protocol Violation|5|||
33270646|NCT01411241|62642393|FG000|Overall Study|Withdrawal by Subject|9|||
33270647|NCT01411241|62642394|FG001|Overall Study|Withdrawal by Subject|10|||
33270648|NCT01411241|62642393|FG000|Overall Study|Serious Adverse Event|0|||
33270649|NCT01411241|62642394|FG001|Overall Study|Serious Adverse Event|3|||
33270650|NCT01411241|62642393|FG000|Overall Study|Lost to Follow-up|2|||
33270651|NCT01411241|62642394|FG001|Overall Study|Lost to Follow-up|4|||
33270652|NCT01374516|62642402|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
33270653|NCT01374516|62642403|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
33270654|NCT01374516|62642402|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
33270655|NCT01374516|62642403|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
33270656|NCT01374516|62642402|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
33270657|NCT01374516|62642403|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
33270658|NCT01374516|62642402|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
33270659|NCT01374516|62642403|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
33270660|NCT01374516|62642402|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
33270661|NCT01374516|62642403|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
33270662|NCT01374516|62642402|FG000|Surveillance Expansion Period|Protocol Violation|386|||
33270663|NCT01374516|62642403|FG001|Surveillance Expansion Period|Protocol Violation|217|||
33270664|NCT01374516|62642402|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
33270665|NCT01374516|62642403|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
33270666|NCT01374516|62642402|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
33270667|NCT01374516|62642403|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
33270668|NCT01374516|62642402|FG000|Surveillance Expansion Period|Serious adverse event|20|||
33270669|NCT01374516|62642403|FG001|Surveillance Expansion Period|Serious adverse event|5|||
33270670|NCT01373281|62642418|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
33270671|NCT01373281|62642419|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
33270672|NCT01373281|62642418|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
33270673|NCT01373281|62642419|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
33270674|NCT01373281|62642418|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
33270675|NCT01373281|62642419|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
33270676|NCT01373281|62642418|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
33270677|NCT01373281|62642419|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
33270678|NCT01373281|62642418|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
33270679|NCT01373281|62642419|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
33270680|NCT01373281|62642418|FG000|Surveillance Expansion Period|Protocol Violation|9|||
33270681|NCT01373281|62642419|FG001|Surveillance Expansion Period|Protocol Violation|1|||
33270682|NCT01373281|62642418|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
33270683|NCT01373281|62642419|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
33270684|NCT01373281|62642418|FG000|Surveillance Expansion Period|Serious adverse event|3|||
33555678|NCT02792699|62948520|FG002|Overall Study|Withdrawal by Subject|3|||
33555679|NCT02792699|62948518|FG000|Overall Study|Lost to Follow-up|0|||
33555680|NCT02792699|62948519|FG001|Overall Study|Lost to Follow-up|1|||
33555681|NCT02792699|62948520|FG002|Overall Study|Lost to Follow-up|2|||
33555682|NCT02792699|62948518|FG000|Overall Study|Physician Decision|2|||
33270685|NCT01373281|62642419|FG001|Surveillance Expansion Period|Serious adverse event|4|||
33270686|NCT01254422|62642434|FG000|Overall Study|Protocol Violation|1|||
33369825|NCT00484939|62748632|FG000|Overall Study|Adverse Event|22|||
33555683|NCT02792699|62948519|FG001|Overall Study|Physician Decision|0|||
33555684|NCT02792699|62948520|FG002|Overall Study|Physician Decision|0|||
33270687|NCT01254422|62642435|FG001|Overall Study|Protocol Violation|0|||
33270688|NCT01254422|62642434|FG000|Overall Study|Adverse Event|1|||
33270689|NCT01254422|62642435|FG001|Overall Study|Adverse Event|0|||
33369826|NCT00484939|62748633|FG001|Overall Study|Adverse Event|12|||
33555685|NCT02792699|62948518|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
33555686|NCT02792699|62948519|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
33555687|NCT02792699|62948520|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
33555688|NCT02792699|62948518|FG000|Overall Study|Other|1|||
33555689|NCT02792699|62948519|FG001|Overall Study|Other|0|||
33555690|NCT02792699|62948520|FG002|Overall Study|Other|0|||
33555691|NCT03010319|62948537|FG000|Overall Study|Adverse Event|15|||
33555692|NCT03010319|62948538|FG001|Overall Study|Adverse Event|9|||
33555693|NCT03010319|62948537|FG000|Overall Study|Withdrawal by Subject|1|||
33555694|NCT03010319|62948538|FG001|Overall Study|Withdrawal by Subject|6|||
33270690|NCT01254422|62642434|FG000|Overall Study|Serious adverse event|0|||
33270691|NCT01254422|62642435|FG001|Overall Study|Serious adverse event|1|||
33270692|NCT01254422|62642434|FG000|Overall Study|Lost to Follow-up|1|||
33270693|NCT01254422|62642435|FG001|Overall Study|Lost to Follow-up|0|||
33270694|NCT01187433|62642443|FG000|Overall Study|Protocol Violation|6|||
33270695|NCT01187433|62642444|FG001|Overall Study|Protocol Violation|2|||
33270696|NCT01187433|62642443|FG000|Overall Study|Withdrawal by Subject|5|||
33270697|NCT01187433|62642444|FG001|Overall Study|Withdrawal by Subject|2|||
33270698|NCT01150045|62642454|FG000|Overall Study|Protocol Violation|0|||
33270699|NCT01150045|62642455|FG001|Overall Study|Protocol Violation|1|||
33270700|NCT01150045|62642456|FG002|Overall Study|Protocol Violation|0|||
33270701|NCT01150045|62642457|FG003|Overall Study|Protocol Violation|1|||
33270702|NCT01098032|62642467|FG000|Overall Study|Withdrawal by Subject|1|||
33270703|NCT01098032|62642468|FG001|Overall Study|Withdrawal by Subject|1|||
33270704|NCT01034306|62642476|FG000|Overall Study|Adverse Event|1|||
33270705|NCT01034306|62642477|FG001|Overall Study|Adverse Event|0|||
33270706|NCT01034306|62642476|FG000|Overall Study|Lost to Follow-up|0|||
33270707|NCT01034306|62642477|FG001|Overall Study|Lost to Follow-up|1|||
33270708|NCT01034306|62642476|FG000|Overall Study|Withdrawal by Subject|2|||
33270709|NCT01034306|62642477|FG001|Overall Study|Withdrawal by Subject|2|||
33270710|NCT01034306|62642476|FG000|Overall Study|hospitalized and decided to stop|1|||
33270711|NCT01034306|62642477|FG001|Overall Study|hospitalized and decided to stop|0|||
33555695|NCT03010319|62948537|FG000|Overall Study|Physician Decision|2|||
33555696|NCT03010319|62948538|FG001|Overall Study|Physician Decision|4|||
33555697|NCT03010319|62948537|FG000|Overall Study|Sponsor requested withdrawal|2|||
33555698|NCT03010319|62948538|FG001|Overall Study|Sponsor requested withdrawal|2|||
33270712|NCT01034306|62642476|FG000|Overall Study|Noncomplience|1|||
33270713|NCT01034306|62642477|FG001|Overall Study|Noncomplience|0|||
33270714|NCT00993447|62642485|FG000|Overall Study|Withdrawal by Subject|23|||
33270715|NCT00993447|62642486|FG001|Overall Study|Withdrawal by Subject|8|||
33270716|NCT00993447|62642485|FG000|Overall Study|Protocol Violation|12|||
33270717|NCT00993447|62642486|FG001|Overall Study|Protocol Violation|8|||
33270718|NCT00993447|62642485|FG000|Overall Study|Lost to Follow-up|1|||
33270719|NCT00993447|62642486|FG001|Overall Study|Lost to Follow-up|3|||
33270720|NCT00993447|62642485|FG000|Overall Study|Adverse Event|1|||
33270721|NCT00993447|62642486|FG001|Overall Study|Adverse Event|0|||
33270722|NCT00945009|62642495|FG000|Overall Study|Lack of Efficacy|10|||
33270723|NCT00945009|62642496|FG001|Overall Study|Lack of Efficacy|0|||
33270724|NCT00945009|62642497|FG002|Overall Study|Lack of Efficacy|0|||
33270725|NCT00945009|62642495|FG000|Overall Study|Physician Decision|21|||
33270726|NCT00945009|62642496|FG001|Overall Study|Physician Decision|4|||
33270727|NCT00945009|62642497|FG002|Overall Study|Physician Decision|3|||
33270728|NCT00945009|62642495|FG000|Overall Study|Protocol Violation|6|||
33270729|NCT00945009|62642496|FG001|Overall Study|Protocol Violation|1|||
33270730|NCT00945009|62642497|FG002|Overall Study|Protocol Violation|0|||
33270731|NCT00945009|62642495|FG000|Overall Study|Withdrawal by Subject|1|||
33270732|NCT00945009|62642496|FG001|Overall Study|Withdrawal by Subject|0|||
33270733|NCT00945009|62642497|FG002|Overall Study|Withdrawal by Subject|0|||
33270734|NCT00945009|62642495|FG000|Overall Study|Ineligible|6|||
33369827|NCT00484939|62748632|FG000|Overall Study|Patient Withdrew Consent|19|||
33369828|NCT00484939|62748633|FG001|Overall Study|Patient Withdrew Consent|10|||
33555699|NCT03010319|62948537|FG000|Overall Study|Death|1|||
33369829|NCT00484939|62748632|FG000|Overall Study|Protocol Violation|3|||
33662014|NCT02696850|63092555|FG001|Overall Study|Withdrawal by Subject|3|||
33270735|NCT00945009|62642496|FG001|Overall Study|Ineligible|1|||
33270736|NCT00945009|62642497|FG002|Overall Study|Ineligible|0|||
33270737|NCT00945009|62642495|FG000|Overall Study|Inevaluable|0|||
33270738|NCT00945009|62642496|FG001|Overall Study|Inevaluable|1|||
33270739|NCT00945009|62642497|FG002|Overall Study|Inevaluable|0|||
33270740|NCT00945009|62642495|FG000|Overall Study|Refusal of further protocol|1|||
33369830|NCT00484939|62748633|FG001|Overall Study|Protocol Violation|3|||
33369831|NCT00484939|62748632|FG000|Overall Study|Lost to Follow-up|0|||
33369832|NCT00484939|62748633|FG001|Overall Study|Lost to Follow-up|3|||
33662015|NCT02696850|63092554|FG000|Overall Study|Lost to Follow-up|8|||
33270741|NCT00945009|62642496|FG001|Overall Study|Refusal of further protocol|0|||
33555700|NCT03010319|62948538|FG001|Overall Study|Death|0|||
33662016|NCT02696850|63092555|FG001|Overall Study|Lost to Follow-up|5|||
33270742|NCT00945009|62642497|FG002|Overall Study|Refusal of further protocol|0|||
33270743|NCT00942877|62642507|FG000|Overall Study|Refused further treatment|1|||
33369833|NCT00484939|62748632|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
33369834|NCT00484939|62748633|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
33369835|NCT00484939|62748632|FG000|Overall Study|Disease progression|67|||
33369836|NCT00484939|62748633|FG001|Overall Study|Disease progression|88|||
33369837|NCT00484939|62748632|FG000|Overall Study|Screen Failure|2|||
33369838|NCT00484939|62748633|FG001|Overall Study|Screen Failure|2|||
33369839|NCT00484939|62748632|FG000|Overall Study|Reason Not Specified|11|||
33270744|NCT00942877|62642508|FG001|Overall Study|Refused further treatment|1|||
33270745|NCT00942877|62642507|FG000|Overall Study|Patient was not treated|1|||
33369840|NCT00484939|62748633|FG001|Overall Study|Reason Not Specified|6|||
33369841|NCT00453973|62748641|FG000|Overall Study|Adverse Event|4|||
33369842|NCT00453973|62748642|FG001|Overall Study|Adverse Event|9|||
33369843|NCT00453973|62748641|FG000|Overall Study|Withdrawal by Subject|7|||
33270746|NCT00942877|62642508|FG001|Overall Study|Patient was not treated|0|||
33270747|NCT00942877|62642507|FG000|Overall Study|Adverse Event|1|||
33270748|NCT00942877|62642508|FG001|Overall Study|Adverse Event|0|||
33270749|NCT00942877|62642507|FG000|Overall Study|Progressive disease|42|||
33270750|NCT00942877|62642508|FG001|Overall Study|Progressive disease|3|||
33270751|NCT00880893|62642523|FG000|Overall Study|Protocol Violation|13|||
33270752|NCT00880893|62642524|FG001|Overall Study|Protocol Violation|1|||
33270753|NCT00880893|62642523|FG000|Overall Study|Withdrawal by Subject|15|||
33270754|NCT00880893|62642524|FG001|Overall Study|Withdrawal by Subject|11|||
33270755|NCT00880893|62642523|FG000|Overall Study|Lost to Follow-up|76|||
33369844|NCT00453973|62748642|FG001|Overall Study|Withdrawal by Subject|6|||
33369845|NCT00453973|62748641|FG000|Overall Study|PI Decision|0|||
33369846|NCT00453973|62748642|FG001|Overall Study|PI Decision|2|||
33369847|NCT00453973|62748641|FG000|Overall Study|Relocation|1|||
33369848|NCT00453973|62748642|FG001|Overall Study|Relocation|0|||
33369849|NCT00453973|62748641|FG000|Overall Study|Renal transplant|1|||
33369850|NCT00453973|62748642|FG001|Overall Study|Renal transplant|1|||
33369851|NCT00453973|62748641|FG000|Overall Study|Site closed by sponsor|3|||
33369852|NCT00453973|62748642|FG001|Overall Study|Site closed by sponsor|0|||
33369853|NCT00453973|62748641|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
33369854|NCT00453973|62748642|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
33369855|NCT00465361|62748648|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
33369856|NCT00464815|62748654|FG000|Overall Study|Withdrawal by Subject|6|||
33369857|NCT00464815|62748655|FG001|Overall Study|Withdrawal by Subject|3|||
33369858|NCT00464737|62748664|FG000|Overall Study|Adverse Event|12|||
33369859|NCT00464737|62748665|FG001|Overall Study|Adverse Event|17|||
33369860|NCT00464737|62748666|FG002|Overall Study|Adverse Event|33|||
33369861|NCT00464737|62748664|FG000|Overall Study|Lack of Efficacy|7|||
33369862|NCT00464737|62748665|FG001|Overall Study|Lack of Efficacy|7|||
33369863|NCT00464737|62748666|FG002|Overall Study|Lack of Efficacy|4|||
33369864|NCT00464737|62748664|FG000|Overall Study|Withdrawal by Subject|5|||
33369865|NCT00464737|62748665|FG001|Overall Study|Withdrawal by Subject|3|||
33369866|NCT00464737|62748666|FG002|Overall Study|Withdrawal by Subject|5|||
33369867|NCT00464737|62748664|FG000|Overall Study|Protocol Violation|1|||
33369868|NCT00464737|62748665|FG001|Overall Study|Protocol Violation|1|||
33369869|NCT00464737|62748666|FG002|Overall Study|Protocol Violation|5|||
33369870|NCT00464737|62748664|FG000|Overall Study|Non-compliance|0|||
33369871|NCT00464737|62748665|FG001|Overall Study|Non-compliance|1|||
33485577|NCT01369498|62863224|FG001|Overall Study|Unknown Reason|0|||
33485578|NCT01369498|62863225|FG002|Overall Study|Unknown Reason|11|||
33485579|NCT01369498|62863226|FG003|Overall Study|Unknown Reason|6|||
33485580|NCT01369498|62863223|FG000|Overall Study|Disease Progression|0|||
33485581|NCT01369498|62863224|FG001|Overall Study|Disease Progression|0|||
33485582|NCT01369498|62863225|FG002|Overall Study|Disease Progression|0|||
33485583|NCT01369498|62863226|FG003|Overall Study|Disease Progression|1|||
33485584|NCT04709835|62863240|FG000|Overall Study|Withdrawal by Subject|0|||
33270756|NCT00880893|62642524|FG001|Overall Study|Lost to Follow-up|33|||
33270757|NCT00880893|62642523|FG000|Overall Study|Serious adverse event|3|||
33485585|NCT04709835|62863241|FG001|Overall Study|Withdrawal by Subject|1|||
33270758|NCT00880893|62642524|FG001|Overall Study|Serious adverse event|0|||
33270759|NCT00587301|62642530|FG000|Overall Study|Screen Failure|9|||
33270760|NCT00587301|62642530|FG000|Overall Study|Lost to Follow-up|22|||
33270761|NCT00587301|62642530|FG000|Overall Study|Withdrawal by Subject|7|||
33369872|NCT00464737|62748666|FG002|Overall Study|Non-compliance|1|||
33369873|NCT00464737|62748664|FG000|Overall Study|Lost to Follow-up|5|||
33369874|NCT00464737|62748665|FG001|Overall Study|Lost to Follow-up|2|||
33369875|NCT00464737|62748666|FG002|Overall Study|Lost to Follow-up|5|||
33369876|NCT00464737|62748664|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
33369877|NCT00464737|62748665|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
33369878|NCT00464737|62748666|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
33369879|NCT00464737|62748664|FG000|Overall Study|Other: Subject left town; family illness|1|||
33369880|NCT00464737|62748665|FG001|Overall Study|Other: Subject left town; family illness|0|||
33369881|NCT00464737|62748666|FG002|Overall Study|Other: Subject left town; family illness|0|||
33270762|NCT00587301|62642530|FG000|Overall Study|Protocol Violation|7|||
33369882|NCT00464737|62748664|FG000|Overall Study|Other: Study demands too great|0|||
33369883|NCT00464737|62748665|FG001|Overall Study|Other: Study demands too great|1|||
33369884|NCT00464737|62748666|FG002|Overall Study|Other: Study demands too great|0|||
33369885|NCT00464737|62748664|FG000|Overall Study|Other: Personal family reasons|0|||
33369886|NCT00464737|62748665|FG001|Overall Study|Other: Personal family reasons|0|||
33369887|NCT00464737|62748666|FG002|Overall Study|Other: Personal family reasons|1|||
33369888|NCT00464737|62748664|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
33369889|NCT00464737|62748665|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
33369890|NCT00464737|62748666|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
33369891|NCT00453349|62748676|FG000|Randomized|Adverse Event|12|||
33369892|NCT00453349|62748677|FG001|Randomized|Adverse Event|11|||
33369893|NCT00453349|62748676|FG000|Randomized|Lack of Efficacy|2|||
33369894|NCT00453349|62748677|FG001|Randomized|Lack of Efficacy|1|||
33369895|NCT00453349|62748676|FG000|Randomized|Lost to Follow-up|7|||
33369896|NCT00453349|62748677|FG001|Randomized|Lost to Follow-up|5|||
33369897|NCT00453349|62748676|FG000|Randomized|Protocol Violation|1|||
33369898|NCT00453349|62748677|FG001|Randomized|Protocol Violation|1|||
33369899|NCT00453349|62748676|FG000|Randomized|Withdrawal by Subject|3|||
33369900|NCT00453349|62748677|FG001|Randomized|Withdrawal by Subject|5|||
33369901|NCT00453349|62748676|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
33369902|NCT00453349|62748677|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
33369903|NCT00453349|62748676|FG000|Completed Study|Adverse Event|12|||
33369904|NCT00453349|62748677|FG001|Completed Study|Adverse Event|11|||
33369905|NCT00453349|62748676|FG000|Completed Study|Lack of Efficacy|2|||
33369906|NCT00453349|62748677|FG001|Completed Study|Lack of Efficacy|1|||
33369907|NCT00453349|62748676|FG000|Completed Study|Lost to Follow-up|7|||
33369908|NCT00453349|62748677|FG001|Completed Study|Lost to Follow-up|5|||
33369909|NCT00453349|62748676|FG000|Completed Study|Protocol Violation|1|||
33369910|NCT00453349|62748677|FG001|Completed Study|Protocol Violation|1|||
33369911|NCT00453349|62748676|FG000|Completed Study|Withdrawal by Subject|3|||
33369912|NCT00453349|62748677|FG001|Completed Study|Withdrawal by Subject|5|||
33369913|NCT00453349|62748676|FG000|Completed Study|Lost to follow up after study treatment|2|||
33369914|NCT00453349|62748677|FG001|Completed Study|Lost to follow up after study treatment|11|||
33270763|NCT00579527|62642534|FG000|Overall Study|Death|4|||
33270764|NCT00576836|62642539|FG000|Overall Study|Death|0|||
33270765|NCT00576836|62642540|FG001|Overall Study|Death|1|||
33270766|NCT00576836|62642539|FG000|Overall Study|Physician Decision|0|||
33270767|NCT00576836|62642540|FG001|Overall Study|Physician Decision|1|||
33270768|NCT00576407|62642544|FG000|Overall Study|Death|7|||
33369915|NCT00464269|62748687|FG000|Overall Study|Lack of Efficacy|1|||
33369916|NCT00464269|62748688|FG001|Overall Study|Lack of Efficacy|0|||
33369917|NCT00464269|62748689|FG002|Overall Study|Lack of Efficacy|0|||
33369918|NCT00464269|62748690|FG003|Overall Study|Lack of Efficacy|0|||
33555701|NCT03010319|62948537|FG000|Overall Study|Lost to Follow-up|0|||
33270769|NCT00576407|62642544|FG000|Overall Study|Physician Decision|1|||
33270770|NCT00531232|62642552|FG000|Overall Study|Investigator decision|0|||
33270771|NCT00531232|62642553|FG001|Overall Study|Investigator decision|0|||
33270772|NCT00531232|62642554|FG002|Overall Study|Investigator decision|4|||
33270773|NCT00531232|62642552|FG000|Overall Study|Participants refused further treatment|0|||
33270774|NCT00531232|62642553|FG001|Overall Study|Participants refused further treatment|1|||
33270775|NCT00531232|62642554|FG002|Overall Study|Participants refused further treatment|2|||
33270776|NCT00531232|62642552|FG000|Overall Study|Adverse events (AEs)|1|||
33270777|NCT00531232|62642553|FG001|Overall Study|Adverse events (AEs)|2|||
33270778|NCT00531232|62642554|FG002|Overall Study|Adverse events (AEs)|2|||
33270779|NCT00531232|62642552|FG000|Overall Study|Treatment failure|1|||
33270780|NCT00531232|62642553|FG001|Overall Study|Treatment failure|3|||
33270781|NCT00531232|62642554|FG002|Overall Study|Treatment failure|7|||
33270782|NCT00531232|62642552|FG000|Overall Study|Disease recurrence|0|||
33270783|NCT00531232|62642553|FG001|Overall Study|Disease recurrence|0|||
33270784|NCT00531232|62642554|FG002|Overall Study|Disease recurrence|1|||
33369919|NCT00464269|62748687|FG000|Overall Study|Lost to Follow-up|0|||
33369920|NCT00464269|62748688|FG001|Overall Study|Lost to Follow-up|4|||
33369921|NCT00464269|62748689|FG002|Overall Study|Lost to Follow-up|0|||
33270785|NCT00531232|62642552|FG000|Overall Study|Deceased|2|||
33270786|NCT00531232|62642553|FG001|Overall Study|Deceased|2|||
33369922|NCT00464269|62748690|FG003|Overall Study|Lost to Follow-up|1|||
33369923|NCT00464269|62748687|FG000|Overall Study|Withdrawal by Subject|0|||
33369924|NCT00464269|62748688|FG001|Overall Study|Withdrawal by Subject|2|||
33369925|NCT00464269|62748689|FG002|Overall Study|Withdrawal by Subject|1|||
33270787|NCT00531232|62642554|FG002|Overall Study|Deceased|2|||
33270788|NCT00531232|62642552|FG000|Overall Study|Withdrawal by Subject|0|||
33369926|NCT00464269|62748690|FG003|Overall Study|Withdrawal by Subject|1|||
33369927|NCT00464269|62748687|FG000|Overall Study|Other reason|3|||
33369928|NCT00464269|62748688|FG001|Overall Study|Other reason|3|||
33369929|NCT00464269|62748689|FG002|Overall Study|Other reason|1|||
33369930|NCT00464269|62748690|FG003|Overall Study|Other reason|1|||
33270789|NCT00531232|62642553|FG001|Overall Study|Withdrawal by Subject|1|||
33369931|NCT00464269|62748687|FG000|Overall Study|AE, serious fatal|0|||
33369932|NCT00464269|62748688|FG001|Overall Study|AE, serious fatal|0|||
33369933|NCT00464269|62748689|FG002|Overall Study|AE, serious fatal|1|||
33369934|NCT00464269|62748690|FG003|Overall Study|AE, serious fatal|1|||
33369935|NCT00464269|62748687|FG000|Overall Study|SAE, non-fatal|0|||
33369936|NCT00464269|62748688|FG001|Overall Study|SAE, non-fatal|0|||
33369937|NCT00464269|62748689|FG002|Overall Study|SAE, non-fatal|0|||
33369938|NCT00464269|62748690|FG003|Overall Study|SAE, non-fatal|1|||
33369939|NCT00464269|62748687|FG000|Overall Study|AE, non-serious non-fatal|2|||
33369940|NCT00464269|62748688|FG001|Overall Study|AE, non-serious non-fatal|8|||
33369941|NCT00464269|62748689|FG002|Overall Study|AE, non-serious non-fatal|3|||
33369942|NCT00464269|62748690|FG003|Overall Study|AE, non-serious non-fatal|4|||
33369943|NCT00464269|62748687|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
33369944|NCT00464269|62748688|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
33369945|NCT00464269|62748689|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
33369946|NCT00464269|62748690|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
33369947|NCT00484315|62748704|FG000|12-Month Clinical Follow-up|Death|6|||
33369948|NCT00484315|62748705|FG001|12-Month Clinical Follow-up|Death|2|||
33369949|NCT00484315|62748704|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
33369950|NCT00484315|62748705|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
33369951|NCT00484315|62748704|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
33369952|NCT00484315|62748705|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
33369953|NCT00484315|62748704|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
33369954|NCT00484315|62748705|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
33369955|NCT00484315|62748704|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
33369956|NCT00484315|62748705|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
33369957|NCT00484315|62748704|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
33369958|NCT00484315|62748705|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
33369959|NCT00484315|62748704|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
33369960|NCT00484315|62748705|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
33369961|NCT00463801|62748711|FG000|Overall Study|Protocol Violation|1|||
33369962|NCT00463801|62748711|FG000|Overall Study|Lack of Efficacy|2|||
33369963|NCT00463801|62748711|FG000|Overall Study|Adverse Event|4|||
33369964|NCT00463801|62748711|FG000|Overall Study|Lost to Follow-up|5|||
33369965|NCT00463801|62748711|FG000|Overall Study|No longer require therapy|1|||
33369966|NCT00463567|62748722|FG000|Overall Study|Adverse Event|29|||
33369967|NCT00463567|62748723|FG001|Overall Study|Adverse Event|26|||
33369968|NCT00463567|62748724|FG002|Overall Study|Adverse Event|17|||
33369969|NCT00463567|62748725|FG003|Overall Study|Adverse Event|46|||
33369970|NCT00463567|62748726|FG004|Overall Study|Adverse Event|10|||
33369971|NCT00463567|62748727|FG005|Overall Study|Adverse Event|10|||
33369972|NCT00463567|62748728|FG006|Overall Study|Adverse Event|4|||
33369973|NCT00463567|62748722|FG000|Overall Study|Withdrawal by Subject|29|||
33369974|NCT00463567|62748723|FG001|Overall Study|Withdrawal by Subject|22|||
33369975|NCT00463567|62748724|FG002|Overall Study|Withdrawal by Subject|20|||
33369976|NCT00463567|62748725|FG003|Overall Study|Withdrawal by Subject|37|||
33369977|NCT00463567|62748726|FG004|Overall Study|Withdrawal by Subject|6|||
33369978|NCT00463567|62748727|FG005|Overall Study|Withdrawal by Subject|5|||
33369979|NCT00463567|62748728|FG006|Overall Study|Withdrawal by Subject|1|||
33369980|NCT00463567|62748722|FG000|Overall Study|Protocol Deviation|13|||
33369981|NCT00463567|62748723|FG001|Overall Study|Protocol Deviation|9|||
33369982|NCT00463567|62748724|FG002|Overall Study|Protocol Deviation|14|||
33369983|NCT00463567|62748725|FG003|Overall Study|Protocol Deviation|11|||
33369984|NCT00463567|62748726|FG004|Overall Study|Protocol Deviation|1|||
33369985|NCT00463567|62748727|FG005|Overall Study|Protocol Deviation|1|||
33369986|NCT00463567|62748728|FG006|Overall Study|Protocol Deviation|2|||
33369987|NCT00463567|62748722|FG000|Overall Study|Lost to Follow-up|12|||
33369988|NCT00463567|62748723|FG001|Overall Study|Lost to Follow-up|6|||
33369989|NCT00463567|62748724|FG002|Overall Study|Lost to Follow-up|13|||
33369990|NCT00463567|62748725|FG003|Overall Study|Lost to Follow-up|8|||
33369991|NCT00463567|62748726|FG004|Overall Study|Lost to Follow-up|1|||
33270790|NCT00531232|62642554|FG002|Overall Study|Withdrawal by Subject|2|||
33270791|NCT00531232|62642552|FG000|Overall Study|Other|0|||
33369992|NCT00463567|62748727|FG005|Overall Study|Lost to Follow-up|1|||
33369993|NCT00463567|62748728|FG006|Overall Study|Lost to Follow-up|1|||
33369994|NCT00463567|62748722|FG000|Overall Study|Administrative problems|5|||
33369995|NCT00463567|62748723|FG001|Overall Study|Administrative problems|3|||
33369996|NCT00463567|62748724|FG002|Overall Study|Administrative problems|6|||
33369997|NCT00463567|62748725|FG003|Overall Study|Administrative problems|9|||
33369998|NCT00463567|62748726|FG004|Overall Study|Administrative problems|3|||
33369999|NCT00463567|62748727|FG005|Overall Study|Administrative problems|2|||
33370000|NCT00463567|62748728|FG006|Overall Study|Administrative problems|2|||
33485586|NCT04709835|62863242|FG002|Overall Study|Withdrawal by Subject|0|||
33370001|NCT00463567|62748722|FG000|Overall Study|Lack of Efficacy|4|||
33370002|NCT00463567|62748723|FG001|Overall Study|Lack of Efficacy|9|||
33370003|NCT00463567|62748724|FG002|Overall Study|Lack of Efficacy|9|||
33370004|NCT00463567|62748725|FG003|Overall Study|Lack of Efficacy|17|||
33370005|NCT00463567|62748726|FG004|Overall Study|Lack of Efficacy|1|||
33370006|NCT00463567|62748727|FG005|Overall Study|Lack of Efficacy|0|||
33370007|NCT00463567|62748728|FG006|Overall Study|Lack of Efficacy|1|||
33370008|NCT00463567|62748722|FG000|Overall Study|Abnormal lab value(s)|1|||
33370009|NCT00463567|62748723|FG001|Overall Study|Abnormal lab value(s)|1|||
33370010|NCT00463567|62748724|FG002|Overall Study|Abnormal lab value(s)|2|||
33370011|NCT00463567|62748725|FG003|Overall Study|Abnormal lab value(s)|1|||
33370012|NCT00463567|62748726|FG004|Overall Study|Abnormal lab value(s)|1|||
33370013|NCT00463567|62748727|FG005|Overall Study|Abnormal lab value(s)|0|||
33370014|NCT00463567|62748728|FG006|Overall Study|Abnormal lab value(s)|0|||
33370015|NCT00463567|62748722|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33270792|NCT00531232|62642553|FG001|Overall Study|Other|0|||
33270793|NCT00531232|62642554|FG002|Overall Study|Other|5|||
33270794|NCT01701583|62642567|FG000|Overall Study|Withdrawal by Subject|2|||
33370016|NCT00463567|62748723|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33370017|NCT00463567|62748724|FG002|Overall Study|Abnormal test procedure result(s)|6|||
33370018|NCT00463567|62748725|FG003|Overall Study|Abnormal test procedure result(s)|2|||
33370019|NCT00463567|62748726|FG004|Overall Study|Abnormal test procedure result(s)|0|||
33370020|NCT00463567|62748727|FG005|Overall Study|Abnormal test procedure result(s)|2|||
33370021|NCT00463567|62748728|FG006|Overall Study|Abnormal test procedure result(s)|0|||
33370022|NCT00463567|62748722|FG000|Overall Study|Death|1|||
33370023|NCT00463567|62748723|FG001|Overall Study|Death|0|||
33370024|NCT00463567|62748724|FG002|Overall Study|Death|2|||
33370025|NCT00463567|62748725|FG003|Overall Study|Death|0|||
33370026|NCT00463567|62748726|FG004|Overall Study|Death|0|||
33370027|NCT00463567|62748727|FG005|Overall Study|Death|0|||
33370028|NCT00463567|62748728|FG006|Overall Study|Death|0|||
33370029|NCT00484159|62748753|FG000|Overall Study|Lost to Follow-up|1|||
33370030|NCT00484159|62748754|FG001|Overall Study|Lost to Follow-up|1|||
33370031|NCT00484159|62748755|FG002|Overall Study|Lost to Follow-up|0|||
33370032|NCT00462865|62748763|FG000|Overall Study|Adverse Event|1|||
33370033|NCT03839641|62748769|FG000|Overall Study|Withdrawal by Subject|1|||
33370034|NCT03839641|62748770|FG001|Overall Study|Withdrawal by Subject|1|||
33485587|NCT04407507|62863256|FG000|Overall Study|Withdrawal by Subject|0|||
33485588|NCT04407507|62863257|FG001|Overall Study|Withdrawal by Subject|1|||
33485589|NCT04698993|62863265|FG000|Overall Study|PCR results not accessible|2|||
33485590|NCT04698993|62863266|FG001|Overall Study|PCR results not accessible|7|||
33485591|NCT04698993|62863265|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
33485592|NCT04698993|62863266|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
33485593|NCT04359771|62863274|FG000|Overall Study|Lack of Efficacy|2|||
33485594|NCT04359771|62863275|FG001|Overall Study|Lack of Efficacy|2|||
33555702|NCT03010319|62948538|FG001|Overall Study|Lost to Follow-up|1|||
33370035|NCT00462709|62748778|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
33370036|NCT00462709|62748778|FG000|Overall Study|Lost to Follow-up|10|||
33370037|NCT00462709|62748778|FG000|Overall Study|Withdrawal by Subject|8|||
33370038|NCT00462709|62748778|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
33370039|NCT00462709|62748778|FG000|Overall Study|Death|2|||
33370040|NCT00462709|62748778|FG000|Overall Study|Logistical reasons|2|||
33370041|NCT00462709|62748778|FG000|Overall Study|Physician Decision|1|||
33370042|NCT00462709|62748778|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
33370043|NCT00461305|62748784|FG000|Treatment|Adverse Event|26|||
33370044|NCT00461305|62748785|FG001|Treatment|Adverse Event|3|||
33370045|NCT00461305|62748784|FG000|Treatment|Lost to Follow-up|4|||
33370046|NCT00461305|62748785|FG001|Treatment|Lost to Follow-up|2|||
33370047|NCT00461305|62748784|FG000|Treatment|Protocol Violation|13|||
33555703|NCT03010319|62948537|FG000|Overall Study|Other Reason|5|||
33555704|NCT03010319|62948538|FG001|Overall Study|Other Reason|7|||
33270795|NCT01701583|62642568|FG001|Overall Study|Withdrawal by Subject|0|||
33370048|NCT00461305|62748785|FG001|Treatment|Protocol Violation|2|||
33485595|NCT04356573|62863283|FG000|Overall Study|Didn't Qualify|1|||
33485596|NCT04356573|62863284|FG001|Overall Study|Didn't Qualify|0|||
33485597|NCT04352127|62863300|FG000|Overall Study|Unable to obtain readings|4|||
33485598|NCT04352127|62863301|FG001|Overall Study|Unable to obtain readings|1|||
33485599|NCT04351269|62863310|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
33485600|NCT04351269|62863311|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
33555705|NCT01369511|62948548|FG000|Overall Study|Adverse Event|1|||
33270796|NCT01714817|62642577|FG000|Year 1 Period|Lack of Efficacy|11|||
33370049|NCT00461305|62748784|FG000|Treatment|Withdrawal by Subject|48|||
33370050|NCT00461305|62748785|FG001|Treatment|Withdrawal by Subject|2|||
33370051|NCT00461305|62748784|FG000|Treatment|Never dispensed|5|||
33370052|NCT00461305|62748785|FG001|Treatment|Never dispensed|0|||
33370053|NCT00461305|62748784|FG000|Treatment|Study drug not taken|1|||
33370054|NCT00461305|62748785|FG001|Treatment|Study drug not taken|0|||
33370055|NCT00461305|62748784|FG000|Treatment|Partially missing diary|2|||
33370056|NCT00461305|62748785|FG001|Treatment|Partially missing diary|0|||
33270797|NCT01714817|62642578|FG001|Year 1 Period|Lack of Efficacy|9|||
33270798|NCT01714817|62642577|FG000|Year 1 Period|Adverse Event|20|||
33270799|NCT01714817|62642578|FG001|Year 1 Period|Adverse Event|17|||
33270800|NCT01714817|62642577|FG000|Year 1 Period|Withdrawal by Subject|6|||
33270801|NCT01714817|62642578|FG001|Year 1 Period|Withdrawal by Subject|7|||
33270802|NCT01714817|62642577|FG000|Year 1 Period|Death|1|||
33270803|NCT01714817|62642578|FG001|Year 1 Period|Death|1|||
33270804|NCT01714817|62642577|FG000|Year 1 Period|Lost to Follow-up|0|||
33270805|NCT01714817|62642578|FG001|Year 1 Period|Lost to Follow-up|2|||
33270806|NCT01714817|62642577|FG000|Year 1 Period|Poor / non-compliance|0|||
33270807|NCT01714817|62642578|FG001|Year 1 Period|Poor / non-compliance|1|||
33270808|NCT01714817|62642577|FG000|Year 1 Period|Pregnancy|2|||
33270809|NCT01714817|62642578|FG001|Year 1 Period|Pregnancy|0|||
33270810|NCT01714817|62642577|FG000|Year 1 Period|Participant no longer meets criteria|6|||
33270811|NCT01714817|62642578|FG001|Year 1 Period|Participant no longer meets criteria|2|||
33270812|NCT01714817|62642577|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
33270813|NCT01714817|62642578|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
33270814|NCT01714817|62642577|FG000|Year 1 Period|Change in Concomitant Medication|0|||
33270815|NCT01714817|62642578|FG001|Year 1 Period|Change in Concomitant Medication|1|||
33270816|NCT01714817|62642577|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
33270817|NCT01714817|62642578|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
33270818|NCT01714817|62642577|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
33270819|NCT01714817|62642578|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
33270820|NCT01714817|62642577|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
33270821|NCT01714817|62642578|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
33270822|NCT01714817|62642577|FG000|Year 2 Period|Lack of Efficacy|4|||
33270823|NCT01714817|62642578|FG001|Year 2 Period|Lack of Efficacy|12|||
33270824|NCT01714817|62642577|FG000|Year 2 Period|Adverse Event|7|||
33270825|NCT01714817|62642578|FG001|Year 2 Period|Adverse Event|6|||
33270826|NCT01714817|62642577|FG000|Year 2 Period|Participant request to stop treatment|4|||
33270827|NCT01714817|62642578|FG001|Year 2 Period|Participant request to stop treatment|4|||
33270828|NCT01714817|62642577|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
33270829|NCT01714817|62642578|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
33270830|NCT01714817|62642577|FG000|Year 2 Period|Participant withdrew consent|1|||
33270831|NCT01714817|62642578|FG001|Year 2 Period|Participant withdrew consent|5|||
33270832|NCT01714817|62642577|FG000|Year 2 Period|Participant no longer meets criteria|1|||
33270833|NCT01714817|62642578|FG001|Year 2 Period|Participant no longer meets criteria|4|||
33270834|NCT01714817|62642577|FG000|Year 2 Period|Lost to Follow-up|2|||
33270835|NCT01714817|62642578|FG001|Year 2 Period|Lost to Follow-up|0|||
33270836|NCT01714817|62642577|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
33270837|NCT01714817|62642578|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
33270838|NCT01714817|62642577|FG000|Year 2 Period|Pregnancy|1|||
33270839|NCT01714817|62642578|FG001|Year 2 Period|Pregnancy|1|||
33270840|NCT01714817|62642577|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
33270841|NCT01714817|62642578|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
33270842|NCT01714817|62642577|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
33270843|NCT01714817|62642578|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
33270844|NCT01714817|62642577|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
33270845|NCT01714817|62642578|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
33270846|NCT01714817|62642577|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
33270847|NCT01714817|62642578|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
33270848|NCT01714817|62642577|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
33270849|NCT01714817|62642578|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
33270850|NCT01714817|62642577|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
33270851|NCT01714817|62642578|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
33270852|NCT01714817|62642577|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
33270853|NCT01714817|62642578|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
33270854|NCT01714817|62642577|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
33270855|NCT01714817|62642578|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
33270856|NCT01714817|62642577|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
33270857|NCT01714817|62642578|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
33270858|NCT01714817|62642577|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
33270859|NCT01714817|62642578|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
33270860|NCT01714817|62642577|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
33270861|NCT01714817|62642578|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
33270862|NCT01714817|62642577|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
33370057|NCT00461305|62748784|FG000|Treatment|Other (missing drug etc)|2|||
33370058|NCT00461305|62748785|FG001|Treatment|Other (missing drug etc)|0|||
33370059|NCT00461305|62748784|FG000|Continued Treatment|Adverse Event|26|||
33370060|NCT00461305|62748785|FG001|Continued Treatment|Adverse Event|0|||
33270863|NCT01714817|62642578|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
33270864|NCT01714817|62642577|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
33270865|NCT01714817|62642578|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
33270866|NCT01714817|62642577|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
33270867|NCT01714817|62642578|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
33270868|NCT01714817|62642577|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
33270869|NCT01714817|62642578|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
33270870|NCT01714817|62642577|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
33270871|NCT01714817|62642578|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
33270872|NCT01755689|62642602|FG000|Overall Study|Withdrawal by Subject|1|||
33270873|NCT01755689|62642603|FG001|Overall Study|Withdrawal by Subject|3|||
33270874|NCT01755689|62642604|FG002|Overall Study|Withdrawal by Subject|2|||
33270875|NCT01755689|62642605|FG003|Overall Study|Withdrawal by Subject|1|||
33270876|NCT01755689|62642606|FG004|Overall Study|Withdrawal by Subject|1|||
33270877|NCT01755689|62642602|FG000|Overall Study|Migrated/moved from study area|0|||
33270878|NCT01755689|62642603|FG001|Overall Study|Migrated/moved from study area|1|||
33270879|NCT01755689|62642604|FG002|Overall Study|Migrated/moved from study area|1|||
33270880|NCT01755689|62642605|FG003|Overall Study|Migrated/moved from study area|1|||
33270881|NCT01755689|62642606|FG004|Overall Study|Migrated/moved from study area|1|||
33270882|NCT01755689|62642602|FG000|Overall Study|Lost to Follow-up|1|||
33270883|NCT01755689|62642603|FG001|Overall Study|Lost to Follow-up|0|||
33270884|NCT01755689|62642604|FG002|Overall Study|Lost to Follow-up|1|||
33270885|NCT01755689|62642605|FG003|Overall Study|Lost to Follow-up|0|||
33270886|NCT01755689|62642606|FG004|Overall Study|Lost to Follow-up|2|||
33270887|NCT01755689|62642602|FG000|Overall Study|Pregnancy|1|||
33270888|NCT01755689|62642603|FG001|Overall Study|Pregnancy|1|||
33270889|NCT01755689|62642604|FG002|Overall Study|Pregnancy|2|||
33270890|NCT01755689|62642605|FG003|Overall Study|Pregnancy|4|||
33270891|NCT01755689|62642606|FG004|Overall Study|Pregnancy|2|||
33270892|NCT01762761|62642628|FG000|Overall Study|Adverse Event|15|||
33270893|NCT01762761|62642629|FG001|Overall Study|Adverse Event|17|||
33270894|NCT01762761|62642628|FG000|Overall Study|Lack of Efficacy|9|||
33270895|NCT01762761|62642629|FG001|Overall Study|Lack of Efficacy|25|||
33270896|NCT01762761|62642628|FG000|Overall Study|Protocol Violation|1|||
33270897|NCT01762761|62642629|FG001|Overall Study|Protocol Violation|1|||
33270898|NCT01762761|62642628|FG000|Overall Study|Study closed/terminated|0|||
33270899|NCT01762761|62642629|FG001|Overall Study|Study closed/terminated|2|||
33270900|NCT01762761|62642628|FG000|Overall Study|Lost to Follow-up|3|||
33270901|NCT01762761|62642629|FG001|Overall Study|Lost to Follow-up|6|||
33270902|NCT01762761|62642628|FG000|Overall Study|Physician Decision|4|||
33270903|NCT01762761|62642629|FG001|Overall Study|Physician Decision|6|||
33270904|NCT01762761|62642628|FG000|Overall Study|Withdrawal by Subject|7|||
33270905|NCT01762761|62642629|FG001|Overall Study|Withdrawal by Subject|8|||
33270906|NCT01763788|62642640|FG000|Overall Study|Lost to Follow-up|0|||
33270907|NCT01763788|62642641|FG001|Overall Study|Lost to Follow-up|0|||
33270908|NCT01763788|62642642|FG002|Overall Study|Lost to Follow-up|1|||
33270909|NCT01763788|62642643|FG003|Overall Study|Lost to Follow-up|0|||
33270910|NCT01774370|62642653|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
33270911|NCT01774370|62642653|FG000|Overall Study|Administered prior to the contract date|4|||
33270912|NCT01774370|62642653|FG000|Overall Study|Subjects of contraindications|34|||
33270913|NCT01774370|62642653|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
33270914|NCT01774370|62642653|FG000|Overall Study|Follow-up failure|34|||
33270915|NCT01777295|62642659|FG000|Overall Study|Withdrawal by Subject|2|||
33270916|NCT01777295|62642660|FG001|Overall Study|Withdrawal by Subject|2|||
33270917|NCT01777295|62642659|FG000|Overall Study|Pregnancy|0|||
33270918|NCT01777295|62642660|FG001|Overall Study|Pregnancy|1|||
33270919|NCT01777295|62642659|FG000|Overall Study|Personal problem|1|||
33270920|NCT01777295|62642660|FG001|Overall Study|Personal problem|0|||
33270921|NCT01777295|62642659|FG000|Overall Study|Investigator call for AEs check|1|||
33270922|NCT01777295|62642660|FG001|Overall Study|Investigator call for AEs check|0|||
33270923|NCT01787552|62642697|FG000|Overall Study|Withdrawal by Subject|2|||
33270924|NCT01787552|62642698|FG001|Overall Study|Withdrawal by Subject|0|||
33270925|NCT01787552|62642699|FG002|Overall Study|Withdrawal by Subject|0|||
33270926|NCT01787552|62642700|FG003|Overall Study|Withdrawal by Subject|4|||
33270927|NCT01787552|62642697|FG000|Overall Study|Physician Decision|2|||
33270928|NCT01787552|62642698|FG001|Overall Study|Physician Decision|2|||
33270929|NCT01787552|62642699|FG002|Overall Study|Physician Decision|1|||
33270930|NCT01787552|62642700|FG003|Overall Study|Physician Decision|2|||
33270931|NCT01787552|62642697|FG000|Overall Study|Death|0|||
33270932|NCT01787552|62642698|FG001|Overall Study|Death|0|||
33270933|NCT01787552|62642699|FG002|Overall Study|Death|0|||
33270934|NCT01787552|62642700|FG003|Overall Study|Death|1|||
33270935|NCT01787552|62642697|FG000|Overall Study|Adverse Event|2|||
33270936|NCT01787552|62642698|FG001|Overall Study|Adverse Event|5|||
33270937|NCT01787552|62642699|FG002|Overall Study|Adverse Event|2|||
33270938|NCT01787552|62642700|FG003|Overall Study|Adverse Event|16|||
33270939|NCT01787552|62642697|FG000|Overall Study|Study terminated by Sponsor|0|||
33270940|NCT01787552|62642698|FG001|Overall Study|Study terminated by Sponsor|0|||
33270941|NCT01787552|62642699|FG002|Overall Study|Study terminated by Sponsor|1|||
33270942|NCT01787552|62642700|FG003|Overall Study|Study terminated by Sponsor|3|||
33270943|NCT01787552|62642697|FG000|Overall Study|Progressive Disease|2|||
33270944|NCT01787552|62642698|FG001|Overall Study|Progressive Disease|2|||
33270945|NCT01787552|62642699|FG002|Overall Study|Progressive Disease|1|||
33270946|NCT01787552|62642700|FG003|Overall Study|Progressive Disease|1|||
33270947|NCT01808261|62642717|FG000|Overall Study|Physician Decision|0|||
33270948|NCT01808261|62642718|FG001|Overall Study|Physician Decision|2|||
33270949|NCT01808261|62642717|FG000|Overall Study|Study Closed/Terminated|25|||
33270950|NCT01808261|62642718|FG001|Overall Study|Study Closed/Terminated|23|||
33270951|NCT01808261|62642717|FG000|Overall Study|Adverse event, non-fatal|2|||
33270952|NCT01808261|62642718|FG001|Overall Study|Adverse event, non-fatal|0|||
33270953|NCT01808261|62642717|FG000|Overall Study|Consent withdrawn by subject|6|||
33270954|NCT01808261|62642718|FG001|Overall Study|Consent withdrawn by subject|7|||
33270955|NCT01808261|62642717|FG000|Overall Study|Lost to Follow-up|3|||
33270956|NCT01808261|62642718|FG001|Overall Study|Lost to Follow-up|1|||
33270957|NCT01814826|62642737|FG000|Overall Study|Other|3|||
33270958|NCT01814826|62642738|FG001|Overall Study|Other|5|||
33270959|NCT01814826|62642739|FG002|Overall Study|Other|0|||
33270960|NCT01814826|62642737|FG000|Overall Study|Death|29|||
33270961|NCT01814826|62642738|FG001|Overall Study|Death|24|||
33270962|NCT01814826|62642739|FG002|Overall Study|Death|3|||
33270963|NCT01819467|62642750|FG000|Overall Study|Physician Decision|20|||
33270964|NCT01819467|62642751|FG001|Overall Study|Physician Decision|9|||
33270965|NCT01829711|62642757|FG000|Overall Study|Lost to Follow-up|2|||
33270966|NCT01829711|62642757|FG000|Overall Study|Withdrawal by Subject|3|||
33270967|NCT01829711|62642757|FG000|Overall Study|Death|4|||
33270968|NCT01829711|62642757|FG000|Overall Study|Started new therapies|17|||
33270969|NCT01829711|62642757|FG000|Overall Study|Adverse Event|3|||
33270970|NCT01829711|62642757|FG000|Overall Study|Due to progression of disease|13|||
33270971|NCT01829711|62642757|FG000|Overall Study|Due to lack of response|1|||
33270972|NCT01846273|62642764|FG000|Overall Study|Adverse Event|9|||
33270973|NCT01846273|62642765|FG001|Overall Study|Adverse Event|7|||
33270974|NCT01846273|62642766|FG002|Overall Study|Adverse Event|0|||
33270975|NCT01846273|62642764|FG000|Overall Study|Subject withdrew consent|5|||
33270976|NCT01846273|62642765|FG001|Overall Study|Subject withdrew consent|8|||
33270977|NCT01846273|62642766|FG002|Overall Study|Subject withdrew consent|0|||
33270978|NCT01846273|62642764|FG000|Overall Study|Lost to Follow-up|2|||
33270979|NCT01846273|62642765|FG001|Overall Study|Lost to Follow-up|1|||
33270980|NCT01846273|62642766|FG002|Overall Study|Lost to Follow-up|0|||
33270981|NCT01846273|62642764|FG000|Overall Study|Administrative problems|1|||
33270982|NCT01846273|62642765|FG001|Overall Study|Administrative problems|0|||
33270983|NCT01846273|62642766|FG002|Overall Study|Administrative problems|0|||
33270984|NCT01846273|62642764|FG000|Overall Study|Death|2|||
33270985|NCT01846273|62642765|FG001|Overall Study|Death|1|||
33270986|NCT01846273|62642766|FG002|Overall Study|Death|0|||
33270987|NCT01846273|62642764|FG000|Overall Study|Disease Progression|0|||
33270988|NCT01846273|62642765|FG001|Overall Study|Disease Progression|4|||
33270989|NCT01846273|62642766|FG002|Overall Study|Disease Progression|0|||
33270990|NCT01846273|62642764|FG000|Overall Study|Protocol Deviation|2|||
33270991|NCT01846273|62642765|FG001|Overall Study|Protocol Deviation|3|||
33270992|NCT01846273|62642766|FG002|Overall Study|Protocol Deviation|0|||
33270993|NCT01846273|62642764|FG000|Overall Study|Physician Decision|1|||
33270994|NCT01846273|62642765|FG001|Overall Study|Physician Decision|2|||
33270995|NCT01846273|62642766|FG002|Overall Study|Physician Decision|0|||
33270996|NCT01871896|62642774|FG000|Overall Study|Lost to Follow-up|1|||
33270997|NCT04752475|62642781|FG000|Overall Study|Withdrawal by Subject|1|||
33270998|NCT04752475|62642782|FG001|Overall Study|Withdrawal by Subject|1|||
33270999|NCT03846947|62642828|FG000|Overall Study|technical issues with imaging sequence|2|||
33271000|NCT03675308|62642841|FG000|Overall Study|Adverse Event|3|||
33271001|NCT03675308|62642842|FG001|Overall Study|Adverse Event|2|||
33271002|NCT03675308|62642841|FG000|Overall Study|Withdrawal by Subject|6|||
33271003|NCT03675308|62642842|FG001|Overall Study|Withdrawal by Subject|4|||
33271004|NCT03675308|62642841|FG000|Overall Study|Lost to Follow-up|3|||
33271005|NCT03675308|62642842|FG001|Overall Study|Lost to Follow-up|0|||
33271006|NCT03675308|62642841|FG000|Overall Study|Lack of Efficacy|1|||
33271007|NCT03675308|62642842|FG001|Overall Study|Lack of Efficacy|1|||
33271008|NCT03675308|62642841|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
33271009|NCT03675308|62642842|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
33271010|NCT03675308|62642841|FG000|Overall Study|Other|0|||
33271011|NCT03675308|62642842|FG001|Overall Study|Other|1|||
33271012|NCT03131219|62642850|FG000|Initial Evaluation Period|Adverse Event|1|||
33271013|NCT03131219|62642851|FG001|Initial Evaluation Period|Adverse Event|0|||
33271014|NCT03131219|62642850|FG000|Initial Evaluation Period|Protocol Violation|1|||
33271015|NCT03131219|62642851|FG001|Initial Evaluation Period|Protocol Violation|0|||
33271016|NCT03131219|62642850|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2|||
33271017|NCT03131219|62642851|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0|||
33271018|NCT02914613|62642859|FG000|Overall Study|Withdrawal by Subject|1|||
33271019|NCT02914613|62642860|FG001|Overall Study|Withdrawal by Subject|2|||
33271020|NCT02914613|62642859|FG000|Overall Study|Adverse Event|1|||
33271021|NCT02914613|62642860|FG001|Overall Study|Adverse Event|0|||
33271022|NCT02586207|62642870|FG000|Overall Study|Physician Decision|1|||
33271023|NCT02586207|62642870|FG000|Overall Study|Withdrawal by Subject|1|||
33271024|NCT02573324|62642877|FG000|Overall Study|Withdrawal by Subject|26|||
33271025|NCT02573324|62642878|FG001|Overall Study|Withdrawal by Subject|23|||
33271026|NCT02573324|62642879|FG002|Overall Study|Withdrawal by Subject|3|||
33271027|NCT02573324|62642877|FG000|Overall Study|Lost to Follow-up|4|||
33271028|NCT02573324|62642878|FG001|Overall Study|Lost to Follow-up|5|||
33271029|NCT02573324|62642879|FG002|Overall Study|Lost to Follow-up|0|||
33271030|NCT02573324|62642877|FG000|Overall Study|Study Terminated by Sponsor|107|||
33271031|NCT02573324|62642878|FG001|Overall Study|Study Terminated by Sponsor|89|||
33271032|NCT02573324|62642879|FG002|Overall Study|Study Terminated by Sponsor|2|||
33271033|NCT02573324|62642877|FG000|Overall Study|Death|182|||
33271034|NCT02573324|62642878|FG001|Overall Study|Death|200|||
33271035|NCT02573324|62642879|FG002|Overall Study|Death|1|||
33271036|NCT02573324|62642877|FG000|Overall Study|Other, Not Specified|20|||
33271037|NCT02573324|62642878|FG001|Overall Study|Other, Not Specified|27|||
33271038|NCT02573324|62642879|FG002|Overall Study|Other, Not Specified|0|||
33271039|NCT02573324|62642877|FG000|Overall Study|Unknown Reason|2|||
33271040|NCT02573324|62642878|FG001|Overall Study|Unknown Reason|0|||
33271041|NCT02573324|62642879|FG002|Overall Study|Unknown Reason|0|||
33271042|NCT02296684|62642895|FG000|Overall Study|Withdrawal by Subject|0|||
33271043|NCT02296684|62642896|FG001|Overall Study|Withdrawal by Subject|1|||
33271044|NCT02296684|62642897|FG002|Overall Study|Withdrawal by Subject|1|||
33271045|NCT02296684|62642895|FG000|Overall Study|Death|2|||
33271046|NCT02296684|62642896|FG001|Overall Study|Death|0|||
33271047|NCT02296684|62642897|FG002|Overall Study|Death|0|||
33271048|NCT02107261|62642906|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
33271049|NCT02107261|62642907|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
33271050|NCT02107261|62642906|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
33271051|NCT02107261|62642907|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
33271052|NCT02014597|62642917|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
33271053|NCT02014597|62642918|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
33271054|NCT01342367|62642930|FG000|Overall Study|Death|1|||
33271055|NCT01342367|62642931|FG001|Overall Study|Death|0|||
33271056|NCT01342367|62642930|FG000|Overall Study|Withdrawal by Subject|1|||
33271057|NCT01342367|62642931|FG001|Overall Study|Withdrawal by Subject|2|||
33271058|NCT01185171|62642937|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
33271059|NCT01185171|62642937|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
33271060|NCT01185171|62642937|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
33271061|NCT01185171|62642937|FG000|Maintenance|Elevated liver transaminases|3|||
33271062|NCT01185171|62642937|FG000|Maintenance|Rush|2|||
33271063|NCT01185171|62642937|FG000|Maintenance|Diarrhea|1|||
33271064|NCT01185171|62642937|FG000|Maintenance|Xerostomia|1|||
33271065|NCT01185171|62642937|FG000|Maintenance|Nausea|1|||
33271066|NCT01185171|62642937|FG000|Maintenance|Comorbid Illness|2|||
33271067|NCT01185171|62642937|FG000|Maintenance|Withdrawal by Subject|1|||
33271068|NCT01185171|62642937|FG000|Maintenance|Disease Recurrence|1|||
33271069|NCT00896493|62642941|FG000|Overall Study|Early disease relapse|3|||
33271070|NCT00408005|62642947|FG000|Induction|Adverse Event|19|||
33271071|NCT00408005|62642948|FG001|Induction|Adverse Event|3|||
33271072|NCT00408005|62642949|FG002|Induction|Adverse Event|0|||
33271073|NCT00408005|62642950|FG003|Induction|Adverse Event|0|||
33271074|NCT00408005|62642951|FG004|Induction|Adverse Event|0|||
33271075|NCT00408005|62642952|FG005|Induction|Adverse Event|0|||
33271076|NCT00408005|62642953|FG006|Induction|Adverse Event|0|||
33271077|NCT00408005|62642954|FG007|Induction|Adverse Event|0|||
33271078|NCT00408005|62642947|FG000|Induction|Death|6|||
33271079|NCT00408005|62642948|FG001|Induction|Death|0|||
33271080|NCT00408005|62642949|FG002|Induction|Death|0|||
33271081|NCT00408005|62642950|FG003|Induction|Death|0|||
33271082|NCT00408005|62642951|FG004|Induction|Death|0|||
33271083|NCT00408005|62642952|FG005|Induction|Death|0|||
33271084|NCT00408005|62642953|FG006|Induction|Death|0|||
33271085|NCT00408005|62642954|FG007|Induction|Death|0|||
33271086|NCT00408005|62642947|FG000|Induction|Physician Decision|83|||
33370061|NCT00461305|62748784|FG000|Continued Treatment|Lost to Follow-up|4|||
33271087|NCT00408005|62642948|FG001|Induction|Physician Decision|9|||
33271088|NCT00408005|62642949|FG002|Induction|Physician Decision|0|||
33271089|NCT00408005|62642950|FG003|Induction|Physician Decision|0|||
33271090|NCT00408005|62642951|FG004|Induction|Physician Decision|0|||
33271091|NCT00408005|62642952|FG005|Induction|Physician Decision|0|||
33271092|NCT00408005|62642953|FG006|Induction|Physician Decision|0|||
33271093|NCT00408005|62642954|FG007|Induction|Physician Decision|0|||
33271094|NCT00408005|62642947|FG000|Induction|Withdrawal by Subject|2|||
33271095|NCT00408005|62642948|FG001|Induction|Withdrawal by Subject|4|||
33370062|NCT00461305|62748785|FG001|Continued Treatment|Lost to Follow-up|0|||
33271096|NCT00408005|62642949|FG002|Induction|Withdrawal by Subject|0|||
33271097|NCT00408005|62642950|FG003|Induction|Withdrawal by Subject|0|||
33271098|NCT00408005|62642951|FG004|Induction|Withdrawal by Subject|0|||
33271099|NCT00408005|62642952|FG005|Induction|Withdrawal by Subject|0|||
33271100|NCT00408005|62642953|FG006|Induction|Withdrawal by Subject|0|||
33271101|NCT00408005|62642954|FG007|Induction|Withdrawal by Subject|0|||
33271102|NCT00408005|62642947|FG000|Induction|Ineligible|33|||
33271103|NCT00408005|62642948|FG001|Induction|Ineligible|14|||
33271104|NCT00408005|62642949|FG002|Induction|Ineligible|0|||
33271105|NCT00408005|62642950|FG003|Induction|Ineligible|0|||
33271106|NCT00408005|62642951|FG004|Induction|Ineligible|0|||
33271107|NCT00408005|62642952|FG005|Induction|Ineligible|0|||
33271108|NCT00408005|62642953|FG006|Induction|Ineligible|0|||
33271109|NCT00408005|62642954|FG007|Induction|Ineligible|0|||
33271110|NCT00408005|62642947|FG000|Induction|Refusal of Further Protocol Therapy|225|||
33271111|NCT00408005|62642948|FG001|Induction|Refusal of Further Protocol Therapy|44|||
33271112|NCT00408005|62642949|FG002|Induction|Refusal of Further Protocol Therapy|0|||
33271113|NCT00408005|62642950|FG003|Induction|Refusal of Further Protocol Therapy|0|||
33271114|NCT00408005|62642951|FG004|Induction|Refusal of Further Protocol Therapy|0|||
33271115|NCT00408005|62642952|FG005|Induction|Refusal of Further Protocol Therapy|0|||
33271116|NCT00408005|62642953|FG006|Induction|Refusal of Further Protocol Therapy|0|||
33271117|NCT00408005|62642954|FG007|Induction|Refusal of Further Protocol Therapy|0|||
33271118|NCT00408005|62642947|FG000|Induction|Entered another COG therapeutic protocol|4|||
33271119|NCT00408005|62642948|FG001|Induction|Entered another COG therapeutic protocol|0|||
33271120|NCT00408005|62642949|FG002|Induction|Entered another COG therapeutic protocol|0|||
33271121|NCT00408005|62642950|FG003|Induction|Entered another COG therapeutic protocol|0|||
33271122|NCT00408005|62642951|FG004|Induction|Entered another COG therapeutic protocol|0|||
33271123|NCT00408005|62642952|FG005|Induction|Entered another COG therapeutic protocol|0|||
33271124|NCT00408005|62642953|FG006|Induction|Entered another COG therapeutic protocol|0|||
33271125|NCT00408005|62642954|FG007|Induction|Entered another COG therapeutic protocol|0|||
33271126|NCT00408005|62642947|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
33271127|NCT00408005|62642948|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
33271128|NCT00408005|62642949|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
33271129|NCT00408005|62642950|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
33271130|NCT00408005|62642951|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
33271131|NCT00408005|62642952|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
33271132|NCT00408005|62642953|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
33271133|NCT00408005|62642954|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
33271134|NCT00408005|62642947|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
33271135|NCT00408005|62642948|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
33271136|NCT00408005|62642949|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
33271137|NCT00408005|62642950|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
33271138|NCT00408005|62642951|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
33271139|NCT00408005|62642952|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
33271140|NCT00408005|62642953|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
33271141|NCT00408005|62642954|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
33271142|NCT00408005|62642947|FG000|Induction|Progressive Disease|0|||
33271143|NCT00408005|62642948|FG001|Induction|Progressive Disease|1|||
33271144|NCT00408005|62642949|FG002|Induction|Progressive Disease|0|||
33271145|NCT00408005|62642950|FG003|Induction|Progressive Disease|0|||
33271146|NCT00408005|62642951|FG004|Induction|Progressive Disease|0|||
33271147|NCT00408005|62642952|FG005|Induction|Progressive Disease|0|||
33271148|NCT00408005|62642953|FG006|Induction|Progressive Disease|0|||
33271149|NCT00408005|62642954|FG007|Induction|Progressive Disease|0|||
33271150|NCT00408005|62642947|FG000|Induction|Inevaluable|18|||
33271151|NCT00408005|62642948|FG001|Induction|Inevaluable|14|||
33271152|NCT00408005|62642949|FG002|Induction|Inevaluable|0|||
33271153|NCT00408005|62642950|FG003|Induction|Inevaluable|0|||
33271154|NCT00408005|62642951|FG004|Induction|Inevaluable|0|||
33271155|NCT00408005|62642952|FG005|Induction|Inevaluable|0|||
33271156|NCT00408005|62642953|FG006|Induction|Inevaluable|0|||
33271157|NCT00408005|62642954|FG007|Induction|Inevaluable|0|||
33485601|NCT04351269|62863312|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
33271158|NCT00408005|62642947|FG000|Induction|Failed to Complete Randomization|3|||
33271159|NCT00408005|62642948|FG001|Induction|Failed to Complete Randomization|2|||
33271160|NCT00408005|62642949|FG002|Induction|Failed to Complete Randomization|0|||
33271161|NCT00408005|62642950|FG003|Induction|Failed to Complete Randomization|0|||
33485602|NCT04351269|62863310|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
33271162|NCT00408005|62642951|FG004|Induction|Failed to Complete Randomization|0|||
33271163|NCT00408005|62642952|FG005|Induction|Failed to Complete Randomization|0|||
33271164|NCT00408005|62642953|FG006|Induction|Failed to Complete Randomization|0|||
33271165|NCT00408005|62642954|FG007|Induction|Failed to Complete Randomization|0|||
33271166|NCT00408005|62642947|FG000|Induction|Protocol Deviation|3|||
33271167|NCT00408005|62642948|FG001|Induction|Protocol Deviation|1|||
33271168|NCT00408005|62642949|FG002|Induction|Protocol Deviation|0|||
33271169|NCT00408005|62642950|FG003|Induction|Protocol Deviation|0|||
33271170|NCT00408005|62642951|FG004|Induction|Protocol Deviation|0|||
33271171|NCT00408005|62642952|FG005|Induction|Protocol Deviation|0|||
33271172|NCT00408005|62642953|FG006|Induction|Protocol Deviation|0|||
33271173|NCT00408005|62642954|FG007|Induction|Protocol Deviation|0|||
33271174|NCT00408005|62642947|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
33271175|NCT00408005|62642948|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
33271176|NCT00408005|62642949|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
33271177|NCT00408005|62642950|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
33271178|NCT00408005|62642951|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
33271179|NCT00408005|62642952|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
33271180|NCT00408005|62642953|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
33271181|NCT00408005|62642954|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
33271182|NCT00408005|62642947|FG000|Induction|Recurrent leukemia|1|||
33271183|NCT00408005|62642948|FG001|Induction|Recurrent leukemia|0|||
33271184|NCT00408005|62642949|FG002|Induction|Recurrent leukemia|0|||
33271185|NCT00408005|62642950|FG003|Induction|Recurrent leukemia|0|||
33271186|NCT00408005|62642951|FG004|Induction|Recurrent leukemia|0|||
33271187|NCT00408005|62642952|FG005|Induction|Recurrent leukemia|0|||
33271188|NCT00408005|62642953|FG006|Induction|Recurrent leukemia|0|||
33271189|NCT00408005|62642954|FG007|Induction|Recurrent leukemia|0|||
33271190|NCT00408005|62642947|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
33271191|NCT00408005|62642948|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
33271192|NCT00408005|62642949|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
33271193|NCT00408005|62642950|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
33271194|NCT00408005|62642951|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
33271195|NCT00408005|62642952|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
33271196|NCT00408005|62642953|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
33271197|NCT00408005|62642954|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
33271198|NCT00408005|62642947|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
33370063|NCT00461305|62748784|FG000|Continued Treatment|Protocol Violation|13|||
33370064|NCT00461305|62748785|FG001|Continued Treatment|Protocol Violation|0|||
33370065|NCT00461305|62748784|FG000|Continued Treatment|Withdrawal by Subject|48|||
33370066|NCT00461305|62748785|FG001|Continued Treatment|Withdrawal by Subject|0|||
33370067|NCT00461305|62748784|FG000|Continued Treatment|Partially missing diary|2|||
33370068|NCT00461305|62748785|FG001|Continued Treatment|Partially missing diary|0|||
33370069|NCT00461305|62748784|FG000|Continued Treatment|Other (missing drug etc)|2|||
33370070|NCT00461305|62748785|FG001|Continued Treatment|Other (missing drug etc)|0|||
33370071|NCT00856544|62748796|FG000|Overall Study|Randomized but not treated|3|||
33370072|NCT00856544|62748797|FG001|Overall Study|Randomized but not treated|0|||
33370073|NCT00856544|62748798|FG002|Overall Study|Randomized but not treated|0|||
33370074|NCT00856544|62748799|FG003|Overall Study|Randomized but not treated|0|||
33370075|NCT00856544|62748796|FG000|Overall Study|Death|0|||
33370076|NCT00856544|62748797|FG001|Overall Study|Death|2|||
33370077|NCT00856544|62748798|FG002|Overall Study|Death|0|||
33370078|NCT00856544|62748799|FG003|Overall Study|Death|0|||
33370079|NCT00856544|62748796|FG000|Overall Study|Adverse Event|20|||
33370080|NCT00856544|62748797|FG001|Overall Study|Adverse Event|29|||
33370081|NCT00856544|62748798|FG002|Overall Study|Adverse Event|2|||
33370082|NCT00856544|62748799|FG003|Overall Study|Adverse Event|3|||
33370083|NCT00856544|62748796|FG000|Overall Study|Lack of Efficacy|16|||
33370084|NCT00856544|62748797|FG001|Overall Study|Lack of Efficacy|12|||
33370085|NCT00856544|62748798|FG002|Overall Study|Lack of Efficacy|3|||
33370086|NCT00856544|62748799|FG003|Overall Study|Lack of Efficacy|3|||
33370087|NCT00856544|62748796|FG000|Overall Study|Other|9|||
33370088|NCT00856544|62748797|FG001|Overall Study|Other|16|||
33370089|NCT00856544|62748798|FG002|Overall Study|Other|1|||
33370090|NCT00856544|62748799|FG003|Overall Study|Other|6|||
33370091|NCT00856544|62748796|FG000|Overall Study|Lost to Follow-up|1|||
33370092|NCT00856544|62748797|FG001|Overall Study|Lost to Follow-up|2|||
33370093|NCT00856544|62748798|FG002|Overall Study|Lost to Follow-up|2|||
33370094|NCT00856544|62748799|FG003|Overall Study|Lost to Follow-up|0|||
33370095|NCT00856544|62748796|FG000|Overall Study|Withdrawal by Subject|8|||
33370096|NCT00856544|62748797|FG001|Overall Study|Withdrawal by Subject|5|||
33370097|NCT00856544|62748798|FG002|Overall Study|Withdrawal by Subject|0|||
33370098|NCT00856544|62748799|FG003|Overall Study|Withdrawal by Subject|1|||
33662017|NCT02698410|63092718|FG000|Overall Study|Adverse Event|2|||
33271199|NCT00408005|62642948|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
33370099|NCT00856388|62748821|FG000|Overall Study|Other|1|||
33370100|NCT00848354|62748828|FG000|Phase 1|Adverse Event|5|||
33370101|NCT00848354|62748829|FG001|Phase 1|Adverse Event|4|||
33370102|NCT00848354|62748828|FG000|Phase 1|Discontinuation of study by sponsor|2|||
33370103|NCT00848354|62748829|FG001|Phase 1|Discontinuation of study by sponsor|1|||
33370104|NCT00848354|62748828|FG000|Phase 1|Failed to return|0|||
33370105|NCT00848354|62748829|FG001|Phase 1|Failed to return|1|||
33370106|NCT00848354|62748828|FG000|Phase 1|Lost to Follow-up|1|||
33271200|NCT00408005|62642949|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
33271201|NCT00408005|62642950|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
33271202|NCT00408005|62642951|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
33271203|NCT00408005|62642952|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
33271204|NCT00408005|62642953|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
33271205|NCT00408005|62642954|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
33271206|NCT00408005|62642947|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
33271207|NCT00408005|62642948|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
33271208|NCT00408005|62642949|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
33271209|NCT00408005|62642950|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
33271210|NCT00408005|62642951|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
33271211|NCT00408005|62642952|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
33271212|NCT00408005|62642953|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
33271213|NCT00408005|62642954|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
33271214|NCT00408005|62642947|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
33271215|NCT00408005|62642948|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
33271216|NCT00408005|62642949|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
33271217|NCT00408005|62642950|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
33271218|NCT00408005|62642951|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
33271219|NCT00408005|62642952|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
33271220|NCT00408005|62642953|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
33271221|NCT00408005|62642954|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
33271222|NCT00408005|62642947|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
33271223|NCT00408005|62642948|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
33271224|NCT00408005|62642949|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
33271225|NCT00408005|62642950|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
33271226|NCT00408005|62642951|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
33271227|NCT00408005|62642952|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
33271228|NCT00408005|62642953|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
33271229|NCT00408005|62642954|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
33271230|NCT00408005|62642947|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
33271231|NCT00408005|62642948|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
33271232|NCT00408005|62642949|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
33271233|NCT00408005|62642950|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
33271234|NCT00408005|62642951|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
33271235|NCT00408005|62642952|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
33271236|NCT00408005|62642953|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
33271237|NCT00408005|62642954|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
33271238|NCT00408005|62642947|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
33271239|NCT00408005|62642948|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
33271240|NCT00408005|62642949|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
33271241|NCT00408005|62642950|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
33271242|NCT00408005|62642951|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
33271243|NCT00408005|62642952|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
33271244|NCT00408005|62642953|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
33271245|NCT00408005|62642954|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
33271246|NCT00408005|62642947|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
33271247|NCT00408005|62642948|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
33271248|NCT00408005|62642949|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
33271249|NCT00408005|62642950|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
33271250|NCT00408005|62642951|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
33271251|NCT00408005|62642952|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
33370107|NCT00848354|62748829|FG001|Phase 1|Lost to Follow-up|1|||
33370108|NCT00848354|62748828|FG000|Phase 1|Unspecified Reason|1|||
33370109|NCT00848354|62748829|FG001|Phase 1|Unspecified Reason|1|||
33370110|NCT00848354|62748828|FG000|Phase 1|Protocol Violation|1|||
33370111|NCT00848354|62748829|FG001|Phase 1|Protocol Violation|1|||
33485603|NCT04351269|62863311|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
33662018|NCT02698410|63092718|FG000|Overall Study|Withdrawal by Subject|1|||
33662019|NCT02698410|63092718|FG000|Overall Study|Other|1|||
33662020|NCT02699892|63092722|FG000|Overall Study|Other|36|||
33662021|NCT02698176|63092729|FG000|Overall Study|Progressive disease|4|||
33271252|NCT00408005|62642953|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
33271253|NCT00408005|62642954|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
33271254|NCT00408005|62642947|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
33271255|NCT00408005|62642948|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
33271256|NCT00408005|62642949|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
33271257|NCT00408005|62642950|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
33271258|NCT00408005|62642951|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
33271259|NCT00408005|62642952|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
33271260|NCT00408005|62642953|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
33271261|NCT00408005|62642954|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
33271262|NCT00408005|62642947|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
33271263|NCT00408005|62642948|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
33271264|NCT00408005|62642949|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
33271265|NCT00408005|62642950|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
33271266|NCT00408005|62642951|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
33271267|NCT00408005|62642952|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
33271268|NCT00408005|62642953|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
33271269|NCT00408005|62642954|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
33271270|NCT00408005|62642947|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
33271271|NCT00408005|62642948|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
33271272|NCT00408005|62642949|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
33271273|NCT00408005|62642950|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
33271274|NCT00408005|62642951|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
33271275|NCT00408005|62642952|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
33271276|NCT00408005|62642953|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
33271277|NCT00408005|62642954|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
33271278|NCT00408005|62642947|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
33271279|NCT00408005|62642948|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
33271280|NCT00408005|62642949|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
33271281|NCT00408005|62642950|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
33271282|NCT00408005|62642951|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
33271283|NCT00408005|62642952|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
33271284|NCT00408005|62642953|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
33271285|NCT00408005|62642954|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
33271286|NCT00408005|62642947|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
33271287|NCT00408005|62642948|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
33271288|NCT00408005|62642949|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
33271289|NCT00408005|62642950|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
33271290|NCT00408005|62642951|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
33271291|NCT00408005|62642952|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
33271292|NCT00408005|62642953|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
33271293|NCT00408005|62642954|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
33271294|NCT00408005|62642947|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
33271295|NCT00408005|62642948|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
33271296|NCT00408005|62642949|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
33271297|NCT00408005|62642950|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
33271298|NCT00408005|62642951|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
33271299|NCT00408005|62642952|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
33271300|NCT00408005|62642953|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
33271301|NCT00408005|62642954|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
33271302|NCT01875185|62642985|FG000|Overall Study|study was terminated|52|||
33271303|NCT01875185|62642986|FG001|Overall Study|study was terminated|48|||
33271304|NCT01901432|62643015|FG000|Overall Study|Adverse Event|0|||
33271305|NCT01901432|62643016|FG001|Overall Study|Adverse Event|1|||
33271306|NCT01901432|62643017|FG002|Overall Study|Adverse Event|1|||
33271307|NCT01901432|62643018|FG003|Overall Study|Adverse Event|0|||
33271308|NCT01901432|62643019|FG004|Overall Study|Adverse Event|1|||
33271309|NCT01901432|62643015|FG000|Overall Study|Withdrawal by Subject|0|||
33370112|NCT00848354|62748828|FG000|Phase 1|Withdrawal by Subject|2|||
33370113|NCT00848354|62748829|FG001|Phase 1|Withdrawal by Subject|4|||
33370114|NCT00848354|62748828|FG000|Phase 1|Lack of Efficacy|0|||
33370115|NCT00848354|62748829|FG001|Phase 1|Lack of Efficacy|1|||
33370116|NCT00848354|62748828|FG000|Phase 2 Year 1|Adverse Event|7|||
33271310|NCT01901432|62643016|FG001|Overall Study|Withdrawal by Subject|0|||
33271311|NCT01901432|62643017|FG002|Overall Study|Withdrawal by Subject|1|||
33271312|NCT01901432|62643018|FG003|Overall Study|Withdrawal by Subject|0|||
33271313|NCT01901432|62643019|FG004|Overall Study|Withdrawal by Subject|5|||
33271314|NCT01901432|62643015|FG000|Overall Study|Physician Decision|0|||
33271315|NCT01901432|62643016|FG001|Overall Study|Physician Decision|0|||
33271316|NCT01901432|62643017|FG002|Overall Study|Physician Decision|0|||
33271317|NCT01901432|62643018|FG003|Overall Study|Physician Decision|0|||
33271318|NCT01901432|62643019|FG004|Overall Study|Physician Decision|2|||
33271319|NCT01901432|62643015|FG000|Overall Study|Patient decision to stop study drug|0|||
33271320|NCT01901432|62643016|FG001|Overall Study|Patient decision to stop study drug|0|||
33271321|NCT01901432|62643017|FG002|Overall Study|Patient decision to stop study drug|0|||
33271322|NCT01901432|62643018|FG003|Overall Study|Patient decision to stop study drug|0|||
33271323|NCT01901432|62643019|FG004|Overall Study|Patient decision to stop study drug|1|||
33271324|NCT01904279|62643040|FG000|Overall Study|Lack of Efficacy|2|||
33271325|NCT01904279|62643041|FG001|Overall Study|Lack of Efficacy|3|||
33271326|NCT01904279|62643040|FG000|Overall Study|Withdrawal by Subject|1|||
33271327|NCT01904279|62643041|FG001|Overall Study|Withdrawal by Subject|0|||
33271328|NCT01917318|62643050|FG000|First Treatment|Withdrawal by Subject|0|||
33271329|NCT01917318|62643051|FG001|First Treatment|Withdrawal by Subject|1|||
33271330|NCT01923168|62643060|FG000|Overall Study|Protocol Violation|1|||
33271331|NCT01923168|62643061|FG001|Overall Study|Protocol Violation|1|||
33271332|NCT01923168|62643062|FG002|Overall Study|Protocol Violation|0|||
33271333|NCT01923168|62643060|FG000|Overall Study|Subject/guardian decision|14|||
33271334|NCT01923168|62643061|FG001|Overall Study|Subject/guardian decision|14|||
33271335|NCT01923168|62643062|FG002|Overall Study|Subject/guardian decision|4|||
33271336|NCT01923168|62643060|FG000|Overall Study|Adverse Event|12|||
33271337|NCT01923168|62643061|FG001|Overall Study|Adverse Event|12|||
33271338|NCT01923168|62643062|FG002|Overall Study|Adverse Event|0|||
33271339|NCT01923168|62643060|FG000|Overall Study|Physician Decision|6|||
33271340|NCT01923168|62643061|FG001|Overall Study|Physician Decision|9|||
33271341|NCT01923168|62643062|FG002|Overall Study|Physician Decision|5|||
33271342|NCT01923168|62643060|FG000|Overall Study|Progressive disease|4|||
33271343|NCT01923168|62643061|FG001|Overall Study|Progressive disease|3|||
33271344|NCT01923168|62643062|FG002|Overall Study|Progressive disease|7|||
33271345|NCT01923168|62643060|FG000|Overall Study|Death|0|||
33271346|NCT01923168|62643061|FG001|Overall Study|Death|0|||
33271347|NCT01923168|62643062|FG002|Overall Study|Death|1|||
33271348|NCT01931098|62643072|FG000|Overall Study|Withdrawal by Subject|0|||
33271349|NCT01931098|62643073|FG001|Overall Study|Withdrawal by Subject|1|||
33271350|NCT01931098|62643072|FG000|Overall Study|Enrolled in different protocol|0|||
33271351|NCT01931098|62643073|FG001|Overall Study|Enrolled in different protocol|1|||
33271352|NCT01931098|62643072|FG000|Overall Study|Unable to begin trmt:active infection|0|||
33271353|NCT01931098|62643073|FG001|Overall Study|Unable to begin trmt:active infection|1|||
33271354|NCT01931098|62643072|FG000|Overall Study|Refused further treatment|0|||
33271355|NCT01931098|62643073|FG001|Overall Study|Refused further treatment|1|||
33271356|NCT01945021|62643081|FG000|Overall Study|Adverse Event|1|||
33271357|NCT01945021|62643081|FG000|Overall Study|Withdrawal of consent|12|||
33271358|NCT01945021|62643081|FG000|Overall Study|Lost to Follow-up|5|||
33271359|NCT01945021|62643081|FG000|Overall Study|Death|65|||
33271360|NCT01945060|62643087|FG000|Overall Study|Lost to follow up|1|||
33271361|NCT01945060|62643088|FG001|Overall Study|Lost to follow up|0|||
33271362|NCT01945060|62643087|FG000|Overall Study|Distress related to IV access|0|||
33271363|NCT01945060|62643088|FG001|Overall Study|Distress related to IV access|1|||
33271364|NCT03951077|62643131|FG000|Overall Study|Adverse Event|1|||
33271365|NCT03951077|62643132|FG001|Overall Study|Adverse Event|0|||
33271366|NCT03951077|62643133|FG002|Overall Study|Adverse Event|0|||
33271367|NCT03951077|62643134|FG003|Overall Study|Adverse Event|0|||
33271368|NCT03951077|62643135|FG004|Overall Study|Adverse Event|0|||
33271369|NCT03951077|62643136|FG005|Overall Study|Adverse Event|0|||
33271370|NCT03951077|62643131|FG000|Overall Study|Withdrawal by Subject|3|||
33271371|NCT03951077|62643132|FG001|Overall Study|Withdrawal by Subject|3|||
33271372|NCT03951077|62643133|FG002|Overall Study|Withdrawal by Subject|0|||
33271373|NCT03951077|62643134|FG003|Overall Study|Withdrawal by Subject|3|||
33271374|NCT03951077|62643135|FG004|Overall Study|Withdrawal by Subject|3|||
33271375|NCT03951077|62643136|FG005|Overall Study|Withdrawal by Subject|2|||
33271376|NCT03951077|62643131|FG000|Overall Study|Lost to Follow-up|1|||
33271377|NCT03951077|62643132|FG001|Overall Study|Lost to Follow-up|1|||
33271378|NCT03951077|62643133|FG002|Overall Study|Lost to Follow-up|2|||
33271379|NCT03951077|62643134|FG003|Overall Study|Lost to Follow-up|3|||
33271380|NCT03951077|62643135|FG004|Overall Study|Lost to Follow-up|2|||
33271381|NCT03951077|62643136|FG005|Overall Study|Lost to Follow-up|3|||
33271382|NCT03951077|62643131|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
33271383|NCT03951077|62643132|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
33271384|NCT03951077|62643133|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
33271385|NCT03951077|62643134|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
33271386|NCT03951077|62643135|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
33271387|NCT03951077|62643136|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
33271388|NCT03951077|62643131|FG000|Overall Study|Other, Not Specified|12|||
33271389|NCT03951077|62643132|FG001|Overall Study|Other, Not Specified|10|||
33271390|NCT03951077|62643133|FG002|Overall Study|Other, Not Specified|10|||
33271391|NCT03951077|62643134|FG003|Overall Study|Other, Not Specified|5|||
33271392|NCT03951077|62643135|FG004|Overall Study|Other, Not Specified|9|||
33271393|NCT03951077|62643136|FG005|Overall Study|Other, Not Specified|6|||
33271394|NCT03951077|62643131|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
33271395|NCT03951077|62643132|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
33271396|NCT03951077|62643133|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
33271397|NCT03951077|62643134|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
33271398|NCT03951077|62643135|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
33271399|NCT03951077|62643136|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
33271400|NCT03873246|62643153|FG000|Overall Study|Adverse Event|1|||
33271401|NCT03873246|62643154|FG001|Overall Study|Adverse Event|3|||
33271402|NCT03873246|62643155|FG002|Overall Study|Adverse Event|3|||
33271403|NCT03873246|62643153|FG000|Overall Study|Lost to Follow-up|4|||
33271404|NCT03873246|62643154|FG001|Overall Study|Lost to Follow-up|4|||
33271405|NCT03873246|62643155|FG002|Overall Study|Lost to Follow-up|5|||
33271406|NCT03873246|62643153|FG000|Overall Study|Protocol Violation|0|||
33271407|NCT03873246|62643154|FG001|Overall Study|Protocol Violation|1|||
33271408|NCT03873246|62643155|FG002|Overall Study|Protocol Violation|0|||
33271409|NCT03873246|62643153|FG000|Overall Study|Withdrawal by Subject|0|||
33271410|NCT03873246|62643154|FG001|Overall Study|Withdrawal by Subject|4|||
33271411|NCT03873246|62643155|FG002|Overall Study|Withdrawal by Subject|1|||
33271412|NCT03769649|62643164|FG000|Overall Study|Lost to Follow-up|4|||
33271413|NCT02862548|62643190|FG000|Randomized Phase (Up to Week 48)|Death|0|||
33271414|NCT02862548|62643191|FG001|Randomized Phase (Up to Week 48)|Death|1|||
33271415|NCT02862548|62643190|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
33271416|NCT02862548|62643191|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
33271417|NCT02862548|62643190|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
33271418|NCT02862548|62643191|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
33271419|NCT02862548|62643190|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
33271420|NCT02862548|62643191|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
33271421|NCT02335099|62643210|FG000|Treatment|Withdrawal by Subject|1|||
33271422|NCT02335099|62643211|FG001|Treatment|Withdrawal by Subject|3|||
33271423|NCT02335099|62643210|FG000|Treatment|Lost to Follow-up|2|||
33271424|NCT02335099|62643211|FG001|Treatment|Lost to Follow-up|0|||
33271425|NCT02335099|62643210|FG000|Treatment|Death|1|||
33271426|NCT02335099|62643211|FG001|Treatment|Death|0|||
33271427|NCT02335099|62643210|FG000|Treatment|Adverse Event|1|||
33271428|NCT02335099|62643211|FG001|Treatment|Adverse Event|2|||
33271429|NCT02335099|62643210|FG000|Follow-up|Death|0|||
33271430|NCT02335099|62643211|FG001|Follow-up|Death|1|||
33271431|NCT02330562|62643228|FG000|Overall Study|Adverse Event|0|||
33271432|NCT02330562|62643229|FG001|Overall Study|Adverse Event|0|||
33271433|NCT02330562|62643230|FG002|Overall Study|Adverse Event|3|||
33271434|NCT02330562|62643231|FG003|Overall Study|Adverse Event|0|||
33271435|NCT02330562|62643232|FG004|Overall Study|Adverse Event|3|||
33271436|NCT02330562|62643233|FG005|Overall Study|Adverse Event|1|||
33271437|NCT02330562|62643234|FG006|Overall Study|Adverse Event|0|||
33271438|NCT02330562|62643235|FG007|Overall Study|Adverse Event|0|||
33271439|NCT02330562|62643236|FG008|Overall Study|Adverse Event|0|||
33271440|NCT02330562|62643237|FG009|Overall Study|Adverse Event|1|||
33271441|NCT02330562|62643238|FG010|Overall Study|Adverse Event|1|||
33271442|NCT02330562|62643228|FG000|Overall Study|Participant decision|1|||
33271443|NCT02330562|62643229|FG001|Overall Study|Participant decision|0|||
33271444|NCT02330562|62643230|FG002|Overall Study|Participant decision|4|||
33271445|NCT02330562|62643231|FG003|Overall Study|Participant decision|1|||
33271446|NCT02330562|62643232|FG004|Overall Study|Participant decision|5|||
33271447|NCT02330562|62643233|FG005|Overall Study|Participant decision|2|||
33271448|NCT02330562|62643234|FG006|Overall Study|Participant decision|0|||
33271449|NCT02330562|62643235|FG007|Overall Study|Participant decision|0|||
33271450|NCT02330562|62643236|FG008|Overall Study|Participant decision|0|||
33271451|NCT02330562|62643237|FG009|Overall Study|Participant decision|3|||
33271452|NCT02330562|62643238|FG010|Overall Study|Participant decision|0|||
33271453|NCT02330562|62643228|FG000|Overall Study|Disease progression|5|||
33271454|NCT02330562|62643229|FG001|Overall Study|Disease progression|3|||
33271455|NCT02330562|62643230|FG002|Overall Study|Disease progression|20|||
33271456|NCT02330562|62643231|FG003|Overall Study|Disease progression|28|||
33271457|NCT02330562|62643232|FG004|Overall Study|Disease progression|23|||
33271458|NCT02330562|62643233|FG005|Overall Study|Disease progression|7|||
33271459|NCT02330562|62643234|FG006|Overall Study|Disease progression|1|||
33271460|NCT02330562|62643235|FG007|Overall Study|Disease progression|1|||
33271461|NCT02330562|62643236|FG008|Overall Study|Disease progression|1|||
33271462|NCT02330562|62643237|FG009|Overall Study|Disease progression|0|||
33271463|NCT02330562|62643238|FG010|Overall Study|Disease progression|5|||
33271464|NCT02330562|62643228|FG000|Overall Study|Other reasons|0|||
33271465|NCT02330562|62643229|FG001|Overall Study|Other reasons|0|||
33271466|NCT02330562|62643230|FG002|Overall Study|Other reasons|0|||
33271467|NCT02330562|62643231|FG003|Overall Study|Other reasons|1|||
33271468|NCT02330562|62643232|FG004|Overall Study|Other reasons|0|||
33271469|NCT02330562|62643233|FG005|Overall Study|Other reasons|0|||
33271470|NCT02330562|62643234|FG006|Overall Study|Other reasons|0|||
33271471|NCT02330562|62643235|FG007|Overall Study|Other reasons|0|||
33271472|NCT02330562|62643236|FG008|Overall Study|Other reasons|0|||
33271473|NCT02330562|62643237|FG009|Overall Study|Other reasons|0|||
33271474|NCT02330562|62643238|FG010|Overall Study|Other reasons|0|||
33271475|NCT02330562|62643228|FG000|Overall Study|Withdrawal by Subject|0|||
33271476|NCT02330562|62643229|FG001|Overall Study|Withdrawal by Subject|0|||
33271477|NCT02330562|62643230|FG002|Overall Study|Withdrawal by Subject|0|||
33271478|NCT02330562|62643231|FG003|Overall Study|Withdrawal by Subject|0|||
33271479|NCT02330562|62643232|FG004|Overall Study|Withdrawal by Subject|0|||
33271480|NCT02330562|62643233|FG005|Overall Study|Withdrawal by Subject|0|||
33271481|NCT02330562|62643234|FG006|Overall Study|Withdrawal by Subject|0|||
33271482|NCT02330562|62643235|FG007|Overall Study|Withdrawal by Subject|0|||
33271483|NCT02330562|62643236|FG008|Overall Study|Withdrawal by Subject|0|||
33271484|NCT02330562|62643237|FG009|Overall Study|Withdrawal by Subject|1|||
33271485|NCT02330562|62643238|FG010|Overall Study|Withdrawal by Subject|0|||
33271486|NCT03703102|62643352|FG000|Overall Study|Adverse Event|4|||
33271487|NCT03703102|62643353|FG001|Overall Study|Adverse Event|3|||
33271488|NCT03703102|62643354|FG002|Overall Study|Adverse Event|7|||
33271489|NCT03703102|62643355|FG003|Overall Study|Adverse Event|3|||
33271490|NCT03703102|62643356|FG004|Overall Study|Adverse Event|13|||
33271491|NCT03703102|62643352|FG000|Overall Study|Lack of Efficacy|4|||
33271492|NCT03703102|62643353|FG001|Overall Study|Lack of Efficacy|0|||
33271493|NCT03703102|62643354|FG002|Overall Study|Lack of Efficacy|1|||
33271494|NCT03703102|62643355|FG003|Overall Study|Lack of Efficacy|4|||
33271495|NCT03703102|62643356|FG004|Overall Study|Lack of Efficacy|1|||
33271496|NCT03703102|62643352|FG000|Overall Study|Lost to Follow-up|0|||
33271497|NCT03703102|62643353|FG001|Overall Study|Lost to Follow-up|0|||
33271498|NCT03703102|62643354|FG002|Overall Study|Lost to Follow-up|1|||
33271499|NCT03703102|62643355|FG003|Overall Study|Lost to Follow-up|2|||
33271500|NCT03703102|62643356|FG004|Overall Study|Lost to Follow-up|2|||
33271501|NCT03703102|62643352|FG000|Overall Study|Physician Decision|2|||
33271502|NCT03703102|62643353|FG001|Overall Study|Physician Decision|2|||
33271503|NCT03703102|62643354|FG002|Overall Study|Physician Decision|2|||
33271504|NCT03703102|62643355|FG003|Overall Study|Physician Decision|2|||
33271505|NCT03703102|62643356|FG004|Overall Study|Physician Decision|4|||
33271506|NCT03703102|62643352|FG000|Overall Study|Withdrawal by Subject|7|||
33271507|NCT03703102|62643353|FG001|Overall Study|Withdrawal by Subject|5|||
33271508|NCT03703102|62643354|FG002|Overall Study|Withdrawal by Subject|5|||
33271509|NCT03703102|62643355|FG003|Overall Study|Withdrawal by Subject|5|||
33271510|NCT03703102|62643356|FG004|Overall Study|Withdrawal by Subject|9|||
33271511|NCT03703102|62643352|FG000|Overall Study|Ineligibility|0|||
33271512|NCT03703102|62643353|FG001|Overall Study|Ineligibility|0|||
33271513|NCT03703102|62643354|FG002|Overall Study|Ineligibility|1|||
33271514|NCT03703102|62643355|FG003|Overall Study|Ineligibility|0|||
33271515|NCT03703102|62643356|FG004|Overall Study|Ineligibility|0|||
33271516|NCT03703102|62643352|FG000|Overall Study|Protocol Deviation|4|||
33271517|NCT03703102|62643353|FG001|Overall Study|Protocol Deviation|4|||
33271518|NCT03703102|62643354|FG002|Overall Study|Protocol Deviation|3|||
33271519|NCT03703102|62643355|FG003|Overall Study|Protocol Deviation|0|||
33271520|NCT03703102|62643356|FG004|Overall Study|Protocol Deviation|0|||
33271521|NCT03703102|62643352|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33271522|NCT03703102|62643353|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33271523|NCT03703102|62643354|FG002|Overall Study|Non-Compliance with Study Drug|2|||
33271524|NCT03703102|62643355|FG003|Overall Study|Non-Compliance with Study Drug|1|||
33271525|NCT03703102|62643356|FG004|Overall Study|Non-Compliance with Study Drug|4|||
33271526|NCT03395704|62643375|FG000|Overall Study|Adverse Event|2|||
33271527|NCT03395704|62643376|FG001|Overall Study|Adverse Event|1|||
33271528|NCT03395704|62643375|FG000|Overall Study|Withdrawal by Subject|2|||
33271529|NCT03395704|62643376|FG001|Overall Study|Withdrawal by Subject|1|||
33271530|NCT03395704|62643375|FG000|Overall Study|Physician Decision|0|||
33271531|NCT03395704|62643376|FG001|Overall Study|Physician Decision|1|||
33271532|NCT03335813|62643382|FG000|Overall Study|Withdrawal by Subject|1|||
33271533|NCT03246503|62643386|FG000|Overall Study|Lost to Follow-up|23|||
33271534|NCT03246503|62643386|FG000|Overall Study|Withdrawal by Subject|20|||
33271535|NCT03246503|62643386|FG000|Overall Study|Physician Decision|5|||
33271536|NCT03246503|62643386|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
33271537|NCT02514447|62643447|FG000|Overall Study|Withdrawal by Subject|3|||
33271538|NCT02514447|62643448|FG001|Overall Study|Withdrawal by Subject|1|||
33271539|NCT02514447|62643449|FG002|Overall Study|Withdrawal by Subject|1|||
33271540|NCT02514447|62643450|FG003|Overall Study|Withdrawal by Subject|0|||
33271541|NCT02514447|62643451|FG004|Overall Study|Withdrawal by Subject|0|||
33271542|NCT02514447|62643452|FG005|Overall Study|Withdrawal by Subject|0|||
33271543|NCT02514447|62643453|FG006|Overall Study|Withdrawal by Subject|0|||
33271544|NCT02514447|62643454|FG007|Overall Study|Withdrawal by Subject|1|||
33271545|NCT02514447|62643455|FG008|Overall Study|Withdrawal by Subject|1|||
33271546|NCT02514447|62643447|FG000|Overall Study|Death|24|||
33271547|NCT02514447|62643448|FG001|Overall Study|Death|28|||
33271548|NCT02514447|62643449|FG002|Overall Study|Death|29|||
33271549|NCT02514447|62643450|FG003|Overall Study|Death|0|||
33271550|NCT02514447|62643451|FG004|Overall Study|Death|3|||
33271551|NCT02514447|62643452|FG005|Overall Study|Death|4|||
33271552|NCT02514447|62643453|FG006|Overall Study|Death|8|||
33271553|NCT02514447|62643454|FG007|Overall Study|Death|6|||
33271554|NCT02514447|62643455|FG008|Overall Study|Death|5|||
33271555|NCT02514447|62643447|FG000|Overall Study|Lost to Follow-up|1|||
33271556|NCT02514447|62643448|FG001|Overall Study|Lost to Follow-up|0|||
33271557|NCT02514447|62643449|FG002|Overall Study|Lost to Follow-up|0|||
33271558|NCT02514447|62643450|FG003|Overall Study|Lost to Follow-up|0|||
33271559|NCT02514447|62643451|FG004|Overall Study|Lost to Follow-up|0|||
33271560|NCT02514447|62643452|FG005|Overall Study|Lost to Follow-up|0|||
33271561|NCT02514447|62643453|FG006|Overall Study|Lost to Follow-up|0|||
33271562|NCT02514447|62643454|FG007|Overall Study|Lost to Follow-up|0|||
33271563|NCT02514447|62643455|FG008|Overall Study|Lost to Follow-up|1|||
33271564|NCT02514447|62643447|FG000|Overall Study|Sponsor Termination of Study|0|||
33271565|NCT02514447|62643448|FG001|Overall Study|Sponsor Termination of Study|1|||
33271566|NCT02514447|62643449|FG002|Overall Study|Sponsor Termination of Study|1|||
33271567|NCT02514447|62643450|FG003|Overall Study|Sponsor Termination of Study|0|||
33271568|NCT02514447|62643451|FG004|Overall Study|Sponsor Termination of Study|0|||
33271569|NCT02514447|62643452|FG005|Overall Study|Sponsor Termination of Study|0|||
33271570|NCT02514447|62643453|FG006|Overall Study|Sponsor Termination of Study|0|||
33271571|NCT02514447|62643454|FG007|Overall Study|Sponsor Termination of Study|0|||
33271572|NCT02514447|62643455|FG008|Overall Study|Sponsor Termination of Study|0|||
33271573|NCT02514447|62643447|FG000|Overall Study|Study completion per Investigator|1|||
33271574|NCT02514447|62643448|FG001|Overall Study|Study completion per Investigator|0|||
33271575|NCT02514447|62643449|FG002|Overall Study|Study completion per Investigator|1|||
33271576|NCT02514447|62643450|FG003|Overall Study|Study completion per Investigator|2|||
33271577|NCT02514447|62643451|FG004|Overall Study|Study completion per Investigator|0|||
33271578|NCT02514447|62643452|FG005|Overall Study|Study completion per Investigator|0|||
33271579|NCT02514447|62643453|FG006|Overall Study|Study completion per Investigator|0|||
33271580|NCT02514447|62643454|FG007|Overall Study|Study completion per Investigator|0|||
33271581|NCT02514447|62643455|FG008|Overall Study|Study completion per Investigator|1|||
33271582|NCT01785563|62643499|FG000|Overall Study|Physician Decision|10|||
33271583|NCT01785563|62643499|FG000|Overall Study|Withdrawal by Subject|1|||
33271584|NCT01785563|62643499|FG000|Overall Study|Protocol Violation|2|||
33271585|NCT01434290|62643505|FG000|Overall Study|Protocol Violation|6|||
33271586|NCT01434290|62643506|FG001|Overall Study|Protocol Violation|3|||
33271587|NCT01434290|62643505|FG000|Overall Study|No protocol treatment|2|||
33271588|NCT01434290|62643506|FG001|Overall Study|No protocol treatment|4|||
33271589|NCT00750269|62643518|FG000|Overall Study|Protocol Violation|0|||
33271590|NCT00750269|62643519|FG001|Overall Study|Protocol Violation|1|||
33271591|NCT00750269|62643520|FG002|Overall Study|Protocol Violation|1|||
33271592|NCT00750269|62643521|FG003|Overall Study|Protocol Violation|2|||
33271593|NCT00750269|62643522|FG004|Overall Study|Protocol Violation|4|||
33271594|NCT00750269|62643518|FG000|Overall Study|Withdrawal by Subject|0|||
33271595|NCT00750269|62643519|FG001|Overall Study|Withdrawal by Subject|0|||
33271596|NCT00750269|62643520|FG002|Overall Study|Withdrawal by Subject|2|||
33271597|NCT00750269|62643521|FG003|Overall Study|Withdrawal by Subject|2|||
33271598|NCT00750269|62643522|FG004|Overall Study|Withdrawal by Subject|2|||
33271599|NCT00750269|62643518|FG000|Overall Study|Physician Decision|0|||
33271600|NCT00750269|62643519|FG001|Overall Study|Physician Decision|0|||
33271601|NCT00750269|62643520|FG002|Overall Study|Physician Decision|0|||
33271602|NCT00750269|62643521|FG003|Overall Study|Physician Decision|0|||
33271603|NCT00750269|62643522|FG004|Overall Study|Physician Decision|2|||
33271604|NCT00750269|62643518|FG000|Overall Study|Patient too large for positioning|0|||
33271605|NCT00750269|62643519|FG001|Overall Study|Patient too large for positioning|0|||
33271606|NCT00750269|62643520|FG002|Overall Study|Patient too large for positioning|1|||
33271607|NCT00750269|62643521|FG003|Overall Study|Patient too large for positioning|0|||
33271608|NCT00750269|62643522|FG004|Overall Study|Patient too large for positioning|0|||
33271609|NCT00750269|62643518|FG000|Overall Study|Site error|0|||
33271610|NCT00750269|62643519|FG001|Overall Study|Site error|0|||
33271611|NCT00750269|62643520|FG002|Overall Study|Site error|0|||
33271612|NCT00750269|62643521|FG003|Overall Study|Site error|1|||
33271613|NCT00750269|62643522|FG004|Overall Study|Site error|0|||
33271614|NCT00750269|62643518|FG000|Overall Study|SBRT plan could not be drawn|0|||
33271615|NCT00750269|62643519|FG001|Overall Study|SBRT plan could not be drawn|0|||
33271616|NCT00750269|62643520|FG002|Overall Study|SBRT plan could not be drawn|0|||
33271617|NCT00750269|62643521|FG003|Overall Study|SBRT plan could not be drawn|0|||
33271618|NCT00750269|62643522|FG004|Overall Study|SBRT plan could not be drawn|1|||
33271619|NCT00750269|62643518|FG000|Overall Study|Fiducials could not be placed|0|||
33271620|NCT00750269|62643519|FG001|Overall Study|Fiducials could not be placed|0|||
33271621|NCT00750269|62643520|FG002|Overall Study|Fiducials could not be placed|0|||
33271622|NCT00750269|62643521|FG003|Overall Study|Fiducials could not be placed|0|||
33271623|NCT00750269|62643522|FG004|Overall Study|Fiducials could not be placed|1|||
33271624|NCT00712322|62643544|FG000|Overall Study|Protocol deviation|0|||
33271625|NCT00712322|62643545|FG001|Overall Study|Protocol deviation|1|||
33271626|NCT00712322|62643546|FG002|Overall Study|Protocol deviation|0|||
33271627|NCT00323856|62643554|FG000|Overall Study|Withdrawal by Subject|1|||
33271628|NCT00323856|62643554|FG000|Overall Study|Was uncooperative and noncompliant|1|||
33271629|NCT00323856|62643554|FG000|Overall Study|Reason not specified|1|||
33271630|NCT00323856|62643554|FG000|Overall Study|Missing|2|||
33271631|NCT04594941|62643569|FG000|Overall Study|Other|0|||
33271632|NCT04594941|62643570|FG001|Overall Study|Other|3|||
33271633|NCT04594941|62643571|FG002|Overall Study|Other|1|||
33271634|NCT04594941|62643572|FG003|Overall Study|Other|0|||
33271635|NCT04524663|62643590|FG000|Overall Study|Withdrawal by Subject|0|||
33271636|NCT04524663|62643591|FG001|Overall Study|Withdrawal by Subject|2|||
33271637|NCT03738423|62643620|FG000|Overall Study|Withdrawal by Subject|9|||
33271638|NCT03738423|62643621|FG001|Overall Study|Withdrawal by Subject|12|||
33271639|NCT03738423|62643622|FG002|Overall Study|Withdrawal by Subject|9|||
33271640|NCT03738423|62643623|FG003|Overall Study|Withdrawal by Subject|12|||
33271641|NCT03738423|62643624|FG004|Overall Study|Withdrawal by Subject|10|||
33271642|NCT03738423|62643620|FG000|Overall Study|Lack of Efficacy|3|||
33271643|NCT03738423|62643621|FG001|Overall Study|Lack of Efficacy|1|||
33271644|NCT03738423|62643622|FG002|Overall Study|Lack of Efficacy|1|||
33271645|NCT03738423|62643623|FG003|Overall Study|Lack of Efficacy|1|||
33271646|NCT03738423|62643624|FG004|Overall Study|Lack of Efficacy|2|||
33271647|NCT03738423|62643620|FG000|Overall Study|Lost to Follow-up|1|||
33271648|NCT03738423|62643621|FG001|Overall Study|Lost to Follow-up|0|||
33271649|NCT03738423|62643622|FG002|Overall Study|Lost to Follow-up|1|||
33271650|NCT03738423|62643623|FG003|Overall Study|Lost to Follow-up|1|||
33271651|NCT03738423|62643624|FG004|Overall Study|Lost to Follow-up|0|||
33271652|NCT03738423|62643620|FG000|Overall Study|Protocol Violation|1|||
33271653|NCT03738423|62643621|FG001|Overall Study|Protocol Violation|0|||
33271654|NCT03738423|62643622|FG002|Overall Study|Protocol Violation|0|||
33271655|NCT03738423|62643623|FG003|Overall Study|Protocol Violation|0|||
33271656|NCT03738423|62643624|FG004|Overall Study|Protocol Violation|1|||
33271657|NCT03738423|62643620|FG000|Overall Study|Physician Decision|0|||
33271658|NCT03738423|62643621|FG001|Overall Study|Physician Decision|0|||
33271659|NCT03738423|62643622|FG002|Overall Study|Physician Decision|1|||
33271660|NCT03738423|62643623|FG003|Overall Study|Physician Decision|0|||
33271661|NCT03738423|62643624|FG004|Overall Study|Physician Decision|1|||
33271662|NCT03738423|62643620|FG000|Overall Study|Death|0|||
33271663|NCT03738423|62643621|FG001|Overall Study|Death|0|||
33271664|NCT03738423|62643622|FG002|Overall Study|Death|0|||
33271665|NCT03738423|62643623|FG003|Overall Study|Death|0|||
33271666|NCT03738423|62643624|FG004|Overall Study|Death|1|||
33271667|NCT03738423|62643620|FG000|Overall Study|Randomized but never treated|0|||
33271668|NCT03738423|62643621|FG001|Overall Study|Randomized but never treated|0|||
33271669|NCT03738423|62643622|FG002|Overall Study|Randomized but never treated|1|||
33271670|NCT03738423|62643623|FG003|Overall Study|Randomized but never treated|1|||
33271671|NCT03738423|62643624|FG004|Overall Study|Randomized but never treated|0|||
33271672|NCT03712228|62643642|FG000|Treatment Period 1|Lack of Efficacy|0|||
33271673|NCT03712228|62643643|FG001|Treatment Period 1|Lack of Efficacy|0|||
33271674|NCT03712228|62643644|FG002|Treatment Period 1|Lack of Efficacy|0|||
33271675|NCT03712228|62643645|FG003|Treatment Period 1|Lack of Efficacy|0|||
33271676|NCT03712228|62643646|FG004|Treatment Period 1|Lack of Efficacy|0|||
33271677|NCT03712228|62643647|FG005|Treatment Period 1|Lack of Efficacy|1|||
33271678|NCT03712228|62643642|FG000|Treatment Period 2|Pregnancy|0|||
33555706|NCT01369511|62948549|FG001|Overall Study|Adverse Event|1|||
33271679|NCT03712228|62643643|FG001|Treatment Period 2|Pregnancy|0|||
33271680|NCT03712228|62643644|FG002|Treatment Period 2|Pregnancy|0|||
33271681|NCT03712228|62643645|FG003|Treatment Period 2|Pregnancy|1|||
33271682|NCT03712228|62643646|FG004|Treatment Period 2|Pregnancy|0|||
33271683|NCT03712228|62643647|FG005|Treatment Period 2|Pregnancy|0|||
33271684|NCT03712228|62643642|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33271685|NCT03712228|62643643|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33271686|NCT03712228|62643644|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33271687|NCT03712228|62643645|FG003|Treatment Period 2|Withdrawal by Subject|1|||
33271688|NCT03712228|62643646|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33271689|NCT03712228|62643647|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33271690|NCT03600818|62643666|FG000|Overall Study|Adverse Event|4|||
33271691|NCT03600818|62643667|FG001|Overall Study|Adverse Event|7|||
33662022|NCT02698176|63092730|FG001|Overall Study|Progressive disease|3|||
33271692|NCT03600818|62643666|FG000|Overall Study|Lack of Efficacy|9|||
33271693|NCT03600818|62643667|FG001|Overall Study|Lack of Efficacy|4|||
33271694|NCT03600818|62643666|FG000|Overall Study|Withdrawal by Subject|4|||
33271695|NCT03600818|62643667|FG001|Overall Study|Withdrawal by Subject|3|||
33555707|NCT01369511|62948550|FG002|Overall Study|Adverse Event|5|||
33271696|NCT03600818|62643666|FG000|Overall Study|Other-unspecified|5|||
33271697|NCT03600818|62643667|FG001|Overall Study|Other-unspecified|3|||
33271698|NCT03600818|62643666|FG000|Overall Study|Randomized and not treated|0|||
33271699|NCT03600818|62643667|FG001|Overall Study|Randomized and not treated|1|||
33271700|NCT03578276|62643676|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
33271701|NCT03578276|62643677|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
33271702|NCT02034110|62643742|FG000|Overall Study|Physician Decision|0|||
33271703|NCT02034110|62643743|FG001|Overall Study|Physician Decision|0|||
33271704|NCT02034110|62643744|FG002|Overall Study|Physician Decision|0|||
33271705|NCT02034110|62643745|FG003|Overall Study|Physician Decision|0|||
33271706|NCT02034110|62643746|FG004|Overall Study|Physician Decision|2|||
33271707|NCT02034110|62643747|FG005|Overall Study|Physician Decision|0|||
33271708|NCT02034110|62643748|FG006|Overall Study|Physician Decision|1|||
33271709|NCT02034110|62643749|FG007|Overall Study|Physician Decision|0|||
33271710|NCT02034110|62643742|FG000|Overall Study|Lost to Follow-up|1|||
33271711|NCT02034110|62643743|FG001|Overall Study|Lost to Follow-up|0|||
33271712|NCT02034110|62643744|FG002|Overall Study|Lost to Follow-up|0|||
33271713|NCT02034110|62643745|FG003|Overall Study|Lost to Follow-up|0|||
33271714|NCT02034110|62643746|FG004|Overall Study|Lost to Follow-up|1|||
33271715|NCT02034110|62643747|FG005|Overall Study|Lost to Follow-up|0|||
33271716|NCT02034110|62643748|FG006|Overall Study|Lost to Follow-up|1|||
33271717|NCT02034110|62643749|FG007|Overall Study|Lost to Follow-up|0|||
33271718|NCT02034110|62643742|FG000|Overall Study|Withdrawal by Subject|5|||
33271719|NCT02034110|62643743|FG001|Overall Study|Withdrawal by Subject|7|||
33271720|NCT02034110|62643744|FG002|Overall Study|Withdrawal by Subject|0|||
33271721|NCT02034110|62643745|FG003|Overall Study|Withdrawal by Subject|3|||
33271722|NCT02034110|62643746|FG004|Overall Study|Withdrawal by Subject|7|||
33271723|NCT02034110|62643747|FG005|Overall Study|Withdrawal by Subject|0|||
33271724|NCT02034110|62643748|FG006|Overall Study|Withdrawal by Subject|3|||
33271725|NCT02034110|62643749|FG007|Overall Study|Withdrawal by Subject|1|||
33271726|NCT02034110|62643742|FG000|Overall Study|Study closed by sponsor|6|||
33271727|NCT02034110|62643743|FG001|Overall Study|Study closed by sponsor|2|||
33271728|NCT02034110|62643744|FG002|Overall Study|Study closed by sponsor|0|||
33271729|NCT02034110|62643745|FG003|Overall Study|Study closed by sponsor|6|||
33271730|NCT02034110|62643746|FG004|Overall Study|Study closed by sponsor|7|||
33271731|NCT02034110|62643747|FG005|Overall Study|Study closed by sponsor|0|||
33271732|NCT02034110|62643748|FG006|Overall Study|Study closed by sponsor|42|||
33271733|NCT02034110|62643749|FG007|Overall Study|Study closed by sponsor|0|||
33271734|NCT01627574|62643797|FG000|Overall Study|Withdrawal by Subject|8|||
33271735|NCT01627574|62643798|FG001|Overall Study|Withdrawal by Subject|5|||
33271736|NCT01627574|62643797|FG000|Overall Study|Lost to Follow-up|13|||
33271737|NCT01627574|62643798|FG001|Overall Study|Lost to Follow-up|13|||
33271738|NCT01498458|62643804|FG000|Overall Study|Adverse Event|4|||
33271739|NCT01498458|62643804|FG000|Overall Study|Physician Decision|3|||
33271740|NCT01427712|62643813|FG000|Overall Study|Transfer to a different hospital|2|||
33271741|NCT01427712|62643813|FG000|Overall Study|Lost to Follow-up|1|||
33271742|NCT01427712|62643813|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
33271743|NCT01427712|62643813|FG000|Overall Study|Failure to visit|1|||
33271744|NCT01369147|62643820|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
33271745|NCT01369147|62643821|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
33271746|NCT01369147|62643822|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
33271747|NCT04846231|62643838|FG000|Overall Study|Lost to Follow-up|1|||
33271748|NCT04846231|62643839|FG001|Overall Study|Lost to Follow-up|0|||
33271749|NCT04846231|62643840|FG002|Overall Study|Lost to Follow-up|0|||
33271750|NCT04846231|62643841|FG003|Overall Study|Lost to Follow-up|0|||
33662023|NCT02698176|63092731|FG002|Overall Study|Progressive disease|1|||
33662024|NCT02698176|63092732|FG003|Overall Study|Progressive disease|0|||
33662025|NCT02698176|63092729|FG000|Overall Study|Adverse Event|2|||
33662026|NCT02698176|63092730|FG001|Overall Study|Adverse Event|0|||
33662027|NCT02698176|63092731|FG002|Overall Study|Adverse Event|0|||
33271751|NCT04846231|62643842|FG004|Overall Study|Lost to Follow-up|0|||
33271752|NCT04846231|62643843|FG005|Overall Study|Lost to Follow-up|0|||
33271753|NCT04846231|62643844|FG006|Overall Study|Lost to Follow-up|0|||
33271754|NCT04846231|62643845|FG007|Overall Study|Lost to Follow-up|1|||
33271755|NCT04846231|62643838|FG000|Overall Study|Withdrawal by Subject|0|||
33271756|NCT04846231|62643839|FG001|Overall Study|Withdrawal by Subject|1|||
33662028|NCT02698176|63092732|FG003|Overall Study|Adverse Event|0|||
33271757|NCT04846231|62643840|FG002|Overall Study|Withdrawal by Subject|2|||
33271758|NCT04846231|62643841|FG003|Overall Study|Withdrawal by Subject|1|||
33271759|NCT04846231|62643842|FG004|Overall Study|Withdrawal by Subject|0|||
33271760|NCT04846231|62643843|FG005|Overall Study|Withdrawal by Subject|0|||
33271761|NCT04846231|62643844|FG006|Overall Study|Withdrawal by Subject|0|||
33271762|NCT04846231|62643845|FG007|Overall Study|Withdrawal by Subject|0|||
33271763|NCT04846231|62643838|FG000|Overall Study|Protocol Violation|0|||
33271764|NCT04846231|62643839|FG001|Overall Study|Protocol Violation|1|||
33271765|NCT04846231|62643840|FG002|Overall Study|Protocol Violation|0|||
33662029|NCT02698176|63092729|FG000|Overall Study|Clinical progression|3|||
33271766|NCT04846231|62643841|FG003|Overall Study|Protocol Violation|0|||
33271767|NCT04846231|62643842|FG004|Overall Study|Protocol Violation|0|||
33271768|NCT04846231|62643843|FG005|Overall Study|Protocol Violation|0|||
33271769|NCT04846231|62643844|FG006|Overall Study|Protocol Violation|0|||
33271770|NCT04846231|62643845|FG007|Overall Study|Protocol Violation|0|||
33271771|NCT04846231|62643838|FG000|Overall Study|Adverse Event|0|||
33271772|NCT04846231|62643839|FG001|Overall Study|Adverse Event|0|||
33271773|NCT04846231|62643840|FG002|Overall Study|Adverse Event|0|||
33271774|NCT04846231|62643841|FG003|Overall Study|Adverse Event|0|||
33271775|NCT04846231|62643842|FG004|Overall Study|Adverse Event|0|||
33271776|NCT04846231|62643843|FG005|Overall Study|Adverse Event|0|||
33271777|NCT04846231|62643844|FG006|Overall Study|Adverse Event|1|||
33271778|NCT04846231|62643845|FG007|Overall Study|Adverse Event|1|||
33271779|NCT04533594|62643871|FG000|Overall Study|Death|26|||
33271780|NCT04533438|62643877|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
33271781|NCT04533438|62643878|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
33271782|NCT04447846|62643886|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
33271783|NCT04405245|62643893|FG000|Overall Study|Adverse Event|0|||
33271784|NCT04405245|62643894|FG001|Overall Study|Adverse Event|1|||
33271785|NCT04405245|62643895|FG002|Overall Study|Adverse Event|0|||
33271786|NCT04277507|62643903|FG000|Overall Study|Lost to Follow-up|17|||
33271787|NCT04277507|62643903|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
33271788|NCT04277507|62643903|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
33271789|NCT04277507|62643903|FG000|Overall Study|Withdrawal by Subject|3|||
33271790|NCT04277507|62643903|FG000|Overall Study|Death due to COVID-19|1|||
33271791|NCT04277507|62643903|FG000|Overall Study|Data missing for full evaluation|5|||
33271792|NCT04198805|62643924|FG000|Overall Study|Death|0|||
33271793|NCT04198805|62643925|FG001|Overall Study|Death|0|||
33271794|NCT04198805|62643926|FG002|Overall Study|Death|0|||
33271795|NCT04198805|62643927|FG003|Overall Study|Death|1|||
33271796|NCT04198805|62643924|FG000|Overall Study|Early Termination|8|||
33271797|NCT04198805|62643925|FG001|Overall Study|Early Termination|4|||
33271798|NCT04198805|62643926|FG002|Overall Study|Early Termination|6|||
33271799|NCT04198805|62643927|FG003|Overall Study|Early Termination|9|||
33271800|NCT04179890|62643943|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
33271801|NCT04179890|62643944|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
33271802|NCT04179890|62643943|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
33271803|NCT04179890|62643944|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
33271804|NCT04179890|62643943|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
33271805|NCT04179890|62643944|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
33271806|NCT04179890|62643943|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
33271807|NCT04179890|62643944|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
33271808|NCT04179890|62643943|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
33271809|NCT04179890|62643944|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
33271810|NCT04179890|62643943|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
33271811|NCT04179890|62643944|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
33271812|NCT04179890|62643943|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
33271813|NCT04179890|62643944|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
33271814|NCT04179890|62643943|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
33271815|NCT04179890|62643944|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
33271816|NCT04179890|62643943|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
33271817|NCT04179890|62643944|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
33271818|NCT03721016|62643985|FG000|Overall Study|Adverse Event|0|||
33271819|NCT03721016|62643986|FG001|Overall Study|Adverse Event|1|||
33271820|NCT03721016|62643987|FG002|Overall Study|Adverse Event|1|||
33271821|NCT03721016|62643985|FG000|Overall Study|Withdrawal by Subject|8|||
33271822|NCT03721016|62643986|FG001|Overall Study|Withdrawal by Subject|16|||
33271823|NCT03721016|62643987|FG002|Overall Study|Withdrawal by Subject|13|||
33271824|NCT03721016|62643985|FG000|Overall Study|Lost to Follow-up|4|||
33271825|NCT03721016|62643986|FG001|Overall Study|Lost to Follow-up|6|||
33271826|NCT03721016|62643987|FG002|Overall Study|Lost to Follow-up|5|||
33555708|NCT01369511|62948551|FG003|Overall Study|Adverse Event|0|||
33555709|NCT01369511|62948548|FG000|Overall Study|Entry criteria not met|2|||
33662030|NCT02698176|63092730|FG001|Overall Study|Clinical progression|0|||
33485604|NCT04351269|62863312|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
33485605|NCT04351269|62863310|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
33485606|NCT04351269|62863311|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
33271827|NCT03721016|62643985|FG000|Overall Study|Physician Decision|0|||
33271828|NCT03721016|62643986|FG001|Overall Study|Physician Decision|1|||
33271829|NCT03721016|62643987|FG002|Overall Study|Physician Decision|2|||
33271830|NCT03721016|62643985|FG000|Overall Study|Protocol Violation|0|||
33271831|NCT03721016|62643986|FG001|Overall Study|Protocol Violation|1|||
33271832|NCT03721016|62643987|FG002|Overall Study|Protocol Violation|0|||
33271833|NCT03721016|62643985|FG000|Overall Study|Site terminated by sponsor|3|||
33271834|NCT03721016|62643986|FG001|Overall Study|Site terminated by sponsor|7|||
33271835|NCT03721016|62643987|FG002|Overall Study|Site terminated by sponsor|6|||
33271836|NCT03721016|62643985|FG000|Overall Study|Subject exited early due to COVID-19|1|||
33271837|NCT03721016|62643986|FG001|Overall Study|Subject exited early due to COVID-19|0|||
33271838|NCT03721016|62643987|FG002|Overall Study|Subject exited early due to COVID-19|0|||
33271839|NCT03563716|62643997|FG000|Overall Study|Death|20|||
33271840|NCT03563716|62643998|FG001|Overall Study|Death|14|||
33271841|NCT03563716|62643997|FG000|Overall Study|Withdrawal by Subject|3|||
33271842|NCT03563716|62643998|FG001|Overall Study|Withdrawal by Subject|3|||
33271843|NCT03563716|62643997|FG000|Overall Study|Still on Study|45|||
33271844|NCT03563716|62643998|FG001|Overall Study|Still on Study|50|||
33271845|NCT03117998|62644032|FG000|Overall Study|Adverse Event|1|||
33271846|NCT03117998|62644033|FG001|Overall Study|Adverse Event|0|||
33271847|NCT03117998|62644034|FG002|Overall Study|Adverse Event|0|||
33271848|NCT03117998|62644035|FG003|Overall Study|Adverse Event|0|||
33271849|NCT03117998|62644036|FG004|Overall Study|Adverse Event|0|||
33271850|NCT03117998|62644037|FG005|Overall Study|Adverse Event|0|||
33271851|NCT03117998|62644032|FG000|Overall Study|Withdrawal by Subject|0|||
33271852|NCT03117998|62644033|FG001|Overall Study|Withdrawal by Subject|0|||
33271853|NCT03117998|62644034|FG002|Overall Study|Withdrawal by Subject|2|||
33271854|NCT03117998|62644035|FG003|Overall Study|Withdrawal by Subject|3|||
33271855|NCT03117998|62644036|FG004|Overall Study|Withdrawal by Subject|3|||
33271856|NCT03117998|62644037|FG005|Overall Study|Withdrawal by Subject|0|||
33271857|NCT03117998|62644032|FG000|Overall Study|Physician Decision|0|||
33271858|NCT03117998|62644033|FG001|Overall Study|Physician Decision|1|||
33271859|NCT03117998|62644034|FG002|Overall Study|Physician Decision|1|||
33271860|NCT03117998|62644035|FG003|Overall Study|Physician Decision|0|||
33271861|NCT03117998|62644036|FG004|Overall Study|Physician Decision|0|||
33271862|NCT03117998|62644037|FG005|Overall Study|Physician Decision|0|||
33271863|NCT03117998|62644032|FG000|Overall Study|Lost to Follow-up|0|||
33271864|NCT03117998|62644033|FG001|Overall Study|Lost to Follow-up|0|||
33271865|NCT03117998|62644034|FG002|Overall Study|Lost to Follow-up|0|||
33271866|NCT03117998|62644035|FG003|Overall Study|Lost to Follow-up|1|||
33271867|NCT03117998|62644036|FG004|Overall Study|Lost to Follow-up|4|||
33271868|NCT03117998|62644037|FG005|Overall Study|Lost to Follow-up|0|||
33271869|NCT03117998|62644032|FG000|Overall Study|Subject noncompliance|0|||
33271870|NCT03117998|62644033|FG001|Overall Study|Subject noncompliance|0|||
33271871|NCT03117998|62644034|FG002|Overall Study|Subject noncompliance|1|||
33271872|NCT03117998|62644035|FG003|Overall Study|Subject noncompliance|0|||
33271873|NCT03117998|62644036|FG004|Overall Study|Subject noncompliance|0|||
33271874|NCT03117998|62644037|FG005|Overall Study|Subject noncompliance|2|||
33271875|NCT03117998|62644032|FG000|Overall Study|Protocol Violation|0|||
33271876|NCT03117998|62644033|FG001|Overall Study|Protocol Violation|0|||
33271877|NCT03117998|62644034|FG002|Overall Study|Protocol Violation|0|||
33271878|NCT03117998|62644035|FG003|Overall Study|Protocol Violation|0|||
33271879|NCT03117998|62644036|FG004|Overall Study|Protocol Violation|0|||
33271880|NCT03117998|62644037|FG005|Overall Study|Protocol Violation|1|||
33271881|NCT03100370|62644062|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33271882|NCT03100370|62644063|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33271883|NCT03100370|62644064|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33271884|NCT03100370|62644065|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
33271885|NCT03100370|62644066|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33271886|NCT03100370|62644067|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33271887|NCT02920008|62644077|FG000|Overall Study|Death|117|||
33271888|NCT02920008|62644078|FG001|Overall Study|Death|127|||
33271889|NCT02920008|62644077|FG000|Overall Study|Withdrawal by Subject|3|||
33271890|NCT02920008|62644078|FG001|Overall Study|Withdrawal by Subject|6|||
33271891|NCT02920008|62644077|FG000|Overall Study|Lost to Follow-up|0|||
33271892|NCT02920008|62644078|FG001|Overall Study|Lost to Follow-up|1|||
33271893|NCT02766335|62644086|FG000|Initial Registration|Adverse Event|6|||
33271894|NCT02766335|62644087|FG001|Initial Registration|Adverse Event|3|||
33271895|NCT02766335|62644088|FG002|Initial Registration|Adverse Event|0|||
33271896|NCT02766335|62644086|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
33271897|NCT02766335|62644087|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
33271898|NCT02766335|62644088|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
33271899|NCT02766335|62644086|FG000|Initial Registration|Progression/relapse|49|||
33271900|NCT02766335|62644087|FG001|Initial Registration|Progression/relapse|15|||
33271901|NCT02766335|62644088|FG002|Initial Registration|Progression/relapse|0|||
33271902|NCT02766335|62644086|FG000|Initial Registration|Death|1|||
33271903|NCT02766335|62644087|FG001|Initial Registration|Death|3|||
33271904|NCT02766335|62644088|FG002|Initial Registration|Death|0|||
33271905|NCT02766335|62644086|FG000|Initial Registration|not protocol specified|1|||
33271906|NCT02766335|62644087|FG001|Initial Registration|not protocol specified|9|||
33271907|NCT02766335|62644088|FG002|Initial Registration|not protocol specified|0|||
33271908|NCT02766335|62644086|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
33271909|NCT02766335|62644087|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
33271910|NCT02766335|62644088|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
33271911|NCT02766335|62644086|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
33271912|NCT02766335|62644087|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
33271913|NCT02766335|62644088|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
33271914|NCT02577523|62644096|FG000|Overall Study|Adverse Event|1|||
33271915|NCT02577523|62644097|FG001|Overall Study|Adverse Event|1|||
33271916|NCT02577523|62644096|FG000|Overall Study|Lack of Efficacy|1|||
33271917|NCT02577523|62644097|FG001|Overall Study|Lack of Efficacy|1|||
33271918|NCT02577523|62644096|FG000|Overall Study|Withdrawal by Subject|1|||
33271919|NCT02577523|62644097|FG001|Overall Study|Withdrawal by Subject|0|||
33271920|NCT02499328|62644122|FG000|Overall Study|Withdrawal by Subject|1|||
33271921|NCT02499328|62644123|FG001|Overall Study|Withdrawal by Subject|1|||
33271922|NCT02499328|62644124|FG002|Overall Study|Withdrawal by Subject|5|||
33271923|NCT02499328|62644125|FG003|Overall Study|Withdrawal by Subject|3|||
33271924|NCT02499328|62644126|FG004|Overall Study|Withdrawal by Subject|5|||
33271925|NCT02499328|62644127|FG005|Overall Study|Withdrawal by Subject|0|||
33271926|NCT02499328|62644128|FG006|Overall Study|Withdrawal by Subject|0|||
33271927|NCT02499328|62644129|FG007|Overall Study|Withdrawal by Subject|0|||
33271928|NCT02499328|62644130|FG008|Overall Study|Withdrawal by Subject|2|||
33271929|NCT02499328|62644131|FG009|Overall Study|Withdrawal by Subject|2|||
33271930|NCT02499328|62644132|FG010|Overall Study|Withdrawal by Subject|0|||
33271931|NCT02499328|62644133|FG011|Overall Study|Withdrawal by Subject|3|||
33271932|NCT02499328|62644134|FG012|Overall Study|Withdrawal by Subject|7|||
33271933|NCT02499328|62644135|FG013|Overall Study|Withdrawal by Subject|3|||
33271934|NCT02499328|62644136|FG014|Overall Study|Withdrawal by Subject|1|||
33271935|NCT02499328|62644137|FG015|Overall Study|Withdrawal by Subject|0|||
33271936|NCT02499328|62644138|FG016|Overall Study|Withdrawal by Subject|0|||
33271937|NCT02499328|62644139|FG017|Overall Study|Withdrawal by Subject|3|||
33271938|NCT02499328|62644140|FG018|Overall Study|Withdrawal by Subject|0|||
33271939|NCT02499328|62644122|FG000|Overall Study|Lost to Follow-up|0|||
33271940|NCT02499328|62644123|FG001|Overall Study|Lost to Follow-up|1|||
33271941|NCT02499328|62644124|FG002|Overall Study|Lost to Follow-up|1|||
33271942|NCT02499328|62644125|FG003|Overall Study|Lost to Follow-up|2|||
33271943|NCT02499328|62644126|FG004|Overall Study|Lost to Follow-up|0|||
33271944|NCT02499328|62644127|FG005|Overall Study|Lost to Follow-up|0|||
33271945|NCT02499328|62644128|FG006|Overall Study|Lost to Follow-up|0|||
33271946|NCT02499328|62644129|FG007|Overall Study|Lost to Follow-up|2|||
33271947|NCT02499328|62644130|FG008|Overall Study|Lost to Follow-up|3|||
33271948|NCT02499328|62644131|FG009|Overall Study|Lost to Follow-up|0|||
33271949|NCT02499328|62644132|FG010|Overall Study|Lost to Follow-up|0|||
33271950|NCT02499328|62644133|FG011|Overall Study|Lost to Follow-up|0|||
33271951|NCT02499328|62644134|FG012|Overall Study|Lost to Follow-up|0|||
33271952|NCT02499328|62644135|FG013|Overall Study|Lost to Follow-up|0|||
33271953|NCT02499328|62644136|FG014|Overall Study|Lost to Follow-up|0|||
33271954|NCT02499328|62644137|FG015|Overall Study|Lost to Follow-up|0|||
33271955|NCT02499328|62644138|FG016|Overall Study|Lost to Follow-up|0|||
33271956|NCT02499328|62644139|FG017|Overall Study|Lost to Follow-up|0|||
33271957|NCT02499328|62644140|FG018|Overall Study|Lost to Follow-up|1|||
33271958|NCT02499328|62644122|FG000|Overall Study|Death|0|||
33271959|NCT02499328|62644123|FG001|Overall Study|Death|3|||
33271960|NCT02499328|62644124|FG002|Overall Study|Death|3|||
33271961|NCT02499328|62644125|FG003|Overall Study|Death|2|||
33370117|NCT00848354|62748829|FG001|Phase 2 Year 1|Adverse Event|2|||
33370118|NCT00848354|62748828|FG000|Phase 2 Year 1|Death|1|||
33370119|NCT00848354|62748829|FG001|Phase 2 Year 1|Death|0|||
33271962|NCT02499328|62644126|FG004|Overall Study|Death|4|||
33271963|NCT02499328|62644127|FG005|Overall Study|Death|7|||
33271964|NCT02499328|62644128|FG006|Overall Study|Death|3|||
33271965|NCT02499328|62644129|FG007|Overall Study|Death|0|||
33271966|NCT02499328|62644130|FG008|Overall Study|Death|2|||
33271967|NCT02499328|62644131|FG009|Overall Study|Death|6|||
33271968|NCT02499328|62644132|FG010|Overall Study|Death|6|||
33271969|NCT02499328|62644133|FG011|Overall Study|Death|20|||
33271970|NCT02499328|62644134|FG012|Overall Study|Death|9|||
33271971|NCT02499328|62644135|FG013|Overall Study|Death|7|||
33271972|NCT02499328|62644136|FG014|Overall Study|Death|3|||
33271973|NCT02499328|62644137|FG015|Overall Study|Death|1|||
33271974|NCT02499328|62644138|FG016|Overall Study|Death|1|||
33271975|NCT02499328|62644139|FG017|Overall Study|Death|16|||
33271976|NCT02499328|62644140|FG018|Overall Study|Death|5|||
33271977|NCT02499328|62644122|FG000|Overall Study|"Other"|2|||
33271978|NCT02499328|62644123|FG001|Overall Study|"Other"|2|||
33271979|NCT02499328|62644124|FG002|Overall Study|"Other"|1|||
33370120|NCT00848354|62748828|FG000|Phase 2 Year 1|Failed to Return|1|||
33271980|NCT02499328|62644125|FG003|Overall Study|"Other"|3|||
33271981|NCT02499328|62644126|FG004|Overall Study|"Other"|6|||
33271982|NCT02499328|62644127|FG005|Overall Study|"Other"|2|||
33271983|NCT02499328|62644128|FG006|Overall Study|"Other"|3|||
33271984|NCT02499328|62644129|FG007|Overall Study|"Other"|4|||
33271985|NCT02499328|62644130|FG008|Overall Study|"Other"|6|||
33271986|NCT02499328|62644131|FG009|Overall Study|"Other"|16|||
33271987|NCT02499328|62644132|FG010|Overall Study|"Other"|13|||
33271988|NCT02499328|62644133|FG011|Overall Study|"Other"|31|||
33271989|NCT02499328|62644134|FG012|Overall Study|"Other"|8|||
33271990|NCT02499328|62644135|FG013|Overall Study|"Other"|7|||
33271991|NCT02499328|62644136|FG014|Overall Study|"Other"|6|||
33271992|NCT02499328|62644137|FG015|Overall Study|"Other"|0|||
33271993|NCT02499328|62644138|FG016|Overall Study|"Other"|0|||
33271994|NCT02499328|62644139|FG017|Overall Study|"Other"|34|||
33271995|NCT02499328|62644140|FG018|Overall Study|"Other"|43|||
33271996|NCT02499328|62644122|FG000|Overall Study|Disease Progression|0|||
33271997|NCT02499328|62644123|FG001|Overall Study|Disease Progression|0|||
33271998|NCT02499328|62644124|FG002|Overall Study|Disease Progression|0|||
33271999|NCT02499328|62644125|FG003|Overall Study|Disease Progression|0|||
33272000|NCT02499328|62644126|FG004|Overall Study|Disease Progression|0|||
33272001|NCT02499328|62644127|FG005|Overall Study|Disease Progression|0|||
33272002|NCT02499328|62644128|FG006|Overall Study|Disease Progression|1|||
33272003|NCT02499328|62644129|FG007|Overall Study|Disease Progression|0|||
33272004|NCT02499328|62644130|FG008|Overall Study|Disease Progression|1|||
33272005|NCT02499328|62644131|FG009|Overall Study|Disease Progression|0|||
33272006|NCT02499328|62644132|FG010|Overall Study|Disease Progression|1|||
33272007|NCT02499328|62644133|FG011|Overall Study|Disease Progression|0|||
33272008|NCT02499328|62644134|FG012|Overall Study|Disease Progression|0|||
33272009|NCT02499328|62644135|FG013|Overall Study|Disease Progression|0|||
33272010|NCT02499328|62644136|FG014|Overall Study|Disease Progression|0|||
33272011|NCT02499328|62644137|FG015|Overall Study|Disease Progression|0|||
33272012|NCT02499328|62644138|FG016|Overall Study|Disease Progression|0|||
33272013|NCT02499328|62644139|FG017|Overall Study|Disease Progression|2|||
33272014|NCT02499328|62644140|FG018|Overall Study|Disease Progression|0|||
33272015|NCT02499328|62644122|FG000|Overall Study|Adverse Event|1|||
33272016|NCT02499328|62644123|FG001|Overall Study|Adverse Event|0|||
33272017|NCT02499328|62644124|FG002|Overall Study|Adverse Event|0|||
33272018|NCT02499328|62644125|FG003|Overall Study|Adverse Event|1|||
33272019|NCT02499328|62644126|FG004|Overall Study|Adverse Event|0|||
33272020|NCT02499328|62644127|FG005|Overall Study|Adverse Event|0|||
33272021|NCT02499328|62644128|FG006|Overall Study|Adverse Event|0|||
33272022|NCT02499328|62644129|FG007|Overall Study|Adverse Event|0|||
33272023|NCT02499328|62644130|FG008|Overall Study|Adverse Event|0|||
33272024|NCT02499328|62644131|FG009|Overall Study|Adverse Event|0|||
33272025|NCT02499328|62644132|FG010|Overall Study|Adverse Event|0|||
33272026|NCT02499328|62644133|FG011|Overall Study|Adverse Event|0|||
33272027|NCT02499328|62644134|FG012|Overall Study|Adverse Event|1|||
33272028|NCT02499328|62644135|FG013|Overall Study|Adverse Event|0|||
33272029|NCT02499328|62644136|FG014|Overall Study|Adverse Event|0|||
33272030|NCT02499328|62644137|FG015|Overall Study|Adverse Event|0|||
33272031|NCT02499328|62644138|FG016|Overall Study|Adverse Event|0|||
33272032|NCT02499328|62644139|FG017|Overall Study|Adverse Event|0|||
33272033|NCT02499328|62644140|FG018|Overall Study|Adverse Event|0|||
33272034|NCT02388906|62644225|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
33272035|NCT02388906|62644226|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
33272036|NCT02388906|62644225|FG000|Treatment Period|Disease progression|121|||
33272037|NCT02388906|62644226|FG001|Treatment Period|Disease progression|101|||
33272038|NCT02388906|62644225|FG000|Treatment Period|Study drug toxicity|41|||
33272039|NCT02388906|62644226|FG001|Treatment Period|Study drug toxicity|208|||
33272040|NCT02388906|62644225|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
33272041|NCT02388906|62644226|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
33272042|NCT02388906|62644225|FG000|Treatment Period|Participant request to stop treatment|5|||
33272043|NCT02388906|62644226|FG001|Treatment Period|Participant request to stop treatment|9|||
33272044|NCT02388906|62644225|FG000|Treatment Period|Participant withdrew consent|2|||
33272045|NCT02388906|62644226|FG001|Treatment Period|Participant withdrew consent|3|||
33272046|NCT02388906|62644225|FG000|Treatment Period|Poor/non-compliance|0|||
33272047|NCT02388906|62644226|FG001|Treatment Period|Poor/non-compliance|1|||
33272048|NCT02388906|62644225|FG000|Treatment Period|Participant no longer meets study criteria|0|||
33272049|NCT02388906|62644226|FG001|Treatment Period|Participant no longer meets study criteria|1|||
33272050|NCT02388906|62644225|FG000|Treatment Period|Other reasons|3|||
33272051|NCT02388906|62644226|FG001|Treatment Period|Other reasons|3|||
33272052|NCT02177695|62644245|FG000|ITT Analysis|Ineligible|5|||
33272053|NCT02177695|62644246|FG001|ITT Analysis|Ineligible|5|||
33272054|NCT02177695|62644245|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
33272055|NCT02177695|62644246|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
33272056|NCT02177695|62644245|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
33272057|NCT02177695|62644246|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
33272058|NCT02177695|62644245|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
33272059|NCT02177695|62644246|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
33272060|NCT01719237|62644261|FG000|Overall Study|Physician Decision|0|||
33272061|NCT01719237|62644262|FG001|Overall Study|Physician Decision|1|||
33272062|NCT01956669|62644285|FG000|Overall Study|Disease Progression|12|||
33272063|NCT01956669|62644286|FG001|Overall Study|Disease Progression|7|||
33272064|NCT01956669|62644287|FG002|Overall Study|Disease Progression|7|||
33272065|NCT01956669|62644288|FG003|Overall Study|Disease Progression|8|||
33272066|NCT01956669|62644289|FG004|Overall Study|Disease Progression|4|||
33272067|NCT01956669|62644290|FG005|Overall Study|Disease Progression|3|||
33272068|NCT01956669|62644291|FG006|Overall Study|Disease Progression|5|||
33272069|NCT01956669|62644285|FG000|Overall Study|Adverse Event|0|||
33272070|NCT01956669|62644286|FG001|Overall Study|Adverse Event|2|||
33272071|NCT01956669|62644287|FG002|Overall Study|Adverse Event|2|||
33272072|NCT01956669|62644288|FG003|Overall Study|Adverse Event|1|||
33272073|NCT01956669|62644289|FG004|Overall Study|Adverse Event|0|||
33272074|NCT01956669|62644290|FG005|Overall Study|Adverse Event|0|||
33272075|NCT01956669|62644291|FG006|Overall Study|Adverse Event|0|||
33272076|NCT01956669|62644285|FG000|Overall Study|Physician Decision|0|||
33272077|NCT01956669|62644286|FG001|Overall Study|Physician Decision|2|||
33272078|NCT01956669|62644287|FG002|Overall Study|Physician Decision|0|||
33272079|NCT01956669|62644288|FG003|Overall Study|Physician Decision|0|||
33272080|NCT01956669|62644289|FG004|Overall Study|Physician Decision|0|||
33272081|NCT01956669|62644290|FG005|Overall Study|Physician Decision|1|||
33272082|NCT01956669|62644291|FG006|Overall Study|Physician Decision|0|||
33272083|NCT01956669|62644285|FG000|Overall Study|Withdrawal by Subject|0|||
33272084|NCT01956669|62644286|FG001|Overall Study|Withdrawal by Subject|0|||
33272085|NCT01956669|62644287|FG002|Overall Study|Withdrawal by Subject|1|||
33272086|NCT01956669|62644288|FG003|Overall Study|Withdrawal by Subject|1|||
33272087|NCT01956669|62644289|FG004|Overall Study|Withdrawal by Subject|0|||
33272088|NCT01956669|62644290|FG005|Overall Study|Withdrawal by Subject|0|||
33272089|NCT01956669|62644291|FG006|Overall Study|Withdrawal by Subject|1|||
33272090|NCT01967823|62644320|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
33272091|NCT01982760|62644330|FG000|Overall Study|Physician Decision|1|||
33272092|NCT01982760|62644331|FG001|Overall Study|Physician Decision|0|||
33272093|NCT01985022|62644339|FG000|Overall Study|Lost to Follow-up|0|||
33272094|NCT01985022|62644340|FG001|Overall Study|Lost to Follow-up|1|||
33272095|NCT01985022|62644339|FG000|Overall Study|Protocol Violation|0|||
33272096|NCT01985022|62644340|FG001|Overall Study|Protocol Violation|1|||
33272097|NCT01985022|62644339|FG000|Overall Study|Withdrawal by Subject|4|||
33272098|NCT01985022|62644340|FG001|Overall Study|Withdrawal by Subject|1|||
33272099|NCT01989676|62644348|FG000|Overall Study|Death|52|||
33272100|NCT01989676|62644349|FG001|Overall Study|Death|60|||
33272101|NCT01989676|62644348|FG000|Overall Study|Protocol Violation|2|||
33272102|NCT01989676|62644349|FG001|Overall Study|Protocol Violation|1|||
33272103|NCT01989676|62644348|FG000|Overall Study|Lost to Follow-up|8|||
33272104|NCT01989676|62644349|FG001|Overall Study|Lost to Follow-up|18|||
33272105|NCT01989676|62644348|FG000|Overall Study|No longer willing to participate in study|26|||
33272106|NCT01989676|62644349|FG001|Overall Study|No longer willing to participate in study|26|||
33272107|NCT01989676|62644348|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
33272108|NCT01989676|62644349|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
33272109|NCT01989676|62644348|FG000|Overall Study|Other|4|||
33272110|NCT01989676|62644349|FG001|Overall Study|Other|3|||
33272111|NCT02001974|62644359|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
33272112|NCT02001974|62644360|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
33272113|NCT02001974|62644361|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
33272114|NCT02001974|62644359|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
33272115|NCT02001974|62644360|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
33272116|NCT02001974|62644361|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
33272117|NCT02001974|62644359|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
33272118|NCT02001974|62644360|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
33272119|NCT02001974|62644361|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
33272120|NCT02001974|62644359|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
33272121|NCT02001974|62644360|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
33272122|NCT02001974|62644361|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
33272123|NCT05229406|62644399|FG000|Overall Study|Withdrawal by Subject|1|||
33272124|NCT05229406|62644400|FG001|Overall Study|Withdrawal by Subject|2|||
33272125|NCT04971187|62644415|FG000|Overall Study|Screen failures|2|||
33272126|NCT04756154|62644440|FG000|Overall Study|Did not meet treatment day baseline|30|||
33272127|NCT04756154|62644441|FG001|Overall Study|Did not meet treatment day baseline|28|||
33272128|NCT04756154|62644442|FG002|Overall Study|Did not meet treatment day baseline|7|||
33272129|NCT04756154|62644440|FG000|Overall Study|Did not return for final sample collection|1|||
33272130|NCT04756154|62644441|FG001|Overall Study|Did not return for final sample collection|1|||
33272131|NCT04756154|62644442|FG002|Overall Study|Did not return for final sample collection|0|||
33272132|NCT04677504|62644457|FG000|Overall Study|Death|31|||
33272133|NCT04677504|62644458|FG001|Overall Study|Death|24|||
33272134|NCT04677504|62644457|FG000|Overall Study|Progressive Disease|1|||
33272135|NCT04677504|62644458|FG001|Overall Study|Progressive Disease|0|||
33272136|NCT04677504|62644457|FG000|Overall Study|Symptomatic Deterioration|1|||
33272137|NCT04677504|62644458|FG001|Overall Study|Symptomatic Deterioration|0|||
33272138|NCT04677504|62644457|FG000|Overall Study|Withdrawal by Subject|2|||
33272139|NCT04677504|62644458|FG001|Overall Study|Withdrawal by Subject|5|||
33272140|NCT04677504|62644457|FG000|Overall Study|Ongoing in study|48|||
33272141|NCT04677504|62644458|FG001|Overall Study|Ongoing in study|50|||
33662031|NCT02698176|63092731|FG002|Overall Study|Clinical progression|0|||
33662032|NCT02698176|63092732|FG003|Overall Study|Clinical progression|0|||
33272144|NCT04614246|62644480|FG000|Overall Study|Adverse Event|0|||
33272145|NCT04614246|62644481|FG001|Overall Study|Adverse Event|1|||
33272146|NCT04614246|62644482|FG002|Overall Study|Adverse Event|1|||
33272147|NCT04614246|62644483|FG003|Overall Study|Adverse Event|2|||
33272148|NCT04614246|62644484|FG004|Overall Study|Adverse Event|1|||
33272149|NCT04614246|62644480|FG000|Overall Study|Lost to Follow-up|0|||
33272150|NCT04614246|62644481|FG001|Overall Study|Lost to Follow-up|1|||
33272151|NCT04614246|62644482|FG002|Overall Study|Lost to Follow-up|0|||
33272152|NCT04614246|62644483|FG003|Overall Study|Lost to Follow-up|1|||
33272153|NCT04614246|62644484|FG004|Overall Study|Lost to Follow-up|3|||
33272154|NCT04614246|62644480|FG000|Overall Study|Other reason|0|||
33272155|NCT04614246|62644481|FG001|Overall Study|Other reason|1|||
33272156|NCT04614246|62644482|FG002|Overall Study|Other reason|2|||
33272157|NCT04614246|62644483|FG003|Overall Study|Other reason|0|||
33272158|NCT04614246|62644484|FG004|Overall Study|Other reason|0|||
33272159|NCT04614246|62644480|FG000|Overall Study|Withdrawal by Subject|4|||
33272160|NCT04614246|62644481|FG001|Overall Study|Withdrawal by Subject|2|||
33272161|NCT04614246|62644482|FG002|Overall Study|Withdrawal by Subject|4|||
33272162|NCT04614246|62644483|FG003|Overall Study|Withdrawal by Subject|3|||
33272163|NCT04614246|62644484|FG004|Overall Study|Withdrawal by Subject|4|||
33272164|NCT04614246|62644480|FG000|Overall Study|Physician Decision|0|||
33272165|NCT04614246|62644481|FG001|Overall Study|Physician Decision|2|||
33272166|NCT04614246|62644482|FG002|Overall Study|Physician Decision|1|||
33272167|NCT04614246|62644483|FG003|Overall Study|Physician Decision|0|||
33272168|NCT04614246|62644484|FG004|Overall Study|Physician Decision|0|||
33272169|NCT04614246|62644480|FG000|Overall Study|Study terminated by sponsor|10|||
33272170|NCT04614246|62644481|FG001|Overall Study|Study terminated by sponsor|15|||
33272171|NCT04614246|62644482|FG002|Overall Study|Study terminated by sponsor|12|||
33272172|NCT04614246|62644483|FG003|Overall Study|Study terminated by sponsor|13|||
33272173|NCT04614246|62644484|FG004|Overall Study|Study terminated by sponsor|9|||
33272174|NCT04614246|62644480|FG000|Overall Study|Pregnancy|2|||
33272175|NCT04614246|62644481|FG001|Overall Study|Pregnancy|0|||
33272176|NCT04614246|62644482|FG002|Overall Study|Pregnancy|1|||
33272177|NCT04614246|62644483|FG003|Overall Study|Pregnancy|0|||
33272178|NCT04614246|62644484|FG004|Overall Study|Pregnancy|0|||
33272179|NCT04593823|62644502|FG000|Overall Study|Withdrawal by Subject|1|||
33272180|NCT04593823|62644503|FG001|Overall Study|Withdrawal by Subject|1|||
33272181|NCT04593823|62644502|FG000|Overall Study|Lost to Follow-up|0|||
33272182|NCT04593823|62644503|FG001|Overall Study|Lost to Follow-up|1|||
33272183|NCT04556383|62644523|FG000|PCP|Lack of Efficacy|28|||
33272184|NCT04556383|62644524|FG001|PCP|Lack of Efficacy|23|||
33272185|NCT04556383|62644525|FG002|PCP|Lack of Efficacy|23|||
33272186|NCT04556383|62644526|FG003|PCP|Lack of Efficacy|0|||
33272187|NCT04556383|62644523|FG000|PCP|Study terminated by sponsor|15|||
33272188|NCT04556383|62644524|FG001|PCP|Study terminated by sponsor|13|||
33272189|NCT04556383|62644525|FG002|PCP|Study terminated by sponsor|16|||
33272190|NCT04556383|62644526|FG003|PCP|Study terminated by sponsor|0|||
33272191|NCT04556383|62644523|FG000|PCP|Withdrawal by Subject|8|||
33272192|NCT04556383|62644524|FG001|PCP|Withdrawal by Subject|6|||
33272193|NCT04556383|62644525|FG002|PCP|Withdrawal by Subject|6|||
33272194|NCT04556383|62644526|FG003|PCP|Withdrawal by Subject|0|||
33272195|NCT04556383|62644523|FG000|PCP|Adverse Event|1|||
33272196|NCT04556383|62644524|FG001|PCP|Adverse Event|7|||
33272197|NCT04556383|62644525|FG002|PCP|Adverse Event|7|||
33272198|NCT04556383|62644526|FG003|PCP|Adverse Event|0|||
33272199|NCT04556383|62644523|FG000|PCP|Other, Not Specified|1|||
33272200|NCT04556383|62644524|FG001|PCP|Other, Not Specified|2|||
33272201|NCT04556383|62644525|FG002|PCP|Other, Not Specified|1|||
33272202|NCT04556383|62644526|FG003|PCP|Other, Not Specified|0|||
33272203|NCT04556383|62644523|FG000|PCP|Protocol Violation|1|||
33272204|NCT04556383|62644524|FG001|PCP|Protocol Violation|0|||
33272205|NCT04556383|62644525|FG002|PCP|Protocol Violation|1|||
33272206|NCT04556383|62644526|FG003|PCP|Protocol Violation|0|||
33272207|NCT04556383|62644523|FG000|PCP|Lost to Follow-up|1|||
33272208|NCT04556383|62644524|FG001|PCP|Lost to Follow-up|0|||
33272209|NCT04556383|62644525|FG002|PCP|Lost to Follow-up|0|||
33272210|NCT04556383|62644526|FG003|PCP|Lost to Follow-up|0|||
33272211|NCT04556383|62644523|FG000|PCP|Physician Decision|0|||
33272212|NCT04556383|62644524|FG001|PCP|Physician Decision|1|||
33272213|NCT04556383|62644525|FG002|PCP|Physician Decision|0|||
33272214|NCT04556383|62644526|FG003|PCP|Physician Decision|0|||
33272215|NCT04556383|62644523|FG000|PCP|Site terminated by sponsor|0|||
33272216|NCT04556383|62644524|FG001|PCP|Site terminated by sponsor|1|||
33272217|NCT04556383|62644525|FG002|PCP|Site terminated by sponsor|0|||
33272218|NCT04556383|62644526|FG003|PCP|Site terminated by sponsor|0|||
33272219|NCT04556383|62644523|FG000|OLE|Study terminated by sponsor|0|||
33272220|NCT04556383|62644524|FG001|OLE|Study terminated by sponsor|0|||
33272221|NCT04556383|62644525|FG002|OLE|Study terminated by sponsor|0|||
33272222|NCT04556383|62644526|FG003|OLE|Study terminated by sponsor|68|||
33272223|NCT04556383|62644523|FG000|OLE|Withdrawal by Subject|0|||
33272224|NCT04556383|62644524|FG001|OLE|Withdrawal by Subject|0|||
33272225|NCT04556383|62644525|FG002|OLE|Withdrawal by Subject|0|||
33272226|NCT04556383|62644526|FG003|OLE|Withdrawal by Subject|10|||
33272227|NCT04556383|62644523|FG000|OLE|Lack of Efficacy|0|||
33272228|NCT04556383|62644524|FG001|OLE|Lack of Efficacy|0|||
33272229|NCT04556383|62644525|FG002|OLE|Lack of Efficacy|0|||
33272230|NCT04556383|62644526|FG003|OLE|Lack of Efficacy|7|||
33272231|NCT04556383|62644523|FG000|OLE|Adverse Event|0|||
33272232|NCT04556383|62644524|FG001|OLE|Adverse Event|0|||
33272233|NCT04556383|62644525|FG002|OLE|Adverse Event|0|||
33272234|NCT04556383|62644526|FG003|OLE|Adverse Event|2|||
33272235|NCT04556383|62644523|FG000|OLE|Other, Not Specified|0|||
33272236|NCT04556383|62644524|FG001|OLE|Other, Not Specified|0|||
33272237|NCT04556383|62644525|FG002|OLE|Other, Not Specified|0|||
33272238|NCT04556383|62644526|FG003|OLE|Other, Not Specified|2|||
33272239|NCT04556383|62644523|FG000|OLE|Death|0|||
33272240|NCT04556383|62644524|FG001|OLE|Death|0|||
33272241|NCT04556383|62644525|FG002|OLE|Death|0|||
33272242|NCT04556383|62644526|FG003|OLE|Death|1|||
33272243|NCT04556383|62644523|FG000|OLE|Lost to Follow-up|0|||
33272244|NCT04556383|62644524|FG001|OLE|Lost to Follow-up|0|||
33272245|NCT04556383|62644525|FG002|OLE|Lost to Follow-up|0|||
33272246|NCT04556383|62644526|FG003|OLE|Lost to Follow-up|1|||
33272247|NCT04444752|62644560|FG000|Overall Study|Adverse Event|1|||
33272248|NCT04444752|62644561|FG001|Overall Study|Adverse Event|0|||
33272249|NCT04444752|62644562|FG002|Overall Study|Adverse Event|0|||
33272250|NCT04444752|62644563|FG003|Overall Study|Adverse Event|2|||
33272251|NCT04444752|62644560|FG000|Overall Study|Lost to Follow-up|2|||
33272252|NCT04444752|62644561|FG001|Overall Study|Lost to Follow-up|6|||
33272253|NCT04444752|62644562|FG002|Overall Study|Lost to Follow-up|2|||
33272254|NCT04444752|62644563|FG003|Overall Study|Lost to Follow-up|5|||
33272255|NCT04444752|62644560|FG000|Overall Study|Physician Decision|0|||
33272256|NCT04444752|62644561|FG001|Overall Study|Physician Decision|0|||
33272257|NCT04444752|62644562|FG002|Overall Study|Physician Decision|0|||
33272258|NCT04444752|62644563|FG003|Overall Study|Physician Decision|2|||
33272259|NCT04444752|62644560|FG000|Overall Study|Pregnancy|0|||
33272260|NCT04444752|62644561|FG001|Overall Study|Pregnancy|0|||
33272261|NCT04444752|62644562|FG002|Overall Study|Pregnancy|0|||
33272262|NCT04444752|62644563|FG003|Overall Study|Pregnancy|1|||
33272263|NCT04444752|62644560|FG000|Overall Study|Withdrawal by Subject|6|||
33272264|NCT04444752|62644561|FG001|Overall Study|Withdrawal by Subject|5|||
33272265|NCT04444752|62644562|FG002|Overall Study|Withdrawal by Subject|3|||
33272266|NCT04444752|62644563|FG003|Overall Study|Withdrawal by Subject|4|||
33272267|NCT04444752|62644560|FG000|Overall Study|Protocol Violation|1|||
33272268|NCT04444752|62644561|FG001|Overall Study|Protocol Violation|1|||
33272269|NCT04444752|62644562|FG002|Overall Study|Protocol Violation|0|||
33272270|NCT04444752|62644563|FG003|Overall Study|Protocol Violation|0|||
33272271|NCT04444752|62644560|FG000|Overall Study|Patient moving out of town|1|||
33272272|NCT04444752|62644561|FG001|Overall Study|Patient moving out of town|0|||
33272273|NCT04444752|62644562|FG002|Overall Study|Patient moving out of town|0|||
33272274|NCT04444752|62644563|FG003|Overall Study|Patient moving out of town|1|||
33485607|NCT04351269|62863312|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
33485608|NCT04351269|62863310|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
33272275|NCT04444752|62644560|FG000|Overall Study|Lack of Efficacy|0|||
33272276|NCT04444752|62644561|FG001|Overall Study|Lack of Efficacy|0|||
33485609|NCT04351269|62863311|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
33485610|NCT04351269|62863312|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
33272277|NCT04444752|62644562|FG002|Overall Study|Lack of Efficacy|0|||
33272278|NCT04444752|62644563|FG003|Overall Study|Lack of Efficacy|1|||
33272279|NCT04444752|62644560|FG000|Overall Study|Death|0|||
33272280|NCT04444752|62644561|FG001|Overall Study|Death|0|||
33272281|NCT04444752|62644562|FG002|Overall Study|Death|1|||
33272282|NCT04444752|62644563|FG003|Overall Study|Death|0|||
33272283|NCT04429022|62644575|FG000|Overall Study|Protocol Violation|18|||
33272284|NCT04429022|62644576|FG001|Overall Study|Protocol Violation|1|||
33272285|NCT04351373|62644606|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
33272286|NCT04239924|62644619|FG000|Overall Study|Lost to Follow-up|2|||
33272287|NCT04154904|62644631|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
33272288|NCT04154904|62644632|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
33272289|NCT04154904|62644633|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
33272290|NCT04114656|62644645|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
33370121|NCT00848354|62748829|FG001|Phase 2 Year 1|Failed to Return|1|||
33272291|NCT04114656|62644646|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
33272292|NCT04114656|62644645|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
33272293|NCT04114656|62644646|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
33272294|NCT04114656|62644645|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
33272295|NCT04114656|62644646|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
33272296|NCT04114656|62644645|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
33272297|NCT04114656|62644646|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
33272298|NCT04114656|62644645|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
33272299|NCT04114656|62644646|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
33272300|NCT04034238|62644664|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
33272301|NCT04034238|62644665|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
33272302|NCT04034238|62644666|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
33272303|NCT04034238|62644667|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
33272304|NCT04034238|62644664|FG000|Dose Escalation Phase|Screen failures|0|||
33272305|NCT04034238|62644665|FG001|Dose Escalation Phase|Screen failures|0|||
33272306|NCT04034238|62644666|FG002|Dose Escalation Phase|Screen failures|0|||
33272307|NCT04034238|62644667|FG003|Dose Escalation Phase|Screen failures|2|||
33272308|NCT04034238|62644664|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
33272309|NCT04034238|62644665|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
33272310|NCT04034238|62644666|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
33272311|NCT04034238|62644667|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
33272312|NCT04034238|62644664|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
33272313|NCT04034238|62644665|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
33272314|NCT04034238|62644666|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
33272315|NCT04034238|62644667|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
33272316|NCT03956056|62644678|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
33272317|NCT03956056|62644678|FG000|Overall Study|Lack of Efficacy|1|||
33272318|NCT03926195|62644684|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
33272319|NCT03926195|62644685|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
33272320|NCT03926195|62644684|FG000|EXT Phase (Through Week 26)|Ongoing in the study|29|||
33272321|NCT03926195|62644685|FG001|EXT Phase (Through Week 26)|Ongoing in the study|36|||
33272322|NCT03926195|62644684|FG000|EXT Phase (Through Week 26)|Adverse Event|5|||
33272323|NCT03926195|62644685|FG001|EXT Phase (Through Week 26)|Adverse Event|0|||
33272324|NCT03926195|62644684|FG000|EXT Phase (Through Week 26)|Pre-Specified Decrease In Sperm Parameters|12|||
33272325|NCT03926195|62644685|FG001|EXT Phase (Through Week 26)|Pre-Specified Decrease In Sperm Parameters|11|||
33272326|NCT03926195|62644684|FG000|EXT Phase (Through Week 26)|Withdrawal by Subject|0|||
33272327|NCT03926195|62644685|FG001|EXT Phase (Through Week 26)|Withdrawal by Subject|2|||
33272328|NCT03908476|62644700|FG000|Overall Study|Death|3|||
33272329|NCT03908476|62644701|FG001|Overall Study|Death|0|||
33272330|NCT03908476|62644700|FG000|Overall Study|Lost to Follow-up|3|||
33272331|NCT03908476|62644701|FG001|Overall Study|Lost to Follow-up|1|||
33272332|NCT03908476|62644700|FG000|Overall Study|Withdrawal by Subject|7|||
33272333|NCT03908476|62644701|FG001|Overall Study|Withdrawal by Subject|1|||
33272334|NCT03908476|62644700|FG000|Overall Study|Physician Decision|2|||
33272335|NCT03908476|62644701|FG001|Overall Study|Physician Decision|0|||
33272336|NCT03908476|62644700|FG000|Overall Study|System Explanted and not Replaced|4|||
33272337|NCT03908476|62644701|FG001|Overall Study|System Explanted and not Replaced|0|||
33272338|NCT03908476|62644700|FG000|Overall Study|Intrathecal Pump|1|||
33272339|NCT03908476|62644701|FG001|Overall Study|Intrathecal Pump|0|||
33272340|NCT03908476|62644700|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
33272341|NCT03908476|62644701|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
33272342|NCT03830866|62644709|FG000|Overall Study|Ongoing study at DCO|312|||
33272343|NCT03830866|62644710|FG001|Overall Study|Ongoing study at DCO|295|||
33272344|NCT03830866|62644709|FG000|Overall Study|Death|58|||
33272345|NCT03830866|62644710|FG001|Overall Study|Death|74|||
33272346|NCT03830866|62644709|FG000|Overall Study|Lost to Follow-up|0|||
33272347|NCT03830866|62644710|FG001|Overall Study|Lost to Follow-up|1|||
33272348|NCT03830866|62644709|FG000|Overall Study|Withdrawal by Subject|15|||
33272349|NCT03830866|62644710|FG001|Overall Study|Withdrawal by Subject|13|||
33272350|NCT03830866|62644709|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
33272351|NCT03830866|62644710|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
33272352|NCT03830866|62644709|FG000|Overall Study|Other|0|||
33272353|NCT03830866|62644710|FG001|Overall Study|Other|1|||
33272354|NCT03699007|62644727|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
33272355|NCT03699007|62644728|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
33272356|NCT03699007|62644727|FG000|6-month Follow Up|Lost to Follow-up|2|||
33662033|NCT02693418|63092748|FG000|Overall Study|Lost to Follow-up|1|||
33272357|NCT03699007|62644728|FG001|6-month Follow Up|Lost to Follow-up|3|||
33272358|NCT03581188|62644738|FG000|Overall Study|Inclusion criteria not met|3|||
33272359|NCT03581188|62644739|FG001|Overall Study|Inclusion criteria not met|2|||
33272360|NCT03581188|62644738|FG000|Overall Study|Lost to Follow-up|5|||
33272361|NCT03581188|62644739|FG001|Overall Study|Lost to Follow-up|5|||
33272362|NCT03581188|62644738|FG000|Overall Study|Discontinued intervention|11|||
33272363|NCT03581188|62644739|FG001|Overall Study|Discontinued intervention|8|||
33272364|NCT03576131|62644756|FG000|Overall Study|Investigator decision|0|||
33272365|NCT03576131|62644757|FG001|Overall Study|Investigator decision|0|||
33272366|NCT03576131|62644758|FG002|Overall Study|Investigator decision|0|||
33272367|NCT03576131|62644759|FG003|Overall Study|Investigator decision|1|||
33272368|NCT03576131|62644760|FG004|Overall Study|Investigator decision|0|||
33272369|NCT03576131|62644761|FG005|Overall Study|Investigator decision|1|||
33272370|NCT03576131|62644762|FG006|Overall Study|Investigator decision|0|||
33272371|NCT03576131|62644763|FG007|Overall Study|Investigator decision|0|||
33272372|NCT03576131|62644756|FG000|Overall Study|Withdrawal by Subject|1|||
33272373|NCT03576131|62644757|FG001|Overall Study|Withdrawal by Subject|1|||
33272374|NCT03576131|62644758|FG002|Overall Study|Withdrawal by Subject|0|||
33272375|NCT03576131|62644759|FG003|Overall Study|Withdrawal by Subject|1|||
33272376|NCT03576131|62644760|FG004|Overall Study|Withdrawal by Subject|2|||
33272377|NCT03576131|62644761|FG005|Overall Study|Withdrawal by Subject|3|||
33272378|NCT03576131|62644762|FG006|Overall Study|Withdrawal by Subject|1|||
33272379|NCT03576131|62644763|FG007|Overall Study|Withdrawal by Subject|0|||
33272380|NCT03576131|62644756|FG000|Overall Study|Death|3|||
33272381|NCT03576131|62644757|FG001|Overall Study|Death|3|||
33272382|NCT03576131|62644758|FG002|Overall Study|Death|1|||
33272383|NCT03576131|62644759|FG003|Overall Study|Death|5|||
33272384|NCT03576131|62644760|FG004|Overall Study|Death|4|||
33272385|NCT03576131|62644761|FG005|Overall Study|Death|1|||
33272386|NCT03576131|62644762|FG006|Overall Study|Death|0|||
33272387|NCT03576131|62644763|FG007|Overall Study|Death|1|||
33272388|NCT03576131|62644756|FG000|Overall Study|New anti-cancer treatment|5|||
33272389|NCT03576131|62644757|FG001|Overall Study|New anti-cancer treatment|1|||
33272390|NCT03576131|62644758|FG002|Overall Study|New anti-cancer treatment|2|||
33272391|NCT03576131|62644759|FG003|Overall Study|New anti-cancer treatment|3|||
33272392|NCT03576131|62644760|FG004|Overall Study|New anti-cancer treatment|0|||
33272393|NCT03576131|62644761|FG005|Overall Study|New anti-cancer treatment|0|||
33272394|NCT03576131|62644762|FG006|Overall Study|New anti-cancer treatment|0|||
33272395|NCT03576131|62644763|FG007|Overall Study|New anti-cancer treatment|0|||
33272396|NCT03576131|62644756|FG000|Overall Study|Unspecified reason|0|||
33272397|NCT03576131|62644757|FG001|Overall Study|Unspecified reason|0|||
33272398|NCT03576131|62644758|FG002|Overall Study|Unspecified reason|1|||
33272399|NCT03576131|62644759|FG003|Overall Study|Unspecified reason|1|||
33272400|NCT03576131|62644760|FG004|Overall Study|Unspecified reason|1|||
33272401|NCT03576131|62644761|FG005|Overall Study|Unspecified reason|1|||
33272402|NCT03576131|62644762|FG006|Overall Study|Unspecified reason|0|||
33272403|NCT03576131|62644763|FG007|Overall Study|Unspecified reason|0|||
33272404|NCT03576131|62644756|FG000|Overall Study|Subject non-compliance|0|||
33272405|NCT03576131|62644757|FG001|Overall Study|Subject non-compliance|0|||
33272406|NCT03576131|62644758|FG002|Overall Study|Subject non-compliance|0|||
33272407|NCT03576131|62644759|FG003|Overall Study|Subject non-compliance|0|||
33272408|NCT03576131|62644760|FG004|Overall Study|Subject non-compliance|0|||
33272409|NCT03576131|62644761|FG005|Overall Study|Subject non-compliance|1|||
33272410|NCT03576131|62644762|FG006|Overall Study|Subject non-compliance|0|||
33272411|NCT03576131|62644763|FG007|Overall Study|Subject non-compliance|0|||
33272412|NCT03454529|62644800|FG000|Overall Study|Did not receive treatment|6|||
33272413|NCT03454529|62644800|FG000|Overall Study|Received < 80% doses|1|||
33272414|NCT03409731|62644804|FG000|Overall Study|Withdrawal by Subject|1|||
33272415|NCT03409731|62644804|FG000|Overall Study|Death|4|||
33272416|NCT03246061|62644819|FG000|Overall Study|Still in follow-up|15|||
33272417|NCT03246061|62644820|FG001|Overall Study|Still in follow-up|21|||
33272418|NCT02988817|62644857|FG000|Overall Study|Withdrawal by Subject|1|||
33272419|NCT02988817|62644858|FG001|Overall Study|Withdrawal by Subject|0|||
33272420|NCT02988817|62644859|FG002|Overall Study|Withdrawal by Subject|0|||
33272421|NCT02988817|62644860|FG003|Overall Study|Withdrawal by Subject|1|||
33272422|NCT02988817|62644861|FG004|Overall Study|Withdrawal by Subject|3|||
33272423|NCT02988817|62644862|FG005|Overall Study|Withdrawal by Subject|1|||
33272424|NCT02988817|62644863|FG006|Overall Study|Withdrawal by Subject|2|||
33272425|NCT02988817|62644864|FG007|Overall Study|Withdrawal by Subject|1|||
33272426|NCT02988817|62644865|FG008|Overall Study|Withdrawal by Subject|1|||
33272427|NCT02988817|62644866|FG009|Overall Study|Withdrawal by Subject|1|||
33272428|NCT02988817|62644867|FG010|Overall Study|Withdrawal by Subject|1|||
33272429|NCT02988817|62644868|FG011|Overall Study|Withdrawal by Subject|12|||
33272430|NCT02988817|62644869|FG012|Overall Study|Withdrawal by Subject|6|||
33272431|NCT02988817|62644870|FG013|Overall Study|Withdrawal by Subject|6|||
33272432|NCT02988817|62644871|FG014|Overall Study|Withdrawal by Subject|4|||
33370122|NCT00848354|62748828|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
33272433|NCT02988817|62644872|FG015|Overall Study|Withdrawal by Subject|5|||
33370123|NCT00848354|62748829|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
33272434|NCT02988817|62644873|FG016|Overall Study|Withdrawal by Subject|4|||
33272435|NCT02988817|62644874|FG017|Overall Study|Withdrawal by Subject|11|||
33272436|NCT02988817|62644875|FG018|Overall Study|Withdrawal by Subject|4|||
33272437|NCT02988817|62644876|FG019|Overall Study|Withdrawal by Subject|2|||
33272438|NCT02988817|62644857|FG000|Overall Study|Death|0|||
33272439|NCT02988817|62644858|FG001|Overall Study|Death|1|||
33272440|NCT02988817|62644859|FG002|Overall Study|Death|3|||
33272441|NCT02988817|62644860|FG003|Overall Study|Death|1|||
33272442|NCT02988817|62644861|FG004|Overall Study|Death|6|||
33272443|NCT02988817|62644862|FG005|Overall Study|Death|10|||
33272444|NCT02988817|62644863|FG006|Overall Study|Death|1|||
33370124|NCT00848354|62748828|FG000|Phase 2 Year 1|Unspecified Reason|3|||
33370125|NCT00848354|62748829|FG001|Phase 2 Year 1|Unspecified Reason|0|||
33370126|NCT00848354|62748828|FG000|Phase 2 Year 1|Protocol Violation|4|||
33370127|NCT00848354|62748829|FG001|Phase 2 Year 1|Protocol Violation|1|||
33370128|NCT00848354|62748828|FG000|Phase 2 Year 1|Subject Request|1|||
33370129|NCT00848354|62748829|FG001|Phase 2 Year 1|Subject Request|2|||
33370130|NCT00848354|62748828|FG000|Phase 2 Year 2|Adverse Event|12|||
33370131|NCT00848354|62748829|FG001|Phase 2 Year 2|Adverse Event|2|||
33485611|NCT04351269|62863310|FG000|Overall Study|Lost to Follow-up|1|||
33485612|NCT04351269|62863311|FG001|Overall Study|Lost to Follow-up|3|||
33485613|NCT04351269|62863312|FG002|Overall Study|Lost to Follow-up|0|||
33485614|NCT04348851|62863327|FG000|Post-Test 1|Withdrawal by Subject|0|||
33485615|NCT04348851|62863328|FG001|Post-Test 1|Withdrawal by Subject|1|||
33485616|NCT04348851|62863329|FG002|Post-Test 1|Withdrawal by Subject|0|||
33485617|NCT04348851|62863330|FG003|Post-Test 1|Withdrawal by Subject|0|||
33485618|NCT04348851|62863327|FG000|Post-Test 1|Lost to Follow-up|0|||
33485619|NCT04348851|62863328|FG001|Post-Test 1|Lost to Follow-up|1|||
33272445|NCT02988817|62644864|FG007|Overall Study|Death|2|||
33272446|NCT02988817|62644865|FG008|Overall Study|Death|1|||
33272447|NCT02988817|62644866|FG009|Overall Study|Death|5|||
33272448|NCT02988817|62644867|FG010|Overall Study|Death|1|||
33272449|NCT02988817|62644868|FG011|Overall Study|Death|8|||
33272450|NCT02988817|62644869|FG012|Overall Study|Death|9|||
33272451|NCT02988817|62644870|FG013|Overall Study|Death|17|||
33272452|NCT02988817|62644871|FG014|Overall Study|Death|18|||
33272453|NCT02988817|62644872|FG015|Overall Study|Death|30|||
33272454|NCT02988817|62644873|FG016|Overall Study|Death|17|||
33272455|NCT02988817|62644874|FG017|Overall Study|Death|38|||
33272456|NCT02988817|62644875|FG018|Overall Study|Death|14|||
33272457|NCT02988817|62644876|FG019|Overall Study|Death|16|||
33272458|NCT02988817|62644857|FG000|Overall Study|Other|0|||
33272459|NCT02988817|62644858|FG001|Overall Study|Other|0|||
33272460|NCT02988817|62644859|FG002|Overall Study|Other|0|||
33272461|NCT02988817|62644860|FG003|Overall Study|Other|1|||
33272462|NCT02988817|62644861|FG004|Overall Study|Other|1|||
33272463|NCT02988817|62644862|FG005|Overall Study|Other|0|||
33272464|NCT02988817|62644863|FG006|Overall Study|Other|0|||
33272465|NCT02988817|62644864|FG007|Overall Study|Other|0|||
33272466|NCT02988817|62644865|FG008|Overall Study|Other|0|||
33272467|NCT02988817|62644866|FG009|Overall Study|Other|0|||
33272468|NCT02988817|62644867|FG010|Overall Study|Other|0|||
33272469|NCT02988817|62644868|FG011|Overall Study|Other|0|||
33272470|NCT02988817|62644869|FG012|Overall Study|Other|0|||
33272471|NCT02988817|62644870|FG013|Overall Study|Other|0|||
33272472|NCT02988817|62644871|FG014|Overall Study|Other|0|||
33272473|NCT02988817|62644872|FG015|Overall Study|Other|1|||
33272474|NCT02988817|62644873|FG016|Overall Study|Other|0|||
33272475|NCT02988817|62644874|FG017|Overall Study|Other|0|||
33272476|NCT02988817|62644875|FG018|Overall Study|Other|0|||
33272477|NCT02988817|62644876|FG019|Overall Study|Other|0|||
33272478|NCT02988817|62644857|FG000|Overall Study|Lost to Follow-up|0|||
33272479|NCT02988817|62644858|FG001|Overall Study|Lost to Follow-up|0|||
33272480|NCT02988817|62644859|FG002|Overall Study|Lost to Follow-up|0|||
33272481|NCT02988817|62644860|FG003|Overall Study|Lost to Follow-up|0|||
33272482|NCT02988817|62644861|FG004|Overall Study|Lost to Follow-up|0|||
33272483|NCT02988817|62644862|FG005|Overall Study|Lost to Follow-up|0|||
33272484|NCT02988817|62644863|FG006|Overall Study|Lost to Follow-up|0|||
33272485|NCT02988817|62644864|FG007|Overall Study|Lost to Follow-up|0|||
33370132|NCT00848354|62748828|FG000|Phase 2 Year 2|Death|2|||
33485620|NCT04348851|62863329|FG002|Post-Test 1|Lost to Follow-up|0|||
33485621|NCT04348851|62863330|FG003|Post-Test 1|Lost to Follow-up|0|||
33485622|NCT04348851|62863327|FG000|Post-Test 2|Stroke survivor death|0|||
33485623|NCT04348851|62863328|FG001|Post-Test 2|Stroke survivor death|1|||
33485624|NCT04348851|62863329|FG002|Post-Test 2|Stroke survivor death|0|||
33272486|NCT02988817|62644865|FG008|Overall Study|Lost to Follow-up|1|||
33272487|NCT02988817|62644866|FG009|Overall Study|Lost to Follow-up|0|||
33272488|NCT02988817|62644867|FG010|Overall Study|Lost to Follow-up|1|||
33272489|NCT02988817|62644868|FG011|Overall Study|Lost to Follow-up|1|||
33272490|NCT02988817|62644869|FG012|Overall Study|Lost to Follow-up|0|||
33272491|NCT02988817|62644870|FG013|Overall Study|Lost to Follow-up|0|||
33272492|NCT02988817|62644871|FG014|Overall Study|Lost to Follow-up|1|||
33370133|NCT00848354|62748829|FG001|Phase 2 Year 2|Death|0|||
33485625|NCT04348851|62863330|FG003|Post-Test 2|Stroke survivor death|1|||
33272493|NCT02988817|62644872|FG015|Overall Study|Lost to Follow-up|1|||
33272494|NCT02988817|62644873|FG016|Overall Study|Lost to Follow-up|2|||
33272495|NCT02988817|62644874|FG017|Overall Study|Lost to Follow-up|3|||
33272496|NCT02988817|62644875|FG018|Overall Study|Lost to Follow-up|0|||
33272497|NCT02988817|62644876|FG019|Overall Study|Lost to Follow-up|0|||
33272498|NCT02988817|62644857|FG000|Overall Study|Sponsor decision|0|||
33272499|NCT02988817|62644858|FG001|Overall Study|Sponsor decision|0|||
33272500|NCT02988817|62644859|FG002|Overall Study|Sponsor decision|0|||
33272501|NCT02988817|62644860|FG003|Overall Study|Sponsor decision|0|||
33272502|NCT02988817|62644861|FG004|Overall Study|Sponsor decision|0|||
33272503|NCT02988817|62644862|FG005|Overall Study|Sponsor decision|0|||
33272504|NCT02988817|62644863|FG006|Overall Study|Sponsor decision|0|||
33272505|NCT02988817|62644864|FG007|Overall Study|Sponsor decision|0|||
33272506|NCT02988817|62644865|FG008|Overall Study|Sponsor decision|0|||
33272507|NCT02988817|62644866|FG009|Overall Study|Sponsor decision|0|||
33272508|NCT02988817|62644867|FG010|Overall Study|Sponsor decision|0|||
33272509|NCT02988817|62644868|FG011|Overall Study|Sponsor decision|1|||
33272510|NCT02988817|62644869|FG012|Overall Study|Sponsor decision|1|||
33272511|NCT02988817|62644870|FG013|Overall Study|Sponsor decision|2|||
33272512|NCT02988817|62644871|FG014|Overall Study|Sponsor decision|2|||
33272513|NCT02988817|62644872|FG015|Overall Study|Sponsor decision|6|||
33272514|NCT02988817|62644873|FG016|Overall Study|Sponsor decision|2|||
33272515|NCT02988817|62644874|FG017|Overall Study|Sponsor decision|3|||
33272516|NCT02988817|62644875|FG018|Overall Study|Sponsor decision|2|||
33272517|NCT02988817|62644876|FG019|Overall Study|Sponsor decision|7|||
33272518|NCT02988817|62644857|FG000|Overall Study|Physician Decision|0|||
33272519|NCT02988817|62644858|FG001|Overall Study|Physician Decision|0|||
33272520|NCT02988817|62644859|FG002|Overall Study|Physician Decision|0|||
33272521|NCT02988817|62644860|FG003|Overall Study|Physician Decision|0|||
33272522|NCT02988817|62644861|FG004|Overall Study|Physician Decision|0|||
33272523|NCT02988817|62644862|FG005|Overall Study|Physician Decision|0|||
33272524|NCT02988817|62644863|FG006|Overall Study|Physician Decision|0|||
33272525|NCT02988817|62644864|FG007|Overall Study|Physician Decision|0|||
33272526|NCT02988817|62644865|FG008|Overall Study|Physician Decision|0|||
33272527|NCT02988817|62644866|FG009|Overall Study|Physician Decision|0|||
33272528|NCT02988817|62644867|FG010|Overall Study|Physician Decision|0|||
33272529|NCT02988817|62644868|FG011|Overall Study|Physician Decision|0|||
33272530|NCT02988817|62644869|FG012|Overall Study|Physician Decision|0|||
33272531|NCT02988817|62644870|FG013|Overall Study|Physician Decision|0|||
33272532|NCT02988817|62644871|FG014|Overall Study|Physician Decision|0|||
33272533|NCT02988817|62644872|FG015|Overall Study|Physician Decision|1|||
33272534|NCT02988817|62644873|FG016|Overall Study|Physician Decision|0|||
33272535|NCT02988817|62644874|FG017|Overall Study|Physician Decision|0|||
33272536|NCT02988817|62644875|FG018|Overall Study|Physician Decision|1|||
33272537|NCT02988817|62644876|FG019|Overall Study|Physician Decision|1|||
33272538|NCT02960659|62644931|FG000|Overall Study|Withdrawal by Subject|1|||
33272539|NCT02960659|62644932|FG001|Overall Study|Withdrawal by Subject|0|||
33272540|NCT02960659|62644931|FG000|Overall Study|Poor compliance|0|||
33272541|NCT02960659|62644932|FG001|Overall Study|Poor compliance|1|||
33272542|NCT02844933|62644940|FG000|Overall Study|Discontinued due to premature termination of study|3|||
33272543|NCT02844933|62644941|FG001|Overall Study|Discontinued due to premature termination of study|2|||
33272544|NCT02831764|62644949|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
33272545|NCT02831764|62644950|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
33272546|NCT02831764|62644951|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
33272547|NCT02831764|62644952|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
33272548|NCT02831764|62644953|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
33272549|NCT02831764|62644949|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
33272550|NCT02831764|62644950|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
33272551|NCT02831764|62644951|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
33370134|NCT00848354|62748828|FG000|Phase 2 Year 2|Failed to return|3|||
33370135|NCT00848354|62748829|FG001|Phase 2 Year 2|Failed to return|0|||
33370136|NCT00848354|62748828|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
33272552|NCT02831764|62644952|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
33272553|NCT02831764|62644953|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
33272554|NCT02831764|62644949|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
33272555|NCT02831764|62644950|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
33272556|NCT02831764|62644951|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
33272557|NCT02831764|62644952|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
33272558|NCT02831764|62644953|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
33272559|NCT02831764|62644949|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
33370137|NCT00848354|62748829|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
33272560|NCT02831764|62644950|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
33272561|NCT02831764|62644951|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
33272562|NCT02831764|62644952|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
33272563|NCT02831764|62644953|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
33272564|NCT02831764|62644949|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
33272565|NCT02831764|62644950|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
33272566|NCT02831764|62644951|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
33272567|NCT02831764|62644952|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
33272568|NCT02831764|62644953|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
33272569|NCT02831764|62644949|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
33272570|NCT02831764|62644950|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
33272571|NCT02831764|62644951|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
33272572|NCT02831764|62644952|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
33272573|NCT02831764|62644953|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
33272574|NCT02831764|62644949|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
33272575|NCT02831764|62644950|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
33272576|NCT02831764|62644951|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
33272577|NCT02831764|62644952|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
33272578|NCT02831764|62644953|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
33272579|NCT02831764|62644949|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
33272580|NCT02831764|62644950|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
33272581|NCT02831764|62644951|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
33272582|NCT02831764|62644952|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
33272583|NCT02831764|62644953|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
33272584|NCT02831764|62644949|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
33272585|NCT02831764|62644950|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
33272586|NCT02831764|62644951|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
33272587|NCT02831764|62644952|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
33272588|NCT02831764|62644953|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
33272589|NCT02831764|62644949|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
33272590|NCT02831764|62644950|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
33272591|NCT02831764|62644951|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
33272592|NCT02831764|62644952|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
33272593|NCT02831764|62644953|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
33272594|NCT02831764|62644949|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
33272595|NCT02831764|62644950|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
33272596|NCT02831764|62644951|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
33272597|NCT02831764|62644952|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
33272598|NCT02831764|62644953|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
33272599|NCT02831764|62644949|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
33272600|NCT02831764|62644950|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
33272601|NCT02831764|62644951|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
33272602|NCT02831764|62644952|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
33272603|NCT02831764|62644953|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
33272604|NCT02831764|62644949|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
33272605|NCT02831764|62644950|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
33272606|NCT02831764|62644951|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
33272607|NCT02831764|62644952|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
33272608|NCT02831764|62644953|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
33272609|NCT02831764|62644949|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
33272610|NCT02831764|62644950|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
33272611|NCT02831764|62644951|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
33272612|NCT02831764|62644952|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
33272613|NCT02831764|62644953|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
33272614|NCT02831764|62644949|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
33272615|NCT02831764|62644950|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
33272616|NCT02831764|62644951|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
33272617|NCT02831764|62644952|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
33272618|NCT02831764|62644953|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
33272619|NCT02831764|62644949|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33272620|NCT02831764|62644950|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33272621|NCT02831764|62644951|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33272622|NCT02831764|62644952|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33485626|NCT04346199|62863342|FG000|Overall Study|Death|8|||
33662034|NCT02693418|63092749|FG001|Overall Study|Lost to Follow-up|2|||
33662035|NCT02693418|63092750|FG002|Overall Study|Lost to Follow-up|0|||
33662036|NCT02693418|63092751|FG003|Overall Study|Lost to Follow-up|0|||
33272623|NCT02831764|62644953|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
33272624|NCT02831764|62644949|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33272625|NCT02831764|62644950|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33272626|NCT02831764|62644951|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33272627|NCT02831764|62644952|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33272628|NCT02831764|62644953|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
33272629|NCT02831764|62644949|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33272630|NCT02831764|62644950|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33272631|NCT02831764|62644951|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33272632|NCT02831764|62644952|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33272633|NCT02831764|62644953|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
33272634|NCT02831764|62644949|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33272635|NCT02831764|62644950|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33272636|NCT02831764|62644951|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33272637|NCT02831764|62644952|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33272638|NCT02831764|62644953|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
33272639|NCT02642042|62644972|FG000|Overall Study|Adverse Event|22|||
33272640|NCT02642042|62644972|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
33272641|NCT02642042|62644972|FG000|Overall Study|Progression/Relapse|28|||
33272642|NCT02642042|62644972|FG000|Overall Study|Death|1|||
33272643|NCT02642042|62644972|FG000|Overall Study|Not Protocol Specified|2|||
33272644|NCT02499835|62644989|FG000|Overall Study|Withdrawal by Subject|1|||
33272645|NCT02499835|62644990|FG001|Overall Study|Withdrawal by Subject|0|||
33272646|NCT02499835|62644991|FG002|Overall Study|Withdrawal by Subject|0|||
33272647|NCT02499835|62644992|FG003|Overall Study|Withdrawal by Subject|1|||
33272648|NCT02499835|62644989|FG000|Overall Study|Physician Decision|0|||
33272649|NCT02499835|62644990|FG001|Overall Study|Physician Decision|3|||
33272650|NCT02499835|62644991|FG002|Overall Study|Physician Decision|18|||
33272651|NCT02499835|62644992|FG003|Overall Study|Physician Decision|7|||
33272652|NCT02499835|62644989|FG000|Overall Study|Adverse Event|0|||
33272653|NCT02499835|62644990|FG001|Overall Study|Adverse Event|0|||
33272654|NCT02499835|62644991|FG002|Overall Study|Adverse Event|0|||
33272655|NCT02499835|62644992|FG003|Overall Study|Adverse Event|1|||
33272656|NCT02499835|62644989|FG000|Overall Study|Disease progression|2|||
33272657|NCT02499835|62644990|FG001|Overall Study|Disease progression|1|||
33272658|NCT02499835|62644991|FG002|Overall Study|Disease progression|0|||
33272659|NCT02499835|62644992|FG003|Overall Study|Disease progression|7|||
33272660|NCT02460497|62645004|FG000|Overall Study|Participant Requested Withdrawal|4|||
33272661|NCT02460497|62645004|FG000|Overall Study|Non-Compliance|1|||
33272662|NCT02460497|62645004|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
33370138|NCT00848354|62748828|FG000|Phase 2 Year 2|Unspecified Reason|1|||
33370139|NCT00848354|62748829|FG001|Phase 2 Year 2|Unspecified Reason|0|||
33370140|NCT00848354|62748828|FG000|Phase 2 Year 2|Protocol Violation|1|||
33370141|NCT00848354|62748829|FG001|Phase 2 Year 2|Protocol Violation|1|||
33370142|NCT00848354|62748828|FG000|Phase 2 Year 2|Subject Request|1|||
33370143|NCT00848354|62748829|FG001|Phase 2 Year 2|Subject Request|1|||
33370144|NCT00848354|62748828|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
33370145|NCT00848354|62748829|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
33370146|NCT00848198|62748839|FG000|Overall Study|Incomplete Case Report Forms|15|||
33370147|NCT00848120|62748847|FG000|Overall Study|Adverse Event|1|||
33370148|NCT00600821|62748853|FG000|Overall Study|Death|45|||
33370149|NCT00600821|62748854|FG001|Overall Study|Death|46|||
33370150|NCT00600821|62748853|FG000|Overall Study|Lost to Follow-up|2|||
33370151|NCT00600821|62748854|FG001|Overall Study|Lost to Follow-up|2|||
33370152|NCT00600821|62748853|FG000|Overall Study|Withdrawal by Subject|1|||
33370153|NCT00600821|62748854|FG001|Overall Study|Withdrawal by Subject|1|||
33370154|NCT00600821|62748853|FG000|Overall Study|Terminated by sponsor|8|||
33370155|NCT00600821|62748854|FG001|Overall Study|Terminated by sponsor|6|||
33370156|NCT00600821|62748853|FG000|Overall Study|Objective progression or relapse|0|||
33370157|NCT00600821|62748854|FG001|Overall Study|Objective progression or relapse|1|||
33370158|NCT00600821|62748853|FG000|Overall Study|Randomized but not treated|0|||
33370159|NCT00600821|62748854|FG001|Overall Study|Randomized but not treated|1|||
33370160|NCT00600821|62748853|FG000|Overall Study|Other|2|||
33370161|NCT00600821|62748854|FG001|Overall Study|Other|3|||
33370162|NCT00592904|62748866|FG000|Overall Study|Adverse Event|15|||
33370163|NCT00592904|62748867|FG001|Overall Study|Adverse Event|25|||
33272663|NCT02460497|62645004|FG000|Overall Study|Lost to Follow-up|2|||
33272664|NCT02460497|62645004|FG000|Overall Study|Investigator Decision|1|||
33272665|NCT02460289|62645008|FG000|Overall Study|Adverse Event|1|||
33272666|NCT02460289|62645008|FG000|Overall Study|Withdrawal by Subject|8|||
33272667|NCT02460289|62645008|FG000|Overall Study|Lost to Follow-up|1|||
33272668|NCT02354651|62645032|FG000|Overall Study|Withdrawal by Subject|2|||
33370164|NCT00592904|62748868|FG002|Overall Study|Adverse Event|13|||
33370165|NCT00592904|62748869|FG003|Overall Study|Adverse Event|5|||
33272669|NCT02354651|62645032|FG000|Overall Study|Physician Decision|1|||
33272670|NCT02253316|62645048|FG000|Consolidation|Progression|4|||
33272671|NCT02253316|62645049|FG001|Consolidation|Progression|0|||
33272672|NCT02253316|62645050|FG002|Consolidation|Progression|0|||
33272673|NCT02253316|62645048|FG000|Consolidation|Non-Compliance|1|||
33272674|NCT02253316|62645049|FG001|Consolidation|Non-Compliance|0|||
33272675|NCT02253316|62645050|FG002|Consolidation|Non-Compliance|0|||
33272676|NCT02253316|62645048|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
33272677|NCT02253316|62645049|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
33272678|NCT02253316|62645050|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
33272679|NCT02253316|62645048|FG000|Consolidation|Secondary Malignancy|2|||
33272680|NCT02253316|62645049|FG001|Consolidation|Secondary Malignancy|0|||
33272681|NCT02253316|62645050|FG002|Consolidation|Secondary Malignancy|0|||
33272682|NCT02253316|62645048|FG000|Consolidation|Adverse Event|7|||
33272683|NCT02253316|62645049|FG001|Consolidation|Adverse Event|0|||
33272684|NCT02253316|62645050|FG002|Consolidation|Adverse Event|0|||
33272685|NCT02253316|62645048|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
33272686|NCT02253316|62645049|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
33272687|NCT02253316|62645050|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
33272688|NCT02253316|62645048|FG000|Maintenance|Physician Decision|0|||
33272689|NCT02253316|62645049|FG001|Maintenance|Physician Decision|5|||
33272690|NCT02253316|62645050|FG002|Maintenance|Physician Decision|16|||
33272691|NCT02253316|62645048|FG000|Maintenance|Non-Compliance|0|||
33272692|NCT02253316|62645049|FG001|Maintenance|Non-Compliance|1|||
33272693|NCT02253316|62645050|FG002|Maintenance|Non-Compliance|1|||
33272694|NCT02253316|62645048|FG000|Maintenance|Secondary Malignancy|0|||
33272695|NCT02253316|62645049|FG001|Maintenance|Secondary Malignancy|2|||
33272696|NCT02253316|62645050|FG002|Maintenance|Secondary Malignancy|5|||
33272697|NCT02253316|62645048|FG000|Maintenance|Adverse Event|0|||
33272698|NCT02253316|62645049|FG001|Maintenance|Adverse Event|8|||
33272699|NCT02253316|62645050|FG002|Maintenance|Adverse Event|12|||
33272700|NCT02253316|62645048|FG000|Maintenance|Still receiving active treatment|0|||
33272701|NCT02253316|62645049|FG001|Maintenance|Still receiving active treatment|8|||
33272702|NCT02253316|62645050|FG002|Maintenance|Still receiving active treatment|1|||
33272703|NCT02214160|62645061|FG000|Overall Study|Withdrawal by Subject|1|||
33272704|NCT02214160|62645062|FG001|Overall Study|Withdrawal by Subject|0|||
33272705|NCT02214160|62645063|FG002|Overall Study|Withdrawal by Subject|6|||
33272706|NCT02214160|62645061|FG000|Overall Study|Death|2|||
33272707|NCT02214160|62645062|FG001|Overall Study|Death|2|||
33272708|NCT02214160|62645063|FG002|Overall Study|Death|1|||
33272709|NCT02214160|62645061|FG000|Overall Study|Subject Non-Compliance|0|||
33272710|NCT02214160|62645062|FG001|Overall Study|Subject Non-Compliance|3|||
33272711|NCT02214160|62645063|FG002|Overall Study|Subject Non-Compliance|1|||
33272712|NCT02214160|62645061|FG000|Overall Study|Adverse Event|0|||
33272713|NCT02214160|62645062|FG001|Overall Study|Adverse Event|1|||
33272714|NCT02214160|62645063|FG002|Overall Study|Adverse Event|1|||
33272715|NCT02214160|62645061|FG000|Overall Study|Sponsor Decision|0|||
33272716|NCT02214160|62645062|FG001|Overall Study|Sponsor Decision|2|||
33272717|NCT02214160|62645063|FG002|Overall Study|Sponsor Decision|0|||
33272718|NCT02214160|62645061|FG000|Overall Study|Protocol Violation|1|||
33272719|NCT02214160|62645062|FG001|Overall Study|Protocol Violation|0|||
33272720|NCT02214160|62645063|FG002|Overall Study|Protocol Violation|0|||
33272721|NCT02214160|62645061|FG000|Overall Study|Physician Decision|0|||
33272722|NCT02214160|62645062|FG001|Overall Study|Physician Decision|0|||
33272723|NCT02214160|62645063|FG002|Overall Study|Physician Decision|1|||
33272724|NCT02059265|62645092|FG000|Overall Study|Ineligible|4|||
33272725|NCT01886872|62645099|FG000|Overall Study|Ineligible|7|||
33272726|NCT01886872|62645100|FG001|Overall Study|Ineligible|4|||
33272727|NCT01886872|62645101|FG002|Overall Study|Ineligible|12|||
33272728|NCT01856192|62645112|FG000|Overall Study|Adverse Event|12|||
33272729|NCT01856192|62645113|FG001|Overall Study|Adverse Event|4|||
33272730|NCT01856192|62645112|FG000|Overall Study|Alternative therapy|0|||
33272731|NCT01856192|62645113|FG001|Overall Study|Alternative therapy|3|||
33272732|NCT01856192|62645112|FG000|Overall Study|Death|3|||
33272733|NCT01856192|62645113|FG001|Overall Study|Death|5|||
33272734|NCT01856192|62645112|FG000|Overall Study|Lack of Efficacy|0|||
33272735|NCT01856192|62645113|FG001|Overall Study|Lack of Efficacy|5|||
33272736|NCT01856192|62645112|FG000|Overall Study|Withdrawal by Subject|1|||
33272737|NCT01856192|62645113|FG001|Overall Study|Withdrawal by Subject|1|||
33272738|NCT01856192|62645112|FG000|Overall Study|Other diseases|1|||
33272739|NCT01856192|62645113|FG001|Overall Study|Other diseases|0|||
33272740|NCT01856192|62645112|FG000|Overall Study|Never started treatment|7|||
33272741|NCT01856192|62645113|FG001|Overall Study|Never started treatment|5|||
33272742|NCT01856192|62645112|FG000|Overall Study|Path ineligible|20|||
33272743|NCT01856192|62645113|FG001|Overall Study|Path ineligible|34|||
33272744|NCT01856192|62645112|FG000|Overall Study|Non-path ineligible|2|||
33272745|NCT01856192|62645113|FG001|Overall Study|Non-path ineligible|2|||
33272746|NCT01856192|62645112|FG000|Overall Study|Physician Decision|1|||
33272747|NCT01856192|62645113|FG001|Overall Study|Physician Decision|1|||
33272748|NCT01856192|62645112|FG000|Overall Study|Suspicion of progressive disease|1|||
33272749|NCT01856192|62645113|FG001|Overall Study|Suspicion of progressive disease|0|||
33272750|NCT01856192|62645112|FG000|Overall Study|Non-compliance|1|||
33272751|NCT01856192|62645113|FG001|Overall Study|Non-compliance|0|||
33272752|NCT01708954|62645126|FG000|Step 1|Disease progression|26|||
33272753|NCT01708954|62645127|FG001|Step 1|Disease progression|17|||
33272754|NCT01708954|62645128|FG002|Step 1|Disease progression|14|||
33272755|NCT01708954|62645126|FG000|Step 1|Adverse Event|3|||
33272756|NCT01708954|62645127|FG001|Step 1|Adverse Event|11|||
33272757|NCT01708954|62645128|FG002|Step 1|Adverse Event|13|||
33272758|NCT01708954|62645126|FG000|Step 1|Death|3|||
33272759|NCT01708954|62645127|FG001|Step 1|Death|2|||
33272760|NCT01708954|62645128|FG002|Step 1|Death|3|||
33272761|NCT01708954|62645126|FG000|Step 1|Withdrawal by Subject|2|||
33272762|NCT01708954|62645127|FG001|Step 1|Withdrawal by Subject|5|||
33272763|NCT01708954|62645128|FG002|Step 1|Withdrawal by Subject|3|||
33272764|NCT01708954|62645126|FG000|Step 1|Other complicating disease|0|||
33272765|NCT01708954|62645127|FG001|Step 1|Other complicating disease|2|||
33272766|NCT01708954|62645128|FG002|Step 1|Other complicating disease|0|||
33272767|NCT01708954|62645126|FG000|Step 1|Crossed over to Step 2|2|||
33272768|NCT01708954|62645127|FG001|Step 1|Crossed over to Step 2|0|||
33272769|NCT01708954|62645128|FG002|Step 1|Crossed over to Step 2|0|||
33272770|NCT01708954|62645126|FG000|Step 1|Symptomatic deterioration|1|||
33272771|NCT01708954|62645127|FG001|Step 1|Symptomatic deterioration|0|||
33272772|NCT01708954|62645128|FG002|Step 1|Symptomatic deterioration|1|||
33272773|NCT01708954|62645126|FG000|Step 1|Off-treatment reason not submitted|1|||
33272774|NCT01708954|62645127|FG001|Step 1|Off-treatment reason not submitted|1|||
33272775|NCT01708954|62645128|FG002|Step 1|Off-treatment reason not submitted|1|||
33272776|NCT01708954|62645126|FG000|Step 1|Ineligible or never received treatment|4|||
33272777|NCT01708954|62645127|FG001|Step 1|Ineligible or never received treatment|2|||
33272778|NCT01708954|62645128|FG002|Step 1|Ineligible or never received treatment|8|||
33272779|NCT01708954|62645126|FG000|Step 2|Disease progression|9|||
33272780|NCT01708954|62645127|FG001|Step 2|Disease progression|4|||
33272781|NCT01708954|62645128|FG002|Step 2|Disease progression|0|||
33272782|NCT01708954|62645126|FG000|Step 2|Adverse Event|3|||
33272783|NCT01708954|62645127|FG001|Step 2|Adverse Event|2|||
33272784|NCT01708954|62645128|FG002|Step 2|Adverse Event|0|||
33272785|NCT01708954|62645126|FG000|Step 2|Withdrawal by Subject|1|||
33272786|NCT01708954|62645127|FG001|Step 2|Withdrawal by Subject|1|||
33272787|NCT01708954|62645128|FG002|Step 2|Withdrawal by Subject|0|||
33272788|NCT01708941|62645141|FG000|Overall Study|Adverse Event|4|||
33272789|NCT01708941|62645142|FG001|Overall Study|Adverse Event|6|||
33272790|NCT01708941|62645143|FG002|Overall Study|Adverse Event|1|||
33272791|NCT01708941|62645144|FG003|Overall Study|Adverse Event|0|||
33272792|NCT01708941|62645141|FG000|Overall Study|Death|1|||
33272793|NCT01708941|62645142|FG001|Overall Study|Death|1|||
33272794|NCT01708941|62645143|FG002|Overall Study|Death|2|||
33272795|NCT01708941|62645144|FG003|Overall Study|Death|14|||
33272796|NCT01708941|62645141|FG000|Overall Study|Withdrawal by Subject|1|||
33272797|NCT01708941|62645142|FG001|Overall Study|Withdrawal by Subject|0|||
33272798|NCT01708941|62645143|FG002|Overall Study|Withdrawal by Subject|3|||
33272799|NCT01708941|62645144|FG003|Overall Study|Withdrawal by Subject|4|||
33272800|NCT01708941|62645141|FG000|Overall Study|Disease progression|9|||
33272801|NCT01708941|62645142|FG001|Overall Study|Disease progression|10|||
33272802|NCT01708941|62645143|FG002|Overall Study|Disease progression|8|||
33272803|NCT01708941|62645144|FG003|Overall Study|Disease progression|0|||
33272804|NCT01708941|62645141|FG000|Overall Study|Alternative therapy|0|||
33272805|NCT01708941|62645142|FG001|Overall Study|Alternative therapy|0|||
33272806|NCT01708941|62645143|FG002|Overall Study|Alternative therapy|2|||
33272807|NCT01708941|62645144|FG003|Overall Study|Alternative therapy|0|||
33272808|NCT01708941|62645141|FG000|Overall Study|Ineligible and never started treatment|1|||
33272809|NCT01708941|62645142|FG001|Overall Study|Ineligible and never started treatment|0|||
33272810|NCT01708941|62645143|FG002|Overall Study|Ineligible and never started treatment|1|||
33370166|NCT00592904|62748866|FG000|Overall Study|Protocol Violation|1|||
33272811|NCT01708941|62645144|FG003|Overall Study|Ineligible and never started treatment|0|||
33272812|NCT01708941|62645141|FG000|Overall Study|Never started treatment|2|||
33272813|NCT01708941|62645142|FG001|Overall Study|Never started treatment|1|||
33272814|NCT01708941|62645143|FG002|Overall Study|Never started treatment|0|||
33272815|NCT01708941|62645144|FG003|Overall Study|Never started treatment|0|||
33272816|NCT01708941|62645141|FG000|Overall Study|Ineligible|0|||
33272817|NCT01708941|62645142|FG001|Overall Study|Ineligible|0|||
33272818|NCT01708941|62645143|FG002|Overall Study|Ineligible|2|||
33272819|NCT01708941|62645144|FG003|Overall Study|Ineligible|0|||
33272820|NCT01142388|62645156|FG000|Overall Study|Lack of Efficacy|21|||
33272821|NCT01142388|62645157|FG001|Overall Study|Lack of Efficacy|31|||
33272822|NCT01142388|62645156|FG000|Overall Study|Adverse Event|9|||
33272823|NCT01142388|62645157|FG001|Overall Study|Adverse Event|5|||
33272824|NCT01142388|62645156|FG000|Overall Study|Death|3|||
33272825|NCT01142388|62645157|FG001|Overall Study|Death|2|||
33272826|NCT01142388|62645156|FG000|Overall Study|Withdrawal by Subject|5|||
33272827|NCT01142388|62645157|FG001|Overall Study|Withdrawal by Subject|3|||
33272828|NCT01142388|62645156|FG000|Overall Study|Alternative therapy|1|||
33272829|NCT01142388|62645157|FG001|Overall Study|Alternative therapy|0|||
33272830|NCT01142388|62645156|FG000|Overall Study|Other complications|0|||
33272831|NCT01142388|62645157|FG001|Overall Study|Other complications|2|||
33272832|NCT01142388|62645156|FG000|Overall Study|Other|1|||
33272833|NCT01142388|62645157|FG001|Overall Study|Other|1|||
33272834|NCT01142388|62645156|FG000|Overall Study|Never started therapy|7|||
33272835|NCT01142388|62645157|FG001|Overall Study|Never started therapy|3|||
33272836|NCT01134614|62645165|FG000|Overall Study|Still on treatment as of March 2013|21|||
33272837|NCT01134614|62645166|FG001|Overall Study|Still on treatment as of March 2013|13|||
33272838|NCT01134614|62645165|FG000|Overall Study|Progressive disease|60|||
33272839|NCT01134614|62645166|FG001|Overall Study|Progressive disease|54|||
33272840|NCT01134614|62645165|FG000|Overall Study|Adverse Event|26|||
33272841|NCT01134614|62645166|FG001|Overall Study|Adverse Event|39|||
33272842|NCT01134614|62645165|FG000|Overall Study|Death|5|||
33272843|NCT01134614|62645166|FG001|Overall Study|Death|8|||
33272844|NCT01134614|62645165|FG000|Overall Study|Withdrawal by Subject|3|||
33272845|NCT01134614|62645166|FG001|Overall Study|Withdrawal by Subject|2|||
33272846|NCT01134614|62645165|FG000|Overall Study|Alternative therapy|2|||
33272847|NCT01134614|62645166|FG001|Overall Study|Alternative therapy|0|||
33272848|NCT01134614|62645165|FG000|Overall Study|Complicating disease|2|||
33272849|NCT01134614|62645166|FG001|Overall Study|Complicating disease|1|||
33272850|NCT01134614|62645165|FG000|Overall Study|Physician's decision|0|||
33272851|NCT01134614|62645166|FG001|Overall Study|Physician's decision|1|||
33272852|NCT01134614|62645165|FG000|Overall Study|Never started treatment|4|||
33272853|NCT01134614|62645166|FG001|Overall Study|Never started treatment|1|||
33272854|NCT01134614|62645165|FG000|Overall Study|Pt received tx not allowed on study|0|||
33272855|NCT01134614|62645166|FG001|Overall Study|Pt received tx not allowed on study|1|||
33272856|NCT01134614|62645165|FG000|Overall Study|Symptomatic deterioration|0|||
33272857|NCT01134614|62645166|FG001|Overall Study|Symptomatic deterioration|1|||
33272858|NCT01134614|62645165|FG000|Overall Study|Patient in hospice care|0|||
33272859|NCT01134614|62645166|FG001|Overall Study|Patient in hospice care|1|||
33272860|NCT00433511|62645192|FG000|Step 1|Adverse Event|50|||
33272861|NCT00433511|62645193|FG001|Step 1|Adverse Event|157|||
33272862|NCT00433511|62645194|FG002|Step 1|Adverse Event|153|||
33272863|NCT00433511|62645192|FG000|Step 1|Withdrawal by Subject|45|||
33272864|NCT00433511|62645193|FG001|Step 1|Withdrawal by Subject|143|||
33272865|NCT00433511|62645194|FG002|Step 1|Withdrawal by Subject|154|||
33272866|NCT00433511|62645192|FG000|Step 1|Death|3|||
33272867|NCT00433511|62645193|FG001|Step 1|Death|1|||
33272868|NCT00433511|62645194|FG002|Step 1|Death|1|||
33272869|NCT00433511|62645192|FG000|Step 1|Physician Decision|1|||
33272870|NCT00433511|62645193|FG001|Step 1|Physician Decision|4|||
33272871|NCT00433511|62645194|FG002|Step 1|Physician Decision|3|||
33272872|NCT00433511|62645192|FG000|Step 1|Never started protocol therapy|28|||
33272873|NCT00433511|62645193|FG001|Step 1|Never started protocol therapy|64|||
33272874|NCT00433511|62645194|FG002|Step 1|Never started protocol therapy|66|||
33272875|NCT00433511|62645192|FG000|Step 1|Alternative therapy|2|||
33272876|NCT00433511|62645193|FG001|Step 1|Alternative therapy|1|||
33272877|NCT00433511|62645194|FG002|Step 1|Alternative therapy|3|||
33272878|NCT00433511|62645192|FG000|Step 1|Disease progression, relapse|5|||
33272879|NCT00433511|62645193|FG001|Step 1|Disease progression, relapse|3|||
33272880|NCT00433511|62645194|FG002|Step 1|Disease progression, relapse|3|||
33272881|NCT00433511|62645192|FG000|Step 1|Other complicating disease|2|||
33272882|NCT00433511|62645193|FG001|Step 1|Other complicating disease|6|||
33272883|NCT00433511|62645194|FG002|Step 1|Other complicating disease|3|||
33272884|NCT00433511|62645192|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
33272885|NCT00433511|62645193|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
33272886|NCT00433511|62645194|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
33272887|NCT00433511|62645192|FG000|Step 1|Suspected recurrence|0|||
33272888|NCT00433511|62645193|FG001|Step 1|Suspected recurrence|1|||
33272889|NCT00433511|62645194|FG002|Step 1|Suspected recurrence|0|||
33272890|NCT00433511|62645192|FG000|Step 1|Insurance/drug distribution issues|0|||
33370167|NCT00592904|62748867|FG001|Overall Study|Protocol Violation|1|||
33272891|NCT00433511|62645193|FG001|Step 1|Insurance/drug distribution issues|1|||
33272892|NCT00433511|62645194|FG002|Step 1|Insurance/drug distribution issues|2|||
33272893|NCT00433511|62645192|FG000|Step 1|Patient moved|0|||
33272894|NCT00433511|62645193|FG001|Step 1|Patient moved|0|||
33272895|NCT00433511|62645194|FG002|Step 1|Patient moved|1|||
33272896|NCT00433511|62645192|FG000|Step 2 (Arm D)|Adverse Event|0|||
33272897|NCT00433511|62645193|FG001|Step 2 (Arm D)|Adverse Event|0|||
33272898|NCT00433511|62645194|FG002|Step 2 (Arm D)|Adverse Event|135|||
33272899|NCT00433511|62645192|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
33272900|NCT00433511|62645193|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
33272901|NCT00433511|62645194|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
33272902|NCT00433511|62645192|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
33272903|NCT00433511|62645193|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
33272904|NCT00433511|62645194|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
33272905|NCT00433511|62645192|FG000|Step 2 (Arm D)|Physician Decision|0|||
33272906|NCT00433511|62645193|FG001|Step 2 (Arm D)|Physician Decision|0|||
33272907|NCT00433511|62645194|FG002|Step 2 (Arm D)|Physician Decision|9|||
33272908|NCT00433511|62645192|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
33272909|NCT00433511|62645193|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
33272910|NCT00433511|62645194|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
33272911|NCT00433511|62645192|FG000|Step 2 (Arm D)|Other complicating disease|0|||
33272912|NCT00433511|62645193|FG001|Step 2 (Arm D)|Other complicating disease|0|||
33272913|NCT00433511|62645194|FG002|Step 2 (Arm D)|Other complicating disease|3|||
33272914|NCT00433511|62645192|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
33272915|NCT00433511|62645193|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
33272916|NCT00433511|62645194|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
33272917|NCT00433511|62645192|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
33272918|NCT00433511|62645193|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
33272919|NCT00433511|62645194|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
33272920|NCT00433511|62645192|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
33272921|NCT00433511|62645193|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
33272922|NCT00433511|62645194|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
33272923|NCT00433511|62645192|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
33272924|NCT00433511|62645193|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
33272925|NCT00433511|62645194|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
33272926|NCT00098475|62645207|FG000|Step 1|Progressive disease|33|||
33272927|NCT00098475|62645208|FG001|Step 1|Progressive disease|35|||
33272928|NCT00098475|62645209|FG002|Step 1|Progressive disease|2|||
33272929|NCT00098475|62645210|FG003|Step 1|Progressive disease|1|||
33272930|NCT00098475|62645207|FG000|Step 1|Adverse Event|56|||
33272931|NCT00098475|62645208|FG001|Step 1|Adverse Event|37|||
33272932|NCT00098475|62645209|FG002|Step 1|Adverse Event|0|||
33272933|NCT00098475|62645210|FG003|Step 1|Adverse Event|1|||
33272934|NCT00098475|62645207|FG000|Step 1|Death|8|||
33272935|NCT00098475|62645208|FG001|Step 1|Death|5|||
33272936|NCT00098475|62645209|FG002|Step 1|Death|0|||
33272937|NCT00098475|62645210|FG003|Step 1|Death|1|||
33272938|NCT00098475|62645207|FG000|Step 1|Withdrawal by Subject|14|||
33272939|NCT00098475|62645208|FG001|Step 1|Withdrawal by Subject|11|||
33272940|NCT00098475|62645209|FG002|Step 1|Withdrawal by Subject|0|||
33272941|NCT00098475|62645210|FG003|Step 1|Withdrawal by Subject|0|||
33272942|NCT00098475|62645207|FG000|Step 1|Physician Decision|5|||
33272943|NCT00098475|62645208|FG001|Step 1|Physician Decision|2|||
33272944|NCT00098475|62645209|FG002|Step 1|Physician Decision|0|||
33272945|NCT00098475|62645210|FG003|Step 1|Physician Decision|0|||
33272946|NCT00098475|62645207|FG000|Step 1|Alternative therapy|31|||
33272947|NCT00098475|62645208|FG001|Step 1|Alternative therapy|43|||
33272948|NCT00098475|62645209|FG002|Step 1|Alternative therapy|1|||
33272949|NCT00098475|62645210|FG003|Step 1|Alternative therapy|0|||
33272950|NCT00098475|62645207|FG000|Step 1|Other disease|2|||
33272951|NCT00098475|62645208|FG001|Step 1|Other disease|1|||
33272952|NCT00098475|62645209|FG002|Step 1|Other disease|1|||
33272953|NCT00098475|62645210|FG003|Step 1|Other disease|0|||
33272954|NCT00098475|62645207|FG000|Step 1|Never started treatment|0|||
33272955|NCT00098475|62645208|FG001|Step 1|Never started treatment|2|||
33272956|NCT00098475|62645209|FG002|Step 1|Never started treatment|0|||
33272957|NCT00098475|62645210|FG003|Step 1|Never started treatment|0|||
33272958|NCT00098475|62645207|FG000|Step 1|Still on treatment as of this analysis|14|||
33272959|NCT00098475|62645208|FG001|Step 1|Still on treatment as of this analysis|27|||
33272960|NCT00098475|62645209|FG002|Step 1|Still on treatment as of this analysis|0|||
33272961|NCT00098475|62645210|FG003|Step 1|Still on treatment as of this analysis|0|||
33272962|NCT00098475|62645207|FG000|Step 1|Knee surgery|1|||
33272963|NCT00098475|62645208|FG001|Step 1|Knee surgery|0|||
33272964|NCT00098475|62645209|FG002|Step 1|Knee surgery|0|||
33272965|NCT00098475|62645210|FG003|Step 1|Knee surgery|0|||
33272966|NCT00098475|62645207|FG000|Step 1|Complications|1|||
33272967|NCT00098475|62645208|FG001|Step 1|Complications|0|||
33272968|NCT00098475|62645209|FG002|Step 1|Complications|0|||
33272969|NCT00098475|62645210|FG003|Step 1|Complications|0|||
33272970|NCT00098475|62645207|FG000|Step 1|Cannot comply due to other tx|0|||
33272971|NCT00098475|62645208|FG001|Step 1|Cannot comply due to other tx|1|||
33272972|NCT00098475|62645209|FG002|Step 1|Cannot comply due to other tx|0|||
33272973|NCT00098475|62645210|FG003|Step 1|Cannot comply due to other tx|0|||
33272974|NCT00098475|62645207|FG000|Step 1|Both patient and physician's decision|2|||
33272975|NCT00098475|62645208|FG001|Step 1|Both patient and physician's decision|1|||
33272976|NCT00098475|62645209|FG002|Step 1|Both patient and physician's decision|0|||
33272977|NCT00098475|62645210|FG003|Step 1|Both patient and physician's decision|0|||
33272978|NCT00098475|62645207|FG000|Step 1|Incorrect disease assessment|2|||
33272979|NCT00098475|62645208|FG001|Step 1|Incorrect disease assessment|0|||
33272980|NCT00098475|62645209|FG002|Step 1|Incorrect disease assessment|0|||
33272981|NCT00098475|62645210|FG003|Step 1|Incorrect disease assessment|0|||
33272982|NCT00098475|62645207|FG000|Step 1|Off treatment for > specified timeframe|1|||
33272983|NCT00098475|62645208|FG001|Step 1|Off treatment for > specified timeframe|1|||
33272984|NCT00098475|62645209|FG002|Step 1|Off treatment for > specified timeframe|0|||
33272985|NCT00098475|62645210|FG003|Step 1|Off treatment for > specified timeframe|0|||
33272986|NCT00098475|62645207|FG000|Step 1|Declining performance status|0|||
33272987|NCT00098475|62645208|FG001|Step 1|Declining performance status|1|||
33272988|NCT00098475|62645209|FG002|Step 1|Declining performance status|0|||
33272989|NCT00098475|62645210|FG003|Step 1|Declining performance status|0|||
33272990|NCT00098475|62645207|FG000|Step 1|Insurance issue|0|||
33272991|NCT00098475|62645208|FG001|Step 1|Insurance issue|1|||
33272992|NCT00098475|62645209|FG002|Step 1|Insurance issue|0|||
33272993|NCT00098475|62645210|FG003|Step 1|Insurance issue|0|||
33272994|NCT00098475|62645207|FG000|Step 1|Rising paraprotein|0|||
33272995|NCT00098475|62645208|FG001|Step 1|Rising paraprotein|1|||
33272996|NCT00098475|62645209|FG002|Step 1|Rising paraprotein|0|||
33272997|NCT00098475|62645210|FG003|Step 1|Rising paraprotein|0|||
33272998|NCT00098475|62645207|FG000|Step 1|Referred to other physicians|0|||
33272999|NCT00098475|62645208|FG001|Step 1|Referred to other physicians|1|||
33273000|NCT00098475|62645209|FG002|Step 1|Referred to other physicians|0|||
33273001|NCT00098475|62645210|FG003|Step 1|Referred to other physicians|0|||
33273002|NCT00098475|62645207|FG000|Step 1|Criteria to continue treatment not met|0|||
33273003|NCT00098475|62645208|FG001|Step 1|Criteria to continue treatment not met|1|||
33273004|NCT00098475|62645209|FG002|Step 1|Criteria to continue treatment not met|0|||
33273005|NCT00098475|62645210|FG003|Step 1|Criteria to continue treatment not met|0|||
33273006|NCT00098475|62645207|FG000|Step 1|Misinterpretation of lab data|0|||
33273007|NCT00098475|62645208|FG001|Step 1|Misinterpretation of lab data|1|||
33273008|NCT00098475|62645209|FG002|Step 1|Misinterpretation of lab data|0|||
33273009|NCT00098475|62645210|FG003|Step 1|Misinterpretation of lab data|0|||
33273010|NCT00098475|62645207|FG000|Step 1|Patient fell with fracture|1|||
33273011|NCT00098475|62645208|FG001|Step 1|Patient fell with fracture|0|||
33273012|NCT00098475|62645209|FG002|Step 1|Patient fell with fracture|0|||
33273013|NCT00098475|62645210|FG003|Step 1|Patient fell with fracture|0|||
33273014|NCT00098475|62645207|FG000|Step 1|Not documented|0|||
33273015|NCT00098475|62645208|FG001|Step 1|Not documented|1|||
33273016|NCT00098475|62645209|FG002|Step 1|Not documented|0|||
33273017|NCT00098475|62645210|FG003|Step 1|Not documented|0|||
33273018|NCT00098475|62645207|FG000|Step 2|Disease progression|1|||
33273019|NCT00098475|62645208|FG001|Step 2|Disease progression|4|||
33273020|NCT00098475|62645209|FG002|Step 2|Disease progression|0|||
33273021|NCT00098475|62645210|FG003|Step 2|Disease progression|0|||
33273022|NCT00098475|62645207|FG000|Step 2|Adverse Event|2|||
33273023|NCT00098475|62645208|FG001|Step 2|Adverse Event|0|||
33273024|NCT00098475|62645209|FG002|Step 2|Adverse Event|0|||
33273025|NCT00098475|62645210|FG003|Step 2|Adverse Event|0|||
33273026|NCT00098475|62645207|FG000|Step 2|Withdrawal by Subject|0|||
33273027|NCT00098475|62645208|FG001|Step 2|Withdrawal by Subject|2|||
33273028|NCT00098475|62645209|FG002|Step 2|Withdrawal by Subject|0|||
33273029|NCT00098475|62645210|FG003|Step 2|Withdrawal by Subject|0|||
33273030|NCT00098475|62645207|FG000|Step 2|Physician Decision|0|||
33273031|NCT00098475|62645208|FG001|Step 2|Physician Decision|1|||
33273032|NCT00098475|62645209|FG002|Step 2|Physician Decision|0|||
33273033|NCT00098475|62645210|FG003|Step 2|Physician Decision|0|||
33273034|NCT00098475|62645207|FG000|Step 2|Alternative therapy|1|||
33273035|NCT00098475|62645208|FG001|Step 2|Alternative therapy|2|||
33273036|NCT00098475|62645209|FG002|Step 2|Alternative therapy|0|||
33273037|NCT00098475|62645210|FG003|Step 2|Alternative therapy|0|||
33273038|NCT00098475|62645207|FG000|Step 2|Never started treatment|1|||
33273039|NCT00098475|62645208|FG001|Step 2|Never started treatment|1|||
33273040|NCT00098475|62645209|FG002|Step 2|Never started treatment|0|||
33273041|NCT00098475|62645210|FG003|Step 2|Never started treatment|0|||
33273042|NCT04983589|62645222|FG000|Overall Study|Withdrawal by Subject|0|||
33273043|NCT04983589|62645223|FG001|Overall Study|Withdrawal by Subject|3|||
33273044|NCT04983589|62645222|FG000|Overall Study|COVID-19 Infection|1|||
33273045|NCT04983589|62645223|FG001|Overall Study|COVID-19 Infection|0|||
33273046|NCT04983589|62645222|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
33273047|NCT04983589|62645223|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
33273048|NCT04556591|62645243|FG000|Overall Study|Lost to Follow-up|1|||
33273049|NCT04556591|62645244|FG001|Overall Study|Lost to Follow-up|0|||
33273050|NCT04556591|62645243|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
33273051|NCT04556591|62645244|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
33273052|NCT04428034|62645253|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
33273053|NCT04364984|62645264|FG000|Overall Study|Death|2|||
33273054|NCT04364984|62645265|FG001|Overall Study|Death|2|||
33273055|NCT04364984|62645266|FG002|Overall Study|Death|0|||
33273056|NCT04294095|62645276|FG000|Overall Study|Adverse Event|1|||
33273057|NCT04294095|62645277|FG001|Overall Study|Adverse Event|0|||
33273058|NCT04266028|62645293|FG000|Overall Study|Adverse Event|0|||
33273059|NCT04266028|62645294|FG001|Overall Study|Adverse Event|0|||
33273060|NCT04266028|62645295|FG002|Overall Study|Adverse Event|1|||
33273061|NCT04266028|62645296|FG003|Overall Study|Adverse Event|0|||
33273062|NCT04266028|62645297|FG004|Overall Study|Adverse Event|1|||
33273063|NCT04266028|62645298|FG005|Overall Study|Adverse Event|0|||
33273064|NCT04266028|62645299|FG006|Overall Study|Adverse Event|2|||
33273065|NCT04266028|62645300|FG007|Overall Study|Adverse Event|0|||
33273066|NCT04266028|62645293|FG000|Overall Study|temporary halt of the study|0|||
33273067|NCT04266028|62645294|FG001|Overall Study|temporary halt of the study|0|||
33273068|NCT04266028|62645295|FG002|Overall Study|temporary halt of the study|0|||
33273069|NCT04266028|62645296|FG003|Overall Study|temporary halt of the study|0|||
33273070|NCT04266028|62645297|FG004|Overall Study|temporary halt of the study|0|||
33273071|NCT04266028|62645298|FG005|Overall Study|temporary halt of the study|0|||
33662037|NCT02693418|63092752|FG004|Overall Study|Lost to Follow-up|0|||
33662038|NCT02693418|63092748|FG000|Overall Study|Menses during study period|0|||
33662039|NCT02693418|63092749|FG001|Overall Study|Menses during study period|0|||
33662040|NCT02693418|63092750|FG002|Overall Study|Menses during study period|2|||
33662041|NCT02693418|63092751|FG003|Overall Study|Menses during study period|0|||
33662042|NCT02693418|63092752|FG004|Overall Study|Menses during study period|0|||
33662043|NCT02693106|63092785|FG000|Overall Study|No time|3|||
33273072|NCT04266028|62645299|FG006|Overall Study|temporary halt of the study|2|||
33273073|NCT04266028|62645300|FG007|Overall Study|temporary halt of the study|1|||
33273074|NCT04266028|62645293|FG000|Overall Study|Onset of birch pollen season|0|||
33273075|NCT04266028|62645294|FG001|Overall Study|Onset of birch pollen season|0|||
33273076|NCT04266028|62645295|FG002|Overall Study|Onset of birch pollen season|0|||
33273077|NCT04266028|62645296|FG003|Overall Study|Onset of birch pollen season|0|||
33273078|NCT04266028|62645297|FG004|Overall Study|Onset of birch pollen season|1|||
33273079|NCT04266028|62645298|FG005|Overall Study|Onset of birch pollen season|0|||
33273080|NCT04266028|62645299|FG006|Overall Study|Onset of birch pollen season|0|||
33273081|NCT04266028|62645300|FG007|Overall Study|Onset of birch pollen season|0|||
33273082|NCT03994731|62645350|FG000|Pegloticase + IMM Period|Death|2|||
33273083|NCT03994731|62645351|FG001|Pegloticase + IMM Period|Death|0|||
33273084|NCT03994731|62645350|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
33273085|NCT03994731|62645351|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
33273086|NCT03994731|62645350|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
33273087|NCT03994731|62645351|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
33273088|NCT03801915|62645363|FG000|Overall Study|Screen failure|0|||
33273089|NCT03801915|62645364|FG001|Overall Study|Screen failure|0|||
33273090|NCT03801915|62645365|FG002|Overall Study|Screen failure|1|||
33273091|NCT03801915|62645363|FG000|Overall Study|Ineligible|1|||
33273092|NCT03801915|62645364|FG001|Overall Study|Ineligible|0|||
33273093|NCT03801915|62645365|FG002|Overall Study|Ineligible|0|||
33273094|NCT03801915|62645363|FG000|Overall Study|Physician Decision|2|||
33273095|NCT03801915|62645364|FG001|Overall Study|Physician Decision|1|||
33273096|NCT03801915|62645365|FG002|Overall Study|Physician Decision|0|||
33273097|NCT03581305|62645379|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
33273098|NCT03581305|62645380|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
33273099|NCT03581305|62645379|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
33273100|NCT03581305|62645380|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
33273101|NCT03581305|62645379|FG000|Serotonergic Study|Withdrawal by Subject|5|||
33273102|NCT03581305|62645380|FG001|Serotonergic Study|Withdrawal by Subject|1|||
33273103|NCT03556202|62645391|FG000|Extension Treatment Period|Adverse Event|18|||
33273104|NCT03556202|62645392|FG001|Extension Treatment Period|Adverse Event|14|||
33273105|NCT03556202|62645393|FG002|Extension Treatment Period|Adverse Event|9|||
33273106|NCT03556202|62645391|FG000|Extension Treatment Period|Death|2|||
33273107|NCT03556202|62645392|FG001|Extension Treatment Period|Death|6|||
33273108|NCT03556202|62645393|FG002|Extension Treatment Period|Death|0|||
33273109|NCT03556202|62645391|FG000|Extension Treatment Period|Lack of Efficacy|5|||
33273110|NCT03556202|62645392|FG001|Extension Treatment Period|Lack of Efficacy|12|||
33273111|NCT03556202|62645393|FG002|Extension Treatment Period|Lack of Efficacy|18|||
33273112|NCT03556202|62645391|FG000|Extension Treatment Period|Lost to Follow-up|9|||
33273113|NCT03556202|62645392|FG001|Extension Treatment Period|Lost to Follow-up|20|||
33273114|NCT03556202|62645393|FG002|Extension Treatment Period|Lost to Follow-up|2|||
33273115|NCT03556202|62645391|FG000|Extension Treatment Period|Pregnancy|2|||
33273116|NCT03556202|62645392|FG001|Extension Treatment Period|Pregnancy|4|||
33273117|NCT03556202|62645393|FG002|Extension Treatment Period|Pregnancy|3|||
33273118|NCT03556202|62645391|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
33273119|NCT03556202|62645392|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
33273120|NCT03556202|62645393|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
33273121|NCT03556202|62645391|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
33273122|NCT03556202|62645392|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
33662044|NCT02546986|63092797|FG000|Treatment Period|Progressive Disease|20|||
33662045|NCT02546986|63092798|FG001|Treatment Period|Progressive Disease|22|||
33273123|NCT03556202|62645393|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
33273124|NCT03556202|62645391|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
33273125|NCT03556202|62645392|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
33662046|NCT02546986|63092797|FG000|Treatment Period|Adverse Event|14|||
33370168|NCT00592904|62748868|FG002|Overall Study|Protocol Violation|0|||
33273126|NCT03556202|62645393|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
33273127|NCT03556202|62645391|FG000|Extension Treatment Period|Physician Decision|0|||
33273128|NCT03556202|62645392|FG001|Extension Treatment Period|Physician Decision|8|||
33273129|NCT03556202|62645393|FG002|Extension Treatment Period|Physician Decision|2|||
33273130|NCT03556202|62645391|FG000|Extension Treatment Period|Protocol Violation|0|||
33273131|NCT03556202|62645392|FG001|Extension Treatment Period|Protocol Violation|1|||
33273132|NCT03556202|62645393|FG002|Extension Treatment Period|Protocol Violation|1|||
33273133|NCT03556202|62645391|FG000|Extension Treatment Period|Sponsor Decision|0|||
33273134|NCT03556202|62645392|FG001|Extension Treatment Period|Sponsor Decision|1|||
33273135|NCT03556202|62645393|FG002|Extension Treatment Period|Sponsor Decision|0|||
33273136|NCT03556202|62645391|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
33273137|NCT03556202|62645392|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
33273138|NCT03556202|62645393|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
33273139|NCT03556202|62645391|FG000|Follow-Up Period (12 Weeks)|Death|1|||
33273140|NCT03556202|62645392|FG001|Follow-Up Period (12 Weeks)|Death|0|||
33273141|NCT03556202|62645393|FG002|Follow-Up Period (12 Weeks)|Death|0|||
33273142|NCT03556202|62645391|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
33273143|NCT03556202|62645392|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
33273144|NCT03556202|62645393|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
33273145|NCT03556202|62645391|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
33273146|NCT03556202|62645392|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
33273147|NCT03556202|62645393|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
33273148|NCT03556202|62645391|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
33273149|NCT03556202|62645392|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
33273150|NCT03556202|62645393|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
33273151|NCT03556202|62645391|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
33273152|NCT03556202|62645392|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
33273153|NCT03556202|62645393|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
33273154|NCT03556202|62645391|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
33273155|NCT03556202|62645392|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
33273156|NCT03556202|62645393|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
33273157|NCT03556202|62645391|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
33273158|NCT03556202|62645392|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
33273159|NCT03556202|62645393|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
33273160|NCT03556202|62645391|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
33273161|NCT03556202|62645392|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
33273162|NCT03556202|62645393|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
33273163|NCT03556202|62645391|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
33273164|NCT03556202|62645392|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
33273165|NCT03556202|62645393|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
33273166|NCT03556202|62645391|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
33273167|NCT03556202|62645392|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
33273168|NCT03556202|62645393|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
33273169|NCT03556202|62645391|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
33273170|NCT03556202|62645392|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
33273171|NCT03556202|62645393|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
33273172|NCT03556202|62645391|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
33273173|NCT03556202|62645392|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
33273174|NCT03556202|62645393|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
33273175|NCT03556202|62645391|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
33273176|NCT03556202|62645392|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
33273177|NCT03556202|62645393|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
33273178|NCT03541174|62645407|FG000|Part 1 Double-Blind|Adverse Event|6|||
33273179|NCT03541174|62645408|FG001|Part 1 Double-Blind|Adverse Event|5|||
33273180|NCT03541174|62645409|FG002|Part 1 Double-Blind|Adverse Event|2|||
33273181|NCT03541174|62645410|FG003|Part 1 Double-Blind|Adverse Event|0|||
33273182|NCT03541174|62645411|FG004|Part 1 Double-Blind|Adverse Event|0|||
33662047|NCT02546986|63092798|FG001|Treatment Period|Adverse Event|6|||
33662048|NCT02546986|63092797|FG000|Treatment Period|Symptomatic Deterioration|4|||
33662049|NCT02546986|63092798|FG001|Treatment Period|Symptomatic Deterioration|3|||
33273183|NCT03541174|62645412|FG005|Part 1 Double-Blind|Adverse Event|0|||
33273184|NCT03541174|62645407|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
33273185|NCT03541174|62645408|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
33273186|NCT03541174|62645409|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
33273187|NCT03541174|62645410|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
33273188|NCT03541174|62645411|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
33273189|NCT03541174|62645412|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
33273190|NCT03541174|62645407|FG000|Part 1 Double-Blind|Other reasons|3|||
33662050|NCT02546986|63092797|FG000|Treatment Period|Death|3|||
33273191|NCT03541174|62645408|FG001|Part 1 Double-Blind|Other reasons|2|||
33273192|NCT03541174|62645409|FG002|Part 1 Double-Blind|Other reasons|3|||
33273193|NCT03541174|62645410|FG003|Part 1 Double-Blind|Other reasons|0|||
33273194|NCT03541174|62645411|FG004|Part 1 Double-Blind|Other reasons|0|||
33273195|NCT03541174|62645412|FG005|Part 1 Double-Blind|Other reasons|0|||
33273196|NCT03541174|62645407|FG000|Part 2 Single-Blind|Adverse Event|0|||
33273197|NCT03541174|62645408|FG001|Part 2 Single-Blind|Adverse Event|0|||
33273198|NCT03541174|62645409|FG002|Part 2 Single-Blind|Adverse Event|0|||
33273199|NCT03541174|62645410|FG003|Part 2 Single-Blind|Adverse Event|25|||
33273200|NCT03541174|62645411|FG004|Part 2 Single-Blind|Adverse Event|0|||
33273201|NCT03541174|62645412|FG005|Part 2 Single-Blind|Adverse Event|0|||
33273202|NCT03541174|62645407|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
33273203|NCT03541174|62645408|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
33273204|NCT03541174|62645409|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
33273205|NCT03541174|62645410|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
33273206|NCT03541174|62645411|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
33273207|NCT03541174|62645412|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
33273208|NCT03541174|62645407|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
33273209|NCT03541174|62645408|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
33273210|NCT03541174|62645409|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
33273211|NCT03541174|62645410|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
33273212|NCT03541174|62645411|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
33273213|NCT03541174|62645412|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
33273214|NCT03541174|62645407|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
33273215|NCT03541174|62645408|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
33273216|NCT03541174|62645409|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
33273217|NCT03541174|62645410|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
33273218|NCT03541174|62645411|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
33273219|NCT03541174|62645412|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
33273220|NCT03541174|62645407|FG000|Part 2 Single-Blind|Death|0|||
33273221|NCT03541174|62645408|FG001|Part 2 Single-Blind|Death|0|||
33273222|NCT03541174|62645409|FG002|Part 2 Single-Blind|Death|0|||
33273223|NCT03541174|62645410|FG003|Part 2 Single-Blind|Death|5|||
33273224|NCT03541174|62645411|FG004|Part 2 Single-Blind|Death|0|||
33273225|NCT03541174|62645412|FG005|Part 2 Single-Blind|Death|0|||
33273226|NCT03541174|62645407|FG000|Part 2 Single-Blind|Pregnancy|0|||
33273227|NCT03541174|62645408|FG001|Part 2 Single-Blind|Pregnancy|0|||
33273228|NCT03541174|62645409|FG002|Part 2 Single-Blind|Pregnancy|0|||
33273229|NCT03541174|62645410|FG003|Part 2 Single-Blind|Pregnancy|1|||
33273230|NCT03541174|62645411|FG004|Part 2 Single-Blind|Pregnancy|0|||
33273231|NCT03541174|62645412|FG005|Part 2 Single-Blind|Pregnancy|0|||
33273232|NCT03541174|62645407|FG000|Part 2 Single-Blind|Other reasons|0|||
33273233|NCT03541174|62645408|FG001|Part 2 Single-Blind|Other reasons|0|||
33273234|NCT03541174|62645409|FG002|Part 2 Single-Blind|Other reasons|0|||
33273235|NCT03541174|62645410|FG003|Part 2 Single-Blind|Other reasons|32|||
33273236|NCT03541174|62645411|FG004|Part 2 Single-Blind|Other reasons|0|||
33273237|NCT03541174|62645412|FG005|Part 2 Single-Blind|Other reasons|0|||
33273238|NCT03541174|62645407|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
33273239|NCT03541174|62645408|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
33273240|NCT03541174|62645409|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
33273241|NCT03541174|62645410|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
33273242|NCT03541174|62645411|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
33273243|NCT03541174|62645412|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
33273244|NCT03541174|62645407|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
33273245|NCT03541174|62645408|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
33273246|NCT03541174|62645409|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
33273247|NCT03541174|62645410|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
33273248|NCT03541174|62645411|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
33273249|NCT03541174|62645412|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
33273250|NCT03541174|62645407|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
33273251|NCT03541174|62645408|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
33370169|NCT00592904|62748869|FG003|Overall Study|Protocol Violation|1|||
33370170|NCT00592904|62748866|FG000|Overall Study|Withdrawal by Subject|4|||
33273252|NCT03541174|62645409|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
33273253|NCT03541174|62645410|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
33273254|NCT03541174|62645411|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
33273255|NCT03541174|62645412|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
33273256|NCT03541174|62645407|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
33370171|NCT00592904|62748867|FG001|Overall Study|Withdrawal by Subject|16|||
33273257|NCT03541174|62645408|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
33273258|NCT03541174|62645409|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
33273259|NCT03541174|62645410|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
33273260|NCT03541174|62645411|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
33273261|NCT03541174|62645412|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
33273262|NCT03541174|62645407|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
33273263|NCT03541174|62645408|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
33273264|NCT03541174|62645409|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
33273265|NCT03541174|62645410|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
33273266|NCT03541174|62645411|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
33273267|NCT03541174|62645412|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
33273268|NCT03289039|62645444|FG000|Overall Study|Withdrawal by Subject|0|||
33273269|NCT03289039|62645445|FG001|Overall Study|Withdrawal by Subject|1|||
33273270|NCT03289039|62645444|FG000|Overall Study|Became ineligible prior to treatment start|0|||
33273271|NCT03289039|62645445|FG001|Overall Study|Became ineligible prior to treatment start|1|||
33273272|NCT03289039|62645444|FG000|Overall Study|progressed before treatment start|1|||
33273273|NCT03289039|62645445|FG001|Overall Study|progressed before treatment start|0|||
33273274|NCT03281304|62645453|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
33273275|NCT03281304|62645454|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
33273276|NCT03281304|62645453|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
33273277|NCT03281304|62645454|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
33273278|NCT03281304|62645453|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
33273279|NCT03281304|62645454|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
33273280|NCT03281304|62645453|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
33273281|NCT03281304|62645454|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
33273282|NCT03281304|62645453|FG000|Treatment Phase (up to 42 Months)|Death|0|||
33273283|NCT03281304|62645454|FG001|Treatment Phase (up to 42 Months)|Death|1|||
33273284|NCT03281304|62645453|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
33273285|NCT03281304|62645454|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
33273286|NCT03281304|62645453|FG000|Treatment Phase (up to 42 Months)|Other|0|||
33273287|NCT03281304|62645454|FG001|Treatment Phase (up to 42 Months)|Other|2|||
33273288|NCT03281304|62645453|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
33273289|NCT03281304|62645454|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
33273290|NCT03204305|62645463|FG000|Overall Study|Lost to Follow-up|6|||
33273291|NCT03204305|62645464|FG001|Overall Study|Lost to Follow-up|4|||
33273292|NCT03204305|62645465|FG002|Overall Study|Lost to Follow-up|0|||
33273293|NCT03204305|62645466|FG003|Overall Study|Lost to Follow-up|0|||
33273294|NCT03204305|62645463|FG000|Overall Study|Physician Decision|1|||
33273295|NCT03204305|62645464|FG001|Overall Study|Physician Decision|0|||
33273296|NCT03204305|62645465|FG002|Overall Study|Physician Decision|0|||
33273297|NCT03204305|62645466|FG003|Overall Study|Physician Decision|0|||
33273298|NCT03204305|62645463|FG000|Overall Study|failure to place arterial line|2|||
33273299|NCT03204305|62645464|FG001|Overall Study|failure to place arterial line|1|||
33273300|NCT03204305|62645465|FG002|Overall Study|failure to place arterial line|0|||
33273301|NCT03204305|62645466|FG003|Overall Study|failure to place arterial line|0|||
33273302|NCT03204305|62645463|FG000|Overall Study|Withdrawal by Subject|2|||
33273303|NCT03204305|62645464|FG001|Overall Study|Withdrawal by Subject|0|||
33273304|NCT03204305|62645465|FG002|Overall Study|Withdrawal by Subject|0|||
33273305|NCT03204305|62645466|FG003|Overall Study|Withdrawal by Subject|0|||
33273306|NCT03200717|62645478|FG000|Overall Study|Progressive disease|24|||
33273307|NCT03200717|62645479|FG001|Overall Study|Progressive disease|5|||
33273308|NCT03200717|62645478|FG000|Overall Study|Adverse Event|11|||
33273309|NCT03200717|62645479|FG001|Overall Study|Adverse Event|8|||
33273310|NCT03200717|62645478|FG000|Overall Study|Physician Decision|3|||
33273311|NCT03200717|62645479|FG001|Overall Study|Physician Decision|2|||
33273312|NCT03200717|62645478|FG000|Overall Study|Death|2|||
33273313|NCT03200717|62645479|FG001|Overall Study|Death|0|||
33273314|NCT03200717|62645478|FG000|Overall Study|Subject/Guardian Decision|1|||
33273315|NCT03200717|62645479|FG001|Overall Study|Subject/Guardian Decision|0|||
33273316|NCT03105700|62645488|FG000|Overall Study|screen fail|3|||
33273317|NCT03105700|62645488|FG000|Overall Study|Lost to Follow-up|4|||
33273318|NCT02738853|62645511|FG000|Enrollment|Inclusion/Exclusion not met|21|||
33273319|NCT02738853|62645511|FG000|Enrollment|Withdrawal by Subject|3|||
33273320|NCT02738853|62645511|FG000|Enrollment|Subject treated with commercially available device|6|||
33273321|NCT02738853|62645511|FG000|Enrollment|Study Enrollment Closed|3|||
33273322|NCT02738853|62645511|FG000|Procedure|Death|1|||
33273323|NCT02738853|62645511|FG000|1 Month|Death|2|||
33370172|NCT00592904|62748868|FG002|Overall Study|Withdrawal by Subject|1|||
33370173|NCT00592904|62748869|FG003|Overall Study|Withdrawal by Subject|2|||
33273324|NCT02738853|62645511|FG000|6 Month|Death|4|||
33273325|NCT02738853|62645511|FG000|6 Month|Withdrawal by Subject|2|||
33273326|NCT02738853|62645511|FG000|1 Year|Death|6|||
33370174|NCT00592904|62748866|FG000|Overall Study|Lack of Efficacy|2|||
33273327|NCT02738853|62645511|FG000|1 Year|Withdrawal by Subject|1|||
33273328|NCT02738853|62645511|FG000|2 Year|Death|2|||
33370175|NCT00592904|62748867|FG001|Overall Study|Lack of Efficacy|7|||
33273329|NCT02738853|62645511|FG000|2 Year|Lost to Follow-up|1|||
33273330|NCT02738853|62645511|FG000|3 Year|Death|2|||
33273331|NCT02738853|62645511|FG000|3 Year|Withdrawal by Subject|1|||
33273332|NCT02738853|62645511|FG000|4 Year|Death|9|||
33273333|NCT02738853|62645511|FG000|5 Year|Lost to Follow-up|4|||
33273334|NCT02358538|62645519|FG000|Through Week 26|Adverse Event|0|||
33273335|NCT02358538|62645520|FG001|Through Week 26|Adverse Event|1|||
33273336|NCT02358538|62645521|FG002|Through Week 26|Adverse Event|1|||
33273337|NCT02358538|62645522|FG003|Through Week 26|Adverse Event|2|||
33273338|NCT02358538|62645519|FG000|Through Week 26|Lack of Efficacy|1|||
33273339|NCT02358538|62645520|FG001|Through Week 26|Lack of Efficacy|1|||
33273340|NCT02358538|62645521|FG002|Through Week 26|Lack of Efficacy|3|||
33273341|NCT02358538|62645522|FG003|Through Week 26|Lack of Efficacy|3|||
33273342|NCT02358538|62645519|FG000|Through Week 26|Withdrawal by Subject|1|||
33273343|NCT02358538|62645520|FG001|Through Week 26|Withdrawal by Subject|0|||
33273344|NCT02358538|62645521|FG002|Through Week 26|Withdrawal by Subject|0|||
33273345|NCT02358538|62645522|FG003|Through Week 26|Withdrawal by Subject|0|||
33273346|NCT02358538|62645519|FG000|Through Week 26|Non-Compliance|0|||
33273347|NCT02358538|62645520|FG001|Through Week 26|Non-Compliance|0|||
33273348|NCT02358538|62645521|FG002|Through Week 26|Non-Compliance|1|||
33273349|NCT02358538|62645522|FG003|Through Week 26|Non-Compliance|0|||
33273350|NCT02358538|62645519|FG000|Through Week 26|Family did not see benefit from IP|1|||
33273351|NCT02358538|62645520|FG001|Through Week 26|Family did not see benefit from IP|0|||
33273352|NCT02358538|62645521|FG002|Through Week 26|Family did not see benefit from IP|0|||
33273353|NCT02358538|62645522|FG003|Through Week 26|Family did not see benefit from IP|0|||
33273354|NCT02358538|62645519|FG000|52 Week Extension Period|Lack of Efficacy|0|||
33273355|NCT02358538|62645520|FG001|52 Week Extension Period|Lack of Efficacy|0|||
33273356|NCT02358538|62645521|FG002|52 Week Extension Period|Lack of Efficacy|2|||
33273357|NCT02358538|62645522|FG003|52 Week Extension Period|Lack of Efficacy|4|||
33273358|NCT02056119|62645557|FG000|Overall Study|Death|1|||
33273359|NCT02056119|62645558|FG001|Overall Study|Death|2|||
33273360|NCT02056119|62645557|FG000|Overall Study|Intubated for less than 24 hrs|2|||
33273361|NCT02056119|62645558|FG001|Overall Study|Intubated for less than 24 hrs|7|||
33273362|NCT02056119|62645557|FG000|Overall Study|No aerosol treatments were given.|3|||
33273363|NCT02056119|62645558|FG001|Overall Study|No aerosol treatments were given.|2|||
33273364|NCT02056119|62645557|FG000|Overall Study|Received Metaneb treatment|0|||
33273365|NCT02056119|62645558|FG001|Overall Study|Received Metaneb treatment|2|||
33273366|NCT02056119|62645557|FG000|Overall Study|Protocol Violation|4|||
33273367|NCT02056119|62645558|FG001|Overall Study|Protocol Violation|7|||
33273368|NCT02038452|62645566|FG000|Overall Study|Withdrawal by Subject|7|||
33273369|NCT02038452|62645567|FG001|Overall Study|Withdrawal by Subject|9|||
33273370|NCT02038452|62645566|FG000|Overall Study|Lost to Follow-up|31|||
33273371|NCT02038452|62645567|FG001|Overall Study|Lost to Follow-up|28|||
33273372|NCT01238172|62645606|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
33273373|NCT01238172|62645607|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
33273374|NCT01238172|62645606|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
33273375|NCT01238172|62645607|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
33273376|NCT00967005|62645615|FG000|Overall Study|Lost to Follow-up|7|||
33273377|NCT00967005|62645616|FG001|Overall Study|Lost to Follow-up|10|||
33273378|NCT00203996|62645674|FG000|Overall Study|Lost to Follow-up|0|||
33273379|NCT00203996|62645675|FG001|Overall Study|Lost to Follow-up|0|||
33273380|NCT00203996|62645676|FG002|Overall Study|Lost to Follow-up|0|||
33273381|NCT00203996|62645677|FG003|Overall Study|Lost to Follow-up|1|||
33273382|NCT00203996|62645678|FG004|Overall Study|Lost to Follow-up|0|||
33273383|NCT00203996|62645679|FG005|Overall Study|Lost to Follow-up|0|||
33273384|NCT00203996|62645680|FG006|Overall Study|Lost to Follow-up|0|||
33273385|NCT00203996|62645681|FG007|Overall Study|Lost to Follow-up|0|||
33273386|NCT00203996|62645682|FG008|Overall Study|Lost to Follow-up|0|||
33273387|NCT00203996|62645683|FG009|Overall Study|Lost to Follow-up|0|||
33273388|NCT00203996|62645674|FG000|Overall Study|Protocol Violation|0|||
33273389|NCT00203996|62645675|FG001|Overall Study|Protocol Violation|0|||
33273390|NCT00203996|62645676|FG002|Overall Study|Protocol Violation|0|||
33273391|NCT00203996|62645677|FG003|Overall Study|Protocol Violation|6|||
33273392|NCT00203996|62645678|FG004|Overall Study|Protocol Violation|1|||
33273393|NCT00203996|62645679|FG005|Overall Study|Protocol Violation|0|||
33273394|NCT00203996|62645680|FG006|Overall Study|Protocol Violation|0|||
33273395|NCT00203996|62645681|FG007|Overall Study|Protocol Violation|0|||
33273396|NCT00203996|62645682|FG008|Overall Study|Protocol Violation|0|||
33273397|NCT00203996|62645683|FG009|Overall Study|Protocol Violation|0|||
33273398|NCT00203996|62645674|FG000|Overall Study|Physician Decision|0|||
33273399|NCT00203996|62645675|FG001|Overall Study|Physician Decision|0|||
33485627|NCT04346199|62863343|FG001|Overall Study|Death|9|||
33273400|NCT00203996|62645676|FG002|Overall Study|Physician Decision|0|||
33273401|NCT00203996|62645677|FG003|Overall Study|Physician Decision|2|||
33273402|NCT00203996|62645678|FG004|Overall Study|Physician Decision|0|||
33273403|NCT00203996|62645679|FG005|Overall Study|Physician Decision|0|||
33273404|NCT00203996|62645680|FG006|Overall Study|Physician Decision|0|||
33273405|NCT00203996|62645681|FG007|Overall Study|Physician Decision|0|||
33273406|NCT00203996|62645682|FG008|Overall Study|Physician Decision|0|||
33273407|NCT00203996|62645683|FG009|Overall Study|Physician Decision|1|||
33273408|NCT00203996|62645674|FG000|Overall Study|CPAP machine malfunction|0|||
33273409|NCT00203996|62645675|FG001|Overall Study|CPAP machine malfunction|0|||
33370176|NCT00592904|62748868|FG002|Overall Study|Lack of Efficacy|2|||
33273410|NCT00203996|62645676|FG002|Overall Study|CPAP machine malfunction|0|||
33273411|NCT00203996|62645677|FG003|Overall Study|CPAP machine malfunction|1|||
33273412|NCT00203996|62645678|FG004|Overall Study|CPAP machine malfunction|0|||
33273413|NCT00203996|62645679|FG005|Overall Study|CPAP machine malfunction|0|||
33273414|NCT00203996|62645680|FG006|Overall Study|CPAP machine malfunction|0|||
33273415|NCT00203996|62645681|FG007|Overall Study|CPAP machine malfunction|0|||
33273416|NCT00203996|62645682|FG008|Overall Study|CPAP machine malfunction|0|||
33273417|NCT00203996|62645683|FG009|Overall Study|CPAP machine malfunction|0|||
33273418|NCT00203996|62645674|FG000|Overall Study|Scheduling issue|0|||
33273419|NCT00203996|62645675|FG001|Overall Study|Scheduling issue|0|||
33273420|NCT00203996|62645676|FG002|Overall Study|Scheduling issue|0|||
33273421|NCT00203996|62645677|FG003|Overall Study|Scheduling issue|0|||
33273422|NCT00203996|62645678|FG004|Overall Study|Scheduling issue|0|||
33273423|NCT00203996|62645679|FG005|Overall Study|Scheduling issue|0|||
33273424|NCT00203996|62645680|FG006|Overall Study|Scheduling issue|0|||
33273425|NCT00203996|62645681|FG007|Overall Study|Scheduling issue|2|||
33273426|NCT00203996|62645682|FG008|Overall Study|Scheduling issue|0|||
33273427|NCT00203996|62645683|FG009|Overall Study|Scheduling issue|0|||
33273428|NCT02014558|62645712|FG000|Overall Study|Never Received Study Drug|0|||
33273429|NCT02014558|62645713|FG001|Overall Study|Never Received Study Drug|0|||
33273430|NCT02014558|62645714|FG002|Overall Study|Never Received Study Drug|0|||
33273431|NCT02014558|62645715|FG003|Overall Study|Never Received Study Drug|0|||
33273432|NCT02014558|62645716|FG004|Overall Study|Never Received Study Drug|1|||
33273433|NCT02014558|62645717|FG005|Overall Study|Never Received Study Drug|0|||
33273434|NCT02014558|62645718|FG006|Overall Study|Never Received Study Drug|1|||
33273435|NCT02014558|62645719|FG007|Overall Study|Never Received Study Drug|0|||
33273436|NCT02014558|62645720|FG008|Overall Study|Never Received Study Drug|2|||
33273437|NCT02014558|62645721|FG009|Overall Study|Never Received Study Drug|0|||
33273438|NCT02014558|62645722|FG010|Overall Study|Never Received Study Drug|2|||
33273439|NCT02014558|62645723|FG011|Overall Study|Never Received Study Drug|2|||
33273440|NCT02014558|62645724|FG012|Overall Study|Never Received Study Drug|0|||
33273441|NCT02014558|62645712|FG000|Overall Study|Adverse Event|0|||
33273442|NCT02014558|62645713|FG001|Overall Study|Adverse Event|0|||
33273443|NCT02014558|62645714|FG002|Overall Study|Adverse Event|0|||
33273444|NCT02014558|62645715|FG003|Overall Study|Adverse Event|0|||
33273445|NCT02014558|62645716|FG004|Overall Study|Adverse Event|1|||
33273446|NCT02014558|62645717|FG005|Overall Study|Adverse Event|0|||
33273447|NCT02014558|62645718|FG006|Overall Study|Adverse Event|0|||
33273448|NCT02014558|62645719|FG007|Overall Study|Adverse Event|0|||
33273449|NCT02014558|62645720|FG008|Overall Study|Adverse Event|2|||
33273450|NCT02014558|62645721|FG009|Overall Study|Adverse Event|2|||
33273451|NCT02014558|62645722|FG010|Overall Study|Adverse Event|5|||
33273452|NCT02014558|62645723|FG011|Overall Study|Adverse Event|21|||
33273453|NCT02014558|62645724|FG012|Overall Study|Adverse Event|3|||
33273454|NCT02014558|62645712|FG000|Overall Study|Death|1|||
33273455|NCT02014558|62645713|FG001|Overall Study|Death|0|||
33273456|NCT02014558|62645714|FG002|Overall Study|Death|0|||
33273457|NCT02014558|62645715|FG003|Overall Study|Death|0|||
33273458|NCT02014558|62645716|FG004|Overall Study|Death|0|||
33273459|NCT02014558|62645717|FG005|Overall Study|Death|0|||
33273460|NCT02014558|62645718|FG006|Overall Study|Death|1|||
33273461|NCT02014558|62645719|FG007|Overall Study|Death|1|||
33273462|NCT02014558|62645720|FG008|Overall Study|Death|2|||
33273463|NCT02014558|62645721|FG009|Overall Study|Death|5|||
33273464|NCT02014558|62645722|FG010|Overall Study|Death|5|||
33273465|NCT02014558|62645723|FG011|Overall Study|Death|19|||
33273466|NCT02014558|62645724|FG012|Overall Study|Death|2|||
33273467|NCT02014558|62645712|FG000|Overall Study|Lack of Efficacy|1|||
33273468|NCT02014558|62645713|FG001|Overall Study|Lack of Efficacy|2|||
33273469|NCT02014558|62645714|FG002|Overall Study|Lack of Efficacy|1|||
33273470|NCT02014558|62645715|FG003|Overall Study|Lack of Efficacy|1|||
33273471|NCT02014558|62645716|FG004|Overall Study|Lack of Efficacy|0|||
33273472|NCT02014558|62645717|FG005|Overall Study|Lack of Efficacy|0|||
33273473|NCT02014558|62645718|FG006|Overall Study|Lack of Efficacy|1|||
33273474|NCT02014558|62645719|FG007|Overall Study|Lack of Efficacy|3|||
33273475|NCT02014558|62645720|FG008|Overall Study|Lack of Efficacy|3|||
33273476|NCT02014558|62645721|FG009|Overall Study|Lack of Efficacy|3|||
33273477|NCT02014558|62645722|FG010|Overall Study|Lack of Efficacy|16|||
33273478|NCT02014558|62645723|FG011|Overall Study|Lack of Efficacy|8|||
33370177|NCT00592904|62748869|FG003|Overall Study|Lack of Efficacy|3|||
33370178|NCT00592904|62748866|FG000|Overall Study|Physician Decision|0|||
33273479|NCT02014558|62645724|FG012|Overall Study|Lack of Efficacy|5|||
33273480|NCT02014558|62645712|FG000|Overall Study|Lost to Follow-up|0|||
33273481|NCT02014558|62645713|FG001|Overall Study|Lost to Follow-up|0|||
33273482|NCT02014558|62645714|FG002|Overall Study|Lost to Follow-up|0|||
33273483|NCT02014558|62645715|FG003|Overall Study|Lost to Follow-up|0|||
33273484|NCT02014558|62645716|FG004|Overall Study|Lost to Follow-up|0|||
33273485|NCT02014558|62645717|FG005|Overall Study|Lost to Follow-up|0|||
33273486|NCT02014558|62645718|FG006|Overall Study|Lost to Follow-up|0|||
33273487|NCT02014558|62645719|FG007|Overall Study|Lost to Follow-up|0|||
33370179|NCT00592904|62748867|FG001|Overall Study|Physician Decision|3|||
33273488|NCT02014558|62645720|FG008|Overall Study|Lost to Follow-up|0|||
33273489|NCT02014558|62645721|FG009|Overall Study|Lost to Follow-up|0|||
33273490|NCT02014558|62645722|FG010|Overall Study|Lost to Follow-up|1|||
33273491|NCT02014558|62645723|FG011|Overall Study|Lost to Follow-up|0|||
33273492|NCT02014558|62645724|FG012|Overall Study|Lost to Follow-up|0|||
33273493|NCT02014558|62645712|FG000|Overall Study|Progressive Disease|1|||
33273494|NCT02014558|62645713|FG001|Overall Study|Progressive Disease|0|||
33273495|NCT02014558|62645714|FG002|Overall Study|Progressive Disease|1|||
33273496|NCT02014558|62645715|FG003|Overall Study|Progressive Disease|1|||
33273497|NCT02014558|62645716|FG004|Overall Study|Progressive Disease|1|||
33273498|NCT02014558|62645717|FG005|Overall Study|Progressive Disease|2|||
33273499|NCT02014558|62645718|FG006|Overall Study|Progressive Disease|1|||
33273500|NCT02014558|62645719|FG007|Overall Study|Progressive Disease|6|||
33273501|NCT02014558|62645720|FG008|Overall Study|Progressive Disease|5|||
33273502|NCT02014558|62645721|FG009|Overall Study|Progressive Disease|6|||
33273503|NCT02014558|62645722|FG010|Overall Study|Progressive Disease|22|||
33273504|NCT02014558|62645723|FG011|Overall Study|Progressive Disease|31|||
33273505|NCT02014558|62645724|FG012|Overall Study|Progressive Disease|6|||
33273506|NCT02014558|62645712|FG000|Overall Study|Withdrawal by Subject|0|||
33273507|NCT02014558|62645713|FG001|Overall Study|Withdrawal by Subject|0|||
33273508|NCT02014558|62645714|FG002|Overall Study|Withdrawal by Subject|0|||
33273509|NCT02014558|62645715|FG003|Overall Study|Withdrawal by Subject|0|||
33273510|NCT02014558|62645716|FG004|Overall Study|Withdrawal by Subject|1|||
33273511|NCT02014558|62645717|FG005|Overall Study|Withdrawal by Subject|0|||
33273512|NCT02014558|62645718|FG006|Overall Study|Withdrawal by Subject|0|||
33273513|NCT02014558|62645719|FG007|Overall Study|Withdrawal by Subject|0|||
33273514|NCT02014558|62645720|FG008|Overall Study|Withdrawal by Subject|0|||
33273515|NCT02014558|62645721|FG009|Overall Study|Withdrawal by Subject|2|||
33273516|NCT02014558|62645722|FG010|Overall Study|Withdrawal by Subject|6|||
33273517|NCT02014558|62645723|FG011|Overall Study|Withdrawal by Subject|10|||
33273518|NCT02014558|62645724|FG012|Overall Study|Withdrawal by Subject|0|||
33273519|NCT02014558|62645712|FG000|Overall Study|Miscellaneous|2|||
33273520|NCT02014558|62645713|FG001|Overall Study|Miscellaneous|1|||
33273521|NCT02014558|62645714|FG002|Overall Study|Miscellaneous|1|||
33273522|NCT02014558|62645715|FG003|Overall Study|Miscellaneous|1|||
33273523|NCT02014558|62645716|FG004|Overall Study|Miscellaneous|0|||
33273524|NCT02014558|62645717|FG005|Overall Study|Miscellaneous|1|||
33273525|NCT02014558|62645718|FG006|Overall Study|Miscellaneous|0|||
33273526|NCT02014558|62645719|FG007|Overall Study|Miscellaneous|1|||
33273527|NCT02014558|62645720|FG008|Overall Study|Miscellaneous|1|||
33273528|NCT02014558|62645721|FG009|Overall Study|Miscellaneous|3|||
33273529|NCT02014558|62645722|FG010|Overall Study|Miscellaneous|12|||
33273530|NCT02014558|62645723|FG011|Overall Study|Miscellaneous|11|||
33273531|NCT02014558|62645724|FG012|Overall Study|Miscellaneous|1|||
33273532|NCT02024555|62645779|FG000|Overall Study|Lost to Follow-up|1|||
33273533|NCT02024555|62645780|FG001|Overall Study|Lost to Follow-up|1|||
33273534|NCT02024555|62645779|FG000|Overall Study|Withdrawal by Subject|5|||
33273535|NCT02024555|62645780|FG001|Overall Study|Withdrawal by Subject|1|||
33273536|NCT02040584|62645788|FG000|Overall Study|Adverse Event|13|||
33273537|NCT02040584|62645789|FG001|Overall Study|Adverse Event|6|||
33273538|NCT02040584|62645788|FG000|Overall Study|Protocol Violation|9|||
33273539|NCT02040584|62645789|FG001|Overall Study|Protocol Violation|11|||
33273540|NCT02040584|62645788|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33273541|NCT02040584|62645789|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33273542|NCT02040584|62645788|FG000|Overall Study|Death|6|||
33273543|NCT02040584|62645789|FG001|Overall Study|Death|3|||
33273544|NCT02040584|62645788|FG000|Overall Study|Transplant rejection/retransplant|0|||
33273545|NCT02040584|62645789|FG001|Overall Study|Transplant rejection/retransplant|1|||
33273546|NCT02040584|62645788|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
33273547|NCT02040584|62645789|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
33273548|NCT02045797|62645808|FG000|Overall Study|Adverse Event|3|||
33273549|NCT02045797|62645809|FG001|Overall Study|Adverse Event|1|||
33273550|NCT02045797|62645810|FG002|Overall Study|Adverse Event|0|||
33273551|NCT02045797|62645808|FG000|Overall Study|Lack of Efficacy|1|||
33273552|NCT02045797|62645809|FG001|Overall Study|Lack of Efficacy|0|||
33273553|NCT02045797|62645810|FG002|Overall Study|Lack of Efficacy|0|||
33273554|NCT02045797|62645808|FG000|Overall Study|Lost to Follow-up|2|||
33273555|NCT02045797|62645809|FG001|Overall Study|Lost to Follow-up|3|||
33273556|NCT02045797|62645810|FG002|Overall Study|Lost to Follow-up|1|||
33273557|NCT02045797|62645808|FG000|Overall Study|Physician Decision|0|||
33273558|NCT02045797|62645809|FG001|Overall Study|Physician Decision|1|||
33273559|NCT02045797|62645810|FG002|Overall Study|Physician Decision|0|||
33273560|NCT02045797|62645808|FG000|Overall Study|Withdrawal by Subject|1|||
33273561|NCT02045797|62645809|FG001|Overall Study|Withdrawal by Subject|2|||
33273562|NCT02045797|62645810|FG002|Overall Study|Withdrawal by Subject|0|||
33273563|NCT03385239|62645840|FG000|Overall Study|Voluntary Withdrawal|2|||
33273564|NCT03385239|62645841|FG001|Overall Study|Voluntary Withdrawal|3|||
33273565|NCT03385239|62645842|FG002|Overall Study|Voluntary Withdrawal|2|||
33370180|NCT00592904|62748868|FG002|Overall Study|Physician Decision|1|||
33273566|NCT03385239|62645843|FG003|Overall Study|Voluntary Withdrawal|3|||
33273567|NCT03385239|62645844|FG004|Overall Study|Voluntary Withdrawal|0|||
33273568|NCT03385239|62645840|FG000|Overall Study|Adverse Event|0|||
33273569|NCT03385239|62645841|FG001|Overall Study|Adverse Event|0|||
33273570|NCT03385239|62645842|FG002|Overall Study|Adverse Event|1|||
33273571|NCT03385239|62645843|FG003|Overall Study|Adverse Event|0|||
33273572|NCT03385239|62645844|FG004|Overall Study|Adverse Event|0|||
33273573|NCT03385239|62645840|FG000|Overall Study|Other|0|||
33273574|NCT03385239|62645841|FG001|Overall Study|Other|0|||
33273575|NCT03385239|62645842|FG002|Overall Study|Other|0|||
33273576|NCT03385239|62645843|FG003|Overall Study|Other|1|||
33555710|NCT01369511|62948549|FG001|Overall Study|Entry criteria not met|0|||
33555711|NCT01369511|62948550|FG002|Overall Study|Entry criteria not met|0|||
33273577|NCT03385239|62645844|FG004|Overall Study|Other|0|||
33273578|NCT03020160|62645862|FG000|Overall Study|Withdrawal by Subject|1|||
33273579|NCT03020160|62645863|FG001|Overall Study|Withdrawal by Subject|0|||
33273580|NCT02593110|62645874|FG000|Overall Study|Withdrawal by Subject|0|||
33273581|NCT02593110|62645875|FG001|Overall Study|Withdrawal by Subject|3|||
33273582|NCT02593110|62645876|FG002|Overall Study|Withdrawal by Subject|3|||
33273583|NCT02593110|62645877|FG003|Overall Study|Withdrawal by Subject|2|||
33273584|NCT02593110|62645874|FG000|Overall Study|Death|0|||
33273585|NCT02593110|62645875|FG001|Overall Study|Death|0|||
33273586|NCT02593110|62645876|FG002|Overall Study|Death|1|||
33273587|NCT02593110|62645877|FG003|Overall Study|Death|0|||
33273588|NCT02373813|62645890|FG000|Run-In Period|Other, Not Specified|5|||
33273589|NCT02373813|62645891|FG001|Run-In Period|Other, Not Specified|0|||
33273590|NCT02373813|62645892|FG002|Run-In Period|Other, Not Specified|0|||
33273591|NCT02373813|62645893|FG003|Run-In Period|Other, Not Specified|0|||
33273592|NCT02373813|62645890|FG000|Run-In Period|Withdrawal by Subject|16|||
33273593|NCT02373813|62645891|FG001|Run-In Period|Withdrawal by Subject|0|||
33273594|NCT02373813|62645892|FG002|Run-In Period|Withdrawal by Subject|0|||
33273595|NCT02373813|62645893|FG003|Run-In Period|Withdrawal by Subject|0|||
33273596|NCT02373813|62645890|FG000|Run-In Period|Decision by Sponsor|11|||
33273597|NCT02373813|62645891|FG001|Run-In Period|Decision by Sponsor|0|||
33273598|NCT02373813|62645892|FG002|Run-In Period|Decision by Sponsor|0|||
33273599|NCT02373813|62645893|FG003|Run-In Period|Decision by Sponsor|0|||
33273600|NCT02373813|62645890|FG000|Run-In Period|Protocol Violation|75|||
33273601|NCT02373813|62645891|FG001|Run-In Period|Protocol Violation|0|||
33273602|NCT02373813|62645892|FG002|Run-In Period|Protocol Violation|0|||
33273603|NCT02373813|62645893|FG003|Run-In Period|Protocol Violation|0|||
33273604|NCT02373813|62645890|FG000|Run-In Period|Lost to Follow-up|2|||
33273605|NCT02373813|62645891|FG001|Run-In Period|Lost to Follow-up|0|||
33273606|NCT02373813|62645892|FG002|Run-In Period|Lost to Follow-up|0|||
33273607|NCT02373813|62645893|FG003|Run-In Period|Lost to Follow-up|0|||
33273608|NCT02373813|62645890|FG000|Run-In Period|Adverse Event|3|||
33273609|NCT02373813|62645891|FG001|Run-In Period|Adverse Event|0|||
33273610|NCT02373813|62645892|FG002|Run-In Period|Adverse Event|0|||
33273611|NCT02373813|62645893|FG003|Run-In Period|Adverse Event|0|||
33273612|NCT02373813|62645890|FG000|Run-In Period|Noncompliance|1|||
33273613|NCT02373813|62645891|FG001|Run-In Period|Noncompliance|0|||
33273614|NCT02373813|62645892|FG002|Run-In Period|Noncompliance|0|||
33273615|NCT02373813|62645893|FG003|Run-In Period|Noncompliance|0|||
33273616|NCT02373813|62645890|FG000|Run-In Period|Ineligibility Determined|3|||
33485628|NCT04346199|62863342|FG000|Overall Study|Lost to Follow-up|0|||
33485629|NCT04346199|62863343|FG001|Overall Study|Lost to Follow-up|1|||
33485630|NCT04346199|62863342|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
33485631|NCT04346199|62863343|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
33485632|NCT04346199|62863342|FG000|Overall Study|Withdrawal by Subject|5|||
33485633|NCT04346199|62863343|FG001|Overall Study|Withdrawal by Subject|1|||
33485634|NCT04345653|62863349|FG000|Overall Study|Withdrawal by Subject|2|||
33485635|NCT04342689|62863356|FG000|Overall Study|Withdrawal by Subject|32|||
33485636|NCT04342689|62863357|FG001|Overall Study|Withdrawal by Subject|33|||
33555712|NCT01369511|62948551|FG003|Overall Study|Entry criteria not met|1|||
33273617|NCT02373813|62645891|FG001|Run-In Period|Ineligibility Determined|0|||
33273618|NCT02373813|62645892|FG002|Run-In Period|Ineligibility Determined|0|||
33273619|NCT02373813|62645893|FG003|Run-In Period|Ineligibility Determined|0|||
33273620|NCT02373813|62645890|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
33273621|NCT02373813|62645891|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
33555713|NCT01369511|62948548|FG000|Overall Study|Lost to Follow-up|0|||
33555714|NCT01369511|62948549|FG001|Overall Study|Lost to Follow-up|1|||
33273622|NCT02373813|62645892|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
33273623|NCT02373813|62645893|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
33273624|NCT02373813|62645890|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
33370181|NCT00592904|62748869|FG003|Overall Study|Physician Decision|0|||
33273625|NCT02373813|62645891|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
33273626|NCT02373813|62645892|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
33273627|NCT02373813|62645893|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
33273628|NCT02373813|62645890|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33273629|NCT02373813|62645891|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
33370182|NCT00592904|62748866|FG000|Overall Study|Other|3|||
33370183|NCT00592904|62748867|FG001|Overall Study|Other|3|||
33370184|NCT00592904|62748868|FG002|Overall Study|Other|0|||
33370185|NCT00592904|62748869|FG003|Overall Study|Other|0|||
33370186|NCT00855920|62748882|FG000|Overall Study|Protocol Violation|0|||
33370187|NCT00855920|62748883|FG001|Overall Study|Protocol Violation|0|||
33370188|NCT00855920|62748884|FG002|Overall Study|Protocol Violation|2|||
33370189|NCT00855920|62748882|FG000|Overall Study|Adverse Event|2|||
33370190|NCT00855920|62748883|FG001|Overall Study|Adverse Event|1|||
33370191|NCT00855920|62748884|FG002|Overall Study|Adverse Event|1|||
33370192|NCT00855920|62748882|FG000|Overall Study|Lack of Efficacy|2|||
33370193|NCT00855920|62748883|FG001|Overall Study|Lack of Efficacy|2|||
33370194|NCT00855920|62748884|FG002|Overall Study|Lack of Efficacy|2|||
33370195|NCT00855920|62748882|FG000|Overall Study|Withdrawal by Subject|2|||
33370196|NCT00855920|62748883|FG001|Overall Study|Withdrawal by Subject|3|||
33370197|NCT00855920|62748884|FG002|Overall Study|Withdrawal by Subject|2|||
33370198|NCT00855920|62748882|FG000|Overall Study|Lost to Follow-up|1|||
33370199|NCT00855920|62748883|FG001|Overall Study|Lost to Follow-up|0|||
33370200|NCT00855920|62748884|FG002|Overall Study|Lost to Follow-up|2|||
33370201|NCT00855920|62748882|FG000|Overall Study|Death|0|||
33370202|NCT00855920|62748883|FG001|Overall Study|Death|1|||
33370203|NCT00855920|62748884|FG002|Overall Study|Death|0|||
33370204|NCT00855920|62748882|FG000|Overall Study|Decision by the sponsor|0|||
33370205|NCT00855920|62748883|FG001|Overall Study|Decision by the sponsor|1|||
33370206|NCT00855920|62748884|FG002|Overall Study|Decision by the sponsor|1|||
33370207|NCT00855920|62748882|FG000|Overall Study|Other than specified above|1|||
33370208|NCT00855920|62748883|FG001|Overall Study|Other than specified above|1|||
33370209|NCT00855920|62748884|FG002|Overall Study|Other than specified above|1|||
33370210|NCT00848042|62748895|FG000|Overall Study|Death|1|||
33370211|NCT00848042|62748896|FG001|Overall Study|Death|2|||
33370212|NCT00848042|62748897|FG002|Overall Study|Death|0|||
33370213|NCT00848042|62748895|FG000|Overall Study|Other Therapy|3|||
33370214|NCT00848042|62748896|FG001|Overall Study|Other Therapy|0|||
33370215|NCT00848042|62748897|FG002|Overall Study|Other Therapy|0|||
33370216|NCT00847886|62748907|FG000|Overall Study|Adverse Event|0|||
33370217|NCT00847886|62748908|FG001|Overall Study|Adverse Event|1|||
33370218|NCT00847808|62748914|FG000|Overall Study|Adverse Event|7|||
33370219|NCT00847808|62748914|FG000|Overall Study|Protocol Violation|1|||
33370220|NCT00847808|62748914|FG000|Overall Study|Lost to Follow-up|1|||
33370221|NCT00847808|62748914|FG000|Overall Study|Withdrawal by Subject|4|||
33370222|NCT00847808|62748914|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
33370223|NCT00847808|62748914|FG000|Overall Study|Participant Took Excluded Medication|1|||
33370224|NCT00600353|62748920|FG000|Overall Study|history of malignancy within 5 years|1|||
33370225|NCT00600353|62748921|FG001|Overall Study|history of malignancy within 5 years|0|||
33370226|NCT00600353|62748920|FG000|Overall Study|History of prepartive regimen|0|||
33370227|NCT00600353|62748921|FG001|Overall Study|History of prepartive regimen|1|||
33370228|NCT00691210|62748935|FG000|Overall Study|Progression of Disease|0|||
33370229|NCT00691210|62748936|FG001|Overall Study|Progression of Disease|0|||
33370230|NCT00691210|62748937|FG002|Overall Study|Progression of Disease|0|||
33370231|NCT00691210|62748938|FG003|Overall Study|Progression of Disease|2|||
33370232|NCT00691210|62748939|FG004|Overall Study|Progression of Disease|0|||
33370233|NCT00691210|62748940|FG005|Overall Study|Progression of Disease|0|||
33370234|NCT00691210|62748941|FG006|Overall Study|Progression of Disease|0|||
33370235|NCT00691210|62748942|FG007|Overall Study|Progression of Disease|0|||
33370236|NCT00691210|62748935|FG000|Overall Study|Lack of Efficacy|0|||
33370237|NCT00691210|62748936|FG001|Overall Study|Lack of Efficacy|0|||
33370238|NCT00691210|62748937|FG002|Overall Study|Lack of Efficacy|0|||
33370239|NCT00691210|62748938|FG003|Overall Study|Lack of Efficacy|1|||
33370240|NCT00691210|62748939|FG004|Overall Study|Lack of Efficacy|0|||
33370241|NCT00691210|62748940|FG005|Overall Study|Lack of Efficacy|1|||
33662051|NCT02546986|63092798|FG001|Treatment Period|Death|4|||
33662052|NCT02546986|63092797|FG000|Treatment Period|Physician Decision|1|||
33273630|NCT02373813|62645892|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
33370242|NCT00691210|62748941|FG006|Overall Study|Lack of Efficacy|0|||
33370243|NCT00691210|62748942|FG007|Overall Study|Lack of Efficacy|0|||
33370244|NCT00691132|62748962|FG000|Overall Study|Adverse Event|2|||
33370245|NCT00691132|62748963|FG001|Overall Study|Adverse Event|3|||
33370246|NCT00691132|62748962|FG000|Overall Study|Withdrawal by Subject|10|||
33370247|NCT00691132|62748963|FG001|Overall Study|Withdrawal by Subject|10|||
33370248|NCT00855218|62748985|FG000|Overall Study|Adverse Event|43|||
33370249|NCT00855218|62748986|FG001|Overall Study|Adverse Event|27|||
33370250|NCT00855218|62748985|FG000|Overall Study|Withdrawal by Subject|10|||
33370251|NCT00855218|62748986|FG001|Overall Study|Withdrawal by Subject|6|||
33370252|NCT00855218|62748985|FG000|Overall Study|Physician Decision|18|||
33370253|NCT00855218|62748986|FG001|Overall Study|Physician Decision|11|||
33370254|NCT00855218|62748985|FG000|Overall Study|Lost to Follow-up|0|||
33273631|NCT02373813|62645893|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
33273632|NCT02373813|62645890|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33273633|NCT02373813|62645891|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
33273634|NCT02373813|62645892|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
33273635|NCT02373813|62645893|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
33273636|NCT01853748|62645910|FG000|Allocation|Withdrawal by Subject|1|||
33273637|NCT01853748|62645911|FG001|Allocation|Withdrawal by Subject|13|||
33273638|NCT01853748|62645910|FG000|Allocation|not sufficient to receive intervention|0|||
33273639|NCT01853748|62645911|FG001|Allocation|not sufficient to receive intervention|1|||
33273640|NCT01853748|62645910|FG000|Follow-Up|Withdrawal by Subject|7|||
33273641|NCT01853748|62645911|FG001|Follow-Up|Withdrawal by Subject|6|||
33273642|NCT01853748|62645910|FG000|Follow-Up|Adverse Event|67|||
33273643|NCT01853748|62645911|FG001|Follow-Up|Adverse Event|7|||
33273644|NCT01853748|62645910|FG000|Follow-Up|not available for data collection|16|||
33273645|NCT01853748|62645911|FG001|Follow-Up|not available for data collection|4|||
33273646|NCT03863509|62645946|FG000|Overall Study|COVID-19 shutdown period|0|||
33273647|NCT03863509|62645947|FG001|Overall Study|COVID-19 shutdown period|4|||
33273648|NCT03863509|62645948|FG002|Overall Study|COVID-19 shutdown period|0|||
33273649|NCT03863509|62645946|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
33273650|NCT03863509|62645947|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
33273651|NCT03863509|62645948|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
33273652|NCT03863509|62645946|FG000|Overall Study|Lost to Follow-up|8|||
33273653|NCT03863509|62645947|FG001|Overall Study|Lost to Follow-up|0|||
33273654|NCT03863509|62645948|FG002|Overall Study|Lost to Follow-up|2|||
33273655|NCT03863509|62645946|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
33273656|NCT03863509|62645947|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
33273657|NCT03863509|62645948|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
33273658|NCT03863509|62645946|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
33273659|NCT03863509|62645947|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
33273660|NCT03863509|62645948|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
33273661|NCT03116347|62645977|FG000|Overall Study|Withdrawal by Subject|1|||
33273662|NCT03116347|62645978|FG001|Overall Study|Withdrawal by Subject|2|||
33273663|NCT00001213|62646024|FG000|Overall Study|Death|18|||
33273664|NCT00000135|62646030|FG000|Overall Study|Death|27|||
33273665|NCT00000135|62646031|FG001|Overall Study|Death|14|||
33273666|NCT00001723|62646039|FG000|Overall Study|Lack of Efficacy|6|||
33273667|NCT00001723|62646040|FG001|Overall Study|Lack of Efficacy|7|||
33273668|NCT00001723|62646039|FG000|Overall Study|Lack of family interest|4|||
33273669|NCT00001723|62646040|FG001|Overall Study|Lack of family interest|5|||
33273670|NCT00001723|62646039|FG000|Overall Study|Lost to Follow-up|2|||
33273671|NCT00001723|62646040|FG001|Overall Study|Lost to Follow-up|2|||
33273672|NCT00001723|62646039|FG000|Overall Study|medication intolerance|1|||
33273673|NCT00001723|62646040|FG001|Overall Study|medication intolerance|2|||
33273674|NCT00000378|62646062|FG000|Overall Study|Lack of Efficacy|16|||
33273675|NCT00000378|62646063|FG001|Overall Study|Lack of Efficacy|14|||
33273676|NCT01350115|62646071|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
33273677|NCT01350115|62646072|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
33273678|NCT01350115|62646071|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
33273679|NCT01350115|62646072|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
33273680|NCT01350115|62646071|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
33273681|NCT01350115|62646072|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
33273682|NCT04142983|62646080|FG000|Overall Study|Lost to Follow-up|73|||
33273683|NCT04142983|62646080|FG000|Overall Study|Withdrawal by Subject|10|||
33273684|NCT04142983|62646080|FG000|Overall Study|Physician Decision|1|||
33273685|NCT04142983|62646080|FG000|Overall Study|Adverse Event|1|||
33273686|NCT04142983|62646080|FG000|Overall Study|No longer eligible|4|||
33273687|NCT04142983|62646080|FG000|Overall Study|Screen Failure|10|||
33273688|NCT03801031|62646087|FG000|Overall Study|Lost to Follow-up|1|||
33273689|NCT03801031|62646088|FG001|Overall Study|Lost to Follow-up|0|||
33273690|NCT03801031|62646087|FG000|Overall Study|Unable to comply|1|||
33273691|NCT03801031|62646088|FG001|Overall Study|Unable to comply|0|||
33370255|NCT00855218|62748986|FG001|Overall Study|Lost to Follow-up|1|||
33370256|NCT00855218|62748985|FG000|Overall Study|Protocol Violation|5|||
33273692|NCT03801031|62646087|FG000|Overall Study|Withdrawal by Subject|0|||
33273693|NCT03801031|62646088|FG001|Overall Study|Withdrawal by Subject|1|||
33273694|NCT03357952|62646096|FG000|Overall Study|Withdrawal by Subject|0|||
33273695|NCT03357952|62646097|FG001|Overall Study|Withdrawal by Subject|1|||
33370257|NCT00855218|62748986|FG001|Overall Study|Protocol Violation|9|||
33273696|NCT03357952|62646096|FG000|Overall Study|Sponsor Decision|9|||
33273697|NCT03357952|62646097|FG001|Overall Study|Sponsor Decision|0|||
33273698|NCT03055858|62646103|FG000|Overall Study|Death|9|||
33273699|NCT03055858|62646103|FG000|Overall Study|Withdrawal by Subject|11|||
33485637|NCT04342689|62863356|FG000|Overall Study|Lost to Follow-up|10|||
33273700|NCT03055858|62646103|FG000|Overall Study|Lost to Follow-up|6|||
33273701|NCT03055858|62646103|FG000|Overall Study|Missed Follow-Up Visits|18|||
33273702|NCT02393716|62646128|FG000|Overall Study|Death|29|||
33273703|NCT02393716|62646128|FG000|Overall Study|Withdrawal by Subject|8|||
33273704|NCT02393716|62646128|FG000|Overall Study|Device Explanted|8|||
33273705|NCT02393716|62646128|FG000|Overall Study|Missed visit|16|||
33273706|NCT01804816|62646133|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
33273707|NCT01804816|62646133|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
33273708|NCT00584233|62646140|FG000|Overall Study|Withdrawal by Subject|5|||
33273709|NCT00584233|62646140|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
33273710|NCT00001566|62646152|FG000|Overall Study|patients' choice to discontinue protocol|3|||
33273711|NCT00001566|62646152|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
33273712|NCT00001566|62646152|FG000|Overall Study|Death|13|||
33273713|NCT00001566|62646152|FG000|Overall Study|Lost to Follow-up|1|||
33273714|NCT00001566|62646152|FG000|Overall Study|unable to complete initial apheresis|1|||
33273715|NCT00001575|62646156|FG000|Overall Study|Screening failures-Ph I portion|22|||
33273716|NCT00001575|62646156|FG000|Overall Study|Withdrawn/deaths|23|||
33273717|NCT00001596|62646162|FG000|Overall Study|Death|1|||
33273718|NCT00001596|62646163|FG001|Overall Study|Death|0|||
33273719|NCT00001596|62646162|FG000|Overall Study|Withdrawal by Subject|3|||
33273720|NCT00001596|62646163|FG001|Overall Study|Withdrawal by Subject|1|||
33273721|NCT00001596|62646162|FG000|Overall Study|Study Termination|12|||
33273722|NCT00001596|62646163|FG001|Overall Study|Study Termination|9|||
33273723|NCT00001596|62646162|FG000|Overall Study|Adverse Event|1|||
33273724|NCT00001596|62646163|FG001|Overall Study|Adverse Event|0|||
33273725|NCT01349803|62646200|FG000|Overall Study|Adverse Event|0|||
33273726|NCT01349803|62646201|FG001|Overall Study|Adverse Event|0|||
33273727|NCT01349803|62646202|FG002|Overall Study|Adverse Event|0|||
33273728|NCT01349803|62646203|FG003|Overall Study|Adverse Event|2|||
33273729|NCT01349803|62646200|FG000|Overall Study|Withdrawal by Subject|1|||
33273730|NCT01349803|62646201|FG001|Overall Study|Withdrawal by Subject|0|||
33273731|NCT01349803|62646202|FG002|Overall Study|Withdrawal by Subject|0|||
33273732|NCT01349803|62646203|FG003|Overall Study|Withdrawal by Subject|0|||
33273733|NCT01349803|62646200|FG000|Overall Study|Protocol-specified criteria|0|||
33273734|NCT01349803|62646201|FG001|Overall Study|Protocol-specified criteria|1|||
33273735|NCT01349803|62646202|FG002|Overall Study|Protocol-specified criteria|3|||
33273736|NCT01349803|62646203|FG003|Overall Study|Protocol-specified criteria|0|||
33273737|NCT04059146|62646345|FG000|Overall Study|Withdrawal by Subject|0|||
33273738|NCT04059146|62646346|FG001|Overall Study|Withdrawal by Subject|1|||
33273739|NCT03969641|62646367|FG000|Overall Study|Lost to Follow-up|5|||
33273740|NCT03969641|62646368|FG001|Overall Study|Lost to Follow-up|3|||
33273741|NCT03969641|62646367|FG000|Overall Study|Withdrawal by Subject|1|||
33273742|NCT03969641|62646368|FG001|Overall Study|Withdrawal by Subject|2|||
33273743|NCT03969641|62646367|FG000|Overall Study|Found to be ineligible|1|||
33273744|NCT03969641|62646368|FG001|Overall Study|Found to be ineligible|1|||
33273745|NCT03969641|62646367|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
33273746|NCT03969641|62646368|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
33273747|NCT03969641|62646367|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
33273748|NCT03969641|62646368|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
33273749|NCT03969641|62646367|FG000|Overall Study|Elective termination|0|||
33273750|NCT03969641|62646368|FG001|Overall Study|Elective termination|1|||
33273751|NCT03721172|62646418|FG000|Placebo-controlled Phase|Adverse Event|7|||
33273752|NCT03721172|62646419|FG001|Placebo-controlled Phase|Adverse Event|7|||
33273753|NCT03721172|62646420|FG002|Placebo-controlled Phase|Adverse Event|0|||
33273754|NCT03721172|62646418|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
33273755|NCT03721172|62646419|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
33273756|NCT03721172|62646420|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
33273757|NCT03721172|62646418|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
33273758|NCT03721172|62646419|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
33273759|NCT03721172|62646420|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
33273760|NCT03721172|62646418|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
33273761|NCT03721172|62646419|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
33273762|NCT03721172|62646420|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
33273763|NCT03721172|62646418|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
33273764|NCT03721172|62646419|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
33273765|NCT03721172|62646420|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
33273766|NCT03721172|62646418|FG000|Placebo-controlled Phase|Other|3|||
33273767|NCT03721172|62646419|FG001|Placebo-controlled Phase|Other|0|||
33273768|NCT03721172|62646420|FG002|Placebo-controlled Phase|Other|0|||
33273769|NCT03721172|62646418|FG000|Apremilast Extension Phase|Adverse Event|0|||
33273770|NCT03721172|62646419|FG001|Apremilast Extension Phase|Adverse Event|0|||
33273771|NCT03721172|62646420|FG002|Apremilast Extension Phase|Adverse Event|10|||
33273772|NCT03721172|62646418|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
33273773|NCT03721172|62646419|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
33273774|NCT03721172|62646420|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
33273775|NCT03721172|62646418|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
33273776|NCT03721172|62646419|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
33273777|NCT03721172|62646420|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
33273778|NCT03721172|62646418|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
33273779|NCT03721172|62646419|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
33273780|NCT03721172|62646420|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
33273781|NCT03721172|62646418|FG000|Apremilast Extension Phase|Protocol Violation|0|||
33273782|NCT03721172|62646419|FG001|Apremilast Extension Phase|Protocol Violation|0|||
33273783|NCT03721172|62646420|FG002|Apremilast Extension Phase|Protocol Violation|1|||
33273784|NCT03721172|62646418|FG000|Apremilast Extension Phase|Physician Decision|0|||
33273785|NCT03721172|62646419|FG001|Apremilast Extension Phase|Physician Decision|0|||
33273786|NCT03721172|62646420|FG002|Apremilast Extension Phase|Physician Decision|1|||
33273787|NCT03721172|62646418|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
33273788|NCT03721172|62646419|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
33273789|NCT03721172|62646420|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
33273790|NCT03721172|62646418|FG000|Apremilast Extension Phase|Other|0|||
33273791|NCT03721172|62646419|FG001|Apremilast Extension Phase|Other|0|||
33273792|NCT03721172|62646420|FG002|Apremilast Extension Phase|Other|3|||
33273793|NCT03721172|62646418|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
33273794|NCT03721172|62646419|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
33273795|NCT03721172|62646420|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
33273796|NCT04540887|62646476|FG000|Overall Study|Withdrawal by Subject|2|||
33273797|NCT04294680|62646487|FG000|Overall Study|Withdrawal by Subject|2|||
33273798|NCT04294680|62646488|FG001|Overall Study|Withdrawal by Subject|1|||
33273799|NCT04294680|62646487|FG000|Overall Study|Follow-up visits completed outside of window|1|||
33273800|NCT04294680|62646488|FG001|Overall Study|Follow-up visits completed outside of window|0|||
33273801|NCT01350102|62646498|FG000|Overall Study|Adverse Event|0|||
33273802|NCT01350102|62646499|FG001|Overall Study|Adverse Event|0|||
33273803|NCT01350102|62646500|FG002|Overall Study|Adverse Event|1|||
33273804|NCT01350102|62646501|FG003|Overall Study|Adverse Event|0|||
33273805|NCT04059549|62646515|FG000|Overall Study|Withdrawal by Subject|2|||
33273806|NCT04059549|62646516|FG001|Overall Study|Withdrawal by Subject|0|||
33273807|NCT04041570|62646528|FG000|Overall Study|Moved from Area|0|||
33273808|NCT04041570|62646529|FG001|Overall Study|Moved from Area|2|||
33273809|NCT03879408|62646541|FG000|Overall Study|Lost to Follow-up|0|||
33273810|NCT03879408|62646542|FG001|Overall Study|Lost to Follow-up|3|||
33273811|NCT03879408|62646543|FG002|Overall Study|Lost to Follow-up|2|||
33273812|NCT03879408|62646544|FG003|Overall Study|Lost to Follow-up|1|||
33273813|NCT03879408|62646545|FG004|Overall Study|Lost to Follow-up|0|||
33273814|NCT03879408|62646541|FG000|Overall Study|Withdrawal by Subject|2|||
33273815|NCT03879408|62646542|FG001|Overall Study|Withdrawal by Subject|1|||
33273816|NCT03879408|62646543|FG002|Overall Study|Withdrawal by Subject|1|||
33273817|NCT03879408|62646544|FG003|Overall Study|Withdrawal by Subject|0|||
33273818|NCT03879408|62646545|FG004|Overall Study|Withdrawal by Subject|1|||
33370258|NCT00855218|62748985|FG000|Overall Study|non-compliant with study drug|3|||
33370259|NCT00855218|62748986|FG001|Overall Study|non-compliant with study drug|1|||
33370260|NCT00855218|62748985|FG000|Overall Study|patient convenience|2|||
33370261|NCT00855218|62748986|FG001|Overall Study|patient convenience|0|||
33370262|NCT00855218|62748985|FG000|Overall Study|technical problems|2|||
33370263|NCT00855218|62748986|FG001|Overall Study|technical problems|1|||
33370264|NCT00855218|62748985|FG000|Overall Study|Still treated with study medication|0|||
33370265|NCT00855218|62748986|FG001|Overall Study|Still treated with study medication|1|||
33370266|NCT00855218|62748985|FG000|Overall Study|Untreatable disease progression|54|||
33370267|NCT00855218|62748986|FG001|Overall Study|Untreatable disease progression|67|||
33485638|NCT04342689|62863357|FG001|Overall Study|Lost to Follow-up|12|||
33273819|NCT00819780|62646569|FG000|Overall Study|Did not receive study drug|3|||
33273820|NCT00819780|62646570|FG001|Overall Study|Did not receive study drug|4|||
33273821|NCT00819780|62646569|FG000|Overall Study|Still in treatment|25|||
33273822|NCT00819780|62646570|FG001|Overall Study|Still in treatment|17|||
33273823|NCT00000620|62646709|FG000|Overall Study|Death|86|||
33273824|NCT00000620|62646710|FG001|Overall Study|Death|67|||
33273825|NCT00000620|62646711|FG002|Overall Study|Death|112|||
33485639|NCT04169061|62863365|FG000|Overall Study|Adverse Event|2|||
33273826|NCT00000620|62646712|FG003|Overall Study|Death|126|||
33273827|NCT00000620|62646713|FG004|Overall Study|Death|64|||
33273828|NCT00000620|62646714|FG005|Overall Study|Death|77|||
33273829|NCT00000620|62646715|FG006|Overall Study|Death|91|||
33273830|NCT00000620|62646716|FG007|Overall Study|Death|95|||
33273831|NCT00000620|62646709|FG000|Overall Study|Lost to Follow-up|14|||
33370268|NCT00855218|62748985|FG000|Overall Study|Second malignancy|0|||
33370269|NCT00855218|62748986|FG001|Overall Study|Second malignancy|1|||
33370270|NCT00855218|62748985|FG000|Overall Study|Progression measurement proven|7|||
33485640|NCT04169061|62863365|FG000|Overall Study|Death|1|||
33555715|NCT01369511|62948550|FG002|Overall Study|Lost to Follow-up|1|||
33273832|NCT00000620|62646710|FG001|Overall Study|Lost to Follow-up|14|||
33273833|NCT00000620|62646711|FG002|Overall Study|Lost to Follow-up|14|||
33273834|NCT00000620|62646712|FG003|Overall Study|Lost to Follow-up|14|||
33273835|NCT00000620|62646713|FG004|Overall Study|Lost to Follow-up|15|||
33273836|NCT00000620|62646714|FG005|Overall Study|Lost to Follow-up|15|||
33273837|NCT00000620|62646715|FG006|Overall Study|Lost to Follow-up|13|||
33273838|NCT00000620|62646716|FG007|Overall Study|Lost to Follow-up|14|||
33273839|NCT00000620|62646709|FG000|Overall Study|Withdrawal by Subject|40|||
33273840|NCT00000620|62646710|FG001|Overall Study|Withdrawal by Subject|27|||
33273841|NCT00000620|62646711|FG002|Overall Study|Withdrawal by Subject|28|||
33273842|NCT00000620|62646712|FG003|Overall Study|Withdrawal by Subject|27|||
33273843|NCT00000620|62646713|FG004|Overall Study|Withdrawal by Subject|30|||
33273844|NCT00000620|62646714|FG005|Overall Study|Withdrawal by Subject|32|||
33273845|NCT00000620|62646715|FG006|Overall Study|Withdrawal by Subject|32|||
33273846|NCT00000620|62646716|FG007|Overall Study|Withdrawal by Subject|21|||
33273847|NCT00000620|62646709|FG000|Overall Study|missed closeout visit|22|||
33273848|NCT00000620|62646710|FG001|Overall Study|missed closeout visit|28|||
33273849|NCT00000620|62646711|FG002|Overall Study|missed closeout visit|16|||
33273850|NCT00000620|62646712|FG003|Overall Study|missed closeout visit|11|||
33273851|NCT00000620|62646713|FG004|Overall Study|missed closeout visit|26|||
33273852|NCT00000620|62646714|FG005|Overall Study|missed closeout visit|28|||
33273853|NCT00000620|62646715|FG006|Overall Study|missed closeout visit|13|||
33273854|NCT00000620|62646716|FG007|Overall Study|missed closeout visit|16|||
33273855|NCT00001262|62646779|FG000|Overall Study|Death|10|||
33273856|NCT00001262|62646780|FG001|Overall Study|Death|11|||
33273857|NCT00001262|62646781|FG002|Overall Study|Death|0|||
33273858|NCT00001262|62646779|FG000|Overall Study|Withdrawal by Subject|0|||
33273859|NCT00001262|62646780|FG001|Overall Study|Withdrawal by Subject|3|||
33273860|NCT00001262|62646781|FG002|Overall Study|Withdrawal by Subject|0|||
33273861|NCT00001277|62646798|FG000|Overall Study|Adverse Event|0|||
33273862|NCT00001277|62646799|FG001|Overall Study|Adverse Event|0|||
33273863|NCT00001277|62646800|FG002|Overall Study|Adverse Event|1|||
33273864|NCT00001277|62646798|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
33273865|NCT00001277|62646799|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
33273866|NCT00001277|62646800|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
33273867|NCT00001703|62646842|FG000|Overall Study|progressed disease|2|||
33273868|NCT00001703|62646842|FG000|Overall Study|No evidence of disease|1|||
33273869|NCT00001703|62646842|FG000|Overall Study|recurrent disease|2|||
33273870|NCT01349907|62646866|FG000|Overall Study|Adverse Event|37|||
33273871|NCT01349907|62646867|FG001|Overall Study|Adverse Event|11|||
33273872|NCT01349907|62646866|FG000|Overall Study|Treatment failure|13|||
33273873|NCT01349907|62646867|FG001|Overall Study|Treatment failure|4|||
33273874|NCT01349907|62646866|FG000|Overall Study|Lost to Follow-up|25|||
33273875|NCT01349907|62646867|FG001|Overall Study|Lost to Follow-up|6|||
33273876|NCT01349907|62646866|FG000|Overall Study|Withdrawal by Subject|30|||
33273877|NCT01349907|62646867|FG001|Overall Study|Withdrawal by Subject|8|||
33273878|NCT01349907|62646866|FG000|Overall Study|Protocol Violation|33|||
33273879|NCT01349907|62646867|FG001|Overall Study|Protocol Violation|13|||
33273880|NCT01349907|62646866|FG000|Overall Study|Administrative|1|||
33273881|NCT01349907|62646867|FG001|Overall Study|Administrative|1|||
33273882|NCT04847141|62646884|FG000|Overall Study|Adverse Event|1|||
33273883|NCT04847141|62646885|FG001|Overall Study|Adverse Event|0|||
33273884|NCT04847141|62646886|FG002|Overall Study|Adverse Event|1|||
33273885|NCT04847141|62646884|FG000|Overall Study|Withdrawal by Subject|2|||
33273886|NCT04847141|62646885|FG001|Overall Study|Withdrawal by Subject|4|||
33273887|NCT04847141|62646886|FG002|Overall Study|Withdrawal by Subject|3|||
33273888|NCT04847141|62646884|FG000|Overall Study|Lost to Follow-up|7|||
33273889|NCT04847141|62646885|FG001|Overall Study|Lost to Follow-up|5|||
33273890|NCT04847141|62646886|FG002|Overall Study|Lost to Follow-up|7|||
33273891|NCT04847141|62646884|FG000|Overall Study|Reason not Specified|0|||
33273892|NCT04847141|62646885|FG001|Overall Study|Reason not Specified|1|||
33273893|NCT04847141|62646886|FG002|Overall Study|Reason not Specified|0|||
33273894|NCT01349829|62646896|FG000|Overall Study|Lost to Follow-up|4|||
33273895|NCT01349829|62646897|FG001|Overall Study|Lost to Follow-up|8|||
33273896|NCT01349829|62646896|FG000|Overall Study|Consent withdrawal|3|||
33273897|NCT01349829|62646897|FG001|Overall Study|Consent withdrawal|8|||
33273898|NCT01349829|62646896|FG000|Overall Study|Migrated/moved|2|||
33273899|NCT01349829|62646897|FG001|Overall Study|Migrated/moved|7|||
33273900|NCT01350128|62646905|FG000|Overall Study|Withdrawal by Subject|3|||
33273901|NCT01350128|62646905|FG000|Overall Study|Protocol discontinuation criteria|8|||
33273902|NCT01350128|62646905|FG000|Overall Study|Physician Decision|1|||
33273903|NCT01350128|62646905|FG000|Overall Study|Lost to Follow-up|2|||
33273904|NCT03893825|62646972|FG000|Overall Study|Death|2|||
33273905|NCT03893825|62646973|FG001|Overall Study|Death|1|||
33273906|NCT03893825|62646972|FG000|Overall Study|Adverse Event|0|||
33273907|NCT03893825|62646973|FG001|Overall Study|Adverse Event|2|||
33273908|NCT03893825|62646972|FG000|Overall Study|Withdrawal by Subject|19|||
33273909|NCT03893825|62646973|FG001|Overall Study|Withdrawal by Subject|21|||
33273910|NCT03893825|62646972|FG000|Overall Study|Protocol deviation|1|||
33273911|NCT03893825|62646973|FG001|Overall Study|Protocol deviation|0|||
33273912|NCT03893825|62646972|FG000|Overall Study|Lost to Follow-up|10|||
33273913|NCT03893825|62646973|FG001|Overall Study|Lost to Follow-up|10|||
33273914|NCT03893825|62646972|FG000|Overall Study|Other than specified|7|||
33273915|NCT03893825|62646973|FG001|Overall Study|Other than specified|6|||
33273916|NCT03890666|62646981|FG000|Overall Study|Withdrawal by Subject|0|||
33273917|NCT03890666|62646982|FG001|Overall Study|Withdrawal by Subject|1|||
33273918|NCT03890666|62646981|FG000|Overall Study|Protocol deviation|1|||
33273919|NCT03890666|62646982|FG001|Overall Study|Protocol deviation|4|||
33273920|NCT03890666|62646981|FG000|Overall Study|Lost to Follow-up|2|||
33273921|NCT03890666|62646982|FG001|Overall Study|Lost to Follow-up|5|||
33273922|NCT03890666|62646981|FG000|Overall Study|Other than specified|1|||
33273923|NCT03890666|62646982|FG001|Overall Study|Other than specified|8|||
33273924|NCT03276572|62647036|FG000|Overall Study|In follow-up|0|||
33273925|NCT03276572|62647037|FG001|Overall Study|In follow-up|0|||
33273926|NCT03276572|62647038|FG002|Overall Study|In follow-up|0|||
33273927|NCT03276572|62647039|FG003|Overall Study|In follow-up|0|||
33273928|NCT03276572|62647040|FG004|Overall Study|In follow-up|0|||
33273929|NCT03276572|62647041|FG005|Overall Study|In follow-up|1|||
33273930|NCT03276572|62647042|FG006|Overall Study|In follow-up|1|||
33273931|NCT03276572|62647036|FG000|Overall Study|Lost to Follow-up|0|||
33273932|NCT03276572|62647037|FG001|Overall Study|Lost to Follow-up|0|||
33273933|NCT03276572|62647038|FG002|Overall Study|Lost to Follow-up|0|||
33273934|NCT03276572|62647039|FG003|Overall Study|Lost to Follow-up|0|||
33273935|NCT03276572|62647040|FG004|Overall Study|Lost to Follow-up|0|||
33273936|NCT03276572|62647041|FG005|Overall Study|Lost to Follow-up|0|||
33273937|NCT03276572|62647042|FG006|Overall Study|Lost to Follow-up|1|||
33273938|NCT03090737|62647067|FG000|Overall Study|Other reasons|1|||
33273939|NCT03090737|62647067|FG000|Overall Study|Completed treatment as per protocol|17|||
33273940|NCT03090737|62647067|FG000|Overall Study|Maximum clinical benefit|2|||
33273941|NCT03090737|62647067|FG000|Overall Study|Adverse event unrelated to study drug|7|||
33273942|NCT03090737|62647067|FG000|Overall Study|Study drug toxicity|4|||
33273943|NCT03090737|62647067|FG000|Overall Study|Disease progression|98|||
33273944|NCT03004976|62647112|FG000|Overall Study|Lost to Follow-up|7|||
33273945|NCT03004976|62647113|FG001|Overall Study|Lost to Follow-up|5|||
33273946|NCT03004976|62647112|FG000|Overall Study|Physician Decision|1|||
33273947|NCT03004976|62647113|FG001|Overall Study|Physician Decision|0|||
33273948|NCT03004976|62647112|FG000|Overall Study|Withdrawal by Subject|1|||
33273949|NCT03004976|62647113|FG001|Overall Study|Withdrawal by Subject|0|||
33273950|NCT03004976|62647112|FG000|Overall Study|Death|4|||
33273951|NCT03004976|62647113|FG001|Overall Study|Death|1|||
33273952|NCT02985866|62647121|FG000|Overall Study|Poor CGM data|1|||
33273953|NCT02985866|62647122|FG001|Overall Study|Poor CGM data|1|||
33273954|NCT02762981|62647147|FG000|Overall Study|Adverse Event|2|||
33273955|NCT02762981|62647148|FG001|Overall Study|Adverse Event|3|||
33273956|NCT02762981|62647149|FG002|Overall Study|Adverse Event|1|||
33273957|NCT02762981|62647150|FG003|Overall Study|Adverse Event|1|||
33273958|NCT02762981|62647151|FG004|Overall Study|Adverse Event|3|||
33273959|NCT02762981|62647147|FG000|Overall Study|Physician Decision|0|||
33273960|NCT02762981|62647148|FG001|Overall Study|Physician Decision|1|||
33273961|NCT02762981|62647149|FG002|Overall Study|Physician Decision|0|||
33273962|NCT02762981|62647150|FG003|Overall Study|Physician Decision|0|||
33273963|NCT02762981|62647151|FG004|Overall Study|Physician Decision|1|||
33273964|NCT02762981|62647147|FG000|Overall Study|Disease progression|11|||
33273965|NCT02762981|62647148|FG001|Overall Study|Disease progression|23|||
33273966|NCT02762981|62647149|FG002|Overall Study|Disease progression|4|||
33273967|NCT02762981|62647150|FG003|Overall Study|Disease progression|10|||
33273968|NCT02762981|62647151|FG004|Overall Study|Disease progression|1|||
33273969|NCT02762981|62647147|FG000|Overall Study|Enrolled not treated|1|||
33273970|NCT02762981|62647148|FG001|Overall Study|Enrolled not treated|5|||
33485641|NCT04169061|62863365|FG000|Overall Study|Withdrawal by Subject|1|||
33485642|NCT04169061|62863365|FG000|Overall Study|Protocol Violation|1|||
33555716|NCT01369511|62948551|FG003|Overall Study|Lost to Follow-up|2|||
33273971|NCT02762981|62647149|FG002|Overall Study|Enrolled not treated|0|||
33273972|NCT02762981|62647150|FG003|Overall Study|Enrolled not treated|2|||
33273973|NCT02762981|62647151|FG004|Overall Study|Enrolled not treated|0|||
33273974|NCT02762981|62647147|FG000|Overall Study|Other|2|||
33273975|NCT02762981|62647148|FG001|Overall Study|Other|3|||
33273976|NCT02762981|62647149|FG002|Overall Study|Other|1|||
33273977|NCT02762981|62647150|FG003|Overall Study|Other|0|||
33273978|NCT02762981|62647151|FG004|Overall Study|Other|0|||
33273979|NCT02762981|62647147|FG000|Overall Study|Missing|1|||
33273980|NCT02762981|62647148|FG001|Overall Study|Missing|0|||
33273981|NCT02762981|62647149|FG002|Overall Study|Missing|0|||
33273982|NCT02762981|62647150|FG003|Overall Study|Missing|0|||
33273983|NCT02762981|62647151|FG004|Overall Study|Missing|0|||
33273984|NCT02762981|62647147|FG000|Overall Study|Withdrawal by Subject|0|||
33273985|NCT02762981|62647148|FG001|Overall Study|Withdrawal by Subject|5|||
33273986|NCT02762981|62647149|FG002|Overall Study|Withdrawal by Subject|1|||
33273987|NCT02762981|62647150|FG003|Overall Study|Withdrawal by Subject|3|||
33273988|NCT02762981|62647151|FG004|Overall Study|Withdrawal by Subject|0|||
33273989|NCT02255435|62647201|FG000|Overall Study|Patient's Limited Time Availability|0|||
33273990|NCT02255435|62647202|FG001|Overall Study|Patient's Limited Time Availability|0|||
33273991|NCT02255435|62647203|FG002|Overall Study|Patient's Limited Time Availability|0|||
33273992|NCT02255435|62647204|FG003|Overall Study|Patient's Limited Time Availability|0|||
33273993|NCT02255435|62647205|FG004|Overall Study|Patient's Limited Time Availability|0|||
33273994|NCT02255435|62647206|FG005|Overall Study|Patient's Limited Time Availability|0|||
33273995|NCT02255435|62647207|FG006|Overall Study|Patient's Limited Time Availability|0|||
33273996|NCT02255435|62647208|FG007|Overall Study|Patient's Limited Time Availability|1|||
33273997|NCT02255435|62647209|FG008|Overall Study|Patient's Limited Time Availability|0|||
33273998|NCT02255435|62647210|FG009|Overall Study|Patient's Limited Time Availability|0|||
33273999|NCT02255435|62647201|FG000|Overall Study|Withdrawal by Subject|0|||
33274000|NCT02255435|62647202|FG001|Overall Study|Withdrawal by Subject|0|||
33274001|NCT02255435|62647203|FG002|Overall Study|Withdrawal by Subject|0|||
33274002|NCT02255435|62647204|FG003|Overall Study|Withdrawal by Subject|0|||
33274003|NCT02255435|62647205|FG004|Overall Study|Withdrawal by Subject|0|||
33274004|NCT02255435|62647206|FG005|Overall Study|Withdrawal by Subject|0|||
33274005|NCT02255435|62647207|FG006|Overall Study|Withdrawal by Subject|0|||
33274006|NCT02255435|62647208|FG007|Overall Study|Withdrawal by Subject|0|||
33274007|NCT02255435|62647209|FG008|Overall Study|Withdrawal by Subject|1|||
33274008|NCT02255435|62647210|FG009|Overall Study|Withdrawal by Subject|4|||
33274009|NCT02255435|62647201|FG000|Overall Study|Administrative reasons|0|||
33274010|NCT02255435|62647202|FG001|Overall Study|Administrative reasons|0|||
33274011|NCT02255435|62647203|FG002|Overall Study|Administrative reasons|0|||
33274012|NCT02255435|62647204|FG003|Overall Study|Administrative reasons|0|||
33274013|NCT02255435|62647205|FG004|Overall Study|Administrative reasons|0|||
33274014|NCT02255435|62647206|FG005|Overall Study|Administrative reasons|0|||
33274015|NCT02255435|62647207|FG006|Overall Study|Administrative reasons|0|||
33274016|NCT02255435|62647208|FG007|Overall Study|Administrative reasons|0|||
33274017|NCT02255435|62647209|FG008|Overall Study|Administrative reasons|0|||
33274018|NCT02255435|62647210|FG009|Overall Study|Administrative reasons|2|||
33274019|NCT00001832|62647281|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
33274020|NCT00001832|62647282|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
33274021|NCT00001832|62647283|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
33274022|NCT00001832|62647284|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
33274023|NCT00001832|62647285|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
33274024|NCT00001832|62647286|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
33274025|NCT00001832|62647287|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
33274026|NCT00001832|62647288|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
33274027|NCT00001832|62647289|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
33274028|NCT00001832|62647290|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
33274029|NCT00001832|62647291|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
33274030|NCT00001832|62647292|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
33274031|NCT00001832|62647293|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
33274032|NCT00001832|62647294|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
33274033|NCT00001832|62647295|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
33274034|NCT00001832|62647281|FG000|Treatment Period|Death during treatment|0|||
33274035|NCT00001832|62647282|FG001|Treatment Period|Death during treatment|0|||
33274036|NCT00001832|62647283|FG002|Treatment Period|Death during treatment|0|||
33274037|NCT00001832|62647284|FG003|Treatment Period|Death during treatment|0|||
33274038|NCT00001832|62647285|FG004|Treatment Period|Death during treatment|0|||
33274039|NCT00001832|62647286|FG005|Treatment Period|Death during treatment|1|||
33274040|NCT00001832|62647287|FG006|Treatment Period|Death during treatment|0|||
33274041|NCT00001832|62647288|FG007|Treatment Period|Death during treatment|0|||
33274042|NCT00001832|62647289|FG008|Treatment Period|Death during treatment|0|||
33274043|NCT00001832|62647290|FG009|Treatment Period|Death during treatment|0|||
33274044|NCT00001832|62647291|FG010|Treatment Period|Death during treatment|0|||
33274045|NCT00001832|62647292|FG011|Treatment Period|Death during treatment|0|||
33274046|NCT00001832|62647293|FG012|Treatment Period|Death during treatment|0|||
33274047|NCT00001832|62647294|FG013|Treatment Period|Death during treatment|0|||
33274048|NCT00001832|62647295|FG014|Treatment Period|Death during treatment|0|||
33274049|NCT00001832|62647281|FG000|Treatment Period|Not treated|0|||
33274050|NCT00001832|62647282|FG001|Treatment Period|Not treated|0|||
33274051|NCT00001832|62647283|FG002|Treatment Period|Not treated|0|||
33274052|NCT00001832|62647284|FG003|Treatment Period|Not treated|0|||
33274053|NCT00001832|62647285|FG004|Treatment Period|Not treated|0|||
33274054|NCT00001832|62647286|FG005|Treatment Period|Not treated|0|||
33274055|NCT00001832|62647287|FG006|Treatment Period|Not treated|0|||
33274056|NCT00001832|62647288|FG007|Treatment Period|Not treated|1|||
33274057|NCT00001832|62647289|FG008|Treatment Period|Not treated|0|||
33274058|NCT00001832|62647290|FG009|Treatment Period|Not treated|0|||
33274059|NCT00001832|62647291|FG010|Treatment Period|Not treated|0|||
33274060|NCT00001832|62647292|FG011|Treatment Period|Not treated|0|||
33274061|NCT00001832|62647293|FG012|Treatment Period|Not treated|0|||
33274062|NCT00001832|62647294|FG013|Treatment Period|Not treated|0|||
33274063|NCT00001832|62647295|FG014|Treatment Period|Not treated|0|||
33274064|NCT01349816|62647529|FG000|Overall Study|Withdrawal by Subject|4|||
33274065|NCT01349816|62647529|FG000|Overall Study|Physician Decision|1|||
33274066|NCT01349816|62647529|FG000|Overall Study|Adverse Event|14|||
33274067|NCT01349816|62647529|FG000|Overall Study|Lost to Follow-up|2|||
33274068|NCT01349816|62647529|FG000|Overall Study|Protocol Violation|1|||
33274069|NCT01349816|62647529|FG000|Overall Study|Protocol-specified criteria|8|||
33274070|NCT05201807|62647708|FG000|Overall Study|Adverse Event|1|||
33274071|NCT05201807|62647708|FG000|Overall Study|COVID-19 Related|1|||
33274072|NCT04978337|62647714|FG000|Overall Study|Withdrawal by Subject|0|||
33274073|NCT04978337|62647715|FG001|Overall Study|Withdrawal by Subject|1|||
33274074|NCT04828707|62647724|FG000|Overall Study|Lost to Follow-up|3|||
33274075|NCT04828707|62647725|FG001|Overall Study|Lost to Follow-up|2|||
33274076|NCT04828707|62647724|FG000|Overall Study|Withdrawal by Subject|2|||
33274077|NCT04828707|62647725|FG001|Overall Study|Withdrawal by Subject|1|||
33274078|NCT04629534|62647733|FG000|Overall Study|Physician Decision|1|||
33274079|NCT04629534|62647734|FG001|Overall Study|Physician Decision|0|||
33274080|NCT04629534|62647733|FG000|Overall Study|Protocol Violation|0|||
33274081|NCT04629534|62647734|FG001|Overall Study|Protocol Violation|2|||
33274082|NCT04481191|62647746|FG000|Overall Study|Withdrawn by parent/guardian|15|||
33274083|NCT04481191|62647747|FG001|Overall Study|Withdrawn by parent/guardian|10|||
33274084|NCT03695185|62647770|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
33274085|NCT03695185|62647770|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
33274086|NCT03695185|62647770|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
33274087|NCT03695185|62647770|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
33274088|NCT03695185|62647770|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
33274089|NCT03695185|62647770|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
33274090|NCT03596164|62647777|FG000|Overall Study|Adverse Event|0|||
33274091|NCT03596164|62647778|FG001|Overall Study|Adverse Event|1|||
33274092|NCT03596164|62647777|FG000|Overall Study|Death|1|||
33274093|NCT03596164|62647778|FG001|Overall Study|Death|0|||
33274094|NCT03240874|62647790|FG000|Overall Study|Lost to Follow-up|0|||
33274095|NCT03240874|62647791|FG001|Overall Study|Lost to Follow-up|2|||
33274096|NCT03240874|62647792|FG002|Overall Study|Lost to Follow-up|4|||
33274097|NCT03240874|62647793|FG003|Overall Study|Lost to Follow-up|1|||
33274098|NCT02990468|62647804|FG000|Phase 2: MTD|Change in treatment|0|||
33274099|NCT02990468|62647805|FG001|Phase 2: MTD|Change in treatment|0|||
33274100|NCT02990468|62647806|FG002|Phase 2: MTD|Change in treatment|1|||
33274101|NCT02855944|62647816|FG000|Period 1: Treatment|Ongoing|14|||
33274102|NCT02855944|62647817|FG001|Period 1: Treatment|Ongoing|0|||
33274103|NCT02855944|62647816|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
33274104|NCT02855944|62647817|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
33274105|NCT02855944|62647816|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
33274106|NCT02855944|62647817|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
33274107|NCT02681055|62647828|FG000|Weeks 5-12|Adverse Event|1|||
33274108|NCT02577354|62647835|FG000|Overall Study|Lack of Efficacy|4|||
33274109|NCT02577354|62647836|FG001|Overall Study|Lack of Efficacy|4|||
33274110|NCT02577354|62647835|FG000|Overall Study|Lost to Follow-up|3|||
33274111|NCT02577354|62647836|FG001|Overall Study|Lost to Follow-up|1|||
33274112|NCT02577354|62647835|FG000|Overall Study|Missed Visit|4|||
33274113|NCT02577354|62647836|FG001|Overall Study|Missed Visit|3|||
33274114|NCT02577354|62647835|FG000|Overall Study|Adverse Event|4|||
33274115|NCT02577354|62647836|FG001|Overall Study|Adverse Event|5|||
33274116|NCT02409342|62647854|FG000|Overall Study|Death|211|||
33274117|NCT02409342|62647855|FG001|Overall Study|Death|201|||
33274118|NCT02409342|62647854|FG000|Overall Study|Withdrawal by Subject|24|||
33274119|NCT02409342|62647855|FG001|Overall Study|Withdrawal by Subject|17|||
33274120|NCT02409342|62647854|FG000|Overall Study|Study Terminated By Sponsor|48|||
33274121|NCT02409342|62647855|FG001|Overall Study|Study Terminated By Sponsor|59|||
33274122|NCT02409342|62647854|FG000|Overall Study|Lost to Follow-up|3|||
33274123|NCT02409342|62647855|FG001|Overall Study|Lost to Follow-up|5|||
33274124|NCT02409342|62647854|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
33274125|NCT02409342|62647855|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
33274126|NCT02409342|62647854|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
33274127|NCT02409342|62647855|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
33274128|NCT02409342|62647854|FG000|Overall Study|Sponsor Decision|1|||
33274129|NCT02409342|62647855|FG001|Overall Study|Sponsor Decision|0|||
33274130|NCT02336503|62647871|FG000|Overall Study|Lost to Follow-up|0|||
33274131|NCT02336503|62647872|FG001|Overall Study|Lost to Follow-up|3|||
33274132|NCT02336503|62647873|FG002|Overall Study|Lost to Follow-up|0|||
33274133|NCT02336503|62647874|FG003|Overall Study|Lost to Follow-up|2|||
33274134|NCT02336503|62647871|FG000|Overall Study|Withdrawal by Subject|2|||
33274135|NCT02336503|62647872|FG001|Overall Study|Withdrawal by Subject|0|||
33274136|NCT02336503|62647873|FG002|Overall Study|Withdrawal by Subject|0|||
33274137|NCT02336503|62647874|FG003|Overall Study|Withdrawal by Subject|4|||
33274138|NCT02336503|62647871|FG000|Overall Study|Adverse Event|0|||
33274139|NCT02336503|62647872|FG001|Overall Study|Adverse Event|0|||
33274140|NCT02336503|62647873|FG002|Overall Study|Adverse Event|1|||
33274141|NCT02336503|62647874|FG003|Overall Study|Adverse Event|0|||
33274142|NCT02255409|62647890|FG000|Overall Study|Administrative Reason|3|||
33274143|NCT02255409|62647891|FG001|Overall Study|Administrative Reason|7|||
33274144|NCT02255409|62647890|FG000|Overall Study|Withdrawal by Subject|1|||
33274145|NCT02255409|62647891|FG001|Overall Study|Withdrawal by Subject|5|||
33274146|NCT02255409|62647890|FG000|Overall Study|Lost to Follow-up|10|||
33274147|NCT02255409|62647891|FG001|Overall Study|Lost to Follow-up|19|||
33274148|NCT00630032|62647922|FG000|Overall Study|Death|55|||
33274149|NCT00630032|62647923|FG001|Overall Study|Death|49|||
33274150|NCT00630032|62647922|FG000|Overall Study|Withdrawal by Subject|3|||
33274151|NCT00630032|62647923|FG001|Overall Study|Withdrawal by Subject|2|||
33274152|NCT00630032|62647922|FG000|Overall Study|Lost to Follow-up|18|||
33274153|NCT00630032|62647923|FG001|Overall Study|Lost to Follow-up|31|||
33274154|NCT00630032|62647922|FG000|Overall Study|Protocol Violation|1|||
33274155|NCT00630032|62647923|FG001|Overall Study|Protocol Violation|0|||
33274156|NCT00630032|62647922|FG000|Overall Study|Patient has moved|1|||
33274157|NCT00630032|62647923|FG001|Overall Study|Patient has moved|1|||
33274158|NCT00630032|62647922|FG000|Overall Study|Disease progression|1|||
33274159|NCT00630032|62647923|FG001|Overall Study|Disease progression|1|||
33274160|NCT00630032|62647922|FG000|Overall Study|End of monitoring in US centers|11|||
33274161|NCT00630032|62647923|FG001|Overall Study|End of monitoring in US centers|11|||
33274162|NCT00465517|62647931|FG000|Overall Study|Adverse Event|7|||
33274163|NCT00465517|62647932|FG001|Overall Study|Adverse Event|3|||
33274164|NCT00465517|62647931|FG000|Overall Study|Lost to Follow-up|1|||
33274165|NCT00465517|62647932|FG001|Overall Study|Lost to Follow-up|0|||
33274166|NCT00465517|62647931|FG000|Overall Study|Withdrawal by Subject|4|||
33274167|NCT00465517|62647932|FG001|Overall Study|Withdrawal by Subject|1|||
33274168|NCT05050578|62647940|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
33274169|NCT05050578|62647941|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
33274170|NCT05050578|62647940|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
33274171|NCT05050578|62647941|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
33274172|NCT05050578|62647940|FG000|Period 2, 30 Days|Protocol Violation|0|||
33274173|NCT05050578|62647941|FG001|Period 2, 30 Days|Protocol Violation|1|||
33274174|NCT04490278|62647950|FG000|Overall Study|Lost to Follow-up|6|||
33274175|NCT04004221|62647954|FG000|Overall Study|Death|89|||
33274176|NCT04004221|62647954|FG000|Overall Study|Withdrawal by Subject|5|||
33274177|NCT04004221|62647954|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
33274178|NCT04004221|62647954|FG000|Overall Study|Sponsor Decision|9|||
33274179|NCT04004221|62647954|FG000|Overall Study|Participant refused to enter LTE|1|||
33274180|NCT03775512|62647964|FG000|Overall Study|Death|1|||
33274181|NCT03775512|62647965|FG001|Overall Study|Death|1|||
33274182|NCT03775512|62647964|FG000|Overall Study|Withdrawal by Subject|7|||
33274183|NCT03775512|62647965|FG001|Overall Study|Withdrawal by Subject|4|||
33274184|NCT03775512|62647964|FG000|Overall Study|Lost to Follow-up|5|||
33274185|NCT03775512|62647965|FG001|Overall Study|Lost to Follow-up|5|||
33274186|NCT03775512|62647964|FG000|Overall Study|Excluded before Catheter insertion|14|||
33274187|NCT03775512|62647965|FG001|Overall Study|Excluded before Catheter insertion|5|||
33274188|NCT03775512|62647964|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
33274189|NCT03775512|62647965|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
33274190|NCT03775512|62647964|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
33274191|NCT03775512|62647965|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
33274192|NCT03620747|62647971|FG000|Overall Study|Participant decision|7|||
33274193|NCT03620747|62647971|FG000|Overall Study|Adverse Event|6|||
33274194|NCT03620747|62647971|FG000|Overall Study|Lack of Efficacy|1|||
33274195|NCT03620747|62647971|FG000|Overall Study|Poor compliance to protocol|2|||
33274196|NCT03620747|62647971|FG000|Overall Study|Other-unspecified|3|||
33274197|NCT03338790|62647996|FG000|Overall Study|Disease Progression|65|||
33274198|NCT03338790|62647997|FG001|Overall Study|Disease Progression|43|||
33274199|NCT03338790|62647998|FG002|Overall Study|Disease Progression|50|||
33274200|NCT03338790|62647999|FG003|Overall Study|Disease Progression|37|||
33485643|NCT02792218|62863371|FG000|Overall Study|Patient/guardian decision|15|||
33274201|NCT03338790|62647996|FG000|Overall Study|Study Drug Toxicity|9|||
33274202|NCT03338790|62647997|FG001|Overall Study|Study Drug Toxicity|8|||
33485644|NCT02792218|62863372|FG001|Overall Study|Patient/guardian decision|42|||
33485645|NCT02792218|62863371|FG000|Overall Study|Adverse Event|15|||
33274203|NCT03338790|62647998|FG002|Overall Study|Study Drug Toxicity|15|||
33274204|NCT03338790|62647999|FG003|Overall Study|Study Drug Toxicity|0|||
33274205|NCT03338790|62647996|FG000|Overall Study|Death|1|||
33274206|NCT03338790|62647997|FG001|Overall Study|Death|1|||
33274207|NCT03338790|62647998|FG002|Overall Study|Death|1|||
33274208|NCT03338790|62647999|FG003|Overall Study|Death|0|||
33274209|NCT03338790|62647996|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
33485646|NCT02792218|62863372|FG001|Overall Study|Adverse Event|14|||
33274210|NCT03338790|62647997|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
33274211|NCT03338790|62647998|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
33274212|NCT03338790|62647999|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
33274213|NCT03338790|62647996|FG000|Overall Study|Participant request to discontinue study treatment|3|||
33274214|NCT03338790|62647997|FG001|Overall Study|Participant request to discontinue study treatment|3|||
33274215|NCT03338790|62647998|FG002|Overall Study|Participant request to discontinue study treatment|2|||
33274216|NCT03338790|62647999|FG003|Overall Study|Participant request to discontinue study treatment|1|||
33274217|NCT03338790|62647996|FG000|Overall Study|Poor/non-compliance|0|||
33274218|NCT03338790|62647997|FG001|Overall Study|Poor/non-compliance|1|||
33274219|NCT03338790|62647998|FG002|Overall Study|Poor/non-compliance|0|||
33274220|NCT03338790|62647999|FG003|Overall Study|Poor/non-compliance|0|||
33274221|NCT03338790|62647996|FG000|Overall Study|Participant withdrew consent|1|||
33274222|NCT03338790|62647997|FG001|Overall Study|Participant withdrew consent|0|||
33274223|NCT03338790|62647998|FG002|Overall Study|Participant withdrew consent|1|||
33274224|NCT03338790|62647999|FG003|Overall Study|Participant withdrew consent|1|||
33274225|NCT03338790|62647996|FG000|Overall Study|Other reasons|0|||
33274226|NCT03338790|62647997|FG001|Overall Study|Other reasons|5|||
33274227|NCT03338790|62647998|FG002|Overall Study|Other reasons|0|||
33274228|NCT03338790|62647999|FG003|Overall Study|Other reasons|2|||
33274229|NCT03338790|62647996|FG000|Overall Study|Not reported|0|||
33274230|NCT03338790|62647997|FG001|Overall Study|Not reported|0|||
33274231|NCT03338790|62647998|FG002|Overall Study|Not reported|1|||
33274232|NCT03338790|62647999|FG003|Overall Study|Not reported|0|||
33274233|NCT03338790|62647996|FG000|Overall Study|Completed treatment period|1|||
33274234|NCT03338790|62647997|FG001|Overall Study|Completed treatment period|2|||
33274235|NCT03338790|62647998|FG002|Overall Study|Completed treatment period|0|||
33274236|NCT03338790|62647999|FG003|Overall Study|Completed treatment period|0|||
33274237|NCT02954536|62648026|FG000|Overall Study|Adverse Event|2|||
33274238|NCT02954536|62648026|FG000|Overall Study|Death|12|||
33274239|NCT02919670|62648032|FG000|Overall Study|Only 17 participants met compliance|43|||
33274240|NCT02919670|62648033|FG001|Overall Study|Only 17 participants met compliance|39|||
33274241|NCT02250326|62648132|FG000|Treatment Period|Death|1|||
33274242|NCT02250326|62648133|FG001|Treatment Period|Death|12|||
33274243|NCT02250326|62648134|FG002|Treatment Period|Death|2|||
33274244|NCT02250326|62648132|FG000|Treatment Period|Adverse Event|8|||
33274245|NCT02250326|62648133|FG001|Treatment Period|Adverse Event|4|||
33274246|NCT02250326|62648134|FG002|Treatment Period|Adverse Event|8|||
33274247|NCT02250326|62648132|FG000|Treatment Period|Progressive Disease|42|||
33274248|NCT02250326|62648133|FG001|Treatment Period|Progressive Disease|36|||
33274249|NCT02250326|62648134|FG002|Treatment Period|Progressive Disease|45|||
33274250|NCT02250326|62648132|FG000|Treatment Period|Symptomatic Deterioration|9|||
33274251|NCT02250326|62648133|FG001|Treatment Period|Symptomatic Deterioration|4|||
33274252|NCT02250326|62648134|FG002|Treatment Period|Symptomatic Deterioration|10|||
33274253|NCT02250326|62648132|FG000|Treatment Period|Withdrawal by Subject|11|||
33274254|NCT02250326|62648133|FG001|Treatment Period|Withdrawal by Subject|5|||
33274255|NCT02250326|62648134|FG002|Treatment Period|Withdrawal by Subject|4|||
33274256|NCT02250326|62648132|FG000|Treatment Period|Miscellaneous|8|||
33370271|NCT00855218|62748986|FG001|Overall Study|Progression measurement proven|15|||
33370272|NCT00855218|62748985|FG000|Overall Study|Clinical endpoint reached|10|||
33370273|NCT00855218|62748986|FG001|Overall Study|Clinical endpoint reached|13|||
33370274|NCT01063348|62748994|FG000|Overall Study|Lost to Follow-up|3|||
33555717|NCT01369511|62948548|FG000|Overall Study|Protocol Violation|0|||
33555718|NCT01369511|62948549|FG001|Overall Study|Protocol Violation|1|||
33555719|NCT01369511|62948550|FG002|Overall Study|Protocol Violation|0|||
33555720|NCT01369511|62948551|FG003|Overall Study|Protocol Violation|2|||
33555721|NCT01369511|62948548|FG000|Overall Study|Physician Decision|3|||
33274257|NCT02250326|62648133|FG001|Treatment Period|Miscellaneous|2|||
33274258|NCT02250326|62648134|FG002|Treatment Period|Miscellaneous|7|||
33274259|NCT02250326|62648132|FG000|Treatment Period|Randomized or assigned; not treated|2|||
33274260|NCT02250326|62648133|FG001|Treatment Period|Randomized or assigned; not treated|1|||
33274261|NCT02250326|62648134|FG002|Treatment Period|Randomized or assigned; not treated|1|||
33370275|NCT01063348|62748995|FG001|Overall Study|Lost to Follow-up|10|||
33485647|NCT02792218|62863371|FG000|Overall Study|Lost to Follow-up|10|||
33274262|NCT02250326|62648132|FG000|Follow-Up Period|Death|46|||
33274263|NCT02250326|62648133|FG001|Follow-Up Period|Death|26|||
33274264|NCT02250326|62648134|FG002|Follow-Up Period|Death|32|||
33274265|NCT02250326|62648132|FG000|Follow-Up Period|Unknown or Missing|2|||
33274266|NCT02250326|62648133|FG001|Follow-Up Period|Unknown or Missing|3|||
33485648|NCT02792218|62863372|FG001|Overall Study|Lost to Follow-up|5|||
33485649|NCT02792218|62863371|FG000|Overall Study|Lack of Efficacy|1|||
33485650|NCT02792218|62863372|FG001|Overall Study|Lack of Efficacy|12|||
33485651|NCT02792218|62863371|FG000|Overall Study|Physician Decision|4|||
33485652|NCT02792218|62863372|FG001|Overall Study|Physician Decision|4|||
33485653|NCT02792218|62863371|FG000|Overall Study|Protocol deviation|3|||
33485654|NCT02792218|62863372|FG001|Overall Study|Protocol deviation|2|||
33485655|NCT02792218|62863371|FG000|Overall Study|New therapy for study indication|0|||
33274267|NCT02250326|62648134|FG002|Follow-Up Period|Unknown or Missing|3|||
33274268|NCT02250326|62648132|FG000|Follow-Up Period|Lost to Follow-up|1|||
33274269|NCT02250326|62648133|FG001|Follow-Up Period|Lost to Follow-up|1|||
33274270|NCT02250326|62648134|FG002|Follow-Up Period|Lost to Follow-up|3|||
33274271|NCT01567722|62648146|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
33274272|NCT01567722|62648147|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
33274273|NCT01567722|62648148|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
33274274|NCT01567722|62648146|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
33274275|NCT01567722|62648147|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
33274276|NCT01567722|62648148|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
33274277|NCT01567722|62648146|FG000|Overall Study|Protocol closure by the OCG|2|||
33274278|NCT01567722|62648147|FG001|Overall Study|Protocol closure by the OCG|0|||
33274279|NCT01567722|62648148|FG002|Overall Study|Protocol closure by the OCG|0|||
33274280|NCT01567722|62648146|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
33274281|NCT01567722|62648147|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
33274282|NCT01567722|62648148|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
33274283|NCT01349790|62648173|FG000|Overall Study|Investigator Judgement|3|||
33274284|NCT01349790|62648173|FG000|Overall Study|Death|2|||
33274285|NCT01349790|62648173|FG000|Overall Study|Withdrawal by Patient|2|||
33274286|NCT01349790|62648173|FG000|Overall Study|Adverse Event|1|||
33274287|NCT01349790|62648173|FG000|Overall Study|Lost to Follow-up|1|||
33274288|NCT01349595|62648179|FG000|Overall Study|Lack of funding|2|||
33274289|NCT01349595|62648180|FG001|Overall Study|Lack of funding|2|||
33274290|NCT01349673|62648190|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
33274291|NCT01349673|62648190|FG000|Overall Study|No Longer Qualified For Study|1|||
33274292|NCT01349673|62648190|FG000|Overall Study|Site Closure|10|||
33274293|NCT01349673|62648190|FG000|Overall Study|Withdrawal by Subject|21|||
33274294|NCT01349673|62648190|FG000|Overall Study|Lost to Follow-up|6|||
33274295|NCT01349673|62648190|FG000|Overall Study|Adverse Event|17|||
33274296|NCT01349673|62648190|FG000|Overall Study|Study Terminated By Sponsor|50|||
33274297|NCT01349673|62648190|FG000|Overall Study|Lack of Efficacy|8|||
33274298|NCT04725682|62648273|FG000|Overall Study|Withdrawal by Subject|7|||
33274299|NCT04725682|62648274|FG001|Overall Study|Withdrawal by Subject|5|||
33274300|NCT04725682|62648273|FG000|Overall Study|Failed to comply with the requirements|2|||
33274301|NCT04725682|62648274|FG001|Overall Study|Failed to comply with the requirements|1|||
33274302|NCT04725682|62648273|FG000|Overall Study|Adverse Event|1|||
33274303|NCT04725682|62648274|FG001|Overall Study|Adverse Event|1|||
33274304|NCT04725682|62648273|FG000|Overall Study|Death|0|||
33274305|NCT04725682|62648274|FG001|Overall Study|Death|1|||
33274306|NCT01349660|62648306|FG000|Overall Study|Still Receiving Study Treatment|0|||
33274307|NCT01349660|62648307|FG001|Overall Study|Still Receiving Study Treatment|0|||
33274308|NCT01349660|62648308|FG002|Overall Study|Still Receiving Study Treatment|1|||
33274309|NCT01349660|62648306|FG000|Overall Study|Disease Progression|2|||
33274310|NCT01349660|62648307|FG001|Overall Study|Disease Progression|4|||
33274311|NCT01349660|62648308|FG002|Overall Study|Disease Progression|50|||
33274312|NCT01349660|62648306|FG000|Overall Study|Adverse Event|1|||
33274313|NCT01349660|62648307|FG001|Overall Study|Adverse Event|1|||
33274314|NCT01349660|62648308|FG002|Overall Study|Adverse Event|12|||
33274315|NCT01349660|62648306|FG000|Overall Study|Withdrawal by Subject|2|||
33274316|NCT01349660|62648307|FG001|Overall Study|Withdrawal by Subject|0|||
33274317|NCT01349660|62648308|FG002|Overall Study|Withdrawal by Subject|9|||
33274318|NCT01349660|62648306|FG000|Overall Study|Death|1|||
33274319|NCT01349660|62648307|FG001|Overall Study|Death|1|||
33274320|NCT01349660|62648308|FG002|Overall Study|Death|0|||
33274321|NCT01349660|62648306|FG000|Overall Study|Non-Permitted Interventions|0|||
33274322|NCT01349660|62648307|FG001|Overall Study|Non-Permitted Interventions|0|||
33274323|NCT01349660|62648308|FG002|Overall Study|Non-Permitted Interventions|2|||
33274324|NCT01349660|62648306|FG000|Overall Study|Study Compliance|0|||
33274325|NCT01349660|62648307|FG001|Overall Study|Study Compliance|0|||
33555722|NCT01369511|62948549|FG001|Overall Study|Physician Decision|4|||
33274326|NCT01349660|62648308|FG002|Overall Study|Study Compliance|1|||
33274327|NCT01349660|62648306|FG000|Overall Study|Declining Performance Status|0|||
33274328|NCT01349660|62648307|FG001|Overall Study|Declining Performance Status|0|||
33274329|NCT01349660|62648308|FG002|Overall Study|Declining Performance Status|1|||
33274330|NCT01349569|62648327|FG000|Overall Study|Lack of Efficacy|4|||
33274331|NCT05221749|62648378|FG000|Overall Study|Lost to Follow-up|2|||
33274332|NCT05221749|62648379|FG001|Overall Study|Lost to Follow-up|3|||
33274333|NCT04965389|62648433|FG000|Overall Study|Other reasons|1|||
33274334|NCT04965389|62648434|FG001|Overall Study|Other reasons|0|||
33274335|NCT04965389|62648435|FG002|Overall Study|Other reasons|0|||
33274336|NCT04965389|62648436|FG003|Overall Study|Other reasons|0|||
33274337|NCT04965389|62648433|FG000|Overall Study|Participant withdrew consent|0|||
33274338|NCT04965389|62648434|FG001|Overall Study|Participant withdrew consent|1|||
33274339|NCT04965389|62648435|FG002|Overall Study|Participant withdrew consent|0|||
33274340|NCT04965389|62648436|FG003|Overall Study|Participant withdrew consent|0|||
33274341|NCT04965389|62648433|FG000|Overall Study|Poor/Non-compliance|0|||
33274342|NCT04965389|62648434|FG001|Overall Study|Poor/Non-compliance|1|||
33274343|NCT04965389|62648435|FG002|Overall Study|Poor/Non-compliance|0|||
33274344|NCT04965389|62648436|FG003|Overall Study|Poor/Non-compliance|0|||
33274345|NCT04935931|62648453|FG000|Overall Study|Withdrawal by Subject|1|||
33274346|NCT04839393|62648465|FG000|Overall Study|Adverse Event|0|||
33274347|NCT04839393|62648466|FG001|Overall Study|Adverse Event|0|||
33274348|NCT04839393|62648467|FG002|Overall Study|Adverse Event|2|||
33274349|NCT04839393|62648465|FG000|Overall Study|Withdrawal by participant|0|||
33274350|NCT04839393|62648466|FG001|Overall Study|Withdrawal by participant|0|||
33274351|NCT04839393|62648467|FG002|Overall Study|Withdrawal by participant|1|||
33274352|NCT04677712|62648542|FG000|Overall Study|Lost to Follow-up|0|||
33274353|NCT04677712|62648543|FG001|Overall Study|Lost to Follow-up|1|||
33274354|NCT04677712|62648544|FG002|Overall Study|Lost to Follow-up|0|||
33274355|NCT04677712|62648545|FG003|Overall Study|Lost to Follow-up|0|||
33274356|NCT04677712|62648546|FG004|Overall Study|Lost to Follow-up|0|||
33274357|NCT04677712|62648547|FG005|Overall Study|Lost to Follow-up|0|||
33274358|NCT04630002|62648574|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
33274359|NCT04630002|62648575|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
33274360|NCT04630002|62648576|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
33274361|NCT04630002|62648574|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
33274362|NCT04630002|62648575|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
33274363|NCT04630002|62648576|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
33274364|NCT04630002|62648574|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
33274365|NCT04630002|62648575|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
33274366|NCT04630002|62648576|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
33274367|NCT04630002|62648574|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
33274368|NCT04630002|62648575|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
33274369|NCT04630002|62648576|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
33274370|NCT04630002|62648574|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
33274371|NCT04630002|62648575|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
33274372|NCT04630002|62648576|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
33274373|NCT04630002|62648574|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
33274374|NCT04630002|62648575|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
33274375|NCT04630002|62648576|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
33274376|NCT04630002|62648574|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
33274377|NCT04630002|62648575|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
33274378|NCT04630002|62648576|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
33274379|NCT04630002|62648574|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
33274380|NCT04630002|62648575|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
33274381|NCT04630002|62648576|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
33274382|NCT04576923|62648609|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
33274383|NCT04526197|62648623|FG000|Period 1|Adverse Event|0|||
33274384|NCT04526197|62648624|FG001|Period 1|Adverse Event|1|||
33274385|NCT04526197|62648623|FG000|Period 1|Withdrawal by Subject|1|||
33274386|NCT04526197|62648624|FG001|Period 1|Withdrawal by Subject|0|||
33274387|NCT04526197|62648623|FG000|Period 2|Adverse Event|0|||
33274388|NCT04526197|62648624|FG001|Period 2|Adverse Event|1|||
33274389|NCT04526197|62648623|FG000|Period 2|Withdrawal by Subject|0|||
33274390|NCT04526197|62648624|FG001|Period 2|Withdrawal by Subject|1|||
33274391|NCT04412668|62648634|FG000|Overall Study|Death - multiple comorbidities|2|||
33274392|NCT04412668|62648635|FG001|Overall Study|Death - multiple comorbidities|0|||
33274393|NCT04412668|62648636|FG002|Overall Study|Death - multiple comorbidities|0|||
33274394|NCT04412668|62648634|FG000|Overall Study|Withdrawal by Subject|3|||
33274395|NCT04412668|62648635|FG001|Overall Study|Withdrawal by Subject|0|||
33274396|NCT04412668|62648636|FG002|Overall Study|Withdrawal by Subject|0|||
33274397|NCT04412668|62648634|FG000|Overall Study|Other than Specified|2|||
33274398|NCT04412668|62648635|FG001|Overall Study|Other than Specified|0|||
33274399|NCT04412668|62648636|FG002|Overall Study|Other than Specified|0|||
33274400|NCT04360551|62648646|FG000|Overall Study|Withdrawal by Subject|1|||
33274401|NCT04360551|62648647|FG001|Overall Study|Withdrawal by Subject|0|||
33274402|NCT04299087|62648655|FG000|Overall Study|Lost to Follow-up|2|||
33662053|NCT02546986|63092798|FG001|Treatment Period|Physician Decision|2|||
33662054|NCT02546986|63092797|FG000|Treatment Period|Protocol Violation|1|||
33274403|NCT04299087|62648656|FG001|Overall Study|Lost to Follow-up|1|||
33274404|NCT04288778|62648662|FG000|Overall Study|Withdrawal by Subject|2|||
33274405|NCT04288778|62648662|FG000|Overall Study|Adverse Event|5|||
33370276|NCT00855062|62749003|FG000|Step1|Early Study Closure|5|||
33370277|NCT00855062|62749004|FG001|Step1|Early Study Closure|7|||
33662055|NCT02546986|63092798|FG001|Treatment Period|Protocol Violation|0|||
33274406|NCT04288778|62648662|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33274407|NCT04288778|62648662|FG000|Overall Study|Other|1|||
33274408|NCT04288778|62648662|FG000|Overall Study|Started but not treated|2|||
33274409|NCT04233164|62648681|FG000|Overall Study|Unable to obtain specimen|0|||
33274410|NCT04233164|62648682|FG001|Overall Study|Unable to obtain specimen|1|||
33274411|NCT04152200|62648698|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
33274412|NCT04152200|62648699|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
33274413|NCT04147195|62648709|FG000|Overall Study|Adverse Event|0|||
33274414|NCT04147195|62648710|FG001|Overall Study|Adverse Event|3|||
33274415|NCT04147195|62648709|FG000|Overall Study|Study Terminated by Sponsor|4|||
33274416|NCT04147195|62648710|FG001|Overall Study|Study Terminated by Sponsor|2|||
33274417|NCT04147195|62648709|FG000|Overall Study|Withdrawal by Subject|0|||
33274418|NCT04147195|62648710|FG001|Overall Study|Withdrawal by Subject|1|||
33274419|NCT04092816|62648723|FG000|Overall Study|Lost to Follow-up|1|||
33274420|NCT04092816|62648724|FG001|Overall Study|Lost to Follow-up|2|||
33274421|NCT03985878|62648741|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
33274422|NCT03985878|62648741|FG000|Overall Study|Study Terminated by Sponsor|12|||
33274423|NCT03985878|62648741|FG000|Overall Study|Withdrawal by Subject|1|||
33274424|NCT03946670|62648806|FG000|Overall Study|Progressive Disease|26|||
33274425|NCT03946670|62648807|FG001|Overall Study|Progressive Disease|23|||
33274426|NCT03946670|62648806|FG000|Overall Study|Adverse Event|7|||
33274427|NCT03946670|62648807|FG001|Overall Study|Adverse Event|9|||
33274428|NCT03946670|62648806|FG000|Overall Study|Death|5|||
33274429|NCT03946670|62648807|FG001|Overall Study|Death|6|||
33274430|NCT03946670|62648806|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
33274431|NCT03946670|62648807|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
33274432|NCT03946670|62648806|FG000|Overall Study|Subject Decision|4|||
33274433|NCT03946670|62648807|FG001|Overall Study|Subject Decision|4|||
33274434|NCT03946670|62648806|FG000|Overall Study|Physician Decision|3|||
33274435|NCT03946670|62648807|FG001|Overall Study|Physician Decision|3|||
33274436|NCT03946670|62648806|FG000|Overall Study|New Therapy for Study Indication|1|||
33274437|NCT03946670|62648807|FG001|Overall Study|New Therapy for Study Indication|0|||
33274438|NCT03946670|62648806|FG000|Overall Study|Not treated|1|||
33274439|NCT03946670|62648807|FG001|Overall Study|Not treated|1|||
33370278|NCT00855062|62749003|FG000|Step1|Adverse Event|1|||
33555723|NCT01369511|62948550|FG002|Overall Study|Physician Decision|0|||
33555724|NCT01369511|62948551|FG003|Overall Study|Physician Decision|0|||
33555725|NCT01369511|62948548|FG000|Overall Study|Sponsor decision|2|||
33555726|NCT01369511|62948549|FG001|Overall Study|Sponsor decision|0|||
33555727|NCT01369511|62948550|FG002|Overall Study|Sponsor decision|1|||
33555728|NCT01369511|62948551|FG003|Overall Study|Sponsor decision|0|||
33555729|NCT01369511|62948548|FG000|Overall Study|Withdrawal by Subject|5|||
33555730|NCT01369511|62948549|FG001|Overall Study|Withdrawal by Subject|6|||
33555731|NCT01369511|62948550|FG002|Overall Study|Withdrawal by Subject|4|||
33555732|NCT01369511|62948551|FG003|Overall Study|Withdrawal by Subject|6|||
33555733|NCT01369433|62948563|FG000|Overall Study|Adverse Event|31|||
33555734|NCT01369433|62948564|FG001|Overall Study|Adverse Event|1|||
33555735|NCT01369433|62948563|FG000|Overall Study|Required significant surgical procedure|1|||
33555736|NCT01369433|62948564|FG001|Overall Study|Required significant surgical procedure|0|||
33555737|NCT01369433|62948563|FG000|Overall Study|Non-compliance|1|||
33555738|NCT01369433|62948564|FG001|Overall Study|Non-compliance|0|||
33555739|NCT01369433|62948563|FG000|Overall Study|Withdrawal by Subject|5|||
33555740|NCT01369433|62948564|FG001|Overall Study|Withdrawal by Subject|2|||
33555741|NCT01369433|62948563|FG000|Overall Study|Study terminated by Sponsor|67|||
33555742|NCT01369433|62948564|FG001|Overall Study|Study terminated by Sponsor|0|||
33555743|NCT01369433|62948563|FG000|Overall Study|Lost to Follow-up|1|||
33555744|NCT01369433|62948564|FG001|Overall Study|Lost to Follow-up|0|||
33555745|NCT01369433|62948563|FG000|Overall Study|Death|5|||
33555746|NCT01369433|62948564|FG001|Overall Study|Death|0|||
33555747|NCT01369433|62948563|FG000|Overall Study|Investigator discretion|6|||
33555748|NCT01369433|62948564|FG001|Overall Study|Investigator discretion|1|||
33555749|NCT01369433|62948563|FG000|Overall Study|Progressive Disease|92|||
33555750|NCT01369433|62948564|FG001|Overall Study|Progressive Disease|12|||
33555751|NCT02624492|62948573|FG000|Overall Study|Adverse Event|2|||
33555752|NCT02624492|62948574|FG001|Overall Study|Adverse Event|2|||
33555753|NCT02624492|62948575|FG002|Overall Study|Adverse Event|2|||
33274440|NCT03774394|62648832|FG000|Overall Study|Withdrawal by Subject|2|||
33274441|NCT03774394|62648833|FG001|Overall Study|Withdrawal by Subject|0|||
33274442|NCT03765788|62648841|FG000|Overall Study|Subject decision|2|||
33274443|NCT03765788|62648842|FG001|Overall Study|Subject decision|3|||
33555754|NCT02624492|62948573|FG000|Overall Study|Progressive disease|0|||
33555755|NCT02624492|62948574|FG001|Overall Study|Progressive disease|2|||
33555756|NCT02624492|62948575|FG002|Overall Study|Progressive disease|3|||
33555757|NCT01975831|62948592|FG000|Overall Study|Adverse Event|1|||
33555758|NCT01975831|62948593|FG001|Overall Study|Adverse Event|2|||
33555759|NCT01975831|62948594|FG002|Overall Study|Adverse Event|2|||
33555760|NCT01975831|62948595|FG003|Overall Study|Adverse Event|0|||
33274444|NCT03765788|62648841|FG000|Overall Study|Physician Decision|2|||
33274445|NCT03765788|62648842|FG001|Overall Study|Physician Decision|4|||
33274446|NCT03765788|62648841|FG000|Overall Study|Death|0|||
33274447|NCT03765788|62648842|FG001|Overall Study|Death|1|||
33274448|NCT03765788|62648841|FG000|Overall Study|Lost to Follow-up|1|||
33274449|NCT03765788|62648842|FG001|Overall Study|Lost to Follow-up|0|||
33274450|NCT03692403|62648853|FG000|Overall Study|Withdrawal by Subject|1|||
33274451|NCT03692403|62648854|FG001|Overall Study|Withdrawal by Subject|0|||
33274452|NCT03692403|62648855|FG002|Overall Study|Withdrawal by Subject|1|||
33274453|NCT03692403|62648856|FG003|Overall Study|Withdrawal by Subject|0|||
33274454|NCT03692403|62648853|FG000|Overall Study|Adverse Event|0|||
33274455|NCT03692403|62648854|FG001|Overall Study|Adverse Event|0|||
33274456|NCT03692403|62648855|FG002|Overall Study|Adverse Event|0|||
33274457|NCT03692403|62648856|FG003|Overall Study|Adverse Event|1|||
33274458|NCT03692403|62648853|FG000|Overall Study|Pregnancy|0|||
33274459|NCT03692403|62648854|FG001|Overall Study|Pregnancy|1|||
33274460|NCT03692403|62648855|FG002|Overall Study|Pregnancy|0|||
33274461|NCT03692403|62648856|FG003|Overall Study|Pregnancy|0|||
33274462|NCT03692403|62648853|FG000|Overall Study|Other|0|||
33274463|NCT03692403|62648854|FG001|Overall Study|Other|0|||
33274464|NCT03692403|62648855|FG002|Overall Study|Other|1|||
33274465|NCT03692403|62648856|FG003|Overall Study|Other|0|||
33274466|NCT03654651|62648871|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
33274467|NCT03654651|62648872|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
33274468|NCT03649230|62648879|FG000|Overall Study|Adverse Event|12|||
33274469|NCT03649230|62648879|FG000|Overall Study|Death|8|||
33274470|NCT03649230|62648879|FG000|Overall Study|Withdrawal by Subject|6|||
33274471|NCT03649230|62648879|FG000|Overall Study|Physician Decision|5|||
33274472|NCT03649230|62648879|FG000|Overall Study|Disease progression|5|||
33274473|NCT03649230|62648879|FG000|Overall Study|Switched to non-HEC|5|||
33274474|NCT03649230|62648879|FG000|Overall Study|Chemotherapy discontinued|4|||
33274475|NCT03649230|62648879|FG000|Overall Study|Received only 3 HEC cycles|4|||
33274476|NCT03649230|62648879|FG000|Overall Study|Screen Failure|3|||
33274477|NCT03649230|62648879|FG000|Overall Study|Patient stopped treatment|2|||
33274478|NCT03649230|62648879|FG000|Overall Study|Protocol Violation|1|||
33274479|NCT03649230|62648879|FG000|Overall Study|Non-compliance|1|||
33274480|NCT03649230|62648879|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
33274481|NCT03626545|62648890|FG000|Overall Study|Progressive disease|3|||
33274482|NCT03626545|62648891|FG001|Overall Study|Progressive disease|82|||
33274483|NCT03626545|62648892|FG002|Overall Study|Progressive disease|85|||
33274484|NCT03626545|62648890|FG000|Overall Study|Adverse Event|3|||
33274485|NCT03626545|62648891|FG001|Overall Study|Adverse Event|13|||
33274486|NCT03626545|62648892|FG002|Overall Study|Adverse Event|10|||
33274487|NCT03626545|62648890|FG000|Overall Study|Physician Decision|1|||
33274488|NCT03626545|62648891|FG001|Overall Study|Physician Decision|18|||
33274489|NCT03626545|62648892|FG002|Overall Study|Physician Decision|14|||
33274490|NCT03626545|62648890|FG000|Overall Study|Subject Decision|0|||
33274491|NCT03626545|62648891|FG001|Overall Study|Subject Decision|5|||
33274492|NCT03626545|62648892|FG002|Overall Study|Subject Decision|5|||
33274493|NCT03626545|62648890|FG000|Overall Study|Death|1|||
33274494|NCT03626545|62648891|FG001|Overall Study|Death|1|||
33274495|NCT03626545|62648892|FG002|Overall Study|Death|1|||
33274496|NCT03626545|62648890|FG000|Overall Study|Protocol Deviation|0|||
33274497|NCT03626545|62648891|FG001|Overall Study|Protocol Deviation|1|||
33274498|NCT03626545|62648892|FG002|Overall Study|Protocol Deviation|1|||
33274499|NCT03626545|62648890|FG000|Overall Study|Guardian Decision|0|||
33274500|NCT03626545|62648891|FG001|Overall Study|Guardian Decision|0|||
33274501|NCT03626545|62648892|FG002|Overall Study|Guardian Decision|1|||
33274502|NCT03575143|62648909|FG000|Overall Study|Lost to Follow-up|0|||
33370279|NCT00855062|62749004|FG001|Step1|Adverse Event|1|||
33370280|NCT00855062|62749003|FG000|Step1|Protocol Violation|1|||
33370281|NCT00855062|62749004|FG001|Step1|Protocol Violation|0|||
33555761|NCT01975831|62948596|FG004|Overall Study|Adverse Event|1|||
33274503|NCT03575143|62648910|FG001|Overall Study|Lost to Follow-up|0|||
33274504|NCT03575143|62648911|FG002|Overall Study|Lost to Follow-up|4|||
33274505|NCT03575143|62648909|FG000|Overall Study|Withdrawal by Subject|0|||
33274506|NCT03575143|62648910|FG001|Overall Study|Withdrawal by Subject|0|||
33274507|NCT03575143|62648911|FG002|Overall Study|Withdrawal by Subject|5|||
33274508|NCT03575143|62648909|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
33274509|NCT03575143|62648910|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
33274510|NCT03575143|62648911|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
33274511|NCT03548064|62648929|FG000|Overall Study|Withdrawal by Subject|0|||
33274512|NCT03548064|62648930|FG001|Overall Study|Withdrawal by Subject|0|||
33274513|NCT03548064|62648931|FG002|Overall Study|Withdrawal by Subject|0|||
33274514|NCT03548064|62648932|FG003|Overall Study|Withdrawal by Subject|1|||
33274515|NCT03548064|62648933|FG004|Overall Study|Withdrawal by Subject|0|||
33274516|NCT03548064|62648934|FG005|Overall Study|Withdrawal by Subject|0|||
33274517|NCT03548064|62648935|FG006|Overall Study|Withdrawal by Subject|0|||
33370282|NCT00855062|62749003|FG000|Step1|Pregnancy|1|||
33274518|NCT03548064|62648936|FG007|Overall Study|Withdrawal by Subject|0|||
33274519|NCT03548064|62648929|FG000|Overall Study|Lost to Follow-up|0|||
33274520|NCT03548064|62648930|FG001|Overall Study|Lost to Follow-up|0|||
33274521|NCT03548064|62648931|FG002|Overall Study|Lost to Follow-up|0|||
33274522|NCT03548064|62648932|FG003|Overall Study|Lost to Follow-up|0|||
33274523|NCT03548064|62648933|FG004|Overall Study|Lost to Follow-up|2|||
33274524|NCT03548064|62648934|FG005|Overall Study|Lost to Follow-up|0|||
33274525|NCT03548064|62648935|FG006|Overall Study|Lost to Follow-up|0|||
33274526|NCT03548064|62648936|FG007|Overall Study|Lost to Follow-up|0|||
33274527|NCT03548064|62648929|FG000|Overall Study|Covid-19 Pandemic|0|||
33274528|NCT03548064|62648930|FG001|Overall Study|Covid-19 Pandemic|0|||
33274529|NCT03548064|62648931|FG002|Overall Study|Covid-19 Pandemic|0|||
33274530|NCT03548064|62648932|FG003|Overall Study|Covid-19 Pandemic|0|||
33274531|NCT03548064|62648933|FG004|Overall Study|Covid-19 Pandemic|10|||
33274532|NCT03548064|62648934|FG005|Overall Study|Covid-19 Pandemic|3|||
33274533|NCT03548064|62648935|FG006|Overall Study|Covid-19 Pandemic|0|||
33274534|NCT03548064|62648936|FG007|Overall Study|Covid-19 Pandemic|0|||
33274535|NCT03512197|62648962|FG000|Overall Study|Guardian decision|1|||
33274536|NCT03512197|62648963|FG001|Overall Study|Guardian decision|1|||
33274537|NCT03512197|62648962|FG000|Overall Study|Lack of Efficacy|19|||
33274538|NCT03512197|62648963|FG001|Overall Study|Lack of Efficacy|11|||
33274539|NCT03512197|62648962|FG000|Overall Study|New Therapy for Study Indication|16|||
33274540|NCT03512197|62648963|FG001|Overall Study|New Therapy for Study Indication|16|||
33274541|NCT03512197|62648962|FG000|Overall Study|Physician Decision|60|||
33274542|NCT03512197|62648963|FG001|Overall Study|Physician Decision|60|||
33274543|NCT03512197|62648962|FG000|Overall Study|Protocol Violation|0|||
33274544|NCT03512197|62648963|FG001|Overall Study|Protocol Violation|2|||
33274545|NCT03512197|62648962|FG000|Overall Study|Terminated by Sponsored|46|||
33274546|NCT03512197|62648963|FG001|Overall Study|Terminated by Sponsored|50|||
33274547|NCT03512197|62648962|FG000|Overall Study|Subject Decision|15|||
33274548|NCT03512197|62648963|FG001|Overall Study|Subject Decision|12|||
33274549|NCT03512197|62648962|FG000|Overall Study|Withdrawal of informed consent|20|||
33274550|NCT03512197|62648963|FG001|Overall Study|Withdrawal of informed consent|14|||
33274551|NCT03512197|62648962|FG000|Overall Study|Adverse Event|30|||
33274552|NCT03512197|62648963|FG001|Overall Study|Adverse Event|34|||
33274553|NCT03512197|62648962|FG000|Overall Study|Death|14|||
33274554|NCT03512197|62648963|FG001|Overall Study|Death|9|||
33274555|NCT03512197|62648962|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
33274556|NCT03512197|62648963|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
33274557|NCT03512197|62648962|FG000|Overall Study|Missing|3|||
33274558|NCT03512197|62648963|FG001|Overall Study|Missing|13|||
33274559|NCT03502330|62648983|FG000|Overall Study|Adverse Event|2|||
33274560|NCT03502330|62648984|FG001|Overall Study|Adverse Event|1|||
33274561|NCT03502330|62648985|FG002|Overall Study|Adverse Event|0|||
33274562|NCT03502330|62648986|FG003|Overall Study|Adverse Event|0|||
33274563|NCT03502330|62648987|FG004|Overall Study|Adverse Event|1|||
33274564|NCT03502330|62648988|FG005|Overall Study|Adverse Event|0|||
33274565|NCT03502330|62648989|FG006|Overall Study|Adverse Event|1|||
33274566|NCT03502330|62648990|FG007|Overall Study|Adverse Event|1|||
33274567|NCT03502330|62648991|FG008|Overall Study|Adverse Event|0|||
33274568|NCT03502330|62648983|FG000|Overall Study|Lack of Efficacy|1|||
33274569|NCT03502330|62648984|FG001|Overall Study|Lack of Efficacy|5|||
33274570|NCT03502330|62648985|FG002|Overall Study|Lack of Efficacy|3|||
33274571|NCT03502330|62648986|FG003|Overall Study|Lack of Efficacy|5|||
33274572|NCT03502330|62648987|FG004|Overall Study|Lack of Efficacy|1|||
33274573|NCT03502330|62648988|FG005|Overall Study|Lack of Efficacy|5|||
33274574|NCT03502330|62648989|FG006|Overall Study|Lack of Efficacy|5|||
33274575|NCT03502330|62648990|FG007|Overall Study|Lack of Efficacy|6|||
33274576|NCT03502330|62648991|FG008|Overall Study|Lack of Efficacy|0|||
33485656|NCT02792218|62863372|FG001|Overall Study|New therapy for study indication|1|||
33485657|NCT02792218|62863371|FG000|Overall Study|Non-compliance with study treatment|0|||
33485658|NCT02792218|62863372|FG001|Overall Study|Non-compliance with study treatment|1|||
33485659|NCT02792218|62863371|FG000|Overall Study|Pregnancy|1|||
33555762|NCT01975831|62948597|FG005|Overall Study|Adverse Event|1|||
33274577|NCT03502330|62648983|FG000|Overall Study|Physician Decision|0|||
33274578|NCT03502330|62648984|FG001|Overall Study|Physician Decision|0|||
33274579|NCT03502330|62648985|FG002|Overall Study|Physician Decision|0|||
33274580|NCT03502330|62648986|FG003|Overall Study|Physician Decision|0|||
33274581|NCT03502330|62648987|FG004|Overall Study|Physician Decision|1|||
33274582|NCT03502330|62648988|FG005|Overall Study|Physician Decision|0|||
33274583|NCT03502330|62648989|FG006|Overall Study|Physician Decision|0|||
33274584|NCT03502330|62648990|FG007|Overall Study|Physician Decision|0|||
33274585|NCT03502330|62648991|FG008|Overall Study|Physician Decision|0|||
33274586|NCT03502330|62648983|FG000|Overall Study|Withdrawal by Subject|0|||
33274587|NCT03502330|62648984|FG001|Overall Study|Withdrawal by Subject|0|||
33274588|NCT03502330|62648985|FG002|Overall Study|Withdrawal by Subject|0|||
33274589|NCT03502330|62648986|FG003|Overall Study|Withdrawal by Subject|0|||
33274590|NCT03502330|62648987|FG004|Overall Study|Withdrawal by Subject|0|||
33485660|NCT02792218|62863372|FG001|Overall Study|Pregnancy|0|||
33274591|NCT03502330|62648988|FG005|Overall Study|Withdrawal by Subject|1|||
33274592|NCT03502330|62648989|FG006|Overall Study|Withdrawal by Subject|0|||
33274593|NCT03502330|62648990|FG007|Overall Study|Withdrawal by Subject|1|||
33274594|NCT03502330|62648991|FG008|Overall Study|Withdrawal by Subject|0|||
33274595|NCT03502330|62648983|FG000|Overall Study|Death|0|||
33274596|NCT03502330|62648984|FG001|Overall Study|Death|0|||
33274597|NCT03502330|62648985|FG002|Overall Study|Death|0|||
33274598|NCT03502330|62648986|FG003|Overall Study|Death|0|||
33274599|NCT03502330|62648987|FG004|Overall Study|Death|0|||
33274600|NCT03502330|62648988|FG005|Overall Study|Death|0|||
33274601|NCT03502330|62648989|FG006|Overall Study|Death|2|||
33274602|NCT03502330|62648990|FG007|Overall Study|Death|0|||
33274603|NCT03502330|62648991|FG008|Overall Study|Death|0|||
33274604|NCT03460756|62649013|FG000|Overall Study|Adverse Event|0|||
33274605|NCT03460756|62649014|FG001|Overall Study|Adverse Event|0|||
33274606|NCT03460756|62649015|FG002|Overall Study|Adverse Event|0|||
33274607|NCT03460756|62649016|FG003|Overall Study|Adverse Event|1|||
33274608|NCT03460756|62649013|FG000|Overall Study|Lack of Efficacy|0|||
33274609|NCT03460756|62649014|FG001|Overall Study|Lack of Efficacy|0|||
33274610|NCT03460756|62649015|FG002|Overall Study|Lack of Efficacy|0|||
33274611|NCT03460756|62649016|FG003|Overall Study|Lack of Efficacy|2|||
33274612|NCT03460756|62649013|FG000|Overall Study|Lost to Follow-up|0|||
33274613|NCT03460756|62649014|FG001|Overall Study|Lost to Follow-up|1|||
33274614|NCT03460756|62649015|FG002|Overall Study|Lost to Follow-up|2|||
33274615|NCT03460756|62649016|FG003|Overall Study|Lost to Follow-up|1|||
33274616|NCT03460756|62649013|FG000|Overall Study|Pregnancy|0|||
33274617|NCT03460756|62649014|FG001|Overall Study|Pregnancy|0|||
33274618|NCT03460756|62649015|FG002|Overall Study|Pregnancy|0|||
33274619|NCT03460756|62649016|FG003|Overall Study|Pregnancy|1|||
33274620|NCT03460756|62649013|FG000|Overall Study|Protocol Violation|0|||
33274621|NCT03460756|62649014|FG001|Overall Study|Protocol Violation|0|||
33274622|NCT03460756|62649015|FG002|Overall Study|Protocol Violation|0|||
33274623|NCT03460756|62649016|FG003|Overall Study|Protocol Violation|1|||
33274624|NCT03460756|62649013|FG000|Overall Study|Withdrawal by Subject|0|||
33274625|NCT03460756|62649014|FG001|Overall Study|Withdrawal by Subject|4|||
33274626|NCT03460756|62649015|FG002|Overall Study|Withdrawal by Subject|7|||
33274627|NCT03460756|62649016|FG003|Overall Study|Withdrawal by Subject|3|||
33274628|NCT03459443|62649028|FG000|Overall Study|Lack of Efficacy|3|||
33274629|NCT03459443|62649028|FG000|Overall Study|Adverse Event|1|||
33274630|NCT03459443|62649028|FG000|Overall Study|Sponsor's decision to close the study|18|||
33274631|NCT03382834|62649034|FG000|Overall Study|Lost to Follow-up|1|||
33274632|NCT03382834|62649035|FG001|Overall Study|Lost to Follow-up|0|||
33274633|NCT03382834|62649034|FG000|Overall Study|Withdrawal by Subject|0|||
33274634|NCT03382834|62649035|FG001|Overall Study|Withdrawal by Subject|1|||
33274635|NCT03367156|62649043|FG000|Overall Study|Lack of interest|3|||
33274636|NCT03367156|62649044|FG001|Overall Study|Lack of interest|1|||
33274637|NCT03367156|62649043|FG000|Overall Study|Death|2|||
33274638|NCT03367156|62649044|FG001|Overall Study|Death|0|||
33274639|NCT03367156|62649043|FG000|Overall Study|Lost to Follow-up|2|||
33274640|NCT03367156|62649044|FG001|Overall Study|Lost to Follow-up|1|||
33274641|NCT03367156|62649043|FG000|Overall Study|Became ineligible|1|||
33274642|NCT03367156|62649044|FG001|Overall Study|Became ineligible|2|||
33274643|NCT03367156|62649043|FG000|Overall Study|Hospitalization|1|||
33274644|NCT03367156|62649044|FG001|Overall Study|Hospitalization|0|||
33274645|NCT03367156|62649043|FG000|Overall Study|Concerned about Treatment|11|||
33274646|NCT03367156|62649044|FG001|Overall Study|Concerned about Treatment|3|||
33274647|NCT03367156|62649043|FG000|Overall Study|Started new treatment|4|||
33274648|NCT03367156|62649044|FG001|Overall Study|Started new treatment|1|||
33274649|NCT03316885|62649061|FG000|Overall Study|Adverse Event|1|||
33370283|NCT00855062|62749004|FG001|Step1|Pregnancy|0|||
33274650|NCT03316885|62649061|FG000|Overall Study|Death|10|||
33274651|NCT03316885|62649061|FG000|Overall Study|Lost to Follow-up|4|||
33274652|NCT03316885|62649061|FG000|Overall Study|Withdrawal by Subject|9|||
33274653|NCT03316885|62649061|FG000|Overall Study|COVID related|8|||
33274654|NCT03259074|62649093|FG000|Overall Study|Adverse Event|9|||
33274655|NCT03259074|62649094|FG001|Overall Study|Adverse Event|12|||
33274656|NCT03259074|62649095|FG002|Overall Study|Adverse Event|8|||
33274657|NCT03259074|62649093|FG000|Overall Study|Death|1|||
33274658|NCT03259074|62649094|FG001|Overall Study|Death|1|||
33274659|NCT03259074|62649095|FG002|Overall Study|Death|3|||
33274660|NCT03259074|62649093|FG000|Overall Study|Lost to Follow-up|2|||
33370284|NCT00855062|62749003|FG000|Step1|Withdrawal by Subject|2|||
33274661|NCT03259074|62649094|FG001|Overall Study|Lost to Follow-up|4|||
33274662|NCT03259074|62649095|FG002|Overall Study|Lost to Follow-up|3|||
33274663|NCT03259074|62649093|FG000|Overall Study|New Therapy For Study Indication|1|||
33274664|NCT03259074|62649094|FG001|Overall Study|New Therapy For Study Indication|2|||
33274665|NCT03259074|62649095|FG002|Overall Study|New Therapy For Study Indication|2|||
33274666|NCT03259074|62649093|FG000|Overall Study|Physician Decision|4|||
33274667|NCT03259074|62649094|FG001|Overall Study|Physician Decision|12|||
33274668|NCT03259074|62649095|FG002|Overall Study|Physician Decision|10|||
33274669|NCT03259074|62649093|FG000|Overall Study|Pregnancy|1|||
33274670|NCT03259074|62649094|FG001|Overall Study|Pregnancy|1|||
33274671|NCT03259074|62649095|FG002|Overall Study|Pregnancy|0|||
33274672|NCT03259074|62649093|FG000|Overall Study|Progressive Disease|1|||
33274673|NCT03259074|62649094|FG001|Overall Study|Progressive Disease|0|||
33274674|NCT03259074|62649095|FG002|Overall Study|Progressive Disease|0|||
33274675|NCT03259074|62649093|FG000|Overall Study|Protocol Deviation|1|||
33274676|NCT03259074|62649094|FG001|Overall Study|Protocol Deviation|1|||
33274677|NCT03259074|62649095|FG002|Overall Study|Protocol Deviation|3|||
33274678|NCT03259074|62649093|FG000|Overall Study|Subject/Guardian Decision|13|||
33274679|NCT03259074|62649094|FG001|Overall Study|Subject/Guardian Decision|16|||
33274680|NCT03259074|62649095|FG002|Overall Study|Subject/Guardian Decision|14|||
33274681|NCT03159104|62649105|FG000|Overall Study|Violation of inclusion criteria|1|||
33274682|NCT03159104|62649106|FG001|Overall Study|Violation of inclusion criteria|2|||
33274683|NCT03149237|62649114|FG000|Overall Study|Withdrawal by Subject|4|||
33274684|NCT03149237|62649115|FG001|Overall Study|Withdrawal by Subject|5|||
33274685|NCT03132467|62649121|FG000|Overall Study|Adverse Event|2|||
33274686|NCT03132467|62649121|FG000|Overall Study|Withdrawal by Subject|2|||
33274687|NCT03127852|62649128|FG000|Overall Study|Withdrawal by Subject|4|||
33274688|NCT03127852|62649129|FG001|Overall Study|Withdrawal by Subject|1|||
33274689|NCT03127852|62649128|FG000|Overall Study|Death|1|||
33274690|NCT03127852|62649129|FG001|Overall Study|Death|1|||
33274691|NCT03107793|62649135|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
33274692|NCT03107793|62649136|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
33274693|NCT03107793|62649137|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
33274694|NCT03107793|62649138|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
33274695|NCT03107793|62649139|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
33274696|NCT03107793|62649135|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
33274697|NCT03107793|62649136|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
33274698|NCT03107793|62649137|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
33274699|NCT03107793|62649138|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
33274700|NCT03107793|62649139|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
33274701|NCT03107793|62649135|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
33274702|NCT03107793|62649136|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
33274703|NCT03107793|62649137|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
33274704|NCT03107793|62649138|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
33274705|NCT03107793|62649139|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
33274706|NCT03107793|62649135|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
33274707|NCT03107793|62649136|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33274708|NCT03107793|62649137|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33274709|NCT03107793|62649138|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33274710|NCT03107793|62649139|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33274711|NCT03107793|62649135|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
33274712|NCT03107793|62649136|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
33274713|NCT03107793|62649137|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
33274714|NCT03107793|62649138|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
33274715|NCT03107793|62649139|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
33274716|NCT03107793|62649135|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
33274717|NCT03107793|62649136|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
33274718|NCT03107793|62649137|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
33274719|NCT03107793|62649138|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
33274720|NCT03107793|62649139|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
33274721|NCT03107793|62649135|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
33274722|NCT03107793|62649136|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
33274723|NCT03107793|62649137|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
33274724|NCT03107793|62649138|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
33274725|NCT03107793|62649139|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
33274726|NCT03107793|62649135|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
33274727|NCT03107793|62649136|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
33274728|NCT03107793|62649137|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
33274729|NCT03107793|62649138|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
33274730|NCT03107793|62649139|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
33274731|NCT03107793|62649135|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
33274732|NCT03107793|62649136|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
33274733|NCT03107793|62649137|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
33274734|NCT03107793|62649138|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
33274735|NCT03107793|62649139|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
33274736|NCT03107793|62649135|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
33274737|NCT03107793|62649136|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
33274738|NCT03107793|62649137|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
33274739|NCT03107793|62649138|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
33274740|NCT03107793|62649139|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
33274741|NCT03107793|62649135|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
33274742|NCT03107793|62649136|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
33274743|NCT03107793|62649137|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
33274744|NCT03107793|62649138|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
33274745|NCT03107793|62649139|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
33274746|NCT03107793|62649135|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
33274747|NCT03107793|62649136|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
33274748|NCT03107793|62649137|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
33274749|NCT03107793|62649138|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
33274750|NCT03107793|62649139|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
33274751|NCT03107793|62649135|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
33274752|NCT03107793|62649136|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
33274753|NCT03107793|62649137|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
33274754|NCT03107793|62649138|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
33274755|NCT03107793|62649139|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
33274756|NCT03107793|62649135|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
33274757|NCT03107793|62649136|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
33274758|NCT03107793|62649137|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
33274759|NCT03107793|62649138|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
33274760|NCT03107793|62649139|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
33274761|NCT03107793|62649135|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
33274762|NCT03107793|62649136|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
33274763|NCT03107793|62649137|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
33274764|NCT03107793|62649138|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
33274765|NCT03107793|62649139|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
33274766|NCT03107793|62649135|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
33274767|NCT03107793|62649136|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
33274768|NCT03107793|62649137|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
33274769|NCT03107793|62649138|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
33274770|NCT03107793|62649139|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
33274771|NCT03107793|62649135|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
33274772|NCT03107793|62649136|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
33274773|NCT03107793|62649137|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
33274774|NCT03107793|62649138|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
33274775|NCT03107793|62649139|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
33274776|NCT03107793|62649135|FG000|Extension Period (Week 48- Week 104)|Death|0|||
33274777|NCT03107793|62649136|FG001|Extension Period (Week 48- Week 104)|Death|0|||
33274778|NCT03107793|62649137|FG002|Extension Period (Week 48- Week 104)|Death|0|||
33274779|NCT03107793|62649138|FG003|Extension Period (Week 48- Week 104)|Death|0|||
33274780|NCT03107793|62649139|FG004|Extension Period (Week 48- Week 104)|Death|1|||
33274781|NCT03107793|62649135|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
33274782|NCT03107793|62649136|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
33274783|NCT03107793|62649137|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
33274784|NCT03107793|62649138|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
33274785|NCT03107793|62649139|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
33274786|NCT03107793|62649135|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
33274787|NCT03107793|62649136|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
33274788|NCT03107793|62649137|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
33274789|NCT03107793|62649138|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
33274790|NCT03107793|62649139|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
33274791|NCT03107793|62649135|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
33274792|NCT03107793|62649136|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
33274793|NCT03107793|62649137|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
33274794|NCT03107793|62649138|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
33274795|NCT03107793|62649139|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
33274796|NCT03107793|62649135|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
33274797|NCT03107793|62649136|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
33274798|NCT03107793|62649137|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
33274799|NCT03107793|62649138|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
33274800|NCT03107793|62649139|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
33274801|NCT03107793|62649135|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
33370285|NCT00855062|62749004|FG001|Step1|Withdrawal by Subject|3|||
33370286|NCT00855062|62749003|FG000|Step2|Early Study Closure|6|||
33485661|NCT00153101|62863383|FG000|Overall Study|Lost to Follow-up|14|||
33485662|NCT00153101|62863384|FG001|Overall Study|Lost to Follow-up|14|||
33274802|NCT03107793|62649136|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
33274803|NCT03107793|62649137|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
33274804|NCT03107793|62649138|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
33274805|NCT03107793|62649139|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
33274806|NCT03107793|62649135|FG000|Extension Period (Week 48- Week 104)|Other|0|||
33274807|NCT03107793|62649136|FG001|Extension Period (Week 48- Week 104)|Other|0|||
33274808|NCT03107793|62649137|FG002|Extension Period (Week 48- Week 104)|Other|0|||
33274809|NCT03107793|62649138|FG003|Extension Period (Week 48- Week 104)|Other|1|||
33274810|NCT03107793|62649139|FG004|Extension Period (Week 48- Week 104)|Other|3|||
33274811|NCT03107793|62649135|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
33274812|NCT03107793|62649136|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
33274813|NCT03107793|62649137|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
33274814|NCT03107793|62649138|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
33274815|NCT03107793|62649139|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
33274816|NCT03013543|62649158|FG000|Overall Study|Withdrawal by Subject|0|||
33274817|NCT03013543|62649159|FG001|Overall Study|Withdrawal by Subject|2|||
33274818|NCT03013543|62649160|FG002|Overall Study|Withdrawal by Subject|0|||
33274819|NCT03013543|62649161|FG003|Overall Study|Withdrawal by Subject|5|||
33274820|NCT03013543|62649162|FG004|Overall Study|Withdrawal by Subject|6|||
33274821|NCT03013543|62649163|FG005|Overall Study|Withdrawal by Subject|2|||
33274822|NCT03013543|62649164|FG006|Overall Study|Withdrawal by Subject|3|||
33274823|NCT03013543|62649165|FG007|Overall Study|Withdrawal by Subject|1|||
33274824|NCT03013543|62649166|FG008|Overall Study|Withdrawal by Subject|0|||
33274825|NCT03013543|62649167|FG009|Overall Study|Withdrawal by Subject|4|||
33274826|NCT03013543|62649158|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
33274827|NCT03013543|62649159|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
33274828|NCT03013543|62649160|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
33274829|NCT03013543|62649161|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
33274830|NCT03013543|62649162|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
33274831|NCT03013543|62649163|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
33274832|NCT03013543|62649164|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
33274833|NCT03013543|62649165|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
33274834|NCT03013543|62649166|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
33274835|NCT03013543|62649167|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
33274836|NCT03013543|62649158|FG000|Overall Study|Other|0|||
33274837|NCT03013543|62649159|FG001|Overall Study|Other|0|||
33274838|NCT03013543|62649160|FG002|Overall Study|Other|2|||
33274839|NCT03013543|62649161|FG003|Overall Study|Other|0|||
33274840|NCT03013543|62649162|FG004|Overall Study|Other|2|||
33274841|NCT03013543|62649163|FG005|Overall Study|Other|0|||
33274842|NCT03013543|62649164|FG006|Overall Study|Other|0|||
33274843|NCT03013543|62649165|FG007|Overall Study|Other|0|||
33274844|NCT03013543|62649166|FG008|Overall Study|Other|1|||
33274845|NCT03013543|62649167|FG009|Overall Study|Other|0|||
33274846|NCT03013543|62649158|FG000|Overall Study|Adverse Event|0|||
33274847|NCT03013543|62649159|FG001|Overall Study|Adverse Event|0|||
33274848|NCT03013543|62649160|FG002|Overall Study|Adverse Event|0|||
33274849|NCT03013543|62649161|FG003|Overall Study|Adverse Event|3|||
33274850|NCT03013543|62649162|FG004|Overall Study|Adverse Event|2|||
33274851|NCT03013543|62649163|FG005|Overall Study|Adverse Event|1|||
33274852|NCT03013543|62649164|FG006|Overall Study|Adverse Event|3|||
33274853|NCT03013543|62649165|FG007|Overall Study|Adverse Event|8|||
33274854|NCT03013543|62649166|FG008|Overall Study|Adverse Event|0|||
33274855|NCT03013543|62649167|FG009|Overall Study|Adverse Event|2|||
33274856|NCT03013543|62649158|FG000|Overall Study|Death|0|||
33274857|NCT03013543|62649159|FG001|Overall Study|Death|0|||
33274858|NCT03013543|62649160|FG002|Overall Study|Death|0|||
33274859|NCT03013543|62649161|FG003|Overall Study|Death|1|||
33274860|NCT03013543|62649162|FG004|Overall Study|Death|0|||
33274861|NCT03013543|62649163|FG005|Overall Study|Death|0|||
33274862|NCT03013543|62649164|FG006|Overall Study|Death|0|||
33555763|NCT01975831|62948598|FG006|Overall Study|Adverse Event|3|||
33274863|NCT03013543|62649165|FG007|Overall Study|Death|0|||
33274864|NCT03013543|62649166|FG008|Overall Study|Death|0|||
33274865|NCT03013543|62649167|FG009|Overall Study|Death|0|||
33274866|NCT03013543|62649158|FG000|Overall Study|Lack of Efficacy|0|||
33274867|NCT03013543|62649159|FG001|Overall Study|Lack of Efficacy|0|||
33274868|NCT03013543|62649160|FG002|Overall Study|Lack of Efficacy|0|||
33274869|NCT03013543|62649161|FG003|Overall Study|Lack of Efficacy|1|||
33274870|NCT03013543|62649162|FG004|Overall Study|Lack of Efficacy|0|||
33274871|NCT03013543|62649163|FG005|Overall Study|Lack of Efficacy|0|||
33274872|NCT03013543|62649164|FG006|Overall Study|Lack of Efficacy|0|||
33274873|NCT03013543|62649165|FG007|Overall Study|Lack of Efficacy|0|||
33274874|NCT03013543|62649166|FG008|Overall Study|Lack of Efficacy|0|||
33274875|NCT03013543|62649167|FG009|Overall Study|Lack of Efficacy|0|||
33274876|NCT03013543|62649158|FG000|Overall Study|Lost to Follow-up|0|||
33274877|NCT03013543|62649159|FG001|Overall Study|Lost to Follow-up|0|||
33274878|NCT03013543|62649160|FG002|Overall Study|Lost to Follow-up|0|||
33274879|NCT03013543|62649161|FG003|Overall Study|Lost to Follow-up|1|||
33274880|NCT03013543|62649162|FG004|Overall Study|Lost to Follow-up|0|||
33274881|NCT03013543|62649163|FG005|Overall Study|Lost to Follow-up|0|||
33274882|NCT03013543|62649164|FG006|Overall Study|Lost to Follow-up|1|||
33274883|NCT03013543|62649165|FG007|Overall Study|Lost to Follow-up|0|||
33274884|NCT03013543|62649166|FG008|Overall Study|Lost to Follow-up|0|||
33274885|NCT03013543|62649167|FG009|Overall Study|Lost to Follow-up|2|||
33274886|NCT03013543|62649158|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33274887|NCT03013543|62649159|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33274888|NCT03013543|62649160|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33274889|NCT03013543|62649161|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33274890|NCT03013543|62649162|FG004|Overall Study|Non-Compliance With Study Drug|0|||
33274891|NCT03013543|62649163|FG005|Overall Study|Non-Compliance With Study Drug|0|||
33274892|NCT03013543|62649164|FG006|Overall Study|Non-Compliance With Study Drug|0|||
33274893|NCT03013543|62649165|FG007|Overall Study|Non-Compliance With Study Drug|0|||
33274894|NCT03013543|62649166|FG008|Overall Study|Non-Compliance With Study Drug|1|||
33274895|NCT03013543|62649167|FG009|Overall Study|Non-Compliance With Study Drug|0|||
33274896|NCT03013543|62649158|FG000|Overall Study|Physician Decision|0|||
33274897|NCT03013543|62649159|FG001|Overall Study|Physician Decision|0|||
33274898|NCT03013543|62649160|FG002|Overall Study|Physician Decision|0|||
33274899|NCT03013543|62649161|FG003|Overall Study|Physician Decision|0|||
33274900|NCT03013543|62649162|FG004|Overall Study|Physician Decision|1|||
33274901|NCT03013543|62649163|FG005|Overall Study|Physician Decision|0|||
33274902|NCT03013543|62649164|FG006|Overall Study|Physician Decision|0|||
33274903|NCT03013543|62649165|FG007|Overall Study|Physician Decision|0|||
33274904|NCT03013543|62649166|FG008|Overall Study|Physician Decision|0|||
33274905|NCT03013543|62649167|FG009|Overall Study|Physician Decision|0|||
33274906|NCT03013543|62649158|FG000|Overall Study|Protocol Violation|0|||
33274907|NCT03013543|62649159|FG001|Overall Study|Protocol Violation|0|||
33274908|NCT03013543|62649160|FG002|Overall Study|Protocol Violation|0|||
33274909|NCT03013543|62649161|FG003|Overall Study|Protocol Violation|0|||
33274910|NCT03013543|62649162|FG004|Overall Study|Protocol Violation|0|||
33274911|NCT03013543|62649163|FG005|Overall Study|Protocol Violation|0|||
33274912|NCT03013543|62649164|FG006|Overall Study|Protocol Violation|0|||
33274913|NCT03013543|62649165|FG007|Overall Study|Protocol Violation|0|||
33274914|NCT03013543|62649166|FG008|Overall Study|Protocol Violation|0|||
33274915|NCT03013543|62649167|FG009|Overall Study|Protocol Violation|1|||
33274916|NCT02908685|62649205|FG000|Part 1 Exploratory|Withdrawal by Subject|0|||
33274917|NCT02908685|62649206|FG001|Part 1 Exploratory|Withdrawal by Subject|1|||
33274918|NCT02908685|62649207|FG002|Part 1 Exploratory|Withdrawal by Subject|0|||
33274919|NCT02908685|62649208|FG003|Part 1 Exploratory|Withdrawal by Subject|0|||
33274920|NCT02908685|62649209|FG004|Part 1 Exploratory|Withdrawal by Subject|0|||
33274921|NCT02908685|62649210|FG005|Part 1 Exploratory|Withdrawal by Subject|0|||
33274922|NCT02908685|62649211|FG006|Part 1 Exploratory|Withdrawal by Subject|0|||
33274923|NCT02908685|62649212|FG007|Part 1 Exploratory|Withdrawal by Subject|0|||
33370287|NCT00855062|62749004|FG001|Step2|Early Study Closure|2|||
33370288|NCT00855062|62749003|FG000|Step2|Adverse Event|0|||
33370289|NCT00855062|62749004|FG001|Step2|Adverse Event|3|||
33370290|NCT00855062|62749003|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
33370291|NCT00855062|62749004|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
33370292|NCT00854906|62749010|FG000|Overall Study|One person had no ocular history|1|||
33370293|NCT00854828|62749021|FG000|Overall Study|Death|1|||
33370294|NCT00854828|62749022|FG001|Overall Study|Death|0|||
33370295|NCT00854828|62749023|FG002|Overall Study|Death|0|||
33370296|NCT00854828|62749024|FG003|Overall Study|Death|0|||
33370297|NCT00854828|62749021|FG000|Overall Study|Withdrawal by Subject|1|||
33370298|NCT00854828|62749022|FG001|Overall Study|Withdrawal by Subject|1|||
33370299|NCT00854828|62749023|FG002|Overall Study|Withdrawal by Subject|0|||
33370300|NCT00854828|62749024|FG003|Overall Study|Withdrawal by Subject|9|||
33370301|NCT00854828|62749021|FG000|Overall Study|Missed 24mo visit|1|||
33370302|NCT00854828|62749022|FG001|Overall Study|Missed 24mo visit|1|||
33370303|NCT00854828|62749023|FG002|Overall Study|Missed 24mo visit|8|||
33485663|NCT00153101|62863385|FG002|Overall Study|Lost to Follow-up|12|||
33485664|NCT00153101|62863386|FG003|Overall Study|Lost to Follow-up|5|||
33485665|NCT00153101|62863387|FG004|Overall Study|Lost to Follow-up|5|||
33370304|NCT00854828|62749024|FG003|Overall Study|Missed 24mo visit|8|||
33274924|NCT02908685|62649213|FG008|Part 1 Exploratory|Withdrawal by Subject|0|||
33274925|NCT02908685|62649214|FG009|Part 1 Exploratory|Withdrawal by Subject|0|||
33370305|NCT00847730|62749034|FG000|Overall Study|Multiple interruptions in therapy|8|||
33370306|NCT00600119|62749044|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
33485666|NCT00153101|62863383|FG000|Overall Study|Withdrawal by Subject|3|||
33274926|NCT02908685|62649215|FG010|Part 1 Exploratory|Withdrawal by Subject|0|||
33274927|NCT02908685|62649216|FG011|Part 1 Exploratory|Withdrawal by Subject|0|||
33274928|NCT02908685|62649205|FG000|Part 2 Confirmatory|Changed to Spinraza|0|||
33274929|NCT02908685|62649206|FG001|Part 2 Confirmatory|Changed to Spinraza|0|||
33485667|NCT00153101|62863384|FG001|Overall Study|Withdrawal by Subject|4|||
33274930|NCT02908685|62649207|FG002|Part 2 Confirmatory|Changed to Spinraza|0|||
33274931|NCT02908685|62649208|FG003|Part 2 Confirmatory|Changed to Spinraza|0|||
33274932|NCT02908685|62649209|FG004|Part 2 Confirmatory|Changed to Spinraza|0|||
33274933|NCT02908685|62649210|FG005|Part 2 Confirmatory|Changed to Spinraza|0|||
33274934|NCT02908685|62649211|FG006|Part 2 Confirmatory|Changed to Spinraza|0|||
33274935|NCT02908685|62649212|FG007|Part 2 Confirmatory|Changed to Spinraza|0|||
33274936|NCT02908685|62649213|FG008|Part 2 Confirmatory|Changed to Spinraza|0|||
33274937|NCT02908685|62649214|FG009|Part 2 Confirmatory|Changed to Spinraza|0|||
33274938|NCT02908685|62649215|FG010|Part 2 Confirmatory|Changed to Spinraza|2|||
33274939|NCT02908685|62649216|FG011|Part 2 Confirmatory|Changed to Spinraza|1|||
33274940|NCT02908685|62649205|FG000|Part 2 Confirmatory|Changed to other treatment|0|||
33274941|NCT02908685|62649206|FG001|Part 2 Confirmatory|Changed to other treatment|0|||
33274942|NCT02908685|62649207|FG002|Part 2 Confirmatory|Changed to other treatment|0|||
33274943|NCT02908685|62649208|FG003|Part 2 Confirmatory|Changed to other treatment|0|||
33274944|NCT02908685|62649209|FG004|Part 2 Confirmatory|Changed to other treatment|0|||
33274945|NCT02908685|62649210|FG005|Part 2 Confirmatory|Changed to other treatment|0|||
33274946|NCT02908685|62649211|FG006|Part 2 Confirmatory|Changed to other treatment|0|||
33274947|NCT02908685|62649212|FG007|Part 2 Confirmatory|Changed to other treatment|0|||
33274948|NCT02908685|62649213|FG008|Part 2 Confirmatory|Changed to other treatment|0|||
33274949|NCT02908685|62649214|FG009|Part 2 Confirmatory|Changed to other treatment|0|||
33274950|NCT02908685|62649215|FG010|Part 2 Confirmatory|Changed to other treatment|1|||
33274951|NCT02908685|62649216|FG011|Part 2 Confirmatory|Changed to other treatment|0|||
33274952|NCT02811549|62649233|FG000|Overall Study|Lost to Follow-up|1|||
33274953|NCT02811549|62649233|FG000|Overall Study|Withdrawal by Subject|3|||
33274954|NCT02811549|62649233|FG000|Overall Study|Subject screen failed|4|||
33274955|NCT02811549|62649233|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
33274956|NCT02773849|62649239|FG000|Overall Study|Adverse Event|3|||
33274957|NCT02773849|62649239|FG000|Overall Study|Lack of Efficacy|89|||
33274958|NCT02773849|62649239|FG000|Overall Study|Withdrawal by Subject|1|||
33274959|NCT02773849|62649239|FG000|Overall Study|Withdrawal of Consent|1|||
33274960|NCT02475681|62649279|FG000|Overall Study|Death|16|||
33274961|NCT02475681|62649280|FG001|Overall Study|Death|6|||
33274962|NCT02475681|62649281|FG002|Overall Study|Death|9|||
33274963|NCT02475681|62649279|FG000|Overall Study|Physician Decision|0|||
33274964|NCT02475681|62649280|FG001|Overall Study|Physician Decision|3|||
33274965|NCT02475681|62649281|FG002|Overall Study|Physician Decision|1|||
33274966|NCT02475681|62649279|FG000|Overall Study|Withdrawal by Subject|12|||
33274967|NCT02475681|62649280|FG001|Overall Study|Withdrawal by Subject|6|||
33274968|NCT02475681|62649281|FG002|Overall Study|Withdrawal by Subject|9|||
33274969|NCT02475681|62649279|FG000|Overall Study|Lost to Follow-up|2|||
33274970|NCT02475681|62649280|FG001|Overall Study|Lost to Follow-up|1|||
33274971|NCT02475681|62649281|FG002|Overall Study|Lost to Follow-up|3|||
33274972|NCT02475681|62649279|FG000|Overall Study|Ongoing in Study|0|||
33274973|NCT02475681|62649280|FG001|Overall Study|Ongoing in Study|163|||
33274974|NCT02475681|62649281|FG002|Overall Study|Ongoing in Study|157|||
33274975|NCT02475681|62649279|FG000|Overall Study|Reasons other than above listed|2|||
33274976|NCT02475681|62649280|FG001|Overall Study|Reasons other than above listed|0|||
33274977|NCT02475681|62649281|FG002|Overall Study|Reasons other than above listed|0|||
33274978|NCT02426125|62649302|FG000|Overall Study|Lost to Follow-up|14|||
33274979|NCT02426125|62649303|FG001|Overall Study|Lost to Follow-up|12|||
33274980|NCT02426125|62649302|FG000|Overall Study|Withdrawal by Subject|13|||
33274981|NCT02426125|62649303|FG001|Overall Study|Withdrawal by Subject|14|||
33274982|NCT02426125|62649302|FG000|Overall Study|Death|185|||
33274983|NCT02426125|62649303|FG001|Overall Study|Death|200|||
33274984|NCT02426125|62649302|FG000|Overall Study|Randomized, But Never Treated|5|||
33274985|NCT02426125|62649303|FG001|Overall Study|Randomized, But Never Treated|2|||
33274986|NCT02331277|62649331|FG000|Overall Study|Withdrawal by Subject|1|||
33274987|NCT02331277|62649332|FG001|Overall Study|Withdrawal by Subject|0|||
33274988|NCT02120365|62649350|FG000|Overall Study|Withdrawal by Subject|0|||
33274989|NCT02120365|62649351|FG001|Overall Study|Withdrawal by Subject|0|||
33274990|NCT02120365|62649352|FG002|Overall Study|Withdrawal by Subject|2|||
33274991|NCT02120365|62649353|FG003|Overall Study|Withdrawal by Subject|4|||
33274992|NCT02120365|62649354|FG004|Overall Study|Withdrawal by Subject|0|||
33274993|NCT02120365|62649355|FG005|Overall Study|Withdrawal by Subject|2|||
33274994|NCT01946204|62649395|FG000|Overall Study|Death|38|||
33274995|NCT01946204|62649396|FG001|Overall Study|Death|59|||
33274996|NCT01946204|62649395|FG000|Overall Study|Withdrawal by Subject|37|||
33274997|NCT01946204|62649396|FG001|Overall Study|Withdrawal by Subject|50|||
33274998|NCT01946204|62649395|FG000|Overall Study|Lost to Follow-up|3|||
33274999|NCT01946204|62649396|FG001|Overall Study|Lost to Follow-up|7|||
33275000|NCT01946204|62649395|FG000|Overall Study|Ongoing|316|||
33370307|NCT00600119|62749045|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
33370308|NCT00600119|62749046|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
33275001|NCT01946204|62649396|FG001|Overall Study|Ongoing|687|||
33275002|NCT01946204|62649395|FG000|Overall Study|Other|7|||
33275003|NCT01946204|62649396|FG001|Overall Study|Other|3|||
33275004|NCT01854775|62649405|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
33275005|NCT01854775|62649406|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
33275006|NCT01854775|62649407|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
33275007|NCT01854775|62649405|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
33275008|NCT01854775|62649406|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
33275009|NCT01854775|62649407|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
33275010|NCT01854775|62649405|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
33275011|NCT01854775|62649406|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
33275012|NCT01854775|62649407|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
33275013|NCT01854775|62649405|FG000|Extension Phase|Pregnancy|3|||
33275014|NCT01854775|62649406|FG001|Extension Phase|Pregnancy|0|||
33275015|NCT01854775|62649407|FG002|Extension Phase|Pregnancy|0|||
33275016|NCT01854775|62649405|FG000|Extension Phase|Investigator's Discretion|1|||
33275017|NCT01854775|62649406|FG001|Extension Phase|Investigator's Discretion|0|||
33275018|NCT01854775|62649407|FG002|Extension Phase|Investigator's Discretion|0|||
33275019|NCT01854775|62649405|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
33275020|NCT01854775|62649406|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
33275021|NCT01854775|62649407|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
33275022|NCT01854775|62649405|FG000|Extension Phase|Lost to Follow-up|2|||
33275023|NCT01854775|62649406|FG001|Extension Phase|Lost to Follow-up|0|||
33275024|NCT01854775|62649407|FG002|Extension Phase|Lost to Follow-up|0|||
33275025|NCT01854775|62649405|FG000|Extension Phase|Still on Study|32|||
33275026|NCT01854775|62649406|FG001|Extension Phase|Still on Study|47|||
33275027|NCT01854775|62649407|FG002|Extension Phase|Still on Study|18|||
33275028|NCT01828099|62649417|FG000|Overall Study|Adverse Event|15|||
33275029|NCT01828099|62649418|FG001|Overall Study|Adverse Event|18|||
33275030|NCT01828099|62649417|FG000|Overall Study|Death|9|||
33275031|NCT01828099|62649418|FG001|Overall Study|Death|11|||
33275032|NCT01828099|62649417|FG000|Overall Study|Lost to Follow-up|2|||
33275033|NCT01828099|62649418|FG001|Overall Study|Lost to Follow-up|0|||
33275034|NCT01828099|62649417|FG000|Overall Study|Non-compliance with study treatment|2|||
33275035|NCT01828099|62649418|FG001|Overall Study|Non-compliance with study treatment|0|||
33275036|NCT01828099|62649417|FG000|Overall Study|Physician Decision|7|||
33275037|NCT01828099|62649418|FG001|Overall Study|Physician Decision|11|||
33275038|NCT01828099|62649417|FG000|Overall Study|Progressive disease|51|||
33275039|NCT01828099|62649418|FG001|Overall Study|Progressive disease|94|||
33275040|NCT01828099|62649417|FG000|Overall Study|Protocol Violation|1|||
33275041|NCT01828099|62649418|FG001|Overall Study|Protocol Violation|0|||
33275042|NCT01828099|62649417|FG000|Overall Study|Subject/guardian decision|7|||
33275043|NCT01828099|62649418|FG001|Overall Study|Subject/guardian decision|23|||
33275044|NCT01199575|62649439|FG000|Overall Study|Withdrawal by Subject|5|||
33275045|NCT00938340|62649474|FG000|Overall Study|Withdrawal by Subject|3|||
33275046|NCT00938340|62649474|FG000|Overall Study|Protocol Violation|1|||
33275047|NCT00938340|62649474|FG000|Overall Study|Adverse Event|1|||
33275048|NCT00539643|62649531|FG000|Overall Study|Adverse Event|1|||
33275049|NCT00539643|62649532|FG001|Overall Study|Adverse Event|0|||
33275050|NCT00539643|62649531|FG000|Overall Study|Death|2|||
33275051|NCT00539643|62649532|FG001|Overall Study|Death|1|||
33275052|NCT00539643|62649531|FG000|Overall Study|Physician Decision|3|||
33275053|NCT00539643|62649532|FG001|Overall Study|Physician Decision|1|||
33275054|NCT00539643|62649531|FG000|Overall Study|Withdrawal by Subject|0|||
33275055|NCT00539643|62649532|FG001|Overall Study|Withdrawal by Subject|1|||
33275056|NCT00085202|62649540|FG000|Overall Study|Still on therapy|2|||
33275057|NCT00085202|62649541|FG001|Overall Study|Still on therapy|0|||
33275058|NCT00085202|62649540|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
33275059|NCT00085202|62649541|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
33275060|NCT00085202|62649540|FG000|Overall Study|Excessive toxicity|6|||
33275061|NCT00085202|62649541|FG001|Overall Study|Excessive toxicity|5|||
33275062|NCT00085202|62649540|FG000|Overall Study|Non-specified|3|||
33275063|NCT00085202|62649541|FG001|Overall Study|Non-specified|5|||
33275064|NCT00085202|62649540|FG000|Overall Study|Withdrawal by Subject|2|||
33275065|NCT00085202|62649541|FG001|Overall Study|Withdrawal by Subject|1|||
33275066|NCT00085202|62649540|FG000|Overall Study|Physician Decision|4|||
33275067|NCT00085202|62649541|FG001|Overall Study|Physician Decision|1|||
33555764|NCT01975831|62948599|FG007|Overall Study|Adverse Event|4|||
33275068|NCT00085202|62649540|FG000|Overall Study|Progressive disease|1|||
33275069|NCT00085202|62649541|FG001|Overall Study|Progressive disease|11|||
33555765|NCT01975831|62948600|FG008|Overall Study|Adverse Event|1|||
33275070|NCT00039130|62649574|FG000|Overall Study|Adverse Event|11|||
33275071|NCT00039130|62649574|FG000|Overall Study|Death|9|||
33555766|NCT01975831|62948592|FG000|Overall Study|Death|1|||
33275072|NCT00039130|62649574|FG000|Overall Study|Withdrawal by Subject|3|||
33275073|NCT00039130|62649574|FG000|Overall Study|Progression|2|||
33275074|NCT00039130|62649574|FG000|Overall Study|Subsequent treatment|2|||
33275075|NCT00039130|62649574|FG000|Overall Study|Physician Decision|3|||
33275076|NCT00005957|62649580|FG000|Overall Study|No treated|3|||
33275077|NCT00005957|62649581|FG001|Overall Study|No treated|9|||
33555767|NCT01975831|62948593|FG001|Overall Study|Death|1|||
33275078|NCT00005957|62649580|FG000|Overall Study|Crossover to the other arm|5|||
33275079|NCT00005957|62649581|FG001|Overall Study|Crossover to the other arm|19|||
33275080|NCT04642079|62649691|FG000|Overall Study|Lost to Follow-up|2|||
33275081|NCT04642079|62649692|FG001|Overall Study|Lost to Follow-up|5|||
33275082|NCT04642079|62649693|FG002|Overall Study|Lost to Follow-up|2|||
33275083|NCT04642079|62649694|FG003|Overall Study|Lost to Follow-up|0|||
33275084|NCT04642079|62649691|FG000|Overall Study|Withdrawal by Subject|0|||
33275085|NCT04642079|62649692|FG001|Overall Study|Withdrawal by Subject|4|||
33275086|NCT04642079|62649693|FG002|Overall Study|Withdrawal by Subject|1|||
33275087|NCT04642079|62649694|FG003|Overall Study|Withdrawal by Subject|2|||
33275088|NCT04642079|62649691|FG000|Overall Study|Other|0|||
33275089|NCT04642079|62649692|FG001|Overall Study|Other|0|||
33275090|NCT04642079|62649693|FG002|Overall Study|Other|0|||
33275091|NCT04642079|62649694|FG003|Overall Study|Other|1|||
33275092|NCT04642079|62649691|FG000|Overall Study|No longer met eligibility criteria|1|||
33275093|NCT04642079|62649692|FG001|Overall Study|No longer met eligibility criteria|0|||
33275094|NCT04642079|62649693|FG002|Overall Study|No longer met eligibility criteria|1|||
33275095|NCT04642079|62649694|FG003|Overall Study|No longer met eligibility criteria|1|||
33275096|NCT04419493|62649713|FG000|Wash-out After Period 1|Adverse Event|1|||
33275097|NCT04419493|62649714|FG001|Wash-out After Period 1|Adverse Event|2|||
33275098|NCT04419493|62649715|FG002|Wash-out After Period 1|Adverse Event|1|||
33275099|NCT04419493|62649716|FG003|Wash-out After Period 1|Adverse Event|0|||
33275100|NCT04359901|62649729|FG000|Overall Study|Withdrawal by Subject|0|||
33275101|NCT04359901|62649730|FG001|Overall Study|Withdrawal by Subject|1|||
33275102|NCT04359901|62649729|FG000|Overall Study|Death|6|||
33275103|NCT04359901|62649730|FG001|Overall Study|Death|2|||
33275104|NCT04147611|62649753|FG000|Overall Study|Physician Decision|0|||
33275105|NCT04147611|62649754|FG001|Overall Study|Physician Decision|1|||
33275106|NCT03635424|62649785|FG000|Overall Study|Adverse Event|1|||
33275107|NCT03635424|62649785|FG000|Overall Study|Death|1|||
33275108|NCT03635424|62649785|FG000|Overall Study|Device not implanted|1|||
33275109|NCT03603964|62649789|FG000|Overall Study|Death|9|||
33275110|NCT03603964|62649789|FG000|Overall Study|Withdrawal by participant|7|||
33275111|NCT03603964|62649789|FG000|Overall Study|Study terminated by Sponsor|19|||
33275112|NCT03191864|62649809|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
33275113|NCT03191864|62649810|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
33275114|NCT03191864|62649811|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
33275115|NCT03191864|62649812|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
33275116|NCT03191864|62649813|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
33275117|NCT03191864|62649814|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
33275118|NCT03191864|62649809|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
33275119|NCT03191864|62649810|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
33275120|NCT03191864|62649811|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
33275121|NCT03191864|62649812|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
33275122|NCT03191864|62649813|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
33275123|NCT03191864|62649814|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
33275124|NCT03191864|62649809|FG000|Baseline Symptom Assessment|Adverse Event|0|||
33275125|NCT03191864|62649810|FG001|Baseline Symptom Assessment|Adverse Event|0|||
33275126|NCT03191864|62649811|FG002|Baseline Symptom Assessment|Adverse Event|0|||
33275127|NCT03191864|62649812|FG003|Baseline Symptom Assessment|Adverse Event|0|||
33275128|NCT03191864|62649813|FG004|Baseline Symptom Assessment|Adverse Event|0|||
33275129|NCT03191864|62649814|FG005|Baseline Symptom Assessment|Adverse Event|2|||
33275130|NCT03191864|62649809|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
33275131|NCT03191864|62649810|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
33275132|NCT03191864|62649811|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
33275133|NCT03191864|62649812|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
33275134|NCT03191864|62649813|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
33275135|NCT03191864|62649814|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
33275136|NCT03191864|62649809|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
33275137|NCT03191864|62649810|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
33275138|NCT03191864|62649811|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
33275139|NCT03191864|62649812|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
33275140|NCT03191864|62649813|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
33275141|NCT03191864|62649814|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
33485668|NCT00153101|62863385|FG002|Overall Study|Withdrawal by Subject|3|||
33275142|NCT03191864|62649809|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
33275143|NCT03191864|62649810|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
33275144|NCT03191864|62649811|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
33275145|NCT03191864|62649812|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
33275146|NCT03191864|62649813|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
33485669|NCT00153101|62863386|FG003|Overall Study|Withdrawal by Subject|3|||
33275147|NCT03191864|62649814|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
33275148|NCT03191864|62649809|FG000|Part 1 - Induction|Adverse Event|0|||
33275149|NCT03191864|62649810|FG001|Part 1 - Induction|Adverse Event|2|||
33275150|NCT03191864|62649811|FG002|Part 1 - Induction|Adverse Event|0|||
33275151|NCT03191864|62649812|FG003|Part 1 - Induction|Adverse Event|1|||
33275152|NCT03191864|62649813|FG004|Part 1 - Induction|Adverse Event|0|||
33275153|NCT03191864|62649814|FG005|Part 1 - Induction|Adverse Event|2|||
33275154|NCT03191864|62649809|FG000|Part 1 - Induction|Randomized but never dosed|0|||
33275155|NCT03191864|62649810|FG001|Part 1 - Induction|Randomized but never dosed|0|||
33275156|NCT03191864|62649811|FG002|Part 1 - Induction|Randomized but never dosed|1|||
33275157|NCT03191864|62649812|FG003|Part 1 - Induction|Randomized but never dosed|0|||
33275158|NCT03191864|62649813|FG004|Part 1 - Induction|Randomized but never dosed|0|||
33275159|NCT03191864|62649814|FG005|Part 1 - Induction|Randomized but never dosed|0|||
33275160|NCT03191864|62649809|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
33275161|NCT03191864|62649810|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
33275162|NCT03191864|62649811|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
33275163|NCT03191864|62649812|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
33275164|NCT03191864|62649813|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
33275165|NCT03191864|62649814|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
33275166|NCT03191864|62649809|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
33275167|NCT03191864|62649810|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
33275168|NCT03191864|62649811|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
33275169|NCT03191864|62649812|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
33275170|NCT03191864|62649813|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
33275171|NCT03191864|62649814|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
33275172|NCT03191864|62649809|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
33275173|NCT03191864|62649810|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
33275174|NCT03191864|62649811|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
33275175|NCT03191864|62649812|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
33275176|NCT03191864|62649813|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
33275177|NCT03191864|62649814|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
33275178|NCT03191864|62649809|FG000|Part 2 - Maintenance|Physician Decision|1|||
33275179|NCT03191864|62649810|FG001|Part 2 - Maintenance|Physician Decision|0|||
33275180|NCT03191864|62649811|FG002|Part 2 - Maintenance|Physician Decision|0|||
33275181|NCT03191864|62649812|FG003|Part 2 - Maintenance|Physician Decision|0|||
33275182|NCT03191864|62649813|FG004|Part 2 - Maintenance|Physician Decision|0|||
33275183|NCT03191864|62649814|FG005|Part 2 - Maintenance|Physician Decision|0|||
33275184|NCT03191864|62649809|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
33275185|NCT03191864|62649810|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
33275186|NCT03191864|62649811|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
33275187|NCT03191864|62649812|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
33275188|NCT03191864|62649813|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
33275189|NCT03191864|62649814|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
33275190|NCT03191864|62649809|FG000|Part 2 - Maintenance|Adverse Event|0|||
33275191|NCT03191864|62649810|FG001|Part 2 - Maintenance|Adverse Event|0|||
33370309|NCT00600119|62749047|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
33370310|NCT00600119|62749048|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
33370311|NCT00600119|62749049|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
33370312|NCT00600119|62749044|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33370313|NCT00600119|62749045|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
33370314|NCT00600119|62749046|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
33370315|NCT00600119|62749047|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33370316|NCT00600119|62749048|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33370317|NCT00600119|62749049|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33370318|NCT00600119|62749044|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
33370319|NCT00600119|62749045|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
33370320|NCT00600119|62749046|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
33370321|NCT00600119|62749047|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
33370322|NCT00600119|62749048|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
33370323|NCT00600119|62749049|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
33370324|NCT00600119|62749044|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
33370325|NCT00600119|62749045|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
33370326|NCT00600119|62749046|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
33370327|NCT00600119|62749047|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
33370328|NCT00600119|62749048|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
33370329|NCT00600119|62749049|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
33275192|NCT03191864|62649811|FG002|Part 2 - Maintenance|Adverse Event|0|||
33370330|NCT00600119|62749044|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
33275193|NCT03191864|62649812|FG003|Part 2 - Maintenance|Adverse Event|0|||
33275194|NCT03191864|62649813|FG004|Part 2 - Maintenance|Adverse Event|1|||
33275195|NCT03191864|62649814|FG005|Part 2 - Maintenance|Adverse Event|0|||
33275196|NCT03191864|62649809|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
33275197|NCT03191864|62649810|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
33275198|NCT03191864|62649811|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
33275199|NCT03191864|62649812|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
33275200|NCT03191864|62649813|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
33275201|NCT03191864|62649814|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
33275202|NCT03191864|62649809|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
33275203|NCT03191864|62649810|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
33275204|NCT03191864|62649811|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
33275205|NCT03191864|62649812|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
33275206|NCT03191864|62649813|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
33275207|NCT03191864|62649814|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
33275208|NCT02975882|62649846|FG000|Overall Study|Adverse Event|1|||
33275209|NCT02975882|62649847|FG001|Overall Study|Adverse Event|2|||
33275210|NCT02975882|62649848|FG002|Overall Study|Adverse Event|1|||
33275211|NCT02975882|62649849|FG003|Overall Study|Adverse Event|1|||
33275212|NCT02975882|62649846|FG000|Overall Study|Death|0|||
33275213|NCT02975882|62649847|FG001|Overall Study|Death|1|||
33275214|NCT02975882|62649848|FG002|Overall Study|Death|0|||
33275215|NCT02975882|62649849|FG003|Overall Study|Death|0|||
33275216|NCT02975882|62649846|FG000|Overall Study|Lack of Efficacy|3|||
33275217|NCT02975882|62649847|FG001|Overall Study|Lack of Efficacy|7|||
33275218|NCT02975882|62649848|FG002|Overall Study|Lack of Efficacy|4|||
33275219|NCT02975882|62649849|FG003|Overall Study|Lack of Efficacy|3|||
33275220|NCT02975882|62649846|FG000|Overall Study|Physician Decision|0|||
33275221|NCT02975882|62649847|FG001|Overall Study|Physician Decision|2|||
33275222|NCT02975882|62649848|FG002|Overall Study|Physician Decision|4|||
33275223|NCT02975882|62649849|FG003|Overall Study|Physician Decision|2|||
33275224|NCT02975882|62649846|FG000|Overall Study|Ineligible|0|||
33275225|NCT02975882|62649847|FG001|Overall Study|Ineligible|1|||
33275226|NCT02975882|62649848|FG002|Overall Study|Ineligible|0|||
33275227|NCT02975882|62649849|FG003|Overall Study|Ineligible|0|||
33275228|NCT02636725|62649895|FG000|Baseline|Adverse Event|1|||
33275229|NCT02636725|62649895|FG000|Baseline|Lack of Efficacy|2|||
33275230|NCT02573493|62649903|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
33275231|NCT02573493|62649904|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
33275232|NCT02573493|62649905|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
33275233|NCT02573493|62649906|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
33275234|NCT02327078|62649939|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
33275235|NCT02327078|62649940|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
33275236|NCT02327078|62649941|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
33275237|NCT02327078|62649942|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
33275238|NCT02327078|62649943|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
33275239|NCT02327078|62649944|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
33275240|NCT02327078|62649945|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
33275241|NCT02327078|62649946|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
33275242|NCT02327078|62649947|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
33275243|NCT02327078|62649939|FG000|Overall Study|Death|2|||
33275244|NCT02327078|62649940|FG001|Overall Study|Death|4|||
33275245|NCT02327078|62649941|FG002|Overall Study|Death|10|||
33275246|NCT02327078|62649942|FG003|Overall Study|Death|6|||
33275247|NCT02327078|62649943|FG004|Overall Study|Death|4|||
33275248|NCT02327078|62649944|FG005|Overall Study|Death|3|||
33275249|NCT02327078|62649945|FG006|Overall Study|Death|2|||
33275250|NCT02327078|62649946|FG007|Overall Study|Death|51|||
33275251|NCT02327078|62649947|FG008|Overall Study|Death|97|||
33275252|NCT02327078|62649939|FG000|Overall Study|Lost to Follow-up|0|||
33275253|NCT02327078|62649940|FG001|Overall Study|Lost to Follow-up|1|||
33275254|NCT02327078|62649941|FG002|Overall Study|Lost to Follow-up|1|||
33275255|NCT02327078|62649942|FG003|Overall Study|Lost to Follow-up|0|||
33275256|NCT02327078|62649943|FG004|Overall Study|Lost to Follow-up|0|||
33275257|NCT02327078|62649944|FG005|Overall Study|Lost to Follow-up|0|||
33275258|NCT02327078|62649945|FG006|Overall Study|Lost to Follow-up|0|||
33275259|NCT02327078|62649946|FG007|Overall Study|Lost to Follow-up|2|||
33275260|NCT02327078|62649947|FG008|Overall Study|Lost to Follow-up|5|||
33275261|NCT02327078|62649939|FG000|Overall Study|Site Terminated by Sponsor|1|||
33275262|NCT02327078|62649940|FG001|Overall Study|Site Terminated by Sponsor|0|||
33275263|NCT02327078|62649941|FG002|Overall Study|Site Terminated by Sponsor|1|||
33275264|NCT02327078|62649942|FG003|Overall Study|Site Terminated by Sponsor|4|||
33555768|NCT01975831|62948594|FG002|Overall Study|Death|0|||
33275265|NCT02327078|62649943|FG004|Overall Study|Site Terminated by Sponsor|0|||
33275266|NCT02327078|62649944|FG005|Overall Study|Site Terminated by Sponsor|0|||
33275267|NCT02327078|62649945|FG006|Overall Study|Site Terminated by Sponsor|0|||
33275268|NCT02327078|62649946|FG007|Overall Study|Site Terminated by Sponsor|11|||
33275269|NCT02327078|62649947|FG008|Overall Study|Site Terminated by Sponsor|25|||
33275270|NCT02327078|62649939|FG000|Overall Study|Physician Decision|0|||
33275271|NCT02327078|62649940|FG001|Overall Study|Physician Decision|0|||
33275272|NCT02327078|62649941|FG002|Overall Study|Physician Decision|0|||
33555769|NCT01975831|62948595|FG003|Overall Study|Death|0|||
33555770|NCT01975831|62948596|FG004|Overall Study|Death|1|||
33555771|NCT01975831|62948597|FG005|Overall Study|Death|0|||
33555772|NCT01975831|62948598|FG006|Overall Study|Death|1|||
33555773|NCT01975831|62948599|FG007|Overall Study|Death|0|||
33555774|NCT01975831|62948600|FG008|Overall Study|Death|0|||
33555775|NCT01975831|62948592|FG000|Overall Study|Progressive Disease|1|||
33555776|NCT01975831|62948593|FG001|Overall Study|Progressive Disease|3|||
33275273|NCT02327078|62649942|FG003|Overall Study|Physician Decision|1|||
33275274|NCT02327078|62649943|FG004|Overall Study|Physician Decision|0|||
33275275|NCT02327078|62649944|FG005|Overall Study|Physician Decision|0|||
33275276|NCT02327078|62649945|FG006|Overall Study|Physician Decision|0|||
33275277|NCT02327078|62649946|FG007|Overall Study|Physician Decision|0|||
33275278|NCT02327078|62649947|FG008|Overall Study|Physician Decision|1|||
33275279|NCT02327078|62649939|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
33275280|NCT02327078|62649940|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
33275281|NCT02327078|62649941|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
33275282|NCT02327078|62649942|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
33275283|NCT02327078|62649943|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
33275284|NCT02327078|62649944|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
33275285|NCT02327078|62649945|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
33275286|NCT02327078|62649946|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
33275287|NCT02327078|62649947|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
33275288|NCT02327078|62649939|FG000|Overall Study|Reason not Specified|0|||
33275289|NCT02327078|62649940|FG001|Overall Study|Reason not Specified|0|||
33275290|NCT02327078|62649941|FG002|Overall Study|Reason not Specified|0|||
33275291|NCT02327078|62649942|FG003|Overall Study|Reason not Specified|0|||
33275292|NCT02327078|62649943|FG004|Overall Study|Reason not Specified|0|||
33275293|NCT02327078|62649944|FG005|Overall Study|Reason not Specified|0|||
33275294|NCT02327078|62649945|FG006|Overall Study|Reason not Specified|0|||
33275295|NCT02327078|62649946|FG007|Overall Study|Reason not Specified|5|||
33275296|NCT02327078|62649947|FG008|Overall Study|Reason not Specified|12|||
33275297|NCT02304458|62649990|FG000|Overall Study|Adverse Event|0|||
33275298|NCT02304458|62649991|FG001|Overall Study|Adverse Event|0|||
33275299|NCT02304458|62649992|FG002|Overall Study|Adverse Event|7|||
33275300|NCT02304458|62649993|FG003|Overall Study|Adverse Event|0|||
33275301|NCT02304458|62649994|FG004|Overall Study|Adverse Event|0|||
33275302|NCT02304458|62649995|FG005|Overall Study|Adverse Event|0|||
33275303|NCT02304458|62649996|FG006|Overall Study|Adverse Event|3|||
33275304|NCT02304458|62649997|FG007|Overall Study|Adverse Event|4|||
33275305|NCT02304458|62649990|FG000|Overall Study|Death|0|||
33275306|NCT02304458|62649991|FG001|Overall Study|Death|0|||
33275307|NCT02304458|62649992|FG002|Overall Study|Death|2|||
33275308|NCT02304458|62649993|FG003|Overall Study|Death|0|||
33275309|NCT02304458|62649994|FG004|Overall Study|Death|0|||
33275310|NCT02304458|62649995|FG005|Overall Study|Death|0|||
33275311|NCT02304458|62649996|FG006|Overall Study|Death|1|||
33275312|NCT02304458|62649997|FG007|Overall Study|Death|0|||
33275313|NCT02304458|62649990|FG000|Overall Study|Lack of Efficacy|4|||
33275314|NCT02304458|62649991|FG001|Overall Study|Lack of Efficacy|6|||
33275315|NCT02304458|62649992|FG002|Overall Study|Lack of Efficacy|38|||
33275316|NCT02304458|62649993|FG003|Overall Study|Lack of Efficacy|5|||
33555777|NCT01975831|62948594|FG002|Overall Study|Progressive Disease|2|||
33555778|NCT01975831|62948595|FG003|Overall Study|Progressive Disease|4|||
33555779|NCT01975831|62948596|FG004|Overall Study|Progressive Disease|13|||
33555780|NCT01975831|62948597|FG005|Overall Study|Progressive Disease|9|||
33275317|NCT02304458|62649994|FG004|Overall Study|Lack of Efficacy|6|||
33275318|NCT02304458|62649995|FG005|Overall Study|Lack of Efficacy|6|||
33275319|NCT02304458|62649996|FG006|Overall Study|Lack of Efficacy|21|||
33275320|NCT02304458|62649997|FG007|Overall Study|Lack of Efficacy|4|||
33275321|NCT02304458|62649990|FG000|Overall Study|Physician Decision|2|||
33275322|NCT02304458|62649991|FG001|Overall Study|Physician Decision|0|||
33275323|NCT02304458|62649992|FG002|Overall Study|Physician Decision|16|||
33275324|NCT02304458|62649993|FG003|Overall Study|Physician Decision|1|||
33275325|NCT02304458|62649994|FG004|Overall Study|Physician Decision|0|||
33275326|NCT02304458|62649995|FG005|Overall Study|Physician Decision|0|||
33275327|NCT02304458|62649996|FG006|Overall Study|Physician Decision|3|||
33275328|NCT02304458|62649997|FG007|Overall Study|Physician Decision|0|||
33555781|NCT01975831|62948598|FG006|Overall Study|Progressive Disease|10|||
33555782|NCT01975831|62948599|FG007|Overall Study|Progressive Disease|8|||
33275329|NCT02304458|62649990|FG000|Overall Study|Protocol Violation|0|||
33275330|NCT02304458|62649991|FG001|Overall Study|Protocol Violation|0|||
33275331|NCT02304458|62649992|FG002|Overall Study|Protocol Violation|1|||
33275332|NCT02304458|62649993|FG003|Overall Study|Protocol Violation|0|||
33275333|NCT02304458|62649994|FG004|Overall Study|Protocol Violation|0|||
33275334|NCT02304458|62649995|FG005|Overall Study|Protocol Violation|0|||
33275335|NCT02304458|62649996|FG006|Overall Study|Protocol Violation|0|||
33275336|NCT02304458|62649997|FG007|Overall Study|Protocol Violation|0|||
33275337|NCT02304458|62649990|FG000|Overall Study|Withdrawal by Subject|1|||
33275338|NCT02304458|62649991|FG001|Overall Study|Withdrawal by Subject|0|||
33275339|NCT02304458|62649992|FG002|Overall Study|Withdrawal by Subject|7|||
33275340|NCT02304458|62649993|FG003|Overall Study|Withdrawal by Subject|0|||
33275341|NCT02304458|62649994|FG004|Overall Study|Withdrawal by Subject|0|||
33275342|NCT02304458|62649995|FG005|Overall Study|Withdrawal by Subject|0|||
33275343|NCT02304458|62649996|FG006|Overall Study|Withdrawal by Subject|1|||
33275344|NCT02304458|62649997|FG007|Overall Study|Withdrawal by Subject|0|||
33275345|NCT02187224|62650033|FG000|Overall Study|Did not show up for test day|1|||
33275346|NCT02187224|62650034|FG001|Overall Study|Did not show up for test day|0|||
33275347|NCT02176226|62650044|FG000|Overall Study|Lost to Follow-up|3|||
33275348|NCT02176226|62650044|FG000|Overall Study|Withdrew prior to treatment|6|||
33275349|NCT02032823|62650050|FG000|Overall Study|Death|75|||
33275350|NCT02032823|62650051|FG001|Overall Study|Death|109|||
33275351|NCT02032823|62650050|FG000|Overall Study|Lost to Follow-up|18|||
33275352|NCT02032823|62650051|FG001|Overall Study|Lost to Follow-up|17|||
33275353|NCT02032823|62650050|FG000|Overall Study|Withdrawal by Subject|70|||
33275354|NCT02032823|62650051|FG001|Overall Study|Withdrawal by Subject|53|||
33275355|NCT02032823|62650050|FG000|Overall Study|Ongoing study at data cut-off|755|||
33275356|NCT02032823|62650051|FG001|Overall Study|Ongoing study at data cut-off|731|||
33275357|NCT02032823|62650050|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
33275358|NCT02032823|62650051|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
33275359|NCT01958021|62650059|FG000|Overall Study|Progressive disease|87|||
33275360|NCT01958021|62650060|FG001|Overall Study|Progressive disease|146|||
33275361|NCT01958021|62650059|FG000|Overall Study|Adverse Event|25|||
33275362|NCT01958021|62650060|FG001|Overall Study|Adverse Event|7|||
33275363|NCT01958021|62650059|FG000|Overall Study|Subject/guardian decision|12|||
33275364|NCT01958021|62650060|FG001|Overall Study|Subject/guardian decision|13|||
33275365|NCT01958021|62650059|FG000|Overall Study|Physician Decision|10|||
33275366|NCT01958021|62650060|FG001|Overall Study|Physician Decision|13|||
33275367|NCT01958021|62650059|FG000|Overall Study|Protocol Violation|3|||
33275368|NCT01958021|62650060|FG001|Overall Study|Protocol Violation|1|||
33275369|NCT01958021|62650059|FG000|Overall Study|Death|2|||
33275370|NCT01958021|62650060|FG001|Overall Study|Death|0|||
33275371|NCT05059600|62650066|FG000|Overall Study|Enrolled but not Treated|10|||
33275372|NCT04608448|62650079|FG000|Overall Study|Withdrawal by Subject|1|||
33275373|NCT04608448|62650079|FG000|Overall Study|Adverse Event|1|||
33275374|NCT04530344|62650089|FG000|Overall Study|Lost to Follow-up|3|||
33275375|NCT04530344|62650090|FG001|Overall Study|Lost to Follow-up|3|||
33275376|NCT04530344|62650091|FG002|Overall Study|Lost to Follow-up|3|||
33275377|NCT04530344|62650092|FG003|Overall Study|Lost to Follow-up|10|||
33275378|NCT04530344|62650089|FG000|Overall Study|Withdrawal by Subject|14|||
33275379|NCT04530344|62650090|FG001|Overall Study|Withdrawal by Subject|5|||
33275380|NCT04530344|62650091|FG002|Overall Study|Withdrawal by Subject|18|||
33275381|NCT04530344|62650092|FG003|Overall Study|Withdrawal by Subject|33|||
33275382|NCT04530344|62650089|FG000|Overall Study|Adverse Event|0|||
33275383|NCT04530344|62650090|FG001|Overall Study|Adverse Event|0|||
33275384|NCT04530344|62650091|FG002|Overall Study|Adverse Event|0|||
33275385|NCT04530344|62650092|FG003|Overall Study|Adverse Event|1|||
33275386|NCT04530344|62650089|FG000|Overall Study|Lack of Efficacy|0|||
33275387|NCT04530344|62650090|FG001|Overall Study|Lack of Efficacy|0|||
33275388|NCT04530344|62650091|FG002|Overall Study|Lack of Efficacy|0|||
33275389|NCT04530344|62650092|FG003|Overall Study|Lack of Efficacy|1|||
33275390|NCT04530344|62650089|FG000|Overall Study|Physician Decision|0|||
33275391|NCT04530344|62650090|FG001|Overall Study|Physician Decision|0|||
33275392|NCT04530344|62650091|FG002|Overall Study|Physician Decision|1|||
33275393|NCT04530344|62650092|FG003|Overall Study|Physician Decision|1|||
33275394|NCT04530344|62650089|FG000|Overall Study|Pregnancy|0|||
33275395|NCT04530344|62650090|FG001|Overall Study|Pregnancy|0|||
33275396|NCT04530344|62650091|FG002|Overall Study|Pregnancy|2|||
33275397|NCT04530344|62650092|FG003|Overall Study|Pregnancy|1|||
33555783|NCT01975831|62948600|FG008|Overall Study|Progressive Disease|10|||
33275398|NCT04530344|62650089|FG000|Overall Study|Protocol Violation|0|||
33555784|NCT01975831|62948592|FG000|Overall Study|Withdrawal by Subject|0|||
33275399|NCT04530344|62650090|FG001|Overall Study|Protocol Violation|0|||
33275400|NCT04530344|62650091|FG002|Overall Study|Protocol Violation|0|||
33275401|NCT04530344|62650092|FG003|Overall Study|Protocol Violation|1|||
33275402|NCT04530344|62650089|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
33275403|NCT04530344|62650090|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
33275404|NCT04530344|62650091|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
33275405|NCT04530344|62650092|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
33275406|NCT04530344|62650089|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
33275407|NCT04530344|62650090|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
33275408|NCT04530344|62650091|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
33275409|NCT04530344|62650092|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
33275410|NCT04530344|62650089|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
33275411|NCT04530344|62650090|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
33275412|NCT04530344|62650091|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
33275413|NCT04530344|62650092|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
33275414|NCT04530344|62650089|FG000|Overall Study|Personal Reasons|0|||
33275415|NCT04530344|62650090|FG001|Overall Study|Personal Reasons|0|||
33275416|NCT04530344|62650091|FG002|Overall Study|Personal Reasons|0|||
33275417|NCT04530344|62650092|FG003|Overall Study|Personal Reasons|1|||
33275418|NCT04530344|62650089|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
33275419|NCT04530344|62650090|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
33275420|NCT04530344|62650091|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
33275421|NCT04530344|62650092|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
33275422|NCT04058886|62650126|FG000|Overall Study|Withdrawal by Subject|4|||
33275423|NCT04058886|62650126|FG000|Overall Study|Inadequate deafness interpreter service|1|||
33275424|NCT03704194|62650149|FG000|Overall Study|Withdrawal by Subject|0|||
33275425|NCT03704194|62650150|FG001|Overall Study|Withdrawal by Subject|1|||
33275426|NCT03451422|62650164|FG000|Overall Study|Lost to Follow-up|0|||
33275427|NCT03451422|62650165|FG001|Overall Study|Lost to Follow-up|0|||
33275428|NCT03451422|62650166|FG002|Overall Study|Lost to Follow-up|0|||
33275429|NCT03451422|62650167|FG003|Overall Study|Lost to Follow-up|0|||
33275430|NCT03451422|62650168|FG004|Overall Study|Lost to Follow-up|0|||
33275431|NCT03451422|62650169|FG005|Overall Study|Lost to Follow-up|1|||
33275432|NCT03451422|62650164|FG000|Overall Study|Decision by sponsor|1|||
33275433|NCT03451422|62650165|FG001|Overall Study|Decision by sponsor|0|||
33275434|NCT03451422|62650166|FG002|Overall Study|Decision by sponsor|1|||
33275435|NCT03451422|62650167|FG003|Overall Study|Decision by sponsor|0|||
33275436|NCT03451422|62650168|FG004|Overall Study|Decision by sponsor|0|||
33275437|NCT03451422|62650169|FG005|Overall Study|Decision by sponsor|0|||
33275438|NCT03451422|62650164|FG000|Overall Study|Withdrawal by Subject|0|||
33275439|NCT03451422|62650165|FG001|Overall Study|Withdrawal by Subject|0|||
33275440|NCT03451422|62650166|FG002|Overall Study|Withdrawal by Subject|2|||
33275441|NCT03451422|62650167|FG003|Overall Study|Withdrawal by Subject|3|||
33275442|NCT03451422|62650168|FG004|Overall Study|Withdrawal by Subject|2|||
33275443|NCT03451422|62650169|FG005|Overall Study|Withdrawal by Subject|1|||
33275444|NCT03446573|62650190|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
33275445|NCT03446573|62650191|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
33275446|NCT03446573|62650190|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
33275447|NCT03446573|62650191|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
33275448|NCT03446573|62650190|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
33275449|NCT03446573|62650191|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
33275450|NCT03446573|62650190|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
33275451|NCT03446573|62650191|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
33275452|NCT03446573|62650190|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
33275453|NCT03446573|62650191|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
33275454|NCT03446573|62650190|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
33275455|NCT03446573|62650191|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
33275456|NCT03446573|62650190|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
33275457|NCT03446573|62650191|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
33275458|NCT03446573|62650190|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
33275459|NCT03446573|62650191|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
33275460|NCT03446573|62650190|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
33275461|NCT03446573|62650191|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
33275462|NCT03446573|62650190|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
33275463|NCT03446573|62650191|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
33275464|NCT03446573|62650190|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
33275465|NCT03446573|62650191|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
33275466|NCT03446573|62650190|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
33275467|NCT03446573|62650191|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
33275468|NCT03446573|62650190|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
33370331|NCT00600119|62749045|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
33370332|NCT00600119|62749046|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
33275469|NCT03446573|62650191|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
33275470|NCT03422536|62650209|FG000|Randomized|Physician Decision|1|||
33275471|NCT03422536|62650210|FG001|Randomized|Physician Decision|1|||
33370333|NCT00600119|62749047|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
33275472|NCT03422536|62650209|FG000|Allocation - Received Intervention|Disease progression|19|||
33275473|NCT03422536|62650210|FG001|Allocation - Received Intervention|Disease progression|25|||
33275474|NCT03422536|62650209|FG000|Allocation - Received Intervention|Death|1|||
33275475|NCT03422536|62650210|FG001|Allocation - Received Intervention|Death|3|||
33275476|NCT03422536|62650209|FG000|Allocation - Received Intervention|Adverse Event|1|||
33275477|NCT03422536|62650210|FG001|Allocation - Received Intervention|Adverse Event|0|||
33275478|NCT03422536|62650209|FG000|Allocation - Received Intervention|Physician Decision|1|||
33275479|NCT03422536|62650210|FG001|Allocation - Received Intervention|Physician Decision|1|||
33275480|NCT03422536|62650209|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
33275481|NCT03422536|62650210|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
33275482|NCT03422536|62650209|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
33275483|NCT03422536|62650210|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
33275484|NCT03228394|62650224|FG000|Overall Study|Lost to Follow-up|0|||
33275485|NCT03228394|62650225|FG001|Overall Study|Lost to Follow-up|0|||
33275486|NCT03228394|62650226|FG002|Overall Study|Lost to Follow-up|1|||
33275487|NCT03228394|62650227|FG003|Overall Study|Lost to Follow-up|1|||
33275488|NCT03228394|62650228|FG004|Overall Study|Lost to Follow-up|0|||
33275489|NCT03228394|62650229|FG005|Overall Study|Lost to Follow-up|0|||
33275490|NCT03228394|62650230|FG006|Overall Study|Lost to Follow-up|2|||
33275491|NCT03228394|62650231|FG007|Overall Study|Lost to Follow-up|0|||
33275492|NCT03228394|62650224|FG000|Overall Study|Withdrawal by Subject|0|||
33275493|NCT03228394|62650225|FG001|Overall Study|Withdrawal by Subject|0|||
33275494|NCT03228394|62650226|FG002|Overall Study|Withdrawal by Subject|1|||
33275495|NCT03228394|62650227|FG003|Overall Study|Withdrawal by Subject|0|||
33275496|NCT03228394|62650228|FG004|Overall Study|Withdrawal by Subject|0|||
33275497|NCT03228394|62650229|FG005|Overall Study|Withdrawal by Subject|0|||
33275498|NCT03228394|62650230|FG006|Overall Study|Withdrawal by Subject|1|||
33275499|NCT03228394|62650231|FG007|Overall Study|Withdrawal by Subject|3|||
33275500|NCT03228394|62650224|FG000|Overall Study|Protocol Violation|0|||
33275501|NCT03228394|62650225|FG001|Overall Study|Protocol Violation|0|||
33275502|NCT03228394|62650226|FG002|Overall Study|Protocol Violation|0|||
33275503|NCT03228394|62650227|FG003|Overall Study|Protocol Violation|1|||
33275504|NCT03228394|62650228|FG004|Overall Study|Protocol Violation|0|||
33275505|NCT03228394|62650229|FG005|Overall Study|Protocol Violation|0|||
33275506|NCT03228394|62650230|FG006|Overall Study|Protocol Violation|0|||
33275507|NCT03228394|62650231|FG007|Overall Study|Protocol Violation|0|||
33275508|NCT03228394|62650224|FG000|Overall Study|Physician Decision|0|||
33275509|NCT03228394|62650225|FG001|Overall Study|Physician Decision|0|||
33275510|NCT03228394|62650226|FG002|Overall Study|Physician Decision|0|||
33275511|NCT03228394|62650227|FG003|Overall Study|Physician Decision|0|||
33485670|NCT00153101|62863387|FG004|Overall Study|Withdrawal by Subject|5|||
33275512|NCT03228394|62650228|FG004|Overall Study|Physician Decision|0|||
33275513|NCT03228394|62650229|FG005|Overall Study|Physician Decision|0|||
33275514|NCT03228394|62650230|FG006|Overall Study|Physician Decision|1|||
33275515|NCT03228394|62650231|FG007|Overall Study|Physician Decision|0|||
33275516|NCT03228394|62650224|FG000|Overall Study|Noncompliance|0|||
33275517|NCT03228394|62650225|FG001|Overall Study|Noncompliance|0|||
33275518|NCT03228394|62650226|FG002|Overall Study|Noncompliance|0|||
33275519|NCT03228394|62650227|FG003|Overall Study|Noncompliance|0|||
33275520|NCT03228394|62650228|FG004|Overall Study|Noncompliance|0|||
33275521|NCT03228394|62650229|FG005|Overall Study|Noncompliance|0|||
33275522|NCT03228394|62650230|FG006|Overall Study|Noncompliance|1|||
33275523|NCT03228394|62650231|FG007|Overall Study|Noncompliance|0|||
33275524|NCT03043872|62650253|FG000|Overall Study|Withdrawal by Subject|6|||
33275525|NCT03043872|62650254|FG001|Overall Study|Withdrawal by Subject|6|||
33275526|NCT03043872|62650255|FG002|Overall Study|Withdrawal by Subject|15|||
33275527|NCT03043872|62650253|FG000|Overall Study|Lost to Follow-up|2|||
33275528|NCT03043872|62650254|FG001|Overall Study|Lost to Follow-up|1|||
33485671|NCT04401579|62863403|FG000|Overall Study|Death|23|||
33485672|NCT04401579|62863404|FG001|Overall Study|Death|36|||
33275529|NCT03043872|62650255|FG002|Overall Study|Lost to Follow-up|1|||
33275530|NCT03043872|62650253|FG000|Overall Study|Death|270|||
33275531|NCT03043872|62650254|FG001|Overall Study|Death|269|||
33275532|NCT03043872|62650255|FG002|Overall Study|Death|296|||
33370334|NCT00600119|62749048|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
33370335|NCT00600119|62749049|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
33485673|NCT04401579|62863403|FG000|Overall Study|Lost to Follow-up|40|||
33485674|NCT04401579|62863404|FG001|Overall Study|Lost to Follow-up|41|||
33275533|NCT03008070|62650276|FG000|Overall Study|Adverse Event|3|||
33275534|NCT03008070|62650277|FG001|Overall Study|Adverse Event|3|||
33275535|NCT03008070|62650278|FG002|Overall Study|Adverse Event|3|||
33275536|NCT03008070|62650276|FG000|Overall Study|Lost to Follow-up|1|||
33275537|NCT03008070|62650277|FG001|Overall Study|Lost to Follow-up|1|||
33275538|NCT03008070|62650278|FG002|Overall Study|Lost to Follow-up|0|||
33275539|NCT03008070|62650276|FG000|Overall Study|Non compliance|0|||
33275540|NCT03008070|62650277|FG001|Overall Study|Non compliance|1|||
33275541|NCT03008070|62650278|FG002|Overall Study|Non compliance|1|||
33275542|NCT03008070|62650276|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
33275543|NCT03008070|62650277|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
33275544|NCT03008070|62650278|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
33275545|NCT03008070|62650276|FG000|Overall Study|Withdrawal by Subject|2|||
33275546|NCT03008070|62650277|FG001|Overall Study|Withdrawal by Subject|0|||
33275547|NCT03008070|62650278|FG002|Overall Study|Withdrawal by Subject|1|||
33275548|NCT03008070|62650276|FG000|Overall Study|Use of prohibited drug|0|||
33275549|NCT03008070|62650277|FG001|Overall Study|Use of prohibited drug|0|||
33275550|NCT03008070|62650278|FG002|Overall Study|Use of prohibited drug|2|||
33275551|NCT02979353|62650290|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
33275552|NCT02979353|62650291|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
33275553|NCT02979353|62650290|FG000|Overall Study|Withdrawal by Subject|16|||
33275554|NCT02979353|62650291|FG001|Overall Study|Withdrawal by Subject|12|||
33275555|NCT02979353|62650290|FG000|Overall Study|Death|10|||
33275556|NCT02979353|62650291|FG001|Overall Study|Death|11|||
33275557|NCT02979353|62650290|FG000|Overall Study|Transfer to Hospice Care|19|||
33275558|NCT02979353|62650291|FG001|Overall Study|Transfer to Hospice Care|14|||
33275559|NCT02979353|62650290|FG000|Overall Study|Lost to Follow-up|1|||
33275560|NCT02979353|62650291|FG001|Overall Study|Lost to Follow-up|5|||
33275561|NCT02633397|62650310|FG000|Overall Study|Adverse Event|8|||
33275562|NCT02633397|62650311|FG001|Overall Study|Adverse Event|8|||
33275563|NCT02633397|62650310|FG000|Overall Study|Study Burden|4|||
33275564|NCT02633397|62650311|FG001|Overall Study|Study Burden|1|||
33275565|NCT02633397|62650310|FG000|Overall Study|Treatment interruption|2|||
33275566|NCT02633397|62650311|FG001|Overall Study|Treatment interruption|5|||
33275567|NCT02633397|62650310|FG000|Overall Study|Death|2|||
33275568|NCT02633397|62650311|FG001|Overall Study|Death|2|||
33275569|NCT02633397|62650310|FG000|Overall Study|Physician Decision|0|||
33275570|NCT02633397|62650311|FG001|Overall Study|Physician Decision|1|||
33275571|NCT02592707|62650321|FG000|Overall Study|Consent Withdrawn|0|||
33275572|NCT02592707|62650322|FG001|Overall Study|Consent Withdrawn|1|||
33275573|NCT02592707|62650323|FG002|Overall Study|Consent Withdrawn|2|||
33275574|NCT02592707|62650324|FG003|Overall Study|Consent Withdrawn|0|||
33275575|NCT02592707|62650321|FG000|Overall Study|Death|1|||
33275576|NCT02592707|62650322|FG001|Overall Study|Death|0|||
33275577|NCT02592707|62650323|FG002|Overall Study|Death|0|||
33275578|NCT02592707|62650324|FG003|Overall Study|Death|0|||
33275579|NCT02592707|62650321|FG000|Overall Study|Progressive Disease|4|||
33275580|NCT02592707|62650322|FG001|Overall Study|Progressive Disease|4|||
33275581|NCT02592707|62650323|FG002|Overall Study|Progressive Disease|3|||
33275582|NCT02592707|62650324|FG003|Overall Study|Progressive Disease|3|||
33275583|NCT02592707|62650321|FG000|Overall Study|Other|0|||
33275584|NCT02592707|62650322|FG001|Overall Study|Other|0|||
33275585|NCT02592707|62650323|FG002|Overall Study|Other|1|||
33275586|NCT02592707|62650324|FG003|Overall Study|Other|2|||
33275587|NCT02592707|62650321|FG000|Overall Study|Never entered LTFU period|1|||
33275588|NCT02592707|62650322|FG001|Overall Study|Never entered LTFU period|0|||
33275589|NCT02592707|62650323|FG002|Overall Study|Never entered LTFU period|0|||
33275590|NCT02592707|62650324|FG003|Overall Study|Never entered LTFU period|2|||
33275591|NCT01423812|62650352|FG000|Overall Study|Lost to Follow-up|2|||
33275592|NCT01423812|62650353|FG001|Overall Study|Lost to Follow-up|2|||
33275593|NCT01423812|62650352|FG000|Overall Study|Withdrawal by Subject|1|||
33275594|NCT01423812|62650353|FG001|Overall Study|Withdrawal by Subject|2|||
33275595|NCT00965718|62650361|FG000|Overall Study|Withdrawal by Subject|4|||
33275596|NCT00792740|62650376|FG000|Overall Study|Disease Worsening|3|||
33275597|NCT00792740|62650377|FG001|Overall Study|Disease Worsening|2|||
33275598|NCT00792740|62650376|FG000|Overall Study|Personal Reason|1|||
33275599|NCT00792740|62650377|FG001|Overall Study|Personal Reason|0|||
33275600|NCT00792740|62650376|FG000|Overall Study|Adverse Event|1|||
33275601|NCT00792740|62650377|FG001|Overall Study|Adverse Event|3|||
33275602|NCT00792740|62650376|FG000|Overall Study|Patient's withdrawal of consent|0|||
33275603|NCT00792740|62650377|FG001|Overall Study|Patient's withdrawal of consent|1|||
33275604|NCT00792740|62650376|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
33275605|NCT00792740|62650377|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
33275606|NCT00792740|62650376|FG000|Overall Study|Other reasons|0|||
33275607|NCT00792740|62650377|FG001|Overall Study|Other reasons|1|||
33275608|NCT00567580|62650396|FG000|Overall Study|Protocol Violation|28|||
33275609|NCT00567580|62650397|FG001|Overall Study|Protocol Violation|24|||
33275610|NCT00567580|62650398|FG002|Overall Study|Protocol Violation|24|||
33275611|NCT01058863|62650409|FG000|Overall Study|Lost to Follow-up|1|||
33275612|NCT01058863|62650409|FG000|Overall Study|Withdrawal by Subject|1|||
33275613|NCT01058863|62650409|FG000|Overall Study|Sponsor requested withdrawal|1|||
33275614|NCT01058863|62650409|FG000|Overall Study|Randomized in error|1|||
33275615|NCT01058395|62650424|FG000|Overall Study|Death|2|||
33275616|NCT01058395|62650425|FG001|Overall Study|Death|1|||
33275617|NCT01058395|62650424|FG000|Overall Study|Lost to Follow-up|1|||
33275618|NCT01058395|62650425|FG001|Overall Study|Lost to Follow-up|0|||
33275619|NCT01058356|62650431|FG000|Overall Study|Adverse Event|5|||
33275620|NCT01058356|62650431|FG000|Overall Study|Administration of contraindicated drugs|12|||
33275621|NCT01058356|62650431|FG000|Overall Study|Withdrawal by Subject|21|||
33275622|NCT01058356|62650431|FG000|Overall Study|Lost to Follow-up|4|||
33275623|NCT01058005|62650438|FG000|Overall Study|Adverse Event|0|||
33275624|NCT01058005|62650439|FG001|Overall Study|Adverse Event|2|||
33275625|NCT01058005|62650440|FG002|Overall Study|Adverse Event|1|||
33275626|NCT01058005|62650438|FG000|Overall Study|Physician Decision|2|||
33275627|NCT01058005|62650439|FG001|Overall Study|Physician Decision|2|||
33275628|NCT01058005|62650440|FG002|Overall Study|Physician Decision|0|||
33275629|NCT01058005|62650438|FG000|Overall Study|Withdrawal by Subject|4|||
33275630|NCT01058005|62650439|FG001|Overall Study|Withdrawal by Subject|5|||
33275631|NCT01058005|62650440|FG002|Overall Study|Withdrawal by Subject|11|||
33275632|NCT01058005|62650438|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
33275633|NCT01058005|62650439|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
33275634|NCT01058005|62650440|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
33275635|NCT01058005|62650438|FG000|Overall Study|Reason Missing|5|||
33275636|NCT01058005|62650439|FG001|Overall Study|Reason Missing|3|||
33275637|NCT01058005|62650440|FG002|Overall Study|Reason Missing|1|||
33275638|NCT01056640|62650450|FG000|Overall Study|Withdrawal by Subject|11|||
33275639|NCT01056640|62650451|FG001|Overall Study|Withdrawal by Subject|8|||
33275640|NCT01056640|62650450|FG000|Overall Study|Death|15|||
33275641|NCT01056640|62650451|FG001|Overall Study|Death|4|||
33275642|NCT01056523|62650457|FG000|Overall Study|Death|1|||
33275643|NCT01056523|62650458|FG001|Overall Study|Death|0|||
33275644|NCT01056523|62650459|FG002|Overall Study|Death|2|||
33275645|NCT01056523|62650460|FG003|Overall Study|Death|3|||
33275646|NCT01056523|62650461|FG004|Overall Study|Death|0|||
33275647|NCT01056523|62650462|FG005|Overall Study|Death|0|||
33275648|NCT01056523|62650463|FG006|Overall Study|Death|1|||
33275649|NCT01056484|62650470|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
33275650|NCT01056484|62650471|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
33275651|NCT01056484|62650470|FG000|Randomized Controlled Trial|Physician Decision|1|||
33275652|NCT01056484|62650471|FG001|Randomized Controlled Trial|Physician Decision|0|||
33275653|NCT01056484|62650470|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
33275654|NCT01056484|62650471|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
33275655|NCT01055314|62650480|FG000|Overall Study|Adverse Event|7|||
33275656|NCT01055314|62650481|FG001|Overall Study|Adverse Event|4|||
33275657|NCT01055314|62650480|FG000|Overall Study|Death|2|||
33275658|NCT01055314|62650481|FG001|Overall Study|Death|1|||
33275659|NCT01055314|62650480|FG000|Overall Study|Lack of Efficacy|11|||
33275660|NCT01055314|62650481|FG001|Overall Study|Lack of Efficacy|19|||
33275661|NCT01055314|62650480|FG000|Overall Study|Physician Decision|10|||
33275662|NCT01055314|62650481|FG001|Overall Study|Physician Decision|5|||
33275663|NCT01055314|62650480|FG000|Overall Study|Withdrawal by Subject|1|||
33275664|NCT01055314|62650481|FG001|Overall Study|Withdrawal by Subject|0|||
33275665|NCT01055314|62650480|FG000|Overall Study|Ineligible|3|||
33275666|NCT01055314|62650481|FG001|Overall Study|Ineligible|5|||
33275667|NCT01055314|62650480|FG000|Overall Study|Refusal of further protocol therapy|10|||
33275668|NCT01055314|62650481|FG001|Overall Study|Refusal of further protocol therapy|4|||
33275669|NCT01055314|62650480|FG000|Overall Study|No treatment|1|||
33275670|NCT01055314|62650481|FG001|Overall Study|No treatment|0|||
33275671|NCT01055197|62650490|FG000|Overall Study|Protocol Violation|7|||
33275672|NCT01055197|62650491|FG001|Overall Study|Protocol Violation|2|||
33275673|NCT01055197|62650490|FG000|Overall Study|Withdrawal by Subject|2|||
33275674|NCT01055197|62650491|FG001|Overall Study|Withdrawal by Subject|0|||
33275675|NCT01054885|62650503|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
33275676|NCT01054885|62650504|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33275677|NCT01054885|62650505|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33275678|NCT01054885|62650506|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33275679|NCT01054885|62650507|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33275680|NCT01054885|62650508|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33555785|NCT01975831|62948593|FG001|Overall Study|Withdrawal by Subject|3|||
33555786|NCT01975831|62948594|FG002|Overall Study|Withdrawal by Subject|0|||
33555787|NCT01975831|62948595|FG003|Overall Study|Withdrawal by Subject|0|||
33662056|NCT02546986|63092797|FG000|Treatment Period|Withdrawal by Subject|1|||
33275681|NCT01054885|62650509|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33275682|NCT01054885|62650503|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
33275683|NCT01054885|62650504|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
33275684|NCT01054885|62650505|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
33275685|NCT01054885|62650506|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
33275686|NCT01054885|62650507|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
33275687|NCT01054885|62650508|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
33275688|NCT01054885|62650509|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
33275689|NCT01054885|62650503|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
33275690|NCT01054885|62650504|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33275691|NCT01054885|62650505|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33275692|NCT01054885|62650506|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33275693|NCT01054885|62650507|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33275694|NCT01054885|62650508|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33275695|NCT01054885|62650509|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33275696|NCT01054885|62650503|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
33275697|NCT01054885|62650504|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33275698|NCT01054885|62650505|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33275699|NCT01054885|62650506|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33275700|NCT01054885|62650507|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33275701|NCT01054885|62650508|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33275702|NCT01054885|62650509|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33275703|NCT01054885|62650503|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
33275704|NCT01054885|62650504|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
33275705|NCT01054885|62650505|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
33275706|NCT01054885|62650506|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
33275707|NCT01054885|62650507|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
33275708|NCT01054885|62650508|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
33275709|NCT01054885|62650509|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
33275710|NCT01054885|62650503|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
33275711|NCT01054885|62650504|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33275712|NCT01054885|62650505|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33275713|NCT01054885|62650506|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33275714|NCT01054885|62650507|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33275715|NCT01054885|62650508|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33275716|NCT01054885|62650509|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33275717|NCT01054885|62650503|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
33275718|NCT01054885|62650504|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
33275719|NCT01054885|62650505|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
33275720|NCT01054885|62650506|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
33275721|NCT01054885|62650507|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
33275722|NCT01054885|62650508|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
33275723|NCT01054885|62650509|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
33275724|NCT01054885|62650503|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33275725|NCT01054885|62650504|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33275726|NCT01054885|62650505|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
33275727|NCT01054885|62650506|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
33275728|NCT01054885|62650507|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33275729|NCT01054885|62650508|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
33275730|NCT01054885|62650509|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33275731|NCT01054885|62650503|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
33275732|NCT01054885|62650504|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
33275733|NCT01054885|62650505|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
33275734|NCT01054885|62650506|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
33275735|NCT01054885|62650507|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
33275736|NCT01054885|62650508|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
33275737|NCT01054885|62650509|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
33275738|NCT01054885|62650503|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
33275739|NCT01054885|62650504|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
33275740|NCT01054885|62650505|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
33275741|NCT01054885|62650506|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
33275742|NCT01054885|62650507|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
33275743|NCT01054885|62650508|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
33275744|NCT01054885|62650509|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
33275745|NCT01054885|62650503|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
33275746|NCT01054885|62650504|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
33275747|NCT01054885|62650505|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
33275748|NCT01054885|62650506|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
33275749|NCT01054885|62650507|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
33275750|NCT01054885|62650508|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
33275751|NCT01054885|62650509|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
33275752|NCT01054885|62650503|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
33275753|NCT01054885|62650504|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
33275754|NCT01054885|62650505|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
33275755|NCT01054885|62650506|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
33275756|NCT01054885|62650507|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
33275757|NCT01054885|62650508|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
33275758|NCT01054885|62650509|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
33275759|NCT01054885|62650503|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33275760|NCT01054885|62650504|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
33275761|NCT01054885|62650505|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
33275762|NCT01054885|62650506|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33275763|NCT01054885|62650507|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33275764|NCT01054885|62650508|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
33275765|NCT01054885|62650509|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
33275766|NCT01054885|62650503|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
33275767|NCT01054885|62650504|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
33275768|NCT01054885|62650505|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
33275769|NCT01054885|62650506|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
33275770|NCT01054885|62650507|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
33275771|NCT01054885|62650508|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
33275772|NCT01054885|62650509|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
33275773|NCT01054885|62650503|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
33275774|NCT01054885|62650504|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
33275775|NCT01054885|62650505|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
33275776|NCT01054885|62650506|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
33275777|NCT01054885|62650507|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
33275778|NCT01054885|62650508|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
33275779|NCT01054885|62650509|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
33275780|NCT01054846|62650526|FG000|Overall Study|Lost to Follow-up|76|||
33275781|NCT01054846|62650527|FG001|Overall Study|Lost to Follow-up|17|||
33275782|NCT01054729|62650536|FG000|Overall Study|Randomized but Not Treated|0|||
33275783|NCT01054729|62650537|FG001|Overall Study|Randomized but Not Treated|1|||
33275784|NCT01054729|62650538|FG002|Overall Study|Randomized but Not Treated|0|||
33275785|NCT01054729|62650539|FG003|Overall Study|Randomized but Not Treated|0|||
33275786|NCT01054729|62650536|FG000|Overall Study|Adverse Event|1|||
33275787|NCT01054729|62650537|FG001|Overall Study|Adverse Event|1|||
33275788|NCT01054729|62650538|FG002|Overall Study|Adverse Event|2|||
33275789|NCT01054729|62650539|FG003|Overall Study|Adverse Event|1|||
33275790|NCT01054729|62650536|FG000|Overall Study|Withdrawal by Subject|1|||
33275791|NCT01054729|62650537|FG001|Overall Study|Withdrawal by Subject|0|||
33275792|NCT01054729|62650538|FG002|Overall Study|Withdrawal by Subject|1|||
33275793|NCT01054729|62650539|FG003|Overall Study|Withdrawal by Subject|0|||
33275794|NCT01054729|62650536|FG000|Overall Study|Lost to Follow-up|0|||
33275795|NCT01054729|62650537|FG001|Overall Study|Lost to Follow-up|1|||
33275796|NCT01054729|62650538|FG002|Overall Study|Lost to Follow-up|0|||
33275797|NCT01054729|62650539|FG003|Overall Study|Lost to Follow-up|0|||
33275798|NCT01054729|62650536|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
33275799|NCT01054729|62650537|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
33275800|NCT01054729|62650538|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
33275801|NCT01054729|62650539|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
33275802|NCT01054729|62650536|FG000|Overall Study|Non-responder|1|||
33275803|NCT01054729|62650537|FG001|Overall Study|Non-responder|0|||
33275804|NCT01054729|62650538|FG002|Overall Study|Non-responder|1|||
33275805|NCT01054729|62650539|FG003|Overall Study|Non-responder|1|||
33275806|NCT01054729|62650536|FG000|Overall Study|PEG/RBV Non-responder|1|||
33275807|NCT01054729|62650537|FG001|Overall Study|PEG/RBV Non-responder|0|||
33275808|NCT01054729|62650538|FG002|Overall Study|PEG/RBV Non-responder|1|||
33275809|NCT01054729|62650539|FG003|Overall Study|PEG/RBV Non-responder|0|||
33275810|NCT01054729|62650536|FG000|Overall Study|Personal/Obligations|0|||
33275811|NCT01054729|62650537|FG001|Overall Study|Personal/Obligations|1|||
33275812|NCT01054729|62650538|FG002|Overall Study|Personal/Obligations|0|||
33275813|NCT01054729|62650539|FG003|Overall Study|Personal/Obligations|0|||
33275814|NCT01054729|62650536|FG000|Overall Study|Subject moved|0|||
33275815|NCT01054729|62650537|FG001|Overall Study|Subject moved|0|||
33275816|NCT01054729|62650538|FG002|Overall Study|Subject moved|1|||
33275817|NCT01054729|62650539|FG003|Overall Study|Subject moved|0|||
33275818|NCT01054729|62650536|FG000|Overall Study|Lack of Efficacy|0|||
33275819|NCT01054729|62650537|FG001|Overall Study|Lack of Efficacy|0|||
33275820|NCT01054729|62650538|FG002|Overall Study|Lack of Efficacy|0|||
33485675|NCT04401579|62863403|FG000|Overall Study|Withdrawal by Subject|8|||
33485676|NCT04401579|62863404|FG001|Overall Study|Withdrawal by Subject|16|||
33275821|NCT01054729|62650539|FG003|Overall Study|Lack of Efficacy|1|||
33275822|NCT01054573|62650553|FG000|Overall Study|Adverse Event|1|||
33275823|NCT01054573|62650554|FG001|Overall Study|Adverse Event|0|||
33275824|NCT01054573|62650555|FG002|Overall Study|Adverse Event|1|||
33275825|NCT01054573|62650556|FG003|Overall Study|Adverse Event|1|||
33275826|NCT01054573|62650553|FG000|Overall Study|Lost to Follow-up|0|||
33275827|NCT01054573|62650554|FG001|Overall Study|Lost to Follow-up|2|||
33275828|NCT01054573|62650555|FG002|Overall Study|Lost to Follow-up|0|||
33275829|NCT01054573|62650556|FG003|Overall Study|Lost to Follow-up|0|||
33275830|NCT01054573|62650553|FG000|Overall Study|Withdrawal by Subject|0|||
33275831|NCT01054573|62650554|FG001|Overall Study|Withdrawal by Subject|2|||
33275832|NCT01054573|62650555|FG002|Overall Study|Withdrawal by Subject|2|||
33275833|NCT01054573|62650556|FG003|Overall Study|Withdrawal by Subject|1|||
33275834|NCT01054456|62650575|FG000|Overall Study|Other|1|||
33275835|NCT01054300|62650581|FG000|Period 1|Adverse Event|1|||
33275836|NCT01054300|62650582|FG001|Period 1|Adverse Event|0|||
33275837|NCT01054300|62650583|FG002|Period 1|Adverse Event|0|||
33275838|NCT01054300|62650584|FG003|Period 1|Adverse Event|0|||
33275839|NCT01054300|62650581|FG000|Period 2|Withdrawal by Subject|0|||
33275840|NCT01054300|62650582|FG001|Period 2|Withdrawal by Subject|0|||
33275841|NCT01054300|62650583|FG002|Period 2|Withdrawal by Subject|1|||
33275842|NCT01054300|62650584|FG003|Period 2|Withdrawal by Subject|0|||
33275843|NCT01053988|62650599|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
33275844|NCT01053988|62650600|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33275845|NCT01053988|62650601|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33275846|NCT01053988|62650602|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33275847|NCT01053988|62650603|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33275848|NCT01053988|62650604|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33275849|NCT01053988|62650599|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
33275850|NCT01053988|62650600|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33275851|NCT01053988|62650601|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33275852|NCT01053988|62650602|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33275853|NCT01053988|62650603|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33275854|NCT01053988|62650604|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33275855|NCT01053988|62650599|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
33275856|NCT01053988|62650600|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33275857|NCT01053988|62650601|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33275858|NCT01053988|62650602|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33275859|NCT01053988|62650603|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33275860|NCT01053988|62650604|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33275861|NCT01053988|62650599|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
33275862|NCT01053988|62650600|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
33275863|NCT01053988|62650601|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
33275864|NCT01053988|62650602|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
33275865|NCT01053988|62650603|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
33275866|NCT01053988|62650604|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
33275867|NCT01053988|62650599|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
33275868|NCT01053988|62650600|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
33275869|NCT01053988|62650601|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
33275870|NCT01053988|62650602|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
33275871|NCT01053988|62650603|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
33275872|NCT01053988|62650604|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
33275873|NCT01053988|62650599|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
33275874|NCT01053988|62650600|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33275875|NCT01053988|62650601|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33275876|NCT01053988|62650602|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33275877|NCT01053988|62650603|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33275878|NCT01053988|62650604|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33275879|NCT01053988|62650599|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
33275880|NCT01053988|62650600|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
33275881|NCT01053988|62650601|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
33275882|NCT01053988|62650602|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
33275883|NCT01053988|62650603|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
33275884|NCT01053988|62650604|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
33275885|NCT01053988|62650599|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33275886|NCT01053988|62650600|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
33275887|NCT01053988|62650601|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
33275888|NCT01053988|62650602|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
33275889|NCT01053988|62650603|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
33275890|NCT01053988|62650604|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33275891|NCT01053988|62650599|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
33275892|NCT01053988|62650600|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
33275893|NCT01053988|62650601|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
33275894|NCT01053988|62650602|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
33370336|NCT00600119|62749044|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
33370337|NCT00600119|62749045|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
33370338|NCT00600119|62749046|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
33370339|NCT00600119|62749047|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
33370340|NCT00600119|62749048|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
33370341|NCT00600119|62749049|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
33370342|NCT00600119|62749044|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
33370343|NCT00600119|62749045|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
33370344|NCT00600119|62749046|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33370345|NCT00600119|62749047|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
33370346|NCT00600119|62749048|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
33370347|NCT00600119|62749049|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
33485677|NCT04401579|62863403|FG000|Overall Study|Physician Decision|1|||
33485678|NCT04401579|62863404|FG001|Overall Study|Physician Decision|2|||
33485679|NCT04401579|62863403|FG000|Overall Study|Became ineligible after enrollment|1|||
33485680|NCT04401579|62863404|FG001|Overall Study|Became ineligible after enrollment|1|||
33485681|NCT04401579|62863403|FG000|Overall Study|Enrolled but treatment not administered|7|||
33275895|NCT01053988|62650603|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
33275896|NCT01053988|62650604|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
33275897|NCT01053988|62650599|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
33275898|NCT01053988|62650600|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
33275899|NCT01053988|62650601|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
33275900|NCT01053988|62650602|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
33275901|NCT01053988|62650603|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
33275902|NCT01053988|62650604|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
33275903|NCT01053988|62650599|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
33275904|NCT01053988|62650600|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
33275905|NCT01053988|62650601|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
33275906|NCT01053988|62650602|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
33275907|NCT01053988|62650603|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
33275908|NCT01053988|62650604|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
33275909|NCT01053988|62650599|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33275910|NCT01053988|62650600|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
33275911|NCT01053988|62650601|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33275912|NCT01053988|62650602|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
33275913|NCT01053988|62650603|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
33275914|NCT01053988|62650604|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
33275915|NCT01053988|62650599|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
33275916|NCT01053988|62650600|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
33275917|NCT01053988|62650601|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
33275918|NCT01053988|62650602|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
33275919|NCT01053988|62650603|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
33275920|NCT01053988|62650604|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
33275921|NCT01053988|62650599|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
33275922|NCT01053988|62650600|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
33275923|NCT01053988|62650601|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
33275924|NCT01053988|62650602|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
33275925|NCT01053988|62650603|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
33275926|NCT01053988|62650604|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
33275927|NCT01053247|62650619|FG000|Overall Study|Withdrawal by Subject|9|||
33275928|NCT01053247|62650620|FG001|Overall Study|Withdrawal by Subject|4|||
33275929|NCT01053247|62650621|FG002|Overall Study|Withdrawal by Subject|15|||
33370348|NCT00600119|62749044|FG000|Double-blind Treatment Period|Other|0|||
33370349|NCT00600119|62749045|FG001|Double-blind Treatment Period|Other|0|||
33370350|NCT00600119|62749046|FG002|Double-blind Treatment Period|Other|0|||
33370351|NCT00600119|62749047|FG003|Double-blind Treatment Period|Other|0|||
33485682|NCT04401579|62863404|FG001|Overall Study|Enrolled but treatment not administered|9|||
33485683|NCT04401579|62863403|FG000|Overall Study|Adverse Event|2|||
33485684|NCT04401579|62863404|FG001|Overall Study|Adverse Event|1|||
33275930|NCT01053247|62650619|FG000|Overall Study|Lack of Efficacy|1|||
33275931|NCT01053247|62650620|FG001|Overall Study|Lack of Efficacy|0|||
33275932|NCT01053247|62650621|FG002|Overall Study|Lack of Efficacy|1|||
33275933|NCT01053247|62650619|FG000|Overall Study|Protocol Violation|2|||
33275934|NCT01053247|62650620|FG001|Overall Study|Protocol Violation|1|||
33275935|NCT01053247|62650621|FG002|Overall Study|Protocol Violation|2|||
33275936|NCT01053247|62650619|FG000|Overall Study|Lost to Follow-up|8|||
33275937|NCT01053247|62650620|FG001|Overall Study|Lost to Follow-up|5|||
33275938|NCT01053247|62650621|FG002|Overall Study|Lost to Follow-up|7|||
33275939|NCT01053247|62650619|FG000|Overall Study|Adverse Event|0|||
33275940|NCT01053247|62650620|FG001|Overall Study|Adverse Event|9|||
33275941|NCT01053247|62650621|FG002|Overall Study|Adverse Event|3|||
33275942|NCT01052662|62650632|FG000|Overall Study|Lost to Follow-up|15|||
33275943|NCT01052662|62650633|FG001|Overall Study|Lost to Follow-up|13|||
33275944|NCT01052662|62650634|FG002|Overall Study|Lost to Follow-up|18|||
33275945|NCT01052662|62650632|FG000|Overall Study|Withdrawal by Subject|3|||
33275946|NCT01052662|62650633|FG001|Overall Study|Withdrawal by Subject|2|||
33275947|NCT01052662|62650634|FG002|Overall Study|Withdrawal by Subject|1|||
33275948|NCT01052662|62650632|FG000|Overall Study|Pharmacy issue|1|||
33275949|NCT01052662|62650633|FG001|Overall Study|Pharmacy issue|3|||
33275950|NCT01052662|62650634|FG002|Overall Study|Pharmacy issue|3|||
33275951|NCT01052662|62650632|FG000|Overall Study|Adverse Event|1|||
33275952|NCT01052662|62650633|FG001|Overall Study|Adverse Event|1|||
33275953|NCT01052662|62650634|FG002|Overall Study|Adverse Event|0|||
33275954|NCT01052662|62650632|FG000|Overall Study|Legal Problem|2|||
33275955|NCT01052662|62650633|FG001|Overall Study|Legal Problem|0|||
33275956|NCT01052662|62650634|FG002|Overall Study|Legal Problem|0|||
33275957|NCT01052662|62650632|FG000|Overall Study|Administrative|0|||
33275958|NCT01052662|62650633|FG001|Overall Study|Administrative|3|||
33275959|NCT01052662|62650634|FG002|Overall Study|Administrative|0|||
33275960|NCT01052116|62650644|FG000|Overall Study|Lost to Follow-up|11|||
33275961|NCT01052116|62650645|FG001|Overall Study|Lost to Follow-up|17|||
33275962|NCT01052116|62650644|FG000|Overall Study|Withdrawal by Subject|3|||
33275963|NCT01052116|62650645|FG001|Overall Study|Withdrawal by Subject|6|||
33275964|NCT01052116|62650644|FG000|Overall Study|Spirometry not performed|0|||
33275965|NCT01052116|62650645|FG001|Overall Study|Spirometry not performed|4|||
33275966|NCT01052077|62650653|FG000|Phase A|Lost to Follow-up|22|||
33275967|NCT01052077|62650654|FG001|Phase A|Lost to Follow-up|0|||
33275968|NCT01052077|62650655|FG002|Phase A|Lost to Follow-up|0|||
33275969|NCT01052077|62650656|FG003|Phase A|Lost to Follow-up|0|||
33275970|NCT01052077|62650653|FG000|Phase A|Adverse Event|32|||
33275971|NCT01052077|62650654|FG001|Phase A|Adverse Event|0|||
33275972|NCT01052077|62650655|FG002|Phase A|Adverse Event|0|||
33275973|NCT01052077|62650656|FG003|Phase A|Adverse Event|0|||
33275974|NCT01052077|62650653|FG000|Phase A|Met Withdrawal Criteria|26|||
33275975|NCT01052077|62650654|FG001|Phase A|Met Withdrawal Criteria|0|||
33275976|NCT01052077|62650655|FG002|Phase A|Met Withdrawal Criteria|0|||
33275977|NCT01052077|62650656|FG003|Phase A|Met Withdrawal Criteria|0|||
33275978|NCT01052077|62650653|FG000|Phase A|Physician Decision|10|||
33275979|NCT01052077|62650654|FG001|Phase A|Physician Decision|0|||
33275980|NCT01052077|62650655|FG002|Phase A|Physician Decision|0|||
33275981|NCT01052077|62650656|FG003|Phase A|Physician Decision|0|||
33275982|NCT01052077|62650653|FG000|Phase A|Withdrawal by Subject|29|||
33275983|NCT01052077|62650654|FG001|Phase A|Withdrawal by Subject|0|||
33275984|NCT01052077|62650655|FG002|Phase A|Withdrawal by Subject|0|||
33275985|NCT01052077|62650656|FG003|Phase A|Withdrawal by Subject|0|||
33275986|NCT01052077|62650653|FG000|Phase A|Protocol Deviation|27|||
33275987|NCT01052077|62650654|FG001|Phase A|Protocol Deviation|0|||
33275988|NCT01052077|62650655|FG002|Phase A|Protocol Deviation|0|||
33275989|NCT01052077|62650656|FG003|Phase A|Protocol Deviation|0|||
33275990|NCT01052077|62650653|FG000|Phase B|Lost to Follow-up|0|||
33275991|NCT01052077|62650654|FG001|Phase B|Lost to Follow-up|2|||
33275992|NCT01052077|62650655|FG002|Phase B|Lost to Follow-up|3|||
33275993|NCT01052077|62650656|FG003|Phase B|Lost to Follow-up|0|||
33275994|NCT01052077|62650653|FG000|Phase B|Adverse Event|0|||
33275995|NCT01052077|62650654|FG001|Phase B|Adverse Event|9|||
33275996|NCT01052077|62650655|FG002|Phase B|Adverse Event|2|||
33275997|NCT01052077|62650656|FG003|Phase B|Adverse Event|0|||
33275998|NCT01052077|62650653|FG000|Phase B|Met Withdrawal Criteria|0|||
33275999|NCT01052077|62650654|FG001|Phase B|Met Withdrawal Criteria|2|||
33276000|NCT01052077|62650655|FG002|Phase B|Met Withdrawal Criteria|1|||
33276001|NCT01052077|62650656|FG003|Phase B|Met Withdrawal Criteria|0|||
33276002|NCT01052077|62650653|FG000|Phase B|Physician Decision|0|||
33276003|NCT01052077|62650654|FG001|Phase B|Physician Decision|1|||
33276004|NCT01052077|62650655|FG002|Phase B|Physician Decision|1|||
33276005|NCT01052077|62650656|FG003|Phase B|Physician Decision|0|||
33276006|NCT01052077|62650653|FG000|Phase B|Withdrawal by Subject|0|||
33276007|NCT01052077|62650654|FG001|Phase B|Withdrawal by Subject|0|||
33276008|NCT01052077|62650655|FG002|Phase B|Withdrawal by Subject|5|||
33276009|NCT01052077|62650656|FG003|Phase B|Withdrawal by Subject|0|||
33276010|NCT01052077|62650653|FG000|Phase B|Protocol Deviation|0|||
33276011|NCT01052077|62650654|FG001|Phase B|Protocol Deviation|3|||
33276012|NCT01052077|62650655|FG002|Phase B|Protocol Deviation|4|||
33276013|NCT01052077|62650656|FG003|Phase B|Protocol Deviation|0|||
33276014|NCT01052077|62650653|FG000|Phase B|Lack of Efficacy|0|||
33276015|NCT01052077|62650654|FG001|Phase B|Lack of Efficacy|1|||
33276016|NCT01052077|62650655|FG002|Phase B|Lack of Efficacy|0|||
33276017|NCT01052077|62650656|FG003|Phase B|Lack of Efficacy|0|||
33276018|NCT01052077|62650653|FG000|Phase A+|Lost to Follow-up|0|||
33370352|NCT00600119|62749048|FG004|Double-blind Treatment Period|Other|2|||
33370353|NCT00600119|62749049|FG005|Double-blind Treatment Period|Other|1|||
33370354|NCT00600119|62749044|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
33370355|NCT00600119|62749045|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
33370356|NCT00600119|62749046|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
33370357|NCT00600119|62749047|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
33370358|NCT00600119|62749048|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
33370359|NCT00600119|62749049|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
33370360|NCT00600119|62749044|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
33370361|NCT00600119|62749045|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
33370362|NCT00600119|62749046|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
33370363|NCT00600119|62749047|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
33370364|NCT00600119|62749048|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
33370365|NCT00600119|62749049|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
33370366|NCT00600119|62749044|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
33370367|NCT00600119|62749045|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
33370368|NCT00600119|62749046|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
33370369|NCT00600119|62749047|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
33370370|NCT00600119|62749048|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
33370371|NCT00600119|62749049|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
33370372|NCT00600119|62749044|FG000|Double-blind Treatment Period|Physician Decision|2|||
33370373|NCT00600119|62749045|FG001|Double-blind Treatment Period|Physician Decision|0|||
33370374|NCT00600119|62749046|FG002|Double-blind Treatment Period|Physician Decision|0|||
33370375|NCT00600119|62749047|FG003|Double-blind Treatment Period|Physician Decision|0|||
33370376|NCT00600119|62749048|FG004|Double-blind Treatment Period|Physician Decision|0|||
33370377|NCT00600119|62749049|FG005|Double-blind Treatment Period|Physician Decision|0|||
33370378|NCT00600119|62749044|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
33370379|NCT00600119|62749045|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
33370380|NCT00600119|62749046|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
33370381|NCT00600119|62749047|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
33370382|NCT00600119|62749048|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
33370383|NCT00600119|62749049|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
33370384|NCT00600119|62749044|FG000|Double-blind Treatment Period|Adverse Event|1|||
33370385|NCT00600119|62749045|FG001|Double-blind Treatment Period|Adverse Event|1|||
33370386|NCT00600119|62749046|FG002|Double-blind Treatment Period|Adverse Event|0|||
33370387|NCT00600119|62749047|FG003|Double-blind Treatment Period|Adverse Event|1|||
33370388|NCT00600119|62749048|FG004|Double-blind Treatment Period|Adverse Event|2|||
33370389|NCT00600119|62749049|FG005|Double-blind Treatment Period|Adverse Event|10|||
33370390|NCT00600119|62749044|FG000|Follow-up Period|Adverse Event|0|||
33370391|NCT00600119|62749045|FG001|Follow-up Period|Adverse Event|0|||
33370392|NCT00600119|62749046|FG002|Follow-up Period|Adverse Event|0|||
33370393|NCT00600119|62749047|FG003|Follow-up Period|Adverse Event|0|||
33370394|NCT00600119|62749048|FG004|Follow-up Period|Adverse Event|0|||
33370395|NCT00600119|62749049|FG005|Follow-up Period|Adverse Event|1|||
33370396|NCT00600119|62749044|FG000|Follow-up Period|Other|1|||
33370397|NCT00600119|62749045|FG001|Follow-up Period|Other|0|||
33370398|NCT00600119|62749046|FG002|Follow-up Period|Other|0|||
33485685|NCT04401579|62863403|FG000|Overall Study|Scheduling error|1|||
33485686|NCT04401579|62863404|FG001|Overall Study|Scheduling error|2|||
33485687|NCT04401579|62863403|FG000|Overall Study|Transferred to another hospital|1|||
33485688|NCT04401579|62863404|FG001|Overall Study|Transferred to another hospital|2|||
33370399|NCT00600119|62749047|FG003|Follow-up Period|Other|0|||
33370400|NCT00600119|62749048|FG004|Follow-up Period|Other|0|||
33370401|NCT00600119|62749049|FG005|Follow-up Period|Other|0|||
33370402|NCT00866294|62749066|FG000|Overall Study|Adverse Event|12|||
33370403|NCT00866294|62749067|FG001|Overall Study|Adverse Event|13|||
33370404|NCT00866294|62749068|FG002|Overall Study|Adverse Event|9|||
33370405|NCT00866294|62749066|FG000|Overall Study|Lack of Efficacy|7|||
33370406|NCT00866294|62749067|FG001|Overall Study|Lack of Efficacy|1|||
33276019|NCT01052077|62650654|FG001|Phase A+|Lost to Follow-up|0|||
33370407|NCT00866294|62749068|FG002|Overall Study|Lack of Efficacy|0|||
33370408|NCT00866294|62749066|FG000|Overall Study|Protocol Violation|2|||
33370409|NCT00866294|62749067|FG001|Overall Study|Protocol Violation|0|||
33485689|NCT04161807|62863410|FG000|Overall Study|Withdrawal by Subject|2|||
33276020|NCT01052077|62650655|FG002|Phase A+|Lost to Follow-up|0|||
33276021|NCT01052077|62650656|FG003|Phase A+|Lost to Follow-up|8|||
33276022|NCT01052077|62650653|FG000|Phase A+|Adverse Event|0|||
33276023|NCT01052077|62650654|FG001|Phase A+|Adverse Event|0|||
33276024|NCT01052077|62650655|FG002|Phase A+|Adverse Event|0|||
33276025|NCT01052077|62650656|FG003|Phase A+|Adverse Event|4|||
33276026|NCT01052077|62650653|FG000|Phase A+|Met Withdrawal Criteria|0|||
33276027|NCT01052077|62650654|FG001|Phase A+|Met Withdrawal Criteria|0|||
33276028|NCT01052077|62650655|FG002|Phase A+|Met Withdrawal Criteria|0|||
33276029|NCT01052077|62650656|FG003|Phase A+|Met Withdrawal Criteria|2|||
33276030|NCT01052077|62650653|FG000|Phase A+|Withdrawal by Subject|0|||
33276031|NCT01052077|62650654|FG001|Phase A+|Withdrawal by Subject|0|||
33276032|NCT01052077|62650655|FG002|Phase A+|Withdrawal by Subject|0|||
33276033|NCT01052077|62650656|FG003|Phase A+|Withdrawal by Subject|7|||
33276034|NCT01052038|62650665|FG000|Overall Study|Lost to Follow-up|2|||
33276035|NCT01052038|62650666|FG001|Overall Study|Lost to Follow-up|3|||
33276036|NCT01052038|62650667|FG002|Overall Study|Lost to Follow-up|1|||
33276037|NCT01052038|62650665|FG000|Overall Study|Protocol Violation|2|||
33276038|NCT01052038|62650666|FG001|Overall Study|Protocol Violation|3|||
33276039|NCT01052038|62650667|FG002|Overall Study|Protocol Violation|3|||
33276040|NCT01051960|62650675|FG000|Overall Study|Adverse Event|1|||
33276041|NCT01051921|62650679|FG000|Overall Study|Physician Decision|9|||
33276042|NCT01051921|62650679|FG000|Overall Study|Adverse Event|8|||
33276043|NCT01051921|62650679|FG000|Overall Study|Withdrawal by Subject|7|||
33276044|NCT01051921|62650679|FG000|Overall Study|Lost to Follow-up|4|||
33276045|NCT01051921|62650679|FG000|Overall Study|virological failure|1|||
33276046|NCT01051921|62650679|FG000|Overall Study|patient moved|1|||
33276047|NCT01051063|62650685|FG000|Overall Study|Death|2|||
33276048|NCT01051063|62650686|FG001|Overall Study|Death|2|||
33276049|NCT01051063|62650685|FG000|Overall Study|Withdrawal by Subject|1|||
33276050|NCT01051063|62650686|FG001|Overall Study|Withdrawal by Subject|1|||
33276051|NCT01051063|62650685|FG000|Overall Study|Termination of the study|5|||
33276052|NCT01051063|62650686|FG001|Overall Study|Termination of the study|0|||
33276053|NCT01051063|62650685|FG000|Overall Study|Moved from the study site area|1|||
33276054|NCT01051063|62650686|FG001|Overall Study|Moved from the study site area|0|||
33276055|NCT01051063|62650685|FG000|Overall Study|Other|1|||
33276056|NCT01051063|62650686|FG001|Overall Study|Other|0|||
33276057|NCT01051063|62650685|FG000|Overall Study|Lost to Follow-up|0|||
33276058|NCT01051063|62650686|FG001|Overall Study|Lost to Follow-up|1|||
33276059|NCT01050790|62650693|FG000|Overall Study|Adverse Event|1|||
33276060|NCT01050673|62650700|FG000|Overall Study|Physician Decision|4|||
33276061|NCT01050673|62650701|FG001|Overall Study|Physician Decision|5|||
33276062|NCT01050205|62650709|FG000|Overall Study|Lost to Follow-up|7|||
33276063|NCT01050205|62650710|FG001|Overall Study|Lost to Follow-up|1|||
33276064|NCT01050205|62650709|FG000|Overall Study|Withdrawal by Subject|1|||
33276065|NCT01050205|62650710|FG001|Overall Study|Withdrawal by Subject|1|||
33276066|NCT01050205|62650709|FG000|Overall Study|Relocated from area|1|||
33276067|NCT01050205|62650710|FG001|Overall Study|Relocated from area|2|||
33276068|NCT01050205|62650709|FG000|Overall Study|Discontinued Intervention|2|||
33276069|NCT01050205|62650710|FG001|Overall Study|Discontinued Intervention|0|||
33276070|NCT01059448|62650720|FG000|Overall Study|Adverse Event|1|||
33276071|NCT01059448|62650721|FG001|Overall Study|Adverse Event|3|||
33370410|NCT00866294|62749068|FG002|Overall Study|Protocol Violation|0|||
33370411|NCT00866294|62749066|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
33370412|NCT00866294|62749067|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33370413|NCT00866294|62749068|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33370414|NCT00866294|62749066|FG000|Overall Study|Lost to Follow-up|1|||
33370415|NCT00866294|62749067|FG001|Overall Study|Lost to Follow-up|3|||
33370416|NCT00866294|62749068|FG002|Overall Study|Lost to Follow-up|0|||
33370417|NCT00866294|62749066|FG000|Overall Study|Physician Decision|6|||
33370418|NCT00866294|62749067|FG001|Overall Study|Physician Decision|2|||
33370419|NCT00866294|62749068|FG002|Overall Study|Physician Decision|1|||
33370420|NCT00854360|62749088|FG000|Overall Study|Adverse Event|0|||
33370421|NCT00854360|62749089|FG001|Overall Study|Adverse Event|1|||
33370422|NCT00854360|62749090|FG002|Overall Study|Adverse Event|2|||
33370423|NCT00854360|62749091|FG003|Overall Study|Adverse Event|6|||
33662057|NCT02546986|63092798|FG001|Treatment Period|Withdrawal by Subject|1|||
33276072|NCT01059448|62650722|FG002|Overall Study|Adverse Event|0|||
33276073|NCT01059448|62650723|FG003|Overall Study|Adverse Event|1|||
33276074|NCT01059448|62650720|FG000|Overall Study|Withdrawal by Subject|2|||
33276075|NCT01059448|62650721|FG001|Overall Study|Withdrawal by Subject|0|||
33276076|NCT01059448|62650722|FG002|Overall Study|Withdrawal by Subject|2|||
33370424|NCT00854360|62749088|FG000|Overall Study|Withdrawal by Subject|0|||
33370425|NCT00854360|62749089|FG001|Overall Study|Withdrawal by Subject|0|||
33276077|NCT01059448|62650723|FG003|Overall Study|Withdrawal by Subject|4|||
33276078|NCT01059448|62650720|FG000|Overall Study|Disease Progression|2|||
33276079|NCT01059448|62650721|FG001|Overall Study|Disease Progression|1|||
33276080|NCT01059448|62650722|FG002|Overall Study|Disease Progression|4|||
33276081|NCT01059448|62650723|FG003|Overall Study|Disease Progression|2|||
33276082|NCT01059448|62650720|FG000|Overall Study|Administrative Decision|43|||
33370426|NCT00854360|62749090|FG002|Overall Study|Withdrawal by Subject|0|||
33276083|NCT01059448|62650721|FG001|Overall Study|Administrative Decision|49|||
33276084|NCT01059448|62650722|FG002|Overall Study|Administrative Decision|45|||
33276085|NCT01059448|62650723|FG003|Overall Study|Administrative Decision|46|||
33276086|NCT01059448|62650720|FG000|Overall Study|Lost to Follow-up|0|||
33276087|NCT01059448|62650721|FG001|Overall Study|Lost to Follow-up|0|||
33276088|NCT01059448|62650722|FG002|Overall Study|Lost to Follow-up|2|||
33276089|NCT01059448|62650723|FG003|Overall Study|Lost to Follow-up|0|||
33276090|NCT01059448|62650720|FG000|Overall Study|Death|0|||
33276091|NCT01059448|62650721|FG001|Overall Study|Death|1|||
33276092|NCT01059448|62650722|FG002|Overall Study|Death|0|||
33276093|NCT01059448|62650723|FG003|Overall Study|Death|0|||
33276094|NCT01059448|62650720|FG000|Overall Study|Other|1|||
33276095|NCT01059448|62650721|FG001|Overall Study|Other|1|||
33276096|NCT01059448|62650722|FG002|Overall Study|Other|0|||
33276097|NCT01059448|62650723|FG003|Overall Study|Other|1|||
33276098|NCT01058707|62650744|FG000|Overall Study|Disease Progression|15|||
33276099|NCT01058707|62650745|FG001|Overall Study|Disease Progression|20|||
33276100|NCT01058707|62650746|FG002|Overall Study|Disease Progression|20|||
33276101|NCT01058707|62650747|FG003|Overall Study|Disease Progression|15|||
33276102|NCT01058707|62650748|FG004|Overall Study|Disease Progression|23|||
33276103|NCT01058707|62650749|FG005|Overall Study|Disease Progression|10|||
33276104|NCT01058707|62650750|FG006|Overall Study|Disease Progression|12|||
33276105|NCT01058707|62650744|FG000|Overall Study|Adverse Event|11|||
33276106|NCT01058707|62650745|FG001|Overall Study|Adverse Event|4|||
33276107|NCT01058707|62650746|FG002|Overall Study|Adverse Event|7|||
33276108|NCT01058707|62650747|FG003|Overall Study|Adverse Event|6|||
33276109|NCT01058707|62650748|FG004|Overall Study|Adverse Event|7|||
33276110|NCT01058707|62650749|FG005|Overall Study|Adverse Event|3|||
33276111|NCT01058707|62650750|FG006|Overall Study|Adverse Event|1|||
33276112|NCT01058707|62650744|FG000|Overall Study|Subject Decision|5|||
33276113|NCT01058707|62650745|FG001|Overall Study|Subject Decision|3|||
33276114|NCT01058707|62650746|FG002|Overall Study|Subject Decision|3|||
33276115|NCT01058707|62650747|FG003|Overall Study|Subject Decision|1|||
33276116|NCT01058707|62650748|FG004|Overall Study|Subject Decision|2|||
33276117|NCT01058707|62650749|FG005|Overall Study|Subject Decision|3|||
33276118|NCT01058707|62650750|FG006|Overall Study|Subject Decision|6|||
33276119|NCT01058707|62650744|FG000|Overall Study|Lost to Follow-up|0|||
33276120|NCT01058707|62650745|FG001|Overall Study|Lost to Follow-up|0|||
33276121|NCT01058707|62650746|FG002|Overall Study|Lost to Follow-up|1|||
33276122|NCT01058707|62650747|FG003|Overall Study|Lost to Follow-up|0|||
33276123|NCT01058707|62650748|FG004|Overall Study|Lost to Follow-up|0|||
33276124|NCT01058707|62650749|FG005|Overall Study|Lost to Follow-up|0|||
33276125|NCT01058707|62650750|FG006|Overall Study|Lost to Follow-up|0|||
33276126|NCT01058707|62650744|FG000|Overall Study|Reason Not Specified|0|||
33276127|NCT01058707|62650745|FG001|Overall Study|Reason Not Specified|3|||
33276128|NCT01058707|62650746|FG002|Overall Study|Reason Not Specified|2|||
33276129|NCT01058707|62650747|FG003|Overall Study|Reason Not Specified|0|||
33276130|NCT01058707|62650748|FG004|Overall Study|Reason Not Specified|7|||
33276131|NCT01058707|62650749|FG005|Overall Study|Reason Not Specified|1|||
33276132|NCT01058707|62650750|FG006|Overall Study|Reason Not Specified|7|||
33276133|NCT01054144|62650788|FG000|Overall Study|Death|2|||
33276134|NCT00105586|62650797|FG000|Overall Study|Adverse Event|4|||
33276135|NCT00105586|62650798|FG001|Overall Study|Adverse Event|3|||
33276136|NCT00105586|62650797|FG000|Overall Study|Physician Decision|13|||
33276137|NCT00105586|62650798|FG001|Overall Study|Physician Decision|13|||
33276138|NCT01059643|62650806|FG000|Overall Study|Adverse Event|3|||
33276139|NCT01059643|62650806|FG000|Overall Study|Withdrawal by Subject|2|||
33276140|NCT01059643|62650806|FG000|Overall Study|Physician Decision|1|||
33276141|NCT01059565|62650815|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
33276142|NCT01059565|62650816|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
33276143|NCT01059565|62650815|FG000|24-Week Randomized Phase|Adverse Event|5|||
33276144|NCT01059565|62650816|FG001|24-Week Randomized Phase|Adverse Event|0|||
33276145|NCT01059565|62650815|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
33276146|NCT01059565|62650816|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
33276147|NCT01059565|62650815|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
33276148|NCT01059565|62650816|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
33276149|NCT01059565|62650815|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
33276150|NCT01059565|62650816|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
33276151|NCT01059565|62650815|FG000|24-Week Open-Label Phase|Adverse Event|2|||
33276152|NCT01059565|62650816|FG001|24-Week Open-Label Phase|Adverse Event|0|||
33276153|NCT01059565|62650815|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
33276154|NCT01059565|62650816|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
33276155|NCT01059565|62650815|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
33276156|NCT01059565|62650816|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
33276157|NCT01059565|62650815|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
33276158|NCT01059565|62650816|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
33276159|NCT01059565|62650815|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
33276160|NCT01059565|62650816|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
33276161|NCT01059565|62650815|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
33276162|NCT01059565|62650816|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
33276163|NCT01059526|62650826|FG000|Overall Study|Patient enrolled but not treated|20|||
33276164|NCT01059526|62650827|FG001|Overall Study|Patient enrolled but not treated|17|||
33276165|NCT01059526|62650826|FG000|Overall Study|Adverse Event|2|||
33276166|NCT01059526|62650827|FG001|Overall Study|Adverse Event|2|||
33276167|NCT01059526|62650826|FG000|Overall Study|Protocol Violation|0|||
33276168|NCT01059526|62650827|FG001|Overall Study|Protocol Violation|1|||
33276169|NCT01059526|62650826|FG000|Overall Study|Withdrawal by Subject|3|||
33276170|NCT01059526|62650827|FG001|Overall Study|Withdrawal by Subject|1|||
33276171|NCT01059526|62650826|FG000|Overall Study|Lost to Follow-up|4|||
33276172|NCT01059526|62650827|FG001|Overall Study|Lost to Follow-up|1|||
33276173|NCT01059526|62650826|FG000|Overall Study|Patient found to be dermatographic|1|||
33276174|NCT01059526|62650827|FG001|Overall Study|Patient found to be dermatographic|0|||
33276175|NCT03277261|62650835|FG000|Overall Study|Adverse Event|17|||
33276176|NCT03277261|62650836|FG001|Overall Study|Adverse Event|1|||
33276177|NCT03277261|62650835|FG000|Overall Study|Participant Withdrawal of Consent|6|||
33276178|NCT03277261|62650836|FG001|Overall Study|Participant Withdrawal of Consent|15|||
33276179|NCT03277261|62650835|FG000|Overall Study|Investigator / Sponsor Decision|4|||
33276180|NCT03277261|62650836|FG001|Overall Study|Investigator / Sponsor Decision|2|||
33276181|NCT03277261|62650835|FG000|Overall Study|Pregnancy|2|||
33276182|NCT03277261|62650836|FG001|Overall Study|Pregnancy|0|||
33276183|NCT03277261|62650835|FG000|Overall Study|Lost to Follow-up|2|||
33276184|NCT03277261|62650836|FG001|Overall Study|Lost to Follow-up|2|||
33276185|NCT03277261|62650835|FG000|Overall Study|Lack of Efficacy|2|||
33276186|NCT03277261|62650836|FG001|Overall Study|Lack of Efficacy|2|||
33276187|NCT03277261|62650835|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
33276188|NCT03277261|62650836|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
33276189|NCT03277690|62650858|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
33276190|NCT03277690|62650859|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
33276191|NCT03277690|62650858|FG000|Dose Titration and Maintenance|Physician Decision|1|||
33276192|NCT03277690|62650859|FG001|Dose Titration and Maintenance|Physician Decision|0|||
33276193|NCT03277690|62650858|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
33276194|NCT03277690|62650859|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
33276195|NCT03277690|62650858|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
33276196|NCT03277690|62650859|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
33276197|NCT03277690|62650858|FG000|Dose Titration and Maintenance|Adverse Event|15|||
33276198|NCT03277690|62650859|FG001|Dose Titration and Maintenance|Adverse Event|0|||
33276199|NCT03277690|62650858|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
33276200|NCT03277690|62650859|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
33276201|NCT03277690|62650858|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
33276202|NCT03277690|62650859|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
33276203|NCT03271021|62650868|FG000|Overall Study|Adverse Event|3|||
33276204|NCT03271021|62650869|FG001|Overall Study|Adverse Event|2|||
33276205|NCT03271021|62650868|FG000|Overall Study|Withdrawal by Subject|36|||
33276206|NCT03271021|62650869|FG001|Overall Study|Withdrawal by Subject|53|||
33276207|NCT03271021|62650868|FG000|Overall Study|Lost to Follow-up|34|||
33276208|NCT03271021|62650869|FG001|Overall Study|Lost to Follow-up|39|||
33276209|NCT03271021|62650868|FG000|Overall Study|Protocol Violation|6|||
33276210|NCT03271021|62650869|FG001|Overall Study|Protocol Violation|4|||
33276211|NCT03271021|62650868|FG000|Overall Study|Abnormal Lab Results|1|||
33276212|NCT03271021|62650869|FG001|Overall Study|Abnormal Lab Results|0|||
33276213|NCT03271021|62650868|FG000|Overall Study|Miscellaneous|9|||
33370427|NCT00854360|62749091|FG003|Overall Study|Withdrawal by Subject|1|||
33370428|NCT00854360|62749088|FG000|Overall Study|Pregnancy|0|||
33370429|NCT00854360|62749089|FG001|Overall Study|Pregnancy|1|||
33370430|NCT00854360|62749090|FG002|Overall Study|Pregnancy|0|||
33370431|NCT00854360|62749091|FG003|Overall Study|Pregnancy|0|||
33370432|NCT00854360|62749088|FG000|Overall Study|Lack of Efficacy|2|||
33370433|NCT00854360|62749089|FG001|Overall Study|Lack of Efficacy|1|||
33370434|NCT00854360|62749090|FG002|Overall Study|Lack of Efficacy|0|||
33370435|NCT00854360|62749091|FG003|Overall Study|Lack of Efficacy|0|||
33370436|NCT00854360|62749088|FG000|Overall Study|Other|0|||
33370437|NCT00854360|62749089|FG001|Overall Study|Other|0|||
33370438|NCT00854360|62749090|FG002|Overall Study|Other|0|||
33276214|NCT03271021|62650869|FG001|Overall Study|Miscellaneous|8|||
33276215|NCT01249651|62650890|FG000|Overall Study|Withdrawal by Subject|4|||
33276216|NCT01249651|62650890|FG000|Overall Study|Adverse Event|1|||
33276217|NCT01249651|62650890|FG000|Overall Study|Protocol Violation|1|||
33276218|NCT01249651|62650890|FG000|Overall Study|Sponsor Decision|1|||
33276219|NCT01249417|62650897|FG000|Randomised Population|Study treatment not received|0|||
33276220|NCT01249417|62650898|FG001|Randomised Population|Study treatment not received|0|||
33370439|NCT00854360|62749091|FG003|Overall Study|Other|3|||
33370440|NCT00853970|62749103|FG000|Overall Study|Withdrawal by Subject|2|||
33276221|NCT01249417|62650899|FG002|Randomised Population|Study treatment not received|2|||
33276222|NCT01249417|62650897|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
33276223|NCT01249417|62650898|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
33276224|NCT01249417|62650899|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
33276225|NCT01249417|62650897|FG000|Treatment Phase - ITT Population|Other|0|||
33276226|NCT01249417|62650898|FG001|Treatment Phase - ITT Population|Other|0|||
33276227|NCT01249417|62650899|FG002|Treatment Phase - ITT Population|Other|1|||
33276228|NCT01249417|62650897|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
33276229|NCT01249417|62650898|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
33276230|NCT01249417|62650899|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
33276231|NCT01249417|62650897|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
33276232|NCT01249417|62650898|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
33276233|NCT01249417|62650899|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
33276234|NCT01249417|62650897|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
33276235|NCT01249417|62650898|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
33276236|NCT01249417|62650899|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
33276237|NCT01249261|62650909|FG000|Overall Study|Withdrawal by Subject|1|||
33276238|NCT01249261|62650910|FG001|Overall Study|Withdrawal by Subject|0|||
33276239|NCT01248949|62650930|FG000|Overall Study|Lost to Follow-up|2|||
33276240|NCT01248949|62650931|FG001|Overall Study|Lost to Follow-up|2|||
33276241|NCT01248949|62650932|FG002|Overall Study|Lost to Follow-up|2|||
33276242|NCT01248949|62650933|FG003|Overall Study|Lost to Follow-up|1|||
33276243|NCT01248949|62650934|FG004|Overall Study|Lost to Follow-up|0|||
33276244|NCT01248949|62650930|FG000|Overall Study|Withdrawal by Subject|5|||
33276245|NCT01248949|62650931|FG001|Overall Study|Withdrawal by Subject|3|||
33276246|NCT01248949|62650932|FG002|Overall Study|Withdrawal by Subject|11|||
33276247|NCT01248949|62650933|FG003|Overall Study|Withdrawal by Subject|3|||
33276248|NCT01248949|62650934|FG004|Overall Study|Withdrawal by Subject|1|||
33276249|NCT01248949|62650930|FG000|Overall Study|Death|22|||
33276250|NCT01248949|62650931|FG001|Overall Study|Death|7|||
33276251|NCT01248949|62650932|FG002|Overall Study|Death|21|||
33276252|NCT01248949|62650933|FG003|Overall Study|Death|6|||
33276253|NCT01248949|62650934|FG004|Overall Study|Death|2|||
33276254|NCT01248949|62650930|FG000|Overall Study|Alternative Therapy|1|||
33276255|NCT01248949|62650931|FG001|Overall Study|Alternative Therapy|0|||
33276256|NCT01248949|62650932|FG002|Overall Study|Alternative Therapy|0|||
33276257|NCT01248949|62650933|FG003|Overall Study|Alternative Therapy|0|||
33276258|NCT01248949|62650934|FG004|Overall Study|Alternative Therapy|0|||
33276259|NCT01248949|62650930|FG000|Overall Study|Alternative Therapy.|1|||
33276260|NCT01248949|62650931|FG001|Overall Study|Alternative Therapy.|0|||
33276261|NCT01248949|62650932|FG002|Overall Study|Alternative Therapy.|0|||
33276262|NCT01248949|62650933|FG003|Overall Study|Alternative Therapy.|0|||
33276263|NCT01248949|62650934|FG004|Overall Study|Alternative Therapy.|0|||
33276264|NCT01248949|62650930|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
33276265|NCT01248949|62650931|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
33276266|NCT01248949|62650932|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
33276267|NCT01248949|62650933|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
33276268|NCT01248949|62650934|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
33276269|NCT01248949|62650930|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
33276270|NCT01248949|62650931|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
33276271|NCT01248949|62650932|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
33276272|NCT01248949|62650933|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
33276273|NCT01248949|62650934|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
33276274|NCT01248949|62650930|FG000|Overall Study|Participant Went To Hospice|0|||
33276275|NCT01248949|62650931|FG001|Overall Study|Participant Went To Hospice|0|||
33276276|NCT01248949|62650932|FG002|Overall Study|Participant Went To Hospice|1|||
33276277|NCT01248949|62650933|FG003|Overall Study|Participant Went To Hospice|0|||
33276278|NCT01248949|62650934|FG004|Overall Study|Participant Went To Hospice|0|||
33276279|NCT01248949|62650930|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
33276280|NCT01248949|62650931|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
33276281|NCT01248949|62650932|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
33276282|NCT01248949|62650933|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
33276283|NCT01248949|62650934|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
33276284|NCT01248949|62650930|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
33276285|NCT01248949|62650931|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
33276286|NCT01248949|62650932|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
33276287|NCT01248949|62650933|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
33276288|NCT01248949|62650934|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
33276289|NCT01248949|62650930|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
33276290|NCT01248949|62650931|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
33276291|NCT01248949|62650932|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
33276292|NCT01248949|62650933|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
33276293|NCT01248949|62650934|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
33276294|NCT01248949|62650930|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
33276295|NCT01248949|62650931|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
33276296|NCT01248949|62650932|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
33276297|NCT01248949|62650933|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
33276298|NCT01248949|62650934|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
33276299|NCT01248793|62650948|FG000|Overall Study|Lost to Follow-up|0|||
33276300|NCT01248793|62650949|FG001|Overall Study|Lost to Follow-up|1|||
33276301|NCT01248793|62650948|FG000|Overall Study|Adverse Event|1|||
33276302|NCT01248793|62650949|FG001|Overall Study|Adverse Event|1|||
33276303|NCT01248793|62650948|FG000|Overall Study|Protocol Violation|0|||
33276304|NCT01248793|62650949|FG001|Overall Study|Protocol Violation|1|||
33276305|NCT01248793|62650948|FG000|Overall Study|Withdrawal by Subject|3|||
33276306|NCT01248793|62650949|FG001|Overall Study|Withdrawal by Subject|3|||
33276307|NCT01248364|62650959|FG000|Overall Study|Adverse Event|0|||
33276308|NCT01248364|62650960|FG001|Overall Study|Adverse Event|1|||
33276309|NCT01248364|62650961|FG002|Overall Study|Adverse Event|0|||
33276310|NCT01248364|62650962|FG003|Overall Study|Adverse Event|0|||
33276311|NCT01248130|62650974|FG000|Overall Study|Protocol Violation|1|||
33276312|NCT01248130|62650975|FG001|Overall Study|Protocol Violation|0|||
33276313|NCT01248130|62650974|FG000|Overall Study|Ineligible|1|||
33276314|NCT01248130|62650975|FG001|Overall Study|Ineligible|0|||
33276315|NCT01248013|62650981|FG000|Overall Study|Withdrawal by Subject|14|||
33276316|NCT01247350|62650990|FG000|Overall Study|Adverse Event|0|||
33276317|NCT01247350|62650991|FG001|Overall Study|Adverse Event|0|||
33276318|NCT01247350|62650992|FG002|Overall Study|Adverse Event|1|||
33276319|NCT01247350|62650993|FG003|Overall Study|Adverse Event|0|||
33276320|NCT01247350|62650994|FG004|Overall Study|Adverse Event|0|||
33276321|NCT01247350|62650990|FG000|Overall Study|Withdrawal by Subject|0|||
33276322|NCT01247350|62650991|FG001|Overall Study|Withdrawal by Subject|0|||
33276323|NCT01247350|62650992|FG002|Overall Study|Withdrawal by Subject|0|||
33276324|NCT01247350|62650993|FG003|Overall Study|Withdrawal by Subject|1|||
33276325|NCT01247350|62650994|FG004|Overall Study|Withdrawal by Subject|0|||
33276326|NCT01247350|62650990|FG000|Overall Study|Entry criteria not met|0|||
33276327|NCT01247350|62650991|FG001|Overall Study|Entry criteria not met|0|||
33276328|NCT01247350|62650992|FG002|Overall Study|Entry criteria not met|0|||
33276329|NCT01247350|62650993|FG003|Overall Study|Entry criteria not met|0|||
33276330|NCT01247350|62650994|FG004|Overall Study|Entry criteria not met|1|||
33276331|NCT01246999|62651024|FG000|Overall Study|Lost to Follow-up|0|||
33276332|NCT01246999|62651025|FG001|Overall Study|Lost to Follow-up|1|||
33276333|NCT01246999|62651026|FG002|Overall Study|Lost to Follow-up|0|||
33276334|NCT01246999|62651027|FG003|Overall Study|Lost to Follow-up|0|||
33276335|NCT01246999|62651024|FG000|Overall Study|Withdrawal by Subject|0|||
33276336|NCT01246999|62651025|FG001|Overall Study|Withdrawal by Subject|0|||
33276337|NCT01246999|62651026|FG002|Overall Study|Withdrawal by Subject|0|||
33276338|NCT01246999|62651027|FG003|Overall Study|Withdrawal by Subject|2|||
33276339|NCT01245751|62651049|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
33276340|NCT01245751|62651050|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
33276341|NCT01245751|62651051|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
33276342|NCT01245751|62651052|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
33276343|NCT01245751|62651049|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
33276344|NCT01245751|62651050|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
33276345|NCT01245751|62651051|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
33276346|NCT01245751|62651052|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
33276347|NCT01245751|62651049|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
33276348|NCT01245751|62651050|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
33276349|NCT01245751|62651051|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
33276350|NCT01245751|62651052|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
33276351|NCT01245673|62651063|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
33276352|NCT01245283|62651070|FG000|Overall Study|Lost to Follow-up|14|||
33276353|NCT01245283|62651071|FG001|Overall Study|Lost to Follow-up|11|||
33276354|NCT01245283|62651072|FG002|Overall Study|Lost to Follow-up|11|||
33276355|NCT01245049|62651085|FG000|Overall Study|Migrated/moved from study area|0|||
33276356|NCT01245049|62651086|FG001|Overall Study|Migrated/moved from study area|1|||
33276357|NCT01245049|62651085|FG000|Overall Study|Withdrawal by Subject|0|||
33276358|NCT01245049|62651086|FG001|Overall Study|Withdrawal by Subject|1|||
33370441|NCT00853970|62749104|FG001|Overall Study|Withdrawal by Subject|1|||
33276359|NCT01245049|62651085|FG000|Overall Study|Lost to Follow-up|1|||
33276360|NCT01245049|62651086|FG001|Overall Study|Lost to Follow-up|2|||
33276361|NCT01244893|62651092|FG000|Baseline|Protocol Violation|0|||
33276362|NCT01244893|62651093|FG001|Baseline|Protocol Violation|1|||
33276363|NCT01244893|62651092|FG000|1-Week Follow Up|Lost to Follow-up|1|||
33276364|NCT01244893|62651093|FG001|1-Week Follow Up|Lost to Follow-up|0|||
33276365|NCT01244815|62651108|FG000|Overall Study|Not Treated|0|||
33276366|NCT01244815|62651109|FG001|Overall Study|Not Treated|1|||
33276367|NCT01244815|62651110|FG002|Overall Study|Not Treated|0|||
33276368|NCT01244815|62651111|FG003|Overall Study|Not Treated|0|||
33276369|NCT01244815|62651108|FG000|Overall Study|Adverse Event|4|||
33276370|NCT01244815|62651109|FG001|Overall Study|Adverse Event|7|||
33276371|NCT01244815|62651110|FG002|Overall Study|Adverse Event|5|||
33276372|NCT01244815|62651111|FG003|Overall Study|Adverse Event|5|||
33276373|NCT01244815|62651108|FG000|Overall Study|Treatment Failure|0|||
33276374|NCT01244815|62651109|FG001|Overall Study|Treatment Failure|0|||
33276375|NCT01244815|62651110|FG002|Overall Study|Treatment Failure|0|||
33276376|NCT01244815|62651111|FG003|Overall Study|Treatment Failure|1|||
33276377|NCT01244815|62651108|FG000|Overall Study|Lost to Follow-up|3|||
33276378|NCT01244815|62651109|FG001|Overall Study|Lost to Follow-up|2|||
33276379|NCT01244815|62651110|FG002|Overall Study|Lost to Follow-up|3|||
33276380|NCT01244815|62651111|FG003|Overall Study|Lost to Follow-up|2|||
33276381|NCT01244815|62651108|FG000|Overall Study|Withdrawal by Subject|0|||
33276382|NCT01244815|62651109|FG001|Overall Study|Withdrawal by Subject|2|||
33276383|NCT01244815|62651110|FG002|Overall Study|Withdrawal by Subject|0|||
33276384|NCT01244815|62651111|FG003|Overall Study|Withdrawal by Subject|3|||
33276385|NCT01244815|62651108|FG000|Overall Study|Protocol Violation|7|||
33276386|NCT01244815|62651109|FG001|Overall Study|Protocol Violation|4|||
33276387|NCT01244815|62651110|FG002|Overall Study|Protocol Violation|3|||
33276388|NCT01244815|62651111|FG003|Overall Study|Protocol Violation|1|||
33276389|NCT01244815|62651108|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
33276390|NCT01244815|62651109|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
33276391|NCT01244815|62651110|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
33276392|NCT01244815|62651111|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
33276393|NCT01244425|62651123|FG000|Overall Study|Withdrawal by Subject|2|||
33276394|NCT01244425|62651124|FG001|Overall Study|Withdrawal by Subject|2|||
33276395|NCT01244425|62651123|FG000|Overall Study|Adverse Event|1|||
33276396|NCT01244425|62651124|FG001|Overall Study|Adverse Event|1|||
33276397|NCT01244191|62651140|FG000|Overall Study|Progressive disease|295|||
33276398|NCT01244191|62651141|FG001|Overall Study|Progressive disease|350|||
33276399|NCT01244191|62651140|FG000|Overall Study|Clinical disease progression|54|||
33276400|NCT01244191|62651141|FG001|Overall Study|Clinical disease progression|36|||
33276401|NCT01244191|62651140|FG000|Overall Study|Adverse Event|65|||
33276402|NCT01244191|62651141|FG001|Overall Study|Adverse Event|48|||
33276403|NCT01244191|62651140|FG000|Overall Study|Death|22|||
33276404|NCT01244191|62651141|FG001|Overall Study|Death|29|||
33276405|NCT01244191|62651140|FG000|Overall Study|Lost to Follow-up|0|||
33276406|NCT01244191|62651141|FG001|Overall Study|Lost to Follow-up|2|||
33276407|NCT01244191|62651140|FG000|Overall Study|Protocol Violation|1|||
33276408|NCT01244191|62651141|FG001|Overall Study|Protocol Violation|2|||
33276409|NCT01244191|62651140|FG000|Overall Study|Withdrawal by Subject|31|||
33276410|NCT01244191|62651141|FG001|Overall Study|Withdrawal by Subject|23|||
33276411|NCT01244191|62651140|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
33276412|NCT01244191|62651141|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
33276413|NCT01244035|62651147|FG000|Part 1: Period 1|Adverse Event|0|||
33276414|NCT01244035|62651148|FG001|Part 1: Period 1|Adverse Event|0|||
33276415|NCT01244035|62651149|FG002|Part 1: Period 1|Adverse Event|0|||
33276416|NCT01244035|62651150|FG003|Part 1: Period 1|Adverse Event|0|||
33276417|NCT01244035|62651151|FG004|Part 1: Period 1|Adverse Event|0|||
33276418|NCT01244035|62651152|FG005|Part 1: Period 1|Adverse Event|1|||
33276419|NCT01244035|62651147|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
33276420|NCT01244035|62651148|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
33276421|NCT01244035|62651149|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
33276422|NCT01244035|62651150|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
33276423|NCT01244035|62651151|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
33276424|NCT01244035|62651152|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
33276425|NCT01244035|62651147|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
33276426|NCT01244035|62651148|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
33276427|NCT01244035|62651149|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
33276428|NCT01244035|62651150|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
33276429|NCT01244035|62651151|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
33276430|NCT01244035|62651152|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
33276431|NCT01244035|62651147|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
33276432|NCT01244035|62651148|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
33276433|NCT01244035|62651149|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
33276434|NCT01244035|62651150|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
33276435|NCT01244035|62651151|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
33276436|NCT01244035|62651152|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
33276437|NCT01244035|62651147|FG000|Part 1: Period 3|Adverse Event|0|||
33276438|NCT01244035|62651148|FG001|Part 1: Period 3|Adverse Event|0|||
33276439|NCT01244035|62651149|FG002|Part 1: Period 3|Adverse Event|0|||
33276440|NCT01244035|62651150|FG003|Part 1: Period 3|Adverse Event|0|||
33276441|NCT01244035|62651151|FG004|Part 1: Period 3|Adverse Event|0|||
33276442|NCT01244035|62651152|FG005|Part 1: Period 3|Adverse Event|1|||
33276443|NCT01244035|62651147|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
33276444|NCT01244035|62651148|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
33276445|NCT01244035|62651149|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
33276446|NCT01244035|62651150|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
33276447|NCT01244035|62651151|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
33276448|NCT01244035|62651152|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
33276449|NCT01244035|62651147|FG000|Part 1: Period 3|Protocol Deviation|0|||
33276450|NCT01244035|62651148|FG001|Part 1: Period 3|Protocol Deviation|1|||
33276451|NCT01244035|62651149|FG002|Part 1: Period 3|Protocol Deviation|0|||
33276452|NCT01244035|62651150|FG003|Part 1: Period 3|Protocol Deviation|0|||
33276453|NCT01244035|62651151|FG004|Part 1: Period 3|Protocol Deviation|0|||
33276454|NCT01244035|62651152|FG005|Part 1: Period 3|Protocol Deviation|0|||
33276455|NCT01243762|62651188|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
33276456|NCT01243762|62651189|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
33276457|NCT01243762|62651190|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
33276458|NCT01243762|62651191|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
33276459|NCT01243762|62651192|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
33276460|NCT01243762|62651193|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
33276461|NCT01243762|62651194|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
33276462|NCT01243762|62651188|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
33276463|NCT01243762|62651189|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
33276464|NCT01243762|62651190|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
33276465|NCT01243762|62651191|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
33276466|NCT01243762|62651192|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
33276467|NCT01243762|62651193|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
33276468|NCT01243762|62651194|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
33276469|NCT01243762|62651188|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
33276470|NCT01243762|62651189|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
33276471|NCT01243762|62651190|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
33276472|NCT01243762|62651191|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
33276473|NCT01243762|62651192|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
33276474|NCT01243762|62651193|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
33276475|NCT01243762|62651194|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
33276476|NCT01243762|62651188|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
33276477|NCT01243762|62651189|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
33276478|NCT01243762|62651190|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
33276479|NCT01243762|62651191|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
33276480|NCT01243762|62651192|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
33276481|NCT01243762|62651193|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
33276482|NCT01243762|62651194|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
33276483|NCT01243762|62651188|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
33276484|NCT01243762|62651189|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
33276485|NCT01243762|62651190|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
33276486|NCT01243762|62651191|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
33276487|NCT01243762|62651192|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
33276488|NCT01243762|62651193|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
33276489|NCT01243762|62651194|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
33276490|NCT01243762|62651188|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
33276491|NCT01243762|62651189|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
33276492|NCT01243762|62651190|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
33276493|NCT01243762|62651191|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
33276494|NCT01243762|62651192|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
33276495|NCT01243762|62651193|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
33276496|NCT01243762|62651194|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
33276497|NCT01243762|62651188|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
33276498|NCT01243762|62651189|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
33276499|NCT01243762|62651190|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
33276500|NCT01243762|62651191|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
33276501|NCT01243762|62651192|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
33276502|NCT01243762|62651193|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
33276503|NCT01243762|62651194|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
33276504|NCT01243762|62651188|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
33276505|NCT01243762|62651189|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
33276506|NCT01243762|62651190|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
33276507|NCT01243762|62651191|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
33276508|NCT01243762|62651192|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
33276509|NCT01243762|62651193|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
33276510|NCT01243762|62651194|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
33276511|NCT01243411|62651213|FG000|Overall Study|Withdrawal by Subject|18|||
33276512|NCT01243411|62651213|FG000|Overall Study|Lost to Follow-up|10|||
33276513|NCT01243411|62651213|FG000|Overall Study|Adverse Event|5|||
33276514|NCT01243411|62651213|FG000|Overall Study|Other|8|||
33276515|NCT01243177|62651219|FG000|Overall Study|Lack of Efficacy|47|||
33276516|NCT01243177|62651220|FG001|Overall Study|Lack of Efficacy|31|||
33276517|NCT01243177|62651219|FG000|Overall Study|Protocol Violation|11|||
33276518|NCT01243177|62651220|FG001|Overall Study|Protocol Violation|10|||
33276519|NCT01243177|62651219|FG000|Overall Study|Lost to Follow-up|15|||
33276520|NCT01243177|62651220|FG001|Overall Study|Lost to Follow-up|18|||
33276521|NCT01243177|62651219|FG000|Overall Study|Withdrawal by Subject|46|||
33276522|NCT01243177|62651220|FG001|Overall Study|Withdrawal by Subject|38|||
33276523|NCT01243177|62651219|FG000|Overall Study|AE, serious fatal|0|||
33276524|NCT01243177|62651220|FG001|Overall Study|AE, serious fatal|1|||
33276525|NCT01243177|62651219|FG000|Overall Study|SAE, non-fatal|7|||
33276526|NCT01243177|62651220|FG001|Overall Study|SAE, non-fatal|9|||
33276527|NCT01243177|62651219|FG000|Overall Study|AE, non-serious non-fatal|40|||
33276528|NCT01243177|62651220|FG001|Overall Study|AE, non-serious non-fatal|58|||
33276529|NCT01243177|62651219|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
33276530|NCT01243177|62651220|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
33276531|NCT01243177|62651219|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
33276532|NCT01243177|62651220|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
33276533|NCT01243177|62651219|FG000|Overall Study|Other Reason|11|||
33276534|NCT01243177|62651220|FG001|Overall Study|Other Reason|12|||
33276535|NCT01242748|62651228|FG000|Overall Study|Adverse Event|10|||
33276536|NCT01242748|62651229|FG001|Overall Study|Adverse Event|5|||
33276537|NCT01242748|62651228|FG000|Overall Study|Lost to Follow-up|6|||
33276538|NCT01242748|62651229|FG001|Overall Study|Lost to Follow-up|2|||
33276539|NCT01242748|62651228|FG000|Overall Study|Physician Decision|3|||
33276540|NCT01242748|62651229|FG001|Overall Study|Physician Decision|2|||
33276541|NCT01242748|62651228|FG000|Overall Study|Protocol Violation|1|||
33276542|NCT01242748|62651229|FG001|Overall Study|Protocol Violation|0|||
33276543|NCT01242748|62651228|FG000|Overall Study|Withdrawal by Subject|10|||
33276544|NCT01242748|62651229|FG001|Overall Study|Withdrawal by Subject|2|||
33276545|NCT01242748|62651228|FG000|Overall Study|Miscellaneous reasons|8|||
33276546|NCT01242748|62651229|FG001|Overall Study|Miscellaneous reasons|3|||
33276547|NCT01242514|62651238|FG000|Overall Study|e.g., project closure|1042|||
33276548|NCT01242514|62651239|FG001|Overall Study|e.g., project closure|305|||
33276549|NCT01242514|62651240|FG002|Overall Study|e.g., project closure|171|||
33276550|NCT01242514|62651238|FG000|Overall Study|Subject decision|33|||
33276551|NCT01242514|62651239|FG001|Overall Study|Subject decision|8|||
33276552|NCT01242514|62651240|FG002|Overall Study|Subject decision|2|||
33276553|NCT01242514|62651238|FG000|Overall Study|Severe non-compliance to protocol|5|||
33276554|NCT01242514|62651239|FG001|Overall Study|Severe non-compliance to protocol|2|||
33276555|NCT01242514|62651240|FG002|Overall Study|Severe non-compliance to protocol|1|||
33276556|NCT01242514|62651238|FG000|Overall Study|Lack of therapeutic response|99|||
33276557|NCT01242514|62651239|FG001|Overall Study|Lack of therapeutic response|16|||
33276558|NCT01242514|62651240|FG002|Overall Study|Lack of therapeutic response|10|||
33276559|NCT01242514|62651238|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
33276560|NCT01242514|62651239|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
33276561|NCT01242514|62651240|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
33276562|NCT01242514|62651238|FG000|Overall Study|Lost to Follow-up|14|||
33276563|NCT01242514|62651239|FG001|Overall Study|Lost to Follow-up|5|||
33276564|NCT01242514|62651240|FG002|Overall Study|Lost to Follow-up|4|||
33276565|NCT01242514|62651238|FG000|Overall Study|Adverse Event|129|||
33276566|NCT01242514|62651239|FG001|Overall Study|Adverse Event|18|||
33276567|NCT01242514|62651240|FG002|Overall Study|Adverse Event|19|||
33276568|NCT01242085|62651251|FG000|Overall Study|Withdrawal by Subject|4|||
33276569|NCT01242085|62651252|FG001|Overall Study|Withdrawal by Subject|2|||
33276570|NCT01242085|62651253|FG002|Overall Study|Withdrawal by Subject|0|||
33276571|NCT01242085|62651251|FG000|Overall Study|medically unable to have surgery|4|||
33276572|NCT01242085|62651252|FG001|Overall Study|medically unable to have surgery|5|||
33276573|NCT01242085|62651253|FG002|Overall Study|medically unable to have surgery|0|||
33276574|NCT01241461|62651261|FG000|Overall Study|Progressive Disease|3|||
33276575|NCT01241461|62651262|FG001|Overall Study|Progressive Disease|6|||
33276576|NCT01240135|62651274|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
33276577|NCT01240135|62651275|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
33276578|NCT01240135|62651274|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
33276579|NCT01240135|62651275|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
33276580|NCT01247701|62651281|FG000|Overall Study|Death|2|||
33276581|NCT01247701|62651281|FG000|Overall Study|Relapsed|8|||
33276582|NCT01248247|62651289|FG000|Overall Study|Adverse Event|2|||
33276583|NCT01248247|62651290|FG001|Overall Study|Adverse Event|4|||
33276584|NCT01248247|62651291|FG002|Overall Study|Adverse Event|4|||
33276585|NCT01248247|62651292|FG003|Overall Study|Adverse Event|2|||
33276586|NCT01248247|62651289|FG000|Overall Study|Death|0|||
33276587|NCT01248247|62651290|FG001|Overall Study|Death|1|||
33276588|NCT01248247|62651291|FG002|Overall Study|Death|4|||
33276589|NCT01248247|62651292|FG003|Overall Study|Death|7|||
33276590|NCT01248247|62651289|FG000|Overall Study|Lost to Follow-up|0|||
33276591|NCT01248247|62651290|FG001|Overall Study|Lost to Follow-up|1|||
33276592|NCT01248247|62651291|FG002|Overall Study|Lost to Follow-up|1|||
33276593|NCT01248247|62651292|FG003|Overall Study|Lost to Follow-up|0|||
33276594|NCT01248247|62651289|FG000|Overall Study|Alternative treatment|0|||
33276595|NCT01248247|62651290|FG001|Overall Study|Alternative treatment|1|||
33276596|NCT01248247|62651291|FG002|Overall Study|Alternative treatment|0|||
33276597|NCT01248247|62651292|FG003|Overall Study|Alternative treatment|0|||
33276598|NCT01248247|62651289|FG000|Overall Study|Other|2|||
33276599|NCT01248247|62651290|FG001|Overall Study|Other|8|||
33276600|NCT01248247|62651291|FG002|Overall Study|Other|8|||
33276601|NCT01248247|62651292|FG003|Overall Study|Other|5|||
33276602|NCT01248247|62651289|FG000|Overall Study|Progression|18|||
33276603|NCT01248247|62651290|FG001|Overall Study|Progression|27|||
33276604|NCT01248247|62651291|FG002|Overall Study|Progression|56|||
33276605|NCT01248247|62651292|FG003|Overall Study|Progression|44|||
33276606|NCT01248247|62651289|FG000|Overall Study|Refuse further treatment|0|||
33276607|NCT01248247|62651290|FG001|Overall Study|Refuse further treatment|0|||
33276608|NCT01248247|62651291|FG002|Overall Study|Refuse further treatment|1|||
33276609|NCT01248247|62651292|FG003|Overall Study|Refuse further treatment|2|||
33276610|NCT01248247|62651289|FG000|Overall Study|Complicating disease|0|||
33276611|NCT01248247|62651290|FG001|Overall Study|Complicating disease|0|||
33276612|NCT01248247|62651291|FG002|Overall Study|Complicating disease|1|||
33276613|NCT01248247|62651292|FG003|Overall Study|Complicating disease|1|||
33276614|NCT02598583|62651304|FG000|Extension Period|Withdrawal by Subject|1|||
33276615|NCT02598583|62651305|FG001|Extension Period|Withdrawal by Subject|0|||
33276616|NCT04831736|62651322|FG000|Overall Study|Withdrawal by Subject|0|||
33276617|NCT04831736|62651323|FG001|Overall Study|Withdrawal by Subject|1|||
33276618|NCT04583956|62651338|FG000|Overall Study|Death|9|||
33276619|NCT04583956|62651339|FG001|Overall Study|Death|11|||
33276620|NCT04583956|62651338|FG000|Overall Study|Lost to Follow-up|7|||
33276621|NCT04583956|62651339|FG001|Overall Study|Lost to Follow-up|9|||
33276622|NCT04583956|62651338|FG000|Overall Study|Protocol Violation|2|||
33276623|NCT04583956|62651339|FG001|Overall Study|Protocol Violation|0|||
33276624|NCT04583956|62651338|FG000|Overall Study|Withdrawal by Subject|0|||
33276625|NCT04583956|62651339|FG001|Overall Study|Withdrawal by Subject|2|||
33276626|NCT04583956|62651338|FG000|Overall Study|Randomized but not dosed|2|||
33276627|NCT04583956|62651339|FG001|Overall Study|Randomized but not dosed|3|||
33276628|NCT04583956|62651338|FG000|Overall Study|Withdrawal of consent before product administration|1|||
33276629|NCT04583956|62651339|FG001|Overall Study|Withdrawal of consent before product administration|0|||
33276630|NCT04463680|62651355|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
33276631|NCT04463680|62651355|FG000|Overall Study|Not eligible due to implant duration of use|1|||
33276632|NCT04463680|62651355|FG000|Overall Study|Withdrawal by Subject|3|||
33276633|NCT04449029|62651367|FG000|Overall Study|Adverse Event|0|||
33276634|NCT04449029|62651368|FG001|Overall Study|Adverse Event|1|||
33276635|NCT04449029|62651369|FG002|Overall Study|Adverse Event|1|||
33276636|NCT04449029|62651370|FG003|Overall Study|Adverse Event|0|||
33276637|NCT04449029|62651371|FG004|Overall Study|Adverse Event|1|||
33276638|NCT04449029|62651372|FG005|Overall Study|Adverse Event|0|||
33276639|NCT04449029|62651373|FG006|Overall Study|Adverse Event|1|||
33276640|NCT04449029|62651374|FG007|Overall Study|Adverse Event|0|||
33276641|NCT04449029|62651367|FG000|Overall Study|Lost to Follow-up|0|||
33276642|NCT04449029|62651368|FG001|Overall Study|Lost to Follow-up|1|||
33276643|NCT04449029|62651369|FG002|Overall Study|Lost to Follow-up|0|||
33276644|NCT04449029|62651370|FG003|Overall Study|Lost to Follow-up|0|||
33276645|NCT04449029|62651371|FG004|Overall Study|Lost to Follow-up|0|||
33276646|NCT04449029|62651372|FG005|Overall Study|Lost to Follow-up|0|||
33276647|NCT04449029|62651373|FG006|Overall Study|Lost to Follow-up|0|||
33276648|NCT04449029|62651374|FG007|Overall Study|Lost to Follow-up|0|||
33276649|NCT04449029|62651367|FG000|Overall Study|Protocol Violation|0|||
33276650|NCT04449029|62651368|FG001|Overall Study|Protocol Violation|1|||
33276651|NCT04449029|62651369|FG002|Overall Study|Protocol Violation|0|||
33276652|NCT04449029|62651370|FG003|Overall Study|Protocol Violation|0|||
33276653|NCT04449029|62651371|FG004|Overall Study|Protocol Violation|0|||
33276654|NCT04449029|62651372|FG005|Overall Study|Protocol Violation|0|||
33276655|NCT04449029|62651373|FG006|Overall Study|Protocol Violation|0|||
33276656|NCT04449029|62651374|FG007|Overall Study|Protocol Violation|0|||
33276657|NCT04449029|62651367|FG000|Overall Study|Physician Decision|0|||
33276658|NCT04449029|62651368|FG001|Overall Study|Physician Decision|0|||
33276659|NCT04449029|62651369|FG002|Overall Study|Physician Decision|0|||
33276660|NCT04449029|62651370|FG003|Overall Study|Physician Decision|0|||
33276661|NCT04449029|62651371|FG004|Overall Study|Physician Decision|0|||
33276662|NCT04449029|62651372|FG005|Overall Study|Physician Decision|1|||
33485690|NCT04161807|62863410|FG000|Overall Study|Performed only 1 treatment|2|||
33276663|NCT04449029|62651373|FG006|Overall Study|Physician Decision|0|||
33276664|NCT04449029|62651374|FG007|Overall Study|Physician Decision|0|||
33276665|NCT04449029|62651367|FG000|Overall Study|Withdrawal by Subject|3|||
33276666|NCT04449029|62651368|FG001|Overall Study|Withdrawal by Subject|0|||
33276667|NCT04449029|62651369|FG002|Overall Study|Withdrawal by Subject|1|||
33555788|NCT01975831|62948596|FG004|Overall Study|Withdrawal by Subject|3|||
33276668|NCT04449029|62651370|FG003|Overall Study|Withdrawal by Subject|1|||
33276669|NCT04449029|62651371|FG004|Overall Study|Withdrawal by Subject|5|||
33276670|NCT04449029|62651372|FG005|Overall Study|Withdrawal by Subject|1|||
33276671|NCT04449029|62651373|FG006|Overall Study|Withdrawal by Subject|4|||
33276672|NCT04449029|62651374|FG007|Overall Study|Withdrawal by Subject|0|||
33276673|NCT04428333|62651404|FG000|Overall Study|Physician Decision|2|||
33276674|NCT04428333|62651405|FG001|Overall Study|Physician Decision|0|||
33276675|NCT04428333|62651404|FG000|Overall Study|Withdrawal by Subject|0|||
33276676|NCT04428333|62651405|FG001|Overall Study|Withdrawal by Subject|1|||
33276677|NCT04428333|62651404|FG000|Overall Study|In Follow-Up|5|||
33276678|NCT04428333|62651405|FG001|Overall Study|In Follow-Up|10|||
33276679|NCT04428333|62651404|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
33276680|NCT04428333|62651405|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
33276681|NCT04193202|62651413|FG000|Overall Study|Adverse Event|2|||
33276682|NCT04193202|62651414|FG001|Overall Study|Adverse Event|1|||
33276683|NCT04193202|62651413|FG000|Overall Study|Death|0|||
33276684|NCT04193202|62651414|FG001|Overall Study|Death|1|||
33276685|NCT04193202|62651413|FG000|Overall Study|Physician Decision|1|||
33276686|NCT04193202|62651414|FG001|Overall Study|Physician Decision|1|||
33276687|NCT04193202|62651413|FG000|Overall Study|Protocol Violation|2|||
33276688|NCT04193202|62651414|FG001|Overall Study|Protocol Violation|2|||
33276689|NCT04193202|62651413|FG000|Overall Study|Withdrawal by Subject|11|||
33276690|NCT04193202|62651414|FG001|Overall Study|Withdrawal by Subject|5|||
33276691|NCT04159935|62651422|FG000|Overall Study|Study terminated due to COVID-19|1|||
33276692|NCT04159935|62651423|FG001|Overall Study|Study terminated due to COVID-19|3|||
33276693|NCT04128696|62651431|FG000|Overall Study|Lost to Follow-up|0|||
33276694|NCT04128696|62651432|FG001|Overall Study|Lost to Follow-up|1|||
33276695|NCT04128696|62651431|FG000|Overall Study|Withdrawal by Subject|8|||
33276696|NCT04128696|62651432|FG001|Overall Study|Withdrawal by Subject|5|||
33276697|NCT04128696|62651431|FG000|Overall Study|In Follow-up|47|||
33370442|NCT00853970|62749103|FG000|Overall Study|Cancelled surgery|4|||
33370443|NCT00853970|62749104|FG001|Overall Study|Cancelled surgery|2|||
33370444|NCT00865904|62749132|FG000|Overall Study|Randomized but not Treated|2|||
33370445|NCT00865904|62749133|FG001|Overall Study|Randomized but not Treated|0|||
33370446|NCT00865904|62749134|FG002|Overall Study|Randomized but not Treated|0|||
33370447|NCT00865904|62749135|FG003|Overall Study|Randomized but not Treated|1|||
33370448|NCT00865904|62749136|FG004|Overall Study|Randomized but not Treated|1|||
33370449|NCT00599339|62749152|FG000|Overall Study|Adverse Event|79|||
33370450|NCT00599339|62749152|FG000|Overall Study|Withdrawal by Subject|137|||
33370451|NCT00599339|62749152|FG000|Overall Study|Other Reason|179|||
33370452|NCT00599339|62749152|FG000|Overall Study|Lost to Follow-up|221|||
33370453|NCT00599339|62749152|FG000|Overall Study|No valid data consent|36|||
33370454|NCT00599339|62749152|FG000|Overall Study|Study Termination Status Unknown|12|||
33370455|NCT00599027|62749176|FG000|Overall Study|Withdrawal by Subject|1|||
33370456|NCT00599027|62749177|FG001|Overall Study|Withdrawal by Subject|1|||
33370457|NCT00599027|62749176|FG000|Overall Study|Adverse Event|0|||
33370458|NCT00599027|62749177|FG001|Overall Study|Adverse Event|1|||
33370459|NCT00599027|62749176|FG000|Overall Study|Treatment Failure|0|||
33370460|NCT00599027|62749177|FG001|Overall Study|Treatment Failure|1|||
33370461|NCT02881151|62749192|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
33370462|NCT00689728|62749200|FG000|Double-Blind Treatment|Adverse Event|1|||
33370463|NCT00689728|62749201|FG001|Double-Blind Treatment|Adverse Event|0|||
33370464|NCT00689728|62749202|FG002|Double-Blind Treatment|Adverse Event|0|||
33370465|NCT00689728|62749200|FG000|Double-Blind Treatment|Protocol Violation|0|||
33370466|NCT00689728|62749201|FG001|Double-Blind Treatment|Protocol Violation|0|||
33370467|NCT00689728|62749202|FG002|Double-Blind Treatment|Protocol Violation|1|||
33370468|NCT00689728|62749200|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
33370469|NCT00689728|62749201|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
33370470|NCT00689728|62749202|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
33370471|NCT00689728|62749200|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
33276698|NCT04128696|62651432|FG001|Overall Study|In Follow-up|51|||
33276699|NCT04128696|62651431|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|52|||
33276700|NCT04128696|62651432|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|62|||
33370472|NCT00689728|62749201|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
33370473|NCT00689728|62749202|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
33370474|NCT00689728|62749200|FG000|Rescue|Adverse Event|0|||
33370475|NCT00689728|62749201|FG001|Rescue|Adverse Event|1|||
33370476|NCT00689728|62749202|FG002|Rescue|Adverse Event|0|||
33370477|NCT00689728|62749200|FG000|Rescue|Withdrawal by Subject|1|||
33555789|NCT01975831|62948597|FG005|Overall Study|Withdrawal by Subject|1|||
33276701|NCT03871543|62651456|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
33370478|NCT00689728|62749201|FG001|Rescue|Withdrawal by Subject|1|||
33370479|NCT00689728|62749202|FG002|Rescue|Withdrawal by Subject|1|||
33370480|NCT00689728|62749200|FG000|Optional Follow-Up|Adverse Event|1|||
33276702|NCT03871543|62651456|FG000|Period 1|Investigator Error|1|||
33276703|NCT03871543|62651456|FG000|Period 1|Protocol Violation|2|||
33276704|NCT03871543|62651456|FG000|Period 1|COVID-19 Related|1|||
33276705|NCT03871543|62651456|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
33276706|NCT03871543|62651456|FG000|Period 1|Withdrawal by Subject|10|||
33276707|NCT03871543|62651456|FG000|Period 2|Adverse Event|1|||
33276708|NCT03871543|62651456|FG000|Period 2|Withdrawal by Subject|1|||
33276709|NCT03843125|62651468|FG000|Overall Study|Adverse Event|17|||
33276710|NCT03843125|62651469|FG001|Overall Study|Adverse Event|13|||
33276711|NCT03843125|62651470|FG002|Overall Study|Adverse Event|5|||
33276712|NCT03843125|62651471|FG003|Overall Study|Adverse Event|9|||
33276713|NCT03843125|62651468|FG000|Overall Study|Death|0|||
33276714|NCT03843125|62651469|FG001|Overall Study|Death|6|||
33276715|NCT03843125|62651470|FG002|Overall Study|Death|2|||
33276716|NCT03843125|62651471|FG003|Overall Study|Death|0|||
33276717|NCT03843125|62651468|FG000|Overall Study|Lack of Efficacy|14|||
33276718|NCT03843125|62651469|FG001|Overall Study|Lack of Efficacy|11|||
33276719|NCT03843125|62651470|FG002|Overall Study|Lack of Efficacy|9|||
33276720|NCT03843125|62651471|FG003|Overall Study|Lack of Efficacy|4|||
33276721|NCT03843125|62651468|FG000|Overall Study|Lost to Follow-up|3|||
33276722|NCT03843125|62651469|FG001|Overall Study|Lost to Follow-up|4|||
33276723|NCT03843125|62651470|FG002|Overall Study|Lost to Follow-up|0|||
33276724|NCT03843125|62651471|FG003|Overall Study|Lost to Follow-up|2|||
33276725|NCT03843125|62651468|FG000|Overall Study|Other|12|||
33276726|NCT03843125|62651469|FG001|Overall Study|Other|14|||
33276727|NCT03843125|62651470|FG002|Overall Study|Other|3|||
33276728|NCT03843125|62651471|FG003|Overall Study|Other|4|||
33276729|NCT03843125|62651468|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
33276730|NCT03843125|62651469|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
33276731|NCT03843125|62651470|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
33276732|NCT03843125|62651471|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
33276733|NCT03843125|62651468|FG000|Overall Study|Study Terminated by Sponsor|318|||
33276734|NCT03843125|62651469|FG001|Overall Study|Study Terminated by Sponsor|318|||
33276735|NCT03843125|62651470|FG002|Overall Study|Study Terminated by Sponsor|163|||
33276736|NCT03843125|62651471|FG003|Overall Study|Study Terminated by Sponsor|163|||
33276737|NCT03843125|62651468|FG000|Overall Study|Withdrawal by Subject|23|||
33276738|NCT03843125|62651469|FG001|Overall Study|Withdrawal by Subject|12|||
33276739|NCT03843125|62651470|FG002|Overall Study|Withdrawal by Subject|6|||
33276740|NCT03843125|62651471|FG003|Overall Study|Withdrawal by Subject|9|||
33276741|NCT03843125|62651468|FG000|Overall Study|Missing data|0|||
33276742|NCT03843125|62651469|FG001|Overall Study|Missing data|1|||
33276743|NCT03843125|62651470|FG002|Overall Study|Missing data|1|||
33276744|NCT03843125|62651471|FG003|Overall Study|Missing data|0|||
33276745|NCT03695237|62651484|FG000|Overall Study|Discontinued to Restart Puberty|1|||
33276746|NCT03695237|62651485|FG001|Overall Study|Discontinued to Restart Puberty|0|||
33276747|NCT03603509|62651494|FG000|Overall Study|Lost to Follow-up|3|||
33276748|NCT03603509|62651495|FG001|Overall Study|Lost to Follow-up|4|||
33276749|NCT03275285|62651512|FG000|Overall Study|Ongoing|61|||
33276750|NCT03275285|62651513|FG001|Overall Study|Ongoing|105|||
33276751|NCT03066258|62651532|FG000|Overall Study|Death|1|||
33276752|NCT03066258|62651533|FG001|Overall Study|Death|0|||
33276753|NCT03066258|62651534|FG002|Overall Study|Death|0|||
33276754|NCT03066258|62651535|FG003|Overall Study|Death|0|||
33276755|NCT03066258|62651536|FG004|Overall Study|Death|1|||
33276756|NCT03024255|62651552|FG000|Overall Study|Adverse Event|1|||
33276757|NCT03024255|62651553|FG001|Overall Study|Adverse Event|4|||
33276758|NCT03024255|62651554|FG002|Overall Study|Adverse Event|8|||
33276759|NCT03024255|62651555|FG003|Overall Study|Adverse Event|0|||
33276760|NCT03024255|62651552|FG000|Overall Study|Withdrawal by Subject|3|||
33276761|NCT03024255|62651553|FG001|Overall Study|Withdrawal by Subject|1|||
33276762|NCT03024255|62651554|FG002|Overall Study|Withdrawal by Subject|0|||
33276763|NCT03024255|62651555|FG003|Overall Study|Withdrawal by Subject|3|||
33276764|NCT03024255|62651552|FG000|Overall Study|Protocol Violation|0|||
33276765|NCT03024255|62651553|FG001|Overall Study|Protocol Violation|0|||
33276766|NCT03024255|62651554|FG002|Overall Study|Protocol Violation|2|||
33276767|NCT03024255|62651555|FG003|Overall Study|Protocol Violation|0|||
33485691|NCT04401423|62863416|FG000|Overall Study|Withdrawal by Subject|3|||
33485692|NCT04401423|62863417|FG001|Overall Study|Withdrawal by Subject|1|||
33555790|NCT01975831|62948598|FG006|Overall Study|Withdrawal by Subject|1|||
33276768|NCT03024255|62651552|FG000|Overall Study|Lost to Follow-up|1|||
33276769|NCT03024255|62651553|FG001|Overall Study|Lost to Follow-up|2|||
33276770|NCT03024255|62651554|FG002|Overall Study|Lost to Follow-up|1|||
33276771|NCT03024255|62651555|FG003|Overall Study|Lost to Follow-up|1|||
33276772|NCT03024255|62651552|FG000|Overall Study|Lack of Efficacy|1|||
33276773|NCT03024255|62651553|FG001|Overall Study|Lack of Efficacy|0|||
33276774|NCT03024255|62651554|FG002|Overall Study|Lack of Efficacy|0|||
33276775|NCT03024255|62651555|FG003|Overall Study|Lack of Efficacy|0|||
33276776|NCT03024255|62651552|FG000|Overall Study|Protocol Noncompliance|1|||
33276777|NCT03024255|62651553|FG001|Overall Study|Protocol Noncompliance|1|||
33276778|NCT03024255|62651554|FG002|Overall Study|Protocol Noncompliance|0|||
33276779|NCT03024255|62651555|FG003|Overall Study|Protocol Noncompliance|1|||
33276780|NCT02636582|62651574|FG000|Overall Study|Surgical Pathology|1|||
33276781|NCT02636582|62651575|FG001|Overall Study|Surgical Pathology|0|||
33276782|NCT02367040|62651583|FG000|Overall Study|Lost to Follow-up|1|||
33276783|NCT02367040|62651584|FG001|Overall Study|Lost to Follow-up|1|||
33276784|NCT02367040|62651583|FG000|Overall Study|Lack of Efficacy|1|||
33276785|NCT02367040|62651584|FG001|Overall Study|Lack of Efficacy|0|||
33276786|NCT02367040|62651583|FG000|Overall Study|Additional primary malignancy|0|||
33276787|NCT02367040|62651584|FG001|Overall Study|Additional primary malignancy|1|||
33276788|NCT02367040|62651583|FG000|Overall Study|AE not associated with clinical disease progression|104|||
33276789|NCT02367040|62651584|FG001|Overall Study|AE not associated with clinical disease progression|9|||
33276790|NCT02367040|62651583|FG000|Overall Study|AE associated with clinical disease progression|1|||
33276791|NCT02367040|62651584|FG001|Overall Study|AE associated with clinical disease progression|3|||
33276792|NCT02367040|62651583|FG000|Overall Study|Physician Decision|2|||
33276793|NCT02367040|62651584|FG001|Overall Study|Physician Decision|8|||
33276794|NCT02367040|62651583|FG000|Overall Study|Non-compliance with study drug|1|||
33276795|NCT02367040|62651584|FG001|Overall Study|Non-compliance with study drug|0|||
33276796|NCT02367040|62651583|FG000|Overall Study|Failure to meet continuation criteria|1|||
33276797|NCT02367040|62651584|FG001|Overall Study|Failure to meet continuation criteria|0|||
33276798|NCT02367040|62651583|FG000|Overall Study|Switching to other therapy|2|||
33276799|NCT02367040|62651584|FG001|Overall Study|Switching to other therapy|0|||
33276800|NCT02367040|62651583|FG000|Overall Study|Withdrawal by Subject|41|||
33276801|NCT02367040|62651584|FG001|Overall Study|Withdrawal by Subject|14|||
33276802|NCT02367040|62651583|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
33276803|NCT02367040|62651584|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
33276804|NCT02367040|62651583|FG000|Overall Study|Patient decision|35|||
33276805|NCT02367040|62651584|FG001|Overall Study|Patient decision|11|||
33276806|NCT02367040|62651583|FG000|Overall Study|Required procedure failed|1|||
33276807|NCT02367040|62651584|FG001|Overall Study|Required procedure failed|0|||
33276808|NCT02367040|62651583|FG000|Overall Study|Randomized by mistake with study treatment|1|||
33276809|NCT02367040|62651584|FG001|Overall Study|Randomized by mistake with study treatment|0|||
33276810|NCT02367040|62651583|FG000|Overall Study|Protocol Violation|1|||
33276811|NCT02367040|62651584|FG001|Overall Study|Protocol Violation|0|||
33276812|NCT02367040|62651583|FG000|Overall Study|Progressive disease - radiological progression|39|||
33276813|NCT02367040|62651584|FG001|Overall Study|Progressive disease - radiological progression|67|||
33276814|NCT02367040|62651583|FG000|Overall Study|Progressive disease - clinical progression|2|||
33276815|NCT02367040|62651584|FG001|Overall Study|Progressive disease - clinical progression|6|||
33276816|NCT02367040|62651583|FG000|Overall Study|Drug not administered|3|||
33276817|NCT02367040|62651584|FG001|Overall Study|Drug not administered|2|||
33276818|NCT01252953|62651596|FG000|Overall Study|Withdrawal by Subject|16|||
33276819|NCT01252953|62651597|FG001|Overall Study|Withdrawal by Subject|17|||
33276820|NCT01252953|62651596|FG000|Overall Study|Lost to Follow-up|22|||
33276821|NCT01252953|62651597|FG001|Overall Study|Lost to Follow-up|21|||
33276822|NCT01234480|62651604|FG000|Overall Study|Pregnancy|88|||
33276823|NCT01234480|62651604|FG000|Overall Study|>36/Normal History|50|||
33276824|NCT01234480|62651604|FG000|Overall Study|Age|3|||
33276825|NCT01234480|62651604|FG000|Overall Study|HPV Vaccine History|28|||
33276826|NCT01234480|62651604|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
33276827|NCT01234480|62651604|FG000|Overall Study|Hysterectomy|2|||
33276828|NCT01234480|62651604|FG000|Overall Study|Hysterectomy post enrollment|1|||
33276829|NCT01234480|62651604|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
33276830|NCT01234480|62651604|FG000|Overall Study|Informed Consent Form Violation|30|||
33276831|NCT01234480|62651604|FG000|Overall Study|Incorrect Visit|3|||
33276832|NCT01234480|62651604|FG000|Overall Study|No Florida Lab License|20|||
33276833|NCT01234480|62651604|FG000|Overall Study|Out of Window|42|||
33276834|NCT01234480|62651604|FG000|Overall Study|Sample Processing/Storage|92|||
33276835|NCT01234480|62651604|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
33276836|NCT01234480|62651604|FG000|Overall Study|Site/Subject non-compliance|44|||
33276837|NCT01234480|62651604|FG000|Overall Study|Missing Sample|9|||
33276838|NCT00877851|62651613|FG000|Overall Study|Lost to Follow-up|5|||
33276839|NCT00877851|62651614|FG001|Overall Study|Lost to Follow-up|5|||
33276840|NCT00877851|62651613|FG000|Overall Study|computer problem|3|||
33485693|NCT04401423|62863416|FG000|Overall Study|Physician Decision|2|||
33276841|NCT00877851|62651614|FG001|Overall Study|computer problem|0|||
33485694|NCT04401423|62863417|FG001|Overall Study|Physician Decision|1|||
33276842|NCT00877851|62651613|FG000|Overall Study|no longer interested in participating|1|||
33276843|NCT00877851|62651614|FG001|Overall Study|no longer interested in participating|0|||
33276844|NCT00846742|62651620|FG000|Overall Study|Withdrawal by Subject|1|||
33276845|NCT00837616|62651627|FG000|Overall Study|Withdrawal by Subject|0|||
33276846|NCT00837616|62651628|FG001|Overall Study|Withdrawal by Subject|1|||
33276847|NCT00176254|62651634|FG000|Overall Study|Lost to Follow-up|1|||
33276848|NCT04834726|62651665|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
33370481|NCT00689728|62749201|FG001|Optional Follow-Up|Adverse Event|0|||
33276849|NCT04834726|62651666|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
33276850|NCT04834726|62651667|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
33276851|NCT04834726|62651668|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
33276852|NCT04834726|62651669|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
33276853|NCT04834726|62651670|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
33276854|NCT04834726|62651671|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
33276855|NCT04834726|62651672|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
33276856|NCT04834726|62651673|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
33276857|NCT04732949|62651689|FG000|Overall Study|Withdrawal by Subject|23|||
33276858|NCT04732949|62651690|FG001|Overall Study|Withdrawal by Subject|27|||
33276859|NCT04732949|62651689|FG000|Overall Study|Protocol Violation|0|||
33276860|NCT04732949|62651690|FG001|Overall Study|Protocol Violation|1|||
33276861|NCT04732949|62651689|FG000|Overall Study|Non-compliance|0|||
33276862|NCT04732949|62651690|FG001|Overall Study|Non-compliance|2|||
33276863|NCT04732949|62651689|FG000|Overall Study|Physician Decision|2|||
33276864|NCT04732949|62651690|FG001|Overall Study|Physician Decision|1|||
33276865|NCT04732949|62651689|FG000|Overall Study|Serious adverse event (Fatal)|16|||
33276866|NCT04732949|62651690|FG001|Overall Study|Serious adverse event (Fatal)|18|||
33276867|NCT04732949|62651689|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
33276868|NCT04732949|62651690|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
33276869|NCT04732949|62651689|FG000|Overall Study|Non-serious adverse event|1|||
33276870|NCT04732949|62651690|FG001|Overall Study|Non-serious adverse event|3|||
33276871|NCT04732949|62651689|FG000|Overall Study|Lost to Follow-up|26|||
33276872|NCT04732949|62651690|FG001|Overall Study|Lost to Follow-up|27|||
33276873|NCT04732949|62651689|FG000|Overall Study|Other|6|||
33276874|NCT04732949|62651690|FG001|Overall Study|Other|3|||
33276875|NCT04235504|62651745|FG000|Study Phase|Withdrawal by Subject|5|||
33276876|NCT04235504|62651746|FG001|Study Phase|Withdrawal by Subject|2|||
33276877|NCT04235504|62651747|FG002|Study Phase|Withdrawal by Subject|0|||
33276878|NCT04235504|62651748|FG003|Study Phase|Withdrawal by Subject|0|||
33276879|NCT04235504|62651745|FG000|Continuation Phase|Withdrawal by Subject|0|||
33276880|NCT04235504|62651746|FG001|Continuation Phase|Withdrawal by Subject|4|||
33276881|NCT04235504|62651747|FG002|Continuation Phase|Withdrawal by Subject|0|||
33276882|NCT04235504|62651748|FG003|Continuation Phase|Withdrawal by Subject|0|||
33276883|NCT04235504|62651745|FG000|Continuation Phase|Adverse Event|0|||
33276884|NCT04235504|62651746|FG001|Continuation Phase|Adverse Event|1|||
33276885|NCT04235504|62651747|FG002|Continuation Phase|Adverse Event|0|||
33276886|NCT04235504|62651748|FG003|Continuation Phase|Adverse Event|0|||
33276887|NCT04235504|62651745|FG000|Continuation Phase|Physician Decision|1|||
33276888|NCT04235504|62651746|FG001|Continuation Phase|Physician Decision|2|||
33276889|NCT04235504|62651747|FG002|Continuation Phase|Physician Decision|1|||
33276890|NCT04235504|62651748|FG003|Continuation Phase|Physician Decision|0|||
33276891|NCT04172987|62651763|FG000|Lead In Period|Adverse Event|1|||
33276892|NCT04172987|62651763|FG000|Lead In Period|Protocol Violation|1|||
33276893|NCT04172987|62651763|FG000|Period 1|Physician Decision|1|||
33276894|NCT04172987|62651763|FG000|Period 2|Adverse Event|5|||
33276895|NCT04172987|62651763|FG000|Period 2|Dosing Termination by Sponsor|4|||
33276896|NCT03705832|62651772|FG000|Overall Study|Physician Decision|0|||
33276897|NCT03705832|62651773|FG001|Overall Study|Physician Decision|1|||
33276898|NCT03705832|62651772|FG000|Overall Study|Withdrawal by Subject|1|||
33276899|NCT03705832|62651773|FG001|Overall Study|Withdrawal by Subject|0|||
33276900|NCT03447743|62651779|FG000|Overall Study|Withdrawal by Subject|2|||
33276901|NCT03447743|62651779|FG000|Overall Study|Lost to Follow-up|3|||
33276902|NCT03447743|62651779|FG000|Overall Study|Adverse Event|1|||
33276903|NCT03447743|62651779|FG000|Overall Study|Did not meet criteria to continue|1|||
33276904|NCT03433755|62651787|FG000|Overall Study|Lost to Follow-up|1|||
33276905|NCT03433755|62651788|FG001|Overall Study|Lost to Follow-up|0|||
33276906|NCT03433755|62651789|FG002|Overall Study|Lost to Follow-up|0|||
33276907|NCT03433755|62651790|FG003|Overall Study|Lost to Follow-up|0|||
33276908|NCT03433755|62651787|FG000|Overall Study|Decision by Sponsor|1|||
33276909|NCT03433755|62651788|FG001|Overall Study|Decision by Sponsor|0|||
33276910|NCT03433755|62651789|FG002|Overall Study|Decision by Sponsor|0|||
33276911|NCT03433755|62651790|FG003|Overall Study|Decision by Sponsor|0|||
33276912|NCT03406507|62651813|FG000|Extension Period|Lack of Efficacy|0|||
33276913|NCT03406507|62651814|FG001|Extension Period|Lack of Efficacy|1|||
33276914|NCT03283150|62651823|FG000|Overall Study|Withdrawal by Subject|6|||
33276915|NCT03283150|62651824|FG001|Overall Study|Withdrawal by Subject|0|||
33276916|NCT03283150|62651825|FG002|Overall Study|Withdrawal by Subject|0|||
33276917|NCT03218917|62651836|FG000|Overall Study|Adverse Event|3|||
33276918|NCT03218917|62651837|FG001|Overall Study|Adverse Event|3|||
33276919|NCT03218917|62651838|FG002|Overall Study|Adverse Event|2|||
33276920|NCT03218917|62651836|FG000|Overall Study|Subject withdrew consent|2|||
33276921|NCT03218917|62651837|FG001|Overall Study|Subject withdrew consent|4|||
33276922|NCT03218917|62651838|FG002|Overall Study|Subject withdrew consent|10|||
33276923|NCT03218917|62651836|FG000|Overall Study|Physician Decision|0|||
33276924|NCT03218917|62651837|FG001|Overall Study|Physician Decision|1|||
33276925|NCT03218917|62651838|FG002|Overall Study|Physician Decision|1|||
33276926|NCT03218917|62651836|FG000|Overall Study|Lost to Follow-up|1|||
33276927|NCT03218917|62651837|FG001|Overall Study|Lost to Follow-up|0|||
33276928|NCT03218917|62651838|FG002|Overall Study|Lost to Follow-up|0|||
33276929|NCT03218917|62651836|FG000|Overall Study|Reason Missing|0|||
33276930|NCT03218917|62651837|FG001|Overall Study|Reason Missing|2|||
33276931|NCT03218917|62651838|FG002|Overall Study|Reason Missing|0|||
33276932|NCT03218917|62651836|FG000|Overall Study|Death|0|||
33276933|NCT03218917|62651837|FG001|Overall Study|Death|1|||
33276934|NCT03218917|62651838|FG002|Overall Study|Death|0|||
33276935|NCT03218917|62651836|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33276936|NCT03218917|62651837|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33276937|NCT03218917|62651838|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33276938|NCT03056040|62651849|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
33276939|NCT03056040|62651850|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
33276940|NCT03056040|62651849|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
33276941|NCT03056040|62651850|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
33276942|NCT03056040|62651849|FG000|Primary Evaluation Period|Pregnancy|0|||
33276943|NCT03056040|62651850|FG001|Primary Evaluation Period|Pregnancy|1|||
33276944|NCT03056040|62651849|FG000|Extension Period|Physician Decision|3|||
33276945|NCT03056040|62651850|FG001|Extension Period|Physician Decision|3|||
33276946|NCT03056040|62651849|FG000|Extension Period|Lost to Follow-up|0|||
33276947|NCT03056040|62651850|FG001|Extension Period|Lost to Follow-up|1|||
33276948|NCT03056040|62651849|FG000|Extension Period|Death|0|||
33276949|NCT03056040|62651850|FG001|Extension Period|Death|3|||
33276950|NCT03056040|62651849|FG000|Extension Period|Withdrawal by Subject|1|||
33276951|NCT03056040|62651850|FG001|Extension Period|Withdrawal by Subject|0|||
33276952|NCT03021499|62651861|FG000|Overall Study|Adverse Event|1|||
33276953|NCT03021499|62651862|FG001|Overall Study|Adverse Event|0|||
33276954|NCT03021499|62651861|FG000|Overall Study|Death|1|||
33276955|NCT03021499|62651862|FG001|Overall Study|Death|5|||
33276956|NCT03021499|62651861|FG000|Overall Study|Lack of Efficacy|0|||
33276957|NCT03021499|62651862|FG001|Overall Study|Lack of Efficacy|1|||
33276958|NCT03021499|62651861|FG000|Overall Study|Lost to Follow-up|1|||
33276959|NCT03021499|62651862|FG001|Overall Study|Lost to Follow-up|3|||
33276960|NCT03021499|62651861|FG000|Overall Study|Physician Decision|2|||
33276961|NCT03021499|62651862|FG001|Overall Study|Physician Decision|3|||
33276962|NCT03021499|62651861|FG000|Overall Study|Pregnancy|1|||
33276963|NCT03021499|62651862|FG001|Overall Study|Pregnancy|0|||
33276964|NCT03021499|62651861|FG000|Overall Study|Withdrawal by Subject|7|||
33276965|NCT03021499|62651862|FG001|Overall Study|Withdrawal by Subject|14|||
33276966|NCT03021499|62651861|FG000|Overall Study|Prohibited medication required|1|||
33276967|NCT03021499|62651862|FG001|Overall Study|Prohibited medication required|0|||
33276968|NCT03021499|62651861|FG000|Overall Study|Protocol non-compliance|1|||
33276969|NCT03021499|62651862|FG001|Overall Study|Protocol non-compliance|1|||
33276970|NCT03021499|62651861|FG000|Overall Study|None of the above|0|||
33276971|NCT03021499|62651862|FG001|Overall Study|None of the above|4|||
33276972|NCT03021499|62651861|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
33276973|NCT03021499|62651862|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
33276974|NCT02726581|62651891|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
33276975|NCT02726581|62651892|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
33276976|NCT02726581|62651893|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
33276977|NCT02726581|62651891|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
33370482|NCT00689728|62749202|FG002|Optional Follow-Up|Adverse Event|0|||
33370483|NCT00689728|62749200|FG000|Optional Follow-Up|Lack of Efficacy|0|||
33276978|NCT02726581|62651892|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
33276979|NCT02726581|62651893|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
33276980|NCT02726581|62651891|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
33276981|NCT02726581|62651892|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33276982|NCT02726581|62651893|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33276983|NCT02726581|62651891|FG000|Treatment Period|Disease progression|47|||
33276984|NCT02726581|62651892|FG001|Treatment Period|Disease progression|50|||
33370484|NCT00689728|62749201|FG001|Optional Follow-Up|Lack of Efficacy|1|||
33370485|NCT00689728|62749202|FG002|Optional Follow-Up|Lack of Efficacy|1|||
33370486|NCT00689728|62749200|FG000|Optional Follow-Up|Lost to Follow-up|0|||
33276985|NCT02726581|62651893|FG002|Treatment Period|Disease progression|16|||
33276986|NCT02726581|62651891|FG000|Treatment Period|Other reasons|9|||
33276987|NCT02726581|62651892|FG001|Treatment Period|Other reasons|8|||
33276988|NCT02726581|62651893|FG002|Treatment Period|Other reasons|2|||
33276989|NCT02726581|62651891|FG000|Treatment Period|Study drug toxicity|6|||
33276990|NCT02726581|62651892|FG001|Treatment Period|Study drug toxicity|3|||
33276991|NCT02726581|62651893|FG002|Treatment Period|Study drug toxicity|2|||
33276992|NCT02726581|62651891|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
33370487|NCT00689728|62749201|FG001|Optional Follow-Up|Lost to Follow-up|1|||
33276993|NCT02726581|62651892|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
33276994|NCT02726581|62651893|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
33276995|NCT02726581|62651891|FG000|Treatment Period|Participant withdrew consent|3|||
33276996|NCT02726581|62651892|FG001|Treatment Period|Participant withdrew consent|1|||
33276997|NCT02726581|62651893|FG002|Treatment Period|Participant withdrew consent|1|||
33276998|NCT02726581|62651891|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
33276999|NCT02726581|62651892|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
33370488|NCT00689728|62749202|FG002|Optional Follow-Up|Lost to Follow-up|1|||
33370489|NCT00689728|62749200|FG000|Optional Follow-Up|Protocol Violation|0|||
33370490|NCT00689728|62749201|FG001|Optional Follow-Up|Protocol Violation|0|||
33370491|NCT00689728|62749202|FG002|Optional Follow-Up|Protocol Violation|1|||
33370492|NCT00689728|62749200|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
33370493|NCT00689728|62749201|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
33370494|NCT00689728|62749202|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
33370495|NCT00691054|62749231|FG000|Overall Study|Withdrawal by Subject|1|||
33370496|NCT00598871|62749239|FG000|Overall Study|Adverse Event|0|||
33370497|NCT00598871|62749240|FG001|Overall Study|Adverse Event|1|||
33370498|NCT00690820|62749248|FG000|Period 1|Withdrawal by Subject|0|||
33370499|NCT00690820|62749249|FG001|Period 1|Withdrawal by Subject|1|||
33370500|NCT00689338|62749255|FG000|Overall Study|Death|65|||
33370501|NCT00689338|62749255|FG000|Overall Study|Adverse Event|13|||
33370502|NCT00689338|62749255|FG000|Overall Study|Insufficient Clinical Response|1|||
33370503|NCT00689338|62749255|FG000|Overall Study|Lack of Efficacy|6|||
33370504|NCT00689338|62749255|FG000|Overall Study|Other|8|||
33370505|NCT00689338|62749255|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
33370506|NCT00689338|62749255|FG000|Overall Study|Lost to Follow-up|5|||
33370507|NCT00689338|62749255|FG000|Overall Study|Withdrawal by Subject|3|||
33370508|NCT00689338|62749255|FG000|Overall Study|Protocol Violation|15|||
33370509|NCT00686998|62749262|FG000|Overall Study|Adverse Event|3|||
33370510|NCT00686998|62749263|FG001|Overall Study|Adverse Event|2|||
33370511|NCT00686998|62749264|FG002|Overall Study|Adverse Event|1|||
33370512|NCT00686998|62749262|FG000|Overall Study|Withdrawal by Subject|2|||
33370513|NCT00686998|62749263|FG001|Overall Study|Withdrawal by Subject|1|||
33370514|NCT00686998|62749264|FG002|Overall Study|Withdrawal by Subject|2|||
33370515|NCT00686998|62749262|FG000|Overall Study|Lack of Efficacy|7|||
33370516|NCT00686998|62749263|FG001|Overall Study|Lack of Efficacy|5|||
33370517|NCT00686998|62749264|FG002|Overall Study|Lack of Efficacy|0|||
33370518|NCT00686998|62749262|FG000|Overall Study|Other|0|||
33370519|NCT00686998|62749263|FG001|Overall Study|Other|0|||
33370520|NCT00686998|62749264|FG002|Overall Study|Other|1|||
33370521|NCT00686998|62749262|FG000|Overall Study|Safety Reasons|1|||
33370522|NCT00686998|62749263|FG001|Overall Study|Safety Reasons|0|||
33370523|NCT00686998|62749264|FG002|Overall Study|Safety Reasons|0|||
33370524|NCT00848718|62749285|FG000|Overall Study|Adverse Event|2|||
33370525|NCT00848718|62749286|FG001|Overall Study|Adverse Event|2|||
33370526|NCT00848718|62749287|FG002|Overall Study|Adverse Event|1|||
33370527|NCT00848718|62749288|FG003|Overall Study|Adverse Event|1|||
33370528|NCT00848718|62749289|FG004|Overall Study|Adverse Event|1|||
33370529|NCT00848718|62749290|FG005|Overall Study|Adverse Event|0|||
33370530|NCT00848718|62749291|FG006|Overall Study|Adverse Event|0|||
33370531|NCT00848718|62749292|FG007|Overall Study|Adverse Event|1|||
33370532|NCT00848718|62749293|FG008|Overall Study|Adverse Event|1|||
33370533|NCT00848718|62749294|FG009|Overall Study|Adverse Event|0|||
33370534|NCT00848718|62749295|FG010|Overall Study|Adverse Event|0|||
33370535|NCT00848718|62749296|FG011|Overall Study|Adverse Event|0|||
33370536|NCT00848718|62749297|FG012|Overall Study|Adverse Event|2|||
33370537|NCT00848718|62749285|FG000|Overall Study|Lack of Efficacy|0|||
33485695|NCT04399161|62863428|FG000|Overall Study|Withdrawal by Subject|1|||
33485696|NCT04399161|62863429|FG001|Overall Study|Withdrawal by Subject|0|||
33485697|NCT04399161|62863430|FG002|Overall Study|Withdrawal by Subject|2|||
33485698|NCT04399161|62863428|FG000|Overall Study|Protocol Violation|1|||
33485699|NCT04399161|62863429|FG001|Overall Study|Protocol Violation|2|||
33370538|NCT00848718|62749286|FG001|Overall Study|Lack of Efficacy|0|||
33370539|NCT00848718|62749287|FG002|Overall Study|Lack of Efficacy|1|||
33370540|NCT00848718|62749288|FG003|Overall Study|Lack of Efficacy|0|||
33370541|NCT00848718|62749289|FG004|Overall Study|Lack of Efficacy|0|||
33370542|NCT00848718|62749290|FG005|Overall Study|Lack of Efficacy|0|||
33370543|NCT00848718|62749291|FG006|Overall Study|Lack of Efficacy|1|||
33370544|NCT00848718|62749292|FG007|Overall Study|Lack of Efficacy|0|||
33370545|NCT00848718|62749293|FG008|Overall Study|Lack of Efficacy|0|||
33370546|NCT00848718|62749294|FG009|Overall Study|Lack of Efficacy|0|||
33370547|NCT00848718|62749295|FG010|Overall Study|Lack of Efficacy|0|||
33370548|NCT00848718|62749296|FG011|Overall Study|Lack of Efficacy|0|||
33370549|NCT00848718|62749297|FG012|Overall Study|Lack of Efficacy|0|||
33485700|NCT04399161|62863430|FG002|Overall Study|Protocol Violation|0|||
33485701|NCT02076178|62863440|FG000|Oral Phase|Adverse Event|0|||
33485702|NCT02076178|62863441|FG001|Oral Phase|Adverse Event|7|||
33370550|NCT00848718|62749285|FG000|Overall Study|Physician Decision|0|||
33277000|NCT02726581|62651893|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
33277001|NCT02726581|62651891|FG000|Treatment Period|Maximum clinical benefit|0|||
33277002|NCT02726581|62651892|FG001|Treatment Period|Maximum clinical benefit|2|||
33277003|NCT02726581|62651893|FG002|Treatment Period|Maximum clinical benefit|0|||
33277004|NCT02726581|62651891|FG000|Treatment Period|Death|1|||
33277005|NCT02726581|62651892|FG001|Treatment Period|Death|0|||
33277006|NCT02726581|62651893|FG002|Treatment Period|Death|0|||
33277007|NCT02726581|62651891|FG000|Treatment Period|Poor/non-compliance|1|||
33277008|NCT02726581|62651892|FG001|Treatment Period|Poor/non-compliance|0|||
33277009|NCT02726581|62651893|FG002|Treatment Period|Poor/non-compliance|0|||
33277010|NCT02726581|62651891|FG000|Treatment Period|Participant no longer meets study criteria|0|||
33277011|NCT02726581|62651892|FG001|Treatment Period|Participant no longer meets study criteria|1|||
33277012|NCT02726581|62651893|FG002|Treatment Period|Participant no longer meets study criteria|0|||
33277013|NCT02700048|62651903|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
33277014|NCT02700048|62651904|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
33277015|NCT02425904|62651921|FG000|Overall Study|Lost to Follow-up|1|||
33277016|NCT02425904|62651922|FG001|Overall Study|Lost to Follow-up|0|||
33277017|NCT02425904|62651921|FG000|Overall Study|Withdrawal by Subject|2|||
33277018|NCT02425904|62651922|FG001|Overall Study|Withdrawal by Subject|0|||
33277019|NCT02425904|62651921|FG000|Overall Study|Death|0|||
33277020|NCT02425904|62651922|FG001|Overall Study|Death|3|||
33277021|NCT02097420|62651942|FG000|Overall Study|Death|4|||
33277022|NCT02097420|62651942|FG000|Overall Study|Device explanted|3|||
33277023|NCT02097420|62651942|FG000|Overall Study|Not reached 12-month visit|7|||
33277024|NCT01964989|62651948|FG000|Overall Study|Protocol Violation|3|||
33277025|NCT01964989|62651949|FG001|Overall Study|Protocol Violation|4|||
33277026|NCT01964989|62651948|FG000|Overall Study|Administrative Reason|103|||
33277027|NCT01964989|62651949|FG001|Overall Study|Administrative Reason|95|||
33277028|NCT01964989|62651948|FG000|Overall Study|Adverse Event|0|||
33277029|NCT01964989|62651949|FG001|Overall Study|Adverse Event|1|||
33277030|NCT01964989|62651948|FG000|Overall Study|Death|1|||
33277031|NCT01964989|62651949|FG001|Overall Study|Death|3|||
33277032|NCT01964989|62651948|FG000|Overall Study|Withdrawal by Subject|156|||
33277033|NCT01964989|62651949|FG001|Overall Study|Withdrawal by Subject|160|||
33277034|NCT01964989|62651948|FG000|Overall Study|Lost to Follow-up|254|||
33277035|NCT01964989|62651949|FG001|Overall Study|Lost to Follow-up|232|||
33277036|NCT01964989|62651948|FG000|Overall Study|Other|267|||
33277037|NCT01964989|62651949|FG001|Overall Study|Other|252|||
33277038|NCT01575860|62651977|FG000|Overall Study|Withdrawal by Subject|1|||
33277039|NCT01575860|62651977|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
33277040|NCT01416831|62651984|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
33277041|NCT01416831|62651985|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
33277042|NCT01064648|62651994|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
33277043|NCT01064648|62651995|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
33277044|NCT01064648|62651996|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
33277045|NCT01064648|62651997|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
33277046|NCT01064648|62651994|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
33277047|NCT01064648|62651995|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
33277048|NCT01064648|62651996|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
33277049|NCT01064648|62651997|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
33277050|NCT01064648|62651994|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
33277051|NCT01064648|62651995|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
33277052|NCT01064648|62651996|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
33277053|NCT01064648|62651997|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
33277054|NCT01064648|62651994|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
33277055|NCT01064648|62651995|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
33277056|NCT01064648|62651996|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
33277057|NCT01064648|62651997|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
33277058|NCT01064648|62651994|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
33277059|NCT01064648|62651995|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
33277060|NCT01064648|62651996|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
33277061|NCT01064648|62651997|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
33277062|NCT01064648|62651994|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
33277063|NCT01064648|62651995|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
33277064|NCT01064648|62651996|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
33277065|NCT01064648|62651997|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
33277066|NCT01064648|62651994|FG000|Phase II|Adverse Event|0|||
33277067|NCT01064648|62651995|FG001|Phase II|Adverse Event|0|||
33277068|NCT01064648|62651996|FG002|Phase II|Adverse Event|15|||
33277069|NCT01064648|62651997|FG003|Phase II|Adverse Event|8|||
33277070|NCT01064648|62651994|FG000|Phase II|Death|0|||
33277071|NCT01064648|62651995|FG001|Phase II|Death|0|||
33277072|NCT01064648|62651996|FG002|Phase II|Death|4|||
33277073|NCT01064648|62651997|FG003|Phase II|Death|5|||
33277074|NCT01064648|62651994|FG000|Phase II|Withdrawal by Subject|0|||
33277075|NCT01064648|62651995|FG001|Phase II|Withdrawal by Subject|0|||
33277076|NCT01064648|62651996|FG002|Phase II|Withdrawal by Subject|2|||
33277077|NCT01064648|62651997|FG003|Phase II|Withdrawal by Subject|5|||
33277078|NCT01064648|62651994|FG000|Phase II|Progression|0|||
33277079|NCT01064648|62651995|FG001|Phase II|Progression|0|||
33277080|NCT01064648|62651996|FG002|Phase II|Progression|21|||
33277081|NCT01064648|62651997|FG003|Phase II|Progression|27|||
33277082|NCT01064648|62651994|FG000|Phase II|Non-protocol specified|0|||
33277083|NCT01064648|62651995|FG001|Phase II|Non-protocol specified|0|||
33277084|NCT01064648|62651996|FG002|Phase II|Non-protocol specified|5|||
33277085|NCT01064648|62651997|FG003|Phase II|Non-protocol specified|3|||
33277086|NCT01064648|62651994|FG000|Phase II|Under Review|0|||
33277087|NCT01064648|62651995|FG001|Phase II|Under Review|0|||
33277088|NCT01064648|62651996|FG002|Phase II|Under Review|2|||
33277089|NCT01064648|62651997|FG003|Phase II|Under Review|0|||
33662058|NCT02546986|63092797|FG000|Treatment Period|Non-compliance with Study Drug|0|||
33662059|NCT02546986|63092798|FG001|Treatment Period|Non-compliance with Study Drug|1|||
33662060|NCT02546986|63092797|FG000|Treatment Period|Study Terminated by Sponsor|0|||
33662061|NCT02546986|63092798|FG001|Treatment Period|Study Terminated by Sponsor|1|||
33662062|NCT02546986|63092797|FG000|Treatment Period|Miscellaneous|7|||
33662063|NCT02546986|63092798|FG001|Treatment Period|Miscellaneous|9|||
33277097|NCT00382070|62652032|FG000|Overall Study|No follow up data mapped to Other|17|||
33277098|NCT00382070|62652033|FG001|Overall Study|No follow up data mapped to Other|19|||
33277099|NCT00382070|62652032|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
33277100|NCT00382070|62652033|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
33277101|NCT00382070|62652032|FG000|Overall Study|No clinical assessment|9|||
33277102|NCT00382070|62652033|FG001|Overall Study|No clinical assessment|11|||
33277103|NCT02921269|62652064|FG000|Overall Study|Did not complete DLT period|1|||
33277104|NCT04303559|62652103|FG000|Overall Study|Study closed due to poor enrollment.|1|||
33277105|NCT03784820|62652109|FG000|Overall Study|Lost to Follow-up|5|||
33277106|NCT03784820|62652110|FG001|Overall Study|Lost to Follow-up|5|||
33277107|NCT03784820|62652111|FG002|Overall Study|Lost to Follow-up|3|||
33277108|NCT03784820|62652112|FG003|Overall Study|Lost to Follow-up|3|||
33277109|NCT03769675|62652120|FG000|Overall Study|Lost to Follow-up|1|||
33277110|NCT03729245|62652126|FG000|Overall Study|Lost to Follow-up|5|||
33277111|NCT03729245|62652127|FG001|Overall Study|Lost to Follow-up|6|||
33277112|NCT03729245|62652126|FG000|Overall Study|Withdrawal by Subject|16|||
33277113|NCT03729245|62652127|FG001|Overall Study|Withdrawal by Subject|19|||
33277114|NCT03729245|62652126|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
33277115|NCT03729245|62652127|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
33277116|NCT03311711|62652147|FG000|Overall Study|Death|1|||
33277117|NCT03311711|62652148|FG001|Overall Study|Death|0|||
33277118|NCT03311711|62652149|FG002|Overall Study|Death|0|||
33277119|NCT03311711|62652150|FG003|Overall Study|Death|0|||
33277120|NCT03311711|62652151|FG004|Overall Study|Death|0|||
33277121|NCT03311711|62652152|FG005|Overall Study|Death|0|||
33277122|NCT03311711|62652153|FG006|Overall Study|Death|1|||
33277123|NCT03311711|62652154|FG007|Overall Study|Death|0|||
33277124|NCT03311711|62652155|FG008|Overall Study|Death|1|||
33277125|NCT03311711|62652156|FG009|Overall Study|Death|0|||
33277126|NCT03311711|62652147|FG000|Overall Study|Death of dyad partner|0|||
33277127|NCT03311711|62652148|FG001|Overall Study|Death of dyad partner|1|||
33277128|NCT03311711|62652149|FG002|Overall Study|Death of dyad partner|0|||
33277129|NCT03311711|62652150|FG003|Overall Study|Death of dyad partner|0|||
33277130|NCT03311711|62652151|FG004|Overall Study|Death of dyad partner|0|||
33277131|NCT03311711|62652152|FG005|Overall Study|Death of dyad partner|0|||
33277132|NCT03311711|62652153|FG006|Overall Study|Death of dyad partner|0|||
33277133|NCT03311711|62652154|FG007|Overall Study|Death of dyad partner|1|||
33277134|NCT03311711|62652155|FG008|Overall Study|Death of dyad partner|0|||
33277135|NCT03311711|62652156|FG009|Overall Study|Death of dyad partner|1|||
33277136|NCT03311711|62652147|FG000|Overall Study|Lost to Follow-up|2|||
33277137|NCT03311711|62652148|FG001|Overall Study|Lost to Follow-up|2|||
33277138|NCT03311711|62652149|FG002|Overall Study|Lost to Follow-up|0|||
33277139|NCT03311711|62652150|FG003|Overall Study|Lost to Follow-up|0|||
33277140|NCT03311711|62652151|FG004|Overall Study|Lost to Follow-up|0|||
33277141|NCT03311711|62652152|FG005|Overall Study|Lost to Follow-up|0|||
33277142|NCT03311711|62652153|FG006|Overall Study|Lost to Follow-up|1|||
33277143|NCT03311711|62652154|FG007|Overall Study|Lost to Follow-up|1|||
33277144|NCT03311711|62652155|FG008|Overall Study|Lost to Follow-up|0|||
33277145|NCT03311711|62652156|FG009|Overall Study|Lost to Follow-up|0|||
33277146|NCT03311711|62652147|FG000|Overall Study|Withdrawal by Subject|1|||
33277147|NCT03311711|62652148|FG001|Overall Study|Withdrawal by Subject|1|||
33277148|NCT03311711|62652149|FG002|Overall Study|Withdrawal by Subject|0|||
33277149|NCT03311711|62652150|FG003|Overall Study|Withdrawal by Subject|0|||
33277150|NCT03311711|62652151|FG004|Overall Study|Withdrawal by Subject|0|||
33277151|NCT03311711|62652152|FG005|Overall Study|Withdrawal by Subject|0|||
33277152|NCT03311711|62652153|FG006|Overall Study|Withdrawal by Subject|3|||
33277153|NCT03311711|62652154|FG007|Overall Study|Withdrawal by Subject|3|||
33277154|NCT03311711|62652155|FG008|Overall Study|Withdrawal by Subject|0|||
33277155|NCT03311711|62652156|FG009|Overall Study|Withdrawal by Subject|0|||
33277156|NCT03270891|62652186|FG000|Overall Study|Lost to Follow-up|3|||
33277157|NCT03270891|62652187|FG001|Overall Study|Lost to Follow-up|6|||
33277158|NCT03270891|62652188|FG002|Overall Study|Lost to Follow-up|0|||
33277159|NCT03270891|62652186|FG000|Overall Study|Withdrawal by Subject|1|||
33277160|NCT03270891|62652187|FG001|Overall Study|Withdrawal by Subject|0|||
33277161|NCT03270891|62652188|FG002|Overall Study|Withdrawal by Subject|0|||
33277162|NCT03270891|62652186|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
33277163|NCT03270891|62652187|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
33277164|NCT03270891|62652188|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
33277165|NCT02992743|62652200|FG000|Overall Study|Withdrawal by Subject|1|||
33277166|NCT02992743|62652201|FG001|Overall Study|Withdrawal by Subject|1|||
33277167|NCT02992743|62652200|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
33277168|NCT02992743|62652201|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
33277169|NCT02992743|62652200|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
33277170|NCT02992743|62652201|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
33277171|NCT02992743|62652200|FG000|Overall Study|No measurable disease|1|||
33277172|NCT02992743|62652201|FG001|Overall Study|No measurable disease|0|||
33277173|NCT02992743|62652200|FG000|Overall Study|Lost to Follow-up|0|||
33277174|NCT02992743|62652201|FG001|Overall Study|Lost to Follow-up|1|||
33277175|NCT02853344|62652209|FG000|Overall Study|Lost to Follow-up|1|||
33277176|NCT02853344|62652210|FG001|Overall Study|Lost to Follow-up|1|||
33277177|NCT02853344|62652209|FG000|Overall Study|Withdrawal by Subject|2|||
33277178|NCT02853344|62652210|FG001|Overall Study|Withdrawal by Subject|4|||
33277179|NCT02853344|62652209|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
33277180|NCT02853344|62652210|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
33277181|NCT02853344|62652209|FG000|Overall Study|Death|70|||
33277182|NCT02853344|62652210|FG001|Overall Study|Death|112|||
33277183|NCT02739620|62652221|FG000|Overall Study|Lost to Follow-up|3|||
33277184|NCT02739620|62652222|FG001|Overall Study|Lost to Follow-up|1|||
33277185|NCT02739620|62652221|FG000|Overall Study|Adverse Event|0|||
33277186|NCT02739620|62652222|FG001|Overall Study|Adverse Event|1|||
33277187|NCT02675426|62652231|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
33277188|NCT02675426|62652232|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
33277189|NCT02675426|62652233|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
33277190|NCT02675426|62652234|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
33277191|NCT02675426|62652231|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
33277192|NCT02675426|62652232|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
33277193|NCT02675426|62652233|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
33277194|NCT02675426|62652234|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
33277195|NCT02675426|62652231|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
33277196|NCT02675426|62652232|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
33277197|NCT02675426|62652233|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
33277198|NCT02675426|62652234|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
33277199|NCT02675426|62652231|FG000|Period 1: Week 1 to Week 12|Other|2|||
33277200|NCT02675426|62652232|FG001|Period 1: Week 1 to Week 12|Other|1|||
33277201|NCT02675426|62652233|FG002|Period 1: Week 1 to Week 12|Other|0|||
33277202|NCT02675426|62652234|FG003|Period 1: Week 1 to Week 12|Other|2|||
33277203|NCT02675426|62652231|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
33277204|NCT02675426|62652232|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
33277205|NCT02675426|62652233|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
33277206|NCT02675426|62652234|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
33277207|NCT02675426|62652231|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
33277208|NCT02675426|62652232|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
33277209|NCT02675426|62652233|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
33277210|NCT02675426|62652234|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
33277211|NCT02675426|62652231|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
33277212|NCT02675426|62652232|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
33277213|NCT02675426|62652233|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
33277214|NCT02675426|62652234|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
33277215|NCT02675426|62652231|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
33277216|NCT02675426|62652232|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
33277217|NCT02675426|62652233|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
33370551|NCT00848718|62749286|FG001|Overall Study|Physician Decision|1|||
33277218|NCT02675426|62652234|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
33277219|NCT02675426|62652231|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
33277220|NCT02675426|62652232|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
33370552|NCT00848718|62749287|FG002|Overall Study|Physician Decision|0|||
33277221|NCT02675426|62652233|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
33277222|NCT02675426|62652234|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
33277223|NCT02675426|62652231|FG000|Period 2: Week 12 to Week 260|Other|8|||
33277224|NCT02675426|62652232|FG001|Period 2: Week 12 to Week 260|Other|12|||
33277225|NCT02675426|62652233|FG002|Period 2: Week 12 to Week 260|Other|23|||
33277226|NCT02675426|62652234|FG003|Period 2: Week 12 to Week 260|Other|15|||
33277227|NCT02060721|62652275|FG000|Overall Study|Lost to Follow-up|1|||
33277228|NCT02060721|62652275|FG000|Overall Study|Physician Decision|2|||
33277229|NCT02060721|62652275|FG000|Overall Study|Death|14|||
33277230|NCT02060721|62652275|FG000|Overall Study|Withdrawal by Subject|2|||
33277231|NCT02060721|62652275|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
33277232|NCT01527149|62652279|FG000|Overall Study|Death|2|||
33277233|NCT01359956|62652287|FG000|Overall Study|Death|58|||
33277234|NCT01359956|62652288|FG001|Overall Study|Death|60|||
33277235|NCT01359956|62652289|FG002|Overall Study|Death|66|||
33277236|NCT01359956|62652290|FG003|Overall Study|Death|57|||
33277237|NCT01359956|62652287|FG000|Overall Study|Lost to Follow-up|3|||
33277238|NCT01359956|62652288|FG001|Overall Study|Lost to Follow-up|4|||
33277239|NCT01359956|62652289|FG002|Overall Study|Lost to Follow-up|1|||
33277240|NCT01359956|62652290|FG003|Overall Study|Lost to Follow-up|1|||
33277241|NCT01306045|62652303|FG000|Met General Eligibility Criteria|Screen failures|193|||
33277242|NCT01306045|62652304|FG001|Met General Eligibility Criteria|Screen failures|11|||
33277243|NCT01306045|62652305|FG002|Met General Eligibility Criteria|Screen failures|8|||
33277244|NCT05121480|62652354|FG000|Overall Study|Lack of Efficacy|2|||
33277245|NCT05121480|62652355|FG001|Overall Study|Lack of Efficacy|2|||
33277246|NCT05121480|62652356|FG002|Overall Study|Lack of Efficacy|1|||
33277247|NCT05121480|62652357|FG003|Overall Study|Lack of Efficacy|4|||
33277248|NCT05121480|62652358|FG004|Overall Study|Lack of Efficacy|0|||
33277249|NCT05121480|62652359|FG005|Overall Study|Lack of Efficacy|1|||
33277250|NCT05121480|62652360|FG006|Overall Study|Lack of Efficacy|0|||
33277251|NCT05121480|62652361|FG007|Overall Study|Lack of Efficacy|2|||
33277252|NCT05121480|62652354|FG000|Overall Study|Treatment Failure|0|||
33277253|NCT05121480|62652355|FG001|Overall Study|Treatment Failure|2|||
33277254|NCT05121480|62652356|FG002|Overall Study|Treatment Failure|0|||
33277255|NCT05121480|62652357|FG003|Overall Study|Treatment Failure|1|||
33277256|NCT05121480|62652358|FG004|Overall Study|Treatment Failure|0|||
33277257|NCT05121480|62652359|FG005|Overall Study|Treatment Failure|0|||
33277258|NCT05121480|62652360|FG006|Overall Study|Treatment Failure|0|||
33277259|NCT05121480|62652361|FG007|Overall Study|Treatment Failure|0|||
33277260|NCT05121480|62652354|FG000|Overall Study|Adverse Event|0|||
33277261|NCT05121480|62652355|FG001|Overall Study|Adverse Event|1|||
33277262|NCT05121480|62652356|FG002|Overall Study|Adverse Event|0|||
33277263|NCT05121480|62652357|FG003|Overall Study|Adverse Event|5|||
33277264|NCT05121480|62652358|FG004|Overall Study|Adverse Event|3|||
33277265|NCT05121480|62652359|FG005|Overall Study|Adverse Event|2|||
33277266|NCT05121480|62652360|FG006|Overall Study|Adverse Event|0|||
33277267|NCT05121480|62652361|FG007|Overall Study|Adverse Event|4|||
33277268|NCT05121480|62652354|FG000|Overall Study|Withdrawal by Subject|4|||
33277269|NCT05121480|62652355|FG001|Overall Study|Withdrawal by Subject|9|||
33277270|NCT05121480|62652356|FG002|Overall Study|Withdrawal by Subject|1|||
33277271|NCT05121480|62652357|FG003|Overall Study|Withdrawal by Subject|8|||
33277272|NCT05121480|62652358|FG004|Overall Study|Withdrawal by Subject|0|||
33277273|NCT05121480|62652359|FG005|Overall Study|Withdrawal by Subject|9|||
33277274|NCT05121480|62652360|FG006|Overall Study|Withdrawal by Subject|0|||
33277275|NCT05121480|62652361|FG007|Overall Study|Withdrawal by Subject|4|||
33277276|NCT05121480|62652354|FG000|Overall Study|Non-compliance with the protocol|0|||
33370553|NCT00848718|62749288|FG003|Overall Study|Physician Decision|0|||
33370554|NCT00848718|62749289|FG004|Overall Study|Physician Decision|1|||
33277277|NCT05121480|62652355|FG001|Overall Study|Non-compliance with the protocol|0|||
33277278|NCT05121480|62652356|FG002|Overall Study|Non-compliance with the protocol|0|||
33277279|NCT05121480|62652357|FG003|Overall Study|Non-compliance with the protocol|0|||
33277280|NCT05121480|62652358|FG004|Overall Study|Non-compliance with the protocol|1|||
33277281|NCT05121480|62652359|FG005|Overall Study|Non-compliance with the protocol|6|||
33277282|NCT05121480|62652360|FG006|Overall Study|Non-compliance with the protocol|0|||
33277283|NCT05121480|62652361|FG007|Overall Study|Non-compliance with the protocol|1|||
33277284|NCT05121480|62652354|FG000|Overall Study|Lost to Follow-up|0|||
33277285|NCT05121480|62652355|FG001|Overall Study|Lost to Follow-up|4|||
33277286|NCT05121480|62652356|FG002|Overall Study|Lost to Follow-up|1|||
33277287|NCT05121480|62652357|FG003|Overall Study|Lost to Follow-up|3|||
33277288|NCT05121480|62652358|FG004|Overall Study|Lost to Follow-up|1|||
33277289|NCT05121480|62652359|FG005|Overall Study|Lost to Follow-up|1|||
33277290|NCT05121480|62652360|FG006|Overall Study|Lost to Follow-up|1|||
33277291|NCT05121480|62652361|FG007|Overall Study|Lost to Follow-up|4|||
33277292|NCT05121480|62652354|FG000|Overall Study|Physician Decision|0|||
33277293|NCT05121480|62652355|FG001|Overall Study|Physician Decision|0|||
33277294|NCT05121480|62652356|FG002|Overall Study|Physician Decision|0|||
33277295|NCT05121480|62652357|FG003|Overall Study|Physician Decision|0|||
33277296|NCT05121480|62652358|FG004|Overall Study|Physician Decision|0|||
33277297|NCT05121480|62652359|FG005|Overall Study|Physician Decision|1|||
33277298|NCT05121480|62652360|FG006|Overall Study|Physician Decision|0|||
33277299|NCT05121480|62652361|FG007|Overall Study|Physician Decision|1|||
33277300|NCT05121480|62652354|FG000|Overall Study|Other Reason|0|||
33277301|NCT05121480|62652355|FG001|Overall Study|Other Reason|0|||
33277302|NCT05121480|62652356|FG002|Overall Study|Other Reason|0|||
33277303|NCT05121480|62652357|FG003|Overall Study|Other Reason|0|||
33277304|NCT05121480|62652358|FG004|Overall Study|Other Reason|0|||
33277305|NCT05121480|62652359|FG005|Overall Study|Other Reason|1|||
33277306|NCT05121480|62652360|FG006|Overall Study|Other Reason|1|||
33277307|NCT05121480|62652361|FG007|Overall Study|Other Reason|1|||
33277308|NCT04772755|62652387|FG000|Overall Study|Withdrawal by Subject|1|||
33277309|NCT04772755|62652388|FG001|Overall Study|Withdrawal by Subject|0|||
33277310|NCT04772755|62652387|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
33277311|NCT04772755|62652388|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
33277312|NCT04590040|62652398|FG000|Treatment Period|Lost to Follow-up|2|||
33277313|NCT04590040|62652399|FG001|Treatment Period|Lost to Follow-up|5|||
33277314|NCT04590040|62652400|FG002|Treatment Period|Lost to Follow-up|0|||
33277315|NCT04590040|62652398|FG000|Treatment Period|Physician Decision|0|||
33277316|NCT04590040|62652399|FG001|Treatment Period|Physician Decision|0|||
33277317|NCT04590040|62652400|FG002|Treatment Period|Physician Decision|2|||
33277318|NCT04430335|62652418|FG000|Overall Study|Withdrawal by Subject|1|||
33277319|NCT03690427|62652431|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
33277320|NCT03690427|62652432|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
33277321|NCT03658668|62652441|FG000|Overall Study|Time Commitment|1|||
33277322|NCT03658668|62652442|FG001|Overall Study|Time Commitment|1|||
33277323|NCT03469934|62652450|FG000|Overall Study|Withdrawal by Subject|0|||
33277324|NCT03469934|62652451|FG001|Overall Study|Withdrawal by Subject|1|||
33277325|NCT03004404|62652468|FG000|Period 2|Adverse Event|0|||
33277326|NCT03004404|62652469|FG001|Period 2|Adverse Event|0|||
33277327|NCT03004404|62652470|FG002|Period 2|Adverse Event|0|||
33277328|NCT03004404|62652471|FG003|Period 2|Adverse Event|0|||
33277329|NCT03004404|62652472|FG004|Period 2|Adverse Event|0|||
33277330|NCT03004404|62652473|FG005|Period 2|Adverse Event|0|||
33277331|NCT03004404|62652474|FG006|Period 2|Adverse Event|0|||
33277332|NCT03004404|62652475|FG007|Period 2|Adverse Event|0|||
33277333|NCT03004404|62652476|FG008|Period 2|Adverse Event|1|||
33277334|NCT03004404|62652477|FG009|Period 2|Adverse Event|0|||
33277335|NCT03004404|62652478|FG010|Period 2|Adverse Event|0|||
33277336|NCT03004404|62652479|FG011|Period 2|Adverse Event|0|||
33277337|NCT03004404|62652480|FG012|Period 2|Adverse Event|0|||
33277338|NCT03004404|62652481|FG013|Period 2|Adverse Event|0|||
33277339|NCT03004404|62652482|FG014|Period 2|Adverse Event|0|||
33277340|NCT03004404|62652483|FG015|Period 2|Adverse Event|1|||
33277341|NCT02512965|62652550|FG000|Overall Study|Withdrawal by Subject|0|||
33277342|NCT02512965|62652551|FG001|Overall Study|Withdrawal by Subject|4|||
33277343|NCT02335268|62652559|FG000|Overall Study|Physician Decision|5|||
33277344|NCT02335268|62652560|FG001|Overall Study|Physician Decision|1|||
33277345|NCT02335268|62652559|FG000|Overall Study|Lack of Efficacy|2|||
33277346|NCT02335268|62652560|FG001|Overall Study|Lack of Efficacy|1|||
33277347|NCT02335268|62652559|FG000|Overall Study|Adverse Event|5|||
33277348|NCT02335268|62652560|FG001|Overall Study|Adverse Event|2|||
33277349|NCT02335268|62652559|FG000|Overall Study|increase blasts|2|||
33277350|NCT02335268|62652560|FG001|Overall Study|increase blasts|0|||
33277351|NCT02335268|62652559|FG000|Overall Study|Withdrawal by Subject|3|||
33277352|NCT02335268|62652560|FG001|Overall Study|Withdrawal by Subject|2|||
33277353|NCT01828112|62652582|FG000|Overall Study|Adverse Event|6|||
33277354|NCT01828112|62652583|FG001|Overall Study|Adverse Event|8|||
33277355|NCT01828112|62652582|FG000|Overall Study|Death|9|||
33277356|NCT01828112|62652583|FG001|Overall Study|Death|5|||
33277357|NCT01828112|62652582|FG000|Overall Study|Physician Decision|5|||
33277358|NCT01828112|62652583|FG001|Overall Study|Physician Decision|5|||
33277359|NCT01828112|62652582|FG000|Overall Study|Progressive disease|56|||
33277360|NCT01828112|62652583|FG001|Overall Study|Progressive disease|82|||
33277361|NCT01828112|62652582|FG000|Overall Study|Subject/guardian decision|6|||
33277362|NCT01828112|62652583|FG001|Overall Study|Subject/guardian decision|8|||
33277363|NCT01286272|62652591|FG000|Overall Study|Ineligible after beginning treatment|1|||
33277364|NCT01286272|62652592|FG001|Overall Study|Ineligible after beginning treatment|3|||
33277365|NCT01029002|62652600|FG000|Overall Study|Lost to Follow-up|2|||
33277366|NCT01029002|62652601|FG001|Overall Study|Lost to Follow-up|4|||
33277367|NCT01011478|62652609|FG000|Overall Study|No follow up data|12|||
33277368|NCT01011478|62652610|FG001|Overall Study|No follow up data|7|||
33277369|NCT00980460|62652621|FG000|Overall Study|Death|0|||
33277370|NCT00980460|62652622|FG001|Overall Study|Death|0|||
33277371|NCT00980460|62652623|FG002|Overall Study|Death|1|||
33277372|NCT00980460|62652624|FG003|Overall Study|Death|2|||
33277373|NCT00980460|62652625|FG004|Overall Study|Death|1|||
33277374|NCT00980460|62652621|FG000|Overall Study|Lack of Efficacy|0|||
33277375|NCT00980460|62652622|FG001|Overall Study|Lack of Efficacy|0|||
33277376|NCT00980460|62652623|FG002|Overall Study|Lack of Efficacy|10|||
33277377|NCT00980460|62652624|FG003|Overall Study|Lack of Efficacy|6|||
33277378|NCT00980460|62652625|FG004|Overall Study|Lack of Efficacy|8|||
33277379|NCT00980460|62652621|FG000|Overall Study|Lost to Follow-up|0|||
33277380|NCT00980460|62652622|FG001|Overall Study|Lost to Follow-up|0|||
33277381|NCT00980460|62652623|FG002|Overall Study|Lost to Follow-up|0|||
33277382|NCT00980460|62652624|FG003|Overall Study|Lost to Follow-up|1|||
33277383|NCT00980460|62652625|FG004|Overall Study|Lost to Follow-up|0|||
33277384|NCT00980460|62652621|FG000|Overall Study|Physician Decision|0|||
33277385|NCT00980460|62652622|FG001|Overall Study|Physician Decision|0|||
33277386|NCT00980460|62652623|FG002|Overall Study|Physician Decision|11|||
33277387|NCT00980460|62652624|FG003|Overall Study|Physician Decision|5|||
33277388|NCT00980460|62652625|FG004|Overall Study|Physician Decision|3|||
33277389|NCT00980460|62652621|FG000|Overall Study|Withdrawal by Subject|0|||
33277390|NCT00980460|62652622|FG001|Overall Study|Withdrawal by Subject|0|||
33277391|NCT00980460|62652623|FG002|Overall Study|Withdrawal by Subject|1|||
33277392|NCT00980460|62652624|FG003|Overall Study|Withdrawal by Subject|0|||
33277393|NCT00980460|62652625|FG004|Overall Study|Withdrawal by Subject|0|||
33277394|NCT00980460|62652621|FG000|Overall Study|Ineligible|0|||
33277395|NCT00980460|62652622|FG001|Overall Study|Ineligible|2|||
33277396|NCT00980460|62652623|FG002|Overall Study|Ineligible|3|||
33277397|NCT00980460|62652624|FG003|Overall Study|Ineligible|1|||
33277398|NCT00980460|62652625|FG004|Overall Study|Ineligible|4|||
33277399|NCT00980460|62652621|FG000|Overall Study|Refusal of further therapy|0|||
33277400|NCT00980460|62652622|FG001|Overall Study|Refusal of further therapy|2|||
33277401|NCT00980460|62652623|FG002|Overall Study|Refusal of further therapy|3|||
33277402|NCT00980460|62652624|FG003|Overall Study|Refusal of further therapy|2|||
33277403|NCT00980460|62652625|FG004|Overall Study|Refusal of further therapy|0|||
33277404|NCT00980460|62652621|FG000|Overall Study|No therapy within 42 days of resection|0|||
33277405|NCT00980460|62652622|FG001|Overall Study|No therapy within 42 days of resection|0|||
33277406|NCT00980460|62652623|FG002|Overall Study|No therapy within 42 days of resection|3|||
33277407|NCT00980460|62652624|FG003|Overall Study|No therapy within 42 days of resection|1|||
33277408|NCT00980460|62652625|FG004|Overall Study|No therapy within 42 days of resection|0|||
33277409|NCT00980460|62652621|FG000|Overall Study|No transplant by protocol timepoints|0|||
33277410|NCT00980460|62652622|FG001|Overall Study|No transplant by protocol timepoints|0|||
33277411|NCT00980460|62652623|FG002|Overall Study|No transplant by protocol timepoints|3|||
33277412|NCT00980460|62652624|FG003|Overall Study|No transplant by protocol timepoints|0|||
33277413|NCT00980460|62652625|FG004|Overall Study|No transplant by protocol timepoints|0|||
33277414|NCT00546260|62652646|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
33277415|NCT00546260|62652647|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
33277416|NCT02896192|62652670|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
33277417|NCT02896192|62652670|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
33277418|NCT02896192|62652670|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
33277419|NCT01356940|62652686|FG000|First Intervention (28 Days)|Adverse Event|1|||
33277420|NCT01356940|62652687|FG001|First Intervention (28 Days)|Adverse Event|0|||
33277421|NCT01356940|62652686|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
33277422|NCT01356940|62652687|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
33277423|NCT01330030|62652706|FG000|Overall Study|Lost to Follow-up|16|||
33277424|NCT01330030|62652707|FG001|Overall Study|Lost to Follow-up|17|||
33277425|NCT00477295|62652818|FG000|Overall Study|Adverse Event|31|||
33277426|NCT00477295|62652819|FG001|Overall Study|Adverse Event|35|||
33277427|NCT00477295|62652818|FG000|Overall Study|Withdrawal by Subject|35|||
33277428|NCT00477295|62652819|FG001|Overall Study|Withdrawal by Subject|24|||
33277429|NCT00477295|62652818|FG000|Overall Study|Lack of Efficacy|23|||
33277430|NCT00477295|62652819|FG001|Overall Study|Lack of Efficacy|23|||
33277431|NCT00477295|62652818|FG000|Overall Study|Protocol Violation|3|||
33277432|NCT00477295|62652819|FG001|Overall Study|Protocol Violation|8|||
33277433|NCT00477295|62652818|FG000|Overall Study|Physician Decision|4|||
33277434|NCT00477295|62652819|FG001|Overall Study|Physician Decision|5|||
33277435|NCT00477295|62652818|FG000|Overall Study|Lost to Follow-up|21|||
33277436|NCT00477295|62652819|FG001|Overall Study|Lost to Follow-up|11|||
33277437|NCT00477295|62652818|FG000|Overall Study|Other|4|||
33277438|NCT00477295|62652819|FG001|Overall Study|Other|3|||
33277439|NCT00476593|62652831|FG000|Overall Study|Lost to Follow-up|10|||
33277440|NCT00476593|62652832|FG001|Overall Study|Lost to Follow-up|2|||
33277441|NCT00476593|62652833|FG002|Overall Study|Lost to Follow-up|8|||
33277442|NCT00476593|62652834|FG003|Overall Study|Lost to Follow-up|22|||
33277443|NCT00476476|62652846|FG000|Overall Study|Adverse Event|2|||
33277444|NCT00476476|62652847|FG001|Overall Study|Adverse Event|7|||
33277445|NCT00476476|62652846|FG000|Overall Study|Progressive Disease|0|||
33277446|NCT00476476|62652847|FG001|Overall Study|Progressive Disease|17|||
33277447|NCT00476086|62652852|FG000|Overall Study|Alternative therapy|1|||
33277448|NCT00476086|62652852|FG000|Overall Study|Progressive Disease|4|||
33277449|NCT00476047|62652858|FG000|Overall Study|Lost to Follow-up|1|||
33277450|NCT00476008|62652866|FG000|Overall Study|Adverse Event|4|||
33277451|NCT00476008|62652867|FG001|Overall Study|Adverse Event|4|||
33277452|NCT00476008|62652866|FG000|Overall Study|Placebo concerns|2|||
33277453|NCT00476008|62652867|FG001|Overall Study|Placebo concerns|2|||
33277454|NCT00476008|62652866|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
33277455|NCT00476008|62652867|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
33277456|NCT00476008|62652866|FG000|Overall Study|Withdrawal by Subject|0|||
33277457|NCT00476008|62652867|FG001|Overall Study|Withdrawal by Subject|1|||
33277458|NCT00476008|62652866|FG000|Overall Study|Death|1|||
33277459|NCT00476008|62652867|FG001|Overall Study|Death|0|||
33277460|NCT00475735|62652883|FG000|Treatment Period 1|Adverse Event|2|||
33277461|NCT00475735|62652884|FG001|Treatment Period 1|Adverse Event|0|||
33277462|NCT00475735|62652885|FG002|Treatment Period 1|Adverse Event|0|||
33277463|NCT00475735|62652886|FG003|Treatment Period 1|Adverse Event|0|||
33277464|NCT00475735|62652887|FG004|Treatment Period 1|Adverse Event|0|||
33277465|NCT00475735|62652888|FG005|Treatment Period 1|Adverse Event|0|||
33277466|NCT00475735|62652883|FG000|Treatment Period 1|Lack of Efficacy|1|||
33277467|NCT00475735|62652884|FG001|Treatment Period 1|Lack of Efficacy|0|||
33277468|NCT00475735|62652885|FG002|Treatment Period 1|Lack of Efficacy|0|||
33277469|NCT00475735|62652886|FG003|Treatment Period 1|Lack of Efficacy|0|||
33277470|NCT00475735|62652887|FG004|Treatment Period 1|Lack of Efficacy|0|||
33277471|NCT00475735|62652888|FG005|Treatment Period 1|Lack of Efficacy|0|||
33277472|NCT00475735|62652883|FG000|Treatment Period 1|Lost to Follow-up|0|||
33277473|NCT00475735|62652884|FG001|Treatment Period 1|Lost to Follow-up|0|||
33277474|NCT00475735|62652885|FG002|Treatment Period 1|Lost to Follow-up|0|||
33277475|NCT00475735|62652886|FG003|Treatment Period 1|Lost to Follow-up|0|||
33277476|NCT00475735|62652887|FG004|Treatment Period 1|Lost to Follow-up|0|||
33277477|NCT00475735|62652888|FG005|Treatment Period 1|Lost to Follow-up|1|||
33277478|NCT00475735|62652883|FG000|Treatment Period 1|Protocol Violation|0|||
33277479|NCT00475735|62652884|FG001|Treatment Period 1|Protocol Violation|0|||
33277480|NCT00475735|62652885|FG002|Treatment Period 1|Protocol Violation|0|||
33277481|NCT00475735|62652886|FG003|Treatment Period 1|Protocol Violation|1|||
33277482|NCT00475735|62652887|FG004|Treatment Period 1|Protocol Violation|0|||
33277483|NCT00475735|62652888|FG005|Treatment Period 1|Protocol Violation|0|||
33277484|NCT00475735|62652883|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33277485|NCT00475735|62652884|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33277486|NCT00475735|62652885|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33277487|NCT00475735|62652886|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33277488|NCT00475735|62652887|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33277489|NCT00475735|62652888|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33277490|NCT00475735|62652883|FG000|Treatment Period 1|DC due to AE but continuing|0|||
33277491|NCT00475735|62652884|FG001|Treatment Period 1|DC due to AE but continuing|0|||
33277492|NCT00475735|62652885|FG002|Treatment Period 1|DC due to AE but continuing|0|||
33277493|NCT00475735|62652886|FG003|Treatment Period 1|DC due to AE but continuing|1|||
33277494|NCT00475735|62652887|FG004|Treatment Period 1|DC due to AE but continuing|2|||
33277495|NCT00475735|62652888|FG005|Treatment Period 1|DC due to AE but continuing|2|||
33277496|NCT00475735|62652883|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
33277497|NCT00475735|62652884|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
33277498|NCT00475735|62652885|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
33277499|NCT00475735|62652886|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
33277500|NCT00475735|62652887|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
33277501|NCT00475735|62652888|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
33277502|NCT00475735|62652883|FG000|Treatment Washout|Lost to Follow-up|0|||
33277503|NCT00475735|62652884|FG001|Treatment Washout|Lost to Follow-up|1|||
33277504|NCT00475735|62652885|FG002|Treatment Washout|Lost to Follow-up|0|||
33277505|NCT00475735|62652886|FG003|Treatment Washout|Lost to Follow-up|0|||
33277506|NCT00475735|62652887|FG004|Treatment Washout|Lost to Follow-up|0|||
33277507|NCT00475735|62652888|FG005|Treatment Washout|Lost to Follow-up|0|||
33277508|NCT00475735|62652883|FG000|Treatment Washout|Protocol Violation|0|||
33277509|NCT00475735|62652884|FG001|Treatment Washout|Protocol Violation|1|||
33277510|NCT00475735|62652885|FG002|Treatment Washout|Protocol Violation|0|||
33277511|NCT00475735|62652886|FG003|Treatment Washout|Protocol Violation|0|||
33277512|NCT00475735|62652887|FG004|Treatment Washout|Protocol Violation|0|||
33277513|NCT00475735|62652888|FG005|Treatment Washout|Protocol Violation|0|||
33555791|NCT01975831|62948599|FG007|Overall Study|Withdrawal by Subject|0|||
33277514|NCT00475735|62652883|FG000|Treatment Period 2|Adverse Event|0|||
33277515|NCT00475735|62652884|FG001|Treatment Period 2|Adverse Event|1|||
33277516|NCT00475735|62652885|FG002|Treatment Period 2|Adverse Event|0|||
33277517|NCT00475735|62652886|FG003|Treatment Period 2|Adverse Event|2|||
33277518|NCT00475735|62652887|FG004|Treatment Period 2|Adverse Event|0|||
33277519|NCT00475735|62652888|FG005|Treatment Period 2|Adverse Event|0|||
33277520|NCT00475735|62652883|FG000|Treatment Period 2|Lack of Efficacy|0|||
33277521|NCT00475735|62652884|FG001|Treatment Period 2|Lack of Efficacy|0|||
33555792|NCT01975831|62948600|FG008|Overall Study|Withdrawal by Subject|0|||
33555793|NCT01975831|62948592|FG000|Overall Study|Physician Decision|0|||
33277522|NCT00475735|62652885|FG002|Treatment Period 2|Lack of Efficacy|0|||
33277523|NCT00475735|62652886|FG003|Treatment Period 2|Lack of Efficacy|0|||
33555794|NCT01975831|62948593|FG001|Overall Study|Physician Decision|0|||
33277524|NCT00475735|62652887|FG004|Treatment Period 2|Lack of Efficacy|0|||
33277525|NCT00475735|62652888|FG005|Treatment Period 2|Lack of Efficacy|1|||
33277526|NCT00475735|62652883|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33277527|NCT00475735|62652884|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33277528|NCT00475735|62652885|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33277529|NCT00475735|62652886|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33277530|NCT00475735|62652887|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33277531|NCT00475735|62652888|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33277532|NCT00475657|62652896|FG000|Overall Study|Death|1|||
33277533|NCT00475657|62652896|FG000|Overall Study|Sponsor's Decision|3|||
33277534|NCT00475423|62652900|FG000|Overall Study|Protocol Violation|5|||
33277535|NCT00475423|62652900|FG000|Overall Study|Adverse Event|4|||
33277536|NCT00475423|62652900|FG000|Overall Study|Withdrawal by Subject|6|||
33277537|NCT00475423|62652900|FG000|Overall Study|Lack of Efficacy|8|||
33277538|NCT00475423|62652900|FG000|Overall Study|Death|1|||
33277539|NCT00475423|62652900|FG000|Overall Study|Reason not specified|1|||
33277540|NCT00475423|62652900|FG000|Overall Study|Lost to Follow-up|7|||
33277541|NCT00475306|62652908|FG000|Overall Study|Protocol Violation|1|||
33277542|NCT00475306|62652909|FG001|Overall Study|Protocol Violation|1|||
33277543|NCT00475306|62652910|FG002|Overall Study|Protocol Violation|0|||
33277544|NCT00475306|62652911|FG003|Overall Study|Protocol Violation|1|||
33277545|NCT00475228|62652923|FG000|Overall Study|Lost to Follow-up|17|||
33277546|NCT00475228|62652924|FG001|Overall Study|Lost to Follow-up|17|||
33277547|NCT00475033|62652936|FG000|Infant Series|Failed to return|3|||
33277548|NCT00475033|62652937|FG001|Infant Series|Failed to return|4|||
33277549|NCT00475033|62652936|FG000|Infant Series|Parent or legal guardian request|1|||
33277550|NCT00475033|62652937|FG001|Infant Series|Parent or legal guardian request|5|||
33277551|NCT00475033|62652936|FG000|Infant Series|Protocol Violation|1|||
33277552|NCT00475033|62652937|FG001|Infant Series|Protocol Violation|2|||
33277553|NCT00475033|62652936|FG000|Infant Series|Lost to Follow-up|2|||
33277554|NCT00475033|62652937|FG001|Infant Series|Lost to Follow-up|0|||
33277555|NCT00475033|62652936|FG000|Infant Series|Adverse Event|0|||
33277556|NCT00475033|62652937|FG001|Infant Series|Adverse Event|2|||
33277557|NCT00475033|62652936|FG000|After the Infant Series|Adverse Event|0|||
33277558|NCT00475033|62652937|FG001|After the Infant Series|Adverse Event|4|||
33277559|NCT00475033|62652936|FG000|After the Infant Series|Parent or legal guardian request|2|||
33277560|NCT00475033|62652937|FG001|After the Infant Series|Parent or legal guardian request|2|||
33277561|NCT00475033|62652936|FG000|After the Infant Series|Failed to return|2|||
33277562|NCT00475033|62652937|FG001|After the Infant Series|Failed to return|1|||
33277563|NCT00475033|62652936|FG000|After the Infant Series|Protocol Violation|1|||
33277564|NCT00475033|62652937|FG001|After the Infant Series|Protocol Violation|0|||
33277565|NCT00475033|62652936|FG000|After the Infant Series|Lost to Follow-up|1|||
33277566|NCT00475033|62652937|FG001|After the Infant Series|Lost to Follow-up|0|||
33277567|NCT00475033|62652936|FG000|After the Infant Series|Other|0|||
33277568|NCT00475033|62652937|FG001|After the Infant Series|Other|1|||
33277569|NCT00475033|62652936|FG000|Toddler Dose|Parent or legal guardian request|2|||
33277570|NCT00475033|62652937|FG001|Toddler Dose|Parent or legal guardian request|0|||
33277571|NCT00475033|62652936|FG000|Toddler Dose|Failed to return|1|||
33277572|NCT00475033|62652937|FG001|Toddler Dose|Failed to return|0|||
33277573|NCT00475033|62652936|FG000|Toddler Dose|Lost to Follow-up|1|||
33277574|NCT00475033|62652937|FG001|Toddler Dose|Lost to Follow-up|0|||
33277575|NCT00474994|62652950|FG000|Overall Study|Patient Not treated|1|||
33277576|NCT00474994|62652950|FG000|Overall Study|Patient evaluable for toxicity only|3|||
33277577|NCT00474994|62652950|FG000|Overall Study|Patient found to be ineligible|1|||
33277578|NCT00474955|62652954|FG000|Overall Study|Adverse Event|2|||
33277579|NCT00474955|62652954|FG000|Overall Study|Drug unavailability|1|||
33277580|NCT00474955|62652954|FG000|Overall Study|Personal reasons|5|||
33277581|NCT00474487|62652962|FG000|Overall Study|Withdrawal by Subject|6|||
33277582|NCT00474487|62652963|FG001|Overall Study|Withdrawal by Subject|0|||
33277583|NCT00474487|62652964|FG002|Overall Study|Withdrawal by Subject|0|||
33277584|NCT00474487|62652965|FG003|Overall Study|Withdrawal by Subject|0|||
33277585|NCT00474487|62652962|FG000|Overall Study|Lost to Follow-up|20|||
33277586|NCT00474487|62652963|FG001|Overall Study|Lost to Follow-up|1|||
33277587|NCT00474487|62652964|FG002|Overall Study|Lost to Follow-up|7|||
33277588|NCT00474487|62652965|FG003|Overall Study|Lost to Follow-up|0|||
33277589|NCT00474487|62652962|FG000|Overall Study|Inappropriate enrollment|4|||
33277590|NCT00474487|62652963|FG001|Overall Study|Inappropriate enrollment|0|||
33277591|NCT00474487|62652964|FG002|Overall Study|Inappropriate enrollment|7|||
33277592|NCT00474487|62652965|FG003|Overall Study|Inappropriate enrollment|0|||
33277593|NCT00474487|62652962|FG000|Overall Study|Death|0|||
33277594|NCT00474487|62652963|FG001|Overall Study|Death|1|||
33277595|NCT00474487|62652964|FG002|Overall Study|Death|0|||
33277596|NCT00474487|62652965|FG003|Overall Study|Death|0|||
33277597|NCT00474253|62652977|FG000|Overall Study|Withdrew consent|2|||
33277598|NCT00474253|62652978|FG001|Overall Study|Withdrew consent|0|||
33277599|NCT00474253|62652977|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
33277600|NCT00474253|62652978|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
33277601|NCT00474253|62652977|FG000|Overall Study|Lost to Follow-up|1|||
33277602|NCT00474253|62652978|FG001|Overall Study|Lost to Follow-up|0|||
33277603|NCT00474253|62652977|FG000|Overall Study|Discharged prior to study completion|0|||
33277604|NCT00474253|62652978|FG001|Overall Study|Discharged prior to study completion|1|||
33277605|NCT00474058|62652986|FG000|Overall Study|Adverse Event|11|||
33277606|NCT00474058|62652987|FG001|Overall Study|Adverse Event|6|||
33277607|NCT00474058|62652986|FG000|Overall Study|Lack of Efficacy|0|||
33277608|NCT00474058|62652987|FG001|Overall Study|Lack of Efficacy|4|||
33277609|NCT00474058|62652986|FG000|Overall Study|Withdrawal by Subject|11|||
33277610|NCT00474058|62652987|FG001|Overall Study|Withdrawal by Subject|7|||
33277611|NCT00474058|62652986|FG000|Overall Study|Other|2|||
33277612|NCT00474058|62652987|FG001|Overall Study|Other|0|||
33277613|NCT00473824|62652995|FG000|Overall Study|Virologic Breakthrough|1|||
33277614|NCT00473824|62652996|FG001|Overall Study|Virologic Breakthrough|0|||
33277615|NCT00473824|62652995|FG000|Overall Study|Adverse Event|1|||
33277616|NCT00473824|62652996|FG001|Overall Study|Adverse Event|0|||
33277617|NCT00473824|62652995|FG000|Overall Study|Death|1|||
33277618|NCT00473824|62652996|FG001|Overall Study|Death|0|||
33277619|NCT00473824|62652995|FG000|Overall Study|Lost to Follow-up|1|||
33277620|NCT00473824|62652996|FG001|Overall Study|Lost to Follow-up|0|||
33277621|NCT00473824|62652995|FG000|Overall Study|Withdrawal by physician|1|||
33277622|NCT00473824|62652996|FG001|Overall Study|Withdrawal by physician|0|||
33277623|NCT00473746|62653007|FG000|Period 1 (Phase 1)|Adverse Event|1|||
33277624|NCT00473746|62653008|FG001|Period 1 (Phase 1)|Adverse Event|0|||
33277625|NCT00473746|62653009|FG002|Period 1 (Phase 1)|Adverse Event|0|||
33277626|NCT00473746|62653010|FG003|Period 1 (Phase 1)|Adverse Event|0|||
33277627|NCT00473746|62653011|FG004|Period 1 (Phase 1)|Adverse Event|0|||
33277628|NCT00473746|62653007|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
33277629|NCT00473746|62653008|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
33277630|NCT00473746|62653009|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
33277631|NCT00473746|62653010|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
33277632|NCT00473746|62653011|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
33277633|NCT00473746|62653007|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
33277634|NCT00473746|62653008|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
33277635|NCT00473746|62653009|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
33277636|NCT00473746|62653010|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
33277637|NCT00473746|62653011|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
33277638|NCT00473746|62653007|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
33277639|NCT00473746|62653008|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
33277640|NCT00473746|62653009|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
33277641|NCT00473746|62653010|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
33277642|NCT00473746|62653011|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
33277643|NCT00473746|62653007|FG000|Period 1 (Phase 1)|Reason not specified|0|||
33277644|NCT00473746|62653008|FG001|Period 1 (Phase 1)|Reason not specified|1|||
33277645|NCT00473746|62653009|FG002|Period 1 (Phase 1)|Reason not specified|0|||
33277646|NCT00473746|62653010|FG003|Period 1 (Phase 1)|Reason not specified|0|||
33277647|NCT00473746|62653011|FG004|Period 1 (Phase 1)|Reason not specified|0|||
33277648|NCT00473746|62653007|FG000|Period 2 (Phase 2)|Adverse Event|0|||
33277649|NCT00473746|62653008|FG001|Period 2 (Phase 2)|Adverse Event|0|||
33277650|NCT00473746|62653009|FG002|Period 2 (Phase 2)|Adverse Event|0|||
33277651|NCT00473746|62653010|FG003|Period 2 (Phase 2)|Adverse Event|0|||
33277652|NCT00473746|62653011|FG004|Period 2 (Phase 2)|Adverse Event|3|||
33277653|NCT00473746|62653007|FG000|Period 2 (Phase 2)|Death|0|||
33277654|NCT00473746|62653008|FG001|Period 2 (Phase 2)|Death|0|||
33277655|NCT00473746|62653009|FG002|Period 2 (Phase 2)|Death|0|||
33277656|NCT00473746|62653010|FG003|Period 2 (Phase 2)|Death|0|||
33277657|NCT00473746|62653011|FG004|Period 2 (Phase 2)|Death|1|||
33277658|NCT00473746|62653007|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
33277659|NCT00473746|62653008|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
33277660|NCT00473746|62653009|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
33277661|NCT00473746|62653010|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
33277662|NCT00473746|62653011|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
33277663|NCT00473746|62653007|FG000|Period 2 (Phase 2)|Reason not specified|0|||
33277664|NCT00473746|62653008|FG001|Period 2 (Phase 2)|Reason not specified|0|||
33277665|NCT00473746|62653009|FG002|Period 2 (Phase 2)|Reason not specified|0|||
33277666|NCT00473746|62653010|FG003|Period 2 (Phase 2)|Reason not specified|0|||
33277667|NCT00473746|62653011|FG004|Period 2 (Phase 2)|Reason not specified|3|||
33277668|NCT00473668|62653028|FG000|Overall Study|Withdrawal by Subject|0|||
33277669|NCT00473668|62653029|FG001|Overall Study|Withdrawal by Subject|2|||
33277670|NCT00473668|62653030|FG002|Overall Study|Withdrawal by Subject|0|||
33370555|NCT00848718|62749290|FG005|Overall Study|Physician Decision|1|||
33277671|NCT00473668|62653028|FG000|Overall Study|Migrated/moved from study area|3|||
33277672|NCT00473668|62653029|FG001|Overall Study|Migrated/moved from study area|2|||
33277673|NCT00473668|62653030|FG002|Overall Study|Migrated/moved from study area|0|||
33277674|NCT00473668|62653028|FG000|Overall Study|Lost to Follow-up|0|||
33277675|NCT00473668|62653029|FG001|Overall Study|Lost to Follow-up|4|||
33277676|NCT00473668|62653030|FG002|Overall Study|Lost to Follow-up|6|||
33277677|NCT00473668|62653028|FG000|Overall Study|Other|2|||
33277678|NCT00473668|62653029|FG001|Overall Study|Other|3|||
33277679|NCT00473668|62653030|FG002|Overall Study|Other|4|||
33277680|NCT00473590|62653040|FG000|Overall Study|Adverse Event|3|||
33277681|NCT00473590|62653041|FG001|Overall Study|Adverse Event|3|||
33277682|NCT00473590|62653040|FG000|Overall Study|Death|4|||
33277683|NCT00473590|62653041|FG001|Overall Study|Death|2|||
33277684|NCT00473590|62653040|FG000|Overall Study|Progression not resulting in death|24|||
33277685|NCT00473590|62653041|FG001|Overall Study|Progression not resulting in death|20|||
33277686|NCT00473590|62653040|FG000|Overall Study|Non-protocol-specified therapy|7|||
33277687|NCT00473590|62653041|FG001|Overall Study|Non-protocol-specified therapy|5|||
33277688|NCT00473590|62653040|FG000|Overall Study|Physician Decision|2|||
33277689|NCT00473590|62653041|FG001|Overall Study|Physician Decision|4|||
33277690|NCT00473590|62653040|FG000|Overall Study|Withdrawal by Subject|5|||
33277691|NCT00473590|62653041|FG001|Overall Study|Withdrawal by Subject|3|||
33277692|NCT00473590|62653040|FG000|Overall Study|Other|0|||
33277693|NCT00473590|62653041|FG001|Overall Study|Other|1|||
33277694|NCT00473512|62653052|FG000|Period 1 (Phase 1)|Adverse Event|0|||
33277695|NCT00473512|62653053|FG001|Period 1 (Phase 1)|Adverse Event|0|||
33277696|NCT00473512|62653054|FG002|Period 1 (Phase 1)|Adverse Event|0|||
33277697|NCT00473512|62653055|FG003|Period 1 (Phase 1)|Adverse Event|5|||
33277698|NCT00473512|62653056|FG004|Period 1 (Phase 1)|Adverse Event|0|||
33277699|NCT00473512|62653052|FG000|Period 1 (Phase 1)|Death|0|||
33277700|NCT00473512|62653053|FG001|Period 1 (Phase 1)|Death|0|||
33277701|NCT00473512|62653054|FG002|Period 1 (Phase 1)|Death|0|||
33277702|NCT00473512|62653055|FG003|Period 1 (Phase 1)|Death|1|||
33277703|NCT00473512|62653056|FG004|Period 1 (Phase 1)|Death|0|||
33277704|NCT00473512|62653052|FG000|Period 1 (Phase 1)|Disease Progression|1|||
33277705|NCT00473512|62653053|FG001|Period 1 (Phase 1)|Disease Progression|1|||
33277706|NCT00473512|62653054|FG002|Period 1 (Phase 1)|Disease Progression|0|||
33277707|NCT00473512|62653055|FG003|Period 1 (Phase 1)|Disease Progression|10|||
33277708|NCT00473512|62653056|FG004|Period 1 (Phase 1)|Disease Progression|1|||
33277709|NCT00473512|62653052|FG000|Period 1 (Phase 1)|Other|0|||
33277710|NCT00473512|62653053|FG001|Period 1 (Phase 1)|Other|0|||
33277711|NCT00473512|62653054|FG002|Period 1 (Phase 1)|Other|0|||
33277712|NCT00473512|62653055|FG003|Period 1 (Phase 1)|Other|1|||
33277713|NCT00473512|62653056|FG004|Period 1 (Phase 1)|Other|0|||
33277714|NCT00473512|62653052|FG000|Period 2 (Phase 2)|Adverse Event|0|||
33277715|NCT00473512|62653053|FG001|Period 2 (Phase 2)|Adverse Event|0|||
33277716|NCT00473512|62653054|FG002|Period 2 (Phase 2)|Adverse Event|0|||
33277717|NCT00473512|62653055|FG003|Period 2 (Phase 2)|Adverse Event|1|||
33277718|NCT00473512|62653056|FG004|Period 2 (Phase 2)|Adverse Event|0|||
33277719|NCT00473512|62653052|FG000|Period 2 (Phase 2)|Death|0|||
33277720|NCT00473512|62653053|FG001|Period 2 (Phase 2)|Death|0|||
33277721|NCT00473512|62653054|FG002|Period 2 (Phase 2)|Death|0|||
33277722|NCT00473512|62653055|FG003|Period 2 (Phase 2)|Death|1|||
33277723|NCT00473512|62653056|FG004|Period 2 (Phase 2)|Death|1|||
33277724|NCT00473512|62653052|FG000|Period 2 (Phase 2)|Disease Progression|0|||
33277725|NCT00473512|62653053|FG001|Period 2 (Phase 2)|Disease Progression|2|||
33277726|NCT00473512|62653054|FG002|Period 2 (Phase 2)|Disease Progression|2|||
33277727|NCT00473512|62653055|FG003|Period 2 (Phase 2)|Disease Progression|17|||
33277728|NCT00473512|62653056|FG004|Period 2 (Phase 2)|Disease Progression|1|||
33277729|NCT00473512|62653052|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
33277730|NCT00473512|62653053|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
33277731|NCT00473512|62653054|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
33277732|NCT00473512|62653055|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
33277733|NCT00473512|62653056|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
33277734|NCT00473512|62653052|FG000|Period 2 (Phase 2)|Other|1|||
33277735|NCT00473512|62653053|FG001|Period 2 (Phase 2)|Other|0|||
33277736|NCT00473512|62653054|FG002|Period 2 (Phase 2)|Other|0|||
33277737|NCT00473512|62653055|FG003|Period 2 (Phase 2)|Other|3|||
33277738|NCT00473512|62653056|FG004|Period 2 (Phase 2)|Other|0|||
33277739|NCT00473434|62653076|FG000|Overall Study|Physician Decision|3|||
33277740|NCT00473434|62653076|FG000|Overall Study|Withdrawal by Subject|9|||
33277741|NCT00473434|62653076|FG000|Overall Study|Compliance|3|||
33277742|NCT00473434|62653076|FG000|Overall Study|Lack of Efficacy|3|||
33277743|NCT00473434|62653076|FG000|Overall Study|Adverse Event|3|||
33277744|NCT00473434|62653076|FG000|Overall Study|Patient was selling medication to others|1|||
33277745|NCT00473434|62653076|FG000|Overall Study|Safety evaluation|1|||
33277746|NCT00473434|62653076|FG000|Overall Study|Reason not specified|6|||
33277747|NCT00473434|62653076|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
33277748|NCT00473434|62653076|FG000|Overall Study|Switching to trial medication|1|||
33277749|NCT00473434|62653076|FG000|Overall Study|No longer required|1|||
33277750|NCT00473083|62653096|FG000|Overall Study|Adverse Event|1|||
33277751|NCT00473083|62653097|FG001|Overall Study|Adverse Event|0|||
33277752|NCT00473083|62653098|FG002|Overall Study|Adverse Event|0|||
33277753|NCT00472420|62653109|FG000|Induction Treatment Period|Physician Decision|9|||
33277754|NCT00472420|62653109|FG000|Induction Treatment Period|Adverse Event|3|||
33277755|NCT00472420|62653109|FG000|Induction Treatment Period|Non-compliance|1|||
33277756|NCT00472420|62653109|FG000|Induction Treatment Period|Death|3|||
33277757|NCT00472420|62653109|FG000|Follow-up Period|Death|5|||
33277758|NCT00472420|62653109|FG000|Follow-up Period|Physician Decision|9|||
33277759|NCT00472420|62653109|FG000|Follow-up Period|Lost to Follow-up|2|||
33277760|NCT00472420|62653109|FG000|Follow-up Period|Protocol Violation|1|||
33277761|NCT00472303|62653115|FG000|Titration Phase|Adverse Event|22|||
33277762|NCT00472303|62653116|FG001|Titration Phase|Adverse Event|12|||
33277763|NCT00472303|62653117|FG002|Titration Phase|Adverse Event|0|||
33277764|NCT00472303|62653115|FG000|Titration Phase|Death|4|||
33277765|NCT00472303|62653116|FG001|Titration Phase|Death|2|||
33277766|NCT00472303|62653117|FG002|Titration Phase|Death|0|||
33277767|NCT00472303|62653115|FG000|Titration Phase|Lack of Efficacy|10|||
33277768|NCT00472303|62653116|FG001|Titration Phase|Lack of Efficacy|0|||
33277769|NCT00472303|62653117|FG002|Titration Phase|Lack of Efficacy|0|||
33277770|NCT00472303|62653115|FG000|Titration Phase|Withdrawal by Subject|16|||
33277771|NCT00472303|62653116|FG001|Titration Phase|Withdrawal by Subject|13|||
33277772|NCT00472303|62653117|FG002|Titration Phase|Withdrawal by Subject|0|||
33277773|NCT00472303|62653115|FG000|Titration Phase|Trial Medication non-compliant|4|||
33277774|NCT00472303|62653116|FG001|Titration Phase|Trial Medication non-compliant|1|||
33277775|NCT00472303|62653117|FG002|Titration Phase|Trial Medication non-compliant|0|||
33277776|NCT00472303|62653115|FG000|Titration Phase|Other|3|||
33277777|NCT00472303|62653116|FG001|Titration Phase|Other|1|||
33277778|NCT00472303|62653117|FG002|Titration Phase|Other|0|||
33277779|NCT00472303|62653115|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
33277780|NCT00472303|62653116|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
33277781|NCT00472303|62653117|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
33277782|NCT00472303|62653115|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
33277783|NCT00472303|62653116|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
33277784|NCT00472303|62653117|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
33277785|NCT00472303|62653115|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
33277786|NCT00472303|62653116|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
33277787|NCT00472303|62653117|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
33277788|NCT00472303|62653115|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
33277789|NCT00472303|62653116|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
33277790|NCT00472303|62653117|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
33277791|NCT00472303|62653115|FG000|Discontinuations After Titration Phase|Other|5|||
33277792|NCT00472303|62653116|FG001|Discontinuations After Titration Phase|Other|0|||
33277793|NCT00472303|62653117|FG002|Discontinuations After Titration Phase|Other|0|||
33277794|NCT00472303|62653115|FG000|Maintenance Phase|Adverse Event|5|||
33277795|NCT00472303|62653116|FG001|Maintenance Phase|Adverse Event|6|||
33277796|NCT00472303|62653117|FG002|Maintenance Phase|Adverse Event|6|||
33277797|NCT00472303|62653115|FG000|Maintenance Phase|Death|3|||
33277798|NCT00472303|62653116|FG001|Maintenance Phase|Death|0|||
33277799|NCT00472303|62653117|FG002|Maintenance Phase|Death|2|||
33277800|NCT00472303|62653115|FG000|Maintenance Phase|Lack of Efficacy|2|||
33277801|NCT00472303|62653116|FG001|Maintenance Phase|Lack of Efficacy|2|||
33277802|NCT00472303|62653117|FG002|Maintenance Phase|Lack of Efficacy|4|||
33277803|NCT00472303|62653115|FG000|Maintenance Phase|Withdrawal by Subject|6|||
33277804|NCT00472303|62653116|FG001|Maintenance Phase|Withdrawal by Subject|7|||
33277805|NCT00472303|62653117|FG002|Maintenance Phase|Withdrawal by Subject|3|||
33277806|NCT00472303|62653115|FG000|Maintenance Phase|Trial medication non-compliant|0|||
33277807|NCT00472303|62653116|FG001|Maintenance Phase|Trial medication non-compliant|0|||
33277808|NCT00472303|62653117|FG002|Maintenance Phase|Trial medication non-compliant|1|||
33277809|NCT00472303|62653115|FG000|Maintenance Phase|Resolution of pain|0|||
33277810|NCT00472303|62653116|FG001|Maintenance Phase|Resolution of pain|0|||
33277811|NCT00472303|62653117|FG002|Maintenance Phase|Resolution of pain|1|||
33277812|NCT00472303|62653115|FG000|Maintenance Phase|Other|1|||
33277813|NCT00472303|62653116|FG001|Maintenance Phase|Other|1|||
33277814|NCT00472303|62653117|FG002|Maintenance Phase|Other|0|||
33277815|NCT00471718|62653145|FG000|Overall Study|Adverse Event|3|||
33277816|NCT00471718|62653145|FG000|Overall Study|other complicating disease|1|||
33277817|NCT00471718|62653145|FG000|Overall Study|disease progression|22|||
33277818|NCT00471718|62653145|FG000|Overall Study|Withdrawal by Subject|1|||
33277819|NCT00471445|62653155|FG000|Overall Study|Withdrawal by Subject|1|||
33277820|NCT00471445|62653156|FG001|Overall Study|Withdrawal by Subject|1|||
33277821|NCT00471445|62653155|FG000|Overall Study|Ineligible|1|||
33277822|NCT00471445|62653156|FG001|Overall Study|Ineligible|0|||
33277823|NCT00471445|62653155|FG000|Overall Study|Protocol Violation|0|||
33277824|NCT00471445|62653156|FG001|Overall Study|Protocol Violation|1|||
33277825|NCT00471328|62653164|FG000|Core Phase|Adverse Event|18|||
33277826|NCT00471328|62653165|FG001|Core Phase|Adverse Event|6|||
33277827|NCT00471328|62653164|FG000|Core Phase|Death|8|||
33277828|NCT00471328|62653165|FG001|Core Phase|Death|4|||
33277829|NCT00471328|62653164|FG000|Core Phase|Withdrawal by Subject|2|||
33277830|NCT00471328|62653165|FG001|Core Phase|Withdrawal by Subject|2|||
33277831|NCT00471328|62653164|FG000|Core Phase|Abnormal laboratory value|1|||
33277832|NCT00471328|62653165|FG001|Core Phase|Abnormal laboratory value|0|||
33277833|NCT00471328|62653164|FG000|Core Phase|Disease Progression|78|||
33277834|NCT00471328|62653165|FG001|Core Phase|Disease Progression|53|||
33277835|NCT00471328|62653164|FG000|Core Phase|Administrative Problem|0|||
33277836|NCT00471328|62653165|FG001|Core Phase|Administrative Problem|1|||
33277837|NCT00471328|62653164|FG000|Core Phase|Protocol Deviation|0|||
33277838|NCT00471328|62653165|FG001|Core Phase|Protocol Deviation|1|||
33277839|NCT00471328|62653164|FG000|Extension Phase|Adverse Event|3|||
33277840|NCT00471328|62653165|FG001|Extension Phase|Adverse Event|12|||
33277841|NCT00471328|62653164|FG000|Extension Phase|Withdrawal by Subject|0|||
33277842|NCT00471328|62653165|FG001|Extension Phase|Withdrawal by Subject|2|||
33277843|NCT00471328|62653164|FG000|Extension Phase|Death|1|||
33277844|NCT00471328|62653165|FG001|Extension Phase|Death|7|||
33277845|NCT00471328|62653164|FG000|Extension Phase|Protocol Deviation|3|||
33277846|NCT00471328|62653165|FG001|Extension Phase|Protocol Deviation|1|||
33277847|NCT00471328|62653164|FG000|Extension Phase|Treatment duration as per protocol|0|||
33277848|NCT00471328|62653165|FG001|Extension Phase|Treatment duration as per protocol|1|||
33277849|NCT00471328|62653164|FG000|Extension Phase|Disease Progression|32|||
33555795|NCT01975831|62948594|FG002|Overall Study|Physician Decision|0|||
33555796|NCT01975831|62948595|FG003|Overall Study|Physician Decision|0|||
33555797|NCT01975831|62948596|FG004|Overall Study|Physician Decision|0|||
33555798|NCT01975831|62948597|FG005|Overall Study|Physician Decision|1|||
33555799|NCT01975831|62948598|FG006|Overall Study|Physician Decision|0|||
33555800|NCT01975831|62948599|FG007|Overall Study|Physician Decision|1|||
33555801|NCT01975831|62948600|FG008|Overall Study|Physician Decision|0|||
33555802|NCT01975831|62948592|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
33555803|NCT01975831|62948593|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
33555804|NCT01975831|62948594|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
33555805|NCT01975831|62948595|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
33555806|NCT01975831|62948596|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
33555807|NCT01975831|62948597|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
33555808|NCT01975831|62948598|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
33555809|NCT01975831|62948599|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
33555810|NCT01975831|62948600|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
33555811|NCT01975831|62948592|FG000|Overall Study|Entered Hospice|0|||
33555812|NCT01975831|62948593|FG001|Overall Study|Entered Hospice|0|||
33555813|NCT01975831|62948594|FG002|Overall Study|Entered Hospice|0|||
33555814|NCT01975831|62948595|FG003|Overall Study|Entered Hospice|0|||
33555815|NCT01975831|62948596|FG004|Overall Study|Entered Hospice|0|||
33277850|NCT00471328|62653165|FG001|Extension Phase|Disease Progression|44|||
33277851|NCT00471328|62653164|FG000|Extension Phase|New cancer Therapy|1|||
33277852|NCT00471328|62653165|FG001|Extension Phase|New cancer Therapy|0|||
33277853|NCT00471328|62653164|FG000|Extension Phase|Administrative Problem|1|||
33277854|NCT00471328|62653165|FG001|Extension Phase|Administrative Problem|0|||
33277855|NCT00470470|62653173|FG000|Overall Study|Adverse Event|2|||
33277856|NCT00470470|62653173|FG000|Overall Study|Death|2|||
33277857|NCT00470470|62653173|FG000|Overall Study|Not treated|1|||
33277858|NCT00470275|62653177|FG000|Overall Study|Death|1|||
33277859|NCT00470275|62653177|FG000|Overall Study|Lack of Efficacy|7|||
33277860|NCT00470275|62653177|FG000|Overall Study|Withdrawal by Subject|2|||
33277861|NCT00470158|62653186|FG000|Overall Study|Death|0|||
33277862|NCT00470158|62653187|FG001|Overall Study|Death|0|||
33277863|NCT00470158|62653188|FG002|Overall Study|Death|0|||
33277864|NCT00470158|62653189|FG003|Overall Study|Death|0|||
33277865|NCT00470158|62653190|FG004|Overall Study|Death|2|||
33277866|NCT00470158|62653186|FG000|Overall Study|Lost to Follow-up|7|||
33277867|NCT00470158|62653187|FG001|Overall Study|Lost to Follow-up|8|||
33277868|NCT00470158|62653188|FG002|Overall Study|Lost to Follow-up|8|||
33277869|NCT00470158|62653189|FG003|Overall Study|Lost to Follow-up|5|||
33277870|NCT00470158|62653190|FG004|Overall Study|Lost to Follow-up|4|||
33277871|NCT00470158|62653186|FG000|Overall Study|Protocol Violation|1|||
33277872|NCT00470158|62653187|FG001|Overall Study|Protocol Violation|0|||
33277873|NCT00470158|62653188|FG002|Overall Study|Protocol Violation|0|||
33277874|NCT00470158|62653189|FG003|Overall Study|Protocol Violation|0|||
33277875|NCT00470158|62653190|FG004|Overall Study|Protocol Violation|0|||
33555816|NCT01975831|62948597|FG005|Overall Study|Entered Hospice|1|||
33555817|NCT01975831|62948598|FG006|Overall Study|Entered Hospice|0|||
33277876|NCT00475540|62653204|FG000|36 Months|Lost to Follow-up|4|||
33277877|NCT00475540|62653205|FG001|36 Months|Lost to Follow-up|4|||
33277878|NCT00475540|62653204|FG000|36 Months|Death|1|||
33277879|NCT00475540|62653205|FG001|36 Months|Death|2|||
33277880|NCT00475540|62653204|FG000|36 Months|Censored due to reoperation|3|||
33277881|NCT00475540|62653205|FG001|36 Months|Censored due to reoperation|0|||
33277882|NCT00472186|62653213|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
33277883|NCT00472186|62653214|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
33277884|NCT00479713|62653224|FG000|Overall Study|Adverse Event|8|||
33277885|NCT00479713|62653225|FG001|Overall Study|Adverse Event|6|||
33277886|NCT00479713|62653224|FG000|Overall Study|Death|1|||
33277887|NCT00479713|62653225|FG001|Overall Study|Death|0|||
33277888|NCT00479713|62653224|FG000|Overall Study|Lost to Follow-up|0|||
33277889|NCT00479713|62653225|FG001|Overall Study|Lost to Follow-up|1|||
33277890|NCT00479713|62653224|FG000|Overall Study|Protocol Violation|0|||
33277891|NCT00479713|62653225|FG001|Overall Study|Protocol Violation|1|||
33277892|NCT00479713|62653224|FG000|Overall Study|Withdrawal by Subject|4|||
33277893|NCT00479713|62653225|FG001|Overall Study|Withdrawal by Subject|1|||
33277894|NCT00474526|62653257|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
33277895|NCT00474526|62653258|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
33277896|NCT00474526|62653259|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
33277897|NCT00474526|62653260|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
33277898|NCT00474526|62653261|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
33277899|NCT00474526|62653262|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
33277900|NCT00474526|62653263|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
33277901|NCT00474526|62653264|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
33277902|NCT00474526|62653265|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
33277903|NCT00474526|62653266|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
33277904|NCT00474526|62653267|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
33277905|NCT00474526|62653268|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
33277906|NCT00474526|62653269|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
33277907|NCT00474526|62653270|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
33277908|NCT00474526|62653271|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
33277909|NCT00474526|62653272|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
33277910|NCT00474526|62653273|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
33277911|NCT00474526|62653257|FG000|Overall Study|Adverse Event|2|||
33277912|NCT00474526|62653258|FG001|Overall Study|Adverse Event|0|||
33277913|NCT00474526|62653259|FG002|Overall Study|Adverse Event|2|||
33277914|NCT00474526|62653260|FG003|Overall Study|Adverse Event|4|||
33277915|NCT00474526|62653261|FG004|Overall Study|Adverse Event|2|||
33277916|NCT00474526|62653262|FG005|Overall Study|Adverse Event|1|||
33277917|NCT00474526|62653263|FG006|Overall Study|Adverse Event|1|||
33277918|NCT00474526|62653264|FG007|Overall Study|Adverse Event|0|||
33277919|NCT00474526|62653265|FG008|Overall Study|Adverse Event|0|||
33277920|NCT00474526|62653266|FG009|Overall Study|Adverse Event|0|||
33277921|NCT00474526|62653267|FG010|Overall Study|Adverse Event|0|||
33277922|NCT00474526|62653268|FG011|Overall Study|Adverse Event|0|||
33277923|NCT00474526|62653269|FG012|Overall Study|Adverse Event|0|||
33277924|NCT00474526|62653270|FG013|Overall Study|Adverse Event|0|||
33277925|NCT00474526|62653271|FG014|Overall Study|Adverse Event|1|||
33277926|NCT00474526|62653272|FG015|Overall Study|Adverse Event|1|||
33277927|NCT00474526|62653273|FG016|Overall Study|Adverse Event|0|||
33277928|NCT00474526|62653257|FG000|Overall Study|Death|0|||
33277929|NCT00474526|62653258|FG001|Overall Study|Death|0|||
33277930|NCT00474526|62653259|FG002|Overall Study|Death|0|||
33277931|NCT00474526|62653260|FG003|Overall Study|Death|0|||
33277932|NCT00474526|62653261|FG004|Overall Study|Death|0|||
33277933|NCT00474526|62653262|FG005|Overall Study|Death|0|||
33277934|NCT00474526|62653263|FG006|Overall Study|Death|0|||
33277935|NCT00474526|62653264|FG007|Overall Study|Death|0|||
33277936|NCT00474526|62653265|FG008|Overall Study|Death|0|||
33277937|NCT00474526|62653266|FG009|Overall Study|Death|0|||
33277938|NCT00474526|62653267|FG010|Overall Study|Death|0|||
33277939|NCT00474526|62653268|FG011|Overall Study|Death|0|||
33277940|NCT00474526|62653269|FG012|Overall Study|Death|0|||
33277941|NCT00474526|62653270|FG013|Overall Study|Death|3|||
33277942|NCT00474526|62653271|FG014|Overall Study|Death|0|||
33277943|NCT00474526|62653272|FG015|Overall Study|Death|0|||
33277944|NCT00474526|62653273|FG016|Overall Study|Death|0|||
33277945|NCT00474526|62653257|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33277946|NCT00474526|62653258|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
33277947|NCT00474526|62653259|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33277948|NCT00474526|62653260|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
33277949|NCT00474526|62653261|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
33277950|NCT00474526|62653262|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33277951|NCT00474526|62653263|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33277952|NCT00474526|62653264|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33277953|NCT00474526|62653265|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33277954|NCT00474526|62653266|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33277955|NCT00474526|62653267|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33277956|NCT00474526|62653268|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33277957|NCT00474526|62653269|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33277958|NCT00474526|62653270|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
33277959|NCT00474526|62653271|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
33277960|NCT00474526|62653272|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33277961|NCT00474526|62653273|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33277962|NCT00474526|62653257|FG000|Overall Study|Lost to Follow-up|8|||
33277963|NCT00474526|62653258|FG001|Overall Study|Lost to Follow-up|6|||
33277964|NCT00474526|62653259|FG002|Overall Study|Lost to Follow-up|13|||
33277965|NCT00474526|62653260|FG003|Overall Study|Lost to Follow-up|29|||
33277966|NCT00474526|62653261|FG004|Overall Study|Lost to Follow-up|11|||
33277967|NCT00474526|62653262|FG005|Overall Study|Lost to Follow-up|5|||
33277968|NCT00474526|62653263|FG006|Overall Study|Lost to Follow-up|8|||
33277969|NCT00474526|62653264|FG007|Overall Study|Lost to Follow-up|1|||
33277970|NCT00474526|62653265|FG008|Overall Study|Lost to Follow-up|0|||
33277971|NCT00474526|62653266|FG009|Overall Study|Lost to Follow-up|6|||
33277972|NCT00474526|62653267|FG010|Overall Study|Lost to Follow-up|2|||
33277973|NCT00474526|62653268|FG011|Overall Study|Lost to Follow-up|4|||
33277974|NCT00474526|62653269|FG012|Overall Study|Lost to Follow-up|6|||
33277975|NCT00474526|62653270|FG013|Overall Study|Lost to Follow-up|74|||
33277976|NCT00474526|62653271|FG014|Overall Study|Lost to Follow-up|29|||
33277977|NCT00474526|62653272|FG015|Overall Study|Lost to Follow-up|4|||
33277978|NCT00474526|62653273|FG016|Overall Study|Lost to Follow-up|5|||
33277979|NCT00474526|62653257|FG000|Overall Study|Protocol Violation|2|||
33277980|NCT00474526|62653258|FG001|Overall Study|Protocol Violation|6|||
33277981|NCT00474526|62653259|FG002|Overall Study|Protocol Violation|4|||
33277982|NCT00474526|62653260|FG003|Overall Study|Protocol Violation|12|||
33277983|NCT00474526|62653261|FG004|Overall Study|Protocol Violation|3|||
33277984|NCT00474526|62653262|FG005|Overall Study|Protocol Violation|1|||
33277985|NCT00474526|62653263|FG006|Overall Study|Protocol Violation|3|||
33277986|NCT00474526|62653264|FG007|Overall Study|Protocol Violation|0|||
33277987|NCT00474526|62653265|FG008|Overall Study|Protocol Violation|0|||
33277988|NCT00474526|62653266|FG009|Overall Study|Protocol Violation|4|||
33277989|NCT00474526|62653267|FG010|Overall Study|Protocol Violation|2|||
33277990|NCT00474526|62653268|FG011|Overall Study|Protocol Violation|2|||
33277991|NCT00474526|62653269|FG012|Overall Study|Protocol Violation|4|||
33277992|NCT00474526|62653270|FG013|Overall Study|Protocol Violation|19|||
33277993|NCT00474526|62653271|FG014|Overall Study|Protocol Violation|9|||
33277994|NCT00474526|62653272|FG015|Overall Study|Protocol Violation|6|||
33277995|NCT00474526|62653273|FG016|Overall Study|Protocol Violation|2|||
33277996|NCT00474526|62653257|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
33277997|NCT00474526|62653258|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
33277998|NCT00474526|62653259|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
33277999|NCT00474526|62653260|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
33278000|NCT00474526|62653261|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
33278001|NCT00474526|62653262|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
33278002|NCT00474526|62653263|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
33278003|NCT00474526|62653264|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
33278004|NCT00474526|62653265|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
33278005|NCT00474526|62653266|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
33278006|NCT00474526|62653267|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
33278007|NCT00474526|62653268|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
33278008|NCT00474526|62653269|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
33278009|NCT00474526|62653270|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
33278010|NCT00474526|62653271|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
33278011|NCT00474526|62653272|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
33278012|NCT00474526|62653273|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
33278013|NCT00474526|62653257|FG000|Overall Study|Withdrawal by Subject|9|||
33278014|NCT00474526|62653258|FG001|Overall Study|Withdrawal by Subject|24|||
33278015|NCT00474526|62653259|FG002|Overall Study|Withdrawal by Subject|21|||
33278016|NCT00474526|62653260|FG003|Overall Study|Withdrawal by Subject|52|||
33278017|NCT00474526|62653261|FG004|Overall Study|Withdrawal by Subject|38|||
33278018|NCT00474526|62653262|FG005|Overall Study|Withdrawal by Subject|6|||
33278019|NCT00474526|62653263|FG006|Overall Study|Withdrawal by Subject|12|||
33278020|NCT00474526|62653264|FG007|Overall Study|Withdrawal by Subject|4|||
33278021|NCT00474526|62653265|FG008|Overall Study|Withdrawal by Subject|4|||
33278022|NCT00474526|62653266|FG009|Overall Study|Withdrawal by Subject|13|||
33278023|NCT00474526|62653267|FG010|Overall Study|Withdrawal by Subject|5|||
33278024|NCT00474526|62653268|FG011|Overall Study|Withdrawal by Subject|4|||
33278025|NCT00474526|62653269|FG012|Overall Study|Withdrawal by Subject|4|||
33278026|NCT00474526|62653270|FG013|Overall Study|Withdrawal by Subject|37|||
33278027|NCT00474526|62653271|FG014|Overall Study|Withdrawal by Subject|22|||
33278028|NCT00474526|62653272|FG015|Overall Study|Withdrawal by Subject|1|||
33278029|NCT00474526|62653273|FG016|Overall Study|Withdrawal by Subject|1|||
33278030|NCT00478426|62653359|FG000|Overall Study|Withdrawal by Subject|1|||
33278031|NCT00477412|62653367|FG000|Overall Study|Death|0|||
33278032|NCT00477412|62653368|FG001|Overall Study|Death|0|||
33278033|NCT00477412|62653369|FG002|Overall Study|Death|0|||
33278034|NCT00477412|62653370|FG003|Overall Study|Death|4|||
33278035|NCT00477412|62653367|FG000|Overall Study|Lost to Follow-up|0|||
33278036|NCT00477412|62653368|FG001|Overall Study|Lost to Follow-up|0|||
33278037|NCT00477412|62653369|FG002|Overall Study|Lost to Follow-up|0|||
33370556|NCT00848718|62749291|FG006|Overall Study|Physician Decision|0|||
33278038|NCT00477412|62653370|FG003|Overall Study|Lost to Follow-up|1|||
33278039|NCT00477412|62653367|FG000|Overall Study|Withdrawal by Subject|0|||
33278040|NCT00477412|62653368|FG001|Overall Study|Withdrawal by Subject|0|||
33278041|NCT00477412|62653369|FG002|Overall Study|Withdrawal by Subject|0|||
33278042|NCT00477412|62653370|FG003|Overall Study|Withdrawal by Subject|2|||
33278043|NCT00477412|62653367|FG000|Overall Study|Second Malignancy|0|||
33278044|NCT00477412|62653368|FG001|Overall Study|Second Malignancy|0|||
33278045|NCT00477412|62653369|FG002|Overall Study|Second Malignancy|0|||
33278046|NCT00477412|62653370|FG003|Overall Study|Second Malignancy|1|||
33278047|NCT00477412|62653367|FG000|Overall Study|Adverse Event|1|||
33278048|NCT00477412|62653368|FG001|Overall Study|Adverse Event|0|||
33278049|NCT00477412|62653369|FG002|Overall Study|Adverse Event|1|||
33278050|NCT00477412|62653370|FG003|Overall Study|Adverse Event|0|||
33278051|NCT01089556|62653380|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
33278052|NCT01089556|62653381|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
33278053|NCT01089556|62653382|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
33278054|NCT01089556|62653383|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
33278055|NCT01089556|62653384|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
33278056|NCT01089556|62653385|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
33278057|NCT01089556|62653380|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
33278058|NCT01089556|62653381|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
33278059|NCT01089556|62653382|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
33278060|NCT01089556|62653383|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
33278061|NCT01089556|62653384|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
33278062|NCT01089556|62653385|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
33278063|NCT01089556|62653380|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
33278064|NCT01089556|62653381|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
33278065|NCT01089556|62653382|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
33278066|NCT01089556|62653383|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
33278067|NCT01089556|62653384|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
33278068|NCT01089556|62653385|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
33278069|NCT01089556|62653380|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
33278070|NCT01089556|62653381|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
33278071|NCT01089556|62653382|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
33278072|NCT01089556|62653383|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
33278073|NCT01089556|62653384|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
33278074|NCT01089556|62653385|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
33278075|NCT01089556|62653380|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
33278076|NCT01089556|62653381|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
33278077|NCT01089556|62653382|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
33278078|NCT01089556|62653383|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
33278079|NCT01089556|62653384|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
33278080|NCT01089556|62653385|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
33370557|NCT00848718|62749292|FG007|Overall Study|Physician Decision|0|||
33370558|NCT00848718|62749293|FG008|Overall Study|Physician Decision|1|||
33370559|NCT00848718|62749294|FG009|Overall Study|Physician Decision|2|||
33370560|NCT00848718|62749295|FG010|Overall Study|Physician Decision|0|||
33370561|NCT00848718|62749296|FG011|Overall Study|Physician Decision|0|||
33370562|NCT00848718|62749297|FG012|Overall Study|Physician Decision|1|||
33370563|NCT00848718|62749285|FG000|Overall Study|Progressive disease before treatment|1|||
33370564|NCT00848718|62749286|FG001|Overall Study|Progressive disease before treatment|5|||
33370565|NCT00848718|62749287|FG002|Overall Study|Progressive disease before treatment|1|||
33370566|NCT00848718|62749288|FG003|Overall Study|Progressive disease before treatment|3|||
33370567|NCT00848718|62749289|FG004|Overall Study|Progressive disease before treatment|4|||
33370568|NCT00848718|62749290|FG005|Overall Study|Progressive disease before treatment|4|||
33370569|NCT00848718|62749291|FG006|Overall Study|Progressive disease before treatment|2|||
33370570|NCT00848718|62749292|FG007|Overall Study|Progressive disease before treatment|1|||
33370571|NCT00848718|62749293|FG008|Overall Study|Progressive disease before treatment|2|||
33278081|NCT01089556|62653380|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
33278082|NCT01089556|62653381|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
33278083|NCT01089556|62653382|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
33278084|NCT01089556|62653383|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
33278085|NCT01089556|62653384|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
33278086|NCT01089556|62653385|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
33278087|NCT01089556|62653380|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
33278088|NCT01089556|62653381|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
33370572|NCT00848718|62749294|FG009|Overall Study|Progressive disease before treatment|7|||
33370573|NCT00848718|62749295|FG010|Overall Study|Progressive disease before treatment|3|||
33370574|NCT00848718|62749296|FG011|Overall Study|Progressive disease before treatment|6|||
33370575|NCT00848718|62749297|FG012|Overall Study|Progressive disease before treatment|2|||
33485703|NCT02076178|62863440|FG000|Oral Phase|Withdrawal by Subject|0|||
33485704|NCT02076178|62863441|FG001|Oral Phase|Withdrawal by Subject|4|||
33278089|NCT01089556|62653382|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
33278090|NCT01089556|62653383|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
33278091|NCT01089556|62653384|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
33278092|NCT01089556|62653385|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
33278093|NCT01089556|62653380|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
33278094|NCT01089556|62653381|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
33370576|NCT00848718|62749285|FG000|Overall Study|Protocol Violation|0|||
33370577|NCT00848718|62749286|FG001|Overall Study|Protocol Violation|1|||
33278095|NCT01089556|62653382|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
33278096|NCT01089556|62653383|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
33278097|NCT01089556|62653384|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
33278098|NCT01089556|62653385|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
33278099|NCT01089556|62653380|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
33278100|NCT01089556|62653381|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
33278101|NCT01089556|62653382|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
33278102|NCT01089556|62653383|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
33278103|NCT01089556|62653384|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
33278104|NCT01089556|62653385|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
33278105|NCT01089556|62653380|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
33278106|NCT01089556|62653381|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
33278107|NCT01089556|62653382|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
33278108|NCT01089556|62653383|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
33278109|NCT01089556|62653384|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
33278110|NCT01089556|62653385|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
33278111|NCT01089556|62653380|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
33278112|NCT01089556|62653381|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
33278113|NCT01089556|62653382|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
33278114|NCT01089556|62653383|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
33278115|NCT01089556|62653384|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
33278116|NCT01089556|62653385|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
33278117|NCT01089556|62653380|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
33278118|NCT01089556|62653381|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
33278119|NCT01089556|62653382|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
33278120|NCT01089556|62653383|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
33278121|NCT01089556|62653384|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
33278122|NCT01089556|62653385|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
33278123|NCT01089556|62653380|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
33278124|NCT01089556|62653381|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
33278125|NCT01089556|62653382|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
33278126|NCT01089556|62653383|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
33278127|NCT01089556|62653384|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
33278128|NCT01089556|62653385|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
33278129|NCT01089556|62653380|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
33278130|NCT01089556|62653381|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
33278131|NCT01089556|62653382|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
33278132|NCT01089556|62653383|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
33278133|NCT01089556|62653384|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
33278134|NCT01089556|62653385|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
33278135|NCT01089556|62653380|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
33278136|NCT01089556|62653381|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
33278137|NCT01089556|62653382|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
33278138|NCT01089556|62653383|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
33278139|NCT01089556|62653384|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
33278140|NCT01089556|62653385|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
33278141|NCT01089127|62653403|FG000|Overall Study|Adverse Event|5|||
33278142|NCT01089127|62653404|FG001|Overall Study|Adverse Event|1|||
33278143|NCT01089127|62653405|FG002|Overall Study|Adverse Event|1|||
33278144|NCT01089127|62653406|FG003|Overall Study|Adverse Event|0|||
33278145|NCT01089127|62653407|FG004|Overall Study|Adverse Event|0|||
33278146|NCT01089127|62653408|FG005|Overall Study|Adverse Event|1|||
33278147|NCT01089127|62653403|FG000|Overall Study|Subject withdrew consent|0|||
33278148|NCT01089127|62653404|FG001|Overall Study|Subject withdrew consent|1|||
33278149|NCT01089127|62653405|FG002|Overall Study|Subject withdrew consent|1|||
33278150|NCT01089127|62653406|FG003|Overall Study|Subject withdrew consent|1|||
33485705|NCT02076178|62863440|FG000|Oral Phase|Physician Decision|0|||
33278151|NCT01089127|62653407|FG004|Overall Study|Subject withdrew consent|0|||
33278152|NCT01089127|62653408|FG005|Overall Study|Subject withdrew consent|2|||
33278153|NCT01089127|62653403|FG000|Overall Study|Abnormal test procedure result(s)|2|||
33278154|NCT01089127|62653404|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33278155|NCT01089127|62653405|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33278156|NCT01089127|62653406|FG003|Overall Study|Abnormal test procedure result(s)|0|||
33485706|NCT02076178|62863441|FG001|Oral Phase|Physician Decision|1|||
33278157|NCT01089127|62653407|FG004|Overall Study|Abnormal test procedure result(s)|0|||
33278158|NCT01089127|62653408|FG005|Overall Study|Abnormal test procedure result(s)|0|||
33278159|NCT01089127|62653403|FG000|Overall Study|Lost to Follow-up|1|||
33278160|NCT01089127|62653404|FG001|Overall Study|Lost to Follow-up|1|||
33278161|NCT01089127|62653405|FG002|Overall Study|Lost to Follow-up|0|||
33278162|NCT01089127|62653406|FG003|Overall Study|Lost to Follow-up|0|||
33278163|NCT01089127|62653407|FG004|Overall Study|Lost to Follow-up|1|||
33278164|NCT01089127|62653408|FG005|Overall Study|Lost to Follow-up|0|||
33278165|NCT01089127|62653403|FG000|Overall Study|Protocol deviation|0|||
33278166|NCT01089127|62653404|FG001|Overall Study|Protocol deviation|1|||
33278167|NCT01089127|62653405|FG002|Overall Study|Protocol deviation|0|||
33278168|NCT01089127|62653406|FG003|Overall Study|Protocol deviation|0|||
33278169|NCT01089127|62653407|FG004|Overall Study|Protocol deviation|1|||
33278170|NCT01089127|62653408|FG005|Overall Study|Protocol deviation|0|||
33278171|NCT01087957|62653424|FG000|Overall Study|Death|2|||
33278172|NCT01087957|62653425|FG001|Overall Study|Death|2|||
33278173|NCT01087957|62653424|FG000|Overall Study|Lost to Follow-up|3|||
33278174|NCT01087957|62653425|FG001|Overall Study|Lost to Follow-up|4|||
33278175|NCT01087957|62653424|FG000|Overall Study|Protocol Violation|13|||
33278176|NCT01087957|62653425|FG001|Overall Study|Protocol Violation|25|||
33278177|NCT01087957|62653424|FG000|Overall Study|Withdrawal by Subject|18|||
33278178|NCT01087957|62653425|FG001|Overall Study|Withdrawal by Subject|15|||
33278179|NCT01087957|62653424|FG000|Overall Study|Physician Decision|5|||
33278180|NCT01087957|62653425|FG001|Overall Study|Physician Decision|9|||
33278181|NCT01087723|62653433|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
33278182|NCT01087723|62653434|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
33278183|NCT01087723|62653433|FG000|Overall Study|Withdrawal by Subject|10|||
33278184|NCT01087723|62653434|FG001|Overall Study|Withdrawal by Subject|13|||
33278185|NCT01087723|62653433|FG000|Overall Study|Physician Decision|2|||
33278186|NCT01087723|62653434|FG001|Overall Study|Physician Decision|0|||
33278187|NCT01087723|62653433|FG000|Overall Study|Lost to Follow-up|1|||
33278188|NCT01087723|62653434|FG001|Overall Study|Lost to Follow-up|4|||
33278189|NCT01087723|62653433|FG000|Overall Study|Reason Not Specified|1|||
33278190|NCT01087723|62653434|FG001|Overall Study|Reason Not Specified|2|||
33278191|NCT01087528|62653440|FG000|Overall Study|Withdrawal by Subject|1|||
33278192|NCT01087528|62653440|FG000|Overall Study|Incomplete CE procedure|6|||
33278193|NCT01085812|62653446|FG000|Open-Label Period|Adverse Event|0|||
33278194|NCT01085812|62653447|FG001|Open-Label Period|Adverse Event|80|||
33278195|NCT01085812|62653446|FG000|Open-Label Period|Lack of Efficacy|0|||
33278196|NCT01085812|62653447|FG001|Open-Label Period|Lack of Efficacy|26|||
33278197|NCT01085812|62653446|FG000|Open-Label Period|Protocol Violation|0|||
33278198|NCT01085812|62653447|FG001|Open-Label Period|Protocol Violation|39|||
33278199|NCT01085812|62653446|FG000|Open-Label Period|Withdrawal by Subject|0|||
33278200|NCT01085812|62653447|FG001|Open-Label Period|Withdrawal by Subject|53|||
33278201|NCT01085812|62653446|FG000|Open-Label Period|Lost to Follow-up|0|||
33278202|NCT01085812|62653447|FG001|Open-Label Period|Lost to Follow-up|42|||
33278203|NCT01085812|62653446|FG000|Double-Blind Period|Adverse Event|3|||
33278204|NCT01085812|62653447|FG001|Double-Blind Period|Adverse Event|8|||
33278205|NCT01085812|62653446|FG000|Double-Blind Period|Protocol Violation|2|||
33278206|NCT01085812|62653447|FG001|Double-Blind Period|Protocol Violation|7|||
33278207|NCT01085812|62653446|FG000|Double-Blind Period|Withdrawal by Subject|11|||
33278208|NCT01085812|62653447|FG001|Double-Blind Period|Withdrawal by Subject|24|||
33278209|NCT01085812|62653446|FG000|Double-Blind Period|Lost to Follow-up|5|||
33278210|NCT01085812|62653447|FG001|Double-Blind Period|Lost to Follow-up|17|||
33278211|NCT01085812|62653446|FG000|Double-Blind Period|Other Reasons|0|||
33278212|NCT01085812|62653447|FG001|Double-Blind Period|Other Reasons|2|||
33278213|NCT01085812|62653446|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
33278214|NCT01085812|62653447|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
33278215|NCT01085812|62653446|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
33278216|NCT01085812|62653447|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
33278217|NCT01085812|62653446|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
33278218|NCT01085812|62653447|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
33278219|NCT01085812|62653446|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
33278220|NCT01085812|62653447|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
33278221|NCT01085812|62653446|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
33662064|NCT02546986|63092797|FG000|Survival Follow-Up Phase|Missing Status|3|||
33278222|NCT01085812|62653447|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
33278223|NCT01085734|62653456|FG000|Overall Study|Adverse Event|0|||
33278224|NCT01085734|62653457|FG001|Overall Study|Adverse Event|2|||
33278225|NCT01085734|62653456|FG000|Overall Study|Death|1|||
33278226|NCT01085734|62653457|FG001|Overall Study|Death|0|||
33662065|NCT02546986|63092798|FG001|Survival Follow-Up Phase|Missing Status|5|||
33278227|NCT01085734|62653456|FG000|Overall Study|Lost to Follow-up|0|||
33278228|NCT01085734|62653457|FG001|Overall Study|Lost to Follow-up|1|||
33278229|NCT01085734|62653456|FG000|Overall Study|Withdrawal by Subject|0|||
33662066|NCT02546986|63092797|FG000|Survival Follow-Up Phase|Death|18|||
33278230|NCT01085734|62653457|FG001|Overall Study|Withdrawal by Subject|1|||
33278231|NCT01084603|62653464|FG000|Baseline|Withdrawal by Subject|2|||
33278232|NCT01084603|62653464|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
33278233|NCT01084603|62653464|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
33278234|NCT01084603|62653464|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
33278235|NCT01084603|62653464|FG000|Washout Period 4|Adverse Event|1|||
33278236|NCT01084174|62653479|FG000|Overall Study|gastrointestinal symptoms|1|||
33278237|NCT01084174|62653480|FG001|Overall Study|gastrointestinal symptoms|1|||
33278238|NCT01084174|62653479|FG000|Overall Study|Eosinophilic esophagitis|0|||
33278239|NCT01084174|62653480|FG001|Overall Study|Eosinophilic esophagitis|1|||
33278240|NCT01084174|62653479|FG000|Overall Study|Anaphylaxis|0|||
33278241|NCT01084174|62653480|FG001|Overall Study|Anaphylaxis|1|||
33278242|NCT01084174|62653479|FG000|Overall Study|Participant noncompliance|0|||
33278243|NCT01084174|62653480|FG001|Overall Study|Participant noncompliance|1|||
33278244|NCT01084135|62653490|FG000|20 Week|Physician Decision|0|||
33278245|NCT01084135|62653491|FG001|20 Week|Physician Decision|1|||
33278246|NCT01083316|62653499|FG000|Overall Study|Adverse Event|2|||
33278247|NCT01083316|62653499|FG000|Overall Study|Withdrawal by Subject|1|||
33278248|NCT01083160|62653504|FG000|Overall Study|Adverse Event|1|||
33278249|NCT01083121|62653508|FG000|Overall Study|Use of Humira outside the approved label|81|||
33278250|NCT01082614|62653518|FG000|Overall Study|Adverse Event|1|||
33278251|NCT01082614|62653519|FG001|Overall Study|Adverse Event|4|||
33278252|NCT01082614|62653518|FG000|Overall Study|Equipment Malfunction|0|||
33278253|NCT01082614|62653519|FG001|Overall Study|Equipment Malfunction|1|||
33278254|NCT01082614|62653518|FG000|Overall Study|Physician Decision|2|||
33278255|NCT01082614|62653519|FG001|Overall Study|Physician Decision|0|||
33278256|NCT01081873|62653525|FG000|Overall Study|Death|86|||
33278257|NCT01081873|62653525|FG000|Overall Study|Withdrawal by Subject|10|||
33278258|NCT01081873|62653525|FG000|Overall Study|Lost to Follow-up|142|||
33278259|NCT01081873|62653525|FG000|Overall Study|Progression of prostate cancer|13|||
33278260|NCT01081873|62653525|FG000|Overall Study|Other|47|||
33278261|NCT01081795|62653557|FG000|Overall Study|Adverse Event|18|||
33278262|NCT01081795|62653558|FG001|Overall Study|Adverse Event|23|||
33278263|NCT01081795|62653559|FG002|Overall Study|Adverse Event|6|||
33278264|NCT01081795|62653557|FG000|Overall Study|Lack of Efficacy|7|||
33278265|NCT01081795|62653558|FG001|Overall Study|Lack of Efficacy|5|||
33278266|NCT01081795|62653559|FG002|Overall Study|Lack of Efficacy|19|||
33278267|NCT01081795|62653557|FG000|Overall Study|Subject's schedule|1|||
33278268|NCT01081795|62653558|FG001|Overall Study|Subject's schedule|1|||
33278269|NCT01081795|62653559|FG002|Overall Study|Subject's schedule|2|||
33278270|NCT01081795|62653557|FG000|Overall Study|Revocation of informed consent|2|||
33278271|NCT01081795|62653558|FG001|Overall Study|Revocation of informed consent|0|||
33278272|NCT01081795|62653559|FG002|Overall Study|Revocation of informed consent|0|||
33278273|NCT01081795|62653557|FG000|Overall Study|Ineligible for participation|1|||
33278274|NCT01081795|62653558|FG001|Overall Study|Ineligible for participation|0|||
33485707|NCT02076178|62863440|FG000|Injection Phase|Protocol defined stopping criteria|1|||
33485708|NCT02076178|62863441|FG001|Injection Phase|Protocol defined stopping criteria|0|||
33485709|NCT02076178|62863440|FG000|Injection Phase|Withdrawal by Subject|0|||
33485710|NCT02076178|62863441|FG001|Injection Phase|Withdrawal by Subject|3|||
33485711|NCT02076178|62863440|FG000|Injection Phase|Physician Decision|0|||
33485712|NCT02076178|62863441|FG001|Injection Phase|Physician Decision|3|||
33485713|NCT02076178|62863440|FG000|Injection Phase|Lost to Follow-up|0|||
33485714|NCT02076178|62863441|FG001|Injection Phase|Lost to Follow-up|1|||
33485715|NCT04160091|62863453|FG000|Overall Study|Terminated by Sponsor|7|||
33485716|NCT04160091|62863454|FG001|Overall Study|Terminated by Sponsor|3|||
33485717|NCT04160091|62863455|FG002|Overall Study|Terminated by Sponsor|5|||
33485718|NCT04160091|62863456|FG003|Overall Study|Terminated by Sponsor|2|||
33485719|NCT04160091|62863453|FG000|Overall Study|Noncompliance|0|||
33485720|NCT04160091|62863454|FG001|Overall Study|Noncompliance|0|||
33485721|NCT04160091|62863455|FG002|Overall Study|Noncompliance|0|||
33485722|NCT04160091|62863456|FG003|Overall Study|Noncompliance|1|||
33485723|NCT04160091|62863453|FG000|Overall Study|Withdrawal by Subject|0|||
33485724|NCT04160091|62863454|FG001|Overall Study|Withdrawal by Subject|0|||
33485725|NCT04160091|62863455|FG002|Overall Study|Withdrawal by Subject|0|||
33485726|NCT04160091|62863456|FG003|Overall Study|Withdrawal by Subject|1|||
33485727|NCT00149825|62863468|FG000|Overall Study|Intolerance to medication side effects|1|||
33485728|NCT00149825|62863469|FG001|Overall Study|Intolerance to medication side effects|2|||
33485729|NCT00149825|62863468|FG000|Overall Study|Time commitments|2|||
33278275|NCT01081795|62653559|FG002|Overall Study|Ineligible for participation|0|||
33485730|NCT00149825|62863469|FG001|Overall Study|Time commitments|1|||
33485731|NCT00149825|62863468|FG000|Overall Study|Not liking insomnia therapy|1|||
33278276|NCT01081795|62653557|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
33278277|NCT01081795|62653558|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
33278278|NCT01081795|62653559|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
33485732|NCT00149825|62863469|FG001|Overall Study|Not liking insomnia therapy|0|||
33485733|NCT00149825|62863468|FG000|Overall Study|Other|1|||
33485734|NCT00149825|62863469|FG001|Overall Study|Other|0|||
33278279|NCT01081795|62653557|FG000|Overall Study|Using drug with restricted days of use|2|||
33278280|NCT01081795|62653558|FG001|Overall Study|Using drug with restricted days of use|3|||
33278281|NCT01081795|62653559|FG002|Overall Study|Using drug with restricted days of use|2|||
33278282|NCT01081795|62653557|FG000|Overall Study|Other|1|||
33278283|NCT01081795|62653558|FG001|Overall Study|Other|2|||
33278284|NCT01081795|62653559|FG002|Overall Study|Other|0|||
33278285|NCT01081678|62653571|FG000|Overall Study|Ineligibility Determined|0|||
33278286|NCT01081678|62653572|FG001|Overall Study|Ineligibility Determined|0|||
33278287|NCT01081678|62653573|FG002|Overall Study|Ineligibility Determined|1|||
33278288|NCT01081678|62653574|FG003|Overall Study|Ineligibility Determined|1|||
33278289|NCT01081678|62653571|FG000|Overall Study|Noncompliance|3|||
33278290|NCT01081678|62653572|FG001|Overall Study|Noncompliance|4|||
33278291|NCT01081678|62653573|FG002|Overall Study|Noncompliance|5|||
33278292|NCT01081678|62653574|FG003|Overall Study|Noncompliance|2|||
33278293|NCT01081678|62653571|FG000|Overall Study|Adverse Event|2|||
33278294|NCT01081678|62653572|FG001|Overall Study|Adverse Event|1|||
33278295|NCT01081678|62653573|FG002|Overall Study|Adverse Event|2|||
33278296|NCT01081678|62653574|FG003|Overall Study|Adverse Event|2|||
33278297|NCT01081678|62653571|FG000|Overall Study|Withdrawal by Subject|15|||
33278298|NCT01081678|62653572|FG001|Overall Study|Withdrawal by Subject|7|||
33278299|NCT01081678|62653573|FG002|Overall Study|Withdrawal by Subject|17|||
33278300|NCT01081678|62653574|FG003|Overall Study|Withdrawal by Subject|14|||
33278301|NCT01081678|62653571|FG000|Overall Study|Administrative Decision|1|||
33278302|NCT01081678|62653572|FG001|Overall Study|Administrative Decision|0|||
33278303|NCT01081678|62653573|FG002|Overall Study|Administrative Decision|0|||
33278304|NCT01081678|62653574|FG003|Overall Study|Administrative Decision|1|||
33278305|NCT01081678|62653571|FG000|Overall Study|Lost to Follow-up|4|||
33278306|NCT01081678|62653572|FG001|Overall Study|Lost to Follow-up|1|||
33278307|NCT01081678|62653573|FG002|Overall Study|Lost to Follow-up|4|||
33278308|NCT01081678|62653574|FG003|Overall Study|Lost to Follow-up|3|||
33278309|NCT01081678|62653571|FG000|Overall Study|Death|2|||
33278310|NCT01081678|62653572|FG001|Overall Study|Death|2|||
33278311|NCT01081678|62653573|FG002|Overall Study|Death|2|||
33278312|NCT01081678|62653574|FG003|Overall Study|Death|6|||
33278313|NCT01081678|62653571|FG000|Overall Study|Other|0|||
33278314|NCT01081678|62653572|FG001|Overall Study|Other|1|||
33278315|NCT01081678|62653573|FG002|Overall Study|Other|0|||
33278316|NCT01081678|62653574|FG003|Overall Study|Other|0|||
33278317|NCT01081249|62653584|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
33278318|NCT01081249|62653585|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
33278319|NCT01081132|62653593|FG000|Overall Study|Lack of Efficacy|25|||
33278320|NCT01081132|62653594|FG001|Overall Study|Lack of Efficacy|9|||
33278321|NCT01081132|62653593|FG000|Overall Study|Withdrawal by Subject|13|||
33278322|NCT01081132|62653594|FG001|Overall Study|Withdrawal by Subject|16|||
33278323|NCT01081132|62653593|FG000|Overall Study|Lost to Follow-up|4|||
33278324|NCT01081132|62653594|FG001|Overall Study|Lost to Follow-up|11|||
33278325|NCT01081132|62653593|FG000|Overall Study|Adverse Event|3|||
33278326|NCT01081132|62653594|FG001|Overall Study|Adverse Event|9|||
33278327|NCT01081132|62653593|FG000|Overall Study|Non Compliance|4|||
33278328|NCT01081132|62653594|FG001|Overall Study|Non Compliance|2|||
33278329|NCT01081132|62653593|FG000|Overall Study|Lack Of Compliance|0|||
33278330|NCT01081132|62653594|FG001|Overall Study|Lack Of Compliance|1|||
33278331|NCT01081132|62653593|FG000|Overall Study|Missed Visits|1|||
33278332|NCT01081132|62653594|FG001|Overall Study|Missed Visits|1|||
33278333|NCT01081132|62653593|FG000|Overall Study|Stopped Taking Meds|2|||
33278334|NCT01081132|62653594|FG001|Overall Study|Stopped Taking Meds|0|||
33278335|NCT01081132|62653593|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
33278336|NCT01081132|62653594|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
33278337|NCT01081132|62653593|FG000|Overall Study|Declined Taper Phase|0|||
33278338|NCT01081132|62653594|FG001|Overall Study|Declined Taper Phase|1|||
33278339|NCT01081132|62653593|FG000|Overall Study|Protocol Violation|3|||
33278340|NCT01081132|62653594|FG001|Overall Study|Protocol Violation|1|||
33278341|NCT01080625|62653603|FG000|Overall Study|Physician Decision|0|||
33278342|NCT01080625|62653604|FG001|Overall Study|Physician Decision|2|||
33278343|NCT01080625|62653605|FG002|Overall Study|Physician Decision|1|||
33278344|NCT01059903|62653615|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
33278345|NCT01059903|62653616|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
33278346|NCT00199888|62653672|FG000|Overall Study|Lost to Follow-up|1|||
33278347|NCT00199849|62653679|FG000|Overall Study|Unrelated illness or complication|0|||
33278348|NCT00199849|62653680|FG001|Overall Study|Unrelated illness or complication|1|||
33278349|NCT00199849|62653681|FG002|Overall Study|Unrelated illness or complication|0|||
33278350|NCT00199849|62653679|FG000|Overall Study|Progressive disease requiring intervention|0|||
33278351|NCT00199849|62653680|FG001|Overall Study|Progressive disease requiring intervention|0|||
33278352|NCT00199849|62653681|FG002|Overall Study|Progressive disease requiring intervention|1|||
33278353|NCT00199849|62653679|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
33278354|NCT00199849|62653680|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
33278355|NCT00199849|62653681|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
33278356|NCT00199381|62653689|FG000|Overall Study|Withdrawal by Subject|38|||
33278357|NCT00199381|62653689|FG000|Overall Study|Adverse Event|73|||
33278358|NCT00199381|62653689|FG000|Overall Study|Protocol Violation|6|||
33278359|NCT00199381|62653689|FG000|Overall Study|Lack of Efficacy|27|||
33278360|NCT00199381|62653689|FG000|Overall Study|Not including due to early termination|37|||
33278361|NCT00199381|62653689|FG000|Overall Study|Study termination by Sponsor|323|||
33278362|NCT00198133|62653695|FG000|Overall Study|Disease progression|2|||
33278363|NCT00198133|62653696|FG001|Overall Study|Disease progression|5|||
33278364|NCT00198133|62653695|FG000|Overall Study|Adverse Event|1|||
33278365|NCT00198133|62653696|FG001|Overall Study|Adverse Event|3|||
33278366|NCT00198133|62653695|FG000|Overall Study|Withdrawal by Subject|1|||
33278367|NCT00198133|62653696|FG001|Overall Study|Withdrawal by Subject|0|||
33278368|NCT00198133|62653695|FG000|Overall Study|Physician Decision|1|||
33278369|NCT00198133|62653696|FG001|Overall Study|Physician Decision|0|||
33278370|NCT00197236|62653705|FG000|Overall Study|Adverse Event|1|||
33278371|NCT00197236|62653706|FG001|Overall Study|Adverse Event|0|||
33278372|NCT00197236|62653707|FG002|Overall Study|Adverse Event|1|||
33278373|NCT00197236|62653705|FG000|Overall Study|Lost to Follow-up|5|||
33278374|NCT00197236|62653706|FG001|Overall Study|Lost to Follow-up|14|||
33278375|NCT00197236|62653707|FG002|Overall Study|Lost to Follow-up|6|||
33278376|NCT00197236|62653705|FG000|Overall Study|Protocol Violation|0|||
33278377|NCT00197236|62653706|FG001|Overall Study|Protocol Violation|0|||
33278378|NCT00197236|62653707|FG002|Overall Study|Protocol Violation|1|||
33278379|NCT00197236|62653705|FG000|Overall Study|Withdrawal by Subject|7|||
33278380|NCT00197236|62653706|FG001|Overall Study|Withdrawal by Subject|3|||
33278381|NCT00197236|62653707|FG002|Overall Study|Withdrawal by Subject|11|||
33278382|NCT00197236|62653705|FG000|Overall Study|Study drug/medication expiration|1|||
33278383|NCT00197236|62653706|FG001|Overall Study|Study drug/medication expiration|0|||
33278384|NCT00197236|62653707|FG002|Overall Study|Study drug/medication expiration|3|||
33278385|NCT00197236|62653705|FG000|Overall Study|Returned out of specified time window|0|||
33278386|NCT00197236|62653706|FG001|Overall Study|Returned out of specified time window|0|||
33278387|NCT00197236|62653707|FG002|Overall Study|Returned out of specified time window|1|||
33278388|NCT00197002|62653721|FG000|Overall Study|Adverse Event|0|||
33278389|NCT00197002|62653722|FG001|Overall Study|Adverse Event|1|||
33278390|NCT00197002|62653723|FG002|Overall Study|Adverse Event|0|||
33278391|NCT00197002|62653721|FG000|Overall Study|Protocol Violation|1|||
33278392|NCT00197002|62653722|FG001|Overall Study|Protocol Violation|0|||
33278393|NCT00197002|62653723|FG002|Overall Study|Protocol Violation|2|||
33278394|NCT00197002|62653721|FG000|Overall Study|Withdrawal by Subject|9|||
33278395|NCT00197002|62653722|FG001|Overall Study|Withdrawal by Subject|5|||
33278396|NCT00197002|62653723|FG002|Overall Study|Withdrawal by Subject|7|||
33278397|NCT00197002|62653721|FG000|Overall Study|Migrated/moved from study area|3|||
33278398|NCT00197002|62653722|FG001|Overall Study|Migrated/moved from study area|5|||
33278399|NCT00197002|62653723|FG002|Overall Study|Migrated/moved from study area|1|||
33278400|NCT00197002|62653721|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
33278401|NCT00197002|62653722|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
33278402|NCT00197002|62653723|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
33278403|NCT00197002|62653721|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
33278404|NCT00197002|62653722|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
33278405|NCT00197002|62653723|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
33278406|NCT00197002|62653721|FG000|Overall Study|Others|3|||
33278407|NCT00197002|62653722|FG001|Overall Study|Others|1|||
33278408|NCT00197002|62653723|FG002|Overall Study|Others|1|||
33278409|NCT00196105|62653737|FG000|Overall Study|Lost to Follow-up|4|||
33278410|NCT00196105|62653738|FG001|Overall Study|Lost to Follow-up|5|||
33278411|NCT00196105|62653739|FG002|Overall Study|Lost to Follow-up|7|||
33278412|NCT00195715|62653747|FG000|Overall Study|Adverse Event|122|||
33278413|NCT00195715|62653747|FG000|Overall Study|Withdrawal by Subject|58|||
33278414|NCT00195715|62653747|FG000|Overall Study|Lost to Follow-up|27|||
33278415|NCT00195715|62653747|FG000|Overall Study|Protocol Violation|13|||
33278416|NCT00195715|62653747|FG000|Overall Study|Lack of Efficacy|93|||
33278417|NCT00195715|62653747|FG000|Overall Study|Pregnancy|14|||
33278418|NCT00195715|62653747|FG000|Overall Study|Investigative site closure|8|||
33278419|NCT00195715|62653747|FG000|Overall Study|Subject moved/relocated|7|||
33278420|NCT00195715|62653747|FG000|Overall Study|Subject non-compliance|6|||
33278421|NCT00195715|62653747|FG000|Overall Study|Subject started commercial Humira|5|||
33278422|NCT00195715|62653747|FG000|Overall Study|Subject choice|3|||
33278423|NCT00195715|62653747|FG000|Overall Study|Loss of response/no improvement|3|||
33278424|NCT00195715|62653747|FG000|Overall Study|Sponsor stopped study|1|||
33278425|NCT00195715|62653747|FG000|Overall Study|Administrative reasons|2|||
33278426|NCT00195715|62653747|FG000|Overall Study|Investigator's decision|2|||
33278427|NCT00195715|62653747|FG000|Overall Study|Subject wants to get pregnant|4|||
33278428|NCT00195715|62653747|FG000|Overall Study|Use of prohibited medication|2|||
33278429|NCT00195715|62653747|FG000|Overall Study|Planned surgery|2|||
33278430|NCT00195715|62653747|FG000|Overall Study|Increased infection rate|1|||
33278431|NCT00195715|62653747|FG000|Overall Study|Ineligible|1|||
33278432|NCT00195715|62653747|FG000|Overall Study|Colonic stricture|1|||
33370578|NCT00848718|62749287|FG002|Overall Study|Protocol Violation|0|||
33370579|NCT00848718|62749288|FG003|Overall Study|Protocol Violation|0|||
33370580|NCT00848718|62749289|FG004|Overall Study|Protocol Violation|0|||
33370581|NCT00848718|62749290|FG005|Overall Study|Protocol Violation|0|||
33370582|NCT00848718|62749291|FG006|Overall Study|Protocol Violation|0|||
33370583|NCT00848718|62749292|FG007|Overall Study|Protocol Violation|1|||
33278433|NCT00195715|62653747|FG000|Overall Study|Sponsor discontinued trial|1|||
33278434|NCT00195715|62653747|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
33278435|NCT00195676|62653751|FG000|Period O - Open-label Treatment|Adverse Event|82|||
33278436|NCT00195676|62653751|FG000|Period O - Open-label Treatment|Death|6|||
33278437|NCT00195676|62653751|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
33278438|NCT00195676|62653751|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
33278439|NCT00195676|62653751|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
33278440|NCT00195676|62653751|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
33278441|NCT00195676|62653751|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
33278442|NCT00195676|62653751|FG000|Period O - Open-label Treatment|Other reasons|68|||
33278443|NCT00195676|62653751|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
33278444|NCT00195676|62653751|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
33278445|NCT00195676|62653751|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
33278446|NCT00195676|62653751|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
33278447|NCT00195676|62653751|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
33278448|NCT00195676|62653751|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
33278449|NCT00195676|62653751|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
33278450|NCT00195676|62653751|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
33278451|NCT00195676|62653751|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
33278452|NCT00195676|62653751|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
33278453|NCT00195676|62653751|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
33278454|NCT00195676|62653751|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
33278455|NCT00195676|62653751|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
33278456|NCT00194077|62653761|FG000|Overall Study|Lack of Efficacy|22|||
33278457|NCT00194077|62653762|FG001|Overall Study|Lack of Efficacy|29|||
33278458|NCT00194077|62653761|FG000|Overall Study|Study nonadherence|1|||
33278459|NCT00194077|62653762|FG001|Overall Study|Study nonadherence|0|||
33278460|NCT00194077|62653761|FG000|Overall Study|Withdrawal by Subject|1|||
33278461|NCT00194077|62653762|FG001|Overall Study|Withdrawal by Subject|1|||
33278462|NCT00193609|62653768|FG000|Overall Study|Lack of Efficacy|2|||
33278463|NCT00193609|62653768|FG000|Overall Study|Adverse Event|2|||
33278464|NCT00193180|62653772|FG000|Overall Study|Lack of Efficacy|1|||
33278465|NCT00193180|62653772|FG000|Overall Study|Adverse Event|8|||
33278466|NCT00193180|62653772|FG000|Overall Study|Protocol Violation|1|||
33278467|NCT00193063|62653777|FG000|Overall Study|Lack of Efficacy|3|||
33278468|NCT00193063|62653777|FG000|Overall Study|Adverse Event|1|||
33278469|NCT00191854|62653784|FG000|Overall Study|Death|26|||
33278470|NCT00191854|62653785|FG001|Overall Study|Death|23|||
33278471|NCT00191854|62653786|FG002|Overall Study|Death|29|||
33278472|NCT00191854|62653784|FG000|Overall Study|Lost to Follow-up|7|||
33278473|NCT00191854|62653785|FG001|Overall Study|Lost to Follow-up|5|||
33278474|NCT00191854|62653786|FG002|Overall Study|Lost to Follow-up|5|||
33278475|NCT00191854|62653784|FG000|Overall Study|Withdrawal by Subject|4|||
33278476|NCT00191854|62653785|FG001|Overall Study|Withdrawal by Subject|2|||
33278477|NCT00191854|62653786|FG002|Overall Study|Withdrawal by Subject|3|||
33278478|NCT00191854|62653784|FG000|Overall Study|Sponsor Decision|0|||
33278479|NCT00191854|62653785|FG001|Overall Study|Sponsor Decision|0|||
33278480|NCT00191854|62653786|FG002|Overall Study|Sponsor Decision|1|||
33278481|NCT00191854|62653784|FG000|Overall Study|Screen Failure|0|||
33278482|NCT00191854|62653785|FG001|Overall Study|Screen Failure|0|||
33278483|NCT00191854|62653786|FG002|Overall Study|Screen Failure|1|||
33278484|NCT00191815|62653794|FG000|Overall Study|Adverse Event|2|||
33278485|NCT00191815|62653794|FG000|Overall Study|Disease progression or relapse|24|||
33278486|NCT00191815|62653794|FG000|Overall Study|Death|2|||
33278487|NCT00191815|62653794|FG000|Overall Study|Protocol Violation|3|||
33278488|NCT00191815|62653794|FG000|Overall Study|Physician Decision|2|||
33278489|NCT00191815|62653794|FG000|Overall Study|Withdrawal by Subject|7|||
33278490|NCT00191386|62653798|FG000|Overall Study|Adverse Event|16|||
33278491|NCT00191386|62653798|FG000|Overall Study|Lost to Follow-up|1|||
33278492|NCT00191386|62653798|FG000|Overall Study|Entry Criteria Exclusion|3|||
33278493|NCT00191386|62653798|FG000|Overall Study|Protocol Violation|18|||
33278494|NCT00191386|62653798|FG000|Overall Study|Withdrawal by Subject|96|||
33278495|NCT00191386|62653798|FG000|Overall Study|Physician Decision|11|||
33278496|NCT00191386|62653798|FG000|Overall Study|Lack of Efficacy|15|||
33278497|NCT00191308|62653802|FG000|Overall Study|Adverse Event|1|||
33278498|NCT00191269|62653808|FG000|Overall Study|Protocol Violation|0|||
33278499|NCT00191269|62653809|FG001|Overall Study|Protocol Violation|2|||
33278500|NCT00191269|62653808|FG000|Overall Study|Adverse Event|1|||
33278501|NCT00191269|62653809|FG001|Overall Study|Adverse Event|4|||
33278502|NCT00191269|62653808|FG000|Overall Study|Progression of Disease|4|||
33278503|NCT00191269|62653809|FG001|Overall Study|Progression of Disease|42|||
33278504|NCT00191269|62653808|FG000|Overall Study|Lack of Efficacy|1|||
33278505|NCT00191269|62653809|FG001|Overall Study|Lack of Efficacy|5|||
33278506|NCT00191269|62653808|FG000|Overall Study|Withdrawal by Subject|0|||
33278507|NCT00191269|62653809|FG001|Overall Study|Withdrawal by Subject|1|||
33278508|NCT00191269|62653808|FG000|Overall Study|Pathologic Aggrevation|0|||
33278509|NCT00191269|62653809|FG001|Overall Study|Pathologic Aggrevation|1|||
33278510|NCT00191269|62653808|FG000|Overall Study|Physician Decision|0|||
33278511|NCT00191269|62653809|FG001|Overall Study|Physician Decision|3|||
33278512|NCT00191191|62653818|FG000|Overall Study|Entry Criteria Exclusion|2|||
33278513|NCT00191191|62653819|FG001|Overall Study|Entry Criteria Exclusion|0|||
33278514|NCT00191191|62653818|FG000|Overall Study|Treated with Another Systemic Agent|1|||
33278515|NCT00191191|62653819|FG001|Overall Study|Treated with Another Systemic Agent|1|||
33278516|NCT00191191|62653818|FG000|Overall Study|Adverse Event|11|||
33278517|NCT00191191|62653819|FG001|Overall Study|Adverse Event|21|||
33278518|NCT00191191|62653818|FG000|Overall Study|Progressive Disease|84|||
33278519|NCT00191191|62653819|FG001|Overall Study|Progressive Disease|72|||
33278520|NCT00191191|62653818|FG000|Overall Study|Toxicity After Dose Reduction|7|||
33278521|NCT00191191|62653819|FG001|Overall Study|Toxicity After Dose Reduction|8|||
33278522|NCT00191191|62653818|FG000|Overall Study|Family/Caregiver Decision|5|||
33278523|NCT00191191|62653819|FG001|Overall Study|Family/Caregiver Decision|7|||
33278524|NCT00191191|62653818|FG000|Overall Study|Lost to Follow-up|1|||
33278525|NCT00191191|62653819|FG001|Overall Study|Lost to Follow-up|0|||
33278526|NCT00191191|62653818|FG000|Overall Study|Physician Decision|3|||
33278527|NCT00191191|62653819|FG001|Overall Study|Physician Decision|2|||
33278528|NCT00191191|62653818|FG000|Overall Study|Good Clinical Practice Violation|0|||
33278529|NCT00191191|62653819|FG001|Overall Study|Good Clinical Practice Violation|1|||
33278530|NCT00191152|62653827|FG000|Initial Treatment|Adverse Event|43|||
33278531|NCT00191152|62653828|FG001|Initial Treatment|Adverse Event|67|||
33278532|NCT00191152|62653827|FG000|Initial Treatment|Physician Decision|40|||
33278533|NCT00191152|62653828|FG001|Initial Treatment|Physician Decision|31|||
33278534|NCT00191152|62653827|FG000|Initial Treatment|Withdrawal by Subject|40|||
33278535|NCT00191152|62653828|FG001|Initial Treatment|Withdrawal by Subject|28|||
33278536|NCT00191152|62653827|FG000|Initial Treatment|Lost to Follow-up|0|||
33278537|NCT00191152|62653828|FG001|Initial Treatment|Lost to Follow-up|6|||
33278538|NCT00191152|62653827|FG000|Initial Treatment|Other|18|||
33278539|NCT00191152|62653828|FG001|Initial Treatment|Other|21|||
33278540|NCT00191152|62653827|FG000|Crossover Treatment|Adverse Event|8|||
33278541|NCT00191152|62653828|FG001|Crossover Treatment|Adverse Event|8|||
33278542|NCT00191152|62653827|FG000|Crossover Treatment|Physician Decision|7|||
33278543|NCT00191152|62653828|FG001|Crossover Treatment|Physician Decision|7|||
33278544|NCT00191152|62653827|FG000|Crossover Treatment|Withdrawal by Subject|6|||
33278545|NCT00191152|62653828|FG001|Crossover Treatment|Withdrawal by Subject|9|||
33278546|NCT00191152|62653827|FG000|Crossover Treatment|Lost to Follow-up|2|||
33278547|NCT00191152|62653828|FG001|Crossover Treatment|Lost to Follow-up|1|||
33278548|NCT00191152|62653827|FG000|Crossover Treatment|Other|4|||
33278549|NCT00191152|62653828|FG001|Crossover Treatment|Other|3|||
33278550|NCT00190684|62653846|FG000|Overall Study|Adverse Event|86|||
33278551|NCT00190684|62653846|FG000|Overall Study|Satisfactory response|80|||
33278552|NCT00190684|62653846|FG000|Overall Study|Lack of efficacy|204|||
33278553|NCT00190684|62653846|FG000|Overall Study|Lost to Follow-up|232|||
33278554|NCT00190684|62653846|FG000|Overall Study|Patient moved|60|||
33278555|NCT00190684|62653846|FG000|Overall Study|Patient Decision|432|||
33278556|NCT00190684|62653846|FG000|Overall Study|Clinical relapse|67|||
33278557|NCT00190684|62653846|FG000|Overall Study|Sponsor's decision|17|||
33278558|NCT00190684|62653846|FG000|Overall Study|Physician Decision|84|||
33278559|NCT00190684|62653846|FG000|Overall Study|Protocol Violation|123|||
33278560|NCT00190684|62653846|FG000|Overall Study|Study Period III Completed|103|||
33278561|NCT00190684|62653846|FG000|Overall Study|Study Period V Completed|1|||
33278562|NCT00179959|62653857|FG000|Overall Study|Lost to Follow-up|3|||
33278563|NCT00179959|62653858|FG001|Overall Study|Lost to Follow-up|1|||
33278564|NCT00179959|62653857|FG000|Overall Study|Withdrawal by Subject|3|||
33278565|NCT00179959|62653858|FG001|Overall Study|Withdrawal by Subject|2|||
33278566|NCT00179647|62653864|FG000|Overall Study|Adverse Event|294|||
33278567|NCT00179647|62653864|FG000|Overall Study|Lack of Efficacy|478|||
33278568|NCT00179647|62653864|FG000|Overall Study|Withdrawal by Subject|83|||
33278569|NCT00179647|62653864|FG000|Overall Study|Lost to Follow-up|4|||
33278570|NCT00179647|62653864|FG000|Overall Study|Death|94|||
33278571|NCT00179647|62653864|FG000|Overall Study|Other|960|||
33278572|NCT00179413|62653870|FG000|Overall Study|Adverse Event|38|||
33278573|NCT00179413|62653871|FG001|Overall Study|Adverse Event|20|||
33278574|NCT00179413|62653870|FG000|Overall Study|Withdrawal by Subject|87|||
33278575|NCT00179413|62653871|FG001|Overall Study|Withdrawal by Subject|95|||
33278576|NCT00178633|62653877|FG000|Overall Study|Lost to Follow-up|6|||
33278577|NCT00178399|62653882|FG000|Overall Study|Physician Decision|4|||
33278578|NCT00178399|62653882|FG000|Overall Study|Withdrawal by Subject|8|||
33278579|NCT00178399|62653882|FG000|Overall Study|Lost to Follow-up|1|||
33278580|NCT00178126|62653889|FG000|Overall Study|Lost to Follow-up|21|||
33278581|NCT00178126|62653890|FG001|Overall Study|Lost to Follow-up|21|||
33278582|NCT00178126|62653889|FG000|Overall Study|did not receive intervention|4|||
33278583|NCT00178126|62653890|FG001|Overall Study|did not receive intervention|6|||
33278584|NCT00177307|62653896|FG000|Overall Study|Withdrawal by Subject|1|||
33278585|NCT00176605|62653904|FG000|Overall Study|Withdrawal by Subject|2|||
33278586|NCT00176488|62653908|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
33278587|NCT00175825|62653916|FG000|Overall Study|Adverse Event|3|||
33278588|NCT00175825|62653917|FG001|Overall Study|Adverse Event|2|||
33278589|NCT00175825|62653918|FG002|Overall Study|Adverse Event|1|||
33278590|NCT00175825|62653919|FG003|Overall Study|Adverse Event|1|||
33278591|NCT00175825|62653916|FG000|Overall Study|Lost to Follow-up|1|||
33278592|NCT00175825|62653917|FG001|Overall Study|Lost to Follow-up|2|||
33278593|NCT00175825|62653918|FG002|Overall Study|Lost to Follow-up|0|||
33278594|NCT00175825|62653919|FG003|Overall Study|Lost to Follow-up|0|||
33278595|NCT00175825|62653916|FG000|Overall Study|Withdrawal by Subject|1|||
33278596|NCT00175825|62653917|FG001|Overall Study|Withdrawal by Subject|0|||
33278597|NCT00175825|62653918|FG002|Overall Study|Withdrawal by Subject|0|||
33278598|NCT00175825|62653919|FG003|Overall Study|Withdrawal by Subject|0|||
33278599|NCT00174967|62653933|FG000|Overall Study|Adverse Event|1|||
33278600|NCT00174967|62653934|FG001|Overall Study|Adverse Event|2|||
33278601|NCT00174967|62653935|FG002|Overall Study|Adverse Event|2|||
33278602|NCT00174967|62653936|FG003|Overall Study|Adverse Event|1|||
33278603|NCT00174967|62653933|FG000|Overall Study|Gout Flare|0|||
33278604|NCT00174967|62653934|FG001|Overall Study|Gout Flare|0|||
33278605|NCT00174967|62653935|FG002|Overall Study|Gout Flare|0|||
33278606|NCT00174967|62653936|FG003|Overall Study|Gout Flare|1|||
33278607|NCT00174967|62653933|FG000|Overall Study|Other|0|||
33278608|NCT00174967|62653934|FG001|Overall Study|Other|1|||
33278609|NCT00174967|62653935|FG002|Overall Study|Other|0|||
33278610|NCT00174967|62653936|FG003|Overall Study|Other|0|||
33278611|NCT00174265|62653948|FG000|Overall Study|Adverse Event|7|||
33278612|NCT00174265|62653949|FG001|Overall Study|Adverse Event|4|||
33278613|NCT00174265|62653948|FG000|Overall Study|Lack of Efficacy|2|||
33278614|NCT00174265|62653949|FG001|Overall Study|Lack of Efficacy|2|||
33278615|NCT00174265|62653948|FG000|Overall Study|Withdrawal by Subject|3|||
33278616|NCT00174265|62653949|FG001|Overall Study|Withdrawal by Subject|5|||
33278617|NCT00174265|62653948|FG000|Overall Study|Lost to Follow-up|1|||
33278618|NCT00174265|62653949|FG001|Overall Study|Lost to Follow-up|0|||
33278619|NCT00174265|62653948|FG000|Overall Study|Other (Not specified)|16|||
33278620|NCT00174265|62653949|FG001|Overall Study|Other (Not specified)|10|||
33278621|NCT00172042|62653957|FG000|Overall Study|Adverse Event|27|||
33278622|NCT00172042|62653958|FG001|Overall Study|Adverse Event|13|||
33278623|NCT00172042|62653957|FG000|Overall Study|Abnormal laboratory value(s)|5|||
33278624|NCT00172042|62653958|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33278625|NCT00172042|62653957|FG000|Overall Study|Abnormal test procedure(s)|0|||
33278626|NCT00172042|62653958|FG001|Overall Study|Abnormal test procedure(s)|3|||
33278627|NCT00172042|62653957|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
33278628|NCT00172042|62653958|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
33278629|NCT00172042|62653957|FG000|Overall Study|Patient no longer requires study drug|10|||
33278630|NCT00172042|62653958|FG001|Overall Study|Patient no longer requires study drug|8|||
33278631|NCT00172042|62653957|FG000|Overall Study|Protocol Violation|8|||
33278632|NCT00172042|62653958|FG001|Overall Study|Protocol Violation|7|||
33278633|NCT00172042|62653957|FG000|Overall Study|Withdrawal by Subject|37|||
33278634|NCT00172042|62653958|FG001|Overall Study|Withdrawal by Subject|25|||
33278635|NCT00172042|62653957|FG000|Overall Study|Lost to Follow-up|3|||
33278636|NCT00172042|62653958|FG001|Overall Study|Lost to Follow-up|5|||
33278637|NCT00172042|62653957|FG000|Overall Study|Administrative problems|13|||
33278638|NCT00172042|62653958|FG001|Overall Study|Administrative problems|10|||
33278639|NCT00172042|62653957|FG000|Overall Study|Death|42|||
33278640|NCT00172042|62653958|FG001|Overall Study|Death|42|||
33278641|NCT00171925|62653966|FG000|Overall Study|Adverse Event|10|||
33278642|NCT00171925|62653967|FG001|Overall Study|Adverse Event|6|||
33278643|NCT00171925|62653966|FG000|Overall Study|Protocol Violation|1|||
33278644|NCT00171925|62653967|FG001|Overall Study|Protocol Violation|1|||
33278645|NCT00171925|62653966|FG000|Overall Study|Withdrawal by Subject|6|||
33278646|NCT00171925|62653967|FG001|Overall Study|Withdrawal by Subject|9|||
33278647|NCT00171925|62653966|FG000|Overall Study|Lost to Follow-up|2|||
33278648|NCT00171925|62653967|FG001|Overall Study|Lost to Follow-up|2|||
33278649|NCT00171925|62653966|FG000|Overall Study|Administrative problems|10|||
33278650|NCT00171925|62653967|FG001|Overall Study|Administrative problems|11|||
33278651|NCT00171925|62653966|FG000|Overall Study|Death|1|||
33278652|NCT00171925|62653967|FG001|Overall Study|Death|2|||
33278653|NCT00171340|62653975|FG000|Overall Study|Adverse Event|46|||
33278654|NCT00171340|62653976|FG001|Overall Study|Adverse Event|42|||
33278655|NCT00171340|62653975|FG000|Overall Study|Lack of Efficacy|29|||
33278656|NCT00171340|62653976|FG001|Overall Study|Lack of Efficacy|41|||
33278657|NCT00171340|62653975|FG000|Overall Study|Protocol Violation|7|||
33278658|NCT00171340|62653976|FG001|Overall Study|Protocol Violation|8|||
33278659|NCT00171340|62653975|FG000|Overall Study|Withdrawal by Subject|22|||
33278660|NCT00171340|62653976|FG001|Overall Study|Withdrawal by Subject|19|||
33278661|NCT00171340|62653975|FG000|Overall Study|Lost to Follow-up|0|||
33278662|NCT00171340|62653976|FG001|Overall Study|Lost to Follow-up|5|||
33278663|NCT00171340|62653975|FG000|Overall Study|Abnormal Laboratory Results|2|||
33278664|NCT00171340|62653976|FG001|Overall Study|Abnormal Laboratory Results|0|||
33278665|NCT00171340|62653975|FG000|Overall Study|Abnormal Test Procedure Results|6|||
33278666|NCT00171340|62653976|FG001|Overall Study|Abnormal Test Procedure Results|11|||
33278667|NCT00171340|62653975|FG000|Overall Study|No Longer Required Study Drug|1|||
33278668|NCT00171340|62653976|FG001|Overall Study|No Longer Required Study Drug|1|||
33278669|NCT00171340|62653975|FG000|Overall Study|Administrative Problems|5|||
33278670|NCT00171340|62653976|FG001|Overall Study|Administrative Problems|2|||
33278671|NCT00171340|62653975|FG000|Overall Study|Death|6|||
33278672|NCT00171340|62653976|FG001|Overall Study|Death|6|||
33278673|NCT00171301|62653986|FG000|Overall Study|Death|1|||
33278674|NCT00171301|62653987|FG001|Overall Study|Death|2|||
33278675|NCT00171301|62653986|FG000|Overall Study|Adverse Event|1|||
33278676|NCT00171301|62653987|FG001|Overall Study|Adverse Event|2|||
33278677|NCT00171301|62653986|FG000|Overall Study|Lost to Follow-up|6|||
33278678|NCT00171301|62653987|FG001|Overall Study|Lost to Follow-up|2|||
33278679|NCT00171301|62653986|FG000|Overall Study|Protocol Violation|0|||
33278680|NCT00171301|62653987|FG001|Overall Study|Protocol Violation|2|||
33278681|NCT00171301|62653986|FG000|Overall Study|Withdrawal by Subject|0|||
33278682|NCT00171301|62653987|FG001|Overall Study|Withdrawal by Subject|1|||
33278683|NCT00171223|62653997|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
33278684|NCT00171223|62653998|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
33278685|NCT00171223|62653999|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
33278686|NCT00171223|62653997|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
33278687|NCT00171223|62653998|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
33278688|NCT00171223|62653999|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
33278689|NCT00171223|62653997|FG000|Overall Study|Abnormal Procedure|1|||
33278690|NCT00171223|62653998|FG001|Overall Study|Abnormal Procedure|0|||
33278691|NCT00171223|62653999|FG002|Overall Study|Abnormal Procedure|0|||
33278692|NCT00171223|62653997|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
33278693|NCT00171223|62653998|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
33278694|NCT00171223|62653999|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
33278695|NCT00171223|62653997|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
33278696|NCT00171223|62653998|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
33278697|NCT00171223|62653999|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
33278698|NCT00171223|62653997|FG000|Overall Study|Protocol Violation|2|||
33278699|NCT00171223|62653998|FG001|Overall Study|Protocol Violation|2|||
33278700|NCT00171223|62653999|FG002|Overall Study|Protocol Violation|3|||
33278701|NCT00171223|62653997|FG000|Overall Study|Participant Withdrew Consent|12|||
33278702|NCT00171223|62653998|FG001|Overall Study|Participant Withdrew Consent|21|||
33278703|NCT00171223|62653999|FG002|Overall Study|Participant Withdrew Consent|15|||
33278704|NCT00171223|62653997|FG000|Overall Study|Lost to Follow-up|5|||
33278705|NCT00171223|62653998|FG001|Overall Study|Lost to Follow-up|2|||
33278706|NCT00171223|62653999|FG002|Overall Study|Lost to Follow-up|3|||
33278707|NCT00171223|62653997|FG000|Overall Study|Administrative Problems|4|||
33278708|NCT00171223|62653998|FG001|Overall Study|Administrative Problems|7|||
33278709|NCT00171223|62653999|FG002|Overall Study|Administrative Problems|6|||
33278710|NCT00171223|62653997|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
33278711|NCT00171223|62653998|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
33278712|NCT00171223|62653999|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
33278713|NCT00171223|62653997|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
33278714|NCT00171223|62653998|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
33278715|NCT00171223|62653999|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
33278716|NCT00479674|62654005|FG000|Overall Study|Adverse Event|18|||
33278717|NCT00479674|62654005|FG000|Overall Study|Withdrawal by Subject|6|||
33278718|NCT00479674|62654005|FG000|Overall Study|Physician Decision|14|||
33278719|NCT00479674|62654005|FG000|Overall Study|none provided|3|||
33278720|NCT00479401|62654012|FG000|Overall Study|Adverse Event|24|||
33278721|NCT00479401|62654013|FG001|Overall Study|Adverse Event|20|||
33278722|NCT00479401|62654014|FG002|Overall Study|Adverse Event|4|||
33278723|NCT00479401|62654012|FG000|Overall Study|Lack of Efficacy|2|||
33278724|NCT00479401|62654013|FG001|Overall Study|Lack of Efficacy|2|||
33278725|NCT00479401|62654014|FG002|Overall Study|Lack of Efficacy|4|||
33278726|NCT00479401|62654012|FG000|Overall Study|Protocol Violation|2|||
33278727|NCT00479401|62654013|FG001|Overall Study|Protocol Violation|1|||
33278728|NCT00479401|62654014|FG002|Overall Study|Protocol Violation|1|||
33278729|NCT00479401|62654012|FG000|Overall Study|Lost to Follow-up|1|||
33278730|NCT00479401|62654013|FG001|Overall Study|Lost to Follow-up|1|||
33278731|NCT00479401|62654014|FG002|Overall Study|Lost to Follow-up|1|||
33278732|NCT00479401|62654012|FG000|Overall Study|Withdrawal by Subject|16|||
33278733|NCT00479401|62654013|FG001|Overall Study|Withdrawal by Subject|10|||
33278734|NCT00479401|62654014|FG002|Overall Study|Withdrawal by Subject|2|||
33278735|NCT00479401|62654012|FG000|Overall Study|Exclusion criteria, relocation|4|||
33278736|NCT00479401|62654013|FG001|Overall Study|Exclusion criteria, relocation|3|||
33278737|NCT00479401|62654014|FG002|Overall Study|Exclusion criteria, relocation|0|||
33278738|NCT00478777|62654022|FG000|Overall Study|Adverse Event|29|||
33278739|NCT00478777|62654022|FG000|Overall Study|Lack of Efficacy|23|||
33278740|NCT00478777|62654022|FG000|Overall Study|Withdrawal by Subject|4|||
33278741|NCT00478777|62654022|FG000|Overall Study|Death|3|||
33278742|NCT00478777|62654022|FG000|Overall Study|Protocol Violation|3|||
33278743|NCT00478777|62654022|FG000|Overall Study|Lost to Follow-up|3|||
33278744|NCT00478777|62654022|FG000|Overall Study|Physician Decision|1|||
33278745|NCT00478777|62654022|FG000|Overall Study|Intolerance of therapy|1|||
33278746|NCT00478777|62654022|FG000|Overall Study|Lack of compliance|1|||
33278747|NCT00478777|62654022|FG000|Overall Study|Lymphocytes infusion|1|||
33278748|NCT00478777|62654022|FG000|Overall Study|End of therapy|2|||
33278749|NCT00478777|62654022|FG000|Overall Study|Not treated with lenalidomide|6|||
33278750|NCT00477607|62654028|FG000|Overall Study|Lost to Follow-up|7|||
33278751|NCT00477607|62654029|FG001|Overall Study|Lost to Follow-up|7|||
33278752|NCT00477490|62654040|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
33278753|NCT00477490|62654041|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
33278754|NCT00477490|62654042|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
33278755|NCT00477490|62654043|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
33278756|NCT00477490|62654044|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
33278757|NCT00477490|62654045|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
33278758|NCT00477490|62654046|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
33278759|NCT00477490|62654047|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
33278760|NCT00477490|62654048|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
33278761|NCT00477490|62654040|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
33278762|NCT00477490|62654041|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
33278763|NCT00477490|62654042|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
33278764|NCT00477490|62654043|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
33278765|NCT00477490|62654044|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
33278766|NCT00477490|62654045|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
33278767|NCT00477490|62654046|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
33278768|NCT00477490|62654047|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
33278769|NCT00477490|62654048|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
33278770|NCT00477490|62654040|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
33278771|NCT00477490|62654041|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
33278772|NCT00477490|62654042|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
33278773|NCT00477490|62654043|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
33278774|NCT00477490|62654044|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
33278775|NCT00477490|62654045|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
33278776|NCT00477490|62654046|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
33278777|NCT00477490|62654047|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
33278778|NCT00477490|62654048|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
33278779|NCT00477490|62654040|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
33278780|NCT00477490|62654041|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
33278781|NCT00477490|62654042|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
33278782|NCT00477490|62654043|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
33278783|NCT00477490|62654044|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
33278784|NCT00477490|62654045|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
33278785|NCT00477490|62654046|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
33278786|NCT00477490|62654047|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
33278787|NCT00477490|62654048|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
33278788|NCT00477490|62654040|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
33278789|NCT00477490|62654041|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
33278790|NCT00477490|62654042|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
33278791|NCT00477490|62654043|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
33278792|NCT00477490|62654044|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
33278793|NCT00477490|62654045|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
33278794|NCT00477490|62654046|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
33278795|NCT00477490|62654047|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
33278796|NCT00477490|62654048|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
33278797|NCT00477490|62654040|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
33278798|NCT00477490|62654041|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
33278799|NCT00477490|62654042|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
33278800|NCT00477490|62654043|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
33278801|NCT00477490|62654044|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
33555818|NCT01975831|62948599|FG007|Overall Study|Entered Hospice|0|||
33278802|NCT00477490|62654045|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
33278803|NCT00477490|62654046|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
33278804|NCT00477490|62654047|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
33278805|NCT00477490|62654048|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
33278806|NCT00477490|62654040|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
33278807|NCT00477490|62654041|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
33485735|NCT04397757|62863477|FG000|Overall Study|Death|3|||
33278808|NCT00477490|62654042|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
33278809|NCT00477490|62654043|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
33278810|NCT00477490|62654044|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
33485736|NCT04397757|62863478|FG001|Overall Study|Death|11|||
33278811|NCT00477490|62654045|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
33278812|NCT00477490|62654046|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
33278813|NCT00477490|62654047|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
33278814|NCT00477490|62654048|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
33278815|NCT00477490|62654040|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
33278816|NCT00477490|62654041|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
33278817|NCT00477490|62654042|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
33278818|NCT00477490|62654043|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
33278819|NCT00477490|62654044|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
33278820|NCT00477490|62654045|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
33278821|NCT00477490|62654046|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
33278822|NCT00477490|62654047|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
33278823|NCT00477490|62654048|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
33278824|NCT00477490|62654040|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
33278825|NCT00477490|62654041|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
33278826|NCT00477490|62654042|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
33278827|NCT00477490|62654043|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
33278828|NCT00477490|62654044|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
33278829|NCT00477490|62654045|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
33278830|NCT00477490|62654046|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
33278831|NCT00477490|62654047|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
33278832|NCT00477490|62654048|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
33278833|NCT00477490|62654040|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
33278834|NCT00477490|62654041|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
33278835|NCT00477490|62654042|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
33278836|NCT00477490|62654043|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
33278837|NCT00477490|62654044|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
33278838|NCT00477490|62654045|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
33278839|NCT00477490|62654046|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
33278840|NCT00477490|62654047|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
33278841|NCT00477490|62654048|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
33278842|NCT00477490|62654040|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
33278843|NCT00477490|62654041|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
33278844|NCT00477490|62654042|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
33278845|NCT00477490|62654043|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
33278846|NCT00477490|62654044|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
33278847|NCT00477490|62654045|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
33278848|NCT00477490|62654046|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
33278849|NCT00477490|62654047|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
33278850|NCT00477490|62654048|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
33278851|NCT00477490|62654040|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33278852|NCT00477490|62654041|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
33278853|NCT00477490|62654042|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33278854|NCT00477490|62654043|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33278855|NCT00477490|62654044|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33278856|NCT00477490|62654045|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33278857|NCT00477490|62654046|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33278858|NCT00477490|62654047|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33278859|NCT00477490|62654048|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33278860|NCT00477490|62654040|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
33278861|NCT00477490|62654041|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
33278862|NCT00477490|62654042|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
33278863|NCT00477490|62654043|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
33278864|NCT00477490|62654044|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
33278865|NCT00477490|62654045|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
33278866|NCT00477490|62654046|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
33278867|NCT00477490|62654047|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
33278868|NCT00477490|62654048|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
33278869|NCT00477490|62654040|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
33278870|NCT00477490|62654041|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
33278871|NCT00477490|62654042|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
33278872|NCT00477490|62654043|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
33370584|NCT00848718|62749293|FG008|Overall Study|Protocol Violation|0|||
33370585|NCT00848718|62749294|FG009|Overall Study|Protocol Violation|0|||
33555819|NCT01975831|62948600|FG008|Overall Study|Entered Hospice|0|||
33278873|NCT00477490|62654044|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
33278874|NCT00477490|62654045|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
33278875|NCT00477490|62654046|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
33278876|NCT00477490|62654047|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
33278877|NCT00477490|62654048|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
33278878|NCT00477334|62654078|FG000|Overall Study|Discontinued prior to taking study drug|106|||
33278879|NCT00477334|62654079|FG001|Overall Study|Discontinued prior to taking study drug|53|||
33278880|NCT00477334|62654078|FG000|Overall Study|Adverse Event|1|||
33278881|NCT00477334|62654079|FG001|Overall Study|Adverse Event|2|||
33278882|NCT00477334|62654078|FG000|Overall Study|Withdrawal by Subject|2|||
33278883|NCT00477334|62654079|FG001|Overall Study|Withdrawal by Subject|1|||
33278884|NCT00477334|62654078|FG000|Overall Study|Lost to Follow-up|15|||
33278885|NCT00477334|62654079|FG001|Overall Study|Lost to Follow-up|4|||
33278886|NCT00477334|62654078|FG000|Overall Study|Administrative Problems|39|||
33278887|NCT00477334|62654079|FG001|Overall Study|Administrative Problems|15|||
33278888|NCT00477334|62654078|FG000|Overall Study|Protocol Violation|7|||
33278889|NCT00477334|62654079|FG001|Overall Study|Protocol Violation|1|||
33278890|NCT04536727|62654170|FG000|Overall Study|Lost to Follow-up|1|||
33278891|NCT04536727|62654171|FG001|Overall Study|Lost to Follow-up|1|||
33278892|NCT04536727|62654170|FG000|Overall Study|Death|0|||
33278893|NCT04536727|62654171|FG001|Overall Study|Death|1|||
33278894|NCT04971967|62654232|FG000|Overall Study|Lost to Follow-up|6|||
33278895|NCT04971967|62654233|FG001|Overall Study|Lost to Follow-up|7|||
33278896|NCT04716881|62654247|FG000|Overall Study|Adverse Event|1|||
33278897|NCT04716881|62654247|FG000|Overall Study|Lost to Follow-up|1|||
33278898|NCT04582266|62654264|FG000|Overall Study|Lost to Follow-up|7|||
33278899|NCT04582266|62654265|FG001|Overall Study|Lost to Follow-up|5|||
33278900|NCT04582266|62654264|FG000|Overall Study|Withdrawal by Subject|1|||
33278901|NCT04582266|62654265|FG001|Overall Study|Withdrawal by Subject|0|||
33278902|NCT04582266|62654264|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
33278903|NCT04582266|62654265|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
33278904|NCT04459338|62654275|FG000|Overall Study|Loss of IV during study|1|||
33278905|NCT04459338|62654276|FG001|Overall Study|Loss of IV during study|0|||
33278906|NCT04166383|62654282|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
33278907|NCT04166383|62654282|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
33278908|NCT04166383|62654282|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
33278909|NCT03740048|62654341|FG000|Overall Study|Withdrawal by Subject|1|||
33278910|NCT03740048|62654342|FG001|Overall Study|Withdrawal by Subject|1|||
33278911|NCT03740048|62654341|FG000|Overall Study|Death|1|||
33278912|NCT03740048|62654342|FG001|Overall Study|Death|6|||
33278913|NCT03740048|62654341|FG000|Overall Study|Switched to thrice-weekly HD|2|||
33278914|NCT03740048|62654342|FG001|Overall Study|Switched to thrice-weekly HD|0|||
33278915|NCT03740048|62654341|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
33278916|NCT03740048|62654342|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
33278917|NCT03740048|62654341|FG000|Overall Study|Lost to Follow-up|0|||
33278918|NCT03740048|62654342|FG001|Overall Study|Lost to Follow-up|1|||
33278919|NCT03740048|62654341|FG000|Overall Study|Non-compliance with HD|0|||
33278920|NCT03740048|62654342|FG001|Overall Study|Non-compliance with HD|1|||
33278921|NCT03436862|62654402|FG000|Overall Study|Adverse Event|4|||
33278922|NCT03436862|62654402|FG000|Overall Study|Progressive Disease|2|||
33278923|NCT03373760|62654423|FG000|Overall Study|Adverse Event|8|||
33278924|NCT03373760|62654423|FG000|Overall Study|Disease Progression|46|||
33278925|NCT03373760|62654423|FG000|Overall Study|Death|4|||
33278926|NCT03324880|62654432|FG000|Overall Study|Adverse Event|0|||
33278927|NCT03324880|62654433|FG001|Overall Study|Adverse Event|2|||
33278928|NCT03324880|62654432|FG000|Overall Study|Withdrawal by Subject|2|||
33278929|NCT03324880|62654433|FG001|Overall Study|Withdrawal by Subject|2|||
33278930|NCT03324880|62654432|FG000|Overall Study|Lost to Follow-up|0|||
33278931|NCT03324880|62654433|FG001|Overall Study|Lost to Follow-up|1|||
33278932|NCT03324880|62654432|FG000|Overall Study|Product Recall|0|||
33278933|NCT03324880|62654433|FG001|Overall Study|Product Recall|1|||
33278934|NCT03053440|62654443|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
33278935|NCT03053440|62654444|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
33278936|NCT03053440|62654443|FG000|Overall Study|Death|18|||
33278937|NCT03053440|62654444|FG001|Overall Study|Death|14|||
33485737|NCT04397757|62863477|FG000|Overall Study|Withdrawal by Subject|2|||
33485738|NCT04397757|62863478|FG001|Overall Study|Withdrawal by Subject|0|||
33278938|NCT03053440|62654443|FG000|Overall Study|Withdrawal by Subject|9|||
33278939|NCT03053440|62654444|FG001|Overall Study|Withdrawal by Subject|8|||
33278940|NCT03053440|62654443|FG000|Overall Study|Lost to Follow-up|1|||
33278941|NCT03053440|62654444|FG001|Overall Study|Lost to Follow-up|0|||
33278942|NCT03053440|62654443|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
33485739|NCT04397757|62863477|FG000|Overall Study|Lost to Follow-up|4|||
33278943|NCT03053440|62654444|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
33278944|NCT03053440|62654443|FG000|Overall Study|Physician Decision|2|||
33278945|NCT03053440|62654444|FG001|Overall Study|Physician Decision|1|||
33278946|NCT03053440|62654443|FG000|Overall Study|Participant Randomized but died before dosing|1|||
33278947|NCT03053440|62654444|FG001|Overall Study|Participant Randomized but died before dosing|0|||
33278948|NCT02985684|62654451|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
33278949|NCT02985684|62654451|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
33278950|NCT02985684|62654451|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
33278951|NCT02949934|62654490|FG000|Natural Drinking Period|Adverse Event|1|||
33278952|NCT02949934|62654491|FG001|Natural Drinking Period|Adverse Event|0|||
33278953|NCT02949934|62654492|FG002|Natural Drinking Period|Adverse Event|0|||
33278954|NCT02949934|62654493|FG003|Natural Drinking Period|Adverse Event|1|||
33278955|NCT02949934|62654494|FG004|Natural Drinking Period|Adverse Event|0|||
33278956|NCT02949934|62654495|FG005|Natural Drinking Period|Adverse Event|0|||
33278957|NCT02949934|62654490|FG000|Natural Drinking Period|Lost to Follow-up|0|||
33278958|NCT02949934|62654491|FG001|Natural Drinking Period|Lost to Follow-up|0|||
33278959|NCT02949934|62654492|FG002|Natural Drinking Period|Lost to Follow-up|0|||
33278960|NCT02949934|62654493|FG003|Natural Drinking Period|Lost to Follow-up|0|||
33278961|NCT02949934|62654494|FG004|Natural Drinking Period|Lost to Follow-up|1|||
33278962|NCT02949934|62654495|FG005|Natural Drinking Period|Lost to Follow-up|0|||
33278963|NCT02949934|62654490|FG000|Neuroimaging|Protocol Violation|2|||
33278964|NCT02949934|62654491|FG001|Neuroimaging|Protocol Violation|0|||
33278965|NCT02949934|62654492|FG002|Neuroimaging|Protocol Violation|0|||
33278966|NCT02949934|62654493|FG003|Neuroimaging|Protocol Violation|0|||
33278967|NCT02949934|62654494|FG004|Neuroimaging|Protocol Violation|1|||
33278968|NCT02949934|62654495|FG005|Neuroimaging|Protocol Violation|0|||
33278969|NCT02949934|62654490|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
33278970|NCT02949934|62654491|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
33278971|NCT02949934|62654492|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
33278972|NCT02949934|62654493|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
33278973|NCT02949934|62654494|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
33278974|NCT02949934|62654495|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
33278975|NCT02949934|62654490|FG000|Neuroimaging|Not scanned|0|||
33278976|NCT02949934|62654491|FG001|Neuroimaging|Not scanned|0|||
33278977|NCT02949934|62654492|FG002|Neuroimaging|Not scanned|1|||
33278978|NCT02949934|62654493|FG003|Neuroimaging|Not scanned|0|||
33278979|NCT02949934|62654494|FG004|Neuroimaging|Not scanned|0|||
33278980|NCT02949934|62654495|FG005|Neuroimaging|Not scanned|2|||
33278981|NCT02949934|62654490|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
33278982|NCT02949934|62654491|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
33278983|NCT02949934|62654492|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
33278984|NCT02949934|62654493|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
33278985|NCT02949934|62654494|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
33278986|NCT02949934|62654495|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
33278987|NCT02949934|62654490|FG000|Bar Laboratory|Adverse Event|1|||
33278988|NCT02949934|62654491|FG001|Bar Laboratory|Adverse Event|0|||
33278989|NCT02949934|62654492|FG002|Bar Laboratory|Adverse Event|2|||
33278990|NCT02949934|62654493|FG003|Bar Laboratory|Adverse Event|0|||
33278991|NCT02949934|62654494|FG004|Bar Laboratory|Adverse Event|1|||
33278992|NCT02949934|62654495|FG005|Bar Laboratory|Adverse Event|0|||
33278993|NCT02949934|62654490|FG000|Bar Laboratory|Protocol Violation|0|||
33278994|NCT02949934|62654491|FG001|Bar Laboratory|Protocol Violation|0|||
33278995|NCT02949934|62654492|FG002|Bar Laboratory|Protocol Violation|0|||
33278996|NCT02949934|62654493|FG003|Bar Laboratory|Protocol Violation|1|||
33278997|NCT02949934|62654494|FG004|Bar Laboratory|Protocol Violation|0|||
33278998|NCT02949934|62654495|FG005|Bar Laboratory|Protocol Violation|0|||
33278999|NCT02935634|62654527|FG000|Randomization|Participant withdrew consent|0|||
33279000|NCT02935634|62654528|FG001|Randomization|Participant withdrew consent|1|||
33279001|NCT02935634|62654529|FG002|Randomization|Participant withdrew consent|0|||
33279002|NCT02935634|62654530|FG003|Randomization|Participant withdrew consent|0|||
33279003|NCT02935634|62654531|FG004|Randomization|Participant withdrew consent|0|||
33279004|NCT02935634|62654532|FG005|Randomization|Participant withdrew consent|0|||
33279005|NCT02935634|62654527|FG000|Randomization|Death|2|||
33662067|NCT02546986|63092798|FG001|Survival Follow-Up Phase|Death|12|||
33279006|NCT02935634|62654528|FG001|Randomization|Death|1|||
33279007|NCT02935634|62654529|FG002|Randomization|Death|1|||
33279008|NCT02935634|62654530|FG003|Randomization|Death|0|||
33279009|NCT02935634|62654531|FG004|Randomization|Death|0|||
33279010|NCT02935634|62654532|FG005|Randomization|Death|0|||
33279011|NCT02935634|62654527|FG000|Randomization|Other reasons|0|||
33279012|NCT02935634|62654528|FG001|Randomization|Other reasons|2|||
33279013|NCT02935634|62654529|FG002|Randomization|Other reasons|2|||
33279014|NCT02935634|62654530|FG003|Randomization|Other reasons|0|||
33279015|NCT02935634|62654531|FG004|Randomization|Other reasons|0|||
33279016|NCT02935634|62654532|FG005|Randomization|Other reasons|0|||
33279017|NCT02935634|62654527|FG000|Treatment: Track 1|Disease progression|15|||
33279018|NCT02935634|62654528|FG001|Treatment: Track 1|Disease progression|17|||
33279019|NCT02935634|62654529|FG002|Treatment: Track 1|Disease progression|28|||
33279020|NCT02935634|62654530|FG003|Treatment: Track 1|Disease progression|4|||
33279021|NCT02935634|62654531|FG004|Treatment: Track 1|Disease progression|6|||
33279022|NCT02935634|62654532|FG005|Treatment: Track 1|Disease progression|2|||
33279023|NCT02935634|62654527|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
33279024|NCT02935634|62654528|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
33279025|NCT02935634|62654529|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
33279026|NCT02935634|62654530|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
33279027|NCT02935634|62654531|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
33279028|NCT02935634|62654532|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
33279029|NCT02935634|62654527|FG000|Treatment: Track 1|Lost to Follow-up|1|||
33279030|NCT02935634|62654528|FG001|Treatment: Track 1|Lost to Follow-up|0|||
33279031|NCT02935634|62654529|FG002|Treatment: Track 1|Lost to Follow-up|0|||
33279032|NCT02935634|62654530|FG003|Treatment: Track 1|Lost to Follow-up|0|||
33279033|NCT02935634|62654531|FG004|Treatment: Track 1|Lost to Follow-up|0|||
33279034|NCT02935634|62654532|FG005|Treatment: Track 1|Lost to Follow-up|0|||
33279035|NCT02935634|62654527|FG000|Treatment: Track 1|Study drug toxicity|2|||
33279036|NCT02935634|62654528|FG001|Treatment: Track 1|Study drug toxicity|1|||
33279037|NCT02935634|62654529|FG002|Treatment: Track 1|Study drug toxicity|3|||
33279038|NCT02935634|62654530|FG003|Treatment: Track 1|Study drug toxicity|0|||
33279039|NCT02935634|62654531|FG004|Treatment: Track 1|Study drug toxicity|0|||
33279040|NCT02935634|62654532|FG005|Treatment: Track 1|Study drug toxicity|1|||
33279041|NCT02935634|62654527|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
33279042|NCT02935634|62654528|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
33279043|NCT02935634|62654529|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
33279044|NCT02935634|62654530|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
33279045|NCT02935634|62654531|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
33279046|NCT02935634|62654532|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
33279047|NCT02935634|62654527|FG000|Treatment: Track 1|Participant withdrew consent|2|||
33279048|NCT02935634|62654528|FG001|Treatment: Track 1|Participant withdrew consent|0|||
33279049|NCT02935634|62654529|FG002|Treatment: Track 1|Participant withdrew consent|1|||
33279050|NCT02935634|62654530|FG003|Treatment: Track 1|Participant withdrew consent|0|||
33279051|NCT02935634|62654531|FG004|Treatment: Track 1|Participant withdrew consent|1|||
33279052|NCT02935634|62654532|FG005|Treatment: Track 1|Participant withdrew consent|0|||
33279053|NCT02935634|62654527|FG000|Treatment: Track 1|Other reasons|0|||
33279054|NCT02935634|62654528|FG001|Treatment: Track 1|Other reasons|0|||
33279055|NCT02935634|62654529|FG002|Treatment: Track 1|Other reasons|2|||
33279056|NCT02935634|62654530|FG003|Treatment: Track 1|Other reasons|0|||
33279057|NCT02935634|62654531|FG004|Treatment: Track 1|Other reasons|0|||
33279058|NCT02935634|62654532|FG005|Treatment: Track 1|Other reasons|0|||
33279059|NCT02935634|62654527|FG000|Treatment: Track 2|Disease progression|13|||
33279060|NCT02935634|62654528|FG001|Treatment: Track 2|Disease progression|26|||
33279061|NCT02935634|62654529|FG002|Treatment: Track 2|Disease progression|20|||
33279062|NCT02935634|62654530|FG003|Treatment: Track 2|Disease progression|5|||
33279063|NCT02935634|62654531|FG004|Treatment: Track 2|Disease progression|1|||
33279064|NCT02935634|62654532|FG005|Treatment: Track 2|Disease progression|4|||
33279065|NCT02935634|62654527|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
33279066|NCT02935634|62654528|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
33279067|NCT02935634|62654529|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
33279068|NCT02935634|62654530|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
33279069|NCT02935634|62654531|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
33279070|NCT02935634|62654532|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
33279071|NCT02935634|62654527|FG000|Treatment: Track 2|Study drug toxicity|7|||
33279072|NCT02935634|62654528|FG001|Treatment: Track 2|Study drug toxicity|3|||
33279073|NCT02935634|62654529|FG002|Treatment: Track 2|Study drug toxicity|0|||
33279074|NCT02935634|62654530|FG003|Treatment: Track 2|Study drug toxicity|0|||
33279075|NCT02935634|62654531|FG004|Treatment: Track 2|Study drug toxicity|0|||
33279076|NCT02935634|62654532|FG005|Treatment: Track 2|Study drug toxicity|0|||
33279077|NCT02935634|62654527|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
33279078|NCT02935634|62654528|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
33279079|NCT02935634|62654529|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
33279080|NCT02935634|62654530|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
33279081|NCT02935634|62654531|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
33279082|NCT02935634|62654532|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
33279083|NCT02935634|62654527|FG000|Treatment: Track 2|Participant withdrew consent|0|||
33279084|NCT02935634|62654528|FG001|Treatment: Track 2|Participant withdrew consent|1|||
33279085|NCT02935634|62654529|FG002|Treatment: Track 2|Participant withdrew consent|1|||
33279086|NCT02935634|62654530|FG003|Treatment: Track 2|Participant withdrew consent|0|||
33279087|NCT02935634|62654531|FG004|Treatment: Track 2|Participant withdrew consent|1|||
33279088|NCT02935634|62654532|FG005|Treatment: Track 2|Participant withdrew consent|0|||
33279089|NCT02864992|62654561|FG000|Overall Study|still on treatment|15|||
33279090|NCT02864992|62654562|FG001|Overall Study|still on treatment|1|||
33279091|NCT02864992|62654563|FG002|Overall Study|still on treatment|33|||
33279092|NCT02684578|62654571|FG000|Overall Study|Withdrawal by Subject|10|||
33279093|NCT02684578|62654572|FG001|Overall Study|Withdrawal by Subject|7|||
33279094|NCT02684578|62654571|FG000|Overall Study|Lost to Follow-up|0|||
33279095|NCT02684578|62654572|FG001|Overall Study|Lost to Follow-up|3|||
33279096|NCT02684578|62654571|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
33279097|NCT02684578|62654572|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
33279098|NCT02684578|62654571|FG000|Overall Study|Missing follow-up data|0|||
33279099|NCT02684578|62654572|FG001|Overall Study|Missing follow-up data|1|||
33279100|NCT02612129|62654580|FG000|Single Dose Treatment Period|Screening Failure|1|||
33279101|NCT02612129|62654581|FG001|Single Dose Treatment Period|Screening Failure|0|||
33279102|NCT02612129|62654582|FG002|Single Dose Treatment Period|Screening Failure|0|||
33279103|NCT02612129|62654580|FG000|Continuous Treatment Period|Early Escape|0|||
33279104|NCT02612129|62654581|FG001|Continuous Treatment Period|Early Escape|2|||
33279105|NCT02612129|62654582|FG002|Continuous Treatment Period|Early Escape|0|||
33279106|NCT02612129|62654580|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
33279107|NCT02612129|62654581|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
33279108|NCT02612129|62654582|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
33279109|NCT02612129|62654580|FG000|Continuous Treatment Period|Safety Reasons|0|||
33279110|NCT02612129|62654581|FG001|Continuous Treatment Period|Safety Reasons|3|||
33279111|NCT02612129|62654582|FG002|Continuous Treatment Period|Safety Reasons|0|||
33279112|NCT02612129|62654580|FG000|Continuous Treatment Period|Death|0|||
33279113|NCT02612129|62654581|FG001|Continuous Treatment Period|Death|1|||
33279114|NCT02612129|62654582|FG002|Continuous Treatment Period|Death|0|||
33279115|NCT02612129|62654580|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
33279116|NCT02612129|62654581|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
33279117|NCT02612129|62654582|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
33279118|NCT02580305|62654592|FG000|Overall Study|Adverse Event|15|||
33279119|NCT02580305|62654593|FG001|Overall Study|Adverse Event|19|||
33279120|NCT02580305|62654594|FG002|Overall Study|Adverse Event|10|||
33279121|NCT02580305|62654592|FG000|Overall Study|Lack of Efficacy|5|||
33279122|NCT02580305|62654593|FG001|Overall Study|Lack of Efficacy|0|||
33279123|NCT02580305|62654594|FG002|Overall Study|Lack of Efficacy|2|||
33279124|NCT02580305|62654592|FG000|Overall Study|Protocol Violation|4|||
33279125|NCT02580305|62654593|FG001|Overall Study|Protocol Violation|9|||
33279126|NCT02580305|62654594|FG002|Overall Study|Protocol Violation|6|||
33279127|NCT02580305|62654592|FG000|Overall Study|Lost to Follow-up|4|||
33279128|NCT02580305|62654593|FG001|Overall Study|Lost to Follow-up|4|||
33279129|NCT02580305|62654594|FG002|Overall Study|Lost to Follow-up|2|||
33279130|NCT02580305|62654592|FG000|Overall Study|Withdrawal by Subject|11|||
33279131|NCT02580305|62654593|FG001|Overall Study|Withdrawal by Subject|9|||
33279132|NCT02580305|62654594|FG002|Overall Study|Withdrawal by Subject|7|||
33279133|NCT02580305|62654592|FG000|Overall Study|Randomized in error and never treated|4|||
33279134|NCT02580305|62654593|FG001|Overall Study|Randomized in error and never treated|8|||
33279135|NCT02580305|62654594|FG002|Overall Study|Randomized in error and never treated|5|||
33279136|NCT02054741|62654613|FG000|Overall Study|Protocol Violation|13|||
33279137|NCT02054741|62654614|FG001|Overall Study|Protocol Violation|2|||
33279138|NCT02054741|62654613|FG000|Overall Study|Withdrawal by Subject|10|||
33279139|NCT02054741|62654614|FG001|Overall Study|Withdrawal by Subject|5|||
33279140|NCT02054741|62654613|FG000|Overall Study|Death|94|||
33279141|NCT02054741|62654614|FG001|Overall Study|Death|90|||
33279142|NCT02054741|62654613|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
33279143|NCT02054741|62654614|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
33279144|NCT01555463|62654622|FG000|Treatment|Adverse Event|6|||
33279145|NCT01555463|62654623|FG001|Treatment|Adverse Event|12|||
33279146|NCT01555463|62654622|FG000|Treatment|Withdrawal by Subject|24|||
33279147|NCT01555463|62654623|FG001|Treatment|Withdrawal by Subject|36|||
33370586|NCT00848718|62749295|FG010|Overall Study|Protocol Violation|0|||
33279148|NCT01555463|62654622|FG000|Treatment|Lost to Follow-up|28|||
33279149|NCT01555463|62654623|FG001|Treatment|Lost to Follow-up|23|||
33279150|NCT01555463|62654622|FG000|Treatment|Protocol Violation|4|||
33279151|NCT01555463|62654623|FG001|Treatment|Protocol Violation|5|||
33279152|NCT01555463|62654622|FG000|Treatment|Other reason|2|||
33279153|NCT01555463|62654623|FG001|Treatment|Other reason|3|||
33485740|NCT04397757|62863478|FG001|Overall Study|Lost to Follow-up|3|||
33485741|NCT02792062|62863495|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
33485742|NCT02792062|62863496|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
33279154|NCT01555463|62654622|FG000|Follow up|Adverse Event|2|||
33279155|NCT01555463|62654623|FG001|Follow up|Adverse Event|5|||
33279156|NCT01555463|62654622|FG000|Follow up|Death|0|||
33485743|NCT02792062|62863497|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
33279157|NCT01555463|62654623|FG001|Follow up|Death|1|||
33279158|NCT01555463|62654622|FG000|Follow up|Withdrawal by Subject|22|||
33279159|NCT01555463|62654623|FG001|Follow up|Withdrawal by Subject|22|||
33279160|NCT01555463|62654622|FG000|Follow up|Lost to Follow-up|9|||
33279161|NCT01555463|62654623|FG001|Follow up|Lost to Follow-up|10|||
33279162|NCT01555463|62654622|FG000|Follow up|Protocol Violation|2|||
33279163|NCT01555463|62654623|FG001|Follow up|Protocol Violation|4|||
33279164|NCT01555463|62654622|FG000|Follow up|Other reason|3|||
33279165|NCT01555463|62654623|FG001|Follow up|Other reason|3|||
33279166|NCT01081951|62654701|FG000|Overall Study|Death|54|||
33279167|NCT01081951|62654702|FG001|Overall Study|Death|47|||
33279168|NCT01081951|62654701|FG000|Overall Study|Withdrawal by Subject|2|||
33279169|NCT01081951|62654702|FG001|Overall Study|Withdrawal by Subject|6|||
33279170|NCT01081951|62654701|FG000|Overall Study|Allocated treatment but did not take it|0|||
33279171|NCT01081951|62654702|FG001|Overall Study|Allocated treatment but did not take it|1|||
33279172|NCT01081951|62654701|FG000|Overall Study|Lost to Follow-up|0|||
33279173|NCT01081951|62654702|FG001|Overall Study|Lost to Follow-up|1|||
33279174|NCT02277106|62654708|FG000|Stage 2|Adverse Event|0|||
33279175|NCT02277106|62654709|FG001|Stage 2|Adverse Event|0|||
33279176|NCT02277106|62654710|FG002|Stage 2|Adverse Event|1|||
33279177|NCT02215096|62654733|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
33279178|NCT02215096|62654734|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
33279179|NCT02215096|62654735|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
33279180|NCT02215096|62654736|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
33279181|NCT02215096|62654737|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
33279182|NCT02215096|62654733|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
33279183|NCT02215096|62654734|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
33279184|NCT02215096|62654735|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
33279185|NCT02215096|62654736|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
33279186|NCT02215096|62654737|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
33279187|NCT02215096|62654733|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
33279188|NCT02215096|62654734|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
33279189|NCT02215096|62654735|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
33279190|NCT02215096|62654736|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
33279191|NCT02215096|62654737|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
33279192|NCT02215096|62654733|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
33279193|NCT02215096|62654734|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
33279194|NCT02215096|62654735|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
33279195|NCT02215096|62654736|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
33279196|NCT02215096|62654737|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
33279197|NCT03189862|62654772|FG000|Overall Study|Withdrawal by Subject|1|||
33279198|NCT03189862|62654773|FG001|Overall Study|Withdrawal by Subject|0|||
33279199|NCT03189862|62654772|FG000|Overall Study|Lost to Follow-up|54|||
33279200|NCT03189862|62654773|FG001|Overall Study|Lost to Follow-up|62|||
33279201|NCT00107614|62654805|FG000|Overall Study|Physician Decision|10|||
33279202|NCT00107614|62654805|FG000|Overall Study|Death|2|||
33279203|NCT00107380|62654809|FG000|Overall Study|Adverse Event|7|||
33279204|NCT00107380|62654809|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
33279205|NCT00107380|62654809|FG000|Overall Study|Progression/relapse|4|||
33279206|NCT00107380|62654809|FG000|Overall Study|Death|3|||
33279207|NCT00107380|62654809|FG000|Overall Study|Other - not protocol specified|7|||
33279208|NCT00107380|62654809|FG000|Overall Study|Ineligible|2|||
33662068|NCT02546986|63092797|FG000|Survival Follow-Up Phase|Alive|13|||
33662069|NCT02546986|63092798|FG001|Survival Follow-Up Phase|Alive|16|||
33662070|NCT02546986|63092797|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
33662071|NCT02546986|63092798|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
33662072|NCT02689206|63092809|FG000|Overall Study|Adverse Event|0|||
33662073|NCT02689206|63092810|FG001|Overall Study|Adverse Event|0|||
33662074|NCT02689206|63092811|FG002|Overall Study|Adverse Event|1|||
33662075|NCT02689206|63092812|FG003|Overall Study|Adverse Event|0|||
33662076|NCT02689206|63092813|FG004|Overall Study|Adverse Event|2|||
33662077|NCT02689206|63092809|FG000|Overall Study|Protocol Violation|1|||
33279209|NCT01340014|62654816|FG000|Period 1, First 7 Days|Adverse Event|1|||
33279210|NCT01340014|62654817|FG001|Period 1, First 7 Days|Adverse Event|0|||
33279211|NCT01340014|62654816|FG000|Period 1, First 7 Days|Personal Reasons|1|||
33279212|NCT01340014|62654817|FG001|Period 1, First 7 Days|Personal Reasons|0|||
33279213|NCT01340014|62654816|FG000|Period 2, Second 7 Days|Adverse Event|0|||
33279214|NCT01340014|62654817|FG001|Period 2, Second 7 Days|Adverse Event|1|||
33279215|NCT01339897|62654827|FG000|Overall Study|Adverse Event|1|||
33279216|NCT01339897|62654828|FG001|Overall Study|Adverse Event|0|||
33279217|NCT01339897|62654829|FG002|Overall Study|Adverse Event|0|||
33279218|NCT01339897|62654830|FG003|Overall Study|Adverse Event|1|||
33662078|NCT02689206|63092810|FG001|Overall Study|Protocol Violation|0|||
33279219|NCT01339429|62654842|FG000|Overall Study|Withdrawal by Subject|1|||
33662079|NCT02689206|63092811|FG002|Overall Study|Protocol Violation|0|||
33279220|NCT01339429|62654842|FG000|Overall Study|Physician Decision|3|||
33279221|NCT01339390|62654848|FG000|Overall Study|Death|32|||
33279222|NCT01339390|62654849|FG001|Overall Study|Death|29|||
33279223|NCT01339390|62654848|FG000|Overall Study|Lost to Follow-up|125|||
33279224|NCT01339390|62654849|FG001|Overall Study|Lost to Follow-up|127|||
33279225|NCT01339273|62654857|FG000|Overall Study|Lost to Follow-up|8|||
33279226|NCT01339273|62654858|FG001|Overall Study|Lost to Follow-up|8|||
33279227|NCT01334866|62654864|FG000|Overall Study|Withdrawal by Subject|10|||
33279228|NCT01334866|62654864|FG000|Overall Study|Lost to Follow-up|3|||
33279229|NCT01334866|62654864|FG000|Overall Study|Physician Decision|3|||
33279230|NCT01334866|62654864|FG000|Overall Study|medically necessary prior to procedure|2|||
33279231|NCT01334866|62654864|FG000|Overall Study|medically necessary post-procedure|1|||
33279232|NCT01334710|62654870|FG000|Overall Study|Trial was terminated|3|||
33279233|NCT01334554|62654877|FG000|Overall Study|Adverse Event|4|||
33279234|NCT01334554|62654878|FG001|Overall Study|Adverse Event|2|||
33279235|NCT01332799|62654888|FG000|Overall Study|Insufficient funding|10|||
33279236|NCT01332799|62654889|FG001|Overall Study|Insufficient funding|10|||
33279237|NCT01332331|62654897|FG000|Overall Study|Lost to Follow-up|0|||
33279238|NCT01332331|62654898|FG001|Overall Study|Lost to Follow-up|1|||
33279239|NCT01332331|62654897|FG000|Overall Study|Adverse Event|1|||
33279240|NCT01332331|62654898|FG001|Overall Study|Adverse Event|1|||
33279241|NCT01332331|62654897|FG000|Overall Study|Physician Decision|1|||
33279242|NCT01332331|62654898|FG001|Overall Study|Physician Decision|0|||
33279243|NCT01332292|62654905|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
33279244|NCT01332292|62654906|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
33279245|NCT01332292|62654905|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
33279246|NCT01332292|62654906|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
33279247|NCT01332292|62654905|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
33279248|NCT01332292|62654906|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
33279249|NCT01332019|62654916|FG000|Overall Study|Was Not Dosed|1|||
33279250|NCT01332019|62654917|FG001|Overall Study|Was Not Dosed|0|||
33279251|NCT01332019|62654916|FG000|Overall Study|Other|16|||
33279252|NCT01332019|62654917|FG001|Overall Study|Other|18|||
33279253|NCT01332019|62654916|FG000|Overall Study|Death|2|||
33279254|NCT01332019|62654917|FG001|Overall Study|Death|1|||
33279255|NCT01332019|62654916|FG000|Overall Study|Physician Decision|4|||
33279256|NCT01332019|62654917|FG001|Overall Study|Physician Decision|3|||
33279257|NCT01332019|62654916|FG000|Overall Study|Withdrawal by Subject|73|||
33279258|NCT01332019|62654917|FG001|Overall Study|Withdrawal by Subject|71|||
33279259|NCT01332019|62654916|FG000|Overall Study|Lost to Follow-up|4|||
33279260|NCT01332019|62654917|FG001|Overall Study|Lost to Follow-up|7|||
33279261|NCT01332019|62654916|FG000|Overall Study|Adverse Event|13|||
33279262|NCT01332019|62654917|FG001|Overall Study|Adverse Event|22|||
33370587|NCT00848718|62749296|FG011|Overall Study|Protocol Violation|0|||
33370588|NCT00848718|62749297|FG012|Overall Study|Protocol Violation|1|||
33370589|NCT00848718|62749285|FG000|Overall Study|Withdrawal by Subject|1|||
33370590|NCT00848718|62749286|FG001|Overall Study|Withdrawal by Subject|0|||
33370591|NCT00848718|62749287|FG002|Overall Study|Withdrawal by Subject|0|||
33370592|NCT00848718|62749288|FG003|Overall Study|Withdrawal by Subject|1|||
33370593|NCT00848718|62749289|FG004|Overall Study|Withdrawal by Subject|0|||
33370594|NCT00848718|62749290|FG005|Overall Study|Withdrawal by Subject|0|||
33370595|NCT00848718|62749291|FG006|Overall Study|Withdrawal by Subject|0|||
33370596|NCT00848718|62749292|FG007|Overall Study|Withdrawal by Subject|0|||
33370597|NCT00848718|62749293|FG008|Overall Study|Withdrawal by Subject|0|||
33370598|NCT00848718|62749294|FG009|Overall Study|Withdrawal by Subject|0|||
33370599|NCT00848718|62749295|FG010|Overall Study|Withdrawal by Subject|1|||
33370600|NCT00848718|62749296|FG011|Overall Study|Withdrawal by Subject|0|||
33370601|NCT00848718|62749297|FG012|Overall Study|Withdrawal by Subject|0|||
33370602|NCT00848718|62749285|FG000|Overall Study|Progressive disease during treatment|3|||
33370603|NCT00848718|62749286|FG001|Overall Study|Progressive disease during treatment|0|||
33370604|NCT00848718|62749287|FG002|Overall Study|Progressive disease during treatment|3|||
33370605|NCT00848718|62749288|FG003|Overall Study|Progressive disease during treatment|0|||
33555820|NCT01975831|62948592|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
33279263|NCT01331239|62654925|FG000|Part II: Core Study|Adverse Event|0|||
33279264|NCT01331239|62654926|FG001|Part II: Core Study|Adverse Event|3|||
33279265|NCT01331239|62654927|FG002|Part II: Core Study|Adverse Event|0|||
33279266|NCT01331239|62654925|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
33370606|NCT00848718|62749289|FG004|Overall Study|Progressive disease during treatment|0|||
33370607|NCT00848718|62749290|FG005|Overall Study|Progressive disease during treatment|0|||
33370608|NCT00848718|62749291|FG006|Overall Study|Progressive disease during treatment|0|||
33370609|NCT00848718|62749292|FG007|Overall Study|Progressive disease during treatment|2|||
33485744|NCT02792062|62863498|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
33485745|NCT02792062|62863499|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
33279267|NCT01331239|62654926|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
33279268|NCT01331239|62654927|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
33279269|NCT01331239|62654925|FG000|Part II: Core Study|Withdrawal by Subject|0|||
33279270|NCT01331239|62654926|FG001|Part II: Core Study|Withdrawal by Subject|2|||
33279271|NCT01331239|62654927|FG002|Part II: Core Study|Withdrawal by Subject|0|||
33279272|NCT01331239|62654925|FG000|Part II: Core Study|Administrative problems|0|||
33279273|NCT01331239|62654926|FG001|Part II: Core Study|Administrative problems|1|||
33279274|NCT01331239|62654927|FG002|Part II: Core Study|Administrative problems|0|||
33279275|NCT01331161|62654945|FG000|Overall Study|Physician Decision|1|||
33279276|NCT01331161|62654946|FG001|Overall Study|Physician Decision|0|||
33279277|NCT01331161|62654945|FG000|Overall Study|Lost to Follow-up|0|||
33279278|NCT01331161|62654946|FG001|Overall Study|Lost to Follow-up|1|||
33279279|NCT01331161|62654945|FG000|Overall Study|Pregnancy|0|||
33279280|NCT01331161|62654946|FG001|Overall Study|Pregnancy|1|||
33279281|NCT01331005|62654956|FG000|Overall Study|Lost to Follow-up|2|||
33279282|NCT01331005|62654957|FG001|Overall Study|Lost to Follow-up|1|||
33279283|NCT01331005|62654956|FG000|Overall Study|Withdrawal by Subject|2|||
33279284|NCT01331005|62654957|FG001|Overall Study|Withdrawal by Subject|3|||
33279285|NCT01330459|62654965|FG000|Overall Study|Physician Decision|0|||
33279286|NCT01330459|62654966|FG001|Overall Study|Physician Decision|2|||
33279287|NCT01330381|62654976|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
33279288|NCT01330381|62654977|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
33279289|NCT01330381|62654978|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
33279290|NCT01330381|62654976|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
33279291|NCT01330381|62654977|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
33279292|NCT01330381|62654978|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
33279293|NCT01330381|62654976|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
33279294|NCT01330381|62654977|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
33279295|NCT01330381|62654978|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
33279296|NCT01330381|62654976|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
33279297|NCT01330381|62654977|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
33279298|NCT01330381|62654978|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
33279299|NCT01330381|62654976|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
33279300|NCT01330381|62654977|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
33279301|NCT01330381|62654978|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
33279302|NCT01330381|62654976|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
33279303|NCT01330381|62654977|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
33279304|NCT01330381|62654978|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
33279305|NCT01330381|62654976|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
33279306|NCT01330381|62654977|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
33279307|NCT01330381|62654978|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
33279308|NCT01330381|62654976|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
33279309|NCT01330381|62654977|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
33279310|NCT01330381|62654978|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
33279311|NCT01330381|62654976|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
33279312|NCT01330381|62654977|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
33279313|NCT01330381|62654978|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
33279314|NCT01330381|62654976|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
33279315|NCT01330381|62654977|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
33279316|NCT01330381|62654978|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
33279317|NCT01330303|62654987|FG000|Period 1|Adverse Event|1|||
33279318|NCT01330303|62654988|FG001|Period 1|Adverse Event|0|||
33279319|NCT01330303|62654987|FG000|Period 1|Protocol Violation|0|||
33279320|NCT01330303|62654988|FG001|Period 1|Protocol Violation|1|||
33279321|NCT01330303|62654987|FG000|Period 1|Withdrawal by Subject|0|||
33279322|NCT01330303|62654988|FG001|Period 1|Withdrawal by Subject|1|||
33279323|NCT01330108|62654995|FG000|Overall Study|Withdrawal by Subject|4|||
33279324|NCT01059825|62655005|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
33279325|NCT01059825|62655006|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
33279326|NCT01059825|62655007|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
33279327|NCT01059825|62655008|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
33279328|NCT01059825|62655009|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
33279329|NCT01059825|62655010|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
33279330|NCT01059825|62655011|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
33279331|NCT01059825|62655005|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
33279332|NCT01059825|62655006|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
33279333|NCT01059825|62655007|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
33279334|NCT01059825|62655008|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
33485746|NCT02792062|62863500|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
33485747|NCT00196937|62863511|FG000|Overall Study|Serious Adverse Event|1|||
33485748|NCT00196937|62863512|FG001|Overall Study|Serious Adverse Event|0|||
33279335|NCT01059825|62655009|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
33279336|NCT01059825|62655010|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
33279337|NCT01059825|62655011|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
33279338|NCT01059825|62655005|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
33279339|NCT01059825|62655006|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
33279340|NCT01059825|62655007|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
33279341|NCT01059825|62655008|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
33279342|NCT01059825|62655009|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
33279343|NCT01059825|62655010|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
33279344|NCT01059825|62655011|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
33279345|NCT01059825|62655005|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
33279346|NCT01059825|62655006|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
33279347|NCT01059825|62655007|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
33279348|NCT01059825|62655008|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
33279349|NCT01059825|62655009|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
33279350|NCT01059825|62655010|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
33279351|NCT01059825|62655011|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
33279352|NCT01059825|62655005|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
33279353|NCT01059825|62655006|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
33279354|NCT01059825|62655007|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
33279355|NCT01059825|62655008|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
33279356|NCT01059825|62655009|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
33279357|NCT01059825|62655010|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
33279358|NCT01059825|62655011|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
33279359|NCT01059825|62655005|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
33279360|NCT01059825|62655006|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
33279361|NCT01059825|62655007|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
33279362|NCT01059825|62655008|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
33279363|NCT01059825|62655009|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
33279364|NCT01059825|62655010|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
33279365|NCT01059825|62655011|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
33279366|NCT01059825|62655005|FG000|Treatment Period|Lost to Follow-up|2|||
33279367|NCT01059825|62655006|FG001|Treatment Period|Lost to Follow-up|1|||
33279368|NCT01059825|62655007|FG002|Treatment Period|Lost to Follow-up|0|||
33279369|NCT01059825|62655008|FG003|Treatment Period|Lost to Follow-up|1|||
33279370|NCT01059825|62655009|FG004|Treatment Period|Lost to Follow-up|2|||
33279371|NCT01059825|62655010|FG005|Treatment Period|Lost to Follow-up|0|||
33279372|NCT01059825|62655011|FG006|Treatment Period|Lost to Follow-up|0|||
33279373|NCT01059825|62655005|FG000|Treatment Period|Withdrawal by Subject|3|||
33279374|NCT01059825|62655006|FG001|Treatment Period|Withdrawal by Subject|0|||
33279375|NCT01059825|62655007|FG002|Treatment Period|Withdrawal by Subject|1|||
33279376|NCT01059825|62655008|FG003|Treatment Period|Withdrawal by Subject|5|||
33279377|NCT01059825|62655009|FG004|Treatment Period|Withdrawal by Subject|4|||
33279378|NCT01059825|62655010|FG005|Treatment Period|Withdrawal by Subject|1|||
33279379|NCT01059825|62655011|FG006|Treatment Period|Withdrawal by Subject|0|||
33279380|NCT01059825|62655005|FG000|Treatment Period|Other reason not specified|1|||
33279381|NCT01059825|62655006|FG001|Treatment Period|Other reason not specified|2|||
33279382|NCT01059825|62655007|FG002|Treatment Period|Other reason not specified|1|||
33279383|NCT01059825|62655008|FG003|Treatment Period|Other reason not specified|2|||
33279384|NCT01059825|62655009|FG004|Treatment Period|Other reason not specified|0|||
33279385|NCT01059825|62655010|FG005|Treatment Period|Other reason not specified|0|||
33279386|NCT01059825|62655011|FG006|Treatment Period|Other reason not specified|0|||
33279387|NCT01059825|62655005|FG000|Treatment Period|Protocol Violation|0|||
33279388|NCT01059825|62655006|FG001|Treatment Period|Protocol Violation|0|||
33279389|NCT01059825|62655007|FG002|Treatment Period|Protocol Violation|1|||
33279390|NCT01059825|62655008|FG003|Treatment Period|Protocol Violation|1|||
33279391|NCT01059825|62655009|FG004|Treatment Period|Protocol Violation|1|||
33279392|NCT01059825|62655010|FG005|Treatment Period|Protocol Violation|1|||
33279393|NCT01059825|62655011|FG006|Treatment Period|Protocol Violation|0|||
33279394|NCT01059825|62655005|FG000|Treatment Period|Adverse event related to study drug|1|||
33279395|NCT01059825|62655006|FG001|Treatment Period|Adverse event related to study drug|0|||
33279396|NCT01059825|62655007|FG002|Treatment Period|Adverse event related to study drug|1|||
33279397|NCT01059825|62655008|FG003|Treatment Period|Adverse event related to study drug|1|||
33279398|NCT01059825|62655009|FG004|Treatment Period|Adverse event related to study drug|0|||
33279399|NCT01059825|62655010|FG005|Treatment Period|Adverse event related to study drug|0|||
33279400|NCT01059825|62655011|FG006|Treatment Period|Adverse event related to study drug|0|||
33279401|NCT01059825|62655005|FG000|Treatment Period|Insufficient clinical response|3|||
33279402|NCT01059825|62655006|FG001|Treatment Period|Insufficient clinical response|0|||
33279403|NCT01059825|62655007|FG002|Treatment Period|Insufficient clinical response|0|||
33370610|NCT00848718|62749293|FG008|Overall Study|Progressive disease during treatment|0|||
33370611|NCT00848718|62749294|FG009|Overall Study|Progressive disease during treatment|0|||
33279404|NCT01059825|62655008|FG003|Treatment Period|Insufficient clinical response|0|||
33279405|NCT01059825|62655009|FG004|Treatment Period|Insufficient clinical response|0|||
33279406|NCT01059825|62655010|FG005|Treatment Period|Insufficient clinical response|0|||
33279407|NCT01059825|62655011|FG006|Treatment Period|Insufficient clinical response|0|||
33279408|NCT01059825|62655005|FG000|Treatment Period|Adverse event not related to study drug|0|||
33279409|NCT01059825|62655006|FG001|Treatment Period|Adverse event not related to study drug|1|||
33279410|NCT01059825|62655007|FG002|Treatment Period|Adverse event not related to study drug|2|||
33279411|NCT01059825|62655008|FG003|Treatment Period|Adverse event not related to study drug|1|||
33279412|NCT01059825|62655009|FG004|Treatment Period|Adverse event not related to study drug|1|||
33279413|NCT01059825|62655010|FG005|Treatment Period|Adverse event not related to study drug|1|||
33279414|NCT01059825|62655011|FG006|Treatment Period|Adverse event not related to study drug|0|||
33279415|NCT01059773|62655070|FG000|Overall Study|Adverse Event|2|||
33279416|NCT01059773|62655071|FG001|Overall Study|Adverse Event|2|||
33279417|NCT01059773|62655070|FG000|Overall Study|Withdrawal by Subject|1|||
33279418|NCT01059773|62655071|FG001|Overall Study|Withdrawal by Subject|5|||
33279419|NCT01059773|62655070|FG000|Overall Study|Lost to Follow-up|1|||
33279420|NCT01059773|62655071|FG001|Overall Study|Lost to Follow-up|1|||
33279421|NCT01059773|62655070|FG000|Overall Study|Pregnancy|1|||
33279422|NCT01059773|62655071|FG001|Overall Study|Pregnancy|1|||
33279423|NCT01059773|62655070|FG000|Overall Study|Protocol Violation|6|||
33279424|NCT01059773|62655071|FG001|Overall Study|Protocol Violation|2|||
33279425|NCT01059773|62655070|FG000|Overall Study|Physician Decision|5|||
33279426|NCT01059773|62655071|FG001|Overall Study|Physician Decision|4|||
33279427|NCT01059773|62655070|FG000|Overall Study|Lack of Efficacy|3|||
33279428|NCT01059773|62655071|FG001|Overall Study|Lack of Efficacy|3|||
33279429|NCT01059773|62655070|FG000|Overall Study|Death|0|||
33279430|NCT01059773|62655071|FG001|Overall Study|Death|1|||
33279431|NCT01059773|62655070|FG000|Overall Study|Malignancy including squamous cell skin|0|||
33279432|NCT01059773|62655071|FG001|Overall Study|Malignancy including squamous cell skin|1|||
33279433|NCT01059773|62655070|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
33279434|NCT01059773|62655071|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
33279435|NCT01059773|62655070|FG000|Overall Study|Other|1|||
33279436|NCT01059773|62655071|FG001|Overall Study|Other|3|||
33279437|NCT01059318|62655082|FG000|Core Study (26 Week)|Adverse Event|3|||
33279438|NCT01059318|62655082|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
33279439|NCT01059318|62655082|FG000|Extension (36 Week)|Adverse Event|3|||
33279440|NCT01058655|62655093|FG000|Overall Study|Withdrawal by Subject|1|||
33279441|NCT01058655|62655094|FG001|Overall Study|Withdrawal by Subject|0|||
33279442|NCT01058655|62655095|FG002|Overall Study|Withdrawal by Subject|3|||
33279443|NCT01058655|62655096|FG003|Overall Study|Withdrawal by Subject|4|||
33279444|NCT01058655|62655093|FG000|Overall Study|Prolonged Treatment Delay|0|||
33279445|NCT01058655|62655094|FG001|Overall Study|Prolonged Treatment Delay|0|||
33279446|NCT01058655|62655095|FG002|Overall Study|Prolonged Treatment Delay|0|||
33279447|NCT01058655|62655096|FG003|Overall Study|Prolonged Treatment Delay|2|||
33279448|NCT01058655|62655093|FG000|Overall Study|Symptomatic Deterioration|0|||
33279449|NCT01058655|62655094|FG001|Overall Study|Symptomatic Deterioration|0|||
33279450|NCT01058655|62655095|FG002|Overall Study|Symptomatic Deterioration|0|||
33279451|NCT01058655|62655096|FG003|Overall Study|Symptomatic Deterioration|1|||
33279452|NCT01058655|62655093|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
33279453|NCT01058655|62655094|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
33279454|NCT01058655|62655095|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
33279455|NCT01058655|62655096|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
33279456|NCT01058655|62655093|FG000|Overall Study|Death|0|||
33279457|NCT01058655|62655094|FG001|Overall Study|Death|1|||
33279458|NCT01058655|62655095|FG002|Overall Study|Death|1|||
33279459|NCT01058655|62655096|FG003|Overall Study|Death|0|||
33279460|NCT01058655|62655093|FG000|Overall Study|Disease Progression|1|||
33279461|NCT01058655|62655094|FG001|Overall Study|Disease Progression|2|||
33279462|NCT01058655|62655095|FG002|Overall Study|Disease Progression|4|||
33279463|NCT01058655|62655096|FG003|Overall Study|Disease Progression|24|||
33279464|NCT01058655|62655093|FG000|Overall Study|Other|0|||
33279465|NCT01058655|62655094|FG001|Overall Study|Other|0|||
33279466|NCT01058655|62655095|FG002|Overall Study|Other|0|||
33279467|NCT01058655|62655096|FG003|Overall Study|Other|4|||
33279468|NCT01058421|62655109|FG000|1 Month Outcomes|Death|10|||
33279469|NCT01058421|62655110|FG001|1 Month Outcomes|Death|6|||
33279470|NCT01058421|62655109|FG000|1 Month Outcomes|Lost to Follow-up|8|||
33279471|NCT01058421|62655110|FG001|1 Month Outcomes|Lost to Follow-up|7|||
33279472|NCT01058421|62655109|FG000|1 Month Outcomes|Remained in Hospital|5|||
33279473|NCT01058421|62655110|FG001|1 Month Outcomes|Remained in Hospital|12|||
33370612|NCT00848718|62749295|FG010|Overall Study|Progressive disease during treatment|0|||
33279474|NCT01058421|62655109|FG000|1 Month Outcomes|Remained in Other Facility|16|||
33279475|NCT01058421|62655110|FG001|1 Month Outcomes|Remained in Other Facility|17|||
33279476|NCT01058421|62655109|FG000|3 Month Outcomes|Death|3|||
33279477|NCT01058421|62655110|FG001|3 Month Outcomes|Death|5|||
33279478|NCT01058421|62655109|FG000|3 Month Outcomes|Lost to Follow-up|12|||
33279479|NCT01058421|62655110|FG001|3 Month Outcomes|Lost to Follow-up|11|||
33279480|NCT01058421|62655109|FG000|3 Month Outcomes|Remained in Hospital|0|||
33279481|NCT01058421|62655110|FG001|3 Month Outcomes|Remained in Hospital|2|||
33279482|NCT01058421|62655109|FG000|3 Month Outcomes|Remained in Other Facility|5|||
33279483|NCT01058421|62655110|FG001|3 Month Outcomes|Remained in Other Facility|8|||
33279484|NCT01058421|62655109|FG000|6 Month Outcomes|Death|2|||
33279485|NCT01058421|62655110|FG001|6 Month Outcomes|Death|2|||
33279486|NCT01058421|62655109|FG000|6 Month Outcomes|Lost to Follow-up|16|||
33279487|NCT01058421|62655110|FG001|6 Month Outcomes|Lost to Follow-up|21|||
33279488|NCT01058421|62655109|FG000|6 Month Outcomes|Remained in Other Facility|1|||
33279489|NCT01058421|62655110|FG001|6 Month Outcomes|Remained in Other Facility|3|||
33279490|NCT01058304|62655118|FG000|Overall Study|Withdrawal by Subject|8|||
33279491|NCT01058304|62655119|FG001|Overall Study|Withdrawal by Subject|5|||
33279492|NCT01058304|62655118|FG000|Overall Study|Lost to Follow-up|13|||
33279493|NCT01058304|62655119|FG001|Overall Study|Lost to Follow-up|16|||
33279494|NCT01058304|62655118|FG000|Overall Study|Developed exclusion criterion|6|||
33279495|NCT01058304|62655119|FG001|Overall Study|Developed exclusion criterion|12|||
33279496|NCT01058265|62655127|FG000|Overall Study|Lost to Follow-up|11|||
33279497|NCT01058265|62655128|FG001|Overall Study|Lost to Follow-up|12|||
33279498|NCT01057251|62655136|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
33279499|NCT01057251|62655137|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
33279500|NCT01057251|62655136|FG000|Overall Study|Adverse Event|4|||
33279501|NCT01057251|62655137|FG001|Overall Study|Adverse Event|2|||
33279502|NCT01057251|62655136|FG000|Overall Study|Lack of Efficacy|2|||
33279503|NCT01057251|62655137|FG001|Overall Study|Lack of Efficacy|11|||
33279504|NCT01057251|62655136|FG000|Overall Study|Protocol Violation|6|||
33279505|NCT01057251|62655137|FG001|Overall Study|Protocol Violation|2|||
33279506|NCT01057251|62655136|FG000|Overall Study|Withdrawal by Subject|4|||
33279507|NCT01057251|62655137|FG001|Overall Study|Withdrawal by Subject|5|||
33279508|NCT01057251|62655136|FG000|Overall Study|Lost to Follow-up|7|||
33279509|NCT01057251|62655137|FG001|Overall Study|Lost to Follow-up|6|||
33279510|NCT01057251|62655136|FG000|Overall Study|Other Reason|1|||
33279511|NCT01057251|62655137|FG001|Overall Study|Other Reason|1|||
33279512|NCT01056822|62655145|FG000|Overall Study|Adverse Event|0|||
33279513|NCT01056822|62655146|FG001|Overall Study|Adverse Event|1|||
33279514|NCT01056822|62655145|FG000|Overall Study|Protocol Violation|6|||
33279515|NCT01056822|62655146|FG001|Overall Study|Protocol Violation|5|||
33279516|NCT01056822|62655145|FG000|Overall Study|Withdrawal by Subject|1|||
33279517|NCT01056822|62655146|FG001|Overall Study|Withdrawal by Subject|1|||
33279518|NCT01056822|62655145|FG000|Overall Study|Lost to Follow-up|1|||
33279519|NCT01056822|62655146|FG001|Overall Study|Lost to Follow-up|0|||
33279520|NCT01051791|62655153|FG000|Overall Study|Failed screening|3|||
33279521|NCT01051791|62655153|FG000|Overall Study|Withdrawal by Subject|1|||
33279522|NCT01056510|62655165|FG000|Overall Study|Dropout Before Start of Treatment|1|||
33279523|NCT01056510|62655166|FG001|Overall Study|Dropout Before Start of Treatment|1|||
33279524|NCT01056510|62655165|FG000|Overall Study|Withdrawal by Subject|4|||
33279525|NCT01056510|62655166|FG001|Overall Study|Withdrawal by Subject|2|||
33279526|NCT01056510|62655165|FG000|Overall Study|Death|29|||
33279527|NCT01056510|62655166|FG001|Overall Study|Death|34|||
33279528|NCT01056510|62655165|FG000|Overall Study|Noncompliance|1|||
33279529|NCT01056510|62655166|FG001|Overall Study|Noncompliance|3|||
33279530|NCT01056510|62655165|FG000|Overall Study|Physician Decision|4|||
33279531|NCT01056510|62655166|FG001|Overall Study|Physician Decision|5|||
33279532|NCT01056510|62655165|FG000|Overall Study|Lost to Follow-up|5|||
33279533|NCT01056510|62655166|FG001|Overall Study|Lost to Follow-up|6|||
33279534|NCT01056510|62655165|FG000|Overall Study|Other|10|||
33279535|NCT01056510|62655166|FG001|Overall Study|Other|12|||
33279536|NCT01056510|62655165|FG000|Overall Study|Missing|0|||
33279537|NCT01056510|62655166|FG001|Overall Study|Missing|1|||
33279538|NCT01051323|62655174|FG000|Overall Study|Discontinuation of treatment|103|||
33279539|NCT01051323|62655174|FG000|Overall Study|Transplantation|28|||
33279540|NCT01051323|62655174|FG000|Overall Study|Dialysis dependency|22|||
33279541|NCT01051323|62655174|FG000|Overall Study|Withdrawal by Subject|13|||
33279542|NCT01051323|62655174|FG000|Overall Study|Lost to Follow-up|31|||
33279543|NCT01051323|62655174|FG000|Overall Study|Death|129|||
33279544|NCT01051323|62655174|FG000|Overall Study|Hospitalization|28|||
33279545|NCT01051323|62655174|FG000|Overall Study|Other|148|||
33279546|NCT01051323|62655174|FG000|Overall Study|Missing|37|||
33279547|NCT01056276|62655184|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
33279548|NCT01056276|62655185|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
33279549|NCT01056276|62655184|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
33279550|NCT01056276|62655185|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
33279551|NCT01056276|62655184|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
33279552|NCT01056276|62655185|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
33279553|NCT01056276|62655184|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
33279554|NCT01056276|62655185|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
33279555|NCT01056276|62655184|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
33279556|NCT01056276|62655185|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
33279557|NCT01056276|62655184|FG000|Treatment Period-Cycles 1-8|Death|3|||
33279558|NCT01056276|62655185|FG001|Treatment Period-Cycles 1-8|Death|1|||
33279559|NCT01056276|62655184|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
33279560|NCT01056276|62655185|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
33279561|NCT01056276|62655184|FG000|Maintenance Therapy|Toxicity|0|||
33279562|NCT01056276|62655185|FG001|Maintenance Therapy|Toxicity|2|||
33279563|NCT01056276|62655184|FG000|Maintenance Therapy|Progressive Disease|0|||
33279564|NCT01056276|62655185|FG001|Maintenance Therapy|Progressive Disease|9|||
33279565|NCT01056276|62655184|FG000|Maintenance Therapy|Physician Decision|0|||
33279566|NCT01056276|62655185|FG001|Maintenance Therapy|Physician Decision|1|||
33279567|NCT01056276|62655184|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
33279568|NCT01056276|62655185|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
33279569|NCT01056276|62655184|FG000|Maintenance Therapy|Intercurrent Illness|0|||
33279570|NCT01056276|62655185|FG001|Maintenance Therapy|Intercurrent Illness|1|||
33279571|NCT01056276|62655184|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
33279572|NCT01056276|62655185|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
33279573|NCT01055886|62655198|FG000|Overall Study|Withdrawal by Subject|4|||
33279574|NCT01055886|62655199|FG001|Overall Study|Withdrawal by Subject|9|||
33279575|NCT01055886|62655198|FG000|Overall Study|Lost to Follow-up|1|||
33279576|NCT01055886|62655199|FG001|Overall Study|Lost to Follow-up|1|||
33279577|NCT01055886|62655198|FG000|Overall Study|Withdrawal by PI|0|||
33279578|NCT01055886|62655199|FG001|Overall Study|Withdrawal by PI|1|||
33279579|NCT01055613|62655207|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
33279580|NCT01055613|62655208|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33279581|NCT01055613|62655207|FG000|Overall Study|Unacceptable lens fit|1|||
33279582|NCT01055613|62655208|FG001|Overall Study|Unacceptable lens fit|0|||
33279583|NCT01055613|62655207|FG000|Overall Study|Discomfort|2|||
33279584|NCT01055613|62655208|FG001|Overall Study|Discomfort|1|||
33279585|NCT01055613|62655207|FG000|Overall Study|Lost to Follow-up|1|||
33279586|NCT01055613|62655208|FG001|Overall Study|Lost to Follow-up|1|||
33279587|NCT01055613|62655207|FG000|Overall Study|Protocol Violation|1|||
33279588|NCT01055613|62655208|FG001|Overall Study|Protocol Violation|1|||
33279589|NCT01055613|62655207|FG000|Overall Study|Subject Disinterest|1|||
33279590|NCT01055613|62655208|FG001|Overall Study|Subject Disinterest|1|||
33279591|NCT01055457|62655224|FG000|Overall Study|Lost to Follow-up|0|||
33279592|NCT01055457|62655225|FG001|Overall Study|Lost to Follow-up|1|||
33279593|NCT01055457|62655226|FG002|Overall Study|Lost to Follow-up|0|||
33279594|NCT01055457|62655227|FG003|Overall Study|Lost to Follow-up|0|||
33279595|NCT01055457|62655228|FG004|Overall Study|Lost to Follow-up|0|||
33279596|NCT01055457|62655229|FG005|Overall Study|Lost to Follow-up|1|||
33279597|NCT01055457|62655230|FG006|Overall Study|Lost to Follow-up|0|||
33279598|NCT01055457|62655231|FG007|Overall Study|Lost to Follow-up|0|||
33279599|NCT01055457|62655232|FG008|Overall Study|Lost to Follow-up|0|||
33279600|NCT01055457|62655233|FG009|Overall Study|Lost to Follow-up|0|||
33279601|NCT01055457|62655224|FG000|Overall Study|Protocol Violation|0|||
33279602|NCT01055457|62655225|FG001|Overall Study|Protocol Violation|0|||
33662080|NCT02689206|63092812|FG003|Overall Study|Protocol Violation|1|||
33662081|NCT02689206|63092813|FG004|Overall Study|Protocol Violation|2|||
33662082|NCT02689206|63092809|FG000|Overall Study|Other: Reached stopping criteria|0|||
33662083|NCT02689206|63092810|FG001|Overall Study|Other: Reached stopping criteria|1|||
33662084|NCT02689206|63092811|FG002|Overall Study|Other: Reached stopping criteria|2|||
33279603|NCT01055457|62655226|FG002|Overall Study|Protocol Violation|1|||
33279604|NCT01055457|62655227|FG003|Overall Study|Protocol Violation|1|||
33279605|NCT01055457|62655228|FG004|Overall Study|Protocol Violation|1|||
33279606|NCT01055457|62655229|FG005|Overall Study|Protocol Violation|2|||
33279607|NCT01055457|62655230|FG006|Overall Study|Protocol Violation|1|||
33279608|NCT01055457|62655231|FG007|Overall Study|Protocol Violation|0|||
33279609|NCT01055457|62655232|FG008|Overall Study|Protocol Violation|0|||
33279610|NCT01055457|62655233|FG009|Overall Study|Protocol Violation|1|||
33279611|NCT01055457|62655224|FG000|Overall Study|Subject Disinterest|0|||
33279612|NCT01055457|62655225|FG001|Overall Study|Subject Disinterest|0|||
33279613|NCT01055457|62655226|FG002|Overall Study|Subject Disinterest|0|||
33279614|NCT01055457|62655227|FG003|Overall Study|Subject Disinterest|0|||
33279615|NCT01055457|62655228|FG004|Overall Study|Subject Disinterest|0|||
33279616|NCT01055457|62655229|FG005|Overall Study|Subject Disinterest|0|||
33279617|NCT01055457|62655230|FG006|Overall Study|Subject Disinterest|0|||
33279618|NCT01055457|62655231|FG007|Overall Study|Subject Disinterest|1|||
33279619|NCT01055457|62655232|FG008|Overall Study|Subject Disinterest|0|||
33279620|NCT01055457|62655233|FG009|Overall Study|Subject Disinterest|0|||
33279621|NCT01055457|62655224|FG000|Overall Study|Subject Ineligible|1|||
33279622|NCT01055457|62655225|FG001|Overall Study|Subject Ineligible|0|||
33279623|NCT01055457|62655226|FG002|Overall Study|Subject Ineligible|1|||
33279624|NCT01055457|62655227|FG003|Overall Study|Subject Ineligible|0|||
33279625|NCT01055457|62655228|FG004|Overall Study|Subject Ineligible|1|||
33279626|NCT01055457|62655229|FG005|Overall Study|Subject Ineligible|0|||
33279627|NCT01055457|62655230|FG006|Overall Study|Subject Ineligible|0|||
33279628|NCT01055457|62655231|FG007|Overall Study|Subject Ineligible|0|||
33279629|NCT01055457|62655232|FG008|Overall Study|Subject Ineligible|0|||
33279630|NCT01055457|62655233|FG009|Overall Study|Subject Ineligible|0|||
33662085|NCT02689206|63092812|FG003|Overall Study|Other: Reached stopping criteria|3|||
33662086|NCT02689206|63092813|FG004|Overall Study|Other: Reached stopping criteria|4|||
33662087|NCT02689206|63092809|FG000|Overall Study|Physician Decision|1|||
33662088|NCT02689206|63092810|FG001|Overall Study|Physician Decision|0|||
33662089|NCT02689206|63092811|FG002|Overall Study|Physician Decision|0|||
33662090|NCT02689206|63092812|FG003|Overall Study|Physician Decision|0|||
33662091|NCT02689206|63092813|FG004|Overall Study|Physician Decision|0|||
33662092|NCT02689206|63092809|FG000|Overall Study|Withdrawal by Subject|1|||
33662093|NCT02689206|63092810|FG001|Overall Study|Withdrawal by Subject|0|||
33279631|NCT01055457|62655224|FG000|Overall Study|Discomfort|0|||
33279632|NCT01055457|62655225|FG001|Overall Study|Discomfort|0|||
33279633|NCT01055457|62655226|FG002|Overall Study|Discomfort|0|||
33279634|NCT01055457|62655227|FG003|Overall Study|Discomfort|0|||
33279635|NCT01055457|62655228|FG004|Overall Study|Discomfort|1|||
33279636|NCT01055457|62655229|FG005|Overall Study|Discomfort|0|||
33279637|NCT01055457|62655230|FG006|Overall Study|Discomfort|0|||
33279638|NCT01055457|62655231|FG007|Overall Study|Discomfort|0|||
33279639|NCT01055457|62655232|FG008|Overall Study|Discomfort|0|||
33279640|NCT01055457|62655233|FG009|Overall Study|Discomfort|0|||
33279641|NCT01055457|62655224|FG000|Overall Study|Pregnancy|0|||
33279642|NCT01055457|62655225|FG001|Overall Study|Pregnancy|0|||
33279643|NCT01055457|62655226|FG002|Overall Study|Pregnancy|0|||
33279644|NCT01055457|62655227|FG003|Overall Study|Pregnancy|1|||
33279645|NCT01055457|62655228|FG004|Overall Study|Pregnancy|0|||
33279646|NCT01055457|62655229|FG005|Overall Study|Pregnancy|0|||
33279647|NCT01055457|62655230|FG006|Overall Study|Pregnancy|0|||
33279648|NCT01055457|62655231|FG007|Overall Study|Pregnancy|0|||
33279649|NCT01055457|62655232|FG008|Overall Study|Pregnancy|0|||
33370613|NCT00848718|62749296|FG011|Overall Study|Progressive disease during treatment|0|||
33370614|NCT00848718|62749297|FG012|Overall Study|Progressive disease during treatment|2|||
33370615|NCT00883337|62749334|FG000|Core Treatment Period|Adverse Event|9|||
33370616|NCT00883337|62749335|FG001|Core Treatment Period|Adverse Event|12|||
33370617|NCT00883337|62749336|FG002|Core Treatment Period|Adverse Event|22|||
33370618|NCT00883337|62749334|FG000|Core Treatment Period|Lack of Efficacy|7|||
33370619|NCT00883337|62749335|FG001|Core Treatment Period|Lack of Efficacy|4|||
33370620|NCT00883337|62749336|FG002|Core Treatment Period|Lack of Efficacy|2|||
33370621|NCT00883337|62749334|FG000|Core Treatment Period|Lost to Follow-up|1|||
33370622|NCT00883337|62749335|FG001|Core Treatment Period|Lost to Follow-up|1|||
33370623|NCT00883337|62749336|FG002|Core Treatment Period|Lost to Follow-up|0|||
33370624|NCT00883337|62749334|FG000|Core Treatment Period|Withdrawal by Subject|2|||
33370625|NCT00883337|62749335|FG001|Core Treatment Period|Withdrawal by Subject|2|||
33370626|NCT00883337|62749336|FG002|Core Treatment Period|Withdrawal by Subject|6|||
33370627|NCT00883337|62749334|FG000|Core Treatment Period|Wish to be pregnant|1|||
33370628|NCT00883337|62749335|FG001|Core Treatment Period|Wish to be pregnant|2|||
33370629|NCT00883337|62749336|FG002|Core Treatment Period|Wish to be pregnant|1|||
33370630|NCT00883337|62749334|FG000|Core Treatment Period|Poor compliance to protocol|0|||
33370631|NCT00883337|62749335|FG001|Core Treatment Period|Poor compliance to protocol|0|||
33370632|NCT00883337|62749336|FG002|Core Treatment Period|Poor compliance to protocol|1|||
33370633|NCT00883337|62749334|FG000|Core Treatment Period|Other than above|0|||
33370634|NCT00883337|62749335|FG001|Core Treatment Period|Other than above|1|||
33370635|NCT00883337|62749336|FG002|Core Treatment Period|Other than above|1|||
33370636|NCT00883337|62749334|FG000|Extension Treatment Period|Adverse Event|8|||
33370637|NCT00883337|62749335|FG001|Extension Treatment Period|Adverse Event|5|||
33370638|NCT00883337|62749336|FG002|Extension Treatment Period|Adverse Event|5|||
33370639|NCT00883337|62749334|FG000|Extension Treatment Period|Lack of Efficacy|8|||
33370640|NCT00883337|62749335|FG001|Extension Treatment Period|Lack of Efficacy|8|||
33370641|NCT00883337|62749336|FG002|Extension Treatment Period|Lack of Efficacy|8|||
33370642|NCT00883337|62749334|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
33370643|NCT00883337|62749335|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
33370644|NCT00883337|62749336|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
33370645|NCT00883337|62749334|FG000|Extension Treatment Period|Lost to Follow-up|1|||
33662094|NCT02689206|63092811|FG002|Overall Study|Withdrawal by Subject|1|||
33662095|NCT02689206|63092812|FG003|Overall Study|Withdrawal by Subject|0|||
33279650|NCT01055457|62655233|FG009|Overall Study|Pregnancy|0|||
33279651|NCT01055457|62655224|FG000|Overall Study|Adverse Event|0|||
33279652|NCT01055457|62655225|FG001|Overall Study|Adverse Event|0|||
33370646|NCT00883337|62749335|FG001|Extension Treatment Period|Lost to Follow-up|0|||
33370647|NCT00883337|62749336|FG002|Extension Treatment Period|Lost to Follow-up|0|||
33662096|NCT02689206|63092813|FG004|Overall Study|Withdrawal by Subject|0|||
33279653|NCT01055457|62655226|FG002|Overall Study|Adverse Event|0|||
33279654|NCT01055457|62655227|FG003|Overall Study|Adverse Event|1|||
33279655|NCT01055457|62655228|FG004|Overall Study|Adverse Event|0|||
33279656|NCT01055457|62655229|FG005|Overall Study|Adverse Event|0|||
33279657|NCT01055457|62655230|FG006|Overall Study|Adverse Event|0|||
33279658|NCT01055457|62655231|FG007|Overall Study|Adverse Event|0|||
33279659|NCT01055457|62655232|FG008|Overall Study|Adverse Event|0|||
33279660|NCT01055457|62655233|FG009|Overall Study|Adverse Event|0|||
33279661|NCT01055028|62655257|FG000|Screening|Screen Failure|1|||
33279662|NCT01055028|62655258|FG001|Screening|Screen Failure|1|||
33279663|NCT01055028|62655257|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
33279664|NCT01055028|62655258|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
33279665|NCT01055028|62655257|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
33279666|NCT01055028|62655258|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
33279667|NCT01055028|62655257|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
33279668|NCT01055028|62655258|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
33279669|NCT01050816|62655290|FG000|Overall Study|Lost to Follow-up|2|||
33279670|NCT01050816|62655290|FG000|Overall Study|patient's refusal|2|||
33279671|NCT01054560|62655296|FG000|Overall Study|Death|10|||
33279672|NCT01054560|62655297|FG001|Overall Study|Death|21|||
33279673|NCT01054560|62655296|FG000|Overall Study|Lost to Follow-up|2|||
33279674|NCT01054560|62655297|FG001|Overall Study|Lost to Follow-up|5|||
33279675|NCT01054560|62655296|FG000|Overall Study|Withdrawal by Subject|0|||
33279676|NCT01054560|62655297|FG001|Overall Study|Withdrawal by Subject|2|||
33279677|NCT01054560|62655296|FG000|Overall Study|Physician Decision|1|||
33279678|NCT01054560|62655297|FG001|Overall Study|Physician Decision|0|||
33279679|NCT01054443|62655309|FG000|Overall Study|Withdrawal by Subject|0|||
33279680|NCT01054443|62655310|FG001|Overall Study|Withdrawal by Subject|0|||
33279681|NCT01054443|62655311|FG002|Overall Study|Withdrawal by Subject|0|||
33279682|NCT01054443|62655312|FG003|Overall Study|Withdrawal by Subject|1|||
33279683|NCT01050543|62655327|FG000|Overall Study|Withdrawal by Subject|0|||
33279684|NCT01050543|62655328|FG001|Overall Study|Withdrawal by Subject|2|||
33279685|NCT01050543|62655327|FG000|Overall Study|Protocol Violation|0|||
33279686|NCT01050543|62655328|FG001|Overall Study|Protocol Violation|1|||
33279687|NCT01050543|62655327|FG000|Overall Study|Administrative|4|||
33279688|NCT01050543|62655328|FG001|Overall Study|Administrative|1|||
33279689|NCT01051557|62655341|FG000|Overall Study|Physician Decision|1|||
33279690|NCT01051557|62655342|FG001|Overall Study|Physician Decision|0|||
33279691|NCT01051557|62655343|FG002|Overall Study|Physician Decision|0|||
33279692|NCT01051557|62655344|FG003|Overall Study|Physician Decision|0|||
33279693|NCT01051557|62655345|FG004|Overall Study|Physician Decision|0|||
33279694|NCT01051557|62655346|FG005|Overall Study|Physician Decision|0|||
33279695|NCT01051557|62655347|FG006|Overall Study|Physician Decision|0|||
33279696|NCT01051557|62655341|FG000|Overall Study|disease progression|3|||
33279697|NCT01051557|62655342|FG001|Overall Study|disease progression|3|||
33279698|NCT01051557|62655343|FG002|Overall Study|disease progression|5|||
33279699|NCT01051557|62655344|FG003|Overall Study|disease progression|2|||
33279700|NCT01051557|62655345|FG004|Overall Study|disease progression|4|||
33279701|NCT01051557|62655346|FG005|Overall Study|disease progression|3|||
33279702|NCT01051557|62655347|FG006|Overall Study|disease progression|1|||
33279703|NCT01051557|62655341|FG000|Overall Study|Withdrawal by Subject|0|||
33279704|NCT01051557|62655342|FG001|Overall Study|Withdrawal by Subject|0|||
33279705|NCT01051557|62655343|FG002|Overall Study|Withdrawal by Subject|1|||
33279706|NCT01051557|62655344|FG003|Overall Study|Withdrawal by Subject|0|||
33279707|NCT01051557|62655345|FG004|Overall Study|Withdrawal by Subject|2|||
33279708|NCT01051557|62655346|FG005|Overall Study|Withdrawal by Subject|0|||
33279709|NCT01051557|62655347|FG006|Overall Study|Withdrawal by Subject|1|||
33279710|NCT01051557|62655341|FG000|Overall Study|Adverse Event|0|||
33279711|NCT01051557|62655342|FG001|Overall Study|Adverse Event|0|||
33279712|NCT01051557|62655343|FG002|Overall Study|Adverse Event|0|||
33279713|NCT01051557|62655344|FG003|Overall Study|Adverse Event|1|||
33279714|NCT01051557|62655345|FG004|Overall Study|Adverse Event|1|||
33279715|NCT01051557|62655346|FG005|Overall Study|Adverse Event|3|||
33279716|NCT01051557|62655347|FG006|Overall Study|Adverse Event|4|||
33279717|NCT01054170|62655366|FG000|Overall Study|Protocol Violation|1|||
33279718|NCT01054170|62655367|FG001|Overall Study|Protocol Violation|0|||
33279719|NCT01054170|62655366|FG000|Overall Study|Withdrawal by Subject|3|||
33485749|NCT00196937|62863513|FG002|Overall Study|Serious Adverse Event|0|||
33485750|NCT00196937|62863511|FG000|Overall Study|Non-serious adverse event|1|||
33279720|NCT01054170|62655367|FG001|Overall Study|Withdrawal by Subject|2|||
33279721|NCT01054170|62655366|FG000|Overall Study|Adverse Event|0|||
33279722|NCT01054170|62655367|FG001|Overall Study|Adverse Event|4|||
33279723|NCT01053741|62655375|FG000|2nd Study Intervention|Physician Decision|0|||
33279724|NCT01053741|62655376|FG001|2nd Study Intervention|Physician Decision|1|||
33279725|NCT01052493|62655382|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
33279726|NCT01052493|62655383|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
33279727|NCT01052493|62655384|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
33279728|NCT01052103|62655399|FG000|Overall Study|Adverse Event|10|||
33485751|NCT00196937|62863512|FG001|Overall Study|Non-serious adverse event|1|||
33485752|NCT00196937|62863513|FG002|Overall Study|Non-serious adverse event|1|||
33485753|NCT00196937|62863511|FG000|Overall Study|Withdrawal by Subject|0|||
33485754|NCT00196937|62863512|FG001|Overall Study|Withdrawal by Subject|0|||
33485755|NCT00196937|62863513|FG002|Overall Study|Withdrawal by Subject|2|||
33485756|NCT00196937|62863511|FG000|Overall Study|Lost to Follow-up|4|||
33485757|NCT00196937|62863512|FG001|Overall Study|Lost to Follow-up|3|||
33279729|NCT01052103|62655400|FG001|Overall Study|Adverse Event|6|||
33279730|NCT01052103|62655399|FG000|Overall Study|Entry Criteria Not Met|3|||
33279731|NCT01052103|62655400|FG001|Overall Study|Entry Criteria Not Met|1|||
33279732|NCT01052103|62655399|FG000|Overall Study|Lost to Follow-up|3|||
33279733|NCT01052103|62655400|FG001|Overall Study|Lost to Follow-up|5|||
33279734|NCT01052103|62655399|FG000|Overall Study|Protocol Violation|10|||
33279735|NCT01052103|62655400|FG001|Overall Study|Protocol Violation|4|||
33279736|NCT01052103|62655399|FG000|Overall Study|Scheduling conflict|2|||
33279737|NCT01052103|62655400|FG001|Overall Study|Scheduling conflict|1|||
33279738|NCT01052103|62655399|FG000|Overall Study|Sponsor Decision|2|||
33279739|NCT01052103|62655400|FG001|Overall Study|Sponsor Decision|0|||
33279740|NCT01052103|62655399|FG000|Overall Study|Withdrawal by Subject|3|||
33279741|NCT01052103|62655400|FG001|Overall Study|Withdrawal by Subject|6|||
33279742|NCT01052103|62655399|FG000|Overall Study|Perceived Lack of Efficacy|1|||
33279743|NCT01052103|62655400|FG001|Overall Study|Perceived Lack of Efficacy|0|||
33279744|NCT01051986|62655409|FG000|Overall Study|Death|1|||
33279745|NCT01051986|62655410|FG001|Overall Study|Death|0|||
33279746|NCT01051986|62655409|FG000|Overall Study|Withdrawal by Subject|2|||
33279747|NCT01051986|62655410|FG001|Overall Study|Withdrawal by Subject|1|||
33279748|NCT01051986|62655409|FG000|Overall Study|Protocol Violation|2|||
33279749|NCT01051986|62655410|FG001|Overall Study|Protocol Violation|3|||
33279750|NCT03279978|62655426|FG000|Overall Study|Withdrawal by Subject|0|||
33279751|NCT03279978|62655427|FG001|Overall Study|Withdrawal by Subject|1|||
33279752|NCT03279978|62655428|FG002|Overall Study|Withdrawal by Subject|0|||
33279753|NCT03279978|62655429|FG003|Overall Study|Withdrawal by Subject|0|||
33279754|NCT03279978|62655430|FG004|Overall Study|Withdrawal by Subject|0|||
33279755|NCT03279978|62655431|FG005|Overall Study|Withdrawal by Subject|0|||
33279756|NCT03279978|62655432|FG006|Overall Study|Withdrawal by Subject|0|||
33279757|NCT03279978|62655433|FG007|Overall Study|Withdrawal by Subject|0|||
33279758|NCT03279978|62655434|FG008|Overall Study|Withdrawal by Subject|0|||
33279759|NCT03279978|62655435|FG009|Overall Study|Withdrawal by Subject|1|||
33279760|NCT03279978|62655426|FG000|Overall Study|Lost to Follow-up|1|||
33279761|NCT03279978|62655427|FG001|Overall Study|Lost to Follow-up|0|||
33279762|NCT03279978|62655428|FG002|Overall Study|Lost to Follow-up|1|||
33279763|NCT03279978|62655429|FG003|Overall Study|Lost to Follow-up|0|||
33279764|NCT03279978|62655430|FG004|Overall Study|Lost to Follow-up|0|||
33279765|NCT03279978|62655431|FG005|Overall Study|Lost to Follow-up|0|||
33279766|NCT03279978|62655432|FG006|Overall Study|Lost to Follow-up|0|||
33279767|NCT03279978|62655433|FG007|Overall Study|Lost to Follow-up|0|||
33279768|NCT03279978|62655434|FG008|Overall Study|Lost to Follow-up|0|||
33279769|NCT03279978|62655435|FG009|Overall Study|Lost to Follow-up|0|||
33279770|NCT03279978|62655426|FG000|Overall Study|Other than stated above|0|||
33279771|NCT03279978|62655427|FG001|Overall Study|Other than stated above|0|||
33279772|NCT03279978|62655428|FG002|Overall Study|Other than stated above|0|||
33279773|NCT03279978|62655429|FG003|Overall Study|Other than stated above|0|||
33279774|NCT03279978|62655430|FG004|Overall Study|Other than stated above|0|||
33279775|NCT03279978|62655431|FG005|Overall Study|Other than stated above|0|||
33279776|NCT03279978|62655432|FG006|Overall Study|Other than stated above|1|||
33279777|NCT03279978|62655433|FG007|Overall Study|Other than stated above|0|||
33279778|NCT03279978|62655434|FG008|Overall Study|Other than stated above|0|||
33279779|NCT03279978|62655435|FG009|Overall Study|Other than stated above|0|||
33279780|NCT00105534|62655468|FG000|Overall Study|Adverse Event|2|||
33279781|NCT00105534|62655469|FG001|Overall Study|Adverse Event|5|||
33279782|NCT00105534|62655468|FG000|Overall Study|Protocol Violation|1|||
33279783|NCT00105534|62655469|FG001|Overall Study|Protocol Violation|4|||
33279784|NCT00105534|62655468|FG000|Overall Study|Withdrawal by Subject|6|||
33279785|NCT00105534|62655469|FG001|Overall Study|Withdrawal by Subject|6|||
33279786|NCT00105534|62655468|FG000|Overall Study|Lost to Follow-up|5|||
33279787|NCT00105534|62655469|FG001|Overall Study|Lost to Follow-up|1|||
33279788|NCT00105534|62655468|FG000|Overall Study|Lack of Efficacy|7|||
33279789|NCT00105534|62655469|FG001|Overall Study|Lack of Efficacy|15|||
33279790|NCT00105534|62655468|FG000|Overall Study|Treatment unmasked|1|||
33279791|NCT00105534|62655469|FG001|Overall Study|Treatment unmasked|0|||
33279792|NCT00105534|62655468|FG000|Overall Study|Other Reason|0|||
33279793|NCT00105534|62655469|FG001|Overall Study|Other Reason|2|||
33279794|NCT00105183|62655478|FG000|Overall Study|Death|19|||
33279795|NCT00105183|62655479|FG001|Overall Study|Death|13|||
33279796|NCT00105183|62655480|FG002|Overall Study|Death|15|||
33279797|NCT00105183|62655478|FG000|Overall Study|Withdrawal by Subject|1|||
33279798|NCT00105183|62655479|FG001|Overall Study|Withdrawal by Subject|1|||
33279799|NCT00105183|62655480|FG002|Overall Study|Withdrawal by Subject|4|||
33279800|NCT00105183|62655478|FG000|Overall Study|Physician Decision|1|||
33279801|NCT00105183|62655479|FG001|Overall Study|Physician Decision|2|||
33279802|NCT00105183|62655480|FG002|Overall Study|Physician Decision|3|||
33279803|NCT00105183|62655478|FG000|Overall Study|Lost to Follow-up|0|||
33279804|NCT00105183|62655479|FG001|Overall Study|Lost to Follow-up|1|||
33279805|NCT00105183|62655480|FG002|Overall Study|Lost to Follow-up|1|||
33279806|NCT00105183|62655478|FG000|Overall Study|Other reason|1|||
33279807|NCT00105183|62655479|FG001|Overall Study|Other reason|2|||
33279808|NCT00105183|62655480|FG002|Overall Study|Other reason|0|||
33279809|NCT01059617|62655492|FG000|Overall Study|Other|7|||
33279810|NCT01059617|62655493|FG001|Overall Study|Other|1|||
33279811|NCT01059617|62655494|FG002|Overall Study|Other|8|||
33279812|NCT01059617|62655495|FG003|Overall Study|Other|6|||
33279813|NCT01059344|62655515|FG000|Overall Study|Adverse Event|12|||
33279814|NCT01059344|62655516|FG001|Overall Study|Adverse Event|30|||
33279815|NCT01059344|62655515|FG000|Overall Study|Withdrawal by Subject|6|||
33279816|NCT01059344|62655516|FG001|Overall Study|Withdrawal by Subject|9|||
33279817|NCT01059344|62655515|FG000|Overall Study|Lost to Follow-up|1|||
33279818|NCT01059344|62655516|FG001|Overall Study|Lost to Follow-up|1|||
33279819|NCT01059344|62655515|FG000|Overall Study|Other|3|||
33279820|NCT01059344|62655516|FG001|Overall Study|Other|6|||
33662097|NCT01695239|63092833|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
33662098|NCT01695239|63092834|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
33662099|NCT01695239|63092835|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
33662100|NCT01695239|63092836|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
33662101|NCT01695239|63092837|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33662102|NCT01695239|63092838|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33662103|NCT01695239|63092839|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33662104|NCT01695239|63092840|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33662105|NCT01695239|63092841|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33662106|NCT01695239|63092842|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33662107|NCT01695239|63092843|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33279833|NCT01058369|62655535|FG000|Overall Study|Adverse Event|1|||
33279834|NCT01058369|62655535|FG000|Overall Study|Early termination study|1|||
33279835|NCT01057433|62655539|FG000|Overall Study|Adverse Event|1|||
33279836|NCT01057394|62655543|FG000|Overall Study|Not eligible|0|||
33279837|NCT01057394|62655544|FG001|Overall Study|Not eligible|2|||
33279838|NCT01058642|62655552|FG000|Treatment Period 1|Adverse Event|0|||
33279839|NCT01058642|62655553|FG001|Treatment Period 1|Adverse Event|1|||
33485758|NCT00196937|62863513|FG002|Overall Study|Lost to Follow-up|3|||
33485759|NCT00196937|62863511|FG000|Overall Study|Other|3|||
33485760|NCT00196937|62863512|FG001|Overall Study|Other|1|||
33485761|NCT00196937|62863513|FG002|Overall Study|Other|1|||
33485762|NCT04397445|62863522|FG000|Overall Study|Withdrawal by Subject|1|||
33485763|NCT04397445|62863523|FG001|Overall Study|Withdrawal by Subject|0|||
33485764|NCT04397445|62863524|FG002|Overall Study|Withdrawal by Subject|0|||
33485765|NCT04397445|62863525|FG003|Overall Study|Withdrawal by Subject|0|||
33279840|NCT01058642|62655554|FG002|Treatment Period 1|Adverse Event|1|||
33279841|NCT01058642|62655555|FG003|Treatment Period 1|Adverse Event|0|||
33485766|NCT00191945|62863542|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
33485767|NCT00191945|62863543|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
33279842|NCT01058642|62655552|FG000|Treatment Period 1|Physician Decision|0|||
33279843|NCT01058642|62655553|FG001|Treatment Period 1|Physician Decision|0|||
33279844|NCT01058642|62655554|FG002|Treatment Period 1|Physician Decision|1|||
33279845|NCT01058642|62655555|FG003|Treatment Period 1|Physician Decision|0|||
33485768|NCT00191945|62863542|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
33485769|NCT00191945|62863543|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
33485770|NCT00191945|62863542|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
33485771|NCT00191945|62863543|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
33485772|NCT00191945|62863542|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
33485773|NCT00191945|62863543|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
33485774|NCT01369342|62863553|FG000|Overall Study|Withdrawal by Subject|7|||
33485775|NCT01369342|62863554|FG001|Overall Study|Withdrawal by Subject|7|||
33485776|NCT01369342|62863555|FG002|Overall Study|Withdrawal by Subject|2|||
33485777|NCT01369342|62863553|FG000|Overall Study|Lost to Follow-up|5|||
33485778|NCT01369342|62863554|FG001|Overall Study|Lost to Follow-up|2|||
33485779|NCT01369342|62863555|FG002|Overall Study|Lost to Follow-up|1|||
33485780|NCT01369342|62863553|FG000|Overall Study|Not Treated|1|||
33485781|NCT01369342|62863554|FG001|Overall Study|Not Treated|0|||
33485782|NCT01369342|62863555|FG002|Overall Study|Not Treated|0|||
33485783|NCT00191477|62863565|FG000|Overall Study|Tumor Recurrence|49|||
33279846|NCT01058642|62655552|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33279847|NCT01058642|62655553|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33279848|NCT01058642|62655554|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33279849|NCT01058642|62655555|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33279850|NCT01058642|62655552|FG000|Treatment Period 1|Lack of Efficacy|0|||
33279851|NCT01058642|62655553|FG001|Treatment Period 1|Lack of Efficacy|0|||
33485784|NCT00191477|62863566|FG001|Overall Study|Tumor Recurrence|48|||
33279852|NCT01058642|62655554|FG002|Treatment Period 1|Lack of Efficacy|0|||
33279853|NCT01058642|62655555|FG003|Treatment Period 1|Lack of Efficacy|1|||
33279854|NCT01058642|62655552|FG000|Treatment Period 1|Protocol Violation|0|||
33279855|NCT01058642|62655553|FG001|Treatment Period 1|Protocol Violation|0|||
33279856|NCT01058642|62655554|FG002|Treatment Period 1|Protocol Violation|0|||
33279857|NCT01058642|62655555|FG003|Treatment Period 1|Protocol Violation|1|||
33485785|NCT00191477|62863565|FG000|Overall Study|Death, Study Disease|1|||
33279858|NCT01058642|62655552|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
33279859|NCT01058642|62655553|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
33279860|NCT01058642|62655554|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
33279861|NCT01058642|62655555|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
33279862|NCT01056653|62655566|FG000|Overall Study|Lost to Follow-up|0|||
33279863|NCT01056653|62655567|FG001|Overall Study|Lost to Follow-up|0|||
33279864|NCT01056653|62655568|FG002|Overall Study|Lost to Follow-up|2|||
33279865|NCT01056536|62655580|FG000|Overall Study|Lost to Follow-up|202|||
33279866|NCT01056536|62655581|FG001|Overall Study|Lost to Follow-up|116|||
33279867|NCT01056536|62655582|FG002|Overall Study|Lost to Follow-up|248|||
33279868|NCT01056380|62655592|FG000|Overall Study|Lost to Follow-up|2|||
33279869|NCT01056380|62655593|FG001|Overall Study|Lost to Follow-up|3|||
33279870|NCT01055834|62655603|FG000|Treatment Period I|Adverse Event|1|||
33279871|NCT01055834|62655604|FG001|Treatment Period I|Adverse Event|0|||
33279872|NCT01055639|62655615|FG000|Overall Study|Adverse Event|0|||
33279873|NCT01055639|62655616|FG001|Overall Study|Adverse Event|1|||
33279874|NCT01055639|62655615|FG000|Overall Study|Lack of Efficacy|0|||
33279875|NCT01055639|62655616|FG001|Overall Study|Lack of Efficacy|1|||
33485786|NCT00191477|62863566|FG001|Overall Study|Death, Study Disease|1|||
33485787|NCT00191477|62863565|FG000|Overall Study|Death, Other Cause|3|||
33485788|NCT00191477|62863566|FG001|Overall Study|Death, Other Cause|6|||
33279876|NCT01055639|62655615|FG000|Overall Study|Lost to Follow-up|8|||
33279877|NCT01055639|62655616|FG001|Overall Study|Lost to Follow-up|11|||
33279878|NCT01055639|62655615|FG000|Overall Study|Protocol Violation|5|||
33279879|NCT01055639|62655616|FG001|Overall Study|Protocol Violation|5|||
33279880|NCT01055639|62655615|FG000|Overall Study|Withdrawal by Subject|8|||
33279881|NCT01055639|62655616|FG001|Overall Study|Withdrawal by Subject|11|||
33279882|NCT01055132|62655631|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
33279883|NCT01055132|62655632|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
33279884|NCT01055132|62655631|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
33279885|NCT01055132|62655632|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
33279886|NCT01054976|62655642|FG000|Overall Study|Adverse Event|16|||
33279887|NCT01054976|62655642|FG000|Overall Study|Uncooperative participations to study|7|||
33485789|NCT00191477|62863565|FG000|Overall Study|Lost to Follow-up|23|||
33485790|NCT00191477|62863566|FG001|Overall Study|Lost to Follow-up|21|||
33485791|NCT00191477|62863565|FG000|Overall Study|Protocol Violation|1|||
33485792|NCT00191477|62863566|FG001|Overall Study|Protocol Violation|1|||
33485793|NCT00191477|62863565|FG000|Overall Study|Treatment Change|2|||
33485794|NCT00191477|62863566|FG001|Overall Study|Treatment Change|0|||
33485795|NCT00191477|62863565|FG000|Overall Study|Withdrawal by Subject|2|||
33485796|NCT00191477|62863566|FG001|Overall Study|Withdrawal by Subject|0|||
33485797|NCT00191477|62863565|FG000|Overall Study|Other|2|||
33485798|NCT00191477|62863566|FG001|Overall Study|Other|0|||
33485799|NCT00191477|62863565|FG000|Overall Study|Not Eligible|41|||
33485800|NCT00191477|62863566|FG001|Overall Study|Not Eligible|38|||
33485801|NCT00191477|62863565|FG000|Overall Study|Pathological Specimen Lost|1|||
33485802|NCT00191477|62863566|FG001|Overall Study|Pathological Specimen Lost|0|||
33485803|NCT00191477|62863565|FG000|Overall Study|Discontinued Prior to Instillation|13|||
33485804|NCT00191477|62863566|FG001|Overall Study|Discontinued Prior to Instillation|14|||
33485805|NCT04320615|62863574|FG000|Overall Study|Withdrawal by Subject|4|||
33485806|NCT04320615|62863575|FG001|Overall Study|Withdrawal by Subject|10|||
33485807|NCT04320615|62863574|FG000|Overall Study|Physician Decision|2|||
33485808|NCT04320615|62863575|FG001|Overall Study|Physician Decision|0|||
33485809|NCT04320615|62863574|FG000|Overall Study|Other|2|||
33485810|NCT04320615|62863575|FG001|Overall Study|Other|0|||
33485811|NCT04320615|62863574|FG000|Overall Study|Lost to Follow-up|5|||
33485812|NCT04320615|62863575|FG001|Overall Study|Lost to Follow-up|23|||
33485813|NCT04320615|62863574|FG000|Overall Study|Death|35|||
33485814|NCT04320615|62863575|FG001|Overall Study|Death|71|||
33485815|NCT00149747|62863587|FG000|Overall Study|Death|1|||
33485816|NCT00149747|62863588|FG001|Overall Study|Death|0|||
33485817|NCT00149747|62863587|FG000|Overall Study|Withdrawal by Subject|3|||
33485818|NCT00149747|62863588|FG001|Overall Study|Withdrawal by Subject|3|||
33485819|NCT00187889|62863596|FG000|Overall Study|Withdrawal by Subject|6|||
33485820|NCT00187889|62863597|FG001|Overall Study|Withdrawal by Subject|4|||
33485821|NCT00148343|62863606|FG000|Overall Study|Withdrawal by Subject|12|||
33485822|NCT00148343|62863607|FG001|Overall Study|Withdrawal by Subject|7|||
33485823|NCT00148343|62863606|FG000|Overall Study|Physician Decision|3|||
33485824|NCT00148343|62863607|FG001|Overall Study|Physician Decision|4|||
33279888|NCT01054976|62655642|FG000|Overall Study|Withdrawal by Subject|4|||
33279889|NCT01054976|62655642|FG000|Overall Study|Other|8|||
33279890|NCT01053962|62655651|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
33279891|NCT01053962|62655652|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
33279892|NCT01053962|62655653|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
33279893|NCT01053962|62655654|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
33485825|NCT04150341|62863613|FG000|Overall Study|Physician Decision|0|||
33279894|NCT01053962|62655655|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
33279895|NCT01053962|62655651|FG000|Pretreatment Period|Venipuncture Failure|0|||
33279896|NCT01053962|62655652|FG001|Pretreatment Period|Venipuncture Failure|0|||
33279897|NCT01053962|62655653|FG002|Pretreatment Period|Venipuncture Failure|1|||
33279898|NCT01053962|62655654|FG003|Pretreatment Period|Venipuncture Failure|0|||
33279899|NCT01053962|62655655|FG004|Pretreatment Period|Venipuncture Failure|0|||
33279900|NCT01053962|62655651|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
33279901|NCT01053962|62655652|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
33279902|NCT01053962|62655653|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
33279903|NCT01053962|62655654|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
33279904|NCT01053962|62655655|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
33279905|NCT01053962|62655651|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
33279906|NCT01053962|62655652|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
33279907|NCT01053962|62655653|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
33279908|NCT01053962|62655654|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
33279909|NCT01053962|62655655|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
33279910|NCT01053962|62655651|FG000|Treatment Period|Lack of Efficacy|0|||
33279911|NCT01053962|62655652|FG001|Treatment Period|Lack of Efficacy|0|||
33279912|NCT01053962|62655653|FG002|Treatment Period|Lack of Efficacy|0|||
33279913|NCT01053962|62655654|FG003|Treatment Period|Lack of Efficacy|0|||
33279914|NCT01053962|62655655|FG004|Treatment Period|Lack of Efficacy|1|||
33485826|NCT04150341|62863614|FG001|Overall Study|Physician Decision|0|||
33485827|NCT04150341|62863615|FG002|Overall Study|Physician Decision|1|||
33485828|NCT04150341|62863616|FG003|Overall Study|Physician Decision|0|||
33485829|NCT04150341|62863617|FG004|Overall Study|Physician Decision|0|||
33485830|NCT04150341|62863618|FG005|Overall Study|Physician Decision|0|||
33485831|NCT04150341|62863613|FG000|Overall Study|Adverse Event|0|||
33485832|NCT04150341|62863614|FG001|Overall Study|Adverse Event|0|||
33485833|NCT04150341|62863615|FG002|Overall Study|Adverse Event|0|||
33485834|NCT04150341|62863616|FG003|Overall Study|Adverse Event|0|||
33485835|NCT04150341|62863617|FG004|Overall Study|Adverse Event|1|||
33485836|NCT04150341|62863618|FG005|Overall Study|Adverse Event|0|||
33485837|NCT00148109|62863630|FG000|Overall Study|Lack of Efficacy|10|||
33485838|NCT00148109|62863631|FG001|Overall Study|Lack of Efficacy|18|||
33485839|NCT00148109|62863630|FG000|Overall Study|Adverse Event|0|||
33485840|NCT00148109|62863631|FG001|Overall Study|Adverse Event|2|||
33485841|NCT00148109|62863630|FG000|Overall Study|Withdrawal by Subject|2|||
33485842|NCT00148109|62863631|FG001|Overall Study|Withdrawal by Subject|0|||
33485843|NCT00186485|62863637|FG000|Overall Study|Lost to Follow-up|3|||
33485844|NCT00147251|62863643|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
33485845|NCT00147251|62863644|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
33485846|NCT04390191|62863654|FG000|Overall Study|Withdrawal by Subject|1|||
33485847|NCT04390191|62863655|FG001|Overall Study|Withdrawal by Subject|0|||
33485848|NCT04405076|62863667|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
33485849|NCT04405076|62863668|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
33485850|NCT04405076|62863669|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
33485851|NCT04405076|62863670|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
33485852|NCT04405076|62863671|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
33485853|NCT04405076|62863672|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
33485854|NCT04405076|62863673|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
33485855|NCT04405076|62863674|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
33555821|NCT01975831|62948593|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
33662108|NCT01695239|63092844|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33662109|NCT01695239|63092845|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33662110|NCT01695239|63092846|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33662111|NCT01695239|63092833|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
33662112|NCT01695239|63092834|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
33662113|NCT01695239|63092835|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
33662114|NCT01695239|63092836|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
33662115|NCT01695239|63092837|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33662116|NCT01695239|63092838|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33662117|NCT01695239|63092839|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33662118|NCT01695239|63092840|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33662119|NCT01695239|63092841|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33662120|NCT01695239|63092842|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33662121|NCT01695239|63092843|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33662122|NCT01695239|63092844|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33662123|NCT01695239|63092845|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33662124|NCT01695239|63092846|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33279915|NCT01053962|62655651|FG000|Treatment Period|Adverse Event|0|||
33279916|NCT01053962|62655652|FG001|Treatment Period|Adverse Event|0|||
33279917|NCT01053962|62655653|FG002|Treatment Period|Adverse Event|0|||
33279918|NCT01053962|62655654|FG003|Treatment Period|Adverse Event|0|||
33485856|NCT04405076|62863675|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
33485857|NCT04405076|62863667|FG000|Part A (Blinded Phase)|Physician Decision|1|||
33485858|NCT04405076|62863668|FG001|Part A (Blinded Phase)|Physician Decision|2|||
33485859|NCT04405076|62863669|FG002|Part A (Blinded Phase)|Physician Decision|0|||
33485860|NCT04405076|62863670|FG003|Part A (Blinded Phase)|Physician Decision|0|||
33485861|NCT04405076|62863671|FG004|Part A (Blinded Phase)|Physician Decision|0|||
33485862|NCT04405076|62863672|FG005|Part A (Blinded Phase)|Physician Decision|0|||
33485863|NCT04405076|62863673|FG006|Part A (Blinded Phase)|Physician Decision|0|||
33485864|NCT04405076|62863674|FG007|Part A (Blinded Phase)|Physician Decision|0|||
33485865|NCT04405076|62863675|FG008|Part A (Blinded Phase)|Physician Decision|0|||
33485866|NCT04405076|62863667|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
33485867|NCT04405076|62863668|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
33485868|NCT04405076|62863669|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
33485869|NCT04405076|62863670|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
33485870|NCT04405076|62863671|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
33485871|NCT04405076|62863672|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
33485872|NCT04405076|62863673|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
33485873|NCT04405076|62863674|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
33485874|NCT04405076|62863675|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
33485875|NCT04405076|62863667|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
33485876|NCT04405076|62863668|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33485877|NCT04405076|62863669|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33485878|NCT04405076|62863670|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33485879|NCT04405076|62863671|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33485880|NCT04405076|62863672|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33485881|NCT04405076|62863673|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33485882|NCT04405076|62863674|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33485883|NCT04405076|62863675|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33485884|NCT04405076|62863667|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
33485885|NCT04405076|62863668|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
33485886|NCT04405076|62863669|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
33485887|NCT04405076|62863670|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
33485888|NCT04405076|62863671|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
33485889|NCT04405076|62863672|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
33485890|NCT04405076|62863673|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
33485891|NCT04405076|62863674|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
33485892|NCT04405076|62863675|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
33485893|NCT04405076|62863667|FG000|Part A (Blinded Phase)|Other than Specified|0|||
33485894|NCT04405076|62863668|FG001|Part A (Blinded Phase)|Other than Specified|0|||
33485895|NCT04405076|62863669|FG002|Part A (Blinded Phase)|Other than Specified|3|||
33485896|NCT04405076|62863670|FG003|Part A (Blinded Phase)|Other than Specified|0|||
33485897|NCT04405076|62863671|FG004|Part A (Blinded Phase)|Other than Specified|0|||
33485898|NCT04405076|62863672|FG005|Part A (Blinded Phase)|Other than Specified|0|||
33485899|NCT04405076|62863673|FG006|Part A (Blinded Phase)|Other than Specified|0|||
33485900|NCT04405076|62863674|FG007|Part A (Blinded Phase)|Other than Specified|0|||
33485901|NCT04405076|62863675|FG008|Part A (Blinded Phase)|Other than Specified|0|||
33485902|NCT04405076|62863667|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
33485903|NCT04405076|62863668|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
33279919|NCT01053962|62655655|FG004|Treatment Period|Adverse Event|1|||
33279920|NCT01053962|62655651|FG000|Treatment Period|Withdrawal by Subject|0|||
33279921|NCT01053962|62655652|FG001|Treatment Period|Withdrawal by Subject|0|||
33279922|NCT01053962|62655653|FG002|Treatment Period|Withdrawal by Subject|0|||
33279923|NCT01053962|62655654|FG003|Treatment Period|Withdrawal by Subject|0|||
33279924|NCT01053962|62655655|FG004|Treatment Period|Withdrawal by Subject|1|||
33279925|NCT01053962|62655651|FG000|Treatment Period|Noncompliance with protocol|1|||
33279926|NCT01053962|62655652|FG001|Treatment Period|Noncompliance with protocol|0|||
33279927|NCT01053962|62655653|FG002|Treatment Period|Noncompliance with protocol|0|||
33279928|NCT01053962|62655654|FG003|Treatment Period|Noncompliance with protocol|0|||
33279929|NCT01053962|62655655|FG004|Treatment Period|Noncompliance with protocol|0|||
33279930|NCT01053221|62655674|FG000|Overall Study|The study was closed prematurely|5|||
33279931|NCT01053221|62655675|FG001|Overall Study|The study was closed prematurely|9|||
33279932|NCT01052012|62655687|FG000|Overall Study|Not treated|2|||
33279933|NCT01052012|62655688|FG001|Overall Study|Not treated|5|||
33485904|NCT04405076|62863669|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
33279934|NCT01052012|62655689|FG002|Overall Study|Not treated|0|||
33279935|NCT01052012|62655690|FG003|Overall Study|Not treated|0|||
33279936|NCT01052012|62655691|FG004|Overall Study|Not treated|11|||
33279937|NCT01052012|62655692|FG005|Overall Study|Not treated|8|||
33279938|NCT01052012|62655687|FG000|Overall Study|Adverse Event|1|||
33279939|NCT01052012|62655688|FG001|Overall Study|Adverse Event|0|||
33279940|NCT01052012|62655689|FG002|Overall Study|Adverse Event|0|||
33279941|NCT01052012|62655690|FG003|Overall Study|Adverse Event|1|||
33279942|NCT01052012|62655691|FG004|Overall Study|Adverse Event|0|||
33279943|NCT01052012|62655692|FG005|Overall Study|Adverse Event|0|||
33279944|NCT01052012|62655687|FG000|Overall Study|Lost to Follow-up|0|||
33279945|NCT01052012|62655688|FG001|Overall Study|Lost to Follow-up|0|||
33279946|NCT01052012|62655689|FG002|Overall Study|Lost to Follow-up|0|||
33279947|NCT01052012|62655690|FG003|Overall Study|Lost to Follow-up|0|||
33279948|NCT01052012|62655691|FG004|Overall Study|Lost to Follow-up|1|||
33279949|NCT01052012|62655692|FG005|Overall Study|Lost to Follow-up|0|||
33279950|NCT01052012|62655687|FG000|Overall Study|Withdrawal by Subject|1|||
33279951|NCT01052012|62655688|FG001|Overall Study|Withdrawal by Subject|1|||
33485905|NCT04405076|62863670|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
33485906|NCT04405076|62863671|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
33485907|NCT04405076|62863672|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
33485908|NCT04405076|62863673|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
33485909|NCT04405076|62863674|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
33485910|NCT04405076|62863675|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
33279952|NCT01052012|62655689|FG002|Overall Study|Withdrawal by Subject|0|||
33279953|NCT01052012|62655690|FG003|Overall Study|Withdrawal by Subject|0|||
33279954|NCT01052012|62655691|FG004|Overall Study|Withdrawal by Subject|3|||
33279955|NCT01052012|62655692|FG005|Overall Study|Withdrawal by Subject|1|||
33279956|NCT01052012|62655687|FG000|Overall Study|Physician Decision|0|||
33279957|NCT01052012|62655688|FG001|Overall Study|Physician Decision|0|||
33279958|NCT01052012|62655689|FG002|Overall Study|Physician Decision|0|||
33279959|NCT01052012|62655690|FG003|Overall Study|Physician Decision|0|||
33279960|NCT01052012|62655691|FG004|Overall Study|Physician Decision|0|||
33279961|NCT01052012|62655692|FG005|Overall Study|Physician Decision|1|||
33279962|NCT01052012|62655687|FG000|Overall Study|Other|0|||
33485911|NCT04405076|62863667|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33485912|NCT04405076|62863668|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33555822|NCT01975831|62948594|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
33555823|NCT01975831|62948595|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
33555824|NCT01975831|62948596|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
33555825|NCT01975831|62948597|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
33555826|NCT01975831|62948598|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
33555827|NCT01975831|62948599|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
33555828|NCT01975831|62948600|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
33555829|NCT00700713|62948623|FG000|Overall Study|Protocol Violation|1|||
33555830|NCT00700713|62948624|FG001|Overall Study|Protocol Violation|0|||
33555831|NCT00700713|62948625|FG002|Overall Study|Protocol Violation|1|||
33555832|NCT00700713|62948623|FG000|Overall Study|Withdrawal by Subject|0|||
33555833|NCT00700713|62948624|FG001|Overall Study|Withdrawal by Subject|0|||
33555834|NCT00700713|62948625|FG002|Overall Study|Withdrawal by Subject|1|||
33555835|NCT02622386|62948633|FG000|First Assignment|Withdrawal by Subject|3|||
33555836|NCT02622386|62948634|FG001|First Assignment|Withdrawal by Subject|2|||
33555837|NCT02622386|62948633|FG000|Washout|Withdrawal by Subject|4|||
33555838|NCT02622386|62948634|FG001|Washout|Withdrawal by Subject|4|||
33662125|NCT01695239|63092833|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
33555839|NCT02622386|62948633|FG000|Second Assignment|Withdrawal by Subject|0|||
33555840|NCT02622386|62948634|FG001|Second Assignment|Withdrawal by Subject|2|||
33555841|NCT02792231|62948642|FG000|Overall Study|Patient/guardian decision|32|||
33555842|NCT02792231|62948643|FG001|Overall Study|Patient/guardian decision|42|||
33555843|NCT02792231|62948642|FG000|Overall Study|Adverse Event|15|||
33555844|NCT02792231|62948643|FG001|Overall Study|Adverse Event|11|||
33555845|NCT02792231|62948642|FG000|Overall Study|Physician Decision|14|||
33662126|NCT01695239|63092834|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33485913|NCT04405076|62863669|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33485914|NCT04405076|62863670|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33485915|NCT04405076|62863671|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
33485916|NCT04405076|62863672|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33555846|NCT02792231|62948643|FG001|Overall Study|Physician Decision|12|||
33555847|NCT02792231|62948642|FG000|Overall Study|Lack of Efficacy|7|||
33555848|NCT02792231|62948643|FG001|Overall Study|Lack of Efficacy|9|||
33662127|NCT01695239|63092835|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
33662128|NCT01695239|63092836|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33279963|NCT01052012|62655688|FG001|Overall Study|Other|0|||
33279964|NCT01052012|62655689|FG002|Overall Study|Other|0|||
33279965|NCT01052012|62655690|FG003|Overall Study|Other|0|||
33279966|NCT01052012|62655691|FG004|Overall Study|Other|1|||
33555849|NCT02792231|62948642|FG000|Overall Study|Lost to Follow-up|9|||
33555850|NCT02792231|62948643|FG001|Overall Study|Lost to Follow-up|5|||
33555851|NCT02792231|62948642|FG000|Overall Study|Pregnancy|1|||
33279967|NCT01052012|62655692|FG005|Overall Study|Other|0|||
33279968|NCT01051817|62655708|FG000|Overall Study|Adverse Event|0|||
33555852|NCT02792231|62948643|FG001|Overall Study|Pregnancy|3|||
33555853|NCT02792231|62948642|FG000|Overall Study|Non-compliance with study treatment|2|||
33555854|NCT02792231|62948643|FG001|Overall Study|Non-compliance with study treatment|1|||
33555855|NCT02792231|62948642|FG000|Overall Study|Protocol deviation|2|||
33555856|NCT02792231|62948643|FG001|Overall Study|Protocol deviation|0|||
33555857|NCT02792231|62948642|FG000|Overall Study|Technical problems|0|||
33555858|NCT02792231|62948643|FG001|Overall Study|Technical problems|1|||
33555859|NCT00700401|62948649|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
33555860|NCT00700401|62948649|FG000|Overall Study|Adverse Event|5|||
33555861|NCT00700401|62948649|FG000|Overall Study|Refused Treatment|2|||
33555862|NCT00700401|62948649|FG000|Overall Study|Lost to Follow-up|1|||
33555863|NCT00700401|62948649|FG000|Overall Study|Treatment never started|1|||
33485917|NCT04405076|62863673|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33485918|NCT04405076|62863674|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33485919|NCT04405076|62863675|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33485920|NCT04405076|62863667|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
33555864|NCT00700401|62948649|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
33555865|NCT00700401|62948649|FG000|Overall Study|Withdrawal by Subject|2|||
33555866|NCT02621606|62948656|FG000|Overall Study|Withdrawal by Subject|0|||
33555867|NCT02621606|62948657|FG001|Overall Study|Withdrawal by Subject|1|||
33555868|NCT02621606|62948658|FG002|Overall Study|Withdrawal by Subject|0|||
33555869|NCT02871401|62948668|FG000|Overall Study|Adverse Event|1|||
33555870|NCT02871401|62948669|FG001|Overall Study|Adverse Event|0|||
33555871|NCT02619812|62948679|FG000|Overall Study|Withdrawal by Subject|0|||
33555872|NCT02619812|62948680|FG001|Overall Study|Withdrawal by Subject|0|||
33555873|NCT02619812|62948681|FG002|Overall Study|Withdrawal by Subject|1|||
33555874|NCT02619812|62948682|FG003|Overall Study|Withdrawal by Subject|2|||
33555875|NCT02623322|62948695|FG000|Overall Study|Lost to Follow-up|2|||
33485921|NCT04405076|62863668|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
33485922|NCT04405076|62863669|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
33555876|NCT02623322|62948696|FG001|Overall Study|Lost to Follow-up|1|||
33555877|NCT02623322|62948697|FG002|Overall Study|Lost to Follow-up|0|||
33555878|NCT00105157|62948711|FG000|Double-Blind (DB)|Never Treated|1|||
33555879|NCT00105157|62948712|FG001|Double-Blind (DB)|Never Treated|0|||
33279969|NCT01051817|62655709|FG001|Overall Study|Adverse Event|2|||
33279970|NCT01051817|62655708|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
33279971|NCT01051817|62655709|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
33279972|NCT01051817|62655708|FG000|Overall Study|Withdrawal by Subject|3|||
33279973|NCT01051817|62655709|FG001|Overall Study|Withdrawal by Subject|5|||
33279974|NCT01051817|62655708|FG000|Overall Study|Protocol Violation|0|||
33279975|NCT01051817|62655709|FG001|Overall Study|Protocol Violation|1|||
33279976|NCT01327846|62655719|FG000|Core Phase|Subject decision (vital status: missing)|1|||
33279977|NCT01327846|62655720|FG001|Core Phase|Subject decision (vital status: missing)|2|||
33279978|NCT01327846|62655721|FG002|Core Phase|Subject decision (vital status: missing)|2|||
33279979|NCT01327846|62655722|FG003|Core Phase|Subject decision (vital status: missing)|1|||
33279980|NCT01327846|62655719|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
33279981|NCT01327846|62655720|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
33279982|NCT01327846|62655721|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
33279983|NCT01327846|62655722|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
33279984|NCT01327846|62655719|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
33279985|NCT01327846|62655720|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
33279986|NCT01327846|62655721|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
33279987|NCT01327846|62655722|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
33279988|NCT01327846|62655719|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
33370648|NCT00883337|62749334|FG000|Extension Treatment Period|Other than above|10|||
33370649|NCT00883337|62749335|FG001|Extension Treatment Period|Other than above|9|||
33370650|NCT00883337|62749336|FG002|Extension Treatment Period|Other than above|5|||
33370651|NCT00838110|62749352|FG000|Overall Study|Death|0|||
33370652|NCT00838110|62749353|FG001|Overall Study|Death|0|||
33370653|NCT00838110|62749354|FG002|Overall Study|Death|1|||
33370654|NCT00838110|62749355|FG003|Overall Study|Death|2|||
33370655|NCT00838110|62749352|FG000|Overall Study|Adverse Event|11|||
33485923|NCT04405076|62863670|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
33485924|NCT04405076|62863671|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
33485925|NCT04405076|62863672|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
33555880|NCT00105157|62948713|FG002|Double-Blind (DB)|Never Treated|0|||
33279989|NCT01327846|62655720|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
33370656|NCT00838110|62749353|FG001|Overall Study|Adverse Event|10|||
33370657|NCT00838110|62749354|FG002|Overall Study|Adverse Event|8|||
33370658|NCT00838110|62749355|FG003|Overall Study|Adverse Event|7|||
33555881|NCT00105157|62948714|FG003|Double-Blind (DB)|Never Treated|0|||
33555882|NCT00105157|62948711|FG000|Double-Blind (DB)|Adverse Event|2|||
33555883|NCT00105157|62948712|FG001|Double-Blind (DB)|Adverse Event|0|||
33555884|NCT00105157|62948713|FG002|Double-Blind (DB)|Adverse Event|1|||
33279990|NCT01327846|62655721|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
33279991|NCT01327846|62655722|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
33279992|NCT01327846|62655719|FG000|Core Phase|Lost to Follow-up|3|||
33279993|NCT01327846|62655720|FG001|Core Phase|Lost to Follow-up|3|||
33279994|NCT01327846|62655721|FG002|Core Phase|Lost to Follow-up|4|||
33279995|NCT01327846|62655722|FG003|Core Phase|Lost to Follow-up|5|||
33279996|NCT01327846|62655719|FG000|Extension Phase|Study terminated by sponsor|1073|||
33279997|NCT01327846|62655720|FG001|Extension Phase|Study terminated by sponsor|1124|||
33279998|NCT01327846|62655721|FG002|Extension Phase|Study terminated by sponsor|1067|||
33279999|NCT01327846|62655722|FG003|Extension Phase|Study terminated by sponsor|1660|||
33280000|NCT01327846|62655719|FG000|Extension Phase|Withdrawal by Subject|20|||
33280001|NCT01327846|62655720|FG001|Extension Phase|Withdrawal by Subject|13|||
33280002|NCT01327846|62655721|FG002|Extension Phase|Withdrawal by Subject|19|||
33280003|NCT01327846|62655722|FG003|Extension Phase|Withdrawal by Subject|37|||
33280004|NCT01327846|62655719|FG000|Extension Phase|Lost to Follow-up|4|||
33280005|NCT01327846|62655720|FG001|Extension Phase|Lost to Follow-up|3|||
33280006|NCT01327846|62655721|FG002|Extension Phase|Lost to Follow-up|4|||
33280007|NCT01327846|62655722|FG003|Extension Phase|Lost to Follow-up|7|||
33280008|NCT01327846|62655719|FG000|Extension Phase|Technical Problems|2|||
33280009|NCT01327846|62655720|FG001|Extension Phase|Technical Problems|4|||
33280010|NCT01327846|62655721|FG002|Extension Phase|Technical Problems|2|||
33280011|NCT01327846|62655722|FG003|Extension Phase|Technical Problems|2|||
33280012|NCT01051739|62655735|FG000|Overall Study|Death|3|||
33280013|NCT01051739|62655736|FG001|Overall Study|Death|3|||
33280014|NCT01051739|62655735|FG000|Overall Study|Withdrawal by Subject|25|||
33280015|NCT01051739|62655736|FG001|Overall Study|Withdrawal by Subject|10|||
33280016|NCT01051661|62655748|FG000|Overall Study|Adverse Event|1|||
33280017|NCT01051661|62655749|FG001|Overall Study|Adverse Event|1|||
33280018|NCT01051661|62655750|FG002|Overall Study|Adverse Event|1|||
33280019|NCT01051661|62655751|FG003|Overall Study|Adverse Event|1|||
33280020|NCT01051661|62655752|FG004|Overall Study|Adverse Event|0|||
33280021|NCT01051661|62655753|FG005|Overall Study|Adverse Event|0|||
33280022|NCT01051661|62655748|FG000|Overall Study|Lost to Follow-up|13|||
33280023|NCT01051661|62655749|FG001|Overall Study|Lost to Follow-up|22|||
33280024|NCT01051661|62655750|FG002|Overall Study|Lost to Follow-up|15|||
33280025|NCT01051661|62655751|FG003|Overall Study|Lost to Follow-up|17|||
33555885|NCT00105157|62948714|FG003|Double-Blind (DB)|Adverse Event|1|||
33555886|NCT00105157|62948711|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
33555887|NCT00105157|62948712|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
33555888|NCT00105157|62948713|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
33555889|NCT00105157|62948714|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
33555890|NCT00105157|62948711|FG000|Open-Label Continuation of DB|Adverse Event|3|||
33555891|NCT00105157|62948712|FG001|Open-Label Continuation of DB|Adverse Event|1|||
33555892|NCT00105157|62948713|FG002|Open-Label Continuation of DB|Adverse Event|0|||
33555893|NCT00105157|62948714|FG003|Open-Label Continuation of DB|Adverse Event|0|||
33555894|NCT00105157|62948711|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
33555895|NCT00105157|62948712|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
33555896|NCT00105157|62948713|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
33555897|NCT00105157|62948714|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
33555898|NCT00105157|62948711|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
33555899|NCT00105157|62948712|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
33555900|NCT00105157|62948713|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
33555901|NCT00105157|62948714|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
33555902|NCT00105157|62948711|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
33555903|NCT00105157|62948712|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
33555904|NCT00105157|62948713|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
33555905|NCT00105157|62948714|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
33555906|NCT00105157|62948711|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
33555907|NCT00105157|62948712|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
33555908|NCT00105157|62948713|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
33555909|NCT00105157|62948714|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
33555910|NCT00105157|62948711|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
33555911|NCT00105157|62948712|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
33555912|NCT00105157|62948713|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
33280026|NCT01051661|62655752|FG004|Overall Study|Lost to Follow-up|10|||
33280027|NCT01051661|62655753|FG005|Overall Study|Lost to Follow-up|24|||
33280028|NCT01051661|62655748|FG000|Overall Study|Migrated/moved from study area|1|||
33280029|NCT01051661|62655749|FG001|Overall Study|Migrated/moved from study area|6|||
33555913|NCT00105157|62948714|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
33662129|NCT01695239|63092837|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33280030|NCT01051661|62655750|FG002|Overall Study|Migrated/moved from study area|6|||
33280031|NCT01051661|62655751|FG003|Overall Study|Migrated/moved from study area|8|||
33280032|NCT01051661|62655752|FG004|Overall Study|Migrated/moved from study area|7|||
33280033|NCT01051661|62655753|FG005|Overall Study|Migrated/moved from study area|3|||
33280034|NCT01051661|62655748|FG000|Overall Study|Refused blood sampling|0|||
33280035|NCT01051661|62655749|FG001|Overall Study|Refused blood sampling|0|||
33280036|NCT01051661|62655750|FG002|Overall Study|Refused blood sampling|0|||
33280037|NCT01051661|62655751|FG003|Overall Study|Refused blood sampling|0|||
33280038|NCT01051661|62655752|FG004|Overall Study|Refused blood sampling|0|||
33280039|NCT01051661|62655753|FG005|Overall Study|Refused blood sampling|1|||
33280040|NCT01051661|62655748|FG000|Overall Study|Data not reliable|1|||
33280041|NCT01051661|62655749|FG001|Overall Study|Data not reliable|0|||
33280042|NCT01051661|62655750|FG002|Overall Study|Data not reliable|0|||
33280043|NCT01051661|62655751|FG003|Overall Study|Data not reliable|0|||
33370659|NCT00838110|62749352|FG000|Overall Study|Withdrawal by Subject|5|||
33485926|NCT04405076|62863673|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
33485927|NCT04405076|62863674|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
33485928|NCT04405076|62863675|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
33485929|NCT04405076|62863667|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
33485930|NCT04405076|62863668|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
33485931|NCT04405076|62863669|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
33485932|NCT04405076|62863670|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
33485933|NCT04405076|62863671|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
33280044|NCT01051661|62655752|FG004|Overall Study|Data not reliable|0|||
33280045|NCT01051661|62655753|FG005|Overall Study|Data not reliable|1|||
33280046|NCT01051661|62655748|FG000|Overall Study|Unable to attend visit(s)|2|||
33280047|NCT01051661|62655749|FG001|Overall Study|Unable to attend visit(s)|4|||
33280048|NCT01051661|62655750|FG002|Overall Study|Unable to attend visit(s)|2|||
33280049|NCT01051661|62655751|FG003|Overall Study|Unable to attend visit(s)|1|||
33280050|NCT01051661|62655752|FG004|Overall Study|Unable to attend visit(s)|3|||
33280051|NCT01051661|62655753|FG005|Overall Study|Unable to attend visit(s)|2|||
33280052|NCT01051661|62655748|FG000|Overall Study|Consent not received from both parents|0|||
33280053|NCT01051661|62655749|FG001|Overall Study|Consent not received from both parents|0|||
33280054|NCT01051661|62655750|FG002|Overall Study|Consent not received from both parents|0|||
33280055|NCT01051661|62655751|FG003|Overall Study|Consent not received from both parents|0|||
33280056|NCT01051661|62655752|FG004|Overall Study|Consent not received from both parents|0|||
33280057|NCT01051661|62655753|FG005|Overall Study|Consent not received from both parents|1|||
33280058|NCT01051661|62655748|FG000|Overall Study|Failure to comply with protocol|0|||
33280059|NCT01051661|62655749|FG001|Overall Study|Failure to comply with protocol|0|||
33280060|NCT01051661|62655750|FG002|Overall Study|Failure to comply with protocol|2|||
33280061|NCT01051661|62655751|FG003|Overall Study|Failure to comply with protocol|0|||
33280062|NCT01051661|62655752|FG004|Overall Study|Failure to comply with protocol|0|||
33280063|NCT01051661|62655753|FG005|Overall Study|Failure to comply with protocol|0|||
33280064|NCT01051661|62655748|FG000|Overall Study|Subject lost legal representation|0|||
33280065|NCT01051661|62655749|FG001|Overall Study|Subject lost legal representation|0|||
33280066|NCT01051661|62655750|FG002|Overall Study|Subject lost legal representation|0|||
33485934|NCT04405076|62863672|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
33485935|NCT04405076|62863673|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
33485936|NCT04405076|62863674|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
33485937|NCT04405076|62863675|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
33485938|NCT04405076|62863667|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33485939|NCT04405076|62863668|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33485940|NCT04405076|62863669|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33485941|NCT04405076|62863670|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33485942|NCT04405076|62863671|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33485943|NCT04405076|62863672|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33485944|NCT04405076|62863673|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
33485945|NCT04405076|62863674|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33485946|NCT04405076|62863675|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33485947|NCT04311177|62863703|FG000|Overall Study|Adverse Event|3|||
33485948|NCT04311177|62863704|FG001|Overall Study|Adverse Event|1|||
33485949|NCT04311177|62863703|FG000|Overall Study|Physician Decision|4|||
33485950|NCT04311177|62863704|FG001|Overall Study|Physician Decision|3|||
33485951|NCT04311177|62863703|FG000|Overall Study|Withdrawal by Subject|1|||
33485952|NCT04311177|62863704|FG001|Overall Study|Withdrawal by Subject|0|||
33555914|NCT00105157|62948711|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
33280067|NCT01051661|62655751|FG003|Overall Study|Subject lost legal representation|0|||
33280068|NCT01051661|62655752|FG004|Overall Study|Subject lost legal representation|1|||
33280069|NCT01051661|62655753|FG005|Overall Study|Subject lost legal representation|0|||
33280070|NCT01051661|62655748|FG000|Overall Study|Protocol Violation|0|||
33280071|NCT01051661|62655749|FG001|Overall Study|Protocol Violation|0|||
33280072|NCT01051661|62655750|FG002|Overall Study|Protocol Violation|0|||
33280073|NCT01051661|62655751|FG003|Overall Study|Protocol Violation|1|||
33280074|NCT01051661|62655752|FG004|Overall Study|Protocol Violation|2|||
33280075|NCT01051661|62655753|FG005|Overall Study|Protocol Violation|1|||
33280076|NCT01051661|62655748|FG000|Overall Study|Withdrawal by Subject|16|||
33280077|NCT01051661|62655749|FG001|Overall Study|Withdrawal by Subject|30|||
33280078|NCT01051661|62655750|FG002|Overall Study|Withdrawal by Subject|13|||
33280079|NCT01051661|62655751|FG003|Overall Study|Withdrawal by Subject|28|||
33280080|NCT01051661|62655752|FG004|Overall Study|Withdrawal by Subject|12|||
33280081|NCT01051661|62655753|FG005|Overall Study|Withdrawal by Subject|34|||
33280082|NCT01051466|62655790|FG000|Overall Study|Adverse Event|1|||
33280083|NCT01051466|62655791|FG001|Overall Study|Adverse Event|0|||
33280084|NCT01051466|62655790|FG000|Overall Study|Lost to Follow-up|1|||
33280085|NCT01051466|62655791|FG001|Overall Study|Lost to Follow-up|1|||
33280086|NCT01051466|62655790|FG000|Overall Study|Withdrawal by Subject|5|||
33280087|NCT01051466|62655791|FG001|Overall Study|Withdrawal by Subject|1|||
33280088|NCT01051466|62655790|FG000|Overall Study|Entry Criteria Not Met|0|||
33280089|NCT01051466|62655791|FG001|Overall Study|Entry Criteria Not Met|3|||
33280090|NCT01051466|62655790|FG000|Overall Study|Physician Decision|1|||
33280091|NCT01051466|62655791|FG001|Overall Study|Physician Decision|0|||
33280092|NCT01051349|62655805|FG000|Overall Study|Adverse Event|88|||
33280093|NCT01051349|62655805|FG000|Overall Study|Consent Withdrawn|54|||
33280094|NCT01051349|62655805|FG000|Overall Study|Investigator Decision|6|||
33280095|NCT01051349|62655805|FG000|Overall Study|Lost to Follow-up|6|||
33280096|NCT01051349|62655805|FG000|Overall Study|Subject non-compliance|7|||
33280097|NCT01051349|62655805|FG000|Overall Study|Reason not Specified|12|||
33280098|NCT01050998|62655817|FG000|Overall Study|Adverse Event|1|||
33280099|NCT01050998|62655818|FG001|Overall Study|Adverse Event|0|||
33280100|NCT01050998|62655819|FG002|Overall Study|Adverse Event|1|||
33280101|NCT01050998|62655820|FG003|Overall Study|Adverse Event|0|||
33280102|NCT01050998|62655821|FG004|Overall Study|Adverse Event|2|||
33280103|NCT01050998|62655817|FG000|Overall Study|Withdrawal by Subject|0|||
33280104|NCT01050998|62655818|FG001|Overall Study|Withdrawal by Subject|0|||
33485953|NCT03267212|62863710|FG000|First Intervention|Lost to Follow-up|0|||
33485954|NCT03267212|62863711|FG001|First Intervention|Lost to Follow-up|2|||
33485955|NCT03267212|62863710|FG000|First Intervention|Withdrawal by Subject|1|||
33485956|NCT03267212|62863711|FG001|First Intervention|Withdrawal by Subject|1|||
33485957|NCT03267212|62863710|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
33485958|NCT03267212|62863711|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
33485959|NCT04292535|62863731|FG000|Overall Study|Withdrawal by Subject|0|||
33485960|NCT04292535|62863732|FG001|Overall Study|Withdrawal by Subject|0|||
33485961|NCT04292535|62863733|FG002|Overall Study|Withdrawal by Subject|0|||
33485962|NCT04292535|62863734|FG003|Overall Study|Withdrawal by Subject|0|||
33485963|NCT04292535|62863735|FG004|Overall Study|Withdrawal by Subject|0|||
33485964|NCT04292535|62863736|FG005|Overall Study|Withdrawal by Subject|0|||
33555915|NCT00105157|62948712|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
33555916|NCT00105157|62948713|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
33555917|NCT00105157|62948714|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
33555918|NCT00105157|62948711|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
33555919|NCT00105157|62948712|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
33555920|NCT00105157|62948713|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
33555921|NCT00105157|62948714|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
33555922|NCT00105157|62948711|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
33555923|NCT00105157|62948712|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
33555924|NCT00105157|62948713|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
33555925|NCT00105157|62948714|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
33555926|NCT00105157|62948711|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
33555927|NCT00105157|62948712|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
33555928|NCT00105157|62948713|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
33555929|NCT00105157|62948714|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
33555930|NCT00105157|62948711|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
33555931|NCT00105157|62948712|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
33555932|NCT00105157|62948713|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
33555933|NCT00105157|62948714|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
33555934|NCT02148133|62948735|FG000|Overall Study|Investigator discretion|1|||
33555935|NCT02148133|62948735|FG000|Overall Study|Lack of Efficacy|1|||
33555936|NCT02148133|62948735|FG000|Overall Study|Protocol deviation|1|||
33280105|NCT01050998|62655819|FG002|Overall Study|Withdrawal by Subject|0|||
33280106|NCT01050998|62655820|FG003|Overall Study|Withdrawal by Subject|1|||
33280107|NCT01050998|62655821|FG004|Overall Study|Withdrawal by Subject|3|||
33280108|NCT01050998|62655817|FG000|Overall Study|Other|3|||
33485965|NCT04292535|62863737|FG006|Overall Study|Withdrawal by Subject|0|||
33485966|NCT04292535|62863738|FG007|Overall Study|Withdrawal by Subject|1|||
33485967|NCT04292535|62863739|FG008|Overall Study|Withdrawal by Subject|0|||
33485968|NCT04292535|62863740|FG009|Overall Study|Withdrawal by Subject|0|||
33485969|NCT04292535|62863741|FG010|Overall Study|Withdrawal by Subject|0|||
33485970|NCT04292535|62863742|FG011|Overall Study|Withdrawal by Subject|0|||
33485971|NCT04292535|62863743|FG012|Overall Study|Withdrawal by Subject|0|||
33485972|NCT04292535|62863744|FG013|Overall Study|Withdrawal by Subject|0|||
33485973|NCT04292535|62863731|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33485974|NCT04292535|62863732|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33485975|NCT04292535|62863733|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33485976|NCT04292535|62863734|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33485977|NCT04292535|62863735|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33485978|NCT04292535|62863736|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33485979|NCT04292535|62863737|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33485980|NCT04292535|62863738|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
33485981|NCT04292535|62863739|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33485982|NCT04292535|62863740|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33485983|NCT04292535|62863741|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33485984|NCT04292535|62863742|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33485985|NCT04292535|62863743|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
33485986|NCT04292535|62863744|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
33485987|NCT04292535|62863731|FG000|Overall Study|Report of Dizziness|0|||
33485988|NCT04292535|62863732|FG001|Overall Study|Report of Dizziness|0|||
33485989|NCT04292535|62863733|FG002|Overall Study|Report of Dizziness|0|||
33485990|NCT04292535|62863734|FG003|Overall Study|Report of Dizziness|0|||
33485991|NCT04292535|62863735|FG004|Overall Study|Report of Dizziness|0|||
33485992|NCT04292535|62863736|FG005|Overall Study|Report of Dizziness|0|||
33485993|NCT04292535|62863737|FG006|Overall Study|Report of Dizziness|0|||
33485994|NCT04292535|62863738|FG007|Overall Study|Report of Dizziness|0|||
33485995|NCT04292535|62863739|FG008|Overall Study|Report of Dizziness|0|||
33485996|NCT04292535|62863740|FG009|Overall Study|Report of Dizziness|0|||
33485997|NCT04292535|62863741|FG010|Overall Study|Report of Dizziness|0|||
33485998|NCT04292535|62863742|FG011|Overall Study|Report of Dizziness|0|||
33485999|NCT04292535|62863743|FG012|Overall Study|Report of Dizziness|0|||
33486000|NCT04292535|62863744|FG013|Overall Study|Report of Dizziness|1|||
33486001|NCT04292535|62863731|FG000|Overall Study|Equipment Failure|0|||
33486002|NCT04292535|62863732|FG001|Overall Study|Equipment Failure|0|||
33486003|NCT04292535|62863733|FG002|Overall Study|Equipment Failure|0|||
33486004|NCT04292535|62863734|FG003|Overall Study|Equipment Failure|0|||
33486005|NCT04292535|62863735|FG004|Overall Study|Equipment Failure|0|||
33486006|NCT04292535|62863736|FG005|Overall Study|Equipment Failure|0|||
33486007|NCT04292535|62863737|FG006|Overall Study|Equipment Failure|0|||
33486008|NCT04292535|62863738|FG007|Overall Study|Equipment Failure|0|||
33486009|NCT04292535|62863739|FG008|Overall Study|Equipment Failure|0|||
33486010|NCT04292535|62863740|FG009|Overall Study|Equipment Failure|0|||
33486011|NCT04292535|62863741|FG010|Overall Study|Equipment Failure|0|||
33486012|NCT04292535|62863742|FG011|Overall Study|Equipment Failure|1|||
33486013|NCT04292535|62863743|FG012|Overall Study|Equipment Failure|0|||
33486014|NCT04292535|62863744|FG013|Overall Study|Equipment Failure|0|||
33486015|NCT04385199|62863776|FG000|Overall Study|Withdrawal by Subject|1|||
33486016|NCT04385199|62863777|FG001|Overall Study|Withdrawal by Subject|0|||
33486017|NCT04284813|62863783|FG000|Overall Study|Withdrawal by Subject|1|||
33486018|NCT03263780|62863787|FG000|Overall Study|Withdrawal by Subject|3|||
33486019|NCT03263780|62863787|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
33486020|NCT02791438|62863793|FG000|Treatment Period|Adverse Event|1|||
33370660|NCT00838110|62749353|FG001|Overall Study|Withdrawal by Subject|6|||
33370661|NCT00838110|62749354|FG002|Overall Study|Withdrawal by Subject|3|||
33370662|NCT00838110|62749355|FG003|Overall Study|Withdrawal by Subject|4|||
33486021|NCT02791438|62863794|FG001|Treatment Period|Adverse Event|0|||
33486022|NCT02791438|62863793|FG000|Treatment Period|Withdrawal by Subject|0|||
33486023|NCT02791438|62863794|FG001|Treatment Period|Withdrawal by Subject|1|||
33280109|NCT01050998|62655818|FG001|Overall Study|Other|2|||
33280110|NCT01050998|62655819|FG002|Overall Study|Other|1|||
33280111|NCT01050998|62655820|FG003|Overall Study|Other|1|||
33280112|NCT01050998|62655821|FG004|Overall Study|Other|5|||
33280113|NCT01050998|62655817|FG000|Overall Study|Data integrity issues|0|||
33280114|NCT01050998|62655818|FG001|Overall Study|Data integrity issues|0|||
33280115|NCT01050998|62655819|FG002|Overall Study|Data integrity issues|1|||
33280116|NCT01050998|62655820|FG003|Overall Study|Data integrity issues|1|||
33280117|NCT01050998|62655821|FG004|Overall Study|Data integrity issues|4|||
33280118|NCT00106028|62655839|FG000|Overall Study|Adverse Event|3|||
33280119|NCT00106028|62655840|FG001|Overall Study|Adverse Event|2|||
33370663|NCT00838110|62749352|FG000|Overall Study|Other|3|||
33486024|NCT02791438|62863793|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
33370664|NCT00838110|62749353|FG001|Overall Study|Other|3|||
33280120|NCT00106028|62655839|FG000|Overall Study|Protocol Violation|1|||
33486025|NCT02791438|62863794|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
33486026|NCT03712124|62863802|FG000|Overall Study|Protocol Violation|1|||
33486027|NCT03712124|62863803|FG001|Overall Study|Protocol Violation|0|||
33486028|NCT02791516|62863817|FG000|Overall Study|Withdrawal by Subject|1|||
33486029|NCT02791516|62863818|FG001|Overall Study|Withdrawal by Subject|1|||
33486030|NCT03263702|62863826|FG000|Overall Study|Lost to Follow-up|2|||
33486031|NCT03263702|62863827|FG001|Overall Study|Lost to Follow-up|2|||
33486032|NCT03263702|62863826|FG000|Overall Study|Withdrawal by Subject|1|||
33486033|NCT03263702|62863827|FG001|Overall Study|Withdrawal by Subject|2|||
33486034|NCT04130919|62863836|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
33486035|NCT04130919|62863837|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
33486036|NCT04130919|62863838|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
33486037|NCT04130919|62863839|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
33486038|NCT04130919|62863840|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
33486039|NCT04130919|62863841|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
33486040|NCT04130919|62863836|FG000|Blinded Treatment Phase|Adverse Event|0|||
33486041|NCT04130919|62863837|FG001|Blinded Treatment Phase|Adverse Event|0|||
33486042|NCT04130919|62863838|FG002|Blinded Treatment Phase|Adverse Event|1|||
33486043|NCT04130919|62863839|FG003|Blinded Treatment Phase|Adverse Event|0|||
33486044|NCT04130919|62863840|FG004|Blinded Treatment Phase|Adverse Event|0|||
33486045|NCT04130919|62863841|FG005|Blinded Treatment Phase|Adverse Event|0|||
33486046|NCT04130919|62863836|FG000|Blinded Treatment Phase|Disease worsening|0|||
33486047|NCT04130919|62863837|FG001|Blinded Treatment Phase|Disease worsening|0|||
33486048|NCT04130919|62863838|FG002|Blinded Treatment Phase|Disease worsening|1|||
33486049|NCT04130919|62863839|FG003|Blinded Treatment Phase|Disease worsening|0|||
33486050|NCT04130919|62863840|FG004|Blinded Treatment Phase|Disease worsening|0|||
33486051|NCT04130919|62863841|FG005|Blinded Treatment Phase|Disease worsening|0|||
33486052|NCT04130919|62863836|FG000|Blinded Treatment Phase|Investigator's decision|0|||
33486053|NCT04130919|62863837|FG001|Blinded Treatment Phase|Investigator's decision|1|||
33486054|NCT04130919|62863838|FG002|Blinded Treatment Phase|Investigator's decision|0|||
33486055|NCT04130919|62863839|FG003|Blinded Treatment Phase|Investigator's decision|0|||
33486056|NCT04130919|62863840|FG004|Blinded Treatment Phase|Investigator's decision|0|||
33486057|NCT04130919|62863841|FG005|Blinded Treatment Phase|Investigator's decision|0|||
33486058|NCT04130919|62863836|FG000|Blinded Treatment Phase|Withdrew consent|1|||
33486059|NCT04130919|62863837|FG001|Blinded Treatment Phase|Withdrew consent|0|||
33486060|NCT04130919|62863838|FG002|Blinded Treatment Phase|Withdrew consent|0|||
33486061|NCT04130919|62863839|FG003|Blinded Treatment Phase|Withdrew consent|0|||
33486062|NCT04130919|62863840|FG004|Blinded Treatment Phase|Withdrew consent|0|||
33486063|NCT04130919|62863841|FG005|Blinded Treatment Phase|Withdrew consent|0|||
33486064|NCT04130919|62863836|FG000|Open-label Treatment Phase|Withdrew consent|0|||
33486065|NCT04130919|62863837|FG001|Open-label Treatment Phase|Withdrew consent|0|||
33486066|NCT04130919|62863838|FG002|Open-label Treatment Phase|Withdrew consent|0|||
33486067|NCT04130919|62863839|FG003|Open-label Treatment Phase|Withdrew consent|1|||
33486068|NCT04130919|62863840|FG004|Open-label Treatment Phase|Withdrew consent|1|||
33486069|NCT04130919|62863841|FG005|Open-label Treatment Phase|Withdrew consent|1|||
33486070|NCT04130919|62863836|FG000|Open-label Treatment Phase|Disease worsening|0|||
33486071|NCT04130919|62863837|FG001|Open-label Treatment Phase|Disease worsening|0|||
33486072|NCT04130919|62863838|FG002|Open-label Treatment Phase|Disease worsening|0|||
33486073|NCT04130919|62863839|FG003|Open-label Treatment Phase|Disease worsening|1|||
33486074|NCT04130919|62863840|FG004|Open-label Treatment Phase|Disease worsening|0|||
33486075|NCT04130919|62863841|FG005|Open-label Treatment Phase|Disease worsening|1|||
33486076|NCT04130919|62863836|FG000|Open-label Treatment Phase|Investigator's decision|0|||
33486077|NCT04130919|62863837|FG001|Open-label Treatment Phase|Investigator's decision|0|||
33486078|NCT04130919|62863838|FG002|Open-label Treatment Phase|Investigator's decision|0|||
33486079|NCT04130919|62863839|FG003|Open-label Treatment Phase|Investigator's decision|1|||
33486080|NCT04130919|62863840|FG004|Open-label Treatment Phase|Investigator's decision|0|||
33486081|NCT04130919|62863841|FG005|Open-label Treatment Phase|Investigator's decision|0|||
33486082|NCT04130919|62863836|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
33486083|NCT04130919|62863837|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
33486084|NCT04130919|62863838|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
33486085|NCT04130919|62863839|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
33486086|NCT04130919|62863840|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
33486087|NCT04130919|62863841|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
33486088|NCT04130919|62863836|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
33370665|NCT00838110|62749354|FG002|Overall Study|Other|3|||
33486089|NCT04130919|62863837|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
33486090|NCT04130919|62863838|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
33486091|NCT04130919|62863839|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
33486092|NCT04130919|62863840|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
33370666|NCT00838110|62749355|FG003|Overall Study|Other|2|||
33486093|NCT04130919|62863841|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
33486094|NCT04128267|62863855|FG000|Overall Study|Withdrawal by Subject|6|||
33486095|NCT04128267|62863855|FG000|Overall Study|Death|2|||
33486096|NCT04128267|62863855|FG000|Overall Study|Disease progression|1|||
33486097|NCT04128267|62863855|FG000|Overall Study|Participant had other medical issues|4|||
33486098|NCT04128267|62863855|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
33486099|NCT03691779|62863859|FG000|Part B (24 Weeks)|Adverse Event|0|||
33486100|NCT03691779|62863860|FG001|Part B (24 Weeks)|Adverse Event|1|||
33486101|NCT03691779|62863859|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
33486102|NCT03691779|62863860|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
33486103|NCT04258995|62863869|FG000|Overall Study|Lost to Follow-up|1|||
33486104|NCT04258995|62863870|FG001|Overall Study|Lost to Follow-up|1|||
33486105|NCT04247061|62863876|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
33486106|NCT04247061|62863876|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
33486107|NCT04247061|62863876|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
33486108|NCT04241133|62863882|FG000|Overall Study|COVID19 Precautions|14|||
33486109|NCT04241133|62863883|FG001|Overall Study|COVID19 Precautions|34|||
33486110|NCT04123665|62863891|FG000|Overall Study|Withdrawal by Subject|7|||
33486111|NCT04123665|62863892|FG001|Overall Study|Withdrawal by Subject|0|||
33486112|NCT04123665|62863891|FG000|Overall Study|Lost to Follow-up|1|||
33486113|NCT04123665|62863892|FG001|Overall Study|Lost to Follow-up|0|||
33486114|NCT04232943|62863901|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
33486115|NCT04232943|62863902|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
33486116|NCT04232943|62863903|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
33486117|NCT04232943|62863901|FG000|Overall Study|Withdrawal by Subject|1|||
33486118|NCT04232943|62863902|FG001|Overall Study|Withdrawal by Subject|1|||
33486119|NCT04232943|62863903|FG002|Overall Study|Withdrawal by Subject|0|||
33486120|NCT03694275|62863914|FG000|Overall Study|Adverse Event|0|||
33486121|NCT03694275|62863915|FG001|Overall Study|Adverse Event|1|||
33486122|NCT03694275|62863914|FG000|Overall Study|Reason not Specified|0|||
33486123|NCT03694275|62863915|FG001|Overall Study|Reason not Specified|1|||
33486124|NCT04230213|62863922|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
33486125|NCT04230213|62863923|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
33486126|NCT04230213|62863924|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
33486127|NCT04230213|62863922|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
33486128|NCT04230213|62863923|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
33486129|NCT04230213|62863924|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
33486130|NCT04230213|62863922|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
33486131|NCT04230213|62863923|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
33486132|NCT04230213|62863924|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
33486133|NCT04230213|62863922|FG000|TP2: Week 10 to Week 16|Other|0|||
33486134|NCT04230213|62863923|FG001|TP2: Week 10 to Week 16|Other|2|||
33486135|NCT04230213|62863924|FG002|TP2: Week 10 to Week 16|Other|1|||
33486136|NCT04230213|62863922|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
33486137|NCT04230213|62863923|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
33486138|NCT04230213|62863924|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
33486139|NCT04230213|62863922|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
33486140|NCT04230213|62863923|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
33486141|NCT04230213|62863924|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
33486142|NCT04230213|62863922|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
33486143|NCT04230213|62863923|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
33486144|NCT04230213|62863924|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
33486145|NCT04230213|62863922|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
33486146|NCT04230213|62863923|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
33486147|NCT04230213|62863924|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
33486148|NCT04230213|62863922|FG000|TP3: Week 16 to Week 22|Other|0|||
33486149|NCT04230213|62863923|FG001|TP3: Week 16 to Week 22|Other|1|||
33486150|NCT04230213|62863924|FG002|TP3: Week 16 to Week 22|Other|3|||
33486151|NCT04230213|62863922|FG000|TP4: Week 22 to Week 32|Other|0|||
33486152|NCT04230213|62863923|FG001|TP4: Week 22 to Week 32|Other|5|||
33486153|NCT04230213|62863924|FG002|TP4: Week 22 to Week 32|Other|5|||
33486154|NCT04230213|62863922|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
33486155|NCT04230213|62863923|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
33486156|NCT04230213|62863924|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
33486157|NCT04230213|62863922|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
33486158|NCT04230213|62863923|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
33486159|NCT04230213|62863924|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
33486160|NCT04230213|62863922|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
33486161|NCT04230213|62863923|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
33486162|NCT04230213|62863924|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
33486163|NCT04230213|62863922|FG000|Follow up: Week 32 to Week 36|Other|0|||
33486164|NCT04230213|62863923|FG001|Follow up: Week 32 to Week 36|Other|1|||
33486165|NCT04230213|62863924|FG002|Follow up: Week 32 to Week 36|Other|1|||
33486166|NCT04222725|62863936|FG000|Overall Study|Adverse Event|0|||
33486167|NCT04222725|62863937|FG001|Overall Study|Adverse Event|1|||
33486168|NCT04222725|62863938|FG002|Overall Study|Adverse Event|0|||
33486169|NCT04222725|62863939|FG003|Overall Study|Adverse Event|0|||
33486170|NCT04213989|62863951|FG000|Overall Study|Withdrawal by Subject|3|||
33486171|NCT04213989|62863952|FG001|Overall Study|Withdrawal by Subject|2|||
33280121|NCT00106028|62655840|FG001|Overall Study|Protocol Violation|1|||
33280122|NCT00106028|62655839|FG000|Overall Study|Withdrawal by Subject|2|||
33280123|NCT00106028|62655840|FG001|Overall Study|Withdrawal by Subject|8|||
33280124|NCT00106028|62655839|FG000|Overall Study|Lost to Follow-up|0|||
33280125|NCT00106028|62655840|FG001|Overall Study|Lost to Follow-up|1|||
33280126|NCT01050764|62655848|FG000|Overall Study|Death, before HSCT|1|||
33280127|NCT01050764|62655848|FG000|Overall Study|Donor mobilization failure, death|1|||
33280128|NCT01050764|62655848|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
33280129|NCT01050569|62655855|FG000|Overall Study|Lost to Follow-up|20|||
33280130|NCT01050569|62655856|FG001|Overall Study|Lost to Follow-up|14|||
33280131|NCT01050569|62655857|FG002|Overall Study|Lost to Follow-up|16|||
33280132|NCT01050569|62655855|FG000|Overall Study|Withdrawal by Subject|9|||
33280133|NCT01050569|62655856|FG001|Overall Study|Withdrawal by Subject|3|||
33280134|NCT01050569|62655857|FG002|Overall Study|Withdrawal by Subject|11|||
33280135|NCT01050569|62655855|FG000|Overall Study|Lack of Efficacy|5|||
33280136|NCT01050569|62655856|FG001|Overall Study|Lack of Efficacy|4|||
33280137|NCT01050569|62655857|FG002|Overall Study|Lack of Efficacy|3|||
33280138|NCT01050569|62655855|FG000|Overall Study|Adverse Event|1|||
33280139|NCT01050569|62655856|FG001|Overall Study|Adverse Event|0|||
33280140|NCT01050569|62655857|FG002|Overall Study|Adverse Event|0|||
33280141|NCT01050569|62655855|FG000|Overall Study|Physician Decision|3|||
33280142|NCT01050569|62655856|FG001|Overall Study|Physician Decision|3|||
33280143|NCT01050569|62655857|FG002|Overall Study|Physician Decision|3|||
33280144|NCT01050530|62655871|FG000|Overall Study|Adverse Event|6|||
33280145|NCT01050530|62655872|FG001|Overall Study|Adverse Event|3|||
33280146|NCT01050530|62655871|FG000|Overall Study|Lack of Efficacy|1|||
33280147|NCT01050530|62655872|FG001|Overall Study|Lack of Efficacy|4|||
33280148|NCT01050530|62655871|FG000|Overall Study|Withdrawal by Subject|0|||
33280149|NCT01050530|62655872|FG001|Overall Study|Withdrawal by Subject|3|||
33280150|NCT01050530|62655871|FG000|Overall Study|Protocol Violation|1|||
33280151|NCT01050530|62655872|FG001|Overall Study|Protocol Violation|0|||
33280152|NCT01050257|62655881|FG000|Overall Study|Adverse Event|4|||
33280153|NCT01050257|62655882|FG001|Overall Study|Adverse Event|4|||
33280154|NCT01050257|62655883|FG002|Overall Study|Adverse Event|2|||
33280155|NCT01050257|62655881|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
33280156|NCT01050257|62655882|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
33280157|NCT01050257|62655883|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
33280158|NCT01050257|62655881|FG000|Overall Study|Withdrawal by Subject|0|||
33280159|NCT01050257|62655882|FG001|Overall Study|Withdrawal by Subject|3|||
33280160|NCT01050257|62655883|FG002|Overall Study|Withdrawal by Subject|0|||
33280161|NCT01050257|62655881|FG000|Overall Study|No reason specified|0|||
33280162|NCT01050257|62655882|FG001|Overall Study|No reason specified|0|||
33280163|NCT01050257|62655883|FG002|Overall Study|No reason specified|2|||
33280164|NCT01050257|62655881|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
33280165|NCT01050257|62655882|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
33280166|NCT01050257|62655883|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
33280167|NCT01050257|62655881|FG000|Overall Study|Violation criteria|0|||
33280168|NCT01050257|62655882|FG001|Overall Study|Violation criteria|1|||
33280169|NCT01050257|62655883|FG002|Overall Study|Violation criteria|0|||
33280170|NCT01050257|62655881|FG000|Overall Study|Failure to return|0|||
33280171|NCT01050257|62655882|FG001|Overall Study|Failure to return|2|||
33280172|NCT01050257|62655883|FG002|Overall Study|Failure to return|0|||
33280173|NCT01050257|62655881|FG000|Overall Study|Death|0|||
33280174|NCT01050257|62655882|FG001|Overall Study|Death|0|||
33280175|NCT01050257|62655883|FG002|Overall Study|Death|1|||
33280176|NCT01050218|62655891|FG000|Overall Study|Adverse Event|37|||
33486172|NCT04213989|62863951|FG000|Overall Study|Physician Decision|1|||
33662130|NCT01695239|63092838|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33662131|NCT01695239|63092839|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33662132|NCT01695239|63092840|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33280177|NCT01050218|62655891|FG000|Overall Study|Lack of Efficacy|8|||
33280178|NCT01050218|62655891|FG000|Overall Study|Protocol Violation|3|||
33280179|NCT01050218|62655891|FG000|Overall Study|Withdrawal by Subject|18|||
33280180|NCT01050218|62655891|FG000|Overall Study|Discontinued by sponsor|18|||
33280181|NCT01050218|62655891|FG000|Overall Study|Compliance|2|||
33280182|NCT01050218|62655891|FG000|Overall Study|Failed to return|7|||
33280183|NCT01050218|62655891|FG000|Overall Study|Serious Adverse Event|1|||
33280184|NCT01050218|62655891|FG000|Overall Study|Family emergency|1|||
33486173|NCT04213989|62863952|FG001|Overall Study|Physician Decision|0|||
33486174|NCT04213989|62863951|FG000|Overall Study|Lost to Follow-up|0|||
33486175|NCT04213989|62863952|FG001|Overall Study|Lost to Follow-up|4|||
33486176|NCT03242252|62863961|FG000|Overall Study|At the Participant's own Request|18|||
33486177|NCT03242252|62863962|FG001|Overall Study|At the Participant's own Request|10|||
33486178|NCT03242252|62863963|FG002|Overall Study|At the Participant's own Request|15|||
33486179|NCT03242252|62863961|FG000|Overall Study|Adverse Event|8|||
33486180|NCT03242252|62863962|FG001|Overall Study|Adverse Event|6|||
33486181|NCT03242252|62863963|FG002|Overall Study|Adverse Event|9|||
33486182|NCT03242252|62863961|FG000|Overall Study|Poor Compliance to Protocol|0|||
33280185|NCT01050062|62655897|FG000|Overall Study|Adverse Event|75|||
33280186|NCT01050062|62655898|FG001|Overall Study|Adverse Event|22|||
33280187|NCT01050062|62655897|FG000|Overall Study|Lost to Follow-up|83|||
33280188|NCT01050062|62655898|FG001|Overall Study|Lost to Follow-up|35|||
33280189|NCT01050062|62655897|FG000|Overall Study|Lack of Efficacy|22|||
33280190|NCT01050062|62655898|FG001|Overall Study|Lack of Efficacy|35|||
33280191|NCT01050062|62655897|FG000|Overall Study|Physician Decision|74|||
33280192|NCT01050062|62655898|FG001|Overall Study|Physician Decision|9|||
33280193|NCT01050062|62655897|FG000|Overall Study|Others|17|||
33280194|NCT01050062|62655898|FG001|Overall Study|Others|11|||
33280195|NCT00105989|62655916|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
33280196|NCT00105989|62655917|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
33280197|NCT00105989|62655916|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
33280198|NCT00105989|62655917|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
33280199|NCT00105989|62655916|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
33280200|NCT00105989|62655917|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
33280201|NCT00105989|62655916|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
33280202|NCT00105989|62655917|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
33280203|NCT00105989|62655916|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
33280204|NCT00105989|62655917|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
33280205|NCT00105989|62655916|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
33280206|NCT00105989|62655917|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
33280207|NCT00105989|62655916|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
33280208|NCT00105989|62655917|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
33486183|NCT03242252|62863962|FG001|Overall Study|Poor Compliance to Protocol|2|||
33486184|NCT03242252|62863963|FG002|Overall Study|Poor Compliance to Protocol|3|||
33280209|NCT00105989|62655916|FG000|Acute - Open Label: Week 0-10|Death|1|||
33280210|NCT00105989|62655917|FG001|Acute - Open Label: Week 0-10|Death|0|||
33280211|NCT00105989|62655916|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
33280212|NCT00105989|62655917|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
33280213|NCT00105989|62655916|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
33280214|NCT00105989|62655917|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
33280215|NCT00105989|62655916|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
33280216|NCT00105989|62655917|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
33280217|NCT00105989|62655916|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
33280218|NCT00105989|62655917|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
33280219|NCT00105989|62655916|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
33280220|NCT00105989|62655917|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
33280221|NCT00105989|62655916|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
33280222|NCT00105989|62655917|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
33370667|NCT00838110|62749352|FG000|Overall Study|Protocol Violation|0|||
33370668|NCT00838110|62749353|FG001|Overall Study|Protocol Violation|2|||
33370669|NCT00838110|62749354|FG002|Overall Study|Protocol Violation|1|||
33370670|NCT00838110|62749355|FG003|Overall Study|Protocol Violation|1|||
33370671|NCT00838110|62749352|FG000|Overall Study|Lost to Follow-up|3|||
33370672|NCT00838110|62749353|FG001|Overall Study|Lost to Follow-up|0|||
33370673|NCT00838110|62749354|FG002|Overall Study|Lost to Follow-up|0|||
33486185|NCT03242252|62863961|FG000|Overall Study|Study Terminated by Sponsor|1|||
33486186|NCT03242252|62863962|FG001|Overall Study|Study Terminated by Sponsor|0|||
33486187|NCT03242252|62863963|FG002|Overall Study|Study Terminated by Sponsor|0|||
33280223|NCT00105989|62655916|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
33280224|NCT00105989|62655917|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
33280225|NCT00105989|62655916|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
33280226|NCT00105989|62655917|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
33486188|NCT03242252|62863961|FG000|Overall Study|Reason not Specified|4|||
33280227|NCT00105989|62655916|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
33370674|NCT00838110|62749355|FG003|Overall Study|Lost to Follow-up|0|||
33370675|NCT00838110|62749352|FG000|Overall Study|Did not meet eligibility criteria|0|||
33486189|NCT03242252|62863962|FG001|Overall Study|Reason not Specified|4|||
33486190|NCT03242252|62863963|FG002|Overall Study|Reason not Specified|1|||
33486191|NCT03242252|62863961|FG000|Overall Study|Lost to Follow-up|5|||
33486192|NCT03242252|62863962|FG001|Overall Study|Lost to Follow-up|1|||
33486193|NCT03242252|62863963|FG002|Overall Study|Lost to Follow-up|4|||
33280228|NCT00105989|62655917|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
33280229|NCT00105989|62655916|FG000|Continuation - Open Label:Week 10-34|Death|0|||
33280230|NCT00105989|62655917|FG001|Continuation - Open Label:Week 10-34|Death|0|||
33280231|NCT00105989|62655916|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
33280232|NCT00105989|62655917|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
33280233|NCT00105989|62655916|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
33280234|NCT00105989|62655917|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
33280235|NCT00105989|62655916|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
33280236|NCT00105989|62655917|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
33280237|NCT00105989|62655916|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
33280238|NCT00105989|62655917|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
33280239|NCT00105989|62655916|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
33280240|NCT00105989|62655917|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
33280241|NCT00105989|62655916|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
33280242|NCT00105989|62655917|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
33280243|NCT00105989|62655916|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
33280244|NCT00105989|62655917|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
33280245|NCT00105989|62655916|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
33280246|NCT00105989|62655917|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
33280247|NCT00105989|62655916|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
33280248|NCT00105989|62655917|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
33280249|NCT00105989|62655916|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
33280250|NCT00105989|62655917|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
33280251|NCT00105989|62655916|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
33280252|NCT00105989|62655917|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
33280253|NCT00105989|62655916|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
33280254|NCT00105989|62655917|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
33280255|NCT03277248|62655935|FG000|Overall Study|Adverse Event|3|||
33280256|NCT03277248|62655936|FG001|Overall Study|Adverse Event|1|||
33280257|NCT03277248|62655935|FG000|Overall Study|Subject Withdrawal of Consent|6|||
33280258|NCT03277248|62655936|FG001|Overall Study|Subject Withdrawal of Consent|23|||
33280259|NCT03277248|62655935|FG000|Overall Study|Investigator/Sponsor Decision|2|||
33280260|NCT03277248|62655936|FG001|Overall Study|Investigator/Sponsor Decision|2|||
33280261|NCT03277248|62655935|FG000|Overall Study|Pregnancy|4|||
33280262|NCT03277248|62655936|FG001|Overall Study|Pregnancy|1|||
33280263|NCT03277248|62655935|FG000|Overall Study|Lost to Follow-up|0|||
33280264|NCT03277248|62655936|FG001|Overall Study|Lost to Follow-up|2|||
33280265|NCT03277248|62655935|FG000|Overall Study|Lack of Efficacy|0|||
33280266|NCT03277248|62655936|FG001|Overall Study|Lack of Efficacy|2|||
33280267|NCT03277248|62655935|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
33280268|NCT03277248|62655936|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
33280269|NCT03276780|62655944|FG000|Overall Study|Withdrawal by Subject|5|||
33280270|NCT03276780|62655945|FG001|Overall Study|Withdrawal by Subject|3|||
33280271|NCT03276780|62655944|FG000|Overall Study|Lost to Follow-up|3|||
33280272|NCT03276780|62655945|FG001|Overall Study|Lost to Follow-up|5|||
33280273|NCT03276780|62655944|FG000|Overall Study|Moved out of state|1|||
33280274|NCT03276780|62655945|FG001|Overall Study|Moved out of state|1|||
33280275|NCT03276780|62655944|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
33280276|NCT03276780|62655945|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
33280277|NCT03276780|62655944|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
33280278|NCT03276780|62655945|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
33280279|NCT03271047|62655961|FG000|Phase 1b: Dose Finding Period|Death|8|||
33280280|NCT03271047|62655962|FG001|Phase 1b: Dose Finding Period|Death|8|||
33280281|NCT03271047|62655963|FG002|Phase 1b: Dose Finding Period|Death|0|||
33280282|NCT03271047|62655964|FG003|Phase 1b: Dose Finding Period|Death|0|||
33280283|NCT03271047|62655961|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
33280284|NCT03271047|62655962|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
33280285|NCT03271047|62655963|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
33280286|NCT03271047|62655964|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
33280287|NCT03271047|62655961|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
33486194|NCT04109391|62863980|FG000|Overall Study|Adverse Event|2|||
33280288|NCT03271047|62655962|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
33280289|NCT03271047|62655963|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
33280290|NCT03271047|62655964|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
33280291|NCT03271047|62655961|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
33280292|NCT03271047|62655962|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
33486195|NCT04109391|62863981|FG001|Overall Study|Adverse Event|2|||
33280293|NCT03271047|62655963|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
33280294|NCT03271047|62655964|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
33280295|NCT03271047|62655961|FG000|Randomized Phase 2 Period|Other|0|||
33280296|NCT03271047|62655962|FG001|Randomized Phase 2 Period|Other|0|||
33280297|NCT03271047|62655963|FG002|Randomized Phase 2 Period|Other|0|||
33280298|NCT03271047|62655964|FG003|Randomized Phase 2 Period|Other|1|||
33280299|NCT03271047|62655961|FG000|Randomized Phase 2 Period|Death|0|||
33370676|NCT00838110|62749353|FG001|Overall Study|Did not meet eligibility criteria|0|||
33370677|NCT00838110|62749354|FG002|Overall Study|Did not meet eligibility criteria|1|||
33370678|NCT00838110|62749355|FG003|Overall Study|Did not meet eligibility criteria|2|||
33486196|NCT04109391|62863982|FG002|Overall Study|Adverse Event|0|||
33486197|NCT04109391|62863980|FG000|Overall Study|Withdrawal by Subject|2|||
33486198|NCT04109391|62863981|FG001|Overall Study|Withdrawal by Subject|0|||
33486199|NCT04109391|62863982|FG002|Overall Study|Withdrawal by Subject|0|||
33486200|NCT04109391|62863980|FG000|Overall Study|Pregnancy|1|||
33486201|NCT04109391|62863981|FG001|Overall Study|Pregnancy|0|||
33486202|NCT04109391|62863982|FG002|Overall Study|Pregnancy|0|||
33486203|NCT04109391|62863980|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
33486204|NCT04109391|62863981|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
33486205|NCT04109391|62863982|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
33486206|NCT04109391|62863980|FG000|Overall Study|Lost to Follow-up|0|||
33486207|NCT04109391|62863981|FG001|Overall Study|Lost to Follow-up|0|||
33486208|NCT04109391|62863982|FG002|Overall Study|Lost to Follow-up|1|||
33486209|NCT04109391|62863980|FG000|Overall Study|Lack of Efficacy|2|||
33370679|NCT00838110|62749352|FG000|Overall Study|Randomized but not treated|0|||
33370680|NCT00838110|62749353|FG001|Overall Study|Randomized but not treated|1|||
33370681|NCT00838110|62749354|FG002|Overall Study|Randomized but not treated|0|||
33370682|NCT00838110|62749355|FG003|Overall Study|Randomized but not treated|0|||
33370683|NCT00837876|62749365|FG000|Overall Study|Death|2|||
33370684|NCT00837876|62749365|FG000|Overall Study|Adverse Event|7|||
33370685|NCT00837876|62749365|FG000|Overall Study|Physician Decision|1|||
33370686|NCT00837876|62749365|FG000|Overall Study|Withdrawal by Subject|3|||
33370687|NCT00837876|62749365|FG000|Overall Study|disease progression|24|||
33370688|NCT02637713|62749369|FG000|Overall Study|Screen Failure|2|||
33370689|NCT00686920|62749375|FG000|Overall Study|Death|45|||
33370690|NCT00686920|62749376|FG001|Overall Study|Death|14|||
33370691|NCT00686920|62749375|FG000|Overall Study|Liver Transplant|23|||
33370692|NCT00686920|62749376|FG001|Overall Study|Liver Transplant|8|||
33370693|NCT00686920|62749375|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
33370694|NCT00686920|62749376|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
33370695|NCT00686920|62749375|FG000|Overall Study|Withdrawal by Subject|23|||
33370696|NCT00686920|62749376|FG001|Overall Study|Withdrawal by Subject|5|||
33370697|NCT00686920|62749375|FG000|Overall Study|Protocol Violation|2|||
33370698|NCT00686920|62749376|FG001|Overall Study|Protocol Violation|1|||
33370699|NCT00686920|62749375|FG000|Overall Study|Adverse Event|10|||
33370700|NCT00686920|62749376|FG001|Overall Study|Adverse Event|2|||
33370701|NCT00686920|62749375|FG000|Overall Study|Personal Reason|0|||
33370702|NCT00686920|62749376|FG001|Overall Study|Personal Reason|1|||
33370703|NCT00686920|62749375|FG000|Overall Study|Lost to Follow-up|15|||
33370704|NCT00686920|62749376|FG001|Overall Study|Lost to Follow-up|3|||
33370705|NCT00686920|62749375|FG000|Overall Study|Moved to Another State|1|||
33370706|NCT00686920|62749376|FG001|Overall Study|Moved to Another State|0|||
33370707|NCT00686920|62749375|FG000|Overall Study|Transferred to Nursing Home|1|||
33370708|NCT00686920|62749376|FG001|Overall Study|Transferred to Nursing Home|0|||
33370709|NCT00686920|62749375|FG000|Overall Study|Noncompliance|9|||
33370710|NCT00686920|62749376|FG001|Overall Study|Noncompliance|0|||
33370711|NCT00686920|62749375|FG000|Overall Study|Principal Investigator Decision|2|||
33370712|NCT00686920|62749376|FG001|Overall Study|Principal Investigator Decision|0|||
33370713|NCT00845832|62749385|FG000|Treatment Period|Adverse Event|0|||
33370714|NCT00845832|62749386|FG001|Treatment Period|Adverse Event|2|||
33370715|NCT00845832|62749387|FG002|Treatment Period|Adverse Event|0|||
33486210|NCT04109391|62863981|FG001|Overall Study|Lack of Efficacy|2|||
33486211|NCT04109391|62863982|FG002|Overall Study|Lack of Efficacy|3|||
33486212|NCT04106817|62863993|FG000|Overall Study|Lost to Follow-up|1|||
33486213|NCT04106817|62863994|FG001|Overall Study|Lost to Follow-up|0|||
33486214|NCT04106817|62863995|FG002|Overall Study|Lost to Follow-up|0|||
33280300|NCT03271047|62655962|FG001|Randomized Phase 2 Period|Death|0|||
33280301|NCT03271047|62655963|FG002|Randomized Phase 2 Period|Death|20|||
33280302|NCT03271047|62655964|FG003|Randomized Phase 2 Period|Death|21|||
33370716|NCT00845832|62749385|FG000|Treatment Period|Protocol Violation|1|||
33370717|NCT00845832|62749386|FG001|Treatment Period|Protocol Violation|1|||
33370718|NCT00845832|62749387|FG002|Treatment Period|Protocol Violation|0|||
33370719|NCT00845832|62749385|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
33370720|NCT00845832|62749386|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
33370721|NCT00845832|62749387|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
33370722|NCT00845832|62749385|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
33280303|NCT03271047|62655961|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
33280304|NCT03271047|62655962|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
33280305|NCT03271047|62655963|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
33280306|NCT03271047|62655964|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
33280307|NCT03271047|62655961|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
33280308|NCT03271047|62655962|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
33280309|NCT03271047|62655963|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
33280310|NCT03271047|62655964|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
33280311|NCT03271047|62655961|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
33280312|NCT03271047|62655962|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
33280313|NCT03271047|62655963|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
33280314|NCT03271047|62655964|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
33280315|NCT03276936|62655978|FG000|Overall Study|Adverse Event|4|||
33280316|NCT03276936|62655979|FG001|Overall Study|Adverse Event|2|||
33280317|NCT03276936|62655978|FG000|Overall Study|Lost to Follow-up|16|||
33280318|NCT03276936|62655979|FG001|Overall Study|Lost to Follow-up|13|||
33280319|NCT03276936|62655978|FG000|Overall Study|Withdrawal by Subject|30|||
33280320|NCT03276936|62655979|FG001|Overall Study|Withdrawal by Subject|20|||
33280321|NCT03276936|62655978|FG000|Overall Study|Not mentioned|6|||
33280322|NCT03276936|62655979|FG001|Overall Study|Not mentioned|3|||
33370723|NCT00845832|62749386|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
33370724|NCT00845832|62749387|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
33370725|NCT00591864|62749395|FG000|Overall Study|Incomplete Imaging|5|||
33370726|NCT00885755|62749403|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
33370727|NCT00885755|62749404|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
33370728|NCT00885755|62749405|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
33370729|NCT00885755|62749403|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
33370730|NCT00885755|62749404|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
33370731|NCT00885755|62749405|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
33370732|NCT00885755|62749403|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
33370733|NCT00885755|62749404|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
33370734|NCT00885755|62749405|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
33370735|NCT00885755|62749403|FG000|Part I: Trastuzumab+Taxane|Death|0|||
33370736|NCT00885755|62749404|FG001|Part I: Trastuzumab+Taxane|Death|0|||
33370737|NCT00885755|62749405|FG002|Part I: Trastuzumab+Taxane|Death|1|||
33370738|NCT00885755|62749403|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
33370739|NCT00885755|62749404|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
33370740|NCT00885755|62749405|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
33370741|NCT00837486|62749415|FG000|Blinded-treatment Phase|Physician Decision|1|||
33370742|NCT00837486|62749416|FG001|Blinded-treatment Phase|Physician Decision|0|||
33370743|NCT00837486|62749415|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
33370744|NCT00837486|62749416|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
33370745|NCT00837486|62749415|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
33370746|NCT00837486|62749416|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
33370747|NCT00837486|62749415|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
33370748|NCT00837486|62749416|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
33370749|NCT00845676|62749424|FG000|Overall Study|Virologic breakthrough at week 20|1|||
33370750|NCT00845676|62749424|FG000|Overall Study|Adverse Event|1|||
33370751|NCT00883181|62749429|FG000|Overall Study|Hematological Adverse Event|26|||
33370752|NCT00883181|62749429|FG000|Overall Study|Non-hematological Adverse Event|55|||
33370753|NCT00883181|62749429|FG000|Overall Study|Disease Progression|94|||
33370754|NCT00883181|62749429|FG000|Overall Study|Administrative Reason|24|||
33370755|NCT00883181|62749429|FG000|Overall Study|Withdrawal by Subject|4|||
33370756|NCT00883181|62749429|FG000|Overall Study|Death|31|||
33370757|NCT00883181|62749429|FG000|Overall Study|Other|38|||
33370758|NCT00883181|62749429|FG000|Overall Study|Protocol Deviation|3|||
33370759|NCT00883181|62749429|FG000|Overall Study|Noncompliance|3|||
33370760|NCT00845520|62749449|FG000|Overall Study|Death|1|||
33370761|NCT00845520|62749450|FG001|Overall Study|Death|2|||
33370762|NCT00845520|62749451|FG002|Overall Study|Death|0|||
33370763|NCT00845520|62749449|FG000|Overall Study|Lost to Follow-up|1|||
33370764|NCT00845520|62749450|FG001|Overall Study|Lost to Follow-up|0|||
33370765|NCT00845520|62749451|FG002|Overall Study|Lost to Follow-up|0|||
33370766|NCT00845520|62749449|FG000|Overall Study|Adverse Event|0|||
33370767|NCT00845520|62749450|FG001|Overall Study|Adverse Event|0|||
33370768|NCT00845520|62749451|FG002|Overall Study|Adverse Event|1|||
33370769|NCT00844896|62749467|FG000|Overall Study|Lost to Follow-up|12|||
33370770|NCT00844896|62749468|FG001|Overall Study|Lost to Follow-up|16|||
33370771|NCT00844896|62749467|FG000|Overall Study|Parents did not have time to complete|0|||
33370772|NCT00844896|62749468|FG001|Overall Study|Parents did not have time to complete|1|||
33370773|NCT00827502|62749475|FG000|Overall Study|randomized but not treated|11|||
33370774|NCT00827502|62749475|FG000|Overall Study|Adverse Event|1|||
33370775|NCT00827502|62749475|FG000|Overall Study|Lost to Follow-up|4|||
33370776|NCT00827502|62749475|FG000|Overall Study|Withdrawal by Subject|5|||
33280323|NCT00106002|62655985|FG000|Overall Study|Did not take any study drug|1|||
33280324|NCT00106002|62655985|FG000|Overall Study|Ineligible after Registration|1|||
33280325|NCT00105482|62656003|FG000|Overall Study|Adverse Event|1|||
33280326|NCT00105482|62656004|FG001|Overall Study|Adverse Event|1|||
33280327|NCT00105482|62656003|FG000|Overall Study|Lost to Follow-up|26|||
33280328|NCT00105482|62656004|FG001|Overall Study|Lost to Follow-up|17|||
33280329|NCT00105482|62656003|FG000|Overall Study|Withdrawal by Subject|0|||
33370777|NCT00837330|62749481|FG000|Overall Study|Lost to Follow-up|1|||
33370778|NCT00837330|62749482|FG001|Overall Study|Lost to Follow-up|3|||
33370779|NCT00837096|62749490|FG000|Overall Study|Physician Decision|1|||
33370780|NCT00837096|62749491|FG001|Overall Study|Physician Decision|1|||
33370781|NCT00837096|62749490|FG000|Overall Study|Not reported|9|||
33370782|NCT00837096|62749491|FG001|Overall Study|Not reported|8|||
33370783|NCT00885677|62749499|FG000|Overall Study|Death|40|||
33370784|NCT00885677|62749500|FG001|Overall Study|Death|34|||
33370785|NCT00885677|62749499|FG000|Overall Study|Lost to Follow-up|15|||
33370786|NCT00885677|62749500|FG001|Overall Study|Lost to Follow-up|13|||
33370787|NCT00885677|62749499|FG000|Overall Study|Protocol Violation|54|||
33370788|NCT00885677|62749500|FG001|Overall Study|Protocol Violation|54|||
33370789|NCT00885677|62749499|FG000|Overall Study|premature study closure|41|||
33370790|NCT00885677|62749500|FG001|Overall Study|premature study closure|44|||
33370791|NCT00885677|62749499|FG000|Overall Study|device/lead revision or replacement|7|||
33370792|NCT00885677|62749500|FG001|Overall Study|device/lead revision or replacement|6|||
33370793|NCT00885677|62749499|FG000|Overall Study|Heart transplantation|1|||
33370794|NCT00885677|62749500|FG001|Overall Study|Heart transplantation|0|||
33486215|NCT04097925|62864003|FG000|Overall Study|Withdrawal by Subject|1|||
33486216|NCT04195893|62864007|FG000|Second Intervention|Withdrawal by Subject|1|||
33486217|NCT04195893|62864008|FG001|Second Intervention|Withdrawal by Subject|0|||
33486218|NCT04195581|62864014|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
33486219|NCT04195581|62864014|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
33486220|NCT04195581|62864014|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
33486221|NCT04195581|62864014|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
33486222|NCT04195581|62864014|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
33486223|NCT04195581|62864014|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
33280330|NCT00105482|62656004|FG001|Overall Study|Withdrawal by Subject|1|||
33280331|NCT00105482|62656003|FG000|Overall Study|Lost Interest|29|||
33280332|NCT00105482|62656004|FG001|Overall Study|Lost Interest|32|||
33280333|NCT00105482|62656003|FG000|Overall Study|Scheduling Conflict|2|||
33280334|NCT00105482|62656004|FG001|Overall Study|Scheduling Conflict|3|||
33280335|NCT00105482|62656003|FG000|Overall Study|Withdrawn by PI|1|||
33280336|NCT00105482|62656004|FG001|Overall Study|Withdrawn by PI|1|||
33280337|NCT01327651|62656019|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
33280338|NCT01327651|62656020|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
33280339|NCT01327651|62656021|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
33280340|NCT01327651|62656022|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
33280341|NCT01327651|62656023|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
33280342|NCT01327651|62656024|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
33280343|NCT01327651|62656025|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
33280344|NCT01327651|62656026|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
33280345|NCT01327651|62656027|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
33280346|NCT01327651|62656019|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
33280347|NCT01327651|62656020|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33280348|NCT01327651|62656021|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33280349|NCT01327651|62656022|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33280350|NCT01327651|62656023|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33280351|NCT01327651|62656024|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33280352|NCT01327651|62656025|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33280353|NCT01327651|62656026|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33280354|NCT01327651|62656027|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33280355|NCT01327651|62656019|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
33280356|NCT01327651|62656020|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
33486224|NCT04096365|62864032|FG000|Overall Study|Adverse Event|1|||
33486225|NCT04194489|62864036|FG000|Overall Study|Withdrawal by Subject|5|||
33555937|NCT02148133|62948735|FG000|Overall Study|Protocol-defined stopping criteria|2|||
33555938|NCT00803569|62948739|FG000|Overall Study|Progressive Disease|3|||
33280357|NCT01327651|62656021|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
33280358|NCT01327651|62656022|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
33280359|NCT01327651|62656023|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
33370795|NCT00885677|62749499|FG000|Overall Study|Inclusion/exclusion not met|25|||
33370796|NCT00885677|62749500|FG001|Overall Study|Inclusion/exclusion not met|27|||
33486226|NCT04194489|62864036|FG000|Overall Study|Lost to Follow-up|48|||
33486227|NCT04094883|62864040|FG000|Overall Study|Withdrawal by Subject|1|||
33486228|NCT01368562|62864044|FG000|Overall Study|Adverse Event|1|||
33280360|NCT01327651|62656024|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
33280361|NCT01327651|62656025|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
33280362|NCT01327651|62656026|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
33280363|NCT01327651|62656027|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
33280364|NCT01327651|62656019|FG000|Post Study Follow-up|Lost to Follow-up|0|||
33280365|NCT01327651|62656020|FG001|Post Study Follow-up|Lost to Follow-up|1|||
33280366|NCT01327651|62656021|FG002|Post Study Follow-up|Lost to Follow-up|1|||
33280367|NCT01327651|62656022|FG003|Post Study Follow-up|Lost to Follow-up|0|||
33280368|NCT01327651|62656023|FG004|Post Study Follow-up|Lost to Follow-up|0|||
33280369|NCT01327651|62656024|FG005|Post Study Follow-up|Lost to Follow-up|0|||
33280370|NCT01327651|62656025|FG006|Post Study Follow-up|Lost to Follow-up|4|||
33280371|NCT01327651|62656026|FG007|Post Study Follow-up|Lost to Follow-up|1|||
33280372|NCT01327651|62656027|FG008|Post Study Follow-up|Lost to Follow-up|2|||
33280373|NCT00105443|62656068|FG000|Double-Blind Treatment|Adverse Event|1|||
33280374|NCT00105443|62656069|FG001|Double-Blind Treatment|Adverse Event|0|||
33280375|NCT00105443|62656070|FG002|Double-Blind Treatment|Adverse Event|0|||
33280376|NCT00105443|62656071|FG003|Double-Blind Treatment|Adverse Event|0|||
33280377|NCT00105443|62656068|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
33280378|NCT00105443|62656069|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
33280379|NCT00105443|62656070|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
33280380|NCT00105443|62656071|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
33280381|NCT00105443|62656068|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
33280382|NCT00105443|62656069|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
33280383|NCT00105443|62656070|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
33280384|NCT00105443|62656071|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
33280385|NCT00105443|62656068|FG000|Double-Blind Treatment|Physician Decision|1|||
33280386|NCT00105443|62656069|FG001|Double-Blind Treatment|Physician Decision|0|||
33280387|NCT00105443|62656070|FG002|Double-Blind Treatment|Physician Decision|2|||
33280388|NCT00105443|62656071|FG003|Double-Blind Treatment|Physician Decision|0|||
33280389|NCT00105443|62656068|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
33280390|NCT00105443|62656069|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
33280391|NCT00105443|62656070|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
33280392|NCT00105443|62656071|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
33280393|NCT00105443|62656068|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
33280394|NCT00105443|62656069|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
33280395|NCT00105443|62656070|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
33280396|NCT00105443|62656071|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
33280397|NCT00105443|62656068|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
33280398|NCT00105443|62656069|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
33280399|NCT00105443|62656070|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
33280400|NCT00105443|62656071|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
33280401|NCT00105443|62656068|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
33280402|NCT00105443|62656069|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
33280403|NCT00105443|62656070|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
33280404|NCT00105443|62656071|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
33280405|NCT00105443|62656068|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
33280406|NCT00105443|62656069|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
33280407|NCT00105443|62656070|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
33280408|NCT00105443|62656071|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
33280409|NCT00105443|62656068|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
33280410|NCT00105443|62656069|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
33280411|NCT00105443|62656070|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
33280412|NCT00105443|62656071|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
33280413|NCT00105443|62656068|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
33280414|NCT00105443|62656069|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
33280415|NCT00105443|62656070|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
33280416|NCT00105443|62656071|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
33280417|NCT00105443|62656068|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
33280418|NCT00105443|62656069|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
33280419|NCT00105443|62656070|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
33280420|NCT00105443|62656071|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
33280421|NCT00105443|62656068|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
33280422|NCT00105443|62656069|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
33370797|NCT00885365|62749508|FG000|4 Weeks ON Treatment|Adverse Event|2|||
33370798|NCT00885365|62749509|FG001|4 Weeks ON Treatment|Adverse Event|4|||
33555939|NCT00803569|62948739|FG000|Overall Study|Noncompliance|1|||
33555940|NCT00112957|62948743|FG000|Overall Study|Progressive disease|18|||
33280423|NCT00105443|62656070|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
33370799|NCT00885365|62749508|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
33280424|NCT00105443|62656071|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
33280425|NCT00105443|62656068|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
33280426|NCT00105443|62656069|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
33280427|NCT00105443|62656070|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
33280428|NCT00105443|62656071|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
33280429|NCT00105443|62656068|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
33280430|NCT00105443|62656069|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
33280431|NCT00105443|62656070|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
33280432|NCT00105443|62656071|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
33280433|NCT00105443|62656068|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
33280434|NCT00105443|62656069|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
33280435|NCT00105443|62656070|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
33280436|NCT00105443|62656071|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
33280437|NCT00105443|62656068|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
33280438|NCT00105443|62656069|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
33280439|NCT00105443|62656070|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
33280440|NCT00105443|62656071|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
33280441|NCT00105443|62656068|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
33280442|NCT00105443|62656069|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
33280443|NCT00105443|62656070|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
33280444|NCT00105443|62656071|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
33280445|NCT00105443|62656068|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
33280446|NCT00105443|62656069|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
33280447|NCT00105443|62656070|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
33280448|NCT00105443|62656071|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
33280449|NCT01327612|62656087|FG000|Overall Study|Withdrawal by Subject|0|||
33280450|NCT01327612|62656088|FG001|Overall Study|Withdrawal by Subject|0|||
33280451|NCT01327612|62656089|FG002|Overall Study|Withdrawal by Subject|0|||
33280452|NCT01327612|62656090|FG003|Overall Study|Withdrawal by Subject|0|||
33280453|NCT01327612|62656091|FG004|Overall Study|Withdrawal by Subject|0|||
33280454|NCT01327612|62656092|FG005|Overall Study|Withdrawal by Subject|1|||
33280455|NCT01327612|62656093|FG006|Overall Study|Withdrawal by Subject|0|||
33280456|NCT01327612|62656087|FG000|Overall Study|Disease Progression|1|||
33280457|NCT01327612|62656088|FG001|Overall Study|Disease Progression|1|||
33280458|NCT01327612|62656089|FG002|Overall Study|Disease Progression|1|||
33280459|NCT01327612|62656090|FG003|Overall Study|Disease Progression|0|||
33280460|NCT01327612|62656091|FG004|Overall Study|Disease Progression|1|||
33280461|NCT01327612|62656092|FG005|Overall Study|Disease Progression|2|||
33280462|NCT01327612|62656093|FG006|Overall Study|Disease Progression|2|||
33280463|NCT01327612|62656087|FG000|Overall Study|Administrative Decision|0|||
33280464|NCT01327612|62656088|FG001|Overall Study|Administrative Decision|0|||
33280465|NCT01327612|62656089|FG002|Overall Study|Administrative Decision|0|||
33280466|NCT01327612|62656090|FG003|Overall Study|Administrative Decision|1|||
33280467|NCT01327612|62656091|FG004|Overall Study|Administrative Decision|0|||
33280468|NCT01327612|62656092|FG005|Overall Study|Administrative Decision|0|||
33280469|NCT01327612|62656093|FG006|Overall Study|Administrative Decision|0|||
33280470|NCT01327612|62656087|FG000|Overall Study|Death|0|||
33280471|NCT01327612|62656088|FG001|Overall Study|Death|0|||
33280472|NCT01327612|62656089|FG002|Overall Study|Death|0|||
33280473|NCT01327612|62656090|FG003|Overall Study|Death|0|||
33280474|NCT01327612|62656091|FG004|Overall Study|Death|1|||
33280475|NCT01327612|62656092|FG005|Overall Study|Death|0|||
33280476|NCT01327612|62656093|FG006|Overall Study|Death|0|||
33280477|NCT01327573|62656112|FG000|Overall Study|Physician Decision|3|||
33280478|NCT01327573|62656113|FG001|Overall Study|Physician Decision|1|||
33280479|NCT01327495|62656126|FG000|Overall Study|Adverse Event|2|||
33280480|NCT01327495|62656127|FG001|Overall Study|Adverse Event|1|||
33280481|NCT01327495|62656128|FG002|Overall Study|Adverse Event|1|||
33280482|NCT01327495|62656129|FG003|Overall Study|Adverse Event|0|||
33280483|NCT01327495|62656130|FG004|Overall Study|Adverse Event|0|||
33280484|NCT01327495|62656131|FG005|Overall Study|Adverse Event|2|||
33280485|NCT01327495|62656126|FG000|Overall Study|Withdrawal by Subject|0|||
33280486|NCT01327495|62656127|FG001|Overall Study|Withdrawal by Subject|1|||
33280487|NCT01327495|62656128|FG002|Overall Study|Withdrawal by Subject|1|||
33280488|NCT01327495|62656129|FG003|Overall Study|Withdrawal by Subject|0|||
33280489|NCT01327495|62656130|FG004|Overall Study|Withdrawal by Subject|1|||
33280490|NCT01327495|62656131|FG005|Overall Study|Withdrawal by Subject|0|||
33280491|NCT01327495|62656126|FG000|Overall Study|Physician Decision|0|||
33280492|NCT01327495|62656127|FG001|Overall Study|Physician Decision|0|||
33280493|NCT01327495|62656128|FG002|Overall Study|Physician Decision|0|||
33555941|NCT00112957|62948743|FG000|Overall Study|Physician Decision|1|||
33280494|NCT01327495|62656129|FG003|Overall Study|Physician Decision|0|||
33280495|NCT01327495|62656130|FG004|Overall Study|Physician Decision|2|||
33280496|NCT01327495|62656131|FG005|Overall Study|Physician Decision|0|||
33280497|NCT01327339|62656151|FG000|Overall Study|Protocol Violation|8|||
33280498|NCT01327300|62656155|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
33280499|NCT01327300|62656156|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
33280500|NCT01379521|62656174|FG000|Overall Study -Treatment Period|Adverse Event|3|||
33280501|NCT01379521|62656175|FG001|Overall Study -Treatment Period|Adverse Event|0|||
33280502|NCT01379521|62656174|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
33280503|NCT01379521|62656175|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
33280504|NCT01379521|62656174|FG000|Overall Study -Treatment Period|Disease Progression|23|||
33280505|NCT01379521|62656175|FG001|Overall Study -Treatment Period|Disease Progression|22|||
33280506|NCT01379521|62656174|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
33280507|NCT01379521|62656175|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
33280508|NCT01379521|62656174|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
33280509|NCT01379521|62656175|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
33280510|NCT01379521|62656174|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
33280511|NCT01379521|62656175|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
33280512|NCT01379521|62656174|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
33280513|NCT01379521|62656175|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
33555942|NCT02376790|62948750|FG000|Overall Study|Withdrawal by Subject|43|||
33555943|NCT02376790|62948751|FG001|Overall Study|Withdrawal by Subject|36|||
33555944|NCT02376790|62948752|FG002|Overall Study|Withdrawal by Subject|37|||
33555945|NCT02376790|62948750|FG000|Overall Study|Decision by Sponsor|2|||
33555946|NCT02376790|62948751|FG001|Overall Study|Decision by Sponsor|1|||
33555947|NCT02376790|62948752|FG002|Overall Study|Decision by Sponsor|4|||
33555948|NCT02376790|62948750|FG000|Overall Study|Lost to Follow-up|15|||
33555949|NCT02376790|62948751|FG001|Overall Study|Lost to Follow-up|10|||
33555950|NCT02376790|62948752|FG002|Overall Study|Lost to Follow-up|12|||
33555951|NCT02376166|62948760|FG000|Overall Study|Adverse Event|1|||
33280514|NCT01379521|62656174|FG000|Overall Study -Treatment Period|Death|2|||
33280515|NCT01379521|62656175|FG001|Overall Study -Treatment Period|Death|1|||
33280516|NCT01379521|62656174|FG000|Post-Treatment Evaluations|Disease Progression|22|||
33280517|NCT01379521|62656175|FG001|Post-Treatment Evaluations|Disease Progression|20|||
33280518|NCT01379521|62656174|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
33280519|NCT01379521|62656175|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
33280520|NCT01379521|62656174|FG000|Post-Treatment Evaluations|Death|1|||
33280521|NCT01379521|62656175|FG001|Post-Treatment Evaluations|Death|0|||
33280522|NCT01371994|62656183|FG000|Overall Study|Adverse Event|3|||
33280523|NCT01371994|62656184|FG001|Overall Study|Adverse Event|6|||
33280524|NCT01371994|62656183|FG000|Overall Study|Lack of Efficacy|3|||
33280525|NCT01371994|62656184|FG001|Overall Study|Lack of Efficacy|0|||
33280526|NCT01371994|62656183|FG000|Overall Study|Withdrawal by Subject|13|||
33280527|NCT01371994|62656184|FG001|Overall Study|Withdrawal by Subject|7|||
33280528|NCT01371994|62656183|FG000|Overall Study|Lost to Follow-up|1|||
33280529|NCT01371994|62656184|FG001|Overall Study|Lost to Follow-up|1|||
33280530|NCT01371994|62656183|FG000|Overall Study|Protocol Violation|24|||
33280531|NCT01371994|62656184|FG001|Overall Study|Protocol Violation|17|||
33280532|NCT01371994|62656183|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
33280533|NCT01371994|62656184|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
33280534|NCT01371994|62656183|FG000|Overall Study|Physician Decision|1|||
33280535|NCT01371994|62656184|FG001|Overall Study|Physician Decision|1|||
33280536|NCT01371994|62656183|FG000|Overall Study|Miscellaneous Reasons|6|||
33280537|NCT01371994|62656184|FG001|Overall Study|Miscellaneous Reasons|4|||
33280538|NCT01371877|62656192|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
33280539|NCT01371877|62656193|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
33280540|NCT01371838|62656201|FG000|Overall Study|Withdrawal by Subject|27|||
33280541|NCT01371838|62656202|FG001|Overall Study|Withdrawal by Subject|33|||
33280542|NCT01371838|62656201|FG000|Overall Study|Lost to Follow-up|10|||
33280543|NCT01371838|62656202|FG001|Overall Study|Lost to Follow-up|20|||
33280544|NCT01371838|62656201|FG000|Overall Study|Death|3|||
33280545|NCT01371838|62656202|FG001|Overall Study|Death|4|||
33280546|NCT01371838|62656201|FG000|Overall Study|Protocol Violation|3|||
33280547|NCT01371838|62656202|FG001|Overall Study|Protocol Violation|0|||
33555952|NCT02376166|62948760|FG000|Overall Study|Discontinued metformin early|2|||
33662133|NCT01695239|63092841|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33280548|NCT01371838|62656201|FG000|Overall Study|Investigator Decision|3|||
33662134|NCT01695239|63092842|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33280549|NCT01371838|62656202|FG001|Overall Study|Investigator Decision|8|||
33280550|NCT01371838|62656201|FG000|Overall Study|Last follow-up visit not conducted|2|||
33280551|NCT01371838|62656202|FG001|Overall Study|Last follow-up visit not conducted|0|||
33280552|NCT01371838|62656201|FG000|Overall Study|Lack of therapeutic response|0|||
33555953|NCT02311894|62948764|FG000|Overall Study|Discontinued in error|1|||
33555954|NCT02311894|62948764|FG000|Overall Study|Lost to Follow-up|1|||
33280553|NCT01371838|62656202|FG001|Overall Study|Lack of therapeutic response|1|||
33280554|NCT01371838|62656201|FG000|Overall Study|Surgery|1|||
33280555|NCT01371838|62656202|FG001|Overall Study|Surgery|0|||
33280556|NCT01371721|62656211|FG000|Overall Study|Adverse Event|5|||
33280557|NCT01371721|62656212|FG001|Overall Study|Adverse Event|4|||
33280558|NCT01371721|62656213|FG002|Overall Study|Adverse Event|5|||
33280559|NCT01371721|62656211|FG000|Overall Study|Protocol Violation|6|||
33280560|NCT01371721|62656212|FG001|Overall Study|Protocol Violation|4|||
33280561|NCT01371721|62656213|FG002|Overall Study|Protocol Violation|5|||
33280562|NCT01371721|62656211|FG000|Overall Study|Lost to Follow-up|8|||
33280563|NCT01371721|62656212|FG001|Overall Study|Lost to Follow-up|2|||
33280564|NCT01371721|62656213|FG002|Overall Study|Lost to Follow-up|6|||
33280565|NCT01371721|62656211|FG000|Overall Study|Withdrawal by Subject|5|||
33280566|NCT01371721|62656212|FG001|Overall Study|Withdrawal by Subject|7|||
33280567|NCT01371721|62656213|FG002|Overall Study|Withdrawal by Subject|11|||
33370800|NCT00885365|62749509|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
33370801|NCT00885365|62749508|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
33370802|NCT00885365|62749509|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
33370803|NCT00827112|62749517|FG000|Overall Study|Adverse Event|2|||
33370804|NCT00827112|62749518|FG001|Overall Study|Adverse Event|0|||
33370805|NCT00827112|62749517|FG000|Overall Study|Lack of Efficacy|2|||
33370806|NCT00827112|62749518|FG001|Overall Study|Lack of Efficacy|0|||
33370807|NCT00827112|62749517|FG000|Overall Study|Lost to Follow-up|3|||
33370808|NCT00827112|62749518|FG001|Overall Study|Lost to Follow-up|2|||
33370809|NCT00827112|62749517|FG000|Overall Study|Pregnancy|0|||
33370810|NCT00827112|62749518|FG001|Overall Study|Pregnancy|1|||
33370811|NCT00827112|62749517|FG000|Overall Study|Protocol Violation|0|||
33370812|NCT00827112|62749518|FG001|Overall Study|Protocol Violation|2|||
33370813|NCT00827112|62749517|FG000|Overall Study|Withdrawal by Subject|2|||
33370814|NCT00827112|62749518|FG001|Overall Study|Withdrawal by Subject|1|||
33370815|NCT00827112|62749517|FG000|Overall Study|Randomized but not treated|5|||
33370816|NCT00827112|62749518|FG001|Overall Study|Randomized but not treated|3|||
33370817|NCT00827112|62749517|FG000|Overall Study|Other|1|||
33370818|NCT00827112|62749518|FG001|Overall Study|Other|3|||
33370819|NCT00689104|62749528|FG000|Overall Study|Eligibility criterion not met|5|||
33370820|NCT00689104|62749529|FG001|Overall Study|Eligibility criterion not met|8|||
33370821|NCT00689104|62749530|FG002|Overall Study|Eligibility criterion not met|0|||
33370822|NCT00689104|62749531|FG003|Overall Study|Eligibility criterion not met|4|||
33370823|NCT00689104|62749528|FG000|Overall Study|Adverse Event|13|||
33370824|NCT00689104|62749529|FG001|Overall Study|Adverse Event|25|||
33370825|NCT00689104|62749530|FG002|Overall Study|Adverse Event|16|||
33370826|NCT00689104|62749531|FG003|Overall Study|Adverse Event|24|||
33370827|NCT00689104|62749528|FG000|Overall Study|Lack of Efficacy|5|||
33370828|NCT00689104|62749529|FG001|Overall Study|Lack of Efficacy|6|||
33370829|NCT00689104|62749530|FG002|Overall Study|Lack of Efficacy|2|||
33370830|NCT00689104|62749531|FG003|Overall Study|Lack of Efficacy|3|||
33370831|NCT00689104|62749528|FG000|Overall Study|Withdrawal by Subject|12|||
33370832|NCT00689104|62749529|FG001|Overall Study|Withdrawal by Subject|11|||
33370833|NCT00689104|62749530|FG002|Overall Study|Withdrawal by Subject|18|||
33370834|NCT00689104|62749531|FG003|Overall Study|Withdrawal by Subject|11|||
33370835|NCT00689104|62749528|FG000|Overall Study|Lost to Follow-up|4|||
33370836|NCT00689104|62749529|FG001|Overall Study|Lost to Follow-up|3|||
33370837|NCT00689104|62749530|FG002|Overall Study|Lost to Follow-up|2|||
33370838|NCT00689104|62749531|FG003|Overall Study|Lost to Follow-up|5|||
33370839|NCT00689104|62749528|FG000|Overall Study|Protocol Violation|2|||
33370840|NCT00689104|62749529|FG001|Overall Study|Protocol Violation|3|||
33370841|NCT00689104|62749530|FG002|Overall Study|Protocol Violation|5|||
33370842|NCT00689104|62749531|FG003|Overall Study|Protocol Violation|3|||
33370843|NCT00689104|62749528|FG000|Overall Study|Randomized but never received study drug|2|||
33370844|NCT00689104|62749529|FG001|Overall Study|Randomized but never received study drug|1|||
33370845|NCT00689104|62749530|FG002|Overall Study|Randomized but never received study drug|1|||
33370846|NCT00689104|62749531|FG003|Overall Study|Randomized but never received study drug|0|||
33370847|NCT00689104|62749528|FG000|Overall Study|Physician Decision|1|||
33280568|NCT01371721|62656211|FG000|Overall Study|Other|2|||
33370848|NCT00689104|62749529|FG001|Overall Study|Physician Decision|0|||
33370849|NCT00689104|62749530|FG002|Overall Study|Physician Decision|0|||
33370850|NCT00689104|62749531|FG003|Overall Study|Physician Decision|0|||
33370851|NCT00689104|62749528|FG000|Overall Study|Non-compliance with study procedures|0|||
33370852|NCT00689104|62749529|FG001|Overall Study|Non-compliance with study procedures|0|||
33280569|NCT01371721|62656212|FG001|Overall Study|Other|3|||
33280570|NCT01371721|62656213|FG002|Overall Study|Other|0|||
33280571|NCT01371721|62656211|FG000|Overall Study|Lack of Efficacy|2|||
33280572|NCT01371721|62656212|FG001|Overall Study|Lack of Efficacy|4|||
33280573|NCT01371721|62656213|FG002|Overall Study|Lack of Efficacy|3|||
33370853|NCT00689104|62749530|FG002|Overall Study|Non-compliance with study procedures|1|||
33370854|NCT00689104|62749531|FG003|Overall Study|Non-compliance with study procedures|0|||
33370855|NCT00689026|62749543|FG000|Overall Study|Withdrawal by Subject|13|||
33370856|NCT00689026|62749544|FG001|Overall Study|Withdrawal by Subject|6|||
33280574|NCT01371721|62656211|FG000|Overall Study|Randomized but not treated|1|||
33280575|NCT01371721|62656212|FG001|Overall Study|Randomized but not treated|0|||
33280576|NCT01371721|62656213|FG002|Overall Study|Randomized but not treated|0|||
33280577|NCT01366534|62656226|FG000|Overall Study|Lost to Follow-up|1|||
33280578|NCT01366534|62656227|FG001|Overall Study|Lost to Follow-up|0|||
33280579|NCT01366534|62656228|FG002|Overall Study|Lost to Follow-up|0|||
33280580|NCT01366534|62656226|FG000|Overall Study|Migrated|1|||
33280581|NCT01366534|62656227|FG001|Overall Study|Migrated|1|||
33280582|NCT01366534|62656228|FG002|Overall Study|Migrated|0|||
33280583|NCT01366534|62656226|FG000|Overall Study|Declined challenged|0|||
33280584|NCT01366534|62656227|FG001|Overall Study|Declined challenged|1|||
33280585|NCT01366534|62656228|FG002|Overall Study|Declined challenged|0|||
33280586|NCT01365910|62656236|FG000|Overall Study|Withdrawal by Subject|7|||
33280587|NCT01365910|62656236|FG000|Overall Study|disease progression|18|||
33280588|NCT01365910|62656236|FG000|Overall Study|Adverse Event|3|||
33280589|NCT01365910|62656236|FG000|Overall Study|other complicating disease|1|||
33280590|NCT01365910|62656236|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
33280591|NCT01365481|62656244|FG000|Overall Study|Adverse Event|6|||
33280592|NCT01365481|62656245|FG001|Overall Study|Adverse Event|9|||
33280593|NCT01365481|62656246|FG002|Overall Study|Adverse Event|0|||
33280594|NCT01365481|62656247|FG003|Overall Study|Adverse Event|2|||
33555955|NCT02311894|62948764|FG000|Overall Study|Adverse Event|1|||
33555956|NCT02311894|62948764|FG000|Overall Study|Withdrawal by Subject|1|||
33555957|NCT02310646|62948770|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
33555958|NCT02310646|62948771|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
33280595|NCT01365481|62656244|FG000|Overall Study|Withdrawal by Subject|0|||
33280596|NCT01365481|62656245|FG001|Overall Study|Withdrawal by Subject|2|||
33280597|NCT01365481|62656246|FG002|Overall Study|Withdrawal by Subject|1|||
33280598|NCT01365481|62656247|FG003|Overall Study|Withdrawal by Subject|1|||
33280599|NCT01365481|62656244|FG000|Overall Study|Lost to Follow-up|1|||
33280600|NCT01365481|62656245|FG001|Overall Study|Lost to Follow-up|1|||
33280601|NCT01365481|62656246|FG002|Overall Study|Lost to Follow-up|2|||
33280602|NCT01365481|62656247|FG003|Overall Study|Lost to Follow-up|3|||
33280603|NCT01365481|62656244|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33370857|NCT00598559|62749553|FG000|Overall Study|Adverse Event|11|||
33370858|NCT00598559|62749554|FG001|Overall Study|Adverse Event|7|||
33370859|NCT00598559|62749555|FG002|Overall Study|Adverse Event|0|||
33370860|NCT00598559|62749553|FG000|Overall Study|Withdrawal by Subject|2|||
33370861|NCT00598559|62749554|FG001|Overall Study|Withdrawal by Subject|2|||
33370862|NCT00598559|62749555|FG002|Overall Study|Withdrawal by Subject|0|||
33370863|NCT00598559|62749553|FG000|Overall Study|Protocol Non-compliance|1|||
33370864|NCT00598559|62749554|FG001|Overall Study|Protocol Non-compliance|0|||
33370865|NCT00598559|62749555|FG002|Overall Study|Protocol Non-compliance|0|||
33370866|NCT00598559|62749553|FG000|Overall Study|Early discharge from hospital|9|||
33370867|NCT00598559|62749554|FG001|Overall Study|Early discharge from hospital|12|||
33370868|NCT00598559|62749555|FG002|Overall Study|Early discharge from hospital|3|||
33370869|NCT00598559|62749553|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
33370870|NCT00598559|62749554|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
33370871|NCT00598559|62749555|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
33370872|NCT00686686|62749563|FG000|Overall Study|Non-compliance|1|||
33370873|NCT00686686|62749563|FG000|Overall Study|Adverse Event|2|||
33370874|NCT00686686|62749563|FG000|Overall Study|Lost to Follow-up|3|||
33370875|NCT04160195|62749569|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
33370876|NCT04160195|62749570|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
33370877|NCT00686374|62749578|FG000|Overall Study|Lack of Efficacy|10|||
33370878|NCT00686374|62749578|FG000|Overall Study|Adverse Event|8|||
33370879|NCT00686374|62749578|FG000|Overall Study|Withdrew consent|5|||
33370880|NCT00686374|62749578|FG000|Overall Study|Lost to Follow-up|1|||
33370881|NCT00686374|62749578|FG000|Overall Study|Missing reason|33|||
33555959|NCT02310646|62948770|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
33280604|NCT01365481|62656245|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33280605|NCT01365481|62656246|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33280606|NCT01365481|62656247|FG003|Overall Study|Abnormal laboratory value(s)|0|||
33280607|NCT01365481|62656244|FG000|Overall Study|Administrative problems|0|||
33280608|NCT01365481|62656245|FG001|Overall Study|Administrative problems|1|||
33280609|NCT01365481|62656246|FG002|Overall Study|Administrative problems|0|||
33370882|NCT00686374|62749578|FG000|Overall Study|Other, not specified|4|||
33370883|NCT00571948|62749584|FG000|Overall Study|Lost to Follow-up|2|||
33370884|NCT00571948|62749585|FG001|Overall Study|Lost to Follow-up|0|||
33555960|NCT02310646|62948771|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
33280610|NCT01365481|62656247|FG003|Overall Study|Administrative problems|0|||
33280611|NCT01365481|62656244|FG000|Overall Study|Protocol deviation|0|||
33280612|NCT01365481|62656245|FG001|Overall Study|Protocol deviation|1|||
33370885|NCT00571948|62749584|FG000|Overall Study|Withdrawal by Subject|1|||
33280613|NCT01365481|62656246|FG002|Overall Study|Protocol deviation|0|||
33280614|NCT01365481|62656247|FG003|Overall Study|Protocol deviation|1|||
33280615|NCT01365481|62656244|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33280616|NCT01365481|62656245|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33280617|NCT01365481|62656246|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
33280618|NCT01365481|62656247|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
33280619|NCT01357915|62656259|FG000|Overall Study|Lost to Follow-up|3|||
33280620|NCT01357915|62656260|FG001|Overall Study|Lost to Follow-up|0|||
33280621|NCT01350973|62656269|FG000|Overall Study|Adverse Event|4|||
33280622|NCT01350973|62656270|FG001|Overall Study|Adverse Event|7|||
33280623|NCT01350973|62656271|FG002|Overall Study|Adverse Event|7|||
33280624|NCT01350973|62656269|FG000|Overall Study|Voluntary Withdrawal|2|||
33280625|NCT01350973|62656270|FG001|Overall Study|Voluntary Withdrawal|1|||
33280626|NCT01350973|62656271|FG002|Overall Study|Voluntary Withdrawal|1|||
33280627|NCT01350544|62656281|FG000|Overall Study|Administrative Withdrawal|0|||
33280628|NCT01350544|62656282|FG001|Overall Study|Administrative Withdrawal|1|||
33280629|NCT01350544|62656281|FG000|Overall Study|Death|1|||
33280630|NCT01350544|62656282|FG001|Overall Study|Death|2|||
33280631|NCT01350544|62656281|FG000|Overall Study|Moved out of LA County|2|||
33280632|NCT01350544|62656282|FG001|Overall Study|Moved out of LA County|2|||
33280633|NCT01350544|62656281|FG000|Overall Study|Medical Issues|1|||
33280634|NCT01350544|62656282|FG001|Overall Study|Medical Issues|1|||
33280635|NCT01350544|62656281|FG000|Overall Study|Withdrawal by Subject|0|||
33280636|NCT01350544|62656282|FG001|Overall Study|Withdrawal by Subject|1|||
33280637|NCT01350544|62656281|FG000|Overall Study|Incarceration|1|||
33280638|NCT01350544|62656282|FG001|Overall Study|Incarceration|0|||
33280639|NCT01350544|62656281|FG000|Overall Study|Lost to Follow-up|18|||
33280640|NCT01350544|62656282|FG001|Overall Study|Lost to Follow-up|15|||
33280641|NCT01350505|62656288|FG000|Overall Study|Lost to Follow-up|4|||
33280642|NCT01350271|62656295|FG000|Overall Study|Lost to Follow-up|21|||
33280643|NCT01350271|62656296|FG001|Overall Study|Lost to Follow-up|17|||
33280644|NCT01350271|62656297|FG002|Overall Study|Lost to Follow-up|26|||
33280645|NCT01348828|62656308|FG000|Overall Study|Death|20|||
33280646|NCT01348828|62656308|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
33280647|NCT01348828|62656308|FG000|Overall Study|Conversion|2|||
33280648|NCT01348828|62656308|FG000|Overall Study|missed visit|1|||
33280649|NCT01348789|62656312|FG000|Overall Study|Protocol Violation|2|||
33280650|NCT01348789|62656312|FG000|Overall Study|Withdrawal by Subject|2|||
33280651|NCT01342510|62656327|FG000|Overall Study|Protocol Violation|12|||
33280652|NCT01342510|62656328|FG001|Overall Study|Protocol Violation|6|||
33280653|NCT01342510|62656329|FG002|Overall Study|Protocol Violation|13|||
33280654|NCT01342510|62656330|FG003|Overall Study|Protocol Violation|11|||
33280655|NCT01340872|62656350|FG000|Double-blind Phase|Adverse Event|6|||
33280656|NCT01340872|62656351|FG001|Double-blind Phase|Adverse Event|4|||
33280657|NCT01340872|62656352|FG002|Double-blind Phase|Adverse Event|0|||
33280658|NCT01340872|62656353|FG003|Double-blind Phase|Adverse Event|0|||
33280659|NCT01340872|62656350|FG000|Double-blind Phase|Withdrawal by Subject|3|||
33280660|NCT01340872|62656351|FG001|Double-blind Phase|Withdrawal by Subject|5|||
33280661|NCT01340872|62656352|FG002|Double-blind Phase|Withdrawal by Subject|0|||
33280662|NCT01340872|62656353|FG003|Double-blind Phase|Withdrawal by Subject|0|||
33280663|NCT01340872|62656350|FG000|Double-blind Phase|Lost to Follow-up|0|||
33280664|NCT01340872|62656351|FG001|Double-blind Phase|Lost to Follow-up|1|||
33280665|NCT01340872|62656352|FG002|Double-blind Phase|Lost to Follow-up|0|||
33280666|NCT01340872|62656353|FG003|Double-blind Phase|Lost to Follow-up|0|||
33280667|NCT01340872|62656350|FG000|Double-blind Phase|Protocol Violation|0|||
33280668|NCT01340872|62656351|FG001|Double-blind Phase|Protocol Violation|1|||
33280669|NCT01340872|62656352|FG002|Double-blind Phase|Protocol Violation|0|||
33280670|NCT01340872|62656353|FG003|Double-blind Phase|Protocol Violation|0|||
33280671|NCT01340872|62656350|FG000|Open-label Phase|Physician Decision|0|||
33280672|NCT01340872|62656351|FG001|Open-label Phase|Physician Decision|0|||
33280673|NCT01340872|62656352|FG002|Open-label Phase|Physician Decision|2|||
33280674|NCT01340872|62656353|FG003|Open-label Phase|Physician Decision|1|||
33280675|NCT01340872|62656350|FG000|Open-label Phase|Pregnancy|0|||
33280676|NCT01340872|62656351|FG001|Open-label Phase|Pregnancy|0|||
33280677|NCT01340872|62656352|FG002|Open-label Phase|Pregnancy|1|||
33280678|NCT01340872|62656353|FG003|Open-label Phase|Pregnancy|0|||
33280679|NCT01340872|62656350|FG000|Open-label Phase|Adverse Event|0|||
33280680|NCT01340872|62656351|FG001|Open-label Phase|Adverse Event|0|||
33280681|NCT01340872|62656352|FG002|Open-label Phase|Adverse Event|8|||
33280682|NCT01340872|62656353|FG003|Open-label Phase|Adverse Event|4|||
33280683|NCT01340872|62656350|FG000|Open-label Phase|Withdrawal by Subject|0|||
33280684|NCT01340872|62656351|FG001|Open-label Phase|Withdrawal by Subject|0|||
33280685|NCT01340872|62656352|FG002|Open-label Phase|Withdrawal by Subject|1|||
33280686|NCT01340872|62656353|FG003|Open-label Phase|Withdrawal by Subject|6|||
33280687|NCT01340872|62656350|FG000|Open-label Phase|Worsening of IBD|0|||
33280688|NCT01340872|62656351|FG001|Open-label Phase|Worsening of IBD|0|||
33280689|NCT01340872|62656352|FG002|Open-label Phase|Worsening of IBD|1|||
33280690|NCT01340872|62656353|FG003|Open-label Phase|Worsening of IBD|0|||
33280691|NCT01340794|62656367|FG000|Overall Study|Withdrawal by Subject|0|||
33280692|NCT01340794|62656368|FG001|Overall Study|Withdrawal by Subject|1|||
33280693|NCT01340482|62656379|FG000|Overall Study|Adverse Event|2|||
33280694|NCT01340482|62656380|FG001|Overall Study|Adverse Event|0|||
33280695|NCT01340482|62656381|FG002|Overall Study|Adverse Event|0|||
33280696|NCT01340209|62656394|FG000|Overall Study|Adverse Event|1|||
33280697|NCT01340209|62656395|FG001|Overall Study|Adverse Event|1|||
33280698|NCT01340209|62656396|FG002|Overall Study|Adverse Event|2|||
33280699|NCT01340209|62656394|FG000|Overall Study|Protocol Violation|1|||
33280700|NCT01340209|62656395|FG001|Overall Study|Protocol Violation|2|||
33280701|NCT01340209|62656396|FG002|Overall Study|Protocol Violation|1|||
33280702|NCT01340209|62656394|FG000|Overall Study|Withdrawal by Subject|0|||
33280703|NCT01340209|62656395|FG001|Overall Study|Withdrawal by Subject|0|||
33280704|NCT01340209|62656396|FG002|Overall Study|Withdrawal by Subject|1|||
33280705|NCT01340209|62656394|FG000|Overall Study|Other reason not defined above|3|||
33280706|NCT01340209|62656395|FG001|Overall Study|Other reason not defined above|5|||
33280707|NCT01340209|62656396|FG002|Overall Study|Other reason not defined above|4|||
33280708|NCT01326910|62656406|FG000|Overall Study|Withdrawal by Subject|3|||
33280709|NCT01326910|62656407|FG001|Overall Study|Withdrawal by Subject|2|||
33280710|NCT01326910|62656406|FG000|Overall Study|Protocol Violation|1|||
33280711|NCT01326910|62656407|FG001|Overall Study|Protocol Violation|1|||
33280712|NCT01326481|62656413|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
33280713|NCT01325701|62656421|FG000|Overall Study|Adverse Event|12|||
33280714|NCT01325701|62656422|FG001|Overall Study|Adverse Event|0|||
33280715|NCT01325701|62656421|FG000|Overall Study|Protocol Violation|1|||
33280716|NCT01325701|62656422|FG001|Overall Study|Protocol Violation|0|||
33280717|NCT01325701|62656421|FG000|Overall Study|Physician Decision|2|||
33280718|NCT01325701|62656422|FG001|Overall Study|Physician Decision|2|||
33280719|NCT01325701|62656421|FG000|Overall Study|Withdrawal by Subject|2|||
33280720|NCT01325701|62656422|FG001|Overall Study|Withdrawal by Subject|1|||
33280721|NCT01325701|62656421|FG000|Overall Study|Rollerover Extension Study|4|||
33280722|NCT01325701|62656422|FG001|Overall Study|Rollerover Extension Study|0|||
33280723|NCT01325623|62656429|FG000|Overall Study|Withdrawal by Subject|3|||
33280724|NCT01325584|62656466|FG000|Overall Study|Death|1|||
33280725|NCT01325428|62656470|FG000|Part A|Progressive disease according to RECIST|9|||
33280726|NCT01325428|62656470|FG000|Part A|Clinical signs, symptoms of progression|2|||
33280727|NCT01325428|62656470|FG000|Part A|Other adverse event|1|||
33280728|NCT01325428|62656470|FG000|Part A|Refused continue taking trial medication|2|||
33280729|NCT01325428|62656470|FG000|Part A|Other reason not defined above|2|||
33280730|NCT01325428|62656470|FG000|Part B|Refused continue taking trial medication|2|||
33280731|NCT01325428|62656470|FG000|Part B|Other reason not defined above|1|||
33280732|NCT01325350|62656484|FG000|Overall Study|Adverse Event|3|||
33280733|NCT01325350|62656485|FG001|Overall Study|Adverse Event|3|||
33280734|NCT01325350|62656486|FG002|Overall Study|Adverse Event|3|||
33280735|NCT01325350|62656487|FG003|Overall Study|Adverse Event|1|||
33280736|NCT01325350|62656488|FG004|Overall Study|Adverse Event|2|||
33280737|NCT01325350|62656484|FG000|Overall Study|Pregnancy|0|||
33280738|NCT01325350|62656485|FG001|Overall Study|Pregnancy|0|||
33280739|NCT01325350|62656486|FG002|Overall Study|Pregnancy|1|||
33280740|NCT01325350|62656487|FG003|Overall Study|Pregnancy|0|||
33280741|NCT01325350|62656488|FG004|Overall Study|Pregnancy|1|||
33280742|NCT01325350|62656484|FG000|Overall Study|Lost to Follow-up|1|||
33280743|NCT01325350|62656485|FG001|Overall Study|Lost to Follow-up|0|||
33280744|NCT01325350|62656486|FG002|Overall Study|Lost to Follow-up|5|||
33280745|NCT01325350|62656487|FG003|Overall Study|Lost to Follow-up|1|||
33280746|NCT01325350|62656488|FG004|Overall Study|Lost to Follow-up|5|||
33280747|NCT01325350|62656484|FG000|Overall Study|Personal Reasons|2|||
33280748|NCT01325350|62656485|FG001|Overall Study|Personal Reasons|1|||
33280749|NCT01325350|62656486|FG002|Overall Study|Personal Reasons|6|||
33280750|NCT01325350|62656487|FG003|Overall Study|Personal Reasons|5|||
33280751|NCT01325350|62656488|FG004|Overall Study|Personal Reasons|3|||
33280752|NCT01325350|62656484|FG000|Overall Study|Protocol Violation|0|||
33280753|NCT01325350|62656485|FG001|Overall Study|Protocol Violation|0|||
33280754|NCT01325350|62656486|FG002|Overall Study|Protocol Violation|0|||
33662135|NCT01695239|63092843|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33280755|NCT01325350|62656487|FG003|Overall Study|Protocol Violation|1|||
33280756|NCT01325350|62656488|FG004|Overall Study|Protocol Violation|0|||
33280757|NCT01325350|62656484|FG000|Overall Study|Withdrawal by Subject|0|||
33280758|NCT01325350|62656485|FG001|Overall Study|Withdrawal by Subject|0|||
33280759|NCT01325350|62656486|FG002|Overall Study|Withdrawal by Subject|1|||
33280760|NCT01325350|62656487|FG003|Overall Study|Withdrawal by Subject|1|||
33280761|NCT01325350|62656488|FG004|Overall Study|Withdrawal by Subject|0|||
33280762|NCT01325350|62656484|FG000|Overall Study|Did Not Receive Treatment|0|||
33280763|NCT01325350|62656485|FG001|Overall Study|Did Not Receive Treatment|1|||
33280764|NCT01325350|62656486|FG002|Overall Study|Did Not Receive Treatment|1|||
33280765|NCT01325350|62656487|FG003|Overall Study|Did Not Receive Treatment|0|||
33280766|NCT01325350|62656488|FG004|Overall Study|Did Not Receive Treatment|1|||
33280767|NCT01324999|62656500|FG000|Overall Study|Adverse Event|3|||
33280768|NCT01324999|62656500|FG000|Overall Study|Withdrawal by Subject|2|||
33280769|NCT01324570|62656506|FG000|Overall Study|Adverse Event|4|||
33280770|NCT01324570|62656507|FG001|Overall Study|Adverse Event|7|||
33280771|NCT01324570|62656506|FG000|Overall Study|Withdrawal by Subject|0|||
33280772|NCT01324570|62656507|FG001|Overall Study|Withdrawal by Subject|3|||
33280773|NCT01324570|62656506|FG000|Overall Study|Lack of Efficacy|0|||
33280774|NCT01324570|62656507|FG001|Overall Study|Lack of Efficacy|1|||
33280775|NCT01324570|62656506|FG000|Overall Study|Confirmed or suspected diversion|0|||
33280776|NCT01324570|62656507|FG001|Overall Study|Confirmed or suspected diversion|1|||
33280777|NCT01324570|62656506|FG000|Overall Study|Administrative|0|||
33280778|NCT01324570|62656507|FG001|Overall Study|Administrative|2|||
33280779|NCT01324141|62656515|FG000|Overall Study|Declined to participate before treatment started|1|||
33280780|NCT01324141|62656515|FG000|Overall Study|Disease progression on study|1|||
33280781|NCT01324102|62656531|FG000|Overall Study|illness|1|||
33280782|NCT01324102|62656532|FG001|Overall Study|illness|6|||
33280783|NCT01324024|62656539|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
33280784|NCT01324024|62656540|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
33280785|NCT01323946|62656553|FG000|Overall Study|Lost to Follow-up|0|||
33280786|NCT01323946|62656554|FG001|Overall Study|Lost to Follow-up|1|||
33280787|NCT01323946|62656555|FG002|Overall Study|Lost to Follow-up|0|||
33280788|NCT01323946|62656553|FG000|Overall Study|Parents refused the last blood draw|1|||
33280789|NCT01323946|62656554|FG001|Overall Study|Parents refused the last blood draw|0|||
33280790|NCT01323946|62656555|FG002|Overall Study|Parents refused the last blood draw|0|||
33280791|NCT01323946|62656553|FG000|Overall Study|Withdrawal by Subject|2|||
33280792|NCT01323946|62656554|FG001|Overall Study|Withdrawal by Subject|2|||
33280793|NCT01323946|62656555|FG002|Overall Study|Withdrawal by Subject|0|||
33280794|NCT01323790|62656568|FG000|Overall Study|Other|3|||
33280795|NCT01323790|62656569|FG001|Overall Study|Other|2|||
33280796|NCT01323790|62656570|FG002|Overall Study|Other|1|||
33280797|NCT01323790|62656568|FG000|Overall Study|Lost to Follow-up|11|||
33280798|NCT01323790|62656569|FG001|Overall Study|Lost to Follow-up|9|||
33280799|NCT01323790|62656570|FG002|Overall Study|Lost to Follow-up|9|||
33280800|NCT01323790|62656568|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
33280801|NCT01323790|62656569|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
33280802|NCT01323790|62656570|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
33280803|NCT01323790|62656568|FG000|Overall Study|Lack of Efficacy|3|||
33280804|NCT01323790|62656569|FG001|Overall Study|Lack of Efficacy|0|||
33280805|NCT01323790|62656570|FG002|Overall Study|Lack of Efficacy|3|||
33280806|NCT01323790|62656568|FG000|Overall Study|Adverse Event|11|||
33280807|NCT01323790|62656569|FG001|Overall Study|Adverse Event|24|||
33280808|NCT01323790|62656570|FG002|Overall Study|Adverse Event|12|||
33280809|NCT01323790|62656568|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
33280810|NCT01323790|62656569|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
33280811|NCT01323790|62656570|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
33280812|NCT01323790|62656568|FG000|Overall Study|Withdrawal by Subject|23|||
33280813|NCT01323790|62656569|FG001|Overall Study|Withdrawal by Subject|20|||
33280814|NCT01323790|62656570|FG002|Overall Study|Withdrawal by Subject|13|||
33280815|NCT01323790|62656568|FG000|Overall Study|Did Not Receive Treatment|2|||
33280816|NCT01323790|62656569|FG001|Overall Study|Did Not Receive Treatment|0|||
33280817|NCT01323790|62656570|FG002|Overall Study|Did Not Receive Treatment|1|||
33280818|NCT01323790|62656568|FG000|Overall Study|Severe non-compliance with protocol|2|||
33280819|NCT01323790|62656569|FG001|Overall Study|Severe non-compliance with protocol|2|||
33280820|NCT01323790|62656570|FG002|Overall Study|Severe non-compliance with protocol|2|||
33280821|NCT01323673|62656580|FG000|Overall Study|Adverse Event|0|||
33280822|NCT01323673|62656581|FG001|Overall Study|Adverse Event|1|||
33280823|NCT01323673|62656580|FG000|Overall Study|Lost to Follow-up|0|||
33280824|NCT01323673|62656581|FG001|Overall Study|Lost to Follow-up|1|||
33280825|NCT01323673|62656580|FG000|Overall Study|Protocol Violation|1|||
33280826|NCT01323673|62656581|FG001|Overall Study|Protocol Violation|0|||
33280827|NCT01323673|62656580|FG000|Overall Study|Withdrawal by Subject|2|||
33280828|NCT01323673|62656581|FG001|Overall Study|Withdrawal by Subject|3|||
33280829|NCT01323634|62656589|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
33280830|NCT01323634|62656590|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
33280831|NCT01323634|62656591|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
33280832|NCT01323634|62656589|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
33280833|NCT01323634|62656590|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
33280834|NCT01323634|62656591|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
33280835|NCT01323634|62656589|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
33280836|NCT01323634|62656590|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
33280837|NCT01323634|62656591|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
33280838|NCT01323634|62656589|FG000|2-week Run-in Period|Physician Decision|5|||
33280839|NCT01323634|62656590|FG001|2-week Run-in Period|Physician Decision|0|||
33280840|NCT01323634|62656591|FG002|2-week Run-in Period|Physician Decision|0|||
33280841|NCT01323634|62656589|FG000|2-week Run-in Period|Protocol Violation|1|||
33280842|NCT01323634|62656590|FG001|2-week Run-in Period|Protocol Violation|0|||
33280843|NCT01323634|62656591|FG002|2-week Run-in Period|Protocol Violation|0|||
33280844|NCT01323634|62656589|FG000|2-week Run-in Period|Adverse Event|1|||
33280845|NCT01323634|62656590|FG001|2-week Run-in Period|Adverse Event|0|||
33280846|NCT01323634|62656591|FG002|2-week Run-in Period|Adverse Event|0|||
33280847|NCT01323634|62656589|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33280848|NCT01323634|62656590|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
33280849|NCT01323634|62656591|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
33280850|NCT01323634|62656589|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33280851|NCT01323634|62656590|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33280852|NCT01323634|62656591|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
33280853|NCT01323634|62656589|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33280854|NCT01323634|62656590|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
33280855|NCT01323634|62656591|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
33280856|NCT01323634|62656589|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33280857|NCT01323634|62656590|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
33280858|NCT01323634|62656591|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
33280859|NCT01323634|62656589|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
33280860|NCT01323634|62656590|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
33280861|NCT01323634|62656591|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
33280862|NCT01323634|62656589|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33280863|NCT01323634|62656590|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
33280864|NCT01323634|62656591|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
33280865|NCT01323634|62656589|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
33280866|NCT01323634|62656590|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
33280867|NCT01323634|62656591|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
33280868|NCT01323478|62656597|FG000|Overall Study|Adverse Event|7|||
33280869|NCT01323478|62656597|FG000|Overall Study|Lack of Efficacy|4|||
33280870|NCT01323478|62656597|FG000|Overall Study|Non-compliance With Study Product|3|||
33280871|NCT01323478|62656597|FG000|Overall Study|Protocol Violation|1|||
33280872|NCT01323478|62656597|FG000|Overall Study|Withdrawal of Consent|1|||
33280873|NCT01323478|62656597|FG000|Overall Study|Administrative or Other Reasons|8|||
33280874|NCT01322386|62656603|FG000|Overall Study|Protocol Violation|0|||
33280875|NCT01322386|62656604|FG001|Overall Study|Protocol Violation|1|||
33280876|NCT01322386|62656603|FG000|Overall Study|Physician Decision|0|||
33280877|NCT01322386|62656604|FG001|Overall Study|Physician Decision|1|||
33280878|NCT01322347|62656614|FG000|Overall Study|Adverse Event|7|||
33280879|NCT01322347|62656615|FG001|Overall Study|Adverse Event|2|||
33280880|NCT01322347|62656614|FG000|Overall Study|Death|5|||
33280881|NCT01322347|62656615|FG001|Overall Study|Death|3|||
33280882|NCT01322347|62656614|FG000|Overall Study|Physician Decision|2|||
33280883|NCT01322347|62656615|FG001|Overall Study|Physician Decision|1|||
33280884|NCT01322347|62656614|FG000|Overall Study|Protocol Violation|5|||
33280885|NCT01322347|62656615|FG001|Overall Study|Protocol Violation|2|||
33280886|NCT01322347|62656614|FG000|Overall Study|Withdrawal by Subject|1|||
33280887|NCT01322347|62656615|FG001|Overall Study|Withdrawal by Subject|4|||
33280888|NCT01322347|62656614|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
33280889|NCT01322347|62656615|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
33280890|NCT01322347|62656614|FG000|Overall Study|blood transfusion|5|||
33280891|NCT01322347|62656615|FG001|Overall Study|blood transfusion|5|||
33280892|NCT01322347|62656614|FG000|Overall Study|sponsor decision|1|||
33280893|NCT01322347|62656615|FG001|Overall Study|sponsor decision|3|||
33280894|NCT01322347|62656614|FG000|Overall Study|ineligible|6|||
33280895|NCT01322347|62656615|FG001|Overall Study|ineligible|3|||
33280896|NCT01322347|62656614|FG000|Overall Study|kidney transplant|3|||
33280897|NCT01322347|62656615|FG001|Overall Study|kidney transplant|1|||
33280898|NCT01322347|62656614|FG000|Overall Study|study drug withheld > 12 wks|0|||
33280899|NCT01322347|62656615|FG001|Overall Study|study drug withheld > 12 wks|1|||
33280900|NCT01322347|62656614|FG000|Overall Study|moved/changed dialysis|2|||
33280901|NCT01322347|62656615|FG001|Overall Study|moved/changed dialysis|4|||
33280902|NCT01321879|62656622|FG000|Overall Study|Lack of Efficacy|5|||
33370886|NCT00571948|62749585|FG001|Overall Study|Withdrawal by Subject|2|||
33280903|NCT01321879|62656622|FG000|Overall Study|Adverse Event|5|||
33280904|NCT01321879|62656622|FG000|Overall Study|Death|3|||
33280905|NCT01321879|62656622|FG000|Overall Study|Withdrawal by Subject|1|||
33280906|NCT01321723|62656629|FG000|Overall Study|Adverse Event|3|||
33280907|NCT01321723|62656630|FG001|Overall Study|Adverse Event|5|||
33280908|NCT01321723|62656631|FG002|Overall Study|Adverse Event|2|||
33280909|NCT01321723|62656629|FG000|Overall Study|Withdrawal by Subject|2|||
33370887|NCT00571948|62749584|FG000|Overall Study|Protocol Violation|3|||
33370888|NCT00571948|62749585|FG001|Overall Study|Protocol Violation|3|||
33280910|NCT01321723|62656630|FG001|Overall Study|Withdrawal by Subject|0|||
33280911|NCT01321723|62656631|FG002|Overall Study|Withdrawal by Subject|2|||
33280912|NCT01321606|62656641|FG000|Overall Study|Lost to Follow-up|0|||
33280913|NCT01321606|62656642|FG001|Overall Study|Lost to Follow-up|0|||
33280914|NCT01321606|62656643|FG002|Overall Study|Lost to Follow-up|0|||
33280915|NCT01321606|62656644|FG003|Overall Study|Lost to Follow-up|1|||
33280916|NCT01320943|62656656|FG000|Overall Study|Lost to Follow-up|1|||
33280917|NCT01320943|62656657|FG001|Overall Study|Lost to Follow-up|0|||
33280918|NCT01320943|62656656|FG000|Overall Study|Physician Decision|0|||
33280919|NCT01320943|62656657|FG001|Overall Study|Physician Decision|1|||
33280920|NCT01320943|62656656|FG000|Overall Study|Randomized but not Treated|0|||
33280921|NCT01320943|62656657|FG001|Overall Study|Randomized but not Treated|1|||
33280922|NCT02482233|62656672|FG000|Overall Study|Lost to Follow-up|1|||
33280923|NCT02482233|62656673|FG001|Overall Study|Lost to Follow-up|1|||
33280924|NCT01320202|62656683|FG000|Overall Study|Adverse Event|5|||
33280925|NCT01320202|62656684|FG001|Overall Study|Adverse Event|5|||
33280926|NCT01320202|62656683|FG000|Overall Study|Death|5|||
33280927|NCT01320202|62656684|FG001|Overall Study|Death|3|||
33280928|NCT01320202|62656683|FG000|Overall Study|Lost to Follow-up|1|||
33280929|NCT01320202|62656684|FG001|Overall Study|Lost to Follow-up|0|||
33280930|NCT01320202|62656683|FG000|Overall Study|Physician Decision|3|||
33280931|NCT01320202|62656684|FG001|Overall Study|Physician Decision|1|||
33280932|NCT01320202|62656683|FG000|Overall Study|Protocol Violation|2|||
33280933|NCT01320202|62656684|FG001|Overall Study|Protocol Violation|1|||
33280934|NCT01320202|62656683|FG000|Overall Study|Withdrawal by Subject|10|||
33280935|NCT01320202|62656684|FG001|Overall Study|Withdrawal by Subject|3|||
33280936|NCT01320202|62656683|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
33280937|NCT01320202|62656684|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
33280938|NCT01320202|62656683|FG000|Overall Study|kidney transplant|1|||
33280939|NCT01320202|62656684|FG001|Overall Study|kidney transplant|2|||
33280940|NCT01320202|62656683|FG000|Overall Study|blood transfusion|1|||
33280941|NCT01320202|62656684|FG001|Overall Study|blood transfusion|7|||
33280942|NCT01320202|62656683|FG000|Overall Study|moved/changed dialysis|5|||
33280943|NCT01320202|62656684|FG001|Overall Study|moved/changed dialysis|2|||
33280944|NCT01320202|62656683|FG000|Overall Study|sponsor request|2|||
33280945|NCT01320202|62656684|FG001|Overall Study|sponsor request|0|||
33280946|NCT01320202|62656683|FG000|Overall Study|ineligible|3|||
33280947|NCT01320202|62656684|FG001|Overall Study|ineligible|0|||
33280948|NCT01320202|62656683|FG000|Overall Study|regained renal function|1|||
33280949|NCT01320202|62656684|FG001|Overall Study|regained renal function|0|||
33280950|NCT01319383|62656693|FG000|Overall Study|No ex vivo or in vivo response|4|||
33280951|NCT01319383|62656694|FG001|Overall Study|No ex vivo or in vivo response|0|||
33280952|NCT01319383|62656693|FG000|Overall Study|Physician Decision|3|||
33280953|NCT01319383|62656694|FG001|Overall Study|Physician Decision|0|||
33280954|NCT01319383|62656693|FG000|Overall Study|Lack of Efficacy|5|||
33280955|NCT01319383|62656694|FG001|Overall Study|Lack of Efficacy|9|||
33280956|NCT01319383|62656693|FG000|Overall Study|No in vivo response to interval doses|0|||
33280957|NCT01319383|62656694|FG001|Overall Study|No in vivo response to interval doses|1|||
33280958|NCT01316614|62656711|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
33280959|NCT01316614|62656711|FG000|Overall Study|Cytology slides not available for review|4|||
33280960|NCT01316614|62656711|FG000|Overall Study|Cystic lesion|5|||
33280961|NCT01316614|62656711|FG000|Overall Study|Inadequate number of passes|2|||
33280962|NCT01316614|62656711|FG000|Overall Study|Medically unstable|1|||
33280963|NCT01316575|62656718|FG000|Overall Study|Withdrawal by Subject|2|||
33280964|NCT01316575|62656719|FG001|Overall Study|Withdrawal by Subject|0|||
33280965|NCT01316575|62656718|FG000|Overall Study|Required alternate treatment|0|||
33280966|NCT01316575|62656719|FG001|Overall Study|Required alternate treatment|1|||
33280967|NCT01315678|62656727|FG000|Overall Study|Withdrawal by Subject|7|||
33280968|NCT01315678|62656728|FG001|Overall Study|Withdrawal by Subject|3|||
33280969|NCT01315678|62656727|FG000|Overall Study|Adverse Event|3|||
33280970|NCT01315678|62656728|FG001|Overall Study|Adverse Event|1|||
33280971|NCT01315678|62656727|FG000|Overall Study|Lost to Follow-up|1|||
33280972|NCT01315678|62656728|FG001|Overall Study|Lost to Follow-up|0|||
33280973|NCT01315678|62656727|FG000|Overall Study|similar reason to those listed above|3|||
33280974|NCT01315678|62656728|FG001|Overall Study|similar reason to those listed above|2|||
33280975|NCT01315249|62656738|FG000|Overall Study|Adverse Event|22|||
33280976|NCT01315249|62656739|FG001|Overall Study|Adverse Event|26|||
33280977|NCT01315249|62656738|FG000|Overall Study|Withdrawal by Subject|11|||
33280978|NCT01315249|62656739|FG001|Overall Study|Withdrawal by Subject|10|||
33280979|NCT01315249|62656738|FG000|Overall Study|Protocol Violation|8|||
33280980|NCT01315249|62656739|FG001|Overall Study|Protocol Violation|5|||
33280981|NCT01315249|62656738|FG000|Overall Study|Abnormal test results|1|||
33280982|NCT01315249|62656739|FG001|Overall Study|Abnormal test results|2|||
33280983|NCT01315249|62656738|FG000|Overall Study|Administrative problems|1|||
33280984|NCT01315249|62656739|FG001|Overall Study|Administrative problems|0|||
33280985|NCT01315249|62656738|FG000|Overall Study|inability to use device|1|||
33280986|NCT01315249|62656739|FG001|Overall Study|inability to use device|0|||
33280987|NCT01315249|62656738|FG000|Overall Study|Lack of Efficacy|0|||
33280988|NCT01315249|62656739|FG001|Overall Study|Lack of Efficacy|1|||
33280989|NCT01315249|62656738|FG000|Overall Study|Lost to Follow-up|0|||
33280990|NCT01315249|62656739|FG001|Overall Study|Lost to Follow-up|2|||
33280991|NCT01315249|62656738|FG000|Overall Study|Death|0|||
33280992|NCT01315249|62656739|FG001|Overall Study|Death|1|||
33280993|NCT01315132|62656745|FG000|Overall Study|not treated due to disease progression|1|||
33280994|NCT01313767|62656751|FG000|Overall Study|Adverse Event|1|||
33280995|NCT01313767|62656752|FG001|Overall Study|Adverse Event|0|||
33280996|NCT01313767|62656751|FG000|Overall Study|Lost to Follow-up|1|||
33280997|NCT01313767|62656752|FG001|Overall Study|Lost to Follow-up|0|||
33280998|NCT01313767|62656751|FG000|Overall Study|Withdrawal by Subject|2|||
33280999|NCT01313767|62656752|FG001|Overall Study|Withdrawal by Subject|1|||
33281000|NCT01313767|62656751|FG000|Overall Study|Protocol Violation|3|||
33281001|NCT01313767|62656752|FG001|Overall Study|Protocol Violation|1|||
33281002|NCT01313728|62656758|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
33281003|NCT01313650|62656767|FG000|Overall Study|Adverse Event|9|||
33281004|NCT01313650|62656768|FG001|Overall Study|Adverse Event|34|||
33281005|NCT01313650|62656769|FG002|Overall Study|Adverse Event|24|||
33281006|NCT01313650|62656770|FG003|Overall Study|Adverse Event|23|||
33281007|NCT01313650|62656767|FG000|Overall Study|Lack of Efficacy|37|||
33281008|NCT01313650|62656768|FG001|Overall Study|Lack of Efficacy|20|||
33281009|NCT01313650|62656769|FG002|Overall Study|Lack of Efficacy|32|||
33281010|NCT01313650|62656770|FG003|Overall Study|Lack of Efficacy|20|||
33281011|NCT01313650|62656767|FG000|Overall Study|Lost to Follow-up|1|||
33281012|NCT01313650|62656768|FG001|Overall Study|Lost to Follow-up|0|||
33281013|NCT01313650|62656769|FG002|Overall Study|Lost to Follow-up|3|||
33281014|NCT01313650|62656770|FG003|Overall Study|Lost to Follow-up|2|||
33281015|NCT01313650|62656767|FG000|Overall Study|Withdrawal by Subject|16|||
33281016|NCT01313650|62656768|FG001|Overall Study|Withdrawal by Subject|20|||
33281017|NCT01313650|62656769|FG002|Overall Study|Withdrawal by Subject|15|||
33281018|NCT01313650|62656770|FG003|Overall Study|Withdrawal by Subject|15|||
33281019|NCT01313650|62656767|FG000|Overall Study|Protocol Violation|4|||
33281020|NCT01313650|62656768|FG001|Overall Study|Protocol Violation|7|||
33281021|NCT01313650|62656769|FG002|Overall Study|Protocol Violation|5|||
33281022|NCT01313650|62656770|FG003|Overall Study|Protocol Violation|6|||
33281023|NCT01313650|62656767|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
33281024|NCT01313650|62656768|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
33281025|NCT01313650|62656769|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
33281026|NCT01313650|62656770|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
33281027|NCT01313299|62656783|FG000|Overall Study|Adverse Event|3|||
33281028|NCT01313299|62656784|FG001|Overall Study|Adverse Event|1|||
33281029|NCT01313299|62656785|FG002|Overall Study|Adverse Event|1|||
33281030|NCT01313299|62656783|FG000|Overall Study|Lost to Follow-up|1|||
33281031|NCT01313299|62656784|FG001|Overall Study|Lost to Follow-up|0|||
33281032|NCT01313299|62656785|FG002|Overall Study|Lost to Follow-up|0|||
33281033|NCT01313299|62656783|FG000|Overall Study|Protocol Violation|2|||
33281034|NCT01313299|62656784|FG001|Overall Study|Protocol Violation|0|||
33281035|NCT01313299|62656785|FG002|Overall Study|Protocol Violation|0|||
33281036|NCT01313299|62656783|FG000|Overall Study|Withdrawal by Subject|1|||
33281037|NCT01313299|62656784|FG001|Overall Study|Withdrawal by Subject|0|||
33281038|NCT01313299|62656785|FG002|Overall Study|Withdrawal by Subject|2|||
33281039|NCT01313299|62656783|FG000|Overall Study|Family reason and moved out of state|0|||
33281040|NCT01313299|62656784|FG001|Overall Study|Family reason and moved out of state|2|||
33281041|NCT01313299|62656785|FG002|Overall Study|Family reason and moved out of state|0|||
33281042|NCT01313299|62656783|FG000|Overall Study|Lack of subject compliance|0|||
33281043|NCT01313299|62656784|FG001|Overall Study|Lack of subject compliance|0|||
33281044|NCT01313299|62656785|FG002|Overall Study|Lack of subject compliance|1|||
33281045|NCT01313221|62656796|FG000|Overall Study|Protocol Violation|0|||
33281046|NCT01313221|62656797|FG001|Overall Study|Protocol Violation|1|||
33281047|NCT01313221|62656798|FG002|Overall Study|Protocol Violation|1|||
33281048|NCT01313221|62656796|FG000|Overall Study|Non-compliance|3|||
33281049|NCT01313221|62656797|FG001|Overall Study|Non-compliance|0|||
33281050|NCT01313221|62656798|FG002|Overall Study|Non-compliance|2|||
33281051|NCT01313221|62656796|FG000|Overall Study|Withdrawal by Subject|2|||
33281052|NCT01313221|62656797|FG001|Overall Study|Withdrawal by Subject|3|||
33281053|NCT01313221|62656798|FG002|Overall Study|Withdrawal by Subject|5|||
33281054|NCT01313221|62656796|FG000|Overall Study|Requirement for alternative therapy|0|||
33281055|NCT01313221|62656797|FG001|Overall Study|Requirement for alternative therapy|1|||
33281056|NCT01313221|62656798|FG002|Overall Study|Requirement for alternative therapy|1|||
33281057|NCT01313221|62656796|FG000|Overall Study|Lost to Follow-up|6|||
33281058|NCT01313221|62656797|FG001|Overall Study|Lost to Follow-up|3|||
33281059|NCT01313221|62656798|FG002|Overall Study|Lost to Follow-up|1|||
33281060|NCT01313221|62656796|FG000|Overall Study|Other|1|||
33281061|NCT01313221|62656797|FG001|Overall Study|Other|0|||
33281062|NCT01313221|62656798|FG002|Overall Study|Other|0|||
33281063|NCT01313221|62656796|FG000|Overall Study|Adverse Event|0|||
33281064|NCT01313221|62656797|FG001|Overall Study|Adverse Event|0|||
33281065|NCT01313221|62656798|FG002|Overall Study|Adverse Event|7|||
33281066|NCT01313221|62656796|FG000|Overall Study|Disease progression|0|||
33281067|NCT01313221|62656797|FG001|Overall Study|Disease progression|0|||
33281068|NCT01313221|62656798|FG002|Overall Study|Disease progression|2|||
33281069|NCT01313221|62656796|FG000|Overall Study|Physician Decision|0|||
33281070|NCT01313221|62656797|FG001|Overall Study|Physician Decision|0|||
33281071|NCT01313221|62656798|FG002|Overall Study|Physician Decision|2|||
33281072|NCT01313221|62656796|FG000|Overall Study|Pregnancy|0|||
33281073|NCT01313221|62656797|FG001|Overall Study|Pregnancy|0|||
33281074|NCT01313221|62656798|FG002|Overall Study|Pregnancy|2|||
33281075|NCT01313182|62656808|FG000|Overall Study|Protocol Violation|66|||
33281076|NCT01313182|62656809|FG001|Overall Study|Protocol Violation|92|||
33281077|NCT01312909|62656818|FG000|Overall Study|Randomized but not treated|1|||
33281078|NCT01312909|62656819|FG001|Overall Study|Randomized but not treated|3|||
33281079|NCT01312909|62656820|FG002|Overall Study|Randomized but not treated|1|||
33281080|NCT01312909|62656818|FG000|Overall Study|Adverse Event|1|||
33281081|NCT01312909|62656819|FG001|Overall Study|Adverse Event|0|||
33281082|NCT01312909|62656820|FG002|Overall Study|Adverse Event|3|||
33281083|NCT01312909|62656818|FG000|Overall Study|Protocol Violation|2|||
33281084|NCT01312909|62656819|FG001|Overall Study|Protocol Violation|0|||
33281085|NCT01312909|62656820|FG002|Overall Study|Protocol Violation|2|||
33281086|NCT01312909|62656818|FG000|Overall Study|Other|9|||
33281087|NCT01312909|62656819|FG001|Overall Study|Other|6|||
33281088|NCT01312909|62656820|FG002|Overall Study|Other|11|||
33281089|NCT01312909|62656818|FG000|Overall Study|Withdrawal by Subject|8|||
33281090|NCT01312909|62656819|FG001|Overall Study|Withdrawal by Subject|10|||
33281091|NCT01312909|62656820|FG002|Overall Study|Withdrawal by Subject|7|||
33281092|NCT01312909|62656818|FG000|Overall Study|Lost to Follow-up|21|||
33281093|NCT01312909|62656819|FG001|Overall Study|Lost to Follow-up|17|||
33281094|NCT01312909|62656820|FG002|Overall Study|Lost to Follow-up|20|||
33281095|NCT01312909|62656818|FG000|Overall Study|Insufficient clinical response|0|||
33281096|NCT01312909|62656819|FG001|Overall Study|Insufficient clinical response|0|||
33281097|NCT01312909|62656820|FG002|Overall Study|Insufficient clinical response|1|||
33281098|NCT01312909|62656818|FG000|Overall Study|Entrance criteria not met|0|||
33281099|NCT01312909|62656819|FG001|Overall Study|Entrance criteria not met|0|||
33281100|NCT01312909|62656820|FG002|Overall Study|Entrance criteria not met|2|||
33281101|NCT01312129|62656830|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
33281102|NCT01312129|62656831|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
33281103|NCT01311661|62656837|FG000|Overall Study|Adverse Event|2|||
33281104|NCT01311661|62656837|FG000|Overall Study|Protocol Violation|3|||
33281105|NCT01311661|62656837|FG000|Overall Study|Withdrawal by Subject|2|||
33281106|NCT01311505|62656849|FG000|First Intervention Period|Protocol Violation|0|||
33281107|NCT01311505|62656850|FG001|First Intervention Period|Protocol Violation|1|||
33281108|NCT01310803|62656861|FG000|Overall Study|Subject terminated by Sponsor|1|||
33281109|NCT01310803|62656862|FG001|Overall Study|Subject terminated by Sponsor|0|||
33281110|NCT01310413|62656874|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
33281111|NCT01310413|62656875|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
33281112|NCT01310413|62656876|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
33281113|NCT01310413|62656877|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
33281114|NCT01310413|62656878|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
33281115|NCT01310413|62656879|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
33281116|NCT01310413|62656880|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
33281117|NCT01310413|62656874|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
33281118|NCT01310413|62656875|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
33281119|NCT01310413|62656876|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
33281120|NCT01310413|62656877|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
33281121|NCT01310413|62656878|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
33281122|NCT01310413|62656879|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
33281123|NCT01310413|62656880|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
33281124|NCT01310413|62656874|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
33281125|NCT01310413|62656875|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
33281126|NCT01310413|62656876|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
33281127|NCT01310413|62656877|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
33281128|NCT01310413|62656878|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
33281129|NCT01310413|62656879|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
33281130|NCT01310413|62656880|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
33281131|NCT01310413|62656874|FG000|Day 0 to Day 385|Other|1|||
33281132|NCT01310413|62656875|FG001|Day 0 to Day 385|Other|0|||
33281133|NCT01310413|62656876|FG002|Day 0 to Day 385|Other|3|||
33281134|NCT01310413|62656877|FG003|Day 0 to Day 385|Other|0|||
33281135|NCT01310413|62656878|FG004|Day 0 to Day 385|Other|0|||
33281136|NCT01310413|62656879|FG005|Day 0 to Day 385|Other|0|||
33281137|NCT01310413|62656880|FG006|Day 0 to Day 385|Other|0|||
33281138|NCT01310413|62656874|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
33281139|NCT01310413|62656875|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
33281140|NCT01310413|62656876|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
33281141|NCT01310413|62656877|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
33281142|NCT01310413|62656878|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
33281143|NCT01310413|62656879|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
33281144|NCT01310413|62656880|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
33281145|NCT01310413|62656874|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
33486229|NCT01368562|62864044|FG000|Overall Study|Disease progression|1|||
33281146|NCT01310413|62656875|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
33281147|NCT01310413|62656876|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
33281148|NCT01310413|62656877|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
33281149|NCT01310413|62656878|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
33281150|NCT01310413|62656879|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
33281151|NCT01310413|62656880|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
33281152|NCT01309828|62656911|FG000|Overall Study|Adverse Event|10|||
33281153|NCT01309828|62656912|FG001|Overall Study|Adverse Event|11|||
33281154|NCT01309828|62656911|FG000|Overall Study|Voluntary Withdrawal|5|||
33281155|NCT01309828|62656912|FG001|Overall Study|Voluntary Withdrawal|4|||
33281156|NCT01309828|62656911|FG000|Overall Study|Major Protocol Deviation|0|||
33281157|NCT01309828|62656912|FG001|Overall Study|Major Protocol Deviation|1|||
33281158|NCT01309828|62656911|FG000|Overall Study|Other|1|||
33281159|NCT01309828|62656912|FG001|Overall Study|Other|0|||
33281160|NCT01309282|62656918|FG000|Overall Study|Lost to Follow-up|1|||
33281161|NCT01309243|62656924|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
33281162|NCT01309243|62656925|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
33281163|NCT01309243|62656924|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
33281164|NCT01309243|62656925|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
33281165|NCT01309243|62656924|FG000|Randomized Phase Through Week 96|Death|0|||
33281166|NCT01309243|62656925|FG001|Randomized Phase Through Week 96|Death|1|||
33281167|NCT01309243|62656924|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
33281168|NCT01309243|62656925|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
33281169|NCT01309243|62656924|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
33281170|NCT01309243|62656925|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
33281171|NCT01309243|62656924|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
33281172|NCT01309243|62656925|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
33281173|NCT01309243|62656924|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
33281174|NCT01309243|62656925|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
33281175|NCT01309243|62656924|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
33281176|NCT01309243|62656925|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
33281177|NCT01309243|62656924|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
33281178|NCT01309243|62656925|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
33281179|NCT01309243|62656924|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
33281180|NCT01309243|62656925|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
33281181|NCT01309243|62656924|FG000|Extension Phase|Lost to Follow-up|6|||
33281182|NCT01309243|62656925|FG001|Extension Phase|Lost to Follow-up|0|||
33281183|NCT01309204|62656933|FG000|Overall Study|Adverse Event|48|||
33281184|NCT01309204|62656934|FG001|Overall Study|Adverse Event|58|||
33281185|NCT01309204|62656933|FG000|Overall Study|Lost to Follow-up|2|||
33281186|NCT01309204|62656934|FG001|Overall Study|Lost to Follow-up|2|||
33281187|NCT01309204|62656933|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
33281188|NCT01309204|62656934|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
33281189|NCT01309204|62656933|FG000|Overall Study|Inadequate control of IOP|4|||
33281190|NCT01309204|62656934|FG001|Overall Study|Inadequate control of IOP|4|||
33281191|NCT01309204|62656933|FG000|Overall Study|Other|4|||
33281192|NCT01309204|62656934|FG001|Overall Study|Other|1|||
33281193|NCT01309165|62656942|FG000|Overall Study|Lost to Follow-up|4|||
33281194|NCT01309165|62656943|FG001|Overall Study|Lost to Follow-up|3|||
33281195|NCT01309165|62656942|FG000|Overall Study|Return to work|1|||
33281196|NCT01309165|62656943|FG001|Overall Study|Return to work|2|||
33281197|NCT01309165|62656942|FG000|Overall Study|Left country|0|||
33281198|NCT01309165|62656943|FG001|Overall Study|Left country|1|||
33281199|NCT01309165|62656942|FG000|Overall Study|No transportation|0|||
33281200|NCT01309165|62656943|FG001|Overall Study|No transportation|1|||
33281201|NCT01309165|62656942|FG000|Overall Study|Admitted to hospital for second stroke|1|||
33281202|NCT01309165|62656943|FG001|Overall Study|Admitted to hospital for second stroke|0|||
33281203|NCT01308853|62656950|FG000|Overall Study|Adverse Event|1|||
33281204|NCT01308853|62656950|FG000|Overall Study|Lost to Follow-up|2|||
33281205|NCT01308853|62656950|FG000|Overall Study|Insertion of permanent implants|1|||
33281206|NCT01308736|62656956|FG000|Overall Study|Did not attend a single session|6|||
33281207|NCT01308736|62656957|FG001|Overall Study|Did not attend a single session|5|||
33281208|NCT01308580|62656965|FG000|Overall Study|Lost to Follow-up|12|||
33662136|NCT01695239|63092844|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33281209|NCT01308580|62656966|FG001|Overall Study|Lost to Follow-up|7|||
33281210|NCT01308463|62656973|FG000|Overall Study|Study Discontinued|23|||
33281211|NCT01308463|62656973|FG000|Overall Study|Death|4|||
33281212|NCT01308463|62656973|FG000|Overall Study|Revision|2|||
33281213|NCT01308424|62656979|FG000|Baseline Eligibility|Screen Failures|71|||
33281214|NCT01308424|62656980|FG001|Baseline Eligibility|Screen Failures|0|||
33281215|NCT01308424|62656981|FG002|Baseline Eligibility|Screen Failures|0|||
33281216|NCT01308424|62656979|FG000|Randomization|Adverse Event|0|||
33281217|NCT01308424|62656980|FG001|Randomization|Adverse Event|1|||
33281218|NCT01308424|62656981|FG002|Randomization|Adverse Event|1|||
33281219|NCT01308424|62656979|FG000|Randomization|Lost to Follow-up|0|||
33281220|NCT01308424|62656980|FG001|Randomization|Lost to Follow-up|1|||
33281221|NCT01308424|62656981|FG002|Randomization|Lost to Follow-up|0|||
33281222|NCT01308424|62656979|FG000|Randomization|Physician Decision|0|||
33281223|NCT01308424|62656980|FG001|Randomization|Physician Decision|1|||
33281224|NCT01308424|62656981|FG002|Randomization|Physician Decision|1|||
33281225|NCT01307800|62656992|FG000|Overall Study|Adverse Event|9|||
33281226|NCT01307800|62656993|FG001|Overall Study|Adverse Event|8|||
33281227|NCT01307800|62656994|FG002|Overall Study|Adverse Event|10|||
33281228|NCT01307800|62656995|FG003|Overall Study|Adverse Event|14|||
33281229|NCT01307800|62656992|FG000|Overall Study|Entry Criteria Not Met|0|||
33281230|NCT01307800|62656993|FG001|Overall Study|Entry Criteria Not Met|0|||
33281231|NCT01307800|62656994|FG002|Overall Study|Entry Criteria Not Met|0|||
33281232|NCT01307800|62656995|FG003|Overall Study|Entry Criteria Not Met|2|||
33281233|NCT01307800|62656992|FG000|Overall Study|Lost to Follow-up|5|||
33281234|NCT01307800|62656993|FG001|Overall Study|Lost to Follow-up|6|||
33281235|NCT01307800|62656994|FG002|Overall Study|Lost to Follow-up|2|||
33281236|NCT01307800|62656995|FG003|Overall Study|Lost to Follow-up|8|||
33281237|NCT01307800|62656992|FG000|Overall Study|Perceived Lack of Efficacy|24|||
33281238|NCT01307800|62656993|FG001|Overall Study|Perceived Lack of Efficacy|23|||
33281239|NCT01307800|62656994|FG002|Overall Study|Perceived Lack of Efficacy|20|||
33281240|NCT01307800|62656995|FG003|Overall Study|Perceived Lack of Efficacy|33|||
33281241|NCT01307800|62656992|FG000|Overall Study|Protocol Violation|0|||
33370889|NCT00571948|62749584|FG000|Overall Study|infant refused study meal|3|||
33370890|NCT00571948|62749585|FG001|Overall Study|infant refused study meal|4|||
33370891|NCT00571948|62749584|FG000|Overall Study|Parent were afraid of blood colection|2|||
33370892|NCT00571948|62749585|FG001|Overall Study|Parent were afraid of blood colection|5|||
33370893|NCT00684424|62749591|FG000|Overall Study|Adverse Event|1|||
33370894|NCT00684424|62749591|FG000|Overall Study|Lost to Follow-up|2|||
33370895|NCT00684424|62749591|FG000|Overall Study|Other|2|||
33370896|NCT00685750|62749603|FG000|Overall Study|Tumor sampling failure|0|||
33370897|NCT00685750|62749604|FG001|Overall Study|Tumor sampling failure|0|||
33370898|NCT00685750|62749605|FG002|Overall Study|Tumor sampling failure|1|||
33370899|NCT00685750|62749606|FG003|Overall Study|Tumor sampling failure|0|||
33370900|NCT00685750|62749607|FG004|Overall Study|Tumor sampling failure|0|||
33370901|NCT00685750|62749608|FG005|Overall Study|Tumor sampling failure|0|||
33370902|NCT00685750|62749609|FG006|Overall Study|Tumor sampling failure|0|||
33370903|NCT00685750|62749603|FG000|Overall Study|Patient didn't receive the treatment|0|||
33370904|NCT00685750|62749604|FG001|Overall Study|Patient didn't receive the treatment|0|||
33370905|NCT00685750|62749605|FG002|Overall Study|Patient didn't receive the treatment|0|||
33370906|NCT00685750|62749606|FG003|Overall Study|Patient didn't receive the treatment|0|||
33370907|NCT00685750|62749607|FG004|Overall Study|Patient didn't receive the treatment|0|||
33370908|NCT00685750|62749608|FG005|Overall Study|Patient didn't receive the treatment|0|||
33370909|NCT00685750|62749609|FG006|Overall Study|Patient didn't receive the treatment|1|||
33370910|NCT00685750|62749603|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33370911|NCT00685750|62749604|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33370912|NCT00685750|62749605|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
33370913|NCT00685750|62749606|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
33370914|NCT00685750|62749607|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
33370915|NCT00685750|62749608|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
33370916|NCT00685750|62749609|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
33370917|NCT00576628|62749629|FG000|Overall Study|Adverse Event|11|||
33370918|NCT00576628|62749629|FG000|Overall Study|Death|2|||
33370919|NCT00576628|62749629|FG000|Overall Study|Failure to return|1|||
33370920|NCT00576628|62749629|FG000|Overall Study|Refused Treatment|8|||
33370921|NCT00576628|62749629|FG000|Overall Study|Pregnancy|1|||
33370922|NCT00576628|62749629|FG000|Overall Study|RBC transfusion|1|||
33370923|NCT00576628|62749629|FG000|Overall Study|Progression of Kidney Disease|1|||
33370924|NCT00576628|62749629|FG000|Overall Study|Progression of Renal Failure|1|||
33370925|NCT00576628|62749629|FG000|Overall Study|The patient move into other town|1|||
33370926|NCT00576628|62749629|FG000|Overall Study|Transplantation|1|||
33370927|NCT00576628|62749629|FG000|Overall Study|Dialysis|15|||
33370928|NCT00683878|62749637|FG000|Overall Study|Lack of Efficacy|3|||
33370929|NCT00683878|62749638|FG001|Overall Study|Lack of Efficacy|0|||
33370930|NCT00683878|62749639|FG002|Overall Study|Lack of Efficacy|1|||
33370931|NCT00683878|62749637|FG000|Overall Study|Adverse Event|4|||
33370932|NCT00683878|62749638|FG001|Overall Study|Adverse Event|3|||
33370933|NCT00683878|62749639|FG002|Overall Study|Adverse Event|3|||
33370934|NCT00683878|62749637|FG000|Overall Study|Withdrawal by Subject|9|||
33370935|NCT00683878|62749638|FG001|Overall Study|Withdrawal by Subject|8|||
33370936|NCT00683878|62749639|FG002|Overall Study|Withdrawal by Subject|6|||
33370937|NCT00683878|62749637|FG000|Overall Study|Death|0|||
33281242|NCT01307800|62656993|FG001|Overall Study|Protocol Violation|3|||
33281243|NCT01307800|62656994|FG002|Overall Study|Protocol Violation|4|||
33281244|NCT01307800|62656995|FG003|Overall Study|Protocol Violation|5|||
33281245|NCT01307800|62656992|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
33281246|NCT01307800|62656993|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
33281247|NCT01307800|62656994|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
33281248|NCT01307800|62656995|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
33281249|NCT01307800|62656992|FG000|Overall Study|Sponsor Decision|6|||
33281250|NCT01307800|62656993|FG001|Overall Study|Sponsor Decision|9|||
33281251|NCT01307800|62656994|FG002|Overall Study|Sponsor Decision|12|||
33281252|NCT01307800|62656995|FG003|Overall Study|Sponsor Decision|28|||
33281253|NCT01307800|62656992|FG000|Overall Study|Withdrawal by Subject|10|||
33281254|NCT01307800|62656993|FG001|Overall Study|Withdrawal by Subject|11|||
33281255|NCT01307800|62656994|FG002|Overall Study|Withdrawal by Subject|8|||
33281256|NCT01307800|62656995|FG003|Overall Study|Withdrawal by Subject|15|||
33281257|NCT01307800|62656992|FG000|Overall Study|Participant Moved|0|||
33281258|NCT01307800|62656993|FG001|Overall Study|Participant Moved|2|||
33281259|NCT01307800|62656994|FG002|Overall Study|Participant Moved|1|||
33281260|NCT01307800|62656995|FG003|Overall Study|Participant Moved|3|||
33281261|NCT01307449|62657009|FG000|Overall Study|Adverse Event|1|||
33281262|NCT01307449|62657010|FG001|Overall Study|Adverse Event|0|||
33281263|NCT01307449|62657011|FG002|Overall Study|Adverse Event|0|||
33281264|NCT01307449|62657012|FG003|Overall Study|Adverse Event|0|||
33281265|NCT01307020|62657032|FG000|Overall Study|Lost to Follow-up|0|||
33281266|NCT01307020|62657033|FG001|Overall Study|Lost to Follow-up|0|||
33281267|NCT01307020|62657034|FG002|Overall Study|Lost to Follow-up|1|||
33281268|NCT01307020|62657035|FG003|Overall Study|Lost to Follow-up|1|||
33281269|NCT01307020|62657036|FG004|Overall Study|Lost to Follow-up|0|||
33281270|NCT01307020|62657037|FG005|Overall Study|Lost to Follow-up|0|||
33281271|NCT01307020|62657038|FG006|Overall Study|Lost to Follow-up|1|||
33281272|NCT01307020|62657039|FG007|Overall Study|Lost to Follow-up|0|||
33281273|NCT01307020|62657040|FG008|Overall Study|Lost to Follow-up|0|||
33281274|NCT01307020|62657041|FG009|Overall Study|Lost to Follow-up|0|||
33281275|NCT01307020|62657032|FG000|Overall Study|Electronic data capture failure|0|||
33281276|NCT01307020|62657033|FG001|Overall Study|Electronic data capture failure|1|||
33281277|NCT01307020|62657034|FG002|Overall Study|Electronic data capture failure|0|||
33281278|NCT01307020|62657035|FG003|Overall Study|Electronic data capture failure|0|||
33281279|NCT01307020|62657036|FG004|Overall Study|Electronic data capture failure|0|||
33281280|NCT01307020|62657037|FG005|Overall Study|Electronic data capture failure|0|||
33281281|NCT01307020|62657038|FG006|Overall Study|Electronic data capture failure|0|||
33281282|NCT01307020|62657039|FG007|Overall Study|Electronic data capture failure|0|||
33281283|NCT01307020|62657040|FG008|Overall Study|Electronic data capture failure|0|||
33281284|NCT01307020|62657041|FG009|Overall Study|Electronic data capture failure|0|||
33281285|NCT01306201|62657063|FG000|Overall Study|Arrhythmia|4|||
33281286|NCT01306201|62657063|FG000|Overall Study|Files could not be processed|3|||
33281287|NCT01306201|62657063|FG000|Overall Study|Files unreadable|3|||
33281288|NCT01306162|62657075|FG000|Period 1|Adverse Event|0|||
33281289|NCT01306162|62657076|FG001|Period 1|Adverse Event|0|||
33281290|NCT01306162|62657077|FG002|Period 1|Adverse Event|0|||
33281291|NCT01306162|62657078|FG003|Period 1|Adverse Event|1|||
33281292|NCT01306162|62657075|FG000|Washout 1|Non-compliance to protocol|0|||
33281293|NCT01306162|62657076|FG001|Washout 1|Non-compliance to protocol|1|||
33281294|NCT01306162|62657077|FG002|Washout 1|Non-compliance to protocol|0|||
33281295|NCT01306162|62657078|FG003|Washout 1|Non-compliance to protocol|0|||
33281296|NCT01305577|62657094|FG000|Overall Study|Adverse Event|2|||
33281297|NCT01305577|62657095|FG001|Overall Study|Adverse Event|2|||
33281298|NCT01305577|62657096|FG002|Overall Study|Adverse Event|1|||
33281299|NCT01305577|62657094|FG000|Overall Study|Withdrawal by Subject|7|||
33370938|NCT00683878|62749638|FG001|Overall Study|Death|1|||
33370939|NCT00683878|62749639|FG002|Overall Study|Death|0|||
33486230|NCT01368562|62864044|FG000|Overall Study|Lost to Follow-up|1|||
33555961|NCT02375698|62948795|FG000|Overall Study|Withdrawal by Subject|0|||
33486231|NCT01368562|62864044|FG000|Overall Study|Death|6|||
33486232|NCT01368562|62864044|FG000|Overall Study|Unresponsive to treatment|5|||
33486233|NCT01368562|62864044|FG000|Overall Study|Other|3|||
33555962|NCT02375698|62948796|FG001|Overall Study|Withdrawal by Subject|2|||
33486234|NCT01368562|62864044|FG000|Overall Study|Other than specified|2|||
33555963|NCT02375698|62948795|FG000|Overall Study|Physician Decision|2|||
33555964|NCT02375698|62948796|FG001|Overall Study|Physician Decision|0|||
33281300|NCT01305577|62657095|FG001|Overall Study|Withdrawal by Subject|5|||
33281301|NCT01305577|62657096|FG002|Overall Study|Withdrawal by Subject|6|||
33281302|NCT01305577|62657094|FG000|Overall Study|Lost to Follow-up|4|||
33281303|NCT01305577|62657095|FG001|Overall Study|Lost to Follow-up|3|||
33281304|NCT01305577|62657096|FG002|Overall Study|Lost to Follow-up|2|||
33281305|NCT01305577|62657094|FG000|Overall Study|Protocol Deviation|0|||
33370940|NCT00683878|62749637|FG000|Overall Study|Lost to Follow-up|4|||
33281306|NCT01305577|62657095|FG001|Overall Study|Protocol Deviation|1|||
33281307|NCT01305577|62657096|FG002|Overall Study|Protocol Deviation|1|||
33281308|NCT01304329|62657104|FG000|Third Intervention (3 Days)|Adverse Event|0|||
33370941|NCT00683878|62749638|FG001|Overall Study|Lost to Follow-up|2|||
33281309|NCT01304329|62657105|FG001|Third Intervention (3 Days)|Adverse Event|1|||
33486235|NCT03242018|62864051|FG000|Overall Study|Adverse Event|7|||
33555965|NCT02374918|62948806|FG000|Overall Study|Protocol Violation|2|||
33281310|NCT01304329|62657106|FG002|Third Intervention (3 Days)|Adverse Event|0|||
33281311|NCT01304329|62657107|FG003|Third Intervention (3 Days)|Adverse Event|0|||
33281312|NCT01304329|62657108|FG004|Third Intervention (3 Days)|Adverse Event|0|||
33281313|NCT01304329|62657109|FG005|Third Intervention (3 Days)|Adverse Event|0|||
33281314|NCT01303861|62657122|FG000|Overall Study|Lost to Follow-up|34|||
33281315|NCT01303861|62657123|FG001|Overall Study|Lost to Follow-up|14|||
33281316|NCT01303861|62657124|FG002|Overall Study|Lost to Follow-up|27|||
33281317|NCT01303861|62657125|FG003|Overall Study|Lost to Follow-up|31|||
33281318|NCT01303861|62657122|FG000|Overall Study|Lack of Efficacy|3|||
33281319|NCT01303861|62657123|FG001|Overall Study|Lack of Efficacy|2|||
33281320|NCT01303861|62657124|FG002|Overall Study|Lack of Efficacy|1|||
33281321|NCT01303861|62657125|FG003|Overall Study|Lack of Efficacy|0|||
33281322|NCT01303861|62657122|FG000|Overall Study|Withdrawal by Subject|16|||
33281323|NCT01303861|62657123|FG001|Overall Study|Withdrawal by Subject|8|||
33281324|NCT01303861|62657124|FG002|Overall Study|Withdrawal by Subject|8|||
33281325|NCT01303861|62657125|FG003|Overall Study|Withdrawal by Subject|23|||
33281326|NCT01303861|62657122|FG000|Overall Study|Adverse Event|4|||
33281327|NCT01303861|62657123|FG001|Overall Study|Adverse Event|1|||
33281328|NCT01303861|62657124|FG002|Overall Study|Adverse Event|0|||
33281329|NCT01303861|62657125|FG003|Overall Study|Adverse Event|5|||
33281330|NCT01303861|62657122|FG000|Overall Study|Pregnancy|1|||
33281331|NCT01303861|62657123|FG001|Overall Study|Pregnancy|0|||
33281332|NCT01303861|62657124|FG002|Overall Study|Pregnancy|0|||
33281333|NCT01303861|62657125|FG003|Overall Study|Pregnancy|0|||
33281334|NCT01303627|62657138|FG000|Overall Study|the failure while performing URS|0|||
33281335|NCT01303627|62657139|FG001|Overall Study|the failure while performing URS|1|||
33281336|NCT01303510|62657147|FG000|Overall Study|Lost to Follow-up|1|||
33281337|NCT01303510|62657148|FG001|Overall Study|Lost to Follow-up|0|||
33281338|NCT01303159|62657154|FG000|Overall Study|Death|16|||
33281339|NCT01303159|62657154|FG000|Overall Study|Study Termination|7|||
33281340|NCT01302964|62657160|FG000|Overall Study|Adverse Event|1|||
33281341|NCT01302964|62657161|FG001|Overall Study|Adverse Event|0|||
33281342|NCT01302691|62657169|FG000|Overall Study|Adverse Event|2|||
33281343|NCT01302691|62657170|FG001|Overall Study|Adverse Event|0|||
33281344|NCT01302691|62657169|FG000|Overall Study|Death|0|||
33281345|NCT01302691|62657170|FG001|Overall Study|Death|1|||
33281346|NCT01302691|62657169|FG000|Overall Study|Lost to Follow-up|1|||
33281347|NCT01302691|62657170|FG001|Overall Study|Lost to Follow-up|0|||
33281348|NCT01302691|62657169|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
33281349|NCT01302691|62657170|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
33281350|NCT01302691|62657169|FG000|Overall Study|Physician Decision|0|||
33281351|NCT01302691|62657170|FG001|Overall Study|Physician Decision|1|||
33281352|NCT01302691|62657169|FG000|Overall Study|Protocol Violation|1|||
33281353|NCT01302691|62657170|FG001|Overall Study|Protocol Violation|0|||
33370942|NCT00683878|62749639|FG002|Overall Study|Lost to Follow-up|4|||
33370943|NCT00683878|62749637|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
33370944|NCT00683878|62749638|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
33370945|NCT00683878|62749639|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
33486236|NCT03242018|62864052|FG001|Overall Study|Adverse Event|7|||
33486237|NCT03242018|62864053|FG002|Overall Study|Adverse Event|6|||
33486238|NCT03242018|62864051|FG000|Overall Study|Lost to Follow-up|2|||
33486239|NCT03242018|62864052|FG001|Overall Study|Lost to Follow-up|2|||
33486240|NCT03242018|62864053|FG002|Overall Study|Lost to Follow-up|2|||
33486241|NCT03242018|62864051|FG000|Overall Study|At the Participant's Own Request|5|||
33486242|NCT03242018|62864052|FG001|Overall Study|At the Participant's Own Request|1|||
33486243|NCT03242018|62864053|FG002|Overall Study|At the Participant's Own Request|4|||
33486244|NCT03242018|62864051|FG000|Overall Study|Reason Not Specified|3|||
33486245|NCT03242018|62864052|FG001|Overall Study|Reason Not Specified|4|||
33486246|NCT03242018|62864053|FG002|Overall Study|Reason Not Specified|1|||
33486247|NCT03242018|62864051|FG000|Overall Study|Study Terminated by Sponsor|1|||
33486248|NCT03242018|62864052|FG001|Overall Study|Study Terminated by Sponsor|0|||
33281354|NCT01302418|62657176|FG000|Overall Study|Protocol Violation|9|||
33281355|NCT01302418|62657176|FG000|Overall Study|Non-evaluable|9|||
33281356|NCT01302067|62657183|FG000|Overall Study|Death|0|||
33281357|NCT01302067|62657184|FG001|Overall Study|Death|0|||
33281358|NCT01302067|62657185|FG002|Overall Study|Death|1|||
33281359|NCT01302067|62657183|FG000|Overall Study|Physician Decision|9|||
33281360|NCT01302067|62657184|FG001|Overall Study|Physician Decision|5|||
33486249|NCT03242018|62864053|FG002|Overall Study|Study Terminated by Sponsor|1|||
33486250|NCT02789176|62864066|FG000|Overall Study|Death|0|||
33281361|NCT01302067|62657185|FG002|Overall Study|Physician Decision|14|||
33281362|NCT01302067|62657183|FG000|Overall Study|Lack of Efficacy|8|||
33281363|NCT01302067|62657184|FG001|Overall Study|Lack of Efficacy|4|||
33281364|NCT01302067|62657185|FG002|Overall Study|Lack of Efficacy|2|||
33281365|NCT01302067|62657183|FG000|Overall Study|Lost to Follow-up|9|||
33281366|NCT01302067|62657184|FG001|Overall Study|Lost to Follow-up|4|||
33486251|NCT02789176|62864067|FG001|Overall Study|Death|0|||
33281367|NCT01302067|62657185|FG002|Overall Study|Lost to Follow-up|15|||
33281368|NCT01302067|62657183|FG000|Overall Study|Withdrawal by Subject|13|||
33281369|NCT01302067|62657184|FG001|Overall Study|Withdrawal by Subject|6|||
33281370|NCT01302067|62657185|FG002|Overall Study|Withdrawal by Subject|10|||
33281371|NCT01302067|62657183|FG000|Overall Study|Other|1|||
33281372|NCT01302067|62657184|FG001|Overall Study|Other|1|||
33281373|NCT01302067|62657185|FG002|Overall Study|Other|3|||
33281374|NCT01302067|62657183|FG000|Overall Study|Protocol Violation|11|||
33281375|NCT01302067|62657184|FG001|Overall Study|Protocol Violation|0|||
33281376|NCT01302067|62657185|FG002|Overall Study|Protocol Violation|8|||
33281377|NCT01302067|62657183|FG000|Overall Study|Adverse Event|27|||
33281378|NCT01302067|62657184|FG001|Overall Study|Adverse Event|14|||
33281379|NCT01302067|62657185|FG002|Overall Study|Adverse Event|45|||
33281380|NCT01301950|62657195|FG000|Overall Study|Surgery was cancelled by patient|0|||
33281381|NCT01301950|62657196|FG001|Overall Study|Surgery was cancelled by patient|1|||
33281382|NCT01301833|62657206|FG000|Overall Study|Adverse Event|7|||
33281383|NCT01301833|62657207|FG001|Overall Study|Adverse Event|5|||
33281384|NCT01301833|62657208|FG002|Overall Study|Adverse Event|5|||
33281385|NCT01301833|62657209|FG003|Overall Study|Adverse Event|5|||
33281386|NCT01301833|62657206|FG000|Overall Study|Lack of Efficacy|1|||
33281387|NCT01301833|62657207|FG001|Overall Study|Lack of Efficacy|1|||
33281388|NCT01301833|62657208|FG002|Overall Study|Lack of Efficacy|0|||
33281389|NCT01301833|62657209|FG003|Overall Study|Lack of Efficacy|0|||
33281390|NCT01301833|62657206|FG000|Overall Study|Physician Decision|3|||
33281391|NCT01301833|62657207|FG001|Overall Study|Physician Decision|1|||
33281392|NCT01301833|62657208|FG002|Overall Study|Physician Decision|1|||
33281393|NCT01301833|62657209|FG003|Overall Study|Physician Decision|0|||
33281394|NCT01301833|62657206|FG000|Overall Study|Withdrawal by Subject|3|||
33281395|NCT01301833|62657207|FG001|Overall Study|Withdrawal by Subject|1|||
33281396|NCT01301833|62657208|FG002|Overall Study|Withdrawal by Subject|1|||
33281397|NCT01301833|62657209|FG003|Overall Study|Withdrawal by Subject|2|||
33281398|NCT01301833|62657206|FG000|Overall Study|Personal matter|1|||
33281399|NCT01301833|62657207|FG001|Overall Study|Personal matter|0|||
33281400|NCT01301833|62657208|FG002|Overall Study|Personal matter|0|||
33281401|NCT01301833|62657209|FG003|Overall Study|Personal matter|0|||
33281402|NCT01301092|62657222|FG000|Overall Study|Lost to Follow-up|0|||
33281403|NCT01301092|62657223|FG001|Overall Study|Lost to Follow-up|0|||
33281404|NCT01301092|62657224|FG002|Overall Study|Lost to Follow-up|1|||
33281405|NCT01300819|62657239|FG000|Overall Study|Adverse Event|9|||
33281406|NCT01300819|62657240|FG001|Overall Study|Adverse Event|27|||
33281407|NCT01300819|62657239|FG000|Overall Study|Lack of Efficacy|2|||
33281408|NCT01300819|62657240|FG001|Overall Study|Lack of Efficacy|1|||
33281409|NCT01300819|62657239|FG000|Overall Study|Withdrawal by Subject|10|||
33281410|NCT01300819|62657240|FG001|Overall Study|Withdrawal by Subject|12|||
33281411|NCT01300819|62657239|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
33281412|NCT01300819|62657240|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
33281413|NCT01300819|62657239|FG000|Overall Study|Refusal to down titrate study drug|0|||
33281414|NCT01300819|62657240|FG001|Overall Study|Refusal to down titrate study drug|1|||
33281415|NCT01300819|62657239|FG000|Overall Study|Administrative reason|0|||
33281416|NCT01300819|62657240|FG001|Overall Study|Administrative reason|1|||
33281417|NCT01300819|62657239|FG000|Overall Study|Safety follow up not done by mistake|0|||
33281418|NCT01300819|62657240|FG001|Overall Study|Safety follow up not done by mistake|1|||
33281419|NCT01300819|62657239|FG000|Overall Study|Follow up call was not done|1|||
33281420|NCT01300819|62657240|FG001|Overall Study|Follow up call was not done|0|||
33281421|NCT01300741|62657246|FG000|Overall Study|Lens deposits|1|||
33281422|NCT01300741|62657246|FG000|Overall Study|Lost to Follow-up|1|||
33281423|NCT01300741|62657246|FG000|Overall Study|Discomfort|1|||
33281424|NCT01300546|62657254|FG000|Overall Study|Withdrawal by Subject|1|||
33281425|NCT01300546|62657255|FG001|Overall Study|Withdrawal by Subject|0|||
33281426|NCT01300546|62657254|FG000|Overall Study|Lost to Follow-up|0|||
33281427|NCT01300546|62657255|FG001|Overall Study|Lost to Follow-up|2|||
33281428|NCT01300546|62657254|FG000|Overall Study|Lack of Efficacy|0|||
33281429|NCT01300546|62657255|FG001|Overall Study|Lack of Efficacy|3|||
33281430|NCT01300546|62657254|FG000|Overall Study|Adverse Event|0|||
33281431|NCT01300546|62657255|FG001|Overall Study|Adverse Event|1|||
33281432|NCT01300351|62657263|FG000|Overall Study|Did not receive treatment|2|||
33281433|NCT01300351|62657264|FG001|Overall Study|Did not receive treatment|0|||
33281434|NCT01300351|62657263|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
33281435|NCT01300351|62657264|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
33281436|NCT01300351|62657263|FG000|Overall Study|Lost to Follow-up|0|||
33281437|NCT01300351|62657264|FG001|Overall Study|Lost to Follow-up|1|||
33281438|NCT01300351|62657263|FG000|Overall Study|Adverse Event|0|||
33281439|NCT01300351|62657264|FG001|Overall Study|Adverse Event|4|||
33281440|NCT01300351|62657263|FG000|Overall Study|Withdrawal by Subject|7|||
33281441|NCT01300351|62657264|FG001|Overall Study|Withdrawal by Subject|10|||
33281442|NCT01300234|62657272|FG000|Overall Study|Adverse Event|1|||
33281443|NCT01300234|62657273|FG001|Overall Study|Adverse Event|1|||
33370946|NCT00884741|62749650|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
33281444|NCT01300234|62657272|FG000|Overall Study|Protocol Violation|2|||
33281445|NCT01300234|62657273|FG001|Overall Study|Protocol Violation|3|||
33281446|NCT01300234|62657272|FG000|Overall Study|Withdrawal by Subject|5|||
33281447|NCT01300234|62657273|FG001|Overall Study|Withdrawal by Subject|9|||
33281448|NCT01300234|62657272|FG000|Overall Study|Lost to Follow-up|14|||
33281449|NCT01300234|62657273|FG001|Overall Study|Lost to Follow-up|12|||
33281450|NCT01300234|62657272|FG000|Overall Study|Pregnancy|2|||
33281451|NCT01300234|62657273|FG001|Overall Study|Pregnancy|1|||
33281452|NCT01300234|62657272|FG000|Overall Study|Participant reached stopping critera|2|||
33281453|NCT01300234|62657273|FG001|Overall Study|Participant reached stopping critera|0|||
33281454|NCT01300234|62657272|FG000|Overall Study|Participant stopped medication|1|||
33281455|NCT01300234|62657273|FG001|Overall Study|Participant stopped medication|1|||
33281456|NCT01300234|62657272|FG000|Overall Study|Participant refused return to hospital|1|||
33281457|NCT01300234|62657273|FG001|Overall Study|Participant refused return to hospital|0|||
33281458|NCT01299961|62657290|FG000|Overall Study|Adverse Event|3|||
33281459|NCT01299961|62657290|FG000|Overall Study|Lack of Efficacy|2|||
33281460|NCT01299961|62657290|FG000|Overall Study|Lost to Follow-up|1|||
33281461|NCT01299805|62657296|FG000|Overall Study|Adverse Event|2|||
33281462|NCT01299805|62657297|FG001|Overall Study|Adverse Event|0|||
33281463|NCT01299766|62657305|FG000|Overall Study|Death|5|||
33281464|NCT01299766|62657306|FG001|Overall Study|Death|4|||
33281465|NCT01299766|62657305|FG000|Overall Study|Withdrawal by Subject|29|||
33281466|NCT01299766|62657306|FG001|Overall Study|Withdrawal by Subject|19|||
33281467|NCT01299727|62657315|FG000|Overall Study|Withdrawal by Subject|1|||
33281468|NCT01299727|62657316|FG001|Overall Study|Withdrawal by Subject|0|||
33281469|NCT01299727|62657317|FG002|Overall Study|Withdrawal by Subject|0|||
33281470|NCT01299727|62657315|FG000|Overall Study|Adverse Event|0|||
33281471|NCT01299727|62657316|FG001|Overall Study|Adverse Event|0|||
33281472|NCT01299727|62657317|FG002|Overall Study|Adverse Event|1|||
33281473|NCT01299727|62657315|FG000|Overall Study|Completed the Treatment Period|3|||
33281474|NCT01299727|62657316|FG001|Overall Study|Completed the Treatment Period|4|||
33281475|NCT01299727|62657317|FG002|Overall Study|Completed the Treatment Period|3|||
33281476|NCT01299571|62657325|FG000|Overall Study|Protocol Violation|107|||
33281477|NCT01299376|62657332|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
33281478|NCT01299376|62657333|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
33281479|NCT01299376|62657332|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
33281480|NCT01299376|62657333|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
33281481|NCT01299376|62657332|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
33281482|NCT01299376|62657333|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
33281483|NCT01299376|62657332|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
33281484|NCT01299376|62657333|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
33281485|NCT01299376|62657332|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
33281486|NCT01299376|62657333|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
33281487|NCT01299376|62657332|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
33281488|NCT01299376|62657333|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
33281489|NCT01299376|62657332|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
33281490|NCT01299376|62657333|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
33281491|NCT01299376|62657332|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
33281492|NCT01299376|62657333|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
33281493|NCT01299376|62657332|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
33281494|NCT01299376|62657333|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
33281495|NCT01299376|62657332|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
33281496|NCT01299376|62657333|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
33281497|NCT01299376|62657332|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
33281498|NCT01299376|62657333|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
33281499|NCT01299025|62657345|FG000|Overall Study|Withdrawal by Subject|2|||
33281500|NCT01299025|62657346|FG001|Overall Study|Withdrawal by Subject|1|||
33281501|NCT01299025|62657345|FG000|Overall Study|Lost to Follow-up|1|||
33281502|NCT01299025|62657346|FG001|Overall Study|Lost to Follow-up|0|||
33281503|NCT01298596|62657354|FG000|Overall Study|Withdrawal by Subject|1|||
33281504|NCT01298596|62657355|FG001|Overall Study|Withdrawal by Subject|1|||
33281505|NCT01298596|62657354|FG000|Overall Study|Death|5|||
33281506|NCT01298596|62657355|FG001|Overall Study|Death|3|||
33281507|NCT01298596|62657354|FG000|Overall Study|Lost to Follow-up|6|||
33281508|NCT01298596|62657355|FG001|Overall Study|Lost to Follow-up|14|||
33281509|NCT01298596|62657354|FG000|Overall Study|Referred for further management|16|||
33281510|NCT01298596|62657355|FG001|Overall Study|Referred for further management|15|||
33281511|NCT01298518|62657364|FG000|Overall Study|Withdrawal by Subject|0|||
33281512|NCT01298518|62657365|FG001|Overall Study|Withdrawal by Subject|0|||
33281513|NCT01298518|62657366|FG002|Overall Study|Withdrawal by Subject|1|||
33281514|NCT01298362|62657376|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
33281515|NCT01298362|62657377|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
33281516|NCT01298323|62657387|FG000|Overall Study|Adverse Event|2|||
33281517|NCT01298323|62657388|FG001|Overall Study|Adverse Event|4|||
33281518|NCT01298323|62657387|FG000|Overall Study|Death|11|||
33281519|NCT01298323|62657388|FG001|Overall Study|Death|16|||
33281520|NCT01298323|62657387|FG000|Overall Study|Lost to Follow-up|1|||
33281521|NCT01298323|62657388|FG001|Overall Study|Lost to Follow-up|0|||
33281522|NCT01298323|62657387|FG000|Overall Study|Withdrawal by Subject|6|||
33281523|NCT01298323|62657388|FG001|Overall Study|Withdrawal by Subject|3|||
33281524|NCT01298323|62657387|FG000|Overall Study|Protocol Violation|1|||
33281525|NCT01298323|62657388|FG001|Overall Study|Protocol Violation|0|||
33281526|NCT01298323|62657387|FG000|Overall Study|Other|10|||
33281527|NCT01298323|62657388|FG001|Overall Study|Other|9|||
33281528|NCT01298323|62657387|FG000|Overall Study|Ongoing|55|||
33281529|NCT01298323|62657388|FG001|Overall Study|Ongoing|55|||
33281530|NCT01298323|62657387|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33281531|NCT01298323|62657388|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33281532|NCT01297504|62657394|FG000|Overall Study|Invalid Consent|1|||
33281533|NCT01297504|62657394|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
33281534|NCT01297504|62657394|FG000|Overall Study|No Study Visits|4|||
33281535|NCT01297504|62657394|FG000|Overall Study|Death|3|||
33281536|NCT01297504|62657394|FG000|Overall Study|Lost to Follow-up|43|||
33281537|NCT01297504|62657394|FG000|Overall Study|Withdrawal by Subject|9|||
33281538|NCT01297504|62657394|FG000|Overall Study|Site Closure|3|||
33281539|NCT01297504|62657394|FG000|Overall Study|Protocol Violation|3|||
33281540|NCT01297465|62657404|FG000|Overall Study|Lack of Ovarian Response|1|||
33281541|NCT01297465|62657405|FG001|Overall Study|Lack of Ovarian Response|1|||
33281542|NCT01297465|62657404|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
33281543|NCT01297465|62657405|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
33281544|NCT01297465|62657404|FG000|Overall Study|No Oocytes Retrieved|1|||
33281545|NCT01297465|62657405|FG001|Overall Study|No Oocytes Retrieved|1|||
33281546|NCT01297465|62657404|FG000|Overall Study|Poor oocyte quality|0|||
33281547|NCT01297465|62657405|FG001|Overall Study|Poor oocyte quality|1|||
33281548|NCT01297465|62657404|FG000|Overall Study|No Fertilization|6|||
33281549|NCT01297465|62657405|FG001|Overall Study|No Fertilization|4|||
33281550|NCT01297465|62657404|FG000|Overall Study|All Embryos Discarded|0|||
33281551|NCT01297465|62657405|FG001|Overall Study|All Embryos Discarded|1|||
33281552|NCT01297465|62657404|FG000|Overall Study|Intention to Freeze all Embryos|0|||
33281553|NCT01297465|62657405|FG001|Overall Study|Intention to Freeze all Embryos|1|||
33281554|NCT01297309|62657411|FG000|Overall Study|Eligibility failure|2|||
33281555|NCT01297309|62657411|FG000|Overall Study|Screen failure|2|||
33281556|NCT01297309|62657411|FG000|Overall Study|Withdrawal by Subject|5|||
33281557|NCT01297309|62657411|FG000|Overall Study|Adverse Event|1|||
33281558|NCT01297309|62657411|FG000|Overall Study|Investigator Decision|2|||
33281559|NCT01297309|62657411|FG000|Overall Study|Death|1|||
33281560|NCT01297309|62657411|FG000|Overall Study|Participant not entering extensionperiod|1|||
33281561|NCT04518462|62657418|FG000|Overall Study|Withdrawal by Subject|0|||
33281562|NCT04518462|62657419|FG001|Overall Study|Withdrawal by Subject|0|||
33281563|NCT04518462|62657420|FG002|Overall Study|Withdrawal by Subject|1|||
33281564|NCT04518462|62657418|FG000|Overall Study|Physician Decision|1|||
33281565|NCT04518462|62657419|FG001|Overall Study|Physician Decision|1|||
33281566|NCT04518462|62657420|FG002|Overall Study|Physician Decision|0|||
33281567|NCT01297270|62657431|FG000|Overall Study|Adverse Event|19|||
33281568|NCT01297270|62657432|FG001|Overall Study|Adverse Event|32|||
33281569|NCT01297270|62657433|FG002|Overall Study|Adverse Event|5|||
33281570|NCT01297270|62657431|FG000|Overall Study|Lack of Efficacy|15|||
33281571|NCT01297270|62657432|FG001|Overall Study|Lack of Efficacy|17|||
33281572|NCT01297270|62657433|FG002|Overall Study|Lack of Efficacy|15|||
33281573|NCT01297270|62657431|FG000|Overall Study|Lost to Follow-up|1|||
33281574|NCT01297270|62657432|FG001|Overall Study|Lost to Follow-up|2|||
33281575|NCT01297270|62657433|FG002|Overall Study|Lost to Follow-up|1|||
33281576|NCT01297270|62657431|FG000|Overall Study|Protocol Violation|0|||
33281577|NCT01297270|62657432|FG001|Overall Study|Protocol Violation|2|||
33281578|NCT01297270|62657433|FG002|Overall Study|Protocol Violation|0|||
33281579|NCT01297270|62657431|FG000|Overall Study|Withdrawal by Subject|7|||
33281580|NCT01297270|62657432|FG001|Overall Study|Withdrawal by Subject|15|||
33281581|NCT01297270|62657433|FG002|Overall Study|Withdrawal by Subject|7|||
33281582|NCT01297270|62657431|FG000|Overall Study|Other reason not defined above|3|||
33281583|NCT01297270|62657432|FG001|Overall Study|Other reason not defined above|3|||
33281584|NCT01297270|62657433|FG002|Overall Study|Other reason not defined above|1|||
33370947|NCT00884741|62749651|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
33370948|NCT00884741|62749652|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
33281585|NCT01297270|62657431|FG000|Overall Study|Not treated|0|||
33486252|NCT02789176|62864068|FG002|Overall Study|Death|3|||
33281586|NCT01297270|62657432|FG001|Overall Study|Not treated|1|||
33281587|NCT01297270|62657433|FG002|Overall Study|Not treated|0|||
33281588|NCT01296568|62657441|FG000|Continued Access Phase|Lost to Follow-up|1|||
33281589|NCT01296568|62657441|FG000|Continued Access Phase|Withdrawal by Subject|1|||
33281590|NCT01296568|62657441|FG000|Continued Access Phase|Disease Progression|1|||
33281591|NCT01296412|62657449|FG000|Overall Study|Adverse Event|8|||
33281592|NCT01296412|62657450|FG001|Overall Study|Adverse Event|29|||
33281593|NCT01296412|62657449|FG000|Overall Study|Lack of Efficacy|1|||
33281594|NCT01296412|62657450|FG001|Overall Study|Lack of Efficacy|0|||
33281595|NCT01296412|62657449|FG000|Overall Study|Lost to Follow-up|10|||
33281596|NCT01296412|62657450|FG001|Overall Study|Lost to Follow-up|7|||
33281597|NCT01296412|62657449|FG000|Overall Study|Non-compliance with study drug|1|||
33281598|NCT01296412|62657450|FG001|Overall Study|Non-compliance with study drug|2|||
33281599|NCT01296412|62657449|FG000|Overall Study|Other reason not specified|20|||
33281600|NCT01296412|62657450|FG001|Overall Study|Other reason not specified|15|||
33281601|NCT01296412|62657449|FG000|Overall Study|Physician Decision|1|||
33281602|NCT01296412|62657450|FG001|Overall Study|Physician Decision|3|||
33281603|NCT01296412|62657449|FG000|Overall Study|Pregnancy|0|||
33281604|NCT01296412|62657450|FG001|Overall Study|Pregnancy|1|||
33281605|NCT01296412|62657449|FG000|Overall Study|Withdrawal by Subject|10|||
33281606|NCT01296412|62657450|FG001|Overall Study|Withdrawal by Subject|13|||
33281607|NCT01295905|62657458|FG000|Overall Study|Did not meet inclusion criteria|1|||
33281608|NCT01295905|62657459|FG001|Overall Study|Did not meet inclusion criteria|0|||
33281609|NCT01295905|62657458|FG000|Overall Study|Met exclusion criteria|1|||
33281610|NCT01295905|62657459|FG001|Overall Study|Met exclusion criteria|0|||
33281611|NCT02596035|62657468|FG000|Overall Study|Disease Progression|64|||
33281612|NCT02596035|62657469|FG001|Overall Study|Disease Progression|32|||
33281613|NCT02596035|62657470|FG002|Overall Study|Disease Progression|1|||
33281614|NCT02596035|62657468|FG000|Overall Study|study drug toxicity|12|||
33281615|NCT02596035|62657469|FG001|Overall Study|study drug toxicity|3|||
33281616|NCT02596035|62657470|FG002|Overall Study|study drug toxicity|0|||
33281617|NCT02596035|62657468|FG000|Overall Study|AE unrelated to study drug|5|||
33281618|NCT02596035|62657469|FG001|Overall Study|AE unrelated to study drug|2|||
33281619|NCT02596035|62657470|FG002|Overall Study|AE unrelated to study drug|0|||
33281620|NCT02596035|62657468|FG000|Overall Study|participant request to discontinue study treatment|2|||
33281621|NCT02596035|62657469|FG001|Overall Study|participant request to discontinue study treatment|0|||
33281622|NCT02596035|62657470|FG002|Overall Study|participant request to discontinue study treatment|0|||
33281623|NCT02596035|62657468|FG000|Overall Study|participant withdrew consent|2|||
33281624|NCT02596035|62657469|FG001|Overall Study|participant withdrew consent|2|||
33281625|NCT02596035|62657470|FG002|Overall Study|participant withdrew consent|0|||
33281626|NCT02596035|62657468|FG000|Overall Study|Poor/Non Comlpiance|0|||
33281627|NCT02596035|62657469|FG001|Overall Study|Poor/Non Comlpiance|1|||
33281628|NCT02596035|62657470|FG002|Overall Study|Poor/Non Comlpiance|0|||
33281629|NCT02596035|62657468|FG000|Overall Study|participant no longer meets study criteria|1|||
33281630|NCT02596035|62657469|FG001|Overall Study|participant no longer meets study criteria|0|||
33281631|NCT02596035|62657470|FG002|Overall Study|participant no longer meets study criteria|0|||
33281632|NCT02596035|62657468|FG000|Overall Study|other reasons|11|||
33281633|NCT02596035|62657469|FG001|Overall Study|other reasons|4|||
33281634|NCT02596035|62657470|FG002|Overall Study|other reasons|0|||
33281635|NCT02595372|62657479|FG000|Overall Study|Adverse Event|6|||
33281636|NCT02595372|62657479|FG000|Overall Study|Physician Decision|2|||
33281637|NCT02595372|62657479|FG000|Overall Study|Disease Progression|1|||
33281638|NCT01248962|62657499|FG000|Overall Study|Withdrawal by Subject|1|||
33281639|NCT01248962|62657500|FG001|Overall Study|Withdrawal by Subject|1|||
33281640|NCT01248962|62657499|FG000|Overall Study|Adverse Event|2|||
33281641|NCT01248962|62657500|FG001|Overall Study|Adverse Event|1|||
33281642|NCT01248962|62657499|FG000|Overall Study|Complete Response after 4 Cycles|1|||
33281643|NCT01248962|62657500|FG001|Overall Study|Complete Response after 4 Cycles|0|||
33281644|NCT01248962|62657499|FG000|Overall Study|Complete Response after 3 Cycles|0|||
33281645|NCT01248962|62657500|FG001|Overall Study|Complete Response after 3 Cycles|1|||
33281646|NCT01248962|62657499|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
33281647|NCT01248962|62657500|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
33281648|NCT01248455|62657507|FG000|Overall Study|switched to alternate treatment|1|||
33281649|NCT01247090|62657514|FG000|Overall Study|Physician Decision|1|||
33281650|NCT01247090|62657515|FG001|Overall Study|Physician Decision|0|||
33281651|NCT01247090|62657516|FG002|Overall Study|Physician Decision|0|||
33281652|NCT01247090|62657514|FG000|Overall Study|Withdrawal by Subject|0|||
33281653|NCT01247090|62657515|FG001|Overall Study|Withdrawal by Subject|1|||
33281654|NCT01247090|62657516|FG002|Overall Study|Withdrawal by Subject|0|||
33370949|NCT00884741|62749653|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
33486253|NCT02789176|62864069|FG003|Overall Study|Death|0|||
33486254|NCT02789176|62864066|FG000|Overall Study|Withdrawal by Subject|0|||
33281655|NCT01249664|62657526|FG000|Overall Study|Withdrawal by Subject|5|||
33281656|NCT01249664|62657527|FG001|Overall Study|Withdrawal by Subject|0|||
33281657|NCT01249664|62657526|FG000|Overall Study|Adverse Event|1|||
33281658|NCT01249664|62657527|FG001|Overall Study|Adverse Event|0|||
33281659|NCT01249274|62657537|FG000|Overall Study|Lost to Follow-up|3|||
33281660|NCT01249274|62657538|FG001|Overall Study|Lost to Follow-up|4|||
33281661|NCT01249274|62657537|FG000|Overall Study|Received inpatient substance treatment|1|||
33281662|NCT01249274|62657538|FG001|Overall Study|Received inpatient substance treatment|2|||
33281663|NCT01249157|62657546|FG000|Overall Study|Withdrawal by Subject|1|||
33281664|NCT01249118|62657550|FG000|First Washout Period|Physician Decision|0|||
33486255|NCT02789176|62864067|FG001|Overall Study|Withdrawal by Subject|0|||
33281665|NCT01249118|62657551|FG001|First Washout Period|Physician Decision|1|||
33281666|NCT01249118|62657552|FG002|First Washout Period|Physician Decision|0|||
33281667|NCT01248884|62657562|FG000|Overall Study|Withdrawal by Subject|1|||
33281668|NCT01248884|62657563|FG001|Overall Study|Withdrawal by Subject|3|||
33281669|NCT01248884|62657564|FG002|Overall Study|Withdrawal by Subject|1|||
33281670|NCT01248884|62657562|FG000|Overall Study|Adverse Event|1|||
33281671|NCT01248884|62657563|FG001|Overall Study|Adverse Event|0|||
33281672|NCT01248884|62657564|FG002|Overall Study|Adverse Event|0|||
33281673|NCT01248728|62657576|FG000|Overall Study|Adverse Event|1|||
33281674|NCT01248728|62657577|FG001|Overall Study|Adverse Event|1|||
33281675|NCT01248728|62657576|FG000|Overall Study|Withdrawal by Subject|2|||
33281676|NCT01248728|62657577|FG001|Overall Study|Withdrawal by Subject|1|||
33281677|NCT01248728|62657576|FG000|Overall Study|Lack of Efficacy|1|||
33281678|NCT01248728|62657577|FG001|Overall Study|Lack of Efficacy|0|||
33281679|NCT01246973|62657587|FG000|Overall Study|Other|38|||
33281680|NCT01246973|62657588|FG001|Overall Study|Other|25|||
33281681|NCT01246973|62657587|FG000|Overall Study|Adverse Event|16|||
33281682|NCT01246973|62657588|FG001|Overall Study|Adverse Event|9|||
33281683|NCT01246973|62657587|FG000|Overall Study|Withdrawal by Subject|7|||
33281684|NCT01246973|62657588|FG001|Overall Study|Withdrawal by Subject|13|||
33281685|NCT01246466|62657594|FG000|Overall Study|Death|1|||
33281686|NCT01246466|62657594|FG000|Overall Study|Withdrawal by Subject|1|||
33281687|NCT01245764|62657603|FG000|Study Phase A|Other|3|||
33281688|NCT01245764|62657604|FG001|Study Phase A|Other|2|||
33281689|NCT01245764|62657605|FG002|Study Phase A|Other|3|||
33281690|NCT01245764|62657606|FG003|Study Phase A|Other|1|||
33281691|NCT01245764|62657603|FG000|Study Phase A|Protocol Violation|6|||
33281692|NCT01245764|62657604|FG001|Study Phase A|Protocol Violation|3|||
33281693|NCT01245764|62657605|FG002|Study Phase A|Protocol Violation|2|||
33281694|NCT01245764|62657606|FG003|Study Phase A|Protocol Violation|2|||
33281695|NCT01245764|62657603|FG000|Study Phase A|Lost to Follow-up|0|||
33281696|NCT01245764|62657604|FG001|Study Phase A|Lost to Follow-up|0|||
33281697|NCT01245764|62657605|FG002|Study Phase A|Lost to Follow-up|5|||
33281698|NCT01245764|62657606|FG003|Study Phase A|Lost to Follow-up|0|||
33281699|NCT01245140|62657626|FG000|Overall Study|Adverse Event|1|||
33281700|NCT01245140|62657627|FG001|Overall Study|Adverse Event|3|||
33281701|NCT01245140|62657626|FG000|Overall Study|Lack of Efficacy|2|||
33281702|NCT01245140|62657627|FG001|Overall Study|Lack of Efficacy|4|||
33281703|NCT01245140|62657626|FG000|Overall Study|Protocol Violation|0|||
33281704|NCT01245140|62657627|FG001|Overall Study|Protocol Violation|1|||
33281705|NCT01245140|62657626|FG000|Overall Study|Withdrawal by Subject|0|||
33281706|NCT01245140|62657627|FG001|Overall Study|Withdrawal by Subject|1|||
33281707|NCT01245140|62657626|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
33281708|NCT01245140|62657627|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
33281709|NCT01245101|62657635|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
33281710|NCT01245101|62657636|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
33281711|NCT01245101|62657635|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
33281712|NCT01245101|62657636|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
33281713|NCT01245101|62657635|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
33281714|NCT01245101|62657636|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
33281715|NCT01245062|62657644|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
33281716|NCT01245062|62657645|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
33370950|NCT00884741|62749650|FG000|Step 1 Registration: Tissue Screening|Death|3|||
33370951|NCT00884741|62749651|FG001|Step 1 Registration: Tissue Screening|Death|0|||
33370952|NCT00884741|62749652|FG002|Step 1 Registration: Tissue Screening|Death|0|||
33370953|NCT00884741|62749653|FG003|Step 1 Registration: Tissue Screening|Death|0|||
33370954|NCT00884741|62749650|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
33370955|NCT00884741|62749651|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
33370956|NCT00884741|62749652|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
33281717|NCT01245062|62657646|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
33281718|NCT01245062|62657644|FG000|Randomization and Crossover Phase|Physician Decision|2|||
33370957|NCT00884741|62749653|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
33555966|NCT02374918|62948807|FG001|Overall Study|Protocol Violation|0|||
33281719|NCT01245062|62657645|FG001|Randomization and Crossover Phase|Physician Decision|4|||
33281720|NCT01245062|62657646|FG002|Randomization and Crossover Phase|Physician Decision|0|||
33281721|NCT01245062|62657644|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
33281722|NCT01245062|62657645|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
33281723|NCT01245062|62657646|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
33281724|NCT01245062|62657644|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
33281725|NCT01245062|62657645|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
33281726|NCT01245062|62657646|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
33281727|NCT01245062|62657644|FG000|Cross-over Phase|Lost to Follow-up|0|||
33281728|NCT01245062|62657645|FG001|Cross-over Phase|Lost to Follow-up|0|||
33281729|NCT01245062|62657646|FG002|Cross-over Phase|Lost to Follow-up|1|||
33281730|NCT01245062|62657644|FG000|Cross-over Phase|Physician Decision|0|||
33281731|NCT01245062|62657645|FG001|Cross-over Phase|Physician Decision|0|||
33281732|NCT01245062|62657646|FG002|Cross-over Phase|Physician Decision|1|||
33281733|NCT01245062|62657644|FG000|Cross-over Phase|Withdrew Consent|0|||
33281734|NCT01245062|62657645|FG001|Cross-over Phase|Withdrew Consent|0|||
33281735|NCT01245062|62657646|FG002|Cross-over Phase|Withdrew Consent|4|||
33281736|NCT01245062|62657644|FG000|Cross-over Phase|Study closed/ terminated|0|||
33281737|NCT01245062|62657645|FG001|Cross-over Phase|Study closed/ terminated|0|||
33281738|NCT01245062|62657646|FG002|Cross-over Phase|Study closed/ terminated|11|||
33281739|NCT01244984|62657657|FG000|Overall Study|Adverse Event|2|||
33281740|NCT01244984|62657658|FG001|Overall Study|Adverse Event|11|||
33281741|NCT01244984|62657659|FG002|Overall Study|Adverse Event|2|||
33281742|NCT01244984|62657657|FG000|Overall Study|Protocol Violation|1|||
33281743|NCT01244984|62657658|FG001|Overall Study|Protocol Violation|0|||
33370958|NCT00884741|62749650|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
33370959|NCT00884741|62749651|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
33370960|NCT00884741|62749652|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
33370961|NCT00884741|62749653|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
33370962|NCT00884741|62749650|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
33370963|NCT00884741|62749651|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
33370964|NCT00884741|62749652|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
33370965|NCT00884741|62749653|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
33370966|NCT00884741|62749650|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
33370967|NCT00884741|62749651|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
33370968|NCT00884741|62749652|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
33370969|NCT00884741|62749653|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
33370970|NCT00884741|62749650|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
33370971|NCT00884741|62749651|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
33370972|NCT00884741|62749652|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
33370973|NCT00884741|62749653|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
33370974|NCT00884741|62749650|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
33370975|NCT00884741|62749651|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
33486256|NCT02789176|62864068|FG002|Overall Study|Withdrawal by Subject|1|||
33486257|NCT02789176|62864069|FG003|Overall Study|Withdrawal by Subject|0|||
33486258|NCT02789176|62864066|FG000|Overall Study|Lost to Follow-up|8|||
33486259|NCT02789176|62864067|FG001|Overall Study|Lost to Follow-up|2|||
33486260|NCT02789176|62864068|FG002|Overall Study|Lost to Follow-up|6|||
33486261|NCT02789176|62864069|FG003|Overall Study|Lost to Follow-up|1|||
33486262|NCT03259490|62864081|FG000|Period 1|Withdrawal by Subject|0|||
33486263|NCT03259490|62864082|FG001|Period 1|Withdrawal by Subject|1|||
33281744|NCT01244984|62657659|FG002|Overall Study|Protocol Violation|0|||
33370976|NCT00884741|62749652|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
33370977|NCT00884741|62749653|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
33370978|NCT00884741|62749650|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
33370979|NCT00884741|62749651|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
33370980|NCT00884741|62749652|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
33370981|NCT00884741|62749653|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
33370982|NCT00884741|62749650|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
33370983|NCT00884741|62749651|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
33370984|NCT00884741|62749652|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
33370985|NCT00884741|62749653|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
33370986|NCT00884741|62749650|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
33486264|NCT03259490|62864081|FG000|Period 2|Protocol Violation|1|||
33486265|NCT03259490|62864082|FG001|Period 2|Protocol Violation|0|||
33281745|NCT01244984|62657657|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
33281746|NCT01244984|62657658|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
33281747|NCT01244984|62657659|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
33281748|NCT01244984|62657657|FG000|Overall Study|Withdrawal by Subject|1|||
33281749|NCT01244984|62657658|FG001|Overall Study|Withdrawal by Subject|2|||
33486266|NCT03259334|62864091|FG000|Overall Study|Adverse Event|3|||
33555967|NCT02374918|62948808|FG002|Overall Study|Protocol Violation|2|||
33281750|NCT01244984|62657659|FG002|Overall Study|Withdrawal by Subject|2|||
33281751|NCT01244516|62657671|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
33281752|NCT01244516|62657672|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
33281753|NCT01244516|62657673|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
33281754|NCT01244516|62657671|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
33281755|NCT01244516|62657672|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
33370987|NCT00884741|62749651|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
33281756|NCT01244516|62657673|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
33370988|NCT00884741|62749652|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
33486267|NCT03259334|62864092|FG001|Overall Study|Adverse Event|8|||
33486268|NCT03259334|62864093|FG002|Overall Study|Adverse Event|5|||
33555968|NCT02374918|62948809|FG003|Overall Study|Protocol Violation|1|||
33281757|NCT01244516|62657671|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
33281758|NCT01244516|62657672|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
33281759|NCT01244516|62657673|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
33281760|NCT01244516|62657671|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
33281761|NCT01244516|62657672|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
33281762|NCT01244516|62657673|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
33281763|NCT01244516|62657671|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
33281764|NCT01244516|62657672|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
33281765|NCT01244516|62657673|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
33281766|NCT01244516|62657671|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
33281767|NCT01244516|62657672|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
33281768|NCT01244516|62657673|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
33281769|NCT01244516|62657671|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
33281770|NCT01244516|62657672|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
33281771|NCT01244516|62657673|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
33281772|NCT01244126|62657685|FG000|Overall Study|Protocol Violation|3|||
33281773|NCT01244126|62657686|FG001|Overall Study|Protocol Violation|3|||
33281774|NCT01244126|62657687|FG002|Overall Study|Protocol Violation|9|||
33281775|NCT01243892|62657697|FG000|Overall Study|Did not meet eligibility criteria|2|||
33281776|NCT01243892|62657698|FG001|Overall Study|Did not meet eligibility criteria|0|||
33281777|NCT01243775|62657704|FG000|Overall Study|Withdrawal by Subject|2|||
33281778|NCT01243268|62657708|FG000|Overall Study|Lost to Follow-up|4|||
33281779|NCT01243268|62657708|FG000|Overall Study|Protocol Violation|51|||
33281780|NCT01243268|62657708|FG000|Overall Study|Deviation with contract date|7|||
33281781|NCT01243268|62657708|FG000|Overall Study|Duplicate subject|2|||
33281782|NCT01242371|62657714|FG000|Overall Study|Withdrawal by Subject|2|||
33281783|NCT01242371|62657715|FG001|Overall Study|Withdrawal by Subject|2|||
33281784|NCT01242371|62657714|FG000|Overall Study|Protocol Violation|0|||
33281785|NCT01242371|62657715|FG001|Overall Study|Protocol Violation|3|||
33281786|NCT01242176|62657721|FG000|Washout Period of 7 Days|Adverse Event|0|||
33281787|NCT01242176|62657722|FG001|Washout Period of 7 Days|Adverse Event|2|||
33281788|NCT01242176|62657721|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
33281789|NCT01242176|62657722|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
33281790|NCT01242020|62657730|FG000|Overall Study|Withdrawal by Subject|2|||
33281791|NCT01242020|62657731|FG001|Overall Study|Withdrawal by Subject|0|||
33281792|NCT01242020|62657730|FG000|Overall Study|Failed screening|1|||
33281793|NCT01242020|62657731|FG001|Overall Study|Failed screening|0|||
33281794|NCT01241786|62657737|FG000|Overall Study|Lack of Efficacy|5|||
33281795|NCT01241318|62657744|FG000|Overall Study|Woman: false pregnancies|27|||
33281796|NCT01241318|62657745|FG001|Overall Study|Woman: false pregnancies|15|||
33281797|NCT01241318|62657744|FG000|Overall Study|Woman: miscarriage/abortion|46|||
33281798|NCT01241318|62657745|FG001|Overall Study|Woman: miscarriage/abortion|38|||
33281799|NCT01241318|62657744|FG000|Overall Study|Withdrawal by Subject|175|||
33281800|NCT01241318|62657745|FG001|Overall Study|Withdrawal by Subject|46|||
33281801|NCT01241318|62657744|FG000|Overall Study|Lost to Follow-up|740|||
33281802|NCT01241318|62657745|FG001|Overall Study|Lost to Follow-up|455|||
33281803|NCT01241318|62657744|FG000|Overall Study|Death|2|||
33281804|NCT01241318|62657745|FG001|Overall Study|Death|4|||
33281805|NCT01241318|62657744|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
33281806|NCT01241318|62657745|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
33281807|NCT01241318|62657744|FG000|Overall Study|Woman: Stillborn infant|129|||
33281808|NCT01241318|62657745|FG001|Overall Study|Woman: Stillborn infant|146|||
33281809|NCT01241279|62657756|FG000|Overall Study|Lost to Follow-up|0|||
33281810|NCT01241279|62657757|FG001|Overall Study|Lost to Follow-up|1|||
33281811|NCT01241240|62657765|FG000|Overall Study|Adverse Event|5|||
33281812|NCT01241240|62657766|FG001|Overall Study|Adverse Event|4|||
33281813|NCT01241240|62657765|FG000|Overall Study|Lost to Follow-up|2|||
33281814|NCT01241240|62657766|FG001|Overall Study|Lost to Follow-up|4|||
33281815|NCT01241240|62657765|FG000|Overall Study|Personal Reasons|1|||
33281816|NCT01241240|62657766|FG001|Overall Study|Personal Reasons|1|||
33281817|NCT01240811|62657775|FG000|Overall Study|Physician Decision|0|||
33281818|NCT01240811|62657776|FG001|Overall Study|Physician Decision|1|||
33281819|NCT01240811|62657777|FG002|Overall Study|Physician Decision|0|||
33370989|NCT00884741|62749653|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
33370990|NCT00884741|62749650|FG000|Randomization|Protocol Violation|0|||
33555969|NCT02374918|62948806|FG000|Overall Study|Withdrawal by Subject|1|||
33370991|NCT00884741|62749651|FG001|Randomization|Protocol Violation|0|||
33370992|NCT00884741|62749652|FG002|Randomization|Protocol Violation|8|||
33281820|NCT01240811|62657775|FG000|Overall Study|Withdrawal by Subject|0|||
33281821|NCT01240811|62657776|FG001|Overall Study|Withdrawal by Subject|0|||
33281822|NCT01240811|62657777|FG002|Overall Study|Withdrawal by Subject|1|||
33281823|NCT01240382|62657789|FG000|Overall Study|Adverse Event|2|||
33281824|NCT01240382|62657790|FG001|Overall Study|Adverse Event|1|||
33281825|NCT01240382|62657789|FG000|Overall Study|Lack of Efficacy|0|||
33281826|NCT01240382|62657790|FG001|Overall Study|Lack of Efficacy|2|||
33281827|NCT01240382|62657789|FG000|Overall Study|Fear of adverse events|0|||
33281828|NCT01240382|62657790|FG001|Overall Study|Fear of adverse events|1|||
33281829|NCT01244828|62657796|FG000|Overall Study|Adverse Event|37|||
33281830|NCT01244828|62657796|FG000|Overall Study|Withdrawal by Subject|31|||
33281831|NCT01244828|62657796|FG000|Overall Study|Lack of Efficacy|7|||
33281832|NCT01244828|62657796|FG000|Overall Study|Lost to Follow-up|2|||
33281833|NCT01244828|62657796|FG000|Overall Study|Other reason (not specified)|1|||
33281834|NCT01249833|62657802|FG000|Overall Study|Lost to Follow-up|0|||
33281835|NCT01249833|62657803|FG001|Overall Study|Lost to Follow-up|1|||
33281836|NCT01249404|62657812|FG000|Overall Study|Study treatment not received|0|||
33281837|NCT01249404|62657813|FG001|Overall Study|Study treatment not received|1|||
33281838|NCT01249404|62657814|FG002|Overall Study|Study treatment not received|2|||
33281839|NCT01249404|62657812|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
33281840|NCT01249404|62657813|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
33281841|NCT01249404|62657814|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
33281842|NCT01249404|62657812|FG000|Overall Study|Adverse Event|2|||
33281843|NCT01249404|62657813|FG001|Overall Study|Adverse Event|2|||
33281844|NCT01249404|62657814|FG002|Overall Study|Adverse Event|2|||
33281845|NCT01249404|62657812|FG000|Overall Study|Withdrawal by Subject|2|||
33281846|NCT01249404|62657813|FG001|Overall Study|Withdrawal by Subject|2|||
33281847|NCT01249404|62657814|FG002|Overall Study|Withdrawal by Subject|0|||
33281848|NCT01249404|62657812|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
33281849|NCT01249404|62657813|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
33281850|NCT01249404|62657814|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
33281851|NCT01249404|62657812|FG000|Overall Study|Non compliance to visit schedule|0|||
33281852|NCT01249404|62657813|FG001|Overall Study|Non compliance to visit schedule|1|||
33281853|NCT01249404|62657814|FG002|Overall Study|Non compliance to visit schedule|0|||
33281854|NCT01249365|62657822|FG000|Overall Study|Lost to Follow-up|1|||
33281855|NCT01249131|62657826|FG000|Washout Period of 10 Days|Adverse Event|0|||
33281856|NCT01249131|62657827|FG001|Washout Period of 10 Days|Adverse Event|0|||
33281857|NCT01249131|62657828|FG002|Washout Period of 10 Days|Adverse Event|0|||
33281858|NCT01249131|62657829|FG003|Washout Period of 10 Days|Adverse Event|0|||
33281859|NCT01249131|62657830|FG004|Washout Period of 10 Days|Adverse Event|1|||
33281860|NCT01249131|62657831|FG005|Washout Period of 10 Days|Adverse Event|0|||
33281861|NCT01249092|62657839|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
33281862|NCT01249092|62657839|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
33281863|NCT01248936|62657845|FG000|Overall Study|Sponsor Decision|259|||
33281864|NCT01248936|62657845|FG000|Overall Study|Progression of Disease|50|||
33281865|NCT01248936|62657845|FG000|Overall Study|Death|26|||
33281866|NCT01248936|62657845|FG000|Overall Study|Withdrawal of Consent|20|||
33281867|NCT01248936|62657845|FG000|Overall Study|Adverse Event|8|||
33370993|NCT00884741|62749653|FG003|Randomization|Protocol Violation|8|||
33370994|NCT00598481|62749660|FG000|Treatment|Physician Decision|1|||
33370995|NCT00880763|62749671|FG000|Extension Period (Part 2)|Adverse Event|0|||
33370996|NCT00880763|62749672|FG001|Extension Period (Part 2)|Adverse Event|0|||
33370997|NCT00880763|62749673|FG002|Extension Period (Part 2)|Adverse Event|1|||
33370998|NCT00880763|62749674|FG003|Extension Period (Part 2)|Adverse Event|1|||
33370999|NCT00880763|62749671|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
33371000|NCT00880763|62749672|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
33371001|NCT00880763|62749673|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
33371002|NCT00880763|62749674|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
33371003|NCT00880763|62749671|FG000|Extension Period (Part 2)|Physician Decision|0|||
33371004|NCT00880763|62749672|FG001|Extension Period (Part 2)|Physician Decision|1|||
33371005|NCT00880763|62749673|FG002|Extension Period (Part 2)|Physician Decision|1|||
33371006|NCT00880763|62749674|FG003|Extension Period (Part 2)|Physician Decision|0|||
33371007|NCT00880763|62749671|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
33371008|NCT00880763|62749672|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
33371009|NCT00880763|62749673|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
33371010|NCT00880763|62749674|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
33371011|NCT00884273|62749686|FG000|Overall Study|Adverse Event|0|||
33371012|NCT00884273|62749687|FG001|Overall Study|Adverse Event|2|||
33371013|NCT00884273|62749686|FG000|Overall Study|Protocol Violation|1|||
33371014|NCT00884273|62749687|FG001|Overall Study|Protocol Violation|3|||
33281868|NCT01248936|62657845|FG000|Overall Study|Lost to Follow-up|7|||
33281869|NCT01248936|62657845|FG000|Overall Study|Refused Treatment|1|||
33281870|NCT01248936|62657845|FG000|Overall Study|Other reason|3|||
33281871|NCT01248780|62657852|FG000|Overall Study|Lack of Efficacy|2|||
33281872|NCT01248780|62657853|FG001|Overall Study|Lack of Efficacy|0|||
33281873|NCT01248780|62657852|FG000|Overall Study|Lost to Follow-up|0|||
33371015|NCT00884273|62749686|FG000|Overall Study|Practical reasons|1|||
33371016|NCT00884273|62749687|FG001|Overall Study|Practical reasons|0|||
33371017|NCT00884117|62749693|FG000|Overall Study|Adverse Event|2|||
33371018|NCT00884117|62749693|FG000|Overall Study|Withdrawal by Subject|89|||
33371019|NCT00884117|62749693|FG000|Overall Study|Death|3|||
33371020|NCT00884117|62749693|FG000|Overall Study|Lost to Follow-up|143|||
33281874|NCT01248780|62657853|FG001|Overall Study|Lost to Follow-up|1|||
33281875|NCT01248780|62657852|FG000|Overall Study|Death|0|||
33281876|NCT01248780|62657853|FG001|Overall Study|Death|1|||
33281877|NCT01248780|62657852|FG000|Overall Study|Adverse Event|2|||
33281878|NCT01248780|62657853|FG001|Overall Study|Adverse Event|7|||
33281879|NCT01248780|62657852|FG000|Overall Study|Protocol Violation|1|||
33281880|NCT01248780|62657853|FG001|Overall Study|Protocol Violation|1|||
33281881|NCT01248780|62657852|FG000|Overall Study|Withdrawal by Subject|4|||
33371021|NCT00884117|62749693|FG000|Overall Study|Other|12|||
33371022|NCT00884039|62749712|FG000|Overall Study|Withdrawal by Subject|0|||
33371023|NCT00884039|62749713|FG001|Overall Study|Withdrawal by Subject|1|||
33371024|NCT00884039|62749712|FG000|Overall Study|Lack of Efficacy|2|||
33371025|NCT00884039|62749713|FG001|Overall Study|Lack of Efficacy|0|||
33371026|NCT00835770|62749721|FG000|Overall Study|MS Relapse|17|||
33371027|NCT00835770|62749722|FG001|Overall Study|MS Relapse|23|||
33371028|NCT00835770|62749721|FG000|Overall Study|MS Progression|14|||
33371029|NCT00835770|62749722|FG001|Overall Study|MS Progression|9|||
33371030|NCT00835770|62749721|FG000|Overall Study|Adverse Event|113|||
33371031|NCT00835770|62749722|FG001|Overall Study|Adverse Event|124|||
33371032|NCT00835770|62749721|FG000|Overall Study|Lost to Follow-up|22|||
33371033|NCT00835770|62749722|FG001|Overall Study|Lost to Follow-up|19|||
33371034|NCT00835770|62749721|FG000|Overall Study|Consent Withdrawn|144|||
33371035|NCT00835770|62749722|FG001|Overall Study|Consent Withdrawn|156|||
33371036|NCT00835770|62749721|FG000|Overall Study|Investigator Decision|42|||
33371037|NCT00835770|62749722|FG001|Overall Study|Investigator Decision|42|||
33371038|NCT00835770|62749721|FG000|Overall Study|Participant Non-Compliance|11|||
33371039|NCT00835770|62749722|FG001|Overall Study|Participant Non-Compliance|9|||
33371040|NCT00835770|62749721|FG000|Overall Study|Death|4|||
33371041|NCT00835770|62749722|FG001|Overall Study|Death|6|||
33371042|NCT00835770|62749721|FG000|Overall Study|Other|115|||
33371043|NCT00835770|62749722|FG001|Overall Study|Other|104|||
33371044|NCT00835770|62749721|FG000|Overall Study|Other|2|||
33371045|NCT00835770|62749722|FG001|Overall Study|Other|1|||
33371046|NCT00880685|62749734|FG000|Memantine 10mg|Lost to Follow-up|2|||
33371047|NCT00880685|62749734|FG000|Memantine 20mg|Withdrawal by Subject|1|||
33371048|NCT00835380|62749741|FG000|Overall Study|Withdrawal by Subject|2|||
33371049|NCT00880607|62749747|FG000|Overall Study|Physician Decision|2|||
33371050|NCT00880607|62749748|FG001|Overall Study|Physician Decision|2|||
33371051|NCT00880607|62749747|FG000|Overall Study|Protocol Violation|2|||
33371052|NCT00880607|62749748|FG001|Overall Study|Protocol Violation|1|||
33371053|NCT00880607|62749747|FG000|Overall Study|surgery did not extend past L1 level|3|||
33371054|NCT00880607|62749748|FG001|Overall Study|surgery did not extend past L1 level|0|||
33371055|NCT00835068|62749758|FG000|Overall Study|Death|1|||
33371056|NCT00835068|62749759|FG001|Overall Study|Death|0|||
33371057|NCT00835068|62749758|FG000|Overall Study|Adverse Event|0|||
33371058|NCT00835068|62749759|FG001|Overall Study|Adverse Event|1|||
33371059|NCT00835068|62749758|FG000|Overall Study|Other|8|||
33371060|NCT00835068|62749759|FG001|Overall Study|Other|0|||
33371061|NCT00835068|62749758|FG000|Overall Study|Withdrawal by Subject|1|||
33371062|NCT00835068|62749759|FG001|Overall Study|Withdrawal by Subject|0|||
33371063|NCT00834912|62749771|FG000|Treatment Period 1|Adverse Event|0|||
33371064|NCT00834912|62749772|FG001|Treatment Period 1|Adverse Event|1|||
33371065|NCT00834912|62749773|FG002|Treatment Period 1|Adverse Event|0|||
33371066|NCT00834912|62749774|FG003|Treatment Period 1|Adverse Event|1|||
33371067|NCT00834912|62749775|FG004|Treatment Period 1|Adverse Event|0|||
33371068|NCT00834912|62749776|FG005|Treatment Period 1|Adverse Event|0|||
33371069|NCT00834912|62749771|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33371070|NCT00834912|62749772|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33371071|NCT00834912|62749773|FG002|Treatment Period 2|Withdrawal by Subject|1|||
33371072|NCT00834912|62749774|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33371073|NCT00834912|62749775|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33371074|NCT00834912|62749776|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33371075|NCT00883493|62749786|FG000|Overall Study|Adverse Event|11|||
33371076|NCT00883493|62749787|FG001|Overall Study|Adverse Event|12|||
33371077|NCT00883493|62749786|FG000|Overall Study|Lack of Efficacy|4|||
33371078|NCT00883493|62749787|FG001|Overall Study|Lack of Efficacy|3|||
33371079|NCT00883493|62749786|FG000|Overall Study|Lost to Follow-up|7|||
33371080|NCT00883493|62749787|FG001|Overall Study|Lost to Follow-up|6|||
33371081|NCT00883493|62749786|FG000|Overall Study|Withdrawal by Subject|11|||
33371082|NCT00883493|62749787|FG001|Overall Study|Withdrawal by Subject|20|||
33371083|NCT00883493|62749786|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
33371084|NCT00883493|62749787|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
33281882|NCT01248780|62657853|FG001|Overall Study|Withdrawal by Subject|4|||
33281883|NCT01248780|62657852|FG000|Overall Study|Not treated|0|||
33281884|NCT01248780|62657853|FG001|Overall Study|Not treated|1|||
33371085|NCT00883493|62749786|FG000|Overall Study|Study specific disc. criteria|2|||
33371086|NCT00883493|62749787|FG001|Overall Study|Study specific disc. criteria|0|||
33371087|NCT00883493|62749786|FG000|Overall Study|Other|5|||
33371088|NCT00883493|62749787|FG001|Overall Study|Other|3|||
33281885|NCT01248468|62657862|FG000|Overall Study|Administrative problem|1|||
33281886|NCT01248468|62657863|FG001|Overall Study|Administrative problem|0|||
33281887|NCT01248468|62657864|FG002|Overall Study|Administrative problem|0|||
33281888|NCT01248468|62657862|FG000|Overall Study|Lost to Follow-up|9|||
33281889|NCT01248468|62657863|FG001|Overall Study|Lost to Follow-up|12|||
33281890|NCT01248468|62657864|FG002|Overall Study|Lost to Follow-up|4|||
33281891|NCT01248468|62657862|FG000|Overall Study|Pregnancy|1|||
33281892|NCT01248468|62657863|FG001|Overall Study|Pregnancy|0|||
33281893|NCT01248468|62657864|FG002|Overall Study|Pregnancy|0|||
33281894|NCT01248468|62657862|FG000|Overall Study|Withdrawal by Subject|4|||
33281895|NCT01248468|62657863|FG001|Overall Study|Withdrawal by Subject|2|||
33281896|NCT01248468|62657864|FG002|Overall Study|Withdrawal by Subject|0|||
33281897|NCT01247922|62657872|FG000|Overall Study|Disease progression|4|||
33281898|NCT01246206|62657876|FG000|Overall Study|Patient did not receive study regiments.|1|||
33281899|NCT01246011|62657883|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
33281900|NCT01246011|62657884|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
33281901|NCT01246011|62657885|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
33281902|NCT01246011|62657883|FG000|Overall Study|Withdrawal by Subject|0|||
33281903|NCT01246011|62657884|FG001|Overall Study|Withdrawal by Subject|0|||
33281904|NCT01246011|62657885|FG002|Overall Study|Withdrawal by Subject|1|||
33281905|NCT01244490|62657897|FG000|Overall Study|Lack of Efficacy|14|||
33281906|NCT01244490|62657898|FG001|Overall Study|Lack of Efficacy|5|||
33281907|NCT01244490|62657899|FG002|Overall Study|Lack of Efficacy|5|||
33281908|NCT01244490|62657897|FG000|Overall Study|Withdrawal by Subject|4|||
33281909|NCT01244490|62657898|FG001|Overall Study|Withdrawal by Subject|4|||
33281910|NCT01244490|62657899|FG002|Overall Study|Withdrawal by Subject|9|||
33281911|NCT01244490|62657897|FG000|Overall Study|Adverse Event|1|||
33281912|NCT01244490|62657898|FG001|Overall Study|Adverse Event|9|||
33281913|NCT01244490|62657899|FG002|Overall Study|Adverse Event|5|||
33281914|NCT01244490|62657897|FG000|Overall Study|Lost to Follow-up|0|||
33281915|NCT01244490|62657898|FG001|Overall Study|Lost to Follow-up|6|||
33281916|NCT01244490|62657899|FG002|Overall Study|Lost to Follow-up|3|||
33281917|NCT01244490|62657897|FG000|Overall Study|Other|0|||
33281918|NCT01244490|62657898|FG001|Overall Study|Other|0|||
33281919|NCT01244490|62657899|FG002|Overall Study|Other|1|||
33281920|NCT01243944|62657909|FG000|Overall Study|Adverse Event|15|||
33281921|NCT01243944|62657910|FG001|Overall Study|Adverse Event|13|||
33281922|NCT01243944|62657909|FG000|Overall Study|Lost to Follow-up|2|||
33281923|NCT01243944|62657910|FG001|Overall Study|Lost to Follow-up|1|||
33281924|NCT01243944|62657909|FG000|Overall Study|Physician Decision|2|||
33281925|NCT01243944|62657910|FG001|Overall Study|Physician Decision|7|||
33281926|NCT01243944|62657909|FG000|Overall Study|Disease progression|12|||
33281927|NCT01243944|62657910|FG001|Overall Study|Disease progression|11|||
33281928|NCT01243944|62657909|FG000|Overall Study|Protocol deviation|1|||
33281929|NCT01243944|62657910|FG001|Overall Study|Protocol deviation|1|||
33281930|NCT01243944|62657909|FG000|Overall Study|Participant decision|10|||
33281931|NCT01243944|62657910|FG001|Overall Study|Participant decision|15|||
33281932|NCT01243944|62657909|FG000|Overall Study|Death|2|||
33281933|NCT01243944|62657910|FG001|Overall Study|Death|3|||
33281934|NCT01243944|62657909|FG000|Overall Study|Non-compliance with study treatment|1|||
33281935|NCT01243944|62657910|FG001|Overall Study|Non-compliance with study treatment|0|||
33281936|NCT01243242|62657919|FG000|Overall Study|Adverse Event|1|||
33281937|NCT01243242|62657920|FG001|Overall Study|Adverse Event|1|||
33281938|NCT01243242|62657919|FG000|Overall Study|Withdrawal by Subject|1|||
33281939|NCT01243242|62657920|FG001|Overall Study|Withdrawal by Subject|1|||
33281940|NCT01243242|62657919|FG000|Overall Study|Physician Decision|0|||
33281941|NCT01243242|62657920|FG001|Overall Study|Physician Decision|1|||
33281942|NCT01243242|62657919|FG000|Overall Study|sponsor decision|0|||
33281943|NCT01243242|62657920|FG001|Overall Study|sponsor decision|1|||
33371089|NCT04887922|62749802|FG000|1st Randomization|Decided not to have surgery|0|||
33371090|NCT04887922|62749803|FG001|1st Randomization|Decided not to have surgery|1|||
33371091|NCT04887922|62749804|FG002|1st Randomization|Decided not to have surgery|0|||
33371092|NCT04887922|62749805|FG003|1st Randomization|Decided not to have surgery|0|||
33281944|NCT01243242|62657919|FG000|Overall Study|non compliance|1|||
33281945|NCT01243242|62657920|FG001|Overall Study|non compliance|0|||
33281946|NCT01242813|62657926|FG000|Overall Study|Lost to Follow-up|2|||
33281947|NCT01242111|62657930|FG000|Overall Study|Adverse Event|1|||
33281948|NCT01242111|62657930|FG000|Overall Study|Withdrawal by Subject|1|||
33281949|NCT01242111|62657930|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
33281950|NCT01241604|62657934|FG000|Screening Period|Screen Failure|3|||
33371093|NCT04887922|62749806|FG004|1st Randomization|Decided not to have surgery|0|||
33486269|NCT03259334|62864091|FG000|Overall Study|Withdrawal by Subject|4|||
33281951|NCT01241604|62657935|FG001|Screening Period|Screen Failure|0|||
33281952|NCT01241604|62657936|FG002|Screening Period|Screen Failure|0|||
33281953|NCT01241292|62657945|FG000|Overall Study|Administrative Reason by Sponsor|1|||
33281954|NCT01241292|62657946|FG001|Overall Study|Administrative Reason by Sponsor|0|||
33281955|NCT01241292|62657945|FG000|Overall Study|Disease Progression|2|||
33281956|NCT01241292|62657946|FG001|Overall Study|Disease Progression|0|||
33281957|NCT01241292|62657945|FG000|Overall Study|Study Drug Toxicity|0|||
33281958|NCT01241292|62657946|FG001|Overall Study|Study Drug Toxicity|1|||
33281959|NCT01241292|62657945|FG000|Overall Study|Participant Discontinued Treatment|0|||
33281960|NCT01241292|62657946|FG001|Overall Study|Participant Discontinued Treatment|2|||
33281961|NCT01240863|62657958|FG000|Open-label Titration Period|Adverse Event|47|||
33281962|NCT01240863|62657959|FG001|Open-label Titration Period|Adverse Event|0|||
33281963|NCT01240863|62657960|FG002|Open-label Titration Period|Adverse Event|0|||
33281964|NCT01240863|62657958|FG000|Open-label Titration Period|Lack of Efficacy|19|||
33281965|NCT01240863|62657959|FG001|Open-label Titration Period|Lack of Efficacy|0|||
33281966|NCT01240863|62657960|FG002|Open-label Titration Period|Lack of Efficacy|0|||
33281967|NCT01240863|62657958|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
33281968|NCT01240863|62657959|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
33281969|NCT01240863|62657960|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
33281970|NCT01240863|62657958|FG000|Open-label Titration Period|Protocol Violation|7|||
33281971|NCT01240863|62657959|FG001|Open-label Titration Period|Protocol Violation|0|||
33281972|NCT01240863|62657960|FG002|Open-label Titration Period|Protocol Violation|0|||
33281973|NCT01240863|62657958|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
33281974|NCT01240863|62657959|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
33281975|NCT01240863|62657960|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
33371094|NCT04771403|62749829|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
33371095|NCT04771403|62749830|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
33371096|NCT04771403|62749829|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
33371097|NCT04771403|62749830|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
33371098|NCT04771403|62749829|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
33371099|NCT04771403|62749830|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
33371100|NCT04771403|62749829|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
33371101|NCT04771403|62749830|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
33371102|NCT04771403|62749829|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
33371103|NCT04771403|62749830|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
33371104|NCT04771403|62749829|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
33371105|NCT04771403|62749830|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
33371106|NCT04771403|62749829|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
33371107|NCT04771403|62749830|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
33371108|NCT04771403|62749829|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
33371109|NCT04771403|62749830|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
33371110|NCT04698525|62749839|FG000|Overall Study|Lost to Follow-up|1|||
33371111|NCT04698525|62749840|FG001|Overall Study|Lost to Follow-up|2|||
33371112|NCT04698525|62749839|FG000|Overall Study|Three suffered of Covid-19|2|||
33371113|NCT04698525|62749840|FG001|Overall Study|Three suffered of Covid-19|1|||
33371114|NCT04510675|62749854|FG000|Overall Study|Withdrawal by Subject|5|||
33371115|NCT04228783|62749876|FG000|Overall Study|Adverse Event|1|||
33371116|NCT04228783|62749877|FG001|Overall Study|Adverse Event|0|||
33371117|NCT04228783|62749878|FG002|Overall Study|Adverse Event|2|||
33371118|NCT04228783|62749879|FG003|Overall Study|Adverse Event|0|||
33371119|NCT04228783|62749880|FG004|Overall Study|Adverse Event|0|||
33371120|NCT04228783|62749881|FG005|Overall Study|Adverse Event|1|||
33371121|NCT04228783|62749876|FG000|Overall Study|Death|0|||
33371122|NCT04228783|62749877|FG001|Overall Study|Death|0|||
33371123|NCT04228783|62749878|FG002|Overall Study|Death|0|||
33371124|NCT04228783|62749879|FG003|Overall Study|Death|0|||
33371125|NCT04228783|62749880|FG004|Overall Study|Death|1|||
33371126|NCT04228783|62749881|FG005|Overall Study|Death|0|||
33371127|NCT04228783|62749876|FG000|Overall Study|Lost to Follow-up|36|||
33371128|NCT04228783|62749877|FG001|Overall Study|Lost to Follow-up|36|||
33371129|NCT04228783|62749878|FG002|Overall Study|Lost to Follow-up|28|||
33371130|NCT04228783|62749879|FG003|Overall Study|Lost to Follow-up|6|||
33371131|NCT04228783|62749880|FG004|Overall Study|Lost to Follow-up|14|||
33371132|NCT04228783|62749881|FG005|Overall Study|Lost to Follow-up|3|||
33371133|NCT04228783|62749876|FG000|Overall Study|Physician Decision|1|||
33486270|NCT03259334|62864092|FG001|Overall Study|Withdrawal by Subject|2|||
33486271|NCT03259334|62864093|FG002|Overall Study|Withdrawal by Subject|4|||
33486272|NCT03259334|62864091|FG000|Overall Study|Physician Decision|1|||
33486273|NCT03259334|62864092|FG001|Overall Study|Physician Decision|0|||
33486274|NCT03259334|62864093|FG002|Overall Study|Physician Decision|0|||
33281976|NCT01240863|62657958|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
33281977|NCT01240863|62657959|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
33281978|NCT01240863|62657960|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
33281979|NCT01240863|62657958|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
33281980|NCT01240863|62657959|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
33281981|NCT01240863|62657960|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
33281982|NCT01240863|62657958|FG000|Open-label Titration Period|Other|7|||
33281983|NCT01240863|62657959|FG001|Open-label Titration Period|Other|0|||
33281984|NCT01240863|62657960|FG002|Open-label Titration Period|Other|0|||
33281985|NCT01240863|62657958|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
33281986|NCT01240863|62657959|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
33281987|NCT01240863|62657960|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
33281988|NCT01240863|62657958|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
33281989|NCT01240863|62657959|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
33281990|NCT01240863|62657960|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
33281991|NCT01240863|62657958|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
33281992|NCT01240863|62657959|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
33281993|NCT01240863|62657960|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
33486275|NCT03259334|62864091|FG000|Overall Study|Lost to Follow-up|0|||
33486276|NCT03259334|62864092|FG001|Overall Study|Lost to Follow-up|2|||
33486277|NCT03259334|62864093|FG002|Overall Study|Lost to Follow-up|1|||
33486278|NCT03259334|62864091|FG000|Overall Study|Protocol Deviation|0|||
33486279|NCT03259334|62864092|FG001|Overall Study|Protocol Deviation|3|||
33486280|NCT03259334|62864093|FG002|Overall Study|Protocol Deviation|2|||
33486281|NCT03259334|62864091|FG000|Overall Study|Lack of Efficacy|2|||
33486282|NCT03259334|62864092|FG001|Overall Study|Lack of Efficacy|0|||
33486283|NCT03259334|62864093|FG002|Overall Study|Lack of Efficacy|1|||
33486284|NCT03259334|62864091|FG000|Overall Study|Randomized but never treated|0|||
33486285|NCT03259334|62864092|FG001|Overall Study|Randomized but never treated|2|||
33486286|NCT03259334|62864093|FG002|Overall Study|Randomized but never treated|0|||
33486287|NCT01331824|62864101|FG000|Overall Study|Adverse Event|2|||
33486288|NCT01331824|62864101|FG000|Overall Study|Death|1|||
33486289|NCT01331824|62864101|FG000|Overall Study|Disease Progression|9|||
33486290|NCT01331824|62864101|FG000|Overall Study|Withdrawal by Subject|1|||
33486291|NCT03258710|62864105|FG000|Overall Study|Adverse Event|1|||
33486292|NCT03258710|62864105|FG000|Overall Study|Protocol-defined stopping criteria|1|||
33281994|NCT01240863|62657958|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
33281995|NCT01240863|62657959|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
33281996|NCT01240863|62657960|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
33281997|NCT01240863|62657958|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
33281998|NCT01240863|62657959|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
33281999|NCT01240863|62657960|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
33282000|NCT01240863|62657958|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
33282001|NCT01240863|62657959|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
33282002|NCT01240863|62657960|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
33282003|NCT01240863|62657958|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
33282004|NCT01240863|62657959|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
33282005|NCT01240863|62657960|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
33282006|NCT01240863|62657958|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
33282007|NCT01240863|62657959|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
33282008|NCT01240863|62657960|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
33282009|NCT01240746|62657975|FG000|Overall Study|Adverse Event|2|||
33282010|NCT01240746|62657976|FG001|Overall Study|Adverse Event|0|||
33282011|NCT01240746|62657977|FG002|Overall Study|Adverse Event|10|||
33282012|NCT01240746|62657975|FG000|Overall Study|Lost to Follow-up|23|||
33282013|NCT01240746|62657976|FG001|Overall Study|Lost to Follow-up|20|||
33282014|NCT01240746|62657977|FG002|Overall Study|Lost to Follow-up|102|||
33282015|NCT01240746|62657975|FG000|Overall Study|Protocol Violation|24|||
33282016|NCT01240746|62657976|FG001|Overall Study|Protocol Violation|15|||
33282017|NCT01240746|62657977|FG002|Overall Study|Protocol Violation|72|||
33282018|NCT01240746|62657975|FG000|Overall Study|Withdrawal by Subject|10|||
33282019|NCT01240746|62657976|FG001|Overall Study|Withdrawal by Subject|13|||
33282020|NCT01240746|62657977|FG002|Overall Study|Withdrawal by Subject|59|||
33282021|NCT01240590|62657990|FG000|Phase I|Refused further treatment|0|||
33282022|NCT01240590|62657991|FG001|Phase I|Refused further treatment|0|||
33282023|NCT01240590|62657992|FG002|Phase I|Refused further treatment|3|||
33282024|NCT01240590|62657993|FG003|Phase I|Refused further treatment|0|||
33282025|NCT01240590|62657994|FG004|Phase I|Refused further treatment|0|||
33282026|NCT01240590|62657990|FG000|Phase II|Refused further treatment|0|||
33282027|NCT01240590|62657991|FG001|Phase II|Refused further treatment|0|||
33486293|NCT03258710|62864105|FG000|Overall Study|Physician Decision|1|||
33486294|NCT03240692|62864109|FG000|Overall Study|Physician Decision|1|||
33282028|NCT01240590|62657992|FG002|Phase II|Refused further treatment|0|||
33282029|NCT01240590|62657993|FG003|Phase II|Refused further treatment|2|||
33282030|NCT01240590|62657994|FG004|Phase II|Refused further treatment|1|||
33282031|NCT01240200|62658022|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
33282032|NCT01240200|62658023|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
33282033|NCT01356966|62658034|FG000|Overall Study|Withdrawal by Subject|1|||
33282034|NCT01356966|62658035|FG001|Overall Study|Withdrawal by Subject|2|||
33371134|NCT04228783|62749877|FG001|Overall Study|Physician Decision|2|||
33371135|NCT04228783|62749878|FG002|Overall Study|Physician Decision|0|||
33555970|NCT02374918|62948807|FG001|Overall Study|Withdrawal by Subject|1|||
33555971|NCT02374918|62948808|FG002|Overall Study|Withdrawal by Subject|1|||
33555972|NCT02374918|62948809|FG003|Overall Study|Withdrawal by Subject|0|||
33555973|NCT02374918|62948806|FG000|Overall Study|Lack of Efficacy|0|||
33555974|NCT02374918|62948807|FG001|Overall Study|Lack of Efficacy|0|||
33555975|NCT02374918|62948808|FG002|Overall Study|Lack of Efficacy|1|||
33555976|NCT02374918|62948809|FG003|Overall Study|Lack of Efficacy|1|||
33555977|NCT02344576|62948821|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
33555978|NCT02344576|62948822|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
33555979|NCT02344576|62948823|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
33555980|NCT02344576|62948824|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
33555981|NCT02344576|62948821|FG000|1-Month Follow-Up|Death|13|||
33555982|NCT02344576|62948822|FG001|1-Month Follow-Up|Death|8|||
33555983|NCT02344576|62948823|FG002|1-Month Follow-Up|Death|0|||
33555984|NCT02344576|62948824|FG003|1-Month Follow-Up|Death|0|||
33555985|NCT02344576|62948821|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
33371136|NCT04228783|62749879|FG003|Overall Study|Physician Decision|0|||
33371137|NCT04228783|62749880|FG004|Overall Study|Physician Decision|0|||
33371138|NCT04228783|62749881|FG005|Overall Study|Physician Decision|0|||
33371139|NCT04228783|62749876|FG000|Overall Study|Protocol Violation|0|||
33371140|NCT04228783|62749877|FG001|Overall Study|Protocol Violation|0|||
33371141|NCT04228783|62749878|FG002|Overall Study|Protocol Violation|0|||
33371142|NCT04228783|62749879|FG003|Overall Study|Protocol Violation|1|||
33371143|NCT04228783|62749880|FG004|Overall Study|Protocol Violation|0|||
33371144|NCT04228783|62749881|FG005|Overall Study|Protocol Violation|0|||
33371145|NCT04228783|62749876|FG000|Overall Study|Withdrawal by Subject|6|||
33371146|NCT04228783|62749877|FG001|Overall Study|Withdrawal by Subject|10|||
33371147|NCT04228783|62749878|FG002|Overall Study|Withdrawal by Subject|19|||
33371148|NCT04228783|62749879|FG003|Overall Study|Withdrawal by Subject|1|||
33371149|NCT04228783|62749880|FG004|Overall Study|Withdrawal by Subject|2|||
33371150|NCT04228783|62749881|FG005|Overall Study|Withdrawal by Subject|0|||
33371151|NCT04228783|62749876|FG000|Overall Study|Other|4|||
33371152|NCT04228783|62749877|FG001|Overall Study|Other|3|||
33371153|NCT04228783|62749878|FG002|Overall Study|Other|2|||
33371154|NCT04228783|62749879|FG003|Overall Study|Other|1|||
33371155|NCT04228783|62749880|FG004|Overall Study|Other|0|||
33371156|NCT04228783|62749881|FG005|Overall Study|Other|0|||
33371157|NCT03950674|62749897|FG000|Overall Study|Death|3|||
33371158|NCT03950674|62749898|FG001|Overall Study|Death|7|||
33371159|NCT03950674|62749897|FG000|Overall Study|Ongoing in Study|22|||
33371160|NCT03950674|62749898|FG001|Overall Study|Ongoing in Study|8|||
33371161|NCT03702621|62749907|FG000|Overall Study|Physician Decision|6|||
33371162|NCT03702621|62749908|FG001|Overall Study|Physician Decision|6|||
33371163|NCT03577990|62749916|FG000|Overall Study|Lost to Follow-up|4|||
33371164|NCT03577990|62749917|FG001|Overall Study|Lost to Follow-up|6|||
33371165|NCT03577990|62749916|FG000|Overall Study|Withdrawal by Subject|4|||
33371166|NCT03577990|62749917|FG001|Overall Study|Withdrawal by Subject|7|||
33371167|NCT03565497|62749927|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
33371168|NCT03565497|62749928|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
33371169|NCT03565497|62749929|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
33371170|NCT03565497|62749927|FG000|Overall Study|Lost to Follow-up|1|||
33371171|NCT03565497|62749928|FG001|Overall Study|Lost to Follow-up|1|||
33371172|NCT03565497|62749929|FG002|Overall Study|Lost to Follow-up|2|||
33371173|NCT03565497|62749927|FG000|Overall Study|Withdrawal by Subject|1|||
33371174|NCT03565497|62749928|FG001|Overall Study|Withdrawal by Subject|1|||
33555986|NCT02344576|62948822|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
33555987|NCT02344576|62948823|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
33555988|NCT02344576|62948824|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
33555989|NCT02344576|62948821|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
33555990|NCT02344576|62948822|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
33371175|NCT03565497|62749929|FG002|Overall Study|Withdrawal by Subject|1|||
33371176|NCT03362931|62749937|FG000|Overall Study|Adverse Event|1|||
33371177|NCT03362931|62749937|FG000|Overall Study|Death|2|||
33371178|NCT03360019|62749944|FG000|Overall Study|Withdrawal by Subject|2|||
33371179|NCT03360019|62749945|FG001|Overall Study|Withdrawal by Subject|0|||
33371180|NCT03360019|62749946|FG002|Overall Study|Withdrawal by Subject|0|||
33555991|NCT02344576|62948823|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
33555992|NCT02344576|62948824|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
33555993|NCT02344576|62948821|FG000|6-Month Follow-Up|Death|14|||
33555994|NCT02344576|62948822|FG001|6-Month Follow-Up|Death|14|||
33555995|NCT02344576|62948823|FG002|6-Month Follow-Up|Death|0|||
33555996|NCT02344576|62948824|FG003|6-Month Follow-Up|Death|0|||
33555997|NCT02344576|62948821|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
33555998|NCT02344576|62948822|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
33555999|NCT02344576|62948823|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
33556000|NCT02344576|62948824|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
33556001|NCT02344576|62948821|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
33556002|NCT02344576|62948822|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
33556003|NCT02344576|62948823|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
33556004|NCT02344576|62948824|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
33556005|NCT02344342|62948840|FG000|Overall Study|Industry partner dropped out|11|||
33556006|NCT02344342|62948841|FG001|Overall Study|Industry partner dropped out|9|||
33556007|NCT02344342|62948842|FG002|Overall Study|Industry partner dropped out|14|||
33556008|NCT02344342|62948843|FG003|Overall Study|Industry partner dropped out|10|||
33282035|NCT01356966|62658034|FG000|Overall Study|Physician Decision|1|||
33282036|NCT01356966|62658035|FG001|Overall Study|Physician Decision|0|||
33282037|NCT05289271|62658073|FG000|Overall Study|Mistakenly allocated, untreated|1|||
33282038|NCT05289271|62658074|FG001|Overall Study|Mistakenly allocated, untreated|0|||
33282039|NCT05101486|62658116|FG000|Overall Study|Death|1|||
33282040|NCT05101486|62658117|FG001|Overall Study|Death|0|||
33282041|NCT05101486|62658118|FG002|Overall Study|Death|1|||
33282042|NCT05101486|62658116|FG000|Overall Study|Lost to Follow-up|12|||
33282043|NCT05101486|62658117|FG001|Overall Study|Lost to Follow-up|8|||
33282044|NCT05101486|62658118|FG002|Overall Study|Lost to Follow-up|17|||
33282045|NCT05101486|62658116|FG000|Overall Study|Physician Decision|1|||
33282046|NCT05101486|62658117|FG001|Overall Study|Physician Decision|0|||
33282047|NCT05101486|62658118|FG002|Overall Study|Physician Decision|0|||
33282048|NCT05101486|62658116|FG000|Overall Study|Protocol Violation|0|||
33282049|NCT05101486|62658117|FG001|Overall Study|Protocol Violation|0|||
33282050|NCT05101486|62658118|FG002|Overall Study|Protocol Violation|1|||
33282051|NCT05101486|62658116|FG000|Overall Study|Withdrawal by Subject|5|||
33282052|NCT05101486|62658117|FG001|Overall Study|Withdrawal by Subject|2|||
33282053|NCT05101486|62658118|FG002|Overall Study|Withdrawal by Subject|4|||
33282054|NCT05101486|62658116|FG000|Overall Study|Randomized but not vaccinated|1|||
33282055|NCT05101486|62658117|FG001|Overall Study|Randomized but not vaccinated|1|||
33282056|NCT05101486|62658118|FG002|Overall Study|Randomized but not vaccinated|1|||
33282057|NCT05080660|62658128|FG000|Overall Study|Adverse Event|4|||
33282058|NCT05080660|62658129|FG001|Overall Study|Adverse Event|0|||
33282059|NCT05080660|62658128|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
33282060|NCT05080660|62658129|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
33282061|NCT05080660|62658128|FG000|Overall Study|Physician Decision|1|||
33282062|NCT05080660|62658129|FG001|Overall Study|Physician Decision|0|||
33282063|NCT05080660|62658128|FG000|Overall Study|Protocol Deviation|2|||
33282064|NCT05080660|62658129|FG001|Overall Study|Protocol Deviation|0|||
33282065|NCT05080660|62658128|FG000|Overall Study|Withdrawal by Subject|5|||
33282066|NCT05080660|62658129|FG001|Overall Study|Withdrawal by Subject|2|||
33282067|NCT05005312|62658137|FG000|Overall Study|Enrolled, but not treated|0|||
33282068|NCT05005312|62658138|FG001|Overall Study|Enrolled, but not treated|1|||
33282069|NCT04867902|62658153|FG000|Overall Study|Lost to Follow-up|1|||
33282070|NCT04867902|62658153|FG000|Overall Study|Withdrawal by Subject|2|||
33282071|NCT04867902|62658153|FG000|Overall Study|Protocol Violation|1|||
33282072|NCT04677179|62658160|FG000|Induction Treatment Period|Adverse Event|1|||
33282073|NCT04677179|62658161|FG001|Induction Treatment Period|Adverse Event|0|||
33282074|NCT04677179|62658162|FG002|Induction Treatment Period|Adverse Event|0|||
33282075|NCT04677179|62658163|FG003|Induction Treatment Period|Adverse Event|0|||
33282076|NCT04677179|62658164|FG004|Induction Treatment Period|Adverse Event|0|||
33371181|NCT03360019|62749944|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
33371182|NCT03360019|62749945|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
33371183|NCT03360019|62749946|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
33371184|NCT03260894|62749960|FG000|Overall Study|Death|6|||
33371185|NCT03260894|62749961|FG001|Overall Study|Death|8|||
33282077|NCT04677179|62658165|FG005|Induction Treatment Period|Adverse Event|0|||
33282078|NCT04677179|62658166|FG006|Induction Treatment Period|Adverse Event|0|||
33282079|NCT04677179|62658167|FG007|Induction Treatment Period|Adverse Event|0|||
33282080|NCT04677179|62658168|FG008|Induction Treatment Period|Adverse Event|0|||
33282081|NCT04677179|62658169|FG009|Induction Treatment Period|Adverse Event|0|||
33371186|NCT03260894|62749960|FG000|Overall Study|Withdrawal by Subject|4|||
33371187|NCT03260894|62749961|FG001|Overall Study|Withdrawal by Subject|11|||
33282082|NCT04677179|62658160|FG000|Induction Treatment Period|Physician Decision|1|||
33282083|NCT04677179|62658161|FG001|Induction Treatment Period|Physician Decision|0|||
33371188|NCT03260894|62749960|FG000|Overall Study|On-going at clinical cut off date|36|||
33556009|NCT02310568|62948862|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
33556010|NCT02310568|62948863|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
33556011|NCT02310568|62948864|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
33282084|NCT04677179|62658162|FG002|Induction Treatment Period|Physician Decision|1|||
33282085|NCT04677179|62658163|FG003|Induction Treatment Period|Physician Decision|0|||
33282086|NCT04677179|62658164|FG004|Induction Treatment Period|Physician Decision|0|||
33282087|NCT04677179|62658165|FG005|Induction Treatment Period|Physician Decision|0|||
33282088|NCT04677179|62658166|FG006|Induction Treatment Period|Physician Decision|0|||
33282089|NCT04677179|62658167|FG007|Induction Treatment Period|Physician Decision|0|||
33282090|NCT04677179|62658168|FG008|Induction Treatment Period|Physician Decision|0|||
33282091|NCT04677179|62658169|FG009|Induction Treatment Period|Physician Decision|0|||
33282092|NCT04677179|62658160|FG000|Induction Treatment Period|Protocol Violation|0|||
33282093|NCT04677179|62658161|FG001|Induction Treatment Period|Protocol Violation|1|||
33282094|NCT04677179|62658162|FG002|Induction Treatment Period|Protocol Violation|0|||
33282095|NCT04677179|62658163|FG003|Induction Treatment Period|Protocol Violation|0|||
33282096|NCT04677179|62658164|FG004|Induction Treatment Period|Protocol Violation|0|||
33282097|NCT04677179|62658165|FG005|Induction Treatment Period|Protocol Violation|0|||
33282098|NCT04677179|62658166|FG006|Induction Treatment Period|Protocol Violation|0|||
33282099|NCT04677179|62658167|FG007|Induction Treatment Period|Protocol Violation|0|||
33282100|NCT04677179|62658168|FG008|Induction Treatment Period|Protocol Violation|0|||
33282101|NCT04677179|62658169|FG009|Induction Treatment Period|Protocol Violation|0|||
33282102|NCT04677179|62658160|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
33282103|NCT04677179|62658161|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
33282104|NCT04677179|62658162|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
33282105|NCT04677179|62658163|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
33282106|NCT04677179|62658164|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
33282107|NCT04677179|62658165|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
33282108|NCT04677179|62658166|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
33282109|NCT04677179|62658167|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
33282110|NCT04677179|62658168|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
33371189|NCT03260894|62749961|FG001|Overall Study|On-going at clinical cut off date|31|||
33371190|NCT03245008|62749972|FG000|Overall Study|Adverse Event|15|||
33371191|NCT03245008|62749973|FG001|Overall Study|Adverse Event|18|||
33371192|NCT03245008|62749974|FG002|Overall Study|Adverse Event|15|||
33371193|NCT03245008|62749975|FG003|Overall Study|Adverse Event|0|||
33371194|NCT03245008|62749976|FG004|Overall Study|Adverse Event|1|||
33371195|NCT03245008|62749972|FG000|Overall Study|Lack of Efficacy|0|||
33371196|NCT03245008|62749973|FG001|Overall Study|Lack of Efficacy|1|||
33371197|NCT03245008|62749974|FG002|Overall Study|Lack of Efficacy|0|||
33371198|NCT03245008|62749975|FG003|Overall Study|Lack of Efficacy|0|||
33371199|NCT03245008|62749976|FG004|Overall Study|Lack of Efficacy|0|||
33371200|NCT03245008|62749972|FG000|Overall Study|Lost to Follow-up|4|||
33371201|NCT03245008|62749973|FG001|Overall Study|Lost to Follow-up|1|||
33371202|NCT03245008|62749974|FG002|Overall Study|Lost to Follow-up|0|||
33371203|NCT03245008|62749975|FG003|Overall Study|Lost to Follow-up|0|||
33371204|NCT03245008|62749976|FG004|Overall Study|Lost to Follow-up|1|||
33371205|NCT03245008|62749972|FG000|Overall Study|Physician Decision|1|||
33371206|NCT03245008|62749973|FG001|Overall Study|Physician Decision|3|||
33371207|NCT03245008|62749974|FG002|Overall Study|Physician Decision|4|||
33371208|NCT03245008|62749975|FG003|Overall Study|Physician Decision|0|||
33371209|NCT03245008|62749976|FG004|Overall Study|Physician Decision|0|||
33371210|NCT03245008|62749972|FG000|Overall Study|Protocol Violation|0|||
33371211|NCT03245008|62749973|FG001|Overall Study|Protocol Violation|1|||
33371212|NCT03245008|62749974|FG002|Overall Study|Protocol Violation|0|||
33371213|NCT03245008|62749975|FG003|Overall Study|Protocol Violation|0|||
33371214|NCT03245008|62749976|FG004|Overall Study|Protocol Violation|0|||
33371215|NCT03245008|62749972|FG000|Overall Study|Withdrawal by Subject|20|||
33486295|NCT03240692|62864109|FG000|Overall Study|Withdrawal by Subject|1|||
33486296|NCT03233048|62864113|FG000|Overall Study|Withdrawal by Subject|1|||
33486297|NCT02937740|62864119|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
33486298|NCT02937740|62864120|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
33486299|NCT02937740|62864119|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
33486300|NCT02937740|62864120|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
33486301|NCT02937740|62864119|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
33486302|NCT02937740|62864120|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
33486303|NCT02937740|62864119|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
33486304|NCT02937740|62864120|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
33486305|NCT02937740|62864119|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
33556012|NCT02310568|62948865|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
33282111|NCT04677179|62658169|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
33282112|NCT04677179|62658160|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
33282113|NCT04677179|62658161|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
33282114|NCT04677179|62658162|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
33282115|NCT04677179|62658163|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
33371216|NCT03245008|62749973|FG001|Overall Study|Withdrawal by Subject|19|||
33371217|NCT03245008|62749974|FG002|Overall Study|Withdrawal by Subject|11|||
33371218|NCT03245008|62749975|FG003|Overall Study|Withdrawal by Subject|0|||
33282116|NCT04677179|62658164|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
33282117|NCT04677179|62658165|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
33282118|NCT04677179|62658166|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
33282119|NCT04677179|62658167|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
33282120|NCT04677179|62658168|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
33282121|NCT04677179|62658169|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
33282122|NCT04677179|62658160|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
33282123|NCT04677179|62658161|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
33282124|NCT04677179|62658162|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
33282125|NCT04677179|62658163|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
33282126|NCT04677179|62658164|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
33282127|NCT04677179|62658165|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
33282128|NCT04677179|62658166|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
33282129|NCT04677179|62658167|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
33282130|NCT04677179|62658168|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
33282131|NCT04677179|62658169|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
33282132|NCT04677179|62658160|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
33282133|NCT04677179|62658161|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
33282134|NCT04677179|62658162|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
33282135|NCT04677179|62658163|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
33282136|NCT04677179|62658164|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
33282137|NCT04677179|62658165|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
33282138|NCT04677179|62658166|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
33282139|NCT04677179|62658167|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
33282140|NCT04677179|62658168|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
33282141|NCT04677179|62658169|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
33282142|NCT04677179|62658160|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
33282143|NCT04677179|62658161|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
33282144|NCT04677179|62658162|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
33282145|NCT04677179|62658163|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
33282146|NCT04677179|62658164|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
33282147|NCT04677179|62658165|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
33282148|NCT04677179|62658166|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
33282149|NCT04677179|62658167|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
33282150|NCT04677179|62658168|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
33282151|NCT04677179|62658169|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
33282152|NCT04677179|62658160|FG000|Extension Treatment Period|Lack of Efficacy|0|||
33282153|NCT04677179|62658161|FG001|Extension Treatment Period|Lack of Efficacy|0|||
33282154|NCT04677179|62658162|FG002|Extension Treatment Period|Lack of Efficacy|0|||
33282155|NCT04677179|62658163|FG003|Extension Treatment Period|Lack of Efficacy|0|||
33282156|NCT04677179|62658164|FG004|Extension Treatment Period|Lack of Efficacy|0|||
33282157|NCT04677179|62658165|FG005|Extension Treatment Period|Lack of Efficacy|0|||
33282158|NCT04677179|62658166|FG006|Extension Treatment Period|Lack of Efficacy|6|||
33282159|NCT04677179|62658167|FG007|Extension Treatment Period|Lack of Efficacy|0|||
33282160|NCT04677179|62658168|FG008|Extension Treatment Period|Lack of Efficacy|0|||
33282161|NCT04677179|62658169|FG009|Extension Treatment Period|Lack of Efficacy|0|||
33282162|NCT04677179|62658160|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
33282163|NCT04677179|62658161|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
33282164|NCT04677179|62658162|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
33282165|NCT04677179|62658163|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
33282166|NCT04677179|62658164|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
33282167|NCT04677179|62658165|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
33282168|NCT04677179|62658166|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
33282169|NCT04677179|62658167|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
33282170|NCT04677179|62658168|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
33282171|NCT04677179|62658169|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
33282172|NCT04677179|62658160|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
33282173|NCT04677179|62658161|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
33282174|NCT04677179|62658162|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
33282175|NCT04677179|62658163|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
33282176|NCT04677179|62658164|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
33282177|NCT04677179|62658165|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
33282178|NCT04677179|62658166|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
33486306|NCT02937740|62864120|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
33486307|NCT02937740|62864119|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
33486308|NCT02937740|62864120|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
33486309|NCT04173741|62864143|FG000|Overall Study|IVC measurement cannot be done|1|||
33282179|NCT04677179|62658167|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
33282180|NCT04677179|62658168|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
33282181|NCT04677179|62658169|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
33282182|NCT04677179|62658160|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
33282183|NCT04677179|62658161|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
33282184|NCT04677179|62658162|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
33282185|NCT04677179|62658163|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
33282186|NCT04677179|62658164|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
33282187|NCT04677179|62658165|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
33282188|NCT04677179|62658166|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
33282189|NCT04677179|62658167|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
33282190|NCT04677179|62658168|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
33282191|NCT04677179|62658169|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
33282192|NCT04677179|62658160|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33282193|NCT04677179|62658161|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33282194|NCT04677179|62658162|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33282195|NCT04677179|62658163|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33282196|NCT04677179|62658164|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33282197|NCT04677179|62658165|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33282198|NCT04677179|62658166|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33282199|NCT04677179|62658167|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
33282200|NCT04677179|62658168|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
33282201|NCT04677179|62658169|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33282202|NCT04677179|62658160|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33282203|NCT04677179|62658161|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33282204|NCT04677179|62658162|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33282205|NCT04677179|62658163|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33282206|NCT04677179|62658164|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33282207|NCT04677179|62658165|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33282208|NCT04677179|62658166|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33282209|NCT04677179|62658167|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
33282210|NCT04677179|62658168|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33371219|NCT03245008|62749976|FG004|Overall Study|Withdrawal by Subject|0|||
33371220|NCT03245008|62749972|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
33371221|NCT03245008|62749973|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
33371222|NCT03245008|62749974|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
33371223|NCT03245008|62749975|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
33371224|NCT03245008|62749976|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
33371225|NCT03245008|62749972|FG000|Overall Study|Failure to meet randomization criteria|0|||
33371226|NCT03245008|62749973|FG001|Overall Study|Failure to meet randomization criteria|1|||
33371227|NCT03245008|62749974|FG002|Overall Study|Failure to meet randomization criteria|0|||
33371228|NCT03245008|62749975|FG003|Overall Study|Failure to meet randomization criteria|1|||
33371229|NCT03245008|62749976|FG004|Overall Study|Failure to meet randomization criteria|0|||
33371230|NCT03203473|62749998|FG000|Induction Phase|Never started primary treatment|2|||
33371231|NCT03203473|62749999|FG001|Induction Phase|Never started primary treatment|0|||
33371232|NCT03203473|62750000|FG002|Induction Phase|Never started primary treatment|0|||
33371233|NCT03203473|62749998|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
33371234|NCT03203473|62749999|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
33371235|NCT03203473|62750000|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
33371236|NCT03203473|62749998|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
33371237|NCT03203473|62749999|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
33371238|NCT03203473|62750000|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
33371239|NCT03203473|62749998|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
33371240|NCT03203473|62749999|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
33371241|NCT03203473|62750000|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
33371242|NCT03203473|62749998|FG000|Arm Allocation Phase|started salvage therapy|0|||
33371243|NCT03203473|62749999|FG001|Arm Allocation Phase|started salvage therapy|5|||
33371244|NCT03203473|62750000|FG002|Arm Allocation Phase|started salvage therapy|0|||
33371245|NCT03203473|62749998|FG000|Arm Allocation Phase|Disease progression|0|||
33371246|NCT03203473|62749999|FG001|Arm Allocation Phase|Disease progression|0|||
33556013|NCT02310568|62948866|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
33282211|NCT04677179|62658169|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33282212|NCT04677179|62658160|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33282213|NCT04677179|62658161|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33282214|NCT04677179|62658162|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33282215|NCT04677179|62658163|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33282216|NCT04677179|62658164|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33371247|NCT03203473|62750000|FG002|Arm Allocation Phase|Disease progression|37|||
33282217|NCT04677179|62658165|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33282218|NCT04677179|62658166|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33282219|NCT04677179|62658167|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
33282220|NCT04677179|62658168|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
33282221|NCT04677179|62658169|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33282222|NCT04677179|62658160|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
33282223|NCT04677179|62658161|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
33282224|NCT04677179|62658162|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
33282225|NCT04677179|62658163|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
33282226|NCT04677179|62658164|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
33282227|NCT04677179|62658165|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
33282228|NCT04677179|62658166|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
33282229|NCT04677179|62658167|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
33282230|NCT04677179|62658168|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
33282231|NCT04677179|62658169|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
33282232|NCT04590937|62658186|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
33282233|NCT04576897|62658200|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
33282234|NCT04166435|62658232|FG000|Overall Study|2 patients ineligible for response|2|||
33282235|NCT04124965|62658238|FG000|Overall Study|Adverse event, non-fatal|3|||
33282236|NCT04124965|62658239|FG001|Overall Study|Adverse event, non-fatal|1|||
33282237|NCT04124965|62658238|FG000|Overall Study|Withdrawal by Subject|1|||
33282238|NCT04124965|62658239|FG001|Overall Study|Withdrawal by Subject|1|||
33282239|NCT04124965|62658238|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
33282240|NCT04124965|62658239|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
33282241|NCT04124965|62658238|FG000|Overall Study|Pregnancy|1|||
33282242|NCT04124965|62658239|FG001|Overall Study|Pregnancy|0|||
33282243|NCT04124965|62658238|FG000|Overall Study|Sponsor and participant decision|0|||
33282244|NCT04124965|62658239|FG001|Overall Study|Sponsor and participant decision|1|||
33282245|NCT04124965|62658238|FG000|Overall Study|Personal surgery|0|||
33282246|NCT04124965|62658239|FG001|Overall Study|Personal surgery|1|||
33282247|NCT04124965|62658238|FG000|Overall Study|Physician Decision|0|||
33282248|NCT04124965|62658239|FG001|Overall Study|Physician Decision|1|||
33282249|NCT04098068|62658245|FG000|Overall Study|Disease Progression|7|||
33282250|NCT04098068|62658245|FG000|Overall Study|Withdrawal by Subject|2|||
33282251|NCT04098068|62658245|FG000|Overall Study|New Cancer Diagnosis|1|||
33282252|NCT04021862|62658252|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
33282253|NCT04021862|62658253|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
33282254|NCT04021862|62658254|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
33282255|NCT04021862|62658255|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
33282256|NCT04021862|62658256|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
33282257|NCT04021862|62658257|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
33282258|NCT04021862|62658252|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
33282259|NCT04021862|62658253|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
33282260|NCT04021862|62658254|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
33282261|NCT04021862|62658255|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
33282262|NCT04021862|62658256|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
33282263|NCT04021862|62658257|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
33282264|NCT04021862|62658252|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
33371248|NCT03203473|62749998|FG000|Arm Allocation Phase|Adverse Event|0|||
33371249|NCT03203473|62749999|FG001|Arm Allocation Phase|Adverse Event|0|||
33371250|NCT03203473|62750000|FG002|Arm Allocation Phase|Adverse Event|11|||
33371251|NCT03203473|62749998|FG000|Arm Allocation Phase|Physician Decision|0|||
33371252|NCT03203473|62749999|FG001|Arm Allocation Phase|Physician Decision|0|||
33371253|NCT03203473|62750000|FG002|Arm Allocation Phase|Physician Decision|3|||
33486310|NCT04173741|62864144|FG001|Overall Study|IVC measurement cannot be done|1|||
33486311|NCT03231800|62864152|FG000|Overall Study|Lost to Follow-up|0|||
33486312|NCT03231800|62864153|FG001|Overall Study|Lost to Follow-up|2|||
33486313|NCT03231800|62864152|FG000|Overall Study|Protocol Violation|1|||
33486314|NCT03231800|62864153|FG001|Overall Study|Protocol Violation|1|||
33282265|NCT04021862|62658253|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
33282266|NCT04021862|62658254|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
33282267|NCT04021862|62658255|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
33282268|NCT04021862|62658256|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
33282269|NCT04021862|62658257|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
33486315|NCT03231800|62864152|FG000|Overall Study|reason not provided|2|||
33486316|NCT03231800|62864153|FG001|Overall Study|reason not provided|0|||
33486317|NCT04085601|62864161|FG000|Overall Study|Lost to Follow-up|1|||
33662137|NCT01695239|63092845|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33662138|NCT01695239|63092846|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33662139|NCT01695239|63092833|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
33282270|NCT04021862|62658252|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
33282271|NCT04021862|62658253|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
33282272|NCT04021862|62658254|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
33282273|NCT04021862|62658255|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
33282274|NCT04021862|62658256|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
33282275|NCT04021862|62658257|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
33282276|NCT04021862|62658252|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
33282277|NCT04021862|62658253|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
33282278|NCT04021862|62658254|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
33282279|NCT04021862|62658255|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
33371254|NCT03203473|62749998|FG000|Arm Allocation Phase|Death|0|||
33371255|NCT03203473|62749999|FG001|Arm Allocation Phase|Death|0|||
33371256|NCT03203473|62750000|FG002|Arm Allocation Phase|Death|1|||
33371257|NCT03203473|62749998|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
33371258|NCT03203473|62749999|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
33371259|NCT03203473|62750000|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
33371260|NCT03203473|62749998|FG000|Arm Allocation Phase|Intercurrent illness|0|||
33371261|NCT03203473|62749999|FG001|Arm Allocation Phase|Intercurrent illness|0|||
33371262|NCT03203473|62750000|FG002|Arm Allocation Phase|Intercurrent illness|1|||
33371263|NCT03203473|62749998|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
33371264|NCT03203473|62749999|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
33371265|NCT03203473|62750000|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
33371266|NCT03158051|62750013|FG000|Overall Study|Lost to Follow-up|41|||
33371267|NCT03158051|62750014|FG001|Overall Study|Lost to Follow-up|47|||
33371268|NCT03158051|62750013|FG000|Overall Study|Physician Decision|6|||
33371269|NCT03158051|62750014|FG001|Overall Study|Physician Decision|7|||
33371270|NCT03158051|62750013|FG000|Overall Study|Withdrawal by Subject|24|||
33371271|NCT03158051|62750014|FG001|Overall Study|Withdrawal by Subject|15|||
33371272|NCT03158051|62750013|FG000|Overall Study|Death|0|||
33371273|NCT03158051|62750014|FG001|Overall Study|Death|1|||
33371274|NCT03051659|62750031|FG000|Treatment Period|Withdrawal by Subject|0|||
33371275|NCT03051659|62750032|FG001|Treatment Period|Withdrawal by Subject|2|||
33371276|NCT03051659|62750031|FG000|Survival Follow-up|Lost to Follow-up|23|||
33371277|NCT03051659|62750032|FG001|Survival Follow-up|Lost to Follow-up|22|||
33371278|NCT02971761|62750038|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
33371279|NCT02724878|62750042|FG000|Overall Study|Still on Active Therapy|15|||
33371280|NCT02724878|62750042|FG000|Overall Study|Disease Progression|31|||
33371281|NCT02724878|62750042|FG000|Overall Study|Toxicity|5|||
33371282|NCT02724878|62750042|FG000|Overall Study|Death|1|||
33371283|NCT02724878|62750042|FG000|Overall Study|Withdrawal by Subject|4|||
33371284|NCT02724878|62750042|FG000|Overall Study|Lost to Follow-up|2|||
33371285|NCT02724878|62750042|FG000|Overall Study|Protocol Violation|1|||
33371286|NCT02724878|62750042|FG000|Overall Study|Ineligible for Study Drug|5|||
33371287|NCT02724878|62750042|FG000|Overall Study|not started|1|||
33371288|NCT02600507|62750049|FG000|Overall Study|Adverse Event|3|||
33371289|NCT02600507|62750050|FG001|Overall Study|Adverse Event|15|||
33486318|NCT04085601|62864162|FG001|Overall Study|Lost to Follow-up|0|||
33486319|NCT04085601|62864161|FG000|Overall Study|Death|1|||
33486320|NCT04085601|62864162|FG001|Overall Study|Death|1|||
33486321|NCT03230864|62864171|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
33486322|NCT03230864|62864172|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
33486323|NCT03230864|62864173|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
33282280|NCT04021862|62658256|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
33282281|NCT04021862|62658257|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
33282282|NCT04003155|62658274|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
33282283|NCT04003155|62658275|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
33556014|NCT02310568|62948862|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
33556015|NCT02310568|62948863|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
33282284|NCT04003155|62658276|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
33282285|NCT04003155|62658277|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
33282286|NCT04003155|62658278|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
33282287|NCT04003155|62658274|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
33282288|NCT04003155|62658275|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
33282289|NCT04003155|62658276|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
33282290|NCT04003155|62658277|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
33282291|NCT04003155|62658278|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
33282292|NCT04003155|62658274|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
33282293|NCT04003155|62658275|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
33282294|NCT04003155|62658276|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
33371290|NCT02600507|62750051|FG002|Overall Study|Adverse Event|5|||
33371291|NCT02600507|62750049|FG000|Overall Study|Lack of Efficacy|3|||
33371292|NCT02600507|62750050|FG001|Overall Study|Lack of Efficacy|8|||
33371293|NCT02600507|62750051|FG002|Overall Study|Lack of Efficacy|5|||
33282295|NCT04003155|62658277|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
33282296|NCT04003155|62658278|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
33282297|NCT04003155|62658274|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
33282298|NCT04003155|62658275|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
33282299|NCT04003155|62658276|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
33282300|NCT04003155|62658277|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
33282301|NCT04003155|62658278|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
33282302|NCT04003155|62658274|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
33282303|NCT04003155|62658275|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
33282304|NCT04003155|62658276|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
33282305|NCT04003155|62658277|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
33282306|NCT04003155|62658278|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
33282307|NCT04003155|62658274|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
33282308|NCT04003155|62658275|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
33282309|NCT04003155|62658276|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
33282310|NCT04003155|62658277|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
33282311|NCT04003155|62658278|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
33282312|NCT04003155|62658274|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
33282313|NCT04003155|62658275|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
33282314|NCT04003155|62658276|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
33282315|NCT04003155|62658277|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
33282316|NCT04003155|62658278|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
33282317|NCT04003155|62658274|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
33282318|NCT04003155|62658275|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
33282319|NCT04003155|62658276|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
33282320|NCT04003155|62658277|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
33282321|NCT04003155|62658278|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
33282322|NCT04003155|62658274|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
33282323|NCT04003155|62658275|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
33282324|NCT04003155|62658276|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
33282325|NCT04003155|62658277|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
33282326|NCT04003155|62658278|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
33282327|NCT04003142|62658299|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
33282328|NCT04003142|62658300|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
33282329|NCT04003142|62658301|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
33282330|NCT04003142|62658302|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
33282331|NCT04003142|62658303|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
33282332|NCT04003142|62658299|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
33282333|NCT04003142|62658300|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
33282334|NCT04003142|62658301|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
33282335|NCT04003142|62658302|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
33282336|NCT04003142|62658303|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
33282337|NCT04003142|62658299|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
33282338|NCT04003142|62658300|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
33282339|NCT04003142|62658301|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
33282340|NCT04003142|62658302|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
33282341|NCT04003142|62658303|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
33282342|NCT04003142|62658299|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
33282343|NCT04003142|62658300|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
33282344|NCT04003142|62658301|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
33282345|NCT04003142|62658302|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
33282346|NCT04003142|62658303|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
33282347|NCT04003142|62658299|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
33282348|NCT04003142|62658300|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
33282349|NCT04003142|62658301|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
33282350|NCT04003142|62658302|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
33282351|NCT04003142|62658303|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
33282352|NCT04003142|62658299|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
33282353|NCT04003142|62658300|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
33282354|NCT04003142|62658301|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
33282355|NCT04003142|62658302|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
33282356|NCT04003142|62658303|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
33282357|NCT04003142|62658299|FG000|Extension Period (40 Weeks)|Death|0|||
33282358|NCT04003142|62658300|FG001|Extension Period (40 Weeks)|Death|0|||
33282359|NCT04003142|62658301|FG002|Extension Period (40 Weeks)|Death|0|||
33282360|NCT04003142|62658302|FG003|Extension Period (40 Weeks)|Death|0|||
33282361|NCT04003142|62658303|FG004|Extension Period (40 Weeks)|Death|1|||
33282362|NCT04003142|62658299|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
33282363|NCT04003142|62658300|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
33371294|NCT02600507|62750049|FG000|Overall Study|Lost to Follow-up|3|||
33282364|NCT04003142|62658301|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
33282365|NCT04003142|62658302|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
33282366|NCT04003142|62658303|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
33282367|NCT04003142|62658299|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
33282368|NCT04003142|62658300|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
33282369|NCT04003142|62658301|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
33282370|NCT04003142|62658302|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
33282371|NCT04003142|62658303|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
33282372|NCT04003142|62658299|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
33282373|NCT04003142|62658300|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
33282374|NCT04003142|62658301|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
33282375|NCT04003142|62658302|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
33282376|NCT04003142|62658303|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
33282377|NCT04003142|62658299|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
33282378|NCT04003142|62658300|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
33282379|NCT04003142|62658301|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
33282380|NCT04003142|62658302|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
33282381|NCT04003142|62658303|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
33282382|NCT03971422|62658324|FG000|Overall Study|Lost to Follow-up|0|||
33282383|NCT03971422|62658325|FG001|Overall Study|Lost to Follow-up|1|||
33282384|NCT03971422|62658326|FG002|Overall Study|Lost to Follow-up|0|||
33282385|NCT03971422|62658324|FG000|Overall Study|Lack of Efficacy|5|||
33282386|NCT03971422|62658325|FG001|Overall Study|Lack of Efficacy|1|||
33282387|NCT03971422|62658326|FG002|Overall Study|Lack of Efficacy|1|||
33282388|NCT03971422|62658324|FG000|Overall Study|Adverse event, not fatal|2|||
33282389|NCT03971422|62658325|FG001|Overall Study|Adverse event, not fatal|2|||
33282390|NCT03971422|62658326|FG002|Overall Study|Adverse event, not fatal|5|||
33282391|NCT03971422|62658324|FG000|Overall Study|Worsening of MG Symptoms|1|||
33282392|NCT03971422|62658325|FG001|Overall Study|Worsening of MG Symptoms|4|||
33282393|NCT03971422|62658326|FG002|Overall Study|Worsening of MG Symptoms|2|||
33282394|NCT03971422|62658324|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
33282395|NCT03971422|62658325|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
33282396|NCT03971422|62658326|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
33282397|NCT03971422|62658324|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
33282398|NCT03971422|62658325|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
33282399|NCT03971422|62658326|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
33282400|NCT03971422|62658324|FG000|Overall Study|Due to COVID-19 pandemic|0|||
33282401|NCT03971422|62658325|FG001|Overall Study|Due to COVID-19 pandemic|1|||
33282402|NCT03971422|62658326|FG002|Overall Study|Due to COVID-19 pandemic|1|||
33282403|NCT03770260|62658341|FG000|Overall Study|Disease progression|0|||
33282404|NCT03770260|62658342|FG001|Overall Study|Disease progression|1|||
33282405|NCT03770260|62658343|FG002|Overall Study|Disease progression|0|||
33282406|NCT03770260|62658344|FG003|Overall Study|Disease progression|0|||
33282407|NCT03737110|62658355|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
33282408|NCT03737110|62658356|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
33371295|NCT02600507|62750050|FG001|Overall Study|Lost to Follow-up|5|||
33371296|NCT02600507|62750051|FG002|Overall Study|Lost to Follow-up|2|||
33282409|NCT03737110|62658357|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
33282410|NCT03737110|62658358|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
33282411|NCT03737110|62658359|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
33282412|NCT03737110|62658360|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
33282413|NCT03737110|62658355|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
33282414|NCT03737110|62658356|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
33282415|NCT03737110|62658357|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
33282416|NCT03737110|62658358|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
33282417|NCT03737110|62658359|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
33282418|NCT03737110|62658360|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
33282419|NCT03737110|62658355|FG000|Run-in (RI) Period|Adverse Event|4|||
33282420|NCT03737110|62658356|FG001|Run-in (RI) Period|Adverse Event|0|||
33282421|NCT03737110|62658357|FG002|Run-in (RI) Period|Adverse Event|0|||
33282422|NCT03737110|62658358|FG003|Run-in (RI) Period|Adverse Event|0|||
33282423|NCT03737110|62658359|FG004|Run-in (RI) Period|Adverse Event|0|||
33282424|NCT03737110|62658360|FG005|Run-in (RI) Period|Adverse Event|0|||
33282425|NCT03737110|62658355|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
33282426|NCT03737110|62658356|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
33282427|NCT03737110|62658357|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
33282428|NCT03737110|62658358|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
33282429|NCT03737110|62658359|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
33282430|NCT03737110|62658360|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
33282431|NCT03737110|62658355|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
33282432|NCT03737110|62658356|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
33371297|NCT02600507|62750049|FG000|Overall Study|Protocol Violation|12|||
33282433|NCT03737110|62658357|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
33282434|NCT03737110|62658358|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
33282435|NCT03737110|62658359|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
33282436|NCT03737110|62658360|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
33282437|NCT03737110|62658355|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
33282438|NCT03737110|62658356|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
33282439|NCT03737110|62658357|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
33282440|NCT03737110|62658358|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
33282441|NCT03737110|62658359|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
33282442|NCT03737110|62658360|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
33282443|NCT03737110|62658355|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
33282444|NCT03737110|62658356|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
33282445|NCT03737110|62658357|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
33282446|NCT03737110|62658358|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
33282447|NCT03737110|62658359|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
33282448|NCT03737110|62658360|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
33282449|NCT03737110|62658355|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
33282450|NCT03737110|62658356|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
33282451|NCT03737110|62658357|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
33282452|NCT03737110|62658358|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
33282453|NCT03737110|62658359|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
33282454|NCT03737110|62658360|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
33282455|NCT03592771|62658411|FG000|Overall Study|Adverse Event|2|||
33282456|NCT03592771|62658412|FG001|Overall Study|Adverse Event|0|||
33282457|NCT03592771|62658413|FG002|Overall Study|Adverse Event|1|||
33282458|NCT03592771|62658411|FG000|Overall Study|Death|0|||
33282459|NCT03592771|62658412|FG001|Overall Study|Death|1|||
33282460|NCT03592771|62658413|FG002|Overall Study|Death|1|||
33282461|NCT03592771|62658411|FG000|Overall Study|Lost to Follow-up|5|||
33282462|NCT03592771|62658412|FG001|Overall Study|Lost to Follow-up|11|||
33282463|NCT03592771|62658413|FG002|Overall Study|Lost to Follow-up|15|||
33282464|NCT03592771|62658411|FG000|Overall Study|Withdrawal by Subject|0|||
33282465|NCT03592771|62658412|FG001|Overall Study|Withdrawal by Subject|2|||
33282466|NCT03592771|62658413|FG002|Overall Study|Withdrawal by Subject|0|||
33556016|NCT02310568|62948864|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
33556017|NCT02310568|62948865|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
33486324|NCT03230864|62864174|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
33486325|NCT03230864|62864171|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
33486326|NCT03230864|62864172|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
33486327|NCT03230864|62864173|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
33556018|NCT02310568|62948866|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
33486328|NCT03230864|62864174|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
33486329|NCT03230864|62864171|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
33486330|NCT03230864|62864172|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
33486331|NCT03230864|62864173|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
33486332|NCT03230864|62864174|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
33486333|NCT03230864|62864171|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
33486334|NCT03230864|62864172|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
33486335|NCT03230864|62864173|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
33486336|NCT03230864|62864174|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
33556019|NCT02310568|62948862|FG000|Stage 1 ( 4 Weeks)|Other|1|||
33556020|NCT02310568|62948863|FG001|Stage 1 ( 4 Weeks)|Other|1|||
33556021|NCT02310568|62948864|FG002|Stage 1 ( 4 Weeks)|Other|0|||
33556022|NCT02310568|62948865|FG003|Stage 1 ( 4 Weeks)|Other|0|||
33556023|NCT02310568|62948866|FG004|Stage 1 ( 4 Weeks)|Other|0|||
33556024|NCT02310568|62948862|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
33556025|NCT02310568|62948863|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
33556026|NCT02310568|62948864|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
33556027|NCT02310568|62948865|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
33556028|NCT02310568|62948866|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
33556029|NCT02310568|62948862|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
33556030|NCT02310568|62948863|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
33556031|NCT02310568|62948864|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
33556032|NCT02310568|62948865|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
33556033|NCT02310568|62948866|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
33556034|NCT02310568|62948862|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
33556035|NCT02310568|62948863|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
33556036|NCT02310568|62948864|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
33282527|NCT03495154|62658442|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
33282528|NCT03495154|62658442|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
33282529|NCT03495154|62658442|FG000|Overall Study|Screen Failures During Surgery|6|||
33282530|NCT03495154|62658442|FG000|Overall Study|Death|2|||
33282531|NCT03495154|62658442|FG000|Overall Study|Lost to Follow-up|16|||
33282532|NCT03495154|62658442|FG000|Overall Study|Withdrawal by Subject|2|||
33282533|NCT03495154|62658442|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
33282534|NCT03334253|62658482|FG000|Overall Study|Withdrawal by Subject|1|||
33282535|NCT03334253|62658483|FG001|Overall Study|Withdrawal by Subject|0|||
33282536|NCT03334253|62658482|FG000|Overall Study|Lost to Follow-up|4|||
33282537|NCT03334253|62658483|FG001|Overall Study|Lost to Follow-up|3|||
33282538|NCT03334253|62658482|FG000|Overall Study|Moved residence|2|||
33282539|NCT03334253|62658483|FG001|Overall Study|Moved residence|2|||
33282540|NCT03314857|62658489|FG000|Overall Study|Death|4|||
33282541|NCT03314857|62658489|FG000|Overall Study|Physician Decision|1|||
33282542|NCT03302156|62658495|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
33282543|NCT03302156|62658496|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
33282544|NCT03302156|62658497|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
33282545|NCT03268954|62658515|FG000|Overall Study|Ongoing|23|||
33371298|NCT02600507|62750050|FG001|Overall Study|Protocol Violation|4|||
33556037|NCT02310568|62948865|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
33556038|NCT02310568|62948866|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
33556039|NCT02310568|62948862|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
33556040|NCT02310568|62948863|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
33556041|NCT02310568|62948864|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
33556042|NCT02310568|62948865|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
33556043|NCT02310568|62948866|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
33556044|NCT02310568|62948862|FG000|Stage 2 (4 Weeks)|Other|0|||
33556045|NCT02310568|62948863|FG001|Stage 2 (4 Weeks)|Other|1|||
33556046|NCT02310568|62948864|FG002|Stage 2 (4 Weeks)|Other|1|||
33556047|NCT02310568|62948865|FG003|Stage 2 (4 Weeks)|Other|0|||
33556048|NCT02310568|62948866|FG004|Stage 2 (4 Weeks)|Other|0|||
33556049|NCT02310568|62948862|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
33556050|NCT02310568|62948863|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
33556051|NCT02310568|62948864|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
33556052|NCT02310568|62948865|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
33556053|NCT02310568|62948866|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
33556054|NCT02310568|62948862|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
33556055|NCT02310568|62948863|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
33556056|NCT02310568|62948864|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
33556057|NCT02310568|62948865|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
33556058|NCT02310568|62948866|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
33556059|NCT02310568|62948862|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
33556060|NCT02310568|62948863|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
33556061|NCT02310568|62948864|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
33556062|NCT02310568|62948865|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
33556063|NCT02310568|62948866|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
33556064|NCT02310100|62948884|FG000|Overall Study|Physician Decision|3|||
33556065|NCT02310100|62948884|FG000|Overall Study|Withdrawal by Subject|10|||
33556066|NCT02310100|62948884|FG000|Overall Study|Enrollment closure|1|||
33556067|NCT02310100|62948884|FG000|Overall Study|Unapproved ablation operator|1|||
33556068|NCT02310100|62948884|FG000|Overall Study|Visit compliance|1|||
33556069|NCT02310100|62948884|FG000|Overall Study|Lost to Follow-up|2|||
33556070|NCT02780167|62948894|FG000|Overall Study|Adverse Event|9|||
33556071|NCT02780167|62948895|FG001|Overall Study|Adverse Event|8|||
33556072|NCT02780167|62948896|FG002|Overall Study|Adverse Event|8|||
33556073|NCT02780167|62948897|FG003|Overall Study|Adverse Event|12|||
33556074|NCT02780167|62948898|FG004|Overall Study|Adverse Event|8|||
33556075|NCT02780167|62948894|FG000|Overall Study|Lack of Efficacy|6|||
33556076|NCT02780167|62948895|FG001|Overall Study|Lack of Efficacy|5|||
33556077|NCT02780167|62948896|FG002|Overall Study|Lack of Efficacy|6|||
33556078|NCT02780167|62948897|FG003|Overall Study|Lack of Efficacy|1|||
33556079|NCT02780167|62948898|FG004|Overall Study|Lack of Efficacy|0|||
33556080|NCT02780167|62948894|FG000|Overall Study|Lost to Follow-up|2|||
33556081|NCT02780167|62948895|FG001|Overall Study|Lost to Follow-up|0|||
33556082|NCT02780167|62948896|FG002|Overall Study|Lost to Follow-up|1|||
33556083|NCT02780167|62948897|FG003|Overall Study|Lost to Follow-up|0|||
33556084|NCT02780167|62948898|FG004|Overall Study|Lost to Follow-up|0|||
33556085|NCT02780167|62948894|FG000|Overall Study|Does not meet entrance criteria|0|||
33556086|NCT02780167|62948895|FG001|Overall Study|Does not meet entrance criteria|0|||
33556087|NCT02780167|62948896|FG002|Overall Study|Does not meet entrance criteria|1|||
33556088|NCT02780167|62948897|FG003|Overall Study|Does not meet entrance criteria|0|||
33556089|NCT02780167|62948898|FG004|Overall Study|Does not meet entrance criteria|0|||
33556090|NCT02780167|62948894|FG000|Overall Study|No longer meets eligibility criteria|0|||
33556091|NCT02780167|62948895|FG001|Overall Study|No longer meets eligibility criteria|0|||
33282546|NCT03268954|62658516|FG001|Overall Study|Ongoing|31|||
33282547|NCT03268954|62658515|FG000|Overall Study|Adverse Event|53|||
33282548|NCT03268954|62658516|FG001|Overall Study|Adverse Event|62|||
33282549|NCT03268954|62658515|FG000|Overall Study|Withdrawal by Subject|25|||
33282550|NCT03268954|62658516|FG001|Overall Study|Withdrawal by Subject|16|||
33282551|NCT03268954|62658515|FG000|Overall Study|Progressive Disease|61|||
33282552|NCT03268954|62658516|FG001|Overall Study|Progressive Disease|48|||
33282553|NCT03268954|62658515|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
33282554|NCT03268954|62658516|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
33282555|NCT03268954|62658515|FG000|Overall Study|Reason not Specified|40|||
33282556|NCT03268954|62658516|FG001|Overall Study|Reason not Specified|40|||
33282557|NCT03235739|62658524|FG000|Overall Study|Withdrawal by Subject|2|||
33282558|NCT03235739|62658525|FG001|Overall Study|Withdrawal by Subject|2|||
33282559|NCT03235739|62658524|FG000|Overall Study|Physician Decision|0|||
33282560|NCT03235739|62658525|FG001|Overall Study|Physician Decision|1|||
33282561|NCT03176771|62658534|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
33282562|NCT03176771|62658535|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
33282563|NCT03176771|62658536|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
33282564|NCT03176771|62658537|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
33282565|NCT03176771|62658538|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
33282566|NCT03176771|62658534|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
33282567|NCT03176771|62658535|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
33282568|NCT03176771|62658536|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
33282569|NCT03176771|62658537|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
33282570|NCT03176771|62658538|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
33282571|NCT03176771|62658534|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
33282572|NCT03176771|62658535|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
33282573|NCT03176771|62658536|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
33282574|NCT03176771|62658537|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
33282575|NCT03176771|62658538|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
33282576|NCT03176771|62658534|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
33282577|NCT03176771|62658535|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
33282578|NCT03176771|62658536|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
33282579|NCT03176771|62658537|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
33282580|NCT03176771|62658538|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
33282581|NCT03176771|62658534|FG000|Double-Blind Extension Period|Adverse Event|0|||
33282582|NCT03176771|62658535|FG001|Double-Blind Extension Period|Adverse Event|0|||
33282583|NCT03176771|62658536|FG002|Double-Blind Extension Period|Adverse Event|0|||
33282584|NCT03176771|62658537|FG003|Double-Blind Extension Period|Adverse Event|15|||
33282585|NCT03176771|62658538|FG004|Double-Blind Extension Period|Adverse Event|18|||
33282586|NCT03176771|62658534|FG000|Double-Blind Extension Period|Death|0|||
33371299|NCT02600507|62750051|FG002|Overall Study|Protocol Violation|4|||
33371300|NCT02600507|62750049|FG000|Overall Study|Physician Decision|1|||
33371301|NCT02600507|62750050|FG001|Overall Study|Physician Decision|0|||
33371302|NCT02600507|62750051|FG002|Overall Study|Physician Decision|1|||
33371303|NCT02600507|62750049|FG000|Overall Study|Withdrawal by Subject|7|||
33371304|NCT02600507|62750050|FG001|Overall Study|Withdrawal by Subject|11|||
33371305|NCT02600507|62750051|FG002|Overall Study|Withdrawal by Subject|7|||
33371306|NCT02600507|62750049|FG000|Overall Study|Other|0|||
33371307|NCT02600507|62750050|FG001|Overall Study|Other|1|||
33371308|NCT02600507|62750051|FG002|Overall Study|Other|1|||
33371309|NCT02578680|62750061|FG000|Overall Study|Death|124|||
33371310|NCT02578680|62750062|FG001|Overall Study|Death|104|||
33371311|NCT02578680|62750061|FG000|Overall Study|Protocol Violation|1|||
33371312|NCT02578680|62750062|FG001|Overall Study|Protocol Violation|1|||
33371313|NCT02578680|62750061|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
33371314|NCT02578680|62750062|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33371315|NCT02578680|62750061|FG000|Overall Study|Withdrawal by Subject|8|||
33371316|NCT02578680|62750062|FG001|Overall Study|Withdrawal by Subject|5|||
33371317|NCT02578680|62750061|FG000|Overall Study|Ongoing in Study|276|||
33486337|NCT03230864|62864171|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
33486338|NCT03230864|62864172|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
33486339|NCT03230864|62864173|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
33486340|NCT03230864|62864174|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
33371318|NCT02578680|62750062|FG001|Overall Study|Ongoing in Study|96|||
33282587|NCT03176771|62658535|FG001|Double-Blind Extension Period|Death|0|||
33282588|NCT03176771|62658536|FG002|Double-Blind Extension Period|Death|0|||
33282589|NCT03176771|62658537|FG003|Double-Blind Extension Period|Death|3|||
33282590|NCT03176771|62658538|FG004|Double-Blind Extension Period|Death|4|||
33371319|NCT02385266|62750070|FG000|Overall Study|Withdrawal by Subject|1|||
33371320|NCT02385266|62750071|FG001|Overall Study|Withdrawal by Subject|3|||
33282591|NCT03176771|62658534|FG000|Double-Blind Extension Period|Physician Decision|0|||
33282592|NCT03176771|62658535|FG001|Double-Blind Extension Period|Physician Decision|0|||
33282593|NCT03176771|62658536|FG002|Double-Blind Extension Period|Physician Decision|0|||
33282594|NCT03176771|62658537|FG003|Double-Blind Extension Period|Physician Decision|3|||
33282595|NCT03176771|62658538|FG004|Double-Blind Extension Period|Physician Decision|1|||
33282596|NCT03176771|62658534|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
33282597|NCT03176771|62658535|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
33282598|NCT03176771|62658536|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
33282599|NCT03176771|62658537|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
33282600|NCT03176771|62658538|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
33282601|NCT02864394|62658554|FG000|Overall Study|Death|184|||
33282602|NCT02864394|62658555|FG001|Overall Study|Death|189|||
33282603|NCT02864394|62658554|FG000|Overall Study|Lost to Follow-up|0|||
33282604|NCT02864394|62658555|FG001|Overall Study|Lost to Follow-up|2|||
33282605|NCT02864394|62658554|FG000|Overall Study|Sponsor Decision|26|||
33282606|NCT02864394|62658555|FG001|Overall Study|Sponsor Decision|11|||
33282607|NCT02864394|62658554|FG000|Overall Study|Withdrawal by Subject|3|||
33282608|NCT02864394|62658555|FG001|Overall Study|Withdrawal by Subject|10|||
33282609|NCT02840721|62658562|FG000|Treatment Period|Adverse Event|1|||
33282610|NCT02840721|62658562|FG000|Follow-Up|Lack of Efficacy|1|||
33282611|NCT02840721|62658562|FG000|Follow-Up|Withdrawal by Subject|4|||
33282612|NCT02840721|62658562|FG000|Follow-Up|Withdrawal of Consent|2|||
33282613|NCT02829918|62658566|FG000|Overall Study|Death|2|||
33282614|NCT02829918|62658566|FG000|Overall Study|Withdrawal by Subject|4|||
33282615|NCT02829918|62658566|FG000|Overall Study|Adverse Event|1|||
33282616|NCT02829918|62658566|FG000|Overall Study|Progression|1|||
33282617|NCT02789020|62658572|FG000|Overall Study|Withdrawal by Subject|6|||
33282618|NCT02789020|62658573|FG001|Overall Study|Withdrawal by Subject|5|||
33282619|NCT02768792|62658579|FG000|Overall Study|Adverse Event|1|||
33282620|NCT02427841|62658614|FG000|Overall Study|Lack of Efficacy|5|||
33282621|NCT02427841|62658614|FG000|Overall Study|Physician Decision|2|||
33282622|NCT02427841|62658614|FG000|Overall Study|Withdrawal by Subject|1|||
33282623|NCT02348216|62658626|FG000|Overall Study|Death|4|||
33282624|NCT02348216|62658627|FG001|Overall Study|Death|27|||
33282625|NCT02348216|62658628|FG002|Overall Study|Death|3|||
33282626|NCT02348216|62658629|FG003|Overall Study|Death|18|||
33282627|NCT02348216|62658630|FG004|Overall Study|Death|9|||
33282628|NCT02348216|62658631|FG005|Overall Study|Death|23|||
33282629|NCT02348216|62658632|FG006|Overall Study|Death|6|||
33282630|NCT02348216|62658626|FG000|Overall Study|Full consent withdrawal|0|||
33282631|NCT02348216|62658627|FG001|Overall Study|Full consent withdrawal|0|||
33282632|NCT02348216|62658628|FG002|Overall Study|Full consent withdrawal|0|||
33282633|NCT02348216|62658629|FG003|Overall Study|Full consent withdrawal|1|||
33282634|NCT02348216|62658630|FG004|Overall Study|Full consent withdrawal|0|||
33282635|NCT02348216|62658631|FG005|Overall Study|Full consent withdrawal|0|||
33282636|NCT02348216|62658632|FG006|Overall Study|Full consent withdrawal|1|||
33282637|NCT02348216|62658626|FG000|Overall Study|Lost to Follow-up|0|||
33282638|NCT02348216|62658627|FG001|Overall Study|Lost to Follow-up|0|||
33282639|NCT02348216|62658628|FG002|Overall Study|Lost to Follow-up|0|||
33282640|NCT02348216|62658629|FG003|Overall Study|Lost to Follow-up|0|||
33282641|NCT02348216|62658630|FG004|Overall Study|Lost to Follow-up|0|||
33282642|NCT02348216|62658631|FG005|Overall Study|Lost to Follow-up|0|||
33282643|NCT02348216|62658632|FG006|Overall Study|Lost to Follow-up|1|||
33282644|NCT02348216|62658626|FG000|Overall Study|Still on study|3|||
33282645|NCT02348216|62658627|FG001|Overall Study|Still on study|50|||
33282646|NCT02348216|62658628|FG002|Overall Study|Still on study|21|||
33282647|NCT02348216|62658629|FG003|Overall Study|Still on study|19|||
33282648|NCT02348216|62658630|FG004|Overall Study|Still on study|32|||
33282649|NCT02348216|62658631|FG005|Overall Study|Still on study|27|||
33282650|NCT02348216|62658632|FG006|Overall Study|Still on study|32|||
33282651|NCT02348216|62658626|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
33282652|NCT02348216|62658627|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
33282653|NCT02348216|62658628|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
33371321|NCT02379988|62750077|FG000|Overall Study|Not eligible|1|||
33371322|NCT02006069|62750092|FG000|Overall Study|MPP other programming|239|||
33371323|NCT02006069|62750093|FG001|Overall Study|MPP other programming|0|||
33371324|NCT02006069|62750092|FG000|Overall Study|RV only pacing|0|||
33662140|NCT01695239|63092834|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
33282654|NCT02348216|62658629|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
33282655|NCT02348216|62658630|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
33371325|NCT02006069|62750093|FG001|Overall Study|RV only pacing|3|||
33282656|NCT02348216|62658631|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
33282657|NCT02348216|62658632|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
33282658|NCT02288247|62658670|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
33282659|NCT02288247|62658671|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
33282660|NCT02288247|62658670|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
33282661|NCT02288247|62658671|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
33282662|NCT02288247|62658670|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
33282663|NCT02288247|62658671|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
33282664|NCT02288247|62658670|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
33282665|NCT02288247|62658671|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
33282666|NCT02288247|62658670|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
33282667|NCT02288247|62658671|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
33282668|NCT02288247|62658670|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
33282669|NCT02288247|62658671|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
33282670|NCT02288247|62658670|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
33282671|NCT02288247|62658671|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
33282672|NCT02288247|62658670|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
33282673|NCT02288247|62658671|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
33282674|NCT02288247|62658670|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
33282675|NCT02288247|62658671|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
33282676|NCT02288247|62658670|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
33282677|NCT02288247|62658671|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
33282678|NCT02288247|62658670|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
33282679|NCT02288247|62658671|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
33282680|NCT02288247|62658670|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
33282681|NCT02288247|62658671|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
33282682|NCT02288247|62658670|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
33282683|NCT02288247|62658671|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
33282684|NCT02288247|62658670|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
33282685|NCT02288247|62658671|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
33282686|NCT02288247|62658670|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
33282687|NCT02288247|62658671|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
33282688|NCT02243605|62658681|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
33282689|NCT02243605|62658682|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
33282690|NCT02243605|62658681|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
33282691|NCT02243605|62658682|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
33282692|NCT02243605|62658681|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
33282693|NCT02243605|62658682|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
33282694|NCT02243605|62658681|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
33282695|NCT02243605|62658682|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
33282696|NCT02243605|62658681|FG000|Stage 2 - Final Analysis Population|Progression|0|||
33282697|NCT02243605|62658682|FG001|Stage 2 - Final Analysis Population|Progression|1|||
33282698|NCT02152995|62658690|FG000|Overall Study|Withdrawal by Subject|1|||
33282699|NCT02152995|62658691|FG001|Overall Study|Withdrawal by Subject|0|||
33282700|NCT02101853|62658698|FG000|Block 1 Induction|Adverse Event|11|||
33282701|NCT02101853|62658699|FG001|Block 1 Induction|Adverse Event|0|||
33282702|NCT02101853|62658700|FG002|Block 1 Induction|Adverse Event|0|||
33282703|NCT02101853|62658701|FG003|Block 1 Induction|Adverse Event|0|||
33282704|NCT02101853|62658702|FG004|Block 1 Induction|Adverse Event|0|||
33282705|NCT02101853|62658703|FG005|Block 1 Induction|Adverse Event|0|||
33282706|NCT02101853|62658698|FG000|Block 1 Induction|Death|20|||
33282707|NCT02101853|62658699|FG001|Block 1 Induction|Death|0|||
33282708|NCT02101853|62658700|FG002|Block 1 Induction|Death|0|||
33282709|NCT02101853|62658701|FG003|Block 1 Induction|Death|0|||
33282710|NCT02101853|62658702|FG004|Block 1 Induction|Death|0|||
33282711|NCT02101853|62658703|FG005|Block 1 Induction|Death|0|||
33282712|NCT02101853|62658698|FG000|Block 1 Induction|Lack of Efficacy|6|||
33282713|NCT02101853|62658699|FG001|Block 1 Induction|Lack of Efficacy|0|||
33282714|NCT02101853|62658700|FG002|Block 1 Induction|Lack of Efficacy|0|||
33282715|NCT02101853|62658701|FG003|Block 1 Induction|Lack of Efficacy|0|||
33282716|NCT02101853|62658702|FG004|Block 1 Induction|Lack of Efficacy|0|||
33282717|NCT02101853|62658703|FG005|Block 1 Induction|Lack of Efficacy|0|||
33282718|NCT02101853|62658698|FG000|Block 1 Induction|Physician Decision|61|||
33282719|NCT02101853|62658699|FG001|Block 1 Induction|Physician Decision|0|||
33371326|NCT01985867|62750101|FG000|Overall Study|Lost to Follow-up|3|||
33371327|NCT01985867|62750102|FG001|Overall Study|Lost to Follow-up|4|||
33371328|NCT01985867|62750101|FG000|Overall Study|Adverse Event|3|||
33371329|NCT01985867|62750102|FG001|Overall Study|Adverse Event|2|||
33371330|NCT01985867|62750101|FG000|Overall Study|Lack of Efficacy|1|||
33282720|NCT02101853|62658700|FG002|Block 1 Induction|Physician Decision|0|||
33282721|NCT02101853|62658701|FG003|Block 1 Induction|Physician Decision|0|||
33371331|NCT01985867|62750102|FG001|Overall Study|Lack of Efficacy|0|||
33282722|NCT02101853|62658702|FG004|Block 1 Induction|Physician Decision|0|||
33282723|NCT02101853|62658703|FG005|Block 1 Induction|Physician Decision|0|||
33371332|NCT01946139|62750108|FG000|Overall Study|Withdrawal by Subject|8|||
33282724|NCT02101853|62658698|FG000|Block 1 Induction|Protocol Violation|2|||
33282725|NCT02101853|62658699|FG001|Block 1 Induction|Protocol Violation|0|||
33282726|NCT02101853|62658700|FG002|Block 1 Induction|Protocol Violation|0|||
33282727|NCT02101853|62658701|FG003|Block 1 Induction|Protocol Violation|0|||
33282728|NCT02101853|62658702|FG004|Block 1 Induction|Protocol Violation|0|||
33282729|NCT02101853|62658703|FG005|Block 1 Induction|Protocol Violation|0|||
33282730|NCT02101853|62658698|FG000|Block 1 Induction|Withdrawal by Subject|65|||
33282731|NCT02101853|62658699|FG001|Block 1 Induction|Withdrawal by Subject|0|||
33282732|NCT02101853|62658700|FG002|Block 1 Induction|Withdrawal by Subject|0|||
33282733|NCT02101853|62658701|FG003|Block 1 Induction|Withdrawal by Subject|0|||
33282734|NCT02101853|62658702|FG004|Block 1 Induction|Withdrawal by Subject|0|||
33282735|NCT02101853|62658703|FG005|Block 1 Induction|Withdrawal by Subject|0|||
33282736|NCT02101853|62658698|FG000|Block 1 Induction|Ineligible|8|||
33282737|NCT02101853|62658699|FG001|Block 1 Induction|Ineligible|0|||
33282738|NCT02101853|62658700|FG002|Block 1 Induction|Ineligible|0|||
33282739|NCT02101853|62658701|FG003|Block 1 Induction|Ineligible|0|||
33282740|NCT02101853|62658702|FG004|Block 1 Induction|Ineligible|0|||
33282741|NCT02101853|62658703|FG005|Block 1 Induction|Ineligible|0|||
33282742|NCT02101853|62658698|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
33282743|NCT02101853|62658699|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
33282744|NCT02101853|62658700|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
33282745|NCT02101853|62658701|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
33282746|NCT02101853|62658702|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
33282747|NCT02101853|62658703|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
33282748|NCT02101853|62658698|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
33282749|NCT02101853|62658699|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33282750|NCT02101853|62658700|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33282751|NCT02101853|62658701|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33282752|NCT02101853|62658702|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33282753|NCT02101853|62658703|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33282754|NCT02101853|62658698|FG000|Post Induction Randomization|Adverse Event|0|||
33282755|NCT02101853|62658699|FG001|Post Induction Randomization|Adverse Event|3|||
33282756|NCT02101853|62658700|FG002|Post Induction Randomization|Adverse Event|8|||
33282757|NCT02101853|62658701|FG003|Post Induction Randomization|Adverse Event|4|||
33282758|NCT02101853|62658702|FG004|Post Induction Randomization|Adverse Event|4|||
33282759|NCT02101853|62658703|FG005|Post Induction Randomization|Adverse Event|0|||
33282760|NCT02101853|62658698|FG000|Post Induction Randomization|Death|0|||
33282761|NCT02101853|62658699|FG001|Post Induction Randomization|Death|9|||
33282762|NCT02101853|62658700|FG002|Post Induction Randomization|Death|2|||
33282763|NCT02101853|62658701|FG003|Post Induction Randomization|Death|2|||
33282764|NCT02101853|62658702|FG004|Post Induction Randomization|Death|0|||
33282765|NCT02101853|62658703|FG005|Post Induction Randomization|Death|0|||
33282766|NCT02101853|62658698|FG000|Post Induction Randomization|Lack of Efficacy|0|||
33282767|NCT02101853|62658699|FG001|Post Induction Randomization|Lack of Efficacy|14|||
33282768|NCT02101853|62658700|FG002|Post Induction Randomization|Lack of Efficacy|23|||
33282769|NCT02101853|62658701|FG003|Post Induction Randomization|Lack of Efficacy|18|||
33282770|NCT02101853|62658702|FG004|Post Induction Randomization|Lack of Efficacy|21|||
33282771|NCT02101853|62658703|FG005|Post Induction Randomization|Lack of Efficacy|0|||
33282772|NCT02101853|62658698|FG000|Post Induction Randomization|Physician Decision|0|||
33282773|NCT02101853|62658699|FG001|Post Induction Randomization|Physician Decision|43|||
33282774|NCT02101853|62658700|FG002|Post Induction Randomization|Physician Decision|23|||
33282775|NCT02101853|62658701|FG003|Post Induction Randomization|Physician Decision|14|||
33282776|NCT02101853|62658702|FG004|Post Induction Randomization|Physician Decision|14|||
33282777|NCT02101853|62658703|FG005|Post Induction Randomization|Physician Decision|0|||
33282778|NCT02101853|62658698|FG000|Post Induction Randomization|Protocol Violation|0|||
33282779|NCT02101853|62658699|FG001|Post Induction Randomization|Protocol Violation|3|||
33282780|NCT02101853|62658700|FG002|Post Induction Randomization|Protocol Violation|0|||
33282781|NCT02101853|62658701|FG003|Post Induction Randomization|Protocol Violation|0|||
33282782|NCT02101853|62658702|FG004|Post Induction Randomization|Protocol Violation|0|||
33282783|NCT02101853|62658703|FG005|Post Induction Randomization|Protocol Violation|0|||
33282784|NCT02101853|62658698|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
33282785|NCT02101853|62658699|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
33282786|NCT02101853|62658700|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
33282787|NCT02101853|62658701|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
33282788|NCT02101853|62658702|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
33371333|NCT01946139|62750108|FG000|Overall Study|ineligible|8|||
33486341|NCT03230864|62864171|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
33282789|NCT02101853|62658703|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
33282790|NCT02101853|62658698|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33282791|NCT02101853|62658699|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33282792|NCT02101853|62658700|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33282793|NCT02101853|62658701|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
33282794|NCT02101853|62658702|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33371334|NCT01946139|62750108|FG000|Overall Study|Specimens not available|4|||
33371335|NCT01367002|62750114|FG000|Overall Study|Withdrawal by Subject|1|||
33371336|NCT01367002|62750115|FG001|Overall Study|Withdrawal by Subject|0|||
33371337|NCT01367002|62750114|FG000|Overall Study|Physician Decision|0|||
33371338|NCT01367002|62750115|FG001|Overall Study|Physician Decision|2|||
33371339|NCT00858273|62750123|FG000|Overall Study|Protocol Violation|3|||
33371340|NCT00858273|62750124|FG001|Overall Study|Protocol Violation|5|||
33371341|NCT00844428|62750155|FG000|Screening Period|Screen Failure|3|||
33371342|NCT00844428|62750155|FG000|Extension Treatment Period|Death|1|||
33371343|NCT00844428|62750155|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
33371344|NCT00834834|62750161|FG000|Overall Study|Withdrawal by Subject|4|||
33371345|NCT00834834|62750162|FG001|Overall Study|Withdrawal by Subject|3|||
33371346|NCT00834366|62750170|FG000|Treatment Period 1|Adverse Event|1|||
33371347|NCT00834366|62750171|FG001|Treatment Period 1|Adverse Event|1|||
33371348|NCT00844194|62750179|FG000|Overall Study|Adverse Event|17|||
33371349|NCT00844194|62750180|FG001|Overall Study|Adverse Event|5|||
33371350|NCT00844194|62750179|FG000|Overall Study|Protocol Violation|1|||
33371351|NCT00844194|62750180|FG001|Overall Study|Protocol Violation|1|||
33371352|NCT00844194|62750179|FG000|Overall Study|Lost to Follow-up|1|||
33371353|NCT00844194|62750180|FG001|Overall Study|Lost to Follow-up|1|||
33371354|NCT00844194|62750179|FG000|Overall Study|Withdrawal by Subject|2|||
33371355|NCT00844194|62750180|FG001|Overall Study|Withdrawal by Subject|1|||
33371356|NCT00844194|62750179|FG000|Overall Study|Lack of Efficacy|3|||
33371357|NCT00844194|62750180|FG001|Overall Study|Lack of Efficacy|0|||
33371358|NCT00844194|62750179|FG000|Overall Study|Other reason (not specified)|1|||
33371359|NCT00844194|62750180|FG001|Overall Study|Other reason (not specified)|0|||
33371360|NCT00826176|62750192|FG000|Overall Study|Lost to Follow-up|1|||
33371361|NCT00826176|62750193|FG001|Overall Study|Lost to Follow-up|0|||
33371362|NCT00826176|62750192|FG000|Overall Study|Subject Withdrew Consent|3|||
33371363|NCT00826176|62750193|FG001|Overall Study|Subject Withdrew Consent|0|||
33371364|NCT00826176|62750192|FG000|Overall Study|Administrative|9|||
33371365|NCT00826176|62750193|FG001|Overall Study|Administrative|0|||
33371366|NCT00878969|62750202|FG000|Overall Study|Physician Decision|5|||
33371367|NCT00878969|62750203|FG001|Overall Study|Physician Decision|3|||
33371368|NCT00878969|62750204|FG002|Overall Study|Physician Decision|2|||
33371369|NCT00878969|62750202|FG000|Overall Study|Withdrawal by Subject|1|||
33371370|NCT00878969|62750203|FG001|Overall Study|Withdrawal by Subject|6|||
33371371|NCT00878969|62750204|FG002|Overall Study|Withdrawal by Subject|3|||
33371372|NCT00878969|62750202|FG000|Overall Study|kidney transplant|2|||
33371373|NCT00878969|62750203|FG001|Overall Study|kidney transplant|3|||
33371374|NCT00878969|62750204|FG002|Overall Study|kidney transplant|2|||
33371375|NCT00878969|62750202|FG000|Overall Study|Adverse Event|3|||
33371376|NCT00878969|62750203|FG001|Overall Study|Adverse Event|1|||
33371377|NCT00878969|62750204|FG002|Overall Study|Adverse Event|2|||
33371378|NCT00878969|62750202|FG000|Overall Study|Lost to Follow-up|2|||
33371379|NCT00878969|62750203|FG001|Overall Study|Lost to Follow-up|1|||
33371380|NCT00878969|62750204|FG002|Overall Study|Lost to Follow-up|0|||
33371381|NCT00878969|62750202|FG000|Overall Study|Protocol Violation|2|||
33371382|NCT00878969|62750203|FG001|Overall Study|Protocol Violation|0|||
33371383|NCT00878969|62750204|FG002|Overall Study|Protocol Violation|0|||
33371384|NCT00878969|62750202|FG000|Overall Study|Death|0|||
33371385|NCT00878969|62750203|FG001|Overall Study|Death|0|||
33371386|NCT00878969|62750204|FG002|Overall Study|Death|2|||
33371387|NCT00878969|62750202|FG000|Overall Study|Pregnancy|0|||
33371388|NCT00878969|62750203|FG001|Overall Study|Pregnancy|1|||
33371389|NCT00878969|62750204|FG002|Overall Study|Pregnancy|0|||
33371390|NCT00843726|62750218|FG000|Overall Study|Death|1|||
33371391|NCT00843726|62750219|FG001|Overall Study|Death|0|||
33371392|NCT00843726|62750218|FG000|Overall Study|Withdrawal by Subject|0|||
33371393|NCT00843726|62750219|FG001|Overall Study|Withdrawal by Subject|1|||
33371394|NCT00843492|62750228|FG000|Overall Study|Adverse Event|0|||
33371395|NCT00843492|62750229|FG001|Overall Study|Adverse Event|3|||
33371396|NCT00843492|62750228|FG000|Overall Study|Lost to Follow-up|4|||
33371397|NCT00843492|62750229|FG001|Overall Study|Lost to Follow-up|4|||
33371398|NCT00843492|62750228|FG000|Overall Study|Withdrawal by Subject|0|||
33371399|NCT00843492|62750229|FG001|Overall Study|Withdrawal by Subject|4|||
33371400|NCT00843492|62750228|FG000|Overall Study|Immobilization Stopped|1|||
33371401|NCT00843492|62750229|FG001|Overall Study|Immobilization Stopped|0|||
33371402|NCT00843492|62750228|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
33282795|NCT02101853|62658703|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33282796|NCT02101853|62658698|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
33282797|NCT02101853|62658699|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
33282798|NCT02101853|62658700|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
33282799|NCT02101853|62658701|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
33282800|NCT02101853|62658702|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
33282801|NCT02101853|62658703|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
33282802|NCT02101853|62658698|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
33282803|NCT02101853|62658699|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
33282804|NCT02101853|62658700|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
33282805|NCT02101853|62658701|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
33282806|NCT02101853|62658702|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
33282807|NCT02101853|62658703|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
33282808|NCT02101853|62658698|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
33282809|NCT02101853|62658699|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
33282810|NCT02101853|62658700|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
33282811|NCT02101853|62658701|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
33282812|NCT02101853|62658702|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
33282813|NCT02101853|62658703|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
33282814|NCT02101853|62658698|FG000|Blinatumomab Salvage Therapy|Death|0|||
33282815|NCT02101853|62658699|FG001|Blinatumomab Salvage Therapy|Death|0|||
33282816|NCT02101853|62658700|FG002|Blinatumomab Salvage Therapy|Death|0|||
33282817|NCT02101853|62658701|FG003|Blinatumomab Salvage Therapy|Death|0|||
33282818|NCT02101853|62658702|FG004|Blinatumomab Salvage Therapy|Death|0|||
33282819|NCT02101853|62658703|FG005|Blinatumomab Salvage Therapy|Death|2|||
33282820|NCT02101853|62658698|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
33282821|NCT02101853|62658699|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
33282822|NCT02101853|62658700|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
33282823|NCT02101853|62658701|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
33282824|NCT02101853|62658702|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
33282825|NCT02101853|62658703|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
33282826|NCT02101853|62658698|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
33282827|NCT02101853|62658699|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
33282828|NCT02101853|62658700|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
33282829|NCT02101853|62658701|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
33282830|NCT02101853|62658702|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
33282831|NCT02101853|62658703|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
33282832|NCT02101853|62658698|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
33282833|NCT02101853|62658699|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
33282834|NCT02101853|62658700|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
33282835|NCT02101853|62658701|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
33282836|NCT02101853|62658702|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
33282837|NCT02101853|62658703|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
33282838|NCT02094261|62658715|FG000|Overall Study|Death|24|||
33282839|NCT02094261|62658715|FG000|Overall Study|Lost to Follow-up|1|||
33282840|NCT02094261|62658715|FG000|Overall Study|Withdrawal by Subject|4|||
33282841|NCT02094261|62658715|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
33282842|NCT02048813|62658721|FG000|Overall Study|Still on treatment|279|||
33282843|NCT02048813|62658722|FG001|Overall Study|Still on treatment|0|||
33282844|NCT02048813|62658721|FG000|Overall Study|Adverse Event|40|||
33282845|NCT02048813|62658722|FG001|Overall Study|Adverse Event|38|||
33282846|NCT02048813|62658721|FG000|Overall Study|Disease progression|13|||
33282847|NCT02048813|62658722|FG001|Overall Study|Disease progression|3|||
33282848|NCT02048813|62658721|FG000|Overall Study|Withdrawal by Subject|7|||
33282849|NCT02048813|62658722|FG001|Overall Study|Withdrawal by Subject|8|||
33282850|NCT02048813|62658721|FG000|Overall Study|Death|2|||
33282851|NCT02048813|62658722|FG001|Overall Study|Death|1|||
33282852|NCT02048813|62658721|FG000|Overall Study|Complication|2|||
33282853|NCT02048813|62658722|FG001|Overall Study|Complication|2|||
33282854|NCT02048813|62658721|FG000|Overall Study|Non-protocol therapy|0|||
33282855|NCT02048813|62658722|FG001|Overall Study|Non-protocol therapy|1|||
33282856|NCT02048813|62658721|FG000|Overall Study|Second primary cancer|2|||
33282857|NCT02048813|62658722|FG001|Overall Study|Second primary cancer|0|||
33282858|NCT02048813|62658721|FG000|Overall Study|Insurance|2|||
33282859|NCT02048813|62658722|FG001|Overall Study|Insurance|0|||
33282860|NCT02048813|62658721|FG000|Overall Study|Wound infection/healing|2|||
33282861|NCT02048813|62658722|FG001|Overall Study|Wound infection/healing|0|||
33282862|NCT02048813|62658721|FG000|Overall Study|Missed appointment|3|||
33282863|NCT02048813|62658722|FG001|Overall Study|Missed appointment|0|||
33282864|NCT02048813|62658721|FG000|Overall Study|Never started treatment|2|||
33282865|NCT02048813|62658722|FG001|Overall Study|Never started treatment|17|||
33282866|NCT02037529|62658730|FG000|Overall Study|Withdrawal by Subject|1|||
33282867|NCT02037529|62658731|FG001|Overall Study|Withdrawal by Subject|3|||
33282868|NCT02037529|62658730|FG000|Overall Study|Adverse Event|0|||
33282869|NCT02037529|62658731|FG001|Overall Study|Adverse Event|1|||
33282870|NCT02030028|62658738|FG000|Overall Study|Withdrawal by Subject|4|||
33282871|NCT02030028|62658738|FG000|Overall Study|lack of transportation|1|||
33282872|NCT01956123|62658744|FG000|COS Cycle 2|Protocol Violation|8|||
33282873|NCT01956123|62658745|FG001|COS Cycle 2|Protocol Violation|3|||
33282874|NCT01956123|62658746|FG002|COS Cycle 2|Protocol Violation|0|||
33282875|NCT01956123|62658747|FG003|COS Cycle 2|Protocol Violation|0|||
33282876|NCT01956123|62658744|FG000|COS Cycle 2|Adverse Event|3|||
33282877|NCT01956123|62658745|FG001|COS Cycle 2|Adverse Event|4|||
33282878|NCT01956123|62658746|FG002|COS Cycle 2|Adverse Event|0|||
33282879|NCT01956123|62658747|FG003|COS Cycle 2|Adverse Event|0|||
33282880|NCT01956123|62658744|FG000|COS Cycle 2|Personal Reasons|2|||
33282881|NCT01956123|62658745|FG001|COS Cycle 2|Personal Reasons|0|||
33282882|NCT01956123|62658746|FG002|COS Cycle 2|Personal Reasons|0|||
33282883|NCT01956123|62658747|FG003|COS Cycle 2|Personal Reasons|0|||
33282884|NCT01956123|62658744|FG000|COS Cycle 2|Withdrawal by Subject|1|||
33282885|NCT01956123|62658745|FG001|COS Cycle 2|Withdrawal by Subject|0|||
33282886|NCT01956123|62658746|FG002|COS Cycle 2|Withdrawal by Subject|0|||
33282887|NCT01956123|62658747|FG003|COS Cycle 2|Withdrawal by Subject|0|||
33282888|NCT01956123|62658744|FG000|COS Cycle 3|Protocol Violation|0|||
33282889|NCT01956123|62658745|FG001|COS Cycle 3|Protocol Violation|0|||
33282890|NCT01956123|62658746|FG002|COS Cycle 3|Protocol Violation|2|||
33282891|NCT01956123|62658747|FG003|COS Cycle 3|Protocol Violation|1|||
33282892|NCT01956123|62658744|FG000|COS Cycle 3|Adverse Event|0|||
33282893|NCT01956123|62658745|FG001|COS Cycle 3|Adverse Event|0|||
33282894|NCT01956123|62658746|FG002|COS Cycle 3|Adverse Event|3|||
33282895|NCT01956123|62658747|FG003|COS Cycle 3|Adverse Event|0|||
33282896|NCT01956123|62658744|FG000|COS Cycle 3|Personal Reasons|0|||
33282897|NCT01956123|62658745|FG001|COS Cycle 3|Personal Reasons|0|||
33282898|NCT01956123|62658746|FG002|COS Cycle 3|Personal Reasons|1|||
33282899|NCT01956123|62658747|FG003|COS Cycle 3|Personal Reasons|0|||
33282900|NCT01956123|62658744|FG000|COS Cycle 3|Withdrawal by Subject|0|||
33282901|NCT01956123|62658745|FG001|COS Cycle 3|Withdrawal by Subject|0|||
33282902|NCT01956123|62658746|FG002|COS Cycle 3|Withdrawal by Subject|0|||
33282903|NCT01956123|62658747|FG003|COS Cycle 3|Withdrawal by Subject|1|||
33662141|NCT01695239|63092835|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
33662142|NCT01695239|63092836|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33662143|NCT01695239|63092837|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33662144|NCT01695239|63092838|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33282908|NCT01263769|62658782|FG000|Overall Study|Non-Compliant with treatment|1|||
33282909|NCT01191697|62658786|FG000|Overall Study|Death|1|||
33282910|NCT01191697|62658786|FG000|Overall Study|Physician Decision|2|||
33282911|NCT01191697|62658786|FG000|Overall Study|Pursue chemoradiation|2|||
33282912|NCT01191697|62658786|FG000|Overall Study|Break from chemotherapy|2|||
33282913|NCT01191697|62658786|FG000|Overall Study|Withdrawal by Subject|1|||
33282914|NCT01191697|62658786|FG000|Overall Study|Surveillance|1|||
33282915|NCT01191697|62658786|FG000|Overall Study|Adverse Event|2|||
33282916|NCT01191697|62658786|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
33282917|NCT01191697|62658786|FG000|Overall Study|Not completed but analyzed|25|||
33282918|NCT01044745|62658790|FG000|Overall Study|Ineiligible|2|||
33282919|NCT00601900|62658797|FG000|Overall Study|Withdrawal by Subject|0|||
33282920|NCT00601900|62658798|FG001|Overall Study|Withdrawal by Subject|3|||
33282921|NCT00588770|62658806|FG000|Overall Study|Disease progression|85|||
33282922|NCT00588770|62658807|FG001|Overall Study|Disease progression|68|||
33282923|NCT00588770|62658806|FG000|Overall Study|Adverse Event|29|||
33282924|NCT00588770|62658807|FG001|Overall Study|Adverse Event|58|||
33282925|NCT00588770|62658806|FG000|Overall Study|Death|13|||
33282926|NCT00588770|62658807|FG001|Overall Study|Death|22|||
33282927|NCT00588770|62658806|FG000|Overall Study|Withdrawal by Subject|15|||
33282928|NCT00588770|62658807|FG001|Overall Study|Withdrawal by Subject|25|||
33282929|NCT00588770|62658806|FG000|Overall Study|Alternative therapy|2|||
33282930|NCT00588770|62658807|FG001|Overall Study|Alternative therapy|4|||
33282931|NCT00588770|62658806|FG000|Overall Study|Other complicating disease|3|||
33282932|NCT00588770|62658807|FG001|Overall Study|Other complicating disease|2|||
33282933|NCT00588770|62658806|FG000|Overall Study|Not start protocol therapy|0|||
33282934|NCT00588770|62658807|FG001|Overall Study|Not start protocol therapy|9|||
33282935|NCT00588770|62658806|FG000|Overall Study|Lack of Efficacy|8|||
33282936|NCT00588770|62658807|FG001|Overall Study|Lack of Efficacy|10|||
33282937|NCT00588770|62658806|FG000|Overall Study|Physician discretion|2|||
33282938|NCT00588770|62658807|FG001|Overall Study|Physician discretion|0|||
33282939|NCT00588770|62658806|FG000|Overall Study|Patient non-compliance|2|||
33282940|NCT00588770|62658807|FG001|Overall Study|Patient non-compliance|2|||
33282941|NCT00557193|62658813|FG000|Induction|Adverse Event|2|||
33282942|NCT00557193|62658814|FG001|Induction|Adverse Event|0|||
33282943|NCT00557193|62658815|FG002|Induction|Adverse Event|0|||
33282944|NCT00557193|62658816|FG003|Induction|Adverse Event|0|||
33282945|NCT00557193|62658817|FG004|Induction|Adverse Event|0|||
33282946|NCT00557193|62658818|FG005|Induction|Adverse Event|0|||
33282947|NCT00557193|62658813|FG000|Induction|Death|6|||
33282948|NCT00557193|62658814|FG001|Induction|Death|0|||
33282949|NCT00557193|62658815|FG002|Induction|Death|0|||
33282950|NCT00557193|62658816|FG003|Induction|Death|0|||
33282951|NCT00557193|62658817|FG004|Induction|Death|0|||
33282952|NCT00557193|62658818|FG005|Induction|Death|0|||
33282953|NCT00557193|62658813|FG000|Induction|Physician Decision|3|||
33282954|NCT00557193|62658814|FG001|Induction|Physician Decision|0|||
33282955|NCT00557193|62658815|FG002|Induction|Physician Decision|0|||
33282956|NCT00557193|62658816|FG003|Induction|Physician Decision|0|||
33282957|NCT00557193|62658817|FG004|Induction|Physician Decision|0|||
33282958|NCT00557193|62658818|FG005|Induction|Physician Decision|0|||
33282959|NCT00557193|62658813|FG000|Induction|Withdrawal by Subject|1|||
33282960|NCT00557193|62658814|FG001|Induction|Withdrawal by Subject|0|||
33282961|NCT00557193|62658815|FG002|Induction|Withdrawal by Subject|0|||
33282962|NCT00557193|62658816|FG003|Induction|Withdrawal by Subject|0|||
33282963|NCT00557193|62658817|FG004|Induction|Withdrawal by Subject|0|||
33282964|NCT00557193|62658818|FG005|Induction|Withdrawal by Subject|0|||
33282965|NCT00557193|62658813|FG000|Induction|Refusal of Further Protocol Therapy|2|||
33282966|NCT00557193|62658814|FG001|Induction|Refusal of Further Protocol Therapy|0|||
33282967|NCT00557193|62658815|FG002|Induction|Refusal of Further Protocol Therapy|0|||
33282968|NCT00557193|62658816|FG003|Induction|Refusal of Further Protocol Therapy|0|||
33282969|NCT00557193|62658817|FG004|Induction|Refusal of Further Protocol Therapy|0|||
33282970|NCT00557193|62658818|FG005|Induction|Refusal of Further Protocol Therapy|0|||
33282971|NCT00557193|62658813|FG000|Induction|Ineligible|8|||
33282972|NCT00557193|62658814|FG001|Induction|Ineligible|0|||
33282973|NCT00557193|62658815|FG002|Induction|Ineligible|0|||
33282974|NCT00557193|62658816|FG003|Induction|Ineligible|0|||
33282975|NCT00557193|62658817|FG004|Induction|Ineligible|0|||
33282976|NCT00557193|62658818|FG005|Induction|Ineligible|0|||
33282977|NCT00557193|62658813|FG000|Induction|Inevaluable for post Induction|2|||
33282978|NCT00557193|62658814|FG001|Induction|Inevaluable for post Induction|0|||
33282979|NCT00557193|62658815|FG002|Induction|Inevaluable for post Induction|0|||
33282980|NCT00557193|62658816|FG003|Induction|Inevaluable for post Induction|0|||
33282981|NCT00557193|62658817|FG004|Induction|Inevaluable for post Induction|0|||
33282982|NCT00557193|62658818|FG005|Induction|Inevaluable for post Induction|0|||
33282983|NCT00557193|62658813|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
33282984|NCT00557193|62658814|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
33282985|NCT00557193|62658815|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
33282986|NCT00557193|62658816|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
33282987|NCT00557193|62658817|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
33282988|NCT00557193|62658818|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
33282989|NCT00557193|62658813|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
33282990|NCT00557193|62658814|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
33282991|NCT00557193|62658815|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
33282992|NCT00557193|62658816|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
33282993|NCT00557193|62658817|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
33282994|NCT00557193|62658818|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
33282995|NCT00557193|62658813|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
33282996|NCT00557193|62658814|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
33282997|NCT00557193|62658815|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
33282998|NCT00557193|62658816|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
33282999|NCT00557193|62658817|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
33283000|NCT00557193|62658818|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
33283001|NCT00557193|62658813|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
33283002|NCT00557193|62658814|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
33283003|NCT00557193|62658815|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
33283004|NCT00557193|62658816|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
33486342|NCT03230864|62864172|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
33486343|NCT03230864|62864173|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
33486344|NCT03230864|62864174|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
33283005|NCT00557193|62658817|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
33283006|NCT00557193|62658818|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
33283007|NCT00557193|62658813|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
33283008|NCT00557193|62658814|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
33283009|NCT00557193|62658815|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
33283010|NCT00557193|62658816|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
33283011|NCT00557193|62658817|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
33283012|NCT00557193|62658818|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
33283013|NCT00557193|62658813|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
33283014|NCT00557193|62658814|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
33283015|NCT00557193|62658815|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
33283016|NCT00557193|62658816|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
33283017|NCT00557193|62658817|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
33283018|NCT00557193|62658818|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
33283019|NCT00557193|62658813|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
33283020|NCT00557193|62658814|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
33283021|NCT00557193|62658815|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
33283022|NCT00557193|62658816|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
33283023|NCT00557193|62658817|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
33283024|NCT00557193|62658818|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
33283025|NCT00557193|62658813|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
33283026|NCT00557193|62658814|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
33283027|NCT00557193|62658815|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
33283028|NCT00557193|62658816|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
33283029|NCT00557193|62658817|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
33283030|NCT00557193|62658818|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
33283031|NCT00557193|62658813|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
33283032|NCT00557193|62658814|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
33283033|NCT00557193|62658815|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
33283034|NCT00557193|62658816|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
33283035|NCT00557193|62658817|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
33283036|NCT00557193|62658818|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
33283037|NCT01295827|62658855|FG000|Overall Study|Adverse Event|1|||
33283038|NCT01295827|62658856|FG001|Overall Study|Adverse Event|2|||
33283039|NCT01295827|62658857|FG002|Overall Study|Adverse Event|2|||
33283040|NCT01295827|62658858|FG003|Overall Study|Adverse Event|1|||
33283041|NCT01295827|62658859|FG004|Overall Study|Adverse Event|1|||
33283042|NCT01295827|62658860|FG005|Overall Study|Adverse Event|4|||
33371403|NCT00843492|62750229|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
33283043|NCT01295827|62658861|FG006|Overall Study|Adverse Event|15|||
33283044|NCT01295827|62658862|FG007|Overall Study|Adverse Event|49|||
33283045|NCT01295827|62658863|FG008|Overall Study|Adverse Event|22|||
33283046|NCT01295827|62658864|FG009|Overall Study|Adverse Event|7|||
33283047|NCT01295827|62658865|FG010|Overall Study|Adverse Event|50|||
33283048|NCT01295827|62658866|FG011|Overall Study|Adverse Event|21|||
33283049|NCT01295827|62658867|FG012|Overall Study|Adverse Event|0|||
33283050|NCT01295827|62658868|FG013|Overall Study|Adverse Event|0|||
33283051|NCT01295827|62658869|FG014|Overall Study|Adverse Event|0|||
33283052|NCT01295827|62658855|FG000|Overall Study|Lost to Follow-up|0|||
33283053|NCT01295827|62658856|FG001|Overall Study|Lost to Follow-up|0|||
33371404|NCT00843492|62750228|FG000|Overall Study|Orthopedic Surgery|0|||
33371405|NCT00843492|62750229|FG001|Overall Study|Orthopedic Surgery|2|||
33371406|NCT00843492|62750228|FG000|Overall Study|Visit Not Performed|1|||
33371407|NCT00843492|62750229|FG001|Overall Study|Visit Not Performed|0|||
33371408|NCT00843492|62750228|FG000|Overall Study|Deep-vein Thrombosis|1|||
33371409|NCT00843492|62750229|FG001|Overall Study|Deep-vein Thrombosis|0|||
33371410|NCT00833976|62750235|FG000|Overall Study|Withdrawal by Subject|5|||
33371411|NCT00833976|62750235|FG000|Overall Study|Lost to Follow-up|4|||
33371412|NCT00833976|62750235|FG000|Overall Study|Did not meet eligibility criteria|41|||
33371413|NCT00833976|62750235|FG000|Overall Study|Physician Decision|1|||
33371414|NCT00833898|62750241|FG000|Overall Study|Withdrawal by Subject|33|||
33371415|NCT00833898|62750242|FG001|Overall Study|Withdrawal by Subject|27|||
33371416|NCT00833898|62750241|FG000|Overall Study|Lost to Follow-up|7|||
33371417|NCT00833898|62750242|FG001|Overall Study|Lost to Follow-up|7|||
33371418|NCT00833898|62750241|FG000|Overall Study|Patient did not receive transplant|0|||
33371419|NCT00833898|62750242|FG001|Overall Study|Patient did not receive transplant|2|||
33371420|NCT00825162|62750251|FG000|Overall Study|Withdrawal by Subject|11|||
33371421|NCT00825162|62750252|FG001|Overall Study|Withdrawal by Subject|13|||
33371422|NCT00825162|62750253|FG002|Overall Study|Withdrawal by Subject|3|||
33486345|NCT03230864|62864171|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
33486346|NCT03230864|62864172|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
33486347|NCT03230864|62864173|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
33486348|NCT03230864|62864174|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
33486349|NCT03230864|62864171|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
33556092|NCT02780167|62948896|FG002|Overall Study|No longer meets eligibility criteria|0|||
33556093|NCT02780167|62948897|FG003|Overall Study|No longer meets eligibility criteria|1|||
33283054|NCT01295827|62658857|FG002|Overall Study|Lost to Follow-up|3|||
33283055|NCT01295827|62658858|FG003|Overall Study|Lost to Follow-up|0|||
33283056|NCT01295827|62658859|FG004|Overall Study|Lost to Follow-up|1|||
33283057|NCT01295827|62658860|FG005|Overall Study|Lost to Follow-up|0|||
33283058|NCT01295827|62658861|FG006|Overall Study|Lost to Follow-up|4|||
33283059|NCT01295827|62658862|FG007|Overall Study|Lost to Follow-up|8|||
33283060|NCT01295827|62658863|FG008|Overall Study|Lost to Follow-up|7|||
33283061|NCT01295827|62658864|FG009|Overall Study|Lost to Follow-up|4|||
33283062|NCT01295827|62658865|FG010|Overall Study|Lost to Follow-up|7|||
33283063|NCT01295827|62658866|FG011|Overall Study|Lost to Follow-up|3|||
33283064|NCT01295827|62658867|FG012|Overall Study|Lost to Follow-up|0|||
33283065|NCT01295827|62658868|FG013|Overall Study|Lost to Follow-up|0|||
33283066|NCT01295827|62658869|FG014|Overall Study|Lost to Follow-up|0|||
33283067|NCT01295827|62658855|FG000|Overall Study|Not Reported|0|||
33283068|NCT01295827|62658856|FG001|Overall Study|Not Reported|0|||
33283069|NCT01295827|62658857|FG002|Overall Study|Not Reported|0|||
33283070|NCT01295827|62658858|FG003|Overall Study|Not Reported|1|||
33283071|NCT01295827|62658859|FG004|Overall Study|Not Reported|0|||
33283072|NCT01295827|62658860|FG005|Overall Study|Not Reported|0|||
33283073|NCT01295827|62658861|FG006|Overall Study|Not Reported|24|||
33283074|NCT01295827|62658862|FG007|Overall Study|Not Reported|58|||
33283075|NCT01295827|62658863|FG008|Overall Study|Not Reported|41|||
33283076|NCT01295827|62658864|FG009|Overall Study|Not Reported|2|||
33283077|NCT01295827|62658865|FG010|Overall Study|Not Reported|23|||
33283078|NCT01295827|62658866|FG011|Overall Study|Not Reported|13|||
33283079|NCT01295827|62658867|FG012|Overall Study|Not Reported|0|||
33283080|NCT01295827|62658868|FG013|Overall Study|Not Reported|0|||
33283081|NCT01295827|62658869|FG014|Overall Study|Not Reported|0|||
33283082|NCT01295827|62658855|FG000|Overall Study|Progressive Disease|2|||
33283083|NCT01295827|62658856|FG001|Overall Study|Progressive Disease|1|||
33371423|NCT00825162|62750251|FG000|Overall Study|Lost to Follow-up|9|||
33371424|NCT00825162|62750252|FG001|Overall Study|Lost to Follow-up|6|||
33371425|NCT00825162|62750253|FG002|Overall Study|Lost to Follow-up|3|||
33371426|NCT00825162|62750251|FG000|Overall Study|Physician Decision|2|||
33371427|NCT00825162|62750252|FG001|Overall Study|Physician Decision|0|||
33371428|NCT00825162|62750253|FG002|Overall Study|Physician Decision|0|||
33371429|NCT00825162|62750251|FG000|Overall Study|Move away from the study area|1|||
33371430|NCT00825162|62750252|FG001|Overall Study|Move away from the study area|0|||
33371431|NCT00825162|62750253|FG002|Overall Study|Move away from the study area|0|||
33371432|NCT00825162|62750251|FG000|Overall Study|Unable to attend the study visit|5|||
33371433|NCT00825162|62750252|FG001|Overall Study|Unable to attend the study visit|2|||
33371434|NCT00825162|62750253|FG002|Overall Study|Unable to attend the study visit|0|||
33371435|NCT00824850|62750268|FG000|Overall Study|Withdrawal by Subject|0|||
33371436|NCT00824850|62750269|FG001|Overall Study|Withdrawal by Subject|1|||
33371437|NCT00596687|62750283|FG000|Overall Study|< 24 hours of insulin treatment|8|||
33283084|NCT01295827|62658857|FG002|Overall Study|Progressive Disease|5|||
33283085|NCT01295827|62658858|FG003|Overall Study|Progressive Disease|2|||
33283086|NCT01295827|62658859|FG004|Overall Study|Progressive Disease|0|||
33283087|NCT01295827|62658860|FG005|Overall Study|Progressive Disease|1|||
33283088|NCT01295827|62658861|FG006|Overall Study|Progressive Disease|87|||
33283089|NCT01295827|62658862|FG007|Overall Study|Progressive Disease|144|||
33283090|NCT01295827|62658863|FG008|Overall Study|Progressive Disease|85|||
33283091|NCT01295827|62658864|FG009|Overall Study|Progressive Disease|40|||
33371438|NCT00596687|62750284|FG001|Overall Study|< 24 hours of insulin treatment|6|||
33371439|NCT00596687|62750283|FG000|Overall Study|continuous insulin infusion during TPN|2|||
33371440|NCT00596687|62750284|FG001|Overall Study|continuous insulin infusion during TPN|1|||
33371441|NCT00596687|62750283|FG000|Overall Study|Withdrawal by Subject|3|||
33371442|NCT00596687|62750284|FG001|Overall Study|Withdrawal by Subject|1|||
33371443|NCT00596687|62750283|FG000|Overall Study|cancelled surgery|1|||
33371444|NCT00596687|62750284|FG001|Overall Study|cancelled surgery|1|||
33371445|NCT00824772|62750290|FG000|Overall Study|Withdrawal by Subject|8|||
33283092|NCT01295827|62658865|FG010|Overall Study|Progressive Disease|175|||
33283093|NCT01295827|62658866|FG011|Overall Study|Progressive Disease|136|||
33371446|NCT00824616|62750296|FG000|Overall Study|Adverse Event|2|||
33486350|NCT03230864|62864172|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
33486351|NCT03230864|62864173|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
33283094|NCT01295827|62658867|FG012|Overall Study|Progressive Disease|0|||
33283095|NCT01295827|62658868|FG013|Overall Study|Progressive Disease|0|||
33283096|NCT01295827|62658869|FG014|Overall Study|Progressive Disease|0|||
33283097|NCT01295827|62658855|FG000|Overall Study|Screen Failure|0|||
33283098|NCT01295827|62658856|FG001|Overall Study|Screen Failure|0|||
33283099|NCT01295827|62658857|FG002|Overall Study|Screen Failure|0|||
33283100|NCT01295827|62658858|FG003|Overall Study|Screen Failure|0|||
33283101|NCT01295827|62658859|FG004|Overall Study|Screen Failure|0|||
33283102|NCT01295827|62658860|FG005|Overall Study|Screen Failure|0|||
33283103|NCT01295827|62658861|FG006|Overall Study|Screen Failure|2|||
33283104|NCT01295827|62658862|FG007|Overall Study|Screen Failure|2|||
33283105|NCT01295827|62658863|FG008|Overall Study|Screen Failure|2|||
33283106|NCT01295827|62658864|FG009|Overall Study|Screen Failure|0|||
33283107|NCT01295827|62658865|FG010|Overall Study|Screen Failure|1|||
33371447|NCT00824616|62750297|FG001|Overall Study|Adverse Event|1|||
33371448|NCT00824616|62750296|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
33371449|NCT00824616|62750297|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
33371450|NCT00824616|62750296|FG000|Overall Study|Hyperglycemia|1|||
33371451|NCT00824616|62750297|FG001|Overall Study|Hyperglycemia|1|||
33371452|NCT00824616|62750296|FG000|Overall Study|Lack of Efficacy|2|||
33371453|NCT00824616|62750297|FG001|Overall Study|Lack of Efficacy|1|||
33283108|NCT01295827|62658866|FG011|Overall Study|Screen Failure|0|||
33283109|NCT01295827|62658867|FG012|Overall Study|Screen Failure|0|||
33283110|NCT01295827|62658868|FG013|Overall Study|Screen Failure|0|||
33283111|NCT01295827|62658869|FG014|Overall Study|Screen Failure|0|||
33283112|NCT01295827|62658855|FG000|Overall Study|Withdrawal by Subject|1|||
33283113|NCT01295827|62658856|FG001|Overall Study|Withdrawal by Subject|0|||
33283114|NCT01295827|62658857|FG002|Overall Study|Withdrawal by Subject|2|||
33283115|NCT01295827|62658858|FG003|Overall Study|Withdrawal by Subject|0|||
33283116|NCT01295827|62658859|FG004|Overall Study|Withdrawal by Subject|0|||
33283117|NCT01295827|62658860|FG005|Overall Study|Withdrawal by Subject|1|||
33283118|NCT01295827|62658861|FG006|Overall Study|Withdrawal by Subject|13|||
33283119|NCT01295827|62658862|FG007|Overall Study|Withdrawal by Subject|35|||
33283120|NCT01295827|62658863|FG008|Overall Study|Withdrawal by Subject|11|||
33283121|NCT01295827|62658864|FG009|Overall Study|Withdrawal by Subject|2|||
33283122|NCT01295827|62658865|FG010|Overall Study|Withdrawal by Subject|18|||
33283123|NCT01295827|62658866|FG011|Overall Study|Withdrawal by Subject|13|||
33283124|NCT01295827|62658867|FG012|Overall Study|Withdrawal by Subject|0|||
33283125|NCT01295827|62658868|FG013|Overall Study|Withdrawal by Subject|0|||
33283126|NCT01295827|62658869|FG014|Overall Study|Withdrawal by Subject|0|||
33283127|NCT01295827|62658855|FG000|Overall Study|Other|0|||
33283128|NCT01295827|62658856|FG001|Overall Study|Other|0|||
33371454|NCT00824616|62750296|FG000|Overall Study|Lost to Follow-up|0|||
33371455|NCT00824616|62750297|FG001|Overall Study|Lost to Follow-up|1|||
33371456|NCT00824616|62750296|FG000|Overall Study|Withdrawal by Subject|1|||
33371457|NCT00824616|62750297|FG001|Overall Study|Withdrawal by Subject|1|||
33283129|NCT01295827|62658857|FG002|Overall Study|Other|0|||
33283130|NCT01295827|62658858|FG003|Overall Study|Other|0|||
33283131|NCT01295827|62658859|FG004|Overall Study|Other|0|||
33283132|NCT01295827|62658860|FG005|Overall Study|Other|0|||
33283133|NCT01295827|62658861|FG006|Overall Study|Other|1|||
33283134|NCT01295827|62658862|FG007|Overall Study|Other|1|||
33283135|NCT01295827|62658863|FG008|Overall Study|Other|1|||
33283136|NCT01295827|62658864|FG009|Overall Study|Other|0|||
33283137|NCT01295827|62658865|FG010|Overall Study|Other|2|||
33283138|NCT01295827|62658866|FG011|Overall Study|Other|0|||
33283139|NCT01295827|62658867|FG012|Overall Study|Other|0|||
33283140|NCT01295827|62658868|FG013|Overall Study|Other|0|||
33283141|NCT01295827|62658869|FG014|Overall Study|Other|0|||
33283142|NCT01295671|62658925|FG000|Overall Study|Lost to Follow-up|4|||
33283143|NCT01295671|62658926|FG001|Overall Study|Lost to Follow-up|6|||
33283144|NCT01295671|62658927|FG002|Overall Study|Lost to Follow-up|3|||
33283145|NCT01295671|62658925|FG000|Overall Study|Withdrawal by Subject|3|||
33283146|NCT01295671|62658926|FG001|Overall Study|Withdrawal by Subject|1|||
33283147|NCT01295671|62658927|FG002|Overall Study|Withdrawal by Subject|0|||
33283148|NCT01295320|62658935|FG000|Overall Study|Adverse Event|2|||
33283149|NCT01295320|62658935|FG000|Overall Study|Lost to Follow-up|4|||
33283150|NCT01295320|62658935|FG000|Overall Study|Withdrawal by Subject|2|||
33283151|NCT01295320|62658935|FG000|Overall Study|Subject was bedridden|1|||
33283152|NCT01295320|62658935|FG000|Overall Study|Unable to travel|1|||
33283153|NCT01295281|62658941|FG000|First Intervention (7 Days)|Death|0|||
33283154|NCT01295281|62658942|FG001|First Intervention (7 Days)|Death|1|||
33283155|NCT01294696|62658950|FG000|Overall Study|Screening failures|7|||
33283156|NCT01294696|62658950|FG000|Overall Study|Protocol Violation|8|||
33283157|NCT01294696|62658950|FG000|Overall Study|Missing BPI Response|7|||
33283158|NCT01294696|62658950|FG000|Overall Study|Site closure|52|||
33283159|NCT01294579|62658955|FG000|Overall Study|Disease progression|12|||
33283160|NCT01294579|62658955|FG000|Overall Study|Adverse Event|11|||
33283161|NCT01294579|62658955|FG000|Overall Study|Study closed/terminated|3|||
33371458|NCT00824382|62750307|FG000|Overall Study|Adverse Event|4|||
33371459|NCT00824382|62750308|FG001|Overall Study|Adverse Event|1|||
33283162|NCT01294579|62658955|FG000|Overall Study|Lost to Follow-up|1|||
33283163|NCT01294579|62658955|FG000|Overall Study|Physician Decision|3|||
33283164|NCT01294579|62658955|FG000|Overall Study|Withdrawal by Subject|5|||
33283165|NCT01294462|62658961|FG000|Overall Study|Lost to Follow-up|1|||
33283166|NCT01294462|62658962|FG001|Overall Study|Lost to Follow-up|0|||
33283167|NCT01294462|62658961|FG000|Overall Study|Withdrawal by Subject|65|||
33371460|NCT00824382|62750309|FG002|Overall Study|Adverse Event|1|||
33371461|NCT00824382|62750310|FG003|Overall Study|Adverse Event|4|||
33283168|NCT01294462|62658962|FG001|Overall Study|Withdrawal by Subject|63|||
33283169|NCT01294423|62658971|FG000|Overall Study|Adverse Event|1|||
33283170|NCT01294423|62658972|FG001|Overall Study|Adverse Event|2|||
33283171|NCT01294423|62658973|FG002|Overall Study|Adverse Event|3|||
33371462|NCT00824382|62750307|FG000|Overall Study|Protocol Violation|1|||
33283172|NCT01294423|62658971|FG000|Overall Study|Withdrawal by Subject|1|||
33283173|NCT01294423|62658972|FG001|Overall Study|Withdrawal by Subject|2|||
33283174|NCT01294423|62658973|FG002|Overall Study|Withdrawal by Subject|2|||
33283175|NCT01294423|62658971|FG000|Overall Study|subject no longer meets study criteria|2|||
33283176|NCT01294423|62658972|FG001|Overall Study|subject no longer meets study criteria|5|||
33283177|NCT01294423|62658973|FG002|Overall Study|subject no longer meets study criteria|2|||
33283178|NCT01294423|62658971|FG000|Overall Study|poor/non-compliance|1|||
33283179|NCT01294423|62658972|FG001|Overall Study|poor/non-compliance|0|||
33283180|NCT01294423|62658973|FG002|Overall Study|poor/non-compliance|1|||
33283181|NCT01294150|62658983|FG000|Overall Study|Physician Decision|2|||
33283182|NCT01294150|62658984|FG001|Overall Study|Physician Decision|2|||
33371463|NCT00824382|62750308|FG001|Overall Study|Protocol Violation|0|||
33371464|NCT00824382|62750309|FG002|Overall Study|Protocol Violation|0|||
33371465|NCT00824382|62750310|FG003|Overall Study|Protocol Violation|1|||
33371466|NCT00824382|62750307|FG000|Overall Study|Investigator's decision|0|||
33371467|NCT00824382|62750308|FG001|Overall Study|Investigator's decision|1|||
33371468|NCT00824382|62750309|FG002|Overall Study|Investigator's decision|2|||
33371469|NCT00824382|62750310|FG003|Overall Study|Investigator's decision|0|||
33371470|NCT00833040|62750322|FG000|Overall Study|Adverse Event|0|||
33371471|NCT00833040|62750323|FG001|Overall Study|Adverse Event|0|||
33371472|NCT00833040|62750324|FG002|Overall Study|Adverse Event|0|||
33371473|NCT00833040|62750325|FG003|Overall Study|Adverse Event|0|||
33371474|NCT00833040|62750326|FG004|Overall Study|Adverse Event|0|||
33371475|NCT00833040|62750327|FG005|Overall Study|Adverse Event|1|||
33371476|NCT00843024|62750336|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
33371477|NCT00843024|62750337|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
33371478|NCT00843024|62750338|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
33371479|NCT00843024|62750339|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
33371480|NCT00843024|62750340|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
33371481|NCT00843024|62750341|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
33371482|NCT00843024|62750336|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
33371483|NCT00843024|62750337|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
33371484|NCT00843024|62750338|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
33371485|NCT00843024|62750339|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
33371486|NCT00843024|62750340|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
33371487|NCT00843024|62750341|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
33371488|NCT00843024|62750336|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
33371489|NCT00843024|62750337|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
33371490|NCT00843024|62750338|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
33371491|NCT00843024|62750339|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
33371492|NCT00843024|62750340|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
33371493|NCT00843024|62750341|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
33371494|NCT00843024|62750336|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
33371495|NCT00843024|62750337|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
33371496|NCT00843024|62750338|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
33371497|NCT00843024|62750339|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
33371498|NCT00843024|62750340|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
33371499|NCT00843024|62750341|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
33371500|NCT00843024|62750336|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
33371501|NCT00843024|62750337|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
33371502|NCT00843024|62750338|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
33371503|NCT00843024|62750339|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
33283183|NCT01292473|62658996|FG000|Overall Study|Adverse Event|1|||
33283184|NCT01292473|62658997|FG001|Overall Study|Adverse Event|0|||
33283185|NCT01292473|62658998|FG002|Overall Study|Adverse Event|1|||
33283186|NCT01292473|62658999|FG003|Overall Study|Adverse Event|1|||
33283187|NCT01292473|62658996|FG000|Overall Study|Lost to Follow-up|1|||
33283188|NCT01292473|62658997|FG001|Overall Study|Lost to Follow-up|1|||
33283189|NCT01292473|62658998|FG002|Overall Study|Lost to Follow-up|2|||
33283190|NCT01292473|62658999|FG003|Overall Study|Lost to Follow-up|2|||
33371504|NCT00843024|62750340|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
33371505|NCT00843024|62750341|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
33371506|NCT00843024|62750336|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
33371507|NCT00843024|62750337|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
33371508|NCT00843024|62750338|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
33486352|NCT03230864|62864174|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
33283191|NCT01292473|62658996|FG000|Overall Study|Withdrawal by Subject|3|||
33283192|NCT01292473|62658997|FG001|Overall Study|Withdrawal by Subject|4|||
33283193|NCT01292473|62658998|FG002|Overall Study|Withdrawal by Subject|3|||
33283194|NCT01292473|62658999|FG003|Overall Study|Withdrawal by Subject|3|||
33283195|NCT01292473|62658996|FG000|Overall Study|Physician Decision|0|||
33283196|NCT01292473|62658997|FG001|Overall Study|Physician Decision|1|||
33283197|NCT01292473|62658998|FG002|Overall Study|Physician Decision|0|||
33283198|NCT01292473|62658999|FG003|Overall Study|Physician Decision|0|||
33283199|NCT01292473|62658996|FG000|Overall Study|Disease Progression|0|||
33283200|NCT01292473|62658997|FG001|Overall Study|Disease Progression|1|||
33283201|NCT01292473|62658998|FG002|Overall Study|Disease Progression|3|||
33283202|NCT01292473|62658999|FG003|Overall Study|Disease Progression|6|||
33283203|NCT01292239|62659015|FG000|Overall Study|Other|1|||
33283204|NCT01292239|62659016|FG001|Overall Study|Other|1|||
33283205|NCT01292239|62659015|FG000|Overall Study|Withdrawal by Subject|3|||
33283206|NCT01292239|62659016|FG001|Overall Study|Withdrawal by Subject|6|||
33283207|NCT01291225|62659024|FG000|Overall Study|Lost to Follow-up|85|||
33283208|NCT01291225|62659025|FG001|Overall Study|Lost to Follow-up|39|||
33283209|NCT01290796|62659035|FG000|Overall Study|Lost to Follow-up|21|||
33283210|NCT01290796|62659035|FG000|Overall Study|Withdrawal by Subject|4|||
33283211|NCT01290796|62659035|FG000|Overall Study|Physician Decision|2|||
33283212|NCT01290796|62659035|FG000|Overall Study|Secondary Surgical Intervention|2|||
33283213|NCT01290796|62659035|FG000|Overall Study|Withdrawal by Sponsor|1|||
33283214|NCT01290757|62659041|FG000|Overall Study|Adverse Event|1|||
33283215|NCT01290757|62659042|FG001|Overall Study|Adverse Event|0|||
33283216|NCT01290757|62659041|FG000|Overall Study|Protocol Violation|1|||
33283217|NCT01290757|62659042|FG001|Overall Study|Protocol Violation|1|||
33283218|NCT01290757|62659041|FG000|Overall Study|Other|0|||
33283219|NCT01290757|62659042|FG001|Overall Study|Other|1|||
33283220|NCT01290718|62659048|FG000|Overall Study|Early termination of the study|4|||
33283221|NCT01290679|62659054|FG000|Overall Study|Adverse Event|2|||
33283222|NCT01290679|62659055|FG001|Overall Study|Adverse Event|0|||
33283223|NCT01290679|62659054|FG000|Overall Study|Lost to Follow-up|8|||
33283224|NCT01290679|62659055|FG001|Overall Study|Lost to Follow-up|10|||
33283225|NCT01290679|62659054|FG000|Overall Study|Protocol Violation|0|||
33283226|NCT01290679|62659055|FG001|Overall Study|Protocol Violation|1|||
33283227|NCT01290679|62659054|FG000|Overall Study|Withdrawal by Subject|6|||
33283228|NCT01290679|62659055|FG001|Overall Study|Withdrawal by Subject|5|||
33371509|NCT00843024|62750339|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
33371510|NCT00843024|62750340|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
33371511|NCT00843024|62750341|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
33371512|NCT00843024|62750336|FG000|Single-blind Placebo Run-In Phase|Other|0|||
33371513|NCT00843024|62750337|FG001|Single-blind Placebo Run-In Phase|Other|1|||
33371514|NCT00843024|62750338|FG002|Single-blind Placebo Run-In Phase|Other|0|||
33371515|NCT00843024|62750339|FG003|Single-blind Placebo Run-In Phase|Other|0|||
33371516|NCT00843024|62750340|FG004|Single-blind Placebo Run-In Phase|Other|0|||
33371517|NCT00843024|62750341|FG005|Single-blind Placebo Run-In Phase|Other|0|||
33371518|NCT00843024|62750336|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
33371519|NCT00843024|62750337|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
33371520|NCT00843024|62750338|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
33371521|NCT00843024|62750339|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
33371522|NCT00843024|62750340|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
33371523|NCT00843024|62750341|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
33371524|NCT00843024|62750336|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
33283229|NCT01290679|62659054|FG000|Overall Study|Subject Entered Another Trial|0|||
33283230|NCT01290679|62659055|FG001|Overall Study|Subject Entered Another Trial|5|||
33283231|NCT01290601|62659063|FG000|Overall Study|Adverse Event|0|||
33371525|NCT00843024|62750337|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
33371526|NCT00843024|62750338|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
33371527|NCT00843024|62750339|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
33371528|NCT00843024|62750340|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
33371529|NCT00843024|62750341|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
33371530|NCT00843024|62750336|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33371531|NCT00843024|62750337|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33371532|NCT00843024|62750338|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33371533|NCT00843024|62750339|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
33556094|NCT02780167|62948898|FG004|Overall Study|No longer meets eligibility criteria|1|||
33371534|NCT00843024|62750340|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33371535|NCT00843024|62750341|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
33371536|NCT00843024|62750336|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
33371537|NCT00843024|62750337|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
33283232|NCT01290601|62659064|FG001|Overall Study|Adverse Event|2|||
33283233|NCT01290601|62659065|FG002|Overall Study|Adverse Event|0|||
33283234|NCT01290601|62659066|FG003|Overall Study|Adverse Event|0|||
33283235|NCT01290601|62659063|FG000|Overall Study|Lack of Efficacy|2|||
33283236|NCT01290601|62659064|FG001|Overall Study|Lack of Efficacy|1|||
33283237|NCT01290601|62659065|FG002|Overall Study|Lack of Efficacy|0|||
33283238|NCT01290601|62659066|FG003|Overall Study|Lack of Efficacy|0|||
33283239|NCT01290601|62659063|FG000|Overall Study|Lost to Follow-up|7|||
33283240|NCT01290601|62659064|FG001|Overall Study|Lost to Follow-up|2|||
33283241|NCT01290601|62659065|FG002|Overall Study|Lost to Follow-up|0|||
33283242|NCT01290601|62659066|FG003|Overall Study|Lost to Follow-up|0|||
33283243|NCT01290601|62659063|FG000|Overall Study|Other|1|||
33283244|NCT01290601|62659064|FG001|Overall Study|Other|0|||
33283245|NCT01290601|62659065|FG002|Overall Study|Other|0|||
33283246|NCT01290601|62659066|FG003|Overall Study|Other|0|||
33283247|NCT01290601|62659063|FG000|Overall Study|Protocol Violation|1|||
33283248|NCT01290601|62659064|FG001|Overall Study|Protocol Violation|0|||
33283249|NCT01290601|62659065|FG002|Overall Study|Protocol Violation|0|||
33283250|NCT01290601|62659066|FG003|Overall Study|Protocol Violation|0|||
33283251|NCT01290523|62659072|FG000|Overall Study|Death|3|||
33283252|NCT01290094|62659076|FG000|Overall Study|Withdrawal by Subject|1|||
33283253|NCT01290094|62659076|FG000|Overall Study|Lost to Follow-up|5|||
33283254|NCT01289821|62659089|FG000|Treatment Period|Withdrawal by Subject|1|||
33371538|NCT00843024|62750338|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
33371539|NCT00843024|62750339|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
33371540|NCT00843024|62750340|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
33371541|NCT00843024|62750341|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
33371542|NCT00843024|62750336|FG000|Double-blind Treatment Phase|Physician Decision|0|||
33371543|NCT00843024|62750337|FG001|Double-blind Treatment Phase|Physician Decision|0|||
33283255|NCT01289821|62659089|FG000|Treatment Period|Physician Decision|3|||
33283256|NCT01289821|62659089|FG000|Treatment Period|Adverse Event|4|||
33283257|NCT01289821|62659089|FG000|Treatment Period|Radiological Progression|43|||
33283258|NCT01289821|62659089|FG000|Treatment Period|Clinical Progression|2|||
33283259|NCT01289821|62659089|FG000|Treatment Period|Therapeutic procedure required|1|||
33283260|NCT01289821|62659089|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
33283261|NCT01289821|62659089|FG000|Safety Follow-up Period|Protocol Violation|3|||
33283262|NCT01289821|62659089|FG000|Safety Follow-up Period|Unspecified reason|1|||
33371544|NCT00843024|62750338|FG002|Double-blind Treatment Phase|Physician Decision|0|||
33371545|NCT00843024|62750339|FG003|Double-blind Treatment Phase|Physician Decision|3|||
33371546|NCT00843024|62750340|FG004|Double-blind Treatment Phase|Physician Decision|1|||
33371547|NCT00843024|62750341|FG005|Double-blind Treatment Phase|Physician Decision|1|||
33556095|NCT02780167|62948894|FG000|Overall Study|Protocol Violation|5|||
33556096|NCT02780167|62948895|FG001|Overall Study|Protocol Violation|5|||
33556097|NCT02780167|62948896|FG002|Overall Study|Protocol Violation|1|||
33283263|NCT01289821|62659089|FG000|Survival Follow-up Period|Protocol Violation|1|||
33283264|NCT01289821|62659089|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
33283265|NCT01289821|62659089|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
33283266|NCT01289782|62659095|FG000|Overall Study|Lost to Follow-up|14|||
33283267|NCT01289782|62659096|FG001|Overall Study|Lost to Follow-up|7|||
33283268|NCT01289782|62659095|FG000|Overall Study|Protocol Violation|1|||
33283269|NCT01289782|62659096|FG001|Overall Study|Protocol Violation|1|||
33283270|NCT01289782|62659095|FG000|Overall Study|Withdrawal by Subject|8|||
33283271|NCT01289782|62659096|FG001|Overall Study|Withdrawal by Subject|2|||
33283272|NCT01289782|62659095|FG000|Overall Study|Sponsor's Decision|1|||
33283273|NCT01289782|62659096|FG001|Overall Study|Sponsor's Decision|0|||
33283274|NCT01289782|62659095|FG000|Overall Study|Reason not specified|1|||
33283275|NCT01289782|62659096|FG001|Overall Study|Reason not specified|2|||
33283276|NCT01289353|62659102|FG000|Overall Study|Lost to Follow-up|2|||
33283277|NCT01289119|62659112|FG000|Overall Study|Adverse Event|2|||
33283278|NCT01289119|62659113|FG001|Overall Study|Adverse Event|1|||
33283279|NCT01289119|62659114|FG002|Overall Study|Adverse Event|0|||
33283280|NCT01289119|62659115|FG003|Overall Study|Adverse Event|2|||
33283281|NCT01289119|62659116|FG004|Overall Study|Adverse Event|1|||
33283282|NCT01289119|62659117|FG005|Overall Study|Adverse Event|0|||
33283283|NCT01289119|62659112|FG000|Overall Study|Major Protocol Deviation|2|||
33283284|NCT01289119|62659113|FG001|Overall Study|Major Protocol Deviation|1|||
33283285|NCT01289119|62659114|FG002|Overall Study|Major Protocol Deviation|3|||
33283286|NCT01289119|62659115|FG003|Overall Study|Major Protocol Deviation|0|||
33283287|NCT01289119|62659116|FG004|Overall Study|Major Protocol Deviation|2|||
33283288|NCT01289119|62659117|FG005|Overall Study|Major Protocol Deviation|1|||
33283289|NCT01289119|62659112|FG000|Overall Study|Lost to Follow-up|0|||
33283290|NCT01289119|62659113|FG001|Overall Study|Lost to Follow-up|3|||
33283291|NCT01289119|62659114|FG002|Overall Study|Lost to Follow-up|0|||
33283292|NCT01289119|62659115|FG003|Overall Study|Lost to Follow-up|0|||
33371548|NCT00843024|62750336|FG000|Double-blind Treatment Phase|Adverse Event|0|||
33371549|NCT00843024|62750337|FG001|Double-blind Treatment Phase|Adverse Event|0|||
33556098|NCT02780167|62948897|FG003|Overall Study|Protocol Violation|1|||
33556099|NCT02780167|62948898|FG004|Overall Study|Protocol Violation|2|||
33283293|NCT01289119|62659116|FG004|Overall Study|Lost to Follow-up|0|||
33283294|NCT01289119|62659117|FG005|Overall Study|Lost to Follow-up|1|||
33283295|NCT01289119|62659112|FG000|Overall Study|Withdrawal by Subject|4|||
33283296|NCT01289119|62659113|FG001|Overall Study|Withdrawal by Subject|2|||
33556100|NCT02780167|62948894|FG000|Overall Study|Withdrawal by Subject|6|||
33283297|NCT01289119|62659114|FG002|Overall Study|Withdrawal by Subject|4|||
33283298|NCT01289119|62659115|FG003|Overall Study|Withdrawal by Subject|3|||
33283299|NCT01289119|62659116|FG004|Overall Study|Withdrawal by Subject|1|||
33283300|NCT01289119|62659117|FG005|Overall Study|Withdrawal by Subject|1|||
33283301|NCT01289119|62659112|FG000|Overall Study|Pregnancy|0|||
33283302|NCT01289119|62659113|FG001|Overall Study|Pregnancy|1|||
33283303|NCT01289119|62659114|FG002|Overall Study|Pregnancy|0|||
33283304|NCT01289119|62659115|FG003|Overall Study|Pregnancy|0|||
33283305|NCT01289119|62659116|FG004|Overall Study|Pregnancy|0|||
33283306|NCT01289119|62659117|FG005|Overall Study|Pregnancy|0|||
33283307|NCT01289119|62659112|FG000|Overall Study|Lack of Efficacy|0|||
33283308|NCT01289119|62659113|FG001|Overall Study|Lack of Efficacy|1|||
33283309|NCT01289119|62659114|FG002|Overall Study|Lack of Efficacy|1|||
33283310|NCT01289119|62659115|FG003|Overall Study|Lack of Efficacy|1|||
33283311|NCT01289119|62659116|FG004|Overall Study|Lack of Efficacy|1|||
33283312|NCT01289119|62659117|FG005|Overall Study|Lack of Efficacy|1|||
33283313|NCT01289119|62659112|FG000|Overall Study|Other|1|||
33283314|NCT01289119|62659113|FG001|Overall Study|Other|0|||
33371550|NCT00843024|62750338|FG002|Double-blind Treatment Phase|Adverse Event|0|||
33371551|NCT00843024|62750339|FG003|Double-blind Treatment Phase|Adverse Event|0|||
33371552|NCT00843024|62750340|FG004|Double-blind Treatment Phase|Adverse Event|1|||
33371553|NCT00843024|62750341|FG005|Double-blind Treatment Phase|Adverse Event|1|||
33371554|NCT00843024|62750336|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
33556101|NCT02780167|62948895|FG001|Overall Study|Withdrawal by Subject|4|||
33556102|NCT02780167|62948896|FG002|Overall Study|Withdrawal by Subject|4|||
33556103|NCT02780167|62948897|FG003|Overall Study|Withdrawal by Subject|3|||
33556104|NCT02780167|62948898|FG004|Overall Study|Withdrawal by Subject|4|||
33556105|NCT02780167|62948894|FG000|Overall Study|Other|0|||
33556106|NCT02780167|62948895|FG001|Overall Study|Other|0|||
33556107|NCT02780167|62948896|FG002|Overall Study|Other|3|||
33556108|NCT02780167|62948897|FG003|Overall Study|Other|1|||
33556109|NCT02780167|62948898|FG004|Overall Study|Other|2|||
33556110|NCT02779075|62948910|FG000|Overall Study|Withdrawal by Subject|1|||
33556111|NCT02779075|62948911|FG001|Overall Study|Withdrawal by Subject|3|||
33556112|NCT02779075|62948910|FG000|Overall Study|IV lost during 2nd study|1|||
33556113|NCT02779075|62948911|FG001|Overall Study|IV lost during 2nd study|0|||
33556114|NCT00105079|62948923|FG000|Overall Study|Adverse Event|5|||
33556115|NCT00105079|62948924|FG001|Overall Study|Adverse Event|12|||
33556116|NCT00105079|62948923|FG000|Overall Study|Death|3|||
33556117|NCT00105079|62948924|FG001|Overall Study|Death|1|||
33556118|NCT00105079|62948923|FG000|Overall Study|Lost to Follow-up|12|||
33556119|NCT00105079|62948924|FG001|Overall Study|Lost to Follow-up|12|||
33556120|NCT00105079|62948923|FG000|Overall Study|Lack of Efficacy|9|||
33556121|NCT00105079|62948924|FG001|Overall Study|Lack of Efficacy|3|||
33371555|NCT00843024|62750337|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
33371556|NCT00843024|62750338|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
33371557|NCT00843024|62750339|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
33371558|NCT00843024|62750340|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
33371559|NCT00843024|62750341|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
33371560|NCT00832650|62750357|FG000|Overall Study|Randomized but not treated|0|||
33371561|NCT00832650|62750358|FG001|Overall Study|Randomized but not treated|0|||
33371562|NCT00832650|62750359|FG002|Overall Study|Randomized but not treated|1|||
33371563|NCT00595517|62750367|FG000|Overall Study|Adverse Event|6|||
33371564|NCT00595517|62750367|FG000|Overall Study|Withdrawal by Subject|4|||
33371565|NCT00595517|62750367|FG000|Overall Study|Protocol Violation|2|||
33371566|NCT00595517|62750367|FG000|Overall Study|Recurrence of ulcer|5|||
33371567|NCT00595517|62750367|FG000|Overall Study|usage of prohibited treatment|1|||
33371568|NCT00595517|62750367|FG000|Overall Study|No intention to attend regularly|1|||
33371569|NCT00823836|62750373|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
33371570|NCT00823836|62750374|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
33371571|NCT00823836|62750373|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
33556122|NCT00105079|62948923|FG000|Overall Study|Refused treatment|6|||
33283315|NCT01289119|62659114|FG002|Overall Study|Other|1|||
33371572|NCT00823836|62750374|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
33371573|NCT00823836|62750373|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
33371574|NCT00823836|62750374|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
33371575|NCT00823836|62750373|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
33556123|NCT00105079|62948924|FG001|Overall Study|Refused treatment|4|||
33556124|NCT00105079|62948923|FG000|Overall Study|Violation of selection criteria at entry|0|||
33556125|NCT00105079|62948924|FG001|Overall Study|Violation of selection criteria at entry|2|||
33283316|NCT01289119|62659115|FG003|Overall Study|Other|0|||
33283317|NCT01289119|62659116|FG004|Overall Study|Other|0|||
33283318|NCT01289119|62659117|FG005|Overall Study|Other|0|||
33283319|NCT01289041|62659131|FG000|Overall Study|Adverse Event|24|||
33283320|NCT01289041|62659131|FG000|Overall Study|Physician Decision|1|||
33556126|NCT00105079|62948923|FG000|Overall Study|Protocol Violation|1|||
33556127|NCT00105079|62948924|FG001|Overall Study|Protocol Violation|0|||
33283321|NCT01289041|62659131|FG000|Overall Study|Progressive Disease|41|||
33283322|NCT01289041|62659131|FG000|Overall Study|Withdrawal by Subject|3|||
33371576|NCT00823836|62750374|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
33371577|NCT00823836|62750373|FG000|Long-term Phase|Adverse Event|3|||
33371578|NCT00823836|62750374|FG001|Long-term Phase|Adverse Event|2|||
33371579|NCT00823836|62750373|FG000|Long-term Phase|Physician Decision|1|||
33371580|NCT00823836|62750374|FG001|Long-term Phase|Physician Decision|2|||
33371581|NCT00823836|62750373|FG000|Long-term Phase|Withdrawal by Subject|1|||
33371582|NCT00823836|62750374|FG001|Long-term Phase|Withdrawal by Subject|1|||
33371583|NCT00879437|62750383|FG000|Overall Study|Protocol Violation|0|||
33371584|NCT00879437|62750384|FG001|Overall Study|Protocol Violation|1|||
33371585|NCT00879437|62750383|FG000|Overall Study|Death|1|||
33556128|NCT00105079|62948923|FG000|Overall Study|Other|3|||
33556129|NCT00105079|62948924|FG001|Overall Study|Other|1|||
33556130|NCT02777827|62948930|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
33556131|NCT02777827|62948931|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
33556132|NCT02777827|62948932|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
33556133|NCT02777827|62948933|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
33556134|NCT02777827|62948934|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
33556135|NCT02777827|62948935|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
33556136|NCT02712333|62948951|FG000|First Period|Withdrawal by Subject|3|||
33556137|NCT02712333|62948952|FG001|First Period|Withdrawal by Subject|2|||
33556138|NCT02343406|62948968|FG000|Overall Study|Progressive disease|72|||
33556139|NCT02343406|62948969|FG001|Overall Study|Progressive disease|70|||
33556140|NCT02343406|62948970|FG002|Overall Study|Progressive disease|43|||
33556141|NCT02343406|62948971|FG003|Overall Study|Progressive disease|15|||
33556142|NCT02343406|62948972|FG004|Overall Study|Progressive disease|5|||
33556143|NCT02343406|62948968|FG000|Overall Study|Adverse Event|6|||
33556144|NCT02343406|62948969|FG001|Overall Study|Adverse Event|8|||
33556145|NCT02343406|62948970|FG002|Overall Study|Adverse Event|6|||
33556146|NCT02343406|62948971|FG003|Overall Study|Adverse Event|3|||
33556147|NCT02343406|62948972|FG004|Overall Study|Adverse Event|0|||
33556148|NCT02343406|62948968|FG000|Overall Study|Withdrawal by Subject|6|||
33556149|NCT02343406|62948969|FG001|Overall Study|Withdrawal by Subject|4|||
33556150|NCT02343406|62948970|FG002|Overall Study|Withdrawal by Subject|8|||
33556151|NCT02343406|62948971|FG003|Overall Study|Withdrawal by Subject|3|||
33556152|NCT02343406|62948972|FG004|Overall Study|Withdrawal by Subject|0|||
33556153|NCT02343406|62948968|FG000|Overall Study|Death|2|||
33556154|NCT02343406|62948969|FG001|Overall Study|Death|1|||
33556155|NCT02343406|62948970|FG002|Overall Study|Death|0|||
33556156|NCT02343406|62948971|FG003|Overall Study|Death|0|||
33556157|NCT02343406|62948972|FG004|Overall Study|Death|0|||
33556158|NCT02343406|62948968|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
33556159|NCT02343406|62948969|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
33556160|NCT02343406|62948970|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
33662145|NCT01695239|63092839|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33662146|NCT01695239|63092840|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33662147|NCT01695239|63092841|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33283323|NCT01289041|62659131|FG000|Overall Study|Death|1|||
33283324|NCT01288729|62659139|FG000|Overall Study|Withdrawal by Subject|1|||
33283325|NCT01288729|62659140|FG001|Overall Study|Withdrawal by Subject|0|||
33283326|NCT01288612|62659149|FG000|Overall Study|Unable to contact|11|||
33283327|NCT01288612|62659150|FG001|Overall Study|Unable to contact|16|||
33283328|NCT01288612|62659151|FG002|Overall Study|Unable to contact|20|||
33283329|NCT01288612|62659149|FG000|Overall Study|Declined|78|||
33283330|NCT01288612|62659150|FG001|Overall Study|Declined|63|||
33283331|NCT01288612|62659151|FG002|Overall Study|Declined|62|||
33283332|NCT01288612|62659149|FG000|Overall Study|Unable to intubate|0|||
33283333|NCT01288612|62659150|FG001|Overall Study|Unable to intubate|3|||
33283334|NCT01288612|62659151|FG002|Overall Study|Unable to intubate|0|||
33283335|NCT01287832|62659161|FG000|Overall Study|Adverse Event|1|||
33283336|NCT01287832|62659162|FG001|Overall Study|Adverse Event|0|||
33283337|NCT01287832|62659161|FG000|Overall Study|Death|0|||
33283338|NCT01287832|62659162|FG001|Overall Study|Death|1|||
33283339|NCT01287754|62659170|FG000|Overall Study|Death|2|||
33283340|NCT01287754|62659171|FG001|Overall Study|Death|12|||
33283341|NCT01287754|62659170|FG000|Overall Study|Lost to Follow-up|1|||
33283342|NCT01287754|62659171|FG001|Overall Study|Lost to Follow-up|6|||
33283343|NCT01287754|62659170|FG000|Overall Study|Protocol Violation|0|||
33283344|NCT01287754|62659171|FG001|Overall Study|Protocol Violation|3|||
33283345|NCT01287520|62659186|FG000|Overall Study|Adverse Event|2|||
33283346|NCT01287520|62659187|FG001|Overall Study|Adverse Event|2|||
33283347|NCT01287520|62659188|FG002|Overall Study|Adverse Event|2|||
33283348|NCT01287520|62659189|FG003|Overall Study|Adverse Event|1|||
33283349|NCT01287520|62659190|FG004|Overall Study|Adverse Event|1|||
33283350|NCT01287520|62659191|FG005|Overall Study|Adverse Event|2|||
33283351|NCT01287520|62659192|FG006|Overall Study|Adverse Event|0|||
33283352|NCT01287520|62659193|FG007|Overall Study|Adverse Event|2|||
33371586|NCT00879437|62750384|FG001|Overall Study|Death|0|||
33283353|NCT01287520|62659194|FG008|Overall Study|Adverse Event|0|||
33556161|NCT02343406|62948971|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
33556162|NCT02343406|62948972|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
33556163|NCT02343406|62948968|FG000|Overall Study|Other primary malignancy|0|||
33556164|NCT02343406|62948969|FG001|Overall Study|Other primary malignancy|1|||
33556165|NCT02343406|62948970|FG002|Overall Study|Other primary malignancy|0|||
33556166|NCT02343406|62948971|FG003|Overall Study|Other primary malignancy|0|||
33556167|NCT02343406|62948972|FG004|Overall Study|Other primary malignancy|0|||
33556168|NCT02343406|62948968|FG000|Overall Study|Other, not specified|2|||
33556169|NCT02343406|62948969|FG001|Overall Study|Other, not specified|1|||
33556170|NCT02343406|62948970|FG002|Overall Study|Other, not specified|1|||
33556171|NCT02343406|62948971|FG003|Overall Study|Other, not specified|4|||
33556172|NCT02343406|62948972|FG004|Overall Study|Other, not specified|0|||
33556173|NCT02710071|62948985|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
33556174|NCT02710071|62948986|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
33556175|NCT02710071|62948985|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
33556176|NCT02710071|62948986|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
33556177|NCT02373202|62948997|FG000|Overall Study|Adverse Event|2|||
33556178|NCT02373202|62948998|FG001|Overall Study|Adverse Event|5|||
33556179|NCT02373202|62948999|FG002|Overall Study|Adverse Event|2|||
33556180|NCT02373202|62949000|FG003|Overall Study|Adverse Event|1|||
33556181|NCT02373202|62948997|FG000|Overall Study|Lack of Efficacy|0|||
33556182|NCT02373202|62948998|FG001|Overall Study|Lack of Efficacy|0|||
33556183|NCT02373202|62948999|FG002|Overall Study|Lack of Efficacy|1|||
33556184|NCT02373202|62949000|FG003|Overall Study|Lack of Efficacy|0|||
33283354|NCT01287520|62659186|FG000|Overall Study|Physician Decision|1|||
33283355|NCT01287520|62659187|FG001|Overall Study|Physician Decision|1|||
33283356|NCT01287520|62659188|FG002|Overall Study|Physician Decision|2|||
33283357|NCT01287520|62659189|FG003|Overall Study|Physician Decision|0|||
33283358|NCT01287520|62659190|FG004|Overall Study|Physician Decision|1|||
33283359|NCT01287520|62659191|FG005|Overall Study|Physician Decision|1|||
33283360|NCT01287520|62659192|FG006|Overall Study|Physician Decision|0|||
33283361|NCT01287520|62659193|FG007|Overall Study|Physician Decision|1|||
33283362|NCT01287520|62659194|FG008|Overall Study|Physician Decision|0|||
33283363|NCT01287520|62659186|FG000|Overall Study|Progressive disease|0|||
33283364|NCT01287520|62659187|FG001|Overall Study|Progressive disease|4|||
33283365|NCT01287520|62659188|FG002|Overall Study|Progressive disease|1|||
33283366|NCT01287520|62659189|FG003|Overall Study|Progressive disease|6|||
33283367|NCT01287520|62659190|FG004|Overall Study|Progressive disease|1|||
33283368|NCT01287520|62659191|FG005|Overall Study|Progressive disease|0|||
33283369|NCT01287520|62659192|FG006|Overall Study|Progressive disease|2|||
33283370|NCT01287520|62659193|FG007|Overall Study|Progressive disease|2|||
33283371|NCT01287520|62659194|FG008|Overall Study|Progressive disease|4|||
33283372|NCT01287520|62659186|FG000|Overall Study|Withdrawal by Subject|0|||
33283373|NCT01287520|62659187|FG001|Overall Study|Withdrawal by Subject|0|||
33283374|NCT01287520|62659188|FG002|Overall Study|Withdrawal by Subject|0|||
33283375|NCT01287520|62659189|FG003|Overall Study|Withdrawal by Subject|0|||
33283376|NCT01287520|62659190|FG004|Overall Study|Withdrawal by Subject|0|||
33283377|NCT01287520|62659191|FG005|Overall Study|Withdrawal by Subject|1|||
33283378|NCT01287520|62659192|FG006|Overall Study|Withdrawal by Subject|0|||
33283379|NCT01287520|62659193|FG007|Overall Study|Withdrawal by Subject|0|||
33283380|NCT01287520|62659194|FG008|Overall Study|Withdrawal by Subject|1|||
33283381|NCT01287403|62659243|FG000|1st Intervention (1 Day)|Adverse Event|1|||
33283382|NCT01287364|62659259|FG000|Overall Study|Adverse Event|0|||
33283383|NCT01287364|62659260|FG001|Overall Study|Adverse Event|3|||
33283384|NCT01287364|62659259|FG000|Overall Study|Protocol Violation|5|||
33283385|NCT01287364|62659260|FG001|Overall Study|Protocol Violation|5|||
33283386|NCT01287364|62659259|FG000|Overall Study|Other Reason|4|||
33283387|NCT01287364|62659260|FG001|Overall Study|Other Reason|2|||
33556185|NCT02373202|62948997|FG000|Overall Study|Other|0|||
33283388|NCT02889835|62659279|FG000|Overall Study|Lost to Follow-up|13|||
33283389|NCT02889835|62659280|FG001|Overall Study|Lost to Follow-up|13|||
33556186|NCT02373202|62948998|FG001|Overall Study|Other|1|||
33283390|NCT02889835|62659281|FG002|Overall Study|Lost to Follow-up|13|||
33283391|NCT02889835|62659279|FG000|Overall Study|Withdrawal by Subject|2|||
33556187|NCT02373202|62948999|FG002|Overall Study|Other|0|||
33556188|NCT02373202|62949000|FG003|Overall Study|Other|0|||
33556189|NCT02622074|62949016|FG000|Overall Study|Death|4|||
33556190|NCT02622074|62949017|FG001|Overall Study|Death|0|||
33283392|NCT02889835|62659280|FG001|Overall Study|Withdrawal by Subject|2|||
33283393|NCT02889835|62659281|FG002|Overall Study|Withdrawal by Subject|2|||
33283394|NCT02889835|62659279|FG000|Overall Study|Protocol Violation|1|||
33283395|NCT02889835|62659280|FG001|Overall Study|Protocol Violation|1|||
33283396|NCT02889835|62659281|FG002|Overall Study|Protocol Violation|1|||
33283397|NCT02889835|62659279|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
33283398|NCT02889835|62659280|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
33283399|NCT02889835|62659281|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
33283400|NCT02889835|62659279|FG000|Overall Study|Death|1|||
33283401|NCT02889835|62659280|FG001|Overall Study|Death|1|||
33283402|NCT02889835|62659281|FG002|Overall Study|Death|1|||
33283403|NCT01287013|62659292|FG000|Overall Study|Non-evaluable|3|||
33283404|NCT01287013|62659293|FG001|Overall Study|Non-evaluable|5|||
33283405|NCT01287013|62659294|FG002|Overall Study|Non-evaluable|21|||
33283406|NCT01286779|62659302|FG000|Overall Study|Withdrawal by Subject|9|||
33283407|NCT01286779|62659302|FG000|Overall Study|Protocol Violation|5|||
33371587|NCT00877799|62750397|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
33371588|NCT00877799|62750398|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
33371589|NCT00877799|62750399|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
33371590|NCT00877799|62750400|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
33486353|NCT03230864|62864171|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
33662148|NCT01695239|63092842|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33662149|NCT01695239|63092843|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33662150|NCT01695239|63092844|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33283408|NCT01286779|62659302|FG000|Overall Study|Physician Decision|2|||
33283409|NCT01286779|62659302|FG000|Overall Study|Participant had scheduled surgery|1|||
33283410|NCT01286779|62659302|FG000|Overall Study|Participant moved to another country|1|||
33283411|NCT01286779|62659302|FG000|Overall Study|Discontinued by sponsor|1|||
33662151|NCT01695239|63092845|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33662152|NCT01695239|63092846|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33662153|NCT01695239|63092833|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
33662154|NCT01695239|63092834|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33283412|NCT01286740|62659316|FG000|Overall Study|Enrolled but not treated|1|||
33283413|NCT01286740|62659316|FG000|Overall Study|Protocol Violation|1|||
33283414|NCT01286311|62659322|FG000|Overall Study|Physician did not want outreach sent|14|||
33283415|NCT01286311|62659323|FG001|Overall Study|Physician did not want outreach sent|0|||
33283416|NCT01286077|62659331|FG000|Overall Study|Adverse Event|2|||
33283417|NCT01286077|62659332|FG001|Overall Study|Adverse Event|0|||
33283418|NCT01286077|62659331|FG000|Overall Study|Death|1|||
33283419|NCT01286077|62659332|FG001|Overall Study|Death|0|||
33283420|NCT01286077|62659331|FG000|Overall Study|Protocol Violation|1|||
33662155|NCT01695239|63092835|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
33283421|NCT01286077|62659332|FG001|Overall Study|Protocol Violation|1|||
33283422|NCT01286077|62659331|FG000|Overall Study|Withdrawal by Subject|0|||
33283423|NCT01286077|62659332|FG001|Overall Study|Withdrawal by Subject|2|||
33283424|NCT01286077|62659331|FG000|Overall Study|Intercurrent illness|1|||
33283425|NCT01286077|62659332|FG001|Overall Study|Intercurrent illness|0|||
33283426|NCT01286077|62659331|FG000|Overall Study|Non-compliance|1|||
33283427|NCT01286077|62659332|FG001|Overall Study|Non-compliance|0|||
33283428|NCT01286077|62659331|FG000|Overall Study|The subject starts with alternative MMY|0|||
33283429|NCT01286077|62659332|FG001|Overall Study|The subject starts with alternative MMY|3|||
33283430|NCT01286077|62659331|FG000|Overall Study|Patient's decision to stop treatment|3|||
33283431|NCT01286077|62659332|FG001|Overall Study|Patient's decision to stop treatment|0|||
33283432|NCT01286077|62659331|FG000|Overall Study|Progression of disease|0|||
33283433|NCT01286077|62659332|FG001|Overall Study|Progression of disease|1|||
33283434|NCT01286077|62659331|FG000|Overall Study|refill medication not received in time|1|||
33283435|NCT01286077|62659332|FG001|Overall Study|refill medication not received in time|0|||
33283436|NCT01285960|62659338|FG000|Overall Study|Withdrawal by Subject|2|||
33283437|NCT01285960|62659338|FG000|Overall Study|Lost to Follow-up|2|||
33283438|NCT01285960|62659338|FG000|Overall Study|2 subjects received less 10 sonications|2|||
33283439|NCT01285609|62659349|FG000|Randomized|Progressive Disease|41|||
33283440|NCT01285609|62659350|FG001|Randomized|Progressive Disease|61|||
33371591|NCT00877799|62750401|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
33486354|NCT03230864|62864172|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
33486355|NCT03230864|62864173|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
33486356|NCT03230864|62864174|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
33486357|NCT03230864|62864171|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
33486358|NCT03230864|62864172|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
33486359|NCT03230864|62864173|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
33486360|NCT03230864|62864174|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
33486361|NCT04085367|62864186|FG000|Overall Study|Adverse Event|1|||
33486362|NCT04085367|62864187|FG001|Overall Study|Adverse Event|1|||
33662156|NCT01695239|63092836|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33283441|NCT01285609|62659349|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
33283442|NCT01285609|62659350|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
33283443|NCT01285609|62659349|FG000|Randomized|Study Drug Toxicity|13|||
33283444|NCT01285609|62659350|FG001|Randomized|Study Drug Toxicity|14|||
33283445|NCT01285609|62659349|FG000|Randomized|Death|5|||
33662157|NCT01695239|63092837|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33662158|NCT01695239|63092838|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33283446|NCT01285609|62659350|FG001|Randomized|Death|7|||
33283447|NCT01285609|62659349|FG000|Randomized|Withdrawal by Subject|8|||
33283448|NCT01285609|62659350|FG001|Randomized|Withdrawal by Subject|11|||
33283449|NCT01285609|62659349|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
33283450|NCT01285609|62659350|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
33283451|NCT01285609|62659349|FG000|Randomized|Undisclosed Reasons|1|||
33283452|NCT01285609|62659350|FG001|Randomized|Undisclosed Reasons|0|||
33283453|NCT01285609|62659349|FG000|Randomized|Randomized but not Treated|4|||
33283454|NCT01285609|62659350|FG001|Randomized|Randomized but not Treated|4|||
33283455|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
33283456|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
33283457|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
33283458|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
33283459|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
33283460|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
33283461|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
33283462|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
33283463|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Death|11|||
33283464|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Death|3|||
33283465|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
33283466|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
33283467|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Not Reported|0|||
33283468|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Not Reported|2|||
33283469|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
33283470|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
33283471|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
33283472|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
33283473|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
33283474|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
33283475|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
33283476|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
33283477|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
33283478|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
33283479|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
33283480|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
33283481|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
33283482|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
33283483|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
33283484|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
33283485|NCT01285609|62659349|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
33283486|NCT01285609|62659350|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
33283487|NCT01285609|62659349|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
33283488|NCT01285609|62659350|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
33283489|NCT01285492|62659360|FG000|Overall Study|Adverse Event|11|||
33283490|NCT01285492|62659361|FG001|Overall Study|Adverse Event|0|||
33283491|NCT01285492|62659360|FG000|Overall Study|Protocol Violation|3|||
33283492|NCT01285492|62659361|FG001|Overall Study|Protocol Violation|0|||
33283493|NCT01285492|62659360|FG000|Overall Study|Withdrawal by Subject|2|||
33283494|NCT01285492|62659361|FG001|Overall Study|Withdrawal by Subject|1|||
33283495|NCT01285492|62659360|FG000|Overall Study|Death|1|||
33283496|NCT01285492|62659361|FG001|Overall Study|Death|0|||
33283497|NCT01284634|62659371|FG000|Overall Study|Adverse Event|1|||
33283498|NCT01284634|62659372|FG001|Overall Study|Adverse Event|0|||
33283499|NCT01284634|62659373|FG002|Overall Study|Adverse Event|2|||
33283500|NCT01284634|62659374|FG003|Overall Study|Adverse Event|1|||
33283501|NCT01284361|62659384|FG000|Overall Study|Withdrawal by Subject|1|||
33283502|NCT01284361|62659384|FG000|Overall Study|Protocol Violation|5|||
33283503|NCT01284361|62659384|FG000|Overall Study|Adverse Event|1|||
33283504|NCT01284361|62659384|FG000|Overall Study|Lost to Follow-up|2|||
33283505|NCT01284127|62659391|FG000|Overall Study|Adverse Event|2|||
33283506|NCT01284127|62659391|FG000|Overall Study|Withdrawal by Subject|4|||
33283507|NCT01284127|62659391|FG000|Overall Study|Physician Decision|1|||
33283508|NCT01283971|62659397|FG000|Overall Study|Adverse Event|3|||
33283509|NCT01283971|62659398|FG001|Overall Study|Adverse Event|5|||
33283510|NCT01283971|62659397|FG000|Overall Study|Insufficient therapeutic responses|3|||
33283511|NCT01283971|62659398|FG001|Overall Study|Insufficient therapeutic responses|3|||
33283512|NCT01283971|62659397|FG000|Overall Study|Protocol Violation|5|||
33283513|NCT01283971|62659398|FG001|Overall Study|Protocol Violation|1|||
33283514|NCT01283971|62659397|FG000|Overall Study|Refused treatment|3|||
33283515|NCT01283971|62659398|FG001|Overall Study|Refused treatment|1|||
33283516|NCT01283971|62659397|FG000|Overall Study|Failure to return|0|||
33662159|NCT01695239|63092839|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33283517|NCT01283971|62659398|FG001|Overall Study|Failure to return|1|||
33371592|NCT00877799|62750397|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
33371593|NCT00877799|62750398|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
33371594|NCT00877799|62750399|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
33371595|NCT00877799|62750400|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
33371596|NCT00877799|62750401|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
33371597|NCT00877799|62750397|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
33371598|NCT00877799|62750398|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
33371599|NCT00877799|62750399|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
33371600|NCT00877799|62750400|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
33371601|NCT00877799|62750401|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
33371602|NCT00877799|62750397|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
33371603|NCT00877799|62750398|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
33371604|NCT00877799|62750399|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
33371605|NCT00877799|62750400|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
33283518|NCT01283971|62659397|FG000|Overall Study|Administrative reasons|1|||
33283519|NCT01283971|62659398|FG001|Overall Study|Administrative reasons|1|||
33283520|NCT01283581|62659407|FG000|Overall Study|Lost to Follow-up|8|||
33283521|NCT01283581|62659408|FG001|Overall Study|Lost to Follow-up|6|||
33283522|NCT01283581|62659409|FG002|Overall Study|Lost to Follow-up|8|||
33283523|NCT01283581|62659407|FG000|Overall Study|Withdrawal by Subject|2|||
33283524|NCT01283581|62659408|FG001|Overall Study|Withdrawal by Subject|5|||
33283525|NCT01283581|62659409|FG002|Overall Study|Withdrawal by Subject|2|||
33283526|NCT01283581|62659407|FG000|Overall Study|Adverse Event|1|||
33283527|NCT01283581|62659408|FG001|Overall Study|Adverse Event|1|||
33283528|NCT01283581|62659409|FG002|Overall Study|Adverse Event|4|||
33283529|NCT01283581|62659407|FG000|Overall Study|Physician Decision|0|||
33283530|NCT01283581|62659408|FG001|Overall Study|Physician Decision|1|||
33283531|NCT01283581|62659409|FG002|Overall Study|Physician Decision|2|||
33283532|NCT01283581|62659407|FG000|Overall Study|Protocol Violation|0|||
33283533|NCT01283581|62659408|FG001|Overall Study|Protocol Violation|1|||
33283534|NCT01283581|62659409|FG002|Overall Study|Protocol Violation|2|||
33283535|NCT01283581|62659407|FG000|Overall Study|Noncompliance|1|||
33283536|NCT01283581|62659408|FG001|Overall Study|Noncompliance|0|||
33283537|NCT01283581|62659409|FG002|Overall Study|Noncompliance|0|||
33283538|NCT01283581|62659407|FG000|Overall Study|Investigator unblinded|0|||
33283539|NCT01283581|62659408|FG001|Overall Study|Investigator unblinded|0|||
33283540|NCT01283581|62659409|FG002|Overall Study|Investigator unblinded|1|||
33283541|NCT01283581|62659407|FG000|Overall Study|"Early termination"|0|||
33371606|NCT00877799|62750401|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
33371607|NCT00877799|62750397|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
33283542|NCT01283581|62659408|FG001|Overall Study|"Early termination"|0|||
33283543|NCT01283581|62659409|FG002|Overall Study|"Early termination"|1|||
33283544|NCT01283542|62659420|FG000|Main Phase|Acute or progressive vision loss|1|||
33283545|NCT01283542|62659420|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
33283546|NCT01283542|62659420|FG000|Main Phase|abnormal laboratory values|5|||
33283547|NCT01283542|62659420|FG000|Extension Phase|Physician Decision|1|||
33283548|NCT01283542|62659420|FG000|Extension Phase|Adverse Event|1|||
33283549|NCT01283542|62659420|FG000|Extension Phase|Administrative problems|1|||
33283550|NCT01283386|62659444|FG000|Overall Study|Death|2|||
33283551|NCT01283386|62659445|FG001|Overall Study|Death|0|||
33283552|NCT01283386|62659444|FG000|Overall Study|Withdrawal by Subject|2|||
33283553|NCT01283386|62659445|FG001|Overall Study|Withdrawal by Subject|1|||
33283554|NCT01283386|62659444|FG000|Overall Study|Relapse of underlying disease|1|||
33283555|NCT01283386|62659445|FG001|Overall Study|Relapse of underlying disease|3|||
33283556|NCT01283386|62659444|FG000|Overall Study|Progression of underlying disease|2|||
33283557|NCT01283386|62659445|FG001|Overall Study|Progression of underlying disease|7|||
33283558|NCT01283386|62659444|FG000|Overall Study|Reason not specified|1|||
33283559|NCT01283386|62659445|FG001|Overall Study|Reason not specified|0|||
33283560|NCT01283386|62659444|FG000|Overall Study|Protocol Violation|0|||
33283561|NCT01283386|62659445|FG001|Overall Study|Protocol Violation|1|||
33283562|NCT01283152|62659453|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
33283563|NCT01283152|62659454|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
33371608|NCT00877799|62750398|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
33556191|NCT02622074|62949018|FG002|Overall Study|Death|0|||
33662160|NCT01695239|63092840|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33662161|NCT01695239|63092841|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33283564|NCT01283152|62659453|FG000|Overall Study|Refused HESA|1|||
33283565|NCT01283152|62659454|FG001|Overall Study|Refused HESA|0|||
33283566|NCT01283035|62659460|FG000|Overall Study|Subject later found ineligible|1|||
33283567|NCT01283464|62659466|FG000|Overall Study|Lost to Follow-up|0|||
33283568|NCT01283464|62659467|FG001|Overall Study|Lost to Follow-up|1|||
33283569|NCT01283464|62659466|FG000|Overall Study|Withdrawal by Subject|1|||
33283570|NCT01283464|62659467|FG001|Overall Study|Withdrawal by Subject|0|||
33283571|NCT01283464|62659466|FG000|Overall Study|Physician Decision|1|||
33283572|NCT01283464|62659467|FG001|Overall Study|Physician Decision|0|||
33283573|NCT01282801|62659475|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
33283574|NCT01282801|62659476|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
33283575|NCT01282372|62659482|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
33283576|NCT01282372|62659482|FG000|Overall Study|Lost to Follow-up|23|||
33283577|NCT01282372|62659482|FG000|Overall Study|Withdrawal by Subject|11|||
33283578|NCT01282372|62659482|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
33283579|NCT01282372|62659482|FG000|Overall Study|Death|1|||
33283580|NCT01282372|62659482|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
33283581|NCT01282372|62659482|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
33283582|NCT01282372|62659482|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
33283583|NCT01282372|62659482|FG000|Overall Study|Adverse Event|12|||
33283584|NCT01282294|62659493|FG000|Overall Study|Lost to Follow-up|14|||
33283585|NCT01282294|62659493|FG000|Overall Study|Screening failure|1|||
33283586|NCT01282294|62659493|FG000|Overall Study|Adverse Event|1|||
33283587|NCT01282294|62659493|FG000|Overall Study|Patient non-compliance|2|||
33283588|NCT01282294|62659493|FG000|Overall Study|Physician Decision|1|||
33283589|NCT01282216|62659499|FG000|Overall Study|Graft failure|0|||
33283590|NCT01282216|62659500|FG001|Overall Study|Graft failure|0|||
33283591|NCT01282216|62659501|FG002|Overall Study|Graft failure|3|||
33283592|NCT01282216|62659502|FG003|Overall Study|Graft failure|2|||
33283593|NCT01282216|62659499|FG000|Overall Study|Physician Decision|0|||
33283594|NCT01282216|62659500|FG001|Overall Study|Physician Decision|0|||
33283595|NCT01282216|62659501|FG002|Overall Study|Physician Decision|11|||
33283596|NCT01282216|62659502|FG003|Overall Study|Physician Decision|0|||
33283597|NCT01282216|62659499|FG000|Overall Study|Relapse|0|||
33283598|NCT01282216|62659500|FG001|Overall Study|Relapse|0|||
33283599|NCT01282216|62659501|FG002|Overall Study|Relapse|17|||
33283600|NCT01282216|62659502|FG003|Overall Study|Relapse|6|||
33283601|NCT01282216|62659499|FG000|Overall Study|Death|0|||
33283602|NCT01282216|62659500|FG001|Overall Study|Death|0|||
33283603|NCT01282216|62659501|FG002|Overall Study|Death|2|||
33283604|NCT01282216|62659502|FG003|Overall Study|Death|0|||
33283605|NCT01281865|62659510|FG000|Overall Study|Adverse Event|1|||
33283606|NCT01281865|62659511|FG001|Overall Study|Adverse Event|1|||
33283607|NCT01281865|62659510|FG000|Overall Study|Withdrawal by Subject|1|||
33283608|NCT01281865|62659511|FG001|Overall Study|Withdrawal by Subject|0|||
33283609|NCT01281865|62659510|FG000|Overall Study|Lack of Efficacy|1|||
33283610|NCT01281865|62659511|FG001|Overall Study|Lack of Efficacy|0|||
33283611|NCT01281202|62659519|FG000|Overall Study|Adverse Event|2|||
33283612|NCT01281202|62659520|FG001|Overall Study|Adverse Event|0|||
33283613|NCT01281202|62659519|FG000|Overall Study|Withdrawal by Subject|2|||
33283614|NCT01281202|62659520|FG001|Overall Study|Withdrawal by Subject|2|||
33283615|NCT01281202|62659519|FG000|Overall Study|Protocol Violation|11|||
33283616|NCT01281202|62659520|FG001|Overall Study|Protocol Violation|10|||
33283617|NCT01281202|62659519|FG000|Overall Study|Administrative|2|||
33283618|NCT01281202|62659520|FG001|Overall Study|Administrative|8|||
33283619|NCT01281202|62659519|FG000|Overall Study|Lost to Follow-up|11|||
33283620|NCT01281202|62659520|FG001|Overall Study|Lost to Follow-up|13|||
33283621|NCT01281202|62659519|FG000|Overall Study|Incarceration|0|||
33283622|NCT01281202|62659520|FG001|Overall Study|Incarceration|3|||
33283623|NCT01281124|62659528|FG000|Overall Study|Death|1|||
33283624|NCT01280968|62659536|FG000|Overall Study|Lost to Follow-up|8|||
33283625|NCT01280968|62659537|FG001|Overall Study|Lost to Follow-up|2|||
33283626|NCT01280968|62659536|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
33283627|NCT01280968|62659537|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
33283628|NCT01280968|62659536|FG000|Overall Study|Commuting Problems|2|||
33283629|NCT01280968|62659537|FG001|Overall Study|Commuting Problems|0|||
33283630|NCT01280968|62659536|FG000|Overall Study|Anxiety|2|||
33283631|NCT01280968|62659537|FG001|Overall Study|Anxiety|0|||
33283632|NCT01280968|62659536|FG000|Overall Study|Adverse Event|1|||
33283633|NCT01280968|62659537|FG001|Overall Study|Adverse Event|0|||
33283634|NCT01280968|62659536|FG000|Overall Study|Scheduling Conflicts|1|||
33283635|NCT01280968|62659537|FG001|Overall Study|Scheduling Conflicts|1|||
33283636|NCT01280968|62659536|FG000|Overall Study|Pre-existing Neurological Condition|1|||
33283637|NCT01280968|62659537|FG001|Overall Study|Pre-existing Neurological Condition|0|||
33371609|NCT00877799|62750399|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
33283638|NCT01280968|62659536|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
33283639|NCT01280968|62659537|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
33283640|NCT01280812|62659547|FG000|Overall Study|Withdrawal by Subject|2|||
33283641|NCT01280812|62659548|FG001|Overall Study|Withdrawal by Subject|1|||
33283642|NCT01280812|62659549|FG002|Overall Study|Withdrawal by Subject|0|||
33283643|NCT01280812|62659547|FG000|Overall Study|Lost to Follow-up|1|||
33283644|NCT01280812|62659548|FG001|Overall Study|Lost to Follow-up|1|||
33283645|NCT01280812|62659549|FG002|Overall Study|Lost to Follow-up|1|||
33283646|NCT01280656|62659561|FG000|Overall Study|Adverse Event|1|||
33283647|NCT01280656|62659562|FG001|Overall Study|Adverse Event|14|||
33283648|NCT01280656|62659563|FG002|Overall Study|Adverse Event|13|||
33283649|NCT01280656|62659561|FG000|Overall Study|Lack of Efficacy|1|||
33283650|NCT01280656|62659562|FG001|Overall Study|Lack of Efficacy|22|||
33283651|NCT01280656|62659563|FG002|Overall Study|Lack of Efficacy|38|||
33283652|NCT01280656|62659561|FG000|Overall Study|Treatment shortening (RGT)|0|||
33283653|NCT01280656|62659562|FG001|Overall Study|Treatment shortening (RGT)|4|||
33283654|NCT01280656|62659563|FG002|Overall Study|Treatment shortening (RGT)|5|||
33283655|NCT01280656|62659561|FG000|Overall Study|Other|1|||
33283656|NCT01280656|62659562|FG001|Overall Study|Other|7|||
33283657|NCT01280656|62659563|FG002|Overall Study|Other|7|||
33283658|NCT01280617|62659573|FG000|Overall Study|Adverse Event|0|||
33283659|NCT01280617|62659574|FG001|Overall Study|Adverse Event|1|||
33283660|NCT01280266|62659582|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
33283661|NCT01280266|62659583|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
33283662|NCT01280266|62659582|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
33283663|NCT01280266|62659583|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
33283664|NCT01279447|62659595|FG000|Overall Study|Lost to Follow-up|3|||
33283665|NCT01279447|62659596|FG001|Overall Study|Lost to Follow-up|1|||
33283666|NCT01276639|62659618|FG000|Week 0 to 16|Death|1|||
33283667|NCT01276639|62659619|FG001|Week 0 to 16|Death|0|||
33283668|NCT01276639|62659620|FG002|Week 0 to 16|Death|0|||
33283669|NCT01276639|62659621|FG003|Week 0 to 16|Death|0|||
33283670|NCT01276639|62659622|FG004|Week 0 to 16|Death|0|||
33283671|NCT01276639|62659618|FG000|Week 0 to 16|Adverse Event|11|||
33283672|NCT01276639|62659619|FG001|Week 0 to 16|Adverse Event|8|||
33283673|NCT01276639|62659620|FG002|Week 0 to 16|Adverse Event|11|||
33283674|NCT01276639|62659621|FG003|Week 0 to 16|Adverse Event|0|||
33283675|NCT01276639|62659622|FG004|Week 0 to 16|Adverse Event|0|||
33283676|NCT01276639|62659618|FG000|Week 0 to 16|Lack of Efficacy|20|||
33283677|NCT01276639|62659619|FG001|Week 0 to 16|Lack of Efficacy|15|||
33283678|NCT01276639|62659620|FG002|Week 0 to 16|Lack of Efficacy|25|||
33283679|NCT01276639|62659621|FG003|Week 0 to 16|Lack of Efficacy|0|||
33283680|NCT01276639|62659622|FG004|Week 0 to 16|Lack of Efficacy|0|||
33283681|NCT01276639|62659618|FG000|Week 0 to 16|Lost to Follow-up|3|||
33283682|NCT01276639|62659619|FG001|Week 0 to 16|Lost to Follow-up|5|||
33283683|NCT01276639|62659620|FG002|Week 0 to 16|Lost to Follow-up|3|||
33283684|NCT01276639|62659621|FG003|Week 0 to 16|Lost to Follow-up|0|||
33283685|NCT01276639|62659622|FG004|Week 0 to 16|Lost to Follow-up|0|||
33283686|NCT01276639|62659618|FG000|Week 0 to 16|Withdrawal by Subject|8|||
33283687|NCT01276639|62659619|FG001|Week 0 to 16|Withdrawal by Subject|5|||
33283688|NCT01276639|62659620|FG002|Week 0 to 16|Withdrawal by Subject|4|||
33283689|NCT01276639|62659621|FG003|Week 0 to 16|Withdrawal by Subject|0|||
33283690|NCT01276639|62659622|FG004|Week 0 to 16|Withdrawal by Subject|0|||
33283691|NCT01276639|62659618|FG000|Week 0 to 16|Other|7|||
33283692|NCT01276639|62659619|FG001|Week 0 to 16|Other|7|||
33283693|NCT01276639|62659620|FG002|Week 0 to 16|Other|2|||
33283694|NCT01276639|62659621|FG003|Week 0 to 16|Other|0|||
33283695|NCT01276639|62659622|FG004|Week 0 to 16|Other|0|||
33283696|NCT01276639|62659618|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
33283697|NCT01276639|62659619|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
33283698|NCT01276639|62659620|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
33283699|NCT01276639|62659621|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
33283700|NCT01276639|62659622|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
33283701|NCT01276639|62659618|FG000|Week 16 to 52|Death|1|||
33283702|NCT01276639|62659619|FG001|Week 16 to 52|Death|0|||
33283703|NCT01276639|62659620|FG002|Week 16 to 52|Death|0|||
33283704|NCT01276639|62659621|FG003|Week 16 to 52|Death|0|||
33283705|NCT01276639|62659622|FG004|Week 16 to 52|Death|0|||
33283706|NCT01276639|62659618|FG000|Week 16 to 52|Adverse Event|10|||
33283707|NCT01276639|62659619|FG001|Week 16 to 52|Adverse Event|13|||
33283708|NCT01276639|62659620|FG002|Week 16 to 52|Adverse Event|0|||
33283709|NCT01276639|62659621|FG003|Week 16 to 52|Adverse Event|1|||
33283710|NCT01276639|62659622|FG004|Week 16 to 52|Adverse Event|3|||
33283711|NCT01276639|62659618|FG000|Week 16 to 52|Lack of Efficacy|99|||
33283712|NCT01276639|62659619|FG001|Week 16 to 52|Lack of Efficacy|71|||
33283713|NCT01276639|62659620|FG002|Week 16 to 52|Lack of Efficacy|0|||
33283714|NCT01276639|62659621|FG003|Week 16 to 52|Lack of Efficacy|14|||
33283715|NCT01276639|62659622|FG004|Week 16 to 52|Lack of Efficacy|13|||
33283716|NCT01276639|62659618|FG000|Week 16 to 52|Lost to Follow-up|3|||
33283717|NCT01276639|62659619|FG001|Week 16 to 52|Lost to Follow-up|1|||
33283718|NCT01276639|62659620|FG002|Week 16 to 52|Lost to Follow-up|0|||
33283719|NCT01276639|62659621|FG003|Week 16 to 52|Lost to Follow-up|0|||
33283720|NCT01276639|62659622|FG004|Week 16 to 52|Lost to Follow-up|1|||
33283721|NCT01276639|62659618|FG000|Week 16 to 52|Withdrawal by Subject|4|||
33283722|NCT01276639|62659619|FG001|Week 16 to 52|Withdrawal by Subject|4|||
33283723|NCT01276639|62659620|FG002|Week 16 to 52|Withdrawal by Subject|0|||
33283724|NCT01276639|62659621|FG003|Week 16 to 52|Withdrawal by Subject|0|||
33283725|NCT01276639|62659622|FG004|Week 16 to 52|Withdrawal by Subject|1|||
33283726|NCT01276639|62659618|FG000|Week 16 to 52|Other|10|||
33283727|NCT01276639|62659619|FG001|Week 16 to 52|Other|12|||
33283728|NCT01276639|62659620|FG002|Week 16 to 52|Other|0|||
33283729|NCT01276639|62659621|FG003|Week 16 to 52|Other|1|||
33283730|NCT01276639|62659622|FG004|Week 16 to 52|Other|3|||
33283731|NCT01275625|62659637|FG000|Overall Study|Death|1|||
33283732|NCT01275625|62659637|FG000|Overall Study|Lack of Efficacy|2|||
33283733|NCT01275625|62659637|FG000|Overall Study|Lost to Follow-up|1|||
33283734|NCT01275625|62659637|FG000|Overall Study|Withdrawal by Subject|3|||
33283735|NCT01275625|62659637|FG000|Overall Study|Protocol Violation|1|||
33283736|NCT01275625|62659637|FG000|Overall Study|Adverse Event|4|||
33283737|NCT01275625|62659637|FG000|Overall Study|Other|1|||
33283738|NCT01272193|62659643|FG000|Overall Study|Adverse Event|1|||
33283739|NCT01272193|62659644|FG001|Overall Study|Adverse Event|1|||
33283740|NCT01272193|62659643|FG000|Overall Study|Lack of Efficacy|0|||
33283741|NCT01272193|62659644|FG001|Overall Study|Lack of Efficacy|3|||
33283742|NCT01272193|62659643|FG000|Overall Study|Withdrawal Criteria|1|||
33283743|NCT01272193|62659644|FG001|Overall Study|Withdrawal Criteria|1|||
33283744|NCT01272193|62659643|FG000|Overall Study|Unclassified|8|||
33283745|NCT01272193|62659644|FG001|Overall Study|Unclassified|7|||
33283746|NCT01270828|62659656|FG000|Pregabalin CR SB|Reason Unspecified|0|||
33283747|NCT01270828|62659657|FG001|Pregabalin CR SB|Reason Unspecified|0|||
33283748|NCT01270828|62659658|FG002|Pregabalin CR SB|Reason Unspecified|8|||
33283749|NCT01270828|62659656|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
33283750|NCT01270828|62659657|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
33283751|NCT01270828|62659658|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
33283752|NCT01270828|62659656|FG000|Pregabalin CR SB|Related adverse event|0|||
33283753|NCT01270828|62659657|FG001|Pregabalin CR SB|Related adverse event|0|||
33283754|NCT01270828|62659658|FG002|Pregabalin CR SB|Related adverse event|46|||
33283755|NCT01270828|62659656|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
33283756|NCT01270828|62659657|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
33283757|NCT01270828|62659658|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
33283758|NCT01270828|62659656|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
33283759|NCT01270828|62659657|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
33283760|NCT01270828|62659658|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
33283761|NCT01270828|62659656|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
33283762|NCT01270828|62659657|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
33283763|NCT01270828|62659658|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
33283764|NCT01270828|62659656|FG000|Pregabalin CR SB|Unrelated AE|0|||
33283765|NCT01270828|62659657|FG001|Pregabalin CR SB|Unrelated AE|0|||
33283766|NCT01270828|62659658|FG002|Pregabalin CR SB|Unrelated AE|8|||
33283767|NCT01270828|62659656|FG000|Pregabalin CR SB|Protocol Violation|0|||
33283768|NCT01270828|62659657|FG001|Pregabalin CR SB|Protocol Violation|0|||
33283769|NCT01270828|62659658|FG002|Pregabalin CR SB|Protocol Violation|8|||
33283770|NCT01270828|62659656|FG000|Double Blind Phase|Death|0|||
33283771|NCT01270828|62659657|FG001|Double Blind Phase|Death|1|||
33283772|NCT01270828|62659658|FG002|Double Blind Phase|Death|0|||
33283773|NCT01270828|62659656|FG000|Double Blind Phase|Protocol Violation|0|||
33283774|NCT01270828|62659657|FG001|Double Blind Phase|Protocol Violation|1|||
33371610|NCT00877799|62750400|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
33371611|NCT00877799|62750401|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
33371612|NCT00595127|62750412|FG000|Overall Study|Death|6|||
33371613|NCT00595127|62750412|FG000|Overall Study|Relapsed|3|||
33371614|NCT00595127|62750412|FG000|Overall Study|joined another trial|1|||
33371615|NCT00877487|62750416|FG000|Open-label Treatment Phase|Adverse Event|1|||
33371616|NCT00877487|62750417|FG001|Open-label Treatment Phase|Adverse Event|0|||
33371617|NCT00877487|62750416|FG000|Open-label Treatment Phase|Protocol Violation|3|||
33371618|NCT00877487|62750417|FG001|Open-label Treatment Phase|Protocol Violation|0|||
33371619|NCT00877487|62750416|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
33371620|NCT00877487|62750417|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
33371621|NCT00877487|62750416|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
33371622|NCT00877487|62750417|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
33662162|NCT01695239|63092842|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33283775|NCT01270828|62659658|FG002|Double Blind Phase|Protocol Violation|0|||
33283776|NCT01270828|62659656|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
33283777|NCT01270828|62659657|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
33283778|NCT01270828|62659658|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
33283779|NCT01270828|62659656|FG000|Double Blind Phase|Reason Unspecified|7|||
33283780|NCT01270828|62659657|FG001|Double Blind Phase|Reason Unspecified|4|||
33283781|NCT01270828|62659658|FG002|Double Blind Phase|Reason Unspecified|0|||
33371623|NCT00877487|62750416|FG000|Open-label Treatment Phase|Out of country for business|1|||
33371624|NCT00877487|62750417|FG001|Open-label Treatment Phase|Out of country for business|0|||
33371625|NCT00877487|62750416|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
33556192|NCT02622074|62949019|FG003|Overall Study|Death|1|||
33283782|NCT01270828|62659656|FG000|Double Blind Phase|Withdrawal by Subject|6|||
33283783|NCT01270828|62659657|FG001|Double Blind Phase|Withdrawal by Subject|15|||
33283784|NCT01270828|62659658|FG002|Double Blind Phase|Withdrawal by Subject|0|||
33371626|NCT00877487|62750417|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
33371627|NCT00877487|62750416|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
33283785|NCT01270828|62659656|FG000|Double Blind Phase|Lost to Follow-up|1|||
33283786|NCT01270828|62659657|FG001|Double Blind Phase|Lost to Follow-up|2|||
33283787|NCT01270828|62659658|FG002|Double Blind Phase|Lost to Follow-up|0|||
33283788|NCT01270828|62659656|FG000|Double Blind Phase|Lack of Efficacy|2|||
33283789|NCT01270828|62659657|FG001|Double Blind Phase|Lack of Efficacy|11|||
33283790|NCT01270828|62659658|FG002|Double Blind Phase|Lack of Efficacy|0|||
33283791|NCT01270828|62659656|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
33283792|NCT01270828|62659657|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
33283793|NCT01270828|62659658|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
33283794|NCT01270828|62659656|FG000|Double Blind Phase|Adverse event related to study drug|5|||
33283795|NCT01270828|62659657|FG001|Double Blind Phase|Adverse event related to study drug|7|||
33283796|NCT01270828|62659658|FG002|Double Blind Phase|Adverse event related to study drug|0|||
33283797|NCT01269385|62659666|FG000|Overall Study|Adverse Event|1|||
33283798|NCT01269385|62659667|FG001|Overall Study|Adverse Event|1|||
33283799|NCT01269385|62659668|FG002|Overall Study|Adverse Event|0|||
33283800|NCT01269385|62659669|FG003|Overall Study|Adverse Event|0|||
33283801|NCT01268683|62659679|FG000|Overall Study|Lost to Follow-up|1|||
33283802|NCT01268683|62659679|FG000|Overall Study|Death|1|||
33283803|NCT01268566|62659683|FG000|Overall Study|Lost to Follow-up|1|||
33283804|NCT01268566|62659683|FG000|Overall Study|Withdrawal by Subject|12|||
33283805|NCT01268566|62659683|FG000|Overall Study|Death|30|||
33283806|NCT01268488|62659687|FG000|Overall Study|Adverse Event|3|||
33283807|NCT01268488|62659687|FG000|Overall Study|Physician Decision|2|||
33283808|NCT01268098|62659694|FG000|Overall Study|Adverse Event|1|||
33283809|NCT01268098|62659695|FG001|Overall Study|Adverse Event|0|||
33283810|NCT01268059|62659705|FG000|Overall Study|Lost to Follow-up|0|||
33283811|NCT01268059|62659706|FG001|Overall Study|Lost to Follow-up|1|||
33283812|NCT01268059|62659707|FG002|Overall Study|Lost to Follow-up|0|||
33283813|NCT01268059|62659708|FG003|Overall Study|Lost to Follow-up|0|||
33283814|NCT01268059|62659705|FG000|Overall Study|Withdrawal by Subject|7|||
33283815|NCT01268059|62659706|FG001|Overall Study|Withdrawal by Subject|4|||
33283816|NCT01268059|62659707|FG002|Overall Study|Withdrawal by Subject|0|||
33283817|NCT01268059|62659708|FG003|Overall Study|Withdrawal by Subject|0|||
33283818|NCT01268059|62659705|FG000|Overall Study|Death|20|||
33283819|NCT01268059|62659706|FG001|Overall Study|Death|30|||
33283820|NCT01268059|62659707|FG002|Overall Study|Death|3|||
33283821|NCT01268059|62659708|FG003|Overall Study|Death|5|||
33283822|NCT01268059|62659705|FG000|Overall Study|Progression of disease|1|||
33283823|NCT01268059|62659706|FG001|Overall Study|Progression of disease|0|||
33283824|NCT01268059|62659707|FG002|Overall Study|Progression of disease|0|||
33283825|NCT01268059|62659708|FG003|Overall Study|Progression of disease|0|||
33283826|NCT01267825|62659723|FG000|Overall Study|study terminated. no data collected.|1|||
33283827|NCT01267825|62659724|FG001|Overall Study|study terminated. no data collected.|0|||
33283828|NCT01260181|62659730|FG000|Overall Study|Decision of Investigator|1|||
33283829|NCT01260142|62659740|FG000|Treatment Period 1|Study on hold|1|||
33283830|NCT01260142|62659741|FG001|Treatment Period 1|Study on hold|1|||
33283831|NCT01260142|62659742|FG002|Treatment Period 1|Study on hold|0|||
33283832|NCT01260142|62659743|FG003|Treatment Period 1|Study on hold|0|||
33283833|NCT01260142|62659744|FG004|Treatment Period 1|Study on hold|1|||
33283834|NCT01260142|62659745|FG005|Treatment Period 1|Study on hold|2|||
33283835|NCT01260142|62659740|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
33283836|NCT01260142|62659741|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
33283837|NCT01260142|62659742|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
33283838|NCT01260142|62659743|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
33283839|NCT01260142|62659744|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
33283840|NCT01260142|62659745|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
33283841|NCT01260142|62659740|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33283842|NCT01260142|62659741|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33283843|NCT01260142|62659742|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33283844|NCT01260142|62659743|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33371628|NCT00877487|62750417|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
33371629|NCT00877487|62750416|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
33283845|NCT01260142|62659744|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33371630|NCT00877487|62750417|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
33283846|NCT01260142|62659745|FG005|Treatment Period 1|Withdrawal by Subject|1|||
33283847|NCT01259869|62659765|FG000|Overall Study|Duplicated registration|1|||
33283848|NCT01259713|62659771|FG000|Overall Study|Adverse Event|54|||
33371631|NCT00877487|62750416|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
33283849|NCT01259713|62659772|FG001|Overall Study|Adverse Event|23|||
33283850|NCT01259713|62659771|FG000|Overall Study|Death Not Related to IFI|8|||
33283851|NCT01259713|62659772|FG001|Overall Study|Death Not Related to IFI|1|||
33283852|NCT01259713|62659771|FG000|Overall Study|Investigators Discretion|14|||
33283853|NCT01259713|62659772|FG001|Overall Study|Investigators Discretion|6|||
33283854|NCT01259713|62659771|FG000|Overall Study|Lack of Efficacy|2|||
33283855|NCT01259713|62659772|FG001|Overall Study|Lack of Efficacy|0|||
33283856|NCT01259713|62659771|FG000|Overall Study|Protocol Violation|5|||
33283857|NCT01259713|62659772|FG001|Overall Study|Protocol Violation|4|||
33283858|NCT01259713|62659771|FG000|Overall Study|Subject Withdrew Consent|12|||
33283859|NCT01259713|62659772|FG001|Overall Study|Subject Withdrew Consent|7|||
33283860|NCT01259401|62659780|FG000|4-month Follow-up|Death|0|||
33283861|NCT01259401|62659781|FG001|4-month Follow-up|Death|1|||
33283862|NCT01259401|62659780|FG000|4-month Follow-up|Lost to Follow-up|0|||
33283863|NCT01259401|62659781|FG001|4-month Follow-up|Lost to Follow-up|1|||
33283864|NCT01313923|62659796|FG000|Overall Study|Physician Decision|3|||
33283865|NCT01313884|62659800|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
33283866|NCT01135459|62659806|FG000|Overall Study|Adverse Event|8|||
33283867|NCT01135459|62659807|FG001|Overall Study|Adverse Event|10|||
33283868|NCT01135459|62659806|FG000|Overall Study|Lack of Efficacy|3|||
33283869|NCT01135459|62659807|FG001|Overall Study|Lack of Efficacy|1|||
33283870|NCT01135459|62659806|FG000|Overall Study|Withdrawal by Subject|2|||
33283871|NCT01135459|62659807|FG001|Overall Study|Withdrawal by Subject|3|||
33283872|NCT01135459|62659806|FG000|Overall Study|Protocol Violation|5|||
33283873|NCT01135459|62659807|FG001|Overall Study|Protocol Violation|3|||
33283874|NCT01135459|62659806|FG000|Overall Study|Lost to Follow-up|2|||
33283875|NCT01135459|62659807|FG001|Overall Study|Lost to Follow-up|1|||
33283876|NCT01135459|62659806|FG000|Overall Study|Non-compliance to study procedures|0|||
33283877|NCT01135459|62659807|FG001|Overall Study|Non-compliance to study procedures|1|||
33283878|NCT01135459|62659806|FG000|Overall Study|Other than specified|1|||
33283879|NCT01135459|62659807|FG001|Overall Study|Other than specified|1|||
33283880|NCT01259284|62659816|FG000|Overall Study|Study Termination|2|||
33283881|NCT01259284|62659817|FG001|Overall Study|Study Termination|0|||
33283882|NCT01259284|62659818|FG002|Overall Study|Study Termination|0|||
33556193|NCT02622074|62949020|FG004|Overall Study|Death|1|||
33556194|NCT02622074|62949021|FG005|Overall Study|Death|0|||
33556195|NCT02622074|62949016|FG000|Overall Study|Withdrawal by Subject|0|||
33556196|NCT02622074|62949017|FG001|Overall Study|Withdrawal by Subject|1|||
33556197|NCT02622074|62949018|FG002|Overall Study|Withdrawal by Subject|0|||
33556198|NCT02622074|62949019|FG003|Overall Study|Withdrawal by Subject|0|||
33283883|NCT01259245|62659828|FG000|Overall Study|Withdrawal by Subject|27|||
33283884|NCT01259245|62659829|FG001|Overall Study|Withdrawal by Subject|24|||
33486363|NCT04085367|62864186|FG000|Overall Study|Withdrawal by Subject|13|||
33486364|NCT04085367|62864187|FG001|Overall Study|Withdrawal by Subject|4|||
33283885|NCT01259245|62659828|FG000|Overall Study|Death|1|||
33283886|NCT01259245|62659829|FG001|Overall Study|Death|2|||
33283887|NCT01259089|62659837|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
33283888|NCT01259089|62659838|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
33283889|NCT01259089|62659839|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
33283890|NCT01259089|62659840|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
33283891|NCT01259089|62659841|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
33283892|NCT01259089|62659842|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
33283893|NCT01259089|62659837|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
33283894|NCT01259089|62659838|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
33283895|NCT01259089|62659839|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
33283896|NCT01259089|62659840|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
33283897|NCT01259089|62659841|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
33486365|NCT04085367|62864186|FG000|Overall Study|Lost to Follow-up|3|||
33486366|NCT04085367|62864187|FG001|Overall Study|Lost to Follow-up|1|||
33486367|NCT04085367|62864186|FG000|Overall Study|Other unspecified|2|||
33486368|NCT04085367|62864187|FG001|Overall Study|Other unspecified|1|||
33486369|NCT04085367|62864186|FG000|Overall Study|Status Unknown|1|||
33486370|NCT04085367|62864187|FG001|Overall Study|Status Unknown|1|||
33486371|NCT03228836|62864193|FG000|Overall Study|Adverse Event|3|||
33486372|NCT03228836|62864193|FG000|Overall Study|Withdrawal by Subject|1|||
33486373|NCT03228836|62864193|FG000|Overall Study|Death|1|||
33486374|NCT03228836|62864193|FG000|Overall Study|Physician Decision|1|||
33486375|NCT03228836|62864193|FG000|Overall Study|Disease Progression|7|||
33486376|NCT03228836|62864193|FG000|Overall Study|Other|4|||
33486377|NCT02937350|62864200|FG000|Overall Study|Withdrawal by Subject|0|||
33662163|NCT01695239|63092843|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33283898|NCT01259089|62659842|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
33283899|NCT01259089|62659837|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
33283900|NCT01259089|62659838|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
33283901|NCT01259089|62659839|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
33283902|NCT01259089|62659840|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
33371632|NCT00877487|62750417|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
33486378|NCT02937350|62864201|FG001|Overall Study|Withdrawal by Subject|1|||
33486379|NCT02937350|62864202|FG002|Overall Study|Withdrawal by Subject|0|||
33556199|NCT02622074|62949020|FG004|Overall Study|Withdrawal by Subject|0|||
33371633|NCT00878501|62750426|FG000|Overall Study|Adverse Event|11|||
33556200|NCT02622074|62949021|FG005|Overall Study|Withdrawal by Subject|0|||
33283903|NCT01259089|62659841|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
33283904|NCT01259089|62659842|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
33283905|NCT01259089|62659837|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
33283906|NCT01259089|62659838|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
33283907|NCT01259089|62659839|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
33283908|NCT01259089|62659840|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
33283909|NCT01259089|62659841|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
33283910|NCT01259089|62659842|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
33371634|NCT00878501|62750427|FG001|Overall Study|Adverse Event|3|||
33371635|NCT00878501|62750428|FG002|Overall Study|Adverse Event|3|||
33371636|NCT00878501|62750426|FG000|Overall Study|Lack of Efficacy|2|||
33371637|NCT00878501|62750427|FG001|Overall Study|Lack of Efficacy|1|||
33371638|NCT00878501|62750428|FG002|Overall Study|Lack of Efficacy|0|||
33371639|NCT00878501|62750426|FG000|Overall Study|Withdrawal by Subject|2|||
33371640|NCT00878501|62750427|FG001|Overall Study|Withdrawal by Subject|1|||
33371641|NCT00878501|62750428|FG002|Overall Study|Withdrawal by Subject|2|||
33371642|NCT00878501|62750426|FG000|Overall Study|Protocol Violation|0|||
33371643|NCT00878501|62750427|FG001|Overall Study|Protocol Violation|0|||
33371644|NCT00878501|62750428|FG002|Overall Study|Protocol Violation|1|||
33371645|NCT00878501|62750426|FG000|Overall Study|Incorrect enrolment|1|||
33371646|NCT00878501|62750427|FG001|Overall Study|Incorrect enrolment|2|||
33371647|NCT00878501|62750428|FG002|Overall Study|Incorrect enrolment|0|||
33371648|NCT00878501|62750426|FG000|Overall Study|Intake of prohibited concom. medication|0|||
33371649|NCT00878501|62750427|FG001|Overall Study|Intake of prohibited concom. medication|0|||
33486380|NCT04085289|62864211|FG000|Overall Study|Withdrawal by Subject|0|||
33283911|NCT01259089|62659837|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
33283912|NCT01259089|62659838|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
33283913|NCT01259089|62659839|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
33283914|NCT01259089|62659840|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
33283915|NCT01259089|62659841|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
33283916|NCT01259089|62659842|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
33283917|NCT01259089|62659837|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
33283918|NCT01259089|62659838|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
33283919|NCT01259089|62659839|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
33283920|NCT01259089|62659840|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
33283921|NCT01259089|62659841|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
33283922|NCT01259089|62659842|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
33283923|NCT01259089|62659837|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
33283924|NCT01259089|62659838|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
33283925|NCT01259089|62659839|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
33283926|NCT01259089|62659840|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
33283927|NCT01259089|62659841|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
33283928|NCT01259089|62659842|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
33283929|NCT01259089|62659837|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
33283930|NCT01259089|62659838|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
33283931|NCT01259089|62659839|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
33283932|NCT01259089|62659840|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
33283933|NCT01259089|62659841|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
33283934|NCT01259089|62659842|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
33283935|NCT01259089|62659837|FG000|Survival Follow up for Two Years|Death|3|||
33283936|NCT01259089|62659838|FG001|Survival Follow up for Two Years|Death|2|||
33283937|NCT01259089|62659839|FG002|Survival Follow up for Two Years|Death|2|||
33283938|NCT01259089|62659840|FG003|Survival Follow up for Two Years|Death|3|||
33283939|NCT01259089|62659841|FG004|Survival Follow up for Two Years|Death|6|||
33283940|NCT01259089|62659842|FG005|Survival Follow up for Two Years|Death|13|||
33283941|NCT01259089|62659837|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
33283942|NCT01259089|62659838|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
33283943|NCT01259089|62659839|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
33283944|NCT01259089|62659840|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
33283945|NCT01259089|62659841|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
33283946|NCT01259089|62659842|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
33283947|NCT01259089|62659837|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
33486381|NCT04085289|62864212|FG001|Overall Study|Withdrawal by Subject|0|||
33486382|NCT04085289|62864213|FG002|Overall Study|Withdrawal by Subject|1|||
33283948|NCT01259089|62659838|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
33371650|NCT00878501|62750428|FG002|Overall Study|Intake of prohibited concom. medication|1|||
33371651|NCT00878501|62750426|FG000|Overall Study|Mis-randomisation of patient|1|||
33371652|NCT00878501|62750427|FG001|Overall Study|Mis-randomisation of patient|0|||
33371653|NCT00878501|62750428|FG002|Overall Study|Mis-randomisation of patient|0|||
33486383|NCT04080297|62864222|FG000|Overall Study|Adverse Event|1|||
33486384|NCT04080297|62864223|FG001|Overall Study|Adverse Event|3|||
33283949|NCT01259089|62659839|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
33283950|NCT01259089|62659840|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
33283951|NCT01259089|62659841|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
33283952|NCT01259089|62659842|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
33283953|NCT01258738|62659858|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
33283954|NCT01258738|62659859|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
33283955|NCT01258738|62659858|FG000|Double-blind Period|Withdrawal by Subject|2|||
33283956|NCT01258738|62659859|FG001|Double-blind Period|Withdrawal by Subject|2|||
33283957|NCT01258738|62659858|FG000|Double-blind Period|Protocol Violation|1|||
33283958|NCT01258738|62659859|FG001|Double-blind Period|Protocol Violation|1|||
33283959|NCT01258738|62659858|FG000|Double-blind Period|Adverse Event|3|||
33283960|NCT01258738|62659859|FG001|Double-blind Period|Adverse Event|1|||
33283961|NCT01258738|62659858|FG000|Open-label Period|Did not meet inclusion criteria|0|||
33283962|NCT01258738|62659859|FG001|Open-label Period|Did not meet inclusion criteria|1|||
33283963|NCT01258738|62659858|FG000|Open-label Period|Insufficient clinical response|5|||
33283964|NCT01258738|62659859|FG001|Open-label Period|Insufficient clinical response|3|||
33283965|NCT01258738|62659858|FG000|Open-label Period|Lost to Follow-up|0|||
33283966|NCT01258738|62659859|FG001|Open-label Period|Lost to Follow-up|2|||
33283967|NCT01258738|62659858|FG000|Open-label Period|Withdrawal by Subject|5|||
33283968|NCT01258738|62659859|FG001|Open-label Period|Withdrawal by Subject|6|||
33283969|NCT01258738|62659858|FG000|Open-label Period|Protocol Violation|2|||
33283970|NCT01258738|62659859|FG001|Open-label Period|Protocol Violation|2|||
33283971|NCT01258738|62659858|FG000|Open-label Period|Adverse Event|4|||
33283972|NCT01258738|62659859|FG001|Open-label Period|Adverse Event|5|||
33283973|NCT01258738|62659858|FG000|Open-label Period|Other Reasons|0|||
33283974|NCT01258738|62659859|FG001|Open-label Period|Other Reasons|1|||
33283975|NCT01258738|62659858|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
33283976|NCT01258738|62659859|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
33283977|NCT01258660|62659867|FG000|Overall Study|Adverse Event|2|||
33283978|NCT01258660|62659868|FG001|Overall Study|Adverse Event|4|||
33283979|NCT01258660|62659867|FG000|Overall Study|Withdrawal by Subject|3|||
33283980|NCT01258660|62659868|FG001|Overall Study|Withdrawal by Subject|0|||
33283981|NCT01258660|62659867|FG000|Overall Study|due to relocation|2|||
33283982|NCT01258660|62659868|FG001|Overall Study|due to relocation|0|||
33283983|NCT01258660|62659867|FG000|Overall Study|Protocol Violation|0|||
33283984|NCT01258660|62659868|FG001|Overall Study|Protocol Violation|1|||
33371654|NCT00878501|62750426|FG000|Overall Study|Administrative|0|||
33371655|NCT00878501|62750427|FG001|Overall Study|Administrative|0|||
33371656|NCT00878501|62750428|FG002|Overall Study|Administrative|1|||
33371657|NCT00882713|62750436|FG000|Overall Study|Adverse Event|2|||
33371658|NCT00882713|62750436|FG000|Overall Study|Death|3|||
33371659|NCT00882713|62750436|FG000|Overall Study|Administrative reasons|4|||
33371660|NCT00882713|62750436|FG000|Overall Study|refused treatment/withdrew consent|4|||
33371661|NCT00882713|62750436|FG000|Overall Study|Blood transfusion|2|||
33371662|NCT00882713|62750436|FG000|Overall Study|Insufficient therapeutic response|3|||
33371663|NCT00882713|62750436|FG000|Overall Study|Failure to return|2|||
33371664|NCT00882713|62750436|FG000|Overall Study|Other - Reasons|2|||
33371665|NCT00809133|62750455|FG000|Overall Study|Progressive disease|2|||
33371666|NCT00809133|62750456|FG001|Overall Study|Progressive disease|5|||
33371667|NCT00809133|62750457|FG002|Overall Study|Progressive disease|5|||
33371668|NCT00809133|62750458|FG003|Overall Study|Progressive disease|3|||
33371669|NCT00809133|62750459|FG004|Overall Study|Progressive disease|4|||
33371670|NCT00809133|62750460|FG005|Overall Study|Progressive disease|1|||
33371671|NCT00809133|62750461|FG006|Overall Study|Progressive disease|3|||
33371672|NCT00809133|62750462|FG007|Overall Study|Progressive disease|3|||
33371673|NCT00809133|62750463|FG008|Overall Study|Progressive disease|3|||
33371674|NCT00809133|62750464|FG009|Overall Study|Progressive disease|9|||
33371675|NCT00809133|62750465|FG010|Overall Study|Progressive disease|5|||
33371676|NCT00809133|62750466|FG011|Overall Study|Progressive disease|7|||
33371677|NCT00809133|62750467|FG012|Overall Study|Progressive disease|5|||
33371678|NCT00809133|62750468|FG013|Overall Study|Progressive disease|4|||
33371679|NCT00809133|62750455|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33371680|NCT00809133|62750456|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33371681|NCT00809133|62750457|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33371682|NCT00809133|62750458|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33556201|NCT02308696|62949037|FG000|Overall Study|Lost to Follow-up|28|||
33556202|NCT02308696|62949038|FG001|Overall Study|Lost to Follow-up|21|||
33283985|NCT01258660|62659867|FG000|Overall Study|Invalid for primary analysis data set|4|||
33283986|NCT01258660|62659868|FG001|Overall Study|Invalid for primary analysis data set|6|||
33283987|NCT01258348|62659875|FG000|Overall Study|Adverse Event|1|||
33371683|NCT00809133|62750459|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33283988|NCT01258348|62659876|FG001|Overall Study|Adverse Event|1|||
33371684|NCT00809133|62750460|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
33371685|NCT00809133|62750461|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
33371686|NCT00809133|62750462|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
33371687|NCT00809133|62750463|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33283989|NCT01258348|62659877|FG002|Overall Study|Adverse Event|3|||
33283990|NCT01258348|62659878|FG003|Overall Study|Adverse Event|2|||
33283991|NCT01258348|62659879|FG004|Overall Study|Adverse Event|4|||
33283992|NCT01258348|62659875|FG000|Overall Study|Progressive Disease|0|||
33283993|NCT01258348|62659876|FG001|Overall Study|Progressive Disease|3|||
33283994|NCT01258348|62659877|FG002|Overall Study|Progressive Disease|0|||
33371688|NCT00809133|62750464|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33371689|NCT00809133|62750465|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33371690|NCT00809133|62750466|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33371691|NCT00809133|62750467|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33371692|NCT00809133|62750468|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
33371693|NCT00809133|62750455|FG000|Overall Study|Other adverse event|1|||
33371694|NCT00809133|62750456|FG001|Overall Study|Other adverse event|1|||
33371695|NCT00809133|62750457|FG002|Overall Study|Other adverse event|1|||
33371696|NCT00809133|62750458|FG003|Overall Study|Other adverse event|0|||
33371697|NCT00809133|62750459|FG004|Overall Study|Other adverse event|0|||
33371698|NCT00809133|62750460|FG005|Overall Study|Other adverse event|3|||
33371699|NCT00809133|62750461|FG006|Overall Study|Other adverse event|2|||
33371700|NCT00809133|62750462|FG007|Overall Study|Other adverse event|4|||
33371701|NCT00809133|62750463|FG008|Overall Study|Other adverse event|0|||
33371702|NCT00809133|62750464|FG009|Overall Study|Other adverse event|0|||
33371703|NCT00809133|62750465|FG010|Overall Study|Other adverse event|1|||
33371704|NCT00809133|62750466|FG011|Overall Study|Other adverse event|1|||
33371705|NCT00809133|62750467|FG012|Overall Study|Other adverse event|0|||
33371706|NCT00809133|62750468|FG013|Overall Study|Other adverse event|1|||
33371707|NCT00809133|62750455|FG000|Overall Study|Lost to Follow-up|0|||
33371708|NCT00809133|62750456|FG001|Overall Study|Lost to Follow-up|0|||
33371709|NCT00809133|62750457|FG002|Overall Study|Lost to Follow-up|0|||
33371710|NCT00809133|62750458|FG003|Overall Study|Lost to Follow-up|0|||
33371711|NCT00809133|62750459|FG004|Overall Study|Lost to Follow-up|0|||
33371712|NCT00809133|62750460|FG005|Overall Study|Lost to Follow-up|1|||
33371713|NCT00809133|62750461|FG006|Overall Study|Lost to Follow-up|0|||
33371714|NCT00809133|62750462|FG007|Overall Study|Lost to Follow-up|0|||
33371715|NCT00809133|62750463|FG008|Overall Study|Lost to Follow-up|0|||
33371716|NCT00809133|62750464|FG009|Overall Study|Lost to Follow-up|0|||
33371717|NCT00809133|62750465|FG010|Overall Study|Lost to Follow-up|0|||
33371718|NCT00809133|62750466|FG011|Overall Study|Lost to Follow-up|0|||
33371719|NCT00809133|62750467|FG012|Overall Study|Lost to Follow-up|0|||
33283995|NCT01258348|62659878|FG003|Overall Study|Progressive Disease|2|||
33283996|NCT01258348|62659879|FG004|Overall Study|Progressive Disease|2|||
33283997|NCT01258348|62659875|FG000|Overall Study|Physician Decision|0|||
33283998|NCT01258348|62659876|FG001|Overall Study|Physician Decision|0|||
33283999|NCT01258348|62659877|FG002|Overall Study|Physician Decision|0|||
33284000|NCT01258348|62659878|FG003|Overall Study|Physician Decision|2|||
33284001|NCT01258348|62659879|FG004|Overall Study|Physician Decision|0|||
33284002|NCT01258348|62659875|FG000|Overall Study|Withdrawal by Subject|0|||
33284003|NCT01258348|62659876|FG001|Overall Study|Withdrawal by Subject|1|||
33284004|NCT01258348|62659877|FG002|Overall Study|Withdrawal by Subject|0|||
33284005|NCT01258348|62659878|FG003|Overall Study|Withdrawal by Subject|0|||
33284006|NCT01258348|62659879|FG004|Overall Study|Withdrawal by Subject|0|||
33284007|NCT01258075|62659895|FG000|Overall Study|Adverse Event|8|||
33284008|NCT01258075|62659896|FG001|Overall Study|Adverse Event|3|||
33371720|NCT00809133|62750468|FG013|Overall Study|Lost to Follow-up|0|||
33371721|NCT00809133|62750455|FG000|Overall Study|Consent withdrawn|0|||
33371722|NCT00809133|62750456|FG001|Overall Study|Consent withdrawn|0|||
33371723|NCT00809133|62750457|FG002|Overall Study|Consent withdrawn|0|||
33371724|NCT00809133|62750458|FG003|Overall Study|Consent withdrawn|0|||
33371725|NCT00809133|62750459|FG004|Overall Study|Consent withdrawn|1|||
33371726|NCT00809133|62750460|FG005|Overall Study|Consent withdrawn|0|||
33284009|NCT01258075|62659895|FG000|Overall Study|Lost to Follow-up|11|||
33284010|NCT01258075|62659896|FG001|Overall Study|Lost to Follow-up|6|||
33284011|NCT01258075|62659895|FG000|Overall Study|Withdrawal by Subject|10|||
33284012|NCT01258075|62659896|FG001|Overall Study|Withdrawal by Subject|7|||
33284013|NCT01258075|62659895|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
33371727|NCT00809133|62750461|FG006|Overall Study|Consent withdrawn|0|||
33371728|NCT00809133|62750462|FG007|Overall Study|Consent withdrawn|0|||
33371729|NCT00809133|62750463|FG008|Overall Study|Consent withdrawn|0|||
33284014|NCT01258075|62659896|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
33284015|NCT01258075|62659895|FG000|Overall Study|Other|12|||
33284016|NCT01258075|62659896|FG001|Overall Study|Other|5|||
33284017|NCT01257568|62659902|FG000|Overall Study|Lost to Follow-up|2|||
33284018|NCT01257568|62659902|FG000|Overall Study|Withdrawal by Subject|6|||
33284019|NCT01257568|62659902|FG000|Overall Study|Terminated|1|||
33371730|NCT00809133|62750464|FG009|Overall Study|Consent withdrawn|0|||
33371731|NCT00809133|62750465|FG010|Overall Study|Consent withdrawn|0|||
33371732|NCT00809133|62750466|FG011|Overall Study|Consent withdrawn|0|||
33371733|NCT00809133|62750467|FG012|Overall Study|Consent withdrawn|0|||
33371734|NCT00809133|62750468|FG013|Overall Study|Consent withdrawn|0|||
33371735|NCT00809133|62750455|FG000|Overall Study|Other not mentioned above|0|||
33371736|NCT00809133|62750456|FG001|Overall Study|Other not mentioned above|1|||
33371737|NCT00809133|62750457|FG002|Overall Study|Other not mentioned above|0|||
33371738|NCT00809133|62750458|FG003|Overall Study|Other not mentioned above|0|||
33371739|NCT00809133|62750459|FG004|Overall Study|Other not mentioned above|0|||
33371740|NCT00809133|62750460|FG005|Overall Study|Other not mentioned above|1|||
33371741|NCT00809133|62750461|FG006|Overall Study|Other not mentioned above|0|||
33371742|NCT00809133|62750462|FG007|Overall Study|Other not mentioned above|0|||
33371743|NCT00809133|62750463|FG008|Overall Study|Other not mentioned above|0|||
33371744|NCT00809133|62750464|FG009|Overall Study|Other not mentioned above|0|||
33371745|NCT00809133|62750465|FG010|Overall Study|Other not mentioned above|0|||
33371746|NCT00809133|62750466|FG011|Overall Study|Other not mentioned above|0|||
33371747|NCT00809133|62750467|FG012|Overall Study|Other not mentioned above|0|||
33371748|NCT00809133|62750468|FG013|Overall Study|Other not mentioned above|0|||
33284020|NCT01257568|62659902|FG000|Overall Study|Component Revision|24|||
33371749|NCT00882557|62750513|FG000|Overall Study|Withdrawal by Subject|1|||
33371750|NCT00882557|62750514|FG001|Overall Study|Withdrawal by Subject|0|||
33371751|NCT00882557|62750513|FG000|Overall Study|Trouble with Vein Access|1|||
33371752|NCT00882557|62750514|FG001|Overall Study|Trouble with Vein Access|0|||
33371753|NCT00882557|62750513|FG000|Overall Study|Randomized Not Treated|0|||
33371754|NCT00882557|62750514|FG001|Overall Study|Randomized Not Treated|1|||
33371755|NCT00808899|62750520|FG000|Overall Study|Death|1|||
33371756|NCT00808899|62750520|FG000|Overall Study|Physician Decision|3|||
33371757|NCT00808665|62750526|FG000|Overall Study|Withdrawal by Subject|1|||
33371758|NCT00808665|62750527|FG001|Overall Study|Withdrawal by Subject|0|||
33371759|NCT00808665|62750526|FG000|Overall Study|only required minimally invasive surgery|1|||
33371760|NCT00808665|62750527|FG001|Overall Study|only required minimally invasive surgery|0|||
33371761|NCT00808665|62750526|FG000|Overall Study|surgery cancelled|1|||
33371762|NCT00808665|62750527|FG001|Overall Study|surgery cancelled|0|||
33371763|NCT00808665|62750526|FG000|Overall Study|required an additional procedure|0|||
33371764|NCT00808665|62750527|FG001|Overall Study|required an additional procedure|1|||
33371765|NCT00808665|62750526|FG000|Overall Study|Physician Decision|3|||
33371766|NCT00808665|62750527|FG001|Overall Study|Physician Decision|1|||
33284021|NCT01256788|62659911|FG000|Overall Study|Lost to Follow-up|5|||
33284022|NCT01256788|62659912|FG001|Overall Study|Lost to Follow-up|8|||
33284023|NCT01256788|62659913|FG002|Overall Study|Lost to Follow-up|3|||
33284024|NCT01256671|62659921|FG000|Overall Study|Adverse Event|29|||
33284025|NCT01256671|62659921|FG000|Overall Study|Lost to Follow-up|16|||
33284026|NCT01256671|62659921|FG000|Overall Study|Withdrawal by Subject|31|||
33284027|NCT01256671|62659921|FG000|Overall Study|Physician Decision|3|||
33284028|NCT01256671|62659921|FG000|Overall Study|Lack of Efficacy|4|||
33284029|NCT01256671|62659921|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
33284030|NCT01256476|62659927|FG000|Overall Study|Adverse Event|2|||
33284031|NCT01256476|62659928|FG001|Overall Study|Adverse Event|1|||
33284032|NCT01256476|62659927|FG000|Overall Study|Withdrawal by Subject|2|||
33284033|NCT01256476|62659928|FG001|Overall Study|Withdrawal by Subject|1|||
33284034|NCT01256476|62659927|FG000|Overall Study|Lost to Follow-up|1|||
33284035|NCT01256476|62659928|FG001|Overall Study|Lost to Follow-up|2|||
33284036|NCT01256476|62659927|FG000|Overall Study|Persistent ALT or AST elevation|1|||
33284037|NCT01256476|62659928|FG001|Overall Study|Persistent ALT or AST elevation|0|||
33284038|NCT01256476|62659927|FG000|Overall Study|Physician Decision|0|||
33284039|NCT01256476|62659928|FG001|Overall Study|Physician Decision|1|||
33284040|NCT01256476|62659927|FG000|Overall Study|Subject non-compliance|0|||
33284041|NCT01256476|62659928|FG001|Overall Study|Subject non-compliance|1|||
33284042|NCT01256476|62659927|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
33371767|NCT00808665|62750526|FG000|Overall Study|Medication stopped by resident|0|||
33371768|NCT00808665|62750527|FG001|Overall Study|Medication stopped by resident|1|||
33371769|NCT00808509|62750535|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
33284043|NCT01256476|62659928|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
33284044|NCT01256008|62659937|FG000|Overall Study|Lost to Follow-up|6|||
33284045|NCT01256008|62659938|FG001|Overall Study|Lost to Follow-up|4|||
33284046|NCT01256008|62659939|FG002|Overall Study|Lost to Follow-up|11|||
33284047|NCT01256008|62659937|FG000|Overall Study|Withdrawal by Subject|2|||
33284048|NCT01256008|62659938|FG001|Overall Study|Withdrawal by Subject|3|||
33284049|NCT01256008|62659939|FG002|Overall Study|Withdrawal by Subject|10|||
33284050|NCT01255423|62659951|FG000|Overall Study|Abnormal Laboratory value|3|||
33284051|NCT01255423|62659952|FG001|Overall Study|Abnormal Laboratory value|2|||
33284052|NCT01255423|62659951|FG000|Overall Study|Use of prohibited medications|0|||
33284053|NCT01255423|62659952|FG001|Overall Study|Use of prohibited medications|1|||
33284054|NCT01255306|62659960|FG000|Overall Study|Physician Decision|1|||
33284055|NCT01255306|62659961|FG001|Overall Study|Physician Decision|1|||
33284056|NCT01254721|62659972|FG000|Overall Study|Lost to Follow-up|0|||
33284057|NCT01254721|62659973|FG001|Overall Study|Lost to Follow-up|4|||
33371770|NCT00808509|62750536|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
33371771|NCT00808509|62750535|FG000|Randomized Phase|Reduced methotrexate dose|1|||
33371772|NCT00808509|62750536|FG001|Randomized Phase|Reduced methotrexate dose|2|||
33284058|NCT01254721|62659972|FG000|Overall Study|Lack of Efficacy|4|||
33284059|NCT01254721|62659973|FG001|Overall Study|Lack of Efficacy|2|||
33284060|NCT01254721|62659972|FG000|Overall Study|Death|0|||
33284061|NCT01254721|62659973|FG001|Overall Study|Death|1|||
33284062|NCT01254721|62659972|FG000|Overall Study|technical problum|1|||
33284063|NCT01254721|62659973|FG001|Overall Study|technical problum|0|||
33284064|NCT01254721|62659972|FG000|Overall Study|Adverse Event|2|||
33284065|NCT01254721|62659973|FG001|Overall Study|Adverse Event|3|||
33284066|NCT01254721|62659972|FG000|Overall Study|Withdrawal by Subject|8|||
33284067|NCT01254721|62659973|FG001|Overall Study|Withdrawal by Subject|11|||
33284068|NCT01254721|62659972|FG000|Overall Study|Wrongly randomization|0|||
33284069|NCT01254721|62659973|FG001|Overall Study|Wrongly randomization|1|||
33284070|NCT01254643|62659979|FG000|Overall Study|Withdrawal by Subject|1|||
33284071|NCT01254604|62659985|FG000|Overall Study|Lost to Follow-up|1|||
33284072|NCT01254604|62659986|FG001|Overall Study|Lost to Follow-up|1|||
33284073|NCT01254604|62659985|FG000|Overall Study|Protocol Violation|2|||
33284074|NCT01254604|62659986|FG001|Overall Study|Protocol Violation|2|||
33284075|NCT01254604|62659985|FG000|Overall Study|Withdrawal by Subject|2|||
33284076|NCT01254604|62659986|FG001|Overall Study|Withdrawal by Subject|4|||
33284077|NCT01254604|62659985|FG000|Overall Study|Adverse Event|3|||
33284078|NCT01254604|62659986|FG001|Overall Study|Adverse Event|2|||
33284079|NCT01254565|62659998|FG000|Overall Study|Non-compliance to Study Procedures|0|||
33284080|NCT01254565|62659999|FG001|Overall Study|Non-compliance to Study Procedures|0|||
33284081|NCT01254565|62660000|FG002|Overall Study|Non-compliance to Study Procedures|0|||
33284082|NCT01254565|62660001|FG003|Overall Study|Non-compliance to Study Procedures|0|||
33284083|NCT01254565|62660002|FG004|Overall Study|Non-compliance to Study Procedures|1|||
33284084|NCT01254565|62660003|FG005|Overall Study|Non-compliance to Study Procedures|0|||
33284085|NCT01254565|62659998|FG000|Overall Study|Did not Receive Treatment|1|||
33371773|NCT00808509|62750535|FG000|Randomized Phase|Patient refused rescue therapy|0|||
33371774|NCT00808509|62750536|FG001|Randomized Phase|Patient refused rescue therapy|3|||
33371775|NCT00807885|62750553|FG000|Overall Study|Lost to Follow-up|0|||
33371776|NCT00807885|62750554|FG001|Overall Study|Lost to Follow-up|0|||
33371777|NCT00807885|62750555|FG002|Overall Study|Lost to Follow-up|0|||
33371778|NCT00807885|62750556|FG003|Overall Study|Lost to Follow-up|0|||
33371779|NCT00807885|62750557|FG004|Overall Study|Lost to Follow-up|0|||
33371780|NCT00807885|62750558|FG005|Overall Study|Lost to Follow-up|1|||
33371781|NCT00807885|62750559|FG006|Overall Study|Lost to Follow-up|0|||
33371782|NCT00807885|62750560|FG007|Overall Study|Lost to Follow-up|0|||
33371783|NCT00807885|62750561|FG008|Overall Study|Lost to Follow-up|0|||
33371784|NCT00807573|62750581|FG000|Overall Study|Withdrawal by Subject|1|||
33371785|NCT00807573|62750581|FG000|Overall Study|Adverse Event|1|||
33371786|NCT00842712|62750592|FG000|Safety Run-in Part|Adverse Event|0|||
33371787|NCT00842712|62750593|FG001|Safety Run-in Part|Adverse Event|1|||
33371788|NCT00842712|62750594|FG002|Safety Run-in Part|Adverse Event|0|||
33371789|NCT00842712|62750595|FG003|Safety Run-in Part|Adverse Event|0|||
33371790|NCT00842712|62750596|FG004|Safety Run-in Part|Adverse Event|0|||
33371791|NCT00842712|62750597|FG005|Safety Run-in Part|Adverse Event|0|||
33371792|NCT00842712|62750598|FG006|Safety Run-in Part|Adverse Event|0|||
33371793|NCT00842712|62750592|FG000|Safety Run-in Part|Progressive disease|3|||
33371794|NCT00842712|62750593|FG001|Safety Run-in Part|Progressive disease|1|||
33371795|NCT00842712|62750594|FG002|Safety Run-in Part|Progressive disease|0|||
33371796|NCT00842712|62750595|FG003|Safety Run-in Part|Progressive disease|1|||
33371797|NCT00842712|62750596|FG004|Safety Run-in Part|Progressive disease|0|||
33371798|NCT00842712|62750597|FG005|Safety Run-in Part|Progressive disease|0|||
33371799|NCT00842712|62750598|FG006|Safety Run-in Part|Progressive disease|0|||
33371800|NCT00842712|62750592|FG000|Randomized Part|Randomized but not treated|0|||
33371801|NCT00842712|62750593|FG001|Randomized Part|Randomized but not treated|0|||
33371802|NCT00842712|62750594|FG002|Randomized Part|Randomized but not treated|0|||
33371803|NCT00842712|62750595|FG003|Randomized Part|Randomized but not treated|0|||
33371804|NCT00842712|62750596|FG004|Randomized Part|Randomized but not treated|0|||
33371805|NCT00842712|62750597|FG005|Randomized Part|Randomized but not treated|1|||
33371806|NCT00842712|62750598|FG006|Randomized Part|Randomized but not treated|4|||
33284086|NCT01254565|62659999|FG001|Overall Study|Did not Receive Treatment|1|||
33284087|NCT01254565|62660000|FG002|Overall Study|Did not Receive Treatment|0|||
33284088|NCT01254565|62660001|FG003|Overall Study|Did not Receive Treatment|0|||
33371807|NCT00842712|62750592|FG000|Randomized Part|Ongoing at cut-off date|0|||
33371808|NCT00842712|62750593|FG001|Randomized Part|Ongoing at cut-off date|0|||
33371809|NCT00842712|62750594|FG002|Randomized Part|Ongoing at cut-off date|0|||
33371810|NCT00842712|62750595|FG003|Randomized Part|Ongoing at cut-off date|0|||
33486385|NCT04080297|62864222|FG000|Overall Study|concurrent illness|1|||
33284089|NCT01254565|62660002|FG004|Overall Study|Did not Receive Treatment|3|||
33284090|NCT01254565|62660003|FG005|Overall Study|Did not Receive Treatment|4|||
33284091|NCT01254565|62659998|FG000|Overall Study|Other|0|||
33371811|NCT00842712|62750596|FG004|Randomized Part|Ongoing at cut-off date|0|||
33371812|NCT00842712|62750597|FG005|Randomized Part|Ongoing at cut-off date|0|||
33371813|NCT00842712|62750598|FG006|Randomized Part|Ongoing at cut-off date|2|||
33284092|NCT01254565|62659999|FG001|Overall Study|Other|0|||
33284093|NCT01254565|62660000|FG002|Overall Study|Other|0|||
33284094|NCT01254565|62660001|FG003|Overall Study|Other|1|||
33284095|NCT01254565|62660002|FG004|Overall Study|Other|0|||
33284096|NCT01254565|62660003|FG005|Overall Study|Other|0|||
33284097|NCT01254409|62660021|FG000|Overall Study|Adverse Event|0|||
33284098|NCT01254409|62660022|FG001|Overall Study|Adverse Event|1|||
33284099|NCT01254409|62660023|FG002|Overall Study|Adverse Event|0|||
33284100|NCT01254409|62660024|FG003|Overall Study|Adverse Event|0|||
33284101|NCT01254331|62660037|FG000|Initial Phase|Adverse Event|3|||
33284102|NCT01254331|62660037|FG000|Initial Phase|Withdrawal by Subject|1|||
33284103|NCT01254331|62660037|FG000|Initial Phase|Pregnancy|1|||
33284104|NCT01254331|62660037|FG000|Extension Phase|Lack of Efficacy|1|||
33284105|NCT01254331|62660037|FG000|Extension Phase|Lost to Follow-up|3|||
33284106|NCT01254292|62660052|FG000|Comparative Phase|Adverse Event|25|||
33284107|NCT01254292|62660053|FG001|Comparative Phase|Adverse Event|25|||
33284108|NCT01254292|62660052|FG000|Comparative Phase|Lost to Follow-up|3|||
33284109|NCT01254292|62660053|FG001|Comparative Phase|Lost to Follow-up|21|||
33284110|NCT01254292|62660052|FG000|Comparative Phase|Pregnancy|2|||
33284111|NCT01254292|62660053|FG001|Comparative Phase|Pregnancy|6|||
33284112|NCT01254292|62660052|FG000|Comparative Phase|Withdrawal by Subject|20|||
33284113|NCT01254292|62660053|FG001|Comparative Phase|Withdrawal by Subject|21|||
33284114|NCT01254292|62660052|FG000|Comparative Phase|Protocol Violation|1|||
33284115|NCT01254292|62660053|FG001|Comparative Phase|Protocol Violation|2|||
33284116|NCT01254292|62660052|FG000|Comparative Phase|Wish for pregnancy|4|||
33284117|NCT01254292|62660053|FG001|Comparative Phase|Wish for pregnancy|6|||
33284118|NCT01254292|62660052|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
33284119|NCT01254292|62660053|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
33284120|NCT01254292|62660052|FG000|LCS12 Extension Phase|Adverse Event|9|||
33284121|NCT01254292|62660053|FG001|LCS12 Extension Phase|Adverse Event|0|||
33284122|NCT01254292|62660052|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
33284123|NCT01254292|62660053|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
33284124|NCT01254292|62660052|FG000|LCS12 Extension Phase|Other unknown|4|||
33284125|NCT01254292|62660053|FG001|LCS12 Extension Phase|Other unknown|0|||
33284126|NCT01254292|62660052|FG000|LCS12 Extension Phase|Pregnancy|2|||
33284127|NCT01254292|62660053|FG001|LCS12 Extension Phase|Pregnancy|0|||
33284128|NCT01254292|62660052|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
33284129|NCT01254292|62660053|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
33284130|NCT01254019|62660062|FG000|Overall Study|Adverse Event|0|||
33284131|NCT01254019|62660063|FG001|Overall Study|Adverse Event|2|||
33284132|NCT01254019|62660062|FG000|Overall Study|Protocol Violation|1|||
33284133|NCT01254019|62660063|FG001|Overall Study|Protocol Violation|0|||
33284134|NCT01254019|62660062|FG000|Overall Study|Withdrawal by Subject|0|||
33284135|NCT01254019|62660063|FG001|Overall Study|Withdrawal by Subject|2|||
33284136|NCT01253317|62660072|FG000|Overall Study|Adverse Event|2|||
33371814|NCT00842244|62750614|FG000|Overall Study|Death|3|||
33371815|NCT00842244|62750614|FG000|Overall Study|Withdrawal by Subject|1|||
33371816|NCT00842244|62750614|FG000|Overall Study|Other|17|||
33371817|NCT00832416|62750625|FG000|Overall Study|Lack of Efficacy|17|||
33371818|NCT00832416|62750626|FG001|Overall Study|Lack of Efficacy|15|||
33371819|NCT00832416|62750627|FG002|Overall Study|Lack of Efficacy|13|||
33371820|NCT00832416|62750628|FG003|Overall Study|Lack of Efficacy|52|||
33371821|NCT00832416|62750625|FG000|Overall Study|Withdrawal by Subject|5|||
33371822|NCT00832416|62750626|FG001|Overall Study|Withdrawal by Subject|7|||
33371823|NCT00832416|62750627|FG002|Overall Study|Withdrawal by Subject|2|||
33371824|NCT00832416|62750628|FG003|Overall Study|Withdrawal by Subject|10|||
33371825|NCT00832416|62750625|FG000|Overall Study|Physician Decision|2|||
33371826|NCT00832416|62750626|FG001|Overall Study|Physician Decision|12|||
33371827|NCT00832416|62750627|FG002|Overall Study|Physician Decision|5|||
33371828|NCT00832416|62750628|FG003|Overall Study|Physician Decision|10|||
33371829|NCT00832416|62750625|FG000|Overall Study|Administrative|0|||
33284137|NCT01253200|62660085|FG000|Overall Study|Death|1|||
33284138|NCT01253200|62660086|FG001|Overall Study|Death|0|||
33284139|NCT01253200|62660087|FG002|Overall Study|Death|0|||
33284140|NCT01253200|62660088|FG003|Overall Study|Death|0|||
33284141|NCT01253200|62660089|FG004|Overall Study|Death|0|||
33284142|NCT01253200|62660085|FG000|Overall Study|Lost to Follow-up|1|||
33284143|NCT01253200|62660086|FG001|Overall Study|Lost to Follow-up|1|||
33284144|NCT01253200|62660087|FG002|Overall Study|Lost to Follow-up|0|||
33284145|NCT01253200|62660088|FG003|Overall Study|Lost to Follow-up|0|||
33284146|NCT01253200|62660089|FG004|Overall Study|Lost to Follow-up|0|||
33284147|NCT01253200|62660085|FG000|Overall Study|Withdrawal by Subject|2|||
33371830|NCT00832416|62750626|FG001|Overall Study|Administrative|0|||
33284148|NCT01253200|62660086|FG001|Overall Study|Withdrawal by Subject|0|||
33284149|NCT01253200|62660087|FG002|Overall Study|Withdrawal by Subject|0|||
33371831|NCT00832416|62750627|FG002|Overall Study|Administrative|0|||
33371832|NCT00832416|62750628|FG003|Overall Study|Administrative|1|||
33371833|NCT00832416|62750625|FG000|Overall Study|Adverse Event|21|||
33371834|NCT00832416|62750626|FG001|Overall Study|Adverse Event|19|||
33284150|NCT01253200|62660088|FG003|Overall Study|Withdrawal by Subject|0|||
33284151|NCT01253200|62660089|FG004|Overall Study|Withdrawal by Subject|0|||
33284152|NCT01253200|62660085|FG000|Overall Study|Protocol Violation|1|||
33284153|NCT01253200|62660086|FG001|Overall Study|Protocol Violation|4|||
33284154|NCT01253200|62660087|FG002|Overall Study|Protocol Violation|0|||
33371835|NCT00832416|62750627|FG002|Overall Study|Adverse Event|41|||
33371836|NCT00832416|62750628|FG003|Overall Study|Adverse Event|10|||
33371837|NCT00832416|62750625|FG000|Overall Study|Death|1|||
33371838|NCT00832416|62750626|FG001|Overall Study|Death|0|||
33371839|NCT00832416|62750627|FG002|Overall Study|Death|0|||
33371840|NCT00832416|62750628|FG003|Overall Study|Death|0|||
33371841|NCT00841776|62750640|FG000|Overall Study|Lack of Efficacy|0|||
33371842|NCT00841776|62750641|FG001|Overall Study|Lack of Efficacy|1|||
33371843|NCT00841776|62750640|FG000|Overall Study|Lost to Follow-up|2|||
33371844|NCT00841776|62750641|FG001|Overall Study|Lost to Follow-up|1|||
33371845|NCT00841776|62750640|FG000|Overall Study|Withdrawal by Subject|0|||
33371846|NCT00841776|62750641|FG001|Overall Study|Withdrawal by Subject|1|||
33371847|NCT00683800|62750649|FG000|Overall Study|Adverse Event|195|||
33371848|NCT00683800|62750650|FG001|Overall Study|Adverse Event|102|||
33371849|NCT00683800|62750649|FG000|Overall Study|Death|0|||
33371850|NCT00683800|62750650|FG001|Overall Study|Death|1|||
33371851|NCT00683800|62750649|FG000|Overall Study|Lost to Follow-up|57|||
33371852|NCT00683800|62750650|FG001|Overall Study|Lost to Follow-up|44|||
33371853|NCT00683800|62750649|FG000|Overall Study|Other|5|||
33371854|NCT00683800|62750650|FG001|Overall Study|Other|2|||
33371855|NCT00683800|62750649|FG000|Overall Study|Protocol Violation|13|||
33371856|NCT00683800|62750650|FG001|Overall Study|Protocol Violation|16|||
33371857|NCT00683800|62750649|FG000|Overall Study|Withdrawal by Subject|66|||
33371858|NCT00683800|62750650|FG001|Overall Study|Withdrawal by Subject|64|||
33371859|NCT00683800|62750649|FG000|Overall Study|Lack of Efficacy|61|||
33371860|NCT00683800|62750650|FG001|Overall Study|Lack of Efficacy|104|||
33371861|NCT00683800|62750649|FG000|Overall Study|Randomized, not treated|35|||
33371862|NCT00683800|62750650|FG001|Overall Study|Randomized, not treated|33|||
33371863|NCT00683644|62750658|FG000|Overall Study|Withdrawal by Subject|4|||
33371864|NCT00683644|62750659|FG001|Overall Study|Withdrawal by Subject|2|||
33371865|NCT00683644|62750658|FG000|Overall Study|Lost to Follow-up|1|||
33371866|NCT00683644|62750659|FG001|Overall Study|Lost to Follow-up|4|||
33371867|NCT00683644|62750658|FG000|Overall Study|Adverse Event|1|||
33371868|NCT00683644|62750659|FG001|Overall Study|Adverse Event|2|||
33371869|NCT00683644|62750658|FG000|Overall Study|Low copper, other health problems,|7|||
33371870|NCT00683644|62750659|FG001|Overall Study|Low copper, other health problems,|6|||
33371871|NCT00685360|62750672|FG000|Overall Study|Lost to Follow-up|0|||
33371872|NCT00685360|62750673|FG001|Overall Study|Lost to Follow-up|1|||
33371873|NCT00685360|62750674|FG002|Overall Study|Lost to Follow-up|2|||
33371874|NCT00685360|62750672|FG000|Overall Study|Adverse Event|4|||
33371875|NCT00685360|62750673|FG001|Overall Study|Adverse Event|6|||
33371876|NCT00685360|62750674|FG002|Overall Study|Adverse Event|4|||
33371877|NCT00685360|62750672|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
33371878|NCT00685360|62750673|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
33371879|NCT00685360|62750674|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
33371880|NCT00685360|62750672|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
33371881|NCT00685360|62750673|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
33371882|NCT00685360|62750674|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
33371883|NCT00685360|62750672|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
33371884|NCT00685360|62750673|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
33371885|NCT00685360|62750674|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
33371886|NCT00685360|62750672|FG000|Overall Study|Protocol Deviation|0|||
33371887|NCT00685360|62750673|FG001|Overall Study|Protocol Deviation|1|||
33371888|NCT00685360|62750674|FG002|Overall Study|Protocol Deviation|1|||
33371889|NCT00684814|62750682|FG000|Washout Period of 7 Days|Adverse Event|1|||
33371890|NCT00684814|62750683|FG001|Washout Period of 7 Days|Adverse Event|2|||
33371891|NCT00684814|62750682|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
33371892|NCT00684814|62750683|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
33371893|NCT00684814|62750682|FG000|Second Intervention|Adverse Event|1|||
33371894|NCT00684814|62750683|FG001|Second Intervention|Adverse Event|0|||
33284155|NCT01253200|62660088|FG003|Overall Study|Protocol Violation|0|||
33284156|NCT01253200|62660089|FG004|Overall Study|Protocol Violation|5|||
33284157|NCT01253200|62660085|FG000|Overall Study|intents|10|||
33284158|NCT01253200|62660086|FG001|Overall Study|intents|10|||
33371895|NCT00576472|62750704|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
33371896|NCT00576472|62750705|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
33371897|NCT00576472|62750706|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
33371898|NCT00576472|62750707|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
33371899|NCT00576472|62750708|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
33371900|NCT00576472|62750709|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
33486386|NCT04080297|62864223|FG001|Overall Study|concurrent illness|0|||
33284159|NCT01253200|62660087|FG002|Overall Study|intents|1|||
33284160|NCT01253200|62660088|FG003|Overall Study|intents|3|||
33284161|NCT01253200|62660089|FG004|Overall Study|intents|0|||
33284162|NCT01253200|62660085|FG000|Overall Study|Attempts|6|||
33284163|NCT01253200|62660086|FG001|Overall Study|Attempts|4|||
33284164|NCT01253200|62660087|FG002|Overall Study|Attempts|1|||
33284165|NCT01253200|62660088|FG003|Overall Study|Attempts|2|||
33284166|NCT01253200|62660089|FG004|Overall Study|Attempts|0|||
33284167|NCT01253044|62660100|FG000|Overall Study|Lost to Follow-up|38|||
33284168|NCT01253044|62660101|FG001|Overall Study|Lost to Follow-up|29|||
33284169|NCT01252966|62660109|FG000|Overall Study|Lost to Follow-up|16|||
33284170|NCT01252966|62660110|FG001|Overall Study|Lost to Follow-up|10|||
33284171|NCT01252966|62660109|FG000|Overall Study|Withdrawal by Subject|7|||
33284172|NCT01252966|62660110|FG001|Overall Study|Withdrawal by Subject|3|||
33284173|NCT01252810|62660120|FG000|Overall Study|Withdrawal by Subject|4|||
33284174|NCT01252810|62660121|FG001|Overall Study|Withdrawal by Subject|1|||
33371901|NCT00576472|62750710|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
33371902|NCT00576472|62750711|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
33371903|NCT00576472|62750712|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
33371904|NCT00576472|62750713|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
33371905|NCT00576472|62750714|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
33371906|NCT00576472|62750715|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
33371907|NCT00576472|62750716|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
33371908|NCT00576472|62750717|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
33371909|NCT00576472|62750718|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
33371910|NCT00576472|62750704|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
33371911|NCT00576472|62750705|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
33371912|NCT00576472|62750706|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
33371913|NCT00576472|62750707|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
33371914|NCT00576472|62750708|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
33371915|NCT00576472|62750709|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
33284175|NCT01252810|62660120|FG000|Overall Study|Lost to Follow-up|0|||
33284176|NCT01252810|62660121|FG001|Overall Study|Lost to Follow-up|1|||
33284177|NCT01252810|62660120|FG000|Overall Study|Physician Decision|2|||
33284178|NCT01252810|62660121|FG001|Overall Study|Physician Decision|1|||
33284179|NCT01252810|62660120|FG000|Overall Study|Various reasons|8|||
33284180|NCT01252810|62660121|FG001|Overall Study|Various reasons|0|||
33284181|NCT01252186|62660130|FG000|Overall Study|Adverse Event|9|||
33284182|NCT01252186|62660131|FG001|Overall Study|Adverse Event|6|||
33284183|NCT01252186|62660132|FG002|Overall Study|Adverse Event|8|||
33284184|NCT01252186|62660130|FG000|Overall Study|Withdrawal by Subject|2|||
33284185|NCT01252186|62660131|FG001|Overall Study|Withdrawal by Subject|5|||
33284186|NCT01252186|62660132|FG002|Overall Study|Withdrawal by Subject|2|||
33284187|NCT01252186|62660130|FG000|Overall Study|Physician Decision|0|||
33284188|NCT01252186|62660131|FG001|Overall Study|Physician Decision|0|||
33284189|NCT01252186|62660132|FG002|Overall Study|Physician Decision|1|||
33284190|NCT01252186|62660130|FG000|Overall Study|Non-compliance|0|||
33284191|NCT01252186|62660131|FG001|Overall Study|Non-compliance|3|||
33284192|NCT01252186|62660132|FG002|Overall Study|Non-compliance|4|||
33284193|NCT01252186|62660130|FG000|Overall Study|Protocol Violation|0|||
33284194|NCT01252186|62660131|FG001|Overall Study|Protocol Violation|0|||
33284195|NCT01252186|62660132|FG002|Overall Study|Protocol Violation|1|||
33284196|NCT01252186|62660130|FG000|Overall Study|Pregnancy|2|||
33284197|NCT01252186|62660131|FG001|Overall Study|Pregnancy|2|||
33284198|NCT01252186|62660132|FG002|Overall Study|Pregnancy|0|||
33284199|NCT01252186|62660130|FG000|Overall Study|Sponsor Request|2|||
33284200|NCT01252186|62660131|FG001|Overall Study|Sponsor Request|1|||
33284201|NCT01252186|62660132|FG002|Overall Study|Sponsor Request|0|||
33284202|NCT01252186|62660130|FG000|Overall Study|Lost to Follow-up|10|||
33284203|NCT01252186|62660131|FG001|Overall Study|Lost to Follow-up|10|||
33284204|NCT01252186|62660132|FG002|Overall Study|Lost to Follow-up|11|||
33486387|NCT04013529|62864231|FG000|Overall Study|Withdrawal by Subject|1|||
33284205|NCT01252186|62660130|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
33284206|NCT01252186|62660131|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
33284207|NCT01252186|62660132|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
33284208|NCT01251952|62660167|FG000|Overall Study|Adverse Event|1|||
33284209|NCT01251367|62660171|FG000|Overall Study|Protocol Violation|1|||
33284210|NCT01251367|62660171|FG000|Overall Study|Lack of Efficacy|2|||
33284211|NCT01251367|62660171|FG000|Overall Study|Adverse Event|19|||
33284212|NCT01251367|62660171|FG000|Overall Study|Withdrawal by Subject|36|||
33284213|NCT01251367|62660171|FG000|Overall Study|Lost to Follow-up|5|||
33284214|NCT01251367|62660171|FG000|Overall Study|Subject Required Alternative Treatment|7|||
33284215|NCT01251367|62660171|FG000|Overall Study|No Study Drug Available|1|||
33284216|NCT01251367|62660171|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
33284217|NCT01251367|62660171|FG000|Overall Study|End of Study Visit Performed in Error|1|||
33284218|NCT01250509|62660177|FG000|Overall Study|Lost to Follow-up|5|||
33284219|NCT01250509|62660178|FG001|Overall Study|Lost to Follow-up|2|||
33284220|NCT01250119|62660186|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
33284221|NCT01250119|62660187|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
33284222|NCT01250119|62660186|FG000|Diagnostic Phase|Participants Not Tested|44|||
33284223|NCT01250119|62660187|FG001|Diagnostic Phase|Participants Not Tested|0|||
33284224|NCT01250119|62660186|FG000|Treatment Phase|Progressive Disease|0|||
33284225|NCT01250119|62660187|FG001|Treatment Phase|Progressive Disease|32|||
33284226|NCT01250119|62660186|FG000|Treatment Phase|Death|0|||
33284227|NCT01250119|62660187|FG001|Treatment Phase|Death|2|||
33284228|NCT01250119|62660186|FG000|Treatment Phase|Withdrawal by Subject|0|||
33284229|NCT01250119|62660187|FG001|Treatment Phase|Withdrawal by Subject|1|||
33284230|NCT01250119|62660186|FG000|Treatment Phase|Adverse Event|0|||
33284231|NCT01250119|62660187|FG001|Treatment Phase|Adverse Event|2|||
33284232|NCT01250119|62660186|FG000|Treatment Phase|Unknown reason|0|||
33284233|NCT01250119|62660187|FG001|Treatment Phase|Unknown reason|4|||
33284234|NCT01250002|62660196|FG000|Overall Study|Change to open surgical procedure|4|||
33284235|NCT01250002|62660197|FG001|Overall Study|Change to open surgical procedure|3|||
33284236|NCT01246960|62660205|FG000|Overall Study|Lost to Follow-up|3|||
33284237|NCT01246960|62660206|FG001|Overall Study|Lost to Follow-up|1|||
33284238|NCT01246960|62660205|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
33284239|NCT01246960|62660206|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
33284240|NCT01244620|62660212|FG000|Overall Study|Study terminated|4|||
33284241|NCT01244620|62660213|FG001|Overall Study|Study terminated|4|||
33284242|NCT01244620|62660214|FG002|Overall Study|Study terminated|4|||
33284243|NCT01244620|62660215|FG003|Overall Study|Study terminated|4|||
33284244|NCT01267201|62660225|FG000|First Intervention Period|Withdrawal by Subject|1|||
33284245|NCT01267201|62660226|FG001|First Intervention Period|Withdrawal by Subject|0|||
33284246|NCT01267201|62660227|FG002|First Intervention Period|Withdrawal by Subject|0|||
33284247|NCT01267201|62660228|FG003|First Intervention Period|Withdrawal by Subject|0|||
33284248|NCT01267201|62660229|FG004|First Intervention Period|Withdrawal by Subject|0|||
33284249|NCT01267201|62660230|FG005|First Intervention Period|Withdrawal by Subject|0|||
33284250|NCT01267201|62660225|FG000|Second Intervention Period|Withdrawal by Subject|0|||
33284251|NCT01267201|62660226|FG001|Second Intervention Period|Withdrawal by Subject|1|||
33284252|NCT01267201|62660227|FG002|Second Intervention Period|Withdrawal by Subject|0|||
33284253|NCT01267201|62660228|FG003|Second Intervention Period|Withdrawal by Subject|0|||
33284254|NCT01267201|62660229|FG004|Second Intervention Period|Withdrawal by Subject|0|||
33284255|NCT01267201|62660230|FG005|Second Intervention Period|Withdrawal by Subject|0|||
33284256|NCT01266967|62660240|FG000|Overall Study|Death|69|||
33284257|NCT01266967|62660241|FG001|Overall Study|Death|61|||
33284258|NCT01266967|62660240|FG000|Overall Study|Study Closed/Terminated|15|||
33284259|NCT01266967|62660241|FG001|Overall Study|Study Closed/Terminated|17|||
33284260|NCT01266967|62660240|FG000|Overall Study|Lost to Follow-up|2|||
33284261|NCT01266967|62660241|FG001|Overall Study|Lost to Follow-up|1|||
33284262|NCT01266967|62660240|FG000|Overall Study|Physician Decision|0|||
33284263|NCT01266967|62660241|FG001|Overall Study|Physician Decision|1|||
33284264|NCT01266967|62660240|FG000|Overall Study|Withdrawal by Subject|3|||
33284265|NCT01266967|62660241|FG001|Overall Study|Withdrawal by Subject|3|||
33284266|NCT01266850|62660255|FG000|Overall Study|Lost to Follow-up|19|||
33284267|NCT01266850|62660256|FG001|Overall Study|Lost to Follow-up|19|||
33284268|NCT01266850|62660257|FG002|Overall Study|Lost to Follow-up|13|||
33284269|NCT01266850|62660258|FG003|Overall Study|Lost to Follow-up|13|||
33284270|NCT01266850|62660259|FG004|Overall Study|Lost to Follow-up|12|||
33284271|NCT01266850|62660255|FG000|Overall Study|Withdrawal by Subject|8|||
33284272|NCT01266850|62660256|FG001|Overall Study|Withdrawal by Subject|9|||
33284273|NCT01266850|62660257|FG002|Overall Study|Withdrawal by Subject|6|||
33284274|NCT01266850|62660258|FG003|Overall Study|Withdrawal by Subject|9|||
33284275|NCT01266850|62660259|FG004|Overall Study|Withdrawal by Subject|12|||
33284276|NCT01266850|62660255|FG000|Overall Study|Physician Decision|3|||
33284277|NCT01266850|62660256|FG001|Overall Study|Physician Decision|6|||
33284278|NCT01266850|62660257|FG002|Overall Study|Physician Decision|4|||
33284279|NCT01266850|62660258|FG003|Overall Study|Physician Decision|4|||
33284280|NCT01266850|62660259|FG004|Overall Study|Physician Decision|3|||
33284281|NCT01266850|62660255|FG000|Overall Study|Protocol Violation|0|||
33284282|NCT01266850|62660256|FG001|Overall Study|Protocol Violation|1|||
33284283|NCT01266850|62660257|FG002|Overall Study|Protocol Violation|0|||
33284284|NCT01266850|62660258|FG003|Overall Study|Protocol Violation|1|||
33284285|NCT01266850|62660259|FG004|Overall Study|Protocol Violation|2|||
33284286|NCT01266850|62660255|FG000|Overall Study|Adverse Event|0|||
33284287|NCT01266850|62660256|FG001|Overall Study|Adverse Event|0|||
33284288|NCT01266850|62660257|FG002|Overall Study|Adverse Event|0|||
33284289|NCT01266850|62660258|FG003|Overall Study|Adverse Event|0|||
33284290|NCT01266850|62660259|FG004|Overall Study|Adverse Event|1|||
33284291|NCT01266850|62660255|FG000|Overall Study|Site Closure|0|||
33284292|NCT01266850|62660256|FG001|Overall Study|Site Closure|1|||
33284293|NCT01266850|62660257|FG002|Overall Study|Site Closure|1|||
33284294|NCT01266850|62660258|FG003|Overall Study|Site Closure|1|||
33284295|NCT01266850|62660259|FG004|Overall Study|Site Closure|0|||
33284296|NCT01266460|62660271|FG000|Overall Study|Adverse Event|3|||
33284297|NCT01266460|62660271|FG000|Overall Study|Withdrawal by Subject|5|||
33284298|NCT01266460|62660271|FG000|Overall Study|Disease Progression|18|||
33284299|NCT01266460|62660271|FG000|Overall Study|Not otherwise specified|8|||
33284300|NCT01266265|62660277|FG000|Overall Study|Death|95|||
33284301|NCT01266265|62660278|FG001|Overall Study|Death|73|||
33284302|NCT01266265|62660277|FG000|Overall Study|Lost to Follow-up|23|||
33284303|NCT01266265|62660278|FG001|Overall Study|Lost to Follow-up|28|||
33284304|NCT01266265|62660277|FG000|Overall Study|Withdrawal by Subject|13|||
33284305|NCT01266265|62660278|FG001|Overall Study|Withdrawal by Subject|11|||
33284306|NCT01266265|62660277|FG000|Overall Study|Respiratory-related adverse event|2|||
33284307|NCT01266265|62660278|FG001|Overall Study|Respiratory-related adverse event|1|||
33284308|NCT01266265|62660277|FG000|Overall Study|Transferred care to another provider|22|||
33284309|NCT01266265|62660278|FG001|Overall Study|Transferred care to another provider|28|||
33284310|NCT01266265|62660277|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
33284311|NCT01266265|62660278|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
33284312|NCT01266265|62660277|FG000|Overall Study|Enrolled in another clinical study|15|||
33284313|NCT01266265|62660278|FG001|Overall Study|Enrolled in another clinical study|26|||
33284314|NCT01266265|62660277|FG000|Overall Study|Non-compliance|8|||
33284315|NCT01266265|62660278|FG001|Overall Study|Non-compliance|5|||
33284316|NCT01266265|62660277|FG000|Overall Study|Lung transplant|6|||
33284317|NCT01266265|62660278|FG001|Overall Study|Lung transplant|5|||
33284318|NCT01266265|62660277|FG000|Overall Study|Site closed early|4|||
33284319|NCT01266265|62660278|FG001|Overall Study|Site closed early|3|||
33284320|NCT01266265|62660277|FG000|Overall Study|Clinical worsening|1|||
33284321|NCT01266265|62660278|FG001|Overall Study|Clinical worsening|1|||
33284322|NCT01266148|62660303|FG000|Overall Study|Adverse Event|2|||
33284323|NCT01266148|62660304|FG001|Overall Study|Adverse Event|0|||
33284324|NCT01266148|62660303|FG000|Overall Study|Ongoing rejection|1|||
33284325|NCT01266148|62660304|FG001|Overall Study|Ongoing rejection|0|||
33284326|NCT01266148|62660303|FG000|Overall Study|2 2R rejections|1|||
33284327|NCT01266148|62660304|FG001|Overall Study|2 2R rejections|0|||
33284328|NCT01266148|62660303|FG000|Overall Study|Death|2|||
33284329|NCT01266148|62660304|FG001|Overall Study|Death|3|||
33284330|NCT01266148|62660303|FG000|Overall Study|missing mGFR value + AE|1|||
33284331|NCT01266148|62660304|FG001|Overall Study|missing mGFR value + AE|0|||
33284332|NCT01266070|62660310|FG000|Overall Study|Adverse Event|3|||
33284333|NCT01266070|62660310|FG000|Overall Study|Protocol Violation|1|||
33284334|NCT01265992|62660314|FG000|Overall Study|Lost to Follow-up|1|||
33284335|NCT01265992|62660314|FG000|Overall Study|Withdrawal by Subject|1|||
33284336|NCT01265992|62660314|FG000|Overall Study|Adverse Event|1|||
33284337|NCT01265992|62660314|FG000|Overall Study|Administrative reasons|2|||
33284338|NCT01265992|62660314|FG000|Overall Study|Stopped treatment|3|||
33284339|NCT01265992|62660314|FG000|Overall Study|Did not receive treatment|1|||
33284340|NCT01265953|62660320|FG000|Overall Study|Non compliance|5|||
33371916|NCT00576472|62750710|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
33371917|NCT00576472|62750711|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
33371918|NCT00576472|62750712|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
33371919|NCT00576472|62750713|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
33371920|NCT00576472|62750714|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
33371921|NCT00576472|62750715|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
33371922|NCT00576472|62750716|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
33371923|NCT00576472|62750717|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
33371924|NCT00576472|62750718|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
33371925|NCT00576472|62750704|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33371926|NCT00576472|62750705|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33371927|NCT00576472|62750706|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33371928|NCT00576472|62750707|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
33371929|NCT00576472|62750708|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33371930|NCT00576472|62750709|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33371931|NCT00576472|62750710|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33284341|NCT01265953|62660321|FG001|Overall Study|Non compliance|3|||
33284342|NCT01265875|62660327|FG000|Overall Study|Uncooperative/unreliable|1|||
33284343|NCT01265797|62660334|FG000|Run-in Month|Withdrawal by Subject|0|||
33662164|NCT01695239|63092844|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33284344|NCT01265797|62660335|FG001|Run-in Month|Withdrawal by Subject|4|||
33284345|NCT01265797|62660334|FG000|Run-in Month|1st seizure during run-in month|0|||
33284346|NCT01265797|62660335|FG001|Run-in Month|1st seizure during run-in month|1|||
33284347|NCT01265797|62660334|FG000|Blinded Month|Lack of Efficacy|5|||
33284348|NCT01265797|62660335|FG001|Blinded Month|Lack of Efficacy|0|||
33284349|NCT01265797|62660334|FG000|Blinded Month|Lost to Follow-up|1|||
33284350|NCT01265797|62660335|FG001|Blinded Month|Lost to Follow-up|0|||
33284351|NCT01265797|62660334|FG000|Blinded Month|Protocol Violation|2|||
33284352|NCT01265797|62660335|FG001|Blinded Month|Protocol Violation|1|||
33284353|NCT01265797|62660334|FG000|Blinded Month|Adverse Event|2|||
33284354|NCT01265797|62660335|FG001|Blinded Month|Adverse Event|0|||
33284355|NCT01265797|62660334|FG000|Blinded Month|Diary data incomplete|0|||
33284356|NCT01265797|62660335|FG001|Blinded Month|Diary data incomplete|1|||
33284357|NCT01265797|62660334|FG000|Open Label Month|Lost to Follow-up|0|||
33284358|NCT01265797|62660335|FG001|Open Label Month|Lost to Follow-up|1|||
33284359|NCT01265719|62660345|FG000|Overall Study|Does not meet entrance criteria|0|||
33284360|NCT01265719|62660346|FG001|Overall Study|Does not meet entrance criteria|3|||
33284361|NCT01265719|62660345|FG000|Overall Study|Other reasons|2|||
33284362|NCT01265719|62660346|FG001|Overall Study|Other reasons|0|||
33284363|NCT01265719|62660345|FG000|Overall Study|Withdrawal by Subject|8|||
33284364|NCT01265719|62660346|FG001|Overall Study|Withdrawal by Subject|3|||
33284365|NCT01265719|62660345|FG000|Overall Study|Lost to Follow-up|2|||
33284366|NCT01265719|62660346|FG001|Overall Study|Lost to Follow-up|7|||
33284367|NCT01265719|62660345|FG000|Overall Study|Adverse Event|2|||
33284368|NCT01265719|62660346|FG001|Overall Study|Adverse Event|0|||
33284369|NCT01265563|62660378|FG000|Overall Study|Withdrawal by Subject|0|||
33284370|NCT01265563|62660379|FG001|Overall Study|Withdrawal by Subject|1|||
33284371|NCT01265563|62660380|FG002|Overall Study|Withdrawal by Subject|1|||
33284372|NCT01265563|62660381|FG003|Overall Study|Withdrawal by Subject|0|||
33284373|NCT01265563|62660382|FG004|Overall Study|Withdrawal by Subject|2|||
33284374|NCT01265056|62660401|FG000|Initial Study Period|Withdrawal by Subject|1|||
33284375|NCT01265056|62660402|FG001|Initial Study Period|Withdrawal by Subject|1|||
33284376|NCT01265056|62660401|FG000|Initial Study Period|Withdrawal by Subject|1|||
33284377|NCT01265056|62660402|FG001|Initial Study Period|Withdrawal by Subject|1|||
33284378|NCT01265056|62660401|FG000|Follow up|Lost to Follow-up|7|||
33284379|NCT01265056|62660402|FG001|Follow up|Lost to Follow-up|3|||
33284380|NCT01264939|62660410|FG000|Overall Study|Adverse Event|1|||
33284381|NCT01264939|62660411|FG001|Overall Study|Adverse Event|3|||
33284382|NCT01264939|62660410|FG000|Overall Study|Lost to Follow-up|0|||
33284383|NCT01264939|62660411|FG001|Overall Study|Lost to Follow-up|3|||
33284384|NCT01264939|62660410|FG000|Overall Study|Physician Decision|1|||
33284385|NCT01264939|62660411|FG001|Overall Study|Physician Decision|1|||
33284386|NCT01264939|62660410|FG000|Overall Study|Patient/Guardian Decision|8|||
33284387|NCT01264939|62660411|FG001|Overall Study|Patient/Guardian Decision|10|||
33284388|NCT01264939|62660410|FG000|Overall Study|Disease Progression|8|||
33284389|NCT01264939|62660411|FG001|Overall Study|Disease Progression|11|||
33284390|NCT01264081|62660417|FG000|Participants Screened|Screening failures|30|||
33284391|NCT01264081|62660417|FG000|Started Treatment|Withdrawal by Subject|1|||
33284392|NCT01264081|62660417|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
33284393|NCT01263925|62660423|FG000|Overall Study|Protocol Violation|1|||
33284394|NCT01263925|62660424|FG001|Overall Study|Protocol Violation|0|||
33284395|NCT01263925|62660423|FG000|Overall Study|Lack of Efficacy|0|||
33284396|NCT01263925|62660424|FG001|Overall Study|Lack of Efficacy|1|||
33284397|NCT01263925|62660423|FG000|Overall Study|Adverse Event|23|||
33284398|NCT01263925|62660424|FG001|Overall Study|Adverse Event|22|||
33284399|NCT01263925|62660423|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
33284400|NCT01263925|62660424|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
33284401|NCT01263925|62660423|FG000|Overall Study|Withdrawal by Subject|6|||
33284402|NCT01263925|62660424|FG001|Overall Study|Withdrawal by Subject|8|||
33284403|NCT01263925|62660423|FG000|Overall Study|Other|4|||
33284404|NCT01263925|62660424|FG001|Overall Study|Other|4|||
33284405|NCT01263925|62660423|FG000|Overall Study|Lost to Follow-up|3|||
33284406|NCT01263925|62660424|FG001|Overall Study|Lost to Follow-up|1|||
33284407|NCT01263925|62660423|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
33284408|NCT01263925|62660424|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
33284409|NCT01263925|62660423|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
33284410|NCT01263925|62660424|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
33284411|NCT01263925|62660423|FG000|Overall Study|AE/ Withdrawal|1|||
33284412|NCT01263925|62660424|FG001|Overall Study|AE/ Withdrawal|4|||
33284413|NCT01263925|62660423|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
33284414|NCT01263925|62660424|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
33284415|NCT01263925|62660423|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
33284416|NCT01263925|62660424|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
33284417|NCT01263925|62660423|FG000|Overall Study|Withdrawal/ Not specified|0|||
33284418|NCT01263925|62660424|FG001|Overall Study|Withdrawal/ Not specified|1|||
33284419|NCT01263691|62660436|FG000|Overall Study|Lost to Follow-up|1|||
33284420|NCT01263691|62660437|FG001|Overall Study|Lost to Follow-up|0|||
33284421|NCT01263691|62660438|FG002|Overall Study|Lost to Follow-up|1|||
33284422|NCT01263691|62660439|FG003|Overall Study|Lost to Follow-up|1|||
33284423|NCT01263691|62660440|FG004|Overall Study|Lost to Follow-up|0|||
33284424|NCT01263691|62660441|FG005|Overall Study|Lost to Follow-up|0|||
33556203|NCT02308696|62949037|FG000|Overall Study|Death|8|||
33284425|NCT01263691|62660436|FG000|Overall Study|Withdrawal by Subject|1|||
33284426|NCT01263691|62660437|FG001|Overall Study|Withdrawal by Subject|0|||
33284427|NCT01263691|62660438|FG002|Overall Study|Withdrawal by Subject|0|||
33284428|NCT01263691|62660439|FG003|Overall Study|Withdrawal by Subject|0|||
33284429|NCT01263691|62660440|FG004|Overall Study|Withdrawal by Subject|0|||
33284430|NCT01263691|62660441|FG005|Overall Study|Withdrawal by Subject|0|||
33284431|NCT01263691|62660436|FG000|Overall Study|Adverse Event|1|||
33284432|NCT01263691|62660437|FG001|Overall Study|Adverse Event|0|||
33284433|NCT01263691|62660438|FG002|Overall Study|Adverse Event|0|||
33284434|NCT01263691|62660439|FG003|Overall Study|Adverse Event|0|||
33284435|NCT01263691|62660440|FG004|Overall Study|Adverse Event|0|||
33284436|NCT01263691|62660441|FG005|Overall Study|Adverse Event|0|||
33284437|NCT01263496|62660518|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
33284438|NCT01263496|62660519|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33284439|NCT01263496|62660520|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33284440|NCT01263496|62660521|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33284441|NCT01263496|62660522|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33284442|NCT01263496|62660523|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33284443|NCT01263496|62660524|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33284444|NCT01263496|62660525|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33284445|NCT01263496|62660526|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33284446|NCT01263496|62660518|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33284447|NCT01263496|62660519|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33284448|NCT01263496|62660520|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33284449|NCT01263496|62660521|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
33284450|NCT01263496|62660522|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
33284451|NCT01263496|62660523|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33284452|NCT01263496|62660524|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33662165|NCT01695239|63092845|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33662166|NCT01695239|63092846|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33662167|NCT01695239|63092833|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
33662168|NCT01695239|63092834|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33662169|NCT01695239|63092835|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
33662170|NCT01695239|63092836|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33662171|NCT01695239|63092837|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33662172|NCT01695239|63092838|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33662173|NCT01695239|63092839|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33284453|NCT01263496|62660525|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33284454|NCT01263496|62660526|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33284455|NCT01263496|62660518|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
33284456|NCT01263496|62660519|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
33284457|NCT01263496|62660520|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
33284458|NCT01263496|62660521|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
33284459|NCT01263496|62660522|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
33284460|NCT01263496|62660523|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
33284461|NCT01263496|62660524|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
33284462|NCT01263496|62660525|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
33284463|NCT01263496|62660526|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
33284464|NCT01263496|62660518|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33284465|NCT01263496|62660519|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
33284466|NCT01263496|62660520|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33284467|NCT01263496|62660521|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33284468|NCT01263496|62660522|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33284469|NCT01263496|62660523|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33284470|NCT01263496|62660524|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33284471|NCT01263496|62660525|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33284472|NCT01263496|62660526|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33284473|NCT01263496|62660518|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33284474|NCT01263496|62660519|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33284475|NCT01263496|62660520|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
33284476|NCT01263496|62660521|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33284477|NCT01263496|62660522|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
33284478|NCT01263496|62660523|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33284479|NCT01263496|62660524|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33284480|NCT01263496|62660525|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
33284481|NCT01263496|62660526|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33284482|NCT01263496|62660518|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
33284483|NCT01263496|62660519|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
33284484|NCT01263496|62660520|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
33284485|NCT01263496|62660521|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
33284486|NCT01263496|62660522|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
33371932|NCT00576472|62750711|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33556204|NCT02308696|62949038|FG001|Overall Study|Death|4|||
33284487|NCT01263496|62660523|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
33284488|NCT01263496|62660524|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
33284489|NCT01263496|62660525|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
33284490|NCT01263496|62660526|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
33284491|NCT01263496|62660518|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33284492|NCT01263496|62660519|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33284493|NCT01263496|62660520|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33284494|NCT01263496|62660521|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33284495|NCT01263496|62660522|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33284496|NCT01263496|62660523|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33284497|NCT01263496|62660524|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33284498|NCT01263496|62660525|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
33284499|NCT01263496|62660526|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33556205|NCT02308696|62949037|FG000|Overall Study|Moved to a Higher Level of Care|17|||
33284500|NCT01263223|62660538|FG000|Period 2|Withdrawal by Subject|0|||
33284501|NCT01263223|62660539|FG001|Period 2|Withdrawal by Subject|1|||
33284502|NCT01263223|62660538|FG000|7-day Follow-up|Withdrawal by Subject|0|||
33284503|NCT01263223|62660539|FG001|7-day Follow-up|Withdrawal by Subject|1|||
33284504|NCT01263223|62660538|FG000|7-day Follow-up|Lost to Follow-up|1|||
33284505|NCT01263223|62660539|FG001|7-day Follow-up|Lost to Follow-up|0|||
33284506|NCT01263106|62660548|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
33284507|NCT01263106|62660549|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
33284508|NCT01263028|62660558|FG000|Overall Study|Withdrawal by Subject|1|||
33284509|NCT01263028|62660558|FG000|Overall Study|Adverse Event|1|||
33284510|NCT01263028|62660558|FG000|Overall Study|Study terminated due to low enrollment.|4|||
33284511|NCT01262989|62660562|FG000|Period 1|Lost to Follow-up|1|||
33284512|NCT01262989|62660563|FG001|Period 1|Lost to Follow-up|1|||
33284513|NCT01262989|62660562|FG000|Period 1|Intercurrent disease|0|||
33284514|NCT01262989|62660563|FG001|Period 1|Intercurrent disease|1|||
33284515|NCT01262989|62660562|FG000|Period 1|Positive answer for exclusion criteria|0|||
33284516|NCT01262989|62660563|FG001|Period 1|Positive answer for exclusion criteria|1|||
33284517|NCT01262989|62660562|FG000|Period 2|Intercurrent disease|0|||
33284518|NCT01262989|62660563|FG001|Period 2|Intercurrent disease|1|||
33284519|NCT01262872|62660577|FG000|Step 2|Death|0|||
33284520|NCT01262872|62660578|FG001|Step 2|Death|0|||
33284521|NCT01262872|62660579|FG002|Step 2|Death|0|||
33284522|NCT01262872|62660580|FG003|Step 2|Death|1|||
33284523|NCT01262872|62660581|FG004|Step 2|Death|0|||
33284524|NCT01262872|62660582|FG005|Step 2|Death|2|||
33284525|NCT01262872|62660583|FG006|Step 2|Death|2|||
33284526|NCT01262872|62660584|FG007|Step 2|Death|1|||
33284527|NCT01262872|62660577|FG000|Step 2|Protocol Violation|0|||
33284528|NCT01262872|62660578|FG001|Step 2|Protocol Violation|0|||
33284529|NCT01262872|62660579|FG002|Step 2|Protocol Violation|1|||
33284530|NCT01262872|62660580|FG003|Step 2|Protocol Violation|0|||
33284531|NCT01262872|62660581|FG004|Step 2|Protocol Violation|0|||
33284532|NCT01262872|62660582|FG005|Step 2|Protocol Violation|0|||
33284533|NCT01262872|62660583|FG006|Step 2|Protocol Violation|3|||
33284534|NCT01262872|62660584|FG007|Step 2|Protocol Violation|1|||
33284535|NCT01262872|62660577|FG000|Step 2|Withdrawal by Subject|0|||
33284536|NCT01262872|62660578|FG001|Step 2|Withdrawal by Subject|0|||
33284537|NCT01262872|62660579|FG002|Step 2|Withdrawal by Subject|4|||
33284538|NCT01262872|62660580|FG003|Step 2|Withdrawal by Subject|6|||
33284539|NCT01262872|62660581|FG004|Step 2|Withdrawal by Subject|3|||
33284540|NCT01262872|62660582|FG005|Step 2|Withdrawal by Subject|1|||
33371933|NCT00576472|62750712|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33371934|NCT00576472|62750713|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33371935|NCT00576472|62750714|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33371936|NCT00576472|62750715|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33371937|NCT00576472|62750716|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33371938|NCT00576472|62750717|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33371939|NCT00576472|62750718|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33371940|NCT00576472|62750704|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
33284541|NCT01262872|62660583|FG006|Step 2|Withdrawal by Subject|2|||
33284542|NCT01262872|62660584|FG007|Step 2|Withdrawal by Subject|1|||
33284543|NCT01262872|62660577|FG000|Step 2|Migrated/moved from study area|0|||
33284544|NCT01262872|62660578|FG001|Step 2|Migrated/moved from study area|0|||
33371941|NCT00576472|62750705|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
33371942|NCT00576472|62750706|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
33284545|NCT01262872|62660579|FG002|Step 2|Migrated/moved from study area|4|||
33284546|NCT01262872|62660580|FG003|Step 2|Migrated/moved from study area|3|||
33284547|NCT01262872|62660581|FG004|Step 2|Migrated/moved from study area|2|||
33284548|NCT01262872|62660582|FG005|Step 2|Migrated/moved from study area|6|||
33284549|NCT01262872|62660583|FG006|Step 2|Migrated/moved from study area|2|||
33284550|NCT01262872|62660584|FG007|Step 2|Migrated/moved from study area|3|||
33284551|NCT01262677|62660621|FG000|Overall Study|Does not meet entrance criteria|0|||
33284552|NCT01262677|62660622|FG001|Overall Study|Does not meet entrance criteria|2|||
33284553|NCT01262677|62660623|FG002|Overall Study|Does not meet entrance criteria|0|||
33371943|NCT00576472|62750707|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
33371944|NCT00576472|62750708|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
33371945|NCT00576472|62750709|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
33371946|NCT00576472|62750710|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
33371947|NCT00576472|62750711|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
33371948|NCT00576472|62750712|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
33371949|NCT00576472|62750713|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
33371950|NCT00576472|62750714|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
33371951|NCT00576472|62750715|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
33371952|NCT00576472|62750716|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
33371953|NCT00576472|62750717|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
33371954|NCT00576472|62750718|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
33371955|NCT00576472|62750704|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
33371956|NCT00576472|62750705|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
33371957|NCT00576472|62750706|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
33371958|NCT00576472|62750707|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
33284554|NCT01262677|62660621|FG000|Overall Study|Insufficient clinical response|0|||
33284555|NCT01262677|62660622|FG001|Overall Study|Insufficient clinical response|0|||
33284556|NCT01262677|62660623|FG002|Overall Study|Insufficient clinical response|1|||
33284557|NCT01262677|62660621|FG000|Overall Study|Lost to Follow-up|1|||
33284558|NCT01262677|62660622|FG001|Overall Study|Lost to Follow-up|0|||
33284559|NCT01262677|62660623|FG002|Overall Study|Lost to Follow-up|2|||
33284560|NCT01262677|62660621|FG000|Overall Study|No longer willing to participate|3|||
33284561|NCT01262677|62660622|FG001|Overall Study|No longer willing to participate|3|||
33284562|NCT01262677|62660623|FG002|Overall Study|No longer willing to participate|2|||
33284563|NCT01262677|62660621|FG000|Overall Study|Reason not provided|2|||
33284564|NCT01262677|62660622|FG001|Overall Study|Reason not provided|1|||
33284565|NCT01262677|62660623|FG002|Overall Study|Reason not provided|3|||
33284566|NCT01262677|62660621|FG000|Overall Study|Protocol Violation|0|||
33284567|NCT01262677|62660622|FG001|Overall Study|Protocol Violation|1|||
33284568|NCT01262677|62660623|FG002|Overall Study|Protocol Violation|1|||
33284569|NCT01262677|62660621|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
33284570|NCT01262677|62660622|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
33284571|NCT01262677|62660623|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
33284572|NCT01262638|62660635|FG000|Overall Study|Adverse Event|3|||
33284573|NCT01262638|62660636|FG001|Overall Study|Adverse Event|4|||
33284574|NCT01262638|62660637|FG002|Overall Study|Adverse Event|3|||
33284575|NCT01262638|62660638|FG003|Overall Study|Adverse Event|4|||
33284576|NCT01262638|62660635|FG000|Overall Study|Protocol Violation|1|||
33284577|NCT01262638|62660636|FG001|Overall Study|Protocol Violation|0|||
33284578|NCT01262638|62660637|FG002|Overall Study|Protocol Violation|0|||
33284579|NCT01262638|62660638|FG003|Overall Study|Protocol Violation|1|||
33284580|NCT01262638|62660635|FG000|Overall Study|Withdrawal by Subject|2|||
33284581|NCT01262638|62660636|FG001|Overall Study|Withdrawal by Subject|1|||
33284582|NCT01262638|62660637|FG002|Overall Study|Withdrawal by Subject|0|||
33284583|NCT01262638|62660638|FG003|Overall Study|Withdrawal by Subject|1|||
33284584|NCT01262638|62660635|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
33284585|NCT01262638|62660636|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
33284586|NCT01262638|62660637|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
33284587|NCT01262638|62660638|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
33284588|NCT01262638|62660635|FG000|Overall Study|Lost to Follow-up|1|||
33284589|NCT01262638|62660636|FG001|Overall Study|Lost to Follow-up|1|||
33284590|NCT01262638|62660637|FG002|Overall Study|Lost to Follow-up|1|||
33284591|NCT01262638|62660638|FG003|Overall Study|Lost to Follow-up|1|||
33284592|NCT01262638|62660635|FG000|Overall Study|Participant Went Out of Town|0|||
33284593|NCT01262638|62660636|FG001|Overall Study|Participant Went Out of Town|0|||
33284594|NCT01262638|62660637|FG002|Overall Study|Participant Went Out of Town|1|||
33284595|NCT01262638|62660638|FG003|Overall Study|Participant Went Out of Town|0|||
33284596|NCT01262560|62660654|FG000|Overall Study|Protocol Violation|0|||
33284597|NCT01262560|62660655|FG001|Overall Study|Protocol Violation|1|||
33284598|NCT01262560|62660656|FG002|Overall Study|Protocol Violation|2|||
33371959|NCT00576472|62750708|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
33371960|NCT00576472|62750709|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
33284599|NCT01262365|62660667|FG000|Overall Study|Lack of Efficacy|35|||
33284600|NCT01262365|62660668|FG001|Overall Study|Lack of Efficacy|30|||
33284601|NCT01262365|62660669|FG002|Overall Study|Lack of Efficacy|47|||
33284602|NCT01262365|62660667|FG000|Overall Study|Protocol Violation|3|||
33284603|NCT01262365|62660668|FG001|Overall Study|Protocol Violation|1|||
33284604|NCT01262365|62660669|FG002|Overall Study|Protocol Violation|1|||
33284605|NCT01262365|62660667|FG000|Overall Study|Lost to Follow-up|3|||
33284606|NCT01262365|62660668|FG001|Overall Study|Lost to Follow-up|7|||
33284607|NCT01262365|62660669|FG002|Overall Study|Lost to Follow-up|6|||
33284608|NCT01262365|62660667|FG000|Overall Study|Withdrawal by Subject|17|||
33284609|NCT01262365|62660668|FG001|Overall Study|Withdrawal by Subject|22|||
33284610|NCT01262365|62660669|FG002|Overall Study|Withdrawal by Subject|22|||
33284611|NCT01262365|62660667|FG000|Overall Study|Death|1|||
33284612|NCT01262365|62660668|FG001|Overall Study|Death|2|||
33284613|NCT01262365|62660669|FG002|Overall Study|Death|1|||
33284614|NCT01262365|62660667|FG000|Overall Study|Adverse Event|26|||
33284615|NCT01262365|62660668|FG001|Overall Study|Adverse Event|16|||
33284616|NCT01262365|62660669|FG002|Overall Study|Adverse Event|11|||
33284617|NCT01262365|62660667|FG000|Overall Study|sponsor decision|1|||
33284618|NCT01262365|62660668|FG001|Overall Study|sponsor decision|1|||
33284619|NCT01262365|62660669|FG002|Overall Study|sponsor decision|0|||
33284620|NCT01262365|62660667|FG000|Overall Study|Randomization error|1|||
33284621|NCT01262365|62660668|FG001|Overall Study|Randomization error|0|||
33284622|NCT01262365|62660669|FG002|Overall Study|Randomization error|2|||
33284623|NCT01262365|62660667|FG000|Overall Study|Non-compliance|1|||
33284624|NCT01262365|62660668|FG001|Overall Study|Non-compliance|0|||
33284625|NCT01262365|62660669|FG002|Overall Study|Non-compliance|2|||
33284626|NCT01262365|62660667|FG000|Overall Study|Suspected pregnancy|1|||
33284627|NCT01262365|62660668|FG001|Overall Study|Suspected pregnancy|0|||
33284628|NCT01262365|62660669|FG002|Overall Study|Suspected pregnancy|0|||
33284629|NCT01262365|62660667|FG000|Overall Study|Patient pregnant|1|||
33284630|NCT01262365|62660668|FG001|Overall Study|Patient pregnant|0|||
33284631|NCT01262365|62660669|FG002|Overall Study|Patient pregnant|1|||
33284632|NCT01262365|62660667|FG000|Overall Study|Toxicity related to study drug|0|||
33284633|NCT01262365|62660668|FG001|Overall Study|Toxicity related to study drug|1|||
33284634|NCT01262365|62660669|FG002|Overall Study|Toxicity related to study drug|0|||
33284635|NCT01262365|62660667|FG000|Overall Study|Cannot tolerate the protocol|0|||
33284636|NCT01262365|62660668|FG001|Overall Study|Cannot tolerate the protocol|1|||
33284637|NCT01262365|62660669|FG002|Overall Study|Cannot tolerate the protocol|0|||
33284638|NCT01262365|62660667|FG000|Overall Study|Patient unavailable|0|||
33284639|NCT01262365|62660668|FG001|Overall Study|Patient unavailable|0|||
33284640|NCT01262365|62660669|FG002|Overall Study|Patient unavailable|1|||
33284641|NCT03932812|62660679|FG000|Overall Study|Lost to Follow-up|12|||
33284642|NCT03932812|62660680|FG001|Overall Study|Lost to Follow-up|14|||
33284643|NCT03932812|62660679|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
33284644|NCT03932812|62660680|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
33284645|NCT01262287|62660689|FG000|Overall Study|Lost to Follow-up|2|||
33284646|NCT01262287|62660690|FG001|Overall Study|Lost to Follow-up|1|||
33371961|NCT00576472|62750710|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
33371962|NCT00576472|62750711|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
33371963|NCT00576472|62750712|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
33371964|NCT00576472|62750713|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
33371965|NCT00576472|62750714|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
33371966|NCT00576472|62750715|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
33371967|NCT00576472|62750716|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
33371968|NCT00576472|62750717|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
33371969|NCT00576472|62750718|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
33371970|NCT00576472|62750704|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
33371971|NCT00576472|62750705|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
33371972|NCT00576472|62750706|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
33371973|NCT00576472|62750707|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
33371974|NCT00576472|62750708|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
33371975|NCT00576472|62750709|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
33371976|NCT00576472|62750710|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
33371977|NCT00576472|62750711|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
33371978|NCT00576472|62750712|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
33371979|NCT00576472|62750713|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
33371980|NCT00576472|62750714|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
33371981|NCT00576472|62750715|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
33371982|NCT00576472|62750716|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
33371983|NCT00576472|62750717|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
33371984|NCT00576472|62750718|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
33371985|NCT00576472|62750704|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
33371986|NCT00576472|62750705|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
33556206|NCT02308696|62949038|FG001|Overall Study|Moved to a Higher Level of Care|6|||
33284647|NCT01262092|62660702|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
33371987|NCT00576472|62750706|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
33284648|NCT01262092|62660703|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
33284649|NCT01262092|62660702|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
33284650|NCT01262092|62660703|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
33284651|NCT01262092|62660702|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
33284652|NCT01262092|62660703|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
33556207|NCT02342704|62949046|FG000|Overall Study|Physician Decision|0|||
33284653|NCT01262092|62660702|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
33284654|NCT01262092|62660703|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
33284655|NCT01261975|62660709|FG000|Overall Study|Surgical complication|1|||
33284656|NCT01261780|62660718|FG000|Overall Study|Withdrawal by Subject|1|||
33284657|NCT01261780|62660719|FG001|Overall Study|Withdrawal by Subject|0|||
33284658|NCT01261780|62660718|FG000|Overall Study|Event not related to subject|1|||
33284659|NCT01261780|62660719|FG001|Overall Study|Event not related to subject|2|||
33284660|NCT01261624|62660727|FG000|Week 0 to Week 12|Disease Progression|1|||
33284661|NCT01261624|62660728|FG001|Week 0 to Week 12|Disease Progression|1|||
33284662|NCT01261624|62660727|FG000|Week 0 to Week 12|Insufficient Response|0|||
33284663|NCT01261624|62660728|FG001|Week 0 to Week 12|Insufficient Response|2|||
33284664|NCT01261624|62660727|FG000|Week 13 to Week 24|Insufficient Response|0|||
33371988|NCT00576472|62750707|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
33371989|NCT00576472|62750708|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
33371990|NCT00576472|62750709|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
33371991|NCT00576472|62750710|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
33371992|NCT00576472|62750711|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
33371993|NCT00576472|62750712|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
33371994|NCT00576472|62750713|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
33371995|NCT00576472|62750714|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
33371996|NCT00576472|62750715|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
33284665|NCT01261624|62660728|FG001|Week 13 to Week 24|Insufficient Response|1|||
33284666|NCT03694522|62660742|FG000|Overall Study|Withdrawal by Subject|8|||
33284667|NCT03694522|62660743|FG001|Overall Study|Withdrawal by Subject|10|||
33284668|NCT03694522|62660742|FG000|Overall Study|Physician Decision|53|||
33284669|NCT03694522|62660743|FG001|Overall Study|Physician Decision|54|||
33284670|NCT03694522|62660742|FG000|Overall Study|Other|1|||
33284671|NCT03694522|62660743|FG001|Overall Study|Other|1|||
33284672|NCT03694522|62660742|FG000|Overall Study|Lost to Follow-up|0|||
33284673|NCT03694522|62660743|FG001|Overall Study|Lost to Follow-up|1|||
33284674|NCT01261390|62660753|FG000|Overall Study|Significant Concurrent Illness|1|||
33284675|NCT01261390|62660754|FG001|Overall Study|Significant Concurrent Illness|0|||
33284676|NCT01261390|62660755|FG002|Overall Study|Significant Concurrent Illness|1|||
33284677|NCT01261390|62660756|FG003|Overall Study|Significant Concurrent Illness|0|||
33284678|NCT01261390|62660753|FG000|Overall Study|Dissatisfaction with Treatment|2|||
33284679|NCT01261390|62660754|FG001|Overall Study|Dissatisfaction with Treatment|1|||
33284680|NCT01261390|62660755|FG002|Overall Study|Dissatisfaction with Treatment|1|||
33284681|NCT01261390|62660756|FG003|Overall Study|Dissatisfaction with Treatment|2|||
33284682|NCT01261390|62660753|FG000|Overall Study|Relocation|0|||
33284683|NCT01261390|62660754|FG001|Overall Study|Relocation|1|||
33284684|NCT01261390|62660755|FG002|Overall Study|Relocation|0|||
33284685|NCT01261390|62660756|FG003|Overall Study|Relocation|0|||
33371997|NCT00576472|62750716|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
33371998|NCT00576472|62750717|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
33371999|NCT00576472|62750718|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
33372000|NCT00576472|62750704|FG000|MPH Cross Over Phase|Physician Decision|0|||
33372001|NCT00576472|62750705|FG001|MPH Cross Over Phase|Physician Decision|0|||
33372002|NCT00576472|62750706|FG002|MPH Cross Over Phase|Physician Decision|0|||
33372003|NCT00576472|62750707|FG003|MPH Cross Over Phase|Physician Decision|0|||
33372004|NCT00576472|62750708|FG004|MPH Cross Over Phase|Physician Decision|0|||
33372005|NCT00576472|62750709|FG005|MPH Cross Over Phase|Physician Decision|0|||
33372006|NCT00576472|62750710|FG006|MPH Cross Over Phase|Physician Decision|4|||
33372007|NCT00576472|62750711|FG007|MPH Cross Over Phase|Physician Decision|0|||
33372008|NCT00576472|62750712|FG008|MPH Cross Over Phase|Physician Decision|0|||
33372009|NCT00576472|62750713|FG009|MPH Cross Over Phase|Physician Decision|0|||
33372010|NCT00576472|62750714|FG010|MPH Cross Over Phase|Physician Decision|0|||
33372011|NCT00576472|62750715|FG011|MPH Cross Over Phase|Physician Decision|0|||
33372012|NCT00576472|62750716|FG012|MPH Cross Over Phase|Physician Decision|0|||
33284686|NCT01261390|62660753|FG000|Overall Study|Loss of Interest in the Study|3|||
33372013|NCT00576472|62750717|FG013|MPH Cross Over Phase|Physician Decision|0|||
33372014|NCT00576472|62750718|FG014|MPH Cross Over Phase|Physician Decision|0|||
33372015|NCT00576472|62750704|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
33372016|NCT00576472|62750705|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
33372017|NCT00576472|62750706|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
33372018|NCT00576472|62750707|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
33372019|NCT00576472|62750708|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
33372020|NCT00576472|62750709|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
33372021|NCT00576472|62750710|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
33284687|NCT01261390|62660754|FG001|Overall Study|Loss of Interest in the Study|1|||
33284688|NCT01261390|62660755|FG002|Overall Study|Loss of Interest in the Study|0|||
33372022|NCT00576472|62750711|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
33284689|NCT01261390|62660756|FG003|Overall Study|Loss of Interest in the Study|0|||
33284690|NCT01261390|62660753|FG000|Overall Study|Lost to Follow-up|1|||
33284691|NCT01261390|62660754|FG001|Overall Study|Lost to Follow-up|6|||
33284692|NCT01261390|62660755|FG002|Overall Study|Lost to Follow-up|5|||
33284693|NCT01261390|62660756|FG003|Overall Study|Lost to Follow-up|6|||
33284694|NCT03391882|62660777|FG000|Study Overall|Adverse Event|3|||
33284695|NCT03391882|62660778|FG001|Study Overall|Adverse Event|6|||
33284696|NCT03391882|62660779|FG002|Study Overall|Adverse Event|1|||
33284697|NCT03391882|62660780|FG003|Study Overall|Adverse Event|1|||
33284698|NCT03391882|62660781|FG004|Study Overall|Adverse Event|3|||
33284699|NCT03391882|62660782|FG005|Study Overall|Adverse Event|1|||
33284700|NCT03391882|62660777|FG000|Study Overall|Lack of Efficacy|13|||
33284701|NCT03391882|62660778|FG001|Study Overall|Lack of Efficacy|9|||
33284702|NCT03391882|62660779|FG002|Study Overall|Lack of Efficacy|0|||
33284703|NCT03391882|62660780|FG003|Study Overall|Lack of Efficacy|0|||
33284704|NCT03391882|62660781|FG004|Study Overall|Lack of Efficacy|0|||
33284705|NCT03391882|62660782|FG005|Study Overall|Lack of Efficacy|0|||
33284706|NCT03391882|62660777|FG000|Study Overall|Withdrawal by Subject|3|||
33284707|NCT03391882|62660778|FG001|Study Overall|Withdrawal by Subject|3|||
33284708|NCT03391882|62660779|FG002|Study Overall|Withdrawal by Subject|2|||
33284709|NCT03391882|62660780|FG003|Study Overall|Withdrawal by Subject|2|||
33284710|NCT03391882|62660781|FG004|Study Overall|Withdrawal by Subject|1|||
33284711|NCT03391882|62660782|FG005|Study Overall|Withdrawal by Subject|3|||
33284712|NCT03391882|62660777|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
33284713|NCT03391882|62660778|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
33284714|NCT03391882|62660779|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
33284715|NCT03391882|62660780|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
33284716|NCT03391882|62660781|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
33284717|NCT03391882|62660782|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
33284718|NCT03391882|62660777|FG000|Study Overall|Protocol Violation|1|||
33284719|NCT03391882|62660778|FG001|Study Overall|Protocol Violation|0|||
33284720|NCT03391882|62660779|FG002|Study Overall|Protocol Violation|0|||
33284721|NCT03391882|62660780|FG003|Study Overall|Protocol Violation|0|||
33284722|NCT03391882|62660781|FG004|Study Overall|Protocol Violation|0|||
33284723|NCT03391882|62660782|FG005|Study Overall|Protocol Violation|0|||
33284724|NCT03391882|62660777|FG000|Part A - Titration Phase|Adverse Event|3|||
33284725|NCT03391882|62660778|FG001|Part A - Titration Phase|Adverse Event|6|||
33284726|NCT03391882|62660779|FG002|Part A - Titration Phase|Adverse Event|0|||
33372023|NCT00576472|62750712|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
33284727|NCT03391882|62660780|FG003|Part A - Titration Phase|Adverse Event|0|||
33284728|NCT03391882|62660781|FG004|Part A - Titration Phase|Adverse Event|0|||
33284729|NCT03391882|62660782|FG005|Part A - Titration Phase|Adverse Event|0|||
33284730|NCT03391882|62660777|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
33284731|NCT03391882|62660778|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
33284732|NCT03391882|62660779|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
33284733|NCT03391882|62660780|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
33284734|NCT03391882|62660781|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
33284735|NCT03391882|62660782|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
33284736|NCT03391882|62660777|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
33284737|NCT03391882|62660778|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
33284738|NCT03391882|62660779|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
33284739|NCT03391882|62660780|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
33284740|NCT03391882|62660781|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
33284741|NCT03391882|62660782|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
33284742|NCT03391882|62660777|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
33284743|NCT03391882|62660778|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
33284744|NCT03391882|62660779|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
33284745|NCT03391882|62660780|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
33284746|NCT03391882|62660781|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
33284747|NCT03391882|62660782|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
33284748|NCT03391882|62660777|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
33284749|NCT03391882|62660778|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
33372024|NCT00576472|62750713|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
33284750|NCT03391882|62660779|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
33284751|NCT03391882|62660780|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
33284752|NCT03391882|62660781|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
33284753|NCT03391882|62660782|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
33284754|NCT03391882|62660777|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
33284755|NCT03391882|62660778|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
33284756|NCT03391882|62660779|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
33284757|NCT03391882|62660780|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
33284758|NCT03391882|62660781|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
33284759|NCT03391882|62660782|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
33284760|NCT03391882|62660777|FG000|Part B - Treatment Phase|Adverse Event|0|||
33284761|NCT03391882|62660778|FG001|Part B - Treatment Phase|Adverse Event|0|||
33284762|NCT03391882|62660779|FG002|Part B - Treatment Phase|Adverse Event|1|||
33284763|NCT03391882|62660780|FG003|Part B - Treatment Phase|Adverse Event|1|||
33284764|NCT03391882|62660781|FG004|Part B - Treatment Phase|Adverse Event|3|||
33284765|NCT03391882|62660782|FG005|Part B - Treatment Phase|Adverse Event|1|||
33284766|NCT03391882|62660777|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
33284767|NCT03391882|62660778|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
33284768|NCT03391882|62660779|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
33284769|NCT03391882|62660780|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
33284770|NCT03391882|62660781|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
33284771|NCT03391882|62660782|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
33284772|NCT01261000|62660792|FG000|Overall Study|Screen failure|1|||
33284773|NCT01234402|62660825|FG000|Overall Study|Lost to Follow-up|0|||
33284774|NCT01234402|62660826|FG001|Overall Study|Lost to Follow-up|1|||
33284775|NCT01234402|62660827|FG002|Overall Study|Lost to Follow-up|3|||
33284776|NCT01234402|62660825|FG000|Overall Study|Withdrawal by Subject|1|||
33284777|NCT01234402|62660826|FG001|Overall Study|Withdrawal by Subject|3|||
33284778|NCT01234402|62660827|FG002|Overall Study|Withdrawal by Subject|4|||
33284779|NCT01234402|62660825|FG000|Overall Study|Never treated: Death|0|||
33284780|NCT01234402|62660826|FG001|Overall Study|Never treated: Death|0|||
33284781|NCT01234402|62660827|FG002|Overall Study|Never treated: Death|1|||
33284782|NCT01234402|62660825|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
33284783|NCT01234402|62660826|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
33284784|NCT01234402|62660827|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
33284785|NCT01234402|62660825|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
33284786|NCT01234402|62660826|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
33284787|NCT01234402|62660827|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
33284788|NCT01260922|62660839|FG000|First Intervention|Withdrawal by Subject|0|||
33372025|NCT00576472|62750714|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
33372026|NCT00576472|62750715|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
33372027|NCT00576472|62750716|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
33372028|NCT00576472|62750717|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
33284789|NCT01260922|62660840|FG001|First Intervention|Withdrawal by Subject|1|||
33284790|NCT01260922|62660839|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
33284791|NCT01260922|62660840|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
33284792|NCT01260922|62660839|FG000|Second Intervention|Emesis|0|||
33284793|NCT01260922|62660840|FG001|Second Intervention|Emesis|2|||
33284794|NCT01233817|62660846|FG000|Overall Study|Lost to Follow-up|1|||
33284795|NCT01233817|62660846|FG000|Overall Study|Withdrawal by Subject|2|||
33284796|NCT01233232|62660853|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
33284797|NCT01233232|62660854|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
33284798|NCT01233232|62660855|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
33284799|NCT01233076|62660865|FG000|Period 2, One Week|Lost to Follow-up|1|||
33284800|NCT01233076|62660866|FG001|Period 2, One Week|Lost to Follow-up|0|||
33284801|NCT01212094|62660875|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
33284802|NCT01212094|62660876|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
33284803|NCT01212094|62660877|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
33284804|NCT01212094|62660875|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
33284805|NCT01212094|62660876|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
33284806|NCT01212094|62660877|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
33284807|NCT01212094|62660875|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
33284808|NCT01212094|62660876|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
33284809|NCT01212094|62660877|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
33284810|NCT01212094|62660875|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
33284811|NCT01212094|62660876|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
33284812|NCT01212094|62660877|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
33284813|NCT01212094|62660875|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
33284814|NCT01212094|62660876|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
33284815|NCT01212094|62660877|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
33284816|NCT01212094|62660875|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
33284817|NCT01212094|62660876|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
33284818|NCT01212094|62660877|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
33284819|NCT01232569|62660886|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
33284820|NCT01232569|62660887|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
33284821|NCT01232569|62660888|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33284822|NCT01232569|62660889|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
33372029|NCT00576472|62750718|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
33372030|NCT00576472|62750704|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33372031|NCT00576472|62750705|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33284823|NCT01232569|62660886|FG000|Double-blind Treatment Period|Escape|2|||
33284824|NCT01232569|62660887|FG001|Double-blind Treatment Period|Escape|2|||
33284825|NCT01232569|62660888|FG002|Double-blind Treatment Period|Escape|0|||
33284826|NCT01232569|62660889|FG003|Double-blind Treatment Period|Escape|0|||
33284827|NCT01232569|62660886|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
33284828|NCT01232569|62660887|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
33284829|NCT01232569|62660888|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
33284830|NCT01232569|62660889|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
33284831|NCT01232569|62660886|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
33284832|NCT01232569|62660887|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
33284833|NCT01232569|62660888|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
33284834|NCT01232569|62660889|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
33284835|NCT01232569|62660886|FG000|Double-blind Treatment Period|Physician Decision|1|||
33284836|NCT01232569|62660887|FG001|Double-blind Treatment Period|Physician Decision|0|||
33284837|NCT01232569|62660888|FG002|Double-blind Treatment Period|Physician Decision|0|||
33284838|NCT01232569|62660889|FG003|Double-blind Treatment Period|Physician Decision|0|||
33284839|NCT01232569|62660886|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
33284840|NCT01232569|62660887|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
33284841|NCT01232569|62660888|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
33284842|NCT01232569|62660889|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
33284843|NCT01232569|62660886|FG000|Double-blind Treatment Period|Death|2|||
33284844|NCT01232569|62660887|FG001|Double-blind Treatment Period|Death|0|||
33284845|NCT01232569|62660888|FG002|Double-blind Treatment Period|Death|0|||
33284846|NCT01232569|62660889|FG003|Double-blind Treatment Period|Death|0|||
33284847|NCT01211665|62660900|FG000|Overall Study|Withdrawal by Subject|1|||
33284848|NCT01211665|62660901|FG001|Overall Study|Withdrawal by Subject|0|||
33284849|NCT01211665|62660900|FG000|Overall Study|Death|1|||
33284850|NCT01211665|62660901|FG001|Overall Study|Death|0|||
33284851|NCT01232491|62660909|FG000|Overall Study|Adverse Event|13|||
33284852|NCT01232491|62660910|FG001|Overall Study|Adverse Event|8|||
33284853|NCT01232491|62660909|FG000|Overall Study|Lack of Efficacy|1|||
33284854|NCT01232491|62660910|FG001|Overall Study|Lack of Efficacy|5|||
33284855|NCT01232491|62660909|FG000|Overall Study|Protocol Violation|13|||
33284856|NCT01232491|62660910|FG001|Overall Study|Protocol Violation|11|||
33284857|NCT01232491|62660909|FG000|Overall Study|Withdrawal Criteria|12|||
33284858|NCT01232491|62660910|FG001|Overall Study|Withdrawal Criteria|21|||
33284859|NCT01232491|62660909|FG000|Overall Study|Other|21|||
33284860|NCT01232491|62660910|FG001|Overall Study|Other|18|||
33284861|NCT01232452|62660918|FG000|Overall Study|Adverse Event|17|||
33284862|NCT01232452|62660919|FG001|Overall Study|Adverse Event|15|||
33284863|NCT01232452|62660918|FG000|Overall Study|Withdrawal by Subject|11|||
33284864|NCT01232452|62660919|FG001|Overall Study|Withdrawal by Subject|8|||
33284865|NCT01232452|62660918|FG000|Overall Study|Physician Decision|8|||
33284866|NCT01232452|62660919|FG001|Overall Study|Physician Decision|12|||
33284867|NCT01232452|62660918|FG000|Overall Study|Protocol entry criterion not met|0|||
33284868|NCT01232452|62660919|FG001|Overall Study|Protocol entry criterion not met|2|||
33284869|NCT01232452|62660918|FG000|Overall Study|Sponsor Decision|3|||
33284870|NCT01232452|62660919|FG001|Overall Study|Sponsor Decision|1|||
33284871|NCT01232452|62660918|FG000|Overall Study|Protocol Violation|0|||
33284872|NCT01232452|62660919|FG001|Overall Study|Protocol Violation|1|||
33284873|NCT01211197|62660925|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33284874|NCT01211197|62660926|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33284875|NCT01211197|62660927|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
33284876|NCT01211197|62660928|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33284877|NCT01211197|62660929|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33284878|NCT01211197|62660930|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33284879|NCT01211197|62660925|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
33284880|NCT01211197|62660926|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
33284881|NCT01211197|62660927|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
33284882|NCT01211197|62660928|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
33284883|NCT01211197|62660929|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
33284884|NCT01211197|62660930|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
33284885|NCT01232296|62660940|FG000|Overall Study|Adverse Event|24|||
33284886|NCT01232296|62660941|FG001|Overall Study|Adverse Event|12|||
33284887|NCT01232296|62660940|FG000|Overall Study|Physician Decision|1|||
33284888|NCT01232296|62660941|FG001|Overall Study|Physician Decision|1|||
33284889|NCT01232296|62660940|FG000|Overall Study|Progressive disease|43|||
33284890|NCT01232296|62660941|FG001|Overall Study|Progressive disease|61|||
33284891|NCT01232296|62660940|FG000|Overall Study|Study terminated by sponsor|0|||
33284892|NCT01232296|62660941|FG001|Overall Study|Study terminated by sponsor|1|||
33284893|NCT01232296|62660940|FG000|Overall Study|Technical problems|3|||
33284894|NCT01232296|62660941|FG001|Overall Study|Technical problems|0|||
33284895|NCT01232296|62660940|FG000|Overall Study|Subject/guardian decision|10|||
33284896|NCT01232296|62660941|FG001|Overall Study|Subject/guardian decision|2|||
33284897|NCT01232296|62660940|FG000|Overall Study|Death|1|||
33284898|NCT01232296|62660941|FG001|Overall Study|Death|6|||
33284899|NCT01231984|62660949|FG000|Study Period 1|Withdrawal by Subject|0|||
33284900|NCT01231984|62660950|FG001|Study Period 1|Withdrawal by Subject|0|||
33284901|NCT01231984|62660951|FG002|Study Period 1|Withdrawal by Subject|0|||
33284902|NCT01231984|62660952|FG003|Study Period 1|Withdrawal by Subject|1|||
33284903|NCT01231984|62660949|FG000|Study Period 1|Lost to Follow-up|1|||
33284904|NCT01231984|62660950|FG001|Study Period 1|Lost to Follow-up|1|||
33284905|NCT01231984|62660951|FG002|Study Period 1|Lost to Follow-up|1|||
33284906|NCT01231984|62660952|FG003|Study Period 1|Lost to Follow-up|0|||
33284907|NCT01231984|62660949|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
33284908|NCT01231984|62660950|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
33284909|NCT01231984|62660951|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
33284910|NCT01231984|62660952|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
33284911|NCT01231984|62660949|FG000|Study Period 1|Screen Failure|0|||
33284912|NCT01231984|62660950|FG001|Study Period 1|Screen Failure|0|||
33284913|NCT01231984|62660951|FG002|Study Period 1|Screen Failure|0|||
33284914|NCT01231984|62660952|FG003|Study Period 1|Screen Failure|1|||
33284915|NCT01231984|62660949|FG000|Study Period 1|Non-compliance with study requirements|5|||
33284916|NCT01231984|62660950|FG001|Study Period 1|Non-compliance with study requirements|0|||
33284917|NCT01231984|62660951|FG002|Study Period 1|Non-compliance with study requirements|2|||
33284918|NCT01231984|62660952|FG003|Study Period 1|Non-compliance with study requirements|1|||
33284919|NCT01231984|62660949|FG000|Study Period 1|Protocol Violation|3|||
33284920|NCT01231984|62660950|FG001|Study Period 1|Protocol Violation|4|||
33284921|NCT01231984|62660951|FG002|Study Period 1|Protocol Violation|2|||
33284922|NCT01231984|62660952|FG003|Study Period 1|Protocol Violation|3|||
33284923|NCT01231984|62660949|FG000|Study Period 1|Adverse Event|1|||
33284924|NCT01231984|62660950|FG001|Study Period 1|Adverse Event|0|||
33284925|NCT01231984|62660951|FG002|Study Period 1|Adverse Event|0|||
33284926|NCT01231984|62660952|FG003|Study Period 1|Adverse Event|0|||
33284927|NCT01231984|62660949|FG000|Study Period 1|Other|0|||
33284928|NCT01231984|62660950|FG001|Study Period 1|Other|0|||
33284929|NCT01231984|62660951|FG002|Study Period 1|Other|0|||
33284930|NCT01231984|62660952|FG003|Study Period 1|Other|1|||
33284931|NCT01231984|62660949|FG000|Study Period 2|Withdrawal by Subject|1|||
33284932|NCT01231984|62660950|FG001|Study Period 2|Withdrawal by Subject|1|||
33284933|NCT01231984|62660951|FG002|Study Period 2|Withdrawal by Subject|0|||
33284934|NCT01231984|62660952|FG003|Study Period 2|Withdrawal by Subject|0|||
33284935|NCT01231984|62660949|FG000|Study Period 2|Lost to Follow-up|1|||
33284936|NCT01231984|62660950|FG001|Study Period 2|Lost to Follow-up|0|||
33284937|NCT01231984|62660951|FG002|Study Period 2|Lost to Follow-up|0|||
33284938|NCT01231984|62660952|FG003|Study Period 2|Lost to Follow-up|3|||
33284939|NCT01231984|62660949|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
33284940|NCT01231984|62660950|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
33284941|NCT01231984|62660951|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
33284942|NCT01231984|62660952|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
33284943|NCT01210807|62660972|FG000|Overall Study|Lost to Follow-up|1|||
33284944|NCT01210807|62660973|FG001|Overall Study|Lost to Follow-up|2|||
33284945|NCT01210807|62660972|FG000|Overall Study|Not implanted bilaterally|2|||
33284946|NCT01210807|62660973|FG001|Overall Study|Not implanted bilaterally|1|||
33284947|NCT01231555|62660982|FG000|Overall Study|Study terminated|8|||
33284948|NCT01231555|62660983|FG001|Overall Study|Study terminated|5|||
33284949|NCT01231555|62660984|FG002|Overall Study|Study terminated|8|||
33284950|NCT01231555|62660982|FG000|Overall Study|Withdrawal by Subject|0|||
33284951|NCT01231555|62660983|FG001|Overall Study|Withdrawal by Subject|2|||
33284952|NCT01231555|62660984|FG002|Overall Study|Withdrawal by Subject|0|||
33284953|NCT01210690|62660992|FG000|Overall Study|Adverse Event|7|||
33284954|NCT01210690|62660992|FG000|Overall Study|Lack of Efficacy|12|||
33284955|NCT01210690|62660992|FG000|Overall Study|Lost to Follow-up|3|||
33284956|NCT01210690|62660992|FG000|Overall Study|Disease Remission|1|||
33284957|NCT01210690|62660992|FG000|Overall Study|Withdrawal by Subject|1|||
33284958|NCT01210690|62660992|FG000|Overall Study|Patient refused to swallow|1|||
33284959|NCT01210690|62660992|FG000|Overall Study|Patient could not take glucose|1|||
33284960|NCT01210651|62660999|FG000|Overall Study|Lost to Follow-up|1|||
33284961|NCT01210651|62661000|FG001|Overall Study|Lost to Follow-up|1|||
33486388|NCT04013529|62864232|FG001|Overall Study|Withdrawal by Subject|1|||
33486389|NCT04011735|62864241|FG000|Overall Study|Withdrawal by Subject|1|||
33486390|NCT04011735|62864242|FG001|Overall Study|Withdrawal by Subject|0|||
33486391|NCT04011735|62864243|FG002|Overall Study|Withdrawal by Subject|1|||
33486392|NCT04011735|62864241|FG000|Overall Study|Met exclusion criteria after study entry|0|||
33486393|NCT04011735|62864242|FG001|Overall Study|Met exclusion criteria after study entry|1|||
33486394|NCT04011735|62864243|FG002|Overall Study|Met exclusion criteria after study entry|0|||
33556208|NCT02342704|62949047|FG001|Overall Study|Physician Decision|3|||
33284962|NCT01210651|62660999|FG000|Overall Study|schedule conflicts|1|||
33284963|NCT01210651|62661000|FG001|Overall Study|schedule conflicts|5|||
33284964|NCT01210651|62660999|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
33284965|NCT01210651|62661000|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
33284966|NCT01210651|62660999|FG000|Overall Study|Withdrawal by Subject|1|||
33284967|NCT01210651|62661000|FG001|Overall Study|Withdrawal by Subject|1|||
33284968|NCT01210651|62660999|FG000|Overall Study|Injury outside study|2|||
33662174|NCT01695239|63092840|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33662175|NCT01695239|63092841|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33662176|NCT01695239|63092842|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33662177|NCT01695239|63092843|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33662178|NCT01695239|63092844|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33662179|NCT01695239|63092845|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33662180|NCT01695239|63092846|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33662181|NCT01695239|63092833|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
33662182|NCT01695239|63092834|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33662183|NCT01695239|63092835|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33662184|NCT01695239|63092836|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33662185|NCT01695239|63092837|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33662186|NCT01695239|63092838|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33662187|NCT01695239|63092839|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33662188|NCT01695239|63092840|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33662189|NCT01695239|63092841|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33662190|NCT01695239|63092842|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33662191|NCT01695239|63092843|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33662192|NCT01695239|63092844|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33662193|NCT01695239|63092845|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33662194|NCT01695239|63092846|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33662195|NCT01695239|63092833|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33662196|NCT01695239|63092834|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33662197|NCT01695239|63092835|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33662198|NCT01695239|63092836|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33662199|NCT01695239|63092837|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33662200|NCT01695239|63092838|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33662201|NCT01695239|63092839|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33662202|NCT01695239|63092840|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
33662203|NCT01695239|63092841|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33662204|NCT01695239|63092842|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33662205|NCT01695239|63092843|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33662206|NCT01695239|63092844|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33662207|NCT01695239|63092845|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33662208|NCT01695239|63092846|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33662209|NCT01695239|63092833|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33284969|NCT01210651|62661000|FG001|Overall Study|Injury outside study|0|||
33284970|NCT01210495|62661079|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
33284971|NCT01210495|62661080|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
33284972|NCT01210495|62661081|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
33284973|NCT01210495|62661082|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
33284974|NCT01210495|62661079|FG000|Overall Study|Death|14|||
33284975|NCT01210495|62661080|FG001|Overall Study|Death|7|||
33284976|NCT01210495|62661081|FG002|Overall Study|Death|112|||
33284977|NCT01210495|62661082|FG003|Overall Study|Death|54|||
33284978|NCT01210495|62661079|FG000|Overall Study|Study Terminated by Sponsor|0|||
33284979|NCT01210495|62661080|FG001|Overall Study|Study Terminated by Sponsor|0|||
33284980|NCT01210495|62661081|FG002|Overall Study|Study Terminated by Sponsor|4|||
33284981|NCT01210495|62661082|FG003|Overall Study|Study Terminated by Sponsor|11|||
33284982|NCT01210495|62661079|FG000|Overall Study|Lost to Follow-up|0|||
33284983|NCT01210495|62661080|FG001|Overall Study|Lost to Follow-up|0|||
33284984|NCT01210495|62661081|FG002|Overall Study|Lost to Follow-up|1|||
33284985|NCT01210495|62661082|FG003|Overall Study|Lost to Follow-up|1|||
33284986|NCT01210495|62661079|FG000|Overall Study|Other unspecified|0|||
33284987|NCT01210495|62661080|FG001|Overall Study|Other unspecified|0|||
33284988|NCT01210495|62661081|FG002|Overall Study|Other unspecified|6|||
33284989|NCT01210495|62661082|FG003|Overall Study|Other unspecified|0|||
33284990|NCT01231516|62661094|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
33284991|NCT01231516|62661095|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
33284992|NCT01231516|62661094|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
33284993|NCT01231516|62661095|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
33284994|NCT01231516|62661094|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
33284995|NCT01231516|62661095|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
33372032|NCT00576472|62750706|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33372033|NCT00576472|62750707|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33372034|NCT00576472|62750708|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33372035|NCT00576472|62750709|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33372036|NCT00576472|62750710|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33284996|NCT01231516|62661094|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
33284997|NCT01231516|62661095|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
33284998|NCT01231516|62661094|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
33284999|NCT01231516|62661095|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
33285000|NCT01231516|62661094|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
33285001|NCT01231516|62661095|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
33285002|NCT01231516|62661094|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
33285003|NCT01231516|62661095|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
33556209|NCT02342704|62949046|FG000|Overall Study|Sponsor Termination|49|||
33556210|NCT02342704|62949047|FG001|Overall Study|Sponsor Termination|43|||
33556211|NCT02342704|62949046|FG000|Overall Study|Other|0|||
33556212|NCT02342704|62949047|FG001|Overall Study|Other|1|||
33556213|NCT02342704|62949046|FG000|Overall Study|Withdrawal by Subject|1|||
33556214|NCT02342704|62949047|FG001|Overall Study|Withdrawal by Subject|0|||
33556215|NCT02342704|62949046|FG000|Overall Study|Lost to Follow-up|2|||
33556216|NCT02342704|62949047|FG001|Overall Study|Lost to Follow-up|1|||
33556217|NCT02342704|62949046|FG000|Overall Study|Adverse Event|1|||
33662210|NCT01695239|63092834|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33662211|NCT01695239|63092835|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33662212|NCT01695239|63092836|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33285004|NCT01231516|62661094|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
33285005|NCT01231516|62661095|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
33285006|NCT01231516|62661094|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
33285007|NCT01231516|62661095|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
33285008|NCT01231516|62661094|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
33285009|NCT01231516|62661095|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
33285010|NCT01231516|62661094|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
33285011|NCT01231516|62661095|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
33285012|NCT01231516|62661094|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
33372037|NCT00576472|62750711|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33372038|NCT00576472|62750712|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33372039|NCT00576472|62750713|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33372040|NCT00576472|62750714|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33372041|NCT00576472|62750715|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33372042|NCT00576472|62750716|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33662213|NCT01695239|63092837|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33662214|NCT01695239|63092838|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33662215|NCT01695239|63092839|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33662216|NCT01695239|63092840|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
33662217|NCT01695239|63092841|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33662218|NCT01695239|63092842|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33372043|NCT00576472|62750717|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
33372044|NCT00576472|62750718|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33372045|NCT00576472|62750704|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
33372046|NCT00576472|62750705|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
33372047|NCT00576472|62750706|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
33372048|NCT00576472|62750707|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
33372049|NCT00576472|62750708|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
33372050|NCT00576472|62750709|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
33372051|NCT00576472|62750710|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
33372052|NCT00576472|62750711|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
33372053|NCT00576472|62750712|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
33372054|NCT00576472|62750713|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
33372055|NCT00576472|62750714|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
33372056|NCT00576472|62750715|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
33372057|NCT00576472|62750716|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
33372058|NCT00576472|62750717|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
33372059|NCT00576472|62750718|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
33372060|NCT00576472|62750704|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
33372061|NCT00576472|62750705|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
33372062|NCT00576472|62750706|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
33372063|NCT00576472|62750707|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
33556218|NCT02342704|62949047|FG001|Overall Study|Adverse Event|3|||
33556219|NCT02342548|62949056|FG000|Overall Study|Adverse Event|12|||
33556220|NCT02342548|62949057|FG001|Overall Study|Adverse Event|17|||
33556221|NCT02342548|62949058|FG002|Overall Study|Adverse Event|13|||
33556222|NCT02342548|62949056|FG000|Overall Study|Lost to Follow-up|0|||
33662219|NCT01695239|63092843|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33662220|NCT01695239|63092844|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33662221|NCT01695239|63092845|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33662222|NCT01695239|63092846|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33662223|NCT01695239|63092833|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33662224|NCT01695239|63092834|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33662225|NCT01695239|63092835|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33662226|NCT01695239|63092836|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33662227|NCT01695239|63092837|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33662228|NCT01695239|63092838|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33662229|NCT01695239|63092839|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33662230|NCT01695239|63092840|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
33662231|NCT01695239|63092841|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33662232|NCT01695239|63092842|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33662233|NCT01695239|63092843|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33662234|NCT01695239|63092844|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33662235|NCT01695239|63092845|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33662236|NCT01695239|63092846|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33662237|NCT01695239|63092833|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33285013|NCT01231516|62661095|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
33285014|NCT01231516|62661094|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
33285015|NCT01231516|62661095|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
33285016|NCT01231516|62661094|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
33285017|NCT01231516|62661095|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
33285018|NCT01231516|62661094|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
33285019|NCT01231516|62661095|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
33285020|NCT01231516|62661094|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
33285021|NCT01231516|62661095|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
33285022|NCT01231321|62661101|FG000|Overall Study|Adverse Event|3|||
33285023|NCT01231321|62661101|FG000|Overall Study|Lack of Efficacy|2|||
33285024|NCT01210222|62661111|FG000|Overall Study|Ineligible|2|||
33285025|NCT01210222|62661111|FG000|Overall Study|Never treated|1|||
33285026|NCT01210144|62661123|FG000|Overall Study|Lack of ovarian response|1|||
33285027|NCT01210144|62661124|FG001|Overall Study|Lack of ovarian response|0|||
33285028|NCT01210144|62661123|FG000|Overall Study|No fertilization|1|||
33285029|NCT01210144|62661124|FG001|Overall Study|No fertilization|0|||
33285030|NCT01210144|62661123|FG000|Overall Study|No transfer|1|||
33285031|NCT01210144|62661124|FG001|Overall Study|No transfer|0|||
33285032|NCT01209949|62661131|FG000|Overall Study|Lost to Follow-up|3|||
33285033|NCT01209832|62661135|FG000|Period 1|Sponsor Decision and was not dosed|1|||
33285034|NCT01209832|62661135|FG000|Period 2|Sponsor Decision|1|||
33285035|NCT01230892|62661148|FG000|Overall Study|Withdrawal by Subject|1|||
33285036|NCT01230892|62661149|FG001|Overall Study|Withdrawal by Subject|1|||
33285037|NCT01230892|62661148|FG000|Overall Study|Lost to Follow-up|2|||
33285038|NCT01230892|62661149|FG001|Overall Study|Lost to Follow-up|0|||
33285039|NCT01230814|62661157|FG000|Overall Study|Lost to Follow-up|11|||
33285040|NCT01230814|62661158|FG001|Overall Study|Lost to Follow-up|3|||
33285041|NCT01230814|62661157|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
33285042|NCT01230814|62661158|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
33285043|NCT01230307|62661166|FG000|Overall Study|LVAD Placement|0|||
33285044|NCT01230307|62661167|FG001|Overall Study|LVAD Placement|2|||
33285045|NCT01209598|62661175|FG000|Overall Study|Withdrawal by Subject|1|||
33285046|NCT01209598|62661176|FG001|Overall Study|Withdrawal by Subject|0|||
33285047|NCT01209520|62661183|FG000|Overall Study|Withdrawal by Subject|3|||
33285048|NCT01209325|62661187|FG000|Overall Study|Lost to Follow-up|24|||
33285049|NCT01209325|62661187|FG000|Overall Study|Adverse Event|1|||
33285050|NCT01209325|62661187|FG000|Overall Study|Relocated|3|||
33285051|NCT01209325|62661187|FG000|Overall Study|Refusal after starting therapy|8|||
33285052|NCT01209325|62661187|FG000|Overall Study|Protocol Violation|4|||
33285053|NCT01209325|62661187|FG000|Overall Study|Refusal prior to therapy|1|||
33285054|NCT01209325|62661187|FG000|Overall Study|Incarceration|2|||
33285055|NCT01209286|62661225|FG000|Overall Study|Adverse Event|4|||
33285056|NCT01209286|62661226|FG001|Overall Study|Adverse Event|3|||
33285057|NCT01209286|62661227|FG002|Overall Study|Adverse Event|1|||
33556223|NCT02342548|62949057|FG001|Overall Study|Lost to Follow-up|1|||
33556224|NCT02342548|62949058|FG002|Overall Study|Lost to Follow-up|0|||
33556225|NCT02342548|62949056|FG000|Overall Study|Study terminated by sponsor|20|||
33662238|NCT01695239|63092834|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33285058|NCT01209286|62661225|FG000|Overall Study|Hematological Relapse After Remission|0|||
33285059|NCT01209286|62661226|FG001|Overall Study|Hematological Relapse After Remission|1|||
33285060|NCT01209286|62661227|FG002|Overall Study|Hematological Relapse After Remission|1|||
33285061|NCT01209286|62661225|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
33285062|NCT01209286|62661226|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
33285063|NCT01209286|62661227|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
33285064|NCT01209286|62661225|FG000|Overall Study|Physician Decision|0|||
33285065|NCT01209286|62661226|FG001|Overall Study|Physician Decision|2|||
33285066|NCT01209286|62661227|FG002|Overall Study|Physician Decision|0|||
33285067|NCT01209286|62661225|FG000|Overall Study|Other|0|||
33285068|NCT01209286|62661226|FG001|Overall Study|Other|1|||
33285069|NCT01209286|62661227|FG002|Overall Study|Other|0|||
33285070|NCT01208233|62661250|FG000|Overall Study|Adverse Event|0|||
33285071|NCT01208233|62661251|FG001|Overall Study|Adverse Event|1|||
33285072|NCT01208233|62661252|FG002|Overall Study|Adverse Event|2|||
33285073|NCT01208233|62661253|FG003|Overall Study|Adverse Event|0|||
33285074|NCT01208233|62661254|FG004|Overall Study|Adverse Event|3|||
33285075|NCT01208233|62661255|FG005|Overall Study|Adverse Event|5|||
33285076|NCT01208233|62661250|FG000|Overall Study|Death|0|||
33285077|NCT01208233|62661251|FG001|Overall Study|Death|0|||
33285078|NCT01208233|62661252|FG002|Overall Study|Death|0|||
33285079|NCT01208233|62661253|FG003|Overall Study|Death|0|||
33285080|NCT01208233|62661254|FG004|Overall Study|Death|3|||
33285081|NCT01208233|62661255|FG005|Overall Study|Death|5|||
33285082|NCT01208233|62661250|FG000|Overall Study|Did not meet entrance criteria|2|||
33285083|NCT01208233|62661251|FG001|Overall Study|Did not meet entrance criteria|1|||
33285084|NCT01208233|62661252|FG002|Overall Study|Did not meet entrance criteria|1|||
33285085|NCT01208233|62661253|FG003|Overall Study|Did not meet entrance criteria|0|||
33372064|NCT00576472|62750708|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
33372065|NCT00576472|62750709|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
33372066|NCT00576472|62750710|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
33372067|NCT00576472|62750711|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
33372068|NCT00576472|62750712|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
33372069|NCT00576472|62750713|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
33372070|NCT00576472|62750714|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
33372071|NCT00576472|62750715|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
33372072|NCT00576472|62750716|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
33372073|NCT00576472|62750717|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
33372074|NCT00576472|62750718|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
33372075|NCT00576472|62750704|FG000|MPH Home Maintenance Phase|Side effects|0|||
33372076|NCT00576472|62750705|FG001|MPH Home Maintenance Phase|Side effects|0|||
33372077|NCT00576472|62750706|FG002|MPH Home Maintenance Phase|Side effects|0|||
33372078|NCT00576472|62750707|FG003|MPH Home Maintenance Phase|Side effects|0|||
33285086|NCT01208233|62661254|FG004|Overall Study|Did not meet entrance criteria|1|||
33285087|NCT01208233|62661255|FG005|Overall Study|Did not meet entrance criteria|0|||
33285088|NCT01208233|62661250|FG000|Overall Study|Medication error without adverse event|0|||
33285089|NCT01208233|62661251|FG001|Overall Study|Medication error without adverse event|0|||
33285090|NCT01208233|62661252|FG002|Overall Study|Medication error without adverse event|0|||
33285091|NCT01208233|62661253|FG003|Overall Study|Medication error without adverse event|0|||
33285092|NCT01208233|62661254|FG004|Overall Study|Medication error without adverse event|0|||
33285093|NCT01208233|62661255|FG005|Overall Study|Medication error without adverse event|1|||
33285094|NCT01208233|62661250|FG000|Overall Study|Study terminated by sponsor|0|||
33285095|NCT01208233|62661251|FG001|Overall Study|Study terminated by sponsor|0|||
33285096|NCT01208233|62661252|FG002|Overall Study|Study terminated by sponsor|0|||
33285097|NCT01208233|62661253|FG003|Overall Study|Study terminated by sponsor|0|||
33285098|NCT01208233|62661254|FG004|Overall Study|Study terminated by sponsor|10|||
33285099|NCT01208233|62661255|FG005|Overall Study|Study terminated by sponsor|7|||
33285100|NCT01208233|62661250|FG000|Overall Study|Protocol Violation|0|||
33285101|NCT01208233|62661251|FG001|Overall Study|Protocol Violation|0|||
33285102|NCT01208233|62661252|FG002|Overall Study|Protocol Violation|0|||
33285103|NCT01208233|62661253|FG003|Overall Study|Protocol Violation|0|||
33285104|NCT01208233|62661254|FG004|Overall Study|Protocol Violation|3|||
33285105|NCT01208233|62661255|FG005|Overall Study|Protocol Violation|0|||
33285106|NCT01208233|62661250|FG000|Overall Study|Other|2|||
33372079|NCT00576472|62750708|FG004|MPH Home Maintenance Phase|Side effects|0|||
33372080|NCT00576472|62750709|FG005|MPH Home Maintenance Phase|Side effects|0|||
33372081|NCT00576472|62750710|FG006|MPH Home Maintenance Phase|Side effects|0|||
33285107|NCT01208233|62661251|FG001|Overall Study|Other|1|||
33285108|NCT01208233|62661252|FG002|Overall Study|Other|0|||
33556226|NCT02342548|62949057|FG001|Overall Study|Study terminated by sponsor|39|||
33285109|NCT01208233|62661253|FG003|Overall Study|Other|0|||
33285110|NCT01208233|62661254|FG004|Overall Study|Other|0|||
33285111|NCT01208233|62661255|FG005|Overall Study|Other|1|||
33285112|NCT01208233|62661250|FG000|Overall Study|Withdrawal by Subject|1|||
33285113|NCT01208233|62661251|FG001|Overall Study|Withdrawal by Subject|0|||
33285114|NCT01208233|62661252|FG002|Overall Study|Withdrawal by Subject|1|||
33285115|NCT01208233|62661253|FG003|Overall Study|Withdrawal by Subject|1|||
33372082|NCT00576472|62750711|FG007|MPH Home Maintenance Phase|Side effects|0|||
33285116|NCT01208233|62661254|FG004|Overall Study|Withdrawal by Subject|4|||
33372083|NCT00576472|62750712|FG008|MPH Home Maintenance Phase|Side effects|0|||
33285117|NCT01208233|62661255|FG005|Overall Study|Withdrawal by Subject|2|||
33285118|NCT01208038|62661275|FG000|Overall Study|Withdrawal by Subject|1|||
33285119|NCT01207687|62661279|FG000|Overall Study|Adverse Event|1|||
33372084|NCT00576472|62750713|FG009|MPH Home Maintenance Phase|Side effects|0|||
33285120|NCT01207687|62661279|FG000|Overall Study|Withdrawal by Subject|1|||
33285121|NCT01207453|62661291|FG000|First Intervention|Adverse Event|2|||
33285122|NCT01207453|62661292|FG001|First Intervention|Adverse Event|1|||
33285123|NCT01207453|62661291|FG000|Washout|Adverse Event|1|||
33285124|NCT01207453|62661292|FG001|Washout|Adverse Event|0|||
33285125|NCT01207453|62661291|FG000|Washout|Lost to Follow-up|1|||
33285126|NCT01207453|62661292|FG001|Washout|Lost to Follow-up|0|||
33285127|NCT01207453|62661291|FG000|2nd Intervention|Adverse Event|1|||
33285128|NCT01207453|62661292|FG001|2nd Intervention|Adverse Event|2|||
33285129|NCT01207453|62661291|FG000|2nd Intervention|Lost to Follow-up|1|||
33285130|NCT01207453|62661292|FG001|2nd Intervention|Lost to Follow-up|0|||
33285131|NCT01207414|62661303|FG000|Overall Study|Adverse Event|25|||
33285132|NCT01207414|62661304|FG001|Overall Study|Adverse Event|39|||
33285133|NCT01207414|62661303|FG000|Overall Study|Abnormal test procedure results|0|||
33285134|NCT01207414|62661304|FG001|Overall Study|Abnormal test procedure results|1|||
33285135|NCT01207414|62661303|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
33285136|NCT01207414|62661304|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
33285137|NCT01207414|62661303|FG000|Overall Study|Patient withdrew consent|14|||
33372085|NCT00576472|62750714|FG010|MPH Home Maintenance Phase|Side effects|0|||
33372086|NCT00576472|62750715|FG011|MPH Home Maintenance Phase|Side effects|0|||
33372087|NCT00576472|62750716|FG012|MPH Home Maintenance Phase|Side effects|0|||
33372088|NCT00576472|62750717|FG013|MPH Home Maintenance Phase|Side effects|0|||
33372089|NCT00576472|62750718|FG014|MPH Home Maintenance Phase|Side effects|8|||
33372090|NCT00576472|62750704|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33372091|NCT00576472|62750705|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33372092|NCT00576472|62750706|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33372093|NCT00576472|62750707|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33372094|NCT00576472|62750708|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33372095|NCT00576472|62750709|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33372096|NCT00576472|62750710|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33372097|NCT00576472|62750711|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33372098|NCT00576472|62750712|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33372099|NCT00576472|62750713|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33372100|NCT00576472|62750714|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33486395|NCT04009629|62864255|FG000|Overall Study|Withdrawal by Subject|2|||
33486396|NCT04009629|62864256|FG001|Overall Study|Withdrawal by Subject|0|||
33486397|NCT04007367|62864265|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
33486398|NCT04007367|62864266|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
33486399|NCT04007367|62864267|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
33486400|NCT04007367|62864265|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
33486401|NCT04007367|62864266|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
33486402|NCT04007367|62864267|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
33486403|NCT04007367|62864265|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
33486404|NCT04007367|62864266|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
33486405|NCT04007367|62864267|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
33486406|NCT04007367|62864265|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
33486407|NCT04007367|62864266|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
33486408|NCT04007367|62864267|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
33486409|NCT04007367|62864265|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
33486410|NCT04007367|62864266|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
33486411|NCT04007367|62864267|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
33486412|NCT03694197|62864277|FG000|Overall Study|Adverse Event|9|||
33486413|NCT03694197|62864277|FG000|Overall Study|Protocol became inconvenient to participate|1|||
33486414|NCT03694197|62864277|FG000|Overall Study|Physician Decision|4|||
33285138|NCT01207414|62661304|FG001|Overall Study|Patient withdrew consent|11|||
33285139|NCT01207414|62661303|FG000|Overall Study|Lost to Follow-up|15|||
33285140|NCT01207414|62661304|FG001|Overall Study|Lost to Follow-up|17|||
33285141|NCT01207414|62661303|FG000|Overall Study|Administrative problems|1|||
33285142|NCT01207414|62661304|FG001|Overall Study|Administrative problems|1|||
33486415|NCT03694197|62864277|FG000|Overall Study|Study terminated by sponsor|1350|||
33486416|NCT03694197|62864277|FG000|Overall Study|Participant moved|5|||
33486417|NCT03694197|62864277|FG000|Overall Study|Participant withdrew consent|10|||
33486418|NCT03694197|62864277|FG000|Overall Study|Related to IMP administration|1|||
33285143|NCT01207414|62661303|FG000|Overall Study|Protocol deviation|12|||
33372101|NCT00576472|62750715|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33372102|NCT00576472|62750716|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33285144|NCT01207414|62661304|FG001|Overall Study|Protocol deviation|9|||
33285145|NCT01207414|62661303|FG000|Overall Study|Randomized in error|1|||
33285146|NCT01207414|62661304|FG001|Overall Study|Randomized in error|0|||
33285147|NCT01207219|62661313|FG000|Overall Study|changed diagnosis during study period|5|||
33285148|NCT01207219|62661314|FG001|Overall Study|changed diagnosis during study period|3|||
33372103|NCT00576472|62750717|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33372104|NCT00576472|62750718|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
33372105|NCT00576472|62750704|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
33372106|NCT00576472|62750705|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
33372107|NCT00576472|62750706|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
33372108|NCT00576472|62750707|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
33372109|NCT00576472|62750708|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
33372110|NCT00576472|62750709|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
33372111|NCT00576472|62750710|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
33372112|NCT00576472|62750711|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
33372113|NCT00576472|62750712|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
33285149|NCT01207219|62661315|FG002|Overall Study|changed diagnosis during study period|1|||
33285150|NCT01207219|62661313|FG000|Overall Study|Lost to Follow-up|6|||
33285151|NCT01207219|62661314|FG001|Overall Study|Lost to Follow-up|8|||
33372114|NCT00576472|62750713|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
33285152|NCT01207219|62661315|FG002|Overall Study|Lost to Follow-up|6|||
33285153|NCT01206517|62661329|FG000|Overall Study|Withdrawal by Subject|0|||
33285154|NCT01206517|62661330|FG001|Overall Study|Withdrawal by Subject|0|||
33285155|NCT01206517|62661331|FG002|Overall Study|Withdrawal by Subject|2|||
33285156|NCT01206517|62661332|FG003|Overall Study|Withdrawal by Subject|0|||
33285157|NCT01206517|62661333|FG004|Overall Study|Withdrawal by Subject|1|||
33285158|NCT01206517|62661334|FG005|Overall Study|Withdrawal by Subject|0|||
33285159|NCT01206439|62661345|FG000|Overall Study|subject did not meet inclusion criteria|1|||
33285160|NCT01206322|62661351|FG000|Overall Study|Adverse Event|0|||
33285161|NCT01206322|62661352|FG001|Overall Study|Adverse Event|0|||
33285162|NCT01206322|62661353|FG002|Overall Study|Adverse Event|0|||
33285163|NCT01206322|62661354|FG003|Overall Study|Adverse Event|1|||
33285164|NCT01206166|62661366|FG000|Overall Study|No evaluable data|2|||
33285165|NCT01206166|62661367|FG001|Overall Study|No evaluable data|3|||
33285166|NCT01207102|62661376|FG000|Overall Study|Withdrawal by Subject|5|||
33285167|NCT01207102|62661376|FG000|Overall Study|Adverse Event|2|||
33285168|NCT01207102|62661376|FG000|Overall Study|progression|2|||
33285169|NCT01207102|62661376|FG000|Overall Study|Withdrawal by Treating Physician|1|||
33285170|NCT01205776|62661392|FG000|Overall Study|Lost to Follow-up|53|||
33285171|NCT01205776|62661393|FG001|Overall Study|Lost to Follow-up|61|||
33285172|NCT01205776|62661392|FG000|Overall Study|Withdrawal by Subject|11|||
33285173|NCT01205776|62661393|FG001|Overall Study|Withdrawal by Subject|34|||
33285174|NCT01205581|62661405|FG000|Overall Study|Withdrawal by Subject|1|||
33285175|NCT01205581|62661406|FG001|Overall Study|Withdrawal by Subject|0|||
33285176|NCT01205581|62661407|FG002|Overall Study|Withdrawal by Subject|0|||
33285177|NCT01205581|62661408|FG003|Overall Study|Withdrawal by Subject|0|||
33285178|NCT01205581|62661409|FG004|Overall Study|Withdrawal by Subject|0|||
33285179|NCT01205581|62661410|FG005|Overall Study|Withdrawal by Subject|0|||
33285180|NCT01205269|62661441|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
33285181|NCT01205269|62661442|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
33285182|NCT01205269|62661443|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
33285183|NCT01205269|62661444|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
33285184|NCT01205269|62661445|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
33285185|NCT01205269|62661446|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
33285186|NCT01240915|62661471|FG000|Overall Study|Adverse Event|0|||
33285187|NCT01240915|62661472|FG001|Overall Study|Adverse Event|0|||
33285188|NCT01240915|62661473|FG002|Overall Study|Adverse Event|0|||
33285189|NCT01240915|62661474|FG003|Overall Study|Adverse Event|1|||
33285190|NCT01240915|62661475|FG004|Overall Study|Adverse Event|0|||
33285191|NCT01240915|62661476|FG005|Overall Study|Adverse Event|2|||
33285192|NCT01240915|62661477|FG006|Overall Study|Adverse Event|0|||
33372115|NCT00576472|62750714|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
33285193|NCT01240915|62661478|FG007|Overall Study|Adverse Event|0|||
33285194|NCT01240915|62661479|FG008|Overall Study|Adverse Event|1|||
33285195|NCT01240915|62661471|FG000|Overall Study|Lost to Follow-up|0|||
33285196|NCT01240915|62661472|FG001|Overall Study|Lost to Follow-up|0|||
33285197|NCT01240915|62661473|FG002|Overall Study|Lost to Follow-up|0|||
33285198|NCT01240915|62661474|FG003|Overall Study|Lost to Follow-up|0|||
33285199|NCT01240915|62661475|FG004|Overall Study|Lost to Follow-up|1|||
33285200|NCT01240915|62661476|FG005|Overall Study|Lost to Follow-up|1|||
33285201|NCT01240915|62661477|FG006|Overall Study|Lost to Follow-up|0|||
33285202|NCT01240915|62661478|FG007|Overall Study|Lost to Follow-up|1|||
33285203|NCT01240915|62661479|FG008|Overall Study|Lost to Follow-up|1|||
33285204|NCT01240915|62661471|FG000|Overall Study|Withdrawal by Subject|2|||
33372116|NCT00576472|62750715|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
33372117|NCT00576472|62750716|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
33285205|NCT01240915|62661472|FG001|Overall Study|Withdrawal by Subject|1|||
33285206|NCT01240915|62661473|FG002|Overall Study|Withdrawal by Subject|0|||
33285207|NCT01240915|62661474|FG003|Overall Study|Withdrawal by Subject|2|||
33285208|NCT01240915|62661475|FG004|Overall Study|Withdrawal by Subject|0|||
33285209|NCT01240915|62661476|FG005|Overall Study|Withdrawal by Subject|4|||
33285210|NCT01240915|62661477|FG006|Overall Study|Withdrawal by Subject|2|||
33285211|NCT01240915|62661478|FG007|Overall Study|Withdrawal by Subject|3|||
33285212|NCT01240915|62661479|FG008|Overall Study|Withdrawal by Subject|3|||
33285213|NCT01240915|62661471|FG000|Overall Study|Other|0|||
33285214|NCT01240915|62661472|FG001|Overall Study|Other|0|||
33285215|NCT01240915|62661473|FG002|Overall Study|Other|0|||
33285216|NCT01240915|62661474|FG003|Overall Study|Other|0|||
33372118|NCT00576472|62750717|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
33372119|NCT00576472|62750718|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
33285217|NCT01240915|62661475|FG004|Overall Study|Other|2|||
33285218|NCT01240915|62661476|FG005|Overall Study|Other|0|||
33285219|NCT01240915|62661477|FG006|Overall Study|Other|0|||
33285220|NCT01240915|62661478|FG007|Overall Study|Other|0|||
33285221|NCT01240915|62661479|FG008|Overall Study|Other|0|||
33285222|NCT01240915|62661471|FG000|Overall Study|Insufficient Clinical Response|0|||
33285223|NCT01240915|62661472|FG001|Overall Study|Insufficient Clinical Response|0|||
33285224|NCT01240915|62661473|FG002|Overall Study|Insufficient Clinical Response|0|||
33285225|NCT01240915|62661474|FG003|Overall Study|Insufficient Clinical Response|0|||
33285226|NCT01240915|62661475|FG004|Overall Study|Insufficient Clinical Response|1|||
33285227|NCT01240915|62661476|FG005|Overall Study|Insufficient Clinical Response|3|||
33285228|NCT01240915|62661477|FG006|Overall Study|Insufficient Clinical Response|6|||
33285229|NCT01240915|62661478|FG007|Overall Study|Insufficient Clinical Response|0|||
33285230|NCT01240915|62661479|FG008|Overall Study|Insufficient Clinical Response|3|||
33285231|NCT01239745|62661501|FG000|Overall Study|Study terminated by sponsor|45|||
33285232|NCT01239745|62661501|FG000|Overall Study|Adverse Event|1|||
33285233|NCT01239472|62661507|FG000|Overall Study|Withdrawal by Subject|5|||
33285234|NCT01239472|62661508|FG001|Overall Study|Withdrawal by Subject|1|||
33285235|NCT01239472|62661507|FG000|Overall Study|Adverse Event|0|||
33285236|NCT01239472|62661508|FG001|Overall Study|Adverse Event|1|||
33285237|NCT01239472|62661507|FG000|Overall Study|Lack of Efficacy|0|||
33285238|NCT01239472|62661508|FG001|Overall Study|Lack of Efficacy|1|||
33285239|NCT01229449|62661521|FG000|Overall Study|Withdrawal by Subject|0|||
33285240|NCT01229449|62661522|FG001|Overall Study|Withdrawal by Subject|3|||
33285241|NCT01229449|62661523|FG002|Overall Study|Withdrawal by Subject|0|||
33285242|NCT01229449|62661524|FG003|Overall Study|Withdrawal by Subject|1|||
33285243|NCT01229449|62661525|FG004|Overall Study|Withdrawal by Subject|1|||
33285244|NCT01229449|62661521|FG000|Overall Study|Lost to Follow-up|1|||
33285245|NCT01229449|62661522|FG001|Overall Study|Lost to Follow-up|1|||
33285246|NCT01229449|62661523|FG002|Overall Study|Lost to Follow-up|1|||
33285247|NCT01229449|62661524|FG003|Overall Study|Lost to Follow-up|0|||
33285248|NCT01229449|62661525|FG004|Overall Study|Lost to Follow-up|0|||
33285249|NCT01229449|62661521|FG000|Overall Study|Physician Decision|0|||
33285250|NCT01229449|62661522|FG001|Overall Study|Physician Decision|0|||
33372120|NCT00576472|62750704|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33285251|NCT01229449|62661523|FG002|Overall Study|Physician Decision|1|||
33285252|NCT01229449|62661524|FG003|Overall Study|Physician Decision|0|||
33285253|NCT01229449|62661525|FG004|Overall Study|Physician Decision|0|||
33285254|NCT01239316|62661537|FG000|Overall Study|Progression/Relapse|11|||
33285255|NCT01239316|62661537|FG000|Overall Study|Adverse Event|1|||
33285256|NCT01239160|62661543|FG000|Overall Study|Lost to Follow-up|3|||
33285257|NCT01239160|62661544|FG001|Overall Study|Lost to Follow-up|5|||
33285258|NCT01239160|62661545|FG002|Overall Study|Lost to Follow-up|0|||
33285259|NCT01239160|62661543|FG000|Overall Study|Withdrawal by Subject|17|||
33285260|NCT01239160|62661544|FG001|Overall Study|Withdrawal by Subject|6|||
33285261|NCT01239160|62661545|FG002|Overall Study|Withdrawal by Subject|2|||
33486419|NCT03694197|62864277|FG000|Overall Study|Not disclosed|5|||
33285262|NCT01239160|62661543|FG000|Overall Study|Physician Decision|5|||
33285263|NCT01239160|62661544|FG001|Overall Study|Physician Decision|7|||
33285264|NCT01239160|62661545|FG002|Overall Study|Physician Decision|2|||
33285265|NCT01239160|62661543|FG000|Overall Study|Early Termination Due to Study Closure|0|||
33285266|NCT01239160|62661544|FG001|Overall Study|Early Termination Due to Study Closure|1|||
33285267|NCT01239160|62661545|FG002|Overall Study|Early Termination Due to Study Closure|6|||
33285268|NCT01239121|62661554|FG000|Overall Study|Withdrawal by Subject|2|||
33285269|NCT01239121|62661555|FG001|Overall Study|Withdrawal by Subject|4|||
33486420|NCT04365699|62864284|FG000|Overall Study|Death|2|||
33486421|NCT04365699|62864285|FG001|Overall Study|Death|5|||
33285270|NCT01239121|62661556|FG002|Overall Study|Withdrawal by Subject|0|||
33285271|NCT01239043|62661566|FG000|Overall Study|Protocol Violation|2|||
33285272|NCT01239043|62661567|FG001|Overall Study|Protocol Violation|1|||
33285273|NCT01238848|62661575|FG000|Overall Study|Physician Decision|13|||
33285274|NCT01238848|62661576|FG001|Overall Study|Physician Decision|5|||
33285275|NCT01238575|62661584|FG000|Overall Study|Lack of Efficacy|2|||
33285276|NCT01238575|62661585|FG001|Overall Study|Lack of Efficacy|4|||
33372121|NCT00576472|62750705|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33372122|NCT00576472|62750706|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33372123|NCT00576472|62750707|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33372124|NCT00576472|62750708|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33372125|NCT00576472|62750709|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33372126|NCT00576472|62750710|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33372127|NCT00576472|62750711|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33372128|NCT00576472|62750712|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33285277|NCT01238575|62661584|FG000|Overall Study|Adverse Event|2|||
33285278|NCT01238575|62661585|FG001|Overall Study|Adverse Event|0|||
33285279|NCT05376215|62661597|FG000|Overall Study|Withdrawal by Subject|2|||
33285280|NCT05376215|62661598|FG001|Overall Study|Withdrawal by Subject|1|||
33285281|NCT05376215|62661597|FG000|Overall Study|Lost to Follow-up|0|||
33285282|NCT05376215|62661598|FG001|Overall Study|Lost to Follow-up|1|||
33285283|NCT04542057|62661606|FG000|Overall Study|Death|3|||
33285284|NCT04542057|62661607|FG001|Overall Study|Death|1|||
33285285|NCT04542057|62661606|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
33285286|NCT04542057|62661607|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
33285287|NCT04542057|62661606|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
33285288|NCT04542057|62661607|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
33285289|NCT04542057|62661606|FG000|Overall Study|Adverse Event|15|||
33285290|NCT04542057|62661607|FG001|Overall Study|Adverse Event|6|||
33285291|NCT04542057|62661606|FG000|Overall Study|COVID-19 adverse event|6|||
33285292|NCT04542057|62661607|FG001|Overall Study|COVID-19 adverse event|4|||
33285293|NCT04542057|62661606|FG000|Overall Study|Lack of Efficacy|2|||
33285294|NCT04542057|62661607|FG001|Overall Study|Lack of Efficacy|5|||
33285295|NCT04542057|62661606|FG000|Overall Study|Study terminated by sponsor|1|||
33285296|NCT04542057|62661607|FG001|Overall Study|Study terminated by sponsor|0|||
33285297|NCT04542057|62661606|FG000|Overall Study|Investigator discretion|2|||
33285298|NCT04542057|62661607|FG001|Overall Study|Investigator discretion|1|||
33285299|NCT04542057|62661606|FG000|Overall Study|Withdrawal by Subject|52|||
33285300|NCT04542057|62661607|FG001|Overall Study|Withdrawal by Subject|30|||
33285301|NCT04542057|62661606|FG000|Overall Study|Lost to Follow-up|8|||
33285302|NCT04542057|62661607|FG001|Overall Study|Lost to Follow-up|11|||
33285303|NCT04542057|62661606|FG000|Overall Study|Other|2|||
33285304|NCT04542057|62661607|FG001|Overall Study|Other|2|||
33285305|NCT04447794|62661636|FG000|Overall Study|Lost to Follow-up|2|||
33285306|NCT04447794|62661637|FG001|Overall Study|Lost to Follow-up|3|||
33285307|NCT04447794|62661638|FG002|Overall Study|Lost to Follow-up|8|||
33285308|NCT04447794|62661636|FG000|Overall Study|Withdrawal by Subject|1|||
33285309|NCT04447794|62661637|FG001|Overall Study|Withdrawal by Subject|1|||
33285310|NCT04447794|62661638|FG002|Overall Study|Withdrawal by Subject|0|||
33285311|NCT04138576|62661651|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
33285312|NCT04009291|62661665|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
33285313|NCT04009291|62661666|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
33285314|NCT04009291|62661667|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
33285315|NCT04009291|62661668|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
33285316|NCT04009291|62661669|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
33285317|NCT04009291|62661665|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
33285318|NCT04009291|62661666|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
33285319|NCT04009291|62661667|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
33285320|NCT04009291|62661668|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
33285321|NCT04009291|62661669|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
33285322|NCT03811340|62661680|FG000|Overall Study|subjects did not complete the survey.|90|||
33285324|NCT03668119|62661699|FG000|Pre-treatment|Disease Progression|1|||
33285325|NCT03668119|62661700|FG001|Pre-treatment|Disease Progression|0|||
33285326|NCT03668119|62661699|FG000|Treatment|Disease Progression|75|||
33372129|NCT00576472|62750713|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33372130|NCT00576472|62750714|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33372131|NCT00576472|62750715|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33372132|NCT00576472|62750716|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33372133|NCT00576472|62750717|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33372134|NCT00576472|62750718|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
33372135|NCT00823212|62750751|FG000|Overall Study|Death|8|||
33285327|NCT03668119|62661700|FG001|Treatment|Disease Progression|55|||
33372136|NCT00823212|62750752|FG001|Overall Study|Death|10|||
33285328|NCT03668119|62661699|FG000|Treatment|Study drug toxicity|19|||
33285329|NCT03668119|62661700|FG001|Treatment|Study drug toxicity|1|||
33285330|NCT03668119|62661699|FG000|Treatment|Death|3|||
33285331|NCT03668119|62661700|FG001|Treatment|Death|0|||
33285332|NCT03668119|62661699|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
33285333|NCT03668119|62661700|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
33372137|NCT00823212|62750751|FG000|Overall Study|Withdrawal by Subject|6|||
33372138|NCT00823212|62750752|FG001|Overall Study|Withdrawal by Subject|1|||
33372139|NCT00823212|62750751|FG000|Overall Study|Incarcerated|0|||
33372140|NCT00823212|62750752|FG001|Overall Study|Incarcerated|1|||
33372141|NCT00823212|62750751|FG000|Overall Study|Missed 12-month visit|21|||
33372142|NCT00823212|62750752|FG001|Overall Study|Missed 12-month visit|21|||
33372143|NCT00807495|62750765|FG000|Overall Study|Adverse Event|6|||
33285334|NCT03668119|62661699|FG000|Treatment|Withdrawal by Subject|2|||
33285335|NCT03668119|62661700|FG001|Treatment|Withdrawal by Subject|1|||
33285336|NCT03668119|62661699|FG000|Treatment|Participant request to discontinue study treatment|3|||
33285337|NCT03668119|62661700|FG001|Treatment|Participant request to discontinue study treatment|1|||
33285338|NCT03668119|62661699|FG000|Treatment|Maximum Clinical Benefit|0|||
33285339|NCT03668119|62661700|FG001|Treatment|Maximum Clinical Benefit|1|||
33285340|NCT03668119|62661699|FG000|Treatment|Participants completed treatment|20|||
33285341|NCT03668119|62661700|FG001|Treatment|Participants completed treatment|8|||
33372144|NCT00807495|62750766|FG001|Overall Study|Adverse Event|3|||
33372145|NCT00807495|62750767|FG002|Overall Study|Adverse Event|1|||
33285342|NCT03668119|62661699|FG000|Treatment|Other reasons|1|||
33285343|NCT03668119|62661700|FG001|Treatment|Other reasons|2|||
33285344|NCT03555591|62661708|FG000|Overall Study|Protocol Violation|77|||
33285345|NCT03224819|62661730|FG000|Overall Study|Withdrawal by Subject|0|||
33285346|NCT03224819|62661731|FG001|Overall Study|Withdrawal by Subject|0|||
33372146|NCT00807495|62750768|FG003|Overall Study|Adverse Event|1|||
33372147|NCT00807495|62750769|FG004|Overall Study|Adverse Event|2|||
33372148|NCT00807495|62750765|FG000|Overall Study|Withdrawal by Patient|2|||
33372149|NCT00807495|62750766|FG001|Overall Study|Withdrawal by Patient|0|||
33372150|NCT00807495|62750767|FG002|Overall Study|Withdrawal by Patient|1|||
33372151|NCT00807495|62750768|FG003|Overall Study|Withdrawal by Patient|0|||
33372152|NCT00807495|62750769|FG004|Overall Study|Withdrawal by Patient|0|||
33372153|NCT00807495|62750765|FG000|Overall Study|Reason Not Specified|0|||
33372154|NCT00807495|62750766|FG001|Overall Study|Reason Not Specified|3|||
33372155|NCT00807495|62750767|FG002|Overall Study|Reason Not Specified|2|||
33372156|NCT00807495|62750768|FG003|Overall Study|Reason Not Specified|0|||
33372157|NCT00807495|62750769|FG004|Overall Study|Reason Not Specified|3|||
33372158|NCT05074433|62750785|FG000|Overall Study|Adverse Event|0|||
33285347|NCT03224819|62661732|FG002|Overall Study|Withdrawal by Subject|0|||
33285348|NCT03224819|62661733|FG003|Overall Study|Withdrawal by Subject|0|||
33285349|NCT03224819|62661734|FG004|Overall Study|Withdrawal by Subject|0|||
33285350|NCT03224819|62661735|FG005|Overall Study|Withdrawal by Subject|0|||
33285351|NCT03224819|62661736|FG006|Overall Study|Withdrawal by Subject|0|||
33285352|NCT03224819|62661737|FG007|Overall Study|Withdrawal by Subject|0|||
33285353|NCT03224819|62661738|FG008|Overall Study|Withdrawal by Subject|0|||
33285354|NCT03224819|62661739|FG009|Overall Study|Withdrawal by Subject|0|||
33285355|NCT03224819|62661740|FG010|Overall Study|Withdrawal by Subject|0|||
33285356|NCT03224819|62661741|FG011|Overall Study|Withdrawal by Subject|0|||
33285357|NCT03224819|62661742|FG012|Overall Study|Withdrawal by Subject|1|||
33285358|NCT03224819|62661743|FG013|Overall Study|Withdrawal by Subject|0|||
33285359|NCT03224819|62661730|FG000|Overall Study|Sponsor Decision|0|||
33285360|NCT03224819|62661731|FG001|Overall Study|Sponsor Decision|0|||
33285361|NCT03224819|62661732|FG002|Overall Study|Sponsor Decision|0|||
33285362|NCT03224819|62661733|FG003|Overall Study|Sponsor Decision|1|||
33486422|NCT04365699|62864286|FG002|Overall Study|Death|15|||
33285363|NCT03224819|62661734|FG004|Overall Study|Sponsor Decision|1|||
33285364|NCT03224819|62661735|FG005|Overall Study|Sponsor Decision|2|||
33285365|NCT03224819|62661736|FG006|Overall Study|Sponsor Decision|1|||
33285366|NCT03224819|62661737|FG007|Overall Study|Sponsor Decision|1|||
33285367|NCT03224819|62661738|FG008|Overall Study|Sponsor Decision|1|||
33285368|NCT03224819|62661739|FG009|Overall Study|Sponsor Decision|2|||
33285369|NCT03224819|62661740|FG010|Overall Study|Sponsor Decision|1|||
33486423|NCT04005885|62864294|FG000|First Intervention|Withdrawal by Subject|1|||
33285370|NCT03224819|62661741|FG011|Overall Study|Sponsor Decision|1|||
33285371|NCT03224819|62661742|FG012|Overall Study|Sponsor Decision|1|||
33285372|NCT03224819|62661743|FG013|Overall Study|Sponsor Decision|0|||
33285373|NCT03224819|62661730|FG000|Overall Study|Lost to Follow-up|0|||
33372159|NCT05074433|62750786|FG001|Overall Study|Adverse Event|2|||
33372160|NCT05074433|62750787|FG002|Overall Study|Adverse Event|0|||
33372161|NCT05074433|62750788|FG003|Overall Study|Adverse Event|1|||
33486424|NCT04005885|62864295|FG001|First Intervention|Withdrawal by Subject|1|||
33372162|NCT05074433|62750785|FG000|Overall Study|Sponsor Request|0|||
33372163|NCT05074433|62750786|FG001|Overall Study|Sponsor Request|1|||
33372164|NCT05074433|62750787|FG002|Overall Study|Sponsor Request|1|||
33372165|NCT05074433|62750788|FG003|Overall Study|Sponsor Request|0|||
33486425|NCT04005885|62864294|FG000|Second Intervention|Withdrawal by Subject|0|||
33285374|NCT03224819|62661731|FG001|Overall Study|Lost to Follow-up|0|||
33285375|NCT03224819|62661732|FG002|Overall Study|Lost to Follow-up|0|||
33285376|NCT03224819|62661733|FG003|Overall Study|Lost to Follow-up|0|||
33285377|NCT03224819|62661734|FG004|Overall Study|Lost to Follow-up|0|||
33285378|NCT03224819|62661735|FG005|Overall Study|Lost to Follow-up|0|||
33372166|NCT05074433|62750785|FG000|Overall Study|Death|1|||
33372167|NCT05074433|62750786|FG001|Overall Study|Death|0|||
33285379|NCT03224819|62661736|FG006|Overall Study|Lost to Follow-up|0|||
33372168|NCT05074433|62750787|FG002|Overall Study|Death|0|||
33372169|NCT05074433|62750788|FG003|Overall Study|Death|0|||
33372170|NCT05074433|62750785|FG000|Overall Study|Lost to Follow-up|0|||
33372171|NCT05074433|62750786|FG001|Overall Study|Lost to Follow-up|0|||
33372172|NCT05074433|62750787|FG002|Overall Study|Lost to Follow-up|2|||
33372173|NCT05074433|62750788|FG003|Overall Study|Lost to Follow-up|0|||
33285380|NCT03224819|62661737|FG007|Overall Study|Lost to Follow-up|0|||
33372174|NCT05074433|62750785|FG000|Overall Study|Subject Decision|8|||
33372175|NCT05074433|62750786|FG001|Overall Study|Subject Decision|6|||
33486426|NCT04005885|62864295|FG001|Second Intervention|Withdrawal by Subject|2|||
33486427|NCT04003623|62864308|FG000|Overall Study|Withdrawal by Subject|1|||
33486428|NCT04003623|62864309|FG001|Overall Study|Withdrawal by Subject|0|||
33486429|NCT04480424|62864317|FG000|Overall Study|Withdrawal by Subject|0|||
33486430|NCT04480424|62864318|FG001|Overall Study|Withdrawal by Subject|2|||
33486431|NCT04480424|62864317|FG000|Overall Study|Lost to Follow-up|3|||
33486432|NCT04480424|62864318|FG001|Overall Study|Lost to Follow-up|3|||
33285381|NCT03224819|62661738|FG008|Overall Study|Lost to Follow-up|1|||
33285382|NCT03224819|62661739|FG009|Overall Study|Lost to Follow-up|0|||
33285383|NCT03224819|62661740|FG010|Overall Study|Lost to Follow-up|0|||
33285384|NCT03224819|62661741|FG011|Overall Study|Lost to Follow-up|0|||
33285385|NCT03224819|62661742|FG012|Overall Study|Lost to Follow-up|0|||
33285386|NCT03224819|62661743|FG013|Overall Study|Lost to Follow-up|0|||
33285387|NCT03224819|62661730|FG000|Overall Study|Death|0|||
33285388|NCT03224819|62661731|FG001|Overall Study|Death|1|||
33285389|NCT03224819|62661732|FG002|Overall Study|Death|0|||
33285390|NCT03224819|62661733|FG003|Overall Study|Death|0|||
33285391|NCT03224819|62661734|FG004|Overall Study|Death|0|||
33285392|NCT03224819|62661735|FG005|Overall Study|Death|0|||
33285393|NCT03224819|62661736|FG006|Overall Study|Death|0|||
33285394|NCT03224819|62661737|FG007|Overall Study|Death|1|||
33285395|NCT03224819|62661738|FG008|Overall Study|Death|0|||
33285396|NCT03224819|62661739|FG009|Overall Study|Death|0|||
33285397|NCT03224819|62661740|FG010|Overall Study|Death|0|||
33285398|NCT03224819|62661741|FG011|Overall Study|Death|1|||
33285399|NCT03224819|62661742|FG012|Overall Study|Death|0|||
33285400|NCT03224819|62661743|FG013|Overall Study|Death|0|||
33285401|NCT02549573|62661786|FG000|Overall Study|Withdrawal by Subject|0|||
33285402|NCT02549573|62661787|FG001|Overall Study|Withdrawal by Subject|2|||
33285403|NCT02549573|62661786|FG000|Overall Study|Protocol Violation|0|||
33285404|NCT02549573|62661787|FG001|Overall Study|Protocol Violation|1|||
33285405|NCT02378181|62661795|FG000|Overall Study|Lost to Follow-up|2|||
33285406|NCT02378181|62661796|FG001|Overall Study|Lost to Follow-up|5|||
33285407|NCT02378181|62661795|FG000|Overall Study|Withdrawal by Subject|1|||
33285408|NCT02378181|62661796|FG001|Overall Study|Withdrawal by Subject|1|||
33285409|NCT02378181|62661795|FG000|Overall Study|Incarcerated|0|||
33285410|NCT02378181|62661796|FG001|Overall Study|Incarcerated|1|||
33486433|NCT04480424|62864317|FG000|Overall Study|Death|14|||
33486434|NCT04480424|62864318|FG001|Overall Study|Death|16|||
33486435|NCT04480424|62864317|FG000|Overall Study|Reason not Specified|5|||
33486436|NCT04480424|62864318|FG001|Overall Study|Reason not Specified|5|||
33486437|NCT03256526|62864327|FG000|Overall Study|Adverse Event|1|||
33486438|NCT03256526|62864328|FG001|Overall Study|Adverse Event|0|||
33285411|NCT02201108|62661804|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
33285412|NCT02201108|62661805|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
33285413|NCT02201108|62661804|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
33285414|NCT02201108|62661805|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
33285415|NCT02201108|62661804|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
33285416|NCT02201108|62661805|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
33285417|NCT02201108|62661804|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
33285418|NCT02201108|62661805|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
33486439|NCT03256526|62864329|FG002|Overall Study|Adverse Event|1|||
33556227|NCT02342548|62949058|FG002|Overall Study|Study terminated by sponsor|25|||
33556228|NCT02342548|62949056|FG000|Overall Study|Protocol Violation|0|||
33556229|NCT02342548|62949057|FG001|Overall Study|Protocol Violation|1|||
33285419|NCT02201108|62661804|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
33285420|NCT02201108|62661805|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
33285421|NCT02201108|62661804|FG000|Open Label Period (up to Week 192)|Other reason|4|||
33285422|NCT02201108|62661805|FG001|Open Label Period (up to Week 192)|Other reason|7|||
33285423|NCT02201108|62661804|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
33372176|NCT05074433|62750787|FG002|Overall Study|Subject Decision|4|||
33486440|NCT03256526|62864327|FG000|Overall Study|Lost to Follow-up|1|||
33486441|NCT03256526|62864328|FG001|Overall Study|Lost to Follow-up|0|||
33486442|NCT03256526|62864329|FG002|Overall Study|Lost to Follow-up|2|||
33285424|NCT02201108|62661805|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
33285425|NCT02180243|62661826|FG000|Overall Study|Withdrawal by Subject|12|||
33372177|NCT05074433|62750788|FG003|Overall Study|Subject Decision|5|||
33486443|NCT03255980|62864341|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
33285426|NCT02180243|62661827|FG001|Overall Study|Withdrawal by Subject|12|||
33285427|NCT02180243|62661826|FG000|Overall Study|Lost to Follow-up|12|||
33285428|NCT02180243|62661827|FG001|Overall Study|Lost to Follow-up|2|||
33285429|NCT01772563|62661834|FG000|Cycle 1|Dose limiting toxicity|2|||
33285430|NCT01772563|62661834|FG000|Cycle 1|Progressive disease|2|||
33285431|NCT01772563|62661834|FG000|Cycle 2 and Beyond|Progressive disease|17|||
33285432|NCT01772563|62661834|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
33285433|NCT01772563|62661834|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
33285434|NCT01496976|62661840|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
33285435|NCT01445171|62661844|FG000|Overall Study|Lost to Follow-up|11|||
33285436|NCT01445171|62661844|FG000|Overall Study|Withdrawal by Subject|16|||
33285437|NCT01445171|62661844|FG000|Overall Study|Death|51|||
33285438|NCT01445171|62661844|FG000|Overall Study|Subjects declined to return for followup|9|||
33285439|NCT01445171|62661844|FG000|Overall Study|Consented but did not receive device|8|||
33285440|NCT00492050|62661850|FG000|Overall Study|Adverse Event|1|||
33285441|NCT00492050|62661850|FG000|Overall Study|Lack of Efficacy|1|||
33285442|NCT00492050|62661850|FG000|Overall Study|Withdrawal by Subject|3|||
33285443|NCT00492050|62661850|FG000|Overall Study|Unable to collect SCT|2|||
33285444|NCT00492050|62661850|FG000|Overall Study|Progressive Disease|2|||
33285445|NCT01237951|62661854|FG000|Overall Study|Death|1|||
33285446|NCT01239394|62661858|FG000|Overall Study|Adverse Event|1|||
33285447|NCT01237678|62661865|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
33285448|NCT01237678|62661866|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
33285449|NCT01237678|62661867|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
33285450|NCT01237678|62661865|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
33285451|NCT01237678|62661866|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
33285452|NCT01237678|62661867|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
33285453|NCT01237678|62661865|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
33285454|NCT01237678|62661866|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
33285455|NCT01237678|62661867|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
33285456|NCT01237678|62661865|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
33285457|NCT01237678|62661866|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
33285458|NCT01237678|62661867|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
33285459|NCT01237678|62661865|FG000|Phase II|Adverse Event|0|||
33285460|NCT01237678|62661866|FG001|Phase II|Adverse Event|39|||
33285461|NCT01237678|62661867|FG002|Phase II|Adverse Event|9|||
33285462|NCT01237678|62661865|FG000|Phase II|Death|0|||
33285463|NCT01237678|62661866|FG001|Phase II|Death|0|||
33285464|NCT01237678|62661867|FG002|Phase II|Death|2|||
33285465|NCT01237678|62661865|FG000|Phase II|Lack of Efficacy|0|||
33285466|NCT01237678|62661866|FG001|Phase II|Lack of Efficacy|25|||
33285467|NCT01237678|62661867|FG002|Phase II|Lack of Efficacy|3|||
33285468|NCT01237678|62661865|FG000|Phase II|Withdrawal by Subject|0|||
33285469|NCT01237678|62661866|FG001|Phase II|Withdrawal by Subject|1|||
33285470|NCT01237678|62661867|FG002|Phase II|Withdrawal by Subject|5|||
33285471|NCT01237678|62661865|FG000|Phase II|Completed Cycles 4-6|0|||
33285472|NCT01237678|62661866|FG001|Phase II|Completed Cycles 4-6|11|||
33285473|NCT01237678|62661867|FG002|Phase II|Completed Cycles 4-6|21|||
33285474|NCT01237678|62661865|FG000|Phase II|Sponsor Decision/Study Closed|0|||
33285475|NCT01237678|62661866|FG001|Phase II|Sponsor Decision/Study Closed|18|||
33285476|NCT01237678|62661867|FG002|Phase II|Sponsor Decision/Study Closed|7|||
33285477|NCT01237678|62661865|FG000|Phase II|Randomized but were not treated|0|||
33285478|NCT01237678|62661866|FG001|Phase II|Randomized but were not treated|4|||
33285479|NCT01237678|62661867|FG002|Phase II|Randomized but were not treated|3|||
33285480|NCT01229371|62661890|FG000|Overall Study|Withdrawal by Subject|0|||
33285481|NCT01229371|62661891|FG001|Overall Study|Withdrawal by Subject|1|||
33285482|NCT01229371|62661892|FG002|Overall Study|Withdrawal by Subject|0|||
33285483|NCT01229371|62661893|FG003|Overall Study|Withdrawal by Subject|0|||
33285484|NCT01237327|62661905|FG000|Overall Study|Protocol Violation: Core Study|1|||
33372178|NCT04922021|62750812|FG000|Overall Study|Withdrawal by Subject|4|||
33486444|NCT03255980|62864342|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
33285485|NCT01237327|62661906|FG001|Overall Study|Protocol Violation: Core Study|0|||
33285486|NCT01237327|62661905|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
33285487|NCT01237327|62661906|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
33285488|NCT01237327|62661905|FG000|Overall Study|Progression of Disease: Core Study|18|||
33285489|NCT01237327|62661906|FG001|Overall Study|Progression of Disease: Core Study|22|||
33285490|NCT01237327|62661905|FG000|Overall Study|Progression of Disease: Extension Study|15|||
33285491|NCT01237327|62661906|FG001|Overall Study|Progression of Disease: Extension Study|13|||
33285492|NCT01237327|62661905|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
33285493|NCT01237327|62661906|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
33285494|NCT01237327|62661905|FG000|Overall Study|Withdrawal by Subject|1|||
33285495|NCT01237327|62661906|FG001|Overall Study|Withdrawal by Subject|3|||
33285496|NCT01237327|62661905|FG000|Overall Study|Lost to Follow-up|3|||
33285497|NCT01237327|62661906|FG001|Overall Study|Lost to Follow-up|0|||
33285498|NCT01237054|62661912|FG000|Overall Study|imaging 10C0096|1|||
33285499|NCT01236352|62661949|FG000|Overall Study|Death|0|||
33285500|NCT01236352|62661950|FG001|Overall Study|Death|0|||
33285501|NCT01236352|62661951|FG002|Overall Study|Death|0|||
33285502|NCT01236352|62661952|FG003|Overall Study|Death|0|||
33285503|NCT01236352|62661953|FG004|Overall Study|Death|0|||
33285504|NCT01236352|62661954|FG005|Overall Study|Death|0|||
33285505|NCT01236352|62661955|FG006|Overall Study|Death|0|||
33285506|NCT01236352|62661956|FG007|Overall Study|Death|1|||
33285507|NCT01236352|62661957|FG008|Overall Study|Death|0|||
33285508|NCT01236352|62661958|FG009|Overall Study|Death|0|||
33285509|NCT01236352|62661959|FG010|Overall Study|Death|0|||
33285510|NCT01236352|62661949|FG000|Overall Study|Withdrawal by Subject|0|||
33285511|NCT01236352|62661950|FG001|Overall Study|Withdrawal by Subject|0|||
33285512|NCT01236352|62661951|FG002|Overall Study|Withdrawal by Subject|0|||
33285513|NCT01236352|62661952|FG003|Overall Study|Withdrawal by Subject|0|||
33285514|NCT01236352|62661953|FG004|Overall Study|Withdrawal by Subject|0|||
33285515|NCT01236352|62661954|FG005|Overall Study|Withdrawal by Subject|0|||
33285516|NCT01236352|62661955|FG006|Overall Study|Withdrawal by Subject|0|||
33285517|NCT01236352|62661956|FG007|Overall Study|Withdrawal by Subject|0|||
33285518|NCT01236352|62661957|FG008|Overall Study|Withdrawal by Subject|0|||
33285519|NCT01236352|62661958|FG009|Overall Study|Withdrawal by Subject|2|||
33285520|NCT01236352|62661959|FG010|Overall Study|Withdrawal by Subject|1|||
33285521|NCT01236352|62661949|FG000|Overall Study|Adverse Event|0|||
33285522|NCT01236352|62661950|FG001|Overall Study|Adverse Event|0|||
33285523|NCT01236352|62661951|FG002|Overall Study|Adverse Event|0|||
33285524|NCT01236352|62661952|FG003|Overall Study|Adverse Event|0|||
33285525|NCT01236352|62661953|FG004|Overall Study|Adverse Event|0|||
33285526|NCT01236352|62661954|FG005|Overall Study|Adverse Event|0|||
33285527|NCT01236352|62661955|FG006|Overall Study|Adverse Event|2|||
33285528|NCT01236352|62661956|FG007|Overall Study|Adverse Event|0|||
33285529|NCT01236352|62661957|FG008|Overall Study|Adverse Event|0|||
33285530|NCT01236352|62661958|FG009|Overall Study|Adverse Event|4|||
33285531|NCT01236352|62661959|FG010|Overall Study|Adverse Event|1|||
33285532|NCT01236352|62661949|FG000|Overall Study|Study drug toxicity|0|||
33285533|NCT01236352|62661950|FG001|Overall Study|Study drug toxicity|0|||
33285534|NCT01236352|62661951|FG002|Overall Study|Study drug toxicity|0|||
33285535|NCT01236352|62661952|FG003|Overall Study|Study drug toxicity|0|||
33285536|NCT01236352|62661953|FG004|Overall Study|Study drug toxicity|0|||
33285537|NCT01236352|62661954|FG005|Overall Study|Study drug toxicity|1|||
33285538|NCT01236352|62661955|FG006|Overall Study|Study drug toxicity|1|||
33285539|NCT01236352|62661956|FG007|Overall Study|Study drug toxicity|0|||
33285540|NCT01236352|62661957|FG008|Overall Study|Study drug toxicity|0|||
33285541|NCT01236352|62661958|FG009|Overall Study|Study drug toxicity|2|||
33285542|NCT01236352|62661959|FG010|Overall Study|Study drug toxicity|2|||
33285543|NCT01236352|62661949|FG000|Overall Study|Disease progression|1|||
33372179|NCT04922021|62750813|FG001|Overall Study|Withdrawal by Subject|10|||
33372180|NCT04922021|62750812|FG000|Overall Study|Adverse Event|2|||
33372181|NCT04922021|62750813|FG001|Overall Study|Adverse Event|2|||
33372182|NCT04922021|62750812|FG000|Overall Study|Lack of Efficacy|0|||
33372183|NCT04922021|62750813|FG001|Overall Study|Lack of Efficacy|1|||
33372184|NCT04922021|62750812|FG000|Overall Study|Multiple reasons|1|||
33372185|NCT04922021|62750813|FG001|Overall Study|Multiple reasons|0|||
33372186|NCT04233580|62750864|FG000|Overall Study|Adverse Event|3|||
33372187|NCT04233580|62750865|FG001|Overall Study|Adverse Event|3|||
33372188|NCT04233580|62750864|FG000|Overall Study|Withdrawal by Subject|2|||
33372189|NCT04233580|62750865|FG001|Overall Study|Withdrawal by Subject|1|||
33372190|NCT04016805|62750885|FG000|Overall Study|Sponsor's Discretion|30|||
33372191|NCT04016805|62750886|FG001|Overall Study|Sponsor's Discretion|6|||
33372192|NCT04016805|62750887|FG002|Overall Study|Sponsor's Discretion|5|||
33285544|NCT01236352|62661950|FG001|Overall Study|Disease progression|2|||
33285545|NCT01236352|62661951|FG002|Overall Study|Disease progression|1|||
33285546|NCT01236352|62661952|FG003|Overall Study|Disease progression|2|||
33285547|NCT01236352|62661953|FG004|Overall Study|Disease progression|2|||
33285548|NCT01236352|62661954|FG005|Overall Study|Disease progression|2|||
33285549|NCT01236352|62661955|FG006|Overall Study|Disease progression|1|||
33372193|NCT03982199|62750897|FG000|Overall Study|Site terminated by sponsor|14|||
33372194|NCT03982199|62750898|FG001|Overall Study|Site terminated by sponsor|17|||
33372195|NCT03982199|62750897|FG000|Overall Study|Lost to Follow-up|137|||
33285550|NCT01236352|62661956|FG007|Overall Study|Disease progression|3|||
33285551|NCT01236352|62661957|FG008|Overall Study|Disease progression|2|||
33285552|NCT01236352|62661958|FG009|Overall Study|Disease progression|2|||
33285553|NCT01236352|62661959|FG010|Overall Study|Disease progression|2|||
33285554|NCT01236352|62661949|FG000|Overall Study|Poor/Non-compliance|1|||
33285555|NCT01236352|62661950|FG001|Overall Study|Poor/Non-compliance|0|||
33285556|NCT01236352|62661951|FG002|Overall Study|Poor/Non-compliance|0|||
33372196|NCT03982199|62750898|FG001|Overall Study|Lost to Follow-up|142|||
33372197|NCT03982199|62750897|FG000|Overall Study|Physician Decision|38|||
33285557|NCT01236352|62661952|FG003|Overall Study|Poor/Non-compliance|0|||
33285558|NCT01236352|62661953|FG004|Overall Study|Poor/Non-compliance|0|||
33372198|NCT03982199|62750898|FG001|Overall Study|Physician Decision|33|||
33372199|NCT03982199|62750897|FG000|Overall Study|Withdrawal by Subject|514|||
33372200|NCT03982199|62750898|FG001|Overall Study|Withdrawal by Subject|496|||
33372201|NCT03982199|62750897|FG000|Overall Study|Adverse Event|10|||
33372202|NCT03982199|62750898|FG001|Overall Study|Adverse Event|14|||
33372203|NCT03982199|62750897|FG000|Overall Study|Technical Problems|9|||
33372204|NCT03982199|62750898|FG001|Overall Study|Technical Problems|8|||
33372205|NCT03982199|62750897|FG000|Overall Study|Death|40|||
33372206|NCT03982199|62750898|FG001|Overall Study|Death|40|||
33372207|NCT03982199|62750897|FG000|Overall Study|Study terminated by sponsor|2|||
33372208|NCT03982199|62750898|FG001|Overall Study|Study terminated by sponsor|1|||
33372209|NCT03982199|62750897|FG000|Overall Study|Other|76|||
33285559|NCT01236352|62661954|FG005|Overall Study|Poor/Non-compliance|0|||
33285560|NCT01236352|62661955|FG006|Overall Study|Poor/Non-compliance|0|||
33285561|NCT01236352|62661956|FG007|Overall Study|Poor/Non-compliance|0|||
33285562|NCT01236352|62661957|FG008|Overall Study|Poor/Non-compliance|0|||
33285563|NCT01236352|62661958|FG009|Overall Study|Poor/Non-compliance|0|||
33285564|NCT01236352|62661959|FG010|Overall Study|Poor/Non-compliance|0|||
33285565|NCT01236352|62661949|FG000|Overall Study|Maximum clinical benefit|1|||
33285566|NCT01236352|62661950|FG001|Overall Study|Maximum clinical benefit|1|||
33285567|NCT01236352|62661951|FG002|Overall Study|Maximum clinical benefit|1|||
33285568|NCT01236352|62661952|FG003|Overall Study|Maximum clinical benefit|0|||
33285569|NCT01236352|62661953|FG004|Overall Study|Maximum clinical benefit|2|||
33285570|NCT01236352|62661954|FG005|Overall Study|Maximum clinical benefit|0|||
33285571|NCT01236352|62661955|FG006|Overall Study|Maximum clinical benefit|3|||
33285572|NCT01236352|62661956|FG007|Overall Study|Maximum clinical benefit|1|||
33285573|NCT01236352|62661957|FG008|Overall Study|Maximum clinical benefit|1|||
33285574|NCT01236352|62661958|FG009|Overall Study|Maximum clinical benefit|4|||
33285575|NCT01236352|62661959|FG010|Overall Study|Maximum clinical benefit|2|||
33285576|NCT01236352|62661949|FG000|Overall Study|Subject request to discontinue treatment|0|||
33285577|NCT01236352|62661950|FG001|Overall Study|Subject request to discontinue treatment|0|||
33285578|NCT01236352|62661951|FG002|Overall Study|Subject request to discontinue treatment|1|||
33285579|NCT01236352|62661952|FG003|Overall Study|Subject request to discontinue treatment|1|||
33285580|NCT01236352|62661953|FG004|Overall Study|Subject request to discontinue treatment|0|||
33285581|NCT01236352|62661954|FG005|Overall Study|Subject request to discontinue treatment|1|||
33285582|NCT01236352|62661955|FG006|Overall Study|Subject request to discontinue treatment|0|||
33285583|NCT01236352|62661956|FG007|Overall Study|Subject request to discontinue treatment|0|||
33285584|NCT01236352|62661957|FG008|Overall Study|Subject request to discontinue treatment|0|||
33285585|NCT01236352|62661958|FG009|Overall Study|Subject request to discontinue treatment|1|||
33285586|NCT01236352|62661959|FG010|Overall Study|Subject request to discontinue treatment|4|||
33285587|NCT01236352|62661949|FG000|Overall Study|Subject to receive drug via EAP|1|||
33285588|NCT01236352|62661950|FG001|Overall Study|Subject to receive drug via EAP|1|||
33285589|NCT01236352|62661951|FG002|Overall Study|Subject to receive drug via EAP|1|||
33285590|NCT01236352|62661952|FG003|Overall Study|Subject to receive drug via EAP|0|||
33285591|NCT01236352|62661953|FG004|Overall Study|Subject to receive drug via EAP|0|||
33285592|NCT01236352|62661954|FG005|Overall Study|Subject to receive drug via EAP|0|||
33285593|NCT01236352|62661955|FG006|Overall Study|Subject to receive drug via EAP|0|||
33285594|NCT01236352|62661956|FG007|Overall Study|Subject to receive drug via EAP|2|||
33285595|NCT01236352|62661957|FG008|Overall Study|Subject to receive drug via EAP|0|||
33285596|NCT01236352|62661958|FG009|Overall Study|Subject to receive drug via EAP|4|||
33285597|NCT01236352|62661959|FG010|Overall Study|Subject to receive drug via EAP|0|||
33285598|NCT01236352|62661949|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
33285599|NCT01236352|62661950|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
33372210|NCT03982199|62750898|FG001|Overall Study|Other|81|||
33372211|NCT03982199|62750897|FG000|Overall Study|Ongoing|743|||
33372212|NCT03982199|62750898|FG001|Overall Study|Ongoing|799|||
33372213|NCT03982199|62750897|FG000|Overall Study|Randomized but not vaccinated|18|||
33372214|NCT03982199|62750898|FG001|Overall Study|Randomized but not vaccinated|15|||
33372215|NCT03828448|62750904|FG000|Overall Study|Sponsor's Discretion|34|||
33372216|NCT03713593|62750914|FG000|Overall Study|Participants Ongoing|140|||
33372217|NCT03713593|62750915|FG001|Overall Study|Participants Ongoing|114|||
33486445|NCT03255980|62864343|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
33486446|NCT03255980|62864344|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
33486447|NCT03255980|62864341|FG000|Overall Study|Adverse Event|1|||
33285600|NCT01236352|62661951|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
33285601|NCT01236352|62661952|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
33372218|NCT03713593|62750914|FG000|Overall Study|Withdrawal by Subject|3|||
33372219|NCT03713593|62750915|FG001|Overall Study|Withdrawal by Subject|6|||
33372220|NCT03713593|62750914|FG000|Overall Study|Death|252|||
33285602|NCT01236352|62661953|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
33285603|NCT01236352|62661954|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
33285604|NCT01236352|62661955|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
33285605|NCT01236352|62661956|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
33372221|NCT03713593|62750915|FG001|Overall Study|Death|279|||
33372222|NCT03580369|62750925|FG000|Overall Study|No treatment due to mis-randomization|1|||
33372223|NCT03580369|62750926|FG001|Overall Study|No treatment due to mis-randomization|0|||
33372224|NCT03580369|62750927|FG002|Overall Study|No treatment due to mis-randomization|0|||
33372225|NCT03580369|62750928|FG003|Overall Study|No treatment due to mis-randomization|0|||
33372226|NCT03580369|62750929|FG004|Overall Study|No treatment due to mis-randomization|3|||
33372227|NCT03580369|62750930|FG005|Overall Study|No treatment due to mis-randomization|0|||
33372228|NCT03580369|62750931|FG006|Overall Study|No treatment due to mis-randomization|0|||
33285606|NCT01236352|62661957|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
33285607|NCT01236352|62661958|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
33285608|NCT01236352|62661959|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
33285609|NCT01236352|62661949|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33285610|NCT01236352|62661950|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33285611|NCT01236352|62661951|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33285612|NCT01236352|62661952|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33285613|NCT01236352|62661953|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33285614|NCT01236352|62661954|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33372229|NCT03580369|62750932|FG007|Overall Study|No treatment due to mis-randomization|0|||
33372230|NCT03580369|62750925|FG000|Overall Study|Reason unknown|0|||
33372231|NCT03580369|62750926|FG001|Overall Study|Reason unknown|0|||
33372232|NCT03580369|62750927|FG002|Overall Study|Reason unknown|1|||
33372233|NCT03580369|62750928|FG003|Overall Study|Reason unknown|0|||
33372234|NCT03580369|62750929|FG004|Overall Study|Reason unknown|0|||
33372235|NCT03580369|62750930|FG005|Overall Study|Reason unknown|0|||
33372236|NCT03580369|62750931|FG006|Overall Study|Reason unknown|0|||
33372237|NCT03580369|62750932|FG007|Overall Study|Reason unknown|0|||
33285615|NCT01236352|62661955|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33285616|NCT01236352|62661956|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33285617|NCT01236352|62661957|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33285618|NCT01236352|62661958|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33285619|NCT01236352|62661959|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
33285620|NCT01236352|62661949|FG000|Overall Study|Lack of response to drug|0|||
33285621|NCT01236352|62661950|FG001|Overall Study|Lack of response to drug|0|||
33285622|NCT01236352|62661951|FG002|Overall Study|Lack of response to drug|0|||
33285623|NCT01236352|62661952|FG003|Overall Study|Lack of response to drug|0|||
33285624|NCT01236352|62661953|FG004|Overall Study|Lack of response to drug|0|||
33285625|NCT01236352|62661954|FG005|Overall Study|Lack of response to drug|0|||
33285626|NCT01236352|62661955|FG006|Overall Study|Lack of response to drug|0|||
33285627|NCT01236352|62661956|FG007|Overall Study|Lack of response to drug|0|||
33285628|NCT01236352|62661957|FG008|Overall Study|Lack of response to drug|0|||
33285629|NCT01236352|62661958|FG009|Overall Study|Lack of response to drug|1|||
33285630|NCT01236352|62661959|FG010|Overall Study|Lack of response to drug|1|||
33285631|NCT01236352|62661949|FG000|Overall Study|Patient transferred to IST|0|||
33285632|NCT01236352|62661950|FG001|Overall Study|Patient transferred to IST|0|||
33285633|NCT01236352|62661951|FG002|Overall Study|Patient transferred to IST|0|||
33285634|NCT01236352|62661952|FG003|Overall Study|Patient transferred to IST|0|||
33285635|NCT01236352|62661953|FG004|Overall Study|Patient transferred to IST|0|||
33285636|NCT01236352|62661954|FG005|Overall Study|Patient transferred to IST|0|||
33285637|NCT01236352|62661955|FG006|Overall Study|Patient transferred to IST|0|||
33285638|NCT01236352|62661956|FG007|Overall Study|Patient transferred to IST|0|||
33285639|NCT01236352|62661957|FG008|Overall Study|Patient transferred to IST|0|||
33285640|NCT01236352|62661958|FG009|Overall Study|Patient transferred to IST|2|||
33285641|NCT01236352|62661959|FG010|Overall Study|Patient transferred to IST|6|||
33285642|NCT01236118|62661986|FG000|Overall Study|Adverse Event|2|||
33285643|NCT01236118|62661987|FG001|Overall Study|Adverse Event|0|||
33285644|NCT01236118|62661988|FG002|Overall Study|Adverse Event|2|||
33285645|NCT01236118|62661986|FG000|Overall Study|Physician Decision|0|||
33285646|NCT01236118|62661987|FG001|Overall Study|Physician Decision|1|||
33285647|NCT01236118|62661988|FG002|Overall Study|Physician Decision|0|||
33285648|NCT01236118|62661986|FG000|Overall Study|Withdrawal by Subject|0|||
33372238|NCT03580369|62750925|FG000|Overall Study|Technical problems|0|||
33372239|NCT03580369|62750926|FG001|Overall Study|Technical problems|0|||
33486448|NCT03255980|62864342|FG001|Overall Study|Adverse Event|1|||
33486449|NCT03255980|62864343|FG002|Overall Study|Adverse Event|0|||
33486450|NCT03255980|62864344|FG003|Overall Study|Adverse Event|1|||
33285649|NCT01236118|62661987|FG001|Overall Study|Withdrawal by Subject|0|||
33285650|NCT01236118|62661988|FG002|Overall Study|Withdrawal by Subject|1|||
33285651|NCT01236001|62661998|FG000|Overall Study|Adverse Event|5|||
33285652|NCT01236001|62661999|FG001|Overall Study|Adverse Event|14|||
33285653|NCT01236001|62661998|FG000|Overall Study|Lack of Efficacy|6|||
33285654|NCT01236001|62661999|FG001|Overall Study|Lack of Efficacy|6|||
33285655|NCT01236001|62661998|FG000|Overall Study|Lost to Follow-up|6|||
33285656|NCT01236001|62661999|FG001|Overall Study|Lost to Follow-up|1|||
33285657|NCT01236001|62661998|FG000|Overall Study|Incompliance|1|||
33372240|NCT03580369|62750927|FG002|Overall Study|Technical problems|0|||
33285658|NCT01236001|62661999|FG001|Overall Study|Incompliance|0|||
33285659|NCT01236001|62661998|FG000|Overall Study|Planned Visit After End of Study|0|||
33285660|NCT01236001|62661999|FG001|Overall Study|Planned Visit After End of Study|1|||
33285661|NCT01229254|62662009|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
33372241|NCT03580369|62750928|FG003|Overall Study|Technical problems|0|||
33486451|NCT03255980|62864341|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
33556230|NCT02342548|62949058|FG002|Overall Study|Protocol Violation|0|||
33556231|NCT02342548|62949056|FG000|Overall Study|Withdrawal by Subject|1|||
33556232|NCT02342548|62949057|FG001|Overall Study|Withdrawal by Subject|3|||
33556233|NCT02342548|62949058|FG002|Overall Study|Withdrawal by Subject|4|||
33556234|NCT02342548|62949056|FG000|Overall Study|Other|1|||
33556235|NCT02342548|62949057|FG001|Overall Study|Other|1|||
33556236|NCT02342548|62949058|FG002|Overall Study|Other|1|||
33556237|NCT03142191|62949071|FG000|Placebo Controlled Period|Death|0|||
33556238|NCT03142191|62949072|FG001|Placebo Controlled Period|Death|1|||
33556239|NCT03142191|62949073|FG002|Placebo Controlled Period|Death|1|||
33556240|NCT03142191|62949074|FG003|Placebo Controlled Period|Death|0|||
33556241|NCT03142191|62949075|FG004|Placebo Controlled Period|Death|0|||
33556242|NCT03142191|62949071|FG000|Placebo Controlled Period|Adverse Event|4|||
33556243|NCT03142191|62949072|FG001|Placebo Controlled Period|Adverse Event|5|||
33556244|NCT03142191|62949073|FG002|Placebo Controlled Period|Adverse Event|1|||
33556245|NCT03142191|62949074|FG003|Placebo Controlled Period|Adverse Event|0|||
33556246|NCT03142191|62949075|FG004|Placebo Controlled Period|Adverse Event|0|||
33556247|NCT03142191|62949071|FG000|Placebo Controlled Period|Progressive Disease|1|||
33556248|NCT03142191|62949072|FG001|Placebo Controlled Period|Progressive Disease|0|||
33556249|NCT03142191|62949073|FG002|Placebo Controlled Period|Progressive Disease|1|||
33556250|NCT03142191|62949074|FG003|Placebo Controlled Period|Progressive Disease|0|||
33556251|NCT03142191|62949075|FG004|Placebo Controlled Period|Progressive Disease|0|||
33556252|NCT03142191|62949071|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
33556253|NCT03142191|62949072|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
33556254|NCT03142191|62949073|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
33556255|NCT03142191|62949074|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
33556256|NCT03142191|62949075|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
33556257|NCT03142191|62949071|FG000|Placebo Controlled Period|Other Reasons|1|||
33556258|NCT03142191|62949072|FG001|Placebo Controlled Period|Other Reasons|0|||
33556259|NCT03142191|62949073|FG002|Placebo Controlled Period|Other Reasons|0|||
33556260|NCT03142191|62949074|FG003|Placebo Controlled Period|Other Reasons|0|||
33556261|NCT03142191|62949075|FG004|Placebo Controlled Period|Other Reasons|0|||
33556262|NCT03142191|62949071|FG000|Active Treatment Extension Period|Death|2|||
33556263|NCT03142191|62949072|FG001|Active Treatment Extension Period|Death|1|||
33285662|NCT01229254|62662010|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
33285663|NCT01229254|62662011|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
33285664|NCT01229254|62662009|FG000|Overall Study|Adverse Event|4|||
33285665|NCT01229254|62662010|FG001|Overall Study|Adverse Event|5|||
33285666|NCT01229254|62662011|FG002|Overall Study|Adverse Event|3|||
33372242|NCT03580369|62750929|FG004|Overall Study|Technical problems|1|||
33486452|NCT03255980|62864342|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
33486453|NCT03255980|62864343|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
33486454|NCT03255980|62864344|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
33486455|NCT03255980|62864341|FG000|Overall Study|Lost to Follow-up|1|||
33486456|NCT03255980|62864342|FG001|Overall Study|Lost to Follow-up|1|||
33486457|NCT03255980|62864343|FG002|Overall Study|Lost to Follow-up|0|||
33486458|NCT03255980|62864344|FG003|Overall Study|Lost to Follow-up|3|||
33486459|NCT03255980|62864341|FG000|Overall Study|Withdrawal by Subject|0|||
33486460|NCT03255980|62864342|FG001|Overall Study|Withdrawal by Subject|1|||
33486461|NCT03255980|62864343|FG002|Overall Study|Withdrawal by Subject|0|||
33486462|NCT03255980|62864344|FG003|Overall Study|Withdrawal by Subject|3|||
33486463|NCT03228212|62864354|FG000|Period 1|Adverse Event|1|||
33486464|NCT03228212|62864355|FG001|Period 1|Adverse Event|0|||
33486465|NCT03228212|62864354|FG000|Period 1|no longer meets eligibility criteria|0|||
33486466|NCT03228212|62864355|FG001|Period 1|no longer meets eligibility criteria|1|||
33486467|NCT03228212|62864354|FG000|Period 2|Lost to Follow-up|1|||
33486468|NCT03228212|62864355|FG001|Period 2|Lost to Follow-up|0|||
33486469|NCT04000815|62864364|FG000|Overall Study|Lost to Follow-up|9|||
33486470|NCT04000815|62864365|FG001|Overall Study|Lost to Follow-up|2|||
33486471|NCT04000815|62864366|FG002|Overall Study|Lost to Follow-up|3|||
33486472|NCT04000815|62864364|FG000|Overall Study|Withdrawal by Subject|4|||
33486473|NCT04000815|62864365|FG001|Overall Study|Withdrawal by Subject|3|||
33486474|NCT04000815|62864366|FG002|Overall Study|Withdrawal by Subject|2|||
33486475|NCT04000815|62864364|FG000|Overall Study|Right ovarian cyst occured|1|||
33486476|NCT04000815|62864365|FG001|Overall Study|Right ovarian cyst occured|0|||
33486477|NCT04000815|62864366|FG002|Overall Study|Right ovarian cyst occured|0|||
33486478|NCT04000815|62864364|FG000|Overall Study|Hypertension occured on follow up|0|||
33486479|NCT04000815|62864365|FG001|Overall Study|Hypertension occured on follow up|0|||
33556264|NCT03142191|62949073|FG002|Active Treatment Extension Period|Death|1|||
33662239|NCT01695239|63092835|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33662240|NCT01695239|63092836|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33662241|NCT01695239|63092837|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33662242|NCT01695239|63092838|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33662243|NCT01695239|63092839|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33662244|NCT01695239|63092840|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33662245|NCT01695239|63092841|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
33662246|NCT01695239|63092842|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
33662247|NCT01695239|63092843|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33662248|NCT01695239|63092844|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33662249|NCT01695239|63092845|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33662250|NCT01695239|63092846|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33372243|NCT03580369|62750930|FG005|Overall Study|Technical problems|0|||
33372244|NCT03580369|62750931|FG006|Overall Study|Technical problems|2|||
33372245|NCT03580369|62750932|FG007|Overall Study|Technical problems|0|||
33372246|NCT03580369|62750925|FG000|Overall Study|Pregnancy|2|||
33372247|NCT03580369|62750926|FG001|Overall Study|Pregnancy|0|||
33372248|NCT03580369|62750927|FG002|Overall Study|Pregnancy|3|||
33372249|NCT03580369|62750928|FG003|Overall Study|Pregnancy|0|||
33372250|NCT03580369|62750929|FG004|Overall Study|Pregnancy|2|||
33662251|NCT01695239|63092833|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
33662252|NCT01695239|63092834|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
33662253|NCT01695239|63092835|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
33662254|NCT01695239|63092836|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
33662255|NCT01695239|63092837|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
33285667|NCT01229254|62662009|FG000|Overall Study|Lost to Follow-up|3|||
33285668|NCT01229254|62662010|FG001|Overall Study|Lost to Follow-up|0|||
33285669|NCT01229254|62662011|FG002|Overall Study|Lost to Follow-up|1|||
33285670|NCT01229254|62662009|FG000|Overall Study|Physician Decision|0|||
33285671|NCT01229254|62662010|FG001|Overall Study|Physician Decision|3|||
33285672|NCT01229254|62662011|FG002|Overall Study|Physician Decision|0|||
33285673|NCT01229254|62662009|FG000|Overall Study|Protocol Violation|4|||
33285674|NCT01229254|62662010|FG001|Overall Study|Protocol Violation|6|||
33285675|NCT01229254|62662011|FG002|Overall Study|Protocol Violation|5|||
33285676|NCT01229254|62662009|FG000|Overall Study|Withdrawal by Subject|1|||
33285677|NCT01229254|62662010|FG001|Overall Study|Withdrawal by Subject|0|||
33285678|NCT01229254|62662011|FG002|Overall Study|Withdrawal by Subject|1|||
33285679|NCT01229254|62662009|FG000|Overall Study|Non-compliance with Study Drug|0|||
33285680|NCT01229254|62662010|FG001|Overall Study|Non-compliance with Study Drug|1|||
33285681|NCT01229254|62662011|FG002|Overall Study|Non-compliance with Study Drug|1|||
33285682|NCT01235728|62662020|FG000|Overall Study|Protocol Violation|0|||
33285683|NCT01235728|62662021|FG001|Overall Study|Protocol Violation|0|||
33285684|NCT01235728|62662022|FG002|Overall Study|Protocol Violation|0|||
33285685|NCT01235728|62662023|FG003|Overall Study|Protocol Violation|1|||
33285686|NCT01235728|62662024|FG004|Overall Study|Protocol Violation|0|||
33285687|NCT01235728|62662025|FG005|Overall Study|Protocol Violation|0|||
33285688|NCT01235728|62662026|FG006|Overall Study|Protocol Violation|0|||
33285689|NCT01235728|62662027|FG007|Overall Study|Protocol Violation|0|||
33285690|NCT01235689|62662037|FG000|Overall Study|Adverse Event|12|||
33285691|NCT01235689|62662038|FG001|Overall Study|Adverse Event|16|||
33285692|NCT01235689|62662037|FG000|Overall Study|Lack of Efficacy|12|||
33372251|NCT03580369|62750930|FG005|Overall Study|Pregnancy|0|||
33486480|NCT04000815|62864366|FG002|Overall Study|Hypertension occured on follow up|2|||
33486481|NCT04000581|62864376|FG000|Overall Study|Withdrawal by Subject|0|||
33486482|NCT04000581|62864377|FG001|Overall Study|Withdrawal by Subject|1|||
33486483|NCT03848403|62864383|FG000|Period 2 (Day 8)|Adverse Event|1|||
33486484|NCT03848403|62864384|FG001|Period 2 (Day 8)|Adverse Event|2|||
33486485|NCT03848403|62864385|FG002|Period 2 (Day 8)|Adverse Event|2|||
33486486|NCT03848403|62864383|FG000|Period 2 (Day 8)|Physician Decision|0|||
33486487|NCT03848403|62864384|FG001|Period 2 (Day 8)|Physician Decision|1|||
33486488|NCT03848403|62864385|FG002|Period 2 (Day 8)|Physician Decision|0|||
33486489|NCT03848403|62864383|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
33486490|NCT03848403|62864384|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
33486491|NCT03848403|62864385|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
33662256|NCT01695239|63092838|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
33285693|NCT01235689|62662038|FG001|Overall Study|Lack of Efficacy|5|||
33285694|NCT01235689|62662037|FG000|Overall Study|Withdrawal by Subject|3|||
33285695|NCT01235689|62662038|FG001|Overall Study|Withdrawal by Subject|4|||
33285696|NCT01235689|62662037|FG000|Overall Study|Lost to Follow-up|1|||
33285697|NCT01235689|62662038|FG001|Overall Study|Lost to Follow-up|2|||
33372252|NCT03580369|62750931|FG006|Overall Study|Pregnancy|0|||
33372253|NCT03580369|62750932|FG007|Overall Study|Pregnancy|0|||
33372254|NCT03580369|62750925|FG000|Overall Study|Lost to Follow-up|2|||
33372255|NCT03580369|62750926|FG001|Overall Study|Lost to Follow-up|0|||
33486492|NCT04054011|62864393|FG000|Overall Study|COVID|3|||
33486493|NCT04053465|62864401|FG000|Overall Study|Withdrawal by Subject|4|||
33285698|NCT01235689|62662037|FG000|Overall Study|Miscellaneous|1|||
33285699|NCT01235689|62662038|FG001|Overall Study|Miscellaneous|5|||
33285700|NCT01229176|62662052|FG000|Overall Study|Withdrawal by Subject|0|||
33285701|NCT01229176|62662053|FG001|Overall Study|Withdrawal by Subject|0|||
33285702|NCT01229176|62662054|FG002|Overall Study|Withdrawal by Subject|0|||
33285703|NCT01229176|62662055|FG003|Overall Study|Withdrawal by Subject|1|||
33285704|NCT01229176|62662056|FG004|Overall Study|Withdrawal by Subject|1|||
33285705|NCT01229176|62662057|FG005|Overall Study|Withdrawal by Subject|1|||
33285706|NCT01229176|62662058|FG006|Overall Study|Withdrawal by Subject|0|||
33285707|NCT01229176|62662059|FG007|Overall Study|Withdrawal by Subject|1|||
33285708|NCT01229176|62662052|FG000|Overall Study|Lost to Follow-up|0|||
33285709|NCT01229176|62662053|FG001|Overall Study|Lost to Follow-up|3|||
33285710|NCT01229176|62662054|FG002|Overall Study|Lost to Follow-up|0|||
33285711|NCT01229176|62662055|FG003|Overall Study|Lost to Follow-up|0|||
33285712|NCT01229176|62662056|FG004|Overall Study|Lost to Follow-up|1|||
33285713|NCT01229176|62662057|FG005|Overall Study|Lost to Follow-up|1|||
33285714|NCT01229176|62662058|FG006|Overall Study|Lost to Follow-up|0|||
33285715|NCT01229176|62662059|FG007|Overall Study|Lost to Follow-up|2|||
33285716|NCT01228747|62662079|FG000|Overall Study|Adverse Event|8|||
33285717|NCT01228747|62662080|FG001|Overall Study|Adverse Event|4|||
33285718|NCT01228747|62662079|FG000|Overall Study|Lack of Efficacy|40|||
33285719|NCT01228747|62662080|FG001|Overall Study|Lack of Efficacy|27|||
33285720|NCT01228747|62662079|FG000|Overall Study|Protocol Violation|6|||
33285721|NCT01228747|62662080|FG001|Overall Study|Protocol Violation|5|||
33285722|NCT01228747|62662079|FG000|Overall Study|Lost to Follow-up|4|||
33285723|NCT01228747|62662080|FG001|Overall Study|Lost to Follow-up|3|||
33285724|NCT01228747|62662079|FG000|Overall Study|Withdrawal by Subject|5|||
33285725|NCT01228747|62662080|FG001|Overall Study|Withdrawal by Subject|1|||
33285726|NCT01228747|62662079|FG000|Overall Study|Other Reason|2|||
33285727|NCT01228747|62662080|FG001|Overall Study|Other Reason|5|||
33285728|NCT01228591|62662086|FG000|Baseline|Lack of Efficacy|1|||
33285729|NCT01228591|62662087|FG001|Baseline|Lack of Efficacy|2|||
33285730|NCT01235338|62662099|FG000|Overall Study|Adverse Event|3|||
33285731|NCT01235338|62662100|FG001|Overall Study|Adverse Event|2|||
33285732|NCT01235338|62662099|FG000|Overall Study|Protocol Violation|1|||
33285733|NCT01235338|62662100|FG001|Overall Study|Protocol Violation|1|||
33285734|NCT01235338|62662099|FG000|Overall Study|Withdrawal by Subject|5|||
33285735|NCT01235338|62662100|FG001|Overall Study|Withdrawal by Subject|0|||
33285736|NCT01235338|62662099|FG000|Overall Study|Exclusion criteria violations|1|||
33285737|NCT01235338|62662100|FG001|Overall Study|Exclusion criteria violations|1|||
33285738|NCT01235338|62662099|FG000|Overall Study|Positive drug screen|0|||
33372256|NCT03580369|62750927|FG002|Overall Study|Lost to Follow-up|2|||
33372257|NCT03580369|62750928|FG003|Overall Study|Lost to Follow-up|0|||
33372258|NCT03580369|62750929|FG004|Overall Study|Lost to Follow-up|3|||
33372259|NCT03580369|62750930|FG005|Overall Study|Lost to Follow-up|0|||
33372260|NCT03580369|62750931|FG006|Overall Study|Lost to Follow-up|1|||
33372261|NCT03580369|62750932|FG007|Overall Study|Lost to Follow-up|0|||
33372262|NCT03580369|62750925|FG000|Overall Study|Physician Decision|4|||
33372263|NCT03580369|62750926|FG001|Overall Study|Physician Decision|0|||
33285739|NCT01235338|62662100|FG001|Overall Study|Positive drug screen|1|||
33372264|NCT03580369|62750927|FG002|Overall Study|Physician Decision|4|||
33372265|NCT03580369|62750928|FG003|Overall Study|Physician Decision|1|||
33285740|NCT01235338|62662099|FG000|Overall Study|Prohibited meds|1|||
33285741|NCT01235338|62662100|FG001|Overall Study|Prohibited meds|0|||
33285742|NCT01234675|62662108|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
33285743|NCT01234675|62662109|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
33285744|NCT01234675|62662108|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
33285745|NCT01234675|62662109|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
33285746|NCT01228318|62662117|FG000|Overall Study|Clinic no show to receive intervention|1|||
33285747|NCT01228318|62662118|FG001|Overall Study|Clinic no show to receive intervention|0|||
33285748|NCT01228318|62662117|FG000|Overall Study|Unable to contact|2|||
33285749|NCT01228318|62662118|FG001|Overall Study|Unable to contact|5|||
33372266|NCT03580369|62750929|FG004|Overall Study|Physician Decision|1|||
33486494|NCT04053465|62864402|FG001|Overall Study|Withdrawal by Subject|4|||
33285750|NCT01228318|62662117|FG000|Overall Study|Moved|0|||
33285751|NCT01228318|62662118|FG001|Overall Study|Moved|2|||
33486495|NCT00143507|62864410|FG000|Overall Study|Death|572|||
33486496|NCT00143507|62864411|FG001|Overall Study|Death|547|||
33285752|NCT01228318|62662117|FG000|Overall Study|Incarcerated|1|||
33285753|NCT01228318|62662118|FG001|Overall Study|Incarcerated|0|||
33285754|NCT01227967|62662126|FG000|Overall Study|Protocol Violation|3|||
33285755|NCT01227967|62662127|FG001|Overall Study|Protocol Violation|1|||
33285756|NCT01227967|62662126|FG000|Overall Study|Death|0|||
33285757|NCT01227967|62662127|FG001|Overall Study|Death|1|||
33372267|NCT03580369|62750930|FG005|Overall Study|Physician Decision|0|||
33372268|NCT03580369|62750931|FG006|Overall Study|Physician Decision|0|||
33372269|NCT03580369|62750932|FG007|Overall Study|Physician Decision|0|||
33372270|NCT03580369|62750925|FG000|Overall Study|Lack of Efficacy|3|||
33486497|NCT00143507|62864410|FG000|Overall Study|Withdrawal by Subject|114|||
33285758|NCT01227967|62662126|FG000|Overall Study|Lost to Follow-up|8|||
33285759|NCT01227967|62662127|FG001|Overall Study|Lost to Follow-up|3|||
33285760|NCT01227967|62662126|FG000|Overall Study|Withdrawal by Subject|4|||
33372271|NCT03580369|62750926|FG001|Overall Study|Lack of Efficacy|0|||
33372272|NCT03580369|62750927|FG002|Overall Study|Lack of Efficacy|7|||
33372273|NCT03580369|62750928|FG003|Overall Study|Lack of Efficacy|0|||
33285761|NCT01227967|62662127|FG001|Overall Study|Withdrawal by Subject|3|||
33285762|NCT01227967|62662126|FG000|Overall Study|Physician Decision|0|||
33285763|NCT01227967|62662127|FG001|Overall Study|Physician Decision|1|||
33285764|NCT01227967|62662126|FG000|Overall Study|Never Started Treatment|0|||
33285765|NCT01227967|62662127|FG001|Overall Study|Never Started Treatment|4|||
33285766|NCT01227967|62662126|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
33285767|NCT01227967|62662127|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
33285768|NCT01227928|62662135|FG000|Overall Study|Lost to Follow-up|4|||
33285769|NCT01227928|62662136|FG001|Overall Study|Lost to Follow-up|2|||
33285770|NCT01227928|62662135|FG000|Overall Study|Withdrawal by Subject|4|||
33285771|NCT01227928|62662136|FG001|Overall Study|Withdrawal by Subject|3|||
33285772|NCT01227928|62662135|FG000|Overall Study|Death|14|||
33372274|NCT03580369|62750929|FG004|Overall Study|Lack of Efficacy|2|||
33372275|NCT03580369|62750930|FG005|Overall Study|Lack of Efficacy|0|||
33372276|NCT03580369|62750931|FG006|Overall Study|Lack of Efficacy|3|||
33372277|NCT03580369|62750932|FG007|Overall Study|Lack of Efficacy|0|||
33372278|NCT03580369|62750925|FG000|Overall Study|Protocol Violation|6|||
33372279|NCT03580369|62750926|FG001|Overall Study|Protocol Violation|0|||
33372280|NCT03580369|62750927|FG002|Overall Study|Protocol Violation|6|||
33372281|NCT03580369|62750928|FG003|Overall Study|Protocol Violation|1|||
33372282|NCT03580369|62750929|FG004|Overall Study|Protocol Violation|8|||
33372283|NCT03580369|62750930|FG005|Overall Study|Protocol Violation|2|||
33372284|NCT03580369|62750931|FG006|Overall Study|Protocol Violation|1|||
33372285|NCT03580369|62750932|FG007|Overall Study|Protocol Violation|0|||
33372286|NCT03580369|62750925|FG000|Overall Study|Adverse Event|7|||
33372287|NCT03580369|62750926|FG001|Overall Study|Adverse Event|0|||
33372288|NCT03580369|62750927|FG002|Overall Study|Adverse Event|14|||
33372289|NCT03580369|62750928|FG003|Overall Study|Adverse Event|1|||
33372290|NCT03580369|62750929|FG004|Overall Study|Adverse Event|6|||
33372291|NCT03580369|62750930|FG005|Overall Study|Adverse Event|0|||
33372292|NCT03580369|62750931|FG006|Overall Study|Adverse Event|1|||
33372293|NCT03580369|62750932|FG007|Overall Study|Adverse Event|0|||
33372294|NCT03580369|62750925|FG000|Overall Study|Withdrawal by Subject|19|||
33372295|NCT03580369|62750926|FG001|Overall Study|Withdrawal by Subject|0|||
33372296|NCT03580369|62750927|FG002|Overall Study|Withdrawal by Subject|17|||
33372297|NCT03580369|62750928|FG003|Overall Study|Withdrawal by Subject|0|||
33372298|NCT03580369|62750929|FG004|Overall Study|Withdrawal by Subject|16|||
33372299|NCT03580369|62750930|FG005|Overall Study|Withdrawal by Subject|1|||
33285773|NCT01227928|62662136|FG001|Overall Study|Death|12|||
33285774|NCT01227889|62662144|FG000|Randomized Phase (RP)|Adverse Event|13|||
33285775|NCT01227889|62662145|FG001|Randomized Phase (RP)|Adverse Event|0|||
33285776|NCT01227889|62662144|FG000|Randomized Phase (RP)|Physician Decision|13|||
33285777|NCT01227889|62662145|FG001|Randomized Phase (RP)|Physician Decision|5|||
33285778|NCT01227889|62662144|FG000|Randomized Phase (RP)|Progressive Disease|135|||
33372300|NCT03580369|62750931|FG006|Overall Study|Withdrawal by Subject|7|||
33285779|NCT01227889|62662145|FG001|Randomized Phase (RP)|Progressive Disease|52|||
33285780|NCT01227889|62662144|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
33285781|NCT01227889|62662145|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
33285782|NCT01227889|62662144|FG000|Randomized Phase (RP)|Missing|1|||
33285783|NCT01227889|62662145|FG001|Randomized Phase (RP)|Missing|3|||
33285784|NCT01227889|62662144|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
33285785|NCT01227889|62662145|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
33285786|NCT01227889|62662144|FG000|Crossover Phase|Adverse Event|0|||
33285787|NCT01227889|62662145|FG001|Crossover Phase|Adverse Event|1|||
33285788|NCT01227889|62662144|FG000|Crossover Phase|Physician Decision|0|||
33285789|NCT01227889|62662145|FG001|Crossover Phase|Physician Decision|3|||
33372301|NCT03580369|62750932|FG007|Overall Study|Withdrawal by Subject|0|||
33372302|NCT03215810|62750978|FG000|Overall Study|Still responding to nivolumab|1|||
33372303|NCT03215810|62750978|FG000|Overall Study|Insufficient TIL growth|1|||
33372304|NCT03215810|62750978|FG000|Overall Study|Decline in performance status|1|||
33372305|NCT03215810|62750978|FG000|Overall Study|Withdrawal by Subject|1|||
33372306|NCT02677922|62751017|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
33372307|NCT02677922|62751018|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
33285790|NCT01227889|62662144|FG000|Crossover Phase|Progressive Disease|0|||
33285791|NCT01227889|62662145|FG001|Crossover Phase|Progressive Disease|31|||
33285792|NCT01227889|62662144|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
33372308|NCT02677922|62751019|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
33372309|NCT02677922|62751020|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
33372310|NCT02677922|62751021|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
33285793|NCT01227889|62662145|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
33372311|NCT02677922|62751022|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
33285794|NCT01227889|62662144|FG000|Crossover Phase|Withdrawal by Subject|0|||
33372312|NCT02677922|62751017|FG000|Treatment Period|Adverse Event|0|||
33372313|NCT02677922|62751018|FG001|Treatment Period|Adverse Event|0|||
33285795|NCT01227889|62662145|FG001|Crossover Phase|Withdrawal by Subject|1|||
33285796|NCT01227577|62662159|FG000|Overall Study|Protocol deviation|3|||
33285797|NCT01227577|62662159|FG000|Overall Study|Death|3|||
33285798|NCT01227577|62662159|FG000|Overall Study|Administrative problems|2|||
33285799|NCT01227577|62662159|FG000|Overall Study|Lost to Follow-up|1|||
33285800|NCT01227577|62662159|FG000|Overall Study|Withdrawal by Subject|4|||
33285801|NCT01227577|62662159|FG000|Overall Study|Lack of Efficacy|5|||
33285802|NCT01227577|62662159|FG000|Overall Study|Adverse Event|17|||
33285803|NCT01227421|62662179|FG000|Overall Study|Lost to Follow-up|6|||
33285804|NCT01227421|62662180|FG001|Overall Study|Lost to Follow-up|7|||
33285805|NCT01227421|62662181|FG002|Overall Study|Lost to Follow-up|5|||
33285806|NCT01227421|62662179|FG000|Overall Study|Adverse Event|2|||
33285807|NCT01227421|62662180|FG001|Overall Study|Adverse Event|7|||
33285808|NCT01227421|62662181|FG002|Overall Study|Adverse Event|2|||
33285809|NCT01227421|62662179|FG000|Overall Study|Withdrawal by Subject|1|||
33285810|NCT01227421|62662180|FG001|Overall Study|Withdrawal by Subject|2|||
33285811|NCT01227421|62662181|FG002|Overall Study|Withdrawal by Subject|1|||
33285812|NCT01227421|62662179|FG000|Overall Study|Protocol Violation|1|||
33285813|NCT01227421|62662180|FG001|Overall Study|Protocol Violation|1|||
33285814|NCT01227421|62662181|FG002|Overall Study|Protocol Violation|2|||
33285815|NCT01227421|62662179|FG000|Overall Study|Randomized in error|1|||
33285816|NCT01227421|62662180|FG001|Overall Study|Randomized in error|1|||
33285817|NCT01227421|62662181|FG002|Overall Study|Randomized in error|0|||
33285818|NCT01227265|62662192|FG000|Overall Study|Did Not Receive Treatment|1|||
33285819|NCT01227265|62662193|FG001|Overall Study|Did Not Receive Treatment|2|||
33285820|NCT01227265|62662194|FG002|Overall Study|Did Not Receive Treatment|0|||
33285821|NCT01227265|62662192|FG000|Overall Study|Administrative|1|||
33285822|NCT01227265|62662193|FG001|Overall Study|Administrative|0|||
33285823|NCT01227265|62662194|FG002|Overall Study|Administrative|2|||
33285824|NCT01227265|62662192|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
33285825|NCT01227265|62662193|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
33285826|NCT01227265|62662194|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
33285827|NCT01227265|62662192|FG000|Overall Study|Protocol Violation|2|||
33372314|NCT02677922|62751019|FG002|Treatment Period|Adverse Event|1|||
33486498|NCT00143507|62864411|FG001|Overall Study|Withdrawal by Subject|102|||
33372315|NCT02677922|62751020|FG003|Treatment Period|Adverse Event|3|||
33372316|NCT02677922|62751021|FG004|Treatment Period|Adverse Event|5|||
33372317|NCT02677922|62751022|FG005|Treatment Period|Adverse Event|2|||
33372318|NCT02677922|62751017|FG000|Treatment Period|Progressive Disease|1|||
33372319|NCT02677922|62751018|FG001|Treatment Period|Progressive Disease|1|||
33372320|NCT02677922|62751019|FG002|Treatment Period|Progressive Disease|0|||
33372321|NCT02677922|62751020|FG003|Treatment Period|Progressive Disease|0|||
33372322|NCT02677922|62751021|FG004|Treatment Period|Progressive Disease|8|||
33372323|NCT02677922|62751022|FG005|Treatment Period|Progressive Disease|7|||
33372324|NCT02677922|62751017|FG000|Treatment Period|Lack of Efficacy|0|||
33372325|NCT02677922|62751018|FG001|Treatment Period|Lack of Efficacy|0|||
33372326|NCT02677922|62751019|FG002|Treatment Period|Lack of Efficacy|0|||
33372327|NCT02677922|62751020|FG003|Treatment Period|Lack of Efficacy|1|||
33372328|NCT02677922|62751021|FG004|Treatment Period|Lack of Efficacy|1|||
33372329|NCT02677922|62751022|FG005|Treatment Period|Lack of Efficacy|6|||
33372330|NCT02677922|62751017|FG000|Treatment Period|Withdrawal by Subject|0|||
33372331|NCT02677922|62751018|FG001|Treatment Period|Withdrawal by Subject|0|||
33372332|NCT02677922|62751019|FG002|Treatment Period|Withdrawal by Subject|1|||
33372333|NCT02677922|62751020|FG003|Treatment Period|Withdrawal by Subject|3|||
33372334|NCT02677922|62751021|FG004|Treatment Period|Withdrawal by Subject|5|||
33372335|NCT02677922|62751022|FG005|Treatment Period|Withdrawal by Subject|5|||
33372336|NCT02677922|62751017|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
33372337|NCT02677922|62751018|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
33372338|NCT02677922|62751019|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
33372339|NCT02677922|62751020|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
33372340|NCT02677922|62751021|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
33372341|NCT02677922|62751022|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
33372342|NCT02677922|62751017|FG000|Treatment Period|Disease Relapse|0|||
33372343|NCT02677922|62751018|FG001|Treatment Period|Disease Relapse|0|||
33486499|NCT00143507|62864410|FG000|Overall Study|Lost to Follow-up|1|||
33285828|NCT01227265|62662193|FG001|Overall Study|Protocol Violation|1|||
33285829|NCT01227265|62662194|FG002|Overall Study|Protocol Violation|0|||
33285830|NCT01227265|62662192|FG000|Overall Study|Withdrawal by Subject|7|||
33285831|NCT01227265|62662193|FG001|Overall Study|Withdrawal by Subject|7|||
33285832|NCT01227265|62662194|FG002|Overall Study|Withdrawal by Subject|3|||
33285833|NCT01227265|62662192|FG000|Overall Study|Lost to Follow-up|2|||
33285834|NCT01227265|62662193|FG001|Overall Study|Lost to Follow-up|0|||
33285835|NCT01227265|62662194|FG002|Overall Study|Lost to Follow-up|3|||
33285836|NCT01227265|62662192|FG000|Overall Study|Adverse Event|6|||
33285837|NCT01227265|62662193|FG001|Overall Study|Adverse Event|10|||
33285838|NCT01227265|62662194|FG002|Overall Study|Adverse Event|5|||
33285839|NCT01226095|62662202|FG000|Overall Study|Poor compliance|1|||
33285840|NCT01225822|62662218|FG000|Overall Study|Adverse Event|13|||
33285841|NCT01225822|62662219|FG001|Overall Study|Adverse Event|31|||
33285842|NCT01225822|62662220|FG002|Overall Study|Adverse Event|18|||
33285843|NCT01225822|62662221|FG003|Overall Study|Adverse Event|23|||
33285844|NCT01225822|62662222|FG004|Overall Study|Adverse Event|14|||
33285845|NCT01225822|62662218|FG000|Overall Study|Protocol Violation|6|||
33285846|NCT01225822|62662219|FG001|Overall Study|Protocol Violation|8|||
33285847|NCT01225822|62662220|FG002|Overall Study|Protocol Violation|6|||
33285848|NCT01225822|62662221|FG003|Overall Study|Protocol Violation|7|||
33285849|NCT01225822|62662222|FG004|Overall Study|Protocol Violation|4|||
33285850|NCT01225822|62662218|FG000|Overall Study|Lost to Follow-up|0|||
33285851|NCT01225822|62662219|FG001|Overall Study|Lost to Follow-up|0|||
33285852|NCT01225822|62662220|FG002|Overall Study|Lost to Follow-up|0|||
33285853|NCT01225822|62662221|FG003|Overall Study|Lost to Follow-up|1|||
33285854|NCT01225822|62662222|FG004|Overall Study|Lost to Follow-up|0|||
33285855|NCT01225822|62662218|FG000|Overall Study|Withdrawal by Subject|6|||
33285856|NCT01225822|62662219|FG001|Overall Study|Withdrawal by Subject|7|||
33285857|NCT01225822|62662220|FG002|Overall Study|Withdrawal by Subject|7|||
33285858|NCT01225822|62662221|FG003|Overall Study|Withdrawal by Subject|11|||
33285859|NCT01225822|62662222|FG004|Overall Study|Withdrawal by Subject|6|||
33285860|NCT01225822|62662218|FG000|Overall Study|Other|13|||
33285861|NCT01225822|62662219|FG001|Overall Study|Other|10|||
33285862|NCT01225822|62662220|FG002|Overall Study|Other|7|||
33285863|NCT01225822|62662221|FG003|Overall Study|Other|10|||
33285864|NCT01225822|62662222|FG004|Overall Study|Other|7|||
33285865|NCT01225549|62662237|FG000|Period 4 - Washout|Disallowed medication|0|||
33285866|NCT01225549|62662238|FG001|Period 4 - Washout|Disallowed medication|1|||
33285867|NCT01225549|62662239|FG002|Period 4 - Washout|Disallowed medication|0|||
33285868|NCT01225549|62662240|FG003|Period 4 - Washout|Disallowed medication|0|||
33285869|NCT01225549|62662241|FG004|Period 4 - Washout|Disallowed medication|0|||
33285870|NCT01225549|62662242|FG005|Period 4 - Washout|Disallowed medication|0|||
33285871|NCT01225549|62662243|FG006|Period 4 - Washout|Disallowed medication|0|||
33285872|NCT01225549|62662244|FG007|Period 4 - Washout|Disallowed medication|0|||
33285873|NCT01225549|62662245|FG008|Period 4 - Washout|Disallowed medication|0|||
33285874|NCT01225549|62662246|FG009|Period 4 - Washout|Disallowed medication|0|||
33372344|NCT02677922|62751019|FG002|Treatment Period|Disease Relapse|0|||
33372345|NCT02677922|62751020|FG003|Treatment Period|Disease Relapse|3|||
33372346|NCT02677922|62751021|FG004|Treatment Period|Disease Relapse|6|||
33372347|NCT02677922|62751022|FG005|Treatment Period|Disease Relapse|1|||
33372348|NCT02677922|62751017|FG000|Treatment Period|Allogeneic HSCT|1|||
33372349|NCT02677922|62751018|FG001|Treatment Period|Allogeneic HSCT|0|||
33372350|NCT02677922|62751019|FG002|Treatment Period|Allogeneic HSCT|0|||
33372351|NCT02677922|62751020|FG003|Treatment Period|Allogeneic HSCT|1|||
33372352|NCT02677922|62751021|FG004|Treatment Period|Allogeneic HSCT|4|||
33372353|NCT02677922|62751022|FG005|Treatment Period|Allogeneic HSCT|1|||
33372354|NCT02677922|62751017|FG000|Treatment Period|Other Reasons|0|||
33372355|NCT02677922|62751018|FG001|Treatment Period|Other Reasons|0|||
33372356|NCT02677922|62751019|FG002|Treatment Period|Other Reasons|0|||
33372357|NCT02677922|62751020|FG003|Treatment Period|Other Reasons|1|||
33372358|NCT02677922|62751021|FG004|Treatment Period|Other Reasons|3|||
33372359|NCT02677922|62751022|FG005|Treatment Period|Other Reasons|5|||
33372360|NCT02677922|62751017|FG000|Treatment Period|Death|0|||
33372361|NCT02677922|62751018|FG001|Treatment Period|Death|0|||
33372362|NCT02677922|62751019|FG002|Treatment Period|Death|0|||
33285875|NCT01225549|62662237|FG000|Period 6 - Washout|Disallowed medication|0|||
33372363|NCT02677922|62751020|FG003|Treatment Period|Death|0|||
33556265|NCT03142191|62949074|FG003|Active Treatment Extension Period|Death|1|||
33556266|NCT03142191|62949075|FG004|Active Treatment Extension Period|Death|0|||
33285876|NCT01225549|62662238|FG001|Period 6 - Washout|Disallowed medication|0|||
33285877|NCT01225549|62662239|FG002|Period 6 - Washout|Disallowed medication|0|||
33285878|NCT01225549|62662240|FG003|Period 6 - Washout|Disallowed medication|1|||
33285879|NCT01225549|62662241|FG004|Period 6 - Washout|Disallowed medication|0|||
33285880|NCT01225549|62662242|FG005|Period 6 - Washout|Disallowed medication|0|||
33285881|NCT01225549|62662243|FG006|Period 6 - Washout|Disallowed medication|0|||
33285882|NCT01225549|62662244|FG007|Period 6 - Washout|Disallowed medication|0|||
33372364|NCT02677922|62751021|FG004|Treatment Period|Death|12|||
33372365|NCT02677922|62751022|FG005|Treatment Period|Death|1|||
33285883|NCT01225549|62662245|FG008|Period 6 - Washout|Disallowed medication|0|||
33285884|NCT01225549|62662246|FG009|Period 6 - Washout|Disallowed medication|0|||
33285885|NCT01225159|62662258|FG000|Overall Study|Change operation|1|||
33285886|NCT01225159|62662259|FG001|Overall Study|Change operation|0|||
33285887|NCT01224925|62662267|FG000|Overall Study|Lost to Follow-up|3|||
33285888|NCT01224925|62662268|FG001|Overall Study|Lost to Follow-up|2|||
33285889|NCT01223404|62662276|FG000|First Intervention (1 Day)|Adverse Event|0|||
33372366|NCT02677922|62751017|FG000|Treatment Period|Non-compliance with Study Drug|0|||
33486500|NCT00143507|62864411|FG001|Overall Study|Lost to Follow-up|0|||
33285890|NCT01223404|62662277|FG001|First Intervention (1 Day)|Adverse Event|0|||
33285891|NCT01223404|62662278|FG002|First Intervention (1 Day)|Adverse Event|0|||
33285892|NCT01223404|62662279|FG003|First Intervention (1 Day)|Adverse Event|1|||
33285893|NCT01223404|62662280|FG004|First Intervention (1 Day)|Adverse Event|0|||
33285894|NCT01223404|62662281|FG005|First Intervention (1 Day)|Adverse Event|0|||
33285895|NCT01223404|62662276|FG000|Second Intervention (1 Day)|Adverse Event|1|||
33285896|NCT01223404|62662277|FG001|Second Intervention (1 Day)|Adverse Event|0|||
33285897|NCT01223404|62662278|FG002|Second Intervention (1 Day)|Adverse Event|0|||
33285898|NCT01223404|62662279|FG003|Second Intervention (1 Day)|Adverse Event|0|||
33285899|NCT01223404|62662280|FG004|Second Intervention (1 Day)|Adverse Event|0|||
33285900|NCT01223404|62662281|FG005|Second Intervention (1 Day)|Adverse Event|0|||
33372367|NCT02677922|62751018|FG001|Treatment Period|Non-compliance with Study Drug|0|||
33372368|NCT02677922|62751019|FG002|Treatment Period|Non-compliance with Study Drug|0|||
33372369|NCT02677922|62751020|FG003|Treatment Period|Non-compliance with Study Drug|0|||
33372370|NCT02677922|62751021|FG004|Treatment Period|Non-compliance with Study Drug|1|||
33285901|NCT01223404|62662276|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
33285902|NCT01223404|62662277|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
33285903|NCT01223404|62662278|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
33372371|NCT02677922|62751022|FG005|Treatment Period|Non-compliance with Study Drug|0|||
33372372|NCT02677922|62751017|FG000|Treatment Period|Physician Decision|0|||
33372373|NCT02677922|62751018|FG001|Treatment Period|Physician Decision|0|||
33372374|NCT02677922|62751019|FG002|Treatment Period|Physician Decision|0|||
33372375|NCT02677922|62751020|FG003|Treatment Period|Physician Decision|0|||
33372376|NCT02677922|62751021|FG004|Treatment Period|Physician Decision|0|||
33372377|NCT02677922|62751022|FG005|Treatment Period|Physician Decision|1|||
33285904|NCT01223404|62662279|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
33285905|NCT01223404|62662280|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
33285906|NCT01223404|62662281|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
33285907|NCT01223365|62662329|FG000|Open-label Titration Period|Enrolled but not treated|1|||
33285908|NCT01223365|62662329|FG000|Open-label Titration Period|Adverse Event|23|||
33285909|NCT01223365|62662329|FG000|Open-label Titration Period|Lack of Efficacy|3|||
33285910|NCT01223365|62662329|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
33285911|NCT01223365|62662329|FG000|Open-label Titration Period|Protocol Violation|1|||
33285912|NCT01223365|62662329|FG000|Open-label Titration Period|Lost to Follow-up|2|||
33285913|NCT01223365|62662329|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
33285914|NCT01223365|62662329|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
33285915|NCT01223365|62662329|FG000|Open-label Titration Period|Starting physical therapy|1|||
33285916|NCT01223365|62662329|FG000|Open-label Treatment Period|Adverse Event|39|||
33285917|NCT01223365|62662329|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
33285918|NCT01223365|62662329|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
33285919|NCT01223365|62662329|FG000|Open-label Treatment Period|Protocol Violation|15|||
33285920|NCT01223365|62662329|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
33285921|NCT01223365|62662329|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
33285922|NCT01223365|62662329|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
33285923|NCT01223365|62662329|FG000|Open-label Treatment Period|Moved out of area|2|||
33285924|NCT01223365|62662329|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
33285925|NCT01223365|62662329|FG000|Open-label Treatment Period|"Out of window"|1|||
33285926|NCT01223365|62662329|FG000|Open-label Treatment Period|Starting physical therapy|1|||
33285927|NCT01223365|62662329|FG000|Open-label Treatment Period|Physician Decision|2|||
33285928|NCT01222507|62662338|FG000|Overall Study|Physician Decision|1|||
33285929|NCT01222507|62662338|FG000|Overall Study|Withdrawal by Subject|1|||
33285930|NCT01222078|62662342|FG000|Overall Study|Early termination of the study|1|||
33285931|NCT01221727|62662349|FG000|Overall Study|Physician Decision|2|||
33285932|NCT01221727|62662350|FG001|Overall Study|Physician Decision|0|||
33285933|NCT01221727|62662349|FG000|Overall Study|Withdrawal by Subject|1|||
33285934|NCT01221727|62662350|FG001|Overall Study|Withdrawal by Subject|1|||
33285935|NCT01221181|62662362|FG000|Overall Study|Lost to Follow-up|1|||
33285936|NCT01220557|62662368|FG000|Overall Study|Lost to Follow-up|5|||
33285937|NCT01220557|62662369|FG001|Overall Study|Lost to Follow-up|3|||
33285938|NCT01220557|62662368|FG000|Overall Study|attended less than 6 lessons|1|||
33372378|NCT02677922|62751017|FG000|Treatment Period|Symptomatic Deterioration|0|||
33662257|NCT01695239|63092839|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
33662258|NCT01695239|63092840|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
33285939|NCT01220557|62662369|FG001|Overall Study|attended less than 6 lessons|2|||
33372379|NCT02677922|62751018|FG001|Treatment Period|Symptomatic Deterioration|0|||
33372380|NCT02677922|62751019|FG002|Treatment Period|Symptomatic Deterioration|0|||
33285940|NCT01220401|62662375|FG000|Overall Study|Withdrawal by Subject|2|||
33285941|NCT01220401|62662375|FG000|Overall Study|Protocol Violation|1|||
33285942|NCT01220167|62662382|FG000|Period 3|Urine positive for substance abuse|0|||
33285943|NCT01220167|62662383|FG001|Period 3|Urine positive for substance abuse|1|||
33285944|NCT01220167|62662384|FG002|Period 3|Urine positive for substance abuse|0|||
33285945|NCT01220128|62662397|FG000|Overall Study|Progressive disease|0|||
33285946|NCT01220128|62662398|FG001|Overall Study|Progressive disease|0|||
33285947|NCT01220128|62662399|FG002|Overall Study|Progressive disease|2|||
33285948|NCT01220128|62662400|FG003|Overall Study|Progressive disease|0|||
33285949|NCT01220128|62662401|FG004|Overall Study|Progressive disease|0|||
33285950|NCT01220128|62662402|FG005|Overall Study|Progressive disease|0|||
33285951|NCT01220128|62662403|FG006|Overall Study|Progressive disease|0|||
33285952|NCT01220128|62662397|FG000|Overall Study|Sponsor study termination|0|||
33285953|NCT01220128|62662398|FG001|Overall Study|Sponsor study termination|1|||
33285954|NCT01220128|62662399|FG002|Overall Study|Sponsor study termination|0|||
33285955|NCT01220128|62662400|FG003|Overall Study|Sponsor study termination|0|||
33285956|NCT01220128|62662401|FG004|Overall Study|Sponsor study termination|0|||
33285957|NCT01220128|62662402|FG005|Overall Study|Sponsor study termination|0|||
33285958|NCT01220128|62662403|FG006|Overall Study|Sponsor study termination|1|||
33285959|NCT01220128|62662397|FG000|Overall Study|Adverse event, serious fatal|2|||
33285960|NCT01220128|62662398|FG001|Overall Study|Adverse event, serious fatal|0|||
33285961|NCT01220128|62662399|FG002|Overall Study|Adverse event, serious fatal|0|||
33285962|NCT01220128|62662400|FG003|Overall Study|Adverse event, serious fatal|0|||
33285963|NCT01220128|62662401|FG004|Overall Study|Adverse event, serious fatal|0|||
33285964|NCT01220128|62662402|FG005|Overall Study|Adverse event, serious fatal|0|||
33285965|NCT01220128|62662403|FG006|Overall Study|Adverse event, serious fatal|1|||
33285966|NCT01220128|62662397|FG000|Overall Study|Adverse event, non-fatal|1|||
33285967|NCT01220128|62662398|FG001|Overall Study|Adverse event, non-fatal|0|||
33285968|NCT01220128|62662399|FG002|Overall Study|Adverse event, non-fatal|0|||
33372381|NCT02677922|62751020|FG003|Treatment Period|Symptomatic Deterioration|0|||
33372382|NCT02677922|62751021|FG004|Treatment Period|Symptomatic Deterioration|1|||
33372383|NCT02677922|62751022|FG005|Treatment Period|Symptomatic Deterioration|0|||
33372384|NCT02634710|62751055|FG000|Overall Study|Death|4|||
33372385|NCT02540993|62751070|FG000|Overall Study|Lost to Follow-up|5|||
33372386|NCT02540993|62751071|FG001|Overall Study|Lost to Follow-up|3|||
33285969|NCT01220128|62662400|FG003|Overall Study|Adverse event, non-fatal|0|||
33285970|NCT01220128|62662401|FG004|Overall Study|Adverse event, non-fatal|0|||
33285971|NCT01220128|62662402|FG005|Overall Study|Adverse event, non-fatal|0|||
33285972|NCT01220128|62662403|FG006|Overall Study|Adverse event, non-fatal|3|||
33285973|NCT01220128|62662397|FG000|Overall Study|Other|0|||
33285974|NCT01220128|62662398|FG001|Overall Study|Other|0|||
33285975|NCT01220128|62662399|FG002|Overall Study|Other|1|||
33285976|NCT01220128|62662400|FG003|Overall Study|Other|0|||
33285977|NCT01220128|62662401|FG004|Overall Study|Other|0|||
33285978|NCT01220128|62662402|FG005|Overall Study|Other|0|||
33285979|NCT01220128|62662403|FG006|Overall Study|Other|0|||
33285980|NCT01220128|62662397|FG000|Overall Study|Consent withdrawn by subject|1|||
33285981|NCT01220128|62662398|FG001|Overall Study|Consent withdrawn by subject|0|||
33285982|NCT01220128|62662399|FG002|Overall Study|Consent withdrawn by subject|0|||
33285983|NCT01220128|62662400|FG003|Overall Study|Consent withdrawn by subject|0|||
33285984|NCT01220128|62662401|FG004|Overall Study|Consent withdrawn by subject|0|||
33285985|NCT01220128|62662402|FG005|Overall Study|Consent withdrawn by subject|0|||
33372387|NCT02540993|62751070|FG000|Overall Study|Withdrawal by Subject|4|||
33372388|NCT02540993|62751071|FG001|Overall Study|Withdrawal by Subject|6|||
33372389|NCT02540993|62751070|FG000|Overall Study|GCP violations|33|||
33372390|NCT02540993|62751071|FG001|Overall Study|GCP violations|27|||
33372391|NCT02449239|62751106|FG000|Induction Phase|Lack of Efficacy|64|||
33486501|NCT00143507|62864410|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
33285986|NCT01220128|62662403|FG006|Overall Study|Consent withdrawn by subject|0|||
33285987|NCT01219933|62662420|FG000|Overall Study|Adverse Event|8|||
33285988|NCT01219933|62662420|FG000|Overall Study|No LDA reached|5|||
33285989|NCT01219933|62662420|FG000|Overall Study|No LDA maintained|7|||
33285990|NCT01219933|62662420|FG000|Overall Study|Lost to Follow-up|3|||
33285991|NCT01219933|62662420|FG000|Overall Study|GC free|1|||
33285992|NCT01219933|62662420|FG000|Overall Study|Withdrawal by Subject|5|||
33285993|NCT01219933|62662420|FG000|Overall Study|Protocol Violation|8|||
33285994|NCT01219933|62662420|FG000|Overall Study|Lack of Efficacy|1|||
33285995|NCT01218802|62662427|FG000|Overall Study|Lost to Follow-up|5|||
33372392|NCT02449239|62751106|FG000|Induction Phase|Adverse Event|1|||
33285996|NCT01218802|62662428|FG001|Overall Study|Lost to Follow-up|6|||
33486502|NCT00143507|62864411|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
33285997|NCT01218802|62662427|FG000|Overall Study|Withdrawal by Subject|3|||
33285998|NCT01218802|62662428|FG001|Overall Study|Withdrawal by Subject|10|||
33285999|NCT01218802|62662427|FG000|Overall Study|Adverse Event|0|||
33286000|NCT01218802|62662428|FG001|Overall Study|Adverse Event|2|||
33286001|NCT01218802|62662427|FG000|Overall Study|Incarcerated|2|||
33286002|NCT01218802|62662428|FG001|Overall Study|Incarcerated|0|||
33286003|NCT01218646|62662438|FG000|Overall Study|Adverse Event|0|||
33286004|NCT01218646|62662439|FG001|Overall Study|Adverse Event|0|||
33372393|NCT02449239|62751106|FG000|Induction Phase|Lost to Follow-up|1|||
33372394|NCT02449239|62751106|FG000|Induction Phase|Protocol Violation|1|||
33372395|NCT02449239|62751106|FG000|Induction Phase|Physician Decision|1|||
33286005|NCT01218646|62662440|FG002|Overall Study|Adverse Event|1|||
33286006|NCT01218646|62662441|FG003|Overall Study|Adverse Event|0|||
33286007|NCT01218646|62662438|FG000|Overall Study|Lost to Follow-up|1|||
33286008|NCT01218646|62662439|FG001|Overall Study|Lost to Follow-up|0|||
33286009|NCT01218646|62662440|FG002|Overall Study|Lost to Follow-up|0|||
33286010|NCT01218646|62662441|FG003|Overall Study|Lost to Follow-up|0|||
33286011|NCT01218646|62662438|FG000|Overall Study|Protocol Violation|0|||
33286012|NCT01218646|62662439|FG001|Overall Study|Protocol Violation|0|||
33286013|NCT01218646|62662440|FG002|Overall Study|Protocol Violation|1|||
33286014|NCT01218646|62662441|FG003|Overall Study|Protocol Violation|1|||
33286015|NCT01188772|62662455|FG000|Overall Study|Randomized but Not Treated|0|||
33286016|NCT01188772|62662456|FG001|Overall Study|Randomized but Not Treated|1|||
33286017|NCT01188772|62662457|FG002|Overall Study|Randomized but Not Treated|0|||
33286018|NCT01188772|62662458|FG003|Overall Study|Randomized but Not Treated|0|||
33286019|NCT01188772|62662455|FG000|Overall Study|Adverse Event|0|||
33286020|NCT01188772|62662456|FG001|Overall Study|Adverse Event|1|||
33286021|NCT01188772|62662457|FG002|Overall Study|Adverse Event|2|||
33286022|NCT01188772|62662458|FG003|Overall Study|Adverse Event|0|||
33286023|NCT01188772|62662455|FG000|Overall Study|Lost to Follow-up|4|||
33286024|NCT01188772|62662456|FG001|Overall Study|Lost to Follow-up|1|||
33286025|NCT01188772|62662457|FG002|Overall Study|Lost to Follow-up|1|||
33286026|NCT01188772|62662458|FG003|Overall Study|Lost to Follow-up|1|||
33286027|NCT01188772|62662455|FG000|Overall Study|Non-responder|0|||
33286028|NCT01188772|62662456|FG001|Overall Study|Non-responder|0|||
33286029|NCT01188772|62662457|FG002|Overall Study|Non-responder|3|||
33286030|NCT01188772|62662458|FG003|Overall Study|Non-responder|0|||
33286031|NCT01188772|62662455|FG000|Overall Study|Physician Decision|0|||
33286032|NCT01188772|62662456|FG001|Overall Study|Physician Decision|0|||
33286033|NCT01188772|62662457|FG002|Overall Study|Physician Decision|1|||
33286034|NCT01188772|62662458|FG003|Overall Study|Physician Decision|0|||
33286035|NCT01188772|62662455|FG000|Overall Study|Terminated by Sponsor|0|||
33286036|NCT01188772|62662456|FG001|Overall Study|Terminated by Sponsor|0|||
33286037|NCT01188772|62662457|FG002|Overall Study|Terminated by Sponsor|1|||
33286038|NCT01188772|62662458|FG003|Overall Study|Terminated by Sponsor|0|||
33286039|NCT01188772|62662455|FG000|Overall Study|Treatment Failure|0|||
33286040|NCT01188772|62662456|FG001|Overall Study|Treatment Failure|0|||
33286041|NCT01188772|62662457|FG002|Overall Study|Treatment Failure|1|||
33286042|NCT01188772|62662458|FG003|Overall Study|Treatment Failure|0|||
33286043|NCT01188772|62662455|FG000|Overall Study|Virologic Failure|1|||
33286044|NCT01188772|62662456|FG001|Overall Study|Virologic Failure|0|||
33286045|NCT01188772|62662457|FG002|Overall Study|Virologic Failure|0|||
33286046|NCT01188772|62662458|FG003|Overall Study|Virologic Failure|0|||
33286047|NCT01188772|62662455|FG000|Overall Study|Withdrawal by Subject|0|||
33286048|NCT01188772|62662456|FG001|Overall Study|Withdrawal by Subject|0|||
33286049|NCT01188772|62662457|FG002|Overall Study|Withdrawal by Subject|2|||
33286050|NCT01188772|62662458|FG003|Overall Study|Withdrawal by Subject|0|||
33286051|NCT01188655|62662471|FG000|Overall Study|Lack of Efficacy|1|||
33286052|NCT01188655|62662471|FG000|Overall Study|Lost to Follow-up|1|||
33286053|NCT01188655|62662471|FG000|Overall Study|Other|11|||
33286054|NCT01188538|62662477|FG000|Overall Study|Lost to Follow-up|0|||
33286055|NCT01188538|62662478|FG001|Overall Study|Lost to Follow-up|1|||
33286056|NCT01188343|62662489|FG000|Overall Study|Not vaccinated|0|||
33286057|NCT01188343|62662490|FG001|Overall Study|Not vaccinated|2|||
33286058|NCT01188343|62662491|FG002|Overall Study|Not vaccinated|1|||
33286059|NCT01188343|62662489|FG000|Overall Study|Withdrawal by Subject|1|||
33286060|NCT01188343|62662490|FG001|Overall Study|Withdrawal by Subject|24|||
33286061|NCT01188343|62662491|FG002|Overall Study|Withdrawal by Subject|0|||
33372396|NCT02449239|62751106|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
33372397|NCT02449239|62751106|FG000|Induction Phase|Withdrawal by Subject|1|||
33372398|NCT02449239|62751106|FG000|Maintenance Month 3|Lack of Efficacy|14|||
33286062|NCT01188226|62662502|FG000|Overall Study|Withdrawal by Subject|4|||
33486503|NCT03988803|62864417|FG000|Period 2|Prematurely discontinued from medication|2|||
33286063|NCT01218100|62662520|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
33486504|NCT03988803|62864417|FG000|Period 2|Adverse Event|1|||
33286064|NCT01218100|62662521|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
33372399|NCT02449239|62751106|FG000|Maintenance Month 6|Lack of Efficacy|10|||
33372400|NCT02449239|62751106|FG000|Maintenance Month 6|Adverse Event|2|||
33286065|NCT01218100|62662522|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
33286066|NCT01218100|62662523|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
33286067|NCT01218100|62662520|FG000|Overall Study|Adverse Event|4|||
33486505|NCT00181883|62864425|FG000|Overall Study|Lack of Efficacy|2|||
33286068|NCT01218100|62662521|FG001|Overall Study|Adverse Event|6|||
33286069|NCT01218100|62662522|FG002|Overall Study|Adverse Event|6|||
33286070|NCT01218100|62662523|FG003|Overall Study|Adverse Event|7|||
33286071|NCT01218100|62662520|FG000|Overall Study|Lack of Efficacy|9|||
33286072|NCT01218100|62662521|FG001|Overall Study|Lack of Efficacy|6|||
33286073|NCT01218100|62662522|FG002|Overall Study|Lack of Efficacy|5|||
33286074|NCT01218100|62662523|FG003|Overall Study|Lack of Efficacy|12|||
33372401|NCT02449239|62751106|FG000|Maintenance Month 6|Physician Decision|1|||
33372402|NCT02449239|62751106|FG000|Maintenance Month 9|Lack of Efficacy|2|||
33372403|NCT02449239|62751106|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
33372404|NCT02449239|62751106|FG000|Maintenance Month 12|Lack of Efficacy|5|||
33372405|NCT02449239|62751106|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
33372406|NCT02449239|62751106|FG000|Maintenance Month 12|Subject moved from area|1|||
33372407|NCT02449239|62751106|FG000|Maintenance Month 15|Lack of Efficacy|1|||
33372408|NCT02449239|62751106|FG000|Maintenance Month 21|Lack of Efficacy|1|||
33372409|NCT02449239|62751106|FG000|Maintenance Month 21|Sponsor decision|1|||
33372410|NCT01292928|62751110|FG000|Overall Study|Death|8|||
33372411|NCT01292928|62751110|FG000|Overall Study|Withdrawal by Subject|8|||
33372412|NCT01292928|62751110|FG000|Overall Study|Lost to Follow-up|6|||
33372413|NCT01292928|62751110|FG000|Overall Study|Physician Decision|2|||
33372414|NCT01012817|62751156|FG000|Overall Study|Withdrawal by Subject|0|||
33372415|NCT01012817|62751157|FG001|Overall Study|Withdrawal by Subject|0|||
33372416|NCT01012817|62751158|FG002|Overall Study|Withdrawal by Subject|0|||
33286075|NCT01218100|62662520|FG000|Overall Study|Protocol Violation|0|||
33286076|NCT01218100|62662521|FG001|Overall Study|Protocol Violation|0|||
33372417|NCT01012817|62751159|FG003|Overall Study|Withdrawal by Subject|1|||
33372418|NCT01012817|62751160|FG004|Overall Study|Withdrawal by Subject|0|||
33286077|NCT01218100|62662522|FG002|Overall Study|Protocol Violation|1|||
33286078|NCT01218100|62662523|FG003|Overall Study|Protocol Violation|1|||
33286079|NCT01218100|62662520|FG000|Overall Study|Withdrawal by Subject|5|||
33286080|NCT01218100|62662521|FG001|Overall Study|Withdrawal by Subject|2|||
33286081|NCT01218100|62662522|FG002|Overall Study|Withdrawal by Subject|6|||
33286082|NCT01218100|62662523|FG003|Overall Study|Withdrawal by Subject|7|||
33286083|NCT01218100|62662520|FG000|Overall Study|Lost to Follow-up|3|||
33286084|NCT01218100|62662521|FG001|Overall Study|Lost to Follow-up|8|||
33286085|NCT01218100|62662522|FG002|Overall Study|Lost to Follow-up|2|||
33286086|NCT01218100|62662523|FG003|Overall Study|Lost to Follow-up|1|||
33286087|NCT01218100|62662520|FG000|Overall Study|Other Reason|2|||
33286088|NCT01218100|62662521|FG001|Overall Study|Other Reason|2|||
33372419|NCT01012817|62751161|FG005|Overall Study|Withdrawal by Subject|0|||
33372420|NCT01012817|62751162|FG006|Overall Study|Withdrawal by Subject|0|||
33372421|NCT01012817|62751163|FG007|Overall Study|Withdrawal by Subject|1|||
33372422|NCT01012817|62751164|FG008|Overall Study|Withdrawal by Subject|0|||
33372423|NCT01012817|62751165|FG009|Overall Study|Withdrawal by Subject|0|||
33372424|NCT01012817|62751166|FG010|Overall Study|Withdrawal by Subject|1|||
33372425|NCT01012817|62751167|FG011|Overall Study|Withdrawal by Subject|1|||
33372426|NCT01012817|62751168|FG012|Overall Study|Withdrawal by Subject|0|||
33372427|NCT01012817|62751169|FG013|Overall Study|Withdrawal by Subject|1|||
33372428|NCT01012817|62751156|FG000|Overall Study|Adverse Event|0|||
33372429|NCT01012817|62751157|FG001|Overall Study|Adverse Event|0|||
33486506|NCT00181883|62864425|FG000|Overall Study|Treatment Limiting AEs|3|||
33486507|NCT00181883|62864425|FG000|Overall Study|Withdrawal by Subject|4|||
33286089|NCT01218100|62662522|FG002|Overall Study|Other Reason|6|||
33286090|NCT01218100|62662523|FG003|Overall Study|Other Reason|4|||
33286091|NCT01187953|62662569|FG000|Overall Study|Death|11|||
33286092|NCT01187953|62662570|FG001|Overall Study|Death|13|||
33286093|NCT01187953|62662569|FG000|Overall Study|Adverse Event|1|||
33286094|NCT01187953|62662570|FG001|Overall Study|Adverse Event|2|||
33286095|NCT01187953|62662569|FG000|Overall Study|Lost to Follow-up|0|||
33286096|NCT01187953|62662570|FG001|Overall Study|Lost to Follow-up|3|||
33286097|NCT01187953|62662569|FG000|Overall Study|Withdrawal by Subject|3|||
33286098|NCT01187953|62662570|FG001|Overall Study|Withdrawal by Subject|3|||
33486508|NCT00181883|62864425|FG000|Overall Study|Lost to Follow-up|1|||
33286099|NCT01217944|62662586|FG000|Overall Study|Protocol Violation|1|||
33286100|NCT01217944|62662587|FG001|Overall Study|Protocol Violation|1|||
33286101|NCT01217944|62662588|FG002|Overall Study|Protocol Violation|0|||
33286102|NCT01217944|62662586|FG000|Overall Study|Lost to Follow-up|3|||
33286103|NCT01217944|62662587|FG001|Overall Study|Lost to Follow-up|1|||
33286104|NCT01217944|62662588|FG002|Overall Study|Lost to Follow-up|0|||
33286105|NCT01217944|62662586|FG000|Overall Study|Withdrawal by Subject|1|||
33286106|NCT01217944|62662587|FG001|Overall Study|Withdrawal by Subject|2|||
33286107|NCT01217944|62662588|FG002|Overall Study|Withdrawal by Subject|0|||
33286108|NCT01217944|62662586|FG000|Overall Study|Lack of Efficacy|1|||
33372430|NCT01012817|62751158|FG002|Overall Study|Adverse Event|0|||
33372431|NCT01012817|62751159|FG003|Overall Study|Adverse Event|0|||
33372432|NCT01012817|62751160|FG004|Overall Study|Adverse Event|0|||
33372433|NCT01012817|62751161|FG005|Overall Study|Adverse Event|1|||
33486509|NCT00180713|62864431|FG000|Overall Study|Withdrawal by Subject|2|||
33486510|NCT00180713|62864432|FG001|Overall Study|Withdrawal by Subject|0|||
33286109|NCT01217944|62662587|FG001|Overall Study|Lack of Efficacy|0|||
33286110|NCT01217944|62662588|FG002|Overall Study|Lack of Efficacy|0|||
33286111|NCT01187446|62662600|FG000|Overall Study|Patient started non-protocol therapy|0|||
33286112|NCT01187446|62662601|FG001|Overall Study|Patient started non-protocol therapy|1|||
33372434|NCT01012817|62751162|FG006|Overall Study|Adverse Event|0|||
33372435|NCT01012817|62751163|FG007|Overall Study|Adverse Event|0|||
33286113|NCT01187407|62662611|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
33286114|NCT01187407|62662612|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33286115|NCT01187407|62662613|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33286116|NCT01187407|62662614|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33286117|NCT01187407|62662615|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33372436|NCT01012817|62751164|FG008|Overall Study|Adverse Event|0|||
33372437|NCT01012817|62751165|FG009|Overall Study|Adverse Event|0|||
33372438|NCT01012817|62751166|FG010|Overall Study|Adverse Event|1|||
33372439|NCT01012817|62751167|FG011|Overall Study|Adverse Event|0|||
33372440|NCT01012817|62751168|FG012|Overall Study|Adverse Event|0|||
33286118|NCT01187407|62662611|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
33556267|NCT03142191|62949071|FG000|Active Treatment Extension Period|Adverse Event|6|||
33372441|NCT01012817|62751169|FG013|Overall Study|Adverse Event|1|||
33372442|NCT00581828|62751199|FG000|Overall Study|Protocol Violation|1|||
33372443|NCT00220337|62751248|FG000|Overall Study|Adverse Event|70|||
33372444|NCT00220337|62751248|FG000|Overall Study|Lack of Efficacy|17|||
33372445|NCT00220337|62751248|FG000|Overall Study|Withdrawal by Subject|68|||
33372446|NCT00220337|62751248|FG000|Overall Study|Protocol Violation|2|||
33372447|NCT00220337|62751248|FG000|Overall Study|Lost to Follow-up|5|||
33372448|NCT00220337|62751248|FG000|Overall Study|Other|12|||
33372449|NCT00220337|62751248|FG000|Overall Study|Unsatisfactory compliance|5|||
33372450|NCT00576316|62751264|FG000|Overall Study|Adverse Event|9|||
33372451|NCT00576316|62751264|FG000|Overall Study|Withdrawal by Subject|2|||
33372452|NCT00576316|62751264|FG000|Overall Study|Protocol Violation|9|||
33372453|NCT00823134|62751268|FG000|Overall Study|Invalid measurement|1|||
33372454|NCT00831792|62751273|FG000|Overall Study|Not Eligible|3|||
33372455|NCT00831792|62751273|FG000|Overall Study|Adverse Event|1|||
33372456|NCT00831792|62751273|FG000|Overall Study|Death|1|||
33372457|NCT00831792|62751273|FG000|Overall Study|Lack of Efficacy|1|||
33372458|NCT00575380|62751279|FG000|Overall Study|Withdrawal by Subject|1|||
33372459|NCT00575380|62751280|FG001|Overall Study|Withdrawal by Subject|0|||
33372460|NCT00575380|62751279|FG000|Overall Study|Adverse Event|0|||
33372461|NCT00575380|62751280|FG001|Overall Study|Adverse Event|1|||
33372462|NCT00575380|62751279|FG000|Overall Study|Various|0|||
33486511|NCT00180713|62864431|FG000|Overall Study|Adverse Event|3|||
33486512|NCT00180713|62864432|FG001|Overall Study|Adverse Event|3|||
33556268|NCT03142191|62949072|FG001|Active Treatment Extension Period|Adverse Event|5|||
33556269|NCT03142191|62949073|FG002|Active Treatment Extension Period|Adverse Event|4|||
33556270|NCT03142191|62949074|FG003|Active Treatment Extension Period|Adverse Event|1|||
33556271|NCT03142191|62949075|FG004|Active Treatment Extension Period|Adverse Event|0|||
33556272|NCT03142191|62949071|FG000|Active Treatment Extension Period|Progressive Disease|10|||
33556273|NCT03142191|62949072|FG001|Active Treatment Extension Period|Progressive Disease|5|||
33556274|NCT03142191|62949073|FG002|Active Treatment Extension Period|Progressive Disease|4|||
33556275|NCT03142191|62949074|FG003|Active Treatment Extension Period|Progressive Disease|1|||
33556276|NCT03142191|62949075|FG004|Active Treatment Extension Period|Progressive Disease|2|||
33556277|NCT03142191|62949071|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
33556278|NCT03142191|62949072|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
33286119|NCT01187407|62662612|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33286120|NCT01187407|62662613|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33286121|NCT01187407|62662614|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33286122|NCT01187407|62662615|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33286123|NCT01187407|62662611|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
33286124|NCT01187407|62662612|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33286125|NCT01187407|62662613|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33372463|NCT00575380|62751280|FG001|Overall Study|Various|2|||
33372464|NCT00840996|62751288|FG000|Overall Study|Withdrawal by Subject|1|||
33486513|NCT03988023|62864440|FG000|Overall Study|Non-compliance|3|||
33486514|NCT03988023|62864441|FG001|Overall Study|Non-compliance|0|||
33486515|NCT03988023|62864440|FG000|Overall Study|Withdrawal by Subject|39|||
33486516|NCT03988023|62864441|FG001|Overall Study|Withdrawal by Subject|37|||
33486517|NCT03988023|62864440|FG000|Overall Study|Adverse Event|0|||
33486518|NCT03988023|62864441|FG001|Overall Study|Adverse Event|2|||
33486519|NCT03988023|62864440|FG000|Overall Study|Physician Decision|0|||
33486520|NCT03988023|62864441|FG001|Overall Study|Physician Decision|1|||
33486521|NCT03988023|62864440|FG000|Overall Study|Lost to Follow-up|5|||
33486522|NCT03988023|62864441|FG001|Overall Study|Lost to Follow-up|8|||
33556279|NCT03142191|62949073|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
33486523|NCT03988023|62864440|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
33486524|NCT03988023|62864441|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
33372465|NCT00840996|62751289|FG001|Overall Study|Withdrawal by Subject|0|||
33372466|NCT00680914|62751297|FG000|Overall Study|Consent withdrawal|6|||
33372467|NCT00680914|62751298|FG001|Overall Study|Consent withdrawal|3|||
33372468|NCT00680914|62751297|FG000|Overall Study|Lost to Follow-up|4|||
33486525|NCT03988023|62864440|FG000|Overall Study|Lack of Efficacy|3|||
33372469|NCT00680914|62751298|FG001|Overall Study|Lost to Follow-up|0|||
33556280|NCT03142191|62949074|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
33286126|NCT01187407|62662614|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33286127|NCT01187407|62662615|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33286128|NCT01187407|62662611|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
33286129|NCT01187407|62662612|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33286130|NCT01187407|62662613|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33286131|NCT01187407|62662614|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33286132|NCT01187407|62662615|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33286133|NCT01187407|62662611|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
33286134|NCT01187407|62662612|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33286135|NCT01187407|62662613|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33286136|NCT01187407|62662614|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33286137|NCT01187407|62662615|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33286138|NCT01187407|62662611|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
33286139|NCT01187407|62662612|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33286140|NCT01187407|62662613|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33286141|NCT01187407|62662614|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33286142|NCT01187407|62662615|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33286143|NCT01187407|62662611|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
33286144|NCT01187407|62662612|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33286145|NCT01187407|62662613|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33286146|NCT01187407|62662614|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33286147|NCT01187407|62662615|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33286148|NCT01187407|62662611|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
33286149|NCT01187407|62662612|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
33286150|NCT01187407|62662613|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
33286151|NCT01187407|62662614|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
33286152|NCT01187407|62662615|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
33286153|NCT01187407|62662611|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
33286154|NCT01187407|62662612|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
33286155|NCT01187407|62662613|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
33286156|NCT01187407|62662614|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
33286157|NCT01187407|62662615|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
33286158|NCT01187407|62662611|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
33372470|NCT00680914|62751297|FG000|Overall Study|serious adverse event (SAE)|0|||
33372471|NCT00680914|62751298|FG001|Overall Study|serious adverse event (SAE)|1|||
33372472|NCT00680836|62751306|FG000|Overall Study|Withdrawal by Subject|3|||
33372473|NCT00680836|62751307|FG001|Overall Study|Withdrawal by Subject|0|||
33372474|NCT00680836|62751306|FG000|Overall Study|Lost to Follow-up|3|||
33372475|NCT00680836|62751307|FG001|Overall Study|Lost to Follow-up|1|||
33372476|NCT00680836|62751306|FG000|Overall Study|Physician Decision|2|||
33372477|NCT00680836|62751307|FG001|Overall Study|Physician Decision|1|||
33372478|NCT00679432|62751318|FG000|Overall Study|Adverse Event|5|||
33372479|NCT00679432|62751319|FG001|Overall Study|Adverse Event|6|||
33372480|NCT00679432|62751320|FG002|Overall Study|Adverse Event|10|||
33372481|NCT00679432|62751321|FG003|Overall Study|Adverse Event|7|||
33372482|NCT00679432|62751318|FG000|Overall Study|Protocol Violation|1|||
33372483|NCT00679432|62751319|FG001|Overall Study|Protocol Violation|1|||
33372484|NCT00679432|62751320|FG002|Overall Study|Protocol Violation|2|||
33372485|NCT00679432|62751321|FG003|Overall Study|Protocol Violation|1|||
33372486|NCT00679432|62751318|FG000|Overall Study|Withdrawal by Subject|8|||
33372487|NCT00679432|62751319|FG001|Overall Study|Withdrawal by Subject|11|||
33372488|NCT00679432|62751320|FG002|Overall Study|Withdrawal by Subject|10|||
33372489|NCT00679432|62751321|FG003|Overall Study|Withdrawal by Subject|9|||
33372490|NCT00679432|62751318|FG000|Overall Study|Lost to Follow-up|1|||
33372491|NCT00679432|62751319|FG001|Overall Study|Lost to Follow-up|5|||
33372492|NCT00679432|62751320|FG002|Overall Study|Lost to Follow-up|4|||
33372493|NCT00679432|62751321|FG003|Overall Study|Lost to Follow-up|2|||
33372494|NCT00679432|62751318|FG000|Overall Study|Physician Decision|3|||
33372495|NCT00679432|62751319|FG001|Overall Study|Physician Decision|2|||
33372496|NCT00679432|62751320|FG002|Overall Study|Physician Decision|2|||
33372497|NCT00679432|62751321|FG003|Overall Study|Physician Decision|2|||
33372498|NCT00679432|62751318|FG000|Overall Study|Sponsor decision|1|||
33372499|NCT00679432|62751319|FG001|Overall Study|Sponsor decision|0|||
33372500|NCT00679432|62751320|FG002|Overall Study|Sponsor decision|0|||
33372501|NCT00679432|62751321|FG003|Overall Study|Sponsor decision|0|||
33372502|NCT00679432|62751318|FG000|Overall Study|Lack of Efficacy|13|||
33372503|NCT00679432|62751319|FG001|Overall Study|Lack of Efficacy|9|||
33372504|NCT00679432|62751320|FG002|Overall Study|Lack of Efficacy|14|||
33372505|NCT00679432|62751321|FG003|Overall Study|Lack of Efficacy|8|||
33372506|NCT00679432|62751318|FG000|Overall Study|Infectious colitis, normal histology|5|||
33486526|NCT03988023|62864441|FG001|Overall Study|Lack of Efficacy|1|||
33286159|NCT01187407|62662612|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
33286160|NCT01187407|62662613|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
33286161|NCT01187407|62662614|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
33286162|NCT01187407|62662615|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
33372507|NCT00679432|62751319|FG001|Overall Study|Infectious colitis, normal histology|4|||
33372508|NCT00679432|62751320|FG002|Overall Study|Infectious colitis, normal histology|8|||
33372509|NCT00679432|62751321|FG003|Overall Study|Infectious colitis, normal histology|3|||
33372510|NCT00679432|62751318|FG000|Overall Study|Randomization error, return to prior Rx|0|||
33372511|NCT00679432|62751319|FG001|Overall Study|Randomization error, return to prior Rx|0|||
33372512|NCT00679432|62751320|FG002|Overall Study|Randomization error, return to prior Rx|3|||
33286163|NCT01187407|62662611|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
33286164|NCT01187407|62662612|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
33286165|NCT01187407|62662613|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
33286166|NCT01187407|62662614|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
33286167|NCT01187407|62662615|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
33286168|NCT01187407|62662611|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
33286169|NCT01187407|62662612|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
33286170|NCT01187407|62662613|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
33286171|NCT01187407|62662614|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
33286172|NCT01187407|62662615|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
33286173|NCT01187407|62662611|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
33286174|NCT01187407|62662612|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
33286175|NCT01187407|62662613|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
33286176|NCT01187407|62662614|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
33286177|NCT01187407|62662615|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
33286178|NCT01187407|62662611|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
33286179|NCT01187407|62662612|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
33286180|NCT01187407|62662613|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
33286181|NCT01187407|62662614|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
33286182|NCT01187407|62662615|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
33286183|NCT01186978|62662632|FG000|Overall Study|Withdrawal by Subject|1|||
33286184|NCT01186939|62662636|FG000|Overall Study|Death|7|||
33286185|NCT01186939|62662636|FG000|Overall Study|Withdrawal by Subject|2|||
33286186|NCT01186939|62662636|FG000|Overall Study|No longer receiving clinical benefit|17|||
33286187|NCT01186939|62662636|FG000|Overall Study|Program closed|5|||
33286188|NCT01186939|62662636|FG000|Overall Study|Sponsor decision|4|||
33286189|NCT01186939|62662636|FG000|Overall Study|Started additional treatment|1|||
33286190|NCT01186939|62662636|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
33286191|NCT01186939|62662636|FG000|Overall Study|Myocardial infarction|1|||
33286192|NCT01186939|62662636|FG000|Overall Study|Bone marrow transplant|1|||
33286193|NCT01186939|62662636|FG000|Overall Study|Transformation to AML|1|||
33286194|NCT04938648|62662661|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
33286195|NCT04938648|62662662|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
33286196|NCT04938648|62662661|FG000|Overall Study|Patient too ill|0|||
33286197|NCT04938648|62662662|FG001|Overall Study|Patient too ill|1|||
33286198|NCT04938648|62662661|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
33286199|NCT04938648|62662662|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
33286200|NCT04938648|62662661|FG000|Overall Study|Patient did not have memory problems|1|||
33286201|NCT04938648|62662662|FG001|Overall Study|Patient did not have memory problems|1|||
33286202|NCT04938648|62662661|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
33286203|NCT04938648|62662662|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
33286204|NCT04938648|62662661|FG000|Overall Study|Care partner could not be reached|0|||
33286205|NCT04938648|62662662|FG001|Overall Study|Care partner could not be reached|1|||
33286206|NCT04938648|62662661|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
33286207|NCT04938648|62662662|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
33286208|NCT04938648|62662661|FG000|Overall Study|Withdrawal by Subject|2|||
33286209|NCT04938648|62662662|FG001|Overall Study|Withdrawal by Subject|1|||
33286210|NCT04564092|62662669|FG000|Overall Study|Withdrawal by Subject|1|||
33372513|NCT00679432|62751321|FG003|Overall Study|Randomization error, return to prior Rx|0|||
33486527|NCT03988023|62864440|FG000|Overall Study|COVID-19 pandemic|225|||
33486528|NCT03988023|62864441|FG001|Overall Study|COVID-19 pandemic|227|||
33486529|NCT04052139|62864450|FG000|Overall Study|Lost to Follow-up|2|||
33486530|NCT04052139|62864451|FG001|Overall Study|Lost to Follow-up|0|||
33286211|NCT02128113|62662707|FG000|Overall Study|Withdrawal by Subject|3|||
33286212|NCT02128113|62662708|FG001|Overall Study|Withdrawal by Subject|1|||
33286213|NCT02128113|62662709|FG002|Overall Study|Withdrawal by Subject|0|||
33486531|NCT04052139|62864452|FG002|Overall Study|Lost to Follow-up|0|||
33372514|NCT00679354|62751331|FG000|Overall Study|Death|3|||
33372515|NCT00679354|62751331|FG000|Overall Study|Lack of Efficacy|22|||
33372516|NCT00679354|62751331|FG000|Overall Study|Physician Decision|4|||
33372517|NCT00679354|62751331|FG000|Overall Study|Ineligible|1|||
33372518|NCT00822900|62751338|FG000|Overall Study|Withdrawal by Subject|14|||
33372519|NCT00822900|62751339|FG001|Overall Study|Withdrawal by Subject|14|||
33372520|NCT00822900|62751338|FG000|Overall Study|Lost to Follow-up|9|||
33372521|NCT00822900|62751339|FG001|Overall Study|Lost to Follow-up|9|||
33372522|NCT00822900|62751338|FG000|Overall Study|Death|83|||
33372523|NCT00822900|62751339|FG001|Overall Study|Death|69|||
33372524|NCT00822900|62751338|FG000|Overall Study|Became a ward of the state|2|||
33372525|NCT00822900|62751339|FG001|Overall Study|Became a ward of the state|1|||
33372526|NCT00682786|62751347|FG000|Overall Study|Withdrawal by Subject|2|||
33372527|NCT00682786|62751348|FG001|Overall Study|Withdrawal by Subject|2|||
33372528|NCT00682786|62751347|FG000|Overall Study|Did not receive irinotecan|0|||
33372529|NCT00682786|62751348|FG001|Overall Study|Did not receive irinotecan|1|||
33372530|NCT00840450|62751360|FG000|Overall Study|Adverse Event|1|||
33372531|NCT00840450|62751360|FG000|Overall Study|Lack of Efficacy|2|||
33372532|NCT00840294|62751366|FG000|Overall Study|Withdrawal by Subject|2|||
33372533|NCT00840294|62751367|FG001|Overall Study|Withdrawal by Subject|1|||
33372534|NCT00840294|62751366|FG000|Overall Study|Protocol Violation|1|||
33286214|NCT02128113|62662707|FG000|Overall Study|Protocol Violation|0|||
33286215|NCT02128113|62662708|FG001|Overall Study|Protocol Violation|1|||
33372535|NCT00840294|62751367|FG001|Overall Study|Protocol Violation|3|||
33372536|NCT00840294|62751366|FG000|Overall Study|Illness|0|||
33372537|NCT00840294|62751367|FG001|Overall Study|Illness|1|||
33372538|NCT00680368|62751373|FG000|Overall Study|not supervised, not eligible|15|||
33372539|NCT00680056|62751381|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
33372540|NCT00680056|62751382|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
33372541|NCT00680056|62751381|FG000|Second Intervention|Protocol Violation|3|||
33372542|NCT00680056|62751382|FG001|Second Intervention|Protocol Violation|1|||
33372543|NCT00680992|62751392|FG000|Overall Study|Complete Resection (as per protocol)|25|||
33372544|NCT00680992|62751393|FG001|Overall Study|Complete Resection (as per protocol)|121|||
33372545|NCT00680992|62751394|FG002|Overall Study|Complete Resection (as per protocol)|0|||
33372546|NCT00680992|62751392|FG000|Overall Study|Administrative Decision|83|||
33372547|NCT00680992|62751393|FG001|Overall Study|Administrative Decision|42|||
33372548|NCT00680992|62751394|FG002|Overall Study|Administrative Decision|5|||
33372549|NCT00680992|62751392|FG000|Overall Study|End of Trial|32|||
33372550|NCT00680992|62751393|FG001|Overall Study|End of Trial|12|||
33372551|NCT00680992|62751394|FG002|Overall Study|End of Trial|3|||
33372552|NCT00680992|62751392|FG000|Overall Study|Withdrawal by Subject|33|||
33372553|NCT00680992|62751393|FG001|Overall Study|Withdrawal by Subject|11|||
33372554|NCT00680992|62751394|FG002|Overall Study|Withdrawal by Subject|1|||
33372555|NCT00680992|62751392|FG000|Overall Study|Adverse Event|21|||
33372556|NCT00680992|62751393|FG001|Overall Study|Adverse Event|19|||
33372557|NCT00680992|62751394|FG002|Overall Study|Adverse Event|1|||
33372558|NCT00680992|62751392|FG000|Overall Study|Other|19|||
33372559|NCT00680992|62751393|FG001|Overall Study|Other|14|||
33372560|NCT00680992|62751394|FG002|Overall Study|Other|1|||
33286216|NCT02128113|62662709|FG002|Overall Study|Protocol Violation|0|||
33286217|NCT02128113|62662707|FG000|Overall Study|Surgery cancelled|0|||
33286218|NCT02128113|62662708|FG001|Overall Study|Surgery cancelled|1|||
33286219|NCT02128113|62662709|FG002|Overall Study|Surgery cancelled|0|||
33286220|NCT02128113|62662707|FG000|Overall Study|Adverse Event|0|||
33286221|NCT02128113|62662708|FG001|Overall Study|Adverse Event|0|||
33286222|NCT02128113|62662709|FG002|Overall Study|Adverse Event|1|||
33286223|NCT01658826|62662723|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
33286224|NCT01658826|62662724|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
33286225|NCT01658826|62662723|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
33286226|NCT01658826|62662724|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
33372561|NCT00680992|62751392|FG000|Overall Study|Disease Progression|21|||
33372562|NCT00680992|62751393|FG001|Overall Study|Disease Progression|9|||
33286227|NCT01658826|62662723|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
33286228|NCT01658826|62662724|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
33286229|NCT01658826|62662723|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
33286230|NCT01658826|62662724|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
33286231|NCT01658826|62662723|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
33372563|NCT00680992|62751394|FG002|Overall Study|Disease Progression|0|||
33372564|NCT00680992|62751392|FG000|Overall Study|Lost to Follow-up|12|||
33372565|NCT00680992|62751393|FG001|Overall Study|Lost to Follow-up|14|||
33372566|NCT00680992|62751394|FG002|Overall Study|Lost to Follow-up|0|||
33372567|NCT00680992|62751392|FG000|Overall Study|Noncompliance|4|||
33372568|NCT00680992|62751393|FG001|Overall Study|Noncompliance|6|||
33372569|NCT00680992|62751394|FG002|Overall Study|Noncompliance|0|||
33372570|NCT00680992|62751392|FG000|Overall Study|Requirement for Alternative Therapy|8|||
33372571|NCT00680992|62751393|FG001|Overall Study|Requirement for Alternative Therapy|2|||
33372572|NCT00680992|62751394|FG002|Overall Study|Requirement for Alternative Therapy|0|||
33372573|NCT00680992|62751392|FG000|Overall Study|Pregnancy|5|||
33372574|NCT00680992|62751393|FG001|Overall Study|Pregnancy|0|||
33372575|NCT00680992|62751394|FG002|Overall Study|Pregnancy|1|||
33372576|NCT00680992|62751392|FG000|Overall Study|Death|5|||
33372577|NCT00680992|62751393|FG001|Overall Study|Death|1|||
33372578|NCT00680992|62751394|FG002|Overall Study|Death|0|||
33372579|NCT00680992|62751392|FG000|Overall Study|Ineligibility Determined|0|||
33372580|NCT00680992|62751393|FG001|Overall Study|Ineligibility Determined|1|||
33372581|NCT00680992|62751394|FG002|Overall Study|Ineligibility Determined|0|||
33286232|NCT01658826|62662724|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
33286233|NCT01658826|62662723|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
33286234|NCT01658826|62662724|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
33286235|NCT01658826|62662723|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
33286236|NCT01658826|62662724|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
33286237|NCT01658826|62662723|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
33286238|NCT01658826|62662724|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
33286239|NCT01658826|62662723|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
33286240|NCT01658826|62662724|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
33286241|NCT01186744|62662740|FG000|Overall Study|Lack of Efficacy|156|||
33286242|NCT01186744|62662741|FG001|Overall Study|Lack of Efficacy|99|||
33286243|NCT01186744|62662742|FG002|Overall Study|Lack of Efficacy|0|||
33286244|NCT01186744|62662743|FG003|Overall Study|Lack of Efficacy|2|||
33286245|NCT01186744|62662744|FG004|Overall Study|Lack of Efficacy|2|||
33286246|NCT01186744|62662745|FG005|Overall Study|Lack of Efficacy|5|||
33286247|NCT01186744|62662740|FG000|Overall Study|Protocol Violation|1|||
33286248|NCT01186744|62662741|FG001|Overall Study|Protocol Violation|2|||
33286249|NCT01186744|62662742|FG002|Overall Study|Protocol Violation|0|||
33286250|NCT01186744|62662743|FG003|Overall Study|Protocol Violation|1|||
33286251|NCT01186744|62662744|FG004|Overall Study|Protocol Violation|1|||
33372582|NCT00805389|62751408|FG000|Overall Study|Adverse Event|0|||
33372583|NCT00805389|62751409|FG001|Overall Study|Adverse Event|0|||
33372584|NCT00805389|62751410|FG002|Overall Study|Adverse Event|1|||
33372585|NCT00805389|62751411|FG003|Overall Study|Adverse Event|2|||
33372586|NCT00805389|62751412|FG004|Overall Study|Adverse Event|0|||
33372587|NCT00805389|62751408|FG000|Overall Study|Lost to Follow-up|4|||
33372588|NCT00805389|62751409|FG001|Overall Study|Lost to Follow-up|3|||
33372589|NCT00805389|62751410|FG002|Overall Study|Lost to Follow-up|6|||
33372590|NCT00805389|62751411|FG003|Overall Study|Lost to Follow-up|10|||
33372591|NCT00805389|62751412|FG004|Overall Study|Lost to Follow-up|9|||
33372592|NCT00805389|62751408|FG000|Overall Study|Protocol Violation|0|||
33372593|NCT00805389|62751409|FG001|Overall Study|Protocol Violation|0|||
33372594|NCT00805389|62751410|FG002|Overall Study|Protocol Violation|1|||
33286252|NCT01186744|62662745|FG005|Overall Study|Protocol Violation|2|||
33286253|NCT01186744|62662740|FG000|Overall Study|Lost to Follow-up|15|||
33286254|NCT01186744|62662741|FG001|Overall Study|Lost to Follow-up|16|||
33286255|NCT01186744|62662742|FG002|Overall Study|Lost to Follow-up|2|||
33286256|NCT01186744|62662743|FG003|Overall Study|Lost to Follow-up|1|||
33286257|NCT01186744|62662744|FG004|Overall Study|Lost to Follow-up|1|||
33286258|NCT01186744|62662745|FG005|Overall Study|Lost to Follow-up|4|||
33286259|NCT01186744|62662740|FG000|Overall Study|Screen failure|1|||
33286260|NCT01186744|62662741|FG001|Overall Study|Screen failure|1|||
33286261|NCT01186744|62662742|FG002|Overall Study|Screen failure|0|||
33286262|NCT01186744|62662743|FG003|Overall Study|Screen failure|1|||
33286263|NCT01186744|62662744|FG004|Overall Study|Screen failure|0|||
33286264|NCT01186744|62662745|FG005|Overall Study|Screen failure|0|||
33286265|NCT01186744|62662740|FG000|Overall Study|Withdrawal by Subject|14|||
33286266|NCT01186744|62662741|FG001|Overall Study|Withdrawal by Subject|10|||
33286267|NCT01186744|62662742|FG002|Overall Study|Withdrawal by Subject|2|||
33286268|NCT01186744|62662743|FG003|Overall Study|Withdrawal by Subject|5|||
33286269|NCT01186744|62662744|FG004|Overall Study|Withdrawal by Subject|0|||
33286270|NCT01186744|62662745|FG005|Overall Study|Withdrawal by Subject|6|||
33372595|NCT00805389|62751411|FG003|Overall Study|Protocol Violation|0|||
33372596|NCT00805389|62751412|FG004|Overall Study|Protocol Violation|0|||
33372597|NCT00805389|62751408|FG000|Overall Study|Withdrawal by Subject|3|||
33372598|NCT00805389|62751409|FG001|Overall Study|Withdrawal by Subject|2|||
33372599|NCT00805389|62751410|FG002|Overall Study|Withdrawal by Subject|4|||
33286271|NCT01186744|62662740|FG000|Overall Study|Study terminated by Sponsor|1|||
33286272|NCT01186744|62662741|FG001|Overall Study|Study terminated by Sponsor|0|||
33286273|NCT01186744|62662742|FG002|Overall Study|Study terminated by Sponsor|0|||
33286274|NCT01186744|62662743|FG003|Overall Study|Study terminated by Sponsor|0|||
33372600|NCT00805389|62751411|FG003|Overall Study|Withdrawal by Subject|5|||
33372601|NCT00805389|62751412|FG004|Overall Study|Withdrawal by Subject|4|||
33372602|NCT00678886|62751436|FG000|Overall Study|Withdrawal by Subject|0|||
33286275|NCT01186744|62662744|FG004|Overall Study|Study terminated by Sponsor|0|||
33286276|NCT01186744|62662745|FG005|Overall Study|Study terminated by Sponsor|0|||
33286277|NCT01186744|62662740|FG000|Overall Study|Other|9|||
33286278|NCT01186744|62662741|FG001|Overall Study|Other|10|||
33286279|NCT01186744|62662742|FG002|Overall Study|Other|1|||
33286280|NCT01186744|62662743|FG003|Overall Study|Other|2|||
33286281|NCT01186744|62662744|FG004|Overall Study|Other|1|||
33286282|NCT01186744|62662745|FG005|Overall Study|Other|5|||
33286283|NCT01186744|62662740|FG000|Overall Study|Adverse Event|10|||
33286284|NCT01186744|62662741|FG001|Overall Study|Adverse Event|14|||
33286285|NCT01186744|62662742|FG002|Overall Study|Adverse Event|1|||
33286286|NCT01186744|62662743|FG003|Overall Study|Adverse Event|0|||
33286287|NCT01186744|62662744|FG004|Overall Study|Adverse Event|1|||
33286288|NCT01186744|62662745|FG005|Overall Study|Adverse Event|4|||
33286289|NCT01186744|62662740|FG000|Overall Study|Death|1|||
33286290|NCT01186744|62662741|FG001|Overall Study|Death|0|||
33286291|NCT01186744|62662742|FG002|Overall Study|Death|0|||
33286292|NCT01186744|62662743|FG003|Overall Study|Death|0|||
33286293|NCT01186744|62662744|FG004|Overall Study|Death|0|||
33286294|NCT01186744|62662745|FG005|Overall Study|Death|0|||
33286295|NCT01185964|62662783|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
33372603|NCT00678886|62751437|FG001|Overall Study|Withdrawal by Subject|0|||
33372604|NCT00678886|62751438|FG002|Overall Study|Withdrawal by Subject|4|||
33286296|NCT01185964|62662784|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
33286297|NCT01185964|62662785|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
33286298|NCT01185964|62662786|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
33286299|NCT01185964|62662783|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
33286300|NCT01185964|62662784|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
33286301|NCT01185964|62662785|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
33286302|NCT01185964|62662786|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
33286303|NCT01185964|62662783|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
33286304|NCT01185964|62662784|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
33286305|NCT01185964|62662785|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
33286306|NCT01185964|62662786|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
33286307|NCT01185964|62662783|FG000|Phase 1b and Phase 2|Adverse Event|1|||
33286308|NCT01185964|62662784|FG001|Phase 1b and Phase 2|Adverse Event|0|||
33286309|NCT01185964|62662785|FG002|Phase 1b and Phase 2|Adverse Event|2|||
33286310|NCT01185964|62662786|FG003|Phase 1b and Phase 2|Adverse Event|0|||
33286311|NCT01185964|62662783|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
33286312|NCT01185964|62662784|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
33286313|NCT01185964|62662785|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
33286314|NCT01185964|62662786|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
33286315|NCT01185964|62662783|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
33286316|NCT01185964|62662784|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
33286317|NCT01185964|62662785|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
33286318|NCT01185964|62662786|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
33286319|NCT01185964|62662783|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
33286320|NCT01185964|62662784|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
33286321|NCT01185964|62662785|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
33286322|NCT01185964|62662786|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
33286323|NCT01185964|62662783|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
33286324|NCT01185964|62662784|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
33286325|NCT01185964|62662785|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
33286326|NCT01185964|62662786|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
33286327|NCT01217476|62662804|FG000|Overall Study|Adverse Event|6|||
33286328|NCT01217476|62662805|FG001|Overall Study|Adverse Event|1|||
33286329|NCT01217476|62662804|FG000|Overall Study|Physician Decision|0|||
33286330|NCT01217476|62662805|FG001|Overall Study|Physician Decision|1|||
33286331|NCT01217476|62662804|FG000|Overall Study|Withdrawal by Subject|3|||
33286332|NCT01217476|62662805|FG001|Overall Study|Withdrawal by Subject|3|||
33286333|NCT01217476|62662804|FG000|Overall Study|Surgery on the Target Limb|0|||
33286334|NCT01217476|62662805|FG001|Overall Study|Surgery on the Target Limb|2|||
33286335|NCT01217476|62662804|FG000|Overall Study|Protocol Deviation|1|||
33372605|NCT00678886|62751439|FG003|Overall Study|Withdrawal by Subject|6|||
33486532|NCT04052139|62864450|FG000|Overall Study|Withdrawal by Subject|1|||
33286336|NCT01217476|62662805|FG001|Overall Study|Protocol Deviation|0|||
33286337|NCT01217476|62662804|FG000|Overall Study|Other|2|||
33286338|NCT01217476|62662805|FG001|Overall Study|Other|0|||
33286339|NCT01217437|62662826|FG000|Overall Study|Adverse Event|0|||
33286340|NCT01217437|62662827|FG001|Overall Study|Adverse Event|8|||
33286341|NCT01217437|62662826|FG000|Overall Study|Death|5|||
33372606|NCT00678886|62751436|FG000|Overall Study|Physician Decision|0|||
33372607|NCT00678886|62751437|FG001|Overall Study|Physician Decision|0|||
33372608|NCT00678886|62751438|FG002|Overall Study|Physician Decision|1|||
33286342|NCT01217437|62662827|FG001|Overall Study|Death|0|||
33286343|NCT01217437|62662826|FG000|Overall Study|Lack of Efficacy|29|||
33286344|NCT01217437|62662827|FG001|Overall Study|Lack of Efficacy|25|||
33286345|NCT01217437|62662826|FG000|Overall Study|Physician Decision|8|||
33286346|NCT01217437|62662827|FG001|Overall Study|Physician Decision|5|||
33286347|NCT01217437|62662826|FG000|Overall Study|Withdrawal by Subject|0|||
33286348|NCT01217437|62662827|FG001|Overall Study|Withdrawal by Subject|2|||
33286349|NCT01217437|62662826|FG000|Overall Study|Ineligible|1|||
33286350|NCT01217437|62662827|FG001|Overall Study|Ineligible|1|||
33286351|NCT01217047|62662837|FG000|Overall Study|Lost to Follow-up|0|||
33286352|NCT01217047|62662838|FG001|Overall Study|Lost to Follow-up|1|||
33286353|NCT01217047|62662839|FG002|Overall Study|Lost to Follow-up|0|||
33286354|NCT01185340|62662851|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
33286355|NCT01185340|62662852|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33286356|NCT01185340|62662853|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33286357|NCT01185340|62662854|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33286358|NCT01185340|62662851|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
33286359|NCT01185340|62662852|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33286360|NCT01185340|62662853|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33286361|NCT01185340|62662854|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33286362|NCT01185340|62662851|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
33286363|NCT01185340|62662852|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33286364|NCT01185340|62662853|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33286365|NCT01185340|62662854|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33286366|NCT01185340|62662851|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
33286367|NCT01185340|62662852|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33286368|NCT01185340|62662853|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33286369|NCT01185340|62662854|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33286370|NCT01185340|62662851|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
33286371|NCT01185340|62662852|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33286372|NCT01185340|62662853|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33286373|NCT01185340|62662854|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33372609|NCT00678886|62751439|FG003|Overall Study|Physician Decision|1|||
33372610|NCT00678886|62751436|FG000|Overall Study|Lost to Follow-up|0|||
33372611|NCT00678886|62751437|FG001|Overall Study|Lost to Follow-up|0|||
33372612|NCT00678886|62751438|FG002|Overall Study|Lost to Follow-up|3|||
33372613|NCT00678886|62751439|FG003|Overall Study|Lost to Follow-up|2|||
33372614|NCT00678886|62751436|FG000|Overall Study|Other|0|||
33372615|NCT00678886|62751437|FG001|Overall Study|Other|0|||
33372616|NCT00678886|62751438|FG002|Overall Study|Other|1|||
33372617|NCT00678886|62751439|FG003|Overall Study|Other|0|||
33286374|NCT01185340|62662851|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
33286375|NCT01185340|62662852|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33286376|NCT01185340|62662853|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33286377|NCT01185340|62662854|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33286378|NCT01185340|62662851|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
33372618|NCT00804843|62751450|FG000|Overall Study|Protocol Violation|1|||
33372619|NCT00804843|62751451|FG001|Overall Study|Protocol Violation|0|||
33372620|NCT00804843|62751450|FG000|Overall Study|Adverse Event|8|||
33372621|NCT00804843|62751451|FG001|Overall Study|Adverse Event|5|||
33372622|NCT00804843|62751450|FG000|Overall Study|Withdrawal by Subject|1|||
33372623|NCT00804843|62751451|FG001|Overall Study|Withdrawal by Subject|2|||
33372624|NCT00822120|62751460|FG000|Initial Registration|Adverse Event|1|||
33372625|NCT00822120|62751461|FG001|Initial Registration|Adverse Event|0|||
33372626|NCT00822120|62751462|FG002|Initial Registration|Adverse Event|0|||
33372627|NCT00822120|62751463|FG003|Initial Registration|Adverse Event|0|||
33372628|NCT00822120|62751464|FG004|Initial Registration|Adverse Event|0|||
33486533|NCT04052139|62864451|FG001|Overall Study|Withdrawal by Subject|0|||
33286379|NCT01185340|62662852|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33286380|NCT01185340|62662853|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33286381|NCT01185340|62662854|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33286382|NCT01185340|62662851|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
33286383|NCT01185340|62662852|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
33286384|NCT01185340|62662853|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
33662259|NCT01695239|63092841|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
33286385|NCT01185340|62662854|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
33372629|NCT00822120|62751465|FG005|Initial Registration|Adverse Event|0|||
33372630|NCT00822120|62751460|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
33372631|NCT00822120|62751461|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
33486534|NCT04052139|62864452|FG002|Overall Study|Withdrawal by Subject|0|||
33286386|NCT01185340|62662851|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
33286387|NCT01185340|62662852|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
33286388|NCT01185340|62662853|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
33286389|NCT01185340|62662854|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
33286390|NCT01185340|62662851|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
33286391|NCT01185340|62662852|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
33372632|NCT00822120|62751462|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
33372633|NCT00822120|62751463|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
33372634|NCT00822120|62751464|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
33372635|NCT00822120|62751465|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
33372636|NCT00822120|62751460|FG000|Initial Registration|Reasons not Protocol Specified|2|||
33372637|NCT00822120|62751461|FG001|Initial Registration|Reasons not Protocol Specified|0|||
33372638|NCT00822120|62751462|FG002|Initial Registration|Reasons not Protocol Specified|0|||
33372639|NCT00822120|62751463|FG003|Initial Registration|Reasons not Protocol Specified|0|||
33286392|NCT01185340|62662853|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
33286393|NCT01185340|62662854|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
33286394|NCT01185340|62662851|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
33372640|NCT00822120|62751464|FG004|Initial Registration|Reasons not Protocol Specified|0|||
33372641|NCT00822120|62751465|FG005|Initial Registration|Reasons not Protocol Specified|0|||
33372642|NCT00822120|62751460|FG000|Initial Registration|Ineligible|22|||
33372643|NCT00822120|62751461|FG001|Initial Registration|Ineligible|1|||
33372644|NCT00822120|62751462|FG002|Initial Registration|Ineligible|0|||
33372645|NCT00822120|62751463|FG003|Initial Registration|Ineligible|0|||
33372646|NCT00822120|62751464|FG004|Initial Registration|Ineligible|0|||
33372647|NCT00822120|62751465|FG005|Initial Registration|Ineligible|0|||
33372648|NCT00822120|62751460|FG000|PET-directed Therapy|Adverse Event|0|||
33372649|NCT00822120|62751461|FG001|PET-directed Therapy|Adverse Event|0|||
33372650|NCT00822120|62751462|FG002|PET-directed Therapy|Adverse Event|0|||
33372651|NCT00822120|62751463|FG003|PET-directed Therapy|Adverse Event|1|||
33372652|NCT00822120|62751464|FG004|PET-directed Therapy|Adverse Event|0|||
33372653|NCT00822120|62751465|FG005|PET-directed Therapy|Adverse Event|0|||
33372654|NCT00822120|62751460|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
33372655|NCT00822120|62751461|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
33372656|NCT00822120|62751462|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
33372657|NCT00822120|62751463|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
33372658|NCT00822120|62751464|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
33372659|NCT00822120|62751465|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
33372660|NCT00822120|62751460|FG000|PET-directed Therapy|Death|0|||
33372661|NCT00822120|62751461|FG001|PET-directed Therapy|Death|0|||
33372662|NCT00822120|62751462|FG002|PET-directed Therapy|Death|0|||
33372663|NCT00822120|62751463|FG003|PET-directed Therapy|Death|2|||
33372664|NCT00822120|62751464|FG004|PET-directed Therapy|Death|0|||
33372665|NCT00822120|62751465|FG005|PET-directed Therapy|Death|0|||
33372666|NCT00822120|62751460|FG000|PET-directed Therapy|Protocol Violation|0|||
33372667|NCT00822120|62751461|FG001|PET-directed Therapy|Protocol Violation|0|||
33286395|NCT01185340|62662852|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
33286396|NCT01185340|62662853|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
33286397|NCT01185340|62662854|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
33286398|NCT01185340|62662851|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
33286399|NCT01185340|62662852|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
33286400|NCT01185340|62662853|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
33286401|NCT01185340|62662854|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
33286402|NCT01185340|62662851|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
33286403|NCT01185340|62662852|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
33286404|NCT01185340|62662853|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
33286405|NCT01185340|62662854|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
33286406|NCT01185340|62662851|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
33286407|NCT01185340|62662852|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
33286408|NCT01185340|62662853|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
33286409|NCT01185340|62662854|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
33286410|NCT01216189|62662868|FG000|Overall Study|Lost to Follow-up|21|||
33286411|NCT01216189|62662869|FG001|Overall Study|Lost to Follow-up|3|||
33286412|NCT01216189|62662868|FG000|Overall Study|Death|4|||
33286413|NCT01216189|62662869|FG001|Overall Study|Death|2|||
33286414|NCT01185301|62662879|FG000|Overall Study|Adverse Event|3|||
33286415|NCT01185301|62662880|FG001|Overall Study|Adverse Event|0|||
33286416|NCT01185301|62662881|FG002|Overall Study|Adverse Event|2|||
33286417|NCT01185301|62662882|FG003|Overall Study|Adverse Event|3|||
33286418|NCT01185301|62662879|FG000|Overall Study|Withdrawal by Subject|7|||
33486535|NCT03984825|62864460|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
33286419|NCT01185301|62662880|FG001|Overall Study|Withdrawal by Subject|5|||
33286420|NCT01185301|62662881|FG002|Overall Study|Withdrawal by Subject|2|||
33286421|NCT01185301|62662882|FG003|Overall Study|Withdrawal by Subject|3|||
33286422|NCT01185301|62662879|FG000|Overall Study|Lost to Follow-up|2|||
33286423|NCT01185301|62662880|FG001|Overall Study|Lost to Follow-up|0|||
33286424|NCT01185301|62662881|FG002|Overall Study|Lost to Follow-up|0|||
33286425|NCT01185301|62662882|FG003|Overall Study|Lost to Follow-up|1|||
33372668|NCT00822120|62751462|FG002|PET-directed Therapy|Protocol Violation|0|||
33372669|NCT00822120|62751463|FG003|PET-directed Therapy|Protocol Violation|6|||
33372670|NCT00822120|62751464|FG004|PET-directed Therapy|Protocol Violation|0|||
33372671|NCT00822120|62751465|FG005|PET-directed Therapy|Protocol Violation|0|||
33372672|NCT00804687|62751486|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
33372673|NCT00804687|62751487|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
33372674|NCT00804687|62751488|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
33372675|NCT00804687|62751489|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
33372676|NCT00804687|62751490|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
33372677|NCT00804687|62751491|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
33372678|NCT00804687|62751486|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
33372679|NCT00804687|62751487|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
33372680|NCT00804687|62751488|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
33372681|NCT00804687|62751489|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
33372682|NCT00804687|62751490|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
33372683|NCT00804687|62751491|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
33372684|NCT00804687|62751486|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
33372685|NCT00804687|62751487|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
33372686|NCT00804687|62751488|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
33372687|NCT00804687|62751489|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
33372688|NCT00804687|62751490|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
33372689|NCT00804687|62751491|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
33372690|NCT00804687|62751486|FG000|Period 5: Treatment Period|Positive drug test|1|||
33372691|NCT00804687|62751487|FG001|Period 5: Treatment Period|Positive drug test|0|||
33372692|NCT00804687|62751488|FG002|Period 5: Treatment Period|Positive drug test|0|||
33372693|NCT00804687|62751489|FG003|Period 5: Treatment Period|Positive drug test|0|||
33372694|NCT00804687|62751490|FG004|Period 5: Treatment Period|Positive drug test|0|||
33372695|NCT00804687|62751491|FG005|Period 5: Treatment Period|Positive drug test|0|||
33372696|NCT00678652|62751503|FG000|Overall Study|Protocol Violation|2|||
33372697|NCT00678652|62751504|FG001|Overall Study|Protocol Violation|0|||
33372698|NCT00678652|62751505|FG002|Overall Study|Protocol Violation|0|||
33372699|NCT00678652|62751506|FG003|Overall Study|Protocol Violation|0|||
33286426|NCT01185301|62662879|FG000|Overall Study|Other Reason|3|||
33286427|NCT01185301|62662880|FG001|Overall Study|Other Reason|2|||
33286428|NCT01185301|62662881|FG002|Overall Study|Other Reason|2|||
33286429|NCT01185301|62662882|FG003|Overall Study|Other Reason|2|||
33286430|NCT01216072|62662894|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
33286431|NCT01216072|62662895|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
33286432|NCT01216072|62662894|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
33286433|NCT01216072|62662895|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
33286434|NCT01216072|62662894|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
33286435|NCT01216072|62662895|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
33286436|NCT01216072|62662894|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
33286437|NCT01216072|62662895|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
33286438|NCT01216072|62662894|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
33286439|NCT01216072|62662895|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
33286440|NCT01216072|62662894|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
33286441|NCT01216072|62662895|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
33286442|NCT01216072|62662894|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
33286443|NCT01216072|62662895|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
33286444|NCT01216072|62662894|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
33286445|NCT01216072|62662895|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
33286446|NCT01216072|62662894|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
33286447|NCT01216072|62662895|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
33286448|NCT01216072|62662894|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
33286449|NCT01216072|62662895|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
33286450|NCT01184989|62662904|FG000|Overall Study|Adverse Event|11|||
33286451|NCT01184989|62662904|FG000|Overall Study|Withdrawal by Subject|1|||
33286452|NCT01215955|62662912|FG000|Overall Study|Adverse Event|1|||
33286453|NCT01215955|62662913|FG001|Overall Study|Adverse Event|4|||
33286454|NCT01215955|62662914|FG002|Overall Study|Adverse Event|2|||
33372700|NCT00678652|62751503|FG000|Overall Study|Pregnancy|0|||
33372701|NCT00678652|62751504|FG001|Overall Study|Pregnancy|0|||
33372702|NCT00678652|62751505|FG002|Overall Study|Pregnancy|1|||
33372703|NCT00678652|62751506|FG003|Overall Study|Pregnancy|0|||
33372704|NCT00678652|62751503|FG000|Overall Study|Relocation|1|||
33372705|NCT00678652|62751504|FG001|Overall Study|Relocation|0|||
33286455|NCT01215955|62662915|FG003|Overall Study|Adverse Event|3|||
33286456|NCT01215955|62662912|FG000|Overall Study|Death|2|||
33286457|NCT01215955|62662913|FG001|Overall Study|Death|0|||
33286458|NCT01215955|62662914|FG002|Overall Study|Death|1|||
33286459|NCT01215955|62662915|FG003|Overall Study|Death|3|||
33286460|NCT01215955|62662912|FG000|Overall Study|Entry Criteria Not Met|1|||
33372706|NCT00678652|62751505|FG002|Overall Study|Relocation|0|||
33372707|NCT00678652|62751506|FG003|Overall Study|Relocation|0|||
33372708|NCT00840060|62751527|FG000|Overall Study|Withdrawal by Subject|1|||
33372709|NCT00840060|62751528|FG001|Overall Study|Withdrawal by Subject|0|||
33372710|NCT00840060|62751527|FG000|Overall Study|Change in emotional/behavioral status|0|||
33372711|NCT00840060|62751528|FG001|Overall Study|Change in emotional/behavioral status|1|||
33372712|NCT00574912|62751534|FG000|Overall Study|Could not place IV lines.|3|||
33372713|NCT00574912|62751534|FG000|Overall Study|scheduling conflicts|3|||
33372714|NCT00574912|62751534|FG000|Overall Study|Physician Decision|2|||
33372715|NCT00674128|62751548|FG000|Overall Study|Withdrawal by Subject|25|||
33372716|NCT00674128|62751549|FG001|Overall Study|Withdrawal by Subject|23|||
33372717|NCT00804141|62751555|FG000|Overall Study|Adverse Event|157|||
33372718|NCT00804141|62751555|FG000|Overall Study|Death|4|||
33372719|NCT00804141|62751555|FG000|Overall Study|Failed to return|96|||
33372720|NCT00804141|62751555|FG000|Overall Study|Investigator request|8|||
33372721|NCT00804141|62751555|FG000|Overall Study|Protocol Violation|85|||
33372722|NCT00804141|62751555|FG000|Overall Study|Withdrawal by Subject|131|||
33372723|NCT00804141|62751555|FG000|Overall Study|Lack of Efficacy|46|||
33372724|NCT00804141|62751555|FG000|Overall Study|Other than specified|30|||
33372725|NCT00804141|62751555|FG000|Overall Study|Enrolled but not treated|6|||
33372726|NCT00677092|62751559|FG000|Overall Study|Adverse Event|1|||
33372727|NCT00677092|62751559|FG000|Overall Study|Lost to Follow-up|1|||
33372728|NCT00677092|62751559|FG000|Overall Study|Withdrawal by Subject|3|||
33372729|NCT00677092|62751559|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
33372730|NCT00677014|62751567|FG000|Overall Study|Lost to Follow-up|20|||
33372731|NCT00677014|62751568|FG001|Overall Study|Lost to Follow-up|12|||
33372732|NCT00677014|62751569|FG002|Overall Study|Lost to Follow-up|24|||
33372733|NCT00677014|62751567|FG000|Overall Study|Death|6|||
33372734|NCT00677014|62751568|FG001|Overall Study|Death|15|||
33372735|NCT00677014|62751569|FG002|Overall Study|Death|7|||
33372736|NCT00677014|62751567|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
33372737|NCT00677014|62751568|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
33372738|NCT00677014|62751569|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
33372739|NCT00839436|62751580|FG000|Overall Study|Developed exclusionary condition|1|||
33372740|NCT00839436|62751581|FG001|Overall Study|Developed exclusionary condition|0|||
33372741|NCT00839436|62751582|FG002|Overall Study|Developed exclusionary condition|0|||
33372742|NCT00839436|62751580|FG000|Overall Study|Withdrawal by Subject|0|||
33372743|NCT00839436|62751581|FG001|Overall Study|Withdrawal by Subject|1|||
33372744|NCT00839436|62751582|FG002|Overall Study|Withdrawal by Subject|0|||
33372745|NCT00839436|62751580|FG000|Overall Study|Study drug no longer available|0|||
33372746|NCT00839436|62751581|FG001|Overall Study|Study drug no longer available|0|||
33372747|NCT00839436|62751582|FG002|Overall Study|Study drug no longer available|1|||
33372748|NCT00675766|62751594|FG000|Overall Study|Lost to Follow-up|6|||
33486536|NCT03984825|62864460|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
33486537|NCT03984825|62864460|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
33486538|NCT03981861|62864469|FG000|Overall Study|Withdrawal by Subject|3|||
33486539|NCT01332266|62864478|FG000|Phase 1b|Death|3|||
33486540|NCT01332266|62864479|FG001|Phase 1b|Death|3|||
33486541|NCT01332266|62864480|FG002|Phase 1b|Death|2|||
33286461|NCT01215955|62662913|FG001|Overall Study|Entry Criteria Not Met|3|||
33286462|NCT01215955|62662914|FG002|Overall Study|Entry Criteria Not Met|4|||
33372749|NCT00675766|62751595|FG001|Overall Study|Lost to Follow-up|5|||
33372750|NCT00675766|62751596|FG002|Overall Study|Lost to Follow-up|21|||
33372751|NCT00675766|62751597|FG003|Overall Study|Lost to Follow-up|26|||
33372752|NCT00673894|62751609|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
33372753|NCT00673894|62751610|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
33372754|NCT00673894|62751609|FG000|First Intervention 4 Weeks|Adverse Event|1|||
33372755|NCT00673894|62751610|FG001|First Intervention 4 Weeks|Adverse Event|0|||
33372756|NCT00674986|62751618|FG000|Overall Study|Adverse Event|2|||
33372757|NCT00674986|62751619|FG001|Overall Study|Adverse Event|1|||
33372758|NCT00674986|62751618|FG000|Overall Study|Subject withdrew consent|12|||
33372759|NCT00674986|62751619|FG001|Overall Study|Subject withdrew consent|19|||
33372760|NCT00674986|62751618|FG000|Overall Study|Lost to Follow-up|25|||
33372761|NCT00674986|62751619|FG001|Overall Study|Lost to Follow-up|53|||
33662260|NCT01695239|63092842|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
33286463|NCT01215955|62662915|FG003|Overall Study|Entry Criteria Not Met|7|||
33372762|NCT00674986|62751618|FG000|Overall Study|Other reasons|4|||
33372763|NCT00674986|62751619|FG001|Overall Study|Other reasons|8|||
33486542|NCT01332266|62864481|FG003|Phase 1b|Death|0|||
33662261|NCT01695239|63092843|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
33286464|NCT01215955|62662912|FG000|Overall Study|Lack of Efficacy|1|||
33286465|NCT01215955|62662913|FG001|Overall Study|Lack of Efficacy|2|||
33286466|NCT01215955|62662914|FG002|Overall Study|Lack of Efficacy|1|||
33286467|NCT01215955|62662915|FG003|Overall Study|Lack of Efficacy|0|||
33286468|NCT01215955|62662912|FG000|Overall Study|Lost to Follow-up|4|||
33286469|NCT01215955|62662913|FG001|Overall Study|Lost to Follow-up|4|||
33286470|NCT01215955|62662914|FG002|Overall Study|Lost to Follow-up|8|||
33286471|NCT01215955|62662915|FG003|Overall Study|Lost to Follow-up|9|||
33286472|NCT01215955|62662912|FG000|Overall Study|Physician Decision|4|||
33286473|NCT01215955|62662913|FG001|Overall Study|Physician Decision|10|||
33286474|NCT01215955|62662914|FG002|Overall Study|Physician Decision|8|||
33286475|NCT01215955|62662915|FG003|Overall Study|Physician Decision|11|||
33286476|NCT01215955|62662912|FG000|Overall Study|Protocol Violation|17|||
33286477|NCT01215955|62662913|FG001|Overall Study|Protocol Violation|13|||
33286478|NCT01215955|62662914|FG002|Overall Study|Protocol Violation|8|||
33286479|NCT01215955|62662915|FG003|Overall Study|Protocol Violation|8|||
33286480|NCT01215955|62662912|FG000|Overall Study|Sponsor Decision|1|||
33286481|NCT01215955|62662913|FG001|Overall Study|Sponsor Decision|2|||
33286482|NCT01215955|62662914|FG002|Overall Study|Sponsor Decision|0|||
33286483|NCT01215955|62662915|FG003|Overall Study|Sponsor Decision|1|||
33286484|NCT01215955|62662912|FG000|Overall Study|Withdrawal by Subject|14|||
33286485|NCT01215955|62662913|FG001|Overall Study|Withdrawal by Subject|15|||
33286486|NCT01215955|62662914|FG002|Overall Study|Withdrawal by Subject|13|||
33286487|NCT01215955|62662915|FG003|Overall Study|Withdrawal by Subject|9|||
33286488|NCT01215955|62662912|FG000|Overall Study|Quality Issues|0|||
33286489|NCT01215955|62662913|FG001|Overall Study|Quality Issues|0|||
33286490|NCT01215955|62662914|FG002|Overall Study|Quality Issues|3|||
33286491|NCT01215955|62662915|FG003|Overall Study|Quality Issues|2|||
33286492|NCT01215916|62662950|FG000|Overall Study|Progressive Disease|0|||
33286493|NCT01215916|62662951|FG001|Overall Study|Progressive Disease|2|||
33286494|NCT01215916|62662952|FG002|Overall Study|Progressive Disease|1|||
33286495|NCT01215916|62662953|FG003|Overall Study|Progressive Disease|2|||
33372764|NCT00673816|62751626|FG000|Overall Study|Adverse Event|1|||
33372765|NCT00673816|62751626|FG000|Overall Study|Withdrawal by Subject|1|||
33372766|NCT00673660|62751631|FG000|Overall Study|Lost to Follow-up|107|||
33372767|NCT00672958|62751642|FG000|Overall Study|Adverse Event|11|||
33372768|NCT00672958|62751643|FG001|Overall Study|Adverse Event|9|||
33372769|NCT00672958|62751642|FG000|Overall Study|Lack of Efficacy|6|||
33372770|NCT00672958|62751643|FG001|Overall Study|Lack of Efficacy|11|||
33372771|NCT00672958|62751642|FG000|Overall Study|Non-compliance with study drug|2|||
33372772|NCT00672958|62751643|FG001|Overall Study|Non-compliance with study drug|3|||
33372773|NCT00672958|62751642|FG000|Overall Study|Protocol deviations|11|||
33372774|NCT00672958|62751643|FG001|Overall Study|Protocol deviations|5|||
33372775|NCT00672958|62751642|FG000|Overall Study|Voluntary withdrawal|12|||
33372776|NCT00672958|62751643|FG001|Overall Study|Voluntary withdrawal|8|||
33372777|NCT00672958|62751642|FG000|Overall Study|Lost to Follow-up|22|||
33372778|NCT00672958|62751643|FG001|Overall Study|Lost to Follow-up|17|||
33372779|NCT00672958|62751642|FG000|Overall Study|Reason not specified|0|||
33372780|NCT00672958|62751643|FG001|Overall Study|Reason not specified|3|||
33372781|NCT00672646|62751652|FG000|Overall Study|Lost to Follow-up|0|||
33372782|NCT00672646|62751653|FG001|Overall Study|Lost to Follow-up|1|||
33372783|NCT00672646|62751654|FG002|Overall Study|Lost to Follow-up|2|||
33372784|NCT00672646|62751652|FG000|Overall Study|Withdrawal by Subject|0|||
33372785|NCT00672646|62751653|FG001|Overall Study|Withdrawal by Subject|0|||
33372786|NCT00672646|62751654|FG002|Overall Study|Withdrawal by Subject|1|||
33372787|NCT00672490|62751664|FG000|Overall Study|Withdrawal by Subject|8|||
33372788|NCT00672490|62751665|FG001|Overall Study|Withdrawal by Subject|8|||
33372789|NCT00672490|62751664|FG000|Overall Study|Lack of Compliance|2|||
33372790|NCT00672490|62751665|FG001|Overall Study|Lack of Compliance|7|||
33372791|NCT00672490|62751664|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
33372792|NCT00672490|62751665|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
33372793|NCT00672490|62751664|FG000|Overall Study|Adverse Event|5|||
33372794|NCT00672490|62751665|FG001|Overall Study|Adverse Event|8|||
33372795|NCT00672490|62751664|FG000|Overall Study|Violation of Concomitant Medicine|1|||
33372796|NCT00672490|62751665|FG001|Overall Study|Violation of Concomitant Medicine|0|||
33372797|NCT00672490|62751664|FG000|Overall Study|Intolerance|0|||
33372798|NCT00672490|62751665|FG001|Overall Study|Intolerance|2|||
33372799|NCT00672490|62751664|FG000|Overall Study|Lost to Follow-up|1|||
33372800|NCT00672490|62751665|FG001|Overall Study|Lost to Follow-up|5|||
33372801|NCT00672490|62751664|FG000|Overall Study|No reason was provided|6|||
33286496|NCT01215916|62662954|FG004|Overall Study|Progressive Disease|5|||
33286497|NCT01215916|62662955|FG005|Overall Study|Progressive Disease|4|||
33286498|NCT01215916|62662956|FG006|Overall Study|Progressive Disease|5|||
33372802|NCT00672490|62751665|FG001|Overall Study|No reason was provided|2|||
33286499|NCT01215916|62662957|FG007|Overall Study|Progressive Disease|3|||
33286500|NCT01215916|62662958|FG008|Overall Study|Progressive Disease|1|||
33286501|NCT01215916|62662950|FG000|Overall Study|Adverse Event|1|||
33286502|NCT01215916|62662951|FG001|Overall Study|Adverse Event|1|||
33286503|NCT01215916|62662952|FG002|Overall Study|Adverse Event|0|||
33286504|NCT01215916|62662953|FG003|Overall Study|Adverse Event|1|||
33372803|NCT00670930|62751673|FG000|Overall Study|Adminstrative Problem|0|||
33372804|NCT00670930|62751674|FG001|Overall Study|Adminstrative Problem|1|||
33372805|NCT00670930|62751673|FG000|Overall Study|Lost to Follow-up|1|||
33372806|NCT00670930|62751674|FG001|Overall Study|Lost to Follow-up|0|||
33286505|NCT01215916|62662954|FG004|Overall Study|Adverse Event|0|||
33286506|NCT01215916|62662955|FG005|Overall Study|Adverse Event|0|||
33286507|NCT01215916|62662956|FG006|Overall Study|Adverse Event|3|||
33286508|NCT01215916|62662957|FG007|Overall Study|Adverse Event|0|||
33286509|NCT01215916|62662958|FG008|Overall Study|Adverse Event|0|||
33286510|NCT01215916|62662950|FG000|Overall Study|Withdrawal by Subject|0|||
33286511|NCT01215916|62662951|FG001|Overall Study|Withdrawal by Subject|1|||
33286512|NCT01215916|62662952|FG002|Overall Study|Withdrawal by Subject|1|||
33286513|NCT01215916|62662953|FG003|Overall Study|Withdrawal by Subject|2|||
33286514|NCT01215916|62662954|FG004|Overall Study|Withdrawal by Subject|0|||
33372807|NCT00670540|62751680|FG000|Overall Study|ineligible|17|||
33372808|NCT00670540|62751680|FG000|Overall Study|not living in France|348|||
33286515|NCT01215916|62662955|FG005|Overall Study|Withdrawal by Subject|0|||
33286516|NCT01215916|62662956|FG006|Overall Study|Withdrawal by Subject|1|||
33286517|NCT01215916|62662957|FG007|Overall Study|Withdrawal by Subject|0|||
33372809|NCT00670540|62751680|FG000|Overall Study|refused to participate|189|||
33372810|NCT00670540|62751680|FG000|Overall Study|controls randomised for no follow up|2770|||
33372811|NCT00670540|62751680|FG000|Overall Study|missing information inclusion criteria|1|||
33372812|NCT00591786|62751694|FG000|Overall Study|Withdrawal of Informed Consent|0|||
33372813|NCT00591786|62751695|FG001|Overall Study|Withdrawal of Informed Consent|0|||
33372814|NCT00591786|62751696|FG002|Overall Study|Withdrawal of Informed Consent|1|||
33372815|NCT00591786|62751697|FG003|Overall Study|Withdrawal of Informed Consent|0|||
33372816|NCT00591786|62751698|FG004|Overall Study|Withdrawal of Informed Consent|0|||
33372817|NCT00591786|62751699|FG005|Overall Study|Withdrawal of Informed Consent|0|||
33372818|NCT00591786|62751700|FG006|Overall Study|Withdrawal of Informed Consent|0|||
33486543|NCT01332266|62864482|FG004|Phase 1b|Death|0|||
33286518|NCT01215916|62662958|FG008|Overall Study|Withdrawal by Subject|0|||
33286519|NCT01215916|62662950|FG000|Overall Study|Death|0|||
33286520|NCT01215916|62662951|FG001|Overall Study|Death|1|||
33286521|NCT01215916|62662952|FG002|Overall Study|Death|0|||
33286522|NCT01215916|62662953|FG003|Overall Study|Death|0|||
33286523|NCT01215916|62662954|FG004|Overall Study|Death|1|||
33286524|NCT01215916|62662955|FG005|Overall Study|Death|0|||
33286525|NCT01215916|62662956|FG006|Overall Study|Death|0|||
33286526|NCT01215916|62662957|FG007|Overall Study|Death|0|||
33286527|NCT01215916|62662958|FG008|Overall Study|Death|1|||
33286528|NCT01215916|62662950|FG000|Overall Study|Physician Decision|0|||
33286529|NCT01215916|62662951|FG001|Overall Study|Physician Decision|0|||
33286530|NCT01215916|62662952|FG002|Overall Study|Physician Decision|1|||
33286531|NCT01215916|62662953|FG003|Overall Study|Physician Decision|1|||
33286532|NCT01215916|62662954|FG004|Overall Study|Physician Decision|0|||
33286533|NCT01215916|62662955|FG005|Overall Study|Physician Decision|0|||
33286534|NCT01215916|62662956|FG006|Overall Study|Physician Decision|0|||
33286535|NCT01215916|62662957|FG007|Overall Study|Physician Decision|0|||
33286536|NCT01215916|62662958|FG008|Overall Study|Physician Decision|0|||
33286537|NCT01184872|62662984|FG000|Overall Study|Adverse Event|3|||
33286538|NCT01184872|62662985|FG001|Overall Study|Adverse Event|4|||
33286539|NCT01184872|62662984|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
33286540|NCT01184872|62662985|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33286541|NCT01184872|62662984|FG000|Overall Study|Withdrawal by Subject|2|||
33286542|NCT01184872|62662985|FG001|Overall Study|Withdrawal by Subject|0|||
33372819|NCT00591786|62751701|FG007|Overall Study|Withdrawal of Informed Consent|0|||
33486544|NCT01332266|62864478|FG000|Phase 1b|Lost to Follow-up|0|||
33286543|NCT01184872|62662984|FG000|Overall Study|Lost to Follow-up|0|||
33286544|NCT01184872|62662985|FG001|Overall Study|Lost to Follow-up|1|||
33286545|NCT01184872|62662984|FG000|Overall Study|Administrative problems|1|||
33286546|NCT01184872|62662985|FG001|Overall Study|Administrative problems|1|||
33286547|NCT01184872|62662984|FG000|Overall Study|Protocol deviation|1|||
33286548|NCT01184872|62662985|FG001|Overall Study|Protocol deviation|0|||
33286549|NCT01215721|62662991|FG000|Overall Study|Adverse Event|2|||
33286550|NCT01184326|62662998|FG000|Overall Study|Adverse Event|1|||
33286551|NCT01184326|62662999|FG001|Overall Study|Adverse Event|2|||
33286552|NCT01184326|62663000|FG002|Overall Study|Adverse Event|0|||
33286553|NCT01184326|62662998|FG000|Overall Study|Death|0|||
33286554|NCT01184326|62662999|FG001|Overall Study|Death|0|||
33286555|NCT01184326|62663000|FG002|Overall Study|Death|1|||
33286556|NCT01184326|62662998|FG000|Overall Study|Withdrawal by Subject|0|||
33286557|NCT01184326|62662999|FG001|Overall Study|Withdrawal by Subject|0|||
33286558|NCT01184326|62663000|FG002|Overall Study|Withdrawal by Subject|1|||
33286559|NCT01184326|62662998|FG000|Overall Study|Physician Decision|1|||
33286560|NCT01184326|62662999|FG001|Overall Study|Physician Decision|1|||
33286561|NCT01184326|62663000|FG002|Overall Study|Physician Decision|0|||
33286562|NCT01184326|62662998|FG000|Overall Study|Disease Progression|1|||
33286563|NCT01184326|62662999|FG001|Overall Study|Disease Progression|3|||
33286564|NCT01184326|62663000|FG002|Overall Study|Disease Progression|12|||
33286565|NCT01215253|62663013|FG000|Overall Study|Withdrawal by Subject|57|||
33286566|NCT01215253|62663014|FG001|Overall Study|Withdrawal by Subject|35|||
33286567|NCT01215253|62663013|FG000|Overall Study|Physician Decision|9|||
33286568|NCT01215253|62663014|FG001|Overall Study|Physician Decision|12|||
33286569|NCT01215253|62663013|FG000|Overall Study|Lost to Follow-up|6|||
33286570|NCT01215253|62663014|FG001|Overall Study|Lost to Follow-up|4|||
33286571|NCT01215253|62663013|FG000|Overall Study|Other|14|||
33372820|NCT00591786|62751702|FG008|Overall Study|Withdrawal of Informed Consent|0|||
33286572|NCT01215253|62663014|FG001|Overall Study|Other|12|||
33286573|NCT01184053|62663021|FG000|Overall Study|progression while on treatment|3|||
33286574|NCT01183975|62663026|FG000|Overall Study|Lost to Follow-up|73|||
33286575|NCT01183858|62663032|FG000|Overall Study|Death not related to Progressive Disease|5|||
33286576|NCT01183858|62663033|FG001|Overall Study|Death not related to Progressive Disease|6|||
33286577|NCT01183858|62663032|FG000|Overall Study|Adverse Event|14|||
33286578|NCT01183858|62663033|FG001|Overall Study|Adverse Event|11|||
33286579|NCT01183858|62663032|FG000|Overall Study|Investigator's Decision|0|||
33286580|NCT01183858|62663033|FG001|Overall Study|Investigator's Decision|3|||
33286581|NCT01183858|62663032|FG000|Overall Study|Insufficient Therapeutic Response|2|||
33286582|NCT01183858|62663033|FG001|Overall Study|Insufficient Therapeutic Response|0|||
33286583|NCT01183858|62663032|FG000|Overall Study|Refused Treatment|1|||
33286584|NCT01183858|62663033|FG001|Overall Study|Refused Treatment|4|||
33286585|NCT01183858|62663032|FG000|Overall Study|Withdrew Consent|4|||
33286586|NCT01183858|62663033|FG001|Overall Study|Withdrew Consent|4|||
33286587|NCT01183858|62663032|FG000|Overall Study|Discontinued Smoking|3|||
33286588|NCT01183858|62663033|FG001|Overall Study|Discontinued Smoking|1|||
33286589|NCT01183858|62663032|FG000|Overall Study|Protocol Violation|1|||
33286590|NCT01183858|62663033|FG001|Overall Study|Protocol Violation|0|||
33286591|NCT01183858|62663032|FG000|Overall Study|Administrative/Other|6|||
33286592|NCT01183858|62663033|FG001|Overall Study|Administrative/Other|6|||
33286593|NCT01183858|62663032|FG000|Overall Study|Progressive Disease|112|||
33286594|NCT01183858|62663033|FG001|Overall Study|Progressive Disease|115|||
33286595|NCT01183858|62663032|FG000|Overall Study|Death related to Progressive Disease|4|||
33286596|NCT01183858|62663033|FG001|Overall Study|Death related to Progressive Disease|5|||
33286597|NCT01183858|62663032|FG000|Overall Study|Lost to Follow-up|1|||
33286598|NCT01183858|62663033|FG001|Overall Study|Lost to Follow-up|1|||
33286599|NCT01215175|62663044|FG000|Overall Study|Lost to Follow-up|0|||
33286600|NCT01215175|62663045|FG001|Overall Study|Lost to Follow-up|1|||
33286601|NCT01215175|62663046|FG002|Overall Study|Lost to Follow-up|0|||
33286602|NCT01215175|62663047|FG003|Overall Study|Lost to Follow-up|1|||
33372821|NCT00591786|62751703|FG009|Overall Study|Withdrawal of Informed Consent|0|||
33372822|NCT00674362|62751727|FG000|Double Blind|Adverse Event|6|||
33372823|NCT00674362|62751728|FG001|Double Blind|Adverse Event|6|||
33372824|NCT00674362|62751727|FG000|Double Blind|Lack of Efficacy|2|||
33372825|NCT00674362|62751728|FG001|Double Blind|Lack of Efficacy|6|||
33372826|NCT00674362|62751727|FG000|Double Blind|Loss of efficacy|0|||
33372827|NCT00674362|62751728|FG001|Double Blind|Loss of efficacy|1|||
33372828|NCT00674362|62751727|FG000|Double Blind|Withdrawal by Subject|4|||
33372829|NCT00674362|62751728|FG001|Double Blind|Withdrawal by Subject|3|||
33372830|NCT00674362|62751727|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
33372831|NCT00674362|62751728|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
33372832|NCT00674362|62751727|FG000|Double Blind|Other: Surgery|0|||
33372833|NCT00674362|62751728|FG001|Double Blind|Other: Surgery|1|||
33372834|NCT00674362|62751727|FG000|Open Label|Adverse Event|1|||
33286603|NCT01215175|62663048|FG004|Overall Study|Lost to Follow-up|0|||
33286604|NCT01215097|62663062|FG000|Overall Study|Adverse Event|1|||
33286605|NCT01215097|62663063|FG001|Overall Study|Adverse Event|3|||
33286606|NCT01215097|62663062|FG000|Overall Study|Protocol Violation|0|||
33286607|NCT01215097|62663063|FG001|Overall Study|Protocol Violation|2|||
33286608|NCT01215097|62663062|FG000|Overall Study|Lost to Follow-up|2|||
33286609|NCT01215097|62663063|FG001|Overall Study|Lost to Follow-up|0|||
33286610|NCT01215097|62663062|FG000|Overall Study|Withdrawal by Subject|6|||
33372835|NCT00674362|62751728|FG001|Open Label|Adverse Event|0|||
33372836|NCT00674362|62751727|FG000|Open Label|Other: Subject moved to extension study|1|||
33372837|NCT00674362|62751728|FG001|Open Label|Other: Subject moved to extension study|0|||
33372838|NCT00820950|62751740|FG000|Overall Study|Scheduling Conflict|0|||
33372839|NCT00820950|62751741|FG001|Overall Study|Scheduling Conflict|0|||
33372840|NCT00820950|62751742|FG002|Overall Study|Scheduling Conflict|0|||
33372841|NCT00820950|62751743|FG003|Overall Study|Scheduling Conflict|0|||
33372842|NCT00820950|62751744|FG004|Overall Study|Scheduling Conflict|0|||
33286611|NCT01215097|62663063|FG001|Overall Study|Withdrawal by Subject|3|||
33286612|NCT01215097|62663062|FG000|Overall Study|Lack of Efficacy|0|||
33286613|NCT01215097|62663063|FG001|Overall Study|Lack of Efficacy|3|||
33286614|NCT01215097|62663062|FG000|Overall Study|patient's refusal to come|2|||
33286615|NCT01215097|62663063|FG001|Overall Study|patient's refusal to come|2|||
33286616|NCT01215097|62663062|FG000|Overall Study|patient's private reason|1|||
33286617|NCT01215097|62663063|FG001|Overall Study|patient's private reason|1|||
33286618|NCT03303339|62663081|FG000|Overall Study|Death|2|||
33286619|NCT03303339|62663082|FG001|Overall Study|Death|2|||
33286620|NCT03303339|62663083|FG002|Overall Study|Death|2|||
33286621|NCT03303339|62663084|FG003|Overall Study|Death|1|||
33286622|NCT03303339|62663085|FG004|Overall Study|Death|4|||
33286623|NCT03303339|62663086|FG005|Overall Study|Death|2|||
33286624|NCT03303339|62663087|FG006|Overall Study|Death|2|||
33286625|NCT03303339|62663088|FG007|Overall Study|Death|2|||
33286626|NCT03303339|62663089|FG008|Overall Study|Death|3|||
33286627|NCT03303339|62663090|FG009|Overall Study|Death|3|||
33286628|NCT03303339|62663091|FG010|Overall Study|Death|4|||
33286629|NCT03303339|62663092|FG011|Overall Study|Death|24|||
33286630|NCT03303339|62663081|FG000|Overall Study|Study Terminated by Sponsor|0|||
33372843|NCT00820950|62751745|FG005|Overall Study|Scheduling Conflict|0|||
33372844|NCT00820950|62751746|FG006|Overall Study|Scheduling Conflict|1|||
33372845|NCT00820950|62751747|FG007|Overall Study|Scheduling Conflict|1|||
33372846|NCT00820950|62751748|FG008|Overall Study|Scheduling Conflict|0|||
33372847|NCT00820950|62751749|FG009|Overall Study|Scheduling Conflict|0|||
33372848|NCT00820950|62751740|FG000|Overall Study|Protocol Violation|1|||
33372849|NCT00820950|62751741|FG001|Overall Study|Protocol Violation|1|||
33372850|NCT00820950|62751742|FG002|Overall Study|Protocol Violation|0|||
33372851|NCT00820950|62751743|FG003|Overall Study|Protocol Violation|0|||
33372852|NCT00820950|62751744|FG004|Overall Study|Protocol Violation|0|||
33372853|NCT00820950|62751745|FG005|Overall Study|Protocol Violation|0|||
33372854|NCT00820950|62751746|FG006|Overall Study|Protocol Violation|0|||
33372855|NCT00820950|62751747|FG007|Overall Study|Protocol Violation|0|||
33372856|NCT00820950|62751748|FG008|Overall Study|Protocol Violation|0|||
33372857|NCT00820950|62751749|FG009|Overall Study|Protocol Violation|0|||
33372858|NCT00670306|62751789|FG000|Overall Study|Adverse Event|8|||
33372859|NCT00670306|62751789|FG000|Overall Study|Lack of Efficacy|10|||
33372860|NCT00670306|62751789|FG000|Overall Study|Withdrawal by Subject|9|||
33372861|NCT00670306|62751789|FG000|Overall Study|Physician Decision|1|||
33372862|NCT00670306|62751789|FG000|Overall Study|Lost to Follow-up|8|||
33372863|NCT00670306|62751789|FG000|Overall Study|incl/excl criterias did not meet|19|||
33372864|NCT00672256|62751793|FG000|Overall Study|PI dropped, bad data|44|||
33372865|NCT00591630|62751801|FG000|Overall Study|Death|0|||
33372866|NCT00591630|62751802|FG001|Overall Study|Death|0|||
33372867|NCT00591630|62751803|FG002|Overall Study|Death|1|||
33372868|NCT00591630|62751804|FG003|Overall Study|Death|0|||
33372869|NCT00670228|62751816|FG000|Overall Study|Adverse Event|1|||
33372870|NCT00670228|62751817|FG001|Overall Study|Adverse Event|0|||
33372871|NCT00670228|62751816|FG000|Overall Study|Death or MACE|0|||
33372872|NCT00670228|62751817|FG001|Overall Study|Death or MACE|1|||
33372873|NCT00670228|62751816|FG000|Overall Study|Not treated|2|||
33372874|NCT00670228|62751817|FG001|Overall Study|Not treated|2|||
33372875|NCT00670228|62751816|FG000|Overall Study|Not meeting the selection criteria|2|||
33286631|NCT03303339|62663082|FG001|Overall Study|Study Terminated by Sponsor|0|||
33286632|NCT03303339|62663083|FG002|Overall Study|Study Terminated by Sponsor|0|||
33372876|NCT00670228|62751817|FG001|Overall Study|Not meeting the selection criteria|0|||
33372877|NCT00570778|62751823|FG000|Overall Study|Protocol deviation|2|||
33372878|NCT00570778|62751824|FG001|Overall Study|Protocol deviation|1|||
33372879|NCT00570778|62751825|FG002|Overall Study|Protocol deviation|2|||
33372880|NCT00570778|62751826|FG003|Overall Study|Protocol deviation|2|||
33372881|NCT00570778|62751823|FG000|Overall Study|Adverse Event|0|||
33372882|NCT00570778|62751824|FG001|Overall Study|Adverse Event|1|||
33372883|NCT00570778|62751825|FG002|Overall Study|Adverse Event|4|||
33372884|NCT00570778|62751826|FG003|Overall Study|Adverse Event|1|||
33486545|NCT01332266|62864479|FG001|Phase 1b|Lost to Follow-up|1|||
33286633|NCT03303339|62663084|FG003|Overall Study|Study Terminated by Sponsor|0|||
33286634|NCT03303339|62663085|FG004|Overall Study|Study Terminated by Sponsor|0|||
33286635|NCT03303339|62663086|FG005|Overall Study|Study Terminated by Sponsor|0|||
33286636|NCT03303339|62663087|FG006|Overall Study|Study Terminated by Sponsor|0|||
33286637|NCT03303339|62663088|FG007|Overall Study|Study Terminated by Sponsor|0|||
33286638|NCT03303339|62663089|FG008|Overall Study|Study Terminated by Sponsor|1|||
33286639|NCT03303339|62663090|FG009|Overall Study|Study Terminated by Sponsor|0|||
33286640|NCT03303339|62663091|FG010|Overall Study|Study Terminated by Sponsor|1|||
33286641|NCT03303339|62663092|FG011|Overall Study|Study Terminated by Sponsor|1|||
33286642|NCT03303339|62663081|FG000|Overall Study|Withdrawal by Subject|1|||
33286643|NCT03303339|62663082|FG001|Overall Study|Withdrawal by Subject|0|||
33372885|NCT00570778|62751823|FG000|Overall Study|Subject withdrew consent|0|||
33372886|NCT00570778|62751824|FG001|Overall Study|Subject withdrew consent|1|||
33372887|NCT00570778|62751825|FG002|Overall Study|Subject withdrew consent|0|||
33372888|NCT00570778|62751826|FG003|Overall Study|Subject withdrew consent|1|||
33372889|NCT00570778|62751823|FG000|Overall Study|Abnormal test procedure|1|||
33372890|NCT00570778|62751824|FG001|Overall Study|Abnormal test procedure|0|||
33286644|NCT03303339|62663083|FG002|Overall Study|Withdrawal by Subject|0|||
33286645|NCT03303339|62663084|FG003|Overall Study|Withdrawal by Subject|0|||
33372891|NCT00570778|62751825|FG002|Overall Study|Abnormal test procedure|0|||
33372892|NCT00570778|62751826|FG003|Overall Study|Abnormal test procedure|0|||
33372893|NCT00570778|62751823|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33372894|NCT00570778|62751824|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33486546|NCT01332266|62864480|FG002|Phase 1b|Lost to Follow-up|0|||
33372895|NCT00570778|62751825|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33372896|NCT00570778|62751826|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
33372897|NCT00570778|62751823|FG000|Overall Study|Lost to Follow-up|0|||
33372898|NCT00570778|62751824|FG001|Overall Study|Lost to Follow-up|0|||
33372899|NCT00570778|62751825|FG002|Overall Study|Lost to Follow-up|1|||
33372900|NCT00570778|62751826|FG003|Overall Study|Lost to Follow-up|0|||
33372901|NCT00570778|62751823|FG000|Overall Study|Subject no longer requires study drug|0|||
33372902|NCT00570778|62751824|FG001|Overall Study|Subject no longer requires study drug|1|||
33286646|NCT03303339|62663085|FG004|Overall Study|Withdrawal by Subject|0|||
33286647|NCT03303339|62663086|FG005|Overall Study|Withdrawal by Subject|1|||
33286648|NCT03303339|62663087|FG006|Overall Study|Withdrawal by Subject|1|||
33286649|NCT03303339|62663088|FG007|Overall Study|Withdrawal by Subject|0|||
33372903|NCT00570778|62751825|FG002|Overall Study|Subject no longer requires study drug|0|||
33372904|NCT00570778|62751826|FG003|Overall Study|Subject no longer requires study drug|0|||
33372905|NCT00668746|62751838|FG000|Overall Study|Lost to Follow-up|2|||
33372906|NCT00668746|62751839|FG001|Overall Study|Lost to Follow-up|1|||
33372907|NCT00878189|62751857|FG000|Overall Study|Death|0|||
33372908|NCT00878189|62751858|FG001|Overall Study|Death|1|||
33372909|NCT00878189|62751859|FG002|Overall Study|Death|0|||
33372910|NCT00878189|62751860|FG003|Overall Study|Death|1|||
33372911|NCT00878189|62751861|FG004|Overall Study|Death|0|||
33372912|NCT00878189|62751862|FG005|Overall Study|Death|0|||
33372913|NCT00878189|62751863|FG006|Overall Study|Death|0|||
33372914|NCT00878189|62751864|FG007|Overall Study|Death|0|||
33372915|NCT00878189|62751865|FG008|Overall Study|Death|1|||
33372916|NCT00878189|62751857|FG000|Overall Study|Participant Refused to Follow-up|0|||
33372917|NCT00878189|62751858|FG001|Overall Study|Participant Refused to Follow-up|0|||
33372918|NCT00878189|62751859|FG002|Overall Study|Participant Refused to Follow-up|0|||
33372919|NCT00878189|62751860|FG003|Overall Study|Participant Refused to Follow-up|0|||
33286650|NCT03303339|62663089|FG008|Overall Study|Withdrawal by Subject|0|||
33286651|NCT03303339|62663090|FG009|Overall Study|Withdrawal by Subject|0|||
33286652|NCT03303339|62663091|FG010|Overall Study|Withdrawal by Subject|0|||
33286653|NCT03303339|62663092|FG011|Overall Study|Withdrawal by Subject|2|||
33286654|NCT03303339|62663081|FG000|Overall Study|Physician Decision|0|||
33286655|NCT03303339|62663082|FG001|Overall Study|Physician Decision|0|||
33286656|NCT03303339|62663083|FG002|Overall Study|Physician Decision|0|||
33286657|NCT03303339|62663084|FG003|Overall Study|Physician Decision|0|||
33286658|NCT03303339|62663085|FG004|Overall Study|Physician Decision|1|||
33286659|NCT03303339|62663086|FG005|Overall Study|Physician Decision|0|||
33286660|NCT03303339|62663087|FG006|Overall Study|Physician Decision|0|||
33286661|NCT03303339|62663088|FG007|Overall Study|Physician Decision|0|||
33286662|NCT03303339|62663089|FG008|Overall Study|Physician Decision|0|||
33286663|NCT03303339|62663090|FG009|Overall Study|Physician Decision|0|||
33286664|NCT03303339|62663091|FG010|Overall Study|Physician Decision|0|||
33286665|NCT03303339|62663092|FG011|Overall Study|Physician Decision|0|||
33286666|NCT03303339|62663081|FG000|Overall Study|Safety/Non-compliance|0|||
33286667|NCT03303339|62663082|FG001|Overall Study|Safety/Non-compliance|0|||
33286668|NCT03303339|62663083|FG002|Overall Study|Safety/Non-compliance|0|||
33286669|NCT03303339|62663084|FG003|Overall Study|Safety/Non-compliance|0|||
33286670|NCT03303339|62663085|FG004|Overall Study|Safety/Non-compliance|0|||
33286671|NCT03303339|62663086|FG005|Overall Study|Safety/Non-compliance|0|||
33286672|NCT03303339|62663087|FG006|Overall Study|Safety/Non-compliance|0|||
33286673|NCT03303339|62663088|FG007|Overall Study|Safety/Non-compliance|0|||
33286674|NCT03303339|62663089|FG008|Overall Study|Safety/Non-compliance|0|||
33286675|NCT03303339|62663090|FG009|Overall Study|Safety/Non-compliance|0|||
33286676|NCT03303339|62663091|FG010|Overall Study|Safety/Non-compliance|0|||
33286677|NCT03303339|62663092|FG011|Overall Study|Safety/Non-compliance|1|||
33286678|NCT01183780|62663137|FG000|Overall Study|Withdrawal by Subject|25|||
33286679|NCT01183780|62663138|FG001|Overall Study|Withdrawal by Subject|14|||
33286680|NCT01183780|62663137|FG000|Overall Study|Lost to Follow-up|6|||
33286681|NCT01183780|62663138|FG001|Overall Study|Lost to Follow-up|11|||
33286682|NCT01183468|62663148|FG000|Overall Study|Lost to Follow-up|2|||
33372920|NCT00878189|62751861|FG004|Overall Study|Participant Refused to Follow-up|0|||
33372921|NCT00878189|62751862|FG005|Overall Study|Participant Refused to Follow-up|4|||
33286683|NCT01183468|62663149|FG001|Overall Study|Lost to Follow-up|1|||
33286684|NCT01183468|62663150|FG002|Overall Study|Lost to Follow-up|0|||
33286685|NCT01183468|62663151|FG003|Overall Study|Lost to Follow-up|0|||
33286686|NCT01183468|62663148|FG000|Overall Study|Physician Decision|1|||
33286687|NCT01183468|62663149|FG001|Overall Study|Physician Decision|0|||
33372922|NCT00878189|62751863|FG006|Overall Study|Participant Refused to Follow-up|0|||
33372923|NCT00878189|62751864|FG007|Overall Study|Participant Refused to Follow-up|0|||
33372924|NCT00878189|62751865|FG008|Overall Study|Participant Refused to Follow-up|0|||
33372925|NCT00878189|62751857|FG000|Overall Study|Other|3|||
33372926|NCT00878189|62751858|FG001|Overall Study|Other|2|||
33372927|NCT00878189|62751859|FG002|Overall Study|Other|4|||
33286688|NCT01183468|62663150|FG002|Overall Study|Physician Decision|0|||
33286689|NCT01183468|62663151|FG003|Overall Study|Physician Decision|0|||
33372928|NCT00878189|62751860|FG003|Overall Study|Other|7|||
33286690|NCT01183468|62663148|FG000|Overall Study|Withdrawal by Subject|0|||
33286691|NCT01183468|62663149|FG001|Overall Study|Withdrawal by Subject|1|||
33286692|NCT01183468|62663150|FG002|Overall Study|Withdrawal by Subject|0|||
33286693|NCT01183468|62663151|FG003|Overall Study|Withdrawal by Subject|0|||
33286694|NCT01183390|62663161|FG000|First Intervention|Adverse Event|0|||
33286695|NCT01183390|62663162|FG001|First Intervention|Adverse Event|1|||
33286696|NCT01214668|62663174|FG000|Overall Study|Adverse Event|0|||
33286697|NCT01214668|62663175|FG001|Overall Study|Adverse Event|1|||
33286698|NCT01214668|62663176|FG002|Overall Study|Adverse Event|0|||
33286699|NCT01214668|62663177|FG003|Overall Study|Adverse Event|2|||
33286700|NCT01214668|62663178|FG004|Overall Study|Adverse Event|1|||
33286701|NCT01214668|62663179|FG005|Overall Study|Adverse Event|1|||
33286702|NCT01214668|62663174|FG000|Overall Study|Death|0|||
33372929|NCT00878189|62751861|FG004|Overall Study|Other|4|||
33372930|NCT00878189|62751862|FG005|Overall Study|Other|18|||
33372931|NCT00878189|62751863|FG006|Overall Study|Other|15|||
33286703|NCT01214668|62663175|FG001|Overall Study|Death|0|||
33286704|NCT01214668|62663176|FG002|Overall Study|Death|1|||
33286705|NCT01214668|62663177|FG003|Overall Study|Death|0|||
33286706|NCT01214668|62663178|FG004|Overall Study|Death|0|||
33286707|NCT01214668|62663179|FG005|Overall Study|Death|0|||
33286708|NCT01214668|62663174|FG000|Overall Study|Progressive Disease|4|||
33286709|NCT01214668|62663175|FG001|Overall Study|Progressive Disease|2|||
33286710|NCT01214668|62663176|FG002|Overall Study|Progressive Disease|5|||
33286711|NCT01214668|62663177|FG003|Overall Study|Progressive Disease|4|||
33286712|NCT01214668|62663178|FG004|Overall Study|Progressive Disease|4|||
33286713|NCT01214668|62663179|FG005|Overall Study|Progressive Disease|5|||
33286714|NCT01214668|62663174|FG000|Overall Study|Withdrawal by Subject|0|||
33286715|NCT01214668|62663175|FG001|Overall Study|Withdrawal by Subject|0|||
33286716|NCT01214668|62663176|FG002|Overall Study|Withdrawal by Subject|0|||
33286717|NCT01214668|62663177|FG003|Overall Study|Withdrawal by Subject|0|||
33286718|NCT01214668|62663178|FG004|Overall Study|Withdrawal by Subject|1|||
33286719|NCT01214668|62663179|FG005|Overall Study|Withdrawal by Subject|0|||
33286720|NCT01191268|62663197|FG000|Overall Study|Withdrawal by Subject|19|||
33286721|NCT01191268|62663198|FG001|Overall Study|Withdrawal by Subject|25|||
33286722|NCT01191268|62663199|FG002|Overall Study|Withdrawal by Subject|21|||
33286723|NCT01191268|62663197|FG000|Overall Study|Adverse Event|21|||
33286724|NCT01191268|62663198|FG001|Overall Study|Adverse Event|13|||
33286725|NCT01191268|62663199|FG002|Overall Study|Adverse Event|8|||
33286726|NCT01191268|62663197|FG000|Overall Study|Physician Decision|6|||
33286727|NCT01191268|62663198|FG001|Overall Study|Physician Decision|8|||
33286728|NCT01191268|62663199|FG002|Overall Study|Physician Decision|9|||
33286729|NCT01191268|62663197|FG000|Overall Study|Lost to Follow-up|8|||
33286730|NCT01191268|62663198|FG001|Overall Study|Lost to Follow-up|5|||
33286731|NCT01191268|62663199|FG002|Overall Study|Lost to Follow-up|9|||
33286732|NCT01191268|62663197|FG000|Overall Study|Entry Criteria Not Met|3|||
33286733|NCT01191268|62663198|FG001|Overall Study|Entry Criteria Not Met|1|||
33286734|NCT01191268|62663199|FG002|Overall Study|Entry Criteria Not Met|1|||
33286735|NCT01191268|62663197|FG000|Overall Study|Death|0|||
33286736|NCT01191268|62663198|FG001|Overall Study|Death|1|||
33286737|NCT01191268|62663199|FG002|Overall Study|Death|3|||
33286738|NCT01191268|62663197|FG000|Overall Study|Protocol Violation|1|||
33286739|NCT01191268|62663198|FG001|Overall Study|Protocol Violation|0|||
33286740|NCT01191268|62663199|FG002|Overall Study|Protocol Violation|1|||
33286741|NCT01191268|62663197|FG000|Overall Study|Sponsor Decision|0|||
33286742|NCT01191268|62663198|FG001|Overall Study|Sponsor Decision|2|||
33286743|NCT01191268|62663199|FG002|Overall Study|Sponsor Decision|0|||
33286744|NCT01191190|62663208|FG000|Overall Study|Withdrawal by Subject|1|||
33556281|NCT03142191|62949075|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
33556282|NCT03142191|62949071|FG000|Active Treatment Extension Period|Physician Decision|2|||
33286745|NCT05751629|62663212|FG000|Overall Study|Withdrawal by Subject|6|||
33286746|NCT05751629|62663212|FG000|Overall Study|Death|25|||
33372932|NCT00878189|62751864|FG007|Overall Study|Other|3|||
33286747|NCT05751629|62663212|FG000|Overall Study|Study Site Closed|9|||
33286748|NCT05751629|62663212|FG000|Overall Study|Physician Decision|1|||
33286749|NCT05306977|62663216|FG000|Overall Study|Withdrawal by Subject|1|||
33286750|NCT05086276|62663222|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
33286751|NCT05086276|62663223|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
33286752|NCT04870710|62663229|FG000|Overall Study|Lost to Follow-up|3|||
33286753|NCT04858802|62663235|FG000|Overall Study|Lost to Follow-up|1|||
33372933|NCT00878189|62751865|FG008|Overall Study|Other|4|||
33372934|NCT00878189|62751857|FG000|Overall Study|Lost to Follow-up|0|||
33286754|NCT04858802|62663236|FG001|Overall Study|Lost to Follow-up|1|||
33286755|NCT04858802|62663235|FG000|Overall Study|Withdrawal by Subject|1|||
33286756|NCT04858802|62663236|FG001|Overall Study|Withdrawal by Subject|1|||
33286757|NCT04562090|62663254|FG000|Overall Study|Withdrawal by Subject|3|||
33286758|NCT04562090|62663255|FG001|Overall Study|Withdrawal by Subject|4|||
33286759|NCT04562090|62663254|FG000|Overall Study|Protocol Violation|2|||
33286760|NCT04562090|62663255|FG001|Overall Study|Protocol Violation|0|||
33286761|NCT04562090|62663254|FG000|Overall Study|Lack of Efficacy|0|||
33372935|NCT00878189|62751858|FG001|Overall Study|Lost to Follow-up|0|||
33372936|NCT00878189|62751859|FG002|Overall Study|Lost to Follow-up|0|||
33372937|NCT00878189|62751860|FG003|Overall Study|Lost to Follow-up|0|||
33372938|NCT00878189|62751861|FG004|Overall Study|Lost to Follow-up|0|||
33372939|NCT00878189|62751862|FG005|Overall Study|Lost to Follow-up|1|||
33372940|NCT00878189|62751863|FG006|Overall Study|Lost to Follow-up|1|||
33372941|NCT00878189|62751864|FG007|Overall Study|Lost to Follow-up|0|||
33372942|NCT00878189|62751865|FG008|Overall Study|Lost to Follow-up|0|||
33372943|NCT00878189|62751857|FG000|Overall Study|Objection Progression or Relapse|0|||
33372944|NCT00878189|62751858|FG001|Overall Study|Objection Progression or Relapse|0|||
33372945|NCT00878189|62751859|FG002|Overall Study|Objection Progression or Relapse|0|||
33372946|NCT00878189|62751860|FG003|Overall Study|Objection Progression or Relapse|0|||
33372947|NCT00878189|62751861|FG004|Overall Study|Objection Progression or Relapse|0|||
33372948|NCT00878189|62751862|FG005|Overall Study|Objection Progression or Relapse|0|||
33372949|NCT00878189|62751863|FG006|Overall Study|Objection Progression or Relapse|0|||
33372950|NCT00878189|62751864|FG007|Overall Study|Objection Progression or Relapse|0|||
33372951|NCT00878189|62751865|FG008|Overall Study|Objection Progression or Relapse|3|||
33372952|NCT00668200|62751899|FG000|Overall Study|Withdrawal by Subject|2|||
33372953|NCT00668200|62751899|FG000|Overall Study|Lost to Follow-up|1|||
33372954|NCT00838578|62751903|FG000|Overall Study|Protocol Violation|2|||
33372955|NCT00829296|62751913|FG000|Overall Study|Adverse Event|5|||
33372956|NCT00829296|62751914|FG001|Overall Study|Adverse Event|4|||
33372957|NCT00881621|62751920|FG000|Overall Study|Physician Decision|34|||
33372958|NCT00818766|62751926|FG000|Overall Study|Could not be Contacted on Day 28|11|||
33372959|NCT00818766|62751927|FG001|Overall Study|Could not be Contacted on Day 28|10|||
33372960|NCT00818766|62751926|FG000|Overall Study|Death|1|||
33372961|NCT00818766|62751927|FG001|Overall Study|Death|0|||
33372962|NCT00818766|62751926|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
33372963|NCT00818766|62751927|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
33372964|NCT00667888|62751935|FG000|Overall Study|Death|1|||
33372965|NCT00667888|62751936|FG001|Overall Study|Death|1|||
33372966|NCT00667888|62751935|FG000|Overall Study|Withdrawal by Subject|6|||
33372967|NCT00667888|62751936|FG001|Overall Study|Withdrawal by Subject|3|||
33372968|NCT00667888|62751935|FG000|Overall Study|Proceed with other treatment|3|||
33372969|NCT00667888|62751936|FG001|Overall Study|Proceed with other treatment|3|||
33372970|NCT00667888|62751935|FG000|Overall Study|Ineligible after SIM|0|||
33372971|NCT00667888|62751936|FG001|Overall Study|Ineligible after SIM|2|||
33372972|NCT00594815|62751942|FG000|Overall Study|Never Treated|3|||
33372973|NCT00594815|62751942|FG000|Overall Study|Withdrawal by Subject|2|||
33372974|NCT00594815|62751942|FG000|Overall Study|Toxicity|4|||
33372975|NCT00820170|62751951|FG000|Overall Study|Adverse Event|0|||
33372976|NCT00820170|62751952|FG001|Overall Study|Adverse Event|0|||
33372977|NCT00820170|62751953|FG002|Overall Study|Adverse Event|0|||
33372978|NCT00820170|62751954|FG003|Overall Study|Adverse Event|0|||
33372979|NCT00820170|62751955|FG004|Overall Study|Adverse Event|2|||
33372980|NCT00820170|62751951|FG000|Overall Study|Progressive Disease|0|||
33372981|NCT00820170|62751952|FG001|Overall Study|Progressive Disease|0|||
33372982|NCT00820170|62751953|FG002|Overall Study|Progressive Disease|0|||
33662262|NCT01695239|63092844|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
33662263|NCT01695239|63092845|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
33286762|NCT04562090|62663255|FG001|Overall Study|Lack of Efficacy|1|||
33286763|NCT04562090|62663254|FG000|Overall Study|Adverse Event|1|||
33286764|NCT04562090|62663255|FG001|Overall Study|Adverse Event|4|||
33286765|NCT04562090|62663254|FG000|Overall Study|Miscellaneous|0|||
33286766|NCT04562090|62663255|FG001|Overall Study|Miscellaneous|3|||
33286767|NCT04557189|62663266|FG000|Overall Study|Adverse Event|0|||
33286768|NCT04557189|62663267|FG001|Overall Study|Adverse Event|1|||
33286769|NCT04557189|62663266|FG000|Overall Study|Lost to Follow-up|1|||
33286770|NCT04557189|62663267|FG001|Overall Study|Lost to Follow-up|1|||
33286771|NCT04557189|62663266|FG000|Overall Study|Withdrawal by Subject|2|||
33286772|NCT04557189|62663267|FG001|Overall Study|Withdrawal by Subject|1|||
33286773|NCT04557189|62663266|FG000|Overall Study|Reason not Specified|3|||
33286774|NCT04557189|62663267|FG001|Overall Study|Reason not Specified|6|||
33286775|NCT04530838|62663280|FG000|Overall Study|Other|2|||
33286776|NCT04530838|62663281|FG001|Overall Study|Other|1|||
33286777|NCT04530838|62663282|FG002|Overall Study|Other|0|||
33286778|NCT04530838|62663280|FG000|Overall Study|Physician Decision|0|||
33286779|NCT04530838|62663281|FG001|Overall Study|Physician Decision|0|||
33286780|NCT04530838|62663282|FG002|Overall Study|Physician Decision|1|||
33286781|NCT04530838|62663280|FG000|Overall Study|Death|0|||
33286782|NCT04530838|62663281|FG001|Overall Study|Death|0|||
33372983|NCT00820170|62751954|FG003|Overall Study|Progressive Disease|0|||
33372984|NCT00820170|62751955|FG004|Overall Study|Progressive Disease|2|||
33372985|NCT00818454|62751972|FG000|Treatment Period 1|Adverse Event|0|||
33286783|NCT04530838|62663282|FG002|Overall Study|Death|1|||
33286784|NCT04530838|62663280|FG000|Overall Study|Adverse Event|0|||
33286785|NCT04530838|62663281|FG001|Overall Study|Adverse Event|1|||
33286786|NCT04530838|62663282|FG002|Overall Study|Adverse Event|0|||
33372986|NCT00818454|62751973|FG001|Treatment Period 1|Adverse Event|1|||
33372987|NCT00818454|62751974|FG002|Treatment Period 1|Adverse Event|0|||
33372988|NCT00818454|62751975|FG003|Treatment Period 1|Adverse Event|0|||
33372989|NCT00818454|62751972|FG000|Treatment Period 1|Other|3|||
33372990|NCT00818454|62751973|FG001|Treatment Period 1|Other|0|||
33372991|NCT00818454|62751974|FG002|Treatment Period 1|Other|0|||
33372992|NCT00818454|62751975|FG003|Treatment Period 1|Other|0|||
33286787|NCT04530838|62663280|FG000|Overall Study|No longer meets eligibility criteria|1|||
33286788|NCT04530838|62663281|FG001|Overall Study|No longer meets eligibility criteria|0|||
33286789|NCT04530838|62663282|FG002|Overall Study|No longer meets eligibility criteria|2|||
33286790|NCT04530838|62663280|FG000|Overall Study|Withdrawal by parent/guardian|5|||
33286791|NCT04530838|62663281|FG001|Overall Study|Withdrawal by parent/guardian|2|||
33286792|NCT04530838|62663282|FG002|Overall Study|Withdrawal by parent/guardian|2|||
33286793|NCT04424901|62663296|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
33286794|NCT04424901|62663297|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
33372993|NCT00818454|62751972|FG000|Washout Period of 1 Week|Adverse Event|1|||
33372994|NCT00818454|62751973|FG001|Washout Period of 1 Week|Adverse Event|1|||
33372995|NCT00818454|62751974|FG002|Washout Period of 1 Week|Adverse Event|0|||
33372996|NCT00818454|62751975|FG003|Washout Period of 1 Week|Adverse Event|0|||
33372997|NCT00818454|62751972|FG000|Washout Period of 1 Week|Protocol Violation|2|||
33372998|NCT00818454|62751973|FG001|Washout Period of 1 Week|Protocol Violation|0|||
33372999|NCT00818454|62751974|FG002|Washout Period of 1 Week|Protocol Violation|0|||
33373000|NCT00818454|62751975|FG003|Washout Period of 1 Week|Protocol Violation|0|||
33373001|NCT00818454|62751972|FG000|Washout Period of 1 Week|Other|1|||
33373002|NCT00818454|62751973|FG001|Washout Period of 1 Week|Other|2|||
33373003|NCT00818454|62751974|FG002|Washout Period of 1 Week|Other|0|||
33373004|NCT00818454|62751975|FG003|Washout Period of 1 Week|Other|0|||
33373005|NCT00818454|62751972|FG000|Treatment Period 2|Other|2|||
33373006|NCT00818454|62751973|FG001|Treatment Period 2|Other|1|||
33373007|NCT00818454|62751974|FG002|Treatment Period 2|Other|0|||
33373008|NCT00818454|62751975|FG003|Treatment Period 2|Other|0|||
33373009|NCT00818454|62751972|FG000|Treatment Period 3|Adverse Event|0|||
33373010|NCT00818454|62751973|FG001|Treatment Period 3|Adverse Event|0|||
33373011|NCT00818454|62751974|FG002|Treatment Period 3|Adverse Event|0|||
33373012|NCT00818454|62751975|FG003|Treatment Period 3|Adverse Event|1|||
33373013|NCT00828984|62751988|FG000|Overall Study|Adverse Event|2|||
33373014|NCT00828984|62751989|FG001|Overall Study|Adverse Event|3|||
33373015|NCT00828984|62751990|FG002|Overall Study|Adverse Event|0|||
33373016|NCT00828984|62751988|FG000|Overall Study|Lost to Follow-up|5|||
33373017|NCT00828984|62751989|FG001|Overall Study|Lost to Follow-up|3|||
33373018|NCT00828984|62751990|FG002|Overall Study|Lost to Follow-up|1|||
33373019|NCT00828984|62751988|FG000|Overall Study|Withdrawal by Subject|4|||
33373020|NCT00828984|62751989|FG001|Overall Study|Withdrawal by Subject|4|||
33373021|NCT00828984|62751990|FG002|Overall Study|Withdrawal by Subject|4|||
33373022|NCT00828984|62751988|FG000|Overall Study|Ineligable|1|||
33373023|NCT00828984|62751989|FG001|Overall Study|Ineligable|2|||
33373024|NCT00828984|62751990|FG002|Overall Study|Ineligable|0|||
33373025|NCT00828984|62751988|FG000|Overall Study|Medical Contraindication|0|||
33373026|NCT00828984|62751989|FG001|Overall Study|Medical Contraindication|1|||
33373027|NCT00828984|62751990|FG002|Overall Study|Medical Contraindication|0|||
33373028|NCT00828984|62751988|FG000|Overall Study|Noncompliant|1|||
33373029|NCT00828984|62751989|FG001|Overall Study|Noncompliant|2|||
33373030|NCT00828984|62751990|FG002|Overall Study|Noncompliant|3|||
33373031|NCT00828984|62751988|FG000|Overall Study|ConMed|1|||
33373032|NCT00828984|62751989|FG001|Overall Study|ConMed|1|||
33373033|NCT00828984|62751990|FG002|Overall Study|ConMed|1|||
33373034|NCT00828750|62751998|FG000|Overall Study|Lack of Efficacy|3|||
33373035|NCT00828750|62751998|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
33373036|NCT00667810|62752007|FG000|Overall Study|Adverse Event|13|||
33486547|NCT01332266|62864481|FG003|Phase 1b|Lost to Follow-up|0|||
33486548|NCT01332266|62864482|FG004|Phase 1b|Lost to Follow-up|0|||
33486549|NCT01332266|62864478|FG000|Phase 1b|Withdrawal by Subject|1|||
33486550|NCT01332266|62864479|FG001|Phase 1b|Withdrawal by Subject|1|||
33486551|NCT01332266|62864480|FG002|Phase 1b|Withdrawal by Subject|1|||
33486552|NCT01332266|62864481|FG003|Phase 1b|Withdrawal by Subject|0|||
33486553|NCT01332266|62864482|FG004|Phase 1b|Withdrawal by Subject|0|||
33486554|NCT01332266|62864478|FG000|Phase 2|Death|0|||
33286795|NCT04410445|62663305|FG000|Overall Study|Lost to Follow-up|3|||
33286796|NCT04410445|62663306|FG001|Overall Study|Lost to Follow-up|9|||
33373037|NCT00667810|62752008|FG001|Overall Study|Adverse Event|14|||
33373038|NCT00667810|62752009|FG002|Overall Study|Adverse Event|19|||
33373039|NCT00667810|62752010|FG003|Overall Study|Adverse Event|1|||
33373040|NCT00667810|62752007|FG000|Overall Study|Death|1|||
33373041|NCT00667810|62752008|FG001|Overall Study|Death|1|||
33373042|NCT00667810|62752009|FG002|Overall Study|Death|3|||
33373043|NCT00667810|62752010|FG003|Overall Study|Death|0|||
33373044|NCT00667810|62752007|FG000|Overall Study|Lack of Efficacy|1|||
33373045|NCT00667810|62752008|FG001|Overall Study|Lack of Efficacy|0|||
33486555|NCT01332266|62864479|FG001|Phase 2|Death|0|||
33486556|NCT01332266|62864480|FG002|Phase 2|Death|0|||
33373046|NCT00667810|62752009|FG002|Overall Study|Lack of Efficacy|2|||
33373047|NCT00667810|62752010|FG003|Overall Study|Lack of Efficacy|0|||
33373048|NCT00667810|62752007|FG000|Overall Study|Lost to Follow-up|1|||
33373049|NCT00667810|62752008|FG001|Overall Study|Lost to Follow-up|4|||
33373050|NCT00667810|62752009|FG002|Overall Study|Lost to Follow-up|2|||
33373051|NCT00667810|62752010|FG003|Overall Study|Lost to Follow-up|0|||
33373052|NCT00667810|62752007|FG000|Overall Study|Physician Decision|1|||
33373053|NCT00667810|62752008|FG001|Overall Study|Physician Decision|1|||
33373054|NCT00667810|62752009|FG002|Overall Study|Physician Decision|2|||
33373055|NCT00667810|62752010|FG003|Overall Study|Physician Decision|0|||
33373056|NCT00667810|62752007|FG000|Overall Study|Protocol Violation|0|||
33373057|NCT00667810|62752008|FG001|Overall Study|Protocol Violation|2|||
33373058|NCT00667810|62752009|FG002|Overall Study|Protocol Violation|0|||
33373059|NCT00667810|62752010|FG003|Overall Study|Protocol Violation|0|||
33373060|NCT00667810|62752007|FG000|Overall Study|Withdrawal by Subject|14|||
33373061|NCT00667810|62752008|FG001|Overall Study|Withdrawal by Subject|20|||
33373062|NCT00667810|62752009|FG002|Overall Study|Withdrawal by Subject|29|||
33373063|NCT00667810|62752010|FG003|Overall Study|Withdrawal by Subject|1|||
33373064|NCT00667810|62752007|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
33373065|NCT00667810|62752008|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
33373066|NCT00667810|62752009|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
33373067|NCT00667810|62752010|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
33373068|NCT00667810|62752007|FG000|Overall Study|Failed to Return|0|||
33373069|NCT00667810|62752008|FG001|Overall Study|Failed to Return|0|||
33373070|NCT00667810|62752009|FG002|Overall Study|Failed to Return|2|||
33373071|NCT00667810|62752010|FG003|Overall Study|Failed to Return|0|||
33286797|NCT04410445|62663305|FG000|Overall Study|Withdrawal by Subject|27|||
33286798|NCT04410445|62663306|FG001|Overall Study|Withdrawal by Subject|15|||
33286799|NCT04062448|62663330|FG000|Overall Study|Lost to Follow-up|1|||
33286800|NCT04062448|62663330|FG000|Overall Study|Withdrawal by Subject|1|||
33286801|NCT04062448|62663330|FG000|Overall Study|Ongoing|14|||
33286802|NCT03970733|62663337|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
33286803|NCT03970733|62663338|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
33286804|NCT03970733|62663339|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
33286805|NCT03970733|62663340|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
33286806|NCT03970733|62663341|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
33286807|NCT03970733|62663337|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
33286808|NCT03970733|62663338|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
33286809|NCT03970733|62663339|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
33286810|NCT03970733|62663340|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
33286811|NCT03970733|62663341|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
33286812|NCT03970733|62663337|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
33286813|NCT03970733|62663338|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
33286814|NCT03970733|62663339|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
33286815|NCT03970733|62663340|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
33286816|NCT03970733|62663341|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
33286817|NCT03970733|62663337|FG000|Main Study Phase (18 Months)|Other|1|||
33286818|NCT03970733|62663338|FG001|Main Study Phase (18 Months)|Other|1|||
33286819|NCT03970733|62663339|FG002|Main Study Phase (18 Months)|Other|0|||
33286820|NCT03970733|62663340|FG003|Main Study Phase (18 Months)|Other|0|||
33286821|NCT03970733|62663341|FG004|Main Study Phase (18 Months)|Other|0|||
33286822|NCT03970733|62663337|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
33286823|NCT03970733|62663338|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
33286824|NCT03970733|62663339|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
33286825|NCT03970733|62663340|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
33286826|NCT03970733|62663341|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
33286827|NCT03921411|62663353|FG000|Overall Study|Withdrawal by Subject|1|||
33373072|NCT00667810|62752007|FG000|Overall Study|Loss of Caregiver|0|||
33373073|NCT00667810|62752008|FG001|Overall Study|Loss of Caregiver|1|||
33373074|NCT00667810|62752009|FG002|Overall Study|Loss of Caregiver|3|||
33373075|NCT00667810|62752010|FG003|Overall Study|Loss of Caregiver|0|||
33373076|NCT00667810|62752007|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
33373077|NCT00667810|62752008|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
33373078|NCT00667810|62752009|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
33373079|NCT00667810|62752010|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
33373080|NCT00667810|62752007|FG000|Overall Study|Other|6|||
33373081|NCT00667810|62752008|FG001|Overall Study|Other|6|||
33373082|NCT00667810|62752009|FG002|Overall Study|Other|5|||
33373083|NCT00667810|62752010|FG003|Overall Study|Other|0|||
33373084|NCT00819390|62752029|FG000|Overall Study|Lost to Follow-up|1|||
33373085|NCT00819390|62752030|FG001|Overall Study|Lost to Follow-up|1|||
33286828|NCT03921411|62663353|FG000|Overall Study|Protocol Deviation|2|||
33286829|NCT03921411|62663353|FG000|Overall Study|Enrolled, but never treated|2|||
33373086|NCT00819390|62752031|FG002|Overall Study|Lost to Follow-up|0|||
33373087|NCT00819390|62752032|FG003|Overall Study|Lost to Follow-up|0|||
33286830|NCT03728582|62663357|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
33286831|NCT03728582|62663358|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
33286832|NCT03728582|62663357|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
33286833|NCT03728582|62663358|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
33286834|NCT03416179|62663377|FG000|Overall Study|Death|90|||
33286835|NCT03416179|62663378|FG001|Overall Study|Death|87|||
33286836|NCT03416179|62663379|FG002|Overall Study|Death|117|||
33286837|NCT03416179|62663380|FG003|Overall Study|Death|113|||
33286838|NCT03416179|62663377|FG000|Overall Study|Withdrawal by Subject|15|||
33286839|NCT03416179|62663378|FG001|Overall Study|Withdrawal by Subject|20|||
33286840|NCT03416179|62663379|FG002|Overall Study|Withdrawal by Subject|6|||
33286841|NCT03416179|62663380|FG003|Overall Study|Withdrawal by Subject|9|||
33286842|NCT03416179|62663377|FG000|Overall Study|Lost to Follow-up|1|||
33286843|NCT03416179|62663378|FG001|Overall Study|Lost to Follow-up|1|||
33286844|NCT03416179|62663379|FG002|Overall Study|Lost to Follow-up|0|||
33286845|NCT03416179|62663380|FG003|Overall Study|Lost to Follow-up|3|||
33286846|NCT03416179|62663377|FG000|Overall Study|Study participation terminated by Sponsor|93|||
33286847|NCT03416179|62663378|FG001|Overall Study|Study participation terminated by Sponsor|91|||
33286848|NCT03416179|62663379|FG002|Overall Study|Study participation terminated by Sponsor|26|||
33286849|NCT03416179|62663380|FG003|Overall Study|Study participation terminated by Sponsor|31|||
33286850|NCT03416179|62663377|FG000|Overall Study|Other|2|||
33286851|NCT03416179|62663378|FG001|Overall Study|Other|3|||
33286852|NCT03416179|62663379|FG002|Overall Study|Other|1|||
33286853|NCT03416179|62663380|FG003|Overall Study|Other|0|||
33286854|NCT02932332|62663407|FG000|Overall Study|Withdrawal by Subject|1|||
33286855|NCT02932332|62663408|FG001|Overall Study|Withdrawal by Subject|1|||
33286856|NCT02932332|62663409|FG002|Overall Study|Withdrawal by Subject|0|||
33286857|NCT02932332|62663410|FG003|Overall Study|Withdrawal by Subject|1|||
33286858|NCT02932332|62663407|FG000|Overall Study|Chest pain|0|||
33286859|NCT02932332|62663408|FG001|Overall Study|Chest pain|0|||
33286860|NCT02932332|62663409|FG002|Overall Study|Chest pain|0|||
33286861|NCT02932332|62663410|FG003|Overall Study|Chest pain|1|||
33286862|NCT02932332|62663407|FG000|Overall Study|Not Dyspneic cough|1|||
33286863|NCT02932332|62663408|FG001|Overall Study|Not Dyspneic cough|2|||
33286864|NCT02932332|62663409|FG002|Overall Study|Not Dyspneic cough|1|||
33286865|NCT02932332|62663410|FG003|Overall Study|Not Dyspneic cough|0|||
33286866|NCT02820623|62663444|FG000|Overall Study|Withdrawal by Subject|1|||
33286867|NCT02820623|62663445|FG001|Overall Study|Withdrawal by Subject|3|||
33286868|NCT02820623|62663446|FG002|Overall Study|Withdrawal by Subject|3|||
33286869|NCT02820623|62663444|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
33286870|NCT02820623|62663445|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
33286871|NCT02820623|62663446|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
33286872|NCT02820623|62663444|FG000|Overall Study|Therapist unable to enroll clients|1|||
33286873|NCT02820623|62663445|FG001|Overall Study|Therapist unable to enroll clients|1|||
33286874|NCT02820623|62663446|FG002|Overall Study|Therapist unable to enroll clients|3|||
33286875|NCT02820623|62663444|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
33286876|NCT02820623|62663445|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
33286877|NCT02820623|62663446|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
33286878|NCT02774005|62663454|FG000|Overall Study|Adverse Event|8|||
33286879|NCT02774005|62663454|FG000|Overall Study|Withdrawal by Subject|23|||
33286880|NCT02774005|62663454|FG000|Overall Study|Lost to Follow-up|7|||
33286881|NCT02774005|62663454|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
33286882|NCT02774005|62663454|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
33373088|NCT00819390|62752029|FG000|Overall Study|Withdrawal by Subject|2|||
33373089|NCT00819390|62752030|FG001|Overall Study|Withdrawal by Subject|0|||
33373090|NCT00819390|62752031|FG002|Overall Study|Withdrawal by Subject|0|||
33373091|NCT00819390|62752032|FG003|Overall Study|Withdrawal by Subject|0|||
33373092|NCT00819390|62752029|FG000|Overall Study|Adverse Event|0|||
33373093|NCT00819390|62752030|FG001|Overall Study|Adverse Event|0|||
33373094|NCT00819390|62752031|FG002|Overall Study|Adverse Event|1|||
33286883|NCT02774005|62663454|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
33286884|NCT02774005|62663454|FG000|Overall Study|Death|1|||
33286885|NCT02774005|62663454|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
33286886|NCT02774005|62663454|FG000|Overall Study|Lack of compliance with study medication|4|||
33373095|NCT00819390|62752032|FG003|Overall Study|Adverse Event|0|||
33373096|NCT00876395|62752047|FG000|Overall Study|Untreated|8|||
33373097|NCT00876395|62752048|FG001|Overall Study|Untreated|1|||
33286887|NCT02774005|62663454|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
33286888|NCT02774005|62663454|FG000|Overall Study|another study|1|||
33286889|NCT02774005|62663454|FG000|Overall Study|cardiologist imposed travel restriction|1|||
33286890|NCT01975428|62663488|FG000|Overall Study|Lost to Follow-up|17|||
33286891|NCT01975428|62663489|FG001|Overall Study|Lost to Follow-up|4|||
33286892|NCT01975428|62663488|FG000|Overall Study|Withdrawal by Subject|3|||
33373098|NCT00876395|62752047|FG000|Overall Study|Adverse Event|63|||
33373099|NCT00876395|62752048|FG001|Overall Study|Adverse Event|11|||
33373100|NCT00876395|62752047|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33373101|NCT00876395|62752048|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33373102|NCT00876395|62752047|FG000|Overall Study|Disease progression|259|||
33373103|NCT00876395|62752048|FG001|Overall Study|Disease progression|162|||
33373104|NCT00876395|62752047|FG000|Overall Study|New cancer therapy|25|||
33373105|NCT00876395|62752048|FG001|Overall Study|New cancer therapy|7|||
33373106|NCT00876395|62752047|FG000|Overall Study|Protocol Violation|5|||
33373107|NCT00876395|62752048|FG001|Overall Study|Protocol Violation|2|||
33373108|NCT00876395|62752047|FG000|Overall Study|Withdrawal by Subject|66|||
33373109|NCT00876395|62752048|FG001|Overall Study|Withdrawal by Subject|33|||
33373110|NCT00876395|62752047|FG000|Overall Study|Lost to Follow-up|2|||
33373111|NCT00876395|62752048|FG001|Overall Study|Lost to Follow-up|0|||
33373112|NCT00876395|62752047|FG000|Overall Study|Administrative problems|39|||
33373113|NCT00876395|62752048|FG001|Overall Study|Administrative problems|23|||
33373114|NCT00876395|62752047|FG000|Overall Study|Death|12|||
33373115|NCT00876395|62752048|FG001|Overall Study|Death|0|||
33373116|NCT00594659|62752062|FG000|Overall Study|Lost to Follow-up|13|||
33373117|NCT00594659|62752063|FG001|Overall Study|Lost to Follow-up|9|||
33286893|NCT01975428|62663489|FG001|Overall Study|Withdrawal by Subject|10|||
33286894|NCT01047540|62663530|FG000|Overall Study|Protocol Violation|1|||
33556283|NCT03142191|62949072|FG001|Active Treatment Extension Period|Physician Decision|0|||
33556284|NCT03142191|62949073|FG002|Active Treatment Extension Period|Physician Decision|0|||
33556285|NCT03142191|62949074|FG003|Active Treatment Extension Period|Physician Decision|0|||
33556286|NCT03142191|62949075|FG004|Active Treatment Extension Period|Physician Decision|0|||
33556287|NCT03142191|62949071|FG000|Active Treatment Extension Period|Other Reasons|3|||
33556288|NCT03142191|62949072|FG001|Active Treatment Extension Period|Other Reasons|3|||
33556289|NCT03142191|62949073|FG002|Active Treatment Extension Period|Other Reasons|3|||
33556290|NCT03142191|62949074|FG003|Active Treatment Extension Period|Other Reasons|8|||
33556291|NCT03142191|62949075|FG004|Active Treatment Extension Period|Other Reasons|3|||
33556292|NCT03142191|62949071|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
33556293|NCT03142191|62949072|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
33556294|NCT03142191|62949073|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
33556295|NCT03142191|62949074|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
33556296|NCT03142191|62949075|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
33556297|NCT02617628|62949104|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
33556298|NCT02617628|62949105|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
33286895|NCT01047540|62663531|FG001|Overall Study|Protocol Violation|0|||
33286896|NCT01047540|62663532|FG002|Overall Study|Protocol Violation|0|||
33286897|NCT01047540|62663533|FG003|Overall Study|Protocol Violation|0|||
33286898|NCT01047540|62663534|FG004|Overall Study|Protocol Violation|0|||
33286899|NCT01047540|62663530|FG000|Overall Study|Lost to Follow-up|1|||
33286900|NCT01047540|62663531|FG001|Overall Study|Lost to Follow-up|0|||
33286901|NCT01047540|62663532|FG002|Overall Study|Lost to Follow-up|0|||
33286902|NCT01047540|62663533|FG003|Overall Study|Lost to Follow-up|0|||
33286903|NCT01047540|62663534|FG004|Overall Study|Lost to Follow-up|0|||
33373118|NCT00594659|62752064|FG002|Overall Study|Lost to Follow-up|7|||
33373119|NCT00667732|62752074|FG000|Run -In (8 Weeks)|Adverse Event|4|||
33373120|NCT00667732|62752075|FG001|Run -In (8 Weeks)|Adverse Event|0|||
33373121|NCT00667732|62752076|FG002|Run -In (8 Weeks)|Adverse Event|0|||
33373122|NCT00667732|62752074|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
33373123|NCT00667732|62752075|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
33373124|NCT00667732|62752076|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
33373125|NCT00667732|62752074|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
33373126|NCT00667732|62752075|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
33373127|NCT00667732|62752076|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
33373128|NCT00671788|62752086|FG000|Overall Study|Adverse Event|8|||
33286904|NCT01047540|62663530|FG000|Overall Study|Withdrawal by Subject|1|||
33286905|NCT01047540|62663531|FG001|Overall Study|Withdrawal by Subject|0|||
33286906|NCT01047540|62663532|FG002|Overall Study|Withdrawal by Subject|3|||
33286907|NCT01047540|62663533|FG003|Overall Study|Withdrawal by Subject|0|||
33286908|NCT01047540|62663534|FG004|Overall Study|Withdrawal by Subject|1|||
33286909|NCT01047540|62663530|FG000|Overall Study|Pregnancy|1|||
33286910|NCT01047540|62663531|FG001|Overall Study|Pregnancy|0|||
33286911|NCT01047540|62663532|FG002|Overall Study|Pregnancy|0|||
33286912|NCT01047540|62663533|FG003|Overall Study|Pregnancy|0|||
33286913|NCT01047540|62663534|FG004|Overall Study|Pregnancy|0|||
33373129|NCT00671788|62752086|FG000|Overall Study|Refused further treatment|3|||
33373130|NCT00671788|62752086|FG000|Overall Study|Ineligible|1|||
33373131|NCT00671788|62752086|FG000|Overall Study|MD Decision|1|||
33373132|NCT00671788|62752086|FG000|Overall Study|Other|1|||
33556299|NCT02308540|62949121|FG000|Overall Study|Lost to Follow-up|0|||
33286914|NCT01047540|62663530|FG000|Overall Study|Adverse Event|1|||
33286915|NCT01047540|62663531|FG001|Overall Study|Adverse Event|0|||
33373133|NCT00875615|62752090|FG000|Overall Study|Withdrawal by Subject|1|||
33373134|NCT00597701|62752096|FG000|Overall Study|Withdrawal by Subject|5|||
33373135|NCT00597701|62752097|FG001|Overall Study|Withdrawal by Subject|5|||
33373136|NCT00597701|62752096|FG000|Overall Study|Death|0|||
33373137|NCT00597701|62752097|FG001|Overall Study|Death|1|||
33373138|NCT00597701|62752096|FG000|Overall Study|Physician Decision|2|||
33373139|NCT00597701|62752097|FG001|Overall Study|Physician Decision|0|||
33373140|NCT00597701|62752096|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
33373141|NCT00597701|62752097|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
33373142|NCT00671554|62752103|FG000|Overall Study|Disease progression|3|||
33373143|NCT00667576|62752113|FG000|Overall Study|Withdrawal by Subject|1|||
33373144|NCT00667576|62752114|FG001|Overall Study|Withdrawal by Subject|0|||
33373145|NCT00667576|62752115|FG002|Overall Study|Withdrawal by Subject|1|||
33373146|NCT00667576|62752116|FG003|Overall Study|Withdrawal by Subject|1|||
33373147|NCT00667576|62752117|FG004|Overall Study|Withdrawal by Subject|1|||
33373148|NCT00667576|62752113|FG000|Overall Study|Adverse Event|1|||
33373149|NCT00667576|62752114|FG001|Overall Study|Adverse Event|1|||
33373150|NCT00667576|62752115|FG002|Overall Study|Adverse Event|0|||
33373151|NCT00667576|62752116|FG003|Overall Study|Adverse Event|0|||
33373152|NCT00667576|62752117|FG004|Overall Study|Adverse Event|0|||
33373153|NCT00667576|62752113|FG000|Overall Study|Lost to Follow-up|0|||
33373154|NCT00667576|62752114|FG001|Overall Study|Lost to Follow-up|0|||
33373155|NCT00667576|62752115|FG002|Overall Study|Lost to Follow-up|1|||
33373156|NCT00667576|62752116|FG003|Overall Study|Lost to Follow-up|0|||
33373157|NCT00667576|62752117|FG004|Overall Study|Lost to Follow-up|0|||
33373158|NCT00667576|62752113|FG000|Overall Study|Protocol Violation|0|||
33373159|NCT00667576|62752114|FG001|Overall Study|Protocol Violation|0|||
33373160|NCT00667576|62752115|FG002|Overall Study|Protocol Violation|0|||
33373161|NCT00667576|62752116|FG003|Overall Study|Protocol Violation|1|||
33373162|NCT00667576|62752117|FG004|Overall Study|Protocol Violation|0|||
33373163|NCT00667576|62752113|FG000|Overall Study|Physician Decision|0|||
33373164|NCT00667576|62752114|FG001|Overall Study|Physician Decision|0|||
33373165|NCT00667576|62752115|FG002|Overall Study|Physician Decision|0|||
33373166|NCT00667576|62752116|FG003|Overall Study|Physician Decision|1|||
33373167|NCT00667576|62752117|FG004|Overall Study|Physician Decision|0|||
33373168|NCT00667576|62752113|FG000|Overall Study|Missed Visit|0|||
33373169|NCT00667576|62752114|FG001|Overall Study|Missed Visit|0|||
33373170|NCT00667576|62752115|FG002|Overall Study|Missed Visit|0|||
33373171|NCT00667576|62752116|FG003|Overall Study|Missed Visit|1|||
33286916|NCT01047540|62663532|FG002|Overall Study|Adverse Event|0|||
33286917|NCT01047540|62663533|FG003|Overall Study|Adverse Event|0|||
33286918|NCT01047540|62663534|FG004|Overall Study|Adverse Event|0|||
33286919|NCT00521222|62663550|FG000|Overall Study|Lost to Follow-up|0|||
33286920|NCT00521222|62663551|FG001|Overall Study|Lost to Follow-up|0|||
33286921|NCT00521222|62663552|FG002|Overall Study|Lost to Follow-up|1|||
33286922|NCT00521222|62663553|FG003|Overall Study|Lost to Follow-up|1|||
33286923|NCT00521222|62663550|FG000|Overall Study|Withdrawal by Subject|0|||
33286924|NCT00521222|62663551|FG001|Overall Study|Withdrawal by Subject|0|||
33286925|NCT00521222|62663552|FG002|Overall Study|Withdrawal by Subject|2|||
33373172|NCT00667576|62752117|FG004|Overall Study|Missed Visit|0|||
33373173|NCT00666718|62752131|FG000|Overall Study|Adverse Event|0|||
33286926|NCT00521222|62663553|FG003|Overall Study|Withdrawal by Subject|0|||
33286927|NCT00521222|62663550|FG000|Overall Study|Physician Decision|0|||
33286928|NCT00521222|62663551|FG001|Overall Study|Physician Decision|1|||
33373174|NCT00666718|62752132|FG001|Overall Study|Adverse Event|1|||
33373175|NCT00666718|62752131|FG000|Overall Study|Death|1|||
33373176|NCT00666718|62752132|FG001|Overall Study|Death|0|||
33373177|NCT00666718|62752131|FG000|Overall Study|Lost to Follow-up|1|||
33373178|NCT00666718|62752132|FG001|Overall Study|Lost to Follow-up|0|||
33373179|NCT00666718|62752131|FG000|Overall Study|Entry Criteria Not Met|2|||
33373180|NCT00666718|62752132|FG001|Overall Study|Entry Criteria Not Met|0|||
33373181|NCT00666718|62752131|FG000|Overall Study|Protocol Violation|1|||
33373182|NCT00666718|62752132|FG001|Overall Study|Protocol Violation|3|||
33286929|NCT00521222|62663552|FG002|Overall Study|Physician Decision|0|||
33286930|NCT00521222|62663553|FG003|Overall Study|Physician Decision|1|||
33373183|NCT00666718|62752131|FG000|Overall Study|Withdrawal by Subject|7|||
33373184|NCT00666718|62752132|FG001|Overall Study|Withdrawal by Subject|12|||
33286931|NCT01214629|62663587|FG000|Overall Study|Progressive Disease|1|||
33286932|NCT01214629|62663588|FG001|Overall Study|Progressive Disease|1|||
33286933|NCT01214629|62663589|FG002|Overall Study|Progressive Disease|0|||
33373185|NCT00666718|62752131|FG000|Overall Study|Physician Decision|0|||
33373186|NCT00666718|62752132|FG001|Overall Study|Physician Decision|2|||
33373187|NCT00667420|62752138|FG000|Overall Study|Adverse Event|2|||
33373188|NCT00667420|62752138|FG000|Overall Study|Lack of Efficacy|5|||
33286934|NCT01214629|62663590|FG003|Overall Study|Progressive Disease|1|||
33373189|NCT00667420|62752138|FG000|Overall Study|Physician Decision|1|||
33373190|NCT00667420|62752138|FG000|Overall Study|Withdrawal by Subject|2|||
33373191|NCT00853658|62752146|FG000|Overall Study|Death|713|||
33373192|NCT00853658|62752147|FG001|Overall Study|Death|768|||
33373193|NCT00853658|62752148|FG002|Overall Study|Death|753|||
33373194|NCT00853658|62752146|FG000|Overall Study|Lost to Follow-up|11|||
33373195|NCT00853658|62752147|FG001|Overall Study|Lost to Follow-up|6|||
33373196|NCT00853658|62752148|FG002|Overall Study|Lost to Follow-up|11|||
33373197|NCT00853658|62752146|FG000|Overall Study|H.A. Request|26|||
33286935|NCT01214629|62663591|FG004|Overall Study|Progressive Disease|2|||
33286936|NCT01214629|62663592|FG005|Overall Study|Progressive Disease|3|||
33286937|NCT01214629|62663593|FG006|Overall Study|Progressive Disease|1|||
33286938|NCT01214629|62663594|FG007|Overall Study|Progressive Disease|1|||
33286939|NCT01214629|62663595|FG008|Overall Study|Progressive Disease|1|||
33286940|NCT01214629|62663596|FG009|Overall Study|Progressive Disease|5|||
33286941|NCT01214629|62663597|FG010|Overall Study|Progressive Disease|1|||
33286942|NCT01214629|62663587|FG000|Overall Study|Adverse Event|0|||
33286943|NCT01214629|62663588|FG001|Overall Study|Adverse Event|0|||
33286944|NCT01214629|62663589|FG002|Overall Study|Adverse Event|0|||
33286945|NCT01214629|62663590|FG003|Overall Study|Adverse Event|1|||
33286946|NCT01214629|62663591|FG004|Overall Study|Adverse Event|0|||
33286947|NCT01214629|62663592|FG005|Overall Study|Adverse Event|1|||
33286948|NCT01214629|62663593|FG006|Overall Study|Adverse Event|0|||
33286949|NCT01214629|62663594|FG007|Overall Study|Adverse Event|0|||
33286950|NCT01214629|62663595|FG008|Overall Study|Adverse Event|0|||
33286951|NCT01214629|62663596|FG009|Overall Study|Adverse Event|1|||
33286952|NCT01214629|62663597|FG010|Overall Study|Adverse Event|0|||
33286953|NCT01214629|62663587|FG000|Overall Study|Physician Decision|0|||
33286954|NCT01214629|62663588|FG001|Overall Study|Physician Decision|0|||
33286955|NCT01214629|62663589|FG002|Overall Study|Physician Decision|0|||
33286956|NCT01214629|62663590|FG003|Overall Study|Physician Decision|0|||
33286957|NCT01214629|62663591|FG004|Overall Study|Physician Decision|0|||
33286958|NCT01214629|62663592|FG005|Overall Study|Physician Decision|0|||
33286959|NCT01214629|62663593|FG006|Overall Study|Physician Decision|0|||
33286960|NCT01214629|62663594|FG007|Overall Study|Physician Decision|0|||
33286961|NCT01214629|62663595|FG008|Overall Study|Physician Decision|0|||
33286962|NCT01214629|62663596|FG009|Overall Study|Physician Decision|0|||
33286963|NCT01214629|62663597|FG010|Overall Study|Physician Decision|1|||
33286964|NCT01214629|62663587|FG000|Overall Study|Withdrawal by Subject|0|||
33286965|NCT01214629|62663588|FG001|Overall Study|Withdrawal by Subject|0|||
33286966|NCT01214629|62663589|FG002|Overall Study|Withdrawal by Subject|0|||
33286967|NCT01214629|62663590|FG003|Overall Study|Withdrawal by Subject|0|||
33286968|NCT01214629|62663591|FG004|Overall Study|Withdrawal by Subject|0|||
33286969|NCT01214629|62663592|FG005|Overall Study|Withdrawal by Subject|0|||
33286970|NCT01214629|62663593|FG006|Overall Study|Withdrawal by Subject|0|||
33286971|NCT01214629|62663594|FG007|Overall Study|Withdrawal by Subject|0|||
33286972|NCT01214629|62663595|FG008|Overall Study|Withdrawal by Subject|0|||
33286973|NCT01214629|62663596|FG009|Overall Study|Withdrawal by Subject|1|||
33286974|NCT01214629|62663597|FG010|Overall Study|Withdrawal by Subject|0|||
33286975|NCT01214434|62663637|FG000|Overall Study|Withdrawal by Subject|1|||
33286976|NCT01214434|62663638|FG001|Overall Study|Withdrawal by Subject|0|||
33286977|NCT01214434|62663637|FG000|Overall Study|Lost to Follow-up|2|||
33286978|NCT01214434|62663638|FG001|Overall Study|Lost to Follow-up|2|||
33286979|NCT01214434|62663637|FG000|Overall Study|Site error|1|||
33286980|NCT01214434|62663638|FG001|Overall Study|Site error|0|||
33286981|NCT01214395|62663644|FG000|Overall Study|All patients had infection|5|||
33286982|NCT01214239|62663651|FG000|Overall Study|Adverse Event|3|||
33286983|NCT01214239|62663652|FG001|Overall Study|Adverse Event|4|||
33286984|NCT01214239|62663651|FG000|Overall Study|Protocol Violation|2|||
33286985|NCT01214239|62663652|FG001|Overall Study|Protocol Violation|1|||
33286986|NCT01214239|62663651|FG000|Overall Study|Lost to Follow-up|1|||
33286987|NCT01214239|62663652|FG001|Overall Study|Lost to Follow-up|1|||
33286988|NCT01214239|62663651|FG000|Overall Study|Withdrawal by Subject|4|||
33286989|NCT01214239|62663652|FG001|Overall Study|Withdrawal by Subject|9|||
33286990|NCT01214239|62663651|FG000|Overall Study|Lack of Efficacy|1|||
33286991|NCT01214239|62663652|FG001|Overall Study|Lack of Efficacy|2|||
33373198|NCT00853658|62752147|FG001|Overall Study|H.A. Request|23|||
33373199|NCT00853658|62752148|FG002|Overall Study|H.A. Request|19|||
33373200|NCT00853658|62752146|FG000|Overall Study|IRB request|0|||
33373201|NCT00853658|62752147|FG001|Overall Study|IRB request|0|||
33373202|NCT00853658|62752148|FG002|Overall Study|IRB request|2|||
33286992|NCT01214239|62663651|FG000|Overall Study|patient's private reason|1|||
33486557|NCT01332266|62864481|FG003|Phase 2|Death|33|||
33286993|NCT01214239|62663652|FG001|Overall Study|patient's private reason|1|||
33286994|NCT01214200|62663658|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
33286995|NCT01214200|62663658|FG000|Overall Study|Withdrawal by Subject|2|||
33286996|NCT01214044|62663664|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
33286997|NCT01214044|62663664|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
33286998|NCT01214044|62663664|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
33286999|NCT01214044|62663664|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
33287000|NCT01214044|62663664|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
33287001|NCT01214044|62663664|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
33287002|NCT01213966|62663676|FG000|Overall Study|Protocol Violation|1|||
33287003|NCT01213966|62663677|FG001|Overall Study|Protocol Violation|0|||
33486558|NCT01332266|62864482|FG004|Phase 2|Death|36|||
33373203|NCT00853658|62752146|FG000|Overall Study|Vital Status known (alive) at study end|2|||
33373204|NCT00853658|62752147|FG001|Overall Study|Vital Status known (alive) at study end|3|||
33373205|NCT00853658|62752148|FG002|Overall Study|Vital Status known (alive) at study end|3|||
33373206|NCT00853658|62752146|FG000|Overall Study|Vital Status unknown at study end|1|||
33373207|NCT00853658|62752147|FG001|Overall Study|Vital Status unknown at study end|1|||
33373208|NCT00853658|62752148|FG002|Overall Study|Vital Status unknown at study end|0|||
33373209|NCT00853658|62752146|FG000|Overall Study|Vital Status at study end N/A|8|||
33373210|NCT00853658|62752147|FG001|Overall Study|Vital Status at study end N/A|10|||
33373211|NCT00853658|62752148|FG002|Overall Study|Vital Status at study end N/A|10|||
33373212|NCT00853658|62752146|FG000|Overall Study|Patient's request|21|||
33373213|NCT00853658|62752147|FG001|Overall Study|Patient's request|17|||
33373214|NCT00853658|62752148|FG002|Overall Study|Patient's request|11|||
33373215|NCT00853658|62752146|FG000|Overall Study|Missing study completion information|5|||
33373216|NCT00853658|62752147|FG001|Overall Study|Missing study completion information|4|||
33373217|NCT00853658|62752148|FG002|Overall Study|Missing study completion information|6|||
33373218|NCT00666562|62752159|FG000|Overall Study|Withdrawal by Subject|0|||
33373219|NCT00666562|62752160|FG001|Overall Study|Withdrawal by Subject|1|||
33373220|NCT00666562|62752161|FG002|Overall Study|Withdrawal by Subject|0|||
33373221|NCT00666562|62752159|FG000|Overall Study|Concomitant Medication|0|||
33373222|NCT00666562|62752160|FG001|Overall Study|Concomitant Medication|1|||
33373223|NCT00666562|62752161|FG002|Overall Study|Concomitant Medication|0|||
33373224|NCT00666328|62752176|FG000|Overall Study|Death|2|||
33373225|NCT00666328|62752176|FG000|Overall Study|Lost to Follow-up|2|||
33373226|NCT00666328|62752176|FG000|Overall Study|No longer met eligibility criteria|1|||
33373227|NCT00853580|62752184|FG000|Overall Study|Lost to Follow-up|3|||
33373228|NCT00853580|62752185|FG001|Overall Study|Lost to Follow-up|5|||
33486559|NCT01332266|62864478|FG000|Phase 2|Lost to Follow-up|0|||
33486560|NCT01332266|62864479|FG001|Phase 2|Lost to Follow-up|0|||
33486561|NCT01332266|62864480|FG002|Phase 2|Lost to Follow-up|0|||
33486562|NCT01332266|62864481|FG003|Phase 2|Lost to Follow-up|2|||
33486563|NCT01332266|62864482|FG004|Phase 2|Lost to Follow-up|0|||
33486564|NCT01332266|62864478|FG000|Phase 2|Physician Decision|0|||
33486565|NCT01332266|62864479|FG001|Phase 2|Physician Decision|0|||
33486566|NCT01332266|62864480|FG002|Phase 2|Physician Decision|0|||
33486567|NCT01332266|62864481|FG003|Phase 2|Physician Decision|3|||
33486568|NCT01332266|62864482|FG004|Phase 2|Physician Decision|1|||
33486569|NCT01332266|62864478|FG000|Phase 2|Symptomatic deterioration|0|||
33486570|NCT01332266|62864479|FG001|Phase 2|Symptomatic deterioration|0|||
33486571|NCT01332266|62864480|FG002|Phase 2|Symptomatic deterioration|0|||
33486572|NCT01332266|62864481|FG003|Phase 2|Symptomatic deterioration|0|||
33486573|NCT01332266|62864482|FG004|Phase 2|Symptomatic deterioration|1|||
33486574|NCT01332266|62864478|FG000|Phase 2|Progression Disease|0|||
33486575|NCT01332266|62864479|FG001|Phase 2|Progression Disease|0|||
33486576|NCT01332266|62864480|FG002|Phase 2|Progression Disease|0|||
33486577|NCT01332266|62864481|FG003|Phase 2|Progression Disease|2|||
33486578|NCT01332266|62864482|FG004|Phase 2|Progression Disease|1|||
33486579|NCT01332266|62864478|FG000|Phase 2|Withdrawal by Subject|0|||
33486580|NCT01332266|62864479|FG001|Phase 2|Withdrawal by Subject|0|||
33287004|NCT01213966|62663678|FG002|Overall Study|Protocol Violation|3|||
33287005|NCT01213966|62663679|FG003|Overall Study|Protocol Violation|1|||
33287006|NCT01213264|62663692|FG000|Overall Study|Adverse Event|1|||
33287007|NCT01213264|62663693|FG001|Overall Study|Adverse Event|0|||
33486581|NCT01332266|62864480|FG002|Phase 2|Withdrawal by Subject|0|||
33486582|NCT01332266|62864481|FG003|Phase 2|Withdrawal by Subject|2|||
33486583|NCT01332266|62864482|FG004|Phase 2|Withdrawal by Subject|2|||
33486584|NCT03255824|62864497|FG000|Overall Study|Under-sedation|2|||
33287008|NCT01213264|62663694|FG002|Overall Study|Adverse Event|0|||
33287009|NCT01213264|62663692|FG000|Overall Study|Lost to Follow-up|1|||
33287010|NCT01213264|62663693|FG001|Overall Study|Lost to Follow-up|2|||
33287011|NCT01213264|62663694|FG002|Overall Study|Lost to Follow-up|6|||
33287012|NCT01212991|62663707|FG000|Double-blind|Lost to Follow-up|8|||
33287013|NCT01212991|62663708|FG001|Double-blind|Lost to Follow-up|4|||
33287014|NCT01212991|62663709|FG002|Double-blind|Lost to Follow-up|0|||
33287015|NCT01212991|62663707|FG000|Double-blind|Death|699|||
33287016|NCT01212991|62663708|FG001|Double-blind|Death|550|||
33486585|NCT03255824|62864498|FG001|Overall Study|Under-sedation|1|||
33486586|NCT03238352|62864507|FG000|Overall Study|Lost to Follow-up|0|||
33486587|NCT03238352|62864508|FG001|Overall Study|Lost to Follow-up|2|||
33373229|NCT00853580|62752184|FG000|Overall Study|Protocol Violation|2|||
33486588|NCT03238352|62864509|FG002|Overall Study|Lost to Follow-up|1|||
33486589|NCT03238352|62864507|FG000|Overall Study|Withdrawal by Subject|0|||
33373230|NCT00853580|62752185|FG001|Overall Study|Protocol Violation|1|||
33486590|NCT03238352|62864508|FG001|Overall Study|Withdrawal by Subject|1|||
33486591|NCT03238352|62864509|FG002|Overall Study|Withdrawal by Subject|0|||
33287017|NCT01212991|62663709|FG002|Double-blind|Death|0|||
33287018|NCT01212991|62663707|FG000|Double-blind|Withdrawal by Subject|16|||
33486592|NCT00180479|62864523|FG000|Overall Study|Death|4|||
33486593|NCT00180479|62864524|FG001|Overall Study|Death|2|||
33287019|NCT01212991|62663708|FG001|Double-blind|Withdrawal by Subject|19|||
33373231|NCT00853580|62752184|FG000|Overall Study|Withdrawal by Subject|2|||
33373232|NCT00853580|62752185|FG001|Overall Study|Withdrawal by Subject|8|||
33373233|NCT00853580|62752184|FG000|Overall Study|Commenced contraindicated therapy|0|||
33373234|NCT00853580|62752185|FG001|Overall Study|Commenced contraindicated therapy|2|||
33373235|NCT00865514|62752191|FG000|Overall Study|Infusion cost exceeded funding|2|||
33373236|NCT00865280|62752198|FG000|Overall Study|Withdrawal by Subject|4|||
33373237|NCT00865280|62752199|FG001|Overall Study|Withdrawal by Subject|1|||
33373238|NCT00865280|62752198|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
33373239|NCT00865280|62752199|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
33373240|NCT00865280|62752198|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
33373241|NCT00865280|62752199|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
33373242|NCT00865280|62752198|FG000|Overall Study|Exclusion Condition|1|||
33373243|NCT00865280|62752199|FG001|Overall Study|Exclusion Condition|0|||
33373244|NCT00865280|62752198|FG000|Overall Study|Adverse Event|0|||
33373245|NCT00865280|62752199|FG001|Overall Study|Adverse Event|1|||
33373246|NCT00865124|62752208|FG000|Overall Study|Physician Decision|2|||
33373247|NCT00865124|62752209|FG001|Overall Study|Physician Decision|1|||
33373248|NCT00865124|62752210|FG002|Overall Study|Physician Decision|0|||
33373249|NCT00865124|62752208|FG000|Overall Study|Withdrawn consent|2|||
33373250|NCT00865124|62752209|FG001|Overall Study|Withdrawn consent|0|||
33373251|NCT00865124|62752210|FG002|Overall Study|Withdrawn consent|0|||
33373252|NCT00871715|62752221|FG000|Overall Study|Withdrawal by Subject|6|||
33373253|NCT00871715|62752222|FG001|Overall Study|Withdrawal by Subject|10|||
33373254|NCT00871715|62752223|FG002|Overall Study|Withdrawal by Subject|15|||
33373255|NCT00871715|62752221|FG000|Overall Study|Physician Decision|6|||
33373256|NCT00871715|62752222|FG001|Overall Study|Physician Decision|0|||
33373257|NCT00871715|62752223|FG002|Overall Study|Physician Decision|2|||
33373258|NCT00871715|62752221|FG000|Overall Study|Lost to Follow-up|3|||
33373259|NCT00871715|62752222|FG001|Overall Study|Lost to Follow-up|6|||
33373260|NCT00871715|62752223|FG002|Overall Study|Lost to Follow-up|9|||
33373261|NCT00819234|62752232|FG000|Overall Study|Withdrawal by Subject|8|||
33287020|NCT01212991|62663709|FG002|Double-blind|Withdrawal by Subject|0|||
33287021|NCT01212991|62663707|FG000|Double-blind|Other|7|||
33287022|NCT01212991|62663708|FG001|Double-blind|Other|0|||
33287023|NCT01212991|62663709|FG002|Double-blind|Other|0|||
33287024|NCT01212991|62663707|FG000|Double-blind|Sponsor decision|142|||
33287025|NCT01212991|62663708|FG001|Double-blind|Sponsor decision|38|||
33287026|NCT01212991|62663709|FG002|Double-blind|Sponsor decision|0|||
33287027|NCT01212991|62663707|FG000|Open-label|Death|0|||
33287028|NCT01212991|62663708|FG001|Open-label|Death|0|||
33287029|NCT01212991|62663709|FG002|Open-label|Death|166|||
33287030|NCT01212991|62663707|FG000|Open-label|Lost to Follow-up|0|||
33287031|NCT01212991|62663708|FG001|Open-label|Lost to Follow-up|0|||
33287032|NCT01212991|62663709|FG002|Open-label|Lost to Follow-up|5|||
33287033|NCT01212991|62663707|FG000|Open-label|Withdrawal by Subject|0|||
33287034|NCT01212991|62663708|FG001|Open-label|Withdrawal by Subject|0|||
33287035|NCT01212991|62663709|FG002|Open-label|Withdrawal by Subject|7|||
33287036|NCT01212991|62663707|FG000|Open-label|Sponsor decision|0|||
33287037|NCT01212991|62663708|FG001|Open-label|Sponsor decision|0|||
33287038|NCT01212991|62663709|FG002|Open-label|Sponsor decision|53|||
33287039|NCT01212991|62663707|FG000|Open-label|Other|0|||
33287040|NCT01212991|62663708|FG001|Open-label|Other|0|||
33287041|NCT01212991|62663709|FG002|Open-label|Other|3|||
33287042|NCT01212757|62663720|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
33287043|NCT01212757|62663721|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
33287044|NCT01212757|62663722|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
33287045|NCT01212757|62663723|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33287046|NCT01212757|62663724|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33287047|NCT01212757|62663725|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33287048|NCT01212757|62663726|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33373262|NCT00819234|62752233|FG001|Overall Study|Withdrawal by Subject|13|||
33287049|NCT01212757|62663727|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33373263|NCT00819234|62752234|FG002|Overall Study|Withdrawal by Subject|6|||
33373264|NCT00819234|62752235|FG003|Overall Study|Withdrawal by Subject|3|||
33373265|NCT00819234|62752236|FG004|Overall Study|Withdrawal by Subject|0|||
33373266|NCT00819234|62752237|FG005|Overall Study|Withdrawal by Subject|4|||
33373267|NCT00819234|62752238|FG006|Overall Study|Withdrawal by Subject|4|||
33373268|NCT00819234|62752239|FG007|Overall Study|Withdrawal by Subject|8|||
33287050|NCT01212757|62663728|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33287051|NCT01212757|62663720|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
33287052|NCT01212757|62663721|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
33373269|NCT00819234|62752240|FG008|Overall Study|Withdrawal by Subject|5|||
33287053|NCT01212757|62663722|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
33287054|NCT01212757|62663723|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33287055|NCT01212757|62663724|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33373270|NCT00819234|62752241|FG009|Overall Study|Withdrawal by Subject|3|||
33287056|NCT01212757|62663725|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33287057|NCT01212757|62663726|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33287058|NCT01212757|62663727|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33287059|NCT01212757|62663728|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33287060|NCT01212757|62663720|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
33287061|NCT01212757|62663721|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
33287062|NCT01212757|62663722|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
33287063|NCT01212757|62663723|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33287064|NCT01212757|62663724|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33287065|NCT01212757|62663725|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33373271|NCT00819234|62752232|FG000|Overall Study|Adverse Event|0|||
33373272|NCT00819234|62752233|FG001|Overall Study|Adverse Event|0|||
33373273|NCT00819234|62752234|FG002|Overall Study|Adverse Event|1|||
33373274|NCT00819234|62752235|FG003|Overall Study|Adverse Event|0|||
33373275|NCT00819234|62752236|FG004|Overall Study|Adverse Event|0|||
33373276|NCT00819234|62752237|FG005|Overall Study|Adverse Event|2|||
33373277|NCT00819234|62752238|FG006|Overall Study|Adverse Event|0|||
33373278|NCT00819234|62752239|FG007|Overall Study|Adverse Event|0|||
33373279|NCT00819234|62752240|FG008|Overall Study|Adverse Event|0|||
33373280|NCT00819234|62752241|FG009|Overall Study|Adverse Event|0|||
33373281|NCT00819234|62752232|FG000|Overall Study|Physician Decision|0|||
33373282|NCT00819234|62752233|FG001|Overall Study|Physician Decision|0|||
33373283|NCT00819234|62752234|FG002|Overall Study|Physician Decision|0|||
33373284|NCT00819234|62752235|FG003|Overall Study|Physician Decision|1|||
33373285|NCT00819234|62752236|FG004|Overall Study|Physician Decision|0|||
33373286|NCT00819234|62752237|FG005|Overall Study|Physician Decision|0|||
33373287|NCT00819234|62752238|FG006|Overall Study|Physician Decision|0|||
33373288|NCT00819234|62752239|FG007|Overall Study|Physician Decision|0|||
33373289|NCT00819234|62752240|FG008|Overall Study|Physician Decision|0|||
33373290|NCT00819234|62752241|FG009|Overall Study|Physician Decision|2|||
33373291|NCT00819234|62752232|FG000|Overall Study|Protocol Violation|0|||
33373292|NCT00819234|62752233|FG001|Overall Study|Protocol Violation|0|||
33373293|NCT00819234|62752234|FG002|Overall Study|Protocol Violation|1|||
33287066|NCT01212757|62663726|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33287067|NCT01212757|62663727|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33287068|NCT01212757|62663728|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33287069|NCT01212757|62663720|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
33287070|NCT01212757|62663721|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33287071|NCT01212757|62663722|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
33287072|NCT01212757|62663723|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33287073|NCT01212757|62663724|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33287074|NCT01212757|62663725|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33287075|NCT01212757|62663726|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33287076|NCT01212757|62663727|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33287077|NCT01212757|62663728|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33287078|NCT01212757|62663720|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
33373294|NCT00819234|62752235|FG003|Overall Study|Protocol Violation|0|||
33373295|NCT00819234|62752236|FG004|Overall Study|Protocol Violation|0|||
33373296|NCT00819234|62752237|FG005|Overall Study|Protocol Violation|0|||
33373297|NCT00819234|62752238|FG006|Overall Study|Protocol Violation|0|||
33373298|NCT00819234|62752239|FG007|Overall Study|Protocol Violation|0|||
33373299|NCT00819234|62752240|FG008|Overall Study|Protocol Violation|0|||
33373300|NCT00819234|62752241|FG009|Overall Study|Protocol Violation|0|||
33373301|NCT00819234|62752232|FG000|Overall Study|Lost to Follow-up|2|||
33373302|NCT00819234|62752233|FG001|Overall Study|Lost to Follow-up|2|||
33373303|NCT00819234|62752234|FG002|Overall Study|Lost to Follow-up|0|||
33373304|NCT00819234|62752235|FG003|Overall Study|Lost to Follow-up|2|||
33373305|NCT00819234|62752236|FG004|Overall Study|Lost to Follow-up|1|||
33287079|NCT01212757|62663721|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
33287080|NCT01212757|62663722|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
33373306|NCT00819234|62752237|FG005|Overall Study|Lost to Follow-up|1|||
33287081|NCT01212757|62663723|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33373307|NCT00819234|62752238|FG006|Overall Study|Lost to Follow-up|1|||
33373308|NCT00819234|62752239|FG007|Overall Study|Lost to Follow-up|1|||
33373309|NCT00819234|62752240|FG008|Overall Study|Lost to Follow-up|1|||
33486594|NCT00180479|62864523|FG000|Overall Study|Lost to Follow-up|9|||
33486595|NCT00180479|62864524|FG001|Overall Study|Lost to Follow-up|7|||
33486596|NCT00180479|62864523|FG000|Overall Study|Withdrawal by Subject|3|||
33287082|NCT01212757|62663724|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33373310|NCT00819234|62752241|FG009|Overall Study|Lost to Follow-up|2|||
33373311|NCT00871403|62752299|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
33373312|NCT00871403|62752300|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
33486597|NCT00180479|62864524|FG001|Overall Study|Withdrawal by Subject|3|||
33373313|NCT00871403|62752301|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
33373314|NCT00871403|62752299|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
33373315|NCT00871403|62752300|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
33373316|NCT00871403|62752301|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
33373317|NCT00871403|62752299|FG000|Combination Treatment Phase|Adverse Event|0|||
33373318|NCT00871403|62752300|FG001|Combination Treatment Phase|Adverse Event|17|||
33373319|NCT00871403|62752301|FG002|Combination Treatment Phase|Adverse Event|2|||
33373320|NCT00871403|62752299|FG000|Combination Treatment Phase|Disease Progression|0|||
33373321|NCT00871403|62752300|FG001|Combination Treatment Phase|Disease Progression|8|||
33373322|NCT00871403|62752301|FG002|Combination Treatment Phase|Disease Progression|5|||
33373323|NCT00871403|62752299|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
33373324|NCT00871403|62752300|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
33287083|NCT01212757|62663725|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33287084|NCT01212757|62663726|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33287085|NCT01212757|62663727|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33287086|NCT01212757|62663728|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33373325|NCT00871403|62752301|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
33373326|NCT00871403|62752299|FG000|Combination Treatment Phase|Physician Decision|0|||
33373327|NCT00871403|62752300|FG001|Combination Treatment Phase|Physician Decision|1|||
33373328|NCT00871403|62752301|FG002|Combination Treatment Phase|Physician Decision|3|||
33373329|NCT00871403|62752299|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
33373330|NCT00871403|62752300|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
33373331|NCT00871403|62752301|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
33373332|NCT00871403|62752299|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
33373333|NCT00871403|62752300|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
33373334|NCT00871403|62752301|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
33373335|NCT00853112|62752315|FG000|Overall Study|Randomized but not treated|0|||
33373336|NCT00853112|62752316|FG001|Overall Study|Randomized but not treated|1|||
33373337|NCT00853112|62752317|FG002|Overall Study|Randomized but not treated|0|||
33373338|NCT00853112|62752318|FG003|Overall Study|Randomized but not treated|2|||
33287087|NCT01212757|62663720|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33287088|NCT01212757|62663721|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
33287089|NCT01212757|62663722|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
33287090|NCT01212757|62663723|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33287091|NCT01212757|62663724|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33287092|NCT01212757|62663725|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33287093|NCT01212757|62663726|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33287094|NCT01212757|62663727|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33287095|NCT01212757|62663728|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33287096|NCT01212757|62663720|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
33287097|NCT01212757|62663721|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
33287098|NCT01212757|62663722|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33287099|NCT01212757|62663723|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33287100|NCT01212757|62663724|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33287101|NCT01212757|62663725|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33287102|NCT01212757|62663726|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33287103|NCT01212757|62663727|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33287104|NCT01212757|62663728|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33287105|NCT01212757|62663720|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
33287106|NCT01212757|62663721|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
33287107|NCT01212757|62663722|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
33287108|NCT01212757|62663723|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
33287109|NCT01212757|62663724|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
33287110|NCT01212757|62663725|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
33287111|NCT01212757|62663726|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
33287112|NCT01212757|62663727|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
33287113|NCT01212757|62663728|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
33287114|NCT01212757|62663720|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
33287115|NCT01212757|62663721|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
33287116|NCT01212757|62663722|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
33287117|NCT01212757|62663723|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
33287118|NCT01212757|62663724|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
33287119|NCT01212757|62663725|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
33287120|NCT01212757|62663726|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
33287121|NCT01212757|62663727|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
33287122|NCT01212757|62663728|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
33373339|NCT00853112|62752319|FG004|Overall Study|Randomized but not treated|0|||
33373340|NCT00853112|62752320|FG005|Overall Study|Randomized but not treated|0|||
33373341|NCT00853112|62752321|FG006|Overall Study|Randomized but not treated|1|||
33373342|NCT00460603|62752349|FG000|Phase 1|Death|1|||
33287123|NCT01212757|62663720|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33287124|NCT01212757|62663721|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33287125|NCT01212757|62663722|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
33287126|NCT01212757|62663723|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33287127|NCT01212757|62663724|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33287128|NCT01212757|62663725|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33287129|NCT01212757|62663726|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33287130|NCT01212757|62663727|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33287131|NCT01212757|62663728|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33287132|NCT01212757|62663720|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
33287133|NCT01212757|62663721|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
33287134|NCT01212757|62663722|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
33287135|NCT01212757|62663723|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
33287136|NCT01212757|62663724|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
33287137|NCT01212757|62663725|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
33373343|NCT00460603|62752350|FG001|Phase 1|Death|0|||
33373344|NCT00460603|62752351|FG002|Phase 1|Death|0|||
33373345|NCT00460603|62752352|FG003|Phase 1|Death|2|||
33373346|NCT00460603|62752353|FG004|Phase 1|Death|0|||
33373347|NCT00460603|62752354|FG005|Phase 1|Death|0|||
33373348|NCT00460603|62752355|FG006|Phase 1|Death|0|||
33287138|NCT01212757|62663726|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
33287139|NCT01212757|62663727|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
33287140|NCT01212757|62663728|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
33287141|NCT01212757|62663720|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33287142|NCT01212757|62663721|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
33287143|NCT01212757|62663722|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33287144|NCT01212757|62663723|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33287145|NCT01212757|62663724|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
33287146|NCT01212757|62663725|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33287147|NCT01212757|62663726|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33287148|NCT01212757|62663727|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33287149|NCT01212757|62663728|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33287150|NCT01212757|62663720|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
33373349|NCT00460603|62752356|FG007|Phase 1|Death|0|||
33373350|NCT00460603|62752357|FG008|Phase 1|Death|1|||
33373351|NCT00460603|62752358|FG009|Phase 1|Death|0|||
33373352|NCT00460603|62752359|FG010|Phase 1|Death|0|||
33373353|NCT00460603|62752360|FG011|Phase 1|Death|0|||
33373354|NCT00460603|62752349|FG000|Phase 1|Adverse Event|3|||
33373355|NCT00460603|62752350|FG001|Phase 1|Adverse Event|1|||
33373356|NCT00460603|62752351|FG002|Phase 1|Adverse Event|1|||
33373357|NCT00460603|62752352|FG003|Phase 1|Adverse Event|2|||
33373358|NCT00460603|62752353|FG004|Phase 1|Adverse Event|0|||
33373359|NCT00460603|62752354|FG005|Phase 1|Adverse Event|0|||
33373360|NCT00460603|62752355|FG006|Phase 1|Adverse Event|3|||
33373361|NCT00460603|62752356|FG007|Phase 1|Adverse Event|0|||
33373362|NCT00460603|62752357|FG008|Phase 1|Adverse Event|4|||
33373363|NCT00460603|62752358|FG009|Phase 1|Adverse Event|0|||
33373364|NCT00460603|62752359|FG010|Phase 1|Adverse Event|0|||
33373365|NCT00460603|62752360|FG011|Phase 1|Adverse Event|0|||
33373366|NCT00460603|62752349|FG000|Phase 1|Lack of Efficacy|1|||
33373367|NCT00460603|62752350|FG001|Phase 1|Lack of Efficacy|0|||
33373368|NCT00460603|62752351|FG002|Phase 1|Lack of Efficacy|1|||
33373369|NCT00460603|62752352|FG003|Phase 1|Lack of Efficacy|2|||
33373370|NCT00460603|62752353|FG004|Phase 1|Lack of Efficacy|2|||
33373371|NCT00460603|62752354|FG005|Phase 1|Lack of Efficacy|2|||
33373372|NCT00460603|62752355|FG006|Phase 1|Lack of Efficacy|2|||
33373373|NCT00460603|62752356|FG007|Phase 1|Lack of Efficacy|2|||
33373374|NCT00460603|62752357|FG008|Phase 1|Lack of Efficacy|11|||
33373375|NCT00460603|62752358|FG009|Phase 1|Lack of Efficacy|0|||
33373376|NCT00460603|62752359|FG010|Phase 1|Lack of Efficacy|0|||
33373377|NCT00460603|62752360|FG011|Phase 1|Lack of Efficacy|0|||
33373378|NCT00460603|62752349|FG000|Phase 1|Withdrawal by Subject|1|||
33373379|NCT00460603|62752350|FG001|Phase 1|Withdrawal by Subject|2|||
33373380|NCT00460603|62752351|FG002|Phase 1|Withdrawal by Subject|1|||
33373381|NCT00460603|62752352|FG003|Phase 1|Withdrawal by Subject|1|||
33373382|NCT00460603|62752353|FG004|Phase 1|Withdrawal by Subject|3|||
33373383|NCT00460603|62752354|FG005|Phase 1|Withdrawal by Subject|0|||
33373384|NCT00460603|62752355|FG006|Phase 1|Withdrawal by Subject|1|||
33373385|NCT00460603|62752356|FG007|Phase 1|Withdrawal by Subject|0|||
33373386|NCT00460603|62752357|FG008|Phase 1|Withdrawal by Subject|2|||
33373387|NCT00460603|62752358|FG009|Phase 1|Withdrawal by Subject|0|||
33373388|NCT00460603|62752359|FG010|Phase 1|Withdrawal by Subject|0|||
33373389|NCT00460603|62752360|FG011|Phase 1|Withdrawal by Subject|0|||
33373390|NCT00460603|62752349|FG000|Phase 1|Other|0|||
33373391|NCT00460603|62752350|FG001|Phase 1|Other|3|||
33373392|NCT00460603|62752351|FG002|Phase 1|Other|1|||
33373393|NCT00460603|62752352|FG003|Phase 1|Other|1|||
33373394|NCT00460603|62752353|FG004|Phase 1|Other|1|||
33373395|NCT00460603|62752354|FG005|Phase 1|Other|2|||
33373396|NCT00460603|62752355|FG006|Phase 1|Other|0|||
33373397|NCT00460603|62752356|FG007|Phase 1|Other|1|||
33373398|NCT00460603|62752357|FG008|Phase 1|Other|0|||
33373399|NCT00460603|62752358|FG009|Phase 1|Other|0|||
33373400|NCT00460603|62752359|FG010|Phase 1|Other|0|||
33373401|NCT00460603|62752360|FG011|Phase 1|Other|0|||
33373402|NCT00460603|62752349|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33287151|NCT01212757|62663721|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
33287152|NCT01212757|62663722|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
33287153|NCT01212757|62663723|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
33287154|NCT01212757|62663724|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
33287155|NCT01212757|62663725|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
33287156|NCT01212757|62663726|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
33287157|NCT01212757|62663727|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
33287158|NCT01212757|62663728|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
33287159|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33287160|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33287161|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33287162|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33287163|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33287164|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33287165|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33287166|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33287167|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
33287168|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
33287169|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
33287170|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
33373403|NCT00460603|62752350|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33373404|NCT00460603|62752351|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33373405|NCT00460603|62752352|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33373406|NCT00460603|62752353|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33373407|NCT00460603|62752354|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33373408|NCT00460603|62752355|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33373409|NCT00460603|62752356|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33373410|NCT00460603|62752357|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33373411|NCT00460603|62752358|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
33373412|NCT00460603|62752359|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33373413|NCT00460603|62752360|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33486598|NCT00180479|62864523|FG000|Overall Study|Informed consent not signed|0|||
33287171|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
33287172|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
33287173|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
33287174|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
33287175|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
33287176|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
33287177|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
33287178|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
33287179|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
33287180|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
33287181|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
33287182|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
33287183|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
33287184|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
33287185|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
33287186|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33287187|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
33287188|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
33373414|NCT00460603|62752349|FG000|Phase 2|Adverse Event|0|||
33373415|NCT00460603|62752350|FG001|Phase 2|Adverse Event|0|||
33373416|NCT00460603|62752351|FG002|Phase 2|Adverse Event|0|||
33486599|NCT00180479|62864524|FG001|Overall Study|Informed consent not signed|1|||
33486600|NCT03224234|62864534|FG000|Main Study|Lost to Follow-up|5|||
33486601|NCT03224234|62864535|FG001|Main Study|Lost to Follow-up|5|||
33556300|NCT02308540|62949122|FG001|Overall Study|Lost to Follow-up|0|||
33556301|NCT02308540|62949123|FG002|Overall Study|Lost to Follow-up|0|||
33373417|NCT00460603|62752352|FG003|Phase 2|Adverse Event|0|||
33373418|NCT00460603|62752353|FG004|Phase 2|Adverse Event|0|||
33373419|NCT00460603|62752354|FG005|Phase 2|Adverse Event|0|||
33486602|NCT02955069|62864549|FG000|Overall Study|Adverse Event|7|||
33486603|NCT02955069|62864550|FG001|Overall Study|Adverse Event|2|||
33486604|NCT02955069|62864549|FG000|Overall Study|Death|7|||
33486605|NCT02955069|62864550|FG001|Overall Study|Death|3|||
33486606|NCT02955069|62864549|FG000|Overall Study|Physician Decision|10|||
33486607|NCT02955069|62864550|FG001|Overall Study|Physician Decision|2|||
33486608|NCT02955069|62864549|FG000|Overall Study|Progressive disease|64|||
33486609|NCT02955069|62864550|FG001|Overall Study|Progressive disease|13|||
33486610|NCT02955069|62864549|FG000|Overall Study|Study terminated by sponsor|4|||
33486611|NCT02955069|62864550|FG001|Overall Study|Study terminated by sponsor|0|||
33486612|NCT02955069|62864549|FG000|Overall Study|Subject/Guardian decision|3|||
33486613|NCT02955069|62864550|FG001|Overall Study|Subject/Guardian decision|1|||
33486614|NCT03254108|62864563|FG000|Overall Study|Adverse Event|0|||
33486615|NCT03254108|62864564|FG001|Overall Study|Adverse Event|2|||
33486616|NCT03254108|62864565|FG002|Overall Study|Adverse Event|0|||
33486617|NCT03254108|62864566|FG003|Overall Study|Adverse Event|1|||
33486618|NCT03254108|62864567|FG004|Overall Study|Adverse Event|1|||
33486619|NCT03254108|62864563|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
33486620|NCT03254108|62864564|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
33486621|NCT03254108|62864565|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
33486622|NCT03254108|62864566|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
33486623|NCT03254108|62864567|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
33486624|NCT03773978|62864591|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
33486625|NCT03773978|62864592|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
33486626|NCT03773978|62864591|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
33486627|NCT03773978|62864592|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
33486628|NCT03773978|62864591|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
33486629|NCT03773978|62864592|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
33486630|NCT03773978|62864591|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
33486631|NCT03773978|62864592|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
33287189|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33287190|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33287191|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33287192|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33287193|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
33287194|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
33287195|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33287196|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33287197|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
33287198|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33287199|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33287200|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33287201|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33287202|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33287203|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33287204|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
33287205|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
33287206|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
33287207|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
33287208|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
33287209|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
33287210|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
33287211|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
33287212|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
33287213|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
33287214|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
33287215|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
33287216|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
33287217|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
33287218|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
33287219|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
33287220|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
33287221|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
33287222|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33287223|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33486632|NCT03773978|62864591|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
33486633|NCT03773978|62864592|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
33486634|NCT03773978|62864591|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
33486635|NCT03773978|62864592|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
33486636|NCT03773978|62864591|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
33373420|NCT00460603|62752355|FG006|Phase 2|Adverse Event|0|||
33373421|NCT00460603|62752356|FG007|Phase 2|Adverse Event|0|||
33373422|NCT00460603|62752357|FG008|Phase 2|Adverse Event|0|||
33373423|NCT00460603|62752358|FG009|Phase 2|Adverse Event|12|||
33373424|NCT00460603|62752359|FG010|Phase 2|Adverse Event|9|||
33373425|NCT00460603|62752360|FG011|Phase 2|Adverse Event|10|||
33373426|NCT00460603|62752349|FG000|Phase 2|Death|0|||
33373427|NCT00460603|62752350|FG001|Phase 2|Death|0|||
33373428|NCT00460603|62752351|FG002|Phase 2|Death|0|||
33373429|NCT00460603|62752352|FG003|Phase 2|Death|0|||
33373430|NCT00460603|62752353|FG004|Phase 2|Death|0|||
33373431|NCT00460603|62752354|FG005|Phase 2|Death|0|||
33373432|NCT00460603|62752355|FG006|Phase 2|Death|0|||
33373433|NCT00460603|62752356|FG007|Phase 2|Death|0|||
33373434|NCT00460603|62752357|FG008|Phase 2|Death|0|||
33373435|NCT00460603|62752358|FG009|Phase 2|Death|4|||
33373436|NCT00460603|62752359|FG010|Phase 2|Death|2|||
33287224|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
33287225|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33287226|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33287227|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33287228|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33287229|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33287230|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33287231|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33287232|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
33287233|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
33373437|NCT00460603|62752360|FG011|Phase 2|Death|2|||
33373438|NCT00460603|62752349|FG000|Phase 2|Protocol Violation|0|||
33373439|NCT00460603|62752350|FG001|Phase 2|Protocol Violation|0|||
33373440|NCT00460603|62752351|FG002|Phase 2|Protocol Violation|0|||
33373441|NCT00460603|62752352|FG003|Phase 2|Protocol Violation|0|||
33373442|NCT00460603|62752353|FG004|Phase 2|Protocol Violation|0|||
33373443|NCT00460603|62752354|FG005|Phase 2|Protocol Violation|0|||
33373444|NCT00460603|62752355|FG006|Phase 2|Protocol Violation|0|||
33373445|NCT00460603|62752356|FG007|Phase 2|Protocol Violation|0|||
33373446|NCT00460603|62752357|FG008|Phase 2|Protocol Violation|0|||
33373447|NCT00460603|62752358|FG009|Phase 2|Protocol Violation|1|||
33373448|NCT00460603|62752359|FG010|Phase 2|Protocol Violation|1|||
33373449|NCT00460603|62752360|FG011|Phase 2|Protocol Violation|0|||
33373450|NCT00460603|62752349|FG000|Phase 2|Lost to Follow-up|0|||
33373451|NCT00460603|62752350|FG001|Phase 2|Lost to Follow-up|0|||
33373452|NCT00460603|62752351|FG002|Phase 2|Lost to Follow-up|0|||
33373453|NCT00460603|62752352|FG003|Phase 2|Lost to Follow-up|0|||
33373454|NCT00460603|62752353|FG004|Phase 2|Lost to Follow-up|0|||
33373455|NCT00460603|62752354|FG005|Phase 2|Lost to Follow-up|0|||
33373456|NCT00460603|62752355|FG006|Phase 2|Lost to Follow-up|0|||
33373457|NCT00460603|62752356|FG007|Phase 2|Lost to Follow-up|0|||
33373458|NCT00460603|62752357|FG008|Phase 2|Lost to Follow-up|0|||
33373459|NCT00460603|62752358|FG009|Phase 2|Lost to Follow-up|1|||
33373460|NCT00460603|62752359|FG010|Phase 2|Lost to Follow-up|0|||
33373461|NCT00460603|62752360|FG011|Phase 2|Lost to Follow-up|0|||
33373462|NCT00460603|62752349|FG000|Phase 2|Other|0|||
33373463|NCT00460603|62752350|FG001|Phase 2|Other|0|||
33373464|NCT00460603|62752351|FG002|Phase 2|Other|0|||
33373465|NCT00460603|62752352|FG003|Phase 2|Other|0|||
33373466|NCT00460603|62752353|FG004|Phase 2|Other|0|||
33373467|NCT00460603|62752354|FG005|Phase 2|Other|0|||
33373468|NCT00460603|62752355|FG006|Phase 2|Other|0|||
33373469|NCT00460603|62752356|FG007|Phase 2|Other|0|||
33287234|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33287235|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33373470|NCT00460603|62752357|FG008|Phase 2|Other|0|||
33373471|NCT00460603|62752358|FG009|Phase 2|Other|6|||
33373472|NCT00460603|62752359|FG010|Phase 2|Other|16|||
33287236|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33287237|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33373473|NCT00460603|62752360|FG011|Phase 2|Other|7|||
33373474|NCT00460603|62752349|FG000|Phase 2|Objective Progression or Relapse|0|||
33373475|NCT00460603|62752350|FG001|Phase 2|Objective Progression or Relapse|0|||
33373476|NCT00460603|62752351|FG002|Phase 2|Objective Progression or Relapse|0|||
33373477|NCT00460603|62752352|FG003|Phase 2|Objective Progression or Relapse|0|||
33373478|NCT00460603|62752353|FG004|Phase 2|Objective Progression or Relapse|0|||
33373479|NCT00460603|62752354|FG005|Phase 2|Objective Progression or Relapse|0|||
33373480|NCT00460603|62752355|FG006|Phase 2|Objective Progression or Relapse|0|||
33373481|NCT00460603|62752356|FG007|Phase 2|Objective Progression or Relapse|0|||
33373482|NCT00460603|62752357|FG008|Phase 2|Objective Progression or Relapse|0|||
33373483|NCT00460603|62752358|FG009|Phase 2|Objective Progression or Relapse|9|||
33373484|NCT00460603|62752359|FG010|Phase 2|Objective Progression or Relapse|10|||
33373485|NCT00460603|62752360|FG011|Phase 2|Objective Progression or Relapse|17|||
33373486|NCT00460603|62752349|FG000|Phase 2|Global Deterioration of Health Status|0|||
33287238|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
33287239|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
33287240|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33287241|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33287242|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33287243|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33373487|NCT00460603|62752350|FG001|Phase 2|Global Deterioration of Health Status|0|||
33373488|NCT00460603|62752351|FG002|Phase 2|Global Deterioration of Health Status|0|||
33373489|NCT00460603|62752352|FG003|Phase 2|Global Deterioration of Health Status|0|||
33373490|NCT00460603|62752353|FG004|Phase 2|Global Deterioration of Health Status|0|||
33287244|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33287245|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33287246|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33287247|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33287248|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
33287249|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33287250|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
33287251|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33287252|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33287253|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33373491|NCT00460603|62752354|FG005|Phase 2|Global Deterioration of Health Status|0|||
33373492|NCT00460603|62752355|FG006|Phase 2|Global Deterioration of Health Status|0|||
33373493|NCT00460603|62752356|FG007|Phase 2|Global Deterioration of Health Status|0|||
33373494|NCT00460603|62752357|FG008|Phase 2|Global Deterioration of Health Status|0|||
33373495|NCT00460603|62752358|FG009|Phase 2|Global Deterioration of Health Status|0|||
33373496|NCT00460603|62752359|FG010|Phase 2|Global Deterioration of Health Status|1|||
33373497|NCT00460603|62752360|FG011|Phase 2|Global Deterioration of Health Status|0|||
33373498|NCT00460603|62752349|FG000|Phase 2|Withdrawal by Subject|0|||
33373499|NCT00460603|62752350|FG001|Phase 2|Withdrawal by Subject|0|||
33373500|NCT00460603|62752351|FG002|Phase 2|Withdrawal by Subject|0|||
33373501|NCT00460603|62752352|FG003|Phase 2|Withdrawal by Subject|0|||
33373502|NCT00460603|62752353|FG004|Phase 2|Withdrawal by Subject|0|||
33373503|NCT00460603|62752354|FG005|Phase 2|Withdrawal by Subject|0|||
33373504|NCT00460603|62752355|FG006|Phase 2|Withdrawal by Subject|0|||
33373505|NCT00460603|62752356|FG007|Phase 2|Withdrawal by Subject|0|||
33373506|NCT00460603|62752357|FG008|Phase 2|Withdrawal by Subject|0|||
33373507|NCT00460603|62752358|FG009|Phase 2|Withdrawal by Subject|5|||
33373508|NCT00460603|62752359|FG010|Phase 2|Withdrawal by Subject|4|||
33373509|NCT00460603|62752360|FG011|Phase 2|Withdrawal by Subject|5|||
33373510|NCT00460603|62752349|FG000|Phase 2|Randomized, but not treated|0|||
33373511|NCT00460603|62752350|FG001|Phase 2|Randomized, but not treated|0|||
33373512|NCT00460603|62752351|FG002|Phase 2|Randomized, but not treated|0|||
33373513|NCT00460603|62752352|FG003|Phase 2|Randomized, but not treated|0|||
33373514|NCT00460603|62752353|FG004|Phase 2|Randomized, but not treated|0|||
33373515|NCT00460603|62752354|FG005|Phase 2|Randomized, but not treated|0|||
33373516|NCT00460603|62752355|FG006|Phase 2|Randomized, but not treated|0|||
33373517|NCT00460603|62752356|FG007|Phase 2|Randomized, but not treated|0|||
33373518|NCT00460603|62752357|FG008|Phase 2|Randomized, but not treated|0|||
33373519|NCT00460603|62752358|FG009|Phase 2|Randomized, but not treated|3|||
33373520|NCT00460603|62752359|FG010|Phase 2|Randomized, but not treated|0|||
33373521|NCT00460603|62752360|FG011|Phase 2|Randomized, but not treated|0|||
33373522|NCT00662038|62752386|FG000|Overall Study|Reason not specified|3|||
33373523|NCT00662038|62752386|FG000|Overall Study|Withdrawn consent|22|||
33373524|NCT00662038|62752386|FG000|Overall Study|Withdrawal by Subject|83|||
33373525|NCT00662038|62752386|FG000|Overall Study|Sponsor decision|1|||
33373526|NCT00662038|62752386|FG000|Overall Study|Physician Decision|19|||
33373527|NCT00662038|62752386|FG000|Overall Study|Lung transplantation|44|||
33373528|NCT00662038|62752386|FG000|Overall Study|Lost to Follow-up|1|||
33373529|NCT00662038|62752386|FG000|Overall Study|Death|95|||
33373530|NCT00662038|62752386|FG000|Overall Study|Adverse Event|358|||
33556302|NCT02308540|62949124|FG003|Overall Study|Lost to Follow-up|0|||
33287254|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33287255|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33287256|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33373531|NCT00662038|62752386|FG000|Overall Study|Continued treatment|5|||
33373532|NCT00819156|62752396|FG000|Overall Study|Adverse Event|1|||
33373533|NCT00819156|62752397|FG001|Overall Study|Adverse Event|4|||
33373534|NCT00819156|62752398|FG002|Overall Study|Adverse Event|2|||
33373535|NCT00819156|62752399|FG003|Overall Study|Adverse Event|1|||
33373536|NCT00819156|62752400|FG004|Overall Study|Adverse Event|2|||
33287257|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33373537|NCT00819156|62752401|FG005|Overall Study|Adverse Event|3|||
33373538|NCT00819156|62752396|FG000|Overall Study|Withdrawal by Subject|0|||
33373539|NCT00819156|62752397|FG001|Overall Study|Withdrawal by Subject|3|||
33373540|NCT00819156|62752398|FG002|Overall Study|Withdrawal by Subject|2|||
33373541|NCT00819156|62752399|FG003|Overall Study|Withdrawal by Subject|0|||
33373542|NCT00819156|62752400|FG004|Overall Study|Withdrawal by Subject|1|||
33373543|NCT00819156|62752401|FG005|Overall Study|Withdrawal by Subject|0|||
33373544|NCT00819156|62752396|FG000|Overall Study|Protocol Violation|1|||
33373545|NCT00819156|62752397|FG001|Overall Study|Protocol Violation|0|||
33373546|NCT00819156|62752398|FG002|Overall Study|Protocol Violation|1|||
33373547|NCT00819156|62752399|FG003|Overall Study|Protocol Violation|0|||
33373548|NCT00819156|62752400|FG004|Overall Study|Protocol Violation|0|||
33373549|NCT00819156|62752401|FG005|Overall Study|Protocol Violation|1|||
33373550|NCT00819156|62752396|FG000|Overall Study|Lost to Follow-up|0|||
33373551|NCT00819156|62752397|FG001|Overall Study|Lost to Follow-up|1|||
33373552|NCT00819156|62752398|FG002|Overall Study|Lost to Follow-up|0|||
33373553|NCT00819156|62752399|FG003|Overall Study|Lost to Follow-up|0|||
33373554|NCT00819156|62752400|FG004|Overall Study|Lost to Follow-up|0|||
33373555|NCT00819156|62752401|FG005|Overall Study|Lost to Follow-up|2|||
33373556|NCT00819156|62752396|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
33373557|NCT00819156|62752397|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
33373558|NCT00819156|62752398|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
33373559|NCT00819156|62752399|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
33373560|NCT00819156|62752400|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
33373561|NCT00819156|62752401|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
33373562|NCT00819156|62752396|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
33373563|NCT00819156|62752397|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
33373564|NCT00819156|62752398|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
33373565|NCT00819156|62752399|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
33373566|NCT00819156|62752400|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
33373567|NCT00819156|62752401|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
33373568|NCT00819156|62752396|FG000|Overall Study|Prostate-specific antigen progression|0|||
33373569|NCT00819156|62752397|FG001|Overall Study|Prostate-specific antigen progression|0|||
33373570|NCT00819156|62752398|FG002|Overall Study|Prostate-specific antigen progression|0|||
33373571|NCT00819156|62752399|FG003|Overall Study|Prostate-specific antigen progression|0|||
33373572|NCT00819156|62752400|FG004|Overall Study|Prostate-specific antigen progression|1|||
33373573|NCT00819156|62752401|FG005|Overall Study|Prostate-specific antigen progression|0|||
33373574|NCT00459979|62752423|FG000|Overall Study|Withdrawal by Subject|1|||
33373575|NCT00459979|62752423|FG000|Overall Study|Protocol Violation|1|||
33373576|NCT00851786|62752429|FG000|Overall Study|Withdrawal by Subject|0|||
33373577|NCT00851786|62752430|FG001|Overall Study|Withdrawal by Subject|1|||
33373578|NCT00851786|62752429|FG000|Overall Study|Protocol Violation|0|||
33486637|NCT03773978|62864592|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
33287258|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
33287259|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
33287260|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
33287261|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
33287262|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
33287263|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
33287264|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
33287265|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
33287266|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
33287267|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
33287268|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
33287269|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
33287270|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
33287271|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
33287272|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
33287273|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
33287274|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
33287275|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
33287276|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
33287277|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
33287278|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
33287279|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
33287280|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
33287281|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
33486638|NCT03773978|62864591|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
33287282|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
33287283|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
33287284|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
33373579|NCT00851786|62752430|FG001|Overall Study|Protocol Violation|1|||
33373580|NCT00851786|62752429|FG000|Overall Study|Lost to Follow-up|1|||
33373581|NCT00851786|62752430|FG001|Overall Study|Lost to Follow-up|0|||
33373582|NCT00851786|62752429|FG000|Overall Study|Incarceration|1|||
33287285|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
33287286|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
33287287|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
33287288|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
33287289|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
33287290|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
33287291|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
33287292|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
33287293|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
33287294|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33287295|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
33287296|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
33287297|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33287298|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33287299|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33287300|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33287301|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
33287302|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
33287303|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
33287304|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
33287305|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
33287306|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
33287307|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
33287308|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
33287309|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
33287310|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
33287311|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
33287312|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33287313|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33287314|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33287315|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33287316|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33287317|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33287318|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33287319|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
33287320|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33373583|NCT00851786|62752430|FG001|Overall Study|Incarceration|0|||
33373584|NCT00851786|62752429|FG000|Overall Study|Site Closure|1|||
33373585|NCT00851786|62752430|FG001|Overall Study|Site Closure|0|||
33373586|NCT00851786|62752429|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
33373587|NCT00851786|62752430|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
33373588|NCT00665626|62752438|FG000|Overall Study|Lack of Efficacy|8|||
33373589|NCT00665626|62752439|FG001|Overall Study|Lack of Efficacy|5|||
33373590|NCT00665626|62752438|FG000|Overall Study|Lost to Follow-up|0|||
33373591|NCT00665626|62752439|FG001|Overall Study|Lost to Follow-up|2|||
33373592|NCT00665626|62752438|FG000|Overall Study|Withdrawal by Subject|0|||
33373593|NCT00665626|62752439|FG001|Overall Study|Withdrawal by Subject|1|||
33373594|NCT00665626|62752438|FG000|Overall Study|Protocol Violation|0|||
33373595|NCT00665626|62752439|FG001|Overall Study|Protocol Violation|2|||
33373596|NCT00665626|62752438|FG000|Overall Study|Adverse Event|1|||
33373597|NCT00665626|62752439|FG001|Overall Study|Adverse Event|9|||
33373598|NCT00665626|62752438|FG000|Overall Study|Due to exclusion criteria|0|||
33373599|NCT00665626|62752439|FG001|Overall Study|Due to exclusion criteria|1|||
33373600|NCT00665626|62752438|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
33373601|NCT00665626|62752439|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
33373602|NCT00665626|62752438|FG000|Overall Study|Unably to comply with dosing regimen|0|||
33373603|NCT00665626|62752439|FG001|Overall Study|Unably to comply with dosing regimen|1|||
33373604|NCT00665626|62752438|FG000|Overall Study|Death|1|||
33373605|NCT00665626|62752439|FG001|Overall Study|Death|0|||
33373606|NCT00828672|62752447|FG000|Study Treatment|Lost to Follow-up|1|||
33373607|NCT00828672|62752448|FG001|Study Treatment|Lost to Follow-up|0|||
33373608|NCT00828672|62752447|FG000|Study Treatment|Adverse Event|0|||
33373609|NCT00828672|62752448|FG001|Study Treatment|Adverse Event|1|||
33373610|NCT00828672|62752447|FG000|Study Treatment|Complete response, no surgery|1|||
33373611|NCT00828672|62752448|FG001|Study Treatment|Complete response, no surgery|1|||
33373612|NCT00828672|62752447|FG000|Post-surgery (<30 Days)|No central review materials|0|||
33373613|NCT00828672|62752448|FG001|Post-surgery (<30 Days)|No central review materials|1|||
33287321|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33287322|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
33373614|NCT00873119|62752456|FG000|Overall Study|Patient request|4|||
33373615|NCT00873119|62752457|FG001|Overall Study|Patient request|2|||
33373616|NCT00873119|62752456|FG000|Overall Study|Adverse Event|8|||
33373617|NCT00873119|62752457|FG001|Overall Study|Adverse Event|0|||
33373618|NCT00873119|62752456|FG000|Overall Study|Progressive disease|26|||
33373619|NCT00873119|62752457|FG001|Overall Study|Progressive disease|18|||
33287323|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
33287324|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33287325|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33287326|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33287327|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33287328|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
33287329|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
33287330|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
33287331|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
33287332|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
33287333|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
33287334|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
33287335|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
33287336|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
33373620|NCT00873119|62752456|FG000|Overall Study|Death|2|||
33373621|NCT00873119|62752457|FG001|Overall Study|Death|1|||
33287337|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
33373622|NCT00873119|62752456|FG000|Overall Study|Other|2|||
33373623|NCT00873119|62752457|FG001|Overall Study|Other|5|||
33373624|NCT00873119|62752456|FG000|Overall Study|Not treated|2|||
33373625|NCT00873119|62752457|FG001|Overall Study|Not treated|0|||
33373626|NCT00661726|62752463|FG000|Overall Study|Adverse Event|1|||
33373627|NCT00865046|62752470|FG000|Overall Study|Lost to Follow-up|1|||
33373628|NCT00865046|62752471|FG001|Overall Study|Lost to Follow-up|4|||
33287338|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
33287339|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
33373629|NCT00865046|62752472|FG002|Overall Study|Lost to Follow-up|0|||
33373630|NCT00865046|62752470|FG000|Overall Study|Death|0|||
33373631|NCT00865046|62752471|FG001|Overall Study|Death|1|||
33373632|NCT00865046|62752472|FG002|Overall Study|Death|1|||
33373633|NCT00865046|62752470|FG000|Overall Study|Withdrawal by Subject|5|||
33373634|NCT00865046|62752471|FG001|Overall Study|Withdrawal by Subject|0|||
33373635|NCT00865046|62752472|FG002|Overall Study|Withdrawal by Subject|0|||
33373636|NCT00828516|62752480|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
33373637|NCT00665392|62752484|FG000|Overall Study|not treated|1|||
33373638|NCT00851630|62752491|FG000|Overall Study|Death|2|||
33373639|NCT00851630|62752492|FG001|Overall Study|Death|1|||
33373640|NCT00851630|62752491|FG000|Overall Study|Clinical failure|0|||
33373641|NCT00851630|62752492|FG001|Overall Study|Clinical failure|1|||
33373642|NCT00459667|62752501|FG000|Overall Study|Adverse Event|9|||
33373643|NCT00459667|62752502|FG001|Overall Study|Adverse Event|12|||
33373644|NCT00459667|62752503|FG002|Overall Study|Adverse Event|8|||
33373645|NCT00459667|62752501|FG000|Overall Study|Lost to Follow-up|5|||
33373646|NCT00459667|62752502|FG001|Overall Study|Lost to Follow-up|9|||
33373647|NCT00459667|62752503|FG002|Overall Study|Lost to Follow-up|3|||
33373648|NCT00459667|62752501|FG000|Overall Study|Pregnancy|1|||
33373649|NCT00459667|62752502|FG001|Overall Study|Pregnancy|1|||
33373650|NCT00459667|62752503|FG002|Overall Study|Pregnancy|1|||
33373651|NCT00459667|62752501|FG000|Overall Study|Protocol Violation|1|||
33373652|NCT00459667|62752502|FG001|Overall Study|Protocol Violation|0|||
33287340|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
33287341|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
33287342|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
33287343|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
33287344|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
33287345|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
33287346|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
33287347|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
33287348|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33287349|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
33287350|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33373653|NCT00459667|62752503|FG002|Overall Study|Protocol Violation|0|||
33373654|NCT00459667|62752501|FG000|Overall Study|Withdrawal by Subject|3|||
33373655|NCT00459667|62752502|FG001|Overall Study|Withdrawal by Subject|5|||
33373656|NCT00459667|62752503|FG002|Overall Study|Withdrawal by Subject|5|||
33373657|NCT00459667|62752501|FG000|Overall Study|Other disease modifying treatment|1|||
33373658|NCT00459667|62752502|FG001|Overall Study|Other disease modifying treatment|2|||
33373659|NCT00459667|62752503|FG002|Overall Study|Other disease modifying treatment|1|||
33373660|NCT00459667|62752501|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
33373661|NCT00459667|62752502|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
33373662|NCT00459667|62752503|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
33373663|NCT00459667|62752501|FG000|Overall Study|No treatment administered|6|||
33373664|NCT00459667|62752502|FG001|Overall Study|No treatment administered|3|||
33287351|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33373665|NCT00459667|62752503|FG002|Overall Study|No treatment administered|1|||
33373666|NCT00828204|62752513|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
33287352|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33373667|NCT00828204|62752514|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
33373668|NCT00828204|62752513|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
33287353|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33287354|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33287355|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33373669|NCT00828204|62752514|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
33373670|NCT00828204|62752513|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
33373671|NCT00828204|62752514|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
33373672|NCT00828204|62752513|FG000|Main Study: After Study Restart|Adverse Event|0|||
33373673|NCT00828204|62752514|FG001|Main Study: After Study Restart|Adverse Event|2|||
33373674|NCT00828204|62752513|FG000|Main Study: After Study Restart|Noncompliance|0|||
33373675|NCT00828204|62752514|FG001|Main Study: After Study Restart|Noncompliance|1|||
33373676|NCT00828204|62752513|FG000|Extension Study|Lost to Follow-up|0|||
33373677|NCT00828204|62752514|FG001|Extension Study|Lost to Follow-up|1|||
33287356|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33287357|NCT01212757|62663720|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
33287358|NCT01212757|62663721|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
33287359|NCT01212757|62663722|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
33287360|NCT01212757|62663723|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
33287361|NCT01212757|62663724|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
33287362|NCT01212757|62663725|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
33287363|NCT01212757|62663726|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
33287364|NCT01212757|62663727|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
33287365|NCT01212757|62663728|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
33373678|NCT00828204|62752513|FG000|Extension Study|Physician Decision|0|||
33373679|NCT00828204|62752514|FG001|Extension Study|Physician Decision|2|||
33373680|NCT00851552|62752521|FG000|Overall Study|Death|2|||
33373681|NCT00851552|62752521|FG000|Overall Study|Adverse Event|1|||
33373682|NCT00851552|62752521|FG000|Overall Study|Disease Progression|4|||
33373683|NCT00459355|62752527|FG000|Overall Study|Subject no longer met inc criteria|20|||
33373684|NCT00459355|62752528|FG001|Overall Study|Subject no longer met inc criteria|18|||
33373685|NCT00459043|62752540|FG000|Overall Study|Withdrawal by Subject|1|||
33373686|NCT00459043|62752541|FG001|Overall Study|Withdrawal by Subject|0|||
33373687|NCT00817206|62752549|FG000|Overall Study|Adverse Event|10|||
33373688|NCT00817206|62752550|FG001|Overall Study|Adverse Event|3|||
33373689|NCT00817206|62752549|FG000|Overall Study|Protocol Violation|0|||
33373690|NCT00817206|62752550|FG001|Overall Study|Protocol Violation|2|||
33287366|NCT01190410|62663748|FG000|Overall Study|Adverse Event|0|||
33287367|NCT01190410|62663749|FG001|Overall Study|Adverse Event|3|||
33287368|NCT01190410|62663748|FG000|Overall Study|Lack of Efficacy|0|||
33287369|NCT01190410|62663749|FG001|Overall Study|Lack of Efficacy|2|||
33287370|NCT01190410|62663748|FG000|Overall Study|Withdrawal by Subject|0|||
33287371|NCT01190410|62663749|FG001|Overall Study|Withdrawal by Subject|2|||
33287372|NCT01190410|62663748|FG000|Overall Study|Administrative decision|1|||
33287373|NCT01190410|62663749|FG001|Overall Study|Administrative decision|0|||
33287374|NCT01190410|62663748|FG000|Overall Study|PI discretion|0|||
33287375|NCT01190410|62663749|FG001|Overall Study|PI discretion|2|||
33287376|NCT01190254|62663764|FG000|Overall Study|Adverse Event|3|||
33287377|NCT01190254|62663765|FG001|Overall Study|Adverse Event|6|||
33287378|NCT01190254|62663766|FG002|Overall Study|Adverse Event|8|||
33287379|NCT01190254|62663764|FG000|Overall Study|Lack of Efficacy|7|||
33287380|NCT01190254|62663765|FG001|Overall Study|Lack of Efficacy|4|||
33287381|NCT01190254|62663766|FG002|Overall Study|Lack of Efficacy|5|||
33287382|NCT01190254|62663764|FG000|Overall Study|Lost to Follow-up|4|||
33287383|NCT01190254|62663765|FG001|Overall Study|Lost to Follow-up|2|||
33287384|NCT01190254|62663766|FG002|Overall Study|Lost to Follow-up|0|||
33287385|NCT01190254|62663764|FG000|Overall Study|Withdrawal by Subject|4|||
33287386|NCT01190254|62663765|FG001|Overall Study|Withdrawal by Subject|5|||
33287387|NCT01190254|62663766|FG002|Overall Study|Withdrawal by Subject|7|||
33287388|NCT01190254|62663764|FG000|Overall Study|Protocol Violation|2|||
33287389|NCT01190254|62663765|FG001|Overall Study|Protocol Violation|0|||
33287390|NCT01190254|62663766|FG002|Overall Study|Protocol Violation|2|||
33287391|NCT01190254|62663764|FG000|Overall Study|Did not meet protocol eligibility|1|||
33287392|NCT01190254|62663765|FG001|Overall Study|Did not meet protocol eligibility|0|||
33287393|NCT01190254|62663766|FG002|Overall Study|Did not meet protocol eligibility|0|||
33287394|NCT01190839|62663776|FG000|Overall Study|Adverse Event|32|||
33373691|NCT00817206|62752549|FG000|Overall Study|Lost to Follow-up|0|||
33373692|NCT00817206|62752550|FG001|Overall Study|Lost to Follow-up|1|||
33373693|NCT00817206|62752549|FG000|Overall Study|Death|2|||
33373694|NCT00817206|62752550|FG001|Overall Study|Death|0|||
33287395|NCT01190839|62663777|FG001|Overall Study|Adverse Event|41|||
33287396|NCT01190839|62663776|FG000|Overall Study|Protocol Violation|2|||
33287397|NCT01190839|62663777|FG001|Overall Study|Protocol Violation|2|||
33287398|NCT01190839|62663776|FG000|Overall Study|Lost to Follow-up|7|||
33287399|NCT01190839|62663777|FG001|Overall Study|Lost to Follow-up|1|||
33287400|NCT01190839|62663776|FG000|Overall Study|Death|1|||
33287401|NCT01190839|62663777|FG001|Overall Study|Death|0|||
33287402|NCT01190839|62663776|FG000|Overall Study|Trial stopped by Sponsor|71|||
33287403|NCT01190839|62663777|FG001|Overall Study|Trial stopped by Sponsor|68|||
33287404|NCT01190839|62663776|FG000|Overall Study|Undefined|35|||
33287405|NCT01190839|62663777|FG001|Overall Study|Undefined|31|||
33287406|NCT01190839|62663776|FG000|Overall Study|Randomized but not treated|2|||
33287407|NCT01190839|62663777|FG001|Overall Study|Randomized but not treated|4|||
33287408|NCT01190215|62663787|FG000|Up to Month 6|Lost to Follow-up|2|||
33287409|NCT01190215|62663788|FG001|Up to Month 6|Lost to Follow-up|0|||
33287410|NCT01190449|62663796|FG000|Overall Study|Ineligible|0|||
33287411|NCT01190449|62663797|FG001|Overall Study|Ineligible|4|||
33287412|NCT01190176|62663803|FG000|Overall Study|Withdrawal by Subject|1|||
33287413|NCT01190176|62663803|FG000|Overall Study|Lost to Follow-up|1|||
33287414|NCT01190098|62663809|FG000|Overall Study|Adverse Event|2|||
33287415|NCT01190098|62663810|FG001|Overall Study|Adverse Event|0|||
33287416|NCT01190098|62663809|FG000|Overall Study|Patient coomorbidity|0|||
33287417|NCT01190098|62663810|FG001|Overall Study|Patient coomorbidity|1|||
33287418|NCT01190098|62663809|FG000|Overall Study|Lack of transportation|1|||
33287419|NCT01190098|62663810|FG001|Overall Study|Lack of transportation|0|||
33287420|NCT01190098|62663809|FG000|Overall Study|Other|0|||
33287421|NCT01190098|62663810|FG001|Overall Study|Other|1|||
33287422|NCT01190020|62663818|FG000|Overall Study|Adverse Event|2|||
33287423|NCT01190020|62663819|FG001|Overall Study|Adverse Event|0|||
33287424|NCT01190020|62663818|FG000|Overall Study|Lost to Follow-up|2|||
33287425|NCT01190020|62663819|FG001|Overall Study|Lost to Follow-up|0|||
33287426|NCT01190020|62663818|FG000|Overall Study|Withdrawal by Subject|3|||
33287427|NCT01190020|62663819|FG001|Overall Study|Withdrawal by Subject|0|||
33287428|NCT01189435|62663825|FG000|Overall Study|Withdrawal by Subject|1|||
33287429|NCT01189435|62663825|FG000|Overall Study|Physician Decision|1|||
33287430|NCT01165996|62663829|FG000|Overall Study|Death|1|||
33287431|NCT01165996|62663829|FG000|Overall Study|Physician Decision|1|||
33287432|NCT01165684|62663836|FG000|Overall Study|Adverse Event|1|||
33287433|NCT01165684|62663837|FG001|Overall Study|Adverse Event|1|||
33287434|NCT01165684|62663836|FG000|Overall Study|Lack of Efficacy|2|||
33287435|NCT01165684|62663837|FG001|Overall Study|Lack of Efficacy|1|||
33287436|NCT01165684|62663836|FG000|Overall Study|Protocol Violation|7|||
33287437|NCT01165684|62663837|FG001|Overall Study|Protocol Violation|15|||
33287438|NCT01165684|62663836|FG000|Overall Study|Withdrawal Criteria|2|||
33287439|NCT01165684|62663837|FG001|Overall Study|Withdrawal Criteria|13|||
33287440|NCT01165684|62663836|FG000|Overall Study|Unclassified|16|||
33287441|NCT01165684|62663837|FG001|Overall Study|Unclassified|22|||
33287442|NCT01189201|62663843|FG000|Overall Study|Adverse Event|1|||
33287443|NCT01188967|62663860|FG000|Overall Study|Withdrawal by Subject|1|||
33287444|NCT01188967|62663861|FG001|Overall Study|Withdrawal by Subject|1|||
33287445|NCT01188967|62663860|FG000|Overall Study|Physician Decision|1|||
33287446|NCT01188967|62663861|FG001|Overall Study|Physician Decision|1|||
33287447|NCT01188967|62663860|FG000|Overall Study|Lost to Follow-up|3|||
33287448|NCT01188967|62663861|FG001|Overall Study|Lost to Follow-up|2|||
33287449|NCT01188811|62663871|FG000|Overall Study|Withdrawal by Subject|0|||
33287450|NCT01188811|62663872|FG001|Overall Study|Withdrawal by Subject|2|||
33287451|NCT01188811|62663871|FG000|Overall Study|Adverse Event|6|||
33287452|NCT01188811|62663872|FG001|Overall Study|Adverse Event|0|||
33287453|NCT01183234|62663880|FG000|First Intervention|Adverse Event|1|||
33287454|NCT01183234|62663881|FG001|First Intervention|Adverse Event|0|||
33287455|NCT01165216|62663889|FG000|Overall Study|Adverse Event|6|||
33287456|NCT01165216|62663890|FG001|Overall Study|Adverse Event|3|||
33287457|NCT01165216|62663889|FG000|Overall Study|Withdrawal by Subject|1|||
33287458|NCT01165216|62663890|FG001|Overall Study|Withdrawal by Subject|1|||
33287459|NCT01165216|62663889|FG000|Overall Study|Disease progression|1|||
33287460|NCT01165216|62663890|FG001|Overall Study|Disease progression|3|||
33287461|NCT04545476|62663915|FG000|Overall Study|Lost to Follow-up|1|||
33287462|NCT04545476|62663916|FG001|Overall Study|Lost to Follow-up|1|||
33287463|NCT04545476|62663917|FG002|Overall Study|Lost to Follow-up|0|||
33287464|NCT04545476|62663918|FG003|Overall Study|Lost to Follow-up|0|||
33287465|NCT01969838|62663933|FG000|Double-blind Phase|Adverse Event|10|||
33287466|NCT01969838|62663934|FG001|Double-blind Phase|Adverse Event|4|||
33287467|NCT01969838|62663935|FG002|Double-blind Phase|Adverse Event|0|||
33287468|NCT01969838|62663936|FG003|Double-blind Phase|Adverse Event|0|||
33287469|NCT01969838|62663933|FG000|Double-blind Phase|Death|5|||
33287470|NCT01969838|62663934|FG001|Double-blind Phase|Death|2|||
33287471|NCT01969838|62663935|FG002|Double-blind Phase|Death|0|||
33287472|NCT01969838|62663936|FG003|Double-blind Phase|Death|0|||
33287473|NCT01969838|62663933|FG000|Double-blind Phase|Physician Decision|5|||
33287474|NCT01969838|62663934|FG001|Double-blind Phase|Physician Decision|1|||
33287475|NCT01969838|62663935|FG002|Double-blind Phase|Physician Decision|0|||
33287476|NCT01969838|62663936|FG003|Double-blind Phase|Physician Decision|0|||
33287477|NCT01969838|62663933|FG000|Double-blind Phase|Subject Decision|4|||
33287478|NCT01969838|62663934|FG001|Double-blind Phase|Subject Decision|2|||
33287479|NCT01969838|62663935|FG002|Double-blind Phase|Subject Decision|0|||
33287480|NCT01969838|62663936|FG003|Double-blind Phase|Subject Decision|0|||
33287481|NCT01969838|62663933|FG000|Double-blind Phase|Disease Progression|2|||
33287482|NCT01969838|62663934|FG001|Double-blind Phase|Disease Progression|0|||
33287483|NCT01969838|62663935|FG002|Double-blind Phase|Disease Progression|0|||
33287484|NCT01969838|62663936|FG003|Double-blind Phase|Disease Progression|0|||
33287485|NCT01969838|62663933|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
33287486|NCT01969838|62663934|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
33287487|NCT01969838|62663935|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
33287488|NCT01969838|62663936|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
33287489|NCT01969838|62663933|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
33287490|NCT01969838|62663934|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
33287491|NCT01969838|62663935|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
33287492|NCT01969838|62663936|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
33373695|NCT00817206|62752549|FG000|Overall Study|Withdrawal by Subject|7|||
33373696|NCT00817206|62752550|FG001|Overall Study|Withdrawal by Subject|3|||
33373697|NCT00817206|62752549|FG000|Overall Study|Physician Decision|2|||
33373698|NCT00817206|62752550|FG001|Overall Study|Physician Decision|0|||
33373699|NCT00665002|62752556|FG000|Overall Study|Progression/relapse during treatment|11|||
33373700|NCT00665002|62752556|FG000|Overall Study|Cytogenetic resistance|1|||
33373701|NCT03847987|62752562|FG000|Overall Study|Lost to Follow-up|1|||
33373702|NCT03847987|62752563|FG001|Overall Study|Lost to Follow-up|0|||
33373703|NCT03847987|62752562|FG000|Overall Study|Adverse Event|2|||
33373704|NCT03847987|62752563|FG001|Overall Study|Adverse Event|0|||
33373705|NCT00660010|62752580|FG000|Overall Study|Withdrawal by Subject|2|||
33373706|NCT00660010|62752580|FG000|Overall Study|Lost to Follow-up|3|||
33373707|NCT00660010|62752580|FG000|Overall Study|Adverse Event|1|||
33373708|NCT00660010|62752580|FG000|Overall Study|Noncompliance with visit schedule|3|||
33373709|NCT00873041|62752587|FG000|Core Study|Adverse Event|2|||
33373710|NCT00873041|62752588|FG001|Core Study|Adverse Event|3|||
33373711|NCT00873041|62752589|FG002|Core Study|Adverse Event|1|||
33373712|NCT00873041|62752587|FG000|Core Study|Withdrawal by Subject|1|||
33373713|NCT00873041|62752588|FG001|Core Study|Withdrawal by Subject|2|||
33373714|NCT00873041|62752589|FG002|Core Study|Withdrawal by Subject|2|||
33373715|NCT00873041|62752587|FG000|Core Study|Lost to Follow-up|3|||
33373716|NCT00873041|62752588|FG001|Core Study|Lost to Follow-up|1|||
33373717|NCT00873041|62752589|FG002|Core Study|Lost to Follow-up|0|||
33373718|NCT00873041|62752587|FG000|Core Study|Abnormal laboratory value|0|||
33373719|NCT00873041|62752588|FG001|Core Study|Abnormal laboratory value|0|||
33373720|NCT00873041|62752589|FG002|Core Study|Abnormal laboratory value|1|||
33373721|NCT00873041|62752587|FG000|Core Study|Protocol deviation|1|||
33373722|NCT00873041|62752588|FG001|Core Study|Protocol deviation|0|||
33373723|NCT00873041|62752589|FG002|Core Study|Protocol deviation|1|||
33373724|NCT00873041|62752587|FG000|Extension Study|Adverse Event|1|||
33373725|NCT00873041|62752588|FG001|Extension Study|Adverse Event|0|||
33287493|NCT01969838|62663933|FG000|Open-label Phase|Adverse Event|0|||
33287494|NCT01969838|62663934|FG001|Open-label Phase|Adverse Event|0|||
33287495|NCT01969838|62663935|FG002|Open-label Phase|Adverse Event|37|||
33287496|NCT01969838|62663936|FG003|Open-label Phase|Adverse Event|49|||
33287497|NCT01969838|62663933|FG000|Open-label Phase|Disease Progression|0|||
33287498|NCT01969838|62663934|FG001|Open-label Phase|Disease Progression|0|||
33287499|NCT01969838|62663935|FG002|Open-label Phase|Disease Progression|26|||
33287500|NCT01969838|62663936|FG003|Open-label Phase|Disease Progression|27|||
33287501|NCT01969838|62663933|FG000|Open-label Phase|Lack of Efficacy|0|||
33287502|NCT01969838|62663934|FG001|Open-label Phase|Lack of Efficacy|0|||
33287503|NCT01969838|62663935|FG002|Open-label Phase|Lack of Efficacy|17|||
33287504|NCT01969838|62663936|FG003|Open-label Phase|Lack of Efficacy|19|||
33287505|NCT01969838|62663933|FG000|Open-label Phase|Subject Decision|0|||
33287506|NCT01969838|62663934|FG001|Open-label Phase|Subject Decision|0|||
33287507|NCT01969838|62663935|FG002|Open-label Phase|Subject Decision|14|||
33287508|NCT01969838|62663936|FG003|Open-label Phase|Subject Decision|15|||
33287509|NCT01969838|62663933|FG000|Open-label Phase|Death|0|||
33287510|NCT01969838|62663934|FG001|Open-label Phase|Death|0|||
33287511|NCT01969838|62663935|FG002|Open-label Phase|Death|13|||
33373726|NCT00873041|62752589|FG002|Extension Study|Adverse Event|1|||
33373727|NCT00873041|62752587|FG000|Extension Study|Administrative reasons|0|||
33373728|NCT00873041|62752588|FG001|Extension Study|Administrative reasons|0|||
33373729|NCT00873041|62752589|FG002|Extension Study|Administrative reasons|1|||
33287512|NCT01969838|62663936|FG003|Open-label Phase|Death|11|||
33287513|NCT01969838|62663933|FG000|Open-label Phase|Physician Decision|0|||
33373730|NCT00458341|62752606|FG000|Cycle 1|Adverse Event|1|||
33373731|NCT00458341|62752607|FG001|Cycle 1|Adverse Event|0|||
33373732|NCT00816036|62752615|FG000|Overall Study|Death|47|||
33373733|NCT00816036|62752616|FG001|Overall Study|Death|28|||
33373734|NCT00816036|62752615|FG000|Overall Study|Lost to Follow-up|75|||
33287514|NCT01969838|62663934|FG001|Open-label Phase|Physician Decision|0|||
33287515|NCT01969838|62663935|FG002|Open-label Phase|Physician Decision|9|||
33287516|NCT01969838|62663936|FG003|Open-label Phase|Physician Decision|14|||
33287517|NCT01969838|62663933|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
33287518|NCT01969838|62663934|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
33287519|NCT01969838|62663935|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
33287520|NCT01969838|62663936|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
33287521|NCT01165177|62663947|FG000|Overall Study|Serious Adverse Event|227|||
33287522|NCT01165177|62663948|FG001|Overall Study|Serious Adverse Event|235|||
33287523|NCT01165177|62663947|FG000|Overall Study|Withdrawal by Subject|368|||
33287524|NCT01165177|62663948|FG001|Overall Study|Withdrawal by Subject|354|||
33287525|NCT01165177|62663947|FG000|Overall Study|Protocol Violation|19|||
33287526|NCT01165177|62663948|FG001|Overall Study|Protocol Violation|21|||
33373735|NCT00816036|62752616|FG001|Overall Study|Lost to Follow-up|57|||
33373736|NCT00816036|62752615|FG000|Overall Study|Withdrawal by Subject|54|||
33373737|NCT00816036|62752616|FG001|Overall Study|Withdrawal by Subject|23|||
33373738|NCT00664534|62752624|FG000|Overall Study|Adverse Event|2|||
33373739|NCT00664534|62752625|FG001|Overall Study|Adverse Event|3|||
33556303|NCT02308540|62949125|FG004|Overall Study|Lost to Follow-up|0|||
33287527|NCT01165177|62663947|FG000|Overall Study|Non-serious adverse event|30|||
33287528|NCT01165177|62663948|FG001|Overall Study|Non-serious adverse event|18|||
33287529|NCT01165177|62663947|FG000|Overall Study|Other unspecified reasons|47|||
33287530|NCT01165177|62663948|FG001|Overall Study|Other unspecified reasons|35|||
33287531|NCT01165177|62663947|FG000|Overall Study|Suspected HZ episode|0|||
33287532|NCT01165177|62663948|FG001|Overall Study|Suspected HZ episode|2|||
33287533|NCT01165177|62663947|FG000|Overall Study|Lost to Follow-up|183|||
33287534|NCT01165177|62663948|FG001|Overall Study|Lost to Follow-up|194|||
33287535|NCT01165177|62663947|FG000|Overall Study|Migrated/ moved from study area|48|||
33287536|NCT01165177|62663948|FG001|Overall Study|Migrated/ moved from study area|43|||
33287537|NCT01165138|62663965|FG000|Overall Study|Adverse Event|0|||
33287538|NCT01165138|62663966|FG001|Overall Study|Adverse Event|1|||
33287539|NCT01165138|62663967|FG002|Overall Study|Adverse Event|0|||
33287540|NCT01165138|62663968|FG003|Overall Study|Adverse Event|2|||
33287541|NCT01165138|62663965|FG000|Overall Study|Lack of Efficacy|0|||
33287542|NCT01165138|62663966|FG001|Overall Study|Lack of Efficacy|32|||
33287543|NCT01165138|62663967|FG002|Overall Study|Lack of Efficacy|6|||
33287544|NCT01165138|62663968|FG003|Overall Study|Lack of Efficacy|7|||
33287545|NCT01165138|62663965|FG000|Overall Study|Protocol Violation|0|||
33287546|NCT01165138|62663966|FG001|Overall Study|Protocol Violation|7|||
33287547|NCT01165138|62663967|FG002|Overall Study|Protocol Violation|0|||
33287548|NCT01165138|62663968|FG003|Overall Study|Protocol Violation|2|||
33287549|NCT01165138|62663965|FG000|Overall Study|Lost to Follow-up|0|||
33287550|NCT01165138|62663966|FG001|Overall Study|Lost to Follow-up|0|||
33287551|NCT01165138|62663967|FG002|Overall Study|Lost to Follow-up|1|||
33287552|NCT01165138|62663968|FG003|Overall Study|Lost to Follow-up|2|||
33287553|NCT01165138|62663965|FG000|Overall Study|Physician Decision|0|||
33287554|NCT01165138|62663966|FG001|Overall Study|Physician Decision|6|||
33287555|NCT01165138|62663967|FG002|Overall Study|Physician Decision|7|||
33287556|NCT01165138|62663968|FG003|Overall Study|Physician Decision|6|||
33287557|NCT01165138|62663965|FG000|Overall Study|Withdrawal by Subject|0|||
33287558|NCT01165138|62663966|FG001|Overall Study|Withdrawal by Subject|6|||
33287559|NCT01165138|62663967|FG002|Overall Study|Withdrawal by Subject|6|||
33287560|NCT01165138|62663968|FG003|Overall Study|Withdrawal by Subject|3|||
33287561|NCT01165021|62663976|FG000|Overall Study|Death|1|||
33287562|NCT01182844|62663982|FG000|Overall Study|Withdrawal by Subject|0|||
33287563|NCT01182844|62663983|FG001|Overall Study|Withdrawal by Subject|2|||
33287564|NCT01164865|62663991|FG000|Overall Study|Lost to Follow-up|2|||
33287565|NCT01164865|62663992|FG001|Overall Study|Lost to Follow-up|1|||
33287566|NCT01164475|62664000|FG000|Overall Study|Lack of Efficacy|1|||
33287567|NCT01164475|62664001|FG001|Overall Study|Lack of Efficacy|0|||
33287568|NCT01164475|62664000|FG000|Overall Study|Other|0|||
33287569|NCT01164475|62664001|FG001|Overall Study|Other|1|||
33287570|NCT01164475|62664000|FG000|Overall Study|Progressive disease|0|||
33287571|NCT01164475|62664001|FG001|Overall Study|Progressive disease|1|||
33287572|NCT01164475|62664000|FG000|Overall Study|Protocol Violation|1|||
33287573|NCT01164475|62664001|FG001|Overall Study|Protocol Violation|0|||
33287574|NCT01164007|62664007|FG000|Overall Study|Adverse Event|5|||
33287575|NCT01164007|62664007|FG000|Overall Study|Progression of Disease|30|||
33287576|NCT01164007|62664007|FG000|Overall Study|Protocol Violation|1|||
33287577|NCT01164007|62664007|FG000|Overall Study|Withdrawal by Subject|1|||
33556304|NCT02308540|62949126|FG005|Overall Study|Lost to Follow-up|1|||
33287578|NCT01164007|62664007|FG000|Overall Study|Medical Decision|3|||
33287579|NCT01163851|62664013|FG000|Overall Study|Site Closure|0|||
33287580|NCT01163851|62664014|FG001|Overall Study|Site Closure|1|||
33287581|NCT01163851|62664013|FG000|Overall Study|Enrolled but not treated|1|||
33287582|NCT01163851|62664014|FG001|Overall Study|Enrolled but not treated|0|||
33287583|NCT01163617|62664020|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
33373740|NCT00664534|62752624|FG000|Overall Study|Lost to Follow-up|6|||
33287584|NCT01163617|62664021|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
33287585|NCT01163617|62664022|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
33287586|NCT01163617|62664023|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
33287587|NCT01163617|62664024|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
33287588|NCT01163617|62664025|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
33287589|NCT01163617|62664026|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
33287590|NCT01163617|62664027|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
33287591|NCT01163617|62664020|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
33287592|NCT01163617|62664021|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
33287593|NCT01163617|62664022|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
33287594|NCT01163617|62664023|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
33287595|NCT01163617|62664024|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
33287596|NCT01163617|62664025|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
33287597|NCT01163617|62664026|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
33287598|NCT01163617|62664027|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
33287599|NCT01163617|62664020|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
33287600|NCT01163617|62664021|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
33287601|NCT01163617|62664022|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
33287602|NCT01163617|62664023|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
33287603|NCT01163617|62664024|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
33287604|NCT01163617|62664025|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
33287605|NCT01163617|62664026|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
33287606|NCT01163617|62664027|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
33287607|NCT01182337|62664049|FG000|Overall Study|Withdrawal by Subject|3|||
33287608|NCT01182337|62664050|FG001|Overall Study|Withdrawal by Subject|1|||
33287609|NCT01182337|62664049|FG000|Overall Study|Lost to Follow-up|0|||
33287610|NCT01182337|62664050|FG001|Overall Study|Lost to Follow-up|1|||
33287611|NCT01182298|62664057|FG000|Overall Study|Lack of Efficacy|4|||
33287612|NCT01182298|62664057|FG000|Overall Study|Withdrawal by Subject|2|||
33287613|NCT01163266|62664064|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
33287614|NCT01163266|62664065|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
33287615|NCT01163266|62664066|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
33287616|NCT01163266|62664064|FG000|Overall Study|Lack of Efficacy|1|||
33287617|NCT01163266|62664065|FG001|Overall Study|Lack of Efficacy|3|||
33287618|NCT01163266|62664066|FG002|Overall Study|Lack of Efficacy|1|||
33287619|NCT01163266|62664064|FG000|Overall Study|Noncompliance with Study Drug|0|||
33287620|NCT01163266|62664065|FG001|Overall Study|Noncompliance with Study Drug|2|||
33287621|NCT01163266|62664066|FG002|Overall Study|Noncompliance with Study Drug|0|||
33287622|NCT01163266|62664064|FG000|Overall Study|Protocol Deviations|2|||
33373741|NCT00664534|62752625|FG001|Overall Study|Lost to Follow-up|10|||
33373742|NCT00664534|62752624|FG000|Overall Study|Protocol Violation|10|||
33373743|NCT00664534|62752625|FG001|Overall Study|Protocol Violation|8|||
33373744|NCT00664534|62752624|FG000|Overall Study|Withdrawal by Subject|7|||
33373745|NCT00664534|62752625|FG001|Overall Study|Withdrawal by Subject|6|||
33373746|NCT00664534|62752624|FG000|Overall Study|Physician Decision|8|||
33373747|NCT00664534|62752625|FG001|Overall Study|Physician Decision|0|||
33373748|NCT00664534|62752624|FG000|Overall Study|Sponsor decision|8|||
33373749|NCT00664534|62752625|FG001|Overall Study|Sponsor decision|6|||
33373750|NCT00594035|62752633|FG000|Overall Study|Lost to Follow-up|1|||
33373751|NCT00594035|62752634|FG001|Overall Study|Lost to Follow-up|1|||
33373752|NCT00594035|62752633|FG000|Overall Study|Withdrawal by Subject|1|||
33373753|NCT00594035|62752634|FG001|Overall Study|Withdrawal by Subject|0|||
33373754|NCT00594035|62752633|FG000|Overall Study|Subject transferred to nursing home|0|||
33373755|NCT00594035|62752634|FG001|Overall Study|Subject transferred to nursing home|1|||
33373756|NCT00594035|62752633|FG000|Overall Study|Subject couldn't return due to job|0|||
33373757|NCT00594035|62752634|FG001|Overall Study|Subject couldn't return due to job|1|||
33373758|NCT00570310|62752642|FG000|Overall Study|Adverse Event|1|||
33373759|NCT00570310|62752643|FG001|Overall Study|Adverse Event|2|||
33373760|NCT00570310|62752642|FG000|Overall Study|Lack of Efficacy|1|||
33373761|NCT00570310|62752643|FG001|Overall Study|Lack of Efficacy|4|||
33373762|NCT00664066|62752649|FG000|Overall Study|Study terminated|3|||
33373763|NCT00814710|62752655|FG000|Overall Study|Adverse Event|1|||
33373764|NCT00814710|62752656|FG001|Overall Study|Adverse Event|0|||
33373765|NCT00814710|62752655|FG000|Overall Study|Lost to Follow-up|7|||
33373766|NCT00814710|62752656|FG001|Overall Study|Lost to Follow-up|3|||
33373767|NCT00871169|62752662|FG000|Overall Study|Protocol Violation|1|||
33373768|NCT00871169|62752662|FG000|Overall Study|Patient did not receive study treatment|2|||
33373769|NCT00814632|62752666|FG000|Overall Study|Lack of Efficacy|2|||
33373770|NCT00851318|62752674|FG000|Overall Study|Withdrawal by Subject|7|||
33287623|NCT01163266|62664065|FG001|Overall Study|Protocol Deviations|2|||
33287624|NCT01163266|62664066|FG002|Overall Study|Protocol Deviations|5|||
33287625|NCT01163266|62664064|FG000|Overall Study|Withdrawal of Consent|5|||
33287626|NCT01163266|62664065|FG001|Overall Study|Withdrawal of Consent|7|||
33287627|NCT01163266|62664066|FG002|Overall Study|Withdrawal of Consent|3|||
33373771|NCT00851318|62752675|FG001|Overall Study|Withdrawal by Subject|1|||
33373772|NCT00851318|62752676|FG002|Overall Study|Withdrawal by Subject|5|||
33373773|NCT00851318|62752677|FG003|Overall Study|Withdrawal by Subject|3|||
33373774|NCT00851318|62752674|FG000|Overall Study|Adverse Event|13|||
33373775|NCT00851318|62752675|FG001|Overall Study|Adverse Event|2|||
33373776|NCT00851318|62752676|FG002|Overall Study|Adverse Event|9|||
33287628|NCT01163266|62664064|FG000|Overall Study|Lost to Follow-up|7|||
33287629|NCT01163266|62664065|FG001|Overall Study|Lost to Follow-up|7|||
33287630|NCT01163266|62664066|FG002|Overall Study|Lost to Follow-up|10|||
33287631|NCT01163266|62664064|FG000|Overall Study|Other|1|||
33287632|NCT01163266|62664065|FG001|Overall Study|Other|1|||
33287633|NCT01163266|62664066|FG002|Overall Study|Other|2|||
33373777|NCT00851318|62752677|FG003|Overall Study|Adverse Event|12|||
33373778|NCT00851318|62752674|FG000|Overall Study|Pregnancy|0|||
33373779|NCT00851318|62752675|FG001|Overall Study|Pregnancy|0|||
33373780|NCT00851318|62752676|FG002|Overall Study|Pregnancy|1|||
33373781|NCT00851318|62752677|FG003|Overall Study|Pregnancy|1|||
33373782|NCT00851318|62752674|FG000|Overall Study|Lack of Efficacy|8|||
33373783|NCT00851318|62752675|FG001|Overall Study|Lack of Efficacy|2|||
33373784|NCT00851318|62752676|FG002|Overall Study|Lack of Efficacy|4|||
33373785|NCT00851318|62752677|FG003|Overall Study|Lack of Efficacy|2|||
33373786|NCT00851318|62752674|FG000|Overall Study|Non-compliance with Study Procedures|2|||
33373787|NCT00851318|62752675|FG001|Overall Study|Non-compliance with Study Procedures|0|||
33373788|NCT00851318|62752676|FG002|Overall Study|Non-compliance with Study Procedures|1|||
33373789|NCT00851318|62752677|FG003|Overall Study|Non-compliance with Study Procedures|0|||
33373790|NCT00851318|62752674|FG000|Overall Study|Physician Decision|0|||
33373791|NCT00851318|62752675|FG001|Overall Study|Physician Decision|0|||
33373792|NCT00851318|62752676|FG002|Overall Study|Physician Decision|1|||
33373793|NCT00851318|62752677|FG003|Overall Study|Physician Decision|1|||
33373794|NCT00593957|62752690|FG000|Overall Study|Physician Decision|0|||
33373795|NCT00593957|62752691|FG001|Overall Study|Physician Decision|1|||
33373796|NCT00593957|62752692|FG002|Overall Study|Physician Decision|2|||
33373797|NCT00870233|62752714|FG000|Overall Study|Withdrawal by Subject|18|||
33373798|NCT00870233|62752714|FG000|Overall Study|Did not undergo laparotomy|3|||
33373799|NCT00870233|62752714|FG000|Overall Study|Incompatible internet browser|2|||
33373800|NCT00870233|62752714|FG000|Overall Study|Death|1|||
33373801|NCT00851084|62752721|FG000|Overall Study|Randomized but not treated|1|||
33373802|NCT00851084|62752722|FG001|Overall Study|Randomized but not treated|0|||
33373803|NCT00851084|62752721|FG000|Overall Study|Adverse Event|26|||
33373804|NCT00851084|62752722|FG001|Overall Study|Adverse Event|36|||
33373805|NCT00851084|62752721|FG000|Overall Study|Disease progression|52|||
33373806|NCT00851084|62752722|FG001|Overall Study|Disease progression|47|||
33373807|NCT00851084|62752721|FG000|Overall Study|Poor compliance to protocol|1|||
33373808|NCT00851084|62752722|FG001|Overall Study|Poor compliance to protocol|1|||
33373809|NCT00851084|62752721|FG000|Overall Study|Physician Decision|13|||
33373810|NCT00851084|62752722|FG001|Overall Study|Physician Decision|14|||
33556305|NCT02308228|62949177|FG000|Overall Study|Adverse Event|3|||
33287634|NCT01163149|62664124|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
33287635|NCT01163149|62664125|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
33287636|NCT01163149|62664126|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
33287637|NCT01163149|62664124|FG000|Extension Treatment Period|Adverse Event|0|||
33287638|NCT01163149|62664125|FG001|Extension Treatment Period|Adverse Event|1|||
33287639|NCT01163149|62664126|FG002|Extension Treatment Period|Adverse Event|0|||
33287640|NCT01163149|62664124|FG000|Extension Treatment Period|Noncompliance|0|||
33287641|NCT01163149|62664125|FG001|Extension Treatment Period|Noncompliance|0|||
33287642|NCT01163149|62664126|FG002|Extension Treatment Period|Noncompliance|1|||
33287643|NCT01163032|62664151|FG000|Randomization Phase|Withdrawal by Subject|2|||
33287644|NCT01163032|62664152|FG001|Randomization Phase|Withdrawal by Subject|3|||
33287645|NCT01163032|62664153|FG002|Randomization Phase|Withdrawal by Subject|0|||
33287646|NCT01163032|62664151|FG000|Randomization Phase|Adverse Event|3|||
33373811|NCT00851084|62752721|FG000|Overall Study|Consent withdrawn|0|||
33373812|NCT00851084|62752722|FG001|Overall Study|Consent withdrawn|2|||
33373813|NCT00851084|62752721|FG000|Overall Study|Withdrawal by Subject|11|||
33373814|NCT00851084|62752722|FG001|Overall Study|Withdrawal by Subject|12|||
33556306|NCT02308228|62949178|FG001|Overall Study|Adverse Event|4|||
33287647|NCT01163032|62664152|FG001|Randomization Phase|Adverse Event|3|||
33287648|NCT01163032|62664153|FG002|Randomization Phase|Adverse Event|0|||
33373815|NCT00851084|62752721|FG000|Overall Study|Metastatic surgery|6|||
33373816|NCT00851084|62752722|FG001|Overall Study|Metastatic surgery|6|||
33373817|NCT00851084|62752721|FG000|Overall Study|Other|7|||
33373818|NCT00851084|62752722|FG001|Overall Study|Other|1|||
33373819|NCT00845858|62752733|FG000|Overall Study|Withdrawal by Subject|5|||
33373820|NCT00845858|62752734|FG001|Overall Study|Withdrawal by Subject|1|||
33287649|NCT01163032|62664151|FG000|Randomization Phase|Protocol Violation|0|||
33287650|NCT01163032|62664152|FG001|Randomization Phase|Protocol Violation|1|||
33287651|NCT01163032|62664153|FG002|Randomization Phase|Protocol Violation|0|||
33287652|NCT01163032|62664151|FG000|Randomization Phase|Various*|5|||
33287653|NCT01163032|62664152|FG001|Randomization Phase|Various*|4|||
33287654|NCT01163032|62664153|FG002|Randomization Phase|Various*|0|||
33287655|NCT01163032|62664151|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
33287656|NCT01163032|62664152|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
33287657|NCT01163032|62664153|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
33287658|NCT01163032|62664151|FG000|Open Label Extension Phase|Adverse Event|0|||
33287659|NCT01163032|62664152|FG001|Open Label Extension Phase|Adverse Event|0|||
33287660|NCT01163032|62664153|FG002|Open Label Extension Phase|Adverse Event|3|||
33287661|NCT01163032|62664151|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
33287662|NCT01163032|62664152|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
33287663|NCT01163032|62664153|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
33287664|NCT01163032|62664151|FG000|Open Label Extension Phase|Protocol Violation|0|||
33287665|NCT01163032|62664152|FG001|Open Label Extension Phase|Protocol Violation|0|||
33287666|NCT01163032|62664153|FG002|Open Label Extension Phase|Protocol Violation|1|||
33287667|NCT01163032|62664151|FG000|Open Label Extension Phase|Study Termination|0|||
33287668|NCT01163032|62664152|FG001|Open Label Extension Phase|Study Termination|0|||
33287669|NCT01163032|62664153|FG002|Open Label Extension Phase|Study Termination|7|||
33287670|NCT01163032|62664151|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
33287671|NCT01163032|62664152|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
33287672|NCT01163032|62664153|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
33287673|NCT01162486|62664166|FG000|Overall Study|low ANC|1|||
33287674|NCT01162486|62664167|FG001|Overall Study|low ANC|0|||
33287675|NCT01162486|62664168|FG002|Overall Study|low ANC|0|||
33287676|NCT01162486|62664169|FG003|Overall Study|low ANC|0|||
33287677|NCT01162486|62664170|FG004|Overall Study|low ANC|0|||
33287678|NCT01162486|62664166|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
33287679|NCT01162486|62664167|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
33287680|NCT01162486|62664168|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
33287681|NCT01162486|62664169|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
33287682|NCT01162486|62664170|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
33287683|NCT01162486|62664166|FG000|Overall Study|elevated LFTs|0|||
33287684|NCT01162486|62664167|FG001|Overall Study|elevated LFTs|0|||
33287685|NCT01162486|62664168|FG002|Overall Study|elevated LFTs|1|||
33287686|NCT01162486|62664169|FG003|Overall Study|elevated LFTs|0|||
33287687|NCT01162486|62664170|FG004|Overall Study|elevated LFTs|0|||
33287688|NCT01162486|62664166|FG000|Overall Study|Pregnancy|0|||
33287689|NCT01162486|62664167|FG001|Overall Study|Pregnancy|0|||
33287690|NCT01162486|62664168|FG002|Overall Study|Pregnancy|0|||
33287691|NCT01162486|62664169|FG003|Overall Study|Pregnancy|1|||
33287692|NCT01162486|62664170|FG004|Overall Study|Pregnancy|0|||
33287693|NCT01162135|62664186|FG000|Overall Study|Withdrawal by Subject|1|||
33287694|NCT01162135|62664186|FG000|Overall Study|Severe back pain|1|||
33287695|NCT01162135|62664186|FG000|Overall Study|Ineligible|1|||
33287696|NCT01161628|62664190|FG000|Overall Study|Death|6|||
33287697|NCT01161628|62664190|FG000|Overall Study|Lack of Efficacy|2|||
33287698|NCT01161472|62664194|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
33287699|NCT01161472|62664195|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
33287700|NCT01161472|62664196|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
33287701|NCT01161472|62664197|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
33287702|NCT01161043|62664207|FG000|Overall Study|Withdrawal by Subject|3|||
33287703|NCT01160770|62664211|FG000|Overall Study|Adverse Event|10|||
33287704|NCT01160770|62664211|FG000|Overall Study|Protocol Violation|2|||
33287705|NCT01160770|62664211|FG000|Overall Study|Subject/parent/caregiver request|33|||
33373821|NCT00845858|62752735|FG002|Overall Study|Withdrawal by Subject|1|||
33373822|NCT00845858|62752733|FG000|Overall Study|Adverse Event|3|||
33373823|NCT00845858|62752734|FG001|Overall Study|Adverse Event|8|||
33287706|NCT01160770|62664211|FG000|Overall Study|Physician Decision|1|||
33287707|NCT01160770|62664211|FG000|Overall Study|Lost to Follow-up|7|||
33287708|NCT01160770|62664211|FG000|Overall Study|Study termination or sponsor request|1|||
33287709|NCT01160770|62664211|FG000|Overall Study|Death|9|||
33373824|NCT00845858|62752735|FG002|Overall Study|Adverse Event|4|||
33287710|NCT01160770|62664211|FG000|Overall Study|Lack of Efficacy|15|||
33287711|NCT01160770|62664211|FG000|Overall Study|Other Reasons|1|||
33287712|NCT01160614|62664217|FG000|Overall Study|Withdrawal by Subject|0|||
33287713|NCT01160614|62664218|FG001|Overall Study|Withdrawal by Subject|2|||
33287714|NCT01159912|62664245|FG000|Overall Study|Adverse Event|2|||
33287715|NCT01159912|62664246|FG001|Overall Study|Adverse Event|2|||
33287716|NCT01159912|62664247|FG002|Overall Study|Adverse Event|3|||
33287717|NCT01159912|62664245|FG000|Overall Study|Lack of Efficacy|23|||
33287718|NCT01159912|62664246|FG001|Overall Study|Lack of Efficacy|15|||
33287719|NCT01159912|62664247|FG002|Overall Study|Lack of Efficacy|14|||
33287720|NCT01159912|62664245|FG000|Overall Study|Protocol Violation|1|||
33287721|NCT01159912|62664246|FG001|Overall Study|Protocol Violation|2|||
33287722|NCT01159912|62664247|FG002|Overall Study|Protocol Violation|3|||
33287723|NCT01159912|62664245|FG000|Overall Study|Lost to Follow-up|4|||
33287724|NCT01159912|62664246|FG001|Overall Study|Lost to Follow-up|0|||
33287725|NCT01159912|62664247|FG002|Overall Study|Lost to Follow-up|0|||
33287726|NCT01159912|62664245|FG000|Overall Study|Physician Decision|0|||
33287727|NCT01159912|62664246|FG001|Overall Study|Physician Decision|0|||
33287728|NCT01159912|62664247|FG002|Overall Study|Physician Decision|3|||
33287729|NCT01159912|62664245|FG000|Overall Study|Withdrawal by Subject|10|||
33287730|NCT01159912|62664246|FG001|Overall Study|Withdrawal by Subject|3|||
33287731|NCT01159912|62664247|FG002|Overall Study|Withdrawal by Subject|3|||
33287732|NCT01159600|62664263|FG000|Overall Study|Not treated|0|||
33287733|NCT01159600|62664264|FG001|Overall Study|Not treated|0|||
33287734|NCT01159600|62664265|FG002|Overall Study|Not treated|1|||
33287735|NCT01159600|62664266|FG003|Overall Study|Not treated|0|||
33287736|NCT01159600|62664267|FG004|Overall Study|Not treated|0|||
33287737|NCT01159600|62664268|FG005|Overall Study|Not treated|1|||
33287738|NCT01159600|62664269|FG006|Overall Study|Not treated|2|||
33287739|NCT01159600|62664270|FG007|Overall Study|Not treated|2|||
33287740|NCT01159600|62664263|FG000|Overall Study|Adverse Event|7|||
33287741|NCT01159600|62664264|FG001|Overall Study|Adverse Event|2|||
33287742|NCT01159600|62664265|FG002|Overall Study|Adverse Event|5|||
33287743|NCT01159600|62664266|FG003|Overall Study|Adverse Event|1|||
33287744|NCT01159600|62664267|FG004|Overall Study|Adverse Event|8|||
33287745|NCT01159600|62664268|FG005|Overall Study|Adverse Event|6|||
33287746|NCT01159600|62664269|FG006|Overall Study|Adverse Event|7|||
33287747|NCT01159600|62664270|FG007|Overall Study|Adverse Event|5|||
33287748|NCT01159600|62664263|FG000|Overall Study|Lack of Efficacy|0|||
33287749|NCT01159600|62664264|FG001|Overall Study|Lack of Efficacy|0|||
33287750|NCT01159600|62664265|FG002|Overall Study|Lack of Efficacy|0|||
33287751|NCT01159600|62664266|FG003|Overall Study|Lack of Efficacy|0|||
33373825|NCT00845858|62752733|FG000|Overall Study|Protocol Violation|0|||
33373826|NCT00845858|62752734|FG001|Overall Study|Protocol Violation|0|||
33373827|NCT00845858|62752735|FG002|Overall Study|Protocol Violation|1|||
33373828|NCT00845858|62752733|FG000|Overall Study|not eligible|0|||
33373829|NCT00845858|62752734|FG001|Overall Study|not eligible|3|||
33373830|NCT00845858|62752735|FG002|Overall Study|not eligible|2|||
33373831|NCT00850538|62752746|FG000|Overall Study|unable/unwilling to complete MRI|13|||
33373832|NCT00850538|62752746|FG000|Overall Study|specimen missed due to scheduling error|14|||
33373833|NCT00850538|62752746|FG000|Overall Study|specimen unusable|7|||
33373834|NCT00850538|62752746|FG000|Overall Study|Withdrawal by Subject|3|||
33373835|NCT00850538|62752746|FG000|Overall Study|radiology error|2|||
33373836|NCT00850538|62752746|FG000|Overall Study|Protocol Violation|2|||
33373837|NCT00850460|62752752|FG000|Overall Study|Lost to Follow-up|4|||
33373838|NCT00850460|62752753|FG001|Overall Study|Lost to Follow-up|4|||
33373839|NCT00661492|62752761|FG000|Overall Study|Adverse Event|16|||
33373840|NCT00661492|62752762|FG001|Overall Study|Adverse Event|13|||
33373841|NCT00661492|62752761|FG000|Overall Study|Disease Progression|44|||
33373842|NCT00661492|62752762|FG001|Overall Study|Disease Progression|14|||
33373843|NCT00661492|62752761|FG000|Overall Study|Patient Request|6|||
33373844|NCT00661492|62752762|FG001|Overall Study|Patient Request|1|||
33662264|NCT01695239|63092846|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
33287752|NCT01159600|62664267|FG004|Overall Study|Lack of Efficacy|2|||
33287753|NCT01159600|62664268|FG005|Overall Study|Lack of Efficacy|0|||
33287754|NCT01159600|62664269|FG006|Overall Study|Lack of Efficacy|0|||
33287755|NCT01159600|62664270|FG007|Overall Study|Lack of Efficacy|1|||
33287756|NCT01159600|62664263|FG000|Overall Study|Non compliant with protocol|2|||
33287757|NCT01159600|62664264|FG001|Overall Study|Non compliant with protocol|1|||
33287758|NCT01159600|62664265|FG002|Overall Study|Non compliant with protocol|0|||
33287759|NCT01159600|62664266|FG003|Overall Study|Non compliant with protocol|0|||
33662265|NCT01695239|63092833|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33287760|NCT01159600|62664267|FG004|Overall Study|Non compliant with protocol|2|||
33287761|NCT01159600|62664268|FG005|Overall Study|Non compliant with protocol|0|||
33287762|NCT01159600|62664269|FG006|Overall Study|Non compliant with protocol|2|||
33287763|NCT01159600|62664270|FG007|Overall Study|Non compliant with protocol|0|||
33373845|NCT00661492|62752761|FG000|Overall Study|Investigator Request|1|||
33287764|NCT01159600|62664263|FG000|Overall Study|Lost to Follow-up|2|||
33287765|NCT01159600|62664264|FG001|Overall Study|Lost to Follow-up|3|||
33287766|NCT01159600|62664265|FG002|Overall Study|Lost to Follow-up|4|||
33287767|NCT01159600|62664266|FG003|Overall Study|Lost to Follow-up|3|||
33287768|NCT01159600|62664267|FG004|Overall Study|Lost to Follow-up|3|||
33287769|NCT01159600|62664268|FG005|Overall Study|Lost to Follow-up|0|||
33287770|NCT01159600|62664269|FG006|Overall Study|Lost to Follow-up|3|||
33287771|NCT01159600|62664270|FG007|Overall Study|Lost to Follow-up|2|||
33373846|NCT00661492|62752762|FG001|Overall Study|Investigator Request|0|||
33373847|NCT00661492|62752761|FG000|Overall Study|Lost to Follow-up|0|||
33287772|NCT01159600|62664263|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
33373848|NCT00661492|62752762|FG001|Overall Study|Lost to Follow-up|1|||
33373849|NCT00661492|62752761|FG000|Overall Study|Other|1|||
33287773|NCT01159600|62664264|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
33287774|NCT01159600|62664265|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
33287775|NCT01159600|62664266|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
33287776|NCT01159600|62664267|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
33287777|NCT01159600|62664268|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
33287778|NCT01159600|62664269|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
33287779|NCT01159600|62664270|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
33287780|NCT01159600|62664263|FG000|Overall Study|Other reason not defined above|3|||
33287781|NCT01159600|62664264|FG001|Overall Study|Other reason not defined above|0|||
33287782|NCT01159600|62664265|FG002|Overall Study|Other reason not defined above|4|||
33287783|NCT01159600|62664266|FG003|Overall Study|Other reason not defined above|2|||
33287784|NCT01159600|62664267|FG004|Overall Study|Other reason not defined above|5|||
33287785|NCT01159600|62664268|FG005|Overall Study|Other reason not defined above|7|||
33287786|NCT01159600|62664269|FG006|Overall Study|Other reason not defined above|3|||
33287787|NCT01159600|62664270|FG007|Overall Study|Other reason not defined above|3|||
33287788|NCT01159171|62664289|FG000|Overall Study|Adverse Event|11|||
33287789|NCT01159171|62664289|FG000|Overall Study|Progression of Disease|28|||
33287790|NCT01159171|62664289|FG000|Overall Study|Protocol Violation|1|||
33287791|NCT01159171|62664289|FG000|Overall Study|Need for Surgery|5|||
33287792|NCT01159171|62664289|FG000|Overall Study|Medical Decision|4|||
33287793|NCT01159171|62664289|FG000|Overall Study|Death|1|||
33287794|NCT01158118|62664296|FG000|Overall Study|Screen failure|1|||
33287795|NCT01158118|62664297|FG001|Overall Study|Screen failure|0|||
33287796|NCT01158118|62664296|FG000|Overall Study|Donor match was a screen failure|0|||
33287797|NCT01158118|62664297|FG001|Overall Study|Donor match was a screen failure|1|||
33287798|NCT01158118|62664296|FG000|Overall Study|Suffered stroke prior to transplant|0|||
33287799|NCT01158118|62664297|FG001|Overall Study|Suffered stroke prior to transplant|1|||
33287800|NCT01158118|62664296|FG000|Overall Study|Death|0|||
33287801|NCT01158118|62664297|FG001|Overall Study|Death|1|||
33287802|NCT01157845|62664303|FG000|Overall Study|Lost to Follow-up|5|||
33287803|NCT01157845|62664303|FG000|Overall Study|Withdrawal by Subject|12|||
33287804|NCT01157845|62664303|FG000|Overall Study|Physician Decision|3|||
33287805|NCT01157845|62664303|FG000|Overall Study|Protocol Violation|13|||
33287806|NCT01157845|62664303|FG000|Overall Study|Study was ended|1|||
33287807|NCT01157845|62664303|FG000|Overall Study|Device malfunction|1|||
33287808|NCT01157377|62664314|FG000|Overall Study|Lost to Follow-up|0|||
33287809|NCT01157377|62664315|FG001|Overall Study|Lost to Follow-up|0|||
33287810|NCT01157377|62664316|FG002|Overall Study|Lost to Follow-up|1|||
33287811|NCT01157377|62664317|FG003|Overall Study|Lost to Follow-up|0|||
33287812|NCT01157377|62664318|FG004|Overall Study|Lost to Follow-up|1|||
33287813|NCT01157377|62664319|FG005|Overall Study|Lost to Follow-up|1|||
33287814|NCT01157377|62664320|FG006|Overall Study|Lost to Follow-up|0|||
33287815|NCT01157377|62664314|FG000|Overall Study|Personal Reasons|2|||
33287816|NCT01157377|62664315|FG001|Overall Study|Personal Reasons|1|||
33287817|NCT01157377|62664316|FG002|Overall Study|Personal Reasons|0|||
33287818|NCT01157377|62664317|FG003|Overall Study|Personal Reasons|1|||
33287819|NCT01157377|62664318|FG004|Overall Study|Personal Reasons|0|||
33287820|NCT01157377|62664319|FG005|Overall Study|Personal Reasons|0|||
33287821|NCT01157377|62664320|FG006|Overall Study|Personal Reasons|0|||
33287822|NCT01157377|62664314|FG000|Overall Study|Protocol Violation|0|||
33287823|NCT01157377|62664315|FG001|Overall Study|Protocol Violation|0|||
33287824|NCT01157377|62664316|FG002|Overall Study|Protocol Violation|0|||
33287825|NCT01157377|62664317|FG003|Overall Study|Protocol Violation|0|||
33287826|NCT01157377|62664318|FG004|Overall Study|Protocol Violation|0|||
33287827|NCT01157377|62664319|FG005|Overall Study|Protocol Violation|1|||
33287828|NCT01157377|62664320|FG006|Overall Study|Protocol Violation|0|||
33373850|NCT00661492|62752762|FG001|Overall Study|Other|0|||
33373851|NCT00850070|62752770|FG000|Overall Study|Lack of Efficacy|1|||
33373852|NCT00850070|62752771|FG001|Overall Study|Lack of Efficacy|1|||
33373853|NCT00850070|62752770|FG000|Overall Study|Adverse Event|2|||
33373854|NCT00850070|62752771|FG001|Overall Study|Adverse Event|0|||
33373855|NCT00592358|62752782|FG000|Overall Study|Withdrawal by Subject|2|||
33373856|NCT00592358|62752782|FG000|Overall Study|Adverse Event|1|||
33287829|NCT01157377|62664314|FG000|Overall Study|Lack of Efficacy|0|||
33287830|NCT01157377|62664315|FG001|Overall Study|Lack of Efficacy|0|||
33287831|NCT01157377|62664316|FG002|Overall Study|Lack of Efficacy|0|||
33373857|NCT00592358|62752782|FG000|Overall Study|Lack of Efficacy|2|||
33287832|NCT01157377|62664317|FG003|Overall Study|Lack of Efficacy|0|||
33287833|NCT01157377|62664318|FG004|Overall Study|Lack of Efficacy|0|||
33287834|NCT01157377|62664319|FG005|Overall Study|Lack of Efficacy|0|||
33373858|NCT00592358|62752782|FG000|Overall Study|Inability to swallow pills|1|||
33287835|NCT01157377|62664320|FG006|Overall Study|Lack of Efficacy|1|||
33287836|NCT01157377|62664314|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33287837|NCT01157377|62664315|FG001|Overall Study|Other Miscellaneous Reasons|2|||
33287838|NCT01157377|62664316|FG002|Overall Study|Other Miscellaneous Reasons|0|||
33287839|NCT01157377|62664317|FG003|Overall Study|Other Miscellaneous Reasons|0|||
33373859|NCT00814320|62752788|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
33373860|NCT00814320|62752789|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
33287840|NCT01157377|62664318|FG004|Overall Study|Other Miscellaneous Reasons|1|||
33287841|NCT01157377|62664319|FG005|Overall Study|Other Miscellaneous Reasons|1|||
33287842|NCT01157377|62664320|FG006|Overall Study|Other Miscellaneous Reasons|1|||
33287843|NCT01157182|62664338|FG000|Washout of 28 Days|Adverse Event|2|||
33287844|NCT01157182|62664339|FG001|Washout of 28 Days|Adverse Event|0|||
33287845|NCT01157065|62664347|FG000|Overall Study|Death|0|||
33287846|NCT01157065|62664348|FG001|Overall Study|Death|1|||
33287847|NCT01156792|62664354|FG000|Overall Study|Adverse Event|1|||
33287848|NCT01156792|62664354|FG000|Overall Study|Lack of Efficacy|36|||
33287849|NCT01156792|62664354|FG000|Overall Study|Protocol Violation|6|||
33373861|NCT00814320|62752788|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
33287850|NCT01156792|62664354|FG000|Overall Study|Lost to Follow-up|3|||
33287851|NCT01156792|62664354|FG000|Overall Study|Physician Decision|3|||
33287852|NCT01156792|62664354|FG000|Overall Study|Withdrawal by Subject|9|||
33287853|NCT01156792|62664354|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
33287854|NCT01156714|62664372|FG000|Overall Study|Withdrawal by Subject|9|||
33287855|NCT01156714|62664373|FG001|Overall Study|Withdrawal by Subject|4|||
33287856|NCT01156714|62664374|FG002|Overall Study|Withdrawal by Subject|3|||
33287857|NCT01156675|62664388|FG000|Overall Study|Death|5|||
33287858|NCT01156675|62664389|FG001|Overall Study|Death|3|||
33287859|NCT01156675|62664390|FG002|Overall Study|Death|0|||
33287860|NCT01156675|62664388|FG000|Overall Study|No data|29|||
33287861|NCT01156675|62664389|FG001|Overall Study|No data|22|||
33287862|NCT01156675|62664390|FG002|Overall Study|No data|2|||
33287863|NCT01156480|62664401|FG000|Overall Study|change in diagnosis|0|||
33287864|NCT01156480|62664402|FG001|Overall Study|change in diagnosis|1|||
33373862|NCT00814320|62752789|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
33373863|NCT00814320|62752788|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
33373864|NCT00814320|62752789|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
33373865|NCT00814320|62752788|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
33373866|NCT00814320|62752789|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
33373867|NCT00814320|62752788|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
33373868|NCT00814320|62752789|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
33373869|NCT00814320|62752788|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
33373870|NCT00814320|62752789|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
33373871|NCT00814320|62752788|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
33373872|NCT00814320|62752789|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
33373873|NCT00814320|62752788|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
33373874|NCT00814320|62752789|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
33373875|NCT00814320|62752788|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
33373876|NCT00814320|62752789|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
33373877|NCT00814320|62752788|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
33373878|NCT00814320|62752789|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
33373879|NCT00869999|62752812|FG000|Overall Study|Withdrawal by Subject|1|||
33373880|NCT00869999|62752812|FG000|Overall Study|removed prior to starting therapy|1|||
33373881|NCT00570232|62752816|FG000|Overall Study|Adverse Event|10|||
33373882|NCT00570232|62752816|FG000|Overall Study|discontinued due to medical condition|3|||
33373883|NCT00570232|62752816|FG000|Overall Study|discontinued due to recurrence|8|||
33373884|NCT00570232|62752816|FG000|Overall Study|discontinued due to noncompliance|2|||
33373885|NCT00809328|62752820|FG000|Overall Study|Lack of Efficacy|18|||
33373886|NCT00809328|62752820|FG000|Overall Study|Adverse Event|6|||
33373887|NCT00809328|62752820|FG000|Overall Study|Protocol Violation|3|||
33373888|NCT00809328|62752820|FG000|Overall Study|Withdrawal by Subject|2|||
33373889|NCT00868517|62752827|FG000|Overall Study|Withdrawal by Subject|3|||
33373890|NCT00868517|62752828|FG001|Overall Study|Withdrawal by Subject|3|||
33373891|NCT00868517|62752829|FG002|Overall Study|Withdrawal by Subject|2|||
33373892|NCT00868517|62752827|FG000|Overall Study|Protocol Violation|1|||
33373893|NCT00868517|62752828|FG001|Overall Study|Protocol Violation|1|||
33373894|NCT00868517|62752829|FG002|Overall Study|Protocol Violation|0|||
33373895|NCT00868439|62752839|FG000|Overall Study|Adverse Event|4|||
33287865|NCT01156363|62664410|FG000|Overall Study|Adverse Event|6|||
33287866|NCT01156363|62664410|FG000|Overall Study|Insufficient Therapeutic Response|5|||
33287867|NCT01156363|62664410|FG000|Overall Study|Failure to Return|1|||
33287868|NCT01156363|62664410|FG000|Overall Study|Refused Treatment|4|||
33287869|NCT01156363|62664410|FG000|Overall Study|Other|6|||
33373896|NCT00868439|62752840|FG001|Overall Study|Adverse Event|3|||
33373897|NCT00868439|62752839|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
33556307|NCT02308228|62949177|FG000|Overall Study|Withdrawal by Subject|5|||
33287870|NCT01156051|62664423|FG000|Overall Study|Lost to Follow-up|1|||
33287871|NCT01156051|62664424|FG001|Overall Study|Lost to Follow-up|0|||
33373898|NCT00868439|62752840|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
33373899|NCT00868439|62752839|FG000|Overall Study|Death|0|||
33287872|NCT01156051|62664423|FG000|Overall Study|patient not compliant with protocol|0|||
33287873|NCT01156051|62664424|FG001|Overall Study|patient not compliant with protocol|1|||
33287874|NCT01156012|62664432|FG000|Overall Study|Adverse Event|3|||
33287875|NCT01156012|62664433|FG001|Overall Study|Adverse Event|1|||
33287876|NCT01156012|62664432|FG000|Overall Study|Lost to Follow-up|1|||
33287877|NCT01156012|62664433|FG001|Overall Study|Lost to Follow-up|0|||
33287878|NCT01156012|62664432|FG000|Overall Study|Withdrawal by Subject|1|||
33287879|NCT01156012|62664433|FG001|Overall Study|Withdrawal by Subject|0|||
33287880|NCT01156012|62664432|FG000|Overall Study|use of commercial drug instead of study|0|||
33287881|NCT01156012|62664433|FG001|Overall Study|use of commercial drug instead of study|1|||
33287882|NCT01156012|62664432|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
33287883|NCT01156012|62664433|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
33287884|NCT01155661|62664439|FG000|Overall Study|Adverse Event|101|||
33287885|NCT01155661|62664439|FG000|Overall Study|Death|1|||
33287886|NCT01155661|62664439|FG000|Overall Study|Lack of Efficacy|32|||
33287887|NCT01155661|62664439|FG000|Overall Study|Lost to Follow-up|22|||
33287888|NCT01155661|62664439|FG000|Overall Study|Physician Decision|3|||
33287889|NCT01155661|62664439|FG000|Overall Study|Protocol Violation|35|||
33287890|NCT01155661|62664439|FG000|Overall Study|Withdrawal by Subject|73|||
33287891|NCT01155661|62664439|FG000|Overall Study|Sponsor Decision|13|||
33287892|NCT01155583|62664454|FG000|Phase I|Screen failure - did not start treatment|0|||
33287893|NCT01155583|62664455|FG001|Phase I|Screen failure - did not start treatment|0|||
33287894|NCT01155583|62664456|FG002|Phase I|Screen failure - did not start treatment|0|||
33287895|NCT01155583|62664457|FG003|Phase I|Screen failure - did not start treatment|0|||
33287896|NCT01155583|62664458|FG004|Phase I|Screen failure - did not start treatment|1|||
33287897|NCT01155583|62664459|FG005|Phase I|Screen failure - did not start treatment|0|||
33287898|NCT01155583|62664460|FG006|Phase I|Screen failure - did not start treatment|0|||
33287899|NCT01155583|62664461|FG007|Phase I|Screen failure - did not start treatment|2|||
33287900|NCT01155583|62664462|FG008|Phase I|Screen failure - did not start treatment|0|||
33287901|NCT01155583|62664454|FG000|Phase I|Withdrawal by Subject|0|||
33287902|NCT01155583|62664455|FG001|Phase I|Withdrawal by Subject|0|||
33287903|NCT01155583|62664456|FG002|Phase I|Withdrawal by Subject|0|||
33287904|NCT01155583|62664457|FG003|Phase I|Withdrawal by Subject|0|||
33287905|NCT01155583|62664458|FG004|Phase I|Withdrawal by Subject|0|||
33287906|NCT01155583|62664459|FG005|Phase I|Withdrawal by Subject|0|||
33373900|NCT00868439|62752840|FG001|Overall Study|Death|1|||
33373901|NCT00868439|62752839|FG000|Overall Study|Protocol Violation|1|||
33373902|NCT00868439|62752840|FG001|Overall Study|Protocol Violation|1|||
33373903|NCT00868439|62752839|FG000|Overall Study|Physician Decision|1|||
33373904|NCT00868439|62752840|FG001|Overall Study|Physician Decision|0|||
33373905|NCT00868439|62752839|FG000|Overall Study|Withdrawal by Subject|0|||
33373906|NCT00868439|62752840|FG001|Overall Study|Withdrawal by Subject|1|||
33373907|NCT00814164|62752846|FG000|Overall Study|Progression|7|||
33373908|NCT00814164|62752846|FG000|Overall Study|not stated|7|||
33373909|NCT00814164|62752846|FG000|Overall Study|Death|5|||
33373910|NCT00659230|62752852|FG000|Overall Study|Lost to Follow-up|2|||
33373911|NCT00659230|62752853|FG001|Overall Study|Lost to Follow-up|5|||
33373912|NCT00659230|62752852|FG000|Overall Study|Lost source documentation|5|||
33373913|NCT00659230|62752853|FG001|Overall Study|Lost source documentation|4|||
33373914|NCT00659230|62752852|FG000|Overall Study|Did not return post-randomization|2|||
33373915|NCT00659230|62752853|FG001|Overall Study|Did not return post-randomization|3|||
33486639|NCT03773978|62864592|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
33486640|NCT03773978|62864591|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
33486641|NCT03773978|62864592|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
33486642|NCT03773978|62864591|FG000|DBW Period|Adverse Event|2|||
33373916|NCT00809094|62752861|FG000|Overall Study|Lost to Follow-up|0|||
33373917|NCT00809094|62752862|FG001|Overall Study|Lost to Follow-up|1|||
33373918|NCT00658996|62752868|FG000|First Intervention|Positive slit lamp finding|1|||
33373919|NCT00658996|62752869|FG001|First Intervention|Positive slit lamp finding|0|||
33373920|NCT00658996|62752868|FG000|First Intervention|Lack of lenses|0|||
33373921|NCT00658996|62752869|FG001|First Intervention|Lack of lenses|1|||
33486643|NCT03773978|62864592|FG001|DBW Period|Adverse Event|2|||
33486644|NCT03773978|62864591|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
33486645|NCT03773978|62864592|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
33486646|NCT03773978|62864591|FG000|DBW Period|Withdrawal by Subject|2|||
33486647|NCT03773978|62864592|FG001|DBW Period|Withdrawal by Subject|1|||
33373922|NCT00658996|62752868|FG000|Crossover Period|Physician Decision|1|||
33287907|NCT01155583|62664460|FG006|Phase I|Withdrawal by Subject|0|||
33287908|NCT01155583|62664461|FG007|Phase I|Withdrawal by Subject|1|||
33287909|NCT01155583|62664462|FG008|Phase I|Withdrawal by Subject|0|||
33287910|NCT01155466|62664483|FG000|Overall Study|Adverse Event|13|||
33287911|NCT01155466|62664484|FG001|Overall Study|Adverse Event|15|||
33373923|NCT00658996|62752869|FG001|Crossover Period|Physician Decision|0|||
33373924|NCT00658996|62752868|FG000|Crossover Period|Ineligible|1|||
33373925|NCT00658996|62752869|FG001|Crossover Period|Ineligible|1|||
33373926|NCT00658996|62752868|FG000|Second Intervention|Developed a stye on upper lid|1|||
33373927|NCT00658996|62752869|FG001|Second Intervention|Developed a stye on upper lid|0|||
33373928|NCT00658996|62752868|FG000|Second Intervention|Positive slit lamp finding|0|||
33373929|NCT00658996|62752869|FG001|Second Intervention|Positive slit lamp finding|1|||
33373930|NCT00867815|62752875|FG000|Overall Study|Lost to Follow-up|1|||
33373931|NCT00452413|62752882|FG000|Overall Study|Progressive Disease|4|||
33373932|NCT00452413|62752883|FG001|Overall Study|Progressive Disease|11|||
33373933|NCT00452413|62752884|FG002|Overall Study|Progressive Disease|30|||
33373934|NCT00452413|62752882|FG000|Overall Study|Withdrawal by Subject|0|||
33373935|NCT00452413|62752883|FG001|Overall Study|Withdrawal by Subject|1|||
33373936|NCT00452413|62752884|FG002|Overall Study|Withdrawal by Subject|4|||
33373937|NCT00452413|62752882|FG000|Overall Study|Adverse Event|0|||
33373938|NCT00452413|62752883|FG001|Overall Study|Adverse Event|0|||
33373939|NCT00452413|62752884|FG002|Overall Study|Adverse Event|5|||
33373940|NCT00452413|62752882|FG000|Overall Study|Physician Decision|0|||
33373941|NCT00452413|62752883|FG001|Overall Study|Physician Decision|0|||
33373942|NCT00452413|62752884|FG002|Overall Study|Physician Decision|4|||
33373943|NCT00452413|62752882|FG000|Overall Study|Death due to study disease|0|||
33373944|NCT00452413|62752883|FG001|Overall Study|Death due to study disease|0|||
33373945|NCT00452413|62752884|FG002|Overall Study|Death due to study disease|2|||
33373946|NCT00452413|62752882|FG000|Overall Study|Death due to adverse event (AE)|0|||
33373947|NCT00452413|62752883|FG001|Overall Study|Death due to adverse event (AE)|0|||
33373948|NCT00452413|62752884|FG002|Overall Study|Death due to adverse event (AE)|1|||
33373949|NCT00452413|62752882|FG000|Overall Study|On treatment|0|||
33373950|NCT00452413|62752883|FG001|Overall Study|On treatment|0|||
33373951|NCT00452413|62752884|FG002|Overall Study|On treatment|3|||
33287912|NCT01155466|62664485|FG002|Overall Study|Adverse Event|6|||
33287913|NCT01155466|62664486|FG003|Overall Study|Adverse Event|17|||
33287914|NCT01155466|62664487|FG004|Overall Study|Adverse Event|18|||
33287915|NCT01155466|62664483|FG000|Overall Study|Lost to Follow-up|0|||
33287916|NCT01155466|62664484|FG001|Overall Study|Lost to Follow-up|0|||
33287917|NCT01155466|62664485|FG002|Overall Study|Lost to Follow-up|0|||
33373952|NCT00867503|62752893|FG000|Overall Study|Withdrawal by Subject|1|||
33287918|NCT01155466|62664486|FG003|Overall Study|Lost to Follow-up|0|||
33287919|NCT01155466|62664487|FG004|Overall Study|Lost to Follow-up|2|||
33373953|NCT00867113|62752899|FG000|Treatment Period|Adverse Event|15|||
33373954|NCT00867113|62752899|FG000|Treatment Period|Death|2|||
33373955|NCT00867113|62752899|FG000|Treatment Period|Withdrawal by Subject|19|||
33373956|NCT00867113|62752899|FG000|Treatment Period|Lost to Follow-up|3|||
33287920|NCT01155466|62664483|FG000|Overall Study|Withdrawal by Subject|7|||
33287921|NCT01155466|62664484|FG001|Overall Study|Withdrawal by Subject|5|||
33373957|NCT00867113|62752899|FG000|Treatment Period|Administrative problems|1|||
33373958|NCT00867113|62752899|FG000|Treatment Period|Disease progression/relapse|1|||
33373959|NCT00867113|62752899|FG000|Treatment Period|Protocol Violation|4|||
33373960|NCT00867113|62752899|FG000|Post Treatment After Survival Follow-up|Death|1|||
33373961|NCT00867113|62752899|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
33373962|NCT00867113|62752899|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
33373963|NCT00867113|62752899|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
33373964|NCT00451555|62752906|FG000|Overall Study|Protocol Violation|2|||
33373965|NCT00451555|62752907|FG001|Overall Study|Protocol Violation|2|||
33373966|NCT00451555|62752906|FG000|Overall Study|Adverse Event|3|||
33287922|NCT01155466|62664485|FG002|Overall Study|Withdrawal by Subject|9|||
33287923|NCT01155466|62664486|FG003|Overall Study|Withdrawal by Subject|4|||
33287924|NCT01155466|62664487|FG004|Overall Study|Withdrawal by Subject|4|||
33287925|NCT01155466|62664483|FG000|Overall Study|Protocol Violation|0|||
33373967|NCT00451555|62752907|FG001|Overall Study|Adverse Event|1|||
33373968|NCT00451555|62752906|FG000|Overall Study|Withdrawal by Subject|6|||
33287926|NCT01155466|62664484|FG001|Overall Study|Protocol Violation|0|||
33287927|NCT01155466|62664485|FG002|Overall Study|Protocol Violation|2|||
33373969|NCT00451555|62752907|FG001|Overall Study|Withdrawal by Subject|0|||
33373970|NCT00451555|62752906|FG000|Overall Study|Physician Decision|2|||
33373971|NCT00451555|62752907|FG001|Overall Study|Physician Decision|1|||
33486648|NCT03773978|62864591|FG000|DBW Period|Due to epidemic or pandemic|5|||
33486649|NCT03773978|62864592|FG001|DBW Period|Due to epidemic or pandemic|6|||
33287928|NCT01155466|62664486|FG003|Overall Study|Protocol Violation|0|||
33287929|NCT01155466|62664487|FG004|Overall Study|Protocol Violation|1|||
33287930|NCT01155466|62664483|FG000|Overall Study|Administrative|0|||
33287931|NCT01155466|62664484|FG001|Overall Study|Administrative|3|||
33287932|NCT01155466|62664485|FG002|Overall Study|Administrative|0|||
33287933|NCT01155466|62664486|FG003|Overall Study|Administrative|0|||
33287934|NCT01155466|62664487|FG004|Overall Study|Administrative|0|||
33373972|NCT00808236|62752924|FG000|Overall Study|Was not resuscitated|50|||
33373973|NCT00808236|62752925|FG001|Overall Study|Was not resuscitated|56|||
33373974|NCT00808236|62752924|FG000|Overall Study|Pre-defined exclusion|13|||
33373975|NCT00808236|62752925|FG001|Overall Study|Pre-defined exclusion|3|||
33373976|NCT00808236|62752924|FG000|Overall Study|Lost to Follow-up|1|||
33373977|NCT00808236|62752925|FG001|Overall Study|Lost to Follow-up|1|||
33373978|NCT00808236|62752924|FG000|Overall Study|Physician Decision|0|||
33373979|NCT00808236|62752925|FG001|Overall Study|Physician Decision|1|||
33373980|NCT00808236|62752924|FG000|Overall Study|Death|18|||
33373981|NCT00808236|62752925|FG001|Overall Study|Death|30|||
33373982|NCT00867035|62752933|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
33287935|NCT01155466|62664483|FG000|Overall Study|Randomized not treated|2|||
33373983|NCT00867035|62752934|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
33287936|NCT01155466|62664484|FG001|Overall Study|Randomized not treated|2|||
33287937|NCT01155466|62664485|FG002|Overall Study|Randomized not treated|3|||
33287938|NCT01155466|62664486|FG003|Overall Study|Randomized not treated|0|||
33287939|NCT01155466|62664487|FG004|Overall Study|Randomized not treated|2|||
33287940|NCT01155388|62664501|FG000|Overall Study|Adverse Event|1|||
33287941|NCT01155388|62664502|FG001|Overall Study|Adverse Event|0|||
33287942|NCT01154452|62664513|FG000|Phase Ib|Not Treated|1|||
33287943|NCT01154452|62664514|FG001|Phase Ib|Not Treated|0|||
33287944|NCT01154452|62664515|FG002|Phase Ib|Not Treated|0|||
33287945|NCT01154452|62664516|FG003|Phase Ib|Not Treated|0|||
33287946|NCT01154452|62664513|FG000|Phase Ib|Adverse Event|2|||
33287947|NCT01154452|62664514|FG001|Phase Ib|Adverse Event|1|||
33287948|NCT01154452|62664515|FG002|Phase Ib|Adverse Event|0|||
33287949|NCT01154452|62664516|FG003|Phase Ib|Adverse Event|0|||
33287950|NCT01154452|62664513|FG000|Phase II|Withdrawal by Subject|0|||
33287951|NCT01154452|62664514|FG001|Phase II|Withdrawal by Subject|0|||
33287952|NCT01154452|62664515|FG002|Phase II|Withdrawal by Subject|1|||
33287953|NCT01154452|62664516|FG003|Phase II|Withdrawal by Subject|2|||
33287954|NCT01154452|62664513|FG000|Phase II|Adverse Event|0|||
33287955|NCT01154452|62664514|FG001|Phase II|Adverse Event|0|||
33287956|NCT01154452|62664515|FG002|Phase II|Adverse Event|4|||
33287957|NCT01154452|62664516|FG003|Phase II|Adverse Event|4|||
33287958|NCT01154296|62664531|FG000|Randomization and Intervention|Decided to decline|1|||
33287959|NCT01154296|62664532|FG001|Randomization and Intervention|Decided to decline|1|||
33373984|NCT00867035|62752933|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
33373985|NCT00867035|62752934|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
33373986|NCT00663208|62752947|FG000|Treatment Period|Lost to Follow-up|0|||
33373987|NCT00663208|62752948|FG001|Treatment Period|Lost to Follow-up|1|||
33373988|NCT00663208|62752949|FG002|Treatment Period|Lost to Follow-up|0|||
33373989|NCT00663208|62752950|FG003|Treatment Period|Lost to Follow-up|0|||
33373990|NCT00663208|62752951|FG004|Treatment Period|Lost to Follow-up|0|||
33373991|NCT00663208|62752952|FG005|Treatment Period|Lost to Follow-up|0|||
33373992|NCT00663208|62752953|FG006|Treatment Period|Lost to Follow-up|0|||
33373993|NCT00663208|62752947|FG000|Follow-up Period|Lost to Follow-up|2|||
33373994|NCT00663208|62752948|FG001|Follow-up Period|Lost to Follow-up|0|||
33373995|NCT00663208|62752949|FG002|Follow-up Period|Lost to Follow-up|3|||
33373996|NCT00663208|62752950|FG003|Follow-up Period|Lost to Follow-up|2|||
33373997|NCT00663208|62752951|FG004|Follow-up Period|Lost to Follow-up|0|||
33373998|NCT00663208|62752952|FG005|Follow-up Period|Lost to Follow-up|0|||
33373999|NCT00663208|62752953|FG006|Follow-up Period|Lost to Follow-up|0|||
33374000|NCT00663208|62752947|FG000|Follow-up Period|Other reason|1|||
33374001|NCT00663208|62752948|FG001|Follow-up Period|Other reason|0|||
33374002|NCT00663208|62752949|FG002|Follow-up Period|Other reason|0|||
33374003|NCT00663208|62752950|FG003|Follow-up Period|Other reason|0|||
33374004|NCT00663208|62752951|FG004|Follow-up Period|Other reason|0|||
33374005|NCT00663208|62752952|FG005|Follow-up Period|Other reason|0|||
33374006|NCT00663208|62752953|FG006|Follow-up Period|Other reason|1|||
33374007|NCT00810810|62752975|FG000|Overall Study|Withdrawal by Subject|0|||
33374008|NCT00810810|62752976|FG001|Overall Study|Withdrawal by Subject|8|||
33374009|NCT00810810|62752977|FG002|Overall Study|Withdrawal by Subject|10|||
33374010|NCT00810810|62752978|FG003|Overall Study|Withdrawal by Subject|8|||
33374011|NCT00810810|62752975|FG000|Overall Study|Physician Decision|0|||
33486650|NCT03773978|62864591|FG000|DBW Period|Study team decision|1|||
33486651|NCT03773978|62864592|FG001|DBW Period|Study team decision|0|||
33486652|NCT03682107|62864608|FG000|Overall Study|Withdrawal by Subject|0|||
33486653|NCT03682107|62864609|FG001|Overall Study|Withdrawal by Subject|1|||
33287960|NCT01154296|62664531|FG000|Randomization and Intervention|Declined by staff|1|||
33287961|NCT01154296|62664532|FG001|Randomization and Intervention|Declined by staff|0|||
33287962|NCT01154296|62664531|FG000|Randomization and Intervention|Did not return|1|||
33287963|NCT01154296|62664532|FG001|Randomization and Intervention|Did not return|0|||
33287964|NCT01154296|62664531|FG000|Randomization and Intervention|Left before test|0|||
33287965|NCT01154296|62664532|FG001|Randomization and Intervention|Left before test|1|||
33287966|NCT01154296|62664531|FG000|Randomization and Intervention|Left clinic early|2|||
33287967|NCT01154296|62664532|FG001|Randomization and Intervention|Left clinic early|0|||
33287968|NCT01154296|62664531|FG000|6-month Follow-up|Lost contact|269|||
33287969|NCT01154296|62664532|FG001|6-month Follow-up|Lost contact|275|||
33374012|NCT00810810|62752976|FG001|Overall Study|Physician Decision|3|||
33374013|NCT00810810|62752977|FG002|Overall Study|Physician Decision|1|||
33374014|NCT00810810|62752978|FG003|Overall Study|Physician Decision|5|||
33374015|NCT00661258|62752990|FG000|Overall Study|Death|1|||
33374016|NCT00661258|62752991|FG001|Overall Study|Death|0|||
33374017|NCT00661258|62752990|FG000|Overall Study|caught by police and in detox center|2|||
33486654|NCT03682107|62864610|FG002|Overall Study|Withdrawal by Subject|0|||
33374018|NCT00661258|62752991|FG001|Overall Study|caught by police and in detox center|1|||
33374019|NCT00871871|62752999|FG000|Part I|Adverse Event|0|||
33374020|NCT00871871|62753000|FG001|Part I|Adverse Event|2|||
33374021|NCT00871871|62753001|FG002|Part I|Adverse Event|0|||
33374022|NCT00871871|62753002|FG003|Part I|Adverse Event|0|||
33374023|NCT00871871|62752999|FG000|Part I|Withdrawal by Subject|3|||
33374024|NCT00871871|62753000|FG001|Part I|Withdrawal by Subject|0|||
33287970|NCT01154296|62664531|FG000|6-month Follow-up|Incarcerated|37|||
33287971|NCT01154296|62664532|FG001|6-month Follow-up|Incarcerated|32|||
33287972|NCT01154296|62664531|FG000|6-month Follow-up|Withdrew consent|14|||
33287973|NCT01154296|62664532|FG001|6-month Follow-up|Withdrew consent|15|||
33374025|NCT00871871|62753001|FG002|Part I|Withdrawal by Subject|0|||
33374026|NCT00871871|62753002|FG003|Part I|Withdrawal by Subject|0|||
33374027|NCT00871871|62752999|FG000|Part I|Laboratory abnormality|0|||
33374028|NCT00871871|62753000|FG001|Part I|Laboratory abnormality|1|||
33374029|NCT00871871|62753001|FG002|Part I|Laboratory abnormality|0|||
33287974|NCT01154296|62664531|FG000|6-month Follow-up|Death|3|||
33287975|NCT01154296|62664532|FG001|6-month Follow-up|Death|2|||
33287976|NCT01154296|62664531|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
33287977|NCT01154296|62664532|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
33287978|NCT01154218|62664538|FG000|Third Intervention Period|Adverse Event|0|||
33287979|NCT01154218|62664539|FG001|Third Intervention Period|Adverse Event|1|||
33374030|NCT00871871|62753002|FG003|Part I|Laboratory abnormality|0|||
33374031|NCT00871871|62752999|FG000|Part II|Lack of Efficacy|0|||
33374032|NCT00871871|62753000|FG001|Part II|Lack of Efficacy|0|||
33374033|NCT00871871|62753001|FG002|Part II|Lack of Efficacy|1|||
33374034|NCT00871871|62753002|FG003|Part II|Lack of Efficacy|0|||
33374035|NCT00871871|62752999|FG000|Part II|Withdrawal by Subject|0|||
33374036|NCT00871871|62753000|FG001|Part II|Withdrawal by Subject|0|||
33374037|NCT00871871|62753001|FG002|Part II|Withdrawal by Subject|2|||
33374038|NCT00871871|62753002|FG003|Part II|Withdrawal by Subject|1|||
33374039|NCT00871871|62752999|FG000|Part II|Adverse Event|0|||
33374040|NCT00871871|62753000|FG001|Part II|Adverse Event|0|||
33374041|NCT00871871|62753001|FG002|Part II|Adverse Event|1|||
33374042|NCT00871871|62753002|FG003|Part II|Adverse Event|2|||
33374043|NCT00871871|62752999|FG000|Part II|Protocol Violation|0|||
33374044|NCT00871871|62753000|FG001|Part II|Protocol Violation|0|||
33374045|NCT00871871|62753001|FG002|Part II|Protocol Violation|0|||
33374046|NCT00871871|62753002|FG003|Part II|Protocol Violation|1|||
33374047|NCT00849680|62753020|FG000|Overall Study|Adverse Event|0|||
33374048|NCT00849680|62753021|FG001|Overall Study|Adverse Event|0|||
33374049|NCT00849680|62753022|FG002|Overall Study|Adverse Event|0|||
33374050|NCT00849680|62753023|FG003|Overall Study|Adverse Event|0|||
33374051|NCT00849680|62753024|FG004|Overall Study|Adverse Event|0|||
33374052|NCT00849680|62753025|FG005|Overall Study|Adverse Event|0|||
33374053|NCT00849680|62753026|FG006|Overall Study|Adverse Event|2|||
33374054|NCT00849680|62753027|FG007|Overall Study|Adverse Event|0|||
33374055|NCT00849680|62753020|FG000|Overall Study|Lost to Follow-up|7|||
33374056|NCT00849680|62753021|FG001|Overall Study|Lost to Follow-up|3|||
33374057|NCT00849680|62753022|FG002|Overall Study|Lost to Follow-up|12|||
33374058|NCT00849680|62753023|FG003|Overall Study|Lost to Follow-up|11|||
33374059|NCT00849680|62753024|FG004|Overall Study|Lost to Follow-up|8|||
33374060|NCT00849680|62753025|FG005|Overall Study|Lost to Follow-up|11|||
33374061|NCT00849680|62753026|FG006|Overall Study|Lost to Follow-up|12|||
33374062|NCT00849680|62753027|FG007|Overall Study|Lost to Follow-up|5|||
33374063|NCT00849680|62753020|FG000|Overall Study|Subject moved|1|||
33374064|NCT00849680|62753021|FG001|Overall Study|Subject moved|0|||
33374065|NCT00849680|62753022|FG002|Overall Study|Subject moved|3|||
33374066|NCT00849680|62753023|FG003|Overall Study|Subject moved|1|||
33374067|NCT00849680|62753024|FG004|Overall Study|Subject moved|0|||
33374068|NCT00849680|62753025|FG005|Overall Study|Subject moved|2|||
33374069|NCT00849680|62753026|FG006|Overall Study|Subject moved|2|||
33374070|NCT00849680|62753027|FG007|Overall Study|Subject moved|2|||
33374071|NCT00849680|62753020|FG000|Overall Study|Withdrawal by Subject|2|||
33287980|NCT01154218|62664540|FG002|Third Intervention Period|Adverse Event|0|||
33374072|NCT00849680|62753021|FG001|Overall Study|Withdrawal by Subject|0|||
33287981|NCT01154218|62664541|FG003|Third Intervention Period|Adverse Event|0|||
33287982|NCT01154218|62664538|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
33374073|NCT00849680|62753022|FG002|Overall Study|Withdrawal by Subject|0|||
33287983|NCT01154218|62664539|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
33374074|NCT00849680|62753023|FG003|Overall Study|Withdrawal by Subject|2|||
33374075|NCT00849680|62753024|FG004|Overall Study|Withdrawal by Subject|2|||
33374076|NCT00849680|62753025|FG005|Overall Study|Withdrawal by Subject|2|||
33374077|NCT00849680|62753026|FG006|Overall Study|Withdrawal by Subject|1|||
33374078|NCT00849680|62753027|FG007|Overall Study|Withdrawal by Subject|1|||
33374079|NCT00849680|62753020|FG000|Overall Study|Subject unable to comply with protocol|1|||
33374080|NCT00849680|62753021|FG001|Overall Study|Subject unable to comply with protocol|0|||
33374081|NCT00849680|62753022|FG002|Overall Study|Subject unable to comply with protocol|0|||
33374082|NCT00849680|62753023|FG003|Overall Study|Subject unable to comply with protocol|0|||
33374083|NCT00849680|62753024|FG004|Overall Study|Subject unable to comply with protocol|0|||
33374084|NCT00849680|62753025|FG005|Overall Study|Subject unable to comply with protocol|0|||
33374085|NCT00849680|62753026|FG006|Overall Study|Subject unable to comply with protocol|0|||
33374086|NCT00849680|62753027|FG007|Overall Study|Subject unable to comply with protocol|0|||
33374087|NCT00810342|62753047|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
33374088|NCT00810342|62753048|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
33374089|NCT00810342|62753047|FG000|Month 1 Follow-up|Pregnancy|1|||
33374090|NCT00810342|62753048|FG001|Month 1 Follow-up|Pregnancy|0|||
33374091|NCT00810342|62753047|FG000|6-month Follow-up|Lost to Follow-up|18|||
33374092|NCT00810342|62753048|FG001|6-month Follow-up|Lost to Follow-up|6|||
33374093|NCT00810342|62753047|FG000|6-month Follow-up|Pregnancy|6|||
33374094|NCT00810342|62753048|FG001|6-month Follow-up|Pregnancy|2|||
33374095|NCT00810342|62753047|FG000|12-month Followup|Pregnancy|9|||
33374096|NCT00810342|62753048|FG001|12-month Followup|Pregnancy|10|||
33374097|NCT00810342|62753047|FG000|12-month Followup|Lost to Follow-up|3|||
33374098|NCT00810342|62753048|FG001|12-month Followup|Lost to Follow-up|1|||
33374099|NCT00849524|62753056|FG000|Overall Study|Lack of Efficacy|3|||
33374100|NCT00808080|62753060|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
33287984|NCT01154218|62664540|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
33287985|NCT01154218|62664541|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
33287986|NCT01154218|62664538|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
33287987|NCT01154218|62664539|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
33287988|NCT01154218|62664540|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
33287989|NCT01154218|62664541|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
33287990|NCT01154140|62664566|FG000|Overall Study|Death|71|||
33287991|NCT01154140|62664567|FG001|Overall Study|Death|81|||
33374101|NCT00866723|62753065|FG000|Overall Study|Withdrawal by Subject|1|||
33374102|NCT00866723|62753065|FG000|Overall Study|Disease Progression|4|||
33374103|NCT00849290|62753069|FG000|Overall Study|Adverse Event|3|||
33374104|NCT00849290|62753069|FG000|Overall Study|Death|14|||
33374105|NCT00849290|62753069|FG000|Overall Study|Withdrawal by Subject|11|||
33374106|NCT00849290|62753069|FG000|Overall Study|Lost to Follow-up|2|||
33374107|NCT00849290|62753069|FG000|Overall Study|Protocol Violation|5|||
33374108|NCT00849290|62753069|FG000|Overall Study|Disease Progression|20|||
33374109|NCT00849212|62753073|FG000|Overall Study|Lack of Efficacy|1|||
33287992|NCT01154140|62664566|FG000|Overall Study|Lost to Follow-up|4|||
33287993|NCT01154140|62664567|FG001|Overall Study|Lost to Follow-up|5|||
33287994|NCT01154140|62664566|FG000|Overall Study|Withdrawal by Subject|12|||
33287995|NCT01154140|62664567|FG001|Overall Study|Withdrawal by Subject|13|||
33287996|NCT01154140|62664566|FG000|Overall Study|Other|3|||
33287997|NCT01154140|62664567|FG001|Overall Study|Other|1|||
33287998|NCT01154140|62664566|FG000|Overall Study|Randomized but not treated|1|||
33287999|NCT01154140|62664567|FG001|Overall Study|Randomized but not treated|2|||
33288000|NCT01154101|62664578|FG000|Overall Study|Adverse Event|0|||
33288001|NCT01154101|62664579|FG001|Overall Study|Adverse Event|2|||
33374110|NCT00849212|62753073|FG000|Overall Study|Withdrawal by Subject|3|||
33288002|NCT01154101|62664580|FG002|Overall Study|Adverse Event|1|||
33288003|NCT01154101|62664581|FG003|Overall Study|Adverse Event|1|||
33288004|NCT01154101|62664582|FG004|Overall Study|Adverse Event|0|||
33288005|NCT01154101|62664578|FG000|Overall Study|Lost to Follow-up|0|||
33288006|NCT01154101|62664579|FG001|Overall Study|Lost to Follow-up|1|||
33288007|NCT01154101|62664580|FG002|Overall Study|Lost to Follow-up|0|||
33288008|NCT01154101|62664581|FG003|Overall Study|Lost to Follow-up|1|||
33288009|NCT01154101|62664582|FG004|Overall Study|Lost to Follow-up|0|||
33288010|NCT01154101|62664578|FG000|Overall Study|Withdrawal by Subject|0|||
33288011|NCT01154101|62664579|FG001|Overall Study|Withdrawal by Subject|1|||
33288012|NCT01154101|62664580|FG002|Overall Study|Withdrawal by Subject|2|||
33288013|NCT01154101|62664581|FG003|Overall Study|Withdrawal by Subject|0|||
33288014|NCT01154101|62664582|FG004|Overall Study|Withdrawal by Subject|1|||
33288015|NCT01153984|62664599|FG000|Overall Study|Withdrawal by Subject|1|||
33288016|NCT01153984|62664599|FG000|Overall Study|Adverse Event|1|||
33288017|NCT01153633|62664605|FG000|Overall Study|Protocol Violation|1|||
33662266|NCT01695239|63092834|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33662267|NCT01695239|63092835|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33288018|NCT01153633|62664606|FG001|Overall Study|Protocol Violation|1|||
33288019|NCT01153633|62664605|FG000|Overall Study|Therapeutic failure|3|||
33288020|NCT01153633|62664606|FG001|Overall Study|Therapeutic failure|3|||
33288021|NCT01153516|62664616|FG000|Overall Study|Both subjects refused surgery|2|||
33288022|NCT01153516|62664617|FG001|Overall Study|Both subjects refused surgery|0|||
33288023|NCT01153321|62664625|FG000|Overall Study|Development of study withdrawal criteria|0|||
33288024|NCT01153321|62664626|FG001|Overall Study|Development of study withdrawal criteria|1|||
33374111|NCT00849212|62753073|FG000|Overall Study|Adverse Event|2|||
33374112|NCT00849212|62753073|FG000|Overall Study|Miscellaneous|1|||
33374113|NCT00810264|62753077|FG000|Overall Study|Lost to Follow-up|191|||
33374114|NCT00810264|62753077|FG000|Overall Study|Withdrawal by subject or physician|721|||
33374115|NCT00810264|62753077|FG000|Overall Study|Death|641|||
33288025|NCT01153321|62664625|FG000|Overall Study|Withdrawal by Subject|0|||
33288026|NCT01153321|62664626|FG001|Overall Study|Withdrawal by Subject|1|||
33288027|NCT01153321|62664625|FG000|Overall Study|Adverse Event|1|||
33288028|NCT01153321|62664626|FG001|Overall Study|Adverse Event|1|||
33288029|NCT01153009|62664636|FG000|Overall Study|Adverse Event|4|||
33288030|NCT01153009|62664637|FG001|Overall Study|Adverse Event|14|||
33288031|NCT01153009|62664638|FG002|Overall Study|Adverse Event|14|||
33288032|NCT01153009|62664639|FG003|Overall Study|Adverse Event|10|||
33288033|NCT01153009|62664636|FG000|Overall Study|Lack of Efficacy|9|||
33288034|NCT01153009|62664637|FG001|Overall Study|Lack of Efficacy|0|||
33288035|NCT01153009|62664638|FG002|Overall Study|Lack of Efficacy|2|||
33288036|NCT01153009|62664639|FG003|Overall Study|Lack of Efficacy|1|||
33288037|NCT01153009|62664636|FG000|Overall Study|Noncompliance with Study Medication|1|||
33288038|NCT01153009|62664637|FG001|Overall Study|Noncompliance with Study Medication|3|||
33288039|NCT01153009|62664638|FG002|Overall Study|Noncompliance with Study Medication|4|||
33288040|NCT01153009|62664639|FG003|Overall Study|Noncompliance with Study Medication|1|||
33288041|NCT01153009|62664636|FG000|Overall Study|Protocol Deviations|4|||
33288042|NCT01153009|62664637|FG001|Overall Study|Protocol Deviations|3|||
33288043|NCT01153009|62664638|FG002|Overall Study|Protocol Deviations|3|||
33288044|NCT01153009|62664639|FG003|Overall Study|Protocol Deviations|2|||
33288045|NCT01153009|62664636|FG000|Overall Study|Withdrawal of Consent|5|||
33288046|NCT01153009|62664637|FG001|Overall Study|Withdrawal of Consent|5|||
33288047|NCT01153009|62664638|FG002|Overall Study|Withdrawal of Consent|4|||
33288048|NCT01153009|62664639|FG003|Overall Study|Withdrawal of Consent|6|||
33288049|NCT01153009|62664636|FG000|Overall Study|Lost to Follow-up|8|||
33288050|NCT01153009|62664637|FG001|Overall Study|Lost to Follow-up|8|||
33288051|NCT01153009|62664638|FG002|Overall Study|Lost to Follow-up|11|||
33288052|NCT01153009|62664639|FG003|Overall Study|Lost to Follow-up|15|||
33288053|NCT01153009|62664636|FG000|Overall Study|Other|1|||
33288054|NCT01153009|62664637|FG001|Overall Study|Other|1|||
33288055|NCT01153009|62664638|FG002|Overall Study|Other|3|||
33288056|NCT01153009|62664639|FG003|Overall Study|Other|2|||
33288057|NCT01152814|62664649|FG000|Overall Study|Lost to Follow-up|2|||
33288058|NCT01152580|62664655|FG000|Overall Study|Withdrawal by Subject|0|||
33288059|NCT01152580|62664656|FG001|Overall Study|Withdrawal by Subject|1|||
33288060|NCT01152385|62664666|FG000|Overall Study|Withdrawal by Subject|3|||
33288061|NCT01152385|62664667|FG001|Overall Study|Withdrawal by Subject|1|||
33288062|NCT01152385|62664668|FG002|Overall Study|Withdrawal by Subject|1|||
33288063|NCT01152385|62664669|FG003|Overall Study|Withdrawal by Subject|1|||
33288064|NCT01152385|62664666|FG000|Overall Study|Protocol Violation|0|||
33288065|NCT01152385|62664667|FG001|Overall Study|Protocol Violation|0|||
33288066|NCT01152385|62664668|FG002|Overall Study|Protocol Violation|0|||
33288067|NCT01152385|62664669|FG003|Overall Study|Protocol Violation|1|||
33288068|NCT01152385|62664666|FG000|Overall Study|Adverse Event|1|||
33288069|NCT01152385|62664667|FG001|Overall Study|Adverse Event|1|||
33288070|NCT01152385|62664668|FG002|Overall Study|Adverse Event|0|||
33288071|NCT01152385|62664669|FG003|Overall Study|Adverse Event|0|||
33288072|NCT01152385|62664666|FG000|Overall Study|Study-specific withdrawal criteria|1|||
33288073|NCT01152385|62664667|FG001|Overall Study|Study-specific withdrawal criteria|1|||
33288074|NCT01152385|62664668|FG002|Overall Study|Study-specific withdrawal criteria|2|||
33288075|NCT01152385|62664669|FG003|Overall Study|Study-specific withdrawal criteria|0|||
33288076|NCT01152385|62664666|FG000|Overall Study|Other|4|||
33288077|NCT01152385|62664667|FG001|Overall Study|Other|3|||
33288078|NCT01152385|62664668|FG002|Overall Study|Other|2|||
33288079|NCT01152385|62664669|FG003|Overall Study|Other|3|||
33288080|NCT01152190|62664685|FG000|Overall Study|Adverse Event|2|||
33288081|NCT01152190|62664686|FG001|Overall Study|Adverse Event|4|||
33288082|NCT01152190|62664685|FG000|Overall Study|Death|1|||
33288083|NCT01152190|62664686|FG001|Overall Study|Death|0|||
33288084|NCT01152190|62664685|FG000|Overall Study|Protocol Violation|1|||
33288085|NCT01152190|62664686|FG001|Overall Study|Protocol Violation|1|||
33288086|NCT01152190|62664685|FG000|Overall Study|Withdrawal by Subject|1|||
33288087|NCT01152190|62664686|FG001|Overall Study|Withdrawal by Subject|3|||
33288088|NCT01151410|62664694|FG000|Overall Study|Withdrawal by Subject|3|||
33288089|NCT01151410|62664695|FG001|Overall Study|Withdrawal by Subject|5|||
33288090|NCT01151410|62664694|FG000|Overall Study|Lost to Follow-up|3|||
33288091|NCT01151410|62664695|FG001|Overall Study|Lost to Follow-up|4|||
33556308|NCT02308228|62949178|FG001|Overall Study|Withdrawal by Subject|3|||
33288092|NCT01151410|62664694|FG000|Overall Study|Adverse Event|1|||
33556309|NCT02616614|62949196|FG000|Overall Study|Withdrawal by Subject|10|||
33556310|NCT02616614|62949197|FG001|Overall Study|Withdrawal by Subject|5|||
33288093|NCT01151410|62664695|FG001|Overall Study|Adverse Event|2|||
33288094|NCT01151410|62664694|FG000|Overall Study|Protocol deviation|2|||
33288095|NCT01151410|62664695|FG001|Overall Study|Protocol deviation|1|||
33288096|NCT01151410|62664694|FG000|Overall Study|Administrative problems|1|||
33288097|NCT01151410|62664695|FG001|Overall Study|Administrative problems|1|||
33288098|NCT01151410|62664694|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33288099|NCT01151410|62664695|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33288100|NCT01151410|62664694|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33288101|NCT01151410|62664695|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33288102|NCT01151215|62664704|FG000|Overall Study|Worsening of condition under study|1|||
33374116|NCT00849056|62753087|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
33374117|NCT00849056|62753088|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
33374118|NCT00849056|62753087|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
33374119|NCT00849056|62753088|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
33486655|NCT03682107|62864611|FG003|Overall Study|Withdrawal by Subject|0|||
33486656|NCT03682107|62864612|FG004|Overall Study|Withdrawal by Subject|0|||
33486657|NCT03673046|62864626|FG000|Overall Study|Adverse Event|1|||
33486658|NCT03673046|62864627|FG001|Overall Study|Adverse Event|1|||
33486659|NCT03673046|62864626|FG000|Overall Study|Withdrawal by Subject|8|||
33486660|NCT03673046|62864627|FG001|Overall Study|Withdrawal by Subject|2|||
33486661|NCT02956005|62864633|FG000|Overall Study|Not eligible|1|||
33486662|NCT02956005|62864633|FG000|Overall Study|Withdrawal by Subject|3|||
33486663|NCT02956005|62864633|FG000|Overall Study|Physician Decision|12|||
33486664|NCT03253094|62864643|FG000|Overall Study|Adverse Event|2|||
33486665|NCT03253094|62864644|FG001|Overall Study|Adverse Event|0|||
33486666|NCT03253094|62864645|FG002|Overall Study|Adverse Event|0|||
33486667|NCT03253094|62864646|FG003|Overall Study|Adverse Event|0|||
33486668|NCT03253094|62864647|FG004|Overall Study|Adverse Event|0|||
33486669|NCT03253094|62864648|FG005|Overall Study|Adverse Event|0|||
33486670|NCT03253094|62864643|FG000|Overall Study|Lack of Efficacy|0|||
33486671|NCT03253094|62864644|FG001|Overall Study|Lack of Efficacy|0|||
33486672|NCT03253094|62864645|FG002|Overall Study|Lack of Efficacy|2|||
33486673|NCT03253094|62864646|FG003|Overall Study|Lack of Efficacy|1|||
33486674|NCT03253094|62864647|FG004|Overall Study|Lack of Efficacy|2|||
33486675|NCT03253094|62864648|FG005|Overall Study|Lack of Efficacy|1|||
33486676|NCT03253094|62864643|FG000|Overall Study|Lost to Follow-up|0|||
33486677|NCT03253094|62864644|FG001|Overall Study|Lost to Follow-up|0|||
33486678|NCT03253094|62864645|FG002|Overall Study|Lost to Follow-up|1|||
33486679|NCT03253094|62864646|FG003|Overall Study|Lost to Follow-up|1|||
33486680|NCT03253094|62864647|FG004|Overall Study|Lost to Follow-up|0|||
33486681|NCT03253094|62864648|FG005|Overall Study|Lost to Follow-up|1|||
33486682|NCT03253094|62864643|FG000|Overall Study|Physician Decision|1|||
33486683|NCT03253094|62864644|FG001|Overall Study|Physician Decision|0|||
33486684|NCT03253094|62864645|FG002|Overall Study|Physician Decision|0|||
33486685|NCT03253094|62864646|FG003|Overall Study|Physician Decision|1|||
33486686|NCT03253094|62864647|FG004|Overall Study|Physician Decision|0|||
33486687|NCT03253094|62864648|FG005|Overall Study|Physician Decision|2|||
33486688|NCT03253094|62864643|FG000|Overall Study|Withdrawal by Subject|1|||
33486689|NCT03253094|62864644|FG001|Overall Study|Withdrawal by Subject|2|||
33486690|NCT03253094|62864645|FG002|Overall Study|Withdrawal by Subject|1|||
33486691|NCT03253094|62864646|FG003|Overall Study|Withdrawal by Subject|0|||
33486692|NCT03253094|62864647|FG004|Overall Study|Withdrawal by Subject|3|||
33486693|NCT03253094|62864648|FG005|Overall Study|Withdrawal by Subject|0|||
33486694|NCT03253094|62864643|FG000|Overall Study|Other|0|||
33486695|NCT03253094|62864644|FG001|Overall Study|Other|1|||
33486696|NCT03253094|62864645|FG002|Overall Study|Other|2|||
33486697|NCT03253094|62864646|FG003|Overall Study|Other|1|||
33486698|NCT03253094|62864647|FG004|Overall Study|Other|0|||
33486699|NCT03253094|62864648|FG005|Overall Study|Other|0|||
33486700|NCT03654885|62864664|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
33486701|NCT03654885|62864665|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
33486702|NCT03654885|62864664|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
33486703|NCT03654885|62864665|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
33486704|NCT03654885|62864664|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
33486705|NCT03654885|62864665|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
33486706|NCT03654885|62864664|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
33486707|NCT03654885|62864665|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
33486708|NCT03654885|62864664|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
33288103|NCT01151215|62664705|FG001|Overall Study|Worsening of condition under study|1|||
33288104|NCT01151215|62664706|FG002|Overall Study|Worsening of condition under study|1|||
33288105|NCT01151215|62664704|FG000|Overall Study|Death|16|||
33288106|NCT01151215|62664705|FG001|Overall Study|Death|20|||
33288107|NCT01151215|62664706|FG002|Overall Study|Death|11|||
33556311|NCT02616614|62949198|FG002|Overall Study|Withdrawal by Subject|6|||
33556312|NCT02616614|62949196|FG000|Overall Study|Physician Decision|2|||
33556313|NCT02616614|62949197|FG001|Overall Study|Physician Decision|1|||
33288108|NCT01151215|62664704|FG000|Overall Study|Lost to Follow-up|0|||
33288109|NCT01151215|62664705|FG001|Overall Study|Lost to Follow-up|0|||
33486709|NCT03654885|62864665|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
33486710|NCT03654885|62864664|FG000|Overall Study|Adverse Event in Study Eye|3|||
33486711|NCT03654885|62864665|FG001|Overall Study|Adverse Event in Study Eye|0|||
33486712|NCT03654885|62864664|FG000|Overall Study|Consent Withdrawn|1|||
33556314|NCT02616614|62949198|FG002|Overall Study|Physician Decision|0|||
33288110|NCT01151215|62664706|FG002|Overall Study|Lost to Follow-up|3|||
33288111|NCT01151215|62664704|FG000|Overall Study|Withdrawal by Subject|3|||
33288112|NCT01151215|62664705|FG001|Overall Study|Withdrawal by Subject|1|||
33288113|NCT01151215|62664706|FG002|Overall Study|Withdrawal by Subject|2|||
33288114|NCT01151215|62664704|FG000|Overall Study|Disease progression|0|||
33288115|NCT01151215|62664705|FG001|Overall Study|Disease progression|1|||
33288116|NCT01151215|62664706|FG002|Overall Study|Disease progression|1|||
33288117|NCT01151215|62664704|FG000|Overall Study|Safety as judged by the investigator|0|||
33288118|NCT01151215|62664705|FG001|Overall Study|Safety as judged by the investigator|0|||
33288119|NCT01151215|62664706|FG002|Overall Study|Safety as judged by the investigator|1|||
33288120|NCT01151137|62664716|FG000|Overall Study|Death|15|||
33288121|NCT01151137|62664717|FG001|Overall Study|Death|27|||
33288122|NCT01151137|62664716|FG000|Overall Study|Lost to Follow-up|1|||
33288123|NCT01151137|62664717|FG001|Overall Study|Lost to Follow-up|1|||
33288124|NCT01151098|62664723|FG000|Overall Study|Adverse Event|82|||
33288125|NCT01151098|62664723|FG000|Overall Study|Lost to Follow-up|6|||
33288126|NCT01151098|62664723|FG000|Overall Study|Lack of Efficacy|15|||
33288127|NCT01151098|62664723|FG000|Overall Study|Protocol Violation|1|||
33374120|NCT00849056|62753087|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
33374121|NCT00849056|62753088|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
33374122|NCT00849056|62753087|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
33374123|NCT00849056|62753088|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
33374124|NCT00849056|62753087|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
33374125|NCT00849056|62753088|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
33288128|NCT01151098|62664723|FG000|Overall Study|Miscellaneous|13|||
33288129|NCT01151020|62664727|FG000|Overall Study|Death|25|||
33288130|NCT01151020|62664727|FG000|Overall Study|Conversion to open repair|1|||
33288131|NCT01151020|62664727|FG000|Overall Study|Lost to Follow-up|4|||
33288132|NCT01151020|62664727|FG000|Overall Study|Withdrawal by Subject|22|||
33288133|NCT01151020|62664727|FG000|Overall Study|Patients did not receive the device|2|||
33288134|NCT01150474|62664733|FG000|Overall Study|Withdrawal by Subject|5|||
33288135|NCT01150474|62664734|FG001|Overall Study|Withdrawal by Subject|2|||
33288136|NCT01150474|62664733|FG000|Overall Study|Cancer found|1|||
33288137|NCT01150474|62664734|FG001|Overall Study|Cancer found|0|||
33288138|NCT01150474|62664733|FG000|Overall Study|Multiple Studies|0|||
33288139|NCT01150474|62664734|FG001|Overall Study|Multiple Studies|1|||
33288140|NCT01150474|62664733|FG000|Overall Study|Rectotomy|1|||
33288141|NCT01150474|62664734|FG001|Overall Study|Rectotomy|0|||
33288142|NCT01150474|62664733|FG000|Overall Study|Drug did not arrive in time|1|||
33288143|NCT01150474|62664734|FG001|Overall Study|Drug did not arrive in time|0|||
33288144|NCT01150474|62664733|FG000|Overall Study|Drug not administered|1|||
33288145|NCT01150474|62664734|FG001|Overall Study|Drug not administered|0|||
33288146|NCT01150474|62664733|FG000|Overall Study|Surgery Changed|1|||
33288147|NCT01150474|62664734|FG001|Overall Study|Surgery Changed|0|||
33288148|NCT01150357|62664743|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
33288149|NCT01150357|62664744|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
33288150|NCT01150357|62664745|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
33288151|NCT01150357|62664743|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
33288152|NCT01150357|62664744|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
33288153|NCT01150357|62664745|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
33288154|NCT01150357|62664743|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
33288155|NCT01150357|62664744|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
33288156|NCT01150357|62664745|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
33288157|NCT01150357|62664743|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
33288158|NCT01150357|62664744|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
33288159|NCT01150357|62664745|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
33288160|NCT01150357|62664743|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
33288161|NCT01150357|62664744|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
33288162|NCT01150357|62664745|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
33288163|NCT01150357|62664743|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
33288164|NCT01150357|62664744|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
33288165|NCT01150357|62664745|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
33288166|NCT01150357|62664743|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
33288167|NCT01150357|62664744|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
33288168|NCT01150357|62664745|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
33288169|NCT01150123|62664795|FG000|Overall Study|Withdrawal by Subject|1|||
33288170|NCT01150123|62664796|FG001|Overall Study|Withdrawal by Subject|1|||
33288171|NCT01150123|62664797|FG002|Overall Study|Withdrawal by Subject|2|||
33556315|NCT02616614|62949196|FG000|Overall Study|Adverse Event|1|||
33288172|NCT01150123|62664798|FG003|Overall Study|Withdrawal by Subject|1|||
33288173|NCT01150123|62664799|FG004|Overall Study|Withdrawal by Subject|1|||
33288174|NCT01150123|62664800|FG005|Overall Study|Withdrawal by Subject|1|||
33556316|NCT02616614|62949197|FG001|Overall Study|Adverse Event|4|||
33288175|NCT01150123|62664801|FG006|Overall Study|Withdrawal by Subject|0|||
33288176|NCT01150123|62664802|FG007|Overall Study|Withdrawal by Subject|3|||
33486713|NCT03654885|62864665|FG001|Overall Study|Consent Withdrawn|0|||
33486714|NCT03654885|62864664|FG000|Overall Study|Death|3|||
33486715|NCT03654885|62864665|FG001|Overall Study|Death|1|||
33374126|NCT00849056|62753087|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
33374127|NCT00849056|62753088|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
33374128|NCT00849056|62753087|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
33374129|NCT00849056|62753088|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
33374130|NCT00849056|62753087|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
33374131|NCT00849056|62753088|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
33374132|NCT00849056|62753087|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
33374133|NCT00849056|62753088|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
33374134|NCT00849056|62753087|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
33374135|NCT00849056|62753088|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
33374136|NCT00849056|62753087|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
33374137|NCT00849056|62753088|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
33374138|NCT00849056|62753087|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
33374139|NCT00849056|62753088|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
33374140|NCT00849056|62753087|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
33374141|NCT00849056|62753088|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
33374142|NCT00849056|62753087|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
33374143|NCT00849056|62753088|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
33374144|NCT00849056|62753087|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
33374145|NCT00849056|62753088|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
33374146|NCT00849056|62753087|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
33374147|NCT00849056|62753088|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
33374148|NCT00837434|62753096|FG000|Overall Study|Physician Decision|3|||
33374149|NCT00837434|62753097|FG001|Overall Study|Physician Decision|0|||
33374150|NCT00837434|62753096|FG000|Overall Study|Lost to Follow-up|1|||
33374151|NCT00837434|62753097|FG001|Overall Study|Lost to Follow-up|1|||
33374152|NCT00837434|62753096|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
33374153|NCT00837434|62753097|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
33374154|NCT00837434|62753096|FG000|Overall Study|Noncompliant|2|||
33374155|NCT00837434|62753097|FG001|Overall Study|Noncompliant|0|||
33374156|NCT00837434|62753096|FG000|Overall Study|Baseline assessments not done in time|1|||
33374157|NCT00837434|62753097|FG001|Overall Study|Baseline assessments not done in time|0|||
33374158|NCT00837434|62753096|FG000|Overall Study|Unable to obtain study drug|1|||
33374159|NCT00837434|62753097|FG001|Overall Study|Unable to obtain study drug|0|||
33374160|NCT00827918|62753106|FG000|Overall Study|Adverse Event|4|||
33374161|NCT00827918|62753107|FG001|Overall Study|Adverse Event|0|||
33374162|NCT00827918|62753108|FG002|Overall Study|Adverse Event|0|||
33486716|NCT03654885|62864664|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
33486717|NCT03654885|62864665|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
33288177|NCT01150123|62664803|FG008|Overall Study|Withdrawal by Subject|2|||
33288178|NCT01150123|62664804|FG009|Overall Study|Withdrawal by Subject|0|||
33288179|NCT01150123|62664805|FG010|Overall Study|Withdrawal by Subject|1|||
33288180|NCT01150123|62664806|FG011|Overall Study|Withdrawal by Subject|0|||
33288181|NCT01150123|62664807|FG012|Overall Study|Withdrawal by Subject|1|||
33288182|NCT01150123|62664808|FG013|Overall Study|Withdrawal by Subject|0|||
33288183|NCT01150123|62664809|FG014|Overall Study|Withdrawal by Subject|0|||
33288184|NCT01150123|62664810|FG015|Overall Study|Withdrawal by Subject|1|||
33288185|NCT01150123|62664811|FG016|Overall Study|Withdrawal by Subject|0|||
33288186|NCT01150123|62664812|FG017|Overall Study|Withdrawal by Subject|1|||
33288187|NCT01150123|62664795|FG000|Overall Study|Lost to Follow-up|2|||
33288188|NCT01150123|62664796|FG001|Overall Study|Lost to Follow-up|1|||
33288189|NCT01150123|62664797|FG002|Overall Study|Lost to Follow-up|2|||
33288190|NCT01150123|62664798|FG003|Overall Study|Lost to Follow-up|2|||
33288191|NCT01150123|62664799|FG004|Overall Study|Lost to Follow-up|2|||
33288192|NCT01150123|62664800|FG005|Overall Study|Lost to Follow-up|5|||
33288193|NCT01150123|62664801|FG006|Overall Study|Lost to Follow-up|0|||
33288194|NCT01150123|62664802|FG007|Overall Study|Lost to Follow-up|0|||
33288195|NCT01150123|62664803|FG008|Overall Study|Lost to Follow-up|3|||
33288196|NCT01150123|62664804|FG009|Overall Study|Lost to Follow-up|1|||
33486718|NCT03654885|62864664|FG000|Overall Study|Lost to Follow-up|3|||
33288197|NCT01150123|62664805|FG010|Overall Study|Lost to Follow-up|1|||
33288198|NCT01150123|62664806|FG011|Overall Study|Lost to Follow-up|1|||
33288199|NCT01150123|62664807|FG012|Overall Study|Lost to Follow-up|2|||
33486719|NCT03654885|62864665|FG001|Overall Study|Lost to Follow-up|3|||
33556317|NCT02616614|62949198|FG002|Overall Study|Adverse Event|1|||
33288200|NCT01150123|62664808|FG013|Overall Study|Lost to Follow-up|0|||
33288201|NCT01150123|62664809|FG014|Overall Study|Lost to Follow-up|0|||
33288202|NCT01150123|62664810|FG015|Overall Study|Lost to Follow-up|0|||
33288203|NCT01150123|62664811|FG016|Overall Study|Lost to Follow-up|0|||
33288204|NCT01150123|62664812|FG017|Overall Study|Lost to Follow-up|0|||
33288205|NCT01149655|62664871|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
33288206|NCT01149655|62664872|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
33288207|NCT01149655|62664873|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
33288208|NCT01149655|62664874|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
33288209|NCT01149655|62664871|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
33288210|NCT01149655|62664872|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
33288211|NCT01149655|62664873|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
33374163|NCT00827918|62753106|FG000|Overall Study|Lack of Efficacy|16|||
33374164|NCT00827918|62753107|FG001|Overall Study|Lack of Efficacy|4|||
33374165|NCT00827918|62753108|FG002|Overall Study|Lack of Efficacy|15|||
33374166|NCT00827918|62753106|FG000|Overall Study|Physician Decision|1|||
33374167|NCT00827918|62753107|FG001|Overall Study|Physician Decision|0|||
33374168|NCT00827918|62753108|FG002|Overall Study|Physician Decision|0|||
33374169|NCT00827918|62753106|FG000|Overall Study|Pregnancy|0|||
33374170|NCT00827918|62753107|FG001|Overall Study|Pregnancy|1|||
33374171|NCT00827918|62753108|FG002|Overall Study|Pregnancy|0|||
33374172|NCT00827918|62753106|FG000|Overall Study|Progressive Disease|1|||
33374173|NCT00827918|62753107|FG001|Overall Study|Progressive Disease|1|||
33374174|NCT00827918|62753108|FG002|Overall Study|Progressive Disease|0|||
33374175|NCT00827918|62753106|FG000|Overall Study|Protocol Violation|0|||
33374176|NCT00827918|62753107|FG001|Overall Study|Protocol Violation|1|||
33374177|NCT00827918|62753108|FG002|Overall Study|Protocol Violation|0|||
33374178|NCT00827918|62753106|FG000|Overall Study|Withdrawal by Subject|6|||
33374179|NCT00827918|62753107|FG001|Overall Study|Withdrawal by Subject|2|||
33288212|NCT01149655|62664874|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
33288213|NCT01149655|62664871|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
33288214|NCT01149655|62664872|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
33288215|NCT01149655|62664873|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
33288216|NCT01149655|62664874|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
33288217|NCT01149655|62664871|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
33374180|NCT00827918|62753108|FG002|Overall Study|Withdrawal by Subject|6|||
33374181|NCT00813150|62753118|FG000|Treatment Period|Adverse Event|16|||
33288218|NCT01149655|62664872|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
33288219|NCT01149655|62664873|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
33288220|NCT01149655|62664874|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
33288221|NCT01149655|62664871|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
33288222|NCT01149655|62664872|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
33288223|NCT01149655|62664873|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
33288224|NCT01149655|62664874|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
33288225|NCT01149655|62664871|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
33288226|NCT01149655|62664872|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
33288227|NCT01149655|62664873|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
33288228|NCT01149655|62664874|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
33288229|NCT01149655|62664871|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
33288230|NCT01149655|62664872|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
33288231|NCT01149655|62664873|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
33288232|NCT01149655|62664874|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
33288233|NCT01149655|62664871|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
33374182|NCT00813150|62753119|FG001|Treatment Period|Adverse Event|15|||
33374183|NCT00813150|62753118|FG000|Treatment Period|Death|2|||
33374184|NCT00813150|62753119|FG001|Treatment Period|Death|0|||
33374185|NCT00813150|62753118|FG000|Treatment Period|Progressive disease|1|||
33288234|NCT01149655|62664872|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
33288235|NCT01149655|62664873|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
33288236|NCT01149655|62664874|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
33374186|NCT00813150|62753119|FG001|Treatment Period|Progressive disease|0|||
33288237|NCT01149655|62664871|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
33374187|NCT00813150|62753118|FG000|Treatment Period|Complete response|0|||
33374188|NCT00813150|62753119|FG001|Treatment Period|Complete response|1|||
33374189|NCT00813150|62753118|FG000|Treatment Period|Stable disease|1|||
33374190|NCT00813150|62753119|FG001|Treatment Period|Stable disease|2|||
33374191|NCT00813150|62753118|FG000|Treatment Period|Protocol Violation|3|||
33374192|NCT00813150|62753119|FG001|Treatment Period|Protocol Violation|4|||
33374193|NCT00813150|62753118|FG000|Treatment Period|Withdrawal by Subject|5|||
33374194|NCT00813150|62753119|FG001|Treatment Period|Withdrawal by Subject|3|||
33374195|NCT00813150|62753118|FG000|Treatment Period|Non compliance|0|||
33374196|NCT00813150|62753119|FG001|Treatment Period|Non compliance|1|||
33374197|NCT00813150|62753118|FG000|Treatment Period|Reason not specified|3|||
33374198|NCT00813150|62753119|FG001|Treatment Period|Reason not specified|4|||
33374199|NCT00813150|62753118|FG000|Treatment Period|Data not available|1|||
33374200|NCT00813150|62753119|FG001|Treatment Period|Data not available|2|||
33374201|NCT00813150|62753118|FG000|Long Term Follow-up|Death|0|||
33288238|NCT01149655|62664872|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
33288239|NCT01149655|62664873|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
33288240|NCT01149655|62664874|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
33288241|NCT01149655|62664871|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
33288242|NCT01149655|62664872|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
33288243|NCT01149655|62664873|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
33288244|NCT01149655|62664874|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
33288245|NCT01149655|62664871|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
33288246|NCT01149655|62664872|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
33288247|NCT01149655|62664873|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
33288248|NCT01149655|62664874|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
33288249|NCT01149655|62664871|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
33374202|NCT00813150|62753119|FG001|Long Term Follow-up|Death|4|||
33374203|NCT00813150|62753118|FG000|Long Term Follow-up|Other|0|||
33374204|NCT00813150|62753119|FG001|Long Term Follow-up|Other|3|||
33288250|NCT01149655|62664872|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
33288251|NCT01149655|62664873|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
33288252|NCT01149655|62664874|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
33374205|NCT00813150|62753118|FG000|Long Term Follow-up|Lost to Follow-up|2|||
33374206|NCT00813150|62753119|FG001|Long Term Follow-up|Lost to Follow-up|0|||
33374207|NCT00813150|62753118|FG000|Long Term Follow-up|Progression/Relapse|22|||
33374208|NCT00813150|62753119|FG001|Long Term Follow-up|Progression/Relapse|24|||
33374209|NCT00807846|62753127|FG000|Overall Study|Adverse Event|5|||
33374210|NCT00807846|62753128|FG001|Overall Study|Adverse Event|0|||
33374211|NCT00807846|62753127|FG000|Overall Study|Lack of Efficacy|2|||
33374212|NCT00807846|62753128|FG001|Overall Study|Lack of Efficacy|0|||
33374213|NCT00807846|62753127|FG000|Overall Study|Protocol Violation|2|||
33374214|NCT00807846|62753128|FG001|Overall Study|Protocol Violation|1|||
33374215|NCT00807846|62753127|FG000|Overall Study|Withdrawal by Subject|2|||
33374216|NCT00807846|62753128|FG001|Overall Study|Withdrawal by Subject|1|||
33374217|NCT00807846|62753127|FG000|Overall Study|Other|1|||
33374218|NCT00807846|62753128|FG001|Overall Study|Other|2|||
33374219|NCT00810108|62753136|FG000|Overall Study|Withdrawal by Subject|1|||
33374220|NCT00810108|62753137|FG001|Overall Study|Withdrawal by Subject|0|||
33374221|NCT00827606|62753144|FG000|Overall Study|Protocol Violation|4|||
33374222|NCT00827606|62753145|FG001|Overall Study|Protocol Violation|3|||
33374223|NCT00827606|62753144|FG000|Overall Study|Lost to Follow-up|3|||
33374224|NCT00827606|62753145|FG001|Overall Study|Lost to Follow-up|1|||
33374225|NCT00827606|62753144|FG000|Overall Study|Withdrawal by Subject|7|||
33374226|NCT00827606|62753145|FG001|Overall Study|Withdrawal by Subject|6|||
33374227|NCT00827606|62753144|FG000|Overall Study|Pregnancy|0|||
33374228|NCT00827606|62753145|FG001|Overall Study|Pregnancy|1|||
33288253|NCT01149655|62664871|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
33288254|NCT01149655|62664872|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
33288255|NCT01149655|62664873|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
33486720|NCT03236246|62864673|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
33288256|NCT01149655|62664874|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
33288257|NCT01149655|62664871|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
33288258|NCT01149655|62664872|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
33288259|NCT01149655|62664873|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
33288260|NCT01149655|62664874|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
33288261|NCT01149655|62664871|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
33288262|NCT01149655|62664872|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
33288263|NCT01149655|62664873|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
33288264|NCT01149655|62664874|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
33288265|NCT01149655|62664871|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
33288266|NCT01149655|62664872|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
33288267|NCT01149655|62664873|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
33288268|NCT01149655|62664874|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
33288269|NCT01149538|62664884|FG000|Overall Study|Lost to Follow-up|0|||
33288270|NCT01149538|62664885|FG001|Overall Study|Lost to Follow-up|1|||
33288271|NCT01149538|62664884|FG000|Overall Study|Withdrawal by Subject|5|||
33288272|NCT01149538|62664885|FG001|Overall Study|Withdrawal by Subject|3|||
33288273|NCT01149460|62664893|FG000|Overall Study|Withdrawal by Subject|0|||
33374229|NCT00827606|62753144|FG000|Overall Study|Other|5|||
33486721|NCT03236246|62864674|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
33374230|NCT00827606|62753145|FG001|Overall Study|Other|13|||
33374231|NCT00827606|62753144|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
33374232|NCT00827606|62753145|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
33486722|NCT03236246|62864673|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
33374233|NCT00827606|62753144|FG000|Overall Study|Adverse Event|4|||
33374234|NCT00827606|62753145|FG001|Overall Study|Adverse Event|2|||
33374235|NCT00663052|62753159|FG000|Overall Study|Adverse Event|6|||
33288274|NCT01149460|62664894|FG001|Overall Study|Withdrawal by Subject|2|||
33288275|NCT01149421|62664903|FG000|Overall Study|Adverse Event|22|||
33288276|NCT01149421|62664904|FG001|Overall Study|Adverse Event|6|||
33288277|NCT01149421|62664905|FG002|Overall Study|Adverse Event|11|||
33288278|NCT01149421|62664903|FG000|Overall Study|Withdrawal by Subject|20|||
33288279|NCT01149421|62664904|FG001|Overall Study|Withdrawal by Subject|12|||
33486723|NCT03236246|62864674|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
33486724|NCT03236246|62864673|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
33486725|NCT03236246|62864674|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
33486726|NCT03236246|62864673|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
33486727|NCT03236246|62864674|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
33486728|NCT03236246|62864673|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
33486729|NCT03236246|62864674|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
33486730|NCT03236246|62864673|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
33486731|NCT03236246|62864674|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
33486732|NCT03236246|62864673|FG000|24-Week Dose Titration Period|Death|3|||
33486733|NCT03236246|62864674|FG001|24-Week Dose Titration Period|Death|1|||
33486734|NCT03236246|62864673|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
33662268|NCT01695239|63092836|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33288280|NCT01149421|62664905|FG002|Overall Study|Withdrawal by Subject|13|||
33288281|NCT01149421|62664903|FG000|Overall Study|Sponsor Decision|0|||
33288282|NCT01149421|62664904|FG001|Overall Study|Sponsor Decision|1|||
33288283|NCT01149421|62664905|FG002|Overall Study|Sponsor Decision|1|||
33288284|NCT01149421|62664903|FG000|Overall Study|Lost to Follow-up|2|||
33288285|NCT01149421|62664904|FG001|Overall Study|Lost to Follow-up|4|||
33288286|NCT01149421|62664905|FG002|Overall Study|Lost to Follow-up|5|||
33288287|NCT01149421|62664903|FG000|Overall Study|Physician Decision|5|||
33288288|NCT01149421|62664904|FG001|Overall Study|Physician Decision|3|||
33288289|NCT01149421|62664905|FG002|Overall Study|Physician Decision|6|||
33288290|NCT01149421|62664903|FG000|Overall Study|Entry Criteria Not Met|1|||
33288291|NCT01149421|62664904|FG001|Overall Study|Entry Criteria Not Met|1|||
33288292|NCT01149421|62664905|FG002|Overall Study|Entry Criteria Not Met|2|||
33288293|NCT01149421|62664903|FG000|Overall Study|Protocol Violation|2|||
33288294|NCT01149421|62664904|FG001|Overall Study|Protocol Violation|2|||
33288295|NCT01149421|62664905|FG002|Overall Study|Protocol Violation|6|||
33288296|NCT01149343|62664923|FG000|Overall Study|Withdrawal by Subject|1|||
33288297|NCT01149343|62664924|FG001|Overall Study|Withdrawal by Subject|1|||
33288298|NCT01149343|62664925|FG002|Overall Study|Withdrawal by Subject|1|||
33288299|NCT01149343|62664926|FG003|Overall Study|Withdrawal by Subject|5|||
33288300|NCT01149343|62664923|FG000|Overall Study|Death|10|||
33288301|NCT01149343|62664924|FG001|Overall Study|Death|13|||
33288302|NCT01149343|62664925|FG002|Overall Study|Death|18|||
33288303|NCT01149343|62664926|FG003|Overall Study|Death|18|||
33288304|NCT01149343|62664923|FG000|Overall Study|Lost to Follow-up|1|||
33288305|NCT01149343|62664924|FG001|Overall Study|Lost to Follow-up|0|||
33288306|NCT01149343|62664925|FG002|Overall Study|Lost to Follow-up|0|||
33288307|NCT01149343|62664926|FG003|Overall Study|Lost to Follow-up|1|||
33288308|NCT01149343|62664923|FG000|Overall Study|Other|8|||
33288309|NCT01149343|62664924|FG001|Overall Study|Other|10|||
33288310|NCT01149343|62664925|FG002|Overall Study|Other|2|||
33288311|NCT01149343|62664926|FG003|Overall Study|Other|14|||
33288312|NCT01149343|62664923|FG000|Overall Study|Sponsor study termination|0|||
33374236|NCT00663052|62753160|FG001|Overall Study|Adverse Event|3|||
33374237|NCT00663052|62753159|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
33374238|NCT00663052|62753160|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
33374239|NCT00663052|62753159|FG000|Overall Study|Protocol Violation|1|||
33374240|NCT00663052|62753160|FG001|Overall Study|Protocol Violation|0|||
33374241|NCT00663052|62753159|FG000|Overall Study|Withdrawal by Subject|2|||
33374242|NCT00663052|62753160|FG001|Overall Study|Withdrawal by Subject|5|||
33374243|NCT00663052|62753159|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
33374244|NCT00663052|62753160|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
33374245|NCT00663052|62753159|FG000|Overall Study|Other|0|||
33374246|NCT00663052|62753160|FG001|Overall Study|Other|1|||
33374247|NCT00827372|62753166|FG000|Overall Study|Adverse Event|5|||
33374248|NCT00827372|62753166|FG000|Overall Study|Lack of Efficacy|3|||
33662269|NCT01695239|63092837|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33288313|NCT01149343|62664924|FG001|Overall Study|Sponsor study termination|0|||
33288314|NCT01149343|62664925|FG002|Overall Study|Sponsor study termination|0|||
33288315|NCT01149343|62664926|FG003|Overall Study|Sponsor study termination|2|||
33288316|NCT01149343|62664923|FG000|Overall Study|Recurrence / Progressive disease|0|||
33288317|NCT01149343|62664924|FG001|Overall Study|Recurrence / Progressive disease|0|||
33374249|NCT00826748|62753174|FG000|Overall Study|Withdrawal by Subject|0|||
33374250|NCT00826748|62753175|FG001|Overall Study|Withdrawal by Subject|0|||
33374251|NCT00826748|62753176|FG002|Overall Study|Withdrawal by Subject|2|||
33288318|NCT01149343|62664925|FG002|Overall Study|Recurrence / Progressive disease|1|||
33288319|NCT01149343|62664926|FG003|Overall Study|Recurrence / Progressive disease|0|||
33288320|NCT01149148|62664942|FG000|Overall Study|Lost to Follow-up|1|||
33288321|NCT01149148|62664943|FG001|Overall Study|Lost to Follow-up|2|||
33288322|NCT01149148|62664942|FG000|Overall Study|Death|1|||
33288323|NCT01149148|62664943|FG001|Overall Study|Death|0|||
33288324|NCT01148017|62664954|FG000|Overall Study|Withdrawal by Subject|31|||
33288325|NCT01148017|62664955|FG001|Overall Study|Withdrawal by Subject|14|||
33288326|NCT01148017|62664956|FG002|Overall Study|Withdrawal by Subject|0|||
33288327|NCT01148017|62664957|FG003|Overall Study|Withdrawal by Subject|0|||
33288328|NCT01148017|62664954|FG000|Overall Study|Lost to Follow-up|23|||
33288329|NCT01148017|62664955|FG001|Overall Study|Lost to Follow-up|10|||
33288330|NCT01148017|62664956|FG002|Overall Study|Lost to Follow-up|0|||
33288331|NCT01148017|62664957|FG003|Overall Study|Lost to Follow-up|0|||
33288332|NCT01148017|62664954|FG000|Overall Study|Inappropriate enrollment|1|||
33288333|NCT01148017|62664955|FG001|Overall Study|Inappropriate enrollment|0|||
33288334|NCT01148017|62664956|FG002|Overall Study|Inappropriate enrollment|0|||
33288335|NCT01148017|62664957|FG003|Overall Study|Inappropriate enrollment|0|||
33288336|NCT01148017|62664954|FG000|Overall Study|Administrative reason|22|||
33288337|NCT01148017|62664955|FG001|Overall Study|Administrative reason|9|||
33288338|NCT01148017|62664956|FG002|Overall Study|Administrative reason|0|||
33288339|NCT01148017|62664957|FG003|Overall Study|Administrative reason|0|||
33288340|NCT01148017|62664954|FG000|Overall Study|Unable to classify|3|||
33288341|NCT01148017|62664955|FG001|Overall Study|Unable to classify|1|||
33288342|NCT01148017|62664956|FG002|Overall Study|Unable to classify|0|||
33288343|NCT01148017|62664957|FG003|Overall Study|Unable to classify|0|||
33288344|NCT01147900|62664971|FG000|At Year 10|Lost to Follow-up|0|||
33288345|NCT01147900|62664972|FG001|At Year 10|Lost to Follow-up|1|||
33288346|NCT01147900|62664973|FG002|At Year 10|Lost to Follow-up|0|||
33288347|NCT01147744|62664988|FG000|Overall Study|Protocol Violation|1|||
33288348|NCT01147744|62664989|FG001|Overall Study|Protocol Violation|0|||
33288349|NCT01147744|62664990|FG002|Overall Study|Protocol Violation|1|||
33374252|NCT00826748|62753174|FG000|Overall Study|Physician Decision|0|||
33374253|NCT00826748|62753175|FG001|Overall Study|Physician Decision|0|||
33374254|NCT00826748|62753176|FG002|Overall Study|Physician Decision|1|||
33374255|NCT00826748|62753174|FG000|Overall Study|Samples Did Not pass QC|0|||
33374256|NCT00826748|62753175|FG001|Overall Study|Samples Did Not pass QC|0|||
33374257|NCT00826748|62753176|FG002|Overall Study|Samples Did Not pass QC|1|||
33374258|NCT00806988|62753186|FG000|Overall Study|Death|15|||
33374259|NCT00806988|62753187|FG001|Overall Study|Death|16|||
33374260|NCT00806988|62753186|FG000|Overall Study|Withdrawal by Subject|8|||
33374261|NCT00806988|62753187|FG001|Overall Study|Withdrawal by Subject|8|||
33374262|NCT00806988|62753186|FG000|Overall Study|Lost to Follow-up|4|||
33374263|NCT00806988|62753187|FG001|Overall Study|Lost to Follow-up|19|||
33374264|NCT00807144|62753195|FG000|Overall Study|Lost to Follow-up|0|||
33374265|NCT00807144|62753196|FG001|Overall Study|Lost to Follow-up|1|||
33374266|NCT00591006|62753202|FG000|Overall Study|Withdrawal by Subject|0|||
33374267|NCT00591006|62753203|FG001|Overall Study|Withdrawal by Subject|0|||
33374268|NCT00591006|62753204|FG002|Overall Study|Withdrawal by Subject|0|||
33374269|NCT00591006|62753205|FG003|Overall Study|Withdrawal by Subject|0|||
33374270|NCT00591006|62753206|FG004|Overall Study|Withdrawal by Subject|0|||
33374271|NCT00591006|62753207|FG005|Overall Study|Withdrawal by Subject|0|||
33374272|NCT00591006|62753208|FG006|Overall Study|Withdrawal by Subject|0|||
33374273|NCT00591006|62753209|FG007|Overall Study|Withdrawal by Subject|0|||
33374274|NCT00591006|62753210|FG008|Overall Study|Withdrawal by Subject|0|||
33374275|NCT00591006|62753211|FG009|Overall Study|Withdrawal by Subject|0|||
33374276|NCT00591006|62753212|FG010|Overall Study|Withdrawal by Subject|0|||
33374277|NCT00591006|62753213|FG011|Overall Study|Withdrawal by Subject|0|||
33374278|NCT00591006|62753214|FG012|Overall Study|Withdrawal by Subject|0|||
33556318|NCT02616614|62949196|FG000|Overall Study|Protocol Violation|0|||
33288350|NCT01147744|62664991|FG003|Overall Study|Protocol Violation|0|||
33288351|NCT01147744|62664992|FG004|Overall Study|Protocol Violation|1|||
33288352|NCT01147744|62664993|FG005|Overall Study|Protocol Violation|3|||
33288353|NCT01147744|62664994|FG006|Overall Study|Protocol Violation|1|||
33288354|NCT01147744|62664988|FG000|Overall Study|Physician Decision|0|||
33288355|NCT01147744|62664989|FG001|Overall Study|Physician Decision|1|||
33288356|NCT01147744|62664990|FG002|Overall Study|Physician Decision|1|||
33288357|NCT01147744|62664991|FG003|Overall Study|Physician Decision|0|||
33288358|NCT01147744|62664992|FG004|Overall Study|Physician Decision|0|||
33288359|NCT01147744|62664993|FG005|Overall Study|Physician Decision|0|||
33288360|NCT01147744|62664994|FG006|Overall Study|Physician Decision|1|||
33288361|NCT01147744|62664988|FG000|Overall Study|Lack of Efficacy|11|||
33288362|NCT01147744|62664989|FG001|Overall Study|Lack of Efficacy|11|||
33374279|NCT00591006|62753215|FG013|Overall Study|Withdrawal by Subject|0|||
33374280|NCT00591006|62753216|FG014|Overall Study|Withdrawal by Subject|0|||
33374281|NCT00591006|62753217|FG015|Overall Study|Withdrawal by Subject|1|||
33374282|NCT00591006|62753218|FG016|Overall Study|Withdrawal by Subject|0|||
33374283|NCT00591006|62753219|FG017|Overall Study|Withdrawal by Subject|0|||
33374284|NCT00591006|62753220|FG018|Overall Study|Withdrawal by Subject|0|||
33374285|NCT00591006|62753221|FG019|Overall Study|Withdrawal by Subject|0|||
33556319|NCT02616614|62949197|FG001|Overall Study|Protocol Violation|3|||
33288363|NCT01147744|62664990|FG002|Overall Study|Lack of Efficacy|9|||
33288364|NCT01147744|62664991|FG003|Overall Study|Lack of Efficacy|11|||
33288365|NCT01147744|62664992|FG004|Overall Study|Lack of Efficacy|13|||
33288366|NCT01147744|62664993|FG005|Overall Study|Lack of Efficacy|8|||
33288367|NCT01147744|62664994|FG006|Overall Study|Lack of Efficacy|7|||
33288368|NCT01147744|62664988|FG000|Overall Study|Adverse Event|1|||
33288369|NCT01147744|62664989|FG001|Overall Study|Adverse Event|2|||
33288370|NCT01147744|62664990|FG002|Overall Study|Adverse Event|3|||
33288371|NCT01147744|62664991|FG003|Overall Study|Adverse Event|0|||
33288372|NCT01147744|62664992|FG004|Overall Study|Adverse Event|2|||
33288373|NCT01147744|62664993|FG005|Overall Study|Adverse Event|1|||
33288374|NCT01147744|62664994|FG006|Overall Study|Adverse Event|2|||
33288375|NCT01147744|62664988|FG000|Overall Study|Withdrawal by Subject|8|||
33288376|NCT01147744|62664989|FG001|Overall Study|Withdrawal by Subject|4|||
33288377|NCT01147744|62664990|FG002|Overall Study|Withdrawal by Subject|2|||
33288378|NCT01147744|62664991|FG003|Overall Study|Withdrawal by Subject|2|||
33288379|NCT01147744|62664992|FG004|Overall Study|Withdrawal by Subject|2|||
33288380|NCT01147744|62664993|FG005|Overall Study|Withdrawal by Subject|5|||
33288381|NCT01147744|62664994|FG006|Overall Study|Withdrawal by Subject|2|||
33288382|NCT01147744|62664988|FG000|Overall Study|Lost to Follow-up|0|||
33288383|NCT01147744|62664989|FG001|Overall Study|Lost to Follow-up|1|||
33288384|NCT01147744|62664990|FG002|Overall Study|Lost to Follow-up|0|||
33288385|NCT01147744|62664991|FG003|Overall Study|Lost to Follow-up|0|||
33288386|NCT01147744|62664992|FG004|Overall Study|Lost to Follow-up|0|||
33288387|NCT01147744|62664993|FG005|Overall Study|Lost to Follow-up|0|||
33288388|NCT01147744|62664994|FG006|Overall Study|Lost to Follow-up|0|||
33288389|NCT01147744|62664988|FG000|Overall Study|Sponsor decision to amend protocol|7|||
33288390|NCT01147744|62664989|FG001|Overall Study|Sponsor decision to amend protocol|4|||
33288391|NCT01147744|62664990|FG002|Overall Study|Sponsor decision to amend protocol|2|||
33374286|NCT00591006|62753222|FG020|Overall Study|Withdrawal by Subject|0|||
33374287|NCT00591006|62753223|FG021|Overall Study|Withdrawal by Subject|0|||
33374288|NCT00591006|62753224|FG022|Overall Study|Withdrawal by Subject|0|||
33374289|NCT00591006|62753225|FG023|Overall Study|Withdrawal by Subject|1|||
33374290|NCT00591006|62753202|FG000|Overall Study|Adverse Event|0|||
33374291|NCT00591006|62753203|FG001|Overall Study|Adverse Event|0|||
33374292|NCT00591006|62753204|FG002|Overall Study|Adverse Event|0|||
33374293|NCT00591006|62753205|FG003|Overall Study|Adverse Event|0|||
33374294|NCT00591006|62753206|FG004|Overall Study|Adverse Event|0|||
33374295|NCT00591006|62753207|FG005|Overall Study|Adverse Event|0|||
33374296|NCT00591006|62753208|FG006|Overall Study|Adverse Event|0|||
33374297|NCT00591006|62753209|FG007|Overall Study|Adverse Event|0|||
33374298|NCT00591006|62753210|FG008|Overall Study|Adverse Event|0|||
33374299|NCT00591006|62753211|FG009|Overall Study|Adverse Event|0|||
33374300|NCT00591006|62753212|FG010|Overall Study|Adverse Event|0|||
33374301|NCT00591006|62753213|FG011|Overall Study|Adverse Event|0|||
33374302|NCT00591006|62753214|FG012|Overall Study|Adverse Event|0|||
33374303|NCT00591006|62753215|FG013|Overall Study|Adverse Event|0|||
33374304|NCT00591006|62753216|FG014|Overall Study|Adverse Event|0|||
33374305|NCT00591006|62753217|FG015|Overall Study|Adverse Event|0|||
33374306|NCT00591006|62753218|FG016|Overall Study|Adverse Event|0|||
33374307|NCT00591006|62753219|FG017|Overall Study|Adverse Event|0|||
33374308|NCT00591006|62753220|FG018|Overall Study|Adverse Event|0|||
33374309|NCT00591006|62753221|FG019|Overall Study|Adverse Event|0|||
33374310|NCT00591006|62753222|FG020|Overall Study|Adverse Event|0|||
33374311|NCT00591006|62753223|FG021|Overall Study|Adverse Event|0|||
33374312|NCT00591006|62753224|FG022|Overall Study|Adverse Event|1|||
33374313|NCT00591006|62753225|FG023|Overall Study|Adverse Event|0|||
33374314|NCT00844844|62753242|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
33374315|NCT00844844|62753242|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
33374316|NCT00844844|62753242|FG000|Extension Treatment Period|Adverse Event|2|||
33374317|NCT00844844|62753242|FG000|Post Treatment Period|Withdrawal by Subject|1|||
33288392|NCT01147744|62664991|FG003|Overall Study|Sponsor decision to amend protocol|5|||
33288393|NCT01147744|62664992|FG004|Overall Study|Sponsor decision to amend protocol|7|||
33288394|NCT01147744|62664993|FG005|Overall Study|Sponsor decision to amend protocol|2|||
33288395|NCT01147744|62664994|FG006|Overall Study|Sponsor decision to amend protocol|6|||
33288396|NCT01147744|62664988|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33288397|NCT01147744|62664989|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
33288398|NCT01147744|62664990|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
33374318|NCT00660790|62753246|FG000|Baseline to 3 Months|Death|1|||
33374319|NCT00660790|62753246|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
33374320|NCT00660790|62753246|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
33374321|NCT00836810|62753252|FG000|Overall Study|New diagnosis|1|||
33374322|NCT00836810|62753253|FG001|Overall Study|New diagnosis|0|||
33374323|NCT00658684|62753262|FG000|Overall Study|Adverse Event|10|||
33374324|NCT00658684|62753263|FG001|Overall Study|Adverse Event|8|||
33374325|NCT00658684|62753264|FG002|Overall Study|Adverse Event|2|||
33374326|NCT00658684|62753265|FG003|Overall Study|Adverse Event|0|||
33374327|NCT00658684|62753262|FG000|Overall Study|Withdrawal by Subject|6|||
33374328|NCT00658684|62753263|FG001|Overall Study|Withdrawal by Subject|4|||
33288399|NCT01147744|62664991|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
33288400|NCT01147744|62664992|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
33288401|NCT01147744|62664993|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33288402|NCT01147744|62664994|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
33288403|NCT01147471|62665018|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
33288404|NCT01147471|62665019|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
33288405|NCT01147471|62665018|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
33288406|NCT01147471|62665019|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
33288407|NCT01147471|62665018|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
33288408|NCT01147471|62665019|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
33288409|NCT01147471|62665018|FG000|3 Month Follow Up|Lost to Follow-up|1|||
33288410|NCT01147471|62665019|FG001|3 Month Follow Up|Lost to Follow-up|1|||
33288411|NCT01147471|62665018|FG000|3 Month Follow Up|Physician Decision|0|||
33288412|NCT01147471|62665019|FG001|3 Month Follow Up|Physician Decision|1|||
33288413|NCT01147471|62665018|FG000|6 Month Follow Up|Lost to Follow-up|4|||
33288414|NCT01147471|62665019|FG001|6 Month Follow Up|Lost to Follow-up|2|||
33288415|NCT01147393|62665025|FG000|Dose Level 1|Dose limiting Toxicity|2|||
33288416|NCT01147393|62665025|FG000|Dose Level -1|Dose Limited Toxicity|1|||
33288417|NCT01146652|62665032|FG000|Overall Study|Adverse Event|506|||
33288418|NCT01146652|62665033|FG001|Overall Study|Adverse Event|15|||
33288419|NCT01146652|62665032|FG000|Overall Study|Lack of Efficacy|91|||
33288420|NCT01146652|62665033|FG001|Overall Study|Lack of Efficacy|7|||
33288421|NCT01146652|62665032|FG000|Overall Study|Poor compliance to protocol|38|||
33288422|NCT01146652|62665033|FG001|Overall Study|Poor compliance to protocol|1|||
33288423|NCT01146652|62665032|FG000|Overall Study|Other unspecified reasons|314|||
33288424|NCT01146652|62665033|FG001|Overall Study|Other unspecified reasons|22|||
33288425|NCT01146652|62665032|FG000|Overall Study|Enrolled but not treated|2|||
33288426|NCT01146652|62665033|FG001|Overall Study|Enrolled but not treated|0|||
33288427|NCT01146613|62665048|FG000|Overall Study|Lost to Follow-up|3|||
33288428|NCT01146613|62665049|FG001|Overall Study|Lost to Follow-up|8|||
33288429|NCT01146613|62665048|FG000|Overall Study|Lack of Efficacy|0|||
33288430|NCT01146613|62665049|FG001|Overall Study|Lack of Efficacy|1|||
33288431|NCT01146613|62665048|FG000|Overall Study|Death|1|||
33288432|NCT01146613|62665049|FG001|Overall Study|Death|0|||
33288433|NCT01146613|62665048|FG000|Overall Study|Physician Decision|1|||
33288434|NCT01146613|62665049|FG001|Overall Study|Physician Decision|0|||
33288435|NCT01146613|62665048|FG000|Overall Study|Withdrawal by Subject|0|||
33288436|NCT01146613|62665049|FG001|Overall Study|Withdrawal by Subject|3|||
33288437|NCT01146613|62665048|FG000|Overall Study|schedule conflict|1|||
33288438|NCT01146613|62665049|FG001|Overall Study|schedule conflict|0|||
33288439|NCT01146613|62665048|FG000|Overall Study|Outpatient detox|1|||
33288440|NCT01146613|62665049|FG001|Overall Study|Outpatient detox|0|||
33288441|NCT01145755|62665058|FG000|Overall Study|Adverse Event|2|||
33374329|NCT00658684|62753264|FG002|Overall Study|Withdrawal by Subject|1|||
33374330|NCT00658684|62753265|FG003|Overall Study|Withdrawal by Subject|1|||
33374331|NCT00658684|62753262|FG000|Overall Study|Lack of Efficacy|1|||
33374332|NCT00658684|62753263|FG001|Overall Study|Lack of Efficacy|1|||
33288442|NCT01145755|62665059|FG001|Overall Study|Adverse Event|4|||
33288443|NCT01145755|62665060|FG002|Overall Study|Adverse Event|2|||
33288444|NCT01145755|62665058|FG000|Overall Study|Withdrawal by Subject|2|||
33288445|NCT01145755|62665059|FG001|Overall Study|Withdrawal by Subject|2|||
33288446|NCT01145755|62665060|FG002|Overall Study|Withdrawal by Subject|2|||
33288447|NCT01145755|62665058|FG000|Overall Study|Lost to Follow-up|2|||
33288448|NCT01145755|62665059|FG001|Overall Study|Lost to Follow-up|3|||
33288449|NCT01145755|62665060|FG002|Overall Study|Lost to Follow-up|1|||
33288450|NCT01145755|62665058|FG000|Overall Study|Protocol Violation|0|||
33288451|NCT01145755|62665059|FG001|Overall Study|Protocol Violation|3|||
33288452|NCT01145755|62665060|FG002|Overall Study|Protocol Violation|1|||
33288453|NCT01145755|62665058|FG000|Overall Study|Study Closure|14|||
33288454|NCT01145755|62665059|FG001|Overall Study|Study Closure|14|||
33288455|NCT01145755|62665060|FG002|Overall Study|Study Closure|17|||
33486735|NCT03236246|62864674|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
33288456|NCT01145755|62665058|FG000|Overall Study|Lack of Efficacy|0|||
33288457|NCT01145755|62665059|FG001|Overall Study|Lack of Efficacy|1|||
33288458|NCT01145755|62665060|FG002|Overall Study|Lack of Efficacy|0|||
33288459|NCT01145755|62665058|FG000|Overall Study|Patient could not swollow medication|0|||
33288460|NCT01145755|62665059|FG001|Overall Study|Patient could not swollow medication|0|||
33288461|NCT01145755|62665060|FG002|Overall Study|Patient could not swollow medication|1|||
33288462|NCT01145755|62665058|FG000|Overall Study|Withdrawal by Subject|0|||
33288463|NCT01145755|62665059|FG001|Overall Study|Withdrawal by Subject|0|||
33288464|NCT01145755|62665060|FG002|Overall Study|Withdrawal by Subject|1|||
33288465|NCT01145755|62665058|FG000|Overall Study|Positive urine ethanol|0|||
33288466|NCT01145755|62665059|FG001|Overall Study|Positive urine ethanol|1|||
33374333|NCT00658684|62753264|FG002|Overall Study|Lack of Efficacy|0|||
33374334|NCT00658684|62753265|FG003|Overall Study|Lack of Efficacy|0|||
33288467|NCT01145755|62665060|FG002|Overall Study|Positive urine ethanol|0|||
33288468|NCT01145560|62665071|FG000|Overall Study|Withdrawal by Subject|2|||
33288469|NCT01145560|62665072|FG001|Overall Study|Withdrawal by Subject|1|||
33288470|NCT01145560|62665073|FG002|Overall Study|Withdrawal by Subject|0|||
33288471|NCT01145560|62665071|FG000|Overall Study|Lost to Follow-up|1|||
33288472|NCT01145560|62665072|FG001|Overall Study|Lost to Follow-up|1|||
33288473|NCT01145560|62665073|FG002|Overall Study|Lost to Follow-up|1|||
33288474|NCT01145560|62665071|FG000|Overall Study|No study drug by 24h after organ failure|1|||
33288475|NCT01145560|62665072|FG001|Overall Study|No study drug by 24h after organ failure|0|||
33288476|NCT01145560|62665073|FG002|Overall Study|No study drug by 24h after organ failure|0|||
33288477|NCT01145560|62665071|FG000|Overall Study|Accidental unblinding of study treatment|0|||
33288478|NCT01145560|62665072|FG001|Overall Study|Accidental unblinding of study treatment|1|||
33288479|NCT01145560|62665073|FG002|Overall Study|Accidental unblinding of study treatment|0|||
33288480|NCT01145560|62665071|FG000|Overall Study|False insurance information|0|||
33288481|NCT01145560|62665072|FG001|Overall Study|False insurance information|1|||
33288482|NCT01145560|62665073|FG002|Overall Study|False insurance information|0|||
33288483|NCT01145560|62665071|FG000|Overall Study|Withdrawal of therapy|0|||
33288484|NCT01145560|62665072|FG001|Overall Study|Withdrawal of therapy|0|||
33288485|NCT01145560|62665073|FG002|Overall Study|Withdrawal of therapy|1|||
33288486|NCT01145482|62665083|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
33288487|NCT01145482|62665084|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
33288488|NCT01145053|62665090|FG000|Overall Study|Adverse Event|22|||
33288489|NCT01145053|62665090|FG000|Overall Study|Lost to Follow-up|28|||
33288490|NCT01145053|62665090|FG000|Overall Study|Withdrawal by Subject|25|||
33288491|NCT01145053|62665090|FG000|Overall Study|Other|18|||
33288492|NCT01144663|62665098|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
33288493|NCT01144663|62665099|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
33288494|NCT01144663|62665100|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
33288495|NCT01144663|62665101|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
33288496|NCT01144663|62665098|FG000|Primary Vaccination Phase|Adverse Event|1|||
33288497|NCT01144663|62665099|FG001|Primary Vaccination Phase|Adverse Event|0|||
33288498|NCT01144663|62665100|FG002|Primary Vaccination Phase|Adverse Event|0|||
33288499|NCT01144663|62665101|FG003|Primary Vaccination Phase|Adverse Event|1|||
33288500|NCT01144663|62665098|FG000|Primary Vaccination Phase|Protocol Violation|2|||
33288501|NCT01144663|62665099|FG001|Primary Vaccination Phase|Protocol Violation|0|||
33288502|NCT01144663|62665100|FG002|Primary Vaccination Phase|Protocol Violation|1|||
33288503|NCT01144663|62665101|FG003|Primary Vaccination Phase|Protocol Violation|0|||
33288504|NCT01144663|62665098|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
33288505|NCT01144663|62665099|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
33288506|NCT01144663|62665100|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
33288507|NCT01144663|62665101|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
33288508|NCT01144663|62665098|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
33288509|NCT01144663|62665099|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
33288510|NCT01144663|62665100|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
33288511|NCT01144663|62665101|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
33288512|NCT01144663|62665098|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
33288513|NCT01144663|62665099|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
33288514|NCT01144663|62665100|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
33288515|NCT01144663|62665101|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
33288516|NCT01144663|62665098|FG000|Primary Vaccination Phase|Other|0|||
33288517|NCT01144663|62665099|FG001|Primary Vaccination Phase|Other|1|||
33288518|NCT01144663|62665100|FG002|Primary Vaccination Phase|Other|0|||
33288519|NCT01144663|62665101|FG003|Primary Vaccination Phase|Other|2|||
33288520|NCT01144663|62665098|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
33288521|NCT01144663|62665099|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
33288522|NCT01144663|62665100|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
33288523|NCT01144663|62665101|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
33288524|NCT01144663|62665098|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
33288525|NCT01144663|62665099|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
33288526|NCT01144663|62665100|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
33288527|NCT01144663|62665101|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
33374335|NCT00658684|62753262|FG000|Overall Study|Protocol Violation|1|||
33374336|NCT00658684|62753263|FG001|Overall Study|Protocol Violation|1|||
33374337|NCT00658684|62753264|FG002|Overall Study|Protocol Violation|0|||
33374338|NCT00658684|62753265|FG003|Overall Study|Protocol Violation|0|||
33288528|NCT01144663|62665098|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
33288529|NCT01144663|62665099|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
33288530|NCT01144663|62665100|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
33486736|NCT03236246|62864673|FG000|24-Week Dose Titration Period|Adverse Event|7|||
33288531|NCT01144663|62665101|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
33374339|NCT00658684|62753262|FG000|Overall Study|Pregnancy|1|||
33374340|NCT00658684|62753263|FG001|Overall Study|Pregnancy|1|||
33288532|NCT01144663|62665098|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
33288533|NCT01144663|62665099|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
33288534|NCT01144663|62665100|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
33288535|NCT01144663|62665101|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
33288536|NCT01144663|62665098|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
33288537|NCT01144663|62665099|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
33288538|NCT01144663|62665100|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
33288539|NCT01144663|62665101|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
33288540|NCT01144663|62665098|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
33288541|NCT01144663|62665099|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
33288542|NCT01144663|62665100|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
33288543|NCT01144663|62665101|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
33288544|NCT01143337|62665113|FG000|Overall Study|Adverse Event|3|||
33288545|NCT01143337|62665114|FG001|Overall Study|Adverse Event|9|||
33288546|NCT01143337|62665115|FG002|Overall Study|Adverse Event|5|||
33288547|NCT01143337|62665113|FG000|Overall Study|Lack of Efficacy|6|||
33288548|NCT01143337|62665114|FG001|Overall Study|Lack of Efficacy|2|||
33288549|NCT01143337|62665115|FG002|Overall Study|Lack of Efficacy|1|||
33288550|NCT01143337|62665113|FG000|Overall Study|Protocol Violation|1|||
33374341|NCT00658684|62753264|FG002|Overall Study|Pregnancy|0|||
33374342|NCT00658684|62753265|FG003|Overall Study|Pregnancy|0|||
33374343|NCT00660400|62753275|FG000|Overall Study|Lack of insurance approval|1|||
33374344|NCT00660400|62753275|FG000|Overall Study|Suboptimal organ function|1|||
33374345|NCT00660400|62753275|FG000|Overall Study|Intracranial hemorrhage|1|||
33374346|NCT00660400|62753275|FG000|Overall Study|Withdrawal by Subject|1|||
33374347|NCT00826514|62753281|FG000|Overall Study|Adverse Event|1|||
33288551|NCT01143337|62665114|FG001|Overall Study|Protocol Violation|0|||
33288552|NCT01143337|62665115|FG002|Overall Study|Protocol Violation|0|||
33288553|NCT01143337|62665113|FG000|Overall Study|Withdrawal by Subject|0|||
33288554|NCT01143337|62665114|FG001|Overall Study|Withdrawal by Subject|0|||
33288555|NCT01143337|62665115|FG002|Overall Study|Withdrawal by Subject|1|||
33288556|NCT01143337|62665113|FG000|Overall Study|Other reason|0|||
33288557|NCT01143337|62665114|FG001|Overall Study|Other reason|0|||
33288558|NCT01143337|62665115|FG002|Overall Study|Other reason|5|||
33288559|NCT01143259|62665132|FG000|Overall Study|Withdrawal by Subject|3|||
33288560|NCT01143259|62665133|FG001|Overall Study|Withdrawal by Subject|2|||
33288561|NCT01143259|62665132|FG000|Overall Study|Protocol Violation|13|||
33288562|NCT01143259|62665133|FG001|Overall Study|Protocol Violation|9|||
33288563|NCT01143259|62665132|FG000|Overall Study|Screen Failure|7|||
33288564|NCT01143259|62665133|FG001|Overall Study|Screen Failure|9|||
33288565|NCT01142791|62665139|FG000|Overall Study|Alternative Treatment|1|||
33288566|NCT01142791|62665140|FG001|Overall Study|Alternative Treatment|0|||
33288567|NCT01142791|62665139|FG000|Overall Study|Lost to Follow-up|1|||
33288568|NCT01142791|62665140|FG001|Overall Study|Lost to Follow-up|0|||
33374348|NCT00826514|62753282|FG001|Overall Study|Adverse Event|1|||
33374349|NCT00826514|62753281|FG000|Overall Study|Lack of Efficacy|0|||
33374350|NCT00826514|62753282|FG001|Overall Study|Lack of Efficacy|1|||
33374351|NCT00826514|62753281|FG000|Overall Study|Withdrawal by Subject|2|||
33374352|NCT00826514|62753282|FG001|Overall Study|Withdrawal by Subject|3|||
33374353|NCT00826280|62753291|FG000|Overall Study|Randomized but drug not received|1|||
33374354|NCT00826280|62753292|FG001|Overall Study|Randomized but drug not received|0|||
33288569|NCT01142791|62665139|FG000|Overall Study|Withdrawal by Subject|5|||
33288570|NCT01142791|62665140|FG001|Overall Study|Withdrawal by Subject|0|||
33288571|NCT01142791|62665139|FG000|Overall Study|Received only 1 sonication|0|||
33288572|NCT01142791|62665140|FG001|Overall Study|Received only 1 sonication|6|||
33288573|NCT01142596|62665146|FG000|Overall Study|Withdrawal by Subject|9|||
33288574|NCT01142596|62665147|FG001|Overall Study|Withdrawal by Subject|35|||
33288575|NCT01142596|62665146|FG000|Overall Study|Adverse Event|8|||
33288576|NCT01142596|62665147|FG001|Overall Study|Adverse Event|35|||
33288577|NCT01142596|62665146|FG000|Overall Study|Lack of Efficacy|5|||
33288578|NCT01142596|62665147|FG001|Overall Study|Lack of Efficacy|9|||
33288579|NCT01142596|62665146|FG000|Overall Study|Lost to Follow-up|2|||
33288580|NCT01142596|62665147|FG001|Overall Study|Lost to Follow-up|3|||
33374355|NCT00826280|62753293|FG002|Overall Study|Randomized but drug not received|1|||
33374356|NCT00826280|62753291|FG000|Overall Study|Adverse Event|1|||
33374357|NCT00826280|62753292|FG001|Overall Study|Adverse Event|3|||
33288581|NCT01142596|62665146|FG000|Overall Study|Other reason (not specified)|5|||
33288582|NCT01142596|62665147|FG001|Overall Study|Other reason (not specified)|4|||
33288583|NCT01142128|62665157|FG000|Overall Study|Physician Decision|1|||
33288584|NCT01142128|62665157|FG000|Overall Study|Lost to Follow-up|1|||
33288585|NCT01142128|62665157|FG000|Overall Study|Withdrawal by Subject|2|||
33374358|NCT00826280|62753293|FG002|Overall Study|Adverse Event|0|||
33374359|NCT00826280|62753291|FG000|Overall Study|Lost to Follow-up|0|||
33374360|NCT00826280|62753292|FG001|Overall Study|Lost to Follow-up|1|||
33374361|NCT00826280|62753293|FG002|Overall Study|Lost to Follow-up|0|||
33374362|NCT00826280|62753291|FG000|Overall Study|Sponsor discontinued subject or study|1|||
33374363|NCT00826280|62753292|FG001|Overall Study|Sponsor discontinued subject or study|0|||
33374364|NCT00826280|62753293|FG002|Overall Study|Sponsor discontinued subject or study|0|||
33374365|NCT00826280|62753291|FG000|Overall Study|Reversible ischemic defect not present|43|||
33374366|NCT00826280|62753292|FG001|Overall Study|Reversible ischemic defect not present|40|||
33374367|NCT00826280|62753293|FG002|Overall Study|Reversible ischemic defect not present|44|||
33374368|NCT00826280|62753291|FG000|Overall Study|Interpretation Failure|1|||
33374369|NCT00826280|62753292|FG001|Overall Study|Interpretation Failure|0|||
33374370|NCT00826280|62753293|FG002|Overall Study|Interpretation Failure|0|||
33374371|NCT00826280|62753291|FG000|Overall Study|Machine Failure|1|||
33374372|NCT00826280|62753292|FG001|Overall Study|Machine Failure|1|||
33374373|NCT00826280|62753293|FG002|Overall Study|Machine Failure|0|||
33374374|NCT00826280|62753291|FG000|Overall Study|One or more non-interpretable scan|0|||
33374375|NCT00826280|62753292|FG001|Overall Study|One or more non-interpretable scan|1|||
33374376|NCT00826280|62753293|FG002|Overall Study|One or more non-interpretable scan|1|||
33374377|NCT00864851|62753304|FG000|Overall Study|Withdrawal by Subject|0|||
33374378|NCT00864851|62753305|FG001|Overall Study|Withdrawal by Subject|1|||
33374379|NCT00864851|62753306|FG002|Overall Study|Withdrawal by Subject|0|||
33374380|NCT00864851|62753304|FG000|Overall Study|Physician Decision|1|||
33374381|NCT00864851|62753305|FG001|Overall Study|Physician Decision|0|||
33374382|NCT00864851|62753306|FG002|Overall Study|Physician Decision|0|||
33374383|NCT00864851|62753304|FG000|Overall Study|Death|1|||
33374384|NCT00864851|62753305|FG001|Overall Study|Death|0|||
33374385|NCT00864851|62753306|FG002|Overall Study|Death|0|||
33374386|NCT00864851|62753304|FG000|Overall Study|Patient uncooperative|1|||
33374387|NCT00864851|62753305|FG001|Overall Study|Patient uncooperative|0|||
33374388|NCT00864851|62753306|FG002|Overall Study|Patient uncooperative|0|||
33374389|NCT00857207|62753318|FG000|Overall Study|Withdrawal by Subject|13|||
33374390|NCT00857207|62753319|FG001|Overall Study|Withdrawal by Subject|0|||
33374391|NCT00857207|62753318|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
33374392|NCT00857207|62753319|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
33288586|NCT01142089|62665169|FG000|Overall Study|Physician Decision|1|||
33288587|NCT01142089|62665170|FG001|Overall Study|Physician Decision|0|||
33288588|NCT01142089|62665169|FG000|Overall Study|Withdrawal by Subject|1|||
33374393|NCT00857207|62753318|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
33374394|NCT00857207|62753319|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
33374395|NCT00836498|62753328|FG000|Overall Study|Adverse Event|1|||
33374396|NCT00836498|62753329|FG001|Overall Study|Adverse Event|0|||
33374397|NCT00836498|62753328|FG000|Overall Study|Lost to Follow-up|1|||
33374398|NCT00836498|62753329|FG001|Overall Study|Lost to Follow-up|0|||
33374399|NCT00836498|62753328|FG000|Overall Study|Withdrawal by Subject|2|||
33374400|NCT00836498|62753329|FG001|Overall Study|Withdrawal by Subject|1|||
33374401|NCT00856973|62753339|FG000|Overall Study|Adverse Event|5|||
33374402|NCT00856973|62753340|FG001|Overall Study|Adverse Event|5|||
33374403|NCT00856973|62753341|FG002|Overall Study|Adverse Event|3|||
33374404|NCT00856973|62753339|FG000|Overall Study|Lost to Follow-up|6|||
33486737|NCT03236246|62864674|FG001|24-Week Dose Titration Period|Adverse Event|8|||
33486738|NCT03236246|62864673|FG000|24-Week Dose Titration Period|Captured as Other|1|||
33486739|NCT03236246|62864674|FG001|24-Week Dose Titration Period|Captured as Other|2|||
33486740|NCT03236246|62864673|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
33486741|NCT03236246|62864674|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
33486742|NCT03236246|62864673|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
33486743|NCT03236246|62864674|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
33486744|NCT03236246|62864673|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
33486745|NCT03236246|62864674|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
33486746|NCT03236246|62864673|FG000|24-Week Dose Maintenance Period|Death|0|||
33288589|NCT01142089|62665170|FG001|Overall Study|Withdrawal by Subject|2|||
33288590|NCT01142089|62665169|FG000|Overall Study|Use of prohibited medications|0|||
33288591|NCT01142089|62665170|FG001|Overall Study|Use of prohibited medications|1|||
33288592|NCT01142089|62665169|FG000|Overall Study|Noncompliance with study procedures|2|||
33288593|NCT01142089|62665170|FG001|Overall Study|Noncompliance with study procedures|1|||
33288594|NCT01142089|62665169|FG000|Overall Study|Patient required rescue medication|8|||
33288595|NCT01142089|62665170|FG001|Overall Study|Patient required rescue medication|17|||
33288596|NCT01141660|62665178|FG000|Overall Study|Physician Decision|0|||
33374405|NCT00856973|62753340|FG001|Overall Study|Lost to Follow-up|3|||
33374406|NCT00856973|62753341|FG002|Overall Study|Lost to Follow-up|5|||
33374407|NCT00856973|62753339|FG000|Overall Study|Physician Decision|0|||
33374408|NCT00856973|62753340|FG001|Overall Study|Physician Decision|3|||
33374409|NCT00856973|62753341|FG002|Overall Study|Physician Decision|1|||
33374410|NCT00856973|62753339|FG000|Overall Study|Protocol Violation|1|||
33374411|NCT00856973|62753340|FG001|Overall Study|Protocol Violation|2|||
33374412|NCT00856973|62753341|FG002|Overall Study|Protocol Violation|1|||
33374413|NCT00856973|62753339|FG000|Overall Study|Withdrawal by Subject|13|||
33288597|NCT01141660|62665179|FG001|Overall Study|Physician Decision|12|||
33288598|NCT01140880|62665187|FG000|Overall Study|Death|0|||
33288599|NCT01140880|62665188|FG001|Overall Study|Death|1|||
33288600|NCT01140880|62665187|FG000|Overall Study|Withdrawal by Subject|6|||
33288601|NCT01140880|62665188|FG001|Overall Study|Withdrawal by Subject|3|||
33288602|NCT01140880|62665187|FG000|Overall Study|Lost to Follow-up|8|||
33288603|NCT01140880|62665188|FG001|Overall Study|Lost to Follow-up|10|||
33288604|NCT01140880|62665187|FG000|Overall Study|Protocol Violation|0|||
33288605|NCT01140880|62665188|FG001|Overall Study|Protocol Violation|30|||
33288606|NCT01140646|62665194|FG000|Overall Study|Adverse Event|4|||
33288607|NCT01140646|62665194|FG000|Overall Study|Refused Further Treatment|5|||
33288608|NCT01140568|62665198|FG000|Overall Study|disease progression|31|||
33288609|NCT01140568|62665198|FG000|Overall Study|Withdrawal by Subject|1|||
33288610|NCT01140568|62665198|FG000|Overall Study|Screen Fail|4|||
33288611|NCT01140451|62665204|FG000|Overall Study|Withdrawal by Subject|26|||
33288612|NCT01140451|62665205|FG001|Overall Study|Withdrawal by Subject|33|||
33288613|NCT01140451|62665204|FG000|Overall Study|Adverse Event|2|||
33288614|NCT01140451|62665205|FG001|Overall Study|Adverse Event|6|||
33288615|NCT01140451|62665204|FG000|Overall Study|Physician Decision|5|||
33288616|NCT01140451|62665205|FG001|Overall Study|Physician Decision|3|||
33288617|NCT01140451|62665204|FG000|Overall Study|Lost to Follow-up|2|||
33288618|NCT01140451|62665205|FG001|Overall Study|Lost to Follow-up|0|||
33288619|NCT01140451|62665204|FG000|Overall Study|Participants Planning Pregnancy|3|||
33288620|NCT01140451|62665205|FG001|Overall Study|Participants Planning Pregnancy|0|||
33288621|NCT01140061|62665222|FG000|Part I|Adverse Event|1|||
33288622|NCT01140061|62665223|FG001|Part I|Adverse Event|0|||
33556320|NCT02616614|62949198|FG002|Overall Study|Protocol Violation|1|||
33556321|NCT02616614|62949196|FG000|Overall Study|Prohibited Medication|12|||
33556322|NCT02616614|62949197|FG001|Overall Study|Prohibited Medication|9|||
33556323|NCT02616614|62949198|FG002|Overall Study|Prohibited Medication|5|||
33556324|NCT02616614|62949196|FG000|Overall Study|More than 3 applications missed|6|||
33288623|NCT01140061|62665224|FG002|Part I|Adverse Event|0|||
33288624|NCT01140061|62665225|FG003|Part I|Adverse Event|0|||
33288625|NCT01140061|62665226|FG004|Part I|Adverse Event|0|||
33288626|NCT01140061|62665227|FG005|Part I|Adverse Event|0|||
33288627|NCT01140061|62665228|FG006|Part I|Adverse Event|0|||
33288628|NCT01140061|62665229|FG007|Part I|Adverse Event|0|||
33288629|NCT01140061|62665230|FG008|Part I|Adverse Event|0|||
33374414|NCT00856973|62753340|FG001|Overall Study|Withdrawal by Subject|16|||
33374415|NCT00856973|62753341|FG002|Overall Study|Withdrawal by Subject|15|||
33374416|NCT00856973|62753339|FG000|Overall Study|Other|11|||
33374417|NCT00856973|62753340|FG001|Overall Study|Other|12|||
33374418|NCT00856973|62753341|FG002|Overall Study|Other|13|||
33374419|NCT00844532|62753353|FG000|Overall Study|Death|16|||
33374420|NCT00844532|62753353|FG000|Overall Study|Withdrawal by Subject|16|||
33374421|NCT00844532|62753353|FG000|Overall Study|Lost to Follow-up|7|||
33374422|NCT00805194|62753359|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
33374423|NCT00805194|62753360|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
33374424|NCT00805194|62753359|FG000|Overall Study|Worsening or AE of underlying disease|64|||
33374425|NCT00805194|62753360|FG001|Overall Study|Worsening or AE of underlying disease|70|||
33374426|NCT00805194|62753359|FG000|Overall Study|Other AE|84|||
33374427|NCT00805194|62753360|FG001|Overall Study|Other AE|73|||
33374428|NCT00805194|62753359|FG000|Overall Study|Protocol Violation|9|||
33374429|NCT00805194|62753360|FG001|Overall Study|Protocol Violation|9|||
33374430|NCT00805194|62753359|FG000|Overall Study|Lost to Follow-up|5|||
33374431|NCT00805194|62753360|FG001|Overall Study|Lost to Follow-up|5|||
33374432|NCT00805194|62753359|FG000|Overall Study|Withdrawal by Subject|60|||
33556325|NCT02616614|62949197|FG001|Overall Study|More than 3 applications missed|8|||
33556326|NCT02616614|62949198|FG002|Overall Study|More than 3 applications missed|1|||
33556327|NCT02616614|62949196|FG000|Overall Study|Lost to Follow-up|31|||
33556328|NCT02616614|62949197|FG001|Overall Study|Lost to Follow-up|28|||
33556329|NCT02616614|62949198|FG002|Overall Study|Lost to Follow-up|13|||
33556330|NCT02616614|62949196|FG000|Overall Study|Pregnancy|2|||
33556331|NCT02616614|62949197|FG001|Overall Study|Pregnancy|0|||
33556332|NCT02616614|62949198|FG002|Overall Study|Pregnancy|1|||
33556333|NCT02616614|62949196|FG000|Overall Study|Other|1|||
33556334|NCT02616614|62949197|FG001|Overall Study|Other|2|||
33556335|NCT02616614|62949198|FG002|Overall Study|Other|1|||
33556336|NCT02616380|62949224|FG000|Overall Study|Lost to Follow-up|1|||
33556337|NCT02616380|62949224|FG000|Overall Study|Other|2|||
33556338|NCT04436822|62949234|FG000|Overall Study|Physician Decision|2|||
33556339|NCT04436822|62949235|FG001|Overall Study|Physician Decision|0|||
33556340|NCT04436822|62949234|FG000|Overall Study|Sponsor request|1|||
33556341|NCT04436822|62949235|FG001|Overall Study|Sponsor request|0|||
33556342|NCT04436822|62949234|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33374433|NCT00805194|62753360|FG001|Overall Study|Withdrawal by Subject|42|||
33374434|NCT00805194|62753359|FG000|Overall Study|Not treated|3|||
33374435|NCT00805194|62753360|FG001|Overall Study|Not treated|4|||
33556343|NCT04436822|62949235|FG001|Overall Study|Withdrawal by parent/guardian|3|||
33288630|NCT01140061|62665231|FG009|Part I|Adverse Event|0|||
33288631|NCT01140061|62665222|FG000|Extension|Laboratory Adverse Event|0|||
33288632|NCT01140061|62665223|FG001|Extension|Laboratory Adverse Event|0|||
33288633|NCT01140061|62665224|FG002|Extension|Laboratory Adverse Event|0|||
33288634|NCT01140061|62665225|FG003|Extension|Laboratory Adverse Event|0|||
33374436|NCT00805194|62753359|FG000|Overall Study|Reasons other than stated above|20|||
33374437|NCT00805194|62753360|FG001|Overall Study|Reasons other than stated above|16|||
33374438|NCT00836186|62753371|FG000|Overall Study|Blood could not be drawn|1|||
33374439|NCT00657046|62753379|FG000|Overall Study|Adverse Event|1|||
33374440|NCT00657046|62753380|FG001|Overall Study|Adverse Event|1|||
33374441|NCT00657046|62753381|FG002|Overall Study|Adverse Event|0|||
33374442|NCT00657046|62753379|FG000|Overall Study|Protocol Violation|2|||
33374443|NCT00657046|62753380|FG001|Overall Study|Protocol Violation|2|||
33374444|NCT00657046|62753381|FG002|Overall Study|Protocol Violation|0|||
33374445|NCT00657046|62753379|FG000|Overall Study|Withdrawal by Subject|1|||
33374446|NCT00657046|62753380|FG001|Overall Study|Withdrawal by Subject|0|||
33374447|NCT00657046|62753381|FG002|Overall Study|Withdrawal by Subject|0|||
33374448|NCT00657046|62753379|FG000|Overall Study|Death|0|||
33374449|NCT00657046|62753380|FG001|Overall Study|Death|0|||
33374450|NCT00657046|62753381|FG002|Overall Study|Death|1|||
33374451|NCT00657046|62753379|FG000|Overall Study|Surgery|0|||
33374452|NCT00657046|62753380|FG001|Overall Study|Surgery|0|||
33374453|NCT00657046|62753381|FG002|Overall Study|Surgery|1|||
33288635|NCT01140061|62665226|FG004|Extension|Laboratory Adverse Event|0|||
33374454|NCT00856661|62753391|FG000|Overall Study|Death|15|||
33374455|NCT00856661|62753392|FG001|Overall Study|Death|18|||
33374456|NCT00856661|62753391|FG000|Overall Study|Protocol Violation|2|||
33374457|NCT00856661|62753392|FG001|Overall Study|Protocol Violation|1|||
33374458|NCT00856661|62753391|FG000|Overall Study|Withdrawal by Subject|1|||
33374459|NCT00856661|62753392|FG001|Overall Study|Withdrawal by Subject|2|||
33374460|NCT00856661|62753391|FG000|Overall Study|Lost to Follow-up|1|||
33374461|NCT00856661|62753392|FG001|Overall Study|Lost to Follow-up|3|||
33374462|NCT00856661|62753391|FG000|Overall Study|Physician Judgement|8|||
33374463|NCT00856661|62753392|FG001|Overall Study|Physician Judgement|5|||
33374464|NCT00844376|62753398|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
33374465|NCT00844376|62753399|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
33374466|NCT00658606|62753407|FG000|Overall Study|Adverse Event|2|||
33374467|NCT00658606|62753408|FG001|Overall Study|Adverse Event|1|||
33374468|NCT00658606|62753407|FG000|Overall Study|Lack of Efficacy|6|||
33374469|NCT00658606|62753408|FG001|Overall Study|Lack of Efficacy|3|||
33374470|NCT00658606|62753407|FG000|Overall Study|Lost to Follow-up|1|||
33374471|NCT00658606|62753408|FG001|Overall Study|Lost to Follow-up|0|||
33374472|NCT00658606|62753407|FG000|Overall Study|Withdrawal by Subject|7|||
33486747|NCT03236246|62864674|FG001|24-Week Dose Maintenance Period|Death|1|||
33486748|NCT03236246|62864673|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
33288636|NCT01140061|62665227|FG005|Extension|Laboratory Adverse Event|0|||
33288637|NCT01140061|62665228|FG006|Extension|Laboratory Adverse Event|0|||
33288638|NCT01140061|62665229|FG007|Extension|Laboratory Adverse Event|0|||
33288639|NCT01140061|62665230|FG008|Extension|Laboratory Adverse Event|0|||
33288640|NCT01140061|62665231|FG009|Extension|Laboratory Adverse Event|1|||
33288641|NCT01139164|62665249|FG000|Overall Study|Withdrawn prior to study start|0|||
33288642|NCT01139164|62665250|FG001|Overall Study|Withdrawn prior to study start|2|||
33288643|NCT01139164|62665251|FG002|Overall Study|Withdrawn prior to study start|0|||
33288644|NCT01139125|62665259|FG000|Overall Study|Withdrawal by Subject|1|||
33288645|NCT01139047|62665263|FG000|Overall Study|Withdrawal by Subject|1|||
33288646|NCT01139008|62665270|FG000|Overall Study|Withdrawal by Subject|5|||
33288647|NCT01139008|62665270|FG000|Overall Study|Non-compliant, lost product|1|||
33288648|NCT01138657|62665279|FG000|Overall Study|Adverse Event|3|||
33288649|NCT01138657|62665280|FG001|Overall Study|Adverse Event|10|||
33288650|NCT01138657|62665279|FG000|Overall Study|Lack of Efficacy|2|||
33374473|NCT00658606|62753408|FG001|Overall Study|Withdrawal by Subject|16|||
33374474|NCT00658606|62753407|FG000|Overall Study|Lack of Compliance|0|||
33486749|NCT03236246|62864674|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
33662270|NCT01695239|63092838|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33288651|NCT01138657|62665280|FG001|Overall Study|Lack of Efficacy|1|||
33374475|NCT00658606|62753408|FG001|Overall Study|Lack of Compliance|3|||
33374476|NCT00589290|62753414|FG000|Overall Study|Withdrawal by Subject|1|||
33288652|NCT01138657|62665279|FG000|Overall Study|Lost to Follow-up|0|||
33288653|NCT01138657|62665280|FG001|Overall Study|Lost to Follow-up|3|||
33288654|NCT01138657|62665279|FG000|Overall Study|Miscellaneous Reasons|3|||
33374477|NCT00843518|62753422|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
33374478|NCT00843518|62753423|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
33374479|NCT00843518|62753422|FG000|Period 2 (Double-blind Treatment)|Death|0|||
33374480|NCT00843518|62753423|FG001|Period 2 (Double-blind Treatment)|Death|1|||
33374481|NCT00843518|62753422|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
33374482|NCT00843518|62753423|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
33374483|NCT00843518|62753422|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
33486750|NCT02937584|62864680|FG000|Period 1|Adverse Event|1|||
33374484|NCT00843518|62753423|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
33374485|NCT00843518|62753422|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
33374486|NCT00843518|62753423|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
33374487|NCT00843518|62753422|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
33374488|NCT00843518|62753423|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
33374489|NCT00843518|62753422|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
33374490|NCT00843518|62753423|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
33374491|NCT00843284|62753433|FG000|Overall Study|Adverse Event|39|||
33374492|NCT00843284|62753433|FG000|Overall Study|Lack of Efficacy|5|||
33374493|NCT00843284|62753433|FG000|Overall Study|Lost to Follow-up|11|||
33374494|NCT00843284|62753433|FG000|Overall Study|Other|10|||
33374495|NCT00843284|62753433|FG000|Overall Study|Withdrawal by Subject|4|||
33374496|NCT00843284|62753433|FG000|Overall Study|Death|3|||
33374497|NCT00652834|62753450|FG000|Overall Study|Withdrawal by Subject|3|||
33374498|NCT00652834|62753450|FG000|Overall Study|Lost to Follow-up|2|||
33374499|NCT00825812|62753458|FG000|Overall Study|Never entered follow up|0|||
33374500|NCT00825812|62753459|FG001|Overall Study|Never entered follow up|0|||
33486751|NCT02937584|62864681|FG001|Period 1|Adverse Event|2|||
33486752|NCT02937584|62864680|FG000|Washout|Adverse Event|0|||
33486753|NCT02937584|62864681|FG001|Washout|Adverse Event|1|||
33486754|NCT00179621|62864690|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
33486755|NCT00179621|62864691|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
33288655|NCT01138657|62665280|FG001|Overall Study|Miscellaneous Reasons|4|||
33288656|NCT01138501|62665288|FG000|Overall Study|Protocol Violation|2|||
33288657|NCT01138501|62665288|FG000|Overall Study|Withdrawal by Subject|3|||
33288658|NCT01138150|62665294|FG000|Overall Study|blood unable to be processed|0|||
33288659|NCT01138150|62665295|FG001|Overall Study|blood unable to be processed|1|||
33288660|NCT01138150|62665294|FG000|Overall Study|Physician Decision|1|||
33288661|NCT01138150|62665295|FG001|Overall Study|Physician Decision|0|||
33288662|NCT01138111|62665311|FG000|Overall Study|Withdrawal by Subject|5|||
33288663|NCT01138111|62665311|FG000|Overall Study|Adverse Event|1|||
33288664|NCT01138111|62665311|FG000|Overall Study|Death|1|||
33288665|NCT01138111|62665311|FG000|Overall Study|Lost to Follow-up|2|||
33288666|NCT01137955|62665342|FG000|Overall Study|Withdrawal by Subject|5|||
33288667|NCT01137955|62665343|FG001|Overall Study|Withdrawal by Subject|4|||
33288668|NCT01137682|62665353|FG000|Overall Study|Adverse Event-CORE|2|||
33288669|NCT01137682|62665354|FG001|Overall Study|Adverse Event-CORE|4|||
33288670|NCT01137682|62665355|FG002|Overall Study|Adverse Event-CORE|0|||
33288671|NCT01137682|62665353|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
33288672|NCT01137682|62665354|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
33288673|NCT01137682|62665355|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
33288674|NCT01137682|62665353|FG000|Overall Study|Administrative problems-CORE|2|||
33288675|NCT01137682|62665354|FG001|Overall Study|Administrative problems-CORE|1|||
33288676|NCT01137682|62665355|FG002|Overall Study|Administrative problems-CORE|0|||
33288677|NCT01137682|62665353|FG000|Overall Study|Protocol Violation-CORE|0|||
33288678|NCT01137682|62665354|FG001|Overall Study|Protocol Violation-CORE|1|||
33288679|NCT01137682|62665355|FG002|Overall Study|Protocol Violation-CORE|1|||
33288680|NCT01137682|62665353|FG000|Overall Study|Adverse Event-Extension|4|||
33288681|NCT01137682|62665354|FG001|Overall Study|Adverse Event-Extension|8|||
33288682|NCT01137682|62665355|FG002|Overall Study|Adverse Event-Extension|7|||
33288683|NCT01137682|62665353|FG000|Overall Study|Lack of Efficacy-Extension|15|||
33288684|NCT01137682|62665354|FG001|Overall Study|Lack of Efficacy-Extension|9|||
33288685|NCT01137682|62665355|FG002|Overall Study|Lack of Efficacy-Extension|13|||
33288686|NCT01137682|62665353|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
33288687|NCT01137682|62665354|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
33288688|NCT01137682|62665355|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
33288689|NCT01137682|62665353|FG000|Overall Study|Lost to Follow Up-Extension|0|||
33288690|NCT01137682|62665354|FG001|Overall Study|Lost to Follow Up-Extension|1|||
33288691|NCT01137682|62665355|FG002|Overall Study|Lost to Follow Up-Extension|0|||
33288692|NCT01137682|62665353|FG000|Overall Study|Administrative problems-Extension|0|||
33288693|NCT01137682|62665354|FG001|Overall Study|Administrative problems-Extension|2|||
33374501|NCT00825812|62753460|FG002|Overall Study|Never entered follow up|0|||
33374502|NCT00825812|62753461|FG003|Overall Study|Never entered follow up|1|||
33374503|NCT00825812|62753458|FG000|Overall Study|Adverse Event|0|||
33374504|NCT00825812|62753459|FG001|Overall Study|Adverse Event|0|||
33374505|NCT00825812|62753460|FG002|Overall Study|Adverse Event|0|||
33374506|NCT00825812|62753461|FG003|Overall Study|Adverse Event|1|||
33374507|NCT00825812|62753458|FG000|Overall Study|Subject withdrew consent|0|||
33374508|NCT00825812|62753459|FG001|Overall Study|Subject withdrew consent|0|||
33374509|NCT00825812|62753460|FG002|Overall Study|Subject withdrew consent|3|||
33288694|NCT01137682|62665355|FG002|Overall Study|Administrative problems-Extension|0|||
33288695|NCT01137682|62665353|FG000|Overall Study|Death-Extension|2|||
33288696|NCT01137682|62665354|FG001|Overall Study|Death-Extension|0|||
33288697|NCT01137682|62665355|FG002|Overall Study|Death-Extension|0|||
33288698|NCT01137682|62665353|FG000|Overall Study|Protocol Violation-Extension|2|||
33288699|NCT01137682|62665354|FG001|Overall Study|Protocol Violation-Extension|1|||
33374510|NCT00825812|62753461|FG003|Overall Study|Subject withdrew consent|2|||
33374511|NCT00825812|62753458|FG000|Overall Study|Non-compliance with protocol|0|||
33374512|NCT00825812|62753459|FG001|Overall Study|Non-compliance with protocol|0|||
33374513|NCT00825812|62753460|FG002|Overall Study|Non-compliance with protocol|0|||
33288700|NCT01137682|62665355|FG002|Overall Study|Protocol Violation-Extension|0|||
33288701|NCT01137682|62665353|FG000|Overall Study|Did not enter extension|2|||
33288702|NCT01137682|62665354|FG001|Overall Study|Did not enter extension|3|||
33288703|NCT01137682|62665355|FG002|Overall Study|Did not enter extension|2|||
33288704|NCT01137682|62665353|FG000|Overall Study|Did not receive treatment in extension|0|||
33288705|NCT01137682|62665354|FG001|Overall Study|Did not receive treatment in extension|0|||
33288706|NCT01137682|62665355|FG002|Overall Study|Did not receive treatment in extension|1|||
33288707|NCT03452397|62665371|FG000|Overall Study|Adverse Event|1|||
33288708|NCT03452397|62665372|FG001|Overall Study|Adverse Event|0|||
33288709|NCT03452397|62665373|FG002|Overall Study|Adverse Event|0|||
33288710|NCT03452397|62665374|FG003|Overall Study|Adverse Event|0|||
33288711|NCT03452397|62665371|FG000|Overall Study|Administrative reason|0|||
33288712|NCT03452397|62665372|FG001|Overall Study|Administrative reason|0|||
33288713|NCT03452397|62665373|FG002|Overall Study|Administrative reason|1|||
33288714|NCT03452397|62665374|FG003|Overall Study|Administrative reason|1|||
33288715|NCT03452397|62665371|FG000|Overall Study|Withdrawal by Subject|0|||
33288716|NCT03452397|62665372|FG001|Overall Study|Withdrawal by Subject|0|||
33288717|NCT03452397|62665373|FG002|Overall Study|Withdrawal by Subject|1|||
33288718|NCT03452397|62665374|FG003|Overall Study|Withdrawal by Subject|0|||
33288719|NCT00199875|62665408|FG000|Overall Study|Withdrawal by Subject|0|||
33288720|NCT00199875|62665409|FG001|Overall Study|Withdrawal by Subject|0|||
33288721|NCT00199875|62665410|FG002|Overall Study|Withdrawal by Subject|0|||
33288722|NCT00199875|62665411|FG003|Overall Study|Withdrawal by Subject|0|||
33374514|NCT00825812|62753461|FG003|Overall Study|Non-compliance with protocol|1|||
33374515|NCT00825812|62753458|FG000|Overall Study|Administrative|0|||
33374516|NCT00825812|62753459|FG001|Overall Study|Administrative|1|||
33374517|NCT00825812|62753460|FG002|Overall Study|Administrative|3|||
33374518|NCT00825812|62753461|FG003|Overall Study|Administrative|5|||
33374519|NCT00824720|62753474|FG000|Overall Study|failed plug insertion|3|||
33374520|NCT00824720|62753475|FG001|Overall Study|failed plug insertion|1|||
33374521|NCT00824720|62753476|FG002|Overall Study|failed plug insertion|0|||
33374522|NCT00824720|62753474|FG000|Overall Study|Protocol Violation|0|||
33374523|NCT00824720|62753475|FG001|Overall Study|Protocol Violation|0|||
33374524|NCT00824720|62753476|FG002|Overall Study|Protocol Violation|1|||
33374525|NCT03704064|62753486|FG000|Overall Study|Lost to Follow-up|8|||
33374526|NCT03704064|62753487|FG001|Overall Study|Lost to Follow-up|4|||
33374527|NCT03704064|62753486|FG000|Overall Study|Withdrawal by Subject|1|||
33374528|NCT03704064|62753487|FG001|Overall Study|Withdrawal by Subject|1|||
33374529|NCT03704064|62753486|FG000|Overall Study|No longer available for study visits|0|||
33374530|NCT03704064|62753487|FG001|Overall Study|No longer available for study visits|1|||
33374531|NCT03704064|62753486|FG000|Overall Study|Censoring event|1|||
33374532|NCT03704064|62753487|FG001|Overall Study|Censoring event|0|||
33374533|NCT00824564|62753495|FG000|Overall Study|Lost to Follow-up|5|||
33486756|NCT00179621|62864692|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
33288723|NCT00199875|62665412|FG004|Overall Study|Withdrawal by Subject|1|||
33288724|NCT00199836|62665424|FG000|Overall Study|Progressive Disease|5|||
33288725|NCT00199836|62665424|FG000|Overall Study|Death|1|||
33288726|NCT00199797|62665429|FG000|Overall Study|Progressive Disease|1|||
33288727|NCT00199797|62665429|FG000|Overall Study|Adverse Event|1|||
33288728|NCT00199797|62665429|FG000|Overall Study|Physician Decision|1|||
33288729|NCT01137604|62665438|FG000|Overall Study|Adverse Event|3|||
33288730|NCT01137604|62665439|FG001|Overall Study|Adverse Event|6|||
33288731|NCT01137604|62665440|FG002|Overall Study|Adverse Event|9|||
33288732|NCT01137604|62665441|FG003|Overall Study|Adverse Event|9|||
33288733|NCT01137604|62665438|FG000|Overall Study|Participant Choice|0|||
33288734|NCT01137604|62665439|FG001|Overall Study|Participant Choice|2|||
33288735|NCT01137604|62665440|FG002|Overall Study|Participant Choice|2|||
33374534|NCT00824564|62753496|FG001|Overall Study|Lost to Follow-up|7|||
33374535|NCT00824564|62753495|FG000|Overall Study|Withdrawal by Subject|1|||
33374536|NCT00824564|62753496|FG001|Overall Study|Withdrawal by Subject|1|||
33486757|NCT00179621|62864693|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
33486758|NCT00179621|62864690|FG000|Double-Blind Period|Adverse Event|2|||
33288736|NCT01137604|62665441|FG003|Overall Study|Participant Choice|0|||
33288737|NCT01137604|62665438|FG000|Overall Study|Withdrawal of consent|0|||
33288738|NCT01137604|62665439|FG001|Overall Study|Withdrawal of consent|0|||
33486759|NCT00179621|62864691|FG001|Double-Blind Period|Adverse Event|7|||
33288739|NCT01137604|62665440|FG002|Overall Study|Withdrawal of consent|0|||
33374537|NCT00824564|62753495|FG000|Overall Study|Other|1|||
33374538|NCT00824564|62753496|FG001|Overall Study|Other|2|||
33374539|NCT00824564|62753495|FG000|Overall Study|Randomized, but not treated|1|||
33374540|NCT00824564|62753496|FG001|Overall Study|Randomized, but not treated|0|||
33374541|NCT00658528|62753504|FG000|Overall Study|Adverse Event|5|||
33374542|NCT00658528|62753505|FG001|Overall Study|Adverse Event|7|||
33374543|NCT00658528|62753504|FG000|Overall Study|Lost to Follow-up|14|||
33374544|NCT00658528|62753505|FG001|Overall Study|Lost to Follow-up|22|||
33374545|NCT00658528|62753504|FG000|Overall Study|Withdrawal by Subject|8|||
33374546|NCT00658528|62753505|FG001|Overall Study|Withdrawal by Subject|6|||
33374547|NCT00658528|62753504|FG000|Overall Study|Withdrawal of consent|5|||
33374548|NCT00658528|62753505|FG001|Overall Study|Withdrawal of consent|6|||
33288740|NCT01137604|62665441|FG003|Overall Study|Withdrawal of consent|2|||
33288741|NCT01137604|62665438|FG000|Overall Study|Clinical progression/deterioration|1|||
33288742|NCT01137604|62665439|FG001|Overall Study|Clinical progression/deterioration|2|||
33288743|NCT01137604|62665440|FG002|Overall Study|Clinical progression/deterioration|2|||
33288744|NCT01137604|62665441|FG003|Overall Study|Clinical progression/deterioration|0|||
33288745|NCT00198822|62665454|FG000|Overall Study|Lost to Follow-up|14|||
33288746|NCT00198822|62665455|FG001|Overall Study|Lost to Follow-up|20|||
33288747|NCT00198822|62665456|FG002|Overall Study|Lost to Follow-up|21|||
33374549|NCT00658528|62753504|FG000|Overall Study|Other|8|||
33374550|NCT00658528|62753505|FG001|Overall Study|Other|4|||
33374551|NCT00856583|62753513|FG000|Overall Study|Lack of Efficacy|389|||
33374552|NCT00856583|62753514|FG001|Overall Study|Lack of Efficacy|377|||
33374553|NCT00856583|62753513|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
33374554|NCT00856583|62753514|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
33288748|NCT01137292|62665464|FG000|Overall Study|Death|30|||
33288749|NCT01137292|62665464|FG000|Overall Study|Adverse Event|3|||
33288750|NCT01137292|62665464|FG000|Overall Study|Lack of Efficacy|13|||
33288751|NCT01137292|62665464|FG000|Overall Study|Lost to Follow-up|1|||
33288752|NCT01137292|62665464|FG000|Overall Study|Other|7|||
33288753|NCT00197496|62665470|FG000|Baseline to Discharge|not interested|1|||
33288754|NCT00197496|62665471|FG001|Baseline to Discharge|not interested|0|||
33288755|NCT00197496|62665470|FG000|Baseline to Discharge|MRSA|1|||
33288756|NCT00197496|62665471|FG001|Baseline to Discharge|MRSA|0|||
33288757|NCT00197496|62665470|FG000|Baseline to Discharge|Physician Decision|0|||
33288758|NCT00197496|62665471|FG001|Baseline to Discharge|Physician Decision|1|||
33288759|NCT00197496|62665470|FG000|Baseline to Discharge|Protocol Violation|0|||
33288760|NCT00197496|62665471|FG001|Baseline to Discharge|Protocol Violation|1|||
33288761|NCT00197496|62665470|FG000|Follow-up|Lost to Follow-up|2|||
33288762|NCT00197496|62665471|FG001|Follow-up|Lost to Follow-up|1|||
33288763|NCT00197145|62665479|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
33288764|NCT00197145|62665480|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
33374555|NCT00856583|62753513|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
33374556|NCT00856583|62753514|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
33374557|NCT00856583|62753513|FG000|Overall Study|Non-compliance|305|||
33374558|NCT00856583|62753514|FG001|Overall Study|Non-compliance|262|||
33374559|NCT00856583|62753513|FG000|Overall Study|Withdrawal by Subject|1092|||
33374560|NCT00856583|62753514|FG001|Overall Study|Withdrawal by Subject|919|||
33374561|NCT00856583|62753513|FG000|Overall Study|Physician Decision|59|||
33374562|NCT00856583|62753514|FG001|Overall Study|Physician Decision|82|||
33374563|NCT00856583|62753513|FG000|Overall Study|Pregnancy|14|||
33374564|NCT00856583|62753514|FG001|Overall Study|Pregnancy|5|||
33374565|NCT00856583|62753513|FG000|Overall Study|Other|92|||
33374566|NCT00856583|62753514|FG001|Overall Study|Other|104|||
33374567|NCT00856583|62753513|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
33374568|NCT00856583|62753514|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
33374569|NCT00856349|62753520|FG000|Overall Study|Death|418|||
33374570|NCT00856349|62753520|FG000|Overall Study|Withdrawal by Subject|116|||
33374571|NCT00856349|62753520|FG000|Overall Study|Lost to Follow-up|91|||
33374572|NCT00856349|62753520|FG000|Overall Study|Protocol Violation|38|||
33374573|NCT00856349|62753520|FG000|Overall Study|Physician Decision|13|||
33374574|NCT00856349|62753520|FG000|Overall Study|Subject relocation|104|||
33374575|NCT00856349|62753520|FG000|Overall Study|Device explant|33|||
33374576|NCT00856349|62753520|FG000|Overall Study|Site closure|78|||
33374577|NCT00856349|62753520|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
33556344|NCT04436822|62949234|FG000|Overall Study|Unsuccessful procedure|0|||
33374578|NCT00803244|62753528|FG000|Overall Study|Adverse Event|1|||
33374579|NCT00803244|62753529|FG001|Overall Study|Adverse Event|2|||
33556345|NCT04436822|62949235|FG001|Overall Study|Unsuccessful procedure|1|||
33288765|NCT00197145|62665479|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
33288766|NCT00197145|62665480|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
33288767|NCT00197145|62665479|FG000|Period 1: Randomized Treatment Phase|Other|2|||
33374580|NCT00803244|62753528|FG000|Overall Study|Withdrawal by Subject|2|||
33374581|NCT00803244|62753529|FG001|Overall Study|Withdrawal by Subject|3|||
33374582|NCT00803244|62753528|FG000|Overall Study|Any other reason not above-mentioned|4|||
33374583|NCT00803244|62753529|FG001|Overall Study|Any other reason not above-mentioned|10|||
33374584|NCT04060212|62753535|FG000|Overall Study|Withdrawal by Subject|7|||
33374585|NCT00804570|62753541|FG000|Overall Study|Adverse Event|14|||
33374586|NCT00804570|62753542|FG001|Overall Study|Adverse Event|7|||
33374587|NCT00804570|62753541|FG000|Overall Study|Lack of Efficacy|0|||
33374588|NCT00804570|62753542|FG001|Overall Study|Lack of Efficacy|1|||
33374589|NCT00804570|62753541|FG000|Overall Study|Lost to Follow-up|18|||
33374590|NCT00804570|62753542|FG001|Overall Study|Lost to Follow-up|21|||
33288768|NCT00197145|62665480|FG001|Period 1: Randomized Treatment Phase|Other|2|||
33288769|NCT00197145|62665479|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
33374591|NCT00804570|62753541|FG000|Overall Study|Entry criteria not met|5|||
33374592|NCT00804570|62753542|FG001|Overall Study|Entry criteria not met|5|||
33374593|NCT00804570|62753541|FG000|Overall Study|Protocol Violation|12|||
33374594|NCT00804570|62753542|FG001|Overall Study|Protocol Violation|16|||
33374595|NCT00804570|62753541|FG000|Overall Study|Physician Decision|1|||
33374596|NCT00804570|62753542|FG001|Overall Study|Physician Decision|2|||
33374597|NCT00804570|62753541|FG000|Overall Study|Sponsor decision|1|||
33374598|NCT00804570|62753542|FG001|Overall Study|Sponsor decision|4|||
33374599|NCT00804570|62753541|FG000|Overall Study|Withdrawal by Subject|21|||
33374600|NCT00804570|62753542|FG001|Overall Study|Withdrawal by Subject|38|||
33374601|NCT00824408|62753554|FG000|Run-in Phase|Progressive disease|4|||
33374602|NCT00824408|62753555|FG001|Run-in Phase|Progressive disease|4|||
33374603|NCT00824408|62753556|FG002|Run-in Phase|Progressive disease|0|||
33374604|NCT00824408|62753557|FG003|Run-in Phase|Progressive disease|0|||
33374605|NCT00824408|62753558|FG004|Run-in Phase|Progressive disease|0|||
33374606|NCT00824408|62753554|FG000|Run-in Phase|Adverse Event|1|||
33374607|NCT00824408|62753555|FG001|Run-in Phase|Adverse Event|1|||
33374608|NCT00824408|62753556|FG002|Run-in Phase|Adverse Event|0|||
33374609|NCT00824408|62753557|FG003|Run-in Phase|Adverse Event|0|||
33374610|NCT00824408|62753558|FG004|Run-in Phase|Adverse Event|0|||
33374611|NCT00824408|62753554|FG000|Run-in Phase|Refused to continue medication|1|||
33374612|NCT00824408|62753555|FG001|Run-in Phase|Refused to continue medication|0|||
33374613|NCT00824408|62753556|FG002|Run-in Phase|Refused to continue medication|0|||
33374614|NCT00824408|62753557|FG003|Run-in Phase|Refused to continue medication|0|||
33288770|NCT00197145|62665480|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
33288771|NCT00197145|62665479|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
33288772|NCT00197145|62665480|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
33374615|NCT00824408|62753558|FG004|Run-in Phase|Refused to continue medication|0|||
33374616|NCT00824408|62753554|FG000|Run-in Phase|Other reason not defined above|0|||
33374617|NCT00824408|62753555|FG001|Run-in Phase|Other reason not defined above|1|||
33374618|NCT00824408|62753556|FG002|Run-in Phase|Other reason not defined above|0|||
33374619|NCT00824408|62753557|FG003|Run-in Phase|Other reason not defined above|0|||
33374620|NCT00824408|62753558|FG004|Run-in Phase|Other reason not defined above|0|||
33374621|NCT00824408|62753554|FG000|Randomized Phase|Not treated|0|||
33374622|NCT00824408|62753555|FG001|Randomized Phase|Not treated|0|||
33288773|NCT00197145|62665479|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
33288774|NCT00197145|62665480|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
33288775|NCT00197145|62665479|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
33288776|NCT00197145|62665480|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
33288777|NCT00197145|62665479|FG000|Period 2 : Open Label Phase|Other|1|||
33288778|NCT00197145|62665480|FG001|Period 2 : Open Label Phase|Other|0|||
33288779|NCT01136785|62665489|FG000|Overall Study|Protocol Violation|2|||
33288780|NCT01136785|62665490|FG001|Overall Study|Protocol Violation|1|||
33288781|NCT00197106|62665502|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
33288782|NCT00197106|62665503|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
33288783|NCT00197106|62665504|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
33288784|NCT00197106|62665502|FG000|Overall Treatment Period|Lack of Efficacy|0|||
33288785|NCT00197106|62665503|FG001|Overall Treatment Period|Lack of Efficacy|1|||
33288786|NCT00197106|62665504|FG002|Overall Treatment Period|Lack of Efficacy|0|||
33288787|NCT00197106|62665502|FG000|Overall Treatment Period|Lost to Follow-up|0|||
33288788|NCT00197106|62665503|FG001|Overall Treatment Period|Lost to Follow-up|0|||
33288789|NCT00197106|62665504|FG002|Overall Treatment Period|Lost to Follow-up|2|||
33288790|NCT00197106|62665502|FG000|Overall Treatment Period|Protocol Violation|0|||
33288791|NCT00197106|62665503|FG001|Overall Treatment Period|Protocol Violation|0|||
33288792|NCT00197106|62665504|FG002|Overall Treatment Period|Protocol Violation|2|||
33288793|NCT00197106|62665502|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
33288794|NCT00197106|62665503|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
33288795|NCT00197106|62665504|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
33374623|NCT00824408|62753556|FG002|Randomized Phase|Not treated|1|||
33374624|NCT00824408|62753557|FG003|Randomized Phase|Not treated|1|||
33374625|NCT00824408|62753558|FG004|Randomized Phase|Not treated|1|||
33374626|NCT00824408|62753554|FG000|Randomized Phase|Progressive disease|0|||
33556346|NCT04436822|62949234|FG000|Overall Study|Withdrawal due to Covid-19|8|||
33288796|NCT01136746|62665512|FG000|Overall Study|Lost to Follow-up|0|||
33374627|NCT00824408|62753555|FG001|Randomized Phase|Progressive disease|0|||
33374628|NCT00824408|62753556|FG002|Randomized Phase|Progressive disease|25|||
33374629|NCT00824408|62753557|FG003|Randomized Phase|Progressive disease|36|||
33374630|NCT00824408|62753558|FG004|Randomized Phase|Progressive disease|34|||
33374631|NCT00824408|62753554|FG000|Randomized Phase|Adverse Event|0|||
33374632|NCT00824408|62753555|FG001|Randomized Phase|Adverse Event|0|||
33288797|NCT01136746|62665513|FG001|Overall Study|Lost to Follow-up|2|||
33288798|NCT01136746|62665512|FG000|Overall Study|Protocol Violation|2|||
33288799|NCT01136746|62665513|FG001|Overall Study|Protocol Violation|1|||
33288800|NCT01136746|62665512|FG000|Overall Study|Death|1|||
33288801|NCT01136746|62665513|FG001|Overall Study|Death|0|||
33288802|NCT01136356|62665519|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
33288803|NCT01136356|62665520|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
33288804|NCT01136356|62665519|FG000|First 18-day Withdrawal|Physician Decision|1|||
33288805|NCT01136356|62665520|FG001|First 18-day Withdrawal|Physician Decision|0|||
33288806|NCT01136356|62665519|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
33288807|NCT01136356|62665520|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
33288808|NCT00196326|62665525|FG000|Overall Study|Did not meet protocol requirements|64|||
33288809|NCT00196326|62665525|FG000|Overall Study|Non-compliance with the protocol|81|||
33288810|NCT00196326|62665525|FG000|Overall Study|Physician Decision|3|||
33288811|NCT00196326|62665525|FG000|Overall Study|Withdrawal by Subject|225|||
33288812|NCT00196326|62665525|FG000|Overall Study|Adverse Event|253|||
33288813|NCT00196326|62665525|FG000|Overall Study|Pregnancy|34|||
33288814|NCT00196326|62665525|FG000|Overall Study|Lost to Follow-up|304|||
33288815|NCT00196326|62665525|FG000|Overall Study|Other|22|||
33288816|NCT00195663|62665532|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
33288817|NCT00195663|62665533|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
33288818|NCT00195663|62665534|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
33288819|NCT00195663|62665532|FG000|2-year Double-blind Treatment Period|Death|0|||
33288820|NCT00195663|62665533|FG001|2-year Double-blind Treatment Period|Death|2|||
33288821|NCT00195663|62665534|FG002|2-year Double-blind Treatment Period|Death|0|||
33288822|NCT00195663|62665532|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
33288823|NCT00195663|62665533|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
33288824|NCT00195663|62665534|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
33288825|NCT00195663|62665532|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
33288826|NCT00195663|62665533|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
33288827|NCT00195663|62665534|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
33662271|NCT01695239|63092839|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33662272|NCT01695239|63092840|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33662273|NCT01695239|63092841|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
33662274|NCT01695239|63092842|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
33662275|NCT01695239|63092843|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33662276|NCT01695239|63092844|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33662277|NCT01695239|63092845|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33662278|NCT01695239|63092846|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33288828|NCT00195663|62665532|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
33374633|NCT00824408|62753556|FG002|Randomized Phase|Adverse Event|4|||
33374634|NCT00824408|62753557|FG003|Randomized Phase|Adverse Event|5|||
33662279|NCT01695239|63092833|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
33662280|NCT01695239|63092834|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
33662281|NCT01695239|63092835|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
33662282|NCT01695239|63092836|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
33662283|NCT01695239|63092837|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
33662284|NCT01695239|63092838|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
33662285|NCT01695239|63092839|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
33662286|NCT01695239|63092840|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
33662287|NCT01695239|63092841|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
33662288|NCT01695239|63092842|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
33662289|NCT01695239|63092843|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
33662290|NCT01695239|63092844|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
33662291|NCT01695239|63092845|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
33662292|NCT01695239|63092846|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
33662293|NCT01695239|63092833|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33662294|NCT01695239|63092834|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33662295|NCT01695239|63092835|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33662296|NCT01695239|63092836|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33662297|NCT01695239|63092837|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33662298|NCT01695239|63092838|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33662299|NCT01695239|63092839|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33662300|NCT01695239|63092840|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33288829|NCT00195663|62665533|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
33288830|NCT00195663|62665534|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
33288831|NCT00195663|62665532|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
33374635|NCT00824408|62753558|FG004|Randomized Phase|Adverse Event|5|||
33288832|NCT00195663|62665533|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
33374636|NCT00824408|62753554|FG000|Randomized Phase|Refused to continue medication|0|||
33374637|NCT00824408|62753555|FG001|Randomized Phase|Refused to continue medication|0|||
33374638|NCT00824408|62753556|FG002|Randomized Phase|Refused to continue medication|2|||
33374639|NCT00824408|62753557|FG003|Randomized Phase|Refused to continue medication|2|||
33374640|NCT00824408|62753558|FG004|Randomized Phase|Refused to continue medication|2|||
33374641|NCT00824408|62753554|FG000|Randomized Phase|Other reason not defined above|0|||
33374642|NCT00824408|62753555|FG001|Randomized Phase|Other reason not defined above|0|||
33374643|NCT00824408|62753556|FG002|Randomized Phase|Other reason not defined above|4|||
33374644|NCT00824408|62753557|FG003|Randomized Phase|Other reason not defined above|2|||
33374645|NCT00824408|62753558|FG004|Randomized Phase|Other reason not defined above|4|||
33374646|NCT00866333|62753579|FG000|Overall Study|Withdrawal of consent|0|||
33374647|NCT00866333|62753580|FG001|Overall Study|Withdrawal of consent|1|||
33374648|NCT00866333|62753581|FG002|Overall Study|Withdrawal of consent|2|||
33374649|NCT00866333|62753579|FG000|Overall Study|Reason not Specified|3|||
33374650|NCT00866333|62753580|FG001|Overall Study|Reason not Specified|1|||
33374651|NCT00866333|62753581|FG002|Overall Study|Reason not Specified|1|||
33374652|NCT00866333|62753579|FG000|Overall Study|Study Terminated by Sponsor|2|||
33374653|NCT00866333|62753580|FG001|Overall Study|Study Terminated by Sponsor|5|||
33288833|NCT00195663|62665534|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
33288834|NCT00195663|62665532|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
33374654|NCT00866333|62753581|FG002|Overall Study|Study Terminated by Sponsor|9|||
33374655|NCT00834080|62753589|FG000|Overall Study|Adverse Event|7|||
33374656|NCT00834080|62753589|FG000|Overall Study|Lost to Follow-up|7|||
33374657|NCT00834080|62753589|FG000|Overall Study|Withdrawal by Subject|5|||
33374658|NCT00834080|62753589|FG000|Overall Study|Other - Pregnancy|1|||
33374659|NCT00834080|62753589|FG000|Overall Study|Other - False positive tests of the UDS|1|||
33288835|NCT00195663|62665533|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
33288836|NCT00195663|62665534|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
33288837|NCT00195663|62665532|FG000|2-year Double-blind Treatment Period|Recovery|1|||
33288838|NCT00195663|62665533|FG001|2-year Double-blind Treatment Period|Recovery|0|||
33288839|NCT00195663|62665534|FG002|2-year Double-blind Treatment Period|Recovery|1|||
33288840|NCT00195663|62665532|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
33288841|NCT00195663|62665533|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
33288842|NCT00195663|62665534|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
33288843|NCT00195663|62665532|FG000|Open-Label Extension Period|Adverse Event|21|||
33288844|NCT00195663|62665533|FG001|Open-Label Extension Period|Adverse Event|32|||
33288845|NCT00195663|62665534|FG002|Open-Label Extension Period|Adverse Event|36|||
33288846|NCT00195663|62665532|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
33288847|NCT00195663|62665533|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
33288848|NCT00195663|62665534|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
33288849|NCT00195663|62665532|FG000|Open-Label Extension Period|Recovery|0|||
33288850|NCT00195663|62665533|FG001|Open-Label Extension Period|Recovery|2|||
33288851|NCT00195663|62665534|FG002|Open-Label Extension Period|Recovery|2|||
33288852|NCT00195663|62665532|FG000|Open-Label Extension Period|Protocol Violation|3|||
33288853|NCT00195663|62665533|FG001|Open-Label Extension Period|Protocol Violation|4|||
33288854|NCT00195663|62665534|FG002|Open-Label Extension Period|Protocol Violation|4|||
33288855|NCT00195663|62665532|FG000|Open-Label Extension Period|Death|2|||
33288856|NCT00195663|62665533|FG001|Open-Label Extension Period|Death|2|||
33288857|NCT00195663|62665534|FG002|Open-Label Extension Period|Death|2|||
33288858|NCT00195663|62665532|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
33288859|NCT00195663|62665533|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
33288860|NCT00195663|62665534|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
33288861|NCT00195663|62665532|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
33288862|NCT00195663|62665533|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
33288863|NCT00195663|62665534|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
33288864|NCT00195663|62665532|FG000|Open-Label Extension Period|Administrative reasons|11|||
33288865|NCT00195663|62665533|FG001|Open-Label Extension Period|Administrative reasons|11|||
33288866|NCT00195663|62665534|FG002|Open-Label Extension Period|Administrative reasons|13|||
33288867|NCT01135498|62665552|FG000|Overall Study|Adverse Event|20|||
33288868|NCT01135498|62665552|FG000|Overall Study|Progressive disease|38|||
33288869|NCT01135498|62665552|FG000|Overall Study|Investigator judgement|25|||
33288870|NCT01135498|62665552|FG000|Overall Study|Withdrawal by Subject|4|||
33288871|NCT01135498|62665552|FG000|Overall Study|Death|1|||
33288872|NCT01135498|62665552|FG000|Overall Study|Ongoing at time of analysis|2|||
33288873|NCT00195507|62665559|FG000|Overall Study|Adverse Event|24|||
33288874|NCT00195507|62665560|FG001|Overall Study|Adverse Event|13|||
33374660|NCT00834080|62753589|FG000|Overall Study|Physician Decision|1|||
33288875|NCT00195507|62665559|FG000|Overall Study|Death|0|||
33288876|NCT00195507|62665560|FG001|Overall Study|Death|1|||
33374661|NCT00834080|62753589|FG000|Overall Study|Subject Relocated|1|||
33374662|NCT00823472|62753595|FG000|Overall Study|Physician Decision|24|||
33374663|NCT00823472|62753596|FG001|Overall Study|Physician Decision|28|||
33374664|NCT00856193|62753602|FG000|Period 2|Abnormal test procedure results|0|||
33374665|NCT00856193|62753603|FG001|Period 2|Abnormal test procedure results|1|||
33374666|NCT00856193|62753602|FG000|Period 2|Lost to Follow-up|0|||
33374667|NCT00856193|62753603|FG001|Period 2|Lost to Follow-up|1|||
33374668|NCT00652366|62753614|FG000|Overall Study|Adverse Event|8|||
33374669|NCT00652366|62753615|FG001|Overall Study|Adverse Event|4|||
33374670|NCT00652366|62753616|FG002|Overall Study|Adverse Event|7|||
33374671|NCT00652366|62753617|FG003|Overall Study|Adverse Event|17|||
33374672|NCT00652366|62753618|FG004|Overall Study|Adverse Event|13|||
33374673|NCT00652366|62753614|FG000|Overall Study|Death|5|||
33374674|NCT00652366|62753615|FG001|Overall Study|Death|4|||
33374675|NCT00652366|62753616|FG002|Overall Study|Death|1|||
33374676|NCT00652366|62753617|FG003|Overall Study|Death|8|||
33374677|NCT00652366|62753618|FG004|Overall Study|Death|5|||
33374678|NCT00652366|62753614|FG000|Overall Study|Lack of Efficacy|84|||
33374679|NCT00652366|62753615|FG001|Overall Study|Lack of Efficacy|58|||
33374680|NCT00652366|62753616|FG002|Overall Study|Lack of Efficacy|53|||
33374681|NCT00652366|62753617|FG003|Overall Study|Lack of Efficacy|133|||
33288877|NCT00195507|62665559|FG000|Overall Study|Failed to Return|4|||
33288878|NCT00195507|62665560|FG001|Overall Study|Failed to Return|3|||
33288879|NCT00195507|62665559|FG000|Overall Study|Physician Decision|1|||
33288880|NCT00195507|62665560|FG001|Overall Study|Physician Decision|2|||
33288881|NCT00195507|62665559|FG000|Overall Study|Lost to Follow-up|3|||
33288882|NCT00195507|62665560|FG001|Overall Study|Lost to Follow-up|2|||
33288883|NCT00195507|62665559|FG000|Overall Study|Protocol Violation|5|||
33288884|NCT00195507|62665560|FG001|Overall Study|Protocol Violation|4|||
33288885|NCT00195507|62665559|FG000|Overall Study|Lack of Efficacy|40|||
33288886|NCT00195507|62665560|FG001|Overall Study|Lack of Efficacy|67|||
33288887|NCT00195507|62665559|FG000|Overall Study|Withdrawal by Subject|16|||
33288888|NCT00195507|62665560|FG001|Overall Study|Withdrawal by Subject|23|||
33288889|NCT00195507|62665559|FG000|Overall Study|Protocol Deviation|6|||
33288890|NCT00195507|62665560|FG001|Overall Study|Protocol Deviation|3|||
33288891|NCT01134562|62665571|FG000|Overall Study|Adverse Event|0|||
33288892|NCT01134562|62665572|FG001|Overall Study|Adverse Event|1|||
33288893|NCT01134562|62665573|FG002|Overall Study|Adverse Event|0|||
33288894|NCT01134562|62665574|FG003|Overall Study|Adverse Event|0|||
33288895|NCT01134562|62665575|FG004|Overall Study|Adverse Event|0|||
33288896|NCT00195429|62665602|FG000|Overall Study|Adverse Event|2|||
33288897|NCT00195429|62665603|FG001|Overall Study|Adverse Event|4|||
33288898|NCT00195429|62665602|FG000|Overall Study|Lack of Efficacy|2|||
33288899|NCT00195429|62665603|FG001|Overall Study|Lack of Efficacy|1|||
33288900|NCT00195429|62665602|FG000|Overall Study|Lost to Follow-up|1|||
33374682|NCT00652366|62753618|FG004|Overall Study|Lack of Efficacy|13|||
33374683|NCT00652366|62753614|FG000|Overall Study|Violation of Selection Criteria|0|||
33374684|NCT00652366|62753615|FG001|Overall Study|Violation of Selection Criteria|0|||
33374685|NCT00652366|62753616|FG002|Overall Study|Violation of Selection Criteria|1|||
33374686|NCT00652366|62753617|FG003|Overall Study|Violation of Selection Criteria|0|||
33374687|NCT00652366|62753618|FG004|Overall Study|Violation of Selection Criteria|0|||
33374688|NCT00652366|62753614|FG000|Overall Study|Protocol Violation|1|||
33374689|NCT00652366|62753615|FG001|Overall Study|Protocol Violation|0|||
33374690|NCT00652366|62753616|FG002|Overall Study|Protocol Violation|0|||
33374691|NCT00652366|62753617|FG003|Overall Study|Protocol Violation|0|||
33374692|NCT00652366|62753618|FG004|Overall Study|Protocol Violation|0|||
33374693|NCT00652366|62753614|FG000|Overall Study|Refused treatment|3|||
33374694|NCT00652366|62753615|FG001|Overall Study|Refused treatment|7|||
33374695|NCT00652366|62753616|FG002|Overall Study|Refused treatment|6|||
33374696|NCT00652366|62753617|FG003|Overall Study|Refused treatment|17|||
33374697|NCT00652366|62753618|FG004|Overall Study|Refused treatment|5|||
33374698|NCT00652366|62753614|FG000|Overall Study|Other|5|||
33374699|NCT00652366|62753615|FG001|Overall Study|Other|2|||
33374700|NCT00652366|62753616|FG002|Overall Study|Other|3|||
33374701|NCT00652366|62753617|FG003|Overall Study|Other|4|||
33486760|NCT00179621|62864692|FG002|Double-Blind Period|Adverse Event|4|||
33486761|NCT00179621|62864693|FG003|Double-Blind Period|Adverse Event|0|||
33486762|NCT00179621|62864690|FG000|Double-Blind Period|Withdrawal by Subject|2|||
33288901|NCT00195429|62665603|FG001|Overall Study|Lost to Follow-up|0|||
33374702|NCT00652366|62753618|FG004|Overall Study|Other|0|||
33374703|NCT00841568|62753632|FG000|Overall Study|Adverse Event|1|||
33288902|NCT00195351|62665611|FG000|Overall Study|Lost to Follow-up|9|||
33288903|NCT00195351|62665612|FG001|Overall Study|Lost to Follow-up|9|||
33288904|NCT00195351|62665611|FG000|Overall Study|Withdrawal by Subject|6|||
33288905|NCT00195351|62665612|FG001|Overall Study|Withdrawal by Subject|3|||
33288906|NCT00195351|62665611|FG000|Overall Study|Protocol Deviation|3|||
33374704|NCT00841568|62753632|FG000|Overall Study|Death|1|||
33374705|NCT00841568|62753632|FG000|Overall Study|Withdrawal by Subject|2|||
33374706|NCT00841568|62753632|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
33374707|NCT00855959|62753640|FG000|Overall Study|Adverse Event|2|||
33374708|NCT00855959|62753640|FG000|Overall Study|Lost to Follow-up|2|||
33374709|NCT00855959|62753640|FG000|Overall Study|Withdrawal by Subject|3|||
33374710|NCT00855959|62753640|FG000|Overall Study|Pregnancy|1|||
33374711|NCT00855959|62753640|FG000|Overall Study|Incorrect enrolment|1|||
33374712|NCT00841100|62753644|FG000|Phase 1 (28 Days)|Adverse Event|1|||
33374713|NCT00841100|62753644|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
33374714|NCT00651820|62753648|FG000|Overall Study|Lost to Follow-up|2|||
33374715|NCT00866177|62753654|FG000|Overall Study|Withdrawal by Subject|1|||
33374716|NCT00866177|62753654|FG000|Overall Study|Not Treated|151|||
33374717|NCT00833924|62753658|FG000|Overall Study|Death|21|||
33374718|NCT00833924|62753658|FG000|Overall Study|Conversion|2|||
33374719|NCT00833924|62753658|FG000|Overall Study|Lost to Follow-up|2|||
33374720|NCT00833924|62753658|FG000|Overall Study|Withdrawal by Subject|13|||
33374721|NCT00833924|62753658|FG000|Overall Study|In study follow-up|71|||
33374722|NCT00840086|62753662|FG000|Overall Study|Adverse Event|1|||
33374723|NCT00840086|62753662|FG000|Overall Study|Protocol Violation|2|||
33374724|NCT00840086|62753662|FG000|Overall Study|Lost to Follow-up|1|||
33374725|NCT00822926|62753671|FG000|Second Injection Visit|Lost to Follow-up|1|||
33374726|NCT00822926|62753672|FG001|Second Injection Visit|Lost to Follow-up|0|||
33374727|NCT00822926|62753671|FG000|Second Injection Visit|Withdrawal by Subject|0|||
33374728|NCT00822926|62753672|FG001|Second Injection Visit|Withdrawal by Subject|1|||
33374729|NCT00822770|62753683|FG000|Overall Study|Not treated|1|||
33374730|NCT00822770|62753684|FG001|Overall Study|Not treated|0|||
33374731|NCT00822770|62753683|FG000|Overall Study|Complication/Incomplete treatment|1|||
33374732|NCT00822770|62753684|FG001|Overall Study|Complication/Incomplete treatment|0|||
33374733|NCT00822770|62753683|FG000|Overall Study|Death|1|||
33374734|NCT00822770|62753684|FG001|Overall Study|Death|1|||
33374735|NCT02842086|62753692|FG000|Overall Study|Randomized but Never Treated|6|||
33374736|NCT02842086|62753693|FG001|Overall Study|Randomized but Never Treated|6|||
33374737|NCT02842086|62753692|FG000|Overall Study|Still in Double-Blind Phase|7|||
33374738|NCT02842086|62753693|FG001|Overall Study|Still in Double-Blind Phase|3|||
33374739|NCT02842086|62753692|FG000|Overall Study|Adverse Event|18|||
33374740|NCT02842086|62753693|FG001|Overall Study|Adverse Event|20|||
33374741|NCT02842086|62753692|FG000|Overall Study|Death|3|||
33374742|NCT02842086|62753693|FG001|Overall Study|Death|3|||
33374743|NCT02842086|62753692|FG000|Overall Study|Investigator's Discretion|9|||
33374744|NCT02842086|62753693|FG001|Overall Study|Investigator's Discretion|13|||
33374745|NCT02842086|62753692|FG000|Overall Study|Non-Compliance with Study Drug|9|||
33374746|NCT02842086|62753693|FG001|Overall Study|Non-Compliance with Study Drug|8|||
33374747|NCT02842086|62753692|FG000|Overall Study|Protocol Violation|8|||
33374748|NCT02842086|62753693|FG001|Overall Study|Protocol Violation|4|||
33374749|NCT02842086|62753692|FG000|Overall Study|Withdrew Consent|205|||
33374750|NCT02842086|62753693|FG001|Overall Study|Withdrew Consent|194|||
33374751|NCT02842086|62753692|FG000|Overall Study|Lost to Follow-up|274|||
33374752|NCT02842086|62753693|FG001|Overall Study|Lost to Follow-up|236|||
33374753|NCT02842086|62753692|FG000|Overall Study|HIV-1 Infection|5|||
33374754|NCT02842086|62753693|FG001|Overall Study|HIV-1 Infection|6|||
33374755|NCT00822692|62753701|FG000|Overall Study|Lost to Follow-up|17|||
33374756|NCT00822692|62753702|FG001|Overall Study|Lost to Follow-up|25|||
33486763|NCT00179621|62864691|FG001|Double-Blind Period|Withdrawal by Subject|1|||
33486764|NCT00179621|62864692|FG002|Double-Blind Period|Withdrawal by Subject|3|||
33288907|NCT00195351|62665612|FG001|Overall Study|Protocol Deviation|2|||
33288908|NCT00195351|62665611|FG000|Overall Study|Death|3|||
33288909|NCT00195351|62665612|FG001|Overall Study|Death|1|||
33288910|NCT00195351|62665611|FG000|Overall Study|Lack of Efficacy|0|||
33288911|NCT00195351|62665612|FG001|Overall Study|Lack of Efficacy|1|||
33288912|NCT00195273|62665620|FG000|Overall Study|Adverse Event|9|||
33288913|NCT00195273|62665621|FG001|Overall Study|Adverse Event|9|||
33288914|NCT00195273|62665620|FG000|Overall Study|Protocol deviation|0|||
33288915|NCT00195273|62665621|FG001|Overall Study|Protocol deviation|1|||
33288916|NCT00195273|62665620|FG000|Overall Study|Lack of Efficacy|3|||
33288917|NCT00195273|62665621|FG001|Overall Study|Lack of Efficacy|1|||
33288918|NCT00195273|62665620|FG000|Overall Study|Procedural complications|9|||
33288919|NCT00195273|62665621|FG001|Overall Study|Procedural complications|3|||
33288920|NCT00193479|62665627|FG000|Induction Chemotherapy|Adverse Event|2|||
33288921|NCT00193479|62665627|FG000|Induction Chemotherapy|Disease Progression|1|||
33288922|NCT00193479|62665627|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
33374757|NCT00806442|62753708|FG000|Overall Study|Lost to Follow-up|3|||
33374758|NCT00806442|62753709|FG001|Overall Study|Lost to Follow-up|2|||
33374759|NCT00806442|62753708|FG000|Overall Study|Withdrawal by Subject|1|||
33374760|NCT00806442|62753709|FG001|Overall Study|Withdrawal by Subject|5|||
33374761|NCT00821678|62753719|FG000|Overall Study|Withdrawal by Subject|8|||
33374762|NCT00821678|62753720|FG001|Overall Study|Withdrawal by Subject|0|||
33374763|NCT00821678|62753719|FG000|Overall Study|Lost to Follow-up|13|||
33374764|NCT00821678|62753720|FG001|Overall Study|Lost to Follow-up|12|||
33374765|NCT00821678|62753719|FG000|Overall Study|Death|0|||
33374766|NCT00821678|62753720|FG001|Overall Study|Death|2|||
33374767|NCT00839852|62753728|FG000|Overall Study|Adverse Event|10|||
33288923|NCT00193479|62665627|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
33486765|NCT00179621|62864693|FG003|Double-Blind Period|Withdrawal by Subject|0|||
33288924|NCT00193206|62665631|FG000|Preoperative Therapy|Lack of Efficacy|2|||
33486766|NCT00179621|62864690|FG000|Double-Blind Period|Death|0|||
33288925|NCT00193206|62665631|FG000|Preoperative Therapy|Adverse Event|2|||
33288926|NCT00193206|62665631|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
33288927|NCT00193206|62665631|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
33288928|NCT00193206|62665631|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
33288929|NCT00193206|62665631|FG000|Postoperative Therapy|Physician Decision|3|||
33374768|NCT00839852|62753728|FG000|Overall Study|Insufficient Therapeutic Response|3|||
33374769|NCT00839852|62753728|FG000|Overall Study|Protocol Violation|9|||
33374770|NCT00839852|62753728|FG000|Overall Study|Withdrawal of Consent|16|||
33374771|NCT00839852|62753728|FG000|Overall Study|Lost to Follow-up|7|||
33374772|NCT00839852|62753728|FG000|Overall Study|Lack of Compliance While in Jail|1|||
33374773|NCT00839852|62753728|FG000|Overall Study|Pregnancy|1|||
33374774|NCT00833690|62753735|FG000|Overall Study|Withdrawal by Subject|1|||
33374775|NCT00833690|62753736|FG001|Overall Study|Withdrawal by Subject|0|||
33374776|NCT00833690|62753737|FG002|Overall Study|Withdrawal by Subject|0|||
33374777|NCT00833690|62753735|FG000|Overall Study|Discontinued study drug|3|||
33374778|NCT00833690|62753736|FG001|Overall Study|Discontinued study drug|2|||
33374779|NCT00833690|62753737|FG002|Overall Study|Discontinued study drug|0|||
33374780|NCT00820898|62753745|FG000|Overall Study|Inelgible - wrong primary site|1|||
33374781|NCT00865709|62753757|FG000|Treatment|Adverse Event|9|||
33374782|NCT00865709|62753758|FG001|Treatment|Adverse Event|6|||
33374783|NCT00865709|62753757|FG000|Treatment|Withdrawal by Subject|10|||
33374784|NCT00865709|62753758|FG001|Treatment|Withdrawal by Subject|7|||
33288930|NCT00193206|62665631|FG000|Postoperative Therapy|Intercurrent Illness|2|||
33288931|NCT00193206|62665631|FG000|Postoperative Therapy|Lack of Efficacy|1|||
33288932|NCT00193206|62665631|FG000|Postoperative Therapy|Protocol Violation|1|||
33288933|NCT00193050|62665635|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
33288934|NCT00193050|62665635|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
33288935|NCT00193050|62665635|FG000|Neoadjuvant Treatment|Physician Decision|2|||
33288936|NCT00193050|62665635|FG000|Neoadjuvant Treatment|Adverse Event|2|||
33288937|NCT00193050|62665635|FG000|Adjuvant|Physician Decision|5|||
33288938|NCT00193050|62665635|FG000|Adjuvant|Intercurrent Hospitalization|3|||
33288939|NCT00193050|62665635|FG000|Adjuvant|Lack of Efficacy|2|||
33288940|NCT00192504|62665644|FG000|Overall Study|Lost to Follow-up|1|||
33288941|NCT00192504|62665645|FG001|Overall Study|Lost to Follow-up|0|||
33288942|NCT00192504|62665646|FG002|Overall Study|Lost to Follow-up|0|||
33288943|NCT00192504|62665647|FG003|Overall Study|Lost to Follow-up|0|||
33288944|NCT00192504|62665644|FG000|Overall Study|Dosing window missed|0|||
33288945|NCT00192504|62665645|FG001|Overall Study|Dosing window missed|0|||
33288946|NCT00192504|62665646|FG002|Overall Study|Dosing window missed|1|||
33288947|NCT00192504|62665647|FG003|Overall Study|Dosing window missed|0|||
33288948|NCT00192114|62665657|FG000|Overall Study|Objective Tumor Progression|19|||
33288949|NCT00192114|62665657|FG000|Overall Study|Adverse Event|2|||
33288950|NCT00192114|62665657|FG000|Overall Study|Clinical Progression|2|||
33288951|NCT00192114|62665657|FG000|Overall Study|Death|1|||
33288952|NCT00192075|62665663|FG000|Overall Study|Disease Progression|23|||
33288953|NCT00192075|62665664|FG001|Overall Study|Disease Progression|6|||
33288954|NCT00192075|62665663|FG000|Overall Study|Adverse Event|1|||
33288955|NCT00192075|62665664|FG001|Overall Study|Adverse Event|3|||
33288956|NCT00192075|62665663|FG000|Overall Study|Death|0|||
33288957|NCT00192075|62665664|FG001|Overall Study|Death|1|||
33288958|NCT00192075|62665663|FG000|Overall Study|Lack of Efficacy|0|||
33288959|NCT00192075|62665664|FG001|Overall Study|Lack of Efficacy|0|||
33288960|NCT00192075|62665663|FG000|Overall Study|Physician Decision|3|||
33288961|NCT00192075|62665664|FG001|Overall Study|Physician Decision|0|||
33288962|NCT00192075|62665663|FG000|Overall Study|Withdrawal by Subject|5|||
33288963|NCT00192075|62665664|FG001|Overall Study|Withdrawal by Subject|5|||
33288964|NCT00192075|62665663|FG000|Overall Study|Patient Non-Compliance|0|||
33288965|NCT00192075|62665664|FG001|Overall Study|Patient Non-Compliance|1|||
33288966|NCT00192075|62665663|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
33288967|NCT00192075|62665664|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
33288968|NCT00192075|62665663|FG000|Overall Study|Other|5|||
33288969|NCT00192075|62665664|FG001|Overall Study|Other|2|||
33288970|NCT00192036|62665675|FG000|Overall Study|Protocol Violation|3|||
33288971|NCT00192036|62665675|FG000|Overall Study|Adverse Event|6|||
33374785|NCT00865709|62753757|FG000|Treatment|Physician Decision|3|||
33374786|NCT00865709|62753758|FG001|Treatment|Physician Decision|2|||
33288972|NCT00192036|62665675|FG000|Overall Study|Patient/Physician Perception|1|||
33288973|NCT00192036|62665675|FG000|Overall Study|Objective Tumor Progression|4|||
33288974|NCT00192036|62665675|FG000|Overall Study|Clinical Disease Progression|1|||
33374787|NCT00865709|62753757|FG000|Treatment|Surgery|8|||
33288975|NCT00192036|62665675|FG000|Overall Study|Death|1|||
33288976|NCT00192036|62665675|FG000|Overall Study|Unknown or Not Specified|5|||
33288977|NCT00191724|62665684|FG000|Overall Study|Adverse Event|0|||
33288978|NCT00191724|62665685|FG001|Overall Study|Adverse Event|0|||
33288979|NCT00191724|62665686|FG002|Overall Study|Adverse Event|1|||
33288980|NCT00191724|62665687|FG003|Overall Study|Adverse Event|0|||
33288981|NCT00191724|62665688|FG004|Overall Study|Adverse Event|0|||
33288982|NCT00191724|62665684|FG000|Overall Study|Lost to Follow-up|1|||
33288983|NCT00191724|62665685|FG001|Overall Study|Lost to Follow-up|1|||
33288984|NCT00191724|62665686|FG002|Overall Study|Lost to Follow-up|0|||
33288985|NCT00191724|62665687|FG003|Overall Study|Lost to Follow-up|2|||
33288986|NCT00191724|62665688|FG004|Overall Study|Lost to Follow-up|3|||
33288987|NCT00191724|62665684|FG000|Overall Study|Withdrawal by Subject|0|||
33288988|NCT00191724|62665685|FG001|Overall Study|Withdrawal by Subject|0|||
33288989|NCT00191724|62665686|FG002|Overall Study|Withdrawal by Subject|0|||
33288990|NCT00191724|62665687|FG003|Overall Study|Withdrawal by Subject|1|||
33288991|NCT00191724|62665688|FG004|Overall Study|Withdrawal by Subject|0|||
33288992|NCT00191646|62665702|FG000|Overall Study|Toxicity|26|||
33374788|NCT00865709|62753758|FG001|Treatment|Surgery|3|||
33374789|NCT00839306|62753768|FG000|Overall Study|Adverse Event|3|||
33288993|NCT00191646|62665703|FG001|Overall Study|Toxicity|37|||
33288994|NCT00191646|62665702|FG000|Overall Study|Disease Progression|5|||
33374790|NCT00839306|62753769|FG001|Overall Study|Adverse Event|5|||
33374791|NCT00839306|62753768|FG000|Overall Study|Lost to Follow-up|6|||
33374792|NCT00839306|62753769|FG001|Overall Study|Lost to Follow-up|9|||
33374793|NCT00839306|62753768|FG000|Overall Study|Withdrawal by Subject|5|||
33374794|NCT00839306|62753769|FG001|Overall Study|Withdrawal by Subject|7|||
33374795|NCT00839306|62753768|FG000|Overall Study|Lack of Efficacy|5|||
33374796|NCT00839306|62753769|FG001|Overall Study|Lack of Efficacy|4|||
33374797|NCT00839306|62753768|FG000|Overall Study|Other|6|||
33374798|NCT00839306|62753769|FG001|Overall Study|Other|18|||
33374799|NCT00839072|62753776|FG000|First Intervention Period|Withdrawal by Subject|1|||
33374800|NCT00839072|62753777|FG001|First Intervention Period|Withdrawal by Subject|0|||
33374801|NCT00839072|62753776|FG000|First Intervention Period|Adverse Event|1|||
33374802|NCT00839072|62753777|FG001|First Intervention Period|Adverse Event|1|||
33374803|NCT00839072|62753776|FG000|Second Intervention Period|Withdrawal by Subject|1|||
33374804|NCT00839072|62753777|FG001|Second Intervention Period|Withdrawal by Subject|0|||
33374805|NCT00855803|62753783|FG000|Overall Study|Death|2|||
33374806|NCT00855803|62753783|FG000|Overall Study|Lost to Follow-up|2|||
33374807|NCT00855803|62753783|FG000|Overall Study|Technical inability to undergo procedure|2|||
33374808|NCT00855803|62753783|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
33374809|NCT00855803|62753783|FG000|Overall Study|Withdrawal by Subject|3|||
33374810|NCT00855803|62753783|FG000|Overall Study|Physician Decision|3|||
33374811|NCT00838916|62753789|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
33374812|NCT00838916|62753790|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
33374813|NCT00838916|62753789|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
33374814|NCT00838916|62753790|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
33374815|NCT00838916|62753789|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
33374816|NCT00838916|62753790|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
33374817|NCT00838916|62753789|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
33374818|NCT00838916|62753790|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
33374819|NCT00838916|62753789|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
33288995|NCT00191646|62665703|FG001|Overall Study|Disease Progression|6|||
33288996|NCT00191646|62665702|FG000|Overall Study|Physician Decision|20|||
33288997|NCT00191646|62665703|FG001|Overall Study|Physician Decision|11|||
33288998|NCT00191646|62665702|FG000|Overall Study|Withdrawal by Subject|58|||
33288999|NCT00191646|62665703|FG001|Overall Study|Withdrawal by Subject|39|||
33289000|NCT00191646|62665702|FG000|Overall Study|Protocol Violation|5|||
33289001|NCT00191646|62665703|FG001|Overall Study|Protocol Violation|7|||
33289002|NCT00191646|62665702|FG000|Overall Study|Death|6|||
33289003|NCT00191646|62665703|FG001|Overall Study|Death|8|||
33289004|NCT00191646|62665702|FG000|Overall Study|Other|33|||
33289005|NCT00191646|62665703|FG001|Overall Study|Other|34|||
33289006|NCT00191646|62665702|FG000|Overall Study|Missing Data|18|||
33374820|NCT00838916|62753790|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
33374821|NCT00838916|62753789|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
33374822|NCT00838916|62753790|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
33374823|NCT00838916|62753789|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
33374824|NCT00838916|62753790|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
33374825|NCT00838916|62753789|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
33374826|NCT00838916|62753790|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
33374827|NCT00838916|62753789|FG000|Treatment Period (156 Weeks)|Missing|3|||
33374828|NCT00838916|62753790|FG001|Treatment Period (156 Weeks)|Missing|1|||
33374829|NCT00838916|62753789|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
33289007|NCT00191646|62665703|FG001|Overall Study|Missing Data|11|||
33289008|NCT00191451|62665720|FG000|Overall Study|Withdrawal by Subject|2|||
33289009|NCT00191451|62665721|FG001|Overall Study|Withdrawal by Subject|3|||
33289010|NCT00191451|62665722|FG002|Overall Study|Withdrawal by Subject|5|||
33289011|NCT00191451|62665720|FG000|Overall Study|Physician Decision|2|||
33289012|NCT00191451|62665721|FG001|Overall Study|Physician Decision|9|||
33289013|NCT00191451|62665722|FG002|Overall Study|Physician Decision|6|||
33289014|NCT00191451|62665720|FG000|Overall Study|Sponsor Decision|1|||
33289015|NCT00191451|62665721|FG001|Overall Study|Sponsor Decision|0|||
33289016|NCT00191451|62665722|FG002|Overall Study|Sponsor Decision|0|||
33374830|NCT00838916|62753790|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
33374831|NCT00838916|62753789|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
33374832|NCT00838916|62753790|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
33374833|NCT00838916|62753789|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
33374834|NCT00838916|62753790|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
33374835|NCT00838916|62753789|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
33374836|NCT00838916|62753790|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
33374837|NCT00838916|62753789|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
33374838|NCT00838916|62753790|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
33374839|NCT00838916|62753789|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
33374840|NCT00838916|62753790|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
33556347|NCT04436822|62949235|FG001|Overall Study|Withdrawal due to Covid-19|1|||
33556348|NCT04436822|62949234|FG000|Overall Study|Withdrawal by Subject|1|||
33556349|NCT04436822|62949235|FG001|Overall Study|Withdrawal by Subject|0|||
33289017|NCT00191451|62665720|FG000|Overall Study|Ineligible|0|||
33374841|NCT00838916|62753789|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
33374842|NCT00838916|62753790|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
33374843|NCT00838916|62753789|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
33374844|NCT00838916|62753790|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
33374845|NCT00838916|62753789|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
33374846|NCT00838916|62753790|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
33374847|NCT00838916|62753789|FG000|Follow-up Period (8 Weeks)|Missing|3|||
33374848|NCT00838916|62753790|FG001|Follow-up Period (8 Weeks)|Missing|0|||
33374849|NCT00838682|62753798|FG000|Overall Study|Lost to Follow-up|21|||
33374850|NCT00838682|62753799|FG001|Overall Study|Lost to Follow-up|14|||
33374851|NCT00838682|62753798|FG000|Overall Study|detection of exclusion criteria|4|||
33374852|NCT00838682|62753799|FG001|Overall Study|detection of exclusion criteria|3|||
33374853|NCT00838682|62753798|FG000|Overall Study|Protocol Violation|0|||
33374854|NCT00838682|62753799|FG001|Overall Study|Protocol Violation|1|||
33374855|NCT00838682|62753798|FG000|Overall Study|Withdrawal by Subject|0|||
33374856|NCT00838682|62753799|FG001|Overall Study|Withdrawal by Subject|1|||
33374857|NCT00820040|62753805|FG000|Overall Study|Death|1|||
33374858|NCT00820040|62753805|FG000|Overall Study|Sponsor terminated study|1|||
33374859|NCT00820040|62753805|FG000|Overall Study|Screen failure|1|||
33374860|NCT00803712|62753811|FG000|Overall Study|Noncompliance|3|||
33374861|NCT00803712|62753812|FG001|Overall Study|Noncompliance|0|||
33374862|NCT00803712|62753811|FG000|Overall Study|Adverse Event|5|||
33374863|NCT00803712|62753812|FG001|Overall Study|Adverse Event|0|||
33374864|NCT00803712|62753811|FG000|Overall Study|Death|8|||
33374865|NCT00803712|62753812|FG001|Overall Study|Death|7|||
33374866|NCT00803712|62753811|FG000|Overall Study|Lost to Follow-up|3|||
33374867|NCT00803712|62753812|FG001|Overall Study|Lost to Follow-up|1|||
33374868|NCT00803712|62753811|FG000|Overall Study|Withdrawal by Subject|2|||
33289018|NCT00191451|62665721|FG001|Overall Study|Ineligible|1|||
33289019|NCT00191451|62665722|FG002|Overall Study|Ineligible|0|||
33289020|NCT00191451|62665720|FG000|Overall Study|Reason Not Specified|2|||
33289021|NCT00191451|62665721|FG001|Overall Study|Reason Not Specified|1|||
33289022|NCT00191451|62665722|FG002|Overall Study|Reason Not Specified|3|||
33289023|NCT00191334|62665730|FG000|Overall Study|Adverse Event|4|||
33289024|NCT00191334|62665730|FG000|Overall Study|Disease Progression or Relapse|8|||
33289025|NCT00191334|62665730|FG000|Overall Study|Physician Decision|1|||
33289026|NCT00191334|62665730|FG000|Overall Study|Withdrawal by Subject|4|||
33289027|NCT00191139|62665736|FG000|Overall Study|Adverse Event|2|||
33374869|NCT00803712|62753812|FG001|Overall Study|Withdrawal by Subject|4|||
33374870|NCT00803712|62753811|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
33374871|NCT00803712|62753812|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
33374872|NCT00803712|62753811|FG000|Overall Study|Protocol criteria (other)|0|||
33374873|NCT00803712|62753812|FG001|Overall Study|Protocol criteria (other)|2|||
33374874|NCT00803712|62753811|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
33374875|NCT00803712|62753812|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
33374876|NCT00803712|62753811|FG000|Overall Study|Administrative decision|2|||
33289028|NCT00191139|62665737|FG001|Overall Study|Adverse Event|6|||
33289029|NCT00191139|62665736|FG000|Overall Study|Death|2|||
33289030|NCT00191139|62665737|FG001|Overall Study|Death|0|||
33374877|NCT00803712|62753812|FG001|Overall Study|Administrative decision|3|||
33374878|NCT00803712|62753811|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
33374879|NCT00803712|62753812|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
33374880|NCT00591344|62753820|FG000|Overall Study|Transportation issues|1|||
33374881|NCT00591344|62753821|FG001|Overall Study|Transportation issues|0|||
33374882|NCT00591344|62753820|FG000|Overall Study|Moved out of state|1|||
33556350|NCT04436822|62949234|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
33289031|NCT00191139|62665736|FG000|Overall Study|Withdrawal by Subject|0|||
33289032|NCT00191139|62665737|FG001|Overall Study|Withdrawal by Subject|3|||
33289033|NCT00191139|62665736|FG000|Overall Study|Disease Progression|0|||
33374883|NCT00591344|62753821|FG001|Overall Study|Moved out of state|0|||
33374884|NCT00591344|62753820|FG000|Overall Study|Medical complications|1|||
33374885|NCT00591344|62753821|FG001|Overall Study|Medical complications|3|||
33374886|NCT00591344|62753820|FG000|Overall Study|Underwent DBS|2|||
33374887|NCT00591344|62753821|FG001|Overall Study|Underwent DBS|2|||
33374888|NCT00591344|62753820|FG000|Overall Study|Death|0|||
33374889|NCT00591344|62753821|FG001|Overall Study|Death|1|||
33374890|NCT00591344|62753820|FG000|Overall Study|Lost to Follow-up|0|||
33374891|NCT00591344|62753821|FG001|Overall Study|Lost to Follow-up|1|||
33374892|NCT00591344|62753820|FG000|Overall Study|Did not want to come off medication|0|||
33374893|NCT00591344|62753821|FG001|Overall Study|Did not want to come off medication|1|||
33374894|NCT00803634|62753833|FG000|Overall Study|Withdrew Consent|1|||
33662301|NCT01695239|63092841|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
33662302|NCT01695239|63092842|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
33662303|NCT01695239|63092843|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33662304|NCT01695239|63092844|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33662305|NCT01695239|63092845|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33662306|NCT01695239|63092846|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33662307|NCT01695239|63092833|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33662308|NCT01695239|63092834|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33662309|NCT01695239|63092835|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33662310|NCT01695239|63092836|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33662311|NCT01695239|63092837|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33662312|NCT01695239|63092838|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33662313|NCT01695239|63092839|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33662314|NCT01695239|63092840|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33289034|NCT00191139|62665737|FG001|Overall Study|Disease Progression|1|||
33289035|NCT00191139|62665736|FG000|Overall Study|Other|1|||
33289036|NCT00191139|62665737|FG001|Overall Study|Other|2|||
33289037|NCT00190983|62665743|FG000|Overall Study|Inevaluable (never treated)|2|||
33289038|NCT00190749|62665749|FG000|Overall Study|Lost to Follow-up|8|||
33289039|NCT00190749|62665750|FG001|Overall Study|Lost to Follow-up|11|||
33289040|NCT00190749|62665749|FG000|Overall Study|Withdrawal by Subject|10|||
33289041|NCT00190749|62665750|FG001|Overall Study|Withdrawal by Subject|6|||
33289042|NCT00190749|62665749|FG000|Overall Study|Protocol Violation|5|||
33289043|NCT00190749|62665750|FG001|Overall Study|Protocol Violation|4|||
33289044|NCT00190749|62665749|FG000|Overall Study|Adverse Event|0|||
33289045|NCT00190749|62665750|FG001|Overall Study|Adverse Event|5|||
33289046|NCT00190749|62665749|FG000|Overall Study|Lack of Efficacy|2|||
33289047|NCT00190749|62665750|FG001|Overall Study|Lack of Efficacy|3|||
33289048|NCT00190749|62665749|FG000|Overall Study|Reason Not Specified|0|||
33289049|NCT00190749|62665750|FG001|Overall Study|Reason Not Specified|2|||
33289050|NCT00190749|62665749|FG000|Overall Study|Sponsor Decision|1|||
33289051|NCT00190749|62665750|FG001|Overall Study|Sponsor Decision|0|||
33289052|NCT00190671|62665758|FG000|Overall Study|Satisfactory Response|4|||
33289053|NCT00190671|62665759|FG001|Overall Study|Satisfactory Response|7|||
33289054|NCT00190671|62665758|FG000|Overall Study|Lack of Efficacy|19|||
33289055|NCT00190671|62665759|FG001|Overall Study|Lack of Efficacy|24|||
33289056|NCT00190671|62665758|FG000|Overall Study|Death from Study Disease|1|||
33289057|NCT00190671|62665759|FG001|Overall Study|Death from Study Disease|1|||
33289058|NCT00190671|62665758|FG000|Overall Study|Adverse Event|3|||
33289059|NCT00190671|62665759|FG001|Overall Study|Adverse Event|2|||
33289060|NCT00190671|62665758|FG000|Overall Study|Clinical Relapse|0|||
33289061|NCT00190671|62665759|FG001|Overall Study|Clinical Relapse|1|||
33662315|NCT01695239|63092841|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
33374895|NCT00803634|62753834|FG001|Overall Study|Withdrew Consent|0|||
33374896|NCT00803634|62753833|FG000|Overall Study|Lost to Follow-up|2|||
33374897|NCT00803634|62753834|FG001|Overall Study|Lost to Follow-up|3|||
33374898|NCT00803634|62753833|FG000|Overall Study|Death|3|||
33374899|NCT00803634|62753834|FG001|Overall Study|Death|2|||
33374900|NCT00838526|62753843|FG000|Overall Study|Adverse Event|3|||
33374901|NCT00838526|62753844|FG001|Overall Study|Adverse Event|12|||
33374902|NCT00838526|62753843|FG000|Overall Study|Lost to Follow-up|4|||
33374903|NCT00838526|62753844|FG001|Overall Study|Lost to Follow-up|12|||
33374904|NCT00838526|62753843|FG000|Overall Study|Withdrawal by Subject|4|||
33662316|NCT01695239|63092842|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
33662317|NCT01695239|63092843|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33289062|NCT00190671|62665758|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
33289063|NCT00190671|62665759|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
33289064|NCT00190671|62665758|FG000|Overall Study|Death from Other Causes|0|||
33289065|NCT00190671|62665759|FG001|Overall Study|Death from Other Causes|2|||
33289066|NCT00190671|62665758|FG000|Overall Study|Protocol Violation|0|||
33289067|NCT00190671|62665759|FG001|Overall Study|Protocol Violation|1|||
33374905|NCT00838526|62753844|FG001|Overall Study|Withdrawal by Subject|5|||
33374906|NCT00838526|62753843|FG000|Overall Study|Lack of Efficacy|2|||
33289068|NCT00190671|62665758|FG000|Overall Study|Withdrawal by Subject|0|||
33289069|NCT00190671|62665759|FG001|Overall Study|Withdrawal by Subject|2|||
33289070|NCT00477165|62665781|FG000|Overall Study|Adverse Event|7|||
33289071|NCT00477165|62665782|FG001|Overall Study|Adverse Event|2|||
33289072|NCT00476229|62665788|FG000|Overall Study|Progressive shortness of breath|1|||
33289073|NCT00476151|62665794|FG000|Overall Study|Adverse Event|0|||
33289074|NCT00476151|62665795|FG001|Overall Study|Adverse Event|2|||
33289075|NCT00476151|62665794|FG000|Overall Study|Protocol Violation|1|||
33289076|NCT00476151|62665795|FG001|Overall Study|Protocol Violation|3|||
33289077|NCT00476151|62665794|FG000|Overall Study|Withdrawal by Subject|2|||
33289078|NCT00476151|62665795|FG001|Overall Study|Withdrawal by Subject|0|||
33374907|NCT00838526|62753844|FG001|Overall Study|Lack of Efficacy|3|||
33374908|NCT00838526|62753843|FG000|Overall Study|Other|11|||
33374909|NCT00838526|62753844|FG001|Overall Study|Other|7|||
33374910|NCT00818246|62753863|FG000|Overall Study|Impossible to match pictures|5|||
33374911|NCT00818168|62753867|FG000|Overall Study|Lack of Efficacy|18|||
33374912|NCT00818168|62753867|FG000|Overall Study|Pregnancy|2|||
33374913|NCT00818168|62753867|FG000|Overall Study|Withdrawal by Subject|16|||
33374914|NCT00818168|62753867|FG000|Overall Study|Lost to Follow-up|7|||
33374915|NCT00818168|62753867|FG000|Overall Study|Adverse Event|19|||
33374916|NCT00818168|62753867|FG000|Overall Study|Reason for Non-completion Not reported|6|||
33374917|NCT00818168|62753867|FG000|Overall Study|Participant Moved|2|||
33289079|NCT00476151|62665794|FG000|Overall Study|Physician Decision|0|||
33289080|NCT00476151|62665795|FG001|Overall Study|Physician Decision|2|||
33289081|NCT00475644|62665801|FG000|Overall Study|Protocol Violation|13|||
33289082|NCT00474903|62665808|FG000|Overall Study|Protocol Violation|1|||
33289083|NCT00474903|62665809|FG001|Overall Study|Protocol Violation|5|||
33289084|NCT00474903|62665810|FG002|Overall Study|Protocol Violation|2|||
33289085|NCT01134055|62665825|FG000|Overall Study|Adverse Event|5|||
33289086|NCT01134055|62665826|FG001|Overall Study|Adverse Event|2|||
33289087|NCT01134055|62665827|FG002|Overall Study|Adverse Event|2|||
33289088|NCT01134055|62665828|FG003|Overall Study|Adverse Event|2|||
33289089|NCT01134055|62665829|FG004|Overall Study|Adverse Event|5|||
33289090|NCT01134055|62665830|FG005|Overall Study|Adverse Event|7|||
33289091|NCT01134055|62665831|FG006|Overall Study|Adverse Event|2|||
33289092|NCT01134055|62665825|FG000|Overall Study|Lost to Follow-up|0|||
33289093|NCT01134055|62665826|FG001|Overall Study|Lost to Follow-up|1|||
33289094|NCT01134055|62665827|FG002|Overall Study|Lost to Follow-up|0|||
33289095|NCT01134055|62665828|FG003|Overall Study|Lost to Follow-up|1|||
33289096|NCT01134055|62665829|FG004|Overall Study|Lost to Follow-up|0|||
33289097|NCT01134055|62665830|FG005|Overall Study|Lost to Follow-up|0|||
33289098|NCT01134055|62665831|FG006|Overall Study|Lost to Follow-up|0|||
33289099|NCT01134055|62665825|FG000|Overall Study|Withdrawal by Subject|3|||
33289100|NCT01134055|62665826|FG001|Overall Study|Withdrawal by Subject|3|||
33289101|NCT01134055|62665827|FG002|Overall Study|Withdrawal by Subject|1|||
33289102|NCT01134055|62665828|FG003|Overall Study|Withdrawal by Subject|2|||
33289103|NCT01134055|62665829|FG004|Overall Study|Withdrawal by Subject|0|||
33289104|NCT01134055|62665830|FG005|Overall Study|Withdrawal by Subject|0|||
33289105|NCT01134055|62665831|FG006|Overall Study|Withdrawal by Subject|8|||
33289106|NCT01134055|62665825|FG000|Overall Study|Protocol Violation|0|||
33289107|NCT01134055|62665826|FG001|Overall Study|Protocol Violation|0|||
33289108|NCT01134055|62665827|FG002|Overall Study|Protocol Violation|0|||
33289109|NCT01134055|62665828|FG003|Overall Study|Protocol Violation|1|||
33289110|NCT01134055|62665829|FG004|Overall Study|Protocol Violation|1|||
33289111|NCT01134055|62665830|FG005|Overall Study|Protocol Violation|0|||
33289112|NCT01134055|62665831|FG006|Overall Study|Protocol Violation|0|||
33289113|NCT01134055|62665825|FG000|Overall Study|Physician Decision|0|||
33289114|NCT01134055|62665826|FG001|Overall Study|Physician Decision|0|||
33289115|NCT01134055|62665827|FG002|Overall Study|Physician Decision|0|||
33374918|NCT00817778|62753873|FG000|Overall Study|Adverse Event|1|||
33374919|NCT00817778|62753874|FG001|Overall Study|Adverse Event|0|||
33374920|NCT00817778|62753873|FG000|Overall Study|Withdrawal by Subject|1|||
33374921|NCT00817778|62753874|FG001|Overall Study|Withdrawal by Subject|1|||
33374922|NCT00817778|62753873|FG000|Overall Study|Protocol Violation|0|||
33486767|NCT00179621|62864691|FG001|Double-Blind Period|Death|1|||
33486768|NCT00179621|62864692|FG002|Double-Blind Period|Death|2|||
33486769|NCT00179621|62864693|FG003|Double-Blind Period|Death|0|||
33486770|NCT00179621|62864690|FG000|Double-Blind Period|Protocol Violation|1|||
33289116|NCT01134055|62665828|FG003|Overall Study|Physician Decision|0|||
33374923|NCT00817778|62753874|FG001|Overall Study|Protocol Violation|1|||
33289117|NCT01134055|62665829|FG004|Overall Study|Physician Decision|0|||
33289118|NCT01134055|62665830|FG005|Overall Study|Physician Decision|0|||
33289119|NCT01134055|62665831|FG006|Overall Study|Physician Decision|1|||
33289120|NCT00474708|62665855|FG000|Overall Study|Lack of Efficacy|11|||
33289121|NCT00474708|62665856|FG001|Overall Study|Lack of Efficacy|5|||
33289122|NCT00474708|62665855|FG000|Overall Study|Suicide ideation/behavior|0|||
33289123|NCT00474708|62665856|FG001|Overall Study|Suicide ideation/behavior|1|||
33289124|NCT00474708|62665855|FG000|Overall Study|Withdrawal by Subject|7|||
33289125|NCT00474708|62665856|FG001|Overall Study|Withdrawal by Subject|0|||
33289126|NCT00474708|62665855|FG000|Overall Study|Lack of compliance|12|||
33486771|NCT00179621|62864691|FG001|Double-Blind Period|Protocol Violation|0|||
33289127|NCT00474708|62665856|FG001|Overall Study|Lack of compliance|4|||
33289128|NCT00474708|62665855|FG000|Overall Study|Lost to Follow-up|18|||
33289129|NCT00474708|62665856|FG001|Overall Study|Lost to Follow-up|9|||
33289130|NCT00474708|62665855|FG000|Overall Study|Physician Decision|9|||
33289131|NCT00474708|62665856|FG001|Overall Study|Physician Decision|6|||
33289132|NCT00474240|62665868|FG000|Overall Study|Withdrawal by Subject|1|||
33289133|NCT00474240|62665869|FG001|Overall Study|Withdrawal by Subject|1|||
33289134|NCT00474240|62665870|FG002|Overall Study|Withdrawal by Subject|0|||
33374924|NCT00817778|62753873|FG000|Overall Study|Study-specific discontinuation criteria|0|||
33374925|NCT00817778|62753874|FG001|Overall Study|Study-specific discontinuation criteria|1|||
33374926|NCT00817778|62753873|FG000|Overall Study|Poor venous access|1|||
33374927|NCT00817778|62753874|FG001|Overall Study|Poor venous access|0|||
33374928|NCT00813098|62753883|FG000|Overall Study|Adverse Event|2|||
33374929|NCT00813098|62753884|FG001|Overall Study|Adverse Event|4|||
33374930|NCT00813098|62753885|FG002|Overall Study|Adverse Event|1|||
33374931|NCT00813098|62753883|FG000|Overall Study|Withdrawal by Subject|0|||
33374932|NCT00813098|62753884|FG001|Overall Study|Withdrawal by Subject|1|||
33374933|NCT00813098|62753885|FG002|Overall Study|Withdrawal by Subject|0|||
33374934|NCT00813098|62753883|FG000|Overall Study|Inability to complete study procedures|1|||
33374935|NCT00813098|62753884|FG001|Overall Study|Inability to complete study procedures|0|||
33374936|NCT00813098|62753885|FG002|Overall Study|Inability to complete study procedures|0|||
33374937|NCT00813098|62753883|FG000|Overall Study|Lost to Follow-up|0|||
33374938|NCT00813098|62753884|FG001|Overall Study|Lost to Follow-up|1|||
33374939|NCT00813098|62753885|FG002|Overall Study|Lost to Follow-up|0|||
33374940|NCT00813098|62753883|FG000|Overall Study|Protocol Violation|0|||
33374941|NCT00813098|62753884|FG001|Overall Study|Protocol Violation|0|||
33374942|NCT00813098|62753885|FG002|Overall Study|Protocol Violation|1|||
33374943|NCT00813098|62753883|FG000|Overall Study|Principal Investigator decision|0|||
33374944|NCT00813098|62753884|FG001|Overall Study|Principal Investigator decision|1|||
33374945|NCT00813098|62753885|FG002|Overall Study|Principal Investigator decision|0|||
33374946|NCT00813098|62753883|FG000|Overall Study|Withdrew Consent|0|||
33374947|NCT00813098|62753884|FG001|Overall Study|Withdrew Consent|1|||
33374948|NCT00813098|62753885|FG002|Overall Study|Withdrew Consent|0|||
33374949|NCT00796653|62753897|FG000|Overall Study|Adverse Event|19|||
33374950|NCT00796653|62753898|FG001|Overall Study|Adverse Event|16|||
33374951|NCT00796653|62753899|FG002|Overall Study|Adverse Event|16|||
33374952|NCT00796653|62753900|FG003|Overall Study|Adverse Event|16|||
33374953|NCT00796653|62753897|FG000|Overall Study|Lost to Follow-up|2|||
33374954|NCT00796653|62753898|FG001|Overall Study|Lost to Follow-up|1|||
33374955|NCT00796653|62753899|FG002|Overall Study|Lost to Follow-up|2|||
33374956|NCT00796653|62753900|FG003|Overall Study|Lost to Follow-up|3|||
33374957|NCT00796653|62753897|FG000|Overall Study|Withdrawal by Subject|16|||
33374958|NCT00796653|62753898|FG001|Overall Study|Withdrawal by Subject|8|||
33374959|NCT00796653|62753899|FG002|Overall Study|Withdrawal by Subject|8|||
33374960|NCT00796653|62753900|FG003|Overall Study|Withdrawal by Subject|13|||
33374961|NCT00796653|62753897|FG000|Overall Study|Lack of Efficacy|8|||
33374962|NCT00796653|62753898|FG001|Overall Study|Lack of Efficacy|1|||
33374963|NCT00796653|62753899|FG002|Overall Study|Lack of Efficacy|3|||
33374964|NCT00796653|62753900|FG003|Overall Study|Lack of Efficacy|2|||
33374965|NCT00796653|62753897|FG000|Overall Study|Non compliance with protocol|2|||
33374966|NCT00796653|62753898|FG001|Overall Study|Non compliance with protocol|2|||
33374967|NCT00796653|62753899|FG002|Overall Study|Non compliance with protocol|0|||
33374968|NCT00796653|62753900|FG003|Overall Study|Non compliance with protocol|2|||
33374969|NCT00796653|62753897|FG000|Overall Study|Other reason not described above|4|||
33374970|NCT00796653|62753898|FG001|Overall Study|Other reason not described above|9|||
33374971|NCT00796653|62753899|FG002|Overall Study|Other reason not described above|7|||
33374972|NCT00796653|62753900|FG003|Overall Study|Other reason not described above|4|||
33374973|NCT00806286|62753921|FG000|Overall Study|Adverse Event|5|||
33374974|NCT00806286|62753922|FG001|Overall Study|Adverse Event|2|||
33374975|NCT00806286|62753923|FG002|Overall Study|Adverse Event|0|||
33374976|NCT00806286|62753921|FG000|Overall Study|Disease progression|31|||
33374977|NCT00806286|62753922|FG001|Overall Study|Disease progression|38|||
33374978|NCT00806286|62753923|FG002|Overall Study|Disease progression|1|||
33374979|NCT00806286|62753921|FG000|Overall Study|Death|1|||
33374980|NCT00806286|62753922|FG001|Overall Study|Death|6|||
33374981|NCT00806286|62753923|FG002|Overall Study|Death|0|||
33374982|NCT00806286|62753921|FG000|Overall Study|Lost to Follow-up|0|||
33289135|NCT00474240|62665871|FG003|Overall Study|Withdrawal by Subject|2|||
33289136|NCT00474240|62665872|FG004|Overall Study|Withdrawal by Subject|3|||
33374983|NCT00806286|62753922|FG001|Overall Study|Lost to Follow-up|1|||
33374984|NCT00806286|62753923|FG002|Overall Study|Lost to Follow-up|0|||
33374985|NCT00806286|62753921|FG000|Overall Study|Withdrawal by Subject|8|||
33289137|NCT00474240|62665873|FG005|Overall Study|Withdrawal by Subject|1|||
33486772|NCT00179621|62864692|FG002|Double-Blind Period|Protocol Violation|0|||
33289138|NCT00474240|62665868|FG000|Overall Study|Adverse Event|0|||
33289139|NCT00474240|62665869|FG001|Overall Study|Adverse Event|0|||
33289140|NCT00474240|62665870|FG002|Overall Study|Adverse Event|9|||
33289141|NCT00474240|62665871|FG003|Overall Study|Adverse Event|14|||
33289142|NCT00474240|62665872|FG004|Overall Study|Adverse Event|5|||
33289143|NCT00474240|62665873|FG005|Overall Study|Adverse Event|16|||
33289144|NCT00474240|62665868|FG000|Overall Study|Removed due to lab value|0|||
33289145|NCT00474240|62665869|FG001|Overall Study|Removed due to lab value|0|||
33289146|NCT00474240|62665870|FG002|Overall Study|Removed due to lab value|0|||
33289147|NCT00474240|62665871|FG003|Overall Study|Removed due to lab value|0|||
33289148|NCT00474240|62665872|FG004|Overall Study|Removed due to lab value|0|||
33289149|NCT00474240|62665873|FG005|Overall Study|Removed due to lab value|1|||
33289150|NCT00473889|62665889|FG000|Overall Study|Did not receive study medication|1|||
33289151|NCT00473889|62665890|FG001|Overall Study|Did not receive study medication|4|||
33289152|NCT00473889|62665889|FG000|Overall Study|Adverse Event|30|||
33289153|NCT00473889|62665890|FG001|Overall Study|Adverse Event|17|||
33289154|NCT00473889|62665889|FG000|Overall Study|Protocol Violation|4|||
33289155|NCT00473889|62665890|FG001|Overall Study|Protocol Violation|2|||
33289156|NCT00473889|62665889|FG000|Overall Study|Lack of Efficacy|28|||
33289157|NCT00473889|62665890|FG001|Overall Study|Lack of Efficacy|29|||
33289158|NCT00473889|62665889|FG000|Overall Study|Lost to Follow-up|2|||
33289159|NCT00473889|62665890|FG001|Overall Study|Lost to Follow-up|1|||
33289160|NCT00473889|62665889|FG000|Overall Study|Physician Decision|10|||
33289161|NCT00473889|62665890|FG001|Overall Study|Physician Decision|5|||
33289162|NCT00473889|62665889|FG000|Overall Study|Trial Terminated|3|||
33289163|NCT00473889|62665890|FG001|Overall Study|Trial Terminated|6|||
33289164|NCT00473889|62665889|FG000|Overall Study|Withdrawal by Subject|5|||
33289165|NCT00473889|62665890|FG001|Overall Study|Withdrawal by Subject|0|||
33289166|NCT00473694|62665900|FG000|Overall Study|Adverse Event|0|||
33289167|NCT00473694|62665901|FG001|Overall Study|Adverse Event|1|||
33289168|NCT00473694|62665902|FG002|Overall Study|Adverse Event|0|||
33289169|NCT00473694|62665903|FG003|Overall Study|Adverse Event|0|||
33289170|NCT00473694|62665900|FG000|Overall Study|Participants did not receive treatment|11|||
33289171|NCT00473694|62665901|FG001|Overall Study|Participants did not receive treatment|3|||
33289172|NCT00473694|62665902|FG002|Overall Study|Participants did not receive treatment|5|||
33289173|NCT00473694|62665903|FG003|Overall Study|Participants did not receive treatment|6|||
33289174|NCT00473694|62665900|FG000|Overall Study|Lost to Follow-up|0|||
33289175|NCT00473694|62665901|FG001|Overall Study|Lost to Follow-up|0|||
33289176|NCT00473694|62665902|FG002|Overall Study|Lost to Follow-up|0|||
33289177|NCT00473694|62665903|FG003|Overall Study|Lost to Follow-up|1|||
33289178|NCT00473655|62665919|FG000|Overall Study|Lost to Follow-up|9|||
33289179|NCT00473655|62665920|FG001|Overall Study|Lost to Follow-up|5|||
33289180|NCT00473655|62665921|FG002|Overall Study|Lost to Follow-up|8|||
33289181|NCT00473382|62665932|FG000|Core Study|Adverse Event|3|||
33289182|NCT00473382|62665933|FG001|Core Study|Adverse Event|1|||
33289183|NCT00473382|62665934|FG002|Core Study|Adverse Event|1|||
33289184|NCT00473382|62665932|FG000|Core Study|Death|3|||
33289185|NCT00473382|62665933|FG001|Core Study|Death|5|||
33289186|NCT00473382|62665934|FG002|Core Study|Death|10|||
33289187|NCT00473382|62665932|FG000|Core Study|Lost to Follow-up|3|||
33289188|NCT00473382|62665933|FG001|Core Study|Lost to Follow-up|3|||
33289189|NCT00473382|62665934|FG002|Core Study|Lost to Follow-up|3|||
33289190|NCT00473382|62665932|FG000|Core Study|Physician Decision|1|||
33289191|NCT00473382|62665933|FG001|Core Study|Physician Decision|2|||
33289192|NCT00473382|62665934|FG002|Core Study|Physician Decision|2|||
33289193|NCT00473382|62665932|FG000|Core Study|Subject non-compliance|5|||
33289194|NCT00473382|62665933|FG001|Core Study|Subject non-compliance|2|||
33374986|NCT00806286|62753922|FG001|Overall Study|Withdrawal by Subject|3|||
33374987|NCT00806286|62753923|FG002|Overall Study|Withdrawal by Subject|1|||
33374988|NCT00806286|62753921|FG000|Overall Study|Physician Decision|2|||
33374989|NCT00806286|62753922|FG001|Overall Study|Physician Decision|2|||
33374990|NCT00806286|62753923|FG002|Overall Study|Physician Decision|0|||
33374991|NCT00806286|62753921|FG000|Overall Study|Due to a variety of reasons|7|||
33374992|NCT00806286|62753922|FG001|Overall Study|Due to a variety of reasons|2|||
33374993|NCT00806286|62753923|FG002|Overall Study|Due to a variety of reasons|1|||
33374994|NCT00590538|62753931|FG000|Overall Study|Study terminated before completed|2|||
33374995|NCT00796419|62753937|FG000|Overall Study|Death|0|||
33374996|NCT00796419|62753938|FG001|Overall Study|Death|1|||
33374997|NCT00796107|62753944|FG000|Overall Study|Lack of Efficacy|1|||
33374998|NCT00796107|62753944|FG000|Overall Study|Progressive Disease|5|||
33374999|NCT00795951|62753948|FG000|Overall Study|Lost to Follow-up|1|||
33289195|NCT00473382|62665934|FG002|Core Study|Subject non-compliance|1|||
33289196|NCT00473382|62665932|FG000|Core Study|Subject needed other treatment|1|||
33289197|NCT00473382|62665933|FG001|Core Study|Subject needed other treatment|3|||
33289198|NCT00473382|62665934|FG002|Core Study|Subject needed other treatment|2|||
33289199|NCT00473382|62665932|FG000|Core Study|Subject's decision|12|||
33289200|NCT00473382|62665933|FG001|Core Study|Subject's decision|11|||
33289201|NCT00473382|62665934|FG002|Core Study|Subject's decision|10|||
33289202|NCT00473382|62665932|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
33289203|NCT00473382|62665933|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
33375000|NCT00795951|62753948|FG000|Overall Study|Withdrawal by Subject|1|||
33375001|NCT00795717|62753955|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
33289204|NCT00473382|62665934|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
33289205|NCT00473382|62665932|FG000|Open-label Extension Through Month 48|Death|1|||
33289206|NCT00473382|62665933|FG001|Open-label Extension Through Month 48|Death|3|||
33289207|NCT00473382|62665934|FG002|Open-label Extension Through Month 48|Death|3|||
33289208|NCT00473382|62665932|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
33289209|NCT00473382|62665933|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
33289210|NCT00473382|62665934|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
33289211|NCT00473382|62665932|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
33289212|NCT00473382|62665933|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
33289213|NCT00473382|62665934|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
33289214|NCT00473382|62665932|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
33289215|NCT00473382|62665933|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
33289216|NCT00473382|62665934|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
33289217|NCT00473382|62665932|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
33289218|NCT00473382|62665933|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
33289219|NCT00473382|62665934|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
33289220|NCT00473382|62665932|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
33375002|NCT00795717|62753956|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
33375003|NCT00795717|62753955|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
33375004|NCT00795717|62753956|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
33375005|NCT00795717|62753955|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
33375006|NCT00795717|62753956|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
33375007|NCT00795717|62753955|FG000|Phase II|too busy|0|||
33375008|NCT00795717|62753956|FG001|Phase II|too busy|1|||
33375009|NCT00805740|62753965|FG000|Overall Study|Death|7|||
33375010|NCT00805740|62753966|FG001|Overall Study|Death|4|||
33375011|NCT00805740|62753965|FG000|Overall Study|Withdrawal by Subject|1|||
33375012|NCT00805740|62753966|FG001|Overall Study|Withdrawal by Subject|0|||
33375013|NCT00805740|62753965|FG000|Overall Study|Lost to Follow-up|1|||
33375014|NCT00805740|62753966|FG001|Overall Study|Lost to Follow-up|0|||
33375015|NCT00805740|62753965|FG000|Overall Study|Randomized, but not treated|2|||
33375016|NCT00805740|62753966|FG001|Overall Study|Randomized, but not treated|0|||
33375017|NCT00795639|62753974|FG000|Overall Study|Death|1|||
33375018|NCT00795639|62753975|FG001|Overall Study|Death|6|||
33375019|NCT00795639|62753974|FG000|Overall Study|Withdrawal by Subject|1|||
33375020|NCT00795639|62753975|FG001|Overall Study|Withdrawal by Subject|3|||
33375021|NCT00795639|62753974|FG000|Overall Study|Pregnancy|1|||
33375022|NCT00795639|62753975|FG001|Overall Study|Pregnancy|0|||
33375023|NCT00795639|62753974|FG000|Overall Study|Adverse Event|5|||
33375024|NCT00795639|62753975|FG001|Overall Study|Adverse Event|2|||
33375025|NCT00795639|62753974|FG000|Overall Study|Other|0|||
33375026|NCT00795639|62753975|FG001|Overall Study|Other|2|||
33375027|NCT00795639|62753974|FG000|Overall Study|Terminated by sponsor|13|||
33375028|NCT00795639|62753975|FG001|Overall Study|Terminated by sponsor|12|||
33375029|NCT00795639|62753974|FG000|Overall Study|Randomized and not treated|0|||
33375030|NCT00795639|62753975|FG001|Overall Study|Randomized and not treated|1|||
33375031|NCT00589602|62753981|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
33375032|NCT00794157|62753990|FG000|Overall Study|Adverse Event|4|||
33375033|NCT00794157|62753991|FG001|Overall Study|Adverse Event|1|||
33375034|NCT00794157|62753992|FG002|Overall Study|Adverse Event|8|||
33375035|NCT00794157|62753990|FG000|Overall Study|Subject withdrew consent|2|||
33375036|NCT00794157|62753991|FG001|Overall Study|Subject withdrew consent|0|||
33375037|NCT00794157|62753992|FG002|Overall Study|Subject withdrew consent|3|||
33375038|NCT00794157|62753990|FG000|Overall Study|Lost to Follow-up|2|||
33375039|NCT00794157|62753991|FG001|Overall Study|Lost to Follow-up|0|||
33375040|NCT00794157|62753992|FG002|Overall Study|Lost to Follow-up|1|||
33375041|NCT00794157|62753990|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33375042|NCT00794157|62753991|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33289221|NCT00473382|62665933|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
33289222|NCT00473382|62665934|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
33289223|NCT00473382|62665932|FG000|Open-label Extension Through Month 60|Death|1|||
33375043|NCT00794157|62753992|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
33375044|NCT00794157|62753990|FG000|Overall Study|Administrative problems|1|||
33375045|NCT00794157|62753991|FG001|Overall Study|Administrative problems|7|||
33289224|NCT00473382|62665933|FG001|Open-label Extension Through Month 60|Death|7|||
33289225|NCT00473382|62665934|FG002|Open-label Extension Through Month 60|Death|4|||
33375046|NCT00794157|62753992|FG002|Overall Study|Administrative problems|4|||
33375047|NCT00794157|62753990|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33375048|NCT00794157|62753991|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33375049|NCT00794157|62753992|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33375050|NCT00794157|62753990|FG000|Overall Study|Protocol deviation|0|||
33375051|NCT00794157|62753991|FG001|Overall Study|Protocol deviation|1|||
33375052|NCT00794157|62753992|FG002|Overall Study|Protocol deviation|1|||
33375053|NCT00588237|62754000|FG000|Overall Study|Evaluable for toxicity only|3|||
33375054|NCT00588237|62754000|FG000|Overall Study|Patien not treated|1|||
33375055|NCT00790023|62754007|FG000|Overall Study|Adverse Event|2|||
33375056|NCT00790023|62754008|FG001|Overall Study|Adverse Event|1|||
33486773|NCT00179621|62864693|FG003|Double-Blind Period|Protocol Violation|0|||
33486774|NCT00179621|62864690|FG000|Double-Blind Period|Other|0|||
33486775|NCT00179621|62864691|FG001|Double-Blind Period|Other|2|||
33486776|NCT00179621|62864692|FG002|Double-Blind Period|Other|2|||
33289226|NCT00473382|62665932|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
33289227|NCT00473382|62665933|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
33289228|NCT00473382|62665934|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
33289229|NCT00473382|62665932|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
33289230|NCT00473382|62665933|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
33289231|NCT00473382|62665934|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
33289232|NCT00473382|62665932|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
33289233|NCT00473382|62665933|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
33289234|NCT00473382|62665934|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
33289235|NCT00473382|62665932|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
33289236|NCT00473382|62665933|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
33289237|NCT00473382|62665934|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
33289238|NCT00473265|62665960|FG000|Overall Study|Unrelated adverse event|5|||
33289239|NCT00473265|62665960|FG000|Overall Study|Off treatment early|15|||
33289240|NCT00472641|62665964|FG000|Overall Study|Lack of Efficacy|3|||
33289241|NCT00472641|62665964|FG000|Overall Study|Adverse Event|3|||
33289242|NCT00472641|62665964|FG000|Overall Study|Lost to Follow-up|1|||
33289243|NCT01133977|62665973|FG000|Overall Study|Adverse Event|0|||
33289244|NCT01133977|62665974|FG001|Overall Study|Adverse Event|0|||
33289245|NCT01133977|62665975|FG002|Overall Study|Adverse Event|1|||
33289246|NCT01133977|62665976|FG003|Overall Study|Adverse Event|0|||
33289247|NCT01133977|62665977|FG004|Overall Study|Adverse Event|0|||
33289248|NCT01133977|62665973|FG000|Overall Study|Death|1|||
33289249|NCT01133977|62665974|FG001|Overall Study|Death|1|||
33289250|NCT01133977|62665975|FG002|Overall Study|Death|1|||
33289251|NCT01133977|62665976|FG003|Overall Study|Death|7|||
33289252|NCT01133977|62665977|FG004|Overall Study|Death|3|||
33289253|NCT01133977|62665973|FG000|Overall Study|Started a New Line of Therapy|2|||
33289254|NCT01133977|62665974|FG001|Overall Study|Started a New Line of Therapy|6|||
33289255|NCT01133977|62665975|FG002|Overall Study|Started a New Line of Therapy|4|||
33289256|NCT01133977|62665976|FG003|Overall Study|Started a New Line of Therapy|25|||
33289257|NCT01133977|62665977|FG004|Overall Study|Started a New Line of Therapy|33|||
33289258|NCT01133977|62665973|FG000|Overall Study|Lost to Follow-up|0|||
33289259|NCT01133977|62665974|FG001|Overall Study|Lost to Follow-up|0|||
33289260|NCT01133977|62665975|FG002|Overall Study|Lost to Follow-up|0|||
33289261|NCT01133977|62665976|FG003|Overall Study|Lost to Follow-up|2|||
33289262|NCT01133977|62665977|FG004|Overall Study|Lost to Follow-up|1|||
33289263|NCT01133977|62665973|FG000|Overall Study|Withdrawal by Subject|0|||
33289264|NCT01133977|62665974|FG001|Overall Study|Withdrawal by Subject|0|||
33289265|NCT01133977|62665975|FG002|Overall Study|Withdrawal by Subject|0|||
33289266|NCT01133977|62665976|FG003|Overall Study|Withdrawal by Subject|5|||
33289267|NCT01133977|62665977|FG004|Overall Study|Withdrawal by Subject|1|||
33289268|NCT01133821|62665994|FG000|Overall Study|Lost to Follow-up|8|||
33289269|NCT01133821|62665995|FG001|Overall Study|Lost to Follow-up|11|||
33289270|NCT01133821|62665994|FG000|Overall Study|Withdrawal by Subject|8|||
33289271|NCT01133821|62665995|FG001|Overall Study|Withdrawal by Subject|3|||
33289272|NCT01133821|62665994|FG000|Overall Study|preferred other treatment|1|||
33289273|NCT01133821|62665995|FG001|Overall Study|preferred other treatment|1|||
33289274|NCT01133821|62665994|FG000|Overall Study|Protocol Violation|0|||
33289275|NCT01133821|62665995|FG001|Overall Study|Protocol Violation|1|||
33289276|NCT01133821|62665994|FG000|Overall Study|Refused participation|1|||
33289277|NCT01133821|62665995|FG001|Overall Study|Refused participation|3|||
33289278|NCT00472446|62666005|FG000|Overall Study|Protocol Violation|0|||
33289279|NCT00472446|62666006|FG001|Overall Study|Protocol Violation|0|||
33289280|NCT00472446|62666007|FG002|Overall Study|Protocol Violation|0|||
33289281|NCT00472446|62666008|FG003|Overall Study|Protocol Violation|1|||
33289282|NCT00472446|62666005|FG000|Overall Study|Reintervention|0|||
33289283|NCT00472446|62666006|FG001|Overall Study|Reintervention|0|||
33289284|NCT00472446|62666007|FG002|Overall Study|Reintervention|1|||
33289285|NCT00472446|62666008|FG003|Overall Study|Reintervention|1|||
33289286|NCT00472446|62666005|FG000|Overall Study|Questionnaires not returned|5|||
33289287|NCT00472446|62666006|FG001|Overall Study|Questionnaires not returned|6|||
33289288|NCT00472446|62666007|FG002|Overall Study|Questionnaires not returned|6|||
33289289|NCT00472446|62666008|FG003|Overall Study|Questionnaires not returned|4|||
33289290|NCT00472290|62666018|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
33375057|NCT00790023|62754009|FG002|Overall Study|Adverse Event|4|||
33375058|NCT00790023|62754007|FG000|Overall Study|Protocol Violation|2|||
33375059|NCT00790023|62754008|FG001|Overall Study|Protocol Violation|4|||
33375060|NCT00790023|62754009|FG002|Overall Study|Protocol Violation|2|||
33375061|NCT00790023|62754007|FG000|Overall Study|Withdrawal by Subject|2|||
33375062|NCT00790023|62754008|FG001|Overall Study|Withdrawal by Subject|0|||
33375063|NCT00790023|62754009|FG002|Overall Study|Withdrawal by Subject|6|||
33375064|NCT00790023|62754007|FG000|Overall Study|Lost to Follow-up|0|||
33289291|NCT00472290|62666018|FG000|Overall Study|Protocol Specified Criteria|7|||
33289292|NCT00472290|62666018|FG000|Overall Study|Administrative Decision|37|||
33375065|NCT00790023|62754008|FG001|Overall Study|Lost to Follow-up|0|||
33375066|NCT00790023|62754009|FG002|Overall Study|Lost to Follow-up|1|||
33289293|NCT00472290|62666018|FG000|Overall Study|Death|3|||
33289294|NCT00472290|62666018|FG000|Overall Study|Lost to Follow-up|1|||
33289295|NCT00472290|62666018|FG000|Overall Study|Lack of Efficacy|1|||
33289296|NCT00472290|62666018|FG000|Overall Study|Disease Progression|4|||
33289297|NCT00472290|62666018|FG000|Overall Study|Withdrawal by Subject|5|||
33289298|NCT00472290|62666018|FG000|Overall Study|Adverse Event|6|||
33289299|NCT00472290|62666018|FG000|Overall Study|Requirement for alternative therapy|7|||
33289300|NCT01133704|62666024|FG000|Overall Study|Death|44|||
33289301|NCT01133704|62666025|FG001|Overall Study|Death|26|||
33289302|NCT01133704|62666024|FG000|Overall Study|Patient refused to continue|4|||
33289303|NCT01133704|62666025|FG001|Overall Study|Patient refused to continue|0|||
33289304|NCT01133704|62666024|FG000|Overall Study|Study Closure|1|||
33289305|NCT01133704|62666025|FG001|Overall Study|Study Closure|0|||
33289306|NCT01133665|62666031|FG000|Overall Study|Physician Decision|2|||
33289307|NCT01133626|62666038|FG000|Overall Study|Adverse Event|0|||
33289308|NCT01133626|62666039|FG001|Overall Study|Adverse Event|1|||
33289309|NCT01133626|62666040|FG002|Overall Study|Adverse Event|0|||
33289310|NCT01133626|62666038|FG000|Overall Study|Withdrawal by Subject|1|||
33289311|NCT01133626|62666039|FG001|Overall Study|Withdrawal by Subject|2|||
33289312|NCT01133626|62666040|FG002|Overall Study|Withdrawal by Subject|2|||
33289313|NCT01133626|62666038|FG000|Overall Study|Other|0|||
33289314|NCT01133626|62666039|FG001|Overall Study|Other|2|||
33289315|NCT01133626|62666040|FG002|Overall Study|Other|0|||
33289316|NCT01133392|62666050|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
33289317|NCT01133392|62666051|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
33289318|NCT01133392|62666050|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
33289319|NCT01133392|62666051|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
33289320|NCT00471354|62666057|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
33289321|NCT00471354|62666057|FG000|Overall Study|Adverse Event|13|||
33289322|NCT00471354|62666057|FG000|Overall Study|Protocol Violation|12|||
33289323|NCT00471354|62666057|FG000|Overall Study|Withdrawal by Subject|1|||
33289324|NCT00471354|62666057|FG000|Overall Study|Physician Decision|4|||
33289325|NCT00471354|62666057|FG000|Overall Study|Sponsor Decision|1|||
33375067|NCT00790023|62754007|FG000|Overall Study|Other|5|||
33486777|NCT00179621|62864693|FG003|Double-Blind Period|Other|0|||
33289326|NCT00471354|62666057|FG000|Overall Study|Lost to Follow-up|3|||
33289327|NCT00471354|62666057|FG000|Overall Study|Lack of Efficacy|5|||
33289328|NCT00471354|62666057|FG000|Overall Study|Patient/Caregiver Decision|12|||
33289329|NCT00471315|62666061|FG000|Overall Study|Adverse Event|7|||
33486778|NCT00179621|62864690|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
33486779|NCT00179621|62864691|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
33486780|NCT00179621|62864692|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
33486781|NCT00179621|62864693|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
33486782|NCT00179621|62864690|FG000|Open-Label Period|Adverse Event|0|||
33289330|NCT00471315|62666061|FG000|Overall Study|Withdrawal by Subject|1|||
33289331|NCT00471237|62666072|FG000|Overall Study|Adverse Event|6|||
33289332|NCT00471237|62666073|FG001|Overall Study|Adverse Event|5|||
33289333|NCT00471237|62666074|FG002|Overall Study|Adverse Event|4|||
33289334|NCT00471237|62666075|FG003|Overall Study|Adverse Event|8|||
33289335|NCT00471237|62666076|FG004|Overall Study|Adverse Event|7|||
33289336|NCT00471237|62666077|FG005|Overall Study|Adverse Event|5|||
33289337|NCT00471237|62666078|FG006|Overall Study|Adverse Event|0|||
33289338|NCT00471237|62666072|FG000|Overall Study|Lost to Follow-up|1|||
33289339|NCT00471237|62666073|FG001|Overall Study|Lost to Follow-up|1|||
33486783|NCT00179621|62864691|FG001|Open-Label Period|Adverse Event|6|||
33580964|NCT01268150|62978110|FG000|Treatment Phase|Progression of disease|18|||
33289340|NCT00471237|62666074|FG002|Overall Study|Lost to Follow-up|0|||
33289341|NCT00471237|62666075|FG003|Overall Study|Lost to Follow-up|2|||
33289342|NCT00471237|62666076|FG004|Overall Study|Lost to Follow-up|3|||
33289343|NCT00471237|62666077|FG005|Overall Study|Lost to Follow-up|0|||
33289344|NCT00471237|62666078|FG006|Overall Study|Lost to Follow-up|0|||
33289345|NCT00471237|62666072|FG000|Overall Study|Protocol Violation|3|||
33289346|NCT00471237|62666073|FG001|Overall Study|Protocol Violation|6|||
33375068|NCT00790023|62754008|FG001|Overall Study|Other|5|||
33486784|NCT00179621|62864692|FG002|Open-Label Period|Adverse Event|5|||
33486785|NCT00179621|62864693|FG003|Open-Label Period|Adverse Event|6|||
33289347|NCT00471237|62666074|FG002|Overall Study|Protocol Violation|3|||
33289348|NCT00471237|62666075|FG003|Overall Study|Protocol Violation|2|||
33375069|NCT00790023|62754009|FG002|Overall Study|Other|8|||
33289349|NCT00471237|62666076|FG004|Overall Study|Protocol Violation|2|||
33289350|NCT00471237|62666077|FG005|Overall Study|Protocol Violation|4|||
33289351|NCT00471237|62666078|FG006|Overall Study|Protocol Violation|1|||
33289352|NCT00471237|62666072|FG000|Overall Study|Withdrawal by Subject|8|||
33289353|NCT00471237|62666073|FG001|Overall Study|Withdrawal by Subject|6|||
33556351|NCT04436822|62949235|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
33556352|NCT01596062|62949245|FG000|Overall Study|Adverse Event|1|||
33556353|NCT01596062|62949246|FG001|Overall Study|Adverse Event|0|||
33556354|NCT01596062|62949247|FG002|Overall Study|Adverse Event|2|||
33289354|NCT00471237|62666074|FG002|Overall Study|Withdrawal by Subject|5|||
33375070|NCT00588822|62754018|FG000|Overall Study|progression of disease|8|||
33375071|NCT00589914|62754024|FG000|Overall Study|Adverse Event|19|||
33375072|NCT00589914|62754025|FG001|Overall Study|Adverse Event|10|||
33375073|NCT00589914|62754024|FG000|Overall Study|Death|2|||
33375074|NCT00589914|62754025|FG001|Overall Study|Death|0|||
33289355|NCT00471237|62666075|FG003|Overall Study|Withdrawal by Subject|8|||
33289356|NCT00471237|62666076|FG004|Overall Study|Withdrawal by Subject|7|||
33289357|NCT00471237|62666077|FG005|Overall Study|Withdrawal by Subject|4|||
33289358|NCT00471237|62666078|FG006|Overall Study|Withdrawal by Subject|2|||
33289359|NCT00471237|62666072|FG000|Overall Study|Sponsor terminated study|20|||
33289360|NCT00471237|62666073|FG001|Overall Study|Sponsor terminated study|23|||
33289361|NCT00471237|62666074|FG002|Overall Study|Sponsor terminated study|19|||
33289362|NCT00471237|62666075|FG003|Overall Study|Sponsor terminated study|22|||
33289363|NCT00471237|62666076|FG004|Overall Study|Sponsor terminated study|18|||
33289364|NCT00471237|62666077|FG005|Overall Study|Sponsor terminated study|24|||
33289365|NCT00471237|62666078|FG006|Overall Study|Sponsor terminated study|0|||
33289366|NCT00471237|62666072|FG000|Overall Study|Non-compliance|0|||
33289367|NCT00471237|62666073|FG001|Overall Study|Non-compliance|1|||
33289368|NCT00471237|62666074|FG002|Overall Study|Non-compliance|0|||
33289369|NCT00471237|62666075|FG003|Overall Study|Non-compliance|1|||
33289370|NCT00471237|62666076|FG004|Overall Study|Non-compliance|0|||
33289371|NCT00471237|62666077|FG005|Overall Study|Non-compliance|0|||
33289372|NCT00471237|62666078|FG006|Overall Study|Non-compliance|0|||
33289373|NCT00471237|62666072|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
33289374|NCT00471237|62666073|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
33289375|NCT00471237|62666074|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
33289376|NCT00471237|62666075|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
33289377|NCT00471237|62666076|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
33289378|NCT00471237|62666077|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
33289379|NCT00471237|62666078|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
33289380|NCT00471237|62666072|FG000|Overall Study|Early stopping due to non-efficacy|1|||
33289381|NCT00471237|62666073|FG001|Overall Study|Early stopping due to non-efficacy|0|||
33289382|NCT00471237|62666074|FG002|Overall Study|Early stopping due to non-efficacy|0|||
33289383|NCT00471237|62666075|FG003|Overall Study|Early stopping due to non-efficacy|0|||
33289384|NCT00471237|62666076|FG004|Overall Study|Early stopping due to non-efficacy|1|||
33289385|NCT00471237|62666077|FG005|Overall Study|Early stopping due to non-efficacy|0|||
33289386|NCT00471237|62666078|FG006|Overall Study|Early stopping due to non-efficacy|0|||
33289387|NCT00471237|62666072|FG000|Overall Study|Participant planned to travel to abraod|1|||
33289388|NCT00471237|62666073|FG001|Overall Study|Participant planned to travel to abraod|0|||
33289389|NCT00471237|62666074|FG002|Overall Study|Participant planned to travel to abraod|0|||
33289390|NCT00471237|62666075|FG003|Overall Study|Participant planned to travel to abraod|0|||
33289391|NCT00471237|62666076|FG004|Overall Study|Participant planned to travel to abraod|0|||
33289392|NCT00471237|62666077|FG005|Overall Study|Participant planned to travel to abraod|1|||
33289393|NCT00471237|62666078|FG006|Overall Study|Participant planned to travel to abraod|0|||
33289394|NCT00471237|62666072|FG000|Overall Study|High parathyroid hormone|0|||
33289395|NCT00471237|62666073|FG001|Overall Study|High parathyroid hormone|0|||
33375075|NCT00589914|62754024|FG000|Overall Study|Lack of Efficacy|40|||
33375076|NCT00589914|62754025|FG001|Overall Study|Lack of Efficacy|43|||
33375077|NCT00589914|62754024|FG000|Overall Study|Lost to Follow-up|11|||
33375078|NCT00589914|62754025|FG001|Overall Study|Lost to Follow-up|18|||
33289396|NCT00471237|62666074|FG002|Overall Study|High parathyroid hormone|1|||
33289397|NCT00471237|62666075|FG003|Overall Study|High parathyroid hormone|0|||
33289398|NCT00471237|62666076|FG004|Overall Study|High parathyroid hormone|0|||
33289399|NCT00471237|62666077|FG005|Overall Study|High parathyroid hormone|0|||
33289400|NCT00471237|62666078|FG006|Overall Study|High parathyroid hormone|0|||
33289401|NCT00471237|62666072|FG000|Overall Study|Participant lost medication|0|||
33289402|NCT00471237|62666073|FG001|Overall Study|Participant lost medication|0|||
33289403|NCT00471237|62666074|FG002|Overall Study|Participant lost medication|0|||
33289404|NCT00471237|62666075|FG003|Overall Study|Participant lost medication|0|||
33289405|NCT00471237|62666076|FG004|Overall Study|Participant lost medication|1|||
33375079|NCT00589914|62754024|FG000|Overall Study|Pregnancy|1|||
33289406|NCT00471237|62666077|FG005|Overall Study|Participant lost medication|0|||
33375080|NCT00589914|62754025|FG001|Overall Study|Pregnancy|0|||
33375081|NCT00589914|62754024|FG000|Overall Study|Withdrawal by Subject|55|||
33289407|NCT00471237|62666078|FG006|Overall Study|Participant lost medication|0|||
33289408|NCT00471237|62666072|FG000|Overall Study|Administration of prohibited medicine|0|||
33289409|NCT00471237|62666073|FG001|Overall Study|Administration of prohibited medicine|0|||
33289410|NCT00471237|62666074|FG002|Overall Study|Administration of prohibited medicine|0|||
33289411|NCT00471237|62666075|FG003|Overall Study|Administration of prohibited medicine|0|||
33289412|NCT00471237|62666076|FG004|Overall Study|Administration of prohibited medicine|1|||
33289413|NCT00471237|62666077|FG005|Overall Study|Administration of prohibited medicine|0|||
33289414|NCT00471237|62666078|FG006|Overall Study|Administration of prohibited medicine|0|||
33289415|NCT00471237|62666072|FG000|Overall Study|Participant shifted residence|0|||
33289416|NCT00471237|62666073|FG001|Overall Study|Participant shifted residence|0|||
33289417|NCT00471237|62666074|FG002|Overall Study|Participant shifted residence|0|||
33289418|NCT00471237|62666075|FG003|Overall Study|Participant shifted residence|0|||
33289419|NCT00471237|62666076|FG004|Overall Study|Participant shifted residence|1|||
33289420|NCT00471237|62666077|FG005|Overall Study|Participant shifted residence|0|||
33289421|NCT00471237|62666078|FG006|Overall Study|Participant shifted residence|0|||
33289422|NCT00471237|62666072|FG000|Overall Study|Participant's decision|0|||
33289423|NCT00471237|62666073|FG001|Overall Study|Participant's decision|0|||
33289424|NCT00471237|62666074|FG002|Overall Study|Participant's decision|0|||
33289425|NCT00471237|62666075|FG003|Overall Study|Participant's decision|0|||
33289426|NCT00471237|62666076|FG004|Overall Study|Participant's decision|0|||
33289427|NCT00471237|62666077|FG005|Overall Study|Participant's decision|1|||
33289428|NCT00471237|62666078|FG006|Overall Study|Participant's decision|0|||
33289429|NCT00471081|62666100|FG000|Active Phase|Protocol Violation|1|||
33289430|NCT00471081|62666101|FG001|Active Phase|Protocol Violation|1|||
33289431|NCT00471081|62666100|FG000|Active Phase|Withdrawal by Subject|0|||
33289432|NCT00471081|62666101|FG001|Active Phase|Withdrawal by Subject|3|||
33289433|NCT00471081|62666100|FG000|Active Phase|Lost to Follow-up|0|||
33289434|NCT00471081|62666101|FG001|Active Phase|Lost to Follow-up|1|||
33289435|NCT00471081|62666100|FG000|Active Phase|Lost health plan/insurance|1|||
33289436|NCT00471081|62666101|FG001|Active Phase|Lost health plan/insurance|8|||
33289437|NCT00471081|62666100|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
33289438|NCT00471081|62666101|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
33289439|NCT00471081|62666100|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
33289440|NCT00471081|62666101|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
33289441|NCT00471081|62666100|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
33486786|NCT00179621|62864690|FG000|Open-Label Period|Withdrawal by Subject|0|||
33486787|NCT00179621|62864691|FG001|Open-Label Period|Withdrawal by Subject|2|||
33486788|NCT00179621|62864692|FG002|Open-Label Period|Withdrawal by Subject|2|||
33486789|NCT00179621|62864693|FG003|Open-Label Period|Withdrawal by Subject|2|||
33486790|NCT00179621|62864690|FG000|Open-Label Period|Death|0|||
33486791|NCT00179621|62864691|FG001|Open-Label Period|Death|0|||
33486792|NCT00179621|62864692|FG002|Open-Label Period|Death|1|||
33486793|NCT00179621|62864693|FG003|Open-Label Period|Death|2|||
33486794|NCT00179621|62864690|FG000|Open-Label Period|Other|0|||
33486795|NCT00179621|62864691|FG001|Open-Label Period|Other|1|||
33486796|NCT00179621|62864692|FG002|Open-Label Period|Other|1|||
33486797|NCT00179621|62864693|FG003|Open-Label Period|Other|2|||
33486798|NCT00179309|62864704|FG000|Treatment|Toxicity|2|||
33486799|NCT00179309|62864705|FG001|Treatment|Toxicity|3|||
33486800|NCT00179309|62864704|FG000|Treatment|Withdrawal by Subject|1|||
33486801|NCT00179309|62864705|FG001|Treatment|Withdrawal by Subject|2|||
33486802|NCT00179309|62864704|FG000|Treatment|Allergy|1|||
33486803|NCT00179309|62864705|FG001|Treatment|Allergy|0|||
33486804|NCT00178685|62864726|FG000|Overall Study|Death|3|||
33486805|NCT00178685|62864727|FG001|Overall Study|Death|3|||
33486806|NCT00178685|62864728|FG002|Overall Study|Death|6|||
33486807|NCT00178685|62864726|FG000|Overall Study|Lost to Follow-up|100|||
33486808|NCT00178685|62864727|FG001|Overall Study|Lost to Follow-up|187|||
33486809|NCT00178685|62864728|FG002|Overall Study|Lost to Follow-up|183|||
33375082|NCT00589914|62754025|FG001|Overall Study|Withdrawal by Subject|49|||
33375083|NCT00589914|62754024|FG000|Overall Study|Other|22|||
33375084|NCT00589914|62754025|FG001|Overall Study|Other|17|||
33375085|NCT00789555|62754034|FG000|Overall Study|Protocol Amendment|78|||
33486810|NCT00178685|62864726|FG000|Overall Study|Withdrawal by Subject|8|||
33486811|NCT00178685|62864727|FG001|Overall Study|Withdrawal by Subject|14|||
33486812|NCT00178685|62864728|FG002|Overall Study|Withdrawal by Subject|7|||
33289442|NCT00471081|62666101|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
33289443|NCT00470847|62666108|FG000|Overall Study|Pt still receiving treatment|1|||
33375086|NCT00789555|62754035|FG001|Overall Study|Protocol Amendment|76|||
33486813|NCT02933528|62864736|FG000|Overall Study|Lost to Follow-up|2|||
33486814|NCT00177671|62864742|FG000|Overall Study|Withdrawal by Subject|5|||
33486815|NCT00177671|62864743|FG001|Overall Study|Withdrawal by Subject|6|||
33486816|NCT00177671|62864742|FG000|Overall Study|medical complications|2|||
33486817|NCT00177671|62864743|FG001|Overall Study|medical complications|0|||
33486818|NCT00177671|62864742|FG000|Overall Study|Adverse Event|6|||
33486819|NCT00177671|62864743|FG001|Overall Study|Adverse Event|0|||
33486820|NCT00177671|62864742|FG000|Overall Study|Physician Decision|12|||
33375087|NCT00789555|62754036|FG002|Overall Study|Protocol Amendment|80|||
33375088|NCT00789555|62754034|FG000|Overall Study|Adverse Event|17|||
33375089|NCT00789555|62754035|FG001|Overall Study|Adverse Event|7|||
33375090|NCT00789555|62754036|FG002|Overall Study|Adverse Event|10|||
33375091|NCT00789555|62754034|FG000|Overall Study|Lost to Follow-up|9|||
33375092|NCT00789555|62754035|FG001|Overall Study|Lost to Follow-up|10|||
33375093|NCT00789555|62754036|FG002|Overall Study|Lost to Follow-up|18|||
33375094|NCT00789555|62754034|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
33375095|NCT00789555|62754035|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
33375096|NCT00789555|62754036|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
33375097|NCT00789555|62754034|FG000|Overall Study|Treatment failure|11|||
33375098|NCT00789555|62754035|FG001|Overall Study|Treatment failure|8|||
33375099|NCT00789555|62754036|FG002|Overall Study|Treatment failure|12|||
33375100|NCT00789555|62754034|FG000|Overall Study|Protocol Violation|6|||
33375101|NCT00789555|62754035|FG001|Overall Study|Protocol Violation|9|||
33375102|NCT00789555|62754036|FG002|Overall Study|Protocol Violation|13|||
33375103|NCT00451321|62754052|FG000|Overall Study|Lost to Follow-up|3|||
33375104|NCT00451321|62754053|FG001|Overall Study|Lost to Follow-up|3|||
33375105|NCT00451321|62754054|FG002|Overall Study|Lost to Follow-up|1|||
33375106|NCT00451321|62754055|FG003|Overall Study|Lost to Follow-up|3|||
33375107|NCT00451321|62754056|FG004|Overall Study|Lost to Follow-up|0|||
33375108|NCT00451321|62754057|FG005|Overall Study|Lost to Follow-up|1|||
33375109|NCT00451321|62754058|FG006|Overall Study|Lost to Follow-up|0|||
33375110|NCT00451321|62754059|FG007|Overall Study|Lost to Follow-up|0|||
33375111|NCT00451321|62754052|FG000|Overall Study|Withdrawal by Subject|3|||
33375112|NCT00451321|62754053|FG001|Overall Study|Withdrawal by Subject|1|||
33375113|NCT00451321|62754054|FG002|Overall Study|Withdrawal by Subject|0|||
33375114|NCT00451321|62754055|FG003|Overall Study|Withdrawal by Subject|4|||
33375115|NCT00451321|62754056|FG004|Overall Study|Withdrawal by Subject|0|||
33375116|NCT00451321|62754057|FG005|Overall Study|Withdrawal by Subject|0|||
33375117|NCT00451321|62754058|FG006|Overall Study|Withdrawal by Subject|0|||
33375118|NCT00451321|62754059|FG007|Overall Study|Withdrawal by Subject|0|||
33375119|NCT00451321|62754052|FG000|Overall Study|Study closed/terminated|1|||
33375120|NCT00451321|62754053|FG001|Overall Study|Study closed/terminated|1|||
33375121|NCT00451321|62754054|FG002|Overall Study|Study closed/terminated|17|||
33375122|NCT00451321|62754055|FG003|Overall Study|Study closed/terminated|5|||
33289444|NCT00470535|62666114|FG000|Overall Study|Disease Progression|13|||
33289445|NCT00470535|62666114|FG000|Overall Study|Withdrawal by Subject|1|||
33289446|NCT00470535|62666114|FG000|Overall Study|Adverse Event|1|||
33289447|NCT00470535|62666114|FG000|Overall Study|Death|1|||
33289448|NCT00470535|62666114|FG000|Overall Study|Other|2|||
33289449|NCT00470418|62666120|FG000|Overall Study|Withdrawal by Subject|1|||
33289450|NCT00470418|62666121|FG001|Overall Study|Withdrawal by Subject|0|||
33289451|NCT01133275|62666127|FG000|Overall Study|Withdrawal by Subject|1|||
33289452|NCT01133275|62666127|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
33289453|NCT00470184|62666131|FG000|Overall Study|Not Treated(became ineligible)|4|||
33289454|NCT00470184|62666131|FG000|Overall Study|Not treated (other)|1|||
33289455|NCT00470184|62666131|FG000|Overall Study|disease Progression|4|||
33289456|NCT00470184|62666131|FG000|Overall Study|Adverse Event|3|||
33289457|NCT00470184|62666131|FG000|Overall Study|Withdrawal by Subject|4|||
33289458|NCT00470184|62666131|FG000|Overall Study|other|5|||
33289459|NCT00470184|62666131|FG000|Overall Study|recurrence|1|||
33289460|NCT00470067|62666136|FG000|Overall Study|Death|1|||
33289461|NCT00470067|62666136|FG000|Overall Study|Disease Progression|6|||
33289462|NCT00475020|62666140|FG000|Overall Study|Physician Decision|3|||
33289463|NCT00475020|62666140|FG000|Overall Study|Insurance Denial|1|||
33289464|NCT00475020|62666140|FG000|Overall Study|Donor not able to donate the last minute|1|||
33289465|NCT02484456|62666146|FG000|Washout Period|Withdrawal by Subject|0|||
33289466|NCT02484456|62666147|FG001|Washout Period|Withdrawal by Subject|1|||
33289467|NCT02484456|62666146|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
33289468|NCT02484456|62666147|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
33289469|NCT02484456|62666146|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
33289470|NCT02484456|62666147|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
33289471|NCT02484456|62666146|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
33289472|NCT02484456|62666147|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
33289473|NCT01132807|62666154|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
33289474|NCT01132807|62666155|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
33289475|NCT01132807|62666156|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
33289476|NCT01132807|62666154|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
33289477|NCT01132807|62666155|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
33375123|NCT00451321|62754056|FG004|Overall Study|Study closed/terminated|7|||
33375124|NCT00451321|62754057|FG005|Overall Study|Study closed/terminated|7|||
33375125|NCT00451321|62754058|FG006|Overall Study|Study closed/terminated|5|||
33375126|NCT00451321|62754059|FG007|Overall Study|Study closed/terminated|3|||
33375127|NCT00451321|62754052|FG000|Overall Study|Sponsor decision to amend protocol|0|||
33375128|NCT00451321|62754053|FG001|Overall Study|Sponsor decision to amend protocol|0|||
33289478|NCT01132807|62666156|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
33289479|NCT01132651|62666166|FG000|Overall Study|Lost to Follow-up|1|||
33289480|NCT01132651|62666167|FG001|Overall Study|Lost to Follow-up|1|||
33289481|NCT01089543|62666177|FG000|Overall Study|Withdrawal by Subject|2|||
33289482|NCT01089543|62666178|FG001|Overall Study|Withdrawal by Subject|3|||
33289483|NCT01089543|62666179|FG002|Overall Study|Withdrawal by Subject|3|||
33289484|NCT01089543|62666180|FG003|Overall Study|Withdrawal by Subject|1|||
33289485|NCT01089543|62666177|FG000|Overall Study|Physician Decision|1|||
33289486|NCT01089543|62666178|FG001|Overall Study|Physician Decision|0|||
33289487|NCT01089543|62666179|FG002|Overall Study|Physician Decision|0|||
33289488|NCT01089543|62666180|FG003|Overall Study|Physician Decision|1|||
33375129|NCT00451321|62754054|FG002|Overall Study|Sponsor decision to amend protocol|0|||
33375130|NCT00451321|62754055|FG003|Overall Study|Sponsor decision to amend protocol|0|||
33375131|NCT00451321|62754056|FG004|Overall Study|Sponsor decision to amend protocol|0|||
33375132|NCT00451321|62754057|FG005|Overall Study|Sponsor decision to amend protocol|1|||
33375133|NCT00451321|62754058|FG006|Overall Study|Sponsor decision to amend protocol|1|||
33662318|NCT01695239|63092844|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33662319|NCT01695239|63092845|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33662320|NCT01695239|63092846|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33662321|NCT01695239|63092833|FG000|Extension Long-Term Extension Periods|Death|0|||
33662322|NCT01695239|63092834|FG001|Extension Long-Term Extension Periods|Death|0|||
33662323|NCT01695239|63092835|FG002|Extension Long-Term Extension Periods|Death|0|||
33662324|NCT01695239|63092836|FG003|Extension Long-Term Extension Periods|Death|0|||
33662325|NCT01695239|63092837|FG004|Extension Long-Term Extension Periods|Death|0|||
33662326|NCT01695239|63092838|FG005|Extension Long-Term Extension Periods|Death|0|||
33662327|NCT01695239|63092839|FG006|Extension Long-Term Extension Periods|Death|0|||
33662328|NCT01695239|63092840|FG007|Extension Long-Term Extension Periods|Death|0|||
33662329|NCT01695239|63092841|FG008|Extension Long-Term Extension Periods|Death|1|||
33662330|NCT01695239|63092842|FG009|Extension Long-Term Extension Periods|Death|0|||
33662331|NCT01695239|63092843|FG010|Extension Long-Term Extension Periods|Death|0|||
33662332|NCT01695239|63092844|FG011|Extension Long-Term Extension Periods|Death|0|||
33662333|NCT01695239|63092845|FG012|Extension Long-Term Extension Periods|Death|0|||
33662334|NCT01695239|63092846|FG013|Extension Long-Term Extension Periods|Death|0|||
33662335|NCT01695239|63092833|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33375134|NCT00451321|62754059|FG007|Overall Study|Sponsor decision to amend protocol|3|||
33375135|NCT00802464|62754085|FG000|Month 0 - Month 8|Adverse Event|0|||
33375136|NCT00802464|62754086|FG001|Month 0 - Month 8|Adverse Event|1|||
33375137|NCT00802464|62754087|FG002|Month 0 - Month 8|Adverse Event|1|||
33375138|NCT00802464|62754088|FG003|Month 0 - Month 8|Adverse Event|2|||
33375139|NCT00802464|62754085|FG000|Month 0 - Month 8|Protocol Violation|0|||
33289489|NCT01089543|62666177|FG000|Overall Study|Adverse Event|0|||
33289490|NCT01089543|62666178|FG001|Overall Study|Adverse Event|1|||
33289491|NCT01089543|62666179|FG002|Overall Study|Adverse Event|0|||
33289492|NCT01089543|62666180|FG003|Overall Study|Adverse Event|0|||
33289493|NCT01089504|62666192|FG000|Overall Study|Lost to Follow-up|1|||
33375140|NCT00802464|62754086|FG001|Month 0 - Month 8|Protocol Violation|0|||
33375141|NCT00802464|62754087|FG002|Month 0 - Month 8|Protocol Violation|1|||
33375142|NCT00802464|62754088|FG003|Month 0 - Month 8|Protocol Violation|0|||
33375143|NCT00802464|62754085|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
33375144|NCT00802464|62754086|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
33486821|NCT00177671|62864743|FG001|Overall Study|Physician Decision|8|||
33486822|NCT02933060|62864751|FG000|Overall Study|Withdrawal by Subject|0|||
33662336|NCT01695239|63092834|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33662337|NCT01695239|63092835|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33662338|NCT01695239|63092836|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33662339|NCT01695239|63092837|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33662340|NCT01695239|63092838|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33662341|NCT01695239|63092839|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33662342|NCT01695239|63092840|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33662343|NCT01695239|63092841|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33662344|NCT01695239|63092842|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33375145|NCT00802464|62754087|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
33375146|NCT00802464|62754088|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
33375147|NCT00802464|62754085|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
33486823|NCT02933060|62864752|FG001|Overall Study|Withdrawal by Subject|1|||
33486824|NCT03235154|62864758|FG000|Overall Study|Withdrawal by Subject|1|||
33662345|NCT01695239|63092843|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33289494|NCT01089504|62666193|FG001|Overall Study|Lost to Follow-up|1|||
33289495|NCT01089504|62666192|FG000|Overall Study|Withdrawal by Subject|2|||
33289496|NCT01089504|62666193|FG001|Overall Study|Withdrawal by Subject|0|||
33289497|NCT01088997|62666201|FG000|Overall Study|Physician Decision|1|||
33289498|NCT01088997|62666202|FG001|Overall Study|Physician Decision|1|||
33662346|NCT01695239|63092844|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
33662347|NCT01695239|63092845|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
33662348|NCT01695239|63092846|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
33662349|NCT01695239|63092833|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33662350|NCT01695239|63092834|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33662351|NCT01695239|63092835|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33662352|NCT01695239|63092836|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33662353|NCT01695239|63092837|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33289499|NCT01088997|62666201|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
33289500|NCT01088997|62666202|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
33289501|NCT01088997|62666201|FG000|Overall Study|Excluded prior to receiving drug|1|||
33289502|NCT01088997|62666202|FG001|Overall Study|Excluded prior to receiving drug|1|||
33289503|NCT01088529|62666213|FG000|Overall Study|Did not receive study treatment|0|||
33289504|NCT01088529|62666214|FG001|Overall Study|Did not receive study treatment|1|||
33289505|NCT01087944|62666220|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
33289506|NCT01087944|62666221|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
33289507|NCT01087944|62666220|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
33289508|NCT01087944|62666221|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
33289509|NCT01132612|62666230|FG000|Overall Study|Death|0|||
33289510|NCT01132612|62666231|FG001|Overall Study|Death|0|||
33289511|NCT01132612|62666232|FG002|Overall Study|Death|1|||
33289512|NCT01132612|62666230|FG000|Overall Study|Protocol deviation|0|||
33289513|NCT01132612|62666231|FG001|Overall Study|Protocol deviation|0|||
33289514|NCT01132612|62666232|FG002|Overall Study|Protocol deviation|3|||
33289515|NCT01132612|62666230|FG000|Overall Study|Lost to Follow-up|2|||
33289516|NCT01132612|62666231|FG001|Overall Study|Lost to Follow-up|2|||
33289517|NCT01132612|62666232|FG002|Overall Study|Lost to Follow-up|7|||
33289518|NCT01132612|62666230|FG000|Overall Study|Adverse Event|5|||
33289519|NCT01132612|62666231|FG001|Overall Study|Adverse Event|2|||
33289520|NCT01132612|62666232|FG002|Overall Study|Adverse Event|15|||
33289521|NCT01132612|62666230|FG000|Overall Study|Withdrawal by Subject|5|||
33289522|NCT01132612|62666231|FG001|Overall Study|Withdrawal by Subject|8|||
33289523|NCT01132612|62666232|FG002|Overall Study|Withdrawal by Subject|19|||
33289524|NCT01132612|62666230|FG000|Overall Study|Administrative problems|5|||
33289525|NCT01132612|62666231|FG001|Overall Study|Administrative problems|1|||
33289526|NCT01132612|62666232|FG002|Overall Study|Administrative problems|52|||
33289527|NCT01132612|62666230|FG000|Overall Study|Lack of Efficacy|23|||
33289528|NCT01132612|62666231|FG001|Overall Study|Lack of Efficacy|22|||
33289529|NCT01132612|62666232|FG002|Overall Study|Lack of Efficacy|73|||
33289530|NCT01132495|62666244|FG000|Overall Study|Various reasons|40|||
33289531|NCT01132495|62666245|FG001|Overall Study|Various reasons|38|||
33289532|NCT01132495|62666246|FG002|Overall Study|Various reasons|20|||
33289533|NCT01132495|62666247|FG003|Overall Study|Various reasons|12|||
33289534|NCT01087905|62666266|FG000|Overall Study|Lost to Follow-up|24|||
33289535|NCT01087905|62666267|FG001|Overall Study|Lost to Follow-up|28|||
33289536|NCT01087905|62666268|FG002|Overall Study|Lost to Follow-up|18|||
33289537|NCT01087905|62666269|FG003|Overall Study|Lost to Follow-up|31|||
33289538|NCT01087905|62666270|FG004|Overall Study|Lost to Follow-up|27|||
33289539|NCT01087905|62666271|FG005|Overall Study|Lost to Follow-up|25|||
33375148|NCT00802464|62754086|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
33375149|NCT00802464|62754087|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
33375150|NCT00802464|62754088|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
33375151|NCT00802464|62754085|FG000|Month 0 - Month 8|Other|0|||
33375152|NCT00802464|62754086|FG001|Month 0 - Month 8|Other|0|||
33375153|NCT00802464|62754087|FG002|Month 0 - Month 8|Other|1|||
33375154|NCT00802464|62754088|FG003|Month 0 - Month 8|Other|0|||
33375155|NCT00802464|62754085|FG000|Month 8 - Month 14|Adverse Event|0|||
33289540|NCT01087905|62666272|FG006|Overall Study|Lost to Follow-up|20|||
33289541|NCT01087905|62666273|FG007|Overall Study|Lost to Follow-up|24|||
33289542|NCT01087905|62666266|FG000|Overall Study|Withdrawal by Subject|5|||
33289543|NCT01087905|62666267|FG001|Overall Study|Withdrawal by Subject|4|||
33289544|NCT01087905|62666268|FG002|Overall Study|Withdrawal by Subject|4|||
33289545|NCT01087905|62666269|FG003|Overall Study|Withdrawal by Subject|5|||
33375156|NCT00802464|62754086|FG001|Month 8 - Month 14|Adverse Event|1|||
33375157|NCT00802464|62754087|FG002|Month 8 - Month 14|Adverse Event|0|||
33375158|NCT00802464|62754088|FG003|Month 8 - Month 14|Adverse Event|0|||
33662354|NCT01695239|63092838|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33375159|NCT00802464|62754085|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
33486825|NCT03235154|62864758|FG000|Overall Study|Adverse Event|1|||
33662355|NCT01695239|63092839|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33289546|NCT01087905|62666270|FG004|Overall Study|Withdrawal by Subject|4|||
33289547|NCT01087905|62666271|FG005|Overall Study|Withdrawal by Subject|3|||
33289548|NCT01087905|62666272|FG006|Overall Study|Withdrawal by Subject|3|||
33289549|NCT01087905|62666273|FG007|Overall Study|Withdrawal by Subject|5|||
33289550|NCT01087788|62666292|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
33289551|NCT01087788|62666293|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
33289552|NCT01087788|62666294|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
33486826|NCT03235154|62864758|FG000|Overall Study|Lost to Follow-up|2|||
33289553|NCT01087788|62666292|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
33289554|NCT01087788|62666293|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
33289555|NCT01087788|62666294|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
33289556|NCT01087788|62666292|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
33289557|NCT01087788|62666293|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
33289558|NCT01087788|62666294|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
33289559|NCT01087788|62666292|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
33289560|NCT01087788|62666293|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
33289561|NCT01087788|62666294|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
33289562|NCT01087788|62666292|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
33289563|NCT01087788|62666293|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
33289564|NCT01087788|62666294|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
33289565|NCT01087788|62666292|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
33289566|NCT01087788|62666293|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
33289567|NCT01087788|62666294|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
33289568|NCT01087788|62666292|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
33289569|NCT01087788|62666293|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
33289570|NCT01087788|62666294|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
33289571|NCT01087788|62666292|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
33289572|NCT01087788|62666293|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
33289573|NCT01087788|62666294|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
33289574|NCT01087788|62666292|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
33289575|NCT01087788|62666293|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
33289576|NCT01087788|62666294|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
33289577|NCT01087788|62666292|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
33289578|NCT01087788|62666293|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
33289579|NCT01087788|62666294|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
33289580|NCT01087788|62666292|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
33289581|NCT01087788|62666293|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
33289582|NCT01087788|62666294|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
33289583|NCT01087788|62666292|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
33289584|NCT01087788|62666293|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
33289585|NCT01087788|62666294|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
33289586|NCT01087788|62666292|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
33289587|NCT01087788|62666293|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
33289588|NCT01087788|62666294|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
33289589|NCT01087788|62666292|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
33289590|NCT01087788|62666293|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
33289591|NCT01087788|62666294|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
33289592|NCT01087788|62666292|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
33289593|NCT01087788|62666293|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
33289594|NCT01087788|62666294|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
33289595|NCT01087788|62666292|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
33289596|NCT01087788|62666293|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
33289597|NCT01087788|62666294|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
33289598|NCT01087788|62666292|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
33289599|NCT01087788|62666293|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
33289600|NCT01087788|62666294|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
33289601|NCT01087788|62666292|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
33289602|NCT01087788|62666293|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
33289603|NCT01087788|62666294|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
33289604|NCT01087788|62666292|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
33289605|NCT01087788|62666293|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
33289606|NCT01087788|62666294|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
33375160|NCT00802464|62754086|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
33375161|NCT00802464|62754087|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
33375162|NCT00802464|62754088|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
33375163|NCT00802464|62754085|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
33375164|NCT00802464|62754086|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
33375165|NCT00802464|62754087|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
33375166|NCT00802464|62754088|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
33375167|NCT00450619|62754102|FG000|Overall Study|refused treatment after randomization|2|||
33375168|NCT00450619|62754103|FG001|Overall Study|refused treatment after randomization|0|||
33289607|NCT01087788|62666292|FG000|24-weeks Dose-blind Period|Patient moved|0|||
33375169|NCT00450619|62754102|FG000|Overall Study|did not progress; refused further trmt|1|||
33289608|NCT01087788|62666293|FG001|24-weeks Dose-blind Period|Patient moved|0|||
33375170|NCT00450619|62754103|FG001|Overall Study|did not progress; refused further trmt|1|||
33375171|NCT00450619|62754102|FG000|Overall Study|Adverse Event|1|||
33375172|NCT00450619|62754103|FG001|Overall Study|Adverse Event|0|||
33375173|NCT00802074|62754116|FG000|Overall Study|Adverse Event|1|||
33375174|NCT00802074|62754117|FG001|Overall Study|Adverse Event|1|||
33375175|NCT00802074|62754118|FG002|Overall Study|Adverse Event|1|||
33375176|NCT00802074|62754119|FG003|Overall Study|Adverse Event|0|||
33375177|NCT00802074|62754120|FG004|Overall Study|Adverse Event|0|||
33375178|NCT00802074|62754121|FG005|Overall Study|Adverse Event|0|||
33375179|NCT00802074|62754116|FG000|Overall Study|Withdrawal by Subject|1|||
33375180|NCT00802074|62754117|FG001|Overall Study|Withdrawal by Subject|0|||
33375181|NCT00802074|62754118|FG002|Overall Study|Withdrawal by Subject|0|||
33375182|NCT00802074|62754119|FG003|Overall Study|Withdrawal by Subject|0|||
33375183|NCT00802074|62754120|FG004|Overall Study|Withdrawal by Subject|0|||
33375184|NCT00802074|62754121|FG005|Overall Study|Withdrawal by Subject|0|||
33375185|NCT00450385|62754138|FG000|Overall Study|Death|3|||
33375186|NCT00450385|62754138|FG000|Overall Study|Protocol Violation|1|||
33375187|NCT00450385|62754138|FG000|Overall Study|Withdrawal by Subject|2|||
33375188|NCT00450385|62754138|FG000|Overall Study|Lack of Efficacy|2|||
33375189|NCT00450385|62754138|FG000|Overall Study|Adverse Event|1|||
33289609|NCT01087788|62666294|FG002|24-weeks Dose-blind Period|Patient moved|1|||
33289610|NCT01087788|62666292|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
33289611|NCT01087788|62666293|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
33289612|NCT01087788|62666294|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
33289613|NCT01087788|62666292|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
33289614|NCT01087788|62666293|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
33289615|NCT01087788|62666294|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
33375190|NCT00450385|62754138|FG000|Overall Study|Physician Decision|1|||
33375191|NCT00450385|62754138|FG000|Overall Study|Other|3|||
33375192|NCT00588354|62754145|FG000|Baseline to 2 Weeks|Adverse Event|1|||
33375193|NCT00588354|62754146|FG001|Baseline to 2 Weeks|Adverse Event|0|||
33375194|NCT00588354|62754145|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
33289616|NCT01087788|62666292|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
33289617|NCT01087788|62666293|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
33289618|NCT01087788|62666294|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
33289619|NCT01087788|62666292|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
33289620|NCT01087788|62666293|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
33289621|NCT01087788|62666294|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
33289622|NCT01087788|62666292|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
33289623|NCT01087788|62666293|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
33289624|NCT01087788|62666294|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
33289625|NCT01087788|62666292|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
33375195|NCT00588354|62754146|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
33375196|NCT00588354|62754145|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
33375197|NCT00588354|62754146|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
33375198|NCT00449761|62754153|FG000|Overall Study|Disease progression|12|||
33375199|NCT00449761|62754153|FG000|Overall Study|Death|5|||
33375200|NCT00449761|62754153|FG000|Overall Study|New cancer therapy|1|||
33375201|NCT00800982|62754160|FG000|Overall Study|Lost to Follow-up|1|||
33375202|NCT00800982|62754161|FG001|Overall Study|Lost to Follow-up|2|||
33375203|NCT00800982|62754160|FG000|Overall Study|Withdrawal by Subject|0|||
33375204|NCT00800982|62754161|FG001|Overall Study|Withdrawal by Subject|1|||
33375205|NCT00800982|62754160|FG000|Overall Study|Patient moved out of state|1|||
33375206|NCT00800982|62754161|FG001|Overall Study|Patient moved out of state|0|||
33375207|NCT00830960|62754173|FG000|Overall Study|Death|5|||
33375208|NCT00830960|62754174|FG001|Overall Study|Death|4|||
33375209|NCT00830960|62754175|FG002|Overall Study|Death|3|||
33375210|NCT00830960|62754176|FG003|Overall Study|Death|2|||
33375211|NCT00830960|62754177|FG004|Overall Study|Death|6|||
33375212|NCT00830960|62754178|FG005|Overall Study|Death|1|||
33289626|NCT01087788|62666293|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
33289627|NCT01087788|62666294|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
33289628|NCT01087788|62666292|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
33289629|NCT01087788|62666293|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
33289630|NCT01087788|62666294|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
33375213|NCT00830960|62754173|FG000|Overall Study|Lost to Follow-up|1|||
33375214|NCT00830960|62754174|FG001|Overall Study|Lost to Follow-up|1|||
33375215|NCT00830960|62754175|FG002|Overall Study|Lost to Follow-up|1|||
33375216|NCT00830960|62754176|FG003|Overall Study|Lost to Follow-up|0|||
33375217|NCT00830960|62754177|FG004|Overall Study|Lost to Follow-up|0|||
33375218|NCT00830960|62754178|FG005|Overall Study|Lost to Follow-up|1|||
33375219|NCT00830960|62754173|FG000|Overall Study|Withdrawal by Subject|19|||
33375220|NCT00830960|62754174|FG001|Overall Study|Withdrawal by Subject|19|||
33289631|NCT01087788|62666292|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
33375221|NCT00830960|62754175|FG002|Overall Study|Withdrawal by Subject|18|||
33375222|NCT00830960|62754176|FG003|Overall Study|Withdrawal by Subject|23|||
33375223|NCT00830960|62754177|FG004|Overall Study|Withdrawal by Subject|16|||
33486827|NCT03234608|62864766|FG000|Overall Study|Lost to Follow-up|23|||
33289632|NCT01087788|62666293|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
33289633|NCT01087788|62666294|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
33486828|NCT03234608|62864767|FG001|Overall Study|Lost to Follow-up|21|||
33486829|NCT03248882|62864778|FG000|Overall Study|Adverse Event|3|||
33486830|NCT03248882|62864779|FG001|Overall Study|Adverse Event|3|||
33486831|NCT03248882|62864780|FG002|Overall Study|Adverse Event|2|||
33486832|NCT03248882|62864781|FG003|Overall Study|Adverse Event|6|||
33486833|NCT03248882|62864782|FG004|Overall Study|Adverse Event|9|||
33486834|NCT03248882|62864778|FG000|Overall Study|Lost to Follow-up|0|||
33486835|NCT03248882|62864779|FG001|Overall Study|Lost to Follow-up|0|||
33486836|NCT03248882|62864780|FG002|Overall Study|Lost to Follow-up|0|||
33486837|NCT03248882|62864781|FG003|Overall Study|Lost to Follow-up|0|||
33486838|NCT03248882|62864782|FG004|Overall Study|Lost to Follow-up|1|||
33486839|NCT03248882|62864778|FG000|Overall Study|Protocol Violation|2|||
33486840|NCT03248882|62864779|FG001|Overall Study|Protocol Violation|0|||
33486841|NCT03248882|62864780|FG002|Overall Study|Protocol Violation|2|||
33289634|NCT01087788|62666292|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
33289635|NCT01087788|62666293|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
33289636|NCT01087788|62666294|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
33289637|NCT01087788|62666292|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
33375224|NCT00830960|62754178|FG005|Overall Study|Withdrawal by Subject|21|||
33375225|NCT00830960|62754173|FG000|Overall Study|Sponsor Decision|1|||
33375226|NCT00830960|62754174|FG001|Overall Study|Sponsor Decision|2|||
33375227|NCT00830960|62754175|FG002|Overall Study|Sponsor Decision|3|||
33375228|NCT00830960|62754176|FG003|Overall Study|Sponsor Decision|4|||
33375229|NCT00830960|62754177|FG004|Overall Study|Sponsor Decision|5|||
33375230|NCT00830960|62754178|FG005|Overall Study|Sponsor Decision|7|||
33375231|NCT00830960|62754173|FG000|Overall Study|No study drug received|7|||
33375232|NCT00830960|62754174|FG001|Overall Study|No study drug received|2|||
33375233|NCT00830960|62754175|FG002|Overall Study|No study drug received|4|||
33375234|NCT00830960|62754176|FG003|Overall Study|No study drug received|3|||
33375235|NCT00830960|62754177|FG004|Overall Study|No study drug received|5|||
33375236|NCT00830960|62754178|FG005|Overall Study|No study drug received|7|||
33375237|NCT00830804|62754215|FG000|Overall Study|Lost to Follow-up|4|||
33375238|NCT00830804|62754215|FG000|Overall Study|Death|1|||
33375239|NCT00830804|62754215|FG000|Overall Study|Unable to get to clinic|7|||
33375240|NCT00830804|62754215|FG000|Overall Study|Consent withdrawn|2|||
33375241|NCT00830804|62754215|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
33375242|NCT00789477|62754225|FG000|Overall Study|Withdrawal by Subject|2|||
33375243|NCT00789477|62754226|FG001|Overall Study|Withdrawal by Subject|1|||
33375244|NCT00789477|62754227|FG002|Overall Study|Withdrawal by Subject|3|||
33375245|NCT00789477|62754228|FG003|Overall Study|Withdrawal by Subject|2|||
33375246|NCT00789477|62754229|FG004|Overall Study|Withdrawal by Subject|3|||
33375247|NCT00789477|62754225|FG000|Overall Study|Protocol Violation|1|||
33375248|NCT00789477|62754226|FG001|Overall Study|Protocol Violation|0|||
33375249|NCT00789477|62754227|FG002|Overall Study|Protocol Violation|0|||
33375250|NCT00789477|62754228|FG003|Overall Study|Protocol Violation|1|||
33375251|NCT00789477|62754229|FG004|Overall Study|Protocol Violation|0|||
33375252|NCT00789477|62754225|FG000|Overall Study|Adverse Event|3|||
33375253|NCT00789477|62754226|FG001|Overall Study|Adverse Event|3|||
33375254|NCT00789477|62754227|FG002|Overall Study|Adverse Event|1|||
33486842|NCT03248882|62864781|FG003|Overall Study|Protocol Violation|0|||
33486843|NCT03248882|62864782|FG004|Overall Study|Protocol Violation|1|||
33662356|NCT01695239|63092840|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33662357|NCT01695239|63092841|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33289638|NCT01087788|62666293|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
33289639|NCT01087788|62666294|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
33289640|NCT01087788|62666292|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
33289641|NCT01087788|62666293|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
33289642|NCT01087788|62666294|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
33289643|NCT01087788|62666292|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
33289644|NCT01087788|62666293|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
33289645|NCT01087788|62666294|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
33289646|NCT01087788|62666292|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
33289647|NCT01087788|62666293|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
33289648|NCT01087788|62666294|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
33375255|NCT00789477|62754228|FG003|Overall Study|Adverse Event|0|||
33375256|NCT00789477|62754229|FG004|Overall Study|Adverse Event|0|||
33375257|NCT00789477|62754225|FG000|Overall Study|Death|1|||
33375258|NCT00789477|62754226|FG001|Overall Study|Death|1|||
33375259|NCT00789477|62754227|FG002|Overall Study|Death|2|||
33375260|NCT00789477|62754228|FG003|Overall Study|Death|2|||
33375261|NCT00789477|62754229|FG004|Overall Study|Death|0|||
33486844|NCT03248882|62864778|FG000|Overall Study|Withdrawal by Subject|2|||
33486845|NCT03248882|62864779|FG001|Overall Study|Withdrawal by Subject|2|||
33486846|NCT03248882|62864780|FG002|Overall Study|Withdrawal by Subject|3|||
33375262|NCT00789477|62754225|FG000|Overall Study|Lost to Follow-up|0|||
33375263|NCT00789477|62754226|FG001|Overall Study|Lost to Follow-up|1|||
33375264|NCT00789477|62754227|FG002|Overall Study|Lost to Follow-up|4|||
33375265|NCT00789477|62754228|FG003|Overall Study|Lost to Follow-up|2|||
33375266|NCT00789477|62754229|FG004|Overall Study|Lost to Follow-up|4|||
33375267|NCT00789477|62754225|FG000|Overall Study|Lack of Efficacy|2|||
33289649|NCT01086969|62666306|FG000|Overall Study|Withdrawal by Subject|1|||
33289650|NCT01086969|62666307|FG001|Overall Study|Withdrawal by Subject|2|||
33375268|NCT00789477|62754226|FG001|Overall Study|Lack of Efficacy|0|||
33375269|NCT00789477|62754227|FG002|Overall Study|Lack of Efficacy|0|||
33375270|NCT00789477|62754228|FG003|Overall Study|Lack of Efficacy|0|||
33375271|NCT00789477|62754229|FG004|Overall Study|Lack of Efficacy|0|||
33375272|NCT00789477|62754225|FG000|Overall Study|Other|2|||
33375273|NCT00789477|62754226|FG001|Overall Study|Other|0|||
33375274|NCT00789477|62754227|FG002|Overall Study|Other|1|||
33375275|NCT00789477|62754228|FG003|Overall Study|Other|3|||
33375276|NCT00789477|62754229|FG004|Overall Study|Other|0|||
33375277|NCT00796614|62754247|FG000|Overall Study|Adverse Event|1|||
33375278|NCT00796614|62754248|FG001|Overall Study|Adverse Event|2|||
33375279|NCT00796614|62754249|FG002|Overall Study|Adverse Event|0|||
33375280|NCT00796614|62754250|FG003|Overall Study|Adverse Event|0|||
33375281|NCT00796614|62754247|FG000|Overall Study|Protocol Violation|0|||
33375282|NCT00796614|62754248|FG001|Overall Study|Protocol Violation|0|||
33375283|NCT00796614|62754249|FG002|Overall Study|Protocol Violation|2|||
33375284|NCT00796614|62754250|FG003|Overall Study|Protocol Violation|0|||
33375285|NCT00796614|62754247|FG000|Overall Study|Lost to Follow-up|2|||
33375286|NCT00796614|62754248|FG001|Overall Study|Lost to Follow-up|2|||
33375287|NCT00796614|62754249|FG002|Overall Study|Lost to Follow-up|1|||
33375288|NCT00796614|62754250|FG003|Overall Study|Lost to Follow-up|0|||
33375289|NCT00796614|62754247|FG000|Overall Study|Withdrawal by Subject|1|||
33375290|NCT00796614|62754248|FG001|Overall Study|Withdrawal by Subject|0|||
33375291|NCT00796614|62754249|FG002|Overall Study|Withdrawal by Subject|0|||
33375292|NCT00796614|62754250|FG003|Overall Study|Withdrawal by Subject|1|||
33375293|NCT00796614|62754247|FG000|Overall Study|Other than stated|1|||
33375294|NCT00796614|62754248|FG001|Overall Study|Other than stated|0|||
33375295|NCT00796614|62754249|FG002|Overall Study|Other than stated|0|||
33556355|NCT01596062|62949245|FG000|Overall Study|Lack of Efficacy|0|||
33289651|NCT01086969|62666308|FG002|Overall Study|Withdrawal by Subject|0|||
33289652|NCT01086423|62666319|FG000|Overall Study|Protocol Violation|0|||
33289653|NCT01086423|62666320|FG001|Overall Study|Protocol Violation|0|||
33289654|NCT01086423|62666321|FG002|Overall Study|Protocol Violation|1|||
33289655|NCT01086423|62666319|FG000|Overall Study|Migrated/moved from study area|2|||
33289656|NCT01086423|62666320|FG001|Overall Study|Migrated/moved from study area|0|||
33289657|NCT01086423|62666321|FG002|Overall Study|Migrated/moved from study area|4|||
33289658|NCT01086423|62666319|FG000|Overall Study|Adverse event, fatal|1|||
33289659|NCT01086423|62666320|FG001|Overall Study|Adverse event, fatal|1|||
33289660|NCT01086423|62666321|FG002|Overall Study|Adverse event, fatal|0|||
33289661|NCT01086423|62666319|FG000|Overall Study|Adverse event, non-fatal|2|||
33289662|NCT01086423|62666320|FG001|Overall Study|Adverse event, non-fatal|1|||
33289663|NCT01086423|62666321|FG002|Overall Study|Adverse event, non-fatal|0|||
33289664|NCT01086423|62666319|FG000|Overall Study|Withdrawal by Subject|5|||
33289665|NCT01086423|62666320|FG001|Overall Study|Withdrawal by Subject|1|||
33289666|NCT01086423|62666321|FG002|Overall Study|Withdrawal by Subject|3|||
33289667|NCT01086423|62666319|FG000|Overall Study|Lost to Follow-up|0|||
33289668|NCT01086423|62666320|FG001|Overall Study|Lost to Follow-up|0|||
33289669|NCT01086423|62666321|FG002|Overall Study|Lost to Follow-up|1|||
33289670|NCT01086150|62666332|FG000|Overall Study|Withdrawal by Subject|0|||
33289671|NCT01086150|62666333|FG001|Overall Study|Withdrawal by Subject|4|||
33289672|NCT01086150|62666334|FG002|Overall Study|Withdrawal by Subject|1|||
33289673|NCT01086150|62666332|FG000|Overall Study|Lost to Follow-up|0|||
33289674|NCT01086150|62666333|FG001|Overall Study|Lost to Follow-up|1|||
33375296|NCT00796614|62754250|FG003|Overall Study|Other than stated|0|||
33375297|NCT00448747|62754262|FG000|Overall Study|collapsed veins|1|||
33375298|NCT00448747|62754263|FG001|Overall Study|collapsed veins|0|||
33375299|NCT00830180|62754279|FG000|Overall Study|Adverse Event|6|||
33375300|NCT00830180|62754279|FG000|Overall Study|Death|11|||
33375301|NCT00830180|62754279|FG000|Overall Study|Insufficient clinical response|1|||
33375302|NCT00830180|62754279|FG000|Overall Study|Withdrawal by Subject|5|||
33375303|NCT00830180|62754279|FG000|Overall Study|Progressive disease|2|||
33375304|NCT00830180|62754279|FG000|Overall Study|Other - Unspecified|1|||
33375305|NCT00863681|62754288|FG000|Overall Study|Other|2|||
33375306|NCT00863681|62754289|FG001|Overall Study|Other|0|||
33375307|NCT00863681|62754290|FG002|Overall Study|Other|0|||
33289675|NCT01086150|62666334|FG002|Overall Study|Lost to Follow-up|0|||
33289676|NCT01086150|62666332|FG000|Overall Study|Screen Failure|0|||
33289677|NCT01086150|62666333|FG001|Overall Study|Screen Failure|1|||
33289678|NCT01086150|62666334|FG002|Overall Study|Screen Failure|0|||
33375308|NCT00863681|62754288|FG000|Overall Study|Missing|1|||
33375309|NCT00863681|62754289|FG001|Overall Study|Missing|0|||
33289679|NCT01086033|62666342|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
33289680|NCT01086033|62666342|FG000|Overall Study|Lost to Follow-up|86|||
33289681|NCT01086033|62666342|FG000|Overall Study|Adverse Event|42|||
33289682|NCT01086033|62666342|FG000|Overall Study|Withdrawal by Subject|41|||
33289683|NCT01086033|62666342|FG000|Overall Study|Other|14|||
33289684|NCT01086033|62666342|FG000|Overall Study|Other|13|||
33289685|NCT01086033|62666342|FG000|Overall Study|AE and Withdrew Consent|5|||
33289686|NCT01086033|62666342|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
33289687|NCT01086033|62666342|FG000|Overall Study|Withdrew consent and Other Reason|4|||
33289688|NCT01086033|62666342|FG000|Overall Study|AE and Lack of Efficacy|4|||
33289689|NCT01086033|62666342|FG000|Overall Study|Death|1|||
33289690|NCT01086033|62666342|FG000|Overall Study|AE and Lost to Follow-up|1|||
33289691|NCT01086033|62666342|FG000|Overall Study|AE and Other Reason|1|||
33289692|NCT01086033|62666342|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
33289693|NCT01085682|62666351|FG000|Overall Study|Withdrawal by Subject|25|||
33289694|NCT01085682|62666352|FG001|Overall Study|Withdrawal by Subject|25|||
33289695|NCT01085214|62666358|FG000|Overall Study|Alternate treatment required|1|||
33289696|NCT01085136|62666362|FG000|Part A|Other Adverse event|223|||
33375310|NCT00863681|62754290|FG002|Overall Study|Missing|0|||
33375311|NCT00863681|62754288|FG000|Overall Study|Death|40|||
33375312|NCT00863681|62754289|FG001|Overall Study|Death|23|||
33375313|NCT00863681|62754290|FG002|Overall Study|Death|6|||
33375314|NCT00863681|62754288|FG000|Overall Study|Withdrawal by Subject|12|||
33375315|NCT00863681|62754289|FG001|Overall Study|Withdrawal by Subject|5|||
33375316|NCT00863681|62754290|FG002|Overall Study|Withdrawal by Subject|2|||
33375317|NCT00863681|62754288|FG000|Overall Study|Protocol Violation|2|||
33375318|NCT00863681|62754289|FG001|Overall Study|Protocol Violation|0|||
33375319|NCT00863681|62754290|FG002|Overall Study|Protocol Violation|0|||
33375320|NCT00863681|62754288|FG000|Overall Study|Lost to Follow-up|3|||
33375321|NCT00863681|62754289|FG001|Overall Study|Lost to Follow-up|0|||
33375322|NCT00863681|62754290|FG002|Overall Study|Lost to Follow-up|3|||
33375323|NCT00863681|62754288|FG000|Overall Study|Adverse Event|28|||
33375324|NCT00863681|62754289|FG001|Overall Study|Adverse Event|10|||
33375325|NCT00863681|62754290|FG002|Overall Study|Adverse Event|6|||
33375326|NCT00863681|62754288|FG000|Overall Study|Lack of Efficacy|2|||
33375327|NCT00863681|62754289|FG001|Overall Study|Lack of Efficacy|2|||
33375328|NCT00863681|62754290|FG002|Overall Study|Lack of Efficacy|1|||
33375329|NCT00863681|62754288|FG000|Overall Study|Non-compliance with study drug|1|||
33375330|NCT00863681|62754289|FG001|Overall Study|Non-compliance with study drug|3|||
33375331|NCT00863681|62754290|FG002|Overall Study|Non-compliance with study drug|0|||
33375332|NCT00789321|62754300|FG000|Overall Study|Adverse Event|0|||
33375333|NCT00789321|62754301|FG001|Overall Study|Adverse Event|1|||
33375334|NCT00811928|62754309|FG000|Overall Study|AEs and SAEs Including Death|7|||
33375335|NCT00811928|62754310|FG001|Overall Study|AEs and SAEs Including Death|11|||
33375336|NCT00811928|62754309|FG000|Overall Study|Withdrawal by Subject|18|||
33375337|NCT00811928|62754310|FG001|Overall Study|Withdrawal by Subject|12|||
33375338|NCT00811928|62754309|FG000|Overall Study|Did Not Take Study Drug|3|||
33375339|NCT00811928|62754310|FG001|Overall Study|Did Not Take Study Drug|0|||
33375340|NCT00811928|62754309|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
33375341|NCT00811928|62754310|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
33375342|NCT00811928|62754309|FG000|Overall Study|Investigator Decision|2|||
33375343|NCT00811928|62754310|FG001|Overall Study|Investigator Decision|1|||
33375344|NCT00811928|62754309|FG000|Overall Study|Poor Compliance|2|||
33375345|NCT00811928|62754310|FG001|Overall Study|Poor Compliance|5|||
33375346|NCT00788775|62754318|FG000|Overall Study|Progressive Disease|8|||
33375347|NCT00788775|62754319|FG001|Overall Study|Progressive Disease|6|||
33375348|NCT00788775|62754318|FG000|Overall Study|Withdrawal by Subject|0|||
33375349|NCT00788775|62754319|FG001|Overall Study|Withdrawal by Subject|2|||
33375350|NCT00788775|62754318|FG000|Overall Study|Patient Non-Compliance|1|||
33375351|NCT00788775|62754319|FG001|Overall Study|Patient Non-Compliance|0|||
33375352|NCT00788775|62754318|FG000|Overall Study|Patient's measurable disease resected.|1|||
33375353|NCT00788775|62754319|FG001|Overall Study|Patient's measurable disease resected.|0|||
33662358|NCT01695239|63092842|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33289697|NCT01085136|62666363|FG001|Part A|Other Adverse event|0|||
33375354|NCT00448669|62754327|FG000|Overall Study|Lost to Follow-up|52|||
33375355|NCT00448669|62754328|FG001|Overall Study|Lost to Follow-up|63|||
33375356|NCT00448669|62754327|FG000|Overall Study|Withdrawal by Subject|90|||
33375357|NCT00448669|62754328|FG001|Overall Study|Withdrawal by Subject|74|||
33289698|NCT01085136|62666364|FG002|Part A|Other Adverse event|0|||
33375358|NCT00448669|62754327|FG000|Overall Study|Relocated|49|||
33375359|NCT00448669|62754328|FG001|Overall Study|Relocated|36|||
33375360|NCT00448669|62754327|FG000|Overall Study|Were withdrawn by investigator|10|||
33375361|NCT00448669|62754328|FG001|Overall Study|Were withdrawn by investigator|6|||
33662359|NCT01695239|63092843|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33289699|NCT01085136|62666362|FG000|Part A|Protocol Violation|3|||
33289700|NCT01085136|62666363|FG001|Part A|Protocol Violation|0|||
33375362|NCT00448669|62754327|FG000|Overall Study|Death|2|||
33375363|NCT00448669|62754328|FG001|Overall Study|Death|4|||
33375364|NCT00448669|62754327|FG000|Overall Study|Had other reasons|5|||
33375365|NCT00448669|62754328|FG001|Overall Study|Had other reasons|6|||
33556356|NCT01596062|62949246|FG001|Overall Study|Lack of Efficacy|0|||
33556357|NCT01596062|62949247|FG002|Overall Study|Lack of Efficacy|1|||
33556358|NCT02614898|62949266|FG000|Overall Study|Participated until study termination|10|||
33556359|NCT02614898|62949267|FG001|Overall Study|Participated until study termination|26|||
33556360|NCT02614898|62949266|FG000|Overall Study|Lost to Follow-up|0|||
33556361|NCT02614898|62949267|FG001|Overall Study|Lost to Follow-up|2|||
33289701|NCT01085136|62666364|FG002|Part A|Protocol Violation|0|||
33289702|NCT01085136|62666362|FG000|Part A|Lost to Follow-up|3|||
33375366|NCT00448669|62754327|FG000|Overall Study|HIV-infected at enrollment|1|||
33375367|NCT00448669|62754328|FG001|Overall Study|HIV-infected at enrollment|2|||
33289703|NCT01085136|62666363|FG001|Part A|Lost to Follow-up|0|||
33289704|NCT01085136|62666364|FG002|Part A|Lost to Follow-up|0|||
33289705|NCT01085136|62666362|FG000|Part A|Refusal to continue trial medication|64|||
33289706|NCT01085136|62666363|FG001|Part A|Refusal to continue trial medication|0|||
33289707|NCT01085136|62666364|FG002|Part A|Refusal to continue trial medication|0|||
33289708|NCT01085136|62666362|FG000|Part A|Other reason not defined above|30|||
33289709|NCT01085136|62666363|FG001|Part A|Other reason not defined above|0|||
33289710|NCT01085136|62666364|FG002|Part A|Other reason not defined above|0|||
33289711|NCT01085136|62666362|FG000|Part B|Other AE|0|||
33289712|NCT01085136|62666363|FG001|Part B|Other AE|29|||
33289713|NCT01085136|62666364|FG002|Part B|Other AE|8|||
33289714|NCT01085136|62666362|FG000|Part B|Refusal to continue trial medication|0|||
33289715|NCT01085136|62666363|FG001|Part B|Refusal to continue trial medication|12|||
33289716|NCT01085136|62666364|FG002|Part B|Refusal to continue trial medication|7|||
33289717|NCT01085136|62666362|FG000|Part B|Not treated|0|||
33289718|NCT01085136|62666363|FG001|Part B|Not treated|4|||
33289719|NCT01085136|62666364|FG002|Part B|Not treated|8|||
33289720|NCT01085136|62666362|FG000|Part B|Other reason not defined above|0|||
33289721|NCT01085136|62666363|FG001|Part B|Other reason not defined above|6|||
33289722|NCT01085136|62666364|FG002|Part B|Other reason not defined above|3|||
33289723|NCT01084707|62666374|FG000|Overall Study|Withdrawal by Subject|6|||
33289724|NCT01084668|62666386|FG000|Overall Study|Lack of Efficacy|5|||
33289725|NCT01084668|62666386|FG000|Overall Study|Withdrawal by Subject|2|||
33289726|NCT01084668|62666386|FG000|Overall Study|Pregnancy|1|||
33289727|NCT01084668|62666386|FG000|Overall Study|Non-compliance|1|||
33289728|NCT01084551|62666395|FG000|Overall Study|Adverse Event|2|||
33289729|NCT01084551|62666396|FG001|Overall Study|Adverse Event|9|||
33289730|NCT01084551|62666397|FG002|Overall Study|Adverse Event|4|||
33289731|NCT01084551|62666395|FG000|Overall Study|Lack of Efficacy|2|||
33289732|NCT01084551|62666396|FG001|Overall Study|Lack of Efficacy|0|||
33289733|NCT01084551|62666397|FG002|Overall Study|Lack of Efficacy|1|||
33289734|NCT01084551|62666395|FG000|Overall Study|Withdrawal by Subject|2|||
33289735|NCT01084551|62666396|FG001|Overall Study|Withdrawal by Subject|1|||
33289736|NCT01084551|62666397|FG002|Overall Study|Withdrawal by Subject|0|||
33289737|NCT01084551|62666395|FG000|Overall Study|Protocol Violation|2|||
33289738|NCT01084551|62666396|FG001|Overall Study|Protocol Violation|4|||
33289739|NCT01084551|62666397|FG002|Overall Study|Protocol Violation|0|||
33289740|NCT01084551|62666395|FG000|Overall Study|Lost to Follow-up|0|||
33289741|NCT01084551|62666396|FG001|Overall Study|Lost to Follow-up|0|||
33289742|NCT01084551|62666397|FG002|Overall Study|Lost to Follow-up|3|||
33289743|NCT01084551|62666395|FG000|Overall Study|Physician Decision|1|||
33289744|NCT01084551|62666396|FG001|Overall Study|Physician Decision|0|||
33289745|NCT01084551|62666397|FG002|Overall Study|Physician Decision|0|||
33289746|NCT01084005|62666407|FG000|Overall Study|Adverse Event|1|||
33289747|NCT01084005|62666408|FG001|Overall Study|Adverse Event|8|||
33289748|NCT01084005|62666407|FG000|Overall Study|Protocol Violation|3|||
33375368|NCT00448669|62754327|FG000|Overall Study|Never started drug|9|||
33375369|NCT00448669|62754328|FG001|Overall Study|Never started drug|7|||
33375370|NCT00591734|62754336|FG000|Overall Study|Lack of Efficacy|35|||
33375371|NCT00591734|62754336|FG000|Overall Study|Adverse Event|5|||
33375372|NCT00591734|62754336|FG000|Overall Study|Physician Decision|5|||
33375373|NCT00591734|62754336|FG000|Overall Study|Intercurrent Illness|8|||
33375374|NCT00788697|62754340|FG000|Overall Study|No study drug administered|12|||
33289749|NCT01084005|62666408|FG001|Overall Study|Protocol Violation|7|||
33289750|NCT01084005|62666407|FG000|Overall Study|Withdrawal by Subject|1|||
33556362|NCT02614898|62949266|FG000|Overall Study|Physician Decision|1|||
33375375|NCT00788697|62754340|FG000|Overall Study|Training Patients|74|||
33556363|NCT02614898|62949267|FG001|Overall Study|Physician Decision|8|||
33289751|NCT01084005|62666408|FG001|Overall Study|Withdrawal by Subject|1|||
33289752|NCT01083810|62666417|FG000|Overall Study|Lost to Follow-up|23|||
33289753|NCT01083810|62666418|FG001|Overall Study|Lost to Follow-up|11|||
33289754|NCT01083810|62666419|FG002|Overall Study|Lost to Follow-up|4|||
33289755|NCT01083810|62666417|FG000|Overall Study|Adverse Event|15|||
33289756|NCT01083810|62666418|FG001|Overall Study|Adverse Event|11|||
33289757|NCT01083810|62666419|FG002|Overall Study|Adverse Event|4|||
33289758|NCT01083810|62666417|FG000|Overall Study|Withdrawal by Subject|7|||
33375376|NCT00788697|62754340|FG000|Overall Study|no truth standard procedure available|5|||
33375377|NCT00788697|62754340|FG000|Overall Study|Technically inadequate truth standard|1|||
33375378|NCT00788697|62754340|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
33375379|NCT00848549|62754354|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
33375380|NCT00848549|62754355|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
33375381|NCT00848549|62754354|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
33375382|NCT00848549|62754355|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
33375383|NCT00848549|62754354|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
33375384|NCT00848549|62754355|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
33375385|NCT00848549|62754354|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
33375386|NCT00848549|62754355|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
33375387|NCT00848549|62754354|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
33375388|NCT00848549|62754355|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
33375389|NCT00848549|62754354|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
33375390|NCT00848549|62754355|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
33375391|NCT00848549|62754354|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
33375392|NCT00848549|62754355|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
33375393|NCT00848549|62754354|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
33375394|NCT00848549|62754355|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
33375395|NCT00848549|62754354|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
33375396|NCT00848549|62754355|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
33375397|NCT00848549|62754354|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
33375398|NCT00848549|62754355|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
33375399|NCT00848549|62754354|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
33375400|NCT00848549|62754355|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
33375401|NCT00848549|62754354|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
33375402|NCT00848549|62754355|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
33375403|NCT00848549|62754354|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
33375404|NCT00848549|62754355|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
33375405|NCT00848549|62754354|FG000|E2090-E044-314 (Extension Study)|Other|5|||
33375406|NCT00848549|62754355|FG001|E2090-E044-314 (Extension Study)|Other|6|||
33375407|NCT00788151|62754365|FG000|Overall Study|Other adverse event|0|||
33375408|NCT00788151|62754366|FG001|Overall Study|Other adverse event|2|||
33375409|NCT00788151|62754365|FG000|Overall Study|Protocol Violation|0|||
33375410|NCT00788151|62754366|FG001|Overall Study|Protocol Violation|1|||
33375411|NCT00788151|62754365|FG000|Overall Study|Withdrawal by Subject|13|||
33375412|NCT00788151|62754366|FG001|Overall Study|Withdrawal by Subject|6|||
33375413|NCT00788151|62754365|FG000|Overall Study|Enrolled but not treated|1|||
33375414|NCT00788151|62754366|FG001|Overall Study|Enrolled but not treated|1|||
33375415|NCT00788073|62754374|FG000|STX209 Then Placebo|Adverse Event|1|||
33375416|NCT00788073|62754375|FG001|STX209 Then Placebo|Adverse Event|0|||
33375417|NCT00788073|62754374|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
33375418|NCT00788073|62754375|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
33375419|NCT00788073|62754374|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
33375420|NCT00788073|62754375|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
33375421|NCT00788073|62754374|FG000|STX209 Then Placebo|unable to return due to travel|0|||
33375422|NCT00788073|62754375|FG001|STX209 Then Placebo|unable to return due to travel|1|||
33375423|NCT00788073|62754374|FG000|Placebo Then STX209|Adverse Event|2|||
33375424|NCT00788073|62754375|FG001|Placebo Then STX209|Adverse Event|0|||
33375425|NCT00788073|62754374|FG000|Placebo Then STX209|Protocol Violation|0|||
33375426|NCT00788073|62754375|FG001|Placebo Then STX209|Protocol Violation|1|||
33375427|NCT00848393|62754384|FG000|Overall Study|Protocol Violation|0|||
33375428|NCT00848393|62754385|FG001|Overall Study|Protocol Violation|0|||
33289759|NCT01083810|62666418|FG001|Overall Study|Withdrawal by Subject|2|||
33289760|NCT01083810|62666419|FG002|Overall Study|Withdrawal by Subject|4|||
33289761|NCT01083810|62666417|FG000|Overall Study|Reason not reported|6|||
33289762|NCT01083810|62666418|FG001|Overall Study|Reason not reported|1|||
33289763|NCT01083810|62666419|FG002|Overall Study|Reason not reported|1|||
33289764|NCT01083810|62666417|FG000|Overall Study|Non-compliance|4|||
33289765|NCT01083810|62666418|FG001|Overall Study|Non-compliance|7|||
33289766|NCT01083810|62666419|FG002|Overall Study|Non-compliance|2|||
33289767|NCT01083810|62666417|FG000|Overall Study|Simplification|4|||
33289768|NCT01083810|62666418|FG001|Overall Study|Simplification|1|||
33375429|NCT00848393|62754386|FG002|Overall Study|Protocol Violation|1|||
33375430|NCT00848393|62754384|FG000|Overall Study|surgical complications unrelated to stud|0|||
33662360|NCT01695239|63092844|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33556364|NCT02614898|62949266|FG000|Overall Study|Study Terminated by Sponsor|3|||
33375431|NCT00848393|62754385|FG001|Overall Study|surgical complications unrelated to stud|0|||
33289769|NCT01083810|62666419|FG002|Overall Study|Simplification|0|||
33289770|NCT01083810|62666417|FG000|Overall Study|Death|2|||
33289771|NCT01083810|62666418|FG001|Overall Study|Death|2|||
33375432|NCT00848393|62754386|FG002|Overall Study|surgical complications unrelated to stud|2|||
33375433|NCT00815516|62754400|FG000|Overall Study|Death|3|||
33375434|NCT00815516|62754401|FG001|Overall Study|Death|1|||
33375435|NCT00815516|62754400|FG000|Overall Study|Physician Decision|1|||
33375436|NCT00815516|62754401|FG001|Overall Study|Physician Decision|0|||
33375437|NCT00787917|62754409|FG000|Blinded Treatment|Adverse Event|1|||
33375438|NCT00787917|62754410|FG001|Blinded Treatment|Adverse Event|0|||
33375439|NCT00787917|62754409|FG000|Blinded Treatment|Lack of Efficacy|1|||
33375440|NCT00787917|62754410|FG001|Blinded Treatment|Lack of Efficacy|0|||
33375441|NCT00787917|62754409|FG000|Blinded Treatment|Administrative problems|3|||
33375442|NCT00787917|62754410|FG001|Blinded Treatment|Administrative problems|2|||
33375443|NCT00787917|62754409|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
33375444|NCT00787917|62754410|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
33375445|NCT00787917|62754409|FG000|Open Label|Administrative problems|3|||
33375446|NCT00787917|62754410|FG001|Open Label|Administrative problems|0|||
33375447|NCT00814892|62754418|FG000|Overall Study|Disease Progression|1|||
33375448|NCT00814892|62754418|FG000|Overall Study|Study Termination|1|||
33289772|NCT01083810|62666419|FG002|Overall Study|Death|3|||
33289773|NCT01083810|62666417|FG000|Overall Study|Co-morbidities|1|||
33289774|NCT01083810|62666418|FG001|Overall Study|Co-morbidities|0|||
33375449|NCT00787839|62754422|FG000|Overall Study|Failure to have the OGTT was most common|404|||
33375450|NCT00829244|62754445|FG000|Overall Study|Adverse Event|1|||
33375451|NCT00829244|62754446|FG001|Overall Study|Adverse Event|3|||
33375452|NCT00829244|62754445|FG000|Overall Study|Protocol Violation|1|||
33375453|NCT00829244|62754446|FG001|Overall Study|Protocol Violation|0|||
33375454|NCT00829244|62754445|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
33375455|NCT00829244|62754446|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
33375456|NCT00829244|62754445|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
33375457|NCT00829244|62754446|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
33375458|NCT00829244|62754445|FG000|Overall Study|No fertilization|2|||
33375459|NCT00829244|62754446|FG001|Overall Study|No fertilization|2|||
33375460|NCT00829244|62754445|FG000|Overall Study|All embryos discarded|0|||
33375461|NCT00829244|62754446|FG001|Overall Study|All embryos discarded|3|||
33375462|NCT00829244|62754445|FG000|Overall Study|No embryo cleavage|0|||
33375463|NCT00829244|62754446|FG001|Overall Study|No embryo cleavage|2|||
33486847|NCT03248882|62864781|FG003|Overall Study|Withdrawal by Subject|4|||
33486848|NCT03248882|62864782|FG004|Overall Study|Withdrawal by Subject|2|||
33486849|NCT03233438|62864796|FG000|Overall Study|Lost to Follow-up|4|||
33289775|NCT01083810|62666419|FG002|Overall Study|Co-morbidities|0|||
33289776|NCT01083810|62666417|FG000|Overall Study|Participation in study|1|||
33289777|NCT01083810|62666418|FG001|Overall Study|Participation in study|0|||
33289778|NCT01083810|62666419|FG002|Overall Study|Participation in study|0|||
33289779|NCT01083810|62666417|FG000|Overall Study|Therapy break|1|||
33289780|NCT01083810|62666418|FG001|Overall Study|Therapy break|2|||
33289781|NCT01083810|62666419|FG002|Overall Study|Therapy break|2|||
33289782|NCT01083810|62666417|FG000|Overall Study|Virologic failure|1|||
33289783|NCT01083810|62666418|FG001|Overall Study|Virologic failure|8|||
33289784|NCT01083810|62666419|FG002|Overall Study|Virologic failure|0|||
33289785|NCT01083771|62666425|FG000|Overall Study|non-compliant|2|||
33289786|NCT01083771|62666425|FG000|Overall Study|Withdrawal by Subject|3|||
33289787|NCT01083693|62666432|FG000|Overall Study|Adverse Event|1|||
33289788|NCT01083693|62666433|FG001|Overall Study|Adverse Event|1|||
33289789|NCT01083693|62666434|FG002|Overall Study|Adverse Event|0|||
33289790|NCT01083693|62666432|FG000|Overall Study|Lost to Follow-up|2|||
33289791|NCT01083693|62666433|FG001|Overall Study|Lost to Follow-up|0|||
33289792|NCT01083693|62666434|FG002|Overall Study|Lost to Follow-up|2|||
33289793|NCT01083693|62666432|FG000|Overall Study|Lack of effectiveness|13|||
33289794|NCT01083693|62666433|FG001|Overall Study|Lack of effectiveness|2|||
33289795|NCT01083693|62666434|FG002|Overall Study|Lack of effectiveness|2|||
33289796|NCT01083693|62666432|FG000|Overall Study|Patient Moved|0|||
33289797|NCT01083693|62666433|FG001|Overall Study|Patient Moved|1|||
33289798|NCT01083693|62666434|FG002|Overall Study|Patient Moved|0|||
33375464|NCT00787605|62754454|FG000|Overall Study|Administrative Problems|3|||
33375465|NCT00787605|62754455|FG001|Overall Study|Administrative Problems|0|||
33375466|NCT00787605|62754454|FG000|Overall Study|Adverse Event|14|||
33486850|NCT03233438|62864797|FG001|Overall Study|Lost to Follow-up|9|||
33289799|NCT01083693|62666432|FG000|Overall Study|Complete remission|0|||
33289800|NCT01083693|62666433|FG001|Overall Study|Complete remission|1|||
33289801|NCT01083693|62666434|FG002|Overall Study|Complete remission|0|||
33289802|NCT01083693|62666432|FG000|Overall Study|Other medical condition/surgery|1|||
33289803|NCT01083693|62666433|FG001|Overall Study|Other medical condition/surgery|1|||
33289804|NCT01083693|62666434|FG002|Overall Study|Other medical condition/surgery|0|||
33289805|NCT01083693|62666432|FG000|Overall Study|Withdrawal by Subject|3|||
33375467|NCT00787605|62754455|FG001|Overall Study|Adverse Event|25|||
33375468|NCT00787605|62754454|FG000|Overall Study|Lost to Follow-up|3|||
33375469|NCT00787605|62754455|FG001|Overall Study|Lost to Follow-up|6|||
33375470|NCT00787605|62754454|FG000|Overall Study|Protocol Violation|7|||
33375471|NCT00787605|62754455|FG001|Overall Study|Protocol Violation|3|||
33289806|NCT01083693|62666433|FG001|Overall Study|Withdrawal by Subject|0|||
33289807|NCT01083693|62666434|FG002|Overall Study|Withdrawal by Subject|2|||
33289808|NCT01083693|62666432|FG000|Overall Study|Reason unknown|0|||
33289809|NCT01083693|62666433|FG001|Overall Study|Reason unknown|0|||
33289810|NCT01083693|62666434|FG002|Overall Study|Reason unknown|1|||
33289811|NCT01083576|62666448|FG000|Overall Study|Treatment Failure|6|||
33289812|NCT01083576|62666449|FG001|Overall Study|Treatment Failure|1|||
33289813|NCT01083186|62666456|FG000|Overall Study|Lost to Follow-up|48|||
33289814|NCT01083186|62666456|FG000|Overall Study|Consent Withdrawal|7|||
33289815|NCT01083186|62666456|FG000|Overall Study|Death|3|||
33289816|NCT01083186|62666456|FG000|Overall Study|Adverse Event|3|||
33289817|NCT01083186|62666456|FG000|Overall Study|Lack of Efficacy|2|||
33289818|NCT01083186|62666456|FG000|Overall Study|Hemodialysis Initiation|28|||
33289819|NCT01083186|62666456|FG000|Overall Study|Administrative Reasons|2|||
33289820|NCT01083186|62666456|FG000|Overall Study|Non-compliance to Study Treatment|1|||
33289821|NCT01082640|62666483|FG000|Overall Study|Adverse Event|9|||
33289822|NCT01082640|62666484|FG001|Overall Study|Adverse Event|5|||
33289823|NCT01082640|62666485|FG002|Overall Study|Adverse Event|3|||
33289824|NCT01082640|62666483|FG000|Overall Study|Withdrawal by Subject|3|||
33289825|NCT01082640|62666484|FG001|Overall Study|Withdrawal by Subject|3|||
33289826|NCT01082640|62666485|FG002|Overall Study|Withdrawal by Subject|2|||
33289827|NCT01082640|62666483|FG000|Overall Study|Major protocol deviation|3|||
33289828|NCT01082640|62666484|FG001|Overall Study|Major protocol deviation|3|||
33289829|NCT01082640|62666485|FG002|Overall Study|Major protocol deviation|0|||
33289830|NCT01082640|62666483|FG000|Overall Study|Lost to Follow-up|0|||
33289831|NCT01082640|62666484|FG001|Overall Study|Lost to Follow-up|3|||
33289832|NCT01082640|62666485|FG002|Overall Study|Lost to Follow-up|0|||
33289833|NCT01082640|62666483|FG000|Overall Study|Other|2|||
33289834|NCT01082640|62666484|FG001|Overall Study|Other|1|||
33289835|NCT01082640|62666485|FG002|Overall Study|Other|3|||
33289836|NCT01082367|62666498|FG000|Double-blind Period|Administrative problems|0|||
33289837|NCT01082367|62666499|FG001|Double-blind Period|Administrative problems|1|||
33289838|NCT01082367|62666498|FG000|Double-blind Period|Lack of Efficacy|5|||
33289839|NCT01082367|62666499|FG001|Double-blind Period|Lack of Efficacy|11|||
33289840|NCT01082367|62666498|FG000|Double-blind Period|Adverse Event|0|||
33289841|NCT01082367|62666499|FG001|Double-blind Period|Adverse Event|1|||
33289842|NCT01082367|62666498|FG000|Follow-up (F-U) Period|Administrative problems|1|||
33289843|NCT01082367|62666499|FG001|Follow-up (F-U) Period|Administrative problems|0|||
33289844|NCT01082367|62666498|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
33289845|NCT01082367|62666499|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
33289846|NCT01082367|62666498|FG000|Follow-up (F-U) Period|Adverse Event|0|||
33289847|NCT01082367|62666499|FG001|Follow-up (F-U) Period|Adverse Event|1|||
33289848|NCT01082211|62666509|FG000|Overall Study|Protocol Violation|4|||
33289849|NCT01082211|62666509|FG000|Overall Study|No protocol treatment received|3|||
33289850|NCT01081665|62666516|FG000|Overall Study|Death|41|||
33289851|NCT01081665|62666516|FG000|Overall Study|Lost to Follow-up|18|||
33289852|NCT01081665|62666516|FG000|Overall Study|Withdrawal by Subject|17|||
33289853|NCT01081665|62666516|FG000|Overall Study|Change of dialysis unit|10|||
33289854|NCT01081665|62666516|FG000|Overall Study|Regulation of iPTH|5|||
33289855|NCT01081665|62666516|FG000|Overall Study|Change in renal replacement therapy|2|||
33289856|NCT01081665|62666516|FG000|Overall Study|Adverse Event|1|||
33289857|NCT01081665|62666516|FG000|Overall Study|Lack of Efficacy|1|||
33289858|NCT01081626|62666522|FG000|Overall Study|Dosing error|1|||
33289859|NCT01081626|62666523|FG001|Overall Study|Dosing error|1|||
33289860|NCT01081626|62666522|FG000|Overall Study|Missing Estradiol|25|||
33289861|NCT01081626|62666523|FG001|Overall Study|Missing Estradiol|28|||
33289862|NCT01081626|62666522|FG000|Overall Study|Low antral follicle count|1|||
33289863|NCT01081626|62666523|FG001|Overall Study|Low antral follicle count|0|||
33375472|NCT00787605|62754454|FG000|Overall Study|Withdrawal by Subject|6|||
33375473|NCT00787605|62754455|FG001|Overall Study|Withdrawal by Subject|13|||
33375474|NCT00787605|62754454|FG000|Overall Study|Lack of Efficacy|13|||
33375475|NCT00787605|62754455|FG001|Overall Study|Lack of Efficacy|9|||
33375476|NCT00448591|62754461|FG000|Overall Study|Withdrawal by Subject|178|||
33375477|NCT00448591|62754461|FG000|Overall Study|Progressive Disease|1382|||
33375478|NCT00448591|62754461|FG000|Overall Study|Adverse Event|382|||
33375479|NCT00448591|62754461|FG000|Overall Study|Protocol Violation|41|||
33289864|NCT01081626|62666522|FG000|Overall Study|Overstimulation|0|||
33289865|NCT01081626|62666523|FG001|Overall Study|Overstimulation|1|||
33289866|NCT01081626|62666522|FG000|Overall Study|Lost to Follow-up|0|||
33289867|NCT01081626|62666523|FG001|Overall Study|Lost to Follow-up|1|||
33289868|NCT01081626|62666522|FG000|Overall Study|Other|33|||
33289869|NCT01081626|62666523|FG001|Overall Study|Other|30|||
33289870|NCT01080768|62666531|FG000|Overall Study|Protocol Deviation|2|||
33289871|NCT01080768|62666532|FG001|Overall Study|Protocol Deviation|1|||
33289872|NCT01080300|62666540|FG000|Overall Study|Adverse Event|49|||
33289873|NCT01080300|62666541|FG001|Overall Study|Adverse Event|35|||
33289874|NCT01080300|62666540|FG000|Overall Study|Lack of Efficacy|12|||
33375480|NCT00448591|62754461|FG000|Overall Study|Lost to Follow-up|19|||
33375481|NCT00448591|62754461|FG000|Overall Study|Treatment Regimen Completed|70|||
33289875|NCT01080300|62666541|FG001|Overall Study|Lack of Efficacy|15|||
33289876|NCT01080300|62666540|FG000|Overall Study|Protocol Violation|7|||
33289877|NCT01080300|62666541|FG001|Overall Study|Protocol Violation|13|||
33289878|NCT01080300|62666540|FG000|Overall Study|Lost to Follow-up|10|||
33289879|NCT01080300|62666541|FG001|Overall Study|Lost to Follow-up|6|||
33289880|NCT01080300|62666540|FG000|Overall Study|Death|0|||
33289881|NCT01080300|62666541|FG001|Overall Study|Death|1|||
33289882|NCT01080300|62666540|FG000|Overall Study|Withdrawal by Subject|12|||
33289883|NCT01080300|62666541|FG001|Overall Study|Withdrawal by Subject|28|||
33289884|NCT01080300|62666540|FG000|Overall Study|Reasons not specified|4|||
33289885|NCT01080300|62666541|FG001|Overall Study|Reasons not specified|6|||
33289886|NCT01085097|62666552|FG000|Overall Study|Adverse Event|0|||
33289887|NCT01085097|62666553|FG001|Overall Study|Adverse Event|0|||
33289888|NCT01085097|62666554|FG002|Overall Study|Adverse Event|2|||
33289889|NCT01085097|62666552|FG000|Overall Study|Treatment failure|2|||
33289890|NCT01085097|62666553|FG001|Overall Study|Treatment failure|0|||
33289891|NCT01085097|62666554|FG002|Overall Study|Treatment failure|0|||
33289892|NCT03450629|62666568|FG000|Overall Study|Adverse Event|15|||
33289893|NCT03450629|62666569|FG001|Overall Study|Adverse Event|14|||
33289894|NCT03450629|62666568|FG000|Overall Study|Physician Decision|2|||
33289895|NCT03450629|62666569|FG001|Overall Study|Physician Decision|2|||
33289896|NCT03450629|62666568|FG000|Overall Study|Lack of Efficacy|2|||
33289897|NCT03450629|62666569|FG001|Overall Study|Lack of Efficacy|0|||
33289898|NCT03450629|62666568|FG000|Overall Study|Lost to Follow-up|4|||
33289899|NCT03450629|62666569|FG001|Overall Study|Lost to Follow-up|2|||
33289900|NCT03450629|62666568|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33289901|NCT03450629|62666569|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
33289902|NCT03450629|62666568|FG000|Overall Study|Non-Compliance With Study Drug|2|||
33289903|NCT03450629|62666569|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33289904|NCT03450629|62666568|FG000|Overall Study|Protocol Violation|11|||
33289905|NCT03450629|62666569|FG001|Overall Study|Protocol Violation|8|||
33289906|NCT03450629|62666568|FG000|Overall Study|Withdrawal by Subject|12|||
33289907|NCT03450629|62666569|FG001|Overall Study|Withdrawal by Subject|6|||
33289908|NCT00198029|62666575|FG000|Overall Study|Withdrawal by Subject|4|||
33289909|NCT00197054|62666582|FG000|Overall Study|Withdrawal by Subject|9|||
33289910|NCT00197054|62666583|FG001|Overall Study|Withdrawal by Subject|3|||
33289911|NCT00197054|62666584|FG002|Overall Study|Withdrawal by Subject|3|||
33289912|NCT00197054|62666582|FG000|Overall Study|Moved from area|7|||
33289913|NCT00197054|62666583|FG001|Overall Study|Moved from area|14|||
33289914|NCT00197054|62666584|FG002|Overall Study|Moved from area|9|||
33289915|NCT00197054|62666582|FG000|Overall Study|Lost to Follow-up|1|||
33289916|NCT00197054|62666583|FG001|Overall Study|Lost to Follow-up|4|||
33375482|NCT00448591|62754461|FG000|Overall Study|Other|154|||
33375483|NCT00448591|62754461|FG000|Overall Study|Termination of Study|70|||
33375484|NCT00651664|62754477|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
33375485|NCT00651664|62754478|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
33375486|NCT00651664|62754479|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
33375487|NCT00651664|62754480|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
33662361|NCT01695239|63092845|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
33662362|NCT01695239|63092846|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
33662363|NCT01695239|63092833|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
33662364|NCT01695239|63092834|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
33289917|NCT00197054|62666584|FG002|Overall Study|Lost to Follow-up|0|||
33289918|NCT00197015|62666605|FG000|Overall Study|Adverse Event|3|||
33289919|NCT00197015|62666606|FG001|Overall Study|Adverse Event|0|||
33289920|NCT00197015|62666607|FG002|Overall Study|Adverse Event|1|||
33289921|NCT00197015|62666605|FG000|Overall Study|Protocol Violation|0|||
33289922|NCT00197015|62666606|FG001|Overall Study|Protocol Violation|3|||
33289923|NCT00197015|62666607|FG002|Overall Study|Protocol Violation|3|||
33289924|NCT00197015|62666605|FG000|Overall Study|Withdrawal by Subject|17|||
33289925|NCT00197015|62666606|FG001|Overall Study|Withdrawal by Subject|37|||
33289926|NCT00197015|62666607|FG002|Overall Study|Withdrawal by Subject|34|||
33289927|NCT00197015|62666605|FG000|Overall Study|Lost to Follow-up|28|||
33289928|NCT00197015|62666606|FG001|Overall Study|Lost to Follow-up|46|||
33289929|NCT00197015|62666607|FG002|Overall Study|Lost to Follow-up|37|||
33289930|NCT00197015|62666605|FG000|Overall Study|Other|2|||
33375488|NCT00651664|62754481|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
33375489|NCT00651664|62754482|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
33289931|NCT00197015|62666606|FG001|Overall Study|Other|3|||
33289932|NCT00197015|62666607|FG002|Overall Study|Other|2|||
33289933|NCT00196976|62666629|FG000|Primary Study|Migrated from study area|0|||
33289934|NCT00196976|62666630|FG001|Primary Study|Migrated from study area|0|||
33289935|NCT00196976|62666631|FG002|Primary Study|Migrated from study area|0|||
33289936|NCT00196976|62666632|FG003|Primary Study|Migrated from study area|0|||
33289937|NCT00196976|62666633|FG004|Primary Study|Migrated from study area|0|||
33289938|NCT00196976|62666634|FG005|Primary Study|Migrated from study area|0|||
33289939|NCT00196976|62666635|FG006|Primary Study|Migrated from study area|0|||
33289940|NCT00196976|62666636|FG007|Primary Study|Migrated from study area|1|||
33289941|NCT00196976|62666637|FG008|Primary Study|Migrated from study area|0|||
33289942|NCT00196976|62666638|FG009|Primary Study|Migrated from study area|0|||
33289943|NCT00196976|62666639|FG010|Primary Study|Migrated from study area|0|||
33289944|NCT00196976|62666640|FG011|Primary Study|Migrated from study area|0|||
33289945|NCT00196976|62666641|FG012|Primary Study|Migrated from study area|0|||
33289946|NCT00196976|62666642|FG013|Primary Study|Migrated from study area|0|||
33289947|NCT00196976|62666629|FG000|Primary Study|Protocol Violation|0|||
33289948|NCT00196976|62666630|FG001|Primary Study|Protocol Violation|1|||
33289949|NCT00196976|62666631|FG002|Primary Study|Protocol Violation|1|||
33289950|NCT00196976|62666632|FG003|Primary Study|Protocol Violation|0|||
33289951|NCT00196976|62666633|FG004|Primary Study|Protocol Violation|0|||
33289952|NCT00196976|62666634|FG005|Primary Study|Protocol Violation|0|||
33289953|NCT00196976|62666635|FG006|Primary Study|Protocol Violation|0|||
33289954|NCT00196976|62666636|FG007|Primary Study|Protocol Violation|0|||
33289955|NCT00196976|62666637|FG008|Primary Study|Protocol Violation|0|||
33375490|NCT00651664|62754483|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
33375491|NCT00651664|62754484|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
33375492|NCT00651664|62754485|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
33375493|NCT00651664|62754486|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
33375494|NCT00651664|62754477|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
33375495|NCT00651664|62754478|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
33375496|NCT00651664|62754479|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
33375497|NCT00651664|62754480|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
33375498|NCT00651664|62754481|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
33375499|NCT00651664|62754482|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
33375500|NCT00651664|62754483|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
33375501|NCT00651664|62754484|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
33375502|NCT00651664|62754485|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
33375503|NCT00651664|62754486|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
33289956|NCT00196976|62666638|FG009|Primary Study|Protocol Violation|0|||
33289957|NCT00196976|62666639|FG010|Primary Study|Protocol Violation|0|||
33289958|NCT00196976|62666640|FG011|Primary Study|Protocol Violation|0|||
33289959|NCT00196976|62666641|FG012|Primary Study|Protocol Violation|0|||
33289960|NCT00196976|62666642|FG013|Primary Study|Protocol Violation|0|||
33289961|NCT00196976|62666629|FG000|Primary Study|Withdrawal by Subject|1|||
33289962|NCT00196976|62666630|FG001|Primary Study|Withdrawal by Subject|0|||
33289963|NCT00196976|62666631|FG002|Primary Study|Withdrawal by Subject|1|||
33289964|NCT00196976|62666632|FG003|Primary Study|Withdrawal by Subject|1|||
33289965|NCT00196976|62666633|FG004|Primary Study|Withdrawal by Subject|2|||
33289966|NCT00196976|62666634|FG005|Primary Study|Withdrawal by Subject|1|||
33289967|NCT00196976|62666635|FG006|Primary Study|Withdrawal by Subject|0|||
33289968|NCT00196976|62666636|FG007|Primary Study|Withdrawal by Subject|0|||
33289969|NCT00196976|62666637|FG008|Primary Study|Withdrawal by Subject|0|||
33289970|NCT00196976|62666638|FG009|Primary Study|Withdrawal by Subject|1|||
33289971|NCT00196976|62666639|FG010|Primary Study|Withdrawal by Subject|0|||
33289972|NCT00196976|62666640|FG011|Primary Study|Withdrawal by Subject|0|||
33289973|NCT00196976|62666641|FG012|Primary Study|Withdrawal by Subject|0|||
33289974|NCT00196976|62666642|FG013|Primary Study|Withdrawal by Subject|0|||
33289975|NCT00196976|62666629|FG000|Primary Study|Lost to Follow-up|0|||
33289976|NCT00196976|62666630|FG001|Primary Study|Lost to Follow-up|0|||
33289977|NCT00196976|62666631|FG002|Primary Study|Lost to Follow-up|0|||
33289978|NCT00196976|62666632|FG003|Primary Study|Lost to Follow-up|0|||
33289979|NCT00196976|62666633|FG004|Primary Study|Lost to Follow-up|1|||
33289980|NCT00196976|62666634|FG005|Primary Study|Lost to Follow-up|1|||
33289981|NCT00196976|62666635|FG006|Primary Study|Lost to Follow-up|0|||
33289982|NCT00196976|62666636|FG007|Primary Study|Lost to Follow-up|2|||
33289983|NCT00196976|62666637|FG008|Primary Study|Lost to Follow-up|0|||
33289984|NCT00196976|62666638|FG009|Primary Study|Lost to Follow-up|0|||
33289985|NCT00196976|62666639|FG010|Primary Study|Lost to Follow-up|0|||
33289986|NCT00196976|62666640|FG011|Primary Study|Lost to Follow-up|0|||
33662365|NCT01695239|63092835|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
33289987|NCT00196976|62666641|FG012|Primary Study|Lost to Follow-up|0|||
33289988|NCT00196976|62666642|FG013|Primary Study|Lost to Follow-up|0|||
33289989|NCT00196976|62666629|FG000|Primary Study|Other|0|||
33289990|NCT00196976|62666630|FG001|Primary Study|Other|0|||
33289991|NCT00196976|62666631|FG002|Primary Study|Other|2|||
33289992|NCT00196976|62666632|FG003|Primary Study|Other|0|||
33289993|NCT00196976|62666633|FG004|Primary Study|Other|0|||
33289994|NCT00196976|62666634|FG005|Primary Study|Other|0|||
33289995|NCT00196976|62666635|FG006|Primary Study|Other|0|||
33289996|NCT00196976|62666636|FG007|Primary Study|Other|0|||
33289997|NCT00196976|62666637|FG008|Primary Study|Other|0|||
33289998|NCT00196976|62666638|FG009|Primary Study|Other|0|||
33289999|NCT00196976|62666639|FG010|Primary Study|Other|0|||
33290000|NCT00196976|62666640|FG011|Primary Study|Other|0|||
33375504|NCT00651664|62754477|FG000|Overall Study|Progressive Disease|3|||
33375505|NCT00651664|62754478|FG001|Overall Study|Progressive Disease|3|||
33290001|NCT00196976|62666641|FG012|Primary Study|Other|0|||
33290002|NCT00196976|62666642|FG013|Primary Study|Other|0|||
33290003|NCT00196976|62666629|FG000|Booster Study|Withdrawal by Subject|0|||
33290004|NCT00196976|62666630|FG001|Booster Study|Withdrawal by Subject|0|||
33290005|NCT00196976|62666631|FG002|Booster Study|Withdrawal by Subject|0|||
33290006|NCT00196976|62666632|FG003|Booster Study|Withdrawal by Subject|0|||
33290007|NCT00196976|62666633|FG004|Booster Study|Withdrawal by Subject|0|||
33290008|NCT00196976|62666634|FG005|Booster Study|Withdrawal by Subject|0|||
33290009|NCT00196976|62666635|FG006|Booster Study|Withdrawal by Subject|0|||
33290010|NCT00196976|62666636|FG007|Booster Study|Withdrawal by Subject|0|||
33290011|NCT00196976|62666637|FG008|Booster Study|Withdrawal by Subject|0|||
33290012|NCT00196976|62666638|FG009|Booster Study|Withdrawal by Subject|0|||
33290013|NCT00196976|62666639|FG010|Booster Study|Withdrawal by Subject|1|||
33290014|NCT00196976|62666640|FG011|Booster Study|Withdrawal by Subject|0|||
33290015|NCT00196976|62666641|FG012|Booster Study|Withdrawal by Subject|0|||
33290016|NCT00196976|62666642|FG013|Booster Study|Withdrawal by Subject|0|||
33290017|NCT00196976|62666629|FG000|Booster Study|Lost to Follow-up|0|||
33290018|NCT00196976|62666630|FG001|Booster Study|Lost to Follow-up|0|||
33290019|NCT00196976|62666631|FG002|Booster Study|Lost to Follow-up|0|||
33375506|NCT00651664|62754479|FG002|Overall Study|Progressive Disease|3|||
33375507|NCT00651664|62754480|FG003|Overall Study|Progressive Disease|12|||
33375508|NCT00651664|62754481|FG004|Overall Study|Progressive Disease|4|||
33375509|NCT00651664|62754482|FG005|Overall Study|Progressive Disease|1|||
33375510|NCT00651664|62754483|FG006|Overall Study|Progressive Disease|3|||
33375511|NCT00651664|62754484|FG007|Overall Study|Progressive Disease|6|||
33290020|NCT00196976|62666632|FG003|Booster Study|Lost to Follow-up|0|||
33375512|NCT00651664|62754485|FG008|Overall Study|Progressive Disease|5|||
33375513|NCT00651664|62754486|FG009|Overall Study|Progressive Disease|5|||
33375514|NCT00651664|62754477|FG000|Overall Study|Patient Declined Further Treatment|0|||
33375515|NCT00651664|62754478|FG001|Overall Study|Patient Declined Further Treatment|0|||
33375516|NCT00651664|62754479|FG002|Overall Study|Patient Declined Further Treatment|0|||
33375517|NCT00651664|62754480|FG003|Overall Study|Patient Declined Further Treatment|1|||
33375518|NCT00651664|62754481|FG004|Overall Study|Patient Declined Further Treatment|1|||
33375519|NCT00651664|62754482|FG005|Overall Study|Patient Declined Further Treatment|1|||
33375520|NCT00651664|62754483|FG006|Overall Study|Patient Declined Further Treatment|0|||
33375521|NCT00651664|62754484|FG007|Overall Study|Patient Declined Further Treatment|0|||
33375522|NCT00651664|62754485|FG008|Overall Study|Patient Declined Further Treatment|0|||
33486851|NCT03233438|62864796|FG000|Overall Study|Withdrawal by Subject|2|||
33486852|NCT03233438|62864797|FG001|Overall Study|Withdrawal by Subject|1|||
33290021|NCT00196976|62666633|FG004|Booster Study|Lost to Follow-up|0|||
33290022|NCT00196976|62666634|FG005|Booster Study|Lost to Follow-up|0|||
33290023|NCT00196976|62666635|FG006|Booster Study|Lost to Follow-up|0|||
33290024|NCT00196976|62666636|FG007|Booster Study|Lost to Follow-up|0|||
33290025|NCT00196976|62666637|FG008|Booster Study|Lost to Follow-up|0|||
33290026|NCT00196976|62666638|FG009|Booster Study|Lost to Follow-up|0|||
33290027|NCT00196976|62666639|FG010|Booster Study|Lost to Follow-up|1|||
33290028|NCT00196976|62666640|FG011|Booster Study|Lost to Follow-up|2|||
33290029|NCT00196976|62666641|FG012|Booster Study|Lost to Follow-up|0|||
33290030|NCT00196976|62666642|FG013|Booster Study|Lost to Follow-up|0|||
33290031|NCT00196313|62666684|FG000|Overall Study|Protocol Violation|2|||
33290032|NCT00196313|62666685|FG001|Overall Study|Protocol Violation|3|||
33290033|NCT00196313|62666684|FG000|Overall Study|Withdrawal by Subject|3|||
33290034|NCT00196313|62666685|FG001|Overall Study|Withdrawal by Subject|1|||
33290035|NCT00196313|62666684|FG000|Overall Study|Adverse Event|3|||
33290036|NCT00196313|62666685|FG001|Overall Study|Adverse Event|1|||
33290037|NCT00196313|62666684|FG000|Overall Study|Subject Pregnant|1|||
33290038|NCT00196313|62666685|FG001|Overall Study|Subject Pregnant|1|||
33290039|NCT00196313|62666684|FG000|Overall Study|Lost to Follow-up|2|||
33290040|NCT00196313|62666685|FG001|Overall Study|Lost to Follow-up|2|||
33290041|NCT00196196|62666692|FG000|Overall Study|Withdrawal by Subject|2|||
33290042|NCT00196196|62666692|FG000|Overall Study|Did not have required condition (hydroce|5|||
33290043|NCT00195650|62666696|FG000|Overall Study|Adverse Event|194|||
33290044|NCT00195650|62666696|FG000|Overall Study|Lack of Efficacy|99|||
33290045|NCT00195650|62666696|FG000|Overall Study|Withdrawal by Subject|67|||
33290046|NCT00195650|62666696|FG000|Overall Study|Lost to Follow-up|44|||
33290047|NCT00195650|62666696|FG000|Overall Study|Death|23|||
33375523|NCT00651664|62754486|FG009|Overall Study|Patient Declined Further Treatment|1|||
33375524|NCT00651664|62754477|FG000|Overall Study|Symptomatic Deterioration|0|||
33375525|NCT00651664|62754478|FG001|Overall Study|Symptomatic Deterioration|0|||
33290048|NCT00195650|62666696|FG000|Overall Study|Protocol Violation|15|||
33290049|NCT00195650|62666696|FG000|Overall Study|Administrative reasons|83|||
33290050|NCT00195494|62666702|FG000|Year 1|Adverse Event|0|||
33290051|NCT00195494|62666703|FG001|Year 1|Adverse Event|0|||
33375526|NCT00651664|62754479|FG002|Overall Study|Symptomatic Deterioration|0|||
33375527|NCT00651664|62754480|FG003|Overall Study|Symptomatic Deterioration|1|||
33375528|NCT00651664|62754481|FG004|Overall Study|Symptomatic Deterioration|0|||
33580965|NCT01268150|62978110|FG000|Treatment Phase|Adverse Event|3|||
33290052|NCT00195494|62666704|FG002|Year 1|Adverse Event|0|||
33375529|NCT00651664|62754482|FG005|Overall Study|Symptomatic Deterioration|0|||
33290053|NCT00195494|62666705|FG003|Year 1|Adverse Event|0|||
33290054|NCT00195494|62666706|FG004|Year 1|Adverse Event|34|||
33290055|NCT00195494|62666707|FG005|Year 1|Adverse Event|27|||
33290056|NCT00195494|62666702|FG000|Year 1|System Toxicity|0|||
33290057|NCT00195494|62666703|FG001|Year 1|System Toxicity|0|||
33290058|NCT00195494|62666704|FG002|Year 1|System Toxicity|0|||
33290059|NCT00195494|62666705|FG003|Year 1|System Toxicity|0|||
33290060|NCT00195494|62666706|FG004|Year 1|System Toxicity|0|||
33290061|NCT00195494|62666707|FG005|Year 1|System Toxicity|1|||
33290062|NCT00195494|62666702|FG000|Year 1|Lack of Efficacy|0|||
33290063|NCT00195494|62666703|FG001|Year 1|Lack of Efficacy|0|||
33290064|NCT00195494|62666704|FG002|Year 1|Lack of Efficacy|0|||
33290065|NCT00195494|62666705|FG003|Year 1|Lack of Efficacy|0|||
33290066|NCT00195494|62666706|FG004|Year 1|Lack of Efficacy|24|||
33290067|NCT00195494|62666707|FG005|Year 1|Lack of Efficacy|9|||
33290068|NCT00195494|62666702|FG000|Year 1|Compliance|0|||
33290069|NCT00195494|62666703|FG001|Year 1|Compliance|0|||
33375530|NCT00651664|62754483|FG006|Overall Study|Symptomatic Deterioration|1|||
33375531|NCT00651664|62754484|FG007|Overall Study|Symptomatic Deterioration|0|||
33375532|NCT00651664|62754485|FG008|Overall Study|Symptomatic Deterioration|1|||
33375533|NCT00651664|62754486|FG009|Overall Study|Symptomatic Deterioration|0|||
33375534|NCT00651664|62754477|FG000|Overall Study|Reason not Specified|0|||
33375535|NCT00651664|62754478|FG001|Overall Study|Reason not Specified|0|||
33375536|NCT00651664|62754479|FG002|Overall Study|Reason not Specified|0|||
33375537|NCT00651664|62754480|FG003|Overall Study|Reason not Specified|0|||
33290070|NCT00195494|62666704|FG002|Year 1|Compliance|0|||
33290071|NCT00195494|62666705|FG003|Year 1|Compliance|0|||
33290072|NCT00195494|62666706|FG004|Year 1|Compliance|5|||
33290073|NCT00195494|62666707|FG005|Year 1|Compliance|1|||
33290074|NCT00195494|62666702|FG000|Year 1|Lost to Follow-up|0|||
33290075|NCT00195494|62666703|FG001|Year 1|Lost to Follow-up|0|||
33290076|NCT00195494|62666704|FG002|Year 1|Lost to Follow-up|0|||
33290077|NCT00195494|62666705|FG003|Year 1|Lost to Follow-up|0|||
33290078|NCT00195494|62666706|FG004|Year 1|Lost to Follow-up|1|||
33290079|NCT00195494|62666707|FG005|Year 1|Lost to Follow-up|0|||
33290080|NCT00195494|62666702|FG000|Year 1|Missed >4 consecutive doses|0|||
33290081|NCT00195494|62666703|FG001|Year 1|Missed >4 consecutive doses|0|||
33290082|NCT00195494|62666704|FG002|Year 1|Missed >4 consecutive doses|0|||
33290083|NCT00195494|62666705|FG003|Year 1|Missed >4 consecutive doses|0|||
33290084|NCT00195494|62666706|FG004|Year 1|Missed >4 consecutive doses|3|||
33290085|NCT00195494|62666707|FG005|Year 1|Missed >4 consecutive doses|2|||
33290086|NCT00195494|62666702|FG000|Year 1|Protocol deviation|0|||
33290087|NCT00195494|62666703|FG001|Year 1|Protocol deviation|0|||
33290088|NCT00195494|62666704|FG002|Year 1|Protocol deviation|0|||
33290089|NCT00195494|62666705|FG003|Year 1|Protocol deviation|0|||
33290090|NCT00195494|62666706|FG004|Year 1|Protocol deviation|2|||
33290091|NCT00195494|62666707|FG005|Year 1|Protocol deviation|3|||
33290092|NCT00195494|62666702|FG000|Year 1|Physician Decision|0|||
33290093|NCT00195494|62666703|FG001|Year 1|Physician Decision|0|||
33290094|NCT00195494|62666704|FG002|Year 1|Physician Decision|0|||
33290095|NCT00195494|62666705|FG003|Year 1|Physician Decision|0|||
33290096|NCT00195494|62666706|FG004|Year 1|Physician Decision|1|||
33290097|NCT00195494|62666707|FG005|Year 1|Physician Decision|0|||
33290098|NCT00195494|62666702|FG000|Year 1|Withdrawal by Subject|0|||
33290099|NCT00195494|62666703|FG001|Year 1|Withdrawal by Subject|0|||
33290100|NCT00195494|62666704|FG002|Year 1|Withdrawal by Subject|0|||
33290101|NCT00195494|62666705|FG003|Year 1|Withdrawal by Subject|0|||
33290102|NCT00195494|62666706|FG004|Year 1|Withdrawal by Subject|8|||
33290103|NCT00195494|62666707|FG005|Year 1|Withdrawal by Subject|9|||
33375538|NCT00651664|62754481|FG004|Overall Study|Reason not Specified|0|||
33375539|NCT00651664|62754482|FG005|Overall Study|Reason not Specified|0|||
33290104|NCT00195494|62666702|FG000|Year 1|Protocol Violation|0|||
33290105|NCT00195494|62666703|FG001|Year 1|Protocol Violation|0|||
33290106|NCT00195494|62666704|FG002|Year 1|Protocol Violation|0|||
33290107|NCT00195494|62666705|FG003|Year 1|Protocol Violation|0|||
33375540|NCT00651664|62754483|FG006|Overall Study|Reason not Specified|1|||
33375541|NCT00651664|62754484|FG007|Overall Study|Reason not Specified|0|||
33290108|NCT00195494|62666706|FG004|Year 1|Protocol Violation|1|||
33290109|NCT00195494|62666707|FG005|Year 1|Protocol Violation|1|||
33290110|NCT00195494|62666702|FG000|Year 2|Adverse Event|3|||
33290111|NCT00195494|62666703|FG001|Year 2|Adverse Event|7|||
33375542|NCT00651664|62754485|FG008|Overall Study|Reason not Specified|0|||
33375543|NCT00651664|62754486|FG009|Overall Study|Reason not Specified|0|||
33375544|NCT00787527|62754512|FG000|Overall Study|Toxicity|3|||
33375545|NCT00787137|62754523|FG000|Overall Study|Study Termination|0|||
33290112|NCT00195494|62666704|FG002|Year 2|Adverse Event|5|||
33290113|NCT00195494|62666705|FG003|Year 2|Adverse Event|9|||
33290114|NCT00195494|62666706|FG004|Year 2|Adverse Event|0|||
33290115|NCT00195494|62666707|FG005|Year 2|Adverse Event|0|||
33290116|NCT00195494|62666702|FG000|Year 2|Lack of Efficacy|0|||
33290117|NCT00195494|62666703|FG001|Year 2|Lack of Efficacy|1|||
33290118|NCT00195494|62666704|FG002|Year 2|Lack of Efficacy|7|||
33290119|NCT00195494|62666705|FG003|Year 2|Lack of Efficacy|7|||
33290120|NCT00195494|62666706|FG004|Year 2|Lack of Efficacy|0|||
33290121|NCT00195494|62666707|FG005|Year 2|Lack of Efficacy|0|||
33290122|NCT00195494|62666702|FG000|Year 2|Compliance|1|||
33290123|NCT00195494|62666703|FG001|Year 2|Compliance|0|||
33290124|NCT00195494|62666704|FG002|Year 2|Compliance|0|||
33290125|NCT00195494|62666705|FG003|Year 2|Compliance|2|||
33375546|NCT00787137|62754524|FG001|Overall Study|Study Termination|0|||
33375547|NCT00787137|62754525|FG002|Overall Study|Study Termination|1|||
33290126|NCT00195494|62666706|FG004|Year 2|Compliance|0|||
33375548|NCT00448435|62754533|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
33375549|NCT00448435|62754534|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
33375550|NCT00448279|62754545|FG000|Overall Study|Lost to Follow-up|2|||
33375551|NCT00448279|62754546|FG001|Overall Study|Lost to Follow-up|2|||
33290127|NCT00195494|62666707|FG005|Year 2|Compliance|0|||
33290128|NCT00195494|62666702|FG000|Year 2|Lost to Follow-up|0|||
33290129|NCT00195494|62666703|FG001|Year 2|Lost to Follow-up|0|||
33290130|NCT00195494|62666704|FG002|Year 2|Lost to Follow-up|1|||
33290131|NCT00195494|62666705|FG003|Year 2|Lost to Follow-up|1|||
33290132|NCT00195494|62666706|FG004|Year 2|Lost to Follow-up|0|||
33375552|NCT00448279|62754545|FG000|Overall Study|Adverse Event|1|||
33375553|NCT00448279|62754546|FG001|Overall Study|Adverse Event|1|||
33375554|NCT00448279|62754545|FG000|Overall Study|Disease progression|16|||
33375555|NCT00448279|62754546|FG001|Overall Study|Disease progression|18|||
33375556|NCT00448279|62754545|FG000|Overall Study|Withdrawal by Subject|4|||
33375557|NCT00448279|62754546|FG001|Overall Study|Withdrawal by Subject|3|||
33375558|NCT00448279|62754545|FG000|Overall Study|Other|6|||
33375559|NCT00448279|62754546|FG001|Overall Study|Other|4|||
33375560|NCT00448279|62754545|FG000|Overall Study|Protocol Violation|0|||
33375561|NCT00448279|62754546|FG001|Overall Study|Protocol Violation|1|||
33375562|NCT00448123|62754554|FG000|Overall Study|Lost to Follow-up|9|||
33375563|NCT00448123|62754555|FG001|Overall Study|Lost to Follow-up|6|||
33290133|NCT00195494|62666707|FG005|Year 2|Lost to Follow-up|0|||
33290134|NCT00195494|62666702|FG000|Year 2|Missed >4 consecutive doses|1|||
33290135|NCT00195494|62666703|FG001|Year 2|Missed >4 consecutive doses|1|||
33290136|NCT00195494|62666704|FG002|Year 2|Missed >4 consecutive doses|1|||
33290137|NCT00195494|62666705|FG003|Year 2|Missed >4 consecutive doses|0|||
33290138|NCT00195494|62666706|FG004|Year 2|Missed >4 consecutive doses|0|||
33290139|NCT00195494|62666707|FG005|Year 2|Missed >4 consecutive doses|0|||
33290140|NCT00195494|62666702|FG000|Year 2|Protocol deviation|0|||
33290141|NCT00195494|62666703|FG001|Year 2|Protocol deviation|1|||
33290142|NCT00195494|62666704|FG002|Year 2|Protocol deviation|0|||
33290143|NCT00195494|62666705|FG003|Year 2|Protocol deviation|0|||
33290144|NCT00195494|62666706|FG004|Year 2|Protocol deviation|0|||
33290145|NCT00195494|62666707|FG005|Year 2|Protocol deviation|0|||
33290146|NCT00195494|62666702|FG000|Year 2|Physician Decision|1|||
33290147|NCT00195494|62666703|FG001|Year 2|Physician Decision|1|||
33290148|NCT00195494|62666704|FG002|Year 2|Physician Decision|0|||
33290149|NCT00195494|62666705|FG003|Year 2|Physician Decision|0|||
33290150|NCT00195494|62666706|FG004|Year 2|Physician Decision|0|||
33290151|NCT00195494|62666707|FG005|Year 2|Physician Decision|0|||
33290152|NCT00195494|62666702|FG000|Year 2|Withdrawal by Subject|1|||
33290153|NCT00195494|62666703|FG001|Year 2|Withdrawal by Subject|5|||
33290154|NCT00195494|62666704|FG002|Year 2|Withdrawal by Subject|4|||
33290155|NCT00195494|62666705|FG003|Year 2|Withdrawal by Subject|3|||
33290156|NCT00195494|62666706|FG004|Year 2|Withdrawal by Subject|0|||
33290157|NCT00195494|62666707|FG005|Year 2|Withdrawal by Subject|0|||
33290158|NCT00195494|62666702|FG000|Year 2|System toxicity|0|||
33290159|NCT00195494|62666703|FG001|Year 2|System toxicity|0|||
33290160|NCT00195494|62666704|FG002|Year 2|System toxicity|0|||
33290161|NCT00195494|62666705|FG003|Year 2|System toxicity|1|||
33290162|NCT00195494|62666706|FG004|Year 2|System toxicity|0|||
33290163|NCT00195494|62666707|FG005|Year 2|System toxicity|0|||
33290164|NCT00194987|62666725|FG000|Overall Study|Withdrawal by Subject|0|||
33375564|NCT00448123|62754554|FG000|Overall Study|Physician Decision|6|||
33375565|NCT00448123|62754555|FG001|Overall Study|Physician Decision|6|||
33375566|NCT00447499|62754564|FG000|Overall Study|Adverse Event|1|||
33486853|NCT03233438|62864796|FG000|Overall Study|No recording of dalbavancin|0|||
33486854|NCT03233438|62864797|FG001|Overall Study|No recording of dalbavancin|1|||
33375567|NCT00447499|62754564|FG000|Overall Study|Patient Decision|4|||
33290165|NCT00194987|62666726|FG001|Overall Study|Withdrawal by Subject|3|||
33290166|NCT00194792|62666734|FG000|Overall Study|Withdrawal by Subject|1|||
33290167|NCT00194675|62666749|FG000|Overall Study|Lost to Follow-up|1|||
33290168|NCT00194675|62666750|FG001|Overall Study|Lost to Follow-up|1|||
33290169|NCT00194675|62666749|FG000|Overall Study|lack of interest|1|||
33290170|NCT00194675|62666750|FG001|Overall Study|lack of interest|1|||
33290171|NCT00194675|62666749|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
33290172|NCT00194675|62666750|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
33290173|NCT00194675|62666749|FG000|Overall Study|Protocol Violation|1|||
33290174|NCT00194675|62666750|FG001|Overall Study|Protocol Violation|0|||
33290175|NCT00194675|62666749|FG000|Overall Study|Death|1|||
33290176|NCT00194675|62666750|FG001|Overall Study|Death|0|||
33290177|NCT00194012|62666760|FG000|Randomized Phase|Lack of Efficacy|8|||
33290178|NCT00194012|62666761|FG001|Randomized Phase|Lack of Efficacy|18|||
33375568|NCT00447499|62754564|FG000|Overall Study|Sponsor Decision|1|||
33290179|NCT00194012|62666760|FG000|Randomized Phase|Study nonadherence|2|||
33290180|NCT00194012|62666761|FG001|Randomized Phase|Study nonadherence|1|||
33290181|NCT00194012|62666760|FG000|Randomized Phase|Withdrawal by Subject|3|||
33290182|NCT00194012|62666761|FG001|Randomized Phase|Withdrawal by Subject|3|||
33290183|NCT00194012|62666760|FG000|Randomized Phase|Adverse Event|2|||
33290184|NCT00194012|62666761|FG001|Randomized Phase|Adverse Event|1|||
33375569|NCT00447499|62754564|FG000|Overall Study|Physician Decision|1|||
33375570|NCT00800436|62754577|FG000|Overall Study|Withdrawal by Subject|0|||
33375571|NCT00800436|62754578|FG001|Overall Study|Withdrawal by Subject|0|||
33375572|NCT00800436|62754579|FG002|Overall Study|Withdrawal by Subject|1|||
33375573|NCT00800436|62754580|FG003|Overall Study|Withdrawal by Subject|1|||
33375574|NCT00800436|62754581|FG004|Overall Study|Withdrawal by Subject|0|||
33375575|NCT00800436|62754582|FG005|Overall Study|Withdrawal by Subject|0|||
33375576|NCT00800436|62754583|FG006|Overall Study|Withdrawal by Subject|0|||
33375577|NCT00655564|62754599|FG000|Overall Study|Adverse Event|1|||
33375578|NCT00655564|62754599|FG000|Overall Study|Lost to Follow-up|1|||
33375579|NCT00655564|62754599|FG000|Overall Study|Desired Alternate Therapy|1|||
33375580|NCT00447421|62754604|FG000|Overall Study|Lack of Efficacy|1|||
33375581|NCT00447421|62754604|FG000|Overall Study|Adverse Event|3|||
33375582|NCT00447421|62754604|FG000|Overall Study|Sponsor Decision|2|||
33375583|NCT00651118|62754612|FG000|Overall Study|Adverse Event|4|||
33375584|NCT00651118|62754613|FG001|Overall Study|Adverse Event|0|||
33375585|NCT00651118|62754614|FG002|Overall Study|Adverse Event|1|||
33375586|NCT00651118|62754615|FG003|Overall Study|Adverse Event|1|||
33375587|NCT00651118|62754612|FG000|Overall Study|Protocol Violation|2|||
33375588|NCT00651118|62754613|FG001|Overall Study|Protocol Violation|2|||
33375589|NCT00651118|62754614|FG002|Overall Study|Protocol Violation|6|||
33375590|NCT00651118|62754615|FG003|Overall Study|Protocol Violation|2|||
33375591|NCT00651118|62754612|FG000|Overall Study|Lost to Follow-up|2|||
33375592|NCT00651118|62754613|FG001|Overall Study|Lost to Follow-up|0|||
33375593|NCT00651118|62754614|FG002|Overall Study|Lost to Follow-up|1|||
33486855|NCT01368406|62864805|FG000|Overall Study|Lost to Follow-up|8|||
33486856|NCT01368406|62864806|FG001|Overall Study|Lost to Follow-up|4|||
33486857|NCT01368406|62864805|FG000|Overall Study|Withdrawal by Subject|8|||
33486858|NCT01368406|62864806|FG001|Overall Study|Withdrawal by Subject|4|||
33486859|NCT01368406|62864805|FG000|Overall Study|relapse of the disease|3|||
33486860|NCT01368406|62864806|FG001|Overall Study|relapse of the disease|2|||
33486861|NCT01368406|62864805|FG000|Overall Study|started working|2|||
33486862|NCT01368406|62864806|FG001|Overall Study|started working|3|||
33486863|NCT00175877|62864812|FG000|Overall Study|Adverse Event|136|||
33486864|NCT00175877|62864812|FG000|Overall Study|Withdrawal by Subject|141|||
33486865|NCT00175877|62864812|FG000|Overall Study|Lost to Follow-up|9|||
33662366|NCT01695239|63092836|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
33662367|NCT01695239|63092837|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
33662368|NCT01695239|63092838|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
33290185|NCT00194012|62666760|FG000|Randomized Phase|Participant reported having a rash|1|||
33290186|NCT00194012|62666761|FG001|Randomized Phase|Participant reported having a rash|0|||
33290187|NCT00194012|62666760|FG000|Randomized Phase|Emesis and enuresis|0|||
33290188|NCT00194012|62666761|FG001|Randomized Phase|Emesis and enuresis|1|||
33290189|NCT00194012|62666760|FG000|Randomized Phase|Oral/nasal twitching|0|||
33290190|NCT00194012|62666761|FG001|Randomized Phase|Oral/nasal twitching|1|||
33290191|NCT00194012|62666760|FG000|Open Label Extension (OLE)|Weight Gain|1|||
33290192|NCT00194012|62666761|FG001|Open Label Extension (OLE)|Weight Gain|0|||
33290193|NCT00194012|62666760|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
33290194|NCT00194012|62666761|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
33290195|NCT00194012|62666760|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
33290196|NCT00194012|62666761|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
33290197|NCT00194012|62666760|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
33290198|NCT00194012|62666761|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
33290199|NCT00192647|62666775|FG000|Overall Study|Death|1|||
33290200|NCT00192647|62666776|FG001|Overall Study|Death|1|||
33290201|NCT00192647|62666775|FG000|Overall Study|Adverse Event|35|||
33290202|NCT00192647|62666776|FG001|Overall Study|Adverse Event|29|||
33290203|NCT00192647|62666775|FG000|Overall Study|Laboratory Test Abnormality|4|||
33290204|NCT00192647|62666776|FG001|Overall Study|Laboratory Test Abnormality|2|||
33290205|NCT00192647|62666775|FG000|Overall Study|Insufficient Therapeutic Response|53|||
33290206|NCT00192647|62666776|FG001|Overall Study|Insufficient Therapeutic Response|83|||
33290207|NCT00192647|62666775|FG000|Overall Study|Entry Criteria Violation|6|||
33375594|NCT00651118|62754615|FG003|Overall Study|Lost to Follow-up|2|||
33375595|NCT00651118|62754612|FG000|Overall Study|administrative|1|||
33375596|NCT00651118|62754613|FG001|Overall Study|administrative|4|||
33375597|NCT00651118|62754614|FG002|Overall Study|administrative|2|||
33375598|NCT00651118|62754615|FG003|Overall Study|administrative|1|||
33486866|NCT00175877|62864812|FG000|Overall Study|Lack of Efficacy|26|||
33486867|NCT00175877|62864812|FG000|Overall Study|Protocol Violation|15|||
33486868|NCT00175877|62864812|FG000|Overall Study|Other Reason|20|||
33375599|NCT00651118|62754612|FG000|Overall Study|Withdrawal by Subject|0|||
33375600|NCT00651118|62754613|FG001|Overall Study|Withdrawal by Subject|1|||
33375601|NCT00651118|62754614|FG002|Overall Study|Withdrawal by Subject|1|||
33662369|NCT01695239|63092839|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
33662370|NCT01695239|63092840|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
33662371|NCT01695239|63092841|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
33662372|NCT01695239|63092842|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
33375602|NCT00651118|62754615|FG003|Overall Study|Withdrawal by Subject|1|||
33375603|NCT00447265|62754628|FG000|Overall Study|Physician Decision|1|||
33375604|NCT00447265|62754629|FG001|Overall Study|Physician Decision|0|||
33375605|NCT00657358|62754633|FG000|Overall Study|Lack of Efficacy|6|||
33375606|NCT00457639|62754638|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
33375607|NCT00457639|62754639|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
33375608|NCT00457639|62754638|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
33486869|NCT00175877|62864812|FG000|Overall Study|AE & Other|1|||
33486870|NCT00175877|62864812|FG000|Overall Study|Withdrawal by subject & Other|1|||
33486871|NCT02788474|62864818|FG000|Double Blind Treatment Period|Not treated|1|||
33486872|NCT02788474|62864819|FG001|Double Blind Treatment Period|Not treated|0|||
33486873|NCT02788474|62864818|FG000|Double Blind Treatment Period|Patient's refusal|3|||
33486874|NCT02788474|62864819|FG001|Double Blind Treatment Period|Patient's refusal|0|||
33486875|NCT02788474|62864818|FG000|Double Blind Treatment Period|Adverse Event|6|||
33486876|NCT02788474|62864819|FG001|Double Blind Treatment Period|Adverse Event|4|||
33486877|NCT02788474|62864818|FG000|Open Label Treatment Period|Adverse Event|29|||
33486878|NCT02788474|62864819|FG001|Open Label Treatment Period|Adverse Event|9|||
33486879|NCT02788474|62864818|FG000|Open Label Treatment Period|Other than reason specified|1|||
33486880|NCT02788474|62864819|FG001|Open Label Treatment Period|Other than reason specified|0|||
33486881|NCT02788474|62864818|FG000|Open Label Treatment Period|Patient's refusal|1|||
33486882|NCT02788474|62864819|FG001|Open Label Treatment Period|Patient's refusal|3|||
33486883|NCT02788474|62864818|FG000|Open Label Treatment Period|Non-compliance|1|||
33486884|NCT02788474|62864819|FG001|Open Label Treatment Period|Non-compliance|0|||
33486885|NCT03248492|62864831|FG000|Overall Study|Ongoing|23|||
33486886|NCT03248492|62864832|FG001|Overall Study|Ongoing|26|||
33486887|NCT03248492|62864833|FG002|Overall Study|Ongoing|3|||
33486888|NCT03248492|62864834|FG003|Overall Study|Ongoing|85|||
33486889|NCT03248492|62864835|FG004|Overall Study|Ongoing|2|||
33486890|NCT03248492|62864831|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
33486891|NCT03248492|62864832|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
33486892|NCT03248492|62864833|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
33486893|NCT03248492|62864834|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
33486894|NCT03248492|62864835|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
33486895|NCT03248492|62864831|FG000|Overall Study|Adverse Event|6|||
33486896|NCT03248492|62864832|FG001|Overall Study|Adverse Event|6|||
33486897|NCT03248492|62864833|FG002|Overall Study|Adverse Event|8|||
33486898|NCT03248492|62864834|FG003|Overall Study|Adverse Event|8|||
33486899|NCT03248492|62864835|FG004|Overall Study|Adverse Event|1|||
33486900|NCT03248492|62864831|FG000|Overall Study|Withdrawal by Subject|3|||
33486901|NCT03248492|62864832|FG001|Overall Study|Withdrawal by Subject|3|||
33486902|NCT03248492|62864833|FG002|Overall Study|Withdrawal by Subject|0|||
33486903|NCT03248492|62864834|FG003|Overall Study|Withdrawal by Subject|3|||
33486904|NCT03248492|62864835|FG004|Overall Study|Withdrawal by Subject|1|||
33486905|NCT03248492|62864831|FG000|Overall Study|Physician Decision|1|||
33486906|NCT03248492|62864832|FG001|Overall Study|Physician Decision|0|||
33486907|NCT03248492|62864833|FG002|Overall Study|Physician Decision|1|||
33486908|NCT03248492|62864834|FG003|Overall Study|Physician Decision|2|||
33486909|NCT03248492|62864835|FG004|Overall Study|Physician Decision|0|||
33290208|NCT00192647|62666776|FG001|Overall Study|Entry Criteria Violation|6|||
33290209|NCT00192647|62666775|FG000|Overall Study|Protocol Violation|3|||
33290210|NCT00192647|62666776|FG001|Overall Study|Protocol Violation|1|||
33290211|NCT00192647|62666775|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
33290212|NCT00192647|62666776|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
33290213|NCT00192647|62666775|FG000|Overall Study|Failure to Return|11|||
33290214|NCT00192647|62666776|FG001|Overall Study|Failure to Return|13|||
33290215|NCT00192647|62666775|FG000|Overall Study|Other/Administrative|5|||
33290216|NCT00192647|62666776|FG001|Overall Study|Other/Administrative|3|||
33290217|NCT00192296|62666786|FG000|Overall Study|Withdrawal by Subject|0|||
33290218|NCT00192296|62666787|FG001|Overall Study|Withdrawal by Subject|1|||
33290219|NCT00192296|62666788|FG002|Overall Study|Withdrawal by Subject|0|||
33486910|NCT03248492|62864831|FG000|Overall Study|Death|1|||
33486911|NCT03248492|62864832|FG001|Overall Study|Death|0|||
33486912|NCT03248492|62864833|FG002|Overall Study|Death|0|||
33486913|NCT03248492|62864834|FG003|Overall Study|Death|6|||
33486914|NCT03248492|62864835|FG004|Overall Study|Death|0|||
33486915|NCT03248492|62864831|FG000|Overall Study|Other|0|||
33486916|NCT03248492|62864832|FG001|Overall Study|Other|1|||
33486917|NCT03248492|62864833|FG002|Overall Study|Other|0|||
33290220|NCT00192296|62666789|FG003|Overall Study|Withdrawal by Subject|0|||
33556365|NCT02614898|62949267|FG001|Overall Study|Study Terminated by Sponsor|0|||
33556366|NCT02614898|62949266|FG000|Overall Study|Withdrawal by Subject|0|||
33556367|NCT02614898|62949267|FG001|Overall Study|Withdrawal by Subject|2|||
33375609|NCT00457639|62754639|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
33375610|NCT00457639|62754638|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
33375611|NCT00457639|62754639|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
33375612|NCT00800202|62754647|FG000|Overall Study|Adverse Event|7|||
33375613|NCT00800202|62754648|FG001|Overall Study|Adverse Event|6|||
33375614|NCT00800202|62754647|FG000|Overall Study|Death|1|||
33375615|NCT00800202|62754648|FG001|Overall Study|Death|0|||
33375616|NCT00800202|62754647|FG000|Overall Study|Other|5|||
33375617|NCT00800202|62754648|FG001|Overall Study|Other|0|||
33375618|NCT00800202|62754647|FG000|Overall Study|Disease Progression|54|||
33375619|NCT00800202|62754648|FG001|Overall Study|Disease Progression|18|||
33375620|NCT00655486|62754654|FG000|Overall Study|Adverse Event|10|||
33375621|NCT00655486|62754654|FG000|Overall Study|Lack of Efficacy|8|||
33375622|NCT00655486|62754654|FG000|Overall Study|Withdrawal by Subject|4|||
33375623|NCT00655486|62754654|FG000|Overall Study|Protocol Violation|1|||
33375624|NCT00655486|62754654|FG000|Overall Study|Unsatisfactory compliance|2|||
33375625|NCT00655486|62754654|FG000|Overall Study|Other: Pregnancy|1|||
33375626|NCT00655486|62754654|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
33375627|NCT00655486|62754654|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
33375628|NCT00457249|62754660|FG000|Overall Study|Lost to Follow-up|3|||
33375629|NCT00457249|62754661|FG001|Overall Study|Lost to Follow-up|0|||
33375630|NCT00457249|62754660|FG000|Overall Study|Protocol Violation|4|||
33375631|NCT00457249|62754661|FG001|Overall Study|Protocol Violation|1|||
33375632|NCT00457249|62754660|FG000|Overall Study|Withdrawal by Subject|3|||
33375633|NCT00457249|62754661|FG001|Overall Study|Withdrawal by Subject|1|||
33375634|NCT00457249|62754660|FG000|Overall Study|Serious Adverse Events|2|||
33375635|NCT00457249|62754661|FG001|Overall Study|Serious Adverse Events|0|||
33375636|NCT00457015|62754671|FG000|Overall Study|Left study site against medical advice|0|||
33375637|NCT00457015|62754672|FG001|Overall Study|Left study site against medical advice|1|||
33375638|NCT00654940|62754680|FG000|Period 1|Adverse Event|0|||
33375639|NCT00654940|62754681|FG001|Period 1|Adverse Event|1|||
33375640|NCT00654940|62754680|FG000|Period 1|Intolerable Pain Level|1|||
33375641|NCT00654940|62754681|FG001|Period 1|Intolerable Pain Level|0|||
33375642|NCT00588666|62754693|FG000|Overall Study|Adverse Event|4|||
33375643|NCT00793182|62754708|FG000|Overall Study|Adverse Event|0|||
33375644|NCT00793182|62754709|FG001|Overall Study|Adverse Event|1|||
33375645|NCT00793104|62754715|FG000|Overall Study|Lost to Follow-up|1|||
33375646|NCT00446797|62754721|FG000|Overall Study|Lack of Efficacy|0|||
33375647|NCT00446797|62754722|FG001|Overall Study|Lack of Efficacy|2|||
33375648|NCT00446797|62754721|FG000|Overall Study|Lost to Follow-up|5|||
33375649|NCT00446797|62754722|FG001|Overall Study|Lost to Follow-up|3|||
33375650|NCT00446797|62754721|FG000|Overall Study|Withdrawal by Subject|2|||
33375651|NCT00446797|62754722|FG001|Overall Study|Withdrawal by Subject|2|||
33375652|NCT00446797|62754721|FG000|Overall Study|Protocol Violation|1|||
33375653|NCT00446797|62754722|FG001|Overall Study|Protocol Violation|3|||
33486918|NCT03248492|62864834|FG003|Overall Study|Other|4|||
33486919|NCT03248492|62864835|FG004|Overall Study|Other|0|||
33486920|NCT03247556|62864858|FG000|Overall Study|Adverse Event|1|||
33486921|NCT03247556|62864859|FG001|Overall Study|Adverse Event|4|||
33486922|NCT03247556|62864860|FG002|Overall Study|Adverse Event|5|||
33486923|NCT03247556|62864858|FG000|Overall Study|Lost to Follow-up|5|||
33486924|NCT03247556|62864859|FG001|Overall Study|Lost to Follow-up|5|||
33486925|NCT03247556|62864860|FG002|Overall Study|Lost to Follow-up|4|||
33290221|NCT00192023|62666801|FG000|Period III - Double-Blind|Adverse Event|3|||
33290222|NCT00192023|62666802|FG001|Period III - Double-Blind|Adverse Event|0|||
33290223|NCT00192023|62666801|FG000|Period III - Double-Blind|Physician Decision|2|||
33290224|NCT00192023|62666802|FG001|Period III - Double-Blind|Physician Decision|0|||
33290225|NCT00192023|62666801|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
33290226|NCT00192023|62666802|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
33290227|NCT00192023|62666801|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
33290228|NCT00192023|62666802|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
33290229|NCT00192023|62666801|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
33290230|NCT00192023|62666802|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
33290231|NCT00192023|62666801|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
33375654|NCT00446797|62754721|FG000|Overall Study|subject entered at another site|0|||
33375655|NCT00446797|62754722|FG001|Overall Study|subject entered at another site|1|||
33375656|NCT00446797|62754721|FG000|Overall Study|did not meet entrance criteria|0|||
33375657|NCT00446797|62754722|FG001|Overall Study|did not meet entrance criteria|1|||
33486926|NCT03247556|62864858|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
33375658|NCT00855335|62754733|FG000|Overall Study|Lost to Follow-up|0|||
33375659|NCT00855335|62754734|FG001|Overall Study|Lost to Follow-up|0|||
33375660|NCT00855335|62754735|FG002|Overall Study|Lost to Follow-up|3|||
33375661|NCT00855335|62754736|FG003|Overall Study|Lost to Follow-up|1|||
33375662|NCT00855335|62754737|FG004|Overall Study|Lost to Follow-up|0|||
33375663|NCT00855335|62754733|FG000|Overall Study|Withdrawal by Subject|0|||
33375664|NCT00855335|62754734|FG001|Overall Study|Withdrawal by Subject|0|||
33375665|NCT00855335|62754735|FG002|Overall Study|Withdrawal by Subject|0|||
33375666|NCT00855335|62754736|FG003|Overall Study|Withdrawal by Subject|1|||
33375667|NCT00855335|62754737|FG004|Overall Study|Withdrawal by Subject|0|||
33375668|NCT00855335|62754733|FG000|Overall Study|Adverse Event|2|||
33375669|NCT00855335|62754734|FG001|Overall Study|Adverse Event|0|||
33375670|NCT00855335|62754735|FG002|Overall Study|Adverse Event|0|||
33375671|NCT00855335|62754736|FG003|Overall Study|Adverse Event|0|||
33486927|NCT03247556|62864859|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
33486928|NCT03247556|62864860|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
33486929|NCT03247556|62864858|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
33486930|NCT03247556|62864859|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
33556368|NCT02614898|62949266|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
33556369|NCT02614898|62949267|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33556370|NCT02614898|62949266|FG000|Overall Study|Other-Additional Information Unavailable|0|||
33556371|NCT02614898|62949267|FG001|Overall Study|Other-Additional Information Unavailable|11|||
33556372|NCT02614898|62949266|FG000|Overall Study|Missing|0|||
33556373|NCT02614898|62949267|FG001|Overall Study|Missing|1|||
33556374|NCT02777593|62949279|FG000|Overall Study|Still in study|66|||
33556375|NCT02777593|62949280|FG001|Overall Study|Still in study|105|||
33556376|NCT02777593|62949281|FG002|Overall Study|Still in study|10|||
33556377|NCT02777593|62949282|FG003|Overall Study|Still in study|8|||
33556378|NCT02777593|62949283|FG004|Overall Study|Still in study|6|||
33556379|NCT02777593|62949279|FG000|Overall Study|Death|11|||
33556380|NCT02777593|62949280|FG001|Overall Study|Death|19|||
33486931|NCT03247556|62864860|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
33486932|NCT03247556|62864858|FG000|Overall Study|Protocol Violation|2|||
33486933|NCT03247556|62864859|FG001|Overall Study|Protocol Violation|0|||
33486934|NCT03247556|62864860|FG002|Overall Study|Protocol Violation|1|||
33486935|NCT03247556|62864858|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
33486936|NCT03247556|62864859|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
33486937|NCT03247556|62864860|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
33486938|NCT03216746|62864872|FG000|Overall Study|Lost to Follow-up|6|||
33486939|NCT03216746|62864873|FG001|Overall Study|Lost to Follow-up|8|||
33486940|NCT03216746|62864874|FG002|Overall Study|Lost to Follow-up|5|||
33486941|NCT03216746|62864875|FG003|Overall Study|Lost to Follow-up|6|||
33486942|NCT02787304|62864889|FG000|Overall Study|Adverse Event|9|||
33486943|NCT02787304|62864890|FG001|Overall Study|Adverse Event|3|||
33486944|NCT02787304|62864891|FG002|Overall Study|Adverse Event|8|||
33486945|NCT02787304|62864892|FG003|Overall Study|Adverse Event|1|||
33486946|NCT02787304|62864889|FG000|Overall Study|Withdrawal by Subject|1|||
33486947|NCT02787304|62864890|FG001|Overall Study|Withdrawal by Subject|4|||
33486948|NCT02787304|62864891|FG002|Overall Study|Withdrawal by Subject|0|||
33486949|NCT02787304|62864892|FG003|Overall Study|Withdrawal by Subject|0|||
33486950|NCT02787304|62864889|FG000|Overall Study|Lost to Follow-up|1|||
33486951|NCT02787304|62864890|FG001|Overall Study|Lost to Follow-up|0|||
33486952|NCT02787304|62864891|FG002|Overall Study|Lost to Follow-up|0|||
33486953|NCT02787304|62864892|FG003|Overall Study|Lost to Follow-up|1|||
33486954|NCT02787304|62864889|FG000|Overall Study|Noncompliance with study drug|0|||
33486955|NCT02787304|62864890|FG001|Overall Study|Noncompliance with study drug|0|||
33486956|NCT02787304|62864891|FG002|Overall Study|Noncompliance with study drug|1|||
33486957|NCT02787304|62864892|FG003|Overall Study|Noncompliance with study drug|0|||
33556381|NCT02777593|62949281|FG002|Overall Study|Death|0|||
33556382|NCT02777593|62949282|FG003|Overall Study|Death|4|||
33556383|NCT02777593|62949283|FG004|Overall Study|Death|0|||
33556384|NCT02777593|62949279|FG000|Overall Study|Withdrawal by Subject|5|||
33556385|NCT02777593|62949280|FG001|Overall Study|Withdrawal by Subject|1|||
33556386|NCT02777593|62949281|FG002|Overall Study|Withdrawal by Subject|0|||
33556387|NCT02777593|62949282|FG003|Overall Study|Withdrawal by Subject|1|||
33556388|NCT02777593|62949283|FG004|Overall Study|Withdrawal by Subject|0|||
33556389|NCT02777593|62949279|FG000|Overall Study|Lost to Follow-up|1|||
33556390|NCT02777593|62949280|FG001|Overall Study|Lost to Follow-up|6|||
33556391|NCT02777593|62949281|FG002|Overall Study|Lost to Follow-up|0|||
33375672|NCT00855335|62754737|FG004|Overall Study|Adverse Event|0|||
33486958|NCT02787304|62864889|FG000|Overall Study|Physician Decision|0|||
33486959|NCT02787304|62864890|FG001|Overall Study|Physician Decision|0|||
33486960|NCT02787304|62864891|FG002|Overall Study|Physician Decision|1|||
33486961|NCT02787304|62864892|FG003|Overall Study|Physician Decision|0|||
33556392|NCT02777593|62949282|FG003|Overall Study|Lost to Follow-up|0|||
33556393|NCT02777593|62949283|FG004|Overall Study|Lost to Follow-up|0|||
33556394|NCT02777593|62949279|FG000|Overall Study|Physician Decision|0|||
33556395|NCT02777593|62949280|FG001|Overall Study|Physician Decision|1|||
33375673|NCT00855335|62754733|FG000|Overall Study|Physician Decision|1|||
33556396|NCT02777593|62949281|FG002|Overall Study|Physician Decision|0|||
33556397|NCT02777593|62949282|FG003|Overall Study|Physician Decision|0|||
33375674|NCT00855335|62754734|FG001|Overall Study|Physician Decision|1|||
33375675|NCT00855335|62754735|FG002|Overall Study|Physician Decision|0|||
33375676|NCT00855335|62754736|FG003|Overall Study|Physician Decision|0|||
33375677|NCT00855335|62754737|FG004|Overall Study|Physician Decision|0|||
33375678|NCT00855335|62754733|FG000|Overall Study|Other|2|||
33375679|NCT00855335|62754734|FG001|Overall Study|Other|1|||
33375680|NCT00855335|62754735|FG002|Overall Study|Other|2|||
33375681|NCT00855335|62754736|FG003|Overall Study|Other|5|||
33375682|NCT00855335|62754737|FG004|Overall Study|Other|1|||
33375683|NCT00799422|62754762|FG000|First Week of Wear|Lost to Follow-up|0|||
33375684|NCT00799422|62754763|FG001|First Week of Wear|Lost to Follow-up|0|||
33375685|NCT00799422|62754764|FG002|First Week of Wear|Lost to Follow-up|1|||
33375686|NCT00799422|62754765|FG003|First Week of Wear|Lost to Follow-up|0|||
33375687|NCT00799422|62754766|FG004|First Week of Wear|Lost to Follow-up|0|||
33375688|NCT00799422|62754767|FG005|First Week of Wear|Lost to Follow-up|0|||
33375689|NCT00799422|62754762|FG000|First Week of Wear|Adverse Event|0|||
33375690|NCT00799422|62754763|FG001|First Week of Wear|Adverse Event|0|||
33375691|NCT00799422|62754764|FG002|First Week of Wear|Adverse Event|0|||
33375692|NCT00799422|62754765|FG003|First Week of Wear|Adverse Event|1|||
33375693|NCT00799422|62754766|FG004|First Week of Wear|Adverse Event|0|||
33556398|NCT02777593|62949283|FG004|Overall Study|Physician Decision|0|||
33556399|NCT02777593|62949279|FG000|Overall Study|Discontinued due to Other|2|||
33375694|NCT00799422|62754767|FG005|First Week of Wear|Adverse Event|0|||
33375695|NCT00593489|62754777|FG000|Allocation|did not attend workshop; allocation not|2|||
33375696|NCT00593489|62754778|FG001|Allocation|did not attend workshop; allocation not|1|||
33375697|NCT00446641|62754788|FG000|Overall Study|Withdrawal by Subject|8|||
33375698|NCT00446641|62754789|FG001|Overall Study|Withdrawal by Subject|3|||
33375699|NCT00446641|62754788|FG000|Overall Study|poor compliance|8|||
33375700|NCT00446641|62754789|FG001|Overall Study|poor compliance|6|||
33375701|NCT00446641|62754788|FG000|Overall Study|Lost to Follow-up|1|||
33375702|NCT00446641|62754789|FG001|Overall Study|Lost to Follow-up|1|||
33375703|NCT00646282|62754797|FG000|Overall Study|Protocol terminated|4|||
33375704|NCT00646282|62754798|FG001|Overall Study|Protocol terminated|4|||
33375705|NCT00792636|62754807|FG000|Overall Study|Protocol Violation|17|||
33375706|NCT00792636|62754808|FG001|Overall Study|Protocol Violation|23|||
33556400|NCT02777593|62949280|FG001|Overall Study|Discontinued due to Other|0|||
33556401|NCT02777593|62949281|FG002|Overall Study|Discontinued due to Other|0|||
33556402|NCT02777593|62949282|FG003|Overall Study|Discontinued due to Other|0|||
33556403|NCT02777593|62949283|FG004|Overall Study|Discontinued due to Other|0|||
33556404|NCT02776033|62949308|FG000|Overall Study|Withdrawal by Subject|0|||
33556405|NCT02776033|62949309|FG001|Overall Study|Withdrawal by Subject|0|||
33556406|NCT02776033|62949310|FG002|Overall Study|Withdrawal by Subject|2|||
33556407|NCT02776033|62949308|FG000|Overall Study|Physician Decision|2|||
33556408|NCT02776033|62949309|FG001|Overall Study|Physician Decision|0|||
33290232|NCT00192023|62666802|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
33290233|NCT00192023|62666801|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
33290234|NCT00192023|62666802|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
33290235|NCT00192023|62666801|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
33290236|NCT00192023|62666802|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
33290237|NCT00192023|62666801|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
33290238|NCT00192023|62666802|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
33290239|NCT00192023|62666801|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
33290240|NCT00192023|62666802|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
33290241|NCT00191984|62666808|FG000|Overall Study|Disease Progression|21|||
33290242|NCT00191984|62666808|FG000|Overall Study|Adverse Event|4|||
33290243|NCT00191984|62666808|FG000|Overall Study|Death|2|||
33290244|NCT00191984|62666808|FG000|Overall Study|Entry Criteria Exclusion|1|||
33290245|NCT00191984|62666808|FG000|Overall Study|Withdrawal by Subject|7|||
33290246|NCT00191984|62666808|FG000|Overall Study|Physician Decision|4|||
33290247|NCT00191906|62666816|FG000|Study Period II|Adverse Event|0|||
33290248|NCT00191906|62666817|FG001|Study Period II|Adverse Event|1|||
33375707|NCT00792636|62754809|FG002|Overall Study|Protocol Violation|20|||
33375708|NCT00792636|62754807|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
33375709|NCT00792636|62754808|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
33375710|NCT00792636|62754809|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
33375711|NCT00792636|62754807|FG000|Overall Study|Lost to Follow-up|13|||
33375712|NCT00792636|62754808|FG001|Overall Study|Lost to Follow-up|19|||
33375713|NCT00792636|62754809|FG002|Overall Study|Lost to Follow-up|14|||
33375714|NCT00792636|62754807|FG000|Overall Study|Withdrew Consent|10|||
33375715|NCT00792636|62754808|FG001|Overall Study|Withdrew Consent|13|||
33375716|NCT00792636|62754809|FG002|Overall Study|Withdrew Consent|9|||
33556409|NCT02776033|62949310|FG002|Overall Study|Physician Decision|0|||
33556410|NCT02776033|62949308|FG000|Overall Study|Lost to Follow-up|1|||
33290249|NCT00191906|62666818|FG002|Study Period II|Adverse Event|0|||
33290250|NCT00191906|62666819|FG003|Study Period II|Adverse Event|0|||
33290251|NCT00191906|62666816|FG000|Study Period II|Withdrawal by Subject|0|||
33290252|NCT00191906|62666817|FG001|Study Period II|Withdrawal by Subject|3|||
33290253|NCT00191906|62666818|FG002|Study Period II|Withdrawal by Subject|0|||
33290254|NCT00191906|62666819|FG003|Study Period II|Withdrawal by Subject|0|||
33290255|NCT00191906|62666816|FG000|Study Period II|Parent/Caregiver Decision|0|||
33290256|NCT00191906|62666817|FG001|Study Period II|Parent/Caregiver Decision|1|||
33290257|NCT00191906|62666818|FG002|Study Period II|Parent/Caregiver Decision|0|||
33290258|NCT00191906|62666819|FG003|Study Period II|Parent/Caregiver Decision|0|||
33290259|NCT00191906|62666816|FG000|Study Period II|Entry Criteria Exclusion|0|||
33290260|NCT00191906|62666817|FG001|Study Period II|Entry Criteria Exclusion|0|||
33290261|NCT00191906|62666818|FG002|Study Period II|Entry Criteria Exclusion|1|||
33375717|NCT00792636|62754807|FG000|Overall Study|Lack of Efficacy|3|||
33375718|NCT00792636|62754808|FG001|Overall Study|Lack of Efficacy|4|||
33375719|NCT00792636|62754809|FG002|Overall Study|Lack of Efficacy|13|||
33375720|NCT00792636|62754807|FG000|Overall Study|Adverse Event|4|||
33375721|NCT00792636|62754808|FG001|Overall Study|Adverse Event|2|||
33375722|NCT00792636|62754809|FG002|Overall Study|Adverse Event|3|||
33375723|NCT00792636|62754807|FG000|Overall Study|Investigator Discretion|2|||
33375724|NCT00792636|62754808|FG001|Overall Study|Investigator Discretion|0|||
33375725|NCT00792636|62754809|FG002|Overall Study|Investigator Discretion|2|||
33375726|NCT00446563|62754821|FG000|Overall Study|Adverse Event|4|||
33375727|NCT00446563|62754822|FG001|Overall Study|Adverse Event|3|||
33375728|NCT00446563|62754821|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33375729|NCT00446563|62754822|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33375730|NCT00446563|62754821|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33375731|NCT00446563|62754822|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33375732|NCT00446563|62754821|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33375733|NCT00446563|62754822|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33375734|NCT00446563|62754821|FG000|Overall Study|Withdrawal by Subject|2|||
33375735|NCT00446563|62754822|FG001|Overall Study|Withdrawal by Subject|1|||
33375736|NCT00446563|62754821|FG000|Overall Study|Administrative problems|0|||
33375737|NCT00446563|62754822|FG001|Overall Study|Administrative problems|1|||
33375738|NCT00650806|62754832|FG000|Overall Study|Adverse Event|0|||
33486962|NCT02787304|62864889|FG000|Overall Study|Study terminated by sponsor|25|||
33486963|NCT02787304|62864890|FG001|Overall Study|Study terminated by sponsor|31|||
33486964|NCT02787304|62864891|FG002|Overall Study|Study terminated by sponsor|31|||
33486965|NCT02787304|62864892|FG003|Overall Study|Study terminated by sponsor|32|||
33486967|NCT02932904|62864910|FG000|Overall Study|Reason not Specified|1|||
33486968|NCT02932904|62864911|FG001|Overall Study|Reason not Specified|0|||
33486969|NCT02932904|62864912|FG002|Overall Study|Reason not Specified|2|||
33486970|NCT02932904|62864913|FG003|Overall Study|Reason not Specified|2|||
33486971|NCT02932904|62864910|FG000|Overall Study|Noncompliance with Study Drug|2|||
33486972|NCT02932904|62864911|FG001|Overall Study|Noncompliance with Study Drug|3|||
33486973|NCT02932904|62864912|FG002|Overall Study|Noncompliance with Study Drug|3|||
33486974|NCT02932904|62864913|FG003|Overall Study|Noncompliance with Study Drug|4|||
33486975|NCT02932904|62864910|FG000|Overall Study|Pregnancy|0|||
33486976|NCT02932904|62864911|FG001|Overall Study|Pregnancy|1|||
33486977|NCT02932904|62864912|FG002|Overall Study|Pregnancy|1|||
33290262|NCT00191906|62666819|FG003|Study Period II|Entry Criteria Exclusion|0|||
33290263|NCT00191906|62666816|FG000|Study Period III|Adverse Event|1|||
33290264|NCT00191906|62666817|FG001|Study Period III|Adverse Event|0|||
33290265|NCT00191906|62666818|FG002|Study Period III|Adverse Event|0|||
33290266|NCT00191906|62666819|FG003|Study Period III|Adverse Event|0|||
33290267|NCT00191906|62666816|FG000|Study Period III|Lost to Follow-up|0|||
33290268|NCT00191906|62666817|FG001|Study Period III|Lost to Follow-up|1|||
33290269|NCT00191906|62666818|FG002|Study Period III|Lost to Follow-up|0|||
33290270|NCT00191906|62666819|FG003|Study Period III|Lost to Follow-up|0|||
33290271|NCT00191906|62666816|FG000|Study Period III|Parent/Caregiver Decision|1|||
33290272|NCT00191906|62666817|FG001|Study Period III|Parent/Caregiver Decision|0|||
33290273|NCT00191906|62666818|FG002|Study Period III|Parent/Caregiver Decision|0|||
33290274|NCT00191906|62666819|FG003|Study Period III|Parent/Caregiver Decision|0|||
33290275|NCT00191906|62666816|FG000|Study Period III|Lack of Efficacy|3|||
33375739|NCT00650806|62754833|FG001|Overall Study|Adverse Event|5|||
33375740|NCT00650806|62754834|FG002|Overall Study|Adverse Event|3|||
33375741|NCT00650806|62754835|FG003|Overall Study|Adverse Event|4|||
33375742|NCT00650806|62754832|FG000|Overall Study|Lost to Follow-up|7|||
33375743|NCT00650806|62754833|FG001|Overall Study|Lost to Follow-up|6|||
33375744|NCT00650806|62754834|FG002|Overall Study|Lost to Follow-up|11|||
33486978|NCT02932904|62864913|FG003|Overall Study|Pregnancy|0|||
33375745|NCT00650806|62754835|FG003|Overall Study|Lost to Follow-up|10|||
33486979|NCT02932904|62864910|FG000|Overall Study|Study Termination|0|||
33486980|NCT02932904|62864911|FG001|Overall Study|Study Termination|1|||
33290276|NCT00191906|62666817|FG001|Study Period III|Lack of Efficacy|3|||
33290277|NCT00191906|62666818|FG002|Study Period III|Lack of Efficacy|0|||
33290278|NCT00191906|62666819|FG003|Study Period III|Lack of Efficacy|0|||
33290279|NCT00191789|62666835|FG000|Overall Study|Adverse Event|5|||
33290280|NCT00191789|62666835|FG000|Overall Study|Patient: Satisfactory Response|5|||
33290281|NCT00191789|62666835|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
33486981|NCT02932904|62864912|FG002|Overall Study|Study Termination|0|||
33290282|NCT00191789|62666835|FG000|Overall Study|Withdrawal by Subject|4|||
33290283|NCT00191789|62666835|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
33290284|NCT00191789|62666835|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
33290285|NCT00191789|62666835|FG000|Overall Study|Death - Not Study-Drug Related|1|||
33290286|NCT00191282|62666841|FG000|Overall Study|Adverse Event|5|||
33290287|NCT00191282|62666842|FG001|Overall Study|Adverse Event|6|||
33290288|NCT00191282|62666841|FG000|Overall Study|Death|51|||
33290289|NCT00191282|62666842|FG001|Overall Study|Death|51|||
33290290|NCT00191282|62666841|FG000|Overall Study|Lack of Efficacy|11|||
33290291|NCT00191282|62666842|FG001|Overall Study|Lack of Efficacy|6|||
33290292|NCT00191282|62666841|FG000|Overall Study|Noncompliance|14|||
33290293|NCT00191282|62666842|FG001|Overall Study|Noncompliance|17|||
33290294|NCT00191282|62666841|FG000|Overall Study|Patient moved|11|||
33290295|NCT00191282|62666842|FG001|Overall Study|Patient moved|14|||
33290296|NCT00191282|62666841|FG000|Overall Study|Withdrawal by Subject|59|||
33290297|NCT00191282|62666842|FG001|Overall Study|Withdrawal by Subject|44|||
33290298|NCT00191282|62666841|FG000|Overall Study|Physician Decision|18|||
33290299|NCT00191282|62666842|FG001|Overall Study|Physician Decision|15|||
33290300|NCT00191282|62666841|FG000|Overall Study|Protocol entry criteria not met|14|||
33290301|NCT00191282|62666842|FG001|Overall Study|Protocol entry criteria not met|9|||
33290302|NCT00191282|62666841|FG000|Overall Study|Protocol Violation|9|||
33290303|NCT00191282|62666842|FG001|Overall Study|Protocol Violation|12|||
33290304|NCT00191282|62666841|FG000|Overall Study|Severity of outcome|2|||
33290305|NCT00191282|62666842|FG001|Overall Study|Severity of outcome|5|||
33290306|NCT00191282|62666841|FG000|Overall Study|Sponsor's decision|2|||
33290307|NCT00191282|62666842|FG001|Overall Study|Sponsor's decision|2|||
33290308|NCT00191282|62666841|FG000|Overall Study|Lost to Follow-up|24|||
33290309|NCT00191282|62666842|FG001|Overall Study|Lost to Follow-up|31|||
33290310|NCT00191165|62666850|FG000|Overall Study|Adverse Event|2|||
33290311|NCT00191165|62666851|FG001|Overall Study|Adverse Event|0|||
33290312|NCT00191165|62666850|FG000|Overall Study|Protocol Violation|0|||
33290313|NCT00191165|62666851|FG001|Overall Study|Protocol Violation|1|||
33290314|NCT00191165|62666850|FG000|Overall Study|Participant Moved Away|0|||
33290315|NCT00191165|62666851|FG001|Overall Study|Participant Moved Away|1|||
33290316|NCT00190775|62666859|FG000|Overall Study|Adverse Event|57|||
33290317|NCT00190775|62666860|FG001|Overall Study|Adverse Event|22|||
33375746|NCT00650806|62754832|FG000|Overall Study|Protocol Violation|0|||
33375747|NCT00650806|62754833|FG001|Overall Study|Protocol Violation|0|||
33375748|NCT00650806|62754834|FG002|Overall Study|Protocol Violation|0|||
33375749|NCT00650806|62754835|FG003|Overall Study|Protocol Violation|1|||
33375750|NCT00650806|62754832|FG000|Overall Study|Pregnancy|0|||
33375751|NCT00650806|62754833|FG001|Overall Study|Pregnancy|0|||
33375752|NCT00650806|62754834|FG002|Overall Study|Pregnancy|0|||
33375753|NCT00650806|62754835|FG003|Overall Study|Pregnancy|1|||
33375754|NCT00650806|62754832|FG000|Overall Study|Withdrawal by Subject|7|||
33375755|NCT00650806|62754833|FG001|Overall Study|Withdrawal by Subject|5|||
33375756|NCT00650806|62754834|FG002|Overall Study|Withdrawal by Subject|8|||
33375757|NCT00650806|62754835|FG003|Overall Study|Withdrawal by Subject|6|||
33375758|NCT00650806|62754832|FG000|Overall Study|Noncompliance with study drug regimen|1|||
33375759|NCT00650806|62754833|FG001|Overall Study|Noncompliance with study drug regimen|1|||
33375760|NCT00650806|62754834|FG002|Overall Study|Noncompliance with study drug regimen|0|||
33375761|NCT00650806|62754835|FG003|Overall Study|Noncompliance with study drug regimen|0|||
33375762|NCT00650806|62754832|FG000|Overall Study|Study terminated by sponsor|2|||
33375763|NCT00650806|62754833|FG001|Overall Study|Study terminated by sponsor|3|||
33375764|NCT00650806|62754834|FG002|Overall Study|Study terminated by sponsor|5|||
33375765|NCT00650806|62754835|FG003|Overall Study|Study terminated by sponsor|4|||
33375766|NCT00650806|62754832|FG000|Overall Study|Other|1|||
33375767|NCT00650806|62754833|FG001|Overall Study|Other|1|||
33375768|NCT00650806|62754834|FG002|Overall Study|Other|2|||
33375769|NCT00650806|62754835|FG003|Overall Study|Other|0|||
33375770|NCT00863057|62754851|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
33375771|NCT00863057|62754852|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
33375772|NCT00863057|62754853|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
33375773|NCT00863057|62754854|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
33375774|NCT00863057|62754851|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
33375775|NCT00863057|62754852|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
33375776|NCT00863057|62754853|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
33290318|NCT00190775|62666859|FG000|Overall Study|Satisfactory Response|1|||
33290319|NCT00190775|62666860|FG001|Overall Study|Satisfactory Response|0|||
33290320|NCT00190775|62666859|FG000|Overall Study|Lack of Efficacy|28|||
33290321|NCT00190775|62666860|FG001|Overall Study|Lack of Efficacy|32|||
33290322|NCT00190775|62666859|FG000|Overall Study|Lost to Follow-up|31|||
33290323|NCT00190775|62666860|FG001|Overall Study|Lost to Follow-up|23|||
33290324|NCT00190775|62666859|FG000|Overall Study|Participant Moved|0|||
33290325|NCT00190775|62666860|FG001|Overall Study|Participant Moved|1|||
33290326|NCT00190775|62666859|FG000|Overall Study|Withdrawal by Subject|24|||
33290327|NCT00190775|62666860|FG001|Overall Study|Withdrawal by Subject|13|||
33290328|NCT00190775|62666859|FG000|Overall Study|Sponsor Decision|1|||
33290329|NCT00190775|62666860|FG001|Overall Study|Sponsor Decision|0|||
33290330|NCT00190775|62666859|FG000|Overall Study|Physician Decision|3|||
33290331|NCT00190775|62666860|FG001|Overall Study|Physician Decision|0|||
33290332|NCT00190775|62666859|FG000|Overall Study|Noncompliance|3|||
33290333|NCT00190775|62666860|FG001|Overall Study|Noncompliance|5|||
33290334|NCT00190775|62666859|FG000|Overall Study|Protocol Violation|0|||
33290335|NCT00190775|62666860|FG001|Overall Study|Protocol Violation|1|||
33290336|NCT00190775|62666859|FG000|Overall Study|Exclusion Criteria Met|1|||
33290337|NCT00190775|62666860|FG001|Overall Study|Exclusion Criteria Met|3|||
33290338|NCT00199901|62666875|FG000|Overall Study|Protocol Violation|2|||
33290339|NCT00199901|62666876|FG001|Overall Study|Protocol Violation|0|||
33290340|NCT00199901|62666875|FG000|Overall Study|Withdrawal by Subject|1|||
33290341|NCT00199901|62666876|FG001|Overall Study|Withdrawal by Subject|0|||
33290342|NCT00199901|62666875|FG000|Overall Study|Progressive Disease|24|||
33290343|NCT00199901|62666876|FG001|Overall Study|Progressive Disease|24|||
33290344|NCT00198107|62666886|FG000|Double-Blind Period|Adverse Event|1|||
33290345|NCT00198107|62666887|FG001|Double-Blind Period|Adverse Event|1|||
33290346|NCT00198107|62666888|FG002|Double-Blind Period|Adverse Event|0|||
33290347|NCT00198107|62666886|FG000|Double-Blind Period|Lack of Efficacy|2|||
33290348|NCT00198107|62666887|FG001|Double-Blind Period|Lack of Efficacy|0|||
33290349|NCT00198107|62666888|FG002|Double-Blind Period|Lack of Efficacy|0|||
33290350|NCT00198107|62666886|FG000|Double-Blind Period|Lost to Follow-up|2|||
33290351|NCT00198107|62666887|FG001|Double-Blind Period|Lost to Follow-up|1|||
33290352|NCT00198107|62666888|FG002|Double-Blind Period|Lost to Follow-up|0|||
33290353|NCT00198107|62666886|FG000|Double-Blind Period|Physician Decision|1|||
33290354|NCT00198107|62666887|FG001|Double-Blind Period|Physician Decision|0|||
33290355|NCT00198107|62666888|FG002|Double-Blind Period|Physician Decision|0|||
33290356|NCT00198107|62666886|FG000|Double-Blind Period|Withdrawal by Subject|0|||
33290357|NCT00198107|62666887|FG001|Double-Blind Period|Withdrawal by Subject|1|||
33290358|NCT00198107|62666888|FG002|Double-Blind Period|Withdrawal by Subject|0|||
33290359|NCT00198107|62666886|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
33290360|NCT00198107|62666887|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
33290361|NCT00198107|62666888|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
33290362|NCT00179660|62666896|FG000|Overall Study|Adverse Event|7|||
33290363|NCT00179660|62666896|FG000|Overall Study|Lack of therapeutic effect|28|||
33290364|NCT00179660|62666896|FG000|Overall Study|Withdrawal by Subject|2|||
33290365|NCT00179660|62666896|FG000|Overall Study|Lost to Follow-up|1|||
33375777|NCT00863057|62754854|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
33375778|NCT00863057|62754851|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
33375779|NCT00863057|62754852|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
33375780|NCT00863057|62754853|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
33375781|NCT00863057|62754854|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
33375782|NCT00863057|62754851|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
33375783|NCT00863057|62754852|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
33662373|NCT01695239|63092843|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
33290366|NCT00179660|62666896|FG000|Overall Study|Death|3|||
33290367|NCT00179660|62666896|FG000|Overall Study|Other - Unspecified|9|||
33290368|NCT00178256|62666900|FG000|Overall Study|Adverse Event|2|||
33290369|NCT00178256|62666901|FG001|Overall Study|Adverse Event|0|||
33290370|NCT00178256|62666902|FG002|Overall Study|Adverse Event|0|||
33290371|NCT00178256|62666903|FG003|Overall Study|Adverse Event|0|||
33290372|NCT00178256|62666900|FG000|Overall Study|Death|0|||
33290373|NCT00178256|62666901|FG001|Overall Study|Death|1|||
33290374|NCT00178256|62666902|FG002|Overall Study|Death|0|||
33290375|NCT00178256|62666903|FG003|Overall Study|Death|1|||
33375784|NCT00863057|62754853|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
33375785|NCT00863057|62754854|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
33290376|NCT00178256|62666900|FG000|Overall Study|Cancer progression|2|||
33290377|NCT00178256|62666901|FG001|Overall Study|Cancer progression|0|||
33290378|NCT00178256|62666902|FG002|Overall Study|Cancer progression|0|||
33290379|NCT00178256|62666903|FG003|Overall Study|Cancer progression|1|||
33290380|NCT00177164|62666912|FG000|Overall Study|Protocol Violation|0|||
33290381|NCT00177164|62666913|FG001|Overall Study|Protocol Violation|7|||
33290382|NCT00177164|62666912|FG000|Overall Study|Lost to Follow-up|4|||
33290383|NCT00177164|62666913|FG001|Overall Study|Lost to Follow-up|5|||
33290384|NCT00177164|62666912|FG000|Overall Study|increase in alcohol and drug use|1|||
33290385|NCT00177164|62666913|FG001|Overall Study|increase in alcohol and drug use|2|||
33290386|NCT00177164|62666912|FG000|Overall Study|Adverse Event|1|||
33290387|NCT00177164|62666913|FG001|Overall Study|Adverse Event|0|||
33290388|NCT00177164|62666912|FG000|Overall Study|discharge from hospital|1|||
33375786|NCT00829166|62754872|FG000|Overall Study|Death|305|||
33375787|NCT00829166|62754873|FG001|Overall Study|Death|333|||
33290389|NCT00177164|62666913|FG001|Overall Study|discharge from hospital|0|||
33290390|NCT00177164|62666912|FG000|Overall Study|Lack of Efficacy|2|||
33290391|NCT00177164|62666913|FG001|Overall Study|Lack of Efficacy|1|||
33290392|NCT00177164|62666912|FG000|Overall Study|Pregnancy|0|||
33290393|NCT00177164|62666913|FG001|Overall Study|Pregnancy|1|||
33290394|NCT02489942|62666936|FG000|Overall Study|Request by patient|602|||
33290395|NCT02489942|62666936|FG000|Overall Study|Improvement/remission|157|||
33290396|NCT02489942|62666936|FG000|Overall Study|No change/Progressive disease|263|||
33290397|NCT02489942|62666936|FG000|Overall Study|Adverse Event|522|||
33290398|NCT02489942|62666936|FG000|Overall Study|Other personal reasons|1218|||
33290399|NCT02489942|62666936|FG000|Overall Study|Lost to Follow-up|456|||
33290400|NCT02489942|62666936|FG000|Overall Study|Not continuously investigated|7|||
33290401|NCT02489942|62666936|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
33290402|NCT02489942|62666936|FG000|Overall Study|Multiple registration|1|||
33290403|NCT02489942|62666936|FG000|Overall Study|No patient visit after entry|100|||
33290404|NCT02489942|62666936|FG000|Overall Study|No treatment with Jardiance|2|||
33290405|NCT02489942|62666936|FG000|Overall Study|Patient received Jardiance before registration|1|||
33290406|NCT02489942|62666936|FG000|Overall Study|No CRF collected|86|||
33290407|NCT00176462|62666942|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
33290408|NCT00176462|62666943|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
33290409|NCT00176462|62666942|FG000|Induction (4 Weeks)|Death|1|||
33290410|NCT00176462|62666943|FG001|Induction (4 Weeks)|Death|2|||
33290411|NCT00176462|62666942|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
33290412|NCT00176462|62666943|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
33290413|NCT00176462|62666942|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
33290414|NCT00176462|62666943|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
33290415|NCT00176462|62666942|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
33290416|NCT00176462|62666943|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
33290417|NCT00176462|62666942|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
33290418|NCT00176462|62666943|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
33290419|NCT00176462|62666942|FG000|Consolidation (12 Weeks)|Not documented|0|||
33290420|NCT00176462|62666943|FG001|Consolidation (12 Weeks)|Not documented|1|||
33375788|NCT00829166|62754872|FG000|Overall Study|Lost to Follow-up|5|||
33375789|NCT00829166|62754873|FG001|Overall Study|Lost to Follow-up|4|||
33375790|NCT00829166|62754872|FG000|Overall Study|Physician's Decision|4|||
33375791|NCT00829166|62754873|FG001|Overall Study|Physician's Decision|3|||
33375792|NCT00829166|62754872|FG000|Overall Study|Subject's Decision|41|||
33375793|NCT00829166|62754873|FG001|Overall Study|Subject's Decision|55|||
33375794|NCT00829166|62754872|FG000|Overall Study|Sponsor's Decision|137|||
33375795|NCT00829166|62754873|FG001|Overall Study|Sponsor's Decision|98|||
33375796|NCT00829166|62754872|FG000|Overall Study|Reason Not Specified|3|||
33375797|NCT00829166|62754873|FG001|Overall Study|Reason Not Specified|3|||
33375798|NCT00799266|62754882|FG000|Overall Study|Adverse Event|0|||
33375799|NCT00799266|62754883|FG001|Overall Study|Adverse Event|1|||
33375800|NCT00799266|62754882|FG000|Overall Study|Subject withdrew consent|3|||
33375801|NCT00799266|62754883|FG001|Overall Study|Subject withdrew consent|0|||
33375802|NCT00650104|62754889|FG000|Overall Study|Adverse Event|17|||
33375803|NCT00650104|62754889|FG000|Overall Study|Death|2|||
33375804|NCT00650104|62754889|FG000|Overall Study|Withdrawal by Subject|11|||
33375805|NCT00650104|62754889|FG000|Overall Study|Physician Decision|7|||
33375806|NCT00650104|62754889|FG000|Overall Study|Lost to Follow-up|1|||
33375807|NCT00650104|62754889|FG000|Overall Study|Non-compliance|2|||
33375808|NCT00650104|62754889|FG000|Overall Study|Sponsor Terminated Dosing|1|||
33375809|NCT00654238|62754893|FG000|Overall Study|Screen Failures|4|||
33375810|NCT00862979|62754900|FG000|Overall Study|Adverse Event|6|||
33375811|NCT00862979|62754901|FG001|Overall Study|Adverse Event|3|||
33375812|NCT00862979|62754900|FG000|Overall Study|Protocol Violation|0|||
33375813|NCT00862979|62754901|FG001|Overall Study|Protocol Violation|1|||
33375814|NCT00862979|62754900|FG000|Overall Study|Patient withdrew consent|2|||
33375815|NCT00862979|62754901|FG001|Overall Study|Patient withdrew consent|1|||
33375816|NCT00862979|62754900|FG000|Overall Study|Administrative problems|0|||
33375817|NCT00862979|62754901|FG001|Overall Study|Administrative problems|1|||
33375818|NCT00862979|62754900|FG000|Overall Study|Death|0|||
33375819|NCT00862979|62754901|FG001|Overall Study|Death|1|||
33375820|NCT00483379|62754909|FG000|Treatment Period|Adverse Event|1|||
33375821|NCT00483379|62754910|FG001|Treatment Period|Adverse Event|0|||
33375822|NCT00483379|62754909|FG000|Treatment Period|Withdrawal by Subject|1|||
33375823|NCT00483379|62754910|FG001|Treatment Period|Withdrawal by Subject|0|||
33375824|NCT00446251|62754918|FG000|Overall Study|On-study Transplants|2|||
33375825|NCT00446251|62754918|FG000|Overall Study|Rituximab Infusion Reaction|2|||
33486982|NCT02932904|62864913|FG003|Overall Study|Study Termination|0|||
33375826|NCT00446251|62754918|FG000|Overall Study|Lost to Follow-up|1|||
33375827|NCT00796224|62754924|FG000|Overall Study|Adverse Event|1|||
33375828|NCT00796224|62754925|FG001|Overall Study|Adverse Event|0|||
33375829|NCT00796224|62754924|FG000|Overall Study|Protocol Violation|0|||
33486983|NCT02932904|62864910|FG000|Overall Study|Voluntary Withdrawal|2|||
33375830|NCT00796224|62754925|FG001|Overall Study|Protocol Violation|1|||
33486984|NCT02932904|62864911|FG001|Overall Study|Voluntary Withdrawal|1|||
33290421|NCT00176462|62666942|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
33290422|NCT00176462|62666943|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
33375831|NCT00791934|62754933|FG000|Overall Study|Withdrawal by Subject|2|||
33375832|NCT00791934|62754933|FG000|Overall Study|Did not consent for extended follow-up|13|||
33556411|NCT02776033|62949309|FG001|Overall Study|Lost to Follow-up|0|||
33556412|NCT02776033|62949310|FG002|Overall Study|Lost to Follow-up|0|||
33556413|NCT02776033|62949308|FG000|Overall Study|Adverse Event|1|||
33556414|NCT02776033|62949309|FG001|Overall Study|Adverse Event|2|||
33556415|NCT02776033|62949310|FG002|Overall Study|Adverse Event|0|||
33556416|NCT02777125|62949326|FG000|Overall Study|Consent form violation|14|||
33556417|NCT02777125|62949327|FG001|Overall Study|Consent form violation|12|||
33556418|NCT02777125|62949326|FG000|Overall Study|Assent form violation|21|||
33556419|NCT02777125|62949327|FG001|Overall Study|Assent form violation|23|||
33556420|NCT02777125|62949326|FG000|Overall Study|Protocol Violation|8|||
33556421|NCT02777125|62949327|FG001|Overall Study|Protocol Violation|12|||
33556422|NCT02769481|62949352|FG000|Overall Study|Protocol Violation|1|||
33556423|NCT02769481|62949353|FG001|Overall Study|Protocol Violation|0|||
33556424|NCT02769481|62949352|FG000|Overall Study|Adverse Event|3|||
33556425|NCT02769481|62949353|FG001|Overall Study|Adverse Event|6|||
33556426|NCT02769481|62949352|FG000|Overall Study|Entry Criteria Not Met|1|||
33556427|NCT02769481|62949353|FG001|Overall Study|Entry Criteria Not Met|2|||
33556428|NCT02769481|62949352|FG000|Overall Study|Withdrawal by Subject|14|||
33556429|NCT02769481|62949353|FG001|Overall Study|Withdrawal by Subject|16|||
33556430|NCT02769481|62949352|FG000|Overall Study|Lost to Follow-up|9|||
33486985|NCT02932904|62864912|FG002|Overall Study|Voluntary Withdrawal|4|||
33486986|NCT02932904|62864913|FG003|Overall Study|Voluntary Withdrawal|2|||
33486987|NCT02932904|62864910|FG000|Overall Study|Lost to Follow-up|5|||
33486988|NCT02932904|62864911|FG001|Overall Study|Lost to Follow-up|3|||
33486989|NCT02932904|62864912|FG002|Overall Study|Lost to Follow-up|6|||
33486990|NCT02932904|62864913|FG003|Overall Study|Lost to Follow-up|0|||
33486991|NCT02932904|62864910|FG000|Overall Study|Significant Protocol Deviation|2|||
33486992|NCT02932904|62864911|FG001|Overall Study|Significant Protocol Deviation|3|||
33486993|NCT02932904|62864912|FG002|Overall Study|Significant Protocol Deviation|6|||
33486994|NCT02932904|62864913|FG003|Overall Study|Significant Protocol Deviation|1|||
33486995|NCT02932904|62864910|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
33486996|NCT02932904|62864911|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
33486997|NCT02932904|62864912|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
33486998|NCT02932904|62864913|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
33486999|NCT02932904|62864910|FG000|Overall Study|Randomized But Not Treated|1|||
33487000|NCT02932904|62864911|FG001|Overall Study|Randomized But Not Treated|1|||
33487001|NCT02932904|62864912|FG002|Overall Study|Randomized But Not Treated|0|||
33487002|NCT02932904|62864913|FG003|Overall Study|Randomized But Not Treated|2|||
33487003|NCT00688376|62864928|FG000|Double-Blind Phase|Adverse Event|4|||
33487004|NCT00688376|62864929|FG001|Double-Blind Phase|Adverse Event|4|||
33487005|NCT00688376|62864928|FG000|Double-Blind Phase|Protocol Violation|1|||
33487006|NCT00688376|62864929|FG001|Double-Blind Phase|Protocol Violation|2|||
33487007|NCT00688376|62864928|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
33487008|NCT00688376|62864929|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
33487009|NCT00688376|62864928|FG000|Double-Blind Phase|Not treated|0|||
33487010|NCT00688376|62864929|FG001|Double-Blind Phase|Not treated|1|||
33487011|NCT00688376|62864928|FG000|Blinded Extension Phase|Adverse Event|3|||
33487012|NCT00688376|62864929|FG001|Blinded Extension Phase|Adverse Event|4|||
33290423|NCT00176462|62666942|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
33290424|NCT00176462|62666943|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
33290425|NCT00175019|62666953|FG000|Overall Study|Adverse Event|54|||
33290426|NCT00175019|62666954|FG001|Overall Study|Adverse Event|22|||
33290427|NCT00175019|62666955|FG002|Overall Study|Adverse Event|2|||
33290428|NCT00175019|62666953|FG000|Overall Study|Protocol Violation|6|||
33290429|NCT00175019|62666954|FG001|Overall Study|Protocol Violation|3|||
33290430|NCT00175019|62666955|FG002|Overall Study|Protocol Violation|3|||
33290431|NCT00175019|62666953|FG000|Overall Study|Lost to Follow-up|42|||
33290432|NCT00175019|62666954|FG001|Overall Study|Lost to Follow-up|39|||
33290433|NCT00175019|62666955|FG002|Overall Study|Lost to Follow-up|9|||
33290434|NCT00175019|62666953|FG000|Overall Study|Did not continue under Amendment 4|1|||
33290435|NCT00175019|62666954|FG001|Overall Study|Did not continue under Amendment 4|1|||
33290436|NCT00175019|62666955|FG002|Overall Study|Did not continue under Amendment 4|2|||
33290437|NCT00175019|62666953|FG000|Overall Study|Personal Reason(s)|39|||
33487013|NCT00688376|62864928|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
33487014|NCT00688376|62864929|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
33487015|NCT00688376|62864928|FG000|Blinded Extension Phase|Physician Decision|1|||
33556431|NCT02769481|62949353|FG001|Overall Study|Lost to Follow-up|9|||
33556432|NCT02769481|62949352|FG000|Overall Study|Physician Decision|0|||
33290438|NCT00175019|62666954|FG001|Overall Study|Personal Reason(s)|31|||
33290439|NCT00175019|62666955|FG002|Overall Study|Personal Reason(s)|8|||
33290440|NCT00175019|62666953|FG000|Overall Study|Therapeutic Failure|10|||
33290441|NCT00175019|62666954|FG001|Overall Study|Therapeutic Failure|38|||
33487016|NCT00688376|62864929|FG001|Blinded Extension Phase|Physician Decision|0|||
33487017|NCT00688376|62864928|FG000|Blinded Extension Phase|Other|1|||
33487018|NCT00688376|62864929|FG001|Blinded Extension Phase|Other|0|||
33556433|NCT02769481|62949353|FG001|Overall Study|Physician Decision|1|||
33556434|NCT02769481|62949352|FG000|Overall Study|Terminated by Sponsor|1|||
33290442|NCT00175019|62666955|FG002|Overall Study|Therapeutic Failure|22|||
33290443|NCT00175019|62666953|FG000|Overall Study|Gout Flare|2|||
33290444|NCT00175019|62666954|FG001|Overall Study|Gout Flare|3|||
33290445|NCT00175019|62666955|FG002|Overall Study|Gout Flare|0|||
33290446|NCT00175019|62666953|FG000|Overall Study|Reason Not Specified|40|||
33290447|NCT00175019|62666954|FG001|Overall Study|Reason Not Specified|34|||
33290448|NCT00175019|62666955|FG002|Overall Study|Reason Not Specified|11|||
33290449|NCT00174941|62666966|FG000|Overall Study|Adverse Event|1|||
33290450|NCT00174941|62666967|FG001|Overall Study|Adverse Event|10|||
33290451|NCT00174941|62666968|FG002|Overall Study|Adverse Event|2|||
33290452|NCT00174941|62666969|FG003|Overall Study|Adverse Event|13|||
33290453|NCT00174941|62666966|FG000|Overall Study|Protocol Violation|0|||
33290454|NCT00174941|62666967|FG001|Overall Study|Protocol Violation|1|||
33290455|NCT00174941|62666968|FG002|Overall Study|Protocol Violation|0|||
33290456|NCT00174941|62666969|FG003|Overall Study|Protocol Violation|1|||
33290457|NCT00174941|62666966|FG000|Overall Study|Lost to Follow-up|0|||
33556435|NCT02769481|62949353|FG001|Overall Study|Terminated by Sponsor|0|||
33556436|NCT02769481|62949352|FG000|Overall Study|Death|0|||
33556437|NCT02769481|62949353|FG001|Overall Study|Death|1|||
33556438|NCT02769481|62949352|FG000|Overall Study|Undefined|4|||
33556439|NCT02769481|62949353|FG001|Overall Study|Undefined|1|||
33556440|NCT02769247|62949363|FG000|Overall Study|Withdrawal by Subject|1|||
33556441|NCT02769247|62949364|FG001|Overall Study|Withdrawal by Subject|0|||
33290458|NCT00174941|62666967|FG001|Overall Study|Lost to Follow-up|3|||
33375833|NCT00848081|62754939|FG000|Overall Study|Adverse Event|6|||
33375834|NCT00848081|62754940|FG001|Overall Study|Adverse Event|7|||
33375835|NCT00848081|62754939|FG000|Overall Study|Protocol Violation|8|||
33375836|NCT00848081|62754940|FG001|Overall Study|Protocol Violation|5|||
33375837|NCT00848081|62754939|FG000|Overall Study|Lost to Follow-up|1|||
33375838|NCT00848081|62754940|FG001|Overall Study|Lost to Follow-up|0|||
33375839|NCT00848081|62754939|FG000|Overall Study|Physician Decision|0|||
33375840|NCT00848081|62754940|FG001|Overall Study|Physician Decision|3|||
33375841|NCT00848081|62754939|FG000|Overall Study|Withdrawal by Subject|5|||
33375842|NCT00848081|62754940|FG001|Overall Study|Withdrawal by Subject|3|||
33375843|NCT00654004|62754948|FG000|Overall Study|Lost to Follow-up|1|||
33290459|NCT00174941|62666968|FG002|Overall Study|Lost to Follow-up|2|||
33290460|NCT00174941|62666969|FG003|Overall Study|Lost to Follow-up|5|||
33290461|NCT00174941|62666966|FG000|Overall Study|Personal Reason(s)|0|||
33375844|NCT00654004|62754949|FG001|Overall Study|Lost to Follow-up|0|||
33375845|NCT00791778|62754957|FG000|Double-blind Treatment|Adverse Event|49|||
33375846|NCT00791778|62754958|FG001|Double-blind Treatment|Adverse Event|9|||
33375847|NCT00791778|62754957|FG000|Double-blind Treatment|Physician Decision|6|||
33375848|NCT00791778|62754958|FG001|Double-blind Treatment|Physician Decision|26|||
33375849|NCT00791778|62754957|FG000|Double-blind Treatment|Protocol Violation|0|||
33375850|NCT00791778|62754958|FG001|Double-blind Treatment|Protocol Violation|4|||
33375851|NCT00791778|62754957|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
33375852|NCT00791778|62754958|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
33375853|NCT00791778|62754957|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
33375854|NCT00791778|62754958|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
33375855|NCT00791778|62754957|FG000|Follow-up|Withdrawal by Subject|3|||
33375856|NCT00791778|62754958|FG001|Follow-up|Withdrawal by Subject|0|||
33375857|NCT00791778|62754957|FG000|Follow-up|Lost to Follow-up|2|||
33375858|NCT00791778|62754958|FG001|Follow-up|Lost to Follow-up|1|||
33375859|NCT00798174|62754964|FG000|Overall Study|inability to implant azygos coil|3|||
33375860|NCT00798174|62754965|FG001|Overall Study|inability to implant azygos coil|3|||
33375861|NCT00798174|62754964|FG000|Overall Study|Inability to sedate for DFT testing|1|||
33375862|NCT00798174|62754965|FG001|Overall Study|Inability to sedate for DFT testing|0|||
33375863|NCT00798096|62754969|FG000|Overall Study|Ongoing|2|||
33375864|NCT00795600|62754975|FG000|Overall Study|Adverse Event|1|||
33290462|NCT00174941|62666967|FG001|Overall Study|Personal Reason(s)|14|||
33290463|NCT00174941|62666968|FG002|Overall Study|Personal Reason(s)|8|||
33290464|NCT00174941|62666969|FG003|Overall Study|Personal Reason(s)|22|||
33375865|NCT00795600|62754976|FG001|Overall Study|Adverse Event|1|||
33375866|NCT00795600|62754975|FG000|Overall Study|Protocol Violation|1|||
33375867|NCT00795600|62754976|FG001|Overall Study|Protocol Violation|2|||
33375868|NCT00795600|62754975|FG000|Overall Study|Withdrawal by Subject|1|||
33375869|NCT00795600|62754976|FG001|Overall Study|Withdrawal by Subject|0|||
33290465|NCT00174941|62666966|FG000|Overall Study|Gout Flare|0|||
33375870|NCT00795600|62754975|FG000|Overall Study|Unclassified|1|||
33375871|NCT00795600|62754976|FG001|Overall Study|Unclassified|1|||
33375872|NCT00795132|62754982|FG000|Overall Study|Death|1|||
33556442|NCT02769247|62949365|FG002|Overall Study|Withdrawal by Subject|0|||
33290466|NCT00174941|62666967|FG001|Overall Study|Gout Flare|4|||
33290467|NCT00174941|62666968|FG002|Overall Study|Gout Flare|4|||
33556443|NCT02769247|62949366|FG003|Overall Study|Withdrawal by Subject|1|||
33290468|NCT00174941|62666969|FG003|Overall Study|Gout Flare|8|||
33290469|NCT00174941|62666966|FG000|Overall Study|Reason Not Specified|1|||
33290470|NCT00174941|62666967|FG001|Overall Study|Reason Not Specified|6|||
33290471|NCT00174941|62666968|FG002|Overall Study|Reason Not Specified|2|||
33375873|NCT00795132|62754982|FG000|Overall Study|Relapse|2|||
33375874|NCT00647296|62754998|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
33375875|NCT00647296|62754999|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
33375876|NCT00647296|62755000|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
33375877|NCT00647296|62755001|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
33375878|NCT00647296|62754998|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
33375879|NCT00647296|62754999|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
33375880|NCT00647296|62755000|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
33375881|NCT00647296|62755001|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
33375882|NCT00647296|62754998|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
33375883|NCT00647296|62754999|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
33375884|NCT00647296|62755000|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
33375885|NCT00647296|62755001|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
33375886|NCT00647296|62754998|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
33375887|NCT00647296|62754999|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
33375888|NCT00647296|62755000|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
33375889|NCT00647296|62755001|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
33290472|NCT00174941|62666969|FG003|Overall Study|Reason Not Specified|9|||
33290473|NCT00171704|62666981|FG000|Overall Study|Adverse Event|24|||
33375890|NCT00647296|62754998|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
33375891|NCT00647296|62754999|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
33375892|NCT00647296|62755000|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
33375893|NCT00647296|62755001|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
33375894|NCT00647296|62754998|FG000|Part 2: 4-week Placebo Washout|Death|3|||
33375895|NCT00647296|62754999|FG001|Part 2: 4-week Placebo Washout|Death|0|||
33375896|NCT00647296|62755000|FG002|Part 2: 4-week Placebo Washout|Death|0|||
33375897|NCT00647296|62755001|FG003|Part 2: 4-week Placebo Washout|Death|0|||
33375898|NCT00647296|62754998|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
33375899|NCT00647296|62754999|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
33290474|NCT00171704|62666982|FG001|Overall Study|Adverse Event|33|||
33290475|NCT00171704|62666981|FG000|Overall Study|Disease Progression|14|||
33290476|NCT00171704|62666982|FG001|Overall Study|Disease Progression|9|||
33290477|NCT00171704|62666981|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
33290478|NCT00171704|62666982|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
33290479|NCT00171704|62666981|FG000|Overall Study|Administrative Problems|2|||
33375900|NCT00647296|62755000|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
33375901|NCT00647296|62755001|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
33375902|NCT00647296|62754998|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
33375903|NCT00647296|62754999|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
33375904|NCT00647296|62755000|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
33375905|NCT00647296|62755001|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
33375906|NCT00647296|62754998|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
33375907|NCT00647296|62754999|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
33375908|NCT00647296|62755000|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
33375909|NCT00647296|62755001|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
33290480|NCT00171704|62666982|FG001|Overall Study|Administrative Problems|1|||
33290481|NCT00171704|62666981|FG000|Overall Study|Death|2|||
33290482|NCT00171704|62666982|FG001|Overall Study|Death|2|||
33290483|NCT00171704|62666981|FG000|Overall Study|Withdrawal by Subject|1|||
33290484|NCT00171704|62666982|FG001|Overall Study|Withdrawal by Subject|3|||
33290485|NCT00171704|62666981|FG000|Overall Study|Protocol Violation|0|||
33290486|NCT00171704|62666982|FG001|Overall Study|Protocol Violation|1|||
33290487|NCT00171314|62666990|FG000|Overall Study|Adverse Event|44|||
33290488|NCT00171314|62666991|FG001|Overall Study|Adverse Event|41|||
33290489|NCT00171314|62666990|FG000|Overall Study|Lack of Efficacy|19|||
33290490|NCT00171314|62666991|FG001|Overall Study|Lack of Efficacy|14|||
33290491|NCT00171314|62666990|FG000|Overall Study|Withdrawal by Subject|9|||
33290492|NCT00171314|62666991|FG001|Overall Study|Withdrawal by Subject|6|||
33290493|NCT00171314|62666990|FG000|Overall Study|Abnormal Test Procedure Results|9|||
33290494|NCT00171314|62666991|FG001|Overall Study|Abnormal Test Procedure Results|3|||
33290495|NCT00171314|62666990|FG000|Overall Study|Protocol Violation|3|||
33290496|NCT00171314|62666991|FG001|Overall Study|Protocol Violation|7|||
33290497|NCT00171314|62666990|FG000|Overall Study|Administrative Problems|4|||
33375910|NCT00647296|62754998|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
33375911|NCT00647296|62754999|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
33375912|NCT00647296|62755000|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
33375913|NCT00647296|62755001|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
33487019|NCT03214952|62864937|FG000|Overall Study|Protocol Deviation|45|||
33290498|NCT00171314|62666991|FG001|Overall Study|Administrative Problems|3|||
33290499|NCT00171314|62666990|FG000|Overall Study|Lost to Follow-up|1|||
33290500|NCT00171314|62666991|FG001|Overall Study|Lost to Follow-up|3|||
33375914|NCT00647296|62754998|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
33375915|NCT00647296|62754999|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
33375916|NCT00647296|62755000|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
33375917|NCT00647296|62755001|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
33375918|NCT00644878|62755023|FG000|Overall Study|Adverse Event|2|||
33375919|NCT00644878|62755023|FG000|Overall Study|Abnormal laboratory value|3|||
33375920|NCT00644878|62755023|FG000|Overall Study|Protocol deviation|2|||
33375921|NCT00644878|62755023|FG000|Overall Study|Treatment duration completed as per protocol|11|||
33375922|NCT00646906|62755031|FG000|Crossover Period 1|Withdrawal by Subject|1|||
33375923|NCT00646906|62755032|FG001|Crossover Period 1|Withdrawal by Subject|0|||
33375924|NCT00646906|62755033|FG002|Crossover Period 1|Withdrawal by Subject|0|||
33375925|NCT00646906|62755034|FG003|Crossover Period 1|Withdrawal by Subject|0|||
33375926|NCT00646906|62755035|FG004|Crossover Period 1|Withdrawal by Subject|0|||
33375927|NCT00646906|62755036|FG005|Crossover Period 1|Withdrawal by Subject|1|||
33375928|NCT00646906|62755037|FG006|Crossover Period 1|Withdrawal by Subject|0|||
33375929|NCT00646906|62755031|FG000|Crossover Period 2|Withdrawal by Subject|0|||
33375930|NCT00646906|62755032|FG001|Crossover Period 2|Withdrawal by Subject|1|||
33375931|NCT00646906|62755033|FG002|Crossover Period 2|Withdrawal by Subject|2|||
33375932|NCT00646906|62755034|FG003|Crossover Period 2|Withdrawal by Subject|1|||
33375933|NCT00646906|62755035|FG004|Crossover Period 2|Withdrawal by Subject|0|||
33375934|NCT00646906|62755036|FG005|Crossover Period 2|Withdrawal by Subject|0|||
33375935|NCT00646906|62755037|FG006|Crossover Period 2|Withdrawal by Subject|0|||
33375936|NCT00646906|62755031|FG000|Crossover Period 2|Physician Decision|0|||
33375937|NCT00646906|62755032|FG001|Crossover Period 2|Physician Decision|0|||
33375938|NCT00646906|62755033|FG002|Crossover Period 2|Physician Decision|0|||
33375939|NCT00646906|62755034|FG003|Crossover Period 2|Physician Decision|0|||
33375940|NCT00646906|62755035|FG004|Crossover Period 2|Physician Decision|0|||
33375941|NCT00646906|62755036|FG005|Crossover Period 2|Physician Decision|0|||
33375942|NCT00646906|62755037|FG006|Crossover Period 2|Physician Decision|1|||
33375943|NCT00642772|62755050|FG000|Overall Study|Lost to Follow-up|3|||
33375944|NCT00642772|62755050|FG000|Overall Study|Withdrawal by Subject|7|||
33375945|NCT00446095|62755059|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
33375946|NCT00446095|62755060|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
33375947|NCT00446095|62755061|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
33375948|NCT00446095|62755062|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
33375949|NCT00446095|62755063|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
33375950|NCT00446095|62755059|FG000|Phase II (8 Weeks)|Adverse Event|0|||
33375951|NCT00446095|62755060|FG001|Phase II (8 Weeks)|Adverse Event|1|||
33375952|NCT00446095|62755061|FG002|Phase II (8 Weeks)|Adverse Event|1|||
33375953|NCT00446095|62755062|FG003|Phase II (8 Weeks)|Adverse Event|0|||
33375954|NCT00446095|62755063|FG004|Phase II (8 Weeks)|Adverse Event|0|||
33375955|NCT00446095|62755059|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
33375956|NCT00446095|62755060|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
33375957|NCT00446095|62755061|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
33375958|NCT00446095|62755062|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
33375959|NCT00446095|62755063|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
33375960|NCT00446095|62755059|FG000|Phase II (8 Weeks)|Physician Decision|1|||
33375961|NCT00446095|62755060|FG001|Phase II (8 Weeks)|Physician Decision|0|||
33375962|NCT00446095|62755061|FG002|Phase II (8 Weeks)|Physician Decision|0|||
33375963|NCT00446095|62755062|FG003|Phase II (8 Weeks)|Physician Decision|0|||
33375964|NCT00446095|62755063|FG004|Phase II (8 Weeks)|Physician Decision|0|||
33375965|NCT00446095|62755059|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
33375966|NCT00446095|62755060|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
33290501|NCT00171314|62666990|FG000|Overall Study|Death|2|||
33290502|NCT00171314|62666991|FG001|Overall Study|Death|1|||
33290503|NCT00171158|62666997|FG000|Core Study|Death|27|||
33290504|NCT00171158|62666997|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
33290505|NCT00171158|62666997|FG000|Core Study|Protocol Violation|4|||
33290506|NCT00171158|62666997|FG000|Core Study|Administrative problems|1|||
33290507|NCT00171158|62666997|FG000|Core Study|Adverse event, non-fatal|21|||
33290508|NCT00171158|62666997|FG000|Core Study|Consent withdrawn by subject|6|||
33290509|NCT00171158|62666997|FG000|Core Study|No longer required drug (BMT)|14|||
33290510|NCT00171158|62666997|FG000|Core Study|Abnormal Laboratory Values|2|||
33290511|NCT00171158|62666997|FG000|Core Study|Lost to Follow-up|1|||
33290512|NCT00171158|62666997|FG000|E2 Extension|Other|7|||
33290513|NCT00170846|62667004|FG000|Overall Study|Subject withdrew Informed Consent|5|||
33290514|NCT00170846|62667005|FG001|Overall Study|Subject withdrew Informed Consent|12|||
33375967|NCT00446095|62755061|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
33375968|NCT00446095|62755062|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
33375969|NCT00446095|62755063|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
33375970|NCT00446095|62755059|FG000|Phase II (8 Weeks)|Ongoing|0|||
33375971|NCT00446095|62755060|FG001|Phase II (8 Weeks)|Ongoing|0|||
33375972|NCT00446095|62755061|FG002|Phase II (8 Weeks)|Ongoing|1|||
33375973|NCT00446095|62755062|FG003|Phase II (8 Weeks)|Ongoing|0|||
33290515|NCT00170846|62667006|FG002|Overall Study|Subject withdrew Informed Consent|8|||
33290516|NCT00170846|62667004|FG000|Overall Study|Lost to Follow-up|6|||
33290517|NCT00170846|62667005|FG001|Overall Study|Lost to Follow-up|3|||
33290518|NCT00170846|62667006|FG002|Overall Study|Lost to Follow-up|2|||
33290519|NCT00170846|62667004|FG000|Overall Study|Death|0|||
33375974|NCT00446095|62755063|FG004|Phase II (8 Weeks)|Ongoing|0|||
33375975|NCT00446095|62755059|FG000|Phase I (28 Days)|Adverse Event|0|||
33375976|NCT00446095|62755060|FG001|Phase I (28 Days)|Adverse Event|0|||
33375977|NCT00446095|62755061|FG002|Phase I (28 Days)|Adverse Event|0|||
33290520|NCT00170846|62667005|FG001|Overall Study|Death|3|||
33290521|NCT00170846|62667006|FG002|Overall Study|Death|3|||
33290522|NCT00170846|62667004|FG000|Overall Study|Reason Missing|0|||
33290523|NCT00170846|62667005|FG001|Overall Study|Reason Missing|1|||
33290524|NCT00170846|62667006|FG002|Overall Study|Reason Missing|0|||
33290525|NCT00479882|62667018|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
33290526|NCT00479882|62667019|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
33290527|NCT00479882|62667020|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
33290528|NCT00479882|62667021|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
33290529|NCT00479882|62667018|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
33290530|NCT00479882|62667019|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
33290531|NCT00479882|62667020|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
33290532|NCT00479882|62667021|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
33290533|NCT00479882|62667018|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
33290534|NCT00479882|62667019|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
33290535|NCT00479882|62667020|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
33375978|NCT00446095|62755062|FG003|Phase I (28 Days)|Adverse Event|1|||
33375979|NCT00446095|62755063|FG004|Phase I (28 Days)|Adverse Event|0|||
33375980|NCT00446095|62755059|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
33375981|NCT00446095|62755060|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
33375982|NCT00446095|62755061|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
33375983|NCT00446095|62755062|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
33375984|NCT00446095|62755063|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
33375985|NCT00829010|62755079|FG000|Overall Study|Adverse Event|1|||
33375986|NCT00829010|62755080|FG001|Overall Study|Adverse Event|0|||
33375987|NCT00829010|62755081|FG002|Overall Study|Adverse Event|0|||
33375988|NCT00829010|62755082|FG003|Overall Study|Adverse Event|0|||
33375989|NCT00829010|62755083|FG004|Overall Study|Adverse Event|0|||
33375990|NCT00829010|62755079|FG000|Overall Study|Withdrawal by Subject|0|||
33375991|NCT00829010|62755080|FG001|Overall Study|Withdrawal by Subject|1|||
33290536|NCT00479882|62667021|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
33290537|NCT00479882|62667018|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
33290538|NCT00479882|62667019|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
33290539|NCT00479882|62667020|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
33290540|NCT00479882|62667021|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
33290541|NCT00479882|62667018|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
33290542|NCT00479882|62667019|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
33290543|NCT00479882|62667020|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
33290544|NCT00479882|62667021|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
33290545|NCT00479882|62667018|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
33290546|NCT00479882|62667019|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
33290547|NCT00479882|62667020|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
33290548|NCT00479882|62667021|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
33290549|NCT00479882|62667018|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
33375992|NCT00829010|62755081|FG002|Overall Study|Withdrawal by Subject|1|||
33375993|NCT00829010|62755082|FG003|Overall Study|Withdrawal by Subject|0|||
33375994|NCT00829010|62755083|FG004|Overall Study|Withdrawal by Subject|2|||
33375995|NCT00829010|62755079|FG000|Overall Study|Lost to Follow-up|1|||
33375996|NCT00829010|62755080|FG001|Overall Study|Lost to Follow-up|0|||
33375997|NCT00829010|62755081|FG002|Overall Study|Lost to Follow-up|2|||
33375998|NCT00829010|62755082|FG003|Overall Study|Lost to Follow-up|0|||
33375999|NCT00829010|62755083|FG004|Overall Study|Lost to Follow-up|0|||
33376000|NCT00829010|62755079|FG000|Overall Study|Fatality|5|||
33376001|NCT00829010|62755080|FG001|Overall Study|Fatality|4|||
33376002|NCT00829010|62755081|FG002|Overall Study|Fatality|0|||
33376003|NCT00829010|62755082|FG003|Overall Study|Fatality|3|||
33376004|NCT00829010|62755083|FG004|Overall Study|Fatality|0|||
33376005|NCT00829010|62755079|FG000|Overall Study|Migrated/Moved from study area|3|||
33376006|NCT00829010|62755080|FG001|Overall Study|Migrated/Moved from study area|4|||
33376007|NCT00829010|62755081|FG002|Overall Study|Migrated/Moved from study area|0|||
33376008|NCT00829010|62755082|FG003|Overall Study|Migrated/Moved from study area|5|||
33376009|NCT00829010|62755083|FG004|Overall Study|Migrated/Moved from study area|0|||
33376010|NCT00644332|62755095|FG000|Overall Study|Adverse Event|11|||
33376011|NCT00644332|62755095|FG000|Overall Study|Withdrawal by Subject|6|||
33376012|NCT00644332|62755095|FG000|Overall Study|Completion Status Unknown|2|||
33290550|NCT00479882|62667019|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
33290551|NCT00479882|62667020|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
33290552|NCT00479882|62667021|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
33290553|NCT00479882|62667018|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
33290554|NCT00479882|62667019|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
33290555|NCT00479882|62667020|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
33290556|NCT00479882|62667021|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
33290557|NCT00479882|62667018|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
33290558|NCT00479882|62667019|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
33376013|NCT00644332|62755095|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
33376014|NCT00644332|62755095|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
33376015|NCT00445939|62755102|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
33376016|NCT00445939|62755103|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
33376017|NCT00445939|62755104|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
33376018|NCT00445939|62755105|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
33376019|NCT00445939|62755102|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
33376020|NCT00445939|62755103|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
33376021|NCT00445939|62755104|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
33376022|NCT00445939|62755105|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
33376023|NCT00482053|62755125|FG000|Inter-treatment Period|Disease progression|1|||
33376024|NCT00455923|62755131|FG000|Overall Study|Pregnancy|0|||
33376025|NCT00455923|62755132|FG001|Overall Study|Pregnancy|2|||
33376026|NCT00455923|62755131|FG000|Overall Study|Other|3|||
33376027|NCT00455923|62755132|FG001|Overall Study|Other|1|||
33376028|NCT00642616|62755142|FG000|Overall Study|Adverse Event|2|||
33376029|NCT00642616|62755143|FG001|Overall Study|Adverse Event|0|||
33376030|NCT00642616|62755144|FG002|Overall Study|Adverse Event|1|||
33376031|NCT00642616|62755145|FG003|Overall Study|Adverse Event|0|||
33376032|NCT00642616|62755142|FG000|Overall Study|Study Terminated by Sponsor|7|||
33376033|NCT00642616|62755143|FG001|Overall Study|Study Terminated by Sponsor|6|||
33376034|NCT00642616|62755144|FG002|Overall Study|Study Terminated by Sponsor|4|||
33376035|NCT00642616|62755145|FG003|Overall Study|Study Terminated by Sponsor|5|||
33376036|NCT00642616|62755142|FG000|Overall Study|Withdrawal by Subject|0|||
33376037|NCT00642616|62755143|FG001|Overall Study|Withdrawal by Subject|1|||
33376038|NCT00642616|62755144|FG002|Overall Study|Withdrawal by Subject|1|||
33376039|NCT00642616|62755145|FG003|Overall Study|Withdrawal by Subject|1|||
33376040|NCT00642616|62755142|FG000|Overall Study|Protocol Violation|0|||
33376041|NCT00642616|62755143|FG001|Overall Study|Protocol Violation|0|||
33376042|NCT00642616|62755144|FG002|Overall Study|Protocol Violation|2|||
33376043|NCT00642616|62755145|FG003|Overall Study|Protocol Violation|0|||
33290559|NCT00479882|62667020|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
33290560|NCT00479882|62667021|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
33376044|NCT00642616|62755142|FG000|Overall Study|Physician Decision|0|||
33376045|NCT00642616|62755143|FG001|Overall Study|Physician Decision|0|||
33376046|NCT00642616|62755144|FG002|Overall Study|Physician Decision|1|||
33376047|NCT00642616|62755145|FG003|Overall Study|Physician Decision|1|||
33376048|NCT03844945|62755161|FG000|Overall Study|Adverse Event|1|||
33376049|NCT03844945|62755162|FG001|Overall Study|Adverse Event|1|||
33376050|NCT03844945|62755163|FG002|Overall Study|Adverse Event|4|||
33376051|NCT03844945|62755164|FG003|Overall Study|Adverse Event|0|||
33376052|NCT03844945|62755161|FG000|Overall Study|Withdrawal by Subject|0|||
33376053|NCT03844945|62755162|FG001|Overall Study|Withdrawal by Subject|0|||
33376054|NCT03844945|62755163|FG002|Overall Study|Withdrawal by Subject|1|||
33376055|NCT03844945|62755164|FG003|Overall Study|Withdrawal by Subject|0|||
33376056|NCT03844945|62755161|FG000|Overall Study|Lack of Efficacy|0|||
33376057|NCT03844945|62755162|FG001|Overall Study|Lack of Efficacy|0|||
33376058|NCT03844945|62755163|FG002|Overall Study|Lack of Efficacy|0|||
33376059|NCT03844945|62755164|FG003|Overall Study|Lack of Efficacy|1|||
33376060|NCT00445549|62755174|FG000|Overall Study|progressive disease|12|||
33376061|NCT00445003|62755181|FG000|Overall Study|Death|1|||
33376062|NCT00445003|62755182|FG001|Overall Study|Death|2|||
33376063|NCT00445003|62755183|FG002|Overall Study|Death|1|||
33376064|NCT00445003|62755181|FG000|Overall Study|Missed Visit|3|||
33376065|NCT00445003|62755182|FG001|Overall Study|Missed Visit|5|||
33556444|NCT02769247|62949363|FG000|Overall Study|Protocol Violation|0|||
33556445|NCT02769247|62949364|FG001|Overall Study|Protocol Violation|0|||
33556446|NCT02769247|62949365|FG002|Overall Study|Protocol Violation|1|||
33556447|NCT02769247|62949366|FG003|Overall Study|Protocol Violation|0|||
33556448|NCT02769247|62949363|FG000|Overall Study|Physician Decision|1|||
33556449|NCT02769247|62949364|FG001|Overall Study|Physician Decision|0|||
33376066|NCT00445003|62755183|FG002|Overall Study|Missed Visit|1|||
33376067|NCT00445003|62755181|FG000|Overall Study|Dropped|1|||
33376068|NCT00445003|62755182|FG001|Overall Study|Dropped|3|||
33376069|NCT00445003|62755183|FG002|Overall Study|Dropped|2|||
33376070|NCT00811070|62755197|FG000|Overall Study|Death|0|||
33376071|NCT00811070|62755198|FG001|Overall Study|Death|0|||
33376072|NCT00811070|62755199|FG002|Overall Study|Death|0|||
33290561|NCT00479882|62667018|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
33290562|NCT00479882|62667019|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
33290563|NCT00479882|62667020|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
33290564|NCT00479882|62667021|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
33290565|NCT00479882|62667018|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
33290566|NCT00479882|62667019|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
33290567|NCT00479882|62667020|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
33290568|NCT00479882|62667021|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
33290569|NCT00479882|62667018|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
33290570|NCT00479882|62667019|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
33290571|NCT00479882|62667020|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
33290572|NCT00479882|62667021|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
33290573|NCT00479882|62667018|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
33290574|NCT00479882|62667019|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
33290575|NCT00479882|62667020|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
33290576|NCT00479882|62667021|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
33290577|NCT00479882|62667018|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
33290578|NCT00479882|62667019|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
33290579|NCT00479882|62667020|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
33290580|NCT00479882|62667021|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
33290581|NCT00479765|62667047|FG000|Overall Study|study terminated|4|||
33290582|NCT00479687|62667053|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
33290583|NCT00479687|62667054|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
33290584|NCT00479687|62667055|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
33290585|NCT00479687|62667053|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
33290586|NCT00479687|62667054|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
33290587|NCT00479687|62667055|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
33290588|NCT00479687|62667053|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
33290589|NCT00479687|62667054|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
33376073|NCT00811070|62755200|FG003|Overall Study|Death|2|||
33376074|NCT00811070|62755201|FG004|Overall Study|Death|5|||
33376075|NCT00811070|62755202|FG005|Overall Study|Death|0|||
33376076|NCT00811070|62755197|FG000|Overall Study|Other|1|||
33376077|NCT00811070|62755198|FG001|Overall Study|Other|0|||
33376078|NCT00811070|62755199|FG002|Overall Study|Other|0|||
33376079|NCT00811070|62755200|FG003|Overall Study|Other|0|||
33556450|NCT02769247|62949365|FG002|Overall Study|Physician Decision|0|||
33556451|NCT02769247|62949366|FG003|Overall Study|Physician Decision|0|||
33556452|NCT02773537|62949383|FG000|Overall Study|Lost to Follow-up|0|||
33556453|NCT02773537|62949384|FG001|Overall Study|Lost to Follow-up|1|||
33556454|NCT02773537|62949385|FG002|Overall Study|Lost to Follow-up|4|||
33556455|NCT02780713|62949393|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
33556456|NCT02780713|62949394|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
33556457|NCT02780713|62949395|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
33556458|NCT02780713|62949396|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
33556459|NCT02780713|62949397|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
33556460|NCT02767765|62949416|FG000|Overall Study|Adverse Event|4|||
33556461|NCT02767765|62949416|FG000|Overall Study|Death|1|||
33556462|NCT02767765|62949416|FG000|Overall Study|Insufficient response|1|||
33290590|NCT00479687|62667055|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
33290591|NCT00479687|62667053|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
33290592|NCT00479687|62667054|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
33290593|NCT00479687|62667055|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
33376080|NCT00811070|62755201|FG004|Overall Study|Other|0|||
33376081|NCT00811070|62755202|FG005|Overall Study|Other|0|||
33376082|NCT00811070|62755197|FG000|Overall Study|Withdrawal by Subject|0|||
33376083|NCT00811070|62755198|FG001|Overall Study|Withdrawal by Subject|1|||
33376084|NCT00811070|62755199|FG002|Overall Study|Withdrawal by Subject|0|||
33487020|NCT03214952|62864937|FG000|Overall Study|Case Report Forms Uncollected|13|||
33487021|NCT01367704|62864943|FG000|Overall Study|Lost to Follow-up|47|||
33487022|NCT01367704|62864944|FG001|Overall Study|Lost to Follow-up|161|||
33487023|NCT03214094|62864950|FG000|Overall Study|Case Report Forms Uncollected|14|||
33487024|NCT03214094|62864950|FG000|Overall Study|Protocol Deviation|46|||
33487025|NCT01367236|62864956|FG000|Overall Study|Withdrawal by Subject|3|||
33487026|NCT01367236|62864957|FG001|Overall Study|Withdrawal by Subject|1|||
33487027|NCT03681951|62864971|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
33487028|NCT03681951|62864972|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
33487029|NCT03681951|62864973|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
33487030|NCT03681951|62864974|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
33487031|NCT03681951|62864975|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
33556463|NCT02767765|62949416|FG000|Overall Study|Lost to Follow-up|2|||
33487032|NCT03681951|62864976|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
33376085|NCT00811070|62755200|FG003|Overall Study|Withdrawal by Subject|0|||
33376086|NCT00811070|62755201|FG004|Overall Study|Withdrawal by Subject|0|||
33376087|NCT00811070|62755202|FG005|Overall Study|Withdrawal by Subject|0|||
33376088|NCT00811070|62755197|FG000|Overall Study|Physician Decision|0|||
33376089|NCT00811070|62755198|FG001|Overall Study|Physician Decision|0|||
33376090|NCT00811070|62755199|FG002|Overall Study|Physician Decision|0|||
33556464|NCT02767765|62949416|FG000|Overall Study|Investigator decision|1|||
33290594|NCT00479687|62667053|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
33290595|NCT00479687|62667054|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
33376091|NCT00811070|62755200|FG003|Overall Study|Physician Decision|0|||
33376092|NCT00811070|62755201|FG004|Overall Study|Physician Decision|0|||
33376093|NCT00811070|62755202|FG005|Overall Study|Physician Decision|1|||
33376094|NCT00642460|62755220|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
33376095|NCT00642460|62755221|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
33376096|NCT00642460|62755222|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
33376097|NCT00642460|62755223|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
33376098|NCT00642460|62755224|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
33376099|NCT00642460|62755225|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
33376100|NCT00642460|62755220|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
33376101|NCT00642460|62755221|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
33376102|NCT00642460|62755222|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
33376103|NCT00642460|62755223|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
33376104|NCT00642460|62755224|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
33376105|NCT00642460|62755225|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
33376106|NCT00642460|62755220|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
33376107|NCT00642460|62755221|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
33376108|NCT00642460|62755222|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
33376109|NCT00642460|62755223|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
33376110|NCT00642460|62755224|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
33376111|NCT00642460|62755225|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
33376112|NCT00642460|62755220|FG000|Part II: Open-Label Up to Week 92|Death|0|||
33376113|NCT00642460|62755221|FG001|Part II: Open-Label Up to Week 92|Death|1|||
33376114|NCT00642460|62755222|FG002|Part II: Open-Label Up to Week 92|Death|0|||
33376115|NCT00642460|62755223|FG003|Part II: Open-Label Up to Week 92|Death|2|||
33376116|NCT00642460|62755224|FG004|Part II: Open-Label Up to Week 92|Death|0|||
33376117|NCT00642460|62755225|FG005|Part II: Open-Label Up to Week 92|Death|0|||
33376118|NCT00642460|62755220|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
33376119|NCT00642460|62755221|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
33376120|NCT00642460|62755222|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
33487033|NCT03681951|62864977|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
33487034|NCT03681951|62864978|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
33487035|NCT03681951|62864971|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
33487036|NCT03681951|62864972|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
33487037|NCT03681951|62864973|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
33487038|NCT03681951|62864974|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
33487039|NCT03681951|62864975|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
33487040|NCT03681951|62864976|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
33487041|NCT03681951|62864977|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
33487042|NCT03681951|62864978|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
33487043|NCT03681951|62864971|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
33556465|NCT02767765|62949416|FG000|Overall Study|Non-Compliance|1|||
33556466|NCT02767765|62949416|FG000|Overall Study|Withdrawal by Subject|1|||
33290596|NCT00479687|62667055|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
33290597|NCT00479687|62667053|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
33290598|NCT00479687|62667054|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
33290599|NCT00479687|62667055|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
33290600|NCT00479687|62667053|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
33290601|NCT00479687|62667054|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
33290602|NCT00479687|62667055|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
33290603|NCT00479687|62667053|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
33290604|NCT00479687|62667054|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
33290605|NCT00479687|62667055|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
33290606|NCT00479687|62667053|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
33290607|NCT00479687|62667054|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
33290608|NCT00479687|62667055|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
33290609|NCT00479336|62667066|FG000|Overall Study|Adverse Event|1|||
33290610|NCT00479336|62667067|FG001|Overall Study|Adverse Event|1|||
33290611|NCT00479336|62667068|FG002|Overall Study|Adverse Event|1|||
33290612|NCT00479336|62667069|FG003|Overall Study|Adverse Event|3|||
33290613|NCT00479336|62667066|FG000|Overall Study|Lack of Efficacy|1|||
33556467|NCT02772757|62949423|FG000|Overall Study|Withdrawal by Subject|1|||
33556468|NCT02772757|62949424|FG001|Overall Study|Withdrawal by Subject|0|||
33556469|NCT02772757|62949425|FG002|Overall Study|Withdrawal by Subject|1|||
33556470|NCT02772757|62949423|FG000|Overall Study|Protocol Violation|0|||
33556471|NCT02772757|62949424|FG001|Overall Study|Protocol Violation|0|||
33556472|NCT02772757|62949425|FG002|Overall Study|Protocol Violation|1|||
33556473|NCT02772757|62949423|FG000|Overall Study|Physician Decision|0|||
33556474|NCT02772757|62949424|FG001|Overall Study|Physician Decision|3|||
33556475|NCT02772757|62949425|FG002|Overall Study|Physician Decision|3|||
33556476|NCT00103207|62949434|FG000|Overall Study|Adverse Event|3|||
33556477|NCT00103207|62949434|FG000|Overall Study|Death|1|||
33556478|NCT00103207|62949434|FG000|Overall Study|Withdrawal by Subject|2|||
33556479|NCT00103207|62949434|FG000|Overall Study|Other complicating disease|1|||
33556480|NCT00103207|62949434|FG000|Overall Study|Ineligible|4|||
33556481|NCT00103207|62949434|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
33556482|NCT01369355|62949446|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
33556483|NCT01369355|62949447|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
33556484|NCT01369355|62949448|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
33556485|NCT01369355|62949449|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
33556486|NCT01369355|62949450|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
33556487|NCT01369355|62949451|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
33556488|NCT01369355|62949452|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
33556489|NCT01369355|62949453|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
33556490|NCT01369355|62949454|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
33556491|NCT01369355|62949446|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
33556492|NCT01369355|62949447|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
33556493|NCT01369355|62949448|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
33556494|NCT01369355|62949449|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
33376121|NCT00642460|62755223|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
33376122|NCT00642460|62755224|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
33376123|NCT00642460|62755225|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
33376124|NCT00642460|62755220|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
33376125|NCT00642460|62755221|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
33376126|NCT00642460|62755222|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
33376127|NCT00642460|62755223|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
33376128|NCT00642460|62755224|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
33376129|NCT00642460|62755225|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
33376130|NCT00642460|62755220|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
33376131|NCT00642460|62755221|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
33376132|NCT00642460|62755222|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
33376133|NCT00642460|62755223|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
33376134|NCT00642460|62755224|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
33376135|NCT00642460|62755225|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
33376136|NCT00642460|62755220|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
33376137|NCT00642460|62755221|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
33376138|NCT00642460|62755222|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
33376139|NCT00642460|62755223|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
33376140|NCT00642460|62755224|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
33376141|NCT00642460|62755225|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
33376142|NCT00642460|62755220|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
33487044|NCT03681951|62864972|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
33487045|NCT03681951|62864973|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
33487046|NCT03681951|62864974|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
33487047|NCT03681951|62864975|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
33487048|NCT03681951|62864976|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
33487049|NCT03681951|62864977|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
33487050|NCT03681951|62864978|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
33487051|NCT03681405|62865003|FG000|Overall Study|Found to be ineligible after randomized|1|||
33487052|NCT03681405|62865004|FG001|Overall Study|Found to be ineligible after randomized|0|||
33487053|NCT00174785|62865014|FG000|Overall Study|Adverse Event|293|||
33487054|NCT00174785|62865015|FG001|Overall Study|Adverse Event|191|||
33487055|NCT00174785|62865014|FG000|Overall Study|Protocol Violation|14|||
33487056|NCT00174785|62865015|FG001|Overall Study|Protocol Violation|14|||
33556495|NCT01369355|62949450|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
33556496|NCT01369355|62949451|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
33556497|NCT01369355|62949452|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
33556498|NCT01369355|62949453|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
33556499|NCT01369355|62949454|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
33662374|NCT01695239|63092844|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
33556500|NCT01369355|62949446|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
33556501|NCT01369355|62949447|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
33556502|NCT01369355|62949448|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
33556503|NCT01369355|62949449|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
33556504|NCT01369355|62949450|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
33556505|NCT01369355|62949451|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
33487057|NCT00174785|62865014|FG000|Overall Study|Withdrawal by Subject|173|||
33376143|NCT00642460|62755221|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
33376144|NCT00642460|62755222|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
33376145|NCT00642460|62755223|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
33376146|NCT00642460|62755224|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
33487058|NCT00174785|62865015|FG001|Overall Study|Withdrawal by Subject|175|||
33487059|NCT00174785|62865014|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
33487060|NCT00174785|62865015|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
33487061|NCT00174785|62865014|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
33487062|NCT00174785|62865015|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
33487063|NCT00174785|62865014|FG000|Overall Study|Other prohibited medication|5|||
33487064|NCT00174785|62865015|FG001|Overall Study|Other prohibited medication|3|||
33487065|NCT00174785|62865014|FG000|Overall Study|Family request|6|||
33556506|NCT01369355|62949452|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
33556507|NCT01369355|62949453|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
33556508|NCT01369355|62949454|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
33556509|NCT01369355|62949446|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
33556510|NCT01369355|62949447|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
33556511|NCT01369355|62949448|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
33556512|NCT01369355|62949449|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
33556513|NCT01369355|62949450|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
33376147|NCT00642460|62755225|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
33376148|NCT00642460|62755220|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
33376149|NCT00642460|62755221|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
33376150|NCT00642460|62755222|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
33376151|NCT00642460|62755223|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
33376152|NCT00642460|62755224|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
33376153|NCT00642460|62755225|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
33376154|NCT00642460|62755220|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
33376155|NCT00642460|62755221|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
33556514|NCT01369355|62949451|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
33556515|NCT01369355|62949452|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
33556516|NCT01369355|62949453|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
33556517|NCT01369355|62949454|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
33556518|NCT01369355|62949446|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
33376156|NCT00642460|62755222|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
33376157|NCT00642460|62755223|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
33376158|NCT00642460|62755224|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
33376159|NCT00642460|62755225|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
33376160|NCT00642460|62755220|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
33376161|NCT00642460|62755221|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
33376162|NCT00642460|62755222|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
33376163|NCT00642460|62755223|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
33376164|NCT00642460|62755224|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
33376165|NCT00642460|62755225|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
33376166|NCT00642460|62755220|FG000|Part III: Open-Label Up to Week 260|Other|0|||
33376167|NCT00642460|62755221|FG001|Part III: Open-Label Up to Week 260|Other|0|||
33376168|NCT00642460|62755222|FG002|Part III: Open-Label Up to Week 260|Other|0|||
33376169|NCT00642460|62755223|FG003|Part III: Open-Label Up to Week 260|Other|0|||
33376170|NCT00642460|62755224|FG004|Part III: Open-Label Up to Week 260|Other|2|||
33376171|NCT00642460|62755225|FG005|Part III: Open-Label Up to Week 260|Other|2|||
33376172|NCT00642460|62755220|FG000|Part III: Open-Label Up to Week 260|Death|0|||
33376173|NCT00642460|62755221|FG001|Part III: Open-Label Up to Week 260|Death|0|||
33376174|NCT00642460|62755222|FG002|Part III: Open-Label Up to Week 260|Death|0|||
33376175|NCT00642460|62755223|FG003|Part III: Open-Label Up to Week 260|Death|0|||
33376176|NCT00642460|62755224|FG004|Part III: Open-Label Up to Week 260|Death|0|||
33376177|NCT00642460|62755225|FG005|Part III: Open-Label Up to Week 260|Death|3|||
33376178|NCT00642460|62755220|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
33376179|NCT00642460|62755221|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
33556519|NCT01369355|62949447|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
33556520|NCT01369355|62949448|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
33556521|NCT01369355|62949449|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
33556522|NCT01369355|62949450|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
33556523|NCT01369355|62949451|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
33556524|NCT01369355|62949452|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
33556525|NCT01369355|62949453|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
33556526|NCT01369355|62949454|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
33556527|NCT01369355|62949446|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
33556528|NCT01369355|62949447|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
33556529|NCT01369355|62949448|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
33556530|NCT01369355|62949449|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
33556531|NCT01369355|62949450|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
33556532|NCT01369355|62949451|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
33556533|NCT01369355|62949452|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
33556534|NCT01369355|62949453|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
33556535|NCT01369355|62949454|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
33556536|NCT01369355|62949446|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
33556537|NCT01369355|62949447|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
33556538|NCT01369355|62949448|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
33556539|NCT01369355|62949449|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
33556540|NCT01369355|62949450|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
33556541|NCT01369355|62949451|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
33556542|NCT01369355|62949452|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
33376180|NCT00642460|62755222|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
33376181|NCT00642460|62755223|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
33376182|NCT00642460|62755224|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
33376183|NCT00642460|62755225|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
33376184|NCT00642460|62755220|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
33376185|NCT00642460|62755221|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
33376186|NCT00642460|62755222|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
33376187|NCT00642460|62755223|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
33376188|NCT00642460|62755224|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
33376189|NCT00642460|62755225|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
33376190|NCT00814658|62755237|FG000|Overall Study|Lost to Follow-up|0|||
33376191|NCT00814658|62755238|FG001|Overall Study|Lost to Follow-up|1|||
33376192|NCT00814658|62755237|FG000|Overall Study|Physician Decision|1|||
33376193|NCT00814658|62755238|FG001|Overall Study|Physician Decision|0|||
33376194|NCT00814658|62755237|FG000|Overall Study|Adverse Event|3|||
33376195|NCT00814658|62755238|FG001|Overall Study|Adverse Event|3|||
33376196|NCT00642304|62755254|FG000|Overall Study|Adverse Event|1|||
33376197|NCT00642304|62755254|FG000|Overall Study|Death|1|||
33376198|NCT00642304|62755254|FG000|Overall Study|Blood transfusion|2|||
33376199|NCT00642304|62755254|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
33376200|NCT00642304|62755254|FG000|Overall Study|Transplantation|1|||
33376201|NCT00814580|62755260|FG000|Overall Study|Adverse Event|6|||
33376202|NCT00814580|62755261|FG001|Overall Study|Adverse Event|15|||
33376203|NCT00814580|62755260|FG000|Overall Study|Lack of Efficacy|18|||
33376204|NCT00814580|62755261|FG001|Overall Study|Lack of Efficacy|25|||
33376205|NCT00814580|62755260|FG000|Overall Study|Protocol Violation|2|||
33376206|NCT00814580|62755261|FG001|Overall Study|Protocol Violation|0|||
33376207|NCT00814580|62755260|FG000|Overall Study|Withdrawal by Subject|2|||
33376208|NCT00814580|62755261|FG001|Overall Study|Withdrawal by Subject|2|||
33376209|NCT00814580|62755260|FG000|Overall Study|Other|1|||
33376210|NCT00814580|62755261|FG001|Overall Study|Other|3|||
33376211|NCT00814580|62755260|FG000|Overall Study|Did Not Take Drug|2|||
33376212|NCT00814580|62755261|FG001|Overall Study|Did Not Take Drug|2|||
33376213|NCT00643162|62755281|FG000|Overall Study|Withdrawal by Subject|1|||
33376214|NCT00643162|62755282|FG001|Overall Study|Withdrawal by Subject|1|||
33376215|NCT00643006|62755290|FG000|Overall Study|Lost to Follow-up|5|||
33376216|NCT00643006|62755291|FG001|Overall Study|Lost to Follow-up|4|||
33376217|NCT00814502|62755301|FG000|Overall Study|Adverse Event|1|||
33376218|NCT00814502|62755302|FG001|Overall Study|Adverse Event|0|||
33376219|NCT00814502|62755301|FG000|Overall Study|Withdrawal by Subject|0|||
33376220|NCT00814502|62755302|FG001|Overall Study|Withdrawal by Subject|2|||
33376221|NCT00653224|62755312|FG000|Overall Study|Adverse Event|2|||
33376222|NCT00653224|62755313|FG001|Overall Study|Adverse Event|1|||
33376223|NCT00653224|62755312|FG000|Overall Study|Lack of Efficacy|1|||
33376224|NCT00653224|62755313|FG001|Overall Study|Lack of Efficacy|2|||
33376225|NCT00653224|62755312|FG000|Overall Study|Loss of efficacy|1|||
33556543|NCT01369355|62949453|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
33556544|NCT01369355|62949454|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
33376226|NCT00653224|62755313|FG001|Overall Study|Loss of efficacy|0|||
33376227|NCT00653224|62755312|FG000|Overall Study|Lost to Follow-up|1|||
33376228|NCT00653224|62755313|FG001|Overall Study|Lost to Follow-up|0|||
33376229|NCT00653224|62755312|FG000|Overall Study|Other|2|||
33376230|NCT00653224|62755313|FG001|Overall Study|Other|4|||
33556545|NCT01369355|62949446|FG000|Long-term Extension (Week 44-272)|Death|0|||
33376231|NCT00444925|62755322|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
33376232|NCT00444925|62755323|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
33376233|NCT00444925|62755324|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
33376234|NCT00444925|62755322|FG000|Double-blind Treatment Period|Death|2|||
33376235|NCT00444925|62755323|FG001|Double-blind Treatment Period|Death|0|||
33376236|NCT00444925|62755324|FG002|Double-blind Treatment Period|Death|0|||
33376237|NCT00444925|62755322|FG000|Double-blind Treatment Period|Adverse Event|6|||
33376238|NCT00444925|62755323|FG001|Double-blind Treatment Period|Adverse Event|28|||
33376239|NCT00444925|62755324|FG002|Double-blind Treatment Period|Adverse Event|44|||
33376240|NCT00444925|62755322|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
33376241|NCT00444925|62755323|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
33376242|NCT00444925|62755324|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
33376243|NCT00444925|62755322|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
33376244|NCT00444925|62755323|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
33376245|NCT00444925|62755324|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
33376246|NCT00444925|62755322|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
33376247|NCT00444925|62755323|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
33376248|NCT00444925|62755324|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
33376249|NCT00444925|62755322|FG000|Double-blind Treatment Period|Other|7|||
33376250|NCT00444925|62755323|FG001|Double-blind Treatment Period|Other|7|||
33376251|NCT00444925|62755324|FG002|Double-blind Treatment Period|Other|12|||
33376252|NCT00641056|62755334|FG000|Overall Study|Adverse Event|12|||
33376253|NCT00641056|62755335|FG001|Overall Study|Adverse Event|2|||
33376254|NCT00641056|62755334|FG000|Overall Study|Lost to Follow-up|2|||
33376255|NCT00641056|62755335|FG001|Overall Study|Lost to Follow-up|1|||
33376256|NCT00641056|62755334|FG000|Overall Study|Physician Decision|3|||
33376257|NCT00641056|62755335|FG001|Overall Study|Physician Decision|1|||
33376258|NCT00641056|62755334|FG000|Overall Study|Protocol Violation|2|||
33376259|NCT00641056|62755335|FG001|Overall Study|Protocol Violation|0|||
33487066|NCT00174785|62865015|FG001|Overall Study|Family request|8|||
33487067|NCT00174785|62865014|FG000|Overall Study|Not pre-specified/Not coded|56|||
33487068|NCT00174785|62865015|FG001|Overall Study|Not pre-specified/Not coded|70|||
33487069|NCT03681093|62865024|FG000|Overall Study|Subject decision|0|||
33487070|NCT03681093|62865025|FG001|Overall Study|Subject decision|2|||
33376260|NCT00641056|62755334|FG000|Overall Study|Entry Criteria Not Met|3|||
33376261|NCT00641056|62755335|FG001|Overall Study|Entry Criteria Not Met|0|||
33376262|NCT00641056|62755334|FG000|Overall Study|Subject Decision|6|||
33376263|NCT00641056|62755335|FG001|Overall Study|Subject Decision|19|||
33376264|NCT00641056|62755334|FG000|Overall Study|Sponsor Decision|1|||
33376265|NCT00641056|62755335|FG001|Overall Study|Sponsor Decision|2|||
33376266|NCT00814346|62755347|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
33376267|NCT00814346|62755348|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
33376268|NCT00814346|62755347|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
33376269|NCT00814346|62755348|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
33376270|NCT00814346|62755347|FG000|Open Phase (17 Months)|Adverse Event|5|||
33376271|NCT00814346|62755348|FG001|Open Phase (17 Months)|Adverse Event|0|||
33376272|NCT00814346|62755347|FG000|Open Phase (17 Months)|Consent|2|||
33376273|NCT00814346|62755348|FG001|Open Phase (17 Months)|Consent|0|||
33376274|NCT00814346|62755347|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
33376275|NCT00814346|62755348|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
33376276|NCT00814346|62755347|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
33376277|NCT00814346|62755348|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
33376278|NCT00569374|62755367|FG000|Overall Study|Withdrawal by Subject|4|||
33376279|NCT00828464|62755371|FG000|Overall Study|Withdrawal by Subject|1|||
33376280|NCT00810602|62755375|FG000|Overall Study|Withdrawal by Subject|8|||
33376281|NCT00810602|62755376|FG001|Overall Study|Withdrawal by Subject|3|||
33376282|NCT00791700|62755384|FG000|Overall Study|Insufficient clinical response|1|||
33376283|NCT00791700|62755385|FG001|Overall Study|Insufficient clinical response|4|||
33376284|NCT00791700|62755386|FG002|Overall Study|Insufficient clinical response|1|||
33376285|NCT00791700|62755387|FG003|Overall Study|Insufficient clinical response|8|||
33376286|NCT00791700|62755384|FG000|Overall Study|No longer willing to participate|1|||
33487071|NCT03681093|62865026|FG002|Overall Study|Subject decision|1|||
33487072|NCT00166517|62865036|FG000|Overall Study|Lost to Follow-up|1|||
33487073|NCT00166517|62865037|FG001|Overall Study|Lost to Follow-up|0|||
33487074|NCT00166517|62865036|FG000|Overall Study|Protocol Violation|4|||
33487075|NCT00166517|62865037|FG001|Overall Study|Protocol Violation|1|||
33487076|NCT00166517|62865036|FG000|Overall Study|Withdrawal by Subject|0|||
33487077|NCT00166517|62865037|FG001|Overall Study|Withdrawal by Subject|1|||
33376287|NCT00791700|62755385|FG001|Overall Study|No longer willing to participate|1|||
33376288|NCT00791700|62755386|FG002|Overall Study|No longer willing to participate|0|||
33376289|NCT00791700|62755387|FG003|Overall Study|No longer willing to participate|8|||
33487078|NCT00166439|62865043|FG000|Overall Study|Ineligible|5|||
33487079|NCT00138671|62865049|FG000|Overall Study|Death|0|||
33487080|NCT00138671|62865050|FG001|Overall Study|Death|3|||
33376290|NCT00791700|62755384|FG000|Overall Study|Non-compliance with study treatment|0|||
33376291|NCT00791700|62755385|FG001|Overall Study|Non-compliance with study treatment|2|||
33376292|NCT00791700|62755386|FG002|Overall Study|Non-compliance with study treatment|0|||
33376293|NCT00791700|62755387|FG003|Overall Study|Non-compliance with study treatment|4|||
33556546|NCT01369355|62949447|FG001|Long-term Extension (Week 44-272)|Death|0|||
33556547|NCT01369355|62949448|FG002|Long-term Extension (Week 44-272)|Death|0|||
33556548|NCT01369355|62949449|FG003|Long-term Extension (Week 44-272)|Death|0|||
33556549|NCT01369355|62949450|FG004|Long-term Extension (Week 44-272)|Death|0|||
33556550|NCT01369355|62949451|FG005|Long-term Extension (Week 44-272)|Death|0|||
33556551|NCT01369355|62949452|FG006|Long-term Extension (Week 44-272)|Death|0|||
33556552|NCT01369355|62949453|FG007|Long-term Extension (Week 44-272)|Death|1|||
33556553|NCT01369355|62949454|FG008|Long-term Extension (Week 44-272)|Death|3|||
33662375|NCT01695239|63092845|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
33376294|NCT00791700|62755384|FG000|Overall Study|Withdrawn due to pregnancy|0|||
33376295|NCT00791700|62755385|FG001|Overall Study|Withdrawn due to pregnancy|0|||
33376296|NCT00791700|62755386|FG002|Overall Study|Withdrawn due to pregnancy|0|||
33376297|NCT00791700|62755387|FG003|Overall Study|Withdrawn due to pregnancy|1|||
33376298|NCT00791700|62755384|FG000|Overall Study|Other|0|||
33376299|NCT00791700|62755385|FG001|Overall Study|Other|1|||
33376300|NCT00791700|62755386|FG002|Overall Study|Other|0|||
33376301|NCT00791700|62755387|FG003|Overall Study|Other|1|||
33376302|NCT00791700|62755384|FG000|Overall Study|Death|0|||
33376303|NCT00791700|62755385|FG001|Overall Study|Death|0|||
33376304|NCT00791700|62755386|FG002|Overall Study|Death|0|||
33376305|NCT00791700|62755387|FG003|Overall Study|Death|1|||
33376306|NCT00791700|62755384|FG000|Overall Study|Lost to Follow-up|4|||
33376307|NCT00791700|62755385|FG001|Overall Study|Lost to Follow-up|3|||
33376308|NCT00791700|62755386|FG002|Overall Study|Lost to Follow-up|4|||
33376309|NCT00791700|62755387|FG003|Overall Study|Lost to Follow-up|6|||
33376310|NCT00791700|62755384|FG000|Overall Study|Adverse Event|0|||
33376311|NCT00791700|62755385|FG001|Overall Study|Adverse Event|0|||
33376312|NCT00791700|62755386|FG002|Overall Study|Adverse Event|1|||
33376313|NCT00791700|62755387|FG003|Overall Study|Adverse Event|1|||
33376314|NCT00810368|62755410|FG000|Overall Study|Lost to Follow-up|4|||
33376315|NCT00810368|62755411|FG001|Overall Study|Lost to Follow-up|2|||
33376316|NCT00810368|62755410|FG000|Overall Study|Lack of Efficacy|2|||
33376317|NCT00810368|62755411|FG001|Overall Study|Lack of Efficacy|0|||
33376318|NCT00628108|62755421|FG000|Overall Study|Adverse Event|0|||
33376319|NCT00628108|62755422|FG001|Overall Study|Adverse Event|3|||
33376320|NCT00628108|62755421|FG000|Overall Study|Withdrawal by Subject|1|||
33487081|NCT00138671|62865049|FG000|Overall Study|Adverse Event|6|||
33487082|NCT00138671|62865050|FG001|Overall Study|Adverse Event|3|||
33487083|NCT00138671|62865049|FG000|Overall Study|Lost to Follow-up|1|||
33487084|NCT00138671|62865050|FG001|Overall Study|Lost to Follow-up|2|||
33487085|NCT00138671|62865049|FG000|Overall Study|Withdrawal by Subject|3|||
33487086|NCT00138671|62865050|FG001|Overall Study|Withdrawal by Subject|5|||
33487087|NCT00138671|62865049|FG000|Overall Study|Other|3|||
33487088|NCT00138671|62865050|FG001|Overall Study|Other|3|||
33487089|NCT01367158|62865069|FG000|Overall Study|Withdrew consent|0|||
33487090|NCT01367158|62865070|FG001|Overall Study|Withdrew consent|2|||
33556554|NCT01369355|62949446|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
33556555|NCT01369355|62949447|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
33290614|NCT00479336|62667067|FG001|Overall Study|Lack of Efficacy|0|||
33290615|NCT00479336|62667068|FG002|Overall Study|Lack of Efficacy|0|||
33290616|NCT00479336|62667069|FG003|Overall Study|Lack of Efficacy|0|||
33290617|NCT00479336|62667066|FG000|Overall Study|Protocol Violation|0|||
33290618|NCT00479336|62667067|FG001|Overall Study|Protocol Violation|1|||
33290619|NCT00479336|62667068|FG002|Overall Study|Protocol Violation|0|||
33290620|NCT00479336|62667069|FG003|Overall Study|Protocol Violation|0|||
33290621|NCT00479336|62667066|FG000|Overall Study|Withdrawal by Subject|1|||
33290622|NCT00479336|62667067|FG001|Overall Study|Withdrawal by Subject|2|||
33290623|NCT00479336|62667068|FG002|Overall Study|Withdrawal by Subject|0|||
33290624|NCT00479336|62667069|FG003|Overall Study|Withdrawal by Subject|0|||
33290625|NCT00479336|62667066|FG000|Overall Study|Physician Decision|0|||
33290626|NCT00479336|62667067|FG001|Overall Study|Physician Decision|1|||
33290627|NCT00479336|62667068|FG002|Overall Study|Physician Decision|0|||
33290628|NCT00479336|62667069|FG003|Overall Study|Physician Decision|2|||
33290629|NCT00479336|62667066|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
33290630|NCT00479336|62667067|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
33376321|NCT00628108|62755422|FG001|Overall Study|Withdrawal by Subject|0|||
33376322|NCT00628030|62755430|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
33376323|NCT00628030|62755431|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
33487091|NCT01367158|62865071|FG002|Overall Study|Withdrew consent|1|||
33290631|NCT00479336|62667068|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
33290632|NCT00479336|62667069|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
33376324|NCT00628030|62755430|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
33376325|NCT00628030|62755431|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
33290633|NCT00478244|62667079|FG000|Overall Study|Did not receive transplant|1|||
33290634|NCT00478205|62667085|FG000|Overall Study|Adverse Event|182|||
33487092|NCT01367158|62865072|FG003|Overall Study|Withdrew consent|0|||
33487093|NCT01367158|62865073|FG004|Overall Study|Withdrew consent|2|||
33487094|NCT01367158|62865074|FG005|Overall Study|Withdrew consent|0|||
33487095|NCT01367158|62865075|FG006|Overall Study|Withdrew consent|0|||
33290635|NCT00478205|62667086|FG001|Overall Study|Adverse Event|39|||
33290636|NCT00478205|62667085|FG000|Overall Study|Medication Non-compliance|9|||
33290637|NCT00478205|62667086|FG001|Overall Study|Medication Non-compliance|4|||
33290638|NCT00478205|62667085|FG000|Overall Study|Protocol Violation|15|||
33290639|NCT00478205|62667086|FG001|Overall Study|Protocol Violation|5|||
33290640|NCT00478205|62667085|FG000|Overall Study|Request of Investigator or Sponsor|4|||
33290641|NCT00478205|62667086|FG001|Overall Study|Request of Investigator or Sponsor|5|||
33290642|NCT00478205|62667085|FG000|Overall Study|Withdrawal by Subject|61|||
33290643|NCT00478205|62667086|FG001|Overall Study|Withdrawal by Subject|22|||
33290644|NCT00478205|62667085|FG000|Overall Study|Lack of Efficacy|1|||
33290645|NCT00478205|62667086|FG001|Overall Study|Lack of Efficacy|0|||
33290646|NCT00478205|62667085|FG000|Overall Study|Other|24|||
33290647|NCT00478205|62667086|FG001|Overall Study|Other|12|||
33290648|NCT00477971|62667094|FG000|Overall Study|Disease progression|6|||
33290649|NCT00477971|62667095|FG001|Overall Study|Disease progression|0|||
33290650|NCT00477971|62667094|FG000|Overall Study|Withdrawal by Subject|3|||
33290651|NCT00477971|62667095|FG001|Overall Study|Withdrawal by Subject|1|||
33290652|NCT00477971|62667094|FG000|Overall Study|Adverse Event|3|||
33290653|NCT00477971|62667095|FG001|Overall Study|Adverse Event|0|||
33487096|NCT01367158|62865076|FG007|Overall Study|Withdrew consent|1|||
33487097|NCT01367158|62865077|FG008|Overall Study|Withdrew consent|0|||
33487098|NCT01367158|62865078|FG009|Overall Study|Withdrew consent|0|||
33487099|NCT01367158|62865079|FG010|Overall Study|Withdrew consent|0|||
33487100|NCT01367158|62865069|FG000|Overall Study|Lost to Follow-up|0|||
33487101|NCT01367158|62865070|FG001|Overall Study|Lost to Follow-up|0|||
33290654|NCT00477971|62667094|FG000|Overall Study|Death|2|||
33290655|NCT00477971|62667095|FG001|Overall Study|Death|4|||
33290656|NCT00477971|62667094|FG000|Overall Study|Alternative treatment|3|||
33290657|NCT00477971|62667095|FG001|Overall Study|Alternative treatment|1|||
33290658|NCT00477464|62667101|FG000|Overall Study|Lost to Follow-up|1|||
33290659|NCT00477464|62667101|FG000|Overall Study|Death|36|||
33290660|NCT00477464|62667101|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
33290661|NCT00477386|62667109|FG000|Overall Study|Adverse Event|4|||
33290662|NCT00477386|62667110|FG001|Overall Study|Adverse Event|8|||
33290663|NCT00477386|62667109|FG000|Overall Study|Disease progression, relapse|3|||
33290664|NCT00477386|62667110|FG001|Overall Study|Disease progression, relapse|4|||
33290665|NCT00477386|62667109|FG000|Overall Study|Disease progression, refractory|1|||
33290666|NCT00477386|62667110|FG001|Overall Study|Disease progression, refractory|3|||
33290667|NCT00477386|62667109|FG000|Overall Study|Other|1|||
33290668|NCT00477386|62667110|FG001|Overall Study|Other|2|||
33290669|NCT00477386|62667109|FG000|Overall Study|Physician Decision|1|||
33290670|NCT00477386|62667110|FG001|Overall Study|Physician Decision|0|||
33290671|NCT00477386|62667109|FG000|Overall Study|Withdrawal by Subject|1|||
33290672|NCT00477386|62667110|FG001|Overall Study|Withdrawal by Subject|0|||
33290673|NCT00477269|62667118|FG000|Core Study|Adverse Event|6|||
33290674|NCT00477269|62667119|FG001|Core Study|Adverse Event|4|||
33376326|NCT00628030|62755430|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
33376327|NCT00628030|62755431|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
33376328|NCT00591578|62755440|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
33376329|NCT00591578|62755441|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
33376330|NCT00591578|62755442|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
33376331|NCT00591578|62755440|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
33376332|NCT00591578|62755441|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
33487102|NCT01367158|62865071|FG002|Overall Study|Lost to Follow-up|0|||
33487103|NCT01367158|62865072|FG003|Overall Study|Lost to Follow-up|1|||
33487104|NCT01367158|62865073|FG004|Overall Study|Lost to Follow-up|0|||
33487105|NCT01367158|62865074|FG005|Overall Study|Lost to Follow-up|2|||
33487106|NCT01367158|62865075|FG006|Overall Study|Lost to Follow-up|0|||
33290675|NCT00477269|62667120|FG002|Core Study|Adverse Event|0|||
33290676|NCT00477269|62667118|FG000|Core Study|Death|3|||
33290677|NCT00477269|62667119|FG001|Core Study|Death|3|||
33290678|NCT00477269|62667120|FG002|Core Study|Death|0|||
33290679|NCT00477269|62667118|FG000|Core Study|Withdrawn Consent|0|||
33290680|NCT00477269|62667119|FG001|Core Study|Withdrawn Consent|1|||
33290681|NCT00477269|62667120|FG002|Core Study|Withdrawn Consent|0|||
33290682|NCT00477269|62667118|FG000|Open Label Extension|Adverse Event|0|||
33290683|NCT00477269|62667119|FG001|Open Label Extension|Adverse Event|0|||
33290684|NCT00477269|62667120|FG002|Open Label Extension|Adverse Event|4|||
33290685|NCT00477269|62667118|FG000|Open Label Extension|Abnormal laboratory values|0|||
33487107|NCT01367158|62865076|FG007|Overall Study|Lost to Follow-up|1|||
33487108|NCT01367158|62865077|FG008|Overall Study|Lost to Follow-up|0|||
33290686|NCT00477269|62667119|FG001|Open Label Extension|Abnormal laboratory values|0|||
33376333|NCT00591578|62755442|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
33290687|NCT00477269|62667120|FG002|Open Label Extension|Abnormal laboratory values|1|||
33290688|NCT00477269|62667118|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
33290689|NCT00477269|62667119|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
33290690|NCT00477269|62667120|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
33290691|NCT00477269|62667118|FG000|Open Label Extension|Adminiatrative problems|0|||
33290692|NCT00477269|62667119|FG001|Open Label Extension|Adminiatrative problems|0|||
33290693|NCT00477269|62667120|FG002|Open Label Extension|Adminiatrative problems|2|||
33290694|NCT00477269|62667118|FG000|Open Label Extension|Death|0|||
33290695|NCT00477269|62667119|FG001|Open Label Extension|Death|0|||
33290696|NCT00477269|62667120|FG002|Open Label Extension|Death|4|||
33290697|NCT00477152|62667128|FG000|Overall Study|Parent withdrew consent|2|||
33290698|NCT00477152|62667128|FG000|Overall Study|Adverse Event|1|||
33290699|NCT00476996|62667135|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
33290700|NCT00476996|62667136|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
33290701|NCT00476996|62667137|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
33290702|NCT00476996|62667138|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
33290703|NCT00476996|62667135|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
33290704|NCT00476996|62667136|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
33290705|NCT00476996|62667137|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
33290706|NCT00476996|62667138|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
33290707|NCT00476996|62667135|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
33290708|NCT00476996|62667136|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
33290709|NCT00476996|62667137|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
33290710|NCT00476996|62667138|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
33290711|NCT00476996|62667135|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
33290712|NCT00476996|62667136|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
33290713|NCT00476996|62667137|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
33290714|NCT00476996|62667138|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
33290715|NCT00476996|62667135|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
33290716|NCT00476996|62667136|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
33290717|NCT00476996|62667137|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
33290718|NCT00476996|62667138|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
33290719|NCT00476996|62667135|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
33290720|NCT00476996|62667136|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
33290721|NCT00476996|62667137|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
33290722|NCT00476996|62667138|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
33290723|NCT00476996|62667135|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
33290724|NCT00476996|62667136|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
33290725|NCT00476996|62667137|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
33290726|NCT00476996|62667138|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
33290727|NCT00476996|62667135|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
33290728|NCT00476996|62667136|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
33290729|NCT00476996|62667137|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
33290730|NCT00476996|62667138|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
33290731|NCT00476996|62667135|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
33290732|NCT00476996|62667136|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
33290733|NCT00476996|62667137|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
33290734|NCT00476996|62667138|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
33290735|NCT00476996|62667135|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
33376334|NCT00591578|62755440|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
33376335|NCT00591578|62755441|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
33376336|NCT00591578|62755442|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
33376337|NCT00591578|62755440|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
33376338|NCT00591578|62755441|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
33376339|NCT00591578|62755442|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
33376340|NCT00591578|62755440|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
33376341|NCT00591578|62755441|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
33376342|NCT00591578|62755442|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
33376343|NCT00591578|62755440|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
33376344|NCT00591578|62755441|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
33376345|NCT00591578|62755442|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
33376346|NCT00591578|62755440|FG000|Double-Blind Treatment Phase|Other|4|||
33376347|NCT00591578|62755441|FG001|Double-Blind Treatment Phase|Other|9|||
33376348|NCT00591578|62755442|FG002|Double-Blind Treatment Phase|Other|4|||
33376349|NCT00591578|62755440|FG000|Open-Label Extension Phase|Adverse Event|3|||
33376350|NCT00591578|62755441|FG001|Open-Label Extension Phase|Adverse Event|5|||
33376351|NCT00591578|62755442|FG002|Open-Label Extension Phase|Adverse Event|0|||
33290736|NCT00476996|62667136|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
33290737|NCT00476996|62667137|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
33290738|NCT00476996|62667138|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
33290739|NCT00476996|62667135|FG000|OLE Phase (From Week 48)|Death|0|||
33290740|NCT00476996|62667136|FG001|OLE Phase (From Week 48)|Death|0|||
33290741|NCT00476996|62667137|FG002|OLE Phase (From Week 48)|Death|0|||
33290742|NCT00476996|62667138|FG003|OLE Phase (From Week 48)|Death|7|||
33290743|NCT00476996|62667135|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
33290744|NCT00476996|62667136|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
33290745|NCT00476996|62667137|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
33290746|NCT00476996|62667138|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
33290747|NCT00476996|62667135|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
33290748|NCT00476996|62667136|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
33290749|NCT00476996|62667137|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
33290750|NCT00476996|62667138|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
33290751|NCT00476996|62667135|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
33290752|NCT00476996|62667136|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
33290753|NCT00476996|62667137|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
33290754|NCT00476996|62667138|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
33290755|NCT00476996|62667135|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
33290756|NCT00476996|62667136|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
33290757|NCT00476996|62667137|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
33290758|NCT00476996|62667138|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
33290759|NCT00476957|62667149|FG000|Overall Study|Lost to Follow-up|176|||
33290760|NCT00476957|62667150|FG001|Overall Study|Lost to Follow-up|193|||
33290761|NCT00475865|62667159|FG000|Overall Study|Adverse Event|0|||
33290762|NCT00475865|62667160|FG001|Overall Study|Adverse Event|3|||
33376352|NCT00591578|62755440|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
33376353|NCT00591578|62755441|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
33376354|NCT00591578|62755442|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
33376355|NCT00591578|62755440|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
33376356|NCT00591578|62755441|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
33376357|NCT00591578|62755442|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
33376358|NCT00591578|62755440|FG000|Open-Label Extension Phase|Other|1|||
33376359|NCT00591578|62755441|FG001|Open-Label Extension Phase|Other|0|||
33376360|NCT00591578|62755442|FG002|Open-Label Extension Phase|Other|0|||
33376361|NCT00797862|62755454|FG000|Overall Study|Adverse Event|86|||
33376362|NCT00797862|62755455|FG001|Overall Study|Adverse Event|44|||
33376363|NCT00797862|62755456|FG002|Overall Study|Adverse Event|58|||
33376364|NCT00797862|62755454|FG000|Overall Study|Abnormal Test Procedure Result|0|||
33376365|NCT00797862|62755455|FG001|Overall Study|Abnormal Test Procedure Result|1|||
33376366|NCT00797862|62755456|FG002|Overall Study|Abnormal Test Procedure Result|1|||
33376367|NCT00797862|62755454|FG000|Overall Study|Lack of Efficacy|1|||
33376368|NCT00797862|62755455|FG001|Overall Study|Lack of Efficacy|7|||
33376369|NCT00797862|62755456|FG002|Overall Study|Lack of Efficacy|6|||
33376370|NCT00797862|62755454|FG000|Overall Study|No longer required study medication|1|||
33376371|NCT00797862|62755455|FG001|Overall Study|No longer required study medication|0|||
33376372|NCT00797862|62755456|FG002|Overall Study|No longer required study medication|0|||
33376373|NCT00797862|62755454|FG000|Overall Study|Withdrawal by Subject|14|||
33376374|NCT00797862|62755455|FG001|Overall Study|Withdrawal by Subject|7|||
33376375|NCT00797862|62755456|FG002|Overall Study|Withdrawal by Subject|7|||
33376376|NCT00797862|62755454|FG000|Overall Study|Lost to Follow-up|11|||
33376377|NCT00797862|62755455|FG001|Overall Study|Lost to Follow-up|0|||
33376378|NCT00797862|62755456|FG002|Overall Study|Lost to Follow-up|5|||
33290763|NCT00475865|62667161|FG002|Overall Study|Adverse Event|4|||
33290764|NCT00475865|62667159|FG000|Overall Study|Lack of Efficacy|1|||
33290765|NCT00475865|62667160|FG001|Overall Study|Lack of Efficacy|0|||
33290766|NCT00475865|62667161|FG002|Overall Study|Lack of Efficacy|0|||
33290767|NCT00475865|62667159|FG000|Overall Study|Progressive disease|0|||
33290768|NCT00475865|62667160|FG001|Overall Study|Progressive disease|1|||
33290769|NCT00475865|62667161|FG002|Overall Study|Progressive disease|2|||
33290770|NCT00475865|62667159|FG000|Overall Study|Participant did not wish to continue|1|||
33376379|NCT00797862|62755454|FG000|Overall Study|Administrative Problem|4|||
33376380|NCT00797862|62755455|FG001|Overall Study|Administrative Problem|0|||
33376381|NCT00797862|62755456|FG002|Overall Study|Administrative Problem|0|||
33556556|NCT01369355|62949448|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
33290771|NCT00475865|62667160|FG001|Overall Study|Participant did not wish to continue|0|||
33290772|NCT00475865|62667161|FG002|Overall Study|Participant did not wish to continue|0|||
33290773|NCT00475865|62667159|FG000|Overall Study|Other than above|0|||
33290774|NCT00475865|62667160|FG001|Overall Study|Other than above|1|||
33290775|NCT00475865|62667161|FG002|Overall Study|Other than above|0|||
33376382|NCT00797862|62755454|FG000|Overall Study|Protocol Violation|4|||
33376383|NCT00797862|62755455|FG001|Overall Study|Protocol Violation|6|||
33376384|NCT00797862|62755456|FG002|Overall Study|Protocol Violation|8|||
33376385|NCT00797862|62755454|FG000|Overall Study|Mis-randomized|3|||
33290776|NCT00475709|62667171|FG000|Overall Study|Did not meet eligibility criteria|8|||
33290777|NCT00475709|62667171|FG000|Overall Study|Death|41|||
33290778|NCT00475709|62667171|FG000|Overall Study|Device Explant|6|||
33290779|NCT00475709|62667171|FG000|Overall Study|Lost to Follow-up|21|||
33290780|NCT00475670|62667177|FG000|Overall Study|Death|0|||
33290781|NCT00475670|62667178|FG001|Overall Study|Death|1|||
33290782|NCT00475670|62667177|FG000|Overall Study|Lack of Efficacy|3|||
33290783|NCT00475670|62667178|FG001|Overall Study|Lack of Efficacy|34|||
33290784|NCT00475670|62667177|FG000|Overall Study|Refused treatment|0|||
33290785|NCT00475670|62667178|FG001|Overall Study|Refused treatment|2|||
33290786|NCT00475670|62667177|FG000|Overall Study|Failure to Return|0|||
33290787|NCT00475670|62667178|FG001|Overall Study|Failure to Return|1|||
33290788|NCT00475670|62667177|FG000|Overall Study|Other|0|||
33290789|NCT00475670|62667178|FG001|Overall Study|Other|3|||
33290790|NCT00474968|62667186|FG000|Overall Study|Withdrawal by Subject|8|||
33376386|NCT00797862|62755455|FG001|Overall Study|Mis-randomized|3|||
33376387|NCT00797862|62755456|FG002|Overall Study|Mis-randomized|1|||
33376388|NCT00794820|62755464|FG000|Overall Study|Adverse Event|11|||
33376389|NCT00794820|62755464|FG000|Overall Study|Secondary Malignancies|2|||
33376390|NCT00794820|62755464|FG000|Overall Study|Resistant Disease|2|||
33376391|NCT00794820|62755464|FG000|Overall Study|Ineligible/Screen Failure|1|||
33376392|NCT00455533|62755470|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
33376393|NCT00455533|62755471|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
33376394|NCT00455533|62755472|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
33376395|NCT00455533|62755470|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
33376396|NCT00455533|62755471|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
33376397|NCT00455533|62755472|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
33376398|NCT00455533|62755470|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
33376399|NCT00455533|62755471|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
33487109|NCT01367158|62865078|FG009|Overall Study|Lost to Follow-up|0|||
33487110|NCT01367158|62865079|FG010|Overall Study|Lost to Follow-up|1|||
33487111|NCT01367158|62865069|FG000|Overall Study|Protocol Violation|0|||
33487112|NCT01367158|62865070|FG001|Overall Study|Protocol Violation|1|||
33376400|NCT00455533|62755472|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
33376401|NCT00455533|62755470|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
33376402|NCT00455533|62755471|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
33376403|NCT00455533|62755472|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
33376404|NCT00455533|62755470|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
33376405|NCT00455533|62755471|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
33376406|NCT00455533|62755472|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
33376407|NCT00455533|62755470|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
33376408|NCT00455533|62755471|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
33376409|NCT00455533|62755472|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
33376410|NCT00455533|62755470|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
33376411|NCT00455533|62755471|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
33376412|NCT00455533|62755472|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
33376413|NCT00455533|62755470|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
33376414|NCT00455533|62755471|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
33376415|NCT00455533|62755472|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
33376416|NCT00455533|62755470|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
33376417|NCT00455533|62755471|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
33376418|NCT00455533|62755472|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
33376419|NCT00455533|62755470|FG000|Period Two: Randomized Period|Death|0|||
33376420|NCT00455533|62755471|FG001|Period Two: Randomized Period|Death|0|||
33376421|NCT00455533|62755472|FG002|Period Two: Randomized Period|Death|3|||
33376422|NCT00455533|62755470|FG000|Period Two: Randomized Period|Disease Progression|0|||
33376423|NCT00455533|62755471|FG001|Period Two: Randomized Period|Disease Progression|1|||
33376424|NCT00455533|62755472|FG002|Period Two: Randomized Period|Disease Progression|1|||
33376425|NCT00455533|62755470|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
33376426|NCT00455533|62755471|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
33376427|NCT00455533|62755472|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
33487113|NCT01367158|62865071|FG002|Overall Study|Protocol Violation|0|||
33376428|NCT00455533|62755470|FG000|Period Two: Randomized Period|Other - need reasons|0|||
33376429|NCT00455533|62755471|FG001|Period Two: Randomized Period|Other - need reasons|1|||
33487114|NCT01367158|62865072|FG003|Overall Study|Protocol Violation|0|||
33487115|NCT01367158|62865073|FG004|Overall Study|Protocol Violation|0|||
33290791|NCT00474968|62667187|FG001|Overall Study|Withdrawal by Subject|7|||
33290792|NCT00474968|62667186|FG000|Overall Study|Protocol Violation|9|||
33290793|NCT00474968|62667187|FG001|Overall Study|Protocol Violation|8|||
33290794|NCT00474968|62667186|FG000|Overall Study|Sample not collected|1|||
33290795|NCT00474968|62667187|FG001|Overall Study|Sample not collected|1|||
33376430|NCT00455533|62755472|FG002|Period Two: Randomized Period|Other - need reasons|0|||
33376431|NCT00455533|62755470|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
33376432|NCT00455533|62755471|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
33376433|NCT00455533|62755472|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
33376434|NCT00455533|62755470|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
33376435|NCT00455533|62755471|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
33376436|NCT00455533|62755472|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
33376437|NCT00627094|62755482|FG000|Overall Study|Adverse Event|8|||
33376438|NCT00627094|62755483|FG001|Overall Study|Adverse Event|7|||
33376439|NCT00627094|62755482|FG000|Overall Study|Lost to Follow-up|1|||
33376440|NCT00627094|62755483|FG001|Overall Study|Lost to Follow-up|0|||
33376441|NCT00627094|62755482|FG000|Overall Study|Withdrawal by Subject|1|||
33376442|NCT00627094|62755483|FG001|Overall Study|Withdrawal by Subject|1|||
33376443|NCT00627094|62755482|FG000|Overall Study|ulcer healed|1|||
33290796|NCT00474929|62667198|FG000|Overall Study|Withdrawal by Subject|0|||
33290797|NCT00474929|62667199|FG001|Overall Study|Withdrawal by Subject|1|||
33290798|NCT00474929|62667200|FG002|Overall Study|Withdrawal by Subject|0|||
33290799|NCT00474929|62667201|FG003|Overall Study|Withdrawal by Subject|0|||
33376444|NCT00627094|62755483|FG001|Overall Study|ulcer healed|7|||
33376445|NCT00627094|62755482|FG000|Overall Study|Other reason|1|||
33376446|NCT00627094|62755483|FG001|Overall Study|Other reason|0|||
33376447|NCT00642850|62755491|FG000|Overall Study|Death|7|||
33376448|NCT00642850|62755491|FG000|Overall Study|Adverse Event|2|||
33376449|NCT00642850|62755491|FG000|Overall Study|Lack of Efficacy|1|||
33376450|NCT00642850|62755491|FG000|Overall Study|Protocol Violation|2|||
33290800|NCT00474929|62667202|FG004|Overall Study|Withdrawal by Subject|0|||
33290801|NCT00474929|62667198|FG000|Overall Study|Unrelated medical condition|0|||
33290802|NCT00474929|62667199|FG001|Overall Study|Unrelated medical condition|0|||
33290803|NCT00474929|62667200|FG002|Overall Study|Unrelated medical condition|1|||
33290804|NCT00474929|62667201|FG003|Overall Study|Unrelated medical condition|0|||
33290805|NCT00474929|62667202|FG004|Overall Study|Unrelated medical condition|0|||
33290806|NCT00474929|62667198|FG000|Overall Study|Physician Decision|0|||
33290807|NCT00474929|62667199|FG001|Overall Study|Physician Decision|0|||
33290808|NCT00474929|62667200|FG002|Overall Study|Physician Decision|1|||
33290809|NCT00474929|62667201|FG003|Overall Study|Physician Decision|2|||
33290810|NCT00474929|62667202|FG004|Overall Study|Physician Decision|0|||
33290811|NCT00474812|62667215|FG000|Overall Study|Withdrawal by Subject|5|||
33290812|NCT00474812|62667215|FG000|Overall Study|No Initiation of treatment|2|||
33290813|NCT00474383|62667219|FG000|Main Study|Adverse Event|11|||
33290814|NCT00474383|62667220|FG001|Main Study|Adverse Event|0|||
33290815|NCT00474383|62667219|FG000|Main Study|Symptomatic Deterioration|1|||
33290816|NCT00474383|62667220|FG001|Main Study|Symptomatic Deterioration|0|||
33376451|NCT00642850|62755491|FG000|Overall Study|Kidney transplantation|8|||
33376452|NCT00642850|62755491|FG000|Overall Study|Blood transfusion|6|||
33376453|NCT00642850|62755491|FG000|Overall Study|Other reasons|7|||
33376454|NCT00455455|62755495|FG000|Washout|Withdrawal by Subject|0|||
33376455|NCT00455455|62755496|FG001|Washout|Withdrawal by Subject|1|||
33376456|NCT00455455|62755495|FG000|Washout|Withdrawal by Subject|1|||
33376457|NCT00455455|62755496|FG001|Washout|Withdrawal by Subject|0|||
33376458|NCT03840811|62755508|FG000|Overall Study|Lost to Follow-up|0|||
33376459|NCT03840811|62755509|FG001|Overall Study|Lost to Follow-up|0|||
33376460|NCT03840811|62755510|FG002|Overall Study|Lost to Follow-up|1|||
33290817|NCT00474383|62667219|FG000|Main Study|Progressive Disease|23|||
33376461|NCT00640510|62755520|FG000|Overall Study|Lack of Efficacy|0|||
33376462|NCT00640510|62755521|FG001|Overall Study|Lack of Efficacy|1|||
33376463|NCT00640510|62755520|FG000|Overall Study|Protocol Violation|1|||
33376464|NCT00640510|62755521|FG001|Overall Study|Protocol Violation|0|||
33376465|NCT00640510|62755520|FG000|Overall Study|Physician Decision|0|||
33376466|NCT00640510|62755521|FG001|Overall Study|Physician Decision|1|||
33376467|NCT00813800|62755527|FG000|Overall Study|Screen Failure after Consent|2|||
33376468|NCT00813800|62755527|FG000|Overall Study|Adverse Event|1|||
33376469|NCT00813800|62755527|FG000|Overall Study|Worsening of depression|2|||
33376470|NCT00813800|62755527|FG000|Overall Study|Physician Decision|1|||
33376471|NCT00627016|62755533|FG000|Overall Study|Adverse Event|1|||
33487116|NCT01367158|62865074|FG005|Overall Study|Protocol Violation|0|||
33487117|NCT01367158|62865075|FG006|Overall Study|Protocol Violation|0|||
33290818|NCT00474383|62667220|FG001|Main Study|Progressive Disease|0|||
33487118|NCT01367158|62865076|FG007|Overall Study|Protocol Violation|0|||
33376472|NCT00627016|62755534|FG001|Overall Study|Adverse Event|1|||
33376473|NCT00627016|62755533|FG000|Overall Study|Protocol Violation|0|||
33556557|NCT01369355|62949449|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
33376474|NCT00627016|62755534|FG001|Overall Study|Protocol Violation|2|||
33290819|NCT00474383|62667219|FG000|Main Study|Other|1|||
33290820|NCT00474383|62667220|FG001|Main Study|Other|0|||
33376475|NCT00627016|62755533|FG000|Overall Study|Lost to Follow-up|0|||
33376476|NCT00627016|62755534|FG001|Overall Study|Lost to Follow-up|1|||
33290821|NCT00474383|62667219|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
33376477|NCT00627016|62755533|FG000|Overall Study|Withdrawal by Subject|2|||
33290822|NCT00474383|62667220|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
33376478|NCT00627016|62755534|FG001|Overall Study|Withdrawal by Subject|1|||
33376479|NCT00627016|62755533|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
33376480|NCT00627016|62755534|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
33376481|NCT00627016|62755533|FG000|Overall Study|Lack of Efficacy|1|||
33376482|NCT00627016|62755534|FG001|Overall Study|Lack of Efficacy|0|||
33376483|NCT00627016|62755533|FG000|Overall Study|Placed on Excluded Drugs|1|||
33376484|NCT00627016|62755534|FG001|Overall Study|Placed on Excluded Drugs|0|||
33376485|NCT00627016|62755533|FG000|Overall Study|Pregnancy|1|||
33376486|NCT00627016|62755534|FG001|Overall Study|Pregnancy|0|||
33376487|NCT00794664|62755542|FG000|Treatment Period|Withdrawal by Subject|0|||
33376488|NCT00794664|62755543|FG001|Treatment Period|Withdrawal by Subject|2|||
33290823|NCT00474383|62667219|FG000|Extension|Progressive Disease|0|||
33290824|NCT00474383|62667220|FG001|Extension|Progressive Disease|5|||
33290825|NCT00474266|62667228|FG000|Overall Study|Withdrawal by Subject|7|||
33290826|NCT00474266|62667229|FG001|Overall Study|Withdrawal by Subject|20|||
33290827|NCT00474266|62667230|FG002|Overall Study|Withdrawal by Subject|4|||
33290828|NCT00474266|62667231|FG003|Overall Study|Withdrawal by Subject|7|||
33290829|NCT00473564|62667244|FG000|Overall Study|robot surgery aborted in OR|23|||
33290830|NCT00472199|62667250|FG000|Overall Study|Adverse Event|19|||
33290831|NCT00472199|62667251|FG001|Overall Study|Adverse Event|23|||
33290832|NCT00472199|62667250|FG000|Overall Study|Lack of Efficacy|4|||
33290833|NCT00472199|62667251|FG001|Overall Study|Lack of Efficacy|25|||
33290834|NCT00472199|62667250|FG000|Overall Study|Lost to Follow-up|2|||
33290835|NCT00472199|62667251|FG001|Overall Study|Lost to Follow-up|4|||
33290836|NCT00472199|62667250|FG000|Overall Study|Protocol Violation|3|||
33290837|NCT00472199|62667251|FG001|Overall Study|Protocol Violation|2|||
33290838|NCT00472199|62667250|FG000|Overall Study|Withdrawal by Subject|6|||
33290839|NCT00472199|62667251|FG001|Overall Study|Withdrawal by Subject|5|||
33290840|NCT00472199|62667250|FG000|Overall Study|personal reason|0|||
33290841|NCT00472199|62667251|FG001|Overall Study|personal reason|1|||
33290842|NCT00472199|62667250|FG000|Overall Study|patient was asymptomatic|1|||
33290843|NCT00472199|62667251|FG001|Overall Study|patient was asymptomatic|0|||
33290844|NCT00472082|62667257|FG000|Overall Study|Study prematurely terminated|5|||
33290845|NCT00471887|62667261|FG000|Overall Study|Adverse Event|9|||
33290846|NCT00471536|62667265|FG000|Overall Study|Withdrawal by Subject|1|||
33290847|NCT00470834|62667271|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
33290848|NCT00470834|62667272|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
33290849|NCT00470834|62667271|FG000|Treatment Period (18 Months)|Adverse Event|7|||
33290850|NCT00470834|62667272|FG001|Treatment Period (18 Months)|Adverse Event|6|||
33290851|NCT00470834|62667271|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
33290852|NCT00470834|62667272|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
33290853|NCT00470834|62667271|FG000|Treatment Period (18 Months)|Physician Decision|4|||
33290854|NCT00470834|62667272|FG001|Treatment Period (18 Months)|Physician Decision|4|||
33290855|NCT00470834|62667271|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
33290856|NCT00470834|62667272|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
33290857|NCT00470834|62667271|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
33290858|NCT00470834|62667272|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
33290859|NCT00470834|62667271|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
33290860|NCT00470834|62667272|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
33290861|NCT00470834|62667271|FG000|Treatment Period (18 Months)|Non-compliance|1|||
33290862|NCT00470834|62667272|FG001|Treatment Period (18 Months)|Non-compliance|0|||
33290863|NCT00470834|62667271|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
33290864|NCT00470834|62667272|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
33290865|NCT00470834|62667271|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
33290866|NCT00470834|62667272|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
33290867|NCT00470834|62667271|FG000|Extension Period (24 Months)|Adverse Event|3|||
33290868|NCT00470834|62667272|FG001|Extension Period (24 Months)|Adverse Event|4|||
33290869|NCT00470834|62667271|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
33290870|NCT00470834|62667272|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
33290871|NCT00470834|62667271|FG000|Extension Period (24 Months)|Physician Decision|4|||
33290872|NCT00470834|62667272|FG001|Extension Period (24 Months)|Physician Decision|3|||
33376489|NCT00794664|62755542|FG000|Treatment Period|Protocol non-compliance|0|||
33376490|NCT00794664|62755543|FG001|Treatment Period|Protocol non-compliance|1|||
33290873|NCT00470834|62667271|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
33290874|NCT00470834|62667272|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
33290875|NCT00470834|62667271|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
33290876|NCT00470834|62667272|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
33290877|NCT00470834|62667271|FG000|Extension Period (24 Months)|Non-compliance|0|||
33290878|NCT00470834|62667272|FG001|Extension Period (24 Months)|Non-compliance|1|||
33376491|NCT00794664|62755542|FG000|Treatment Period|Other|0|||
33376492|NCT00794664|62755543|FG001|Treatment Period|Other|1|||
33376493|NCT00794664|62755542|FG000|Treatment Period|Adverse Event|1|||
33290879|NCT00470834|62667271|FG000|Extension Period (24 Months)|Disease Progression|0|||
33376494|NCT00794664|62755543|FG001|Treatment Period|Adverse Event|8|||
33376495|NCT00794664|62755542|FG000|Follow-up Period|Other|1|||
33376496|NCT00794664|62755543|FG001|Follow-up Period|Other|2|||
33376497|NCT00794664|62755542|FG000|Follow-up Period|Withdrawal by Subject|0|||
33376498|NCT00794664|62755543|FG001|Follow-up Period|Withdrawal by Subject|2|||
33376499|NCT00794664|62755542|FG000|Follow-up Period|Protocol non-compliance|0|||
33376500|NCT00794664|62755543|FG001|Follow-up Period|Protocol non-compliance|1|||
33376501|NCT00444535|62755549|FG000|Overall Study|Withdrawal by Subject|5|||
33376502|NCT00444535|62755549|FG000|Overall Study|Physician Decision|5|||
33376503|NCT00444535|62755549|FG000|Overall Study|progressive disease|1|||
33376504|NCT00444535|62755549|FG000|Overall Study|Adverse Event|2|||
33376505|NCT00847613|62755557|FG000|Overall Study|Ongoing at cut-off date|250|||
33376506|NCT00847613|62755558|FG001|Overall Study|Ongoing at cut-off date|265|||
33376507|NCT00847613|62755559|FG002|Overall Study|Ongoing at cut-off date|64|||
33376508|NCT00847613|62755560|FG003|Overall Study|Ongoing at cut-off date|64|||
33376509|NCT00847613|62755557|FG000|Overall Study|Death|1|||
33376510|NCT00847613|62755558|FG001|Overall Study|Death|1|||
33376511|NCT00847613|62755559|FG002|Overall Study|Death|0|||
33376512|NCT00847613|62755560|FG003|Overall Study|Death|0|||
33376513|NCT00847613|62755557|FG000|Overall Study|Adverse Event|36|||
33376514|NCT00847613|62755558|FG001|Overall Study|Adverse Event|26|||
33376515|NCT00847613|62755559|FG002|Overall Study|Adverse Event|5|||
33376516|NCT00847613|62755560|FG003|Overall Study|Adverse Event|6|||
33376517|NCT00847613|62755557|FG000|Overall Study|Lack of Efficacy|7|||
33376518|NCT00847613|62755558|FG001|Overall Study|Lack of Efficacy|3|||
33376519|NCT00847613|62755559|FG002|Overall Study|Lack of Efficacy|3|||
33376520|NCT00847613|62755560|FG003|Overall Study|Lack of Efficacy|1|||
33376521|NCT00847613|62755557|FG000|Overall Study|Study terminated by Sponsor|1|||
33376522|NCT00847613|62755558|FG001|Overall Study|Study terminated by Sponsor|0|||
33376523|NCT00847613|62755559|FG002|Overall Study|Study terminated by Sponsor|2|||
33376524|NCT00847613|62755560|FG003|Overall Study|Study terminated by Sponsor|1|||
33376525|NCT00847613|62755557|FG000|Overall Study|Lost to Follow-up|5|||
33376526|NCT00847613|62755558|FG001|Overall Study|Lost to Follow-up|0|||
33376527|NCT00847613|62755559|FG002|Overall Study|Lost to Follow-up|0|||
33376528|NCT00847613|62755560|FG003|Overall Study|Lost to Follow-up|3|||
33376529|NCT00847613|62755557|FG000|Overall Study|Protocol Violation|6|||
33376530|NCT00847613|62755558|FG001|Overall Study|Protocol Violation|6|||
33376531|NCT00847613|62755559|FG002|Overall Study|Protocol Violation|3|||
33376532|NCT00847613|62755560|FG003|Overall Study|Protocol Violation|1|||
33376533|NCT00847613|62755557|FG000|Overall Study|Pregnancy|1|||
33376534|NCT00847613|62755558|FG001|Overall Study|Pregnancy|1|||
33376535|NCT00847613|62755559|FG002|Overall Study|Pregnancy|0|||
33376536|NCT00847613|62755560|FG003|Overall Study|Pregnancy|0|||
33376537|NCT00847613|62755557|FG000|Overall Study|Site closure|1|||
33376538|NCT00847613|62755558|FG001|Overall Study|Site closure|0|||
33376539|NCT00847613|62755559|FG002|Overall Study|Site closure|0|||
33376540|NCT00847613|62755560|FG003|Overall Study|Site closure|1|||
33376541|NCT00847613|62755557|FG000|Overall Study|Withdrawal by Subject|8|||
33290880|NCT00470834|62667272|FG001|Extension Period (24 Months)|Disease Progression|1|||
33290881|NCT00470366|62667278|FG000|Overall Study|Adverse Event|3|||
33290882|NCT00470366|62667278|FG000|Overall Study|Poor compliance|1|||
33290883|NCT00470093|62667282|FG000|Overall Study|Adverse Event|2|||
33290884|NCT00470054|62667286|FG000|Overall Study|Ineligible|1|||
33290885|NCT00474188|62667290|FG000|Overall Study|Withdrawal by Subject|1|||
33290886|NCT00474188|62667290|FG000|Overall Study|Study discontinued by sponsor|5|||
33290887|NCT00475982|62667295|FG000|Overall Study|surgery rescheduled|7|||
33290888|NCT00475982|62667296|FG001|Overall Study|surgery rescheduled|3|||
33290889|NCT01089647|62667304|FG000|Overall Study|Lost to Follow-up|2|||
33290890|NCT01089647|62667305|FG001|Overall Study|Lost to Follow-up|2|||
33290891|NCT01089647|62667304|FG000|Overall Study|Withdrawal by Subject|2|||
33290892|NCT01089647|62667305|FG001|Overall Study|Withdrawal by Subject|1|||
33290893|NCT01089647|62667304|FG000|Overall Study|Adverse Event|0|||
33290894|NCT01089647|62667305|FG001|Overall Study|Adverse Event|1|||
33290895|NCT01089608|62667313|FG000|Overall Study|Adverse Event|0|||
33290896|NCT01089608|62667314|FG001|Overall Study|Adverse Event|4|||
33290897|NCT01089608|62667313|FG000|Overall Study|Lost to Follow-up|0|||
33290898|NCT01089608|62667314|FG001|Overall Study|Lost to Follow-up|2|||
33290899|NCT01089413|62667323|FG000|Overall Study|Lost to Follow-up|1|||
33290900|NCT01089413|62667323|FG000|Overall Study|Progressive Disease|93|||
33290901|NCT01089413|62667323|FG000|Overall Study|Participant Withdrew Consent|1|||
33376542|NCT00847613|62755558|FG001|Overall Study|Withdrawal by Subject|11|||
33376543|NCT00847613|62755559|FG002|Overall Study|Withdrawal by Subject|2|||
33376544|NCT00847613|62755560|FG003|Overall Study|Withdrawal by Subject|2|||
33376545|NCT00847613|62755557|FG000|Overall Study|Participant moved|4|||
33376546|NCT00847613|62755558|FG001|Overall Study|Participant moved|1|||
33376547|NCT00847613|62755559|FG002|Overall Study|Participant moved|0|||
33376548|NCT00847613|62755560|FG003|Overall Study|Participant moved|0|||
33376549|NCT00847613|62755557|FG000|Overall Study|Sponsor request|0|||
33376550|NCT00847613|62755558|FG001|Overall Study|Sponsor request|1|||
33376551|NCT00847613|62755559|FG002|Overall Study|Sponsor request|0|||
33376552|NCT00847613|62755560|FG003|Overall Study|Sponsor request|0|||
33376553|NCT00847613|62755557|FG000|Overall Study|Randomized, but not treated|0|||
33376554|NCT00847613|62755558|FG001|Overall Study|Randomized, but not treated|3|||
33376555|NCT00847613|62755559|FG002|Overall Study|Randomized, but not treated|0|||
33376556|NCT00847613|62755560|FG003|Overall Study|Randomized, but not treated|0|||
33376557|NCT00847613|62755557|FG000|Overall Study|Other|1|||
33376558|NCT00847613|62755558|FG001|Overall Study|Other|1|||
33376559|NCT00847613|62755559|FG002|Overall Study|Other|2|||
33376560|NCT00847613|62755560|FG003|Overall Study|Other|0|||
33376561|NCT00794196|62755579|FG000|Overall Study|Lost to Follow-up|5|||
33376562|NCT00794196|62755580|FG001|Overall Study|Lost to Follow-up|23|||
33376563|NCT00807092|62755588|FG000|Overall Study|Adverse Event|0|||
33376564|NCT00807092|62755589|FG001|Overall Study|Adverse Event|1|||
33376565|NCT00807092|62755588|FG000|Overall Study|Protocol Violation|0|||
33376566|NCT00807092|62755589|FG001|Overall Study|Protocol Violation|2|||
33376567|NCT00807092|62755588|FG000|Overall Study|Withdrawal by Subject|1|||
33376568|NCT00807092|62755589|FG001|Overall Study|Withdrawal by Subject|0|||
33376569|NCT00807092|62755588|FG000|Overall Study|CGMS data collection failed|0|||
33376570|NCT00807092|62755589|FG001|Overall Study|CGMS data collection failed|1|||
33376571|NCT00794118|62755595|FG000|Overall Study|Lost to Follow-up|16|||
33376572|NCT00794118|62755595|FG000|Overall Study|Withdrawal by Subject|9|||
33376573|NCT00794118|62755595|FG000|Overall Study|Changed hospital center|2|||
33376574|NCT00640042|62755599|FG000|Enrollment|Did not receive study drug|83|||
33376575|NCT00807014|62755605|FG000|Overall Study|Participant Considered Disease Cured|13|||
33376576|NCT00807014|62755606|FG001|Overall Study|Participant Considered Disease Cured|2|||
33376577|NCT00807014|62755605|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
33376578|NCT00807014|62755606|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
33376579|NCT00807014|62755605|FG000|Overall Study|Protocol Violation|2|||
33376580|NCT00807014|62755606|FG001|Overall Study|Protocol Violation|8|||
33376581|NCT00807014|62755605|FG000|Overall Study|Adverse Event|0|||
33376582|NCT00807014|62755606|FG001|Overall Study|Adverse Event|2|||
33376583|NCT00807014|62755605|FG000|Overall Study|Lost to Follow-up|9|||
33376584|NCT00807014|62755606|FG001|Overall Study|Lost to Follow-up|7|||
33376585|NCT00807014|62755605|FG000|Overall Study|Recovery|1|||
33376586|NCT00807014|62755606|FG001|Overall Study|Recovery|0|||
33376587|NCT00807014|62755605|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
33376588|NCT00807014|62755606|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
33376589|NCT00592631|62755614|FG000|Overall Study|Lost to Follow-up|0|||
33376590|NCT00592631|62755615|FG001|Overall Study|Lost to Follow-up|2|||
33376591|NCT00791388|62755626|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
33376592|NCT00791388|62755627|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
33376593|NCT00791388|62755628|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
33376594|NCT00791388|62755629|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
33376595|NCT00791388|62755630|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
33376596|NCT00791388|62755626|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
33376597|NCT00791388|62755627|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
33376598|NCT00791388|62755628|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
33376599|NCT00791388|62755629|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
33290902|NCT01089413|62667323|FG000|Overall Study|Unacceptable Toxicity|12|||
33290903|NCT01089413|62667323|FG000|Overall Study|Death|10|||
33290904|NCT01089413|62667323|FG000|Overall Study|Metastasectomy|13|||
33290905|NCT01089413|62667323|FG000|Overall Study|Other|71|||
33290906|NCT01089023|62667333|FG000|Overall Study|Lost to Follow-up|3|||
33290907|NCT01089023|62667333|FG000|Overall Study|Adverse Event|1|||
33290908|NCT01089023|62667333|FG000|Overall Study|Withdrawal by Subject|1|||
33376600|NCT00791388|62755630|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
33376601|NCT00791388|62755626|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
33376602|NCT00791388|62755627|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
33376603|NCT00791388|62755628|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
33376604|NCT00791388|62755629|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
33376605|NCT00791388|62755630|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
33376606|NCT00794040|62755644|FG000|Overall Study|Withdrawal by Subject|3|||
33376607|NCT00794040|62755645|FG001|Overall Study|Withdrawal by Subject|4|||
33290909|NCT01089023|62667333|FG000|Overall Study|Protocol Violation|1|||
33376608|NCT00794040|62755644|FG000|Overall Study|Physician Decision|0|||
33376609|NCT00794040|62755645|FG001|Overall Study|Physician Decision|1|||
33376610|NCT00813488|62755651|FG000|Titration Period 1|Adverse Event|6|||
33662376|NCT01695239|63092846|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
33662377|NCT01695239|63092833|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33290910|NCT01089023|62667333|FG000|Overall Study|Lack of Efficacy|1|||
33376611|NCT00813488|62755652|FG001|Titration Period 1|Adverse Event|1|||
33376612|NCT00813488|62755651|FG000|Titration Period 1|Lack of Efficacy|9|||
33376613|NCT00813488|62755652|FG001|Titration Period 1|Lack of Efficacy|7|||
33376614|NCT00813488|62755651|FG000|Titration Period 1|Withdrawal by Subject|2|||
33376615|NCT00813488|62755652|FG001|Titration Period 1|Withdrawal by Subject|2|||
33376616|NCT00813488|62755651|FG000|Titration Period 1|Protocol Violation|4|||
33376617|NCT00813488|62755652|FG001|Titration Period 1|Protocol Violation|3|||
33376618|NCT00813488|62755651|FG000|Titration Period 1|Non-compliance to study medication|4|||
33376619|NCT00813488|62755652|FG001|Titration Period 1|Non-compliance to study medication|1|||
33376620|NCT00813488|62755651|FG000|Titration Period 1|Non-compliance to study procedures|2|||
33376621|NCT00813488|62755652|FG001|Titration Period 1|Non-compliance to study procedures|2|||
33376622|NCT00813488|62755651|FG000|Titration Period 1|Technical Difficulties|0|||
33376623|NCT00813488|62755652|FG001|Titration Period 1|Technical Difficulties|1|||
33376624|NCT00813488|62755651|FG000|Titration Period 2|Adverse Event|2|||
33376625|NCT00813488|62755652|FG001|Titration Period 2|Adverse Event|3|||
33376626|NCT00813488|62755651|FG000|Titration Period 2|Lack of Efficacy|8|||
33376627|NCT00813488|62755652|FG001|Titration Period 2|Lack of Efficacy|4|||
33376628|NCT00813488|62755651|FG000|Titration Period 2|Protocol Violation|3|||
33376629|NCT00813488|62755652|FG001|Titration Period 2|Protocol Violation|2|||
33376630|NCT00813488|62755651|FG000|Titration Period 2|Lost to Follow-up|1|||
33376631|NCT00813488|62755652|FG001|Titration Period 2|Lost to Follow-up|0|||
33376632|NCT00813488|62755651|FG000|Titration Period 2|Non-compliance with study procedures|2|||
33376633|NCT00813488|62755652|FG001|Titration Period 2|Non-compliance with study procedures|1|||
33376634|NCT00813488|62755651|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
33376635|NCT00813488|62755652|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
33376636|NCT00813488|62755651|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
33376637|NCT00813488|62755652|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
33376638|NCT00813488|62755651|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
33290911|NCT01088984|62667339|FG000|Phase 1|Death|2|||
33290912|NCT01088984|62667340|FG001|Phase 1|Death|1|||
33290913|NCT01088984|62667339|FG000|Phase 1|Disease Progression|2|||
33290914|NCT01088984|62667340|FG001|Phase 1|Disease Progression|4|||
33290915|NCT01088984|62667339|FG000|Phase 1|Other|1|||
33290916|NCT01088984|62667340|FG001|Phase 1|Other|1|||
33290917|NCT01088984|62667339|FG000|Phase 2|Death|0|||
33290918|NCT01088984|62667340|FG001|Phase 2|Death|5|||
33376639|NCT00813488|62755652|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
33376640|NCT00813488|62755651|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
33376641|NCT00813488|62755652|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
33376642|NCT00813488|62755651|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
33376643|NCT00813488|62755652|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
33376644|NCT00813488|62755651|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
33487119|NCT01367158|62865077|FG008|Overall Study|Protocol Violation|0|||
33487120|NCT01367158|62865078|FG009|Overall Study|Protocol Violation|0|||
33487121|NCT01367158|62865079|FG010|Overall Study|Protocol Violation|0|||
33487122|NCT00130637|62865114|FG000|Overall Study|Adverse Event|2|||
33487123|NCT00130637|62865114|FG000|Overall Study|Withdrawal by Subject|1|||
33487124|NCT03679767|62865122|FG000|Overall Study|Death|16|||
33487125|NCT03679767|62865123|FG001|Overall Study|Death|11|||
33487126|NCT03679767|62865124|FG002|Overall Study|Death|17|||
33487127|NCT03679767|62865125|FG003|Overall Study|Death|10|||
33487128|NCT03679767|62865122|FG000|Overall Study|Lost to Follow-up|1|||
33487129|NCT03679767|62865123|FG001|Overall Study|Lost to Follow-up|1|||
33487130|NCT03679767|62865124|FG002|Overall Study|Lost to Follow-up|1|||
33487131|NCT03679767|62865125|FG003|Overall Study|Lost to Follow-up|1|||
33487132|NCT03679767|62865122|FG000|Overall Study|Withdrawal by Subject|0|||
33376645|NCT00813488|62755652|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
33376646|NCT00813488|62755651|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
33376647|NCT00813488|62755652|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
33376648|NCT00813488|62755651|FG000|Double-blind Treatment Period 2|Other|1|||
33376649|NCT00813488|62755652|FG001|Double-blind Treatment Period 2|Other|0|||
33376650|NCT00813488|62755651|FG000|Open-label Extension|Adverse Event|1|||
33376651|NCT00813488|62755652|FG001|Open-label Extension|Adverse Event|2|||
33376652|NCT00813488|62755651|FG000|Open-label Extension|Lack of Efficacy|3|||
33376653|NCT00813488|62755652|FG001|Open-label Extension|Lack of Efficacy|0|||
33376654|NCT00813488|62755651|FG000|Open-label Extension|Withdrawal by Subject|0|||
33487133|NCT03679767|62865123|FG001|Overall Study|Withdrawal by Subject|0|||
33487134|NCT03679767|62865124|FG002|Overall Study|Withdrawal by Subject|0|||
33487135|NCT03679767|62865125|FG003|Overall Study|Withdrawal by Subject|1|||
33556558|NCT01369355|62949450|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
33556559|NCT01369355|62949451|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
33290919|NCT01088984|62667339|FG000|Phase 2|Withdrawal by Subject|0|||
33290920|NCT01088984|62667340|FG001|Phase 2|Withdrawal by Subject|1|||
33376655|NCT00813488|62755652|FG001|Open-label Extension|Withdrawal by Subject|2|||
33487136|NCT03679767|62865122|FG000|Overall Study|Follow-up Completed|18|||
33290921|NCT01088984|62667339|FG000|Phase 2|DIsease Progression|0|||
33376656|NCT00813488|62755651|FG000|Open-label Extension|Protocol Violation|1|||
33290922|NCT01088984|62667340|FG001|Phase 2|DIsease Progression|25|||
33290923|NCT01088984|62667339|FG000|Phase 2|Other|0|||
33290924|NCT01088984|62667340|FG001|Phase 2|Other|1|||
33290925|NCT01088438|62667351|FG000|Overall Study|Withdrawal by Subject|11|||
33290926|NCT01088438|62667352|FG001|Overall Study|Withdrawal by Subject|6|||
33290927|NCT01088438|62667351|FG000|Overall Study|Lost to Follow-up|18|||
33290928|NCT01088438|62667352|FG001|Overall Study|Lost to Follow-up|30|||
33290929|NCT01088243|62667360|FG000|Overall Study|Adverse Event|1|||
33290930|NCT01088243|62667361|FG001|Overall Study|Adverse Event|0|||
33290931|NCT01088048|62667377|FG000|Overall Study|Adverse Event|7|||
33290932|NCT01088048|62667378|FG001|Overall Study|Adverse Event|9|||
33290933|NCT01088048|62667379|FG002|Overall Study|Adverse Event|7|||
33290934|NCT01088048|62667380|FG003|Overall Study|Adverse Event|5|||
33290935|NCT01088048|62667381|FG004|Overall Study|Adverse Event|6|||
33290936|NCT01088048|62667382|FG005|Overall Study|Adverse Event|3|||
33376657|NCT00813488|62755652|FG001|Open-label Extension|Protocol Violation|2|||
33376658|NCT00813488|62755651|FG000|Open-label Extension|Non-compliance study medication|4|||
33376659|NCT00813488|62755652|FG001|Open-label Extension|Non-compliance study medication|0|||
33376660|NCT00813488|62755651|FG000|Open-label Extension|Non-compliance study procedures|2|||
33376661|NCT00813488|62755652|FG001|Open-label Extension|Non-compliance study procedures|1|||
33376662|NCT00813488|62755651|FG000|Open-label Extension|Other|1|||
33376663|NCT00813488|62755652|FG001|Open-label Extension|Other|0|||
33376664|NCT00797316|62755664|FG000|Overall Study|Administrative problems|1|||
33376665|NCT00797316|62755665|FG001|Overall Study|Administrative problems|0|||
33376666|NCT00797316|62755664|FG000|Overall Study|Adverse Event|5|||
33376667|NCT00797316|62755665|FG001|Overall Study|Adverse Event|3|||
33376668|NCT00797316|62755664|FG000|Overall Study|Lost to Follow-up|4|||
33376669|NCT00797316|62755665|FG001|Overall Study|Lost to Follow-up|8|||
33376670|NCT00797316|62755664|FG000|Overall Study|Protocol Deviation|1|||
33376671|NCT00797316|62755665|FG001|Overall Study|Protocol Deviation|2|||
33376672|NCT00797316|62755664|FG000|Overall Study|Patient withdrew consent|12|||
33376673|NCT00797316|62755665|FG001|Overall Study|Patient withdrew consent|6|||
33376674|NCT00797316|62755664|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33376675|NCT00797316|62755665|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
33376676|NCT00587964|62755671|FG000|Overall Study|Withdrawal by Subject|1|||
33376677|NCT00587964|62755671|FG000|Overall Study|Lost to Follow-up|1|||
33376678|NCT00587964|62755671|FG000|Overall Study|Patient found to be ineligible|1|||
33376679|NCT00587964|62755671|FG000|Overall Study|Patient did not receive intervention|5|||
33376680|NCT00587964|62755671|FG000|Overall Study|Progression of Disease|4|||
33376681|NCT00590954|62755675|FG000|Overall Study|Inevaluable|2|||
33376682|NCT00791076|62755681|FG000|Overall Study|Study was terminated,PI left institution|8|||
33376683|NCT00590720|62755689|FG000|Overall Study|Lost to Follow-up|1|||
33290937|NCT01088048|62667383|FG006|Overall Study|Adverse Event|3|||
33290938|NCT01088048|62667384|FG007|Overall Study|Adverse Event|0|||
33290939|NCT01088048|62667385|FG008|Overall Study|Adverse Event|2|||
33290940|NCT01088048|62667386|FG009|Overall Study|Adverse Event|2|||
33290941|NCT01088048|62667377|FG000|Overall Study|Withdrew Consent|1|||
33290942|NCT01088048|62667378|FG001|Overall Study|Withdrew Consent|1|||
33376684|NCT00590720|62755690|FG001|Overall Study|Lost to Follow-up|0|||
33376685|NCT00590720|62755689|FG000|Overall Study|Withdrawal by Subject|0|||
33376686|NCT00590720|62755690|FG001|Overall Study|Withdrawal by Subject|1|||
33376687|NCT00625378|62755698|FG000|Overall Study|Adverse Event|22|||
33376688|NCT00625378|62755699|FG001|Overall Study|Adverse Event|0|||
33376689|NCT00625378|62755698|FG000|Overall Study|Withdrawal by Subject|16|||
33376690|NCT00625378|62755699|FG001|Overall Study|Withdrawal by Subject|0|||
33376691|NCT00625378|62755698|FG000|Overall Study|Death|38|||
33376692|NCT00625378|62755699|FG001|Overall Study|Death|0|||
33376693|NCT00625378|62755698|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
33376694|NCT00625378|62755699|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
33376695|NCT00625378|62755698|FG000|Overall Study|Lost to Follow-up|17|||
33376696|NCT00625378|62755699|FG001|Overall Study|Lost to Follow-up|0|||
33376697|NCT00625378|62755698|FG000|Overall Study|Non-compliant with study medication|3|||
33376698|NCT00625378|62755699|FG001|Overall Study|Non-compliant with study medication|0|||
33376699|NCT00625378|62755698|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
33376700|NCT00625378|62755699|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
33487137|NCT03679767|62865123|FG001|Overall Study|Follow-up Completed|11|||
33487138|NCT03679767|62865124|FG002|Overall Study|Follow-up Completed|11|||
33487139|NCT03679767|62865125|FG003|Overall Study|Follow-up Completed|20|||
33290943|NCT01088048|62667379|FG002|Overall Study|Withdrew Consent|1|||
33290944|NCT01088048|62667380|FG003|Overall Study|Withdrew Consent|1|||
33290945|NCT01088048|62667381|FG004|Overall Study|Withdrew Consent|2|||
33290946|NCT01088048|62667382|FG005|Overall Study|Withdrew Consent|1|||
33376701|NCT00625378|62755698|FG000|Overall Study|Medical decision|1|||
33376702|NCT00625378|62755699|FG001|Overall Study|Medical decision|0|||
33376703|NCT00625378|62755698|FG000|Overall Study|Multiple toxicities|1|||
33376704|NCT00625378|62755699|FG001|Overall Study|Multiple toxicities|0|||
33376705|NCT00625378|62755698|FG000|Overall Study|New cancer|1|||
33376706|NCT00625378|62755699|FG001|Overall Study|New cancer|0|||
33487140|NCT03679767|62865122|FG000|Overall Study|Entered Hospice Care|0|||
33376707|NCT00625378|62755698|FG000|Overall Study|PTA program|2|||
33376708|NCT00625378|62755699|FG001|Overall Study|PTA program|0|||
33290947|NCT01088048|62667383|FG006|Overall Study|Withdrew Consent|0|||
33290948|NCT01088048|62667384|FG007|Overall Study|Withdrew Consent|2|||
33290949|NCT01088048|62667385|FG008|Overall Study|Withdrew Consent|2|||
33290950|NCT01088048|62667386|FG009|Overall Study|Withdrew Consent|1|||
33290951|NCT01088048|62667377|FG000|Overall Study|Concomitant Medication Prohibited|1|||
33290952|NCT01088048|62667378|FG001|Overall Study|Concomitant Medication Prohibited|0|||
33290953|NCT01088048|62667379|FG002|Overall Study|Concomitant Medication Prohibited|0|||
33290954|NCT01088048|62667380|FG003|Overall Study|Concomitant Medication Prohibited|0|||
33290955|NCT01088048|62667381|FG004|Overall Study|Concomitant Medication Prohibited|0|||
33376709|NCT00625378|62755698|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
33376710|NCT00625378|62755699|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
33376711|NCT00625378|62755698|FG000|Overall Study|Sponsor decision|1|||
33376712|NCT00625378|62755699|FG001|Overall Study|Sponsor decision|0|||
33376713|NCT00625378|62755698|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
33376714|NCT00625378|62755699|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
33376715|NCT00625378|62755698|FG000|Overall Study|Switch to commercial drug|6|||
33376716|NCT00625378|62755699|FG001|Overall Study|Switch to commercial drug|1|||
33376717|NCT00625378|62755698|FG000|Overall Study|Missing|2|||
33376718|NCT00625378|62755699|FG001|Overall Study|Missing|0|||
33376719|NCT00625378|62755698|FG000|Overall Study|End of treatment not available|2|||
33376720|NCT00625378|62755699|FG001|Overall Study|End of treatment not available|0|||
33376721|NCT00625378|62755698|FG000|Overall Study|Never treated|2|||
33376722|NCT00625378|62755699|FG001|Overall Study|Never treated|0|||
33376723|NCT00806624|62755708|FG000|Overall Study|Adverse Event|2|||
33376724|NCT00806624|62755709|FG001|Overall Study|Adverse Event|8|||
33376725|NCT00806624|62755710|FG002|Overall Study|Adverse Event|0|||
33376726|NCT00806624|62755708|FG000|Overall Study|Death|0|||
33376727|NCT00806624|62755709|FG001|Overall Study|Death|1|||
33376728|NCT00806624|62755710|FG002|Overall Study|Death|1|||
33376729|NCT00806624|62755708|FG000|Overall Study|Lost to Follow-up|1|||
33376730|NCT00806624|62755709|FG001|Overall Study|Lost to Follow-up|0|||
33376731|NCT00806624|62755710|FG002|Overall Study|Lost to Follow-up|1|||
33376732|NCT00806624|62755708|FG000|Overall Study|Withdrawal by Subject|6|||
33376733|NCT00806624|62755709|FG001|Overall Study|Withdrawal by Subject|3|||
33376734|NCT00806624|62755710|FG002|Overall Study|Withdrawal by Subject|3|||
33376735|NCT00806624|62755708|FG000|Overall Study|discontinued before start of treatment|0|||
33376736|NCT00806624|62755709|FG001|Overall Study|discontinued before start of treatment|0|||
33376737|NCT00806624|62755710|FG002|Overall Study|discontinued before start of treatment|1|||
33376738|NCT00806546|62755718|FG000|Overall Study|Enrolled, not treated|35|||
33376739|NCT00806546|62755718|FG000|Overall Study|Lost to Follow-up|32|||
33376740|NCT00806546|62755718|FG000|Overall Study|Adverse Event|74|||
33376741|NCT00806546|62755718|FG000|Overall Study|Withdrawal by Subject|75|||
33376742|NCT00806546|62755718|FG000|Overall Study|Protocol Violation|49|||
33376743|NCT00806546|62755718|FG000|Overall Study|Various|42|||
33376744|NCT00624832|62755726|FG000|Overall Study|Adverse Event|0|||
33376745|NCT00624832|62755727|FG001|Overall Study|Adverse Event|1|||
33376746|NCT00624832|62755728|FG002|Overall Study|Adverse Event|0|||
33376747|NCT00624832|62755729|FG003|Overall Study|Adverse Event|1|||
33376748|NCT00624832|62755726|FG000|Overall Study|Abnormal Laboratory Value|2|||
33376749|NCT00624832|62755727|FG001|Overall Study|Abnormal Laboratory Value|0|||
33376750|NCT00624832|62755728|FG002|Overall Study|Abnormal Laboratory Value|0|||
33376751|NCT00624832|62755729|FG003|Overall Study|Abnormal Laboratory Value|0|||
33376752|NCT00633880|62755741|FG000|Open Label Titration|Lack of Efficacy|1|||
33376753|NCT00633880|62755742|FG001|Open Label Titration|Lack of Efficacy|0|||
33376754|NCT00633880|62755743|FG002|Open Label Titration|Lack of Efficacy|0|||
33376755|NCT00633880|62755741|FG000|Open Label Titration|Adverse Event|13|||
33376756|NCT00633880|62755742|FG001|Open Label Titration|Adverse Event|0|||
33376757|NCT00633880|62755743|FG002|Open Label Titration|Adverse Event|0|||
33376758|NCT00633880|62755741|FG000|Open Label Titration|Treatment Failure|55|||
33376759|NCT00633880|62755742|FG001|Open Label Titration|Treatment Failure|0|||
33376760|NCT00633880|62755743|FG002|Open Label Titration|Treatment Failure|0|||
33376761|NCT00633880|62755741|FG000|Open Label Titration|Protocol Violation|6|||
33376762|NCT00633880|62755742|FG001|Open Label Titration|Protocol Violation|0|||
33376763|NCT00633880|62755743|FG002|Open Label Titration|Protocol Violation|0|||
33376764|NCT00633880|62755741|FG000|Open Label Titration|Physician Decision|1|||
33376765|NCT00633880|62755742|FG001|Open Label Titration|Physician Decision|0|||
33290956|NCT01088048|62667382|FG005|Overall Study|Concomitant Medication Prohibited|0|||
33290957|NCT01088048|62667383|FG006|Overall Study|Concomitant Medication Prohibited|0|||
33376766|NCT00633880|62755743|FG002|Open Label Titration|Physician Decision|0|||
33376767|NCT00633880|62755741|FG000|Open Label Titration|Withdrawal by Subject|4|||
33376768|NCT00633880|62755742|FG001|Open Label Titration|Withdrawal by Subject|0|||
33376769|NCT00633880|62755743|FG002|Open Label Titration|Withdrawal by Subject|0|||
33376770|NCT00590564|62755750|FG000|Overall Study|Withdrawal by Subject|4|||
33376771|NCT00590564|62755750|FG000|Overall Study|Lost to Follow-up|6|||
33290958|NCT01088048|62667384|FG007|Overall Study|Concomitant Medication Prohibited|0|||
33376772|NCT00590564|62755750|FG000|Overall Study|Protocol Violation|1|||
33376773|NCT00590564|62755750|FG000|Overall Study|Patient Found to be Ineligible|1|||
33376774|NCT00590564|62755750|FG000|Overall Study|Patient Non-compliance|6|||
33376775|NCT00631696|62755756|FG000|Overall Study|Entered, not randomized to treatment|1|||
33376776|NCT00631696|62755757|FG001|Overall Study|Entered, not randomized to treatment|1|||
33376777|NCT00631696|62755756|FG000|Overall Study|Discontinued after database release date|1|||
33376778|NCT00631696|62755757|FG001|Overall Study|Discontinued after database release date|0|||
33376779|NCT00631696|62755756|FG000|Overall Study|Follow up after database release date|1|||
33376780|NCT00631696|62755757|FG001|Overall Study|Follow up after database release date|0|||
33376781|NCT00631696|62755756|FG000|Overall Study|Lost to Follow-up|7|||
33376782|NCT00631696|62755757|FG001|Overall Study|Lost to Follow-up|10|||
33376783|NCT00631696|62755756|FG000|Overall Study|Withdrawal by Subject|2|||
33376784|NCT00631696|62755757|FG001|Overall Study|Withdrawal by Subject|9|||
33376785|NCT00631696|62755756|FG000|Overall Study|Other|8|||
33376786|NCT00631696|62755757|FG001|Overall Study|Other|8|||
33376787|NCT00631696|62755756|FG000|Overall Study|Protocol Violation|9|||
33376788|NCT00631696|62755757|FG001|Overall Study|Protocol Violation|9|||
33376789|NCT00631696|62755756|FG000|Overall Study|Study terminated by sponsor|3|||
33376790|NCT00631696|62755757|FG001|Overall Study|Study terminated by sponsor|3|||
33376791|NCT00631696|62755756|FG000|Overall Study|Adverse Event|5|||
33376792|NCT00631696|62755757|FG001|Overall Study|Adverse Event|0|||
33487141|NCT03679767|62865123|FG001|Overall Study|Entered Hospice Care|0|||
33487142|NCT03679767|62865124|FG002|Overall Study|Entered Hospice Care|0|||
33487143|NCT03679767|62865125|FG003|Overall Study|Entered Hospice Care|1|||
33487144|NCT03679767|62865122|FG000|Overall Study|Progressive Disease|0|||
33487145|NCT03679767|62865123|FG001|Overall Study|Progressive Disease|0|||
33487146|NCT03679767|62865124|FG002|Overall Study|Progressive Disease|0|||
33487147|NCT03679767|62865125|FG003|Overall Study|Progressive Disease|1|||
33487148|NCT00130247|62865139|FG000|Overall Study|Pregnancy|1|||
33487149|NCT00130247|62865140|FG001|Overall Study|Pregnancy|0|||
33290959|NCT01088048|62667385|FG008|Overall Study|Concomitant Medication Prohibited|0|||
33290960|NCT01088048|62667386|FG009|Overall Study|Concomitant Medication Prohibited|0|||
33290961|NCT01088048|62667377|FG000|Overall Study|Investigator Request|2|||
33290962|NCT01088048|62667378|FG001|Overall Study|Investigator Request|2|||
33290963|NCT01088048|62667379|FG002|Overall Study|Investigator Request|0|||
33290964|NCT01088048|62667380|FG003|Overall Study|Investigator Request|0|||
33290965|NCT01088048|62667381|FG004|Overall Study|Investigator Request|3|||
33290966|NCT01088048|62667382|FG005|Overall Study|Investigator Request|1|||
33290967|NCT01088048|62667383|FG006|Overall Study|Investigator Request|1|||
33290968|NCT01088048|62667384|FG007|Overall Study|Investigator Request|0|||
33290969|NCT01088048|62667385|FG008|Overall Study|Investigator Request|0|||
33290970|NCT01088048|62667386|FG009|Overall Study|Investigator Request|0|||
33290971|NCT01088048|62667377|FG000|Overall Study|Patient Non-compliance|0|||
33290972|NCT01088048|62667378|FG001|Overall Study|Patient Non-compliance|1|||
33290973|NCT01088048|62667379|FG002|Overall Study|Patient Non-compliance|0|||
33290974|NCT01088048|62667380|FG003|Overall Study|Patient Non-compliance|0|||
33290975|NCT01088048|62667381|FG004|Overall Study|Patient Non-compliance|0|||
33290976|NCT01088048|62667382|FG005|Overall Study|Patient Non-compliance|0|||
33290977|NCT01088048|62667383|FG006|Overall Study|Patient Non-compliance|0|||
33290978|NCT01088048|62667384|FG007|Overall Study|Patient Non-compliance|0|||
33290979|NCT01088048|62667385|FG008|Overall Study|Patient Non-compliance|0|||
33290980|NCT01088048|62667386|FG009|Overall Study|Patient Non-compliance|0|||
33290981|NCT01088048|62667377|FG000|Overall Study|Disease Progression|7|||
33290982|NCT01088048|62667378|FG001|Overall Study|Disease Progression|4|||
33290983|NCT01088048|62667379|FG002|Overall Study|Disease Progression|3|||
33290984|NCT01088048|62667380|FG003|Overall Study|Disease Progression|5|||
33290985|NCT01088048|62667381|FG004|Overall Study|Disease Progression|3|||
33290986|NCT01088048|62667382|FG005|Overall Study|Disease Progression|3|||
33290987|NCT01088048|62667383|FG006|Overall Study|Disease Progression|2|||
33290988|NCT01088048|62667384|FG007|Overall Study|Disease Progression|1|||
33290989|NCT01088048|62667385|FG008|Overall Study|Disease Progression|0|||
33290990|NCT01088048|62667386|FG009|Overall Study|Disease Progression|0|||
33290991|NCT01088048|62667377|FG000|Overall Study|Death|1|||
33290992|NCT01088048|62667378|FG001|Overall Study|Death|5|||
33290993|NCT01088048|62667379|FG002|Overall Study|Death|3|||
33290994|NCT01088048|62667380|FG003|Overall Study|Death|3|||
33290995|NCT01088048|62667381|FG004|Overall Study|Death|1|||
33290996|NCT01088048|62667382|FG005|Overall Study|Death|3|||
33290997|NCT01088048|62667383|FG006|Overall Study|Death|0|||
33290998|NCT01088048|62667384|FG007|Overall Study|Death|0|||
33376793|NCT00631540|62755763|FG000|Overall Study|Withdrawal by Subject|5|||
33376794|NCT00631540|62755763|FG000|Overall Study|Death|4|||
33376795|NCT00631540|62755763|FG000|Overall Study|Lost to Follow-up|2|||
33487150|NCT00130247|62865139|FG000|Overall Study|Post-randomization exclusion|1|||
33487151|NCT00130247|62865140|FG001|Overall Study|Post-randomization exclusion|2|||
33290999|NCT01088048|62667385|FG008|Overall Study|Death|3|||
33376796|NCT00631540|62755763|FG000|Overall Study|Core Lab Data Unavailable|3|||
33376797|NCT00630916|62755767|FG000|Overall Study|Death|110|||
33376798|NCT00630916|62755767|FG000|Overall Study|Explant|8|||
33376799|NCT00630916|62755767|FG000|Overall Study|Lost to Follow-up|5|||
33376800|NCT00630916|62755767|FG000|Overall Study|Withdrawal by Subject|30|||
33376801|NCT00630916|62755767|FG000|Overall Study|Protocol Violation|7|||
33376802|NCT00630916|62755767|FG000|Overall Study|Physician Decision|47|||
33376803|NCT00630916|62755767|FG000|Overall Study|Lack of Efficacy|3|||
33376804|NCT00630292|62755771|FG000|Overall Study|Withdrawal by Subject|1|||
33376805|NCT00626548|62755777|FG000|Overall Study|Adverse Event|164|||
33376806|NCT00626548|62755778|FG001|Overall Study|Adverse Event|44|||
33376807|NCT00626548|62755777|FG000|Overall Study|Withdrawal by Subject|42|||
33376808|NCT00626548|62755778|FG001|Overall Study|Withdrawal by Subject|46|||
33376809|NCT00626548|62755777|FG000|Overall Study|Protocol Violation|4|||
33376810|NCT00626548|62755778|FG001|Overall Study|Protocol Violation|11|||
33376811|NCT00626548|62755777|FG000|Overall Study|Lost to Follow-up|2|||
33376812|NCT00626548|62755778|FG001|Overall Study|Lost to Follow-up|2|||
33376813|NCT00626548|62755777|FG000|Overall Study|Other termination reason|493|||
33376814|NCT00626548|62755778|FG001|Overall Study|Other termination reason|613|||
33376815|NCT00847379|62755787|FG000|Overall Study|Study terminated by Sponsor|59|||
33376816|NCT00847379|62755788|FG001|Overall Study|Study terminated by Sponsor|57|||
33376817|NCT00847379|62755789|FG002|Overall Study|Study terminated by Sponsor|57|||
33376818|NCT00847301|62755799|FG000|Overall Study|Adverse Event|35|||
33376819|NCT00847301|62755799|FG000|Overall Study|Switch to other anticoagulants|16|||
33376820|NCT00847301|62755799|FG000|Overall Study|Lost to Follow-up|1|||
33376821|NCT00847301|62755799|FG000|Overall Study|No prescription after hospital discharge|1|||
33376822|NCT00847301|62755799|FG000|Overall Study|Other reason not defined above|1|||
33376823|NCT00624520|62755805|FG000|Overall Study|Withdrawal by Subject|12|||
33376824|NCT00624520|62755806|FG001|Overall Study|Withdrawal by Subject|7|||
33376825|NCT00624520|62755805|FG000|Overall Study|Death|0|||
33376826|NCT00624520|62755806|FG001|Overall Study|Death|1|||
33376827|NCT00847145|62755820|FG000|Overall Study|AE or Death|0|||
33376828|NCT00847145|62755821|FG001|Overall Study|AE or Death|1|||
33376829|NCT00847145|62755822|FG002|Overall Study|AE or Death|1|||
33376830|NCT00847145|62755823|FG003|Overall Study|AE or Death|0|||
33376831|NCT00847145|62755824|FG004|Overall Study|AE or Death|0|||
33376832|NCT00847145|62755825|FG005|Overall Study|AE or Death|0|||
33376833|NCT00847145|62755826|FG006|Overall Study|AE or Death|0|||
33376834|NCT00847145|62755827|FG007|Overall Study|AE or Death|0|||
33376835|NCT00847145|62755820|FG000|Overall Study|Withdrawal by Subject|3|||
33376836|NCT00847145|62755821|FG001|Overall Study|Withdrawal by Subject|4|||
33376837|NCT00847145|62755822|FG002|Overall Study|Withdrawal by Subject|6|||
33376838|NCT00847145|62755823|FG003|Overall Study|Withdrawal by Subject|1|||
33376839|NCT00847145|62755824|FG004|Overall Study|Withdrawal by Subject|0|||
33376840|NCT00847145|62755825|FG005|Overall Study|Withdrawal by Subject|0|||
33376841|NCT00847145|62755826|FG006|Overall Study|Withdrawal by Subject|1|||
33376842|NCT00847145|62755827|FG007|Overall Study|Withdrawal by Subject|1|||
33376843|NCT00847145|62755820|FG000|Overall Study|Lost to Follow-up|3|||
33376844|NCT00847145|62755821|FG001|Overall Study|Lost to Follow-up|1|||
33376845|NCT00847145|62755822|FG002|Overall Study|Lost to Follow-up|1|||
33376846|NCT00847145|62755823|FG003|Overall Study|Lost to Follow-up|0|||
33376847|NCT00847145|62755824|FG004|Overall Study|Lost to Follow-up|4|||
33376848|NCT00847145|62755825|FG005|Overall Study|Lost to Follow-up|4|||
33376849|NCT00847145|62755826|FG006|Overall Study|Lost to Follow-up|8|||
33376850|NCT00847145|62755827|FG007|Overall Study|Lost to Follow-up|2|||
33376851|NCT00847145|62755820|FG000|Overall Study|Inappropriate enrollment|0|||
33376852|NCT00847145|62755821|FG001|Overall Study|Inappropriate enrollment|0|||
33376853|NCT00847145|62755822|FG002|Overall Study|Inappropriate enrollment|0|||
33376854|NCT00847145|62755823|FG003|Overall Study|Inappropriate enrollment|0|||
33376855|NCT00847145|62755824|FG004|Overall Study|Inappropriate enrollment|1|||
33376856|NCT00847145|62755825|FG005|Overall Study|Inappropriate enrollment|0|||
33376857|NCT00847145|62755826|FG006|Overall Study|Inappropriate enrollment|0|||
33376858|NCT00847145|62755827|FG007|Overall Study|Inappropriate enrollment|0|||
33376859|NCT00847145|62755820|FG000|Overall Study|Protocol Violation|0|||
33376860|NCT00847145|62755821|FG001|Overall Study|Protocol Violation|0|||
33376861|NCT00847145|62755822|FG002|Overall Study|Protocol Violation|3|||
33376862|NCT00847145|62755823|FG003|Overall Study|Protocol Violation|0|||
33376863|NCT00847145|62755824|FG004|Overall Study|Protocol Violation|1|||
33376864|NCT00847145|62755825|FG005|Overall Study|Protocol Violation|0|||
33376865|NCT00847145|62755826|FG006|Overall Study|Protocol Violation|0|||
33376866|NCT00847145|62755827|FG007|Overall Study|Protocol Violation|1|||
33376867|NCT00846521|62755854|FG000|Overall Study|Withdrawal by Subject|5|||
33376868|NCT00846521|62755854|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
33376869|NCT00846521|62755854|FG000|Overall Study|Protocol Violation|1|||
33376870|NCT00862823|62755858|FG000|First Intervention|Withdrawal by Subject|1|||
33376871|NCT00862823|62755859|FG001|First Intervention|Withdrawal by Subject|1|||
33376872|NCT00790842|62755867|FG000|Dose Level 1|Adverse Event|1|||
33376873|NCT00790842|62755868|FG001|Dose Level 1|Adverse Event|0|||
33376874|NCT00790842|62755869|FG002|Dose Level 1|Adverse Event|0|||
33376875|NCT00790842|62755870|FG003|Dose Level 1|Adverse Event|2|||
33376876|NCT00790842|62755871|FG004|Dose Level 1|Adverse Event|0|||
33376877|NCT00790842|62755872|FG005|Dose Level 1|Adverse Event|0|||
33376878|NCT00790842|62755873|FG006|Dose Level 1|Adverse Event|0|||
33376879|NCT00790842|62755874|FG007|Dose Level 1|Adverse Event|1|||
33376880|NCT00790842|62755875|FG008|Dose Level 1|Adverse Event|0|||
33376881|NCT00790842|62755876|FG009|Dose Level 1|Adverse Event|0|||
33376882|NCT00790842|62755877|FG010|Dose Level 1|Adverse Event|0|||
33376883|NCT00790842|62755867|FG000|Dose Level 1|Physician Decision|1|||
33376884|NCT00790842|62755868|FG001|Dose Level 1|Physician Decision|0|||
33376885|NCT00790842|62755869|FG002|Dose Level 1|Physician Decision|0|||
33376886|NCT00790842|62755870|FG003|Dose Level 1|Physician Decision|0|||
33376887|NCT00790842|62755871|FG004|Dose Level 1|Physician Decision|0|||
33376888|NCT00790842|62755872|FG005|Dose Level 1|Physician Decision|0|||
33291000|NCT01088048|62667386|FG009|Overall Study|Death|1|||
33291001|NCT01088048|62667377|FG000|Overall Study|Other|3|||
33291002|NCT01088048|62667378|FG001|Overall Study|Other|5|||
33376889|NCT00790842|62755873|FG006|Dose Level 1|Physician Decision|0|||
33376890|NCT00790842|62755874|FG007|Dose Level 1|Physician Decision|1|||
33376891|NCT00790842|62755875|FG008|Dose Level 1|Physician Decision|0|||
33376892|NCT00790842|62755876|FG009|Dose Level 1|Physician Decision|0|||
33376893|NCT00790842|62755877|FG010|Dose Level 1|Physician Decision|0|||
33376894|NCT00790842|62755867|FG000|Dose Level 1|Withdrawal by Subject|1|||
33376895|NCT00790842|62755868|FG001|Dose Level 1|Withdrawal by Subject|0|||
33376896|NCT00790842|62755869|FG002|Dose Level 1|Withdrawal by Subject|0|||
33376897|NCT00790842|62755870|FG003|Dose Level 1|Withdrawal by Subject|0|||
33376898|NCT00790842|62755871|FG004|Dose Level 1|Withdrawal by Subject|0|||
33376899|NCT00790842|62755872|FG005|Dose Level 1|Withdrawal by Subject|0|||
33376900|NCT00790842|62755873|FG006|Dose Level 1|Withdrawal by Subject|0|||
33376901|NCT00790842|62755874|FG007|Dose Level 1|Withdrawal by Subject|0|||
33376902|NCT00790842|62755875|FG008|Dose Level 1|Withdrawal by Subject|0|||
33376903|NCT00790842|62755876|FG009|Dose Level 1|Withdrawal by Subject|0|||
33376904|NCT00790842|62755877|FG010|Dose Level 1|Withdrawal by Subject|0|||
33376905|NCT00790842|62755867|FG000|Dose Level 2|Death|0|||
33376906|NCT00790842|62755868|FG001|Dose Level 2|Death|1|||
33291003|NCT01088048|62667379|FG002|Overall Study|Other|0|||
33291004|NCT01088048|62667380|FG003|Overall Study|Other|0|||
33291005|NCT01088048|62667381|FG004|Overall Study|Other|2|||
33291006|NCT01088048|62667382|FG005|Overall Study|Other|0|||
33291007|NCT01088048|62667383|FG006|Overall Study|Other|0|||
33291008|NCT01088048|62667384|FG007|Overall Study|Other|2|||
33291009|NCT01088048|62667385|FG008|Overall Study|Other|0|||
33291010|NCT01088048|62667386|FG009|Overall Study|Other|0|||
33291011|NCT01087970|62667419|FG000|Overall Study|Protocol Violation|2|||
33291012|NCT01087814|62667426|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
33291013|NCT01087814|62667427|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
33291014|NCT01087814|62667426|FG000|Second Intervention (5 Days)|Physician Decision|1|||
33291015|NCT01087814|62667427|FG001|Second Intervention (5 Days)|Physician Decision|0|||
33291016|NCT01087775|62667433|FG000|Overall Study|failed inclusion criteria|2|||
33291017|NCT01087502|62667440|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
33291018|NCT01087502|62667441|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
33291019|NCT01087502|62667440|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
33291020|NCT01087502|62667441|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
33291021|NCT01087502|62667440|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
33291022|NCT01087502|62667441|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
33291023|NCT01087502|62667440|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
33376907|NCT00790842|62755869|FG002|Dose Level 2|Death|0|||
33376908|NCT00790842|62755870|FG003|Dose Level 2|Death|0|||
33376909|NCT00790842|62755871|FG004|Dose Level 2|Death|1|||
33376910|NCT00790842|62755872|FG005|Dose Level 2|Death|0|||
33376911|NCT00790842|62755873|FG006|Dose Level 2|Death|0|||
33376912|NCT00790842|62755874|FG007|Dose Level 2|Death|0|||
33376913|NCT00790842|62755875|FG008|Dose Level 2|Death|0|||
33376914|NCT00790842|62755876|FG009|Dose Level 2|Death|0|||
33376915|NCT00790842|62755877|FG010|Dose Level 2|Death|0|||
33376916|NCT00790842|62755867|FG000|Dose Level 2|Physician Decision|0|||
33376917|NCT00790842|62755868|FG001|Dose Level 2|Physician Decision|1|||
33376918|NCT00790842|62755869|FG002|Dose Level 2|Physician Decision|0|||
33376919|NCT00790842|62755870|FG003|Dose Level 2|Physician Decision|0|||
33376920|NCT00790842|62755871|FG004|Dose Level 2|Physician Decision|0|||
33376921|NCT00790842|62755872|FG005|Dose Level 2|Physician Decision|0|||
33376922|NCT00790842|62755873|FG006|Dose Level 2|Physician Decision|0|||
33376923|NCT00790842|62755874|FG007|Dose Level 2|Physician Decision|0|||
33291024|NCT01087502|62667441|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
33291025|NCT01087502|62667440|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
33376924|NCT00790842|62755875|FG008|Dose Level 2|Physician Decision|0|||
33662378|NCT01695239|63092834|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33376925|NCT00790842|62755876|FG009|Dose Level 2|Physician Decision|0|||
33376926|NCT00790842|62755877|FG010|Dose Level 2|Physician Decision|0|||
33376927|NCT00790842|62755867|FG000|Dose Level 2|Withdrawal by Subject|0|||
33376928|NCT00790842|62755868|FG001|Dose Level 2|Withdrawal by Subject|1|||
33376929|NCT00790842|62755869|FG002|Dose Level 2|Withdrawal by Subject|0|||
33376930|NCT00790842|62755870|FG003|Dose Level 2|Withdrawal by Subject|0|||
33376931|NCT00790842|62755871|FG004|Dose Level 2|Withdrawal by Subject|0|||
33376932|NCT00790842|62755872|FG005|Dose Level 2|Withdrawal by Subject|0|||
33376933|NCT00790842|62755873|FG006|Dose Level 2|Withdrawal by Subject|0|||
33376934|NCT00790842|62755874|FG007|Dose Level 2|Withdrawal by Subject|0|||
33376935|NCT00790842|62755875|FG008|Dose Level 2|Withdrawal by Subject|0|||
33376936|NCT00790842|62755876|FG009|Dose Level 2|Withdrawal by Subject|0|||
33376937|NCT00790842|62755877|FG010|Dose Level 2|Withdrawal by Subject|0|||
33376938|NCT00790842|62755867|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33376939|NCT00790842|62755868|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33376940|NCT00790842|62755869|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33376941|NCT00790842|62755870|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33376942|NCT00790842|62755871|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33376943|NCT00790842|62755872|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33376944|NCT00790842|62755873|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33376945|NCT00790842|62755874|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33376946|NCT00790842|62755875|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
33376947|NCT00790842|62755876|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33376948|NCT00790842|62755877|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33376949|NCT00790842|62755867|FG000|Dose Level 3|Adverse Event|0|||
33376950|NCT00790842|62755868|FG001|Dose Level 3|Adverse Event|0|||
33376951|NCT00790842|62755869|FG002|Dose Level 3|Adverse Event|1|||
33376952|NCT00790842|62755870|FG003|Dose Level 3|Adverse Event|0|||
33376953|NCT00790842|62755871|FG004|Dose Level 3|Adverse Event|0|||
33376954|NCT00790842|62755872|FG005|Dose Level 3|Adverse Event|0|||
33376955|NCT00790842|62755873|FG006|Dose Level 3|Adverse Event|0|||
33376956|NCT00790842|62755874|FG007|Dose Level 3|Adverse Event|0|||
33376957|NCT00790842|62755875|FG008|Dose Level 3|Adverse Event|0|||
33376958|NCT00790842|62755876|FG009|Dose Level 3|Adverse Event|0|||
33376959|NCT00790842|62755877|FG010|Dose Level 3|Adverse Event|0|||
33376960|NCT00790842|62755867|FG000|Dose Level 3|Withdrawal by Subject|0|||
33376961|NCT00790842|62755868|FG001|Dose Level 3|Withdrawal by Subject|0|||
33376962|NCT00790842|62755869|FG002|Dose Level 3|Withdrawal by Subject|3|||
33376963|NCT00790842|62755870|FG003|Dose Level 3|Withdrawal by Subject|0|||
33376964|NCT00790842|62755871|FG004|Dose Level 3|Withdrawal by Subject|0|||
33376965|NCT00790842|62755872|FG005|Dose Level 3|Withdrawal by Subject|0|||
33376966|NCT00790842|62755873|FG006|Dose Level 3|Withdrawal by Subject|0|||
33376967|NCT00790842|62755874|FG007|Dose Level 3|Withdrawal by Subject|0|||
33376968|NCT00790842|62755875|FG008|Dose Level 3|Withdrawal by Subject|0|||
33376969|NCT00790842|62755876|FG009|Dose Level 3|Withdrawal by Subject|2|||
33376970|NCT00790842|62755877|FG010|Dose Level 3|Withdrawal by Subject|0|||
33376971|NCT00790842|62755867|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33376972|NCT00790842|62755868|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33376973|NCT00790842|62755869|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33376974|NCT00790842|62755870|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33376975|NCT00790842|62755871|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33376976|NCT00790842|62755872|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
33376977|NCT00790842|62755873|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33376978|NCT00790842|62755874|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33376979|NCT00790842|62755875|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33376980|NCT00790842|62755876|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33376981|NCT00790842|62755877|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33376982|NCT00790842|62755867|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33376983|NCT00790842|62755868|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33376984|NCT00790842|62755869|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
33376985|NCT00790842|62755870|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33376986|NCT00790842|62755871|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33376987|NCT00790842|62755872|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33376988|NCT00790842|62755873|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33376989|NCT00790842|62755874|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33376990|NCT00790842|62755875|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33376991|NCT00790842|62755876|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33376992|NCT00790842|62755877|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33376993|NCT00790842|62755867|FG000|Dose Level 4|Adverse Event|0|||
33376994|NCT00790842|62755868|FG001|Dose Level 4|Adverse Event|0|||
33376995|NCT00790842|62755869|FG002|Dose Level 4|Adverse Event|0|||
33376996|NCT00790842|62755870|FG003|Dose Level 4|Adverse Event|0|||
33376997|NCT00790842|62755871|FG004|Dose Level 4|Adverse Event|0|||
33376998|NCT00790842|62755872|FG005|Dose Level 4|Adverse Event|0|||
33376999|NCT00790842|62755873|FG006|Dose Level 4|Adverse Event|1|||
33377000|NCT00790842|62755874|FG007|Dose Level 4|Adverse Event|0|||
33377001|NCT00790842|62755875|FG008|Dose Level 4|Adverse Event|0|||
33377002|NCT00790842|62755876|FG009|Dose Level 4|Adverse Event|0|||
33377003|NCT00790842|62755877|FG010|Dose Level 4|Adverse Event|0|||
33377004|NCT00790842|62755867|FG000|Dose Level 4|Physician Decision|0|||
33377005|NCT00790842|62755868|FG001|Dose Level 4|Physician Decision|0|||
33377006|NCT00790842|62755869|FG002|Dose Level 4|Physician Decision|0|||
33377007|NCT00790842|62755870|FG003|Dose Level 4|Physician Decision|0|||
33377008|NCT00790842|62755871|FG004|Dose Level 4|Physician Decision|0|||
33377009|NCT00790842|62755872|FG005|Dose Level 4|Physician Decision|0|||
33377010|NCT00790842|62755873|FG006|Dose Level 4|Physician Decision|1|||
33377011|NCT00790842|62755874|FG007|Dose Level 4|Physician Decision|0|||
33377012|NCT00790842|62755875|FG008|Dose Level 4|Physician Decision|0|||
33377013|NCT00790842|62755876|FG009|Dose Level 4|Physician Decision|0|||
33377014|NCT00790842|62755877|FG010|Dose Level 4|Physician Decision|1|||
33377015|NCT00790842|62755867|FG000|Dose Level 4|Withdrawal by Subject|0|||
33377016|NCT00790842|62755868|FG001|Dose Level 4|Withdrawal by Subject|0|||
33377017|NCT00790842|62755869|FG002|Dose Level 4|Withdrawal by Subject|0|||
33377018|NCT00790842|62755870|FG003|Dose Level 4|Withdrawal by Subject|0|||
33377019|NCT00790842|62755871|FG004|Dose Level 4|Withdrawal by Subject|0|||
33377020|NCT00790842|62755872|FG005|Dose Level 4|Withdrawal by Subject|0|||
33377021|NCT00790842|62755873|FG006|Dose Level 4|Withdrawal by Subject|0|||
33377022|NCT00790842|62755874|FG007|Dose Level 4|Withdrawal by Subject|0|||
33377023|NCT00790842|62755875|FG008|Dose Level 4|Withdrawal by Subject|0|||
33377024|NCT00790842|62755876|FG009|Dose Level 4|Withdrawal by Subject|0|||
33377025|NCT00790842|62755877|FG010|Dose Level 4|Withdrawal by Subject|1|||
33377026|NCT00790842|62755867|FG000|Expansion Cohort|Adverse Event|0|||
33377027|NCT00790842|62755868|FG001|Expansion Cohort|Adverse Event|0|||
33377028|NCT00790842|62755869|FG002|Expansion Cohort|Adverse Event|0|||
33377029|NCT00790842|62755870|FG003|Expansion Cohort|Adverse Event|0|||
33377030|NCT00790842|62755871|FG004|Expansion Cohort|Adverse Event|0|||
33377031|NCT00790842|62755872|FG005|Expansion Cohort|Adverse Event|0|||
33377032|NCT00790842|62755873|FG006|Expansion Cohort|Adverse Event|1|||
33377033|NCT00790842|62755874|FG007|Expansion Cohort|Adverse Event|0|||
33377034|NCT00790842|62755875|FG008|Expansion Cohort|Adverse Event|0|||
33377035|NCT00790842|62755876|FG009|Expansion Cohort|Adverse Event|0|||
33377036|NCT00790842|62755877|FG010|Expansion Cohort|Adverse Event|0|||
33377037|NCT00790842|62755867|FG000|Expansion Cohort|Death|0|||
33291026|NCT01087502|62667441|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
33291027|NCT01087502|62667440|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
33291028|NCT01087502|62667441|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
33291029|NCT01087502|62667440|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
33291030|NCT01087502|62667441|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
33291031|NCT01087502|62667440|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
33291032|NCT01087502|62667441|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
33291033|NCT01087502|62667440|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
33291034|NCT01087502|62667441|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
33291035|NCT01087502|62667440|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
33291036|NCT01087502|62667441|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
33291037|NCT01087502|62667440|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
33291038|NCT01087502|62667441|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
33291039|NCT01087502|62667440|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
33291040|NCT01087502|62667441|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
33291041|NCT01086410|62667453|FG000|Overall Study|Adverse Event|1|||
33377038|NCT00790842|62755868|FG001|Expansion Cohort|Death|0|||
33291042|NCT01086410|62667454|FG001|Overall Study|Adverse Event|0|||
33291043|NCT01086410|62667455|FG002|Overall Study|Adverse Event|0|||
33291044|NCT01086410|62667456|FG003|Overall Study|Adverse Event|2|||
33291045|NCT01086410|62667453|FG000|Overall Study|Lack of Efficacy|1|||
33291046|NCT01086410|62667454|FG001|Overall Study|Lack of Efficacy|1|||
33291047|NCT01086410|62667455|FG002|Overall Study|Lack of Efficacy|0|||
33291048|NCT01086410|62667456|FG003|Overall Study|Lack of Efficacy|0|||
33291049|NCT01086410|62667453|FG000|Overall Study|Protocol Violation|1|||
33291050|NCT01086410|62667454|FG001|Overall Study|Protocol Violation|1|||
33291051|NCT01086410|62667455|FG002|Overall Study|Protocol Violation|0|||
33291052|NCT01086410|62667456|FG003|Overall Study|Protocol Violation|0|||
33377039|NCT00790842|62755869|FG002|Expansion Cohort|Death|2|||
33377040|NCT00790842|62755870|FG003|Expansion Cohort|Death|0|||
33377041|NCT00790842|62755871|FG004|Expansion Cohort|Death|0|||
33377042|NCT00790842|62755872|FG005|Expansion Cohort|Death|0|||
33291053|NCT01086410|62667453|FG000|Overall Study|Lost to Follow-up|0|||
33291054|NCT01086410|62667454|FG001|Overall Study|Lost to Follow-up|0|||
33377043|NCT00790842|62755873|FG006|Expansion Cohort|Death|0|||
33377044|NCT00790842|62755874|FG007|Expansion Cohort|Death|0|||
33377045|NCT00790842|62755875|FG008|Expansion Cohort|Death|0|||
33377046|NCT00790842|62755876|FG009|Expansion Cohort|Death|0|||
33377047|NCT00790842|62755877|FG010|Expansion Cohort|Death|0|||
33377048|NCT00790842|62755867|FG000|Expansion Cohort|Physician Decision|0|||
33377049|NCT00790842|62755868|FG001|Expansion Cohort|Physician Decision|0|||
33377050|NCT00790842|62755869|FG002|Expansion Cohort|Physician Decision|1|||
33377051|NCT00790842|62755870|FG003|Expansion Cohort|Physician Decision|0|||
33291055|NCT01086410|62667455|FG002|Overall Study|Lost to Follow-up|1|||
33291056|NCT01086410|62667456|FG003|Overall Study|Lost to Follow-up|0|||
33291057|NCT04553679|62667468|FG000|Overall Study|Withdrawal by Subject|2|||
33291058|NCT04553679|62667469|FG001|Overall Study|Withdrawal by Subject|0|||
33291059|NCT04553679|62667468|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
33291060|NCT04553679|62667469|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
33291061|NCT01086215|62667483|FG000|Overall Study|Death|14|||
33291062|NCT01086215|62667484|FG001|Overall Study|Death|8|||
33291063|NCT01086215|62667485|FG002|Overall Study|Death|8|||
33377052|NCT00790842|62755871|FG004|Expansion Cohort|Physician Decision|0|||
33377053|NCT00790842|62755872|FG005|Expansion Cohort|Physician Decision|0|||
33377054|NCT00790842|62755873|FG006|Expansion Cohort|Physician Decision|0|||
33377055|NCT00790842|62755874|FG007|Expansion Cohort|Physician Decision|0|||
33377056|NCT00790842|62755875|FG008|Expansion Cohort|Physician Decision|0|||
33377057|NCT00790842|62755876|FG009|Expansion Cohort|Physician Decision|0|||
33377058|NCT00790842|62755877|FG010|Expansion Cohort|Physician Decision|0|||
33377059|NCT00790842|62755867|FG000|Expansion Cohort|Withdrawal by Subject|0|||
33377060|NCT00790842|62755868|FG001|Expansion Cohort|Withdrawal by Subject|0|||
33377061|NCT00790842|62755869|FG002|Expansion Cohort|Withdrawal by Subject|3|||
33291064|NCT01086215|62667486|FG003|Overall Study|Death|1|||
33291065|NCT01086215|62667483|FG000|Overall Study|Lost to Follow-up|22|||
33291066|NCT01086215|62667484|FG001|Overall Study|Lost to Follow-up|39|||
33291067|NCT01086215|62667485|FG002|Overall Study|Lost to Follow-up|18|||
33291068|NCT01086215|62667486|FG003|Overall Study|Lost to Follow-up|2|||
33291069|NCT01085591|62667499|FG000|Overall Study|Adverse Event|0|||
33291070|NCT01085591|62667500|FG001|Overall Study|Adverse Event|1|||
33291071|NCT01085591|62667501|FG002|Overall Study|Adverse Event|3|||
33291072|NCT01085591|62667499|FG000|Overall Study|Physician Decision|1|||
33291073|NCT01085591|62667500|FG001|Overall Study|Physician Decision|0|||
33291074|NCT01085591|62667501|FG002|Overall Study|Physician Decision|1|||
33291075|NCT01085591|62667499|FG000|Overall Study|Withdrawal by Subject|0|||
33291076|NCT01085591|62667500|FG001|Overall Study|Withdrawal by Subject|2|||
33291077|NCT01085591|62667501|FG002|Overall Study|Withdrawal by Subject|1|||
33377062|NCT00790842|62755870|FG003|Expansion Cohort|Withdrawal by Subject|0|||
33377063|NCT00790842|62755871|FG004|Expansion Cohort|Withdrawal by Subject|0|||
33377064|NCT00790842|62755872|FG005|Expansion Cohort|Withdrawal by Subject|0|||
33377065|NCT00790842|62755873|FG006|Expansion Cohort|Withdrawal by Subject|0|||
33377066|NCT00790842|62755874|FG007|Expansion Cohort|Withdrawal by Subject|0|||
33377067|NCT00790842|62755875|FG008|Expansion Cohort|Withdrawal by Subject|0|||
33377068|NCT00790842|62755876|FG009|Expansion Cohort|Withdrawal by Subject|0|||
33377069|NCT00790842|62755877|FG010|Expansion Cohort|Withdrawal by Subject|0|||
33377070|NCT00790842|62755867|FG000|Expansion Cohort|Study Closure|0|||
33377071|NCT00790842|62755868|FG001|Expansion Cohort|Study Closure|0|||
33377072|NCT00790842|62755869|FG002|Expansion Cohort|Study Closure|1|||
33377073|NCT00790842|62755870|FG003|Expansion Cohort|Study Closure|0|||
33377074|NCT00790842|62755871|FG004|Expansion Cohort|Study Closure|0|||
33291078|NCT01085591|62667499|FG000|Overall Study|Lost to Follow-up|0|||
33291079|NCT01085591|62667500|FG001|Overall Study|Lost to Follow-up|1|||
33291080|NCT01085591|62667501|FG002|Overall Study|Lost to Follow-up|1|||
33291081|NCT01085591|62667499|FG000|Overall Study|Protocol Violation|1|||
33291082|NCT01085591|62667500|FG001|Overall Study|Protocol Violation|1|||
33291083|NCT01085591|62667501|FG002|Overall Study|Protocol Violation|1|||
33291084|NCT01085591|62667499|FG000|Overall Study|Other|0|||
33291085|NCT01085591|62667500|FG001|Overall Study|Other|1|||
33291086|NCT01085591|62667501|FG002|Overall Study|Other|0|||
33291087|NCT01085591|62667499|FG000|Overall Study|Not Properly Consented|1|||
33291088|NCT01085591|62667500|FG001|Overall Study|Not Properly Consented|0|||
33291089|NCT01085591|62667501|FG002|Overall Study|Not Properly Consented|0|||
33291090|NCT01085357|62667512|FG000|Overall Study|Adverse Event|1|||
33291091|NCT01085357|62667513|FG001|Overall Study|Adverse Event|1|||
33291092|NCT01085357|62667512|FG000|Overall Study|Subject Decision|4|||
33377075|NCT00790842|62755872|FG005|Expansion Cohort|Study Closure|0|||
33377076|NCT00790842|62755873|FG006|Expansion Cohort|Study Closure|0|||
33377077|NCT00790842|62755874|FG007|Expansion Cohort|Study Closure|0|||
33377078|NCT00790842|62755875|FG008|Expansion Cohort|Study Closure|0|||
33377079|NCT00790842|62755876|FG009|Expansion Cohort|Study Closure|0|||
33291093|NCT01085357|62667513|FG001|Overall Study|Subject Decision|3|||
33291094|NCT01085357|62667512|FG000|Overall Study|Investigator Decision|1|||
33291095|NCT01085357|62667513|FG001|Overall Study|Investigator Decision|1|||
33291096|NCT01085357|62667512|FG000|Overall Study|Death|11|||
33291097|NCT01085357|62667513|FG001|Overall Study|Death|1|||
33291098|NCT01085357|62667512|FG000|Overall Study|Lost to Follow-up|2|||
33377080|NCT00790842|62755877|FG010|Expansion Cohort|Study Closure|0|||
33291099|NCT01085357|62667513|FG001|Overall Study|Lost to Follow-up|0|||
33377081|NCT00574288|62755932|FG000|Overall Study|Adverse Event|2|||
33377082|NCT00574288|62755933|FG001|Overall Study|Adverse Event|0|||
33377083|NCT00574288|62755934|FG002|Overall Study|Adverse Event|0|||
33377084|NCT00574288|62755935|FG003|Overall Study|Adverse Event|0|||
33377085|NCT00574288|62755936|FG004|Overall Study|Adverse Event|1|||
33377086|NCT00574288|62755937|FG005|Overall Study|Adverse Event|0|||
33377087|NCT00574288|62755938|FG006|Overall Study|Adverse Event|0|||
33377088|NCT00574288|62755932|FG000|Overall Study|Death|0|||
33377089|NCT00574288|62755933|FG001|Overall Study|Death|0|||
33377090|NCT00574288|62755934|FG002|Overall Study|Death|0|||
33377091|NCT00574288|62755935|FG003|Overall Study|Death|0|||
33377092|NCT00574288|62755936|FG004|Overall Study|Death|0|||
33377093|NCT00574288|62755937|FG005|Overall Study|Death|25|||
33377094|NCT00574288|62755938|FG006|Overall Study|Death|21|||
33377095|NCT00574288|62755932|FG000|Overall Study|Lost to Follow-up|0|||
33377096|NCT00574288|62755933|FG001|Overall Study|Lost to Follow-up|0|||
33377097|NCT00574288|62755934|FG002|Overall Study|Lost to Follow-up|0|||
33377098|NCT00574288|62755935|FG003|Overall Study|Lost to Follow-up|0|||
33377099|NCT00574288|62755936|FG004|Overall Study|Lost to Follow-up|0|||
33377100|NCT00574288|62755937|FG005|Overall Study|Lost to Follow-up|1|||
33377101|NCT00574288|62755938|FG006|Overall Study|Lost to Follow-up|2|||
33377102|NCT00574288|62755932|FG000|Overall Study|Study Terminated By Sponsor|0|||
33377103|NCT00574288|62755933|FG001|Overall Study|Study Terminated By Sponsor|0|||
33377104|NCT00574288|62755934|FG002|Overall Study|Study Terminated By Sponsor|0|||
33377105|NCT00574288|62755935|FG003|Overall Study|Study Terminated By Sponsor|0|||
33377106|NCT00574288|62755936|FG004|Overall Study|Study Terminated By Sponsor|0|||
33377107|NCT00574288|62755937|FG005|Overall Study|Study Terminated By Sponsor|0|||
33377108|NCT00574288|62755938|FG006|Overall Study|Study Terminated By Sponsor|5|||
33377109|NCT00574288|62755932|FG000|Overall Study|Progressive Disease|17|||
33377110|NCT00574288|62755933|FG001|Overall Study|Progressive Disease|2|||
33377111|NCT00574288|62755934|FG002|Overall Study|Progressive Disease|3|||
33377112|NCT00574288|62755935|FG003|Overall Study|Progressive Disease|2|||
33377113|NCT00574288|62755936|FG004|Overall Study|Progressive Disease|1|||
33377114|NCT00574288|62755937|FG005|Overall Study|Progressive Disease|0|||
33377115|NCT00574288|62755938|FG006|Overall Study|Progressive Disease|0|||
33377116|NCT00574288|62755932|FG000|Overall Study|Other|1|||
33377117|NCT00574288|62755933|FG001|Overall Study|Other|1|||
33377118|NCT00574288|62755934|FG002|Overall Study|Other|0|||
33377119|NCT00574288|62755935|FG003|Overall Study|Other|0|||
33377120|NCT00574288|62755936|FG004|Overall Study|Other|0|||
33377121|NCT00574288|62755937|FG005|Overall Study|Other|0|||
33377122|NCT00574288|62755938|FG006|Overall Study|Other|0|||
33377123|NCT00790452|62755966|FG000|Overall Study|Drug supply issue|1|||
33377124|NCT00790452|62755967|FG001|Overall Study|Drug supply issue|0|||
33377125|NCT00626392|62755979|FG000|Run-in Period|Adverse Event|0|||
33291100|NCT01085201|62667524|FG000|Overall Study|Scheduling conflict|1|||
33291101|NCT01085201|62667525|FG001|Overall Study|Scheduling conflict|0|||
33291102|NCT01085201|62667526|FG002|Overall Study|Scheduling conflict|1|||
33291103|NCT01085201|62667527|FG003|Overall Study|Scheduling conflict|0|||
33291104|NCT01085201|62667528|FG004|Overall Study|Scheduling conflict|0|||
33291105|NCT01085201|62667524|FG000|Overall Study|Unknown- no study drug|2|||
33291106|NCT01085201|62667525|FG001|Overall Study|Unknown- no study drug|0|||
33377126|NCT00626392|62755980|FG001|Run-in Period|Adverse Event|0|||
33377127|NCT00626392|62755981|FG002|Run-in Period|Adverse Event|1|||
33377128|NCT00626392|62755982|FG003|Run-in Period|Adverse Event|0|||
33377129|NCT00626392|62755983|FG004|Run-in Period|Adverse Event|1|||
33291107|NCT01085201|62667526|FG002|Overall Study|Unknown- no study drug|0|||
33291108|NCT01085201|62667527|FG003|Overall Study|Unknown- no study drug|0|||
33291109|NCT01085201|62667528|FG004|Overall Study|Unknown- no study drug|0|||
33291110|NCT01085201|62667524|FG000|Overall Study|Fond ineligible after consent|0|||
33291111|NCT01085201|62667525|FG001|Overall Study|Fond ineligible after consent|1|||
33291112|NCT01085201|62667526|FG002|Overall Study|Fond ineligible after consent|1|||
33377130|NCT00626392|62755984|FG005|Run-in Period|Adverse Event|0|||
33377131|NCT00626392|62755979|FG000|Run-in Period|Withdrawal by Subject|0|||
33377132|NCT00626392|62755980|FG001|Run-in Period|Withdrawal by Subject|1|||
33377133|NCT00626392|62755981|FG002|Run-in Period|Withdrawal by Subject|1|||
33377134|NCT00626392|62755982|FG003|Run-in Period|Withdrawal by Subject|1|||
33291113|NCT01085201|62667527|FG003|Overall Study|Fond ineligible after consent|0|||
33291114|NCT01085201|62667528|FG004|Overall Study|Fond ineligible after consent|0|||
33291115|NCT01085084|62667548|FG000|Overall Study|Withdrawal by Subject|1|||
33377135|NCT00626392|62755983|FG004|Run-in Period|Withdrawal by Subject|3|||
33377136|NCT00626392|62755984|FG005|Run-in Period|Withdrawal by Subject|1|||
33377137|NCT00626392|62755979|FG000|Run-in Period|Noncompliance|1|||
33377138|NCT00626392|62755980|FG001|Run-in Period|Noncompliance|0|||
33377139|NCT00626392|62755981|FG002|Run-in Period|Noncompliance|1|||
33291116|NCT01085084|62667549|FG001|Overall Study|Withdrawal by Subject|0|||
33377140|NCT00626392|62755982|FG003|Run-in Period|Noncompliance|0|||
33377141|NCT00626392|62755983|FG004|Run-in Period|Noncompliance|0|||
33377142|NCT00626392|62755984|FG005|Run-in Period|Noncompliance|0|||
33377143|NCT00626392|62755979|FG000|Coadministration Period|Adverse Event|3|||
33377144|NCT00626392|62755980|FG001|Coadministration Period|Adverse Event|1|||
33377145|NCT00626392|62755981|FG002|Coadministration Period|Adverse Event|7|||
33377146|NCT00626392|62755982|FG003|Coadministration Period|Adverse Event|4|||
33377147|NCT00626392|62755983|FG004|Coadministration Period|Adverse Event|3|||
33377148|NCT00626392|62755984|FG005|Coadministration Period|Adverse Event|4|||
33377149|NCT00626392|62755979|FG000|Coadministration Period|Withdrawal by Subject|1|||
33377150|NCT00626392|62755980|FG001|Coadministration Period|Withdrawal by Subject|1|||
33377151|NCT00626392|62755981|FG002|Coadministration Period|Withdrawal by Subject|0|||
33377152|NCT00626392|62755982|FG003|Coadministration Period|Withdrawal by Subject|1|||
33377153|NCT00626392|62755983|FG004|Coadministration Period|Withdrawal by Subject|0|||
33377154|NCT00626392|62755984|FG005|Coadministration Period|Withdrawal by Subject|1|||
33377155|NCT00626392|62755979|FG000|Coadministration Period|Protocol Violation|0|||
33377156|NCT00626392|62755980|FG001|Coadministration Period|Protocol Violation|1|||
33377157|NCT00626392|62755981|FG002|Coadministration Period|Protocol Violation|0|||
33377158|NCT00626392|62755982|FG003|Coadministration Period|Protocol Violation|1|||
33377159|NCT00626392|62755983|FG004|Coadministration Period|Protocol Violation|1|||
33291117|NCT01085084|62667550|FG002|Overall Study|Withdrawal by Subject|0|||
33291118|NCT01085084|62667548|FG000|Overall Study|Lost to Follow-up|2|||
33291119|NCT01085084|62667549|FG001|Overall Study|Lost to Follow-up|1|||
33377160|NCT00626392|62755984|FG005|Coadministration Period|Protocol Violation|0|||
33377161|NCT00626392|62755979|FG000|Coadministration Period|Other|0|||
33377162|NCT00626392|62755980|FG001|Coadministration Period|Other|2|||
33377163|NCT00626392|62755981|FG002|Coadministration Period|Other|3|||
33291120|NCT01085084|62667550|FG002|Overall Study|Lost to Follow-up|1|||
33291121|NCT01085084|62667548|FG000|Overall Study|Adverse Event|4|||
33291122|NCT01085084|62667549|FG001|Overall Study|Adverse Event|3|||
33291123|NCT01085084|62667550|FG002|Overall Study|Adverse Event|6|||
33291124|NCT01085084|62667548|FG000|Overall Study|Treatment Failure|0|||
33291125|NCT01085084|62667549|FG001|Overall Study|Treatment Failure|1|||
33291126|NCT01085084|62667550|FG002|Overall Study|Treatment Failure|2|||
33291127|NCT01085045|62667558|FG000|Part A|Withdrawal by Subject|4|||
33291128|NCT01085045|62667558|FG000|Part A|Adverse Event|6|||
33291129|NCT01085045|62667558|FG000|Part A|Protocol Violation|1|||
33291130|NCT01085045|62667558|FG000|Part A|Protocol Specified Criteria|7|||
33291131|NCT01085045|62667558|FG000|Part B|Withdrawal by Subject|2|||
33291132|NCT01085045|62667558|FG000|Part B|Protocol Specified Criteria|6|||
33291133|NCT01085045|62667558|FG000|Part B|Lost to Follow-up|1|||
33377164|NCT00626392|62755982|FG003|Coadministration Period|Other|1|||
33377165|NCT00626392|62755983|FG004|Coadministration Period|Other|1|||
33291134|NCT01085045|62667558|FG000|Part B|Adverse Event|6|||
33291135|NCT01084772|62667580|FG000|Baseline|Withdrawal by Subject|7|||
33291136|NCT01084772|62667581|FG001|Baseline|Withdrawal by Subject|6|||
33291137|NCT01084772|62667580|FG000|3 Months|Death|1|||
33291138|NCT01084772|62667581|FG001|3 Months|Death|0|||
33291139|NCT01084772|62667580|FG000|3 Months|Study Termination|2|||
33377166|NCT00626392|62755984|FG005|Coadministration Period|Other|1|||
33377167|NCT00624286|62755992|FG000|Overall Study|Protocol Deviation|7|||
33377168|NCT00624286|62755993|FG001|Overall Study|Protocol Deviation|9|||
33377169|NCT00624286|62755992|FG000|Overall Study|Adverse Event|6|||
33377170|NCT00624286|62755993|FG001|Overall Study|Adverse Event|3|||
33377171|NCT00624286|62755992|FG000|Overall Study|Withdrawal by Subject|5|||
33377172|NCT00624286|62755993|FG001|Overall Study|Withdrawal by Subject|4|||
33377173|NCT00624286|62755992|FG000|Overall Study|Lost to Follow-up|3|||
33377174|NCT00624286|62755993|FG001|Overall Study|Lost to Follow-up|2|||
33377175|NCT00624286|62755992|FG000|Overall Study|Administrative problems|3|||
33377176|NCT00624286|62755993|FG001|Overall Study|Administrative problems|0|||
33377177|NCT00624286|62755992|FG000|Overall Study|Lack of Efficacy|1|||
33377178|NCT00624286|62755993|FG001|Overall Study|Lack of Efficacy|6|||
33291140|NCT01084772|62667581|FG001|3 Months|Study Termination|2|||
33291141|NCT01084772|62667580|FG000|1 Year|Withdrawal by Subject|0|||
33377179|NCT00624286|62755992|FG000|Overall Study|Not stated|0|||
33377180|NCT00624286|62755993|FG001|Overall Study|Not stated|1|||
33377181|NCT00624286|62755992|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33556560|NCT01369355|62949452|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
33556561|NCT01369355|62949453|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
33662379|NCT01695239|63092835|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33291142|NCT01084772|62667581|FG001|1 Year|Withdrawal by Subject|1|||
33291143|NCT01084772|62667580|FG000|1 Year|Lost to Follow-up|3|||
33291144|NCT01084772|62667581|FG001|1 Year|Lost to Follow-up|0|||
33291145|NCT01084772|62667580|FG000|1 Year|Study Termination|0|||
33291146|NCT01084772|62667581|FG001|1 Year|Study Termination|7|||
33291147|NCT01084772|62667580|FG000|2 Years|Withdrawal by Subject|1|||
33291148|NCT01084772|62667581|FG001|2 Years|Withdrawal by Subject|0|||
33291149|NCT01084772|62667580|FG000|2 Years|Lost to Follow-up|5|||
33377182|NCT00624286|62755993|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33377183|NCT00624286|62755992|FG000|Overall Study|Death|0|||
33377184|NCT00624286|62755993|FG001|Overall Study|Death|1|||
33377185|NCT00624052|62756003|FG000|Overall Study|Adverse Event|7|||
33377186|NCT00624052|62756004|FG001|Overall Study|Adverse Event|6|||
33377187|NCT00624052|62756005|FG002|Overall Study|Adverse Event|0|||
33377188|NCT00624052|62756006|FG003|Overall Study|Adverse Event|3|||
33377189|NCT00624052|62756003|FG000|Overall Study|Lack of Efficacy|1|||
33377190|NCT00624052|62756004|FG001|Overall Study|Lack of Efficacy|1|||
33377191|NCT00624052|62756005|FG002|Overall Study|Lack of Efficacy|0|||
33377192|NCT00624052|62756006|FG003|Overall Study|Lack of Efficacy|0|||
33377193|NCT00624052|62756003|FG000|Overall Study|Lost to Follow-up|2|||
33377194|NCT00624052|62756004|FG001|Overall Study|Lost to Follow-up|3|||
33377195|NCT00624052|62756005|FG002|Overall Study|Lost to Follow-up|1|||
33377196|NCT00624052|62756006|FG003|Overall Study|Lost to Follow-up|0|||
33377197|NCT00624052|62756003|FG000|Overall Study|Non compliant with the protocol|2|||
33377198|NCT00624052|62756004|FG001|Overall Study|Non compliant with the protocol|1|||
33377199|NCT00624052|62756005|FG002|Overall Study|Non compliant with the protocol|1|||
33377200|NCT00624052|62756006|FG003|Overall Study|Non compliant with the protocol|1|||
33377201|NCT00624052|62756003|FG000|Overall Study|Consent withdrawn|3|||
33377202|NCT00624052|62756004|FG001|Overall Study|Consent withdrawn|1|||
33377203|NCT00624052|62756005|FG002|Overall Study|Consent withdrawn|1|||
33377204|NCT00624052|62756006|FG003|Overall Study|Consent withdrawn|0|||
33377205|NCT00624052|62756003|FG000|Overall Study|Changed job/ran out if meds|0|||
33377206|NCT00624052|62756004|FG001|Overall Study|Changed job/ran out if meds|2|||
33377207|NCT00624052|62756005|FG002|Overall Study|Changed job/ran out if meds|0|||
33377208|NCT00624052|62756006|FG003|Overall Study|Changed job/ran out if meds|0|||
33377209|NCT00785577|62756025|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
33377210|NCT00785577|62756026|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
33377211|NCT00785577|62756027|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
33377212|NCT00785577|62756028|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
33377213|NCT00785577|62756029|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
33377214|NCT00785577|62756025|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
33377215|NCT00785577|62756026|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
33377216|NCT00785577|62756027|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
33377217|NCT00785577|62756028|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
33377218|NCT00785577|62756029|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
33377219|NCT00785577|62756025|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
33377220|NCT00785577|62756026|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
33377221|NCT00785577|62756027|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
33377222|NCT00785577|62756028|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
33377223|NCT00785577|62756029|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
33377224|NCT00785577|62756025|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
33377225|NCT00785577|62756026|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
33377226|NCT00785577|62756027|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
33377227|NCT00785577|62756028|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
33377228|NCT00785577|62756029|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
33377229|NCT00785577|62756025|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
33377230|NCT00785577|62756026|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
33377231|NCT00785577|62756027|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
33377232|NCT00785577|62756028|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
33291150|NCT01084772|62667581|FG001|2 Years|Lost to Follow-up|2|||
33487152|NCT00130247|62865139|FG000|Overall Study|Not compliant with DOT|0|||
33291151|NCT01084772|62667580|FG000|2 Years|Study Termination|3|||
33291152|NCT01084772|62667581|FG001|2 Years|Study Termination|2|||
33291153|NCT00179673|62667587|FG000|Overall Study|Adverse Event|7|||
33291154|NCT00179673|62667587|FG000|Overall Study|Lack of Efficacy|15|||
33291155|NCT00179673|62667587|FG000|Overall Study|Withdrawal by Subject|3|||
33291156|NCT00179673|62667587|FG000|Overall Study|Death|4|||
33291157|NCT00179673|62667587|FG000|Overall Study|Other Observations and options|14|||
33291158|NCT01084655|62667594|FG000|Overall Study|Radiographic disease progression|3|||
33291159|NCT01084655|62667595|FG001|Overall Study|Radiographic disease progression|2|||
33291160|NCT01084655|62667596|FG002|Overall Study|Radiographic disease progression|8|||
33291161|NCT01084655|62667594|FG000|Overall Study|Withdrawal by Subject|1|||
33291162|NCT01084655|62667595|FG001|Overall Study|Withdrawal by Subject|0|||
33377233|NCT00785577|62756029|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
33377234|NCT00785577|62756025|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
33377235|NCT00785577|62756026|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
33377236|NCT00785577|62756027|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
33377237|NCT00785577|62756028|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
33556562|NCT01369355|62949454|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
33377238|NCT00785577|62756029|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
33377239|NCT00785577|62756025|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
33377240|NCT00785577|62756026|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
33377241|NCT00785577|62756027|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
33556563|NCT01369355|62949446|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
33291163|NCT01084655|62667596|FG002|Overall Study|Withdrawal by Subject|4|||
33291164|NCT01084655|62667594|FG000|Overall Study|Adverse Event|2|||
33377242|NCT00785577|62756028|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
33377243|NCT00785577|62756029|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
33377244|NCT00785577|62756025|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
33377245|NCT00785577|62756026|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
33377246|NCT00785577|62756027|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
33377247|NCT00785577|62756028|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
33377248|NCT00785577|62756029|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
33377249|NCT00785577|62756025|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
33377250|NCT00785577|62756026|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
33377251|NCT00785577|62756027|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
33377252|NCT00785577|62756028|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
33377253|NCT00785577|62756029|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
33377254|NCT00785577|62756025|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
33377255|NCT00785577|62756026|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
33377256|NCT00785577|62756027|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
33377257|NCT00785577|62756028|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
33377258|NCT00785577|62756029|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
33377259|NCT00789828|62756053|FG000|Core Period (48 Weeks)|Administrative problems|0|||
33377260|NCT00789828|62756054|FG001|Core Period (48 Weeks)|Administrative problems|1|||
33377261|NCT00789828|62756053|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
33377262|NCT00789828|62756054|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
33377263|NCT00789828|62756053|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
33377264|NCT00789828|62756054|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
33377265|NCT00789828|62756053|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
33377266|NCT00789828|62756054|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
33377267|NCT00789828|62756053|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
33377268|NCT00789828|62756054|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
33377269|NCT00789828|62756053|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
33377270|NCT00789828|62756054|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
33377271|NCT00789828|62756053|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
33377272|NCT00789828|62756054|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
33377273|NCT00789828|62756053|FG000|Open-label Extension Period (4 Years)|Death|1|||
33377274|NCT00789828|62756054|FG001|Open-label Extension Period (4 Years)|Death|0|||
33291165|NCT01084655|62667595|FG001|Overall Study|Adverse Event|1|||
33377275|NCT00789828|62756053|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
33377276|NCT00789828|62756054|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
33377277|NCT00789828|62756053|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
33377278|NCT00789828|62756054|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
33377279|NCT00790296|62756065|FG000|Overall Study|Did not meet study eligibility criteria|1|||
33377280|NCT00790296|62756066|FG001|Overall Study|Did not meet study eligibility criteria|1|||
33377281|NCT00790296|62756065|FG000|Overall Study|Adverse Event|0|||
33377282|NCT00790296|62756066|FG001|Overall Study|Adverse Event|1|||
33487153|NCT00130247|62865140|FG001|Overall Study|Not compliant with DOT|2|||
33487154|NCT03678285|62865146|FG000|Overall Study|Adverse Event|2|||
33487155|NCT03678285|62865146|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
33556564|NCT01369355|62949447|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
33291166|NCT01084655|62667596|FG002|Overall Study|Adverse Event|2|||
33291167|NCT01084655|62667594|FG000|Overall Study|Other|0|||
33291168|NCT01084655|62667595|FG001|Overall Study|Other|3|||
33291169|NCT01084655|62667596|FG002|Overall Study|Other|2|||
33291170|NCT01084655|62667594|FG000|Overall Study|Symptomatic deterioration|0|||
33291171|NCT01084655|62667595|FG001|Overall Study|Symptomatic deterioration|0|||
33291172|NCT01084655|62667596|FG002|Overall Study|Symptomatic deterioration|2|||
33291173|NCT01084655|62667594|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
33291174|NCT01084655|62667595|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
33291175|NCT01084655|62667596|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
33291176|NCT01084538|62667608|FG000|Overall Study|Drug not available|30|||
33291177|NCT01084538|62667608|FG000|Overall Study|Adverse Event|9|||
33291178|NCT01084538|62667608|FG000|Overall Study|Kidney transplant|6|||
33291179|NCT01084538|62667608|FG000|Overall Study|Serious Adverse Event|3|||
33291180|NCT01084538|62667608|FG000|Overall Study|Lack of effectiveness|2|||
33291181|NCT01084538|62667608|FG000|Overall Study|Patient noncompliance|2|||
33291182|NCT01084538|62667608|FG000|Overall Study|Hyperphosphatemia|2|||
33377283|NCT00623194|62756072|FG000|Overall Study|Lack of Efficacy|1|||
33377284|NCT00623194|62756072|FG000|Overall Study|Protocol Violation|3|||
33377285|NCT00623194|62756072|FG000|Overall Study|Unclassified|1|||
33377286|NCT00784368|62756079|FG000|Overall Study|Physician Decision|0|||
33377287|NCT00784368|62756080|FG001|Overall Study|Physician Decision|0|||
33291183|NCT01084538|62667608|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
33291184|NCT01084538|62667608|FG000|Overall Study|Change of residence|2|||
33291185|NCT01084538|62667608|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
33291186|NCT01084538|62667608|FG000|Overall Study|Reason unknown|8|||
33291187|NCT01083680|62667612|FG000|Overall Study|Lost to Follow-up|2758|||
33291188|NCT01083680|62667612|FG000|Overall Study|Withdrawal by Subject|1086|||
33377288|NCT00784368|62756081|FG002|Overall Study|Physician Decision|6|||
33377289|NCT00784368|62756079|FG000|Overall Study|Lack of Efficacy|2|||
33377290|NCT00784368|62756080|FG001|Overall Study|Lack of Efficacy|0|||
33377291|NCT00784368|62756081|FG002|Overall Study|Lack of Efficacy|1|||
33377292|NCT00784368|62756079|FG000|Overall Study|Adverse Event|6|||
33377293|NCT00784368|62756080|FG001|Overall Study|Adverse Event|9|||
33377294|NCT00784368|62756081|FG002|Overall Study|Adverse Event|2|||
33377295|NCT00784368|62756079|FG000|Overall Study|Diagnosis of fever|0|||
33377296|NCT00784368|62756080|FG001|Overall Study|Diagnosis of fever|0|||
33377297|NCT00784368|62756081|FG002|Overall Study|Diagnosis of fever|1|||
33377298|NCT00784368|62756079|FG000|Overall Study|Worsening of complications|0|||
33377299|NCT00784368|62756080|FG001|Overall Study|Worsening of complications|0|||
33377300|NCT00784368|62756081|FG002|Overall Study|Worsening of complications|1|||
33377301|NCT00784368|62756079|FG000|Overall Study|Worsening of symptoms|0|||
33377302|NCT00784368|62756080|FG001|Overall Study|Worsening of symptoms|1|||
33377303|NCT00784368|62756081|FG002|Overall Study|Worsening of symptoms|0|||
33377304|NCT00784368|62756079|FG000|Overall Study|Withdrawal of informed consent|0|||
33377305|NCT00784368|62756080|FG001|Overall Study|Withdrawal of informed consent|1|||
33377306|NCT00784368|62756081|FG002|Overall Study|Withdrawal of informed consent|0|||
33377307|NCT00622726|62756094|FG000|March, 2008 to August, 2010|Death|5|||
33377308|NCT00622726|62756095|FG001|March, 2008 to August, 2010|Death|2|||
33377309|NCT00622726|62756094|FG000|August, 2010 to April, 2013|Death|1|||
33377310|NCT00622726|62756095|FG001|August, 2010 to April, 2013|Death|5|||
33377311|NCT00623428|62756107|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
33377312|NCT00623428|62756108|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
33377313|NCT00623428|62756107|FG000|Treatment Period|Death|0|||
33377314|NCT00623428|62756108|FG001|Treatment Period|Death|1|||
33377315|NCT00623428|62756107|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
33377316|NCT00623428|62756108|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
33377317|NCT00623428|62756107|FG000|Treatment Period|Insufficient therapeutic response|0|||
33377318|NCT00623428|62756108|FG001|Treatment Period|Insufficient therapeutic response|2|||
33377319|NCT00623428|62756107|FG000|Treatment Period|Other|0|||
33377320|NCT00623428|62756108|FG001|Treatment Period|Other|1|||
33377321|NCT00623428|62756107|FG000|Treatment Period|Withdrawal by Subject|0|||
33377322|NCT00623428|62756108|FG001|Treatment Period|Withdrawal by Subject|1|||
33377323|NCT00623428|62756107|FG000|Follow-up Period|Relapse post-treatment|11|||
33377324|NCT00623428|62756108|FG001|Follow-up Period|Relapse post-treatment|3|||
33377325|NCT00623428|62756107|FG000|Follow-up Period|Failure to return|10|||
33377326|NCT00623428|62756108|FG001|Follow-up Period|Failure to return|2|||
33377327|NCT00623428|62756107|FG000|Follow-up Period|Patient withdrew consent|5|||
33377328|NCT00623428|62756108|FG001|Follow-up Period|Patient withdrew consent|4|||
33377329|NCT00623428|62756107|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
33291189|NCT00179517|62667618|FG000|Overall Study|Withdrawal by Subject|2|||
33291190|NCT00179517|62667619|FG001|Overall Study|Withdrawal by Subject|1|||
33291191|NCT01083641|62667625|FG000|Overall Study|Withdrawal by Subject|2|||
33291192|NCT00179010|62667631|FG000|Overall Study|Muscle probe defective|1|||
33291193|NCT00179010|62667632|FG001|Overall Study|Muscle probe defective|1|||
33291194|NCT00179010|62667631|FG000|Overall Study|Failure to place arterial line|0|||
33291195|NCT00179010|62667632|FG001|Overall Study|Failure to place arterial line|1|||
33291196|NCT01083602|62667639|FG000|Overall Study|Adverse Event|11|||
33291197|NCT01083602|62667639|FG000|Overall Study|New Cancer Therapy|2|||
33291198|NCT01083602|62667639|FG000|Overall Study|Death|1|||
33291199|NCT01083602|62667639|FG000|Overall Study|Withdrawal by Subject|5|||
33291200|NCT01083602|62667639|FG000|Overall Study|Lack of Efficacy|36|||
33291201|NCT00178464|62667643|FG000|Overall Study|Withdrawal by Subject|1|||
33291202|NCT00178464|62667643|FG000|Overall Study|Physician Decision|1|||
33291203|NCT01083485|62667649|FG000|Overall Study|Adverse Event|0|||
33377330|NCT00623428|62756108|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
33377331|NCT00623428|62756107|FG000|Follow-up Period|Did not cooperate|0|||
33377332|NCT00623428|62756108|FG001|Follow-up Period|Did not cooperate|3|||
33377333|NCT00623428|62756107|FG000|Follow-up Period|Reason not specified|1|||
33377334|NCT00623428|62756108|FG001|Follow-up Period|Reason not specified|1|||
33377335|NCT00623428|62756107|FG000|Follow-up Period|Death|0|||
33487156|NCT03678285|62865146|FG000|Overall Study|Dehydrated prior to start of workout|1|||
33487157|NCT04032171|62865152|FG000|Overall Study|Study Termination|1|||
33556565|NCT01369355|62949448|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
33377336|NCT00623428|62756108|FG001|Follow-up Period|Death|1|||
33377337|NCT00784134|62756116|FG000|Overall Study|Lost to Follow-up|3|||
33291204|NCT01083485|62667650|FG001|Overall Study|Adverse Event|1|||
33291205|NCT01083485|62667649|FG000|Overall Study|Protocol Violation|1|||
33377338|NCT00784134|62756117|FG001|Overall Study|Lost to Follow-up|6|||
33291206|NCT01083485|62667650|FG001|Overall Study|Protocol Violation|0|||
33377339|NCT00776100|62756125|FG000|Overall Study|Disease Progression|1|||
33377340|NCT00776100|62756126|FG001|Overall Study|Disease Progression|0|||
33377341|NCT00783432|62756134|FG000|Overall Study|Adverse Event|22|||
33377342|NCT00783432|62756135|FG001|Overall Study|Adverse Event|17|||
33377343|NCT00783432|62756134|FG000|Overall Study|Lack of Efficacy|20|||
33377344|NCT00783432|62756135|FG001|Overall Study|Lack of Efficacy|21|||
33377345|NCT00783432|62756134|FG000|Overall Study|Lost to Follow-up|11|||
33377346|NCT00783432|62756135|FG001|Overall Study|Lost to Follow-up|6|||
33377347|NCT00783432|62756134|FG000|Overall Study|Withdrawal by Subject|23|||
33377348|NCT00783432|62756135|FG001|Overall Study|Withdrawal by Subject|20|||
33377349|NCT00783432|62756134|FG000|Overall Study|subject moved|3|||
33377350|NCT00783432|62756135|FG001|Overall Study|subject moved|5|||
33377351|NCT00783432|62756134|FG000|Overall Study|Protocol Violation|6|||
33291207|NCT01083485|62667649|FG000|Overall Study|Withdrawal by Subject|5|||
33291208|NCT01083485|62667650|FG001|Overall Study|Withdrawal by Subject|2|||
33291209|NCT01083485|62667649|FG000|Overall Study|Other|1|||
33291210|NCT01083485|62667650|FG001|Overall Study|Other|0|||
33291211|NCT01083173|62667658|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
33291212|NCT01083173|62667659|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
33291213|NCT01083173|62667658|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
33377352|NCT00783432|62756135|FG001|Overall Study|Protocol Violation|9|||
33377353|NCT00783198|62756144|FG000|Overall Study|Adverse Event|15|||
33377354|NCT00783198|62756145|FG001|Overall Study|Adverse Event|19|||
33377355|NCT00783198|62756146|FG002|Overall Study|Adverse Event|3|||
33377356|NCT00783198|62756144|FG000|Overall Study|Lost to Follow-up|11|||
33377357|NCT00783198|62756145|FG001|Overall Study|Lost to Follow-up|1|||
33377358|NCT00783198|62756146|FG002|Overall Study|Lost to Follow-up|7|||
33377359|NCT00783198|62756144|FG000|Overall Study|Withdrawal by Subject|22|||
33377360|NCT00783198|62756145|FG001|Overall Study|Withdrawal by Subject|14|||
33377361|NCT00783198|62756146|FG002|Overall Study|Withdrawal by Subject|20|||
33377362|NCT00783198|62756144|FG000|Overall Study|Noncompliance with protocol|7|||
33377363|NCT00783198|62756145|FG001|Overall Study|Noncompliance with protocol|7|||
33377364|NCT00783198|62756146|FG002|Overall Study|Noncompliance with protocol|10|||
33377365|NCT00783198|62756144|FG000|Overall Study|Did not meet protocol eligibility|0|||
33377366|NCT00783198|62756145|FG001|Overall Study|Did not meet protocol eligibility|1|||
33377367|NCT00783198|62756146|FG002|Overall Study|Did not meet protocol eligibility|0|||
33377368|NCT00783198|62756144|FG000|Overall Study|Administrative|2|||
33377369|NCT00783198|62756145|FG001|Overall Study|Administrative|1|||
33377370|NCT00783198|62756146|FG002|Overall Study|Administrative|2|||
33377371|NCT00789360|62756156|FG000|Overall Study|Protocol Violation|3|||
33377372|NCT00789360|62756157|FG001|Overall Study|Protocol Violation|1|||
33377373|NCT00782496|62756166|FG000|Overall Study|Lost to Follow-up|14|||
33377374|NCT00782496|62756167|FG001|Overall Study|Lost to Follow-up|15|||
33377375|NCT00782418|62756174|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
33377376|NCT00782418|62756175|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
33487158|NCT04032171|62865153|FG001|Overall Study|Study Termination|0|||
33487159|NCT00137423|62865161|FG000|Overall Study|Adverse Event|7|||
33487160|NCT00137423|62865162|FG001|Overall Study|Adverse Event|9|||
33487161|NCT00137423|62865161|FG000|Overall Study|consent withdrawn|1|||
33487162|NCT00137423|62865162|FG001|Overall Study|consent withdrawn|1|||
33487163|NCT00137423|62865161|FG000|Overall Study|Lack of Efficacy|31|||
33487164|NCT00137423|62865162|FG001|Overall Study|Lack of Efficacy|33|||
33291214|NCT01083173|62667659|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
33377377|NCT00782418|62756176|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
33377378|NCT00782418|62756177|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
33377379|NCT00782418|62756178|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
33377380|NCT00782418|62756179|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
33377381|NCT00782418|62756180|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
33377382|NCT00782418|62756174|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
33377383|NCT00782418|62756175|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
33377384|NCT00782418|62756176|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
33377385|NCT00782418|62756177|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
33487165|NCT00137423|62865161|FG000|Overall Study|Death|0|||
33377386|NCT00782418|62756178|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
33377387|NCT00782418|62756179|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
33377388|NCT00782418|62756180|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
33377389|NCT00782340|62756197|FG000|Open Label Titration|Adverse Event|12|||
33487166|NCT00137423|62865162|FG001|Overall Study|Death|1|||
33487167|NCT02786836|62865172|FG000|Overall Study|Death|1|||
33487168|NCT02786836|62865172|FG000|Overall Study|Lack of Efficacy|2|||
33377390|NCT00782340|62756198|FG001|Open Label Titration|Adverse Event|0|||
33377391|NCT00782340|62756199|FG002|Open Label Titration|Adverse Event|0|||
33377392|NCT00782340|62756197|FG000|Open Label Titration|Treatment failure|50|||
33487169|NCT02786836|62865172|FG000|Overall Study|Protocol Violation|3|||
33377393|NCT00782340|62756198|FG001|Open Label Titration|Treatment failure|0|||
33377394|NCT00782340|62756199|FG002|Open Label Titration|Treatment failure|0|||
33377395|NCT00782340|62756197|FG000|Open Label Titration|Protocol Violation|5|||
33377396|NCT00782340|62756198|FG001|Open Label Titration|Protocol Violation|0|||
33377397|NCT00782340|62756199|FG002|Open Label Titration|Protocol Violation|0|||
33377398|NCT00782340|62756197|FG000|Open Label Titration|Withdrawal by Subject|5|||
33377399|NCT00782340|62756198|FG001|Open Label Titration|Withdrawal by Subject|0|||
33377400|NCT00782340|62756199|FG002|Open Label Titration|Withdrawal by Subject|0|||
33377401|NCT00782340|62756197|FG000|Open Label Titration|Enrollment capped|16|||
33377402|NCT00782340|62756198|FG001|Open Label Titration|Enrollment capped|0|||
33377403|NCT00782340|62756199|FG002|Open Label Titration|Enrollment capped|0|||
33377404|NCT00782340|62756197|FG000|Open Label Titration|Did not meet responder criteria|2|||
33377405|NCT00782340|62756198|FG001|Open Label Titration|Did not meet responder criteria|0|||
33377406|NCT00782340|62756199|FG002|Open Label Titration|Did not meet responder criteria|0|||
33377407|NCT00782340|62756197|FG000|Open Label Titration|Lost to Follow-up|5|||
33377408|NCT00782340|62756198|FG001|Open Label Titration|Lost to Follow-up|0|||
33377409|NCT00782340|62756199|FG002|Open Label Titration|Lost to Follow-up|0|||
33377410|NCT00782340|62756197|FG000|Open Label Titration|Randomized in error|6|||
33377411|NCT00782340|62756198|FG001|Open Label Titration|Randomized in error|0|||
33377412|NCT00782340|62756199|FG002|Open Label Titration|Randomized in error|0|||
33377413|NCT00774852|62756208|FG000|Overall Study|Adverse Event|9|||
33377414|NCT00774852|62756209|FG001|Overall Study|Adverse Event|6|||
33377415|NCT00774852|62756208|FG000|Overall Study|Death|2|||
33377416|NCT00774852|62756209|FG001|Overall Study|Death|1|||
33377417|NCT00774852|62756208|FG000|Overall Study|Lack of Efficacy|3|||
33377418|NCT00774852|62756209|FG001|Overall Study|Lack of Efficacy|7|||
33377419|NCT00774852|62756208|FG000|Overall Study|Lost to Follow-up|9|||
33377420|NCT00774852|62756209|FG001|Overall Study|Lost to Follow-up|5|||
33377421|NCT00774852|62756208|FG000|Overall Study|Physician Decision|2|||
33377422|NCT00774852|62756209|FG001|Overall Study|Physician Decision|6|||
33377423|NCT00774852|62756208|FG000|Overall Study|Pregnancy|1|||
33377424|NCT00774852|62756209|FG001|Overall Study|Pregnancy|2|||
33377425|NCT00774852|62756208|FG000|Overall Study|Withdrawal by Subject|2|||
33377426|NCT00774852|62756209|FG001|Overall Study|Withdrawal by Subject|2|||
33377427|NCT00774852|62756208|FG000|Overall Study|Non-responder|15|||
33377428|NCT00774852|62756209|FG001|Overall Study|Non-responder|11|||
33377429|NCT00774852|62756208|FG000|Overall Study|Subject non-compliance|0|||
33377430|NCT00774852|62756209|FG001|Overall Study|Subject non-compliance|1|||
33377431|NCT00774852|62756208|FG000|Overall Study|Protocol Violation|1|||
33377432|NCT00774852|62756209|FG001|Overall Study|Protocol Violation|0|||
33377433|NCT00774852|62756208|FG000|Overall Study|Subject received prohibited medication|1|||
33377434|NCT00774852|62756209|FG001|Overall Study|Subject received prohibited medication|0|||
33662380|NCT01695239|63092836|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33291215|NCT01083173|62667658|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
33291216|NCT01083173|62667659|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
33291217|NCT01083173|62667658|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
33291218|NCT01083173|62667659|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
33291219|NCT01083173|62667658|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
33291220|NCT01083173|62667659|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
33291221|NCT01083173|62667658|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
33662381|NCT01695239|63092837|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33662382|NCT01695239|63092838|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33291222|NCT01083173|62667659|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
33291223|NCT01083173|62667658|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
33291224|NCT01083173|62667659|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
33291225|NCT01083173|62667658|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
33291226|NCT01083173|62667659|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
33291227|NCT01083173|62667658|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
33291228|NCT01083173|62667659|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
33291229|NCT01083173|62667658|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
33291230|NCT01083173|62667659|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
33377435|NCT00774306|62756229|FG000|Overall Study|Adverse Event|3|||
33377436|NCT00774306|62756230|FG001|Overall Study|Adverse Event|0|||
33377437|NCT00774306|62756231|FG002|Overall Study|Adverse Event|0|||
33377438|NCT00774306|62756232|FG003|Overall Study|Adverse Event|0|||
33377439|NCT00774306|62756229|FG000|Overall Study|Protocol Violation|2|||
33377440|NCT00774306|62756230|FG001|Overall Study|Protocol Violation|0|||
33377441|NCT00774306|62756231|FG002|Overall Study|Protocol Violation|3|||
33377442|NCT00774306|62756232|FG003|Overall Study|Protocol Violation|0|||
33377443|NCT00774306|62756229|FG000|Overall Study|Withdrawal by Subject|6|||
33377444|NCT00774306|62756230|FG001|Overall Study|Withdrawal by Subject|1|||
33377445|NCT00774306|62756231|FG002|Overall Study|Withdrawal by Subject|1|||
33377446|NCT00774306|62756232|FG003|Overall Study|Withdrawal by Subject|0|||
33377447|NCT00774306|62756229|FG000|Overall Study|Lost to Follow-up|6|||
33377448|NCT00774306|62756230|FG001|Overall Study|Lost to Follow-up|0|||
33377449|NCT00774306|62756231|FG002|Overall Study|Lost to Follow-up|4|||
33377450|NCT00774306|62756232|FG003|Overall Study|Lost to Follow-up|5|||
33377451|NCT00774306|62756229|FG000|Overall Study|Death|1|||
33377452|NCT00774306|62756230|FG001|Overall Study|Death|1|||
33377453|NCT00774306|62756231|FG002|Overall Study|Death|0|||
33377454|NCT00774306|62756232|FG003|Overall Study|Death|0|||
33377455|NCT00781326|62756242|FG000|Phase I|Adverse Event|1|||
33377456|NCT00781326|62756242|FG000|Phase I|Withdrawal by Subject|1|||
33377457|NCT00781326|62756242|FG000|Phase I|Physician Decision|2|||
33377458|NCT00787800|62756248|FG000|Overall Study|Withdrawal by Subject|3|||
33377459|NCT00787800|62756249|FG001|Overall Study|Withdrawal by Subject|5|||
33377460|NCT00787800|62756248|FG000|Overall Study|Death|0|||
33377461|NCT00787800|62756249|FG001|Overall Study|Death|2|||
33377462|NCT00773838|62756256|FG000|Overall Study|Adverse Event|29|||
33291231|NCT01083173|62667658|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
33291232|NCT01083173|62667659|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
33291233|NCT00177294|62667670|FG000|Overall Study|Withdrawal by Subject|7|||
33291234|NCT00177294|62667671|FG001|Overall Study|Withdrawal by Subject|5|||
33291235|NCT01082081|62667680|FG000|Overall Study|Lost to Follow-up|0|||
33291236|NCT01082081|62667681|FG001|Overall Study|Lost to Follow-up|0|||
33291237|NCT01082081|62667682|FG002|Overall Study|Lost to Follow-up|1|||
33291238|NCT01082081|62667680|FG000|Overall Study|Withdrawal by Subject|0|||
33291239|NCT01082081|62667681|FG001|Overall Study|Withdrawal by Subject|0|||
33291240|NCT01082081|62667682|FG002|Overall Study|Withdrawal by Subject|1|||
33291241|NCT01082081|62667680|FG000|Overall Study|Other Reason|0|||
33291242|NCT01082081|62667681|FG001|Overall Study|Other Reason|1|||
33291243|NCT01082081|62667682|FG002|Overall Study|Other Reason|0|||
33291244|NCT00177216|62667693|FG000|Overall Study|Withdrawal by Subject|6|||
33377463|NCT00773838|62756256|FG000|Overall Study|Lost to Follow-up|1|||
33377464|NCT00773838|62756256|FG000|Overall Study|Physician Decision|8|||
33377465|NCT00773838|62756256|FG000|Overall Study|Progressive Disease|82|||
33377466|NCT00773838|62756256|FG000|Overall Study|Protocol Violation|2|||
33377467|NCT00773838|62756256|FG000|Overall Study|Withdrawal by Subject|21|||
33377468|NCT00787644|62756262|FG000|Overall Study|Lost to Follow-up|1|||
33377469|NCT00787644|62756263|FG001|Overall Study|Lost to Follow-up|1|||
33377470|NCT00787644|62756262|FG000|Overall Study|Withdrawal by Subject|1|||
33377471|NCT00787644|62756263|FG001|Overall Study|Withdrawal by Subject|1|||
33377472|NCT00787566|62756272|FG000|Overall Study|AE related to chemotherapy|0|||
33377473|NCT00787566|62756273|FG001|Overall Study|AE related to chemotherapy|1|||
33291245|NCT00177216|62667694|FG001|Overall Study|Withdrawal by Subject|3|||
33291246|NCT00177216|62667695|FG002|Overall Study|Withdrawal by Subject|1|||
33291247|NCT01081886|62667709|FG000|Overall Study|Study termination|11|||
33291248|NCT01081886|62667710|FG001|Overall Study|Study termination|13|||
33291249|NCT01081769|62667718|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
33291250|NCT01081769|62667719|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
33291251|NCT01081769|62667718|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
33291252|NCT01081769|62667719|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
33291253|NCT01081769|62667718|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
33291254|NCT01081769|62667719|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
33291255|NCT01081769|62667718|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
33291256|NCT01081769|62667719|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
33291257|NCT01081769|62667718|FG000|CORE Intent-To-Treat|Adverse Event|14|||
33291258|NCT01081769|62667719|FG001|CORE Intent-To-Treat|Adverse Event|11|||
33291259|NCT01081769|62667718|FG000|CORE Intent-To-Treat|Death|1|||
33291260|NCT01081769|62667719|FG001|CORE Intent-To-Treat|Death|1|||
33291261|NCT01081769|62667718|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
33291262|NCT01081769|62667719|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
33291263|NCT01081769|62667718|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
33291264|NCT01081769|62667719|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
33291265|NCT01081769|62667718|FG000|CORE Intent-To-Treat|Pregnancy|1|||
33291266|NCT01081769|62667719|FG001|CORE Intent-To-Treat|Pregnancy|0|||
33291267|NCT01081769|62667718|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
33377474|NCT00787566|62756274|FG002|Overall Study|AE related to chemotherapy|0|||
33377475|NCT00787254|62756284|FG000|Overall Study|Adverse Event|24|||
33377476|NCT00787254|62756285|FG001|Overall Study|Adverse Event|23|||
33377477|NCT00787254|62756284|FG000|Overall Study|Protocol Violation|26|||
33291268|NCT01081769|62667719|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
33377478|NCT00787254|62756285|FG001|Overall Study|Protocol Violation|23|||
33377479|NCT00787254|62756284|FG000|Overall Study|Withdrawal by Subject|16|||
33377480|NCT00787254|62756285|FG001|Overall Study|Withdrawal by Subject|11|||
33377481|NCT00787254|62756284|FG000|Overall Study|Lack of Efficacy|4|||
33377482|NCT00787254|62756285|FG001|Overall Study|Lack of Efficacy|15|||
33377483|NCT00787254|62756284|FG000|Overall Study|NSAIDs discontinuation|1|||
33377484|NCT00787254|62756285|FG001|Overall Study|NSAIDs discontinuation|2|||
33377485|NCT00787254|62756284|FG000|Overall Study|Institution closed|1|||
33377486|NCT00787254|62756285|FG001|Overall Study|Institution closed|0|||
33377487|NCT00787254|62756284|FG000|Overall Study|Physician Decision|4|||
33377488|NCT00787254|62756285|FG001|Overall Study|Physician Decision|8|||
33377489|NCT00625846|62756295|FG000|Overall Study|Withdrawal by Subject|2|||
33377490|NCT00625846|62756296|FG001|Overall Study|Withdrawal by Subject|0|||
33377491|NCT00625846|62756297|FG002|Overall Study|Withdrawal by Subject|1|||
33377492|NCT00625846|62756298|FG003|Overall Study|Withdrawal by Subject|2|||
33377493|NCT00773292|62756312|FG000|Treatment 48 Weeks|Adverse Event|1|||
33377494|NCT00773292|62756312|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
33377495|NCT00786864|62756318|FG000|Overall Study|Lost to Follow-up|0|||
33377496|NCT00786864|62756319|FG001|Overall Study|Lost to Follow-up|1|||
33377497|NCT00786864|62756318|FG000|Overall Study|Sustained serious back injury|1|||
33377498|NCT00786864|62756319|FG001|Overall Study|Sustained serious back injury|0|||
33377499|NCT00621322|62756331|FG000|Overall Study|Lost to Follow-up|0|||
33377500|NCT00621322|62756332|FG001|Overall Study|Lost to Follow-up|0|||
33377501|NCT00621322|62756333|FG002|Overall Study|Lost to Follow-up|0|||
33377502|NCT00621322|62756334|FG003|Overall Study|Lost to Follow-up|0|||
33377503|NCT00621322|62756335|FG004|Overall Study|Lost to Follow-up|1|||
33377504|NCT00621322|62756336|FG005|Overall Study|Lost to Follow-up|0|||
33377505|NCT00621322|62756331|FG000|Overall Study|Physician Decision|0|||
33377506|NCT00621322|62756332|FG001|Overall Study|Physician Decision|0|||
33377507|NCT00621322|62756333|FG002|Overall Study|Physician Decision|1|||
33291269|NCT01081769|62667718|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
33291270|NCT01081769|62667719|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
33291271|NCT01081769|62667718|FG000|CORE Intent-To-Treat|Other|0|||
33291272|NCT01081769|62667719|FG001|CORE Intent-To-Treat|Other|1|||
33377508|NCT00621322|62756334|FG003|Overall Study|Physician Decision|1|||
33377509|NCT00621322|62756335|FG004|Overall Study|Physician Decision|0|||
33377510|NCT00621322|62756336|FG005|Overall Study|Physician Decision|0|||
33377511|NCT00621322|62756331|FG000|Overall Study|Withdrawal by Subject|0|||
33377512|NCT00621322|62756332|FG001|Overall Study|Withdrawal by Subject|0|||
33377513|NCT00621322|62756333|FG002|Overall Study|Withdrawal by Subject|0|||
33291273|NCT01081769|62667718|FG000|CORE Intent-To-Treat|Ineligibility|3|||
33291274|NCT01081769|62667719|FG001|CORE Intent-To-Treat|Ineligibility|4|||
33291275|NCT01081769|62667718|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
33291276|NCT01081769|62667719|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
33291277|NCT01081769|62667718|FG000|CORE Intent-To-Treat|Patient Moved|2|||
33291278|NCT01081769|62667719|FG001|CORE Intent-To-Treat|Patient Moved|2|||
33291279|NCT01081301|62667725|FG000|Overall Study|Bereaved|3|||
33291280|NCT01081301|62667725|FG000|Overall Study|Too busy|5|||
33291281|NCT01081301|62667725|FG000|Overall Study|Patient too ill|2|||
33291282|NCT01081301|62667725|FG000|Overall Study|Lost to Follow-up|4|||
33291283|NCT00174954|62667746|FG000|Overall Study|Adverse Event|2|||
33291284|NCT00174954|62667746|FG000|Overall Study|No tophi found in MRI|1|||
33291285|NCT00174954|62667746|FG000|Overall Study|Physician Decision|1|||
33291286|NCT01081145|62667750|FG000|Open-Label Phase|Lack of Efficacy|56|||
33291287|NCT01081145|62667751|FG001|Open-Label Phase|Lack of Efficacy|0|||
33291288|NCT01081145|62667750|FG000|Open-Label Phase|Response criteria not met|46|||
33291289|NCT01081145|62667751|FG001|Open-Label Phase|Response criteria not met|0|||
33291290|NCT01081145|62667750|FG000|Open-Label Phase|Adverse Event|42|||
33291291|NCT01081145|62667751|FG001|Open-Label Phase|Adverse Event|0|||
33291292|NCT01081145|62667750|FG000|Open-Label Phase|Withdrawal by Subject|41|||
33291293|NCT01081145|62667751|FG001|Open-Label Phase|Withdrawal by Subject|0|||
33291294|NCT01081145|62667750|FG000|Open-Label Phase|Other|12|||
33291295|NCT01081145|62667751|FG001|Open-Label Phase|Other|0|||
33291296|NCT01081145|62667750|FG000|Open-Label Phase|Lost to Follow-up|11|||
33291297|NCT01081145|62667751|FG001|Open-Label Phase|Lost to Follow-up|0|||
33291298|NCT01081145|62667750|FG000|Open-Label Phase|Protocol Violation|4|||
33291299|NCT01081145|62667751|FG001|Open-Label Phase|Protocol Violation|0|||
33291300|NCT01081145|62667750|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
33377514|NCT00621322|62756334|FG003|Overall Study|Withdrawal by Subject|1|||
33377515|NCT00621322|62756335|FG004|Overall Study|Withdrawal by Subject|0|||
33377516|NCT00621322|62756336|FG005|Overall Study|Withdrawal by Subject|2|||
33377517|NCT00621322|62756331|FG000|Overall Study|Migrated/moved from study area|1|||
33377518|NCT00621322|62756332|FG001|Overall Study|Migrated/moved from study area|0|||
33556566|NCT01369355|62949449|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
33291301|NCT01081145|62667751|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
33556567|NCT01369355|62949450|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
33291302|NCT01081145|62667750|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
33377519|NCT00621322|62756333|FG002|Overall Study|Migrated/moved from study area|1|||
33377520|NCT00621322|62756334|FG003|Overall Study|Migrated/moved from study area|1|||
33291303|NCT01081145|62667751|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
33377521|NCT00621322|62756335|FG004|Overall Study|Migrated/moved from study area|0|||
33291304|NCT01081145|62667750|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
33291305|NCT01081145|62667751|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
33291306|NCT01081145|62667750|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
33291307|NCT01081145|62667751|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
33291308|NCT01081145|62667750|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
33291309|NCT01081145|62667751|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
33291310|NCT01081145|62667750|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
33291311|NCT01081145|62667751|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
33291312|NCT01081145|62667750|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
33291313|NCT01081145|62667751|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
33291314|NCT00174915|62667764|FG000|Overall Study|Lost to Follow-up|19|||
33291315|NCT00174915|62667765|FG001|Overall Study|Lost to Follow-up|17|||
33291316|NCT00174915|62667766|FG002|Overall Study|Lost to Follow-up|9|||
33291317|NCT00174915|62667767|FG003|Overall Study|Lost to Follow-up|17|||
33291318|NCT00174915|62667768|FG004|Overall Study|Lost to Follow-up|10|||
33291319|NCT00174915|62667764|FG000|Overall Study|Adverse Event|18|||
33291320|NCT00174915|62667765|FG001|Overall Study|Adverse Event|16|||
33291321|NCT00174915|62667766|FG002|Overall Study|Adverse Event|11|||
33291322|NCT00174915|62667767|FG003|Overall Study|Adverse Event|18|||
33291323|NCT00174915|62667768|FG004|Overall Study|Adverse Event|5|||
33291324|NCT00174915|62667764|FG000|Overall Study|Personal Reason(s)|16|||
33291325|NCT00174915|62667765|FG001|Overall Study|Personal Reason(s)|16|||
33291326|NCT00174915|62667766|FG002|Overall Study|Personal Reason(s)|9|||
33291327|NCT00174915|62667767|FG003|Overall Study|Personal Reason(s)|9|||
33291328|NCT00174915|62667768|FG004|Overall Study|Personal Reason(s)|9|||
33291329|NCT00174915|62667764|FG000|Overall Study|Other|15|||
33291330|NCT00174915|62667765|FG001|Overall Study|Other|8|||
33291331|NCT00174915|62667766|FG002|Overall Study|Other|6|||
33291332|NCT00174915|62667767|FG003|Overall Study|Other|5|||
33291333|NCT00174915|62667768|FG004|Overall Study|Other|3|||
33291334|NCT00174915|62667764|FG000|Overall Study|Gout Flare|13|||
33291335|NCT00174915|62667765|FG001|Overall Study|Gout Flare|6|||
33291336|NCT00174915|62667766|FG002|Overall Study|Gout Flare|8|||
33291337|NCT00174915|62667767|FG003|Overall Study|Gout Flare|1|||
33291338|NCT00174915|62667768|FG004|Overall Study|Gout Flare|0|||
33291339|NCT00174915|62667764|FG000|Overall Study|Protocol Violation|6|||
33291340|NCT00174915|62667765|FG001|Overall Study|Protocol Violation|3|||
33291341|NCT00174915|62667766|FG002|Overall Study|Protocol Violation|3|||
33291342|NCT00174915|62667767|FG003|Overall Study|Protocol Violation|6|||
33291343|NCT00174915|62667768|FG004|Overall Study|Protocol Violation|3|||
33291344|NCT00174915|62667764|FG000|Overall Study|Therapeutic Failure|6|||
33291345|NCT00174915|62667765|FG001|Overall Study|Therapeutic Failure|3|||
33291346|NCT00174915|62667766|FG002|Overall Study|Therapeutic Failure|2|||
33291347|NCT00174915|62667767|FG003|Overall Study|Therapeutic Failure|1|||
33291348|NCT00174915|62667768|FG004|Overall Study|Therapeutic Failure|3|||
33291349|NCT01080716|62667784|FG000|Part 1|Physician Decision|1|||
33291350|NCT01080716|62667785|FG001|Part 1|Physician Decision|0|||
33291351|NCT01080716|62667786|FG002|Part 1|Physician Decision|0|||
33291352|NCT01080716|62667787|FG003|Part 1|Physician Decision|0|||
33291353|NCT00172185|62667805|FG000|Overall Study|Adverse Event|0|||
33291354|NCT00172185|62667806|FG001|Overall Study|Adverse Event|1|||
33291355|NCT00172185|62667807|FG002|Overall Study|Adverse Event|3|||
33291356|NCT00172185|62667808|FG003|Overall Study|Adverse Event|4|||
33291357|NCT00172185|62667805|FG000|Overall Study|Physician Decision|0|||
33291358|NCT00172185|62667806|FG001|Overall Study|Physician Decision|0|||
33291359|NCT00172185|62667807|FG002|Overall Study|Physician Decision|1|||
33291360|NCT00172185|62667808|FG003|Overall Study|Physician Decision|0|||
33291361|NCT00172185|62667805|FG000|Overall Study|SPONSOR Decision|0|||
33377522|NCT00621322|62756336|FG005|Overall Study|Migrated/moved from study area|2|||
33377523|NCT00853385|62756355|FG000|Overall Study|Death|0|||
33377524|NCT00853385|62756356|FG001|Overall Study|Death|0|||
33487170|NCT02786836|62865172|FG000|Overall Study|Withdrawal by Subject|3|||
33487171|NCT02786836|62865172|FG000|Overall Study|Liver Transplantation|2|||
33487172|NCT02786836|62865172|FG000|Overall Study|Device or Pharmacy Issues|3|||
33291362|NCT00172185|62667806|FG001|Overall Study|SPONSOR Decision|1|||
33487173|NCT00137267|62865179|FG000|Overall Study|Lost to Follow-up|15|||
33291363|NCT00172185|62667807|FG002|Overall Study|SPONSOR Decision|0|||
33291364|NCT00172185|62667808|FG003|Overall Study|SPONSOR Decision|0|||
33291365|NCT00172185|62667805|FG000|Overall Study|Withdrawal by Subject|0|||
33377525|NCT00853385|62756357|FG002|Overall Study|Death|0|||
33291366|NCT00172185|62667806|FG001|Overall Study|Withdrawal by Subject|0|||
33291367|NCT00172185|62667807|FG002|Overall Study|Withdrawal by Subject|1|||
33291368|NCT00172185|62667808|FG003|Overall Study|Withdrawal by Subject|0|||
33291369|NCT01080326|62667822|FG000|Overall Study|Patient deterioration prior to procedure|3|||
33291370|NCT01080326|62667822|FG000|Overall Study|Surgeon decision|1|||
33291371|NCT00171951|62667826|FG000|Overall Study|Adverse Event|1|||
33291372|NCT00171951|62667826|FG000|Overall Study|Abnormal Laboratory Values|2|||
33291373|NCT00171951|62667826|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
33377526|NCT00853385|62756358|FG003|Overall Study|Death|0|||
33377527|NCT00853385|62756359|FG004|Overall Study|Death|1|||
33377528|NCT00853385|62756355|FG000|Overall Study|Adverse Event|24|||
33377529|NCT00853385|62756356|FG001|Overall Study|Adverse Event|24|||
33377530|NCT00853385|62756357|FG002|Overall Study|Adverse Event|2|||
33377531|NCT00853385|62756358|FG003|Overall Study|Adverse Event|5|||
33377532|NCT00853385|62756359|FG004|Overall Study|Adverse Event|22|||
33377533|NCT00853385|62756355|FG000|Overall Study|Lack of Efficacy|6|||
33377534|NCT00853385|62756356|FG001|Overall Study|Lack of Efficacy|7|||
33377535|NCT00853385|62756357|FG002|Overall Study|Lack of Efficacy|3|||
33377536|NCT00853385|62756358|FG003|Overall Study|Lack of Efficacy|3|||
33377537|NCT00853385|62756359|FG004|Overall Study|Lack of Efficacy|6|||
33377538|NCT00853385|62756355|FG000|Overall Study|Lost to Follow-up|2|||
33377539|NCT00853385|62756356|FG001|Overall Study|Lost to Follow-up|1|||
33377540|NCT00853385|62756357|FG002|Overall Study|Lost to Follow-up|0|||
33377541|NCT00853385|62756358|FG003|Overall Study|Lost to Follow-up|0|||
33377542|NCT00853385|62756359|FG004|Overall Study|Lost to Follow-up|0|||
33377543|NCT00853385|62756355|FG000|Overall Study|Withdrawal by Subject|4|||
33377544|NCT00853385|62756356|FG001|Overall Study|Withdrawal by Subject|2|||
33377545|NCT00853385|62756357|FG002|Overall Study|Withdrawal by Subject|0|||
33377546|NCT00853385|62756358|FG003|Overall Study|Withdrawal by Subject|1|||
33377547|NCT00853385|62756359|FG004|Overall Study|Withdrawal by Subject|1|||
33377548|NCT00853385|62756355|FG000|Overall Study|Other|18|||
33377549|NCT00853385|62756356|FG001|Overall Study|Other|9|||
33377550|NCT00853385|62756357|FG002|Overall Study|Other|4|||
33377551|NCT00853385|62756358|FG003|Overall Study|Other|4|||
33556568|NCT01369355|62949451|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
33556569|NCT01369355|62949452|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
33291374|NCT00171951|62667826|FG000|Overall Study|Participants Withdrew Consent|3|||
33291375|NCT00171951|62667826|FG000|Overall Study|New Cancer Therapy|5|||
33291376|NCT00171951|62667826|FG000|Overall Study|Reason not Specified|2|||
33291377|NCT01080131|62667835|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
33291378|NCT01080131|62667836|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
33291379|NCT01080131|62667835|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
33291380|NCT01080131|62667836|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
33291381|NCT01080131|62667835|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
33291382|NCT01080131|62667836|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
33291383|NCT01080131|62667835|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
33291384|NCT01080131|62667836|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
33291385|NCT01080131|62667835|FG000|Core Study (0- 12 Weeks)|Death|1|||
33291386|NCT01080131|62667836|FG001|Core Study (0- 12 Weeks)|Death|0|||
33291387|NCT01080131|62667835|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
33291388|NCT01080131|62667836|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
33291389|NCT01080131|62667835|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
33291390|NCT01080131|62667836|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
33291391|NCT01080131|62667835|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
33291392|NCT01080131|62667836|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
33291393|NCT01080131|62667835|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
33291394|NCT01080131|62667836|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
33291395|NCT01080131|62667835|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
33291396|NCT01080131|62667836|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
33291397|NCT01080131|62667835|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
33291398|NCT01080131|62667836|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
33291399|NCT01080131|62667835|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
33291400|NCT01080131|62667836|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
33291401|NCT01080131|62667835|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
33291402|NCT01080131|62667836|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
33291403|NCT00171873|62667862|FG000|Overall Study|Withdrawal by Subject|4|||
33291404|NCT00171873|62667863|FG001|Overall Study|Withdrawal by Subject|2|||
33291405|NCT00171873|62667862|FG000|Overall Study|Adverse Event|5|||
33291406|NCT00171873|62667863|FG001|Overall Study|Adverse Event|0|||
33291407|NCT00171873|62667862|FG000|Overall Study|Switched to Octreotide|0|||
33291408|NCT00171873|62667863|FG001|Overall Study|Switched to Octreotide|1|||
33291409|NCT00171834|62667876|FG000|Overall Study|Adverse Event|2|||
33291410|NCT00171834|62667877|FG001|Overall Study|Adverse Event|1|||
33291411|NCT00171834|62667878|FG002|Overall Study|Adverse Event|3|||
33291412|NCT00171834|62667879|FG003|Overall Study|Adverse Event|2|||
33291413|NCT00171834|62667880|FG004|Overall Study|Adverse Event|2|||
33377552|NCT00853385|62756359|FG004|Overall Study|Other|12|||
33377553|NCT00622336|62756381|FG000|Treatment Phase|Progression of Disease|181|||
33377554|NCT00622336|62756381|FG000|Treatment Phase|Adverse Event|46|||
33291414|NCT00171834|62667881|FG005|Overall Study|Adverse Event|15|||
33291415|NCT00171834|62667882|FG006|Overall Study|Adverse Event|1|||
33291416|NCT00171834|62667876|FG000|Overall Study|Withdrawal by Subject|0|||
33377555|NCT00622336|62756381|FG000|Treatment Phase|Other|40|||
33377556|NCT00622336|62756381|FG000|Treatment Phase|Death|14|||
33377557|NCT00622336|62756381|FG000|Treatment Phase|Lack of therapeutic effect|13|||
33377558|NCT00622336|62756381|FG000|Treatment Phase|Withdrawal by Subject|13|||
33377559|NCT00622336|62756381|FG000|Treatment Phase|Lost to Follow-up|2|||
33377560|NCT00622336|62756381|FG000|Extension Phase|Adverse Event|2|||
33377561|NCT00622336|62756381|FG000|Extension Phase|Progressive Disease|6|||
33377562|NCT00622336|62756381|FG000|Extension Phase|Lack of therapeutic effect|2|||
33377563|NCT00622336|62756381|FG000|Extension Phase|Withdrawal by Subject|1|||
33377564|NCT00622336|62756381|FG000|Extension Phase|Lost to Follow-up|1|||
33377565|NCT00622336|62756381|FG000|Extension Phase|Other|9|||
33377566|NCT00779766|62756389|FG000|Month 24|Serious Adverse Event|2|||
33377567|NCT00779766|62756390|FG001|Month 24|Serious Adverse Event|3|||
33377568|NCT00779766|62756389|FG000|Month 24|Adverse Event|3|||
33377569|NCT00779766|62756390|FG001|Month 24|Adverse Event|3|||
33377570|NCT00779766|62756389|FG000|Month 24|Protocol Violation|3|||
33377571|NCT00779766|62756390|FG001|Month 24|Protocol Violation|1|||
33377572|NCT00779766|62756389|FG000|Month 24|Withdrawal by Subject|159|||
33377573|NCT00779766|62756390|FG001|Month 24|Withdrawal by Subject|127|||
33377574|NCT00779766|62756389|FG000|Month 24|Migrated/moved from study area|138|||
33377575|NCT00779766|62756390|FG001|Month 24|Migrated/moved from study area|162|||
33377576|NCT00779766|62756389|FG000|Month 24|Lost to Follow-up|9|||
33377577|NCT00779766|62756390|FG001|Month 24|Lost to Follow-up|9|||
33377578|NCT00779766|62756389|FG000|Month 24|Other|18|||
33377579|NCT00779766|62756390|FG001|Month 24|Other|27|||
33377580|NCT00779766|62756389|FG000|Month 48|Withdrawal by Subject|68|||
33377581|NCT00779766|62756390|FG001|Month 48|Withdrawal by Subject|63|||
33291417|NCT00171834|62667877|FG001|Overall Study|Withdrawal by Subject|2|||
33291418|NCT00171834|62667878|FG002|Overall Study|Withdrawal by Subject|0|||
33291419|NCT00171834|62667879|FG003|Overall Study|Withdrawal by Subject|1|||
33291420|NCT00171834|62667880|FG004|Overall Study|Withdrawal by Subject|1|||
33291421|NCT00171834|62667881|FG005|Overall Study|Withdrawal by Subject|1|||
33291422|NCT00171834|62667882|FG006|Overall Study|Withdrawal by Subject|0|||
33377582|NCT00779766|62756389|FG000|Month 48|Migrated/moved from study area|76|||
33377583|NCT00779766|62756390|FG001|Month 48|Migrated/moved from study area|75|||
33377584|NCT00779766|62756389|FG000|Month 48|Lost to Follow-up|29|||
33377585|NCT00779766|62756390|FG001|Month 48|Lost to Follow-up|30|||
33377586|NCT00779766|62756389|FG000|Month 48|Other|1|||
33377587|NCT00779766|62756390|FG001|Month 48|Other|0|||
33487174|NCT00137267|62865180|FG001|Overall Study|Lost to Follow-up|21|||
33487175|NCT00137111|62865190|FG000|Total Therapy|Death|35|||
33487176|NCT00137111|62865191|FG001|Total Therapy|Death|0|||
33487177|NCT00137111|62865192|FG002|Total Therapy|Death|0|||
33556570|NCT01369355|62949453|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
33291423|NCT00171834|62667876|FG000|Overall Study|Death from study indication|0|||
33291424|NCT00171834|62667877|FG001|Overall Study|Death from study indication|1|||
33291425|NCT00171834|62667878|FG002|Overall Study|Death from study indication|0|||
33291426|NCT00171834|62667879|FG003|Overall Study|Death from study indication|0|||
33291427|NCT00171834|62667880|FG004|Overall Study|Death from study indication|1|||
33291428|NCT00171834|62667881|FG005|Overall Study|Death from study indication|0|||
33291429|NCT00171834|62667882|FG006|Overall Study|Death from study indication|0|||
33291430|NCT00171834|62667876|FG000|Overall Study|Disease Progression|4|||
33291431|NCT00171834|62667877|FG001|Overall Study|Disease Progression|8|||
33291432|NCT00171834|62667878|FG002|Overall Study|Disease Progression|8|||
33291433|NCT00171834|62667879|FG003|Overall Study|Disease Progression|9|||
33291434|NCT00171834|62667880|FG004|Overall Study|Disease Progression|2|||
33291435|NCT00171834|62667881|FG005|Overall Study|Disease Progression|18|||
33291436|NCT00171834|62667882|FG006|Overall Study|Disease Progression|3|||
33291437|NCT00171834|62667876|FG000|Overall Study|Treatment Duration Completed|0|||
33291438|NCT00171834|62667877|FG001|Overall Study|Treatment Duration Completed|0|||
33291439|NCT00171834|62667878|FG002|Overall Study|Treatment Duration Completed|1|||
33291440|NCT00171834|62667879|FG003|Overall Study|Treatment Duration Completed|0|||
33291441|NCT00171834|62667880|FG004|Overall Study|Treatment Duration Completed|2|||
33291442|NCT00171834|62667881|FG005|Overall Study|Treatment Duration Completed|1|||
33377588|NCT00779766|62756389|FG000|Month 72|Withdrawal by Subject|55|||
33377589|NCT00779766|62756390|FG001|Month 72|Withdrawal by Subject|71|||
33377590|NCT00779766|62756389|FG000|Month 72|Migrated/moved from study area|124|||
33377591|NCT00779766|62756390|FG001|Month 72|Migrated/moved from study area|109|||
33377592|NCT00779766|62756389|FG000|Month 72|Lost to Follow-up|6|||
33377593|NCT00779766|62756390|FG001|Month 72|Lost to Follow-up|8|||
33377594|NCT00779766|62756389|FG000|Month 72|Other|0|||
33377595|NCT00779766|62756390|FG001|Month 72|Other|1|||
33377596|NCT00846365|62756400|FG000|Overall Study|Adverse Event|20|||
33487178|NCT00137111|62865193|FG003|Total Therapy|Death|0|||
33291443|NCT00171834|62667882|FG006|Overall Study|Treatment Duration Completed|0|||
33291444|NCT00171249|62667912|FG000|Overall Study|Withdrawal by Subject|2|||
33291445|NCT00171249|62667913|FG001|Overall Study|Withdrawal by Subject|0|||
33291446|NCT00171249|62667914|FG002|Overall Study|Withdrawal by Subject|0|||
33377597|NCT00846365|62756401|FG001|Overall Study|Adverse Event|30|||
33377598|NCT00846365|62756402|FG002|Overall Study|Adverse Event|11|||
33487179|NCT00137111|62865190|FG000|Total Therapy|Non Compliance|5|||
33291447|NCT00171249|62667915|FG003|Overall Study|Withdrawal by Subject|6|||
33291448|NCT00171249|62667916|FG004|Overall Study|Withdrawal by Subject|0|||
33291449|NCT00171249|62667917|FG005|Overall Study|Withdrawal by Subject|0|||
33291450|NCT00171249|62667918|FG006|Overall Study|Withdrawal by Subject|0|||
33291451|NCT00171249|62667912|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
33291452|NCT00171249|62667913|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
33291453|NCT00171249|62667914|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
33291454|NCT00171249|62667915|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
33291455|NCT00171249|62667916|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
33291456|NCT00171249|62667917|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
33291457|NCT00171249|62667918|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
33291458|NCT00171249|62667912|FG000|Overall Study|Death|7|||
33291459|NCT00171249|62667913|FG001|Overall Study|Death|1|||
33291460|NCT00171249|62667914|FG002|Overall Study|Death|0|||
33291461|NCT00171249|62667915|FG003|Overall Study|Death|4|||
33291462|NCT00171249|62667916|FG004|Overall Study|Death|0|||
33291463|NCT00171249|62667917|FG005|Overall Study|Death|3|||
33556571|NCT01369355|62949454|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
33556572|NCT01369355|62949446|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
33291464|NCT00171249|62667918|FG006|Overall Study|Death|1|||
33291465|NCT00171249|62667912|FG000|Overall Study|Other|10|||
33291466|NCT00171249|62667913|FG001|Overall Study|Other|0|||
33291467|NCT00171249|62667914|FG002|Overall Study|Other|0|||
33291468|NCT00171249|62667915|FG003|Overall Study|Other|43|||
33377599|NCT00846365|62756400|FG000|Overall Study|Protocol Violation|5|||
33377600|NCT00846365|62756401|FG001|Overall Study|Protocol Violation|4|||
33377601|NCT00846365|62756402|FG002|Overall Study|Protocol Violation|0|||
33377602|NCT00846365|62756400|FG000|Overall Study|Lost to Follow-up|8|||
33377603|NCT00846365|62756401|FG001|Overall Study|Lost to Follow-up|2|||
33377604|NCT00846365|62756402|FG002|Overall Study|Lost to Follow-up|5|||
33377605|NCT00846365|62756400|FG000|Overall Study|Withdrawal by Subject|11|||
33377606|NCT00846365|62756401|FG001|Overall Study|Withdrawal by Subject|11|||
33377607|NCT00846365|62756402|FG002|Overall Study|Withdrawal by Subject|9|||
33377608|NCT00846365|62756400|FG000|Overall Study|Pregnancy|1|||
33377609|NCT00846365|62756401|FG001|Overall Study|Pregnancy|0|||
33487180|NCT00137111|62865191|FG001|Total Therapy|Non Compliance|0|||
33487181|NCT00137111|62865192|FG002|Total Therapy|Non Compliance|0|||
33487182|NCT00137111|62865193|FG003|Total Therapy|Non Compliance|0|||
33487183|NCT00136955|62865200|FG000|Overall Study|Adverse Event|8|||
33487184|NCT00136955|62865200|FG000|Overall Study|Lost to Follow-up|1|||
33487185|NCT00136955|62865200|FG000|Overall Study|Withdrawal by Subject|2|||
33487186|NCT00136955|62865200|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
33487187|NCT00135707|62865206|FG000|Overall Study|Lost to Follow-up|94|||
33487188|NCT00135707|62865207|FG001|Overall Study|Lost to Follow-up|89|||
33487189|NCT00135707|62865206|FG000|Overall Study|Withdrawal by Subject|0|||
33487190|NCT00135707|62865207|FG001|Overall Study|Withdrawal by Subject|1|||
33487191|NCT00135707|62865206|FG000|Overall Study|Institutional review board request|1|||
33487192|NCT00135707|62865207|FG001|Overall Study|Institutional review board request|0|||
33487193|NCT00129701|62865217|FG000|Overall Study|Withdrawal by Subject|33|||
33487194|NCT00129623|62865226|FG000|Overall Study|Adverse Event|3|||
33487195|NCT00129623|62865227|FG001|Overall Study|Adverse Event|7|||
33487196|NCT00129623|62865226|FG000|Overall Study|Refused Treatment|5|||
33487197|NCT00129623|62865227|FG001|Overall Study|Refused Treatment|3|||
33487198|NCT00129623|62865226|FG000|Overall Study|Failure to Return|1|||
33487199|NCT00129623|62865227|FG001|Overall Study|Failure to Return|1|||
33556573|NCT01369355|62949447|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
33556574|NCT01369355|62949448|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
33556575|NCT01369355|62949449|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
33556576|NCT01369355|62949450|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
33556577|NCT01369355|62949451|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
33556578|NCT01369355|62949452|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
33377610|NCT00846365|62756402|FG002|Overall Study|Pregnancy|0|||
33487200|NCT00129623|62865226|FG000|Overall Study|Relocated job out of state|1|||
33487201|NCT00129623|62865227|FG001|Overall Study|Relocated job out of state|0|||
33487202|NCT00129623|62865226|FG000|Overall Study|Uncertainty to return|0|||
33487203|NCT00129623|62865227|FG001|Overall Study|Uncertainty to return|1|||
33487204|NCT00129545|62865238|FG000|Overall Study|Death|5|||
33487205|NCT00129545|62865239|FG001|Overall Study|Death|60|||
33291469|NCT00171249|62667916|FG004|Overall Study|Other|0|||
33291470|NCT00171249|62667917|FG005|Overall Study|Other|2|||
33291471|NCT00171249|62667918|FG006|Overall Study|Other|0|||
33291472|NCT00171249|62667912|FG000|Overall Study|No Longer Requires Study Drug|4|||
33377611|NCT00846365|62756400|FG000|Overall Study|Lack of Efficacy|1|||
33377612|NCT00846365|62756401|FG001|Overall Study|Lack of Efficacy|1|||
33487206|NCT00129545|62865240|FG002|Overall Study|Death|44|||
33487207|NCT00129545|62865238|FG000|Overall Study|Withdrawal by Subject|3|||
33487208|NCT00129545|62865239|FG001|Overall Study|Withdrawal by Subject|18|||
33487209|NCT00129545|62865240|FG002|Overall Study|Withdrawal by Subject|44|||
33377613|NCT00846365|62756402|FG002|Overall Study|Lack of Efficacy|2|||
33377614|NCT00846365|62756400|FG000|Overall Study|Other|9|||
33377615|NCT00846365|62756401|FG001|Overall Study|Other|1|||
33377616|NCT00846365|62756402|FG002|Overall Study|Other|6|||
33377617|NCT00779142|62756410|FG000|Overall Study|Screen Failures|3|||
33377618|NCT00622180|62756415|FG000|Overall Study|Lost to Follow-up|1|||
33377619|NCT00622180|62756416|FG001|Overall Study|Lost to Follow-up|2|||
33377620|NCT00773136|62756422|FG000|Overall Study|Physician Decision|2|||
33377621|NCT00853307|62756429|FG000|Overall Study|Adverse Event|1|||
33377622|NCT00853307|62756430|FG001|Overall Study|Adverse Event|2|||
33377623|NCT00853307|62756429|FG000|Overall Study|Withdrawal by Subject|1|||
33377624|NCT00853307|62756430|FG001|Overall Study|Withdrawal by Subject|2|||
33377625|NCT00853307|62756429|FG000|Overall Study|Reason Not Specified|0|||
33377626|NCT00853307|62756430|FG001|Overall Study|Reason Not Specified|1|||
33377627|NCT00778830|62756438|FG000|Overall Study|Ongoing at data cut-off|0|||
33377628|NCT00778830|62756439|FG001|Overall Study|Ongoing at data cut-off|1|||
33377629|NCT00772668|62756445|FG000|Overall Study|Physician Decision|3|||
33291473|NCT00171249|62667913|FG001|Overall Study|No Longer Requires Study Drug|0|||
33291474|NCT00171249|62667914|FG002|Overall Study|No Longer Requires Study Drug|0|||
33291475|NCT00171249|62667915|FG003|Overall Study|No Longer Requires Study Drug|3|||
33291476|NCT00171249|62667916|FG004|Overall Study|No Longer Requires Study Drug|0|||
33377630|NCT00786474|62756452|FG000|Overall Study|Death|5|||
33377631|NCT00786474|62756453|FG001|Overall Study|Death|4|||
33377632|NCT00786474|62756452|FG000|Overall Study|Withdrawal by Subject|23|||
33487210|NCT00129545|62865238|FG000|Overall Study|Lost to Follow-up|2|||
33487211|NCT00129545|62865239|FG001|Overall Study|Lost to Follow-up|22|||
33487212|NCT00129545|62865240|FG002|Overall Study|Lost to Follow-up|13|||
33487213|NCT00129545|62865238|FG000|Overall Study|Physician Decision|0|||
33487214|NCT00129545|62865239|FG001|Overall Study|Physician Decision|3|||
33487215|NCT00129545|62865240|FG002|Overall Study|Physician Decision|10|||
33487216|NCT00129545|62865238|FG000|Overall Study|Device not implanted|16|||
33487217|NCT00129545|62865239|FG001|Overall Study|Device not implanted|61|||
33487218|NCT00129545|62865240|FG002|Overall Study|Device not implanted|0|||
33487219|NCT00129467|62865250|FG000|Received Intervention|Death|1|||
33487220|NCT00129467|62865251|FG001|Received Intervention|Death|1|||
33487221|NCT00129467|62865250|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
33487222|NCT00129467|62865251|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
33487223|NCT00129467|62865250|FG000|Received Intervention|Delirium|2|||
33487224|NCT00129467|62865251|FG001|Received Intervention|Delirium|0|||
33487225|NCT00129467|62865250|FG000|Received Intervention|Withdrawal by Subject|1|||
33487226|NCT00129467|62865251|FG001|Received Intervention|Withdrawal by Subject|0|||
33487227|NCT00129467|62865250|FG000|Received Intervention|Nausea|1|||
33487228|NCT00129467|62865251|FG001|Received Intervention|Nausea|0|||
33487229|NCT00129467|62865250|FG000|Received Intervention|Intolerance to citalopram|0|||
33487230|NCT00129467|62865251|FG001|Received Intervention|Intolerance to citalopram|1|||
33487231|NCT00129467|62865250|FG000|Received Intervention|Dizzyness, fatigue|0|||
33487232|NCT00129467|62865251|FG001|Received Intervention|Dizzyness, fatigue|1|||
33487233|NCT00129467|62865250|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
33487234|NCT00129467|62865251|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
33662383|NCT01695239|63092839|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33662384|NCT01695239|63092840|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33291477|NCT00171249|62667917|FG005|Overall Study|No Longer Requires Study Drug|5|||
33291478|NCT00171249|62667918|FG006|Overall Study|No Longer Requires Study Drug|0|||
33291479|NCT00171249|62667912|FG000|Overall Study|Administrative Problems|1|||
33291480|NCT00171249|62667913|FG001|Overall Study|Administrative Problems|0|||
33291481|NCT00171249|62667914|FG002|Overall Study|Administrative Problems|0|||
33291482|NCT00171249|62667915|FG003|Overall Study|Administrative Problems|2|||
33291483|NCT00171249|62667916|FG004|Overall Study|Administrative Problems|0|||
33377633|NCT00786474|62756453|FG001|Overall Study|Withdrawal by Subject|31|||
33377634|NCT00786474|62756452|FG000|Overall Study|Lost to Follow-up|3|||
33377635|NCT00786474|62756453|FG001|Overall Study|Lost to Follow-up|3|||
33377636|NCT00786474|62756452|FG000|Overall Study|Physician Decision|2|||
33377637|NCT00786474|62756453|FG001|Overall Study|Physician Decision|1|||
33377638|NCT00786474|62756452|FG000|Overall Study|Other|4|||
33487235|NCT00129467|62865250|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
33487236|NCT00129467|62865251|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
33487237|NCT00129311|62865259|FG000|Overall Study|Withdrawal by Subject|12|||
33487238|NCT00129311|62865260|FG001|Overall Study|Withdrawal by Subject|19|||
33487239|NCT00133991|62865266|FG000|Overall Study|Death|4|||
33487240|NCT02784106|62865272|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
33487241|NCT02784106|62865273|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
33487242|NCT02784106|62865274|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
33487243|NCT02784106|62865275|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
33377639|NCT00786474|62756453|FG001|Overall Study|Other|4|||
33487244|NCT02784106|62865272|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
33377640|NCT00784875|62756463|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
33377641|NCT00784875|62756464|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
33377642|NCT00784875|62756465|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
33377643|NCT00784875|62756466|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
33377644|NCT00784875|62756463|FG000|Period A - Baseline|Adverse Event|0|||
33377645|NCT00784875|62756464|FG001|Period A - Baseline|Adverse Event|0|||
33377646|NCT00784875|62756465|FG002|Period A - Baseline|Adverse Event|0|||
33377647|NCT00784875|62756466|FG003|Period A - Baseline|Adverse Event|8|||
33377648|NCT00784875|62756463|FG000|Period A - Baseline|Protocol Violation|0|||
33377649|NCT00784875|62756464|FG001|Period A - Baseline|Protocol Violation|0|||
33377650|NCT00784875|62756465|FG002|Period A - Baseline|Protocol Violation|0|||
33377651|NCT00784875|62756466|FG003|Period A - Baseline|Protocol Violation|25|||
33377652|NCT00784875|62756463|FG000|Period A - Baseline|Withdrawal by Subject|0|||
33377653|NCT00784875|62756464|FG001|Period A - Baseline|Withdrawal by Subject|0|||
33377654|NCT00784875|62756465|FG002|Period A - Baseline|Withdrawal by Subject|0|||
33377655|NCT00784875|62756466|FG003|Period A - Baseline|Withdrawal by Subject|27|||
33377656|NCT00784875|62756463|FG000|Period A - Baseline|Physician Decision|0|||
33377657|NCT00784875|62756464|FG001|Period A - Baseline|Physician Decision|0|||
33377658|NCT00784875|62756465|FG002|Period A - Baseline|Physician Decision|0|||
33377659|NCT00784875|62756466|FG003|Period A - Baseline|Physician Decision|2|||
33377660|NCT00784875|62756463|FG000|Period A - Baseline|Sponsor Decision|0|||
33377661|NCT00784875|62756464|FG001|Period A - Baseline|Sponsor Decision|0|||
33377662|NCT00784875|62756465|FG002|Period A - Baseline|Sponsor Decision|0|||
33377663|NCT00784875|62756466|FG003|Period A - Baseline|Sponsor Decision|113|||
33377664|NCT00784875|62756463|FG000|Period A - Baseline|Lost to Follow-up|0|||
33377665|NCT00784875|62756464|FG001|Period A - Baseline|Lost to Follow-up|0|||
33377666|NCT00784875|62756465|FG002|Period A - Baseline|Lost to Follow-up|0|||
33377667|NCT00784875|62756466|FG003|Period A - Baseline|Lost to Follow-up|2|||
33377668|NCT00784875|62756463|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
33377669|NCT00784875|62756464|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
33377670|NCT00784875|62756465|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
33377671|NCT00784875|62756466|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
33377672|NCT00784875|62756463|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
33377673|NCT00784875|62756464|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
33377674|NCT00784875|62756465|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
33377675|NCT00784875|62756466|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
33377676|NCT00784875|62756463|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
33377677|NCT00784875|62756464|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
33377678|NCT00784875|62756465|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
33377679|NCT00784875|62756466|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
33377680|NCT00784875|62756463|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
33377681|NCT00784875|62756464|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
33377682|NCT00784875|62756465|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
33377683|NCT00784875|62756466|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
33377684|NCT00784875|62756463|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
33377685|NCT00784875|62756464|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
33377686|NCT00784875|62756465|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
33377687|NCT00784875|62756466|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
33377688|NCT00784875|62756463|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
33377689|NCT00784875|62756464|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
33377690|NCT00784875|62756465|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
33377691|NCT00784875|62756466|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
33377692|NCT00784875|62756463|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
33377693|NCT00784875|62756464|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
33291484|NCT00171249|62667917|FG005|Overall Study|Administrative Problems|0|||
33291485|NCT00171249|62667918|FG006|Overall Study|Administrative Problems|0|||
33291486|NCT00171249|62667912|FG000|Overall Study|Adverse Event|3|||
33291487|NCT00171249|62667913|FG001|Overall Study|Adverse Event|1|||
33291488|NCT00171249|62667914|FG002|Overall Study|Adverse Event|0|||
33291489|NCT00171249|62667915|FG003|Overall Study|Adverse Event|15|||
33291490|NCT00171249|62667916|FG004|Overall Study|Adverse Event|0|||
33291491|NCT00171249|62667917|FG005|Overall Study|Adverse Event|2|||
33291492|NCT00171249|62667918|FG006|Overall Study|Adverse Event|0|||
33377694|NCT00784875|62756465|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
33377695|NCT00784875|62756466|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
33377696|NCT00784875|62756463|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
33377697|NCT00784875|62756464|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
33291493|NCT00171249|62667912|FG000|Overall Study|Lost to Follow-up|5|||
33291494|NCT00171249|62667913|FG001|Overall Study|Lost to Follow-up|0|||
33377698|NCT00784875|62756465|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
33377699|NCT00784875|62756466|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
33377700|NCT00784875|62756463|FG000|Period C|Adverse Event|1|||
33291495|NCT00171249|62667914|FG002|Overall Study|Lost to Follow-up|0|||
33291496|NCT00171249|62667915|FG003|Overall Study|Lost to Follow-up|9|||
33377701|NCT00784875|62756464|FG001|Period C|Adverse Event|0|||
33377702|NCT00784875|62756465|FG002|Period C|Adverse Event|4|||
33377703|NCT00784875|62756466|FG003|Period C|Adverse Event|2|||
33377704|NCT00784875|62756463|FG000|Period C|Protocol Violation|0|||
33377705|NCT00784875|62756464|FG001|Period C|Protocol Violation|0|||
33377706|NCT00784875|62756465|FG002|Period C|Protocol Violation|1|||
33377707|NCT00784875|62756466|FG003|Period C|Protocol Violation|2|||
33377708|NCT00784875|62756463|FG000|Period C|Lack of Efficacy|0|||
33377709|NCT00784875|62756464|FG001|Period C|Lack of Efficacy|0|||
33377710|NCT00784875|62756465|FG002|Period C|Lack of Efficacy|1|||
33377711|NCT00784875|62756466|FG003|Period C|Lack of Efficacy|0|||
33377712|NCT00784875|62756463|FG000|Period C|Withdrawal by Subject|1|||
33377713|NCT00784875|62756464|FG001|Period C|Withdrawal by Subject|1|||
33377714|NCT00784875|62756465|FG002|Period C|Withdrawal by Subject|2|||
33377715|NCT00784875|62756466|FG003|Period C|Withdrawal by Subject|0|||
33487245|NCT02784106|62865273|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
33487246|NCT02784106|62865274|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
33487247|NCT02784106|62865275|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
33377716|NCT00784875|62756463|FG000|Period C|Physician Decision|0|||
33377717|NCT00784875|62756464|FG001|Period C|Physician Decision|0|||
33377718|NCT00784875|62756465|FG002|Period C|Physician Decision|1|||
33377719|NCT00784875|62756466|FG003|Period C|Physician Decision|1|||
33377720|NCT00784875|62756463|FG000|Period C|Sponsor Decision|5|||
33377721|NCT00784875|62756464|FG001|Period C|Sponsor Decision|5|||
33377722|NCT00784875|62756465|FG002|Period C|Sponsor Decision|4|||
33377723|NCT00784875|62756466|FG003|Period C|Sponsor Decision|2|||
33377724|NCT00784875|62756463|FG000|Period D|Adverse Event|0|||
33377725|NCT00784875|62756464|FG001|Period D|Adverse Event|2|||
33377726|NCT00784875|62756465|FG002|Period D|Adverse Event|2|||
33377727|NCT00784875|62756466|FG003|Period D|Adverse Event|0|||
33377728|NCT00784875|62756463|FG000|Period D|Protocol Violation|1|||
33377729|NCT00784875|62756464|FG001|Period D|Protocol Violation|0|||
33377730|NCT00784875|62756465|FG002|Period D|Protocol Violation|0|||
33377731|NCT00784875|62756466|FG003|Period D|Protocol Violation|0|||
33377732|NCT00784875|62756463|FG000|Period D|Withdrawal by Subject|2|||
33377733|NCT00784875|62756464|FG001|Period D|Withdrawal by Subject|0|||
33377734|NCT00784875|62756465|FG002|Period D|Withdrawal by Subject|2|||
33377735|NCT00784875|62756466|FG003|Period D|Withdrawal by Subject|0|||
33377736|NCT00784875|62756463|FG000|Period D|Physician Decision|0|||
33377737|NCT00784875|62756464|FG001|Period D|Physician Decision|1|||
33377738|NCT00784875|62756465|FG002|Period D|Physician Decision|0|||
33377739|NCT00784875|62756466|FG003|Period D|Physician Decision|0|||
33377740|NCT00784875|62756463|FG000|Period D|Sponsor Decision|1|||
33377741|NCT00784875|62756464|FG001|Period D|Sponsor Decision|1|||
33377742|NCT00784875|62756465|FG002|Period D|Sponsor Decision|1|||
33377743|NCT00784875|62756466|FG003|Period D|Sponsor Decision|0|||
33291497|NCT00171249|62667916|FG004|Overall Study|Lost to Follow-up|0|||
33291498|NCT00171249|62667917|FG005|Overall Study|Lost to Follow-up|0|||
33291499|NCT00171249|62667918|FG006|Overall Study|Lost to Follow-up|0|||
33291500|NCT01085630|62667929|FG000|Overall Study|Insufficient data|1|||
33291501|NCT01085630|62667930|FG001|Overall Study|Insufficient data|0|||
33291502|NCT01085630|62667929|FG000|Overall Study|Ineligible|3|||
33291503|NCT01085630|62667930|FG001|Overall Study|Ineligible|0|||
33291504|NCT00171210|62667938|FG000|Overall Study|Adverse Event|16|||
33291505|NCT00171210|62667939|FG001|Overall Study|Adverse Event|27|||
33291506|NCT00171210|62667938|FG000|Overall Study|Abnormal laboratory value(s)|6|||
33291507|NCT00171210|62667939|FG001|Overall Study|Abnormal laboratory value(s)|3|||
33291508|NCT00171210|62667938|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33291509|NCT00171210|62667939|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33291510|NCT00171210|62667938|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
33291511|NCT00171210|62667939|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
33291512|NCT00171210|62667938|FG000|Overall Study|Protocol Violation|0|||
33377744|NCT00784875|62756463|FG000|Period D|Lost to Follow-up|1|||
33291513|NCT00171210|62667939|FG001|Overall Study|Protocol Violation|2|||
33291514|NCT00171210|62667938|FG000|Overall Study|Withdrawal by Subject|32|||
33291515|NCT00171210|62667939|FG001|Overall Study|Withdrawal by Subject|30|||
33291516|NCT00171210|62667938|FG000|Overall Study|Lost to Follow-up|1|||
33377745|NCT00784875|62756464|FG001|Period D|Lost to Follow-up|0|||
33377746|NCT00784875|62756465|FG002|Period D|Lost to Follow-up|1|||
33377747|NCT00784875|62756466|FG003|Period D|Lost to Follow-up|1|||
33377748|NCT00592553|62756492|FG000|Overall Study|Protocol Noncompliance|1|||
33377749|NCT00592553|62756493|FG001|Overall Study|Protocol Noncompliance|0|||
33377750|NCT00592553|62756494|FG002|Overall Study|Protocol Noncompliance|0|||
33377751|NCT00853229|62756504|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
33377752|NCT00853229|62756505|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
33377753|NCT00853151|62756517|FG000|Overall Study|Adverse Event|1|||
33377754|NCT00853151|62756518|FG001|Overall Study|Adverse Event|4|||
33377755|NCT00853151|62756519|FG002|Overall Study|Adverse Event|2|||
33377756|NCT00853151|62756520|FG003|Overall Study|Adverse Event|0|||
33377757|NCT00853151|62756517|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
33377758|NCT00853151|62756518|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33377759|NCT00853151|62756519|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33377760|NCT00853151|62756520|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33377761|NCT00853151|62756517|FG000|Overall Study|Lost to Follow-up|2|||
33377762|NCT00853151|62756518|FG001|Overall Study|Lost to Follow-up|0|||
33377763|NCT00853151|62756519|FG002|Overall Study|Lost to Follow-up|3|||
33377764|NCT00853151|62756520|FG003|Overall Study|Lost to Follow-up|0|||
33377765|NCT00853151|62756517|FG000|Overall Study|Death|1|||
33377766|NCT00853151|62756518|FG001|Overall Study|Death|0|||
33377767|NCT00853151|62756519|FG002|Overall Study|Death|0|||
33377768|NCT00853151|62756520|FG003|Overall Study|Death|1|||
33377769|NCT00853151|62756517|FG000|Overall Study|Protocol Violation|0|||
33377770|NCT00853151|62756518|FG001|Overall Study|Protocol Violation|0|||
33377771|NCT00853151|62756519|FG002|Overall Study|Protocol Violation|0|||
33377772|NCT00853151|62756520|FG003|Overall Study|Protocol Violation|1|||
33377773|NCT00853151|62756517|FG000|Overall Study|Withdrawal by Subject|5|||
33377774|NCT00853151|62756518|FG001|Overall Study|Withdrawal by Subject|4|||
33377775|NCT00853151|62756519|FG002|Overall Study|Withdrawal by Subject|2|||
33377776|NCT00853151|62756520|FG003|Overall Study|Withdrawal by Subject|1|||
33377777|NCT00853151|62756517|FG000|Overall Study|Physician Decision|0|||
33377778|NCT00853151|62756518|FG001|Overall Study|Physician Decision|2|||
33377779|NCT00853151|62756519|FG002|Overall Study|Physician Decision|1|||
33377780|NCT00853151|62756520|FG003|Overall Study|Physician Decision|0|||
33377781|NCT00853151|62756517|FG000|Overall Study|Sponsor Decision|0|||
33377782|NCT00853151|62756518|FG001|Overall Study|Sponsor Decision|3|||
33377783|NCT00853151|62756519|FG002|Overall Study|Sponsor Decision|0|||
33377784|NCT00853151|62756520|FG003|Overall Study|Sponsor Decision|0|||
33377785|NCT00853073|62756535|FG000|Overall Study|Withdrawal by Subject|3|||
33377786|NCT00853073|62756536|FG001|Overall Study|Withdrawal by Subject|2|||
33377787|NCT00846053|62756544|FG000|Overall Study|Physician Decision|3|||
33556579|NCT01369355|62949453|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
33556580|NCT01369355|62949454|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
33556581|NCT01369355|62949446|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
33662385|NCT01695239|63092841|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33662386|NCT01695239|63092842|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33291517|NCT00171210|62667939|FG001|Overall Study|Lost to Follow-up|0|||
33291518|NCT00171210|62667938|FG000|Overall Study|Administrative problems|1|||
33291519|NCT00171210|62667939|FG001|Overall Study|Administrative problems|1|||
33291520|NCT00171210|62667938|FG000|Overall Study|Death|2|||
33291521|NCT00171210|62667939|FG001|Overall Study|Death|3|||
33291522|NCT00171210|62667938|FG000|Overall Study|Stopped at end of core|0|||
33291523|NCT00171210|62667939|FG001|Overall Study|Stopped at end of core|32|||
33291524|NCT00171210|62667938|FG000|Overall Study|Stopped at end of extension 1|0|||
33291525|NCT00171210|62667939|FG001|Overall Study|Stopped at end of extension 1|1|||
33291526|NCT00171054|62667947|FG000|Overall Study|Protocol Violation|1|||
33291527|NCT00171054|62667948|FG001|Overall Study|Protocol Violation|2|||
33291528|NCT00171054|62667947|FG000|Overall Study|Patient withdrew consent|1|||
33291529|NCT00171054|62667948|FG001|Overall Study|Patient withdrew consent|0|||
33291530|NCT00171054|62667947|FG000|Overall Study|Lost to Follow-up|0|||
33291531|NCT00171054|62667948|FG001|Overall Study|Lost to Follow-up|1|||
33291532|NCT00171054|62667947|FG000|Overall Study|Adverse Event|8|||
33291533|NCT00171054|62667948|FG001|Overall Study|Adverse Event|8|||
33291534|NCT00171054|62667947|FG000|Overall Study|Condition no longer required study drug|0|||
33291535|NCT00171054|62667948|FG001|Overall Study|Condition no longer required study drug|1|||
33291536|NCT01084694|62667956|FG000|Overall Study|Withdrawal by Subject|2|||
33377788|NCT00846053|62756545|FG001|Overall Study|Physician Decision|0|||
33377789|NCT00845897|62756556|FG000|Overall Study|Lost to Follow-up|1|||
33377790|NCT00845897|62756557|FG001|Overall Study|Lost to Follow-up|1|||
33377791|NCT00845897|62756558|FG002|Overall Study|Lost to Follow-up|0|||
33377792|NCT00845897|62756556|FG000|Overall Study|Withdrawal by Subject|0|||
33377793|NCT00845897|62756557|FG001|Overall Study|Withdrawal by Subject|3|||
33377794|NCT00845897|62756558|FG002|Overall Study|Withdrawal by Subject|2|||
33377795|NCT00845897|62756556|FG000|Overall Study|Ulcer did not heal|1|||
33377796|NCT00845897|62756557|FG001|Overall Study|Ulcer did not heal|0|||
33377797|NCT00845897|62756558|FG002|Overall Study|Ulcer did not heal|1|||
33377798|NCT00845897|62756556|FG000|Overall Study|Too ill to participate|0|||
33377799|NCT00845897|62756557|FG001|Overall Study|Too ill to participate|1|||
33377800|NCT00845897|62756558|FG002|Overall Study|Too ill to participate|0|||
33291537|NCT01084694|62667957|FG001|Overall Study|Withdrawal by Subject|1|||
33377801|NCT00862277|62756569|FG000|Overall Study|Protocol Violation|1|||
33377802|NCT00862277|62756570|FG001|Overall Study|Protocol Violation|2|||
33377803|NCT00862277|62756571|FG002|Overall Study|Protocol Violation|5|||
33377804|NCT00852995|62756584|FG000|Overall Study|Adverse Event|1|||
33377805|NCT00852995|62756585|FG001|Overall Study|Adverse Event|0|||
33377806|NCT00852995|62756586|FG002|Overall Study|Adverse Event|4|||
33377807|NCT00852995|62756587|FG003|Overall Study|Adverse Event|0|||
33377808|NCT00852995|62756588|FG004|Overall Study|Adverse Event|0|||
33377809|NCT00852995|62756584|FG000|Overall Study|Lost to Follow-up|0|||
33377810|NCT00852995|62756585|FG001|Overall Study|Lost to Follow-up|1|||
33377811|NCT00852995|62756586|FG002|Overall Study|Lost to Follow-up|1|||
33377812|NCT00852995|62756587|FG003|Overall Study|Lost to Follow-up|0|||
33377813|NCT00852995|62756588|FG004|Overall Study|Lost to Follow-up|0|||
33377814|NCT00852995|62756584|FG000|Overall Study|Withdrawal by Subject|4|||
33377815|NCT00852995|62756585|FG001|Overall Study|Withdrawal by Subject|0|||
33377816|NCT00852995|62756586|FG002|Overall Study|Withdrawal by Subject|0|||
33377817|NCT00852995|62756587|FG003|Overall Study|Withdrawal by Subject|1|||
33377818|NCT00852995|62756588|FG004|Overall Study|Withdrawal by Subject|2|||
33377819|NCT00852995|62756584|FG000|Overall Study|Non-Compliance|0|||
33377820|NCT00852995|62756585|FG001|Overall Study|Non-Compliance|0|||
33377821|NCT00852995|62756586|FG002|Overall Study|Non-Compliance|0|||
33377822|NCT00852995|62756587|FG003|Overall Study|Non-Compliance|2|||
33377823|NCT00852995|62756588|FG004|Overall Study|Non-Compliance|0|||
33377824|NCT00852995|62756584|FG000|Overall Study|Progressive Disease|1|||
33377825|NCT00852995|62756585|FG001|Overall Study|Progressive Disease|0|||
33377826|NCT00852995|62756586|FG002|Overall Study|Progressive Disease|0|||
33377827|NCT00852995|62756587|FG003|Overall Study|Progressive Disease|2|||
33377828|NCT00852995|62756588|FG004|Overall Study|Progressive Disease|1|||
33377829|NCT00852995|62756584|FG000|Overall Study|Physician Decision|1|||
33377830|NCT00852995|62756585|FG001|Overall Study|Physician Decision|0|||
33377831|NCT00852995|62756586|FG002|Overall Study|Physician Decision|0|||
33377832|NCT00852995|62756587|FG003|Overall Study|Physician Decision|0|||
33377833|NCT00852995|62756588|FG004|Overall Study|Physician Decision|0|||
33377834|NCT00852995|62756584|FG000|Overall Study|Protocol Violation|0|||
33377835|NCT00852995|62756585|FG001|Overall Study|Protocol Violation|0|||
33377836|NCT00852995|62756586|FG002|Overall Study|Protocol Violation|0|||
33377837|NCT00852995|62756587|FG003|Overall Study|Protocol Violation|0|||
33377838|NCT00852995|62756588|FG004|Overall Study|Protocol Violation|1|||
33377839|NCT00852995|62756584|FG000|Overall Study|Moved Out of Area|1|||
33377840|NCT00852995|62756585|FG001|Overall Study|Moved Out of Area|0|||
33377841|NCT00852995|62756586|FG002|Overall Study|Moved Out of Area|0|||
33377842|NCT00852995|62756587|FG003|Overall Study|Moved Out of Area|0|||
33377843|NCT00852995|62756588|FG004|Overall Study|Moved Out of Area|0|||
33377844|NCT00592319|62756607|FG000|Overall Study|Lost to Follow-up|0|||
33377845|NCT00592319|62756608|FG001|Overall Study|Lost to Follow-up|3|||
33377846|NCT00862121|62756618|FG000|Overall Study|Adverse Event|1|||
33377847|NCT00862121|62756619|FG001|Overall Study|Adverse Event|2|||
33377848|NCT00862121|62756618|FG000|Overall Study|Lack of Efficacy|0|||
33377849|NCT00862121|62756619|FG001|Overall Study|Lack of Efficacy|3|||
33377850|NCT00862121|62756618|FG000|Overall Study|Protocol Violation|0|||
33377851|NCT00862121|62756619|FG001|Overall Study|Protocol Violation|1|||
33377852|NCT00862121|62756618|FG000|Overall Study|Exclusion criterion violation|0|||
33377853|NCT00862121|62756619|FG001|Overall Study|Exclusion criterion violation|1|||
33377854|NCT00862121|62756618|FG000|Overall Study|Incorrect randomisation|0|||
33377855|NCT00862121|62756619|FG001|Overall Study|Incorrect randomisation|1|||
33377856|NCT00784719|62756632|FG000|Overall Study|Adverse Event|0|||
33377857|NCT00784719|62756633|FG001|Overall Study|Adverse Event|2|||
33377858|NCT00784719|62756634|FG002|Overall Study|Adverse Event|0|||
33377859|NCT00784719|62756635|FG003|Overall Study|Adverse Event|0|||
33377860|NCT00784719|62756636|FG004|Overall Study|Adverse Event|1|||
33377861|NCT00784719|62756637|FG005|Overall Study|Adverse Event|1|||
33377862|NCT00784719|62756638|FG006|Overall Study|Adverse Event|1|||
33377863|NCT00784719|62756632|FG000|Overall Study|Lost to Follow-up|0|||
33377864|NCT00784719|62756633|FG001|Overall Study|Lost to Follow-up|0|||
33377865|NCT00784719|62756634|FG002|Overall Study|Lost to Follow-up|0|||
33377866|NCT00784719|62756635|FG003|Overall Study|Lost to Follow-up|0|||
33377867|NCT00784719|62756636|FG004|Overall Study|Lost to Follow-up|1|||
33377868|NCT00784719|62756637|FG005|Overall Study|Lost to Follow-up|1|||
33377869|NCT00784719|62756638|FG006|Overall Study|Lost to Follow-up|0|||
33377870|NCT00784719|62756632|FG000|Overall Study|Other|2|||
33377871|NCT00784719|62756633|FG001|Overall Study|Other|1|||
33377872|NCT00784719|62756634|FG002|Overall Study|Other|1|||
33556582|NCT01369355|62949447|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
33377873|NCT00784719|62756635|FG003|Overall Study|Other|0|||
33377874|NCT00784719|62756636|FG004|Overall Study|Other|2|||
33377875|NCT00784719|62756637|FG005|Overall Study|Other|1|||
33377876|NCT00784719|62756638|FG006|Overall Study|Other|3|||
33377877|NCT00784719|62756632|FG000|Overall Study|Withdrawal by Subject|1|||
33377878|NCT00784719|62756633|FG001|Overall Study|Withdrawal by Subject|0|||
33377879|NCT00784719|62756634|FG002|Overall Study|Withdrawal by Subject|0|||
33377880|NCT00784719|62756635|FG003|Overall Study|Withdrawal by Subject|0|||
33556583|NCT01369355|62949448|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
33377881|NCT00784719|62756636|FG004|Overall Study|Withdrawal by Subject|2|||
33377882|NCT00784719|62756637|FG005|Overall Study|Withdrawal by Subject|0|||
33377883|NCT00784719|62756638|FG006|Overall Study|Withdrawal by Subject|1|||
33377884|NCT00852917|62756658|FG000|Overall Study|Adverse Event|13|||
33377885|NCT00852917|62756659|FG001|Overall Study|Adverse Event|20|||
33377886|NCT00852917|62756660|FG002|Overall Study|Adverse Event|35|||
33377887|NCT00852917|62756661|FG003|Overall Study|Adverse Event|17|||
33377888|NCT00852917|62756658|FG000|Overall Study|Lack of Efficacy|21|||
33377889|NCT00852917|62756659|FG001|Overall Study|Lack of Efficacy|11|||
33377890|NCT00852917|62756660|FG002|Overall Study|Lack of Efficacy|11|||
33377891|NCT00852917|62756661|FG003|Overall Study|Lack of Efficacy|47|||
33377892|NCT00852917|62756658|FG000|Overall Study|Withdrawal by Subject|4|||
33377893|NCT00852917|62756659|FG001|Overall Study|Withdrawal by Subject|8|||
33377894|NCT00852917|62756660|FG002|Overall Study|Withdrawal by Subject|10|||
33377895|NCT00852917|62756661|FG003|Overall Study|Withdrawal by Subject|9|||
33377896|NCT00852917|62756658|FG000|Overall Study|Physician Decision|6|||
33377897|NCT00852917|62756659|FG001|Overall Study|Physician Decision|7|||
33377898|NCT00852917|62756660|FG002|Overall Study|Physician Decision|2|||
33377899|NCT00852917|62756661|FG003|Overall Study|Physician Decision|19|||
33377900|NCT00852917|62756658|FG000|Overall Study|Death|0|||
33377901|NCT00852917|62756659|FG001|Overall Study|Death|0|||
33377902|NCT00852917|62756660|FG002|Overall Study|Death|0|||
33377903|NCT00852917|62756661|FG003|Overall Study|Death|1|||
33377904|NCT00845429|62756674|FG000|Overall Study|Protocol Violation|5|||
33377905|NCT00845429|62756675|FG001|Overall Study|Protocol Violation|4|||
33377906|NCT00845429|62756676|FG002|Overall Study|Protocol Violation|7|||
33377907|NCT00845429|62756674|FG000|Overall Study|Lost to Follow-up|7|||
33377908|NCT00845429|62756675|FG001|Overall Study|Lost to Follow-up|9|||
33377909|NCT00845429|62756676|FG002|Overall Study|Lost to Follow-up|10|||
33377910|NCT00845429|62756674|FG000|Overall Study|Withdrawal by Subject|2|||
33377911|NCT00845429|62756675|FG001|Overall Study|Withdrawal by Subject|2|||
33377912|NCT00845429|62756676|FG002|Overall Study|Withdrawal by Subject|2|||
33377913|NCT00845429|62756674|FG000|Overall Study|Serious adverse event|0|||
33377914|NCT00845429|62756675|FG001|Overall Study|Serious adverse event|0|||
33377915|NCT00845429|62756676|FG002|Overall Study|Serious adverse event|1|||
33377916|NCT00593333|62756686|FG000|Overall Study|Lost to Follow-up|10|||
33377917|NCT00593333|62756687|FG001|Overall Study|Lost to Follow-up|11|||
33662387|NCT01695239|63092843|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33662388|NCT01695239|63092844|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33291538|NCT01084694|62667956|FG000|Overall Study|Death|2|||
33291539|NCT01084694|62667957|FG001|Overall Study|Death|12|||
33291540|NCT01084694|62667956|FG000|Overall Study|eligibility not maintained|2|||
33291541|NCT01084694|62667957|FG001|Overall Study|eligibility not maintained|7|||
33291542|NCT00479856|62667971|FG000|Overall Study|Adverse Event|1|||
33291543|NCT00479856|62667971|FG000|Overall Study|Withdrawal by Subject|1|||
33291544|NCT00479856|62667971|FG000|Overall Study|Physician Decision|1|||
33291545|NCT00479466|62667981|FG000|Overall Study|Adverse Event|5|||
33291546|NCT00479466|62667982|FG001|Overall Study|Adverse Event|1|||
33291547|NCT00479466|62667983|FG002|Overall Study|Adverse Event|0|||
33291548|NCT00479466|62667984|FG003|Overall Study|Adverse Event|1|||
33291549|NCT00479466|62667985|FG004|Overall Study|Adverse Event|2|||
33291550|NCT00479466|62667986|FG005|Overall Study|Adverse Event|0|||
33291551|NCT00479466|62667981|FG000|Overall Study|Hyperglycemia|0|||
33291552|NCT00479466|62667982|FG001|Overall Study|Hyperglycemia|0|||
33291553|NCT00479466|62667983|FG002|Overall Study|Hyperglycemia|0|||
33291554|NCT00479466|62667984|FG003|Overall Study|Hyperglycemia|0|||
33291555|NCT00479466|62667985|FG004|Overall Study|Hyperglycemia|0|||
33291556|NCT00479466|62667986|FG005|Overall Study|Hyperglycemia|1|||
33291557|NCT00479466|62667981|FG000|Overall Study|Lack of Efficacy|2|||
33291558|NCT00479466|62667982|FG001|Overall Study|Lack of Efficacy|0|||
33291559|NCT00479466|62667983|FG002|Overall Study|Lack of Efficacy|1|||
33291560|NCT00479466|62667984|FG003|Overall Study|Lack of Efficacy|0|||
33291561|NCT00479466|62667985|FG004|Overall Study|Lack of Efficacy|0|||
33291562|NCT00479466|62667986|FG005|Overall Study|Lack of Efficacy|0|||
33291563|NCT00479466|62667981|FG000|Overall Study|Lost to Follow-up|0|||
33291564|NCT00479466|62667982|FG001|Overall Study|Lost to Follow-up|1|||
33377918|NCT00844883|62756693|FG000|Overall Study|Bridged to liver transplant|3|||
33662389|NCT01695239|63092845|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33662390|NCT01695239|63092846|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
33291565|NCT00479466|62667983|FG002|Overall Study|Lost to Follow-up|1|||
33377919|NCT00844883|62756693|FG000|Overall Study|Bridged to resection|1|||
33291566|NCT00479466|62667984|FG003|Overall Study|Lost to Follow-up|0|||
33291567|NCT00479466|62667985|FG004|Overall Study|Lost to Follow-up|2|||
33291568|NCT00479466|62667986|FG005|Overall Study|Lost to Follow-up|2|||
33291569|NCT00479466|62667981|FG000|Overall Study|Physician Decision|2|||
33291570|NCT00479466|62667982|FG001|Overall Study|Physician Decision|1|||
33291571|NCT00479466|62667983|FG002|Overall Study|Physician Decision|1|||
33291572|NCT00479466|62667984|FG003|Overall Study|Physician Decision|0|||
33291573|NCT00479466|62667985|FG004|Overall Study|Physician Decision|0|||
33377920|NCT00851903|62756697|FG000|Overall Study|Withdrawal by Subject|2|||
33377921|NCT00587457|62756704|FG000|Overall Study|Adverse Event|1|||
33377922|NCT00587457|62756705|FG001|Overall Study|Adverse Event|2|||
33377923|NCT00587457|62756706|FG002|Overall Study|Adverse Event|1|||
33291574|NCT00479466|62667986|FG005|Overall Study|Physician Decision|0|||
33291575|NCT00479466|62667981|FG000|Overall Study|Pregnancy|0|||
33291576|NCT00479466|62667982|FG001|Overall Study|Pregnancy|0|||
33291577|NCT00479466|62667983|FG002|Overall Study|Pregnancy|0|||
33291578|NCT00479466|62667984|FG003|Overall Study|Pregnancy|0|||
33291579|NCT00479466|62667985|FG004|Overall Study|Pregnancy|1|||
33291580|NCT00479466|62667986|FG005|Overall Study|Pregnancy|0|||
33291581|NCT00479466|62667981|FG000|Overall Study|Protocol Violation|1|||
33291582|NCT00479466|62667982|FG001|Overall Study|Protocol Violation|0|||
33291583|NCT00479466|62667983|FG002|Overall Study|Protocol Violation|0|||
33291584|NCT00479466|62667984|FG003|Overall Study|Protocol Violation|0|||
33291585|NCT00479466|62667985|FG004|Overall Study|Protocol Violation|0|||
33291586|NCT00479466|62667986|FG005|Overall Study|Protocol Violation|0|||
33291587|NCT00479466|62667981|FG000|Overall Study|Withdrawal by Subject|3|||
33291588|NCT00479466|62667982|FG001|Overall Study|Withdrawal by Subject|5|||
33291589|NCT00479466|62667983|FG002|Overall Study|Withdrawal by Subject|0|||
33291590|NCT00479466|62667984|FG003|Overall Study|Withdrawal by Subject|2|||
33291591|NCT00479466|62667985|FG004|Overall Study|Withdrawal by Subject|3|||
33291592|NCT00479466|62667986|FG005|Overall Study|Withdrawal by Subject|1|||
33291593|NCT00479388|62668002|FG000|Overall Study|Adverse Event|90|||
33377924|NCT00587457|62756704|FG000|Overall Study|Disease progression|2|||
33377925|NCT00587457|62756705|FG001|Overall Study|Disease progression|0|||
33377926|NCT00587457|62756706|FG002|Overall Study|Disease progression|2|||
33377927|NCT00587457|62756704|FG000|Overall Study|Initiation of alternative therapy|0|||
33377928|NCT00587457|62756705|FG001|Overall Study|Initiation of alternative therapy|1|||
33377929|NCT00587457|62756706|FG002|Overall Study|Initiation of alternative therapy|0|||
33377930|NCT00587457|62756704|FG000|Overall Study|Undefined|0|||
33377931|NCT00587457|62756705|FG001|Overall Study|Undefined|0|||
33377932|NCT00587457|62756706|FG002|Overall Study|Undefined|1|||
33377933|NCT00587457|62756704|FG000|Overall Study|Development of neutralizing Abs|0|||
33377934|NCT00587457|62756705|FG001|Overall Study|Development of neutralizing Abs|0|||
33377935|NCT00587457|62756706|FG002|Overall Study|Development of neutralizing Abs|1|||
33377936|NCT00851747|62756717|FG000|Overall Study|Physician Decision|6|||
33377937|NCT00851747|62756718|FG001|Overall Study|Physician Decision|6|||
33377938|NCT00851747|62756719|FG002|Overall Study|Physician Decision|6|||
33377939|NCT00767325|62756726|FG000|Overall Study|Lack of Efficacy|2|||
33377940|NCT00767325|62756726|FG000|Overall Study|Adverse Event|7|||
33377941|NCT00767325|62756726|FG000|Overall Study|Lost to Follow-up|3|||
33377942|NCT00767325|62756726|FG000|Overall Study|No longer met study criteria|2|||
33377943|NCT00767325|62756726|FG000|Overall Study|Missed visit due to family reasons|1|||
33377944|NCT00851591|62756732|FG000|Overall Study|Withdrawal by Subject|2|||
33377945|NCT00851591|62756733|FG001|Overall Study|Withdrawal by Subject|0|||
33377946|NCT00861341|62756739|FG000|Overall Study|Withdrawal by Subject|2|||
33377947|NCT00766467|62756745|FG000|Overall Study|Withdrawal by Subject|7|||
33377948|NCT00766467|62756746|FG001|Overall Study|Withdrawal by Subject|2|||
33377949|NCT00766467|62756745|FG000|Overall Study|Adverse Event|1|||
33377950|NCT00766467|62756746|FG001|Overall Study|Adverse Event|1|||
33377951|NCT00766467|62756745|FG000|Overall Study|Protocol Violation|2|||
33377952|NCT00766467|62756746|FG001|Overall Study|Protocol Violation|4|||
33377953|NCT00766467|62756745|FG000|Overall Study|Tumor Progression on Study|0|||
33377954|NCT00766467|62756746|FG001|Overall Study|Tumor Progression on Study|1|||
33377955|NCT00766467|62756745|FG000|Overall Study|Physician Decision|1|||
33377956|NCT00766467|62756746|FG001|Overall Study|Physician Decision|0|||
33377957|NCT00850499|62756754|FG000|Overall Study|Adverse Event|3|||
33377958|NCT00850499|62756755|FG001|Overall Study|Adverse Event|1|||
33377959|NCT00850499|62756754|FG000|Overall Study|Lack of Efficacy|0|||
33377960|NCT00850499|62756755|FG001|Overall Study|Lack of Efficacy|1|||
33377961|NCT00860951|62756761|FG000|Overall Study|Withdrawal by Subject|2|||
33377962|NCT00860951|62756761|FG000|Overall Study|Lost to Follow-up|5|||
33377963|NCT00844805|62756779|FG000|Treatment Phase|Adverse Event|5|||
33377964|NCT00844805|62756780|FG001|Treatment Phase|Adverse Event|1|||
33487248|NCT02784106|62865272|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
33487249|NCT02784106|62865273|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
33291594|NCT00479388|62668003|FG001|Overall Study|Adverse Event|45|||
33291595|NCT00479388|62668002|FG000|Overall Study|Lost to Follow-up|0|||
33291596|NCT00479388|62668003|FG001|Overall Study|Lost to Follow-up|2|||
33291597|NCT00479388|62668002|FG000|Overall Study|Protocol Violation|10|||
33291598|NCT00479388|62668003|FG001|Overall Study|Protocol Violation|9|||
33377965|NCT00844805|62756781|FG002|Treatment Phase|Adverse Event|0|||
33377966|NCT00844805|62756782|FG003|Treatment Phase|Adverse Event|0|||
33377967|NCT00844805|62756779|FG000|Treatment Phase|Withdrawal by Subject|3|||
33377968|NCT00844805|62756780|FG001|Treatment Phase|Withdrawal by Subject|4|||
33487250|NCT02784106|62865274|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
33291599|NCT00479388|62668002|FG000|Overall Study|Withdrawal by Subject|32|||
33291600|NCT00479388|62668003|FG001|Overall Study|Withdrawal by Subject|17|||
33377969|NCT00844805|62756781|FG002|Treatment Phase|Withdrawal by Subject|0|||
33377970|NCT00844805|62756782|FG003|Treatment Phase|Withdrawal by Subject|0|||
33377971|NCT00844805|62756779|FG000|Treatment Phase|Noncompliance With Protocol|1|||
33377972|NCT00844805|62756780|FG001|Treatment Phase|Noncompliance With Protocol|0|||
33377973|NCT00844805|62756781|FG002|Treatment Phase|Noncompliance With Protocol|0|||
33377974|NCT00844805|62756782|FG003|Treatment Phase|Noncompliance With Protocol|0|||
33377975|NCT00844805|62756779|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
33291601|NCT00479232|62668011|FG000|Overall Study|Adverse Event|0|||
33291602|NCT00479232|62668012|FG001|Overall Study|Adverse Event|0|||
33291603|NCT00479232|62668013|FG002|Overall Study|Adverse Event|5|||
33291604|NCT00479232|62668014|FG003|Overall Study|Adverse Event|0|||
33291605|NCT00479232|62668015|FG004|Overall Study|Adverse Event|0|||
33291606|NCT00479232|62668016|FG005|Overall Study|Adverse Event|10|||
33291607|NCT00479232|62668011|FG000|Overall Study|Deviation from Protocol|0|||
33291608|NCT00479232|62668012|FG001|Overall Study|Deviation from Protocol|0|||
33291609|NCT00479232|62668013|FG002|Overall Study|Deviation from Protocol|1|||
33291610|NCT00479232|62668014|FG003|Overall Study|Deviation from Protocol|0|||
33291611|NCT00479232|62668015|FG004|Overall Study|Deviation from Protocol|0|||
33291612|NCT00479232|62668016|FG005|Overall Study|Deviation from Protocol|0|||
33291613|NCT00479232|62668011|FG000|Overall Study|Lack of Efficacy|0|||
33291614|NCT00479232|62668012|FG001|Overall Study|Lack of Efficacy|0|||
33291615|NCT00479232|62668013|FG002|Overall Study|Lack of Efficacy|2|||
33291616|NCT00479232|62668014|FG003|Overall Study|Lack of Efficacy|0|||
33291617|NCT00479232|62668015|FG004|Overall Study|Lack of Efficacy|0|||
33291618|NCT00479232|62668016|FG005|Overall Study|Lack of Efficacy|4|||
33377976|NCT00844805|62756780|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
33377977|NCT00844805|62756781|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
33377978|NCT00844805|62756782|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
33377979|NCT00844805|62756779|FG000|Follow-Up Phase|Adverse Event|0|||
33377980|NCT00844805|62756780|FG001|Follow-Up Phase|Adverse Event|0|||
33377981|NCT00844805|62756781|FG002|Follow-Up Phase|Adverse Event|1|||
33377982|NCT00844805|62756782|FG003|Follow-Up Phase|Adverse Event|0|||
33377983|NCT00844805|62756779|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
33377984|NCT00844805|62756780|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
33377985|NCT00844805|62756781|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
33377986|NCT00844805|62756782|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
33377987|NCT00844805|62756779|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
33291619|NCT00479232|62668011|FG000|Overall Study|Physician Decision|0|||
33291620|NCT00479232|62668012|FG001|Overall Study|Physician Decision|0|||
33291621|NCT00479232|62668013|FG002|Overall Study|Physician Decision|2|||
33291622|NCT00479232|62668014|FG003|Overall Study|Physician Decision|0|||
33291623|NCT00479232|62668015|FG004|Overall Study|Physician Decision|0|||
33291624|NCT00479232|62668016|FG005|Overall Study|Physician Decision|1|||
33291625|NCT00479232|62668011|FG000|Overall Study|Progressive Disease|3|||
33291626|NCT00479232|62668012|FG001|Overall Study|Progressive Disease|1|||
33291627|NCT00479232|62668013|FG002|Overall Study|Progressive Disease|12|||
33291628|NCT00479232|62668014|FG003|Overall Study|Progressive Disease|3|||
33291629|NCT00479232|62668015|FG004|Overall Study|Progressive Disease|3|||
33291630|NCT00479232|62668016|FG005|Overall Study|Progressive Disease|12|||
33291631|NCT00479232|62668011|FG000|Overall Study|Withdrew Consent|0|||
33291632|NCT00479232|62668012|FG001|Overall Study|Withdrew Consent|2|||
33291633|NCT00479232|62668013|FG002|Overall Study|Withdrew Consent|6|||
33291634|NCT00479232|62668014|FG003|Overall Study|Withdrew Consent|0|||
33291635|NCT00479232|62668015|FG004|Overall Study|Withdrew Consent|1|||
33377988|NCT00844805|62756780|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
33377989|NCT00844805|62756781|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
33377990|NCT00844805|62756782|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
33377991|NCT00844805|62756779|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
33377992|NCT00844805|62756780|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
33377993|NCT00844805|62756781|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
33377994|NCT00844805|62756782|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
33377995|NCT00844805|62756779|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
33377996|NCT00844805|62756780|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
33377997|NCT00844805|62756781|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
33377998|NCT00844805|62756782|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
33377999|NCT00765999|62756793|FG000|Overall Study|Adverse Event|203|||
33291636|NCT00479232|62668016|FG005|Overall Study|Withdrew Consent|3|||
33291637|NCT00478881|62668036|FG000|Overall Study|Adverse Event|31|||
33291638|NCT00478881|62668037|FG001|Overall Study|Adverse Event|12|||
33291639|NCT00478881|62668036|FG000|Overall Study|Lack of Efficacy|0|||
33291640|NCT00478881|62668037|FG001|Overall Study|Lack of Efficacy|3|||
33291641|NCT00478881|62668036|FG000|Overall Study|Lost to Follow-up|0|||
33291642|NCT00478881|62668037|FG001|Overall Study|Lost to Follow-up|1|||
33291643|NCT00478881|62668036|FG000|Overall Study|Protocol Violation|2|||
33291644|NCT00478881|62668037|FG001|Overall Study|Protocol Violation|2|||
33291645|NCT00478881|62668036|FG000|Overall Study|Withdrawal by Subject|6|||
33378000|NCT00765999|62756793|FG000|Overall Study|Insufficient Therapeutic Response|100|||
33378001|NCT00765999|62756793|FG000|Overall Study|Protocol Violation|95|||
33378002|NCT00765999|62756793|FG000|Overall Study|Consent Withdrawn|202|||
33378003|NCT00765999|62756793|FG000|Overall Study|Lost to Follow-up|131|||
33378004|NCT00765999|62756793|FG000|Overall Study|Study Terminated by Sponsor|2|||
33378005|NCT00765999|62756793|FG000|Overall Study|Other Miscellaneous Reasons|51|||
33378006|NCT00765843|62756802|FG000|Overall Study|Lost to Follow-up|1|||
33378007|NCT00765843|62756803|FG001|Overall Study|Lost to Follow-up|3|||
33378008|NCT00765843|62756804|FG002|Overall Study|Lost to Follow-up|2|||
33378009|NCT00765843|62756802|FG000|Overall Study|did not return to receive intervention|0|||
33378010|NCT00765843|62756803|FG001|Overall Study|did not return to receive intervention|1|||
33378011|NCT00765843|62756804|FG002|Overall Study|did not return to receive intervention|0|||
33378012|NCT00765843|62756802|FG000|Overall Study|Adverse Event|0|||
33378013|NCT00765843|62756803|FG001|Overall Study|Adverse Event|0|||
33378014|NCT00765843|62756804|FG002|Overall Study|Adverse Event|1|||
33378015|NCT00765063|62756812|FG000|Overall Study|Lack of Efficacy|5|||
33378016|NCT00765063|62756812|FG000|Overall Study|Withdrawal by Subject|1|||
33378017|NCT00765063|62756812|FG000|Overall Study|Other|16|||
33378018|NCT00765063|62756812|FG000|Overall Study|Protocol Violation|6|||
33378019|NCT00765063|62756812|FG000|Overall Study|Adverse Event|4|||
33378020|NCT00764751|62756818|FG000|Overall Study|Adverse Event|1|||
33378021|NCT00764751|62756819|FG001|Overall Study|Adverse Event|1|||
33378022|NCT00764751|62756818|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
33378023|NCT00764751|62756819|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
33378024|NCT00764673|62756830|FG000|Overall Study|Death|1|||
33378025|NCT00764673|62756830|FG000|Overall Study|Lost to Follow-up|3|||
33378026|NCT00764673|62756830|FG000|Overall Study|Withdrawal by Subject|6|||
33378027|NCT00764673|62756830|FG000|Overall Study|Revision of Device|2|||
33378028|NCT00764517|62756836|FG000|Overall Study|Adverse Event|9|||
33378029|NCT00764517|62756837|FG001|Overall Study|Adverse Event|3|||
33378030|NCT00764517|62756836|FG000|Overall Study|Death|3|||
33378031|NCT00764517|62756837|FG001|Overall Study|Death|11|||
33378032|NCT00764517|62756836|FG000|Overall Study|Physician Decision|3|||
33378033|NCT00764517|62756837|FG001|Overall Study|Physician Decision|0|||
33378034|NCT00764361|62756845|FG000|Overall Study|Withdrawal by Subject|2|||
33378035|NCT00764361|62756846|FG001|Overall Study|Withdrawal by Subject|3|||
33378036|NCT00764361|62756845|FG000|Overall Study|Adverse Event|0|||
33378037|NCT00764361|62756846|FG001|Overall Study|Adverse Event|1|||
33291646|NCT00478881|62668037|FG001|Overall Study|Withdrawal by Subject|2|||
33291647|NCT00478881|62668036|FG000|Overall Study|Non-Compliance with Study Medication|0|||
33291648|NCT00478881|62668037|FG001|Overall Study|Non-Compliance with Study Medication|2|||
33378038|NCT00763971|62756855|FG000|Overall Study|Adverse Event|5|||
33378039|NCT00763971|62756856|FG001|Overall Study|Adverse Event|2|||
33378040|NCT00763971|62756857|FG002|Overall Study|Adverse Event|4|||
33378041|NCT00763971|62756855|FG000|Overall Study|Protocol Violation|3|||
33378042|NCT00763971|62756856|FG001|Overall Study|Protocol Violation|3|||
33378043|NCT00763971|62756857|FG002|Overall Study|Protocol Violation|2|||
33378044|NCT00763971|62756855|FG000|Overall Study|Withdrawal by Subject|4|||
33487251|NCT02784106|62865275|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
33487252|NCT02784106|62865272|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
33487253|NCT02784106|62865273|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
33487254|NCT02784106|62865274|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
33487255|NCT02784106|62865275|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
33487256|NCT02784106|62865272|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
33291649|NCT00478647|62668043|FG000|Overall Study|Adverse Event|1|||
33291650|NCT00478647|62668043|FG000|Overall Study|Withdrawal by Subject|1|||
33291651|NCT00478608|62668047|FG000|Overall Study|Adverse Event|1|||
33291652|NCT00478608|62668047|FG000|Overall Study|Serious Adverse Event|14|||
33291653|NCT00478608|62668047|FG000|Overall Study|Withdrawal by Subject|2|||
33291654|NCT00478608|62668047|FG000|Overall Study|Protocol Violation|3|||
33291655|NCT00478257|62668053|FG000|Overall Study|Withdrawal by Subject|8|||
33291656|NCT00478257|62668054|FG001|Overall Study|Withdrawal by Subject|3|||
33291657|NCT00478140|62668060|FG000|Overall Study|Clinical Disease Progression|1|||
33291658|NCT00478023|62668069|FG000|Overall Study|Adverse Event|11|||
33291659|NCT00478023|62668070|FG001|Overall Study|Adverse Event|7|||
33291660|NCT00478023|62668071|FG002|Overall Study|Adverse Event|8|||
33291661|NCT00478023|62668072|FG003|Overall Study|Adverse Event|14|||
33378045|NCT00763971|62756856|FG001|Overall Study|Withdrawal by Subject|5|||
33378046|NCT00763971|62756857|FG002|Overall Study|Withdrawal by Subject|5|||
33378047|NCT00763971|62756855|FG000|Overall Study|Lost to Follow-up|0|||
33378048|NCT00763971|62756856|FG001|Overall Study|Lost to Follow-up|1|||
33378049|NCT00763971|62756857|FG002|Overall Study|Lost to Follow-up|0|||
33291662|NCT00478023|62668073|FG004|Overall Study|Adverse Event|6|||
33378050|NCT00763971|62756855|FG000|Overall Study|Lack of Efficacy|11|||
33487257|NCT02784106|62865273|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
33487258|NCT02784106|62865274|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
33378051|NCT00763971|62756856|FG001|Overall Study|Lack of Efficacy|22|||
33378052|NCT00763971|62756857|FG002|Overall Study|Lack of Efficacy|54|||
33378053|NCT00763971|62756855|FG000|Overall Study|Unable to swallow capsule|2|||
33378054|NCT00763971|62756856|FG001|Overall Study|Unable to swallow capsule|1|||
33378055|NCT00763971|62756857|FG002|Overall Study|Unable to swallow capsule|1|||
33378056|NCT00763971|62756855|FG000|Overall Study|Personal reason|3|||
33378057|NCT00763971|62756856|FG001|Overall Study|Personal reason|0|||
33378058|NCT00763971|62756857|FG002|Overall Study|Personal reason|0|||
33378059|NCT00763971|62756855|FG000|Overall Study|Exclusion criteria met|1|||
33378060|NCT00763971|62756856|FG001|Overall Study|Exclusion criteria met|0|||
33378061|NCT00763971|62756857|FG002|Overall Study|Exclusion criteria met|0|||
33378062|NCT00763971|62756855|FG000|Overall Study|Sponsor decision|1|||
33378063|NCT00763971|62756856|FG001|Overall Study|Sponsor decision|0|||
33378064|NCT00763971|62756857|FG002|Overall Study|Sponsor decision|0|||
33378065|NCT00763971|62756855|FG000|Overall Study|Due to holiday season|2|||
33378066|NCT00763971|62756856|FG001|Overall Study|Due to holiday season|0|||
33378067|NCT00763971|62756857|FG002|Overall Study|Due to holiday season|1|||
33378068|NCT00763971|62756855|FG000|Overall Study|Randomization error|0|||
33378069|NCT00763971|62756856|FG001|Overall Study|Randomization error|0|||
33378070|NCT00763971|62756857|FG002|Overall Study|Randomization error|1|||
33378071|NCT00763971|62756855|FG000|Overall Study|Medical monitor decision|0|||
33378072|NCT00763971|62756856|FG001|Overall Study|Medical monitor decision|0|||
33378073|NCT00763971|62756857|FG002|Overall Study|Medical monitor decision|1|||
33378074|NCT00763971|62756855|FG000|Overall Study|Moved to another country|0|||
33378075|NCT00763971|62756856|FG001|Overall Study|Moved to another country|1|||
33378076|NCT00763971|62756857|FG002|Overall Study|Moved to another country|0|||
33378077|NCT00763971|62756855|FG000|Overall Study|Subject wanted dose reduction|0|||
33378078|NCT00763971|62756856|FG001|Overall Study|Subject wanted dose reduction|1|||
33378079|NCT00763971|62756857|FG002|Overall Study|Subject wanted dose reduction|0|||
33378080|NCT00763971|62756855|FG000|Overall Study|Lack of availability|0|||
33378081|NCT00763971|62756856|FG001|Overall Study|Lack of availability|1|||
33378082|NCT00763971|62756857|FG002|Overall Study|Lack of availability|0|||
33378083|NCT00763971|62756855|FG000|Overall Study|Performed final visit on phone|0|||
33378084|NCT00763971|62756856|FG001|Overall Study|Performed final visit on phone|1|||
33378085|NCT00763971|62756857|FG002|Overall Study|Performed final visit on phone|0|||
33378086|NCT00763971|62756855|FG000|Overall Study|Participation in 489-326 required|1|||
33378087|NCT00763971|62756856|FG001|Overall Study|Participation in 489-326 required|0|||
33378088|NCT00763971|62756857|FG002|Overall Study|Participation in 489-326 required|0|||
33378089|NCT00763815|62756867|FG000|Overall Study|Adverse Event|14|||
33378090|NCT00763815|62756868|FG001|Overall Study|Adverse Event|29|||
33487259|NCT02784106|62865275|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
33487260|NCT02784106|62865272|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
33487261|NCT02784106|62865273|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
33487262|NCT02784106|62865274|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
33487263|NCT02784106|62865275|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
33487264|NCT02785900|62865286|FG000|Overall Study|Study Termination by Sponsor|64|||
33487265|NCT02785900|62865287|FG001|Overall Study|Study Termination by Sponsor|81|||
33487266|NCT02785900|62865286|FG000|Overall Study|Death|46|||
33487267|NCT02785900|62865287|FG001|Overall Study|Death|32|||
33487268|NCT02785900|62865286|FG000|Overall Study|Withdrawal by Subject|4|||
33487269|NCT02785900|62865287|FG001|Overall Study|Withdrawal by Subject|8|||
33487270|NCT02785900|62865286|FG000|Overall Study|Physician Decision|3|||
33487271|NCT02785900|62865287|FG001|Overall Study|Physician Decision|2|||
33487272|NCT00127205|62865296|FG000|Overall Study|Adverse Event|228|||
33487273|NCT00127205|62865297|FG001|Overall Study|Adverse Event|387|||
33487274|NCT00127205|62865298|FG002|Overall Study|Adverse Event|273|||
33487275|NCT00127205|62865296|FG000|Overall Study|Death|8|||
33487276|NCT00127205|62865297|FG001|Overall Study|Death|6|||
33487277|NCT00127205|62865298|FG002|Overall Study|Death|5|||
33487278|NCT00127205|62865296|FG000|Overall Study|Withdrawal by Subject|318|||
33487279|NCT00127205|62865297|FG001|Overall Study|Withdrawal by Subject|310|||
33487280|NCT00127205|62865298|FG002|Overall Study|Withdrawal by Subject|172|||
33378091|NCT00763815|62756867|FG000|Overall Study|Lack of Efficacy|10|||
33378092|NCT00763815|62756868|FG001|Overall Study|Lack of Efficacy|11|||
33487281|NCT00127205|62865296|FG000|Overall Study|Other-non protocol specified|142|||
33487282|NCT00127205|62865297|FG001|Overall Study|Other-non protocol specified|129|||
33487283|NCT00127205|62865298|FG002|Overall Study|Other-non protocol specified|77|||
33487284|NCT00127205|62865296|FG000|Overall Study|Data not reported|6|||
33487285|NCT00127205|62865297|FG001|Overall Study|Data not reported|10|||
33487286|NCT00127205|62865298|FG002|Overall Study|Data not reported|1|||
33487287|NCT00127205|62865296|FG000|Overall Study|Progression|127|||
33487288|NCT00127205|62865297|FG001|Overall Study|Progression|131|||
33487289|NCT00127205|62865298|FG002|Overall Study|Progression|84|||
33378093|NCT00763815|62756867|FG000|Overall Study|Poor Compliance to Protocol|6|||
33378094|NCT00763815|62756868|FG001|Overall Study|Poor Compliance to Protocol|6|||
33378095|NCT00763815|62756867|FG000|Overall Study|Lost to Follow-up|2|||
33487290|NCT02785588|62865308|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
33487291|NCT02785588|62865308|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
33487292|NCT03670641|62865312|FG000|Overall Study|Lost to Follow-up|3|||
33487293|NCT04029519|62865319|FG000|Overall Study|Protocol Violation|1|||
33378096|NCT00763815|62756868|FG001|Overall Study|Lost to Follow-up|4|||
33378097|NCT00763815|62756867|FG000|Overall Study|Early Termination|1|||
33378098|NCT00763815|62756868|FG001|Overall Study|Early Termination|0|||
33378099|NCT00763815|62756867|FG000|Overall Study|Familial and Personal Reasons|9|||
33378100|NCT00763815|62756868|FG001|Overall Study|Familial and Personal Reasons|16|||
33378101|NCT00763815|62756867|FG000|Overall Study|Physician Decision|1|||
33378102|NCT00763815|62756868|FG001|Overall Study|Physician Decision|0|||
33378103|NCT00763815|62756867|FG000|Overall Study|Withdrawal by Subject|7|||
33378104|NCT00763815|62756868|FG001|Overall Study|Withdrawal by Subject|12|||
33378105|NCT00763815|62756867|FG000|Overall Study|Protocol Violation|2|||
33378106|NCT00763815|62756868|FG001|Overall Study|Protocol Violation|5|||
33378107|NCT00763815|62756867|FG000|Overall Study|Sponsor's Decision|0|||
33378108|NCT00763815|62756868|FG001|Overall Study|Sponsor's Decision|1|||
33378109|NCT00763269|62756876|FG000|Overall Study|Lost to Follow-up|12|||
33378110|NCT00763269|62756877|FG001|Overall Study|Lost to Follow-up|13|||
33378111|NCT00763035|62756883|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
33378112|NCT00763035|62756884|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
33378113|NCT00763035|62756883|FG000|First Intervention|Adverse Event|0|||
33378114|NCT00763035|62756884|FG001|First Intervention|Adverse Event|1|||
33378115|NCT00763035|62756883|FG000|Second Intervention|Adverse Event|1|||
33378116|NCT00763035|62756884|FG001|Second Intervention|Adverse Event|0|||
33378117|NCT00763035|62756883|FG000|Second Intervention|Physician Decision|2|||
33378118|NCT00763035|62756884|FG001|Second Intervention|Physician Decision|0|||
33378119|NCT00844649|62756892|FG000|Overall Study|Progressive Disease|196|||
33378120|NCT00844649|62756893|FG001|Overall Study|Progressive Disease|245|||
33378121|NCT00844649|62756892|FG000|Overall Study|Adverse Event|128|||
33378122|NCT00844649|62756893|FG001|Overall Study|Adverse Event|73|||
33378123|NCT00844649|62756892|FG000|Overall Study|Physician Decision|25|||
33378124|NCT00844649|62756893|FG001|Overall Study|Physician Decision|18|||
33378125|NCT00844649|62756892|FG000|Overall Study|Protocol Violation|10|||
33378126|NCT00844649|62756893|FG001|Overall Study|Protocol Violation|6|||
33378127|NCT00844649|62756892|FG000|Overall Study|Withdrawal by Subject|28|||
33378128|NCT00844649|62756893|FG001|Overall Study|Withdrawal by Subject|39|||
33378129|NCT00844649|62756892|FG000|Overall Study|Other|7|||
33378130|NCT00844649|62756893|FG001|Overall Study|Other|10|||
33378131|NCT00844649|62756892|FG000|Overall Study|Withdrew prior to starting treatment|11|||
33378132|NCT00844649|62756893|FG001|Overall Study|Withdrew prior to starting treatment|27|||
33378133|NCT00762723|62756904|FG000|Overall Study|Study Terminated slow enrollement|5|||
33378134|NCT00762723|62756905|FG001|Overall Study|Study Terminated slow enrollement|5|||
33378135|NCT00762723|62756906|FG002|Overall Study|Study Terminated slow enrollement|3|||
33378136|NCT00850343|62756918|FG000|Overall Study|Withdrawal by Subject|11|||
33378137|NCT00850343|62756919|FG001|Overall Study|Withdrawal by Subject|0|||
33378138|NCT00850343|62756920|FG002|Overall Study|Withdrawal by Subject|3|||
33291663|NCT00478023|62668069|FG000|Overall Study|Death|1|||
33291664|NCT00478023|62668070|FG001|Overall Study|Death|0|||
33291665|NCT00478023|62668071|FG002|Overall Study|Death|0|||
33291666|NCT00478023|62668072|FG003|Overall Study|Death|0|||
33291667|NCT00478023|62668073|FG004|Overall Study|Death|0|||
33291668|NCT00478023|62668069|FG000|Overall Study|Lack of Efficacy|11|||
33291669|NCT00478023|62668070|FG001|Overall Study|Lack of Efficacy|10|||
33291670|NCT00478023|62668071|FG002|Overall Study|Lack of Efficacy|4|||
33291671|NCT00478023|62668072|FG003|Overall Study|Lack of Efficacy|5|||
33291672|NCT00478023|62668073|FG004|Overall Study|Lack of Efficacy|41|||
33291673|NCT00478023|62668069|FG000|Overall Study|Lost to Follow-up|3|||
33291674|NCT00478023|62668070|FG001|Overall Study|Lost to Follow-up|1|||
33291675|NCT00478023|62668071|FG002|Overall Study|Lost to Follow-up|1|||
33291676|NCT00478023|62668072|FG003|Overall Study|Lost to Follow-up|1|||
33291677|NCT00478023|62668073|FG004|Overall Study|Lost to Follow-up|0|||
33291678|NCT00478023|62668069|FG000|Overall Study|Withdrawal by Subject|2|||
33291679|NCT00478023|62668070|FG001|Overall Study|Withdrawal by Subject|3|||
33291680|NCT00478023|62668071|FG002|Overall Study|Withdrawal by Subject|2|||
33291681|NCT00478023|62668072|FG003|Overall Study|Withdrawal by Subject|4|||
33378139|NCT00850343|62756921|FG003|Overall Study|Withdrawal by Subject|2|||
33378140|NCT00850343|62756918|FG000|Overall Study|Adverse Event|15|||
33378141|NCT00850343|62756919|FG001|Overall Study|Adverse Event|2|||
33378142|NCT00850343|62756920|FG002|Overall Study|Adverse Event|6|||
33378143|NCT00850343|62756921|FG003|Overall Study|Adverse Event|6|||
33378144|NCT00850343|62756918|FG000|Overall Study|Pregnancy|0|||
33378145|NCT00850343|62756919|FG001|Overall Study|Pregnancy|0|||
33662391|NCT02163694|63092870|FG000|Overall Study|Adverse event- related to progression|3|||
33291682|NCT00478023|62668073|FG004|Overall Study|Withdrawal by Subject|5|||
33291683|NCT00478023|62668069|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
33378146|NCT00850343|62756920|FG002|Overall Study|Pregnancy|0|||
33378147|NCT00850343|62756921|FG003|Overall Study|Pregnancy|1|||
33378148|NCT00850343|62756918|FG000|Overall Study|Lack of Efficacy|17|||
33291684|NCT00478023|62668070|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
33291685|NCT00478023|62668071|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
33291686|NCT00478023|62668072|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
33378149|NCT00850343|62756919|FG001|Overall Study|Lack of Efficacy|0|||
33378150|NCT00850343|62756920|FG002|Overall Study|Lack of Efficacy|3|||
33291687|NCT00478023|62668073|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
33291688|NCT00477750|62668085|FG000|Overall Study|Currently Receiving Treatment|11|||
33291689|NCT00477672|62668094|FG000|Overall Study|Adverse Event|3|||
33291690|NCT00477672|62668095|FG001|Overall Study|Adverse Event|5|||
33291691|NCT00477672|62668096|FG002|Overall Study|Adverse Event|6|||
33291692|NCT00477672|62668094|FG000|Overall Study|Death|0|||
33291693|NCT00477672|62668095|FG001|Overall Study|Death|1|||
33291694|NCT00477672|62668096|FG002|Overall Study|Death|0|||
33291695|NCT00477672|62668094|FG000|Overall Study|Disease progression|0|||
33291696|NCT00477672|62668095|FG001|Overall Study|Disease progression|1|||
33291697|NCT00477672|62668096|FG002|Overall Study|Disease progression|0|||
33291698|NCT00477672|62668094|FG000|Overall Study|Physician Decision|1|||
33291699|NCT00477672|62668095|FG001|Overall Study|Physician Decision|0|||
33291700|NCT00477672|62668096|FG002|Overall Study|Physician Decision|0|||
33487294|NCT04029519|62865319|FG000|Overall Study|Withdrawal by Subject|3|||
33487295|NCT04029519|62865319|FG000|Overall Study|Lost to Follow-up|1|||
33487296|NCT03669861|62865323|FG000|Overall Study|Disease Flare|5|||
33487297|NCT03669861|62865323|FG000|Overall Study|Lack of Efficacy|2|||
33487298|NCT00127127|62865331|FG000|Overall Study|Adverse Event|0|||
33487299|NCT00127127|62865332|FG001|Overall Study|Adverse Event|2|||
33487300|NCT00127127|62865333|FG002|Overall Study|Adverse Event|0|||
33487301|NCT00127127|62865334|FG003|Overall Study|Adverse Event|1|||
33487302|NCT00127127|62865331|FG000|Overall Study|Lack of Efficacy|1|||
33378151|NCT00850343|62756921|FG003|Overall Study|Lack of Efficacy|2|||
33378152|NCT00850343|62756918|FG000|Overall Study|Non-compliance with Study Procedures|1|||
33378153|NCT00850343|62756919|FG001|Overall Study|Non-compliance with Study Procedures|0|||
33378154|NCT00850343|62756920|FG002|Overall Study|Non-compliance with Study Procedures|1|||
33378155|NCT00850343|62756921|FG003|Overall Study|Non-compliance with Study Procedures|1|||
33378156|NCT00850343|62756918|FG000|Overall Study|Physician Decision|2|||
33378157|NCT00850343|62756919|FG001|Overall Study|Physician Decision|1|||
33378158|NCT00850343|62756920|FG002|Overall Study|Physician Decision|1|||
33378159|NCT00850343|62756921|FG003|Overall Study|Physician Decision|1|||
33378160|NCT00849875|62756934|FG000|Overall Study|Death|28|||
33378161|NCT00849875|62756934|FG000|Overall Study|Ongoing (unknown completion status)|11|||
33487303|NCT00127127|62865332|FG001|Overall Study|Lack of Efficacy|3|||
33487304|NCT00127127|62865333|FG002|Overall Study|Lack of Efficacy|0|||
33487305|NCT00127127|62865334|FG003|Overall Study|Lack of Efficacy|2|||
33487306|NCT03669549|62865371|FG000|Overall Study|Adverse Event|4|||
33487307|NCT03669549|62865371|FG000|Overall Study|Withdrawal by Subject|1|||
33487308|NCT03669549|62865371|FG000|Overall Study|Study terminated by the Sponsor|1|||
33487309|NCT00126659|62865382|FG000|Overall Study|Adverse Event|0|||
33487310|NCT00126659|62865383|FG001|Overall Study|Adverse Event|0|||
33487311|NCT00126659|62865384|FG002|Overall Study|Adverse Event|2|||
33487312|NCT04022733|62865392|FG000|Overall Study|conversion to open surgery|3|||
33487313|NCT04022733|62865393|FG001|Overall Study|conversion to open surgery|2|||
33487314|NCT04022733|62865392|FG000|Overall Study|bradycardia|0|||
33487315|NCT04022733|62865393|FG001|Overall Study|bradycardia|1|||
33487316|NCT03669081|62865401|FG000|Overall Study|Data could not be validated|1|||
33487317|NCT03669081|62865402|FG001|Overall Study|Data could not be validated|1|||
33487318|NCT03667053|62865411|FG000|Overall Study|Withdrawal by Subject|1|||
33487319|NCT03667053|62865412|FG001|Overall Study|Withdrawal by Subject|0|||
33487320|NCT03667053|62865413|FG002|Overall Study|Withdrawal by Subject|0|||
33487321|NCT03631407|62865430|FG000|Overall Study|Withdrawal by Subject|3|||
33487322|NCT03631407|62865431|FG001|Overall Study|Withdrawal by Subject|2|||
33487323|NCT03631407|62865430|FG000|Overall Study|Sponsor Decision|0|||
33487324|NCT03631407|62865431|FG001|Overall Study|Sponsor Decision|2|||
33487325|NCT03631407|62865430|FG000|Overall Study|Death|16|||
33487326|NCT03631407|62865431|FG001|Overall Study|Death|16|||
33487327|NCT03631407|62865430|FG000|Overall Study|Randomized by mistake without study treatment|1|||
33291701|NCT00477672|62668094|FG000|Overall Study|Protocol noncompliance|0|||
33291702|NCT00477672|62668095|FG001|Overall Study|Protocol noncompliance|2|||
33378162|NCT00849875|62756934|FG000|Overall Study|Others|6|||
33378163|NCT00849875|62756934|FG000|Overall Study|Lost to Follow-up|2|||
33378164|NCT00844415|62756945|FG000|Overall Study|Withdrawal by Subject|1|||
33487328|NCT03631407|62865431|FG001|Overall Study|Randomized by mistake without study treatment|0|||
33487329|NCT03630393|62865448|FG000|Overall Study|Death|1|||
33487330|NCT03630393|62865449|FG001|Overall Study|Death|0|||
33487331|NCT03628599|62865466|FG000|Overall Study|Adverse Event|0|||
33291703|NCT00477672|62668096|FG002|Overall Study|Protocol noncompliance|0|||
33378165|NCT00843635|62756953|FG000|Overall Study|Adverse Event|2|||
33378166|NCT00843635|62756954|FG001|Overall Study|Adverse Event|2|||
33378167|NCT00843635|62756955|FG002|Overall Study|Adverse Event|0|||
33378168|NCT00843167|62756969|FG000|Treatment Period|Adverse Event|1|||
33487332|NCT03628599|62865467|FG001|Overall Study|Adverse Event|1|||
33487333|NCT03627195|62865493|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
33487334|NCT03627195|62865494|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
33291704|NCT00477672|62668094|FG000|Overall Study|Consent withdrawn|2|||
33291705|NCT00477672|62668095|FG001|Overall Study|Consent withdrawn|5|||
33291706|NCT00477672|62668096|FG002|Overall Study|Consent withdrawn|10|||
33291707|NCT00477672|62668094|FG000|Overall Study|Discretion of Sponsor|1|||
33291708|NCT00477672|62668095|FG001|Overall Study|Discretion of Sponsor|2|||
33291709|NCT00477672|62668096|FG002|Overall Study|Discretion of Sponsor|0|||
33291710|NCT00477633|62668104|FG000|Overall Study|Did not receive treatment|23|||
33291711|NCT00477633|62668104|FG000|Overall Study|Adverse Event|143|||
33291712|NCT00477633|62668104|FG000|Overall Study|Pregnancy|23|||
33291713|NCT00477633|62668104|FG000|Overall Study|Lost to Follow-up|271|||
33291714|NCT00477633|62668104|FG000|Overall Study|Withdrawal by Subject|149|||
33291715|NCT00477633|62668104|FG000|Overall Study|Protocol Violation|25|||
33291716|NCT00477633|62668104|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
33291717|NCT01131676|62668120|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
33291718|NCT01131676|62668121|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
33291719|NCT01131676|62668122|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
33291720|NCT01131676|62668120|FG000|Discontinuation From Treatment|Not treated|4|||
33291721|NCT01131676|62668121|FG001|Discontinuation From Treatment|Not treated|2|||
33291722|NCT01131676|62668122|FG002|Discontinuation From Treatment|Not treated|2|||
33291723|NCT01131676|62668120|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
33291724|NCT01131676|62668121|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
33291725|NCT01131676|62668122|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
33291726|NCT01131676|62668120|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
33291727|NCT01131676|62668121|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
33291728|NCT01131676|62668122|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
33291729|NCT01131676|62668120|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
33291730|NCT01131676|62668121|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
33291731|NCT01131676|62668122|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
33291732|NCT01131676|62668120|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
33291733|NCT01131676|62668121|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
33291734|NCT01131676|62668122|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
33291735|NCT01131676|62668120|FG000|Discontinuation From Treatment|Other than those specified|162|||
33291736|NCT01131676|62668121|FG001|Discontinuation From Treatment|Other than those specified|142|||
33291737|NCT01131676|62668122|FG002|Discontinuation From Treatment|Other than those specified|125|||
33291738|NCT01131676|62668120|FG000|Discontinuation From Treatment|Adverse Event|303|||
33378169|NCT00843167|62756970|FG001|Treatment Period|Adverse Event|5|||
33378170|NCT00843167|62756969|FG000|Treatment Period|Withdrawal by Subject|2|||
33378171|NCT00843167|62756970|FG001|Treatment Period|Withdrawal by Subject|3|||
33378172|NCT00849017|62756983|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
33378173|NCT00849017|62756984|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
33378174|NCT00849017|62756985|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
33378175|NCT00849017|62756983|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
33378176|NCT00849017|62756984|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
33378177|NCT00849017|62756985|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
33378178|NCT00849017|62756983|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
33378179|NCT00849017|62756984|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
33378180|NCT00849017|62756985|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
33378181|NCT00849017|62756983|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
33378182|NCT00849017|62756984|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
33378183|NCT00849017|62756985|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
33378184|NCT00849017|62756983|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
33487335|NCT03627195|62865495|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
33487336|NCT03627195|62865496|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
33487337|NCT03627195|62865497|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
33487338|NCT03627195|62865498|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
33487339|NCT00126581|62865514|FG000|Overall Study|Adverse Event|3|||
33487340|NCT00126581|62865515|FG001|Overall Study|Adverse Event|7|||
33487341|NCT00126581|62865514|FG000|Overall Study|Death|3|||
33487342|NCT00126581|62865515|FG001|Overall Study|Death|2|||
33487343|NCT00126581|62865514|FG000|Overall Study|Withdrawal by Subject|1|||
33487344|NCT00126581|62865515|FG001|Overall Study|Withdrawal by Subject|4|||
33487345|NCT00126581|62865514|FG000|Overall Study|Alternative therapy|3|||
33556584|NCT01369355|62949449|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
33556585|NCT01369355|62949450|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
33291739|NCT01131676|62668121|FG001|Discontinuation From Treatment|Adverse Event|267|||
33291740|NCT01131676|62668122|FG002|Discontinuation From Treatment|Adverse Event|273|||
33291741|NCT01131676|62668120|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
33378185|NCT00849017|62756984|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
33487346|NCT00126581|62865515|FG001|Overall Study|Alternative therapy|3|||
33487347|NCT00126581|62865514|FG000|Overall Study|Other illness/MD discretion|3|||
33556586|NCT01369355|62949451|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
33487348|NCT00126581|62865515|FG001|Overall Study|Other illness/MD discretion|4|||
33487349|NCT03704584|62865525|FG000|Overall Study|Withdrawal by Subject|1|||
33487350|NCT03704584|62865526|FG001|Overall Study|Withdrawal by Subject|0|||
33487351|NCT03662997|62865536|FG000|Overall Study|Adverse Event|0|||
33487352|NCT03662997|62865537|FG001|Overall Study|Adverse Event|2|||
33487353|NCT03662997|62865538|FG002|Overall Study|Adverse Event|0|||
33487354|NCT03662997|62865539|FG003|Overall Study|Adverse Event|0|||
33487355|NCT03648879|62865551|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
33487356|NCT03647709|62865555|FG000|Overall Study|Lost to Follow-up|5|||
33487357|NCT03647709|62865555|FG000|Overall Study|Physician Decision|6|||
33487358|NCT03647709|62865555|FG000|Overall Study|Withdrawal by Subject|3|||
33487359|NCT03661983|62865561|FG000|Open Label Stabilization Phase|Adverse Event|5|||
33487360|NCT03661983|62865562|FG001|Open Label Stabilization Phase|Adverse Event|0|||
33487361|NCT03661983|62865563|FG002|Open Label Stabilization Phase|Adverse Event|0|||
33487362|NCT03661983|62865564|FG003|Open Label Stabilization Phase|Adverse Event|0|||
33487363|NCT03661983|62865561|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
33487364|NCT03661983|62865562|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
33487365|NCT03661983|62865563|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
33487366|NCT03661983|62865564|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
33487367|NCT03661983|62865561|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
33487368|NCT03661983|62865562|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
33487369|NCT03661983|62865563|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
33487370|NCT03661983|62865564|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
33291742|NCT01131676|62668121|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
33291743|NCT01131676|62668122|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
33291744|NCT01131676|62668120|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
33291745|NCT01131676|62668121|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
33291746|NCT01131676|62668122|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
33291747|NCT01131676|62668120|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
33291748|NCT01131676|62668121|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
33291749|NCT01131676|62668122|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
33291750|NCT01131676|62668120|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
33291751|NCT01131676|62668121|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
33291752|NCT01131676|62668122|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
33291753|NCT01131676|62668120|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
33291754|NCT01131676|62668121|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
33291755|NCT01131676|62668122|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
33291756|NCT01131676|62668120|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
33291757|NCT01131676|62668121|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
33291758|NCT01131676|62668122|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
33291759|NCT01131520|62668144|FG000|Overall Study|Computer problem|1|||
33291760|NCT01131520|62668145|FG001|Overall Study|Computer problem|0|||
33291761|NCT01131520|62668144|FG000|Overall Study|Counselor not available|0|||
33291762|NCT01131520|62668145|FG001|Overall Study|Counselor not available|3|||
33291763|NCT01131520|62668144|FG000|Overall Study|Subject changed history after enrollment|0|||
33291764|NCT01131520|62668145|FG001|Overall Study|Subject changed history after enrollment|1|||
33291765|NCT01131325|62668151|FG000|Overall Study|Adverse Event|1|||
33291766|NCT01131325|62668151|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
33291767|NCT01131130|62668155|FG000|Period 1 - Baseline|Pregnancy|1|||
33291768|NCT01131130|62668155|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
33291769|NCT01130974|62668165|FG000|Overall Study|Protocol Violation|10|||
33291770|NCT01130974|62668166|FG001|Overall Study|Protocol Violation|10|||
33291771|NCT01130974|62668165|FG000|Overall Study|Withdrawal by Subject|0|||
33291772|NCT01130974|62668166|FG001|Overall Study|Withdrawal by Subject|1|||
33291773|NCT01130974|62668165|FG000|Overall Study|Ineligibility criteria|5|||
33291774|NCT01130974|62668166|FG001|Overall Study|Ineligibility criteria|2|||
33291775|NCT01130272|62668178|FG000|Overall Study|Adverse Event|2|||
33291776|NCT01130272|62668179|FG001|Overall Study|Adverse Event|5|||
33291777|NCT01130272|62668180|FG002|Overall Study|Adverse Event|6|||
33291778|NCT01130272|62668181|FG003|Overall Study|Adverse Event|22|||
33291779|NCT01130272|62668182|FG004|Overall Study|Adverse Event|7|||
33291780|NCT01130272|62668178|FG000|Overall Study|IVRS-confirmed constipation|0|||
33291781|NCT01130272|62668179|FG001|Overall Study|IVRS-confirmed constipation|1|||
33291782|NCT01130272|62668180|FG002|Overall Study|IVRS-confirmed constipation|1|||
33487371|NCT03661983|62865561|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
33487372|NCT03661983|62865562|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
33662392|NCT02163694|63092871|FG001|Overall Study|Adverse event- related to progression|8|||
33378186|NCT00849017|62756985|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
33378187|NCT00849017|62756983|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
33378188|NCT00849017|62756984|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
33378189|NCT00849017|62756985|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
33378190|NCT00849017|62756983|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
33378191|NCT00849017|62756984|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
33378192|NCT00849017|62756985|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
33378193|NCT00849017|62756983|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
33378194|NCT00849017|62756984|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
33378195|NCT00849017|62756985|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
33378196|NCT00849017|62756983|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
33378197|NCT00849017|62756984|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
33378198|NCT00849017|62756985|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
33378199|NCT00849017|62756983|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
33378200|NCT00849017|62756984|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
33378201|NCT00849017|62756985|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
33378202|NCT00849017|62756983|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
33378203|NCT00849017|62756984|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
33378204|NCT00849017|62756985|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
33378205|NCT00849017|62756983|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
33378206|NCT00849017|62756984|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
33378207|NCT00849017|62756985|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
33378208|NCT00849017|62756983|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
33378209|NCT00849017|62756984|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
33378210|NCT00849017|62756985|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
33378211|NCT00849017|62756983|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
33378212|NCT00849017|62756984|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
33378213|NCT00849017|62756985|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
33378214|NCT00849017|62756983|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
33378215|NCT00849017|62756984|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
33378216|NCT00849017|62756985|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
33378217|NCT00849017|62756983|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
33378218|NCT00849017|62756984|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
33378219|NCT00849017|62756985|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
33378220|NCT00849017|62756983|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
33378221|NCT00849017|62756984|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
33378222|NCT00849017|62756985|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
33378223|NCT00849017|62756983|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
33378224|NCT00849017|62756984|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
33378225|NCT00849017|62756985|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
33378226|NCT00849017|62756983|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
33378227|NCT00849017|62756984|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
33378228|NCT00849017|62756985|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
33378229|NCT00842543|62757001|FG000|Overall Study|Withdrawal by Subject|2|||
33378230|NCT00842543|62757002|FG001|Overall Study|Withdrawal by Subject|0|||
33378231|NCT00842543|62757003|FG002|Overall Study|Withdrawal by Subject|3|||
33378232|NCT00842543|62757004|FG003|Overall Study|Withdrawal by Subject|4|||
33378233|NCT00785928|62757023|FG000|Treatment Phase|Adverse Event|1|||
33378234|NCT00785928|62757024|FG001|Treatment Phase|Adverse Event|1|||
33378235|NCT00785928|62757025|FG002|Treatment Phase|Adverse Event|2|||
33378236|NCT00785928|62757026|FG003|Treatment Phase|Adverse Event|0|||
33291783|NCT01130272|62668181|FG003|Overall Study|IVRS-confirmed constipation|2|||
33291784|NCT01130272|62668182|FG004|Overall Study|IVRS-confirmed constipation|0|||
33291785|NCT01130272|62668178|FG000|Overall Study|Rescue medications due to diarrhea|3|||
33291786|NCT01130272|62668179|FG001|Overall Study|Rescue medications due to diarrhea|5|||
33291787|NCT01130272|62668180|FG002|Overall Study|Rescue medications due to diarrhea|8|||
33291788|NCT01130272|62668181|FG003|Overall Study|Rescue medications due to diarrhea|8|||
33291789|NCT01130272|62668182|FG004|Overall Study|Rescue medications due to diarrhea|6|||
33291790|NCT01130272|62668178|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
33291791|NCT01130272|62668179|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
33291792|NCT01130272|62668180|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
33291793|NCT01130272|62668181|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
33291794|NCT01130272|62668182|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
33291795|NCT01130272|62668178|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
33291796|NCT01130272|62668179|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
33291797|NCT01130272|62668180|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
33378237|NCT00785928|62757027|FG004|Treatment Phase|Adverse Event|0|||
33378238|NCT00785928|62757028|FG005|Treatment Phase|Adverse Event|0|||
33378239|NCT00785928|62757029|FG006|Treatment Phase|Adverse Event|2|||
33378240|NCT00785928|62757023|FG000|Treatment Phase|Inadequate Response|0|||
33378241|NCT00785928|62757024|FG001|Treatment Phase|Inadequate Response|1|||
33378242|NCT00785928|62757025|FG002|Treatment Phase|Inadequate Response|0|||
33378243|NCT00785928|62757026|FG003|Treatment Phase|Inadequate Response|0|||
33291798|NCT01130272|62668181|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
33291799|NCT01130272|62668182|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
33291800|NCT01130272|62668178|FG000|Overall Study|Protocol Violation|0|||
33291801|NCT01130272|62668179|FG001|Overall Study|Protocol Violation|0|||
33291802|NCT01130272|62668180|FG002|Overall Study|Protocol Violation|3|||
33291803|NCT01130272|62668181|FG003|Overall Study|Protocol Violation|5|||
33291804|NCT01130272|62668182|FG004|Overall Study|Protocol Violation|5|||
33291805|NCT01130272|62668178|FG000|Overall Study|Lost to Follow-up|4|||
33291806|NCT01130272|62668179|FG001|Overall Study|Lost to Follow-up|3|||
33291807|NCT01130272|62668180|FG002|Overall Study|Lost to Follow-up|4|||
33291808|NCT01130272|62668181|FG003|Overall Study|Lost to Follow-up|7|||
33291809|NCT01130272|62668182|FG004|Overall Study|Lost to Follow-up|6|||
33291810|NCT01130272|62668178|FG000|Overall Study|Withdrawal by Subject|4|||
33291811|NCT01130272|62668179|FG001|Overall Study|Withdrawal by Subject|11|||
33291812|NCT01130272|62668180|FG002|Overall Study|Withdrawal by Subject|10|||
33291813|NCT01130272|62668181|FG003|Overall Study|Withdrawal by Subject|9|||
33291814|NCT01130272|62668182|FG004|Overall Study|Withdrawal by Subject|8|||
33291815|NCT01130272|62668178|FG000|Overall Study|Physician Decision|1|||
33378244|NCT00785928|62757027|FG004|Treatment Phase|Inadequate Response|0|||
33378245|NCT00785928|62757028|FG005|Treatment Phase|Inadequate Response|0|||
33378246|NCT00785928|62757029|FG006|Treatment Phase|Inadequate Response|0|||
33378247|NCT00785928|62757023|FG000|Treatment Phase|Lack of Efficacy|0|||
33378248|NCT00785928|62757024|FG001|Treatment Phase|Lack of Efficacy|1|||
33378249|NCT00785928|62757025|FG002|Treatment Phase|Lack of Efficacy|1|||
33378250|NCT00785928|62757026|FG003|Treatment Phase|Lack of Efficacy|0|||
33378251|NCT00785928|62757027|FG004|Treatment Phase|Lack of Efficacy|0|||
33378252|NCT00785928|62757028|FG005|Treatment Phase|Lack of Efficacy|0|||
33378253|NCT00785928|62757029|FG006|Treatment Phase|Lack of Efficacy|0|||
33378254|NCT00785928|62757023|FG000|Treatment Phase|Physician Decision|0|||
33378255|NCT00785928|62757024|FG001|Treatment Phase|Physician Decision|0|||
33378256|NCT00785928|62757025|FG002|Treatment Phase|Physician Decision|0|||
33378257|NCT00785928|62757026|FG003|Treatment Phase|Physician Decision|0|||
33378258|NCT00785928|62757027|FG004|Treatment Phase|Physician Decision|1|||
33378259|NCT00785928|62757028|FG005|Treatment Phase|Physician Decision|0|||
33378260|NCT00785928|62757029|FG006|Treatment Phase|Physician Decision|0|||
33378261|NCT00785928|62757023|FG000|Treatment Phase|Sponsor Decision|1|||
33378262|NCT00785928|62757024|FG001|Treatment Phase|Sponsor Decision|0|||
33378263|NCT00785928|62757025|FG002|Treatment Phase|Sponsor Decision|0|||
33378264|NCT00785928|62757026|FG003|Treatment Phase|Sponsor Decision|0|||
33378265|NCT00785928|62757027|FG004|Treatment Phase|Sponsor Decision|0|||
33378266|NCT00785928|62757028|FG005|Treatment Phase|Sponsor Decision|0|||
33378267|NCT00785928|62757029|FG006|Treatment Phase|Sponsor Decision|1|||
33378268|NCT00785928|62757023|FG000|Treatment Phase|Withdrawal by Subject|1|||
33378269|NCT00785928|62757024|FG001|Treatment Phase|Withdrawal by Subject|2|||
33378270|NCT00785928|62757025|FG002|Treatment Phase|Withdrawal by Subject|0|||
33291816|NCT01130272|62668179|FG001|Overall Study|Physician Decision|1|||
33487373|NCT03661983|62865563|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
33487374|NCT03661983|62865564|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
33487375|NCT03661983|62865561|FG000|Double-blind Randomized Phase|Adverse Event|0|||
33487376|NCT03661983|62865562|FG001|Double-blind Randomized Phase|Adverse Event|1|||
33487377|NCT03661983|62865563|FG002|Double-blind Randomized Phase|Adverse Event|0|||
33487378|NCT03661983|62865564|FG003|Double-blind Randomized Phase|Adverse Event|0|||
33291817|NCT01130272|62668180|FG002|Overall Study|Physician Decision|0|||
33291818|NCT01130272|62668181|FG003|Overall Study|Physician Decision|1|||
33291819|NCT01130272|62668182|FG004|Overall Study|Physician Decision|2|||
33291820|NCT01130272|62668178|FG000|Overall Study|Sponsor decision|6|||
33291821|NCT01130272|62668179|FG001|Overall Study|Sponsor decision|15|||
33291822|NCT01130272|62668180|FG002|Overall Study|Sponsor decision|16|||
33291823|NCT01130272|62668181|FG003|Overall Study|Sponsor decision|13|||
33378271|NCT00785928|62757026|FG003|Treatment Phase|Withdrawal by Subject|0|||
33378272|NCT00785928|62757027|FG004|Treatment Phase|Withdrawal by Subject|1|||
33378273|NCT00785928|62757028|FG005|Treatment Phase|Withdrawal by Subject|0|||
33378274|NCT00785928|62757029|FG006|Treatment Phase|Withdrawal by Subject|0|||
33378275|NCT00842309|62757069|FG000|Overall Study|Withdrawal by Subject|3|||
33662393|NCT02163694|63092870|FG000|Overall Study|Adverse event- not related to progression|7|||
33291824|NCT01130272|62668182|FG004|Overall Study|Sponsor decision|16|||
33378276|NCT00842309|62757070|FG001|Overall Study|Withdrawal by Subject|1|||
33378277|NCT00842153|62757078|FG000|Overall Study|Adverse Event|0|||
33291825|NCT01130272|62668178|FG000|Overall Study|Study arm discontinued|38|||
33291826|NCT01130272|62668179|FG001|Overall Study|Study arm discontinued|0|||
33291827|NCT01130272|62668180|FG002|Overall Study|Study arm discontinued|0|||
33291828|NCT01130272|62668181|FG003|Overall Study|Study arm discontinued|0|||
33378278|NCT00842153|62757079|FG001|Overall Study|Adverse Event|1|||
33378279|NCT00842153|62757078|FG000|Overall Study|Lost to Follow-up|1|||
33378280|NCT00842153|62757079|FG001|Overall Study|Lost to Follow-up|2|||
33378281|NCT00762411|62757087|FG000|Initial Treatment|Death|7|||
33378282|NCT00762411|62757088|FG001|Initial Treatment|Death|6|||
33378283|NCT00762411|62757087|FG000|Initial Treatment|Adverse Event|132|||
33378284|NCT00762411|62757088|FG001|Initial Treatment|Adverse Event|40|||
33378285|NCT00762411|62757087|FG000|Initial Treatment|Protocol Violation|4|||
33378286|NCT00762411|62757088|FG001|Initial Treatment|Protocol Violation|1|||
33378287|NCT00762411|62757087|FG000|Initial Treatment|Withdrawal by Subject|65|||
33378288|NCT00762411|62757088|FG001|Initial Treatment|Withdrawal by Subject|52|||
33378289|NCT00762411|62757087|FG000|Initial Treatment|Physician Decision|1|||
33378290|NCT00762411|62757088|FG001|Initial Treatment|Physician Decision|0|||
33378291|NCT00762411|62757087|FG000|Initial Treatment|Sponsor Decision|293|||
33378292|NCT00762411|62757088|FG001|Initial Treatment|Sponsor Decision|401|||
33378293|NCT00762411|62757087|FG000|Initial Treatment|Lost to Follow-up|5|||
33378294|NCT00762411|62757088|FG001|Initial Treatment|Lost to Follow-up|0|||
33378295|NCT00762411|62757087|FG000|Initial Treatment|Caregiver Decision|21|||
33378296|NCT00762411|62757088|FG001|Initial Treatment|Caregiver Decision|16|||
33378297|NCT00762411|62757087|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
33378298|NCT00762411|62757088|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
33378299|NCT00762411|62757087|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
33378300|NCT00762411|62757088|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
33378301|NCT00762411|62757087|FG000|Delayed Start|Adverse Event|0|||
33378302|NCT00762411|62757088|FG001|Delayed Start|Adverse Event|4|||
33378303|NCT00762411|62757087|FG000|Delayed Start|Protocol Violation|0|||
33378304|NCT00762411|62757088|FG001|Delayed Start|Protocol Violation|1|||
33378305|NCT00762411|62757087|FG000|Delayed Start|Sponsor Decision|16|||
33378306|NCT00762411|62757088|FG001|Delayed Start|Sponsor Decision|20|||
33378307|NCT00762411|62757087|FG000|Delayed Start|Caregiver Decision|1|||
33378308|NCT00762411|62757088|FG001|Delayed Start|Caregiver Decision|1|||
33378309|NCT00762411|62757087|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
33378310|NCT00762411|62757088|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
33378311|NCT00762411|62757087|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
33378312|NCT00762411|62757088|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
33378313|NCT00762411|62757087|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
33378314|NCT00762411|62757088|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
33378315|NCT00762411|62757087|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
33378316|NCT00762411|62757088|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
33378317|NCT00762411|62757087|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
33378318|NCT00762411|62757088|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
33378319|NCT00762411|62757087|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
33378320|NCT00762411|62757088|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
33378321|NCT00761865|62757100|FG000|Overall Study|Lost to Follow-up|8|||
33378322|NCT00761865|62757101|FG001|Overall Study|Lost to Follow-up|7|||
33378323|NCT00841763|62757109|FG000|Overall Study|Withdrawal by Subject|60|||
33378324|NCT00841763|62757110|FG001|Overall Study|Withdrawal by Subject|17|||
33378325|NCT00841763|62757111|FG002|Overall Study|Withdrawal by Subject|4|||
33378326|NCT00841763|62757112|FG003|Overall Study|Withdrawal by Subject|1|||
33378327|NCT00841763|62757109|FG000|Overall Study|Adverse Event|9|||
33378328|NCT00841763|62757110|FG001|Overall Study|Adverse Event|10|||
33378329|NCT00841763|62757111|FG002|Overall Study|Adverse Event|3|||
33378330|NCT00841763|62757112|FG003|Overall Study|Adverse Event|2|||
33291829|NCT01130272|62668182|FG004|Overall Study|Study arm discontinued|0|||
33291830|NCT01129960|62668198|FG000|Overall Study|Withdrawal by Subject|3|||
33291831|NCT01129960|62668199|FG001|Overall Study|Withdrawal by Subject|0|||
33291832|NCT01129960|62668200|FG002|Overall Study|Withdrawal by Subject|3|||
33291833|NCT01129960|62668201|FG003|Overall Study|Withdrawal by Subject|2|||
33291834|NCT01129960|62668198|FG000|Overall Study|Lack of Efficacy|1|||
33291835|NCT01129960|62668199|FG001|Overall Study|Lack of Efficacy|1|||
33291836|NCT01129960|62668200|FG002|Overall Study|Lack of Efficacy|1|||
33291837|NCT01129960|62668201|FG003|Overall Study|Lack of Efficacy|1|||
33291838|NCT01129960|62668198|FG000|Overall Study|Adverse Event|23|||
33291839|NCT01129960|62668199|FG001|Overall Study|Adverse Event|16|||
33291840|NCT01129960|62668200|FG002|Overall Study|Adverse Event|16|||
33378331|NCT00841763|62757109|FG000|Overall Study|Lost to Follow-up|63|||
33378332|NCT00841763|62757110|FG001|Overall Study|Lost to Follow-up|25|||
33378333|NCT00841763|62757111|FG002|Overall Study|Lost to Follow-up|0|||
33378334|NCT00841763|62757112|FG003|Overall Study|Lost to Follow-up|0|||
33291841|NCT01129960|62668201|FG003|Overall Study|Adverse Event|7|||
33378335|NCT00841763|62757109|FG000|Overall Study|Protocol Violation|20|||
33378336|NCT00841763|62757110|FG001|Overall Study|Protocol Violation|3|||
33378337|NCT00841763|62757111|FG002|Overall Study|Protocol Violation|1|||
33378338|NCT00841763|62757112|FG003|Overall Study|Protocol Violation|0|||
33378339|NCT00841763|62757109|FG000|Overall Study|Administrative Reasons|3|||
33378340|NCT00841763|62757110|FG001|Overall Study|Administrative Reasons|1|||
33378341|NCT00841763|62757111|FG002|Overall Study|Administrative Reasons|0|||
33378342|NCT00841763|62757112|FG003|Overall Study|Administrative Reasons|0|||
33378343|NCT00841763|62757109|FG000|Overall Study|Unable to Classify|7|||
33378344|NCT00841763|62757110|FG001|Overall Study|Unable to Classify|1|||
33378345|NCT00841763|62757111|FG002|Overall Study|Unable to Classify|0|||
33378346|NCT00841763|62757112|FG003|Overall Study|Unable to Classify|0|||
33378347|NCT00838331|62757157|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
33378348|NCT00785538|62757165|FG000|Treatment Period|Adverse Event|1|||
33378349|NCT00785538|62757166|FG001|Treatment Period|Adverse Event|2|||
33378350|NCT00785538|62757167|FG002|Treatment Period|Adverse Event|2|||
33378351|NCT00785538|62757168|FG003|Treatment Period|Adverse Event|0|||
33378352|NCT00785538|62757165|FG000|Treatment Period|Withdrawal by Subject|0|||
33378353|NCT00785538|62757166|FG001|Treatment Period|Withdrawal by Subject|0|||
33378354|NCT00785538|62757167|FG002|Treatment Period|Withdrawal by Subject|0|||
33378355|NCT00785538|62757168|FG003|Treatment Period|Withdrawal by Subject|1|||
33378356|NCT00860405|62757181|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
33291842|NCT01129960|62668198|FG000|Overall Study|Protocol Violation|1|||
33291843|NCT01129960|62668199|FG001|Overall Study|Protocol Violation|2|||
33291844|NCT01129960|62668200|FG002|Overall Study|Protocol Violation|3|||
33291845|NCT01129960|62668201|FG003|Overall Study|Protocol Violation|0|||
33291846|NCT01129960|62668198|FG000|Overall Study|Lost to Follow-up|0|||
33378357|NCT00860405|62757182|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
33378358|NCT00838097|62757188|FG000|Overall Study|Ineligibility determined|6|||
33378359|NCT00838097|62757188|FG000|Overall Study|Adverse Event|2|||
33378360|NCT00838097|62757188|FG000|Overall Study|Withdrawal by Subject|3|||
33378361|NCT00838097|62757188|FG000|Overall Study|Requirement for alternative therapy|2|||
33378362|NCT00838097|62757188|FG000|Overall Study|Physician Decision|4|||
33378363|NCT00838097|62757188|FG000|Overall Study|Lost to Follow-up|11|||
33378364|NCT00838097|62757188|FG000|Overall Study|Death|6|||
33378365|NCT00838097|62757188|FG000|Overall Study|Protocol-specified criteria|142|||
33378366|NCT00840827|62757192|FG000|Overall Study|Adverse Event|1|||
33378367|NCT00840827|62757192|FG000|Overall Study|Lack of Efficacy|4|||
33378368|NCT00840827|62757192|FG000|Overall Study|Physician Decision|1|||
33378369|NCT00860249|62757199|FG000|Overall Study|trial was terminated prior to completion|21|||
33378370|NCT00860249|62757200|FG001|Overall Study|trial was terminated prior to completion|18|||
33378371|NCT00860249|62757201|FG002|Overall Study|trial was terminated prior to completion|21|||
33378372|NCT00840749|62757211|FG000|Overall Study|Death|1|||
33378373|NCT00840749|62757212|FG001|Overall Study|Death|2|||
33378374|NCT00840749|62757211|FG000|Overall Study|not treated on study arm|11|||
33378375|NCT00840749|62757212|FG001|Overall Study|not treated on study arm|11|||
33378376|NCT00840749|62757211|FG000|Overall Study|study closed|19|||
33378377|NCT00840749|62757212|FG001|Overall Study|study closed|14|||
33378378|NCT00859937|62757220|FG000|Overall Study|Protocol Violation|1|||
33291847|NCT01129960|62668199|FG001|Overall Study|Lost to Follow-up|2|||
33378379|NCT00859937|62757221|FG001|Overall Study|Protocol Violation|0|||
33378380|NCT00592007|62757227|FG000|Overall Study|Withdrawal by Subject|1|||
33378381|NCT00592007|62757227|FG000|Overall Study|patient ineligible (out of lab range)|1|||
33378382|NCT00837473|62757231|FG000|Overall Study|Lost to Follow-up|1|||
33378383|NCT00837473|62757231|FG000|Overall Study|Withdrawal by Subject|2|||
33378384|NCT00839423|62757239|FG000|Overall Study|Adverse Event|4|||
33378385|NCT00839423|62757240|FG001|Overall Study|Adverse Event|3|||
33291848|NCT01129960|62668200|FG002|Overall Study|Lost to Follow-up|3|||
33291849|NCT01129960|62668201|FG003|Overall Study|Lost to Follow-up|3|||
33291850|NCT01129960|62668198|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
33291851|NCT01129960|62668199|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
33291852|NCT01129960|62668200|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
33291853|NCT01129960|62668201|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
33291854|NCT01129960|62668198|FG000|Overall Study|Physician Decision|1|||
33291855|NCT01129960|62668199|FG001|Overall Study|Physician Decision|0|||
33291856|NCT01129960|62668200|FG002|Overall Study|Physician Decision|0|||
33291857|NCT01129960|62668201|FG003|Overall Study|Physician Decision|0|||
33378386|NCT00839423|62757241|FG002|Overall Study|Adverse Event|7|||
33378387|NCT00839423|62757242|FG003|Overall Study|Adverse Event|16|||
33378388|NCT00839423|62757239|FG000|Overall Study|Lack of Efficacy|6|||
33378389|NCT00839423|62757240|FG001|Overall Study|Lack of Efficacy|6|||
33291858|NCT01129960|62668198|FG000|Overall Study|Pregnancy|1|||
33291859|NCT01129960|62668199|FG001|Overall Study|Pregnancy|0|||
33291860|NCT01129960|62668200|FG002|Overall Study|Pregnancy|0|||
33378390|NCT00839423|62757241|FG002|Overall Study|Lack of Efficacy|3|||
33378391|NCT00839423|62757242|FG003|Overall Study|Lack of Efficacy|2|||
33378392|NCT00839423|62757239|FG000|Overall Study|Non-compliance|0|||
33378393|NCT00839423|62757240|FG001|Overall Study|Non-compliance|0|||
33378394|NCT00839423|62757241|FG002|Overall Study|Non-compliance|0|||
33378395|NCT00839423|62757242|FG003|Overall Study|Non-compliance|1|||
33378396|NCT00839423|62757239|FG000|Overall Study|Protocol Violation|0|||
33378397|NCT00839423|62757240|FG001|Overall Study|Protocol Violation|1|||
33378398|NCT00839423|62757241|FG002|Overall Study|Protocol Violation|2|||
33378399|NCT00839423|62757242|FG003|Overall Study|Protocol Violation|0|||
33291861|NCT01129960|62668201|FG003|Overall Study|Pregnancy|0|||
33291862|NCT01129921|62668213|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
33291863|NCT01129921|62668214|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
33291864|NCT01129921|62668213|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
33291865|NCT01129921|62668214|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
33291866|NCT01129921|62668213|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
33291867|NCT01129921|62668214|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
33378400|NCT00839423|62757239|FG000|Overall Study|Withdrawal of consent|4|||
33378401|NCT00839423|62757240|FG001|Overall Study|Withdrawal of consent|0|||
33378402|NCT00839423|62757241|FG002|Overall Study|Withdrawal of consent|4|||
33378403|NCT00839423|62757242|FG003|Overall Study|Withdrawal of consent|1|||
33378404|NCT00839423|62757239|FG000|Overall Study|Lost to Follow-up|1|||
33378405|NCT00839423|62757240|FG001|Overall Study|Lost to Follow-up|0|||
33378406|NCT00839423|62757241|FG002|Overall Study|Lost to Follow-up|1|||
33291868|NCT01129921|62668213|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
33291869|NCT01129921|62668214|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
33291870|NCT01129882|62668233|FG000|Overall Study|Adverse Event|39|||
33291871|NCT01129882|62668233|FG000|Overall Study|Death|6|||
33291872|NCT01129882|62668233|FG000|Overall Study|Lack of Efficacy|5|||
33291873|NCT01129882|62668233|FG000|Overall Study|Lost to Follow-up|13|||
33291874|NCT01129882|62668233|FG000|Overall Study|Physician Decision|27|||
33291875|NCT01129882|62668233|FG000|Overall Study|Protocol Deviation|3|||
33291876|NCT01129882|62668233|FG000|Overall Study|Withdrawal Criteria Met|19|||
33378407|NCT00839423|62757242|FG003|Overall Study|Lost to Follow-up|0|||
33378408|NCT00839423|62757239|FG000|Overall Study|Administrative or other reasons|3|||
33378409|NCT00839423|62757240|FG001|Overall Study|Administrative or other reasons|0|||
33378410|NCT00839423|62757241|FG002|Overall Study|Administrative or other reasons|1|||
33378411|NCT00839423|62757242|FG003|Overall Study|Administrative or other reasons|0|||
33378412|NCT00837161|62757252|FG000|Overall Study|refused hysterectomy|2|||
33378413|NCT00859547|62757256|FG000|Overall Study|Lost to Follow-up|1|||
33378414|NCT00859547|62757256|FG000|Overall Study|Parent withdrew consent|1|||
33378415|NCT00859469|62757260|FG000|Overall Study|Adverse Event|2|||
33378416|NCT00859469|62757260|FG000|Overall Study|Lack of Efficacy|9|||
33378417|NCT00859469|62757260|FG000|Overall Study|Withdrawal by Subject|1|||
33378418|NCT00859469|62757260|FG000|Overall Study|Death|16|||
33378419|NCT00859313|62757264|FG000|Overall Study|Lack of Efficacy|2|||
33378420|NCT00859313|62757264|FG000|Overall Study|Adverse Event|1|||
33378421|NCT00859313|62757264|FG000|Overall Study|staff error|1|||
33378422|NCT00771810|62757271|FG000|Overall Study|Adverse Event|3|||
33378423|NCT00771810|62757272|FG001|Overall Study|Adverse Event|0|||
33378424|NCT00771810|62757273|FG002|Overall Study|Adverse Event|2|||
33378425|NCT00771810|62757271|FG000|Overall Study|Lost to Follow-up|0|||
33378426|NCT00771810|62757272|FG001|Overall Study|Lost to Follow-up|0|||
33378427|NCT00771810|62757273|FG002|Overall Study|Lost to Follow-up|1|||
33378428|NCT00771810|62757271|FG000|Overall Study|Physician Decision|1|||
33378429|NCT00771810|62757272|FG001|Overall Study|Physician Decision|2|||
33378430|NCT00771810|62757273|FG002|Overall Study|Physician Decision|2|||
33378431|NCT00771810|62757271|FG000|Overall Study|Protocol Violation|0|||
33378432|NCT00771810|62757272|FG001|Overall Study|Protocol Violation|1|||
33378433|NCT00771810|62757273|FG002|Overall Study|Protocol Violation|1|||
33378434|NCT00771810|62757271|FG000|Overall Study|Withdrawal by Subject|1|||
33378435|NCT00771810|62757272|FG001|Overall Study|Withdrawal by Subject|2|||
33378436|NCT00771810|62757273|FG002|Overall Study|Withdrawal by Subject|0|||
33378437|NCT00771810|62757271|FG000|Overall Study|Other|0|||
33378438|NCT00771810|62757272|FG001|Overall Study|Other|0|||
33378439|NCT00771810|62757273|FG002|Overall Study|Other|1|||
33378440|NCT00836927|62757287|FG000|Overall Study|Progressive disease|2|||
33378441|NCT00836927|62757288|FG001|Overall Study|Progressive disease|0|||
33378442|NCT00836927|62757289|FG002|Overall Study|Progressive disease|0|||
33378443|NCT00836927|62757290|FG003|Overall Study|Progressive disease|1|||
33487379|NCT03661983|62865561|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
33487380|NCT03661983|62865562|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
33487381|NCT03661983|62865563|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
33487382|NCT03661983|62865564|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
33291877|NCT01129882|62668233|FG000|Overall Study|Trial Termination by Sponsor|6|||
33291878|NCT01129882|62668233|FG000|Overall Study|Withdrawal by Subject|160|||
33291879|NCT01129102|62668240|FG000|Overall Study|No study drug treatment|2|||
33378444|NCT00836927|62757291|FG004|Overall Study|Progressive disease|1|||
33378445|NCT00836927|62757287|FG000|Overall Study|Withdrawal by Subject|1|||
33378446|NCT00836927|62757288|FG001|Overall Study|Withdrawal by Subject|0|||
33378447|NCT00836927|62757289|FG002|Overall Study|Withdrawal by Subject|0|||
33378448|NCT00836927|62757290|FG003|Overall Study|Withdrawal by Subject|0|||
33378449|NCT00836927|62757291|FG004|Overall Study|Withdrawal by Subject|0|||
33378450|NCT00771030|62757312|FG000|Overall Study|Adverse Event|0|||
33378451|NCT00771030|62757313|FG001|Overall Study|Adverse Event|1|||
33378452|NCT00771030|62757314|FG002|Overall Study|Adverse Event|0|||
33378453|NCT00771030|62757315|FG003|Overall Study|Adverse Event|0|||
33378454|NCT00771030|62757316|FG004|Overall Study|Adverse Event|0|||
33378455|NCT00771030|62757317|FG005|Overall Study|Adverse Event|0|||
33378456|NCT00771030|62757318|FG006|Overall Study|Adverse Event|0|||
33378457|NCT00768300|62757341|FG000|Overall Study|Randomized but not treated|1|||
33378458|NCT00768300|62757342|FG001|Overall Study|Randomized but not treated|1|||
33378459|NCT00768300|62757341|FG000|Overall Study|Adverse Event|10|||
33378460|NCT00768300|62757342|FG001|Overall Study|Adverse Event|2|||
33378461|NCT00768300|62757341|FG000|Overall Study|Protocol Violation|6|||
33378462|NCT00768300|62757342|FG001|Overall Study|Protocol Violation|1|||
33378463|NCT00768300|62757341|FG000|Overall Study|Withdrawal by Subject|13|||
33378464|NCT00768300|62757342|FG001|Overall Study|Withdrawal by Subject|7|||
33378465|NCT00768300|62757341|FG000|Overall Study|Physician Decision|2|||
33378466|NCT00768300|62757342|FG001|Overall Study|Physician Decision|3|||
33378467|NCT00768300|62757341|FG000|Overall Study|Study discontinued by Sponsor|271|||
33291880|NCT01129102|62668241|FG001|Overall Study|No study drug treatment|3|||
33291881|NCT01129102|62668242|FG002|Overall Study|No study drug treatment|1|||
33291882|NCT01129102|62668240|FG000|Overall Study|Withdrawal by Subject|2|||
33291883|NCT01129102|62668241|FG001|Overall Study|Withdrawal by Subject|0|||
33291884|NCT01129102|62668242|FG002|Overall Study|Withdrawal by Subject|3|||
33291885|NCT01129102|62668240|FG000|Overall Study|Protocol Violation|0|||
33291886|NCT01129102|62668241|FG001|Overall Study|Protocol Violation|1|||
33291887|NCT01129102|62668242|FG002|Overall Study|Protocol Violation|1|||
33291888|NCT01129102|62668240|FG000|Overall Study|Pregnancy|0|||
33291889|NCT01129102|62668241|FG001|Overall Study|Pregnancy|0|||
33291890|NCT01129102|62668242|FG002|Overall Study|Pregnancy|1|||
33291891|NCT01129102|62668240|FG000|Overall Study|Adverse Event|2|||
33291892|NCT01129102|62668241|FG001|Overall Study|Adverse Event|2|||
33291893|NCT01129102|62668242|FG002|Overall Study|Adverse Event|1|||
33291894|NCT01129102|62668240|FG000|Overall Study|Lost to Follow-up|2|||
33291895|NCT01129102|62668241|FG001|Overall Study|Lost to Follow-up|0|||
33291896|NCT01129102|62668242|FG002|Overall Study|Lost to Follow-up|0|||
33291897|NCT01129024|62668249|FG000|Overall Study|Physician Decision|5|||
33291898|NCT01129024|62668249|FG000|Overall Study|Study Terminated by Sponsor|8|||
33291899|NCT01129024|62668249|FG000|Overall Study|Withdrawal by Subject|2|||
33291900|NCT01129024|62668249|FG000|Overall Study|Lack of Efficacy|3|||
33291901|NCT01129024|62668249|FG000|Overall Study|Needed a Platelet Transfusion|1|||
33291902|NCT01128946|62668253|FG000|Period I|Protocol Violation|0|||
33291903|NCT01128946|62668254|FG001|Period I|Protocol Violation|1|||
33291904|NCT01128946|62668255|FG002|Period I|Protocol Violation|0|||
33291905|NCT01128946|62668256|FG003|Period I|Protocol Violation|0|||
33291906|NCT01128946|62668253|FG000|Period I|Withdrawal by Subject|0|||
33291907|NCT01128946|62668254|FG001|Period I|Withdrawal by Subject|0|||
33291908|NCT01128946|62668255|FG002|Period I|Withdrawal by Subject|1|||
33291909|NCT01128946|62668256|FG003|Period I|Withdrawal by Subject|1|||
33291910|NCT01128946|62668253|FG000|Period II|Protocol Violation|0|||
33291911|NCT01128946|62668254|FG001|Period II|Protocol Violation|1|||
33291912|NCT01128946|62668255|FG002|Period II|Protocol Violation|0|||
33291913|NCT01128946|62668256|FG003|Period II|Protocol Violation|0|||
33291914|NCT01128946|62668253|FG000|Period II|Withdrawal by Subject|0|||
33291915|NCT01128946|62668254|FG001|Period II|Withdrawal by Subject|0|||
33291916|NCT01128946|62668255|FG002|Period II|Withdrawal by Subject|0|||
33291917|NCT01128946|62668256|FG003|Period II|Withdrawal by Subject|1|||
33291918|NCT01128946|62668253|FG000|Period III|Protocol Violation|1|||
33291919|NCT01128946|62668254|FG001|Period III|Protocol Violation|0|||
33291920|NCT01128946|62668255|FG002|Period III|Protocol Violation|0|||
33291921|NCT01128946|62668256|FG003|Period III|Protocol Violation|0|||
33378468|NCT00768300|62757342|FG001|Overall Study|Study discontinued by Sponsor|140|||
33378469|NCT00768300|62757341|FG000|Overall Study|Death|21|||
33378470|NCT00768300|62757342|FG001|Overall Study|Death|5|||
33291922|NCT01128595|62668267|FG000|Treatment Period 3|Withdrawal by Subject|0|||
33291923|NCT01128595|62668268|FG001|Treatment Period 3|Withdrawal by Subject|1|||
33291924|NCT01128595|62668269|FG002|Treatment Period 3|Withdrawal by Subject|0|||
33291925|NCT01128595|62668270|FG003|Treatment Period 3|Withdrawal by Subject|0|||
33291926|NCT01129336|62668283|FG000|Overall Study|Protocol Violation|1|||
33291927|NCT01129336|62668284|FG001|Overall Study|Protocol Violation|0|||
33291928|NCT01129336|62668283|FG000|Overall Study|Disease Progression|1|||
33291929|NCT01129336|62668284|FG001|Overall Study|Disease Progression|4|||
33291930|NCT01129336|62668283|FG000|Overall Study|Lost to Follow-up|1|||
33291931|NCT01129336|62668284|FG001|Overall Study|Lost to Follow-up|0|||
33291932|NCT01129336|62668283|FG000|Overall Study|Withdrawal by Subject|7|||
33291933|NCT01129336|62668284|FG001|Overall Study|Withdrawal by Subject|4|||
33291934|NCT01129336|62668283|FG000|Overall Study|Adverse Event|0|||
33291935|NCT01129336|62668284|FG001|Overall Study|Adverse Event|1|||
33291936|NCT01129336|62668283|FG000|Overall Study|Missing Study Completion Status|2|||
33487383|NCT03661983|62865561|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
33378471|NCT00768300|62757341|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
33378472|NCT00768300|62757342|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
33378473|NCT00768300|62757341|FG000|Overall Study|Screen failure following randomization|1|||
33291937|NCT01129336|62668284|FG001|Overall Study|Missing Study Completion Status|3|||
33291938|NCT01129336|62668283|FG000|Overall Study|Death|0|||
33378474|NCT00768300|62757342|FG001|Overall Study|Screen failure following randomization|0|||
33378475|NCT00768300|62757341|FG000|Overall Study|Received lung transplant|1|||
33378476|NCT00768300|62757342|FG001|Overall Study|Received lung transplant|1|||
33378477|NCT00768300|62757341|FG000|Overall Study|Lost to Follow-up|0|||
33378478|NCT00768300|62757342|FG001|Overall Study|Lost to Follow-up|1|||
33378479|NCT00768300|62757341|FG000|Overall Study|Began prohibited concomitant medication|0|||
33378480|NCT00768300|62757342|FG001|Overall Study|Began prohibited concomitant medication|1|||
33378481|NCT00768300|62757341|FG000|Overall Study|Treated but never dosed with Study drug|1|||
33378482|NCT00768300|62757342|FG001|Overall Study|Treated but never dosed with Study drug|0|||
33378483|NCT00768300|62757341|FG000|Overall Study|Missing data|1|||
33378484|NCT00768300|62757342|FG001|Overall Study|Missing data|0|||
33378485|NCT00768222|62757350|FG000|Overall Study|Lost to Follow-up|1|||
33378486|NCT00768222|62757351|FG001|Overall Study|Lost to Follow-up|1|||
33378487|NCT00768222|62757350|FG000|Overall Study|Withdrawal by Subject|3|||
33378488|NCT00768222|62757351|FG001|Overall Study|Withdrawal by Subject|1|||
33378489|NCT00768222|62757350|FG000|Overall Study|Protocol Violation|0|||
33378490|NCT00768222|62757351|FG001|Overall Study|Protocol Violation|2|||
33378491|NCT00768144|62757357|FG000|Overall Study|Adverse Event|13|||
33378492|NCT00768144|62757357|FG000|Overall Study|Progressive Disease|21|||
33378493|NCT00768144|62757357|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
33378494|NCT00768144|62757357|FG000|Overall Study|Pt Withdrew Consent|1|||
33378495|NCT00784836|62757361|FG000|Overall Study|Early Study Termination|3|||
33662394|NCT02163694|63092871|FG001|Overall Study|Adverse event- not related to progression|17|||
33662395|NCT02163694|63092870|FG000|Overall Study|Withdrew consent|8|||
33662396|NCT02163694|63092871|FG001|Overall Study|Withdrew consent|21|||
33662397|NCT02163694|63092870|FG000|Overall Study|Lost to Follow-up|1|||
33662398|NCT02163694|63092871|FG001|Overall Study|Lost to Follow-up|2|||
33662399|NCT02163694|63092870|FG000|Overall Study|Progressive disease per protocol|122|||
33662400|NCT02163694|63092871|FG001|Overall Study|Progressive disease per protocol|197|||
33662401|NCT02163694|63092870|FG000|Overall Study|Other, not specified|13|||
33291939|NCT01129336|62668284|FG001|Overall Study|Death|4|||
33291940|NCT01128400|62668293|FG000|Overall Study|Lost to Follow-up|1|||
33291941|NCT01128400|62668294|FG001|Overall Study|Lost to Follow-up|0|||
33291942|NCT01128400|62668295|FG002|Overall Study|Lost to Follow-up|1|||
33378496|NCT00784758|62757367|FG000|Overall Study|Withdrawal by Subject|3|||
33378497|NCT00784758|62757368|FG001|Overall Study|Withdrawal by Subject|0|||
33378498|NCT00784758|62757367|FG000|Overall Study|Adverse Event|1|||
33378499|NCT00784758|62757368|FG001|Overall Study|Adverse Event|0|||
33378500|NCT00768066|62757379|FG000|Overall Study|Did not receive study product injection.|3|||
33378501|NCT00768066|62757380|FG001|Overall Study|Did not receive study product injection.|3|||
33378502|NCT00768066|62757381|FG002|Overall Study|Did not receive study product injection.|0|||
33378503|NCT00767676|62757389|FG000|Overall Study|Investigator error|54|||
33378504|NCT00767520|62757395|FG000|Overall Study|Participants still on treatment|11|||
33378505|NCT00767520|62757396|FG001|Overall Study|Participants still on treatment|15|||
33378506|NCT00767520|62757395|FG000|Overall Study|Randomized in error and Never treated|0|||
33378507|NCT00767520|62757396|FG001|Overall Study|Randomized in error and Never treated|2|||
33378508|NCT00838565|62757408|FG000|Overall Study|Withdrawal by Subject|0|||
33378509|NCT00838565|62757409|FG001|Overall Study|Withdrawal by Subject|0|||
33378510|NCT00838565|62757410|FG002|Overall Study|Withdrawal by Subject|1|||
33378511|NCT00838565|62757411|FG003|Overall Study|Withdrawal by Subject|0|||
33378512|NCT00838565|62757412|FG004|Overall Study|Withdrawal by Subject|0|||
33378513|NCT00838565|62757413|FG005|Overall Study|Withdrawal by Subject|2|||
33378514|NCT00838565|62757408|FG000|Overall Study|Other|0|||
33378515|NCT00838565|62757409|FG001|Overall Study|Other|2|||
33378516|NCT00838565|62757410|FG002|Overall Study|Other|0|||
33378517|NCT00838565|62757411|FG003|Overall Study|Other|0|||
33378518|NCT00838565|62757412|FG004|Overall Study|Other|0|||
33291943|NCT01128400|62668293|FG000|Overall Study|Screening failure|1|||
33291944|NCT01128400|62668294|FG001|Overall Study|Screening failure|0|||
33291945|NCT01128400|62668295|FG002|Overall Study|Screening failure|0|||
33291946|NCT01128400|62668293|FG000|Overall Study|were not invited to participate on taste|0|||
33378519|NCT00838565|62757413|FG005|Overall Study|Other|0|||
33378520|NCT00838565|62757408|FG000|Overall Study|Randomized but not Treated|0|||
33662402|NCT02163694|63092871|FG001|Overall Study|Other, not specified|22|||
33291947|NCT01128400|62668294|FG001|Overall Study|were not invited to participate on taste|0|||
33291948|NCT01128400|62668295|FG002|Overall Study|were not invited to participate on taste|15|||
33378521|NCT00838565|62757409|FG001|Overall Study|Randomized but not Treated|1|||
33378522|NCT00838565|62757410|FG002|Overall Study|Randomized but not Treated|0|||
33378523|NCT00838565|62757411|FG003|Overall Study|Randomized but not Treated|0|||
33291949|NCT01128400|62668293|FG000|Overall Study|Excluded due to sinus problems|0|||
33378524|NCT00838565|62757412|FG004|Overall Study|Randomized but not Treated|0|||
33291950|NCT01128400|62668294|FG001|Overall Study|Excluded due to sinus problems|1|||
33378525|NCT00838565|62757413|FG005|Overall Study|Randomized but not Treated|0|||
33378526|NCT00858845|62757434|FG000|Overall Study|Patient underwent heart transplant.|0|||
33378527|NCT00858845|62757435|FG001|Overall Study|Patient underwent heart transplant.|1|||
33378528|NCT00770562|62757443|FG000|Overall Study|Did not take treatment|1|||
33378529|NCT00770562|62757444|FG001|Overall Study|Did not take treatment|1|||
33378530|NCT00836693|62757453|FG000|Overall Study|Adverse Event|4|||
33378531|NCT00836693|62757454|FG001|Overall Study|Adverse Event|1|||
33378532|NCT00836693|62757453|FG000|Overall Study|Sponsor Decision|0|||
33378533|NCT00836693|62757454|FG001|Overall Study|Sponsor Decision|1|||
33378534|NCT00836693|62757453|FG000|Overall Study|Physician Decision|2|||
33378535|NCT00836693|62757454|FG001|Overall Study|Physician Decision|0|||
33378536|NCT00836693|62757453|FG000|Overall Study|Withdrawal by Subject|9|||
33378537|NCT00836693|62757454|FG001|Overall Study|Withdrawal by Subject|4|||
33378538|NCT00836693|62757453|FG000|Overall Study|Protocol Violation|1|||
33378539|NCT00836693|62757454|FG001|Overall Study|Protocol Violation|0|||
33378540|NCT00836693|62757453|FG000|Overall Study|Lost to Follow-up|1|||
33378541|NCT00836693|62757454|FG001|Overall Study|Lost to Follow-up|0|||
33378542|NCT00770484|62757462|FG000|Overall Study|Withdrawal by Subject|1|||
33378543|NCT00770484|62757463|FG001|Overall Study|Withdrawal by Subject|0|||
33378544|NCT00835679|62757473|FG000|Overall Study|Withdrawal by Subject|1|||
33378545|NCT00835679|62757474|FG001|Overall Study|Withdrawal by Subject|0|||
33378546|NCT00835679|62757475|FG002|Overall Study|Withdrawal by Subject|0|||
33378547|NCT00835679|62757476|FG003|Overall Study|Withdrawal by Subject|0|||
33378548|NCT00766506|62757492|FG000|Overall Study|Use rescue medication after 3 hours|3|||
33378549|NCT00766506|62757493|FG001|Overall Study|Use rescue medication after 3 hours|0|||
33378550|NCT00766506|62757492|FG000|Overall Study|Other|2|||
33378551|NCT00766506|62757493|FG001|Overall Study|Other|2|||
33378552|NCT00770328|62757501|FG000|Overall Study|Adverse Event|11|||
33378553|NCT00770328|62757502|FG001|Overall Study|Adverse Event|2|||
33378554|NCT00770328|62757501|FG000|Overall Study|Lost to Follow-up|2|||
33378555|NCT00770328|62757502|FG001|Overall Study|Lost to Follow-up|2|||
33378556|NCT00766038|62757510|FG000|Overall Study|Lost to Follow-up|15|||
33378557|NCT00766038|62757511|FG001|Overall Study|Lost to Follow-up|14|||
33378558|NCT00765882|62757522|FG000|Overall Study|Adverse Event|10|||
33378559|NCT00765882|62757523|FG001|Overall Study|Adverse Event|21|||
33378560|NCT00765882|62757524|FG002|Overall Study|Adverse Event|20|||
33378561|NCT00765882|62757522|FG000|Overall Study|Lack of Efficacy|4|||
33378562|NCT00765882|62757523|FG001|Overall Study|Lack of Efficacy|0|||
33378563|NCT00765882|62757524|FG002|Overall Study|Lack of Efficacy|1|||
33378564|NCT00765882|62757522|FG000|Overall Study|Protocol Violation|4|||
33378565|NCT00765882|62757523|FG001|Overall Study|Protocol Violation|3|||
33378566|NCT00765882|62757524|FG002|Overall Study|Protocol Violation|1|||
33378567|NCT00765882|62757522|FG000|Overall Study|Withdrawal by Subject|2|||
33378568|NCT00765882|62757523|FG001|Overall Study|Withdrawal by Subject|6|||
33378569|NCT00765882|62757524|FG002|Overall Study|Withdrawal by Subject|6|||
33378570|NCT00765882|62757522|FG000|Overall Study|Lost to Follow-up|1|||
33378571|NCT00765882|62757523|FG001|Overall Study|Lost to Follow-up|9|||
33378572|NCT00765882|62757524|FG002|Overall Study|Lost to Follow-up|6|||
33378573|NCT00765882|62757522|FG000|Overall Study|Other Reason|3|||
33378574|NCT00765882|62757523|FG001|Overall Study|Other Reason|1|||
33378575|NCT00765882|62757524|FG002|Overall Study|Other Reason|2|||
33378576|NCT00769860|62757534|FG000|Overall Study|Withdrawal by Subject|2|||
33378577|NCT00769860|62757535|FG001|Overall Study|Withdrawal by Subject|0|||
33378578|NCT00858143|62757541|FG000|Overall Study|Adverse Event|16|||
33291951|NCT01128400|62668295|FG002|Overall Study|Excluded due to sinus problems|0|||
33291952|NCT01128361|62668305|FG000|Overall Study|Lost to Follow-up|0|||
33291953|NCT01128361|62668306|FG001|Overall Study|Lost to Follow-up|1|||
33291954|NCT01128361|62668305|FG000|Overall Study|Withdrawal by Subject|5|||
33291955|NCT01128361|62668306|FG001|Overall Study|Withdrawal by Subject|2|||
33291956|NCT01128244|62668312|FG000|Overall Study|Adverse Event|1|||
33291957|NCT01128244|62668312|FG000|Overall Study|Scheduling conflict|2|||
33291958|NCT01127893|62668320|FG000|Overall Study|Study Termination by the Sponsor|1|||
33291959|NCT01126879|62668326|FG000|Overall Study|Progressive Disease|3|||
33291960|NCT01126879|62668327|FG001|Overall Study|Progressive Disease|1|||
33291961|NCT01126879|62668326|FG000|Overall Study|Withdrawal by Subject|1|||
33291962|NCT01126879|62668327|FG001|Overall Study|Withdrawal by Subject|0|||
33291963|NCT01126879|62668326|FG000|Overall Study|Adverse Event|0|||
33291964|NCT01126879|62668327|FG001|Overall Study|Adverse Event|1|||
33378579|NCT00858143|62757541|FG000|Overall Study|Lack of Efficacy|4|||
33378580|NCT00858143|62757541|FG000|Overall Study|Death|7|||
33378581|NCT00858143|62757541|FG000|Overall Study|Other|23|||
33378582|NCT00828113|62757547|FG000|Overall Study|Withdrawal by Subject|27|||
33378583|NCT00828113|62757548|FG001|Overall Study|Withdrawal by Subject|26|||
33378584|NCT00828113|62757547|FG000|Overall Study|Lost to Follow-up|3|||
33378585|NCT00828113|62757548|FG001|Overall Study|Lost to Follow-up|5|||
33378586|NCT00769704|62757556|FG000|Overall Study|Lost to Follow-up|3|||
33378587|NCT00769704|62757557|FG001|Overall Study|Lost to Follow-up|2|||
33378588|NCT00769704|62757556|FG000|Overall Study|Death|95|||
33378589|NCT00769704|62757557|FG001|Overall Study|Death|190|||
33378590|NCT00769704|62757556|FG000|Overall Study|Withdrawal by Subject|12|||
33378591|NCT00769704|62757557|FG001|Overall Study|Withdrawal by Subject|5|||
33378592|NCT00769704|62757556|FG000|Overall Study|Other|1|||
33378593|NCT00769704|62757557|FG001|Overall Study|Other|2|||
33378594|NCT00818753|62757567|FG000|Overall Study|Protocol Violation|1|||
33291965|NCT01126879|62668326|FG000|Overall Study|Physician Decision|1|||
33291966|NCT01126879|62668327|FG001|Overall Study|Physician Decision|0|||
33291967|NCT01126060|62668335|FG000|Overall Study|Protocol Violation|0|||
33291968|NCT01126060|62668336|FG001|Overall Study|Protocol Violation|2|||
33291969|NCT01125748|62668344|FG000|Overall Study|Adverse Event|0|||
33291970|NCT01125748|62668345|FG001|Overall Study|Adverse Event|2|||
33378595|NCT00818753|62757568|FG001|Overall Study|Protocol Violation|0|||
33378596|NCT00818753|62757569|FG002|Overall Study|Protocol Violation|0|||
33378597|NCT00818753|62757567|FG000|Overall Study|Other reason (not specified)|0|||
33378598|NCT00818753|62757568|FG001|Overall Study|Other reason (not specified)|0|||
33378599|NCT00818753|62757569|FG002|Overall Study|Other reason (not specified)|1|||
33378600|NCT00818753|62757567|FG000|Overall Study|Randomised and not treated|2|||
33378601|NCT00818753|62757568|FG001|Overall Study|Randomised and not treated|0|||
33378602|NCT00818753|62757569|FG002|Overall Study|Randomised and not treated|0|||
33378603|NCT00765726|62757577|FG000|Overall Study|Withdrawal by Subject|1|||
33378604|NCT00765726|62757577|FG000|Overall Study|Discontinuation of study by sponsor|8|||
33378605|NCT00765336|62757583|FG000|Overall Study|Protocol Violation|4|||
33378606|NCT00765336|62757584|FG001|Overall Study|Protocol Violation|2|||
33378607|NCT00765336|62757583|FG000|Overall Study|Withdrawal by Subject|6|||
33378608|NCT00765336|62757584|FG001|Overall Study|Withdrawal by Subject|4|||
33378609|NCT00765336|62757583|FG000|Overall Study|Lost to Follow-up|7|||
33378610|NCT00765336|62757584|FG001|Overall Study|Lost to Follow-up|9|||
33378611|NCT00765336|62757583|FG000|Overall Study|Adverse Event|2|||
33378612|NCT00765336|62757584|FG001|Overall Study|Adverse Event|1|||
33378613|NCT00818519|62757592|FG000|Overall Study|Adverse Event|2|||
33378614|NCT00818519|62757593|FG001|Overall Study|Adverse Event|2|||
33378615|NCT00818519|62757592|FG000|Overall Study|Lost to Follow-up|4|||
33378616|NCT00818519|62757593|FG001|Overall Study|Lost to Follow-up|6|||
33378617|NCT00818519|62757592|FG000|Overall Study|Protocol Violation|2|||
33378618|NCT00818519|62757593|FG001|Overall Study|Protocol Violation|1|||
33378619|NCT00818519|62757592|FG000|Overall Study|Pregnancy|0|||
33378620|NCT00818519|62757593|FG001|Overall Study|Pregnancy|1|||
33378621|NCT00818519|62757592|FG000|Overall Study|Withdrawal by Subject|4|||
33378622|NCT00818519|62757593|FG001|Overall Study|Withdrawal by Subject|9|||
33378623|NCT00818519|62757592|FG000|Overall Study|participant recovered completely|1|||
33378624|NCT00818519|62757593|FG001|Overall Study|participant recovered completely|0|||
33378625|NCT00818519|62757592|FG000|Overall Study|participant will leave for long tme|1|||
33378626|NCT00818519|62757593|FG001|Overall Study|participant will leave for long tme|0|||
33378627|NCT00827567|62757599|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
33378628|NCT00765102|62757603|FG000|Overall Study|Progressive disease|18|||
33378629|NCT00765102|62757603|FG000|Overall Study|Adverse Event|6|||
33378630|NCT00765102|62757603|FG000|Overall Study|Physician Decision|4|||
33378631|NCT00765102|62757603|FG000|Overall Study|Withdrawal by Subject|2|||
33378632|NCT00765102|62757603|FG000|Overall Study|Protocol Violation|1|||
33378633|NCT00809354|62757619|FG000|Overall Study|Adverse Event|32|||
33378634|NCT00809354|62757620|FG001|Overall Study|Adverse Event|45|||
33378635|NCT00809354|62757621|FG002|Overall Study|Adverse Event|37|||
33378636|NCT00809354|62757622|FG003|Overall Study|Adverse Event|53|||
33378637|NCT00809354|62757623|FG004|Overall Study|Adverse Event|26|||
33378638|NCT00809354|62757624|FG005|Overall Study|Adverse Event|33|||
33378639|NCT00809354|62757625|FG006|Overall Study|Adverse Event|44|||
33378640|NCT00809354|62757626|FG007|Overall Study|Adverse Event|40|||
33378641|NCT00809354|62757627|FG008|Overall Study|Adverse Event|46|||
33378642|NCT00809354|62757628|FG009|Overall Study|Adverse Event|26|||
33291971|NCT01125748|62668344|FG000|Overall Study|Lost to Follow-up|0|||
33378643|NCT00809354|62757619|FG000|Overall Study|Lack of Efficacy|23|||
33378644|NCT00809354|62757620|FG001|Overall Study|Lack of Efficacy|23|||
33378645|NCT00809354|62757621|FG002|Overall Study|Lack of Efficacy|22|||
33378646|NCT00809354|62757622|FG003|Overall Study|Lack of Efficacy|15|||
33378647|NCT00809354|62757623|FG004|Overall Study|Lack of Efficacy|40|||
33378648|NCT00809354|62757624|FG005|Overall Study|Lack of Efficacy|19|||
33378649|NCT00809354|62757625|FG006|Overall Study|Lack of Efficacy|21|||
33378650|NCT00809354|62757626|FG007|Overall Study|Lack of Efficacy|15|||
33378651|NCT00809354|62757627|FG008|Overall Study|Lack of Efficacy|18|||
33378652|NCT00809354|62757628|FG009|Overall Study|Lack of Efficacy|38|||
33378653|NCT00809354|62757619|FG000|Overall Study|Lost to Follow-up|10|||
33378654|NCT00809354|62757620|FG001|Overall Study|Lost to Follow-up|11|||
33378655|NCT00809354|62757621|FG002|Overall Study|Lost to Follow-up|8|||
33291972|NCT01125748|62668345|FG001|Overall Study|Lost to Follow-up|1|||
33291973|NCT01125748|62668344|FG000|Overall Study|Physician Decision|8|||
33291974|NCT01125748|62668345|FG001|Overall Study|Physician Decision|7|||
33291975|NCT01125748|62668344|FG000|Overall Study|Patient Decision to Withdraw|2|||
33378656|NCT00809354|62757622|FG003|Overall Study|Lost to Follow-up|13|||
33378657|NCT00809354|62757623|FG004|Overall Study|Lost to Follow-up|6|||
33378658|NCT00809354|62757624|FG005|Overall Study|Lost to Follow-up|2|||
33378659|NCT00809354|62757625|FG006|Overall Study|Lost to Follow-up|0|||
33378660|NCT00809354|62757626|FG007|Overall Study|Lost to Follow-up|5|||
33291976|NCT01125748|62668345|FG001|Overall Study|Patient Decision to Withdraw|4|||
33291977|NCT01125514|62668351|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
33291978|NCT01125514|62668351|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
33291979|NCT01125514|62668351|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
33291980|NCT01125514|62668351|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
33291981|NCT01125514|62668351|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
33291982|NCT01125514|62668351|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
33291983|NCT01125358|62668369|FG000|Overall Study|Adverse Event|3|||
33291984|NCT01125358|62668370|FG001|Overall Study|Adverse Event|0|||
33291985|NCT01125358|62668371|FG002|Overall Study|Adverse Event|0|||
33378661|NCT00809354|62757627|FG008|Overall Study|Lost to Follow-up|4|||
33378662|NCT00809354|62757628|FG009|Overall Study|Lost to Follow-up|0|||
33378663|NCT00809354|62757619|FG000|Overall Study|Protocol Violation|7|||
33378664|NCT00809354|62757620|FG001|Overall Study|Protocol Violation|14|||
33378665|NCT00809354|62757621|FG002|Overall Study|Protocol Violation|14|||
33378666|NCT00809354|62757622|FG003|Overall Study|Protocol Violation|12|||
33378667|NCT00809354|62757623|FG004|Overall Study|Protocol Violation|14|||
33378668|NCT00809354|62757624|FG005|Overall Study|Protocol Violation|6|||
33378669|NCT00809354|62757625|FG006|Overall Study|Protocol Violation|4|||
33378670|NCT00809354|62757626|FG007|Overall Study|Protocol Violation|6|||
33378671|NCT00809354|62757627|FG008|Overall Study|Protocol Violation|9|||
33378672|NCT00809354|62757628|FG009|Overall Study|Protocol Violation|3|||
33378673|NCT00809354|62757619|FG000|Overall Study|Withdrawal by Subject|32|||
33378674|NCT00809354|62757620|FG001|Overall Study|Withdrawal by Subject|27|||
33378675|NCT00809354|62757621|FG002|Overall Study|Withdrawal by Subject|31|||
33378676|NCT00809354|62757622|FG003|Overall Study|Withdrawal by Subject|33|||
33378677|NCT00809354|62757623|FG004|Overall Study|Withdrawal by Subject|34|||
33378678|NCT00809354|62757624|FG005|Overall Study|Withdrawal by Subject|29|||
33378679|NCT00809354|62757625|FG006|Overall Study|Withdrawal by Subject|27|||
33378680|NCT00809354|62757626|FG007|Overall Study|Withdrawal by Subject|19|||
33378681|NCT00809354|62757627|FG008|Overall Study|Withdrawal by Subject|18|||
33378682|NCT00809354|62757628|FG009|Overall Study|Withdrawal by Subject|20|||
33378683|NCT00809354|62757619|FG000|Overall Study|Other|10|||
33378684|NCT00809354|62757620|FG001|Overall Study|Other|2|||
33378685|NCT00809354|62757621|FG002|Overall Study|Other|7|||
33378686|NCT00809354|62757622|FG003|Overall Study|Other|10|||
33291986|NCT01125358|62668372|FG003|Overall Study|Adverse Event|2|||
33291987|NCT01125358|62668369|FG000|Overall Study|Perceived Lack of Efficacy|6|||
33291988|NCT01125358|62668370|FG001|Overall Study|Perceived Lack of Efficacy|3|||
33291989|NCT01125358|62668371|FG002|Overall Study|Perceived Lack of Efficacy|7|||
33291990|NCT01125358|62668372|FG003|Overall Study|Perceived Lack of Efficacy|4|||
33291991|NCT01125358|62668369|FG000|Overall Study|Protocol Violation|1|||
33291992|NCT01125358|62668370|FG001|Overall Study|Protocol Violation|0|||
33291993|NCT01125358|62668371|FG002|Overall Study|Protocol Violation|0|||
33291994|NCT01125358|62668372|FG003|Overall Study|Protocol Violation|0|||
33291995|NCT01125358|62668369|FG000|Overall Study|Sponsor Decision|0|||
33291996|NCT01125358|62668370|FG001|Overall Study|Sponsor Decision|0|||
33291997|NCT01125358|62668371|FG002|Overall Study|Sponsor Decision|1|||
33291998|NCT01125358|62668372|FG003|Overall Study|Sponsor Decision|1|||
33291999|NCT01125358|62668369|FG000|Overall Study|Withdrawal by Subject|2|||
33292000|NCT01125358|62668370|FG001|Overall Study|Withdrawal by Subject|1|||
33292001|NCT01125358|62668371|FG002|Overall Study|Withdrawal by Subject|1|||
33292002|NCT01125358|62668372|FG003|Overall Study|Withdrawal by Subject|1|||
33292003|NCT01125046|62668382|FG000|First 6 Months of Treatment|Death|1|||
33292004|NCT01125046|62668382|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
33292005|NCT01125046|62668382|FG000|First 6 Months of Treatment|Non-compliance|1|||
33292006|NCT01125046|62668382|FG000|First 6 Months of Treatment|Surgery|1|||
33292007|NCT01125046|62668382|FG000|First 6 Months of Treatment|Progressive Disease|7|||
33292008|NCT01125046|62668382|FG000|First 6 Months of Treatment|Adverse Event|2|||
33292009|NCT01125046|62668382|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
33292010|NCT01125046|62668382|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
33378687|NCT00809354|62757623|FG004|Overall Study|Other|5|||
33378688|NCT00809354|62757624|FG005|Overall Study|Other|3|||
33292011|NCT01125046|62668382|FG000|Follow-up/Data Cut Off Point|Death|29|||
33292012|NCT01125046|62668382|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
33292013|NCT01124734|62668386|FG000|Overall Study|Disease progression|13|||
33292014|NCT01124734|62668386|FG000|Overall Study|Adverse Event|1|||
33378689|NCT00809354|62757625|FG006|Overall Study|Other|2|||
33378690|NCT00809354|62757626|FG007|Overall Study|Other|3|||
33378691|NCT00809354|62757627|FG008|Overall Study|Other|4|||
33378692|NCT00809354|62757628|FG009|Overall Study|Other|3|||
33378693|NCT00809354|62757619|FG000|Overall Study|Study terminated by sponsor|138|||
33378694|NCT00809354|62757620|FG001|Overall Study|Study terminated by sponsor|134|||
33378695|NCT00809354|62757621|FG002|Overall Study|Study terminated by sponsor|129|||
33378696|NCT00809354|62757622|FG003|Overall Study|Study terminated by sponsor|120|||
33292015|NCT01124734|62668386|FG000|Overall Study|Withdrawal by Subject|1|||
33292016|NCT01124734|62668386|FG000|Overall Study|Elected for alternative treatment|2|||
33292017|NCT01124617|62668397|FG000|Overall Study|Adverse Event|5|||
33292018|NCT01124617|62668398|FG001|Overall Study|Adverse Event|2|||
33292019|NCT01124617|62668397|FG000|Overall Study|Lack of Efficacy|2|||
33292020|NCT01124617|62668398|FG001|Overall Study|Lack of Efficacy|1|||
33292021|NCT01124617|62668397|FG000|Overall Study|Protocol Violation|1|||
33292022|NCT01124617|62668398|FG001|Overall Study|Protocol Violation|1|||
33292023|NCT01124617|62668397|FG000|Overall Study|Withdrawal by Subject|9|||
33292024|NCT01124617|62668398|FG001|Overall Study|Withdrawal by Subject|1|||
33292025|NCT01124617|62668397|FG000|Overall Study|Other|2|||
33292026|NCT01124617|62668398|FG001|Overall Study|Other|1|||
33292027|NCT01124422|62668406|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
33292028|NCT01124422|62668407|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
33292029|NCT01124422|62668408|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
33292030|NCT01124422|62668406|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
33378697|NCT00809354|62757623|FG004|Overall Study|Study terminated by sponsor|126|||
33378698|NCT00809354|62757624|FG005|Overall Study|Study terminated by sponsor|133|||
33378699|NCT00809354|62757625|FG006|Overall Study|Study terminated by sponsor|124|||
33378700|NCT00809354|62757626|FG007|Overall Study|Study terminated by sponsor|148|||
33378701|NCT00809354|62757627|FG008|Overall Study|Study terminated by sponsor|127|||
33378702|NCT00809354|62757628|FG009|Overall Study|Study terminated by sponsor|135|||
33378703|NCT00809354|62757619|FG000|Overall Study|Withdrawn due to pregnancy|0|||
33378704|NCT00809354|62757620|FG001|Overall Study|Withdrawn due to pregnancy|1|||
33378705|NCT00809354|62757621|FG002|Overall Study|Withdrawn due to pregnancy|0|||
33378706|NCT00809354|62757622|FG003|Overall Study|Withdrawn due to pregnancy|0|||
33378707|NCT00809354|62757623|FG004|Overall Study|Withdrawn due to pregnancy|0|||
33378708|NCT00809354|62757624|FG005|Overall Study|Withdrawn due to pregnancy|0|||
33378709|NCT00809354|62757625|FG006|Overall Study|Withdrawn due to pregnancy|0|||
33378710|NCT00809354|62757626|FG007|Overall Study|Withdrawn due to pregnancy|0|||
33378711|NCT00809354|62757627|FG008|Overall Study|Withdrawn due to pregnancy|0|||
33378712|NCT00809354|62757628|FG009|Overall Study|Withdrawn due to pregnancy|0|||
33378713|NCT00809354|62757619|FG000|Overall Study|Randomized but not Treated|3|||
33378714|NCT00809354|62757620|FG001|Overall Study|Randomized but not Treated|1|||
33378715|NCT00809354|62757621|FG002|Overall Study|Randomized but not Treated|6|||
33487384|NCT03661983|62865562|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
33487385|NCT03661983|62865563|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
33487386|NCT03661983|62865564|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
33292031|NCT01124422|62668407|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
33292032|NCT01124422|62668408|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
33292033|NCT01124422|62668406|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
33378716|NCT00809354|62757622|FG003|Overall Study|Randomized but not Treated|0|||
33378717|NCT00809354|62757623|FG004|Overall Study|Randomized but not Treated|5|||
33378718|NCT00809354|62757624|FG005|Overall Study|Randomized but not Treated|0|||
33378719|NCT00809354|62757625|FG006|Overall Study|Randomized but not Treated|1|||
33378720|NCT00809354|62757626|FG007|Overall Study|Randomized but not Treated|1|||
33378721|NCT00809354|62757627|FG008|Overall Study|Randomized but not Treated|2|||
33378722|NCT00809354|62757628|FG009|Overall Study|Randomized but not Treated|1|||
33378723|NCT00809354|62757619|FG000|Overall Study|Death|0|||
33378724|NCT00809354|62757620|FG001|Overall Study|Death|0|||
33378725|NCT00809354|62757621|FG002|Overall Study|Death|0|||
33378726|NCT00809354|62757622|FG003|Overall Study|Death|0|||
33378727|NCT00809354|62757623|FG004|Overall Study|Death|0|||
33378728|NCT00809354|62757624|FG005|Overall Study|Death|0|||
33378729|NCT00809354|62757625|FG006|Overall Study|Death|0|||
33378730|NCT00809354|62757626|FG007|Overall Study|Death|1|||
33378731|NCT00809354|62757627|FG008|Overall Study|Death|0|||
33378732|NCT00809354|62757628|FG009|Overall Study|Death|0|||
33378733|NCT00834899|62757657|FG000|Overall Study|Withdrawal by Subject|1|||
33378734|NCT00834899|62757658|FG001|Overall Study|Withdrawal by Subject|1|||
33378735|NCT00764946|62757667|FG000|Overall Study|Lack of Efficacy|1|||
33378736|NCT00764946|62757668|FG001|Overall Study|Lack of Efficacy|0|||
33487387|NCT03661983|62865561|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
33556587|NCT01369355|62949452|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
33556588|NCT01369355|62949453|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
33556589|NCT01369355|62949454|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
33292034|NCT01124422|62668407|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
33378737|NCT00764946|62757669|FG002|Overall Study|Lack of Efficacy|0|||
33378738|NCT00764946|62757667|FG000|Overall Study|Lost to Follow-up|3|||
33378739|NCT00764946|62757668|FG001|Overall Study|Lost to Follow-up|4|||
33378740|NCT00764946|62757669|FG002|Overall Study|Lost to Follow-up|0|||
33378741|NCT00764946|62757667|FG000|Overall Study|Physician Decision|2|||
33378742|NCT00764946|62757668|FG001|Overall Study|Physician Decision|4|||
33378743|NCT00764946|62757669|FG002|Overall Study|Physician Decision|0|||
33378744|NCT00764946|62757667|FG000|Overall Study|Adverse Event|3|||
33378745|NCT00764946|62757668|FG001|Overall Study|Adverse Event|2|||
33292035|NCT01124422|62668408|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
33292036|NCT01124422|62668406|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
33292037|NCT01124422|62668407|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
33662403|NCT01694849|63092905|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
33662404|NCT01694849|63092906|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
33662405|NCT01694849|63092907|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
33662406|NCT01694849|63092905|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
33292038|NCT01124422|62668408|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
33292039|NCT01124422|62668406|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
33292040|NCT01124422|62668407|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
33292041|NCT01124422|62668408|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
33292042|NCT01124422|62668406|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
33292043|NCT01124422|62668407|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
33292044|NCT01124422|62668408|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
33292045|NCT01124422|62668406|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
33292046|NCT01124422|62668407|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
33292047|NCT01124422|62668408|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
33292048|NCT01124422|62668406|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
33292049|NCT01124422|62668407|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
33292050|NCT01124422|62668408|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
33292051|NCT01124422|62668406|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
33292052|NCT01124422|62668407|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
33292053|NCT01124422|62668408|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
33292054|NCT01124422|62668406|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
33292055|NCT01124422|62668407|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
33292056|NCT01124422|62668408|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
33292057|NCT01124149|62668415|FG000|Acute Phase|Withdrawal by Subject|22|||
33292058|NCT01124149|62668415|FG000|Acute Phase|Adverse Event|21|||
33292059|NCT01124149|62668415|FG000|Acute Phase|Lack of Efficacy|17|||
33378746|NCT00764946|62757669|FG002|Overall Study|Adverse Event|1|||
33378747|NCT00764946|62757667|FG000|Overall Study|Withdrawal by Subject|3|||
33378748|NCT00764946|62757668|FG001|Overall Study|Withdrawal by Subject|6|||
33378749|NCT00764946|62757669|FG002|Overall Study|Withdrawal by Subject|2|||
33378750|NCT00764946|62757667|FG000|Overall Study|Never Treated|1|||
33378751|NCT00764946|62757668|FG001|Overall Study|Never Treated|1|||
33378752|NCT00764946|62757669|FG002|Overall Study|Never Treated|1|||
33378753|NCT00764868|62757683|FG000|Overall Study|Adverse Event|18|||
33378754|NCT00764868|62757683|FG000|Overall Study|Withdrawal by Subject|31|||
33378755|NCT00764868|62757683|FG000|Overall Study|Non-compliance|16|||
33378756|NCT00764868|62757683|FG000|Overall Study|Lost to Follow-up|25|||
33378757|NCT00764868|62757683|FG000|Overall Study|Lack of Efficacy|5|||
33378758|NCT00764868|62757683|FG000|Overall Study|Subject moved|7|||
33378759|NCT00764868|62757683|FG000|Overall Study|Pregnancy|3|||
33378760|NCT00764868|62757683|FG000|Overall Study|Prohibited medication|1|||
33378761|NCT00764868|62757683|FG000|Overall Study|Out of town|1|||
33378762|NCT00764868|62757683|FG000|Overall Study|Misuse and compliance of study drug|1|||
33378763|NCT00764868|62757683|FG000|Overall Study|Subject sent to boarding school|1|||
33378764|NCT00764868|62757683|FG000|Overall Study|Met an exclusion criteria|1|||
33378765|NCT00764868|62757683|FG000|Overall Study|Positive drug screen|2|||
33378766|NCT00764868|62757683|FG000|Overall Study|Sponsor requested withdrawal|1|||
33378767|NCT00764790|62757690|FG000|Overall Study|Protocol Violation|0|||
33378768|NCT00764790|62757691|FG001|Overall Study|Protocol Violation|0|||
33378769|NCT00764790|62757692|FG002|Overall Study|Protocol Violation|1|||
33378770|NCT00764790|62757690|FG000|Overall Study|Withdrawal by Subject|10|||
33378771|NCT00764790|62757691|FG001|Overall Study|Withdrawal by Subject|12|||
33378772|NCT00764790|62757692|FG002|Overall Study|Withdrawal by Subject|6|||
33378773|NCT00764790|62757690|FG000|Overall Study|Lost to Follow-up|28|||
33378774|NCT00764790|62757691|FG001|Overall Study|Lost to Follow-up|29|||
33378775|NCT00764790|62757692|FG002|Overall Study|Lost to Follow-up|23|||
33378776|NCT00756444|62757702|FG000|Overall Study|Adverse Event|1|||
33378777|NCT00756444|62757703|FG001|Overall Study|Adverse Event|1|||
33378778|NCT00756444|62757702|FG000|Overall Study|Withdrawal by Subject|6|||
33378779|NCT00756444|62757703|FG001|Overall Study|Withdrawal by Subject|8|||
33378780|NCT00756444|62757702|FG000|Overall Study|Lost to Follow-up|0|||
33378781|NCT00756444|62757703|FG001|Overall Study|Lost to Follow-up|1|||
33378782|NCT00756444|62757702|FG000|Overall Study|Death|5|||
33292060|NCT01124149|62668415|FG000|Acute Phase|Protocol Violation|14|||
33378783|NCT00756444|62757703|FG001|Overall Study|Death|4|||
33378784|NCT00756444|62757702|FG000|Overall Study|Disease Progression|2|||
33378785|NCT00756444|62757703|FG001|Overall Study|Disease Progression|7|||
33378786|NCT00756444|62757702|FG000|Overall Study|Ineligibility Determined|1|||
33378787|NCT00756444|62757703|FG001|Overall Study|Ineligibility Determined|0|||
33378788|NCT00769002|62757714|FG000|Overall Study|Study was not completed, no data|9|||
33378789|NCT00769002|62757715|FG001|Overall Study|Study was not completed, no data|9|||
33378790|NCT00753012|62757722|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
33378791|NCT00753012|62757723|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
33378792|NCT00753012|62757722|FG000|Overall Study|Adverse Event|2|||
33378793|NCT00753012|62757723|FG001|Overall Study|Adverse Event|0|||
33378794|NCT00753012|62757722|FG000|Overall Study|Withdrawal by Subject|0|||
33378795|NCT00753012|62757723|FG001|Overall Study|Withdrawal by Subject|1|||
33378796|NCT00753012|62757722|FG000|Overall Study|Lost to Follow-up|4|||
33378797|NCT00753012|62757723|FG001|Overall Study|Lost to Follow-up|0|||
33378798|NCT00753012|62757722|FG000|Overall Study|Confounded endpoint data|1|||
33378799|NCT00753012|62757723|FG001|Overall Study|Confounded endpoint data|0|||
33378800|NCT00806156|62757732|FG000|Overall Study|Death|35|||
33378801|NCT00806156|62757733|FG001|Overall Study|Death|95|||
33378802|NCT00806156|62757732|FG000|Overall Study|Did not meet eligibility criteria|1|||
33378803|NCT00806156|62757733|FG001|Overall Study|Did not meet eligibility criteria|0|||
33378804|NCT00806156|62757732|FG000|Overall Study|Study terminated by Sponsor|2|||
33378805|NCT00806156|62757733|FG001|Overall Study|Study terminated by Sponsor|40|||
33378806|NCT00806156|62757732|FG000|Overall Study|Consent withdrawn by subject|1|||
33378807|NCT00806156|62757733|FG001|Overall Study|Consent withdrawn by subject|3|||
33378808|NCT00806156|62757732|FG000|Overall Study|Lost to Follow-up|0|||
33378809|NCT00806156|62757733|FG001|Overall Study|Lost to Follow-up|1|||
33378810|NCT00764478|62757754|FG000|Overall Study|Adverse Event|1|||
33378811|NCT00764478|62757755|FG001|Overall Study|Adverse Event|1|||
33378812|NCT00764478|62757756|FG002|Overall Study|Adverse Event|1|||
33378813|NCT00764478|62757754|FG000|Overall Study|Withdrawal by Subject|7|||
33378814|NCT00764478|62757755|FG001|Overall Study|Withdrawal by Subject|12|||
33378815|NCT00764478|62757756|FG002|Overall Study|Withdrawal by Subject|1|||
33378816|NCT00764478|62757754|FG000|Overall Study|Lost to Follow-up|7|||
33378817|NCT00764478|62757755|FG001|Overall Study|Lost to Follow-up|8|||
33378818|NCT00764478|62757756|FG002|Overall Study|Lost to Follow-up|5|||
33378819|NCT00764478|62757754|FG000|Overall Study|Protocol Violation|0|||
33378820|NCT00764478|62757755|FG001|Overall Study|Protocol Violation|1|||
33378821|NCT00764478|62757756|FG002|Overall Study|Protocol Violation|1|||
33378822|NCT00805766|62757764|FG000|Screening Period|Adverse Event|1|||
33378823|NCT00805766|62757764|FG000|Screening Period|Lack of Efficacy|2|||
33378824|NCT00805766|62757764|FG000|Screening Period|Pregnancy|1|||
33378825|NCT00805766|62757764|FG000|Screening Period|Responder|2|||
33378826|NCT00805766|62757764|FG000|Increased Dose Period|Adverse Event|4|||
33378827|NCT00805766|62757764|FG000|Increased Dose Period|Lack of Efficacy|7|||
33378828|NCT00805766|62757764|FG000|Increased Dose Period|Pregnancy|1|||
33378829|NCT00805766|62757764|FG000|Increased Dose Period|Withdrawal by Subject|1|||
33378830|NCT00805532|62757774|FG000|Overall Study|invalid data|0|||
33378831|NCT00805532|62757775|FG001|Overall Study|invalid data|1|||
33378832|NCT00764322|62757785|FG000|Overall Study|Withdrawal by Subject|11|||
33378833|NCT00764322|62757785|FG000|Overall Study|No CYP2D6 genotyping|9|||
33378834|NCT00752856|62757804|FG000|Overall Study|randomized but did not do viral kinetics|0|||
33378835|NCT00752856|62757805|FG001|Overall Study|randomized but did not do viral kinetics|1|||
33378836|NCT00755196|62757811|FG000|Overall Study|Lost to Follow-up|1|||
33378837|NCT00755196|62757811|FG000|Overall Study|Lack of Efficiency|1|||
33378838|NCT00805142|62757818|FG000|Titration Period|Adverse Event|3|||
33378839|NCT00805142|62757819|FG001|Titration Period|Adverse Event|3|||
33292061|NCT01124149|62668415|FG000|Acute Phase|Lost to Follow-up|2|||
33292062|NCT01124149|62668415|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
33292063|NCT01124149|62668415|FG000|Acute Phase|Sponsor request|1|||
33292064|NCT01124149|62668415|FG000|Acute Phase|UC symptoms not ameliorated|1|||
33292065|NCT01124149|62668415|FG000|Acute Phase|Non-compliance|1|||
33292066|NCT01124149|62668415|FG000|Acute Phase|Low hemoglobin|1|||
33292067|NCT01124149|62668415|FG000|Acute Phase|Travelling to another country|1|||
33292068|NCT01124149|62668415|FG000|Acute Phase|Sponsor decision|1|||
33292069|NCT01124149|62668415|FG000|Maintenance Phase|Lack of Efficacy|40|||
33292070|NCT01124149|62668415|FG000|Maintenance Phase|Adverse Event|24|||
33292071|NCT01124149|62668415|FG000|Maintenance Phase|Lost to Follow-up|15|||
33292072|NCT01124149|62668415|FG000|Maintenance Phase|Withdrawal by Subject|10|||
33292073|NCT01124149|62668415|FG000|Maintenance Phase|Protocol Violation|5|||
33292074|NCT01124149|62668415|FG000|Maintenance Phase|Coordinator error|1|||
33378840|NCT00805142|62757818|FG000|Titration Period|Lack of Efficacy|1|||
33378841|NCT00805142|62757819|FG001|Titration Period|Lack of Efficacy|1|||
33378842|NCT00805142|62757818|FG000|Titration Period|Lost to Follow-up|0|||
33292075|NCT01124149|62668415|FG000|Maintenance Phase|Non-compliance|1|||
33292076|NCT01123642|62668422|FG000|Overall Study|Lost to Follow-up|23|||
33292077|NCT01123642|62668422|FG000|Overall Study|Withdrawal by Subject|9|||
33378843|NCT00805142|62757819|FG001|Titration Period|Lost to Follow-up|1|||
33378844|NCT00805142|62757818|FG000|Titration Period|Disease Progression|2|||
33378845|NCT00805142|62757819|FG001|Titration Period|Disease Progression|1|||
33378846|NCT00805142|62757818|FG000|Titration Period|Withdrawal of consent|0|||
33378847|NCT00805142|62757819|FG001|Titration Period|Withdrawal of consent|1|||
33378848|NCT00805142|62757818|FG000|Titration Period|Other|0|||
33378849|NCT00805142|62757819|FG001|Titration Period|Other|3|||
33378850|NCT00805142|62757818|FG000|Maintenance Period|Adverse Event|0|||
33378851|NCT00805142|62757819|FG001|Maintenance Period|Adverse Event|1|||
33378852|NCT00805142|62757818|FG000|Maintenance Period|Other|0|||
33378853|NCT00805142|62757819|FG001|Maintenance Period|Other|1|||
33378854|NCT00761631|62757836|FG000|Overall Study|Parent/legal guardian request|8|||
33378855|NCT00761631|62757837|FG001|Overall Study|Parent/legal guardian request|3|||
33378856|NCT00761631|62757838|FG002|Overall Study|Parent/legal guardian request|8|||
33378857|NCT00761631|62757839|FG003|Overall Study|Parent/legal guardian request|0|||
33378858|NCT00761631|62757840|FG004|Overall Study|Parent/legal guardian request|5|||
33378859|NCT00761631|62757841|FG005|Overall Study|Parent/legal guardian request|0|||
33378860|NCT00761631|62757836|FG000|Overall Study|Lost to Follow-up|2|||
33378861|NCT00761631|62757837|FG001|Overall Study|Lost to Follow-up|4|||
33378862|NCT00761631|62757838|FG002|Overall Study|Lost to Follow-up|7|||
33378863|NCT00761631|62757839|FG003|Overall Study|Lost to Follow-up|1|||
33378864|NCT00761631|62757840|FG004|Overall Study|Lost to Follow-up|6|||
33378865|NCT00761631|62757841|FG005|Overall Study|Lost to Follow-up|1|||
33378866|NCT00761631|62757836|FG000|Overall Study|Protocol Violation|2|||
33378867|NCT00761631|62757837|FG001|Overall Study|Protocol Violation|0|||
33378868|NCT00761631|62757838|FG002|Overall Study|Protocol Violation|0|||
33378869|NCT00761631|62757839|FG003|Overall Study|Protocol Violation|1|||
33378870|NCT00761631|62757840|FG004|Overall Study|Protocol Violation|5|||
33378871|NCT00761631|62757841|FG005|Overall Study|Protocol Violation|1|||
33378872|NCT00761631|62757836|FG000|Overall Study|Randomized, not treated|1|||
33378873|NCT00761631|62757837|FG001|Overall Study|Randomized, not treated|0|||
33378874|NCT00761631|62757838|FG002|Overall Study|Randomized, not treated|0|||
33378875|NCT00761631|62757839|FG003|Overall Study|Randomized, not treated|0|||
33378876|NCT00761631|62757840|FG004|Overall Study|Randomized, not treated|0|||
33378877|NCT00761631|62757841|FG005|Overall Study|Randomized, not treated|0|||
33378878|NCT00761631|62757836|FG000|Overall Study|Failed to return|1|||
33378879|NCT00761631|62757837|FG001|Overall Study|Failed to return|0|||
33378880|NCT00761631|62757838|FG002|Overall Study|Failed to return|1|||
33378881|NCT00761631|62757839|FG003|Overall Study|Failed to return|1|||
33378882|NCT00761631|62757840|FG004|Overall Study|Failed to return|5|||
33378883|NCT00761631|62757841|FG005|Overall Study|Failed to return|2|||
33378884|NCT00761631|62757836|FG000|Overall Study|Physician Decision|1|||
33378885|NCT00761631|62757837|FG001|Overall Study|Physician Decision|0|||
33378886|NCT00761631|62757838|FG002|Overall Study|Physician Decision|0|||
33378887|NCT00761631|62757839|FG003|Overall Study|Physician Decision|0|||
33378888|NCT00761631|62757840|FG004|Overall Study|Physician Decision|0|||
33378889|NCT00761631|62757841|FG005|Overall Study|Physician Decision|0|||
33378890|NCT00761631|62757836|FG000|Overall Study|Other|0|||
33378891|NCT00761631|62757837|FG001|Overall Study|Other|0|||
33378892|NCT00761631|62757838|FG002|Overall Study|Other|0|||
33378893|NCT00761631|62757839|FG003|Overall Study|Other|0|||
33378894|NCT00761631|62757840|FG004|Overall Study|Other|1|||
33378895|NCT00761631|62757841|FG005|Overall Study|Other|1|||
33378896|NCT00763698|62757864|FG000|Overall Study|Unsuccessful Implant|5|||
33378897|NCT00763698|62757864|FG000|Overall Study|Death|4|||
33378898|NCT00763698|62757864|FG000|Overall Study|Withdrawal by Subject|1|||
33378899|NCT00763386|62757871|FG000|Overall Study|Adverse Event|43|||
33378900|NCT00763386|62757872|FG001|Overall Study|Adverse Event|33|||
33662407|NCT01694849|63092906|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
33292078|NCT01123642|62668422|FG000|Overall Study|ineligible at baseline assessment|36|||
33292079|NCT01122862|62668427|FG000|Period 1|Protocol Violation|0|||
33292080|NCT01122862|62668428|FG001|Period 1|Protocol Violation|1|||
33292081|NCT01122862|62668429|FG002|Period 1|Protocol Violation|0|||
33292082|NCT01122862|62668427|FG000|Period 2|Adverse Event|0|||
33292083|NCT01122862|62668428|FG001|Period 2|Adverse Event|0|||
33292084|NCT01122862|62668429|FG002|Period 2|Adverse Event|1|||
33292085|NCT01122394|62668440|FG000|Overall Study|Withdrawal by Subject|1|||
33292086|NCT01122394|62668441|FG001|Overall Study|Withdrawal by Subject|1|||
33378901|NCT00763386|62757871|FG000|Overall Study|Death|1|||
33378902|NCT00763386|62757872|FG001|Overall Study|Death|2|||
33378903|NCT00763386|62757871|FG000|Overall Study|Lost to Follow-up|3|||
33378904|NCT00763386|62757872|FG001|Overall Study|Lost to Follow-up|3|||
33662408|NCT01694849|63092907|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
33292087|NCT01122394|62668440|FG000|Overall Study|Lost to Follow-up|2|||
33292088|NCT01122394|62668441|FG001|Overall Study|Lost to Follow-up|2|||
33292089|NCT01122394|62668440|FG000|Overall Study|Adverse Event|0|||
33378905|NCT00763386|62757871|FG000|Overall Study|Withdrawal by Subject|0|||
33378906|NCT00763386|62757872|FG001|Overall Study|Withdrawal by Subject|1|||
33378907|NCT00763386|62757871|FG000|Overall Study|CRF missing|0|||
33378908|NCT00763386|62757872|FG001|Overall Study|CRF missing|1|||
33378909|NCT00763386|62757871|FG000|Overall Study|Study Prosthesis Removed|1|||
33378910|NCT00763386|62757872|FG001|Overall Study|Study Prosthesis Removed|0|||
33378911|NCT00761319|62757880|FG000|Overall Study|Protocol Violation|21|||
33378912|NCT00761319|62757881|FG001|Overall Study|Protocol Violation|14|||
33378913|NCT00761319|62757880|FG000|Overall Study|Adverse Event|11|||
33378914|NCT00761319|62757881|FG001|Overall Study|Adverse Event|7|||
33292090|NCT01122394|62668441|FG001|Overall Study|Adverse Event|1|||
33292091|NCT01121926|62668449|FG000|First Intervention Period|Adverse Event|1|||
33292092|NCT01121926|62668450|FG001|First Intervention Period|Adverse Event|0|||
33292093|NCT01121926|62668449|FG000|Washout Period|Adverse Event|0|||
33292094|NCT01121926|62668450|FG001|Washout Period|Adverse Event|1|||
33292095|NCT01121926|62668449|FG000|Washout Period|Positive pregnancy test|0|||
33292096|NCT01121926|62668450|FG001|Washout Period|Positive pregnancy test|1|||
33292097|NCT01121575|62668471|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
33292098|NCT01121575|62668472|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
33292099|NCT01121575|62668473|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
33292100|NCT01121575|62668474|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
33292101|NCT01121575|62668475|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
33292102|NCT01121575|62668476|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
33292103|NCT01121575|62668471|FG000|Overall Study|Unspecified Reasons|8|||
33292104|NCT01121575|62668472|FG001|Overall Study|Unspecified Reasons|6|||
33292105|NCT01121575|62668473|FG002|Overall Study|Unspecified Reasons|7|||
33292106|NCT01121575|62668474|FG003|Overall Study|Unspecified Reasons|5|||
33378915|NCT00761319|62757880|FG000|Overall Study|Withdrawal by Subject|8|||
33378916|NCT00761319|62757881|FG001|Overall Study|Withdrawal by Subject|7|||
33378917|NCT00761319|62757880|FG000|Overall Study|Noncompliance|4|||
33378918|NCT00761319|62757881|FG001|Overall Study|Noncompliance|3|||
33378919|NCT00761319|62757880|FG000|Overall Study|Lost to Follow-up|1|||
33378920|NCT00761319|62757881|FG001|Overall Study|Lost to Follow-up|1|||
33378921|NCT00761319|62757880|FG000|Overall Study|Nonspecified|2|||
33378922|NCT00761319|62757881|FG001|Overall Study|Nonspecified|2|||
33487388|NCT03661983|62865562|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
33487389|NCT03661983|62865563|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
33487390|NCT03661983|62865564|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
33487391|NCT02783170|62865575|FG000|Overall Study|Randomized but not Vaccinated|1|||
33487392|NCT02783170|62865576|FG001|Overall Study|Randomized but not Vaccinated|0|||
33487393|NCT03646305|62865587|FG000|Overall Study|Lost to Follow-up|4|||
33487394|NCT03646305|62865588|FG001|Overall Study|Lost to Follow-up|2|||
33487395|NCT03646305|62865589|FG002|Overall Study|Lost to Follow-up|2|||
33487396|NCT03646305|62865590|FG003|Overall Study|Lost to Follow-up|1|||
33487397|NCT03646305|62865587|FG000|Overall Study|Withdrawal by Subject|1|||
33487398|NCT03646305|62865588|FG001|Overall Study|Withdrawal by Subject|0|||
33487399|NCT03646305|62865589|FG002|Overall Study|Withdrawal by Subject|0|||
33487400|NCT03646305|62865590|FG003|Overall Study|Withdrawal by Subject|1|||
33292107|NCT01121575|62668475|FG004|Overall Study|Unspecified Reasons|13|||
33292108|NCT01121575|62668476|FG005|Overall Study|Unspecified Reasons|10|||
33292109|NCT01121575|62668471|FG000|Overall Study|Death|6|||
33292110|NCT01121575|62668472|FG001|Overall Study|Death|0|||
33378923|NCT00761319|62757880|FG000|Overall Study|Missing|1|||
33378924|NCT00761319|62757881|FG001|Overall Study|Missing|0|||
33378925|NCT00762996|62757887|FG000|Period One|Protocol Violation|0|||
33378926|NCT00762996|62757888|FG001|Period One|Protocol Violation|0|||
33378927|NCT00762996|62757889|FG002|Period One|Protocol Violation|1|||
33378928|NCT00762996|62757890|FG003|Period One|Protocol Violation|0|||
33378929|NCT00762996|62757887|FG000|Period One|ineligible|0|||
33378930|NCT00762996|62757888|FG001|Period One|ineligible|0|||
33378931|NCT00762996|62757889|FG002|Period One|ineligible|1|||
33378932|NCT00762996|62757890|FG003|Period One|ineligible|1|||
33378933|NCT00762996|62757887|FG000|Period One|Adverse Event|0|||
33378934|NCT00762996|62757888|FG001|Period One|Adverse Event|0|||
33378935|NCT00762996|62757889|FG002|Period One|Adverse Event|1|||
33378936|NCT00762996|62757890|FG003|Period One|Adverse Event|0|||
33378937|NCT00762996|62757887|FG000|Period One|Withdrawal by Subject|0|||
33378938|NCT00762996|62757888|FG001|Period One|Withdrawal by Subject|0|||
33378939|NCT00762996|62757889|FG002|Period One|Withdrawal by Subject|1|||
33378940|NCT00762996|62757890|FG003|Period One|Withdrawal by Subject|0|||
33378941|NCT00762606|62757900|FG000|Overall Study|Lost to Follow-up|18|||
33378942|NCT00762606|62757901|FG001|Overall Study|Lost to Follow-up|13|||
33378943|NCT00818441|62757909|FG000|Overall Study|Death|69|||
33378944|NCT00818441|62757910|FG001|Overall Study|Death|26|||
33378945|NCT00818441|62757909|FG000|Overall Study|Other|5|||
33378946|NCT00818441|62757910|FG001|Overall Study|Other|0|||
33487401|NCT02782780|62865606|FG000|Overall Study|dropped out after randomization.|7|||
33487402|NCT02782780|62865607|FG001|Overall Study|dropped out after randomization.|5|||
33487403|NCT02782780|62865606|FG000|Overall Study|Protocol Violation|0|||
33487404|NCT02782780|62865607|FG001|Overall Study|Protocol Violation|2|||
33487405|NCT00126503|62865619|FG000|Overall Study|disease progression|23|||
33487406|NCT00126503|62865620|FG001|Overall Study|disease progression|14|||
33292111|NCT01121575|62668473|FG002|Overall Study|Death|0|||
33378947|NCT00818441|62757909|FG000|Overall Study|Lost to Follow-up|2|||
33378948|NCT00818441|62757910|FG001|Overall Study|Lost to Follow-up|1|||
33378949|NCT00818441|62757909|FG000|Overall Study|Withdrawal by Subject|2|||
33378950|NCT00818441|62757910|FG001|Overall Study|Withdrawal by Subject|0|||
33378951|NCT00818441|62757909|FG000|Overall Study|Adverse Event|0|||
33378952|NCT00818441|62757910|FG001|Overall Study|Adverse Event|1|||
33292112|NCT01121575|62668474|FG003|Overall Study|Death|1|||
33292113|NCT01121575|62668475|FG004|Overall Study|Death|7|||
33292114|NCT01121575|62668476|FG005|Overall Study|Death|1|||
33292115|NCT01121536|62668499|FG000|Overall Study|Adverse Event|63|||
33292116|NCT01121536|62668499|FG000|Overall Study|Lack of Efficacy|35|||
33292117|NCT01121536|62668499|FG000|Overall Study|Withdrawal by Subject|65|||
33292118|NCT01121536|62668499|FG000|Overall Study|Protocol Violation|20|||
33292119|NCT01121536|62668499|FG000|Overall Study|Noncompliance with study medication|12|||
33292120|NCT01121536|62668499|FG000|Overall Study|Noncompliance with study procedures|9|||
33292121|NCT01121536|62668499|FG000|Overall Study|Lost to Follow-up|39|||
33292122|NCT01121536|62668499|FG000|Overall Study|Other|118|||
33292123|NCT01121263|62668505|FG000|Overall Study|Death|3|||
33292124|NCT01121263|62668506|FG001|Overall Study|Death|2|||
33292125|NCT01121263|62668505|FG000|Overall Study|Lost to Follow-up|22|||
33292126|NCT01121263|62668506|FG001|Overall Study|Lost to Follow-up|12|||
33292127|NCT01121263|62668505|FG000|Overall Study|Withdrawal by Subject|0|||
33292128|NCT01121263|62668506|FG001|Overall Study|Withdrawal by Subject|1|||
33292129|NCT01121185|62668516|FG000|Overall Study|Not infused|0|||
33292130|NCT01121185|62668517|FG001|Overall Study|Not infused|1|||
33292131|NCT01121185|62668516|FG000|Overall Study|Not transplanted|1|||
33292132|NCT01121185|62668517|FG001|Overall Study|Not transplanted|0|||
33292133|NCT01121146|62668525|FG000|Overall Study|Death|17|||
33292134|NCT01121146|62668526|FG001|Overall Study|Death|15|||
33292135|NCT01121146|62668525|FG000|Overall Study|Adverse Event|2|||
33292136|NCT01121146|62668526|FG001|Overall Study|Adverse Event|11|||
33292137|NCT01121146|62668525|FG000|Overall Study|Lost to Follow-up|7|||
33292138|NCT01121146|62668526|FG001|Overall Study|Lost to Follow-up|16|||
33292139|NCT01120756|62668535|FG000|Overall Study|Withdrawal by Subject|1|||
33292140|NCT01120756|62668536|FG001|Overall Study|Withdrawal by Subject|1|||
33292141|NCT01120717|62668544|FG000|Overall Study|Withdrawal by Subject|11|||
33292142|NCT01120717|62668545|FG001|Overall Study|Withdrawal by Subject|6|||
33292143|NCT01120717|62668544|FG000|Overall Study|Adverse Event|10|||
33292144|NCT01120717|62668545|FG001|Overall Study|Adverse Event|6|||
33292145|NCT01120717|62668544|FG000|Overall Study|Protocol Deviation|2|||
33292146|NCT01120717|62668545|FG001|Overall Study|Protocol Deviation|5|||
33292147|NCT01120717|62668544|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
33292148|NCT01120717|62668545|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
33292149|NCT01120717|62668544|FG000|Overall Study|Lost to Follow-up|2|||
33292150|NCT01120717|62668545|FG001|Overall Study|Lost to Follow-up|3|||
33292151|NCT01120717|62668544|FG000|Overall Study|Death|3|||
33292152|NCT01120717|62668545|FG001|Overall Study|Death|1|||
33292153|NCT01120717|62668544|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
33292154|NCT01120717|62668545|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
33292155|NCT01120600|62668553|FG000|Overall Study|Adverse Event|7|||
33292156|NCT01120600|62668554|FG001|Overall Study|Adverse Event|7|||
33292157|NCT01120600|62668553|FG000|Overall Study|Excessive Bone Loss|0|||
33292158|NCT01120600|62668554|FG001|Overall Study|Excessive Bone Loss|4|||
33292159|NCT01120600|62668553|FG000|Overall Study|Lost to Follow-up|1|||
33292160|NCT01120600|62668554|FG001|Overall Study|Lost to Follow-up|3|||
33292161|NCT01120600|62668553|FG000|Overall Study|Physician Decision|1|||
33292162|NCT01120600|62668554|FG001|Overall Study|Physician Decision|3|||
33292163|NCT01120600|62668553|FG000|Overall Study|Protocol Violation|0|||
33292164|NCT01120600|62668554|FG001|Overall Study|Protocol Violation|4|||
33292165|NCT01120600|62668553|FG000|Overall Study|Withdrawal by Subject|10|||
33292166|NCT01120600|62668554|FG001|Overall Study|Withdrawal by Subject|11|||
33378953|NCT00818441|62757909|FG000|Overall Study|Study terminated by sponsor|11|||
33378954|NCT00818441|62757910|FG001|Overall Study|Study terminated by sponsor|2|||
33378955|NCT00826943|62757917|FG000|Overall Study|Withdrawal by Subject|0|||
33378956|NCT00826943|62757918|FG001|Overall Study|Withdrawal by Subject|0|||
33378957|NCT00826943|62757919|FG002|Overall Study|Withdrawal by Subject|0|||
33378958|NCT00826943|62757920|FG003|Overall Study|Withdrawal by Subject|0|||
33378959|NCT00826943|62757921|FG004|Overall Study|Withdrawal by Subject|1|||
33378960|NCT00826943|62757922|FG005|Overall Study|Withdrawal by Subject|0|||
33378961|NCT00834041|62757932|FG000|Overall Study|Withdrawal by Subject|1|||
33378962|NCT00834041|62757933|FG001|Overall Study|Withdrawal by Subject|0|||
33378963|NCT00834041|62757932|FG000|Overall Study|Lost to Follow-up|0|||
33487407|NCT00126503|62865619|FG000|Overall Study|Withdrawal by Subject|0|||
33487408|NCT00126503|62865620|FG001|Overall Study|Withdrawal by Subject|1|||
33662409|NCT01694849|63092905|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
33292167|NCT01120210|62668562|FG000|MAIN INFUSION|Adverse Event|1|||
33292168|NCT01120210|62668563|FG001|MAIN INFUSION|Adverse Event|0|||
33292169|NCT01120210|62668562|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
33487409|NCT00126503|62865619|FG000|Overall Study|alternative therapy|1|||
33292170|NCT01120210|62668563|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
33292171|NCT01120093|62668569|FG000|Treatment Period 1|Adverse Event|0|||
33292172|NCT01120093|62668570|FG001|Treatment Period 1|Adverse Event|0|||
33292173|NCT01120093|62668571|FG002|Treatment Period 1|Adverse Event|1|||
33292174|NCT01120093|62668572|FG003|Treatment Period 1|Adverse Event|0|||
33378964|NCT00834041|62757933|FG001|Overall Study|Lost to Follow-up|1|||
33378965|NCT00760929|62757943|FG000|Overall Study|Adverse Event|2|||
33378966|NCT00760929|62757944|FG001|Overall Study|Adverse Event|0|||
33378967|NCT00760929|62757945|FG002|Overall Study|Adverse Event|6|||
33378968|NCT00760929|62757946|FG003|Overall Study|Adverse Event|10|||
33378969|NCT00760929|62757943|FG000|Overall Study|Lack of Efficacy|0|||
33378970|NCT00760929|62757944|FG001|Overall Study|Lack of Efficacy|2|||
33378971|NCT00760929|62757945|FG002|Overall Study|Lack of Efficacy|1|||
33378972|NCT00760929|62757946|FG003|Overall Study|Lack of Efficacy|0|||
33378973|NCT00760929|62757943|FG000|Overall Study|Withdrawal by Subject|1|||
33378974|NCT00760929|62757944|FG001|Overall Study|Withdrawal by Subject|0|||
33378975|NCT00760929|62757945|FG002|Overall Study|Withdrawal by Subject|9|||
33378976|NCT00760929|62757946|FG003|Overall Study|Withdrawal by Subject|1|||
33378977|NCT00760929|62757943|FG000|Overall Study|Lost to Follow-up|0|||
33378978|NCT00760929|62757944|FG001|Overall Study|Lost to Follow-up|0|||
33378979|NCT00760929|62757945|FG002|Overall Study|Lost to Follow-up|1|||
33378980|NCT00760929|62757946|FG003|Overall Study|Lost to Follow-up|0|||
33378981|NCT00760929|62757943|FG000|Overall Study|Progression of Disease|21|||
33378982|NCT00760929|62757944|FG001|Overall Study|Progression of Disease|26|||
33378983|NCT00760929|62757945|FG002|Overall Study|Progression of Disease|38|||
33378984|NCT00760929|62757946|FG003|Overall Study|Progression of Disease|42|||
33378985|NCT00760929|62757943|FG000|Overall Study|Other|2|||
33378986|NCT00760929|62757944|FG001|Overall Study|Other|0|||
33378987|NCT00760929|62757945|FG002|Overall Study|Other|2|||
33378988|NCT00760929|62757946|FG003|Overall Study|Other|1|||
33378989|NCT00760929|62757943|FG000|Overall Study|Death|0|||
33378990|NCT00760929|62757944|FG001|Overall Study|Death|0|||
33378991|NCT00760929|62757945|FG002|Overall Study|Death|1|||
33378992|NCT00760929|62757946|FG003|Overall Study|Death|0|||
33378993|NCT00760929|62757943|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
33378994|NCT00760929|62757944|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
33378995|NCT00760929|62757945|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
33378996|NCT00760929|62757946|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
33378997|NCT00818207|62757957|FG000|Overall Study|Adverse Event|6|||
33378998|NCT00818207|62757958|FG001|Overall Study|Adverse Event|0|||
33378999|NCT00818207|62757957|FG000|Overall Study|Lost to Follow-up|160|||
33379000|NCT00818207|62757958|FG001|Overall Study|Lost to Follow-up|146|||
33379001|NCT00818207|62757957|FG000|Overall Study|Multiple reasons|11|||
33379002|NCT00818207|62757958|FG001|Overall Study|Multiple reasons|12|||
33379003|NCT00818207|62757957|FG000|Overall Study|Withdrawal by Subject|42|||
33379004|NCT00818207|62757958|FG001|Overall Study|Withdrawal by Subject|104|||
33379005|NCT00818207|62757957|FG000|Overall Study|Death|3|||
33379006|NCT00818207|62757958|FG001|Overall Study|Death|5|||
33379007|NCT00760617|62757967|FG000|Overall Study|Adverse Event|5|||
33379008|NCT00760617|62757968|FG001|Overall Study|Adverse Event|2|||
33379009|NCT00760617|62757969|FG002|Overall Study|Adverse Event|0|||
33379010|NCT00760617|62757967|FG000|Overall Study|Lost to Follow-up|0|||
33379011|NCT00760617|62757968|FG001|Overall Study|Lost to Follow-up|0|||
33379012|NCT00760617|62757969|FG002|Overall Study|Lost to Follow-up|5|||
33379013|NCT00760383|62757979|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
33379014|NCT00760383|62757980|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
33379015|NCT00759915|62757988|FG000|Overall Study|Withdrawal by Subject|1|||
33379016|NCT00759915|62757989|FG001|Overall Study|Withdrawal by Subject|0|||
33379017|NCT00759915|62757988|FG000|Overall Study|Adverse Event|0|||
33379018|NCT00759915|62757989|FG001|Overall Study|Adverse Event|1|||
33379019|NCT00759759|62757997|FG000|Overall Study|didn't return for period 2|1|||
33379020|NCT00759759|62757998|FG001|Overall Study|didn't return for period 2|0|||
33379021|NCT00759759|62757997|FG000|Overall Study|Didn't receive drug in period 2|1|||
33379022|NCT00759759|62757998|FG001|Overall Study|Didn't receive drug in period 2|0|||
33379023|NCT00759759|62757997|FG000|Overall Study|Withdrawal by Subject|2|||
33379024|NCT00759759|62757998|FG001|Overall Study|Withdrawal by Subject|1|||
33379025|NCT00759681|62758006|FG000|Overall Study|Death|2|||
33662410|NCT01694849|63092906|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
33662411|NCT01694849|63092907|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
33662412|NCT01694849|63092905|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
33379026|NCT00759681|62758007|FG001|Overall Study|Death|5|||
33379027|NCT00759681|62758006|FG000|Overall Study|Lost to Follow-up|8|||
33379028|NCT00759681|62758007|FG001|Overall Study|Lost to Follow-up|5|||
33379029|NCT00826241|62758014|FG000|Overall Study|Withdrawal from Follow-up|1|||
33379030|NCT00826241|62758014|FG000|Overall Study|Withdrew consent|2|||
33379031|NCT00826241|62758014|FG000|Overall Study|Death|4|||
33379032|NCT00826241|62758014|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
33379033|NCT00826241|62758014|FG000|Overall Study|Non-compliance|1|||
33379034|NCT00826241|62758014|FG000|Overall Study|Progression of disease|1|||
33379035|NCT00826241|62758014|FG000|Overall Study|Patient refused follow-up|3|||
33379036|NCT00826241|62758014|FG000|Overall Study|Lost to Follow-up|9|||
33379037|NCT00826241|62758014|FG000|Overall Study|Could not obtain records|1|||
33379038|NCT00826241|62758014|FG000|Overall Study|Screen failure|2|||
33487410|NCT00126503|62865620|FG001|Overall Study|alternative therapy|1|||
33379039|NCT00826241|62758014|FG000|Overall Study|Pt unable to proceed to registration|1|||
33379040|NCT00826241|62758014|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
33379041|NCT00758589|62758022|FG000|Overall Study|Adverse Event|3|||
33379042|NCT00758589|62758023|FG001|Overall Study|Adverse Event|2|||
33379043|NCT00758589|62758024|FG002|Overall Study|Adverse Event|5|||
33379044|NCT00758589|62758025|FG003|Overall Study|Adverse Event|4|||
33292175|NCT01120093|62668573|FG004|Treatment Period 1|Adverse Event|1|||
33292176|NCT01120093|62668569|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33292177|NCT01120093|62668570|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33292178|NCT01120093|62668571|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33379045|NCT00758589|62758022|FG000|Overall Study|Withdrawal by Subject|0|||
33379046|NCT00758589|62758023|FG001|Overall Study|Withdrawal by Subject|1|||
33379047|NCT00758589|62758024|FG002|Overall Study|Withdrawal by Subject|1|||
33379048|NCT00758589|62758025|FG003|Overall Study|Withdrawal by Subject|1|||
33379049|NCT00758589|62758022|FG000|Overall Study|Palm stopped to work|0|||
33379050|NCT00758589|62758023|FG001|Overall Study|Palm stopped to work|0|||
33379051|NCT00758589|62758024|FG002|Overall Study|Palm stopped to work|0|||
33379052|NCT00758589|62758025|FG003|Overall Study|Palm stopped to work|1|||
33379053|NCT00833417|62758037|FG000|Overall Study|Adverse Event|5|||
33379054|NCT00833417|62758038|FG001|Overall Study|Adverse Event|16|||
33379055|NCT00833417|62758037|FG000|Overall Study|Death|1|||
33379056|NCT00833417|62758038|FG001|Overall Study|Death|3|||
33379057|NCT00833417|62758037|FG000|Overall Study|Lost to Follow-up|1|||
33379058|NCT00833417|62758038|FG001|Overall Study|Lost to Follow-up|2|||
33379059|NCT00833417|62758037|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
33379060|NCT00833417|62758038|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
33379061|NCT00833417|62758037|FG000|Overall Study|Patient Decision to Withdraw|4|||
33379062|NCT00833417|62758038|FG001|Overall Study|Patient Decision to Withdraw|23|||
33379063|NCT00833417|62758037|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
33379064|NCT00833417|62758038|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
33292179|NCT01120093|62668572|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33379065|NCT00833417|62758037|FG000|Overall Study|Disease Progression|18|||
33379066|NCT00833417|62758038|FG001|Overall Study|Disease Progression|17|||
33379067|NCT00833417|62758037|FG000|Overall Study|Reason Not Specified|0|||
33379068|NCT00833417|62758038|FG001|Overall Study|Reason Not Specified|1|||
33379069|NCT00762372|62758048|FG000|Overall Study|Adverse Event|1|||
33379070|NCT00762372|62758049|FG001|Overall Study|Adverse Event|0|||
33379071|NCT00762372|62758050|FG002|Overall Study|Adverse Event|0|||
33379072|NCT00833261|62758064|FG000|Overall Study|Withdrawal by Subject|4|||
33379073|NCT00833105|62758068|FG000|Overall Study|Withdrawal by Subject|1|||
33292180|NCT01120093|62668573|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33292181|NCT01120093|62668569|FG000|Treatment Period 2|Adverse Event|0|||
33292182|NCT01120093|62668570|FG001|Treatment Period 2|Adverse Event|0|||
33292183|NCT01120093|62668571|FG002|Treatment Period 2|Adverse Event|0|||
33292184|NCT01120093|62668572|FG003|Treatment Period 2|Adverse Event|1|||
33292185|NCT01120093|62668573|FG004|Treatment Period 2|Adverse Event|0|||
33292186|NCT01120093|62668569|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33292187|NCT01120093|62668570|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33292188|NCT01120093|62668571|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33292189|NCT01120093|62668572|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33292190|NCT01120093|62668573|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33292191|NCT01120093|62668569|FG000|Treatment Period 3|Lack of Efficacy|0|||
33292192|NCT01120093|62668570|FG001|Treatment Period 3|Lack of Efficacy|0|||
33379074|NCT00833105|62758068|FG000|Overall Study|Adverse Event|2|||
33379075|NCT00833027|62758074|FG000|Overall Study|Adverse Event|33|||
33379076|NCT00833027|62758074|FG000|Overall Study|Death|1|||
33379077|NCT00833027|62758074|FG000|Overall Study|Lack of Efficacy|12|||
33379078|NCT00833027|62758074|FG000|Overall Study|Lost to Follow-up|24|||
33379079|NCT00833027|62758074|FG000|Overall Study|Protocol Violation|115|||
33379080|NCT00833027|62758074|FG000|Overall Study|Withdrawal by Subject|16|||
33292193|NCT01120093|62668571|FG002|Treatment Period 3|Lack of Efficacy|0|||
33292194|NCT01120093|62668572|FG003|Treatment Period 3|Lack of Efficacy|1|||
33379081|NCT00833027|62758074|FG000|Overall Study|Missing|10|||
33292195|NCT01120093|62668573|FG004|Treatment Period 3|Lack of Efficacy|0|||
33292196|NCT01120093|62668569|FG000|Treatment Period 3|Adverse Event|0|||
33292197|NCT01120093|62668570|FG001|Treatment Period 3|Adverse Event|0|||
33292198|NCT01120093|62668571|FG002|Treatment Period 3|Adverse Event|0|||
33379082|NCT00752622|62758078|FG000|Induction Phase|Adverse Event|3|||
33379083|NCT00752622|62758078|FG000|Induction Phase|Other|3|||
33379084|NCT00752622|62758078|FG000|Induction Phase|Non-responder|14|||
33379085|NCT00752622|62758078|FG000|Induction Phase|Withdrawal by Subject|1|||
33379086|NCT00752622|62758078|FG000|Induction Phase|Premature study termination|14|||
33379087|NCT00752622|62758078|FG000|Observational Phase|Premature Study Termination|36|||
33379088|NCT00752622|62758078|FG000|Observational Phase|Non-responder|2|||
33379089|NCT00752622|62758078|FG000|Observational Phase|Withdrawal by Subject|2|||
33292199|NCT01120093|62668572|FG003|Treatment Period 3|Adverse Event|0|||
33292200|NCT01120093|62668573|FG004|Treatment Period 3|Adverse Event|1|||
33292201|NCT01120093|62668569|FG000|Treatment Period 3|Withdrawal by Subject|0|||
33292202|NCT01120093|62668570|FG001|Treatment Period 3|Withdrawal by Subject|0|||
33292203|NCT01120093|62668571|FG002|Treatment Period 3|Withdrawal by Subject|1|||
33292204|NCT01120093|62668572|FG003|Treatment Period 3|Withdrawal by Subject|0|||
33292205|NCT01120093|62668573|FG004|Treatment Period 3|Withdrawal by Subject|0|||
33292206|NCT01120093|62668569|FG000|Treatment Period 4|Adverse Event|1|||
33292207|NCT01120093|62668570|FG001|Treatment Period 4|Adverse Event|0|||
33292208|NCT01120093|62668571|FG002|Treatment Period 4|Adverse Event|0|||
33292209|NCT01120093|62668572|FG003|Treatment Period 4|Adverse Event|0|||
33292210|NCT01120093|62668573|FG004|Treatment Period 4|Adverse Event|0|||
33292211|NCT01120093|62668569|FG000|Treatment Period 5|Adverse Event|0|||
33292212|NCT01120093|62668570|FG001|Treatment Period 5|Adverse Event|1|||
33379090|NCT00752622|62758078|FG000|Observational Phase|Adverse Event|1|||
33379091|NCT00752622|62758078|FG000|Observational Phase|Other|2|||
33379092|NCT00752622|62758078|FG000|Interventional Phase|Non-responder|2|||
33379093|NCT00752622|62758078|FG000|Interventional Phase|Physician Decision|1|||
33379094|NCT00752622|62758078|FG000|Interventional Phase|Premature Study Termination|5|||
33379095|NCT00754650|62758083|FG000|Overall Study|Disease Progression|2|||
33379096|NCT00761748|62758087|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
33379097|NCT00761748|62758088|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
33379098|NCT00761748|62758087|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
33379099|NCT00761748|62758088|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
33379100|NCT00825305|62758096|FG000|Overall Study|Adverse Event|1|||
33379101|NCT00825305|62758097|FG001|Overall Study|Adverse Event|1|||
33379102|NCT00825305|62758096|FG000|Overall Study|Withdrawal by Subject|6|||
33379103|NCT00825305|62758097|FG001|Overall Study|Withdrawal by Subject|12|||
33379104|NCT00825305|62758096|FG000|Overall Study|Inappropriate inclusion|1|||
33379105|NCT00825305|62758097|FG001|Overall Study|Inappropriate inclusion|0|||
33379106|NCT00825305|62758096|FG000|Overall Study|Protocol Violation|9|||
33379107|NCT00825305|62758097|FG001|Overall Study|Protocol Violation|9|||
33379108|NCT00825305|62758096|FG000|Overall Study|Can not be classified|0|||
33379109|NCT00825305|62758097|FG001|Overall Study|Can not be classified|1|||
33379110|NCT00754572|62758103|FG000|Overall Study|Adverse Event|19|||
33379111|NCT00754572|62758103|FG000|Overall Study|Other|39|||
33379112|NCT00754572|62758103|FG000|Overall Study|Protocol Violation|3|||
33379113|NCT00754572|62758103|FG000|Overall Study|Withdrawal by Subject|3|||
33379114|NCT00754572|62758103|FG000|Overall Study|Lack of Efficacy|2|||
33379115|NCT00754572|62758103|FG000|Overall Study|Death|1|||
33379116|NCT00754572|62758103|FG000|Overall Study|Administrative Reason|3|||
33379117|NCT00754572|62758103|FG000|Overall Study|Lost to Follow-up|1|||
33379118|NCT00824993|62758109|FG000|Overall Study|Withdrawal by Subject|1|||
33379119|NCT00824993|62758110|FG001|Overall Study|Withdrawal by Subject|1|||
33379120|NCT00824993|62758109|FG000|Overall Study|Malignancy Relapse|9|||
33379121|NCT00824993|62758110|FG001|Overall Study|Malignancy Relapse|10|||
33379122|NCT00824993|62758109|FG000|Overall Study|Rapid Bone Loss|0|||
33379123|NCT00824993|62758110|FG001|Overall Study|Rapid Bone Loss|1|||
33379124|NCT00824993|62758109|FG000|Overall Study|Non-Compliant|2|||
33379125|NCT00824993|62758110|FG001|Overall Study|Non-Compliant|1|||
33379126|NCT00824993|62758109|FG000|Overall Study|Insurance Issue|2|||
33379127|NCT00824993|62758110|FG001|Overall Study|Insurance Issue|1|||
33379128|NCT00824993|62758109|FG000|Overall Study|Death|0|||
33379129|NCT00824993|62758110|FG001|Overall Study|Death|3|||
33379130|NCT00832091|62758118|FG000|Overall Study|Adverse Event|1|||
33379131|NCT00832091|62758119|FG001|Overall Study|Adverse Event|1|||
33662413|NCT01694849|63092906|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
33662414|NCT01694849|63092907|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
33662415|NCT01694849|63092905|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
33662416|NCT01694849|63092906|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
33662417|NCT01694849|63092907|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
33292213|NCT01120093|62668571|FG002|Treatment Period 5|Adverse Event|0|||
33292214|NCT01120093|62668572|FG003|Treatment Period 5|Adverse Event|1|||
33292215|NCT01120093|62668573|FG004|Treatment Period 5|Adverse Event|0|||
33379132|NCT00832091|62758118|FG000|Overall Study|Protocol Violation|1|||
33379133|NCT00832091|62758119|FG001|Overall Study|Protocol Violation|0|||
33379134|NCT00832091|62758118|FG000|Overall Study|Withdrawal by Subject|2|||
33292216|NCT01119937|62668587|FG000|Overall Study|Adverse Event|11|||
33292217|NCT01119937|62668588|FG001|Overall Study|Adverse Event|5|||
33292218|NCT01119937|62668587|FG000|Overall Study|Protocol deviation|3|||
33292219|NCT01119937|62668588|FG001|Overall Study|Protocol deviation|1|||
33292220|NCT01119937|62668587|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
33379135|NCT00832091|62758119|FG001|Overall Study|Withdrawal by Subject|1|||
33379136|NCT00832091|62758118|FG000|Overall Study|Prohibited Medication|1|||
33379137|NCT00832091|62758119|FG001|Overall Study|Prohibited Medication|0|||
33662418|NCT01694849|63092905|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
33662419|NCT01694849|63092906|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
33292221|NCT01119937|62668588|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33662420|NCT01694849|63092907|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
33662421|NCT01694849|63092905|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
33662422|NCT01694849|63092906|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
33662423|NCT01694849|63092907|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
33662424|NCT01694849|63092905|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
33379146|NCT00761514|62758144|FG000|Overall Study|Adverse Event|1|||
33292222|NCT01119937|62668587|FG000|Overall Study|Withdrawal by Subject|2|||
33292223|NCT01119937|62668588|FG001|Overall Study|Withdrawal by Subject|1|||
33292224|NCT01119898|62668596|FG000|Overall Study|Adverse Event|4|||
33292225|NCT01119898|62668597|FG001|Overall Study|Adverse Event|5|||
33292226|NCT01119898|62668596|FG000|Overall Study|Withdrawal by Subject|1|||
33292227|NCT01119898|62668597|FG001|Overall Study|Withdrawal by Subject|4|||
33292228|NCT01119898|62668596|FG000|Overall Study|Lack of Efficacy|0|||
33292229|NCT01119898|62668597|FG001|Overall Study|Lack of Efficacy|2|||
33292230|NCT01119898|62668596|FG000|Overall Study|Protocol Violation|1|||
33292231|NCT01119898|62668597|FG001|Overall Study|Protocol Violation|1|||
33292232|NCT01119898|62668596|FG000|Overall Study|Medical procedure|1|||
33292233|NCT01119898|62668597|FG001|Overall Study|Medical procedure|0|||
33292234|NCT01119898|62668596|FG000|Overall Study|Randomized in error did not participate|1|||
33292235|NCT01119898|62668597|FG001|Overall Study|Randomized in error did not participate|0|||
33292236|NCT01119859|62668605|FG000|Overall Study|Adverse Event|9|||
33292237|NCT01119859|62668606|FG001|Overall Study|Adverse Event|10|||
33292238|NCT01119859|62668605|FG000|Overall Study|Death|2|||
33292239|NCT01119859|62668606|FG001|Overall Study|Death|0|||
33292240|NCT01119859|62668605|FG000|Overall Study|Insufficient therapeutic response|7|||
33292241|NCT01119859|62668606|FG001|Overall Study|Insufficient therapeutic response|14|||
33292242|NCT01119859|62668605|FG000|Overall Study|Refused treatment|3|||
33379147|NCT00761514|62758144|FG000|Overall Study|Withdrawal by Subject|2|||
33379148|NCT00761514|62758144|FG000|Overall Study|Lost to Follow-up|1|||
33379149|NCT00761514|62758144|FG000|Overall Study|Health insurance didn't cover study drug|1|||
33379150|NCT00761514|62758144|FG000|Overall Study|Problem complying with study visit|1|||
33379151|NCT00761514|62758144|FG000|Overall Study|Unable to pay for medications|1|||
33379152|NCT00831779|62758150|FG000|Overall Study|Lost to Follow-up|1|||
33379153|NCT00831779|62758151|FG001|Overall Study|Lost to Follow-up|0|||
33379154|NCT00831779|62758150|FG000|Overall Study|No longer met criteria|0|||
33379155|NCT00831779|62758151|FG001|Overall Study|No longer met criteria|1|||
33379156|NCT00758043|62758161|FG000|Overall Study|Adverse Event|1|||
33379157|NCT00758043|62758162|FG001|Overall Study|Adverse Event|20|||
33379158|NCT00758043|62758163|FG002|Overall Study|Adverse Event|12|||
33379159|NCT00758043|62758164|FG003|Overall Study|Adverse Event|62|||
33379160|NCT00758043|62758161|FG000|Overall Study|Lack of Efficacy|0|||
33379161|NCT00758043|62758162|FG001|Overall Study|Lack of Efficacy|6|||
33379162|NCT00758043|62758163|FG002|Overall Study|Lack of Efficacy|18|||
33379163|NCT00758043|62758164|FG003|Overall Study|Lack of Efficacy|12|||
33379164|NCT00758043|62758161|FG000|Overall Study|Refused Further Treatment|0|||
33379165|NCT00758043|62758162|FG001|Overall Study|Refused Further Treatment|11|||
33379166|NCT00758043|62758163|FG002|Overall Study|Refused Further Treatment|5|||
33379167|NCT00758043|62758164|FG003|Overall Study|Refused Further Treatment|8|||
33379168|NCT00758043|62758161|FG000|Overall Study|Lost to Follow-up|0|||
33379169|NCT00758043|62758162|FG001|Overall Study|Lost to Follow-up|2|||
33379170|NCT00758043|62758163|FG002|Overall Study|Lost to Follow-up|2|||
33379171|NCT00758043|62758164|FG003|Overall Study|Lost to Follow-up|5|||
33379172|NCT00758043|62758161|FG000|Overall Study|Withdrawal by Subject|0|||
33379173|NCT00758043|62758162|FG001|Overall Study|Withdrawal by Subject|1|||
33379174|NCT00758043|62758163|FG002|Overall Study|Withdrawal by Subject|1|||
33379175|NCT00758043|62758164|FG003|Overall Study|Withdrawal by Subject|4|||
33379176|NCT00758043|62758161|FG000|Overall Study|Required Prohibited Medication|0|||
33379177|NCT00758043|62758162|FG001|Overall Study|Required Prohibited Medication|0|||
33379178|NCT00758043|62758163|FG002|Overall Study|Required Prohibited Medication|1|||
33379179|NCT00758043|62758164|FG003|Overall Study|Required Prohibited Medication|3|||
33379180|NCT00758043|62758161|FG000|Overall Study|Non-Compliant With study Drug|0|||
33292243|NCT01119859|62668606|FG001|Overall Study|Refused treatment|6|||
33379181|NCT00758043|62758162|FG001|Overall Study|Non-Compliant With study Drug|0|||
33379182|NCT00758043|62758163|FG002|Overall Study|Non-Compliant With study Drug|0|||
33379183|NCT00758043|62758164|FG003|Overall Study|Non-Compliant With study Drug|1|||
33379184|NCT00758043|62758161|FG000|Overall Study|Other Reasons|0|||
33379185|NCT00758043|62758162|FG001|Overall Study|Other Reasons|1|||
33379186|NCT00758043|62758163|FG002|Overall Study|Other Reasons|0|||
33379187|NCT00758043|62758164|FG003|Overall Study|Other Reasons|5|||
33379188|NCT00831701|62758182|FG000|Overall Study|Withdrawal by Subject|2|||
33292244|NCT01119859|62668605|FG000|Overall Study|Failure to return|3|||
33292245|NCT01119859|62668606|FG001|Overall Study|Failure to return|0|||
33292246|NCT01119703|62668614|FG000|Overall Study|Adverse Event|0|||
33379189|NCT00831701|62758183|FG001|Overall Study|Withdrawal by Subject|0|||
33379190|NCT00831701|62758182|FG000|Overall Study|Stone expulsion before first medication|2|||
33662425|NCT01694849|63092906|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
33292247|NCT01119703|62668615|FG001|Overall Study|Adverse Event|1|||
33292248|NCT01119625|62668622|FG000|Overall Study|Lost to Follow-up|1|||
33379191|NCT00831701|62758183|FG001|Overall Study|Stone expulsion before first medication|2|||
33379192|NCT00831701|62758182|FG000|Overall Study|Lost to Follow-up|1|||
33379193|NCT00831701|62758183|FG001|Overall Study|Lost to Follow-up|3|||
33379194|NCT00752895|62758191|FG000|Overall Study|Withdrawal by Subject|8|||
33379195|NCT00752895|62758192|FG001|Overall Study|Withdrawal by Subject|3|||
33379196|NCT00831389|62758200|FG000|Overall Study|Withdrawal by Subject|0|||
33379197|NCT00831389|62758201|FG001|Overall Study|Withdrawal by Subject|1|||
33379198|NCT00831311|62758209|FG000|Overall Study|Definitive Contraindication|3|||
33379199|NCT00831311|62758210|FG001|Overall Study|Definitive Contraindication|3|||
33379200|NCT00831311|62758209|FG000|Overall Study|Lost to Follow-up|3|||
33487411|NCT00126503|62865619|FG000|Overall Study|other complicating disease|4|||
33487412|NCT00126503|62865620|FG001|Overall Study|other complicating disease|1|||
33487413|NCT00126503|62865619|FG000|Overall Study|Death|3|||
33487414|NCT00126503|62865620|FG001|Overall Study|Death|0|||
33487415|NCT00126503|62865619|FG000|Overall Study|Adverse Event|13|||
33487416|NCT00126503|62865620|FG001|Overall Study|Adverse Event|3|||
33487417|NCT00126503|62865619|FG000|Overall Study|non-compliant|1|||
33487418|NCT00126503|62865620|FG001|Overall Study|non-compliant|0|||
33487419|NCT00126503|62865619|FG000|Overall Study|Physician Decision|2|||
33487420|NCT00126503|62865620|FG001|Overall Study|Physician Decision|1|||
33487421|NCT00126425|62865632|FG000|Overall Study|Withdrawal by Subject|17|||
33487422|NCT00126425|62865633|FG001|Overall Study|Withdrawal by Subject|1|||
33487423|NCT00126425|62865632|FG000|Overall Study|Lost to Follow-up|8|||
33487424|NCT00126425|62865633|FG001|Overall Study|Lost to Follow-up|4|||
33487425|NCT00126425|62865632|FG000|Overall Study|Protocol Violation|9|||
33487426|NCT00126425|62865633|FG001|Overall Study|Protocol Violation|6|||
33487427|NCT00126425|62865632|FG000|Overall Study|Adverse Event|1|||
33487428|NCT00126425|62865633|FG001|Overall Study|Adverse Event|0|||
33292249|NCT01119625|62668623|FG001|Overall Study|Lost to Follow-up|2|||
33292250|NCT01119625|62668622|FG000|Overall Study|Withdrawal by Subject|2|||
33292251|NCT01119625|62668623|FG001|Overall Study|Withdrawal by Subject|1|||
33292252|NCT01119625|62668622|FG000|Overall Study|Other|0|||
33487429|NCT00126425|62865632|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
33487430|NCT00126425|62865633|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
33487431|NCT00126425|62865632|FG000|Overall Study|Other|5|||
33487432|NCT00126425|62865633|FG001|Overall Study|Other|0|||
33487433|NCT00126191|62865641|FG000|Overall Study|Physician Decision|0|||
33487434|NCT00126191|62865642|FG001|Overall Study|Physician Decision|1|||
33487435|NCT00126191|62865641|FG000|Overall Study|Death|0|||
33487436|NCT00126191|62865642|FG001|Overall Study|Death|1|||
33662426|NCT01694849|63092907|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
33662427|NCT01694771|63092956|FG000|Overall Study|Adverse Event|18|||
33662428|NCT01694771|63092957|FG001|Overall Study|Adverse Event|16|||
33292253|NCT01119625|62668623|FG001|Overall Study|Other|1|||
33292254|NCT01119118|62668629|FG000|Overall Study|Adverse Event|1|||
33292255|NCT01119001|62668633|FG000|Overall Study|Withdrawal by Subject|2|||
33292256|NCT01118962|62668639|FG000|Overall Study|Adverse Event|2|||
33292257|NCT01118962|62668639|FG000|Overall Study|Lack of Efficacy|1|||
33292258|NCT01118962|62668639|FG000|Overall Study|Protocol Violation|1|||
33292259|NCT01118962|62668639|FG000|Overall Study|Withdrawal by Subject|4|||
33292260|NCT01118962|62668639|FG000|Overall Study|Pregnancy|1|||
33292261|NCT01118962|62668639|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
33292262|NCT01118728|62668643|FG000|Overall Study|Adverse Event|17|||
33292263|NCT01118728|62668643|FG000|Overall Study|Lack of Efficacy|27|||
33292264|NCT01118728|62668643|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
33292265|NCT01118728|62668643|FG000|Overall Study|Withdrawal by Subject|3|||
33292266|NCT01118728|62668643|FG000|Overall Study|Lost to Follow-up|4|||
33292267|NCT01118455|62668649|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
33292268|NCT01118455|62668650|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
33292269|NCT01118377|62668664|FG000|Overall Study|Did Not Receive Study Medication|1|||
33379201|NCT00831311|62758210|FG001|Overall Study|Lost to Follow-up|0|||
33379202|NCT00831311|62758209|FG000|Overall Study|Physician Decision|0|||
33487437|NCT00124943|62865652|FG000|Phase II|Adverse Event|0|||
33487438|NCT00124943|62865653|FG001|Phase II|Adverse Event|2|||
33487439|NCT00124943|62865654|FG002|Phase II|Adverse Event|0|||
33487440|NCT00124943|62865655|FG003|Phase II|Adverse Event|1|||
33487441|NCT00124943|62865652|FG000|Phase II|Protocol Violation|0|||
33487442|NCT00124943|62865653|FG001|Phase II|Protocol Violation|0|||
33487443|NCT00124943|62865654|FG002|Phase II|Protocol Violation|0|||
33487444|NCT00124943|62865655|FG003|Phase II|Protocol Violation|1|||
33487445|NCT00124943|62865652|FG000|Phase II|Lost to Follow-up|0|||
33487446|NCT00124943|62865653|FG001|Phase II|Lost to Follow-up|0|||
33487447|NCT00124943|62865654|FG002|Phase II|Lost to Follow-up|0|||
33662429|NCT01694771|63092956|FG000|Overall Study|Lack of Efficacy|1|||
33292270|NCT01118377|62668664|FG000|Overall Study|Death|38|||
33292271|NCT01118377|62668664|FG000|Overall Study|Failure to Return|3|||
33292272|NCT01118299|62668670|FG000|Overall Study|Death|7|||
33487448|NCT00124943|62865655|FG003|Phase II|Lost to Follow-up|1|||
33292273|NCT01118299|62668671|FG001|Overall Study|Death|5|||
33292274|NCT01118299|62668670|FG000|Overall Study|Withdrawal by Subject|8|||
33292275|NCT01118299|62668671|FG001|Overall Study|Withdrawal by Subject|8|||
33292276|NCT01118299|62668670|FG000|Overall Study|Lost to Follow-up|2|||
33292277|NCT01118299|62668671|FG001|Overall Study|Lost to Follow-up|1|||
33292278|NCT01118299|62668670|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
33292279|NCT01118299|62668671|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
33379203|NCT00831311|62758210|FG001|Overall Study|Physician Decision|1|||
33379204|NCT00831311|62758209|FG000|Overall Study|Withdrawal by Subject|6|||
33379205|NCT00831311|62758210|FG001|Overall Study|Withdrawal by Subject|4|||
33379206|NCT00831233|62758219|FG000|Overall Study|Adverse Event|0|||
33379207|NCT00831233|62758220|FG001|Overall Study|Adverse Event|1|||
33379208|NCT00831233|62758219|FG000|Overall Study|Protocol Violation|1|||
33379209|NCT00831233|62758220|FG001|Overall Study|Protocol Violation|0|||
33379210|NCT00831233|62758219|FG000|Overall Study|Selection Criteria Not Met|2|||
33379211|NCT00831233|62758220|FG001|Overall Study|Selection Criteria Not Met|0|||
33379212|NCT00761280|62758237|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
33379213|NCT00761280|62758238|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
33379214|NCT00761280|62758237|FG000|Randomization to First Dose|Sponsor decision|1|||
33379215|NCT00761280|62758238|FG001|Randomization to First Dose|Sponsor decision|0|||
33487449|NCT00124943|62865652|FG000|Phase II|Withdrawal by Subject|0|||
33487450|NCT00124943|62865653|FG001|Phase II|Withdrawal by Subject|0|||
33487451|NCT00124943|62865654|FG002|Phase II|Withdrawal by Subject|0|||
33487452|NCT00124943|62865655|FG003|Phase II|Withdrawal by Subject|2|||
33487453|NCT00124709|62865667|FG000|Overall Study|Randomized but did not take medication|3|||
33487454|NCT00124709|62865668|FG001|Overall Study|Randomized but did not take medication|1|||
33487455|NCT00124709|62865667|FG000|Overall Study|Adverse Event|3|||
33487456|NCT00124709|62865668|FG001|Overall Study|Adverse Event|0|||
33487457|NCT00124709|62865667|FG000|Overall Study|Lack of Efficacy|5|||
33487458|NCT00124709|62865668|FG001|Overall Study|Lack of Efficacy|10|||
33487459|NCT00124709|62865667|FG000|Overall Study|Protocol Violation|3|||
33487460|NCT00124709|62865668|FG001|Overall Study|Protocol Violation|5|||
33487461|NCT00124709|62865667|FG000|Overall Study|Withdrawal by Subject|127|||
33487462|NCT00124709|62865668|FG001|Overall Study|Withdrawal by Subject|136|||
33487463|NCT00124709|62865667|FG000|Overall Study|Lost to Follow-up|114|||
33487464|NCT00124709|62865668|FG001|Overall Study|Lost to Follow-up|120|||
33487465|NCT00108862|62865676|FG000|Overall Study|Death|31|||
33487466|NCT00108862|62865677|FG001|Overall Study|Death|37|||
33487467|NCT00108862|62865676|FG000|Overall Study|Withdrawal by Subject|10|||
33487468|NCT00108862|62865677|FG001|Overall Study|Withdrawal by Subject|6|||
33487469|NCT00108862|62865676|FG000|Overall Study|Lost to Follow-up|27|||
33487470|NCT00108862|62865677|FG001|Overall Study|Lost to Follow-up|19|||
33487471|NCT00564850|62865683|FG000|Overall Study|Protocol Violation|2|||
33487472|NCT00561340|62865689|FG000|Overall Study|refused to drink pediasure|6|||
33487473|NCT00561340|62865690|FG001|Overall Study|refused to drink pediasure|0|||
33487474|NCT00108628|62865698|FG000|Overall Study|Withdrawal by Subject|17|||
33487475|NCT00108628|62865699|FG001|Overall Study|Withdrawal by Subject|9|||
33487476|NCT00108628|62865698|FG000|Overall Study|Lack of Efficacy|2|||
33487477|NCT00108628|62865699|FG001|Overall Study|Lack of Efficacy|1|||
33487478|NCT00108628|62865698|FG000|Overall Study|Death|1|||
33487479|NCT00108628|62865699|FG001|Overall Study|Death|0|||
33487480|NCT02715856|62865707|FG000|Overall Study|Software Issues|12|||
33487481|NCT02715856|62865708|FG001|Overall Study|Software Issues|7|||
33662430|NCT01694771|63092957|FG001|Overall Study|Lack of Efficacy|0|||
33379216|NCT00761280|62758237|FG000|Randomization to First Dose|Other|1|||
33379217|NCT00761280|62758238|FG001|Randomization to First Dose|Other|0|||
33379218|NCT00761280|62758237|FG000|First Dose to End of Study|End of trial|5|||
33379219|NCT00761280|62758238|FG001|First Dose to End of Study|End of trial|5|||
33487482|NCT02715856|62865707|FG000|Overall Study|Death|6|||
33487483|NCT02715856|62865708|FG001|Overall Study|Death|5|||
33487484|NCT02715856|62865707|FG000|Overall Study|Non- Compliant|0|||
33487485|NCT02715856|62865708|FG001|Overall Study|Non- Compliant|40|||
33487486|NCT00108160|62865716|FG000|Overall Study|Lost to Follow-up|25|||
33487487|NCT00108160|62865717|FG001|Overall Study|Lost to Follow-up|12|||
33487488|NCT00108160|62865716|FG000|Overall Study|Death|1|||
33487489|NCT00108160|62865717|FG001|Overall Study|Death|2|||
33487490|NCT00108160|62865716|FG000|Overall Study|Withdrawal by Subject|4|||
33487491|NCT00108160|62865717|FG001|Overall Study|Withdrawal by Subject|2|||
33487492|NCT00108160|62865716|FG000|Overall Study|Protocol Violation|9|||
33487493|NCT00108160|62865717|FG001|Overall Study|Protocol Violation|5|||
33487494|NCT01366846|62865729|FG000|Overall Study|Withdrawal by Subject|2|||
33487495|NCT01366846|62865730|FG001|Overall Study|Withdrawal by Subject|0|||
33487496|NCT01366846|62865731|FG002|Overall Study|Withdrawal by Subject|0|||
33292280|NCT01118143|62668678|FG000|Overall Study|Withdrawal by Subject|2|||
33379220|NCT00761280|62758237|FG000|First Dose to End of Study|Progressive disease|5|||
33487497|NCT01366846|62865732|FG003|Overall Study|Withdrawal by Subject|0|||
33487498|NCT01366846|62865729|FG000|Overall Study|Communication Difficulties|1|||
33487499|NCT01366846|62865730|FG001|Overall Study|Communication Difficulties|4|||
33292281|NCT01118143|62668679|FG001|Overall Study|Withdrawal by Subject|5|||
33292282|NCT01117987|62668689|FG000|Overall Study|Protocol deviation|0|||
33292283|NCT01117987|62668690|FG001|Overall Study|Protocol deviation|1|||
33292284|NCT01117987|62668689|FG000|Overall Study|Subject no longer requires study drug|1|||
33292285|NCT01117987|62668690|FG001|Overall Study|Subject no longer requires study drug|0|||
33379221|NCT00761280|62758238|FG001|First Dose to End of Study|Progressive disease|3|||
33379222|NCT00761280|62758237|FG000|First Dose to End of Study|Sponsor decision|1|||
33379223|NCT00761280|62758238|FG001|First Dose to End of Study|Sponsor decision|2|||
33379224|NCT00761280|62758237|FG000|First Dose to End of Study|Death|1|||
33379225|NCT00761280|62758238|FG001|First Dose to End of Study|Death|0|||
33379226|NCT00761280|62758237|FG000|First Dose to End of Study|Lost to Follow-up|0|||
33379227|NCT00761280|62758238|FG001|First Dose to End of Study|Lost to Follow-up|1|||
33379228|NCT00824369|62758250|FG000|Overall Study|Nolonger willing to participate in study|1|||
33292286|NCT01117987|62668689|FG000|Overall Study|Lost to Follow-up|1|||
33292287|NCT01117987|62668690|FG001|Overall Study|Lost to Follow-up|1|||
33292288|NCT01117987|62668689|FG000|Overall Study|Abnormal test procedure result|2|||
33292289|NCT01117987|62668690|FG001|Overall Study|Abnormal test procedure result|0|||
33292290|NCT01117987|62668689|FG000|Overall Study|Lack of Efficacy|3|||
33292291|NCT01117987|62668690|FG001|Overall Study|Lack of Efficacy|4|||
33292292|NCT01117987|62668689|FG000|Overall Study|Death|5|||
33292293|NCT01117987|62668690|FG001|Overall Study|Death|10|||
33292294|NCT01117987|62668689|FG000|Overall Study|Withdrawal by Subject|5|||
33292295|NCT01117987|62668690|FG001|Overall Study|Withdrawal by Subject|10|||
33292296|NCT01117987|62668689|FG000|Overall Study|Adverse Event|19|||
33292297|NCT01117987|62668690|FG001|Overall Study|Adverse Event|26|||
33292298|NCT01117987|62668689|FG000|Overall Study|Administrative problems|25|||
33292299|NCT01117987|62668690|FG001|Overall Study|Administrative problems|22|||
33292300|NCT01117870|62668698|FG000|Overall Study|Inability to place needle|1|||
33292301|NCT01117870|62668699|FG001|Overall Study|Inability to place needle|0|||
33379229|NCT00824369|62758251|FG001|Overall Study|Nolonger willing to participate in study|0|||
33379230|NCT00824369|62758252|FG002|Overall Study|Nolonger willing to participate in study|1|||
33379231|NCT00824369|62758253|FG003|Overall Study|Nolonger willing to participate in study|2|||
33379232|NCT00824369|62758254|FG004|Overall Study|Nolonger willing to participate in study|0|||
33379233|NCT00824369|62758255|FG005|Overall Study|Nolonger willing to participate in study|1|||
33379234|NCT00824369|62758250|FG000|Overall Study|Lost to Follow-up|0|||
33379235|NCT00824369|62758251|FG001|Overall Study|Lost to Follow-up|0|||
33379236|NCT00824369|62758252|FG002|Overall Study|Lost to Follow-up|0|||
33379237|NCT00824369|62758253|FG003|Overall Study|Lost to Follow-up|0|||
33379238|NCT00824369|62758254|FG004|Overall Study|Lost to Follow-up|1|||
33487500|NCT01366846|62865731|FG002|Overall Study|Communication Difficulties|0|||
33487501|NCT01366846|62865732|FG003|Overall Study|Communication Difficulties|1|||
33487502|NCT01366846|62865729|FG000|Overall Study|Scheduling Conflicts|0|||
33487503|NCT01366846|62865730|FG001|Overall Study|Scheduling Conflicts|0|||
33487504|NCT01366846|62865731|FG002|Overall Study|Scheduling Conflicts|1|||
33292302|NCT01117792|62668709|FG000|Overall Study|Death|1|||
33487505|NCT01366846|62865732|FG003|Overall Study|Scheduling Conflicts|0|||
33487506|NCT00108082|62865748|FG000|Overall Study|Adverse Event|14|||
33487507|NCT00108082|62865749|FG001|Overall Study|Adverse Event|12|||
33487508|NCT00108082|62865750|FG002|Overall Study|Adverse Event|17|||
33487509|NCT00108082|62865748|FG000|Overall Study|Lost to Follow-up|6|||
33487510|NCT00108082|62865749|FG001|Overall Study|Lost to Follow-up|3|||
33487511|NCT00108082|62865750|FG002|Overall Study|Lost to Follow-up|7|||
33487512|NCT00108082|62865748|FG000|Overall Study|Consent Withdrawn|3|||
33487513|NCT00108082|62865749|FG001|Overall Study|Consent Withdrawn|3|||
33487514|NCT00108082|62865750|FG002|Overall Study|Consent Withdrawn|5|||
33487515|NCT00108082|62865748|FG000|Overall Study|Protocol Violation|1|||
33487516|NCT00108082|62865749|FG001|Overall Study|Protocol Violation|2|||
33487517|NCT00108082|62865750|FG002|Overall Study|Protocol Violation|0|||
33487518|NCT00108082|62865748|FG000|Overall Study|Lack of Efficacy|3|||
33487519|NCT00108082|62865749|FG001|Overall Study|Lack of Efficacy|1|||
33487520|NCT00108082|62865750|FG002|Overall Study|Lack of Efficacy|2|||
33487521|NCT00108082|62865748|FG000|Overall Study|Amendment 4: > Month 12|5|||
33292303|NCT01117792|62668709|FG000|Overall Study|Adverse Event|3|||
33379239|NCT00824369|62758255|FG005|Overall Study|Lost to Follow-up|0|||
33487522|NCT00108082|62865749|FG001|Overall Study|Amendment 4: > Month 12|7|||
33487523|NCT00108082|62865750|FG002|Overall Study|Amendment 4: > Month 12|5|||
33487524|NCT00108082|62865748|FG000|Overall Study|Woman of Child-bearing Potential|2|||
33487525|NCT00108082|62865749|FG001|Overall Study|Woman of Child-bearing Potential|0|||
33292304|NCT02219490|62668713|FG000|Overall Study|Adverse Event|24|||
33292305|NCT02219490|62668713|FG000|Overall Study|Withdrew consent|96|||
33292306|NCT02219490|62668713|FG000|Overall Study|Lost to Follow-up|126|||
33292307|NCT02219490|62668713|FG000|Overall Study|COVID-19 infection|2|||
33379240|NCT00824291|62758271|FG000|Overall Study|Adverse Event|15|||
33379241|NCT00824291|62758272|FG001|Overall Study|Adverse Event|6|||
33379242|NCT00824291|62758271|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
33487526|NCT00108082|62865750|FG002|Overall Study|Woman of Child-bearing Potential|2|||
33292308|NCT02219490|62668713|FG000|Overall Study|COVID-19 logistical restrictions|33|||
33379243|NCT00824291|62758272|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
33379244|NCT00824291|62758271|FG000|Overall Study|Lost to Follow-up|11|||
33379245|NCT00824291|62758272|FG001|Overall Study|Lost to Follow-up|9|||
33379246|NCT00824291|62758271|FG000|Overall Study|Non-compliance|1|||
33292309|NCT02219490|62668713|FG000|Overall Study|Other, not specified|57|||
33292310|NCT01117480|62668721|FG000|Overall Study|Protocol Violation|8|||
33292311|NCT01117480|62668721|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
33292312|NCT01117051|62668727|FG000|Overall Study|Withdrawal by Subject|5|||
33292313|NCT01117051|62668728|FG001|Overall Study|Withdrawal by Subject|3|||
33292314|NCT01117051|62668727|FG000|Overall Study|Adverse Event|4|||
33292315|NCT01117051|62668728|FG001|Overall Study|Adverse Event|3|||
33379247|NCT00824291|62758272|FG001|Overall Study|Non-compliance|1|||
33379248|NCT00824291|62758271|FG000|Overall Study|Protocol Violation|4|||
33379249|NCT00824291|62758272|FG001|Overall Study|Protocol Violation|1|||
33379250|NCT00824291|62758271|FG000|Overall Study|Withdrawal by Subject|14|||
33379251|NCT00824291|62758272|FG001|Overall Study|Withdrawal by Subject|8|||
33379252|NCT00824291|62758271|FG000|Overall Study|Lack of Efficacy|7|||
33292316|NCT01117051|62668727|FG000|Overall Study|Lost to Follow-up|0|||
33292317|NCT01117051|62668728|FG001|Overall Study|Lost to Follow-up|1|||
33379253|NCT00824291|62758272|FG001|Overall Study|Lack of Efficacy|8|||
33379254|NCT00824291|62758271|FG000|Overall Study|Participant on prohibited medication|1|||
33379255|NCT00824291|62758272|FG001|Overall Study|Participant on prohibited medication|0|||
33379256|NCT00804986|62758284|FG000|Overall Study|Adverse Event|0|||
33379257|NCT00804986|62758285|FG001|Overall Study|Adverse Event|1|||
33379258|NCT00804986|62758286|FG002|Overall Study|Adverse Event|2|||
33379259|NCT00804986|62758287|FG003|Overall Study|Adverse Event|1|||
33379260|NCT00804986|62758288|FG004|Overall Study|Adverse Event|3|||
33379261|NCT00804986|62758289|FG005|Overall Study|Adverse Event|0|||
33379262|NCT00804986|62758284|FG000|Overall Study|Lack of Efficacy|0|||
33379263|NCT00804986|62758285|FG001|Overall Study|Lack of Efficacy|0|||
33292318|NCT01117051|62668727|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
33292319|NCT01117051|62668728|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
33379264|NCT00804986|62758286|FG002|Overall Study|Lack of Efficacy|0|||
33379265|NCT00804986|62758287|FG003|Overall Study|Lack of Efficacy|1|||
33379266|NCT00804986|62758288|FG004|Overall Study|Lack of Efficacy|0|||
33379267|NCT00804986|62758289|FG005|Overall Study|Lack of Efficacy|3|||
33379268|NCT00804986|62758284|FG000|Overall Study|Lost to Follow-up|0|||
33379269|NCT00804986|62758285|FG001|Overall Study|Lost to Follow-up|0|||
33379270|NCT00804986|62758286|FG002|Overall Study|Lost to Follow-up|0|||
33379271|NCT00804986|62758287|FG003|Overall Study|Lost to Follow-up|1|||
33379272|NCT00804986|62758288|FG004|Overall Study|Lost to Follow-up|1|||
33379273|NCT00804986|62758289|FG005|Overall Study|Lost to Follow-up|3|||
33379274|NCT00804986|62758284|FG000|Overall Study|Protocol Violation|0|||
33379275|NCT00804986|62758285|FG001|Overall Study|Protocol Violation|1|||
33379276|NCT00804986|62758286|FG002|Overall Study|Protocol Violation|0|||
33379277|NCT00804986|62758287|FG003|Overall Study|Protocol Violation|1|||
33379278|NCT00804986|62758288|FG004|Overall Study|Protocol Violation|0|||
33379279|NCT00804986|62758289|FG005|Overall Study|Protocol Violation|0|||
33379280|NCT00804986|62758284|FG000|Overall Study|Withdrawal by Subject|0|||
33379281|NCT00804986|62758285|FG001|Overall Study|Withdrawal by Subject|3|||
33379282|NCT00804986|62758286|FG002|Overall Study|Withdrawal by Subject|0|||
33379283|NCT00804986|62758287|FG003|Overall Study|Withdrawal by Subject|3|||
33379284|NCT00804986|62758288|FG004|Overall Study|Withdrawal by Subject|5|||
33379285|NCT00804986|62758289|FG005|Overall Study|Withdrawal by Subject|3|||
33379286|NCT00804986|62758284|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
33379287|NCT00804986|62758285|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
33379288|NCT00804986|62758286|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
33379289|NCT00804986|62758287|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
33379290|NCT00804986|62758288|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
33379291|NCT00804986|62758289|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
33379292|NCT00804986|62758284|FG000|Overall Study|Sponsor Decision|0|||
33379293|NCT00804986|62758285|FG001|Overall Study|Sponsor Decision|1|||
33379294|NCT00804986|62758286|FG002|Overall Study|Sponsor Decision|0|||
33292320|NCT01117051|62668727|FG000|Overall Study|Sponsor's decision|3|||
33379295|NCT00804986|62758287|FG003|Overall Study|Sponsor Decision|0|||
33379296|NCT00804986|62758288|FG004|Overall Study|Sponsor Decision|0|||
33662431|NCT01694771|63092956|FG000|Overall Study|Non compliance protocol|7|||
33292321|NCT01117051|62668728|FG001|Overall Study|Sponsor's decision|1|||
33292322|NCT01117051|62668727|FG000|Overall Study|Surgical procedure|0|||
33292323|NCT01117051|62668728|FG001|Overall Study|Surgical procedure|1|||
33292324|NCT01117051|62668727|FG000|Overall Study|Randomized by mistake|0|||
33379297|NCT00804986|62758289|FG005|Overall Study|Sponsor Decision|0|||
33379298|NCT00804986|62758284|FG000|Overall Study|Physician Decision|1|||
33379299|NCT00804986|62758285|FG001|Overall Study|Physician Decision|0|||
33379300|NCT00804986|62758286|FG002|Overall Study|Physician Decision|0|||
33379301|NCT00804986|62758287|FG003|Overall Study|Physician Decision|0|||
33292325|NCT01117051|62668728|FG001|Overall Study|Randomized by mistake|1|||
33292326|NCT01117051|62668727|FG000|Overall Study|Convenience issue|1|||
33292327|NCT01117051|62668728|FG001|Overall Study|Convenience issue|0|||
33292328|NCT02211417|62668737|FG000|Overall Study|Withdrawal by Subject|11|||
33292329|NCT02211417|62668738|FG001|Overall Study|Withdrawal by Subject|8|||
33292330|NCT02211417|62668737|FG000|Overall Study|Protocol Violation|1|||
33292331|NCT02211417|62668738|FG001|Overall Study|Protocol Violation|0|||
33292332|NCT02211417|62668737|FG000|Overall Study|Pregnancy|0|||
33292333|NCT02211417|62668738|FG001|Overall Study|Pregnancy|1|||
33292334|NCT02211417|62668737|FG000|Overall Study|Lost to Follow-up|2|||
33292335|NCT02211417|62668738|FG001|Overall Study|Lost to Follow-up|3|||
33292336|NCT02211417|62668737|FG000|Overall Study|Adverse Event|1|||
33292337|NCT02211417|62668738|FG001|Overall Study|Adverse Event|4|||
33292338|NCT01117012|62668751|FG000|Overall Study|Adverse Event|0|||
33292339|NCT01117012|62668752|FG001|Overall Study|Adverse Event|1|||
33292340|NCT01117012|62668751|FG000|Overall Study|Death|1|||
33292341|NCT01117012|62668752|FG001|Overall Study|Death|1|||
33292342|NCT01117012|62668751|FG000|Overall Study|Withdrawal by Subject|3|||
33292343|NCT01117012|62668752|FG001|Overall Study|Withdrawal by Subject|0|||
33292344|NCT01117012|62668751|FG000|Overall Study|Undefined|4|||
33292345|NCT01117012|62668752|FG001|Overall Study|Undefined|3|||
33292346|NCT01116739|62668760|FG000|Overall Study|Child had 2 years of HS|110|||
33292347|NCT01116739|62668761|FG001|Overall Study|Child had 2 years of HS|128|||
33292348|NCT01116739|62668760|FG000|Overall Study|Withdrawal by Subject|6|||
33292349|NCT01116739|62668761|FG001|Overall Study|Withdrawal by Subject|0|||
33292350|NCT01116739|62668760|FG000|Overall Study|child too young|2|||
33292351|NCT01116739|62668761|FG001|Overall Study|child too young|6|||
33292352|NCT01116739|62668760|FG000|Overall Study|child not enrolled in head start|10|||
33292353|NCT01116739|62668761|FG001|Overall Study|child not enrolled in head start|2|||
33292354|NCT01116739|62668760|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
33292355|NCT01116739|62668761|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
33292356|NCT01116544|62668769|FG000|Overall Study|Protocol Violation|1|||
33292357|NCT01116544|62668770|FG001|Overall Study|Protocol Violation|0|||
33292358|NCT01116544|62668769|FG000|Overall Study|Withdrawal by Subject|1|||
33292359|NCT01116544|62668770|FG001|Overall Study|Withdrawal by Subject|1|||
33292360|NCT01116427|62668778|FG000|Core Phase|Adverse Event|0|||
33292361|NCT01116427|62668779|FG001|Core Phase|Adverse Event|1|||
33292362|NCT01116427|62668778|FG000|Core Phase|Lost to Follow-up|1|||
33292363|NCT01116427|62668779|FG001|Core Phase|Lost to Follow-up|0|||
33292364|NCT01116427|62668778|FG000|Core Phase|Withdrawal by Subject|3|||
33292365|NCT01116427|62668779|FG001|Core Phase|Withdrawal by Subject|0|||
33292366|NCT01116427|62668778|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
33292367|NCT01116427|62668779|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
33292368|NCT01116427|62668778|FG000|Extension Phase|Adverse Event|1|||
33292369|NCT01116427|62668779|FG001|Extension Phase|Adverse Event|1|||
33292370|NCT01116427|62668778|FG000|Extension Phase|Lost to Follow-up|2|||
33292371|NCT01116427|62668779|FG001|Extension Phase|Lost to Follow-up|0|||
33292372|NCT01116427|62668778|FG000|Extension Phase|Withdrawal by Subject|5|||
33292373|NCT01116427|62668779|FG001|Extension Phase|Withdrawal by Subject|1|||
33292374|NCT01116427|62668778|FG000|Extension Phase|Not using appropriate birth control|1|||
33292375|NCT01116427|62668779|FG001|Extension Phase|Not using appropriate birth control|0|||
33292376|NCT01116232|62668789|FG000|Overall Study|Progressive diease|4|||
33292377|NCT01115998|62668798|FG000|Overall Study|Lost to Follow-up|6|||
33292378|NCT01115998|62668799|FG001|Overall Study|Lost to Follow-up|6|||
33292379|NCT01205230|62668807|FG000|Overall Study|Adverse Event|4|||
33292380|NCT01205230|62668808|FG001|Overall Study|Adverse Event|0|||
33292381|NCT01205230|62668807|FG000|Overall Study|Physician Decision|1|||
33292382|NCT01205230|62668808|FG001|Overall Study|Physician Decision|0|||
33292383|NCT01205152|62668819|FG000|Overall Study|Death|1|||
33292384|NCT01205035|62668827|FG000|Overall Study|Withdrawal by Subject|1|||
33292385|NCT01205035|62668828|FG001|Overall Study|Withdrawal by Subject|0|||
33292386|NCT01205035|62668827|FG000|Overall Study|Physician Decision|1|||
33292387|NCT01205035|62668828|FG001|Overall Study|Physician Decision|0|||
33292388|NCT01204918|62668837|FG000|Overall Study|Withdrawal by Subject|4|||
33292389|NCT01204918|62668838|FG001|Overall Study|Withdrawal by Subject|10|||
33292390|NCT01204918|62668839|FG002|Overall Study|Withdrawal by Subject|5|||
33292391|NCT01204294|62668854|FG000|Overall Study|Adverse Event|2|||
33292392|NCT01204294|62668855|FG001|Overall Study|Adverse Event|6|||
33292393|NCT01204294|62668856|FG002|Overall Study|Adverse Event|0|||
33292394|NCT01204294|62668857|FG003|Overall Study|Adverse Event|7|||
33292395|NCT01204294|62668858|FG004|Overall Study|Adverse Event|1|||
33292396|NCT01204294|62668859|FG005|Overall Study|Adverse Event|4|||
33292397|NCT01204294|62668860|FG006|Overall Study|Adverse Event|0|||
33292398|NCT01204294|62668854|FG000|Overall Study|Protocol Violation|1|||
33292399|NCT01204294|62668855|FG001|Overall Study|Protocol Violation|0|||
33292400|NCT01204294|62668856|FG002|Overall Study|Protocol Violation|2|||
33292401|NCT01204294|62668857|FG003|Overall Study|Protocol Violation|1|||
33292402|NCT01204294|62668858|FG004|Overall Study|Protocol Violation|0|||
33292403|NCT01204294|62668859|FG005|Overall Study|Protocol Violation|0|||
33292404|NCT01204294|62668860|FG006|Overall Study|Protocol Violation|0|||
33292405|NCT01204294|62668854|FG000|Overall Study|Withdrawal by Subject|0|||
33292406|NCT01204294|62668855|FG001|Overall Study|Withdrawal by Subject|2|||
33292407|NCT01204294|62668856|FG002|Overall Study|Withdrawal by Subject|2|||
33292408|NCT01204294|62668857|FG003|Overall Study|Withdrawal by Subject|1|||
33292409|NCT01204294|62668858|FG004|Overall Study|Withdrawal by Subject|1|||
33292410|NCT01204294|62668859|FG005|Overall Study|Withdrawal by Subject|1|||
33292411|NCT01204294|62668860|FG006|Overall Study|Withdrawal by Subject|2|||
33292412|NCT01204294|62668854|FG000|Overall Study|Lack of Efficacy|0|||
33292413|NCT01204294|62668855|FG001|Overall Study|Lack of Efficacy|0|||
33292414|NCT01204294|62668856|FG002|Overall Study|Lack of Efficacy|0|||
33379302|NCT00804986|62758288|FG004|Overall Study|Physician Decision|0|||
33379303|NCT00804986|62758289|FG005|Overall Study|Physician Decision|0|||
33379304|NCT00752232|62758310|FG000|Overall Study|Protocol Violation|0|||
33379305|NCT00752232|62758311|FG001|Overall Study|Protocol Violation|0|||
33379306|NCT00752232|62758312|FG002|Overall Study|Protocol Violation|0|||
33379307|NCT00752232|62758313|FG003|Overall Study|Protocol Violation|0|||
33379308|NCT00752232|62758314|FG004|Overall Study|Protocol Violation|0|||
33379309|NCT00752232|62758315|FG005|Overall Study|Protocol Violation|1|||
33379310|NCT00752232|62758316|FG006|Overall Study|Protocol Violation|0|||
33379311|NCT00752232|62758310|FG000|Overall Study|Caregiver request|2|||
33379312|NCT00752232|62758311|FG001|Overall Study|Caregiver request|0|||
33379313|NCT00752232|62758312|FG002|Overall Study|Caregiver request|0|||
33379314|NCT00752232|62758313|FG003|Overall Study|Caregiver request|0|||
33379315|NCT00752232|62758314|FG004|Overall Study|Caregiver request|1|||
33379316|NCT00752232|62758315|FG005|Overall Study|Caregiver request|0|||
33379317|NCT00752232|62758316|FG006|Overall Study|Caregiver request|0|||
33379318|NCT00752232|62758310|FG000|Overall Study|Investigator request|0|||
33379319|NCT00752232|62758311|FG001|Overall Study|Investigator request|0|||
33379320|NCT00752232|62758312|FG002|Overall Study|Investigator request|0|||
33379321|NCT00752232|62758313|FG003|Overall Study|Investigator request|0|||
33379322|NCT00752232|62758314|FG004|Overall Study|Investigator request|1|||
33379323|NCT00752232|62758315|FG005|Overall Study|Investigator request|0|||
33379324|NCT00752232|62758316|FG006|Overall Study|Investigator request|0|||
33379325|NCT00752232|62758310|FG000|Overall Study|Subject request|0|||
33379326|NCT00752232|62758311|FG001|Overall Study|Subject request|0|||
33379327|NCT00752232|62758312|FG002|Overall Study|Subject request|1|||
33379328|NCT00752232|62758313|FG003|Overall Study|Subject request|0|||
33379329|NCT00752232|62758314|FG004|Overall Study|Subject request|0|||
33379330|NCT00752232|62758315|FG005|Overall Study|Subject request|0|||
33379331|NCT00752232|62758316|FG006|Overall Study|Subject request|0|||
33379332|NCT00752232|62758310|FG000|Overall Study|Group home admission|0|||
33379333|NCT00752232|62758311|FG001|Overall Study|Group home admission|0|||
33379334|NCT00752232|62758312|FG002|Overall Study|Group home admission|0|||
33379335|NCT00752232|62758313|FG003|Overall Study|Group home admission|1|||
33379336|NCT00752232|62758314|FG004|Overall Study|Group home admission|0|||
33379337|NCT00752232|62758315|FG005|Overall Study|Group home admission|0|||
33379338|NCT00752232|62758316|FG006|Overall Study|Group home admission|0|||
33379339|NCT00752232|62758310|FG000|Overall Study|Caregiver could not attend the subject|0|||
33379340|NCT00752232|62758311|FG001|Overall Study|Caregiver could not attend the subject|0|||
33379341|NCT00752232|62758312|FG002|Overall Study|Caregiver could not attend the subject|0|||
33379342|NCT00752232|62758313|FG003|Overall Study|Caregiver could not attend the subject|0|||
33379343|NCT00752232|62758314|FG004|Overall Study|Caregiver could not attend the subject|1|||
33379344|NCT00752232|62758315|FG005|Overall Study|Caregiver could not attend the subject|0|||
33379345|NCT00752232|62758316|FG006|Overall Study|Caregiver could not attend the subject|0|||
33379346|NCT00760266|62758335|FG000|Overall Study|Adverse Event|13|||
33379347|NCT00760266|62758336|FG001|Overall Study|Adverse Event|7|||
33379348|NCT00760266|62758335|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33379349|NCT00760266|62758336|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33292415|NCT01204294|62668857|FG003|Overall Study|Lack of Efficacy|2|||
33292416|NCT01204294|62668858|FG004|Overall Study|Lack of Efficacy|0|||
33292417|NCT01204294|62668859|FG005|Overall Study|Lack of Efficacy|0|||
33292418|NCT01204294|62668860|FG006|Overall Study|Lack of Efficacy|0|||
33292419|NCT01204294|62668854|FG000|Overall Study|Other (house moving)|0|||
33379350|NCT00760266|62758335|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33379351|NCT00760266|62758336|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33379352|NCT00760266|62758335|FG000|Overall Study|Lack of Efficacy|2|||
33379353|NCT00760266|62758336|FG001|Overall Study|Lack of Efficacy|2|||
33379354|NCT00760266|62758335|FG000|Overall Study|Protocol deviation|2|||
33292420|NCT01204294|62668855|FG001|Overall Study|Other (house moving)|0|||
33292421|NCT01204294|62668856|FG002|Overall Study|Other (house moving)|1|||
33292422|NCT01204294|62668857|FG003|Overall Study|Other (house moving)|0|||
33292423|NCT01204294|62668858|FG004|Overall Study|Other (house moving)|0|||
33292424|NCT01204294|62668859|FG005|Overall Study|Other (house moving)|0|||
33292425|NCT01204294|62668860|FG006|Overall Study|Other (house moving)|0|||
33379355|NCT00760266|62758336|FG001|Overall Study|Protocol deviation|4|||
33379356|NCT00760266|62758335|FG000|Overall Study|Patient withdrew consent|3|||
33292426|NCT01182181|62668878|FG000|First Intervention|Adverse Event|1|||
33292427|NCT01182181|62668879|FG001|First Intervention|Adverse Event|0|||
33292428|NCT01182181|62668878|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
33292429|NCT01182181|62668879|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
33292430|NCT01181986|62668887|FG000|Phase 1|Lost to Follow-up|0|||
33292431|NCT01181986|62668888|FG001|Phase 1|Lost to Follow-up|1|||
33292432|NCT01181986|62668889|FG002|Phase 1|Lost to Follow-up|1|||
33292433|NCT01181986|62668887|FG000|Phase 1|Adverse Event|0|||
33292434|NCT01181986|62668888|FG001|Phase 1|Adverse Event|0|||
33292435|NCT01181986|62668889|FG002|Phase 1|Adverse Event|1|||
33292436|NCT01181986|62668887|FG000|Phase 1|Protocol Violation|1|||
33292437|NCT01181986|62668888|FG001|Phase 1|Protocol Violation|0|||
33292438|NCT01181986|62668889|FG002|Phase 1|Protocol Violation|0|||
33292439|NCT01181986|62668887|FG000|Phase 2|Adverse Event|0|||
33292440|NCT01181986|62668888|FG001|Phase 2|Adverse Event|3|||
33292441|NCT01181986|62668889|FG002|Phase 2|Adverse Event|0|||
33292442|NCT01181986|62668887|FG000|Phase 2|Medical condition|0|||
33292443|NCT01181986|62668888|FG001|Phase 2|Medical condition|1|||
33292444|NCT01181986|62668889|FG002|Phase 2|Medical condition|0|||
33379357|NCT00760266|62758336|FG001|Overall Study|Patient withdrew consent|3|||
33379358|NCT00760266|62758335|FG000|Overall Study|Lost to Follow-up|2|||
33379359|NCT00760266|62758336|FG001|Overall Study|Lost to Follow-up|1|||
33379360|NCT00760266|62758335|FG000|Overall Study|Administrative Problems|0|||
33379361|NCT00760266|62758336|FG001|Overall Study|Administrative Problems|1|||
33379362|NCT00753714|62758344|FG000|Overall Study|Lack of Efficacy|21|||
33379363|NCT00753714|62758345|FG001|Overall Study|Lack of Efficacy|34|||
33379364|NCT00753714|62758344|FG000|Overall Study|Adverse Event|26|||
33379365|NCT00753714|62758345|FG001|Overall Study|Adverse Event|18|||
33379366|NCT00753714|62758344|FG000|Overall Study|Protocol Violation|1|||
33379367|NCT00753714|62758345|FG001|Overall Study|Protocol Violation|0|||
33379368|NCT00753714|62758344|FG000|Overall Study|Lost to Follow-up|0|||
33379369|NCT00753714|62758345|FG001|Overall Study|Lost to Follow-up|1|||
33379370|NCT00753714|62758344|FG000|Overall Study|Withdrawal by Subject|2|||
33379371|NCT00753714|62758345|FG001|Overall Study|Withdrawal by Subject|1|||
33379372|NCT00753714|62758344|FG000|Overall Study|Death|3|||
33379373|NCT00753714|62758345|FG001|Overall Study|Death|3|||
33379374|NCT00753714|62758344|FG000|Overall Study|Other|7|||
33379375|NCT00753714|62758345|FG001|Overall Study|Other|5|||
33379376|NCT00759954|62758356|FG000|Overall Study|Personal reason|1|||
33379377|NCT00759954|62758357|FG001|Overall Study|Personal reason|0|||
33379378|NCT00759954|62758356|FG000|Overall Study|Adverse Event|1|||
33379379|NCT00759954|62758357|FG001|Overall Study|Adverse Event|2|||
33379380|NCT00804908|62758366|FG000|Overall Study|Other|115|||
33379381|NCT00804908|62758367|FG001|Overall Study|Other|116|||
33379382|NCT00804908|62758368|FG002|Overall Study|Other|114|||
33379383|NCT00808808|62758379|FG000|Overall Study|Vaccinated; survey not completed|131|||
33379384|NCT00808808|62758380|FG001|Overall Study|Vaccinated; survey not completed|169|||
33379385|NCT00808808|62758381|FG002|Overall Study|Vaccinated; survey not completed|302|||
33379386|NCT00808808|62758379|FG000|Overall Study|Employee was not vaccinated.|2686|||
33379387|NCT00808808|62758380|FG001|Overall Study|Employee was not vaccinated.|2268|||
33379388|NCT00808808|62758381|FG002|Overall Study|Employee was not vaccinated.|2255|||
33379389|NCT00589784|62758397|FG000|Overall Study|Withdrawal by Subject|0|||
33379390|NCT00589784|62758398|FG001|Overall Study|Withdrawal by Subject|6|||
33379391|NCT00589784|62758397|FG000|Overall Study|Patient inevaluable|1|||
33379392|NCT00589784|62758398|FG001|Overall Study|Patient inevaluable|0|||
33379393|NCT00589784|62758397|FG000|Overall Study|Adverse Event|0|||
33379394|NCT00589784|62758398|FG001|Overall Study|Adverse Event|4|||
33379395|NCT00759876|62758403|FG000|Overall Study|Sponsor terminated study early|36|||
33379396|NCT00823979|62758410|FG000|Overall Study|Lack of Efficacy|13|||
33379397|NCT00823979|62758411|FG001|Overall Study|Lack of Efficacy|16|||
33379398|NCT00823979|62758412|FG002|Overall Study|Lack of Efficacy|9|||
33379399|NCT00823979|62758410|FG000|Overall Study|Lost to Follow-up|2|||
33379400|NCT00823979|62758411|FG001|Overall Study|Lost to Follow-up|1|||
33379401|NCT00823979|62758412|FG002|Overall Study|Lost to Follow-up|0|||
33379402|NCT00823979|62758410|FG000|Overall Study|Withdrawal by Subject|2|||
33379403|NCT00823979|62758411|FG001|Overall Study|Withdrawal by Subject|3|||
33379404|NCT00823979|62758412|FG002|Overall Study|Withdrawal by Subject|2|||
33379405|NCT00823979|62758410|FG000|Overall Study|Protocol Violation|1|||
33379406|NCT00823979|62758411|FG001|Overall Study|Protocol Violation|1|||
33292445|NCT01181167|62668905|FG000|Overall Study|Adverse Event|11|||
33292446|NCT01181167|62668906|FG001|Overall Study|Adverse Event|21|||
33292447|NCT01181167|62668905|FG000|Overall Study|Lost to Follow-up|1|||
33292448|NCT01181167|62668906|FG001|Overall Study|Lost to Follow-up|0|||
33292449|NCT01181167|62668905|FG000|Overall Study|Physician Decision|2|||
33292450|NCT01181167|62668906|FG001|Overall Study|Physician Decision|3|||
33379407|NCT00823979|62758412|FG002|Overall Study|Protocol Violation|0|||
33292451|NCT01181167|62668905|FG000|Overall Study|Protocol Violation|3|||
33292452|NCT01181167|62668906|FG001|Overall Study|Protocol Violation|0|||
33292453|NCT01181167|62668905|FG000|Overall Study|Withdrawal by Subject|6|||
33292454|NCT01181167|62668906|FG001|Overall Study|Withdrawal by Subject|8|||
33379408|NCT00823979|62758410|FG000|Overall Study|Pregnancy|0|||
33379409|NCT00823979|62758411|FG001|Overall Study|Pregnancy|1|||
33379410|NCT00823979|62758412|FG002|Overall Study|Pregnancy|0|||
33379411|NCT00823979|62758410|FG000|Overall Study|Adverse Event|0|||
33379412|NCT00823979|62758411|FG001|Overall Study|Adverse Event|2|||
33379413|NCT00823979|62758412|FG002|Overall Study|Adverse Event|4|||
33379414|NCT00823979|62758410|FG000|Overall Study|Other|2|||
33379415|NCT00823979|62758411|FG001|Overall Study|Other|0|||
33379416|NCT00823979|62758412|FG002|Overall Study|Other|1|||
33379417|NCT00823979|62758410|FG000|Overall Study|Randomized but not Treated|4|||
33379418|NCT00823979|62758411|FG001|Overall Study|Randomized but not Treated|3|||
33379419|NCT00823979|62758412|FG002|Overall Study|Randomized but not Treated|1|||
33379420|NCT00823979|62758410|FG000|Overall Study|Study Terminated by Sponsor|5|||
33379421|NCT00823979|62758411|FG001|Overall Study|Study Terminated by Sponsor|5|||
33379422|NCT00823979|62758412|FG002|Overall Study|Study Terminated by Sponsor|7|||
33487527|NCT00108082|62865748|FG000|Overall Study|Incorrectly Randomized|0|||
33487528|NCT00108082|62865749|FG001|Overall Study|Incorrectly Randomized|0|||
33487529|NCT00108082|62865750|FG002|Overall Study|Incorrectly Randomized|2|||
33487530|NCT00108082|62865748|FG000|Overall Study|Non-compliance|1|||
33487531|NCT00108082|62865749|FG001|Overall Study|Non-compliance|0|||
33292455|NCT01181128|62668915|FG000|Overall Study|Withdrawal by Subject|2|||
33292456|NCT01181128|62668916|FG001|Overall Study|Withdrawal by Subject|2|||
33292457|NCT01181128|62668917|FG002|Overall Study|Withdrawal by Subject|0|||
33292458|NCT01181128|62668915|FG000|Overall Study|Death|1|||
33292459|NCT01181128|62668916|FG001|Overall Study|Death|0|||
33292460|NCT01181128|62668917|FG002|Overall Study|Death|0|||
33292461|NCT01181128|62668915|FG000|Overall Study|Physician Decision|2|||
33292462|NCT01181128|62668916|FG001|Overall Study|Physician Decision|0|||
33292463|NCT01181128|62668917|FG002|Overall Study|Physician Decision|0|||
33292464|NCT01181128|62668915|FG000|Overall Study|Adverse Event|0|||
33292465|NCT01181128|62668916|FG001|Overall Study|Adverse Event|2|||
33292466|NCT01181128|62668917|FG002|Overall Study|Adverse Event|0|||
33292467|NCT01181128|62668915|FG000|Overall Study|Other|1|||
33292468|NCT01181128|62668916|FG001|Overall Study|Other|1|||
33292469|NCT01181128|62668917|FG002|Overall Study|Other|1|||
33292470|NCT01203787|62668939|FG000|Overall Study|Death|12|||
33292471|NCT01203787|62668940|FG001|Overall Study|Death|10|||
33292472|NCT01203787|62668939|FG000|Overall Study|Withdrawal by Subject|6|||
33292473|NCT01203787|62668940|FG001|Overall Study|Withdrawal by Subject|2|||
33292474|NCT01203787|62668939|FG000|Overall Study|Lost to Follow-up|2|||
33292475|NCT01203787|62668940|FG001|Overall Study|Lost to Follow-up|0|||
33292476|NCT01203787|62668939|FG000|Overall Study|Adverse Event|11|||
33292477|NCT01203787|62668940|FG001|Overall Study|Adverse Event|15|||
33292478|NCT01181011|62668948|FG000|Overall Study|Adverse Event|2|||
33292479|NCT01181011|62668948|FG000|Overall Study|Lost to Follow-up|1|||
33292480|NCT01180777|62668957|FG000|Overall Study|Protocol Violation|6|||
33379423|NCT00823901|62758422|FG000|Overall Study|Adverse Event|1|||
33379424|NCT00823901|62758423|FG001|Overall Study|Adverse Event|1|||
33487532|NCT00108082|62865750|FG002|Overall Study|Non-compliance|2|||
33487533|NCT00108082|62865748|FG000|Overall Study|Stopped Study Medication|0|||
33487534|NCT00108082|62865749|FG001|Overall Study|Stopped Study Medication|0|||
33487535|NCT00108082|62865750|FG002|Overall Study|Stopped Study Medication|1|||
33487536|NCT00108082|62865748|FG000|Overall Study|Site Closed Study|0|||
33487537|NCT00108082|62865749|FG001|Overall Study|Site Closed Study|2|||
33487538|NCT00108082|62865750|FG002|Overall Study|Site Closed Study|0|||
33487539|NCT00108082|62865748|FG000|Overall Study|Protocol Amendment|0|||
33487540|NCT00108082|62865749|FG001|Overall Study|Protocol Amendment|1|||
33487541|NCT00108082|62865750|FG002|Overall Study|Protocol Amendment|0|||
33487542|NCT00108082|62865748|FG000|Overall Study|Study Medication Not Tapered|0|||
33292481|NCT01180777|62668957|FG000|Overall Study|Poor lens fit|4|||
33292482|NCT01180777|62668957|FG000|Overall Study|Lost to Follow-up|1|||
33292483|NCT01180777|62668957|FG000|Overall Study|Adverse Event|1|||
33292484|NCT01648023|62668965|FG000|Overall Study|Screen Fail Post Randomization|1|||
33292485|NCT01648023|62668966|FG001|Overall Study|Screen Fail Post Randomization|2|||
33292486|NCT02756208|62668980|FG000|Overall Study|Withdrawal by Subject|1|||
33292487|NCT02756208|62668981|FG001|Overall Study|Withdrawal by Subject|0|||
33292488|NCT02756208|62668982|FG002|Overall Study|Withdrawal by Subject|1|||
33292489|NCT02756208|62668983|FG003|Overall Study|Withdrawal by Subject|3|||
33292490|NCT02756208|62668980|FG000|Overall Study|Lost to Follow-up|3|||
33292491|NCT02756208|62668981|FG001|Overall Study|Lost to Follow-up|1|||
33292492|NCT02756208|62668982|FG002|Overall Study|Lost to Follow-up|1|||
33292493|NCT02756208|62668983|FG003|Overall Study|Lost to Follow-up|1|||
33292494|NCT02756208|62668980|FG000|Overall Study|Physician Decision|1|||
33292495|NCT02756208|62668981|FG001|Overall Study|Physician Decision|0|||
33292496|NCT02756208|62668982|FG002|Overall Study|Physician Decision|0|||
33292497|NCT02756208|62668983|FG003|Overall Study|Physician Decision|0|||
33292498|NCT02756208|62668980|FG000|Overall Study|Protocol Violation|0|||
33379425|NCT00823901|62758422|FG000|Overall Study|Lack of Efficacy|1|||
33292499|NCT02756208|62668981|FG001|Overall Study|Protocol Violation|1|||
33379426|NCT00823901|62758423|FG001|Overall Study|Lack of Efficacy|0|||
33292500|NCT02756208|62668982|FG002|Overall Study|Protocol Violation|0|||
33292501|NCT02756208|62668983|FG003|Overall Study|Protocol Violation|0|||
33292502|NCT02756013|62668993|FG000|Overall Study|Adverse Event|1|||
33292503|NCT02756013|62668993|FG000|Overall Study|Hypersensitivity|1|||
33292504|NCT01202773|62669000|FG000|Overall Study|Adverse Event|4|||
33292505|NCT01202773|62669001|FG001|Overall Study|Adverse Event|5|||
33292506|NCT01202773|62669002|FG002|Overall Study|Adverse Event|5|||
33292507|NCT01202773|62669000|FG000|Overall Study|Lack of Efficacy|5|||
33292508|NCT01202773|62669001|FG001|Overall Study|Lack of Efficacy|4|||
33292509|NCT01202773|62669002|FG002|Overall Study|Lack of Efficacy|9|||
33292510|NCT01202773|62669000|FG000|Overall Study|Entry Criteria Not Met|2|||
33292511|NCT01202773|62669001|FG001|Overall Study|Entry Criteria Not Met|0|||
33292512|NCT01202773|62669002|FG002|Overall Study|Entry Criteria Not Met|1|||
33292513|NCT01202773|62669000|FG000|Overall Study|Lost to Follow-up|1|||
33292514|NCT01202773|62669001|FG001|Overall Study|Lost to Follow-up|2|||
33292515|NCT01202773|62669002|FG002|Overall Study|Lost to Follow-up|2|||
33292516|NCT01202773|62669000|FG000|Overall Study|Withdrawal by Subject|13|||
33292517|NCT01202773|62669001|FG001|Overall Study|Withdrawal by Subject|6|||
33292518|NCT01202773|62669002|FG002|Overall Study|Withdrawal by Subject|5|||
33292519|NCT01202773|62669000|FG000|Overall Study|Physician Decision|2|||
33292520|NCT01202773|62669001|FG001|Overall Study|Physician Decision|0|||
33292521|NCT01202773|62669002|FG002|Overall Study|Physician Decision|0|||
33292522|NCT01202773|62669000|FG000|Overall Study|Protocol Violation|11|||
33292523|NCT01202773|62669001|FG001|Overall Study|Protocol Violation|6|||
33292524|NCT01202773|62669002|FG002|Overall Study|Protocol Violation|10|||
33292525|NCT01202773|62669000|FG000|Overall Study|Sponsor Decision|19|||
33292526|NCT01202773|62669001|FG001|Overall Study|Sponsor Decision|20|||
33292527|NCT01202773|62669002|FG002|Overall Study|Sponsor Decision|23|||
33292528|NCT01180660|62669022|FG000|Overall Study|Changed to open surgery|1|||
33292529|NCT01180660|62669023|FG001|Overall Study|Changed to open surgery|0|||
33292530|NCT01202227|62669029|FG000|Overall Study|Adverse Event|16|||
33292531|NCT01202227|62669029|FG000|Overall Study|Withdrawal by Subject|2|||
33292532|NCT01202227|62669029|FG000|Overall Study|Lack of Efficacy|1|||
33292533|NCT01202188|62669038|FG000|Overall Study|Protocol deviation|14|||
33292534|NCT01202188|62669039|FG001|Overall Study|Protocol deviation|8|||
33292535|NCT01202188|62669040|FG002|Overall Study|Protocol deviation|12|||
33292536|NCT01202188|62669041|FG003|Overall Study|Protocol deviation|10|||
33292537|NCT01202188|62669042|FG004|Overall Study|Protocol deviation|11|||
33292538|NCT01202188|62669038|FG000|Overall Study|Subject withdrew consent|12|||
33292539|NCT01202188|62669039|FG001|Overall Study|Subject withdrew consent|13|||
33292540|NCT01202188|62669040|FG002|Overall Study|Subject withdrew consent|22|||
33292541|NCT01202188|62669041|FG003|Overall Study|Subject withdrew consent|11|||
33292542|NCT01202188|62669042|FG004|Overall Study|Subject withdrew consent|13|||
33292543|NCT01202188|62669038|FG000|Overall Study|Adverse Event|5|||
33292544|NCT01202188|62669039|FG001|Overall Study|Adverse Event|23|||
33292545|NCT01202188|62669040|FG002|Overall Study|Adverse Event|13|||
33292546|NCT01202188|62669041|FG003|Overall Study|Adverse Event|10|||
33292547|NCT01202188|62669042|FG004|Overall Study|Adverse Event|10|||
33292548|NCT01202188|62669038|FG000|Overall Study|Administrative problems|3|||
33379427|NCT00823901|62758422|FG000|Overall Study|Lost to Follow-up|2|||
33379428|NCT00823901|62758423|FG001|Overall Study|Lost to Follow-up|1|||
33379429|NCT00823823|62758431|FG000|Overall Study|Lost to Follow-up|3|||
33379430|NCT00823823|62758432|FG001|Overall Study|Lost to Follow-up|1|||
33379431|NCT00823823|62758431|FG000|Overall Study|Protocol Violation|5|||
33379432|NCT00823823|62758432|FG001|Overall Study|Protocol Violation|5|||
33379433|NCT00759564|62758452|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
33379434|NCT00759564|62758453|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
33379435|NCT00759564|62758454|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
33379436|NCT00759564|62758455|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
33379437|NCT00759564|62758456|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
33379438|NCT00816023|62758492|FG000|Overall Study|Lost to Follow-up|1|||
33379439|NCT00816023|62758493|FG001|Overall Study|Lost to Follow-up|1|||
33662432|NCT01694771|63092957|FG001|Overall Study|Non compliance protocol|6|||
33292549|NCT01202188|62669039|FG001|Overall Study|Administrative problems|2|||
33292550|NCT01202188|62669040|FG002|Overall Study|Administrative problems|1|||
33292551|NCT01202188|62669041|FG003|Overall Study|Administrative problems|1|||
33292552|NCT01202188|62669042|FG004|Overall Study|Administrative problems|2|||
33292553|NCT01202188|62669038|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33292554|NCT01202188|62669039|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
33292555|NCT01202188|62669040|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
33292556|NCT01202188|62669041|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
33292557|NCT01202188|62669042|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
33292558|NCT01202188|62669038|FG000|Overall Study|Lost to Follow-up|1|||
33292559|NCT01202188|62669039|FG001|Overall Study|Lost to Follow-up|1|||
33292560|NCT01202188|62669040|FG002|Overall Study|Lost to Follow-up|0|||
33292561|NCT01202188|62669041|FG003|Overall Study|Lost to Follow-up|4|||
33379440|NCT00816023|62758494|FG002|Overall Study|Lost to Follow-up|0|||
33379441|NCT00816023|62758495|FG003|Overall Study|Lost to Follow-up|0|||
33379442|NCT00816023|62758492|FG000|Overall Study|Withdrawal by Subject|1|||
33379443|NCT00816023|62758493|FG001|Overall Study|Withdrawal by Subject|0|||
33379444|NCT00816023|62758494|FG002|Overall Study|Withdrawal by Subject|0|||
33379445|NCT00816023|62758495|FG003|Overall Study|Withdrawal by Subject|0|||
33379446|NCT00816023|62758492|FG000|Overall Study|Physician Decision|0|||
33379447|NCT00816023|62758493|FG001|Overall Study|Physician Decision|0|||
33379448|NCT00816023|62758494|FG002|Overall Study|Physician Decision|1|||
33379449|NCT00816023|62758495|FG003|Overall Study|Physician Decision|0|||
33292562|NCT01202188|62669042|FG004|Overall Study|Lost to Follow-up|1|||
33292563|NCT01202188|62669038|FG000|Overall Study|Death|1|||
33292564|NCT01202188|62669039|FG001|Overall Study|Death|1|||
33379450|NCT00816023|62758492|FG000|Overall Study|assessments complete prior to window|1|||
33379451|NCT00816023|62758493|FG001|Overall Study|assessments complete prior to window|1|||
33379452|NCT00816023|62758494|FG002|Overall Study|assessments complete prior to window|2|||
33379453|NCT00816023|62758495|FG003|Overall Study|assessments complete prior to window|1|||
33379454|NCT00816023|62758492|FG000|Overall Study|Randomized Not Treated|6|||
33379455|NCT00816023|62758493|FG001|Overall Study|Randomized Not Treated|4|||
33379456|NCT00816023|62758494|FG002|Overall Study|Randomized Not Treated|6|||
33379457|NCT00816023|62758495|FG003|Overall Study|Randomized Not Treated|11|||
33379458|NCT00759174|62758507|FG000|Overall Study|Other|0|||
33379459|NCT00759174|62758508|FG001|Overall Study|Other|2|||
33379460|NCT00815633|62758515|FG000|Overall Study|study terminated|1|||
33379461|NCT00830765|62758521|FG000|Overall Study|Protocol Violation|3|||
33379462|NCT00830765|62758522|FG001|Overall Study|Protocol Violation|2|||
33379463|NCT00830375|62758528|FG000|Overall Study|Lost to Follow-up|1|||
33379464|NCT00803270|62758534|FG000|Overall Study|Lost to Follow-up|1|||
33379465|NCT00803270|62758535|FG001|Overall Study|Lost to Follow-up|2|||
33379466|NCT00751998|62758541|FG000|Overall Study|Lost to Follow-up|7|||
33379467|NCT00751998|62758541|FG000|Overall Study|Death|11|||
33487543|NCT00108082|62865749|FG001|Overall Study|Study Medication Not Tapered|1|||
33487544|NCT00108082|62865750|FG002|Overall Study|Study Medication Not Tapered|0|||
33487545|NCT00108082|62865748|FG000|Overall Study|Subject Left Site Location|1|||
33487546|NCT00108082|62865749|FG001|Overall Study|Subject Left Site Location|0|||
33487547|NCT00108082|62865750|FG002|Overall Study|Subject Left Site Location|0|||
33487548|NCT00108082|62865748|FG000|Overall Study|Investigator Not at Site|1|||
33292565|NCT01202188|62669040|FG002|Overall Study|Death|1|||
33487549|NCT00108082|62865749|FG001|Overall Study|Investigator Not at Site|0|||
33487550|NCT00108082|62865750|FG002|Overall Study|Investigator Not at Site|0|||
33487551|NCT00108082|62865748|FG000|Overall Study|Blood Pressure Not Controlled|1|||
33487552|NCT00108082|62865749|FG001|Overall Study|Blood Pressure Not Controlled|0|||
33487553|NCT00108082|62865750|FG002|Overall Study|Blood Pressure Not Controlled|0|||
33487554|NCT00104728|62865762|FG000|Overall Study|screen failures|19|||
33487555|NCT02781844|62865770|FG000|Treatment Period 1|Adverse Event|0|||
33487556|NCT02781844|62865771|FG001|Treatment Period 1|Adverse Event|0|||
33487557|NCT02781844|62865772|FG002|Treatment Period 1|Adverse Event|0|||
33487558|NCT02781844|62865773|FG003|Treatment Period 1|Adverse Event|0|||
33487559|NCT02781844|62865774|FG004|Treatment Period 1|Adverse Event|0|||
33487560|NCT02781844|62865775|FG005|Treatment Period 1|Adverse Event|1|||
33487561|NCT02781844|62865776|FG006|Treatment Period 1|Adverse Event|0|||
33487562|NCT02781844|62865777|FG007|Treatment Period 1|Adverse Event|0|||
33487563|NCT02775916|62865795|FG000|Overall Study|Adverse Event|1|||
33292566|NCT01202188|62669041|FG003|Overall Study|Death|1|||
33292567|NCT01202188|62669042|FG004|Overall Study|Death|0|||
33292568|NCT01202188|62669038|FG000|Overall Study|Abnormal test procedure result (s)|0|||
33292569|NCT01202188|62669039|FG001|Overall Study|Abnormal test procedure result (s)|0|||
33292570|NCT01202188|62669040|FG002|Overall Study|Abnormal test procedure result (s)|2|||
33292571|NCT01202188|62669041|FG003|Overall Study|Abnormal test procedure result (s)|0|||
33292572|NCT01202188|62669042|FG004|Overall Study|Abnormal test procedure result (s)|0|||
33292573|NCT01201915|62669063|FG000|Overall Study|Adverse Event|2|||
33292574|NCT01201915|62669064|FG001|Overall Study|Adverse Event|1|||
33379468|NCT00751998|62758541|FG000|Overall Study|Withdrawal by Subject|2|||
33379469|NCT00803738|62758547|FG000|Overall Study|Adverse Event|3|||
33379470|NCT00803738|62758548|FG001|Overall Study|Adverse Event|5|||
33379471|NCT00803738|62758547|FG000|Overall Study|Lost to Follow-up|4|||
33379472|NCT00803738|62758548|FG001|Overall Study|Lost to Follow-up|4|||
33379473|NCT00803738|62758547|FG000|Overall Study|Protocol Violation|18|||
33487564|NCT02775916|62865796|FG001|Overall Study|Adverse Event|0|||
33379474|NCT00803738|62758548|FG001|Overall Study|Protocol Violation|10|||
33379475|NCT00803738|62758547|FG000|Overall Study|Withdrawal by Subject|1|||
33487565|NCT02775916|62865795|FG000|Overall Study|Subject/Guardian Decision|2|||
33487566|NCT02775916|62865796|FG001|Overall Study|Subject/Guardian Decision|0|||
33487567|NCT00122681|62865804|FG000|Overall Study|Adverse Event|20|||
33379476|NCT00803738|62758548|FG001|Overall Study|Withdrawal by Subject|4|||
33379477|NCT00803738|62758547|FG000|Overall Study|Lack of Efficacy|10|||
33292575|NCT01201915|62669065|FG002|Overall Study|Adverse Event|1|||
33292576|NCT01201915|62669063|FG000|Overall Study|Lost to Follow-up|0|||
33292577|NCT01201915|62669064|FG001|Overall Study|Lost to Follow-up|4|||
33292578|NCT01201915|62669065|FG002|Overall Study|Lost to Follow-up|0|||
33292579|NCT01201915|62669063|FG000|Overall Study|Physician Decision|3|||
33292580|NCT01201915|62669064|FG001|Overall Study|Physician Decision|0|||
33292581|NCT01201915|62669065|FG002|Overall Study|Physician Decision|0|||
33292582|NCT01201915|62669063|FG000|Overall Study|Subject Decision|3|||
33292583|NCT01201915|62669064|FG001|Overall Study|Subject Decision|3|||
33292584|NCT01201915|62669065|FG002|Overall Study|Subject Decision|5|||
33292585|NCT01201915|62669063|FG000|Overall Study|Target Lesion Progression|0|||
33292586|NCT01201915|62669064|FG001|Overall Study|Target Lesion Progression|3|||
33292587|NCT01201915|62669065|FG002|Overall Study|Target Lesion Progression|0|||
33292588|NCT01179919|62669073|FG000|Overall Study|Protocol Violation|1|||
33292589|NCT01179919|62669073|FG000|Overall Study|Adverse Event|1|||
33292590|NCT01201798|62669079|FG000|Overall Study|Adverse Event|2|||
33292591|NCT01201798|62669080|FG001|Overall Study|Adverse Event|0|||
33292592|NCT01201798|62669079|FG000|Overall Study|Lost to Follow-up|3|||
33292593|NCT01201798|62669080|FG001|Overall Study|Lost to Follow-up|5|||
33379478|NCT00803738|62758548|FG001|Overall Study|Lack of Efficacy|16|||
33379479|NCT00803738|62758547|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
33379480|NCT00803738|62758548|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
33379481|NCT00803738|62758547|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
33379482|NCT00803738|62758548|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
33379483|NCT00758706|62758556|FG000|Overall Study|Adverse Event|4|||
33379484|NCT00758706|62758557|FG001|Overall Study|Adverse Event|4|||
33379485|NCT00591266|62758566|FG000|Overall Study|Adverse Event|2|||
33379486|NCT00591266|62758567|FG001|Overall Study|Adverse Event|2|||
33379487|NCT00591266|62758568|FG002|Overall Study|Adverse Event|3|||
33379488|NCT00591266|62758566|FG000|Overall Study|Lost to Follow-up|0|||
33379489|NCT00591266|62758567|FG001|Overall Study|Lost to Follow-up|1|||
33379490|NCT00591266|62758568|FG002|Overall Study|Lost to Follow-up|0|||
33379491|NCT00591266|62758566|FG000|Overall Study|Protocol Violation|0|||
33379492|NCT00591266|62758567|FG001|Overall Study|Protocol Violation|0|||
33379493|NCT00591266|62758568|FG002|Overall Study|Protocol Violation|1|||
33379494|NCT00591266|62758566|FG000|Overall Study|Withdrawal by Subject|6|||
33379495|NCT00591266|62758567|FG001|Overall Study|Withdrawal by Subject|2|||
33379496|NCT00591266|62758568|FG002|Overall Study|Withdrawal by Subject|5|||
33379497|NCT00591266|62758566|FG000|Overall Study|Lack of Efficacy|0|||
33379498|NCT00591266|62758567|FG001|Overall Study|Lack of Efficacy|2|||
33379499|NCT00591266|62758568|FG002|Overall Study|Lack of Efficacy|0|||
33379500|NCT00591266|62758566|FG000|Overall Study|Other|1|||
33379501|NCT00591266|62758567|FG001|Overall Study|Other|4|||
33379502|NCT00591266|62758568|FG002|Overall Study|Other|5|||
33379503|NCT00758394|62758580|FG000|2nd Intervention Order|Lost to Follow-up|0|||
33379504|NCT00758394|62758581|FG001|2nd Intervention Order|Lost to Follow-up|1|||
33379505|NCT00758394|62758582|FG002|2nd Intervention Order|Lost to Follow-up|0|||
33379506|NCT00758394|62758583|FG003|2nd Intervention Order|Lost to Follow-up|0|||
33379507|NCT00758394|62758580|FG000|3rd Intervention|Lost to Follow-up|1|||
33379508|NCT00758394|62758581|FG001|3rd Intervention|Lost to Follow-up|0|||
33379509|NCT00758394|62758582|FG002|3rd Intervention|Lost to Follow-up|0|||
33379510|NCT00758394|62758583|FG003|3rd Intervention|Lost to Follow-up|1|||
33379511|NCT04450394|62758596|FG000|Overall Study|Adverse Event|2|||
33379512|NCT04450394|62758597|FG001|Overall Study|Adverse Event|0|||
33487568|NCT00122681|62865805|FG001|Overall Study|Adverse Event|16|||
33487569|NCT00122681|62865804|FG000|Overall Study|Lost to Follow-up|1080|||
33487570|NCT00122681|62865805|FG001|Overall Study|Lost to Follow-up|1097|||
33487571|NCT00122681|62865804|FG000|Overall Study|Protocol Violation|7|||
33487572|NCT00122681|62865805|FG001|Overall Study|Protocol Violation|10|||
33487573|NCT00122681|62865804|FG000|Overall Study|Withdrawal by Subject|257|||
33487574|NCT00122681|62865805|FG001|Overall Study|Withdrawal by Subject|251|||
33487575|NCT00122681|62865804|FG000|Overall Study|Personal reasons|150|||
33379513|NCT04450394|62758598|FG002|Overall Study|Adverse Event|0|||
33487576|NCT00122681|62865805|FG001|Overall Study|Personal reasons|147|||
33379514|NCT04450394|62758596|FG000|Overall Study|Death|0|||
33379515|NCT04450394|62758597|FG001|Overall Study|Death|1|||
33379516|NCT04450394|62758598|FG002|Overall Study|Death|0|||
33379517|NCT04450394|62758596|FG000|Overall Study|Lost to Follow-up|0|||
33379518|NCT04450394|62758597|FG001|Overall Study|Lost to Follow-up|3|||
33487577|NCT02774278|62865819|FG000|Overall Study|Lack of Efficacy|199|||
33487578|NCT02774278|62865819|FG000|Overall Study|Death|29|||
33487579|NCT02774278|62865819|FG000|Overall Study|Adverse event/intercurrent illness|16|||
33487580|NCT02774278|62865819|FG000|Overall Study|Refused treatment/did not cooperate|9|||
33487581|NCT02774278|62865819|FG000|Overall Study|Administrative reasons|6|||
33487582|NCT02774278|62865819|FG000|Overall Study|Withdrawal by Subject|3|||
33487583|NCT02774278|62865819|FG000|Overall Study|Protocol Violation|2|||
33662433|NCT01694771|63092956|FG000|Overall Study|Lost to Follow-up|2|||
33292594|NCT01201798|62669079|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
33292595|NCT01201798|62669080|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
33292596|NCT01201798|62669079|FG000|Overall Study|Noncompliance|1|||
33379519|NCT04450394|62758598|FG002|Overall Study|Lost to Follow-up|0|||
33379520|NCT04450394|62758596|FG000|Overall Study|Physician Decision|0|||
33379521|NCT04450394|62758597|FG001|Overall Study|Physician Decision|1|||
33292597|NCT01201798|62669080|FG001|Overall Study|Noncompliance|0|||
33292598|NCT01201798|62669079|FG000|Overall Study|Protocol Violation|1|||
33292599|NCT01201798|62669080|FG001|Overall Study|Protocol Violation|1|||
33292600|NCT01201798|62669079|FG000|Overall Study|Treatment Failure|1|||
33292601|NCT01201798|62669080|FG001|Overall Study|Treatment Failure|8|||
33292602|NCT01201759|62669088|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
33292603|NCT01201759|62669089|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
33292604|NCT01201759|62669088|FG000|Visit 3 - Washout|Adverse Event|0|||
33292605|NCT01201759|62669089|FG001|Visit 3 - Washout|Adverse Event|3|||
33292606|NCT01201759|62669088|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
33292607|NCT01201759|62669089|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
33292608|NCT01201759|62669088|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
33379522|NCT04450394|62758598|FG002|Overall Study|Physician Decision|0|||
33379523|NCT04450394|62758596|FG000|Overall Study|Protocol Violation|2|||
33379524|NCT04450394|62758597|FG001|Overall Study|Protocol Violation|0|||
33379525|NCT04450394|62758598|FG002|Overall Study|Protocol Violation|0|||
33292609|NCT01201759|62669089|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
33292610|NCT01200589|62669099|FG000|Overall Study|Withdrawal by Subject|13|||
33292611|NCT01200589|62669100|FG001|Overall Study|Withdrawal by Subject|11|||
33379526|NCT04450394|62758596|FG000|Overall Study|Withdrawal by Subject|6|||
33379527|NCT04450394|62758597|FG001|Overall Study|Withdrawal by Subject|9|||
33292612|NCT01200589|62669099|FG000|Overall Study|Physician Decision|2|||
33292613|NCT01200589|62669100|FG001|Overall Study|Physician Decision|2|||
33292614|NCT01200589|62669099|FG000|Overall Study|Lost to Follow-up|5|||
33292615|NCT01200589|62669100|FG001|Overall Study|Lost to Follow-up|4|||
33292616|NCT01200589|62669099|FG000|Overall Study|Study terminated|170|||
33292617|NCT01200589|62669100|FG001|Overall Study|Study terminated|172|||
33292618|NCT01200511|62669106|FG000|Overall Study|Lost to Follow-up|3|||
33292619|NCT01200511|62669106|FG000|Overall Study|Withdrawal by Subject|1|||
33292620|NCT01200511|62669106|FG000|Overall Study|Adverse Event|1|||
33292621|NCT01179334|62669114|FG000|Treatment Period|Adverse Event|1|||
33292622|NCT01179334|62669115|FG001|Treatment Period|Adverse Event|0|||
33292623|NCT01179334|62669114|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
33379528|NCT04450394|62758598|FG002|Overall Study|Withdrawal by Subject|0|||
33379529|NCT00758160|62758605|FG000|Overall Study|No Longer Requires Study Medication|4|||
33379530|NCT00758160|62758605|FG000|Overall Study|Administration Problems|3|||
33379531|NCT00758160|62758605|FG000|Overall Study|Adverse Event|15|||
33379532|NCT00758160|62758605|FG000|Overall Study|Lack of Efficacy|10|||
33379533|NCT00758160|62758605|FG000|Overall Study|Lost to Follow-up|14|||
33379534|NCT00758160|62758605|FG000|Overall Study|Protocol Violation|12|||
33379535|NCT00758160|62758605|FG000|Overall Study|Withdrawal by Subject|8|||
33379536|NCT00757848|62758615|FG000|Overall Study|Voluntary discontinuation|1|||
33379537|NCT00757848|62758616|FG001|Overall Study|Voluntary discontinuation|0|||
33379538|NCT00757848|62758615|FG000|Overall Study|Adverse Event|1|||
33379539|NCT00757848|62758616|FG001|Overall Study|Adverse Event|2|||
33379540|NCT00757848|62758615|FG000|Overall Study|Incorrect enrolment|1|||
33379541|NCT00757848|62758616|FG001|Overall Study|Incorrect enrolment|0|||
33379542|NCT00751296|62758622|FG000|Overall Study|Adverse Event|2|||
33379543|NCT00751140|62758626|FG000|Overall Study|benign angioma excluded from analysis|1|||
33379544|NCT00751881|62758637|FG000|Core Treatment Period|Not treated|1|||
33379545|NCT00751881|62758638|FG001|Core Treatment Period|Not treated|1|||
33379546|NCT00751881|62758639|FG002|Core Treatment Period|Not treated|2|||
33379547|NCT00751881|62758637|FG000|Core Treatment Period|Adverse Event|26|||
33379548|NCT00751881|62758638|FG001|Core Treatment Period|Adverse Event|54|||
33379549|NCT00751881|62758639|FG002|Core Treatment Period|Adverse Event|58|||
33379550|NCT00751881|62758637|FG000|Core Treatment Period|Lack of Efficacy|37|||
33379551|NCT00751881|62758638|FG001|Core Treatment Period|Lack of Efficacy|30|||
33379552|NCT00751881|62758639|FG002|Core Treatment Period|Lack of Efficacy|20|||
33379553|NCT00751881|62758637|FG000|Core Treatment Period|Poor compliance to protocol|15|||
33487584|NCT03621189|62865825|FG000|Overall Study|Withdrawal by Subject|0|||
33487585|NCT03621189|62865826|FG001|Overall Study|Withdrawal by Subject|3|||
33487586|NCT03621189|62865825|FG000|Overall Study|Physician Decision|0|||
33487587|NCT03621189|62865826|FG001|Overall Study|Physician Decision|2|||
33487588|NCT00122135|62865835|FG000|Overall Study|Withdrawal by Subject|3|||
33292624|NCT01179334|62669115|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
33292625|NCT01179334|62669114|FG000|Long-term Extension (LTE) Period|Death|3|||
33292626|NCT01179334|62669115|FG001|Long-term Extension (LTE) Period|Death|0|||
33292627|NCT01179334|62669114|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
33292628|NCT01179334|62669115|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
33379554|NCT00751881|62758638|FG001|Core Treatment Period|Poor compliance to protocol|3|||
33379555|NCT00751881|62758639|FG002|Core Treatment Period|Poor compliance to protocol|4|||
33379556|NCT00751881|62758637|FG000|Core Treatment Period|Lost to Follow-up|6|||
33379557|NCT00751881|62758638|FG001|Core Treatment Period|Lost to Follow-up|4|||
33379558|NCT00751881|62758639|FG002|Core Treatment Period|Lost to Follow-up|3|||
33379559|NCT00751881|62758637|FG000|Core Treatment Period|Other: protocol deviation|3|||
33379560|NCT00751881|62758638|FG001|Core Treatment Period|Other: protocol deviation|3|||
33379561|NCT00751881|62758639|FG002|Core Treatment Period|Other: protocol deviation|7|||
33379562|NCT00751881|62758637|FG000|Core Treatment Period|Other: wish to parent|5|||
33379563|NCT00751881|62758638|FG001|Core Treatment Period|Other: wish to parent|7|||
33379564|NCT00751881|62758639|FG002|Core Treatment Period|Other: wish to parent|4|||
33379565|NCT00751881|62758637|FG000|Core Treatment Period|Other: personal/family constraints|6|||
33379566|NCT00751881|62758638|FG001|Core Treatment Period|Other: personal/family constraints|7|||
33379567|NCT00751881|62758639|FG002|Core Treatment Period|Other: personal/family constraints|10|||
33379568|NCT00751881|62758637|FG000|Core Treatment Period|Other: MS treatment change|6|||
33379569|NCT00751881|62758638|FG001|Core Treatment Period|Other: MS treatment change|4|||
33292629|NCT01178671|62669123|FG000|Overall Study|Adverse Event|4|||
33292630|NCT01178671|62669124|FG001|Overall Study|Adverse Event|6|||
33292631|NCT01178671|62669123|FG000|Overall Study|Protocol Violation|1|||
33292632|NCT01178671|62669124|FG001|Overall Study|Protocol Violation|1|||
33292633|NCT01178671|62669123|FG000|Overall Study|Lack of Efficacy|0|||
33292634|NCT01178671|62669124|FG001|Overall Study|Lack of Efficacy|1|||
33292635|NCT01178671|62669123|FG000|Overall Study|Lost to Follow-up|3|||
33292636|NCT01178671|62669124|FG001|Overall Study|Lost to Follow-up|1|||
33292637|NCT01178671|62669123|FG000|Overall Study|Physician Decision|4|||
33292638|NCT01178671|62669124|FG001|Overall Study|Physician Decision|6|||
33292639|NCT01178125|62669130|FG000|Overall Study|Lost to Follow-up|397|||
33292640|NCT01178125|62669130|FG000|Overall Study|Adverse Event|244|||
33292641|NCT01178125|62669130|FG000|Overall Study|Withdrawal by Subject|209|||
33292642|NCT01178125|62669130|FG000|Overall Study|Noncompliance|184|||
33292643|NCT01178125|62669130|FG000|Overall Study|Pregnancy|55|||
33292644|NCT01178125|62669130|FG000|Overall Study|Other Reason|39|||
33292645|NCT01178125|62669130|FG000|Overall Study|Sponsor Decision|28|||
33292646|NCT01178125|62669130|FG000|Overall Study|Protocol Violation|17|||
33379570|NCT00751881|62758639|FG002|Core Treatment Period|Other: MS treatment change|4|||
33379571|NCT00751881|62758637|FG000|Core Treatment Period|Other: tolerability complaints|2|||
33379572|NCT00751881|62758638|FG001|Core Treatment Period|Other: tolerability complaints|0|||
33379573|NCT00751881|62758639|FG002|Core Treatment Period|Other: tolerability complaints|0|||
33379574|NCT00751881|62758637|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
33379575|NCT00751881|62758638|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
33379576|NCT00751881|62758639|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
33379577|NCT00751881|62758637|FG000|Extension Study Period|Adverse Event|18|||
33292647|NCT01178125|62669130|FG000|Overall Study|Investigator Decision|5|||
33292648|NCT01178086|62669152|FG000|Overall Study|Participant refusal|7|||
33292649|NCT01178086|62669152|FG000|Overall Study|Physician Decision|44|||
33292650|NCT01178086|62669152|FG000|Overall Study|Switch to other CLL therapy|113|||
33292651|NCT01178086|62669152|FG000|Overall Study|Death|59|||
33292652|NCT01178086|62669152|FG000|Overall Study|Other unspecified|89|||
33292653|NCT01178086|62669152|FG000|Overall Study|Excluded from EAS|20|||
33292654|NCT01177969|62669160|FG000|Overall Study|Protocol Violation|2|||
33292655|NCT01177969|62669161|FG001|Overall Study|Protocol Violation|1|||
33292656|NCT01177969|62669160|FG000|Overall Study|Withdrawal by Subject|1|||
33292657|NCT01177969|62669161|FG001|Overall Study|Withdrawal by Subject|2|||
33292658|NCT01177813|62669172|FG000|Overall Study|Adverse Event|8|||
33292659|NCT01177813|62669173|FG001|Overall Study|Adverse Event|2|||
33292660|NCT01177813|62669174|FG002|Overall Study|Adverse Event|4|||
33292661|NCT01177813|62669175|FG003|Overall Study|Adverse Event|6|||
33292662|NCT01177813|62669176|FG004|Overall Study|Adverse Event|3|||
33292663|NCT01177813|62669172|FG000|Overall Study|Lack of Efficacy|1|||
33292664|NCT01177813|62669173|FG001|Overall Study|Lack of Efficacy|0|||
33379578|NCT00751881|62758638|FG001|Extension Study Period|Adverse Event|20|||
33379579|NCT00751881|62758639|FG002|Extension Study Period|Adverse Event|21|||
33379580|NCT00751881|62758637|FG000|Extension Study Period|Lack of Efficacy|14|||
33379581|NCT00751881|62758638|FG001|Extension Study Period|Lack of Efficacy|10|||
33379582|NCT00751881|62758639|FG002|Extension Study Period|Lack of Efficacy|20|||
33379583|NCT00751881|62758637|FG000|Extension Study Period|Lost to Follow-up|4|||
33292665|NCT01177813|62669174|FG002|Overall Study|Lack of Efficacy|0|||
33292666|NCT01177813|62669175|FG003|Overall Study|Lack of Efficacy|0|||
33487589|NCT00122135|62865836|FG001|Overall Study|Withdrawal by Subject|0|||
33556590|NCT01369355|62949446|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
33292667|NCT01177813|62669176|FG004|Overall Study|Lack of Efficacy|0|||
33292668|NCT01177813|62669172|FG000|Overall Study|Protocol Violation|3|||
33292669|NCT01177813|62669173|FG001|Overall Study|Protocol Violation|2|||
33292670|NCT01177813|62669174|FG002|Overall Study|Protocol Violation|2|||
33292671|NCT01177813|62669175|FG003|Overall Study|Protocol Violation|0|||
33292672|NCT01177813|62669176|FG004|Overall Study|Protocol Violation|1|||
33292673|NCT01177813|62669172|FG000|Overall Study|Lost to Follow-up|12|||
33379584|NCT00751881|62758638|FG001|Extension Study Period|Lost to Follow-up|9|||
33379585|NCT00751881|62758639|FG002|Extension Study Period|Lost to Follow-up|6|||
33379586|NCT00751881|62758637|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
33379587|NCT00751881|62758638|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
33292674|NCT01177813|62669173|FG001|Overall Study|Lost to Follow-up|5|||
33292675|NCT01177813|62669174|FG002|Overall Study|Lost to Follow-up|6|||
33379588|NCT00751881|62758639|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
33379589|NCT00751881|62758637|FG000|Extension Study Period|Other than specified above|26|||
33379590|NCT00751881|62758638|FG001|Extension Study Period|Other than specified above|30|||
33379591|NCT00751881|62758639|FG002|Extension Study Period|Other than specified above|18|||
33379592|NCT00747474|62758653|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33379593|NCT00747474|62758654|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33379594|NCT00747474|62758655|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33379595|NCT00747474|62758656|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33379596|NCT00747474|62758657|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33379597|NCT00747474|62758658|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33379598|NCT00747474|62758659|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33379599|NCT00747474|62758660|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
33379600|NCT00747474|62758661|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33379601|NCT00747474|62758662|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33379602|NCT00747474|62758663|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33379603|NCT00747474|62758664|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33379604|NCT00830063|62758673|FG000|Overall Study|Adverse Event|7|||
33379605|NCT00830063|62758674|FG001|Overall Study|Adverse Event|13|||
33379606|NCT00830063|62758675|FG002|Overall Study|Adverse Event|16|||
33379607|NCT00830063|62758676|FG003|Overall Study|Adverse Event|13|||
33292676|NCT01177813|62669175|FG003|Overall Study|Lost to Follow-up|3|||
33292677|NCT01177813|62669176|FG004|Overall Study|Lost to Follow-up|0|||
33379608|NCT00830063|62758673|FG000|Overall Study|Death|1|||
33556591|NCT01369355|62949447|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
33292678|NCT01177813|62669172|FG000|Overall Study|Withdrawal by Subject|12|||
33292679|NCT01177813|62669173|FG001|Overall Study|Withdrawal by Subject|7|||
33292680|NCT01177813|62669174|FG002|Overall Study|Withdrawal by Subject|6|||
33292681|NCT01177813|62669175|FG003|Overall Study|Withdrawal by Subject|5|||
33292682|NCT01177813|62669176|FG004|Overall Study|Withdrawal by Subject|3|||
33292683|NCT01177813|62669172|FG000|Overall Study|Other reason not defined above|5|||
33292684|NCT01177813|62669173|FG001|Overall Study|Other reason not defined above|2|||
33292685|NCT01177813|62669174|FG002|Overall Study|Other reason not defined above|2|||
33292686|NCT01177813|62669175|FG003|Overall Study|Other reason not defined above|3|||
33292687|NCT01177813|62669176|FG004|Overall Study|Other reason not defined above|2|||
33292688|NCT01200394|62669190|FG000|Overall Study|Adverse Event|0|||
33292689|NCT01200394|62669191|FG001|Overall Study|Adverse Event|14|||
33292690|NCT01200394|62669190|FG000|Overall Study|Death|1|||
33292691|NCT01200394|62669191|FG001|Overall Study|Death|0|||
33292692|NCT01200394|62669190|FG000|Overall Study|Lost to Follow-up|0|||
33292693|NCT01200394|62669191|FG001|Overall Study|Lost to Follow-up|1|||
33292694|NCT01200394|62669190|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
33292695|NCT01200394|62669191|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
33292696|NCT01200394|62669190|FG000|Overall Study|Protocol Violation|0|||
33292697|NCT01200394|62669191|FG001|Overall Study|Protocol Violation|3|||
33292698|NCT01200394|62669190|FG000|Overall Study|Withdrawal by Subject|0|||
33292699|NCT01200394|62669191|FG001|Overall Study|Withdrawal by Subject|5|||
33292700|NCT01200394|62669190|FG000|Overall Study|Other|0|||
33292701|NCT01200394|62669191|FG001|Overall Study|Other|1|||
33292702|NCT01200355|62669200|FG000|Overall Study|Death|7|||
33292703|NCT01200355|62669201|FG001|Overall Study|Death|2|||
33292704|NCT01200238|62669209|FG000|Overall Study|Adverse Event|2|||
33292705|NCT01200238|62669210|FG001|Overall Study|Adverse Event|1|||
33292706|NCT01200238|62669209|FG000|Overall Study|Progressive Disease|5|||
33292707|NCT01200238|62669210|FG001|Overall Study|Progressive Disease|8|||
33292708|NCT01200238|62669209|FG000|Overall Study|Withdrawal by Subject|0|||
33292709|NCT01200238|62669210|FG001|Overall Study|Withdrawal by Subject|1|||
33292710|NCT01199731|62669219|FG000|Overall Study|Adverse Event|0|||
33292711|NCT01199731|62669220|FG001|Overall Study|Adverse Event|1|||
33292712|NCT01199731|62669221|FG002|Overall Study|Adverse Event|0|||
33292713|NCT01199731|62669219|FG000|Overall Study|Study closed/terminated|7|||
33292714|NCT01199731|62669220|FG001|Overall Study|Study closed/terminated|9|||
33292715|NCT01199731|62669221|FG002|Overall Study|Study closed/terminated|7|||
33292716|NCT01199731|62669219|FG000|Overall Study|Lost to Follow-up|0|||
33292717|NCT01199731|62669220|FG001|Overall Study|Lost to Follow-up|0|||
33292718|NCT01199731|62669221|FG002|Overall Study|Lost to Follow-up|2|||
33292719|NCT01199731|62669219|FG000|Overall Study|Physician Decision|0|||
33292720|NCT01199731|62669220|FG001|Overall Study|Physician Decision|1|||
33292721|NCT01199731|62669221|FG002|Overall Study|Physician Decision|1|||
33292722|NCT01199731|62669219|FG000|Overall Study|Withdrawal by Subject|2|||
33292723|NCT01199731|62669220|FG001|Overall Study|Withdrawal by Subject|0|||
33292724|NCT01199731|62669221|FG002|Overall Study|Withdrawal by Subject|0|||
33292725|NCT01199263|62669231|FG000|Overall Study|Ineligible|0|||
33379609|NCT00830063|62758674|FG001|Overall Study|Death|0|||
33379610|NCT00830063|62758675|FG002|Overall Study|Death|0|||
33379611|NCT00830063|62758676|FG003|Overall Study|Death|0|||
33292726|NCT01199263|62669232|FG001|Overall Study|Ineligible|2|||
33292727|NCT01199263|62669231|FG000|Overall Study|Never Treated|6|||
33292728|NCT01199263|62669232|FG001|Overall Study|Never Treated|0|||
33292729|NCT01199068|62669243|FG000|Overall Study|Unacceptable toxicity|0|||
33292730|NCT01199068|62669244|FG001|Overall Study|Unacceptable toxicity|0|||
33292731|NCT01199068|62669245|FG002|Overall Study|Unacceptable toxicity|2|||
33292732|NCT01199068|62669243|FG000|Overall Study|Progressive disease|3|||
33292733|NCT01199068|62669244|FG001|Overall Study|Progressive disease|3|||
33292734|NCT01199068|62669245|FG002|Overall Study|Progressive disease|6|||
33292735|NCT01199068|62669243|FG000|Overall Study|Withdrawal by Subject|0|||
33292736|NCT01199068|62669244|FG001|Overall Study|Withdrawal by Subject|0|||
33292737|NCT01199068|62669245|FG002|Overall Study|Withdrawal by Subject|1|||
33292738|NCT01198873|62669262|FG000|Overall Study|Adverse Event|4|||
33292739|NCT01198873|62669263|FG001|Overall Study|Adverse Event|7|||
33292740|NCT01198873|62669262|FG000|Overall Study|Study closure|29|||
33292741|NCT01198873|62669263|FG001|Overall Study|Study closure|23|||
33292742|NCT01198873|62669262|FG000|Overall Study|Other than above|4|||
33292743|NCT01198873|62669263|FG001|Overall Study|Other than above|2|||
33292744|NCT01198795|62669269|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
33379612|NCT00830063|62758673|FG000|Overall Study|Lost to Follow-up|0|||
33379613|NCT00830063|62758674|FG001|Overall Study|Lost to Follow-up|0|||
33379614|NCT00830063|62758675|FG002|Overall Study|Lost to Follow-up|3|||
33379615|NCT00830063|62758676|FG003|Overall Study|Lost to Follow-up|1|||
33379616|NCT00830063|62758673|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
33379617|NCT00830063|62758674|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
33379618|NCT00830063|62758675|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
33379619|NCT00830063|62758676|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
33379620|NCT00830063|62758673|FG000|Overall Study|Lack of Efficacy|51|||
33379621|NCT00830063|62758674|FG001|Overall Study|Lack of Efficacy|23|||
33379622|NCT00830063|62758675|FG002|Overall Study|Lack of Efficacy|25|||
33379623|NCT00830063|62758676|FG003|Overall Study|Lack of Efficacy|32|||
33379624|NCT00830063|62758673|FG000|Overall Study|Other|5|||
33379625|NCT00830063|62758674|FG001|Overall Study|Other|5|||
33379626|NCT00830063|62758675|FG002|Overall Study|Other|8|||
33379627|NCT00830063|62758676|FG003|Overall Study|Other|6|||
33379628|NCT00830063|62758673|FG000|Overall Study|Withdrawal by Subject|16|||
33379629|NCT00830063|62758674|FG001|Overall Study|Withdrawal by Subject|10|||
33379630|NCT00830063|62758675|FG002|Overall Study|Withdrawal by Subject|16|||
33379631|NCT00830063|62758676|FG003|Overall Study|Withdrawal by Subject|13|||
33292745|NCT01198795|62669269|FG000|Overall Study|Withdrawal by Subject|17|||
33292746|NCT01198795|62669269|FG000|Overall Study|Lost to Follow-up|15|||
33292747|NCT01198795|62669269|FG000|Overall Study|Adverse Event|9|||
33292748|NCT01198795|62669269|FG000|Overall Study|Lack of Efficacy|5|||
33379632|NCT00830063|62758673|FG000|Overall Study|Protocol Violation|1|||
33379633|NCT00830063|62758674|FG001|Overall Study|Protocol Violation|0|||
33379634|NCT00830063|62758675|FG002|Overall Study|Protocol Violation|3|||
33379635|NCT00830063|62758676|FG003|Overall Study|Protocol Violation|2|||
33379636|NCT00830063|62758673|FG000|Overall Study|Randomized But Not Treated|0|||
33379637|NCT00830063|62758674|FG001|Overall Study|Randomized But Not Treated|2|||
33487590|NCT03645057|62865846|FG000|Randomization to Baseline|Lost to Follow-up|1|||
33487591|NCT03645057|62865847|FG001|Randomization to Baseline|Lost to Follow-up|0|||
33487592|NCT03645057|62865848|FG002|Randomization to Baseline|Lost to Follow-up|1|||
33487593|NCT03645057|62865849|FG003|Randomization to Baseline|Lost to Follow-up|0|||
33487594|NCT03645057|62865846|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
33487595|NCT03645057|62865847|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
33487596|NCT03645057|62865848|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
33487597|NCT03645057|62865849|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
33487598|NCT03645057|62865846|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
33487599|NCT03645057|62865847|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
33487600|NCT03645057|62865848|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
33487601|NCT03645057|62865849|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
33487602|NCT03645057|62865846|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
33379638|NCT00830063|62758675|FG002|Overall Study|Randomized But Not Treated|0|||
33379639|NCT00830063|62758676|FG003|Overall Study|Randomized But Not Treated|2|||
33487603|NCT03645057|62865847|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
33662434|NCT01694771|63092957|FG001|Overall Study|Lost to Follow-up|3|||
33379640|NCT00750438|62758690|FG000|Overall Study|Protocol Violation|4|||
33379641|NCT00750438|62758691|FG001|Overall Study|Protocol Violation|1|||
33379642|NCT00750438|62758690|FG000|Overall Study|Physician Decision|2|||
33379643|NCT00750438|62758691|FG001|Overall Study|Physician Decision|2|||
33292749|NCT01198795|62669269|FG000|Overall Study|Protocol Violation|2|||
33292750|NCT01198795|62669269|FG000|Overall Study|Other Reason|4|||
33292751|NCT01198756|62669277|FG000|Overall Study|Adverse Event|0|||
33292752|NCT01198756|62669278|FG001|Overall Study|Adverse Event|0|||
33292753|NCT01198756|62669279|FG002|Overall Study|Adverse Event|0|||
33292754|NCT01198756|62669280|FG003|Overall Study|Adverse Event|1|||
33379644|NCT00750438|62758690|FG000|Overall Study|Withdrawal by Subject|1|||
33379645|NCT00750438|62758691|FG001|Overall Study|Withdrawal by Subject|1|||
33379646|NCT00586326|62758697|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
33379647|NCT00586326|62758697|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
33379648|NCT00586326|62758697|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
33379649|NCT00586326|62758697|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
33487604|NCT03645057|62865848|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
33487605|NCT03645057|62865849|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
33487606|NCT00132041|62865855|FG000|Baseline|Ineligible|6|||
33487607|NCT00132041|62865855|FG000|3 Months Post Ablation|Transplant|1|||
33487608|NCT00132041|62865855|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
33487609|NCT00132041|62865855|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
33487610|NCT00132041|62865855|FG000|6 Months Post Ablation|Death|2|||
33487611|NCT00132041|62865855|FG000|6 Months Post Ablation|Transplant|6|||
33487612|NCT00132041|62865855|FG000|9 Months Post Ablation|Death|1|||
33487613|NCT00132041|62865855|FG000|9 Months Post Ablation|Transplant|1|||
33487614|NCT00132041|62865855|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
33487615|NCT00132041|62865855|FG000|12 Months Post Ablation|Death|1|||
33487616|NCT00132041|62865855|FG000|12 Months Post Ablation|Transplant|1|||
33487617|NCT00132041|62865855|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
33487618|NCT00132041|62865855|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
33487619|NCT00132041|62865855|FG000|15 Months Post Ablation|Death|1|||
33487620|NCT00132041|62865855|FG000|15 Months Post Ablation|Transplant|5|||
33292755|NCT01198756|62669277|FG000|Overall Study|Protocol Violation|0|||
33292756|NCT01198756|62669278|FG001|Overall Study|Protocol Violation|0|||
33292757|NCT01198756|62669279|FG002|Overall Study|Protocol Violation|0|||
33292758|NCT01198756|62669280|FG003|Overall Study|Protocol Violation|2|||
33292759|NCT01198756|62669277|FG000|Overall Study|Withdrawal by Subject|9|||
33292760|NCT01198756|62669278|FG001|Overall Study|Withdrawal by Subject|4|||
33292761|NCT01198756|62669279|FG002|Overall Study|Withdrawal by Subject|7|||
33292762|NCT01198756|62669280|FG003|Overall Study|Withdrawal by Subject|5|||
33292763|NCT01198756|62669277|FG000|Overall Study|Lost to Follow-up|29|||
33292764|NCT01198756|62669278|FG001|Overall Study|Lost to Follow-up|36|||
33292765|NCT01198756|62669279|FG002|Overall Study|Lost to Follow-up|23|||
33292766|NCT01198756|62669280|FG003|Overall Study|Lost to Follow-up|18|||
33292767|NCT01198600|62669297|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
33292768|NCT01198600|62669298|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
33292769|NCT01198600|62669299|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
33292770|NCT01198600|62669300|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
33292771|NCT01198600|62669297|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
33292772|NCT01198600|62669298|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
33292773|NCT01198600|62669299|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
33292774|NCT01198600|62669300|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
33292775|NCT01198600|62669297|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
33292776|NCT01198600|62669298|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
33292777|NCT01198600|62669299|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
33292778|NCT01198600|62669300|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
33292779|NCT01198600|62669297|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
33292780|NCT01198600|62669298|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
33292781|NCT01198600|62669299|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
33292782|NCT01198600|62669300|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
33292783|NCT01198600|62669297|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
33292784|NCT01198600|62669298|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
33292785|NCT01198600|62669299|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
33292786|NCT01198600|62669300|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
33292787|NCT01198600|62669297|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
33292788|NCT01198600|62669298|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
33292789|NCT01198600|62669299|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
33292790|NCT01198600|62669300|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
33292791|NCT01198600|62669297|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
33487621|NCT00132041|62865855|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
33487622|NCT00132041|62865855|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
33487623|NCT00132041|62865855|FG000|18 Months Post Ablation|Transplant|1|||
33487624|NCT00132041|62865855|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
33487625|NCT00132041|62865855|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
33292792|NCT01198600|62669298|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
33292793|NCT01198600|62669299|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
33379650|NCT00586326|62758697|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
33379651|NCT00586326|62758697|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
33487626|NCT03643575|62865865|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
33487627|NCT03643575|62865866|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
33487628|NCT03643575|62865867|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
33292794|NCT01198600|62669300|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
33292795|NCT01198132|62669310|FG000|Overall Study|Withdrawal by Subject|4|||
33292796|NCT01198132|62669311|FG001|Overall Study|Withdrawal by Subject|5|||
33292797|NCT01198132|62669310|FG000|Overall Study|Physician Decision|5|||
33292798|NCT01198132|62669311|FG001|Overall Study|Physician Decision|4|||
33292799|NCT01198132|62669310|FG000|Overall Study|Other Unspecified|3|||
33292800|NCT01198132|62669311|FG001|Overall Study|Other Unspecified|6|||
33292801|NCT01198132|62669310|FG000|Overall Study|Lack of Efficacy|2|||
33292802|NCT01198132|62669311|FG001|Overall Study|Lack of Efficacy|3|||
33292803|NCT01198132|62669310|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
33292804|NCT01198132|62669311|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
33292805|NCT01198132|62669310|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
33292806|NCT01198132|62669311|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
33292807|NCT01198132|62669310|FG000|Overall Study|Adverse Event|0|||
33292808|NCT01198132|62669311|FG001|Overall Study|Adverse Event|1|||
33292809|NCT01198132|62669310|FG000|Overall Study|Protocol Violation|1|||
33292810|NCT01198132|62669311|FG001|Overall Study|Protocol Violation|0|||
33292811|NCT01197508|62669323|FG000|Overall Study|Withdrawal by Subject|8|||
33292812|NCT01197508|62669324|FG001|Overall Study|Withdrawal by Subject|7|||
33292813|NCT01197508|62669325|FG002|Overall Study|Withdrawal by Subject|15|||
33292814|NCT01197508|62669326|FG003|Overall Study|Withdrawal by Subject|4|||
33292815|NCT01197508|62669323|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
33292816|NCT01197508|62669324|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
33292817|NCT01197508|62669325|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
33292818|NCT01197508|62669326|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
33292819|NCT01197508|62669323|FG000|Overall Study|Adverse Event|10|||
33292820|NCT01197508|62669324|FG001|Overall Study|Adverse Event|13|||
33292821|NCT01197508|62669325|FG002|Overall Study|Adverse Event|23|||
33292822|NCT01197508|62669326|FG003|Overall Study|Adverse Event|3|||
33292823|NCT01197508|62669323|FG000|Overall Study|Severe non-compliance to protocol|0|||
33292824|NCT01197508|62669324|FG001|Overall Study|Severe non-compliance to protocol|3|||
33292825|NCT01197508|62669325|FG002|Overall Study|Severe non-compliance to protocol|1|||
33292826|NCT01197508|62669326|FG003|Overall Study|Severe non-compliance to protocol|3|||
33292827|NCT01197508|62669323|FG000|Overall Study|Condition under investigation worsened|1|||
33292828|NCT01197508|62669324|FG001|Overall Study|Condition under investigation worsened|1|||
33292829|NCT01197508|62669325|FG002|Overall Study|Condition under investigation worsened|1|||
33292830|NCT01197508|62669326|FG003|Overall Study|Condition under investigation worsened|1|||
33292831|NCT01197508|62669323|FG000|Overall Study|Lack of Efficacy|1|||
33292832|NCT01197508|62669324|FG001|Overall Study|Lack of Efficacy|2|||
33292833|NCT01197508|62669325|FG002|Overall Study|Lack of Efficacy|2|||
33292834|NCT01197508|62669326|FG003|Overall Study|Lack of Efficacy|1|||
33292835|NCT01197508|62669323|FG000|Overall Study|Study-specific withdrawal criteria|0|||
33487629|NCT03643575|62865868|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
33487630|NCT03643575|62865869|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
33487631|NCT03643575|62865870|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
33487632|NCT03643575|62865865|FG000|Washout: 7 Days|Adverse Event|1|||
33379652|NCT00586326|62758697|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
33487633|NCT03643575|62865866|FG001|Washout: 7 Days|Adverse Event|0|||
33487634|NCT03643575|62865867|FG002|Washout: 7 Days|Adverse Event|0|||
33379653|NCT00586326|62758697|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
33379654|NCT00586326|62758697|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
33379655|NCT00586326|62758697|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
33379656|NCT00586326|62758697|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
33379657|NCT00586326|62758697|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
33379658|NCT00586326|62758697|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
33379659|NCT00586326|62758697|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
33379660|NCT00586326|62758697|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
33379661|NCT00586326|62758697|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
33379662|NCT00586326|62758697|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
33379663|NCT00751101|62758707|FG000|Overall Study|Withdrawal by Subject|1|||
33379664|NCT00751101|62758708|FG001|Overall Study|Withdrawal by Subject|0|||
33379665|NCT00751101|62758707|FG000|Overall Study|No HFS / Never Started Patch/|0|||
33379666|NCT00751101|62758708|FG001|Overall Study|No HFS / Never Started Patch/|4|||
33487635|NCT03643575|62865868|FG003|Washout: 7 Days|Adverse Event|0|||
33487636|NCT03643575|62865869|FG004|Washout: 7 Days|Adverse Event|0|||
33379667|NCT00751101|62758707|FG000|Overall Study|Never began capecitabine|1|||
33487637|NCT03643575|62865870|FG005|Washout: 7 Days|Adverse Event|0|||
33292836|NCT01197508|62669324|FG001|Overall Study|Study-specific withdrawal criteria|0|||
33487638|NCT03643575|62865865|FG000|Washout: 7 Days|Non compliance check in|0|||
33292837|NCT01197508|62669325|FG002|Overall Study|Study-specific withdrawal criteria|1|||
33292838|NCT01197508|62669326|FG003|Overall Study|Study-specific withdrawal criteria|2|||
33292839|NCT01197508|62669323|FG000|Overall Study|Lost to Follow-up|1|||
33379668|NCT00751101|62758708|FG001|Overall Study|Never began capecitabine|0|||
33292840|NCT01197508|62669324|FG001|Overall Study|Lost to Follow-up|1|||
33292841|NCT01197508|62669325|FG002|Overall Study|Lost to Follow-up|2|||
33292842|NCT01197508|62669326|FG003|Overall Study|Lost to Follow-up|0|||
33292843|NCT01197508|62669323|FG000|Overall Study|Other|2|||
33292844|NCT01197508|62669324|FG001|Overall Study|Other|3|||
33292845|NCT01197508|62669325|FG002|Overall Study|Other|2|||
33292846|NCT01197508|62669326|FG003|Overall Study|Other|2|||
33292847|NCT01196416|62669343|FG000|Overall Study|Withdrawal by Subject|2|||
33292848|NCT01196104|62669349|FG000|Overall Study|Lost to Follow-up|1|||
33292849|NCT01196104|62669350|FG001|Overall Study|Lost to Follow-up|0|||
33292850|NCT01196104|62669349|FG000|Overall Study|Physician Decision|0|||
33292851|NCT01196104|62669350|FG001|Overall Study|Physician Decision|1|||
33292852|NCT01196104|62669349|FG000|Overall Study|Withdrawal by Subject|3|||
33292853|NCT01196104|62669350|FG001|Overall Study|Withdrawal by Subject|3|||
33292854|NCT01196104|62669349|FG000|Overall Study|Various|0|||
33292855|NCT01196104|62669350|FG001|Overall Study|Various|1|||
33292856|NCT01196026|62669368|FG000|Overall Study|Withdrawal by Subject|1|||
33292857|NCT01196026|62669369|FG001|Overall Study|Withdrawal by Subject|4|||
33292858|NCT01196026|62669370|FG002|Overall Study|Withdrawal by Subject|0|||
33292859|NCT01196026|62669371|FG003|Overall Study|Withdrawal by Subject|0|||
33292860|NCT01196026|62669372|FG004|Overall Study|Withdrawal by Subject|0|||
33292861|NCT01196026|62669373|FG005|Overall Study|Withdrawal by Subject|0|||
33292862|NCT01196026|62669368|FG000|Overall Study|Lost to Follow-up|0|||
33292863|NCT01196026|62669369|FG001|Overall Study|Lost to Follow-up|3|||
33292864|NCT01196026|62669370|FG002|Overall Study|Lost to Follow-up|0|||
33292865|NCT01196026|62669371|FG003|Overall Study|Lost to Follow-up|0|||
33292866|NCT01196026|62669372|FG004|Overall Study|Lost to Follow-up|1|||
33292867|NCT01196026|62669373|FG005|Overall Study|Lost to Follow-up|0|||
33292868|NCT01196026|62669368|FG000|Overall Study|Other|0|||
33292869|NCT01196026|62669369|FG001|Overall Study|Other|1|||
33292870|NCT01196026|62669370|FG002|Overall Study|Other|0|||
33292871|NCT01196026|62669371|FG003|Overall Study|Other|0|||
33292872|NCT01196026|62669372|FG004|Overall Study|Other|0|||
33292873|NCT01196026|62669373|FG005|Overall Study|Other|0|||
33292874|NCT01195948|62669392|FG000|Overall Study|Lost to Follow-up|0|||
33292875|NCT01195948|62669393|FG001|Overall Study|Lost to Follow-up|1|||
33292876|NCT01195948|62669394|FG002|Overall Study|Lost to Follow-up|2|||
33292877|NCT01195831|62669407|FG000|Overall Study|Lost to Follow-up|2|||
33292878|NCT01195831|62669408|FG001|Overall Study|Lost to Follow-up|4|||
33292879|NCT01195831|62669407|FG000|Overall Study|Withdrawal by Subject|2|||
33292880|NCT01195831|62669408|FG001|Overall Study|Withdrawal by Subject|2|||
33292881|NCT01195831|62669407|FG000|Overall Study|Adverse Event|4|||
33292882|NCT01195831|62669408|FG001|Overall Study|Adverse Event|2|||
33292883|NCT01195831|62669407|FG000|Overall Study|Protocol Violation|0|||
33292884|NCT01195831|62669408|FG001|Overall Study|Protocol Violation|2|||
33292885|NCT01195675|62669414|FG000|Overall Study|Adverse Event|1|||
33292886|NCT01195675|62669414|FG000|Overall Study|Withdrawal by Subject|2|||
33292887|NCT01195636|62669431|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
33292888|NCT01195636|62669432|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
33292889|NCT01195636|62669431|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
33487639|NCT03643575|62865866|FG001|Washout: 7 Days|Non compliance check in|1|||
33487640|NCT03643575|62865867|FG002|Washout: 7 Days|Non compliance check in|0|||
33487641|NCT03643575|62865868|FG003|Washout: 7 Days|Non compliance check in|0|||
33487642|NCT03643575|62865869|FG004|Washout: 7 Days|Non compliance check in|0|||
33487643|NCT03643575|62865870|FG005|Washout: 7 Days|Non compliance check in|0|||
33487644|NCT02768194|62865878|FG000|Period 1|Adverse Event|0|||
33487645|NCT02768194|62865879|FG001|Period 1|Adverse Event|0|||
33487646|NCT02768194|62865880|FG002|Period 1|Adverse Event|0|||
33487647|NCT02768194|62865881|FG003|Period 1|Adverse Event|1|||
33487648|NCT02768194|62865882|FG004|Period 1|Adverse Event|0|||
33487649|NCT02768194|62865883|FG005|Period 1|Adverse Event|0|||
33487650|NCT02768194|62865878|FG000|Period 2|Other (Reason not specified)|1|||
33292890|NCT01195636|62669432|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
33292891|NCT01195636|62669431|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33292892|NCT01195636|62669432|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
33292893|NCT01195636|62669431|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
33292894|NCT01195636|62669432|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
33292895|NCT01195636|62669431|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
33292896|NCT01195636|62669432|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
33379669|NCT00751101|62758707|FG000|Overall Study|Physician Decision|0|||
33292897|NCT01195636|62669431|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
33379670|NCT00751101|62758708|FG001|Overall Study|Physician Decision|1|||
33487651|NCT02768194|62865879|FG001|Period 2|Other (Reason not specified)|0|||
33487652|NCT02768194|62865880|FG002|Period 2|Other (Reason not specified)|0|||
33292898|NCT01195636|62669432|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
33292899|NCT01195636|62669431|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
33292900|NCT01195636|62669432|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
33292901|NCT01195636|62669431|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
33662435|NCT01694771|63092956|FG000|Overall Study|Consent withdrawn|7|||
33379671|NCT00750204|62758720|FG000|Overall Study|study halted prematurely|1|||
33379672|NCT00750204|62758721|FG001|Overall Study|study halted prematurely|1|||
33379673|NCT00751023|62758729|FG000|Overall Study|Lost to Follow-up|11|||
33379674|NCT00751023|62758730|FG001|Overall Study|Lost to Follow-up|7|||
33379675|NCT00591773|62758739|FG000|Overall Study|Adverse Event|9|||
33379676|NCT00591773|62758740|FG001|Overall Study|Adverse Event|9|||
33379677|NCT00591773|62758741|FG002|Overall Study|Adverse Event|6|||
33379678|NCT00591773|62758739|FG000|Overall Study|Protocol Violation|2|||
33379679|NCT00591773|62758740|FG001|Overall Study|Protocol Violation|3|||
33379680|NCT00591773|62758741|FG002|Overall Study|Protocol Violation|0|||
33379681|NCT00591773|62758739|FG000|Overall Study|Lost to Follow-up|1|||
33379682|NCT00591773|62758740|FG001|Overall Study|Lost to Follow-up|4|||
33379683|NCT00591773|62758741|FG002|Overall Study|Lost to Follow-up|1|||
33379684|NCT00591773|62758739|FG000|Overall Study|Withdrawal by Subject|2|||
33379685|NCT00591773|62758740|FG001|Overall Study|Withdrawal by Subject|5|||
33379686|NCT00591773|62758741|FG002|Overall Study|Withdrawal by Subject|3|||
33292902|NCT01195636|62669432|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
33292903|NCT01195363|62669440|FG000|Overall Study|Lost to Follow-up|7|||
33292904|NCT01195363|62669441|FG001|Overall Study|Lost to Follow-up|4|||
33292905|NCT01195363|62669440|FG000|Overall Study|Adverse Event|3|||
33292906|NCT01195363|62669441|FG001|Overall Study|Adverse Event|1|||
33292907|NCT01195363|62669440|FG000|Overall Study|Lack of Efficacy|0|||
33292908|NCT01195363|62669441|FG001|Overall Study|Lack of Efficacy|4|||
33292909|NCT01195363|62669440|FG000|Overall Study|incarceration|1|||
33292910|NCT01195363|62669441|FG001|Overall Study|incarceration|0|||
33379687|NCT00591773|62758739|FG000|Overall Study|Lack of Efficacy|1|||
33379688|NCT00591773|62758740|FG001|Overall Study|Lack of Efficacy|2|||
33379689|NCT00591773|62758741|FG002|Overall Study|Lack of Efficacy|2|||
33379690|NCT00591773|62758739|FG000|Overall Study|Other|1|||
33379691|NCT00591773|62758740|FG001|Overall Study|Other|1|||
33379692|NCT00591773|62758741|FG002|Overall Study|Other|4|||
33379693|NCT00750867|62758749|FG000|Overall Study|Adverse Event|2|||
33379694|NCT00744042|62758753|FG000|Overall Study|Withdrawal by Subject|1|||
33379695|NCT00829829|62758766|FG000|Overall Study|Protocol Violation|0|||
33379696|NCT00829829|62758767|FG001|Overall Study|Protocol Violation|3|||
33379697|NCT00829829|62758768|FG002|Overall Study|Protocol Violation|0|||
33379698|NCT00829829|62758766|FG000|Overall Study|Adverse Event|4|||
33379699|NCT00829829|62758767|FG001|Overall Study|Adverse Event|4|||
33379700|NCT00829829|62758768|FG002|Overall Study|Adverse Event|3|||
33379701|NCT00829829|62758766|FG000|Overall Study|Withdrawal by Subject|8|||
33379702|NCT00829829|62758767|FG001|Overall Study|Withdrawal by Subject|4|||
33292911|NCT01195090|62669449|FG000|Overall Study|Adverse Event|1|||
33292912|NCT01195090|62669450|FG001|Overall Study|Adverse Event|2|||
33292913|NCT01195090|62669449|FG000|Overall Study|Lost to Follow-up|2|||
33379703|NCT00829829|62758768|FG002|Overall Study|Withdrawal by Subject|2|||
33379704|NCT00829829|62758766|FG000|Overall Study|Decision by the Sponsor|1|||
33379705|NCT00829829|62758767|FG001|Overall Study|Decision by the Sponsor|0|||
33379706|NCT00829829|62758768|FG002|Overall Study|Decision by the Sponsor|2|||
33487653|NCT02768194|62865881|FG003|Period 2|Other (Reason not specified)|0|||
33487654|NCT02768194|62865882|FG004|Period 2|Other (Reason not specified)|0|||
33487655|NCT02768194|62865883|FG005|Period 2|Other (Reason not specified)|0|||
33487656|NCT02768194|62865878|FG000|Period 3|Other (Reason not specified)|0|||
33487657|NCT02768194|62865879|FG001|Period 3|Other (Reason not specified)|1|||
33487658|NCT02768194|62865880|FG002|Period 3|Other (Reason not specified)|0|||
33487659|NCT02768194|62865881|FG003|Period 3|Other (Reason not specified)|0|||
33487660|NCT02768194|62865882|FG004|Period 3|Other (Reason not specified)|0|||
33487661|NCT02768194|62865883|FG005|Period 3|Other (Reason not specified)|0|||
33487662|NCT00130793|62865893|FG000|Overall Study|Lost to Follow-up|1|||
33487663|NCT00130793|62865894|FG001|Overall Study|Lost to Follow-up|4|||
33487664|NCT00130793|62865893|FG000|Overall Study|Withdrew consent|2|||
33292914|NCT01195090|62669450|FG001|Overall Study|Lost to Follow-up|2|||
33292915|NCT01195090|62669449|FG000|Overall Study|Protocol Violation|3|||
33379707|NCT00829829|62758766|FG000|Overall Study|Lost to Follow-up|7|||
33379708|NCT00829829|62758767|FG001|Overall Study|Lost to Follow-up|3|||
33292916|NCT01195090|62669450|FG001|Overall Study|Protocol Violation|4|||
33379709|NCT00829829|62758768|FG002|Overall Study|Lost to Follow-up|3|||
33379710|NCT00829829|62758766|FG000|Overall Study|Other than specified above|2|||
33379711|NCT00829829|62758767|FG001|Overall Study|Other than specified above|2|||
33379712|NCT00829829|62758768|FG002|Overall Study|Other than specified above|1|||
33379713|NCT00823199|62758777|FG000|Overall Study|Withdrawal by Subject|2|||
33379714|NCT00829439|62758782|FG000|Overall Study|Adverse Event|0|||
33379715|NCT00829439|62758783|FG001|Overall Study|Adverse Event|0|||
33379716|NCT00829439|62758784|FG002|Overall Study|Adverse Event|1|||
33379717|NCT00829439|62758785|FG003|Overall Study|Adverse Event|0|||
33379718|NCT00749775|62758789|FG000|Overall Study|Protocol Violation|24|||
33487665|NCT00130793|62865894|FG001|Overall Study|Withdrew consent|0|||
33487666|NCT03818399|62865901|FG000|Overall Study|Lost to Follow-up|11|||
33292917|NCT01194973|62669456|FG000|Screening Period|Screen Failure|3|||
33379719|NCT00749775|62758789|FG000|Overall Study|Lost to Follow-up|36|||
33292918|NCT01194973|62669456|FG000|26 Week Treatment Period|Adverse Event|1|||
33292919|NCT01194973|62669456|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
33379720|NCT00749775|62758789|FG000|Overall Study|No visit after first day of treatment|44|||
33379721|NCT00749775|62758789|FG000|Overall Study|No drug administration|3|||
33379722|NCT00829283|62758805|FG000|Overall Study|Lost to Follow-up|7|||
33379723|NCT00829283|62758806|FG001|Overall Study|Lost to Follow-up|25|||
33379724|NCT00821873|62758812|FG000|Overall Study|Lost to Follow-up|4|||
33379725|NCT00749463|62758819|FG000|Overall Study|Adverse Event|0|||
33379726|NCT00749463|62758820|FG001|Overall Study|Adverse Event|4|||
33379727|NCT00749463|62758821|FG002|Overall Study|Adverse Event|1|||
33379728|NCT00749463|62758819|FG000|Overall Study|Withdrawal by Subject|1|||
33379729|NCT00749463|62758820|FG001|Overall Study|Withdrawal by Subject|0|||
33379730|NCT00749463|62758821|FG002|Overall Study|Withdrawal by Subject|0|||
33379731|NCT00821327|62758829|FG000|Overall Study|Adverse Event|13|||
33379732|NCT00821327|62758829|FG000|Overall Study|Patient Request|1|||
33379733|NCT00821327|62758829|FG000|Overall Study|Investigator Request|2|||
33379734|NCT00821327|62758829|FG000|Overall Study|Sponsor Request|1|||
33379735|NCT00821327|62758829|FG000|Overall Study|Disease Progression|13|||
33379736|NCT00821327|62758829|FG000|Overall Study|Other/Unknown|5|||
33379737|NCT00821093|62758835|FG000|Overall Study|Adverse Event|20|||
33292920|NCT01194973|62669456|FG000|26 Week Treatment Period|Pregnancy|1|||
33292921|NCT02218697|62669462|FG000|Overall Study|Adverse Event|0|||
33292922|NCT02218697|62669463|FG001|Overall Study|Adverse Event|2|||
33292923|NCT02218697|62669462|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
33292924|NCT02218697|62669463|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
33292925|NCT02218697|62669462|FG000|Overall Study|Withdrawal by Subject|2|||
33292926|NCT02218697|62669463|FG001|Overall Study|Withdrawal by Subject|3|||
33292927|NCT01177540|62669471|FG000|Overall Study|Adverse Event|1|||
33379738|NCT00821093|62758836|FG001|Overall Study|Adverse Event|12|||
33379739|NCT00821093|62758835|FG000|Overall Study|Withdrawal by Subject|9|||
33379740|NCT00821093|62758836|FG001|Overall Study|Withdrawal by Subject|13|||
33379741|NCT00821093|62758835|FG000|Overall Study|Lost to Follow-up|9|||
33379742|NCT00821093|62758836|FG001|Overall Study|Lost to Follow-up|3|||
33379743|NCT00821093|62758835|FG000|Overall Study|Protocol deviation|3|||
33379744|NCT00821093|62758836|FG001|Overall Study|Protocol deviation|6|||
33379745|NCT00821093|62758835|FG000|Overall Study|Abnormal laboratory value(s)|2|||
33379746|NCT00821093|62758836|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33379747|NCT00821093|62758835|FG000|Overall Study|Lack of Efficacy|2|||
33379748|NCT00821093|62758836|FG001|Overall Study|Lack of Efficacy|2|||
33379749|NCT00821093|62758835|FG000|Overall Study|Death|2|||
33379750|NCT00821093|62758836|FG001|Overall Study|Death|1|||
33379751|NCT00821093|62758835|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33379752|NCT00821093|62758836|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33379753|NCT00821093|62758835|FG000|Overall Study|Administrative problems|1|||
33379754|NCT00821093|62758836|FG001|Overall Study|Administrative problems|2|||
33292928|NCT01177540|62669472|FG001|Overall Study|Adverse Event|0|||
33379755|NCT00821015|62758842|FG000|Overall Study|Lost to Follow-up|12|||
33292929|NCT01177384|62669480|FG000|Overall Study|Adverse Event|6|||
33292930|NCT01177384|62669481|FG001|Overall Study|Adverse Event|4|||
33292931|NCT01177384|62669480|FG000|Overall Study|Lack of Efficacy|0|||
33292932|NCT01177384|62669481|FG001|Overall Study|Lack of Efficacy|1|||
33292933|NCT01177384|62669480|FG000|Overall Study|Lost to Follow-up|3|||
33292934|NCT01177384|62669481|FG001|Overall Study|Lost to Follow-up|4|||
33292935|NCT01177384|62669480|FG000|Overall Study|Physician Decision|0|||
33292936|NCT01177384|62669481|FG001|Overall Study|Physician Decision|3|||
33292937|NCT01177384|62669480|FG000|Overall Study|Protocol Violation|0|||
33292938|NCT01177384|62669481|FG001|Overall Study|Protocol Violation|2|||
33292939|NCT01177384|62669480|FG000|Overall Study|Withdrawal by Subject|5|||
33292940|NCT01177384|62669481|FG001|Overall Study|Withdrawal by Subject|12|||
33292941|NCT01194154|62669489|FG000|Overall Study|Adverse Event|12|||
33292942|NCT01194154|62669490|FG001|Overall Study|Adverse Event|7|||
33292943|NCT01194154|62669489|FG000|Overall Study|Lost to Follow-up|2|||
33292944|NCT01194154|62669490|FG001|Overall Study|Lost to Follow-up|3|||
33379756|NCT00814463|62758846|FG000|Overall Study|Lost to Follow-up|1|||
33379757|NCT00743652|62758856|FG000|Overall Study|Parent/Legal Guardian Request|3|||
33379758|NCT00743652|62758857|FG001|Overall Study|Parent/Legal Guardian Request|2|||
33379759|NCT00743652|62758858|FG002|Overall Study|Parent/Legal Guardian Request|2|||
33379760|NCT00743652|62758859|FG003|Overall Study|Parent/Legal Guardian Request|2|||
33487667|NCT03818399|62865901|FG000|Overall Study|Withdrawal by Subject|1|||
33487668|NCT03818399|62865901|FG000|Overall Study|Protocol Violation|2|||
33379761|NCT00743652|62758860|FG004|Overall Study|Parent/Legal Guardian Request|0|||
33379762|NCT00743652|62758856|FG000|Overall Study|Adverse Event|3|||
33379763|NCT00743652|62758857|FG001|Overall Study|Adverse Event|0|||
33379764|NCT00743652|62758858|FG002|Overall Study|Adverse Event|0|||
33379765|NCT00743652|62758859|FG003|Overall Study|Adverse Event|0|||
33487669|NCT03642873|62865905|FG000|Third Intervention (1 Day)|Screen failure|0|||
33292945|NCT01194154|62669489|FG000|Overall Study|Protocol Violation|0|||
33292946|NCT01194154|62669490|FG001|Overall Study|Protocol Violation|1|||
33379766|NCT00743652|62758860|FG004|Overall Study|Adverse Event|0|||
33379767|NCT00743652|62758856|FG000|Overall Study|Death|2|||
33379768|NCT00743652|62758857|FG001|Overall Study|Death|0|||
33379769|NCT00743652|62758858|FG002|Overall Study|Death|0|||
33379770|NCT00743652|62758859|FG003|Overall Study|Death|0|||
33379771|NCT00743652|62758860|FG004|Overall Study|Death|0|||
33379772|NCT00743652|62758856|FG000|Overall Study|Investigator Request|0|||
33379773|NCT00743652|62758857|FG001|Overall Study|Investigator Request|0|||
33379774|NCT00743652|62758858|FG002|Overall Study|Investigator Request|0|||
33379775|NCT00743652|62758859|FG003|Overall Study|Investigator Request|2|||
33379776|NCT00743652|62758860|FG004|Overall Study|Investigator Request|0|||
33379777|NCT00743652|62758856|FG000|Overall Study|Other|1|||
33379778|NCT00743652|62758857|FG001|Overall Study|Other|1|||
33379779|NCT00743652|62758858|FG002|Overall Study|Other|0|||
33379780|NCT00743652|62758859|FG003|Overall Study|Other|0|||
33487670|NCT03642873|62865906|FG001|Third Intervention (1 Day)|Screen failure|0|||
33487671|NCT03642873|62865907|FG002|Third Intervention (1 Day)|Screen failure|0|||
33487672|NCT03642873|62865908|FG003|Third Intervention (1 Day)|Screen failure|0|||
33487673|NCT03642873|62865909|FG004|Third Intervention (1 Day)|Screen failure|1|||
33487674|NCT03642873|62865910|FG005|Third Intervention (1 Day)|Screen failure|0|||
33487675|NCT03818321|62865924|FG000|Overall Study|Withdrawal by Subject|1|||
33487676|NCT03818321|62865925|FG001|Overall Study|Withdrawal by Subject|2|||
33487677|NCT03616977|62865931|FG000|Period 1|Physician Decision|0|||
33487678|NCT03616977|62865932|FG001|Period 1|Physician Decision|1|||
33487679|NCT03616977|62865931|FG000|Period 3|Adverse Event|1|||
33556592|NCT01369355|62949448|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
33556593|NCT01369355|62949449|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
33556594|NCT01369355|62949450|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
33556595|NCT01369355|62949451|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
33556596|NCT01369355|62949452|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
33556597|NCT01369355|62949453|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
33556598|NCT01369355|62949454|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
33556599|NCT01369355|62949446|FG000|Long-term Extension (Week 44-272)|Other|0|||
33556600|NCT01369355|62949447|FG001|Long-term Extension (Week 44-272)|Other|0|||
33556601|NCT01369355|62949448|FG002|Long-term Extension (Week 44-272)|Other|0|||
33556602|NCT01369355|62949449|FG003|Long-term Extension (Week 44-272)|Other|0|||
33556603|NCT01369355|62949450|FG004|Long-term Extension (Week 44-272)|Other|0|||
33556604|NCT01369355|62949451|FG005|Long-term Extension (Week 44-272)|Other|0|||
33556605|NCT01369355|62949452|FG006|Long-term Extension (Week 44-272)|Other|110|||
33556606|NCT01369355|62949453|FG007|Long-term Extension (Week 44-272)|Other|9|||
33556607|NCT01369355|62949454|FG008|Long-term Extension (Week 44-272)|Other|17|||
33556608|NCT02614196|62949477|FG000|Double Blind Treatment Phase|Adverse Event|8|||
33292947|NCT01194154|62669489|FG000|Overall Study|Withdrawal by Subject|5|||
33292948|NCT01194154|62669490|FG001|Overall Study|Withdrawal by Subject|6|||
33292949|NCT01194154|62669489|FG000|Overall Study|Blood pressure increase|5|||
33292950|NCT01194154|62669490|FG001|Overall Study|Blood pressure increase|3|||
33292951|NCT01194154|62669489|FG000|Overall Study|Hemoglobin decrease|0|||
33292952|NCT01194154|62669490|FG001|Overall Study|Hemoglobin decrease|1|||
33292953|NCT01194154|62669489|FG000|Overall Study|Hemoglobin increase|12|||
33292954|NCT01194154|62669490|FG001|Overall Study|Hemoglobin increase|3|||
33292955|NCT01194154|62669489|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
33292956|NCT01194154|62669490|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
33292957|NCT01194154|62669489|FG000|Overall Study|Treatment with prohibited medication|4|||
33292958|NCT01194154|62669490|FG001|Overall Study|Treatment with prohibited medication|5|||
33292959|NCT01194154|62669489|FG000|Overall Study|Other|4|||
33292960|NCT01194154|62669490|FG001|Overall Study|Other|0|||
33292961|NCT01194154|62669489|FG000|Overall Study|Did not receive study medication|2|||
33292962|NCT01194154|62669490|FG001|Overall Study|Did not receive study medication|4|||
33292963|NCT05186311|62669516|FG000|Part A: Serum|Withdrawal by Subject|1|||
33379781|NCT00743652|62758860|FG004|Overall Study|Other|0|||
33379782|NCT00743652|62758856|FG000|Overall Study|Lost to Follow-up|1|||
33379783|NCT00743652|62758857|FG001|Overall Study|Lost to Follow-up|0|||
33379784|NCT00743652|62758858|FG002|Overall Study|Lost to Follow-up|0|||
33379785|NCT00743652|62758859|FG003|Overall Study|Lost to Follow-up|0|||
33487680|NCT03616977|62865932|FG001|Period 3|Adverse Event|1|||
33556609|NCT02614196|62949478|FG001|Double Blind Treatment Phase|Adverse Event|5|||
33556610|NCT02614196|62949479|FG002|Double Blind Treatment Phase|Adverse Event|9|||
33556611|NCT02614196|62949480|FG003|Double Blind Treatment Phase|Adverse Event|0|||
33292964|NCT05034731|62669523|FG000|Overall Study|Screen fail|1|||
33292965|NCT05034731|62669524|FG001|Overall Study|Screen fail|1|||
33292966|NCT04984993|62669534|FG000|Overall Study|Withdrawal by Subject|8|||
33292967|NCT04984993|62669535|FG001|Overall Study|Withdrawal by Subject|2|||
33292968|NCT04984993|62669534|FG000|Overall Study|Lost to Follow-up|2|||
33292969|NCT04984993|62669535|FG001|Overall Study|Lost to Follow-up|2|||
33292970|NCT04984993|62669534|FG000|Overall Study|Both patients moved to another country|4|||
33379786|NCT00743652|62758860|FG004|Overall Study|Lost to Follow-up|0|||
33379787|NCT00748215|62758878|FG000|Overall Study|Withdrawal by Subject|7|||
33379788|NCT00748215|62758879|FG001|Overall Study|Withdrawal by Subject|7|||
33379789|NCT00748215|62758878|FG000|Overall Study|Treatment change|2|||
33379790|NCT00748215|62758879|FG001|Overall Study|Treatment change|1|||
33379791|NCT00748215|62758878|FG000|Overall Study|Change in patient condition|0|||
33292971|NCT04984993|62669535|FG001|Overall Study|Both patients moved to another country|0|||
33292972|NCT04949802|62669540|FG000|Overall Study|Lost to Follow-up|4|||
33292981|NCT04880161|62669556|FG000|Overall Study|Withdrawal by Subject|1|||
33379792|NCT00748215|62758879|FG001|Overall Study|Change in patient condition|3|||
33379793|NCT00748215|62758878|FG000|Overall Study|Non-compliant|0|||
33379794|NCT00748215|62758879|FG001|Overall Study|Non-compliant|2|||
33379795|NCT00748215|62758878|FG000|Overall Study|Adverse Event|0|||
33379796|NCT00748215|62758879|FG001|Overall Study|Adverse Event|5|||
33379797|NCT00749892|62758885|FG000|Overall Study|Withdrawal by Subject|3|||
33379798|NCT00749580|62758891|FG000|Overall Study|Lost to Follow-up|4|||
33379799|NCT00749580|62758892|FG001|Overall Study|Lost to Follow-up|8|||
33379800|NCT00749580|62758891|FG000|Overall Study|Adverse Event|0|||
33379801|NCT00749580|62758892|FG001|Overall Study|Adverse Event|1|||
33379802|NCT00747006|62758901|FG000|Overall Study|Adverse Event|1|||
33379803|NCT00747006|62758902|FG001|Overall Study|Adverse Event|0|||
33379804|NCT00747006|62758903|FG002|Overall Study|Adverse Event|0|||
33379805|NCT00747006|62758901|FG000|Overall Study|Lost to Follow-up|0|||
33379806|NCT00747006|62758902|FG001|Overall Study|Lost to Follow-up|1|||
33379807|NCT00747006|62758903|FG002|Overall Study|Lost to Follow-up|0|||
33379808|NCT00747006|62758901|FG000|Overall Study|Physician Decision|2|||
33379809|NCT00747006|62758902|FG001|Overall Study|Physician Decision|0|||
33379810|NCT00747006|62758903|FG002|Overall Study|Physician Decision|1|||
33379811|NCT00743340|62758914|FG000|Overall Study|Study medication non-compliance|1|||
33379812|NCT00743340|62758914|FG000|Overall Study|Lost to Follow-up|1|||
33379813|NCT00743340|62758914|FG000|Overall Study|Withdrawal from the Study|5|||
33379814|NCT00743340|62758914|FG000|Overall Study|Protocol Violation|1|||
33379815|NCT00743340|62758914|FG000|Overall Study|Virologic failure|8|||
33379816|NCT00743340|62758914|FG000|Overall Study|Pregnancy|1|||
33379817|NCT00743340|62758914|FG000|Overall Study|Rolled over to other Gilead Study|23|||
33379818|NCT00743340|62758914|FG000|Overall Study|Participant Relocated|1|||
33379819|NCT00749190|62758925|FG000|Overall Study|Adverse Event|0|||
33379820|NCT00749190|62758926|FG001|Overall Study|Adverse Event|2|||
33379821|NCT00749190|62758927|FG002|Overall Study|Adverse Event|0|||
33379822|NCT00749190|62758928|FG003|Overall Study|Adverse Event|4|||
33379823|NCT00749190|62758929|FG004|Overall Study|Adverse Event|0|||
33379824|NCT00749190|62758930|FG005|Overall Study|Adverse Event|3|||
33379825|NCT00749190|62758931|FG006|Overall Study|Adverse Event|0|||
33379826|NCT00749190|62758925|FG000|Overall Study|Lack of Efficacy|3|||
33379827|NCT00749190|62758926|FG001|Overall Study|Lack of Efficacy|1|||
33379828|NCT00749190|62758927|FG002|Overall Study|Lack of Efficacy|1|||
33379829|NCT00749190|62758928|FG003|Overall Study|Lack of Efficacy|0|||
33379830|NCT00749190|62758929|FG004|Overall Study|Lack of Efficacy|0|||
33379831|NCT00749190|62758930|FG005|Overall Study|Lack of Efficacy|1|||
33556612|NCT02614196|62949481|FG004|Double Blind Treatment Phase|Adverse Event|0|||
33556613|NCT02614196|62949482|FG005|Double Blind Treatment Phase|Adverse Event|0|||
33292982|NCT04880161|62669557|FG001|Overall Study|Withdrawal by Subject|0|||
33379832|NCT00749190|62758931|FG006|Overall Study|Lack of Efficacy|0|||
33379833|NCT00749190|62758925|FG000|Overall Study|Withdrawal by Subject|2|||
33379834|NCT00749190|62758926|FG001|Overall Study|Withdrawal by Subject|1|||
33379835|NCT00749190|62758927|FG002|Overall Study|Withdrawal by Subject|0|||
33379836|NCT00749190|62758928|FG003|Overall Study|Withdrawal by Subject|0|||
33379837|NCT00749190|62758929|FG004|Overall Study|Withdrawal by Subject|0|||
33379838|NCT00749190|62758930|FG005|Overall Study|Withdrawal by Subject|1|||
33379839|NCT00749190|62758931|FG006|Overall Study|Withdrawal by Subject|0|||
33379840|NCT00749190|62758925|FG000|Overall Study|Protocol Violation|0|||
33379841|NCT00749190|62758926|FG001|Overall Study|Protocol Violation|1|||
33487681|NCT02767570|62865941|FG000|Overall Study|Lost to Follow-up|3|||
33487682|NCT02767570|62865942|FG001|Overall Study|Lost to Follow-up|0|||
33556614|NCT02614196|62949477|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
33292983|NCT04880161|62669556|FG000|Overall Study|Lack of Compliance|1|||
33292984|NCT04880161|62669557|FG001|Overall Study|Lack of Compliance|1|||
33379842|NCT00749190|62758927|FG002|Overall Study|Protocol Violation|0|||
33379843|NCT00749190|62758928|FG003|Overall Study|Protocol Violation|0|||
33379844|NCT00749190|62758929|FG004|Overall Study|Protocol Violation|0|||
33379845|NCT00749190|62758930|FG005|Overall Study|Protocol Violation|0|||
33379846|NCT00749190|62758931|FG006|Overall Study|Protocol Violation|1|||
33556615|NCT02614196|62949478|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
33556616|NCT02614196|62949479|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
33556617|NCT02614196|62949480|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
33556618|NCT02614196|62949481|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
33556619|NCT02614196|62949482|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
33556620|NCT02614196|62949477|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
33556621|NCT02614196|62949478|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
33379847|NCT00749190|62758925|FG000|Overall Study|Other reason not defined above|0|||
33379848|NCT00749190|62758926|FG001|Overall Study|Other reason not defined above|0|||
33379849|NCT00749190|62758927|FG002|Overall Study|Other reason not defined above|0|||
33379850|NCT00749190|62758928|FG003|Overall Study|Other reason not defined above|1|||
33379851|NCT00749190|62758929|FG004|Overall Study|Other reason not defined above|0|||
33379852|NCT00749190|62758930|FG005|Overall Study|Other reason not defined above|0|||
33379853|NCT00749190|62758931|FG006|Overall Study|Other reason not defined above|0|||
33379854|NCT00748566|62758952|FG000|Overall Study|Adverse Event|49|||
33379855|NCT00748566|62758952|FG000|Overall Study|Death|1|||
33379856|NCT00748566|62758952|FG000|Overall Study|Lack of Efficacy|12|||
33379857|NCT00748566|62758952|FG000|Overall Study|Lost to Follow-up|1|||
33379858|NCT00748566|62758952|FG000|Overall Study|Protocol Violation|13|||
33379859|NCT00748566|62758952|FG000|Overall Study|Withdrawal by Subject|22|||
33379860|NCT00748566|62758952|FG000|Overall Study|Study terminated by sponsor|5|||
33379861|NCT00748566|62758952|FG000|Overall Study|Other|9|||
33379862|NCT00743106|62758958|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
33292985|NCT04880161|62669556|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
33292986|NCT04880161|62669557|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
33292987|NCT04880161|62669556|FG000|Overall Study|Screen Failure|0|||
33292988|NCT04880161|62669557|FG001|Overall Study|Screen Failure|1|||
33292989|NCT04809220|62669565|FG000|Overall Study|Adverse Event|4|||
33292990|NCT04809220|62669566|FG001|Overall Study|Adverse Event|0|||
33292991|NCT04809220|62669565|FG000|Overall Study|Death|1|||
33292992|NCT04809220|62669566|FG001|Overall Study|Death|0|||
33292993|NCT04809220|62669565|FG000|Overall Study|Lost to Follow-up|3|||
33292994|NCT04809220|62669566|FG001|Overall Study|Lost to Follow-up|0|||
33292995|NCT04809220|62669565|FG000|Overall Study|Physician Decision|0|||
33292996|NCT04809220|62669566|FG001|Overall Study|Physician Decision|1|||
33292997|NCT04809220|62669565|FG000|Overall Study|Withdrawal by Subject|9|||
33292998|NCT04809220|62669566|FG001|Overall Study|Withdrawal by Subject|5|||
33292999|NCT04809220|62669565|FG000|Overall Study|Due to long-term overseas business trips|1|||
33293000|NCT04809220|62669566|FG001|Overall Study|Due to long-term overseas business trips|0|||
33293001|NCT04740827|62669575|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
33293002|NCT04740827|62669576|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
33293003|NCT04740827|62669575|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
33293004|NCT04740827|62669576|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
33293005|NCT04740827|62669575|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
33293006|NCT04740827|62669576|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
33293007|NCT04740827|62669575|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
33293008|NCT04740827|62669576|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
33293009|NCT04740827|62669575|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
33293010|NCT04740827|62669576|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
33293011|NCT04740827|62669575|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
33293012|NCT04740827|62669576|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
33379863|NCT00743106|62758959|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
33379864|NCT00738699|62758967|FG000|Overall Study|Withdrawal by Subject|5|||
33379865|NCT00738699|62758968|FG001|Overall Study|Withdrawal by Subject|0|||
33379866|NCT00738699|62758967|FG000|Overall Study|Lost to Follow-up|1|||
33379867|NCT00738699|62758968|FG001|Overall Study|Lost to Follow-up|0|||
33379868|NCT00738699|62758967|FG000|Overall Study|Death|144|||
33379869|NCT00738699|62758968|FG001|Overall Study|Death|68|||
33379870|NCT00738699|62758967|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
33379871|NCT00738699|62758968|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
33379872|NCT00738699|62758967|FG000|Overall Study|Other|2|||
33379873|NCT00738699|62758968|FG001|Overall Study|Other|0|||
33379874|NCT00814307|62758978|FG000|Overall Study|Randomized but not treated|1|||
33293013|NCT04725240|62669582|FG000|Overall Study|Adverse Event|2|||
33379875|NCT00814307|62758979|FG001|Overall Study|Randomized but not treated|0|||
33379876|NCT00814307|62758980|FG002|Overall Study|Randomized but not treated|0|||
33379877|NCT00814307|62758981|FG003|Overall Study|Randomized but not treated|0|||
33379878|NCT00814307|62758978|FG000|Overall Study|Adverse Event|3|||
33293014|NCT04620746|62669597|FG000|Overall Study|Adverse Event|2|||
33293015|NCT04620746|62669598|FG001|Overall Study|Adverse Event|0|||
33293016|NCT04620746|62669597|FG000|Overall Study|Uniterpretable skin test|1|||
33293017|NCT04620746|62669598|FG001|Overall Study|Uniterpretable skin test|0|||
33293018|NCT04620746|62669597|FG000|Overall Study|Withdrawal by Subject|0|||
33293019|NCT04620746|62669598|FG001|Overall Study|Withdrawal by Subject|1|||
33379879|NCT00814307|62758979|FG001|Overall Study|Adverse Event|9|||
33379880|NCT00814307|62758980|FG002|Overall Study|Adverse Event|3|||
33293020|NCT04524858|62669629|FG000|Overall Study|Adverse Event|1|||
33293021|NCT04464265|62669633|FG000|Overall Study|Physician Decision|2|||
33293022|NCT04380857|62669646|FG000|Overall Study|Lost to Follow-up|3|||
33379881|NCT00814307|62758981|FG003|Overall Study|Adverse Event|2|||
33379882|NCT00814307|62758978|FG000|Overall Study|Lack of Efficacy|1|||
33379883|NCT00814307|62758979|FG001|Overall Study|Lack of Efficacy|1|||
33293023|NCT04380857|62669647|FG001|Overall Study|Lost to Follow-up|3|||
33379884|NCT00814307|62758980|FG002|Overall Study|Lack of Efficacy|3|||
33379885|NCT00814307|62758981|FG003|Overall Study|Lack of Efficacy|4|||
33379886|NCT00814307|62758978|FG000|Overall Study|Other|1|||
33379887|NCT00814307|62758979|FG001|Overall Study|Other|2|||
33379888|NCT00814307|62758980|FG002|Overall Study|Other|0|||
33379889|NCT00814307|62758981|FG003|Overall Study|Other|1|||
33379890|NCT00814307|62758978|FG000|Overall Study|Protocol Violation|2|||
33379891|NCT00814307|62758979|FG001|Overall Study|Protocol Violation|8|||
33293024|NCT04326231|62669654|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
33293025|NCT04275336|62669661|FG000|Overall Study|First venipuncture failed|4|||
33293026|NCT04275336|62669662|FG001|Overall Study|First venipuncture failed|6|||
33293027|NCT04275336|62669663|FG002|Overall Study|First venipuncture failed|5|||
33293028|NCT04275336|62669661|FG000|Overall Study|Unscheduled venipuncture|9|||
33293029|NCT04275336|62669662|FG001|Overall Study|Unscheduled venipuncture|13|||
33293030|NCT04275336|62669663|FG002|Overall Study|Unscheduled venipuncture|7|||
33293031|NCT04275336|62669661|FG000|Overall Study|Failed specimen of saliva|4|||
33293032|NCT04275336|62669662|FG001|Overall Study|Failed specimen of saliva|3|||
33379892|NCT00814307|62758980|FG002|Overall Study|Protocol Violation|1|||
33379893|NCT00814307|62758981|FG003|Overall Study|Protocol Violation|1|||
33379894|NCT00814307|62758978|FG000|Overall Study|Withdrawal by Subject|4|||
33379895|NCT00814307|62758979|FG001|Overall Study|Withdrawal by Subject|6|||
33379896|NCT00814307|62758980|FG002|Overall Study|Withdrawal by Subject|0|||
33379897|NCT00814307|62758981|FG003|Overall Study|Withdrawal by Subject|2|||
33379898|NCT00814307|62758978|FG000|Overall Study|Death|0|||
33379899|NCT00814307|62758979|FG001|Overall Study|Death|1|||
33379900|NCT00814307|62758980|FG002|Overall Study|Death|0|||
33379901|NCT00814307|62758981|FG003|Overall Study|Death|0|||
33379902|NCT00748098|62758993|FG000|First Treatment Intervention Period|Adverse Event|1|||
33379903|NCT00748098|62758994|FG001|First Treatment Intervention Period|Adverse Event|1|||
33379904|NCT00748098|62758993|FG000|First Treatment Intervention Period|Protocol Violation|1|||
33379905|NCT00748098|62758994|FG001|First Treatment Intervention Period|Protocol Violation|0|||
33379906|NCT00748098|62758993|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
33379907|NCT00748098|62758994|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
33379908|NCT00748098|62758993|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
33379909|NCT00748098|62758994|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
33379910|NCT00748098|62758993|FG000|First Taper Period|Protocol Violation|1|||
33379911|NCT00748098|62758994|FG001|First Taper Period|Protocol Violation|0|||
33379912|NCT00748098|62758993|FG000|First Taper Period|Withdrawal by Subject|2|||
33379913|NCT00748098|62758994|FG001|First Taper Period|Withdrawal by Subject|0|||
33293033|NCT04275336|62669663|FG002|Overall Study|Failed specimen of saliva|4|||
33293034|NCT04251910|62669689|FG000|Overall Study|Covid 19 lockdown|0|||
33293035|NCT04251910|62669690|FG001|Overall Study|Covid 19 lockdown|5|||
33293036|NCT04251910|62669691|FG002|Overall Study|Covid 19 lockdown|0|||
33293037|NCT04251910|62669692|FG003|Overall Study|Covid 19 lockdown|4|||
33379914|NCT00748098|62758993|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
33379915|NCT00748098|62758994|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
33379916|NCT00748098|62758993|FG000|1-Week Washout Period|Adverse Event|0|||
33487683|NCT02767570|62865941|FG000|Overall Study|COVID shutdown|2|||
33487684|NCT02767570|62865942|FG001|Overall Study|COVID shutdown|5|||
33487685|NCT02767570|62865941|FG000|Overall Study|Increased pain|2|||
33487686|NCT02767570|62865942|FG001|Overall Study|Increased pain|0|||
33487687|NCT02767570|62865941|FG000|Overall Study|Withdrawal by Subject|1|||
33487688|NCT02767570|62865942|FG001|Overall Study|Withdrawal by Subject|3|||
33487689|NCT02767570|62865941|FG000|Overall Study|Unrelated medical issue|1|||
33487690|NCT02767570|62865942|FG001|Overall Study|Unrelated medical issue|1|||
33487691|NCT02767570|62865941|FG000|Overall Study|Received intra-articular injection|0|||
33487692|NCT02767570|62865942|FG001|Overall Study|Received intra-articular injection|1|||
33487693|NCT03816761|62865951|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
33487694|NCT03816761|62865952|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
33487695|NCT03816761|62865953|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
33487696|NCT03816761|62865954|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
33293038|NCT04251910|62669693|FG004|Overall Study|Covid 19 lockdown|0|||
33379917|NCT00748098|62758994|FG001|1-Week Washout Period|Adverse Event|1|||
33487697|NCT03816761|62865955|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
33487698|NCT03816761|62865956|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
33293039|NCT04251910|62669694|FG005|Overall Study|Covid 19 lockdown|0|||
33293040|NCT04251910|62669689|FG000|Overall Study|Assisted living facility was closed|0|||
33293041|NCT04251910|62669690|FG001|Overall Study|Assisted living facility was closed|0|||
33379918|NCT00748098|62758993|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
33379919|NCT00748098|62758994|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
33379920|NCT00748098|62758993|FG000|Second Treatment Intervention Period|Adverse Event|4|||
33379921|NCT00748098|62758994|FG001|Second Treatment Intervention Period|Adverse Event|1|||
33379922|NCT00748098|62758993|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
33487699|NCT03816761|62865951|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
33487700|NCT03816761|62865952|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
33487701|NCT03816761|62865953|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
33487702|NCT03816761|62865954|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
33487703|NCT03816761|62865955|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
33487704|NCT03816761|62865956|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
33487705|NCT02770612|62865978|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
33487706|NCT03575871|62865985|FG000|Overall Study|Adverse Event|5|||
33487707|NCT03575871|62865986|FG001|Overall Study|Adverse Event|5|||
33487708|NCT03575871|62865987|FG002|Overall Study|Adverse Event|8|||
33379923|NCT00748098|62758994|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
33379924|NCT00748098|62758993|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
33379925|NCT00748098|62758994|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
33379926|NCT00813995|62759003|FG000|Overall Study|Clinical adverse event|9|||
33379927|NCT00813995|62759004|FG001|Overall Study|Clinical adverse event|3|||
33379928|NCT00813995|62759003|FG000|Overall Study|Laboratory adverse event|0|||
33379929|NCT00813995|62759004|FG001|Overall Study|Laboratory adverse event|2|||
33379930|NCT00813995|62759003|FG000|Overall Study|Lack of Efficacy|1|||
33487709|NCT03575871|62865985|FG000|Overall Study|Death|1|||
33487710|NCT03575871|62865986|FG001|Overall Study|Death|0|||
33293042|NCT04251910|62669691|FG002|Overall Study|Assisted living facility was closed|0|||
33293043|NCT04251910|62669692|FG003|Overall Study|Assisted living facility was closed|0|||
33293044|NCT04251910|62669693|FG004|Overall Study|Assisted living facility was closed|1|||
33293045|NCT04251910|62669694|FG005|Overall Study|Assisted living facility was closed|0|||
33293046|NCT04248491|62669713|FG000|Overall Study|Lost to Follow-up|1|||
33293047|NCT04248491|62669714|FG001|Overall Study|Lost to Follow-up|0|||
33293048|NCT04101318|62669728|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
33293049|NCT04101318|62669729|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
33293050|NCT04101318|62669728|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
33293051|NCT04101318|62669729|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
33293052|NCT04101318|62669728|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
33293053|NCT04101318|62669729|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
33293054|NCT04091672|62669737|FG000|Overall Study|Death|6|||
33293055|NCT04091672|62669738|FG001|Overall Study|Death|6|||
33293056|NCT04091672|62669737|FG000|Overall Study|Lost to Follow-up|7|||
33293057|NCT04091672|62669738|FG001|Overall Study|Lost to Follow-up|7|||
33293058|NCT04091672|62669737|FG000|Overall Study|Withdrawal by Subject|3|||
33293059|NCT04091672|62669738|FG001|Overall Study|Withdrawal by Subject|3|||
33293060|NCT04091672|62669737|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
33293061|NCT04091672|62669738|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
33293062|NCT04003389|62669754|FG000|Overall Study|Adverse Event|27|||
33293063|NCT04003389|62669755|FG001|Overall Study|Adverse Event|34|||
33293064|NCT04003389|62669756|FG002|Overall Study|Adverse Event|28|||
33293065|NCT04003389|62669754|FG000|Overall Study|Lost to Follow-up|39|||
33293066|NCT04003389|62669755|FG001|Overall Study|Lost to Follow-up|30|||
33293067|NCT04003389|62669756|FG002|Overall Study|Lost to Follow-up|33|||
33293068|NCT04003389|62669754|FG000|Overall Study|Protocol Violation|1|||
33379931|NCT00813995|62759004|FG001|Overall Study|Lack of Efficacy|0|||
33379932|NCT00813995|62759003|FG000|Overall Study|Lost to Follow-up|4|||
33379933|NCT00813995|62759004|FG001|Overall Study|Lost to Follow-up|2|||
33379934|NCT00813995|62759003|FG000|Overall Study|Other reason|2|||
33379935|NCT00813995|62759004|FG001|Overall Study|Other reason|2|||
33379936|NCT00813995|62759003|FG000|Overall Study|Protocol Violation|3|||
33379937|NCT00813995|62759004|FG001|Overall Study|Protocol Violation|2|||
33379938|NCT00813995|62759003|FG000|Overall Study|Subject moved|4|||
33379939|NCT00813995|62759004|FG001|Overall Study|Subject moved|0|||
33379940|NCT00813995|62759003|FG000|Overall Study|Withdrawal by Subject|0|||
33379941|NCT00813995|62759004|FG001|Overall Study|Withdrawal by Subject|5|||
33379942|NCT00737529|62759014|FG000|Overall Study|Disease Progression|95|||
33379943|NCT00737529|62759014|FG000|Overall Study|Adverse Event|24|||
33379944|NCT00737529|62759014|FG000|Overall Study|Withdrawal by Subject|5|||
33379945|NCT00737529|62759014|FG000|Overall Study|Death|4|||
33487711|NCT03575871|62865987|FG002|Overall Study|Death|0|||
33487712|NCT03575871|62865985|FG000|Overall Study|Lack of Efficacy|5|||
33487713|NCT03575871|62865986|FG001|Overall Study|Lack of Efficacy|4|||
33487714|NCT03575871|62865987|FG002|Overall Study|Lack of Efficacy|7|||
33662436|NCT01694771|63092957|FG001|Overall Study|Consent withdrawn|9|||
33487715|NCT03575871|62865985|FG000|Overall Study|Lost to Follow-up|1|||
33487716|NCT03575871|62865986|FG001|Overall Study|Lost to Follow-up|1|||
33487717|NCT03575871|62865987|FG002|Overall Study|Lost to Follow-up|1|||
33293069|NCT04003389|62669755|FG001|Overall Study|Protocol Violation|6|||
33293070|NCT04003389|62669756|FG002|Overall Study|Protocol Violation|5|||
33293071|NCT04003389|62669754|FG000|Overall Study|Withdrawal by Subject|119|||
33293072|NCT04003389|62669755|FG001|Overall Study|Withdrawal by Subject|79|||
33293073|NCT04003389|62669756|FG002|Overall Study|Withdrawal by Subject|85|||
33379946|NCT00737529|62759014|FG000|Overall Study|Protocol Violation|1|||
33293074|NCT04003389|62669754|FG000|Overall Study|Miscellaneous|14|||
33293075|NCT04003389|62669755|FG001|Overall Study|Miscellaneous|11|||
33293076|NCT04003389|62669756|FG002|Overall Study|Miscellaneous|14|||
33293077|NCT04003389|62669754|FG000|Overall Study|Participant did not receive study drug|1|||
33293078|NCT04003389|62669755|FG001|Overall Study|Participant did not receive study drug|0|||
33293079|NCT04003389|62669756|FG002|Overall Study|Participant did not receive study drug|0|||
33379947|NCT00737529|62759014|FG000|Overall Study|Other|4|||
33379948|NCT00813917|62759020|FG000|Overall Study|Adverse Event|0|||
33379949|NCT00813917|62759021|FG001|Overall Study|Adverse Event|1|||
33379950|NCT00813917|62759020|FG000|Overall Study|Withdrawal by Subject|3|||
33487718|NCT03575871|62865985|FG000|Overall Study|Protocol Deviation|1|||
33487719|NCT03575871|62865986|FG001|Overall Study|Protocol Deviation|1|||
33293080|NCT03960437|62669764|FG000|Overall Study|Removed by PI|4|||
33293081|NCT03960437|62669764|FG000|Overall Study|Lost to Follow-up|2|||
33293082|NCT03960437|62669764|FG000|Overall Study|Withdrawal by Subject|1|||
33293083|NCT03960437|62669764|FG000|Overall Study|Death|2|||
33293084|NCT03959488|62669773|FG000|Season 1|Other|6|||
33293085|NCT03959488|62669774|FG001|Season 1|Other|7|||
33293086|NCT03959488|62669775|FG002|Season 1|Other|0|||
33293087|NCT03959488|62669776|FG003|Season 1|Other|0|||
33293088|NCT03959488|62669777|FG004|Season 1|Other|0|||
33293089|NCT03959488|62669773|FG000|Season 1|Withdrawal by parent/guardian|43|||
33293090|NCT03959488|62669774|FG001|Season 1|Withdrawal by parent/guardian|28|||
33293091|NCT03959488|62669775|FG002|Season 1|Withdrawal by parent/guardian|0|||
33293092|NCT03959488|62669776|FG003|Season 1|Withdrawal by parent/guardian|0|||
33293093|NCT03959488|62669777|FG004|Season 1|Withdrawal by parent/guardian|0|||
33293094|NCT03959488|62669773|FG000|Season 1|Due to COVID-19 pandemic|2|||
33293095|NCT03959488|62669774|FG001|Season 1|Due to COVID-19 pandemic|3|||
33293096|NCT03959488|62669775|FG002|Season 1|Due to COVID-19 pandemic|0|||
33293097|NCT03959488|62669776|FG003|Season 1|Due to COVID-19 pandemic|0|||
33293098|NCT03959488|62669777|FG004|Season 1|Due to COVID-19 pandemic|0|||
33293099|NCT03959488|62669773|FG000|Season 1|Lost to Follow-up|17|||
33293100|NCT03959488|62669774|FG001|Season 1|Lost to Follow-up|7|||
33293101|NCT03959488|62669775|FG002|Season 1|Lost to Follow-up|0|||
33293102|NCT03959488|62669776|FG003|Season 1|Lost to Follow-up|0|||
33293103|NCT03959488|62669777|FG004|Season 1|Lost to Follow-up|0|||
33293104|NCT03959488|62669773|FG000|Season 1|Death|5|||
33293105|NCT03959488|62669774|FG001|Season 1|Death|1|||
33293106|NCT03959488|62669775|FG002|Season 1|Death|0|||
33293107|NCT03959488|62669776|FG003|Season 1|Death|0|||
33293108|NCT03959488|62669777|FG004|Season 1|Death|0|||
33293109|NCT03959488|62669773|FG000|Season 2|Other|0|||
33293110|NCT03959488|62669774|FG001|Season 2|Other|0|||
33293111|NCT03959488|62669775|FG002|Season 2|Other|2|||
33293112|NCT03959488|62669776|FG003|Season 2|Other|0|||
33293113|NCT03959488|62669777|FG004|Season 2|Other|0|||
33293114|NCT03959488|62669773|FG000|Season 2|Withdrawal by parent/guardian|0|||
33293115|NCT03959488|62669774|FG001|Season 2|Withdrawal by parent/guardian|0|||
33293116|NCT03959488|62669775|FG002|Season 2|Withdrawal by parent/guardian|3|||
33293117|NCT03959488|62669776|FG003|Season 2|Withdrawal by parent/guardian|1|||
33293118|NCT03959488|62669777|FG004|Season 2|Withdrawal by parent/guardian|1|||
33293119|NCT03959488|62669773|FG000|Season 2|Lost to Follow-up|0|||
33293120|NCT03959488|62669774|FG001|Season 2|Lost to Follow-up|0|||
33293121|NCT03959488|62669775|FG002|Season 2|Lost to Follow-up|1|||
33293122|NCT03959488|62669776|FG003|Season 2|Lost to Follow-up|0|||
33293123|NCT03959488|62669777|FG004|Season 2|Lost to Follow-up|1|||
33293124|NCT03880019|62669796|FG000|Overall Study|Competing disease|1|||
33293125|NCT03878134|62669800|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
33293126|NCT03847194|62669806|FG000|Overall Study|Lost to Follow-up|2|||
33293127|NCT03847194|62669807|FG001|Overall Study|Lost to Follow-up|5|||
33293128|NCT03847194|62669806|FG000|Overall Study|Withdrawal by Subject|1|||
33293129|NCT03847194|62669807|FG001|Overall Study|Withdrawal by Subject|2|||
33293130|NCT03847194|62669806|FG000|Overall Study|Death|0|||
33487720|NCT03575871|62865987|FG002|Overall Study|Protocol Deviation|1|||
33487721|NCT03575871|62865985|FG000|Overall Study|Withdrawal by Subject|6|||
33487722|NCT03575871|62865986|FG001|Overall Study|Withdrawal by Subject|1|||
33379951|NCT00813917|62759021|FG001|Overall Study|Withdrawal by Subject|4|||
33487723|NCT03575871|62865987|FG002|Overall Study|Withdrawal by Subject|9|||
33487724|NCT03575871|62865985|FG000|Overall Study|Other than specified|2|||
33293131|NCT03847194|62669807|FG001|Overall Study|Death|1|||
33293132|NCT03828747|62669815|FG000|Double-Blind Treatment Period|Adverse Event|6|||
33293133|NCT03828747|62669816|FG001|Double-Blind Treatment Period|Adverse Event|6|||
33293134|NCT03828747|62669815|FG000|Double-Blind Treatment Period|Death|1|||
33293135|NCT03828747|62669816|FG001|Double-Blind Treatment Period|Death|2|||
33293136|NCT03828747|62669815|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33293137|NCT03828747|62669816|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
33293138|NCT03828747|62669815|FG000|Double-Blind Treatment Period|Withdrawal by Subject|19|||
33293139|NCT03828747|62669816|FG001|Double-Blind Treatment Period|Withdrawal by Subject|21|||
33293140|NCT03828747|62669815|FG000|Double-Blind Treatment Period|Physician Decision|0|||
33293141|NCT03828747|62669816|FG001|Double-Blind Treatment Period|Physician Decision|3|||
33293142|NCT03828747|62669815|FG000|Double-Blind Treatment Period|Various reasons|5|||
33293143|NCT03828747|62669816|FG001|Double-Blind Treatment Period|Various reasons|3|||
33293144|NCT03828747|62669815|FG000|Open-Label Extension|Continuing on Study|77|||
33293145|NCT03828747|62669816|FG001|Open-Label Extension|Continuing on Study|72|||
33293146|NCT03828747|62669815|FG000|Open-Label Extension|Adverse Event|3|||
33293147|NCT03828747|62669816|FG001|Open-Label Extension|Adverse Event|4|||
33293148|NCT03828747|62669815|FG000|Open-Label Extension|Death|0|||
33293149|NCT03828747|62669816|FG001|Open-Label Extension|Death|2|||
33293150|NCT03828747|62669815|FG000|Open-Label Extension|Lost to Follow-up|4|||
33293151|NCT03828747|62669816|FG001|Open-Label Extension|Lost to Follow-up|0|||
33293152|NCT03828747|62669815|FG000|Open-Label Extension|Withdrawal by Subject|19|||
33293153|NCT03828747|62669816|FG001|Open-Label Extension|Withdrawal by Subject|16|||
33293154|NCT03828747|62669815|FG000|Open-Label Extension|Various reasons|1|||
33293155|NCT03828747|62669816|FG001|Open-Label Extension|Various reasons|1|||
33293156|NCT03816176|62669854|FG000|Overall Study|Miscellaneous|5|||
33293157|NCT03816176|62669854|FG000|Overall Study|Lack of Efficacy|4|||
33379952|NCT00813917|62759020|FG000|Overall Study|Lost to Follow-up|3|||
33379953|NCT00813917|62759021|FG001|Overall Study|Lost to Follow-up|1|||
33379954|NCT00737061|62759027|FG000|Waiting Period|Lost to Follow-up|6|||
33379955|NCT00737061|62759027|FG000|Waiting Period|Withdrawal by Subject|1|||
33379956|NCT00737061|62759027|FG000|Waiting Period|Bilateral placement failure|34|||
33379957|NCT00737061|62759027|FG000|Waiting Period|Deemed patent following HSG|26|||
33379958|NCT00737061|62759027|FG000|Waiting Period|Alternative contraception failure|3|||
33379959|NCT00737061|62759027|FG000|Waiting Period|Elected surgical tubal ligation|5|||
33379960|NCT00737061|62759027|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
33379961|NCT00737061|62759027|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
33379962|NCT00737061|62759027|FG000|1 Year Wearing Period|Discontinued reilance|3|||
33379963|NCT00737061|62759027|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
33293158|NCT03816176|62669854|FG000|Overall Study|Adverse Event|3|||
33293159|NCT03712098|62669866|FG000|Overall Study|Lost to Follow-up|3|||
33293160|NCT03712098|62669867|FG001|Overall Study|Lost to Follow-up|7|||
33293161|NCT03712098|62669866|FG000|Overall Study|Withdrawal by Subject|9|||
33293162|NCT03712098|62669867|FG001|Overall Study|Withdrawal by Subject|4|||
33293163|NCT03712098|62669866|FG000|Overall Study|Protocol Violation|2|||
33293164|NCT03712098|62669867|FG001|Overall Study|Protocol Violation|1|||
33293165|NCT03704688|62669879|FG000|Overall Study|Adverse Event|0|||
33293166|NCT03704688|62669880|FG001|Overall Study|Adverse Event|0|||
33293167|NCT03704688|62669881|FG002|Overall Study|Adverse Event|0|||
33293168|NCT03704688|62669882|FG003|Overall Study|Adverse Event|4|||
33293169|NCT03704688|62669883|FG004|Overall Study|Adverse Event|1|||
33293170|NCT03704688|62669884|FG005|Overall Study|Adverse Event|0|||
33293171|NCT03704688|62669879|FG000|Overall Study|Disease Progression|0|||
33293172|NCT03704688|62669880|FG001|Overall Study|Disease Progression|0|||
33293173|NCT03704688|62669881|FG002|Overall Study|Disease Progression|0|||
33293174|NCT03704688|62669882|FG003|Overall Study|Disease Progression|3|||
33293175|NCT03704688|62669883|FG004|Overall Study|Disease Progression|1|||
33293176|NCT03704688|62669884|FG005|Overall Study|Disease Progression|0|||
33293177|NCT03704688|62669879|FG000|Overall Study|Death|0|||
33293178|NCT03704688|62669880|FG001|Overall Study|Death|0|||
33293179|NCT03704688|62669881|FG002|Overall Study|Death|0|||
33293180|NCT03704688|62669882|FG003|Overall Study|Death|0|||
33293181|NCT03704688|62669883|FG004|Overall Study|Death|3|||
33293182|NCT03704688|62669884|FG005|Overall Study|Death|0|||
33293183|NCT03683394|62669901|FG000|Overall Study|Withdrawal by Subject|4|||
33293184|NCT03683394|62669902|FG001|Overall Study|Withdrawal by Subject|8|||
33293185|NCT03683394|62669901|FG000|Overall Study|Lost to Follow-up|7|||
33293186|NCT03683394|62669902|FG001|Overall Study|Lost to Follow-up|0|||
33293187|NCT03683394|62669901|FG000|Overall Study|Death|3|||
33293188|NCT03683394|62669902|FG001|Overall Study|Death|1|||
33293189|NCT03656510|62669914|FG000|Overall Study|Lost to Follow-up|1|||
33379964|NCT00585975|62759033|FG000|Overall Study|Withdrawal by Subject|3|||
33379965|NCT00585975|62759034|FG001|Overall Study|Withdrawal by Subject|3|||
33379966|NCT00585975|62759033|FG000|Overall Study|Lost to Follow-up|2|||
33487725|NCT03575871|62865986|FG001|Overall Study|Other than specified|2|||
33379967|NCT00585975|62759034|FG001|Overall Study|Lost to Follow-up|1|||
33379968|NCT00585975|62759033|FG000|Overall Study|Enrollment met/over-enrolled|10|||
33379969|NCT00585975|62759034|FG001|Overall Study|Enrollment met/over-enrolled|9|||
33379970|NCT00585585|62759040|FG000|Overall Study|Adverse Event|1|||
33487726|NCT03575871|62865987|FG002|Overall Study|Other than specified|0|||
33487727|NCT03642717|62865995|FG000|Overall Study|Lost to Follow-up|2|||
33379971|NCT00734097|62759044|FG000|Screening|Protocol Violation|12|||
33487728|NCT03642717|62865995|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
33293190|NCT03656510|62669915|FG001|Overall Study|Lost to Follow-up|0|||
33293191|NCT03656510|62669916|FG002|Overall Study|Lost to Follow-up|0|||
33293192|NCT03656510|62669917|FG003|Overall Study|Lost to Follow-up|0|||
33293193|NCT03656510|62669918|FG004|Overall Study|Lost to Follow-up|0|||
33293194|NCT03656510|62669919|FG005|Overall Study|Lost to Follow-up|0|||
33379972|NCT00734097|62759044|FG000|Screening|Withdrawal by Subject|5|||
33379973|NCT00734097|62759044|FG000|Screening|Lost to Follow-up|2|||
33379974|NCT00734097|62759044|FG000|Screening|Unconfirmed pregnancy|1|||
33379975|NCT00734097|62759044|FG000|Open Label|Lost to Follow-up|7|||
33379976|NCT00734097|62759044|FG000|Open Label|Withdrawal by Subject|5|||
33379977|NCT00734097|62759044|FG000|Open Label|Protocol Violation|4|||
33379978|NCT00819767|62759050|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33293195|NCT03656510|62669914|FG000|Overall Study|Withdrawal by Subject|1|||
33293196|NCT03656510|62669915|FG001|Overall Study|Withdrawal by Subject|1|||
33293197|NCT03656510|62669916|FG002|Overall Study|Withdrawal by Subject|0|||
33293198|NCT03656510|62669917|FG003|Overall Study|Withdrawal by Subject|1|||
33293199|NCT03656510|62669918|FG004|Overall Study|Withdrawal by Subject|0|||
33293200|NCT03656510|62669919|FG005|Overall Study|Withdrawal by Subject|0|||
33293201|NCT03539081|62669948|FG000|Overall Study|Withdrawal by Subject|2|||
33293202|NCT03539081|62669949|FG001|Overall Study|Withdrawal by Subject|3|||
33293203|NCT03539081|62669950|FG002|Overall Study|Withdrawal by Subject|0|||
33293204|NCT03539081|62669948|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
33293205|NCT03539081|62669949|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
33293206|NCT03539081|62669950|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
33293207|NCT03538626|62669969|FG000|Overall Study|Withdrawal by Subject|0|||
33293208|NCT03538626|62669970|FG001|Overall Study|Withdrawal by Subject|1|||
33293209|NCT03538626|62669971|FG002|Overall Study|Withdrawal by Subject|0|||
33293210|NCT03538626|62669972|FG003|Overall Study|Withdrawal by Subject|0|||
33293211|NCT03538626|62669973|FG004|Overall Study|Withdrawal by Subject|0|||
33293212|NCT03538626|62669974|FG005|Overall Study|Withdrawal by Subject|0|||
33293213|NCT03538626|62669975|FG006|Overall Study|Withdrawal by Subject|0|||
33293214|NCT03538626|62669976|FG007|Overall Study|Withdrawal by Subject|0|||
33293215|NCT03538626|62669969|FG000|Overall Study|Lost to Follow-up|0|||
33293216|NCT03538626|62669970|FG001|Overall Study|Lost to Follow-up|0|||
33293217|NCT03538626|62669971|FG002|Overall Study|Lost to Follow-up|0|||
33293218|NCT03538626|62669972|FG003|Overall Study|Lost to Follow-up|0|||
33293219|NCT03538626|62669973|FG004|Overall Study|Lost to Follow-up|0|||
33293220|NCT03538626|62669974|FG005|Overall Study|Lost to Follow-up|0|||
33293221|NCT03538626|62669975|FG006|Overall Study|Lost to Follow-up|1|||
33293222|NCT03538626|62669976|FG007|Overall Study|Lost to Follow-up|0|||
33293223|NCT03518203|62669994|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
33293224|NCT03518203|62669994|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
33293225|NCT03500172|62670008|FG000|Period 1: Baseline Randomization|Death|0|||
33293226|NCT03500172|62670009|FG001|Period 1: Baseline Randomization|Death|0|||
33293227|NCT03500172|62670010|FG002|Period 1: Baseline Randomization|Death|0|||
33293228|NCT03500172|62670011|FG003|Period 1: Baseline Randomization|Death|0|||
33293229|NCT03500172|62670012|FG004|Period 1: Baseline Randomization|Death|0|||
33293230|NCT03500172|62670013|FG005|Period 1: Baseline Randomization|Death|0|||
33293231|NCT03500172|62670014|FG006|Period 1: Baseline Randomization|Death|0|||
33293232|NCT03500172|62670015|FG007|Period 1: Baseline Randomization|Death|0|||
33293233|NCT03500172|62670016|FG008|Period 1: Baseline Randomization|Death|0|||
33293234|NCT03500172|62670017|FG009|Period 1: Baseline Randomization|Death|2|||
33293235|NCT03500172|62670018|FG010|Period 1: Baseline Randomization|Death|0|||
33379979|NCT00819767|62759051|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33379980|NCT00733005|62759059|FG000|Overall Study|Adverse Event|0|||
33379981|NCT00733005|62759060|FG001|Overall Study|Adverse Event|1|||
33379982|NCT00733005|62759059|FG000|Overall Study|Treatment Failure|0|||
33379983|NCT00733005|62759060|FG001|Overall Study|Treatment Failure|1|||
33379984|NCT00733005|62759059|FG000|Overall Study|Withdrawal by Subject|0|||
33379985|NCT00733005|62759060|FG001|Overall Study|Withdrawal by Subject|1|||
33379986|NCT00733005|62759059|FG000|Overall Study|Protocol Violation|2|||
33293236|NCT03500172|62670008|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
33293237|NCT03500172|62670009|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
33379987|NCT00733005|62759060|FG001|Overall Study|Protocol Violation|0|||
33379988|NCT00812981|62759068|FG000|Overall Study|Other|0|||
33379989|NCT00812981|62759069|FG001|Overall Study|Other|1|||
33379990|NCT00732615|62759077|FG000|Overall Study|Withdrawal by Subject|3|||
33379991|NCT00732615|62759078|FG001|Overall Study|Withdrawal by Subject|1|||
33379992|NCT00732615|62759077|FG000|Overall Study|Lost to Follow-up|0|||
33487729|NCT03642717|62865995|FG000|Overall Study|Taken study drug prior to contract date|3|||
33487730|NCT02766478|62866002|FG000|Overall Study|Withdrawal by Subject|1|||
33293238|NCT03500172|62670010|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
33293239|NCT03500172|62670011|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
33293240|NCT03500172|62670012|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
33379993|NCT00732615|62759078|FG001|Overall Study|Lost to Follow-up|1|||
33379994|NCT00732615|62759077|FG000|Overall Study|Adverse Event|0|||
33379995|NCT00732615|62759078|FG001|Overall Study|Adverse Event|2|||
33379996|NCT00732615|62759077|FG000|Overall Study|Physician Decision|3|||
33379997|NCT00732615|62759078|FG001|Overall Study|Physician Decision|0|||
33293241|NCT03500172|62670013|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
33293242|NCT03500172|62670014|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
33293243|NCT03500172|62670015|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
33379998|NCT00732615|62759077|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
33379999|NCT00732615|62759078|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
33380000|NCT00732381|62759087|FG000|Overall Study|Adverse Event|1|||
33380001|NCT00732381|62759088|FG001|Overall Study|Adverse Event|0|||
33380002|NCT00732381|62759087|FG000|Overall Study|Treatment Failure|1|||
33380003|NCT00732381|62759088|FG001|Overall Study|Treatment Failure|1|||
33293244|NCT03500172|62670016|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
33293245|NCT03500172|62670017|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
33293246|NCT03500172|62670018|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
33293247|NCT03500172|62670008|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
33293248|NCT03500172|62670009|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
33293249|NCT03500172|62670010|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
33293250|NCT03500172|62670011|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
33293251|NCT03500172|62670012|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
33293252|NCT03500172|62670013|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
33293253|NCT03500172|62670014|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
33293254|NCT03500172|62670015|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
33293255|NCT03500172|62670016|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
33293256|NCT03500172|62670017|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
33293257|NCT03500172|62670018|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
33293258|NCT03500172|62670008|FG000|Period 2: Re-Randomization|Death|0|||
33293259|NCT03500172|62670009|FG001|Period 2: Re-Randomization|Death|0|||
33293260|NCT03500172|62670010|FG002|Period 2: Re-Randomization|Death|0|||
33293261|NCT03500172|62670011|FG003|Period 2: Re-Randomization|Death|4|||
33380004|NCT00732303|62759094|FG000|Overall Study|Study Terminated|2|||
33380005|NCT00813761|62759100|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
33380006|NCT00813761|62759101|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
33380007|NCT00813761|62759102|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
33380008|NCT00813761|62759103|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
33380009|NCT00813761|62759100|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
33380010|NCT00813761|62759101|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
33380011|NCT00813761|62759102|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
33380012|NCT00813761|62759103|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
33380013|NCT00813761|62759100|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
33380014|NCT00813761|62759101|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
33380015|NCT00813761|62759102|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
33380016|NCT00813761|62759103|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
33380017|NCT00813761|62759100|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
33380018|NCT00813761|62759101|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
33380019|NCT00813761|62759102|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
33380020|NCT00813761|62759103|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
33380021|NCT00813761|62759100|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
33380022|NCT00813761|62759101|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
33380023|NCT00813761|62759102|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
33380024|NCT00813761|62759103|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
33380025|NCT00813761|62759100|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
33380026|NCT00813761|62759101|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
33380027|NCT00813761|62759102|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
33380028|NCT00813761|62759103|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
33380029|NCT00813761|62759100|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
33380030|NCT00813761|62759101|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
33380031|NCT00813761|62759102|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
33380032|NCT00813761|62759103|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
33380033|NCT00813761|62759100|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
33380034|NCT00813761|62759101|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
33380035|NCT00813761|62759102|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
33380036|NCT00813761|62759103|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
33556622|NCT02614196|62949479|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
33556623|NCT02614196|62949480|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
33293262|NCT03500172|62670012|FG004|Period 2: Re-Randomization|Death|2|||
33293263|NCT03500172|62670013|FG005|Period 2: Re-Randomization|Death|0|||
33293264|NCT03500172|62670014|FG006|Period 2: Re-Randomization|Death|5|||
33293265|NCT03500172|62670015|FG007|Period 2: Re-Randomization|Death|2|||
33380037|NCT00813761|62759100|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
33380038|NCT00813761|62759101|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
33380039|NCT00813761|62759102|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
33380040|NCT00813761|62759103|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
33380041|NCT00813761|62759100|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
33380042|NCT00813761|62759101|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
33380043|NCT00813761|62759102|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
33380044|NCT00813761|62759103|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
33380045|NCT00813761|62759100|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
33380046|NCT00813761|62759101|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
33380047|NCT00813761|62759102|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
33380048|NCT00813761|62759103|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
33380049|NCT00813761|62759100|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
33380050|NCT00813761|62759101|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
33380051|NCT00813761|62759102|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
33380052|NCT00813761|62759103|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
33380053|NCT00732069|62759119|FG000|Washout After First Study Drug|Adverse Event|1|||
33380054|NCT00732069|62759120|FG001|Washout After First Study Drug|Adverse Event|0|||
33380055|NCT00732069|62759121|FG002|Washout After First Study Drug|Adverse Event|0|||
33380056|NCT00732069|62759122|FG003|Washout After First Study Drug|Adverse Event|0|||
33380057|NCT00732069|62759123|FG004|Washout After First Study Drug|Adverse Event|0|||
33380058|NCT00732069|62759124|FG005|Washout After First Study Drug|Adverse Event|0|||
33380059|NCT00731679|62759134|FG000|Overall Study|Adverse Event|7|||
33380060|NCT00731679|62759135|FG001|Overall Study|Adverse Event|8|||
33380061|NCT00731679|62759134|FG000|Overall Study|Withdrawal by Subject|8|||
33380062|NCT00731679|62759135|FG001|Overall Study|Withdrawal by Subject|8|||
33380063|NCT00731679|62759134|FG000|Overall Study|Lost to Follow-up|7|||
33380064|NCT00731679|62759135|FG001|Overall Study|Lost to Follow-up|8|||
33380065|NCT00731679|62759134|FG000|Overall Study|Noncompliance|0|||
33380066|NCT00731679|62759135|FG001|Overall Study|Noncompliance|1|||
33380067|NCT00731679|62759134|FG000|Overall Study|Pregnancy|0|||
33380068|NCT00731679|62759135|FG001|Overall Study|Pregnancy|1|||
33380069|NCT00731133|62759141|FG000|Overall Study|Withdrawal by Subject|10|||
33380070|NCT00730275|62759149|FG000|Overall Study|Withdrawal by Subject|0|||
33380071|NCT00730275|62759150|FG001|Overall Study|Withdrawal by Subject|0|||
33380072|NCT00730275|62759151|FG002|Overall Study|Withdrawal by Subject|0|||
33380073|NCT00730275|62759152|FG003|Overall Study|Withdrawal by Subject|1|||
33380074|NCT00730041|62759170|FG000|Overall Study|Lost to Follow-up|0|||
33380075|NCT00730041|62759171|FG001|Overall Study|Lost to Follow-up|2|||
33380076|NCT00729651|62759179|FG000|Overall Study|Withdrawal by Subject|5|||
33380077|NCT00729651|62759180|FG001|Overall Study|Withdrawal by Subject|6|||
33380078|NCT00729651|62759179|FG000|Overall Study|Lost to Follow-up|5|||
33380079|NCT00729651|62759180|FG001|Overall Study|Lost to Follow-up|4|||
33380080|NCT00729651|62759179|FG000|Overall Study|Protocol Violation|0|||
33380081|NCT00729651|62759180|FG001|Overall Study|Protocol Violation|1|||
33380082|NCT00729651|62759179|FG000|Overall Study|Adverse Event|7|||
33380083|NCT00729651|62759180|FG001|Overall Study|Adverse Event|3|||
33380084|NCT00729651|62759179|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
33380085|NCT00729651|62759180|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
33380086|NCT00729651|62759179|FG000|Overall Study|Subject's private reason|2|||
33380087|NCT00729651|62759180|FG001|Overall Study|Subject's private reason|0|||
33380088|NCT00729183|62759188|FG000|Overall Study|Adverse Event|11|||
33380089|NCT00729183|62759189|FG001|Overall Study|Adverse Event|5|||
33380090|NCT00729183|62759188|FG000|Overall Study|Lack of Efficacy|0|||
33380091|NCT00729183|62759189|FG001|Overall Study|Lack of Efficacy|1|||
33380092|NCT00729183|62759188|FG000|Overall Study|Lost to Follow-up|3|||
33380093|NCT00729183|62759189|FG001|Overall Study|Lost to Follow-up|1|||
33380094|NCT00729183|62759188|FG000|Overall Study|Physician Decision|1|||
33380095|NCT00729183|62759189|FG001|Overall Study|Physician Decision|1|||
33380096|NCT00729183|62759188|FG000|Overall Study|Protocol Violation|1|||
33380097|NCT00729183|62759189|FG001|Overall Study|Protocol Violation|0|||
33380098|NCT00729183|62759188|FG000|Overall Study|Withdrawal by Subject|9|||
33380099|NCT00729183|62759189|FG001|Overall Study|Withdrawal by Subject|7|||
33380100|NCT00811733|62759197|FG000|Overall Study|Investigator Discretion|10|||
33380101|NCT00811733|62759198|FG001|Overall Study|Investigator Discretion|8|||
33380102|NCT00811733|62759197|FG000|Overall Study|Withdrawal by Subject|1|||
33487731|NCT02766478|62866003|FG001|Overall Study|Withdrawal by Subject|1|||
33487732|NCT02766400|62866011|FG000|Overall Study|Death|1|||
33380103|NCT00811733|62759198|FG001|Overall Study|Withdrawal by Subject|2|||
33380104|NCT00728949|62759206|FG000|Overall Study|Adverse Event|8|||
33380105|NCT00728949|62759207|FG001|Overall Study|Adverse Event|0|||
33380106|NCT00728949|62759206|FG000|Overall Study|Withdrawal by Subject|2|||
33380107|NCT00728949|62759207|FG001|Overall Study|Withdrawal by Subject|2|||
33487733|NCT02766400|62866012|FG001|Overall Study|Death|2|||
33487734|NCT02766400|62866011|FG000|Overall Study|Withdrawal by Subject|1|||
33487735|NCT02766400|62866012|FG001|Overall Study|Withdrawal by Subject|0|||
33380108|NCT00728949|62759206|FG000|Overall Study|Abnormal Lab Results|0|||
33380109|NCT00728949|62759207|FG001|Overall Study|Abnormal Lab Results|2|||
33487736|NCT00104650|62866021|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
33380110|NCT00728949|62759206|FG000|Overall Study|On treatment at cutoff date|1|||
33380111|NCT00728949|62759207|FG001|Overall Study|On treatment at cutoff date|0|||
33380112|NCT00728481|62759215|FG000|Overall Study|Withdrawal by Subject|0|||
33380113|NCT00728481|62759216|FG001|Overall Study|Withdrawal by Subject|1|||
33380114|NCT00728481|62759215|FG000|Overall Study|Adverse Event|0|||
33380115|NCT00728481|62759216|FG001|Overall Study|Adverse Event|1|||
33380116|NCT00728481|62759215|FG000|Overall Study|Study medication non-compliance|0|||
33380117|NCT00728481|62759216|FG001|Overall Study|Study medication non-compliance|2|||
33380118|NCT00728481|62759215|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
33293266|NCT03500172|62670016|FG008|Period 2: Re-Randomization|Death|0|||
33293267|NCT03500172|62670017|FG009|Period 2: Re-Randomization|Death|0|||
33293268|NCT03500172|62670018|FG010|Period 2: Re-Randomization|Death|0|||
33293269|NCT03470922|62670036|FG000|Overall Study|Death|107|||
33293270|NCT03470922|62670037|FG001|Overall Study|Death|118|||
33380119|NCT00728481|62759216|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
33380120|NCT00811655|62759222|FG000|Overall Study|Physician Decision|1|||
33380121|NCT00727311|62759226|FG000|Overall Study|Did not receive drug|316|||
33380122|NCT00727311|62759226|FG000|Overall Study|Missing end of therapy data|205|||
33380123|NCT00727311|62759226|FG000|Overall Study|Adverse Event|58|||
33380124|NCT00727311|62759226|FG000|Overall Study|Lack of Efficacy|242|||
33293271|NCT03470922|62670036|FG000|Overall Study|Lost to Follow-up|5|||
33293272|NCT03470922|62670037|FG001|Overall Study|Lost to Follow-up|5|||
33293273|NCT03470922|62670036|FG000|Overall Study|Participant Withdrew Consent|4|||
33293274|NCT03470922|62670037|FG001|Overall Study|Participant Withdrew Consent|9|||
33293275|NCT03470922|62670036|FG000|Overall Study|Other reasons|1|||
33293276|NCT03470922|62670037|FG001|Overall Study|Other reasons|0|||
33293277|NCT03470922|62670036|FG000|Overall Study|Not reported|1|||
33293278|NCT03470922|62670037|FG001|Overall Study|Not reported|0|||
33380125|NCT00727311|62759226|FG000|Overall Study|Lost to Follow-up|73|||
33380126|NCT00727311|62759226|FG000|Overall Study|Withdrawal by Subject|77|||
33380127|NCT00727311|62759226|FG000|Overall Study|Other|97|||
33380128|NCT00727311|62759226|FG000|Overall Study|Multiple reasons|39|||
33380129|NCT00726999|62759232|FG000|Overall Study|Physician Decision|0|||
33380130|NCT00726999|62759233|FG001|Overall Study|Physician Decision|1|||
33380131|NCT00726999|62759232|FG000|Overall Study|Withdrawal by Subject|2|||
33380132|NCT00726999|62759233|FG001|Overall Study|Withdrawal by Subject|0|||
33380133|NCT00726999|62759232|FG000|Overall Study|Protocol Violation|1|||
33380134|NCT00726999|62759233|FG001|Overall Study|Protocol Violation|0|||
33380135|NCT00585351|62759247|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
33380136|NCT00585351|62759248|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
33380137|NCT00585351|62759249|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
33380138|NCT00585351|62759250|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
33380139|NCT00585351|62759251|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
33380140|NCT00585351|62759252|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
33380141|NCT00585351|62759253|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
33380142|NCT00585351|62759254|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
33380143|NCT00585351|62759247|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
33380144|NCT00585351|62759248|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
33380145|NCT00585351|62759249|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
33380146|NCT00585351|62759250|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
33380147|NCT00585351|62759251|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
33380148|NCT00585351|62759252|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
33380149|NCT00585351|62759253|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
33380150|NCT00585351|62759254|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
33380151|NCT00585351|62759247|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
33380152|NCT00585351|62759248|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
33380153|NCT00585351|62759249|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
33380154|NCT00585351|62759250|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
33662437|NCT01694771|63092956|FG000|Overall Study|Other reasons|5|||
33293279|NCT03440814|62670045|FG000|Overall Study|Adverse Event|2|||
33380155|NCT00585351|62759251|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
33487737|NCT00104650|62866022|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
33487738|NCT00104650|62866023|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
33380156|NCT00585351|62759252|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
33380157|NCT00585351|62759253|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
33380158|NCT00585351|62759254|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
33487739|NCT00104650|62866021|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
33487740|NCT00104650|62866022|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
33662438|NCT01694771|63092957|FG001|Overall Study|Other reasons|6|||
33662439|NCT01582061|63092986|FG000|Overall Study|Lack of Efficacy|3|||
33662440|NCT01582061|63092987|FG001|Overall Study|Lack of Efficacy|23|||
33293280|NCT03440814|62670046|FG001|Overall Study|Adverse Event|1|||
33293281|NCT03440814|62670045|FG000|Overall Study|Lost to Follow-up|2|||
33293282|NCT03440814|62670046|FG001|Overall Study|Lost to Follow-up|0|||
33293283|NCT03440814|62670045|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
33293284|NCT03440814|62670046|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
33293285|NCT03427814|62670054|FG000|Overall Study|Withdrawal by Subject|4|||
33293286|NCT03427814|62670055|FG001|Overall Study|Withdrawal by Subject|4|||
33293287|NCT03427814|62670054|FG000|Overall Study|Lost to Follow-up|0|||
33380159|NCT00585351|62759247|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
33380160|NCT00585351|62759248|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
33380161|NCT00585351|62759249|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
33380162|NCT00585351|62759250|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
33380163|NCT00585351|62759251|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
33380164|NCT00585351|62759252|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
33487741|NCT00104650|62866023|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
33487742|NCT00104650|62866021|FG000|Treatment Period (25 Weeks)|Death|7|||
33380165|NCT00585351|62759253|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
33380166|NCT00585351|62759254|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
33380167|NCT00585351|62759247|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
33380168|NCT00585351|62759248|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
33380169|NCT00585351|62759249|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
33380170|NCT00585351|62759250|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
33380171|NCT00585351|62759251|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
33380172|NCT00585351|62759252|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
33380173|NCT00585351|62759253|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
33380174|NCT00585351|62759254|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
33380175|NCT00585351|62759247|FG000|Enrollment Period (Intervention)|Death|0|||
33380176|NCT00585351|62759248|FG001|Enrollment Period (Intervention)|Death|0|||
33380177|NCT00585351|62759249|FG002|Enrollment Period (Intervention)|Death|0|||
33380178|NCT00585351|62759250|FG003|Enrollment Period (Intervention)|Death|0|||
33380179|NCT00585351|62759251|FG004|Enrollment Period (Intervention)|Death|1|||
33380180|NCT00585351|62759252|FG005|Enrollment Period (Intervention)|Death|0|||
33380181|NCT00585351|62759253|FG006|Enrollment Period (Intervention)|Death|1|||
33380182|NCT00585351|62759254|FG007|Enrollment Period (Intervention)|Death|0|||
33380183|NCT00585351|62759247|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
33380184|NCT00585351|62759248|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
33380185|NCT00585351|62759249|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
33487743|NCT00104650|62866022|FG001|Treatment Period (25 Weeks)|Death|5|||
33487744|NCT00104650|62866023|FG002|Treatment Period (25 Weeks)|Death|6|||
33487745|NCT00104650|62866021|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
33487746|NCT00104650|62866022|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
33487747|NCT00104650|62866023|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
33487748|NCT00104650|62866021|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
33487749|NCT00104650|62866022|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
33487750|NCT00104650|62866023|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
33487751|NCT00104650|62866021|FG000|Treatment Period (25 Weeks)|Other|1|||
33487752|NCT00104650|62866022|FG001|Treatment Period (25 Weeks)|Other|0|||
33487753|NCT00104650|62866023|FG002|Treatment Period (25 Weeks)|Other|0|||
33487754|NCT00104650|62866021|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
33487755|NCT00104650|62866022|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
33487756|NCT00104650|62866023|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
33487757|NCT00104650|62866021|FG000|Follow-up Period|Physician Decision|1|||
33293288|NCT03427814|62670055|FG001|Overall Study|Lost to Follow-up|2|||
33293289|NCT03427814|62670054|FG000|Overall Study|Death|42|||
33293290|NCT03427814|62670055|FG001|Overall Study|Death|31|||
33293291|NCT03427814|62670054|FG000|Overall Study|Sponsor's Decision|1|||
33293292|NCT03427814|62670055|FG001|Overall Study|Sponsor's Decision|0|||
33293293|NCT03427814|62670054|FG000|Overall Study|Investigator's Decision|1|||
33293294|NCT03427814|62670055|FG001|Overall Study|Investigator's Decision|2|||
33293295|NCT03427814|62670054|FG000|Overall Study|Disease progression|1|||
33293296|NCT03427814|62670055|FG001|Overall Study|Disease progression|0|||
33293297|NCT03427814|62670054|FG000|Overall Study|Treatment Completed|0|||
33293298|NCT03427814|62670055|FG001|Overall Study|Treatment Completed|1|||
33293299|NCT03427814|62670054|FG000|Overall Study|Sponsor's Decision to End study|21|||
33293300|NCT03427814|62670055|FG001|Overall Study|Sponsor's Decision to End study|25|||
33293301|NCT03427814|62670054|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
33380186|NCT00585351|62759250|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
33380187|NCT00585351|62759251|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
33487758|NCT00104650|62866022|FG001|Follow-up Period|Physician Decision|1|||
33487759|NCT00104650|62866023|FG002|Follow-up Period|Physician Decision|0|||
33487760|NCT00104650|62866021|FG000|Follow-up Period|Adverse Event|1|||
33293302|NCT03427814|62670055|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
33293303|NCT03418493|62670072|FG000|Overall Study|Adverse Event|1|||
33293304|NCT03418493|62670073|FG001|Overall Study|Adverse Event|0|||
33380188|NCT00585351|62759252|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
33380189|NCT00585351|62759253|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
33380190|NCT00585351|62759254|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
33380191|NCT00726609|62759268|FG000|Overall Study|Adverse Event|10|||
33380192|NCT00726609|62759268|FG000|Overall Study|Withdrawal by Subject|2|||
33380193|NCT00726609|62759268|FG000|Overall Study|Lack of Efficacy|25|||
33380194|NCT00726609|62759268|FG000|Overall Study|Other|16|||
33380195|NCT00726609|62759268|FG000|Overall Study|Missing|42|||
33380196|NCT00726609|62759268|FG000|Overall Study|Other|3|||
33380197|NCT00726453|62759274|FG000|Primary Enrollment Group|Death|18|||
33380198|NCT00726453|62759275|FG001|Primary Enrollment Group|Death|0|||
33380199|NCT00726453|62759274|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
33380200|NCT00726453|62759275|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
33380201|NCT00726453|62759274|FG000|38 mm Length Group|Death|0|||
33380202|NCT00726453|62759275|FG001|38 mm Length Group|Death|3|||
33380203|NCT00726063|62759282|FG000|Overall Study|Adverse Event|9|||
33380204|NCT00726063|62759283|FG001|Overall Study|Adverse Event|7|||
33380205|NCT00808028|62759293|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
33380206|NCT00808028|62759294|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
33380207|NCT00808028|62759295|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
33380208|NCT00808028|62759296|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
33380209|NCT00808028|62759293|FG000|Stage 1 (6 Months)|Other|1|||
33380210|NCT00808028|62759294|FG001|Stage 1 (6 Months)|Other|0|||
33380211|NCT00808028|62759295|FG002|Stage 1 (6 Months)|Other|2|||
33380212|NCT00808028|62759296|FG003|Stage 1 (6 Months)|Other|4|||
33380213|NCT00808028|62759293|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
33380214|NCT00808028|62759294|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
33380215|NCT00808028|62759295|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
33380216|NCT00808028|62759296|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
33380217|NCT00808028|62759293|FG000|Stage 1 (6 Months)|Adverse Event|0|||
33380218|NCT00808028|62759294|FG001|Stage 1 (6 Months)|Adverse Event|0|||
33380219|NCT00808028|62759295|FG002|Stage 1 (6 Months)|Adverse Event|1|||
33380220|NCT00808028|62759296|FG003|Stage 1 (6 Months)|Adverse Event|2|||
33380221|NCT00808028|62759293|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
33380222|NCT00808028|62759294|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
33380223|NCT00808028|62759295|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
33380224|NCT00808028|62759296|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
33380225|NCT00808028|62759293|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
33380226|NCT00808028|62759294|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
33380227|NCT00808028|62759295|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
33380228|NCT00808028|62759296|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
33380229|NCT00808028|62759293|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
33380230|NCT00808028|62759294|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
33380231|NCT00808028|62759295|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
33380232|NCT00808028|62759296|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
33380233|NCT00808028|62759293|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
33380234|NCT00808028|62759294|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
33380235|NCT00808028|62759295|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
33380236|NCT00808028|62759296|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
33380237|NCT00808028|62759293|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
33380238|NCT00808028|62759294|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
33380239|NCT00808028|62759295|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
33380240|NCT00808028|62759296|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
33380241|NCT00808028|62759293|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
33380242|NCT00808028|62759294|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
33380243|NCT00808028|62759295|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
33380244|NCT00808028|62759296|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
33380245|NCT00808028|62759293|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
33380246|NCT00808028|62759294|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
33380247|NCT00808028|62759295|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
33380248|NCT00808028|62759296|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
33380249|NCT00808028|62759293|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
33380250|NCT00808028|62759294|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
33380251|NCT00808028|62759295|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
33380252|NCT00808028|62759296|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
33380253|NCT00808028|62759293|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
33380254|NCT00808028|62759294|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
33380255|NCT00808028|62759295|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
33380256|NCT00808028|62759296|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
33380257|NCT00808028|62759293|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
33380258|NCT00808028|62759294|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
33380259|NCT00808028|62759295|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
33380260|NCT00808028|62759296|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
33380261|NCT00808028|62759293|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
33293305|NCT03418493|62670074|FG002|Overall Study|Adverse Event|0|||
33293306|NCT03418493|62670075|FG003|Overall Study|Adverse Event|0|||
33293307|NCT03418493|62670076|FG004|Overall Study|Adverse Event|0|||
33293308|NCT03418493|62670077|FG005|Overall Study|Adverse Event|0|||
33293309|NCT03418493|62670078|FG006|Overall Study|Adverse Event|0|||
33293310|NCT03418493|62670079|FG007|Overall Study|Adverse Event|0|||
33293311|NCT03418493|62670080|FG008|Overall Study|Adverse Event|0|||
33293312|NCT03418493|62670081|FG009|Overall Study|Adverse Event|0|||
33293313|NCT03418493|62670082|FG010|Overall Study|Adverse Event|0|||
33293314|NCT03418493|62670072|FG000|Overall Study|Protocol Violation|0|||
33293315|NCT03418493|62670073|FG001|Overall Study|Protocol Violation|0|||
33380262|NCT00808028|62759294|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
33380263|NCT00808028|62759295|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
33380264|NCT00808028|62759296|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
33380265|NCT00809783|62759319|FG000|Overall Study|Death|1|||
33380266|NCT00809783|62759320|FG001|Overall Study|Death|0|||
33380267|NCT00809783|62759321|FG002|Overall Study|Death|0|||
33380268|NCT00809783|62759319|FG000|Overall Study|Adverse Event|34|||
33380269|NCT00809783|62759320|FG001|Overall Study|Adverse Event|52|||
33380270|NCT00809783|62759321|FG002|Overall Study|Adverse Event|71|||
33380271|NCT00809783|62759319|FG000|Overall Study|Lack of Efficacy|39|||
33380272|NCT00809783|62759320|FG001|Overall Study|Lack of Efficacy|52|||
33380273|NCT00809783|62759321|FG002|Overall Study|Lack of Efficacy|63|||
33380274|NCT00809783|62759319|FG000|Overall Study|Lost to Follow-up|0|||
33380275|NCT00809783|62759320|FG001|Overall Study|Lost to Follow-up|3|||
33380276|NCT00809783|62759321|FG002|Overall Study|Lost to Follow-up|4|||
33380277|NCT00809783|62759319|FG000|Overall Study|Withdrawal by Subject|47|||
33380278|NCT00809783|62759320|FG001|Overall Study|Withdrawal by Subject|72|||
33380279|NCT00809783|62759321|FG002|Overall Study|Withdrawal by Subject|64|||
33380280|NCT00809783|62759319|FG000|Overall Study|Protocol Violation|2|||
33380281|NCT00809783|62759320|FG001|Overall Study|Protocol Violation|6|||
33380282|NCT00809783|62759321|FG002|Overall Study|Protocol Violation|5|||
33380283|NCT00809783|62759319|FG000|Overall Study|Randomized, but not treated|3|||
33380284|NCT00809783|62759320|FG001|Overall Study|Randomized, but not treated|0|||
33380285|NCT00809783|62759321|FG002|Overall Study|Randomized, but not treated|2|||
33380286|NCT00809783|62759319|FG000|Overall Study|Study Terminated by Sponsor|378|||
33380287|NCT00809783|62759320|FG001|Overall Study|Study Terminated by Sponsor|626|||
33380288|NCT00809783|62759321|FG002|Overall Study|Study Terminated by Sponsor|565|||
33380289|NCT00809783|62759319|FG000|Overall Study|Other|21|||
33380290|NCT00809783|62759320|FG001|Overall Study|Other|21|||
33380291|NCT00809783|62759321|FG002|Overall Study|Other|16|||
33380292|NCT00809471|62759332|FG000|Overall Study|Protocol non-compliance|15|||
33380293|NCT00809471|62759333|FG001|Overall Study|Protocol non-compliance|15|||
33380294|NCT00809471|62759334|FG002|Overall Study|Protocol non-compliance|6|||
33380295|NCT00809471|62759332|FG000|Overall Study|Lost to Follow-up|4|||
33380296|NCT00809471|62759333|FG001|Overall Study|Lost to Follow-up|2|||
33380297|NCT00809471|62759334|FG002|Overall Study|Lost to Follow-up|9|||
33380298|NCT00809471|62759332|FG000|Overall Study|Adverse Event|0|||
33380299|NCT00809471|62759333|FG001|Overall Study|Adverse Event|2|||
33380300|NCT00809471|62759334|FG002|Overall Study|Adverse Event|2|||
33380301|NCT00809471|62759332|FG000|Overall Study|Requirement for restricted medication|1|||
33380302|NCT00809471|62759333|FG001|Overall Study|Requirement for restricted medication|1|||
33380303|NCT00809471|62759334|FG002|Overall Study|Requirement for restricted medication|0|||
33380304|NCT00807248|62759346|FG000|Overall Study|Adverse Event|1|||
33487761|NCT00104650|62866022|FG001|Follow-up Period|Adverse Event|0|||
33487762|NCT00104650|62866023|FG002|Follow-up Period|Adverse Event|1|||
33380305|NCT00807248|62759347|FG001|Overall Study|Adverse Event|2|||
33380306|NCT00807248|62759348|FG002|Overall Study|Adverse Event|2|||
33380307|NCT00807248|62759349|FG003|Overall Study|Adverse Event|6|||
33380308|NCT00807248|62759346|FG000|Overall Study|Lack of Efficacy|14|||
33380309|NCT00807248|62759347|FG001|Overall Study|Lack of Efficacy|4|||
33380310|NCT00807248|62759348|FG002|Overall Study|Lack of Efficacy|8|||
33380311|NCT00807248|62759349|FG003|Overall Study|Lack of Efficacy|3|||
33487763|NCT00104650|62866021|FG000|Follow-up Period|Withdrawal by Subject|0|||
33487764|NCT00104650|62866022|FG001|Follow-up Period|Withdrawal by Subject|3|||
33487765|NCT00104650|62866023|FG002|Follow-up Period|Withdrawal by Subject|3|||
33487766|NCT00104650|62866021|FG000|Follow-up Period|Death|6|||
33487767|NCT00104650|62866022|FG001|Follow-up Period|Death|6|||
33380312|NCT00807248|62759346|FG000|Overall Study|Protocol Violation|0|||
33380313|NCT00807248|62759347|FG001|Overall Study|Protocol Violation|1|||
33293316|NCT03418493|62670074|FG002|Overall Study|Protocol Violation|0|||
33293317|NCT03418493|62670075|FG003|Overall Study|Protocol Violation|0|||
33293318|NCT03418493|62670076|FG004|Overall Study|Protocol Violation|0|||
33380314|NCT00807248|62759348|FG002|Overall Study|Protocol Violation|1|||
33380315|NCT00807248|62759349|FG003|Overall Study|Protocol Violation|0|||
33380316|NCT00807248|62759346|FG000|Overall Study|Withdrawal of Consent|5|||
33380317|NCT00807248|62759347|FG001|Overall Study|Withdrawal of Consent|5|||
33487768|NCT00104650|62866023|FG002|Follow-up Period|Death|4|||
33380318|NCT00807248|62759348|FG002|Overall Study|Withdrawal of Consent|5|||
33380319|NCT00807248|62759349|FG003|Overall Study|Withdrawal of Consent|5|||
33380320|NCT00807248|62759346|FG000|Overall Study|Lost to Follow-up|1|||
33380321|NCT00807248|62759347|FG001|Overall Study|Lost to Follow-up|0|||
33380322|NCT00807248|62759348|FG002|Overall Study|Lost to Follow-up|0|||
33380323|NCT00807248|62759349|FG003|Overall Study|Lost to Follow-up|0|||
33380324|NCT00807248|62759346|FG000|Overall Study|Other Reason|0|||
33380325|NCT00807248|62759347|FG001|Overall Study|Other Reason|0|||
33380326|NCT00807248|62759348|FG002|Overall Study|Other Reason|2|||
33380327|NCT00807248|62759349|FG003|Overall Study|Other Reason|0|||
33380328|NCT00589628|62759361|FG000|Overall Study|Lost to Follow-up|0|||
33380329|NCT00589628|62759362|FG001|Overall Study|Lost to Follow-up|1|||
33380330|NCT00588848|62759370|FG000|Overall Study|Physician Decision|0|||
33380331|NCT00588848|62759371|FG001|Overall Study|Physician Decision|3|||
33380332|NCT00797108|62759382|FG000|Overall Study|Adverse Event|1|||
33380333|NCT00797108|62759383|FG001|Overall Study|Adverse Event|0|||
33380334|NCT00797108|62759384|FG002|Overall Study|Adverse Event|3|||
33380335|NCT00797108|62759382|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
33487769|NCT00104650|62866021|FG000|Follow-up Period|Disease progression|3|||
33487770|NCT00104650|62866022|FG001|Follow-up Period|Disease progression|1|||
33487771|NCT00104650|62866023|FG002|Follow-up Period|Disease progression|0|||
33487772|NCT00104650|62866021|FG000|Follow-up Period|Lost to Follow-up|0|||
33487773|NCT00104650|62866022|FG001|Follow-up Period|Lost to Follow-up|1|||
33487774|NCT00104650|62866023|FG002|Follow-up Period|Lost to Follow-up|2|||
33380336|NCT00797108|62759383|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
33380337|NCT00797108|62759384|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
33380338|NCT00797108|62759382|FG000|Overall Study|Global Deterioration of Health Status|0|||
33380339|NCT00797108|62759383|FG001|Overall Study|Global Deterioration of Health Status|1|||
33380340|NCT00797108|62759384|FG002|Overall Study|Global Deterioration of Health Status|0|||
33380341|NCT00797108|62759382|FG000|Overall Study|Lack of Efficacy|1|||
33380342|NCT00797108|62759383|FG001|Overall Study|Lack of Efficacy|0|||
33380343|NCT00797108|62759384|FG002|Overall Study|Lack of Efficacy|1|||
33380344|NCT00797108|62759382|FG000|Overall Study|Other|0|||
33380345|NCT00797108|62759383|FG001|Overall Study|Other|0|||
33380346|NCT00797108|62759384|FG002|Overall Study|Other|2|||
33380347|NCT00797108|62759382|FG000|Overall Study|Randomized but not Treated|2|||
33380348|NCT00797108|62759383|FG001|Overall Study|Randomized but not Treated|0|||
33380349|NCT00797108|62759384|FG002|Overall Study|Randomized but not Treated|0|||
33380350|NCT00742560|62759397|FG000|Overall Study|Adverse Event|0|||
33380351|NCT00742560|62759398|FG001|Overall Study|Adverse Event|0|||
33380352|NCT00742560|62759399|FG002|Overall Study|Adverse Event|1|||
33380353|NCT00742560|62759400|FG003|Overall Study|Adverse Event|1|||
33487775|NCT00104650|62866021|FG000|Follow-up Period|Other|0|||
33487776|NCT00104650|62866022|FG001|Follow-up Period|Other|1|||
33487777|NCT00104650|62866023|FG002|Follow-up Period|Other|0|||
33487778|NCT03732807|62866038|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
33487779|NCT03732807|62866039|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
33487780|NCT03732807|62866040|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
33487781|NCT03732807|62866041|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
33487782|NCT03732807|62866042|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
33487783|NCT03732807|62866043|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
33487784|NCT03732807|62866044|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
33487785|NCT03732807|62866038|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
33487786|NCT03732807|62866039|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
33293319|NCT03418493|62670077|FG005|Overall Study|Protocol Violation|0|||
33293320|NCT03418493|62670078|FG006|Overall Study|Protocol Violation|0|||
33293321|NCT03418493|62670079|FG007|Overall Study|Protocol Violation|0|||
33293322|NCT03418493|62670080|FG008|Overall Study|Protocol Violation|0|||
33293323|NCT03418493|62670081|FG009|Overall Study|Protocol Violation|1|||
33293324|NCT03418493|62670082|FG010|Overall Study|Protocol Violation|0|||
33293325|NCT03383692|62670117|FG000|Overall Study|Progressive disease as per RECIST|3|||
33293326|NCT03383692|62670118|FG001|Overall Study|Progressive disease as per RECIST|3|||
33293327|NCT03383692|62670117|FG000|Overall Study|Clinical progression|0|||
33293328|NCT03383692|62670118|FG001|Overall Study|Clinical progression|1|||
33293329|NCT03383692|62670117|FG000|Overall Study|Adverse Event|3|||
33380354|NCT00742560|62759401|FG004|Overall Study|Adverse Event|1|||
33380355|NCT00742560|62759397|FG000|Overall Study|Death|0|||
33380356|NCT00742560|62759398|FG001|Overall Study|Death|2|||
33380357|NCT00742560|62759399|FG002|Overall Study|Death|0|||
33487787|NCT03732807|62866040|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
33487788|NCT03732807|62866041|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
33293330|NCT03383692|62670118|FG001|Overall Study|Adverse Event|0|||
33293331|NCT03368664|62670126|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
33380358|NCT00742560|62759400|FG003|Overall Study|Death|2|||
33380359|NCT00742560|62759401|FG004|Overall Study|Death|3|||
33380360|NCT00742560|62759397|FG000|Overall Study|Subject's Decision|1|||
33487789|NCT03732807|62866042|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
33380361|NCT00742560|62759398|FG001|Overall Study|Subject's Decision|0|||
33380362|NCT00742560|62759399|FG002|Overall Study|Subject's Decision|2|||
33380363|NCT00742560|62759400|FG003|Overall Study|Subject's Decision|3|||
33380364|NCT00742560|62759401|FG004|Overall Study|Subject's Decision|3|||
33380365|NCT00742560|62759397|FG000|Overall Study|Investigator's Decision|0|||
33380366|NCT00742560|62759398|FG001|Overall Study|Investigator's Decision|0|||
33380367|NCT00742560|62759399|FG002|Overall Study|Investigator's Decision|4|||
33380368|NCT00742560|62759400|FG003|Overall Study|Investigator's Decision|1|||
33380369|NCT00742560|62759401|FG004|Overall Study|Investigator's Decision|0|||
33380370|NCT00742560|62759397|FG000|Overall Study|Disease Progression|1|||
33380371|NCT00742560|62759398|FG001|Overall Study|Disease Progression|0|||
33380372|NCT00742560|62759399|FG002|Overall Study|Disease Progression|5|||
33380373|NCT00742560|62759400|FG003|Overall Study|Disease Progression|17|||
33380374|NCT00742560|62759401|FG004|Overall Study|Disease Progression|16|||
33380375|NCT00742560|62759397|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
33380376|NCT00742560|62759398|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
33380377|NCT00742560|62759399|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
33380378|NCT00742560|62759400|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
33380379|NCT00742560|62759401|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
33380380|NCT00742560|62759397|FG000|Overall Study|Other|0|||
33380381|NCT00742560|62759398|FG001|Overall Study|Other|1|||
33380382|NCT00742560|62759399|FG002|Overall Study|Other|8|||
33380383|NCT00742560|62759400|FG003|Overall Study|Other|9|||
33380384|NCT00742560|62759401|FG004|Overall Study|Other|9|||
33380385|NCT00742560|62759397|FG000|Overall Study|MIssing|0|||
33380386|NCT00742560|62759398|FG001|Overall Study|MIssing|0|||
33380387|NCT00742560|62759399|FG002|Overall Study|MIssing|0|||
33380388|NCT00742560|62759400|FG003|Overall Study|MIssing|0|||
33380389|NCT00742560|62759401|FG004|Overall Study|MIssing|1|||
33380390|NCT00740220|62759432|FG000|Overall Study|screen failures (non-COPD patients)|9|||
33380391|NCT00796718|62759436|FG000|Overall Study|Adverse Event|2|||
33380392|NCT00796718|62759436|FG000|Overall Study|Exclusion Criteria|1|||
33380393|NCT00796718|62759436|FG000|Overall Study|Lost to Follow-up|5|||
33380394|NCT00796718|62759436|FG000|Overall Study|Withdrawal by Informed Consent|1|||
33380395|NCT00809159|62759444|FG000|Part 1|Adverse Event|1|||
33380396|NCT00809159|62759445|FG001|Part 1|Adverse Event|1|||
33380397|NCT00809159|62759446|FG002|Part 1|Adverse Event|0|||
33380398|NCT00809159|62759447|FG003|Part 1|Adverse Event|0|||
33380399|NCT00809159|62759448|FG004|Part 1|Adverse Event|0|||
33293332|NCT03368664|62670126|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
33293333|NCT03368664|62670126|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
33293334|NCT03368664|62670126|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
33293335|NCT03343054|62670137|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
33293336|NCT03343054|62670138|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
33293337|NCT03343054|62670139|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
33293338|NCT03343054|62670137|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
33293339|NCT03343054|62670138|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
33293340|NCT03343054|62670139|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
33293341|NCT03343054|62670137|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
33293342|NCT03343054|62670138|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
33293343|NCT03343054|62670139|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
33293344|NCT03343054|62670137|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
33293345|NCT03343054|62670138|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
33293346|NCT03343054|62670139|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
33293347|NCT03330847|62670160|FG000|Overall Study|Patients ongoing study|62|||
33293348|NCT03330847|62670161|FG001|Overall Study|Patients ongoing study|65|||
33293349|NCT03330847|62670162|FG002|Overall Study|Patients ongoing study|15|||
33293350|NCT03309878|62670201|FG000|Overall Study|Adverse Event|1|||
33293351|NCT03309878|62670202|FG001|Overall Study|Adverse Event|0|||
33380400|NCT00809159|62759449|FG005|Part 1|Adverse Event|0|||
33380401|NCT00809159|62759444|FG000|Part 1|Lost to Follow-up|1|||
33380402|NCT00809159|62759445|FG001|Part 1|Lost to Follow-up|0|||
33380403|NCT00809159|62759446|FG002|Part 1|Lost to Follow-up|0|||
33380404|NCT00809159|62759447|FG003|Part 1|Lost to Follow-up|0|||
33380405|NCT00809159|62759448|FG004|Part 1|Lost to Follow-up|0|||
33380406|NCT00809159|62759449|FG005|Part 1|Lost to Follow-up|0|||
33293352|NCT03309878|62670203|FG002|Overall Study|Adverse Event|0|||
33293353|NCT03309878|62670204|FG003|Overall Study|Adverse Event|0|||
33380407|NCT00809159|62759444|FG000|Part 1|Withdrawal by Subject|3|||
33380408|NCT00809159|62759445|FG001|Part 1|Withdrawal by Subject|1|||
33380409|NCT00809159|62759446|FG002|Part 1|Withdrawal by Subject|0|||
33380410|NCT00809159|62759447|FG003|Part 1|Withdrawal by Subject|0|||
33380411|NCT00809159|62759448|FG004|Part 1|Withdrawal by Subject|0|||
33380412|NCT00809159|62759449|FG005|Part 1|Withdrawal by Subject|0|||
33380413|NCT00809159|62759444|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
33380414|NCT00809159|62759445|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
33380415|NCT00809159|62759446|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
33380416|NCT00809159|62759447|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
33380417|NCT00809159|62759448|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
33380418|NCT00809159|62759449|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
33380419|NCT00809159|62759444|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
33380420|NCT00809159|62759445|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
33380421|NCT00809159|62759446|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
33380422|NCT00809159|62759447|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
33380423|NCT00809159|62759448|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
33380424|NCT00809159|62759449|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
33380425|NCT00809159|62759444|FG000|Part 1 and 2|Administrative problems|0|||
33380426|NCT00809159|62759445|FG001|Part 1 and 2|Administrative problems|0|||
33380427|NCT00809159|62759446|FG002|Part 1 and 2|Administrative problems|0|||
33380428|NCT00809159|62759447|FG003|Part 1 and 2|Administrative problems|1|||
33380429|NCT00809159|62759448|FG004|Part 1 and 2|Administrative problems|0|||
33293354|NCT03309878|62670201|FG000|Overall Study|Did not maintain eligibility|2|||
33293355|NCT03309878|62670202|FG001|Overall Study|Did not maintain eligibility|1|||
33293356|NCT03309878|62670203|FG002|Overall Study|Did not maintain eligibility|0|||
33293357|NCT03309878|62670204|FG003|Overall Study|Did not maintain eligibility|0|||
33293358|NCT03309878|62670201|FG000|Overall Study|Withdrawal by Subject|0|||
33293359|NCT03309878|62670202|FG001|Overall Study|Withdrawal by Subject|1|||
33293360|NCT03309878|62670203|FG002|Overall Study|Withdrawal by Subject|0|||
33380430|NCT00809159|62759449|FG005|Part 1 and 2|Administrative problems|0|||
33380431|NCT00809159|62759444|FG000|Part 1 and 2|Adverse Event|0|||
33380432|NCT00809159|62759445|FG001|Part 1 and 2|Adverse Event|0|||
33380433|NCT00809159|62759446|FG002|Part 1 and 2|Adverse Event|1|||
33380434|NCT00809159|62759447|FG003|Part 1 and 2|Adverse Event|0|||
33380435|NCT00809159|62759448|FG004|Part 1 and 2|Adverse Event|1|||
33380436|NCT00809159|62759449|FG005|Part 1 and 2|Adverse Event|1|||
33380437|NCT00809159|62759444|FG000|Part 1 and 2|Lost to Follow-up|0|||
33380438|NCT00809159|62759445|FG001|Part 1 and 2|Lost to Follow-up|0|||
33380439|NCT00809159|62759446|FG002|Part 1 and 2|Lost to Follow-up|1|||
33380440|NCT00809159|62759447|FG003|Part 1 and 2|Lost to Follow-up|1|||
33380441|NCT00809159|62759448|FG004|Part 1 and 2|Lost to Follow-up|0|||
33380442|NCT00809159|62759449|FG005|Part 1 and 2|Lost to Follow-up|0|||
33380443|NCT00809159|62759444|FG000|Part 1 and 2|Withdrawal by Subject|0|||
33380444|NCT00809159|62759445|FG001|Part 1 and 2|Withdrawal by Subject|0|||
33380445|NCT00809159|62759446|FG002|Part 1 and 2|Withdrawal by Subject|4|||
33380446|NCT00809159|62759447|FG003|Part 1 and 2|Withdrawal by Subject|0|||
33380447|NCT00809159|62759448|FG004|Part 1 and 2|Withdrawal by Subject|0|||
33380448|NCT00809159|62759449|FG005|Part 1 and 2|Withdrawal by Subject|1|||
33380449|NCT00745368|62759463|FG000|Overall Study|Unable to provide sample|3|||
33380450|NCT00589472|62759467|FG000|Overall Study|Adverse Event|1|||
33380451|NCT00811577|62759473|FG000|Overall Study|Lost to Follow-up|7|||
33380452|NCT00811577|62759474|FG001|Overall Study|Lost to Follow-up|1|||
33380453|NCT00811577|62759473|FG000|Overall Study|Withdrawal by Subject|3|||
33380454|NCT00811577|62759474|FG001|Overall Study|Withdrawal by Subject|0|||
33380455|NCT00802178|62759523|FG000|Overall Study|Lack of Efficacy|36|||
33380456|NCT00802178|62759523|FG000|Overall Study|Insufficient tolerability (IT)|17|||
33380457|NCT00802178|62759523|FG000|Overall Study|Withdrawal by Subject|18|||
33380458|NCT00802178|62759523|FG000|Overall Study|Other|32|||
33380459|NCT00802178|62759523|FG000|Overall Study|Lack of efficacy and patient wish|1|||
33380460|NCT00802178|62759523|FG000|Overall Study|IT and patient wish|8|||
33380461|NCT00802178|62759523|FG000|Overall Study|Patients wish and other reason|1|||
33380462|NCT00744978|62759529|FG000|Period 1|Lost to Follow-up|1|||
33380463|NCT00744978|62759530|FG001|Period 1|Lost to Follow-up|0|||
33380464|NCT00744978|62759529|FG000|Period 1|Withdrawal by Subject|0|||
33380465|NCT00744978|62759530|FG001|Period 1|Withdrawal by Subject|2|||
33380466|NCT00744978|62759529|FG000|Period 1|Other|0|||
33487790|NCT03732807|62866043|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
33487791|NCT03732807|62866044|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
33293361|NCT03309878|62670204|FG003|Overall Study|Withdrawal by Subject|0|||
33293362|NCT03218826|62670223|FG000|Overall Study|Non-compliance with protocol|1|||
33293363|NCT03218826|62670224|FG001|Overall Study|Non-compliance with protocol|0|||
33293364|NCT03218826|62670225|FG002|Overall Study|Non-compliance with protocol|2|||
33293365|NCT03218826|62670226|FG003|Overall Study|Non-compliance with protocol|1|||
33293366|NCT03218826|62670227|FG004|Overall Study|Non-compliance with protocol|1|||
33293367|NCT03200704|62670243|FG000|Overall Study|Withdrawal by Subject|1|||
33293368|NCT03176472|62670249|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
33293369|NCT03176472|62670250|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
33293370|NCT03176472|62670249|FG000|Double Blind Treatment Period|Adverse Event|0|||
33380467|NCT00744978|62759530|FG001|Period 1|Other|2|||
33380468|NCT00744978|62759529|FG000|Period 1|Adverse Event|4|||
33380469|NCT00744978|62759530|FG001|Period 1|Adverse Event|0|||
33380470|NCT00744978|62759529|FG000|Period 1|Randomized but not Treated|1|||
33380471|NCT00744978|62759530|FG001|Period 1|Randomized but not Treated|1|||
33293371|NCT03176472|62670250|FG001|Double Blind Treatment Period|Adverse Event|5|||
33293372|NCT03176472|62670249|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
33293373|NCT03176472|62670250|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
33293374|NCT03176472|62670249|FG000|Double Blind Treatment Period|Physician Decision|0|||
33293375|NCT03176472|62670250|FG001|Double Blind Treatment Period|Physician Decision|1|||
33293376|NCT03176472|62670249|FG000|Double Blind Treatment Period|Protocol Violation|1|||
33293377|NCT03176472|62670250|FG001|Double Blind Treatment Period|Protocol Violation|0|||
33293378|NCT03176472|62670249|FG000|Double Blind Treatment Period|Not Provided|1|||
33293379|NCT03176472|62670250|FG001|Double Blind Treatment Period|Not Provided|0|||
33293380|NCT03176472|62670249|FG000|Open Label Extension|Withdrawal by Subject|3|||
33293381|NCT03176472|62670250|FG001|Open Label Extension|Withdrawal by Subject|4|||
33293382|NCT03176472|62670249|FG000|Open Label Extension|Adverse Event|2|||
33293383|NCT03176472|62670250|FG001|Open Label Extension|Adverse Event|4|||
33293384|NCT03176472|62670249|FG000|Open Label Extension|Lost to Follow-up|1|||
33293385|NCT03176472|62670250|FG001|Open Label Extension|Lost to Follow-up|2|||
33293386|NCT03176472|62670249|FG000|Open Label Extension|Protocol Violation|0|||
33293387|NCT03176472|62670250|FG001|Open Label Extension|Protocol Violation|1|||
33293388|NCT03176472|62670249|FG000|Open Label Extension|Not Provided|2|||
33293389|NCT03176472|62670250|FG001|Open Label Extension|Not Provided|1|||
33293390|NCT02903420|62670290|FG000|Overall Study|Death|3|||
33293391|NCT02873195|62670296|FG000|Overall Study|Ineligible|5|||
33293392|NCT02873195|62670297|FG001|Overall Study|Ineligible|0|||
33293393|NCT02831933|62670303|FG000|Overall Study|Physician Decision|11|||
33293394|NCT02813668|62670307|FG000|Overall Study|Death|4|||
33293395|NCT02813668|62670307|FG000|Overall Study|Lost to Follow-up|509|||
33293396|NCT02813668|62670307|FG000|Overall Study|Withdrawal by Subject|148|||
33293397|NCT02813668|62670307|FG000|Overall Study|No longer at worksite|85|||
33293398|NCT02813668|62670307|FG000|Overall Study|Medical reasons not related to the study|4|||
33293399|NCT02763566|62670319|FG000|Overall Study|Lost to Follow-up|1|||
33293400|NCT02763566|62670320|FG001|Overall Study|Lost to Follow-up|4|||
33293401|NCT02763566|62670321|FG002|Overall Study|Lost to Follow-up|0|||
33293402|NCT02763566|62670322|FG003|Overall Study|Lost to Follow-up|1|||
33293403|NCT02763566|62670319|FG000|Overall Study|On study treatment at study conclusion|114|||
33293404|NCT02763566|62670320|FG001|Overall Study|On study treatment at study conclusion|34|||
33293405|NCT02763566|62670321|FG002|Overall Study|On study treatment at study conclusion|54|||
33293406|NCT02763566|62670322|FG003|Overall Study|On study treatment at study conclusion|13|||
33293407|NCT02763566|62670319|FG000|Overall Study|Withdrawal by Subject|3|||
33293408|NCT02763566|62670320|FG001|Overall Study|Withdrawal by Subject|1|||
33293409|NCT02763566|62670321|FG002|Overall Study|Withdrawal by Subject|0|||
33293410|NCT02763566|62670322|FG003|Overall Study|Withdrawal by Subject|0|||
33293411|NCT02760433|62670341|FG000|Overall Study|Lost to Follow-up|1|||
33293412|NCT02760433|62670342|FG001|Overall Study|Lost to Follow-up|0|||
33293413|NCT02760433|62670343|FG002|Overall Study|Lost to Follow-up|1|||
33293414|NCT02760433|62670344|FG003|Overall Study|Lost to Follow-up|0|||
33293415|NCT02760433|62670345|FG004|Overall Study|Lost to Follow-up|0|||
33293416|NCT02760433|62670341|FG000|Overall Study|Withdrawal by Subject|23|||
33293417|NCT02760433|62670342|FG001|Overall Study|Withdrawal by Subject|9|||
33293418|NCT02760433|62670343|FG002|Overall Study|Withdrawal by Subject|0|||
33293419|NCT02760433|62670344|FG003|Overall Study|Withdrawal by Subject|2|||
33293420|NCT02760433|62670345|FG004|Overall Study|Withdrawal by Subject|9|||
33293421|NCT02760433|62670341|FG000|Overall Study|Lack of Response At Week 14|0|||
33293422|NCT02760433|62670342|FG001|Overall Study|Lack of Response At Week 14|0|||
33293423|NCT02760433|62670343|FG002|Overall Study|Lack of Response At Week 14|0|||
33293424|NCT02760433|62670344|FG003|Overall Study|Lack of Response At Week 14|0|||
33293425|NCT02760433|62670345|FG004|Overall Study|Lack of Response At Week 14|1|||
33293426|NCT02760433|62670341|FG000|Overall Study|Subject refused to continue the study|1|||
33293427|NCT02760433|62670342|FG001|Overall Study|Subject refused to continue the study|0|||
33293428|NCT02760433|62670343|FG002|Overall Study|Subject refused to continue the study|0|||
33293429|NCT02760433|62670344|FG003|Overall Study|Subject refused to continue the study|0|||
33293430|NCT02760433|62670345|FG004|Overall Study|Subject refused to continue the study|0|||
33293431|NCT02760433|62670341|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
33293432|NCT02760433|62670342|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
33293433|NCT02760433|62670343|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
33293434|NCT02760433|62670344|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
33293435|NCT02760433|62670345|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
33293436|NCT02760433|62670341|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
33293437|NCT02760433|62670342|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
33293438|NCT02760433|62670343|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
33380472|NCT00744978|62759529|FG000|Period 2|Adverse Event|0|||
33380473|NCT00744978|62759530|FG001|Period 2|Adverse Event|1|||
33380474|NCT00739908|62759538|FG000|Overall Study|Adverse Event|5|||
33293439|NCT02760433|62670344|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
33293440|NCT02760433|62670345|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
33293441|NCT02760407|62670365|FG000|Overall Study|Death|2|||
33293442|NCT02760407|62670366|FG001|Overall Study|Death|3|||
33293443|NCT02760407|62670367|FG002|Overall Study|Death|1|||
33293444|NCT02760407|62670368|FG003|Overall Study|Death|1|||
33293445|NCT02760407|62670365|FG000|Overall Study|Lost to Follow-up|1|||
33293446|NCT02760407|62670366|FG001|Overall Study|Lost to Follow-up|7|||
33293447|NCT02760407|62670367|FG002|Overall Study|Lost to Follow-up|4|||
33293448|NCT02760407|62670368|FG003|Overall Study|Lost to Follow-up|6|||
33293449|NCT02760407|62670365|FG000|Overall Study|Withdrawal by Subject|25|||
33293450|NCT02760407|62670366|FG001|Overall Study|Withdrawal by Subject|31|||
33293451|NCT02760407|62670367|FG002|Overall Study|Withdrawal by Subject|37|||
33293452|NCT02760407|62670368|FG003|Overall Study|Withdrawal by Subject|25|||
33293453|NCT02760407|62670365|FG000|Overall Study|Violation of Eligibility criteria|0|||
33293454|NCT02760407|62670366|FG001|Overall Study|Violation of Eligibility criteria|0|||
33293455|NCT02760407|62670367|FG002|Overall Study|Violation of Eligibility criteria|1|||
33293456|NCT02760407|62670368|FG003|Overall Study|Violation of Eligibility criteria|1|||
33293457|NCT02760407|62670365|FG000|Overall Study|Personal reasons|0|||
33293458|NCT02760407|62670366|FG001|Overall Study|Personal reasons|0|||
33293459|NCT02760407|62670367|FG002|Overall Study|Personal reasons|0|||
33293460|NCT02760407|62670368|FG003|Overall Study|Personal reasons|1|||
33293461|NCT02760407|62670365|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
33293462|NCT02760407|62670366|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
33293463|NCT02760407|62670367|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
33293464|NCT02760407|62670368|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
33293465|NCT02760407|62670365|FG000|Overall Study|Use of prohibited Medication|0|||
33293466|NCT02760407|62670366|FG001|Overall Study|Use of prohibited Medication|0|||
33293467|NCT02760407|62670367|FG002|Overall Study|Use of prohibited Medication|1|||
33293468|NCT02760407|62670368|FG003|Overall Study|Use of prohibited Medication|0|||
33293469|NCT02760407|62670365|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
33293470|NCT02760407|62670366|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
33293471|NCT02760407|62670367|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
33293472|NCT02760407|62670368|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
33380475|NCT00739908|62759539|FG001|Overall Study|Adverse Event|6|||
33380476|NCT00739908|62759538|FG000|Overall Study|Withdrawal by Subject|4|||
33380477|NCT00739908|62759539|FG001|Overall Study|Withdrawal by Subject|2|||
33380478|NCT00739908|62759538|FG000|Overall Study|Lost to Follow-up|14|||
33380479|NCT00739908|62759539|FG001|Overall Study|Lost to Follow-up|9|||
33380480|NCT00739908|62759538|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
33380481|NCT00739908|62759539|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
33380482|NCT00739908|62759538|FG000|Overall Study|Non-Compliance With Study Medication|0|||
33380483|NCT00739908|62759539|FG001|Overall Study|Non-Compliance With Study Medication|3|||
33380484|NCT00739908|62759538|FG000|Overall Study|Lack of Efficacy|0|||
33380485|NCT00739908|62759539|FG001|Overall Study|Lack of Efficacy|1|||
33380486|NCT00739908|62759538|FG000|Overall Study|Relocation|0|||
33380487|NCT00739908|62759539|FG001|Overall Study|Relocation|1|||
33380488|NCT00739596|62759549|FG000|Overall Study|Adverse Event|12|||
33380489|NCT00739596|62759550|FG001|Overall Study|Adverse Event|6|||
33380490|NCT00739596|62759549|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
33293473|NCT02760407|62670365|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
33293474|NCT02760407|62670366|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
33293475|NCT02760407|62670367|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
33380491|NCT00739596|62759550|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33380492|NCT00739596|62759549|FG000|Overall Study|Patient Withdrew Consent|8|||
33380493|NCT00739596|62759550|FG001|Overall Study|Patient Withdrew Consent|8|||
33380494|NCT00739596|62759549|FG000|Overall Study|Lost to Follow-up|0|||
33380495|NCT00739596|62759550|FG001|Overall Study|Lost to Follow-up|2|||
33380496|NCT00739596|62759549|FG000|Overall Study|Protocol Deviation|1|||
33380497|NCT00739596|62759550|FG001|Overall Study|Protocol Deviation|1|||
33380498|NCT00742326|62759558|FG000|Overall Study|Physician Decision|0|||
33380499|NCT00742326|62759559|FG001|Overall Study|Physician Decision|1|||
33380500|NCT00741936|62759567|FG000|Overall Study|Lost to Follow-up|1|||
33380501|NCT00741936|62759568|FG001|Overall Study|Lost to Follow-up|1|||
33662441|NCT01582061|63092986|FG000|Overall Study|Adverse Event|12|||
33380502|NCT00741936|62759567|FG000|Overall Study|Adverse Event|3|||
33380503|NCT00741936|62759568|FG001|Overall Study|Adverse Event|4|||
33380504|NCT00741936|62759567|FG000|Overall Study|Pregnancy|0|||
33380505|NCT00741936|62759568|FG001|Overall Study|Pregnancy|1|||
33380506|NCT00741936|62759567|FG000|Overall Study|Protocol Violation|2|||
33293476|NCT02760407|62670368|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
33293477|NCT02760407|62670365|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
33293478|NCT02760407|62670366|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
33293479|NCT02760407|62670367|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
33293480|NCT02760407|62670368|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
33293481|NCT02760407|62670365|FG000|Overall Study|Inadequately Enrolled|0|||
33293482|NCT02760407|62670366|FG001|Overall Study|Inadequately Enrolled|0|||
33293483|NCT02760407|62670367|FG002|Overall Study|Inadequately Enrolled|0|||
33293484|NCT02760407|62670368|FG003|Overall Study|Inadequately Enrolled|1|||
33293485|NCT02760407|62670365|FG000|Overall Study|Withdrawal By PI's Decision|0|||
33293486|NCT02760407|62670366|FG001|Overall Study|Withdrawal By PI's Decision|1|||
33293487|NCT02760407|62670367|FG002|Overall Study|Withdrawal By PI's Decision|0|||
33293488|NCT02760407|62670368|FG003|Overall Study|Withdrawal By PI's Decision|0|||
33293489|NCT02760407|62670365|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
33293490|NCT02760407|62670366|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
33293491|NCT02760407|62670367|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
33293492|NCT02760407|62670368|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
33293493|NCT02760407|62670365|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
33293494|NCT02760407|62670366|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
33293495|NCT02760407|62670367|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
33293496|NCT02760407|62670368|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
33293497|NCT02760407|62670365|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
33293498|NCT02760407|62670366|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
33380507|NCT00741936|62759568|FG001|Overall Study|Protocol Violation|0|||
33380508|NCT00741936|62759567|FG000|Overall Study|Lack of Efficacy|0|||
33380509|NCT00741936|62759568|FG001|Overall Study|Lack of Efficacy|2|||
33380510|NCT00741936|62759567|FG000|Overall Study|Low compliance|3|||
33380511|NCT00741936|62759568|FG001|Overall Study|Low compliance|0|||
33380512|NCT00811187|62759576|FG000|Overall Study|Unable to place device / procedure abort|3|||
33380513|NCT00811187|62759577|FG001|Overall Study|Unable to place device / procedure abort|3|||
33380514|NCT00591149|62759583|FG000|Overall Study|Adverse Event|4|||
33380515|NCT00591149|62759583|FG000|Overall Study|Withdrawal by Subject|1|||
33380516|NCT00735072|62759589|FG000|Overall Study|interrupted study med during ARV change|1|||
33380517|NCT00735072|62759590|FG001|Overall Study|interrupted study med during ARV change|0|||
33380518|NCT00735072|62759589|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
33380519|NCT00735072|62759590|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
33380520|NCT00810641|62759601|FG000|Overall Study|Withdrawal by Subject|0|||
33380521|NCT00810641|62759602|FG001|Overall Study|Withdrawal by Subject|1|||
33380522|NCT00810641|62759603|FG002|Overall Study|Withdrawal by Subject|2|||
33380523|NCT00793598|62759616|FG000|Overall Study|Patient Request|0|||
33380524|NCT00793598|62759617|FG001|Overall Study|Patient Request|1|||
33380525|NCT00793598|62759618|FG002|Overall Study|Patient Request|0|||
33380526|NCT00793598|62759619|FG003|Overall Study|Patient Request|0|||
33380527|NCT00793598|62759620|FG004|Overall Study|Patient Request|0|||
33380528|NCT00793598|62759621|FG005|Overall Study|Patient Request|0|||
33380529|NCT00793598|62759622|FG006|Overall Study|Patient Request|0|||
33556624|NCT02614196|62949481|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
33662442|NCT01582061|63092987|FG001|Overall Study|Adverse Event|8|||
33380530|NCT00793598|62759623|FG007|Overall Study|Patient Request|0|||
33380531|NCT00793598|62759616|FG000|Overall Study|Protocol Violation|0|||
33380532|NCT00793598|62759617|FG001|Overall Study|Protocol Violation|0|||
33380533|NCT00793598|62759618|FG002|Overall Study|Protocol Violation|0|||
33487792|NCT03732807|62866038|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
33487793|NCT03732807|62866039|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
33487794|NCT03732807|62866040|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
33487795|NCT03732807|62866041|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
33487796|NCT03732807|62866042|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
33487797|NCT03732807|62866043|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
33487798|NCT03732807|62866044|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
33487799|NCT03732807|62866038|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
33487800|NCT03732807|62866039|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
33487801|NCT03732807|62866040|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
33487802|NCT03732807|62866041|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
33487803|NCT03732807|62866042|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
33380534|NCT00793598|62759619|FG003|Overall Study|Protocol Violation|0|||
33380535|NCT00793598|62759620|FG004|Overall Study|Protocol Violation|0|||
33380536|NCT00793598|62759621|FG005|Overall Study|Protocol Violation|0|||
33556625|NCT02614196|62949482|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
33380537|NCT00793598|62759622|FG006|Overall Study|Protocol Violation|0|||
33380538|NCT00793598|62759623|FG007|Overall Study|Protocol Violation|1|||
33380539|NCT00793598|62759616|FG000|Overall Study|Subject not dosed|0|||
33380540|NCT00793598|62759617|FG001|Overall Study|Subject not dosed|0|||
33380541|NCT00793598|62759618|FG002|Overall Study|Subject not dosed|0|||
33380542|NCT00793598|62759619|FG003|Overall Study|Subject not dosed|0|||
33380543|NCT00793598|62759620|FG004|Overall Study|Subject not dosed|0|||
33380544|NCT00793598|62759621|FG005|Overall Study|Subject not dosed|1|||
33380545|NCT00793598|62759622|FG006|Overall Study|Subject not dosed|0|||
33380546|NCT00793598|62759623|FG007|Overall Study|Subject not dosed|0|||
33380547|NCT00796562|62759645|FG000|Overall Study|Death|49|||
33380548|NCT00801632|62759649|FG000|Overall Study|Re-transplant|1|||
33380549|NCT00806819|62759655|FG000|Overall Study|progressive disease (modified RECIST )|217|||
33380550|NCT00806819|62759656|FG001|Overall Study|progressive disease (modified RECIST )|216|||
33380551|NCT00806819|62759655|FG000|Overall Study|Worsening or AE of underlying disease|18|||
33380552|NCT00806819|62759656|FG001|Overall Study|Worsening or AE of underlying disease|25|||
33380553|NCT00806819|62759655|FG000|Overall Study|Other AE|38|||
33380554|NCT00806819|62759656|FG001|Overall Study|Other AE|40|||
33380555|NCT00806819|62759655|FG000|Overall Study|Protocol Violation|9|||
33380556|NCT00806819|62759656|FG001|Overall Study|Protocol Violation|4|||
33380557|NCT00806819|62759655|FG000|Overall Study|Lost to Follow-up|1|||
33380558|NCT00806819|62759656|FG001|Overall Study|Lost to Follow-up|0|||
33380559|NCT00806819|62759655|FG000|Overall Study|Withdrawal by Subject|32|||
33380560|NCT00806819|62759656|FG001|Overall Study|Withdrawal by Subject|29|||
33380561|NCT00806819|62759655|FG000|Overall Study|Not treated|6|||
33380562|NCT00806819|62759656|FG001|Overall Study|Not treated|3|||
33380563|NCT00806819|62759655|FG000|Overall Study|Reasons other than stated above|25|||
33380564|NCT00806819|62759656|FG001|Overall Study|Reasons other than stated above|41|||
33380565|NCT00801242|62759663|FG000|Overall Study|Adverse Event|10|||
33380566|NCT00801242|62759663|FG000|Overall Study|Withdrawal by Subject|13|||
33380567|NCT00801242|62759663|FG000|Overall Study|Protocol Violation|5|||
33380568|NCT00801242|62759663|FG000|Overall Study|Physician Decision|3|||
33380569|NCT00801242|62759663|FG000|Overall Study|Lost to Follow-up|1|||
33380570|NCT00801242|62759663|FG000|Overall Study|Miscellaneous reasons|20|||
33380571|NCT00800540|62759676|FG000|Period One: 6 Weeks|Noncompliance|1|||
33380572|NCT00800540|62759677|FG001|Period One: 6 Weeks|Noncompliance|0|||
33380573|NCT00800540|62759676|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
33380574|NCT00800540|62759677|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
33380575|NCT00800540|62759676|FG000|Period 2: 6 Weeks|Adverse Event|0|||
33380576|NCT00800540|62759677|FG001|Period 2: 6 Weeks|Adverse Event|1|||
33380577|NCT00800384|62759685|FG000|Overall Study|Withdrawal by Subject|24|||
33380578|NCT00800384|62759686|FG001|Overall Study|Withdrawal by Subject|17|||
33380579|NCT00800384|62759685|FG000|Overall Study|Lost to Follow-up|17|||
33380580|NCT00800384|62759686|FG001|Overall Study|Lost to Follow-up|26|||
33380581|NCT00796328|62759693|FG000|Overall Study|experienced hypotension requiring tx|6|||
33380582|NCT00588692|62759699|FG000|Overall Study|Withdrawal by Subject|4|||
33380583|NCT00588692|62759700|FG001|Overall Study|Withdrawal by Subject|2|||
33380584|NCT00588692|62759699|FG000|Overall Study|Hip Surgery|0|||
33380585|NCT00588692|62759700|FG001|Overall Study|Hip Surgery|1|||
33380586|NCT00588692|62759699|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
33380587|NCT00588692|62759700|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
33380588|NCT00588692|62759699|FG000|Overall Study|Cancer|1|||
33380589|NCT00588692|62759700|FG001|Overall Study|Cancer|0|||
33380590|NCT00588692|62759699|FG000|Overall Study|Death|1|||
33380591|NCT00588692|62759700|FG001|Overall Study|Death|0|||
33380592|NCT00588146|62759708|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
33380593|NCT00588146|62759709|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
33380594|NCT00795704|62759717|FG000|Overall Study|Withdrawal by Subject|3|||
33380595|NCT00795704|62759718|FG001|Overall Study|Withdrawal by Subject|2|||
33380596|NCT00795704|62759717|FG000|Overall Study|Adverse Event|1|||
33380597|NCT00795704|62759718|FG001|Overall Study|Adverse Event|1|||
33380598|NCT00444457|62759728|FG000|Infant Series|Other|0|||
33380599|NCT00444457|62759729|FG001|Infant Series|Other|1|||
33380600|NCT00444457|62759730|FG002|Infant Series|Other|0|||
33380601|NCT00444457|62759731|FG003|Infant Series|Other|0|||
33380602|NCT00444457|62759728|FG000|Infant Series|Parent or legal guardian request|18|||
33380603|NCT00444457|62759729|FG001|Infant Series|Parent or legal guardian request|29|||
33380604|NCT00444457|62759730|FG002|Infant Series|Parent or legal guardian request|34|||
33380605|NCT00444457|62759731|FG003|Infant Series|Parent or legal guardian request|14|||
33380606|NCT00444457|62759728|FG000|Infant Series|Lost to Follow-up|10|||
33380607|NCT00444457|62759729|FG001|Infant Series|Lost to Follow-up|11|||
33380608|NCT00444457|62759730|FG002|Infant Series|Lost to Follow-up|7|||
33380609|NCT00444457|62759731|FG003|Infant Series|Lost to Follow-up|6|||
33380610|NCT00444457|62759728|FG000|Infant Series|Protocol Violation|16|||
33380611|NCT00444457|62759729|FG001|Infant Series|Protocol Violation|8|||
33380612|NCT00444457|62759730|FG002|Infant Series|Protocol Violation|6|||
33380613|NCT00444457|62759731|FG003|Infant Series|Protocol Violation|3|||
33380614|NCT00444457|62759728|FG000|Infant Series|Failed to return|5|||
33380615|NCT00444457|62759729|FG001|Infant Series|Failed to return|4|||
33380616|NCT00444457|62759730|FG002|Infant Series|Failed to return|4|||
33293499|NCT02760407|62670367|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
33293500|NCT02760407|62670368|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
33293501|NCT02760407|62670365|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
33293502|NCT02760407|62670366|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
33293503|NCT02760407|62670367|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
33293504|NCT02760407|62670368|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
33293505|NCT02760407|62670365|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
33293506|NCT02760407|62670366|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
33293507|NCT02760407|62670367|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
33293508|NCT02760407|62670368|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
33293509|NCT02760407|62670365|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
33293510|NCT02760407|62670366|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
33293511|NCT02760407|62670367|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
33293512|NCT02760407|62670368|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
33380617|NCT00444457|62759731|FG003|Infant Series|Failed to return|2|||
33380618|NCT00444457|62759728|FG000|Infant Series|Investigator request|4|||
33380619|NCT00444457|62759729|FG001|Infant Series|Investigator request|3|||
33380620|NCT00444457|62759730|FG002|Infant Series|Investigator request|3|||
33380621|NCT00444457|62759731|FG003|Infant Series|Investigator request|2|||
33380622|NCT00444457|62759728|FG000|Infant Series|Other|0|||
33380623|NCT00444457|62759729|FG001|Infant Series|Other|2|||
33380624|NCT00444457|62759730|FG002|Infant Series|Other|4|||
33380625|NCT00444457|62759731|FG003|Infant Series|Other|0|||
33380626|NCT00444457|62759728|FG000|Infant Series|Adverse Event|1|||
33380627|NCT00444457|62759729|FG001|Infant Series|Adverse Event|2|||
33380628|NCT00444457|62759730|FG002|Infant Series|Adverse Event|2|||
33380629|NCT00444457|62759731|FG003|Infant Series|Adverse Event|0|||
33380630|NCT00444457|62759728|FG000|Infant Series|Death|0|||
33380631|NCT00444457|62759729|FG001|Infant Series|Death|1|||
33380632|NCT00444457|62759730|FG002|Infant Series|Death|1|||
33380633|NCT00444457|62759731|FG003|Infant Series|Death|1|||
33380634|NCT00444457|62759728|FG000|After Infant Series|Other|0|||
33380635|NCT00444457|62759729|FG001|After Infant Series|Other|1|||
33380636|NCT00444457|62759730|FG002|After Infant Series|Other|1|||
33380637|NCT00444457|62759731|FG003|After Infant Series|Other|1|||
33380638|NCT00444457|62759728|FG000|After Infant Series|Parent or legal guardian request|4|||
33380639|NCT00444457|62759729|FG001|After Infant Series|Parent or legal guardian request|11|||
33380640|NCT00444457|62759730|FG002|After Infant Series|Parent or legal guardian request|6|||
33487804|NCT03732807|62866043|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
33487805|NCT03732807|62866044|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
33487806|NCT03732807|62866038|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
33487807|NCT03732807|62866039|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
33487808|NCT03732807|62866040|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
33487809|NCT03732807|62866041|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
33487810|NCT03732807|62866042|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
33487811|NCT03732807|62866043|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
33487812|NCT03732807|62866044|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
33487813|NCT03732807|62866038|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
33487814|NCT03732807|62866039|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
33487815|NCT03732807|62866040|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
33380641|NCT00444457|62759731|FG003|After Infant Series|Parent or legal guardian request|3|||
33380642|NCT00444457|62759728|FG000|After Infant Series|Failed to return|7|||
33380643|NCT00444457|62759729|FG001|After Infant Series|Failed to return|6|||
33487816|NCT03732807|62866041|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
33487817|NCT03732807|62866042|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
33487818|NCT03732807|62866043|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
33487819|NCT03732807|62866044|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
33487820|NCT03732807|62866038|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
33662443|NCT01582061|63092986|FG000|Overall Study|Withdrawal by Subject|10|||
33662444|NCT01582061|63092987|FG001|Overall Study|Withdrawal by Subject|4|||
33293513|NCT02760407|62670365|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
33380644|NCT00444457|62759730|FG002|After Infant Series|Failed to return|5|||
33380645|NCT00444457|62759731|FG003|After Infant Series|Failed to return|1|||
33380646|NCT00444457|62759728|FG000|After Infant Series|Lost to Follow-up|5|||
33380647|NCT00444457|62759729|FG001|After Infant Series|Lost to Follow-up|5|||
33380648|NCT00444457|62759730|FG002|After Infant Series|Lost to Follow-up|5|||
33380649|NCT00444457|62759731|FG003|After Infant Series|Lost to Follow-up|2|||
33380650|NCT00444457|62759728|FG000|After Infant Series|Protocol Violation|2|||
33380651|NCT00444457|62759729|FG001|After Infant Series|Protocol Violation|4|||
33380652|NCT00444457|62759730|FG002|After Infant Series|Protocol Violation|2|||
33380653|NCT00444457|62759731|FG003|After Infant Series|Protocol Violation|2|||
33380654|NCT00444457|62759728|FG000|After Infant Series|Adverse Event|2|||
33380655|NCT00444457|62759729|FG001|After Infant Series|Adverse Event|2|||
33380656|NCT00444457|62759730|FG002|After Infant Series|Adverse Event|0|||
33380657|NCT00444457|62759731|FG003|After Infant Series|Adverse Event|0|||
33380658|NCT00444457|62759728|FG000|After Infant Series|Investigator request|0|||
33380659|NCT00444457|62759729|FG001|After Infant Series|Investigator request|0|||
33380660|NCT00444457|62759730|FG002|After Infant Series|Investigator request|0|||
33380661|NCT00444457|62759731|FG003|After Infant Series|Investigator request|1|||
33293514|NCT02760407|62670366|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
33293515|NCT02760407|62670367|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
33293516|NCT02760407|62670368|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
33293517|NCT02760407|62670365|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
33293518|NCT02760407|62670366|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
33293519|NCT02760407|62670367|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
33380662|NCT00444457|62759728|FG000|After Infant Series|Other|0|||
33380663|NCT00444457|62759729|FG001|After Infant Series|Other|1|||
33380664|NCT00444457|62759730|FG002|After Infant Series|Other|0|||
33380665|NCT00444457|62759731|FG003|After Infant Series|Other|0|||
33380666|NCT00444457|62759728|FG000|Toddler Dose|Lost to Follow-up|4|||
33293520|NCT02760407|62670368|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
33293521|NCT02760407|62670365|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
33380667|NCT00444457|62759729|FG001|Toddler Dose|Lost to Follow-up|1|||
33380668|NCT00444457|62759730|FG002|Toddler Dose|Lost to Follow-up|1|||
33380669|NCT00444457|62759731|FG003|Toddler Dose|Lost to Follow-up|3|||
33380670|NCT00444457|62759728|FG000|Toddler Dose|Failed to return|2|||
33380671|NCT00444457|62759729|FG001|Toddler Dose|Failed to return|2|||
33380672|NCT00444457|62759730|FG002|Toddler Dose|Failed to return|1|||
33380673|NCT00444457|62759731|FG003|Toddler Dose|Failed to return|3|||
33380674|NCT00444457|62759728|FG000|Toddler Dose|Parent or legal guardian request|0|||
33380675|NCT00444457|62759729|FG001|Toddler Dose|Parent or legal guardian request|3|||
33380676|NCT00444457|62759730|FG002|Toddler Dose|Parent or legal guardian request|2|||
33380677|NCT00444457|62759731|FG003|Toddler Dose|Parent or legal guardian request|1|||
33380678|NCT00444457|62759728|FG000|Toddler Dose|Protocol Violation|1|||
33380679|NCT00444457|62759729|FG001|Toddler Dose|Protocol Violation|0|||
33380680|NCT00444457|62759730|FG002|Toddler Dose|Protocol Violation|0|||
33380681|NCT00444457|62759731|FG003|Toddler Dose|Protocol Violation|1|||
33380682|NCT00799058|62759755|FG000|Overall Study|Withdrawal by Subject|2|||
33380683|NCT00799058|62759756|FG001|Overall Study|Withdrawal by Subject|2|||
33380684|NCT00799058|62759757|FG002|Overall Study|Withdrawal by Subject|2|||
33293522|NCT02760407|62670366|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
33293523|NCT02760407|62670367|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
33293524|NCT02760407|62670368|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
33293525|NCT02760368|62670384|FG000|Overall Study|Withdrawal by Subject|8|||
33293526|NCT02760368|62670385|FG001|Overall Study|Withdrawal by Subject|12|||
33293527|NCT02760368|62670386|FG002|Overall Study|Withdrawal by Subject|9|||
33293528|NCT02760368|62670384|FG000|Overall Study|Screen Failure|0|||
33293529|NCT02760368|62670385|FG001|Overall Study|Screen Failure|0|||
33293530|NCT02760368|62670386|FG002|Overall Study|Screen Failure|1|||
33293531|NCT02760368|62670384|FG000|Overall Study|Death|0|||
33380685|NCT00799058|62759755|FG000|Overall Study|Lost to Follow-up|1|||
33380686|NCT00799058|62759756|FG001|Overall Study|Lost to Follow-up|2|||
33380687|NCT00799058|62759757|FG002|Overall Study|Lost to Follow-up|1|||
33380688|NCT00799058|62759755|FG000|Overall Study|Adverse Event|0|||
33487821|NCT03732807|62866039|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
33662445|NCT01582061|63092986|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33662446|NCT01582061|63092987|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33293532|NCT02760368|62670385|FG001|Overall Study|Death|1|||
33293533|NCT02760368|62670386|FG002|Overall Study|Death|0|||
33293534|NCT02760368|62670384|FG000|Overall Study|Withdrawal by Sponsor|0|||
33293535|NCT02760368|62670385|FG001|Overall Study|Withdrawal by Sponsor|0|||
33293536|NCT02760368|62670386|FG002|Overall Study|Withdrawal by Sponsor|1|||
33293537|NCT02747004|62670456|FG000|Overall Study|Withdrawal by Subject|8|||
33293538|NCT02747004|62670457|FG001|Overall Study|Withdrawal by Subject|5|||
33293539|NCT02747004|62670458|FG002|Overall Study|Withdrawal by Subject|4|||
33380689|NCT00799058|62759756|FG001|Overall Study|Adverse Event|2|||
33380690|NCT00799058|62759757|FG002|Overall Study|Adverse Event|0|||
33380691|NCT00799058|62759755|FG000|Overall Study|Pregnancy|1|||
33380692|NCT00799058|62759756|FG001|Overall Study|Pregnancy|0|||
33380693|NCT00799058|62759757|FG002|Overall Study|Pregnancy|0|||
33380694|NCT00799058|62759755|FG000|Overall Study|Not adherent|3|||
33380695|NCT00799058|62759756|FG001|Overall Study|Not adherent|2|||
33487822|NCT03732807|62866040|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
33380696|NCT00799058|62759757|FG002|Overall Study|Not adherent|1|||
33380697|NCT00799058|62759755|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
33380698|NCT00799058|62759756|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
33380699|NCT00799058|62759757|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
33380700|NCT00799058|62759755|FG000|Overall Study|IP dispensing error|1|||
33380701|NCT00799058|62759756|FG001|Overall Study|IP dispensing error|0|||
33380702|NCT00799058|62759757|FG002|Overall Study|IP dispensing error|0|||
33380703|NCT00799058|62759755|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
33380704|NCT00799058|62759756|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
33380705|NCT00799058|62759757|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
33380706|NCT00799058|62759755|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
33380707|NCT00799058|62759756|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
33380708|NCT00799058|62759757|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
33380709|NCT00799058|62759755|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
33380710|NCT00799058|62759756|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
33380711|NCT00799058|62759757|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
33380712|NCT00799058|62759755|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
33380713|NCT00799058|62759756|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
33380714|NCT00799058|62759757|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
33293540|NCT02747004|62670456|FG000|Overall Study|Lost to Follow-up|1|||
33293541|NCT02747004|62670457|FG001|Overall Study|Lost to Follow-up|2|||
33293542|NCT02747004|62670458|FG002|Overall Study|Lost to Follow-up|2|||
33380715|NCT00725985|62759770|FG000|ITP- Treatment Disposition|Adverse Event|20|||
33380716|NCT00725985|62759771|FG001|ITP- Treatment Disposition|Adverse Event|10|||
33380717|NCT00725985|62759772|FG002|ITP- Treatment Disposition|Adverse Event|5|||
33487823|NCT03732807|62866041|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
33293543|NCT02747004|62670456|FG000|Overall Study|on study treatment/follow-up|48|||
33293544|NCT02747004|62670457|FG001|Overall Study|on study treatment/follow-up|42|||
33293545|NCT02747004|62670458|FG002|Overall Study|on study treatment/follow-up|41|||
33293546|NCT02741570|62670468|FG000|Pre-Treatment Period|Other reasons|0|||
33293547|NCT02741570|62670469|FG001|Pre-Treatment Period|Other reasons|3|||
33293548|NCT02741570|62670468|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
33293549|NCT02741570|62670469|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
33293550|NCT02741570|62670468|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
33293551|NCT02741570|62670469|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
33293552|NCT02741570|62670468|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
33293553|NCT02741570|62670469|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
33293554|NCT02741570|62670468|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
33293555|NCT02741570|62670469|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
33293556|NCT02741570|62670468|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
33293557|NCT02741570|62670469|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
33293558|NCT02741570|62670468|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
33293559|NCT02741570|62670469|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33293560|NCT02741570|62670468|FG000|Pre-Treatment Period|Death|0|||
33293561|NCT02741570|62670469|FG001|Pre-Treatment Period|Death|1|||
33293562|NCT02741570|62670468|FG000|Pre-Treatment Period|Disease progression|0|||
33293563|NCT02741570|62670469|FG001|Pre-Treatment Period|Disease progression|1|||
33293564|NCT02741570|62670468|FG000|Treatment Period|Other reasons|47|||
33293565|NCT02741570|62670469|FG001|Treatment Period|Other reasons|12|||
33293566|NCT02741570|62670468|FG000|Treatment Period|Poor/non-compliance|0|||
33293567|NCT02741570|62670469|FG001|Treatment Period|Poor/non-compliance|2|||
33293568|NCT02741570|62670468|FG000|Treatment Period|Maximum clinical benefit|4|||
33293569|NCT02741570|62670469|FG001|Treatment Period|Maximum clinical benefit|6|||
33293570|NCT02741570|62670468|FG000|Treatment Period|Lost to Follow-up|1|||
33293571|NCT02741570|62670469|FG001|Treatment Period|Lost to Follow-up|3|||
33293572|NCT02741570|62670468|FG000|Treatment Period|Participant withdrew consent|9|||
33293573|NCT02741570|62670469|FG001|Treatment Period|Participant withdrew consent|13|||
33293574|NCT02741570|62670468|FG000|Treatment Period|Participant request to discontinue treatment|8|||
33293575|NCT02741570|62670469|FG001|Treatment Period|Participant request to discontinue treatment|23|||
33293576|NCT02741570|62670468|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
33293577|NCT02741570|62670469|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
33293578|NCT02741570|62670468|FG000|Treatment Period|Death|9|||
33293579|NCT02741570|62670469|FG001|Treatment Period|Death|7|||
33293580|NCT02741570|62670468|FG000|Treatment Period|Study drug toxicity|55|||
33293581|NCT02741570|62670469|FG001|Treatment Period|Study drug toxicity|47|||
33293582|NCT02741570|62670468|FG000|Treatment Period|Disease progression|294|||
33293583|NCT02741570|62670469|FG001|Treatment Period|Disease progression|301|||
33293584|NCT02741570|62670468|FG000|Treatment Period|Administrative reason by sponsor|0|||
33293585|NCT02741570|62670469|FG001|Treatment Period|Administrative reason by sponsor|1|||
33380718|NCT00725985|62759773|FG003|ITP- Treatment Disposition|Adverse Event|0|||
33380719|NCT00725985|62759774|FG004|ITP- Treatment Disposition|Adverse Event|0|||
33380720|NCT00725985|62759775|FG005|ITP- Treatment Disposition|Adverse Event|0|||
33380721|NCT00725985|62759776|FG006|ITP- Treatment Disposition|Adverse Event|0|||
33380722|NCT00725985|62759777|FG007|ITP- Treatment Disposition|Adverse Event|0|||
33380723|NCT00725985|62759778|FG008|ITP- Treatment Disposition|Adverse Event|0|||
33380724|NCT00725985|62759779|FG009|ITP- Treatment Disposition|Adverse Event|0|||
33380725|NCT00725985|62759780|FG010|ITP- Treatment Disposition|Adverse Event|0|||
33380726|NCT00725985|62759781|FG011|ITP- Treatment Disposition|Adverse Event|0|||
33380727|NCT00725985|62759770|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
33380728|NCT00725985|62759771|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
33380729|NCT00725985|62759772|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
33380730|NCT00725985|62759773|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
33380731|NCT00725985|62759774|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
33380732|NCT00725985|62759775|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
33380733|NCT00725985|62759776|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
33380734|NCT00725985|62759777|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
33380735|NCT00725985|62759778|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
33380736|NCT00725985|62759779|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
33380737|NCT00725985|62759780|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
33380738|NCT00725985|62759781|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
33380739|NCT00725985|62759770|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
33380740|NCT00725985|62759771|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
33380741|NCT00725985|62759772|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
33380742|NCT00725985|62759773|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
33487824|NCT03732807|62866042|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
33487825|NCT03732807|62866043|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
33487826|NCT03732807|62866044|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
33487827|NCT03732807|62866038|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
33487828|NCT03732807|62866039|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
33487829|NCT03732807|62866040|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
33487830|NCT03732807|62866041|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
33487831|NCT03732807|62866042|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
33487832|NCT03732807|62866043|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
33556626|NCT02614196|62949477|FG000|Double Blind Treatment Phase|Physician Decision|4|||
33556627|NCT02614196|62949478|FG001|Double Blind Treatment Phase|Physician Decision|0|||
33293586|NCT02675244|62670495|FG000|Overall Study|Death|9|||
33293587|NCT02675244|62670496|FG001|Overall Study|Death|6|||
33293588|NCT02675244|62670495|FG000|Overall Study|Withdrawal by Subject|3|||
33293589|NCT02675244|62670496|FG001|Overall Study|Withdrawal by Subject|6|||
33293590|NCT02675244|62670495|FG000|Overall Study|Lost to Follow-up|1|||
33293591|NCT02675244|62670496|FG001|Overall Study|Lost to Follow-up|1|||
33293592|NCT02675244|62670495|FG000|Overall Study|Ongoing at 2 Years|190|||
33293593|NCT02675244|62670496|FG001|Overall Study|Ongoing at 2 Years|185|||
33293594|NCT02675231|62670511|FG000|Overall Study|Withdrawal by Subject|1|||
33293595|NCT02675231|62670512|FG001|Overall Study|Withdrawal by Subject|3|||
33293596|NCT02675231|62670513|FG002|Overall Study|Withdrawal by Subject|1|||
33293597|NCT02675231|62670511|FG000|Overall Study|Lost to Follow-up|2|||
33293598|NCT02675231|62670512|FG001|Overall Study|Lost to Follow-up|2|||
33293599|NCT02675231|62670513|FG002|Overall Study|Lost to Follow-up|2|||
33293600|NCT02675231|62670511|FG000|Overall Study|On study treatment/follow up|23|||
33293601|NCT02675231|62670512|FG001|Overall Study|On study treatment/follow up|31|||
33293602|NCT02675231|62670513|FG002|Overall Study|On study treatment/follow up|23|||
33380743|NCT00725985|62759774|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
33380744|NCT00725985|62759775|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
33556628|NCT02614196|62949479|FG002|Double Blind Treatment Phase|Physician Decision|2|||
33556629|NCT02614196|62949480|FG003|Double Blind Treatment Phase|Physician Decision|0|||
33556630|NCT02614196|62949481|FG004|Double Blind Treatment Phase|Physician Decision|0|||
33556631|NCT02614196|62949482|FG005|Double Blind Treatment Phase|Physician Decision|0|||
33556632|NCT02614196|62949477|FG000|Double Blind Treatment Phase|Pregnancy|1|||
33556633|NCT02614196|62949478|FG001|Double Blind Treatment Phase|Pregnancy|2|||
33556634|NCT02614196|62949479|FG002|Double Blind Treatment Phase|Pregnancy|0|||
33556635|NCT02614196|62949480|FG003|Double Blind Treatment Phase|Pregnancy|0|||
33556636|NCT02614196|62949481|FG004|Double Blind Treatment Phase|Pregnancy|0|||
33556637|NCT02614196|62949482|FG005|Double Blind Treatment Phase|Pregnancy|0|||
33556638|NCT02614196|62949477|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
33556639|NCT02614196|62949478|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
33556640|NCT02614196|62949479|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
33556641|NCT02614196|62949480|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
33556642|NCT02614196|62949481|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
33556643|NCT02614196|62949482|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
33380745|NCT00725985|62759776|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
33380746|NCT00725985|62759777|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
33380747|NCT00725985|62759778|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
33662447|NCT01582061|63092986|FG000|Overall Study|Death|0|||
33662448|NCT01582061|63092987|FG001|Overall Study|Death|1|||
33662449|NCT01582061|63092986|FG000|Overall Study|condition no longer requires study drug|1|||
33662450|NCT01582061|63092987|FG001|Overall Study|condition no longer requires study drug|0|||
33293625|NCT02603887|62670535|FG000|Stage 1|Adverse Event|4|||
33293626|NCT02603887|62670535|FG000|Stage 1|Disease progression|1|||
33380748|NCT00725985|62759779|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
33380749|NCT00725985|62759780|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
33380750|NCT00725985|62759781|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
33380751|NCT00725985|62759770|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
33380752|NCT00725985|62759771|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
33380753|NCT00725985|62759772|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
33380754|NCT00725985|62759773|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
33380755|NCT00725985|62759774|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
33380756|NCT00725985|62759775|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
33380757|NCT00725985|62759776|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
33380758|NCT00725985|62759777|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
33380759|NCT00725985|62759778|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
33380760|NCT00725985|62759779|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
33380761|NCT00725985|62759780|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
33380762|NCT00725985|62759781|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
33380763|NCT00725985|62759770|FG000|ITP- Treatment Disposition|Other|50|||
33380764|NCT00725985|62759771|FG001|ITP- Treatment Disposition|Other|38|||
33380765|NCT00725985|62759772|FG002|ITP- Treatment Disposition|Other|24|||
33380766|NCT00725985|62759773|FG003|ITP- Treatment Disposition|Other|0|||
33380767|NCT00725985|62759774|FG004|ITP- Treatment Disposition|Other|0|||
33380768|NCT00725985|62759775|FG005|ITP- Treatment Disposition|Other|0|||
33380769|NCT00725985|62759776|FG006|ITP- Treatment Disposition|Other|0|||
33380770|NCT00725985|62759777|FG007|ITP- Treatment Disposition|Other|0|||
33380771|NCT00725985|62759778|FG008|ITP- Treatment Disposition|Other|0|||
33380772|NCT00725985|62759779|FG009|ITP- Treatment Disposition|Other|0|||
33380773|NCT00725985|62759780|FG010|ITP- Treatment Disposition|Other|0|||
33380774|NCT00725985|62759781|FG011|ITP- Treatment Disposition|Other|0|||
33380775|NCT00725985|62759770|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33380776|NCT00725985|62759771|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33380777|NCT00725985|62759772|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33380778|NCT00725985|62759773|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
33380779|NCT00725985|62759774|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
33380780|NCT00725985|62759775|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
33380781|NCT00725985|62759776|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33487833|NCT03732807|62866044|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
33662451|NCT01582061|63092986|FG000|Overall Study|Lost to Follow-up|1|||
33293627|NCT02603887|62670535|FG000|Stage 2|FDA guidance|1|||
33293628|NCT02576509|62670541|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
33293629|NCT02576509|62670542|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
33293630|NCT02576509|62670541|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
33293631|NCT02576509|62670542|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
33293632|NCT02576509|62670541|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
33293633|NCT02576509|62670542|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
33293634|NCT02576509|62670541|FG000|Treatment Period|Disease progression|245|||
33293635|NCT02576509|62670542|FG001|Treatment Period|Disease progression|240|||
33293636|NCT02576509|62670541|FG000|Treatment Period|Study drug toxicity|32|||
33293637|NCT02576509|62670542|FG001|Treatment Period|Study drug toxicity|41|||
33293638|NCT02576509|62670541|FG000|Treatment Period|Death|1|||
33293639|NCT02576509|62670542|FG001|Treatment Period|Death|1|||
33293640|NCT02576509|62670541|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
33293641|NCT02576509|62670542|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
33293642|NCT02576509|62670541|FG000|Treatment Period|Participant request to stop treatment|8|||
33293643|NCT02576509|62670542|FG001|Treatment Period|Participant request to stop treatment|17|||
33293644|NCT02576509|62670541|FG000|Treatment Period|Participant withdrew consent|2|||
33293645|NCT02576509|62670542|FG001|Treatment Period|Participant withdrew consent|7|||
33293646|NCT02576509|62670541|FG000|Treatment Period|Lost to Follow-up|0|||
33293647|NCT02576509|62670542|FG001|Treatment Period|Lost to Follow-up|1|||
33293648|NCT02576509|62670541|FG000|Treatment Period|Maximum clinical benefit|1|||
33293649|NCT02576509|62670542|FG001|Treatment Period|Maximum clinical benefit|0|||
33380782|NCT00725985|62759777|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33380783|NCT00725985|62759778|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33380784|NCT00725985|62759779|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33380785|NCT00725985|62759780|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33380786|NCT00725985|62759781|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33293650|NCT02576509|62670541|FG000|Treatment Period|Poor/non-compliance|0|||
33293651|NCT02576509|62670542|FG001|Treatment Period|Poor/non-compliance|1|||
33293652|NCT02576509|62670541|FG000|Treatment Period|Participant no longer meets criteria|1|||
33293653|NCT02576509|62670542|FG001|Treatment Period|Participant no longer meets criteria|0|||
33293654|NCT02576509|62670541|FG000|Treatment Period|Other reason|2|||
33293655|NCT02576509|62670542|FG001|Treatment Period|Other reason|7|||
33293656|NCT02576509|62670541|FG000|Follow-up Period|Death|41|||
33293657|NCT02576509|62670542|FG001|Follow-up Period|Death|35|||
33293658|NCT02576509|62670541|FG000|Follow-up Period|Participant withdrew consent|7|||
33293659|NCT02576509|62670542|FG001|Follow-up Period|Participant withdrew consent|14|||
33293660|NCT02576509|62670541|FG000|Follow-up Period|Lost to Follow-up|0|||
33293661|NCT02576509|62670542|FG001|Follow-up Period|Lost to Follow-up|1|||
33293662|NCT02576509|62670541|FG000|Follow-up Period|Other reason|1|||
33293663|NCT02576509|62670542|FG001|Follow-up Period|Other reason|2|||
33293664|NCT02564900|62670563|FG000|Dose Escalation|Progressive disease per RECIST|2|||
33293665|NCT02564900|62670564|FG001|Dose Escalation|Progressive disease per RECIST|3|||
33293666|NCT02564900|62670565|FG002|Dose Escalation|Progressive disease per RECIST|3|||
33380787|NCT00725985|62759770|FG000|OLMP (Up to 96 Weeks)|Death|0|||
33380788|NCT00725985|62759771|FG001|OLMP (Up to 96 Weeks)|Death|0|||
33380789|NCT00725985|62759772|FG002|OLMP (Up to 96 Weeks)|Death|0|||
33380790|NCT00725985|62759773|FG003|OLMP (Up to 96 Weeks)|Death|0|||
33380791|NCT00725985|62759774|FG004|OLMP (Up to 96 Weeks)|Death|1|||
33380792|NCT00725985|62759775|FG005|OLMP (Up to 96 Weeks)|Death|0|||
33380793|NCT00725985|62759776|FG006|OLMP (Up to 96 Weeks)|Death|0|||
33380794|NCT00725985|62759777|FG007|OLMP (Up to 96 Weeks)|Death|0|||
33380795|NCT00725985|62759778|FG008|OLMP (Up to 96 Weeks)|Death|0|||
33380796|NCT00725985|62759779|FG009|OLMP (Up to 96 Weeks)|Death|0|||
33380797|NCT00725985|62759780|FG010|OLMP (Up to 96 Weeks)|Death|0|||
33380798|NCT00725985|62759781|FG011|OLMP (Up to 96 Weeks)|Death|0|||
33380799|NCT00725985|62759770|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33380800|NCT00725985|62759771|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33380801|NCT00725985|62759772|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33380802|NCT00725985|62759773|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
33380803|NCT00725985|62759774|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33380804|NCT00725985|62759775|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33293667|NCT02564900|62670566|FG003|Dose Escalation|Progressive disease per RECIST|3|||
33380805|NCT00725985|62759776|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33380806|NCT00725985|62759777|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33380807|NCT00725985|62759778|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33380808|NCT00725985|62759779|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33380809|NCT00725985|62759780|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33380810|NCT00725985|62759781|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33380811|NCT00725985|62759770|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
33380812|NCT00725985|62759771|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
33380813|NCT00725985|62759772|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
33380814|NCT00725985|62759773|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
33380815|NCT00725985|62759774|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
33380816|NCT00725985|62759775|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
33380817|NCT00725985|62759776|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
33556644|NCT02614196|62949477|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
33293668|NCT02564900|62670567|FG004|Dose Escalation|Progressive disease per RECIST|3|||
33293669|NCT02564900|62670568|FG005|Dose Escalation|Progressive disease per RECIST|1|||
33293670|NCT02564900|62670569|FG006|Dose Escalation|Progressive disease per RECIST|0|||
33293671|NCT02564900|62670570|FG007|Dose Escalation|Progressive disease per RECIST|0|||
33293672|NCT02564900|62670571|FG008|Dose Escalation|Progressive disease per RECIST|0|||
33293673|NCT02564900|62670572|FG009|Dose Escalation|Progressive disease per RECIST|0|||
33293674|NCT02564900|62670573|FG010|Dose Escalation|Progressive disease per RECIST|0|||
33293675|NCT02564900|62670574|FG011|Dose Escalation|Progressive disease per RECIST|0|||
33293676|NCT02564900|62670575|FG012|Dose Escalation|Progressive disease per RECIST|0|||
33293677|NCT02564900|62670576|FG013|Dose Escalation|Progressive disease per RECIST|0|||
33293678|NCT02564900|62670577|FG014|Dose Escalation|Progressive disease per RECIST|0|||
33556645|NCT02614196|62949478|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
33293679|NCT02564900|62670563|FG000|Dose Escalation|Ongoing|1|||
33293680|NCT02564900|62670564|FG001|Dose Escalation|Ongoing|0|||
33293681|NCT02564900|62670565|FG002|Dose Escalation|Ongoing|0|||
33293682|NCT02564900|62670566|FG003|Dose Escalation|Ongoing|2|||
33293683|NCT02564900|62670567|FG004|Dose Escalation|Ongoing|2|||
33380818|NCT00725985|62759777|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
33380819|NCT00725985|62759778|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
33380820|NCT00725985|62759779|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
33380821|NCT00725985|62759780|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
33380822|NCT00725985|62759781|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
33380823|NCT00725985|62759770|FG000|OLMP (Up to 96 Weeks)|Other|0|||
33380824|NCT00725985|62759771|FG001|OLMP (Up to 96 Weeks)|Other|0|||
33380825|NCT00725985|62759772|FG002|OLMP (Up to 96 Weeks)|Other|0|||
33293684|NCT02564900|62670568|FG005|Dose Escalation|Ongoing|2|||
33380826|NCT00725985|62759773|FG003|OLMP (Up to 96 Weeks)|Other|15|||
33380827|NCT00725985|62759774|FG004|OLMP (Up to 96 Weeks)|Other|20|||
33293685|NCT02564900|62670569|FG006|Dose Escalation|Ongoing|0|||
33293686|NCT02564900|62670570|FG007|Dose Escalation|Ongoing|0|||
33293687|NCT02564900|62670571|FG008|Dose Escalation|Ongoing|0|||
33293688|NCT02564900|62670572|FG009|Dose Escalation|Ongoing|0|||
33293689|NCT02564900|62670573|FG010|Dose Escalation|Ongoing|0|||
33293690|NCT02564900|62670574|FG011|Dose Escalation|Ongoing|0|||
33293691|NCT02564900|62670575|FG012|Dose Escalation|Ongoing|0|||
33293692|NCT02564900|62670576|FG013|Dose Escalation|Ongoing|0|||
33293693|NCT02564900|62670577|FG014|Dose Escalation|Ongoing|0|||
33293694|NCT02564900|62670563|FG000|Dose Escalation|Adverse Event|0|||
33293695|NCT02564900|62670564|FG001|Dose Escalation|Adverse Event|0|||
33293696|NCT02564900|62670565|FG002|Dose Escalation|Adverse Event|0|||
33293697|NCT02564900|62670566|FG003|Dose Escalation|Adverse Event|1|||
33293698|NCT02564900|62670567|FG004|Dose Escalation|Adverse Event|1|||
33293699|NCT02564900|62670568|FG005|Dose Escalation|Adverse Event|3|||
33293700|NCT02564900|62670569|FG006|Dose Escalation|Adverse Event|0|||
33293701|NCT02564900|62670570|FG007|Dose Escalation|Adverse Event|0|||
33293702|NCT02564900|62670571|FG008|Dose Escalation|Adverse Event|0|||
33293703|NCT02564900|62670572|FG009|Dose Escalation|Adverse Event|0|||
33380828|NCT00725985|62759775|FG005|OLMP (Up to 96 Weeks)|Other|44|||
33380829|NCT00725985|62759776|FG006|OLMP (Up to 96 Weeks)|Other|0|||
33380830|NCT00725985|62759777|FG007|OLMP (Up to 96 Weeks)|Other|0|||
33380831|NCT00725985|62759778|FG008|OLMP (Up to 96 Weeks)|Other|0|||
33380832|NCT00725985|62759779|FG009|OLMP (Up to 96 Weeks)|Other|0|||
33487834|NCT03732807|62866038|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
33487835|NCT03732807|62866039|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
33487836|NCT03732807|62866040|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
33487837|NCT03732807|62866041|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
33293704|NCT02564900|62670573|FG010|Dose Escalation|Adverse Event|0|||
33293705|NCT02564900|62670574|FG011|Dose Escalation|Adverse Event|0|||
33293706|NCT02564900|62670575|FG012|Dose Escalation|Adverse Event|0|||
33293707|NCT02564900|62670576|FG013|Dose Escalation|Adverse Event|0|||
33293708|NCT02564900|62670577|FG014|Dose Escalation|Adverse Event|0|||
33293709|NCT02564900|62670563|FG000|Dose Expansion|Progressive disease per RECIST|0|||
33293710|NCT02564900|62670564|FG001|Dose Expansion|Progressive disease per RECIST|0|||
33293711|NCT02564900|62670565|FG002|Dose Expansion|Progressive disease per RECIST|0|||
33293712|NCT02564900|62670566|FG003|Dose Expansion|Progressive disease per RECIST|0|||
33293713|NCT02564900|62670567|FG004|Dose Expansion|Progressive disease per RECIST|0|||
33293714|NCT02564900|62670568|FG005|Dose Expansion|Progressive disease per RECIST|0|||
33293715|NCT02564900|62670569|FG006|Dose Expansion|Progressive disease per RECIST|19|||
33293716|NCT02564900|62670570|FG007|Dose Expansion|Progressive disease per RECIST|17|||
33293717|NCT02564900|62670571|FG008|Dose Expansion|Progressive disease per RECIST|8|||
33293718|NCT02564900|62670572|FG009|Dose Expansion|Progressive disease per RECIST|16|||
33293719|NCT02564900|62670573|FG010|Dose Expansion|Progressive disease per RECIST|13|||
33293720|NCT02564900|62670574|FG011|Dose Expansion|Progressive disease per RECIST|19|||
33293721|NCT02564900|62670575|FG012|Dose Expansion|Progressive disease per RECIST|10|||
33293722|NCT02564900|62670576|FG013|Dose Expansion|Progressive disease per RECIST|13|||
33293723|NCT02564900|62670577|FG014|Dose Expansion|Progressive disease per RECIST|11|||
33293724|NCT02564900|62670563|FG000|Dose Expansion|Clinical progression|0|||
33293725|NCT02564900|62670564|FG001|Dose Expansion|Clinical progression|0|||
33293726|NCT02564900|62670565|FG002|Dose Expansion|Clinical progression|0|||
33293727|NCT02564900|62670566|FG003|Dose Expansion|Clinical progression|0|||
33293728|NCT02564900|62670567|FG004|Dose Expansion|Clinical progression|0|||
33293729|NCT02564900|62670568|FG005|Dose Expansion|Clinical progression|0|||
33293730|NCT02564900|62670569|FG006|Dose Expansion|Clinical progression|5|||
33293731|NCT02564900|62670570|FG007|Dose Expansion|Clinical progression|12|||
33293732|NCT02564900|62670571|FG008|Dose Expansion|Clinical progression|0|||
33293733|NCT02564900|62670572|FG009|Dose Expansion|Clinical progression|3|||
33487838|NCT03732807|62866042|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
33487839|NCT03732807|62866043|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
33487840|NCT03732807|62866044|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
33293734|NCT02564900|62670573|FG010|Dose Expansion|Clinical progression|2|||
33293735|NCT02564900|62670574|FG011|Dose Expansion|Clinical progression|0|||
33293736|NCT02564900|62670575|FG012|Dose Expansion|Clinical progression|1|||
33380833|NCT00725985|62759780|FG010|OLMP (Up to 96 Weeks)|Other|0|||
33293737|NCT02564900|62670576|FG013|Dose Expansion|Clinical progression|3|||
33293738|NCT02564900|62670577|FG014|Dose Expansion|Clinical progression|1|||
33293739|NCT02564900|62670563|FG000|Dose Expansion|Adverse Event|0|||
33293740|NCT02564900|62670564|FG001|Dose Expansion|Adverse Event|0|||
33293741|NCT02564900|62670565|FG002|Dose Expansion|Adverse Event|0|||
33293742|NCT02564900|62670566|FG003|Dose Expansion|Adverse Event|0|||
33293743|NCT02564900|62670567|FG004|Dose Expansion|Adverse Event|0|||
33380834|NCT00725985|62759781|FG011|OLMP (Up to 96 Weeks)|Other|0|||
33380835|NCT00725985|62759770|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33380836|NCT00725985|62759771|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33380837|NCT00725985|62759772|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33380838|NCT00725985|62759773|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33380839|NCT00725985|62759774|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33380840|NCT00725985|62759775|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33487841|NCT03732807|62866038|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
33487842|NCT03732807|62866039|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
33487843|NCT03732807|62866040|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
33487844|NCT03732807|62866041|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
33487845|NCT03732807|62866042|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
33487846|NCT03732807|62866043|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
33487847|NCT03732807|62866044|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
33487848|NCT03732807|62866038|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
33487849|NCT03732807|62866039|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
33487850|NCT03732807|62866040|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
33487851|NCT03732807|62866041|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
33662452|NCT01582061|63092987|FG001|Overall Study|Lost to Follow-up|0|||
33293744|NCT02564900|62670568|FG005|Dose Expansion|Adverse Event|0|||
33293745|NCT02564900|62670569|FG006|Dose Expansion|Adverse Event|9|||
33293746|NCT02564900|62670570|FG007|Dose Expansion|Adverse Event|22|||
33293747|NCT02564900|62670571|FG008|Dose Expansion|Adverse Event|0|||
33293748|NCT02564900|62670572|FG009|Dose Expansion|Adverse Event|11|||
33293749|NCT02564900|62670573|FG010|Dose Expansion|Adverse Event|0|||
33293750|NCT02564900|62670574|FG011|Dose Expansion|Adverse Event|5|||
33293751|NCT02564900|62670575|FG012|Dose Expansion|Adverse Event|2|||
33293752|NCT02564900|62670576|FG013|Dose Expansion|Adverse Event|2|||
33293753|NCT02564900|62670577|FG014|Dose Expansion|Adverse Event|1|||
33293754|NCT02564900|62670563|FG000|Dose Expansion|Ongoing|0|||
33293755|NCT02564900|62670564|FG001|Dose Expansion|Ongoing|0|||
33293756|NCT02564900|62670565|FG002|Dose Expansion|Ongoing|0|||
33293757|NCT02564900|62670566|FG003|Dose Expansion|Ongoing|0|||
33380841|NCT00725985|62759776|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33380842|NCT00725985|62759777|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
33380843|NCT00725985|62759778|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33380844|NCT00725985|62759779|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33380845|NCT00725985|62759780|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33380846|NCT00725985|62759781|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33380847|NCT00725985|62759770|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33380848|NCT00725985|62759771|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33380849|NCT00725985|62759772|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33380850|NCT00725985|62759773|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33380851|NCT00725985|62759774|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33380852|NCT00725985|62759775|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33380853|NCT00725985|62759776|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33380854|NCT00725985|62759777|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33380855|NCT00725985|62759778|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
33380856|NCT00725985|62759779|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33380857|NCT00725985|62759780|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33380858|NCT00725985|62759781|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33380859|NCT00725985|62759770|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33380860|NCT00725985|62759771|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33380861|NCT00725985|62759772|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33380862|NCT00725985|62759773|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33380863|NCT00725985|62759774|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33380864|NCT00725985|62759775|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33380865|NCT00725985|62759776|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
33380866|NCT00725985|62759777|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
33380867|NCT00725985|62759778|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
33380868|NCT00725985|62759779|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33380869|NCT00725985|62759780|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33380870|NCT00725985|62759781|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33380871|NCT00725985|62759770|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33380872|NCT00725985|62759771|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33380873|NCT00725985|62759772|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33380874|NCT00725985|62759773|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33380875|NCT00725985|62759774|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33380876|NCT00725985|62759775|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33380877|NCT00725985|62759776|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33487852|NCT03732807|62866042|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
33293758|NCT02564900|62670567|FG004|Dose Expansion|Ongoing|0|||
33380878|NCT00725985|62759777|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33380879|NCT00725985|62759778|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33380880|NCT00725985|62759779|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
33380881|NCT00725985|62759780|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
33380882|NCT00725985|62759781|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
33380883|NCT00793910|62759809|FG000|Overall Study|discarded study pills|0|||
33380884|NCT00793910|62759810|FG001|Overall Study|discarded study pills|1|||
33380885|NCT00793910|62759809|FG000|Overall Study|did not pick up medications|1|||
33380886|NCT00793910|62759810|FG001|Overall Study|did not pick up medications|1|||
33293759|NCT02564900|62670568|FG005|Dose Expansion|Ongoing|0|||
33293760|NCT02564900|62670569|FG006|Dose Expansion|Ongoing|9|||
33293761|NCT02564900|62670570|FG007|Dose Expansion|Ongoing|10|||
33293762|NCT02564900|62670571|FG008|Dose Expansion|Ongoing|11|||
33293763|NCT02564900|62670572|FG009|Dose Expansion|Ongoing|3|||
33293764|NCT02564900|62670573|FG010|Dose Expansion|Ongoing|0|||
33293765|NCT02564900|62670574|FG011|Dose Expansion|Ongoing|0|||
33293766|NCT02564900|62670575|FG012|Dose Expansion|Ongoing|4|||
33293767|NCT02564900|62670576|FG013|Dose Expansion|Ongoing|0|||
33487853|NCT03732807|62866043|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
33487854|NCT03732807|62866044|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
33487855|NCT03732807|62866038|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
33487856|NCT03732807|62866039|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
33487857|NCT03732807|62866040|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
33487858|NCT03732807|62866041|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
33487859|NCT03732807|62866042|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
33487860|NCT03732807|62866043|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
33487861|NCT03732807|62866044|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
33487862|NCT03732807|62866038|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
33487863|NCT03732807|62866039|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
33487864|NCT03732807|62866040|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
33487865|NCT03732807|62866041|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
33487866|NCT03732807|62866042|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
33487867|NCT03732807|62866043|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
33487868|NCT03732807|62866044|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
33487869|NCT03732807|62866038|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
33487870|NCT03732807|62866039|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
33487871|NCT03732807|62866040|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
33487872|NCT03732807|62866041|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
33487873|NCT03732807|62866042|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
33487874|NCT03732807|62866043|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
33487875|NCT03732807|62866044|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
33487876|NCT00104416|62866063|FG000|Double-Blind Phase|Adverse Event|2|||
33487877|NCT00104416|62866064|FG001|Double-Blind Phase|Adverse Event|1|||
33487878|NCT00104416|62866065|FG002|Double-Blind Phase|Adverse Event|0|||
33487879|NCT00104416|62866066|FG003|Double-Blind Phase|Adverse Event|0|||
33487880|NCT00104416|62866067|FG004|Double-Blind Phase|Adverse Event|0|||
33487881|NCT00104416|62866063|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33487882|NCT00104416|62866064|FG001|Double-Blind Phase|Lost to Follow-up|1|||
33487883|NCT00104416|62866065|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33487884|NCT00104416|62866066|FG003|Double-Blind Phase|Lost to Follow-up|0|||
33487885|NCT00104416|62866067|FG004|Double-Blind Phase|Lost to Follow-up|0|||
33487886|NCT00104416|62866063|FG000|Double-Blind Phase|Protocol Violation|0|||
33487887|NCT00104416|62866064|FG001|Double-Blind Phase|Protocol Violation|1|||
33487888|NCT00104416|62866065|FG002|Double-Blind Phase|Protocol Violation|0|||
33487889|NCT00104416|62866066|FG003|Double-Blind Phase|Protocol Violation|0|||
33487890|NCT00104416|62866067|FG004|Double-Blind Phase|Protocol Violation|0|||
33487891|NCT00104416|62866063|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
33487892|NCT00104416|62866064|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
33487893|NCT00104416|62866065|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
33487894|NCT00104416|62866066|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
33487895|NCT00104416|62866067|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
33487896|NCT00104416|62866063|FG000|Double-Blind Phase|Pregnancy|1|||
33556646|NCT02614196|62949479|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
33293768|NCT02564900|62670577|FG014|Dose Expansion|Ongoing|6|||
33487897|NCT00104416|62866064|FG001|Double-Blind Phase|Pregnancy|0|||
33662453|NCT01693523|63093006|FG000|Overall Study|Adverse Event|2|||
33293769|NCT02564900|62670563|FG000|Dose Expansion|Death|0|||
33293770|NCT02564900|62670564|FG001|Dose Expansion|Death|0|||
33293771|NCT02564900|62670565|FG002|Dose Expansion|Death|0|||
33487898|NCT00104416|62866065|FG002|Double-Blind Phase|Pregnancy|0|||
33487899|NCT00104416|62866066|FG003|Double-Blind Phase|Pregnancy|0|||
33293772|NCT02564900|62670566|FG003|Dose Expansion|Death|0|||
33380887|NCT00793910|62759809|FG000|Overall Study|ineligible based on entry criteria|2|||
33380888|NCT00793910|62759810|FG001|Overall Study|ineligible based on entry criteria|3|||
33293773|NCT02564900|62670567|FG004|Dose Expansion|Death|0|||
33293774|NCT02564900|62670568|FG005|Dose Expansion|Death|0|||
33293775|NCT02564900|62670569|FG006|Dose Expansion|Death|1|||
33293776|NCT02564900|62670570|FG007|Dose Expansion|Death|0|||
33293777|NCT02564900|62670571|FG008|Dose Expansion|Death|0|||
33293778|NCT02564900|62670572|FG009|Dose Expansion|Death|0|||
33293779|NCT02564900|62670573|FG010|Dose Expansion|Death|1|||
33293780|NCT02564900|62670574|FG011|Dose Expansion|Death|0|||
33293781|NCT02564900|62670575|FG012|Dose Expansion|Death|1|||
33293782|NCT02564900|62670576|FG013|Dose Expansion|Death|1|||
33293783|NCT02564900|62670577|FG014|Dose Expansion|Death|0|||
33293784|NCT02564900|62670563|FG000|Dose Expansion|Withdrawal by Subject|0|||
33293785|NCT02564900|62670564|FG001|Dose Expansion|Withdrawal by Subject|0|||
33293786|NCT02564900|62670565|FG002|Dose Expansion|Withdrawal by Subject|0|||
33293787|NCT02564900|62670566|FG003|Dose Expansion|Withdrawal by Subject|0|||
33293788|NCT02564900|62670567|FG004|Dose Expansion|Withdrawal by Subject|0|||
33293789|NCT02564900|62670568|FG005|Dose Expansion|Withdrawal by Subject|0|||
33293790|NCT02564900|62670569|FG006|Dose Expansion|Withdrawal by Subject|4|||
33293791|NCT02564900|62670570|FG007|Dose Expansion|Withdrawal by Subject|0|||
33293792|NCT02564900|62670571|FG008|Dose Expansion|Withdrawal by Subject|0|||
33293793|NCT02564900|62670572|FG009|Dose Expansion|Withdrawal by Subject|0|||
33293794|NCT02564900|62670573|FG010|Dose Expansion|Withdrawal by Subject|1|||
33293795|NCT02564900|62670574|FG011|Dose Expansion|Withdrawal by Subject|0|||
33293796|NCT02564900|62670575|FG012|Dose Expansion|Withdrawal by Subject|0|||
33293797|NCT02564900|62670576|FG013|Dose Expansion|Withdrawal by Subject|1|||
33293798|NCT02564900|62670577|FG014|Dose Expansion|Withdrawal by Subject|1|||
33293799|NCT02564900|62670563|FG000|Dose Expansion|Other|0|||
33293800|NCT02564900|62670564|FG001|Dose Expansion|Other|0|||
33293801|NCT02564900|62670565|FG002|Dose Expansion|Other|0|||
33487900|NCT00104416|62866067|FG004|Double-Blind Phase|Pregnancy|0|||
33487901|NCT00104416|62866063|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
33487902|NCT00104416|62866064|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
33487903|NCT00104416|62866065|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
33487904|NCT00104416|62866066|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
33487905|NCT00104416|62866067|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
33487906|NCT00104416|62866063|FG000|Continuation Phase|Adverse Event|0|||
33487907|NCT00104416|62866064|FG001|Continuation Phase|Adverse Event|0|||
33487908|NCT00104416|62866065|FG002|Continuation Phase|Adverse Event|2|||
33487909|NCT00104416|62866066|FG003|Continuation Phase|Adverse Event|0|||
33487910|NCT00104416|62866067|FG004|Continuation Phase|Adverse Event|2|||
33487911|NCT00104416|62866063|FG000|Continuation Phase|Lost to Follow-up|0|||
33487912|NCT00104416|62866064|FG001|Continuation Phase|Lost to Follow-up|0|||
33487913|NCT00104416|62866065|FG002|Continuation Phase|Lost to Follow-up|1|||
33487914|NCT00104416|62866066|FG003|Continuation Phase|Lost to Follow-up|0|||
33487915|NCT00104416|62866067|FG004|Continuation Phase|Lost to Follow-up|1|||
33556647|NCT02614196|62949480|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
33380889|NCT00793910|62759809|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
33380890|NCT00793910|62759810|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
33380891|NCT00793910|62759809|FG000|Overall Study|Withdrawal by Subject|0|||
33380892|NCT00793910|62759810|FG001|Overall Study|Withdrawal by Subject|1|||
33380893|NCT00444145|62759816|FG000|Overall Study|Withdrawal by Subject|2|||
33380894|NCT00444145|62759816|FG000|Overall Study|Lost to Follow-up|1|||
33380895|NCT00444145|62759816|FG000|Overall Study|non-compliant|11|||
33380896|NCT00444145|62759816|FG000|Overall Study|Screen Failures|5|||
33380897|NCT00725283|62759820|FG000|Overall Study|Missing Code|3|||
33380898|NCT00725283|62759820|FG000|Overall Study|Death|5|||
33380899|NCT00725283|62759820|FG000|Overall Study|Other|6|||
33380900|NCT00725283|62759820|FG000|Overall Study|Withdrawal by Subject|10|||
33380901|NCT00444067|62759826|FG000|Overall Study|Lost to Follow-up|0|||
33380902|NCT00444067|62759827|FG001|Overall Study|Lost to Follow-up|1|||
33380903|NCT00789854|62759836|FG000|Overall Study|Adverse Event|28|||
33380904|NCT00789854|62759837|FG001|Overall Study|Adverse Event|23|||
33556648|NCT02614196|62949481|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
33293802|NCT02564900|62670566|FG003|Dose Expansion|Other|0|||
33293803|NCT02564900|62670567|FG004|Dose Expansion|Other|0|||
33293804|NCT02564900|62670568|FG005|Dose Expansion|Other|0|||
33293805|NCT02564900|62670569|FG006|Dose Expansion|Other|1|||
33293806|NCT02564900|62670570|FG007|Dose Expansion|Other|0|||
33380905|NCT00789854|62759838|FG002|Overall Study|Adverse Event|18|||
33380906|NCT00789854|62759836|FG000|Overall Study|Lost to Follow-up|1|||
33380907|NCT00789854|62759837|FG001|Overall Study|Lost to Follow-up|1|||
33380908|NCT00789854|62759838|FG002|Overall Study|Lost to Follow-up|4|||
33380909|NCT00789854|62759836|FG000|Overall Study|Withdrawal by Subject|9|||
33380910|NCT00789854|62759837|FG001|Overall Study|Withdrawal by Subject|6|||
33293807|NCT02564900|62670571|FG008|Dose Expansion|Other|1|||
33293808|NCT02564900|62670572|FG009|Dose Expansion|Other|0|||
33293809|NCT02564900|62670573|FG010|Dose Expansion|Other|0|||
33293810|NCT02564900|62670574|FG011|Dose Expansion|Other|0|||
33293811|NCT02564900|62670575|FG012|Dose Expansion|Other|0|||
33293812|NCT02564900|62670576|FG013|Dose Expansion|Other|0|||
33293813|NCT02564900|62670577|FG014|Dose Expansion|Other|1|||
33293814|NCT02564900|62670563|FG000|Dose Expansion|Did not receive treatment|0|||
33380911|NCT00789854|62759838|FG002|Overall Study|Withdrawal by Subject|17|||
33380912|NCT00789854|62759836|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33380913|NCT00789854|62759837|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
33380914|NCT00789854|62759838|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
33380915|NCT00789854|62759836|FG000|Overall Study|Severe non-compliance to the protocol|3|||
33380916|NCT00789854|62759837|FG001|Overall Study|Severe non-compliance to the protocol|0|||
33487916|NCT00104416|62866063|FG000|Continuation Phase|Withdrawal by Subject|0|||
33487917|NCT00104416|62866064|FG001|Continuation Phase|Withdrawal by Subject|0|||
33487918|NCT00104416|62866065|FG002|Continuation Phase|Withdrawal by Subject|2|||
33487919|NCT00104416|62866066|FG003|Continuation Phase|Withdrawal by Subject|1|||
33487920|NCT00104416|62866067|FG004|Continuation Phase|Withdrawal by Subject|1|||
33487921|NCT00104416|62866063|FG000|Continuation Phase|Pregnancy|0|||
33487922|NCT00104416|62866064|FG001|Continuation Phase|Pregnancy|0|||
33487923|NCT00104416|62866065|FG002|Continuation Phase|Pregnancy|1|||
33487924|NCT00104416|62866066|FG003|Continuation Phase|Pregnancy|1|||
33487925|NCT00104416|62866067|FG004|Continuation Phase|Pregnancy|0|||
33487926|NCT00104416|62866063|FG000|Continuation Phase|Non-compliance|0|||
33487927|NCT00104416|62866064|FG001|Continuation Phase|Non-compliance|0|||
33487928|NCT00104416|62866065|FG002|Continuation Phase|Non-compliance|0|||
33487929|NCT00104416|62866066|FG003|Continuation Phase|Non-compliance|0|||
33487930|NCT00104416|62866067|FG004|Continuation Phase|Non-compliance|1|||
33487931|NCT03639987|62866081|FG000|Overall Study|Study terminated by sponsor|26|||
33487932|NCT03639987|62866082|FG001|Overall Study|Study terminated by sponsor|25|||
33487933|NCT03639987|62866081|FG000|Overall Study|Lost to Follow-up|0|||
33487934|NCT03639987|62866082|FG001|Overall Study|Lost to Follow-up|1|||
33487935|NCT02766088|62866088|FG000|Overall Study|Sponsor study termination|498|||
33487936|NCT02766088|62866088|FG000|Overall Study|Migrated/moved from the study area|1|||
33487937|NCT02766088|62866088|FG000|Overall Study|Lost to Follow-up|5|||
33487938|NCT02766088|62866088|FG000|Overall Study|Other|1|||
33487939|NCT02766088|62866088|FG000|Overall Study|Death|1|||
33487940|NCT03639675|62866092|FG000|Overall Study|Withdrawal by Subject|1|||
33293815|NCT02564900|62670564|FG001|Dose Expansion|Did not receive treatment|0|||
33293816|NCT02564900|62670565|FG002|Dose Expansion|Did not receive treatment|0|||
33293817|NCT02564900|62670566|FG003|Dose Expansion|Did not receive treatment|0|||
33293818|NCT02564900|62670567|FG004|Dose Expansion|Did not receive treatment|0|||
33293819|NCT02564900|62670568|FG005|Dose Expansion|Did not receive treatment|0|||
33293820|NCT02564900|62670569|FG006|Dose Expansion|Did not receive treatment|1|||
33293821|NCT02564900|62670570|FG007|Dose Expansion|Did not receive treatment|1|||
33293822|NCT02564900|62670571|FG008|Dose Expansion|Did not receive treatment|0|||
33293823|NCT02564900|62670572|FG009|Dose Expansion|Did not receive treatment|0|||
33293824|NCT02564900|62670573|FG010|Dose Expansion|Did not receive treatment|0|||
33293825|NCT02564900|62670574|FG011|Dose Expansion|Did not receive treatment|0|||
33293826|NCT02564900|62670575|FG012|Dose Expansion|Did not receive treatment|0|||
33293827|NCT02564900|62670576|FG013|Dose Expansion|Did not receive treatment|0|||
33293828|NCT02564900|62670577|FG014|Dose Expansion|Did not receive treatment|1|||
33293829|NCT02554279|62670620|FG000|Overall Study|Adverse Event|2|||
33293830|NCT02554279|62670621|FG001|Overall Study|Adverse Event|5|||
33293831|NCT02554279|62670620|FG000|Overall Study|Lost to Follow-up|3|||
33293832|NCT02554279|62670621|FG001|Overall Study|Lost to Follow-up|2|||
33293833|NCT02554279|62670620|FG000|Overall Study|Withdrawal by Subject|6|||
33380917|NCT00789854|62759838|FG002|Overall Study|Severe non-compliance to the protocol|0|||
33380918|NCT00789854|62759836|FG000|Overall Study|Safety reasons|0|||
33380919|NCT00789854|62759837|FG001|Overall Study|Safety reasons|0|||
33380920|NCT00789854|62759838|FG002|Overall Study|Safety reasons|2|||
33380921|NCT00789854|62759836|FG000|Overall Study|Other|6|||
33380922|NCT00789854|62759837|FG001|Overall Study|Other|0|||
33380923|NCT00789854|62759838|FG002|Overall Study|Other|5|||
33380924|NCT00725205|62759846|FG000|Overall Study|Adverse Event|22|||
33380925|NCT00725205|62759846|FG000|Overall Study|Investigator Discontinued|1|||
33380926|NCT00725205|62759846|FG000|Overall Study|Non-compliance With Protocol|14|||
33380927|NCT00725205|62759846|FG000|Overall Study|Other|8|||
33487941|NCT03635775|62866100|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
33487942|NCT03635775|62866101|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
33293834|NCT02554279|62670621|FG001|Overall Study|Withdrawal by Subject|4|||
33380928|NCT00725205|62759846|FG000|Overall Study|Protocol Defined Clinical Event|1|||
33380929|NCT00725205|62759846|FG000|Overall Study|Treatment Failure|41|||
33380930|NCT00443755|62759852|FG000|Overall Study|Withdrawal by Subject|2|||
33293835|NCT02554279|62670620|FG000|Overall Study|Protocol Violation|2|||
33293836|NCT02554279|62670621|FG001|Overall Study|Protocol Violation|1|||
33293837|NCT02554279|62670620|FG000|Overall Study|Other reason|19|||
33293838|NCT02554279|62670621|FG001|Overall Study|Other reason|6|||
33293839|NCT02542293|62670636|FG000|Overall Study|Death|367|||
33380931|NCT00443755|62759853|FG001|Overall Study|Withdrawal by Subject|1|||
33556649|NCT02614196|62949482|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
33380932|NCT00724971|62759859|FG000|Overall Study|Adverse Event|5|||
33380933|NCT00724971|62759859|FG000|Overall Study|Withdrawal by Subject|1|||
33380934|NCT00443599|62759865|FG000|Overall Study|Physician Decision|2|||
33380935|NCT00443599|62759866|FG001|Overall Study|Physician Decision|1|||
33380936|NCT00443599|62759865|FG000|Overall Study|Death|1|||
33380937|NCT00443599|62759866|FG001|Overall Study|Death|1|||
33380938|NCT00443599|62759865|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
33380939|NCT00443599|62759866|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
33380940|NCT00455143|62759872|FG000|Overall Study|Physician Decision|1|||
33380941|NCT00455143|62759872|FG000|Overall Study|Withdrawal by Subject|1|||
33380942|NCT00455143|62759872|FG000|Overall Study|Staff was not avail to follow patient|2|||
33380943|NCT00455143|62759872|FG000|Overall Study|No longer met Inclusion Criteria|1|||
33380944|NCT00455143|62759872|FG000|Overall Study|Surgical time, staff not available|1|||
33380945|NCT00454987|62759880|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
33293840|NCT02542293|62670637|FG001|Overall Study|Death|377|||
33293841|NCT02542293|62670636|FG000|Overall Study|Withdrawal by Subject|8|||
33293842|NCT02542293|62670637|FG001|Overall Study|Withdrawal by Subject|19|||
33293843|NCT02439450|62670665|FG000|Overall Study|Adverse Event|4|||
33293844|NCT02439450|62670666|FG001|Overall Study|Adverse Event|1|||
33293845|NCT02439450|62670667|FG002|Overall Study|Adverse Event|0|||
33380946|NCT00454987|62759881|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
33380947|NCT00454987|62759882|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
33380948|NCT00454987|62759880|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
33380949|NCT00454987|62759881|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
33380950|NCT00454987|62759882|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
33380951|NCT00454987|62759880|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
33380952|NCT00454987|62759881|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
33380953|NCT00454987|62759882|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
33380954|NCT00724893|62759893|FG000|Overall Study|Adverse Event|76|||
33380955|NCT00724893|62759894|FG001|Overall Study|Adverse Event|142|||
33380956|NCT00724893|62759893|FG000|Overall Study|Withdrawal by Subject|0|||
33380957|NCT00724893|62759894|FG001|Overall Study|Withdrawal by Subject|1|||
33380958|NCT00724893|62759893|FG000|Overall Study|Lack of virologic response|94|||
33293846|NCT02439450|62670668|FG003|Overall Study|Adverse Event|0|||
33380959|NCT00724893|62759894|FG001|Overall Study|Lack of virologic response|202|||
33380960|NCT00724893|62759893|FG000|Overall Study|Reason not specified|193|||
33380961|NCT00724893|62759894|FG001|Overall Study|Reason not specified|7|||
33380962|NCT00724893|62759893|FG000|Overall Study|Patient choice|0|||
33380963|NCT00724893|62759894|FG001|Overall Study|Patient choice|26|||
33380964|NCT00724893|62759893|FG000|Overall Study|Geographic reasons|0|||
33380965|NCT00724893|62759894|FG001|Overall Study|Geographic reasons|11|||
33380966|NCT00724893|62759893|FG000|Overall Study|Incarceration|0|||
33380967|NCT00724893|62759894|FG001|Overall Study|Incarceration|9|||
33380968|NCT00724893|62759893|FG000|Overall Study|Substance abuse|0|||
33380969|NCT00724893|62759894|FG001|Overall Study|Substance abuse|3|||
33380970|NCT00724893|62759893|FG000|Overall Study|Financial reasons|0|||
33380971|NCT00724893|62759894|FG001|Overall Study|Financial reasons|2|||
33380972|NCT00724893|62759893|FG000|Overall Study|Assigned shorter treatment|0|||
33380973|NCT00724893|62759894|FG001|Overall Study|Assigned shorter treatment|2|||
33380974|NCT00724893|62759893|FG000|Overall Study|Lost to Follow-up|0|||
33380975|NCT00724893|62759894|FG001|Overall Study|Lost to Follow-up|52|||
33380976|NCT00724893|62759893|FG000|Overall Study|Unknown, missing data|1|||
33380977|NCT00724893|62759894|FG001|Overall Study|Unknown, missing data|1|||
33380978|NCT00789698|62759919|FG000|Overall Study|Lack of Efficacy|10|||
33380979|NCT00789698|62759920|FG001|Overall Study|Lack of Efficacy|4|||
33380980|NCT00789698|62759921|FG002|Overall Study|Lack of Efficacy|5|||
33380981|NCT00789698|62759922|FG003|Overall Study|Lack of Efficacy|18|||
33380982|NCT00789698|62759919|FG000|Overall Study|Adverse Event|5|||
33293847|NCT02439450|62670665|FG000|Overall Study|Withdrawal by Subject|1|||
33293848|NCT02439450|62670666|FG001|Overall Study|Withdrawal by Subject|2|||
33380983|NCT00789698|62759920|FG001|Overall Study|Adverse Event|5|||
33380984|NCT00789698|62759921|FG002|Overall Study|Adverse Event|3|||
33380985|NCT00789698|62759922|FG003|Overall Study|Adverse Event|4|||
33380986|NCT00789698|62759919|FG000|Overall Study|Lost to Follow-up|5|||
33662454|NCT01693523|63093007|FG001|Overall Study|Adverse Event|1|||
33293849|NCT02439450|62670667|FG002|Overall Study|Withdrawal by Subject|0|||
33293850|NCT02439450|62670668|FG003|Overall Study|Withdrawal by Subject|0|||
33293851|NCT02439450|62670665|FG000|Overall Study|Death|3|||
33380987|NCT00789698|62759920|FG001|Overall Study|Lost to Follow-up|5|||
33380988|NCT00789698|62759921|FG002|Overall Study|Lost to Follow-up|2|||
33380989|NCT00789698|62759922|FG003|Overall Study|Lost to Follow-up|9|||
33380990|NCT00789698|62759919|FG000|Overall Study|Protocol Violation|6|||
33380991|NCT00789698|62759920|FG001|Overall Study|Protocol Violation|1|||
33380992|NCT00789698|62759921|FG002|Overall Study|Protocol Violation|2|||
33293852|NCT02439450|62670666|FG001|Overall Study|Death|0|||
33293853|NCT02439450|62670667|FG002|Overall Study|Death|0|||
33380993|NCT00789698|62759922|FG003|Overall Study|Protocol Violation|1|||
33380994|NCT00789698|62759919|FG000|Overall Study|Withdrawal by Subject|14|||
33380995|NCT00789698|62759920|FG001|Overall Study|Withdrawal by Subject|15|||
33380996|NCT00789698|62759921|FG002|Overall Study|Withdrawal by Subject|12|||
33380997|NCT00789698|62759922|FG003|Overall Study|Withdrawal by Subject|19|||
33380998|NCT00789698|62759919|FG000|Overall Study|Administrative|0|||
33380999|NCT00789698|62759920|FG001|Overall Study|Administrative|3|||
33381000|NCT00789698|62759921|FG002|Overall Study|Administrative|3|||
33381001|NCT00789698|62759922|FG003|Overall Study|Administrative|1|||
33381002|NCT00724815|62759933|FG000|Overall Study|Randomized, not treated|31|||
33381003|NCT00724815|62759934|FG001|Overall Study|Randomized, not treated|30|||
33381004|NCT00724815|62759933|FG000|Overall Study|Adverse Event|5|||
33381005|NCT00724815|62759934|FG001|Overall Study|Adverse Event|3|||
33381006|NCT00724815|62759933|FG000|Overall Study|Lost to Follow-up|4|||
33381007|NCT00724815|62759934|FG001|Overall Study|Lost to Follow-up|1|||
33381008|NCT00724815|62759933|FG000|Overall Study|Other Various|3|||
33381009|NCT00724815|62759934|FG001|Overall Study|Other Various|5|||
33381010|NCT00454909|62759943|FG000|Overall Study|Withdrawal by Subject|1|||
33381011|NCT00454909|62759944|FG001|Overall Study|Withdrawal by Subject|0|||
33381012|NCT00454909|62759945|FG002|Overall Study|Withdrawal by Subject|0|||
33381013|NCT00454909|62759943|FG000|Overall Study|Migrated/moved from study area|0|||
33381014|NCT00454909|62759944|FG001|Overall Study|Migrated/moved from study area|0|||
33381015|NCT00454909|62759945|FG002|Overall Study|Migrated/moved from study area|1|||
33381016|NCT00454909|62759943|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
33381017|NCT00454909|62759944|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
33381018|NCT00454909|62759945|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
33381019|NCT00454909|62759943|FG000|Overall Study|Others|1|||
33381020|NCT00454909|62759944|FG001|Overall Study|Others|0|||
33381021|NCT00454909|62759945|FG002|Overall Study|Others|0|||
33381022|NCT00798590|62759956|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
33381023|NCT00798590|62759957|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
33381024|NCT00481195|62759965|FG000|Overall Study|Adverse Event|16|||
33381025|NCT00481195|62759966|FG001|Overall Study|Adverse Event|11|||
33381026|NCT00481195|62759965|FG000|Overall Study|Lack of Efficacy|1|||
33381027|NCT00481195|62759966|FG001|Overall Study|Lack of Efficacy|3|||
33381028|NCT00481195|62759965|FG000|Overall Study|Lost to Follow-up|4|||
33381029|NCT00481195|62759966|FG001|Overall Study|Lost to Follow-up|6|||
33381030|NCT00481195|62759965|FG000|Overall Study|Physician Decision|3|||
33381031|NCT00481195|62759966|FG001|Overall Study|Physician Decision|1|||
33381032|NCT00481195|62759965|FG000|Overall Study|Protocol Violation|10|||
33381033|NCT00481195|62759966|FG001|Overall Study|Protocol Violation|7|||
33381034|NCT00481195|62759965|FG000|Overall Study|Withdrawal by Subject|3|||
33381035|NCT00481195|62759966|FG001|Overall Study|Withdrawal by Subject|9|||
33381036|NCT00481195|62759965|FG000|Overall Study|Miscellaneous|2|||
33381037|NCT00481195|62759966|FG001|Overall Study|Miscellaneous|2|||
33381038|NCT00454363|62759983|FG000|Overall Study|Adverse Event|1|||
33381039|NCT00454363|62759984|FG001|Overall Study|Adverse Event|2|||
33381040|NCT00454363|62759983|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
33381041|NCT00454363|62759984|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
33381042|NCT00454207|62759991|FG000|Overall Study|Adverse Event|3|||
33381043|NCT00454207|62759992|FG001|Overall Study|Adverse Event|1|||
33293854|NCT02439450|62670668|FG003|Overall Study|Death|1|||
33293855|NCT02439450|62670665|FG000|Overall Study|Progressive Disease|18|||
33293856|NCT02439450|62670666|FG001|Overall Study|Progressive Disease|41|||
33293857|NCT02439450|62670667|FG002|Overall Study|Progressive Disease|2|||
33293858|NCT02439450|62670668|FG003|Overall Study|Progressive Disease|3|||
33381044|NCT00454207|62759991|FG000|Overall Study|Lack of Efficacy|1|||
33381045|NCT00454207|62759992|FG001|Overall Study|Lack of Efficacy|0|||
33293861|NCT02421939|62670684|FG000|Overall Study|Progressive disease|70|||
33293862|NCT02421939|62670685|FG001|Overall Study|Progressive disease|16|||
33293863|NCT02421939|62670684|FG000|Overall Study|Lack of Efficacy|21|||
33381046|NCT00454207|62759991|FG000|Overall Study|Protocol Violation|0|||
33381047|NCT00454207|62759992|FG001|Overall Study|Protocol Violation|1|||
33381048|NCT00738894|62760012|FG000|Overall Study|Lost to Follow-up|23|||
33381049|NCT00738894|62760013|FG001|Overall Study|Lost to Follow-up|13|||
33381050|NCT00738894|62760012|FG000|Overall Study|Withdrawal by Subject|10|||
33487943|NCT03635775|62866102|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
33662455|NCT01693523|63093008|FG002|Overall Study|Adverse Event|0|||
33293864|NCT02421939|62670685|FG001|Overall Study|Lack of Efficacy|31|||
33293865|NCT02421939|62670684|FG000|Overall Study|Death|36|||
33293866|NCT02421939|62670685|FG001|Overall Study|Death|10|||
33293867|NCT02421939|62670684|FG000|Overall Study|Disease relapse|33|||
33293868|NCT02421939|62670685|FG001|Overall Study|Disease relapse|2|||
33293869|NCT02421939|62670684|FG000|Overall Study|Adverse Event|28|||
33293870|NCT02421939|62670685|FG001|Overall Study|Adverse Event|5|||
33381051|NCT00738894|62760013|FG001|Overall Study|Withdrawal by Subject|15|||
33381052|NCT00738894|62760012|FG000|Overall Study|Physician Decision|4|||
33381053|NCT00738894|62760013|FG001|Overall Study|Physician Decision|5|||
33662456|NCT01693523|63093006|FG000|Overall Study|Death|0|||
33662457|NCT01693523|63093007|FG001|Overall Study|Death|1|||
33293871|NCT02421939|62670684|FG000|Overall Study|Withdrawal by Subject|5|||
33293872|NCT02421939|62670685|FG001|Overall Study|Withdrawal by Subject|24|||
33293873|NCT02421939|62670684|FG000|Overall Study|Physician Decision|11|||
33293874|NCT02421939|62670685|FG001|Overall Study|Physician Decision|11|||
33293875|NCT02421939|62670684|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
33293876|NCT02421939|62670685|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
33293877|NCT02421939|62670684|FG000|Overall Study|Miscellaneous|4|||
33381054|NCT00738894|62760012|FG000|Overall Study|Death|2|||
33381055|NCT00738894|62760013|FG001|Overall Study|Death|0|||
33381056|NCT00480493|62760021|FG000|Overall Study|moved|2|||
33381057|NCT00480493|62760022|FG001|Overall Study|moved|7|||
33381058|NCT00734994|62760030|FG000|Overall Study|Withdrawal by Subject|1|||
33381059|NCT00798434|62760037|FG000|Double-Blind|Adverse Event|22|||
33381060|NCT00798434|62760038|FG001|Double-Blind|Adverse Event|46|||
33381061|NCT00798434|62760037|FG000|Double-Blind|Death|0|||
33381062|NCT00798434|62760038|FG001|Double-Blind|Death|1|||
33381063|NCT00798434|62760037|FG000|Double-Blind|Lost to Follow-up|1|||
33381064|NCT00798434|62760038|FG001|Double-Blind|Lost to Follow-up|0|||
33381065|NCT00798434|62760037|FG000|Double-Blind|Lack of Efficacy|8|||
33381066|NCT00798434|62760038|FG001|Double-Blind|Lack of Efficacy|12|||
33381067|NCT00798434|62760037|FG000|Double-Blind|Withdrawal by Subject|17|||
33381068|NCT00798434|62760038|FG001|Double-Blind|Withdrawal by Subject|14|||
33381069|NCT00798434|62760037|FG000|Double-Blind|Protocol Violation|1|||
33381070|NCT00798434|62760038|FG001|Double-Blind|Protocol Violation|4|||
33381071|NCT00798434|62760037|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
33381072|NCT00798434|62760038|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
33381073|NCT00798434|62760037|FG000|Double-Blind|Other|1|||
33381074|NCT00798434|62760038|FG001|Double-Blind|Other|0|||
33381075|NCT00798434|62760037|FG000|Double-Blind|Not Treated|3|||
33487944|NCT03635775|62866103|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
33487945|NCT03610581|62866115|FG000|Overall Study|Study terminated by sponsor|2|||
33487946|NCT03610581|62866116|FG001|Overall Study|Study terminated by sponsor|0|||
33487947|NCT03610581|62866115|FG000|Overall Study|Other|0|||
33487948|NCT03610581|62866116|FG001|Overall Study|Other|1|||
33487949|NCT03610581|62866115|FG000|Overall Study|Withdrawal by Subject|1|||
33487950|NCT03610581|62866116|FG001|Overall Study|Withdrawal by Subject|0|||
33487951|NCT03610269|62866122|FG000|Overall Study|Physician Decision|10|||
33487952|NCT03610269|62866122|FG000|Overall Study|Protocol Violation|1|||
33487953|NCT03610269|62866122|FG000|Overall Study|Unable to draw blood|1|||
33487954|NCT03610269|62866122|FG000|Overall Study|Screen fail|4|||
33487955|NCT00121667|62866130|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
33487956|NCT00121667|62866131|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
33487957|NCT00121667|62866132|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
33487958|NCT00121667|62866133|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
33487959|NCT00121667|62866130|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
33487960|NCT00121667|62866131|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
33487961|NCT00121667|62866132|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
33487962|NCT00121667|62866133|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
33487963|NCT00121667|62866130|FG000|Short Term (ST) Period|Adverse Event|5|||
33487964|NCT00121667|62866131|FG001|Short Term (ST) Period|Adverse Event|6|||
33487965|NCT00121667|62866132|FG002|Short Term (ST) Period|Adverse Event|5|||
33487966|NCT00121667|62866133|FG003|Short Term (ST) Period|Adverse Event|3|||
33487967|NCT00121667|62866130|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
33487968|NCT00121667|62866131|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
33487969|NCT00121667|62866132|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
33487970|NCT00121667|62866133|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
33487971|NCT00121667|62866130|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
33487972|NCT00121667|62866131|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
33487973|NCT00121667|62866132|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
33293878|NCT02421939|62670685|FG001|Overall Study|Miscellaneous|5|||
33293879|NCT02421939|62670684|FG000|Overall Study|Protocol deviation|1|||
33381076|NCT00798434|62760038|FG001|Double-Blind|Not Treated|6|||
33381077|NCT00798434|62760037|FG000|Open-Label|Adverse Event|33|||
33381078|NCT00798434|62760038|FG001|Open-Label|Adverse Event|11|||
33487974|NCT00121667|62866133|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
33487975|NCT00121667|62866130|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
33487976|NCT00121667|62866131|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
33487977|NCT00121667|62866132|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
33487978|NCT00121667|62866133|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
33381079|NCT00798434|62760037|FG000|Open-Label|Lack of Efficacy|5|||
33662458|NCT01693523|63093008|FG002|Overall Study|Death|1|||
33293880|NCT02421939|62670685|FG001|Overall Study|Protocol deviation|1|||
33293881|NCT02362464|62670700|FG000|Overall Study|Switched to alternative therapy|1|||
33381080|NCT00798434|62760038|FG001|Open-Label|Lack of Efficacy|11|||
33381081|NCT00798434|62760037|FG000|Open-Label|Withdrawal by Subject|2|||
33381082|NCT00798434|62760038|FG001|Open-Label|Withdrawal by Subject|7|||
33381083|NCT00798434|62760037|FG000|Open-Label|Protocol Violation|1|||
33381084|NCT00798434|62760038|FG001|Open-Label|Protocol Violation|0|||
33381085|NCT00798434|62760037|FG000|Open-Label|Other|1|||
33381086|NCT00798434|62760038|FG001|Open-Label|Other|2|||
33381087|NCT00798434|62760037|FG000|Open-Label|Not Treated|0|||
33381088|NCT00798434|62760038|FG001|Open-Label|Not Treated|1|||
33381089|NCT00724503|62760051|FG000|Overall Study|Lost to Follow-up|4|||
33381090|NCT00724503|62760052|FG001|Overall Study|Lost to Follow-up|8|||
33381091|NCT00724503|62760051|FG000|Overall Study|Withdrawal by Subject|11|||
33381092|NCT00724503|62760052|FG001|Overall Study|Withdrawal by Subject|23|||
33381093|NCT00724503|62760051|FG000|Overall Study|Death|190|||
33381094|NCT00724503|62760052|FG001|Overall Study|Death|182|||
33381095|NCT00724503|62760051|FG000|Overall Study|Adverse Event|1|||
33381096|NCT00724503|62760052|FG001|Overall Study|Adverse Event|0|||
33381097|NCT00724503|62760051|FG000|Overall Study|Not otherwise specified|4|||
33381098|NCT00724503|62760052|FG001|Overall Study|Not otherwise specified|7|||
33381099|NCT00791648|62760062|FG000|Overall Study|Physician Decision|0|||
33381100|NCT00791648|62760063|FG001|Overall Study|Physician Decision|1|||
33381101|NCT00791648|62760062|FG000|Overall Study|Withdrawal by Subject|0|||
33381102|NCT00791648|62760063|FG001|Overall Study|Withdrawal by Subject|1|||
33381103|NCT00791492|62760071|FG000|Overall Study|Withdrawal by Subject|1|||
33381104|NCT00791492|62760072|FG001|Overall Study|Withdrawal by Subject|2|||
33381105|NCT00791492|62760071|FG000|Overall Study|Liver transplantation|5|||
33381106|NCT00791492|62760072|FG001|Overall Study|Liver transplantation|1|||
33381107|NCT00723957|62760080|FG000|Overall Study|Adverse event unrelated to study drug|1|||
33381108|NCT00723957|62760081|FG001|Overall Study|Adverse event unrelated to study drug|4|||
33381109|NCT00723957|62760080|FG000|Overall Study|Death|3|||
33381110|NCT00723957|62760081|FG001|Overall Study|Death|4|||
33381111|NCT00723957|62760080|FG000|Overall Study|Disease progression|27|||
33381112|NCT00723957|62760081|FG001|Overall Study|Disease progression|25|||
33381113|NCT00723957|62760080|FG000|Overall Study|Maximum clinical benefit|4|||
33381114|NCT00723957|62760081|FG001|Overall Study|Maximum clinical benefit|5|||
33381115|NCT00723957|62760080|FG000|Overall Study|Investigator decision|1|||
33381116|NCT00723957|62760081|FG001|Overall Study|Investigator decision|1|||
33381117|NCT00723957|62760080|FG000|Overall Study|Study drug toxicity|4|||
33381118|NCT00723957|62760081|FG001|Overall Study|Study drug toxicity|6|||
33381119|NCT00723957|62760080|FG000|Overall Study|Withdrawal by Subject|7|||
33381120|NCT00723957|62760081|FG001|Overall Study|Withdrawal by Subject|5|||
33381121|NCT00723957|62760080|FG000|Overall Study|Reason not analyzed|1|||
33381122|NCT00723957|62760081|FG001|Overall Study|Reason not analyzed|0|||
33381123|NCT00723957|62760080|FG000|Overall Study|Never received treatment|3|||
33381124|NCT00723957|62760081|FG001|Overall Study|Never received treatment|3|||
33381125|NCT00723801|62760089|FG000|Overall Study|Lost to Follow-up|1|||
33381126|NCT00723801|62760090|FG001|Overall Study|Lost to Follow-up|2|||
33381127|NCT00723801|62760089|FG000|Overall Study|Protocol Violation|2|||
33381128|NCT00723801|62760090|FG001|Overall Study|Protocol Violation|1|||
33381129|NCT00797966|62760100|FG000|Phase A|Lost to Follow-up|0|||
33381130|NCT00797966|62760101|FG001|Phase A|Lost to Follow-up|0|||
33381131|NCT00797966|62760102|FG002|Phase A|Lost to Follow-up|0|||
33381132|NCT00797966|62760103|FG003|Phase A|Lost to Follow-up|0|||
33381133|NCT00797966|62760104|FG004|Phase A|Lost to Follow-up|33|||
33381134|NCT00797966|62760105|FG005|Phase A|Lost to Follow-up|0|||
33381135|NCT00797966|62760100|FG000|Phase A|Adverse Event|0|||
33381136|NCT00797966|62760101|FG001|Phase A|Adverse Event|0|||
33381137|NCT00797966|62760102|FG002|Phase A|Adverse Event|0|||
33381138|NCT00797966|62760103|FG003|Phase A|Adverse Event|0|||
33381139|NCT00797966|62760104|FG004|Phase A|Adverse Event|46|||
33381140|NCT00797966|62760105|FG005|Phase A|Adverse Event|0|||
33381141|NCT00797966|62760100|FG000|Phase A|Met withdrawal criteria|0|||
33381142|NCT00797966|62760101|FG001|Phase A|Met withdrawal criteria|0|||
33381143|NCT00797966|62760102|FG002|Phase A|Met withdrawal criteria|0|||
33381144|NCT00797966|62760103|FG003|Phase A|Met withdrawal criteria|0|||
33381145|NCT00797966|62760104|FG004|Phase A|Met withdrawal criteria|4|||
33381146|NCT00797966|62760105|FG005|Phase A|Met withdrawal criteria|0|||
33381147|NCT00797966|62760100|FG000|Phase A|Physician Decision|0|||
33556650|NCT02614196|62949477|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
33662459|NCT01693523|63093006|FG000|Overall Study|Lost to Follow-up|0|||
33381148|NCT00797966|62760101|FG001|Phase A|Physician Decision|0|||
33381149|NCT00797966|62760102|FG002|Phase A|Physician Decision|0|||
33381150|NCT00797966|62760103|FG003|Phase A|Physician Decision|0|||
33381151|NCT00797966|62760104|FG004|Phase A|Physician Decision|13|||
33381152|NCT00797966|62760105|FG005|Phase A|Physician Decision|0|||
33381153|NCT00797966|62760100|FG000|Phase A|Withdrawal by Subject|0|||
33381154|NCT00797966|62760101|FG001|Phase A|Withdrawal by Subject|0|||
33381155|NCT00797966|62760102|FG002|Phase A|Withdrawal by Subject|0|||
33556651|NCT02614196|62949478|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
33662460|NCT01693523|63093007|FG001|Overall Study|Lost to Follow-up|0|||
33381156|NCT00797966|62760103|FG003|Phase A|Withdrawal by Subject|0|||
33381157|NCT00797966|62760104|FG004|Phase A|Withdrawal by Subject|33|||
33381158|NCT00797966|62760105|FG005|Phase A|Withdrawal by Subject|0|||
33381159|NCT00797966|62760100|FG000|Phase A|Protocol deviation|0|||
33381160|NCT00797966|62760101|FG001|Phase A|Protocol deviation|0|||
33381161|NCT00797966|62760102|FG002|Phase A|Protocol deviation|0|||
33381162|NCT00797966|62760103|FG003|Phase A|Protocol deviation|0|||
33381163|NCT00797966|62760104|FG004|Phase A|Protocol deviation|56|||
33381164|NCT00797966|62760105|FG005|Phase A|Protocol deviation|0|||
33381165|NCT00797966|62760100|FG000|Phase B|Lost to Follow-up|0|||
33381166|NCT00797966|62760101|FG001|Phase B|Lost to Follow-up|1|||
33381167|NCT00797966|62760102|FG002|Phase B|Lost to Follow-up|3|||
33381168|NCT00797966|62760103|FG003|Phase B|Lost to Follow-up|0|||
33381169|NCT00797966|62760104|FG004|Phase B|Lost to Follow-up|0|||
33381170|NCT00797966|62760105|FG005|Phase B|Lost to Follow-up|0|||
33381171|NCT00797966|62760100|FG000|Phase B|Adverse Event|2|||
33381172|NCT00797966|62760101|FG001|Phase B|Adverse Event|1|||
33381173|NCT00797966|62760102|FG002|Phase B|Adverse Event|3|||
33381174|NCT00797966|62760103|FG003|Phase B|Adverse Event|1|||
33381175|NCT00797966|62760104|FG004|Phase B|Adverse Event|0|||
33381176|NCT00797966|62760105|FG005|Phase B|Adverse Event|0|||
33381177|NCT00797966|62760100|FG000|Phase B|Met Withdrawal Criteria|3|||
33381178|NCT00797966|62760101|FG001|Phase B|Met Withdrawal Criteria|3|||
33381179|NCT00797966|62760102|FG002|Phase B|Met Withdrawal Criteria|6|||
33381180|NCT00797966|62760103|FG003|Phase B|Met Withdrawal Criteria|1|||
33381181|NCT00797966|62760104|FG004|Phase B|Met Withdrawal Criteria|0|||
33381182|NCT00797966|62760105|FG005|Phase B|Met Withdrawal Criteria|0|||
33381183|NCT00797966|62760100|FG000|Phase B|Physician Decision|1|||
33381184|NCT00797966|62760101|FG001|Phase B|Physician Decision|0|||
33381185|NCT00797966|62760102|FG002|Phase B|Physician Decision|3|||
33381186|NCT00797966|62760103|FG003|Phase B|Physician Decision|1|||
33381187|NCT00797966|62760104|FG004|Phase B|Physician Decision|0|||
33381188|NCT00797966|62760105|FG005|Phase B|Physician Decision|0|||
33381189|NCT00797966|62760100|FG000|Phase B|Withdrawal by Subject|1|||
33293882|NCT02362464|62670700|FG000|Overall Study|Refused further treatment|1|||
33293883|NCT02362464|62670700|FG000|Overall Study|Physician Decision|4|||
33293884|NCT02312258|62670706|FG000|Overall Study|Lost to Follow-up|8|||
33293885|NCT02312258|62670707|FG001|Overall Study|Lost to Follow-up|8|||
33293886|NCT02312258|62670706|FG000|Overall Study|Withdrawal by Patient|49|||
33293887|NCT02312258|62670707|FG001|Overall Study|Withdrawal by Patient|76|||
33293888|NCT02312258|62670706|FG000|Overall Study|Reason not Specified|107|||
33293889|NCT02312258|62670707|FG001|Overall Study|Reason not Specified|159|||
33293890|NCT02312258|62670706|FG000|Overall Study|Missing|2|||
33293891|NCT02312258|62670707|FG001|Overall Study|Missing|1|||
33293892|NCT02312258|62670706|FG000|Overall Study|Death|115|||
33293893|NCT02312258|62670707|FG001|Overall Study|Death|181|||
33293894|NCT02294461|62670717|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
33293895|NCT02294461|62670718|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
33293896|NCT02294461|62670717|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
33293897|NCT02294461|62670718|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
33293898|NCT02294461|62670717|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
33293899|NCT02294461|62670718|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
33293900|NCT02294461|62670717|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
33293901|NCT02294461|62670718|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
33293902|NCT02294461|62670717|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
33293903|NCT02294461|62670718|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
33293904|NCT02294461|62670717|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
33293905|NCT02294461|62670718|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
33293906|NCT02294461|62670717|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
33293907|NCT02294461|62670718|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
33381190|NCT00797966|62760101|FG001|Phase B|Withdrawal by Subject|4|||
33381191|NCT00797966|62760102|FG002|Phase B|Withdrawal by Subject|3|||
33381192|NCT00797966|62760103|FG003|Phase B|Withdrawal by Subject|3|||
33381193|NCT00797966|62760104|FG004|Phase B|Withdrawal by Subject|0|||
33381194|NCT00797966|62760105|FG005|Phase B|Withdrawal by Subject|0|||
33381195|NCT00797966|62760100|FG000|Phase B|Protocol Deviation|4|||
33293908|NCT02294461|62670717|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
33381196|NCT00797966|62760101|FG001|Phase B|Protocol Deviation|8|||
33381197|NCT00797966|62760102|FG002|Phase B|Protocol Deviation|2|||
33381198|NCT00797966|62760103|FG003|Phase B|Protocol Deviation|6|||
33381199|NCT00797966|62760104|FG004|Phase B|Protocol Deviation|0|||
33381200|NCT00797966|62760105|FG005|Phase B|Protocol Deviation|0|||
33662461|NCT01693523|63093008|FG002|Overall Study|Lost to Follow-up|4|||
33381201|NCT00797966|62760100|FG000|Phase B|Lack of Efficacy|0|||
33381202|NCT00797966|62760101|FG001|Phase B|Lack of Efficacy|1|||
33381203|NCT00797966|62760102|FG002|Phase B|Lack of Efficacy|1|||
33381204|NCT00797966|62760103|FG003|Phase B|Lack of Efficacy|4|||
33381205|NCT00797966|62760104|FG004|Phase B|Lack of Efficacy|0|||
33381206|NCT00797966|62760105|FG005|Phase B|Lack of Efficacy|0|||
33381207|NCT00797966|62760100|FG000|Phase A+|Lost to Follow-up|0|||
33381208|NCT00797966|62760101|FG001|Phase A+|Lost to Follow-up|0|||
33381209|NCT00797966|62760102|FG002|Phase A+|Lost to Follow-up|0|||
33381210|NCT00797966|62760103|FG003|Phase A+|Lost to Follow-up|0|||
33381211|NCT00797966|62760104|FG004|Phase A+|Lost to Follow-up|0|||
33293909|NCT02294461|62670718|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
33293910|NCT02294461|62670717|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
33293911|NCT02294461|62670718|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
33293912|NCT02294461|62670717|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
33293913|NCT02294461|62670718|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
33293914|NCT02294461|62670717|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
33293915|NCT02294461|62670718|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
33293916|NCT02294461|62670717|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
33381212|NCT00797966|62760105|FG005|Phase A+|Lost to Follow-up|9|||
33381213|NCT00797966|62760100|FG000|Phase A+|Met withdrawal criteria|0|||
33381214|NCT00797966|62760101|FG001|Phase A+|Met withdrawal criteria|0|||
33381215|NCT00797966|62760102|FG002|Phase A+|Met withdrawal criteria|0|||
33381216|NCT00797966|62760103|FG003|Phase A+|Met withdrawal criteria|0|||
33381217|NCT00797966|62760104|FG004|Phase A+|Met withdrawal criteria|0|||
33381218|NCT00797966|62760105|FG005|Phase A+|Met withdrawal criteria|5|||
33381219|NCT00797966|62760100|FG000|Phase A+|Withdrawal by Subject|0|||
33381220|NCT00797966|62760101|FG001|Phase A+|Withdrawal by Subject|0|||
33381221|NCT00797966|62760102|FG002|Phase A+|Withdrawal by Subject|0|||
33381222|NCT00797966|62760103|FG003|Phase A+|Withdrawal by Subject|0|||
33381223|NCT00797966|62760104|FG004|Phase A+|Withdrawal by Subject|0|||
33381224|NCT00797966|62760105|FG005|Phase A+|Withdrawal by Subject|6|||
33381225|NCT00797966|62760100|FG000|Phase A+|Adverse Event|0|||
33381226|NCT00797966|62760101|FG001|Phase A+|Adverse Event|0|||
33381227|NCT00797966|62760102|FG002|Phase A+|Adverse Event|0|||
33381228|NCT00797966|62760103|FG003|Phase A+|Adverse Event|0|||
33381229|NCT00797966|62760104|FG004|Phase A+|Adverse Event|0|||
33381230|NCT00797966|62760105|FG005|Phase A+|Adverse Event|4|||
33381231|NCT00797966|62760100|FG000|Phase A+|Protocol deviation|0|||
33381232|NCT00797966|62760101|FG001|Phase A+|Protocol deviation|0|||
33381233|NCT00797966|62760102|FG002|Phase A+|Protocol deviation|0|||
33381234|NCT00797966|62760103|FG003|Phase A+|Protocol deviation|0|||
33381235|NCT00797966|62760104|FG004|Phase A+|Protocol deviation|0|||
33381236|NCT00797966|62760105|FG005|Phase A+|Protocol deviation|4|||
33381237|NCT00723489|62760121|FG000|Overall Study|Physician Decision|0|||
33381238|NCT00723489|62760122|FG001|Overall Study|Physician Decision|1|||
33381239|NCT00723489|62760123|FG002|Overall Study|Physician Decision|0|||
33381240|NCT00723489|62760124|FG003|Overall Study|Physician Decision|0|||
33381241|NCT00723489|62760121|FG000|Overall Study|Pregnancy|0|||
33381242|NCT00723489|62760122|FG001|Overall Study|Pregnancy|0|||
33381243|NCT00723489|62760123|FG002|Overall Study|Pregnancy|0|||
33381244|NCT00723489|62760124|FG003|Overall Study|Pregnancy|1|||
33381245|NCT00723489|62760121|FG000|Overall Study|Withdrawal by Subject|0|||
33381246|NCT00723489|62760122|FG001|Overall Study|Withdrawal by Subject|0|||
33381247|NCT00723489|62760123|FG002|Overall Study|Withdrawal by Subject|0|||
33381248|NCT00723489|62760124|FG003|Overall Study|Withdrawal by Subject|1|||
33381249|NCT00723489|62760121|FG000|Overall Study|Seropositive at baseline|1|||
33381250|NCT00723489|62760122|FG001|Overall Study|Seropositive at baseline|0|||
33487979|NCT00121667|62866130|FG000|Short Term (ST) Period|Other Reason|3|||
33487980|NCT00121667|62866131|FG001|Short Term (ST) Period|Other Reason|0|||
33487981|NCT00121667|62866132|FG002|Short Term (ST) Period|Other Reason|0|||
33293917|NCT02294461|62670718|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
33293918|NCT02294461|62670717|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
33381251|NCT00723489|62760123|FG002|Overall Study|Seropositive at baseline|0|||
33487982|NCT00121667|62866133|FG003|Short Term (ST) Period|Other Reason|0|||
33487983|NCT00121667|62866130|FG000|Short Term (ST) Period|Death|0|||
33487984|NCT00121667|62866131|FG001|Short Term (ST) Period|Death|0|||
33487985|NCT00121667|62866132|FG002|Short Term (ST) Period|Death|0|||
33487986|NCT00121667|62866133|FG003|Short Term (ST) Period|Death|1|||
33487987|NCT00121667|62866130|FG000|Short Term (ST) Period|Pregnancy|0|||
33487988|NCT00121667|62866131|FG001|Short Term (ST) Period|Pregnancy|0|||
33487989|NCT00121667|62866132|FG002|Short Term (ST) Period|Pregnancy|0|||
33487990|NCT00121667|62866133|FG003|Short Term (ST) Period|Pregnancy|1|||
33487991|NCT00121667|62866130|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
33487992|NCT00121667|62866131|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
33487993|NCT00121667|62866132|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
33487994|NCT00121667|62866133|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
33487995|NCT00121667|62866130|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
33487996|NCT00121667|62866131|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
33662462|NCT01693523|63093006|FG000|Overall Study|Physician Decision|0|||
33381252|NCT00723489|62760124|FG003|Overall Study|Seropositive at baseline|0|||
33381253|NCT00723489|62760121|FG000|Overall Study|Prohibited Medication|0|||
33381254|NCT00723489|62760122|FG001|Overall Study|Prohibited Medication|0|||
33381255|NCT00723489|62760123|FG002|Overall Study|Prohibited Medication|0|||
33381256|NCT00723489|62760124|FG003|Overall Study|Prohibited Medication|1|||
33381257|NCT00723489|62760121|FG000|Overall Study|Samples Collected Out of Window|0|||
33381258|NCT00723489|62760122|FG001|Overall Study|Samples Collected Out of Window|3|||
33556652|NCT02614196|62949479|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
33556653|NCT02614196|62949480|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
33556654|NCT02614196|62949481|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
33556655|NCT02614196|62949482|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
33556656|NCT02614196|62949477|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
33293919|NCT02294461|62670718|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
33293920|NCT02294461|62670717|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
33293921|NCT02294461|62670718|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
33293922|NCT02294461|62670717|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
33293923|NCT02294461|62670718|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
33293924|NCT02268851|62670751|FG000|Overall Study|Death|0|||
33293925|NCT02268851|62670752|FG001|Overall Study|Death|0|||
33293926|NCT02268851|62670753|FG002|Overall Study|Death|0|||
33293927|NCT02268851|62670754|FG003|Overall Study|Death|1|||
33293928|NCT02268851|62670755|FG004|Overall Study|Death|2|||
33293929|NCT02268851|62670756|FG005|Overall Study|Death|1|||
33293930|NCT02268851|62670751|FG000|Overall Study|Adverse Event|0|||
33293931|NCT02268851|62670752|FG001|Overall Study|Adverse Event|0|||
33293932|NCT02268851|62670753|FG002|Overall Study|Adverse Event|0|||
33293933|NCT02268851|62670754|FG003|Overall Study|Adverse Event|0|||
33293934|NCT02268851|62670755|FG004|Overall Study|Adverse Event|2|||
33293935|NCT02268851|62670756|FG005|Overall Study|Adverse Event|2|||
33293936|NCT02268851|62670751|FG000|Overall Study|Withdrawal by Subject|0|||
33293937|NCT02268851|62670752|FG001|Overall Study|Withdrawal by Subject|0|||
33293938|NCT02268851|62670753|FG002|Overall Study|Withdrawal by Subject|0|||
33293939|NCT02268851|62670754|FG003|Overall Study|Withdrawal by Subject|2|||
33293940|NCT02268851|62670755|FG004|Overall Study|Withdrawal by Subject|0|||
33293941|NCT02268851|62670756|FG005|Overall Study|Withdrawal by Subject|1|||
33293942|NCT02268851|62670751|FG000|Overall Study|Progressive Disease|1|||
33293943|NCT02268851|62670752|FG001|Overall Study|Progressive Disease|3|||
33293944|NCT02268851|62670753|FG002|Overall Study|Progressive Disease|0|||
33293945|NCT02268851|62670754|FG003|Overall Study|Progressive Disease|0|||
33293946|NCT02268851|62670755|FG004|Overall Study|Progressive Disease|1|||
33293947|NCT02268851|62670756|FG005|Overall Study|Progressive Disease|4|||
33293948|NCT02268851|62670751|FG000|Overall Study|Physician Decision|0|||
33293949|NCT02268851|62670752|FG001|Overall Study|Physician Decision|0|||
33293950|NCT02268851|62670753|FG002|Overall Study|Physician Decision|1|||
33487997|NCT00121667|62866132|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
33487998|NCT00121667|62866133|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
33487999|NCT00121667|62866130|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
33488000|NCT00121667|62866131|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
33488001|NCT00121667|62866132|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
33488002|NCT00121667|62866133|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
33488003|NCT00121667|62866130|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
33488004|NCT00121667|62866131|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
33488005|NCT00121667|62866132|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
33488006|NCT00121667|62866133|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
33488007|NCT00121667|62866130|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
33488008|NCT00121667|62866131|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
33488009|NCT00121667|62866132|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
33488010|NCT00121667|62866133|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
33488011|NCT00121667|62866130|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
33488012|NCT00121667|62866131|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
33488013|NCT00121667|62866132|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
33488014|NCT00121667|62866133|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
33488015|NCT00121667|62866130|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
33488016|NCT00121667|62866131|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
33556657|NCT02614196|62949478|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
33556658|NCT02614196|62949479|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
33556659|NCT02614196|62949480|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
33662463|NCT01693523|63093007|FG001|Overall Study|Physician Decision|0|||
33293951|NCT02268851|62670754|FG003|Overall Study|Physician Decision|0|||
33293952|NCT02268851|62670755|FG004|Overall Study|Physician Decision|0|||
33293953|NCT02268851|62670756|FG005|Overall Study|Physician Decision|1|||
33293954|NCT02268851|62670751|FG000|Overall Study|Patient Compliance|0|||
33293955|NCT02268851|62670752|FG001|Overall Study|Patient Compliance|0|||
33293956|NCT02268851|62670753|FG002|Overall Study|Patient Compliance|0|||
33293957|NCT02268851|62670754|FG003|Overall Study|Patient Compliance|0|||
33293958|NCT02268851|62670755|FG004|Overall Study|Patient Compliance|1|||
33293959|NCT02268851|62670756|FG005|Overall Study|Patient Compliance|1|||
33293960|NCT02268851|62670751|FG000|Overall Study|Co-Morbid Condition|0|||
33293961|NCT02268851|62670752|FG001|Overall Study|Co-Morbid Condition|0|||
33293962|NCT02268851|62670753|FG002|Overall Study|Co-Morbid Condition|0|||
33293963|NCT02268851|62670754|FG003|Overall Study|Co-Morbid Condition|0|||
33293964|NCT02268851|62670755|FG004|Overall Study|Co-Morbid Condition|1|||
33293965|NCT02268851|62670756|FG005|Overall Study|Co-Morbid Condition|1|||
33293966|NCT02242942|62670773|FG000|Overall Study|Death|17|||
33293967|NCT02242942|62670774|FG001|Overall Study|Death|20|||
33293968|NCT02242942|62670775|FG002|Overall Study|Death|2|||
33293969|NCT02242942|62670773|FG000|Overall Study|Physician Decision|1|||
33293970|NCT02242942|62670774|FG001|Overall Study|Physician Decision|0|||
33293971|NCT02242942|62670775|FG002|Overall Study|Physician Decision|0|||
33293972|NCT02242942|62670773|FG000|Overall Study|Withdrawal by Subject|8|||
33293973|NCT02242942|62670774|FG001|Overall Study|Withdrawal by Subject|10|||
33293974|NCT02242942|62670775|FG002|Overall Study|Withdrawal by Subject|0|||
33293975|NCT02242942|62670773|FG000|Overall Study|On-going in Study|190|||
33293976|NCT02242942|62670774|FG001|Overall Study|On-going in Study|186|||
33293977|NCT02242942|62670775|FG002|Overall Study|On-going in Study|11|||
33293978|NCT02091960|62670803|FG000|Overall Study|Death|7|||
33293979|NCT02091960|62670803|FG000|Overall Study|Withdrawal by Subject|1|||
33293980|NCT02091960|62670803|FG000|Overall Study|Miscellaneous Reasons|31|||
33293981|NCT02091960|62670803|FG000|Overall Study|On Study at Data Cut-off|12|||
33293982|NCT02049515|62670809|FG000|Overall Study|Adverse Event|46|||
33293983|NCT02049515|62670810|FG001|Overall Study|Adverse Event|2|||
33293984|NCT02049515|62670809|FG000|Overall Study|Protocol-specified Disease Progression|23|||
33293985|NCT02049515|62670810|FG001|Overall Study|Protocol-specified Disease Progression|2|||
33293986|NCT02049515|62670809|FG000|Overall Study|Death|6|||
33293987|NCT02049515|62670810|FG001|Overall Study|Death|0|||
33293988|NCT02049515|62670809|FG000|Overall Study|Physician Decision|5|||
33293989|NCT02049515|62670810|FG001|Overall Study|Physician Decision|1|||
33293990|NCT02049515|62670809|FG000|Overall Study|Withdrawal by Subject|3|||
33293991|NCT02049515|62670810|FG001|Overall Study|Withdrawal by Subject|0|||
33293992|NCT02049515|62670809|FG000|Overall Study|Termination of the Study by Sponsor|2|||
33293993|NCT02049515|62670810|FG001|Overall Study|Termination of the Study by Sponsor|0|||
33293994|NCT02049515|62670809|FG000|Overall Study|Protocol Violation|1|||
33293995|NCT02049515|62670810|FG001|Overall Study|Protocol Violation|1|||
33293996|NCT02049515|62670809|FG000|Overall Study|Clinical Deterioration|1|||
33293997|NCT02049515|62670810|FG001|Overall Study|Clinical Deterioration|0|||
33293998|NCT02049515|62670809|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
33293999|NCT02049515|62670810|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
33294000|NCT02049515|62670809|FG000|Overall Study|Treatment Interruption >42 Days|1|||
33294001|NCT02049515|62670810|FG001|Overall Study|Treatment Interruption >42 Days|0|||
33294002|NCT02049515|62670809|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
33294003|NCT02049515|62670810|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
33294004|NCT02039401|62670818|FG000|Overall Study|Adverse Event|0|||
33294005|NCT02039401|62670819|FG001|Overall Study|Adverse Event|1|||
33294006|NCT02004691|62670828|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
33294007|NCT02004691|62670829|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
33294008|NCT02004691|62670828|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1|||
33294009|NCT02004691|62670829|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0|||
33294010|NCT02004691|62670828|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0|||
33294011|NCT02004691|62670829|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1|||
33294012|NCT02004691|62670828|FG000|ETP: Ongoing From Week 52|Other|0|||
33294013|NCT02004691|62670829|FG001|ETP: Ongoing From Week 52|Other|1|||
33294014|NCT02004691|62670828|FG000|ETP: Ongoing From Week 52|Ongoing|16|||
33294015|NCT02004691|62670829|FG001|ETP: Ongoing From Week 52|Ongoing|16|||
33294016|NCT02004522|62670837|FG000|Overall Study|Adverse Event|55|||
33294017|NCT02004522|62670838|FG001|Overall Study|Adverse Event|6|||
33294018|NCT02004522|62670837|FG000|Overall Study|Withdrawal by Subject|13|||
33294019|NCT02004522|62670838|FG001|Overall Study|Withdrawal by Subject|7|||
33294020|NCT02004522|62670837|FG000|Overall Study|Death|12|||
33294021|NCT02004522|62670838|FG001|Overall Study|Death|3|||
33294022|NCT02004522|62670837|FG000|Overall Study|Physician Decision|3|||
33294023|NCT02004522|62670838|FG001|Overall Study|Physician Decision|4|||
33294024|NCT02004522|62670837|FG000|Overall Study|Protocol Violation|1|||
33294025|NCT02004522|62670838|FG001|Overall Study|Protocol Violation|0|||
33294026|NCT02004522|62670837|FG000|Overall Study|Other is reason listed by PI|4|||
33294027|NCT02004522|62670838|FG001|Overall Study|Other is reason listed by PI|1|||
33294028|NCT02004522|62670837|FG000|Overall Study|Never Dosed|2|||
33294029|NCT02004522|62670838|FG001|Overall Study|Never Dosed|4|||
33294030|NCT02004522|62670837|FG000|Overall Study|Disease Progression|35|||
33294031|NCT02004522|62670838|FG001|Overall Study|Disease Progression|31|||
33294032|NCT02004522|62670837|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
33294033|NCT02004522|62670838|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
33294034|NCT01959139|62670848|FG000|Phase II|Disease progression|0|||
33294035|NCT01959139|62670849|FG001|Phase II|Disease progression|0|||
33294036|NCT01959139|62670850|FG002|Phase II|Disease progression|26|||
33294037|NCT01959139|62670851|FG003|Phase II|Disease progression|34|||
33294038|NCT01959139|62670848|FG000|Phase II|Adverse Event|0|||
33294039|NCT01959139|62670849|FG001|Phase II|Adverse Event|0|||
33294040|NCT01959139|62670850|FG002|Phase II|Adverse Event|10|||
33294041|NCT01959139|62670851|FG003|Phase II|Adverse Event|11|||
33294042|NCT01959139|62670848|FG000|Phase II|Patient Refusal|0|||
33294043|NCT01959139|62670849|FG001|Phase II|Patient Refusal|0|||
33294044|NCT01959139|62670850|FG002|Phase II|Patient Refusal|5|||
33294045|NCT01959139|62670851|FG003|Phase II|Patient Refusal|4|||
33294046|NCT01959139|62670848|FG000|Phase II|Death|0|||
33294047|NCT01959139|62670849|FG001|Phase II|Death|0|||
33294048|NCT01959139|62670850|FG002|Phase II|Death|3|||
33294049|NCT01959139|62670851|FG003|Phase II|Death|1|||
33294050|NCT01959139|62670848|FG000|Phase II|Other/Unknown|0|||
33294051|NCT01959139|62670849|FG001|Phase II|Other/Unknown|0|||
33294052|NCT01959139|62670850|FG002|Phase II|Other/Unknown|8|||
33294053|NCT01959139|62670851|FG003|Phase II|Other/Unknown|5|||
33294054|NCT01959139|62670848|FG000|Phase II|On treatment|0|||
33294055|NCT01959139|62670849|FG001|Phase II|On treatment|0|||
33294056|NCT01959139|62670850|FG002|Phase II|On treatment|4|||
33294057|NCT01959139|62670851|FG003|Phase II|On treatment|0|||
33294058|NCT01932697|62670868|FG000|Overall Study|Received a different amount of tx|1|||
33294059|NCT01932697|62670869|FG001|Overall Study|Received a different amount of tx|0|||
33294060|NCT01932697|62670868|FG000|Overall Study|Ineligible|1|||
33294061|NCT01932697|62670869|FG001|Overall Study|Ineligible|0|||
33294062|NCT01844505|62670883|FG000|Overall Study|Disease progression|170|||
33294063|NCT01844505|62670884|FG001|Overall Study|Disease progression|88|||
33294064|NCT01844505|62670885|FG002|Overall Study|Disease progression|224|||
33294065|NCT01844505|62670883|FG000|Overall Study|Study drug toxicity|40|||
33294066|NCT01844505|62670884|FG001|Overall Study|Study drug toxicity|131|||
33294067|NCT01844505|62670885|FG002|Overall Study|Study drug toxicity|50|||
33294068|NCT01844505|62670883|FG000|Overall Study|Death|1|||
33294069|NCT01844505|62670884|FG001|Overall Study|Death|3|||
33294070|NCT01844505|62670885|FG002|Overall Study|Death|1|||
33294071|NCT01844505|62670883|FG000|Overall Study|Adverse event unrelated to study drug|7|||
33294072|NCT01844505|62670884|FG001|Overall Study|Adverse event unrelated to study drug|15|||
33294073|NCT01844505|62670885|FG002|Overall Study|Adverse event unrelated to study drug|6|||
33294074|NCT01844505|62670883|FG000|Overall Study|Subject request discontinue treatment|17|||
33294075|NCT01844505|62670884|FG001|Overall Study|Subject request discontinue treatment|14|||
33294076|NCT01844505|62670885|FG002|Overall Study|Subject request discontinue treatment|8|||
33294077|NCT01844505|62670883|FG000|Overall Study|Withdrawal by Subject|0|||
33294078|NCT01844505|62670884|FG001|Overall Study|Withdrawal by Subject|3|||
33294079|NCT01844505|62670885|FG002|Overall Study|Withdrawal by Subject|0|||
33294080|NCT01844505|62670883|FG000|Overall Study|Lost to Follow-up|1|||
33294081|NCT01844505|62670884|FG001|Overall Study|Lost to Follow-up|0|||
33294082|NCT01844505|62670885|FG002|Overall Study|Lost to Follow-up|0|||
33294083|NCT01844505|62670883|FG000|Overall Study|Maximum clinical benefit|8|||
33294084|NCT01844505|62670884|FG001|Overall Study|Maximum clinical benefit|11|||
33294085|NCT01844505|62670885|FG002|Overall Study|Maximum clinical benefit|2|||
33294086|NCT01844505|62670883|FG000|Overall Study|Poor/non-compliance|1|||
33294087|NCT01844505|62670884|FG001|Overall Study|Poor/non-compliance|1|||
33294088|NCT01844505|62670885|FG002|Overall Study|Poor/non-compliance|1|||
33294089|NCT01844505|62670883|FG000|Overall Study|Subject no longer meets criteria|0|||
33294090|NCT01844505|62670884|FG001|Overall Study|Subject no longer meets criteria|1|||
33294091|NCT01844505|62670885|FG002|Overall Study|Subject no longer meets criteria|0|||
33294092|NCT01844505|62670883|FG000|Overall Study|Other Reasons|4|||
33294093|NCT01844505|62670884|FG001|Overall Study|Other Reasons|2|||
33294094|NCT01844505|62670885|FG002|Overall Study|Other Reasons|2|||
33294095|NCT01844505|62670883|FG000|Overall Study|Not Reported|0|||
33294096|NCT01844505|62670884|FG001|Overall Study|Not Reported|0|||
33294097|NCT01844505|62670885|FG002|Overall Study|Not Reported|1|||
33294098|NCT01739309|62670928|FG000|Overall Study|Adverse Event|1|||
33294099|NCT01739309|62670928|FG000|Overall Study|Withdrawal by Subject|1|||
33294100|NCT01659658|62670939|FG000|Overall Study|Withdrawal by Patient|18|||
33294101|NCT01659658|62670940|FG001|Overall Study|Withdrawal by Patient|4|||
33294102|NCT01659658|62670941|FG002|Overall Study|Withdrawal by Patient|2|||
33294103|NCT01659658|62670942|FG003|Overall Study|Withdrawal by Patient|0|||
33294104|NCT01659658|62670943|FG004|Overall Study|Withdrawal by Patient|11|||
33294105|NCT01659658|62670939|FG000|Overall Study|Study Terminated by Sponsor|9|||
33294106|NCT01659658|62670940|FG001|Overall Study|Study Terminated by Sponsor|7|||
33294107|NCT01659658|62670941|FG002|Overall Study|Study Terminated by Sponsor|0|||
33294108|NCT01659658|62670942|FG003|Overall Study|Study Terminated by Sponsor|1|||
33294109|NCT01659658|62670943|FG004|Overall Study|Study Terminated by Sponsor|4|||
33294110|NCT01659658|62670939|FG000|Overall Study|Reason not Specified|61|||
33294111|NCT01659658|62670940|FG001|Overall Study|Reason not Specified|15|||
33294112|NCT01659658|62670941|FG002|Overall Study|Reason not Specified|8|||
33294113|NCT01659658|62670942|FG003|Overall Study|Reason not Specified|1|||
33294114|NCT01659658|62670943|FG004|Overall Study|Reason not Specified|34|||
33294115|NCT01659658|62670939|FG000|Overall Study|Lost to Follow-up|2|||
33294116|NCT01659658|62670940|FG001|Overall Study|Lost to Follow-up|0|||
33294117|NCT01659658|62670941|FG002|Overall Study|Lost to Follow-up|0|||
33294118|NCT01659658|62670942|FG003|Overall Study|Lost to Follow-up|0|||
33294119|NCT01659658|62670943|FG004|Overall Study|Lost to Follow-up|0|||
33294120|NCT01357161|62670972|FG000|Part 1 (Open Label Run-in)|Death|5|||
33294121|NCT01357161|62670973|FG001|Part 1 (Open Label Run-in)|Death|0|||
33294122|NCT01357161|62670974|FG002|Part 1 (Open Label Run-in)|Death|0|||
33294123|NCT01357161|62670972|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
33294124|NCT01357161|62670973|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
33294125|NCT01357161|62670974|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
33294126|NCT01357161|62670972|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
33294127|NCT01357161|62670973|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
33294128|NCT01357161|62670974|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
33294129|NCT01357161|62670972|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
33294130|NCT01357161|62670973|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
33294131|NCT01357161|62670974|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
33294132|NCT01357161|62670972|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
33294133|NCT01357161|62670973|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
33294134|NCT01357161|62670974|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
33294135|NCT01357161|62670972|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
33294136|NCT01357161|62670973|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
33294137|NCT01357161|62670974|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
33294138|NCT01357161|62670972|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
33294139|NCT01357161|62670973|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
33294140|NCT01357161|62670974|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
33294141|NCT01357161|62670972|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
33294142|NCT01357161|62670973|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
33294143|NCT01357161|62670974|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
33294144|NCT01357161|62670972|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
33294145|NCT01357161|62670973|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
33294146|NCT01357161|62670974|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
33294147|NCT01357161|62670972|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
33294148|NCT01357161|62670973|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
33294149|NCT01357161|62670974|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
33294150|NCT01357161|62670972|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
33294151|NCT01357161|62670973|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
33294152|NCT01357161|62670974|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
33294153|NCT01321073|62670982|FG000|Overall Study|Did not attempt implant|4|||
33294154|NCT01321073|62670982|FG000|Overall Study|Death|3|||
33294155|NCT01276704|62670988|FG000|Overall Study|Lost to Follow-up|2|||
33294156|NCT01276704|62670989|FG001|Overall Study|Lost to Follow-up|3|||
33294157|NCT01276704|62670988|FG000|Overall Study|Non-compliant|2|||
33294158|NCT01276704|62670989|FG001|Overall Study|Non-compliant|2|||
33294159|NCT01276704|62670988|FG000|Overall Study|Withdrawal by Subject|7|||
33294160|NCT01276704|62670989|FG001|Overall Study|Withdrawal by Subject|1|||
33294161|NCT01276704|62670988|FG000|Overall Study|Physician Decision|3|||
33294162|NCT01276704|62670989|FG001|Overall Study|Physician Decision|5|||
33294163|NCT01190930|62670997|FG000|Induction|Adverse Event|17|||
33294164|NCT01190930|62670998|FG001|Induction|Adverse Event|0|||
33294165|NCT01190930|62670999|FG002|Induction|Adverse Event|0|||
33294166|NCT01190930|62671000|FG003|Induction|Adverse Event|0|||
33294167|NCT01190930|62671001|FG004|Induction|Adverse Event|0|||
33294168|NCT01190930|62671002|FG005|Induction|Adverse Event|0|||
33294169|NCT01190930|62671003|FG006|Induction|Adverse Event|0|||
33294170|NCT01190930|62671004|FG007|Induction|Adverse Event|0|||
33294171|NCT01190930|62671005|FG008|Induction|Adverse Event|0|||
33294172|NCT01190930|62671006|FG009|Induction|Adverse Event|0|||
33294173|NCT01190930|62670997|FG000|Induction|Death|34|||
33294174|NCT01190930|62670998|FG001|Induction|Death|0|||
33294175|NCT01190930|62670999|FG002|Induction|Death|0|||
33294176|NCT01190930|62671000|FG003|Induction|Death|0|||
33294177|NCT01190930|62671001|FG004|Induction|Death|0|||
33294178|NCT01190930|62671002|FG005|Induction|Death|0|||
33294179|NCT01190930|62671003|FG006|Induction|Death|0|||
33294180|NCT01190930|62671004|FG007|Induction|Death|0|||
33294181|NCT01190930|62671005|FG008|Induction|Death|0|||
33294182|NCT01190930|62671006|FG009|Induction|Death|0|||
33294183|NCT01190930|62670997|FG000|Induction|Lost to Follow-up|1|||
33294184|NCT01190930|62670998|FG001|Induction|Lost to Follow-up|0|||
33294185|NCT01190930|62670999|FG002|Induction|Lost to Follow-up|0|||
33294186|NCT01190930|62671000|FG003|Induction|Lost to Follow-up|0|||
33294187|NCT01190930|62671001|FG004|Induction|Lost to Follow-up|0|||
33294188|NCT01190930|62671002|FG005|Induction|Lost to Follow-up|0|||
33294189|NCT01190930|62671003|FG006|Induction|Lost to Follow-up|0|||
33294190|NCT01190930|62671004|FG007|Induction|Lost to Follow-up|0|||
33294191|NCT01190930|62671005|FG008|Induction|Lost to Follow-up|0|||
33294192|NCT01190930|62671006|FG009|Induction|Lost to Follow-up|0|||
33294193|NCT01190930|62670997|FG000|Induction|Physician Decision|125|||
33294194|NCT01190930|62670998|FG001|Induction|Physician Decision|3|||
33294195|NCT01190930|62670999|FG002|Induction|Physician Decision|0|||
33294196|NCT01190930|62671000|FG003|Induction|Physician Decision|0|||
33294197|NCT01190930|62671001|FG004|Induction|Physician Decision|0|||
33294198|NCT01190930|62671002|FG005|Induction|Physician Decision|0|||
33294199|NCT01190930|62671003|FG006|Induction|Physician Decision|0|||
33294200|NCT01190930|62671004|FG007|Induction|Physician Decision|0|||
33294201|NCT01190930|62671005|FG008|Induction|Physician Decision|0|||
33294202|NCT01190930|62671006|FG009|Induction|Physician Decision|0|||
33294203|NCT01190930|62670997|FG000|Induction|Withdrawal by Subject|9|||
33294204|NCT01190930|62670998|FG001|Induction|Withdrawal by Subject|0|||
33294205|NCT01190930|62670999|FG002|Induction|Withdrawal by Subject|0|||
33294206|NCT01190930|62671000|FG003|Induction|Withdrawal by Subject|0|||
33294207|NCT01190930|62671001|FG004|Induction|Withdrawal by Subject|0|||
33294208|NCT01190930|62671002|FG005|Induction|Withdrawal by Subject|0|||
33294209|NCT01190930|62671003|FG006|Induction|Withdrawal by Subject|0|||
33294210|NCT01190930|62671004|FG007|Induction|Withdrawal by Subject|0|||
33294211|NCT01190930|62671005|FG008|Induction|Withdrawal by Subject|0|||
33294212|NCT01190930|62671006|FG009|Induction|Withdrawal by Subject|0|||
33294213|NCT01190930|62670997|FG000|Induction|Refusal|235|||
33294214|NCT01190930|62670998|FG001|Induction|Refusal|0|||
33294215|NCT01190930|62670999|FG002|Induction|Refusal|0|||
33294216|NCT01190930|62671000|FG003|Induction|Refusal|0|||
33294217|NCT01190930|62671001|FG004|Induction|Refusal|0|||
33294218|NCT01190930|62671002|FG005|Induction|Refusal|0|||
33294219|NCT01190930|62671003|FG006|Induction|Refusal|0|||
33294220|NCT01190930|62671004|FG007|Induction|Refusal|0|||
33294221|NCT01190930|62671005|FG008|Induction|Refusal|0|||
33294222|NCT01190930|62671006|FG009|Induction|Refusal|0|||
33294223|NCT01190930|62670997|FG000|Induction|Inevaluable|23|||
33294224|NCT01190930|62670998|FG001|Induction|Inevaluable|1|||
33294225|NCT01190930|62670999|FG002|Induction|Inevaluable|0|||
33294226|NCT01190930|62671000|FG003|Induction|Inevaluable|0|||
33294227|NCT01190930|62671001|FG004|Induction|Inevaluable|0|||
33294228|NCT01190930|62671002|FG005|Induction|Inevaluable|0|||
33294229|NCT01190930|62671003|FG006|Induction|Inevaluable|0|||
33294230|NCT01190930|62671004|FG007|Induction|Inevaluable|0|||
33294231|NCT01190930|62671005|FG008|Induction|Inevaluable|0|||
33294232|NCT01190930|62671006|FG009|Induction|Inevaluable|0|||
33294233|NCT01190930|62670997|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
33294234|NCT01190930|62670998|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33294235|NCT01190930|62670999|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33294236|NCT01190930|62671000|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33294237|NCT01190930|62671001|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33294238|NCT01190930|62671002|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33294239|NCT01190930|62671003|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33294240|NCT01190930|62671004|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33294241|NCT01190930|62671005|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33294242|NCT01190930|62671006|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33294243|NCT01190930|62670997|FG000|Induction|High Risk Downs|80|||
33294244|NCT01190930|62670998|FG001|Induction|High Risk Downs|0|||
33294245|NCT01190930|62670999|FG002|Induction|High Risk Downs|0|||
33294246|NCT01190930|62671000|FG003|Induction|High Risk Downs|0|||
33294247|NCT01190930|62671001|FG004|Induction|High Risk Downs|0|||
33294248|NCT01190930|62671002|FG005|Induction|High Risk Downs|0|||
33294249|NCT01190930|62671003|FG006|Induction|High Risk Downs|0|||
33294250|NCT01190930|62671004|FG007|Induction|High Risk Downs|0|||
33294251|NCT01190930|62671005|FG008|Induction|High Risk Downs|0|||
33294252|NCT01190930|62671006|FG009|Induction|High Risk Downs|0|||
33294253|NCT01190930|62670997|FG000|Induction|Enrollment onto another COG Protocol|1|||
33294254|NCT01190930|62670998|FG001|Induction|Enrollment onto another COG Protocol|0|||
33294255|NCT01190930|62670999|FG002|Induction|Enrollment onto another COG Protocol|0|||
33294256|NCT01190930|62671000|FG003|Induction|Enrollment onto another COG Protocol|0|||
33294257|NCT01190930|62671001|FG004|Induction|Enrollment onto another COG Protocol|0|||
33294258|NCT01190930|62671002|FG005|Induction|Enrollment onto another COG Protocol|0|||
33294259|NCT01190930|62671003|FG006|Induction|Enrollment onto another COG Protocol|0|||
33294260|NCT01190930|62671004|FG007|Induction|Enrollment onto another COG Protocol|0|||
33294261|NCT01190930|62671005|FG008|Induction|Enrollment onto another COG Protocol|0|||
33294262|NCT01190930|62671006|FG009|Induction|Enrollment onto another COG Protocol|0|||
33381259|NCT00723489|62760123|FG002|Overall Study|Samples Collected Out of Window|0|||
33294263|NCT01190930|62670997|FG000|Induction|Average Risk|1847|||
33294264|NCT01190930|62670998|FG001|Induction|Average Risk|0|||
33294265|NCT01190930|62670999|FG002|Induction|Average Risk|0|||
33294266|NCT01190930|62671000|FG003|Induction|Average Risk|0|||
33294267|NCT01190930|62671001|FG004|Induction|Average Risk|0|||
33294268|NCT01190930|62671002|FG005|Induction|Average Risk|0|||
33294269|NCT01190930|62671003|FG006|Induction|Average Risk|0|||
33294270|NCT01190930|62671004|FG007|Induction|Average Risk|0|||
33294271|NCT01190930|62671005|FG008|Induction|Average Risk|0|||
33294272|NCT01190930|62671006|FG009|Induction|Average Risk|0|||
33294273|NCT01190930|62670997|FG000|Induction|High Risk|1227|||
33294274|NCT01190930|62670998|FG001|Induction|High Risk|0|||
33294275|NCT01190930|62670999|FG002|Induction|High Risk|0|||
33294276|NCT01190930|62671000|FG003|Induction|High Risk|0|||
33294277|NCT01190930|62671001|FG004|Induction|High Risk|0|||
33294278|NCT01190930|62671002|FG005|Induction|High Risk|0|||
33294279|NCT01190930|62671003|FG006|Induction|High Risk|0|||
33294280|NCT01190930|62671004|FG007|Induction|High Risk|0|||
33294281|NCT01190930|62671005|FG008|Induction|High Risk|0|||
33294282|NCT01190930|62671006|FG009|Induction|High Risk|0|||
33294283|NCT01190930|62670997|FG000|Induction|Low Risk|443|||
33294284|NCT01190930|62670998|FG001|Induction|Low Risk|0|||
33294285|NCT01190930|62670999|FG002|Induction|Low Risk|0|||
33294286|NCT01190930|62671000|FG003|Induction|Low Risk|0|||
33294287|NCT01190930|62671001|FG004|Induction|Low Risk|0|||
33294288|NCT01190930|62671002|FG005|Induction|Low Risk|0|||
33294289|NCT01190930|62671003|FG006|Induction|Low Risk|0|||
33294290|NCT01190930|62671004|FG007|Induction|Low Risk|0|||
33294291|NCT01190930|62671005|FG008|Induction|Low Risk|0|||
33294292|NCT01190930|62671006|FG009|Induction|Low Risk|0|||
33294293|NCT01190930|62670997|FG000|Induction|Very High Risk|1012|||
33294294|NCT01190930|62670998|FG001|Induction|Very High Risk|0|||
33294295|NCT01190930|62670999|FG002|Induction|Very High Risk|0|||
33294296|NCT01190930|62671000|FG003|Induction|Very High Risk|0|||
33294297|NCT01190930|62671001|FG004|Induction|Very High Risk|0|||
33294298|NCT01190930|62671002|FG005|Induction|Very High Risk|0|||
33294299|NCT01190930|62671003|FG006|Induction|Very High Risk|0|||
33294300|NCT01190930|62671004|FG007|Induction|Very High Risk|0|||
33294301|NCT01190930|62671005|FG008|Induction|Very High Risk|0|||
33294302|NCT01190930|62671006|FG009|Induction|Very High Risk|0|||
33294303|NCT01190930|62670997|FG000|Induction|Philadelphia chromosome-positive|99|||
33294304|NCT01190930|62670998|FG001|Induction|Philadelphia chromosome-positive|0|||
33294305|NCT01190930|62670999|FG002|Induction|Philadelphia chromosome-positive|0|||
33294306|NCT01190930|62671000|FG003|Induction|Philadelphia chromosome-positive|0|||
33294307|NCT01190930|62671001|FG004|Induction|Philadelphia chromosome-positive|0|||
33294308|NCT01190930|62671002|FG005|Induction|Philadelphia chromosome-positive|0|||
33294309|NCT01190930|62671003|FG006|Induction|Philadelphia chromosome-positive|0|||
33294310|NCT01190930|62671004|FG007|Induction|Philadelphia chromosome-positive|0|||
33294311|NCT01190930|62671005|FG008|Induction|Philadelphia chromosome-positive|0|||
33294312|NCT01190930|62671006|FG009|Induction|Philadelphia chromosome-positive|0|||
33294313|NCT01190930|62670997|FG000|Induction|Incomplete Induction data|63|||
33294314|NCT01190930|62670998|FG001|Induction|Incomplete Induction data|0|||
33294315|NCT01190930|62670999|FG002|Induction|Incomplete Induction data|0|||
33294316|NCT01190930|62671000|FG003|Induction|Incomplete Induction data|0|||
33294317|NCT01190930|62671001|FG004|Induction|Incomplete Induction data|0|||
33294318|NCT01190930|62671002|FG005|Induction|Incomplete Induction data|0|||
33294319|NCT01190930|62671003|FG006|Induction|Incomplete Induction data|0|||
33294320|NCT01190930|62671004|FG007|Induction|Incomplete Induction data|0|||
33294321|NCT01190930|62671005|FG008|Induction|Incomplete Induction data|0|||
33294322|NCT01190930|62671006|FG009|Induction|Incomplete Induction data|0|||
33381260|NCT00723489|62760124|FG003|Overall Study|Samples Collected Out of Window|0|||
33381261|NCT00587990|62760137|FG000|Overall Study|Death|0|||
33381262|NCT00587990|62760138|FG001|Overall Study|Death|0|||
33381263|NCT00587990|62760139|FG002|Overall Study|Death|1|||
33381264|NCT00723255|62760147|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
33381265|NCT00723255|62760147|FG000|Overall Study|Ineligible: Second primary|1|||
33381266|NCT00723255|62760147|FG000|Overall Study|Ineligible: Wrong Primary|2|||
33381267|NCT00791258|62760163|FG000|Overall Study|Adverse Event|87|||
33381268|NCT00791258|62760163|FG000|Overall Study|Lost to Follow-up|18|||
33381269|NCT00791258|62760163|FG000|Overall Study|Protocol Violation|109|||
33381270|NCT00791258|62760163|FG000|Overall Study|Withdrawal by Subject|40|||
33381271|NCT00791258|62760163|FG000|Overall Study|Did not take medication for >3 days|1|||
33381272|NCT00791258|62760163|FG000|Overall Study|subject left area|2|||
33381273|NCT00791258|62760163|FG000|Overall Study|non-compliance|3|||
33381274|NCT00791258|62760163|FG000|Overall Study|Subject incarcerated|1|||
33381275|NCT00791258|62760163|FG000|Overall Study|Subject required restricted medication|1|||
33381276|NCT00791258|62760163|FG000|Overall Study|Lack of Efficacy|1|||
33381277|NCT00808067|62760169|FG000|Overall Study|Major/minor bleed|30|||
33381278|NCT00808067|62760170|FG001|Overall Study|Major/minor bleed|44|||
33488017|NCT00121667|62866132|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
33488018|NCT00121667|62866133|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
33488019|NCT00121667|62866130|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
33294323|NCT01190930|62670997|FG000|Induction|Progressive disease|0|||
33294324|NCT01190930|62670998|FG001|Induction|Progressive disease|1|||
33294325|NCT01190930|62670999|FG002|Induction|Progressive disease|0|||
33294326|NCT01190930|62671000|FG003|Induction|Progressive disease|0|||
33294327|NCT01190930|62671001|FG004|Induction|Progressive disease|0|||
33294328|NCT01190930|62671002|FG005|Induction|Progressive disease|0|||
33294329|NCT01190930|62671003|FG006|Induction|Progressive disease|0|||
33381279|NCT00808067|62760169|FG000|Overall Study|Outcome event - other|33|||
33381280|NCT00808067|62760170|FG001|Overall Study|Outcome event - other|25|||
33381281|NCT00808067|62760169|FG000|Overall Study|Adverse Event|111|||
33381282|NCT00808067|62760170|FG001|Overall Study|Adverse Event|121|||
33381283|NCT00808067|62760169|FG000|Overall Study|Hospitalization (not including surgery)|18|||
33381284|NCT00808067|62760170|FG001|Overall Study|Hospitalization (not including surgery)|17|||
33381285|NCT00808067|62760169|FG000|Overall Study|Hospitalization due to surgery|37|||
33381286|NCT00808067|62760170|FG001|Overall Study|Hospitalization due to surgery|40|||
33381287|NCT00808067|62760169|FG000|Overall Study|Reduced creatinine clearance|53|||
33381288|NCT00808067|62760170|FG001|Overall Study|Reduced creatinine clearance|55|||
33381289|NCT00808067|62760169|FG000|Overall Study|Elevated LFT results|7|||
33381290|NCT00808067|62760170|FG001|Overall Study|Elevated LFT results|3|||
33381291|NCT00808067|62760169|FG000|Overall Study|Patient refused to take study medication|65|||
33381292|NCT00808067|62760170|FG001|Overall Study|Patient refused to take study medication|76|||
33381293|NCT00808067|62760169|FG000|Overall Study|Missing|1|||
33381294|NCT00808067|62760170|FG001|Overall Study|Missing|0|||
33381295|NCT00808067|62760169|FG000|Overall Study|Death|1|||
33381296|NCT00808067|62760170|FG001|Overall Study|Death|1|||
33381297|NCT00808067|62760169|FG000|Overall Study|Procedure|6|||
33381298|NCT00808067|62760170|FG001|Overall Study|Procedure|7|||
33294330|NCT01190930|62671004|FG007|Induction|Progressive disease|0|||
33294331|NCT01190930|62671005|FG008|Induction|Progressive disease|0|||
33294332|NCT01190930|62671006|FG009|Induction|Progressive disease|0|||
33294333|NCT01190930|62670997|FG000|Induction|No treatment|3|||
33294334|NCT01190930|62670998|FG001|Induction|No treatment|0|||
33294335|NCT01190930|62670999|FG002|Induction|No treatment|0|||
33294336|NCT01190930|62671000|FG003|Induction|No treatment|0|||
33294337|NCT01190930|62671001|FG004|Induction|No treatment|0|||
33294338|NCT01190930|62671002|FG005|Induction|No treatment|0|||
33294339|NCT01190930|62671003|FG006|Induction|No treatment|0|||
33294340|NCT01190930|62671004|FG007|Induction|No treatment|0|||
33294341|NCT01190930|62671005|FG008|Induction|No treatment|0|||
33294342|NCT01190930|62671006|FG009|Induction|No treatment|0|||
33294343|NCT01190930|62670997|FG000|Induction|Ineligible|69|||
33294344|NCT01190930|62670998|FG001|Induction|Ineligible|4|||
33294345|NCT01190930|62670999|FG002|Induction|Ineligible|0|||
33294346|NCT01190930|62671000|FG003|Induction|Ineligible|0|||
33294347|NCT01190930|62671001|FG004|Induction|Ineligible|0|||
33294348|NCT01190930|62671002|FG005|Induction|Ineligible|0|||
33294349|NCT01190930|62671003|FG006|Induction|Ineligible|0|||
33294350|NCT01190930|62671004|FG007|Induction|Ineligible|0|||
33294351|NCT01190930|62671005|FG008|Induction|Ineligible|0|||
33294352|NCT01190930|62671006|FG009|Induction|Ineligible|0|||
33294353|NCT01190930|62670997|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
33294354|NCT01190930|62670998|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
33294355|NCT01190930|62670999|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
33294356|NCT01190930|62671000|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
33294357|NCT01190930|62671001|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
33294358|NCT01190930|62671002|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
33294359|NCT01190930|62671003|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
33294360|NCT01190930|62671004|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
33294361|NCT01190930|62671005|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
33294362|NCT01190930|62671006|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
33294363|NCT01190930|62670997|FG000|Post Induction Pre-Maintenance|Death|0|||
33294364|NCT01190930|62670998|FG001|Post Induction Pre-Maintenance|Death|0|||
33294365|NCT01190930|62670999|FG002|Post Induction Pre-Maintenance|Death|8|||
33294366|NCT01190930|62671000|FG003|Post Induction Pre-Maintenance|Death|4|||
33294367|NCT01190930|62671001|FG004|Post Induction Pre-Maintenance|Death|0|||
33294368|NCT01190930|62671002|FG005|Post Induction Pre-Maintenance|Death|0|||
33294369|NCT01190930|62671003|FG006|Post Induction Pre-Maintenance|Death|0|||
33294370|NCT01190930|62671004|FG007|Post Induction Pre-Maintenance|Death|0|||
33294371|NCT01190930|62671005|FG008|Post Induction Pre-Maintenance|Death|0|||
33294372|NCT01190930|62671006|FG009|Post Induction Pre-Maintenance|Death|0|||
33294373|NCT01190930|62670997|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
33294374|NCT01190930|62670998|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
33381299|NCT00808067|62760169|FG000|Overall Study|Withdrawal by Subject|21|||
33381300|NCT00808067|62760170|FG001|Overall Study|Withdrawal by Subject|25|||
33381301|NCT00808067|62760169|FG000|Overall Study|Site closed|4|||
33381302|NCT00808067|62760170|FG001|Overall Study|Site closed|3|||
33381303|NCT00808067|62760169|FG000|Overall Study|Physician Decision|47|||
33662464|NCT01693523|63093008|FG002|Overall Study|Physician Decision|1|||
33294375|NCT01190930|62670999|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
33294376|NCT01190930|62671000|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
33294377|NCT01190930|62671001|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
33294378|NCT01190930|62671002|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
33294379|NCT01190930|62671003|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
33294380|NCT01190930|62671004|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
33294381|NCT01190930|62671005|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
33381304|NCT00808067|62760170|FG001|Overall Study|Physician Decision|38|||
33381305|NCT00808067|62760169|FG000|Overall Study|Protocol Violation|3|||
33381306|NCT00808067|62760170|FG001|Overall Study|Protocol Violation|11|||
33294382|NCT01190930|62671006|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
33294383|NCT01190930|62670997|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
33294384|NCT01190930|62670998|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
33294385|NCT01190930|62670999|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
33294386|NCT01190930|62671000|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
33294387|NCT01190930|62671001|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
33381307|NCT00808067|62760169|FG000|Overall Study|Patient elected|7|||
33381308|NCT00808067|62760170|FG001|Overall Study|Patient elected|9|||
33381309|NCT00808067|62760169|FG000|Overall Study|Site closed for cause|19|||
33381310|NCT00808067|62760170|FG001|Overall Study|Site closed for cause|19|||
33381311|NCT00808067|62760169|FG000|Overall Study|Other reason not defined above|5|||
33381312|NCT00808067|62760170|FG001|Overall Study|Other reason not defined above|5|||
33381313|NCT00808067|62760169|FG000|Overall Study|Excluded from analysis|13|||
33381314|NCT00808067|62760170|FG001|Overall Study|Excluded from analysis|19|||
33381315|NCT00723021|62760176|FG000|Intervention Period 4|Adverse Event|0|||
33381316|NCT00723021|62760177|FG001|Intervention Period 4|Adverse Event|0|||
33381317|NCT00723021|62760178|FG002|Intervention Period 4|Adverse Event|0|||
33381318|NCT00723021|62760179|FG003|Intervention Period 4|Adverse Event|0|||
33381319|NCT00723021|62760180|FG004|Intervention Period 4|Adverse Event|1|||
33381320|NCT00721227|62760201|FG000|Overall Study|Lost to Follow-up|3|||
33381321|NCT00721227|62760202|FG001|Overall Study|Lost to Follow-up|0|||
33381322|NCT00721227|62760201|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
33381323|NCT00721227|62760202|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
33381324|NCT00807599|62760210|FG000|Overall Study|Not treated on protocol study|0|||
33381325|NCT00807599|62760211|FG001|Overall Study|Not treated on protocol study|0|||
33381326|NCT00807599|62760212|FG002|Overall Study|Not treated on protocol study|2|||
33381327|NCT00807599|62760210|FG000|Overall Study|Adverse Event|0|||
33381328|NCT00807599|62760211|FG001|Overall Study|Adverse Event|0|||
33381329|NCT00807599|62760212|FG002|Overall Study|Adverse Event|5|||
33381330|NCT00807599|62760210|FG000|Overall Study|Inadequate response to induction|0|||
33381331|NCT00807599|62760211|FG001|Overall Study|Inadequate response to induction|0|||
33381332|NCT00807599|62760212|FG002|Overall Study|Inadequate response to induction|9|||
33381333|NCT00807599|62760210|FG000|Overall Study|Withdrawal by Subject|0|||
33381334|NCT00807599|62760211|FG001|Overall Study|Withdrawal by Subject|0|||
33381335|NCT00807599|62760212|FG002|Overall Study|Withdrawal by Subject|1|||
33381336|NCT00721149|62760218|FG000|Overall Study|Physician Decision|1|||
33381337|NCT00788372|62760222|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
33381338|NCT00788372|62760222|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
33381339|NCT00788372|62760222|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
33381340|NCT00788372|62760222|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
33381341|NCT00788372|62760222|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
33381342|NCT00788372|62760222|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
33294388|NCT01190930|62671002|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
33294389|NCT01190930|62671003|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
33294390|NCT01190930|62671004|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
33294391|NCT01190930|62671005|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
33294392|NCT01190930|62671006|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
33294393|NCT01190930|62670997|FG000|Post Induction Pre-Maintenance|Refusal|0|||
33294394|NCT01190930|62670998|FG001|Post Induction Pre-Maintenance|Refusal|2|||
33294395|NCT01190930|62670999|FG002|Post Induction Pre-Maintenance|Refusal|694|||
33294396|NCT01190930|62671000|FG003|Post Induction Pre-Maintenance|Refusal|4|||
33294397|NCT01190930|62671001|FG004|Post Induction Pre-Maintenance|Refusal|0|||
33294398|NCT01190930|62671002|FG005|Post Induction Pre-Maintenance|Refusal|3|||
33294399|NCT01190930|62671003|FG006|Post Induction Pre-Maintenance|Refusal|0|||
33294400|NCT01190930|62671004|FG007|Post Induction Pre-Maintenance|Refusal|0|||
33294401|NCT01190930|62671005|FG008|Post Induction Pre-Maintenance|Refusal|0|||
33294402|NCT01190930|62671006|FG009|Post Induction Pre-Maintenance|Refusal|0|||
33294403|NCT01190930|62670997|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
33294404|NCT01190930|62670998|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
33294405|NCT01190930|62670999|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
33294406|NCT01190930|62671000|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
33381343|NCT00788372|62760222|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
33294407|NCT01190930|62671001|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
33294408|NCT01190930|62671002|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
33294409|NCT01190930|62671003|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
33381344|NCT00738582|62760226|FG000|Combination Therapy|Completed Combination Therapy|1|||
33381345|NCT00738582|62760227|FG001|Combination Therapy|Completed Combination Therapy|0|||
33381346|NCT00738582|62760226|FG000|Combination Therapy|Physician Decision|1|||
33381347|NCT00738582|62760227|FG001|Combination Therapy|Physician Decision|0|||
33381348|NCT00738582|62760226|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
33381349|NCT00738582|62760227|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
33381350|NCT00738582|62760226|FG000|Combination Therapy|Other|5|||
33294410|NCT01190930|62671004|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
33294411|NCT01190930|62671005|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
33294412|NCT01190930|62671006|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
33294413|NCT01190930|62670997|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33294414|NCT01190930|62670998|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
33294415|NCT01190930|62670999|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33294416|NCT01190930|62671000|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33294417|NCT01190930|62671001|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33294418|NCT01190930|62671002|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33294419|NCT01190930|62671003|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33294420|NCT01190930|62671004|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33294421|NCT01190930|62671005|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33294422|NCT01190930|62671006|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33294423|NCT01190930|62670997|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
33294424|NCT01190930|62670998|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
33294425|NCT01190930|62670999|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
33294426|NCT01190930|62671000|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
33294427|NCT01190930|62671001|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
33294428|NCT01190930|62671002|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
33294429|NCT01190930|62671003|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
33294430|NCT01190930|62671004|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
33294431|NCT01190930|62671005|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
33381351|NCT00738582|62760227|FG001|Combination Therapy|Other|0|||
33381352|NCT00738582|62760226|FG000|Combination Therapy|Adverse Event|16|||
33381353|NCT00738582|62760227|FG001|Combination Therapy|Adverse Event|0|||
33381354|NCT00738582|62760226|FG000|Combination Therapy|Progressive Disease|9|||
33381355|NCT00738582|62760227|FG001|Combination Therapy|Progressive Disease|0|||
33381356|NCT00738582|62760226|FG000|Maintenance Therapy|Other|0|||
33381357|NCT00738582|62760227|FG001|Maintenance Therapy|Other|2|||
33381358|NCT00738582|62760226|FG000|Maintenance Therapy|Adverse Event|0|||
33381359|NCT00738582|62760227|FG001|Maintenance Therapy|Adverse Event|6|||
33381360|NCT00738582|62760226|FG000|Maintenance Therapy|Progressive Disease|0|||
33381361|NCT00738582|62760227|FG001|Maintenance Therapy|Progressive Disease|47|||
33381362|NCT00738582|62760226|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
33381363|NCT00738582|62760227|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
33381364|NCT00720759|62760238|FG000|Overall Study|Lost to Follow-up|0|||
33381365|NCT00720759|62760239|FG001|Overall Study|Lost to Follow-up|1|||
33381366|NCT00720759|62760240|FG002|Overall Study|Lost to Follow-up|1|||
33381367|NCT00720759|62760241|FG003|Overall Study|Lost to Follow-up|0|||
33381368|NCT00720213|62760251|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
33381369|NCT00720213|62760252|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
33381370|NCT00720213|62760253|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
33381371|NCT00810407|62760261|FG000|Overall Study|Protocol Violation|3|||
33381372|NCT00810407|62760261|FG000|Overall Study|No Visit After First Day of Treatment|3|||
33381373|NCT00720057|62760267|FG000|Overall Study|Lost to Follow-up|0|||
33381374|NCT00720057|62760268|FG001|Overall Study|Lost to Follow-up|2|||
33381375|NCT00720057|62760267|FG000|Overall Study|Protocol Violation|1|||
33381376|NCT00720057|62760268|FG001|Overall Study|Protocol Violation|0|||
33381377|NCT00720057|62760267|FG000|Overall Study|Withdrawal by Subject|0|||
33381378|NCT00720057|62760268|FG001|Overall Study|Withdrawal by Subject|1|||
33381379|NCT00790868|62760276|FG000|Overall Study|Withdrawal by Subject|4|||
33381380|NCT00790868|62760277|FG001|Overall Study|Withdrawal by Subject|5|||
33381381|NCT00790868|62760276|FG000|Overall Study|Lost to Follow-up|2|||
33381382|NCT00790868|62760277|FG001|Overall Study|Lost to Follow-up|12|||
33381383|NCT00719901|62760285|FG000|Overall Study|Adverse Event|5|||
33381384|NCT00719901|62760285|FG000|Overall Study|Withdrawal by Subject|1|||
33381385|NCT00719901|62760285|FG000|Overall Study|Alternate Treatment|1|||
33381386|NCT00719901|62760285|FG000|Overall Study|Disease Progression|3|||
33294432|NCT01190930|62671006|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
33294433|NCT01190930|62670997|FG000|Post Induction Pre-Maintenance|Relapse|0|||
33294434|NCT01190930|62670998|FG001|Post Induction Pre-Maintenance|Relapse|0|||
33294435|NCT01190930|62670999|FG002|Post Induction Pre-Maintenance|Relapse|1|||
33294436|NCT01190930|62671000|FG003|Post Induction Pre-Maintenance|Relapse|0|||
33381387|NCT00719901|62760285|FG000|Overall Study|Availability of Study Drug|1|||
33381388|NCT00807365|62760289|FG000|Overall Study|Study Terminated|5|||
33381389|NCT00719355|62760295|FG000|Overall Study|Death|0|||
33381390|NCT00719355|62760296|FG001|Overall Study|Death|1|||
33381391|NCT00719355|62760295|FG000|Overall Study|Medical|14|||
33381392|NCT00719355|62760296|FG001|Overall Study|Medical|5|||
33381393|NCT00719355|62760295|FG000|Overall Study|Compliance|4|||
33381394|NCT00719355|62760296|FG001|Overall Study|Compliance|6|||
33381395|NCT00719355|62760295|FG000|Overall Study|Moved|0|||
33381396|NCT00719355|62760296|FG001|Overall Study|Moved|1|||
33294437|NCT01190930|62671001|FG004|Post Induction Pre-Maintenance|Relapse|0|||
33294438|NCT01190930|62671002|FG005|Post Induction Pre-Maintenance|Relapse|0|||
33294439|NCT01190930|62671003|FG006|Post Induction Pre-Maintenance|Relapse|0|||
33294440|NCT01190930|62671004|FG007|Post Induction Pre-Maintenance|Relapse|0|||
33294441|NCT01190930|62671005|FG008|Post Induction Pre-Maintenance|Relapse|0|||
33294442|NCT01190930|62671006|FG009|Post Induction Pre-Maintenance|Relapse|0|||
33294443|NCT01190930|62670997|FG000|Maintenance|Adverse Event|0|||
33294444|NCT01190930|62670998|FG001|Maintenance|Adverse Event|0|||
33294445|NCT01190930|62670999|FG002|Maintenance|Adverse Event|0|||
33294446|NCT01190930|62671000|FG003|Maintenance|Adverse Event|0|||
33294447|NCT01190930|62671001|FG004|Maintenance|Adverse Event|0|||
33294448|NCT01190930|62671002|FG005|Maintenance|Adverse Event|1|||
33294449|NCT01190930|62671003|FG006|Maintenance|Adverse Event|1|||
33294450|NCT01190930|62671004|FG007|Maintenance|Adverse Event|3|||
33294451|NCT01190930|62671005|FG008|Maintenance|Adverse Event|3|||
33294452|NCT01190930|62671006|FG009|Maintenance|Adverse Event|0|||
33294453|NCT01190930|62670997|FG000|Maintenance|Death|0|||
33294454|NCT01190930|62670998|FG001|Maintenance|Death|0|||
33294455|NCT01190930|62670999|FG002|Maintenance|Death|0|||
33294456|NCT01190930|62671000|FG003|Maintenance|Death|1|||
33294457|NCT01190930|62671001|FG004|Maintenance|Death|0|||
33294458|NCT01190930|62671002|FG005|Maintenance|Death|0|||
33294459|NCT01190930|62671003|FG006|Maintenance|Death|2|||
33294460|NCT01190930|62671004|FG007|Maintenance|Death|2|||
33294461|NCT01190930|62671005|FG008|Maintenance|Death|2|||
33294462|NCT01190930|62671006|FG009|Maintenance|Death|2|||
33381397|NCT00590759|62760302|FG000|Overall Study|Death|52|||
33381398|NCT00590759|62760302|FG000|Overall Study|Lost to Follow-up|28|||
33381399|NCT00734604|62760312|FG000|Overall Study|Adverse Event|0|||
33381400|NCT00734604|62760313|FG001|Overall Study|Adverse Event|2|||
33381401|NCT00734604|62760314|FG002|Overall Study|Adverse Event|0|||
33381402|NCT00734604|62760315|FG003|Overall Study|Adverse Event|2|||
33381403|NCT00734604|62760316|FG004|Overall Study|Adverse Event|1|||
33381404|NCT00734604|62760317|FG005|Overall Study|Adverse Event|1|||
33381405|NCT00734604|62760312|FG000|Overall Study|Serious Adverse Event|1|||
33381406|NCT00734604|62760313|FG001|Overall Study|Serious Adverse Event|0|||
33381407|NCT00734604|62760314|FG002|Overall Study|Serious Adverse Event|1|||
33381408|NCT00734604|62760315|FG003|Overall Study|Serious Adverse Event|2|||
33381409|NCT00734604|62760316|FG004|Overall Study|Serious Adverse Event|0|||
33381410|NCT00734604|62760317|FG005|Overall Study|Serious Adverse Event|1|||
33381411|NCT00734604|62760312|FG000|Overall Study|Lost to Follow-up|1|||
33381412|NCT00734604|62760313|FG001|Overall Study|Lost to Follow-up|2|||
33381413|NCT00734604|62760314|FG002|Overall Study|Lost to Follow-up|2|||
33381414|NCT00734604|62760315|FG003|Overall Study|Lost to Follow-up|4|||
33381415|NCT00734604|62760316|FG004|Overall Study|Lost to Follow-up|2|||
33381416|NCT00734604|62760317|FG005|Overall Study|Lost to Follow-up|3|||
33381417|NCT00734604|62760312|FG000|Overall Study|Physician Decision|0|||
33381418|NCT00734604|62760313|FG001|Overall Study|Physician Decision|1|||
33381419|NCT00734604|62760314|FG002|Overall Study|Physician Decision|1|||
33381420|NCT00734604|62760315|FG003|Overall Study|Physician Decision|0|||
33381421|NCT00734604|62760316|FG004|Overall Study|Physician Decision|0|||
33381422|NCT00734604|62760317|FG005|Overall Study|Physician Decision|0|||
33381423|NCT00734604|62760312|FG000|Overall Study|Protocol Violation|0|||
33381424|NCT00734604|62760313|FG001|Overall Study|Protocol Violation|2|||
33381425|NCT00734604|62760314|FG002|Overall Study|Protocol Violation|0|||
33381426|NCT00734604|62760315|FG003|Overall Study|Protocol Violation|0|||
33381427|NCT00734604|62760316|FG004|Overall Study|Protocol Violation|1|||
33381428|NCT00734604|62760317|FG005|Overall Study|Protocol Violation|0|||
33381429|NCT00734604|62760312|FG000|Overall Study|Sponsor Decision|1|||
33381430|NCT00734604|62760313|FG001|Overall Study|Sponsor Decision|2|||
33381431|NCT00734604|62760314|FG002|Overall Study|Sponsor Decision|1|||
33381432|NCT00734604|62760315|FG003|Overall Study|Sponsor Decision|0|||
33381433|NCT00734604|62760316|FG004|Overall Study|Sponsor Decision|2|||
33556660|NCT02614196|62949481|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
33294463|NCT01190930|62670997|FG000|Maintenance|Lost to Follow-up|0|||
33294464|NCT01190930|62670998|FG001|Maintenance|Lost to Follow-up|0|||
33294465|NCT01190930|62670999|FG002|Maintenance|Lost to Follow-up|0|||
33294466|NCT01190930|62671000|FG003|Maintenance|Lost to Follow-up|0|||
33294467|NCT01190930|62671001|FG004|Maintenance|Lost to Follow-up|0|||
33381434|NCT00734604|62760317|FG005|Overall Study|Sponsor Decision|0|||
33381435|NCT00734604|62760312|FG000|Overall Study|Withdrawal by Subject|0|||
33381436|NCT00734604|62760313|FG001|Overall Study|Withdrawal by Subject|2|||
33381437|NCT00734604|62760314|FG002|Overall Study|Withdrawal by Subject|0|||
33381438|NCT00734604|62760315|FG003|Overall Study|Withdrawal by Subject|1|||
33381439|NCT00734604|62760316|FG004|Overall Study|Withdrawal by Subject|2|||
33381440|NCT00734604|62760317|FG005|Overall Study|Withdrawal by Subject|1|||
33381441|NCT00734604|62760312|FG000|Overall Study|Lack of Efficacy|0|||
33294468|NCT01190930|62671002|FG005|Maintenance|Lost to Follow-up|0|||
33294469|NCT01190930|62671003|FG006|Maintenance|Lost to Follow-up|1|||
33294470|NCT01190930|62671004|FG007|Maintenance|Lost to Follow-up|1|||
33294471|NCT01190930|62671005|FG008|Maintenance|Lost to Follow-up|1|||
33294472|NCT01190930|62671006|FG009|Maintenance|Lost to Follow-up|0|||
33381442|NCT00734604|62760313|FG001|Overall Study|Lack of Efficacy|1|||
33381443|NCT00734604|62760314|FG002|Overall Study|Lack of Efficacy|1|||
33381444|NCT00734604|62760315|FG003|Overall Study|Lack of Efficacy|0|||
33381445|NCT00734604|62760316|FG004|Overall Study|Lack of Efficacy|0|||
33381446|NCT00734604|62760317|FG005|Overall Study|Lack of Efficacy|0|||
33381447|NCT00590681|62760328|FG000|Overall Study|Withdrawal by Subject|7|||
33381448|NCT00590681|62760328|FG000|Overall Study|Adverse Event|8|||
33381449|NCT00590681|62760328|FG000|Overall Study|Death|3|||
33381450|NCT00590681|62760328|FG000|Overall Study|Lost to Follow-up|1|||
33381451|NCT00590681|62760328|FG000|Overall Study|disease progression|1|||
33381452|NCT00727272|62760332|FG000|Washout Period A|Adverse Event|0|||
33381453|NCT00727272|62760333|FG001|Washout Period A|Adverse Event|0|||
33294473|NCT01190930|62670997|FG000|Maintenance|Physician Decision|0|||
33294474|NCT01190930|62670998|FG001|Maintenance|Physician Decision|1|||
33381454|NCT00727272|62760334|FG002|Washout Period A|Adverse Event|1|||
33381455|NCT00727272|62760332|FG000|Washout Period B|Withdrawal by Subject|0|||
33381456|NCT00727272|62760333|FG001|Washout Period B|Withdrawal by Subject|0|||
33381457|NCT00727272|62760334|FG002|Washout Period B|Withdrawal by Subject|1|||
33381458|NCT00805025|62760344|FG000|Overall Study|Screened but not enrolled/treated|42|||
33381459|NCT00805025|62760344|FG000|Overall Study|Adverse Event|4|||
33381460|NCT00805025|62760344|FG000|Overall Study|Withdrawal by Subject|2|||
33381461|NCT00805025|62760344|FG000|Overall Study|Physician Decision|1|||
33381462|NCT00734214|62760350|FG000|Overall Study|Withdrawal by Subject|3|||
33381463|NCT00734214|62760351|FG001|Overall Study|Withdrawal by Subject|4|||
33381464|NCT00734214|62760350|FG000|Overall Study|MD withdrawal|1|||
33381465|NCT00734214|62760351|FG001|Overall Study|MD withdrawal|0|||
33381466|NCT00787202|62760362|FG000|Overall Study|Adverse Event|3|||
33381467|NCT00787202|62760363|FG001|Overall Study|Adverse Event|2|||
33381468|NCT00787202|62760364|FG002|Overall Study|Adverse Event|0|||
33381469|NCT00787202|62760365|FG003|Overall Study|Adverse Event|0|||
33488020|NCT00121667|62866131|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
33488021|NCT00121667|62866132|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
33488022|NCT00121667|62866133|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
33488023|NCT00121667|62866130|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
33488024|NCT00121667|62866131|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
33488025|NCT00121667|62866132|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
33488026|NCT00121667|62866133|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
33488027|NCT02954601|62866147|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
33488028|NCT02954601|62866148|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
33488029|NCT02954601|62866149|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
33488030|NCT02954601|62866150|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
33488031|NCT03633903|62866162|FG000|Overall Study|Withdrawal by Subject|1|||
33488032|NCT03633903|62866163|FG001|Overall Study|Withdrawal by Subject|2|||
33488033|NCT03633903|62866162|FG000|Overall Study|Lost to Follow-up|5|||
33488034|NCT03633903|62866163|FG001|Overall Study|Lost to Follow-up|5|||
33488035|NCT03607695|62866169|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
33488036|NCT03607695|62866169|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
33488037|NCT03557775|62866176|FG000|Overall Study|Withdrawal by Subject|1|||
33488038|NCT03557775|62866177|FG001|Overall Study|Withdrawal by Subject|2|||
33488039|NCT03557775|62866178|FG002|Overall Study|Withdrawal by Subject|4|||
33488040|NCT03557775|62866176|FG000|Overall Study|Physician Decision|0|||
33488041|NCT03557775|62866177|FG001|Overall Study|Physician Decision|1|||
33488042|NCT03557775|62866178|FG002|Overall Study|Physician Decision|0|||
33488043|NCT00121199|62866186|FG000|Overall Study|Adverse Event|11|||
33488044|NCT00121199|62866186|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
33488045|NCT00121199|62866186|FG000|Overall Study|Progression/Relapse|1|||
33488046|NCT00121199|62866186|FG000|Overall Study|Death|3|||
33294475|NCT01190930|62670999|FG002|Maintenance|Physician Decision|0|||
33294476|NCT01190930|62671000|FG003|Maintenance|Physician Decision|5|||
33294477|NCT01190930|62671001|FG004|Maintenance|Physician Decision|9|||
33294478|NCT01190930|62671002|FG005|Maintenance|Physician Decision|4|||
33294479|NCT01190930|62671003|FG006|Maintenance|Physician Decision|8|||
33294480|NCT01190930|62671004|FG007|Maintenance|Physician Decision|8|||
33488047|NCT00121199|62866186|FG000|Overall Study|Other - Not Protocol Specified|3|||
33488048|NCT00121199|62866186|FG000|Overall Study|Ineligible|9|||
33488049|NCT00119405|62866190|FG000|Overall Study|Withdrawal by Subject|1|||
33381470|NCT00787202|62760366|FG004|Overall Study|Adverse Event|2|||
33381471|NCT00787202|62760362|FG000|Overall Study|Lack of Efficacy|5|||
33381472|NCT00787202|62760363|FG001|Overall Study|Lack of Efficacy|6|||
33381473|NCT00787202|62760364|FG002|Overall Study|Lack of Efficacy|5|||
33488050|NCT00119015|62866196|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
33488051|NCT00119015|62866197|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
33488052|NCT00119015|62866198|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
33294481|NCT01190930|62671005|FG008|Maintenance|Physician Decision|10|||
33381474|NCT00787202|62760365|FG003|Overall Study|Lack of Efficacy|2|||
33381475|NCT00787202|62760366|FG004|Overall Study|Lack of Efficacy|1|||
33381476|NCT00787202|62760362|FG000|Overall Study|Lost to Follow-up|1|||
33381477|NCT00787202|62760363|FG001|Overall Study|Lost to Follow-up|0|||
33381478|NCT00787202|62760364|FG002|Overall Study|Lost to Follow-up|0|||
33381479|NCT00787202|62760365|FG003|Overall Study|Lost to Follow-up|0|||
33381480|NCT00787202|62760366|FG004|Overall Study|Lost to Follow-up|0|||
33381481|NCT00787202|62760362|FG000|Overall Study|Withdrawal by Subject|2|||
33381482|NCT00787202|62760363|FG001|Overall Study|Withdrawal by Subject|2|||
33294482|NCT01190930|62671006|FG009|Maintenance|Physician Decision|17|||
33294483|NCT01190930|62670997|FG000|Maintenance|Withdrawal by Subject|0|||
33294484|NCT01190930|62670998|FG001|Maintenance|Withdrawal by Subject|0|||
33294485|NCT01190930|62670999|FG002|Maintenance|Withdrawal by Subject|0|||
33294486|NCT01190930|62671000|FG003|Maintenance|Withdrawal by Subject|0|||
33294487|NCT01190930|62671001|FG004|Maintenance|Withdrawal by Subject|0|||
33294488|NCT01190930|62671002|FG005|Maintenance|Withdrawal by Subject|0|||
33294489|NCT01190930|62671003|FG006|Maintenance|Withdrawal by Subject|2|||
33294490|NCT01190930|62671004|FG007|Maintenance|Withdrawal by Subject|1|||
33294491|NCT01190930|62671005|FG008|Maintenance|Withdrawal by Subject|4|||
33294492|NCT01190930|62671006|FG009|Maintenance|Withdrawal by Subject|1|||
33294493|NCT01190930|62670997|FG000|Maintenance|Refusal|0|||
33381483|NCT00787202|62760364|FG002|Overall Study|Withdrawal by Subject|2|||
33381484|NCT00787202|62760365|FG003|Overall Study|Withdrawal by Subject|0|||
33381485|NCT00787202|62760366|FG004|Overall Study|Withdrawal by Subject|0|||
33381486|NCT00787202|62760362|FG000|Overall Study|Protocol Violation|2|||
33381487|NCT00787202|62760363|FG001|Overall Study|Protocol Violation|1|||
33381488|NCT00787202|62760364|FG002|Overall Study|Protocol Violation|0|||
33381489|NCT00787202|62760365|FG003|Overall Study|Protocol Violation|0|||
33381490|NCT00787202|62760366|FG004|Overall Study|Protocol Violation|1|||
33381491|NCT00787202|62760362|FG000|Overall Study|Randomized, not treated|1|||
33381492|NCT00787202|62760363|FG001|Overall Study|Randomized, not treated|0|||
33381493|NCT00787202|62760364|FG002|Overall Study|Randomized, not treated|0|||
33381494|NCT00787202|62760365|FG003|Overall Study|Randomized, not treated|0|||
33381495|NCT00787202|62760366|FG004|Overall Study|Randomized, not treated|0|||
33381496|NCT04033367|62760384|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
33381497|NCT04033367|62760385|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
33381498|NCT04033367|62760384|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
33381499|NCT04033367|62760385|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
33381500|NCT04033367|62760384|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
33294494|NCT01190930|62670998|FG001|Maintenance|Refusal|1|||
33294495|NCT01190930|62670999|FG002|Maintenance|Refusal|0|||
33381501|NCT04033367|62760385|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
33381502|NCT04033367|62760384|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
33381503|NCT04033367|62760385|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
33381504|NCT00733980|62760397|FG000|Overall Study|Adverse Event|5|||
33381505|NCT00733980|62760398|FG001|Overall Study|Adverse Event|2|||
33381506|NCT00733980|62760397|FG000|Overall Study|Lack of Efficacy|0|||
33381507|NCT00733980|62760398|FG001|Overall Study|Lack of Efficacy|1|||
33381508|NCT00733980|62760397|FG000|Overall Study|Protocol Violation|2|||
33381509|NCT00733980|62760398|FG001|Overall Study|Protocol Violation|1|||
33381510|NCT00733980|62760397|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
33381511|NCT00733980|62760398|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
33381512|NCT00733980|62760397|FG000|Overall Study|Lost to Follow-up|6|||
33381513|NCT00733980|62760398|FG001|Overall Study|Lost to Follow-up|11|||
33381514|NCT00733980|62760397|FG000|Overall Study|Physician Decision|2|||
33381515|NCT00733980|62760398|FG001|Overall Study|Physician Decision|3|||
33488053|NCT01981850|62866211|FG000|Main Phase Stage 1|Death|2|||
33294496|NCT01190930|62671000|FG003|Maintenance|Refusal|2|||
33294497|NCT01190930|62671001|FG004|Maintenance|Refusal|0|||
33294498|NCT01190930|62671002|FG005|Maintenance|Refusal|4|||
33294499|NCT01190930|62671003|FG006|Maintenance|Refusal|5|||
33294500|NCT01190930|62671004|FG007|Maintenance|Refusal|17|||
33294501|NCT01190930|62671005|FG008|Maintenance|Refusal|13|||
33294502|NCT01190930|62671006|FG009|Maintenance|Refusal|6|||
33294503|NCT01190930|62670997|FG000|Maintenance|second malignant neoplasm|0|||
33294504|NCT01190930|62670998|FG001|Maintenance|second malignant neoplasm|0|||
33294505|NCT01190930|62670999|FG002|Maintenance|second malignant neoplasm|0|||
33381516|NCT00733980|62760397|FG000|Overall Study|Withdrawal by Subject|6|||
33488054|NCT01981850|62866212|FG001|Main Phase Stage 1|Death|0|||
33662465|NCT01693523|63093006|FG000|Overall Study|Withdrawal by Subject|1|||
33381517|NCT00733980|62760398|FG001|Overall Study|Withdrawal by Subject|2|||
33381518|NCT00806585|62760410|FG000|Overall Study|Study terminated by Sponsor|0|||
33381519|NCT00806585|62760411|FG001|Overall Study|Study terminated by Sponsor|0|||
33381520|NCT00806585|62760412|FG002|Overall Study|Study terminated by Sponsor|1|||
33488055|NCT01981850|62866213|FG002|Main Phase Stage 1|Death|0|||
33488056|NCT01981850|62866214|FG003|Main Phase Stage 1|Death|0|||
33662466|NCT01693523|63093007|FG001|Overall Study|Withdrawal by Subject|2|||
33294506|NCT01190930|62671000|FG003|Maintenance|second malignant neoplasm|1|||
33294507|NCT01190930|62671001|FG004|Maintenance|second malignant neoplasm|0|||
33294508|NCT01190930|62671002|FG005|Maintenance|second malignant neoplasm|1|||
33294509|NCT01190930|62671003|FG006|Maintenance|second malignant neoplasm|0|||
33294510|NCT01190930|62671004|FG007|Maintenance|second malignant neoplasm|0|||
33294511|NCT01190930|62671005|FG008|Maintenance|second malignant neoplasm|1|||
33294512|NCT01190930|62671006|FG009|Maintenance|second malignant neoplasm|0|||
33294513|NCT01190930|62670997|FG000|Maintenance|Inevaluable|0|||
33381521|NCT00806585|62760413|FG003|Overall Study|Study terminated by Sponsor|2|||
33381522|NCT00806585|62760414|FG004|Overall Study|Study terminated by Sponsor|0|||
33381523|NCT00806585|62760410|FG000|Overall Study|Protocol Violation|3|||
33381524|NCT00806585|62760411|FG001|Overall Study|Protocol Violation|1|||
33381525|NCT00806585|62760412|FG002|Overall Study|Protocol Violation|2|||
33381526|NCT00806585|62760413|FG003|Overall Study|Protocol Violation|0|||
33381527|NCT00806585|62760414|FG004|Overall Study|Protocol Violation|0|||
33381528|NCT00806585|62760410|FG000|Overall Study|Physician Decision|0|||
33381529|NCT00806585|62760411|FG001|Overall Study|Physician Decision|2|||
33381530|NCT00806585|62760412|FG002|Overall Study|Physician Decision|3|||
33381531|NCT00806585|62760413|FG003|Overall Study|Physician Decision|0|||
33381532|NCT00806585|62760414|FG004|Overall Study|Physician Decision|1|||
33381533|NCT00806585|62760410|FG000|Overall Study|Lost to Follow-up|2|||
33381534|NCT00806585|62760411|FG001|Overall Study|Lost to Follow-up|1|||
33381535|NCT00806585|62760412|FG002|Overall Study|Lost to Follow-up|2|||
33381536|NCT00806585|62760413|FG003|Overall Study|Lost to Follow-up|2|||
33381537|NCT00806585|62760414|FG004|Overall Study|Lost to Follow-up|5|||
33294514|NCT01190930|62670998|FG001|Maintenance|Inevaluable|0|||
33294515|NCT01190930|62670999|FG002|Maintenance|Inevaluable|0|||
33294516|NCT01190930|62671000|FG003|Maintenance|Inevaluable|0|||
33294517|NCT01190930|62671001|FG004|Maintenance|Inevaluable|0|||
33381538|NCT00806585|62760410|FG000|Overall Study|Lack of Efficacy|1|||
33381539|NCT00806585|62760411|FG001|Overall Study|Lack of Efficacy|0|||
33381540|NCT00806585|62760412|FG002|Overall Study|Lack of Efficacy|0|||
33381541|NCT00806585|62760413|FG003|Overall Study|Lack of Efficacy|0|||
33381542|NCT00806585|62760414|FG004|Overall Study|Lack of Efficacy|0|||
33381543|NCT00806585|62760410|FG000|Overall Study|Adverse Event|1|||
33381544|NCT00806585|62760411|FG001|Overall Study|Adverse Event|5|||
33381545|NCT00806585|62760412|FG002|Overall Study|Adverse Event|3|||
33381546|NCT00806585|62760413|FG003|Overall Study|Adverse Event|4|||
33381547|NCT00806585|62760414|FG004|Overall Study|Adverse Event|2|||
33381548|NCT00806585|62760410|FG000|Overall Study|Withdrawal by Subject|10|||
33381549|NCT00806585|62760411|FG001|Overall Study|Withdrawal by Subject|8|||
33381550|NCT00806585|62760412|FG002|Overall Study|Withdrawal by Subject|9|||
33381551|NCT00806585|62760413|FG003|Overall Study|Withdrawal by Subject|3|||
33381552|NCT00806585|62760414|FG004|Overall Study|Withdrawal by Subject|11|||
33381553|NCT00806585|62760410|FG000|Overall Study|Completion status unknown|15|||
33381554|NCT00806585|62760411|FG001|Overall Study|Completion status unknown|14|||
33381555|NCT00806585|62760412|FG002|Overall Study|Completion status unknown|12|||
33381556|NCT00806585|62760413|FG003|Overall Study|Completion status unknown|4|||
33381557|NCT00806585|62760414|FG004|Overall Study|Completion status unknown|12|||
33294518|NCT01190930|62671002|FG005|Maintenance|Inevaluable|1|||
33294519|NCT01190930|62671003|FG006|Maintenance|Inevaluable|1|||
33294520|NCT01190930|62671004|FG007|Maintenance|Inevaluable|1|||
33294521|NCT01190930|62671005|FG008|Maintenance|Inevaluable|0|||
33294522|NCT01190930|62671006|FG009|Maintenance|Inevaluable|0|||
33294523|NCT01190930|62670997|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
33294524|NCT01190930|62670998|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
33294525|NCT01190930|62670999|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
33294526|NCT01190930|62671000|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
33294527|NCT01190930|62671001|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
33294528|NCT01190930|62671002|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
33294529|NCT01190930|62671003|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
33294530|NCT01190930|62671004|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
33294531|NCT01190930|62671005|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
33294532|NCT01190930|62671006|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
33294533|NCT01190930|62670997|FG000|Maintenance|Relapse|0|||
33294534|NCT01190930|62670998|FG001|Maintenance|Relapse|0|||
33294535|NCT01190930|62670999|FG002|Maintenance|Relapse|0|||
33294536|NCT01190930|62671000|FG003|Maintenance|Relapse|2|||
33381558|NCT00480025|62760428|FG000|Overall Study|Protocol Violation|12|||
33381559|NCT00480025|62760429|FG001|Overall Study|Protocol Violation|7|||
33381560|NCT00480025|62760428|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
33381561|NCT00480025|62760429|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
33381562|NCT00480025|62760428|FG000|Overall Study|Disease Progression / Recurrence|449|||
33381563|NCT00480025|62760429|FG001|Overall Study|Disease Progression / Recurrence|224|||
33294537|NCT01190930|62671001|FG004|Maintenance|Relapse|0|||
33381564|NCT00480025|62760428|FG000|Overall Study|Adverse Event|44|||
33381565|NCT00480025|62760429|FG001|Overall Study|Adverse Event|12|||
33381566|NCT00480025|62760428|FG000|Overall Study|Other|70|||
33294538|NCT01190930|62671002|FG005|Maintenance|Relapse|1|||
33294539|NCT01190930|62671003|FG006|Maintenance|Relapse|6|||
33294540|NCT01190930|62671004|FG007|Maintenance|Relapse|13|||
33294541|NCT01190930|62671005|FG008|Maintenance|Relapse|11|||
33294542|NCT01190930|62671006|FG009|Maintenance|Relapse|11|||
33294543|NCT01190930|62670997|FG000|Maintenance|Still on therapy|0|||
33294544|NCT01190930|62670998|FG001|Maintenance|Still on therapy|8|||
33294545|NCT01190930|62670999|FG002|Maintenance|Still on therapy|0|||
33294546|NCT01190930|62671000|FG003|Maintenance|Still on therapy|29|||
33294547|NCT01190930|62671001|FG004|Maintenance|Still on therapy|0|||
33294548|NCT01190930|62671002|FG005|Maintenance|Still on therapy|0|||
33294549|NCT01190930|62671003|FG006|Maintenance|Still on therapy|0|||
33294550|NCT01190930|62671004|FG007|Maintenance|Still on therapy|0|||
33294551|NCT01190930|62671005|FG008|Maintenance|Still on therapy|0|||
33294552|NCT01190930|62671006|FG009|Maintenance|Still on therapy|0|||
33294553|NCT01163682|62671055|FG000|Overall Study|Lost to Follow-up|6|||
33294554|NCT01163682|62671056|FG001|Overall Study|Lost to Follow-up|9|||
33294555|NCT01047007|62671066|FG000|Overall Study|Adverse Event|0|||
33294556|NCT01047007|62671067|FG001|Overall Study|Adverse Event|2|||
33294557|NCT01047007|62671068|FG002|Overall Study|Adverse Event|1|||
33294558|NCT01047007|62671069|FG003|Overall Study|Adverse Event|0|||
33294559|NCT01047007|62671066|FG000|Overall Study|Progressive Disease|2|||
33381567|NCT00480025|62760429|FG001|Overall Study|Other|29|||
33381568|NCT00480025|62760428|FG000|Overall Study|SAE including intercurrent illness|76|||
33381569|NCT00480025|62760429|FG001|Overall Study|SAE including intercurrent illness|42|||
33381570|NCT00806351|62760443|FG000|Overall Study|Death|5|||
33381571|NCT00806351|62760444|FG001|Overall Study|Death|4|||
33381572|NCT00733902|62760454|FG000|Overall Study|Death|0|||
33294560|NCT01047007|62671067|FG001|Overall Study|Progressive Disease|4|||
33294561|NCT01047007|62671068|FG002|Overall Study|Progressive Disease|1|||
33381573|NCT00733902|62760455|FG001|Overall Study|Death|0|||
33381574|NCT00733902|62760456|FG002|Overall Study|Death|0|||
33381575|NCT00733902|62760457|FG003|Overall Study|Death|1|||
33381576|NCT00733902|62760454|FG000|Overall Study|Adverse Event|3|||
33381577|NCT00733902|62760455|FG001|Overall Study|Adverse Event|4|||
33381578|NCT00733902|62760456|FG002|Overall Study|Adverse Event|7|||
33381579|NCT00733902|62760457|FG003|Overall Study|Adverse Event|11|||
33381580|NCT00733902|62760454|FG000|Overall Study|Lack of Efficacy|56|||
33381581|NCT00733902|62760455|FG001|Overall Study|Lack of Efficacy|21|||
33381582|NCT00733902|62760456|FG002|Overall Study|Lack of Efficacy|34|||
33381583|NCT00733902|62760457|FG003|Overall Study|Lack of Efficacy|23|||
33381584|NCT00733902|62760454|FG000|Overall Study|Protocol Violation|4|||
33381585|NCT00733902|62760455|FG001|Overall Study|Protocol Violation|6|||
33381586|NCT00733902|62760456|FG002|Overall Study|Protocol Violation|3|||
33294562|NCT01047007|62671069|FG003|Overall Study|Progressive Disease|0|||
33294563|NCT00680901|62671094|FG000|Overall Study|Lost to Follow-up|8|||
33294564|NCT00680901|62671095|FG001|Overall Study|Lost to Follow-up|8|||
33294565|NCT00680901|62671094|FG000|Overall Study|Withdrawal by Subject|4|||
33294566|NCT00680901|62671095|FG001|Overall Study|Withdrawal by Subject|13|||
33294567|NCT00680901|62671094|FG000|Overall Study|Physician Decision|0|||
33294568|NCT00680901|62671095|FG001|Overall Study|Physician Decision|1|||
33294569|NCT00680901|62671094|FG000|Overall Study|Ongoing: On Study Treatment|16|||
33294570|NCT00680901|62671095|FG001|Overall Study|Ongoing: On Study Treatment|13|||
33294571|NCT00680901|62671094|FG000|Overall Study|Ongoing: In Follow Up|45|||
33294572|NCT00680901|62671095|FG001|Overall Study|Ongoing: In Follow Up|41|||
33294573|NCT00546351|62671218|FG000|Overall Study|Adverse Event|76|||
33294574|NCT00546351|62671218|FG000|Overall Study|Lack of Efficacy|15|||
33294575|NCT00546351|62671218|FG000|Overall Study|Withdrawal by Subject|109|||
33294576|NCT00546351|62671218|FG000|Overall Study|Lost to Follow-up|9|||
33294577|NCT00546351|62671218|FG000|Overall Study|Protocol Deviation|1|||
33294578|NCT00546351|62671218|FG000|Overall Study|Unsatisfactory compliance|9|||
33294579|NCT00546351|62671218|FG000|Overall Study|Other reasons for premature termination|17|||
33662467|NCT01693523|63093008|FG002|Overall Study|Withdrawal by Subject|2|||
33662468|NCT01693523|63093006|FG000|Overall Study|Lack of compliance study medication|1|||
33662469|NCT01693523|63093007|FG001|Overall Study|Lack of compliance study medication|2|||
33662470|NCT01693523|63093008|FG002|Overall Study|Lack of compliance study medication|0|||
33662471|NCT01693523|63093006|FG000|Overall Study|Chemotherapy was held|1|||
33662472|NCT01693523|63093007|FG001|Overall Study|Chemotherapy was held|2|||
33662473|NCT01693523|63093008|FG002|Overall Study|Chemotherapy was held|0|||
33662474|NCT01581593|63093024|FG000|Overall Study|Withdrawal by Subject|1|||
33662475|NCT01581281|63093035|FG000|Overall Study|Early Study Closure|15|||
33662476|NCT01581281|63093036|FG001|Overall Study|Early Study Closure|6|||
33662477|NCT01581281|63093037|FG002|Overall Study|Early Study Closure|12|||
33662478|NCT02692716|63093048|FG000|Overall Study|Lost to Follow-up|2|||
33662479|NCT02692716|63093049|FG001|Overall Study|Lost to Follow-up|5|||
33662480|NCT02692716|63093048|FG000|Overall Study|Withdrawal by Subject|3|||
33662481|NCT02692716|63093049|FG001|Overall Study|Withdrawal by Subject|1|||
33662482|NCT01580969|63093058|FG000|Overall Study|Physician Decision|3|||
33662483|NCT01580969|63093059|FG001|Overall Study|Physician Decision|0|||
33662484|NCT01580969|63093060|FG002|Overall Study|Physician Decision|0|||
33381587|NCT00733902|62760457|FG003|Overall Study|Protocol Violation|3|||
33381588|NCT00733902|62760454|FG000|Overall Study|Withdrawal by Subject|10|||
33662485|NCT01693367|63093070|FG000|Overall Study|Withdrawal by Subject|1|||
33381589|NCT00733902|62760455|FG001|Overall Study|Withdrawal by Subject|5|||
33381590|NCT00733902|62760456|FG002|Overall Study|Withdrawal by Subject|4|||
33381591|NCT00733902|62760457|FG003|Overall Study|Withdrawal by Subject|16|||
33381592|NCT00733902|62760454|FG000|Overall Study|Entered extension study|89|||
33381593|NCT00733902|62760455|FG001|Overall Study|Entered extension study|124|||
33381594|NCT00733902|62760456|FG002|Overall Study|Entered extension study|111|||
33381595|NCT00733902|62760457|FG003|Overall Study|Entered extension study|109|||
33381596|NCT00733902|62760454|FG000|Overall Study|Randomized but not treated|2|||
33294600|NCT00003838|62671247|FG000|Overall Study|Death|0|||
33294601|NCT00003838|62671248|FG001|Overall Study|Death|12|||
33381597|NCT00733902|62760455|FG001|Overall Study|Randomized but not treated|2|||
33381598|NCT00733902|62760456|FG002|Overall Study|Randomized but not treated|2|||
33381599|NCT00733902|62760457|FG003|Overall Study|Randomized but not treated|1|||
33381600|NCT00790790|62760470|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
33381601|NCT00790790|62760471|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
33381602|NCT00790790|62760472|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
33294602|NCT00003838|62671249|FG002|Overall Study|Death|7|||
33294603|NCT00003838|62671247|FG000|Overall Study|Lost to Follow-up|0|||
33294604|NCT00003838|62671248|FG001|Overall Study|Lost to Follow-up|1|||
33294605|NCT00003838|62671249|FG002|Overall Study|Lost to Follow-up|1|||
33294606|NCT00003838|62671247|FG000|Overall Study|Disease Progression|0|||
33294607|NCT00003838|62671248|FG001|Overall Study|Disease Progression|12|||
33294608|NCT00003838|62671249|FG002|Overall Study|Disease Progression|0|||
33294609|NCT05083585|62671258|FG000|Overall Study|Death|1|||
33294610|NCT05083585|62671259|FG001|Overall Study|Death|1|||
33294611|NCT05083585|62671258|FG000|Overall Study|Lost to Follow-up|1|||
33294612|NCT05083585|62671259|FG001|Overall Study|Lost to Follow-up|1|||
33294613|NCT05083585|62671258|FG000|Overall Study|Withdrawal by Subject|2|||
33294614|NCT05083585|62671259|FG001|Overall Study|Withdrawal by Subject|0|||
33294615|NCT05083585|62671258|FG000|Overall Study|Randomized but not vaccinated|2|||
33294616|NCT05083585|62671259|FG001|Overall Study|Randomized but not vaccinated|0|||
33294617|NCT04276883|62671290|FG000|Overall Study|Withdrawal by Subject|2|||
33294618|NCT04276883|62671291|FG001|Overall Study|Withdrawal by Subject|3|||
33294619|NCT04276883|62671292|FG002|Overall Study|Withdrawal by Subject|6|||
33294620|NCT04276883|62671290|FG000|Overall Study|Lost to Follow-up|1|||
33294621|NCT04276883|62671291|FG001|Overall Study|Lost to Follow-up|3|||
33294622|NCT04276883|62671292|FG002|Overall Study|Lost to Follow-up|0|||
33294623|NCT04276883|62671290|FG000|Overall Study|Adverse Event|0|||
33294624|NCT04276883|62671291|FG001|Overall Study|Adverse Event|1|||
33294625|NCT04276883|62671292|FG002|Overall Study|Adverse Event|0|||
33294626|NCT04276883|62671290|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
33294627|NCT04276883|62671291|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
33294628|NCT04276883|62671292|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
33294629|NCT04099888|62671302|FG000|Overall Study|Study terminated by sponsor|9|||
33294630|NCT04099888|62671303|FG001|Overall Study|Study terminated by sponsor|11|||
33294631|NCT04099888|62671302|FG000|Overall Study|Lost to Follow-up|1|||
33294632|NCT04099888|62671303|FG001|Overall Study|Lost to Follow-up|1|||
33294633|NCT04099888|62671302|FG000|Overall Study|Withdrawal by Subject|5|||
33294634|NCT04099888|62671303|FG001|Overall Study|Withdrawal by Subject|6|||
33381603|NCT00790790|62760470|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
33381604|NCT00790790|62760471|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
33381605|NCT00790790|62760472|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
33381606|NCT00790790|62760470|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
33381607|NCT00790790|62760471|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
33381608|NCT00790790|62760472|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
33381609|NCT00790790|62760470|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
33381610|NCT00790790|62760471|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
33381611|NCT00790790|62760472|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
33381612|NCT00790790|62760470|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
33381613|NCT00790790|62760471|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
33381614|NCT00790790|62760472|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
33381615|NCT00719043|62760492|FG000|Overall Study|Adverse Event|5|||
33381616|NCT00719043|62760493|FG001|Overall Study|Adverse Event|1|||
33488057|NCT01981850|62866215|FG004|Main Phase Stage 1|Death|0|||
33488058|NCT01981850|62866216|FG005|Main Phase Stage 1|Death|0|||
33488059|NCT01981850|62866217|FG006|Main Phase Stage 1|Death|0|||
33381617|NCT00719043|62760494|FG002|Overall Study|Adverse Event|2|||
33381618|NCT00719043|62760495|FG003|Overall Study|Adverse Event|2|||
33294635|NCT04099888|62671302|FG000|Overall Study|Death|5|||
33662486|NCT01693367|63093071|FG001|Overall Study|Withdrawal by Subject|1|||
33294636|NCT04099888|62671303|FG001|Overall Study|Death|2|||
33294637|NCT04099888|62671302|FG000|Overall Study|Other|1|||
33294638|NCT04099888|62671303|FG001|Overall Study|Other|0|||
33294639|NCT04081389|62671313|FG000|Overall Study|Withdrawal by Subject|0|||
33294640|NCT04081389|62671314|FG001|Overall Study|Withdrawal by Subject|0|||
33294641|NCT04081389|62671315|FG002|Overall Study|Withdrawal by Subject|1|||
33294642|NCT04081389|62671316|FG003|Overall Study|Withdrawal by Subject|0|||
33294643|NCT04032080|62671326|FG000|Overall Study|Death|6|||
33294644|NCT03781323|62671340|FG000|Overall Study|Withdrawal by Subject|1|||
33294645|NCT03729362|62671346|FG000|Overall Study|Withdrawal by Subject|2|||
33294646|NCT03729362|62671347|FG001|Overall Study|Withdrawal by Subject|0|||
33294647|NCT03729362|62671346|FG000|Overall Study|Physician Decision|1|||
33294648|NCT03729362|62671347|FG001|Overall Study|Physician Decision|0|||
33381619|NCT00719043|62760496|FG004|Overall Study|Adverse Event|1|||
33381620|NCT00719043|62760497|FG005|Overall Study|Adverse Event|4|||
33381621|NCT00719043|62760498|FG006|Overall Study|Adverse Event|4|||
33381622|NCT00719043|62760492|FG000|Overall Study|Lost to Follow-up|14|||
33294649|NCT03729362|62671346|FG000|Overall Study|COVID-19 Pandemic|1|||
33294650|NCT03729362|62671347|FG001|Overall Study|COVID-19 Pandemic|0|||
33294651|NCT03729362|62671346|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
33381623|NCT00719043|62760493|FG001|Overall Study|Lost to Follow-up|10|||
33381624|NCT00719043|62760494|FG002|Overall Study|Lost to Follow-up|8|||
33381625|NCT00719043|62760495|FG003|Overall Study|Lost to Follow-up|9|||
33381626|NCT00719043|62760496|FG004|Overall Study|Lost to Follow-up|10|||
33381627|NCT00719043|62760497|FG005|Overall Study|Lost to Follow-up|9|||
33381628|NCT00719043|62760498|FG006|Overall Study|Lost to Follow-up|9|||
33381629|NCT00719043|62760492|FG000|Overall Study|Protocol Violation|0|||
33381630|NCT00719043|62760493|FG001|Overall Study|Protocol Violation|0|||
33381631|NCT00719043|62760494|FG002|Overall Study|Protocol Violation|0|||
33381632|NCT00719043|62760495|FG003|Overall Study|Protocol Violation|0|||
33381633|NCT00719043|62760496|FG004|Overall Study|Protocol Violation|0|||
33381634|NCT00719043|62760497|FG005|Overall Study|Protocol Violation|1|||
33381635|NCT00719043|62760498|FG006|Overall Study|Protocol Violation|0|||
33381636|NCT00719043|62760492|FG000|Overall Study|Other|1|||
33381637|NCT00719043|62760493|FG001|Overall Study|Other|0|||
33381638|NCT00719043|62760494|FG002|Overall Study|Other|1|||
33381639|NCT00719043|62760495|FG003|Overall Study|Other|2|||
33381640|NCT00719043|62760496|FG004|Overall Study|Other|0|||
33381641|NCT00719043|62760497|FG005|Overall Study|Other|2|||
33381642|NCT00719043|62760498|FG006|Overall Study|Other|1|||
33381643|NCT00719043|62760492|FG000|Overall Study|Withdrawal by Subject|12|||
33381644|NCT00719043|62760493|FG001|Overall Study|Withdrawal by Subject|14|||
33381645|NCT00719043|62760494|FG002|Overall Study|Withdrawal by Subject|9|||
33381646|NCT00719043|62760495|FG003|Overall Study|Withdrawal by Subject|10|||
33381647|NCT00719043|62760496|FG004|Overall Study|Withdrawal by Subject|16|||
33381648|NCT00719043|62760497|FG005|Overall Study|Withdrawal by Subject|18|||
33381649|NCT00719043|62760498|FG006|Overall Study|Withdrawal by Subject|14|||
33381650|NCT00786422|62760526|FG000|Rivaroxaban Treatment|Death|2|||
33381651|NCT00786422|62760526|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
33381652|NCT00786422|62760526|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
33381653|NCT00786422|62760526|FG000|Rivaroxaban Treatment|Physician Decision|1|||
33381654|NCT00786422|62760526|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
33381655|NCT00786422|62760526|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
33381656|NCT00786422|62760526|FG000|Rivaroxaban Treatment|Adverse Event|2|||
33381657|NCT00786422|62760526|FG000|Follow-up Period|Death|1|||
33381658|NCT00786422|62760526|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
33381659|NCT00718887|62760534|FG000|Overall Study|Withdrawal by Subject|3|||
33381660|NCT00718887|62760535|FG001|Overall Study|Withdrawal by Subject|2|||
33381661|NCT00718887|62760534|FG000|Overall Study|Not identified|2|||
33381662|NCT00718887|62760535|FG001|Overall Study|Not identified|7|||
33381663|NCT00786188|62760549|FG000|Overall Study|Adverse Event|3|||
33381664|NCT00786188|62760550|FG001|Overall Study|Adverse Event|1|||
33381665|NCT00786188|62760549|FG000|Overall Study|Withdrawal by Subject|2|||
33381666|NCT00786188|62760550|FG001|Overall Study|Withdrawal by Subject|0|||
33381667|NCT00790556|62760558|FG000|Treatment Period 1|Physician Decision|1|||
33381668|NCT00790556|62760559|FG001|Treatment Period 1|Physician Decision|0|||
33381669|NCT00790556|62760558|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33381670|NCT00790556|62760559|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33381671|NCT00733824|62760570|FG000|Phase I|Withdrawal by Subject|1|||
33381672|NCT00733824|62760571|FG001|Phase I|Withdrawal by Subject|0|||
33381673|NCT00733824|62760572|FG002|Phase I|Withdrawal by Subject|0|||
33381674|NCT00733824|62760573|FG003|Phase I|Withdrawal by Subject|0|||
33381675|NCT00733824|62760574|FG004|Phase I|Withdrawal by Subject|0|||
33381676|NCT00718809|62760590|FG000|Overall Study|Disease progression|9|||
33294652|NCT03729362|62671347|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
33381677|NCT00718809|62760591|FG001|Overall Study|Disease progression|7|||
33381678|NCT00718809|62760590|FG000|Overall Study|Adverse Event|1|||
33294653|NCT03729362|62671346|FG000|Overall Study|Adverse Event|0|||
33381679|NCT00718809|62760591|FG001|Overall Study|Adverse Event|1|||
33381680|NCT00718809|62760590|FG000|Overall Study|Withdrawal by Subject|0|||
33381681|NCT00718809|62760591|FG001|Overall Study|Withdrawal by Subject|1|||
33294654|NCT03729362|62671347|FG001|Overall Study|Adverse Event|1|||
33381682|NCT00718809|62760590|FG000|Overall Study|Lost to Follow-up|1|||
33381683|NCT00718809|62760591|FG001|Overall Study|Lost to Follow-up|0|||
33381684|NCT00718809|62760590|FG000|Overall Study|Noncompliance|1|||
33294655|NCT03729362|62671346|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
33294656|NCT03729362|62671347|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
33381685|NCT00718809|62760591|FG001|Overall Study|Noncompliance|0|||
33381686|NCT00585039|62760599|FG000|Overall Study|medication spilled|2|||
33381687|NCT00585039|62760600|FG001|Overall Study|medication spilled|0|||
33381688|NCT00806195|62760612|FG000|Overall Study|Death|6|||
33381689|NCT00806195|62760613|FG001|Overall Study|Death|0|||
33381690|NCT00806195|62760614|FG002|Overall Study|Death|1|||
33381691|NCT00806195|62760615|FG003|Overall Study|Death|0|||
33381692|NCT00806195|62760612|FG000|Overall Study|Adverse Event|25|||
33381693|NCT00806195|62760613|FG001|Overall Study|Adverse Event|5|||
33381694|NCT00806195|62760614|FG002|Overall Study|Adverse Event|11|||
33381695|NCT00806195|62760615|FG003|Overall Study|Adverse Event|2|||
33381696|NCT00806195|62760612|FG000|Overall Study|Withdrawal by Subject|119|||
33381697|NCT00806195|62760613|FG001|Overall Study|Withdrawal by Subject|31|||
33381698|NCT00806195|62760614|FG002|Overall Study|Withdrawal by Subject|76|||
33381699|NCT00806195|62760615|FG003|Overall Study|Withdrawal by Subject|35|||
33381700|NCT00806195|62760612|FG000|Overall Study|Lost to Follow-up|217|||
33381701|NCT00806195|62760613|FG001|Overall Study|Lost to Follow-up|66|||
33381702|NCT00806195|62760614|FG002|Overall Study|Lost to Follow-up|90|||
33381703|NCT00806195|62760615|FG003|Overall Study|Lost to Follow-up|34|||
33381704|NCT00806195|62760612|FG000|Overall Study|Inappropriate Enrollment|0|||
33381705|NCT00806195|62760613|FG001|Overall Study|Inappropriate Enrollment|1|||
33381706|NCT00806195|62760614|FG002|Overall Study|Inappropriate Enrollment|0|||
33381707|NCT00806195|62760615|FG003|Overall Study|Inappropriate Enrollment|0|||
33381708|NCT00806195|62760612|FG000|Overall Study|Administrative Reason|113|||
33381709|NCT00806195|62760613|FG001|Overall Study|Administrative Reason|35|||
33381710|NCT00806195|62760614|FG002|Overall Study|Administrative Reason|66|||
33381711|NCT00806195|62760615|FG003|Overall Study|Administrative Reason|26|||
33381712|NCT00806195|62760612|FG000|Overall Study|Protocol Violation|34|||
33381713|NCT00806195|62760613|FG001|Overall Study|Protocol Violation|24|||
33381714|NCT00806195|62760614|FG002|Overall Study|Protocol Violation|26|||
33381715|NCT00806195|62760615|FG003|Overall Study|Protocol Violation|9|||
33381716|NCT00733746|62760627|FG000|Overall Study|Ineligible|5|||
33381717|NCT00718419|62760633|FG000|Overall Study|Adverse Event|2|||
33381718|NCT00718419|62760634|FG001|Overall Study|Adverse Event|1|||
33381719|NCT00718419|62760633|FG000|Overall Study|Physician Decision|1|||
33381720|NCT00718419|62760634|FG001|Overall Study|Physician Decision|6|||
33381721|NCT00718419|62760633|FG000|Overall Study|Sponsor decision|0|||
33381722|NCT00718419|62760634|FG001|Overall Study|Sponsor decision|1|||
33381723|NCT00718419|62760633|FG000|Overall Study|Withdrawal by Subject|0|||
33381724|NCT00718419|62760634|FG001|Overall Study|Withdrawal by Subject|5|||
33381725|NCT00718419|62760633|FG000|Overall Study|Progressive Disease|7|||
33381726|NCT00718419|62760634|FG001|Overall Study|Progressive Disease|25|||
33488060|NCT01981850|62866218|FG007|Main Phase Stage 1|Death|0|||
33488061|NCT01981850|62866219|FG008|Main Phase Stage 1|Death|0|||
33294657|NCT03340766|62671374|FG000|Overall Study|Death|6|||
33294658|NCT03340766|62671375|FG001|Overall Study|Death|6|||
33294659|NCT03340766|62671376|FG002|Overall Study|Death|2|||
33294660|NCT03340766|62671374|FG000|Overall Study|Withdrawal by Subject|2|||
33294661|NCT03340766|62671375|FG001|Overall Study|Withdrawal by Subject|1|||
33294662|NCT03340766|62671376|FG002|Overall Study|Withdrawal by Subject|2|||
33294663|NCT03340766|62671374|FG000|Overall Study|Continuing Study|3|||
33294664|NCT03340766|62671375|FG001|Overall Study|Continuing Study|3|||
33294665|NCT03340766|62671376|FG002|Overall Study|Continuing Study|5|||
33294666|NCT02872116|62671415|FG000|Pre-Treatment|Disease Progression|0|||
33294667|NCT02872116|62671416|FG001|Pre-Treatment|Disease Progression|1|||
33294668|NCT02872116|62671417|FG002|Pre-Treatment|Disease Progression|0|||
33294669|NCT02872116|62671415|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
33294670|NCT02872116|62671416|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
33294671|NCT02872116|62671417|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
33294672|NCT02872116|62671415|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
33294673|NCT02872116|62671416|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
33294674|NCT02872116|62671417|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
33294675|NCT02872116|62671415|FG000|Pre-Treatment|Participant withdrew consent|2|||
33294676|NCT02872116|62671416|FG001|Pre-Treatment|Participant withdrew consent|20|||
33294677|NCT02872116|62671417|FG002|Pre-Treatment|Participant withdrew consent|3|||
33381727|NCT00718419|62760633|FG000|Overall Study|Death Due to Progressive Disease|2|||
33381728|NCT00718419|62760634|FG001|Overall Study|Death Due to Progressive Disease|0|||
33381729|NCT00718419|62760633|FG000|Overall Study|Death Due to Study Drug Related|0|||
33381730|NCT00718419|62760634|FG001|Overall Study|Death Due to Study Drug Related|1|||
33294678|NCT02872116|62671415|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
33294679|NCT02872116|62671416|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
33381731|NCT00718419|62760633|FG000|Overall Study|Death Due to Adverse Events|1|||
33381732|NCT00718419|62760634|FG001|Overall Study|Death Due to Adverse Events|0|||
33381733|NCT00717249|62760642|FG000|Overall Study|Lens Discomfort|4|||
33381734|NCT00717249|62760643|FG001|Overall Study|Lens Discomfort|1|||
33381735|NCT00717249|62760642|FG000|Overall Study|Unsatisfactory visual Response|0|||
33381736|NCT00717249|62760643|FG001|Overall Study|Unsatisfactory visual Response|2|||
33381737|NCT00717249|62760642|FG000|Overall Study|Adverse Event|4|||
33381738|NCT00717249|62760643|FG001|Overall Study|Adverse Event|2|||
33381739|NCT00717249|62760642|FG000|Overall Study|Lost to Follow-up|2|||
33381740|NCT00717249|62760643|FG001|Overall Study|Lost to Follow-up|0|||
33381741|NCT00717249|62760642|FG000|Overall Study|Withdrawal by Subject|1|||
33381742|NCT00717249|62760643|FG001|Overall Study|Withdrawal by Subject|2|||
33381743|NCT00717249|62760642|FG000|Overall Study|Pregnancy|6|||
33381744|NCT00717249|62760643|FG001|Overall Study|Pregnancy|3|||
33381745|NCT00717249|62760642|FG000|Overall Study|Protocol Violation|0|||
33381746|NCT00717249|62760643|FG001|Overall Study|Protocol Violation|2|||
33381747|NCT00717249|62760642|FG000|Overall Study|Subject became Ineligible|1|||
33381748|NCT00717249|62760643|FG001|Overall Study|Subject became Ineligible|1|||
33381749|NCT00717249|62760642|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
33381750|NCT00717249|62760643|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
33381751|NCT00717249|62760642|FG000|Overall Study|Gastric Surgery|0|||
33381752|NCT00717249|62760643|FG001|Overall Study|Gastric Surgery|1|||
33381753|NCT00717249|62760642|FG000|Overall Study|Diagnosed with Diabetes|1|||
33381754|NCT00717249|62760643|FG001|Overall Study|Diagnosed with Diabetes|0|||
33381755|NCT00717249|62760642|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
33381756|NCT00717249|62760643|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
33381757|NCT00717249|62760642|FG000|Overall Study|Subject relocated|1|||
33381758|NCT00717249|62760643|FG001|Overall Study|Subject relocated|0|||
33294680|NCT02872116|62671417|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
33294681|NCT02872116|62671415|FG000|Pre-Treatment|Other reasons|1|||
33294682|NCT02872116|62671416|FG001|Pre-Treatment|Other reasons|2|||
33294683|NCT02872116|62671417|FG002|Pre-Treatment|Other reasons|2|||
33294684|NCT02872116|62671415|FG000|Treatment|Death|122|||
33294685|NCT02872116|62671416|FG001|Treatment|Death|94|||
33294686|NCT02872116|62671417|FG002|Treatment|Death|68|||
33381759|NCT00717249|62760642|FG000|Overall Study|Headaches|1|||
33381760|NCT00717249|62760643|FG001|Overall Study|Headaches|0|||
33381761|NCT00727194|62760649|FG000|Screening Period|Low QMG scores|0|||
33381762|NCT00727194|62760650|FG001|Screening Period|Low QMG scores|0|||
33381763|NCT00727194|62760651|FG002|Screening Period|Low QMG scores|6|||
33488062|NCT01981850|62866220|FG009|Main Phase Stage 1|Death|0|||
33488063|NCT01981850|62866211|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
33488064|NCT01981850|62866212|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33488065|NCT01981850|62866213|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33488066|NCT01981850|62866214|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33488067|NCT01981850|62866215|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33488068|NCT01981850|62866216|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33488069|NCT01981850|62866217|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33488070|NCT01981850|62866218|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33488071|NCT01981850|62866219|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33488072|NCT01981850|62866220|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33488073|NCT01981850|62866211|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
33488074|NCT01981850|62866212|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
33488075|NCT01981850|62866213|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
33488076|NCT01981850|62866214|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
33488077|NCT01981850|62866215|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
33488078|NCT01981850|62866216|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
33488079|NCT01981850|62866217|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
33488080|NCT01981850|62866218|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
33488081|NCT01981850|62866219|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
33488082|NCT01981850|62866220|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
33488083|NCT01981850|62866211|FG000|Main Phase Stage 1|Various reasons|0|||
33488084|NCT01981850|62866212|FG001|Main Phase Stage 1|Various reasons|0|||
33488085|NCT01981850|62866213|FG002|Main Phase Stage 1|Various reasons|2|||
33488086|NCT01981850|62866214|FG003|Main Phase Stage 1|Various reasons|0|||
33488087|NCT01981850|62866215|FG004|Main Phase Stage 1|Various reasons|0|||
33488088|NCT01981850|62866216|FG005|Main Phase Stage 1|Various reasons|0|||
33488089|NCT01981850|62866217|FG006|Main Phase Stage 1|Various reasons|0|||
33294687|NCT02872116|62671415|FG000|Treatment|Lost to Follow-up|5|||
33294688|NCT02872116|62671416|FG001|Treatment|Lost to Follow-up|7|||
33488090|NCT01981850|62866218|FG007|Main Phase Stage 1|Various reasons|0|||
33294689|NCT02872116|62671417|FG002|Treatment|Lost to Follow-up|3|||
33381764|NCT00727194|62760649|FG000|Screening Period|Lacked AChR antibodies|0|||
33381765|NCT00727194|62760650|FG001|Screening Period|Lacked AChR antibodies|0|||
33381766|NCT00727194|62760651|FG002|Screening Period|Lacked AChR antibodies|5|||
33488091|NCT01981850|62866219|FG008|Main Phase Stage 1|Various reasons|0|||
33488092|NCT01981850|62866220|FG009|Main Phase Stage 1|Various reasons|0|||
33488093|NCT01981850|62866211|FG000|Main Phase Stage 2|Adverse Event|0|||
33488094|NCT01981850|62866212|FG001|Main Phase Stage 2|Adverse Event|0|||
33488095|NCT01981850|62866213|FG002|Main Phase Stage 2|Adverse Event|0|||
33381767|NCT00727194|62760649|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
33381768|NCT00727194|62760650|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
33381769|NCT00727194|62760651|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
33381770|NCT00727194|62760649|FG000|Screening Period|Severe infections|0|||
33381771|NCT00727194|62760650|FG001|Screening Period|Severe infections|0|||
33381772|NCT00727194|62760651|FG002|Screening Period|Severe infections|2|||
33381773|NCT00727194|62760649|FG000|Screening Period|History of thymoma|0|||
33381774|NCT00727194|62760650|FG001|Screening Period|History of thymoma|0|||
33381775|NCT00727194|62760651|FG002|Screening Period|History of thymoma|1|||
33381776|NCT00727194|62760649|FG000|Treatment Period 2|Lack of Efficacy|0|||
33381777|NCT00727194|62760650|FG001|Treatment Period 2|Lack of Efficacy|1|||
33294690|NCT02872116|62671415|FG000|Treatment|Participant withdrew consent|20|||
33294691|NCT02872116|62671416|FG001|Treatment|Participant withdrew consent|40|||
33294692|NCT02872116|62671417|FG002|Treatment|Participant withdrew consent|8|||
33294693|NCT02872116|62671415|FG000|Treatment|Other reasons|12|||
33294694|NCT02872116|62671416|FG001|Treatment|Other reasons|12|||
33294695|NCT02872116|62671417|FG002|Treatment|Other reasons|5|||
33294696|NCT02711852|62671429|FG000|Overall Study|Death|5|||
33294697|NCT02711852|62671429|FG000|Overall Study|Lost to Follow-up|1|||
33294698|NCT02711852|62671429|FG000|Overall Study|Completed follow-up|3|||
33294699|NCT02711852|62671429|FG000|Overall Study|Withdrawal by Subject|1|||
33381778|NCT00727194|62760651|FG002|Treatment Period 2|Lack of Efficacy|0|||
33381779|NCT00717093|62760667|FG000|Overall Study|Adverse Event|19|||
33381780|NCT00717093|62760668|FG001|Overall Study|Adverse Event|9|||
33294700|NCT01977417|62671467|FG000|Overall Study|Adverse Event|1|||
33381781|NCT00717093|62760667|FG000|Overall Study|Lack of Efficacy|3|||
33381782|NCT00717093|62760668|FG001|Overall Study|Lack of Efficacy|13|||
33381783|NCT00717093|62760667|FG000|Overall Study|Lost to Follow-up|9|||
33381784|NCT00717093|62760668|FG001|Overall Study|Lost to Follow-up|6|||
33381785|NCT00717093|62760667|FG000|Overall Study|Withdrawal by Subject|12|||
33381786|NCT00717093|62760668|FG001|Overall Study|Withdrawal by Subject|19|||
33381787|NCT00717093|62760667|FG000|Overall Study|Other|0|||
33381788|NCT00717093|62760668|FG001|Overall Study|Other|1|||
33381789|NCT00717093|62760667|FG000|Overall Study|Randomized but not treated|1|||
33381790|NCT00717093|62760668|FG001|Overall Study|Randomized but not treated|0|||
33381791|NCT00716859|62760676|FG000|Overall Study|Adverse Event|4|||
33381792|NCT00716859|62760677|FG001|Overall Study|Adverse Event|1|||
33381793|NCT00716859|62760676|FG000|Overall Study|Lack of Efficacy|3|||
33381794|NCT00716859|62760677|FG001|Overall Study|Lack of Efficacy|0|||
33381795|NCT00716859|62760676|FG000|Overall Study|Withdrawal by Subject|1|||
33381796|NCT00716859|62760677|FG001|Overall Study|Withdrawal by Subject|3|||
33381797|NCT00716859|62760676|FG000|Overall Study|Not treated|1|||
33381798|NCT00716859|62760677|FG001|Overall Study|Not treated|1|||
33381799|NCT00589121|62760685|FG000|Overall Study|Protocol Violation|2|||
33381800|NCT00589121|62760686|FG001|Overall Study|Protocol Violation|6|||
33381801|NCT00589121|62760685|FG000|Overall Study|No protocol treatment received|0|||
33381802|NCT00589121|62760686|FG001|Overall Study|No protocol treatment received|1|||
33381803|NCT00590135|62760695|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
33381804|NCT00589667|62760700|FG000|Overall Study|Adverse Event|2|||
33381805|NCT00589667|62760700|FG000|Overall Study|Withdrawal by Subject|1|||
33381806|NCT00737568|62760706|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
33381807|NCT00737568|62760707|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
33381808|NCT00737568|62760706|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
33381809|NCT00737568|62760707|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
33381810|NCT00737568|62760706|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
33381811|NCT00737568|62760707|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
33381812|NCT00737568|62760706|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
33381813|NCT00737568|62760707|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
33381814|NCT00737568|62760706|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
33381815|NCT00737568|62760707|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
33381816|NCT00737568|62760706|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
33381817|NCT00737568|62760707|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
33381818|NCT00737568|62760706|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
33381819|NCT00737568|62760707|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
33294701|NCT01977417|62671468|FG001|Overall Study|Adverse Event|0|||
33294702|NCT01977417|62671467|FG000|Overall Study|Withdrawal by Subject|2|||
33294703|NCT01977417|62671468|FG001|Overall Study|Withdrawal by Subject|4|||
33294704|NCT01977417|62671467|FG000|Overall Study|Female enrollment goal met|0|||
33381820|NCT00737568|62760706|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
33381821|NCT00737568|62760707|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
33381822|NCT00737568|62760706|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
33381823|NCT00737568|62760707|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
33381824|NCT00737100|62760716|FG000|Overall Study|Adverse Event|6|||
33381825|NCT00737100|62760717|FG001|Overall Study|Adverse Event|5|||
33381826|NCT00737100|62760718|FG002|Overall Study|Adverse Event|3|||
33381827|NCT00737100|62760716|FG000|Overall Study|Lost to Follow-up|0|||
33381828|NCT00737100|62760717|FG001|Overall Study|Lost to Follow-up|1|||
33381829|NCT00737100|62760718|FG002|Overall Study|Lost to Follow-up|0|||
33381830|NCT00737100|62760716|FG000|Overall Study|Withdrawal by Subject|0|||
33381831|NCT00737100|62760717|FG001|Overall Study|Withdrawal by Subject|0|||
33381832|NCT00737100|62760718|FG002|Overall Study|Withdrawal by Subject|3|||
33381833|NCT00737100|62760716|FG000|Overall Study|Reason discontinued not explained above|1|||
33294705|NCT01977417|62671468|FG001|Overall Study|Female enrollment goal met|2|||
33294706|NCT01951885|62671476|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
33294707|NCT01951885|62671477|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
33294708|NCT01951885|62671476|FG000|Overall Study|Adverse Event|1|||
33381834|NCT00737100|62760717|FG001|Overall Study|Reason discontinued not explained above|1|||
33294709|NCT01951885|62671477|FG001|Overall Study|Adverse Event|0|||
33294710|NCT01951885|62671476|FG000|Overall Study|Withdrawal by Subject|0|||
33294711|NCT01951885|62671477|FG001|Overall Study|Withdrawal by Subject|1|||
33381835|NCT00737100|62760718|FG002|Overall Study|Reason discontinued not explained above|1|||
33381836|NCT00732498|62760728|FG000|Overall Study|Ineligible|1|||
33381837|NCT00732498|62760728|FG000|Overall Study|Adverse Event|2|||
33381838|NCT00732498|62760728|FG000|Overall Study|Physician Decision|3|||
33381839|NCT00726882|62760732|FG000|Overall Study|Withdrawal by Subject|5|||
33381840|NCT00726882|62760732|FG000|Overall Study|Lost to Follow-up|7|||
33381841|NCT00726882|62760732|FG000|Overall Study|Other|10|||
33381842|NCT00790400|62760740|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
33381843|NCT00790400|62760741|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
33381844|NCT00790400|62760740|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
33381845|NCT00790400|62760741|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
33381846|NCT00790400|62760740|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
33381847|NCT00790400|62760741|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
33381848|NCT00790400|62760740|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
33381849|NCT00790400|62760741|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
33381850|NCT00790400|62760740|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
33381851|NCT00790400|62760741|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
33381852|NCT00790400|62760740|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
33381853|NCT00790400|62760741|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
33381854|NCT00790400|62760740|FG000|Double-blind Period (Core Phase)|Death|1|||
33381855|NCT00790400|62760741|FG001|Double-blind Period (Core Phase)|Death|0|||
33381856|NCT00790400|62760740|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
33381857|NCT00790400|62760741|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
33381858|NCT00790400|62760740|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
33381859|NCT00790400|62760741|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
33381860|NCT00790400|62760740|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
33381861|NCT00790400|62760741|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
33381862|NCT00790400|62760740|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
33381863|NCT00790400|62760741|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
33381864|NCT00790400|62760740|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
33381865|NCT00790400|62760741|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
33381866|NCT00790400|62760740|FG000|Everolimus Period (Core or Extension)|Death|1|||
33381867|NCT00790400|62760741|FG001|Everolimus Period (Core or Extension)|Death|0|||
33381868|NCT00790400|62760740|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
33381869|NCT00790400|62760741|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
33381870|NCT00790400|62760740|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
33381871|NCT00790400|62760741|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
33381872|NCT00790400|62760740|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
33381873|NCT00790400|62760741|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
33381874|NCT00786032|62760750|FG000|Overall Study|Death|4|||
33381875|NCT00786032|62760750|FG000|Overall Study|Withdrawal by Subject|14|||
33381876|NCT00786032|62760750|FG000|Overall Study|Did not complete in the timeframe|6|||
33381877|NCT00785486|62760756|FG000|Midazolam Alone|Withdrawal by Subject|1|||
33381878|NCT00589979|62760779|FG000|Run-In Period|Adverse Event|5|||
33381879|NCT00589979|62760780|FG001|Run-In Period|Adverse Event|0|||
33294712|NCT01951885|62671476|FG000|Overall Study|ineligible due to a change in donor|0|||
33488096|NCT01981850|62866214|FG003|Main Phase Stage 2|Adverse Event|0|||
33381880|NCT00589979|62760781|FG002|Run-In Period|Adverse Event|0|||
33381881|NCT00589979|62760779|FG000|Run-In Period|Protocol Violation|3|||
33381882|NCT00589979|62760780|FG001|Run-In Period|Protocol Violation|0|||
33381883|NCT00589979|62760781|FG002|Run-In Period|Protocol Violation|0|||
33381884|NCT00589979|62760779|FG000|Run-In Period|Did not qualify for randomization|54|||
33381885|NCT00589979|62760780|FG001|Run-In Period|Did not qualify for randomization|0|||
33662487|NCT01693367|63093070|FG000|Overall Study|Physician Decision|0|||
33294713|NCT01951885|62671477|FG001|Overall Study|ineligible due to a change in donor|1|||
33294714|NCT01951885|62671476|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
33294715|NCT01951885|62671477|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
33294716|NCT00626990|62671487|FG000|Overall Study|Lack of Efficacy|6|||
33294717|NCT00626990|62671488|FG001|Overall Study|Lack of Efficacy|7|||
33294718|NCT00626990|62671489|FG002|Overall Study|Lack of Efficacy|49|||
33294719|NCT00626990|62671490|FG003|Overall Study|Lack of Efficacy|40|||
33294720|NCT00626990|62671487|FG000|Overall Study|Adverse Event|1|||
33294721|NCT00626990|62671488|FG001|Overall Study|Adverse Event|7|||
33294722|NCT00626990|62671489|FG002|Overall Study|Adverse Event|14|||
33294723|NCT00626990|62671490|FG003|Overall Study|Adverse Event|28|||
33294724|NCT00626990|62671487|FG000|Overall Study|Death|0|||
33294725|NCT00626990|62671488|FG001|Overall Study|Death|1|||
33294726|NCT00626990|62671489|FG002|Overall Study|Death|0|||
33381886|NCT00589979|62760781|FG002|Run-In Period|Did not qualify for randomization|0|||
33381887|NCT00589979|62760779|FG000|Run-In Period|Withdrawal by Subject|10|||
33381888|NCT00589979|62760780|FG001|Run-In Period|Withdrawal by Subject|0|||
33381889|NCT00589979|62760781|FG002|Run-In Period|Withdrawal by Subject|0|||
33381890|NCT00589979|62760779|FG000|Run-In Period|Informed Consent Withdrawn|4|||
33381891|NCT00589979|62760780|FG001|Run-In Period|Informed Consent Withdrawn|0|||
33381892|NCT00589979|62760781|FG002|Run-In Period|Informed Consent Withdrawn|0|||
33381893|NCT00589979|62760779|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
33294727|NCT00626990|62671490|FG003|Overall Study|Death|0|||
33294728|NCT00626990|62671487|FG000|Overall Study|Withdrawal by Subject|3|||
33294729|NCT00626990|62671488|FG001|Overall Study|Withdrawal by Subject|1|||
33294730|NCT00626990|62671489|FG002|Overall Study|Withdrawal by Subject|5|||
33294731|NCT00626990|62671490|FG003|Overall Study|Withdrawal by Subject|11|||
33294732|NCT00626990|62671487|FG000|Overall Study|Protocol Violation|0|||
33294733|NCT00626990|62671488|FG001|Overall Study|Protocol Violation|1|||
33294734|NCT00626990|62671489|FG002|Overall Study|Protocol Violation|1|||
33294735|NCT00626990|62671490|FG003|Overall Study|Protocol Violation|0|||
33294736|NCT00626990|62671487|FG000|Overall Study|Various different reasons/missing|4|||
33294737|NCT00626990|62671488|FG001|Overall Study|Various different reasons/missing|8|||
33294738|NCT00626990|62671489|FG002|Overall Study|Various different reasons/missing|8|||
33294739|NCT00626990|62671490|FG003|Overall Study|Various different reasons/missing|16|||
33294740|NCT00107198|62671504|FG000|Overall Study|Lack of Efficacy|28|||
33294741|NCT00107198|62671504|FG000|Overall Study|Lost to Follow-up|12|||
33294742|NCT00107198|62671504|FG000|Overall Study|Protocol Violation|1|||
33381894|NCT00589979|62760780|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
33381895|NCT00589979|62760781|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
33294743|NCT00107198|62671504|FG000|Overall Study|Withdrawal by Subject|6|||
33294744|NCT00107198|62671504|FG000|Overall Study|Ineligible|5|||
33381896|NCT00589979|62760779|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
33381897|NCT00589979|62760780|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
33381898|NCT00589979|62760781|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
33381899|NCT00589979|62760779|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
33381900|NCT00589979|62760780|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
33381901|NCT00589979|62760781|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
33381902|NCT00589979|62760779|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
33381903|NCT00589979|62760780|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
33381904|NCT00589979|62760781|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
33381905|NCT00589979|62760779|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
33381906|NCT00589979|62760780|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
33381907|NCT00589979|62760781|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
33381908|NCT00589979|62760779|FG000|Double-Blind Treatment Period 2|Other|0|||
33381909|NCT00589979|62760780|FG001|Double-Blind Treatment Period 2|Other|0|||
33381910|NCT00589979|62760781|FG002|Double-Blind Treatment Period 2|Other|1|||
33381911|NCT00589979|62760779|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
33381912|NCT00589979|62760780|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
33381913|NCT00589979|62760781|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
33381914|NCT00589979|62760779|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
33381915|NCT00589979|62760780|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
33381916|NCT00589979|62760781|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
33488097|NCT01981850|62866215|FG004|Main Phase Stage 2|Adverse Event|6|||
33488098|NCT01981850|62866216|FG005|Main Phase Stage 2|Adverse Event|5|||
33294745|NCT01193920|62671527|FG000|Overall Study|Withdrawal by Subject|1|||
33381917|NCT00797732|62760795|FG000|Overall Study|Withdrawal by Subject|3|||
33381918|NCT00797732|62760796|FG001|Overall Study|Withdrawal by Subject|3|||
33662488|NCT01693367|63093071|FG001|Overall Study|Physician Decision|1|||
33294746|NCT01193920|62671528|FG001|Overall Study|Withdrawal by Subject|0|||
33294747|NCT01193920|62671529|FG002|Overall Study|Withdrawal by Subject|5|||
33294748|NCT01193920|62671530|FG003|Overall Study|Withdrawal by Subject|1|||
33488099|NCT01981850|62866217|FG006|Main Phase Stage 2|Adverse Event|7|||
33294749|NCT01193920|62671531|FG004|Overall Study|Withdrawal by Subject|3|||
33294750|NCT01193920|62671532|FG005|Overall Study|Withdrawal by Subject|1|||
33381919|NCT00797732|62760797|FG002|Overall Study|Withdrawal by Subject|0|||
33381920|NCT00797732|62760795|FG000|Overall Study|Lost to Follow-up|1|||
33381921|NCT00797732|62760796|FG001|Overall Study|Lost to Follow-up|0|||
33381922|NCT00797732|62760797|FG002|Overall Study|Lost to Follow-up|0|||
33381923|NCT00797732|62760795|FG000|Overall Study|Death|1|||
33381924|NCT00797732|62760796|FG001|Overall Study|Death|0|||
33381925|NCT00797732|62760797|FG002|Overall Study|Death|0|||
33381926|NCT00797732|62760795|FG000|Overall Study|Not meet inclusion criteria|0|||
33381927|NCT00797732|62760796|FG001|Overall Study|Not meet inclusion criteria|0|||
33381928|NCT00797732|62760797|FG002|Overall Study|Not meet inclusion criteria|7|||
33381929|NCT00797732|62760795|FG000|Overall Study|Excluded due to time constraints|0|||
33381930|NCT00797732|62760796|FG001|Overall Study|Excluded due to time constraints|0|||
33381931|NCT00797732|62760797|FG002|Overall Study|Excluded due to time constraints|24|||
33381932|NCT00797732|62760795|FG000|Overall Study|Refused to Participate|0|||
33381933|NCT00797732|62760796|FG001|Overall Study|Refused to Participate|0|||
33381934|NCT00797732|62760797|FG002|Overall Study|Refused to Participate|123|||
33381935|NCT00790088|62760803|FG000|Overall Study|Protocol Violation|11|||
33381936|NCT00790088|62760803|FG000|Overall Study|Withdrawal by Subject|17|||
33381937|NCT00790088|62760803|FG000|Overall Study|Lost to Follow-up|7|||
33381938|NCT00790088|62760803|FG000|Overall Study|Physician Decision|4|||
33381939|NCT00736944|62760809|FG000|Induction|Death|1|||
33381940|NCT00736944|62760809|FG000|Definitive Treatment|Physician Decision|1|||
33381941|NCT00736476|62760818|FG000|Overall Study|Adverse Event|1|||
33381942|NCT00736476|62760819|FG001|Overall Study|Adverse Event|0|||
33381943|NCT00715299|62760831|FG000|Overall Study|Withdrawal by Subject|1|||
33381944|NCT00715299|62760831|FG000|Overall Study|Adverse Event|3|||
33381945|NCT00715299|62760831|FG000|Overall Study|failed the pre-screen exercise test|2|||
33381946|NCT00730236|62760835|FG000|Overall Study|Adverse Event|4|||
33381947|NCT00730236|62760835|FG000|Overall Study|Withdrawal by Subject|1|||
33381948|NCT00730236|62760835|FG000|Overall Study|Non-compliance|1|||
33381949|NCT00714285|62760843|FG000|Overall Study|Lost to Follow-up|0|||
33381950|NCT00714285|62760844|FG001|Overall Study|Lost to Follow-up|2|||
33381951|NCT00714285|62760845|FG002|Overall Study|Lost to Follow-up|0|||
33381952|NCT00714285|62760846|FG003|Overall Study|Lost to Follow-up|1|||
33381953|NCT00714285|62760843|FG000|Overall Study|Migrated/moved from study area|0|||
33381954|NCT00714285|62760844|FG001|Overall Study|Migrated/moved from study area|1|||
33381955|NCT00714285|62760845|FG002|Overall Study|Migrated/moved from study area|0|||
33381956|NCT00714285|62760846|FG003|Overall Study|Migrated/moved from study area|0|||
33381957|NCT00776984|62760860|FG000|Overall Study|Adverse Event|8|||
33381958|NCT00776984|62760861|FG001|Overall Study|Adverse Event|2|||
33381959|NCT00776984|62760860|FG000|Overall Study|Protocol Violation|4|||
33381960|NCT00776984|62760861|FG001|Overall Study|Protocol Violation|2|||
33381961|NCT00776984|62760860|FG000|Overall Study|Lost to Follow-up|2|||
33381962|NCT00776984|62760861|FG001|Overall Study|Lost to Follow-up|0|||
33381963|NCT00776984|62760860|FG000|Overall Study|Withdrawal by Subject|12|||
33381964|NCT00776984|62760861|FG001|Overall Study|Withdrawal by Subject|7|||
33381965|NCT00776984|62760860|FG000|Overall Study|Lack of Efficacy|0|||
33381966|NCT00776984|62760861|FG001|Overall Study|Lack of Efficacy|1|||
33381967|NCT00776984|62760860|FG000|Overall Study|Other|5|||
33381968|NCT00776984|62760861|FG001|Overall Study|Other|9|||
33381969|NCT00714051|62760869|FG000|Overall Study|Withdrawal by Subject|1|||
33294751|NCT01193920|62671533|FG006|Overall Study|Withdrawal by Subject|3|||
33294752|NCT01193920|62671534|FG007|Overall Study|Withdrawal by Subject|0|||
33294753|NCT01193920|62671535|FG008|Overall Study|Withdrawal by Subject|1|||
33294754|NCT01193920|62671536|FG009|Overall Study|Withdrawal by Subject|0|||
33294755|NCT01193920|62671527|FG000|Overall Study|Lost to Follow-up|1|||
33294756|NCT01193920|62671528|FG001|Overall Study|Lost to Follow-up|0|||
33294757|NCT01193920|62671529|FG002|Overall Study|Lost to Follow-up|1|||
33294758|NCT01193920|62671530|FG003|Overall Study|Lost to Follow-up|1|||
33294759|NCT01193920|62671531|FG004|Overall Study|Lost to Follow-up|3|||
33294760|NCT01193920|62671532|FG005|Overall Study|Lost to Follow-up|3|||
33294761|NCT01193920|62671533|FG006|Overall Study|Lost to Follow-up|1|||
33294762|NCT01193920|62671534|FG007|Overall Study|Lost to Follow-up|0|||
33294763|NCT01193920|62671535|FG008|Overall Study|Lost to Follow-up|2|||
33294764|NCT01193920|62671536|FG009|Overall Study|Lost to Follow-up|3|||
33294765|NCT01193920|62671527|FG000|Overall Study|Protocol Violation|1|||
33294766|NCT01193920|62671528|FG001|Overall Study|Protocol Violation|0|||
33381970|NCT00714051|62760870|FG001|Overall Study|Withdrawal by Subject|0|||
33381971|NCT00714051|62760869|FG000|Overall Study|Death|0|||
33381972|NCT00714051|62760870|FG001|Overall Study|Death|1|||
33381973|NCT00784784|62760878|FG000|Overall Study|Withdrawal by Subject|2|||
33381974|NCT00784784|62760879|FG001|Overall Study|Withdrawal by Subject|2|||
33294767|NCT01193920|62671529|FG002|Overall Study|Protocol Violation|0|||
33381975|NCT00801983|62760887|FG000|Period 1|Lost to Follow-up|2|||
33381976|NCT00801983|62760888|FG001|Period 1|Lost to Follow-up|0|||
33381977|NCT00801983|62760887|FG000|Period 1|Withdrawal by Subject|2|||
33381978|NCT00801983|62760888|FG001|Period 1|Withdrawal by Subject|8|||
33381979|NCT00801983|62760887|FG000|Period 2|Withdrawal by Subject|2|||
33381980|NCT00801983|62760888|FG001|Period 2|Withdrawal by Subject|1|||
33294768|NCT01193920|62671530|FG003|Overall Study|Protocol Violation|0|||
33294769|NCT01193920|62671531|FG004|Overall Study|Protocol Violation|0|||
33294770|NCT01193920|62671532|FG005|Overall Study|Protocol Violation|0|||
33294771|NCT01193920|62671533|FG006|Overall Study|Protocol Violation|0|||
33294772|NCT01193920|62671534|FG007|Overall Study|Protocol Violation|0|||
33294773|NCT01193920|62671535|FG008|Overall Study|Protocol Violation|0|||
33294774|NCT01193920|62671536|FG009|Overall Study|Protocol Violation|0|||
33294775|NCT01193920|62671527|FG000|Overall Study|Death|0|||
33294776|NCT01193920|62671528|FG001|Overall Study|Death|0|||
33294777|NCT01193920|62671529|FG002|Overall Study|Death|0|||
33294778|NCT01193920|62671530|FG003|Overall Study|Death|1|||
33294779|NCT01193920|62671531|FG004|Overall Study|Death|0|||
33294780|NCT01193920|62671532|FG005|Overall Study|Death|0|||
33294781|NCT01193920|62671533|FG006|Overall Study|Death|2|||
33294782|NCT01193920|62671534|FG007|Overall Study|Death|3|||
33294783|NCT01193920|62671535|FG008|Overall Study|Death|2|||
33294784|NCT01193920|62671536|FG009|Overall Study|Death|4|||
33294785|NCT01193920|62671527|FG000|Overall Study|Unable to classify|0|||
33294786|NCT01193920|62671528|FG001|Overall Study|Unable to classify|0|||
33381981|NCT00587288|62760896|FG000|Overall Study|Adverse Event|0|||
33381982|NCT00587288|62760897|FG001|Overall Study|Adverse Event|1|||
33381983|NCT00587288|62760896|FG000|Overall Study|Lack of Efficacy|2|||
33381984|NCT00587288|62760897|FG001|Overall Study|Lack of Efficacy|8|||
33381985|NCT00587288|62760896|FG000|Overall Study|Protocol Violation|1|||
33381986|NCT00587288|62760897|FG001|Overall Study|Protocol Violation|0|||
33381987|NCT00800735|62760905|FG000|Overall Study|Administrative/Other|2|||
33381988|NCT00800735|62760905|FG000|Overall Study|Insufficient Therapeutic Response|2|||
33381989|NCT00800735|62760905|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
33381990|NCT00800735|62760905|FG000|Overall Study|Withdrew Consent|3|||
33381991|NCT00730158|62760911|FG000|Overall Study|Withdrawal by Subject|1|||
33381992|NCT00730158|62760912|FG001|Overall Study|Withdrawal by Subject|1|||
33381993|NCT00784550|62760924|FG000|Overall Study|Adverse Event|12|||
33381994|NCT00784550|62760925|FG001|Overall Study|Adverse Event|10|||
33294787|NCT01193920|62671529|FG002|Overall Study|Unable to classify|0|||
33294788|NCT01193920|62671530|FG003|Overall Study|Unable to classify|1|||
33294789|NCT01193920|62671531|FG004|Overall Study|Unable to classify|0|||
33294790|NCT01193920|62671532|FG005|Overall Study|Unable to classify|0|||
33294791|NCT01193920|62671533|FG006|Overall Study|Unable to classify|0|||
33294792|NCT01193920|62671534|FG007|Overall Study|Unable to classify|1|||
33381995|NCT00784550|62760924|FG000|Overall Study|Lack of Efficacy|0|||
33381996|NCT00784550|62760925|FG001|Overall Study|Lack of Efficacy|1|||
33381997|NCT00784550|62760924|FG000|Overall Study|Protocol Violation|10|||
33381998|NCT00784550|62760925|FG001|Overall Study|Protocol Violation|10|||
33381999|NCT00784550|62760924|FG000|Overall Study|Lost to Follow-up|8|||
33382000|NCT00784550|62760925|FG001|Overall Study|Lost to Follow-up|5|||
33382001|NCT00784550|62760924|FG000|Overall Study|Physician Decision|2|||
33382002|NCT00784550|62760925|FG001|Overall Study|Physician Decision|3|||
33382003|NCT00784550|62760924|FG000|Overall Study|Withdrawal by Subject|4|||
33382004|NCT00784550|62760925|FG001|Overall Study|Withdrawal by Subject|13|||
33382005|NCT00729690|62760934|FG000|Overall Study|IT Catheter Malfunction|0|||
33382006|NCT00729690|62760935|FG001|Overall Study|IT Catheter Malfunction|2|||
33382007|NCT00729690|62760936|FG002|Overall Study|IT Catheter Malfunction|2|||
33382008|NCT00784238|62760944|FG000|Overall Study|Adverse Event|14|||
33382009|NCT00784238|62760944|FG000|Overall Study|Death|2|||
33382010|NCT00784238|62760944|FG000|Overall Study|Lack of Efficacy|33|||
33382011|NCT00784238|62760944|FG000|Overall Study|Lost to Follow-up|29|||
33382012|NCT00784238|62760944|FG000|Overall Study|Pregnancy|1|||
33382013|NCT00784238|62760944|FG000|Overall Study|Withdrawal by Subject|26|||
33382014|NCT00784238|62760944|FG000|Overall Study|Other|14|||
33294793|NCT01193920|62671535|FG008|Overall Study|Unable to classify|0|||
33294794|NCT01193920|62671536|FG009|Overall Study|Unable to classify|0|||
33294795|NCT01193686|62671561|FG000|Overall Study|Withdrawal by Subject|4|||
33294796|NCT01193686|62671562|FG001|Overall Study|Withdrawal by Subject|1|||
33294797|NCT01193686|62671561|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
33294798|NCT01193686|62671562|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
33382015|NCT00729612|62760951|FG000|Overall Study|Non evaluable for response|10|||
33382016|NCT00585546|62760955|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
33556661|NCT02614196|62949482|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
33294799|NCT01193608|62671575|FG000|Overall Study|Other|0|||
33294800|NCT01193608|62671576|FG001|Overall Study|Other|1|||
33294801|NCT01193608|62671577|FG002|Overall Study|Other|0|||
33294802|NCT01193608|62671578|FG003|Overall Study|Other|0|||
33382017|NCT00585546|62760955|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
33382018|NCT00768248|62760961|FG000|Overall Study|Research coordinator didn't collect data|1|||
33382019|NCT00768248|62760962|FG001|Overall Study|Research coordinator didn't collect data|1|||
33382020|NCT00775268|62760970|FG000|Baseline|Drug not synthesize dose|1|||
33556662|NCT02614196|62949477|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
33294803|NCT01193608|62671579|FG004|Overall Study|Other|0|||
33294804|NCT01193608|62671580|FG005|Overall Study|Other|0|||
33382021|NCT00775268|62760971|FG001|Baseline|Drug not synthesize dose|0|||
33294805|NCT01193608|62671575|FG000|Overall Study|Withdrawal by Subject|0|||
33294806|NCT01193608|62671576|FG001|Overall Study|Withdrawal by Subject|1|||
33294807|NCT01193608|62671577|FG002|Overall Study|Withdrawal by Subject|2|||
33294808|NCT01193608|62671578|FG003|Overall Study|Withdrawal by Subject|3|||
33294809|NCT01193608|62671579|FG004|Overall Study|Withdrawal by Subject|3|||
33294810|NCT01193608|62671580|FG005|Overall Study|Withdrawal by Subject|0|||
33294811|NCT01193608|62671575|FG000|Overall Study|Lost to Follow-up|0|||
33294812|NCT01193608|62671576|FG001|Overall Study|Lost to Follow-up|0|||
33294813|NCT01193608|62671577|FG002|Overall Study|Lost to Follow-up|0|||
33382022|NCT00775268|62760970|FG000|Baseline|Not treated-ineligible per CT|0|||
33382023|NCT00775268|62760971|FG001|Baseline|Not treated-ineligible per CT|1|||
33382024|NCT00775268|62760970|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
33382025|NCT00775268|62760971|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
33382026|NCT00775268|62760970|FG000|After Completion|Participant missed scan appointment|1|||
33382027|NCT00775268|62760971|FG001|After Completion|Participant missed scan appointment|0|||
33382028|NCT00775190|62760990|FG000|Overall Study|Lost to Follow-up|2|||
33382029|NCT00775190|62760991|FG001|Overall Study|Lost to Follow-up|3|||
33382030|NCT00775190|62760990|FG000|Overall Study|Withdrawal by Subject|1|||
33382031|NCT00775190|62760991|FG001|Overall Study|Withdrawal by Subject|2|||
33382032|NCT00775190|62760990|FG000|Overall Study|Protocol Violation|1|||
33382033|NCT00775190|62760991|FG001|Overall Study|Protocol Violation|0|||
33382034|NCT00479557|62761004|FG000|Overall Study|Death|0|||
33382035|NCT00479557|62761005|FG001|Overall Study|Death|0|||
33382036|NCT00479557|62761006|FG002|Overall Study|Death|0|||
33382037|NCT00479557|62761007|FG003|Overall Study|Death|0|||
33382038|NCT00479557|62761008|FG004|Overall Study|Death|0|||
33382039|NCT00479557|62761009|FG005|Overall Study|Death|1|||
33382040|NCT00479557|62761010|FG006|Overall Study|Death|0|||
33382041|NCT00479557|62761004|FG000|Overall Study|Lack of Efficacy|1|||
33382042|NCT00479557|62761005|FG001|Overall Study|Lack of Efficacy|0|||
33382043|NCT00479557|62761006|FG002|Overall Study|Lack of Efficacy|0|||
33382044|NCT00479557|62761007|FG003|Overall Study|Lack of Efficacy|0|||
33382045|NCT00479557|62761008|FG004|Overall Study|Lack of Efficacy|0|||
33382046|NCT00479557|62761009|FG005|Overall Study|Lack of Efficacy|0|||
33382047|NCT00479557|62761010|FG006|Overall Study|Lack of Efficacy|0|||
33382048|NCT00479557|62761004|FG000|Overall Study|Lost to Follow-up|0|||
33382049|NCT00479557|62761005|FG001|Overall Study|Lost to Follow-up|2|||
33382050|NCT00479557|62761006|FG002|Overall Study|Lost to Follow-up|0|||
33382051|NCT00479557|62761007|FG003|Overall Study|Lost to Follow-up|2|||
33382052|NCT00479557|62761008|FG004|Overall Study|Lost to Follow-up|0|||
33382053|NCT00479557|62761009|FG005|Overall Study|Lost to Follow-up|0|||
33382054|NCT00479557|62761010|FG006|Overall Study|Lost to Follow-up|0|||
33382055|NCT00479557|62761004|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
33382056|NCT00479557|62761005|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
33382057|NCT00479557|62761006|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
33382058|NCT00479557|62761007|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
33382059|NCT00479557|62761008|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
33382060|NCT00479557|62761009|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
33382061|NCT00479557|62761010|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
33382062|NCT00479557|62761004|FG000|Overall Study|AE not related to Study Drug|1|||
33382063|NCT00479557|62761005|FG001|Overall Study|AE not related to Study Drug|3|||
33382064|NCT00479557|62761006|FG002|Overall Study|AE not related to Study Drug|0|||
33382065|NCT00479557|62761007|FG003|Overall Study|AE not related to Study Drug|0|||
33382066|NCT00479557|62761008|FG004|Overall Study|AE not related to Study Drug|2|||
33382067|NCT00479557|62761009|FG005|Overall Study|AE not related to Study Drug|2|||
33382068|NCT00479557|62761010|FG006|Overall Study|AE not related to Study Drug|1|||
33382069|NCT00479557|62761004|FG000|Overall Study|Caregiver Request|2|||
33382070|NCT00479557|62761005|FG001|Overall Study|Caregiver Request|2|||
33382071|NCT00479557|62761006|FG002|Overall Study|Caregiver Request|2|||
33382072|NCT00479557|62761007|FG003|Overall Study|Caregiver Request|0|||
33382073|NCT00479557|62761008|FG004|Overall Study|Caregiver Request|1|||
33382074|NCT00479557|62761009|FG005|Overall Study|Caregiver Request|2|||
33382075|NCT00479557|62761010|FG006|Overall Study|Caregiver Request|0|||
33382076|NCT00479557|62761004|FG000|Overall Study|Investigator Request|0|||
33294814|NCT01193608|62671578|FG003|Overall Study|Lost to Follow-up|0|||
33294815|NCT01193608|62671579|FG004|Overall Study|Lost to Follow-up|1|||
33294816|NCT01193608|62671580|FG005|Overall Study|Lost to Follow-up|2|||
33382077|NCT00479557|62761005|FG001|Overall Study|Investigator Request|0|||
33382078|NCT00479557|62761006|FG002|Overall Study|Investigator Request|1|||
33382079|NCT00479557|62761007|FG003|Overall Study|Investigator Request|0|||
33382080|NCT00479557|62761008|FG004|Overall Study|Investigator Request|0|||
33382081|NCT00479557|62761009|FG005|Overall Study|Investigator Request|0|||
33382082|NCT00479557|62761010|FG006|Overall Study|Investigator Request|0|||
33382083|NCT00479557|62761004|FG000|Overall Study|Subject Request|3|||
33382084|NCT00479557|62761005|FG001|Overall Study|Subject Request|0|||
33382085|NCT00479557|62761006|FG002|Overall Study|Subject Request|1|||
33382086|NCT00479557|62761007|FG003|Overall Study|Subject Request|1|||
33382087|NCT00479557|62761008|FG004|Overall Study|Subject Request|1|||
33382088|NCT00479557|62761009|FG005|Overall Study|Subject Request|4|||
33382089|NCT00479557|62761010|FG006|Overall Study|Subject Request|1|||
33382090|NCT00479557|62761004|FG000|Overall Study|Other|2|||
33382091|NCT00479557|62761005|FG001|Overall Study|Other|3|||
33382092|NCT00479557|62761006|FG002|Overall Study|Other|1|||
33382093|NCT00479557|62761007|FG003|Overall Study|Other|0|||
33382094|NCT00479557|62761008|FG004|Overall Study|Other|0|||
33382095|NCT00479557|62761009|FG005|Overall Study|Other|3|||
33382096|NCT00479557|62761010|FG006|Overall Study|Other|0|||
33382097|NCT00774800|62761032|FG000|Intervention 4|Withdrawal by Subject|1|||
33382098|NCT00439309|62761044|FG000|Follow-Up|Death|1|||
33382099|NCT00439309|62761045|FG001|Follow-Up|Death|0|||
33382100|NCT00439309|62761044|FG000|Follow-Up|Lost to Follow-up|2|||
33382101|NCT00439309|62761045|FG001|Follow-Up|Lost to Follow-up|0|||
33382102|NCT00439309|62761044|FG000|Follow-Up|Withdrawal by Subject|0|||
33382103|NCT00439309|62761045|FG001|Follow-Up|Withdrawal by Subject|1|||
33382104|NCT00439309|62761044|FG000|Follow-Up|Late response by subject|0|||
33382105|NCT00439309|62761045|FG001|Follow-Up|Late response by subject|1|||
33382106|NCT00479167|62761051|FG000|Overall Study|Withdrawal by Subject|1|||
33382107|NCT00725712|62761058|FG000|Overall Study|Withdrawal by Subject|2|||
33382108|NCT00725712|62761059|FG001|Overall Study|Withdrawal by Subject|1|||
33382109|NCT00725712|62761058|FG000|Overall Study|Protocol Violation|1|||
33382110|NCT00725712|62761059|FG001|Overall Study|Protocol Violation|0|||
33382111|NCT00725712|62761058|FG000|Overall Study|Progressive disease|37|||
33382112|NCT00725712|62761059|FG001|Overall Study|Progressive disease|16|||
33382113|NCT00725712|62761058|FG000|Overall Study|Clinical progression not based on RECIST|0|||
33382114|NCT00725712|62761059|FG001|Overall Study|Clinical progression not based on RECIST|3|||
33382115|NCT00725712|62761058|FG000|Overall Study|Adverse Event|5|||
33294817|NCT01193608|62671575|FG000|Overall Study|Adverse Event|0|||
33294818|NCT01193608|62671576|FG001|Overall Study|Adverse Event|0|||
33294819|NCT01193608|62671577|FG002|Overall Study|Adverse Event|0|||
33294820|NCT01193608|62671578|FG003|Overall Study|Adverse Event|0|||
33382116|NCT00725712|62761059|FG001|Overall Study|Adverse Event|5|||
33382117|NCT00725712|62761058|FG000|Overall Study|Death|2|||
33382118|NCT00725712|62761059|FG001|Overall Study|Death|0|||
33294821|NCT01193608|62671579|FG004|Overall Study|Adverse Event|1|||
33294822|NCT01193608|62671580|FG005|Overall Study|Adverse Event|0|||
33294823|NCT01177228|62671603|FG000|Overall Study|Positive tuberculosis test|0|||
33294824|NCT01177228|62671604|FG001|Overall Study|Positive tuberculosis test|1|||
33294825|NCT01177228|62671605|FG002|Overall Study|Positive tuberculosis test|0|||
33294826|NCT01177228|62671606|FG003|Overall Study|Positive tuberculosis test|0|||
33294827|NCT01177228|62671603|FG000|Overall Study|Worsening disease activity|1|||
33294828|NCT01177228|62671604|FG001|Overall Study|Worsening disease activity|0|||
33294829|NCT01177228|62671605|FG002|Overall Study|Worsening disease activity|0|||
33294830|NCT01177228|62671606|FG003|Overall Study|Worsening disease activity|0|||
33294831|NCT01177228|62671603|FG000|Overall Study|Withdrawal by Subject|0|||
33294832|NCT01177228|62671604|FG001|Overall Study|Withdrawal by Subject|1|||
33294833|NCT01177228|62671605|FG002|Overall Study|Withdrawal by Subject|0|||
33294834|NCT01177228|62671606|FG003|Overall Study|Withdrawal by Subject|0|||
33294835|NCT01193530|62671623|FG000|Overall Study|Withdrawal by Subject|2|||
33294836|NCT01193530|62671624|FG001|Overall Study|Withdrawal by Subject|2|||
33294837|NCT01193530|62671623|FG000|Overall Study|Began Contraindicated Therapy|1|||
33294838|NCT01193530|62671624|FG001|Overall Study|Began Contraindicated Therapy|0|||
33294839|NCT01193530|62671623|FG000|Overall Study|Lost Light Box|0|||
33294840|NCT01193530|62671624|FG001|Overall Study|Lost Light Box|1|||
33294841|NCT01193530|62671623|FG000|Overall Study|Returned home - out of state|0|||
33294842|NCT01193530|62671624|FG001|Overall Study|Returned home - out of state|1|||
33294843|NCT01193530|62671623|FG000|Overall Study|Non-Compliance|0|||
33294844|NCT01193530|62671624|FG001|Overall Study|Non-Compliance|1|||
33294845|NCT00107172|62671632|FG000|Overall Study|Withdrawal by Subject|1|||
33294846|NCT00107172|62671633|FG001|Overall Study|Withdrawal by Subject|0|||
33382119|NCT00725712|62761058|FG000|Overall Study|Other: Death|1|||
33382120|NCT00725712|62761059|FG001|Overall Study|Other: Death|0|||
33382121|NCT00725712|62761058|FG000|Overall Study|Hospitalized, unable to continue|0|||
33382122|NCT00725712|62761059|FG001|Overall Study|Hospitalized, unable to continue|1|||
33382123|NCT00729378|62761071|FG000|Baseline|Did not complete study measurements|72|||
33294847|NCT00107172|62671632|FG000|Overall Study|Death|0|||
33294848|NCT00107172|62671633|FG001|Overall Study|Death|2|||
33294849|NCT00107172|62671632|FG000|Overall Study|Other Reason|4|||
33294850|NCT00107172|62671633|FG001|Overall Study|Other Reason|3|||
33294851|NCT01680965|62671647|FG000|Overall Study|Death|0|||
33294852|NCT01680965|62671648|FG001|Overall Study|Death|0|||
33382124|NCT00729378|62761072|FG001|Baseline|Did not complete study measurements|33|||
33382125|NCT00729378|62761071|FG000|Baseline|Withdrawal by Subject|66|||
33382126|NCT00729378|62761072|FG001|Baseline|Withdrawal by Subject|59|||
33382127|NCT00729378|62761071|FG000|12-months|Lost to Follow-up|100|||
33382128|NCT00729378|62761072|FG001|12-months|Lost to Follow-up|65|||
33382129|NCT00729378|62761071|FG000|24-months|Lost to Follow-up|72|||
33382130|NCT00729378|62761072|FG001|24-months|Lost to Follow-up|51|||
33382131|NCT00729378|62761071|FG000|36-months|Lost to Follow-up|15|||
33382132|NCT00729378|62761072|FG001|36-months|Lost to Follow-up|6|||
33382133|NCT00478933|62761081|FG000|Overall Study|Protocol Violation|22|||
33382134|NCT00478933|62761081|FG000|Overall Study|Informed consent not verified|3|||
33382135|NCT00478933|62761081|FG000|Overall Study|Inadequate data available|53|||
33382136|NCT00725322|62761107|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
33382137|NCT00725322|62761108|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
33382138|NCT00725322|62761107|FG000|Washout (28 Days)|Protocol Violation|0|||
33382139|NCT00725322|62761108|FG001|Washout (28 Days)|Protocol Violation|1|||
33382140|NCT00725010|62761114|FG000|Overall Study|Toxicity|9|||
33382141|NCT00725010|62761114|FG000|Overall Study|Tumor Progression|7|||
33382142|NCT00725010|62761114|FG000|Overall Study|Withdrawal by Subject|2|||
33382143|NCT00725010|62761114|FG000|Overall Study|Death|1|||
33382144|NCT00725010|62761114|FG000|Overall Study|Lost to Follow-up|1|||
33382145|NCT00725010|62761114|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
33382146|NCT00725010|62761114|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
33382147|NCT00725010|62761114|FG000|Overall Study|No further documentation|1|||
33382148|NCT00725010|62761114|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
33382149|NCT00767000|62761125|FG000|54-week Study|Adverse Event|4|||
33382150|NCT00767000|62761126|FG001|54-week Study|Adverse Event|6|||
33382151|NCT00767000|62761127|FG002|54-week Study|Adverse Event|6|||
33382152|NCT00767000|62761128|FG003|54-week Study|Adverse Event|8|||
33382153|NCT00767000|62761129|FG004|54-week Study|Adverse Event|4|||
33382154|NCT00767000|62761125|FG000|54-week Study|Creaninine/creatinine clearance|2|||
33382155|NCT00767000|62761126|FG001|54-week Study|Creaninine/creatinine clearance|1|||
33382156|NCT00767000|62761127|FG002|54-week Study|Creaninine/creatinine clearance|2|||
33382157|NCT00767000|62761128|FG003|54-week Study|Creaninine/creatinine clearance|2|||
33382158|NCT00767000|62761129|FG004|54-week Study|Creaninine/creatinine clearance|4|||
33382159|NCT00767000|62761125|FG000|54-week Study|Hyperglycemia|0|||
33382160|NCT00767000|62761126|FG001|54-week Study|Hyperglycemia|0|||
33382161|NCT00767000|62761127|FG002|54-week Study|Hyperglycemia|1|||
33488100|NCT01981850|62866218|FG007|Main Phase Stage 2|Adverse Event|0|||
33488101|NCT01981850|62866219|FG008|Main Phase Stage 2|Adverse Event|0|||
33488102|NCT01981850|62866220|FG009|Main Phase Stage 2|Adverse Event|0|||
33488103|NCT01981850|62866211|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
33488104|NCT01981850|62866212|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
33488105|NCT01981850|62866213|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
33488106|NCT01981850|62866214|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
33488107|NCT01981850|62866215|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
33294853|NCT01680965|62671649|FG002|Overall Study|Death|0|||
33294854|NCT01680965|62671650|FG003|Overall Study|Death|6|||
33294855|NCT01339923|62671665|FG000|Overall Study|Adverse Event|1|||
33294856|NCT01339923|62671666|FG001|Overall Study|Adverse Event|1|||
33294857|NCT01339923|62671667|FG002|Overall Study|Adverse Event|1|||
33294858|NCT01339923|62671668|FG003|Overall Study|Adverse Event|0|||
33294859|NCT01339923|62671669|FG004|Overall Study|Adverse Event|0|||
33294860|NCT01339923|62671670|FG005|Overall Study|Adverse Event|0|||
33294861|NCT01339923|62671671|FG006|Overall Study|Adverse Event|1|||
33294862|NCT01339923|62671665|FG000|Overall Study|Inappropriate Enrollment|1|||
33294863|NCT01339923|62671666|FG001|Overall Study|Inappropriate Enrollment|0|||
33294864|NCT01339923|62671667|FG002|Overall Study|Inappropriate Enrollment|0|||
33294865|NCT01339923|62671668|FG003|Overall Study|Inappropriate Enrollment|0|||
33294866|NCT01339923|62671669|FG004|Overall Study|Inappropriate Enrollment|0|||
33294867|NCT01339923|62671670|FG005|Overall Study|Inappropriate Enrollment|1|||
33294868|NCT01339923|62671671|FG006|Overall Study|Inappropriate Enrollment|0|||
33294869|NCT01339923|62671665|FG000|Overall Study|Lost to Follow-up|4|||
33294870|NCT01339923|62671666|FG001|Overall Study|Lost to Follow-up|4|||
33294871|NCT01339923|62671667|FG002|Overall Study|Lost to Follow-up|0|||
33294872|NCT01339923|62671668|FG003|Overall Study|Lost to Follow-up|3|||
33294873|NCT01339923|62671669|FG004|Overall Study|Lost to Follow-up|1|||
33294874|NCT01339923|62671670|FG005|Overall Study|Lost to Follow-up|1|||
33294875|NCT01339923|62671671|FG006|Overall Study|Lost to Follow-up|5|||
33294876|NCT01339923|62671665|FG000|Overall Study|Protocol Violation|0|||
33294877|NCT01339923|62671666|FG001|Overall Study|Protocol Violation|0|||
33382162|NCT00767000|62761128|FG003|54-week Study|Hyperglycemia|0|||
33382163|NCT00767000|62761129|FG004|54-week Study|Hyperglycemia|1|||
33662489|NCT02696226|63093081|FG000|Overall Study|Study terminated - lack of enrollment|1|||
33294878|NCT01339923|62671667|FG002|Overall Study|Protocol Violation|0|||
33382164|NCT00767000|62761125|FG000|54-week Study|Hypoglycemia|0|||
33382165|NCT00767000|62761126|FG001|54-week Study|Hypoglycemia|1|||
33294879|NCT01339923|62671668|FG003|Overall Study|Protocol Violation|0|||
33294880|NCT01339923|62671669|FG004|Overall Study|Protocol Violation|0|||
33294881|NCT01339923|62671670|FG005|Overall Study|Protocol Violation|3|||
33382166|NCT00767000|62761127|FG002|54-week Study|Hypoglycemia|0|||
33382167|NCT00767000|62761128|FG003|54-week Study|Hypoglycemia|0|||
33382168|NCT00767000|62761129|FG004|54-week Study|Hypoglycemia|0|||
33294882|NCT01339923|62671671|FG006|Overall Study|Protocol Violation|1|||
33294883|NCT01339923|62671665|FG000|Overall Study|Unable to Classify|1|||
33294884|NCT01339923|62671666|FG001|Overall Study|Unable to Classify|0|||
33294885|NCT01339923|62671667|FG002|Overall Study|Unable to Classify|1|||
33294886|NCT01339923|62671668|FG003|Overall Study|Unable to Classify|0|||
33294887|NCT01339923|62671669|FG004|Overall Study|Unable to Classify|0|||
33294888|NCT01339923|62671670|FG005|Overall Study|Unable to Classify|1|||
33294889|NCT01339923|62671671|FG006|Overall Study|Unable to Classify|5|||
33294890|NCT01339923|62671665|FG000|Overall Study|Withdrawal by Subject|7|||
33294891|NCT01339923|62671666|FG001|Overall Study|Withdrawal by Subject|11|||
33294892|NCT01339923|62671667|FG002|Overall Study|Withdrawal by Subject|6|||
33294893|NCT01339923|62671668|FG003|Overall Study|Withdrawal by Subject|1|||
33294894|NCT01339923|62671669|FG004|Overall Study|Withdrawal by Subject|4|||
33294895|NCT01339923|62671670|FG005|Overall Study|Withdrawal by Subject|3|||
33294896|NCT01339923|62671671|FG006|Overall Study|Withdrawal by Subject|2|||
33294897|NCT01380093|62671704|FG000|Naloxone Challenge Phase|Screen failures|21|||
33294898|NCT01380093|62671705|FG001|Naloxone Challenge Phase|Screen failures|0|||
33294899|NCT01380093|62671706|FG002|Naloxone Challenge Phase|Screen failures|0|||
33294900|NCT01380093|62671707|FG003|Naloxone Challenge Phase|Screen failures|0|||
33294901|NCT01380093|62671708|FG004|Naloxone Challenge Phase|Screen failures|0|||
33294902|NCT01380093|62671709|FG005|Naloxone Challenge Phase|Screen failures|0|||
33294903|NCT01380093|62671710|FG006|Naloxone Challenge Phase|Screen failures|0|||
33294904|NCT01380093|62671711|FG007|Naloxone Challenge Phase|Screen failures|0|||
33294905|NCT01380093|62671712|FG008|Naloxone Challenge Phase|Screen failures|0|||
33294906|NCT01380093|62671704|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33294907|NCT01380093|62671705|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
33294908|NCT01380093|62671706|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33294909|NCT01380093|62671707|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33294910|NCT01380093|62671708|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33294911|NCT01380093|62671709|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33294912|NCT01380093|62671710|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33294913|NCT01380093|62671711|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33294914|NCT01380093|62671712|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33294915|NCT01380093|62671704|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
33294916|NCT01380093|62671705|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
33294917|NCT01380093|62671706|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
33294918|NCT01380093|62671707|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
33294919|NCT01380093|62671708|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
33294920|NCT01380093|62671709|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
33294921|NCT01380093|62671710|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
33294922|NCT01380093|62671711|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
33294923|NCT01380093|62671712|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
33294924|NCT01380093|62671704|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33294925|NCT01380093|62671705|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
33382169|NCT00767000|62761125|FG000|54-week Study|Interruption of study medication|0|||
33382170|NCT00767000|62761126|FG001|54-week Study|Interruption of study medication|0|||
33382171|NCT00767000|62761127|FG002|54-week Study|Interruption of study medication|1|||
33382172|NCT00767000|62761128|FG003|54-week Study|Interruption of study medication|0|||
33382173|NCT00767000|62761129|FG004|54-week Study|Interruption of study medication|0|||
33382174|NCT00767000|62761125|FG000|54-week Study|Lack of Efficacy|2|||
33382175|NCT00767000|62761126|FG001|54-week Study|Lack of Efficacy|0|||
33382176|NCT00767000|62761127|FG002|54-week Study|Lack of Efficacy|1|||
33382177|NCT00767000|62761128|FG003|54-week Study|Lack of Efficacy|0|||
33382178|NCT00767000|62761129|FG004|54-week Study|Lack of Efficacy|5|||
33382179|NCT00767000|62761125|FG000|54-week Study|Lost to Follow-up|4|||
33382180|NCT00767000|62761126|FG001|54-week Study|Lost to Follow-up|0|||
33556663|NCT02614196|62949478|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
33556664|NCT02614196|62949479|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
33556665|NCT02614196|62949480|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
33556666|NCT02614196|62949481|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
33556667|NCT02614196|62949482|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
33556668|NCT02614196|62949477|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
33294926|NCT01380093|62671706|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33294927|NCT01380093|62671707|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33294928|NCT01380093|62671708|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33382181|NCT00767000|62761127|FG002|54-week Study|Lost to Follow-up|1|||
33382182|NCT00767000|62761128|FG003|54-week Study|Lost to Follow-up|4|||
33294929|NCT01380093|62671709|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33382183|NCT00767000|62761129|FG004|54-week Study|Lost to Follow-up|2|||
33294930|NCT01380093|62671710|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33294931|NCT01380093|62671711|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33294932|NCT01380093|62671712|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33294933|NCT01380093|62671704|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
33294934|NCT01380093|62671705|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
33382184|NCT00767000|62761125|FG000|54-week Study|Physician Decision|4|||
33382185|NCT00767000|62761126|FG001|54-week Study|Physician Decision|0|||
33382186|NCT00767000|62761127|FG002|54-week Study|Physician Decision|1|||
33382187|NCT00767000|62761128|FG003|54-week Study|Physician Decision|1|||
33382188|NCT00767000|62761129|FG004|54-week Study|Physician Decision|1|||
33382189|NCT00767000|62761125|FG000|54-week Study|Progressive disease|0|||
33382190|NCT00767000|62761126|FG001|54-week Study|Progressive disease|0|||
33382191|NCT00767000|62761127|FG002|54-week Study|Progressive disease|1|||
33382192|NCT00767000|62761128|FG003|54-week Study|Progressive disease|0|||
33382193|NCT00767000|62761129|FG004|54-week Study|Progressive disease|0|||
33382194|NCT00767000|62761125|FG000|54-week Study|Protocol Violation|0|||
33382195|NCT00767000|62761126|FG001|54-week Study|Protocol Violation|0|||
33382196|NCT00767000|62761127|FG002|54-week Study|Protocol Violation|1|||
33382197|NCT00767000|62761128|FG003|54-week Study|Protocol Violation|2|||
33382198|NCT00767000|62761129|FG004|54-week Study|Protocol Violation|0|||
33382199|NCT00767000|62761125|FG000|54-week Study|Withdrawal by Subject|2|||
33382200|NCT00767000|62761126|FG001|54-week Study|Withdrawal by Subject|3|||
33382201|NCT00767000|62761127|FG002|54-week Study|Withdrawal by Subject|5|||
33382202|NCT00767000|62761128|FG003|54-week Study|Withdrawal by Subject|11|||
33382203|NCT00767000|62761129|FG004|54-week Study|Withdrawal by Subject|13|||
33382204|NCT00767000|62761125|FG000|54-week Study|Study terminated by sponsor|90|||
33382205|NCT00767000|62761126|FG001|54-week Study|Study terminated by sponsor|102|||
33382206|NCT00767000|62761127|FG002|54-week Study|Study terminated by sponsor|89|||
33382207|NCT00767000|62761128|FG003|54-week Study|Study terminated by sponsor|196|||
33382208|NCT00767000|62761129|FG004|54-week Study|Study terminated by sponsor|194|||
33382209|NCT00767000|62761125|FG000|54-week Study|Reason not reported|0|||
33382210|NCT00767000|62761126|FG001|54-week Study|Reason not reported|0|||
33382211|NCT00767000|62761127|FG002|54-week Study|Reason not reported|0|||
33382212|NCT00767000|62761128|FG003|54-week Study|Reason not reported|1|||
33382213|NCT00767000|62761129|FG004|54-week Study|Reason not reported|0|||
33382214|NCT00767000|62761125|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
33382215|NCT00767000|62761126|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
33382216|NCT00767000|62761127|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
33382217|NCT00767000|62761128|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
33382218|NCT00767000|62761129|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
33382219|NCT00724932|62761143|FG000|Overall Study|Lost to Follow-up|1|||
33382220|NCT00724932|62761144|FG001|Overall Study|Lost to Follow-up|0|||
33382221|NCT00724932|62761143|FG000|Overall Study|Not treated|4|||
33382222|NCT00724932|62761144|FG001|Overall Study|Not treated|3|||
33382223|NCT00766532|62761152|FG000|Overall Study|Protocol Violation|2|||
33382224|NCT00774566|62761158|FG000|Overall Study|Protocol Violation|18|||
33382225|NCT00774566|62761159|FG001|Overall Study|Protocol Violation|15|||
33382226|NCT00766376|62761165|FG000|Overall Study|Withdrawal by Subject|27|||
33382227|NCT00587054|62761169|FG000|Overall Study|Patient not treated|9|||
33382228|NCT00766142|62761173|FG000|Overall Study|Protocol Violation|4|||
33382229|NCT00724854|62761179|FG000|Overall Study|Lack of Efficacy|187|||
33556669|NCT02614196|62949478|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
33294935|NCT01380093|62671706|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
33294936|NCT01380093|62671707|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
33294937|NCT01380093|62671708|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
33294938|NCT01380093|62671709|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
33294939|NCT01380093|62671710|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
33294940|NCT01380093|62671711|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
33294941|NCT01380093|62671712|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
33294942|NCT01380093|62671704|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
33294943|NCT01380093|62671705|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
33294944|NCT01380093|62671706|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
33294945|NCT01380093|62671707|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
33294946|NCT01380093|62671708|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
33294947|NCT01380093|62671709|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
33382230|NCT00724854|62761180|FG001|Overall Study|Lack of Efficacy|13|||
33382231|NCT00724854|62761179|FG000|Overall Study|Lost to Follow-up|87|||
33382232|NCT00724854|62761180|FG001|Overall Study|Lost to Follow-up|10|||
33382233|NCT00724854|62761179|FG000|Overall Study|Adverse Event|62|||
33382234|NCT00724854|62761180|FG001|Overall Study|Adverse Event|4|||
33382235|NCT00724854|62761179|FG000|Overall Study|Other|42|||
33382236|NCT00724854|62761180|FG001|Overall Study|Other|3|||
33382237|NCT00724854|62761179|FG000|Overall Study|Death|11|||
33382238|NCT00724854|62761180|FG001|Overall Study|Death|0|||
33382239|NCT00724854|62761179|FG000|Overall Study|Change of treatment|7|||
33382240|NCT00724854|62761180|FG001|Overall Study|Change of treatment|0|||
33382241|NCT00724854|62761179|FG000|Overall Study|Withdrawal by Subject|5|||
33382242|NCT00724854|62761180|FG001|Overall Study|Withdrawal by Subject|0|||
33382243|NCT00724854|62761179|FG000|Overall Study|Adverse event + lack of efficacy|2|||
33382244|NCT00724854|62761180|FG001|Overall Study|Adverse event + lack of efficacy|1|||
33382245|NCT00728988|62761189|FG000|Overall Study|Not Treated|2|||
33382246|NCT00728988|62761190|FG001|Overall Study|Not Treated|2|||
33382247|NCT00728988|62761189|FG000|Overall Study|Death|1|||
33382248|NCT00728988|62761190|FG001|Overall Study|Death|1|||
33382249|NCT00728988|62761189|FG000|Overall Study|Adverse Event|3|||
33382250|NCT00728988|62761190|FG001|Overall Study|Adverse Event|2|||
33382251|NCT00728988|62761189|FG000|Overall Study|Other|85|||
33382252|NCT00728988|62761190|FG001|Overall Study|Other|77|||
33382253|NCT00728988|62761189|FG000|Overall Study|Withdrawal by Subject|2|||
33382254|NCT00728988|62761190|FG001|Overall Study|Withdrawal by Subject|6|||
33382255|NCT00728754|62761199|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
33382256|NCT00728754|62761200|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
33382257|NCT00728754|62761199|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
33382258|NCT00728754|62761200|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
33382259|NCT00728754|62761199|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
33382260|NCT00728754|62761200|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
33382261|NCT00728130|62761206|FG000|Overall Study|Withdrawal by Subject|1|||
33382262|NCT00728130|62761206|FG000|Overall Study|Paperwork not completed in time|1|||
33382263|NCT00728130|62761206|FG000|Overall Study|Physician Decision|1|||
33382264|NCT00735696|62761210|FG000|Overall Study|Withdrawal by Subject|1|||
33382265|NCT00735696|62761210|FG000|Overall Study|Enrolled but never Treated|1|||
33382266|NCT00478231|62761219|FG000|Overall Study|Death|7|||
33382267|NCT00478231|62761219|FG000|Overall Study|Lack of Efficacy|47|||
33382268|NCT00478231|62761219|FG000|Overall Study|Lost to Follow-up|7|||
33382269|NCT00478231|62761219|FG000|Overall Study|Withdrawal by Subject|6|||
33382270|NCT00478231|62761219|FG000|Overall Study|Other|9|||
33382271|NCT00478231|62761219|FG000|Overall Study|Adverse Event|5|||
33294948|NCT01380093|62671710|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
33294949|NCT01380093|62671711|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
33294950|NCT01380093|62671712|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
33294951|NCT01380093|62671704|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
33294952|NCT01380093|62671705|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
33294953|NCT01380093|62671706|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
33294954|NCT01380093|62671707|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
33294955|NCT01380093|62671708|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
33294956|NCT01380093|62671709|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
33294957|NCT01380093|62671710|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
33294958|NCT01380093|62671711|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
33294959|NCT01380093|62671712|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
33294960|NCT01380093|62671704|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33294961|NCT01380093|62671705|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33294962|NCT01380093|62671706|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
33294963|NCT01380093|62671707|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33294964|NCT01380093|62671708|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33294965|NCT01380093|62671709|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33294966|NCT01380093|62671710|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33294967|NCT01380093|62671711|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33382272|NCT00478231|62761219|FG000|Overall Study|Randomized, not treated|3|||
33382273|NCT00474175|62761226|FG000|Overall Study|Lack of Efficacy|0|||
33382274|NCT00474175|62761227|FG001|Overall Study|Lack of Efficacy|0|||
33382275|NCT00474175|62761228|FG002|Overall Study|Lack of Efficacy|1|||
33382276|NCT00474175|62761226|FG000|Overall Study|Withdrawal by Subject|0|||
33382277|NCT00474175|62761227|FG001|Overall Study|Withdrawal by Subject|1|||
33382278|NCT00474175|62761228|FG002|Overall Study|Withdrawal by Subject|1|||
33488108|NCT01981850|62866216|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
33488109|NCT01981850|62866217|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
33556670|NCT02614196|62949479|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
33294968|NCT01380093|62671712|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33294969|NCT01380093|62671704|FG000|Treatment Phase: Second Intervention|Other|0|||
33382279|NCT00474175|62761226|FG000|Overall Study|Ineligible|1|||
33382280|NCT00474175|62761227|FG001|Overall Study|Ineligible|3|||
33382281|NCT00474175|62761228|FG002|Overall Study|Ineligible|1|||
33556671|NCT02614196|62949480|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
33294970|NCT01380093|62671705|FG001|Treatment Phase: Second Intervention|Other|0|||
33294971|NCT01380093|62671706|FG002|Treatment Phase: Second Intervention|Other|0|||
33294972|NCT01380093|62671707|FG003|Treatment Phase: Second Intervention|Other|1|||
33382282|NCT00474175|62761226|FG000|Overall Study|Protocol Violation|0|||
33382283|NCT00474175|62761227|FG001|Overall Study|Protocol Violation|2|||
33382284|NCT00474175|62761228|FG002|Overall Study|Protocol Violation|1|||
33382285|NCT00474175|62761226|FG000|Overall Study|Administrative|0|||
33382286|NCT00474175|62761227|FG001|Overall Study|Administrative|1|||
33382287|NCT00474175|62761228|FG002|Overall Study|Administrative|0|||
33294973|NCT01380093|62671708|FG004|Treatment Phase: Second Intervention|Other|0|||
33294974|NCT01380093|62671709|FG005|Treatment Phase: Second Intervention|Other|0|||
33294975|NCT01380093|62671710|FG006|Treatment Phase: Second Intervention|Other|0|||
33294976|NCT01380093|62671711|FG007|Treatment Phase: Second Intervention|Other|0|||
33294977|NCT01380093|62671712|FG008|Treatment Phase: Second Intervention|Other|0|||
33294978|NCT01380093|62671704|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
33294979|NCT01380093|62671705|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
33294980|NCT01380093|62671706|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
33294981|NCT01380093|62671707|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
33294982|NCT01380093|62671708|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
33294983|NCT01380093|62671709|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
33294984|NCT01380093|62671710|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
33382288|NCT00443209|62761259|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
33382289|NCT00443209|62761260|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
33382290|NCT00443209|62761259|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
33382291|NCT00443209|62761260|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
33382292|NCT00443209|62761259|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
33382293|NCT00443209|62761260|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
33382294|NCT00443209|62761259|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
33382295|NCT00443209|62761260|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
33382296|NCT00443209|62761259|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
33382297|NCT00443209|62761260|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
33382298|NCT00443209|62761259|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
33382299|NCT00443209|62761260|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
33382300|NCT00443209|62761259|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
33382301|NCT00443209|62761260|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
33382302|NCT00443209|62761259|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
33382303|NCT00443209|62761260|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
33382304|NCT00443209|62761259|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
33382305|NCT00443209|62761260|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
33382306|NCT00443209|62761259|FG000|Months 1 to 12 Treatment Period|Missing|2|||
33382307|NCT00443209|62761260|FG001|Months 1 to 12 Treatment Period|Missing|1|||
33382308|NCT00443209|62761259|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
33382309|NCT00443209|62761260|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
33382310|NCT00443209|62761259|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
33382311|NCT00443209|62761260|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
33382312|NCT00443209|62761259|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
33382313|NCT00443209|62761260|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
33382314|NCT00443209|62761259|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
33382315|NCT00443209|62761260|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
33382316|NCT00443209|62761259|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
33382317|NCT00443209|62761260|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
33382318|NCT00443209|62761259|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
33382319|NCT00443209|62761260|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
33382320|NCT00443209|62761259|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
33382321|NCT00443209|62761260|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
33382322|NCT00439231|62761266|FG000|Overall Study|Lack of Efficacy|28|||
33382323|NCT00437983|62761272|FG000|Overall Study|Adverse Event|6|||
33294985|NCT01380093|62671711|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
33294986|NCT01380093|62671712|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
33294987|NCT01380093|62671704|FG000|Treatment Phase: Third Intervention|Other|0|||
33294988|NCT01380093|62671705|FG001|Treatment Phase: Third Intervention|Other|0|||
33294989|NCT01380093|62671706|FG002|Treatment Phase: Third Intervention|Other|0|||
33294990|NCT01380093|62671707|FG003|Treatment Phase: Third Intervention|Other|0|||
33294991|NCT01380093|62671708|FG004|Treatment Phase: Third Intervention|Other|0|||
33294992|NCT01380093|62671709|FG005|Treatment Phase: Third Intervention|Other|0|||
33382324|NCT00437983|62761273|FG001|Overall Study|Adverse Event|6|||
33382325|NCT00437983|62761272|FG000|Overall Study|Protocol Violation|2|||
33382326|NCT00437983|62761273|FG001|Overall Study|Protocol Violation|1|||
33382327|NCT00437983|62761272|FG000|Overall Study|Withdrawal by Subject|5|||
33382328|NCT00437983|62761273|FG001|Overall Study|Withdrawal by Subject|6|||
33382329|NCT00783692|62761282|FG000|Induction Phase|Adverse Event|7|||
33382330|NCT00783692|62761283|FG001|Induction Phase|Adverse Event|9|||
33382331|NCT00783692|62761284|FG002|Induction Phase|Adverse Event|24|||
33382332|NCT00783692|62761285|FG003|Induction Phase|Adverse Event|0|||
33382333|NCT00783692|62761286|FG004|Induction Phase|Adverse Event|0|||
33662490|NCT02696226|63093082|FG001|Overall Study|Study terminated - lack of enrollment|0|||
33294993|NCT01380093|62671710|FG006|Treatment Phase: Third Intervention|Other|0|||
33294994|NCT01380093|62671711|FG007|Treatment Phase: Third Intervention|Other|0|||
33294995|NCT01380093|62671712|FG008|Treatment Phase: Third Intervention|Other|1|||
33294996|NCT01379937|62671730|FG000|Overall Study|Protocol Violation|0|||
33294997|NCT01379937|62671731|FG001|Overall Study|Protocol Violation|0|||
33294998|NCT01379937|62671732|FG002|Overall Study|Protocol Violation|0|||
33294999|NCT01379937|62671733|FG003|Overall Study|Protocol Violation|1|||
33295000|NCT01379937|62671730|FG000|Overall Study|Consent withdrawal|0|||
33295001|NCT01379937|62671731|FG001|Overall Study|Consent withdrawal|1|||
33295002|NCT01379937|62671732|FG002|Overall Study|Consent withdrawal|0|||
33295003|NCT01379937|62671733|FG003|Overall Study|Consent withdrawal|0|||
33295004|NCT01379937|62671730|FG000|Overall Study|Lost to Follow-up|1|||
33295005|NCT01379937|62671731|FG001|Overall Study|Lost to Follow-up|2|||
33295006|NCT01379937|62671732|FG002|Overall Study|Lost to Follow-up|2|||
33295007|NCT01379937|62671733|FG003|Overall Study|Lost to Follow-up|0|||
33295008|NCT01379781|62671759|FG000|Overall Study|Lost to Follow-up|11|||
33295009|NCT01379781|62671760|FG001|Overall Study|Lost to Follow-up|8|||
33382334|NCT00783692|62761287|FG005|Induction Phase|Adverse Event|0|||
33382335|NCT00783692|62761288|FG006|Induction Phase|Adverse Event|0|||
33382336|NCT00783692|62761282|FG000|Induction Phase|Protocol Violation|0|||
33295010|NCT01379703|62671766|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
33295011|NCT01379703|62671767|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
33382337|NCT00783692|62761283|FG001|Induction Phase|Protocol Violation|0|||
33382338|NCT00783692|62761284|FG002|Induction Phase|Protocol Violation|1|||
33382339|NCT00783692|62761285|FG003|Induction Phase|Protocol Violation|0|||
33382340|NCT00783692|62761286|FG004|Induction Phase|Protocol Violation|0|||
33382341|NCT00783692|62761287|FG005|Induction Phase|Protocol Violation|0|||
33488110|NCT01981850|62866218|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
33488111|NCT01981850|62866219|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
33556672|NCT02614196|62949481|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
33556673|NCT02614196|62949482|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
33556674|NCT02614196|62949477|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
33662491|NCT02696226|63093083|FG002|Overall Study|Study terminated - lack of enrollment|2|||
33662492|NCT02696226|63093084|FG003|Overall Study|Study terminated - lack of enrollment|0|||
33662493|NCT01692275|63093100|FG000|Overall Study|Lost to Follow-up|57|||
33662494|NCT01692275|63093101|FG001|Overall Study|Lost to Follow-up|48|||
33488112|NCT01981850|62866220|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
33488113|NCT01981850|62866211|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
33488114|NCT01981850|62866212|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
33488115|NCT01981850|62866213|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
33488116|NCT01981850|62866214|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
33662495|NCT01692275|63093100|FG000|Overall Study|Withdrawal by Subject|9|||
33662496|NCT01692275|63093101|FG001|Overall Study|Withdrawal by Subject|11|||
33662497|NCT02692560|63093121|FG000|Overall Study|Withdrawal by Subject|0|||
33662498|NCT02692560|63093122|FG001|Overall Study|Withdrawal by Subject|6|||
33662499|NCT02688192|63093130|FG000|Overall Study|Lost to Follow-up|11|||
33662500|NCT02688192|63093131|FG001|Overall Study|Lost to Follow-up|5|||
33662501|NCT02688192|63093130|FG000|Overall Study|Physician Decision|1|||
33662502|NCT02688192|63093131|FG001|Overall Study|Physician Decision|0|||
33662503|NCT01579565|63093140|FG000|Randomized|Adverse Event|1|||
33662504|NCT01579565|63093141|FG001|Randomized|Adverse Event|3|||
33662505|NCT01579565|63093140|FG000|Randomized|Withdrawal by Subject|3|||
33662506|NCT01579565|63093141|FG001|Randomized|Withdrawal by Subject|0|||
33662507|NCT01579565|63093140|FG000|Randomized|inadequate preoperative pupil dilation|0|||
33662508|NCT01579565|63093141|FG001|Randomized|inadequate preoperative pupil dilation|1|||
33488117|NCT01981850|62866215|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
33488118|NCT01981850|62866216|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
33488119|NCT01981850|62866217|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
33488120|NCT01981850|62866218|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
33488121|NCT01981850|62866219|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
33488122|NCT01981850|62866220|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
33488123|NCT01981850|62866211|FG000|Main Phase Stage 2|Various reasons|0|||
33556675|NCT02614196|62949478|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
33662509|NCT01579565|63093140|FG000|Randomized|prohibited preoperative eating|1|||
33662510|NCT01579565|63093141|FG001|Randomized|prohibited preoperative eating|0|||
33662511|NCT01579565|63093140|FG000|Randomized|prohibited preoperative medication|0|||
33662512|NCT01579565|63093141|FG001|Randomized|prohibited preoperative medication|1|||
33662513|NCT01579565|63093140|FG000|Treated|Physician Decision|0|||
33295012|NCT01379703|62671768|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
33295013|NCT01379703|62671766|FG000|Study Start Through 9 Months|Adverse Event|0|||
33295014|NCT01379703|62671767|FG001|Study Start Through 9 Months|Adverse Event|14|||
33295015|NCT01379703|62671768|FG002|Study Start Through 9 Months|Adverse Event|10|||
33295016|NCT01379703|62671766|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
33488124|NCT01981850|62866212|FG001|Main Phase Stage 2|Various reasons|0|||
33488125|NCT01981850|62866213|FG002|Main Phase Stage 2|Various reasons|0|||
33662514|NCT01579565|63093141|FG001|Treated|Physician Decision|1|||
33662515|NCT01579565|63093140|FG000|Treated|Lost to Follow-up|2|||
33295017|NCT01379703|62671767|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
33295018|NCT01379703|62671768|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
33662516|NCT01579565|63093141|FG001|Treated|Lost to Follow-up|1|||
33295019|NCT01379703|62671766|FG000|Study Start Through 9 Months|Treatment Failure|0|||
33295020|NCT01379703|62671767|FG001|Study Start Through 9 Months|Treatment Failure|2|||
33295021|NCT01379703|62671768|FG002|Study Start Through 9 Months|Treatment Failure|2|||
33295022|NCT01379703|62671766|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
33295023|NCT01379703|62671767|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
33295024|NCT01379703|62671768|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
33295025|NCT01379703|62671766|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
33295026|NCT01379703|62671767|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
33295027|NCT01379703|62671768|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
33295028|NCT01379703|62671766|FG000|Study Start Through 9 Months|Medication not available|0|||
33295029|NCT01379703|62671767|FG001|Study Start Through 9 Months|Medication not available|2|||
33295030|NCT01379703|62671768|FG002|Study Start Through 9 Months|Medication not available|1|||
33295031|NCT01379703|62671766|FG000|Study Start Through 9 Months|Poor general condition|0|||
33295032|NCT01379703|62671767|FG001|Study Start Through 9 Months|Poor general condition|1|||
33295033|NCT01379703|62671768|FG002|Study Start Through 9 Months|Poor general condition|0|||
33295034|NCT01379703|62671766|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
33295035|NCT01379703|62671767|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
33295036|NCT01379703|62671768|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
33295037|NCT01379703|62671766|FG000|Study Start Through 9 Months|Reason unknown|2|||
33295038|NCT01379703|62671767|FG001|Study Start Through 9 Months|Reason unknown|31|||
33295039|NCT01379703|62671768|FG002|Study Start Through 9 Months|Reason unknown|24|||
33295040|NCT01379703|62671766|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
33295041|NCT01379703|62671767|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
33295042|NCT01379703|62671768|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
33295043|NCT01379703|62671766|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
33295044|NCT01379703|62671767|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
33295045|NCT01379703|62671768|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
33295046|NCT01379703|62671766|FG000|9 Months Through 18 Months|Adverse Event|0|||
33295047|NCT01379703|62671767|FG001|9 Months Through 18 Months|Adverse Event|6|||
33295048|NCT01379703|62671768|FG002|9 Months Through 18 Months|Adverse Event|0|||
33295049|NCT01379703|62671766|FG000|9 Months Through 18 Months|Treatment failure|0|||
33295050|NCT01379703|62671767|FG001|9 Months Through 18 Months|Treatment failure|5|||
33295051|NCT01379703|62671768|FG002|9 Months Through 18 Months|Treatment failure|0|||
33295052|NCT01379703|62671766|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
33295053|NCT01379703|62671767|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
33295054|NCT01379703|62671768|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
33295055|NCT01379703|62671766|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
33295056|NCT01379703|62671767|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
33295057|NCT01379703|62671768|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
33295058|NCT01379703|62671766|FG000|9 Months Through 18 Months|Fatigue|0|||
33295059|NCT01379703|62671767|FG001|9 Months Through 18 Months|Fatigue|1|||
33295060|NCT01379703|62671768|FG002|9 Months Through 18 Months|Fatigue|0|||
33295061|NCT01379703|62671766|FG000|9 Months Through 18 Months|Reason Unknown|0|||
33295062|NCT01379703|62671767|FG001|9 Months Through 18 Months|Reason Unknown|23|||
33295063|NCT01379703|62671768|FG002|9 Months Through 18 Months|Reason Unknown|0|||
33295064|NCT01335477|62671779|FG000|Overall Study|Adverse Event|30|||
33295065|NCT01335477|62671780|FG001|Overall Study|Adverse Event|42|||
33295066|NCT01335477|62671779|FG000|Overall Study|Non compliant with protocol|0|||
33295067|NCT01335477|62671780|FG001|Overall Study|Non compliant with protocol|2|||
33295068|NCT01335477|62671779|FG000|Overall Study|Lost to Follow-up|1|||
33295069|NCT01335477|62671780|FG001|Overall Study|Lost to Follow-up|2|||
33488126|NCT01981850|62866214|FG003|Main Phase Stage 2|Various reasons|0|||
33662517|NCT01579565|63093140|FG000|Treated|declined to return for final visit|0|||
33662518|NCT01579565|63093141|FG001|Treated|declined to return for final visit|1|||
33295070|NCT01335477|62671779|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
33295071|NCT01335477|62671780|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
33295072|NCT01335477|62671779|FG000|Overall Study|Not treated|1|||
33295073|NCT01335477|62671780|FG001|Overall Study|Not treated|2|||
33295074|NCT01335477|62671779|FG000|Overall Study|Reason other than those stated above|2|||
33295075|NCT01335477|62671780|FG001|Overall Study|Reason other than those stated above|2|||
33295076|NCT01371825|62671786|FG000|Overall Study|Death|4|||
33295077|NCT01371747|62671796|FG000|Overall Study|Adverse Event|4|||
33295078|NCT01371747|62671797|FG001|Overall Study|Adverse Event|2|||
33295079|NCT01371747|62671798|FG002|Overall Study|Adverse Event|7|||
33295080|NCT01371747|62671799|FG003|Overall Study|Adverse Event|2|||
33295081|NCT01371747|62671800|FG004|Overall Study|Adverse Event|2|||
33295082|NCT01371747|62671801|FG005|Overall Study|Adverse Event|2|||
33295083|NCT01371747|62671796|FG000|Overall Study|Death|1|||
33295084|NCT01371747|62671797|FG001|Overall Study|Death|0|||
33295085|NCT01371747|62671798|FG002|Overall Study|Death|4|||
33295086|NCT01371747|62671799|FG003|Overall Study|Death|1|||
33295087|NCT01371747|62671800|FG004|Overall Study|Death|2|||
33295088|NCT01371747|62671801|FG005|Overall Study|Death|0|||
33295089|NCT01371747|62671796|FG000|Overall Study|Abnormal Renal Function|0|||
33295090|NCT01371747|62671797|FG001|Overall Study|Abnormal Renal Function|2|||
33295091|NCT01371747|62671798|FG002|Overall Study|Abnormal Renal Function|0|||
33295092|NCT01371747|62671799|FG003|Overall Study|Abnormal Renal Function|1|||
33295093|NCT01371747|62671800|FG004|Overall Study|Abnormal Renal Function|0|||
33295094|NCT01371747|62671801|FG005|Overall Study|Abnormal Renal Function|1|||
33295095|NCT01371747|62671796|FG000|Overall Study|High Serum Potassium Results|1|||
33295096|NCT01371747|62671797|FG001|Overall Study|High Serum Potassium Results|1|||
33295097|NCT01371747|62671798|FG002|Overall Study|High Serum Potassium Results|1|||
33295098|NCT01371747|62671799|FG003|Overall Study|High Serum Potassium Results|2|||
33295099|NCT01371747|62671800|FG004|Overall Study|High Serum Potassium Results|0|||
33295100|NCT01371747|62671801|FG005|Overall Study|High Serum Potassium Results|2|||
33382342|NCT00783692|62761288|FG006|Induction Phase|Protocol Violation|0|||
33295101|NCT01371747|62671796|FG000|Overall Study|Low Serum Potassium Results|1|||
33295102|NCT01371747|62671797|FG001|Overall Study|Low Serum Potassium Results|1|||
33295103|NCT01371747|62671798|FG002|Overall Study|Low Serum Potassium Results|1|||
33295104|NCT01371747|62671799|FG003|Overall Study|Low Serum Potassium Results|1|||
33382343|NCT00783692|62761282|FG000|Induction Phase|Lack of Efficacy|1|||
33382344|NCT00783692|62761283|FG001|Induction Phase|Lack of Efficacy|3|||
33382345|NCT00783692|62761284|FG002|Induction Phase|Lack of Efficacy|28|||
33382346|NCT00783692|62761285|FG003|Induction Phase|Lack of Efficacy|0|||
33382347|NCT00783692|62761286|FG004|Induction Phase|Lack of Efficacy|0|||
33382348|NCT00783692|62761287|FG005|Induction Phase|Lack of Efficacy|0|||
33382349|NCT00783692|62761288|FG006|Induction Phase|Lack of Efficacy|0|||
33382350|NCT00783692|62761282|FG000|Induction Phase|Withdrawal by Subject|3|||
33295105|NCT01371747|62671800|FG004|Overall Study|Low Serum Potassium Results|0|||
33295106|NCT01371747|62671801|FG005|Overall Study|Low Serum Potassium Results|3|||
33295107|NCT01371747|62671796|FG000|Overall Study|Protocol Violation|0|||
33295108|NCT01371747|62671797|FG001|Overall Study|Protocol Violation|0|||
33295109|NCT01371747|62671798|FG002|Overall Study|Protocol Violation|1|||
33295110|NCT01371747|62671799|FG003|Overall Study|Protocol Violation|0|||
33295111|NCT01371747|62671800|FG004|Overall Study|Protocol Violation|0|||
33295112|NCT01371747|62671801|FG005|Overall Study|Protocol Violation|0|||
33295113|NCT01371747|62671796|FG000|Overall Study|Non-Compliance|3|||
33295114|NCT01371747|62671797|FG001|Overall Study|Non-Compliance|4|||
33295115|NCT01371747|62671798|FG002|Overall Study|Non-Compliance|3|||
33295116|NCT01371747|62671799|FG003|Overall Study|Non-Compliance|0|||
33295117|NCT01371747|62671800|FG004|Overall Study|Non-Compliance|0|||
33295118|NCT01371747|62671801|FG005|Overall Study|Non-Compliance|1|||
33295119|NCT01371747|62671796|FG000|Overall Study|Physician Decision|0|||
33295120|NCT01371747|62671797|FG001|Overall Study|Physician Decision|0|||
33295121|NCT01371747|62671798|FG002|Overall Study|Physician Decision|0|||
33382351|NCT00783692|62761283|FG001|Induction Phase|Withdrawal by Subject|9|||
33382352|NCT00783692|62761284|FG002|Induction Phase|Withdrawal by Subject|16|||
33382353|NCT00783692|62761285|FG003|Induction Phase|Withdrawal by Subject|0|||
33382354|NCT00783692|62761286|FG004|Induction Phase|Withdrawal by Subject|0|||
33382355|NCT00783692|62761287|FG005|Induction Phase|Withdrawal by Subject|0|||
33382356|NCT00783692|62761288|FG006|Induction Phase|Withdrawal by Subject|0|||
33382357|NCT00783692|62761282|FG000|Induction Phase|Lost to Follow-up|0|||
33382358|NCT00783692|62761283|FG001|Induction Phase|Lost to Follow-up|0|||
33295122|NCT01371747|62671799|FG003|Overall Study|Physician Decision|0|||
33295123|NCT01371747|62671800|FG004|Overall Study|Physician Decision|1|||
33295124|NCT01371747|62671801|FG005|Overall Study|Physician Decision|0|||
33295125|NCT01371747|62671796|FG000|Overall Study|Withdrawal by Subject|6|||
33295126|NCT01371747|62671797|FG001|Overall Study|Withdrawal by Subject|12|||
33295127|NCT01371747|62671798|FG002|Overall Study|Withdrawal by Subject|5|||
33295128|NCT01371747|62671799|FG003|Overall Study|Withdrawal by Subject|2|||
33295129|NCT01371747|62671800|FG004|Overall Study|Withdrawal by Subject|2|||
33295130|NCT01371747|62671801|FG005|Overall Study|Withdrawal by Subject|4|||
33295131|NCT01371747|62671796|FG000|Overall Study|Other Reasons|2|||
33295132|NCT01371747|62671797|FG001|Overall Study|Other Reasons|1|||
33295133|NCT01371747|62671798|FG002|Overall Study|Other Reasons|2|||
33295134|NCT01371747|62671799|FG003|Overall Study|Other Reasons|0|||
33295135|NCT01371747|62671800|FG004|Overall Study|Other Reasons|0|||
33382359|NCT00783692|62761284|FG002|Induction Phase|Lost to Follow-up|3|||
33295136|NCT01371747|62671801|FG005|Overall Study|Other Reasons|1|||
33295137|NCT01371708|62671836|FG000|Overall Study|Insufficient clinical response|3|||
33295138|NCT01371708|62671837|FG001|Overall Study|Insufficient clinical response|2|||
33295139|NCT01371708|62671838|FG002|Overall Study|Insufficient clinical response|0|||
33295140|NCT01371708|62671836|FG000|Overall Study|Lost to Follow-up|5|||
33295141|NCT01371708|62671837|FG001|Overall Study|Lost to Follow-up|9|||
33295142|NCT01371708|62671838|FG002|Overall Study|Lost to Follow-up|7|||
33295143|NCT01371708|62671836|FG000|Overall Study|Protocol Violation|2|||
33382360|NCT00783692|62761285|FG003|Induction Phase|Lost to Follow-up|0|||
33382361|NCT00783692|62761286|FG004|Induction Phase|Lost to Follow-up|0|||
33295144|NCT01371708|62671837|FG001|Overall Study|Protocol Violation|1|||
33382362|NCT00783692|62761287|FG005|Induction Phase|Lost to Follow-up|0|||
33295145|NCT01371708|62671838|FG002|Overall Study|Protocol Violation|2|||
33295146|NCT01371708|62671836|FG000|Overall Study|No longer willing to participate|7|||
33295147|NCT01371708|62671837|FG001|Overall Study|No longer willing to participate|7|||
33295148|NCT01371708|62671838|FG002|Overall Study|No longer willing to participate|13|||
33295149|NCT01371708|62671836|FG000|Overall Study|Medication error/not related to AE|0|||
33295150|NCT01371708|62671837|FG001|Overall Study|Medication error/not related to AE|1|||
33295151|NCT01371708|62671838|FG002|Overall Study|Medication error/not related to AE|0|||
33295152|NCT01371708|62671836|FG000|Overall Study|Other|3|||
33295153|NCT01371708|62671837|FG001|Overall Study|Other|2|||
33295154|NCT01371708|62671838|FG002|Overall Study|Other|4|||
33295155|NCT01371708|62671836|FG000|Overall Study|Adverse Event|5|||
33295156|NCT01371708|62671837|FG001|Overall Study|Adverse Event|8|||
33295157|NCT01371708|62671838|FG002|Overall Study|Adverse Event|12|||
33295158|NCT01371708|62671836|FG000|Overall Study|Started but did not receive treatment|1|||
33295159|NCT01371708|62671837|FG001|Overall Study|Started but did not receive treatment|0|||
33295160|NCT01371708|62671838|FG002|Overall Study|Started but did not receive treatment|1|||
33295161|NCT01335399|62671850|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
33295162|NCT01335399|62671851|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
33295163|NCT01335399|62671850|FG000|Pre-treatment Period|Participant request to discontinue|0|||
33295164|NCT01335399|62671851|FG001|Pre-treatment Period|Participant request to discontinue|1|||
33295165|NCT01335399|62671850|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
33295166|NCT01335399|62671851|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
33295167|NCT01335399|62671850|FG000|Pre-treatment Period|Consent withdrawal|3|||
33295168|NCT01335399|62671851|FG001|Pre-treatment Period|Consent withdrawal|0|||
33295169|NCT01335399|62671850|FG000|Treatment Period|Disease progression|117|||
33295170|NCT01335399|62671851|FG001|Treatment Period|Disease progression|145|||
33295171|NCT01335399|62671850|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
33295172|NCT01335399|62671851|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
33295173|NCT01335399|62671850|FG000|Treatment Period|Study drug toxicity|52|||
33295174|NCT01335399|62671851|FG001|Treatment Period|Study drug toxicity|64|||
33295175|NCT01335399|62671850|FG000|Treatment Period|Participant request to discontinue|30|||
33295176|NCT01335399|62671851|FG001|Treatment Period|Participant request to discontinue|22|||
33295177|NCT01335399|62671850|FG000|Treatment Period|Other reasons|30|||
33382363|NCT00783692|62761288|FG006|Induction Phase|Lost to Follow-up|0|||
33382364|NCT00783692|62761282|FG000|Induction Phase|Other|0|||
33382365|NCT00783692|62761283|FG001|Induction Phase|Other|0|||
33382366|NCT00783692|62761284|FG002|Induction Phase|Other|2|||
33295178|NCT01335399|62671851|FG001|Treatment Period|Other reasons|30|||
33382367|NCT00783692|62761285|FG003|Induction Phase|Other|0|||
33382368|NCT00783692|62761286|FG004|Induction Phase|Other|0|||
33382369|NCT00783692|62761287|FG005|Induction Phase|Other|0|||
33382370|NCT00783692|62761288|FG006|Induction Phase|Other|0|||
33382371|NCT00783692|62761282|FG000|Maintenance Phase|Adverse Event|7|||
33382372|NCT00783692|62761283|FG001|Maintenance Phase|Adverse Event|0|||
33382373|NCT00783692|62761284|FG002|Maintenance Phase|Adverse Event|0|||
33382374|NCT00783692|62761285|FG003|Maintenance Phase|Adverse Event|15|||
33382375|NCT00783692|62761286|FG004|Maintenance Phase|Adverse Event|12|||
33382376|NCT00783692|62761287|FG005|Maintenance Phase|Adverse Event|9|||
33382377|NCT00783692|62761288|FG006|Maintenance Phase|Adverse Event|38|||
33382378|NCT00783692|62761282|FG000|Maintenance Phase|Protocol Violation|0|||
33382379|NCT00783692|62761283|FG001|Maintenance Phase|Protocol Violation|0|||
33382380|NCT00783692|62761284|FG002|Maintenance Phase|Protocol Violation|0|||
33382381|NCT00783692|62761285|FG003|Maintenance Phase|Protocol Violation|1|||
33382382|NCT00783692|62761286|FG004|Maintenance Phase|Protocol Violation|2|||
33382383|NCT00783692|62761287|FG005|Maintenance Phase|Protocol Violation|3|||
33382384|NCT00783692|62761288|FG006|Maintenance Phase|Protocol Violation|4|||
33382385|NCT00783692|62761282|FG000|Maintenance Phase|Lack of Efficacy|79|||
33382386|NCT00783692|62761283|FG001|Maintenance Phase|Lack of Efficacy|0|||
33382387|NCT00783692|62761284|FG002|Maintenance Phase|Lack of Efficacy|0|||
33382388|NCT00783692|62761285|FG003|Maintenance Phase|Lack of Efficacy|64|||
33382389|NCT00783692|62761286|FG004|Maintenance Phase|Lack of Efficacy|58|||
33382390|NCT00783692|62761287|FG005|Maintenance Phase|Lack of Efficacy|48|||
33488127|NCT01981850|62866215|FG004|Main Phase Stage 2|Various reasons|2|||
33488128|NCT01981850|62866216|FG005|Main Phase Stage 2|Various reasons|0|||
33295179|NCT01335399|62671850|FG000|Treatment Period|Consent withdrawal|10|||
33295180|NCT01335399|62671851|FG001|Treatment Period|Consent withdrawal|7|||
33295181|NCT01335399|62671850|FG000|Treatment Period|Death|7|||
33295182|NCT01335399|62671851|FG001|Treatment Period|Death|6|||
33295183|NCT01335399|62671850|FG000|Treatment Period|Poor/Non-compliance|3|||
33382391|NCT00783692|62761288|FG006|Maintenance Phase|Lack of Efficacy|177|||
33382392|NCT00783692|62761282|FG000|Maintenance Phase|Withdrawal by Subject|7|||
33382393|NCT00783692|62761283|FG001|Maintenance Phase|Withdrawal by Subject|0|||
33382394|NCT00783692|62761284|FG002|Maintenance Phase|Withdrawal by Subject|0|||
33382395|NCT00783692|62761285|FG003|Maintenance Phase|Withdrawal by Subject|7|||
33382396|NCT00783692|62761286|FG004|Maintenance Phase|Withdrawal by Subject|6|||
33295184|NCT01335399|62671851|FG001|Treatment Period|Poor/Non-compliance|4|||
33382397|NCT00783692|62761287|FG005|Maintenance Phase|Withdrawal by Subject|9|||
33382398|NCT00783692|62761288|FG006|Maintenance Phase|Withdrawal by Subject|24|||
33382399|NCT00783692|62761282|FG000|Maintenance Phase|Lost to Follow-up|2|||
33382400|NCT00783692|62761283|FG001|Maintenance Phase|Lost to Follow-up|0|||
33382401|NCT00783692|62761284|FG002|Maintenance Phase|Lost to Follow-up|0|||
33382402|NCT00783692|62761285|FG003|Maintenance Phase|Lost to Follow-up|1|||
33382403|NCT00783692|62761286|FG004|Maintenance Phase|Lost to Follow-up|3|||
33382404|NCT00783692|62761287|FG005|Maintenance Phase|Lost to Follow-up|2|||
33382405|NCT00783692|62761288|FG006|Maintenance Phase|Lost to Follow-up|5|||
33382406|NCT00783692|62761282|FG000|Maintenance Phase|Other|0|||
33382407|NCT00783692|62761283|FG001|Maintenance Phase|Other|0|||
33382408|NCT00783692|62761284|FG002|Maintenance Phase|Other|0|||
33382409|NCT00783692|62761285|FG003|Maintenance Phase|Other|1|||
33382410|NCT00783692|62761286|FG004|Maintenance Phase|Other|0|||
33382411|NCT00783692|62761287|FG005|Maintenance Phase|Other|1|||
33382412|NCT00783692|62761288|FG006|Maintenance Phase|Other|1|||
33382413|NCT04992273|62761303|FG000|Overall Study|Lost to Follow-up|0|||
33382414|NCT04992273|62761304|FG001|Overall Study|Lost to Follow-up|1|||
33382415|NCT00783302|62761311|FG000|Overall Study|Lost to Follow-up|17|||
33382416|NCT00783302|62761311|FG000|Overall Study|Technical Problems|11|||
33382417|NCT00783302|62761311|FG000|Overall Study|Protocol Violation|3|||
33382418|NCT00783302|62761311|FG000|Overall Study|Physician Decision|1|||
33382419|NCT00783302|62761311|FG000|Overall Study|Withdrawal by Subject|3|||
33382420|NCT00783224|62761333|FG000|Overall Study|Adverse Event|0|||
33295185|NCT01335399|62671850|FG000|Treatment Period|Lost to Follow-up|2|||
33295186|NCT01335399|62671851|FG001|Treatment Period|Lost to Follow-up|2|||
33295187|NCT01335399|62671850|FG000|Treatment Period|Maximum clinical benefit|1|||
33295188|NCT01335399|62671851|FG001|Treatment Period|Maximum clinical benefit|1|||
33295189|NCT01335399|62671850|FG000|Treatment Period|No longer meet study criteria|1|||
33295190|NCT01335399|62671851|FG001|Treatment Period|No longer meet study criteria|1|||
33295191|NCT01335399|62671850|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
33295192|NCT01335399|62671851|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
33295193|NCT01366521|62671861|FG000|Overall Study|Adverse Event|1|||
33295194|NCT01366521|62671862|FG001|Overall Study|Adverse Event|0|||
33382421|NCT00783224|62761334|FG001|Overall Study|Adverse Event|0|||
33382422|NCT00783224|62761335|FG002|Overall Study|Adverse Event|1|||
33382423|NCT00783224|62761336|FG003|Overall Study|Adverse Event|0|||
33382424|NCT00783224|62761333|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
33382425|NCT00783224|62761334|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
33382426|NCT00783224|62761335|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
33382427|NCT00783224|62761336|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
33382428|NCT00783224|62761333|FG000|Overall Study|Inappropriate as a study subject|0|||
33382429|NCT00783224|62761334|FG001|Overall Study|Inappropriate as a study subject|0|||
33382430|NCT00783224|62761335|FG002|Overall Study|Inappropriate as a study subject|0|||
33382431|NCT00783224|62761336|FG003|Overall Study|Inappropriate as a study subject|1|||
33382432|NCT00782834|62761345|FG000|Treatment Phase|fibrous tumor not GIST|1|||
33382433|NCT00584805|62761349|FG000|Overall Study|No longer at risk of exposure|39|||
33382434|NCT00584805|62761349|FG000|Overall Study|Relocation|36|||
33382435|NCT00584805|62761349|FG000|Overall Study|Withdrawal by Subject|18|||
33382436|NCT00584805|62761349|FG000|Overall Study|Non-compliance|1|||
33382437|NCT00584805|62761349|FG000|Overall Study|Lost to follow up|3|||
33382438|NCT00584805|62761349|FG000|Overall Study|Screen failures|2|||
33382439|NCT00765674|62761359|FG000|Overall Study|Adverse Event|7|||
33382440|NCT00765674|62761360|FG001|Overall Study|Adverse Event|2|||
33382441|NCT00765674|62761361|FG002|Overall Study|Adverse Event|8|||
33382442|NCT00765674|62761362|FG003|Overall Study|Adverse Event|11|||
33382443|NCT00765674|62761359|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
33382444|NCT00765674|62761360|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
33382445|NCT00765674|62761361|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
33382446|NCT00765674|62761362|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
33382447|NCT00765674|62761359|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
33382448|NCT00765674|62761360|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
33488129|NCT01981850|62866217|FG006|Main Phase Stage 2|Various reasons|1|||
33295195|NCT01366521|62671863|FG002|Overall Study|Adverse Event|0|||
33295196|NCT01366521|62671864|FG003|Overall Study|Adverse Event|0|||
33295197|NCT01366521|62671861|FG000|Overall Study|Protocol Violation|0|||
33382449|NCT00765674|62761361|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
33382450|NCT00765674|62761362|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
33382451|NCT00765674|62761359|FG000|Overall Study|Lack of Efficacy|2|||
33382452|NCT00765674|62761360|FG001|Overall Study|Lack of Efficacy|3|||
33382453|NCT00765674|62761361|FG002|Overall Study|Lack of Efficacy|1|||
33382454|NCT00765674|62761362|FG003|Overall Study|Lack of Efficacy|2|||
33382455|NCT00765674|62761359|FG000|Overall Study|Protocol Violation|2|||
33382456|NCT00765674|62761360|FG001|Overall Study|Protocol Violation|0|||
33382457|NCT00765674|62761361|FG002|Overall Study|Protocol Violation|1|||
33382458|NCT00765674|62761362|FG003|Overall Study|Protocol Violation|0|||
33382459|NCT00765674|62761359|FG000|Overall Study|Withdrawal by Subject|5|||
33382460|NCT00765674|62761360|FG001|Overall Study|Withdrawal by Subject|7|||
33382461|NCT00765674|62761361|FG002|Overall Study|Withdrawal by Subject|3|||
33382462|NCT00765674|62761362|FG003|Overall Study|Withdrawal by Subject|8|||
33382463|NCT00765674|62761359|FG000|Overall Study|Lost to Follow-up|4|||
33295198|NCT01366521|62671862|FG001|Overall Study|Protocol Violation|0|||
33295199|NCT01366521|62671863|FG002|Overall Study|Protocol Violation|1|||
33295200|NCT01366521|62671864|FG003|Overall Study|Protocol Violation|0|||
33295201|NCT01366521|62671861|FG000|Overall Study|Physician Decision|0|||
33295202|NCT01366521|62671862|FG001|Overall Study|Physician Decision|0|||
33295203|NCT01366521|62671863|FG002|Overall Study|Physician Decision|1|||
33295204|NCT01366521|62671864|FG003|Overall Study|Physician Decision|0|||
33295205|NCT01366521|62671861|FG000|Overall Study|Withdrawal by Subject|0|||
33295206|NCT01366521|62671862|FG001|Overall Study|Withdrawal by Subject|1|||
33295207|NCT01366521|62671863|FG002|Overall Study|Withdrawal by Subject|0|||
33295208|NCT01366521|62671864|FG003|Overall Study|Withdrawal by Subject|0|||
33295209|NCT01335009|62671878|FG000|Overall Study|Too ill to travel to study sites|1|||
33295210|NCT01335009|62671879|FG001|Overall Study|Too ill to travel to study sites|0|||
33295211|NCT01335009|62671878|FG000|Overall Study|Death|28|||
33295212|NCT01335009|62671879|FG001|Overall Study|Death|32|||
33295213|NCT01335009|62671878|FG000|Overall Study|Withdrawal by Subject|1|||
33295214|NCT01335009|62671879|FG001|Overall Study|Withdrawal by Subject|1|||
33295215|NCT01335009|62671878|FG000|Overall Study|Lost to Follow-up|1|||
33295216|NCT01335009|62671879|FG001|Overall Study|Lost to Follow-up|0|||
33295217|NCT01366443|62671894|FG000|Overall Study|Lost to Follow-up|2|||
33295218|NCT01366443|62671894|FG000|Overall Study|Under 18 yo|1|||
33295219|NCT01332630|62671899|FG000|Overall Study|Withdrawal by Subject|3|||
33295220|NCT01366209|62671905|FG000|Overall Study|Adverse Event|6|||
33295221|NCT01366209|62671906|FG001|Overall Study|Adverse Event|7|||
33295222|NCT01366209|62671905|FG000|Overall Study|Withdrawal by Subject|4|||
33382464|NCT00765674|62761360|FG001|Overall Study|Lost to Follow-up|6|||
33382465|NCT00765674|62761361|FG002|Overall Study|Lost to Follow-up|2|||
33382466|NCT00765674|62761362|FG003|Overall Study|Lost to Follow-up|1|||
33488130|NCT01981850|62866218|FG007|Main Phase Stage 2|Various reasons|0|||
33488131|NCT01981850|62866219|FG008|Main Phase Stage 2|Various reasons|0|||
33488132|NCT01981850|62866220|FG009|Main Phase Stage 2|Various reasons|0|||
33488133|NCT01981850|62866211|FG000|Main Phase Stage 2|Progressive Disease|0|||
33488134|NCT01981850|62866212|FG001|Main Phase Stage 2|Progressive Disease|0|||
33488135|NCT01981850|62866213|FG002|Main Phase Stage 2|Progressive Disease|0|||
33488136|NCT01981850|62866214|FG003|Main Phase Stage 2|Progressive Disease|0|||
33488137|NCT01981850|62866215|FG004|Main Phase Stage 2|Progressive Disease|0|||
33488138|NCT01981850|62866216|FG005|Main Phase Stage 2|Progressive Disease|6|||
33488139|NCT01981850|62866217|FG006|Main Phase Stage 2|Progressive Disease|6|||
33488140|NCT01981850|62866218|FG007|Main Phase Stage 2|Progressive Disease|0|||
33488141|NCT01981850|62866219|FG008|Main Phase Stage 2|Progressive Disease|0|||
33488142|NCT01981850|62866220|FG009|Main Phase Stage 2|Progressive Disease|0|||
33488143|NCT01981850|62866211|FG000|Open Label Extension (OLE)|Adverse Event|0|||
33488144|NCT01981850|62866212|FG001|Open Label Extension (OLE)|Adverse Event|0|||
33488145|NCT01981850|62866213|FG002|Open Label Extension (OLE)|Adverse Event|0|||
33488146|NCT01981850|62866214|FG003|Open Label Extension (OLE)|Adverse Event|0|||
33488147|NCT01981850|62866215|FG004|Open Label Extension (OLE)|Adverse Event|0|||
33488148|NCT01981850|62866216|FG005|Open Label Extension (OLE)|Adverse Event|0|||
33488149|NCT01981850|62866217|FG006|Open Label Extension (OLE)|Adverse Event|0|||
33488150|NCT01981850|62866218|FG007|Open Label Extension (OLE)|Adverse Event|2|||
33488151|NCT01981850|62866219|FG008|Open Label Extension (OLE)|Adverse Event|1|||
33488152|NCT01981850|62866220|FG009|Open Label Extension (OLE)|Adverse Event|8|||
33488153|NCT01981850|62866211|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
33488154|NCT01981850|62866212|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
33488155|NCT01981850|62866213|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
33488156|NCT01981850|62866214|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
33488157|NCT01981850|62866215|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
33488158|NCT01981850|62866216|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
33488159|NCT01981850|62866217|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
33382467|NCT00765674|62761359|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
33382468|NCT00765674|62761360|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
33382469|NCT00765674|62761361|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
33488160|NCT01981850|62866218|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
33662519|NCT01578785|63093151|FG000|Overall Study|Withdrawal by Subject|0|||
33295223|NCT01366209|62671906|FG001|Overall Study|Withdrawal by Subject|4|||
33295224|NCT01366209|62671905|FG000|Overall Study|Death|12|||
33295225|NCT01366209|62671906|FG001|Overall Study|Death|19|||
33295226|NCT01366209|62671905|FG000|Overall Study|Lung transplantation|6|||
33295227|NCT01366209|62671906|FG001|Overall Study|Lung transplantation|1|||
33295228|NCT01366209|62671905|FG000|Overall Study|Lost to Follow-up|2|||
33295229|NCT01366209|62671906|FG001|Overall Study|Lost to Follow-up|1|||
33295230|NCT01366209|62671905|FG000|Overall Study|Physician Decision|1|||
33295231|NCT01366209|62671906|FG001|Overall Study|Physician Decision|0|||
33295232|NCT01366209|62671905|FG000|Overall Study|Sponsors decision|0|||
33295233|NCT01366209|62671906|FG001|Overall Study|Sponsors decision|1|||
33295234|NCT01366209|62671905|FG000|Overall Study|Withdrew consent|4|||
33295235|NCT01366209|62671906|FG001|Overall Study|Withdrew consent|3|||
33295236|NCT01365546|62671912|FG000|Overall Study|Withdrawal by Subject|1|||
33295237|NCT01365546|62671912|FG000|Overall Study|Screen failure|9|||
33295238|NCT01365546|62671912|FG000|Overall Study|Study termination|1|||
33295239|NCT01365507|62671922|FG000|Overall Study|Withdrawal Criteria|8|||
33382470|NCT00765674|62761362|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
33382471|NCT00765362|62761372|FG000|Overall Study|Death|9|||
33382472|NCT00765362|62761372|FG000|Overall Study|Adverse Event|2|||
33382473|NCT00765362|62761372|FG000|Overall Study|Protocol Violation|18|||
33382474|NCT00765362|62761372|FG000|Overall Study|Withdrawal by Subject|13|||
33382475|NCT00765362|62761372|FG000|Overall Study|Lost to Follow-up|95|||
33382476|NCT00586898|62761376|FG000|Overall Study|Adverse Event|1|||
33382477|NCT00586898|62761376|FG000|Overall Study|Patiemt Non-compliance|1|||
33382478|NCT00586898|62761376|FG000|Overall Study|Evaluable for Toxicity Only|5|||
33382479|NCT04912245|62761380|FG000|Overall Study|Withdrawal by Subject|21|||
33382480|NCT04912245|62761381|FG001|Overall Study|Withdrawal by Subject|4|||
33382481|NCT04912245|62761380|FG000|Overall Study|Lost to Follow-up|5|||
33382482|NCT04912245|62761381|FG001|Overall Study|Lost to Follow-up|11|||
33382483|NCT00796991|62761388|FG000|Overall Study|Adverse Event|0|||
33382484|NCT00796991|62761389|FG001|Overall Study|Adverse Event|0|||
33382485|NCT00796991|62761390|FG002|Overall Study|Adverse Event|1|||
33382486|NCT00796991|62761388|FG000|Overall Study|Death|2|||
33382487|NCT00796991|62761389|FG001|Overall Study|Death|0|||
33382488|NCT00796991|62761390|FG002|Overall Study|Death|0|||
33382489|NCT00796991|62761388|FG000|Overall Study|Disease Progression|10|||
33382490|NCT00796991|62761389|FG001|Overall Study|Disease Progression|9|||
33382491|NCT00796991|62761390|FG002|Overall Study|Disease Progression|7|||
33382492|NCT00796991|62761388|FG000|Overall Study|Study Drug Toxicity|3|||
33382493|NCT00796991|62761389|FG001|Overall Study|Study Drug Toxicity|3|||
33382494|NCT00796991|62761390|FG002|Overall Study|Study Drug Toxicity|5|||
33382495|NCT00796991|62761388|FG000|Overall Study|Withdrawal by Subject|0|||
33382496|NCT00796991|62761389|FG001|Overall Study|Withdrawal by Subject|0|||
33382497|NCT00796991|62761390|FG002|Overall Study|Withdrawal by Subject|1|||
33382498|NCT00799487|62761401|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
33382499|NCT00799487|62761402|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
33382500|NCT00799487|62761403|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
33295240|NCT01365507|62671923|FG001|Overall Study|Withdrawal Criteria|5|||
33382501|NCT00799487|62761401|FG000|Dose Adjustment Period|Adverse Event|2|||
33382502|NCT00799487|62761402|FG001|Dose Adjustment Period|Adverse Event|0|||
33382503|NCT00799487|62761403|FG002|Dose Adjustment Period|Adverse Event|0|||
33382504|NCT00799487|62761401|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
33382505|NCT00799487|62761402|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
33382506|NCT00799487|62761403|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
33295241|NCT01365507|62671922|FG000|Overall Study|Unclassified|1|||
33295242|NCT01365507|62671923|FG001|Overall Study|Unclassified|4|||
33382507|NCT00799487|62761401|FG000|Dose Adjustment Period|Investigator Discretion|2|||
33382508|NCT00799487|62761402|FG001|Dose Adjustment Period|Investigator Discretion|0|||
33382509|NCT00799487|62761403|FG002|Dose Adjustment Period|Investigator Discretion|0|||
33382510|NCT00799487|62761401|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
33382511|NCT00799487|62761402|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
33382512|NCT00799487|62761403|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
33382513|NCT00799487|62761401|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
33382514|NCT00799487|62761402|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
33382515|NCT00799487|62761403|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
33382516|NCT00799487|62761401|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
33382517|NCT00799487|62761402|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
33382518|NCT00799487|62761403|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
33662520|NCT01578785|63093152|FG001|Overall Study|Withdrawal by Subject|1|||
33662521|NCT01578785|63093151|FG000|Overall Study|Study terminated by sponsor|59|||
33295243|NCT01365468|62671947|FG000|Overall Study|Physician Decision|1|||
33295244|NCT01365468|62671948|FG001|Overall Study|Physician Decision|0|||
33295245|NCT01365468|62671947|FG000|Overall Study|Disease progression|1|||
33295246|NCT01365468|62671948|FG001|Overall Study|Disease progression|0|||
33295247|NCT01365468|62671947|FG000|Overall Study|Lost to Follow-up|2|||
33295248|NCT01365468|62671948|FG001|Overall Study|Lost to Follow-up|0|||
33295249|NCT01357980|62671959|FG000|Overall Study|Lack of Efficacy|0|||
33382519|NCT00799487|62761401|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
33382520|NCT00799487|62761402|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
33382521|NCT00799487|62761403|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
33662522|NCT01578785|63093152|FG001|Overall Study|Study terminated by sponsor|118|||
33295250|NCT01357980|62671960|FG001|Overall Study|Lack of Efficacy|1|||
33382522|NCT00799487|62761401|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
33382523|NCT00799487|62761402|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
33382524|NCT00799487|62761403|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
33382525|NCT00799487|62761401|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
33382526|NCT00799487|62761402|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
33382527|NCT00799487|62761403|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
33382528|NCT00799487|62761401|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
33382529|NCT00799487|62761402|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
33382530|NCT00799487|62761403|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
33382531|NCT00799487|62761401|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
33382532|NCT00799487|62761402|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
33382533|NCT00799487|62761403|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
33382534|NCT00584727|62761414|FG000|First Intervention|Discontinuation|0|||
33382535|NCT00584727|62761415|FG001|First Intervention|Discontinuation|0|||
33295251|NCT01357980|62671961|FG002|Overall Study|Lack of Efficacy|0|||
33295252|NCT01357980|62671962|FG003|Overall Study|Lack of Efficacy|0|||
33382536|NCT00584727|62761416|FG002|First Intervention|Discontinuation|1|||
33382537|NCT00584727|62761417|FG003|First Intervention|Discontinuation|0|||
33382538|NCT00584727|62761418|FG004|First Intervention|Discontinuation|0|||
33382539|NCT00584727|62761419|FG005|First Intervention|Discontinuation|0|||
33382540|NCT00584727|62761414|FG000|Third Intervention|Protocol Violation|0|||
33382541|NCT00584727|62761415|FG001|Third Intervention|Protocol Violation|0|||
33295253|NCT01357980|62671959|FG000|Overall Study|Consent withdrawn|0|||
33295254|NCT01357980|62671960|FG001|Overall Study|Consent withdrawn|0|||
33295255|NCT01357980|62671961|FG002|Overall Study|Consent withdrawn|1|||
33295256|NCT01357980|62671962|FG003|Overall Study|Consent withdrawn|0|||
33295257|NCT01332318|62671976|FG000|Overall Study|Adverse Event|0|||
33295258|NCT01332318|62671977|FG001|Overall Study|Adverse Event|3|||
33295259|NCT01332318|62671978|FG002|Overall Study|Adverse Event|0|||
33382542|NCT00584727|62761416|FG002|Third Intervention|Protocol Violation|1|||
33382543|NCT00584727|62761417|FG003|Third Intervention|Protocol Violation|0|||
33295260|NCT01332318|62671979|FG003|Overall Study|Adverse Event|0|||
33295261|NCT01332318|62671976|FG000|Overall Study|Withdrawal by Subject|1|||
33295262|NCT01332318|62671977|FG001|Overall Study|Withdrawal by Subject|1|||
33295263|NCT01332318|62671978|FG002|Overall Study|Withdrawal by Subject|0|||
33295264|NCT01332318|62671979|FG003|Overall Study|Withdrawal by Subject|1|||
33295265|NCT01332318|62671976|FG000|Overall Study|Protocol Violation|1|||
33295266|NCT01332318|62671977|FG001|Overall Study|Protocol Violation|0|||
33295267|NCT01332318|62671978|FG002|Overall Study|Protocol Violation|1|||
33295268|NCT01332318|62671979|FG003|Overall Study|Protocol Violation|1|||
33295269|NCT01331109|62671994|FG000|Overall Study|Adverse Event|6|||
33295270|NCT01331109|62671994|FG000|Overall Study|Lack of Efficacy|2|||
33295271|NCT01331109|62671994|FG000|Overall Study|Protocol Violation|3|||
33382544|NCT00584727|62761418|FG004|Third Intervention|Protocol Violation|4|||
33382545|NCT00584727|62761419|FG005|Third Intervention|Protocol Violation|2|||
33382546|NCT00799409|62761433|FG000|Overall Study|Withdrawal by Subject|1|||
33382547|NCT00799409|62761434|FG001|Overall Study|Withdrawal by Subject|0|||
33382548|NCT00799409|62761435|FG002|Overall Study|Withdrawal by Subject|0|||
33382549|NCT00799409|62761433|FG000|Overall Study|Lost to Follow-up|1|||
33382550|NCT00799409|62761434|FG001|Overall Study|Lost to Follow-up|0|||
33382551|NCT00799409|62761435|FG002|Overall Study|Lost to Follow-up|0|||
33382552|NCT00799409|62761433|FG000|Overall Study|Optimal Dose Not Achieved|2|||
33382553|NCT00799409|62761434|FG001|Overall Study|Optimal Dose Not Achieved|0|||
33382554|NCT00799409|62761435|FG002|Overall Study|Optimal Dose Not Achieved|0|||
33382555|NCT00799409|62761433|FG000|Overall Study|Failure to follow study protocol)|1|||
33382556|NCT00799409|62761434|FG001|Overall Study|Failure to follow study protocol)|0|||
33382557|NCT00799409|62761435|FG002|Overall Study|Failure to follow study protocol)|0|||
33382558|NCT00799409|62761433|FG000|Overall Study|Did not attend lab school day 1|1|||
33382559|NCT00799409|62761434|FG001|Overall Study|Did not attend lab school day 1|0|||
33382560|NCT00799409|62761435|FG002|Overall Study|Did not attend lab school day 1|0|||
33382561|NCT00799409|62761433|FG000|Overall Study|medication compliance|1|||
33382562|NCT00799409|62761434|FG001|Overall Study|medication compliance|0|||
33382563|NCT00799409|62761435|FG002|Overall Study|medication compliance|0|||
33382564|NCT00782210|62761446|FG000|Overall Study|Adverse Event|21|||
33295272|NCT01331109|62671994|FG000|Overall Study|Withdrawal by Subject|7|||
33295273|NCT01331109|62671994|FG000|Overall Study|Lost to Follow-up|1|||
33382565|NCT00782210|62761447|FG001|Overall Study|Adverse Event|17|||
33382566|NCT00782210|62761448|FG002|Overall Study|Adverse Event|16|||
33382567|NCT00782210|62761446|FG000|Overall Study|Lost to Follow-up|2|||
33382568|NCT00782210|62761447|FG001|Overall Study|Lost to Follow-up|1|||
33295274|NCT01331109|62671994|FG000|Overall Study|Study Terminated by Sponsor|38|||
33295275|NCT01357551|62672000|FG000|Overall Study|Withdrawal by Subject|6|||
33295276|NCT01357551|62672001|FG001|Overall Study|Withdrawal by Subject|4|||
33295277|NCT01357551|62672000|FG000|Overall Study|Death|0|||
33382569|NCT00782210|62761448|FG002|Overall Study|Lost to Follow-up|2|||
33382570|NCT00782210|62761446|FG000|Overall Study|Withdrawal by Subject|11|||
33382571|NCT00782210|62761447|FG001|Overall Study|Withdrawal by Subject|8|||
33382572|NCT00782210|62761448|FG002|Overall Study|Withdrawal by Subject|11|||
33382573|NCT00782210|62761446|FG000|Overall Study|Non compliance with protocol|0|||
33382574|NCT00782210|62761447|FG001|Overall Study|Non compliance with protocol|3|||
33382575|NCT00782210|62761448|FG002|Overall Study|Non compliance with protocol|2|||
33382576|NCT00782210|62761446|FG000|Overall Study|Lack of Efficacy|13|||
33382577|NCT00782210|62761447|FG001|Overall Study|Lack of Efficacy|4|||
33382578|NCT00782210|62761448|FG002|Overall Study|Lack of Efficacy|1|||
33382579|NCT00782210|62761446|FG000|Overall Study|Other reason not described above|3|||
33382580|NCT00782210|62761447|FG001|Overall Study|Other reason not described above|2|||
33382581|NCT00782210|62761448|FG002|Overall Study|Other reason not described above|3|||
33382582|NCT01558115|62761465|FG000|Overall Study|Withdrawal by Subject|3|||
33382583|NCT01558115|62761465|FG000|Overall Study|Study closed due to poor enrollment|4|||
33382584|NCT00764660|62761488|FG000|Overall Study|Adverse Event|6|||
33382585|NCT00764660|62761489|FG001|Overall Study|Adverse Event|3|||
33382586|NCT00764660|62761488|FG000|Overall Study|Lost to Follow-up|3|||
33382587|NCT00764660|62761489|FG001|Overall Study|Lost to Follow-up|4|||
33382588|NCT00764660|62761488|FG000|Overall Study|Withdrawal by Subject|7|||
33382589|NCT00764660|62761489|FG001|Overall Study|Withdrawal by Subject|3|||
33382590|NCT00764660|62761488|FG000|Overall Study|Noncompliance With Protocol|5|||
33382591|NCT00764660|62761489|FG001|Overall Study|Noncompliance With Protocol|1|||
33382592|NCT00764660|62761488|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
33488161|NCT01981850|62866219|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
33488162|NCT01981850|62866220|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
33488163|NCT01981850|62866211|FG000|Open Label Extension (OLE)|Various reasons|0|||
33488164|NCT01981850|62866212|FG001|Open Label Extension (OLE)|Various reasons|0|||
33488165|NCT01981850|62866213|FG002|Open Label Extension (OLE)|Various reasons|0|||
33488166|NCT01981850|62866214|FG003|Open Label Extension (OLE)|Various reasons|0|||
33488167|NCT01981850|62866215|FG004|Open Label Extension (OLE)|Various reasons|0|||
33488168|NCT01981850|62866216|FG005|Open Label Extension (OLE)|Various reasons|0|||
33488169|NCT01981850|62866217|FG006|Open Label Extension (OLE)|Various reasons|0|||
33488170|NCT01981850|62866218|FG007|Open Label Extension (OLE)|Various reasons|3|||
33488171|NCT01981850|62866219|FG008|Open Label Extension (OLE)|Various reasons|1|||
33488172|NCT01981850|62866220|FG009|Open Label Extension (OLE)|Various reasons|3|||
33488173|NCT01981850|62866211|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
33488174|NCT01981850|62866212|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
33488175|NCT01981850|62866213|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
33488176|NCT01981850|62866214|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
33662523|NCT02692482|63093160|FG000|Overall Study|Death|2|||
33295278|NCT01357551|62672001|FG001|Overall Study|Death|1|||
33295279|NCT01357551|62672000|FG000|Overall Study|Lost to Follow-up|16|||
33295280|NCT01357551|62672001|FG001|Overall Study|Lost to Follow-up|6|||
33295281|NCT01357239|62672014|FG000|Stratum: All Patients|Adverse Event|0|||
33295282|NCT01357239|62672015|FG001|Stratum: All Patients|Adverse Event|0|||
33295283|NCT01357239|62672016|FG002|Stratum: All Patients|Adverse Event|1|||
33295284|NCT01357239|62672017|FG003|Stratum: All Patients|Adverse Event|1|||
33295285|NCT01357239|62672014|FG000|Stratum: All Patients|Subject withdrew consent|0|||
33295286|NCT01357239|62672015|FG001|Stratum: All Patients|Subject withdrew consent|0|||
33295287|NCT01357239|62672016|FG002|Stratum: All Patients|Subject withdrew consent|1|||
33295288|NCT01357239|62672017|FG003|Stratum: All Patients|Subject withdrew consent|1|||
33295289|NCT01357239|62672014|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
33295290|NCT01357239|62672015|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
33295291|NCT01357239|62672016|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
33295292|NCT01357239|62672017|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
33295293|NCT01357239|62672014|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
33295294|NCT01357239|62672015|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
33295295|NCT01357239|62672016|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
33295296|NCT01357239|62672017|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
33295297|NCT01357239|62672014|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
33295298|NCT01357239|62672015|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
33295299|NCT01357239|62672016|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
33295300|NCT01357239|62672017|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
33382593|NCT00764660|62761489|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
33382594|NCT00584415|62761495|FG000|Overall Study|Adverse Event|7|||
33382595|NCT00764504|62761503|FG000|Overall Study|Death|12|||
33382596|NCT00764504|62761504|FG001|Overall Study|Death|6|||
33382597|NCT00764504|62761505|FG002|Overall Study|Death|13|||
33382598|NCT00764504|62761503|FG000|Overall Study|Revision of Device|12|||
33382599|NCT00764504|62761504|FG001|Overall Study|Revision of Device|23|||
33382600|NCT00764504|62761505|FG002|Overall Study|Revision of Device|14|||
33382601|NCT00764504|62761503|FG000|Overall Study|Physician Decision|1|||
33295301|NCT01351350|62672035|FG000|Overall Study|Disease Progression|5|||
33295302|NCT01351350|62672036|FG001|Overall Study|Disease Progression|13|||
33382602|NCT00764504|62761504|FG001|Overall Study|Physician Decision|0|||
33382603|NCT00764504|62761505|FG002|Overall Study|Physician Decision|0|||
33382604|NCT00764504|62761503|FG000|Overall Study|Withdrawal by Subject|1|||
33382605|NCT00764504|62761504|FG001|Overall Study|Withdrawal by Subject|7|||
33382606|NCT00764504|62761505|FG002|Overall Study|Withdrawal by Subject|4|||
33382607|NCT00764504|62761503|FG000|Overall Study|Lost to Follow-up|40|||
33382608|NCT00764504|62761504|FG001|Overall Study|Lost to Follow-up|34|||
33382609|NCT00764504|62761505|FG002|Overall Study|Lost to Follow-up|72|||
33382610|NCT00763958|62761515|FG000|Overall Study|did not meet final criteria|4|||
33382611|NCT00763958|62761516|FG001|Overall Study|did not meet final criteria|4|||
33382612|NCT00763958|62761515|FG000|Overall Study|Lost to Follow-up|10|||
33382613|NCT00763958|62761516|FG001|Overall Study|Lost to Follow-up|2|||
33382614|NCT00763958|62761515|FG000|Overall Study|Believed they were receiving placebo|0|||
33382615|NCT00763958|62761516|FG001|Overall Study|Believed they were receiving placebo|5|||
33382616|NCT00763256|62761525|FG000|Overall Study|Didn't return for appointments|7|||
33382617|NCT00763256|62761526|FG001|Overall Study|Didn't return for appointments|10|||
33382618|NCT00762788|62761538|FG000|Overall Study|Lost to Follow-up|26|||
33382619|NCT00762788|62761539|FG001|Overall Study|Lost to Follow-up|37|||
33382620|NCT00762788|62761540|FG002|Overall Study|Lost to Follow-up|21|||
33382621|NCT00762788|62761541|FG003|Overall Study|Lost to Follow-up|26|||
33382622|NCT00762788|62761542|FG004|Overall Study|Lost to Follow-up|13|||
33382623|NCT00762788|62761543|FG005|Overall Study|Lost to Follow-up|21|||
33382624|NCT00583947|62761559|FG000|Cross-over Period|Adverse Event|2|||
33382625|NCT00583947|62761560|FG001|Cross-over Period|Adverse Event|0|||
33382626|NCT00583947|62761559|FG000|Cross-over Period|Withdrawal by Subject|2|||
33382627|NCT00583947|62761560|FG001|Cross-over Period|Withdrawal by Subject|0|||
33382628|NCT00583947|62761559|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
33382629|NCT00583947|62761560|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
33382630|NCT00583947|62761559|FG000|Cross-over Period|Other|1|||
33382631|NCT00583947|62761560|FG001|Cross-over Period|Other|1|||
33382632|NCT00772928|62761570|FG000|Overall Study|Lost to Follow-up|9|||
33382633|NCT00772928|62761571|FG001|Overall Study|Lost to Follow-up|6|||
33382634|NCT00772928|62761570|FG000|Overall Study|Protocol Violation|10|||
33382635|NCT00772928|62761571|FG001|Overall Study|Protocol Violation|12|||
33382636|NCT00772928|62761570|FG000|Overall Study|Withdrawal by Subject|25|||
33382637|NCT00772928|62761571|FG001|Overall Study|Withdrawal by Subject|22|||
33382638|NCT00772928|62761570|FG000|Overall Study|Did not receive vaccine|0|||
33382639|NCT00772928|62761571|FG001|Overall Study|Did not receive vaccine|1|||
33382640|NCT00762476|62761579|FG000|Overall Study|Adverse Event|7|||
33382641|NCT00762476|62761580|FG001|Overall Study|Adverse Event|1|||
33382642|NCT00762476|62761579|FG000|Overall Study|Lost to Follow-up|2|||
33382643|NCT00762476|62761580|FG001|Overall Study|Lost to Follow-up|0|||
33295303|NCT01351350|62672037|FG002|Overall Study|Disease Progression|6|||
33295304|NCT01351350|62672038|FG003|Overall Study|Disease Progression|8|||
33295305|NCT01351350|62672039|FG004|Overall Study|Disease Progression|5|||
33295306|NCT01351350|62672035|FG000|Overall Study|Adverse Event|1|||
33295307|NCT01351350|62672036|FG001|Overall Study|Adverse Event|10|||
33295308|NCT01351350|62672037|FG002|Overall Study|Adverse Event|1|||
33295309|NCT01351350|62672038|FG003|Overall Study|Adverse Event|2|||
33295310|NCT01351350|62672039|FG004|Overall Study|Adverse Event|0|||
33295311|NCT01351350|62672035|FG000|Overall Study|Participant Decision|2|||
33295312|NCT01351350|62672036|FG001|Overall Study|Participant Decision|6|||
33382644|NCT00762476|62761579|FG000|Overall Study|Protocol Violation|5|||
33382645|NCT00762476|62761580|FG001|Overall Study|Protocol Violation|6|||
33382646|NCT00762476|62761579|FG000|Overall Study|Physician Decision|2|||
33382647|NCT00762476|62761580|FG001|Overall Study|Physician Decision|14|||
33382648|NCT00762476|62761579|FG000|Overall Study|Withdrawal by Subject|6|||
33382649|NCT00762476|62761580|FG001|Overall Study|Withdrawal by Subject|12|||
33488177|NCT01981850|62866215|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
33488178|NCT01981850|62866216|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
33488179|NCT01981850|62866217|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
33488180|NCT01981850|62866218|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
33295313|NCT01351350|62672037|FG002|Overall Study|Participant Decision|3|||
33295314|NCT01351350|62672038|FG003|Overall Study|Participant Decision|3|||
33382650|NCT00762476|62761579|FG000|Overall Study|antibiotic use|0|||
33382651|NCT00762476|62761580|FG001|Overall Study|antibiotic use|1|||
33488181|NCT01981850|62866219|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
33488182|NCT01981850|62866220|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
33382652|NCT00762476|62761579|FG000|Overall Study|non-compliance with study visits|0|||
33382653|NCT00762476|62761580|FG001|Overall Study|non-compliance with study visits|2|||
33488183|NCT01981850|62866211|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33662524|NCT02692482|63093161|FG001|Overall Study|Death|2|||
33295315|NCT01351350|62672039|FG004|Overall Study|Participant Decision|2|||
33295316|NCT01351350|62672035|FG000|Overall Study|Enrolled but not Treated|0|||
33295317|NCT01351350|62672036|FG001|Overall Study|Enrolled but not Treated|0|||
33295318|NCT01351350|62672037|FG002|Overall Study|Enrolled but not Treated|1|||
33295319|NCT01351350|62672038|FG003|Overall Study|Enrolled but not Treated|0|||
33295320|NCT01351350|62672039|FG004|Overall Study|Enrolled but not Treated|0|||
33295321|NCT01350999|62672067|FG000|Overall Study|Adverse Event|4|||
33295322|NCT01350999|62672068|FG001|Overall Study|Adverse Event|9|||
33295323|NCT01350999|62672069|FG002|Overall Study|Adverse Event|10|||
33295324|NCT01350999|62672067|FG000|Overall Study|Voluntary withdrawal|3|||
33295325|NCT01350999|62672068|FG001|Overall Study|Voluntary withdrawal|4|||
33295326|NCT01350999|62672069|FG002|Overall Study|Voluntary withdrawal|6|||
33295327|NCT01350999|62672067|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
33295328|NCT01350999|62672068|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
33295329|NCT01350999|62672069|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
33295330|NCT01330914|62672088|FG000|Overall Study|Withdrawal by Subject|4|||
33295331|NCT01330914|62672088|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
33295332|NCT01350804|62672096|FG000|Core Study|Withdrawal by Subject|11|||
33295333|NCT01350804|62672097|FG001|Core Study|Withdrawal by Subject|17|||
33295334|NCT01350804|62672098|FG002|Core Study|Withdrawal by Subject|16|||
33295335|NCT01350804|62672099|FG003|Core Study|Withdrawal by Subject|7|||
33295336|NCT01350804|62672096|FG000|Core Study|Study terminated by Sponsor|0|||
33295337|NCT01350804|62672097|FG001|Core Study|Study terminated by Sponsor|0|||
33295338|NCT01350804|62672098|FG002|Core Study|Study terminated by Sponsor|0|||
33295339|NCT01350804|62672099|FG003|Core Study|Study terminated by Sponsor|2|||
33295340|NCT01350804|62672096|FG000|Core Study|Protocol deviation|1|||
33295341|NCT01350804|62672097|FG001|Core Study|Protocol deviation|0|||
33295342|NCT01350804|62672098|FG002|Core Study|Protocol deviation|1|||
33295343|NCT01350804|62672099|FG003|Core Study|Protocol deviation|0|||
33295344|NCT01350804|62672096|FG000|Core Study|Physician Decision|1|||
33295345|NCT01350804|62672097|FG001|Core Study|Physician Decision|0|||
33295346|NCT01350804|62672098|FG002|Core Study|Physician Decision|1|||
33295347|NCT01350804|62672099|FG003|Core Study|Physician Decision|3|||
33295348|NCT01350804|62672096|FG000|Core Study|Lost to Follow-up|3|||
33295349|NCT01350804|62672097|FG001|Core Study|Lost to Follow-up|0|||
33295350|NCT01350804|62672098|FG002|Core Study|Lost to Follow-up|2|||
33295351|NCT01350804|62672099|FG003|Core Study|Lost to Follow-up|1|||
33382654|NCT00762476|62761579|FG000|Overall Study|Seasonal allergies|1|||
33382655|NCT00762476|62761580|FG001|Overall Study|Seasonal allergies|0|||
33382656|NCT00762164|62761589|FG000|Overall Study|Lost to Follow-up|1|||
33382657|NCT00762164|62761590|FG001|Overall Study|Lost to Follow-up|1|||
33382658|NCT00762164|62761589|FG000|Overall Study|Discontinued medication|2|||
33382659|NCT00762164|62761590|FG001|Overall Study|Discontinued medication|0|||
33382660|NCT00762164|62761589|FG000|Overall Study|Withdrawal by Subject|0|||
33382661|NCT00762164|62761590|FG001|Overall Study|Withdrawal by Subject|1|||
33382662|NCT00762086|62761598|FG000|Overall Study|Adverse Event|2|||
33382663|NCT00762086|62761599|FG001|Overall Study|Adverse Event|0|||
33382664|NCT00762086|62761598|FG000|Overall Study|Lost to Follow-up|0|||
33382665|NCT00762086|62761599|FG001|Overall Study|Lost to Follow-up|2|||
33382666|NCT00762086|62761598|FG000|Overall Study|Non compliance|1|||
33488184|NCT01981850|62866212|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33488185|NCT01981850|62866213|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33488186|NCT01981850|62866214|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33488187|NCT01981850|62866215|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33488188|NCT01981850|62866216|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33488189|NCT01981850|62866217|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33488190|NCT01981850|62866218|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33488191|NCT01981850|62866219|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33488192|NCT01981850|62866220|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
33488193|NCT01981850|62866211|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
33488194|NCT01981850|62866212|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
33488195|NCT01981850|62866213|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
33488196|NCT01981850|62866214|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
33488197|NCT01981850|62866215|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
33488198|NCT01981850|62866216|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
33488199|NCT01981850|62866217|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
33295352|NCT01350804|62672096|FG000|Core Study|Lack of Efficacy|16|||
33295353|NCT01350804|62672097|FG001|Core Study|Lack of Efficacy|19|||
33295354|NCT01350804|62672098|FG002|Core Study|Lack of Efficacy|18|||
33295355|NCT01350804|62672099|FG003|Core Study|Lack of Efficacy|5|||
33295356|NCT01350804|62672096|FG000|Core Study|Death|1|||
33382667|NCT00762086|62761599|FG001|Overall Study|Non compliance|0|||
33382668|NCT00762086|62761598|FG000|Overall Study|Withdrawal by Subject|2|||
33382669|NCT00762086|62761599|FG001|Overall Study|Withdrawal by Subject|2|||
33488200|NCT01981850|62866218|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
33295357|NCT01350804|62672097|FG001|Core Study|Death|1|||
33382670|NCT00762086|62761598|FG000|Overall Study|Ineligible to participate in the study|1|||
33295358|NCT01350804|62672098|FG002|Core Study|Death|1|||
33295359|NCT01350804|62672099|FG003|Core Study|Death|0|||
33295360|NCT01350804|62672096|FG000|Core Study|Adverse Event|8|||
33295361|NCT01350804|62672097|FG001|Core Study|Adverse Event|10|||
33295362|NCT01350804|62672098|FG002|Core Study|Adverse Event|8|||
33295363|NCT01350804|62672099|FG003|Core Study|Adverse Event|8|||
33295364|NCT01350804|62672096|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
33295365|NCT01350804|62672097|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
33488201|NCT01981850|62866219|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
33488202|NCT01981850|62866220|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
33488203|NCT03557307|62866252|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
33488204|NCT03557307|62866252|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
33488205|NCT03557307|62866252|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
33488206|NCT03557307|62866252|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
33488207|NCT03557307|62866252|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
33488208|NCT03557307|62866252|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
33488209|NCT03557307|62866252|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
33488210|NCT03557307|62866252|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
33488211|NCT03557307|62866252|FG000|Period 2: Maintenance Phase|Death|3|||
33488212|NCT03557307|62866252|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
33488213|NCT03557307|62866252|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
33488214|NCT03557307|62866252|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
33488215|NCT03557307|62866252|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
33488216|NCT03557307|62866252|FG000|Period 2: Maintenance Phase|other|3|||
33488217|NCT00118703|62866264|FG000|Overall Study|Protocol Violation|1|||
33488218|NCT00118703|62866265|FG001|Overall Study|Protocol Violation|0|||
33488219|NCT00118703|62866264|FG000|Overall Study|Adverse Event|1|||
33488220|NCT00118703|62866265|FG001|Overall Study|Adverse Event|1|||
33488221|NCT00118703|62866264|FG000|Overall Study|Participant took two different treatment|0|||
33488222|NCT00118703|62866265|FG001|Overall Study|Participant took two different treatment|1|||
33488223|NCT00118703|62866264|FG000|Overall Study|Withdrawal by Subject|2|||
33488224|NCT00118703|62866265|FG001|Overall Study|Withdrawal by Subject|5|||
33488225|NCT00118703|62866264|FG000|Overall Study|Lost to Follow-up|1|||
33488226|NCT00118703|62866265|FG001|Overall Study|Lost to Follow-up|2|||
33488227|NCT00104104|62866273|FG000|Overall Study|Adverse Event|8|||
33488228|NCT00104104|62866274|FG001|Overall Study|Adverse Event|8|||
33488229|NCT00104104|62866273|FG000|Overall Study|Abnormal laboratory value(s)|20|||
33488230|NCT00104104|62866274|FG001|Overall Study|Abnormal laboratory value(s)|14|||
33488231|NCT00104104|62866273|FG000|Overall Study|Lack of Efficacy|0|||
33488232|NCT00104104|62866274|FG001|Overall Study|Lack of Efficacy|3|||
33488233|NCT00104104|62866273|FG000|Overall Study|Condition no longer requires study drug|7|||
33488234|NCT00104104|62866274|FG001|Overall Study|Condition no longer requires study drug|4|||
33488235|NCT00104104|62866273|FG000|Overall Study|Protocol Violation|5|||
33488236|NCT00104104|62866274|FG001|Overall Study|Protocol Violation|2|||
33488237|NCT00104104|62866273|FG000|Overall Study|Withdrawal by Subject|11|||
33295366|NCT01350804|62672098|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
33295367|NCT01350804|62672099|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
33295368|NCT01350804|62672096|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
33295369|NCT01350804|62672097|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
33295370|NCT01350804|62672098|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
33295371|NCT01350804|62672099|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
33295372|NCT01350804|62672096|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
33295373|NCT01350804|62672097|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
33382671|NCT00762086|62761599|FG001|Overall Study|Ineligible to participate in the study|0|||
33382672|NCT00761774|62761605|FG000|Overall Study|Adverse Event|17|||
33382673|NCT00761774|62761605|FG000|Overall Study|Lack of Efficacy|37|||
33382674|NCT00761774|62761605|FG000|Overall Study|Lost to Follow-up|2|||
33382675|NCT00761774|62761605|FG000|Overall Study|Withdrawal by Subject|9|||
33382676|NCT00761774|62761605|FG000|Overall Study|Non-compliance|4|||
33295374|NCT01350804|62672098|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
33382677|NCT00761774|62761605|FG000|Overall Study|End of study|2|||
33382678|NCT00761774|62761605|FG000|Overall Study|Reclassification of seizures|1|||
33382679|NCT00761774|62761605|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
33488238|NCT00104104|62866274|FG001|Overall Study|Withdrawal by Subject|15|||
33488239|NCT00104104|62866273|FG000|Overall Study|Lost to Follow-up|3|||
33488240|NCT00104104|62866274|FG001|Overall Study|Lost to Follow-up|7|||
33662525|NCT02692482|63093160|FG000|Overall Study|Withdrawal by Subject|1|||
33295375|NCT01350804|62672099|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
33382680|NCT00761774|62761605|FG000|Overall Study|Sponsor decision|1|||
33382681|NCT00761774|62761605|FG000|Overall Study|Investigator clinical judgement|1|||
33488241|NCT00104104|62866273|FG000|Overall Study|Administrative problems|12|||
33488242|NCT00104104|62866274|FG001|Overall Study|Administrative problems|13|||
33488243|NCT00104104|62866273|FG000|Overall Study|Death|9|||
33488244|NCT00104104|62866274|FG001|Overall Study|Death|6|||
33488245|NCT03557151|62866282|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
33662526|NCT02692482|63093161|FG001|Overall Study|Withdrawal by Subject|2|||
33382682|NCT00761774|62761605|FG000|Overall Study|Patient moved out of study area|1|||
33382683|NCT00761774|62761605|FG000|Overall Study|Coordinator leaving site|1|||
33382684|NCT00761774|62761605|FG000|Overall Study|Subject IP non-compliance|1|||
33382685|NCT00761774|62761605|FG000|Overall Study|IP stopped by hospital physician|1|||
33382686|NCT00583791|62761611|FG000|Overall Study|Other|67|||
33382687|NCT00583791|62761611|FG000|Overall Study|Death|6|||
33382688|NCT00781274|62761615|FG000|Overall Study|Withdrawal by Subject|2|||
33382689|NCT00780416|62761621|FG000|Overall Study|Physician Decision|3|||
33382690|NCT00780416|62761622|FG001|Overall Study|Physician Decision|3|||
33382691|NCT00780416|62761621|FG000|Overall Study|Protocol Violation|1|||
33382692|NCT00780416|62761622|FG001|Overall Study|Protocol Violation|0|||
33382693|NCT00780416|62761621|FG000|Overall Study|Withdrawal by Subject|8|||
33382694|NCT00780416|62761622|FG001|Overall Study|Withdrawal by Subject|6|||
33382695|NCT00761462|62761630|FG000|Treatment|Subjects never received study medication|23|||
33382696|NCT00761462|62761631|FG001|Treatment|Subjects never received study medication|12|||
33382697|NCT00761462|62761630|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
33382698|NCT00761462|62761631|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
33382699|NCT00761462|62761630|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
33382700|NCT00761462|62761631|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
33382701|NCT00761462|62761630|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
33382702|NCT00761462|62761631|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
33382703|NCT00761306|62761637|FG000|Overall Study|Adverse Event|5|||
33382704|NCT00761306|62761637|FG000|Overall Study|Lack of Efficacy|4|||
33382705|NCT00761306|62761637|FG000|Overall Study|Protocol Violation|2|||
33382706|NCT00761306|62761637|FG000|Overall Study|Withdrawal of Consent|3|||
33382707|NCT00761306|62761637|FG000|Overall Study|Lost to Follow-up|1|||
33382708|NCT00761306|62761637|FG000|Overall Study|Administrative or Other Reasons|5|||
33382709|NCT00772538|62761643|FG000|Overall Study|Adverse Event|6|||
33382710|NCT00772538|62761644|FG001|Overall Study|Adverse Event|6|||
33382711|NCT00772538|62761643|FG000|Overall Study|Protocol Violation|3|||
33382712|NCT00772538|62761644|FG001|Overall Study|Protocol Violation|3|||
33382713|NCT00772538|62761643|FG000|Overall Study|Lost to Follow-up|1|||
33382714|NCT00772538|62761644|FG001|Overall Study|Lost to Follow-up|1|||
33295376|NCT01350804|62672096|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
33295377|NCT01350804|62672097|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
33295378|NCT01350804|62672098|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
33295379|NCT01350804|62672099|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
33382715|NCT00772538|62761643|FG000|Overall Study|Withdrawal by Subject|3|||
33382716|NCT00772538|62761644|FG001|Overall Study|Withdrawal by Subject|8|||
33295380|NCT01350804|62672096|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
33295381|NCT01350804|62672097|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
33295382|NCT01350804|62672098|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
33295383|NCT01350804|62672099|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
33295384|NCT01350804|62672096|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
33295385|NCT01350804|62672097|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
33295386|NCT01350804|62672098|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
33295387|NCT01350804|62672099|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
33295388|NCT01350492|62672121|FG000|Intervention|Lost to Follow-up|2|||
33382717|NCT00772538|62761643|FG000|Overall Study|Lack of Efficacy|0|||
33382718|NCT00772538|62761644|FG001|Overall Study|Lack of Efficacy|1|||
33295389|NCT01350492|62672122|FG001|Intervention|Lost to Follow-up|5|||
33295390|NCT01350492|62672121|FG000|Intervention|Withdrawal by Subject|3|||
33295391|NCT01350492|62672122|FG001|Intervention|Withdrawal by Subject|1|||
33382719|NCT00772538|62761643|FG000|Overall Study|Other|7|||
33382720|NCT00772538|62761644|FG001|Overall Study|Other|7|||
33382721|NCT00761150|62761653|FG000|Open-label Period|Adverse Event|36|||
33382722|NCT00761150|62761654|FG001|Open-label Period|Adverse Event|0|||
33382723|NCT00761150|62761655|FG002|Open-label Period|Adverse Event|0|||
33382724|NCT00761150|62761653|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
33382725|NCT00761150|62761654|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
33382726|NCT00761150|62761655|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
33382727|NCT00761150|62761653|FG000|Open-label Period|Lost to Follow-up|7|||
33382728|NCT00761150|62761654|FG001|Open-label Period|Lost to Follow-up|0|||
33382729|NCT00761150|62761655|FG002|Open-label Period|Lost to Follow-up|0|||
33382730|NCT00761150|62761653|FG000|Open-label Period|Lack of Efficacy|4|||
33295392|NCT01350492|62672121|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
33382731|NCT00761150|62761654|FG001|Open-label Period|Lack of Efficacy|0|||
33295393|NCT01350492|62672122|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
33295394|NCT01350492|62672121|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
33295395|NCT01350492|62672122|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
33382732|NCT00761150|62761655|FG002|Open-label Period|Lack of Efficacy|0|||
33382733|NCT00761150|62761653|FG000|Open-label Period|Withdrawal by Subject|5|||
33382734|NCT00761150|62761654|FG001|Open-label Period|Withdrawal by Subject|0|||
33382735|NCT00761150|62761655|FG002|Open-label Period|Withdrawal by Subject|0|||
33295396|NCT02270957|62672130|FG000|Overall Study|Lack of Efficacy|2|||
33295397|NCT02270957|62672131|FG001|Overall Study|Lack of Efficacy|4|||
33295398|NCT02270957|62672130|FG000|Overall Study|Adverse Event|2|||
33295399|NCT02270957|62672131|FG001|Overall Study|Adverse Event|0|||
33295400|NCT01350414|62672138|FG000|Overall Study|Lost to Follow-up|13|||
33295401|NCT01350414|62672138|FG000|Overall Study|Withdrawal by Subject|4|||
33295402|NCT01350414|62672138|FG000|Overall Study|Physician Decision|2|||
33295403|NCT01350336|62672148|FG000|Overall Study|Lost to Follow-up|31|||
33295404|NCT01350336|62672148|FG000|Overall Study|Withdrawal by Subject|14|||
33295405|NCT01350336|62672148|FG000|Overall Study|Physician Decision|8|||
33295406|NCT01350336|62672148|FG000|Overall Study|Death|4|||
33295407|NCT01349049|62672206|FG000|Overall Study|Disease progression|3|||
33382736|NCT00761150|62761653|FG000|Open-label Period|Noncompliance|2|||
33382737|NCT00761150|62761654|FG001|Open-label Period|Noncompliance|0|||
33382738|NCT00761150|62761655|FG002|Open-label Period|Noncompliance|0|||
33382739|NCT00761150|62761653|FG000|Open-label Period|Other|5|||
33382740|NCT00761150|62761654|FG001|Open-label Period|Other|0|||
33382741|NCT00761150|62761655|FG002|Open-label Period|Other|0|||
33382742|NCT00761150|62761653|FG000|Double-blind Period|Lack of Efficacy|0|||
33382743|NCT00761150|62761654|FG001|Double-blind Period|Lack of Efficacy|2|||
33382744|NCT00761150|62761655|FG002|Double-blind Period|Lack of Efficacy|19|||
33382745|NCT00761150|62761653|FG000|Double-blind Period|Adverse Event|0|||
33382746|NCT00761150|62761654|FG001|Double-blind Period|Adverse Event|3|||
33382747|NCT00761150|62761655|FG002|Double-blind Period|Adverse Event|3|||
33382748|NCT00761150|62761653|FG000|Double-blind Period|Withdrawal by Subject|0|||
33382749|NCT00761150|62761654|FG001|Double-blind Period|Withdrawal by Subject|3|||
33295408|NCT01349049|62672207|FG001|Overall Study|Disease progression|5|||
33382750|NCT00761150|62761655|FG002|Double-blind Period|Withdrawal by Subject|2|||
33295409|NCT01349049|62672208|FG002|Overall Study|Disease progression|3|||
33295410|NCT01349049|62672209|FG003|Overall Study|Disease progression|2|||
33382751|NCT00761150|62761653|FG000|Double-blind Period|Lost to Follow-up|0|||
33382752|NCT00761150|62761654|FG001|Double-blind Period|Lost to Follow-up|2|||
33382753|NCT00761150|62761655|FG002|Double-blind Period|Lost to Follow-up|1|||
33382754|NCT00761150|62761653|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
33382755|NCT00761150|62761654|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
33382756|NCT00761150|62761655|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
33382757|NCT00761150|62761653|FG000|Double-blind Period|Noncompliance|0|||
33382758|NCT00761150|62761654|FG001|Double-blind Period|Noncompliance|1|||
33382759|NCT00761150|62761655|FG002|Double-blind Period|Noncompliance|0|||
33382760|NCT00761150|62761653|FG000|Double-blind Period|Other|0|||
33382761|NCT00761150|62761654|FG001|Double-blind Period|Other|3|||
33382762|NCT00761150|62761655|FG002|Double-blind Period|Other|3|||
33382763|NCT00760994|62761665|FG000|Overall Study|Lost to Follow-up|4|||
33382764|NCT00760994|62761666|FG001|Overall Study|Lost to Follow-up|4|||
33382765|NCT00760994|62761667|FG002|Overall Study|Lost to Follow-up|3|||
33382766|NCT00583557|62761677|FG000|Overall Study|Withdrawal by Subject|18|||
33382767|NCT00583557|62761677|FG000|Overall Study|Adverse Event|9|||
33382768|NCT00583557|62761677|FG000|Overall Study|Lack of Efficacy|31|||
33382769|NCT00583557|62761677|FG000|Overall Study|Lack of Compliance|5|||
33382770|NCT00583557|62761677|FG000|Overall Study|Other|5|||
33382771|NCT00583557|62761677|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
33382772|NCT00586820|62761683|FG000|Overall Study|Unsuccessful PCI|1|||
33382773|NCT00586820|62761684|FG001|Overall Study|Unsuccessful PCI|0|||
33382774|NCT00760838|62761692|FG000|Overall Study|Adverse Event|1|||
33382775|NCT00760838|62761693|FG001|Overall Study|Adverse Event|1|||
33382776|NCT00760838|62761692|FG000|Overall Study|Lack of Efficacy|1|||
33382777|NCT00760838|62761693|FG001|Overall Study|Lack of Efficacy|0|||
33382778|NCT00760838|62761692|FG000|Overall Study|Lost to Follow-up|2|||
33382779|NCT00760838|62761693|FG001|Overall Study|Lost to Follow-up|0|||
33382780|NCT00760838|62761692|FG000|Overall Study|Withdrawal by Subject|1|||
33382781|NCT00760838|62761693|FG001|Overall Study|Withdrawal by Subject|1|||
33382782|NCT00586664|62761702|FG000|Overall Study|Withdrawal by Subject|3|||
33382783|NCT00586664|62761703|FG001|Overall Study|Withdrawal by Subject|7|||
33382784|NCT00586664|62761704|FG002|Overall Study|Withdrawal by Subject|1|||
33382785|NCT00586664|62761702|FG000|Overall Study|Exclusion criteria met|2|||
33382786|NCT00586664|62761703|FG001|Overall Study|Exclusion criteria met|0|||
33382787|NCT00586664|62761704|FG002|Overall Study|Exclusion criteria met|0|||
33382788|NCT00437281|62761732|FG000|Overall Study|Adverse Event|0|||
33382789|NCT00437281|62761733|FG001|Overall Study|Adverse Event|0|||
33382790|NCT00437281|62761734|FG002|Overall Study|Adverse Event|0|||
33382791|NCT00437281|62761735|FG003|Overall Study|Adverse Event|1|||
33382792|NCT00437281|62761736|FG004|Overall Study|Adverse Event|0|||
33382793|NCT00437281|62761737|FG005|Overall Study|Adverse Event|1|||
33382794|NCT00437281|62761738|FG006|Overall Study|Adverse Event|0|||
33382795|NCT00437281|62761739|FG007|Overall Study|Adverse Event|0|||
33488246|NCT03557151|62866283|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
33382796|NCT00437281|62761740|FG008|Overall Study|Adverse Event|0|||
33295411|NCT01349049|62672210|FG004|Overall Study|Disease progression|2|||
33295412|NCT01349049|62672211|FG005|Overall Study|Disease progression|2|||
33382797|NCT00437281|62761741|FG009|Overall Study|Adverse Event|1|||
33488247|NCT03557151|62866282|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
33488248|NCT03557151|62866283|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
33488249|NCT03557151|62866282|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
33488250|NCT03557151|62866283|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
33488251|NCT00115739|62866291|FG000|Overall Study|Lost to Follow-up|3|||
33488252|NCT01347086|62866307|FG000|Overall Study|failed screening visit|0|||
33488253|NCT01347086|62866308|FG001|Overall Study|failed screening visit|0|||
33488254|NCT01347086|62866309|FG002|Overall Study|failed screening visit|1|||
33488255|NCT01347086|62866310|FG003|Overall Study|failed screening visit|0|||
33488256|NCT01347086|62866311|FG004|Overall Study|failed screening visit|0|||
33488257|NCT01347086|62866312|FG005|Overall Study|failed screening visit|0|||
33488258|NCT01347086|62866313|FG006|Overall Study|failed screening visit|1|||
33488259|NCT01347086|62866314|FG007|Overall Study|failed screening visit|1|||
33488260|NCT01347086|62866315|FG008|Overall Study|failed screening visit|0|||
33488261|NCT01347086|62866316|FG009|Overall Study|failed screening visit|1|||
33488262|NCT03605745|62866348|FG000|Overall Study|Study was terminated for business reasons|47|||
33488263|NCT03246152|62866352|FG000|Overall Study|Lost to Follow-up|2|||
33488264|NCT03246152|62866352|FG000|Overall Study|Protocol Violation|1|||
33488265|NCT03571581|62866356|FG000|Overall Study|Death|2|||
33488266|NCT03571581|62866356|FG000|Overall Study|Withdrawal by Subject|2|||
33488267|NCT00115349|62866365|FG000|Overall Study|Study closed due to low enrollment.|11|||
33488268|NCT00115349|62866366|FG001|Overall Study|Study closed due to low enrollment.|9|||
33488269|NCT00115037|62866374|FG000|Phase1|Lost to Follow-up|16|||
33488270|NCT00115037|62866375|FG001|Phase1|Lost to Follow-up|23|||
33488271|NCT00115037|62866376|FG002|Phase1|Lost to Follow-up|0|||
33488272|NCT00115037|62866377|FG003|Phase1|Lost to Follow-up|0|||
33488273|NCT00115037|62866378|FG004|Phase1|Lost to Follow-up|0|||
33488274|NCT00115037|62866379|FG005|Phase1|Lost to Follow-up|0|||
33488275|NCT00115037|62866374|FG000|Phase1|Withdrawal by Subject|9|||
33488276|NCT00115037|62866375|FG001|Phase1|Withdrawal by Subject|4|||
33488277|NCT00115037|62866376|FG002|Phase1|Withdrawal by Subject|0|||
33488278|NCT00115037|62866377|FG003|Phase1|Withdrawal by Subject|0|||
33488279|NCT00115037|62866378|FG004|Phase1|Withdrawal by Subject|0|||
33488280|NCT00115037|62866379|FG005|Phase1|Withdrawal by Subject|0|||
33488281|NCT00115037|62866374|FG000|Phase2|Death|0|||
33488282|NCT00115037|62866375|FG001|Phase2|Death|0|||
33488283|NCT00115037|62866376|FG002|Phase2|Death|1|||
33488284|NCT00115037|62866377|FG003|Phase2|Death|0|||
33488285|NCT00115037|62866378|FG004|Phase2|Death|0|||
33488286|NCT00115037|62866379|FG005|Phase2|Death|1|||
33488287|NCT00115037|62866374|FG000|Phase2|Withdrawal by Subject|0|||
33488288|NCT00115037|62866375|FG001|Phase2|Withdrawal by Subject|0|||
33488289|NCT00115037|62866376|FG002|Phase2|Withdrawal by Subject|2|||
33488290|NCT00115037|62866377|FG003|Phase2|Withdrawal by Subject|1|||
33488291|NCT00115037|62866378|FG004|Phase2|Withdrawal by Subject|2|||
33488292|NCT00115037|62866379|FG005|Phase2|Withdrawal by Subject|1|||
33488293|NCT00115037|62866374|FG000|Phase2|Lost to Follow-up|0|||
33488294|NCT00115037|62866375|FG001|Phase2|Lost to Follow-up|0|||
33488295|NCT00115037|62866376|FG002|Phase2|Lost to Follow-up|12|||
33295413|NCT01349049|62672212|FG006|Overall Study|Disease progression|3|||
33295414|NCT01349049|62672213|FG007|Overall Study|Disease progression|2|||
33295415|NCT01349049|62672214|FG008|Overall Study|Disease progression|33|||
33295416|NCT01349049|62672206|FG000|Overall Study|Adverse Event|0|||
33295417|NCT01349049|62672207|FG001|Overall Study|Adverse Event|1|||
33295418|NCT01349049|62672208|FG002|Overall Study|Adverse Event|0|||
33295419|NCT01349049|62672209|FG003|Overall Study|Adverse Event|0|||
33295420|NCT01349049|62672210|FG004|Overall Study|Adverse Event|0|||
33295421|NCT01349049|62672211|FG005|Overall Study|Adverse Event|3|||
33295422|NCT01349049|62672212|FG006|Overall Study|Adverse Event|1|||
33295423|NCT01349049|62672213|FG007|Overall Study|Adverse Event|0|||
33295424|NCT01349049|62672214|FG008|Overall Study|Adverse Event|4|||
33295425|NCT01349049|62672206|FG000|Overall Study|Physician Decision|0|||
33295426|NCT01349049|62672207|FG001|Overall Study|Physician Decision|1|||
33488296|NCT00115037|62866377|FG003|Phase2|Lost to Follow-up|14|||
33488297|NCT00115037|62866378|FG004|Phase2|Lost to Follow-up|4|||
33488298|NCT00115037|62866379|FG005|Phase2|Lost to Follow-up|10|||
33488299|NCT03214640|62866397|FG000|Overall Study|Protocol Violation|1|||
33488300|NCT03214640|62866398|FG001|Overall Study|Protocol Violation|2|||
33488301|NCT03214640|62866399|FG002|Overall Study|Protocol Violation|1|||
33488302|NCT03214640|62866400|FG003|Overall Study|Protocol Violation|4|||
33488303|NCT03214406|62866412|FG000|Overall Study|did not meet enrollment criteria|9|||
33295427|NCT01349049|62672208|FG002|Overall Study|Physician Decision|0|||
33382798|NCT00437281|62761742|FG010|Overall Study|Adverse Event|0|||
33382799|NCT00437281|62761743|FG011|Overall Study|Adverse Event|0|||
33488304|NCT03214406|62866413|FG001|Overall Study|did not meet enrollment criteria|13|||
33488305|NCT03214406|62866412|FG000|Overall Study|Withdrawal by Subject|1|||
33488306|NCT03214406|62866413|FG001|Overall Study|Withdrawal by Subject|0|||
33382800|NCT00437281|62761744|FG012|Overall Study|Adverse Event|0|||
33488307|NCT03214406|62866412|FG000|Overall Study|Lost to Follow-up|0|||
33382801|NCT00437281|62761745|FG013|Overall Study|Adverse Event|1|||
33382802|NCT00437281|62761746|FG014|Overall Study|Adverse Event|1|||
33382803|NCT00437281|62761747|FG015|Overall Study|Adverse Event|0|||
33382804|NCT00437281|62761748|FG016|Overall Study|Adverse Event|0|||
33382805|NCT00437281|62761749|FG017|Overall Study|Adverse Event|0|||
33488308|NCT03214406|62866413|FG001|Overall Study|Lost to Follow-up|2|||
33488309|NCT03213938|62866421|FG000|Overall Study|Lost to Follow-up|4|||
33488310|NCT03213938|62866422|FG001|Overall Study|Lost to Follow-up|3|||
33488311|NCT03213938|62866421|FG000|Overall Study|Lack of Efficacy|1|||
33488312|NCT03213938|62866422|FG001|Overall Study|Lack of Efficacy|0|||
33488313|NCT03213938|62866421|FG000|Overall Study|Decline to participate|5|||
33488314|NCT03213938|62866422|FG001|Overall Study|Decline to participate|4|||
33488315|NCT03213938|62866421|FG000|Overall Study|Without reason|4|||
33488316|NCT03213938|62866422|FG001|Overall Study|Without reason|5|||
33488317|NCT03604497|62866428|FG000|Overall Study|Protocol Violation|52|||
33488318|NCT03213626|62866436|FG000|Overall Study|Adverse Event|1|||
33488319|NCT03213626|62866436|FG000|Overall Study|Progressive Disease|6|||
33488320|NCT03604341|62866442|FG000|Overall Study|Withdrawal by Subject|1|||
33488321|NCT03604341|62866443|FG001|Overall Study|Withdrawal by Subject|1|||
33488322|NCT03604341|62866442|FG000|Overall Study|Adverse Event|1|||
33556676|NCT02614196|62949479|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
33556677|NCT02614196|62949480|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
33556678|NCT02614196|62949481|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
33556679|NCT02614196|62949482|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
33556680|NCT02614196|62949477|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
33556681|NCT02614196|62949478|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
33556682|NCT02614196|62949479|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
33556683|NCT02614196|62949480|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
33556684|NCT02614196|62949481|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
33556685|NCT02614196|62949482|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
33556686|NCT02765035|62949512|FG000|First Intervention (90 Days)|Adverse Event|1|||
33556687|NCT02765035|62949513|FG001|First Intervention (90 Days)|Adverse Event|1|||
33556688|NCT02765035|62949512|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
33556689|NCT02765035|62949513|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
33556690|NCT02307682|62949523|FG000|Overall Study|Adverse Event|9|||
33556691|NCT02307682|62949524|FG001|Overall Study|Adverse Event|8|||
33556692|NCT02307682|62949525|FG002|Overall Study|Adverse Event|12|||
33556693|NCT02307682|62949523|FG000|Overall Study|Lack of Efficacy|1|||
33556694|NCT02307682|62949524|FG001|Overall Study|Lack of Efficacy|0|||
33556695|NCT02307682|62949525|FG002|Overall Study|Lack of Efficacy|1|||
33556696|NCT02307682|62949523|FG000|Overall Study|Physician Decision|2|||
33556697|NCT02307682|62949524|FG001|Overall Study|Physician Decision|2|||
33556698|NCT02307682|62949525|FG002|Overall Study|Physician Decision|8|||
33556699|NCT02307682|62949523|FG000|Overall Study|Progressive Disease|1|||
33556700|NCT02307682|62949524|FG001|Overall Study|Progressive Disease|0|||
33556701|NCT02307682|62949525|FG002|Overall Study|Progressive Disease|0|||
33556702|NCT02307682|62949523|FG000|Overall Study|Withdrawal by Subject|26|||
33556703|NCT02307682|62949524|FG001|Overall Study|Withdrawal by Subject|34|||
33556704|NCT02307682|62949525|FG002|Overall Study|Withdrawal by Subject|23|||
33556705|NCT02307682|62949523|FG000|Overall Study|Death|9|||
33556706|NCT02307682|62949524|FG001|Overall Study|Death|7|||
33556707|NCT02307682|62949525|FG002|Overall Study|Death|12|||
33556708|NCT02307682|62949523|FG000|Overall Study|Lost to Follow-up|1|||
33556709|NCT02307682|62949524|FG001|Overall Study|Lost to Follow-up|5|||
33556710|NCT02307682|62949525|FG002|Overall Study|Lost to Follow-up|6|||
33556711|NCT02307682|62949523|FG000|Overall Study|Protocol Deviation|0|||
33556712|NCT02307682|62949524|FG001|Overall Study|Protocol Deviation|0|||
33556713|NCT02307682|62949525|FG002|Overall Study|Protocol Deviation|2|||
33556714|NCT02307682|62949523|FG000|Overall Study|Other|1|||
33662527|NCT01578551|63093170|FG000|Overall Study|Adverse Event|1|||
33662528|NCT01578551|63093171|FG001|Overall Study|Adverse Event|0|||
33556715|NCT02307682|62949524|FG001|Overall Study|Other|1|||
33556716|NCT02307682|62949525|FG002|Overall Study|Other|0|||
33662529|NCT01692197|63093178|FG000|Overall Study|Failed Screening|3|||
33662530|NCT01692119|63093185|FG000|Overall Study|Protocol Violation|3|||
33662531|NCT01692119|63093186|FG001|Overall Study|Protocol Violation|1|||
33488323|NCT03604341|62866443|FG001|Overall Study|Adverse Event|0|||
33662532|NCT01692119|63093185|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
33382806|NCT00437281|62761750|FG018|Overall Study|Adverse Event|1|||
33488324|NCT03604341|62866442|FG000|Overall Study|Protocol Violation|0|||
33556717|NCT02615990|62949535|FG000|Overall Study|study terminated|1|||
33556718|NCT02615990|62949536|FG001|Overall Study|study terminated|1|||
33556719|NCT02613884|62949542|FG000|Overall Study|Death|1|||
33556720|NCT02613884|62949542|FG000|Overall Study|Lost to Follow-up|1|||
33556721|NCT02791763|62949550|FG000|Overall Study|Protocol Violation|0|||
33556722|NCT02791763|62949551|FG001|Overall Study|Protocol Violation|0|||
33556723|NCT02791763|62949552|FG002|Overall Study|Protocol Violation|1|||
33556724|NCT02791763|62949550|FG000|Overall Study|Withdrawal by Subject|5|||
33382807|NCT00437281|62761751|FG019|Overall Study|Adverse Event|0|||
33382808|NCT00437281|62761732|FG000|Overall Study|Lost to Follow-up|0|||
33382809|NCT00437281|62761733|FG001|Overall Study|Lost to Follow-up|0|||
33382810|NCT00437281|62761734|FG002|Overall Study|Lost to Follow-up|0|||
33382811|NCT00437281|62761735|FG003|Overall Study|Lost to Follow-up|0|||
33382812|NCT00437281|62761736|FG004|Overall Study|Lost to Follow-up|0|||
33382813|NCT00437281|62761737|FG005|Overall Study|Lost to Follow-up|0|||
33382814|NCT00437281|62761738|FG006|Overall Study|Lost to Follow-up|0|||
33382815|NCT00437281|62761739|FG007|Overall Study|Lost to Follow-up|0|||
33382816|NCT00437281|62761740|FG008|Overall Study|Lost to Follow-up|0|||
33382817|NCT00437281|62761741|FG009|Overall Study|Lost to Follow-up|0|||
33382818|NCT00437281|62761742|FG010|Overall Study|Lost to Follow-up|0|||
33382819|NCT00437281|62761743|FG011|Overall Study|Lost to Follow-up|0|||
33382820|NCT00437281|62761744|FG012|Overall Study|Lost to Follow-up|0|||
33382821|NCT00437281|62761745|FG013|Overall Study|Lost to Follow-up|0|||
33382822|NCT00437281|62761746|FG014|Overall Study|Lost to Follow-up|0|||
33382823|NCT00437281|62761747|FG015|Overall Study|Lost to Follow-up|0|||
33382824|NCT00437281|62761748|FG016|Overall Study|Lost to Follow-up|0|||
33382825|NCT00437281|62761749|FG017|Overall Study|Lost to Follow-up|0|||
33382826|NCT00437281|62761750|FG018|Overall Study|Lost to Follow-up|0|||
33382827|NCT00437281|62761751|FG019|Overall Study|Lost to Follow-up|1|||
33382828|NCT00741039|62761825|FG000|Overall Study|Patient non-compliance|2|||
33382829|NCT00741039|62761826|FG001|Overall Study|Patient non-compliance|0|||
33382830|NCT00772382|62761832|FG000|Overall Study|Adverse Event|19|||
33382831|NCT00772382|62761832|FG000|Overall Study|Death|6|||
33382832|NCT00772382|62761832|FG000|Overall Study|Lack of Efficacy|4|||
33382833|NCT00772382|62761832|FG000|Overall Study|Physician Decision|5|||
33382834|NCT00772382|62761832|FG000|Overall Study|Protocol Violation|1|||
33382835|NCT00772382|62761832|FG000|Overall Study|Withdrawal by Subject|10|||
33382836|NCT00772382|62761832|FG000|Overall Study|Other Reasons|10|||
33382837|NCT00798707|62761839|FG000|Overall Study|Adverse Event|6|||
33382838|NCT00798707|62761840|FG001|Overall Study|Adverse Event|8|||
33382839|NCT00798707|62761841|FG002|Overall Study|Adverse Event|8|||
33382840|NCT00798707|62761839|FG000|Overall Study|Failed to return|2|||
33382841|NCT00798707|62761840|FG001|Overall Study|Failed to return|2|||
33382842|NCT00798707|62761841|FG002|Overall Study|Failed to return|0|||
33382843|NCT00798707|62761839|FG000|Overall Study|Investigator|0|||
33382844|NCT00798707|62761840|FG001|Overall Study|Investigator|1|||
33382845|NCT00798707|62761841|FG002|Overall Study|Investigator|2|||
33382846|NCT00798707|62761839|FG000|Overall Study|Lack of Efficacy|2|||
33382847|NCT00798707|62761840|FG001|Overall Study|Lack of Efficacy|2|||
33382848|NCT00798707|62761841|FG002|Overall Study|Lack of Efficacy|1|||
33382849|NCT00798707|62761839|FG000|Overall Study|Lost to Follow-up|5|||
33382850|NCT00798707|62761840|FG001|Overall Study|Lost to Follow-up|6|||
33382851|NCT00798707|62761841|FG002|Overall Study|Lost to Follow-up|6|||
33382852|NCT00798707|62761839|FG000|Overall Study|Other|0|||
33382853|NCT00798707|62761840|FG001|Overall Study|Other|1|||
33382854|NCT00798707|62761841|FG002|Overall Study|Other|0|||
33382855|NCT00798707|62761839|FG000|Overall Study|Protocol Violation|4|||
33382856|NCT00798707|62761840|FG001|Overall Study|Protocol Violation|0|||
33382857|NCT00798707|62761841|FG002|Overall Study|Protocol Violation|2|||
33382858|NCT00798707|62761839|FG000|Overall Study|Withdrawal by Subject|3|||
33382859|NCT00798707|62761840|FG001|Overall Study|Withdrawal by Subject|8|||
33382860|NCT00798707|62761841|FG002|Overall Study|Withdrawal by Subject|2|||
33382861|NCT00798707|62761839|FG000|Overall Study|Randomized not treated|4|||
33382862|NCT00798707|62761840|FG001|Overall Study|Randomized not treated|5|||
33382863|NCT00798707|62761841|FG002|Overall Study|Randomized not treated|1|||
33382864|NCT00760214|62761852|FG000|Overall Study|Adverse Event|8|||
33382865|NCT00760214|62761853|FG001|Overall Study|Adverse Event|9|||
33382866|NCT00760214|62761854|FG002|Overall Study|Adverse Event|12|||
33382867|NCT00760214|62761852|FG000|Overall Study|Protocol Violation|3|||
33382868|NCT00760214|62761853|FG001|Overall Study|Protocol Violation|0|||
33382869|NCT00760214|62761854|FG002|Overall Study|Protocol Violation|3|||
33382870|NCT00760214|62761852|FG000|Overall Study|Lost to Follow-up|0|||
33382871|NCT00760214|62761853|FG001|Overall Study|Lost to Follow-up|0|||
33382872|NCT00760214|62761854|FG002|Overall Study|Lost to Follow-up|1|||
33382873|NCT00760214|62761852|FG000|Overall Study|Withdrawal by Subject|12|||
33488325|NCT03604341|62866443|FG001|Overall Study|Protocol Violation|1|||
33382874|NCT00760214|62761853|FG001|Overall Study|Withdrawal by Subject|14|||
33382875|NCT00760214|62761854|FG002|Overall Study|Withdrawal by Subject|13|||
33382876|NCT00760214|62761852|FG000|Overall Study|Lack of Efficacy|3|||
33382877|NCT00760214|62761853|FG001|Overall Study|Lack of Efficacy|2|||
33488326|NCT03603639|62866449|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
33382878|NCT00760214|62761854|FG002|Overall Study|Lack of Efficacy|4|||
33382879|NCT00760214|62761852|FG000|Overall Study|Pregnancy|0|||
33382880|NCT00760214|62761853|FG001|Overall Study|Pregnancy|0|||
33382881|NCT00760214|62761854|FG002|Overall Study|Pregnancy|1|||
33382882|NCT00760214|62761852|FG000|Overall Study|Physician Decision|1|||
33382883|NCT00760214|62761853|FG001|Overall Study|Physician Decision|1|||
33382884|NCT00760214|62761854|FG002|Overall Study|Physician Decision|1|||
33382885|NCT00760214|62761852|FG000|Overall Study|Other|3|||
33382886|NCT00760214|62761853|FG001|Overall Study|Other|4|||
33382887|NCT00760214|62761854|FG002|Overall Study|Other|6|||
33382888|NCT00802841|62761864|FG000|Overall Study|Administrative problems|1|||
33382889|NCT00802841|62761865|FG001|Overall Study|Administrative problems|0|||
33382890|NCT00802841|62761864|FG000|Overall Study|Lost to Follow-up|2|||
33382891|NCT00802841|62761865|FG001|Overall Study|Lost to Follow-up|1|||
33382892|NCT00802841|62761864|FG000|Overall Study|Death|1|||
33382893|NCT00802841|62761865|FG001|Overall Study|Death|2|||
33382894|NCT00802841|62761864|FG000|Overall Study|Adverse Event|8|||
33382895|NCT00802841|62761865|FG001|Overall Study|Adverse Event|2|||
33382896|NCT00802841|62761864|FG000|Overall Study|Disease progression|7|||
33382897|NCT00802841|62761865|FG001|Overall Study|Disease progression|3|||
33382898|NCT00802841|62761864|FG000|Overall Study|Withdrawal by Subject|9|||
33382899|NCT00802841|62761865|FG001|Overall Study|Withdrawal by Subject|5|||
33382900|NCT00802841|62761864|FG000|Overall Study|Protocol deviation|2|||
33382901|NCT00802841|62761865|FG001|Overall Study|Protocol deviation|6|||
33382902|NCT00802841|62761864|FG000|Overall Study|Treatment duration completed|66|||
33382903|NCT00802841|62761865|FG001|Overall Study|Treatment duration completed|76|||
33382904|NCT00772148|62761875|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
33382905|NCT00772148|62761876|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
33382906|NCT00772148|62761875|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
33382907|NCT00772148|62761876|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
33382908|NCT00772148|62761875|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
33382909|NCT00772148|62761876|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
33382910|NCT00772148|62761875|FG000|Maintenance Phase (Week 52)|Death|2|||
33382911|NCT00772148|62761876|FG001|Maintenance Phase (Week 52)|Death|2|||
33382912|NCT00772148|62761875|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
33488327|NCT03603639|62866450|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
33488328|NCT03603639|62866451|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
33488329|NCT03603639|62866452|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
33488330|NCT03603639|62866453|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
33488331|NCT03603639|62866454|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
33488332|NCT03603639|62866449|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
33488333|NCT03603639|62866450|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
33488334|NCT03603639|62866451|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
33488335|NCT03603639|62866452|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
33488336|NCT03603639|62866453|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
33488337|NCT03603639|62866454|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
33488338|NCT00114959|62866464|FG000|Overall Study|Lack of Efficacy|6|||
33488339|NCT00114959|62866464|FG000|Overall Study|Physician Decision|1|||
33488340|NCT00114959|62866464|FG000|Overall Study|Death|1|||
33488341|NCT02778100|62866470|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
33488342|NCT02778100|62866471|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
33488343|NCT00118157|62866479|FG000|Overall Study|Adverse Event|2|||
33488344|NCT00118157|62866479|FG000|Overall Study|Death|8|||
33488345|NCT00118157|62866479|FG000|Overall Study|Withdrawal by Subject|2|||
33488346|NCT02762500|62866486|FG000|Overall Study|Lack of Efficacy|1|||
33488347|NCT02762500|62866487|FG001|Overall Study|Lack of Efficacy|0|||
33488348|NCT02762500|62866486|FG000|Overall Study|Withdrawal by Subject|1|||
33488349|NCT02762500|62866487|FG001|Overall Study|Withdrawal by Subject|1|||
33488350|NCT02762500|62866486|FG000|Overall Study|Adverse Event|0|||
33488351|NCT02762500|62866487|FG001|Overall Study|Adverse Event|2|||
33488352|NCT03552549|62866495|FG000|Overall Study|Disease progression|25|||
33488353|NCT03552549|62866496|FG001|Overall Study|Disease progression|17|||
33488354|NCT03552549|62866495|FG000|Overall Study|Adverse event in first 12 months|12|||
33488355|NCT03552549|62866496|FG001|Overall Study|Adverse event in first 12 months|8|||
33488356|NCT03552549|62866495|FG000|Overall Study|Withdrawal by Subject|7|||
33488357|NCT03552549|62866496|FG001|Overall Study|Withdrawal by Subject|7|||
33488358|NCT03552549|62866495|FG000|Overall Study|Unknown (no reason provided)|4|||
33488359|NCT03552549|62866496|FG001|Overall Study|Unknown (no reason provided)|2|||
33488360|NCT03552549|62866495|FG000|Overall Study|Not in participant's best interest|2|||
33488361|NCT03552549|62866496|FG001|Overall Study|Not in participant's best interest|1|||
33488362|NCT03552549|62866495|FG000|Overall Study|Did not complete study treatment|2|||
33488363|NCT03552549|62866496|FG001|Overall Study|Did not complete study treatment|3|||
33488364|NCT03552549|62866495|FG000|Overall Study|Did not meet eligibility criteria|1|||
33488365|NCT03552549|62866496|FG001|Overall Study|Did not meet eligibility criteria|0|||
33488366|NCT03552549|62866495|FG000|Overall Study|Administrative|0|||
33382913|NCT00772148|62761876|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
33382914|NCT00772148|62761875|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
33382915|NCT00772148|62761876|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
33382916|NCT00772148|62761875|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
33382917|NCT00772148|62761876|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
33382918|NCT00759902|62761884|FG000|Overall Study|Adverse Event|0|||
33488367|NCT03552549|62866496|FG001|Overall Study|Administrative|14|||
33382919|NCT00759902|62761885|FG001|Overall Study|Adverse Event|1|||
33382920|NCT00772070|62761893|FG000|Overall Study|Lost to Follow-up|0|||
33382921|NCT00772070|62761894|FG001|Overall Study|Lost to Follow-up|8|||
33382922|NCT00772070|62761893|FG000|Overall Study|Withdrawal by Subject|0|||
33382923|NCT00772070|62761894|FG001|Overall Study|Withdrawal by Subject|2|||
33382924|NCT00772070|62761893|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
33382925|NCT00772070|62761894|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
33382926|NCT00796757|62761900|FG000|Overall Study|Withdrawal by Subject|14|||
33382927|NCT00796757|62761900|FG000|Overall Study|Death|61|||
33382928|NCT00796757|62761900|FG000|Overall Study|Protocol Violation|1|||
33382929|NCT00796757|62761900|FG000|Overall Study|Participant noncompliance|1|||
33382930|NCT00796757|62761900|FG000|Overall Study|Investigator's decision|2|||
33382931|NCT00796757|62761900|FG000|Overall Study|Other|7|||
33382932|NCT00759356|62761906|FG000|Overall Study|Adverse Event|0|||
33382933|NCT00759356|62761907|FG001|Overall Study|Adverse Event|1|||
33382934|NCT00759356|62761906|FG000|Overall Study|Withdrawal by Subject|0|||
33382935|NCT00759356|62761907|FG001|Overall Study|Withdrawal by Subject|2|||
33382936|NCT00759356|62761906|FG000|Overall Study|Subject was unable to return|1|||
33382937|NCT00759356|62761907|FG001|Overall Study|Subject was unable to return|0|||
33382938|NCT00721734|62761918|FG000|Overall Study|Progressive Disease|3|||
33382939|NCT00721734|62761919|FG001|Overall Study|Progressive Disease|10|||
33382940|NCT00721734|62761920|FG002|Overall Study|Progressive Disease|4|||
33382941|NCT00721734|62761921|FG003|Overall Study|Progressive Disease|5|||
33382942|NCT00721734|62761922|FG004|Overall Study|Progressive Disease|2|||
33382943|NCT00721734|62761918|FG000|Overall Study|Adverse Event|3|||
33382944|NCT00721734|62761919|FG001|Overall Study|Adverse Event|1|||
33382945|NCT00721734|62761920|FG002|Overall Study|Adverse Event|4|||
33488368|NCT00117845|62866502|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
33488369|NCT02761642|62866506|FG000|Overall Study|Did not Receive Study Treatment|3|||
33488370|NCT02761642|62866506|FG000|Overall Study|Adverse Event|13|||
33295428|NCT01349049|62672209|FG003|Overall Study|Physician Decision|0|||
33295429|NCT01349049|62672210|FG004|Overall Study|Physician Decision|0|||
33295430|NCT01349049|62672211|FG005|Overall Study|Physician Decision|0|||
33295431|NCT01349049|62672212|FG006|Overall Study|Physician Decision|0|||
33295432|NCT01349049|62672213|FG007|Overall Study|Physician Decision|0|||
33295433|NCT01349049|62672214|FG008|Overall Study|Physician Decision|2|||
33295434|NCT01349049|62672206|FG000|Overall Study|Protocol Violation|0|||
33295435|NCT01349049|62672207|FG001|Overall Study|Protocol Violation|0|||
33488371|NCT02761642|62866506|FG000|Overall Study|Withdrawal by Subject|2|||
33488372|NCT02761642|62866506|FG000|Overall Study|Non-compliant|7|||
33488373|NCT02761642|62866506|FG000|Overall Study|Death|3|||
33488374|NCT02761642|62866506|FG000|Overall Study|Lack of Efficacy|20|||
33488375|NCT02761642|62866506|FG000|Overall Study|Physician Decision|1|||
33488376|NCT02761642|62866506|FG000|Overall Study|Reason Unspecified|21|||
33488377|NCT00113555|62866510|FG000|Overall Study|Baseline Failure|59|||
33488378|NCT00113555|62866510|FG000|Overall Study|Permanently Explanted|7|||
33488379|NCT00113555|62866510|FG000|Overall Study|Death|1|||
33488380|NCT00113555|62866510|FG000|Overall Study|Missed Followup|4|||
33488381|NCT00113555|62866510|FG000|Overall Study|Lost to Follow-up|8|||
33488382|NCT03189524|62866518|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
33488383|NCT03189524|62866519|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
33488384|NCT03189524|62866520|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
33488385|NCT03189524|62866518|FG000|Overall Study|Death|2|||
33488386|NCT03189524|62866519|FG001|Overall Study|Death|2|||
33488387|NCT03189524|62866520|FG002|Overall Study|Death|1|||
33488388|NCT03189524|62866518|FG000|Overall Study|Lost to Follow-up|1|||
33488389|NCT03189524|62866519|FG001|Overall Study|Lost to Follow-up|0|||
33488390|NCT03189524|62866520|FG002|Overall Study|Lost to Follow-up|8|||
33488391|NCT03189524|62866518|FG000|Overall Study|Withdrawal by Subject|1|||
33488392|NCT03189524|62866519|FG001|Overall Study|Withdrawal by Subject|1|||
33488393|NCT03189524|62866520|FG002|Overall Study|Withdrawal by Subject|3|||
33488394|NCT03189524|62866518|FG000|Overall Study|Progressive Disease|0|||
33488395|NCT03189524|62866519|FG001|Overall Study|Progressive Disease|2|||
33488396|NCT03189524|62866520|FG002|Overall Study|Progressive Disease|0|||
33488397|NCT03600909|62866535|FG000|Overall Study|Not treated|0|||
33488398|NCT03600909|62866536|FG001|Overall Study|Not treated|3|||
33488399|NCT03600909|62866537|FG002|Overall Study|Not treated|0|||
33295436|NCT01349049|62672208|FG002|Overall Study|Protocol Violation|0|||
33488400|NCT03189446|62866545|FG000|Overall Study|Adverse Event|2|||
33295437|NCT01349049|62672209|FG003|Overall Study|Protocol Violation|0|||
33295438|NCT01349049|62672210|FG004|Overall Study|Protocol Violation|0|||
33382946|NCT00721734|62761921|FG003|Overall Study|Adverse Event|0|||
33382947|NCT00721734|62761922|FG004|Overall Study|Adverse Event|3|||
33382948|NCT00721734|62761918|FG000|Overall Study|Withdrawal by Subject|2|||
33382949|NCT00721734|62761919|FG001|Overall Study|Withdrawal by Subject|1|||
33382950|NCT00721734|62761920|FG002|Overall Study|Withdrawal by Subject|0|||
33382951|NCT00721734|62761921|FG003|Overall Study|Withdrawal by Subject|0|||
33295439|NCT01349049|62672211|FG005|Overall Study|Protocol Violation|0|||
33295440|NCT01349049|62672212|FG006|Overall Study|Protocol Violation|0|||
33295441|NCT01349049|62672213|FG007|Overall Study|Protocol Violation|0|||
33382952|NCT00721734|62761922|FG004|Overall Study|Withdrawal by Subject|1|||
33382953|NCT00721734|62761918|FG000|Overall Study|Other|0|||
33382954|NCT00721734|62761919|FG001|Overall Study|Other|0|||
33382955|NCT00721734|62761920|FG002|Overall Study|Other|0|||
33382956|NCT00721734|62761921|FG003|Overall Study|Other|1|||
33382957|NCT00721734|62761922|FG004|Overall Study|Other|0|||
33382958|NCT00798317|62761936|FG000|Overall Study|Physician Decision|0|||
33382959|NCT00798317|62761937|FG001|Overall Study|Physician Decision|1|||
33382960|NCT00798317|62761936|FG000|Overall Study|Withdrawal by Subject|5|||
33382961|NCT00798317|62761937|FG001|Overall Study|Withdrawal by Subject|4|||
33295442|NCT01349049|62672214|FG008|Overall Study|Protocol Violation|1|||
33295443|NCT01349049|62672206|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
33295444|NCT01349049|62672207|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
33295445|NCT01349049|62672208|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
33295446|NCT01349049|62672209|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
33295447|NCT01349049|62672210|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
33295448|NCT01349049|62672211|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
33295449|NCT01349049|62672212|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
33295450|NCT01349049|62672213|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
33295451|NCT01349049|62672214|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
33382962|NCT00798317|62761936|FG000|Overall Study|Lost to Follow-up|2|||
33382963|NCT00798317|62761937|FG001|Overall Study|Lost to Follow-up|2|||
33382964|NCT00798317|62761936|FG000|Overall Study|Adverse Event|2|||
33382965|NCT00798317|62761937|FG001|Overall Study|Adverse Event|0|||
33382966|NCT00798317|62761936|FG000|Overall Study|Death|1|||
33382967|NCT00798317|62761937|FG001|Overall Study|Death|0|||
33382968|NCT00779402|62761945|FG000|Treatment Phase 1|Disease Progression|1|||
33382969|NCT00779402|62761946|FG001|Treatment Phase 1|Disease Progression|0|||
33382970|NCT00779402|62761945|FG000|Treatment Phase 1|Adverse Event|2|||
33382971|NCT00779402|62761946|FG001|Treatment Phase 1|Adverse Event|0|||
33488401|NCT03189446|62866545|FG000|Overall Study|Withdrawal by Subject|2|||
33488402|NCT03189446|62866545|FG000|Overall Study|Physician Decision|1|||
33488403|NCT03212690|62866549|FG000|Overall Study|Protocol Violation|1|||
33295452|NCT01349049|62672206|FG000|Overall Study|Other|0|||
33295453|NCT01349049|62672207|FG001|Overall Study|Other|0|||
33295454|NCT01349049|62672208|FG002|Overall Study|Other|0|||
33295455|NCT01349049|62672209|FG003|Overall Study|Other|0|||
33382972|NCT00779402|62761945|FG000|Treatment Phase 1|Protocol Violation|1|||
33488404|NCT03188120|62866553|FG000|Overall Study|Adverse Event|4|||
33488405|NCT03188120|62866553|FG000|Overall Study|Insufficient Effectiveness|8|||
33488406|NCT03188120|62866553|FG000|Overall Study|Improved|12|||
33488407|NCT03188120|62866553|FG000|Overall Study|Lost to Follow-up|7|||
33488408|NCT03188120|62866553|FG000|Overall Study|Other than specified|3|||
33488409|NCT03188120|62866553|FG000|Overall Study|No visit after the first visit|13|||
33488410|NCT02895945|62866559|FG000|Overall Study|Physician Decision|2|||
33488411|NCT02895945|62866560|FG001|Overall Study|Physician Decision|1|||
33488412|NCT02777554|62866568|FG000|Overall Study|Adverse Event|4|||
33488413|NCT02777554|62866569|FG001|Overall Study|Adverse Event|4|||
33488414|NCT02777554|62866570|FG002|Overall Study|Adverse Event|0|||
33488415|NCT02777554|62866571|FG003|Overall Study|Adverse Event|1|||
33488416|NCT02777554|62866572|FG004|Overall Study|Adverse Event|0|||
33488417|NCT02777554|62866573|FG005|Overall Study|Adverse Event|0|||
33488418|NCT02777554|62866568|FG000|Overall Study|Withdrawal by Subject|3|||
33488419|NCT02777554|62866569|FG001|Overall Study|Withdrawal by Subject|1|||
33488420|NCT02777554|62866570|FG002|Overall Study|Withdrawal by Subject|1|||
33488421|NCT02777554|62866571|FG003|Overall Study|Withdrawal by Subject|0|||
33488422|NCT02777554|62866572|FG004|Overall Study|Withdrawal by Subject|0|||
33488423|NCT02777554|62866573|FG005|Overall Study|Withdrawal by Subject|0|||
33488424|NCT02777554|62866568|FG000|Overall Study|Discharged early due to hurricane|22|||
33488425|NCT02777554|62866569|FG001|Overall Study|Discharged early due to hurricane|20|||
33488426|NCT02777554|62866570|FG002|Overall Study|Discharged early due to hurricane|0|||
33488427|NCT02777554|62866571|FG003|Overall Study|Discharged early due to hurricane|0|||
33488428|NCT02777554|62866572|FG004|Overall Study|Discharged early due to hurricane|0|||
33295456|NCT01349049|62672210|FG004|Overall Study|Other|0|||
33295457|NCT01349049|62672211|FG005|Overall Study|Other|1|||
33382973|NCT00779402|62761946|FG001|Treatment Phase 1|Protocol Violation|0|||
33382974|NCT00779402|62761945|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
33382975|NCT00779402|62761946|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
33488429|NCT02777554|62866573|FG005|Overall Study|Discharged early due to hurricane|0|||
33488430|NCT02777554|62866568|FG000|Overall Study|Other - Miscellaneous|1|||
33488431|NCT02777554|62866569|FG001|Overall Study|Other - Miscellaneous|0|||
33382976|NCT00779402|62761945|FG000|Treatment Phase 1|Lost to Follow-up|0|||
33382977|NCT00779402|62761946|FG001|Treatment Phase 1|Lost to Follow-up|1|||
33488432|NCT02777554|62866570|FG002|Overall Study|Other - Miscellaneous|0|||
33488433|NCT02777554|62866571|FG003|Overall Study|Other - Miscellaneous|0|||
33295458|NCT01349049|62672212|FG006|Overall Study|Other|0|||
33295459|NCT01349049|62672213|FG007|Overall Study|Other|0|||
33295460|NCT01349049|62672214|FG008|Overall Study|Other|4|||
33295461|NCT01349049|62672206|FG000|Overall Study|Death|0|||
33295462|NCT01349049|62672207|FG001|Overall Study|Death|0|||
33295463|NCT01349049|62672208|FG002|Overall Study|Death|0|||
33295464|NCT01349049|62672209|FG003|Overall Study|Death|0|||
33295465|NCT01349049|62672210|FG004|Overall Study|Death|0|||
33295466|NCT01349049|62672211|FG005|Overall Study|Death|0|||
33295467|NCT01349049|62672212|FG006|Overall Study|Death|0|||
33382978|NCT00779402|62761945|FG000|Treatment Phase 1|Death|0|||
33382979|NCT00779402|62761946|FG001|Treatment Phase 1|Death|1|||
33382980|NCT00779402|62761945|FG000|Treatment Phase 1|Intercurrent Illness|1|||
33382981|NCT00779402|62761946|FG001|Treatment Phase 1|Intercurrent Illness|1|||
33382982|NCT00779402|62761945|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
33382983|NCT00779402|62761946|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
33382984|NCT00779402|62761945|FG000|Treatment Phase 1|Other|4|||
33382985|NCT00779402|62761946|FG001|Treatment Phase 1|Other|2|||
33382986|NCT00779402|62761945|FG000|Treatment Phase 1|Closure of Study|3|||
33382987|NCT00779402|62761946|FG001|Treatment Phase 1|Closure of Study|2|||
33382988|NCT00779402|62761945|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
33382989|NCT00779402|62761946|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
33382990|NCT00779402|62761945|FG000|Surveillance Phase|Protocol Violation|0|||
33382991|NCT00779402|62761946|FG001|Surveillance Phase|Protocol Violation|1|||
33382992|NCT00779402|62761945|FG000|Surveillance Phase|Patient refused to continue|22|||
33382993|NCT00779402|62761946|FG001|Surveillance Phase|Patient refused to continue|14|||
33382994|NCT00779402|62761945|FG000|Surveillance Phase|Lost to Follow-up|2|||
33382995|NCT00779402|62761946|FG001|Surveillance Phase|Lost to Follow-up|1|||
33382996|NCT00779402|62761945|FG000|Surveillance Phase|Death|0|||
33382997|NCT00779402|62761946|FG001|Surveillance Phase|Death|1|||
33382998|NCT00779402|62761945|FG000|Surveillance Phase|Intercurrent Illness|2|||
33382999|NCT00779402|62761946|FG001|Surveillance Phase|Intercurrent Illness|0|||
33383000|NCT00779402|62761945|FG000|Surveillance Phase|Other|5|||
33383001|NCT00779402|62761946|FG001|Surveillance Phase|Other|5|||
33383002|NCT00779402|62761945|FG000|Surveillance Phase|Withdrawal by Subject|4|||
33383003|NCT00779402|62761946|FG001|Surveillance Phase|Withdrawal by Subject|1|||
33383004|NCT00779402|62761945|FG000|Surveillance Phase|Closure of study|5|||
33383005|NCT00779402|62761946|FG001|Surveillance Phase|Closure of study|6|||
33383006|NCT00779402|62761945|FG000|Surveillance Phase|Completed Protocol Visits|3|||
33383007|NCT00779402|62761946|FG001|Surveillance Phase|Completed Protocol Visits|2|||
33383008|NCT00779402|62761945|FG000|Long-term Follow-up|Patient refused to continue|2|||
33383009|NCT00779402|62761946|FG001|Long-term Follow-up|Patient refused to continue|0|||
33383010|NCT00779402|62761945|FG000|Long-term Follow-up|Other|5|||
33383011|NCT00779402|62761946|FG001|Long-term Follow-up|Other|0|||
33383012|NCT00779402|62761945|FG000|Long-term Follow-up|Closure of Study|8|||
33383013|NCT00779402|62761946|FG001|Long-term Follow-up|Closure of Study|4|||
33383014|NCT00779402|62761945|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
33383015|NCT00779402|62761946|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
33383016|NCT00771914|62761956|FG000|Overall Study|Physician Decision|0|||
33383017|NCT00771914|62761957|FG001|Overall Study|Physician Decision|0|||
33295468|NCT01349049|62672213|FG007|Overall Study|Death|1|||
33295469|NCT01349049|62672214|FG008|Overall Study|Death|5|||
33295470|NCT01349049|62672206|FG000|Overall Study|Non-compliance|0|||
33295471|NCT01349049|62672207|FG001|Overall Study|Non-compliance|0|||
33295472|NCT01349049|62672208|FG002|Overall Study|Non-compliance|0|||
33295473|NCT01349049|62672209|FG003|Overall Study|Non-compliance|1|||
33295474|NCT01349049|62672210|FG004|Overall Study|Non-compliance|0|||
33295475|NCT01349049|62672211|FG005|Overall Study|Non-compliance|0|||
33295476|NCT01349049|62672212|FG006|Overall Study|Non-compliance|0|||
33295477|NCT01349049|62672213|FG007|Overall Study|Non-compliance|0|||
33295478|NCT01349049|62672214|FG008|Overall Study|Non-compliance|0|||
33295479|NCT01349049|62672206|FG000|Overall Study|Withdrawal by Subject|0|||
33295480|NCT01349049|62672207|FG001|Overall Study|Withdrawal by Subject|0|||
33295481|NCT01349049|62672208|FG002|Overall Study|Withdrawal by Subject|0|||
33295482|NCT01349049|62672209|FG003|Overall Study|Withdrawal by Subject|0|||
33295483|NCT01349049|62672210|FG004|Overall Study|Withdrawal by Subject|0|||
33383018|NCT00771914|62761958|FG002|Overall Study|Physician Decision|0|||
33295484|NCT01349049|62672211|FG005|Overall Study|Withdrawal by Subject|0|||
33295485|NCT01349049|62672212|FG006|Overall Study|Withdrawal by Subject|0|||
33295486|NCT01349049|62672213|FG007|Overall Study|Withdrawal by Subject|0|||
33295487|NCT01349049|62672214|FG008|Overall Study|Withdrawal by Subject|6|||
33295488|NCT01348854|62672248|FG000|Overall Study|Lost to Follow-up|2|||
33295489|NCT01348854|62672249|FG001|Overall Study|Lost to Follow-up|1|||
33295490|NCT01348854|62672248|FG000|Overall Study|Withdrawal by Subject|1|||
33295491|NCT01348854|62672249|FG001|Overall Study|Withdrawal by Subject|0|||
33383019|NCT00771914|62761959|FG003|Overall Study|Physician Decision|1|||
33383020|NCT00771914|62761956|FG000|Overall Study|Lost to Follow-up|0|||
33383021|NCT00771914|62761957|FG001|Overall Study|Lost to Follow-up|0|||
33383022|NCT00771914|62761958|FG002|Overall Study|Lost to Follow-up|0|||
33383023|NCT00771914|62761959|FG003|Overall Study|Lost to Follow-up|1|||
33383024|NCT00779324|62761971|FG000|Overall Study|Lost to Follow-up|2|||
33383025|NCT00779324|62761972|FG001|Overall Study|Lost to Follow-up|1|||
33383026|NCT00779324|62761971|FG000|Overall Study|Withdrawal by Subject|4|||
33383027|NCT00779324|62761972|FG001|Overall Study|Withdrawal by Subject|2|||
33383028|NCT00779324|62761971|FG000|Overall Study|Missed visit|1|||
33383029|NCT00779324|62761972|FG001|Overall Study|Missed visit|1|||
33383030|NCT00779246|62761980|FG000|Overall Study|Missing sufficient data for analysis|33|||
33383031|NCT00779246|62761981|FG001|Overall Study|Missing sufficient data for analysis|53|||
33383032|NCT00771758|62761990|FG000|Overall Study|Adverse Event|2|||
33295492|NCT01348776|62672255|FG000|Overall Study|Lost to Follow-up|3|||
33295493|NCT01348698|62672268|FG000|Overall Study|Does not meet lesion size criteria|1|||
33295494|NCT01348698|62672268|FG000|Overall Study|Death|3|||
33295495|NCT01348698|62672268|FG000|Overall Study|PI decision to close study|68|||
33295496|NCT01348542|62672274|FG000|Overall Study|Withdrawal by Subject|3|||
33295497|NCT01348542|62672275|FG001|Overall Study|Withdrawal by Subject|0|||
33295498|NCT01346709|62672281|FG000|Overall Study|Protocol Violation|35|||
33295499|NCT01346709|62672281|FG000|Overall Study|Lost to Follow-up|31|||
33383033|NCT00771758|62761991|FG001|Overall Study|Adverse Event|8|||
33383034|NCT00771758|62761992|FG002|Overall Study|Adverse Event|1|||
33383035|NCT00771758|62761990|FG000|Overall Study|Lack of Efficacy|0|||
33383036|NCT00771758|62761991|FG001|Overall Study|Lack of Efficacy|2|||
33383037|NCT00771758|62761992|FG002|Overall Study|Lack of Efficacy|1|||
33383038|NCT00771758|62761990|FG000|Overall Study|Lost to Follow-up|1|||
33383039|NCT00771758|62761991|FG001|Overall Study|Lost to Follow-up|0|||
33383040|NCT00771758|62761992|FG002|Overall Study|Lost to Follow-up|0|||
33383041|NCT00771758|62761990|FG000|Overall Study|Protocol Violation|1|||
33383042|NCT00771758|62761991|FG001|Overall Study|Protocol Violation|0|||
33383043|NCT00771758|62761992|FG002|Overall Study|Protocol Violation|0|||
33383044|NCT00771758|62761990|FG000|Overall Study|Withdrawal by Subject|1|||
33383045|NCT00771758|62761991|FG001|Overall Study|Withdrawal by Subject|0|||
33383046|NCT00771758|62761992|FG002|Overall Study|Withdrawal by Subject|0|||
33383047|NCT00771758|62761990|FG000|Overall Study|Other|3|||
33383048|NCT00771758|62761991|FG001|Overall Study|Other|2|||
33383049|NCT00771758|62761992|FG002|Overall Study|Other|0|||
33383050|NCT00758498|62762020|FG000|Overall Study|Adverse Event|2|||
33383051|NCT00758498|62762021|FG001|Overall Study|Adverse Event|2|||
33383052|NCT00758498|62762022|FG002|Overall Study|Adverse Event|3|||
33383053|NCT00758498|62762020|FG000|Overall Study|Subject legally detained out of state|1|||
33383054|NCT00758498|62762021|FG001|Overall Study|Subject legally detained out of state|0|||
33383055|NCT00758498|62762022|FG002|Overall Study|Subject legally detained out of state|0|||
33488434|NCT02777554|62866572|FG004|Overall Study|Other - Miscellaneous|0|||
33295500|NCT01346709|62672281|FG000|Overall Study|Missing data in candidate risk factor|285|||
33295501|NCT01346592|62672288|FG000|Overall Study|Lost to Follow-up|62|||
33295502|NCT01346592|62672289|FG001|Overall Study|Lost to Follow-up|29|||
33295503|NCT01346592|62672290|FG002|Overall Study|Lost to Follow-up|29|||
33295504|NCT01346592|62672288|FG000|Overall Study|Protocol Violation|2|||
33295505|NCT01346592|62672289|FG001|Overall Study|Protocol Violation|1|||
33295506|NCT01346592|62672290|FG002|Overall Study|Protocol Violation|0|||
33295507|NCT01346592|62672288|FG000|Overall Study|Death|1|||
33295508|NCT01346592|62672289|FG001|Overall Study|Death|3|||
33295509|NCT01346592|62672290|FG002|Overall Study|Death|4|||
33295510|NCT01346592|62672288|FG000|Overall Study|Adverse Event|0|||
33295511|NCT01346592|62672289|FG001|Overall Study|Adverse Event|1|||
33295512|NCT01346592|62672290|FG002|Overall Study|Adverse Event|0|||
33295513|NCT01346592|62672288|FG000|Overall Study|Withdrawal by Subject|77|||
33295514|NCT01346592|62672289|FG001|Overall Study|Withdrawal by Subject|51|||
33295515|NCT01346592|62672290|FG002|Overall Study|Withdrawal by Subject|38|||
33295516|NCT01346592|62672288|FG000|Overall Study|Inappropriate enrollment|3|||
33295517|NCT01346592|62672289|FG001|Overall Study|Inappropriate enrollment|1|||
33295518|NCT01346592|62672290|FG002|Overall Study|Inappropriate enrollment|1|||
33295519|NCT01346592|62672288|FG000|Overall Study|Administrative reason|1|||
33295520|NCT01346592|62672289|FG001|Overall Study|Administrative reason|0|||
33295521|NCT01346592|62672290|FG002|Overall Study|Administrative reason|0|||
33295522|NCT01346592|62672288|FG000|Overall Study|Unable to Classify|7|||
33295523|NCT01346592|62672289|FG001|Overall Study|Unable to Classify|3|||
33295524|NCT01346592|62672290|FG002|Overall Study|Unable to Classify|6|||
33383056|NCT00758498|62762020|FG000|Overall Study|Withdrawal by Subject|0|||
33383057|NCT00758498|62762021|FG001|Overall Study|Withdrawal by Subject|0|||
33383058|NCT00758498|62762022|FG002|Overall Study|Withdrawal by Subject|1|||
33383059|NCT00758498|62762020|FG000|Overall Study|Noncompliance to study procedures|0|||
33383060|NCT00758498|62762021|FG001|Overall Study|Noncompliance to study procedures|0|||
33383061|NCT00758498|62762022|FG002|Overall Study|Noncompliance to study procedures|1|||
33383062|NCT00798161|62762037|FG000|Overall Study|Adverse Event|3|||
33383063|NCT00798161|62762038|FG001|Overall Study|Adverse Event|4|||
33383064|NCT00798161|62762039|FG002|Overall Study|Adverse Event|6|||
33383065|NCT00798161|62762040|FG003|Overall Study|Adverse Event|6|||
33383066|NCT00798161|62762041|FG004|Overall Study|Adverse Event|5|||
33383067|NCT00798161|62762042|FG005|Overall Study|Adverse Event|2|||
33383068|NCT00798161|62762043|FG006|Overall Study|Adverse Event|4|||
33383069|NCT00798161|62762037|FG000|Overall Study|Protocol Violation|2|||
33383070|NCT00798161|62762038|FG001|Overall Study|Protocol Violation|1|||
33383071|NCT00798161|62762039|FG002|Overall Study|Protocol Violation|3|||
33383072|NCT00798161|62762040|FG003|Overall Study|Protocol Violation|3|||
33383073|NCT00798161|62762041|FG004|Overall Study|Protocol Violation|3|||
33383074|NCT00798161|62762042|FG005|Overall Study|Protocol Violation|2|||
33383075|NCT00798161|62762043|FG006|Overall Study|Protocol Violation|0|||
33383076|NCT00798161|62762037|FG000|Overall Study|Lost to Follow-up|1|||
33383077|NCT00798161|62762038|FG001|Overall Study|Lost to Follow-up|3|||
33383078|NCT00798161|62762039|FG002|Overall Study|Lost to Follow-up|4|||
33383079|NCT00798161|62762040|FG003|Overall Study|Lost to Follow-up|3|||
33383080|NCT00798161|62762041|FG004|Overall Study|Lost to Follow-up|4|||
33488435|NCT02777554|62866573|FG005|Overall Study|Other - Miscellaneous|0|||
33488436|NCT03550209|62866597|FG000|Overall Study|Lost to Follow-up|1|||
33488437|NCT03550209|62866598|FG001|Overall Study|Lost to Follow-up|0|||
33488438|NCT03550209|62866599|FG002|Overall Study|Lost to Follow-up|1|||
33662533|NCT01692119|63093186|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
33662534|NCT01691885|63093192|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
33662535|NCT01691885|63093193|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
33662536|NCT01691885|63093192|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
33662537|NCT01691885|63093193|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
33295525|NCT01346514|62672317|FG000|Overall Study|Lost to Follow-up|19|||
33295526|NCT01346514|62672318|FG001|Overall Study|Lost to Follow-up|30|||
33295527|NCT01346514|62672317|FG000|Overall Study|Withdrawal by Subject|7|||
33295528|NCT01346514|62672318|FG001|Overall Study|Withdrawal by Subject|3|||
33295529|NCT01346514|62672317|FG000|Overall Study|Death|3|||
33295530|NCT01346514|62672318|FG001|Overall Study|Death|4|||
33295531|NCT01193335|62672328|FG000|After Infant Series|Lost to Follow-up|1|||
33295532|NCT01193335|62672329|FG001|After Infant Series|Lost to Follow-up|2|||
33295533|NCT01193335|62672328|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
33295534|NCT01193335|62672329|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
33295535|NCT01193335|62672328|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
33295536|NCT01193335|62672329|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
33295537|NCT01193335|62672328|FG000|1-Year Follow-up|Lost to Follow-up|4|||
33295538|NCT01193335|62672329|FG001|1-Year Follow-up|Lost to Follow-up|0|||
33295539|NCT01193335|62672328|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
33295540|NCT01193335|62672329|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
33295541|NCT01193335|62672328|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
33295542|NCT01193335|62672329|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
33295543|NCT01342887|62672351|FG000|Overall Study|Death|2|||
33295544|NCT01342341|62672357|FG000|Overall Study|Lost to Follow-up|4|||
33295545|NCT01342341|62672358|FG001|Overall Study|Lost to Follow-up|4|||
33295546|NCT01340664|62672367|FG000|Overall Study|Adverse Event|0|||
33295547|NCT01340664|62672368|FG001|Overall Study|Adverse Event|1|||
33295548|NCT01340664|62672369|FG002|Overall Study|Adverse Event|7|||
33295549|NCT01340664|62672367|FG000|Overall Study|Lost to Follow-up|2|||
33295550|NCT01340664|62672368|FG001|Overall Study|Lost to Follow-up|0|||
33295551|NCT01340664|62672369|FG002|Overall Study|Lost to Follow-up|2|||
33295552|NCT01340664|62672367|FG000|Overall Study|Withdrawal by Subject|2|||
33295553|NCT01340664|62672368|FG001|Overall Study|Withdrawal by Subject|4|||
33295554|NCT01340664|62672369|FG002|Overall Study|Withdrawal by Subject|0|||
33295555|NCT01340664|62672367|FG000|Overall Study|Glycemic withdrawal criteria|2|||
33295556|NCT01340664|62672368|FG001|Overall Study|Glycemic withdrawal criteria|0|||
33295557|NCT01340664|62672369|FG002|Overall Study|Glycemic withdrawal criteria|0|||
33295558|NCT01340664|62672367|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
33295559|NCT01340664|62672368|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
33295560|NCT01340664|62672369|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
33488439|NCT03550209|62866600|FG003|Overall Study|Lost to Follow-up|0|||
33488440|NCT03550209|62866597|FG000|Overall Study|Withdrawal by Subject|0|||
33295561|NCT01340664|62672367|FG000|Overall Study|Other|1|||
33295562|NCT01340664|62672368|FG001|Overall Study|Other|2|||
33295563|NCT01340664|62672369|FG002|Overall Study|Other|2|||
33295564|NCT01340625|62672379|FG000|First Intervention|Adverse Event|1|||
33295565|NCT01340625|62672380|FG001|First Intervention|Adverse Event|0|||
33295566|NCT01340625|62672379|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
33295567|NCT01340625|62672380|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
33295568|NCT01340196|62672386|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
33383081|NCT00798161|62762042|FG005|Overall Study|Lost to Follow-up|0|||
33383082|NCT00798161|62762043|FG006|Overall Study|Lost to Follow-up|0|||
33383083|NCT00798161|62762037|FG000|Overall Study|Withdrawal by Subject|5|||
33383084|NCT00798161|62762038|FG001|Overall Study|Withdrawal by Subject|4|||
33383085|NCT00798161|62762039|FG002|Overall Study|Withdrawal by Subject|5|||
33488441|NCT03550209|62866598|FG001|Overall Study|Withdrawal by Subject|3|||
33383086|NCT00798161|62762040|FG003|Overall Study|Withdrawal by Subject|4|||
33662538|NCT01587703|63093226|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
33662539|NCT01587703|63093227|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662540|NCT01587703|63093228|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662541|NCT01587703|63093229|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662542|NCT01587703|63093230|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662543|NCT01587703|63093231|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662544|NCT01587703|63093232|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662545|NCT01587703|63093233|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662546|NCT01587703|63093234|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662547|NCT01587703|63093235|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662548|NCT01587703|63093236|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662549|NCT01587703|63093237|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662550|NCT01587703|63093238|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662551|NCT01587703|63093239|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33295569|NCT01327599|62672395|FG000|Overall Study|Adverse Event|1|||
33295570|NCT01327599|62672395|FG000|Overall Study|Could Not Attend Visit|1|||
33295571|NCT01327599|62672395|FG000|Overall Study|Withdrawal of Consent|1|||
33295572|NCT01193257|62672401|FG000|Overall Study|Death|202|||
33295573|NCT01193257|62672402|FG001|Overall Study|Death|391|||
33295574|NCT01193257|62672401|FG000|Overall Study|Study termination by sponsor|0|||
33662552|NCT01587703|63093240|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662553|NCT01587703|63093241|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662554|NCT01587703|63093242|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662555|NCT01587703|63093243|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662556|NCT01587703|63093244|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33662557|NCT01587703|63093226|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33662558|NCT01587703|63093227|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33662559|NCT01587703|63093228|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33662560|NCT01587703|63093229|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33295575|NCT01193257|62672402|FG001|Overall Study|Study termination by sponsor|3|||
33295576|NCT01193257|62672401|FG000|Overall Study|Withdrawal by Subject|26|||
33295577|NCT01193257|62672402|FG001|Overall Study|Withdrawal by Subject|86|||
33383087|NCT00798161|62762041|FG004|Overall Study|Withdrawal by Subject|2|||
33383088|NCT00798161|62762042|FG005|Overall Study|Withdrawal by Subject|3|||
33383089|NCT00798161|62762043|FG006|Overall Study|Withdrawal by Subject|1|||
33383090|NCT00798161|62762037|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
33383091|NCT00798161|62762038|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
33383092|NCT00798161|62762039|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
33383093|NCT00798161|62762040|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
33383094|NCT00798161|62762041|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
33383095|NCT00798161|62762042|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
33383096|NCT00798161|62762043|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
33383097|NCT00588341|62762059|FG000|Overall Study|Withdrawal by Subject|3|||
33383098|NCT00588341|62762059|FG000|Overall Study|Not treated due to metastatic disease|1|||
33383099|NCT00588341|62762059|FG000|Overall Study|Patient ineligible|1|||
33383100|NCT00802529|62762065|FG000|Overall Study|Lost to Follow-up|0|||
33383101|NCT00802529|62762066|FG001|Overall Study|Lost to Follow-up|1|||
33383102|NCT00758264|62762075|FG000|Active Phase|Withdrawal by Subject|0|||
33383103|NCT00758264|62762076|FG001|Active Phase|Withdrawal by Subject|0|||
33383104|NCT00758264|62762077|FG002|Active Phase|Withdrawal by Subject|1|||
33383105|NCT00758264|62762075|FG000|Active Phase|Lost to Follow-up|1|||
33383106|NCT00758264|62762076|FG001|Active Phase|Lost to Follow-up|0|||
33383107|NCT00758264|62762077|FG002|Active Phase|Lost to Follow-up|0|||
33383108|NCT00758264|62762075|FG000|Active Phase|Other|0|||
33662561|NCT01587703|63093230|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33295578|NCT01193257|62672401|FG000|Overall Study|Lost to Follow-up|2|||
33295579|NCT01193257|62672402|FG001|Overall Study|Lost to Follow-up|3|||
33383109|NCT00758264|62762076|FG001|Active Phase|Other|0|||
33383110|NCT00758264|62762077|FG002|Active Phase|Other|4|||
33383111|NCT00588731|62762087|FG000|Overall Study|Withdrawal by Subject|3|||
33383112|NCT00588731|62762088|FG001|Overall Study|Withdrawal by Subject|2|||
33383113|NCT00757172|62762094|FG000|Overall Study|Withdrawal by Subject|4|||
33383114|NCT00757172|62762094|FG000|Overall Study|Physician Decision|3|||
33383115|NCT00757172|62762094|FG000|Overall Study|Progression|4|||
33383116|NCT00797225|62762102|FG000|Weeks 1 to 12|Adverse Event|0|||
33383117|NCT00797225|62762103|FG001|Weeks 1 to 12|Adverse Event|0|||
33383118|NCT00797225|62762104|FG002|Weeks 1 to 12|Adverse Event|1|||
33383119|NCT00797225|62762105|FG003|Weeks 1 to 12|Adverse Event|0|||
33383120|NCT00797225|62762106|FG004|Weeks 1 to 12|Adverse Event|0|||
33295580|NCT01193257|62672401|FG000|Overall Study|Unblinded due to futility|135|||
33383121|NCT00797225|62762107|FG005|Weeks 1 to 12|Adverse Event|0|||
33383122|NCT00797225|62762108|FG006|Weeks 1 to 12|Adverse Event|0|||
33383123|NCT00797225|62762109|FG007|Weeks 1 to 12|Adverse Event|0|||
33383124|NCT00797225|62762102|FG000|Weeks 1 to 12|Non-compliance|0|||
33383125|NCT00797225|62762103|FG001|Weeks 1 to 12|Non-compliance|1|||
33383126|NCT00797225|62762104|FG002|Weeks 1 to 12|Non-compliance|0|||
33383127|NCT00797225|62762105|FG003|Weeks 1 to 12|Non-compliance|0|||
33383128|NCT00797225|62762106|FG004|Weeks 1 to 12|Non-compliance|0|||
33383129|NCT00797225|62762107|FG005|Weeks 1 to 12|Non-compliance|0|||
33383130|NCT00797225|62762108|FG006|Weeks 1 to 12|Non-compliance|0|||
33383131|NCT00797225|62762109|FG007|Weeks 1 to 12|Non-compliance|0|||
33383132|NCT00797225|62762102|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
33383133|NCT00797225|62762103|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
33662562|NCT01587703|63093231|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
33662563|NCT01587703|63093232|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33662564|NCT01587703|63093233|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
33662565|NCT01587703|63093234|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33662566|NCT01587703|63093235|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33662567|NCT01587703|63093236|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33662568|NCT01587703|63093237|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33662569|NCT01587703|63093238|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33662570|NCT01587703|63093239|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33662571|NCT01587703|63093240|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33662572|NCT01587703|63093241|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33295581|NCT01193257|62672402|FG001|Overall Study|Unblinded due to futility|251|||
33295582|NCT01193218|62672413|FG000|0-12 Weeks|Adverse Event|6|||
33295583|NCT01193218|62672414|FG001|0-12 Weeks|Adverse Event|0|||
33295584|NCT01193218|62672415|FG002|0-12 Weeks|Adverse Event|1|||
33295585|NCT01193218|62672416|FG003|0-12 Weeks|Adverse Event|0|||
33295586|NCT01193218|62672417|FG004|0-12 Weeks|Adverse Event|0|||
33295587|NCT01193218|62672418|FG005|0-12 Weeks|Adverse Event|2|||
33295588|NCT01193218|62672419|FG006|0-12 Weeks|Adverse Event|2|||
33295589|NCT01193218|62672420|FG007|0-12 Weeks|Adverse Event|0|||
33295590|NCT01193218|62672413|FG000|0-12 Weeks|Protocol Violation|0|||
33295591|NCT01193218|62672414|FG001|0-12 Weeks|Protocol Violation|0|||
33295592|NCT01193218|62672415|FG002|0-12 Weeks|Protocol Violation|0|||
33295593|NCT01193218|62672416|FG003|0-12 Weeks|Protocol Violation|0|||
33295594|NCT01193218|62672417|FG004|0-12 Weeks|Protocol Violation|1|||
33295595|NCT01193218|62672418|FG005|0-12 Weeks|Protocol Violation|1|||
33295596|NCT01193218|62672419|FG006|0-12 Weeks|Protocol Violation|0|||
33295597|NCT01193218|62672420|FG007|0-12 Weeks|Protocol Violation|0|||
33295598|NCT01193218|62672413|FG000|0-12 Weeks|Withdrawal by Subject|3|||
33295599|NCT01193218|62672414|FG001|0-12 Weeks|Withdrawal by Subject|0|||
33295600|NCT01193218|62672415|FG002|0-12 Weeks|Withdrawal by Subject|2|||
33295601|NCT01193218|62672416|FG003|0-12 Weeks|Withdrawal by Subject|0|||
33295602|NCT01193218|62672417|FG004|0-12 Weeks|Withdrawal by Subject|0|||
33295603|NCT01193218|62672418|FG005|0-12 Weeks|Withdrawal by Subject|0|||
33295604|NCT01193218|62672419|FG006|0-12 Weeks|Withdrawal by Subject|1|||
33295605|NCT01193218|62672420|FG007|0-12 Weeks|Withdrawal by Subject|0|||
33295606|NCT01193218|62672413|FG000|12-52 Weeks|Adverse Event|1|||
33295607|NCT01193218|62672414|FG001|12-52 Weeks|Adverse Event|0|||
33295608|NCT01193218|62672415|FG002|12-52 Weeks|Adverse Event|1|||
33295609|NCT01193218|62672416|FG003|12-52 Weeks|Adverse Event|2|||
33295610|NCT01193218|62672417|FG004|12-52 Weeks|Adverse Event|3|||
33295611|NCT01193218|62672418|FG005|12-52 Weeks|Adverse Event|3|||
33295612|NCT01193218|62672419|FG006|12-52 Weeks|Adverse Event|1|||
33295613|NCT01193218|62672420|FG007|12-52 Weeks|Adverse Event|2|||
33295614|NCT01193218|62672413|FG000|12-52 Weeks|Lack of Efficacy|0|||
33295615|NCT01193218|62672414|FG001|12-52 Weeks|Lack of Efficacy|0|||
33295616|NCT01193218|62672415|FG002|12-52 Weeks|Lack of Efficacy|0|||
33383134|NCT00797225|62762104|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
33383135|NCT00797225|62762105|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
33383136|NCT00797225|62762106|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
33383137|NCT00797225|62762107|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
33383138|NCT00797225|62762108|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
33383139|NCT00797225|62762109|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
33383140|NCT00797225|62762102|FG000|Weeks 1 to 12|Sponsor Decision|1|||
33383141|NCT00797225|62762103|FG001|Weeks 1 to 12|Sponsor Decision|0|||
33383142|NCT00797225|62762104|FG002|Weeks 1 to 12|Sponsor Decision|0|||
33383143|NCT00797225|62762105|FG003|Weeks 1 to 12|Sponsor Decision|0|||
33295617|NCT01193218|62672416|FG003|12-52 Weeks|Lack of Efficacy|0|||
33295618|NCT01193218|62672417|FG004|12-52 Weeks|Lack of Efficacy|0|||
33295619|NCT01193218|62672418|FG005|12-52 Weeks|Lack of Efficacy|0|||
33295620|NCT01193218|62672419|FG006|12-52 Weeks|Lack of Efficacy|1|||
33295621|NCT01193218|62672420|FG007|12-52 Weeks|Lack of Efficacy|0|||
33295622|NCT01193218|62672413|FG000|12-52 Weeks|Withdrawal by Subject|3|||
33295623|NCT01193218|62672414|FG001|12-52 Weeks|Withdrawal by Subject|0|||
33383144|NCT00797225|62762106|FG004|Weeks 1 to 12|Sponsor Decision|0|||
33383145|NCT00797225|62762107|FG005|Weeks 1 to 12|Sponsor Decision|0|||
33383146|NCT00797225|62762108|FG006|Weeks 1 to 12|Sponsor Decision|0|||
33295624|NCT01193218|62672415|FG002|12-52 Weeks|Withdrawal by Subject|3|||
33295625|NCT01193218|62672416|FG003|12-52 Weeks|Withdrawal by Subject|0|||
33295626|NCT01193218|62672417|FG004|12-52 Weeks|Withdrawal by Subject|0|||
33295627|NCT01193218|62672418|FG005|12-52 Weeks|Withdrawal by Subject|2|||
33295628|NCT01193218|62672419|FG006|12-52 Weeks|Withdrawal by Subject|1|||
33295629|NCT01193218|62672420|FG007|12-52 Weeks|Withdrawal by Subject|2|||
33295630|NCT01193218|62672413|FG000|12-52 Weeks|Other reason than above|1|||
33295631|NCT01193218|62672414|FG001|12-52 Weeks|Other reason than above|0|||
33383147|NCT00797225|62762109|FG007|Weeks 1 to 12|Sponsor Decision|0|||
33383148|NCT00797225|62762102|FG000|Weeks 13 to 24|Non-compliance|0|||
33383149|NCT00797225|62762103|FG001|Weeks 13 to 24|Non-compliance|2|||
33383150|NCT00797225|62762104|FG002|Weeks 13 to 24|Non-compliance|0|||
33383151|NCT00797225|62762105|FG003|Weeks 13 to 24|Non-compliance|0|||
33383152|NCT00797225|62762106|FG004|Weeks 13 to 24|Non-compliance|0|||
33383153|NCT00797225|62762107|FG005|Weeks 13 to 24|Non-compliance|0|||
33383154|NCT00797225|62762108|FG006|Weeks 13 to 24|Non-compliance|0|||
33383155|NCT00797225|62762109|FG007|Weeks 13 to 24|Non-compliance|0|||
33383156|NCT00797225|62762102|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
33383157|NCT00797225|62762103|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
33383158|NCT00797225|62762104|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
33383159|NCT00797225|62762105|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
33295632|NCT01193218|62672415|FG002|12-52 Weeks|Other reason than above|0|||
33295633|NCT01193218|62672416|FG003|12-52 Weeks|Other reason than above|1|||
33295634|NCT01193218|62672417|FG004|12-52 Weeks|Other reason than above|1|||
33295635|NCT01193218|62672418|FG005|12-52 Weeks|Other reason than above|0|||
33383160|NCT00797225|62762106|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
33383161|NCT00797225|62762107|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
33383162|NCT00797225|62762108|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
33383163|NCT00797225|62762109|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
33383164|NCT00797225|62762102|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
33383165|NCT00797225|62762103|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
33383166|NCT00797225|62762104|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
33383167|NCT00797225|62762105|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
33383168|NCT00797225|62762106|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
33383169|NCT00797225|62762107|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
33383170|NCT00797225|62762108|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
33383171|NCT00797225|62762109|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
33383172|NCT00797225|62762102|FG000|Weeks 13 to 24|Adverse Event|0|||
33295636|NCT01193218|62672419|FG006|12-52 Weeks|Other reason than above|0|||
33295637|NCT01193218|62672420|FG007|12-52 Weeks|Other reason than above|0|||
33295638|NCT01193101|62672440|FG000|Overall Study|Adverse Event|0|||
33295639|NCT01193101|62672441|FG001|Overall Study|Adverse Event|1|||
33295640|NCT01193101|62672442|FG002|Overall Study|Adverse Event|1|||
33295641|NCT01193101|62672443|FG003|Overall Study|Adverse Event|3|||
33488442|NCT03550209|62866599|FG002|Overall Study|Withdrawal by Subject|1|||
33488443|NCT03550209|62866600|FG003|Overall Study|Withdrawal by Subject|2|||
33488444|NCT03550209|62866597|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
33295642|NCT01193101|62672440|FG000|Overall Study|Lack of Efficacy|3|||
33295643|NCT01193101|62672441|FG001|Overall Study|Lack of Efficacy|1|||
33295644|NCT01193101|62672442|FG002|Overall Study|Lack of Efficacy|0|||
33295645|NCT01193101|62672443|FG003|Overall Study|Lack of Efficacy|8|||
33295646|NCT01193101|62672440|FG000|Overall Study|Withdrawal by Subject|2|||
33383173|NCT00797225|62762103|FG001|Weeks 13 to 24|Adverse Event|1|||
33383174|NCT00797225|62762104|FG002|Weeks 13 to 24|Adverse Event|0|||
33383175|NCT00797225|62762105|FG003|Weeks 13 to 24|Adverse Event|0|||
33383176|NCT00797225|62762106|FG004|Weeks 13 to 24|Adverse Event|0|||
33383177|NCT00797225|62762107|FG005|Weeks 13 to 24|Adverse Event|0|||
33488445|NCT03550209|62866598|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
33488446|NCT03550209|62866599|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
33383178|NCT00797225|62762108|FG006|Weeks 13 to 24|Adverse Event|1|||
33488447|NCT03550209|62866600|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
33488448|NCT03032510|62866612|FG000|Overall Study|Adverse Event|5|||
33488449|NCT03032510|62866613|FG001|Overall Study|Adverse Event|2|||
33383179|NCT00797225|62762109|FG007|Weeks 13 to 24|Adverse Event|0|||
33383180|NCT00797225|62762102|FG000|Weeks 13 to 24|Sponsor Decision|0|||
33383181|NCT00797225|62762103|FG001|Weeks 13 to 24|Sponsor Decision|0|||
33383182|NCT00797225|62762104|FG002|Weeks 13 to 24|Sponsor Decision|0|||
33383183|NCT00797225|62762105|FG003|Weeks 13 to 24|Sponsor Decision|0|||
33383184|NCT00797225|62762106|FG004|Weeks 13 to 24|Sponsor Decision|0|||
33383185|NCT00797225|62762107|FG005|Weeks 13 to 24|Sponsor Decision|0|||
33383186|NCT00797225|62762108|FG006|Weeks 13 to 24|Sponsor Decision|1|||
33383187|NCT00797225|62762109|FG007|Weeks 13 to 24|Sponsor Decision|0|||
33383188|NCT00778700|62762129|FG000|Overall Study|Adverse Event|6|||
33295647|NCT01193101|62672441|FG001|Overall Study|Withdrawal by Subject|4|||
33295648|NCT01193101|62672442|FG002|Overall Study|Withdrawal by Subject|1|||
33295649|NCT01193101|62672443|FG003|Overall Study|Withdrawal by Subject|1|||
33295650|NCT01193101|62672440|FG000|Overall Study|Administrative problems|0|||
33295651|NCT01193101|62672441|FG001|Overall Study|Administrative problems|0|||
33295652|NCT01193101|62672442|FG002|Overall Study|Administrative problems|1|||
33295653|NCT01193101|62672443|FG003|Overall Study|Administrative problems|0|||
33295654|NCT01193101|62672440|FG000|Overall Study|Abnormal test procedure results|0|||
33383189|NCT00778700|62762130|FG001|Overall Study|Adverse Event|1|||
33383190|NCT00778700|62762131|FG002|Overall Study|Adverse Event|3|||
33383191|NCT00778700|62762132|FG003|Overall Study|Adverse Event|5|||
33383192|NCT00778700|62762129|FG000|Overall Study|Protocol Violation|1|||
33295655|NCT01193101|62672441|FG001|Overall Study|Abnormal test procedure results|1|||
33295656|NCT01193101|62672442|FG002|Overall Study|Abnormal test procedure results|0|||
33295657|NCT01193101|62672443|FG003|Overall Study|Abnormal test procedure results|0|||
33295658|NCT01192516|62672456|FG000|Overall Study|Lost to Follow-up|7|||
33295659|NCT01192516|62672457|FG001|Overall Study|Lost to Follow-up|10|||
33295660|NCT01192516|62672458|FG002|Overall Study|Lost to Follow-up|7|||
33295661|NCT01192516|62672456|FG000|Overall Study|Withdrawal by Subject|4|||
33295662|NCT01192516|62672457|FG001|Overall Study|Withdrawal by Subject|4|||
33295663|NCT01192516|62672458|FG002|Overall Study|Withdrawal by Subject|1|||
33295664|NCT01192516|62672456|FG000|Overall Study|started new treatment|5|||
33295665|NCT01192516|62672457|FG001|Overall Study|started new treatment|1|||
33295666|NCT01192516|62672458|FG002|Overall Study|started new treatment|0|||
33295667|NCT01192516|62672456|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
33383193|NCT00778700|62762130|FG001|Overall Study|Protocol Violation|1|||
33383194|NCT00778700|62762131|FG002|Overall Study|Protocol Violation|0|||
33383195|NCT00778700|62762132|FG003|Overall Study|Protocol Violation|0|||
33295668|NCT01192516|62672457|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
33295669|NCT01192516|62672458|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
33295670|NCT01192399|62672470|FG000|Overall Study|Lack of Efficacy|2|||
33295671|NCT01176916|62672474|FG000|Overall Study|Adverse Event|61|||
33295672|NCT01176916|62672474|FG000|Overall Study|Death|1|||
33295673|NCT01176916|62672474|FG000|Overall Study|Lost to Follow-up|15|||
33295674|NCT01176916|62672474|FG000|Overall Study|Objective progression or relapse|17|||
33295675|NCT01176916|62672474|FG000|Overall Study|Protocol Violation|24|||
33295676|NCT01176916|62672474|FG000|Overall Study|Withdrawal by Subject|37|||
33295677|NCT01176916|62672474|FG000|Overall Study|Other|6|||
33295678|NCT01176916|62672474|FG000|Overall Study|Withdrawal prior to Treatment|6|||
33295679|NCT01192204|62672480|FG000|Overall Study|could not keep recall appointments|1|||
33383196|NCT00778700|62762129|FG000|Overall Study|Subject Withdrew Consent|6|||
33295680|NCT01192204|62672481|FG001|Overall Study|could not keep recall appointments|0|||
33295681|NCT01192126|62672488|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
33295682|NCT01192126|62672489|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
33295683|NCT01192126|62672488|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
33295684|NCT01192126|62672489|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
33295685|NCT01327482|62672495|FG000|Overall Study|Adverse Event|1|||
33295686|NCT01176565|62672501|FG000|Overall Study|Lost to Follow-up|12|||
33295687|NCT01176565|62672502|FG001|Overall Study|Lost to Follow-up|16|||
33383197|NCT00778700|62762130|FG001|Overall Study|Subject Withdrew Consent|4|||
33488450|NCT03032510|62866612|FG000|Overall Study|Lost to Follow-up|8|||
33488451|NCT03032510|62866613|FG001|Overall Study|Lost to Follow-up|7|||
33295688|NCT01176565|62672501|FG000|Overall Study|Withdrawal by Subject|7|||
33295689|NCT01176565|62672502|FG001|Overall Study|Withdrawal by Subject|1|||
33295690|NCT01176565|62672501|FG000|Overall Study|Not Analyzed (any other reason)|1|||
33295691|NCT01176565|62672502|FG001|Overall Study|Not Analyzed (any other reason)|2|||
33295692|NCT01176292|62672510|FG000|Overall Study|Lost to Follow-up|2|||
33295693|NCT01176292|62672511|FG001|Overall Study|Lost to Follow-up|4|||
33295694|NCT01176292|62672510|FG000|Overall Study|Adverse Event|1|||
33295695|NCT01176292|62672511|FG001|Overall Study|Adverse Event|1|||
33295696|NCT01176292|62672510|FG000|Overall Study|Physician Decision|0|||
33295697|NCT01176292|62672511|FG001|Overall Study|Physician Decision|2|||
33295698|NCT01176292|62672510|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
33295699|NCT01176292|62672511|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
33295700|NCT01113541|62672517|FG000|Overall Study|Withdrawal by Subject|1|||
33383198|NCT00778700|62762131|FG002|Overall Study|Subject Withdrew Consent|1|||
33295701|NCT01113541|62672517|FG000|Overall Study|Protocol Violation|1|||
33295702|NCT01113541|62672517|FG000|Overall Study|Study Terminated by Sponsor|7|||
33295703|NCT01113541|62672517|FG000|Overall Study|Adverse Event|4|||
33295704|NCT01113502|62672530|FG000|Overall Study|Withdrawal by Subject|1|||
33295705|NCT01113502|62672531|FG001|Overall Study|Withdrawal by Subject|0|||
33488452|NCT03032510|62866612|FG000|Overall Study|Withdrawal by Subject|8|||
33488453|NCT03032510|62866613|FG001|Overall Study|Withdrawal by Subject|7|||
33488454|NCT03032510|62866612|FG000|Overall Study|Subject noncompliance|4|||
33295706|NCT01113502|62672532|FG002|Overall Study|Withdrawal by Subject|1|||
33295707|NCT01113502|62672533|FG003|Overall Study|Withdrawal by Subject|1|||
33383199|NCT00778700|62762132|FG003|Overall Study|Subject Withdrew Consent|4|||
33383200|NCT00778700|62762129|FG000|Overall Study|Lost to Follow-up|3|||
33295708|NCT01113502|62672534|FG004|Overall Study|Withdrawal by Subject|0|||
33295709|NCT01113502|62672530|FG000|Overall Study|Adverse Event|0|||
33383201|NCT00778700|62762130|FG001|Overall Study|Lost to Follow-up|1|||
33383202|NCT00778700|62762131|FG002|Overall Study|Lost to Follow-up|0|||
33383203|NCT00778700|62762132|FG003|Overall Study|Lost to Follow-up|1|||
33383204|NCT00778700|62762129|FG000|Overall Study|Reason not Specified|2|||
33383205|NCT00778700|62762130|FG001|Overall Study|Reason not Specified|0|||
33383206|NCT00778700|62762131|FG002|Overall Study|Reason not Specified|1|||
33383207|NCT00778700|62762132|FG003|Overall Study|Reason not Specified|3|||
33383208|NCT00778700|62762129|FG000|Overall Study|Other|0|||
33383209|NCT00778700|62762130|FG001|Overall Study|Other|0|||
33295710|NCT01113502|62672531|FG001|Overall Study|Adverse Event|0|||
33295711|NCT01113502|62672532|FG002|Overall Study|Adverse Event|3|||
33295712|NCT01113502|62672533|FG003|Overall Study|Adverse Event|2|||
33295713|NCT01113502|62672534|FG004|Overall Study|Adverse Event|0|||
33295714|NCT01113463|62672547|FG000|Overall Study|Physician Decision|5|||
33295715|NCT01112917|62672551|FG000|Overall Study|Death|2|||
33295716|NCT01112917|62672552|FG001|Overall Study|Death|11|||
33295717|NCT01112917|62672551|FG000|Overall Study|Lost to Follow-up|1|||
33295718|NCT01112917|62672552|FG001|Overall Study|Lost to Follow-up|1|||
33295719|NCT01112917|62672551|FG000|Overall Study|Withdrawal by Subject|1|||
33295720|NCT01112917|62672552|FG001|Overall Study|Withdrawal by Subject|3|||
33295721|NCT01112917|62672551|FG000|Overall Study|Unable to Convert Filter|3|||
33295722|NCT01112917|62672552|FG001|Overall Study|Unable to Convert Filter|0|||
33383210|NCT00778700|62762131|FG002|Overall Study|Other|1|||
33383211|NCT00778700|62762132|FG003|Overall Study|Other|0|||
33383212|NCT00793403|62762146|FG000|Overall Study|Other|73|||
33383213|NCT00793325|62762150|FG000|Overall Study|Protocol Violation|18|||
33383214|NCT00793325|62762150|FG000|Overall Study|Lost to Follow-up|1|||
33383215|NCT00778622|62762176|FG000|Overall Study|Adverse Event|5|||
33383216|NCT00778622|62762177|FG001|Overall Study|Adverse Event|4|||
33383217|NCT00778622|62762178|FG002|Overall Study|Adverse Event|7|||
33383218|NCT00778622|62762176|FG000|Overall Study|Withdrawal by Subject|4|||
33383219|NCT00778622|62762177|FG001|Overall Study|Withdrawal by Subject|5|||
33383220|NCT00778622|62762178|FG002|Overall Study|Withdrawal by Subject|5|||
33383221|NCT00778622|62762176|FG000|Overall Study|Lost to Follow-up|3|||
33383222|NCT00778622|62762177|FG001|Overall Study|Lost to Follow-up|3|||
33383223|NCT00778622|62762178|FG002|Overall Study|Lost to Follow-up|2|||
33383224|NCT00778622|62762176|FG000|Overall Study|Protocol Violation|0|||
33383225|NCT00778622|62762177|FG001|Overall Study|Protocol Violation|3|||
33383226|NCT00778622|62762178|FG002|Overall Study|Protocol Violation|0|||
33383227|NCT00778622|62762176|FG000|Overall Study|Lack of Efficacy|2|||
33383228|NCT00778622|62762177|FG001|Overall Study|Lack of Efficacy|0|||
33383229|NCT00778622|62762178|FG002|Overall Study|Lack of Efficacy|0|||
33383230|NCT00778622|62762176|FG000|Overall Study|immigration|1|||
33383231|NCT00778622|62762177|FG001|Overall Study|immigration|0|||
33383232|NCT00778622|62762178|FG002|Overall Study|immigration|0|||
33383233|NCT00778622|62762176|FG000|Overall Study|Other|1|||
33383234|NCT00778622|62762177|FG001|Overall Study|Other|0|||
33383235|NCT00778622|62762178|FG002|Overall Study|Other|1|||
33383236|NCT00777920|62762190|FG000|Overall Study|Adverse Event|39|||
33383237|NCT00777920|62762190|FG000|Overall Study|Withdrawal of Consent|4|||
33383238|NCT00777920|62762190|FG000|Overall Study|Lost to Follow-up|1|||
33383239|NCT00777920|62762190|FG000|Overall Study|Investigator's discretion|1|||
33383240|NCT00777920|62762190|FG000|Overall Study|Clinical status did not improve|1|||
33383241|NCT00777920|62762190|FG000|Overall Study|Other, not specified|4|||
33383242|NCT04236141|62762196|FG000|Overall Study|Death|18|||
33383243|NCT04236141|62762197|FG001|Overall Study|Death|10|||
33383244|NCT04236141|62762196|FG000|Overall Study|Withdrawal by Participant|1|||
33383245|NCT04236141|62762197|FG001|Overall Study|Withdrawal by Participant|0|||
33383246|NCT04236141|62762196|FG000|Overall Study|Reason not Specified|1|||
33383247|NCT04236141|62762197|FG001|Overall Study|Reason not Specified|0|||
33383248|NCT04236141|62762196|FG000|Overall Study|Study terminated by Sponsor|8|||
33383249|NCT04236141|62762197|FG001|Overall Study|Study terminated by Sponsor|4|||
33383250|NCT00796445|62762205|FG000|Overall Study|Protocol Violation|5|||
33383251|NCT00796445|62762206|FG001|Overall Study|Protocol Violation|3|||
33488455|NCT03032510|62866613|FG001|Overall Study|Subject noncompliance|2|||
33295723|NCT01176058|62672558|FG000|Overall Study|Adverse Event|1|||
33383252|NCT00796445|62762205|FG000|Overall Study|Adverse event, serious fatal|10|||
33383253|NCT00796445|62762206|FG001|Overall Study|Adverse event, serious fatal|5|||
33383254|NCT00796445|62762205|FG000|Overall Study|Adverse event, non-fatal|4|||
33295724|NCT01176058|62672559|FG001|Overall Study|Adverse Event|0|||
33383255|NCT00796445|62762206|FG001|Overall Study|Adverse event, non-fatal|0|||
33295725|NCT01176058|62672558|FG000|Overall Study|Insufficient clinical response|2|||
33295726|NCT01176058|62672559|FG001|Overall Study|Insufficient clinical response|2|||
33383256|NCT00796445|62762205|FG000|Overall Study|Disease progression/recurrence|537|||
33383257|NCT00796445|62762206|FG001|Overall Study|Disease progression/recurrence|268|||
33383258|NCT00796445|62762205|FG000|Overall Study|Other|10|||
33383259|NCT00796445|62762206|FG001|Overall Study|Other|7|||
33383260|NCT00796445|62762205|FG000|Overall Study|Withdrawal by Subject|18|||
33383261|NCT00796445|62762206|FG001|Overall Study|Withdrawal by Subject|9|||
33383262|NCT00796445|62762205|FG000|Overall Study|Invalid Informed Consent Form|1|||
33383263|NCT00796445|62762206|FG001|Overall Study|Invalid Informed Consent Form|0|||
33383264|NCT03939819|62762222|FG000|Overall Study|Death|2|||
33383265|NCT03939819|62762223|FG001|Overall Study|Death|0|||
33295727|NCT01176058|62672558|FG000|Overall Study|Insufficient mycological response|0|||
33295728|NCT01176058|62672559|FG001|Overall Study|Insufficient mycological response|1|||
33383266|NCT00756938|62762232|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
33295729|NCT01176058|62672558|FG000|Overall Study|Withdrawal by Subject|1|||
33295730|NCT01176058|62672559|FG001|Overall Study|Withdrawal by Subject|0|||
33295731|NCT01175824|62672567|FG000|Overall Study|Adverse Event|2|||
33295732|NCT01175824|62672568|FG001|Overall Study|Adverse Event|1|||
33295733|NCT01175824|62672567|FG000|Overall Study|Lack of Efficacy|2|||
33295734|NCT01175824|62672568|FG001|Overall Study|Lack of Efficacy|0|||
33295735|NCT01175824|62672567|FG000|Overall Study|Lost to Follow-up|0|||
33383267|NCT00756938|62762233|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
33488456|NCT03032510|62866612|FG000|Overall Study|Physician Decision|2|||
33295736|NCT01175824|62672568|FG001|Overall Study|Lost to Follow-up|1|||
33295737|NCT01175824|62672567|FG000|Overall Study|Physician Decision|0|||
33295738|NCT01175824|62672568|FG001|Overall Study|Physician Decision|4|||
33295739|NCT01175824|62672567|FG000|Overall Study|Protocol Violation|2|||
33295740|NCT01175824|62672568|FG001|Overall Study|Protocol Violation|5|||
33295741|NCT01175824|62672567|FG000|Overall Study|Withdrawal by Subject|3|||
33295742|NCT01175824|62672568|FG001|Overall Study|Withdrawal by Subject|7|||
33295743|NCT01175824|62672567|FG000|Overall Study|Sponsor Decision|1|||
33295744|NCT01175824|62672568|FG001|Overall Study|Sponsor Decision|0|||
33295745|NCT01175824|62672567|FG000|Overall Study|Entry Criteria Not Met|6|||
33295746|NCT01175824|62672568|FG001|Overall Study|Entry Criteria Not Met|4|||
33295747|NCT01175707|62672576|FG000|Overall Study|Adverse Event|4|||
33295748|NCT01175707|62672577|FG001|Overall Study|Adverse Event|6|||
33295749|NCT01112059|62672586|FG000|Overall Study|Withdrawal by Subject|1|||
33383268|NCT00756938|62762234|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
33383269|NCT00756938|62762235|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
33488457|NCT03032510|62866613|FG001|Overall Study|Physician Decision|0|||
33488458|NCT03599349|62866623|FG000|Overall Study|Lost to Follow-up|1|||
33488459|NCT03599193|62866633|FG000|Overall Study|Adverse Event|0|||
33488460|NCT03599193|62866634|FG001|Overall Study|Adverse Event|2|||
33488461|NCT03599193|62866633|FG000|Overall Study|Withdrawal by Subject|1|||
33488462|NCT03599193|62866634|FG001|Overall Study|Withdrawal by Subject|0|||
33488463|NCT03599193|62866633|FG000|Overall Study|Protocol Violation|1|||
33488464|NCT03599193|62866634|FG001|Overall Study|Protocol Violation|0|||
33488465|NCT03599193|62866633|FG000|Overall Study|Lost to Follow-up|0|||
33488466|NCT03599193|62866634|FG001|Overall Study|Lost to Follow-up|1|||
33488467|NCT03166124|62866643|FG000|Treatment Period 1|Adverse Event|0|||
33488468|NCT03166124|62866644|FG001|Treatment Period 1|Adverse Event|0|||
33488469|NCT03166124|62866645|FG002|Treatment Period 1|Adverse Event|1|||
33488470|NCT03166124|62866646|FG003|Treatment Period 1|Adverse Event|0|||
33488471|NCT03166124|62866643|FG000|Wash-out Period|Withdrawal by Subject|0|||
33488472|NCT03166124|62866644|FG001|Wash-out Period|Withdrawal by Subject|1|||
33488473|NCT03166124|62866645|FG002|Wash-out Period|Withdrawal by Subject|0|||
33488474|NCT03166124|62866646|FG003|Wash-out Period|Withdrawal by Subject|1|||
33488475|NCT03166124|62866643|FG000|Wash-out Period|Adverse Event|0|||
33488476|NCT03166124|62866644|FG001|Wash-out Period|Adverse Event|1|||
33488477|NCT03166124|62866645|FG002|Wash-out Period|Adverse Event|1|||
33488478|NCT03166124|62866646|FG003|Wash-out Period|Adverse Event|0|||
33488479|NCT03567291|62866657|FG000|Period I|Adverse Event|14|||
33488480|NCT03567291|62866658|FG001|Period I|Adverse Event|0|||
33488481|NCT03567291|62866659|FG002|Period I|Adverse Event|0|||
33488482|NCT03567291|62866660|FG003|Period I|Adverse Event|0|||
33488483|NCT03567291|62866657|FG000|Period I|Protocol Violation|1|||
33488484|NCT03567291|62866658|FG001|Period I|Protocol Violation|0|||
33488485|NCT03567291|62866659|FG002|Period I|Protocol Violation|0|||
33488486|NCT03567291|62866660|FG003|Period I|Protocol Violation|0|||
33295750|NCT01112059|62672587|FG001|Overall Study|Withdrawal by Subject|0|||
33488487|NCT03567291|62866657|FG000|Period I|Withdrawal by Subject|23|||
33488488|NCT03567291|62866658|FG001|Period I|Withdrawal by Subject|0|||
33488489|NCT03567291|62866659|FG002|Period I|Withdrawal by Subject|0|||
33488490|NCT03567291|62866660|FG003|Period I|Withdrawal by Subject|0|||
33488491|NCT03567291|62866657|FG000|Period I|Lost to Follow-up|2|||
33295751|NCT01175668|62672598|FG000|Overall Study|Withdrawal by Subject|2|||
33295752|NCT01175668|62672599|FG001|Overall Study|Withdrawal by Subject|0|||
33295753|NCT01111825|62672609|FG000|Overall Study|Withdrawal by Subject|0|||
33295754|NCT01111825|62672610|FG001|Overall Study|Withdrawal by Subject|0|||
33295755|NCT01111825|62672611|FG002|Overall Study|Withdrawal by Subject|1|||
33295756|NCT01111825|62672612|FG003|Overall Study|Withdrawal by Subject|0|||
33383270|NCT00756938|62762232|FG000|12-week Base Study|Protocol Violation|0|||
33383271|NCT00756938|62762233|FG001|12-week Base Study|Protocol Violation|0|||
33295757|NCT01111825|62672609|FG000|Overall Study|Lost to Follow-up|0|||
33295758|NCT01111825|62672610|FG001|Overall Study|Lost to Follow-up|0|||
33488492|NCT03567291|62866658|FG001|Period I|Lost to Follow-up|0|||
33488493|NCT03567291|62866659|FG002|Period I|Lost to Follow-up|0|||
33383272|NCT00756938|62762234|FG002|12-week Base Study|Protocol Violation|1|||
33295759|NCT01111825|62672611|FG002|Overall Study|Lost to Follow-up|3|||
33295760|NCT01111825|62672612|FG003|Overall Study|Lost to Follow-up|1|||
33295761|NCT01111825|62672609|FG000|Overall Study|Adverse Event|2|||
33295762|NCT01111825|62672610|FG001|Overall Study|Adverse Event|1|||
33383273|NCT00756938|62762235|FG003|12-week Base Study|Protocol Violation|0|||
33383274|NCT00756938|62762232|FG000|12-week Base Study|Lost to Follow-up|1|||
33383275|NCT00756938|62762233|FG001|12-week Base Study|Lost to Follow-up|0|||
33383276|NCT00756938|62762234|FG002|12-week Base Study|Lost to Follow-up|0|||
33383277|NCT00756938|62762235|FG003|12-week Base Study|Lost to Follow-up|0|||
33383278|NCT00756938|62762232|FG000|Optional Extension|Lack of Efficacy|0|||
33383279|NCT00756938|62762233|FG001|Optional Extension|Lack of Efficacy|0|||
33383280|NCT00756938|62762234|FG002|Optional Extension|Lack of Efficacy|0|||
33383281|NCT00756938|62762235|FG003|Optional Extension|Lack of Efficacy|1|||
33383282|NCT00756938|62762232|FG000|Optional Extension|End of Study|0|||
33383283|NCT00756938|62762233|FG001|Optional Extension|End of Study|0|||
33383284|NCT00756938|62762234|FG002|Optional Extension|End of Study|0|||
33383285|NCT00756938|62762235|FG003|Optional Extension|End of Study|11|||
33383286|NCT00756938|62762232|FG000|Optional Extension|Protocol-specific criteria met|0|||
33383287|NCT00756938|62762233|FG001|Optional Extension|Protocol-specific criteria met|0|||
33383288|NCT00756938|62762234|FG002|Optional Extension|Protocol-specific criteria met|0|||
33383289|NCT00756938|62762235|FG003|Optional Extension|Protocol-specific criteria met|9|||
33383290|NCT00756938|62762232|FG000|Optional Extension|Physician Decision|0|||
33383291|NCT00756938|62762233|FG001|Optional Extension|Physician Decision|0|||
33383292|NCT00756938|62762234|FG002|Optional Extension|Physician Decision|0|||
33383293|NCT00756938|62762235|FG003|Optional Extension|Physician Decision|3|||
33383294|NCT00756938|62762232|FG000|Optional Extension|Lost to Follow-up|0|||
33383295|NCT00756938|62762233|FG001|Optional Extension|Lost to Follow-up|0|||
33383296|NCT00756938|62762234|FG002|Optional Extension|Lost to Follow-up|0|||
33383297|NCT00756938|62762235|FG003|Optional Extension|Lost to Follow-up|1|||
33383298|NCT00756938|62762232|FG000|Optional Extension|Protocol Violation|0|||
33383299|NCT00756938|62762233|FG001|Optional Extension|Protocol Violation|0|||
33383300|NCT00756938|62762234|FG002|Optional Extension|Protocol Violation|0|||
33383301|NCT00756938|62762235|FG003|Optional Extension|Protocol Violation|1|||
33383302|NCT00756938|62762232|FG000|Optional Extension|Withdrawal by Subject|0|||
33383303|NCT00756938|62762233|FG001|Optional Extension|Withdrawal by Subject|0|||
33383304|NCT00756938|62762234|FG002|Optional Extension|Withdrawal by Subject|0|||
33383305|NCT00756938|62762235|FG003|Optional Extension|Withdrawal by Subject|10|||
33383306|NCT00756938|62762232|FG000|Optional Extension|Adverse Event|0|||
33383307|NCT00756938|62762233|FG001|Optional Extension|Adverse Event|0|||
33383308|NCT00756938|62762234|FG002|Optional Extension|Adverse Event|0|||
33383309|NCT00756938|62762235|FG003|Optional Extension|Adverse Event|1|||
33383310|NCT00796367|62762256|FG000|Overall Study|Adverse Event|6|||
33383311|NCT00796367|62762257|FG001|Overall Study|Adverse Event|4|||
33383312|NCT00796367|62762258|FG002|Overall Study|Adverse Event|7|||
33383313|NCT00796367|62762256|FG000|Overall Study|Lost to Follow-up|5|||
33383314|NCT00796367|62762257|FG001|Overall Study|Lost to Follow-up|4|||
33556725|NCT02791763|62949551|FG001|Overall Study|Withdrawal by Subject|1|||
33295763|NCT01111825|62672611|FG002|Overall Study|Adverse Event|4|||
33295764|NCT01111825|62672612|FG003|Overall Study|Adverse Event|0|||
33295765|NCT01111825|62672609|FG000|Overall Study|Disease Progression|1|||
33295766|NCT01111825|62672610|FG001|Overall Study|Disease Progression|0|||
33295767|NCT01111825|62672611|FG002|Overall Study|Disease Progression|0|||
33295768|NCT01111825|62672612|FG003|Overall Study|Disease Progression|0|||
33295769|NCT01111825|62672609|FG000|Overall Study|Discontinuation by Sponsor|0|||
33295770|NCT01111825|62672610|FG001|Overall Study|Discontinuation by Sponsor|0|||
33295771|NCT01111825|62672611|FG002|Overall Study|Discontinuation by Sponsor|0|||
33295772|NCT01111825|62672612|FG003|Overall Study|Discontinuation by Sponsor|20|||
33295773|NCT01175590|62672624|FG000|Overall Study|Lost to Follow-up|1|||
33295774|NCT01175590|62672625|FG001|Overall Study|Lost to Follow-up|0|||
33295775|NCT01175590|62672624|FG000|Overall Study|Withdrawal by Subject|0|||
33295776|NCT01175590|62672625|FG001|Overall Study|Withdrawal by Subject|2|||
33383315|NCT00796367|62762258|FG002|Overall Study|Lost to Follow-up|21|||
33383316|NCT00796367|62762256|FG000|Overall Study|Withdrawal by Subject|9|||
33383317|NCT00796367|62762257|FG001|Overall Study|Withdrawal by Subject|11|||
33383318|NCT00796367|62762258|FG002|Overall Study|Withdrawal by Subject|12|||
33383319|NCT00796367|62762256|FG000|Overall Study|Lack of Efficacy|2|||
33383320|NCT00796367|62762257|FG001|Overall Study|Lack of Efficacy|1|||
33383321|NCT00796367|62762258|FG002|Overall Study|Lack of Efficacy|0|||
33383322|NCT00796367|62762256|FG000|Overall Study|non compliance|3|||
33383323|NCT00796367|62762257|FG001|Overall Study|non compliance|1|||
33383324|NCT00796367|62762258|FG002|Overall Study|non compliance|1|||
33383325|NCT00796367|62762256|FG000|Overall Study|Pregnancy|1|||
33295777|NCT01175590|62672624|FG000|Overall Study|Adverse Event|4|||
33383326|NCT00796367|62762257|FG001|Overall Study|Pregnancy|0|||
33295778|NCT01175590|62672625|FG001|Overall Study|Adverse Event|0|||
33295779|NCT01175590|62672624|FG000|Overall Study|Physician Decision|1|||
33383327|NCT00796367|62762258|FG002|Overall Study|Pregnancy|1|||
33295780|NCT01175590|62672625|FG001|Overall Study|Physician Decision|4|||
33295781|NCT01175590|62672624|FG000|Overall Study|Lack of Efficacy|1|||
33295782|NCT01175590|62672625|FG001|Overall Study|Lack of Efficacy|1|||
33295783|NCT01175590|62672624|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
33295784|NCT01175590|62672625|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
33295785|NCT01175590|62672624|FG000|Overall Study|Treated not as randomized|3|||
33295786|NCT01175590|62672625|FG001|Overall Study|Treated not as randomized|2|||
33295787|NCT01175590|62672624|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
33295788|NCT01175590|62672625|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
33295789|NCT01175590|62672624|FG000|Overall Study|Protocol Violation|0|||
33383328|NCT00796367|62762256|FG000|Overall Study|Requirement for restricted medication|2|||
33383329|NCT00796367|62762257|FG001|Overall Study|Requirement for restricted medication|0|||
33383330|NCT00796367|62762258|FG002|Overall Study|Requirement for restricted medication|2|||
33383331|NCT00796367|62762256|FG000|Overall Study|other|2|||
33383332|NCT00796367|62762257|FG001|Overall Study|other|4|||
33383333|NCT00796367|62762258|FG002|Overall Study|other|3|||
33383334|NCT00770588|62762268|FG000|Overall Study|Adverse Event|9|||
33383335|NCT00770588|62762269|FG001|Overall Study|Adverse Event|2|||
33383336|NCT00770588|62762268|FG000|Overall Study|Death caused by progression of disease|70|||
33383337|NCT00770588|62762269|FG001|Overall Study|Death caused by progression of disease|91|||
33383338|NCT00770588|62762268|FG000|Overall Study|Lost to Follow-up|1|||
33383339|NCT00770588|62762269|FG001|Overall Study|Lost to Follow-up|1|||
33383340|NCT00770588|62762268|FG000|Overall Study|Withdrawal by Subject|1|||
33383341|NCT00770588|62762269|FG001|Overall Study|Withdrawal by Subject|1|||
33383342|NCT00777608|62762278|FG000|Overall Study|Lost to Follow-up|1|||
33383343|NCT00777608|62762279|FG001|Overall Study|Lost to Follow-up|1|||
33383344|NCT00777608|62762278|FG000|Overall Study|Withdrawal by Subject|1|||
33383345|NCT00777608|62762279|FG001|Overall Study|Withdrawal by Subject|3|||
33383346|NCT00777608|62762278|FG000|Overall Study|Protocol Violation|1|||
33383347|NCT00777608|62762279|FG001|Overall Study|Protocol Violation|0|||
33383348|NCT00777608|62762278|FG000|Overall Study|Investigator Decision|1|||
33383349|NCT00777608|62762279|FG001|Overall Study|Investigator Decision|2|||
33383350|NCT00792935|62762287|FG000|Overall Study|Adverse Event|2|||
33383351|NCT00792935|62762288|FG001|Overall Study|Adverse Event|1|||
33383352|NCT00792935|62762287|FG000|Overall Study|Lost to Follow-up|0|||
33383353|NCT00792935|62762288|FG001|Overall Study|Lost to Follow-up|1|||
33383354|NCT00792935|62762287|FG000|Overall Study|Protocol Violation|2|||
33383355|NCT00792935|62762288|FG001|Overall Study|Protocol Violation|0|||
33383356|NCT00792935|62762287|FG000|Overall Study|Withdrawal by Subject|0|||
33383357|NCT00792935|62762288|FG001|Overall Study|Withdrawal by Subject|1|||
33383358|NCT00770510|62762294|FG000|Overall Study|Lost to Follow-up|2|||
33383359|NCT00770510|62762294|FG000|Overall Study|Pregnancy|1|||
33383360|NCT00770510|62762294|FG000|Overall Study|Withdrawal by Subject|2|||
33383361|NCT00770432|62762308|FG000|Overall Study|Other|4|||
33383362|NCT00770432|62762309|FG001|Overall Study|Other|6|||
33383363|NCT00770432|62762308|FG000|Overall Study|Non-compliance|0|||
33383364|NCT00770432|62762309|FG001|Overall Study|Non-compliance|1|||
33383365|NCT00792701|62762317|FG000|Overall Study|Adverse Event|0|||
33383366|NCT00792701|62762318|FG001|Overall Study|Adverse Event|22|||
33383367|NCT00792701|62762317|FG000|Overall Study|Ineligible|1|||
33383368|NCT00792701|62762318|FG001|Overall Study|Ineligible|3|||
33383369|NCT00792701|62762317|FG000|Overall Study|Withdrawal by Subject|1|||
33383370|NCT00792701|62762318|FG001|Overall Study|Withdrawal by Subject|19|||
33383371|NCT00792701|62762317|FG000|Overall Study|Not protocol specified|17|||
33383372|NCT00792701|62762318|FG001|Overall Study|Not protocol specified|0|||
33383373|NCT00777296|62762330|FG000|Overall Study|Adverse Event|0|||
33383374|NCT00777296|62762331|FG001|Overall Study|Adverse Event|1|||
33383375|NCT00777296|62762332|FG002|Overall Study|Adverse Event|0|||
33383376|NCT00777296|62762333|FG003|Overall Study|Adverse Event|1|||
33383377|NCT00777296|62762330|FG000|Overall Study|Withdrawal by Subject|1|||
33383378|NCT00777296|62762331|FG001|Overall Study|Withdrawal by Subject|0|||
33383379|NCT00777296|62762332|FG002|Overall Study|Withdrawal by Subject|0|||
33383380|NCT00777296|62762333|FG003|Overall Study|Withdrawal by Subject|0|||
33488494|NCT03567291|62866660|FG003|Period I|Lost to Follow-up|0|||
33295790|NCT01175590|62672625|FG001|Overall Study|Protocol Violation|1|||
33295791|NCT01175473|62672634|FG000|Overall Study|Adverse Event|2|||
33295792|NCT01175473|62672635|FG001|Overall Study|Adverse Event|2|||
33295793|NCT01111552|62672641|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
33383381|NCT00777296|62762330|FG000|Overall Study|CRF form not completed|0|||
33383382|NCT00777296|62762331|FG001|Overall Study|CRF form not completed|0|||
33383383|NCT00777296|62762332|FG002|Overall Study|CRF form not completed|2|||
33383384|NCT00777296|62762333|FG003|Overall Study|CRF form not completed|0|||
33383385|NCT00756470|62762355|FG000|Overall Study|Withdrawal by Subject|1|||
33383386|NCT00756470|62762355|FG000|Overall Study|Adverse Event|4|||
33488495|NCT03567291|62866657|FG000|Period I|Terminated by sponsor|44|||
33488496|NCT03567291|62866658|FG001|Period I|Terminated by sponsor|0|||
33383387|NCT00792623|62762359|FG000|Overall Study|Adverse Event|2|||
33383388|NCT00792623|62762359|FG000|Overall Study|Withdrawal by Subject|5|||
33383389|NCT00756314|62762366|FG000|Overall Study|Lost to Follow-up|2|||
33383390|NCT00756314|62762367|FG001|Overall Study|Lost to Follow-up|59|||
33383391|NCT00727506|62762379|FG000|Overall Study|Adverse Event|0|||
33383392|NCT00727506|62762380|FG001|Overall Study|Adverse Event|0|||
33383393|NCT00727506|62762381|FG002|Overall Study|Adverse Event|4|||
33383394|NCT00727506|62762382|FG003|Overall Study|Adverse Event|4|||
33383395|NCT00727506|62762383|FG004|Overall Study|Adverse Event|1|||
33383396|NCT00727506|62762384|FG005|Overall Study|Adverse Event|8|||
33383397|NCT00727506|62762379|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
33383398|NCT00727506|62762380|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33383399|NCT00727506|62762381|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
33383400|NCT00727506|62762382|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33383401|NCT00727506|62762383|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33383402|NCT00727506|62762384|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33383403|NCT00727506|62762379|FG000|Overall Study|Progressive disease|4|||
33383404|NCT00727506|62762380|FG001|Overall Study|Progressive disease|7|||
33383405|NCT00727506|62762381|FG002|Overall Study|Progressive disease|9|||
33383406|NCT00727506|62762382|FG003|Overall Study|Progressive disease|28|||
33383407|NCT00727506|62762383|FG004|Overall Study|Progressive disease|38|||
33383408|NCT00727506|62762384|FG005|Overall Study|Progressive disease|28|||
33383409|NCT00727506|62762379|FG000|Overall Study|Refused to continue medication|0|||
33383410|NCT00727506|62762380|FG001|Overall Study|Refused to continue medication|1|||
33383411|NCT00727506|62762381|FG002|Overall Study|Refused to continue medication|2|||
33383412|NCT00727506|62762382|FG003|Overall Study|Refused to continue medication|3|||
33383413|NCT00727506|62762383|FG004|Overall Study|Refused to continue medication|1|||
33383414|NCT00727506|62762384|FG005|Overall Study|Refused to continue medication|2|||
33383415|NCT00727506|62762379|FG000|Overall Study|Other reason not described above|0|||
33383416|NCT00727506|62762380|FG001|Overall Study|Other reason not described above|0|||
33383417|NCT00727506|62762381|FG002|Overall Study|Other reason not described above|1|||
33383418|NCT00727506|62762382|FG003|Overall Study|Other reason not described above|4|||
33383419|NCT00727506|62762383|FG004|Overall Study|Other reason not described above|1|||
33383420|NCT00727506|62762384|FG005|Overall Study|Other reason not described above|1|||
33383421|NCT00789815|62762406|FG000|Overall Study|Protocol Violation|6|||
33383422|NCT00789815|62762407|FG001|Overall Study|Protocol Violation|1|||
33383423|NCT00789815|62762406|FG000|Overall Study|Intubation due to massive bleeding|1|||
33383424|NCT00789815|62762407|FG001|Overall Study|Intubation due to massive bleeding|0|||
33383425|NCT00721578|62762413|FG000|Overall Study|Death|1|||
33383426|NCT00721578|62762414|FG001|Overall Study|Death|1|||
33383427|NCT00721578|62762413|FG000|Overall Study|Withdrawal by Subject|1|||
33383428|NCT00721578|62762414|FG001|Overall Study|Withdrawal by Subject|1|||
33383429|NCT00789737|62762422|FG000|Overall Study|Withdrawal by Subject|13|||
33383430|NCT00789737|62762423|FG001|Overall Study|Withdrawal by Subject|22|||
33383431|NCT00789737|62762422|FG000|Overall Study|Lost to Follow-up|10|||
33383432|NCT00789737|62762423|FG001|Overall Study|Lost to Follow-up|14|||
33383433|NCT00789737|62762422|FG000|Overall Study|Adverse Event|8|||
33383434|NCT00789737|62762423|FG001|Overall Study|Adverse Event|8|||
33383435|NCT00789737|62762422|FG000|Overall Study|Protocol Violation|3|||
33383436|NCT00789737|62762423|FG001|Overall Study|Protocol Violation|0|||
33383437|NCT00789737|62762422|FG000|Overall Study|Lack of Efficacy|3|||
33383438|NCT00789737|62762423|FG001|Overall Study|Lack of Efficacy|0|||
33383439|NCT00789737|62762422|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
33383440|NCT00789737|62762423|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
33383441|NCT00789737|62762422|FG000|Overall Study|Other|11|||
33383442|NCT00789737|62762423|FG001|Overall Study|Other|7|||
33383443|NCT00792467|62762429|FG000|Overall Study|progression of disease|17|||
33383444|NCT00792467|62762429|FG000|Overall Study|Adverse Event|1|||
33383445|NCT00792467|62762429|FG000|Overall Study|patient request|1|||
33383446|NCT00792467|62762429|FG000|Overall Study|Lost to Follow-up|1|||
33383447|NCT00792467|62762429|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
33383448|NCT00792467|62762429|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
33383449|NCT00585468|62762434|FG000|First Intervention|Withdrawal by Subject|1|||
33383450|NCT00585468|62762435|FG001|First Intervention|Withdrawal by Subject|1|||
33383451|NCT00724152|62762448|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
33383452|NCT00724152|62762449|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
33383453|NCT00724152|62762450|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
33383454|NCT00724152|62762448|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
33383455|NCT00724152|62762449|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
33383456|NCT00724152|62762450|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
33383457|NCT00721110|62762464|FG000|Overall Study|Ultram use|1|||
33383458|NCT00721110|62762465|FG001|Overall Study|Ultram use|0|||
33383459|NCT00721110|62762466|FG002|Overall Study|Ultram use|0|||
33383460|NCT00721110|62762467|FG003|Overall Study|Ultram use|0|||
33383461|NCT00721110|62762464|FG000|Overall Study|vertical incision|0|||
33383462|NCT00721110|62762465|FG001|Overall Study|vertical incision|0|||
33383463|NCT00721110|62762466|FG002|Overall Study|vertical incision|1|||
33383464|NCT00721110|62762467|FG003|Overall Study|vertical incision|0|||
33383465|NCT00791999|62762481|FG000|Overall Study|Protocol planed withdrawal|14|||
33383466|NCT00791999|62762482|FG001|Overall Study|Protocol planed withdrawal|11|||
33383467|NCT00791999|62762483|FG002|Overall Study|Protocol planed withdrawal|11|||
33383468|NCT00791999|62762484|FG003|Overall Study|Protocol planed withdrawal|45|||
33383469|NCT00791999|62762481|FG000|Overall Study|Withdrawal by Subject|0|||
33383470|NCT00791999|62762482|FG001|Overall Study|Withdrawal by Subject|1|||
33383471|NCT00791999|62762483|FG002|Overall Study|Withdrawal by Subject|0|||
33383472|NCT00791999|62762484|FG003|Overall Study|Withdrawal by Subject|2|||
33383473|NCT00791999|62762481|FG000|Overall Study|Protocol Violation|3|||
33383474|NCT00791999|62762482|FG001|Overall Study|Protocol Violation|0|||
33383475|NCT00791999|62762483|FG002|Overall Study|Protocol Violation|1|||
33383476|NCT00791999|62762484|FG003|Overall Study|Protocol Violation|0|||
33383477|NCT00791999|62762481|FG000|Overall Study|Adverse Event|3|||
33383478|NCT00791999|62762482|FG001|Overall Study|Adverse Event|3|||
33488497|NCT03567291|62866659|FG002|Period I|Terminated by sponsor|0|||
33295794|NCT01111552|62672642|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33488498|NCT03567291|62866660|FG003|Period I|Terminated by sponsor|0|||
33488499|NCT03567291|62866657|FG000|Period I|Missing or unknown|7|||
33488500|NCT03567291|62866658|FG001|Period I|Missing or unknown|0|||
33488501|NCT03567291|62866659|FG002|Period I|Missing or unknown|0|||
33295795|NCT01111552|62672643|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33295796|NCT01111552|62672644|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33295797|NCT01111552|62672645|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33295798|NCT01111552|62672641|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
33295799|NCT01111552|62672642|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33295800|NCT01111552|62672643|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33295801|NCT01111552|62672644|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33295802|NCT01111552|62672645|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33295803|NCT01111552|62672641|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
33295804|NCT01111552|62672642|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33295805|NCT01111552|62672643|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33295806|NCT01111552|62672644|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33295807|NCT01111552|62672645|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33295808|NCT01111552|62672641|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
33295809|NCT01111552|62672642|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
33295810|NCT01111552|62672643|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
33295811|NCT01111552|62672644|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
33295812|NCT01111552|62672645|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
33295813|NCT01111552|62672641|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
33295814|NCT01111552|62672642|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
33295815|NCT01111552|62672643|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
33295816|NCT01111552|62672644|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
33295817|NCT01111552|62672645|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
33295818|NCT01111552|62672641|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
33295819|NCT01111552|62672642|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
33295820|NCT01111552|62672643|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
33295821|NCT01111552|62672644|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
33295822|NCT01111552|62672645|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
33295823|NCT01111552|62672641|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
33295824|NCT01111552|62672642|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33295825|NCT01111552|62672643|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33295826|NCT01111552|62672644|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33295827|NCT01111552|62672645|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33295828|NCT01111552|62672641|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
33295829|NCT01111552|62672642|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
33295830|NCT01111552|62672643|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
33295831|NCT01111552|62672644|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
33295832|NCT01111552|62672645|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
33295833|NCT01111552|62672641|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33295834|NCT01111552|62672642|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33295835|NCT01111552|62672643|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33295836|NCT01111552|62672644|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
33295837|NCT01111552|62672645|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33295838|NCT01111552|62672641|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
33295839|NCT01111552|62672642|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
33295840|NCT01111552|62672643|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
33295841|NCT01111552|62672644|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
33488502|NCT03567291|62866660|FG003|Period I|Missing or unknown|0|||
33295842|NCT01111552|62672645|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
33295843|NCT01111552|62672641|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
33295844|NCT01111552|62672642|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
33295845|NCT01111552|62672643|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
33295846|NCT01111552|62672644|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
33295847|NCT01111552|62672645|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
33295848|NCT01111552|62672641|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
33383479|NCT00791999|62762483|FG002|Overall Study|Adverse Event|7|||
33383480|NCT00791999|62762484|FG003|Overall Study|Adverse Event|3|||
33383481|NCT00791999|62762481|FG000|Overall Study|Lack of Efficacy|0|||
33383482|NCT00791999|62762482|FG001|Overall Study|Lack of Efficacy|1|||
33383483|NCT00791999|62762483|FG002|Overall Study|Lack of Efficacy|0|||
33383484|NCT00791999|62762484|FG003|Overall Study|Lack of Efficacy|2|||
33383485|NCT00791999|62762481|FG000|Overall Study|Reason other than those above|1|||
33383486|NCT00791999|62762482|FG001|Overall Study|Reason other than those above|0|||
33383487|NCT00791999|62762483|FG002|Overall Study|Reason other than those above|1|||
33383488|NCT00791999|62762484|FG003|Overall Study|Reason other than those above|0|||
33383489|NCT00585078|62762498|FG000|Overall Study|Withdrawal by Subject|4|||
33383490|NCT00585078|62762498|FG000|Overall Study|Poor performance status|1|||
33383491|NCT00585078|62762498|FG000|Overall Study|Disease Progression|24|||
33383492|NCT00585078|62762498|FG000|Overall Study|Adverse Event|10|||
33383493|NCT00585078|62762498|FG000|Overall Study|Death|1|||
33383494|NCT00720876|62762502|FG000|Overall Study|found to be ineligible after starting tx|2|||
33383495|NCT00723840|62762506|FG000|Overall Study|Lost to Follow-up|2|||
33383496|NCT00723840|62762506|FG000|Overall Study|Failure to return|18|||
33383497|NCT00723840|62762506|FG000|Overall Study|Withdrawal by Subject|55|||
33383498|NCT00723840|62762506|FG000|Overall Study|Serious Adverse Events|3|||
33383499|NCT00723840|62762506|FG000|Overall Study|Other Medical Event|2|||
33383500|NCT00723840|62762506|FG000|Overall Study|Unspecified reason|2|||
33383501|NCT00789581|62762519|FG000|AC Therapy|Adverse Event|2|||
33383502|NCT00789581|62762520|FG001|AC Therapy|Adverse Event|3|||
33383503|NCT00789581|62762519|FG000|AC Therapy|Withdrawal by Subject|4|||
33383504|NCT00789581|62762520|FG001|AC Therapy|Withdrawal by Subject|7|||
33383505|NCT00789581|62762519|FG000|AC Therapy|Disease recurrence|3|||
33383506|NCT00789581|62762520|FG001|AC Therapy|Disease recurrence|1|||
33383507|NCT00789581|62762519|FG000|AC Therapy|Intercurrent Illness|1|||
33383508|NCT00789581|62762520|FG001|AC Therapy|Intercurrent Illness|0|||
33383509|NCT00789581|62762519|FG000|AC Therapy|Never Treated|1|||
33383510|NCT00789581|62762520|FG001|AC Therapy|Never Treated|4|||
33383511|NCT00789581|62762519|FG000|AC Therapy|Other|0|||
33383512|NCT00789581|62762520|FG001|AC Therapy|Other|2|||
33383513|NCT00789581|62762519|FG000|Adjuvant Therapy|Never treated|2|||
33383514|NCT00789581|62762520|FG001|Adjuvant Therapy|Never treated|2|||
33383515|NCT00789581|62762519|FG000|Adjuvant Therapy|Adverse Event|20|||
33383516|NCT00789581|62762520|FG001|Adjuvant Therapy|Adverse Event|44|||
33383517|NCT00789581|62762519|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
33383518|NCT00789581|62762520|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
33383519|NCT00789581|62762519|FG000|Adjuvant Therapy|Disease recurrence|2|||
33383520|NCT00789581|62762520|FG001|Adjuvant Therapy|Disease recurrence|1|||
33383521|NCT00789581|62762519|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
33383522|NCT00789581|62762520|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
33383523|NCT00789581|62762519|FG000|Adjuvant Therapy|Protocol Violation|1|||
33383524|NCT00789581|62762520|FG001|Adjuvant Therapy|Protocol Violation|1|||
33383525|NCT00789581|62762519|FG000|Adjuvant Therapy|Other|0|||
33383526|NCT00789581|62762520|FG001|Adjuvant Therapy|Other|1|||
33383527|NCT00717756|62762527|FG000|Overall Study|Withdrawal by Subject|1|||
33383528|NCT00717522|62762531|FG000|Overall Study|Disease Progression|5|||
33383529|NCT00717522|62762531|FG000|Overall Study|Adverse Event|1|||
33383530|NCT00717522|62762531|FG000|Overall Study|Death|1|||
33383531|NCT00791921|62762537|FG000|Overall Study|Protocol planed|24|||
33383532|NCT00791921|62762538|FG001|Overall Study|Protocol planed|88|||
33383533|NCT00791921|62762537|FG000|Overall Study|Withdrawal by Subject|1|||
33383534|NCT00791921|62762538|FG001|Overall Study|Withdrawal by Subject|2|||
33488503|NCT03567291|62866657|FG000|Period II|Adverse Event|0|||
33488504|NCT03567291|62866658|FG001|Period II|Adverse Event|1|||
33383535|NCT00791921|62762537|FG000|Overall Study|Adverse Event|8|||
33383536|NCT00791921|62762538|FG001|Overall Study|Adverse Event|2|||
33383537|NCT00791921|62762537|FG000|Overall Study|Lack of Efficacy|0|||
33383538|NCT00791921|62762538|FG001|Overall Study|Lack of Efficacy|2|||
33383539|NCT00791921|62762537|FG000|Overall Study|Lack of study drug administration|1|||
33383540|NCT00791921|62762538|FG001|Overall Study|Lack of study drug administration|1|||
33383541|NCT00791921|62762537|FG000|Overall Study|Reason other than those above|0|||
33383542|NCT00791921|62762538|FG001|Overall Study|Reason other than those above|1|||
33383543|NCT00582933|62762544|FG000|Overall Study|Physician Decision|3|||
33383544|NCT00791765|62762550|FG000|Weeks 1 to 12|Adverse Event|0|||
33383545|NCT00791765|62762551|FG001|Weeks 1 to 12|Adverse Event|1|||
33383546|NCT00791765|62762550|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
33383547|NCT00791765|62762551|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
33383548|NCT00791765|62762550|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
33383549|NCT00791765|62762551|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
33383550|NCT00791765|62762550|FG000|Weeks 1 to 12|Physician Decision|1|||
33383551|NCT00791765|62762551|FG001|Weeks 1 to 12|Physician Decision|0|||
33383552|NCT00791765|62762550|FG000|Weeks 1 to 12|Disease progression|3|||
33383553|NCT00791765|62762551|FG001|Weeks 1 to 12|Disease progression|0|||
33383554|NCT00791765|62762550|FG000|Weeks 1 to 12|Ineligibility determined|0|||
33383555|NCT00791765|62762551|FG001|Weeks 1 to 12|Ineligibility determined|3|||
33383556|NCT00791765|62762550|FG000|Weeks 13 to 24|Protocol deviation|2|||
33383557|NCT00791765|62762551|FG001|Weeks 13 to 24|Protocol deviation|0|||
33383558|NCT00791765|62762550|FG000|Weeks 13 to 24|Adverse Event|0|||
33383559|NCT00791765|62762551|FG001|Weeks 13 to 24|Adverse Event|3|||
33383560|NCT00791765|62762550|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
33383561|NCT00791765|62762551|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
33383562|NCT00791765|62762550|FG000|Weeks 13 to 24|Disease progression|0|||
33383563|NCT00791765|62762551|FG001|Weeks 13 to 24|Disease progression|1|||
33383564|NCT00791765|62762550|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
33383565|NCT00791765|62762551|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
33383566|NCT00791765|62762550|FG000|Weeks 13 to 24|Other|0|||
33295849|NCT01111552|62672642|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
33295850|NCT01111552|62672643|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
33295851|NCT01111552|62672644|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
33295852|NCT01111552|62672645|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
33295853|NCT01111552|62672641|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
33295854|NCT01111552|62672642|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
33295855|NCT01111552|62672643|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
33383567|NCT00791765|62762551|FG001|Weeks 13 to 24|Other|1|||
33383568|NCT00789191|62762559|FG000|Overall Study|Adverse Event|2|||
33383569|NCT00789191|62762560|FG001|Overall Study|Adverse Event|4|||
33383570|NCT00789191|62762559|FG000|Overall Study|Lack of Efficacy|0|||
33383571|NCT00789191|62762560|FG001|Overall Study|Lack of Efficacy|5|||
33383572|NCT00789191|62762559|FG000|Overall Study|Protocol Violation|5|||
33383573|NCT00789191|62762560|FG001|Overall Study|Protocol Violation|3|||
33383574|NCT00789191|62762559|FG000|Overall Study|Withdrawal Criteria|2|||
33383575|NCT00789191|62762560|FG001|Overall Study|Withdrawal Criteria|4|||
33383576|NCT00789191|62762559|FG000|Overall Study|Unclassified|5|||
33383577|NCT00789191|62762560|FG001|Overall Study|Unclassified|3|||
33383578|NCT00789035|62762571|FG000|Overall Study|Adverse Event|0|||
33383579|NCT00789035|62762572|FG001|Overall Study|Adverse Event|2|||
33383580|NCT00789035|62762573|FG002|Overall Study|Adverse Event|0|||
33383581|NCT00789035|62762574|FG003|Overall Study|Adverse Event|1|||
33383582|NCT00789035|62762575|FG004|Overall Study|Adverse Event|3|||
33383583|NCT00789035|62762571|FG000|Overall Study|Lack of Efficacy|3|||
33383584|NCT00789035|62762572|FG001|Overall Study|Lack of Efficacy|0|||
33383585|NCT00789035|62762573|FG002|Overall Study|Lack of Efficacy|0|||
33383586|NCT00789035|62762574|FG003|Overall Study|Lack of Efficacy|0|||
33383587|NCT00789035|62762575|FG004|Overall Study|Lack of Efficacy|2|||
33662573|NCT01587703|63093242|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33383588|NCT00789035|62762571|FG000|Overall Study|Protocol Violation|1|||
33383589|NCT00789035|62762572|FG001|Overall Study|Protocol Violation|0|||
33383590|NCT00789035|62762573|FG002|Overall Study|Protocol Violation|0|||
33383591|NCT00789035|62762574|FG003|Overall Study|Protocol Violation|0|||
33383592|NCT00789035|62762575|FG004|Overall Study|Protocol Violation|0|||
33383593|NCT00789035|62762571|FG000|Overall Study|Withdrawal by Subject|0|||
33383594|NCT00789035|62762572|FG001|Overall Study|Withdrawal by Subject|2|||
33383595|NCT00789035|62762573|FG002|Overall Study|Withdrawal by Subject|0|||
33488505|NCT03567291|62866659|FG002|Period II|Adverse Event|0|||
33488506|NCT03567291|62866660|FG003|Period II|Adverse Event|0|||
33488507|NCT03567291|62866657|FG000|Period II|Missing or unknown|0|||
33488508|NCT03567291|62866658|FG001|Period II|Missing or unknown|2|||
33488509|NCT03567291|62866659|FG002|Period II|Missing or unknown|1|||
33488510|NCT03567291|62866660|FG003|Period II|Missing or unknown|0|||
33295856|NCT01111552|62672644|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
33383596|NCT00789035|62762574|FG003|Overall Study|Withdrawal by Subject|0|||
33383597|NCT00789035|62762575|FG004|Overall Study|Withdrawal by Subject|0|||
33383598|NCT00789035|62762571|FG000|Overall Study|Other reason not defined above|2|||
33383599|NCT00789035|62762572|FG001|Overall Study|Other reason not defined above|3|||
33383600|NCT00789035|62762573|FG002|Overall Study|Other reason not defined above|1|||
33383601|NCT00789035|62762574|FG003|Overall Study|Other reason not defined above|0|||
33383602|NCT00789035|62762575|FG004|Overall Study|Other reason not defined above|1|||
33383603|NCT03326193|62762599|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
33488511|NCT03567291|62866657|FG000|Period III|Adverse Event|0|||
33383604|NCT03326193|62762599|FG000|Overall Study|Death|19|||
33383605|NCT03326193|62762599|FG000|Overall Study|Withdrawal by Subject|8|||
33488512|NCT03567291|62866658|FG001|Period III|Adverse Event|0|||
33383606|NCT00437203|62762622|FG000|Overall Study|Death|0|||
33383607|NCT00437203|62762623|FG001|Overall Study|Death|0|||
33383608|NCT00437203|62762624|FG002|Overall Study|Death|1|||
33383609|NCT00437203|62762625|FG003|Overall Study|Death|0|||
33383610|NCT00437203|62762626|FG004|Overall Study|Death|0|||
33383611|NCT00437203|62762627|FG005|Overall Study|Death|0|||
33383612|NCT00437203|62762628|FG006|Overall Study|Death|0|||
33383613|NCT00437203|62762629|FG007|Overall Study|Death|1|||
33383614|NCT00437203|62762630|FG008|Overall Study|Death|0|||
33383615|NCT00437203|62762631|FG009|Overall Study|Death|1|||
33383616|NCT00437203|62762622|FG000|Overall Study|Adverse Event|1|||
33383617|NCT00437203|62762623|FG001|Overall Study|Adverse Event|1|||
33383618|NCT00437203|62762624|FG002|Overall Study|Adverse Event|0|||
33383619|NCT00437203|62762625|FG003|Overall Study|Adverse Event|0|||
33383620|NCT00437203|62762626|FG004|Overall Study|Adverse Event|0|||
33383621|NCT00437203|62762627|FG005|Overall Study|Adverse Event|0|||
33295857|NCT01111552|62672645|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
33295858|NCT01111552|62672641|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33295859|NCT01111552|62672642|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33295860|NCT01111552|62672643|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
33295861|NCT01111552|62672644|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33295862|NCT01111552|62672645|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33383622|NCT00437203|62762628|FG006|Overall Study|Adverse Event|0|||
33383623|NCT00437203|62762629|FG007|Overall Study|Adverse Event|1|||
33383624|NCT00437203|62762630|FG008|Overall Study|Adverse Event|0|||
33383625|NCT00437203|62762631|FG009|Overall Study|Adverse Event|1|||
33383626|NCT00437203|62762622|FG000|Overall Study|Study terminated by sponsor|0|||
33383627|NCT00437203|62762623|FG001|Overall Study|Study terminated by sponsor|0|||
33383628|NCT00437203|62762624|FG002|Overall Study|Study terminated by sponsor|0|||
33383629|NCT00437203|62762625|FG003|Overall Study|Study terminated by sponsor|0|||
33295863|NCT01175083|62672661|FG000|Primary Epoch|Withdrawal by Subject|0|||
33295864|NCT01175083|62672662|FG001|Primary Epoch|Withdrawal by Subject|0|||
33295865|NCT01175083|62672663|FG002|Primary Epoch|Withdrawal by Subject|0|||
33295866|NCT01175083|62672664|FG003|Primary Epoch|Withdrawal by Subject|0|||
33295867|NCT01175083|62672665|FG004|Primary Epoch|Withdrawal by Subject|0|||
33295868|NCT01175083|62672666|FG005|Primary Epoch|Withdrawal by Subject|2|||
33295869|NCT01175083|62672661|FG000|Primary Epoch|Lost to Follow-up|0|||
33295870|NCT01175083|62672662|FG001|Primary Epoch|Lost to Follow-up|0|||
33295871|NCT01175083|62672663|FG002|Primary Epoch|Lost to Follow-up|0|||
33295872|NCT01175083|62672664|FG003|Primary Epoch|Lost to Follow-up|0|||
33295873|NCT01175083|62672665|FG004|Primary Epoch|Lost to Follow-up|0|||
33295874|NCT01175083|62672666|FG005|Primary Epoch|Lost to Follow-up|1|||
33383630|NCT00437203|62762626|FG004|Overall Study|Study terminated by sponsor|0|||
33383631|NCT00437203|62762627|FG005|Overall Study|Study terminated by sponsor|0|||
33383632|NCT00437203|62762628|FG006|Overall Study|Study terminated by sponsor|0|||
33383633|NCT00437203|62762629|FG007|Overall Study|Study terminated by sponsor|0|||
33295875|NCT01175083|62672661|FG000|Booster Epoch|Death|0|||
33295876|NCT01175083|62672662|FG001|Booster Epoch|Death|0|||
33295877|NCT01175083|62672663|FG002|Booster Epoch|Death|1|||
33295878|NCT01175083|62672664|FG003|Booster Epoch|Death|0|||
33295879|NCT01175083|62672665|FG004|Booster Epoch|Death|0|||
33295880|NCT01175083|62672666|FG005|Booster Epoch|Death|0|||
33295881|NCT01175083|62672661|FG000|Booster Epoch|Withdrawal by Subject|0|||
33295882|NCT01175083|62672662|FG001|Booster Epoch|Withdrawal by Subject|0|||
33295883|NCT01175083|62672663|FG002|Booster Epoch|Withdrawal by Subject|0|||
33295884|NCT01175083|62672664|FG003|Booster Epoch|Withdrawal by Subject|1|||
33295885|NCT01175083|62672665|FG004|Booster Epoch|Withdrawal by Subject|0|||
33295886|NCT01175083|62672666|FG005|Booster Epoch|Withdrawal by Subject|0|||
33383634|NCT00437203|62762630|FG008|Overall Study|Study terminated by sponsor|1|||
33383635|NCT00437203|62762631|FG009|Overall Study|Study terminated by sponsor|0|||
33383636|NCT00437203|62762622|FG000|Overall Study|Objective progression or relapse|5|||
33383637|NCT00437203|62762623|FG001|Overall Study|Objective progression or relapse|6|||
33383638|NCT00437203|62762624|FG002|Overall Study|Objective progression or relapse|2|||
33383639|NCT00437203|62762625|FG003|Overall Study|Objective progression or relapse|3|||
33383640|NCT00437203|62762626|FG004|Overall Study|Objective progression or relapse|3|||
33383641|NCT00437203|62762627|FG005|Overall Study|Objective progression or relapse|3|||
33383642|NCT00437203|62762628|FG006|Overall Study|Objective progression or relapse|6|||
33383643|NCT00437203|62762629|FG007|Overall Study|Objective progression or relapse|1|||
33383644|NCT00437203|62762630|FG008|Overall Study|Objective progression or relapse|2|||
33383645|NCT00437203|62762631|FG009|Overall Study|Objective progression or relapse|2|||
33383646|NCT00437203|62762622|FG000|Overall Study|Other|0|||
33295887|NCT01174459|62672684|FG000|Overall Study|case report form (CRF) not collected|5|||
33295888|NCT01174342|62672688|FG000|Overall Study|Conversion to cesarean section|4|||
33295889|NCT01111474|62672692|FG000|Overall Study|Lost to Follow-up|12|||
33295890|NCT01174264|62672701|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
33383647|NCT00437203|62762623|FG001|Overall Study|Other|1|||
33383648|NCT00437203|62762624|FG002|Overall Study|Other|0|||
33295891|NCT01174264|62672702|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
33295892|NCT01174264|62672703|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
33295893|NCT01174264|62672701|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
33295894|NCT01174264|62672702|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
33295895|NCT01174264|62672703|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
33295896|NCT01174264|62672701|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
33295897|NCT01174264|62672702|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
33295898|NCT01174264|62672703|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
33295899|NCT01174186|62672713|FG000|Overall Study|Lost to Follow-up|0|||
33295900|NCT01174186|62672714|FG001|Overall Study|Lost to Follow-up|1|||
33383649|NCT00437203|62762625|FG003|Overall Study|Other|0|||
33383650|NCT00437203|62762626|FG004|Overall Study|Other|0|||
33383651|NCT00437203|62762627|FG005|Overall Study|Other|0|||
33383652|NCT00437203|62762628|FG006|Overall Study|Other|1|||
33383653|NCT00437203|62762629|FG007|Overall Study|Other|0|||
33383654|NCT00437203|62762630|FG008|Overall Study|Other|0|||
33383655|NCT00437203|62762631|FG009|Overall Study|Other|0|||
33383656|NCT00753272|62762664|FG000|Overall Study|Adverse Event|878|||
33383657|NCT00753272|62762665|FG001|Overall Study|Adverse Event|869|||
33383658|NCT00753272|62762664|FG000|Overall Study|Protocol Violation|28|||
33383659|NCT00753272|62762665|FG001|Overall Study|Protocol Violation|46|||
33383660|NCT00753272|62762664|FG000|Overall Study|Withdrawal by Subject|2481|||
33383661|NCT00753272|62762665|FG001|Overall Study|Withdrawal by Subject|2407|||
33383662|NCT00753272|62762664|FG000|Overall Study|Lost to Follow-up|491|||
33383663|NCT00753272|62762665|FG001|Overall Study|Lost to Follow-up|497|||
33383664|NCT00753272|62762664|FG000|Overall Study|Other|1104|||
33383665|NCT00753272|62762665|FG001|Overall Study|Other|1088|||
33488513|NCT03567291|62866659|FG002|Period III|Adverse Event|0|||
33295901|NCT01174186|62672713|FG000|Overall Study|Withdrawal by Subject|0|||
33295902|NCT01174186|62672714|FG001|Overall Study|Withdrawal by Subject|2|||
33295903|NCT01173718|62672720|FG000|Overall Study|Death|17|||
33295904|NCT01173718|62672720|FG000|Overall Study|Abandonment of study graft|27|||
33295905|NCT01111240|62672724|FG000|Overall Study|Adverse Event|190|||
33295906|NCT01111240|62672724|FG000|Overall Study|Lack of Efficacy|545|||
33295907|NCT01111240|62672724|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
33295908|NCT01111240|62672724|FG000|Overall Study|Other|312|||
33295909|NCT01111123|62672730|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
33295910|NCT01111123|62672731|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
33295911|NCT01111123|62672730|FG000|Maintenance Phase|Lost to Follow-up|0|||
33295912|NCT01111123|62672731|FG001|Maintenance Phase|Lost to Follow-up|2|||
33295913|NCT01173679|62672739|FG000|Overall Study|Death|1|||
33295914|NCT01110382|62672746|FG000|Overall Study|Withdrawal by Subject|0|||
33295915|NCT01110382|62672747|FG001|Overall Study|Withdrawal by Subject|1|||
33295916|NCT01110382|62672746|FG000|Overall Study|Protocol Violation|0|||
33295917|NCT01110382|62672747|FG001|Overall Study|Protocol Violation|1|||
33295918|NCT01173601|62672757|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
33295919|NCT01173601|62672758|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33295920|NCT01173601|62672759|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33295921|NCT01173601|62672760|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33295922|NCT01173601|62672761|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33295923|NCT01173601|62672757|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
33295924|NCT01173601|62672758|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33295925|NCT01173601|62672759|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33295926|NCT01173601|62672760|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33295927|NCT01173601|62672761|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33295928|NCT01173601|62672757|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
33295929|NCT01173601|62672758|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33295930|NCT01173601|62672759|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33295931|NCT01173601|62672760|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33295932|NCT01173601|62672761|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33295933|NCT01173601|62672757|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
33295934|NCT01173601|62672758|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33488514|NCT03567291|62866660|FG003|Period III|Adverse Event|4|||
33556726|NCT02791763|62949552|FG002|Overall Study|Withdrawal by Subject|0|||
33383666|NCT00437125|62762674|FG000|Overall Study|Adverse Event|12|||
33295935|NCT01173601|62672759|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33295936|NCT01173601|62672760|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33295937|NCT01173601|62672761|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33295938|NCT01173601|62672757|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
33383667|NCT00437125|62762674|FG000|Overall Study|Death|1|||
33383668|NCT00437125|62762674|FG000|Overall Study|Clinical Relapse|1|||
33383669|NCT00437125|62762674|FG000|Overall Study|Lack of Efficacy|1|||
33383670|NCT00437125|62762674|FG000|Overall Study|Lost to Follow-up|1|||
33383671|NCT00437125|62762674|FG000|Overall Study|Withdrawal by Subject|13|||
33488515|NCT03567291|62866657|FG000|Period III|Withdrawal by Subject|0|||
33295939|NCT01173601|62672758|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33295940|NCT01173601|62672759|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33295941|NCT01173601|62672760|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33295942|NCT01173601|62672761|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33295943|NCT01173601|62672757|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
33295944|NCT01173601|62672758|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33295945|NCT01173601|62672759|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33295946|NCT01173601|62672760|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33295947|NCT01173601|62672761|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33295948|NCT01173601|62672757|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
33295949|NCT01173601|62672758|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33295950|NCT01173601|62672759|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33295951|NCT01173601|62672760|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33383672|NCT00437125|62762674|FG000|Overall Study|Withdrawal by Caregiver|2|||
33383673|NCT00437125|62762674|FG000|Overall Study|Physician Decision|1|||
33383674|NCT00582309|62762690|FG000|Overall Study|Protocol Violation|0|||
33383675|NCT00582309|62762691|FG001|Overall Study|Protocol Violation|0|||
33383676|NCT00582309|62762692|FG002|Overall Study|Protocol Violation|2|||
33383677|NCT00443053|62762702|FG000|Overall Study|Adverse Event|2|||
33383678|NCT00443053|62762703|FG001|Overall Study|Adverse Event|1|||
33383679|NCT00443053|62762702|FG000|Overall Study|Withdrawal by Subject|9|||
33383680|NCT00443053|62762703|FG001|Overall Study|Withdrawal by Subject|18|||
33383681|NCT00443053|62762702|FG000|Overall Study|Lost to Follow-up|4|||
33383682|NCT00443053|62762703|FG001|Overall Study|Lost to Follow-up|5|||
33383683|NCT00443053|62762702|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
33383684|NCT00443053|62762703|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
33383685|NCT00443053|62762702|FG000|Overall Study|Noncompliance|2|||
33383686|NCT00443053|62762703|FG001|Overall Study|Noncompliance|1|||
33383687|NCT00443053|62762702|FG000|Overall Study|Other|3|||
33383688|NCT00443053|62762703|FG001|Overall Study|Other|4|||
33383689|NCT00443053|62762702|FG000|Overall Study|Physician Decision|0|||
33383690|NCT00443053|62762703|FG001|Overall Study|Physician Decision|4|||
33383691|NCT00720798|62762709|FG000|Overall Study|Adverse Event|304|||
33383692|NCT00720798|62762709|FG000|Overall Study|Death|39|||
33383693|NCT00720798|62762709|FG000|Overall Study|Insufficient Therapeutic Response|129|||
33383694|NCT00720798|62762709|FG000|Overall Study|Protocol Violation|4|||
33383695|NCT00720798|62762709|FG000|Overall Study|Refused Treatment|151|||
33383696|NCT00720798|62762709|FG000|Overall Study|Failure to Return|46|||
33383697|NCT00720798|62762709|FG000|Overall Study|Reason not Specified|83|||
33383698|NCT00756002|62762719|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
33383699|NCT00756002|62762720|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
33383700|NCT00756002|62762719|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33383701|NCT00756002|62762720|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
33383702|NCT00756002|62762719|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
33383703|NCT00756002|62762720|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
33383704|NCT00756002|62762719|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
33383705|NCT00756002|62762720|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
33383706|NCT00756002|62762719|FG000|Double-Blind Treatment Period|Other|2|||
33383707|NCT00756002|62762720|FG001|Double-Blind Treatment Period|Other|2|||
33383708|NCT00717366|62762728|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
33383709|NCT00717366|62762729|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
33383710|NCT00717366|62762728|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
33383711|NCT00717366|62762729|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
33383712|NCT00717366|62762728|FG000|Core Study Period (20 Weeks)|Death|0|||
33383713|NCT00717366|62762729|FG001|Core Study Period (20 Weeks)|Death|1|||
33383714|NCT00717366|62762728|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
33383715|NCT00717366|62762729|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
33383716|NCT00717366|62762728|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
33383717|NCT00717366|62762729|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
33662574|NCT01587703|63093243|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33295952|NCT01173601|62672761|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33295953|NCT01173601|62672757|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
33295954|NCT01173601|62672758|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
33295955|NCT01173601|62672759|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
33295956|NCT01173601|62672760|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
33295957|NCT01173601|62672761|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
33383718|NCT00717366|62762728|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
33383719|NCT00717366|62762729|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
33383720|NCT00717366|62762728|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
33383721|NCT00717366|62762729|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
33383722|NCT00723606|62762748|FG000|Overall Study|Adverse Event|2|||
33383723|NCT00723606|62762749|FG001|Overall Study|Adverse Event|5|||
33383724|NCT00723606|62762748|FG000|Overall Study|Other|2|||
33295958|NCT01173601|62672757|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
33295959|NCT01173601|62672758|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
33295960|NCT01173601|62672759|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
33295961|NCT01173601|62672760|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
33295962|NCT01173601|62672761|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
33295963|NCT01173601|62672757|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
33295964|NCT01173601|62672758|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
33295965|NCT01173601|62672759|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
33295966|NCT01173601|62672760|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
33295967|NCT01173601|62672761|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
33383725|NCT00723606|62762749|FG001|Overall Study|Other|0|||
33383726|NCT00723606|62762748|FG000|Overall Study|Withdrawal by Subject|0|||
33383727|NCT00723606|62762749|FG001|Overall Study|Withdrawal by Subject|2|||
33383728|NCT00442351|62762757|FG000|Overall Study|Administrative|6|||
33383729|NCT00442351|62762758|FG001|Overall Study|Administrative|5|||
33383730|NCT00442351|62762757|FG000|Overall Study|Did not meet protocol eligibility|1|||
33383731|NCT00442351|62762758|FG001|Overall Study|Did not meet protocol eligibility|0|||
33383732|NCT00442351|62762757|FG000|Overall Study|Other|0|||
33383733|NCT00442351|62762758|FG001|Overall Study|Other|1|||
33383734|NCT00436501|62762766|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
33383735|NCT00436501|62762767|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
33383736|NCT00436501|62762766|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
33383737|NCT00436501|62762767|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
33383738|NCT00755846|62762780|FG000|Overall Study|Adverse Event|0|||
33383739|NCT00755846|62762781|FG001|Overall Study|Adverse Event|0|||
33383740|NCT00755846|62762782|FG002|Overall Study|Adverse Event|0|||
33383741|NCT00755846|62762783|FG003|Overall Study|Adverse Event|1|||
33383742|NCT00755846|62762784|FG004|Overall Study|Adverse Event|3|||
33383743|NCT00755846|62762785|FG005|Overall Study|Adverse Event|2|||
33383744|NCT00755846|62762780|FG000|Overall Study|Protocol Violation|1|||
33383745|NCT00755846|62762781|FG001|Overall Study|Protocol Violation|1|||
33383746|NCT00755846|62762782|FG002|Overall Study|Protocol Violation|1|||
33383747|NCT00755846|62762783|FG003|Overall Study|Protocol Violation|1|||
33383748|NCT00755846|62762784|FG004|Overall Study|Protocol Violation|1|||
33383749|NCT00755846|62762785|FG005|Overall Study|Protocol Violation|1|||
33383750|NCT00755846|62762780|FG000|Overall Study|Lost to Follow-up|0|||
33383751|NCT00755846|62762781|FG001|Overall Study|Lost to Follow-up|2|||
33383752|NCT00755846|62762782|FG002|Overall Study|Lost to Follow-up|1|||
33383753|NCT00755846|62762783|FG003|Overall Study|Lost to Follow-up|0|||
33383754|NCT00755846|62762784|FG004|Overall Study|Lost to Follow-up|4|||
33295968|NCT01173601|62672757|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
33295969|NCT01173601|62672758|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
33295970|NCT01173601|62672759|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
33295971|NCT01173601|62672760|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
33295972|NCT01173601|62672761|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
33295973|NCT01173601|62672757|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
33295974|NCT01173601|62672758|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
33295975|NCT01173601|62672759|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
33295976|NCT01173601|62672760|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
33295977|NCT01173601|62672761|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
33295978|NCT01173601|62672757|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
33295979|NCT01173601|62672758|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
33295980|NCT01173601|62672759|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
33295981|NCT01173601|62672760|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
33295982|NCT01173601|62672761|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
33295983|NCT01173601|62672757|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
33295984|NCT01173601|62672758|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
33295985|NCT01173601|62672759|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
33295986|NCT01173601|62672760|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
33383755|NCT00755846|62762785|FG005|Overall Study|Lost to Follow-up|2|||
33383756|NCT00755846|62762780|FG000|Overall Study|Withdrawal by Subject|2|||
33383757|NCT00755846|62762781|FG001|Overall Study|Withdrawal by Subject|3|||
33295987|NCT01173601|62672761|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
33383758|NCT00755846|62762782|FG002|Overall Study|Withdrawal by Subject|5|||
33383759|NCT00755846|62762783|FG003|Overall Study|Withdrawal by Subject|2|||
33383760|NCT00755846|62762784|FG004|Overall Study|Withdrawal by Subject|0|||
33383761|NCT00755846|62762785|FG005|Overall Study|Withdrawal by Subject|1|||
33383762|NCT00755846|62762780|FG000|Overall Study|Hyperglycemic Rescue|21|||
33383763|NCT00755846|62762781|FG001|Overall Study|Hyperglycemic Rescue|7|||
33383764|NCT00755846|62762782|FG002|Overall Study|Hyperglycemic Rescue|5|||
33295988|NCT01173523|62672781|FG000|Overall Study|Clinical Progression|1|||
33295989|NCT01173523|62672782|FG001|Overall Study|Clinical Progression|1|||
33295990|NCT01173523|62672781|FG000|Overall Study|Progressive Disease|10|||
33295991|NCT01173523|62672782|FG001|Overall Study|Progressive Disease|8|||
33295992|NCT01173523|62672781|FG000|Overall Study|Other|2|||
33295993|NCT01173523|62672782|FG001|Overall Study|Other|3|||
33295994|NCT01173055|62672790|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
33295995|NCT01173055|62672791|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
33295996|NCT01173055|62672790|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
33295997|NCT01173055|62672791|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
33295998|NCT01172938|62672800|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
33295999|NCT01172938|62672801|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
33296000|NCT01172938|62672802|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
33296001|NCT01172938|62672803|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33296002|NCT01172938|62672804|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33296003|NCT01172938|62672805|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33296004|NCT01172938|62672806|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33296005|NCT01172938|62672807|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33296006|NCT01172938|62672808|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33296007|NCT01172938|62672800|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
33296008|NCT01172938|62672801|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
33296009|NCT01172938|62672802|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
33296010|NCT01172938|62672803|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33296011|NCT01172938|62672804|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33296012|NCT01172938|62672805|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33296013|NCT01172938|62672806|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33296014|NCT01172938|62672807|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33296015|NCT01172938|62672808|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33296016|NCT01172938|62672800|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33296017|NCT01172938|62672801|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
33296018|NCT01172938|62672802|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
33296019|NCT01172938|62672803|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33296020|NCT01172938|62672804|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33296021|NCT01172938|62672805|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33296022|NCT01172938|62672806|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33296023|NCT01172938|62672807|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33296024|NCT01172938|62672808|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33296025|NCT01172938|62672800|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
33296026|NCT01172938|62672801|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
33296027|NCT01172938|62672802|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
33296028|NCT01172938|62672803|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33296029|NCT01172938|62672804|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33296030|NCT01172938|62672805|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33296031|NCT01172938|62672806|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33296032|NCT01172938|62672807|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33296033|NCT01172938|62672808|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33296034|NCT01172938|62672800|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
33296035|NCT01172938|62672801|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
33296036|NCT01172938|62672802|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
33296037|NCT01172938|62672803|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
33296038|NCT01172938|62672804|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
33296039|NCT01172938|62672805|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
33296040|NCT01172938|62672806|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
33296041|NCT01172938|62672807|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
33296042|NCT01172938|62672808|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
33296043|NCT01172938|62672800|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
33296044|NCT01172938|62672801|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33296045|NCT01172938|62672802|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33296046|NCT01172938|62672803|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33296047|NCT01172938|62672804|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33296048|NCT01172938|62672805|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33296049|NCT01172938|62672806|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33296050|NCT01172938|62672807|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33296051|NCT01172938|62672808|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33296052|NCT01172938|62672800|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
33296053|NCT01172938|62672801|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
33296054|NCT01172938|62672802|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
33296055|NCT01172938|62672803|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
33383765|NCT00755846|62762783|FG003|Overall Study|Hyperglycemic Rescue|8|||
33383766|NCT00755846|62762784|FG004|Overall Study|Hyperglycemic Rescue|8|||
33383767|NCT00755846|62762785|FG005|Overall Study|Hyperglycemic Rescue|7|||
33383768|NCT00755846|62762780|FG000|Overall Study|Physician Decision|1|||
33383769|NCT00755846|62762781|FG001|Overall Study|Physician Decision|3|||
33383770|NCT00755846|62762782|FG002|Overall Study|Physician Decision|0|||
33383771|NCT00755846|62762783|FG003|Overall Study|Physician Decision|1|||
33383772|NCT00755846|62762784|FG004|Overall Study|Physician Decision|0|||
33383773|NCT00755846|62762785|FG005|Overall Study|Physician Decision|1|||
33383774|NCT00755846|62762780|FG000|Overall Study|Administrative Error|0|||
33383775|NCT00755846|62762781|FG001|Overall Study|Administrative Error|1|||
33383776|NCT00755846|62762782|FG002|Overall Study|Administrative Error|0|||
33383777|NCT00755846|62762783|FG003|Overall Study|Administrative Error|0|||
33383778|NCT00755846|62762784|FG004|Overall Study|Administrative Error|0|||
33383779|NCT00755846|62762785|FG005|Overall Study|Administrative Error|0|||
33383780|NCT00755846|62762780|FG000|Overall Study|Participant Non-compliance|0|||
33383781|NCT00755846|62762781|FG001|Overall Study|Participant Non-compliance|0|||
33383782|NCT00755846|62762782|FG002|Overall Study|Participant Non-compliance|0|||
33383783|NCT00755846|62762783|FG003|Overall Study|Participant Non-compliance|0|||
33383784|NCT00755846|62762784|FG004|Overall Study|Participant Non-compliance|1|||
33383785|NCT00755846|62762785|FG005|Overall Study|Participant Non-compliance|0|||
33383786|NCT03850093|62762802|FG000|Overall Study|Withdrawal by Subject|1|||
33383787|NCT03850093|62762803|FG001|Overall Study|Withdrawal by Subject|0|||
33383788|NCT03850093|62762804|FG002|Overall Study|Withdrawal by Subject|2|||
33383789|NCT00442117|62762814|FG000|Overall Study|Adverse Event|3|||
33383790|NCT00442117|62762815|FG001|Overall Study|Adverse Event|2|||
33383791|NCT00442117|62762814|FG000|Overall Study|Lack of Efficacy|2|||
33383792|NCT00442117|62762815|FG001|Overall Study|Lack of Efficacy|6|||
33383793|NCT00442117|62762814|FG000|Overall Study|Lost to Follow-up|1|||
33383794|NCT00442117|62762815|FG001|Overall Study|Lost to Follow-up|2|||
33383795|NCT00442117|62762814|FG000|Overall Study|Withdrawal by Subject|2|||
33383796|NCT00442117|62762815|FG001|Overall Study|Withdrawal by Subject|2|||
33383797|NCT00442117|62762814|FG000|Overall Study|Major Deviation|25|||
33383798|NCT00442117|62762815|FG001|Overall Study|Major Deviation|20|||
33383799|NCT00442117|62762814|FG000|Overall Study|Non compliance with protocol|3|||
33383800|NCT00442117|62762815|FG001|Overall Study|Non compliance with protocol|5|||
33383801|NCT00442117|62762814|FG000|Overall Study|Met Withdrawal Criteria|2|||
33383802|NCT00442117|62762815|FG001|Overall Study|Met Withdrawal Criteria|1|||
33383803|NCT00752726|62762823|FG000|Overall Study|Lost to Follow-up|2|||
33383804|NCT00752726|62762824|FG001|Overall Study|Lost to Follow-up|1|||
33383805|NCT00752726|62762823|FG000|Overall Study|Adverse Event|3|||
33383806|NCT00752726|62762824|FG001|Overall Study|Adverse Event|0|||
33383807|NCT00752726|62762823|FG000|Overall Study|Withdrawal by Subject|5|||
33383808|NCT00752726|62762824|FG001|Overall Study|Withdrawal by Subject|10|||
33383809|NCT00752726|62762823|FG000|Overall Study|Other Reason|1|||
33383810|NCT00752726|62762824|FG001|Overall Study|Other Reason|2|||
33383811|NCT00755222|62762832|FG000|Overall Study|Withdrawal by Subject|4|||
33383812|NCT00755222|62762833|FG001|Overall Study|Withdrawal by Subject|2|||
33383813|NCT00755222|62762832|FG000|Overall Study|Adverse Event|2|||
33383814|NCT00755222|62762833|FG001|Overall Study|Adverse Event|0|||
33383815|NCT00755222|62762832|FG000|Overall Study|Protocol Violation|2|||
33383816|NCT00755222|62762833|FG001|Overall Study|Protocol Violation|0|||
33488516|NCT03567291|62866658|FG001|Period III|Withdrawal by Subject|0|||
33296056|NCT01172938|62672804|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
33296057|NCT01172938|62672805|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
33296058|NCT01172938|62672806|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
33296059|NCT01172938|62672807|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
33296060|NCT01172938|62672808|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
33296061|NCT01172938|62672800|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
33296062|NCT01172938|62672801|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
33383817|NCT00441727|62762842|FG000|Overall Study|Protocol Violation|19|||
33383818|NCT00441727|62762843|FG001|Overall Study|Protocol Violation|28|||
33383819|NCT00441727|62762844|FG002|Overall Study|Protocol Violation|32|||
33488517|NCT03567291|62866659|FG002|Period III|Withdrawal by Subject|0|||
33296063|NCT01172938|62672802|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
33383820|NCT00441727|62762842|FG000|Overall Study|Adverse Event|26|||
33383821|NCT00441727|62762843|FG001|Overall Study|Adverse Event|33|||
33383822|NCT00441727|62762844|FG002|Overall Study|Adverse Event|28|||
33383823|NCT00441727|62762842|FG000|Overall Study|Lack of Efficacy|7|||
33383824|NCT00441727|62762843|FG001|Overall Study|Lack of Efficacy|8|||
33383825|NCT00441727|62762844|FG002|Overall Study|Lack of Efficacy|48|||
33383826|NCT00441727|62762842|FG000|Overall Study|Withdrawal by Subject|40|||
33383827|NCT00441727|62762843|FG001|Overall Study|Withdrawal by Subject|34|||
33383828|NCT00441727|62762844|FG002|Overall Study|Withdrawal by Subject|47|||
33383829|NCT00441727|62762842|FG000|Overall Study|Lost to Follow-up|5|||
33296064|NCT01172938|62672803|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
33296065|NCT01172938|62672804|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
33296066|NCT01172938|62672805|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
33296067|NCT01172938|62672806|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
33296068|NCT01172938|62672807|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
33296069|NCT01172938|62672808|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
33296070|NCT01172938|62672800|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
33296071|NCT01172938|62672801|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
33296072|NCT01172938|62672802|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
33296073|NCT01172938|62672803|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
33296074|NCT01172938|62672804|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
33383830|NCT00441727|62762843|FG001|Overall Study|Lost to Follow-up|6|||
33383831|NCT00441727|62762844|FG002|Overall Study|Lost to Follow-up|5|||
33383832|NCT00441727|62762842|FG000|Overall Study|Safety Reasons|3|||
33383833|NCT00441727|62762843|FG001|Overall Study|Safety Reasons|1|||
33383834|NCT00441727|62762844|FG002|Overall Study|Safety Reasons|3|||
33383835|NCT00441727|62762842|FG000|Overall Study|Various reason specified|6|||
33383836|NCT00441727|62762843|FG001|Overall Study|Various reason specified|8|||
33383837|NCT00441727|62762844|FG002|Overall Study|Various reason specified|5|||
33383838|NCT00770120|62762866|FG000|Overall Study|Progression|31|||
33383839|NCT00770120|62762866|FG000|Overall Study|Adverse Event|11|||
33383840|NCT00770120|62762866|FG000|Overall Study|Not Protocol Specified|11|||
33383841|NCT00770120|62762866|FG000|Overall Study|Death|3|||
33383842|NCT00770120|62762866|FG000|Overall Study|Withdrawal by Subject|2|||
33383843|NCT00770120|62762866|FG000|Overall Study|Ineligible|1|||
33383844|NCT00770120|62762866|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
33383845|NCT00770120|62762866|FG000|Overall Study|Reason under Review|1|||
33383846|NCT00436345|62762873|FG000|Overall Study|ICU resident beyond follow-up period|3|||
33383847|NCT00436345|62762874|FG001|Overall Study|ICU resident beyond follow-up period|0|||
33383848|NCT00769184|62762881|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
33383849|NCT00769184|62762882|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
33383850|NCT00769184|62762881|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
33383851|NCT00769184|62762882|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
33383852|NCT00769184|62762881|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
33383853|NCT00769184|62762882|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
33383854|NCT00768560|62762896|FG000|Intervention Set 1|Adverse Event|0|||
33383855|NCT00768560|62762897|FG001|Intervention Set 1|Adverse Event|1|||
33383856|NCT00768560|62762898|FG002|Intervention Set 1|Adverse Event|0|||
33383857|NCT00768560|62762899|FG003|Intervention Set 1|Adverse Event|0|||
33383858|NCT00768560|62762900|FG004|Intervention Set 1|Adverse Event|0|||
33383859|NCT00768560|62762901|FG005|Intervention Set 1|Adverse Event|0|||
33383860|NCT00468559|62762911|FG000|Open-label Treatment Phase|Adverse Event|5|||
33383861|NCT00468559|62762912|FG001|Open-label Treatment Phase|Adverse Event|0|||
33383862|NCT00468559|62762913|FG002|Open-label Treatment Phase|Adverse Event|0|||
33383863|NCT00468559|62762911|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
33383864|NCT00468559|62762912|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
33383865|NCT00468559|62762913|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
33383866|NCT00468559|62762911|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
33383867|NCT00468559|62762912|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
33383868|NCT00468559|62762913|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
33383869|NCT00468559|62762911|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
33383870|NCT00468559|62762912|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
33383871|NCT00468559|62762913|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
33383872|NCT00468559|62762911|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
33383873|NCT00468559|62762912|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
33383874|NCT00468559|62762913|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
33383875|NCT00754442|62762923|FG000|Overall Study|Withdrawal by Subject|5|||
33383876|NCT00754442|62762924|FG001|Overall Study|Withdrawal by Subject|3|||
33383877|NCT00754052|62762933|FG000|Overall Study|Study terminated by Sponsor|5|||
33383878|NCT00754052|62762934|FG001|Overall Study|Study terminated by Sponsor|3|||
33383879|NCT00747812|62762942|FG000|Overall Study|Research Site Staff Relocation|5|||
33383880|NCT00747812|62762943|FG001|Overall Study|Research Site Staff Relocation|3|||
33383881|NCT02927067|62762951|FG000|Overall Study|Withdrawn Consent|20|||
33383882|NCT02927067|62762952|FG001|Overall Study|Withdrawn Consent|12|||
33383883|NCT02927067|62762951|FG000|Overall Study|Death|18|||
33556727|NCT02791763|62949550|FG000|Overall Study|Physician Decision|0|||
33383884|NCT02927067|62762952|FG001|Overall Study|Death|31|||
33383885|NCT02927067|62762951|FG000|Overall Study|Adverse Event|13|||
33383886|NCT02927067|62762952|FG001|Overall Study|Adverse Event|10|||
33383887|NCT02927067|62762951|FG000|Overall Study|Noncompliance|5|||
33383888|NCT02927067|62762952|FG001|Overall Study|Noncompliance|2|||
33383889|NCT02927067|62762951|FG000|Overall Study|Reason not Specified|4|||
33488518|NCT03567291|62866660|FG003|Period III|Withdrawal by Subject|4|||
33296075|NCT01172938|62672805|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
33383890|NCT02927067|62762952|FG001|Overall Study|Reason not Specified|6|||
33383891|NCT01751685|62762962|FG000|6-mo Followup|Missed study visit|1|||
33383892|NCT01751685|62762963|FG001|6-mo Followup|Missed study visit|0|||
33383893|NCT01751685|62762962|FG000|6-mo Followup|Withdrawal by Subject|2|||
33383894|NCT01751685|62762963|FG001|6-mo Followup|Withdrawal by Subject|2|||
33383895|NCT01751685|62762962|FG000|6-mo Followup|Lost to Follow-up|0|||
33383896|NCT01751685|62762963|FG001|6-mo Followup|Lost to Follow-up|1|||
33296076|NCT01172938|62672806|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
33296077|NCT01172938|62672807|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
33296078|NCT01172938|62672808|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
33296079|NCT01172938|62672800|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33296080|NCT01172938|62672801|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33296081|NCT01172938|62672802|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
33296082|NCT01172938|62672803|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33383897|NCT01751685|62762962|FG000|12-mo Followup|Lost to Follow-up|5|||
33383898|NCT01751685|62762963|FG001|12-mo Followup|Lost to Follow-up|0|||
33296083|NCT01172938|62672804|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33296084|NCT01172938|62672805|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33383899|NCT00586508|62762971|FG000|Overall Study|Progressive disease|52|||
33383900|NCT00586508|62762972|FG001|Overall Study|Progressive disease|8|||
33383901|NCT00586508|62762971|FG000|Overall Study|Death|0|||
33383902|NCT00586508|62762972|FG001|Overall Study|Death|1|||
33383903|NCT00586508|62762971|FG000|Overall Study|Adverse Event|12|||
33383904|NCT00586508|62762972|FG001|Overall Study|Adverse Event|4|||
33383905|NCT00586508|62762971|FG000|Overall Study|Withdrawal by Subject|4|||
33383906|NCT00586508|62762972|FG001|Overall Study|Withdrawal by Subject|0|||
33383907|NCT00581919|62762978|FG000|Overall Study|Adverse Event|8|||
33383908|NCT00581919|62762978|FG000|Overall Study|Death|1|||
33383909|NCT00581919|62762978|FG000|Overall Study|Disease Progression|10|||
33383910|NCT00581919|62762978|FG000|Overall Study|Physician Decision|1|||
33383911|NCT00581919|62762978|FG000|Overall Study|Other Complicating Disease|1|||
33383912|NCT00581919|62762978|FG000|Overall Study|Started Non-Protocol Therapy|2|||
33383913|NCT00581919|62762978|FG000|Overall Study|Withdrawal by Subject|1|||
33383914|NCT00723528|62762986|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
33383915|NCT00723528|62762987|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
33383916|NCT00723528|62762988|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
33383917|NCT00723528|62762989|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
33383918|NCT00723528|62762990|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
33383919|NCT00723528|62762991|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
33383920|NCT00723528|62762992|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
33383921|NCT00723528|62762986|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
33383922|NCT00723528|62762987|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
33383923|NCT00723528|62762988|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
33488519|NCT03567291|62866657|FG000|Period III|Lost to Follow-up|0|||
33488520|NCT03567291|62866658|FG001|Period III|Lost to Follow-up|0|||
33488521|NCT03567291|62866659|FG002|Period III|Lost to Follow-up|0|||
33488522|NCT03567291|62866660|FG003|Period III|Lost to Follow-up|1|||
33488523|NCT03567291|62866657|FG000|Period III|Terminated by sponsor|0|||
33488524|NCT03567291|62866658|FG001|Period III|Terminated by sponsor|0|||
33488525|NCT03567291|62866659|FG002|Period III|Terminated by sponsor|0|||
33488526|NCT03567291|62866660|FG003|Period III|Terminated by sponsor|68|||
33488527|NCT03567291|62866657|FG000|Period III|Missing or unknown|0|||
33488528|NCT03567291|62866658|FG001|Period III|Missing or unknown|0|||
33296085|NCT01172938|62672806|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33296086|NCT01172938|62672807|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33296087|NCT01172938|62672808|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33296088|NCT01172938|62672800|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
33296089|NCT01172938|62672801|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
33296090|NCT01172938|62672802|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
33296091|NCT01172938|62672803|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
33383924|NCT00723528|62762989|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
33383925|NCT00723528|62762990|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
33383926|NCT00723528|62762991|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
33383927|NCT00723528|62762992|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
33383928|NCT00723528|62762986|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
33383929|NCT00723528|62762987|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
33383930|NCT00723528|62762988|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
33488529|NCT03567291|62866659|FG002|Period III|Missing or unknown|0|||
33556728|NCT02791763|62949551|FG001|Overall Study|Physician Decision|1|||
33488530|NCT03567291|62866660|FG003|Period III|Missing or unknown|8|||
33296092|NCT01172938|62672804|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
33296093|NCT01172938|62672805|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
33296094|NCT01172938|62672806|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
33296095|NCT01172938|62672807|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
33296096|NCT01172938|62672808|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
33296097|NCT01172938|62672800|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
33296098|NCT01172938|62672801|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
33296099|NCT01172938|62672802|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
33296100|NCT01172938|62672803|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
33296101|NCT01172938|62672804|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
33296102|NCT01172938|62672805|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
33296103|NCT01172938|62672806|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
33296104|NCT01172938|62672807|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
33296105|NCT01172938|62672808|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
33296106|NCT01172938|62672800|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
33296107|NCT01172938|62672801|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
33296108|NCT01172938|62672802|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
33296109|NCT01172938|62672803|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
33296110|NCT01172938|62672804|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
33296111|NCT01172938|62672805|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
33296112|NCT01172938|62672806|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
33296113|NCT01172938|62672807|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
33296114|NCT01172938|62672808|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
33296115|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
33296116|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
33296117|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
33296118|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
33296119|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
33296120|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
33296121|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
33296122|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
33296123|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
33296124|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
33296125|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
33296126|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
33296127|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
33296128|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
33296129|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
33296130|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
33296131|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
33296132|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
33296133|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33296134|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33296135|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
33383931|NCT00723528|62762989|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
33383932|NCT00723528|62762990|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
33383933|NCT00723528|62762991|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
33383934|NCT00723528|62762992|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
33383935|NCT00723528|62762986|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
33383936|NCT00723528|62762987|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
33488531|NCT02777242|62866666|FG000|Overall Study|Other|2|||
33488532|NCT02777242|62866666|FG000|Overall Study|Lost to Follow-up|1|||
33488533|NCT02777242|62866666|FG000|Overall Study|Multiple|1|||
33488534|NCT02777242|62866666|FG000|Overall Study|Sponsor's request|1|||
33488535|NCT02777242|62866666|FG000|Overall Study|Withdrawal by Subject|1|||
33488536|NCT03212144|62866672|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
33488537|NCT03212144|62866673|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
33488538|NCT03212144|62866672|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
33488539|NCT03212144|62866673|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
33488540|NCT03566979|62866683|FG000|Overall Study|Withdrawal by Subject|2|||
33488541|NCT03566979|62866684|FG001|Overall Study|Withdrawal by Subject|0|||
33296136|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33383937|NCT00723528|62762988|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
33383938|NCT00723528|62762989|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
33488542|NCT03566979|62866685|FG002|Overall Study|Withdrawal by Subject|1|||
33488543|NCT03566979|62866686|FG003|Overall Study|Withdrawal by Subject|1|||
33488544|NCT03566979|62866683|FG000|Overall Study|Lost to Follow-up|2|||
33383939|NCT00723528|62762990|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
33383940|NCT00723528|62762991|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
33383941|NCT00723528|62762992|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
33383942|NCT00723528|62762986|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
33383943|NCT00723528|62762987|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
33383944|NCT00723528|62762988|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
33383945|NCT00723528|62762989|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
33383946|NCT00723528|62762990|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
33383947|NCT00723528|62762991|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
33383948|NCT00723528|62762992|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
33383949|NCT00723528|62762986|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
33383950|NCT00723528|62762987|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
33383951|NCT00723528|62762988|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
33383952|NCT00723528|62762989|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
33383953|NCT00723528|62762990|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
33383954|NCT00723528|62762991|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
33383955|NCT00723528|62762992|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
33383956|NCT00723528|62762986|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
33383957|NCT00723528|62762987|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
33383958|NCT00723528|62762988|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
33383959|NCT00723528|62762989|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
33383960|NCT00723528|62762990|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
33383961|NCT00723528|62762991|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
33383962|NCT00723528|62762992|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
33383963|NCT00723528|62762986|FG000|Period 2: After Controlled Period|Other|0|||
33383964|NCT00723528|62762987|FG001|Period 2: After Controlled Period|Other|0|||
33383965|NCT00723528|62762988|FG002|Period 2: After Controlled Period|Other|0|||
33383966|NCT00723528|62762989|FG003|Period 2: After Controlled Period|Other|0|||
33383967|NCT00723528|62762990|FG004|Period 2: After Controlled Period|Other|1|||
33383968|NCT00723528|62762991|FG005|Period 2: After Controlled Period|Other|4|||
33383969|NCT00723528|62762992|FG006|Period 2: After Controlled Period|Other|0|||
33383970|NCT00723528|62762986|FG000|Period 2: After Controlled Period|Adverse Event|0|||
33383971|NCT00723528|62762987|FG001|Period 2: After Controlled Period|Adverse Event|0|||
33296137|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33296138|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33296139|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33296140|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33383972|NCT00723528|62762988|FG002|Period 2: After Controlled Period|Adverse Event|0|||
33383973|NCT00723528|62762989|FG003|Period 2: After Controlled Period|Adverse Event|0|||
33383974|NCT00723528|62762990|FG004|Period 2: After Controlled Period|Adverse Event|1|||
33383975|NCT00723528|62762991|FG005|Period 2: After Controlled Period|Adverse Event|0|||
33488545|NCT03566979|62866684|FG001|Overall Study|Lost to Follow-up|7|||
33488546|NCT03566979|62866685|FG002|Overall Study|Lost to Follow-up|9|||
33488547|NCT03566979|62866686|FG003|Overall Study|Lost to Follow-up|5|||
33488548|NCT03566979|62866683|FG000|Overall Study|Adverse Event|1|||
33488549|NCT03566979|62866684|FG001|Overall Study|Adverse Event|0|||
33488550|NCT03566979|62866685|FG002|Overall Study|Adverse Event|0|||
33488551|NCT03566979|62866686|FG003|Overall Study|Adverse Event|0|||
33488552|NCT00116831|62866698|FG000|Overall Study|Adverse Event|14|||
33488553|NCT00116831|62866699|FG001|Overall Study|Adverse Event|16|||
33488554|NCT00116831|62866698|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
33488555|NCT00116831|62866699|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
33488556|NCT00116831|62866698|FG000|Overall Study|Lost to Follow-up|8|||
33296141|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33296142|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
33296143|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
33296144|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
33296145|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
33296146|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
33488557|NCT00116831|62866699|FG001|Overall Study|Lost to Follow-up|6|||
33488558|NCT00116831|62866698|FG000|Overall Study|Protocol Violation|3|||
33488559|NCT00116831|62866699|FG001|Overall Study|Protocol Violation|6|||
33488560|NCT00116831|62866698|FG000|Overall Study|Hypoglycaemic events|1|||
33488561|NCT00116831|62866699|FG001|Overall Study|Hypoglycaemic events|0|||
33488562|NCT00116831|62866698|FG000|Overall Study|Low haemoglobin on screening|1|||
33488563|NCT00116831|62866699|FG001|Overall Study|Low haemoglobin on screening|0|||
33556729|NCT02791763|62949552|FG002|Overall Study|Physician Decision|0|||
33383976|NCT00723528|62762992|FG006|Period 2: After Controlled Period|Adverse Event|1|||
33296147|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
33296148|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
33296149|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
33296150|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
33296151|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33296152|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33296153|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
33296154|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33296155|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33296156|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33383977|NCT00723528|62762986|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
33383978|NCT00723528|62762987|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
33383979|NCT00723528|62762988|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
33383980|NCT00723528|62762989|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
33383981|NCT00723528|62762990|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
33383982|NCT00723528|62762991|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
33383983|NCT00723528|62762992|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
33383984|NCT00723528|62762986|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
33383985|NCT00723528|62762987|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
33383986|NCT00723528|62762988|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
33383987|NCT00723528|62762989|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
33383988|NCT00723528|62762990|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
33383989|NCT00723528|62762991|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
33383990|NCT00723528|62762992|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
33383991|NCT00751790|62763008|FG000|Overall Study|Lost to Follow-up|1|||
33383992|NCT00751790|62763008|FG000|Overall Study|Death|3|||
33383993|NCT00751790|62763008|FG000|Overall Study|Withdrawal by Subject|1|||
33383994|NCT00723450|62763014|FG000|Open-Label Phase|Adverse Event|26|||
33383995|NCT00723450|62763015|FG001|Open-Label Phase|Adverse Event|0|||
33383996|NCT00723450|62763016|FG002|Open-Label Phase|Adverse Event|0|||
33383997|NCT00723450|62763014|FG000|Open-Label Phase|Lack of Efficacy|18|||
33383998|NCT00723450|62763015|FG001|Open-Label Phase|Lack of Efficacy|0|||
33383999|NCT00723450|62763016|FG002|Open-Label Phase|Lack of Efficacy|0|||
33384000|NCT00723450|62763014|FG000|Open-Label Phase|Protocol Violation|35|||
33384001|NCT00723450|62763015|FG001|Open-Label Phase|Protocol Violation|0|||
33384002|NCT00723450|62763016|FG002|Open-Label Phase|Protocol Violation|0|||
33384003|NCT00723450|62763014|FG000|Open-Label Phase|Lost to Follow-up|7|||
33384004|NCT00723450|62763015|FG001|Open-Label Phase|Lost to Follow-up|0|||
33384005|NCT00723450|62763016|FG002|Open-Label Phase|Lost to Follow-up|0|||
33384006|NCT00723450|62763014|FG000|Open-Label Phase|Physician Decision|2|||
33384007|NCT00723450|62763015|FG001|Open-Label Phase|Physician Decision|0|||
33384008|NCT00723450|62763016|FG002|Open-Label Phase|Physician Decision|0|||
33384009|NCT00723450|62763014|FG000|Open-Label Phase|Withdrawal by Subject|37|||
33384010|NCT00723450|62763015|FG001|Open-Label Phase|Withdrawal by Subject|0|||
33384011|NCT00723450|62763016|FG002|Open-Label Phase|Withdrawal by Subject|0|||
33384012|NCT00723450|62763014|FG000|Randomized Phase|Adverse Event|0|||
33296157|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33384013|NCT00723450|62763015|FG001|Randomized Phase|Adverse Event|26|||
33384014|NCT00723450|62763016|FG002|Randomized Phase|Adverse Event|17|||
33384015|NCT00723450|62763014|FG000|Randomized Phase|Lack of Efficacy|0|||
33384016|NCT00723450|62763015|FG001|Randomized Phase|Lack of Efficacy|11|||
33384017|NCT00723450|62763016|FG002|Randomized Phase|Lack of Efficacy|11|||
33384018|NCT00723450|62763014|FG000|Randomized Phase|Protocol Violation|0|||
33384019|NCT00723450|62763015|FG001|Randomized Phase|Protocol Violation|9|||
33384020|NCT00723450|62763016|FG002|Randomized Phase|Protocol Violation|13|||
33384021|NCT00723450|62763014|FG000|Randomized Phase|Lost to Follow-up|0|||
33384022|NCT00723450|62763015|FG001|Randomized Phase|Lost to Follow-up|2|||
33296158|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33296159|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33296160|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
33384023|NCT00723450|62763016|FG002|Randomized Phase|Lost to Follow-up|3|||
33384024|NCT00723450|62763014|FG000|Randomized Phase|Physician Decision|0|||
33384025|NCT00723450|62763015|FG001|Randomized Phase|Physician Decision|3|||
33384026|NCT00723450|62763016|FG002|Randomized Phase|Physician Decision|1|||
33384027|NCT00723450|62763014|FG000|Randomized Phase|Withdrawal by Subject|0|||
33296161|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
33384028|NCT00723450|62763015|FG001|Randomized Phase|Withdrawal by Subject|14|||
33384029|NCT00723450|62763016|FG002|Randomized Phase|Withdrawal by Subject|22|||
33384030|NCT00751400|62763025|FG000|Overall Study|Lost to Follow-up|10|||
33296162|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
33384031|NCT00585312|62763031|FG000|Overall Study|Adverse Event|3|||
33384032|NCT00585312|62763032|FG001|Overall Study|Adverse Event|0|||
33384033|NCT00585312|62763031|FG000|Overall Study|Lack of Efficacy|6|||
33384034|NCT00585312|62763032|FG001|Overall Study|Lack of Efficacy|11|||
33384035|NCT00585312|62763031|FG000|Overall Study|Lost to Follow-up|1|||
33384036|NCT00585312|62763032|FG001|Overall Study|Lost to Follow-up|1|||
33296163|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
33296164|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
33296165|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
33296166|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
33296167|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
33296168|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
33296169|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
33296170|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
33296171|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
33296172|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
33384037|NCT00585312|62763031|FG000|Overall Study|Reason not specified|2|||
33384038|NCT00585312|62763032|FG001|Overall Study|Reason not specified|0|||
33384039|NCT00585312|62763031|FG000|Overall Study|Withdrawal by Subject|5|||
33384040|NCT00585312|62763032|FG001|Overall Study|Withdrawal by Subject|1|||
33384041|NCT00585312|62763031|FG000|Overall Study|Study terminated by the sponsor|34|||
33384042|NCT00585312|62763032|FG001|Overall Study|Study terminated by the sponsor|31|||
33384043|NCT00753506|62763040|FG000|Overall Study|Withdrawal by Subject|4|||
33384044|NCT00753506|62763041|FG001|Overall Study|Withdrawal by Subject|1|||
33384045|NCT00753506|62763040|FG000|Overall Study|Lost to Follow-up|2|||
33384046|NCT00753506|62763041|FG001|Overall Study|Lost to Follow-up|0|||
33384047|NCT00753506|62763040|FG000|Overall Study|Other reason|1|||
33384048|NCT00753506|62763041|FG001|Overall Study|Other reason|1|||
33384049|NCT00720096|62763049|FG000|Overall Study|Withdrawal by Subject|0|||
33296173|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
33296174|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
33296175|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
33296176|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
33296177|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
33296178|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33296179|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
33296180|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33296181|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33296182|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33296183|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33296184|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33296185|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33296186|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33384050|NCT00720096|62763050|FG001|Overall Study|Withdrawal by Subject|2|||
33384051|NCT00723294|62763056|FG000|Overall Study|Lobular histology|2|||
33384052|NCT00723294|62763056|FG000|Overall Study|>25% intraductal component|1|||
33384053|NCT00723294|62763056|FG000|Overall Study|No MRI tumor enhancement|1|||
33384054|NCT00723294|62763056|FG000|Overall Study|1.0-Tesla MRI|1|||
33384055|NCT00723294|62763056|FG000|Overall Study|No cryoabalation|2|||
33384056|NCT00723294|62763056|FG000|Overall Study|Did not undergo surgery|1|||
33296187|NCT01172938|62672800|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33384057|NCT00723294|62763056|FG000|Overall Study|Treated prior to registration|1|||
33384058|NCT00723294|62763056|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
33384059|NCT00723294|62763056|FG000|Overall Study|Benign lesion|1|||
33384060|NCT00723294|62763056|FG000|Overall Study|Withdrawal by Subject|1|||
33384061|NCT00723294|62763056|FG000|Overall Study|No treatment due to probe failure|1|||
33384062|NCT00747344|62763062|FG000|Controlled Period|Adverse Event|3|||
33384063|NCT00747344|62763063|FG001|Controlled Period|Adverse Event|0|||
33384064|NCT00747344|62763064|FG002|Controlled Period|Adverse Event|0|||
33384065|NCT00747344|62763065|FG003|Controlled Period|Adverse Event|0|||
33384066|NCT00747344|62763062|FG000|Controlled Period|Lack of Efficacy|2|||
33384067|NCT00747344|62763063|FG001|Controlled Period|Lack of Efficacy|1|||
33384068|NCT00747344|62763064|FG002|Controlled Period|Lack of Efficacy|0|||
33384069|NCT00747344|62763065|FG003|Controlled Period|Lack of Efficacy|0|||
33296188|NCT01172938|62672801|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33296189|NCT01172938|62672802|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33296190|NCT01172938|62672803|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33296191|NCT01172938|62672804|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33384070|NCT00747344|62763062|FG000|Controlled Period|Other|0|||
33384071|NCT00747344|62763063|FG001|Controlled Period|Other|3|||
33384072|NCT00747344|62763064|FG002|Controlled Period|Other|0|||
33384073|NCT00747344|62763065|FG003|Controlled Period|Other|0|||
33384074|NCT00747344|62763062|FG000|After Controlled Period|Adverse Event|0|||
33384075|NCT00747344|62763063|FG001|After Controlled Period|Adverse Event|0|||
33384076|NCT00747344|62763064|FG002|After Controlled Period|Adverse Event|0|||
33384077|NCT00747344|62763065|FG003|After Controlled Period|Adverse Event|1|||
33384078|NCT00580983|62763073|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
33384079|NCT00753896|62763077|FG000|Overall Study|Adverse Event|4|||
33384080|NCT00753896|62763077|FG000|Overall Study|Death|1|||
33384081|NCT00753896|62763077|FG000|Overall Study|Lost to Follow-up|2|||
33384082|NCT00753896|62763077|FG000|Overall Study|Protocol Violation|1|||
33384083|NCT00753896|62763077|FG000|Overall Study|Withdrawal by Subject|4|||
33384084|NCT00753896|62763077|FG000|Overall Study|Entry Criteria Not Met|4|||
33384085|NCT00716976|62763083|FG000|Overall Study|Adverse Event|2|||
33384086|NCT00716976|62763084|FG001|Overall Study|Adverse Event|0|||
33384087|NCT00716976|62763083|FG000|Overall Study|Death|1|||
33384088|NCT00716976|62763084|FG001|Overall Study|Death|0|||
33384089|NCT00716976|62763083|FG000|Overall Study|Physician Decision|2|||
33384090|NCT00716976|62763084|FG001|Overall Study|Physician Decision|2|||
33384091|NCT00716976|62763083|FG000|Overall Study|Withdrawal by Subject|5|||
33384092|NCT00716976|62763084|FG001|Overall Study|Withdrawal by Subject|1|||
33384093|NCT00716976|62763083|FG000|Overall Study|Premature discontinuation cisplatin|5|||
33384094|NCT00716976|62763084|FG001|Overall Study|Premature discontinuation cisplatin|4|||
33384095|NCT00716976|62763083|FG000|Overall Study|Radiation during protocol|1|||
33384096|NCT00716976|62763084|FG001|Overall Study|Radiation during protocol|0|||
33384097|NCT00716976|62763083|FG000|Overall Study|Ineligibles|4|||
33384098|NCT00716976|62763084|FG001|Overall Study|Ineligibles|2|||
33384099|NCT00743444|62763092|FG000|First Intervention|Catheter placement problems|0|||
33384100|NCT00743444|62763093|FG001|First Intervention|Catheter placement problems|1|||
33384101|NCT00743444|62763092|FG000|Washout Period|Adverse Event|0|||
33384102|NCT00743444|62763093|FG001|Washout Period|Adverse Event|1|||
33384103|NCT00743366|62763099|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
33384104|NCT00743366|62763100|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
33384105|NCT00721968|62763108|FG000|Overall Study|Lost to Follow-up|2|||
33384106|NCT00721968|62763109|FG001|Overall Study|Lost to Follow-up|0|||
33384107|NCT00743288|62763115|FG000|Overall Study|Adverse Event|1|||
33384108|NCT00743288|62763116|FG001|Overall Study|Adverse Event|1|||
33384109|NCT00743288|62763117|FG002|Overall Study|Adverse Event|2|||
33384110|NCT00743288|62763118|FG003|Overall Study|Adverse Event|2|||
33384111|NCT00743288|62763119|FG004|Overall Study|Adverse Event|1|||
33296192|NCT01172938|62672805|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33296193|NCT01172938|62672806|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33296194|NCT01172938|62672807|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33296195|NCT01172938|62672808|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
33296196|NCT01172938|62672800|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
33296197|NCT01172938|62672801|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
33296198|NCT01172938|62672802|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
33384112|NCT00743288|62763120|FG005|Overall Study|Adverse Event|1|||
33384113|NCT00743288|62763121|FG006|Overall Study|Adverse Event|2|||
33384114|NCT00743288|62763115|FG000|Overall Study|Withdrawal by Subject|0|||
33384115|NCT00743288|62763116|FG001|Overall Study|Withdrawal by Subject|0|||
33384116|NCT00743288|62763117|FG002|Overall Study|Withdrawal by Subject|1|||
33384117|NCT00743288|62763118|FG003|Overall Study|Withdrawal by Subject|0|||
33384118|NCT00743288|62763119|FG004|Overall Study|Withdrawal by Subject|0|||
33384119|NCT00743288|62763120|FG005|Overall Study|Withdrawal by Subject|1|||
33384120|NCT00743288|62763121|FG006|Overall Study|Withdrawal by Subject|1|||
33384121|NCT00743288|62763115|FG000|Overall Study|Progressive disease (PD)|2|||
33384122|NCT00743288|62763116|FG001|Overall Study|Progressive disease (PD)|0|||
33384123|NCT00743288|62763117|FG002|Overall Study|Progressive disease (PD)|1|||
33384124|NCT00743288|62763118|FG003|Overall Study|Progressive disease (PD)|4|||
33384125|NCT00743288|62763119|FG004|Overall Study|Progressive disease (PD)|5|||
33384126|NCT00743288|62763120|FG005|Overall Study|Progressive disease (PD)|3|||
33384127|NCT00743288|62763121|FG006|Overall Study|Progressive disease (PD)|6|||
33384128|NCT00743288|62763115|FG000|Overall Study|Worsening of condition (Not PD)|0|||
33384129|NCT00743288|62763116|FG001|Overall Study|Worsening of condition (Not PD)|2|||
33296199|NCT01172938|62672803|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
33296200|NCT01172938|62672804|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
33296201|NCT01172938|62672805|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
33296202|NCT01172938|62672806|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
33384130|NCT00743288|62763117|FG002|Overall Study|Worsening of condition (Not PD)|1|||
33384131|NCT00743288|62763118|FG003|Overall Study|Worsening of condition (Not PD)|1|||
33384132|NCT00743288|62763119|FG004|Overall Study|Worsening of condition (Not PD)|0|||
33384133|NCT00743288|62763120|FG005|Overall Study|Worsening of condition (Not PD)|0|||
33384134|NCT00743288|62763121|FG006|Overall Study|Worsening of condition (Not PD)|0|||
33384135|NCT00750308|62763132|FG000|First Treatment|Adverse Event|0|||
33384136|NCT00750308|62763133|FG001|First Treatment|Adverse Event|1|||
33384137|NCT00750308|62763134|FG002|First Treatment|Adverse Event|0|||
33384138|NCT00750308|62763135|FG003|First Treatment|Adverse Event|0|||
33384139|NCT00750308|62763136|FG004|First Treatment|Adverse Event|0|||
33296203|NCT01172938|62672807|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
33296204|NCT01172938|62672808|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
33296205|NCT01172938|62672800|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
33296206|NCT01172938|62672801|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
33296207|NCT01172938|62672802|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
33296208|NCT01172938|62672803|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
33296209|NCT01172938|62672804|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
33296210|NCT01172938|62672805|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
33296211|NCT01172938|62672806|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
33296212|NCT01172938|62672807|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
33384140|NCT00750308|62763137|FG005|First Treatment|Adverse Event|0|||
33384141|NCT00750308|62763138|FG006|First Treatment|Adverse Event|0|||
33488564|NCT00116831|62866698|FG000|Overall Study|Withdrawn investigational product|1|||
33488565|NCT00116831|62866699|FG001|Overall Study|Withdrawn investigational product|0|||
33488566|NCT00116831|62866698|FG000|Overall Study|Withdrawal by Subject|32|||
33488567|NCT00116831|62866699|FG001|Overall Study|Withdrawal by Subject|32|||
33488568|NCT00116831|62866698|FG000|Overall Study|Insufficient therapeutic effect|0|||
33488569|NCT00116831|62866699|FG001|Overall Study|Insufficient therapeutic effect|1|||
33488570|NCT00116831|62866698|FG000|Overall Study|Missing data for participant|1|||
33488571|NCT00116831|62866699|FG001|Overall Study|Missing data for participant|0|||
33488572|NCT02777086|62866707|FG000|Overall Study|Lost to Follow-up|96|||
33488573|NCT02777086|62866708|FG001|Overall Study|Lost to Follow-up|99|||
33488574|NCT03549429|62866716|FG000|Overall Study|Protocol Violation|5|||
33488575|NCT03549429|62866717|FG001|Overall Study|Protocol Violation|3|||
33488576|NCT02784704|62866727|FG000|Overall Study|Adverse Event|4|||
33488577|NCT02784704|62866728|FG001|Overall Study|Adverse Event|2|||
33488578|NCT02784704|62866727|FG000|Overall Study|Lost to Follow-up|6|||
33488579|NCT02784704|62866728|FG001|Overall Study|Lost to Follow-up|4|||
33488580|NCT02784704|62866727|FG000|Overall Study|Withdrawal by Subject|1|||
33488581|NCT02784704|62866728|FG001|Overall Study|Withdrawal by Subject|3|||
33488582|NCT02784704|62866727|FG000|Overall Study|Subject Non Compliance|2|||
33488583|NCT02784704|62866728|FG001|Overall Study|Subject Non Compliance|0|||
33488584|NCT03566823|62866739|FG000|Overall Study|Lack of Efficacy|0|||
33488585|NCT03566823|62866740|FG001|Overall Study|Lack of Efficacy|1|||
33488586|NCT03566823|62866741|FG002|Overall Study|Lack of Efficacy|0|||
33488587|NCT03566823|62866739|FG000|Overall Study|Withdrawal by Subject|1|||
33488588|NCT03566823|62866740|FG001|Overall Study|Withdrawal by Subject|2|||
33488589|NCT03566823|62866741|FG002|Overall Study|Withdrawal by Subject|0|||
33488590|NCT03566823|62866739|FG000|Overall Study|Adverse Event|1|||
33488591|NCT03566823|62866740|FG001|Overall Study|Adverse Event|0|||
33488592|NCT03566823|62866741|FG002|Overall Study|Adverse Event|2|||
33488593|NCT03549117|62866751|FG000|Overall Study|Withdrawal by Subject|1|||
33488594|NCT03549117|62866752|FG001|Overall Study|Withdrawal by Subject|0|||
33488595|NCT03183908|62866760|FG000|Overall Study|Missing Symptom Diary Data|0|||
33488596|NCT03183908|62866761|FG001|Overall Study|Missing Symptom Diary Data|2|||
33488597|NCT03565887|62866773|FG000|Overall Study|Adverse Event|1|||
33488598|NCT03565887|62866774|FG001|Overall Study|Adverse Event|0|||
33488599|NCT03565887|62866773|FG000|Overall Study|Withdrawal by Subject|0|||
33488600|NCT03565887|62866774|FG001|Overall Study|Withdrawal by Subject|2|||
33488601|NCT03183518|62866780|FG000|Overall Study|Other (Not specified)|2|||
33488602|NCT03183518|62866780|FG000|Overall Study|Other (Withdrawal of consent)|1|||
33488603|NCT00116753|62866788|FG000|Overall Study|Adverse Event|16|||
33488604|NCT00116753|62866789|FG001|Overall Study|Adverse Event|10|||
33488605|NCT00116753|62866790|FG002|Overall Study|Adverse Event|7|||
33384142|NCT00750308|62763139|FG007|First Treatment|Adverse Event|0|||
33384143|NCT00750308|62763140|FG008|First Treatment|Adverse Event|0|||
33384144|NCT00750308|62763141|FG009|First Treatment|Adverse Event|0|||
33384145|NCT00750308|62763142|FG010|First Treatment|Adverse Event|1|||
33384146|NCT00750308|62763143|FG011|First Treatment|Adverse Event|1|||
33384147|NCT00750308|62763132|FG000|First Treatment|Withdrawal by Subject|0|||
33384148|NCT00750308|62763133|FG001|First Treatment|Withdrawal by Subject|0|||
33296213|NCT01172938|62672808|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
33384149|NCT00750308|62763134|FG002|First Treatment|Withdrawal by Subject|0|||
33384150|NCT00750308|62763135|FG003|First Treatment|Withdrawal by Subject|1|||
33384151|NCT00750308|62763136|FG004|First Treatment|Withdrawal by Subject|0|||
33488606|NCT00116753|62866788|FG000|Overall Study|Withdrawal by Subject|11|||
33488607|NCT00116753|62866789|FG001|Overall Study|Withdrawal by Subject|12|||
33488608|NCT00116753|62866790|FG002|Overall Study|Withdrawal by Subject|8|||
33488609|NCT00116753|62866788|FG000|Overall Study|Lost to Follow-up|0|||
33488610|NCT00116753|62866789|FG001|Overall Study|Lost to Follow-up|2|||
33488611|NCT00116753|62866790|FG002|Overall Study|Lost to Follow-up|1|||
33488612|NCT00116753|62866788|FG000|Overall Study|Protocol Violation|0|||
33488613|NCT00116753|62866789|FG001|Overall Study|Protocol Violation|0|||
33296214|NCT01172938|62672800|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
33384152|NCT00750308|62763137|FG005|First Treatment|Withdrawal by Subject|0|||
33384153|NCT00750308|62763138|FG006|First Treatment|Withdrawal by Subject|0|||
33384154|NCT00750308|62763139|FG007|First Treatment|Withdrawal by Subject|1|||
33384155|NCT00750308|62763140|FG008|First Treatment|Withdrawal by Subject|0|||
33384156|NCT00750308|62763141|FG009|First Treatment|Withdrawal by Subject|0|||
33384157|NCT00750308|62763142|FG010|First Treatment|Withdrawal by Subject|0|||
33384158|NCT00750308|62763143|FG011|First Treatment|Withdrawal by Subject|0|||
33384159|NCT00750308|62763132|FG000|Second Treatment|Adverse Event|0|||
33384160|NCT00750308|62763133|FG001|Second Treatment|Adverse Event|0|||
33384161|NCT00750308|62763134|FG002|Second Treatment|Adverse Event|0|||
33384162|NCT00750308|62763135|FG003|Second Treatment|Adverse Event|0|||
33384163|NCT00750308|62763136|FG004|Second Treatment|Adverse Event|0|||
33384164|NCT00750308|62763137|FG005|Second Treatment|Adverse Event|1|||
33384165|NCT00750308|62763138|FG006|Second Treatment|Adverse Event|0|||
33384166|NCT00750308|62763139|FG007|Second Treatment|Adverse Event|0|||
33296215|NCT01172938|62672801|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
33296216|NCT01172938|62672802|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
33296217|NCT01172938|62672803|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
33296218|NCT01172938|62672804|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
33296219|NCT01172938|62672805|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
33296220|NCT01172938|62672806|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
33296221|NCT01172938|62672807|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
33296222|NCT01172938|62672808|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
33296223|NCT01172938|62672800|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33296224|NCT01172938|62672801|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
33296225|NCT01172938|62672802|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33296226|NCT01172938|62672803|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33384167|NCT00750308|62763140|FG008|Second Treatment|Adverse Event|1|||
33384168|NCT00750308|62763141|FG009|Second Treatment|Adverse Event|0|||
33384169|NCT00750308|62763142|FG010|Second Treatment|Adverse Event|0|||
33384170|NCT00750308|62763143|FG011|Second Treatment|Adverse Event|0|||
33384171|NCT00750308|62763132|FG000|Second Treatment|Withdrawal by Subject|0|||
33384172|NCT00750308|62763133|FG001|Second Treatment|Withdrawal by Subject|0|||
33384173|NCT00750308|62763134|FG002|Second Treatment|Withdrawal by Subject|0|||
33384174|NCT00750308|62763135|FG003|Second Treatment|Withdrawal by Subject|0|||
33384175|NCT00750308|62763136|FG004|Second Treatment|Withdrawal by Subject|1|||
33384176|NCT00750308|62763137|FG005|Second Treatment|Withdrawal by Subject|0|||
33384177|NCT00750308|62763138|FG006|Second Treatment|Withdrawal by Subject|0|||
33384178|NCT00750308|62763139|FG007|Second Treatment|Withdrawal by Subject|0|||
33384179|NCT00750308|62763140|FG008|Second Treatment|Withdrawal by Subject|0|||
33384180|NCT00750308|62763141|FG009|Second Treatment|Withdrawal by Subject|0|||
33384181|NCT00750308|62763142|FG010|Second Treatment|Withdrawal by Subject|0|||
33384182|NCT00750308|62763143|FG011|Second Treatment|Withdrawal by Subject|0|||
33384183|NCT00750308|62763132|FG000|Third Treatment|Withdrawal by Subject|0|||
33384184|NCT00750308|62763133|FG001|Third Treatment|Withdrawal by Subject|1|||
33384185|NCT00750308|62763134|FG002|Third Treatment|Withdrawal by Subject|0|||
33296227|NCT01172938|62672804|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33296228|NCT01172938|62672805|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33296229|NCT01172938|62672806|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33296230|NCT01172938|62672807|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33296231|NCT01172938|62672808|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33296232|NCT01172938|62672800|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33296233|NCT01172938|62672801|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33296234|NCT01172938|62672802|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
33384186|NCT00750308|62763135|FG003|Third Treatment|Withdrawal by Subject|0|||
33384187|NCT00750308|62763136|FG004|Third Treatment|Withdrawal by Subject|0|||
33384188|NCT00750308|62763137|FG005|Third Treatment|Withdrawal by Subject|0|||
33384189|NCT00750308|62763138|FG006|Third Treatment|Withdrawal by Subject|0|||
33384190|NCT00750308|62763139|FG007|Third Treatment|Withdrawal by Subject|0|||
33384191|NCT00750308|62763140|FG008|Third Treatment|Withdrawal by Subject|0|||
33384192|NCT00750308|62763141|FG009|Third Treatment|Withdrawal by Subject|0|||
33384193|NCT00750308|62763142|FG010|Third Treatment|Withdrawal by Subject|0|||
33384194|NCT00750308|62763143|FG011|Third Treatment|Withdrawal by Subject|0|||
33384195|NCT00750152|62763159|FG000|Overall Study|Adverse Event|2|||
33488614|NCT00116753|62866790|FG002|Overall Study|Protocol Violation|1|||
33488615|NCT00116753|62866788|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
33384196|NCT00750152|62763160|FG001|Overall Study|Adverse Event|1|||
33384197|NCT00750152|62763159|FG000|Overall Study|Lost to Follow-up|8|||
33384198|NCT00750152|62763160|FG001|Overall Study|Lost to Follow-up|13|||
33296235|NCT01172938|62672803|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33296236|NCT01172938|62672804|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33296237|NCT01172938|62672805|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33296238|NCT01172938|62672806|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33296239|NCT01172938|62672807|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33488616|NCT00116753|62866789|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
33488617|NCT00116753|62866790|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
33488618|NCT00116753|62866788|FG000|Overall Study|Disease Progression|3|||
33384199|NCT00750152|62763159|FG000|Overall Study|Withdrawal by Subject|3|||
33384200|NCT00750152|62763160|FG001|Overall Study|Withdrawal by Subject|3|||
33384201|NCT00750152|62763159|FG000|Overall Study|Physician Decision|1|||
33384202|NCT00750152|62763160|FG001|Overall Study|Physician Decision|1|||
33384203|NCT00750152|62763159|FG000|Overall Study|Non-compliance|0|||
33384204|NCT00750152|62763160|FG001|Overall Study|Non-compliance|1|||
33384205|NCT00750152|62763159|FG000|Overall Study|Termination by sponsor|1|||
33384206|NCT00750152|62763160|FG001|Overall Study|Termination by sponsor|0|||
33384207|NCT00750152|62763159|FG000|Overall Study|Other|7|||
33384208|NCT00750152|62763160|FG001|Overall Study|Other|8|||
33384209|NCT00749996|62763168|FG000|Overall Study|Lost to Follow-up|7|||
33488619|NCT00116753|62866789|FG001|Overall Study|Disease Progression|4|||
33488620|NCT00116753|62866790|FG002|Overall Study|Disease Progression|3|||
33488621|NCT00116753|62866788|FG000|Overall Study|Abnormal Echocardiogram|0|||
33488622|NCT00116753|62866789|FG001|Overall Study|Abnormal Echocardiogram|0|||
33488623|NCT00116753|62866790|FG002|Overall Study|Abnormal Echocardiogram|1|||
33488624|NCT00116753|62866788|FG000|Overall Study|Progressive Parkinson's Disease|1|||
33488625|NCT00116753|62866789|FG001|Overall Study|Progressive Parkinson's Disease|0|||
33488626|NCT00116753|62866790|FG002|Overall Study|Progressive Parkinson's Disease|0|||
33488627|NCT00116753|62866788|FG000|Overall Study|Dosing Error|0|||
33488628|NCT00116753|62866789|FG001|Overall Study|Dosing Error|1|||
33488629|NCT00116753|62866790|FG002|Overall Study|Dosing Error|0|||
33488630|NCT00113399|62866809|FG000|Overall Study|Death|1|||
33296240|NCT01172938|62672808|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33296241|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
33296242|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
33296243|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
33296244|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
33296245|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
33296246|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
33296247|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
33296248|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
33296249|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
33296250|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
33296251|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
33296252|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
33296253|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
33296254|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
33296255|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
33296256|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
33296257|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
33296258|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
33296259|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
33296260|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
33296261|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
33296262|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
33296263|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
33296264|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
33296265|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
33296266|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
33296267|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
33296268|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
33296269|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
33296270|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
33296271|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
33384210|NCT00749996|62763169|FG001|Overall Study|Lost to Follow-up|4|||
33384211|NCT00749996|62763168|FG000|Overall Study|Withdrawal by Subject|5|||
33384212|NCT00749996|62763169|FG001|Overall Study|Withdrawal by Subject|4|||
33488631|NCT00113399|62866810|FG001|Overall Study|Death|1|||
33488632|NCT00113399|62866809|FG000|Overall Study|Withdrawal by Subject|1|||
33384213|NCT00749996|62763168|FG000|Overall Study|Protocol Violation|2|||
33488633|NCT00113399|62866810|FG001|Overall Study|Withdrawal by Subject|2|||
33296272|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
33296273|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
33296274|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
33384214|NCT00749996|62763169|FG001|Overall Study|Protocol Violation|3|||
33384215|NCT00749996|62763168|FG000|Overall Study|Physician Decision|2|||
33384216|NCT00749996|62763169|FG001|Overall Study|Physician Decision|0|||
33384217|NCT00749996|62763168|FG000|Overall Study|Pregnancy|0|||
33384218|NCT00749996|62763169|FG001|Overall Study|Pregnancy|2|||
33384219|NCT00749996|62763168|FG000|Overall Study|Adverse Event|1|||
33384220|NCT00749996|62763169|FG001|Overall Study|Adverse Event|0|||
33384221|NCT00749996|62763168|FG000|Overall Study|Death|1|||
33384222|NCT00749996|62763169|FG001|Overall Study|Death|0|||
33384223|NCT00749684|62763175|FG000|Overall Study|Death|1|||
33384224|NCT00749684|62763175|FG000|Overall Study|Adverse Event|27|||
33384225|NCT00749684|62763175|FG000|Overall Study|Participant's Wish|10|||
33384226|NCT00749684|62763175|FG000|Overall Study|Not Documented|1|||
33384227|NCT00749684|62763175|FG000|Overall Study|Progressive Desease|31|||
33296275|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
33296276|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
33296277|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33296278|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33296279|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33296280|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33384228|NCT00749684|62763175|FG000|Overall Study|Therapy according to protocol + AE|2|||
33384229|NCT00749684|62763175|FG000|Overall Study|AE+discontinuation on participants wish|1|||
33384230|NCT00749684|62763175|FG000|Overall Study|Missing|9|||
33384231|NCT00746798|62763183|FG000|Overall Study|Protocol Violation|0|||
33384232|NCT00746798|62763184|FG001|Overall Study|Protocol Violation|1|||
33384233|NCT00746798|62763185|FG002|Overall Study|Protocol Violation|0|||
33384234|NCT00746798|62763186|FG003|Overall Study|Protocol Violation|0|||
33384235|NCT00746798|62763183|FG000|Overall Study|Withdrawal by Subject|0|||
33384236|NCT00746798|62763184|FG001|Overall Study|Withdrawal by Subject|1|||
33384237|NCT00746798|62763185|FG002|Overall Study|Withdrawal by Subject|1|||
33384238|NCT00746798|62763186|FG003|Overall Study|Withdrawal by Subject|0|||
33384239|NCT00746798|62763183|FG000|Overall Study|Death|0|||
33384240|NCT00746798|62763184|FG001|Overall Study|Death|0|||
33296281|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33296282|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33296283|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33296284|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
33296285|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33296286|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
33296287|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
33296288|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
33296289|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
33296290|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
33296291|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
33296292|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
33296293|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
33296294|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
33296295|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33296296|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33296297|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
33296298|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33296299|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33296300|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33296301|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33296302|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33296303|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33296304|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
33296305|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
33296306|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
33296307|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
33296308|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
33296309|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
33296310|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
33296311|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
33384241|NCT00746798|62763185|FG002|Overall Study|Death|2|||
33384242|NCT00746798|62763186|FG003|Overall Study|Death|0|||
33384243|NCT00746798|62763183|FG000|Overall Study|Participant unable to return for visit|1|||
33384244|NCT00746798|62763184|FG001|Overall Study|Participant unable to return for visit|0|||
33384245|NCT00746798|62763185|FG002|Overall Study|Participant unable to return for visit|0|||
33384246|NCT00746798|62763186|FG003|Overall Study|Participant unable to return for visit|0|||
33296312|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
33296313|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
33296314|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
33296315|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
33296316|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
33296317|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
33296318|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
33296319|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
33296320|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
33296321|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
33296322|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33296323|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33296324|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
33296325|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33296326|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33296327|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33296328|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33296329|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33296330|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33296331|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33296332|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33296333|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
33296334|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33296335|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33296336|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33296337|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33296338|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33296339|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33296340|NCT01172938|62672800|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33296341|NCT01172938|62672801|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33296342|NCT01172938|62672802|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33296343|NCT01172938|62672803|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33296344|NCT01172938|62672804|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33296345|NCT01172938|62672805|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33296346|NCT01172938|62672806|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33296347|NCT01172938|62672807|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33296348|NCT01172938|62672808|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
33296349|NCT01109992|62672828|FG000|Overall Study|Withdrawal by Subject|0|||
33296350|NCT01109992|62672829|FG001|Overall Study|Withdrawal by Subject|1|||
33296351|NCT01109992|62672828|FG000|Overall Study|Movement during rest scan.|0|||
33296352|NCT01109992|62672829|FG001|Overall Study|Movement during rest scan.|1|||
33296353|NCT01109524|62672838|FG000|Overall Study|Disease Progression|29|||
33296354|NCT01109524|62672838|FG000|Overall Study|Study Drug toxicity|6|||
33296355|NCT01109524|62672838|FG000|Overall Study|Adverse Event|4|||
33296356|NCT01109524|62672838|FG000|Overall Study|Withdrawal by Subject|2|||
33296357|NCT01109524|62672838|FG000|Overall Study|Maximum clinical benefit|3|||
33296358|NCT01109524|62672838|FG000|Overall Study|Death|2|||
33296359|NCT01109524|62672838|FG000|Overall Study|No longer meets criteria|2|||
33296360|NCT01109524|62672838|FG000|Overall Study|Participant requested to end treatment|4|||
33296361|NCT01109524|62672838|FG000|Overall Study|Other|5|||
33296362|NCT01109173|62672853|FG000|Overall Study|Adverse Event|15|||
33296363|NCT01109173|62672854|FG001|Overall Study|Adverse Event|17|||
33296364|NCT01109173|62672855|FG002|Overall Study|Adverse Event|9|||
33296365|NCT01109173|62672856|FG003|Overall Study|Adverse Event|6|||
33296366|NCT01109173|62672853|FG000|Overall Study|Lost to Follow-up|0|||
33296367|NCT01109173|62672854|FG001|Overall Study|Lost to Follow-up|1|||
33296368|NCT01109173|62672855|FG002|Overall Study|Lost to Follow-up|0|||
33296369|NCT01109173|62672856|FG003|Overall Study|Lost to Follow-up|0|||
33296370|NCT01109173|62672853|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
33296371|NCT01109173|62672854|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
33296372|NCT01109173|62672855|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
33296373|NCT01109173|62672856|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
33384247|NCT00716274|62763199|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
33384248|NCT00716274|62763200|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
33384249|NCT00716274|62763201|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
33384250|NCT00716274|62763202|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
33296374|NCT01109173|62672853|FG000|Overall Study|Noncompliance|0|||
33296375|NCT01109173|62672854|FG001|Overall Study|Noncompliance|1|||
33296376|NCT01109173|62672855|FG002|Overall Study|Noncompliance|0|||
33384251|NCT00716274|62763203|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
33296377|NCT01109173|62672856|FG003|Overall Study|Noncompliance|0|||
33296378|NCT01109173|62672853|FG000|Overall Study|Treatment Failure|25|||
33296379|NCT01109173|62672854|FG001|Overall Study|Treatment Failure|32|||
33384252|NCT00716274|62763204|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
33384253|NCT00716274|62763199|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
33384254|NCT00716274|62763200|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
33384255|NCT00716274|62763201|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
33384256|NCT00716274|62763202|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
33384257|NCT00716274|62763203|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
33384258|NCT00716274|62763204|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
33384259|NCT00716274|62763199|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
33384260|NCT00716274|62763200|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
33384261|NCT00716274|62763201|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
33384262|NCT00716274|62763202|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
33384263|NCT00716274|62763203|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
33384264|NCT00716274|62763204|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
33384265|NCT00716274|62763199|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
33384266|NCT00716274|62763200|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
33384267|NCT00716274|62763201|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
33384268|NCT00716274|62763202|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
33384269|NCT00716274|62763203|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
33384270|NCT00716274|62763204|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
33384271|NCT00716274|62763199|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
33384272|NCT00716274|62763200|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
33384273|NCT00716274|62763201|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
33384274|NCT00716274|62763202|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
33384275|NCT00716274|62763203|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
33384276|NCT00716274|62763204|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
33384277|NCT00716274|62763199|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
33384278|NCT00716274|62763200|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
33384279|NCT00716274|62763201|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
33384280|NCT00716274|62763202|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
33384281|NCT00716274|62763203|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
33384282|NCT00716274|62763204|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
33384283|NCT00716274|62763199|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
33384284|NCT00716274|62763200|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
33384285|NCT00716274|62763201|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
33384286|NCT00716274|62763202|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
33384287|NCT00716274|62763203|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
33384288|NCT00716274|62763204|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
33384289|NCT00716274|62763199|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
33384290|NCT00716274|62763200|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
33384291|NCT00716274|62763201|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
33384292|NCT00716274|62763202|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
33384293|NCT00716274|62763203|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
33384294|NCT00716274|62763204|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
33384295|NCT00716274|62763199|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
33384296|NCT00716274|62763200|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
33384297|NCT00716274|62763201|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
33384298|NCT00716274|62763202|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
33384299|NCT00716274|62763203|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
33384300|NCT00716274|62763204|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
33384301|NCT00716274|62763199|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
33384302|NCT00716274|62763200|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
33488634|NCT00113399|62866809|FG000|Overall Study|Complete Response|0|||
33296380|NCT01109173|62672855|FG002|Overall Study|Treatment Failure|69|||
33296381|NCT01109173|62672856|FG003|Overall Study|Treatment Failure|64|||
33296382|NCT01109173|62672853|FG000|Overall Study|Protocol Violation|4|||
33296383|NCT01109173|62672854|FG001|Overall Study|Protocol Violation|5|||
33296384|NCT01109173|62672855|FG002|Overall Study|Protocol Violation|1|||
33296385|NCT01109173|62672856|FG003|Overall Study|Protocol Violation|2|||
33296386|NCT01109173|62672853|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
33296387|NCT01109173|62672854|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
33296388|NCT01109173|62672855|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
33384303|NCT00716274|62763201|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
33384304|NCT00716274|62763202|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
33384305|NCT00716274|62763203|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
33384306|NCT00716274|62763204|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
33384307|NCT00746564|62763221|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
33296389|NCT01109173|62672856|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
33384308|NCT01298193|62763227|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
33384309|NCT01298193|62763227|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
33384310|NCT01298193|62763227|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
33384311|NCT01298193|62763227|FG000|Efficacy Phase (Second Cycle)|Death|1|||
33384312|NCT00719862|62763236|FG000|Overall Study|Adverse Event|1|||
33296390|NCT01109173|62672853|FG000|Overall Study|Not Specifiied|5|||
33296391|NCT01109173|62672854|FG001|Overall Study|Not Specifiied|4|||
33296392|NCT01109173|62672855|FG002|Overall Study|Not Specifiied|9|||
33296393|NCT01109173|62672856|FG003|Overall Study|Not Specifiied|14|||
33296394|NCT01172821|62672870|FG000|Overall Study|Adverse Event|5|||
33296395|NCT01172821|62672871|FG001|Overall Study|Adverse Event|2|||
33296396|NCT01172821|62672872|FG002|Overall Study|Adverse Event|2|||
33296397|NCT01172821|62672873|FG003|Overall Study|Adverse Event|7|||
33296398|NCT01172821|62672870|FG000|Overall Study|Protocol Violation|0|||
33296399|NCT01172821|62672871|FG001|Overall Study|Protocol Violation|2|||
33296400|NCT01172821|62672872|FG002|Overall Study|Protocol Violation|1|||
33296401|NCT01172821|62672873|FG003|Overall Study|Protocol Violation|2|||
33296402|NCT01172821|62672870|FG000|Overall Study|Lost to Follow-up|4|||
33296403|NCT01172821|62672871|FG001|Overall Study|Lost to Follow-up|1|||
33296404|NCT01172821|62672872|FG002|Overall Study|Lost to Follow-up|2|||
33296405|NCT01172821|62672873|FG003|Overall Study|Lost to Follow-up|2|||
33296406|NCT01172821|62672870|FG000|Overall Study|Withdrawal by Subject|2|||
33296407|NCT01172821|62672871|FG001|Overall Study|Withdrawal by Subject|3|||
33296408|NCT01172821|62672872|FG002|Overall Study|Withdrawal by Subject|3|||
33296409|NCT01172821|62672873|FG003|Overall Study|Withdrawal by Subject|3|||
33296410|NCT01172821|62672870|FG000|Overall Study|Other|3|||
33296411|NCT01172821|62672871|FG001|Overall Study|Other|4|||
33296412|NCT01172821|62672872|FG002|Overall Study|Other|5|||
33296413|NCT01172821|62672873|FG003|Overall Study|Other|3|||
33296414|NCT01172275|62672885|FG000|Overall Study|Lost to Follow-up|1|||
33296415|NCT01172275|62672886|FG001|Overall Study|Lost to Follow-up|0|||
33488635|NCT00113399|62866810|FG001|Overall Study|Complete Response|1|||
33488636|NCT00113399|62866809|FG000|Overall Study|Other|0|||
33296416|NCT01172275|62672885|FG000|Overall Study|Protocol Violation|1|||
33296417|NCT01172275|62672886|FG001|Overall Study|Protocol Violation|0|||
33296418|NCT01108510|62672894|FG000|Overall Study|Randomized but Not Treated|5|||
33296419|NCT01108510|62672895|FG001|Overall Study|Randomized but Not Treated|1|||
33296420|NCT01108510|62672894|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
33296421|NCT01108510|62672895|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
33296422|NCT01108510|62672894|FG000|Overall Study|Adverse Event|26|||
33296423|NCT01108510|62672895|FG001|Overall Study|Adverse Event|19|||
33296424|NCT01108510|62672894|FG000|Overall Study|Lost to Follow-up|20|||
33296425|NCT01108510|62672895|FG001|Overall Study|Lost to Follow-up|17|||
33296426|NCT01108510|62672894|FG000|Overall Study|Withdrew Consent|21|||
33296427|NCT01108510|62672895|FG001|Overall Study|Withdrew Consent|15|||
33296428|NCT01108510|62672894|FG000|Overall Study|Investigator's Discretion|12|||
33384313|NCT00719862|62763237|FG001|Overall Study|Adverse Event|2|||
33384314|NCT00719862|62763236|FG000|Overall Study|Lack of Efficacy|3|||
33384315|NCT00719862|62763237|FG001|Overall Study|Lack of Efficacy|0|||
33384316|NCT00719862|62763236|FG000|Overall Study|Non-Compliance|1|||
33384317|NCT00719862|62763237|FG001|Overall Study|Non-Compliance|0|||
33384318|NCT00719862|62763236|FG000|Overall Study|Withdrawal by Subject|1|||
33384319|NCT00719862|62763237|FG001|Overall Study|Withdrawal by Subject|0|||
33384320|NCT00719862|62763236|FG000|Overall Study|Lost to Follow-up|0|||
33384321|NCT00719862|62763237|FG001|Overall Study|Lost to Follow-up|1|||
33384322|NCT00719862|62763236|FG000|Overall Study|Other|2|||
33384323|NCT00719862|62763237|FG001|Overall Study|Other|3|||
33384324|NCT00742508|62763245|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
33384325|NCT00742508|62763246|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
33384326|NCT00742508|62763245|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
33384327|NCT00742508|62763246|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
33384328|NCT00742508|62763245|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
33384329|NCT00742508|62763246|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
33384330|NCT00742508|62763245|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
33384331|NCT00742508|62763246|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
33488637|NCT00113399|62866810|FG001|Overall Study|Other|1|||
33296429|NCT01108510|62672895|FG001|Overall Study|Investigator's Discretion|10|||
33296430|NCT01108510|62672894|FG000|Overall Study|Participant Noncompliance|5|||
33384332|NCT00742508|62763245|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
33488638|NCT00113087|62866818|FG000|Overall Study|Death or Transplant|14|||
33488639|NCT00113087|62866819|FG001|Overall Study|Death or Transplant|16|||
33488640|NCT00113087|62866818|FG000|Overall Study|Family or MD withdrew subject|10|||
33296431|NCT01108510|62672895|FG001|Overall Study|Participant Noncompliance|7|||
33296432|NCT01108510|62672894|FG000|Overall Study|Lack of Efficacy|3|||
33296433|NCT01108510|62672895|FG001|Overall Study|Lack of Efficacy|0|||
33296434|NCT01108510|62672894|FG000|Overall Study|Pregnancy|0|||
33384333|NCT00742508|62763246|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
33384334|NCT00719706|62763254|FG000|Overall Study|Adverse Event|5|||
33384335|NCT00719706|62763255|FG001|Overall Study|Adverse Event|4|||
33384336|NCT00719706|62763254|FG000|Overall Study|Withdrawal by Subject|1|||
33384337|NCT00719706|62763255|FG001|Overall Study|Withdrawal by Subject|2|||
33384338|NCT00719706|62763254|FG000|Overall Study|Protocol Violation|3|||
33384339|NCT00719706|62763255|FG001|Overall Study|Protocol Violation|0|||
33384340|NCT00742274|62763263|FG000|Overall Study|Death|1|||
33384341|NCT00742274|62763264|FG001|Overall Study|Death|0|||
33384342|NCT00742274|62763263|FG000|Overall Study|Withdrawal by Subject|1|||
33384343|NCT00742274|62763264|FG001|Overall Study|Withdrawal by Subject|2|||
33384344|NCT00742274|62763263|FG000|Overall Study|Removed for medical reasons|1|||
33384345|NCT00742274|62763264|FG001|Overall Study|Removed for medical reasons|1|||
33384346|NCT00719472|62763270|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
33384347|NCT00719472|62763270|FG000|Enrolled in Study|Subject decision to withdraw|8|||
33384348|NCT00719472|62763270|FG000|Enrolled in Study|Various Reasons|17|||
33384349|NCT00719472|62763270|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
33384350|NCT00719472|62763270|FG000|Received Cycle 1 Treatment|Death|5|||
33384351|NCT00719472|62763270|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
33384352|NCT00719472|62763270|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
33384353|NCT00719472|62763270|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
33384354|NCT00719472|62763270|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
33384355|NCT00719472|62763270|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
33384356|NCT00719472|62763270|FG000|Received Cycle 2 Treatment|Death|6|||
33384357|NCT00719472|62763270|FG000|Received Cycle 2 Treatment|Disease progression|3|||
33384358|NCT00719472|62763270|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
33384359|NCT00719472|62763270|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
33384360|NCT00719472|62763270|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
33384361|NCT00719472|62763270|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
33384362|NCT00579501|62763274|FG000|Overall Study|Death|1|||
33384363|NCT00579501|62763274|FG000|Overall Study|End of neoadjuvant therapy|25|||
33384364|NCT00579501|62763274|FG000|Overall Study|toxicity|1|||
33384365|NCT00579501|62763274|FG000|Overall Study|Secondary lesion|1|||
33384366|NCT00579501|62763274|FG000|Overall Study|Radiation therapy before surgery|1|||
33384367|NCT00741338|62763280|FG000|Overall Study|Adverse Event|0|||
33384368|NCT00741338|62763281|FG001|Overall Study|Adverse Event|1|||
33384369|NCT00746330|62763291|FG000|Period 1|Abnormal test procedure result|0|||
33384370|NCT00746330|62763292|FG001|Period 1|Abnormal test procedure result|0|||
33384371|NCT00746330|62763293|FG002|Period 1|Abnormal test procedure result|1|||
33384372|NCT00746330|62763294|FG003|Period 1|Abnormal test procedure result|0|||
33384373|NCT00746252|62763307|FG000|Overall Study|weight gain >7.5 %|1|||
33384374|NCT00746252|62763308|FG001|Overall Study|weight gain >7.5 %|2|||
33296435|NCT01108510|62672895|FG001|Overall Study|Pregnancy|3|||
33296436|NCT01108510|62672894|FG000|Overall Study|Death|1|||
33296437|NCT01108510|62672895|FG001|Overall Study|Death|1|||
33296438|NCT01108237|62672903|FG000|Overall Study|No alignment data|2|||
33296439|NCT01108237|62672904|FG001|Overall Study|No alignment data|17|||
33296440|NCT01108237|62672903|FG000|Overall Study|Did not meet criteria for analysis|7|||
33296441|NCT01108237|62672904|FG001|Overall Study|Did not meet criteria for analysis|0|||
33296442|NCT01340027|62672922|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
33296443|NCT01340027|62672923|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
33296444|NCT01340027|62672924|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
33296445|NCT01340027|62672925|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
33296446|NCT01340027|62672926|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
33296447|NCT01340027|62672927|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
33296448|NCT01340027|62672928|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
33296449|NCT01340027|62672929|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
33296450|NCT01340027|62672930|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
33296451|NCT01340027|62672931|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
33296452|NCT01340027|62672932|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
33296453|NCT01340027|62672933|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
33296454|NCT01340027|62672922|FG000|Overall Study|Adverse Event|0|||
33296455|NCT01340027|62672923|FG001|Overall Study|Adverse Event|1|||
33296456|NCT01340027|62672924|FG002|Overall Study|Adverse Event|2|||
33296457|NCT01340027|62672925|FG003|Overall Study|Adverse Event|0|||
33384375|NCT00718770|62763314|FG000|Overall Study|Adverse Event|1|||
33384376|NCT00718770|62763314|FG000|Overall Study|Lack of Efficacy|1|||
33384377|NCT00718770|62763314|FG000|Overall Study|Lack of Efficacy|1|||
33384378|NCT00718770|62763314|FG000|Overall Study|Adverse Event|1|||
33384379|NCT00718770|62763314|FG000|Overall Study|Lack of Efficacy|1|||
33384380|NCT00718770|62763314|FG000|Overall Study|Adverse Event|1|||
33384381|NCT00718770|62763314|FG000|Overall Study|Lack of Efficacy|1|||
33384382|NCT00718770|62763314|FG000|Overall Study|Adverse Event|1|||
33296458|NCT01340027|62672926|FG004|Overall Study|Adverse Event|1|||
33296459|NCT01340027|62672927|FG005|Overall Study|Adverse Event|2|||
33296460|NCT01340027|62672928|FG006|Overall Study|Adverse Event|2|||
33296461|NCT01340027|62672929|FG007|Overall Study|Adverse Event|1|||
33296462|NCT01340027|62672930|FG008|Overall Study|Adverse Event|4|||
33296463|NCT01340027|62672931|FG009|Overall Study|Adverse Event|1|||
33296464|NCT01340027|62672932|FG010|Overall Study|Adverse Event|1|||
33296465|NCT01340027|62672933|FG011|Overall Study|Adverse Event|3|||
33296466|NCT01340027|62672922|FG000|Overall Study|Lack of Efficacy|0|||
33296467|NCT01340027|62672923|FG001|Overall Study|Lack of Efficacy|0|||
33296468|NCT01340027|62672924|FG002|Overall Study|Lack of Efficacy|0|||
33296469|NCT01340027|62672925|FG003|Overall Study|Lack of Efficacy|0|||
33296470|NCT01340027|62672926|FG004|Overall Study|Lack of Efficacy|0|||
33296471|NCT01340027|62672927|FG005|Overall Study|Lack of Efficacy|0|||
33296472|NCT01340027|62672928|FG006|Overall Study|Lack of Efficacy|1|||
33296473|NCT01340027|62672929|FG007|Overall Study|Lack of Efficacy|1|||
33296474|NCT01340027|62672930|FG008|Overall Study|Lack of Efficacy|1|||
33296475|NCT01340027|62672931|FG009|Overall Study|Lack of Efficacy|0|||
33296476|NCT01340027|62672932|FG010|Overall Study|Lack of Efficacy|0|||
33296477|NCT01340027|62672933|FG011|Overall Study|Lack of Efficacy|0|||
33296478|NCT01340027|62672922|FG000|Overall Study|Lost to Follow-up|0|||
33384383|NCT00746096|62763320|FG000|Overall Study|Adverse Event|1|||
33384384|NCT00746096|62763321|FG001|Overall Study|Adverse Event|0|||
33384385|NCT00746096|62763320|FG000|Overall Study|Withdrawal by Subject|5|||
33384386|NCT00746096|62763321|FG001|Overall Study|Withdrawal by Subject|1|||
33384387|NCT00746096|62763320|FG000|Overall Study|Lost to Follow-up|2|||
33384388|NCT00746096|62763321|FG001|Overall Study|Lost to Follow-up|1|||
33384389|NCT00746096|62763320|FG000|Overall Study|Protocol Violation|1|||
33384390|NCT00746096|62763321|FG001|Overall Study|Protocol Violation|0|||
33384391|NCT00746096|62763320|FG000|Overall Study|No study drug treatment|1|||
33384392|NCT00746096|62763321|FG001|Overall Study|No study drug treatment|1|||
33384393|NCT00715026|62763327|FG000|Overall Study|Withdrawal by Subject|5|||
33384394|NCT00715026|62763327|FG000|Overall Study|Lost to Follow-up|3|||
33384395|NCT00715026|62763327|FG000|Overall Study|Protocol Violation|1|||
33384396|NCT00715026|62763327|FG000|Overall Study|Surgery done on non-study consented hip|1|||
33384397|NCT00714948|62763331|FG000|Overall Study|Adverse Event|2|||
33384398|NCT00714870|62763337|FG000|Overall Study|Lost to Follow-up|22|||
33384399|NCT00714870|62763338|FG001|Overall Study|Lost to Follow-up|5|||
33384400|NCT00714870|62763337|FG000|Overall Study|patient unable to come b/c back pain|1|||
33384401|NCT00714870|62763338|FG001|Overall Study|patient unable to come b/c back pain|0|||
33384402|NCT00714870|62763337|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
33384403|NCT00714870|62763338|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
33384404|NCT00714714|62763344|FG000|Overall Study|Adverse Event|1|||
33384405|NCT00441337|62763354|FG000|Overall Study|Disease Progression|6|||
33384406|NCT00441337|62763355|FG001|Overall Study|Disease Progression|6|||
33384407|NCT00441337|62763356|FG002|Overall Study|Disease Progression|4|||
33384408|NCT00441337|62763357|FG003|Overall Study|Disease Progression|18|||
33384409|NCT00441337|62763354|FG000|Overall Study|Lost to Follow-up|0|||
33296479|NCT01340027|62672923|FG001|Overall Study|Lost to Follow-up|1|||
33296480|NCT01340027|62672924|FG002|Overall Study|Lost to Follow-up|0|||
33296481|NCT01340027|62672925|FG003|Overall Study|Lost to Follow-up|0|||
33296482|NCT01340027|62672926|FG004|Overall Study|Lost to Follow-up|0|||
33384410|NCT00441337|62763355|FG001|Overall Study|Lost to Follow-up|0|||
33384411|NCT00441337|62763356|FG002|Overall Study|Lost to Follow-up|0|||
33384412|NCT00441337|62763357|FG003|Overall Study|Lost to Follow-up|1|||
33384413|NCT00441337|62763354|FG000|Overall Study|Sponsor Decision|0|||
33384414|NCT00441337|62763355|FG001|Overall Study|Sponsor Decision|0|||
33384415|NCT00441337|62763356|FG002|Overall Study|Sponsor Decision|1|||
33384416|NCT00441337|62763357|FG003|Overall Study|Sponsor Decision|2|||
33296483|NCT01340027|62672927|FG005|Overall Study|Lost to Follow-up|0|||
33296484|NCT01340027|62672928|FG006|Overall Study|Lost to Follow-up|1|||
33296485|NCT01340027|62672929|FG007|Overall Study|Lost to Follow-up|0|||
33296486|NCT01340027|62672930|FG008|Overall Study|Lost to Follow-up|0|||
33296487|NCT01340027|62672931|FG009|Overall Study|Lost to Follow-up|1|||
33384417|NCT00441337|62763354|FG000|Overall Study|Did not meet inclusion criteria|0|||
33384418|NCT00441337|62763355|FG001|Overall Study|Did not meet inclusion criteria|0|||
33384419|NCT00441337|62763356|FG002|Overall Study|Did not meet inclusion criteria|1|||
33384420|NCT00441337|62763357|FG003|Overall Study|Did not meet inclusion criteria|0|||
33384421|NCT00578877|62763377|FG000|Overall Study|Lost to Follow-up|8|||
33384422|NCT00578877|62763378|FG001|Overall Study|Lost to Follow-up|10|||
33384423|NCT00578877|62763377|FG000|Overall Study|early discontinue|61|||
33384424|NCT00578877|62763378|FG001|Overall Study|early discontinue|101|||
33384425|NCT00578877|62763377|FG000|Overall Study|did not provide follow-up data|12|||
33384426|NCT00578877|62763378|FG001|Overall Study|did not provide follow-up data|17|||
33384427|NCT00468481|62763386|FG000|Overall Study|Adverse Event|13|||
33296488|NCT01340027|62672932|FG010|Overall Study|Lost to Follow-up|0|||
33296489|NCT01340027|62672933|FG011|Overall Study|Lost to Follow-up|0|||
33296490|NCT01340027|62672922|FG000|Overall Study|Protocol Violation|1|||
33296491|NCT01340027|62672923|FG001|Overall Study|Protocol Violation|2|||
33384428|NCT00468481|62763387|FG001|Overall Study|Adverse Event|3|||
33556730|NCT02791763|62949550|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
33556731|NCT02791763|62949551|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
33296492|NCT01340027|62672924|FG002|Overall Study|Protocol Violation|0|||
33296493|NCT01340027|62672925|FG003|Overall Study|Protocol Violation|0|||
33296494|NCT01340027|62672926|FG004|Overall Study|Protocol Violation|6|||
33296495|NCT01340027|62672927|FG005|Overall Study|Protocol Violation|0|||
33296496|NCT01340027|62672928|FG006|Overall Study|Protocol Violation|0|||
33296497|NCT01340027|62672929|FG007|Overall Study|Protocol Violation|1|||
33296498|NCT01340027|62672930|FG008|Overall Study|Protocol Violation|2|||
33296499|NCT01340027|62672931|FG009|Overall Study|Protocol Violation|2|||
33296500|NCT01340027|62672932|FG010|Overall Study|Protocol Violation|0|||
33296501|NCT01340027|62672933|FG011|Overall Study|Protocol Violation|0|||
33296502|NCT01340027|62672922|FG000|Overall Study|Withdrawal by Subject|4|||
33296503|NCT01340027|62672923|FG001|Overall Study|Withdrawal by Subject|3|||
33296504|NCT01340027|62672924|FG002|Overall Study|Withdrawal by Subject|1|||
33296505|NCT01340027|62672925|FG003|Overall Study|Withdrawal by Subject|3|||
33296506|NCT01340027|62672926|FG004|Overall Study|Withdrawal by Subject|3|||
33296507|NCT01340027|62672927|FG005|Overall Study|Withdrawal by Subject|2|||
33296508|NCT01340027|62672928|FG006|Overall Study|Withdrawal by Subject|3|||
33296509|NCT01340027|62672929|FG007|Overall Study|Withdrawal by Subject|4|||
33296510|NCT01340027|62672930|FG008|Overall Study|Withdrawal by Subject|1|||
33296511|NCT01340027|62672931|FG009|Overall Study|Withdrawal by Subject|2|||
33296512|NCT01340027|62672932|FG010|Overall Study|Withdrawal by Subject|0|||
33296513|NCT01340027|62672933|FG011|Overall Study|Withdrawal by Subject|1|||
33296514|NCT01340027|62672922|FG000|Overall Study|Miscellaneous|0|||
33296515|NCT01340027|62672923|FG001|Overall Study|Miscellaneous|0|||
33296516|NCT01340027|62672924|FG002|Overall Study|Miscellaneous|0|||
33296517|NCT01340027|62672925|FG003|Overall Study|Miscellaneous|1|||
33296518|NCT01340027|62672926|FG004|Overall Study|Miscellaneous|0|||
33296519|NCT01340027|62672927|FG005|Overall Study|Miscellaneous|0|||
33296520|NCT01340027|62672928|FG006|Overall Study|Miscellaneous|0|||
33296521|NCT01340027|62672929|FG007|Overall Study|Miscellaneous|0|||
33296522|NCT01340027|62672930|FG008|Overall Study|Miscellaneous|0|||
33296523|NCT01340027|62672931|FG009|Overall Study|Miscellaneous|0|||
33296524|NCT01340027|62672932|FG010|Overall Study|Miscellaneous|1|||
33296525|NCT01340027|62672933|FG011|Overall Study|Miscellaneous|0|||
33296526|NCT01327053|62672961|FG000|Overall Study|Adverse Event|23|||
33296527|NCT01327053|62672962|FG001|Overall Study|Adverse Event|57|||
33296528|NCT01327053|62672961|FG000|Overall Study|Patient/guardian decision|11|||
33296529|NCT01327053|62672962|FG001|Overall Study|Patient/guardian decision|35|||
33296530|NCT01327053|62672961|FG000|Overall Study|Physician Decision|10|||
33296531|NCT01327053|62672962|FG001|Overall Study|Physician Decision|14|||
33296532|NCT01327053|62672961|FG000|Overall Study|Death|1|||
33296533|NCT01327053|62672962|FG001|Overall Study|Death|5|||
33296534|NCT01327053|62672961|FG000|Overall Study|Lost to Follow-up|2|||
33296535|NCT01327053|62672962|FG001|Overall Study|Lost to Follow-up|4|||
33296536|NCT01327053|62672961|FG000|Overall Study|Non-compliance with study treatment|0|||
33296537|NCT01327053|62672962|FG001|Overall Study|Non-compliance with study treatment|5|||
33296538|NCT01327053|62672961|FG000|Overall Study|Study terminated by Sponsor|1|||
33296539|NCT01327053|62672962|FG001|Overall Study|Study terminated by Sponsor|3|||
33296540|NCT01327053|62672961|FG000|Overall Study|Progressive disease|31|||
33296541|NCT01327053|62672962|FG001|Overall Study|Progressive disease|26|||
33296542|NCT01327053|62672961|FG000|Overall Study|Protocol Violation|0|||
33296543|NCT01327053|62672962|FG001|Overall Study|Protocol Violation|1|||
33296544|NCT01327053|62672961|FG000|Overall Study|Untreated|0|||
33296545|NCT01327053|62672962|FG001|Overall Study|Untreated|1|||
33296546|NCT01107925|62672976|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
33296547|NCT01107925|62672977|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
33296548|NCT01107925|62672978|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
33296549|NCT01107925|62672979|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
33296550|NCT01107925|62672980|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
33296551|NCT01107925|62672981|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
33296552|NCT01107925|62672976|FG000|Period 2|Withdrawal by Subject|0|||
33296553|NCT01107925|62672977|FG001|Period 2|Withdrawal by Subject|1|||
33296554|NCT01107925|62672978|FG002|Period 2|Withdrawal by Subject|0|||
33296555|NCT01107925|62672979|FG003|Period 2|Withdrawal by Subject|0|||
33296556|NCT01107925|62672980|FG004|Period 2|Withdrawal by Subject|0|||
33296557|NCT01107925|62672981|FG005|Period 2|Withdrawal by Subject|1|||
33296558|NCT01339832|62673009|FG000|Overall Study|Lost to Follow-up|3|||
33296559|NCT01339832|62673009|FG000|Overall Study|Death|11|||
33296560|NCT01339559|62673013|FG000|Overall Study|Adverse Event|92|||
33296561|NCT01339559|62673013|FG000|Overall Study|Death|5|||
33296562|NCT01339559|62673013|FG000|Overall Study|Lack of Efficacy|164|||
33296563|NCT01339559|62673013|FG000|Overall Study|Lost to Follow-up|22|||
33296564|NCT01339559|62673013|FG000|Overall Study|Subject choice|89|||
33296565|NCT01339559|62673013|FG000|Overall Study|Protocol Violation|15|||
33296566|NCT01339559|62673013|FG000|Overall Study|Study closure at site|1|||
33384429|NCT00468481|62763386|FG000|Overall Study|Lost to Follow-up|25|||
33384430|NCT00468481|62763387|FG001|Overall Study|Lost to Follow-up|8|||
33384431|NCT00468481|62763386|FG000|Overall Study|Pregnancy|2|||
33384432|NCT00468481|62763387|FG001|Overall Study|Pregnancy|0|||
33384433|NCT00468481|62763386|FG000|Overall Study|Protocol Violation|18|||
33384434|NCT00468481|62763387|FG001|Overall Study|Protocol Violation|8|||
33384435|NCT00468481|62763386|FG000|Overall Study|Withdrawal by Subject|12|||
33384436|NCT00468481|62763387|FG001|Overall Study|Withdrawal by Subject|3|||
33384437|NCT00468481|62763386|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
33384438|NCT00468481|62763387|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
33296567|NCT01339559|62673013|FG000|Overall Study|Incarcerated|2|||
33296568|NCT01339559|62673013|FG000|Overall Study|Epilepsy surgery|1|||
33296569|NCT01339559|62673013|FG000|Overall Study|Pregnancy planned|2|||
33296570|NCT01339559|62673013|FG000|Overall Study|Left the country|1|||
33296571|NCT01339559|62673013|FG000|Overall Study|Investigator decision|2|||
33296572|NCT01339559|62673013|FG000|Overall Study|Patient didn't wish to continue|1|||
33296573|NCT01339559|62673013|FG000|Overall Study|PI decision|1|||
33384439|NCT00468481|62763386|FG000|Overall Study|Prohibited Medication|1|||
33384440|NCT00468481|62763387|FG001|Overall Study|Prohibited Medication|1|||
33384441|NCT00468481|62763386|FG000|Overall Study|Egg Donor|1|||
33384442|NCT00468481|62763387|FG001|Overall Study|Egg Donor|0|||
33384443|NCT00468481|62763386|FG000|Overall Study|Moved out of area|4|||
33384444|NCT00468481|62763387|FG001|Overall Study|Moved out of area|1|||
33488641|NCT00113087|62866819|FG001|Overall Study|Family or MD withdrew subject|5|||
33488642|NCT00112463|62866825|FG000|Overall Study|Physician Decision|1|||
33488643|NCT00112463|62866825|FG000|Overall Study|Progression|30|||
33488644|NCT00112463|62866825|FG000|Overall Study|Second Primary|1|||
33488645|NCT00112463|62866825|FG000|Overall Study|Toxicity|3|||
33488646|NCT00112463|62866825|FG000|Overall Study|Withdrawal by Subject|2|||
33488647|NCT00112463|62866825|FG000|Overall Study|Never started treatment|2|||
33488648|NCT03548415|62866835|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
33488649|NCT03548415|62866836|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
33488650|NCT03548415|62866837|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
33488651|NCT03548415|62866838|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
33488652|NCT03548415|62866839|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
33488653|NCT00112385|62866855|FG000|Overall Study|Lost to Follow-up|1|||
33488654|NCT00112385|62866856|FG001|Overall Study|Lost to Follow-up|0|||
33488655|NCT00112385|62866855|FG000|Overall Study|Withdrawal by Subject|0|||
33488656|NCT00112385|62866856|FG001|Overall Study|Withdrawal by Subject|1|||
33488657|NCT03548337|62866864|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
33488658|NCT03548337|62866865|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
33488659|NCT03548337|62866864|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
33488660|NCT03548337|62866865|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
33488661|NCT03548337|62866864|FG000|Infant Series|Lost to Follow-up|2|||
33488662|NCT03548337|62866865|FG001|Infant Series|Lost to Follow-up|1|||
33488663|NCT03548337|62866864|FG000|Infant Series|Adverse Event|0|||
33488664|NCT03548337|62866865|FG001|Infant Series|Adverse Event|2|||
33488665|NCT03548337|62866864|FG000|Infant Series|Randomized but Not Vaccinated|1|||
33488666|NCT03548337|62866865|FG001|Infant Series|Randomized but Not Vaccinated|0|||
33488667|NCT03548337|62866864|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
33488668|NCT03548337|62866865|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
33488669|NCT03596151|62866877|FG000|Overall Study|Withdrawal by Subject|1|||
33488670|NCT03547635|62866884|FG000|Overall Study|Adverse Event|5|||
33488671|NCT03547635|62866885|FG001|Overall Study|Adverse Event|2|||
33488672|NCT03547635|62866886|FG002|Overall Study|Adverse Event|3|||
33488673|NCT03547635|62866884|FG000|Overall Study|Lost to Follow-up|1|||
33488674|NCT03547635|62866885|FG001|Overall Study|Lost to Follow-up|3|||
33488675|NCT03547635|62866886|FG002|Overall Study|Lost to Follow-up|4|||
33488676|NCT03547635|62866884|FG000|Overall Study|Withdrawal by Subject|1|||
33296574|NCT00107900|62673024|FG000|Overall Study|Adverse Event|3|||
33296575|NCT00107900|62673025|FG001|Overall Study|Adverse Event|2|||
33296576|NCT00107900|62673026|FG002|Overall Study|Adverse Event|10|||
33296577|NCT00107900|62673027|FG003|Overall Study|Adverse Event|3|||
33384445|NCT00468481|62763386|FG000|Overall Study|Non-Compliance|5|||
33384446|NCT00468481|62763387|FG001|Overall Study|Non-Compliance|0|||
33384447|NCT00468481|62763386|FG000|Overall Study|Other|6|||
33384448|NCT00468481|62763387|FG001|Overall Study|Other|0|||
33488677|NCT03547635|62866885|FG001|Overall Study|Withdrawal by Subject|0|||
33488678|NCT03547635|62866886|FG002|Overall Study|Withdrawal by Subject|0|||
33488679|NCT03547635|62866884|FG000|Overall Study|Withdrawal By PI|0|||
33488680|NCT03547635|62866885|FG001|Overall Study|Withdrawal By PI|1|||
33488681|NCT03547635|62866886|FG002|Overall Study|Withdrawal By PI|0|||
33488682|NCT03547635|62866884|FG000|Overall Study|Withdrawal by Sponsor|0|||
33296578|NCT00107900|62673028|FG004|Overall Study|Adverse Event|5|||
33384449|NCT00714168|62763395|FG000|Overall Study|Pregnancy|5|||
33384450|NCT00714168|62763396|FG001|Overall Study|Pregnancy|4|||
33384451|NCT00714168|62763395|FG000|Overall Study|Lost to Follow-up|32|||
33384452|NCT00714168|62763396|FG001|Overall Study|Lost to Follow-up|50|||
33296579|NCT00107900|62673029|FG005|Overall Study|Adverse Event|3|||
33296580|NCT00107900|62673024|FG000|Overall Study|Death|0|||
33384453|NCT00714168|62763395|FG000|Overall Study|Relocation|4|||
33384454|NCT00714168|62763396|FG001|Overall Study|Relocation|3|||
33384455|NCT00714168|62763395|FG000|Overall Study|Non-study medical condition|3|||
33384456|NCT00714168|62763396|FG001|Overall Study|Non-study medical condition|2|||
33384457|NCT00713700|62763402|FG000|Overall Study|Lost to Follow-up|3|||
33384458|NCT00713700|62763402|FG000|Overall Study|Withdrawal by Subject|1|||
33384459|NCT00468169|62763408|FG000|Overall Study|Withdrawal by Subject|1|||
33384460|NCT00468169|62763409|FG001|Overall Study|Withdrawal by Subject|0|||
33488683|NCT03547635|62866885|FG001|Overall Study|Withdrawal by Sponsor|0|||
33488684|NCT03547635|62866886|FG002|Overall Study|Withdrawal by Sponsor|1|||
33488685|NCT03547635|62866884|FG000|Overall Study|Errant Randomization before Treatment|0|||
33488686|NCT03547635|62866885|FG001|Overall Study|Errant Randomization before Treatment|1|||
33488687|NCT03547635|62866886|FG002|Overall Study|Errant Randomization before Treatment|0|||
33488688|NCT03547635|62866884|FG000|Overall Study|Withdrawal by Subject|1|||
33488689|NCT03547635|62866885|FG001|Overall Study|Withdrawal by Subject|0|||
33488690|NCT03547635|62866886|FG002|Overall Study|Withdrawal by Subject|0|||
33488691|NCT03182738|62866940|FG000|Overall Study|Lost to Follow-up|9|||
33488692|NCT03182738|62866941|FG001|Overall Study|Lost to Follow-up|3|||
33488693|NCT03182738|62866940|FG000|Overall Study|Pregnancy|0|||
33488694|NCT03182738|62866941|FG001|Overall Study|Pregnancy|1|||
33488695|NCT03182738|62866940|FG000|Overall Study|Withdrawal by Subject|0|||
33488696|NCT03182738|62866941|FG001|Overall Study|Withdrawal by Subject|1|||
33488697|NCT03547167|62866949|FG000|Overall Study|Withdrawal by Subject|34|||
33488698|NCT03547167|62866950|FG001|Overall Study|Withdrawal by Subject|12|||
33488699|NCT03547167|62866949|FG000|Overall Study|Screen Failure|0|||
33488700|NCT03547167|62866950|FG001|Overall Study|Screen Failure|1|||
33488701|NCT03547167|62866949|FG000|Overall Study|Lost to Follow-up|59|||
33488702|NCT03547167|62866950|FG001|Overall Study|Lost to Follow-up|15|||
33488703|NCT03547167|62866949|FG000|Overall Study|Death|4|||
33488704|NCT03547167|62866950|FG001|Overall Study|Death|2|||
33488705|NCT03560739|62866964|FG000|Overall Study|Adverse Event|0|||
33488706|NCT03560739|62866965|FG001|Overall Study|Adverse Event|1|||
33488707|NCT03560739|62866966|FG002|Overall Study|Adverse Event|0|||
33488708|NCT03560739|62866967|FG003|Overall Study|Adverse Event|0|||
33488709|NCT00101686|62866987|FG000|Overall Study|Progressive Disease|37|||
33488710|NCT00101686|62866988|FG001|Overall Study|Progressive Disease|28|||
33488711|NCT00101686|62866989|FG002|Overall Study|Progressive Disease|37|||
33488712|NCT00101686|62866990|FG003|Overall Study|Progressive Disease|38|||
33488713|NCT00101686|62866991|FG004|Overall Study|Progressive Disease|28|||
33488714|NCT00101686|62866992|FG005|Overall Study|Progressive Disease|25|||
33488715|NCT00101686|62866993|FG006|Overall Study|Progressive Disease|5|||
33488716|NCT00101686|62866994|FG007|Overall Study|Progressive Disease|7|||
33488717|NCT00101686|62866995|FG008|Overall Study|Progressive Disease|10|||
33488718|NCT00101686|62866996|FG009|Overall Study|Progressive Disease|8|||
33488719|NCT00101686|62866987|FG000|Overall Study|initiation other anti-cancer treatment|4|||
33384461|NCT00435487|62763419|FG000|Overall Study|Death|3|||
33384462|NCT00435487|62763420|FG001|Overall Study|Death|4|||
33488720|NCT00101686|62866988|FG001|Overall Study|initiation other anti-cancer treatment|3|||
33488721|NCT00101686|62866989|FG002|Overall Study|initiation other anti-cancer treatment|4|||
33488722|NCT00101686|62866990|FG003|Overall Study|initiation other anti-cancer treatment|3|||
33488723|NCT00101686|62866991|FG004|Overall Study|initiation other anti-cancer treatment|1|||
33488724|NCT00101686|62866992|FG005|Overall Study|initiation other anti-cancer treatment|1|||
33556732|NCT02791763|62949552|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
33556733|NCT02791763|62949550|FG000|Overall Study|Cancer event|1|||
33296581|NCT00107900|62673025|FG001|Overall Study|Death|0|||
33296582|NCT00107900|62673026|FG002|Overall Study|Death|0|||
33296583|NCT00107900|62673027|FG003|Overall Study|Death|0|||
33296584|NCT00107900|62673028|FG004|Overall Study|Death|1|||
33296585|NCT00107900|62673029|FG005|Overall Study|Death|0|||
33296586|NCT00107900|62673024|FG000|Overall Study|Lost to Follow-up|4|||
33296587|NCT00107900|62673025|FG001|Overall Study|Lost to Follow-up|1|||
33384463|NCT00435487|62763419|FG000|Overall Study|Adverse Event|0|||
33384464|NCT00435487|62763420|FG001|Overall Study|Adverse Event|3|||
33384465|NCT00435487|62763419|FG000|Overall Study|Lost to Follow-up|2|||
33488725|NCT00101686|62866993|FG006|Overall Study|initiation other anti-cancer treatment|2|||
33488726|NCT00101686|62866994|FG007|Overall Study|initiation other anti-cancer treatment|2|||
33488727|NCT00101686|62866995|FG008|Overall Study|initiation other anti-cancer treatment|3|||
33488728|NCT00101686|62866996|FG009|Overall Study|initiation other anti-cancer treatment|3|||
33488729|NCT00101686|62866987|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
33556734|NCT02791763|62949551|FG001|Overall Study|Cancer event|3|||
33384466|NCT00435487|62763420|FG001|Overall Study|Lost to Follow-up|2|||
33296588|NCT00107900|62673026|FG002|Overall Study|Lost to Follow-up|3|||
33296589|NCT00107900|62673027|FG003|Overall Study|Lost to Follow-up|2|||
33384467|NCT00435487|62763419|FG000|Overall Study|Other|5|||
33384468|NCT00435487|62763420|FG001|Overall Study|Other|2|||
33384469|NCT00435487|62763419|FG000|Overall Study|Withdrawal by Subject|2|||
33384470|NCT00435487|62763420|FG001|Overall Study|Withdrawal by Subject|1|||
33384471|NCT00435487|62763419|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
33384472|NCT00435487|62763420|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
33384473|NCT00435487|62763419|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
33384474|NCT00435487|62763420|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
33384475|NCT00579345|62763434|FG000|Overall Study|Withdrawal by Subject|2|||
33384476|NCT00579345|62763435|FG001|Overall Study|Withdrawal by Subject|0|||
33384477|NCT00579345|62763436|FG002|Overall Study|Withdrawal by Subject|0|||
33384478|NCT00579345|62763437|FG003|Overall Study|Withdrawal by Subject|0|||
33384479|NCT00579345|62763438|FG004|Overall Study|Withdrawal by Subject|0|||
33384480|NCT00579345|62763439|FG005|Overall Study|Withdrawal by Subject|0|||
33296590|NCT00107900|62673028|FG004|Overall Study|Lost to Follow-up|5|||
33296591|NCT00107900|62673029|FG005|Overall Study|Lost to Follow-up|5|||
33296592|NCT00107900|62673024|FG000|Overall Study|Protocol Violation|1|||
33296593|NCT00107900|62673025|FG001|Overall Study|Protocol Violation|0|||
33296594|NCT00107900|62673026|FG002|Overall Study|Protocol Violation|5|||
33296595|NCT00107900|62673027|FG003|Overall Study|Protocol Violation|5|||
33296596|NCT00107900|62673028|FG004|Overall Study|Protocol Violation|7|||
33296597|NCT00107900|62673029|FG005|Overall Study|Protocol Violation|0|||
33296598|NCT00107900|62673024|FG000|Overall Study|Withdrawal by Subject|1|||
33296599|NCT00107900|62673025|FG001|Overall Study|Withdrawal by Subject|0|||
33296600|NCT00107900|62673026|FG002|Overall Study|Withdrawal by Subject|5|||
33296601|NCT00107900|62673027|FG003|Overall Study|Withdrawal by Subject|0|||
33296602|NCT00107900|62673028|FG004|Overall Study|Withdrawal by Subject|1|||
33296603|NCT00107900|62673029|FG005|Overall Study|Withdrawal by Subject|1|||
33384481|NCT00579345|62763440|FG006|Overall Study|Withdrawal by Subject|0|||
33384482|NCT00579345|62763441|FG007|Overall Study|Withdrawal by Subject|1|||
33384483|NCT00579345|62763434|FG000|Overall Study|Lost to Follow-up|1|||
33384484|NCT00579345|62763435|FG001|Overall Study|Lost to Follow-up|0|||
33384485|NCT00579345|62763436|FG002|Overall Study|Lost to Follow-up|0|||
33384486|NCT00579345|62763437|FG003|Overall Study|Lost to Follow-up|0|||
33384487|NCT00579345|62763438|FG004|Overall Study|Lost to Follow-up|0|||
33384488|NCT00579345|62763439|FG005|Overall Study|Lost to Follow-up|0|||
33384489|NCT00579345|62763440|FG006|Overall Study|Lost to Follow-up|0|||
33384490|NCT00579345|62763441|FG007|Overall Study|Lost to Follow-up|0|||
33384491|NCT00579345|62763434|FG000|Overall Study|Adverse Event|0|||
33384492|NCT00579345|62763435|FG001|Overall Study|Adverse Event|0|||
33384493|NCT00579345|62763436|FG002|Overall Study|Adverse Event|1|||
33384494|NCT00579345|62763437|FG003|Overall Study|Adverse Event|0|||
33384495|NCT00579345|62763438|FG004|Overall Study|Adverse Event|0|||
33384496|NCT00579345|62763439|FG005|Overall Study|Adverse Event|0|||
33384497|NCT00579345|62763440|FG006|Overall Study|Adverse Event|0|||
33384498|NCT00579345|62763441|FG007|Overall Study|Adverse Event|0|||
33384499|NCT00579345|62763434|FG000|Overall Study|Protocol Violation|1|||
33384500|NCT00579345|62763435|FG001|Overall Study|Protocol Violation|0|||
33384501|NCT00579345|62763436|FG002|Overall Study|Protocol Violation|0|||
33384502|NCT00579345|62763437|FG003|Overall Study|Protocol Violation|0|||
33384503|NCT00579345|62763438|FG004|Overall Study|Protocol Violation|0|||
33384504|NCT00579345|62763439|FG005|Overall Study|Protocol Violation|0|||
33384505|NCT00579345|62763440|FG006|Overall Study|Protocol Violation|0|||
33384506|NCT00579345|62763441|FG007|Overall Study|Protocol Violation|1|||
33296604|NCT00107900|62673024|FG000|Overall Study|Administrative Reasons|1|||
33296605|NCT00107900|62673025|FG001|Overall Study|Administrative Reasons|0|||
33296606|NCT00107900|62673026|FG002|Overall Study|Administrative Reasons|2|||
33296607|NCT00107900|62673027|FG003|Overall Study|Administrative Reasons|2|||
33296608|NCT00107900|62673028|FG004|Overall Study|Administrative Reasons|2|||
33296609|NCT00107900|62673029|FG005|Overall Study|Administrative Reasons|0|||
33296610|NCT01339052|62673045|FG000|Overall Study|Disease progression|13|||
33296611|NCT01339052|62673046|FG001|Overall Study|Disease progression|46|||
33384507|NCT00579345|62763434|FG000|Overall Study|Death|1|||
33384508|NCT00579345|62763435|FG001|Overall Study|Death|1|||
33384509|NCT00579345|62763436|FG002|Overall Study|Death|1|||
33384510|NCT00579345|62763437|FG003|Overall Study|Death|1|||
33384511|NCT00579345|62763438|FG004|Overall Study|Death|0|||
33296612|NCT01339052|62673045|FG000|Overall Study|Adverse Event|1|||
33296613|NCT01339052|62673046|FG001|Overall Study|Adverse Event|1|||
33384512|NCT00579345|62763439|FG005|Overall Study|Death|0|||
33384513|NCT00579345|62763440|FG006|Overall Study|Death|0|||
33384514|NCT00579345|62763441|FG007|Overall Study|Death|0|||
33384515|NCT00795821|62763489|FG000|Acute Treatment Phase|Adverse Event|23|||
33384516|NCT00795821|62763490|FG001|Acute Treatment Phase|Adverse Event|4|||
33556735|NCT02791763|62949552|FG002|Overall Study|Cancer event|0|||
33296614|NCT01339052|62673045|FG000|Overall Study|Withdrawal by Subject|0|||
33296615|NCT01339052|62673046|FG001|Overall Study|Withdrawal by Subject|3|||
33296616|NCT01339052|62673045|FG000|Overall Study|Physician Decision|1|||
33296617|NCT01339052|62673046|FG001|Overall Study|Physician Decision|0|||
33384517|NCT00795821|62763489|FG000|Acute Treatment Phase|Death|1|||
33384518|NCT00795821|62763490|FG001|Acute Treatment Phase|Death|0|||
33384519|NCT00795821|62763489|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
33296618|NCT00107315|62673055|FG000|Overall Study|Disease Progression|9|||
33296619|NCT00107315|62673055|FG000|Overall Study|Adverse Event|4|||
33296620|NCT00107315|62673055|FG000|Overall Study|Withdrawal by Subject|2|||
33384520|NCT00795821|62763490|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
33384521|NCT00795821|62763489|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
33384522|NCT00795821|62763490|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
33384523|NCT00795821|62763489|FG000|Acute Treatment Phase|Physician Decision|1|||
33384524|NCT00795821|62763490|FG001|Acute Treatment Phase|Physician Decision|1|||
33384525|NCT00795821|62763489|FG000|Acute Treatment Phase|Protocol Violation|1|||
33384526|NCT00795821|62763490|FG001|Acute Treatment Phase|Protocol Violation|2|||
33384527|NCT00795821|62763489|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
33384528|NCT00795821|62763490|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
33384529|NCT00795821|62763489|FG000|Long-term Extension Phase|Adverse Event|25|||
33384530|NCT00795821|62763490|FG001|Long-term Extension Phase|Adverse Event|32|||
33384531|NCT00795821|62763489|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
33384532|NCT00795821|62763490|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
33384533|NCT00795821|62763489|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
33384534|NCT00795821|62763490|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
33384535|NCT00795821|62763489|FG000|Long-term Extension Phase|Physician Decision|1|||
33384536|NCT00795821|62763490|FG001|Long-term Extension Phase|Physician Decision|2|||
33384537|NCT00795821|62763489|FG000|Long-term Extension Phase|Protocol Violation|3|||
33384538|NCT00795821|62763490|FG001|Long-term Extension Phase|Protocol Violation|5|||
33384539|NCT00795821|62763489|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
33384540|NCT00795821|62763490|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
33384541|NCT00795821|62763489|FG000|Taper Phase|Adverse Event|2|||
33384542|NCT00795821|62763490|FG001|Taper Phase|Adverse Event|0|||
33384543|NCT00795821|62763489|FG000|Taper Phase|Lost to Follow-up|1|||
33384544|NCT00795821|62763490|FG001|Taper Phase|Lost to Follow-up|0|||
33384545|NCT00795821|62763489|FG000|Taper Phase|Physician Decision|2|||
33296621|NCT01335971|62673062|FG000|Overall Study|Withdrawal by Subject|1|||
33296622|NCT01335971|62673063|FG001|Overall Study|Withdrawal by Subject|0|||
33296623|NCT01335971|62673064|FG002|Overall Study|Withdrawal by Subject|0|||
33296624|NCT01335971|62673062|FG000|Overall Study|Did not complete bronchoscopy|1|||
33296625|NCT01335971|62673063|FG001|Overall Study|Did not complete bronchoscopy|1|||
33296626|NCT01335971|62673064|FG002|Overall Study|Did not complete bronchoscopy|1|||
33296627|NCT00107276|62673072|FG000|Overall Study|Progression|46|||
33296628|NCT00107276|62673072|FG000|Overall Study|Adverse Event|6|||
33296629|NCT00107276|62673072|FG000|Overall Study|M.D. decision|2|||
33296630|NCT00107276|62673072|FG000|Overall Study|Patient refusal|1|||
33296631|NCT00107276|62673072|FG000|Overall Study|Death|1|||
33296632|NCT00107276|62673072|FG000|Overall Study|Ineligible|16|||
33296633|NCT01335698|62673082|FG000|Treatment Stage 1|Lack of Efficacy|3|||
33296634|NCT01335698|62673083|FG001|Treatment Stage 1|Lack of Efficacy|1|||
33296635|NCT01335698|62673084|FG002|Treatment Stage 1|Lack of Efficacy|3|||
33296636|NCT01335698|62673085|FG003|Treatment Stage 1|Lack of Efficacy|3|||
33384546|NCT00795821|62763490|FG001|Taper Phase|Physician Decision|0|||
33384547|NCT00795821|62763489|FG000|Taper Phase|Withdrawal by Subject|4|||
33384548|NCT00795821|62763490|FG001|Taper Phase|Withdrawal by Subject|0|||
33384549|NCT00578643|62763506|FG000|Overall Study|Death|1|||
33384550|NCT00578643|62763506|FG000|Overall Study|Lost to Follow-up|1|||
33384551|NCT00578565|62763510|FG000|Overall Study|Adverse Event|3|||
33384552|NCT00741260|62763522|FG000|Overall Study|Disease Progression|3|||
33384553|NCT00741260|62763523|FG001|Overall Study|Disease Progression|5|||
33384554|NCT00741260|62763524|FG002|Overall Study|Disease Progression|3|||
33296637|NCT01335698|62673086|FG004|Treatment Stage 1|Lack of Efficacy|1|||
33296638|NCT01335698|62673082|FG000|Treatment Stage 1|Adverse Event|1|||
33296639|NCT01335698|62673083|FG001|Treatment Stage 1|Adverse Event|2|||
33296640|NCT01335698|62673084|FG002|Treatment Stage 1|Adverse Event|2|||
33296641|NCT01335698|62673085|FG003|Treatment Stage 1|Adverse Event|1|||
33296642|NCT01335698|62673086|FG004|Treatment Stage 1|Adverse Event|1|||
33296643|NCT01335698|62673082|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
33296644|NCT01335698|62673083|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
33296645|NCT01335698|62673084|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
33384555|NCT00741260|62763525|FG003|Overall Study|Disease Progression|3|||
33384556|NCT00741260|62763526|FG004|Overall Study|Disease Progression|5|||
33384557|NCT00741260|62763527|FG005|Overall Study|Disease Progression|37|||
33384558|NCT00741260|62763528|FG006|Overall Study|Disease Progression|4|||
33384559|NCT00741260|62763522|FG000|Overall Study|Death|0|||
33384560|NCT00741260|62763523|FG001|Overall Study|Death|1|||
33296646|NCT01335698|62673085|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
33296647|NCT01335698|62673086|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
33296648|NCT01335698|62673082|FG000|Treatment Stage 1|Lost to Follow-up|1|||
33384561|NCT00741260|62763524|FG002|Overall Study|Death|0|||
33296649|NCT01335698|62673083|FG001|Treatment Stage 1|Lost to Follow-up|1|||
33296650|NCT01335698|62673084|FG002|Treatment Stage 1|Lost to Follow-up|0|||
33384562|NCT00741260|62763525|FG003|Overall Study|Death|1|||
33488730|NCT00101686|62866988|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
33384563|NCT00741260|62763526|FG004|Overall Study|Death|2|||
33384564|NCT00741260|62763527|FG005|Overall Study|Death|2|||
33384565|NCT00741260|62763528|FG006|Overall Study|Death|1|||
33384566|NCT00741260|62763522|FG000|Overall Study|Withdrawal by Subject|0|||
33384567|NCT00741260|62763523|FG001|Overall Study|Withdrawal by Subject|0|||
33384568|NCT00741260|62763524|FG002|Overall Study|Withdrawal by Subject|0|||
33384569|NCT00741260|62763525|FG003|Overall Study|Withdrawal by Subject|0|||
33384570|NCT00741260|62763526|FG004|Overall Study|Withdrawal by Subject|1|||
33384571|NCT00741260|62763527|FG005|Overall Study|Withdrawal by Subject|3|||
33384572|NCT00741260|62763528|FG006|Overall Study|Withdrawal by Subject|1|||
33384573|NCT00741260|62763522|FG000|Overall Study|Physician Decision|1|||
33384574|NCT00741260|62763523|FG001|Overall Study|Physician Decision|1|||
33384575|NCT00741260|62763524|FG002|Overall Study|Physician Decision|0|||
33384576|NCT00741260|62763525|FG003|Overall Study|Physician Decision|0|||
33384577|NCT00741260|62763526|FG004|Overall Study|Physician Decision|0|||
33384578|NCT00741260|62763527|FG005|Overall Study|Physician Decision|0|||
33384579|NCT00741260|62763528|FG006|Overall Study|Physician Decision|0|||
33384580|NCT00741260|62763522|FG000|Overall Study|Other|2|||
33384581|NCT00741260|62763523|FG001|Overall Study|Other|1|||
33384582|NCT00741260|62763524|FG002|Overall Study|Other|1|||
33384583|NCT00741260|62763525|FG003|Overall Study|Other|2|||
33384584|NCT00741260|62763526|FG004|Overall Study|Other|1|||
33384585|NCT00741260|62763527|FG005|Overall Study|Other|3|||
33384586|NCT00741260|62763528|FG006|Overall Study|Other|1|||
33384587|NCT00740870|62763549|FG000|Overall Study|Not Catheterized|4|||
33384588|NCT00740870|62763549|FG000|Overall Study|Further testing contraindicated implant|17|||
33384589|NCT00740792|62763560|FG000|Overall Study|Adverse Event|3|||
33384590|NCT00740792|62763561|FG001|Overall Study|Adverse Event|1|||
33384591|NCT00740792|62763562|FG002|Overall Study|Adverse Event|1|||
33384592|NCT00740792|62763563|FG003|Overall Study|Adverse Event|3|||
33384593|NCT00740792|62763560|FG000|Overall Study|Lack of Efficacy|1|||
33384594|NCT00740792|62763561|FG001|Overall Study|Lack of Efficacy|1|||
33384595|NCT00740792|62763562|FG002|Overall Study|Lack of Efficacy|0|||
33384596|NCT00740792|62763563|FG003|Overall Study|Lack of Efficacy|3|||
33384597|NCT00740792|62763560|FG000|Overall Study|Lost to Follow-up|2|||
33384598|NCT00740792|62763561|FG001|Overall Study|Lost to Follow-up|1|||
33384599|NCT00740792|62763562|FG002|Overall Study|Lost to Follow-up|0|||
33384600|NCT00740792|62763563|FG003|Overall Study|Lost to Follow-up|0|||
33384601|NCT00740792|62763560|FG000|Overall Study|Protocol Violation|0|||
33384602|NCT00740792|62763561|FG001|Overall Study|Protocol Violation|1|||
33384603|NCT00740792|62763562|FG002|Overall Study|Protocol Violation|0|||
33384604|NCT00740792|62763563|FG003|Overall Study|Protocol Violation|2|||
33384605|NCT00740792|62763560|FG000|Overall Study|Withdrawal by Subject|1|||
33384606|NCT00740792|62763561|FG001|Overall Study|Withdrawal by Subject|1|||
33384607|NCT00740792|62763562|FG002|Overall Study|Withdrawal by Subject|0|||
33384608|NCT00740792|62763563|FG003|Overall Study|Withdrawal by Subject|0|||
33384609|NCT00740792|62763560|FG000|Overall Study|administrative|3|||
33384610|NCT00740792|62763561|FG001|Overall Study|administrative|3|||
33384611|NCT00740792|62763562|FG002|Overall Study|administrative|8|||
33384612|NCT00740792|62763563|FG003|Overall Study|administrative|2|||
33384613|NCT00740714|62763576|FG000|Overall Study|Withdrawal by Subject|17|||
33384614|NCT00740714|62763577|FG001|Overall Study|Withdrawal by Subject|19|||
33384615|NCT00740714|62763578|FG002|Overall Study|Withdrawal by Subject|29|||
33384616|NCT00788957|62763590|FG000|Part 1|Death|8|||
33384617|NCT00788957|62763591|FG001|Part 1|Death|0|||
33384618|NCT00788957|62763592|FG002|Part 1|Death|0|||
33384619|NCT00788957|62763593|FG003|Part 1|Death|0|||
33384620|NCT00788957|62763594|FG004|Part 1|Death|0|||
33384621|NCT00788957|62763595|FG005|Part 1|Death|0|||
33384622|NCT00788957|62763590|FG000|Part 1|Lost to Follow-up|1|||
33384623|NCT00788957|62763591|FG001|Part 1|Lost to Follow-up|0|||
33384624|NCT00788957|62763592|FG002|Part 1|Lost to Follow-up|0|||
33384625|NCT00788957|62763593|FG003|Part 1|Lost to Follow-up|0|||
33488731|NCT00101686|62866989|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
33488732|NCT00101686|62866990|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
33488733|NCT00101686|62866991|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
33488734|NCT00101686|62866992|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
33488735|NCT00101686|62866993|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
33488736|NCT00101686|62866994|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
33488737|NCT00101686|62866995|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
33384626|NCT00788957|62763594|FG004|Part 1|Lost to Follow-up|0|||
33384627|NCT00788957|62763595|FG005|Part 1|Lost to Follow-up|0|||
33384628|NCT00788957|62763590|FG000|Part 2|Withdrawal by Subject|0|||
33384629|NCT00788957|62763591|FG001|Part 2|Withdrawal by Subject|9|||
33384630|NCT00788957|62763592|FG002|Part 2|Withdrawal by Subject|5|||
33384631|NCT00788957|62763593|FG003|Part 2|Withdrawal by Subject|3|||
33384632|NCT00788957|62763594|FG004|Part 2|Withdrawal by Subject|0|||
33384633|NCT00788957|62763595|FG005|Part 2|Withdrawal by Subject|0|||
33384634|NCT00788957|62763590|FG000|Part 2|Death|0|||
33384635|NCT00788957|62763591|FG001|Part 2|Death|32|||
33384636|NCT00788957|62763592|FG002|Part 2|Death|35|||
33384637|NCT00788957|62763593|FG003|Part 2|Death|37|||
33384638|NCT00788957|62763594|FG004|Part 2|Death|0|||
33384639|NCT00788957|62763595|FG005|Part 2|Death|0|||
33384640|NCT00788957|62763590|FG000|Part 2|Lost to Follow-up|0|||
33384641|NCT00788957|62763591|FG001|Part 2|Lost to Follow-up|0|||
33384642|NCT00788957|62763592|FG002|Part 2|Lost to Follow-up|3|||
33384643|NCT00788957|62763593|FG003|Part 2|Lost to Follow-up|0|||
33384644|NCT00788957|62763594|FG004|Part 2|Lost to Follow-up|0|||
33384645|NCT00788957|62763595|FG005|Part 2|Lost to Follow-up|0|||
33384646|NCT00788957|62763590|FG000|Part 2|On-study at time of data cut-off|0|||
33384647|NCT00788957|62763591|FG001|Part 2|On-study at time of data cut-off|1|||
33384648|NCT00788957|62763592|FG002|Part 2|On-study at time of data cut-off|1|||
33384649|NCT00788957|62763593|FG003|Part 2|On-study at time of data cut-off|1|||
33384650|NCT00788957|62763594|FG004|Part 2|On-study at time of data cut-off|0|||
33384651|NCT00788957|62763595|FG005|Part 2|On-study at time of data cut-off|0|||
33384652|NCT00788957|62763590|FG000|Part 3|Withdrawal by Subject|0|||
33384653|NCT00788957|62763591|FG001|Part 3|Withdrawal by Subject|0|||
33384654|NCT00788957|62763592|FG002|Part 3|Withdrawal by Subject|0|||
33384655|NCT00788957|62763593|FG003|Part 3|Withdrawal by Subject|0|||
33384656|NCT00788957|62763594|FG004|Part 3|Withdrawal by Subject|0|||
33384657|NCT00788957|62763595|FG005|Part 3|Withdrawal by Subject|2|||
33384658|NCT00788957|62763590|FG000|Part 3|Death|0|||
33384659|NCT00788957|62763591|FG001|Part 3|Death|0|||
33384660|NCT00788957|62763592|FG002|Part 3|Death|0|||
33384661|NCT00788957|62763593|FG003|Part 3|Death|0|||
33384662|NCT00788957|62763594|FG004|Part 3|Death|8|||
33384663|NCT00788957|62763595|FG005|Part 3|Death|9|||
33384664|NCT00788957|62763590|FG000|Part 3|On-study at time of data cut-off|0|||
33384665|NCT00788957|62763591|FG001|Part 3|On-study at time of data cut-off|0|||
33384666|NCT00788957|62763592|FG002|Part 3|On-study at time of data cut-off|0|||
33384667|NCT00788957|62763593|FG003|Part 3|On-study at time of data cut-off|0|||
33384668|NCT00788957|62763594|FG004|Part 3|On-study at time of data cut-off|1|||
33384669|NCT00788957|62763595|FG005|Part 3|On-study at time of data cut-off|0|||
33384670|NCT00740636|62763614|FG000|Overall Study|Adverse Event|0|||
33384671|NCT00740636|62763615|FG001|Overall Study|Adverse Event|2|||
33384672|NCT00740636|62763614|FG000|Overall Study|Patient Ineligible|0|||
33384673|NCT00740636|62763615|FG001|Overall Study|Patient Ineligible|1|||
33384674|NCT00740636|62763614|FG000|Overall Study|Patient Not Treated|0|||
33384675|NCT00740636|62763615|FG001|Overall Study|Patient Not Treated|1|||
33384676|NCT00740636|62763614|FG000|Overall Study|Progressive Disease|1|||
33384677|NCT00740636|62763615|FG001|Overall Study|Progressive Disease|0|||
33384678|NCT00740636|62763614|FG000|Overall Study|Death|1|||
33384679|NCT00740636|62763615|FG001|Overall Study|Death|0|||
33384680|NCT00735254|62763625|FG000|Overall Study|Protocol Violation|1|||
33384681|NCT00735254|62763626|FG001|Overall Study|Protocol Violation|1|||
33384682|NCT00735254|62763627|FG002|Overall Study|Protocol Violation|1|||
33556736|NCT02791763|62949550|FG000|Overall Study|Participant had renal transplant|3|||
33296651|NCT01335698|62673085|FG003|Treatment Stage 1|Lost to Follow-up|0|||
33296652|NCT01335698|62673086|FG004|Treatment Stage 1|Lost to Follow-up|0|||
33296653|NCT01335698|62673082|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
33296654|NCT01335698|62673083|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
33296655|NCT01335698|62673084|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
33296656|NCT01335698|62673085|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
33296657|NCT01335698|62673086|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
33296658|NCT01335698|62673082|FG000|Treatment Stage 1|No longer meets study criteria|1|||
33296659|NCT01335698|62673083|FG001|Treatment Stage 1|No longer meets study criteria|1|||
33296660|NCT01335698|62673084|FG002|Treatment Stage 1|No longer meets study criteria|0|||
33296661|NCT01335698|62673085|FG003|Treatment Stage 1|No longer meets study criteria|1|||
33296662|NCT01335698|62673086|FG004|Treatment Stage 1|No longer meets study criteria|0|||
33296663|NCT01335698|62673082|FG000|Treatment Stage 1|Other|1|||
33296664|NCT01335698|62673083|FG001|Treatment Stage 1|Other|0|||
33296665|NCT01335698|62673084|FG002|Treatment Stage 1|Other|0|||
33296666|NCT01335698|62673085|FG003|Treatment Stage 1|Other|1|||
33296667|NCT01335698|62673086|FG004|Treatment Stage 1|Other|0|||
33296668|NCT01335698|62673082|FG000|Treatment Stage 2|Lack of Efficacy|2|||
33296669|NCT01335698|62673083|FG001|Treatment Stage 2|Lack of Efficacy|1|||
33296670|NCT01335698|62673084|FG002|Treatment Stage 2|Lack of Efficacy|3|||
33296671|NCT01335698|62673085|FG003|Treatment Stage 2|Lack of Efficacy|1|||
33296672|NCT01335698|62673086|FG004|Treatment Stage 2|Lack of Efficacy|0|||
33384683|NCT00735254|62763628|FG003|Overall Study|Protocol Violation|0|||
33384684|NCT00795509|62763638|FG000|Overall Study|Protocol Violation|31|||
33556737|NCT02791763|62949551|FG001|Overall Study|Participant had renal transplant|0|||
33296673|NCT01335698|62673082|FG000|Treatment Stage 2|Adverse Event|2|||
33384685|NCT00787787|62763642|FG000|Overall Study|Lack of Efficacy|4|||
33384686|NCT00787787|62763642|FG000|Overall Study|Adverse Event|3|||
33384687|NCT00787319|62763646|FG000|Overall Study|Lost to Follow-up|2|||
33384688|NCT00787319|62763646|FG000|Overall Study|Withdrawal by Subject|15|||
33384689|NCT00787319|62763646|FG000|Overall Study|Adverse Event|3|||
33384690|NCT00787319|62763646|FG000|Overall Study|Objective progression or relapse|30|||
33384691|NCT00787319|62763646|FG000|Overall Study|Lack of Efficacy|1|||
33384692|NCT00787319|62763646|FG000|Overall Study|Budget exhausted/exceeded|1|||
33384693|NCT00787319|62763646|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
33384694|NCT00787319|62763646|FG000|Overall Study|No health insurance reimbursement|2|||
33384695|NCT00787319|62763646|FG000|Overall Study|Stabilized disease findings|3|||
33384696|NCT00787319|62763646|FG000|Overall Study|Inactive disease|5|||
33384697|NCT00794963|62763652|FG000|Overall Study|Withdrawal by Subject|1|||
33384698|NCT00794963|62763653|FG001|Overall Study|Withdrawal by Subject|4|||
33384699|NCT00794573|62763661|FG000|Overall Study|Death|3|||
33384700|NCT00794573|62763662|FG001|Overall Study|Death|0|||
33384701|NCT00794573|62763661|FG000|Overall Study|Withdrawal by Subject|9|||
33384702|NCT00794573|62763662|FG001|Overall Study|Withdrawal by Subject|12|||
33384703|NCT00794573|62763661|FG000|Overall Study|Lost to Follow-up|26|||
33384704|NCT00794573|62763662|FG001|Overall Study|Lost to Follow-up|33|||
33384705|NCT00584844|62763668|FG000|Overall Study|Withdrawal by Subject|59|||
33384706|NCT00584844|62763668|FG000|Overall Study|Screen Failure|20|||
33384707|NCT00739934|62763676|FG000|Voriconazole IV|Adverse Event|6|||
33384708|NCT00739934|62763676|FG000|Voriconazole Oral|Other|3|||
33384709|NCT00739310|62763685|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
33384710|NCT00739310|62763685|FG000|Overall Study|Withdrawal by Subject|1|||
33384711|NCT00739310|62763685|FG000|Overall Study|Lost to Follow-up|2|||
33384712|NCT00734630|62763692|FG000|Overall Study|Lack of Efficacy|4|||
33384713|NCT00734630|62763693|FG001|Overall Study|Lack of Efficacy|4|||
33384714|NCT00734630|62763692|FG000|Overall Study|Withdrawal by Subject|7|||
33384715|NCT00734630|62763693|FG001|Overall Study|Withdrawal by Subject|9|||
33384716|NCT00734630|62763692|FG000|Overall Study|Lost to Follow-up|13|||
33384717|NCT00734630|62763693|FG001|Overall Study|Lost to Follow-up|7|||
33384718|NCT00734630|62763692|FG000|Overall Study|Protocol Violation|0|||
33384719|NCT00734630|62763693|FG001|Overall Study|Protocol Violation|3|||
33384720|NCT00734630|62763692|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
33384721|NCT00734630|62763693|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
33384722|NCT00734630|62763692|FG000|Overall Study|Adverse Event|3|||
33384723|NCT00734630|62763693|FG001|Overall Study|Adverse Event|6|||
33384724|NCT00734630|62763692|FG000|Overall Study|Randomized in Error|0|||
33384725|NCT00734630|62763693|FG001|Overall Study|Randomized in Error|1|||
33384726|NCT00734630|62763692|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
33384727|NCT00734630|62763693|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
33384728|NCT00734630|62763692|FG000|Overall Study|Poor Compliance|1|||
33384729|NCT00734630|62763693|FG001|Overall Study|Poor Compliance|1|||
33384730|NCT00584454|62763699|FG000|Overall Study|Adverse Event|1|||
33384731|NCT00584454|62763699|FG000|Overall Study|Relocation|1|||
33384732|NCT00584454|62763699|FG000|Overall Study|Clinical Hold|2|||
33384733|NCT00578175|62763706|FG000|Overall Study|Adverse Event|0|||
33384734|NCT00578175|62763707|FG001|Overall Study|Adverse Event|1|||
33384735|NCT00578175|62763708|FG002|Overall Study|Adverse Event|1|||
33384736|NCT00578175|62763706|FG000|Overall Study|Other reasons|70|||
33384737|NCT00578175|62763707|FG001|Overall Study|Other reasons|42|||
33384738|NCT00578175|62763708|FG002|Overall Study|Other reasons|23|||
33384739|NCT00435409|62763720|FG000|Overall Study|Protocol Violation|1|||
33384740|NCT00435409|62763721|FG001|Overall Study|Protocol Violation|2|||
33384741|NCT00435409|62763722|FG002|Overall Study|Protocol Violation|0|||
33384742|NCT00435409|62763720|FG000|Overall Study|Lost to Follow-up|1|||
33384743|NCT00435409|62763721|FG001|Overall Study|Lost to Follow-up|2|||
33384744|NCT00435409|62763722|FG002|Overall Study|Lost to Follow-up|0|||
33384745|NCT00435409|62763720|FG000|Overall Study|Death|8|||
33384746|NCT00435409|62763721|FG001|Overall Study|Death|6|||
33384747|NCT00435409|62763722|FG002|Overall Study|Death|6|||
33384748|NCT00435409|62763720|FG000|Overall Study|Objective progression or relapse|158|||
33384749|NCT00435409|62763721|FG001|Overall Study|Objective progression or relapse|93|||
33384750|NCT00435409|62763722|FG002|Overall Study|Objective progression or relapse|58|||
33384751|NCT00435409|62763720|FG000|Overall Study|Global deterioration of health status|0|||
33384752|NCT00435409|62763721|FG001|Overall Study|Global deterioration of health status|0|||
33384753|NCT00435409|62763722|FG002|Overall Study|Global deterioration of health status|4|||
33488738|NCT00101686|62866996|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
33488739|NCT00101686|62866987|FG000|Overall Study|unacceptable toxicity|3|||
33488740|NCT00101686|62866988|FG001|Overall Study|unacceptable toxicity|9|||
33296674|NCT01335698|62673083|FG001|Treatment Stage 2|Adverse Event|0|||
33384754|NCT00435409|62763720|FG000|Overall Study|Withdrawal by Subject|8|||
33384755|NCT00435409|62763721|FG001|Overall Study|Withdrawal by Subject|7|||
33488741|NCT00101686|62866989|FG002|Overall Study|unacceptable toxicity|10|||
33296675|NCT01335698|62673084|FG002|Treatment Stage 2|Adverse Event|0|||
33296676|NCT01335698|62673085|FG003|Treatment Stage 2|Adverse Event|3|||
33296677|NCT01335698|62673086|FG004|Treatment Stage 2|Adverse Event|0|||
33296678|NCT01335698|62673082|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
33296679|NCT01335698|62673083|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
33296680|NCT01335698|62673084|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
33296681|NCT01335698|62673085|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
33296682|NCT01335698|62673086|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
33384756|NCT00435409|62763722|FG002|Overall Study|Withdrawal by Subject|1|||
33384757|NCT00435409|62763720|FG000|Overall Study|Other|45|||
33384758|NCT00435409|62763721|FG001|Overall Study|Other|30|||
33384759|NCT00435409|62763722|FG002|Overall Study|Other|1|||
33384760|NCT00435409|62763720|FG000|Overall Study|Adverse Event|0|||
33384761|NCT00435409|62763721|FG001|Overall Study|Adverse Event|0|||
33384762|NCT00435409|62763722|FG002|Overall Study|Adverse Event|8|||
33384763|NCT00435409|62763720|FG000|Overall Study|Sponsor decision|0|||
33384764|NCT00435409|62763721|FG001|Overall Study|Sponsor decision|3|||
33384765|NCT00435409|62763722|FG002|Overall Study|Sponsor decision|0|||
33384766|NCT00467857|62763739|FG000|Overall Study|Adverse Event|1|||
33384767|NCT00467857|62763740|FG001|Overall Study|Adverse Event|0|||
33384768|NCT00467857|62763739|FG000|Overall Study|Withdrew consent|2|||
33384769|NCT00467857|62763740|FG001|Overall Study|Withdrew consent|0|||
33488742|NCT00101686|62866990|FG003|Overall Study|unacceptable toxicity|6|||
33488743|NCT00101686|62866991|FG004|Overall Study|unacceptable toxicity|16|||
33488744|NCT00101686|62866992|FG005|Overall Study|unacceptable toxicity|10|||
33488745|NCT00101686|62866993|FG006|Overall Study|unacceptable toxicity|4|||
33488746|NCT00101686|62866994|FG007|Overall Study|unacceptable toxicity|2|||
33488747|NCT00101686|62866995|FG008|Overall Study|unacceptable toxicity|1|||
33488748|NCT00101686|62866996|FG009|Overall Study|unacceptable toxicity|4|||
33488749|NCT00101686|62866987|FG000|Overall Study|Randomized but did not receive treament|1|||
33488750|NCT00101686|62866988|FG001|Overall Study|Randomized but did not receive treament|6|||
33488751|NCT00101686|62866989|FG002|Overall Study|Randomized but did not receive treament|2|||
33488752|NCT00101686|62866990|FG003|Overall Study|Randomized but did not receive treament|2|||
33488753|NCT00101686|62866991|FG004|Overall Study|Randomized but did not receive treament|2|||
33488754|NCT00101686|62866992|FG005|Overall Study|Randomized but did not receive treament|2|||
33488755|NCT00101686|62866993|FG006|Overall Study|Randomized but did not receive treament|0|||
33488756|NCT00101686|62866994|FG007|Overall Study|Randomized but did not receive treament|1|||
33488757|NCT00101686|62866995|FG008|Overall Study|Randomized but did not receive treament|0|||
33488758|NCT00101686|62866996|FG009|Overall Study|Randomized but did not receive treament|1|||
33488759|NCT00101686|62866987|FG000|Overall Study|intercurrent non-cancer related illness|0|||
33488760|NCT00101686|62866988|FG001|Overall Study|intercurrent non-cancer related illness|0|||
33488761|NCT00101686|62866989|FG002|Overall Study|intercurrent non-cancer related illness|2|||
33488762|NCT00101686|62866990|FG003|Overall Study|intercurrent non-cancer related illness|0|||
33488763|NCT00101686|62866991|FG004|Overall Study|intercurrent non-cancer related illness|1|||
33488764|NCT00101686|62866992|FG005|Overall Study|intercurrent non-cancer related illness|3|||
33488765|NCT00101686|62866993|FG006|Overall Study|intercurrent non-cancer related illness|1|||
33488766|NCT00101686|62866994|FG007|Overall Study|intercurrent non-cancer related illness|0|||
33488767|NCT00101686|62866995|FG008|Overall Study|intercurrent non-cancer related illness|1|||
33488768|NCT00101686|62866996|FG009|Overall Study|intercurrent non-cancer related illness|1|||
33488769|NCT00101686|62866987|FG000|Overall Study|Physician Decision|10|||
33488770|NCT00101686|62866988|FG001|Overall Study|Physician Decision|13|||
33488771|NCT00101686|62866989|FG002|Overall Study|Physician Decision|6|||
33296683|NCT01335698|62673082|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
33296684|NCT01335698|62673083|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
33296685|NCT01335698|62673084|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
33296686|NCT01335698|62673085|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
33296687|NCT01335698|62673086|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
33296688|NCT01335698|62673082|FG000|Treatment Stage 2|Lost to Follow-up|1|||
33296689|NCT01335698|62673083|FG001|Treatment Stage 2|Lost to Follow-up|0|||
33296690|NCT01335698|62673084|FG002|Treatment Stage 2|Lost to Follow-up|0|||
33296691|NCT01335698|62673085|FG003|Treatment Stage 2|Lost to Follow-up|0|||
33296692|NCT01335698|62673086|FG004|Treatment Stage 2|Lost to Follow-up|0|||
33296693|NCT01335698|62673082|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
33296694|NCT01335698|62673083|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
33296695|NCT01335698|62673084|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
33296696|NCT01335698|62673085|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
33296697|NCT01335698|62673086|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
33384770|NCT00467857|62763739|FG000|Overall Study|Death|0|||
33384771|NCT00467857|62763740|FG001|Overall Study|Death|1|||
33384772|NCT00467857|62763739|FG000|Overall Study|Discharged from court service|0|||
33488772|NCT00101686|62866990|FG003|Overall Study|Physician Decision|7|||
33488773|NCT00101686|62866991|FG004|Overall Study|Physician Decision|8|||
33488774|NCT00101686|62866992|FG005|Overall Study|Physician Decision|9|||
33488775|NCT00101686|62866993|FG006|Overall Study|Physician Decision|5|||
33556738|NCT02791763|62949552|FG002|Overall Study|Participant had renal transplant|0|||
33384773|NCT00467857|62763740|FG001|Overall Study|Discharged from court service|1|||
33384774|NCT00467857|62763739|FG000|Overall Study|Emergency care required|0|||
33384775|NCT00467857|62763740|FG001|Overall Study|Emergency care required|1|||
33384776|NCT00467857|62763739|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
33384777|NCT00467857|62763740|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
33384778|NCT00467857|62763739|FG000|Overall Study|Discontinuation reason missing|0|||
33296698|NCT01335698|62673082|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
33296699|NCT01335698|62673083|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
33384779|NCT00467857|62763740|FG001|Overall Study|Discontinuation reason missing|3|||
33296700|NCT01335698|62673084|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
33296701|NCT01335698|62673085|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
33296702|NCT01335698|62673086|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
33296703|NCT01335698|62673082|FG000|Treatment Stage 2|Switched to another formulation|1|||
33296704|NCT01335698|62673083|FG001|Treatment Stage 2|Switched to another formulation|1|||
33296705|NCT01335698|62673084|FG002|Treatment Stage 2|Switched to another formulation|0|||
33296706|NCT01335698|62673085|FG003|Treatment Stage 2|Switched to another formulation|0|||
33384780|NCT00435019|62763748|FG000|Overall Study|Adverse Event|1|||
33384781|NCT00435019|62763749|FG001|Overall Study|Adverse Event|0|||
33384782|NCT00435019|62763748|FG000|Overall Study|Lack of Efficacy|1|||
33384783|NCT00435019|62763749|FG001|Overall Study|Lack of Efficacy|2|||
33384784|NCT00435019|62763748|FG000|Overall Study|Protocol Violation|3|||
33384785|NCT00435019|62763749|FG001|Overall Study|Protocol Violation|1|||
33384786|NCT00435019|62763748|FG000|Overall Study|Personal reasons for withdrawal|8|||
33384787|NCT00435019|62763749|FG001|Overall Study|Personal reasons for withdrawal|7|||
33384788|NCT00577863|62763757|FG000|Overall Study|Adverse Event|4|||
33384789|NCT00577863|62763758|FG001|Overall Study|Adverse Event|2|||
33384790|NCT00577863|62763757|FG000|Overall Study|Death|1|||
33384791|NCT00577863|62763758|FG001|Overall Study|Death|0|||
33384792|NCT00577863|62763757|FG000|Overall Study|Lost to Follow-up|2|||
33384793|NCT00577863|62763758|FG001|Overall Study|Lost to Follow-up|2|||
33384794|NCT00577863|62763757|FG000|Overall Study|Entry Criteria Exclusion|1|||
33384795|NCT00577863|62763758|FG001|Overall Study|Entry Criteria Exclusion|0|||
33384796|NCT00577863|62763757|FG000|Overall Study|Withdrawal by Subject|0|||
33384797|NCT00577863|62763758|FG001|Overall Study|Withdrawal by Subject|2|||
33384798|NCT00577863|62763757|FG000|Overall Study|Sponsor Decision|2|||
33384799|NCT00577863|62763758|FG001|Overall Study|Sponsor Decision|7|||
33384800|NCT00577863|62763757|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
33384801|NCT00577863|62763758|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
33384802|NCT00794417|62763768|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
33296707|NCT01335698|62673086|FG004|Treatment Stage 2|Switched to another formulation|0|||
33296708|NCT00107120|62673102|FG000|Overall Study|Adverse Event|4|||
33296709|NCT00107120|62673103|FG001|Overall Study|Adverse Event|1|||
33296710|NCT00107120|62673102|FG000|Overall Study|Lack of Efficacy|5|||
33296711|NCT00107120|62673103|FG001|Overall Study|Lack of Efficacy|5|||
33296712|NCT00107120|62673102|FG000|Overall Study|Protocol Violation|3|||
33296713|NCT00107120|62673103|FG001|Overall Study|Protocol Violation|0|||
33296714|NCT00107120|62673102|FG000|Overall Study|Withdrawal by Subject|8|||
33296715|NCT00107120|62673103|FG001|Overall Study|Withdrawal by Subject|9|||
33296716|NCT00107120|62673102|FG000|Overall Study|Lost to Follow-up|8|||
33296717|NCT00107120|62673103|FG001|Overall Study|Lost to Follow-up|6|||
33296718|NCT00107120|62673102|FG000|Overall Study|Pregnancy|0|||
33296719|NCT00107120|62673103|FG001|Overall Study|Pregnancy|1|||
33296720|NCT00107120|62673102|FG000|Overall Study|moving away from site|1|||
33296721|NCT00107120|62673103|FG001|Overall Study|moving away from site|1|||
33296722|NCT00107120|62673102|FG000|Overall Study|death of parent|0|||
33296723|NCT00107120|62673103|FG001|Overall Study|death of parent|1|||
33296724|NCT01335464|62673111|FG000|Overall Study|Adverse Event|15|||
33296725|NCT01335464|62673112|FG001|Overall Study|Adverse Event|25|||
33296726|NCT01335464|62673111|FG000|Overall Study|Non compliant with protocol|2|||
33296727|NCT01335464|62673112|FG001|Overall Study|Non compliant with protocol|0|||
33296728|NCT01335464|62673111|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
33296729|NCT01335464|62673112|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
33296730|NCT01335464|62673111|FG000|Overall Study|Not treated|2|||
33296731|NCT01335464|62673112|FG001|Overall Study|Not treated|0|||
33296732|NCT01335464|62673111|FG000|Overall Study|Reason other than those stated above|1|||
33296733|NCT01335464|62673112|FG001|Overall Study|Reason other than those stated above|1|||
33296734|NCT00107042|62673120|FG000|Overall Study|Lost to Follow-up|9|||
33296735|NCT00107042|62673121|FG001|Overall Study|Lost to Follow-up|7|||
33296736|NCT00107042|62673120|FG000|Overall Study|Withdrawal by Subject|6|||
33296737|NCT00107042|62673121|FG001|Overall Study|Withdrawal by Subject|1|||
33384803|NCT00794417|62763769|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
33384804|NCT00794417|62763770|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
33384805|NCT00794417|62763771|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
33384806|NCT00794417|62763768|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
33384807|NCT00794417|62763769|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
33296738|NCT00107042|62673120|FG000|Overall Study|Moved out of area|5|||
33296739|NCT00107042|62673121|FG001|Overall Study|Moved out of area|3|||
33296740|NCT00107042|62673120|FG000|Overall Study|Pregnancy|1|||
33384808|NCT00794417|62763770|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
33296741|NCT00107042|62673121|FG001|Overall Study|Pregnancy|1|||
33296742|NCT00107042|62673120|FG000|Overall Study|Inadvertent enrollment|0|||
33296743|NCT00107042|62673121|FG001|Overall Study|Inadvertent enrollment|1|||
33296744|NCT00107042|62673120|FG000|Overall Study|vaccinated outside window|1|||
33296745|NCT00107042|62673121|FG001|Overall Study|vaccinated outside window|1|||
33296746|NCT00107042|62673120|FG000|Overall Study|Disallowed medications|0|||
33296747|NCT00107042|62673121|FG001|Overall Study|Disallowed medications|2|||
33296748|NCT00106964|62673172|FG000|Overall Study|Lost to Follow-up|8|||
33296749|NCT00106964|62673173|FG001|Overall Study|Lost to Follow-up|6|||
33296750|NCT00106964|62673174|FG002|Overall Study|Lost to Follow-up|2|||
33296751|NCT00106964|62673172|FG000|Overall Study|Pregnancy|2|||
33296752|NCT00106964|62673173|FG001|Overall Study|Pregnancy|3|||
33296753|NCT00106964|62673174|FG002|Overall Study|Pregnancy|2|||
33296754|NCT00106964|62673172|FG000|Overall Study|Death|1|||
33296755|NCT00106964|62673173|FG001|Overall Study|Death|1|||
33296756|NCT00106964|62673174|FG002|Overall Study|Death|0|||
33296757|NCT00106964|62673172|FG000|Overall Study|Incarceration|0|||
33296758|NCT00106964|62673173|FG001|Overall Study|Incarceration|1|||
33296759|NCT00106964|62673174|FG002|Overall Study|Incarceration|0|||
33296760|NCT00106964|62673172|FG000|Overall Study|Site Funding Terminated|0|||
33296761|NCT00106964|62673173|FG001|Overall Study|Site Funding Terminated|1|||
33296762|NCT00106964|62673174|FG002|Overall Study|Site Funding Terminated|1|||
33296763|NCT00106964|62673172|FG000|Overall Study|Failure to adhere|2|||
33296764|NCT00106964|62673173|FG001|Overall Study|Failure to adhere|0|||
33296765|NCT00106964|62673174|FG002|Overall Study|Failure to adhere|0|||
33296766|NCT00106964|62673172|FG000|Overall Study|Did not meet eligibility criteria|0|||
33296767|NCT00106964|62673173|FG001|Overall Study|Did not meet eligibility criteria|2|||
33296768|NCT00106964|62673174|FG002|Overall Study|Did not meet eligibility criteria|2|||
33296769|NCT00106964|62673172|FG000|Overall Study|Required disallowed medication|0|||
33296770|NCT00106964|62673173|FG001|Overall Study|Required disallowed medication|1|||
33296771|NCT00106964|62673174|FG002|Overall Study|Required disallowed medication|0|||
33296772|NCT00106184|62673193|FG000|Overall Study|Withdrawal by Subject|3|||
33296773|NCT00106184|62673194|FG001|Overall Study|Withdrawal by Subject|2|||
33296774|NCT01334918|62673204|FG000|Overall Study|Did not receive study drug|6|||
33296775|NCT01334918|62673205|FG001|Overall Study|Did not receive study drug|0|||
33296776|NCT01334918|62673204|FG000|Overall Study|Adverse Event|2|||
33296777|NCT01334918|62673205|FG001|Overall Study|Adverse Event|0|||
33296778|NCT01334918|62673204|FG000|Overall Study|Withdrawal by Subject|0|||
33296779|NCT01334918|62673205|FG001|Overall Study|Withdrawal by Subject|1|||
33296780|NCT01332968|62673224|FG000|Induction Period|Adverse Event|23|||
33296781|NCT01332968|62673225|FG001|Induction Period|Adverse Event|26|||
33296782|NCT01332968|62673226|FG002|Induction Period|Adverse Event|0|||
33296783|NCT01332968|62673227|FG003|Induction Period|Adverse Event|0|||
33296784|NCT01332968|62673228|FG004|Induction Period|Adverse Event|0|||
33296785|NCT01332968|62673229|FG005|Induction Period|Adverse Event|0|||
33296786|NCT01332968|62673230|FG006|Induction Period|Adverse Event|0|||
33296787|NCT01332968|62673231|FG007|Induction Period|Adverse Event|0|||
33296788|NCT01332968|62673224|FG000|Induction Period|Death|1|||
33296789|NCT01332968|62673225|FG001|Induction Period|Death|4|||
33296790|NCT01332968|62673226|FG002|Induction Period|Death|0|||
33296791|NCT01332968|62673227|FG003|Induction Period|Death|0|||
33384809|NCT00794417|62763771|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
33384810|NCT00794417|62763768|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
33384811|NCT00794417|62763769|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
33384812|NCT00794417|62763770|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
33384813|NCT00794417|62763771|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
33384814|NCT00794417|62763768|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
33384815|NCT00794417|62763769|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
33384816|NCT00794417|62763770|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
33384817|NCT00794417|62763771|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
33384818|NCT00794417|62763768|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
33384819|NCT00794417|62763769|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
33384820|NCT00794417|62763770|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
33384821|NCT00794417|62763771|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
33384822|NCT00794417|62763768|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
33384823|NCT00794417|62763769|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
33384824|NCT00794417|62763770|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
33384825|NCT00794417|62763771|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
33384826|NCT00790907|62763786|FG000|Overall Study|Adverse Event|9|||
33384827|NCT00790907|62763787|FG001|Overall Study|Adverse Event|7|||
33384828|NCT00790907|62763788|FG002|Overall Study|Adverse Event|6|||
33296792|NCT01332968|62673228|FG004|Induction Period|Death|0|||
33296793|NCT01332968|62673229|FG005|Induction Period|Death|0|||
33296794|NCT01332968|62673230|FG006|Induction Period|Death|0|||
33296795|NCT01332968|62673231|FG007|Induction Period|Death|0|||
33296796|NCT01332968|62673224|FG000|Induction Period|Non-compliance|1|||
33296797|NCT01332968|62673225|FG001|Induction Period|Non-compliance|0|||
33384829|NCT00790907|62763786|FG000|Overall Study|Physician Decision|304|||
33384830|NCT00790907|62763787|FG001|Overall Study|Physician Decision|271|||
33384831|NCT00790907|62763788|FG002|Overall Study|Physician Decision|255|||
33384832|NCT00790907|62763786|FG000|Overall Study|Withdrawal by Subject|1|||
33384833|NCT00790907|62763787|FG001|Overall Study|Withdrawal by Subject|7|||
33384834|NCT00790907|62763788|FG002|Overall Study|Withdrawal by Subject|5|||
33384835|NCT00790907|62763786|FG000|Overall Study|Bleeding Event|11|||
33384836|NCT00790907|62763787|FG001|Overall Study|Bleeding Event|16|||
33384837|NCT00790907|62763788|FG002|Overall Study|Bleeding Event|21|||
33384838|NCT00790907|62763786|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
33384839|NCT00790907|62763787|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
33384840|NCT00790907|62763788|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
33296798|NCT01332968|62673226|FG002|Induction Period|Non-compliance|0|||
33384841|NCT00790907|62763786|FG000|Overall Study|Qualifying Condition Not Present|29|||
33384842|NCT00790907|62763787|FG001|Overall Study|Qualifying Condition Not Present|14|||
33384843|NCT00790907|62763788|FG002|Overall Study|Qualifying Condition Not Present|16|||
33384844|NCT00790907|62763786|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
33384845|NCT00790907|62763787|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
33384846|NCT00790907|62763788|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
33384847|NCT00790907|62763786|FG000|Overall Study|Did Not Receive Study Drug|10|||
33384848|NCT00790907|62763787|FG001|Overall Study|Did Not Receive Study Drug|0|||
33384849|NCT00790907|62763788|FG002|Overall Study|Did Not Receive Study Drug|0|||
33384850|NCT00793871|62763806|FG000|Overall Study|Death|50|||
33488776|NCT00101686|62866994|FG007|Overall Study|Physician Decision|5|||
33488777|NCT00101686|62866995|FG008|Overall Study|Physician Decision|1|||
33488778|NCT00101686|62866996|FG009|Overall Study|Physician Decision|1|||
33488779|NCT00101686|62866987|FG000|Overall Study|Other|1|||
33488780|NCT00101686|62866988|FG001|Overall Study|Other|4|||
33488781|NCT00101686|62866989|FG002|Overall Study|Other|1|||
33488782|NCT00101686|62866990|FG003|Overall Study|Other|6|||
33488783|NCT00101686|62866991|FG004|Overall Study|Other|2|||
33488784|NCT00101686|62866992|FG005|Overall Study|Other|12|||
33488785|NCT00101686|62866993|FG006|Overall Study|Other|1|||
33488786|NCT00101686|62866994|FG007|Overall Study|Other|5|||
33488787|NCT00101686|62866995|FG008|Overall Study|Other|3|||
33488788|NCT00101686|62866996|FG009|Overall Study|Other|3|||
33488789|NCT00101686|62866987|FG000|Overall Study|Withdrawal by Subject|9|||
33488790|NCT00101686|62866988|FG001|Overall Study|Withdrawal by Subject|8|||
33488791|NCT00101686|62866989|FG002|Overall Study|Withdrawal by Subject|6|||
33488792|NCT00101686|62866990|FG003|Overall Study|Withdrawal by Subject|8|||
33488793|NCT00101686|62866991|FG004|Overall Study|Withdrawal by Subject|8|||
33488794|NCT00101686|62866992|FG005|Overall Study|Withdrawal by Subject|7|||
33488795|NCT00101686|62866993|FG006|Overall Study|Withdrawal by Subject|7|||
33488796|NCT00101686|62866994|FG007|Overall Study|Withdrawal by Subject|7|||
33488797|NCT00101686|62866995|FG008|Overall Study|Withdrawal by Subject|8|||
33488798|NCT00101686|62866996|FG009|Overall Study|Withdrawal by Subject|9|||
33488799|NCT00101452|62867016|FG000|Overall Study|Adverse Event|2|||
33488800|NCT00101452|62867017|FG001|Overall Study|Adverse Event|0|||
33488801|NCT00101452|62867018|FG002|Overall Study|Adverse Event|1|||
33488802|NCT00101452|62867016|FG000|Overall Study|Lost to Follow-up|13|||
33488803|NCT00101452|62867017|FG001|Overall Study|Lost to Follow-up|8|||
33488804|NCT00101452|62867018|FG002|Overall Study|Lost to Follow-up|14|||
33296799|NCT01332968|62673227|FG003|Induction Period|Non-compliance|0|||
33296800|NCT01332968|62673228|FG004|Induction Period|Non-compliance|0|||
33296801|NCT01332968|62673229|FG005|Induction Period|Non-compliance|0|||
33296802|NCT01332968|62673230|FG006|Induction Period|Non-compliance|0|||
33296803|NCT01332968|62673231|FG007|Induction Period|Non-compliance|0|||
33296804|NCT01332968|62673224|FG000|Induction Period|Other|2|||
33296805|NCT01332968|62673225|FG001|Induction Period|Other|2|||
33296806|NCT01332968|62673226|FG002|Induction Period|Other|0|||
33296807|NCT01332968|62673227|FG003|Induction Period|Other|0|||
33296808|NCT01332968|62673228|FG004|Induction Period|Other|0|||
33384851|NCT00793871|62763806|FG000|Overall Study|Lost to Follow-up|3|||
33488805|NCT00101452|62867016|FG000|Overall Study|Withdrawal by Subject|10|||
33488806|NCT00101452|62867017|FG001|Overall Study|Withdrawal by Subject|14|||
33384852|NCT00793871|62763806|FG000|Overall Study|Study terminated by the Sponsor|7|||
33488807|NCT00101452|62867018|FG002|Overall Study|Withdrawal by Subject|9|||
33488808|NCT00101452|62867016|FG000|Overall Study|Baseline Fail|2|||
33488809|NCT00101452|62867017|FG001|Overall Study|Baseline Fail|1|||
33488810|NCT00101452|62867018|FG002|Overall Study|Baseline Fail|2|||
33488811|NCT00101452|62867016|FG000|Overall Study|Physician Decision|0|||
33488812|NCT00101452|62867017|FG001|Overall Study|Physician Decision|3|||
33384853|NCT00577707|62763814|FG000|Overall Study|Withdrawal by Subject|3|||
33384854|NCT00713349|62763818|FG000|Overall Study|Protocol Violation|1|||
33488813|NCT00101452|62867018|FG002|Overall Study|Physician Decision|2|||
33488814|NCT00101452|62867016|FG000|Overall Study|Protocol Violation|2|||
33488815|NCT00101452|62867017|FG001|Overall Study|Protocol Violation|1|||
33296809|NCT01332968|62673229|FG005|Induction Period|Other|0|||
33296810|NCT01332968|62673230|FG006|Induction Period|Other|0|||
33296811|NCT01332968|62673231|FG007|Induction Period|Other|0|||
33296812|NCT01332968|62673224|FG000|Induction Period|Physician Decision|6|||
33296813|NCT01332968|62673225|FG001|Induction Period|Physician Decision|1|||
33296814|NCT01332968|62673226|FG002|Induction Period|Physician Decision|0|||
33296815|NCT01332968|62673227|FG003|Induction Period|Physician Decision|0|||
33296816|NCT01332968|62673228|FG004|Induction Period|Physician Decision|0|||
33296817|NCT01332968|62673229|FG005|Induction Period|Physician Decision|0|||
33296818|NCT01332968|62673230|FG006|Induction Period|Physician Decision|0|||
33296819|NCT01332968|62673231|FG007|Induction Period|Physician Decision|0|||
33296820|NCT01332968|62673224|FG000|Induction Period|Progressive Disease|15|||
33296821|NCT01332968|62673225|FG001|Induction Period|Progressive Disease|7|||
33296822|NCT01332968|62673226|FG002|Induction Period|Progressive Disease|0|||
33296823|NCT01332968|62673227|FG003|Induction Period|Progressive Disease|0|||
33296824|NCT01332968|62673228|FG004|Induction Period|Progressive Disease|0|||
33296825|NCT01332968|62673229|FG005|Induction Period|Progressive Disease|0|||
33296826|NCT01332968|62673230|FG006|Induction Period|Progressive Disease|0|||
33296827|NCT01332968|62673231|FG007|Induction Period|Progressive Disease|0|||
33296828|NCT01332968|62673224|FG000|Induction Period|Protocol Violation|3|||
33296829|NCT01332968|62673225|FG001|Induction Period|Protocol Violation|4|||
33296830|NCT01332968|62673226|FG002|Induction Period|Protocol Violation|0|||
33296831|NCT01332968|62673227|FG003|Induction Period|Protocol Violation|0|||
33296832|NCT01332968|62673228|FG004|Induction Period|Protocol Violation|0|||
33296833|NCT01332968|62673229|FG005|Induction Period|Protocol Violation|0|||
33296834|NCT01332968|62673230|FG006|Induction Period|Protocol Violation|0|||
33296835|NCT01332968|62673231|FG007|Induction Period|Protocol Violation|0|||
33296836|NCT01332968|62673224|FG000|Induction Period|Withdrawal by Subject|3|||
33296837|NCT01332968|62673225|FG001|Induction Period|Withdrawal by Subject|5|||
33296838|NCT01332968|62673226|FG002|Induction Period|Withdrawal by Subject|0|||
33296839|NCT01332968|62673227|FG003|Induction Period|Withdrawal by Subject|0|||
33296840|NCT01332968|62673228|FG004|Induction Period|Withdrawal by Subject|0|||
33296841|NCT01332968|62673229|FG005|Induction Period|Withdrawal by Subject|0|||
33384855|NCT00712959|62763826|FG000|Overall Study|Protocol Violation|3|||
33384856|NCT00712959|62763827|FG001|Overall Study|Protocol Violation|1|||
33384857|NCT00712959|62763826|FG000|Overall Study|Lost to Follow-up|13|||
33384858|NCT00712959|62763827|FG001|Overall Study|Lost to Follow-up|2|||
33384859|NCT00712959|62763826|FG000|Overall Study|Withdrawal by Subject|3|||
33384860|NCT00712959|62763827|FG001|Overall Study|Withdrawal by Subject|0|||
33384861|NCT00712725|62763841|FG000|Overall Study|Adverse Event|1|||
33296842|NCT01332968|62673230|FG006|Induction Period|Withdrawal by Subject|0|||
33296843|NCT01332968|62673231|FG007|Induction Period|Withdrawal by Subject|0|||
33296844|NCT01332968|62673224|FG000|Induction Period|Randomised but not treated|4|||
33296845|NCT01332968|62673225|FG001|Induction Period|Randomised but not treated|7|||
33296846|NCT01332968|62673226|FG002|Induction Period|Randomised but not treated|0|||
33296847|NCT01332968|62673227|FG003|Induction Period|Randomised but not treated|0|||
33296848|NCT01332968|62673228|FG004|Induction Period|Randomised but not treated|0|||
33384862|NCT00712725|62763842|FG001|Overall Study|Adverse Event|0|||
33384863|NCT00712725|62763843|FG002|Overall Study|Adverse Event|0|||
33384864|NCT00712725|62763844|FG003|Overall Study|Adverse Event|1|||
33384865|NCT00712725|62763845|FG004|Overall Study|Adverse Event|0|||
33384866|NCT00712725|62763846|FG005|Overall Study|Adverse Event|0|||
33384867|NCT00712725|62763847|FG006|Overall Study|Adverse Event|0|||
33384868|NCT00712725|62763848|FG007|Overall Study|Adverse Event|0|||
33384869|NCT00712725|62763841|FG000|Overall Study|Lost to Follow-up|3|||
33384870|NCT00712725|62763842|FG001|Overall Study|Lost to Follow-up|2|||
33384871|NCT00712725|62763843|FG002|Overall Study|Lost to Follow-up|1|||
33384872|NCT00712725|62763844|FG003|Overall Study|Lost to Follow-up|1|||
33296849|NCT01332968|62673229|FG005|Induction Period|Randomised but not treated|0|||
33296850|NCT01332968|62673230|FG006|Induction Period|Randomised but not treated|0|||
33296851|NCT01332968|62673231|FG007|Induction Period|Randomised but not treated|0|||
33296852|NCT01332968|62673224|FG000|Maintenance/Observation Period|Adverse Event|0|||
33296853|NCT01332968|62673225|FG001|Maintenance/Observation Period|Adverse Event|0|||
33296854|NCT01332968|62673226|FG002|Maintenance/Observation Period|Adverse Event|53|||
33296855|NCT01332968|62673227|FG003|Maintenance/Observation Period|Adverse Event|66|||
33296856|NCT01332968|62673228|FG004|Maintenance/Observation Period|Adverse Event|0|||
33384873|NCT00712725|62763845|FG004|Overall Study|Lost to Follow-up|2|||
33556739|NCT02791763|62949550|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
33384874|NCT00712725|62763846|FG005|Overall Study|Lost to Follow-up|2|||
33384875|NCT00712725|62763847|FG006|Overall Study|Lost to Follow-up|3|||
33384876|NCT00712725|62763848|FG007|Overall Study|Lost to Follow-up|1|||
33384877|NCT00712725|62763841|FG000|Overall Study|Physician Decision|2|||
33384878|NCT00712725|62763842|FG001|Overall Study|Physician Decision|0|||
33384879|NCT00712725|62763843|FG002|Overall Study|Physician Decision|0|||
33556740|NCT02791763|62949551|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
33384880|NCT00712725|62763844|FG003|Overall Study|Physician Decision|0|||
33384881|NCT00712725|62763845|FG004|Overall Study|Physician Decision|1|||
33556741|NCT02791763|62949552|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
33384882|NCT00712725|62763846|FG005|Overall Study|Physician Decision|0|||
33384883|NCT00712725|62763847|FG006|Overall Study|Physician Decision|2|||
33384884|NCT00712725|62763848|FG007|Overall Study|Physician Decision|0|||
33384885|NCT00712725|62763841|FG000|Overall Study|Pregnancy|0|||
33384886|NCT00712725|62763842|FG001|Overall Study|Pregnancy|1|||
33488816|NCT00101452|62867018|FG002|Overall Study|Protocol Violation|3|||
33488817|NCT00101452|62867016|FG000|Overall Study|Other|15|||
33488818|NCT00101452|62867017|FG001|Overall Study|Other|16|||
33488819|NCT00101452|62867018|FG002|Overall Study|Other|12|||
33488820|NCT03546621|62867034|FG000|Overall Study|Withdrawal by Subject|0|||
33488821|NCT03546621|62867035|FG001|Overall Study|Withdrawal by Subject|1|||
33488822|NCT03546621|62867036|FG002|Overall Study|Withdrawal by Subject|2|||
33488823|NCT03546621|62867037|FG003|Overall Study|Withdrawal by Subject|1|||
33488824|NCT03546621|62867034|FG000|Overall Study|Lost to Follow-up|0|||
33488825|NCT03546621|62867035|FG001|Overall Study|Lost to Follow-up|1|||
33488826|NCT03546621|62867036|FG002|Overall Study|Lost to Follow-up|0|||
33488827|NCT03546621|62867037|FG003|Overall Study|Lost to Follow-up|0|||
33488828|NCT03546621|62867034|FG000|Overall Study|Adverse Event|0|||
33296857|NCT01332968|62673229|FG005|Maintenance/Observation Period|Adverse Event|0|||
33296858|NCT01332968|62673230|FG006|Maintenance/Observation Period|Adverse Event|0|||
33296859|NCT01332968|62673231|FG007|Maintenance/Observation Period|Adverse Event|0|||
33296860|NCT01332968|62673224|FG000|Maintenance/Observation Period|Death|0|||
33296861|NCT01332968|62673225|FG001|Maintenance/Observation Period|Death|0|||
33296862|NCT01332968|62673226|FG002|Maintenance/Observation Period|Death|5|||
33488829|NCT03546621|62867035|FG001|Overall Study|Adverse Event|1|||
33488830|NCT03546621|62867036|FG002|Overall Study|Adverse Event|0|||
33488831|NCT03546621|62867037|FG003|Overall Study|Adverse Event|1|||
33488832|NCT03546621|62867034|FG000|Overall Study|Progressive disease|0|||
33488833|NCT03546621|62867035|FG001|Overall Study|Progressive disease|0|||
33488834|NCT03546621|62867036|FG002|Overall Study|Progressive disease|0|||
33488835|NCT03546621|62867037|FG003|Overall Study|Progressive disease|1|||
33488836|NCT02761330|62867047|FG000|Treatment Week 1|Withdrawal by Subject|0|||
33488837|NCT02761330|62867048|FG001|Treatment Week 1|Withdrawal by Subject|0|||
33488838|NCT02761330|62867049|FG002|Treatment Week 1|Withdrawal by Subject|0|||
33488839|NCT02761330|62867050|FG003|Treatment Week 1|Withdrawal by Subject|1|||
33488840|NCT02761330|62867051|FG004|Treatment Week 1|Withdrawal by Subject|0|||
33488841|NCT02761330|62867052|FG005|Treatment Week 1|Withdrawal by Subject|1|||
33488842|NCT03559257|62867068|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
33488843|NCT03559257|62867069|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
33488844|NCT03559257|62867068|FG000|Double Blind Treatment Period|Protocol Violation|1|||
33488845|NCT03559257|62867069|FG001|Double Blind Treatment Period|Protocol Violation|4|||
33488846|NCT03559257|62867068|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
33488847|NCT03559257|62867069|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
33488848|NCT03559257|62867068|FG000|Double Blind Treatment Period|Adverse Event|0|||
33296863|NCT01332968|62673227|FG003|Maintenance/Observation Period|Death|6|||
33296864|NCT01332968|62673228|FG004|Maintenance/Observation Period|Death|0|||
33296865|NCT01332968|62673229|FG005|Maintenance/Observation Period|Death|0|||
33296866|NCT01332968|62673230|FG006|Maintenance/Observation Period|Death|0|||
33296867|NCT01332968|62673231|FG007|Maintenance/Observation Period|Death|0|||
33296868|NCT01332968|62673224|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
33296869|NCT01332968|62673225|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
33296870|NCT01332968|62673226|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
33384887|NCT00712725|62763843|FG002|Overall Study|Pregnancy|0|||
33384888|NCT00712725|62763844|FG003|Overall Study|Pregnancy|0|||
33384889|NCT00712725|62763845|FG004|Overall Study|Pregnancy|1|||
33488849|NCT03559257|62867069|FG001|Double Blind Treatment Period|Adverse Event|1|||
33488850|NCT03559257|62867068|FG000|Double Blind Treatment Period|Screen Failure|0|||
33488851|NCT03559257|62867069|FG001|Double Blind Treatment Period|Screen Failure|1|||
33488852|NCT03559257|62867068|FG000|Open-label Treatment Period|Adverse Event|1|||
33488853|NCT03559257|62867069|FG001|Open-label Treatment Period|Adverse Event|4|||
33488854|NCT03559257|62867068|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
33488855|NCT03559257|62867069|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
33488856|NCT03559257|62867068|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
33488857|NCT03559257|62867069|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
33662575|NCT01587703|63093244|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33384890|NCT00712725|62763846|FG005|Overall Study|Pregnancy|0|||
33488858|NCT03559257|62867068|FG000|Open-label Treatment Period|Protocol Violation|2|||
33488859|NCT03559257|62867069|FG001|Open-label Treatment Period|Protocol Violation|0|||
33488860|NCT03559257|62867068|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
33488861|NCT03559257|62867069|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
33296871|NCT01332968|62673227|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
33384891|NCT00712725|62763847|FG006|Overall Study|Pregnancy|2|||
33384892|NCT00712725|62763848|FG007|Overall Study|Pregnancy|0|||
33384893|NCT00712725|62763841|FG000|Overall Study|Protocol Violation|2|||
33488862|NCT03559257|62867068|FG000|Open-label Treatment Period|Physician Decision|0|||
33662576|NCT01587703|63093226|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33384894|NCT00712725|62763842|FG001|Overall Study|Protocol Violation|0|||
33384895|NCT00712725|62763843|FG002|Overall Study|Protocol Violation|1|||
33384896|NCT00712725|62763844|FG003|Overall Study|Protocol Violation|3|||
33384897|NCT00712725|62763845|FG004|Overall Study|Protocol Violation|2|||
33384898|NCT00712725|62763846|FG005|Overall Study|Protocol Violation|0|||
33384899|NCT00712725|62763847|FG006|Overall Study|Protocol Violation|1|||
33384900|NCT00712725|62763848|FG007|Overall Study|Protocol Violation|1|||
33384901|NCT00712725|62763841|FG000|Overall Study|Withdrawal by Subject|2|||
33384902|NCT00712725|62763842|FG001|Overall Study|Withdrawal by Subject|1|||
33384903|NCT00712725|62763843|FG002|Overall Study|Withdrawal by Subject|1|||
33384904|NCT00712725|62763844|FG003|Overall Study|Withdrawal by Subject|2|||
33296872|NCT01332968|62673228|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
33296873|NCT01332968|62673229|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
33384905|NCT00712725|62763845|FG004|Overall Study|Withdrawal by Subject|1|||
33384906|NCT00712725|62763846|FG005|Overall Study|Withdrawal by Subject|1|||
33384907|NCT00712725|62763847|FG006|Overall Study|Withdrawal by Subject|1|||
33384908|NCT00712725|62763848|FG007|Overall Study|Withdrawal by Subject|2|||
33384909|NCT00712725|62763841|FG000|Overall Study|Lack of Qualifying Event|16|||
33384910|NCT00712725|62763842|FG001|Overall Study|Lack of Qualifying Event|2|||
33296874|NCT01332968|62673230|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
33296875|NCT01332968|62673231|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
33296876|NCT01332968|62673224|FG000|Maintenance/Observation Period|Non-compliance|0|||
33296877|NCT01332968|62673225|FG001|Maintenance/Observation Period|Non-compliance|0|||
33296878|NCT01332968|62673226|FG002|Maintenance/Observation Period|Non-compliance|4|||
33296879|NCT01332968|62673227|FG003|Maintenance/Observation Period|Non-compliance|3|||
33296880|NCT01332968|62673228|FG004|Maintenance/Observation Period|Non-compliance|0|||
33296881|NCT01332968|62673229|FG005|Maintenance/Observation Period|Non-compliance|0|||
33296882|NCT01332968|62673230|FG006|Maintenance/Observation Period|Non-compliance|0|||
33296883|NCT01332968|62673231|FG007|Maintenance/Observation Period|Non-compliance|0|||
33296884|NCT01332968|62673224|FG000|Maintenance/Observation Period|Other|0|||
33296885|NCT01332968|62673225|FG001|Maintenance/Observation Period|Other|0|||
33296886|NCT01332968|62673226|FG002|Maintenance/Observation Period|Other|4|||
33296887|NCT01332968|62673227|FG003|Maintenance/Observation Period|Other|7|||
33296888|NCT01332968|62673228|FG004|Maintenance/Observation Period|Other|0|||
33296889|NCT01332968|62673229|FG005|Maintenance/Observation Period|Other|0|||
33296890|NCT01332968|62673230|FG006|Maintenance/Observation Period|Other|0|||
33296891|NCT01332968|62673231|FG007|Maintenance/Observation Period|Other|0|||
33296892|NCT01332968|62673224|FG000|Maintenance/Observation Period|Physician Decision|0|||
33296893|NCT01332968|62673225|FG001|Maintenance/Observation Period|Physician Decision|0|||
33296894|NCT01332968|62673226|FG002|Maintenance/Observation Period|Physician Decision|14|||
33296895|NCT01332968|62673227|FG003|Maintenance/Observation Period|Physician Decision|19|||
33296896|NCT01332968|62673228|FG004|Maintenance/Observation Period|Physician Decision|0|||
33296897|NCT01332968|62673229|FG005|Maintenance/Observation Period|Physician Decision|1|||
33384911|NCT00712725|62763843|FG002|Overall Study|Lack of Qualifying Event|6|||
33384912|NCT00712725|62763844|FG003|Overall Study|Lack of Qualifying Event|8|||
33384913|NCT00712725|62763845|FG004|Overall Study|Lack of Qualifying Event|11|||
33384914|NCT00712725|62763846|FG005|Overall Study|Lack of Qualifying Event|13|||
33384915|NCT00712725|62763847|FG006|Overall Study|Lack of Qualifying Event|11|||
33384916|NCT00712725|62763848|FG007|Overall Study|Lack of Qualifying Event|6|||
33384917|NCT00712725|62763841|FG000|Overall Study|Protocol Specified Criteria|3|||
33384918|NCT00712725|62763842|FG001|Overall Study|Protocol Specified Criteria|0|||
33384919|NCT00712725|62763843|FG002|Overall Study|Protocol Specified Criteria|1|||
33384920|NCT00712725|62763844|FG003|Overall Study|Protocol Specified Criteria|2|||
33384921|NCT00712725|62763845|FG004|Overall Study|Protocol Specified Criteria|1|||
33384922|NCT00712725|62763846|FG005|Overall Study|Protocol Specified Criteria|0|||
33384923|NCT00712725|62763847|FG006|Overall Study|Protocol Specified Criteria|2|||
33384924|NCT00712725|62763848|FG007|Overall Study|Protocol Specified Criteria|1|||
33384925|NCT00712335|62763871|FG000|Overall Study|Withdrawal by Subject|0|||
33384926|NCT00712335|62763872|FG001|Overall Study|Withdrawal by Subject|7|||
33384927|NCT00712335|62763873|FG002|Overall Study|Withdrawal by Subject|2|||
33384928|NCT00712335|62763874|FG003|Overall Study|Withdrawal by Subject|3|||
33384929|NCT00712335|62763875|FG004|Overall Study|Withdrawal by Subject|0|||
33384930|NCT00712335|62763871|FG000|Overall Study|Lost to Follow-up|2|||
33384931|NCT00712335|62763872|FG001|Overall Study|Lost to Follow-up|5|||
33384932|NCT00712335|62763873|FG002|Overall Study|Lost to Follow-up|0|||
33296898|NCT01332968|62673230|FG006|Maintenance/Observation Period|Physician Decision|0|||
33296899|NCT01332968|62673231|FG007|Maintenance/Observation Period|Physician Decision|0|||
33296900|NCT01332968|62673224|FG000|Maintenance/Observation Period|Progressive Disease|0|||
33296901|NCT01332968|62673225|FG001|Maintenance/Observation Period|Progressive Disease|0|||
33384933|NCT00712335|62763874|FG003|Overall Study|Lost to Follow-up|1|||
33384934|NCT00712335|62763875|FG004|Overall Study|Lost to Follow-up|0|||
33384935|NCT00712335|62763871|FG000|Overall Study|Protocol Violation|1|||
33384936|NCT00712335|62763872|FG001|Overall Study|Protocol Violation|2|||
33384937|NCT00712335|62763873|FG002|Overall Study|Protocol Violation|1|||
33384938|NCT00712335|62763874|FG003|Overall Study|Protocol Violation|0|||
33384939|NCT00712335|62763875|FG004|Overall Study|Protocol Violation|0|||
33384940|NCT00712335|62763871|FG000|Overall Study|Lack of Efficacy|0|||
33384941|NCT00712335|62763872|FG001|Overall Study|Lack of Efficacy|0|||
33384942|NCT00712335|62763873|FG002|Overall Study|Lack of Efficacy|1|||
33384943|NCT00712335|62763874|FG003|Overall Study|Lack of Efficacy|1|||
33384944|NCT00712335|62763875|FG004|Overall Study|Lack of Efficacy|0|||
33384945|NCT00712335|62763871|FG000|Overall Study|Other Reason|0|||
33384946|NCT00712335|62763872|FG001|Overall Study|Other Reason|3|||
33384947|NCT00712335|62763873|FG002|Overall Study|Other Reason|1|||
33384948|NCT00712335|62763874|FG003|Overall Study|Other Reason|0|||
33384949|NCT00712335|62763875|FG004|Overall Study|Other Reason|0|||
33384950|NCT00577629|62763887|FG000|Treatment Period|Death|1|||
33384951|NCT00577629|62763887|FG000|Long Term Follow-Up|Death|15|||
33384952|NCT00577629|62763887|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
33384953|NCT00577629|62763887|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
33384954|NCT00577629|62763887|FG000|Long Term Follow-Up|Physician Decision|1|||
33384955|NCT00710385|62763893|FG000|Overall Study|Did not qualify|1|||
33384956|NCT00710385|62763893|FG000|Overall Study|Withdrawal by Subject|1|||
33384957|NCT00710385|62763893|FG000|Overall Study|Undisclosed back pain|1|||
33296902|NCT01332968|62673226|FG002|Maintenance/Observation Period|Progressive Disease|72|||
33296903|NCT01332968|62673227|FG003|Maintenance/Observation Period|Progressive Disease|40|||
33296904|NCT01332968|62673228|FG004|Maintenance/Observation Period|Progressive Disease|0|||
33296905|NCT01332968|62673229|FG005|Maintenance/Observation Period|Progressive Disease|0|||
33296906|NCT01332968|62673230|FG006|Maintenance/Observation Period|Progressive Disease|0|||
33296907|NCT01332968|62673231|FG007|Maintenance/Observation Period|Progressive Disease|0|||
33296908|NCT01332968|62673224|FG000|Maintenance/Observation Period|Protocol Violation|0|||
33296909|NCT01332968|62673225|FG001|Maintenance/Observation Period|Protocol Violation|0|||
33296910|NCT01332968|62673226|FG002|Maintenance/Observation Period|Protocol Violation|1|||
33296911|NCT01332968|62673227|FG003|Maintenance/Observation Period|Protocol Violation|1|||
33296912|NCT01332968|62673228|FG004|Maintenance/Observation Period|Protocol Violation|0|||
33296913|NCT01332968|62673229|FG005|Maintenance/Observation Period|Protocol Violation|0|||
33296914|NCT01332968|62673230|FG006|Maintenance/Observation Period|Protocol Violation|0|||
33384958|NCT00710385|62763893|FG000|Overall Study|Physician Decision|1|||
33384959|NCT00710385|62763893|FG000|Overall Study|Undisclosed excessive methadone use|1|||
33384960|NCT00701415|62763905|FG000|Overall Study|Adverse Event|0|||
33384961|NCT00701415|62763906|FG001|Overall Study|Adverse Event|1|||
33384962|NCT00701415|62763905|FG000|Overall Study|Social/family issues and needle phobia|1|||
33384963|NCT00701415|62763906|FG001|Overall Study|Social/family issues and needle phobia|0|||
33384964|NCT00700011|62763914|FG000|Overall Study|Death|0|||
33384965|NCT00700011|62763915|FG001|Overall Study|Death|1|||
33384966|NCT00707031|62763923|FG000|Overall Study|Adverse Event|45|||
33384967|NCT00707031|62763924|FG001|Overall Study|Adverse Event|45|||
33384968|NCT00707031|62763923|FG000|Overall Study|Lack of Efficacy|19|||
33384969|NCT00707031|62763924|FG001|Overall Study|Lack of Efficacy|6|||
33384970|NCT00707031|62763923|FG000|Overall Study|Lost to Follow-up|2|||
33384971|NCT00707031|62763924|FG001|Overall Study|Lost to Follow-up|1|||
33384972|NCT00707031|62763923|FG000|Overall Study|Protocol Violation|1|||
33384973|NCT00707031|62763924|FG001|Overall Study|Protocol Violation|0|||
33384974|NCT00707031|62763923|FG000|Overall Study|Withdrawal by Subject|7|||
33384975|NCT00707031|62763924|FG001|Overall Study|Withdrawal by Subject|8|||
33384976|NCT00707031|62763923|FG000|Overall Study|Poor Compliance to Protocol|7|||
33384977|NCT00707031|62763924|FG001|Overall Study|Poor Compliance to Protocol|13|||
33384978|NCT00707031|62763923|FG000|Overall Study|Familial or Personal Reasons|12|||
33384979|NCT00707031|62763924|FG001|Overall Study|Familial or Personal Reasons|15|||
33384980|NCT00707031|62763923|FG000|Overall Study|Serious Noncompliance|2|||
33384981|NCT00707031|62763924|FG001|Overall Study|Serious Noncompliance|3|||
33384982|NCT00707031|62763923|FG000|Overall Study|Sponsor Decision|9|||
33384983|NCT00707031|62763924|FG001|Overall Study|Sponsor Decision|8|||
33384984|NCT00711477|62763933|FG000|Overall Study|Adverse Event|3|||
33384985|NCT00711477|62763934|FG001|Overall Study|Adverse Event|1|||
33384986|NCT00711477|62763933|FG000|Overall Study|Lost to Follow-up|0|||
33488863|NCT03559257|62867069|FG001|Open-label Treatment Period|Physician Decision|1|||
33296915|NCT01332968|62673231|FG007|Maintenance/Observation Period|Protocol Violation|0|||
33384987|NCT00711477|62763934|FG001|Overall Study|Lost to Follow-up|1|||
33384988|NCT00711477|62763933|FG000|Overall Study|Noncompliance|0|||
33384989|NCT00711477|62763934|FG001|Overall Study|Noncompliance|1|||
33384990|NCT00699699|62763942|FG000|Overall Study|Adverse Event|36|||
33488864|NCT02892513|62867080|FG000|Overall Study|Withdrawal by Subject|0|||
33296916|NCT01332968|62673224|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
33384991|NCT00699699|62763942|FG000|Overall Study|Individual different reasons|21|||
33384992|NCT00734474|62763955|FG000|Overall Study|Entry Criteria Not Met|0|||
33384993|NCT00734474|62763956|FG001|Overall Study|Entry Criteria Not Met|0|||
33384994|NCT00734474|62763957|FG002|Overall Study|Entry Criteria Not Met|5|||
33384995|NCT00734474|62763958|FG003|Overall Study|Entry Criteria Not Met|0|||
33384996|NCT00734474|62763959|FG004|Overall Study|Entry Criteria Not Met|3|||
33384997|NCT00734474|62763960|FG005|Overall Study|Entry Criteria Not Met|1|||
33384998|NCT00734474|62763961|FG006|Overall Study|Entry Criteria Not Met|0|||
33384999|NCT00734474|62763962|FG007|Overall Study|Entry Criteria Not Met|1|||
33296917|NCT01332968|62673225|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
33296918|NCT01332968|62673226|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
33296919|NCT01332968|62673227|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
33385000|NCT00734474|62763963|FG008|Overall Study|Entry Criteria Not Met|1|||
33385001|NCT00734474|62763955|FG000|Overall Study|Lost to Follow-up|1|||
33385002|NCT00734474|62763956|FG001|Overall Study|Lost to Follow-up|0|||
33385003|NCT00734474|62763957|FG002|Overall Study|Lost to Follow-up|13|||
33385004|NCT00734474|62763958|FG003|Overall Study|Lost to Follow-up|0|||
33385005|NCT00734474|62763959|FG004|Overall Study|Lost to Follow-up|11|||
33385006|NCT00734474|62763960|FG005|Overall Study|Lost to Follow-up|1|||
33385007|NCT00734474|62763961|FG006|Overall Study|Lost to Follow-up|0|||
33385008|NCT00734474|62763962|FG007|Overall Study|Lost to Follow-up|9|||
33385009|NCT00734474|62763963|FG008|Overall Study|Lost to Follow-up|4|||
33385010|NCT00734474|62763955|FG000|Overall Study|Withdrawal by Subject|2|||
33385011|NCT00734474|62763956|FG001|Overall Study|Withdrawal by Subject|1|||
33385012|NCT00734474|62763957|FG002|Overall Study|Withdrawal by Subject|18|||
33385013|NCT00734474|62763958|FG003|Overall Study|Withdrawal by Subject|0|||
33385014|NCT00734474|62763959|FG004|Overall Study|Withdrawal by Subject|24|||
33385015|NCT00734474|62763960|FG005|Overall Study|Withdrawal by Subject|2|||
33385016|NCT00734474|62763961|FG006|Overall Study|Withdrawal by Subject|0|||
33385017|NCT00734474|62763962|FG007|Overall Study|Withdrawal by Subject|36|||
33385018|NCT00734474|62763963|FG008|Overall Study|Withdrawal by Subject|21|||
33385019|NCT00734474|62763955|FG000|Overall Study|Physician Decision|0|||
33385020|NCT00734474|62763956|FG001|Overall Study|Physician Decision|0|||
33385021|NCT00734474|62763957|FG002|Overall Study|Physician Decision|4|||
33385022|NCT00734474|62763958|FG003|Overall Study|Physician Decision|1|||
33385023|NCT00734474|62763959|FG004|Overall Study|Physician Decision|11|||
33385024|NCT00734474|62763960|FG005|Overall Study|Physician Decision|0|||
33385025|NCT00734474|62763961|FG006|Overall Study|Physician Decision|0|||
33385026|NCT00734474|62763962|FG007|Overall Study|Physician Decision|9|||
33385027|NCT00734474|62763963|FG008|Overall Study|Physician Decision|9|||
33385028|NCT00734474|62763955|FG000|Overall Study|Adverse Event|4|||
33385029|NCT00734474|62763956|FG001|Overall Study|Adverse Event|4|||
33385030|NCT00734474|62763957|FG002|Overall Study|Adverse Event|63|||
33385031|NCT00734474|62763958|FG003|Overall Study|Adverse Event|1|||
33385032|NCT00734474|62763959|FG004|Overall Study|Adverse Event|64|||
33385033|NCT00734474|62763960|FG005|Overall Study|Adverse Event|0|||
33488865|NCT02892513|62867081|FG001|Overall Study|Withdrawal by Subject|1|||
33488866|NCT03558555|62867089|FG000|Overall Study|Lost to Follow-up|2|||
33488867|NCT03558555|62867090|FG001|Overall Study|Lost to Follow-up|1|||
33488868|NCT03541317|62867098|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
33488869|NCT03541317|62867099|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
33296920|NCT01332968|62673228|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
33296921|NCT01332968|62673229|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
33488870|NCT03541317|62867100|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
33488871|NCT03541317|62867101|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
33488872|NCT03541317|62867102|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
33488873|NCT03541317|62867103|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
33488874|NCT03590613|62867115|FG000|Period 2, 4 Days|Physician Decision|0|||
33488875|NCT03590613|62867116|FG001|Period 2, 4 Days|Physician Decision|0|||
33488876|NCT03590613|62867117|FG002|Period 2, 4 Days|Physician Decision|0|||
33488877|NCT03590613|62867118|FG003|Period 2, 4 Days|Physician Decision|1|||
33488878|NCT03557931|62867134|FG000|Overall Study|Adverse Event|4|||
33488879|NCT03557931|62867135|FG001|Overall Study|Adverse Event|6|||
33488880|NCT03557931|62867136|FG002|Overall Study|Adverse Event|1|||
33488881|NCT03557931|62867134|FG000|Overall Study|Lost to Follow-up|4|||
33488882|NCT03557931|62867135|FG001|Overall Study|Lost to Follow-up|4|||
33488883|NCT03557931|62867136|FG002|Overall Study|Lost to Follow-up|1|||
33296922|NCT01332968|62673230|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
33296923|NCT01332968|62673231|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
33296924|NCT01332968|62673224|FG000|Follow-Up Period|Adverse Event|0|||
33385034|NCT00734474|62763961|FG006|Overall Study|Adverse Event|1|||
33385035|NCT00734474|62763962|FG007|Overall Study|Adverse Event|65|||
33488884|NCT03557931|62867134|FG000|Overall Study|Protocol Violation|1|||
33488885|NCT03557931|62867135|FG001|Overall Study|Protocol Violation|4|||
33488886|NCT03557931|62867136|FG002|Overall Study|Protocol Violation|1|||
33488887|NCT03557931|62867134|FG000|Overall Study|Withdrawal by Subject|14|||
33296925|NCT01332968|62673225|FG001|Follow-Up Period|Adverse Event|0|||
33385036|NCT00734474|62763963|FG008|Overall Study|Adverse Event|39|||
33556742|NCT02791763|62949550|FG000|Overall Study|Adverse Event|12|||
33385037|NCT00734474|62763955|FG000|Overall Study|Protocol Violation|0|||
33385038|NCT00734474|62763956|FG001|Overall Study|Protocol Violation|0|||
33385039|NCT00734474|62763957|FG002|Overall Study|Protocol Violation|4|||
33385040|NCT00734474|62763958|FG003|Overall Study|Protocol Violation|0|||
33385041|NCT00734474|62763959|FG004|Overall Study|Protocol Violation|3|||
33385042|NCT00734474|62763960|FG005|Overall Study|Protocol Violation|0|||
33385043|NCT00734474|62763961|FG006|Overall Study|Protocol Violation|0|||
33385044|NCT00734474|62763962|FG007|Overall Study|Protocol Violation|3|||
33385045|NCT00734474|62763963|FG008|Overall Study|Protocol Violation|1|||
33385046|NCT00734474|62763955|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
33385047|NCT00734474|62763956|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
33385048|NCT00734474|62763957|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
33385049|NCT00734474|62763958|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
33385050|NCT00734474|62763959|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
33385051|NCT00734474|62763960|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
33385052|NCT00734474|62763961|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
33385053|NCT00734474|62763962|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
33385054|NCT00734474|62763963|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
33488888|NCT03557931|62867135|FG001|Overall Study|Withdrawal by Subject|0|||
33488889|NCT03557931|62867136|FG002|Overall Study|Withdrawal by Subject|7|||
33488890|NCT03557931|62867134|FG000|Overall Study|Miscellaneous|8|||
33488891|NCT03557931|62867135|FG001|Overall Study|Miscellaneous|5|||
33488892|NCT03557931|62867136|FG002|Overall Study|Miscellaneous|3|||
33488893|NCT03522675|62867146|FG000|Overall Study|Screen fail|1|||
33488894|NCT03522675|62867146|FG000|Overall Study|Non-reactive to histamine|1|||
33488895|NCT00294047|62867156|FG000|Month 48|Adverse Event|28|||
33488896|NCT00294047|62867157|FG001|Month 48|Adverse Event|13|||
33488897|NCT00294047|62867156|FG000|Month 48|Protocol Violation|4|||
33488898|NCT00294047|62867157|FG001|Month 48|Protocol Violation|4|||
33488899|NCT00294047|62867156|FG000|Month 48|Withdrawal by Subject|111|||
33488900|NCT00294047|62867157|FG001|Month 48|Withdrawal by Subject|115|||
33488901|NCT00294047|62867156|FG000|Month 48|Lost to Follow-up|272|||
33488902|NCT00294047|62867157|FG001|Month 48|Lost to Follow-up|287|||
33488903|NCT00294047|62867156|FG000|Month 48|Other|10|||
33488904|NCT00294047|62867157|FG001|Month 48|Other|14|||
33488905|NCT00294047|62867156|FG000|Month 84|Adverse Event|4|||
33488906|NCT00294047|62867157|FG001|Month 84|Adverse Event|2|||
33488907|NCT00294047|62867156|FG000|Month 84|Protocol Violation|1|||
33488908|NCT00294047|62867157|FG001|Month 84|Protocol Violation|1|||
33488909|NCT00294047|62867156|FG000|Month 84|Withdrawal by Subject|33|||
33488910|NCT00294047|62867157|FG001|Month 84|Withdrawal by Subject|31|||
33488911|NCT00294047|62867156|FG000|Month 84|Lost to Follow-up|187|||
33488912|NCT00294047|62867157|FG001|Month 84|Lost to Follow-up|190|||
33488913|NCT00294047|62867156|FG000|Month 84|Absent Cervix|2|||
33488914|NCT00294047|62867157|FG001|Month 84|Absent Cervix|0|||
33488915|NCT00294047|62867156|FG000|Month 84|Work related reasons|4|||
33488916|NCT00294047|62867157|FG001|Month 84|Work related reasons|2|||
33488917|NCT00294047|62867156|FG000|Month 84|Center closed, subject did not transfer|1|||
33488918|NCT00294047|62867157|FG001|Month 84|Center closed, subject did not transfer|0|||
33488919|NCT00294047|62867156|FG000|Month 84|Family problems|2|||
33488920|NCT00294047|62867157|FG001|Month 84|Family problems|2|||
33488921|NCT00294047|62867156|FG000|Month 84|Lack of time|3|||
33488922|NCT00294047|62867157|FG001|Month 84|Lack of time|1|||
33488923|NCT00294047|62867156|FG000|Month 84|Personal reason|2|||
33488924|NCT00294047|62867157|FG001|Month 84|Personal reason|4|||
33488925|NCT00294047|62867156|FG000|Month 84|Subject does not want male physician|1|||
33488926|NCT00294047|62867157|FG001|Month 84|Subject does not want male physician|0|||
33488927|NCT00294047|62867156|FG000|Month 84|Transport reimbursement delayed|0|||
33296926|NCT01332968|62673226|FG002|Follow-Up Period|Adverse Event|0|||
33296927|NCT01332968|62673227|FG003|Follow-Up Period|Adverse Event|0|||
33296928|NCT01332968|62673228|FG004|Follow-Up Period|Adverse Event|0|||
33296929|NCT01332968|62673229|FG005|Follow-Up Period|Adverse Event|0|||
33296930|NCT01332968|62673230|FG006|Follow-Up Period|Adverse Event|0|||
33296931|NCT01332968|62673231|FG007|Follow-Up Period|Adverse Event|4|||
33296932|NCT01332968|62673224|FG000|Follow-Up Period|Death|0|||
33385055|NCT00734474|62763955|FG000|Overall Study|Sponsor Decision|0|||
33385056|NCT00734474|62763956|FG001|Overall Study|Sponsor Decision|0|||
33488928|NCT00294047|62867157|FG001|Month 84|Transport reimbursement delayed|1|||
33488929|NCT00294047|62867156|FG000|Month 84|Unable to reach study site|1|||
33488930|NCT00294047|62867157|FG001|Month 84|Unable to reach study site|0|||
33488931|NCT00294047|62867156|FG000|Month 84|Under investigation locally|1|||
33488932|NCT00294047|62867157|FG001|Month 84|Under investigation locally|0|||
33296933|NCT01332968|62673225|FG001|Follow-Up Period|Death|0|||
33385057|NCT00734474|62763957|FG002|Overall Study|Sponsor Decision|0|||
33385058|NCT00734474|62763958|FG003|Overall Study|Sponsor Decision|0|||
33488933|NCT00294047|62867156|FG000|Month 84|Visit missed|0|||
33385059|NCT00734474|62763959|FG004|Overall Study|Sponsor Decision|2|||
33385060|NCT00734474|62763960|FG005|Overall Study|Sponsor Decision|0|||
33385061|NCT00734474|62763961|FG006|Overall Study|Sponsor Decision|0|||
33488934|NCT00294047|62867157|FG001|Month 84|Visit missed|1|||
33488935|NCT00294047|62867156|FG000|Month 84|No consent for Month 84 Follow-up|731|||
33488936|NCT00294047|62867157|FG001|Month 84|No consent for Month 84 Follow-up|754|||
33488937|NCT00293813|62867167|FG000|Overall Study|Physician Decision|0|||
33385062|NCT00734474|62763962|FG007|Overall Study|Sponsor Decision|0|||
33385063|NCT00734474|62763963|FG008|Overall Study|Sponsor Decision|0|||
33385064|NCT00734474|62763955|FG000|Overall Study|Death|0|||
33385065|NCT00734474|62763956|FG001|Overall Study|Death|0|||
33385066|NCT00734474|62763957|FG002|Overall Study|Death|1|||
33385067|NCT00734474|62763958|FG003|Overall Study|Death|0|||
33385068|NCT00734474|62763959|FG004|Overall Study|Death|0|||
33385069|NCT00734474|62763960|FG005|Overall Study|Death|0|||
33385070|NCT00734474|62763961|FG006|Overall Study|Death|0|||
33385071|NCT00734474|62763962|FG007|Overall Study|Death|2|||
33385072|NCT00734474|62763963|FG008|Overall Study|Death|1|||
33385073|NCT00734474|62763955|FG000|Overall Study|Lack of Efficacy|0|||
33385074|NCT00734474|62763956|FG001|Overall Study|Lack of Efficacy|0|||
33385075|NCT00734474|62763957|FG002|Overall Study|Lack of Efficacy|4|||
33385076|NCT00734474|62763958|FG003|Overall Study|Lack of Efficacy|0|||
33385077|NCT00734474|62763959|FG004|Overall Study|Lack of Efficacy|0|||
33385078|NCT00734474|62763960|FG005|Overall Study|Lack of Efficacy|0|||
33385079|NCT00734474|62763961|FG006|Overall Study|Lack of Efficacy|0|||
33385080|NCT00734474|62763962|FG007|Overall Study|Lack of Efficacy|4|||
33385081|NCT00734474|62763963|FG008|Overall Study|Lack of Efficacy|6|||
33385082|NCT00583362|62763989|FG000|Overall Study|Adverse Event|44|||
33385083|NCT00583362|62763989|FG000|Overall Study|Lack of Efficacy|22|||
33385084|NCT00583362|62763989|FG000|Overall Study|Lost to Follow-up|4|||
33385085|NCT00583362|62763989|FG000|Overall Study|Non-compliance with study drug|28|||
33385086|NCT00583362|62763989|FG000|Overall Study|Pregnancy|7|||
33385087|NCT00583362|62763989|FG000|Overall Study|Miscommunication of visit window|5|||
33385088|NCT00583362|62763989|FG000|Overall Study|Current site closed|7|||
33385089|NCT00583362|62763989|FG000|Overall Study|Subject not dosed in LBSL99|1|||
33385090|NCT00583362|62763989|FG000|Overall Study|Subject moved out of the country/state|2|||
33385091|NCT00583362|62763989|FG000|Overall Study|Missed visits due to staff changes|1|||
33385092|NCT00583362|62763989|FG000|Overall Study|Misunderstanding of protocol|1|||
33385093|NCT00583362|62763989|FG000|Overall Study|Behavioral problems and non-compliance|1|||
33385094|NCT00583362|62763989|FG000|Overall Study|Sponsor request due to missed doses|1|||
33385095|NCT00583362|62763989|FG000|Overall Study|Physician Decision|19|||
33385096|NCT00583362|62763989|FG000|Overall Study|Protocol Violation|2|||
33385097|NCT00583362|62763989|FG000|Overall Study|Withdrawal by Subject|57|||
33385098|NCT00577473|62763995|FG000|Overall Study|Protocol Violation|1|||
33385099|NCT00577473|62763996|FG001|Overall Study|Protocol Violation|4|||
33385100|NCT00577473|62763995|FG000|Overall Study|Adverse Event|8|||
33385101|NCT00577473|62763996|FG001|Overall Study|Adverse Event|5|||
33385102|NCT00577473|62763995|FG000|Overall Study|Withdrawal by Subject|2|||
33488938|NCT00293813|62867168|FG001|Overall Study|Physician Decision|1|||
33488939|NCT00293813|62867169|FG002|Overall Study|Physician Decision|0|||
33488940|NCT00293813|62867167|FG000|Overall Study|Adverse Event|3|||
33488941|NCT00293813|62867168|FG001|Overall Study|Adverse Event|1|||
33488942|NCT00293813|62867169|FG002|Overall Study|Adverse Event|1|||
33488943|NCT00293813|62867167|FG000|Overall Study|Withdrawal by Subject|7|||
33488944|NCT00293813|62867168|FG001|Overall Study|Withdrawal by Subject|4|||
33488945|NCT00293813|62867169|FG002|Overall Study|Withdrawal by Subject|4|||
33488946|NCT00293813|62867167|FG000|Overall Study|Lost to Follow-up|3|||
33488947|NCT00293813|62867168|FG001|Overall Study|Lost to Follow-up|2|||
33488948|NCT00293813|62867169|FG002|Overall Study|Lost to Follow-up|3|||
33556743|NCT02791763|62949551|FG001|Overall Study|Adverse Event|13|||
33662577|NCT01587703|63093227|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33296934|NCT01332968|62673226|FG002|Follow-Up Period|Death|0|||
33296935|NCT01332968|62673227|FG003|Follow-Up Period|Death|0|||
33296936|NCT01332968|62673228|FG004|Follow-Up Period|Death|0|||
33296937|NCT01332968|62673229|FG005|Follow-Up Period|Death|0|||
33296938|NCT01332968|62673230|FG006|Follow-Up Period|Death|27|||
33296939|NCT01332968|62673231|FG007|Follow-Up Period|Death|30|||
33296940|NCT01332968|62673224|FG000|Follow-Up Period|Lost to Follow-up|0|||
33385103|NCT00577473|62763996|FG001|Overall Study|Withdrawal by Subject|6|||
33385104|NCT00577473|62763995|FG000|Overall Study|Physician Decision|2|||
33385105|NCT00577473|62763996|FG001|Overall Study|Physician Decision|2|||
33385106|NCT00577473|62763995|FG000|Overall Study|Lack of Efficacy|8|||
33385107|NCT00577473|62763996|FG001|Overall Study|Lack of Efficacy|7|||
33385108|NCT00785291|62764005|FG000|Overall Study|Never began treatment|8|||
33385109|NCT00785291|62764006|FG001|Overall Study|Never began treatment|4|||
33385110|NCT00785291|62764007|FG002|Overall Study|Never began treatment|4|||
33385111|NCT00785291|62764005|FG000|Overall Study|Adverse Event|39|||
33385112|NCT00785291|62764006|FG001|Overall Study|Adverse Event|70|||
33385113|NCT00785291|62764007|FG002|Overall Study|Adverse Event|56|||
33488949|NCT00293813|62867167|FG000|Overall Study|Noncompliance|0|||
33385114|NCT00785291|62764005|FG000|Overall Study|Death|7|||
33296941|NCT01332968|62673225|FG001|Follow-Up Period|Lost to Follow-up|0|||
33296942|NCT01332968|62673226|FG002|Follow-Up Period|Lost to Follow-up|0|||
33385115|NCT00785291|62764006|FG001|Overall Study|Death|4|||
33385116|NCT00785291|62764007|FG002|Overall Study|Death|3|||
33385117|NCT00785291|62764005|FG000|Overall Study|Withdrawal by Subject|35|||
33488950|NCT00293813|62867168|FG001|Overall Study|Noncompliance|1|||
33296943|NCT01332968|62673227|FG003|Follow-Up Period|Lost to Follow-up|0|||
33296944|NCT01332968|62673228|FG004|Follow-Up Period|Lost to Follow-up|0|||
33385118|NCT00785291|62764006|FG001|Overall Study|Withdrawal by Subject|36|||
33385119|NCT00785291|62764007|FG002|Overall Study|Withdrawal by Subject|17|||
33385120|NCT00785291|62764005|FG000|Overall Study|Alternative Therapy|12|||
33296945|NCT01332968|62673229|FG005|Follow-Up Period|Lost to Follow-up|0|||
33296946|NCT01332968|62673230|FG006|Follow-Up Period|Lost to Follow-up|11|||
33296947|NCT01332968|62673231|FG007|Follow-Up Period|Lost to Follow-up|15|||
33296948|NCT01332968|62673224|FG000|Follow-Up Period|Non-compliance|0|||
33296949|NCT01332968|62673225|FG001|Follow-Up Period|Non-compliance|0|||
33296950|NCT01332968|62673226|FG002|Follow-Up Period|Non-compliance|0|||
33296951|NCT01332968|62673227|FG003|Follow-Up Period|Non-compliance|0|||
33296952|NCT01332968|62673228|FG004|Follow-Up Period|Non-compliance|0|||
33296953|NCT01332968|62673229|FG005|Follow-Up Period|Non-compliance|0|||
33296954|NCT01332968|62673230|FG006|Follow-Up Period|Non-compliance|4|||
33296955|NCT01332968|62673231|FG007|Follow-Up Period|Non-compliance|9|||
33296956|NCT01332968|62673224|FG000|Follow-Up Period|Other|0|||
33296957|NCT01332968|62673225|FG001|Follow-Up Period|Other|0|||
33296958|NCT01332968|62673226|FG002|Follow-Up Period|Other|0|||
33296959|NCT01332968|62673227|FG003|Follow-Up Period|Other|0|||
33296960|NCT01332968|62673228|FG004|Follow-Up Period|Other|0|||
33296961|NCT01332968|62673229|FG005|Follow-Up Period|Other|0|||
33296962|NCT01332968|62673230|FG006|Follow-Up Period|Other|18|||
33296963|NCT01332968|62673231|FG007|Follow-Up Period|Other|21|||
33296964|NCT01332968|62673224|FG000|Follow-Up Period|Physician Decision|0|||
33296965|NCT01332968|62673225|FG001|Follow-Up Period|Physician Decision|0|||
33296966|NCT01332968|62673226|FG002|Follow-Up Period|Physician Decision|0|||
33296967|NCT01332968|62673227|FG003|Follow-Up Period|Physician Decision|0|||
33296968|NCT01332968|62673228|FG004|Follow-Up Period|Physician Decision|0|||
33385121|NCT00785291|62764006|FG001|Overall Study|Alternative Therapy|6|||
33385122|NCT00785291|62764007|FG002|Overall Study|Alternative Therapy|7|||
33385123|NCT00785291|62764005|FG000|Overall Study|Complicating illness|6|||
33385124|NCT00785291|62764006|FG001|Overall Study|Complicating illness|4|||
33296969|NCT01332968|62673229|FG005|Follow-Up Period|Physician Decision|0|||
33296970|NCT01332968|62673230|FG006|Follow-Up Period|Physician Decision|12|||
33296971|NCT01332968|62673231|FG007|Follow-Up Period|Physician Decision|15|||
33296972|NCT01332968|62673224|FG000|Follow-Up Period|Progressive Disease|0|||
33385125|NCT00785291|62764007|FG002|Overall Study|Complicating illness|4|||
33385126|NCT00785291|62764005|FG000|Overall Study|Other Medical Reasons|29|||
33385127|NCT00785291|62764006|FG001|Overall Study|Other Medical Reasons|25|||
33385128|NCT00785291|62764007|FG002|Overall Study|Other Medical Reasons|15|||
33385129|NCT00705939|62764018|FG000|Overall Study|Protocol Violation|0|||
33385130|NCT00705939|62764019|FG001|Overall Study|Protocol Violation|0|||
33385131|NCT00705939|62764020|FG002|Overall Study|Protocol Violation|1|||
33385132|NCT00705939|62764018|FG000|Overall Study|Withdrawal by Subject|0|||
33385133|NCT00705939|62764019|FG001|Overall Study|Withdrawal by Subject|1|||
33385134|NCT00705939|62764020|FG002|Overall Study|Withdrawal by Subject|3|||
33385135|NCT00705939|62764018|FG000|Overall Study|Physician Decision|0|||
33385136|NCT00705939|62764019|FG001|Overall Study|Physician Decision|1|||
33385137|NCT00705939|62764020|FG002|Overall Study|Physician Decision|0|||
33385138|NCT00785213|62764029|FG000|Quinine Sulfate Alone|Adverse Event|4|||
33385139|NCT00785213|62764029|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
33488951|NCT00293813|62867169|FG002|Overall Study|Noncompliance|0|||
33488952|NCT00293579|62867177|FG000|Overall Study|Withdrawal by Subject|1|||
33488953|NCT00293423|62867184|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
33296973|NCT01332968|62673225|FG001|Follow-Up Period|Progressive Disease|0|||
33488954|NCT00293423|62867185|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
33488955|NCT00293423|62867184|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
33488956|NCT00293423|62867185|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
33488957|NCT00293423|62867184|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
33488958|NCT00293423|62867185|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
33488959|NCT00293423|62867184|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
33488960|NCT00293423|62867185|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
33296974|NCT01332968|62673226|FG002|Follow-Up Period|Progressive Disease|0|||
33296975|NCT01332968|62673227|FG003|Follow-Up Period|Progressive Disease|0|||
33296976|NCT01332968|62673228|FG004|Follow-Up Period|Progressive Disease|0|||
33296977|NCT01332968|62673229|FG005|Follow-Up Period|Progressive Disease|0|||
33296978|NCT01332968|62673230|FG006|Follow-Up Period|Progressive Disease|126|||
33296979|NCT01332968|62673231|FG007|Follow-Up Period|Progressive Disease|106|||
33296980|NCT01332968|62673224|FG000|Follow-Up Period|Protocol Violation|0|||
33385140|NCT00577317|62764038|FG000|Overall Study|Study Terminated|0|||
33385141|NCT00577317|62764039|FG001|Overall Study|Study Terminated|2|||
33385142|NCT00734162|62764049|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
33385143|NCT00734162|62764050|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
33385144|NCT00734162|62764051|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
33296981|NCT01332968|62673225|FG001|Follow-Up Period|Protocol Violation|0|||
33296982|NCT01332968|62673226|FG002|Follow-Up Period|Protocol Violation|0|||
33296983|NCT01332968|62673227|FG003|Follow-Up Period|Protocol Violation|0|||
33296984|NCT01332968|62673228|FG004|Follow-Up Period|Protocol Violation|0|||
33296985|NCT01332968|62673229|FG005|Follow-Up Period|Protocol Violation|0|||
33296986|NCT01332968|62673230|FG006|Follow-Up Period|Protocol Violation|1|||
33296987|NCT01332968|62673231|FG007|Follow-Up Period|Protocol Violation|0|||
33296988|NCT01332968|62673224|FG000|Follow-Up Period|Withdrawal by Subject|0|||
33296989|NCT01332968|62673225|FG001|Follow-Up Period|Withdrawal by Subject|0|||
33296990|NCT01332968|62673226|FG002|Follow-Up Period|Withdrawal by Subject|0|||
33296991|NCT01332968|62673227|FG003|Follow-Up Period|Withdrawal by Subject|0|||
33296992|NCT01332968|62673228|FG004|Follow-Up Period|Withdrawal by Subject|0|||
33296993|NCT01332968|62673229|FG005|Follow-Up Period|Withdrawal by Subject|0|||
33296994|NCT01332968|62673230|FG006|Follow-Up Period|Withdrawal by Subject|29|||
33296995|NCT01332968|62673231|FG007|Follow-Up Period|Withdrawal by Subject|32|||
33296996|NCT01332968|62673224|FG000|Follow-Up Period|No reason provided|0|||
33296997|NCT01332968|62673225|FG001|Follow-Up Period|No reason provided|0|||
33296998|NCT01332968|62673226|FG002|Follow-Up Period|No reason provided|0|||
33296999|NCT01332968|62673227|FG003|Follow-Up Period|No reason provided|0|||
33297000|NCT01332968|62673228|FG004|Follow-Up Period|No reason provided|0|||
33297001|NCT01332968|62673229|FG005|Follow-Up Period|No reason provided|0|||
33297002|NCT01332968|62673230|FG006|Follow-Up Period|No reason provided|2|||
33297003|NCT01332968|62673231|FG007|Follow-Up Period|No reason provided|3|||
33297004|NCT01332851|62673241|FG000|Overall Study|Withdrawal by Subject|4|||
33297005|NCT01332851|62673242|FG001|Overall Study|Withdrawal by Subject|2|||
33297006|NCT01332851|62673241|FG000|Overall Study|Lost to Follow-up|7|||
33297007|NCT01332851|62673242|FG001|Overall Study|Lost to Follow-up|11|||
33297008|NCT01332305|62673257|FG000|Overall Study|Adverse Event|1|||
33297009|NCT01332305|62673258|FG001|Overall Study|Adverse Event|4|||
33297010|NCT01332305|62673259|FG002|Overall Study|Adverse Event|6|||
33297011|NCT01332305|62673260|FG003|Overall Study|Adverse Event|3|||
33297012|NCT01332305|62673261|FG004|Overall Study|Adverse Event|5|||
33297013|NCT01332305|62673257|FG000|Overall Study|Withdrawal by Subject|6|||
33297014|NCT01332305|62673258|FG001|Overall Study|Withdrawal by Subject|5|||
33297015|NCT01332305|62673259|FG002|Overall Study|Withdrawal by Subject|4|||
33297016|NCT01332305|62673260|FG003|Overall Study|Withdrawal by Subject|1|||
33297017|NCT01332305|62673261|FG004|Overall Study|Withdrawal by Subject|0|||
33297018|NCT01332305|62673257|FG000|Overall Study|Lost to Follow-up|0|||
33297019|NCT01332305|62673258|FG001|Overall Study|Lost to Follow-up|2|||
33297020|NCT01332305|62673259|FG002|Overall Study|Lost to Follow-up|3|||
33297021|NCT01332305|62673260|FG003|Overall Study|Lost to Follow-up|2|||
33297022|NCT01332305|62673261|FG004|Overall Study|Lost to Follow-up|3|||
33297023|NCT01332305|62673257|FG000|Overall Study|Protocol Violation|1|||
33297024|NCT01332305|62673258|FG001|Overall Study|Protocol Violation|2|||
33297025|NCT01332305|62673259|FG002|Overall Study|Protocol Violation|1|||
33297026|NCT01332305|62673260|FG003|Overall Study|Protocol Violation|0|||
33297027|NCT01332305|62673261|FG004|Overall Study|Protocol Violation|3|||
33297028|NCT01332305|62673257|FG000|Overall Study|Withdrawal by Sponsor|1|||
33297029|NCT01332305|62673258|FG001|Overall Study|Withdrawal by Sponsor|0|||
33297030|NCT01332305|62673259|FG002|Overall Study|Withdrawal by Sponsor|0|||
33297031|NCT01332305|62673260|FG003|Overall Study|Withdrawal by Sponsor|1|||
33297032|NCT01332305|62673261|FG004|Overall Study|Withdrawal by Sponsor|1|||
33297033|NCT01332305|62673257|FG000|Overall Study|Treatment Failure|1|||
33297034|NCT01332305|62673258|FG001|Overall Study|Treatment Failure|1|||
33297035|NCT01332305|62673259|FG002|Overall Study|Treatment Failure|0|||
33297036|NCT01332305|62673260|FG003|Overall Study|Treatment Failure|0|||
33297037|NCT01332305|62673261|FG004|Overall Study|Treatment Failure|0|||
33297038|NCT01332305|62673257|FG000|Overall Study|Physician Decision|0|||
33488961|NCT00293423|62867184|FG000|Surgical Resection|processing error during surgical resection|1|||
33488962|NCT00293423|62867185|FG001|Surgical Resection|processing error during surgical resection|0|||
33297039|NCT01332305|62673258|FG001|Overall Study|Physician Decision|0|||
33297040|NCT01332305|62673259|FG002|Overall Study|Physician Decision|0|||
33297041|NCT01332305|62673260|FG003|Overall Study|Physician Decision|1|||
33297042|NCT01332305|62673261|FG004|Overall Study|Physician Decision|0|||
33297043|NCT01332227|62673275|FG000|Overall Study|Adverse Event|4|||
33297044|NCT01332227|62673276|FG001|Overall Study|Adverse Event|1|||
33297045|NCT01332227|62673275|FG000|Overall Study|Withdrawal by Subject|5|||
33297046|NCT01332227|62673276|FG001|Overall Study|Withdrawal by Subject|1|||
33488963|NCT00293423|62867184|FG000|Surgical Resection|Withdrawal by Subject|4|||
33297047|NCT01332227|62673275|FG000|Overall Study|Lost to Follow-up|2|||
33297048|NCT01332227|62673276|FG001|Overall Study|Lost to Follow-up|0|||
33297049|NCT01332227|62673275|FG000|Overall Study|Lack of Efficacy|3|||
33297050|NCT01332227|62673276|FG001|Overall Study|Lack of Efficacy|1|||
33297051|NCT01332227|62673275|FG000|Overall Study|Poor compliance/noncompliance|1|||
33297052|NCT01332227|62673276|FG001|Overall Study|Poor compliance/noncompliance|1|||
33297053|NCT01332227|62673275|FG000|Overall Study|Patient moved from area|1|||
33297054|NCT01332227|62673276|FG001|Overall Study|Patient moved from area|0|||
33297055|NCT01332227|62673275|FG000|Overall Study|Patient began prohibited medication|0|||
33297056|NCT01332227|62673276|FG001|Overall Study|Patient began prohibited medication|1|||
33297057|NCT01332149|62673284|FG000|Overall Study|Adverse Event|11|||
33297058|NCT01332149|62673285|FG001|Overall Study|Adverse Event|9|||
33297059|NCT01332149|62673284|FG000|Overall Study|Other unspecified|5|||
33297060|NCT01332149|62673285|FG001|Overall Study|Other unspecified|7|||
33297061|NCT01332149|62673284|FG000|Overall Study|Protocol Violation|1|||
33297062|NCT01332149|62673285|FG001|Overall Study|Protocol Violation|3|||
33297063|NCT01332149|62673284|FG000|Overall Study|Withdrawal by Subject|4|||
33297064|NCT01332149|62673285|FG001|Overall Study|Withdrawal by Subject|5|||
33297065|NCT01332149|62673284|FG000|Overall Study|Lost to Follow-up|1|||
33297066|NCT01332149|62673285|FG001|Overall Study|Lost to Follow-up|1|||
33297067|NCT01332149|62673284|FG000|Overall Study|Insufficient clinical response|4|||
33297068|NCT01332149|62673285|FG001|Overall Study|Insufficient clinical response|7|||
33297069|NCT01332149|62673284|FG000|Overall Study|Did not meet entrance criteria|3|||
33297070|NCT01332149|62673285|FG001|Overall Study|Did not meet entrance criteria|4|||
33297071|NCT01332149|62673284|FG000|Overall Study|Randomized but not treated|1|||
33297072|NCT01332149|62673285|FG001|Overall Study|Randomized but not treated|2|||
33297073|NCT01330628|62673293|FG000|Overall Study|Death|2|||
33297074|NCT01330628|62673294|FG001|Overall Study|Death|3|||
33297075|NCT01330628|62673293|FG000|Overall Study|Lost to Follow-up|5|||
33297076|NCT01330628|62673294|FG001|Overall Study|Lost to Follow-up|6|||
33297077|NCT01330628|62673293|FG000|Overall Study|Adverse Event|44|||
33385145|NCT00734162|62764052|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
33385146|NCT00734162|62764049|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
33385147|NCT00734162|62764050|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
33385148|NCT00734162|62764051|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
33385149|NCT00734162|62764052|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
33385150|NCT00734162|62764049|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
33385151|NCT00734162|62764050|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
33385152|NCT00734162|62764051|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
33385153|NCT00734162|62764052|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
33385154|NCT00734162|62764049|FG000|Open-Label Phase|Withdrew Consent|1|||
33297078|NCT01330628|62673294|FG001|Overall Study|Adverse Event|25|||
33297079|NCT01330628|62673293|FG000|Overall Study|Withdrawn|18|||
33297080|NCT01330628|62673294|FG001|Overall Study|Withdrawn|6|||
33297081|NCT01330628|62673293|FG000|Overall Study|Didn't receive study treatment|1|||
33297082|NCT01330628|62673294|FG001|Overall Study|Didn't receive study treatment|0|||
33297083|NCT01330433|62673302|FG000|Overall Study|Death|1|||
33297084|NCT01330433|62673303|FG001|Overall Study|Death|3|||
33297085|NCT01330433|62673302|FG000|Overall Study|Lost to Follow-up|1|||
33297086|NCT01330433|62673303|FG001|Overall Study|Lost to Follow-up|0|||
33297087|NCT01330316|62673311|FG000|Overall Study|Adverse Event|2|||
33297088|NCT01330316|62673312|FG001|Overall Study|Adverse Event|2|||
33297089|NCT01330316|62673311|FG000|Overall Study|Lack of Efficacy|0|||
33385155|NCT00734162|62764050|FG001|Open-Label Phase|Withdrew Consent|0|||
33385156|NCT00734162|62764051|FG002|Open-Label Phase|Withdrew Consent|1|||
33385157|NCT00734162|62764052|FG003|Open-Label Phase|Withdrew Consent|1|||
33385158|NCT00734162|62764049|FG000|Open-Label Phase|Lost to Follow-up|1|||
33385159|NCT00734162|62764050|FG001|Open-Label Phase|Lost to Follow-up|2|||
33385160|NCT00734162|62764051|FG002|Open-Label Phase|Lost to Follow-up|0|||
33385161|NCT00734162|62764052|FG003|Open-Label Phase|Lost to Follow-up|1|||
33385162|NCT00734162|62764049|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
33385163|NCT00734162|62764050|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
33385164|NCT00734162|62764051|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
33385165|NCT00734162|62764052|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
33385166|NCT00790751|62764070|FG000|Overall Study|Protocol non-compliance|16|||
33385167|NCT00790751|62764071|FG001|Overall Study|Protocol non-compliance|16|||
33385168|NCT00790751|62764072|FG002|Overall Study|Protocol non-compliance|10|||
33385169|NCT00790751|62764073|FG003|Overall Study|Protocol non-compliance|11|||
33385170|NCT00790751|62764070|FG000|Overall Study|Lost to Follow-up|4|||
33385171|NCT00790751|62764071|FG001|Overall Study|Lost to Follow-up|9|||
33385172|NCT00790751|62764072|FG002|Overall Study|Lost to Follow-up|4|||
33385173|NCT00790751|62764073|FG003|Overall Study|Lost to Follow-up|5|||
33297090|NCT01330316|62673312|FG001|Overall Study|Lack of Efficacy|10|||
33297091|NCT01330316|62673311|FG000|Overall Study|Lost to Follow-up|0|||
33297092|NCT01330316|62673312|FG001|Overall Study|Lost to Follow-up|1|||
33297093|NCT01330316|62673311|FG000|Overall Study|Withdrawal by Subject|0|||
33297094|NCT01330316|62673312|FG001|Overall Study|Withdrawal by Subject|1|||
33297095|NCT01330316|62673311|FG000|Overall Study|other than above|0|||
33297096|NCT01330316|62673312|FG001|Overall Study|other than above|1|||
33385174|NCT00790751|62764070|FG000|Overall Study|Adverse Event|5|||
33385175|NCT00790751|62764071|FG001|Overall Study|Adverse Event|3|||
33385176|NCT00790751|62764072|FG002|Overall Study|Adverse Event|5|||
33385177|NCT00790751|62764073|FG003|Overall Study|Adverse Event|4|||
33385178|NCT00790751|62764070|FG000|Overall Study|Requirement for restricted medication|0|||
33385179|NCT00790751|62764071|FG001|Overall Study|Requirement for restricted medication|2|||
33385180|NCT00790751|62764072|FG002|Overall Study|Requirement for restricted medication|0|||
33385181|NCT00790751|62764073|FG003|Overall Study|Requirement for restricted medication|0|||
33385182|NCT00790751|62764070|FG000|Overall Study|Death|0|||
33385183|NCT00790751|62764071|FG001|Overall Study|Death|0|||
33385184|NCT00790751|62764072|FG002|Overall Study|Death|1|||
33385185|NCT00790751|62764073|FG003|Overall Study|Death|0|||
33385186|NCT00790751|62764070|FG000|Overall Study|Physician Decision|0|||
33385187|NCT00790751|62764071|FG001|Overall Study|Physician Decision|0|||
33385188|NCT00790751|62764072|FG002|Overall Study|Physician Decision|0|||
33385189|NCT00790751|62764073|FG003|Overall Study|Physician Decision|1|||
33385190|NCT00784979|62764083|FG000|Overall Study|incomplete data|6|||
33385191|NCT00738920|62764090|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
33385192|NCT00738920|62764091|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
33385193|NCT00738920|62764092|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
33385194|NCT00738920|62764090|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
33385195|NCT00738920|62764091|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
33385196|NCT00738920|62764092|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
33385197|NCT00738920|62764090|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
33385198|NCT00738920|62764091|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
33385199|NCT00738920|62764092|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
33385200|NCT00738920|62764090|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
33385201|NCT00738920|62764091|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
33385202|NCT00738920|62764092|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
33385203|NCT00738920|62764090|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
33385204|NCT00738920|62764091|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
33385205|NCT00738920|62764092|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
33385206|NCT00738920|62764090|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
33385207|NCT00738920|62764091|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
33385208|NCT00738920|62764092|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
33385209|NCT00738920|62764090|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
33385210|NCT00738920|62764091|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
33385211|NCT00738920|62764092|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
33385212|NCT00738920|62764090|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
33385213|NCT00738920|62764091|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
33385214|NCT00738920|62764092|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
33385215|NCT00738920|62764090|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
33385216|NCT00738920|62764091|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
33385217|NCT00738920|62764092|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
33385218|NCT00738920|62764090|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
33297097|NCT01326702|62673325|FG000|Overall Study|Other|1|||
33297098|NCT01326702|62673326|FG001|Overall Study|Other|0|||
33297099|NCT01326702|62673327|FG002|Overall Study|Other|0|||
33297100|NCT01326702|62673328|FG003|Overall Study|Other|0|||
33297101|NCT01326702|62673329|FG004|Overall Study|Other|0|||
33297102|NCT01326702|62673330|FG005|Overall Study|Other|1|||
33297103|NCT01326702|62673331|FG006|Overall Study|Other|0|||
33297104|NCT01326702|62673325|FG000|Overall Study|progressive disease|1|||
33297105|NCT01326702|62673326|FG001|Overall Study|progressive disease|1|||
33297106|NCT01326702|62673327|FG002|Overall Study|progressive disease|3|||
33297107|NCT01326702|62673328|FG003|Overall Study|progressive disease|1|||
33297108|NCT01326702|62673329|FG004|Overall Study|progressive disease|3|||
33297109|NCT01326702|62673330|FG005|Overall Study|progressive disease|2|||
33297110|NCT01326702|62673331|FG006|Overall Study|progressive disease|3|||
33297111|NCT01326702|62673325|FG000|Overall Study|Death|0|||
33297112|NCT01326702|62673326|FG001|Overall Study|Death|1|||
33297113|NCT01326702|62673327|FG002|Overall Study|Death|0|||
33297114|NCT01326702|62673328|FG003|Overall Study|Death|0|||
33297115|NCT01326702|62673329|FG004|Overall Study|Death|0|||
33297116|NCT01326702|62673330|FG005|Overall Study|Death|0|||
33297117|NCT01326702|62673331|FG006|Overall Study|Death|0|||
33297118|NCT01326702|62673325|FG000|Overall Study|Adverse Event|0|||
33297119|NCT01326702|62673326|FG001|Overall Study|Adverse Event|0|||
33297120|NCT01326702|62673327|FG002|Overall Study|Adverse Event|1|||
33297121|NCT01326702|62673328|FG003|Overall Study|Adverse Event|1|||
33297122|NCT01326702|62673329|FG004|Overall Study|Adverse Event|0|||
33297123|NCT01326702|62673330|FG005|Overall Study|Adverse Event|3|||
33385219|NCT00738920|62764091|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
33385220|NCT00738920|62764092|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
33385221|NCT00582972|62764100|FG000|Overall Study|Protocol Violation|2|||
33385222|NCT04319718|62764107|FG000|Overall Study|Adverse Event|0|||
33385223|NCT04319718|62764108|FG001|Overall Study|Adverse Event|2|||
33385224|NCT04319718|62764107|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
33385225|NCT04319718|62764108|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
33385226|NCT04372602|62764116|FG000|Overall Study|Withdrawal by Subject|1|||
33385227|NCT04372602|62764117|FG001|Overall Study|Withdrawal by Subject|1|||
33385228|NCT04372602|62764116|FG000|Overall Study|Adverse Event|0|||
33385229|NCT04372602|62764117|FG001|Overall Study|Adverse Event|1|||
33385230|NCT04372602|62764116|FG000|Overall Study|Transitioned to comfort care|0|||
33385231|NCT04372602|62764117|FG001|Overall Study|Transitioned to comfort care|1|||
33385232|NCT00733304|62764126|FG000|Overall Study|Adverse Event|3|||
33385233|NCT00733304|62764127|FG001|Overall Study|Adverse Event|0|||
33385234|NCT00733304|62764128|FG002|Overall Study|Adverse Event|0|||
33385235|NCT00733304|62764126|FG000|Overall Study|Lack of Efficacy|0|||
33385236|NCT00733304|62764127|FG001|Overall Study|Lack of Efficacy|0|||
33385237|NCT00733304|62764128|FG002|Overall Study|Lack of Efficacy|2|||
33385238|NCT00733304|62764126|FG000|Overall Study|Lost to Follow-up|0|||
33385239|NCT00733304|62764127|FG001|Overall Study|Lost to Follow-up|1|||
33385240|NCT00733304|62764128|FG002|Overall Study|Lost to Follow-up|0|||
33385241|NCT00733304|62764126|FG000|Overall Study|Physician Decision|3|||
33385242|NCT00733304|62764127|FG001|Overall Study|Physician Decision|1|||
33385243|NCT00733304|62764128|FG002|Overall Study|Physician Decision|3|||
33385244|NCT00733304|62764126|FG000|Overall Study|Withdrawal by Subject|1|||
33385245|NCT00733304|62764127|FG001|Overall Study|Withdrawal by Subject|1|||
33385246|NCT00733304|62764128|FG002|Overall Study|Withdrawal by Subject|0|||
33385247|NCT00711243|62764142|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
33385248|NCT00711243|62764143|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
33385249|NCT00711243|62764144|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
33385250|NCT00711243|62764145|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
33385251|NCT00711243|62764146|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
33385252|NCT00711243|62764147|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
33385253|NCT00711243|62764142|FG000|Reached First Response/4 Cycles|Death|0|||
33385254|NCT00711243|62764143|FG001|Reached First Response/4 Cycles|Death|0|||
33385255|NCT00711243|62764144|FG002|Reached First Response/4 Cycles|Death|0|||
33385256|NCT00711243|62764145|FG003|Reached First Response/4 Cycles|Death|0|||
33385257|NCT00711243|62764146|FG004|Reached First Response/4 Cycles|Death|0|||
33385258|NCT00711243|62764147|FG005|Reached First Response/4 Cycles|Death|2|||
33385259|NCT00711243|62764142|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
33385260|NCT00711243|62764143|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
33385261|NCT00711243|62764144|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
33385262|NCT00711243|62764145|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
33385263|NCT00711243|62764146|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
33385264|NCT00711243|62764147|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
33385265|NCT00711243|62764142|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
33385266|NCT00711243|62764143|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
33385267|NCT00711243|62764144|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
33385268|NCT00711243|62764145|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
33385269|NCT00711243|62764146|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
33385270|NCT00711243|62764147|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
33385271|NCT00711243|62764142|FG000|Treated Cycle 5 After First Response|Death|0|||
33385272|NCT00711243|62764143|FG001|Treated Cycle 5 After First Response|Death|0|||
33385273|NCT00711243|62764144|FG002|Treated Cycle 5 After First Response|Death|0|||
33297124|NCT01326702|62673331|FG006|Overall Study|Adverse Event|1|||
33297125|NCT01326702|62673325|FG000|Overall Study|Withdrawal by Subject|0|||
33297126|NCT01326702|62673326|FG001|Overall Study|Withdrawal by Subject|0|||
33297127|NCT01326702|62673327|FG002|Overall Study|Withdrawal by Subject|1|||
33297128|NCT01326702|62673328|FG003|Overall Study|Withdrawal by Subject|0|||
33297129|NCT01326702|62673329|FG004|Overall Study|Withdrawal by Subject|1|||
33297130|NCT01326702|62673330|FG005|Overall Study|Withdrawal by Subject|1|||
33297131|NCT01326702|62673331|FG006|Overall Study|Withdrawal by Subject|3|||
33297132|NCT01326702|62673325|FG000|Overall Study|Not Treated|0|||
33297133|NCT01326702|62673326|FG001|Overall Study|Not Treated|0|||
33297134|NCT01326702|62673327|FG002|Overall Study|Not Treated|0|||
33297135|NCT01326702|62673328|FG003|Overall Study|Not Treated|1|||
33297136|NCT01326702|62673329|FG004|Overall Study|Not Treated|0|||
33297137|NCT01326702|62673330|FG005|Overall Study|Not Treated|1|||
33297138|NCT01326702|62673331|FG006|Overall Study|Not Treated|0|||
33297139|NCT01327703|62673350|FG000|Second Treatment Period|Adverse Event|1|||
33297140|NCT01327703|62673351|FG001|Second Treatment Period|Adverse Event|1|||
33385274|NCT00711243|62764145|FG003|Treated Cycle 5 After First Response|Death|0|||
33297141|NCT01327703|62673350|FG000|Second Treatment Period|Protocol Violation|0|||
33297142|NCT01327703|62673351|FG001|Second Treatment Period|Protocol Violation|1|||
33297143|NCT01380080|62673362|FG000|Overall Study|Death|36|||
33297144|NCT01380080|62673363|FG001|Overall Study|Death|44|||
33297145|NCT01380080|62673362|FG000|Overall Study|Site is closing|28|||
33385275|NCT00711243|62764146|FG004|Treated Cycle 5 After First Response|Death|0|||
33297146|NCT01380080|62673363|FG001|Overall Study|Site is closing|31|||
33385276|NCT00711243|62764147|FG005|Treated Cycle 5 After First Response|Death|2|||
33385277|NCT00711243|62764142|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
33385278|NCT00711243|62764143|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
33385279|NCT00711243|62764144|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
33385280|NCT00711243|62764145|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
33385281|NCT00711243|62764146|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
33385282|NCT00711243|62764147|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
33297147|NCT01380080|62673362|FG000|Overall Study|Not able to get to clinic|7|||
33297148|NCT01380080|62673363|FG001|Overall Study|Not able to get to clinic|1|||
33297149|NCT01380080|62673362|FG000|Overall Study|Not willing to adhere to requirements|6|||
33297150|NCT01380080|62673363|FG001|Overall Study|Not willing to adhere to requirements|2|||
33297151|NCT01380080|62673362|FG000|Overall Study|Withdrawal by Subject|5|||
33385283|NCT00711243|62764142|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
33385284|NCT00711243|62764143|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
33385285|NCT00711243|62764144|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
33385286|NCT00711243|62764145|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
33385287|NCT00711243|62764146|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
33385288|NCT00711243|62764147|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
33385289|NCT00733226|62764165|FG000|Overall Study|Withdrawal by Subject|1|||
33385290|NCT00733226|62764166|FG001|Overall Study|Withdrawal by Subject|0|||
33385291|NCT00733226|62764165|FG000|Overall Study|Lost to Follow-up|2|||
33385292|NCT00733226|62764166|FG001|Overall Study|Lost to Follow-up|0|||
33385293|NCT00733226|62764165|FG000|Overall Study|moved to another place|2|||
33385294|NCT00733226|62764166|FG001|Overall Study|moved to another place|0|||
33385295|NCT00732992|62764174|FG000|Overall Study|Adverse Event|1|||
33385296|NCT00732992|62764175|FG001|Overall Study|Adverse Event|1|||
33297152|NCT01380080|62673363|FG001|Overall Study|Withdrawal by Subject|2|||
33297153|NCT01380080|62673362|FG000|Overall Study|Lost to Follow-up|3|||
33297154|NCT01380080|62673363|FG001|Overall Study|Lost to Follow-up|3|||
33385297|NCT00732992|62764174|FG000|Overall Study|Objective Progression or Relapse|3|||
33385298|NCT00732992|62764175|FG001|Overall Study|Objective Progression or Relapse|5|||
33385299|NCT00732992|62764174|FG000|Overall Study|Global Deterioration of Health Status|1|||
33385300|NCT00732992|62764175|FG001|Overall Study|Global Deterioration of Health Status|0|||
33385301|NCT00732992|62764174|FG000|Overall Study|Withdrawal by Subject|1|||
33385302|NCT00732992|62764175|FG001|Overall Study|Withdrawal by Subject|0|||
33385303|NCT00732758|62764184|FG000|Overall Study|Lost to Follow-up|8|||
33385304|NCT00732758|62764185|FG001|Overall Study|Lost to Follow-up|16|||
33385305|NCT00699153|62764193|FG000|Overall Study|Lost to Follow-up|1|||
33385306|NCT00699153|62764194|FG001|Overall Study|Lost to Follow-up|0|||
33385307|NCT00699153|62764193|FG000|Overall Study|Adverse Event|0|||
33385308|NCT00699153|62764194|FG001|Overall Study|Adverse Event|2|||
33385309|NCT00699153|62764193|FG000|Overall Study|Protocol Violation|1|||
33385310|NCT00699153|62764194|FG001|Overall Study|Protocol Violation|0|||
33385311|NCT00699153|62764193|FG000|Overall Study|Travel Problem|1|||
33385312|NCT00699153|62764194|FG001|Overall Study|Travel Problem|0|||
33385313|NCT00698997|62764202|FG000|Overall Study|Lost to Follow-up|3|||
33385314|NCT00698997|62764203|FG001|Overall Study|Lost to Follow-up|0|||
33385315|NCT00698997|62764202|FG000|Overall Study|Withdrawal by Subject|7|||
33385316|NCT00698997|62764203|FG001|Overall Study|Withdrawal by Subject|27|||
33385317|NCT00711087|62764212|FG000|Overall Study|Lost to Follow-up|1|||
33385318|NCT00711087|62764213|FG001|Overall Study|Lost to Follow-up|0|||
33385319|NCT00738530|62764221|FG000|Overall Study|Death|220|||
33385320|NCT00738530|62764222|FG001|Overall Study|Death|224|||
33385321|NCT00738530|62764221|FG000|Overall Study|Lost to Follow-up|8|||
33385322|NCT00738530|62764222|FG001|Overall Study|Lost to Follow-up|6|||
33385323|NCT00738530|62764221|FG000|Overall Study|Withdrawal by Subject|6|||
33385324|NCT00738530|62764222|FG001|Overall Study|Withdrawal by Subject|8|||
33385325|NCT00711009|62764230|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
33488964|NCT00293423|62867185|FG001|Surgical Resection|Withdrawal by Subject|0|||
33488965|NCT00293423|62867184|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
33488966|NCT00293423|62867185|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
33488967|NCT03538743|62867200|FG000|Overall Study|Adverse Event|0|||
33488968|NCT03538743|62867201|FG001|Overall Study|Adverse Event|0|||
33488969|NCT03538743|62867202|FG002|Overall Study|Adverse Event|1|||
33297155|NCT01379768|62673372|FG000|Overall Study|Adverse Event|1|||
33297156|NCT01379768|62673373|FG001|Overall Study|Adverse Event|1|||
33385326|NCT00711009|62764231|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
33385327|NCT00711009|62764230|FG000|Overall Study|Withdrawal by Subject|4|||
33385328|NCT00711009|62764231|FG001|Overall Study|Withdrawal by Subject|2|||
33385329|NCT00711009|62764230|FG000|Overall Study|Lost to Follow-up|3|||
33385330|NCT00711009|62764231|FG001|Overall Study|Lost to Follow-up|9|||
33488970|NCT03538743|62867203|FG003|Overall Study|Adverse Event|1|||
33488971|NCT03538743|62867204|FG004|Overall Study|Adverse Event|0|||
33488972|NCT03538743|62867205|FG005|Overall Study|Adverse Event|0|||
33385331|NCT00711009|62764230|FG000|Overall Study|Participant Noncompliant|0|||
33385332|NCT00711009|62764231|FG001|Overall Study|Participant Noncompliant|1|||
33385333|NCT00711009|62764230|FG000|Overall Study|Virologic Failure|2|||
33385334|NCT00711009|62764231|FG001|Overall Study|Virologic Failure|1|||
33385335|NCT00711009|62764230|FG000|Overall Study|Pregnancy|1|||
33385336|NCT00711009|62764231|FG001|Overall Study|Pregnancy|0|||
33385337|NCT00711009|62764230|FG000|Overall Study|Site closing|0|||
33385338|NCT00711009|62764231|FG001|Overall Study|Site closing|1|||
33385339|NCT00711009|62764230|FG000|Overall Study|Dose adjustment|1|||
33385340|NCT00711009|62764231|FG001|Overall Study|Dose adjustment|0|||
33385341|NCT00577005|62764239|FG000|Overall Study|Lost to Follow-up|3|||
33385342|NCT00577005|62764240|FG001|Overall Study|Lost to Follow-up|2|||
33385343|NCT00577005|62764239|FG000|Overall Study|Withdrawal by Subject|2|||
33385344|NCT00577005|62764240|FG001|Overall Study|Withdrawal by Subject|1|||
33385345|NCT00576927|62764251|FG000|Clinical Assessment|Lack of Efficacy|24|||
33385346|NCT00576927|62764251|FG000|Clinical Assessment|Death|1|||
33385347|NCT00576927|62764251|FG000|Clinical Assessment|Withdrawal by Subject|10|||
33385348|NCT00576927|62764251|FG000|Clinical Assessment|Physician Decision|1|||
33385349|NCT00576927|62764251|FG000|Baseline|Physician Decision|9|||
33385350|NCT00576927|62764251|FG000|Baseline|Medication Change by PCP of subject|1|||
33385351|NCT00576927|62764251|FG000|Baseline|Withdrawal by Subject|3|||
33385352|NCT00576927|62764251|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
33385353|NCT00576927|62764251|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
33385354|NCT00576927|62764251|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
33385355|NCT00576927|62764251|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
33385356|NCT00576927|62764251|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
33385357|NCT00698841|62764257|FG000|Overall Study|Withdrawal by Subject|2|||
33385358|NCT00698841|62764257|FG000|Overall Study|Adverse Event|3|||
33385359|NCT00698841|62764257|FG000|Overall Study|Disease progression|7|||
33385360|NCT00698841|62764257|FG000|Overall Study|Failure to meet eligibility criteria|2|||
33385361|NCT00698841|62764257|FG000|Overall Study|Study drug toxicity|2|||
33385362|NCT00698841|62764257|FG000|Overall Study|Other|2|||
33385363|NCT00577395|62764263|FG000|Overall Study|Study was terminated early by Sponsor|7|||
33385364|NCT00577395|62764264|FG001|Overall Study|Study was terminated early by Sponsor|6|||
33385365|NCT00738374|62764273|FG000|Induction Treatment Phase|Adverse Event|14|||
33385366|NCT00738374|62764274|FG001|Induction Treatment Phase|Adverse Event|0|||
33385367|NCT00738374|62764275|FG002|Induction Treatment Phase|Adverse Event|0|||
33385368|NCT00738374|62764276|FG003|Induction Treatment Phase|Adverse Event|0|||
33385369|NCT00738374|62764273|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
33385370|NCT00738374|62764274|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
33385371|NCT00738374|62764275|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
33385372|NCT00738374|62764276|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
33385373|NCT00738374|62764273|FG000|Induction Treatment Phase|Physician Decision|2|||
33385374|NCT00738374|62764274|FG001|Induction Treatment Phase|Physician Decision|0|||
33385375|NCT00738374|62764275|FG002|Induction Treatment Phase|Physician Decision|0|||
33385376|NCT00738374|62764276|FG003|Induction Treatment Phase|Physician Decision|0|||
33385377|NCT00738374|62764273|FG000|Induction Treatment Phase|Protocol Violation|2|||
33385378|NCT00738374|62764274|FG001|Induction Treatment Phase|Protocol Violation|0|||
33488973|NCT03538743|62867206|FG006|Overall Study|Adverse Event|0|||
33297157|NCT01379768|62673374|FG002|Overall Study|Adverse Event|0|||
33297158|NCT01379768|62673372|FG000|Overall Study|Lost to Follow-up|2|||
33297159|NCT01379768|62673373|FG001|Overall Study|Lost to Follow-up|0|||
33297160|NCT01379768|62673374|FG002|Overall Study|Lost to Follow-up|0|||
33297161|NCT01379573|62673382|FG000|Overall Study|Lost to Follow-up|1|||
33297162|NCT01379573|62673382|FG000|Overall Study|Screen Failure|10|||
33297163|NCT01379534|62673388|FG000|Treatment Phase|Withdrawal by Subject|2|||
33297164|NCT01379534|62673389|FG001|Treatment Phase|Withdrawal by Subject|2|||
33297165|NCT01379534|62673388|FG000|Treatment Phase|Progressive disease|13|||
33297166|NCT01379534|62673389|FG001|Treatment Phase|Progressive disease|22|||
33297167|NCT01379534|62673388|FG000|Treatment Phase|Adverse Event|7|||
33297168|NCT01379534|62673389|FG001|Treatment Phase|Adverse Event|7|||
33297169|NCT01379534|62673388|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
33297170|NCT01379534|62673389|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
33297171|NCT01379534|62673388|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
33297172|NCT01379534|62673389|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
33297173|NCT01379534|62673388|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
33385379|NCT00738374|62764275|FG002|Induction Treatment Phase|Protocol Violation|0|||
33385380|NCT00738374|62764276|FG003|Induction Treatment Phase|Protocol Violation|0|||
33385381|NCT00738374|62764273|FG000|Induction Treatment Phase|Non-compliance|1|||
33385382|NCT00738374|62764274|FG001|Induction Treatment Phase|Non-compliance|0|||
33297174|NCT01379534|62673389|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
33297175|NCT01379534|62673388|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
33297176|NCT01379534|62673389|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
33385383|NCT00738374|62764275|FG002|Induction Treatment Phase|Non-compliance|0|||
33385384|NCT00738374|62764276|FG003|Induction Treatment Phase|Non-compliance|0|||
33385385|NCT00738374|62764273|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
33385386|NCT00738374|62764274|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
33385387|NCT00738374|62764275|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
33488974|NCT03538743|62867207|FG007|Overall Study|Adverse Event|0|||
33488975|NCT03538743|62867208|FG008|Overall Study|Adverse Event|0|||
33488976|NCT03538743|62867200|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
33488977|NCT03538743|62867201|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
33488978|NCT03538743|62867202|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
33488979|NCT03538743|62867203|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
33488980|NCT03538743|62867204|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
33488981|NCT03538743|62867205|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
33488982|NCT03538743|62867206|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
33488983|NCT03538743|62867207|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
33488984|NCT03538743|62867208|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
33488985|NCT03538743|62867200|FG000|Overall Study|Withdrawal by Subject|0|||
33488986|NCT03538743|62867201|FG001|Overall Study|Withdrawal by Subject|0|||
33488987|NCT03538743|62867202|FG002|Overall Study|Withdrawal by Subject|0|||
33297177|NCT01371851|62673397|FG000|Overall Study|Lost to Follow-up|5|||
33297178|NCT01371851|62673398|FG001|Overall Study|Lost to Follow-up|8|||
33297179|NCT01371851|62673397|FG000|Overall Study|was arrested and put in jail|0|||
33488988|NCT03538743|62867203|FG003|Overall Study|Withdrawal by Subject|1|||
33488989|NCT03538743|62867204|FG004|Overall Study|Withdrawal by Subject|0|||
33488990|NCT03538743|62867205|FG005|Overall Study|Withdrawal by Subject|0|||
33488991|NCT03538743|62867206|FG006|Overall Study|Withdrawal by Subject|0|||
33488992|NCT03538743|62867207|FG007|Overall Study|Withdrawal by Subject|0|||
33488993|NCT03538743|62867208|FG008|Overall Study|Withdrawal by Subject|0|||
33488994|NCT03521817|62867238|FG000|Overall Study|Protocol Violation|0|||
33488995|NCT03521817|62867239|FG001|Overall Study|Protocol Violation|1|||
33488996|NCT03538431|62867245|FG000|Overall Study|Physician Decision|0|||
33488997|NCT03538431|62867246|FG001|Overall Study|Physician Decision|1|||
33488998|NCT03538431|62867245|FG000|Overall Study|Withdrawal by Subject|1|||
33488999|NCT03538431|62867246|FG001|Overall Study|Withdrawal by Subject|0|||
33489000|NCT03521193|62867256|FG000|Overall Study|Withdrawal by Subject|8|||
33489001|NCT03521193|62867257|FG001|Overall Study|Withdrawal by Subject|0|||
33489002|NCT03521193|62867256|FG000|Overall Study|non compliant to ASA treatment|8|||
33489003|NCT03521193|62867257|FG001|Overall Study|non compliant to ASA treatment|0|||
33489004|NCT00293267|62867266|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
33489005|NCT00293267|62867267|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
33489006|NCT00293267|62867266|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
33489007|NCT00293267|62867267|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
33297180|NCT01371851|62673398|FG001|Overall Study|was arrested and put in jail|1|||
33297181|NCT01371851|62673397|FG000|Overall Study|non study related adverse event|1|||
33297182|NCT01371851|62673398|FG001|Overall Study|non study related adverse event|0|||
33297183|NCT01371851|62673397|FG000|Overall Study|Blood Pressure outside study parameters|2|||
33297184|NCT01371851|62673398|FG001|Overall Study|Blood Pressure outside study parameters|0|||
33297185|NCT01371734|62673407|FG000|Overall Study|Other|2|||
33297186|NCT01371734|62673408|FG001|Overall Study|Other|1|||
33297187|NCT01371734|62673409|FG002|Overall Study|Other|2|||
33297188|NCT01371734|62673407|FG000|Overall Study|Withdrawal by Subject|3|||
33297189|NCT01371734|62673408|FG001|Overall Study|Withdrawal by Subject|4|||
33297190|NCT01371734|62673409|FG002|Overall Study|Withdrawal by Subject|9|||
33297191|NCT01371734|62673407|FG000|Overall Study|Lost to Follow-up|5|||
33297192|NCT01371734|62673408|FG001|Overall Study|Lost to Follow-up|3|||
33297193|NCT01371734|62673409|FG002|Overall Study|Lost to Follow-up|1|||
33297194|NCT01371734|62673407|FG000|Overall Study|Protocol Violation|3|||
33297195|NCT01371734|62673408|FG001|Overall Study|Protocol Violation|1|||
33297196|NCT01371734|62673409|FG002|Overall Study|Protocol Violation|2|||
33297197|NCT01371734|62673407|FG000|Overall Study|Adverse Event|8|||
33385388|NCT00738374|62764276|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
33385389|NCT00738374|62764273|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
33385390|NCT00738374|62764274|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
33385391|NCT00738374|62764275|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
33385392|NCT00738374|62764276|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
33297198|NCT01371734|62673408|FG001|Overall Study|Adverse Event|8|||
33489008|NCT00293267|62867266|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
33489009|NCT00293267|62867267|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
33489010|NCT00293267|62867266|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
33556744|NCT02791763|62949552|FG002|Overall Study|Adverse Event|7|||
33297199|NCT01371734|62673409|FG002|Overall Study|Adverse Event|3|||
33297200|NCT01371734|62673407|FG000|Overall Study|Lack of Efficacy|2|||
33297201|NCT01371734|62673408|FG001|Overall Study|Lack of Efficacy|2|||
33297202|NCT01371734|62673409|FG002|Overall Study|Lack of Efficacy|0|||
33385393|NCT00738374|62764273|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
33385394|NCT00738374|62764274|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
33385395|NCT00738374|62764275|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
33385396|NCT00738374|62764276|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
33385397|NCT00738374|62764273|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
33385398|NCT00738374|62764274|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
33385399|NCT00738374|62764275|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
33385400|NCT00738374|62764276|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
33385401|NCT00738374|62764273|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
33385402|NCT00738374|62764274|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
33385403|NCT00738374|62764275|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
33385404|NCT00738374|62764276|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
33385405|NCT00738374|62764273|FG000|Maintenance Treatment/Observation Phase|Other|0|||
33385406|NCT00738374|62764274|FG001|Maintenance Treatment/Observation Phase|Other|1|||
33385407|NCT00738374|62764275|FG002|Maintenance Treatment/Observation Phase|Other|0|||
33385408|NCT00738374|62764276|FG003|Maintenance Treatment/Observation Phase|Other|0|||
33385409|NCT00697593|62764285|FG000|Overall Study|Adverse Event|3|||
33385410|NCT00697593|62764285|FG000|Overall Study|Protocol Violation|1|||
33385411|NCT00697593|62764285|FG000|Overall Study|Lack of Efficacy|3|||
33385412|NCT00697593|62764285|FG000|Overall Study|Suspension of the study by sponsor|12|||
33385413|NCT00697515|62764289|FG000|Dose Optimization Period|Adverse Event|4|||
33385414|NCT00697515|62764290|FG001|Dose Optimization Period|Adverse Event|0|||
33385415|NCT00697515|62764289|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
33385416|NCT00697515|62764290|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
33385417|NCT00697515|62764289|FG000|Dose Optimization Period|Lost to Follow-up|2|||
33385418|NCT00697515|62764290|FG001|Dose Optimization Period|Lost to Follow-up|0|||
33385419|NCT00697515|62764289|FG000|Dose Optimization Period|sponsor request|2|||
33385420|NCT00697515|62764290|FG001|Dose Optimization Period|sponsor request|0|||
33385421|NCT00697515|62764289|FG000|Dose Optimization Period|called to active duty|1|||
33385422|NCT00697515|62764290|FG001|Dose Optimization Period|called to active duty|0|||
33385423|NCT00697515|62764289|FG000|Dose Optimization Period|elevated QTc|1|||
33385424|NCT00697515|62764290|FG001|Dose Optimization Period|elevated QTc|0|||
33385425|NCT00697515|62764289|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
33385426|NCT00697515|62764290|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
33385427|NCT00697515|62764289|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
33385428|NCT00697515|62764290|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
33385429|NCT00697515|62764289|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
33297203|NCT01365494|62673419|FG000|Overall Study|Adverse Event|1|||
33297204|NCT01365494|62673420|FG001|Overall Study|Adverse Event|0|||
33297205|NCT01365494|62673419|FG000|Overall Study|Withdrawal by Subject|0|||
33297206|NCT01365494|62673420|FG001|Overall Study|Withdrawal by Subject|1|||
33297207|NCT01365494|62673419|FG000|Overall Study|Lost to Follow-up|1|||
33297208|NCT01365494|62673420|FG001|Overall Study|Lost to Follow-up|2|||
33297209|NCT01357889|62673429|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
33297210|NCT01357889|62673430|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
33297211|NCT01357889|62673429|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
33297212|NCT01357889|62673430|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
33297213|NCT01357889|62673429|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
33297214|NCT01357889|62673430|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
33297215|NCT01357889|62673429|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
33297216|NCT01357889|62673430|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
33297217|NCT01357889|62673429|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
33297218|NCT01357889|62673430|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
33385430|NCT00697515|62764290|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
33385431|NCT00697515|62764289|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
33385432|NCT00697515|62764290|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
33385433|NCT00738062|62764299|FG000|Open Label Treatment|Lack of Efficacy|5|||
33385434|NCT00738062|62764300|FG001|Open Label Treatment|Lack of Efficacy|0|||
33385435|NCT00738062|62764301|FG002|Open Label Treatment|Lack of Efficacy|0|||
33385436|NCT00738062|62764299|FG000|Open Label Treatment|Adverse Event|11|||
33385437|NCT00738062|62764300|FG001|Open Label Treatment|Adverse Event|0|||
33385438|NCT00738062|62764301|FG002|Open Label Treatment|Adverse Event|0|||
33385439|NCT00738062|62764299|FG000|Open Label Treatment|Protocol Violation|2|||
33385440|NCT00738062|62764300|FG001|Open Label Treatment|Protocol Violation|0|||
33385441|NCT00738062|62764301|FG002|Open Label Treatment|Protocol Violation|0|||
33385442|NCT00738062|62764299|FG000|Open Label Treatment|Withdrawal by Subject|9|||
33385443|NCT00738062|62764300|FG001|Open Label Treatment|Withdrawal by Subject|0|||
33297219|NCT01357889|62673429|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
33385444|NCT00738062|62764301|FG002|Open Label Treatment|Withdrawal by Subject|0|||
33385445|NCT00738062|62764299|FG000|Open Label Treatment|Investigator Decision|1|||
33385446|NCT00738062|62764300|FG001|Open Label Treatment|Investigator Decision|0|||
33385447|NCT00738062|62764301|FG002|Open Label Treatment|Investigator Decision|0|||
33385448|NCT00738062|62764299|FG000|Open-Label Extension|Adverse Event|5|||
33385449|NCT00738062|62764300|FG001|Open-Label Extension|Adverse Event|0|||
33385450|NCT00738062|62764301|FG002|Open-Label Extension|Adverse Event|0|||
33385451|NCT00738062|62764299|FG000|Open-Label Extension|Physician Decision|1|||
33385452|NCT00738062|62764300|FG001|Open-Label Extension|Physician Decision|0|||
33385453|NCT00738062|62764301|FG002|Open-Label Extension|Physician Decision|0|||
33385454|NCT00738062|62764299|FG000|Open-Label Extension|Lack of Efficacy|2|||
33385455|NCT00738062|62764300|FG001|Open-Label Extension|Lack of Efficacy|0|||
33385456|NCT00738062|62764301|FG002|Open-Label Extension|Lack of Efficacy|0|||
33385457|NCT00738062|62764299|FG000|Open-Label Extension|Withdrawal by Subject|6|||
33385458|NCT00738062|62764300|FG001|Open-Label Extension|Withdrawal by Subject|0|||
33385459|NCT00738062|62764301|FG002|Open-Label Extension|Withdrawal by Subject|0|||
33385460|NCT00738062|62764299|FG000|Open-Label Extension|Protocol Violation|1|||
33385461|NCT00738062|62764300|FG001|Open-Label Extension|Protocol Violation|0|||
33385462|NCT00738062|62764301|FG002|Open-Label Extension|Protocol Violation|0|||
33385463|NCT00738062|62764299|FG000|Open-Label Extension|Study Terminated|2|||
33385464|NCT00738062|62764300|FG001|Open-Label Extension|Study Terminated|0|||
33385465|NCT00738062|62764301|FG002|Open-Label Extension|Study Terminated|0|||
33385466|NCT04245345|62764310|FG000|Overall Study|Death|1|||
33385467|NCT04245345|62764310|FG000|Overall Study|Exited prior to implant|5|||
33385468|NCT04245345|62764310|FG000|Overall Study|Exited prior to 1-month|9|||
33385469|NCT04245345|62764310|FG000|Overall Study|Missed 1-month visit|3|||
33385470|NCT04245345|62764310|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
33385471|NCT04245345|62764310|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
33385472|NCT00698685|62764316|FG000|Overall Study|Sister withdrew as donor|1|||
33385473|NCT00698685|62764316|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
33385474|NCT00737672|62764322|FG000|Overall Study|Graft Abandonment|48|||
33385475|NCT00737672|62764323|FG001|Overall Study|Graft Abandonment|56|||
33385476|NCT00737672|62764322|FG000|Overall Study|Death|23|||
33385477|NCT00737672|62764323|FG001|Overall Study|Death|22|||
33297220|NCT01357889|62673430|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
33297221|NCT01357889|62673429|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
33297222|NCT01357889|62673430|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
33297223|NCT01357889|62673429|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
33297224|NCT01357889|62673430|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
33297225|NCT01357889|62673429|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
33297226|NCT01357889|62673430|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
33297227|NCT01357889|62673429|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
33297228|NCT01357889|62673430|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
33297229|NCT01357889|62673429|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
33297230|NCT01357889|62673430|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
33385478|NCT00737672|62764322|FG000|Overall Study|Withdrawal by Subject|1|||
33385479|NCT00737672|62764323|FG001|Overall Study|Withdrawal by Subject|2|||
33385480|NCT00737672|62764322|FG000|Overall Study|Lost to Follow-up|1|||
33385481|NCT00737672|62764323|FG001|Overall Study|Lost to Follow-up|0|||
33385482|NCT00737672|62764322|FG000|Overall Study|Miscellaneous|7|||
33385483|NCT00737672|62764323|FG001|Overall Study|Miscellaneous|1|||
33489011|NCT00293267|62867267|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
33489012|NCT00293267|62867266|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
33489013|NCT00293267|62867267|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
33297231|NCT01357889|62673429|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
33297232|NCT01357889|62673430|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
33297233|NCT01357889|62673429|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
33297234|NCT01357889|62673430|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
33297235|NCT01357850|62673442|FG000|Overall Study|Lost to Follow-up|1|||
33297236|NCT01357850|62673443|FG001|Overall Study|Lost to Follow-up|0|||
33297237|NCT01357850|62673444|FG002|Overall Study|Lost to Follow-up|0|||
33297238|NCT01357850|62673445|FG003|Overall Study|Lost to Follow-up|0|||
33297239|NCT01357655|62673458|FG000|Overall Study|Administrative Reason by Sponsor|45|||
33297240|NCT01357655|62673459|FG001|Overall Study|Administrative Reason by Sponsor|0|||
33297241|NCT01357655|62673458|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
33489014|NCT00293267|62867266|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
33489015|NCT00293267|62867267|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
33489016|NCT00293267|62867266|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
33385484|NCT00737672|62764322|FG000|Overall Study|Physician Decision|0|||
33385485|NCT00737672|62764323|FG001|Overall Study|Physician Decision|2|||
33385486|NCT00737438|62764329|FG000|Overall Study|Withdrawal by Subject|2|||
33385487|NCT00737438|62764329|FG000|Overall Study|Patient ineligible|1|||
33297242|NCT01357655|62673459|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33297243|NCT01357655|62673458|FG000|Overall Study|Disease Progression|1|||
33297244|NCT01357655|62673459|FG001|Overall Study|Disease Progression|0|||
33297245|NCT01357655|62673458|FG000|Overall Study|Lost to Follow-up|2|||
33297246|NCT01357655|62673459|FG001|Overall Study|Lost to Follow-up|0|||
33297247|NCT01357655|62673458|FG000|Overall Study|Maximum Clinical Benefit|2|||
33297248|NCT01357655|62673459|FG001|Overall Study|Maximum Clinical Benefit|0|||
33297249|NCT01357655|62673458|FG000|Overall Study|Reason Unspecified|1|||
33297250|NCT01357655|62673459|FG001|Overall Study|Reason Unspecified|0|||
33297251|NCT01357655|62673458|FG000|Overall Study|Study Drug Toxicity|11|||
33297252|NCT01357655|62673459|FG001|Overall Study|Study Drug Toxicity|0|||
33297253|NCT01357655|62673458|FG000|Overall Study|Subject Withdrew Consent|1|||
33297254|NCT01357655|62673459|FG001|Overall Study|Subject Withdrew Consent|0|||
33297255|NCT01357616|62673466|FG000|Overall Study|Adverse Event|1|||
33297256|NCT01357616|62673467|FG001|Overall Study|Adverse Event|1|||
33297257|NCT01357616|62673466|FG000|Overall Study|Lost to Follow-up|4|||
33297258|NCT01357616|62673467|FG001|Overall Study|Lost to Follow-up|3|||
33297259|NCT01357616|62673466|FG000|Overall Study|Protocol Violation|0|||
33385488|NCT00737282|62764335|FG000|Overall Study|Study prematurely terminated|175|||
33385489|NCT03884478|62764344|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
33385490|NCT03884478|62764345|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
33385491|NCT03884478|62764346|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
33385492|NCT03884478|62764344|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
33385493|NCT03884478|62764345|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
33385494|NCT03884478|62764346|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
33385495|NCT03884478|62764344|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
33297260|NCT01357616|62673467|FG001|Overall Study|Protocol Violation|2|||
33385496|NCT03884478|62764345|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
33385497|NCT03884478|62764346|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
33385498|NCT03884478|62764344|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
33385499|NCT03884478|62764345|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
33385500|NCT03884478|62764346|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
33385501|NCT00582816|62764367|FG000|Overall Study|Engraftment Failure|3|||
33385502|NCT00737048|62764374|FG000|Overall Study|Physician Decision|0|||
33385503|NCT00737048|62764375|FG001|Overall Study|Physician Decision|0|||
33385504|NCT00737048|62764376|FG002|Overall Study|Physician Decision|1|||
33385505|NCT00737048|62764374|FG000|Overall Study|Adverse Event|0|||
33385506|NCT00737048|62764375|FG001|Overall Study|Adverse Event|1|||
33385507|NCT00737048|62764376|FG002|Overall Study|Adverse Event|0|||
33297261|NCT01357616|62673466|FG000|Overall Study|Inadequate Control of IOP|1|||
33297262|NCT01357616|62673467|FG001|Overall Study|Inadequate Control of IOP|2|||
33297263|NCT01357616|62673466|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
33297264|NCT01357616|62673467|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
33297265|NCT01357616|62673466|FG000|Overall Study|Withdrawal by Subject|1|||
33297266|NCT01357616|62673467|FG001|Overall Study|Withdrawal by Subject|0|||
33297267|NCT01357577|62673475|FG000|Overall Study|Lost to Follow-up|20|||
33385508|NCT00737048|62764374|FG000|Overall Study|Worsening of the symptoms|3|||
33385509|NCT00737048|62764375|FG001|Overall Study|Worsening of the symptoms|5|||
33385510|NCT00737048|62764376|FG002|Overall Study|Worsening of the symptoms|3|||
33385511|NCT00731822|62764386|FG000|Overall Study|Adverse Event|2|||
33385512|NCT00731822|62764387|FG001|Overall Study|Adverse Event|1|||
33385513|NCT00731822|62764386|FG000|Overall Study|Protocol Violation|1|||
33385514|NCT00731822|62764387|FG001|Overall Study|Protocol Violation|0|||
33385515|NCT00731822|62764386|FG000|Overall Study|Lost to Follow-up|1|||
33385516|NCT00731822|62764387|FG001|Overall Study|Lost to Follow-up|0|||
33385517|NCT00731666|62764393|FG000|Overall Study|Adverse Event|2|||
33385518|NCT00731666|62764393|FG000|Overall Study|Lost to Follow-up|8|||
33385519|NCT00731666|62764393|FG000|Overall Study|Withdrawal by Subject|2|||
33385520|NCT00731120|62764400|FG000|Overall Study|Adverse Event|7|||
33385521|NCT00731120|62764401|FG001|Overall Study|Adverse Event|6|||
33385522|NCT00731120|62764402|FG002|Overall Study|Adverse Event|8|||
33489017|NCT00293267|62867267|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
33297268|NCT01357577|62673476|FG001|Overall Study|Lost to Follow-up|16|||
33297269|NCT01357577|62673475|FG000|Overall Study|Withdrawal by Subject|16|||
33297270|NCT01357577|62673476|FG001|Overall Study|Withdrawal by Subject|8|||
33297271|NCT01357577|62673475|FG000|Overall Study|look at data in database?|1|||
33297272|NCT01357577|62673476|FG001|Overall Study|look at data in database?|2|||
33297273|NCT01351025|62673485|FG000|Week 0 - 20|Lost to Follow-up|2|||
33385523|NCT00731120|62764400|FG000|Overall Study|Lack of Efficacy|4|||
33385524|NCT00731120|62764401|FG001|Overall Study|Lack of Efficacy|5|||
33385525|NCT00731120|62764402|FG002|Overall Study|Lack of Efficacy|4|||
33385526|NCT00731120|62764400|FG000|Overall Study|Noncompliance with Study Drug|3|||
33385527|NCT00731120|62764401|FG001|Overall Study|Noncompliance with Study Drug|3|||
33297274|NCT01351025|62673486|FG001|Week 0 - 20|Lost to Follow-up|1|||
33297275|NCT01351025|62673485|FG000|Week 0 - 20|Withdrawal by Subject|1|||
33385528|NCT00731120|62764402|FG002|Overall Study|Noncompliance with Study Drug|1|||
33385529|NCT00731120|62764400|FG000|Overall Study|Protocol Deviations|1|||
33385530|NCT00731120|62764401|FG001|Overall Study|Protocol Deviations|6|||
33385531|NCT00731120|62764402|FG002|Overall Study|Protocol Deviations|1|||
33385532|NCT00731120|62764400|FG000|Overall Study|Withdrawal of Consent|13|||
33385533|NCT00731120|62764401|FG001|Overall Study|Withdrawal of Consent|8|||
33385534|NCT00731120|62764402|FG002|Overall Study|Withdrawal of Consent|4|||
33385535|NCT00731120|62764400|FG000|Overall Study|Lost to Follow-up|10|||
33385536|NCT00731120|62764401|FG001|Overall Study|Lost to Follow-up|15|||
33385537|NCT00731120|62764402|FG002|Overall Study|Lost to Follow-up|17|||
33385538|NCT00731120|62764400|FG000|Overall Study|Other|4|||
33385539|NCT00731120|62764401|FG001|Overall Study|Other|0|||
33385540|NCT00731120|62764402|FG002|Overall Study|Other|1|||
33385541|NCT00731042|62764412|FG000|Second Intervention|Did not meet inclusion criteria|0|||
33385542|NCT00731042|62764413|FG001|Second Intervention|Did not meet inclusion criteria|2|||
33385543|NCT00726986|62764419|FG000|Induction Phase|Adverse Event|4|||
33385544|NCT00726986|62764419|FG000|Induction Phase|Withdrawal by Subject|2|||
33385545|NCT00726986|62764419|FG000|Induction Phase|Death|2|||
33385546|NCT00726986|62764419|FG000|Induction Phase|Lack of Efficacy|5|||
33385547|NCT00726986|62764419|FG000|Induction Phase|Secondary Disease|2|||
33385548|NCT00726986|62764419|FG000|Maintenance Phase|Adverse Event|1|||
33385549|NCT00726986|62764419|FG000|Maintenance Phase|Lack of Efficacy|2|||
33385550|NCT00696657|62764432|FG000|Overall Study|Protocol Violation|0|||
33385551|NCT00696657|62764433|FG001|Overall Study|Protocol Violation|0|||
33489018|NCT00293267|62867266|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
33489019|NCT00293267|62867267|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
33489020|NCT00293267|62867266|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
33489021|NCT00293267|62867267|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
33489022|NCT00293267|62867266|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
33489023|NCT00293267|62867267|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
33489024|NCT00293267|62867266|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
33489025|NCT00293267|62867267|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
33489026|NCT00293267|62867266|FG000|Extension - Double-Blind Week 49-156|Death|3|||
33489027|NCT00293267|62867267|FG001|Extension - Double-Blind Week 49-156|Death|0|||
33489028|NCT00293267|62867266|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
33489029|NCT00293267|62867267|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
33489030|NCT00293267|62867266|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
33489031|NCT00293267|62867267|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
33489032|NCT00293267|62867266|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
33489033|NCT00293267|62867267|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
33489034|NCT00293267|62867266|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
33489035|NCT00293267|62867267|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
33489036|NCT00293267|62867266|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
33489037|NCT00293267|62867267|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
33489038|NCT00293267|62867266|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
33489039|NCT00293267|62867267|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
33489040|NCT00293267|62867266|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
33489041|NCT00293267|62867267|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
33489042|NCT00293267|62867266|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
33489043|NCT00293267|62867267|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
33489044|NCT00293267|62867266|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
33489045|NCT00293267|62867267|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
33489046|NCT00293267|62867266|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
33489047|NCT00293267|62867267|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
33556745|NCT02613572|62949572|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
33297276|NCT01351025|62673486|FG001|Week 0 - 20|Withdrawal by Subject|0|||
33297277|NCT01351025|62673485|FG000|Week 24 - 44|Lost to Follow-up|0|||
33297278|NCT01351025|62673486|FG001|Week 24 - 44|Lost to Follow-up|2|||
33297279|NCT01351025|62673485|FG000|Week 24 - 44|Site closed|0|||
33297280|NCT01351025|62673486|FG001|Week 24 - 44|Site closed|1|||
33297281|NCT01351025|62673485|FG000|Week 24 - 44|unable to get to clinic|1|||
33297282|NCT01351025|62673486|FG001|Week 24 - 44|unable to get to clinic|1|||
33297283|NCT01349036|62673500|FG000|Overall Study|Disease progression|13|||
33297284|NCT01349036|62673501|FG001|Overall Study|Disease progression|22|||
33297285|NCT01349036|62673500|FG000|Overall Study|Other|1|||
33297286|NCT01349036|62673501|FG001|Overall Study|Other|0|||
33385552|NCT00696657|62764434|FG002|Overall Study|Protocol Violation|0|||
33385553|NCT00696657|62764435|FG003|Overall Study|Protocol Violation|0|||
33385554|NCT00696657|62764436|FG004|Overall Study|Protocol Violation|0|||
33385555|NCT00696657|62764437|FG005|Overall Study|Protocol Violation|1|||
33385556|NCT00696657|62764438|FG006|Overall Study|Protocol Violation|0|||
33385557|NCT00696657|62764439|FG007|Overall Study|Protocol Violation|0|||
33385558|NCT00696657|62764440|FG008|Overall Study|Protocol Violation|1|||
33385559|NCT00696657|62764432|FG000|Overall Study|Lack of Efficacy|0|||
33385560|NCT00696657|62764433|FG001|Overall Study|Lack of Efficacy|1|||
33385561|NCT00696657|62764434|FG002|Overall Study|Lack of Efficacy|0|||
33385562|NCT00696657|62764435|FG003|Overall Study|Lack of Efficacy|0|||
33385563|NCT00696657|62764436|FG004|Overall Study|Lack of Efficacy|0|||
33385564|NCT00696657|62764437|FG005|Overall Study|Lack of Efficacy|0|||
33385565|NCT00696657|62764438|FG006|Overall Study|Lack of Efficacy|0|||
33297287|NCT01349036|62673500|FG000|Overall Study|Withdrawal by Subject|0|||
33297288|NCT01349036|62673501|FG001|Overall Study|Withdrawal by Subject|2|||
33297289|NCT01348763|62673511|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
33297290|NCT01348763|62673511|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
33297291|NCT01346969|62673519|FG000|Overall Study|Withdrawal by Subject|0|||
33297292|NCT01346969|62673520|FG001|Overall Study|Withdrawal by Subject|0|||
33297293|NCT01346969|62673521|FG002|Overall Study|Withdrawal by Subject|1|||
33297294|NCT01346969|62673522|FG003|Overall Study|Withdrawal by Subject|0|||
33297295|NCT01346969|62673519|FG000|Overall Study|Lost to Follow-up|1|||
33297296|NCT01346969|62673520|FG001|Overall Study|Lost to Follow-up|0|||
33297297|NCT01346969|62673521|FG002|Overall Study|Lost to Follow-up|2|||
33297298|NCT01346969|62673522|FG003|Overall Study|Lost to Follow-up|0|||
33297299|NCT01346969|62673519|FG000|Overall Study|Physician Decision|0|||
33297300|NCT01346969|62673520|FG001|Overall Study|Physician Decision|0|||
33297301|NCT01346969|62673521|FG002|Overall Study|Physician Decision|0|||
33297302|NCT01346969|62673522|FG003|Overall Study|Physician Decision|1|||
33297303|NCT01346969|62673519|FG000|Overall Study|Randomized but not treated|1|||
33297304|NCT01346969|62673520|FG001|Overall Study|Randomized but not treated|0|||
33297305|NCT01346969|62673521|FG002|Overall Study|Randomized but not treated|0|||
33297306|NCT01346969|62673522|FG003|Overall Study|Randomized but not treated|0|||
33297307|NCT01346774|62673534|FG000|Overall Study|Did not take a single dose|6|||
33297308|NCT01346774|62673535|FG001|Overall Study|Did not take a single dose|4|||
33297309|NCT01346774|62673534|FG000|Overall Study|Lost to Follow-up|3|||
33297310|NCT01346774|62673535|FG001|Overall Study|Lost to Follow-up|4|||
33297311|NCT01346774|62673534|FG000|Overall Study|Withdrawal by Subject|1|||
33297312|NCT01346774|62673535|FG001|Overall Study|Withdrawal by Subject|4|||
33297313|NCT01346774|62673534|FG000|Overall Study|Protocol Violation|2|||
33297314|NCT01346774|62673535|FG001|Overall Study|Protocol Violation|3|||
33297315|NCT01346774|62673534|FG000|Overall Study|Adverse Event|1|||
33297316|NCT01346774|62673535|FG001|Overall Study|Adverse Event|2|||
33297317|NCT01346696|62673541|FG000|Overall Study|Death|1|||
33297318|NCT01346540|62673547|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
33297319|NCT01346540|62673548|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
33297320|NCT01346540|62673547|FG000|Overall Study|Adverse Event|0|||
33297321|NCT01346540|62673548|FG001|Overall Study|Adverse Event|4|||
33297322|NCT01342913|62673557|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
33297323|NCT01342913|62673558|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33297324|NCT01342913|62673559|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33297325|NCT01342913|62673557|FG000|2-week Run-in Period|Physician Decision|6|||
33297326|NCT01342913|62673558|FG001|2-week Run-in Period|Physician Decision|0|||
33297327|NCT01342913|62673559|FG002|2-week Run-in Period|Physician Decision|0|||
33297328|NCT01342913|62673557|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
33297329|NCT01342913|62673558|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
33297330|NCT01342913|62673559|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
33297331|NCT01342913|62673557|FG000|2-week Run-in Period|Adverse Event|2|||
33297332|NCT01342913|62673558|FG001|2-week Run-in Period|Adverse Event|0|||
33385566|NCT00696657|62764439|FG007|Overall Study|Lack of Efficacy|0|||
33385567|NCT00696657|62764440|FG008|Overall Study|Lack of Efficacy|0|||
33385568|NCT00696657|62764432|FG000|Overall Study|Withdrawal criteria|1|||
33385569|NCT00696657|62764433|FG001|Overall Study|Withdrawal criteria|3|||
33385570|NCT00696657|62764434|FG002|Overall Study|Withdrawal criteria|2|||
33385571|NCT00696657|62764435|FG003|Overall Study|Withdrawal criteria|2|||
33385572|NCT00696657|62764436|FG004|Overall Study|Withdrawal criteria|0|||
33297333|NCT01342913|62673559|FG002|2-week Run-in Period|Adverse Event|0|||
33297334|NCT01342913|62673557|FG000|2-week Run-in Period|Protocol Violation|5|||
33385573|NCT00696657|62764437|FG005|Overall Study|Withdrawal criteria|0|||
33385574|NCT00696657|62764438|FG006|Overall Study|Withdrawal criteria|1|||
33385575|NCT00696657|62764439|FG007|Overall Study|Withdrawal criteria|1|||
33385576|NCT00696657|62764440|FG008|Overall Study|Withdrawal criteria|2|||
33385577|NCT00696657|62764432|FG000|Overall Study|Unclassified|0|||
33385578|NCT00696657|62764433|FG001|Overall Study|Unclassified|1|||
33385579|NCT00696657|62764434|FG002|Overall Study|Unclassified|3|||
33297335|NCT01342913|62673558|FG001|2-week Run-in Period|Protocol Violation|0|||
33297336|NCT01342913|62673559|FG002|2-week Run-in Period|Protocol Violation|0|||
33297337|NCT01342913|62673557|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
33297338|NCT01342913|62673558|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
33297339|NCT01342913|62673559|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
33385580|NCT00696657|62764435|FG003|Overall Study|Unclassified|2|||
33297340|NCT01342913|62673557|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33297341|NCT01342913|62673558|FG001|Double-Blind Treatment Period|Adverse Event|3|||
33297342|NCT01342913|62673559|FG002|Double-Blind Treatment Period|Adverse Event|6|||
33297343|NCT01342913|62673557|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
33297344|NCT01342913|62673558|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
33297345|NCT01342913|62673559|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
33297346|NCT01342913|62673557|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
33297347|NCT01342913|62673558|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
33297348|NCT01342913|62673559|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
33385581|NCT00696657|62764436|FG004|Overall Study|Unclassified|4|||
33385582|NCT00696657|62764437|FG005|Overall Study|Unclassified|2|||
33385583|NCT00696657|62764438|FG006|Overall Study|Unclassified|0|||
33385584|NCT00696657|62764439|FG007|Overall Study|Unclassified|0|||
33385585|NCT00696657|62764440|FG008|Overall Study|Unclassified|1|||
33385586|NCT00696657|62764432|FG000|Overall Study|Adverse Event|0|||
33385587|NCT00696657|62764433|FG001|Overall Study|Adverse Event|0|||
33489048|NCT00293267|62867266|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
33489049|NCT00293267|62867267|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
33489050|NCT00293267|62867266|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
33489051|NCT00293267|62867267|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
33489052|NCT00293267|62867266|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
33489053|NCT00293267|62867267|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
33489054|NCT00293267|62867266|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
33489055|NCT00293267|62867267|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
33489056|NCT00293267|62867266|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
33489057|NCT00293267|62867267|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
33489058|NCT00293267|62867266|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
33489059|NCT00293267|62867267|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
33489060|NCT03520959|62867277|FG000|Overall Study|Study terminated by Sponsor|0|||
33489061|NCT03520959|62867278|FG001|Overall Study|Study terminated by Sponsor|1|||
33489062|NCT03537261|62867286|FG000|Overall Study|Lost to Follow-up|4|||
33489063|NCT03537261|62867287|FG001|Overall Study|Lost to Follow-up|5|||
33489064|NCT03537261|62867286|FG000|Overall Study|Withdrawal by Subject|4|||
33489065|NCT03537261|62867287|FG001|Overall Study|Withdrawal by Subject|6|||
33489066|NCT03537261|62867286|FG000|Overall Study|Did not return study questionnaires|0|||
33489067|NCT03537261|62867287|FG001|Overall Study|Did not return study questionnaires|1|||
33489068|NCT03536949|62867295|FG000|Overall Study|Adverse Event|4|||
33489069|NCT03536949|62867296|FG001|Overall Study|Adverse Event|0|||
33489070|NCT03536949|62867295|FG000|Overall Study|Lost to Follow-up|2|||
33489071|NCT03536949|62867296|FG001|Overall Study|Lost to Follow-up|1|||
33489072|NCT03536949|62867295|FG000|Overall Study|Withdrawal by Subject|6|||
33489073|NCT03536949|62867296|FG001|Overall Study|Withdrawal by Subject|0|||
33489074|NCT03536949|62867295|FG000|Overall Study|Non-compliance|2|||
33489075|NCT03536949|62867296|FG001|Overall Study|Non-compliance|1|||
33489076|NCT03588741|62867302|FG000|Overall Study|Withdrawal by Subject|1|||
33489077|NCT00111917|62867308|FG000|Overall Study|Withdrawal by Subject|1|||
33489078|NCT00111917|62867309|FG001|Overall Study|Withdrawal by Subject|1|||
33297349|NCT01342913|62673557|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33297350|NCT01342913|62673558|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
33297351|NCT01342913|62673559|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
33297352|NCT01342913|62673557|FG000|Double-Blind Treatment Period|Physician Decision|0|||
33297353|NCT01342913|62673558|FG001|Double-Blind Treatment Period|Physician Decision|2|||
33297354|NCT01342913|62673559|FG002|Double-Blind Treatment Period|Physician Decision|0|||
33297355|NCT01342913|62673557|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33297356|NCT01342913|62673558|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
33297357|NCT01342913|62673559|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
33297358|NCT01342796|62673567|FG000|Overall Study|Withdrawal by Subject|2|||
33297359|NCT01342796|62673568|FG001|Overall Study|Withdrawal by Subject|0|||
33297360|NCT01342796|62673567|FG000|Overall Study|Lost to Follow-up|0|||
33297361|NCT01342796|62673568|FG001|Overall Study|Lost to Follow-up|3|||
33297362|NCT01342796|62673567|FG000|Overall Study|Inappropriate enrollment|1|||
33297363|NCT01342796|62673568|FG001|Overall Study|Inappropriate enrollment|0|||
33297364|NCT01342640|62673574|FG000|Overall Study|Adverse Event|3|||
33297365|NCT01342640|62673574|FG000|Overall Study|Protocol Violation|16|||
33297366|NCT01342640|62673574|FG000|Overall Study|Lost to Follow-up|21|||
33385588|NCT00696657|62764434|FG002|Overall Study|Adverse Event|3|||
33385589|NCT00696657|62764435|FG003|Overall Study|Adverse Event|7|||
33385590|NCT00696657|62764436|FG004|Overall Study|Adverse Event|6|||
33489079|NCT03520569|62867319|FG000|Overall Study|Withdrawal by Subject|1|||
33489080|NCT00111839|62867332|FG000|Overall Study|Disease Progression|30|||
33489081|NCT00111839|62867333|FG001|Overall Study|Disease Progression|33|||
33385591|NCT00696657|62764437|FG005|Overall Study|Adverse Event|9|||
33385592|NCT00696657|62764438|FG006|Overall Study|Adverse Event|14|||
33297367|NCT01342640|62673574|FG000|Overall Study|Other|1|||
33297368|NCT01342484|62673581|FG000|Overall Study|Other Reasons|1|||
33297369|NCT01342484|62673582|FG001|Overall Study|Other Reasons|0|||
33297370|NCT01342484|62673583|FG002|Overall Study|Other Reasons|0|||
33297371|NCT01342484|62673581|FG000|Overall Study|Protocol Violation|0|||
33297372|NCT01342484|62673582|FG001|Overall Study|Protocol Violation|0|||
33297373|NCT01342484|62673583|FG002|Overall Study|Protocol Violation|1|||
33297374|NCT01342484|62673581|FG000|Overall Study|Withdrawal by Subject|1|||
33297375|NCT01342484|62673582|FG001|Overall Study|Withdrawal by Subject|0|||
33297376|NCT01342484|62673583|FG002|Overall Study|Withdrawal by Subject|0|||
33297377|NCT01342445|62673593|FG000|Overall Study|Experienced side effects|0|||
33297378|NCT01342445|62673594|FG001|Overall Study|Experienced side effects|2|||
33297379|NCT01342211|62673609|FG000|Overall Study|Lost to Follow-up|0|||
33297380|NCT01342211|62673610|FG001|Overall Study|Lost to Follow-up|0|||
33297381|NCT01342211|62673611|FG002|Overall Study|Lost to Follow-up|0|||
33297382|NCT01342211|62673612|FG003|Overall Study|Lost to Follow-up|1|||
33297383|NCT01342211|62673613|FG004|Overall Study|Lost to Follow-up|0|||
33385593|NCT00696657|62764439|FG007|Overall Study|Adverse Event|2|||
33385594|NCT00696657|62764440|FG008|Overall Study|Adverse Event|5|||
33385595|NCT00730886|62764462|FG000|Overall Study|Lost to Follow-up|1|||
33385596|NCT00730886|62764463|FG001|Overall Study|Lost to Follow-up|0|||
33385597|NCT00730886|62764462|FG000|Overall Study|Physician Decision|1|||
33385598|NCT00730886|62764463|FG001|Overall Study|Physician Decision|0|||
33297384|NCT01342211|62673609|FG000|Overall Study|Adverse Event|0|||
33297385|NCT01342211|62673610|FG001|Overall Study|Adverse Event|0|||
33297386|NCT01342211|62673611|FG002|Overall Study|Adverse Event|0|||
33297387|NCT01342211|62673612|FG003|Overall Study|Adverse Event|0|||
33297388|NCT01342211|62673613|FG004|Overall Study|Adverse Event|1|||
33297389|NCT01342211|62673609|FG000|Overall Study|Withdrawal by Subject|0|||
33297390|NCT01342211|62673610|FG001|Overall Study|Withdrawal by Subject|0|||
33297391|NCT01342211|62673611|FG002|Overall Study|Withdrawal by Subject|0|||
33297392|NCT01342211|62673612|FG003|Overall Study|Withdrawal by Subject|1|||
33297393|NCT01342211|62673613|FG004|Overall Study|Withdrawal by Subject|0|||
33297394|NCT01342211|62673609|FG000|Overall Study|Randomized, but not Treated|0|||
33297395|NCT01342211|62673610|FG001|Overall Study|Randomized, but not Treated|2|||
33297396|NCT01342211|62673611|FG002|Overall Study|Randomized, but not Treated|0|||
33385599|NCT00726752|62764469|FG000|Overall Study|Lack of Efficacy|6|||
33385600|NCT00730028|62764487|FG000|Overall Study|Adverse Event|23|||
33385601|NCT00730028|62764488|FG001|Overall Study|Adverse Event|26|||
33385602|NCT00730028|62764489|FG002|Overall Study|Adverse Event|16|||
33385603|NCT00730028|62764490|FG003|Overall Study|Adverse Event|20|||
33385604|NCT00730028|62764491|FG004|Overall Study|Adverse Event|43|||
33385605|NCT00730028|62764487|FG000|Overall Study|Lost to Follow-up|13|||
33385606|NCT00730028|62764488|FG001|Overall Study|Lost to Follow-up|26|||
33385607|NCT00730028|62764489|FG002|Overall Study|Lost to Follow-up|22|||
33489082|NCT00111839|62867334|FG002|Overall Study|Disease Progression|33|||
33489083|NCT00111839|62867332|FG000|Overall Study|Adverse Event|5|||
33489084|NCT00111839|62867333|FG001|Overall Study|Adverse Event|3|||
33385608|NCT00730028|62764490|FG003|Overall Study|Lost to Follow-up|26|||
33385609|NCT00730028|62764491|FG004|Overall Study|Lost to Follow-up|25|||
33385610|NCT00730028|62764487|FG000|Overall Study|Protocol Violation|6|||
33385611|NCT00730028|62764488|FG001|Overall Study|Protocol Violation|1|||
33385612|NCT00730028|62764489|FG002|Overall Study|Protocol Violation|1|||
33385613|NCT00730028|62764490|FG003|Overall Study|Protocol Violation|2|||
33385614|NCT00730028|62764491|FG004|Overall Study|Protocol Violation|0|||
33385615|NCT00730028|62764487|FG000|Overall Study|Withdrawal by Subject|9|||
33385616|NCT00730028|62764488|FG001|Overall Study|Withdrawal by Subject|5|||
33385617|NCT00730028|62764489|FG002|Overall Study|Withdrawal by Subject|4|||
33489085|NCT00111839|62867334|FG002|Overall Study|Adverse Event|1|||
33489086|NCT00111839|62867332|FG000|Overall Study|Protocol Violation|2|||
33489087|NCT00111839|62867333|FG001|Overall Study|Protocol Violation|4|||
33489088|NCT00111839|62867334|FG002|Overall Study|Protocol Violation|2|||
33489089|NCT00111839|62867332|FG000|Overall Study|Death|1|||
33489090|NCT00111839|62867333|FG001|Overall Study|Death|1|||
33662578|NCT01587703|63093228|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33297397|NCT01342211|62673612|FG003|Overall Study|Randomized, but not Treated|0|||
33297398|NCT01342211|62673613|FG004|Overall Study|Randomized, but not Treated|1|||
33297399|NCT01342094|62673631|FG000|Overall Study|Adverse Event|5|||
33385618|NCT00730028|62764490|FG003|Overall Study|Withdrawal by Subject|5|||
33662579|NCT01587703|63093229|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33297400|NCT01342094|62673632|FG001|Overall Study|Adverse Event|0|||
33297401|NCT01342094|62673631|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
33297402|NCT01342094|62673632|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
33297403|NCT01342094|62673631|FG000|Overall Study|Withdrawal by Subject|0|||
33385619|NCT00730028|62764491|FG004|Overall Study|Withdrawal by Subject|9|||
33385620|NCT00730028|62764487|FG000|Overall Study|Physician Decision|3|||
33385621|NCT00730028|62764488|FG001|Overall Study|Physician Decision|3|||
33385622|NCT00730028|62764489|FG002|Overall Study|Physician Decision|2|||
33489091|NCT00111839|62867334|FG002|Overall Study|Death|6|||
33297404|NCT01342094|62673632|FG001|Overall Study|Withdrawal by Subject|2|||
33297405|NCT01340768|62673640|FG000|Overall Study|Lost to Follow-up|10|||
33297406|NCT01340768|62673641|FG001|Overall Study|Lost to Follow-up|4|||
33297407|NCT01340768|62673640|FG000|Overall Study|Withdrawal by Subject|5|||
33297408|NCT01340768|62673641|FG001|Overall Study|Withdrawal by Subject|1|||
33297409|NCT01340768|62673640|FG000|Overall Study|Other|2|||
33297410|NCT01340768|62673641|FG001|Overall Study|Other|0|||
33489092|NCT00111839|62867332|FG000|Overall Study|Withdrawal by Subject|2|||
33489093|NCT00111839|62867333|FG001|Overall Study|Withdrawal by Subject|2|||
33489094|NCT00111839|62867334|FG002|Overall Study|Withdrawal by Subject|2|||
33489095|NCT00111839|62867332|FG000|Overall Study|Lost to Follow-up|1|||
33489096|NCT00111839|62867333|FG001|Overall Study|Lost to Follow-up|0|||
33489097|NCT00111839|62867334|FG002|Overall Study|Lost to Follow-up|0|||
33489098|NCT00111839|62867332|FG000|Overall Study|Logistical Constraint|1|||
33489099|NCT00111839|62867333|FG001|Overall Study|Logistical Constraint|0|||
33489100|NCT00111839|62867334|FG002|Overall Study|Logistical Constraint|0|||
33489101|NCT00111839|62867332|FG000|Overall Study|Other|6|||
33489102|NCT00111839|62867333|FG001|Overall Study|Other|3|||
33489103|NCT00111839|62867334|FG002|Overall Study|Other|3|||
33489104|NCT00111839|62867332|FG000|Overall Study|Randomized but Not Treated|0|||
33489105|NCT00111839|62867333|FG001|Overall Study|Randomized but Not Treated|0|||
33489106|NCT00111839|62867334|FG002|Overall Study|Randomized but Not Treated|2|||
33489107|NCT00111761|62867344|FG000|Part 1|Physician Decision|0|||
33385623|NCT00730028|62764490|FG003|Overall Study|Physician Decision|3|||
33385624|NCT00730028|62764491|FG004|Overall Study|Physician Decision|2|||
33385625|NCT00730028|62764487|FG000|Overall Study|Treatment Failure|5|||
33385626|NCT00730028|62764488|FG001|Overall Study|Treatment Failure|5|||
33385627|NCT00730028|62764489|FG002|Overall Study|Treatment Failure|0|||
33385628|NCT00730028|62764490|FG003|Overall Study|Treatment Failure|0|||
33385629|NCT00730028|62764491|FG004|Overall Study|Treatment Failure|1|||
33385630|NCT00730028|62764487|FG000|Overall Study|Randomization Error|1|||
33385631|NCT00730028|62764488|FG001|Overall Study|Randomization Error|0|||
33385632|NCT00730028|62764489|FG002|Overall Study|Randomization Error|0|||
33385633|NCT00730028|62764490|FG003|Overall Study|Randomization Error|0|||
33385634|NCT00730028|62764491|FG004|Overall Study|Randomization Error|2|||
33385635|NCT00736502|62764503|FG000|Overall Study|Adverse Event|22|||
33385636|NCT00736502|62764503|FG000|Overall Study|Lack of Efficacy|16|||
33385637|NCT00736502|62764503|FG000|Overall Study|Lost to Follow-up|27|||
33385638|NCT00729560|62764507|FG000|Overall Study|Withdrawal by Subject|3|||
33385639|NCT00736190|62764511|FG000|Overall Study|Pregnancy|1|||
33385640|NCT00736190|62764511|FG000|Overall Study|Withdrawal by Subject|1|||
33385641|NCT00736190|62764511|FG000|Overall Study|Adverse Event|1|||
33385642|NCT00729326|62764517|FG000|Overall Study|Lost to Follow-up|2|||
33385643|NCT00729326|62764518|FG001|Overall Study|Lost to Follow-up|0|||
33385644|NCT00729326|62764517|FG000|Overall Study|Physician Decision|0|||
33385645|NCT00729326|62764518|FG001|Overall Study|Physician Decision|1|||
33385646|NCT00729326|62764517|FG000|Overall Study|Protocol Violation|3|||
33385647|NCT00729326|62764518|FG001|Overall Study|Protocol Violation|2|||
33385648|NCT00729326|62764517|FG000|Overall Study|Subject Decision|4|||
33385649|NCT00729326|62764518|FG001|Overall Study|Subject Decision|4|||
33385650|NCT00729326|62764517|FG000|Overall Study|Sponsor Decision|1|||
33385651|NCT00729326|62764518|FG001|Overall Study|Sponsor Decision|2|||
33385652|NCT00729248|62764524|FG000|Overall Study|Physician Decision|2|||
33385653|NCT00696423|62764531|FG000|Overall Study|Lost to Follow-up|0|||
33385654|NCT00696423|62764532|FG001|Overall Study|Lost to Follow-up|5|||
33385655|NCT00736034|62764538|FG000|Overall Study|Adverse Event|2|||
33385656|NCT00576693|62764544|FG000|Overall Study|Lost to Follow-up|7|||
33385657|NCT00576693|62764545|FG001|Overall Study|Lost to Follow-up|11|||
33385658|NCT00576693|62764544|FG000|Overall Study|Withdrawal by Subject|3|||
33385659|NCT00576693|62764545|FG001|Overall Study|Withdrawal by Subject|13|||
33385660|NCT00698451|62764551|FG000|Overall Study|Adverse Event|22|||
33385661|NCT00698451|62764551|FG000|Overall Study|Physician Decision|2|||
33385662|NCT00698451|62764551|FG000|Overall Study|Protocol Violation|6|||
33489108|NCT00111761|62867345|FG001|Part 1|Physician Decision|1|||
33297411|NCT01340651|62673647|FG000|Overall Study|Adverse Event|3|||
33385663|NCT00698451|62764551|FG000|Overall Study|Withdrawal by Subject|6|||
33385664|NCT00698451|62764551|FG000|Overall Study|Disease progression|3|||
33385665|NCT00697827|62764557|FG000|Overall Study|enrolled but not treated|2|||
33385666|NCT00697827|62764558|FG001|Overall Study|enrolled but not treated|1|||
33489109|NCT00111761|62867344|FG000|Part 1|Death|0|||
33489110|NCT00111761|62867345|FG001|Part 1|Death|2|||
33489111|NCT00111761|62867344|FG000|Part 1|Other|0|||
33297412|NCT01340651|62673647|FG000|Overall Study|Consent Withdrawn|2|||
33297413|NCT01340651|62673647|FG000|Overall Study|Commercial Supply per Sponsor|12|||
33385667|NCT00728936|62764571|FG000|Overall Study|Withdrawal by Subject|0|||
33385668|NCT00728936|62764572|FG001|Overall Study|Withdrawal by Subject|0|||
33385669|NCT00728936|62764573|FG002|Overall Study|Withdrawal by Subject|0|||
33385670|NCT00728936|62764574|FG003|Overall Study|Withdrawal by Subject|0|||
33489112|NCT00111761|62867345|FG001|Part 1|Other|1|||
33385671|NCT00728936|62764575|FG004|Overall Study|Withdrawal by Subject|0|||
33297414|NCT01340495|62673653|FG000|Overall Study|Withdrawal by Subject|1|||
33297415|NCT01340300|62673661|FG000|Overall Study|Lost to Follow-up|3|||
33297416|NCT01340300|62673662|FG001|Overall Study|Lost to Follow-up|0|||
33297417|NCT01340300|62673663|FG002|Overall Study|Lost to Follow-up|5|||
33297418|NCT01340300|62673664|FG003|Overall Study|Lost to Follow-up|10|||
33297419|NCT01340300|62673661|FG000|Overall Study|Withdrawal by Subject|5|||
33297420|NCT01340300|62673662|FG001|Overall Study|Withdrawal by Subject|6|||
33297421|NCT01340300|62673663|FG002|Overall Study|Withdrawal by Subject|6|||
33297422|NCT01340300|62673664|FG003|Overall Study|Withdrawal by Subject|3|||
33385672|NCT00728936|62764576|FG005|Overall Study|Withdrawal by Subject|1|||
33385673|NCT00728936|62764577|FG006|Overall Study|Withdrawal by Subject|0|||
33385674|NCT00693693|62764596|FG000|Overall Study|Lost to Follow-up|1|||
33385675|NCT00693693|62764597|FG001|Overall Study|Lost to Follow-up|1|||
33385676|NCT00693693|62764598|FG002|Overall Study|Lost to Follow-up|2|||
33385677|NCT00728468|62764606|FG000|Overall Study|Enrolled but not treated|1|||
33385678|NCT00728468|62764606|FG000|Overall Study|Death|1|||
33385679|NCT00728468|62764606|FG000|Overall Study|Protocol Violation|4|||
33385680|NCT00728468|62764606|FG000|Overall Study|Objective progression or relapse|9|||
33385681|NCT00728468|62764606|FG000|Overall Study|Study terminated by sponsor|1|||
33385682|NCT00727844|62764612|FG000|Initial Randomization|Physician Decision|2|||
33385683|NCT00727844|62764613|FG001|Initial Randomization|Physician Decision|0|||
33385684|NCT00727844|62764614|FG002|Initial Randomization|Physician Decision|0|||
33385685|NCT00727844|62764615|FG003|Initial Randomization|Physician Decision|0|||
33385686|NCT00735878|62764623|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
33385687|NCT00735878|62764624|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
33385688|NCT00735878|62764625|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
33385689|NCT00695955|62764636|FG000|Cohort 1|Adverse Event|26|||
33385690|NCT00695955|62764636|FG000|Cohort 1|Protocol Violation|2|||
33385691|NCT00695955|62764636|FG000|Cohort 1|Lost to Follow-up|30|||
33385692|NCT00695955|62764636|FG000|Cohort 1|Withdrawal by Subject|25|||
33385693|NCT00695955|62764636|FG000|Cohort 1|Lack of Efficacy|3|||
33385694|NCT00695955|62764636|FG000|Cohort 1|Other|16|||
33385695|NCT00695955|62764636|FG000|Cohort 2|Adverse Event|24|||
33385696|NCT00695955|62764636|FG000|Cohort 2|Protocol Violation|5|||
33385697|NCT00695955|62764636|FG000|Cohort 2|Lost to Follow-up|38|||
33385698|NCT00695955|62764636|FG000|Cohort 2|Withdrawal by Subject|28|||
33385699|NCT00695955|62764636|FG000|Cohort 2|Lack of Efficacy|4|||
33385700|NCT00695955|62764636|FG000|Cohort 2|Other|5|||
33385701|NCT00693225|62764644|FG000|Overall Study|Lost to Follow-up|1|||
33385702|NCT00693225|62764645|FG001|Overall Study|Lost to Follow-up|2|||
33385703|NCT00693225|62764644|FG000|Overall Study|Adverse Event|1|||
33385704|NCT00693225|62764645|FG001|Overall Study|Adverse Event|3|||
33385705|NCT00735644|62764656|FG000|Overall Study|Did not receive study vaccine|0|||
33385706|NCT00735644|62764657|FG001|Overall Study|Did not receive study vaccine|1|||
33385707|NCT00735644|62764658|FG002|Overall Study|Did not receive study vaccine|0|||
33385708|NCT00735644|62764659|FG003|Overall Study|Did not receive study vaccine|0|||
33385709|NCT00735644|62764660|FG004|Overall Study|Did not receive study vaccine|0|||
33385710|NCT00735644|62764656|FG000|Overall Study|Withdrawal by Subject|0|||
33385711|NCT00735644|62764657|FG001|Overall Study|Withdrawal by Subject|1|||
33385712|NCT00735644|62764658|FG002|Overall Study|Withdrawal by Subject|1|||
33385713|NCT00735644|62764659|FG003|Overall Study|Withdrawal by Subject|1|||
33385714|NCT00735644|62764660|FG004|Overall Study|Withdrawal by Subject|0|||
33385715|NCT03718299|62764679|FG000|Overall Study|Adverse Event|1|||
33385716|NCT03718299|62764679|FG000|Overall Study|Withdrawal by Subject|6|||
33385717|NCT03718299|62764679|FG000|Overall Study|Physician Decision|2|||
33385718|NCT03718299|62764679|FG000|Overall Study|Lost to Follow-up|1|||
33385719|NCT00724958|62764683|FG000|Overall Study|Adverse Event|28|||
33385720|NCT00724958|62764683|FG000|Overall Study|Loss of Response|40|||
33385721|NCT00724958|62764683|FG000|Overall Study|No Response|18|||
33385722|NCT00724958|62764683|FG000|Overall Study|Remission|7|||
33385723|NCT00724958|62764683|FG000|Overall Study|Other Reason|76|||
33385724|NCT00724958|62764683|FG000|Overall Study|No documentation for end of therapy|13|||
33489113|NCT00111761|62867344|FG000|Part 1|Withdrawal by Subject|0|||
33297423|NCT01340300|62673661|FG000|Overall Study|Adverse Event|1|||
33385725|NCT00695565|62764689|FG000|Overall Study|Lost to Follow-up|4|||
33385726|NCT00695565|62764690|FG001|Overall Study|Lost to Follow-up|4|||
33385727|NCT00695565|62764689|FG000|Overall Study|Adverse Event|3|||
33385728|NCT00695565|62764690|FG001|Overall Study|Adverse Event|1|||
33385729|NCT00695565|62764689|FG000|Overall Study|Protocol Violation|3|||
33385730|NCT00695565|62764690|FG001|Overall Study|Protocol Violation|1|||
33385731|NCT00695565|62764689|FG000|Overall Study|Withdrawal by Subject|1|||
33385732|NCT00695565|62764690|FG001|Overall Study|Withdrawal by Subject|1|||
33385733|NCT00695565|62764689|FG000|Overall Study|Lack of Efficacy|1|||
33385734|NCT00695565|62764690|FG001|Overall Study|Lack of Efficacy|1|||
33385735|NCT00695565|62764689|FG000|Overall Study|Subject did not follow instructions|1|||
33489114|NCT00111761|62867345|FG001|Part 1|Withdrawal by Subject|1|||
33385736|NCT00695565|62764690|FG001|Overall Study|Subject did not follow instructions|1|||
33385737|NCT00727532|62764696|FG000|Overall Study|Adverse Event|1|||
33489115|NCT00111761|62867344|FG000|Part 2|Adverse Event|1|||
33297424|NCT01340300|62673662|FG001|Overall Study|Adverse Event|0|||
33297425|NCT01340300|62673663|FG002|Overall Study|Adverse Event|4|||
33297426|NCT01340300|62673664|FG003|Overall Study|Adverse Event|0|||
33297427|NCT01340300|62673661|FG000|Overall Study|Physician Decision|0|||
33297428|NCT01340300|62673662|FG001|Overall Study|Physician Decision|1|||
33297429|NCT01340300|62673663|FG002|Overall Study|Physician Decision|0|||
33297430|NCT01340300|62673664|FG003|Overall Study|Physician Decision|0|||
33297431|NCT01340300|62673661|FG000|Overall Study|Unrelated sickness|0|||
33297432|NCT01340300|62673662|FG001|Overall Study|Unrelated sickness|2|||
33297433|NCT01340300|62673663|FG002|Overall Study|Unrelated sickness|0|||
33297434|NCT01340300|62673664|FG003|Overall Study|Unrelated sickness|1|||
33297435|NCT01340066|62673676|FG000|Placebo Run in Period|Screen Failures|27|||
33297436|NCT01340066|62673677|FG001|Placebo Run in Period|Screen Failures|0|||
33297437|NCT01340066|62673678|FG002|Placebo Run in Period|Screen Failures|0|||
33297438|NCT01340066|62673676|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
33385738|NCT00727532|62764696|FG000|Overall Study|Withdrawal by Subject|1|||
33385739|NCT00721214|62764700|FG000|Overall Study|Chose another center for transplant|1|||
33385740|NCT00721214|62764700|FG000|Overall Study|Death|3|||
33385741|NCT00720902|62764706|FG000|Overall Study|Withdrawal by Subject|1|||
33385742|NCT00720902|62764707|FG001|Overall Study|Withdrawal by Subject|0|||
33385743|NCT00720902|62764706|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
33385744|NCT00720902|62764707|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
33385745|NCT00695019|62764716|FG000|Overall Study|Withdrawal by Subject|8|||
33385746|NCT00695019|62764717|FG001|Overall Study|Withdrawal by Subject|6|||
33385747|NCT00695019|62764718|FG002|Overall Study|Withdrawal by Subject|4|||
33385748|NCT00695019|62764716|FG000|Overall Study|Protocol Violation|1|||
33385749|NCT00695019|62764717|FG001|Overall Study|Protocol Violation|3|||
33385750|NCT00695019|62764718|FG002|Overall Study|Protocol Violation|1|||
33385751|NCT00695019|62764716|FG000|Overall Study|Lack of Efficacy|0|||
33385752|NCT00695019|62764717|FG001|Overall Study|Lack of Efficacy|0|||
33385753|NCT00695019|62764718|FG002|Overall Study|Lack of Efficacy|1|||
33385754|NCT00695019|62764716|FG000|Overall Study|Various|4|||
33385755|NCT00695019|62764717|FG001|Overall Study|Various|5|||
33385756|NCT00695019|62764718|FG002|Overall Study|Various|4|||
33385757|NCT00694707|62764731|FG000|Overall Study|Did Not Receive Treatment|0|||
33385758|NCT00694707|62764732|FG001|Overall Study|Did Not Receive Treatment|0|||
33385759|NCT00694707|62764733|FG002|Overall Study|Did Not Receive Treatment|1|||
33385760|NCT00694707|62764734|FG003|Overall Study|Did Not Receive Treatment|1|||
33385761|NCT00694707|62764735|FG004|Overall Study|Did Not Receive Treatment|1|||
33385762|NCT00694707|62764731|FG000|Overall Study|Adverse Event|22|||
33385763|NCT00694707|62764732|FG001|Overall Study|Adverse Event|14|||
33385764|NCT00694707|62764733|FG002|Overall Study|Adverse Event|8|||
33385765|NCT00694707|62764734|FG003|Overall Study|Adverse Event|12|||
33385766|NCT00694707|62764735|FG004|Overall Study|Adverse Event|13|||
33385767|NCT00694707|62764731|FG000|Overall Study|Insufficient Therapeutic Response|33|||
33385768|NCT00694707|62764732|FG001|Overall Study|Insufficient Therapeutic Response|18|||
33385769|NCT00694707|62764733|FG002|Overall Study|Insufficient Therapeutic Response|17|||
33385770|NCT00694707|62764734|FG003|Overall Study|Insufficient Therapeutic Response|15|||
33385771|NCT00694707|62764735|FG004|Overall Study|Insufficient Therapeutic Response|10|||
33385772|NCT00694707|62764731|FG000|Overall Study|Protocol Violation|1|||
33385773|NCT00694707|62764732|FG001|Overall Study|Protocol Violation|2|||
33385774|NCT00694707|62764733|FG002|Overall Study|Protocol Violation|1|||
33385775|NCT00694707|62764734|FG003|Overall Study|Protocol Violation|3|||
33385776|NCT00694707|62764735|FG004|Overall Study|Protocol Violation|1|||
33385777|NCT00694707|62764731|FG000|Overall Study|Withdrawal of Consent|14|||
33385778|NCT00694707|62764732|FG001|Overall Study|Withdrawal of Consent|18|||
33385779|NCT00694707|62764733|FG002|Overall Study|Withdrawal of Consent|22|||
33385780|NCT00694707|62764734|FG003|Overall Study|Withdrawal of Consent|16|||
33385781|NCT00694707|62764735|FG004|Overall Study|Withdrawal of Consent|15|||
33385782|NCT00694707|62764731|FG000|Overall Study|Lost to Follow-up|0|||
33385783|NCT00694707|62764732|FG001|Overall Study|Lost to Follow-up|1|||
33385784|NCT00694707|62764733|FG002|Overall Study|Lost to Follow-up|2|||
33385785|NCT00694707|62764734|FG003|Overall Study|Lost to Follow-up|0|||
33297439|NCT01340066|62673677|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
33297440|NCT01340066|62673678|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
33297441|NCT01340066|62673676|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
33385786|NCT00694707|62764735|FG004|Overall Study|Lost to Follow-up|0|||
33385787|NCT00694707|62764731|FG000|Overall Study|Jeopardizing Parole Status|1|||
33385788|NCT00694707|62764732|FG001|Overall Study|Jeopardizing Parole Status|0|||
33385789|NCT00694707|62764733|FG002|Overall Study|Jeopardizing Parole Status|0|||
33385790|NCT00694707|62764734|FG003|Overall Study|Jeopardizing Parole Status|0|||
33385791|NCT00694707|62764735|FG004|Overall Study|Jeopardizing Parole Status|0|||
33385792|NCT00694707|62764731|FG000|Overall Study|Death in the Family|1|||
33385793|NCT00694707|62764732|FG001|Overall Study|Death in the Family|0|||
33385794|NCT00694707|62764733|FG002|Overall Study|Death in the Family|0|||
33385795|NCT00694707|62764734|FG003|Overall Study|Death in the Family|0|||
33385796|NCT00694707|62764735|FG004|Overall Study|Death in the Family|0|||
33385797|NCT00694707|62764731|FG000|Overall Study|Arrest by Police|0|||
33297442|NCT01340066|62673677|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
33297443|NCT01340066|62673678|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
33297444|NCT01340066|62673676|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
33297445|NCT01340066|62673677|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
33297446|NCT01340066|62673678|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
33297447|NCT01107535|62673685|FG000|Overall Study|Death|5|||
33297448|NCT01326546|62673691|FG000|Overall Study|Lost to Follow-up|8|||
33297449|NCT01326546|62673692|FG001|Overall Study|Lost to Follow-up|7|||
33297450|NCT01326546|62673691|FG000|Overall Study|Protocol Violation|3|||
33385798|NCT00694707|62764732|FG001|Overall Study|Arrest by Police|1|||
33385799|NCT00694707|62764733|FG002|Overall Study|Arrest by Police|0|||
33385800|NCT00694707|62764734|FG003|Overall Study|Arrest by Police|0|||
33385801|NCT00694707|62764735|FG004|Overall Study|Arrest by Police|0|||
33385802|NCT00694707|62764731|FG000|Overall Study|Administrative Reasons|0|||
33385803|NCT00694707|62764732|FG001|Overall Study|Administrative Reasons|1|||
33385804|NCT00694707|62764733|FG002|Overall Study|Administrative Reasons|0|||
33385805|NCT00694707|62764734|FG003|Overall Study|Administrative Reasons|2|||
33385806|NCT00694707|62764735|FG004|Overall Study|Administrative Reasons|0|||
33385807|NCT00694707|62764731|FG000|Overall Study|Notification of Past Head Injury|0|||
33385808|NCT00694707|62764732|FG001|Overall Study|Notification of Past Head Injury|0|||
33385809|NCT00694707|62764733|FG002|Overall Study|Notification of Past Head Injury|0|||
33385810|NCT00694707|62764734|FG003|Overall Study|Notification of Past Head Injury|1|||
33385811|NCT00694707|62764735|FG004|Overall Study|Notification of Past Head Injury|0|||
33385812|NCT00692913|62764749|FG000|Overall Study|Adverse Event|8|||
33385813|NCT00692913|62764750|FG001|Overall Study|Adverse Event|4|||
33385814|NCT00692913|62764749|FG000|Overall Study|Lost to Follow-up|3|||
33385815|NCT00692913|62764750|FG001|Overall Study|Lost to Follow-up|5|||
33385816|NCT00692913|62764749|FG000|Overall Study|Physician Decision|2|||
33385817|NCT00692913|62764750|FG001|Overall Study|Physician Decision|0|||
33385818|NCT00692913|62764749|FG000|Overall Study|Protocol Violation|1|||
33385819|NCT00692913|62764750|FG001|Overall Study|Protocol Violation|1|||
33385820|NCT00692913|62764749|FG000|Overall Study|Withdrawal by Subject|15|||
33385821|NCT00692913|62764750|FG001|Overall Study|Withdrawal by Subject|20|||
33385822|NCT00694551|62764759|FG000|Overall Study|Disease Progression|1|||
33385823|NCT00694551|62764760|FG001|Overall Study|Disease Progression|0|||
33385824|NCT00694551|62764761|FG002|Overall Study|Disease Progression|1|||
33489116|NCT00111761|62867345|FG001|Part 2|Adverse Event|0|||
33489117|NCT00111761|62867344|FG000|Part 2|Physician Decision|1|||
33297451|NCT01326546|62673692|FG001|Overall Study|Protocol Violation|4|||
33297452|NCT01326546|62673691|FG000|Overall Study|Pregnancy|0|||
33297453|NCT01326546|62673692|FG001|Overall Study|Pregnancy|1|||
33297454|NCT01326546|62673691|FG000|Overall Study|Adverse Event|1|||
33297455|NCT01326546|62673692|FG001|Overall Study|Adverse Event|0|||
33297456|NCT01326546|62673691|FG000|Overall Study|Withdrawal by Subject|5|||
33297457|NCT01326546|62673692|FG001|Overall Study|Withdrawal by Subject|1|||
33297458|NCT01325532|62673700|FG000|Overall Study|Withdrawal by Subject|2|||
33297459|NCT01325532|62673701|FG001|Overall Study|Withdrawal by Subject|0|||
33297460|NCT01171963|62673709|FG000|Overall Study|Adverse Event|10|||
33297461|NCT01171963|62673710|FG001|Overall Study|Adverse Event|15|||
33297462|NCT01171963|62673709|FG000|Overall Study|Lost to Follow-up|23|||
33297463|NCT01171963|62673710|FG001|Overall Study|Lost to Follow-up|24|||
33297464|NCT01171963|62673709|FG000|Overall Study|Other - diarrhoea|1|||
33297465|NCT01171963|62673710|FG001|Overall Study|Other - diarrhoea|0|||
33297466|NCT01171963|62673709|FG000|Overall Study|Withdrawal by Subject|114|||
33297467|NCT01171963|62673710|FG001|Overall Study|Withdrawal by Subject|129|||
33297468|NCT01171183|62673721|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
33297469|NCT01171183|62673722|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
33297470|NCT01171183|62673721|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
33297471|NCT01171183|62673722|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
33297472|NCT01171183|62673721|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
33297473|NCT01171183|62673722|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
33297474|NCT01171183|62673721|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
33297475|NCT01171183|62673722|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
33297476|NCT01171183|62673721|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
33385825|NCT00689871|62764774|FG000|Overall Study|Lost to Follow-up|123|||
33297477|NCT01171183|62673722|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
33297478|NCT01171183|62673721|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
33385826|NCT00689871|62764775|FG001|Overall Study|Lost to Follow-up|13|||
33385827|NCT00689871|62764776|FG002|Overall Study|Lost to Follow-up|37|||
33385828|NCT00689871|62764777|FG003|Overall Study|Lost to Follow-up|1|||
33385829|NCT00689871|62764774|FG000|Overall Study|Explanted of All Study Devices|36|||
33385830|NCT00689871|62764775|FG001|Overall Study|Explanted of All Study Devices|25|||
33489118|NCT00111761|62867345|FG001|Part 2|Physician Decision|0|||
33385831|NCT00689871|62764776|FG002|Overall Study|Explanted of All Study Devices|29|||
33385832|NCT00689871|62764777|FG003|Overall Study|Explanted of All Study Devices|3|||
33385833|NCT00689871|62764774|FG000|Overall Study|Withdrawal by Subject|13|||
33385834|NCT00689871|62764775|FG001|Overall Study|Withdrawal by Subject|3|||
33489119|NCT00111761|62867344|FG000|Part 2|Death|1|||
33489120|NCT00111761|62867345|FG001|Part 2|Death|0|||
33489121|NCT00111761|62867344|FG000|Part 2|Disease progression|3|||
33489122|NCT00111761|62867345|FG001|Part 2|Disease progression|0|||
33489123|NCT00111761|62867344|FG000|Part 2|Protocol-specified criteria|1|||
33489124|NCT00111761|62867345|FG001|Part 2|Protocol-specified criteria|0|||
33489125|NCT00111761|62867344|FG000|Part 2|Other|1|||
33489126|NCT00111761|62867345|FG001|Part 2|Other|0|||
33489127|NCT03519867|62867361|FG000|Overall Study|Adverse Event|1|||
33489128|NCT03519867|62867362|FG001|Overall Study|Adverse Event|1|||
33489129|NCT03519867|62867363|FG002|Overall Study|Adverse Event|0|||
33489130|NCT03519867|62867364|FG003|Overall Study|Adverse Event|0|||
33489131|NCT03519867|62867365|FG004|Overall Study|Adverse Event|0|||
33489132|NCT03519867|62867366|FG005|Overall Study|Adverse Event|0|||
33489133|NCT03519867|62867367|FG006|Overall Study|Adverse Event|0|||
33489134|NCT03519867|62867368|FG007|Overall Study|Adverse Event|0|||
33489135|NCT03519867|62867369|FG008|Overall Study|Adverse Event|0|||
33489136|NCT03519867|62867370|FG009|Overall Study|Adverse Event|0|||
33489137|NCT03519867|62867361|FG000|Overall Study|Protocol Violation|0|||
33489138|NCT03519867|62867362|FG001|Overall Study|Protocol Violation|0|||
33489139|NCT03519867|62867363|FG002|Overall Study|Protocol Violation|0|||
33489140|NCT03519867|62867364|FG003|Overall Study|Protocol Violation|0|||
33489141|NCT03519867|62867365|FG004|Overall Study|Protocol Violation|0|||
33489142|NCT03519867|62867366|FG005|Overall Study|Protocol Violation|1|||
33489143|NCT03519867|62867367|FG006|Overall Study|Protocol Violation|0|||
33489144|NCT03519867|62867368|FG007|Overall Study|Protocol Violation|0|||
33489145|NCT03519867|62867369|FG008|Overall Study|Protocol Violation|0|||
33489146|NCT03519867|62867370|FG009|Overall Study|Protocol Violation|0|||
33489147|NCT03519867|62867361|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33489148|NCT03519867|62867362|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33489149|NCT03519867|62867363|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33489150|NCT03519867|62867364|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33489151|NCT03519867|62867365|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33489152|NCT03519867|62867366|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33489153|NCT03519867|62867367|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
33489154|NCT03519867|62867368|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33489155|NCT03519867|62867369|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33489156|NCT03519867|62867370|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33489157|NCT03519867|62867361|FG000|Overall Study|Admin. of other reversal agent|1|||
33489158|NCT03519867|62867362|FG001|Overall Study|Admin. of other reversal agent|1|||
33489159|NCT03519867|62867363|FG002|Overall Study|Admin. of other reversal agent|0|||
33489160|NCT03519867|62867364|FG003|Overall Study|Admin. of other reversal agent|0|||
33489161|NCT03519867|62867365|FG004|Overall Study|Admin. of other reversal agent|0|||
33489162|NCT03519867|62867366|FG005|Overall Study|Admin. of other reversal agent|1|||
33489163|NCT03519867|62867367|FG006|Overall Study|Admin. of other reversal agent|0|||
33489164|NCT03519867|62867368|FG007|Overall Study|Admin. of other reversal agent|0|||
33489165|NCT03519867|62867369|FG008|Overall Study|Admin. of other reversal agent|0|||
33489166|NCT03519867|62867370|FG009|Overall Study|Admin. of other reversal agent|0|||
33489167|NCT03519867|62867361|FG000|Overall Study|Reason not provided|1|||
33489168|NCT03519867|62867362|FG001|Overall Study|Reason not provided|1|||
33297479|NCT01171183|62673722|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
33297480|NCT01170091|62673728|FG000|Overall Study|Missing efficacy evaluation|3|||
33297481|NCT01170091|62673728|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
33297482|NCT01169779|62673734|FG000|Overall Study|Adverse Event|3|||
33297483|NCT01169779|62673735|FG001|Overall Study|Adverse Event|11|||
33297484|NCT01169779|62673734|FG000|Overall Study|Lack of Efficacy|1|||
33297485|NCT01169779|62673735|FG001|Overall Study|Lack of Efficacy|0|||
33297486|NCT01169779|62673734|FG000|Overall Study|Protocol Violation|1|||
33297487|NCT01169779|62673735|FG001|Overall Study|Protocol Violation|1|||
33297488|NCT01169779|62673734|FG000|Overall Study|Withdrawal by Subject|3|||
33489169|NCT03519867|62867363|FG002|Overall Study|Reason not provided|1|||
33489170|NCT03519867|62867364|FG003|Overall Study|Reason not provided|1|||
33489171|NCT03519867|62867365|FG004|Overall Study|Reason not provided|0|||
33297489|NCT01169779|62673735|FG001|Overall Study|Withdrawal by Subject|2|||
33297490|NCT01169779|62673734|FG000|Overall Study|Familial and personal reasons|3|||
33297491|NCT01169779|62673735|FG001|Overall Study|Familial and personal reasons|3|||
33489172|NCT03519867|62867366|FG005|Overall Study|Reason not provided|1|||
33489173|NCT03519867|62867367|FG006|Overall Study|Reason not provided|0|||
33489174|NCT03519867|62867368|FG007|Overall Study|Reason not provided|1|||
33489175|NCT03519867|62867369|FG008|Overall Study|Reason not provided|1|||
33489176|NCT03519867|62867370|FG009|Overall Study|Reason not provided|0|||
33385835|NCT00689871|62764776|FG002|Overall Study|Withdrawal by Subject|4|||
33385836|NCT00689871|62764777|FG003|Overall Study|Withdrawal by Subject|1|||
33385837|NCT00689871|62764774|FG000|Overall Study|Death|1|||
33385838|NCT00689871|62764775|FG001|Overall Study|Death|10|||
33385839|NCT00689871|62764776|FG002|Overall Study|Death|2|||
33385840|NCT00689871|62764777|FG003|Overall Study|Death|2|||
33385841|NCT00689871|62764774|FG000|Overall Study|Physician Decision|2|||
33385842|NCT00689871|62764775|FG001|Overall Study|Physician Decision|1|||
33385843|NCT00689871|62764776|FG002|Overall Study|Physician Decision|1|||
33385844|NCT00689871|62764777|FG003|Overall Study|Physician Decision|0|||
33385845|NCT00793793|62764799|FG000|Overall Study|Adverse Event|0|||
33385846|NCT00793793|62764800|FG001|Overall Study|Adverse Event|0|||
33385847|NCT00793793|62764801|FG002|Overall Study|Adverse Event|1|||
33385848|NCT00793793|62764802|FG003|Overall Study|Adverse Event|1|||
33385849|NCT00793793|62764803|FG004|Overall Study|Adverse Event|0|||
33385850|NCT00793793|62764804|FG005|Overall Study|Adverse Event|1|||
33385851|NCT00793793|62764805|FG006|Overall Study|Adverse Event|2|||
33385852|NCT00793793|62764806|FG007|Overall Study|Adverse Event|0|||
33385853|NCT00793793|62764807|FG008|Overall Study|Adverse Event|0|||
33385854|NCT00793793|62764808|FG009|Overall Study|Adverse Event|0|||
33385855|NCT00793793|62764809|FG010|Overall Study|Adverse Event|0|||
33385856|NCT00793793|62764810|FG011|Overall Study|Adverse Event|2|||
33385857|NCT00793793|62764799|FG000|Overall Study|Protocol Violation|0|||
33385858|NCT00793793|62764800|FG001|Overall Study|Protocol Violation|0|||
33385859|NCT00793793|62764801|FG002|Overall Study|Protocol Violation|0|||
33385860|NCT00793793|62764802|FG003|Overall Study|Protocol Violation|1|||
33385861|NCT00793793|62764803|FG004|Overall Study|Protocol Violation|0|||
33385862|NCT00793793|62764804|FG005|Overall Study|Protocol Violation|0|||
33385863|NCT00793793|62764805|FG006|Overall Study|Protocol Violation|0|||
33385864|NCT00793793|62764806|FG007|Overall Study|Protocol Violation|0|||
33385865|NCT00793793|62764807|FG008|Overall Study|Protocol Violation|0|||
33385866|NCT00793793|62764808|FG009|Overall Study|Protocol Violation|0|||
33385867|NCT00793793|62764809|FG010|Overall Study|Protocol Violation|0|||
33385868|NCT00793793|62764810|FG011|Overall Study|Protocol Violation|0|||
33385869|NCT00793793|62764799|FG000|Overall Study|Lost to Follow-up|0|||
33385870|NCT00793793|62764800|FG001|Overall Study|Lost to Follow-up|0|||
33385871|NCT00793793|62764801|FG002|Overall Study|Lost to Follow-up|1|||
33385872|NCT00793793|62764802|FG003|Overall Study|Lost to Follow-up|0|||
33385873|NCT00793793|62764803|FG004|Overall Study|Lost to Follow-up|0|||
33297492|NCT01169701|62673743|FG000|Overall Study|Lost to Follow-up|1|||
33297493|NCT01169701|62673744|FG001|Overall Study|Lost to Follow-up|1|||
33297494|NCT01169701|62673743|FG000|Overall Study|Withdrawal by Subject|1|||
33385874|NCT00793793|62764804|FG005|Overall Study|Lost to Follow-up|0|||
33385875|NCT00793793|62764805|FG006|Overall Study|Lost to Follow-up|0|||
33385876|NCT00793793|62764806|FG007|Overall Study|Lost to Follow-up|0|||
33385877|NCT00793793|62764807|FG008|Overall Study|Lost to Follow-up|1|||
33385878|NCT00793793|62764808|FG009|Overall Study|Lost to Follow-up|3|||
33385879|NCT00793793|62764809|FG010|Overall Study|Lost to Follow-up|1|||
33385880|NCT00793793|62764810|FG011|Overall Study|Lost to Follow-up|0|||
33385881|NCT00793793|62764799|FG000|Overall Study|Withdrawal by Subject|0|||
33489177|NCT03519087|62867394|FG000|Clinic Evaluation|Physician Decision|15|||
33489178|NCT03519087|62867395|FG001|Clinic Evaluation|Physician Decision|18|||
33489179|NCT03519087|62867396|FG002|Clinic Evaluation|Physician Decision|0|||
33489180|NCT03519087|62867397|FG003|Clinic Evaluation|Physician Decision|0|||
33489181|NCT03519087|62867398|FG004|Clinic Evaluation|Physician Decision|0|||
33489182|NCT03519087|62867394|FG000|Clinic Evaluation|Protocol Violation|1|||
33489183|NCT03519087|62867395|FG001|Clinic Evaluation|Protocol Violation|0|||
33489184|NCT03519087|62867396|FG002|Clinic Evaluation|Protocol Violation|0|||
33489185|NCT03519087|62867397|FG003|Clinic Evaluation|Protocol Violation|0|||
33489186|NCT03519087|62867398|FG004|Clinic Evaluation|Protocol Violation|0|||
33489187|NCT03519087|62867394|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
33297495|NCT01169701|62673744|FG001|Overall Study|Withdrawal by Subject|3|||
33297496|NCT01169701|62673743|FG000|Overall Study|Adverse Event|1|||
33297497|NCT01169701|62673744|FG001|Overall Study|Adverse Event|2|||
33297498|NCT01169701|62673743|FG000|Overall Study|Exclusion criteria|2|||
33297499|NCT01169701|62673744|FG001|Overall Study|Exclusion criteria|0|||
33489188|NCT03519087|62867395|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
33489189|NCT03519087|62867396|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
33489190|NCT03519087|62867397|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
33489191|NCT03519087|62867398|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
33489192|NCT03519087|62867394|FG000|Re-randomization for Treatment|Not appropriate|2|||
33489193|NCT03519087|62867395|FG001|Re-randomization for Treatment|Not appropriate|3|||
33489194|NCT03519087|62867396|FG002|Re-randomization for Treatment|Not appropriate|0|||
33297500|NCT01169701|62673743|FG000|Overall Study|Death|0|||
33297501|NCT01169701|62673744|FG001|Overall Study|Death|1|||
33297502|NCT01169701|62673743|FG000|Overall Study|Administrative problems|0|||
33385882|NCT00793793|62764800|FG001|Overall Study|Withdrawal by Subject|0|||
33385883|NCT00793793|62764801|FG002|Overall Study|Withdrawal by Subject|0|||
33385884|NCT00793793|62764802|FG003|Overall Study|Withdrawal by Subject|0|||
33297503|NCT01169701|62673744|FG001|Overall Study|Administrative problems|1|||
33297504|NCT01169701|62673743|FG000|Overall Study|Serious adverse event|0|||
33297505|NCT01169701|62673744|FG001|Overall Study|Serious adverse event|1|||
33297506|NCT01169701|62673743|FG000|Overall Study|Sponsor decision|0|||
33297507|NCT01169701|62673744|FG001|Overall Study|Sponsor decision|1|||
33297508|NCT01168999|62673754|FG000|Overall Study|Lost to Follow-up|2|||
33297509|NCT01168999|62673755|FG001|Overall Study|Lost to Follow-up|1|||
33297510|NCT01168999|62673756|FG002|Overall Study|Lost to Follow-up|0|||
33297511|NCT01168999|62673757|FG003|Overall Study|Lost to Follow-up|0|||
33297512|NCT01167907|62673769|FG000|Overall Study|Protocol Violation|1|||
33297513|NCT01167907|62673770|FG001|Overall Study|Protocol Violation|0|||
33297514|NCT01167907|62673769|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
33297515|NCT01167907|62673770|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
33297516|NCT01166659|62673776|FG000|Overall Study|Subject Decision|8|||
33297517|NCT01166659|62673776|FG000|Overall Study|Investigator Decision|2|||
33297518|NCT01166659|62673776|FG000|Overall Study|Death|1|||
33297519|NCT01166659|62673776|FG000|Overall Study|Lost to Follow-up|1|||
33297520|NCT01166659|62673776|FG000|Overall Study|Study Closed at Site|1|||
33297521|NCT01115491|62673781|FG000|Overall Study|Death|22|||
33297522|NCT01115491|62673781|FG000|Overall Study|Adverse Event|3|||
33297523|NCT01115491|62673781|FG000|Overall Study|Lost to Follow-up|3|||
33297524|NCT01115491|62673781|FG000|Overall Study|Withdrawal by Subject|1|||
33297525|NCT01115491|62673781|FG000|Overall Study|Physician Decision|1|||
33297526|NCT01113931|62673787|FG000|Overall Study|Adverse Event|2|||
33297527|NCT01113931|62673788|FG001|Overall Study|Adverse Event|2|||
33297528|NCT01113931|62673787|FG000|Overall Study|Physician Decision|0|||
33297529|NCT01113931|62673788|FG001|Overall Study|Physician Decision|2|||
33297530|NCT01113931|62673787|FG000|Overall Study|Lost to Follow-up|12|||
33297531|NCT01113931|62673788|FG001|Overall Study|Lost to Follow-up|9|||
33297532|NCT01113931|62673787|FG000|Overall Study|Various|2|||
33297533|NCT01113931|62673788|FG001|Overall Study|Various|4|||
33297534|NCT01113931|62673787|FG000|Overall Study|Withdrawal by Subject|3|||
33297535|NCT01113931|62673788|FG001|Overall Study|Withdrawal by Subject|0|||
33297536|NCT01107379|62673794|FG000|Overall Study|Withdrawal by Subject|18|||
33297537|NCT01107379|62673794|FG000|Overall Study|Lost to Follow-up|3|||
33297538|NCT01106911|62673798|FG000|Overall Study|Physician Decision|2|||
33297539|NCT01106911|62673798|FG000|Overall Study|deemed ineligible after screening|3|||
33297540|NCT01106677|62673806|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
33297541|NCT01106677|62673807|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
33297542|NCT01106677|62673808|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
33297543|NCT01106677|62673809|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
33297544|NCT01106677|62673806|FG000|Core Period: Baseline to Week 26|Death|0|||
33297545|NCT01106677|62673807|FG001|Core Period: Baseline to Week 26|Death|0|||
33297546|NCT01106677|62673808|FG002|Core Period: Baseline to Week 26|Death|1|||
33297547|NCT01106677|62673809|FG003|Core Period: Baseline to Week 26|Death|0|||
33297548|NCT01106677|62673806|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
33297549|NCT01106677|62673807|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
33297550|NCT01106677|62673808|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
33297551|NCT01106677|62673809|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
33297552|NCT01106677|62673806|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
33297553|NCT01106677|62673807|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
33297554|NCT01106677|62673808|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
33297555|NCT01106677|62673809|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
33297556|NCT01106677|62673806|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
33297557|NCT01106677|62673807|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
33297558|NCT01106677|62673808|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
33297559|NCT01106677|62673809|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
33297560|NCT01106677|62673806|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
33297561|NCT01106677|62673807|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
33297562|NCT01106677|62673808|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
33297563|NCT01106677|62673809|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
33297564|NCT01106677|62673806|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
33297565|NCT01106677|62673807|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
33297566|NCT01106677|62673808|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
33297567|NCT01106677|62673809|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
33297568|NCT01106677|62673806|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
33297569|NCT01106677|62673807|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
33297570|NCT01106677|62673808|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
33297571|NCT01106677|62673809|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
33489195|NCT03519087|62867397|FG003|Re-randomization for Treatment|Not appropriate|0|||
33297572|NCT01106677|62673806|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
33297573|NCT01106677|62673807|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
33297574|NCT01106677|62673808|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33297575|NCT01106677|62673809|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33297576|NCT01106677|62673806|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
33297577|NCT01106677|62673807|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
33297578|NCT01106677|62673808|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
33297579|NCT01106677|62673809|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
33297580|NCT01106677|62673806|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
33297581|NCT01106677|62673807|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
33297582|NCT01106677|62673808|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
33297583|NCT01106677|62673809|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
33297584|NCT01106677|62673806|FG000|Core Period: Baseline to Week 26|Other|8|||
33297585|NCT01106677|62673807|FG001|Core Period: Baseline to Week 26|Other|14|||
33297586|NCT01106677|62673808|FG002|Core Period: Baseline to Week 26|Other|8|||
33297587|NCT01106677|62673809|FG003|Core Period: Baseline to Week 26|Other|23|||
33297588|NCT01106677|62673806|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
33297589|NCT01106677|62673807|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
33385885|NCT00793793|62764803|FG004|Overall Study|Withdrawal by Subject|1|||
33385886|NCT00793793|62764804|FG005|Overall Study|Withdrawal by Subject|0|||
33385887|NCT00793793|62764805|FG006|Overall Study|Withdrawal by Subject|0|||
33385888|NCT00793793|62764806|FG007|Overall Study|Withdrawal by Subject|0|||
33385889|NCT00793793|62764807|FG008|Overall Study|Withdrawal by Subject|1|||
33385890|NCT00793793|62764808|FG009|Overall Study|Withdrawal by Subject|0|||
33385891|NCT00793793|62764809|FG010|Overall Study|Withdrawal by Subject|0|||
33385892|NCT00793793|62764810|FG011|Overall Study|Withdrawal by Subject|0|||
33385893|NCT00793793|62764799|FG000|Overall Study|reason not specified|0|||
33385894|NCT00793793|62764800|FG001|Overall Study|reason not specified|1|||
33385895|NCT00793793|62764801|FG002|Overall Study|reason not specified|0|||
33385896|NCT00793793|62764802|FG003|Overall Study|reason not specified|1|||
33297590|NCT01106677|62673808|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
33297591|NCT01106677|62673809|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
33297592|NCT01106677|62673806|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
33297593|NCT01106677|62673807|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
33385897|NCT00793793|62764803|FG004|Overall Study|reason not specified|1|||
33385898|NCT00793793|62764804|FG005|Overall Study|reason not specified|1|||
33385899|NCT00793793|62764805|FG006|Overall Study|reason not specified|2|||
33385900|NCT00793793|62764806|FG007|Overall Study|reason not specified|0|||
33385901|NCT00793793|62764807|FG008|Overall Study|reason not specified|7|||
33385902|NCT00793793|62764808|FG009|Overall Study|reason not specified|6|||
33385903|NCT00793793|62764809|FG010|Overall Study|reason not specified|2|||
33385904|NCT00793793|62764810|FG011|Overall Study|reason not specified|4|||
33385905|NCT00776789|62764858|FG000|Overall Study|Consent refusal|2|||
33385906|NCT00776789|62764859|FG001|Overall Study|Consent refusal|2|||
33385907|NCT00776789|62764858|FG000|Overall Study|Poor quality video|1|||
33385908|NCT00776789|62764859|FG001|Overall Study|Poor quality video|1|||
33385909|NCT00776555|62764869|FG000|Overall Study|Study terminated|3|||
33385910|NCT00776555|62764870|FG001|Overall Study|Study terminated|0|||
33385911|NCT00720434|62764880|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
33297594|NCT01106677|62673808|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
33297595|NCT01106677|62673809|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
33297596|NCT01106677|62673806|FG000|Extension Period: Week 26 to Week 52|Death|0|||
33297597|NCT01106677|62673807|FG001|Extension Period: Week 26 to Week 52|Death|0|||
33297598|NCT01106677|62673808|FG002|Extension Period: Week 26 to Week 52|Death|0|||
33297599|NCT01106677|62673809|FG003|Extension Period: Week 26 to Week 52|Death|1|||
33297600|NCT01106677|62673806|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
33385912|NCT00720434|62764881|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
33385913|NCT00720434|62764882|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
33385914|NCT00720434|62764883|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
33385915|NCT00720434|62764880|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
33385916|NCT00720434|62764881|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
33385917|NCT00720434|62764882|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
33385918|NCT00720434|62764883|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
33385919|NCT00720434|62764880|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
33385920|NCT00720434|62764881|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
33385921|NCT00720434|62764882|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
33297601|NCT01106677|62673807|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
33385922|NCT00720434|62764883|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
33385923|NCT00720434|62764880|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
33385924|NCT00720434|62764881|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
33489196|NCT03519087|62867398|FG004|Re-randomization for Treatment|Not appropriate|0|||
33556746|NCT02613572|62949573|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
33385925|NCT00720434|62764882|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
33385926|NCT00720434|62764883|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
33385927|NCT00720434|62764880|FG000|Open-Label Period (Week 5-72)|Other|4|||
33385928|NCT00720434|62764881|FG001|Open-Label Period (Week 5-72)|Other|3|||
33385929|NCT00720434|62764882|FG002|Open-Label Period (Week 5-72)|Other|3|||
33385930|NCT00720434|62764883|FG003|Open-Label Period (Week 5-72)|Other|2|||
33385931|NCT00776009|62764899|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
33385932|NCT00776009|62764900|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
33385933|NCT00776009|62764901|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
33385934|NCT00776009|62764902|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
33385935|NCT00776009|62764903|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
33385936|NCT00776009|62764904|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
33385937|NCT00776009|62764899|FG000|Period 1: First Intervention|Protocol Violation|0|||
33385938|NCT00776009|62764900|FG001|Period 1: First Intervention|Protocol Violation|1|||
33385939|NCT00776009|62764901|FG002|Period 1: First Intervention|Protocol Violation|0|||
33385940|NCT00776009|62764902|FG003|Period 1: First Intervention|Protocol Violation|0|||
33385941|NCT00776009|62764903|FG004|Period 1: First Intervention|Protocol Violation|1|||
33385942|NCT00776009|62764904|FG005|Period 1: First Intervention|Protocol Violation|0|||
33385943|NCT00776009|62764899|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
33385944|NCT00776009|62764900|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
33385945|NCT00776009|62764901|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
33385946|NCT00776009|62764902|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
33385947|NCT00776009|62764903|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
33385948|NCT00776009|62764904|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
33385949|NCT00776009|62764899|FG000|Period 2: Second Intervention|Protocol Violation|1|||
33385950|NCT00776009|62764900|FG001|Period 2: Second Intervention|Protocol Violation|0|||
33385951|NCT00776009|62764901|FG002|Period 2: Second Intervention|Protocol Violation|1|||
33385952|NCT00776009|62764902|FG003|Period 2: Second Intervention|Protocol Violation|0|||
33385953|NCT00776009|62764903|FG004|Period 2: Second Intervention|Protocol Violation|0|||
33385954|NCT00776009|62764904|FG005|Period 2: Second Intervention|Protocol Violation|0|||
33385955|NCT00776009|62764899|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
33385956|NCT00776009|62764900|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
33385957|NCT00776009|62764901|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
33385958|NCT00776009|62764902|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
33385959|NCT00776009|62764903|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
33385960|NCT00776009|62764904|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
33489197|NCT03519087|62867394|FG000|Laboratory Testing|Lost to Follow-up|0|||
33297602|NCT01106677|62673808|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
33297603|NCT01106677|62673809|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
33297604|NCT01106677|62673806|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33297605|NCT01106677|62673807|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
33297606|NCT01106677|62673808|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
33297607|NCT01106677|62673809|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
33297608|NCT01106677|62673806|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
33297609|NCT01106677|62673807|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
33297610|NCT01106677|62673808|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
33297611|NCT01106677|62673809|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
33297612|NCT01106677|62673806|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
33297613|NCT01106677|62673807|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33297614|NCT01106677|62673808|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33297615|NCT01106677|62673809|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33297616|NCT01106677|62673806|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33297617|NCT01106677|62673807|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
33297618|NCT01106677|62673808|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
33297619|NCT01106677|62673809|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33297620|NCT01106677|62673806|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
33297621|NCT01106677|62673807|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
33297622|NCT01106677|62673808|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
33297623|NCT01106677|62673809|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
33297624|NCT01106677|62673806|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
33297625|NCT01106677|62673807|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
33297626|NCT01106677|62673808|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
33385961|NCT00694161|62764912|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
33385962|NCT00694161|62764912|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
33385963|NCT00694161|62764912|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
33489198|NCT03519087|62867395|FG001|Laboratory Testing|Lost to Follow-up|0|||
33385964|NCT00720356|62764916|FG000|Registration to Study|Determined to have methylated MGMT|67|||
33385965|NCT00720356|62764916|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
33385966|NCT00720356|62764916|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
33385967|NCT00720356|62764916|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
33385968|NCT00720356|62764916|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
33385969|NCT00720356|62764916|FG000|Follow up Until Death|Withdrawal by Subject|1|||
33385970|NCT00720356|62764916|FG000|Follow up Until Death|Alive at last data collection|4|||
33385971|NCT00720278|62764923|FG000|Overall Study|Adverse Event|5|||
33385972|NCT00720278|62764924|FG001|Overall Study|Adverse Event|3|||
33385973|NCT00720278|62764925|FG002|Overall Study|Adverse Event|4|||
33385974|NCT00720278|62764923|FG000|Overall Study|Withdrawal by Subject|0|||
33385975|NCT00720278|62764924|FG001|Overall Study|Withdrawal by Subject|1|||
33385976|NCT00720278|62764925|FG002|Overall Study|Withdrawal by Subject|0|||
33385977|NCT00720278|62764923|FG000|Overall Study|Lost to Follow-up|0|||
33385978|NCT00720278|62764924|FG001|Overall Study|Lost to Follow-up|0|||
33385979|NCT00720278|62764925|FG002|Overall Study|Lost to Follow-up|1|||
33385980|NCT00720278|62764923|FG000|Overall Study|Non-compliance|1|||
33385981|NCT00720278|62764924|FG001|Overall Study|Non-compliance|0|||
33385982|NCT00720278|62764925|FG002|Overall Study|Non-compliance|0|||
33385983|NCT00720278|62764923|FG000|Overall Study|eligibility criteria violation|1|||
33385984|NCT00720278|62764924|FG001|Overall Study|eligibility criteria violation|0|||
33297627|NCT01106677|62673809|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
33297628|NCT01106677|62673806|FG000|Extension Period: Week 26 to Week 52|Other|6|||
33297629|NCT01106677|62673807|FG001|Extension Period: Week 26 to Week 52|Other|5|||
33297630|NCT01106677|62673808|FG002|Extension Period: Week 26 to Week 52|Other|8|||
33297631|NCT01106677|62673809|FG003|Extension Period: Week 26 to Week 52|Other|5|||
33297632|NCT01106287|62673830|FG000|Overall Study|Adverse Event|1|||
33297633|NCT01106287|62673831|FG001|Overall Study|Adverse Event|0|||
33297634|NCT01106287|62673832|FG002|Overall Study|Adverse Event|0|||
33385985|NCT00720278|62764925|FG002|Overall Study|eligibility criteria violation|1|||
33385986|NCT00720122|62764933|FG000|Overall Study|Lost to Follow-up|1|||
33385987|NCT00720122|62764933|FG000|Overall Study|Physician Decision|1|||
33385988|NCT00720122|62764933|FG000|Overall Study|Withdrawal by Subject|7|||
33385989|NCT00717860|62764939|FG000|Overall Study|Clinical adverse experience|5|||
33385990|NCT00717860|62764940|FG001|Overall Study|Clinical adverse experience|9|||
33385991|NCT00717860|62764939|FG000|Overall Study|Laboratory adverse experience|2|||
33385992|NCT00717860|62764940|FG001|Overall Study|Laboratory adverse experience|2|||
33385993|NCT00717860|62764939|FG000|Overall Study|Lack of Efficacy|7|||
33385994|NCT00717860|62764940|FG001|Overall Study|Lack of Efficacy|13|||
33297635|NCT01106287|62673833|FG003|Overall Study|Adverse Event|0|||
33297636|NCT01104493|62673849|FG000|Overall Study|Lost to Follow-up|0|||
33297637|NCT01104493|62673850|FG001|Overall Study|Lost to Follow-up|2|||
33297638|NCT01104415|62673856|FG000|Core Phase|Consent withdrawn by subjects|1|||
33297639|NCT01104415|62673857|FG001|Core Phase|Consent withdrawn by subjects|0|||
33297640|NCT01104415|62673856|FG000|Extension Period|Progressive disease|0|||
33297641|NCT01104415|62673857|FG001|Extension Period|Progressive disease|4|||
33385995|NCT00717860|62764939|FG000|Overall Study|Discontinued for other reason|6|||
33385996|NCT00717860|62764940|FG001|Overall Study|Discontinued for other reason|1|||
33385997|NCT00717860|62764939|FG000|Overall Study|Withdrew consent|7|||
33385998|NCT00717860|62764940|FG001|Overall Study|Withdrew consent|3|||
33385999|NCT00717314|62764948|FG000|Overall Study|Adverse Event|3|||
33386000|NCT00717314|62764949|FG001|Overall Study|Adverse Event|2|||
33386001|NCT00717314|62764948|FG000|Overall Study|Protocol Violation|1|||
33386002|NCT00717314|62764949|FG001|Overall Study|Protocol Violation|0|||
33386003|NCT00717314|62764948|FG000|Overall Study|Lost to Follow-up|1|||
33386004|NCT00717314|62764949|FG001|Overall Study|Lost to Follow-up|5|||
33386005|NCT00717314|62764948|FG000|Overall Study|Withdrawal by Subject|1|||
33297642|NCT01104415|62673856|FG000|Extension Period|Death|0|||
33386006|NCT00717314|62764949|FG001|Overall Study|Withdrawal by Subject|3|||
33386007|NCT00689793|62764957|FG000|Overall Study|Lost to Follow-up|4|||
33386008|NCT00689793|62764958|FG001|Overall Study|Lost to Follow-up|5|||
33386009|NCT00723944|62764968|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
33386010|NCT00723944|62764969|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
33386011|NCT00723944|62764968|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
33386012|NCT00723944|62764969|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
33386013|NCT00723944|62764968|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
33386014|NCT00723944|62764969|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
33386015|NCT00689481|62764977|FG000|Overall Study|Adverse Event|7|||
33386016|NCT00689481|62764978|FG001|Overall Study|Adverse Event|1|||
33386017|NCT00689481|62764977|FG000|Overall Study|Lost to Follow-up|4|||
33386018|NCT00689481|62764978|FG001|Overall Study|Lost to Follow-up|3|||
33297643|NCT01104415|62673857|FG001|Extension Period|Death|1|||
33297644|NCT01104415|62673856|FG000|Extension Period|Physician Decision|0|||
33297645|NCT01104415|62673857|FG001|Extension Period|Physician Decision|1|||
33297646|NCT01104415|62673856|FG000|Extension Period|Transition to Study LX1606.302|0|||
33297647|NCT01104415|62673857|FG001|Extension Period|Transition to Study LX1606.302|4|||
33297648|NCT01104415|62673856|FG000|Extension Period|Heart surgery/feeling miserable|0|||
33297649|NCT01104415|62673857|FG001|Extension Period|Heart surgery/feeling miserable|1|||
33297650|NCT01099579|62673867|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
33297651|NCT01099579|62673868|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
33297652|NCT01099579|62673869|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
33297653|NCT01099579|62673867|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
33297654|NCT01099579|62673868|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
33297655|NCT01099579|62673869|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
33297656|NCT01099579|62673867|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
33297657|NCT01099579|62673868|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
33297658|NCT01099579|62673869|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
33297659|NCT01099579|62673867|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
33297660|NCT01099579|62673868|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
33297661|NCT01099579|62673869|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
33297662|NCT01099579|62673867|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
33297663|NCT01099579|62673868|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
33386019|NCT00689481|62764977|FG000|Overall Study|Lack of Efficacy|4|||
33386020|NCT00689481|62764978|FG001|Overall Study|Lack of Efficacy|3|||
33386021|NCT00689481|62764977|FG000|Overall Study|Non-compliance with study treatment|1|||
33386022|NCT00689481|62764978|FG001|Overall Study|Non-compliance with study treatment|1|||
33386023|NCT00689481|62764977|FG000|Overall Study|Withdrawal by Subject|8|||
33386024|NCT00689481|62764978|FG001|Overall Study|Withdrawal by Subject|4|||
33386025|NCT00689481|62764977|FG000|Overall Study|Excluded medication started during study|0|||
33386026|NCT00689481|62764978|FG001|Overall Study|Excluded medication started during study|1|||
33386027|NCT00689481|62764977|FG000|Overall Study|Subject early term, left on vacation|0|||
33386028|NCT00689481|62764978|FG001|Overall Study|Subject early term, left on vacation|1|||
33386029|NCT00688701|62764987|FG000|Overall Study|Adverse Event|1|||
33386030|NCT00688701|62764988|FG001|Overall Study|Adverse Event|0|||
33386031|NCT00688701|62764989|FG002|Overall Study|Adverse Event|5|||
33386032|NCT00688701|62764990|FG003|Overall Study|Adverse Event|3|||
33386033|NCT00688701|62764987|FG000|Overall Study|Lack of Efficacy|0|||
33386034|NCT00688701|62764988|FG001|Overall Study|Lack of Efficacy|1|||
33386035|NCT00688701|62764989|FG002|Overall Study|Lack of Efficacy|0|||
33386036|NCT00688701|62764990|FG003|Overall Study|Lack of Efficacy|0|||
33386037|NCT00688701|62764987|FG000|Overall Study|Withdrawal by Subject|3|||
33386038|NCT00688701|62764988|FG001|Overall Study|Withdrawal by Subject|3|||
33386039|NCT00688701|62764989|FG002|Overall Study|Withdrawal by Subject|4|||
33386040|NCT00688701|62764990|FG003|Overall Study|Withdrawal by Subject|8|||
33386041|NCT00688701|62764987|FG000|Overall Study|Poor compliance to protocol|0|||
33386042|NCT00688701|62764988|FG001|Overall Study|Poor compliance to protocol|1|||
33386043|NCT00688701|62764989|FG002|Overall Study|Poor compliance to protocol|1|||
33386044|NCT00688701|62764990|FG003|Overall Study|Poor compliance to protocol|0|||
33386045|NCT00688623|62765010|FG000|Overall Study|Adverse Event|22|||
33386046|NCT00688623|62765010|FG000|Overall Study|abnormal lab value|1|||
33386047|NCT00688623|62765010|FG000|Overall Study|Withdrawal by Subject|4|||
33386048|NCT00688623|62765010|FG000|Overall Study|Death|3|||
33386049|NCT00688623|62765010|FG000|Overall Study|disease progression|23|||
33386050|NCT00688623|62765010|FG000|Overall Study|Protocol Violation|2|||
33386051|NCT00717236|62765016|FG000|Double-Blind Period|Adverse Event|33|||
33386052|NCT00717236|62765017|FG001|Double-Blind Period|Adverse Event|6|||
33386053|NCT00717236|62765016|FG000|Double-Blind Period|Lack of Efficacy|6|||
33386054|NCT00717236|62765017|FG001|Double-Blind Period|Lack of Efficacy|6|||
33386055|NCT00717236|62765016|FG000|Double-Blind Period|Lost to Follow-up|3|||
33386056|NCT00717236|62765017|FG001|Double-Blind Period|Lost to Follow-up|5|||
33386057|NCT00717236|62765016|FG000|Double-Blind Period|Withdrawal by Subject|10|||
33386058|NCT00717236|62765017|FG001|Double-Blind Period|Withdrawal by Subject|2|||
33386059|NCT00717236|62765016|FG000|Double-Blind Period|Loss of efficacy|3|||
33386060|NCT00717236|62765017|FG001|Double-Blind Period|Loss of efficacy|0|||
33386061|NCT00717236|62765016|FG000|Double-Blind Period|Other: Death|1|||
33386062|NCT00717236|62765017|FG001|Double-Blind Period|Other: Death|0|||
33386063|NCT00717236|62765016|FG000|Double-Blind Period|Other: Pregnancy|1|||
33386064|NCT00717236|62765017|FG001|Double-Blind Period|Other: Pregnancy|0|||
33386065|NCT00717236|62765016|FG000|Double-Blind Period|Other: Protocol Violation|2|||
33386066|NCT00717236|62765017|FG001|Double-Blind Period|Other: Protocol Violation|0|||
33386067|NCT00717236|62765016|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
33386068|NCT00717236|62765017|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
33386069|NCT00717236|62765016|FG000|Double-Blind Period|Other: Site withdrew|2|||
33386070|NCT00717236|62765017|FG001|Double-Blind Period|Other: Site withdrew|0|||
33297664|NCT01099579|62673869|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
33297665|NCT01099579|62673867|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
33297666|NCT01099579|62673868|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
33386071|NCT00717236|62765016|FG000|Double-Blind Period|Other: Screening failure|1|||
33386072|NCT00717236|62765017|FG001|Double-Blind Period|Other: Screening failure|0|||
33386073|NCT00717236|62765016|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
33386074|NCT00717236|62765017|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
33386075|NCT00717236|62765016|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
33386076|NCT00717236|62765017|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
33386077|NCT00717236|62765016|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
33386078|NCT00717236|62765017|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
33386079|NCT00717236|62765016|FG000|Double-Blind Period|Other: History of cancer|1|||
33386080|NCT00717236|62765017|FG001|Double-Blind Period|Other: History of cancer|0|||
33386081|NCT00717236|62765016|FG000|Double-Blind Period|Other: Sponsor request|1|||
33297667|NCT01099579|62673869|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
33297668|NCT01099579|62673867|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
33386082|NCT00717236|62765017|FG001|Double-Blind Period|Other: Sponsor request|0|||
33386083|NCT00717236|62765016|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
33386084|NCT00717236|62765017|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
33386085|NCT00717236|62765016|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
33386086|NCT00717236|62765017|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
33386087|NCT00717236|62765016|FG000|Double-Blind Period|Other: Subject moved|1|||
33386088|NCT00717236|62765017|FG001|Double-Blind Period|Other: Subject moved|1|||
33386089|NCT00717236|62765016|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
33386090|NCT00717236|62765017|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
33386091|NCT00717236|62765016|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
33386092|NCT00717236|62765017|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
33386093|NCT00717236|62765016|FG000|Double-Blind Period|Other: Transportation problems|0|||
33386094|NCT00717236|62765017|FG001|Double-Blind Period|Other: Transportation problems|1|||
33386095|NCT00717236|62765016|FG000|Double-Blind Period|Other: Investigator Decision|0|||
33297669|NCT01099579|62673868|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
33297670|NCT01099579|62673869|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
33297671|NCT01099579|62673867|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
33297672|NCT01099579|62673868|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
33297673|NCT01099579|62673869|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
33297674|NCT01099579|62673867|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
33297675|NCT01099579|62673868|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
33297676|NCT01099579|62673869|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
33297677|NCT01099579|62673867|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
33297678|NCT01099579|62673868|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
33297679|NCT01099579|62673869|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
33297680|NCT01103713|62673879|FG000|Overall Study|Lost to Follow-up|2|||
33297681|NCT01103713|62673879|FG000|Overall Study|Withdrawal by Subject|8|||
33297682|NCT01103713|62673879|FG000|Overall Study|Study terminated by sponsor|2|||
33297683|NCT01103713|62673879|FG000|Overall Study|Other|1|||
33297684|NCT01103479|62673889|FG000|Overall Study|Up to date with CRC screening|1|||
33297685|NCT01103479|62673890|FG001|Overall Study|Up to date with CRC screening|9|||
33297686|NCT01103479|62673891|FG002|Overall Study|Up to date with CRC screening|12|||
33297687|NCT01103479|62673889|FG000|Overall Study|Family history of CRC|1|||
33297688|NCT01103479|62673890|FG001|Overall Study|Family history of CRC|0|||
33297689|NCT01103479|62673891|FG002|Overall Study|Family history of CRC|2|||
33297690|NCT01103479|62673889|FG000|Overall Study|Active cancer|1|||
33297691|NCT01103479|62673890|FG001|Overall Study|Active cancer|0|||
33297692|NCT01103479|62673891|FG002|Overall Study|Active cancer|0|||
33297693|NCT01103479|62673889|FG000|Overall Study|Saw non-study physician|2|||
33297694|NCT01103479|62673890|FG001|Overall Study|Saw non-study physician|0|||
33297695|NCT01103479|62673891|FG002|Overall Study|Saw non-study physician|0|||
33297696|NCT01103323|62673902|FG000|Without/Before Drug Switch|Adverse Event|50|||
33297697|NCT01103323|62673903|FG001|Without/Before Drug Switch|Adverse Event|7|||
33297698|NCT01103323|62673902|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
33297699|NCT01103323|62673903|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
33297700|NCT01103323|62673902|FG000|Without/Before Drug Switch|Protocol Violation|2|||
33386096|NCT00717236|62765017|FG001|Double-Blind Period|Other: Investigator Decision|1|||
33386097|NCT00717236|62765016|FG000|Open-Label Period|Adverse Event|29|||
33386098|NCT00717236|62765017|FG001|Open-Label Period|Adverse Event|4|||
33386099|NCT00717236|62765016|FG000|Open-Label Period|Lack of Efficacy|30|||
33297701|NCT01103323|62673903|FG001|Without/Before Drug Switch|Protocol Violation|0|||
33297702|NCT01103323|62673902|FG000|Without/Before Drug Switch|Physician Decision|2|||
33297703|NCT01103323|62673903|FG001|Without/Before Drug Switch|Physician Decision|0|||
33297704|NCT01103323|62673902|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
33297705|NCT01103323|62673903|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
33297706|NCT01103323|62673902|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
33297707|NCT01103323|62673903|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
33297708|NCT01103323|62673902|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
33386100|NCT00717236|62765017|FG001|Open-Label Period|Lack of Efficacy|8|||
33386101|NCT00717236|62765016|FG000|Open-Label Period|Lost to Follow-up|28|||
33386102|NCT00717236|62765017|FG001|Open-Label Period|Lost to Follow-up|4|||
33386103|NCT00717236|62765016|FG000|Open-Label Period|Withdrawal by Subject|20|||
33386104|NCT00717236|62765017|FG001|Open-Label Period|Withdrawal by Subject|2|||
33386105|NCT00717236|62765016|FG000|Open-Label Period|Loss of Efficacy|6|||
33386106|NCT00717236|62765017|FG001|Open-Label Period|Loss of Efficacy|1|||
33386107|NCT00717236|62765016|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
33386108|NCT00717236|62765017|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
33386109|NCT00717236|62765016|FG000|Open-Label Period|Other: Lack of Compliance|1|||
33386110|NCT00717236|62765017|FG001|Open-Label Period|Other: Lack of Compliance|1|||
33386111|NCT00717236|62765016|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
33386112|NCT00717236|62765017|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
33386113|NCT00717236|62765016|FG000|Open-Label Period|Other: Moved|1|||
33386114|NCT00717236|62765017|FG001|Open-Label Period|Other: Moved|0|||
33386115|NCT00717236|62765016|FG000|Open-Label Period|Other: Investigator Decision|1|||
33386116|NCT00717236|62765017|FG001|Open-Label Period|Other: Investigator Decision|0|||
33297709|NCT01103323|62673903|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
33297710|NCT01103245|62673914|FG000|Overall Study|Withdrawal by Subject|1|||
33297711|NCT01103245|62673915|FG001|Overall Study|Withdrawal by Subject|0|||
33297712|NCT01103245|62673916|FG002|Overall Study|Withdrawal by Subject|3|||
33386117|NCT00717236|62765016|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
33386118|NCT00717236|62765017|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
33386119|NCT00717236|62765016|FG000|Open-Label Period|Other: Sponsor Request|3|||
33386120|NCT00717236|62765017|FG001|Open-Label Period|Other: Sponsor Request|0|||
33386121|NCT00717236|62765016|FG000|Open-Label Period|Other: Cataract Surgery|1|||
33386122|NCT00717236|62765017|FG001|Open-Label Period|Other: Cataract Surgery|0|||
33386123|NCT00717236|62765016|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
33386124|NCT00717236|62765017|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
33386125|NCT00717236|62765016|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
33386126|NCT00717236|62765017|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
33386127|NCT00717236|62765016|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
33386128|NCT00717236|62765017|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
33386129|NCT00719810|62765028|FG000|Overall Study|Adverse Event|0|||
33386130|NCT00719810|62765029|FG001|Overall Study|Adverse Event|2|||
33386131|NCT00719810|62765030|FG002|Overall Study|Adverse Event|3|||
33662580|NCT01587703|63093230|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33662581|NCT01587703|63093231|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33662582|NCT01587703|63093232|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
33662583|NCT01587703|63093233|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33662584|NCT01587703|63093234|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33662585|NCT01587703|63093235|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33662586|NCT01587703|63093236|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33662587|NCT01587703|63093237|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33662588|NCT01587703|63093238|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33662589|NCT01587703|63093239|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33662590|NCT01587703|63093240|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33662591|NCT01587703|63093241|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33662592|NCT01587703|63093242|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33662593|NCT01587703|63093243|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33662594|NCT01587703|63093244|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33662595|NCT01587703|63093226|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
33662596|NCT01587703|63093227|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
33662597|NCT01587703|63093228|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
33662598|NCT01587703|63093229|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
33662599|NCT01587703|63093230|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
33297713|NCT01103245|62673917|FG003|Overall Study|Withdrawal by Subject|0|||
33297714|NCT01103245|62673914|FG000|Overall Study|Inadequate IV access|1|||
33297715|NCT01103245|62673915|FG001|Overall Study|Inadequate IV access|0|||
33297716|NCT01103245|62673916|FG002|Overall Study|Inadequate IV access|0|||
33297717|NCT01103245|62673917|FG003|Overall Study|Inadequate IV access|0|||
33297718|NCT01103245|62673914|FG000|Overall Study|Adverse Event|0|||
33297719|NCT01103245|62673915|FG001|Overall Study|Adverse Event|2|||
33297720|NCT01103245|62673916|FG002|Overall Study|Adverse Event|1|||
33386132|NCT00719810|62765028|FG000|Overall Study|Lost to Follow-up|2|||
33386133|NCT00719810|62765029|FG001|Overall Study|Lost to Follow-up|0|||
33386134|NCT00719810|62765030|FG002|Overall Study|Lost to Follow-up|3|||
33386135|NCT00719810|62765028|FG000|Overall Study|Physician Decision|0|||
33386136|NCT00719810|62765029|FG001|Overall Study|Physician Decision|1|||
33297721|NCT01103245|62673917|FG003|Overall Study|Adverse Event|0|||
33297722|NCT01103245|62673914|FG000|Overall Study|Physician Decision|1|||
33297723|NCT01103245|62673915|FG001|Overall Study|Physician Decision|0|||
33297724|NCT01103245|62673916|FG002|Overall Study|Physician Decision|0|||
33297725|NCT01103245|62673917|FG003|Overall Study|Physician Decision|0|||
33297726|NCT01099267|62673927|FG000|MDS-003 Study|Adverse Event|37|||
33297727|NCT01099267|62673927|FG000|MDS-003 Study|Lack of Efficacy|52|||
33297728|NCT01099267|62673927|FG000|MDS-003 Study|Withdrawal by Subject|8|||
33297729|NCT01099267|62673927|FG000|MDS-003 Study|Lost to Follow-up|1|||
33297730|NCT01099267|62673927|FG000|MDS-003 Study|Death|11|||
33297731|NCT01099267|62673927|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
33297732|NCT01099267|62673927|FG000|MDS-003 Study|Disease Progression|7|||
33297733|NCT01099267|62673927|FG000|MDS-003 Study|Investigator Decision|2|||
33297734|NCT01099267|62673927|FG000|MDS-003 Study|Non-Compliance|2|||
33297735|NCT01099267|62673927|FG000|MDS-003 Study|Loss of Response|1|||
33297736|NCT01099267|62673927|FG000|MDS-003 Study|Secondary Malign Disease|1|||
33297737|NCT01098487|62673931|FG000|Overall Study|Adverse Event|22|||
33297738|NCT01098487|62673931|FG000|Overall Study|Lack of Efficacy|11|||
33386137|NCT00719810|62765030|FG002|Overall Study|Physician Decision|0|||
33386138|NCT00719810|62765028|FG000|Overall Study|Withdrawal by Subject|1|||
33386139|NCT00719810|62765029|FG001|Overall Study|Withdrawal by Subject|1|||
33386140|NCT00719810|62765030|FG002|Overall Study|Withdrawal by Subject|2|||
33386141|NCT00719732|62765038|FG000|Overall Study|Lost to Follow-up|20|||
33386142|NCT00719732|62765038|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
33489199|NCT03519087|62867396|FG002|Laboratory Testing|Lost to Follow-up|2|||
33489200|NCT03519087|62867397|FG003|Laboratory Testing|Lost to Follow-up|3|||
33489201|NCT03519087|62867398|FG004|Laboratory Testing|Lost to Follow-up|6|||
33489202|NCT03519087|62867394|FG000|Laboratory Testing|Protocol Violation|0|||
33489203|NCT03519087|62867395|FG001|Laboratory Testing|Protocol Violation|0|||
33489204|NCT03519087|62867396|FG002|Laboratory Testing|Protocol Violation|0|||
33489205|NCT03519087|62867397|FG003|Laboratory Testing|Protocol Violation|1|||
33489206|NCT03519087|62867398|FG004|Laboratory Testing|Protocol Violation|0|||
33489207|NCT02763046|62867417|FG000|Overall Study|Adverse Event|5|||
33489208|NCT02763046|62867418|FG001|Overall Study|Adverse Event|4|||
33386143|NCT00719732|62765038|FG000|Overall Study|Illness not associated with device|1|||
33386144|NCT00723710|62765042|FG000|Overall Study|Disease progression|48|||
33386145|NCT00723710|62765042|FG000|Overall Study|Adverse Event|88|||
33386146|NCT00723710|62765042|FG000|Overall Study|Withdrawal by Subject|36|||
33386147|NCT00723710|62765042|FG000|Overall Study|Physician Decision|2|||
33386148|NCT00688545|62765048|FG000|Overall Study|Lost to Follow-up|1|||
33386149|NCT00688545|62765049|FG001|Overall Study|Lost to Follow-up|4|||
33386150|NCT00688545|62765048|FG000|Overall Study|Insurance/cost of drug|0|||
33386151|NCT00688545|62765049|FG001|Overall Study|Insurance/cost of drug|1|||
33386152|NCT00688545|62765048|FG000|Overall Study|Withdrawal by Subject|2|||
33489209|NCT02763046|62867419|FG002|Overall Study|Adverse Event|0|||
33489210|NCT02763046|62867417|FG000|Overall Study|Lack of Efficacy|1|||
33489211|NCT02763046|62867418|FG001|Overall Study|Lack of Efficacy|1|||
33489212|NCT02763046|62867419|FG002|Overall Study|Lack of Efficacy|3|||
33489213|NCT02763046|62867417|FG000|Overall Study|Physician Decision|1|||
33489214|NCT02763046|62867418|FG001|Overall Study|Physician Decision|0|||
33489215|NCT02763046|62867419|FG002|Overall Study|Physician Decision|1|||
33489216|NCT02763046|62867417|FG000|Overall Study|Subject/guardian decision|2|||
33489217|NCT02763046|62867418|FG001|Overall Study|Subject/guardian decision|0|||
33489218|NCT02763046|62867419|FG002|Overall Study|Subject/guardian decision|4|||
33489219|NCT03518073|62867436|FG000|Overall Study|Adverse Event|2|||
33489220|NCT03518073|62867437|FG001|Overall Study|Adverse Event|4|||
33489221|NCT03518073|62867438|FG002|Overall Study|Adverse Event|2|||
33489222|NCT03518073|62867436|FG000|Overall Study|Death|2|||
33489223|NCT03518073|62867437|FG001|Overall Study|Death|1|||
33489224|NCT03518073|62867438|FG002|Overall Study|Death|3|||
33489225|NCT03518073|62867436|FG000|Overall Study|Lost to Follow-up|1|||
33662600|NCT01587703|63093231|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
33297739|NCT01098487|62673931|FG000|Overall Study|Withdrawal by Subject|7|||
33297740|NCT01098487|62673931|FG000|Overall Study|Lost to Follow-up|3|||
33297741|NCT01098487|62673931|FG000|Overall Study|Physician Decision|1|||
33386153|NCT00688545|62765049|FG001|Overall Study|Withdrawal by Subject|3|||
33386154|NCT00688545|62765048|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
33386155|NCT00688545|62765049|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
33489226|NCT03518073|62867437|FG001|Overall Study|Lost to Follow-up|0|||
33489227|NCT03518073|62867438|FG002|Overall Study|Lost to Follow-up|1|||
33489228|NCT03518073|62867436|FG000|Overall Study|Physician Decision|5|||
33489229|NCT03518073|62867437|FG001|Overall Study|Physician Decision|0|||
33489230|NCT03518073|62867438|FG002|Overall Study|Physician Decision|2|||
33489231|NCT03518073|62867436|FG000|Overall Study|Progressive disease|1|||
33489232|NCT03518073|62867437|FG001|Overall Study|Progressive disease|1|||
33297742|NCT01098097|62673935|FG000|Overall Study|Adverse Event|17|||
33297743|NCT01098097|62673935|FG000|Overall Study|Lost to Follow-up|18|||
33297744|NCT01098097|62673935|FG000|Overall Study|Status unknown|16|||
33386156|NCT00688467|62765059|FG000|Treatment Period 1|Adverse Event|2|||
33489233|NCT03518073|62867438|FG002|Overall Study|Progressive disease|1|||
33489234|NCT03518073|62867436|FG000|Overall Study|Protocol Violation|1|||
33386157|NCT00688467|62765060|FG001|Treatment Period 1|Adverse Event|1|||
33386158|NCT00688467|62765059|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
33386159|NCT00688467|62765060|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
33386160|NCT00688467|62765059|FG000|Treatment Period 2|Protocol Violation|0|||
33386161|NCT00688467|62765060|FG001|Treatment Period 2|Protocol Violation|1|||
33386162|NCT00688467|62765059|FG000|Treatment Period 2|Adverse Event|0|||
33386163|NCT00688467|62765060|FG001|Treatment Period 2|Adverse Event|1|||
33386164|NCT00688155|62765070|FG000|Overall Study|Withdrawal by Subject|2|||
33386165|NCT00688155|62765071|FG001|Overall Study|Withdrawal by Subject|2|||
33386166|NCT00688155|62765072|FG002|Overall Study|Withdrawal by Subject|1|||
33386167|NCT00688155|62765073|FG003|Overall Study|Withdrawal by Subject|1|||
33386168|NCT00690573|62765083|FG000|Overall Study|Lack of Efficacy|8|||
33489235|NCT03518073|62867437|FG001|Overall Study|Protocol Violation|0|||
33489236|NCT03518073|62867438|FG002|Overall Study|Protocol Violation|0|||
33489237|NCT03518073|62867436|FG000|Overall Study|Withdrawal by Subject|30|||
33662601|NCT01587703|63093232|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
33662602|NCT01587703|63093233|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
33662603|NCT01587703|63093234|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33662604|NCT01587703|63093235|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33662605|NCT01587703|63093236|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33662606|NCT01587703|63093237|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33662607|NCT01587703|63093238|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33662608|NCT01587703|63093239|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33662609|NCT01587703|63093240|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33662610|NCT01587703|63093241|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33662611|NCT01587703|63093242|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33662612|NCT01587703|63093243|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33662613|NCT01587703|63093244|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33662614|NCT01587703|63093226|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33662615|NCT01587703|63093227|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33662616|NCT01587703|63093228|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33662617|NCT01587703|63093229|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33662618|NCT01587703|63093230|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33297745|NCT01098097|62673935|FG000|Overall Study|No reason reported|31|||
33297746|NCT01097863|62673942|FG000|Overall Study|Discomfort|1|||
33297747|NCT01097863|62673943|FG001|Overall Study|Discomfort|0|||
33489238|NCT03518073|62867437|FG001|Overall Study|Withdrawal by Subject|34|||
33489239|NCT03518073|62867438|FG002|Overall Study|Withdrawal by Subject|29|||
33489240|NCT03518073|62867436|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
33489241|NCT03518073|62867437|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
33489242|NCT03518073|62867438|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
33489243|NCT03518073|62867436|FG000|Overall Study|Covid-19|1|||
33489244|NCT03518073|62867437|FG001|Overall Study|Covid-19|2|||
33662619|NCT01587703|63093231|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33297748|NCT01097863|62673944|FG002|Overall Study|Discomfort|1|||
33297749|NCT01097863|62673942|FG000|Overall Study|Did not return for final visit|0|||
33297750|NCT01097863|62673943|FG001|Overall Study|Did not return for final visit|0|||
33297751|NCT01097863|62673944|FG002|Overall Study|Did not return for final visit|1|||
33297752|NCT01326962|62673952|FG000|Overall Study|Adverse Event|1|||
33297753|NCT01326962|62673952|FG000|Overall Study|Withdrawal by Subject|1|||
33297754|NCT01326962|62673952|FG000|Overall Study|Lost to Follow-up|3|||
33297755|NCT01326962|62673952|FG000|Overall Study|Other|2|||
33297756|NCT01326728|62673958|FG000|Overall Study|Death|13|||
33297757|NCT01326728|62673959|FG001|Overall Study|Death|0|||
33297758|NCT01326728|62673958|FG000|Overall Study|Early closure of study|34|||
33297759|NCT01326728|62673959|FG001|Overall Study|Early closure of study|9|||
33297760|NCT01097707|62673969|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
33297761|NCT01097707|62673970|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
33297762|NCT01097707|62673971|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
33297763|NCT01097707|62673972|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
33297764|NCT01097707|62673973|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
33297765|NCT01097707|62673969|FG000|Overall Study|Adverse Event|4|||
33386169|NCT00690573|62765083|FG000|Overall Study|Withdrawal by Subject|1|||
33386170|NCT00719264|62765089|FG000|Overall Study|Adverse Event|41|||
33662620|NCT01587703|63093232|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33662621|NCT01587703|63093233|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33297766|NCT01097707|62673970|FG001|Overall Study|Adverse Event|2|||
33297767|NCT01097707|62673971|FG002|Overall Study|Adverse Event|3|||
33297768|NCT01097707|62673972|FG003|Overall Study|Adverse Event|1|||
33489245|NCT03518073|62867438|FG002|Overall Study|Covid-19|1|||
33489246|NCT02759692|62867448|FG000|Period 1|Test article no longer available|1|||
33489247|NCT02759692|62867449|FG001|Period 1|Test article no longer available|1|||
33297769|NCT01097707|62673973|FG004|Overall Study|Adverse Event|3|||
33386171|NCT00719264|62765090|FG001|Overall Study|Adverse Event|49|||
33662622|NCT01587703|63093234|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
33297770|NCT01097707|62673969|FG000|Overall Study|Entry Criteria Not Met|2|||
33297771|NCT01097707|62673970|FG001|Overall Study|Entry Criteria Not Met|1|||
33297772|NCT01097707|62673971|FG002|Overall Study|Entry Criteria Not Met|1|||
33297773|NCT01097707|62673972|FG003|Overall Study|Entry Criteria Not Met|0|||
33297774|NCT01097707|62673973|FG004|Overall Study|Entry Criteria Not Met|1|||
33297775|NCT01097707|62673969|FG000|Overall Study|Lack of Efficacy|1|||
33297776|NCT01097707|62673970|FG001|Overall Study|Lack of Efficacy|0|||
33386172|NCT00719264|62765089|FG000|Overall Study|Death|13|||
33386173|NCT00719264|62765090|FG001|Overall Study|Death|10|||
33386174|NCT00719264|62765089|FG000|Overall Study|Administrative Problems|6|||
33386175|NCT00719264|62765090|FG001|Overall Study|Administrative Problems|4|||
33386176|NCT00719264|62765089|FG000|Overall Study|Lost to Follow-up|1|||
33386177|NCT00719264|62765090|FG001|Overall Study|Lost to Follow-up|1|||
33386178|NCT00719264|62765089|FG000|Overall Study|Withdrawal by Subject|12|||
33386179|NCT00719264|62765090|FG001|Overall Study|Withdrawal by Subject|7|||
33386180|NCT00719264|62765089|FG000|Overall Study|Protocol Deviation|1|||
33386181|NCT00719264|62765090|FG001|Overall Study|Protocol Deviation|3|||
33297777|NCT01097707|62673971|FG002|Overall Study|Lack of Efficacy|0|||
33297778|NCT01097707|62673972|FG003|Overall Study|Lack of Efficacy|1|||
33297779|NCT01097707|62673973|FG004|Overall Study|Lack of Efficacy|0|||
33297780|NCT01097707|62673969|FG000|Overall Study|Lost to Follow-up|1|||
33297781|NCT01097707|62673970|FG001|Overall Study|Lost to Follow-up|1|||
33297782|NCT01097707|62673971|FG002|Overall Study|Lost to Follow-up|2|||
33386182|NCT00719264|62765089|FG000|Overall Study|New Cancer Therapy|4|||
33386183|NCT00719264|62765090|FG001|Overall Study|New Cancer Therapy|2|||
33386184|NCT00719264|62765089|FG000|Overall Study|Disease Progression|104|||
33386185|NCT00719264|62765090|FG001|Overall Study|Disease Progression|107|||
33386186|NCT00687609|62765096|FG000|Overall Study|Physician Decision|1|||
33297783|NCT01097707|62673972|FG003|Overall Study|Lost to Follow-up|0|||
33297784|NCT01097707|62673973|FG004|Overall Study|Lost to Follow-up|3|||
33297785|NCT01097707|62673969|FG000|Overall Study|Protocol Violation|2|||
33297786|NCT01097707|62673970|FG001|Overall Study|Protocol Violation|2|||
33297787|NCT01097707|62673971|FG002|Overall Study|Protocol Violation|3|||
33297788|NCT01097707|62673972|FG003|Overall Study|Protocol Violation|2|||
33297789|NCT01097707|62673973|FG004|Overall Study|Protocol Violation|2|||
33297790|NCT01097707|62673969|FG000|Overall Study|Sponsor Decision|31|||
33297791|NCT01097707|62673970|FG001|Overall Study|Sponsor Decision|31|||
33297792|NCT01097707|62673971|FG002|Overall Study|Sponsor Decision|34|||
33297793|NCT01097707|62673972|FG003|Overall Study|Sponsor Decision|35|||
33386187|NCT00687609|62765096|FG000|Overall Study|Withdrawal by Subject|2|||
33386188|NCT00723554|62765100|FG000|Overall Study|Adverse Event|12|||
33386189|NCT00723554|62765100|FG000|Overall Study|Investigator's judgement|5|||
33386190|NCT00723554|62765100|FG000|Overall Study|Inhaled medication other than iloprost|4|||
33386191|NCT00723554|62765100|FG000|Overall Study|Withdrawal of consent|3|||
33386192|NCT00723554|62765100|FG000|Overall Study|Other|3|||
33386193|NCT00723554|62765100|FG000|Overall Study|Lost to Follow-up|1|||
33386194|NCT00723554|62765100|FG000|Overall Study|Non-compliance|1|||
33386195|NCT00687219|62765106|FG000|Overall Study|Adverse Event|8|||
33386196|NCT00687219|62765106|FG000|Overall Study|Discontinuance criteria met|7|||
33386197|NCT00687219|62765106|FG000|Overall Study|HCV-RNA positive conversion|34|||
33386198|NCT00687219|62765106|FG000|Overall Study|Withdrawal by Subject|1|||
33386199|NCT00687219|62765106|FG000|Overall Study|Lack of Efficacy|1|||
33386200|NCT00723398|62765115|FG000|Overall Study|Withdrawal by Subject|2|||
33386201|NCT00723398|62765116|FG001|Overall Study|Withdrawal by Subject|6|||
33386202|NCT00723398|62765117|FG002|Overall Study|Withdrawal by Subject|4|||
33386203|NCT00723398|62765118|FG003|Overall Study|Withdrawal by Subject|4|||
33386204|NCT00723398|62765119|FG004|Overall Study|Withdrawal by Subject|4|||
33386205|NCT00723398|62765115|FG000|Overall Study|Protocol Violation|2|||
33386206|NCT00723398|62765116|FG001|Overall Study|Protocol Violation|1|||
33386207|NCT00723398|62765117|FG002|Overall Study|Protocol Violation|5|||
33386208|NCT00723398|62765118|FG003|Overall Study|Protocol Violation|0|||
33386209|NCT00723398|62765119|FG004|Overall Study|Protocol Violation|0|||
33386210|NCT00723398|62765115|FG000|Overall Study|Physician Decision|2|||
33489248|NCT02759692|62867448|FG000|Period 1|No longer meets eligibility criteria.|1|||
33556747|NCT02613572|62949574|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
33386211|NCT00723398|62765116|FG001|Overall Study|Physician Decision|2|||
33386212|NCT00723398|62765117|FG002|Overall Study|Physician Decision|5|||
33556748|NCT02613572|62949572|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
33556749|NCT02613572|62949573|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
33556750|NCT02613572|62949574|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
33556751|NCT02087189|62949586|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
33556752|NCT02341456|62949593|FG000|Overall Study|Disease progression|2|||
33556753|NCT02341456|62949594|FG001|Overall Study|Disease progression|3|||
33556754|NCT02341456|62949595|FG002|Overall Study|Disease progression|1|||
33556755|NCT02341456|62949593|FG000|Overall Study|Death|1|||
33556756|NCT02341456|62949594|FG001|Overall Study|Death|1|||
33556757|NCT02341456|62949595|FG002|Overall Study|Death|1|||
33386213|NCT00723398|62765118|FG003|Overall Study|Physician Decision|0|||
33386214|NCT00723398|62765119|FG004|Overall Study|Physician Decision|1|||
33386215|NCT00723398|62765115|FG000|Overall Study|Adverse Event|0|||
33386216|NCT00723398|62765116|FG001|Overall Study|Adverse Event|5|||
33386217|NCT00723398|62765117|FG002|Overall Study|Adverse Event|3|||
33386218|NCT00723398|62765118|FG003|Overall Study|Adverse Event|1|||
33386219|NCT00723398|62765119|FG004|Overall Study|Adverse Event|4|||
33386220|NCT00723398|62765115|FG000|Overall Study|Lost to Follow-up|0|||
33386221|NCT00723398|62765116|FG001|Overall Study|Lost to Follow-up|1|||
33386222|NCT00723398|62765117|FG002|Overall Study|Lost to Follow-up|0|||
33386223|NCT00723398|62765118|FG003|Overall Study|Lost to Follow-up|0|||
33386224|NCT00723398|62765119|FG004|Overall Study|Lost to Follow-up|0|||
33386225|NCT00716456|62765134|FG000|Overall Study|Adverse Event|0|||
33386226|NCT00716456|62765135|FG001|Overall Study|Adverse Event|2|||
33386227|NCT00716456|62765136|FG002|Overall Study|Adverse Event|0|||
33386228|NCT00684645|62765144|FG000|Overall Study|Death|2|||
33386229|NCT00684645|62765144|FG000|Overall Study|Progressive disease|67|||
33386230|NCT00684645|62765144|FG000|Overall Study|Adverse Event|27|||
33386231|NCT00684645|62765144|FG000|Overall Study|Lost to Follow-up|3|||
33386232|NCT00684645|62765144|FG000|Overall Study|Other|15|||
33386233|NCT00716144|62765152|FG000|Overall Study|Withdrawal by Subject|4|||
33386234|NCT00716144|62765153|FG001|Overall Study|Withdrawal by Subject|2|||
33386235|NCT00716144|62765154|FG002|Overall Study|Withdrawal by Subject|6|||
33386236|NCT00716144|62765155|FG003|Overall Study|Withdrawal by Subject|6|||
33386237|NCT00716144|62765152|FG000|Overall Study|Lost to Follow-up|2|||
33386238|NCT00716144|62765153|FG001|Overall Study|Lost to Follow-up|2|||
33386239|NCT00716144|62765154|FG002|Overall Study|Lost to Follow-up|1|||
33386240|NCT00716144|62765155|FG003|Overall Study|Lost to Follow-up|2|||
33489249|NCT02759692|62867449|FG001|Period 1|No longer meets eligibility criteria.|0|||
33489250|NCT02759692|62867448|FG000|Period 1|Miss-Randomized|1|||
33489251|NCT02759692|62867449|FG001|Period 1|Miss-Randomized|1|||
33489252|NCT02759692|62867448|FG000|Period 2|Lost to Follow-up|1|||
33489253|NCT02759692|62867449|FG001|Period 2|Lost to Follow-up|0|||
33489254|NCT02759692|62867448|FG000|Period 2|Test article no longer available|0|||
33489255|NCT02759692|62867449|FG001|Period 2|Test article no longer available|1|||
33489256|NCT03586167|62867457|FG000|Overall Study|Other|1|||
33489257|NCT03586167|62867458|FG001|Overall Study|Other|0|||
33489258|NCT02762578|62867466|FG000|Overall Study|Adverse Event|1|||
33489259|NCT02762578|62867467|FG001|Overall Study|Adverse Event|6|||
33489260|NCT02762578|62867466|FG000|Overall Study|Protocol Violation|4|||
33489261|NCT02762578|62867467|FG001|Overall Study|Protocol Violation|2|||
33489262|NCT02762578|62867466|FG000|Overall Study|Withdrawal by Subject|4|||
33489263|NCT02762578|62867467|FG001|Overall Study|Withdrawal by Subject|2|||
33489264|NCT02762578|62867466|FG000|Overall Study|Unclassified|6|||
33489265|NCT02762578|62867467|FG001|Overall Study|Unclassified|0|||
33489266|NCT03514641|62867477|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
33489267|NCT03514641|62867478|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
33489268|NCT03514641|62867479|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
33386241|NCT00716144|62765152|FG000|Overall Study|Adverse Event|0|||
33489269|NCT03514641|62867480|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
33489270|NCT03514641|62867477|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
33489271|NCT03514641|62867478|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
33489272|NCT03514641|62867479|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
33489273|NCT03514641|62867480|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
33489274|NCT03514641|62867477|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
33489275|NCT03514641|62867478|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
33489276|NCT03514641|62867479|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
33489277|NCT03514641|62867480|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
33489278|NCT03514641|62867477|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
33489279|NCT03514641|62867478|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
33489280|NCT03514641|62867479|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
33489281|NCT03514641|62867480|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
33489282|NCT03514641|62867477|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
33489283|NCT03514641|62867478|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
33489284|NCT03514641|62867479|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
33386242|NCT00716144|62765153|FG001|Overall Study|Adverse Event|0|||
33386243|NCT00716144|62765154|FG002|Overall Study|Adverse Event|0|||
33386244|NCT00716144|62765155|FG003|Overall Study|Adverse Event|2|||
33386245|NCT00716144|62765152|FG000|Overall Study|Non-compliance|1|||
33489285|NCT03514641|62867480|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
33489286|NCT03514641|62867477|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
33489287|NCT03514641|62867478|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
33489288|NCT03514641|62867479|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
33489289|NCT03514641|62867480|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
33386246|NCT00716144|62765153|FG001|Overall Study|Non-compliance|0|||
33386247|NCT00716144|62765154|FG002|Overall Study|Non-compliance|0|||
33386248|NCT00716144|62765155|FG003|Overall Study|Non-compliance|0|||
33386249|NCT00716144|62765152|FG000|Overall Study|Protocol Violation|2|||
33386250|NCT00716144|62765153|FG001|Overall Study|Protocol Violation|0|||
33386251|NCT00716144|62765154|FG002|Overall Study|Protocol Violation|1|||
33386252|NCT00716144|62765155|FG003|Overall Study|Protocol Violation|0|||
33386253|NCT00716144|62765152|FG000|Overall Study|Physician Decision|0|||
33386254|NCT00716144|62765153|FG001|Overall Study|Physician Decision|1|||
33386255|NCT00716144|62765154|FG002|Overall Study|Physician Decision|2|||
33386256|NCT00716144|62765155|FG003|Overall Study|Physician Decision|2|||
33386257|NCT00716144|62765152|FG000|Overall Study|Intercurrent illness|0|||
33386258|NCT00716144|62765153|FG001|Overall Study|Intercurrent illness|0|||
33386259|NCT00716144|62765154|FG002|Overall Study|Intercurrent illness|1|||
33489290|NCT03514641|62867477|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
33489291|NCT03514641|62867478|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
33489292|NCT03514641|62867479|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
33489293|NCT03514641|62867480|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
33489294|NCT03514641|62867477|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
33489295|NCT03514641|62867478|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
33489296|NCT03514641|62867479|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
33489297|NCT03514641|62867480|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
33489298|NCT03514641|62867477|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
33489299|NCT03514641|62867478|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
33489300|NCT03514641|62867479|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
33489301|NCT03514641|62867480|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
33489302|NCT03514641|62867477|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
33489303|NCT03514641|62867478|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
33489304|NCT03514641|62867479|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
33489305|NCT03514641|62867480|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
33489306|NCT03514641|62867477|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
33489307|NCT03514641|62867478|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
33489308|NCT03514641|62867479|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
33489309|NCT03514641|62867480|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
33489310|NCT03514641|62867477|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
33489311|NCT03514641|62867478|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
33489312|NCT03514641|62867479|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
33489313|NCT03514641|62867480|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
33489314|NCT00100828|62867492|FG000|Overall Study|Physician Decision|6|||
33489315|NCT00100048|62867501|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
33489316|NCT00100048|62867502|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
33489317|NCT00100048|62867503|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
33489318|NCT00100048|62867504|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
33489319|NCT00100048|62867505|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
33489320|NCT00100048|62867506|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
33489321|NCT00100048|62867501|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
33489322|NCT00100048|62867502|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
33489323|NCT00100048|62867503|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
33489324|NCT00100048|62867504|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
33489325|NCT00100048|62867505|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
33489326|NCT00100048|62867506|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
33489327|NCT00100048|62867501|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
33489328|NCT00100048|62867502|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
33489329|NCT00100048|62867503|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
33489330|NCT00100048|62867504|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
33662623|NCT01587703|63093235|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
33386260|NCT00716144|62765155|FG003|Overall Study|Intercurrent illness|0|||
33386261|NCT00716144|62765152|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
33386262|NCT00716144|62765153|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
33386263|NCT00716144|62765154|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
33386264|NCT00716144|62765155|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
33386265|NCT00716144|62765152|FG000|Overall Study|Adverse event: left foot pain|0|||
33386266|NCT00716144|62765153|FG001|Overall Study|Adverse event: left foot pain|1|||
33386267|NCT00716144|62765154|FG002|Overall Study|Adverse event: left foot pain|0|||
33386268|NCT00716144|62765155|FG003|Overall Study|Adverse event: left foot pain|0|||
33386269|NCT00716144|62765152|FG000|Overall Study|Clinical Depression|0|||
33386270|NCT00716144|62765153|FG001|Overall Study|Clinical Depression|1|||
33386271|NCT00716144|62765154|FG002|Overall Study|Clinical Depression|0|||
33489331|NCT00100048|62867505|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
33489332|NCT00100048|62867506|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
33489333|NCT00100048|62867501|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
33489334|NCT00100048|62867502|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
33386272|NCT00716144|62765155|FG003|Overall Study|Clinical Depression|0|||
33386273|NCT00576381|62765165|FG000|Overall Study|Reoperation|3|||
33386274|NCT00576381|62765165|FG000|Overall Study|Adverse Event|4|||
33386275|NCT00684567|62765169|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
33386276|NCT00684567|62765169|FG000|Monotherapy Period|Adverse Event|2|||
33386277|NCT00684567|62765169|FG000|Monotherapy Period|Death|1|||
33386278|NCT00684567|62765169|FG000|Monotherapy Period|Progression of primary disease|11|||
33386279|NCT00684411|62765173|FG000|Overall Study|New Primary Cancer|1|||
33386280|NCT00684411|62765173|FG000|Overall Study|Disease Progression|10|||
33386281|NCT00684411|62765173|FG000|Overall Study|Adverse Event|1|||
33386282|NCT00686829|62765177|FG000|Overall Study|Adverse Event|5|||
33386283|NCT00686829|62765177|FG000|Overall Study|Lack of Efficacy|6|||
33386284|NCT00686829|62765177|FG000|Overall Study|Lost to Follow-up|4|||
33386285|NCT00686829|62765177|FG000|Overall Study|Withdrawal by Subject|14|||
33386286|NCT00686829|62765177|FG000|Overall Study|Protocol Violation|3|||
33386287|NCT00686829|62765177|FG000|Overall Study|Sponsor discontinued VCV|47|||
33386288|NCT00687297|62765183|FG000|Randomization|Withdrawal by Subject|2|||
33386289|NCT00687297|62765184|FG001|Randomization|Withdrawal by Subject|0|||
33386290|NCT00687297|62765183|FG000|Randomization|Withdrew before treatment, ineligible|1|||
33386291|NCT00687297|62765184|FG001|Randomization|Withdrew before treatment, ineligible|1|||
33386292|NCT00687297|62765183|FG000|Induction|Withdrawal by Subject|4|||
33386293|NCT00687297|62765184|FG001|Induction|Withdrawal by Subject|4|||
33386294|NCT00687297|62765183|FG000|Induction|Adverse Event|16|||
33386295|NCT00687297|62765184|FG001|Induction|Adverse Event|15|||
33386296|NCT00687297|62765183|FG000|Induction|Death|7|||
33386297|NCT00687297|62765184|FG001|Induction|Death|11|||
33386298|NCT00687297|62765183|FG000|Induction|Lack of Efficacy|17|||
33386299|NCT00687297|62765184|FG001|Induction|Lack of Efficacy|21|||
33386300|NCT00687297|62765183|FG000|Induction|Ineligible|0|||
33386301|NCT00687297|62765184|FG001|Induction|Ineligible|1|||
33386302|NCT00687297|62765183|FG000|Induction|Patient Noncompliance|1|||
33386303|NCT00687297|62765184|FG001|Induction|Patient Noncompliance|0|||
33386304|NCT00687297|62765183|FG000|Induction|Physician Decision|0|||
33386305|NCT00687297|62765184|FG001|Induction|Physician Decision|2|||
33386306|NCT00687297|62765183|FG000|Induction|Other|0|||
33386307|NCT00687297|62765184|FG001|Induction|Other|1|||
33386308|NCT00684177|62765194|FG000|Overall Study|Adverse Event|4|||
33386309|NCT00684177|62765195|FG001|Overall Study|Adverse Event|3|||
33386310|NCT00684177|62765194|FG000|Overall Study|Lack of Efficacy|10|||
33386311|NCT00684177|62765195|FG001|Overall Study|Lack of Efficacy|15|||
33386312|NCT00684177|62765194|FG000|Overall Study|Protocol Violation|1|||
33386313|NCT00684177|62765195|FG001|Overall Study|Protocol Violation|0|||
33386314|NCT00684177|62765194|FG000|Overall Study|Lost to Follow-up|2|||
33386315|NCT00684177|62765195|FG001|Overall Study|Lost to Follow-up|1|||
33386316|NCT00684177|62765194|FG000|Overall Study|Physician Decision|2|||
33386317|NCT00684177|62765195|FG001|Overall Study|Physician Decision|0|||
33386318|NCT00684177|62765194|FG000|Overall Study|Withdrawal by Subject|1|||
33386319|NCT00684177|62765195|FG001|Overall Study|Withdrawal by Subject|2|||
33386320|NCT00684177|62765194|FG000|Overall Study|Other|1|||
33386321|NCT00684177|62765195|FG001|Overall Study|Other|2|||
33386322|NCT00684021|62765205|FG000|Overall Study|MRI Contraindicated|1|||
33386323|NCT00684021|62765206|FG001|Overall Study|MRI Contraindicated|1|||
33386324|NCT00684021|62765207|FG002|Overall Study|MRI Contraindicated|1|||
33386325|NCT00684021|62765208|FG003|Overall Study|MRI Contraindicated|0|||
33386326|NCT00684021|62765205|FG000|Overall Study|MRI not performed|0|||
33386327|NCT00684021|62765206|FG001|Overall Study|MRI not performed|1|||
33386328|NCT00684021|62765207|FG002|Overall Study|MRI not performed|1|||
33297794|NCT01097707|62673973|FG004|Overall Study|Sponsor Decision|36|||
33297795|NCT01097707|62673969|FG000|Overall Study|Withdrawal by Subject|3|||
33297796|NCT01097707|62673970|FG001|Overall Study|Withdrawal by Subject|6|||
33297797|NCT01097707|62673971|FG002|Overall Study|Withdrawal by Subject|1|||
33297798|NCT01097707|62673972|FG003|Overall Study|Withdrawal by Subject|4|||
33297799|NCT01097707|62673973|FG004|Overall Study|Withdrawal by Subject|3|||
33297800|NCT01097707|62673969|FG000|Overall Study|Reason unknown|0|||
33297801|NCT01097707|62673970|FG001|Overall Study|Reason unknown|0|||
33386329|NCT00684021|62765208|FG003|Overall Study|MRI not performed|2|||
33386330|NCT00684021|62765205|FG000|Overall Study|Death|1|||
33386331|NCT00684021|62765206|FG001|Overall Study|Death|0|||
33386332|NCT00684021|62765207|FG002|Overall Study|Death|0|||
33386333|NCT00684021|62765208|FG003|Overall Study|Death|0|||
33386334|NCT00576303|62765218|FG000|Dose Titration Period|Early withdrawal|17|||
33386335|NCT00576303|62765218|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
33386336|NCT00576303|62765218|FG000|Long Term Safety Period|Early withdrawal|16|||
33297802|NCT01097707|62673971|FG002|Overall Study|Reason unknown|0|||
33386337|NCT00686517|62765225|FG000|Treatment|Serious Adverse Event|1|||
33386338|NCT00686517|62765226|FG001|Treatment|Serious Adverse Event|2|||
33386339|NCT00686517|62765227|FG002|Treatment|Serious Adverse Event|1|||
33386340|NCT00686517|62765225|FG000|Treatment|Adverse Event|2|||
33386341|NCT00686517|62765226|FG001|Treatment|Adverse Event|0|||
33386342|NCT00686517|62765227|FG002|Treatment|Adverse Event|0|||
33386343|NCT00686517|62765225|FG000|Treatment|Poor Protocol Compliance|1|||
33297803|NCT01097707|62673972|FG003|Overall Study|Reason unknown|0|||
33297804|NCT01097707|62673973|FG004|Overall Study|Reason unknown|1|||
33297805|NCT01326104|62673987|FG000|Overall Study|progressed prior to vaccine|0|||
33297806|NCT01326104|62673988|FG001|Overall Study|progressed prior to vaccine|2|||
33297807|NCT01326104|62673987|FG000|Overall Study|unable to make vaccine|0|||
33297808|NCT01326104|62673988|FG001|Overall Study|unable to make vaccine|2|||
33297809|NCT01326026|62673996|FG000|Overall Study|Adverse Event|4|||
33297810|NCT01326026|62673997|FG001|Overall Study|Adverse Event|3|||
33297811|NCT01326026|62673996|FG000|Overall Study|Withdrawal Criteria|5|||
33297812|NCT01326026|62673997|FG001|Overall Study|Withdrawal Criteria|7|||
33297813|NCT01326026|62673996|FG000|Overall Study|Other|3|||
33297814|NCT01326026|62673997|FG001|Overall Study|Other|3|||
33297815|NCT01097629|62674006|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
33386344|NCT00686517|62765226|FG001|Treatment|Poor Protocol Compliance|0|||
33386345|NCT00686517|62765227|FG002|Treatment|Poor Protocol Compliance|0|||
33386346|NCT00686517|62765225|FG000|Treatment|Protocol Violation|2|||
33386347|NCT00686517|62765226|FG001|Treatment|Protocol Violation|1|||
33386348|NCT00686517|62765227|FG002|Treatment|Protocol Violation|0|||
33386349|NCT00686205|62765237|FG000|Overall Study|Protocol Violation|127|||
33386350|NCT00686205|62765238|FG001|Overall Study|Protocol Violation|0|||
33386351|NCT00686205|62765237|FG000|Overall Study|Withdrawal by Subject|2|||
33386352|NCT00686205|62765238|FG001|Overall Study|Withdrawal by Subject|0|||
33386353|NCT00686205|62765237|FG000|Overall Study|Specimen handling procedure altered|5878|||
33386354|NCT00686205|62765238|FG001|Overall Study|Specimen handling procedure altered|0|||
33386355|NCT00686205|62765237|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
33386356|NCT00686205|62765238|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
33386357|NCT00571701|62765246|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
33386358|NCT00571701|62765247|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
33386359|NCT00571701|62765246|FG000|First Intervention 12 Months|Death|1|||
33386360|NCT00571701|62765247|FG001|First Intervention 12 Months|Death|0|||
33386361|NCT00571701|62765246|FG000|Second Intervention 12 Months|Adverse Event|0|||
33386362|NCT00571701|62765247|FG001|Second Intervention 12 Months|Adverse Event|1|||
33386363|NCT00571701|62765246|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
33386364|NCT00571701|62765247|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
33386365|NCT00686127|62765273|FG000|Overall Study|Withdrawal by Subject|14|||
33386366|NCT00686127|62765274|FG001|Overall Study|Withdrawal by Subject|6|||
33386367|NCT00718718|62765287|FG000|Prior to Week 12|Adverse Event|0|||
33386368|NCT00718718|62765288|FG001|Prior to Week 12|Adverse Event|0|||
33386369|NCT00718718|62765289|FG002|Prior to Week 12|Adverse Event|0|||
33386370|NCT00718718|62765290|FG003|Prior to Week 12|Adverse Event|0|||
33386371|NCT00718718|62765291|FG004|Prior to Week 12|Adverse Event|0|||
33386372|NCT00718718|62765292|FG005|Prior to Week 12|Adverse Event|0|||
33386373|NCT00718718|62765293|FG006|Prior to Week 12|Adverse Event|0|||
33386374|NCT00718718|62765294|FG007|Prior to Week 12|Adverse Event|1|||
33386375|NCT00718718|62765295|FG008|Prior to Week 12|Adverse Event|1|||
33386376|NCT00718718|62765296|FG009|Prior to Week 12|Adverse Event|0|||
33297816|NCT01097629|62674007|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
33297817|NCT01097629|62674008|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
33386377|NCT00718718|62765287|FG000|Prior to Week 12|Withdrawal by Subject|0|||
33386378|NCT00718718|62765288|FG001|Prior to Week 12|Withdrawal by Subject|0|||
33386379|NCT00718718|62765289|FG002|Prior to Week 12|Withdrawal by Subject|0|||
33386380|NCT00718718|62765290|FG003|Prior to Week 12|Withdrawal by Subject|0|||
33386381|NCT00718718|62765291|FG004|Prior to Week 12|Withdrawal by Subject|3|||
33386382|NCT00718718|62765292|FG005|Prior to Week 12|Withdrawal by Subject|0|||
33386383|NCT00718718|62765293|FG006|Prior to Week 12|Withdrawal by Subject|1|||
33386384|NCT00718718|62765294|FG007|Prior to Week 12|Withdrawal by Subject|1|||
33297818|NCT01097629|62674009|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33297819|NCT01097629|62674010|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33297820|NCT01097629|62674011|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33297821|NCT01097629|62674012|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33297822|NCT01097629|62674013|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33297823|NCT01097629|62674006|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
33297824|NCT01097629|62674007|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
33386385|NCT00718718|62765295|FG008|Prior to Week 12|Withdrawal by Subject|1|||
33386386|NCT00718718|62765296|FG009|Prior to Week 12|Withdrawal by Subject|0|||
33386387|NCT00718718|62765287|FG000|Prior to Week 12|Other|1|||
33386388|NCT00718718|62765288|FG001|Prior to Week 12|Other|0|||
33386389|NCT00718718|62765289|FG002|Prior to Week 12|Other|1|||
33386390|NCT00718718|62765290|FG003|Prior to Week 12|Other|0|||
33386391|NCT00718718|62765291|FG004|Prior to Week 12|Other|0|||
33386392|NCT00718718|62765292|FG005|Prior to Week 12|Other|0|||
33386393|NCT00718718|62765293|FG006|Prior to Week 12|Other|0|||
33386394|NCT00718718|62765294|FG007|Prior to Week 12|Other|0|||
33386395|NCT00718718|62765295|FG008|Prior to Week 12|Other|0|||
33386396|NCT00718718|62765296|FG009|Prior to Week 12|Other|0|||
33386397|NCT00718718|62765287|FG000|Week 12 to End of Study|Adverse Event|0|||
33386398|NCT00718718|62765288|FG001|Week 12 to End of Study|Adverse Event|0|||
33386399|NCT00718718|62765289|FG002|Week 12 to End of Study|Adverse Event|0|||
33386400|NCT00718718|62765290|FG003|Week 12 to End of Study|Adverse Event|0|||
33386401|NCT00718718|62765291|FG004|Week 12 to End of Study|Adverse Event|0|||
33386402|NCT00718718|62765292|FG005|Week 12 to End of Study|Adverse Event|0|||
33386403|NCT00718718|62765293|FG006|Week 12 to End of Study|Adverse Event|0|||
33386404|NCT00718718|62765294|FG007|Week 12 to End of Study|Adverse Event|1|||
33386405|NCT00718718|62765295|FG008|Week 12 to End of Study|Adverse Event|0|||
33386406|NCT00718718|62765296|FG009|Week 12 to End of Study|Adverse Event|0|||
33386407|NCT00718718|62765287|FG000|Week 12 to End of Study|Death|0|||
33386408|NCT00718718|62765288|FG001|Week 12 to End of Study|Death|0|||
33386409|NCT00718718|62765289|FG002|Week 12 to End of Study|Death|0|||
33386410|NCT00718718|62765290|FG003|Week 12 to End of Study|Death|0|||
33386411|NCT00718718|62765291|FG004|Week 12 to End of Study|Death|0|||
33297825|NCT01097629|62674008|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
33297826|NCT01097629|62674009|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33297827|NCT01097629|62674010|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33297828|NCT01097629|62674011|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33297829|NCT01097629|62674012|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33297830|NCT01097629|62674013|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33297831|NCT01097629|62674006|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
33297832|NCT01097629|62674007|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
33297833|NCT01097629|62674008|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
33297834|NCT01097629|62674009|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33297835|NCT01097629|62674010|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33297836|NCT01097629|62674011|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33386412|NCT00718718|62765292|FG005|Week 12 to End of Study|Death|1|||
33386413|NCT00718718|62765293|FG006|Week 12 to End of Study|Death|0|||
33386414|NCT00718718|62765294|FG007|Week 12 to End of Study|Death|0|||
33386415|NCT00718718|62765295|FG008|Week 12 to End of Study|Death|0|||
33386416|NCT00718718|62765296|FG009|Week 12 to End of Study|Death|0|||
33386417|NCT00718718|62765287|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
33386418|NCT00718718|62765288|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
33386419|NCT00718718|62765289|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
33386420|NCT00718718|62765290|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
33386421|NCT00718718|62765291|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
33386422|NCT00718718|62765292|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
33386423|NCT00718718|62765293|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
33386424|NCT00718718|62765294|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
33386425|NCT00718718|62765295|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
33386426|NCT00718718|62765296|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
33386427|NCT00718718|62765287|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
33386428|NCT00718718|62765288|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
33386429|NCT00718718|62765289|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
33297837|NCT01097629|62674012|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33297838|NCT01097629|62674013|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33297839|NCT01097629|62674006|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
33297840|NCT01097629|62674007|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
33297841|NCT01097629|62674008|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
33297842|NCT01097629|62674009|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33297843|NCT01097629|62674010|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33297844|NCT01097629|62674011|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33297845|NCT01097629|62674012|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33297846|NCT01097629|62674013|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33386430|NCT00718718|62765290|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
33386431|NCT00718718|62765291|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
33386432|NCT00718718|62765292|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
33386433|NCT00718718|62765293|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
33386434|NCT00718718|62765294|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
33386435|NCT00718718|62765295|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
33386436|NCT00718718|62765296|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
33386437|NCT00718718|62765287|FG000|Week 12 to End of Study|Other|0|||
33386438|NCT00718718|62765288|FG001|Week 12 to End of Study|Other|1|||
33386439|NCT00718718|62765289|FG002|Week 12 to End of Study|Other|0|||
33386440|NCT00718718|62765290|FG003|Week 12 to End of Study|Other|1|||
33386441|NCT00718718|62765291|FG004|Week 12 to End of Study|Other|0|||
33386442|NCT00718718|62765292|FG005|Week 12 to End of Study|Other|0|||
33386443|NCT00718718|62765293|FG006|Week 12 to End of Study|Other|1|||
33386444|NCT00718718|62765294|FG007|Week 12 to End of Study|Other|0|||
33386445|NCT00718718|62765295|FG008|Week 12 to End of Study|Other|0|||
33386446|NCT00718718|62765296|FG009|Week 12 to End of Study|Other|0|||
33386447|NCT00683787|62765325|FG000|Overall Study|Progression|3|||
33386448|NCT00683787|62765326|FG001|Overall Study|Progression|3|||
33386449|NCT00683787|62765327|FG002|Overall Study|Progression|0|||
33386450|NCT00683787|62765325|FG000|Overall Study|Adverse Event|0|||
33386451|NCT00683787|62765326|FG001|Overall Study|Adverse Event|0|||
33386452|NCT00683787|62765327|FG002|Overall Study|Adverse Event|2|||
33386453|NCT00723008|62765337|FG000|Enrollment|Lost to Follow-up|1|||
33386454|NCT00723008|62765338|FG001|Enrollment|Lost to Follow-up|0|||
33386455|NCT00723008|62765337|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
33386456|NCT00723008|62765338|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
33386457|NCT00723008|62765337|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
33386458|NCT00723008|62765338|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
33386459|NCT00723008|62765337|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
33386460|NCT00723008|62765338|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
33386461|NCT00723008|62765337|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
33386462|NCT00723008|62765338|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
33386463|NCT00723008|62765337|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
33386464|NCT00723008|62765338|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
33386465|NCT00718640|62765352|FG000|Overall Study|Adverse Event|4|||
33386466|NCT00718640|62765352|FG000|Overall Study|Death|1|||
33386467|NCT00718640|62765352|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
33386468|NCT00715910|62765360|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
33386469|NCT00715910|62765361|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
33386470|NCT00715910|62765362|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
33386471|NCT00715910|62765363|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
33386472|NCT00715910|62765364|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
33386473|NCT00715910|62765365|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
33386474|NCT00715910|62765360|FG000|Booster and ESFU Phase|Other|0|||
33386475|NCT00715910|62765361|FG001|Booster and ESFU Phase|Other|0|||
33386476|NCT00715910|62765362|FG002|Booster and ESFU Phase|Other|0|||
33386477|NCT00715910|62765363|FG003|Booster and ESFU Phase|Other|5|||
33386478|NCT00715910|62765364|FG004|Booster and ESFU Phase|Other|1|||
33386479|NCT00715910|62765365|FG005|Booster and ESFU Phase|Other|0|||
33386480|NCT00715676|62765384|FG000|Overall Study|Adverse Event|3|||
33386481|NCT00715676|62765385|FG001|Overall Study|Adverse Event|5|||
33386482|NCT00715676|62765386|FG002|Overall Study|Adverse Event|21|||
33386483|NCT00715676|62765384|FG000|Overall Study|Withdrawal by Subject|1|||
33386484|NCT00715676|62765385|FG001|Overall Study|Withdrawal by Subject|3|||
33386485|NCT00715676|62765386|FG002|Overall Study|Withdrawal by Subject|8|||
33386486|NCT00715676|62765384|FG000|Overall Study|Lost to Follow-up|1|||
33386487|NCT00715676|62765385|FG001|Overall Study|Lost to Follow-up|2|||
33386488|NCT00715676|62765386|FG002|Overall Study|Lost to Follow-up|1|||
33386489|NCT00715676|62765384|FG000|Overall Study|Terminated by Sponsor|1|||
33386490|NCT00715676|62765385|FG001|Overall Study|Terminated by Sponsor|0|||
33386491|NCT00715676|62765386|FG002|Overall Study|Terminated by Sponsor|0|||
33386492|NCT00715676|62765384|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
33386493|NCT00715676|62765385|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
33386494|NCT00715676|62765386|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
33386495|NCT00715676|62765384|FG000|Overall Study|Use of Exclusionary Medication|0|||
33386496|NCT00715676|62765385|FG001|Overall Study|Use of Exclusionary Medication|0|||
33386497|NCT00715676|62765386|FG002|Overall Study|Use of Exclusionary Medication|1|||
33386498|NCT00715676|62765384|FG000|Overall Study|Elevated Blood Glucose|0|||
33386499|NCT00715676|62765385|FG001|Overall Study|Elevated Blood Glucose|1|||
33386500|NCT00715676|62765386|FG002|Overall Study|Elevated Blood Glucose|0|||
33386501|NCT00718328|62765396|FG000|Overall Study|Lost to Follow-up|1|||
33386502|NCT00718328|62765397|FG001|Overall Study|Lost to Follow-up|0|||
33386503|NCT00715520|62765406|FG000|Overall Study|Screen failure|8|||
33386504|NCT00715520|62765407|FG001|Overall Study|Screen failure|1|||
33386505|NCT00715520|62765408|FG002|Overall Study|Screen failure|1|||
33297847|NCT01097629|62674006|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
33297848|NCT01097629|62674007|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
33297849|NCT01097629|62674008|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
33297850|NCT01097629|62674009|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33297851|NCT01097629|62674010|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33297852|NCT01097629|62674011|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33386506|NCT00715520|62765406|FG000|Overall Study|Withdrawal by Subject|2|||
33556758|NCT02341456|62949593|FG000|Overall Study|Withdrawal by Subject|0|||
33386507|NCT00715520|62765407|FG001|Overall Study|Withdrawal by Subject|0|||
33386508|NCT00715520|62765408|FG002|Overall Study|Withdrawal by Subject|1|||
33386509|NCT00790205|62765418|FG000|Overall Study|Lost to Follow-up|61|||
33386510|NCT00790205|62765419|FG001|Overall Study|Lost to Follow-up|71|||
33386511|NCT00790205|62765418|FG000|Overall Study|Withdrawal by Subject|299|||
33386512|NCT00790205|62765419|FG001|Overall Study|Withdrawal by Subject|363|||
33386513|NCT00715208|62765427|FG000|Overall Study|Withdrawal by Subject|1|||
33386514|NCT00715208|62765428|FG001|Overall Study|Withdrawal by Subject|1|||
33386515|NCT00715208|62765427|FG000|Overall Study|Adverse Event|0|||
33297853|NCT01097629|62674012|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33297854|NCT01097629|62674013|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33297855|NCT01097629|62674006|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
33297856|NCT01097629|62674007|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
33297857|NCT01097629|62674008|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33297858|NCT01097629|62674009|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33297859|NCT01097629|62674010|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33297860|NCT01097629|62674011|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33386516|NCT00715208|62765428|FG001|Overall Study|Adverse Event|6|||
33386517|NCT00715208|62765427|FG000|Overall Study|Lack of Efficacy|0|||
33386518|NCT00715208|62765428|FG001|Overall Study|Lack of Efficacy|2|||
33386519|NCT00775463|62765436|FG000|Overall Study|Withdrawal by Subject|0|||
33386520|NCT00775463|62765437|FG001|Overall Study|Withdrawal by Subject|1|||
33386521|NCT00775463|62765436|FG000|Overall Study|Adverse Event|7|||
33386522|NCT00775463|62765437|FG001|Overall Study|Adverse Event|9|||
33386523|NCT00775463|62765436|FG000|Overall Study|Protocol Violation|2|||
33386524|NCT00775463|62765437|FG001|Overall Study|Protocol Violation|2|||
33386525|NCT00775463|62765436|FG000|Overall Study|Lost to Follow-up|1|||
33386526|NCT00775463|62765437|FG001|Overall Study|Lost to Follow-up|0|||
33386527|NCT00775463|62765436|FG000|Overall Study|Lack of Efficacy|1|||
33386528|NCT00775463|62765437|FG001|Overall Study|Lack of Efficacy|1|||
33386529|NCT00587795|62765452|FG000|Overall Study|Withdrawal by Subject|1|||
33386530|NCT00587795|62765453|FG001|Overall Study|Withdrawal by Subject|0|||
33386531|NCT00587639|62765459|FG000|Overall Study|Withdrawal by Subject|1|||
33386532|NCT00774995|62765467|FG000|Overall Study|Protocol Violation|0|||
33386533|NCT00774995|62765468|FG001|Overall Study|Protocol Violation|0|||
33386534|NCT00774995|62765469|FG002|Overall Study|Protocol Violation|1|||
33386535|NCT00774995|62765470|FG003|Overall Study|Protocol Violation|0|||
33386536|NCT00713648|62765480|FG000|Overall Study|Adverse Event|1|||
33386537|NCT00713648|62765480|FG000|Overall Study|Unclassified|2|||
33386538|NCT00713648|62765480|FG000|Overall Study|According to Protocol|2|||
33386539|NCT00713648|62765480|FG000|Overall Study|Development of antibodies|3|||
33386540|NCT00768053|62765484|FG000|Overall Study|Adverse Event|10|||
33386541|NCT00768053|62765484|FG000|Overall Study|Lost to Follow-up|1|||
33386542|NCT00683475|62765490|FG000|Overall Study|Withdrawal by Subject|1|||
33386543|NCT00683475|62765491|FG001|Overall Study|Withdrawal by Subject|0|||
33386544|NCT00683475|62765490|FG000|Overall Study|Never Treated: Adverse Event|2|||
33386545|NCT00683475|62765491|FG001|Overall Study|Never Treated: Adverse Event|3|||
33386546|NCT00683475|62765490|FG000|Overall Study|Never Treated: Progressive Disease|1|||
33386547|NCT00683475|62765491|FG001|Overall Study|Never Treated: Progressive Disease|0|||
33386548|NCT00685035|62765498|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
33386549|NCT00685035|62765499|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
33386550|NCT00773747|62765525|FG000|Overall Study|Lack of Efficacy|112|||
33386551|NCT00773747|62765526|FG001|Overall Study|Lack of Efficacy|144|||
33297861|NCT01097629|62674012|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33297862|NCT01097629|62674013|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33297863|NCT01097629|62674006|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
33297864|NCT01097629|62674007|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
33297865|NCT01097629|62674008|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
33297866|NCT01097629|62674009|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33297867|NCT01097629|62674010|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33297868|NCT01097629|62674011|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33297869|NCT01097629|62674012|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33297870|NCT01097629|62674013|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33297871|NCT01097629|62674006|FG000|DB RO Phase|Withdrawal by Subject|0|||
33297872|NCT01097629|62674007|FG001|DB RO Phase|Withdrawal by Subject|0|||
33297873|NCT01097629|62674008|FG002|DB RO Phase|Withdrawal by Subject|0|||
33297874|NCT01097629|62674009|FG003|DB RO Phase|Withdrawal by Subject|0|||
33386552|NCT00773747|62765525|FG000|Overall Study|Physician Decision|26|||
33386553|NCT00773747|62765526|FG001|Overall Study|Physician Decision|18|||
33386554|NCT00773747|62765525|FG000|Overall Study|Lost to Follow-up|0|||
33386555|NCT00773747|62765526|FG001|Overall Study|Lost to Follow-up|1|||
33297875|NCT01097629|62674010|FG004|DB RO Phase|Withdrawal by Subject|0|||
33386556|NCT00773747|62765525|FG000|Overall Study|Protocol Violation|2|||
33386557|NCT00773747|62765526|FG001|Overall Study|Protocol Violation|2|||
33386558|NCT00773747|62765525|FG000|Overall Study|Withdrawal by Subject|89|||
33386559|NCT00773747|62765526|FG001|Overall Study|Withdrawal by Subject|61|||
33386560|NCT00773747|62765525|FG000|Overall Study|Adverse Event|61|||
33386561|NCT00773747|62765526|FG001|Overall Study|Adverse Event|62|||
33386562|NCT00773747|62765525|FG000|Overall Study|Death|5|||
33386563|NCT00773747|62765526|FG001|Overall Study|Death|8|||
33386564|NCT00773747|62765525|FG000|Overall Study|Not Treated|2|||
33386565|NCT00773747|62765526|FG001|Overall Study|Not Treated|0|||
33386566|NCT00784277|62765536|FG000|IR Treatment|Adverse Event|4|||
33386567|NCT00784277|62765537|FG001|IR Treatment|Adverse Event|8|||
33386568|NCT00784277|62765538|FG002|IR Treatment|Adverse Event|19|||
33386569|NCT00784277|62765539|FG003|IR Treatment|Adverse Event|35|||
33386570|NCT00784277|62765540|FG004|IR Treatment|Adverse Event|0|||
33386571|NCT00784277|62765541|FG005|IR Treatment|Adverse Event|0|||
33386572|NCT00784277|62765542|FG006|IR Treatment|Adverse Event|0|||
33386573|NCT00784277|62765536|FG000|IR Treatment|Lack of Efficacy|4|||
33386574|NCT00784277|62765537|FG001|IR Treatment|Lack of Efficacy|4|||
33386575|NCT00784277|62765538|FG002|IR Treatment|Lack of Efficacy|1|||
33386576|NCT00784277|62765539|FG003|IR Treatment|Lack of Efficacy|0|||
33386577|NCT00784277|62765540|FG004|IR Treatment|Lack of Efficacy|0|||
33386578|NCT00784277|62765541|FG005|IR Treatment|Lack of Efficacy|0|||
33386579|NCT00784277|62765542|FG006|IR Treatment|Lack of Efficacy|0|||
33386580|NCT00784277|62765536|FG000|IR Treatment|Lost to Follow-up|1|||
33386581|NCT00784277|62765537|FG001|IR Treatment|Lost to Follow-up|0|||
33386582|NCT00784277|62765538|FG002|IR Treatment|Lost to Follow-up|1|||
33386583|NCT00784277|62765539|FG003|IR Treatment|Lost to Follow-up|0|||
33386584|NCT00784277|62765540|FG004|IR Treatment|Lost to Follow-up|0|||
33386585|NCT00784277|62765541|FG005|IR Treatment|Lost to Follow-up|0|||
33386586|NCT00784277|62765542|FG006|IR Treatment|Lost to Follow-up|0|||
33386587|NCT00784277|62765536|FG000|IR Treatment|Withdrawal by Subject|5|||
33386588|NCT00784277|62765537|FG001|IR Treatment|Withdrawal by Subject|1|||
33386589|NCT00784277|62765538|FG002|IR Treatment|Withdrawal by Subject|4|||
33386590|NCT00784277|62765539|FG003|IR Treatment|Withdrawal by Subject|6|||
33386591|NCT00784277|62765540|FG004|IR Treatment|Withdrawal by Subject|0|||
33386592|NCT00784277|62765541|FG005|IR Treatment|Withdrawal by Subject|0|||
33386593|NCT00784277|62765542|FG006|IR Treatment|Withdrawal by Subject|0|||
33386594|NCT00784277|62765536|FG000|IR Treatment|Resolution Of Pain|0|||
33386595|NCT00784277|62765537|FG001|IR Treatment|Resolution Of Pain|1|||
33386596|NCT00784277|62765538|FG002|IR Treatment|Resolution Of Pain|0|||
33386597|NCT00784277|62765539|FG003|IR Treatment|Resolution Of Pain|0|||
33386598|NCT00784277|62765540|FG004|IR Treatment|Resolution Of Pain|0|||
33297876|NCT01097629|62674011|FG005|DB RO Phase|Withdrawal by Subject|0|||
33297877|NCT01097629|62674012|FG006|DB RO Phase|Withdrawal by Subject|0|||
33297878|NCT01097629|62674013|FG007|DB RO Phase|Withdrawal by Subject|1|||
33386599|NCT00784277|62765541|FG005|IR Treatment|Resolution Of Pain|0|||
33386600|NCT00784277|62765542|FG006|IR Treatment|Resolution Of Pain|0|||
33386601|NCT00784277|62765536|FG000|IR Treatment|Other|2|||
33386602|NCT00784277|62765537|FG001|IR Treatment|Other|3|||
33386603|NCT00784277|62765538|FG002|IR Treatment|Other|3|||
33386604|NCT00784277|62765539|FG003|IR Treatment|Other|2|||
33386605|NCT00784277|62765540|FG004|IR Treatment|Other|0|||
33386606|NCT00784277|62765541|FG005|IR Treatment|Other|0|||
33386607|NCT00784277|62765542|FG006|IR Treatment|Other|0|||
33386608|NCT00784277|62765536|FG000|ER Treatment|Adverse Event|0|||
33386609|NCT00784277|62765537|FG001|ER Treatment|Adverse Event|0|||
33386610|NCT00784277|62765538|FG002|ER Treatment|Adverse Event|0|||
33386611|NCT00784277|62765539|FG003|ER Treatment|Adverse Event|0|||
33386612|NCT00784277|62765540|FG004|ER Treatment|Adverse Event|1|||
33386613|NCT00784277|62765541|FG005|ER Treatment|Adverse Event|7|||
33386614|NCT00784277|62765542|FG006|ER Treatment|Adverse Event|7|||
33386615|NCT00784277|62765536|FG000|ER Treatment|Lack of Efficacy|0|||
33386616|NCT00784277|62765537|FG001|ER Treatment|Lack of Efficacy|0|||
33489335|NCT00100048|62867503|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
33489336|NCT00100048|62867504|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
33489337|NCT00100048|62867505|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
33489338|NCT00100048|62867506|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
33297879|NCT01097629|62674006|FG000|DB RO Phase|Protocol Violation|0|||
33297880|NCT01097629|62674007|FG001|DB RO Phase|Protocol Violation|0|||
33297881|NCT01097629|62674008|FG002|DB RO Phase|Protocol Violation|0|||
33297882|NCT01097629|62674009|FG003|DB RO Phase|Protocol Violation|1|||
33386617|NCT00784277|62765538|FG002|ER Treatment|Lack of Efficacy|0|||
33386618|NCT00784277|62765539|FG003|ER Treatment|Lack of Efficacy|0|||
33386619|NCT00784277|62765540|FG004|ER Treatment|Lack of Efficacy|3|||
33386620|NCT00784277|62765541|FG005|ER Treatment|Lack of Efficacy|4|||
33386621|NCT00784277|62765542|FG006|ER Treatment|Lack of Efficacy|0|||
33489339|NCT00100048|62867501|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
33489340|NCT00100048|62867502|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
33297883|NCT01097629|62674010|FG004|DB RO Phase|Protocol Violation|0|||
33297884|NCT01097629|62674011|FG005|DB RO Phase|Protocol Violation|1|||
33386622|NCT00784277|62765536|FG000|ER Treatment|Lost to Follow-up|0|||
33386623|NCT00784277|62765537|FG001|ER Treatment|Lost to Follow-up|0|||
33386624|NCT00784277|62765538|FG002|ER Treatment|Lost to Follow-up|0|||
33386625|NCT00784277|62765539|FG003|ER Treatment|Lost to Follow-up|0|||
33386626|NCT00784277|62765540|FG004|ER Treatment|Lost to Follow-up|0|||
33386627|NCT00784277|62765541|FG005|ER Treatment|Lost to Follow-up|2|||
33386628|NCT00784277|62765542|FG006|ER Treatment|Lost to Follow-up|0|||
33297885|NCT01097629|62674012|FG006|DB RO Phase|Protocol Violation|1|||
33386629|NCT00784277|62765536|FG000|ER Treatment|Withdrawal by Subject|0|||
33297886|NCT01097629|62674013|FG007|DB RO Phase|Protocol Violation|0|||
33297887|NCT01097629|62674006|FG000|DB RO Phase|Lost to Follow-up|0|||
33297888|NCT01097629|62674007|FG001|DB RO Phase|Lost to Follow-up|0|||
33297889|NCT01097629|62674008|FG002|DB RO Phase|Lost to Follow-up|0|||
33297890|NCT01097629|62674009|FG003|DB RO Phase|Lost to Follow-up|0|||
33297891|NCT01097629|62674010|FG004|DB RO Phase|Lost to Follow-up|0|||
33297892|NCT01097629|62674011|FG005|DB RO Phase|Lost to Follow-up|0|||
33386630|NCT00784277|62765537|FG001|ER Treatment|Withdrawal by Subject|0|||
33386631|NCT00784277|62765538|FG002|ER Treatment|Withdrawal by Subject|0|||
33386632|NCT00784277|62765539|FG003|ER Treatment|Withdrawal by Subject|0|||
33386633|NCT00784277|62765540|FG004|ER Treatment|Withdrawal by Subject|2|||
33386634|NCT00784277|62765541|FG005|ER Treatment|Withdrawal by Subject|5|||
33386635|NCT00784277|62765542|FG006|ER Treatment|Withdrawal by Subject|3|||
33386636|NCT00784277|62765536|FG000|ER Treatment|Study Medication Non-Compliant|0|||
33386637|NCT00784277|62765537|FG001|ER Treatment|Study Medication Non-Compliant|0|||
33386638|NCT00784277|62765538|FG002|ER Treatment|Study Medication Non-Compliant|0|||
33386639|NCT00784277|62765539|FG003|ER Treatment|Study Medication Non-Compliant|0|||
33386640|NCT00784277|62765540|FG004|ER Treatment|Study Medication Non-Compliant|2|||
33386641|NCT00784277|62765541|FG005|ER Treatment|Study Medication Non-Compliant|3|||
33386642|NCT00784277|62765542|FG006|ER Treatment|Study Medication Non-Compliant|3|||
33386643|NCT00784277|62765536|FG000|ER Treatment|Other|0|||
33386644|NCT00784277|62765537|FG001|ER Treatment|Other|0|||
33386645|NCT00784277|62765538|FG002|ER Treatment|Other|0|||
33386646|NCT00784277|62765539|FG003|ER Treatment|Other|0|||
33386647|NCT00784277|62765540|FG004|ER Treatment|Other|1|||
33386648|NCT00784277|62765541|FG005|ER Treatment|Other|3|||
33386649|NCT00784277|62765542|FG006|ER Treatment|Other|2|||
33386650|NCT00682929|62765558|FG000|Overall Study|Adverse Event|4|||
33489341|NCT00100048|62867503|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
33489342|NCT00100048|62867504|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
33489343|NCT00100048|62867505|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
33489344|NCT00100048|62867506|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
33489345|NCT00100048|62867501|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
33489346|NCT00100048|62867502|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
33489347|NCT00100048|62867503|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
33297893|NCT01097629|62674012|FG006|DB RO Phase|Lost to Follow-up|2|||
33297894|NCT01097629|62674013|FG007|DB RO Phase|Lost to Follow-up|0|||
33489348|NCT00100048|62867504|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
33489349|NCT00100048|62867505|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
33489350|NCT00100048|62867506|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
33489351|NCT00100048|62867501|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
33489352|NCT00100048|62867502|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
33489353|NCT00100048|62867503|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
33489354|NCT00100048|62867504|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
33489355|NCT00100048|62867505|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
33489356|NCT00100048|62867506|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
33489357|NCT00100048|62867501|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
33489358|NCT00100048|62867502|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
33489359|NCT00100048|62867503|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
33489360|NCT00100048|62867504|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
33489361|NCT00100048|62867505|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
33489362|NCT00100048|62867506|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
33489363|NCT02757430|62867531|FG000|Overall Study|Physician Decision|6|||
33489364|NCT02757430|62867531|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
33489365|NCT02757430|62867531|FG000|Overall Study|No informed consent|1|||
33489366|NCT02757430|62867531|FG000|Overall Study|No procedure performed|2|||
33297895|NCT01324622|62674038|FG000|Overall Study|Lost to Follow-up|7|||
33386651|NCT00682929|62765559|FG001|Overall Study|Adverse Event|1|||
33386652|NCT00682929|62765560|FG002|Overall Study|Adverse Event|1|||
33489367|NCT02757352|62867547|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
33489368|NCT02757352|62867548|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33297896|NCT01324622|62674039|FG001|Overall Study|Lost to Follow-up|7|||
33297897|NCT01324622|62674038|FG000|Overall Study|Death|1|||
33297898|NCT01324622|62674039|FG001|Overall Study|Death|0|||
33386653|NCT00682929|62765558|FG000|Overall Study|Withdrawal by Subject|1|||
33386654|NCT00682929|62765559|FG001|Overall Study|Withdrawal by Subject|2|||
33386655|NCT00682929|62765560|FG002|Overall Study|Withdrawal by Subject|1|||
33297899|NCT01324622|62674038|FG000|Overall Study|Lack of Efficacy|1|||
33386656|NCT00682929|62765558|FG000|Overall Study|dosing compliance < 80%|0|||
33386657|NCT00682929|62765559|FG001|Overall Study|dosing compliance < 80%|2|||
33297900|NCT01324622|62674039|FG001|Overall Study|Lack of Efficacy|0|||
33297901|NCT01097005|62674046|FG000|Overall Study|Case Report Form not collected|18|||
33489369|NCT02757352|62867549|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
33489370|NCT02757352|62867550|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33556759|NCT02341456|62949594|FG001|Overall Study|Withdrawal by Subject|1|||
33556760|NCT02341456|62949595|FG002|Overall Study|Withdrawal by Subject|1|||
33556761|NCT02341456|62949593|FG000|Overall Study|Moved to local access programme.|0|||
33556762|NCT02341456|62949594|FG001|Overall Study|Moved to local access programme.|1|||
33556763|NCT02341456|62949595|FG002|Overall Study|Moved to local access programme.|1|||
33556764|NCT02341456|62949593|FG000|Overall Study|Physician Decision|1|||
33556765|NCT02341456|62949594|FG001|Overall Study|Physician Decision|0|||
33556766|NCT02341456|62949595|FG002|Overall Study|Physician Decision|0|||
33556767|NCT02370784|62949605|FG000|Overall Study|Patient started prohibited medication|0|||
33556768|NCT02370784|62949606|FG001|Overall Study|Patient started prohibited medication|1|||
33556769|NCT02307370|62949614|FG000|Overall Study|Death|5|||
33556770|NCT02307370|62949614|FG000|Overall Study|Lost to Follow-up|1|||
33556771|NCT02307370|62949614|FG000|Overall Study|Withdrawal by Subject|1|||
33556772|NCT02307370|62949614|FG000|Overall Study|Declined Addendum ICF|6|||
33556773|NCT02307370|62949614|FG000|Overall Study|No response during telephone contact|5|||
33556774|NCT02307370|62949614|FG000|Overall Study|Protocol Violation|1|||
33556775|NCT02370394|62949622|FG000|Overall Study|Lost to Follow-up|2|||
33556776|NCT02370394|62949623|FG001|Overall Study|Lost to Follow-up|1|||
33556777|NCT02370394|62949622|FG000|Overall Study|Withdrawal by Subject|0|||
33556778|NCT02370394|62949623|FG001|Overall Study|Withdrawal by Subject|1|||
33556779|NCT01595438|62949632|FG000|Overall Study|Lost to Follow-up|20|||
33556780|NCT01595438|62949633|FG001|Overall Study|Lost to Follow-up|20|||
33556781|NCT01595438|62949632|FG000|Overall Study|Withdrawal by Subject|12|||
33556782|NCT01595438|62949633|FG001|Overall Study|Withdrawal by Subject|12|||
33556783|NCT01595438|62949632|FG000|Overall Study|Other Eligibility criteria|11|||
33556784|NCT01595438|62949633|FG001|Overall Study|Other Eligibility criteria|9|||
33297902|NCT01097005|62674046|FG000|Overall Study|Subjects cannot visit the hospital|1|||
33297903|NCT01097005|62674046|FG000|Overall Study|Poor medication compliance|1|||
33297904|NCT01097005|62674046|FG000|Overall Study|No examination data available|244|||
33297905|NCT01097005|62674046|FG000|Overall Study|Deviation from exclusion criteria|37|||
33489371|NCT02757352|62867551|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33489372|NCT02757352|62867552|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33489373|NCT02757352|62867553|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33489374|NCT02757352|62867554|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33297906|NCT01097005|62674046|FG000|Overall Study|Adverse Event|14|||
33297907|NCT01097005|62674046|FG000|Overall Study|Discontinuance by complication|50|||
33297908|NCT01096849|62674055|FG000|Overall Study|Consent Withdrawn|1|||
33297909|NCT01096849|62674056|FG001|Overall Study|Consent Withdrawn|4|||
33297910|NCT01096849|62674057|FG002|Overall Study|Consent Withdrawn|2|||
33297911|NCT01096849|62674055|FG000|Overall Study|Lack of Efficacy|0|||
33297912|NCT01096849|62674056|FG001|Overall Study|Lack of Efficacy|2|||
33297913|NCT01096849|62674057|FG002|Overall Study|Lack of Efficacy|0|||
33297914|NCT01096849|62674055|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
33297915|NCT01096849|62674056|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
33297916|NCT01096849|62674057|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
33297917|NCT01096849|62674055|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
33386658|NCT00682929|62765560|FG002|Overall Study|dosing compliance < 80%|0|||
33386659|NCT00682929|62765558|FG000|Overall Study|lag in DEA renewal|1|||
33386660|NCT00682929|62765559|FG001|Overall Study|lag in DEA renewal|0|||
33386661|NCT00682929|62765560|FG002|Overall Study|lag in DEA renewal|0|||
33386662|NCT00680745|62765572|FG000|Overall Study|Withdrawal by Subject|8|||
33386663|NCT00680745|62765573|FG001|Overall Study|Withdrawal by Subject|3|||
33386664|NCT00680745|62765574|FG002|Overall Study|Withdrawal by Subject|2|||
33489375|NCT02757352|62867555|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33489376|NCT02757352|62867556|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33489377|NCT02757352|62867547|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33489378|NCT02757352|62867548|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33489379|NCT02757352|62867549|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
33489380|NCT02757352|62867550|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33489381|NCT02757352|62867551|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33556785|NCT02340520|62949639|FG000|Overall Study|Lost to Follow-up|1|||
33556786|NCT02340520|62949639|FG000|Overall Study|Patient did not take drug as specified|1|||
33556787|NCT02340520|62949639|FG000|Overall Study|Withdrawal by Subject|1|||
33297918|NCT01096849|62674056|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
33297919|NCT01096849|62674057|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
33297920|NCT01096849|62674055|FG000|Overall Study|Administrative Reasons|0|||
33386665|NCT00680745|62765575|FG003|Overall Study|Withdrawal by Subject|8|||
33556788|NCT02339584|62949645|FG000|Overall Study|Adverse Event|11|||
33556789|NCT02339584|62949646|FG001|Overall Study|Adverse Event|7|||
33297921|NCT01096849|62674056|FG001|Overall Study|Administrative Reasons|1|||
33386666|NCT00680745|62765572|FG000|Overall Study|Lost to Follow-up|0|||
33386667|NCT00680745|62765573|FG001|Overall Study|Lost to Follow-up|1|||
33386668|NCT00680745|62765574|FG002|Overall Study|Lost to Follow-up|1|||
33386669|NCT00680745|62765575|FG003|Overall Study|Lost to Follow-up|0|||
33386670|NCT00680745|62765572|FG000|Overall Study|Death|1|||
33386671|NCT00680745|62765573|FG001|Overall Study|Death|0|||
33386672|NCT00680745|62765574|FG002|Overall Study|Death|1|||
33386673|NCT00680745|62765575|FG003|Overall Study|Death|0|||
33386674|NCT00680745|62765572|FG000|Overall Study|Adverse Event|5|||
33386675|NCT00680745|62765573|FG001|Overall Study|Adverse Event|3|||
33386676|NCT00680745|62765574|FG002|Overall Study|Adverse Event|3|||
33386677|NCT00680745|62765575|FG003|Overall Study|Adverse Event|3|||
33386678|NCT00680745|62765572|FG000|Overall Study|Poor/Non-compliance|0|||
33386679|NCT00680745|62765573|FG001|Overall Study|Poor/Non-compliance|3|||
33386680|NCT00680745|62765574|FG002|Overall Study|Poor/Non-compliance|0|||
33386681|NCT00680745|62765575|FG003|Overall Study|Poor/Non-compliance|0|||
33386682|NCT00680745|62765572|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
33386683|NCT00680745|62765573|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
33386684|NCT00680745|62765574|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
33386685|NCT00680745|62765575|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
33386686|NCT00680745|62765572|FG000|Overall Study|False Treatment|0|||
33386687|NCT00680745|62765573|FG001|Overall Study|False Treatment|1|||
33386688|NCT00680745|62765574|FG002|Overall Study|False Treatment|3|||
33386689|NCT00680745|62765575|FG003|Overall Study|False Treatment|0|||
33386690|NCT00680121|62765588|FG000|Overall Study|Lost to Follow-up|27|||
33386691|NCT00680121|62765589|FG001|Overall Study|Lost to Follow-up|23|||
33386692|NCT00767819|62765598|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
33386693|NCT00767819|62765599|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
33386694|NCT00767819|62765600|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33386695|NCT00767819|62765598|FG000|Overall Study|Withdrawal by Subject|1|||
33386696|NCT00767819|62765599|FG001|Overall Study|Withdrawal by Subject|1|||
33386697|NCT00767819|62765600|FG002|Overall Study|Withdrawal by Subject|0|||
33386698|NCT00767819|62765598|FG000|Overall Study|Administrative problems|0|||
33386699|NCT00767819|62765599|FG001|Overall Study|Administrative problems|1|||
33386700|NCT00767819|62765600|FG002|Overall Study|Administrative problems|0|||
33386701|NCT00767819|62765598|FG000|Overall Study|Death|2|||
33386702|NCT00767819|62765599|FG001|Overall Study|Death|3|||
33386703|NCT00767819|62765600|FG002|Overall Study|Death|0|||
33386704|NCT00767819|62765598|FG000|Overall Study|Adverse Event|2|||
33297922|NCT01096849|62674057|FG002|Overall Study|Administrative Reasons|2|||
33297923|NCT01096849|62674055|FG000|Overall Study|Lost to Follow-up|1|||
33297924|NCT01096849|62674056|FG001|Overall Study|Lost to Follow-up|3|||
33297925|NCT01096849|62674057|FG002|Overall Study|Lost to Follow-up|1|||
33297926|NCT01324388|62674068|FG000|Part 1 of Study|Adverse Event|2|||
33297927|NCT01324388|62674069|FG001|Part 1 of Study|Adverse Event|0|||
33297928|NCT01324388|62674070|FG002|Part 1 of Study|Adverse Event|0|||
33297929|NCT01324388|62674071|FG003|Part 1 of Study|Adverse Event|0|||
33297930|NCT01324388|62674068|FG000|Part 1 of Study|Protocol Violation|1|||
33297931|NCT01324388|62674069|FG001|Part 1 of Study|Protocol Violation|2|||
33297932|NCT01324388|62674070|FG002|Part 1 of Study|Protocol Violation|0|||
33297933|NCT01324388|62674071|FG003|Part 1 of Study|Protocol Violation|0|||
33297934|NCT01324388|62674068|FG000|Part 1 of Study|Physician Decision|1|||
33297935|NCT01324388|62674069|FG001|Part 1 of Study|Physician Decision|0|||
33297936|NCT01324388|62674070|FG002|Part 1 of Study|Physician Decision|0|||
33297937|NCT01324388|62674071|FG003|Part 1 of Study|Physician Decision|0|||
33297938|NCT01324388|62674068|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
33297939|NCT01324388|62674069|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
33297940|NCT01324388|62674070|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
33297941|NCT01324388|62674071|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
33297942|NCT01324388|62674068|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
33297943|NCT01324388|62674069|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
33297944|NCT01324388|62674070|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
33297945|NCT01324388|62674071|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
33386705|NCT00767819|62765599|FG001|Overall Study|Adverse Event|0|||
33297946|NCT01102777|62674085|FG000|Overall Study|Death|2|||
33297947|NCT01102777|62674086|FG001|Overall Study|Death|6|||
33662624|NCT01587703|63093236|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
33386706|NCT00767819|62765600|FG002|Overall Study|Adverse Event|0|||
33386707|NCT00767819|62765598|FG000|Overall Study|Abnormal lab values|1|||
33386708|NCT00767819|62765599|FG001|Overall Study|Abnormal lab values|0|||
33386709|NCT00767819|62765600|FG002|Overall Study|Abnormal lab values|0|||
33386710|NCT00767819|62765598|FG000|Overall Study|Lost to Follow-up|1|||
33386711|NCT00767819|62765599|FG001|Overall Study|Lost to Follow-up|0|||
33386712|NCT00767819|62765600|FG002|Overall Study|Lost to Follow-up|0|||
33386713|NCT00584870|62765611|FG000|Overall Study|Adverse Event|4|||
33386714|NCT00584870|62765612|FG001|Overall Study|Adverse Event|3|||
33386715|NCT00584870|62765613|FG002|Overall Study|Adverse Event|2|||
33386716|NCT00584870|62765611|FG000|Overall Study|Lost to Follow-up|4|||
33386717|NCT00584870|62765612|FG001|Overall Study|Lost to Follow-up|1|||
33386718|NCT00584870|62765613|FG002|Overall Study|Lost to Follow-up|1|||
33386719|NCT00584870|62765611|FG000|Overall Study|Lack of Efficacy|7|||
33386720|NCT00584870|62765612|FG001|Overall Study|Lack of Efficacy|14|||
33386721|NCT00584870|62765613|FG002|Overall Study|Lack of Efficacy|8|||
33386722|NCT00584870|62765611|FG000|Overall Study|Withdrawal by Subject|10|||
33386723|NCT00584870|62765612|FG001|Overall Study|Withdrawal by Subject|5|||
33386724|NCT00584870|62765613|FG002|Overall Study|Withdrawal by Subject|3|||
33386725|NCT00584870|62765611|FG000|Overall Study|Protocol Violation|1|||
33386726|NCT00584870|62765612|FG001|Overall Study|Protocol Violation|1|||
33386727|NCT00584870|62765613|FG002|Overall Study|Protocol Violation|2|||
33386728|NCT00584870|62765611|FG000|Overall Study|Did not met entrance criteria|1|||
33386729|NCT00584870|62765612|FG001|Overall Study|Did not met entrance criteria|0|||
33386730|NCT00584870|62765613|FG002|Overall Study|Did not met entrance criteria|0|||
33386731|NCT00584870|62765611|FG000|Overall Study|Other|2|||
33386732|NCT00584870|62765612|FG001|Overall Study|Other|0|||
33386733|NCT00584870|62765613|FG002|Overall Study|Other|0|||
33386734|NCT00584870|62765611|FG000|Overall Study|Randomized but not treated|0|||
33386735|NCT00584870|62765612|FG001|Overall Study|Randomized but not treated|1|||
33386736|NCT00584870|62765613|FG002|Overall Study|Randomized but not treated|2|||
33386737|NCT00679341|62765623|FG000|Overall Study|Disease progression|42|||
33386738|NCT00679341|62765624|FG001|Overall Study|Disease progression|36|||
33386739|NCT00679341|62765623|FG000|Overall Study|Adverse Event|5|||
33386740|NCT00679341|62765624|FG001|Overall Study|Adverse Event|6|||
33386741|NCT00679341|62765623|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
33386742|NCT00679341|62765624|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
33386743|NCT00679341|62765623|FG000|Overall Study|Death|1|||
33386744|NCT00679341|62765624|FG001|Overall Study|Death|1|||
33386745|NCT00679341|62765623|FG000|Overall Study|Other|1|||
33386746|NCT00679341|62765624|FG001|Overall Study|Other|0|||
33386747|NCT00679341|62765623|FG000|Overall Study|Physician Decision|1|||
33386748|NCT00679341|62765624|FG001|Overall Study|Physician Decision|0|||
33386749|NCT00679341|62765623|FG000|Overall Study|Not treated|0|||
33386750|NCT00679341|62765624|FG001|Overall Study|Not treated|2|||
33386751|NCT00679341|62765623|FG000|Overall Study|Physician/patient decision to withdraw|0|||
33386752|NCT00679341|62765624|FG001|Overall Study|Physician/patient decision to withdraw|6|||
33386753|NCT00679263|62765634|FG000|Visit 2/Dose 1|Adverse Event|1|||
33386754|NCT00679263|62765635|FG001|Visit 2/Dose 1|Adverse Event|0|||
33386755|NCT00679263|62765636|FG002|Visit 2/Dose 1|Adverse Event|0|||
33386756|NCT00679263|62765634|FG000|Visit 2/Dose 1|subject not compliance|1|||
33386757|NCT00679263|62765635|FG001|Visit 2/Dose 1|subject not compliance|1|||
33386758|NCT00679263|62765636|FG002|Visit 2/Dose 1|subject not compliance|0|||
33386759|NCT00680043|62765647|FG000|Overall Study|Withdrawal by Subject|1|||
33386760|NCT00680043|62765648|FG001|Overall Study|Withdrawal by Subject|0|||
33386761|NCT00680043|62765649|FG002|Overall Study|Withdrawal by Subject|0|||
33386762|NCT00680043|62765647|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
33386763|NCT00680043|62765648|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
33386764|NCT00680043|62765649|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
33386765|NCT00680043|62765647|FG000|Overall Study|Renal Transplant|1|||
33386766|NCT00680043|62765648|FG001|Overall Study|Renal Transplant|0|||
33386767|NCT00680043|62765649|FG002|Overall Study|Renal Transplant|4|||
33386768|NCT00682539|62765660|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
33386769|NCT00682539|62765661|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
33386770|NCT00682539|62765662|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
33386771|NCT00682539|62765660|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
33386772|NCT00682539|62765661|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
33386773|NCT00682539|62765662|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
33386774|NCT00682461|62765672|FG000|Overall Study|Adverse Event|5|||
33386775|NCT00682461|62765673|FG001|Overall Study|Adverse Event|7|||
33386776|NCT00682461|62765672|FG000|Overall Study|Lost to Follow-up|8|||
33386777|NCT00682461|62765673|FG001|Overall Study|Lost to Follow-up|5|||
33386778|NCT00682461|62765672|FG000|Overall Study|Withdrawal by Subject|12|||
33386779|NCT00682461|62765673|FG001|Overall Study|Withdrawal by Subject|19|||
33386780|NCT00679029|62765680|FG000|Overall Study|Adverse Event|3|||
33386781|NCT00679029|62765680|FG000|Overall Study|Withdrawal by Subject|1|||
33556790|NCT02339584|62949645|FG000|Overall Study|Lack of Efficacy|0|||
33556791|NCT02339584|62949646|FG001|Overall Study|Lack of Efficacy|1|||
33386782|NCT00679029|62765680|FG000|Overall Study|Lost to Follow-up|1|||
33386783|NCT00677235|62765686|FG000|Overall Study|Withdrawal by Subject|1|||
33386784|NCT00677235|62765687|FG001|Overall Study|Withdrawal by Subject|1|||
33386785|NCT00677235|62765686|FG000|Overall Study|Lost to Follow-up|2|||
33386786|NCT00677235|62765687|FG001|Overall Study|Lost to Follow-up|1|||
33386787|NCT00677235|62765686|FG000|Overall Study|Death|37|||
33386788|NCT00677235|62765687|FG001|Overall Study|Death|36|||
33386789|NCT00677235|62765686|FG000|Overall Study|Adverse Experience|1|||
33556792|NCT02339584|62949645|FG000|Overall Study|Physician Decision|1|||
33386790|NCT00677235|62765687|FG001|Overall Study|Adverse Experience|0|||
33386791|NCT00676689|62765693|FG000|Overall Study|Screen Failure|2|||
33386792|NCT00676689|62765693|FG000|Overall Study|Death|2|||
33386793|NCT00676689|62765693|FG000|Overall Study|Lost to Follow-up|4|||
33386794|NCT00676689|62765693|FG000|Overall Study|Physician Decision|1|||
33386795|NCT00676689|62765693|FG000|Overall Study|Withdrawal by Subject|3|||
33386796|NCT00676689|62765693|FG000|Overall Study|Continuing FU|49|||
33386797|NCT00678795|62765699|FG000|Overall Study|Adverse Event|7|||
33386798|NCT00678795|62765700|FG001|Overall Study|Adverse Event|3|||
33386799|NCT00678795|62765699|FG000|Overall Study|Withdrawal by Subject|3|||
33386800|NCT00678795|62765700|FG001|Overall Study|Withdrawal by Subject|0|||
33386801|NCT00678795|62765699|FG000|Overall Study|Protocol Violation|0|||
33386802|NCT00678795|62765700|FG001|Overall Study|Protocol Violation|1|||
33386803|NCT00678795|62765699|FG000|Overall Study|Lost to Follow-up|0|||
33386804|NCT00678795|62765700|FG001|Overall Study|Lost to Follow-up|1|||
33386805|NCT00678795|62765699|FG000|Overall Study|Lack of Efficacy|1|||
33386806|NCT00678795|62765700|FG001|Overall Study|Lack of Efficacy|1|||
33386807|NCT00678639|62765708|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
33386808|NCT00678639|62765709|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
33386809|NCT00678561|62765759|FG000|Overall Study|Adverse Event|0|||
33386810|NCT00678561|62765760|FG001|Overall Study|Adverse Event|1|||
33386811|NCT00678561|62765761|FG002|Overall Study|Adverse Event|1|||
33386812|NCT00678561|62765762|FG003|Overall Study|Adverse Event|0|||
33386813|NCT00678561|62765763|FG004|Overall Study|Adverse Event|1|||
33386814|NCT00678561|62765764|FG005|Overall Study|Adverse Event|0|||
33386815|NCT00678561|62765765|FG006|Overall Study|Adverse Event|0|||
33386816|NCT00678561|62765766|FG007|Overall Study|Adverse Event|0|||
33386817|NCT00678561|62765759|FG000|Overall Study|Protocol Violation|0|||
33386818|NCT00678561|62765760|FG001|Overall Study|Protocol Violation|0|||
33386819|NCT00678561|62765761|FG002|Overall Study|Protocol Violation|0|||
33386820|NCT00678561|62765762|FG003|Overall Study|Protocol Violation|0|||
33386821|NCT00678561|62765763|FG004|Overall Study|Protocol Violation|1|||
33386822|NCT00678561|62765764|FG005|Overall Study|Protocol Violation|1|||
33386823|NCT00678561|62765765|FG006|Overall Study|Protocol Violation|0|||
33386824|NCT00678561|62765766|FG007|Overall Study|Protocol Violation|0|||
33386825|NCT00678561|62765759|FG000|Overall Study|Withdrawal by Subject|0|||
33386826|NCT00678561|62765760|FG001|Overall Study|Withdrawal by Subject|0|||
33386827|NCT00678561|62765761|FG002|Overall Study|Withdrawal by Subject|0|||
33386828|NCT00678561|62765762|FG003|Overall Study|Withdrawal by Subject|0|||
33386829|NCT00678561|62765763|FG004|Overall Study|Withdrawal by Subject|0|||
33386830|NCT00678561|62765764|FG005|Overall Study|Withdrawal by Subject|0|||
33386831|NCT00678561|62765765|FG006|Overall Study|Withdrawal by Subject|0|||
33386832|NCT00678561|62765766|FG007|Overall Study|Withdrawal by Subject|1|||
33297948|NCT01102777|62674085|FG000|Overall Study|Lost to Follow-up|7|||
33297949|NCT01102777|62674086|FG001|Overall Study|Lost to Follow-up|10|||
33297950|NCT01324310|62674093|FG000|Overall Study|Adverse Event|1|||
33297951|NCT01324310|62674093|FG000|Overall Study|Disease Progression|1|||
33386833|NCT00676143|62765793|FG000|Overall Study|Adverse Event|34|||
33386834|NCT00676143|62765794|FG001|Overall Study|Adverse Event|60|||
33386835|NCT00676143|62765793|FG000|Overall Study|Death|4|||
33386836|NCT00676143|62765794|FG001|Overall Study|Death|4|||
33386837|NCT00676143|62765793|FG000|Overall Study|Lack of Efficacy|0|||
33386838|NCT00676143|62765794|FG001|Overall Study|Lack of Efficacy|6|||
33386839|NCT00676143|62765793|FG000|Overall Study|Lost to Follow-up|0|||
33386840|NCT00676143|62765794|FG001|Overall Study|Lost to Follow-up|13|||
33489382|NCT02757352|62867552|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33297952|NCT01102231|62674099|FG000|Overall Study|Protocol Violation|3|||
33297953|NCT01102231|62674099|FG000|Overall Study|Lack of Efficacy|2|||
33297954|NCT01102231|62674099|FG000|Overall Study|Death|2|||
33297955|NCT01102231|62674099|FG000|Overall Study|Adverse Event|3|||
33297956|NCT01102231|62674099|FG000|Overall Study|Withdrawal by Subject|1|||
33297957|NCT01102231|62674099|FG000|Overall Study|Did not received the treatment|4|||
33297958|NCT01094743|62674104|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
33386841|NCT00676143|62765793|FG000|Overall Study|Physician Decision|5|||
33489383|NCT02757352|62867553|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33489384|NCT02757352|62867554|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33297959|NCT01095835|62674112|FG000|Overall Study|Adverse Event|8|||
33386842|NCT00676143|62765794|FG001|Overall Study|Physician Decision|8|||
33386843|NCT00676143|62765793|FG000|Overall Study|Protocol Violation|4|||
33386844|NCT00676143|62765794|FG001|Overall Study|Protocol Violation|8|||
33386845|NCT00676143|62765793|FG000|Overall Study|Withdrawal by Subject|24|||
33386846|NCT00676143|62765794|FG001|Overall Study|Withdrawal by Subject|42|||
33386847|NCT00676143|62765793|FG000|Overall Study|Discontinuation of study by sponsor|65|||
33297960|NCT01095835|62674113|FG001|Overall Study|Adverse Event|6|||
33386848|NCT00676143|62765794|FG001|Overall Study|Discontinuation of study by sponsor|88|||
33386849|NCT00676143|62765793|FG000|Overall Study|Failed to return|2|||
33386850|NCT00676143|62765794|FG001|Overall Study|Failed to return|1|||
33386851|NCT00676143|62765793|FG000|Overall Study|Loss of caregiver|5|||
33556793|NCT02339584|62949646|FG001|Overall Study|Physician Decision|2|||
33386852|NCT00676143|62765794|FG001|Overall Study|Loss of caregiver|3|||
33386853|NCT00676143|62765793|FG000|Overall Study|Other|11|||
33386854|NCT00676143|62765794|FG001|Overall Study|Other|20|||
33386855|NCT00676143|62765793|FG000|Overall Study|Participant participation unknown|1|||
33386856|NCT00676143|62765794|FG001|Overall Study|Participant participation unknown|4|||
33386857|NCT00676143|62765793|FG000|Overall Study|Vasogenic edema recurrence|1|||
33489385|NCT02757352|62867555|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33489386|NCT02757352|62867556|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33489387|NCT02757352|62867547|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
33489388|NCT02757352|62867548|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
33489389|NCT02757352|62867549|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
33489390|NCT02757352|62867550|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
33489391|NCT02757352|62867551|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
33489392|NCT02757352|62867552|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
33489393|NCT02757352|62867553|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
33489394|NCT02757352|62867554|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
33489395|NCT02757352|62867555|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
33489396|NCT02757352|62867556|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
33489397|NCT02757352|62867547|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33489398|NCT02757352|62867548|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
33489399|NCT02757352|62867549|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33489400|NCT02757352|62867550|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33489401|NCT02757352|62867551|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33489402|NCT02757352|62867552|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33489403|NCT02757352|62867553|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33489404|NCT02757352|62867554|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33489405|NCT02757352|62867555|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33489406|NCT02757352|62867556|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33489407|NCT02757352|62867547|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33489408|NCT02757352|62867548|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
33489409|NCT02757352|62867549|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33489410|NCT02757352|62867550|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33489411|NCT02757352|62867551|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33489412|NCT02757352|62867552|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33489413|NCT02757352|62867553|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33489414|NCT02757352|62867554|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33489415|NCT02757352|62867555|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33489416|NCT02757352|62867556|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33297961|NCT01095835|62674114|FG002|Overall Study|Adverse Event|6|||
33297962|NCT01095835|62674112|FG000|Overall Study|Lack of Efficacy|0|||
33297963|NCT01095835|62674113|FG001|Overall Study|Lack of Efficacy|1|||
33297964|NCT01095835|62674114|FG002|Overall Study|Lack of Efficacy|0|||
33297965|NCT01095835|62674112|FG000|Overall Study|Physician Decision|0|||
33297966|NCT01095835|62674113|FG001|Overall Study|Physician Decision|0|||
33297967|NCT01095835|62674114|FG002|Overall Study|Physician Decision|1|||
33297968|NCT01095835|62674112|FG000|Overall Study|Withdrawal by Subject|1|||
33297969|NCT01095835|62674113|FG001|Overall Study|Withdrawal by Subject|3|||
33297970|NCT01095835|62674114|FG002|Overall Study|Withdrawal by Subject|0|||
33297971|NCT01095835|62674112|FG000|Overall Study|Non study compliance|0|||
33297972|NCT01095835|62674113|FG001|Overall Study|Non study compliance|0|||
33297973|NCT01095835|62674114|FG002|Overall Study|Non study compliance|1|||
33297974|NCT01095835|62674112|FG000|Overall Study|Protocol Violation|1|||
33297975|NCT01095835|62674113|FG001|Overall Study|Protocol Violation|2|||
33297976|NCT01095835|62674114|FG002|Overall Study|Protocol Violation|0|||
33297977|NCT01324232|62674127|FG000|Overall Study|Protocol Violation|0|||
33489417|NCT02757352|62867547|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
33489418|NCT02757352|62867548|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
33489419|NCT02757352|62867549|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
33489420|NCT02757352|62867550|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33489421|NCT02757352|62867551|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33489422|NCT02757352|62867552|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33489423|NCT02757352|62867553|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33556794|NCT02339584|62949645|FG000|Overall Study|Protocol Violation|1|||
33662625|NCT01587703|63093237|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33662626|NCT01587703|63093238|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33297978|NCT01324232|62674128|FG001|Overall Study|Protocol Violation|0|||
33297979|NCT01324232|62674129|FG002|Overall Study|Protocol Violation|0|||
33297980|NCT01324232|62674130|FG003|Overall Study|Protocol Violation|2|||
33297981|NCT01324232|62674127|FG000|Overall Study|Missing|0|||
33386858|NCT00676143|62765794|FG001|Overall Study|Vasogenic edema recurrence|3|||
33386859|NCT00675597|62765819|FG000|Overall Study|Withdrawal by Subject|3|||
33386860|NCT00675441|62765827|FG000|Overall Study|Withdrawal by Subject|2|||
33386861|NCT00675441|62765827|FG000|Overall Study|Death|1|||
33386862|NCT00674973|62765842|FG000|Overall Study|Insufficient Therapeutic Response|77|||
33386863|NCT00674973|62765843|FG001|Overall Study|Insufficient Therapeutic Response|72|||
33386864|NCT00674973|62765842|FG000|Overall Study|Refused Treatment|1|||
33386865|NCT00674973|62765843|FG001|Overall Study|Refused Treatment|5|||
33386866|NCT00674973|62765842|FG000|Overall Study|Failure to Return|1|||
33386867|NCT00674973|62765843|FG001|Overall Study|Failure to Return|0|||
33386868|NCT00674973|62765842|FG000|Overall Study|Adverse Event|2|||
33386869|NCT00674973|62765843|FG001|Overall Study|Adverse Event|9|||
33386870|NCT00674973|62765842|FG000|Overall Study|Death|19|||
33386871|NCT00674973|62765843|FG001|Overall Study|Death|15|||
33386872|NCT00674973|62765842|FG000|Overall Study|Protocol Violation|0|||
33386873|NCT00674973|62765843|FG001|Overall Study|Protocol Violation|1|||
33297982|NCT01324232|62674128|FG001|Overall Study|Missing|0|||
33297983|NCT01324232|62674129|FG002|Overall Study|Missing|1|||
33297984|NCT01324232|62674130|FG003|Overall Study|Missing|0|||
33297985|NCT01324232|62674127|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
33297986|NCT01324232|62674128|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
33386874|NCT00673179|62765851|FG000|Overall Study|Toxicity/Complications|3|||
33386875|NCT00673179|62765852|FG001|Overall Study|Toxicity/Complications|0|||
33386876|NCT00584012|62765858|FG000|Overall Study|Withdrawal by Subject|1|||
33297987|NCT01324232|62674129|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
33297988|NCT01324232|62674130|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
33297989|NCT01324232|62674127|FG000|Overall Study|Lack of Efficacy|2|||
33297990|NCT01324232|62674128|FG001|Overall Study|Lack of Efficacy|1|||
33297991|NCT01324232|62674129|FG002|Overall Study|Lack of Efficacy|2|||
33297992|NCT01324232|62674130|FG003|Overall Study|Lack of Efficacy|2|||
33297993|NCT01324232|62674127|FG000|Overall Study|Participant Refused Medication|0|||
33297994|NCT01324232|62674128|FG001|Overall Study|Participant Refused Medication|1|||
33297995|NCT01324232|62674129|FG002|Overall Study|Participant Refused Medication|0|||
33297996|NCT01324232|62674130|FG003|Overall Study|Participant Refused Medication|0|||
33297997|NCT01324232|62674127|FG000|Overall Study|Intercurrent illness|0|||
33297998|NCT01324232|62674128|FG001|Overall Study|Intercurrent illness|0|||
33297999|NCT01324232|62674129|FG002|Overall Study|Intercurrent illness|0|||
33298000|NCT01324232|62674130|FG003|Overall Study|Intercurrent illness|1|||
33298001|NCT01324232|62674127|FG000|Overall Study|Adverse Event|2|||
33386877|NCT00674817|62765862|FG000|Period 1|Withdrawal by Subject|2|||
33386878|NCT00674817|62765862|FG000|Period 1|Protocol Violation|1|||
33386879|NCT00674817|62765862|FG000|Period 3|Adverse Event|1|||
33386880|NCT00674817|62765862|FG000|Period 3|Protocol Violation|1|||
33386881|NCT00674817|62765862|FG000|Period 4|Adverse Event|1|||
33386882|NCT00672633|62765878|FG000|Overall Study|Withdrawal by Subject|0|||
33386883|NCT00672633|62765879|FG001|Overall Study|Withdrawal by Subject|1|||
33386884|NCT00672555|62765885|FG000|Overall Study|Lost to Follow-up|4|||
33386885|NCT00672555|62765885|FG000|Overall Study|Did not want to answer questionnaire|2|||
33386886|NCT00672477|62765891|FG000|Overall Study|Adverse Event|10|||
33386887|NCT00672477|62765892|FG001|Overall Study|Adverse Event|7|||
33386888|NCT00672477|62765891|FG000|Overall Study|Death|7|||
33386889|NCT00672477|62765892|FG001|Overall Study|Death|11|||
33386890|NCT00672477|62765891|FG000|Overall Study|Physician Decision|2|||
33386891|NCT00672477|62765892|FG001|Overall Study|Physician Decision|0|||
33386892|NCT00672477|62765891|FG000|Overall Study|Protocol Violation|1|||
33386893|NCT00672477|62765892|FG001|Overall Study|Protocol Violation|1|||
33386894|NCT00672477|62765891|FG000|Overall Study|Withdrawal by Subject|5|||
33386895|NCT00672477|62765892|FG001|Overall Study|Withdrawal by Subject|3|||
33298002|NCT01324232|62674128|FG001|Overall Study|Adverse Event|5|||
33386896|NCT00672477|62765891|FG000|Overall Study|Lack of Efficacy|1|||
33298003|NCT01324232|62674129|FG002|Overall Study|Adverse Event|6|||
33298004|NCT01324232|62674130|FG003|Overall Study|Adverse Event|6|||
33298005|NCT01324232|62674127|FG000|Overall Study|Withdrawal by Subject|0|||
33298006|NCT01324232|62674128|FG001|Overall Study|Withdrawal by Subject|3|||
33386897|NCT00672477|62765892|FG001|Overall Study|Lack of Efficacy|1|||
33386898|NCT00672477|62765891|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
33386899|NCT00672477|62765892|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
33386900|NCT00674661|62765900|FG000|Overall Study|Other|5|||
33386901|NCT00674661|62765901|FG001|Overall Study|Other|7|||
33386902|NCT00674661|62765900|FG000|Overall Study|Lost to Follow-up|6|||
33386903|NCT00674661|62765901|FG001|Overall Study|Lost to Follow-up|3|||
33386904|NCT00674661|62765900|FG000|Overall Study|Withdrawal by Subject|0|||
33386905|NCT00674661|62765901|FG001|Overall Study|Withdrawal by Subject|5|||
33386906|NCT00671931|62765912|FG000|Overall Study|Physician Decision|1|||
33386907|NCT00671931|62765913|FG001|Overall Study|Physician Decision|0|||
33298007|NCT01324232|62674129|FG002|Overall Study|Withdrawal by Subject|4|||
33298008|NCT01324232|62674130|FG003|Overall Study|Withdrawal by Subject|0|||
33386908|NCT00671931|62765914|FG002|Overall Study|Physician Decision|0|||
33298009|NCT01324232|62674127|FG000|Overall Study|Lost to Follow-up|1|||
33298010|NCT01324232|62674128|FG001|Overall Study|Lost to Follow-up|0|||
33298011|NCT01324232|62674129|FG002|Overall Study|Lost to Follow-up|0|||
33489424|NCT02757352|62867554|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33489425|NCT02757352|62867555|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33489426|NCT02757352|62867556|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33489427|NCT02757352|62867547|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
33489428|NCT02757352|62867548|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
33489429|NCT02757352|62867549|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
33489430|NCT02757352|62867550|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
33489431|NCT02757352|62867551|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
33489432|NCT02757352|62867552|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
33489433|NCT02757352|62867553|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
33489434|NCT02757352|62867554|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
33489435|NCT02757352|62867555|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
33489436|NCT02757352|62867556|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
33489437|NCT02757352|62867547|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33489438|NCT02757352|62867548|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33489439|NCT02757352|62867549|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33489440|NCT02757352|62867550|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
33489441|NCT02757352|62867551|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33489442|NCT02757352|62867552|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
33298012|NCT01324232|62674130|FG003|Overall Study|Lost to Follow-up|0|||
33298013|NCT01094119|62674147|FG000|Overall Study|Lack of Efficacy|2|||
33298014|NCT01094119|62674148|FG001|Overall Study|Lack of Efficacy|4|||
33298015|NCT01323920|62674154|FG000|Overall Study|Death|5|||
33298016|NCT01323920|62674154|FG000|Overall Study|Withdrawal by Subject|1|||
33298017|NCT01093885|62674158|FG000|Overall Study|Adverse Event|4|||
33298018|NCT01093885|62674158|FG000|Overall Study|Lost to Follow-up|1|||
33298019|NCT01101997|62674163|FG000|Overall Study|Withdrawal by Subject|2|||
33298020|NCT01324830|62674193|FG000|Overall Study|Progressive Disease|3|||
33298021|NCT01324830|62674194|FG001|Overall Study|Progressive Disease|2|||
33298022|NCT01324830|62674195|FG002|Overall Study|Progressive Disease|3|||
33298023|NCT01324830|62674196|FG003|Overall Study|Progressive Disease|3|||
33298024|NCT01324830|62674197|FG004|Overall Study|Progressive Disease|6|||
33298025|NCT01324830|62674198|FG005|Overall Study|Progressive Disease|6|||
33298026|NCT01324830|62674199|FG006|Overall Study|Progressive Disease|3|||
33386909|NCT00671931|62765915|FG003|Overall Study|Physician Decision|2|||
33386910|NCT00671931|62765916|FG004|Overall Study|Physician Decision|1|||
33386911|NCT00673881|62765932|FG000|Overall Study|Withdrawal by Subject|1|||
33386912|NCT00671853|62765938|FG000|Overall Study|Lack of Efficacy|3|||
33386913|NCT00671853|62765939|FG001|Overall Study|Lack of Efficacy|7|||
33386914|NCT00671853|62765938|FG000|Overall Study|Adverse Event|7|||
33386915|NCT00671853|62765939|FG001|Overall Study|Adverse Event|1|||
33386916|NCT00671853|62765938|FG000|Overall Study|Withdrawal by Subject|1|||
33386917|NCT00671853|62765939|FG001|Overall Study|Withdrawal by Subject|5|||
33386918|NCT00671853|62765938|FG000|Overall Study|Lost to Follow-up|8|||
33386919|NCT00671853|62765939|FG001|Overall Study|Lost to Follow-up|8|||
33489443|NCT02757352|62867553|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33489444|NCT02757352|62867554|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33489445|NCT02757352|62867555|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33489446|NCT02757352|62867556|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33489447|NCT02757352|62867547|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33489448|NCT02757352|62867548|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33489449|NCT02757352|62867549|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33489450|NCT02757352|62867550|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
33489451|NCT02757352|62867551|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
33489452|NCT02757352|62867552|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
33489453|NCT02757352|62867553|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33489454|NCT02757352|62867554|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33489455|NCT02757352|62867555|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33489456|NCT02757352|62867556|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33489457|NCT02757352|62867547|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33489458|NCT02757352|62867548|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33489459|NCT02757352|62867549|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33489460|NCT02757352|62867550|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33298027|NCT01324830|62674200|FG007|Overall Study|Progressive Disease|3|||
33298028|NCT01324830|62674201|FG008|Overall Study|Progressive Disease|3|||
33386920|NCT00671853|62765938|FG000|Overall Study|Physician Decision|0|||
33298029|NCT01324830|62674202|FG009|Overall Study|Progressive Disease|6|||
33298030|NCT01324830|62674203|FG010|Overall Study|Progressive Disease|2|||
33298031|NCT01324830|62674204|FG011|Overall Study|Progressive Disease|1|||
33298032|NCT01324830|62674205|FG012|Overall Study|Progressive Disease|1|||
33298033|NCT01324830|62674206|FG013|Overall Study|Progressive Disease|1|||
33298034|NCT01324830|62674207|FG014|Overall Study|Progressive Disease|1|||
33298035|NCT01324830|62674208|FG015|Overall Study|Progressive Disease|3|||
33298036|NCT01324830|62674209|FG016|Overall Study|Progressive Disease|2|||
33298037|NCT01324830|62674210|FG017|Overall Study|Progressive Disease|3|||
33298038|NCT01324830|62674211|FG018|Overall Study|Progressive Disease|4|||
33298039|NCT01324830|62674193|FG000|Overall Study|Dose limiting toxicity|0|||
33298040|NCT01324830|62674194|FG001|Overall Study|Dose limiting toxicity|0|||
33298041|NCT01324830|62674195|FG002|Overall Study|Dose limiting toxicity|0|||
33298042|NCT01324830|62674196|FG003|Overall Study|Dose limiting toxicity|0|||
33298043|NCT01324830|62674197|FG004|Overall Study|Dose limiting toxicity|1|||
33386921|NCT00671853|62765939|FG001|Overall Study|Physician Decision|2|||
33386922|NCT00671853|62765938|FG000|Overall Study|Non-adherence with study procedures|1|||
33386923|NCT00671853|62765939|FG001|Overall Study|Non-adherence with study procedures|4|||
33386924|NCT00570921|62765947|FG000|Overall Study|Protocol Violation|1|||
33386925|NCT00570921|62765947|FG000|Overall Study|Physician Decision|1|||
33386926|NCT00670449|62765955|FG000|Overall Study|Adverse Event|6|||
33386927|NCT00670449|62765956|FG001|Overall Study|Adverse Event|2|||
33386928|NCT00670449|62765957|FG002|Overall Study|Adverse Event|8|||
33386929|NCT00670449|62765958|FG003|Overall Study|Adverse Event|5|||
33386930|NCT00670449|62765955|FG000|Overall Study|Protocol Deviation|1|||
33386931|NCT00670449|62765956|FG001|Overall Study|Protocol Deviation|2|||
33386932|NCT00670449|62765957|FG002|Overall Study|Protocol Deviation|0|||
33386933|NCT00670449|62765958|FG003|Overall Study|Protocol Deviation|1|||
33386934|NCT00670449|62765955|FG000|Overall Study|Administrative Problems|0|||
33386935|NCT00670449|62765956|FG001|Overall Study|Administrative Problems|2|||
33386936|NCT00670449|62765957|FG002|Overall Study|Administrative Problems|0|||
33386937|NCT00670449|62765958|FG003|Overall Study|Administrative Problems|1|||
33386938|NCT00670449|62765955|FG000|Overall Study|Subject Withdrew Consent|0|||
33386939|NCT00670449|62765956|FG001|Overall Study|Subject Withdrew Consent|2|||
33298044|NCT01324830|62674198|FG005|Overall Study|Dose limiting toxicity|0|||
33298045|NCT01324830|62674199|FG006|Overall Study|Dose limiting toxicity|0|||
33298046|NCT01324830|62674200|FG007|Overall Study|Dose limiting toxicity|0|||
33298047|NCT01324830|62674201|FG008|Overall Study|Dose limiting toxicity|0|||
33298048|NCT01324830|62674202|FG009|Overall Study|Dose limiting toxicity|0|||
33298049|NCT01324830|62674203|FG010|Overall Study|Dose limiting toxicity|0|||
33298050|NCT01324830|62674204|FG011|Overall Study|Dose limiting toxicity|0|||
33298051|NCT01324830|62674205|FG012|Overall Study|Dose limiting toxicity|0|||
33386940|NCT00670449|62765957|FG002|Overall Study|Subject Withdrew Consent|0|||
33386941|NCT00670449|62765958|FG003|Overall Study|Subject Withdrew Consent|1|||
33386942|NCT00670449|62765955|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
33386943|NCT00670449|62765956|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33386944|NCT00670449|62765957|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
33386945|NCT00670449|62765958|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33386946|NCT00670449|62765955|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
33386947|NCT00670449|62765956|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
33386948|NCT00670449|62765957|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
33386949|NCT00670449|62765958|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
33386950|NCT00668733|62765969|FG000|Overall Study|Lost to Follow-up|2|||
33386951|NCT00668733|62765970|FG001|Overall Study|Lost to Follow-up|3|||
33386952|NCT00668733|62765969|FG000|Overall Study|Withdrawal by Subject|0|||
33386953|NCT00668733|62765970|FG001|Overall Study|Withdrawal by Subject|4|||
33386954|NCT00673257|62765976|FG000|Overall Study|Withdrawal by Subject|4|||
33386955|NCT00673257|62765976|FG000|Overall Study|Unable to obtain specimen|1|||
33386956|NCT00667875|62765983|FG000|Overall Study|Adverse Event|0|||
33386957|NCT00667875|62765984|FG001|Overall Study|Adverse Event|2|||
33386958|NCT00667875|62765985|FG002|Overall Study|Adverse Event|6|||
33386959|NCT00667875|62765983|FG000|Overall Study|Withdrawal by Subject|10|||
33298052|NCT01324830|62674206|FG013|Overall Study|Dose limiting toxicity|0|||
33298053|NCT01324830|62674207|FG014|Overall Study|Dose limiting toxicity|0|||
33298054|NCT01324830|62674208|FG015|Overall Study|Dose limiting toxicity|0|||
33386960|NCT00667875|62765984|FG001|Overall Study|Withdrawal by Subject|9|||
33386961|NCT00667875|62765985|FG002|Overall Study|Withdrawal by Subject|7|||
33386962|NCT03468998|62766005|FG000|Overall Study|Withdrawal by Subject|1|||
33298055|NCT01324830|62674209|FG016|Overall Study|Dose limiting toxicity|1|||
33298056|NCT01324830|62674210|FG017|Overall Study|Dose limiting toxicity|1|||
33386963|NCT03468998|62766006|FG001|Overall Study|Withdrawal by Subject|1|||
33386964|NCT03468998|62766007|FG002|Overall Study|Withdrawal by Subject|0|||
33386965|NCT03468998|62766008|FG003|Overall Study|Withdrawal by Subject|4|||
33386966|NCT03468998|62766009|FG004|Overall Study|Withdrawal by Subject|1|||
33298057|NCT01324830|62674211|FG018|Overall Study|Dose limiting toxicity|1|||
33386967|NCT03468998|62766010|FG005|Overall Study|Withdrawal by Subject|0|||
33386968|NCT00667251|62766024|FG000|Overall Study|Adverse Event|13|||
33386969|NCT00667251|62766025|FG001|Overall Study|Adverse Event|4|||
33386970|NCT00667251|62766024|FG000|Overall Study|Withdrawal by Subject|6|||
33386971|NCT00667251|62766025|FG001|Overall Study|Withdrawal by Subject|2|||
33386972|NCT00667251|62766024|FG000|Overall Study|Other/missing|46|||
33386973|NCT00667251|62766025|FG001|Overall Study|Other/missing|84|||
33386974|NCT00667251|62766024|FG000|Overall Study|Intercurrent Illness|4|||
33386975|NCT00667251|62766025|FG001|Overall Study|Intercurrent Illness|3|||
33386976|NCT00667251|62766024|FG000|Overall Study|Symptomatic progression|1|||
33386977|NCT00667251|62766025|FG001|Overall Study|Symptomatic progression|2|||
33386978|NCT00669903|62766043|FG000|Overall Study|Adverse Event|0|||
33386979|NCT00669903|62766044|FG001|Overall Study|Adverse Event|1|||
33386980|NCT00669903|62766045|FG002|Overall Study|Adverse Event|3|||
33386981|NCT00669903|62766046|FG003|Overall Study|Adverse Event|1|||
33386982|NCT00669903|62766043|FG000|Overall Study|Withdrawal by Subject|0|||
33386983|NCT00669903|62766044|FG001|Overall Study|Withdrawal by Subject|2|||
33386984|NCT00669903|62766045|FG002|Overall Study|Withdrawal by Subject|2|||
33386985|NCT00669903|62766046|FG003|Overall Study|Withdrawal by Subject|2|||
33386986|NCT00669903|62766043|FG000|Overall Study|Lost to Follow-up|1|||
33386987|NCT00669903|62766044|FG001|Overall Study|Lost to Follow-up|1|||
33386988|NCT00669903|62766045|FG002|Overall Study|Lost to Follow-up|0|||
33386989|NCT00669903|62766046|FG003|Overall Study|Lost to Follow-up|1|||
33386990|NCT00669903|62766043|FG000|Overall Study|Protocol Violation|0|||
33386991|NCT00669903|62766044|FG001|Overall Study|Protocol Violation|1|||
33386992|NCT00669903|62766045|FG002|Overall Study|Protocol Violation|0|||
33386993|NCT00669903|62766046|FG003|Overall Study|Protocol Violation|0|||
33386994|NCT03759392|62766058|FG000|Overall Study|Adverse Event|12|||
33386995|NCT03759392|62766059|FG001|Overall Study|Adverse Event|4|||
33489461|NCT02757352|62867551|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
33489462|NCT02757352|62867552|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33489463|NCT02757352|62867553|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33489464|NCT02757352|62867554|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33489465|NCT02757352|62867555|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33489466|NCT02757352|62867556|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33489467|NCT02757352|62867547|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33489468|NCT02757352|62867548|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33489469|NCT02757352|62867549|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33489470|NCT02757352|62867550|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33489471|NCT02757352|62867551|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33489472|NCT02757352|62867552|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
33489473|NCT02757352|62867553|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33489474|NCT02757352|62867554|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33489475|NCT02757352|62867555|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33489476|NCT02757352|62867556|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33489477|NCT02757352|62867547|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33489478|NCT02757352|62867548|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33489479|NCT02757352|62867549|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33489480|NCT02757352|62867550|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
33489481|NCT02757352|62867551|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
33386996|NCT03759392|62766058|FG000|Overall Study|Death|2|||
33386997|NCT03759392|62766059|FG001|Overall Study|Death|1|||
33386998|NCT03759392|62766058|FG000|Overall Study|Withdrawal by Subject|2|||
33489482|NCT02757352|62867552|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
33489483|NCT02757352|62867553|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33489484|NCT02757352|62867554|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33489485|NCT02757352|62867555|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33298058|NCT01324830|62674193|FG000|Overall Study|Reason not mentioned above|0|||
33298059|NCT01324830|62674194|FG001|Overall Study|Reason not mentioned above|0|||
33298060|NCT01324830|62674195|FG002|Overall Study|Reason not mentioned above|0|||
33298061|NCT01324830|62674196|FG003|Overall Study|Reason not mentioned above|0|||
33298062|NCT01324830|62674197|FG004|Overall Study|Reason not mentioned above|0|||
33298063|NCT01324830|62674198|FG005|Overall Study|Reason not mentioned above|0|||
33298064|NCT01324830|62674199|FG006|Overall Study|Reason not mentioned above|0|||
33298065|NCT01324830|62674200|FG007|Overall Study|Reason not mentioned above|0|||
33386999|NCT03759392|62766059|FG001|Overall Study|Withdrawal by Subject|0|||
33556795|NCT02339584|62949646|FG001|Overall Study|Protocol Violation|1|||
33298066|NCT01324830|62674201|FG008|Overall Study|Reason not mentioned above|0|||
33387000|NCT03759392|62766058|FG000|Overall Study|Protocol Violation|2|||
33387001|NCT03759392|62766059|FG001|Overall Study|Protocol Violation|0|||
33387002|NCT03759392|62766058|FG000|Overall Study|Physician Decision|0|||
33387003|NCT03759392|62766059|FG001|Overall Study|Physician Decision|1|||
33298067|NCT01324830|62674202|FG009|Overall Study|Reason not mentioned above|0|||
33298068|NCT01324830|62674203|FG010|Overall Study|Reason not mentioned above|0|||
33387004|NCT03759392|62766058|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
33387005|NCT03759392|62766059|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
33387006|NCT03759392|62766058|FG000|Overall Study|No longer able to take medicines|1|||
33387007|NCT03759392|62766059|FG001|Overall Study|No longer able to take medicines|0|||
33387008|NCT03759392|62766058|FG000|Overall Study|Stopped taking study drug|1|||
33387009|NCT03759392|62766059|FG001|Overall Study|Stopped taking study drug|0|||
33387010|NCT00667719|62766065|FG000|Overall Study|Adverse Event|39|||
33387011|NCT00667719|62766065|FG000|Overall Study|Abnormal Test Procedure|1|||
33387012|NCT00667719|62766065|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
33387013|NCT00667719|62766065|FG000|Overall Study|Protocol Violation|3|||
33387014|NCT00667719|62766065|FG000|Overall Study|Withdrawal by Subject|17|||
33387015|NCT00667719|62766065|FG000|Overall Study|Lost to Follow-up|8|||
33387016|NCT00669669|62766074|FG000|Overall Study|To late to start treatment|1|||
33387017|NCT00467779|62766093|FG000|Stage 1|Adverse Event|1|||
33387018|NCT00467779|62766094|FG001|Stage 1|Adverse Event|0|||
33387019|NCT00467779|62766095|FG002|Stage 1|Adverse Event|0|||
33387020|NCT00467779|62766096|FG003|Stage 1|Adverse Event|0|||
33387021|NCT00467779|62766097|FG004|Stage 1|Adverse Event|0|||
33387022|NCT00467779|62766098|FG005|Stage 1|Adverse Event|1|||
33387023|NCT00467779|62766099|FG006|Stage 1|Adverse Event|2|||
33387024|NCT00467779|62766100|FG007|Stage 1|Adverse Event|1|||
33387025|NCT00467779|62766101|FG008|Stage 1|Adverse Event|0|||
33387026|NCT00467779|62766102|FG009|Stage 1|Adverse Event|0|||
33387027|NCT00467779|62766103|FG010|Stage 1|Adverse Event|0|||
33387028|NCT00467779|62766104|FG011|Stage 1|Adverse Event|0|||
33387029|NCT00467779|62766105|FG012|Stage 1|Adverse Event|0|||
33387030|NCT00467779|62766106|FG013|Stage 1|Adverse Event|0|||
33387031|NCT00467779|62766107|FG014|Stage 1|Adverse Event|0|||
33387032|NCT00467779|62766093|FG000|Stage 1|Disease Progression|2|||
33387033|NCT00467779|62766094|FG001|Stage 1|Disease Progression|2|||
33387034|NCT00467779|62766095|FG002|Stage 1|Disease Progression|2|||
33298069|NCT01324830|62674204|FG011|Overall Study|Reason not mentioned above|0|||
33298070|NCT01324830|62674205|FG012|Overall Study|Reason not mentioned above|0|||
33298071|NCT01324830|62674206|FG013|Overall Study|Reason not mentioned above|0|||
33298072|NCT01324830|62674207|FG014|Overall Study|Reason not mentioned above|0|||
33298073|NCT01324830|62674208|FG015|Overall Study|Reason not mentioned above|0|||
33298074|NCT01324830|62674209|FG016|Overall Study|Reason not mentioned above|0|||
33298075|NCT01324830|62674210|FG017|Overall Study|Reason not mentioned above|1|||
33298076|NCT01324830|62674211|FG018|Overall Study|Reason not mentioned above|0|||
33298077|NCT01324830|62674193|FG000|Overall Study|Adverse Event, serious fatal|0|||
33298078|NCT01324830|62674194|FG001|Overall Study|Adverse Event, serious fatal|1|||
33298079|NCT01324830|62674195|FG002|Overall Study|Adverse Event, serious fatal|0|||
33298080|NCT01324830|62674196|FG003|Overall Study|Adverse Event, serious fatal|0|||
33298081|NCT01324830|62674197|FG004|Overall Study|Adverse Event, serious fatal|0|||
33298082|NCT01324830|62674198|FG005|Overall Study|Adverse Event, serious fatal|0|||
33298083|NCT01324830|62674199|FG006|Overall Study|Adverse Event, serious fatal|0|||
33298084|NCT01324830|62674200|FG007|Overall Study|Adverse Event, serious fatal|0|||
33298085|NCT01324830|62674201|FG008|Overall Study|Adverse Event, serious fatal|0|||
33298086|NCT01324830|62674202|FG009|Overall Study|Adverse Event, serious fatal|0|||
33298087|NCT01324830|62674203|FG010|Overall Study|Adverse Event, serious fatal|0|||
33298088|NCT01324830|62674204|FG011|Overall Study|Adverse Event, serious fatal|0|||
33298089|NCT01324830|62674205|FG012|Overall Study|Adverse Event, serious fatal|0|||
33298090|NCT01324830|62674206|FG013|Overall Study|Adverse Event, serious fatal|0|||
33298091|NCT01324830|62674207|FG014|Overall Study|Adverse Event, serious fatal|0|||
33298092|NCT01324830|62674208|FG015|Overall Study|Adverse Event, serious fatal|0|||
33298093|NCT01324830|62674209|FG016|Overall Study|Adverse Event, serious fatal|0|||
33298094|NCT01324830|62674210|FG017|Overall Study|Adverse Event, serious fatal|0|||
33298095|NCT01324830|62674211|FG018|Overall Study|Adverse Event, serious fatal|0|||
33298096|NCT01324830|62674193|FG000|Overall Study|Adverse Event, non-fatal|0|||
33298097|NCT01324830|62674194|FG001|Overall Study|Adverse Event, non-fatal|0|||
33298098|NCT01324830|62674195|FG002|Overall Study|Adverse Event, non-fatal|0|||
33298099|NCT01324830|62674196|FG003|Overall Study|Adverse Event, non-fatal|0|||
33298100|NCT01324830|62674197|FG004|Overall Study|Adverse Event, non-fatal|0|||
33298101|NCT01324830|62674198|FG005|Overall Study|Adverse Event, non-fatal|0|||
33387035|NCT00467779|62766096|FG003|Stage 1|Disease Progression|3|||
33387036|NCT00467779|62766097|FG004|Stage 1|Disease Progression|2|||
33298102|NCT01324830|62674199|FG006|Overall Study|Adverse Event, non-fatal|0|||
33298103|NCT01324830|62674200|FG007|Overall Study|Adverse Event, non-fatal|0|||
33387037|NCT00467779|62766098|FG005|Stage 1|Disease Progression|2|||
33387038|NCT00467779|62766099|FG006|Stage 1|Disease Progression|4|||
33387039|NCT00467779|62766100|FG007|Stage 1|Disease Progression|5|||
33387040|NCT00467779|62766101|FG008|Stage 1|Disease Progression|0|||
33387041|NCT00467779|62766102|FG009|Stage 1|Disease Progression|0|||
33387042|NCT00467779|62766103|FG010|Stage 1|Disease Progression|0|||
33298104|NCT01324830|62674201|FG008|Overall Study|Adverse Event, non-fatal|2|||
33298105|NCT01324830|62674202|FG009|Overall Study|Adverse Event, non-fatal|0|||
33298106|NCT01324830|62674203|FG010|Overall Study|Adverse Event, non-fatal|1|||
33298107|NCT01324830|62674204|FG011|Overall Study|Adverse Event, non-fatal|0|||
33298108|NCT01324830|62674205|FG012|Overall Study|Adverse Event, non-fatal|0|||
33298109|NCT01324830|62674206|FG013|Overall Study|Adverse Event, non-fatal|0|||
33298110|NCT01324830|62674207|FG014|Overall Study|Adverse Event, non-fatal|0|||
33298111|NCT01324830|62674208|FG015|Overall Study|Adverse Event, non-fatal|0|||
33298112|NCT01324830|62674209|FG016|Overall Study|Adverse Event, non-fatal|0|||
33387043|NCT00467779|62766104|FG011|Stage 1|Disease Progression|0|||
33387044|NCT00467779|62766105|FG012|Stage 1|Disease Progression|0|||
33387045|NCT00467779|62766106|FG013|Stage 1|Disease Progression|0|||
33387046|NCT00467779|62766107|FG014|Stage 1|Disease Progression|0|||
33387047|NCT00467779|62766093|FG000|Stage 1|Unspecified Reason|1|||
33387048|NCT00467779|62766094|FG001|Stage 1|Unspecified Reason|0|||
33387049|NCT00467779|62766095|FG002|Stage 1|Unspecified Reason|1|||
33387050|NCT00467779|62766096|FG003|Stage 1|Unspecified Reason|0|||
33387051|NCT00467779|62766097|FG004|Stage 1|Unspecified Reason|1|||
33387052|NCT00467779|62766098|FG005|Stage 1|Unspecified Reason|2|||
33387053|NCT00467779|62766099|FG006|Stage 1|Unspecified Reason|0|||
33387054|NCT00467779|62766100|FG007|Stage 1|Unspecified Reason|0|||
33387055|NCT00467779|62766101|FG008|Stage 1|Unspecified Reason|0|||
33387056|NCT00467779|62766102|FG009|Stage 1|Unspecified Reason|0|||
33387057|NCT00467779|62766103|FG010|Stage 1|Unspecified Reason|0|||
33387058|NCT00467779|62766104|FG011|Stage 1|Unspecified Reason|0|||
33387059|NCT00467779|62766105|FG012|Stage 1|Unspecified Reason|0|||
33387060|NCT00467779|62766106|FG013|Stage 1|Unspecified Reason|0|||
33387061|NCT00467779|62766107|FG014|Stage 1|Unspecified Reason|0|||
33387062|NCT00467779|62766093|FG000|Stage 1|Physician Decision|0|||
33387063|NCT00467779|62766094|FG001|Stage 1|Physician Decision|1|||
33387064|NCT00467779|62766095|FG002|Stage 1|Physician Decision|0|||
33387065|NCT00467779|62766096|FG003|Stage 1|Physician Decision|0|||
33387066|NCT00467779|62766097|FG004|Stage 1|Physician Decision|0|||
33387067|NCT00467779|62766098|FG005|Stage 1|Physician Decision|0|||
33387068|NCT00467779|62766099|FG006|Stage 1|Physician Decision|0|||
33387069|NCT00467779|62766100|FG007|Stage 1|Physician Decision|0|||
33387070|NCT00467779|62766101|FG008|Stage 1|Physician Decision|0|||
33387071|NCT00467779|62766102|FG009|Stage 1|Physician Decision|0|||
33387072|NCT00467779|62766103|FG010|Stage 1|Physician Decision|0|||
33387073|NCT00467779|62766104|FG011|Stage 1|Physician Decision|0|||
33387074|NCT00467779|62766105|FG012|Stage 1|Physician Decision|0|||
33387075|NCT00467779|62766106|FG013|Stage 1|Physician Decision|0|||
33387076|NCT00467779|62766107|FG014|Stage 1|Physician Decision|0|||
33387077|NCT00467779|62766093|FG000|Stage 1|Withdrawal by Subject|0|||
33387078|NCT00467779|62766094|FG001|Stage 1|Withdrawal by Subject|0|||
33387079|NCT00467779|62766095|FG002|Stage 1|Withdrawal by Subject|0|||
33387080|NCT00467779|62766096|FG003|Stage 1|Withdrawal by Subject|0|||
33387081|NCT00467779|62766097|FG004|Stage 1|Withdrawal by Subject|0|||
33387082|NCT00467779|62766098|FG005|Stage 1|Withdrawal by Subject|0|||
33387083|NCT00467779|62766099|FG006|Stage 1|Withdrawal by Subject|1|||
33387084|NCT00467779|62766100|FG007|Stage 1|Withdrawal by Subject|1|||
33387085|NCT00467779|62766101|FG008|Stage 1|Withdrawal by Subject|0|||
33387086|NCT00467779|62766102|FG009|Stage 1|Withdrawal by Subject|0|||
33387087|NCT00467779|62766103|FG010|Stage 1|Withdrawal by Subject|0|||
33387088|NCT00467779|62766104|FG011|Stage 1|Withdrawal by Subject|0|||
33387089|NCT00467779|62766105|FG012|Stage 1|Withdrawal by Subject|0|||
33387090|NCT00467779|62766106|FG013|Stage 1|Withdrawal by Subject|0|||
33387091|NCT00467779|62766107|FG014|Stage 1|Withdrawal by Subject|0|||
33387092|NCT00467779|62766093|FG000|Stage 1A|Adverse Event|0|||
33387093|NCT00467779|62766094|FG001|Stage 1A|Adverse Event|0|||
33387094|NCT00467779|62766095|FG002|Stage 1A|Adverse Event|0|||
33387095|NCT00467779|62766096|FG003|Stage 1A|Adverse Event|0|||
33387096|NCT00467779|62766097|FG004|Stage 1A|Adverse Event|0|||
33387097|NCT00467779|62766098|FG005|Stage 1A|Adverse Event|0|||
33387098|NCT00467779|62766099|FG006|Stage 1A|Adverse Event|0|||
33298113|NCT01324830|62674210|FG017|Overall Study|Adverse Event, non-fatal|1|||
33298114|NCT01324830|62674211|FG018|Overall Study|Adverse Event, non-fatal|0|||
33387099|NCT00467779|62766100|FG007|Stage 1A|Adverse Event|0|||
33387100|NCT00467779|62766101|FG008|Stage 1A|Adverse Event|0|||
33298115|NCT01324830|62674193|FG000|Overall Study|Withdrawal by Subject|0|||
33387101|NCT00467779|62766102|FG009|Stage 1A|Adverse Event|0|||
33387102|NCT00467779|62766103|FG010|Stage 1A|Adverse Event|0|||
33387103|NCT00467779|62766104|FG011|Stage 1A|Adverse Event|0|||
33387104|NCT00467779|62766105|FG012|Stage 1A|Adverse Event|1|||
33387105|NCT00467779|62766106|FG013|Stage 1A|Adverse Event|0|||
33387106|NCT00467779|62766107|FG014|Stage 1A|Adverse Event|0|||
33387107|NCT00467779|62766093|FG000|Stage 1A|Death|0|||
33387108|NCT00467779|62766094|FG001|Stage 1A|Death|0|||
33387109|NCT00467779|62766095|FG002|Stage 1A|Death|0|||
33387110|NCT00467779|62766096|FG003|Stage 1A|Death|0|||
33387111|NCT00467779|62766097|FG004|Stage 1A|Death|0|||
33387112|NCT00467779|62766098|FG005|Stage 1A|Death|0|||
33387113|NCT00467779|62766099|FG006|Stage 1A|Death|0|||
33387114|NCT00467779|62766100|FG007|Stage 1A|Death|0|||
33387115|NCT00467779|62766101|FG008|Stage 1A|Death|0|||
33387116|NCT00467779|62766102|FG009|Stage 1A|Death|0|||
33387117|NCT00467779|62766103|FG010|Stage 1A|Death|0|||
33387118|NCT00467779|62766104|FG011|Stage 1A|Death|1|||
33387119|NCT00467779|62766105|FG012|Stage 1A|Death|1|||
33387120|NCT00467779|62766106|FG013|Stage 1A|Death|0|||
33387121|NCT00467779|62766107|FG014|Stage 1A|Death|0|||
33387122|NCT00467779|62766093|FG000|Stage 1A|Disease Progression|0|||
33387123|NCT00467779|62766094|FG001|Stage 1A|Disease Progression|0|||
33387124|NCT00467779|62766095|FG002|Stage 1A|Disease Progression|0|||
33387125|NCT00467779|62766096|FG003|Stage 1A|Disease Progression|0|||
33387126|NCT00467779|62766097|FG004|Stage 1A|Disease Progression|0|||
33387127|NCT00467779|62766098|FG005|Stage 1A|Disease Progression|0|||
33387128|NCT00467779|62766099|FG006|Stage 1A|Disease Progression|0|||
33387129|NCT00467779|62766100|FG007|Stage 1A|Disease Progression|0|||
33387130|NCT00467779|62766101|FG008|Stage 1A|Disease Progression|0|||
33387131|NCT00467779|62766102|FG009|Stage 1A|Disease Progression|2|||
33387132|NCT00467779|62766103|FG010|Stage 1A|Disease Progression|2|||
33489486|NCT02757352|62867556|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33489487|NCT02757352|62867547|FG000|Follow-Up Period|Adverse Event|0|||
33489488|NCT02757352|62867548|FG001|Follow-Up Period|Adverse Event|0|||
33489489|NCT02757352|62867549|FG002|Follow-Up Period|Adverse Event|0|||
33489490|NCT02757352|62867550|FG003|Follow-Up Period|Adverse Event|0|||
33489491|NCT02757352|62867551|FG004|Follow-Up Period|Adverse Event|0|||
33489492|NCT02757352|62867552|FG005|Follow-Up Period|Adverse Event|0|||
33489493|NCT02757352|62867553|FG006|Follow-Up Period|Adverse Event|1|||
33489494|NCT02757352|62867554|FG007|Follow-Up Period|Adverse Event|0|||
33489495|NCT02757352|62867555|FG008|Follow-Up Period|Adverse Event|2|||
33298116|NCT01324830|62674194|FG001|Overall Study|Withdrawal by Subject|0|||
33298117|NCT01324830|62674195|FG002|Overall Study|Withdrawal by Subject|0|||
33298118|NCT01324830|62674196|FG003|Overall Study|Withdrawal by Subject|0|||
33298119|NCT01324830|62674197|FG004|Overall Study|Withdrawal by Subject|0|||
33298120|NCT01324830|62674198|FG005|Overall Study|Withdrawal by Subject|1|||
33298121|NCT01324830|62674199|FG006|Overall Study|Withdrawal by Subject|0|||
33489496|NCT02757352|62867556|FG009|Follow-Up Period|Adverse Event|0|||
33489497|NCT02757352|62867547|FG000|Follow-Up Period|Lost to Follow-up|0|||
33489498|NCT02757352|62867548|FG001|Follow-Up Period|Lost to Follow-up|0|||
33489499|NCT02757352|62867549|FG002|Follow-Up Period|Lost to Follow-up|0|||
33489500|NCT02757352|62867550|FG003|Follow-Up Period|Lost to Follow-up|0|||
33489501|NCT02757352|62867551|FG004|Follow-Up Period|Lost to Follow-up|0|||
33489502|NCT02757352|62867552|FG005|Follow-Up Period|Lost to Follow-up|0|||
33298122|NCT01324830|62674200|FG007|Overall Study|Withdrawal by Subject|0|||
33298123|NCT01324830|62674201|FG008|Overall Study|Withdrawal by Subject|0|||
33298124|NCT01324830|62674202|FG009|Overall Study|Withdrawal by Subject|0|||
33298125|NCT01324830|62674203|FG010|Overall Study|Withdrawal by Subject|1|||
33298126|NCT01324830|62674204|FG011|Overall Study|Withdrawal by Subject|0|||
33298127|NCT01324830|62674205|FG012|Overall Study|Withdrawal by Subject|0|||
33298128|NCT01324830|62674206|FG013|Overall Study|Withdrawal by Subject|0|||
33298129|NCT01324830|62674207|FG014|Overall Study|Withdrawal by Subject|0|||
33298130|NCT01324830|62674208|FG015|Overall Study|Withdrawal by Subject|0|||
33298131|NCT01324830|62674209|FG016|Overall Study|Withdrawal by Subject|0|||
33298132|NCT01324830|62674210|FG017|Overall Study|Withdrawal by Subject|0|||
33298133|NCT01324830|62674211|FG018|Overall Study|Withdrawal by Subject|1|||
33298134|NCT01324440|62674259|FG000|Overall Study|Subject moved|0|||
33298135|NCT01324440|62674260|FG001|Overall Study|Subject moved|1|||
33298136|NCT01325493|62674268|FG000|Overall Study|Protocol Violation|0|||
33298137|NCT01325493|62674269|FG001|Overall Study|Protocol Violation|1|||
33298138|NCT01325493|62674268|FG000|Overall Study|loss of neuromonitoring signals|0|||
33298139|NCT01325493|62674269|FG001|Overall Study|loss of neuromonitoring signals|2|||
33298140|NCT01325493|62674268|FG000|Overall Study|Allergy|1|||
33298141|NCT01325493|62674269|FG001|Overall Study|Allergy|0|||
33298142|NCT01323972|62674279|FG000|Overall Study|Withdrawal by Subject|1|||
33298143|NCT01323972|62674280|FG001|Overall Study|Withdrawal by Subject|0|||
33387133|NCT00467779|62766104|FG011|Stage 1A|Disease Progression|5|||
33489503|NCT02757352|62867553|FG006|Follow-Up Period|Lost to Follow-up|0|||
33387134|NCT00467779|62766105|FG012|Stage 1A|Disease Progression|2|||
33387135|NCT00467779|62766106|FG013|Stage 1A|Disease Progression|0|||
33489504|NCT02757352|62867554|FG007|Follow-Up Period|Lost to Follow-up|0|||
33298144|NCT01323972|62674281|FG002|Overall Study|Withdrawal by Subject|1|||
33298145|NCT01323972|62674282|FG003|Overall Study|Withdrawal by Subject|0|||
33489505|NCT02757352|62867555|FG008|Follow-Up Period|Lost to Follow-up|1|||
33387136|NCT00467779|62766107|FG014|Stage 1A|Disease Progression|0|||
33387137|NCT00467779|62766093|FG000|Stage 1A|Physician Decision|0|||
33387138|NCT00467779|62766094|FG001|Stage 1A|Physician Decision|0|||
33489506|NCT02757352|62867556|FG009|Follow-Up Period|Lost to Follow-up|0|||
33298146|NCT01323972|62674279|FG000|Overall Study|Migrated/moved from study area|1|||
33298147|NCT01323972|62674280|FG001|Overall Study|Migrated/moved from study area|2|||
33387139|NCT00467779|62766095|FG002|Stage 1A|Physician Decision|0|||
33387140|NCT00467779|62766096|FG003|Stage 1A|Physician Decision|0|||
33387141|NCT00467779|62766097|FG004|Stage 1A|Physician Decision|0|||
33387142|NCT00467779|62766098|FG005|Stage 1A|Physician Decision|0|||
33387143|NCT00467779|62766099|FG006|Stage 1A|Physician Decision|0|||
33298148|NCT01323972|62674281|FG002|Overall Study|Migrated/moved from study area|0|||
33298149|NCT01323972|62674282|FG003|Overall Study|Migrated/moved from study area|0|||
33298150|NCT01323972|62674279|FG000|Overall Study|Lost to Follow-up|0|||
33298151|NCT01323972|62674280|FG001|Overall Study|Lost to Follow-up|1|||
33298152|NCT01323972|62674281|FG002|Overall Study|Lost to Follow-up|1|||
33298153|NCT01323972|62674282|FG003|Overall Study|Lost to Follow-up|1|||
33298154|NCT01325337|62674299|FG000|Overall Study|Adverse Event|0|||
33298155|NCT01325337|62674300|FG001|Overall Study|Adverse Event|2|||
33298156|NCT01325337|62674301|FG002|Overall Study|Adverse Event|2|||
33387144|NCT00467779|62766100|FG007|Stage 1A|Physician Decision|0|||
33387145|NCT00467779|62766101|FG008|Stage 1A|Physician Decision|0|||
33387146|NCT00467779|62766102|FG009|Stage 1A|Physician Decision|1|||
33387147|NCT00467779|62766103|FG010|Stage 1A|Physician Decision|0|||
33387148|NCT00467779|62766104|FG011|Stage 1A|Physician Decision|0|||
33387149|NCT00467779|62766105|FG012|Stage 1A|Physician Decision|0|||
33387150|NCT00467779|62766106|FG013|Stage 1A|Physician Decision|0|||
33387151|NCT00467779|62766107|FG014|Stage 1A|Physician Decision|0|||
33387152|NCT00467779|62766093|FG000|Stage 1A|Withdrawal by Subject|0|||
33387153|NCT00467779|62766094|FG001|Stage 1A|Withdrawal by Subject|0|||
33387154|NCT00467779|62766095|FG002|Stage 1A|Withdrawal by Subject|0|||
33387155|NCT00467779|62766096|FG003|Stage 1A|Withdrawal by Subject|0|||
33387156|NCT00467779|62766097|FG004|Stage 1A|Withdrawal by Subject|0|||
33387157|NCT00467779|62766098|FG005|Stage 1A|Withdrawal by Subject|0|||
33387158|NCT00467779|62766099|FG006|Stage 1A|Withdrawal by Subject|0|||
33387159|NCT00467779|62766100|FG007|Stage 1A|Withdrawal by Subject|0|||
33387160|NCT00467779|62766101|FG008|Stage 1A|Withdrawal by Subject|0|||
33387161|NCT00467779|62766102|FG009|Stage 1A|Withdrawal by Subject|0|||
33387162|NCT00467779|62766103|FG010|Stage 1A|Withdrawal by Subject|1|||
33387163|NCT00467779|62766104|FG011|Stage 1A|Withdrawal by Subject|1|||
33387164|NCT00467779|62766105|FG012|Stage 1A|Withdrawal by Subject|1|||
33387165|NCT00467779|62766106|FG013|Stage 1A|Withdrawal by Subject|0|||
33387166|NCT00467779|62766107|FG014|Stage 1A|Withdrawal by Subject|0|||
33387167|NCT00467779|62766093|FG000|Stage 1A|Unspecified Reason|0|||
33387168|NCT00467779|62766094|FG001|Stage 1A|Unspecified Reason|0|||
33387169|NCT00467779|62766095|FG002|Stage 1A|Unspecified Reason|0|||
33387170|NCT00467779|62766096|FG003|Stage 1A|Unspecified Reason|0|||
33387171|NCT00467779|62766097|FG004|Stage 1A|Unspecified Reason|0|||
33387172|NCT00467779|62766098|FG005|Stage 1A|Unspecified Reason|0|||
33387173|NCT00467779|62766099|FG006|Stage 1A|Unspecified Reason|0|||
33387174|NCT00467779|62766100|FG007|Stage 1A|Unspecified Reason|0|||
33387175|NCT00467779|62766101|FG008|Stage 1A|Unspecified Reason|0|||
33387176|NCT00467779|62766102|FG009|Stage 1A|Unspecified Reason|0|||
33387177|NCT00467779|62766103|FG010|Stage 1A|Unspecified Reason|0|||
33387178|NCT00467779|62766104|FG011|Stage 1A|Unspecified Reason|1|||
33387179|NCT00467779|62766105|FG012|Stage 1A|Unspecified Reason|1|||
33387180|NCT00467779|62766106|FG013|Stage 1A|Unspecified Reason|0|||
33387181|NCT00467779|62766107|FG014|Stage 1A|Unspecified Reason|0|||
33387182|NCT00467779|62766093|FG000|Stage 2|Adverse Event|0|||
33387183|NCT00467779|62766094|FG001|Stage 2|Adverse Event|0|||
33387184|NCT00467779|62766095|FG002|Stage 2|Adverse Event|0|||
33387185|NCT00467779|62766096|FG003|Stage 2|Adverse Event|0|||
33298157|NCT01325337|62674302|FG003|Overall Study|Adverse Event|1|||
33298158|NCT01325337|62674303|FG004|Overall Study|Adverse Event|2|||
33298159|NCT01325337|62674299|FG000|Overall Study|Lost to Follow-up|2|||
33298160|NCT01325337|62674300|FG001|Overall Study|Lost to Follow-up|2|||
33298161|NCT01325337|62674301|FG002|Overall Study|Lost to Follow-up|2|||
33298162|NCT01325337|62674302|FG003|Overall Study|Lost to Follow-up|1|||
33298163|NCT01325337|62674303|FG004|Overall Study|Lost to Follow-up|2|||
33298164|NCT01325337|62674299|FG000|Overall Study|Personal Reasons|2|||
33298165|NCT01325337|62674300|FG001|Overall Study|Personal Reasons|5|||
33298166|NCT01325337|62674301|FG002|Overall Study|Personal Reasons|4|||
33298167|NCT01325337|62674302|FG003|Overall Study|Personal Reasons|8|||
33387186|NCT00467779|62766097|FG004|Stage 2|Adverse Event|0|||
33387187|NCT00467779|62766098|FG005|Stage 2|Adverse Event|0|||
33387188|NCT00467779|62766099|FG006|Stage 2|Adverse Event|0|||
33387189|NCT00467779|62766100|FG007|Stage 2|Adverse Event|0|||
33387190|NCT00467779|62766101|FG008|Stage 2|Adverse Event|1|||
33387191|NCT00467779|62766102|FG009|Stage 2|Adverse Event|0|||
33387192|NCT00467779|62766103|FG010|Stage 2|Adverse Event|0|||
33298168|NCT01325337|62674303|FG004|Overall Study|Personal Reasons|3|||
33298169|NCT01325337|62674299|FG000|Overall Study|Withdrawal by Subject|1|||
33387193|NCT00467779|62766104|FG011|Stage 2|Adverse Event|0|||
33387194|NCT00467779|62766105|FG012|Stage 2|Adverse Event|0|||
33387195|NCT00467779|62766106|FG013|Stage 2|Adverse Event|0|||
33387196|NCT00467779|62766107|FG014|Stage 2|Adverse Event|0|||
33387197|NCT00467779|62766093|FG000|Stage 2|Death|0|||
33387198|NCT00467779|62766094|FG001|Stage 2|Death|0|||
33387199|NCT00467779|62766095|FG002|Stage 2|Death|0|||
33387200|NCT00467779|62766096|FG003|Stage 2|Death|0|||
33387201|NCT00467779|62766097|FG004|Stage 2|Death|0|||
33387202|NCT00467779|62766098|FG005|Stage 2|Death|0|||
33387203|NCT00467779|62766099|FG006|Stage 2|Death|0|||
33387204|NCT00467779|62766100|FG007|Stage 2|Death|0|||
33387205|NCT00467779|62766101|FG008|Stage 2|Death|1|||
33387206|NCT00467779|62766102|FG009|Stage 2|Death|0|||
33298170|NCT01325337|62674300|FG001|Overall Study|Withdrawal by Subject|0|||
33298171|NCT01325337|62674301|FG002|Overall Study|Withdrawal by Subject|1|||
33298172|NCT01325337|62674302|FG003|Overall Study|Withdrawal by Subject|0|||
33298173|NCT01325337|62674303|FG004|Overall Study|Withdrawal by Subject|1|||
33298174|NCT01324947|62674315|FG000|Overall Study|Adverse Event|7|||
33298175|NCT01324947|62674315|FG000|Overall Study|Death|10|||
33298176|NCT01324947|62674315|FG000|Overall Study|Other|3|||
33298177|NCT01324947|62674315|FG000|Overall Study|Progressive Disease|50|||
33298178|NCT01324947|62674315|FG000|Overall Study|Withdrawal by Subject|3|||
33387207|NCT00467779|62766103|FG010|Stage 2|Death|0|||
33387208|NCT00467779|62766104|FG011|Stage 2|Death|0|||
33387209|NCT00467779|62766105|FG012|Stage 2|Death|0|||
33387210|NCT00467779|62766106|FG013|Stage 2|Death|0|||
33387211|NCT00467779|62766107|FG014|Stage 2|Death|0|||
33387212|NCT00467779|62766093|FG000|Stage 2|Disease Progression|0|||
33387213|NCT00467779|62766094|FG001|Stage 2|Disease Progression|0|||
33387214|NCT00467779|62766095|FG002|Stage 2|Disease Progression|0|||
33387215|NCT00467779|62766096|FG003|Stage 2|Disease Progression|0|||
33387216|NCT00467779|62766097|FG004|Stage 2|Disease Progression|0|||
33387217|NCT00467779|62766098|FG005|Stage 2|Disease Progression|0|||
33387218|NCT00467779|62766099|FG006|Stage 2|Disease Progression|0|||
33387219|NCT00467779|62766100|FG007|Stage 2|Disease Progression|0|||
33387220|NCT00467779|62766101|FG008|Stage 2|Disease Progression|16|||
33387221|NCT00467779|62766102|FG009|Stage 2|Disease Progression|0|||
33387222|NCT00467779|62766103|FG010|Stage 2|Disease Progression|0|||
33387223|NCT00467779|62766104|FG011|Stage 2|Disease Progression|0|||
33387224|NCT00467779|62766105|FG012|Stage 2|Disease Progression|0|||
33387225|NCT00467779|62766106|FG013|Stage 2|Disease Progression|0|||
33387226|NCT00467779|62766107|FG014|Stage 2|Disease Progression|0|||
33387227|NCT00467779|62766093|FG000|Stage 2|Unspecified Reason|0|||
33387228|NCT00467779|62766094|FG001|Stage 2|Unspecified Reason|0|||
33387229|NCT00467779|62766095|FG002|Stage 2|Unspecified Reason|0|||
33387230|NCT00467779|62766096|FG003|Stage 2|Unspecified Reason|0|||
33387231|NCT00467779|62766097|FG004|Stage 2|Unspecified Reason|0|||
33387232|NCT00467779|62766098|FG005|Stage 2|Unspecified Reason|0|||
33387233|NCT00467779|62766099|FG006|Stage 2|Unspecified Reason|0|||
33387234|NCT00467779|62766100|FG007|Stage 2|Unspecified Reason|0|||
33387235|NCT00467779|62766101|FG008|Stage 2|Unspecified Reason|3|||
33387236|NCT00467779|62766102|FG009|Stage 2|Unspecified Reason|0|||
33387237|NCT00467779|62766103|FG010|Stage 2|Unspecified Reason|0|||
33387238|NCT00467779|62766104|FG011|Stage 2|Unspecified Reason|0|||
33387239|NCT00467779|62766105|FG012|Stage 2|Unspecified Reason|0|||
33387240|NCT00467779|62766106|FG013|Stage 2|Unspecified Reason|0|||
33387241|NCT00467779|62766107|FG014|Stage 2|Unspecified Reason|0|||
33387242|NCT00467779|62766093|FG000|Stage 2A|Adverse Event|0|||
33387243|NCT00467779|62766094|FG001|Stage 2A|Adverse Event|0|||
33387244|NCT00467779|62766095|FG002|Stage 2A|Adverse Event|0|||
33387245|NCT00467779|62766096|FG003|Stage 2A|Adverse Event|0|||
33387246|NCT00467779|62766097|FG004|Stage 2A|Adverse Event|0|||
33387247|NCT00467779|62766098|FG005|Stage 2A|Adverse Event|0|||
33387248|NCT00467779|62766099|FG006|Stage 2A|Adverse Event|0|||
33387249|NCT00467779|62766100|FG007|Stage 2A|Adverse Event|0|||
33387250|NCT00467779|62766101|FG008|Stage 2A|Adverse Event|0|||
33387251|NCT00467779|62766102|FG009|Stage 2A|Adverse Event|0|||
33387252|NCT00467779|62766103|FG010|Stage 2A|Adverse Event|0|||
33387253|NCT00467779|62766104|FG011|Stage 2A|Adverse Event|0|||
33387254|NCT00467779|62766105|FG012|Stage 2A|Adverse Event|0|||
33387255|NCT00467779|62766106|FG013|Stage 2A|Adverse Event|2|||
33387256|NCT00467779|62766107|FG014|Stage 2A|Adverse Event|0|||
33387257|NCT00467779|62766093|FG000|Stage 2A|Death|0|||
33556796|NCT02339584|62949645|FG000|Overall Study|Withdrawal by Subject|2|||
33387258|NCT00467779|62766094|FG001|Stage 2A|Death|0|||
33387259|NCT00467779|62766095|FG002|Stage 2A|Death|0|||
33387260|NCT00467779|62766096|FG003|Stage 2A|Death|0|||
33298179|NCT01324947|62674315|FG000|Overall Study|1 discontinued before starting drug|1|||
33387261|NCT00467779|62766097|FG004|Stage 2A|Death|0|||
33387262|NCT00467779|62766098|FG005|Stage 2A|Death|0|||
33387263|NCT00467779|62766099|FG006|Stage 2A|Death|0|||
33387264|NCT00467779|62766100|FG007|Stage 2A|Death|0|||
33387265|NCT00467779|62766101|FG008|Stage 2A|Death|0|||
33298180|NCT01101841|62674323|FG000|Overall Study|Adverse Event|15|||
33387266|NCT00467779|62766102|FG009|Stage 2A|Death|0|||
33387267|NCT00467779|62766103|FG010|Stage 2A|Death|0|||
33298181|NCT01101841|62674324|FG001|Overall Study|Adverse Event|15|||
33387268|NCT00467779|62766104|FG011|Stage 2A|Death|0|||
33387269|NCT00467779|62766105|FG012|Stage 2A|Death|0|||
33387270|NCT00467779|62766106|FG013|Stage 2A|Death|1|||
33387271|NCT00467779|62766107|FG014|Stage 2A|Death|0|||
33387272|NCT00467779|62766093|FG000|Stage 2A|Disease Progression|0|||
33387273|NCT00467779|62766094|FG001|Stage 2A|Disease Progression|0|||
33387274|NCT00467779|62766095|FG002|Stage 2A|Disease Progression|0|||
33387275|NCT00467779|62766096|FG003|Stage 2A|Disease Progression|0|||
33387276|NCT00467779|62766097|FG004|Stage 2A|Disease Progression|0|||
33387277|NCT00467779|62766098|FG005|Stage 2A|Disease Progression|0|||
33387278|NCT00467779|62766099|FG006|Stage 2A|Disease Progression|0|||
33387279|NCT00467779|62766100|FG007|Stage 2A|Disease Progression|0|||
33387280|NCT00467779|62766101|FG008|Stage 2A|Disease Progression|0|||
33387281|NCT00467779|62766102|FG009|Stage 2A|Disease Progression|0|||
33387282|NCT00467779|62766103|FG010|Stage 2A|Disease Progression|0|||
33387283|NCT00467779|62766104|FG011|Stage 2A|Disease Progression|0|||
33387284|NCT00467779|62766105|FG012|Stage 2A|Disease Progression|0|||
33387285|NCT00467779|62766106|FG013|Stage 2A|Disease Progression|10|||
33387286|NCT00467779|62766107|FG014|Stage 2A|Disease Progression|0|||
33387287|NCT00467779|62766093|FG000|Stage 2A|Unspecified Reason|0|||
33387288|NCT00467779|62766094|FG001|Stage 2A|Unspecified Reason|0|||
33387289|NCT00467779|62766095|FG002|Stage 2A|Unspecified Reason|0|||
33387290|NCT00467779|62766096|FG003|Stage 2A|Unspecified Reason|0|||
33387291|NCT00467779|62766097|FG004|Stage 2A|Unspecified Reason|0|||
33387292|NCT00467779|62766098|FG005|Stage 2A|Unspecified Reason|0|||
33387293|NCT00467779|62766099|FG006|Stage 2A|Unspecified Reason|0|||
33387294|NCT00467779|62766100|FG007|Stage 2A|Unspecified Reason|0|||
33387295|NCT00467779|62766101|FG008|Stage 2A|Unspecified Reason|0|||
33387296|NCT00467779|62766102|FG009|Stage 2A|Unspecified Reason|0|||
33387297|NCT00467779|62766103|FG010|Stage 2A|Unspecified Reason|0|||
33387298|NCT00467779|62766104|FG011|Stage 2A|Unspecified Reason|0|||
33387299|NCT00467779|62766105|FG012|Stage 2A|Unspecified Reason|0|||
33387300|NCT00467779|62766106|FG013|Stage 2A|Unspecified Reason|7|||
33387301|NCT00467779|62766107|FG014|Stage 2A|Unspecified Reason|0|||
33387302|NCT00467779|62766093|FG000|Stage 2A|Withdrawal by Subject|0|||
33387303|NCT00467779|62766094|FG001|Stage 2A|Withdrawal by Subject|0|||
33387304|NCT00467779|62766095|FG002|Stage 2A|Withdrawal by Subject|0|||
33298182|NCT01101841|62674323|FG000|Overall Study|Lost to Follow-up|9|||
33298183|NCT01101841|62674324|FG001|Overall Study|Lost to Follow-up|3|||
33298184|NCT01101841|62674323|FG000|Overall Study|Withdrawal by Subject|21|||
33298185|NCT01101841|62674324|FG001|Overall Study|Withdrawal by Subject|40|||
33387305|NCT00467779|62766096|FG003|Stage 2A|Withdrawal by Subject|0|||
33298186|NCT01101841|62674323|FG000|Overall Study|Protocol Violation|1|||
33298187|NCT01101841|62674324|FG001|Overall Study|Protocol Violation|1|||
33298188|NCT01101841|62674323|FG000|Overall Study|Physician Decision|0|||
33298189|NCT01101841|62674324|FG001|Overall Study|Physician Decision|2|||
33298190|NCT01101841|62674323|FG000|Overall Study|Lack of Efficacy|0|||
33298191|NCT01101841|62674324|FG001|Overall Study|Lack of Efficacy|2|||
33387306|NCT00467779|62766097|FG004|Stage 2A|Withdrawal by Subject|0|||
33387307|NCT00467779|62766098|FG005|Stage 2A|Withdrawal by Subject|0|||
33387308|NCT00467779|62766099|FG006|Stage 2A|Withdrawal by Subject|0|||
33387309|NCT00467779|62766100|FG007|Stage 2A|Withdrawal by Subject|0|||
33387310|NCT00467779|62766101|FG008|Stage 2A|Withdrawal by Subject|0|||
33387311|NCT00467779|62766102|FG009|Stage 2A|Withdrawal by Subject|0|||
33387312|NCT00467779|62766103|FG010|Stage 2A|Withdrawal by Subject|0|||
33387313|NCT00467779|62766104|FG011|Stage 2A|Withdrawal by Subject|0|||
33387314|NCT00467779|62766105|FG012|Stage 2A|Withdrawal by Subject|0|||
33387315|NCT00467779|62766106|FG013|Stage 2A|Withdrawal by Subject|1|||
33387316|NCT00467779|62766107|FG014|Stage 2A|Withdrawal by Subject|0|||
33387317|NCT00467779|62766093|FG000|Stage 3|Adverse Event|0|||
33387318|NCT00467779|62766094|FG001|Stage 3|Adverse Event|0|||
33489507|NCT02757352|62867547|FG000|Follow-Up Period|Lack of Efficacy|0|||
33489508|NCT02757352|62867548|FG001|Follow-Up Period|Lack of Efficacy|0|||
33489509|NCT02757352|62867549|FG002|Follow-Up Period|Lack of Efficacy|0|||
33489510|NCT02757352|62867550|FG003|Follow-Up Period|Lack of Efficacy|0|||
33489511|NCT02757352|62867551|FG004|Follow-Up Period|Lack of Efficacy|0|||
33489512|NCT02757352|62867552|FG005|Follow-Up Period|Lack of Efficacy|0|||
33387319|NCT00467779|62766095|FG002|Stage 3|Adverse Event|0|||
33387320|NCT00467779|62766096|FG003|Stage 3|Adverse Event|0|||
33387321|NCT00467779|62766097|FG004|Stage 3|Adverse Event|0|||
33387322|NCT00467779|62766098|FG005|Stage 3|Adverse Event|0|||
33387323|NCT00467779|62766099|FG006|Stage 3|Adverse Event|0|||
33387324|NCT00467779|62766100|FG007|Stage 3|Adverse Event|0|||
33387325|NCT00467779|62766101|FG008|Stage 3|Adverse Event|0|||
33387326|NCT00467779|62766102|FG009|Stage 3|Adverse Event|0|||
33387327|NCT00467779|62766103|FG010|Stage 3|Adverse Event|0|||
33387328|NCT00467779|62766104|FG011|Stage 3|Adverse Event|0|||
33387329|NCT00467779|62766105|FG012|Stage 3|Adverse Event|0|||
33489513|NCT02757352|62867553|FG006|Follow-Up Period|Lack of Efficacy|0|||
33489514|NCT02757352|62867554|FG007|Follow-Up Period|Lack of Efficacy|0|||
33298192|NCT01101841|62674323|FG000|Overall Study|Other|0|||
33298193|NCT01101841|62674324|FG001|Overall Study|Other|1|||
33387330|NCT00467779|62766106|FG013|Stage 3|Adverse Event|0|||
33387331|NCT00467779|62766107|FG014|Stage 3|Adverse Event|2|||
33387332|NCT00467779|62766093|FG000|Stage 3|Death|0|||
33387333|NCT00467779|62766094|FG001|Stage 3|Death|0|||
33387334|NCT00467779|62766095|FG002|Stage 3|Death|0|||
33387335|NCT00467779|62766096|FG003|Stage 3|Death|0|||
33387336|NCT00467779|62766097|FG004|Stage 3|Death|0|||
33387337|NCT00467779|62766098|FG005|Stage 3|Death|0|||
33387338|NCT00467779|62766099|FG006|Stage 3|Death|0|||
33387339|NCT00467779|62766100|FG007|Stage 3|Death|0|||
33387340|NCT00467779|62766101|FG008|Stage 3|Death|0|||
33387341|NCT00467779|62766102|FG009|Stage 3|Death|0|||
33387342|NCT00467779|62766103|FG010|Stage 3|Death|0|||
33387343|NCT00467779|62766104|FG011|Stage 3|Death|0|||
33387344|NCT00467779|62766105|FG012|Stage 3|Death|0|||
33387345|NCT00467779|62766106|FG013|Stage 3|Death|0|||
33387346|NCT00467779|62766107|FG014|Stage 3|Death|1|||
33387347|NCT00467779|62766093|FG000|Stage 3|Disease Progression|0|||
33387348|NCT00467779|62766094|FG001|Stage 3|Disease Progression|0|||
33387349|NCT00467779|62766095|FG002|Stage 3|Disease Progression|0|||
33387350|NCT00467779|62766096|FG003|Stage 3|Disease Progression|0|||
33387351|NCT00467779|62766097|FG004|Stage 3|Disease Progression|0|||
33387352|NCT00467779|62766098|FG005|Stage 3|Disease Progression|0|||
33387353|NCT00467779|62766099|FG006|Stage 3|Disease Progression|0|||
33387354|NCT00467779|62766100|FG007|Stage 3|Disease Progression|0|||
33387355|NCT00467779|62766101|FG008|Stage 3|Disease Progression|0|||
33387356|NCT00467779|62766102|FG009|Stage 3|Disease Progression|0|||
33387357|NCT00467779|62766103|FG010|Stage 3|Disease Progression|0|||
33387358|NCT00467779|62766104|FG011|Stage 3|Disease Progression|0|||
33387359|NCT00467779|62766105|FG012|Stage 3|Disease Progression|0|||
33387360|NCT00467779|62766106|FG013|Stage 3|Disease Progression|0|||
33387361|NCT00467779|62766107|FG014|Stage 3|Disease Progression|9|||
33387362|NCT00467779|62766093|FG000|Stage 3|Unspecified Reason|0|||
33387363|NCT00467779|62766094|FG001|Stage 3|Unspecified Reason|0|||
33387364|NCT00467779|62766095|FG002|Stage 3|Unspecified Reason|0|||
33387365|NCT00467779|62766096|FG003|Stage 3|Unspecified Reason|0|||
33387366|NCT00467779|62766097|FG004|Stage 3|Unspecified Reason|0|||
33387367|NCT00467779|62766098|FG005|Stage 3|Unspecified Reason|0|||
33387368|NCT00467779|62766099|FG006|Stage 3|Unspecified Reason|0|||
33387369|NCT00467779|62766100|FG007|Stage 3|Unspecified Reason|0|||
33387370|NCT00467779|62766101|FG008|Stage 3|Unspecified Reason|0|||
33387371|NCT00467779|62766102|FG009|Stage 3|Unspecified Reason|0|||
33387372|NCT00467779|62766103|FG010|Stage 3|Unspecified Reason|0|||
33387373|NCT00467779|62766104|FG011|Stage 3|Unspecified Reason|0|||
33387374|NCT00467779|62766105|FG012|Stage 3|Unspecified Reason|0|||
33387375|NCT00467779|62766106|FG013|Stage 3|Unspecified Reason|0|||
33387376|NCT00467779|62766107|FG014|Stage 3|Unspecified Reason|5|||
33387377|NCT00570687|62766147|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387378|NCT00570687|62766148|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387379|NCT00570687|62766149|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387380|NCT00570687|62766150|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33298194|NCT01101841|62674323|FG000|Overall Study|Suicidality Tracking Scale|3|||
33298195|NCT01101841|62674324|FG001|Overall Study|Suicidality Tracking Scale|1|||
33298196|NCT01101841|62674323|FG000|Overall Study|Eligibility Criteria|1|||
33298197|NCT01101841|62674324|FG001|Overall Study|Eligibility Criteria|2|||
33298198|NCT01324401|62674333|FG000|Overall Study|Withdrawn before any treatment|0|||
33298199|NCT01324401|62674334|FG001|Overall Study|Withdrawn before any treatment|3|||
33298200|NCT01324401|62674333|FG000|Overall Study|Adverse Event|1|||
33298201|NCT01324401|62674334|FG001|Overall Study|Adverse Event|3|||
33298202|NCT01323660|62674340|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
33298203|NCT01323660|62674341|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
33298204|NCT01323660|62674342|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
33298205|NCT01323660|62674343|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
33298206|NCT01323660|62674344|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
33298207|NCT01323660|62674345|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
33298208|NCT01323660|62674340|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
33298209|NCT01323660|62674341|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
33298210|NCT01323660|62674342|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
33298211|NCT01323660|62674343|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
33387381|NCT00570687|62766151|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
33387382|NCT00570687|62766152|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
33387383|NCT00570687|62766153|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
33387384|NCT00570687|62766154|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
33387385|NCT00570687|62766155|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
33387386|NCT00570687|62766156|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
33387387|NCT00570687|62766147|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387388|NCT00570687|62766148|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33298212|NCT01323660|62674344|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
33387389|NCT00570687|62766149|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387390|NCT00570687|62766150|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387391|NCT00570687|62766151|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387392|NCT00570687|62766152|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387393|NCT00570687|62766153|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387394|NCT00570687|62766154|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387395|NCT00570687|62766155|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
33387396|NCT00570687|62766156|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387397|NCT00570687|62766147|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387398|NCT00570687|62766148|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387399|NCT00570687|62766149|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33298213|NCT01323660|62674345|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
33298214|NCT01323660|62674340|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
33298215|NCT01323660|62674341|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
33298216|NCT01323660|62674342|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
33298217|NCT01323660|62674343|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
33298218|NCT01323660|62674344|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
33298219|NCT01323660|62674345|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
33489515|NCT02757352|62867555|FG008|Follow-Up Period|Lack of Efficacy|1|||
33556797|NCT02339584|62949646|FG001|Overall Study|Withdrawal by Subject|4|||
33298220|NCT01323660|62674340|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33298221|NCT01323660|62674341|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33298222|NCT01323660|62674342|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33298223|NCT01323660|62674343|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33298224|NCT01323660|62674344|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
33298225|NCT01323660|62674345|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33298226|NCT01323660|62674340|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33298227|NCT01323660|62674341|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33298228|NCT01323660|62674342|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33298229|NCT01323660|62674343|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33298230|NCT01323660|62674344|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
33387400|NCT00570687|62766150|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387401|NCT00570687|62766151|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387402|NCT00570687|62766152|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387403|NCT00570687|62766153|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
33387404|NCT00570687|62766154|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387405|NCT00570687|62766155|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387406|NCT00570687|62766156|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33387407|NCT03836677|62766170|FG000|Period 1|Adverse Event|0|||
33298231|NCT01323660|62674345|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33298232|NCT01323660|62674340|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
33298233|NCT01323660|62674341|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33298234|NCT01323660|62674342|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
33298235|NCT01323660|62674343|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
33298236|NCT01323660|62674344|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
33298237|NCT01323660|62674345|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33298238|NCT01323660|62674340|FG000|Washout Period (14 Days)|Adverse Event|0|||
33298239|NCT01323660|62674341|FG001|Washout Period (14 Days)|Adverse Event|0|||
33298240|NCT01323660|62674342|FG002|Washout Period (14 Days)|Adverse Event|0|||
33298241|NCT01323660|62674343|FG003|Washout Period (14 Days)|Adverse Event|0|||
33298242|NCT01323660|62674344|FG004|Washout Period (14 Days)|Adverse Event|1|||
33298243|NCT01323660|62674345|FG005|Washout Period (14 Days)|Adverse Event|0|||
33298244|NCT01323660|62674340|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
33298245|NCT01323660|62674341|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
33298246|NCT01323660|62674342|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
33298247|NCT01323660|62674343|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
33298248|NCT01323660|62674344|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
33298249|NCT01323660|62674345|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
33298250|NCT01323660|62674340|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
33298251|NCT01323660|62674341|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
33298252|NCT01323660|62674342|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
33298253|NCT01323660|62674343|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
33298254|NCT01323660|62674344|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
33298255|NCT01323660|62674345|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
33298256|NCT01323660|62674340|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
33298257|NCT01323660|62674341|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
33298258|NCT01323660|62674342|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
33298259|NCT01323660|62674343|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
33298260|NCT01323660|62674344|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
33298261|NCT01323660|62674345|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
33298262|NCT01323660|62674340|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
33387408|NCT03836677|62766171|FG001|Period 1|Adverse Event|1|||
33556798|NCT02339506|62949652|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
33298263|NCT01323660|62674341|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
33387409|NCT03836677|62766170|FG000|Period 2|Severe non-compliance to protocol|1|||
33387410|NCT03836677|62766171|FG001|Period 2|Severe non-compliance to protocol|0|||
33387411|NCT00434161|62766202|FG000|Overall Study|Adverse Event|5|||
33387412|NCT00434161|62766203|FG001|Overall Study|Adverse Event|1|||
33387413|NCT00434161|62766204|FG002|Overall Study|Adverse Event|4|||
33387414|NCT00434161|62766202|FG000|Overall Study|Lost to Follow-up|0|||
33387415|NCT00434161|62766203|FG001|Overall Study|Lost to Follow-up|1|||
33387416|NCT00434161|62766204|FG002|Overall Study|Lost to Follow-up|0|||
33387417|NCT00434161|62766202|FG000|Overall Study|Death|1|||
33387418|NCT00434161|62766203|FG001|Overall Study|Death|0|||
33387419|NCT00434161|62766204|FG002|Overall Study|Death|1|||
33387420|NCT00434161|62766202|FG000|Overall Study|Non-Compliance|1|||
33387421|NCT00434161|62766203|FG001|Overall Study|Non-Compliance|1|||
33387422|NCT00434161|62766204|FG002|Overall Study|Non-Compliance|0|||
33387423|NCT00434161|62766202|FG000|Overall Study|Withdrawal by Subject|2|||
33387424|NCT00434161|62766203|FG001|Overall Study|Withdrawal by Subject|0|||
33387425|NCT00434161|62766204|FG002|Overall Study|Withdrawal by Subject|3|||
33387426|NCT00434161|62766202|FG000|Overall Study|Logistical error study assessments|1|||
33387427|NCT00434161|62766203|FG001|Overall Study|Logistical error study assessments|0|||
33387428|NCT00434161|62766204|FG002|Overall Study|Logistical error study assessments|3|||
33387429|NCT00441103|62766221|FG000|Overall Study|Adverse Event|2|||
33387430|NCT00441103|62766222|FG001|Overall Study|Adverse Event|1|||
33387431|NCT00441103|62766221|FG000|Overall Study|Death|1|||
33387432|NCT00441103|62766222|FG001|Overall Study|Death|0|||
33387433|NCT00441103|62766221|FG000|Overall Study|Disease Progression|2|||
33387434|NCT00441103|62766222|FG001|Overall Study|Disease Progression|0|||
33387435|NCT00441103|62766221|FG000|Overall Study|Lost to Follow-up|1|||
33387436|NCT00441103|62766222|FG001|Overall Study|Lost to Follow-up|0|||
33387437|NCT00441103|62766221|FG000|Overall Study|Protocol Violation|1|||
33387438|NCT00441103|62766222|FG001|Overall Study|Protocol Violation|0|||
33387439|NCT00441103|62766221|FG000|Overall Study|Participant unable to use Rebiject II|1|||
33387440|NCT00441103|62766222|FG001|Overall Study|Participant unable to use Rebiject II|0|||
33387441|NCT00441103|62766221|FG000|Overall Study|Participant refused MRI|1|||
33387442|NCT00441103|62766222|FG001|Overall Study|Participant refused MRI|0|||
33387443|NCT00441103|62766221|FG000|Overall Study|Inclusion criteria absent|1|||
33298264|NCT01323660|62674342|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
33298265|NCT01323660|62674343|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
33298266|NCT01323660|62674344|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
33298267|NCT01323660|62674345|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
33298268|NCT01323660|62674340|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
33298269|NCT01323660|62674341|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
33298270|NCT01323660|62674342|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
33387444|NCT00441103|62766222|FG001|Overall Study|Inclusion criteria absent|0|||
33387445|NCT00441103|62766221|FG000|Overall Study|Non-compliant|0|||
33387446|NCT00441103|62766222|FG001|Overall Study|Non-compliant|1|||
33387447|NCT00441103|62766221|FG000|Overall Study|Participant decided to withdraw|1|||
33387448|NCT00441103|62766222|FG001|Overall Study|Participant decided to withdraw|0|||
33387449|NCT00441103|62766221|FG000|Overall Study|Participant's reason|0|||
33387450|NCT00441103|62766222|FG001|Overall Study|Participant's reason|1|||
33387451|NCT00441103|62766221|FG000|Overall Study|Participant decided to stop|0|||
33387452|NCT00441103|62766222|FG001|Overall Study|Participant decided to stop|1|||
33387453|NCT00433771|62766229|FG000|Overall Study|screen fail|14|||
33387454|NCT00433771|62766229|FG000|Overall Study|Treated and later found to be ineligible|2|||
33387455|NCT00433771|62766229|FG000|Overall Study|Death|2|||
33387456|NCT00433771|62766229|FG000|Overall Study|Failure to deploy stent|1|||
33387457|NCT00433537|62766233|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
33387458|NCT00433537|62766234|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
33387459|NCT00433537|62766235|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
33387460|NCT00433537|62766233|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
33387461|NCT00433537|62766234|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
33387462|NCT00433537|62766235|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
33387463|NCT00433537|62766233|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
33298271|NCT01323660|62674343|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
33298272|NCT01323660|62674344|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
33387464|NCT00433537|62766234|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
33387465|NCT00433537|62766235|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
33387466|NCT00433537|62766233|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
33387467|NCT00433537|62766234|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
33387468|NCT00433537|62766235|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
33387469|NCT00433537|62766233|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
33387470|NCT00433537|62766234|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
33387471|NCT00433537|62766235|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
33387472|NCT00433537|62766233|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
33489516|NCT02757352|62867556|FG009|Follow-Up Period|Lack of Efficacy|1|||
33387473|NCT00433537|62766234|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
33387474|NCT00433537|62766235|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
33387475|NCT00433537|62766233|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
33298273|NCT01323660|62674345|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
33298274|NCT01323660|62674340|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33298275|NCT01323660|62674341|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33298276|NCT01323660|62674342|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33298277|NCT01323660|62674343|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33298278|NCT01323660|62674344|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
33298279|NCT01323660|62674345|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33298280|NCT01092637|62674361|FG000|Overall Study|Death|47|||
33387476|NCT00433537|62766234|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
33387477|NCT00433537|62766235|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
33387478|NCT00433537|62766233|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
33387479|NCT00433537|62766234|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
33387480|NCT00433537|62766235|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
33387481|NCT00433537|62766233|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
33387482|NCT00433537|62766234|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
33387483|NCT00433537|62766235|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
33387484|NCT00570765|62766245|FG000|DB Phase|Withdrawal by Subject|1|||
33387485|NCT00570765|62766246|FG001|DB Phase|Withdrawal by Subject|0|||
33387486|NCT00570765|62766247|FG002|DB Phase|Withdrawal by Subject|0|||
33387487|NCT00570765|62766248|FG003|DB Phase|Withdrawal by Subject|0|||
33387488|NCT00570765|62766245|FG000|DB Phase|Protocol Violation|0|||
33387489|NCT00570765|62766246|FG001|DB Phase|Protocol Violation|1|||
33387490|NCT00570765|62766247|FG002|DB Phase|Protocol Violation|0|||
33387491|NCT00570765|62766248|FG003|DB Phase|Protocol Violation|0|||
33387492|NCT00570765|62766245|FG000|DB Phase|Adverse Event|3|||
33387493|NCT00570765|62766246|FG001|DB Phase|Adverse Event|6|||
33387494|NCT00570765|62766247|FG002|DB Phase|Adverse Event|0|||
33387495|NCT00570765|62766248|FG003|DB Phase|Adverse Event|0|||
33387496|NCT00570765|62766245|FG000|DB Phase|Did Not Receive Study Drug|0|||
33387497|NCT00570765|62766246|FG001|DB Phase|Did Not Receive Study Drug|0|||
33387498|NCT00570765|62766247|FG002|DB Phase|Did Not Receive Study Drug|1|||
33387499|NCT00570765|62766248|FG003|DB Phase|Did Not Receive Study Drug|0|||
33387500|NCT00570765|62766245|FG000|LTSE Phase|Withdrawal by Subject|0|||
33387501|NCT00570765|62766246|FG001|LTSE Phase|Withdrawal by Subject|0|||
33387502|NCT00570765|62766247|FG002|LTSE Phase|Withdrawal by Subject|0|||
33387503|NCT00570765|62766248|FG003|LTSE Phase|Withdrawal by Subject|1|||
33387504|NCT00570765|62766245|FG000|LTSE Phase|Adverse Event|0|||
33387505|NCT00570765|62766246|FG001|LTSE Phase|Adverse Event|0|||
33387506|NCT00570765|62766247|FG002|LTSE Phase|Adverse Event|0|||
33387507|NCT00570765|62766248|FG003|LTSE Phase|Adverse Event|7|||
33387508|NCT00570765|62766245|FG000|LTSE Phase|Physician Decision|0|||
33387509|NCT00570765|62766246|FG001|LTSE Phase|Physician Decision|0|||
33387510|NCT00570765|62766247|FG002|LTSE Phase|Physician Decision|0|||
33387511|NCT00570765|62766248|FG003|LTSE Phase|Physician Decision|4|||
33387512|NCT00667563|62766259|FG000|Overall Study|Protocol Violation|24|||
33387513|NCT00667095|62766265|FG000|Overall Study|Withdrawal by Subject|0|||
33387514|NCT00667095|62766266|FG001|Overall Study|Withdrawal by Subject|1|||
33387515|NCT00433381|62766274|FG000|Overall Study|Ineligible / no protocol treatment|3|||
33298281|NCT01092637|62674362|FG001|Overall Study|Death|49|||
33298282|NCT01324323|62674369|FG000|Overall Study|Withdrawal by Subject|1|||
33298283|NCT01323582|62674383|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
33298284|NCT01323582|62674384|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
33298285|NCT01323582|62674383|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
33298286|NCT01323582|62674384|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
33298287|NCT01323582|62674383|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
33298288|NCT01323582|62674384|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
33387516|NCT00433381|62766275|FG001|Overall Study|Ineligible / no protocol treatment|3|||
33387517|NCT00667017|62766289|FG000|Overall Study|Withdrawal by Subject|1|||
33387518|NCT00666705|62766293|FG000|Overall Study|Withdrawal by Subject|1|||
33387519|NCT00433147|62766306|FG000|Overall Study|Adverse Event|0|||
33387520|NCT00433147|62766307|FG001|Overall Study|Adverse Event|1|||
33387521|NCT00433147|62766308|FG002|Overall Study|Adverse Event|0|||
33387522|NCT00433147|62766309|FG003|Overall Study|Adverse Event|0|||
33387523|NCT00666237|62766321|FG000|Overall Study|Death|5|||
33387524|NCT00666237|62766322|FG001|Overall Study|Death|5|||
33387525|NCT00666237|62766321|FG000|Overall Study|Lost to Follow-up|29|||
33387526|NCT00666237|62766322|FG001|Overall Study|Lost to Follow-up|25|||
33387527|NCT00662025|62766328|FG000|Overall Study|Objective progression or relapse|51|||
33387528|NCT00662025|62766328|FG000|Overall Study|Adverse Event|7|||
33387529|NCT00662025|62766328|FG000|Overall Study|Withdrawal by Subject|1|||
33298289|NCT01323621|62674394|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
33298290|NCT01323621|62674395|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
33298291|NCT01323621|62674396|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
33298292|NCT01323621|62674394|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
33298293|NCT01323621|62674395|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
33298294|NCT01323621|62674396|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
33298295|NCT01323621|62674394|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
33298296|NCT01323621|62674395|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
33298297|NCT01323621|62674396|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
33298298|NCT01323621|62674394|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
33298299|NCT01323621|62674395|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
33298300|NCT01323621|62674396|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
33387530|NCT00662025|62766328|FG000|Overall Study|Results of other clinical study|2|||
33387531|NCT00662025|62766328|FG000|Overall Study|Target lesion cannot be evaluated|1|||
33387532|NCT00662025|62766328|FG000|Overall Study|Domestic circumstances|1|||
33387533|NCT00440947|62766332|FG000|36-Week Induction Phase|Adverse Event|16|||
33387534|NCT00440947|62766333|FG001|36-Week Induction Phase|Adverse Event|0|||
33387535|NCT00440947|62766334|FG002|36-Week Induction Phase|Adverse Event|0|||
33387536|NCT00440947|62766335|FG003|36-Week Induction Phase|Adverse Event|0|||
33387537|NCT00440947|62766336|FG004|36-Week Induction Phase|Adverse Event|0|||
33387538|NCT00440947|62766332|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
33387539|NCT00440947|62766333|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
33387540|NCT00440947|62766334|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
33387541|NCT00440947|62766335|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
33387542|NCT00440947|62766336|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
33387543|NCT00440947|62766332|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
33387544|NCT00440947|62766333|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
33387545|NCT00440947|62766334|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
33298301|NCT01323621|62674394|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
33298302|NCT01323621|62674395|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
33298303|NCT01323621|62674396|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
33298304|NCT01323621|62674394|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
33298305|NCT01323621|62674395|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
33298306|NCT01323621|62674396|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
33387546|NCT00440947|62766335|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
33387547|NCT00440947|62766336|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
33387548|NCT00440947|62766332|FG000|36-Week Induction Phase|Non-compliance|10|||
33387549|NCT00440947|62766333|FG001|36-Week Induction Phase|Non-compliance|0|||
33387550|NCT00440947|62766334|FG002|36-Week Induction Phase|Non-compliance|0|||
33387551|NCT00440947|62766335|FG003|36-Week Induction Phase|Non-compliance|0|||
33387552|NCT00440947|62766336|FG004|36-Week Induction Phase|Non-compliance|0|||
33387553|NCT00440947|62766332|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
33387554|NCT00440947|62766333|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
33387555|NCT00440947|62766334|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
33387556|NCT00440947|62766335|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
33387557|NCT00440947|62766336|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
33387558|NCT00440947|62766332|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
33387559|NCT00440947|62766333|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
33387560|NCT00440947|62766334|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
33489517|NCT02757352|62867547|FG000|Follow-Up Period|Withdrawal by Subject|0|||
33489518|NCT02757352|62867548|FG001|Follow-Up Period|Withdrawal by Subject|0|||
33298307|NCT01323621|62674394|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
33298308|NCT01323621|62674395|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
33298309|NCT01323621|62674396|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
33298310|NCT01323621|62674394|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
33298311|NCT01323621|62674395|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
33298312|NCT01323621|62674396|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
33298313|NCT01323621|62674394|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
33298314|NCT01323621|62674395|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
33298315|NCT01323621|62674396|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
33298316|NCT01323621|62674394|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33298317|NCT01323621|62674395|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
33387561|NCT00440947|62766335|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
33387562|NCT00440947|62766336|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
33387563|NCT00440947|62766332|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
33387564|NCT00440947|62766333|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
33489519|NCT02757352|62867549|FG002|Follow-Up Period|Withdrawal by Subject|0|||
33489520|NCT02757352|62867550|FG003|Follow-Up Period|Withdrawal by Subject|0|||
33489521|NCT02757352|62867551|FG004|Follow-Up Period|Withdrawal by Subject|0|||
33489522|NCT02757352|62867552|FG005|Follow-Up Period|Withdrawal by Subject|0|||
33298318|NCT01323621|62674396|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33298319|NCT01323621|62674394|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
33298320|NCT01323621|62674395|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
33298321|NCT01323621|62674396|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
33298322|NCT01323621|62674394|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
33298323|NCT01323621|62674395|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
33298324|NCT01323621|62674396|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
33298325|NCT01323192|62674404|FG000|Overall Study|Adverse Event|6|||
33298326|NCT01323192|62674405|FG001|Overall Study|Adverse Event|1|||
33387565|NCT00440947|62766334|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
33387566|NCT00440947|62766335|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
33387567|NCT00440947|62766336|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
33387568|NCT00440947|62766332|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
33387569|NCT00440947|62766333|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
33387570|NCT00440947|62766334|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
33387571|NCT00440947|62766335|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
33387572|NCT00440947|62766336|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
33387573|NCT00440947|62766332|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
33387574|NCT00440947|62766333|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
33387575|NCT00440947|62766334|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
33387576|NCT00440947|62766335|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
33387577|NCT00440947|62766336|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
33387578|NCT00440947|62766332|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
33387579|NCT00440947|62766333|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
33387580|NCT00440947|62766334|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
33387581|NCT00440947|62766335|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
33387582|NCT00440947|62766336|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
33387583|NCT00440947|62766332|FG000|36-Week Induction Phase|Incarceration|3|||
33298327|NCT01323192|62674404|FG000|Overall Study|Withdrawal by Subject|3|||
33298328|NCT01323192|62674405|FG001|Overall Study|Withdrawal by Subject|1|||
33387584|NCT00440947|62766333|FG001|36-Week Induction Phase|Incarceration|0|||
33387585|NCT00440947|62766334|FG002|36-Week Induction Phase|Incarceration|0|||
33387586|NCT00440947|62766335|FG003|36-Week Induction Phase|Incarceration|0|||
33387587|NCT00440947|62766336|FG004|36-Week Induction Phase|Incarceration|0|||
33387588|NCT00440947|62766332|FG000|36-Week Induction Phase|Pregnancy|1|||
33387589|NCT00440947|62766333|FG001|36-Week Induction Phase|Pregnancy|0|||
33387590|NCT00440947|62766334|FG002|36-Week Induction Phase|Pregnancy|0|||
33387591|NCT00440947|62766335|FG003|36-Week Induction Phase|Pregnancy|0|||
33387592|NCT00440947|62766336|FG004|36-Week Induction Phase|Pregnancy|0|||
33387593|NCT00440947|62766332|FG000|48-Week Randomization Phase|Adverse Event|0|||
33387594|NCT00440947|62766333|FG001|48-Week Randomization Phase|Adverse Event|2|||
33387595|NCT00440947|62766334|FG002|48-Week Randomization Phase|Adverse Event|5|||
33387596|NCT00440947|62766335|FG003|48-Week Randomization Phase|Adverse Event|0|||
33387597|NCT00440947|62766336|FG004|48-Week Randomization Phase|Adverse Event|0|||
33387598|NCT00440947|62766332|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
33387599|NCT00440947|62766333|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
33387600|NCT00440947|62766334|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
33387601|NCT00440947|62766335|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
33387602|NCT00440947|62766336|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
33387603|NCT00440947|62766332|FG000|48-Week Randomization Phase|Non-compliance|0|||
33387604|NCT00440947|62766333|FG001|48-Week Randomization Phase|Non-compliance|3|||
33298329|NCT01323192|62674404|FG000|Overall Study|Noncompliance with study medication|0|||
33298330|NCT01323192|62674405|FG001|Overall Study|Noncompliance with study medication|3|||
33298331|NCT01323192|62674404|FG000|Overall Study|Nonmedical reasons|0|||
33298332|NCT01323192|62674405|FG001|Overall Study|Nonmedical reasons|1|||
33298333|NCT01323387|62674411|FG000|Overall Study|Withdrawal by Subject|41|||
33298334|NCT01323387|62674411|FG000|Overall Study|Radiographic Data Unavailable|1|||
33298335|NCT01323387|62674411|FG000|Overall Study|Revision|14|||
33298336|NCT01323387|62674411|FG000|Overall Study|Protocol Violation|12|||
33298337|NCT01323387|62674411|FG000|Overall Study|Randomized but Never Treated|16|||
33298338|NCT01321749|62674419|FG000|Overall Study|Lost to Follow-up|4|||
33387605|NCT00440947|62766334|FG002|48-Week Randomization Phase|Non-compliance|4|||
33387606|NCT00440947|62766335|FG003|48-Week Randomization Phase|Non-compliance|0|||
33387607|NCT00440947|62766336|FG004|48-Week Randomization Phase|Non-compliance|0|||
33387608|NCT00440947|62766332|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
33387609|NCT00440947|62766333|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
33556799|NCT02339506|62949653|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
33298339|NCT01321749|62674420|FG001|Overall Study|Lost to Follow-up|11|||
33298340|NCT01321749|62674419|FG000|Overall Study|Protocol Violation|4|||
33387610|NCT00440947|62766334|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
33387611|NCT00440947|62766335|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
33387612|NCT00440947|62766336|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
33387613|NCT00440947|62766332|FG000|48-Week Randomization Phase|Protocol Violation|0|||
33387614|NCT00440947|62766333|FG001|48-Week Randomization Phase|Protocol Violation|0|||
33387615|NCT00440947|62766334|FG002|48-Week Randomization Phase|Protocol Violation|1|||
33387616|NCT00440947|62766335|FG003|48-Week Randomization Phase|Protocol Violation|0|||
33387617|NCT00440947|62766336|FG004|48-Week Randomization Phase|Protocol Violation|0|||
33387618|NCT00440947|62766332|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
33387619|NCT00440947|62766333|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
33387620|NCT00440947|62766334|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
33387621|NCT00440947|62766335|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
33387622|NCT00440947|62766336|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
33387623|NCT00440947|62766332|FG000|48-Week Randomization Phase|Pregnancy|0|||
33387624|NCT00440947|62766333|FG001|48-Week Randomization Phase|Pregnancy|0|||
33298341|NCT01321749|62674420|FG001|Overall Study|Protocol Violation|7|||
33298342|NCT01321749|62674419|FG000|Overall Study|Withdrawal by Subject|5|||
33298343|NCT01321749|62674420|FG001|Overall Study|Withdrawal by Subject|4|||
33387625|NCT00440947|62766334|FG002|48-Week Randomization Phase|Pregnancy|1|||
33387626|NCT00440947|62766335|FG003|48-Week Randomization Phase|Pregnancy|0|||
33387627|NCT00440947|62766336|FG004|48-Week Randomization Phase|Pregnancy|0|||
33387628|NCT00440947|62766332|FG000|48-Week Randomization Phase|Incarceration|0|||
33387629|NCT00440947|62766333|FG001|48-Week Randomization Phase|Incarceration|3|||
33387630|NCT00440947|62766334|FG002|48-Week Randomization Phase|Incarceration|0|||
33387631|NCT00440947|62766335|FG003|48-Week Randomization Phase|Incarceration|0|||
33387632|NCT00440947|62766336|FG004|48-Week Randomization Phase|Incarceration|0|||
33387633|NCT00440947|62766332|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
33387634|NCT00440947|62766333|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
33387635|NCT00440947|62766334|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
33387636|NCT00440947|62766335|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
33387637|NCT00440947|62766336|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
33387638|NCT00440947|62766332|FG000|48-Week Randomization Phase|Physician Decision|0|||
33387639|NCT00440947|62766333|FG001|48-Week Randomization Phase|Physician Decision|2|||
33387640|NCT00440947|62766334|FG002|48-Week Randomization Phase|Physician Decision|0|||
33387641|NCT00440947|62766335|FG003|48-Week Randomization Phase|Physician Decision|0|||
33387642|NCT00440947|62766336|FG004|48-Week Randomization Phase|Physician Decision|0|||
33387643|NCT00440947|62766332|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
33387644|NCT00440947|62766333|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
33387645|NCT00440947|62766334|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
33387646|NCT00440947|62766335|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
33387647|NCT00440947|62766336|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
33387648|NCT00440947|62766332|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
33387649|NCT00440947|62766333|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
33387650|NCT00440947|62766334|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
33387651|NCT00440947|62766335|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
33387652|NCT00440947|62766336|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
33387653|NCT00440947|62766332|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
33387654|NCT00440947|62766333|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
33387655|NCT00440947|62766334|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
33387656|NCT00440947|62766335|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
33387657|NCT00440947|62766336|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
33298344|NCT01320735|62674426|FG000|Overall Study|Adverse Event|3|||
33387658|NCT00440947|62766332|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
33489523|NCT02757352|62867553|FG006|Follow-Up Period|Withdrawal by Subject|0|||
33489524|NCT02757352|62867554|FG007|Follow-Up Period|Withdrawal by Subject|1|||
33298345|NCT01320735|62674426|FG000|Overall Study|Withdrawal by Subject|3|||
33298346|NCT01320735|62674426|FG000|Overall Study|Lost to Follow-up|13|||
33298347|NCT01320735|62674426|FG000|Overall Study|Administrative Reason|6|||
33298348|NCT01320735|62674426|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
33298349|NCT01320735|62674426|FG000|Overall Study|Protocol Violation|1|||
33298350|NCT01320735|62674426|FG000|Overall Study|Other|1|||
33298351|NCT01320735|62674426|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
33298352|NCT01320735|62674426|FG000|Overall Study|Investigator Unable to be Contacted|17|||
33298353|NCT01320033|62674433|FG000|Overall Study|Lack of Efficacy|0|||
33298354|NCT01320033|62674434|FG001|Overall Study|Lack of Efficacy|0|||
33489525|NCT02757352|62867555|FG008|Follow-Up Period|Withdrawal by Subject|6|||
33298355|NCT01320033|62674435|FG002|Overall Study|Lack of Efficacy|1|||
33298356|NCT01320033|62674433|FG000|Overall Study|Adverse Event|9|||
33387659|NCT00440947|62766333|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
33387660|NCT00440947|62766334|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
33387661|NCT00440947|62766335|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
33387662|NCT00440947|62766336|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
33387663|NCT00440947|62766332|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
33387664|NCT00440947|62766333|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
33387665|NCT00440947|62766334|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
33662627|NCT01587703|63093239|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33662628|NCT01587703|63093240|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33662629|NCT01587703|63093241|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33662630|NCT01587703|63093242|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33662631|NCT01587703|63093243|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33662632|NCT01587703|63093244|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33298357|NCT01320033|62674434|FG001|Overall Study|Adverse Event|7|||
33298358|NCT01320033|62674435|FG002|Overall Study|Adverse Event|8|||
33298359|NCT01320033|62674433|FG000|Overall Study|Withdrawal by Subject|22|||
33298360|NCT01320033|62674434|FG001|Overall Study|Withdrawal by Subject|23|||
33298361|NCT01320033|62674435|FG002|Overall Study|Withdrawal by Subject|23|||
33298362|NCT01320033|62674433|FG000|Overall Study|Protocol Violation|3|||
33298363|NCT01320033|62674434|FG001|Overall Study|Protocol Violation|5|||
33298364|NCT01320033|62674435|FG002|Overall Study|Protocol Violation|3|||
33298365|NCT01320033|62674433|FG000|Overall Study|Lost to Follow-up|22|||
33298366|NCT01320033|62674434|FG001|Overall Study|Lost to Follow-up|26|||
33298367|NCT01320033|62674435|FG002|Overall Study|Lost to Follow-up|17|||
33298368|NCT01320033|62674433|FG000|Overall Study|Other|2|||
33298369|NCT01320033|62674434|FG001|Overall Study|Other|3|||
33298370|NCT01320033|62674435|FG002|Overall Study|Other|1|||
33298371|NCT01101061|62674449|FG000|Overall Study|Adverse Event|0|||
33298372|NCT01101061|62674450|FG001|Overall Study|Adverse Event|0|||
33298373|NCT01101061|62674451|FG002|Overall Study|Adverse Event|1|||
33298374|NCT01101061|62674452|FG003|Overall Study|Adverse Event|0|||
33298375|NCT01101061|62674453|FG004|Overall Study|Adverse Event|0|||
33298376|NCT01101061|62674454|FG005|Overall Study|Adverse Event|0|||
33298377|NCT01317615|62674472|FG000|Overall Study|Disease progression|25|||
33298378|NCT01317615|62674472|FG000|Overall Study|New cancer therapy|5|||
33298379|NCT01317615|62674472|FG000|Overall Study|Death|6|||
33298380|NCT01317615|62674472|FG000|Overall Study|Withdrawal by Subject|5|||
33298381|NCT01317615|62674472|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33298382|NCT01317615|62674472|FG000|Overall Study|Adverse Event|7|||
33298383|NCT01078675|62674478|FG000|Overall Study|Withdrawal by Subject|7|||
33298384|NCT01078675|62674479|FG001|Overall Study|Withdrawal by Subject|3|||
33298385|NCT01078675|62674478|FG000|Overall Study|Protocol Violation|56|||
33298386|NCT01078675|62674479|FG001|Overall Study|Protocol Violation|0|||
33298387|NCT01078675|62674478|FG000|Overall Study|Provided in CRF for specific reasons|2|||
33298388|NCT01078675|62674479|FG001|Overall Study|Provided in CRF for specific reasons|3|||
33298389|NCT01078675|62674478|FG000|Overall Study|Adverse Event|3|||
33298390|NCT01078675|62674479|FG001|Overall Study|Adverse Event|0|||
33298391|NCT01100437|62674485|FG000|Titration/Stabilization|Adverse Event|0|||
33298392|NCT01100437|62674486|FG001|Titration/Stabilization|Adverse Event|0|||
33298393|NCT01100437|62674487|FG002|Titration/Stabilization|Adverse Event|4|||
33298394|NCT01100437|62674485|FG000|Titration/Stabilization|Non-compliance|0|||
33298395|NCT01100437|62674486|FG001|Titration/Stabilization|Non-compliance|0|||
33298396|NCT01100437|62674487|FG002|Titration/Stabilization|Non-compliance|1|||
33298397|NCT01100437|62674485|FG000|Titration/Stabilization|Sponsor canceled study|0|||
33298398|NCT01100437|62674486|FG001|Titration/Stabilization|Sponsor canceled study|0|||
33298399|NCT01100437|62674487|FG002|Titration/Stabilization|Sponsor canceled study|1|||
33298400|NCT01100437|62674485|FG000|Maintenance|Withdrawal by Subject|0|||
33298401|NCT01100437|62674486|FG001|Maintenance|Withdrawal by Subject|0|||
33298402|NCT01100437|62674487|FG002|Maintenance|Withdrawal by Subject|1|||
33298403|NCT01100437|62674485|FG000|Maintenance|Sponsor termination of study|0|||
33298404|NCT01100437|62674486|FG001|Maintenance|Sponsor termination of study|0|||
33298405|NCT01100437|62674487|FG002|Maintenance|Sponsor termination of study|1|||
33298406|NCT01322490|62674499|FG000|Treatment Period|Adverse Event|12|||
33298407|NCT01322490|62674500|FG001|Treatment Period|Adverse Event|18|||
33298408|NCT01322490|62674501|FG002|Treatment Period|Adverse Event|15|||
33298409|NCT01322490|62674499|FG000|Treatment Period|Death|5|||
33298410|NCT01322490|62674500|FG001|Treatment Period|Death|7|||
33662633|NCT01587703|63093226|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33298411|NCT01322490|62674501|FG002|Treatment Period|Death|3|||
33298412|NCT01322490|62674499|FG000|Treatment Period|Lack of Efficacy|89|||
33298413|NCT01322490|62674500|FG001|Treatment Period|Lack of Efficacy|100|||
33298414|NCT01322490|62674501|FG002|Treatment Period|Lack of Efficacy|112|||
33298415|NCT01322490|62674499|FG000|Treatment Period|Physician Decision|0|||
33298416|NCT01322490|62674500|FG001|Treatment Period|Physician Decision|2|||
33298417|NCT01322490|62674501|FG002|Treatment Period|Physician Decision|1|||
33298418|NCT01322490|62674499|FG000|Treatment Period|Protocol Violation|7|||
33298419|NCT01322490|62674500|FG001|Treatment Period|Protocol Violation|5|||
33298420|NCT01322490|62674501|FG002|Treatment Period|Protocol Violation|4|||
33298421|NCT01322490|62674499|FG000|Treatment Period|Withdrawal by Subject|14|||
33298422|NCT01322490|62674500|FG001|Treatment Period|Withdrawal by Subject|16|||
33298423|NCT01322490|62674501|FG002|Treatment Period|Withdrawal by Subject|11|||
33298424|NCT01322490|62674499|FG000|Treatment Period|Non-compliance with study drug|0|||
33298425|NCT01322490|62674500|FG001|Treatment Period|Non-compliance with study drug|0|||
33298426|NCT01322490|62674501|FG002|Treatment Period|Non-compliance with study drug|1|||
33298427|NCT01322490|62674499|FG000|Treatment Period|Other per report|2|||
33298428|NCT01322490|62674500|FG001|Treatment Period|Other per report|2|||
33298429|NCT01322490|62674501|FG002|Treatment Period|Other per report|1|||
33298430|NCT01322490|62674499|FG000|Treatment Period|Randomized but Not Treated|3|||
33298431|NCT01322490|62674500|FG001|Treatment Period|Randomized but Not Treated|3|||
33298432|NCT01322490|62674501|FG002|Treatment Period|Randomized but Not Treated|5|||
33298433|NCT01322490|62674499|FG000|Long Term Follow-up Period|Death|235|||
33298434|NCT01322490|62674500|FG001|Long Term Follow-up Period|Death|239|||
33298435|NCT01322490|62674501|FG002|Long Term Follow-up Period|Death|236|||
33298436|NCT01322490|62674499|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
33298437|NCT01322490|62674500|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
33298438|NCT01322490|62674501|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
33298439|NCT01322490|62674499|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
33298440|NCT01322490|62674500|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
33298441|NCT01322490|62674501|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
33298442|NCT01322490|62674499|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
33298443|NCT01322490|62674500|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
33298444|NCT01322490|62674501|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
33298445|NCT01322490|62674499|FG000|Long Term Follow-up Period|Other per report|3|||
33298446|NCT01322490|62674500|FG001|Long Term Follow-up Period|Other per report|2|||
33298447|NCT01322490|62674501|FG002|Long Term Follow-up Period|Other per report|2|||
33298448|NCT01322490|62674499|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
33298449|NCT01322490|62674500|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
33298450|NCT01322490|62674501|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
33298451|NCT01314261|62674513|FG000|Overall Study|Adverse Event|1|||
33298452|NCT01314261|62674514|FG001|Overall Study|Adverse Event|0|||
33298453|NCT01314261|62674515|FG002|Overall Study|Adverse Event|0|||
33298454|NCT01314261|62674516|FG003|Overall Study|Adverse Event|0|||
33298455|NCT01314261|62674513|FG000|Overall Study|Withdrawal by Subject|0|||
33298456|NCT01314261|62674514|FG001|Overall Study|Withdrawal by Subject|3|||
33298457|NCT01314261|62674515|FG002|Overall Study|Withdrawal by Subject|1|||
33298458|NCT01314261|62674516|FG003|Overall Study|Withdrawal by Subject|0|||
33298459|NCT01314261|62674513|FG000|Overall Study|Lost to Follow-up|1|||
33298460|NCT01314261|62674514|FG001|Overall Study|Lost to Follow-up|0|||
33298461|NCT01314261|62674515|FG002|Overall Study|Lost to Follow-up|2|||
33298462|NCT01314261|62674516|FG003|Overall Study|Lost to Follow-up|2|||
33298463|NCT01314261|62674513|FG000|Overall Study|Virologic Failure|0|||
33298464|NCT01314261|62674514|FG001|Overall Study|Virologic Failure|1|||
33298465|NCT01314261|62674515|FG002|Overall Study|Virologic Failure|0|||
33298466|NCT01314261|62674516|FG003|Overall Study|Virologic Failure|1|||
33298467|NCT01321710|62674529|FG000|Overall Study|Lost to Follow-up|4|||
33298468|NCT01321710|62674530|FG001|Overall Study|Lost to Follow-up|5|||
33298469|NCT01321710|62674531|FG002|Overall Study|Lost to Follow-up|0|||
33298470|NCT01321008|62674541|FG000|Overall Study|Early Study Termination|1|||
33298471|NCT01320150|62674547|FG000|Overall Study|Protocol Violation|15|||
33298472|NCT01320150|62674547|FG000|Overall Study|Withdrawal by Subject|5|||
33298473|NCT01320150|62674547|FG000|Overall Study|Death|2|||
33298474|NCT01320150|62674547|FG000|Overall Study|Lost to Follow-up|44|||
33387666|NCT00440947|62766335|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
33387667|NCT00440947|62766336|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
33387668|NCT00440947|62766332|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
33387669|NCT00440947|62766333|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
33387670|NCT00440947|62766334|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
33387671|NCT00440947|62766335|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
33387672|NCT00440947|62766336|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
33387673|NCT00440947|62766332|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
33489526|NCT02757352|62867556|FG009|Follow-Up Period|Withdrawal by Subject|2|||
33489527|NCT04588480|62867589|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
33489528|NCT04588480|62867590|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
33489529|NCT04588480|62867591|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
33298475|NCT01323530|62674558|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
33298476|NCT01323530|62674559|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
33298477|NCT01323530|62674560|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
33298478|NCT01323530|62674561|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
33298479|NCT01323530|62674562|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
33298480|NCT01323530|62674563|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
33298481|NCT01323530|62674564|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
33298482|NCT01323530|62674558|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
33298483|NCT01323530|62674559|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
33298484|NCT01323530|62674560|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
33298485|NCT01323530|62674561|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
33298486|NCT01323530|62674562|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
33298487|NCT01323530|62674563|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
33298488|NCT01323530|62674564|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
33298489|NCT01323530|62674558|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
33298490|NCT01323530|62674559|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
33298491|NCT01323530|62674560|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
33298492|NCT01323530|62674561|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
33298493|NCT01323530|62674562|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
33298494|NCT01323530|62674563|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
33298495|NCT01323530|62674564|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
33298496|NCT01323530|62674558|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
33298497|NCT01323530|62674559|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
33298498|NCT01323530|62674560|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
33298499|NCT01323530|62674561|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
33298500|NCT01323530|62674562|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
33298501|NCT01323530|62674563|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
33298502|NCT01323530|62674564|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
33298503|NCT01323530|62674558|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
33298504|NCT01323530|62674559|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
33298505|NCT01323530|62674560|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
33298506|NCT01323530|62674561|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
33298507|NCT01323530|62674562|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
33298508|NCT01323530|62674563|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
33298509|NCT01323530|62674564|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
33298510|NCT01323530|62674558|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
33298511|NCT01323530|62674559|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
33298512|NCT01323530|62674560|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
33298513|NCT01323530|62674561|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
33298514|NCT01323530|62674562|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
33298515|NCT01323530|62674563|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
33298516|NCT01323530|62674564|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
33298517|NCT01323530|62674558|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
33298518|NCT01323530|62674559|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
33298519|NCT01323530|62674560|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
33298520|NCT01323530|62674561|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
33298521|NCT01323530|62674562|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
33298522|NCT01323530|62674563|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
33298523|NCT01323530|62674564|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
33298524|NCT01323530|62674558|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
33298525|NCT01323530|62674559|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
33298526|NCT01323530|62674560|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
33387674|NCT00440947|62766333|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
33387675|NCT00440947|62766334|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
33387676|NCT00440947|62766335|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
33387677|NCT00440947|62766336|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
33387678|NCT00440947|62766332|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
33387679|NCT00440947|62766333|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
33387680|NCT00440947|62766334|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
33387681|NCT00440947|62766335|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
33387682|NCT00440947|62766336|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
33387683|NCT00440947|62766332|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
33387684|NCT00440947|62766333|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
33387685|NCT00440947|62766334|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
33387686|NCT00440947|62766335|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
33387687|NCT00440947|62766336|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
33387688|NCT00440947|62766332|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
33387689|NCT00440947|62766333|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
33387690|NCT00440947|62766334|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
33387691|NCT00440947|62766335|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
33387692|NCT00440947|62766336|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
33387693|NCT00440947|62766332|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
33387694|NCT00440947|62766333|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
33387695|NCT00440947|62766334|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
33387696|NCT00440947|62766335|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
33387697|NCT00440947|62766336|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
33387698|NCT00440947|62766332|FG000|Optional 60-Week Extension Phase|Other|0|||
33387699|NCT00440947|62766333|FG001|Optional 60-Week Extension Phase|Other|0|||
33387700|NCT00440947|62766334|FG002|Optional 60-Week Extension Phase|Other|0|||
33387701|NCT00440947|62766335|FG003|Optional 60-Week Extension Phase|Other|1|||
33387702|NCT00440947|62766336|FG004|Optional 60-Week Extension Phase|Other|0|||
33387703|NCT00440947|62766332|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
33387704|NCT00440947|62766333|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
33387705|NCT00440947|62766334|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
33387706|NCT00440947|62766335|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
33387707|NCT00440947|62766336|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
33387708|NCT00440947|62766332|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
33387709|NCT00440947|62766333|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
33387710|NCT00440947|62766334|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
33387711|NCT00440947|62766335|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
33387712|NCT00440947|62766336|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
33387713|NCT00664521|62766359|FG000|Overall Study|Adverse Event|4|||
33387714|NCT00664521|62766360|FG001|Overall Study|Adverse Event|1|||
33387715|NCT00664521|62766359|FG000|Overall Study|Lost to Follow-up|1|||
33387716|NCT00664521|62766360|FG001|Overall Study|Lost to Follow-up|0|||
33387717|NCT00664521|62766359|FG000|Overall Study|Other|1|||
33387718|NCT00664521|62766360|FG001|Overall Study|Other|0|||
33387719|NCT00664209|62766366|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
33387720|NCT00664209|62766366|FG000|Study Treatment Period|Physician Decision|4|||
33387721|NCT00664209|62766366|FG000|Study Treatment Period|Withdrawal by Subject|2|||
33387722|NCT00440557|62766374|FG000|Overall Study|Withdrawal by Subject|10|||
33387723|NCT00440557|62766375|FG001|Overall Study|Withdrawal by Subject|5|||
33387724|NCT00440557|62766376|FG002|Overall Study|Withdrawal by Subject|11|||
33387725|NCT00440557|62766374|FG000|Overall Study|Lost to Follow-up|1|||
33387726|NCT00440557|62766375|FG001|Overall Study|Lost to Follow-up|2|||
33387727|NCT00440557|62766376|FG002|Overall Study|Lost to Follow-up|6|||
33387728|NCT00440557|62766374|FG000|Overall Study|Adverse Event|3|||
33387729|NCT00440557|62766375|FG001|Overall Study|Adverse Event|3|||
33387730|NCT00440557|62766376|FG002|Overall Study|Adverse Event|5|||
33387731|NCT00440557|62766374|FG000|Overall Study|Death|2|||
33387732|NCT00440557|62766375|FG001|Overall Study|Death|6|||
33387733|NCT00440557|62766376|FG002|Overall Study|Death|3|||
33387734|NCT00440557|62766374|FG000|Overall Study|Began Dialysis|4|||
33387735|NCT00440557|62766375|FG001|Overall Study|Began Dialysis|1|||
33387736|NCT00440557|62766376|FG002|Overall Study|Began Dialysis|4|||
33387737|NCT00440557|62766374|FG000|Overall Study|Principal Investigator decision|0|||
33387738|NCT00440557|62766375|FG001|Overall Study|Principal Investigator decision|3|||
33387739|NCT00440557|62766376|FG002|Overall Study|Principal Investigator decision|1|||
33387740|NCT00440557|62766374|FG000|Overall Study|Patient moved|1|||
33387741|NCT00440557|62766375|FG001|Overall Study|Patient moved|2|||
33387742|NCT00440557|62766376|FG002|Overall Study|Patient moved|1|||
33387743|NCT00440557|62766374|FG000|Overall Study|Principal Investigator's office closed|3|||
33387744|NCT00440557|62766375|FG001|Overall Study|Principal Investigator's office closed|6|||
33387745|NCT00440557|62766376|FG002|Overall Study|Principal Investigator's office closed|4|||
33387746|NCT00440557|62766374|FG000|Overall Study|Patient transferred to nursing home|0|||
33387747|NCT00440557|62766375|FG001|Overall Study|Patient transferred to nursing home|1|||
33387748|NCT00440557|62766376|FG002|Overall Study|Patient transferred to nursing home|0|||
33387749|NCT00440557|62766374|FG000|Overall Study|Patient had surgery|1|||
33387750|NCT00440557|62766375|FG001|Overall Study|Patient had surgery|0|||
33387751|NCT00440557|62766376|FG002|Overall Study|Patient had surgery|0|||
33387752|NCT00582608|62766436|FG000|Overall Study|Not Treated|7|||
33387753|NCT00582608|62766436|FG000|Overall Study|Patient Ineligible|1|||
33387754|NCT00582608|62766436|FG000|Overall Study|Lack of accrual|4|||
33387755|NCT03014570|62766442|FG000|Overall Study|COVID-19 Restrictions|38|||
33387756|NCT03014570|62766443|FG001|Overall Study|COVID-19 Restrictions|24|||
33387757|NCT03014570|62766442|FG000|Overall Study|Death|70|||
33387758|NCT03014570|62766443|FG001|Overall Study|Death|79|||
33387759|NCT03014570|62766442|FG000|Overall Study|Transfer from facility|11|||
33387760|NCT03014570|62766443|FG001|Overall Study|Transfer from facility|14|||
33387761|NCT03014570|62766442|FG000|Overall Study|Hospitalized|5|||
33387762|NCT03014570|62766443|FG001|Overall Study|Hospitalized|3|||
33387763|NCT03014570|62766442|FG000|Overall Study|Transfer within facility|1|||
33387764|NCT03014570|62766443|FG001|Overall Study|Transfer within facility|0|||
33387765|NCT03014570|62766442|FG000|Overall Study|Site refusal|0|||
33387766|NCT03014570|62766443|FG001|Overall Study|Site refusal|11|||
33387767|NCT00427999|62766450|FG000|Overall Study|Adverse Event|6|||
33387768|NCT00427999|62766450|FG000|Overall Study|Abnormal laboratory values|1|||
33387769|NCT00427999|62766450|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
33387770|NCT00427999|62766450|FG000|Overall Study|Protocol Violation|2|||
33387771|NCT00427999|62766450|FG000|Overall Study|Withdrawal by Subject|9|||
33387772|NCT00427999|62766450|FG000|Overall Study|Death|1|||
33387773|NCT00661713|62766463|FG000|Overall Study|Death|1|||
33387774|NCT00661713|62766464|FG001|Overall Study|Death|0|||
33387775|NCT00661713|62766465|FG002|Overall Study|Death|0|||
33387776|NCT00661713|62766466|FG003|Overall Study|Death|0|||
33387777|NCT00661713|62766467|FG004|Overall Study|Death|1|||
33387778|NCT00661713|62766468|FG005|Overall Study|Death|0|||
33387779|NCT00661713|62766469|FG006|Overall Study|Death|0|||
33387780|NCT00661713|62766470|FG007|Overall Study|Death|0|||
33387781|NCT00661713|62766463|FG000|Overall Study|Unable to Classify|1|||
33387782|NCT00661713|62766464|FG001|Overall Study|Unable to Classify|0|||
33387783|NCT00661713|62766465|FG002|Overall Study|Unable to Classify|0|||
33387784|NCT00661713|62766466|FG003|Overall Study|Unable to Classify|0|||
33387785|NCT00661713|62766467|FG004|Overall Study|Unable to Classify|0|||
33387786|NCT00661713|62766468|FG005|Overall Study|Unable to Classify|0|||
33387787|NCT00661713|62766469|FG006|Overall Study|Unable to Classify|0|||
33298527|NCT01323530|62674561|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
33298528|NCT01323530|62674562|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
33298529|NCT01323530|62674563|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
33298530|NCT01323530|62674564|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
33298531|NCT01313637|62674585|FG000|Overall Study|Adverse Event|17|||
33298532|NCT01313637|62674586|FG001|Overall Study|Adverse Event|24|||
33298533|NCT01313637|62674587|FG002|Overall Study|Adverse Event|25|||
33298534|NCT01313637|62674588|FG003|Overall Study|Adverse Event|18|||
33298535|NCT01313637|62674585|FG000|Overall Study|Lack of Efficacy|44|||
33298536|NCT01313637|62674586|FG001|Overall Study|Lack of Efficacy|38|||
33298537|NCT01313637|62674587|FG002|Overall Study|Lack of Efficacy|37|||
33298538|NCT01313637|62674588|FG003|Overall Study|Lack of Efficacy|24|||
33298539|NCT01313637|62674585|FG000|Overall Study|Protocol Violation|4|||
33298540|NCT01313637|62674586|FG001|Overall Study|Protocol Violation|3|||
33298541|NCT01313637|62674587|FG002|Overall Study|Protocol Violation|11|||
33298542|NCT01313637|62674588|FG003|Overall Study|Protocol Violation|5|||
33298543|NCT01313637|62674585|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
33298544|NCT01313637|62674586|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
33298545|NCT01313637|62674587|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
33298546|NCT01313637|62674588|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
33298547|NCT01313637|62674585|FG000|Overall Study|Lost to Follow-up|0|||
33298548|NCT01313637|62674586|FG001|Overall Study|Lost to Follow-up|2|||
33298549|NCT01313637|62674587|FG002|Overall Study|Lost to Follow-up|1|||
33298550|NCT01313637|62674588|FG003|Overall Study|Lost to Follow-up|3|||
33298551|NCT01313637|62674585|FG000|Overall Study|Withdrawal by Subject|11|||
33298552|NCT01313637|62674586|FG001|Overall Study|Withdrawal by Subject|13|||
33298553|NCT01313637|62674587|FG002|Overall Study|Withdrawal by Subject|18|||
33298554|NCT01313637|62674588|FG003|Overall Study|Withdrawal by Subject|15|||
33298555|NCT01320722|62674603|FG000|Overall Study|Did not Receive Intervention|3|||
33298556|NCT01320722|62674604|FG001|Overall Study|Did not Receive Intervention|2|||
33387788|NCT00661713|62766470|FG007|Overall Study|Unable to Classify|0|||
33387789|NCT00661713|62766463|FG000|Overall Study|Protocol Violation|1|||
33387790|NCT00661713|62766464|FG001|Overall Study|Protocol Violation|6|||
33387791|NCT00661713|62766465|FG002|Overall Study|Protocol Violation|3|||
33387792|NCT00661713|62766466|FG003|Overall Study|Protocol Violation|3|||
33387793|NCT00661713|62766467|FG004|Overall Study|Protocol Violation|0|||
33387794|NCT00661713|62766468|FG005|Overall Study|Protocol Violation|2|||
33387795|NCT00661713|62766469|FG006|Overall Study|Protocol Violation|2|||
33387796|NCT00661713|62766470|FG007|Overall Study|Protocol Violation|1|||
33387797|NCT00661713|62766463|FG000|Overall Study|Withdrawal by Subject|11|||
33387798|NCT00661713|62766464|FG001|Overall Study|Withdrawal by Subject|25|||
33387799|NCT00661713|62766465|FG002|Overall Study|Withdrawal by Subject|12|||
33387800|NCT00661713|62766466|FG003|Overall Study|Withdrawal by Subject|21|||
33387801|NCT00661713|62766467|FG004|Overall Study|Withdrawal by Subject|12|||
33298557|NCT01320722|62674605|FG002|Overall Study|Did not Receive Intervention|1|||
33298558|NCT01320722|62674606|FG003|Overall Study|Did not Receive Intervention|1|||
33298559|NCT01320722|62674607|FG004|Overall Study|Did not Receive Intervention|2|||
33298560|NCT01320722|62674603|FG000|Overall Study|Lost to Follow-up|0|||
33298561|NCT01320722|62674604|FG001|Overall Study|Lost to Follow-up|1|||
33298562|NCT01320722|62674605|FG002|Overall Study|Lost to Follow-up|0|||
33298563|NCT01320722|62674606|FG003|Overall Study|Lost to Follow-up|1|||
33298564|NCT01320722|62674607|FG004|Overall Study|Lost to Follow-up|3|||
33298565|NCT01320722|62674603|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
33298566|NCT01320722|62674604|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
33387802|NCT00661713|62766468|FG005|Overall Study|Withdrawal by Subject|26|||
33387803|NCT00661713|62766469|FG006|Overall Study|Withdrawal by Subject|45|||
33387804|NCT00661713|62766470|FG007|Overall Study|Withdrawal by Subject|9|||
33387805|NCT00661713|62766463|FG000|Overall Study|Lost to Follow-up|2|||
33387806|NCT00661713|62766464|FG001|Overall Study|Lost to Follow-up|7|||
33387807|NCT00661713|62766465|FG002|Overall Study|Lost to Follow-up|2|||
33387808|NCT00661713|62766466|FG003|Overall Study|Lost to Follow-up|2|||
33387809|NCT00661713|62766467|FG004|Overall Study|Lost to Follow-up|5|||
33387810|NCT00661713|62766468|FG005|Overall Study|Lost to Follow-up|7|||
33387811|NCT00661713|62766469|FG006|Overall Study|Lost to Follow-up|14|||
33387812|NCT00661713|62766470|FG007|Overall Study|Lost to Follow-up|1|||
33387813|NCT00661713|62766463|FG000|Overall Study|Administrative Reason|0|||
33387814|NCT00661713|62766464|FG001|Overall Study|Administrative Reason|1|||
33387815|NCT00661713|62766465|FG002|Overall Study|Administrative Reason|0|||
33387816|NCT00661713|62766466|FG003|Overall Study|Administrative Reason|2|||
33387817|NCT00661713|62766467|FG004|Overall Study|Administrative Reason|2|||
33387818|NCT00661713|62766468|FG005|Overall Study|Administrative Reason|2|||
33387819|NCT00661713|62766469|FG006|Overall Study|Administrative Reason|1|||
33387820|NCT00661713|62766470|FG007|Overall Study|Administrative Reason|0|||
33387821|NCT00661713|62766463|FG000|Overall Study|Adverse Event|0|||
33387822|NCT00661713|62766464|FG001|Overall Study|Adverse Event|0|||
33387823|NCT00661713|62766465|FG002|Overall Study|Adverse Event|0|||
33387824|NCT00661713|62766466|FG003|Overall Study|Adverse Event|0|||
33387825|NCT00661713|62766467|FG004|Overall Study|Adverse Event|0|||
33387826|NCT00661713|62766468|FG005|Overall Study|Adverse Event|0|||
33387827|NCT00661713|62766469|FG006|Overall Study|Adverse Event|1|||
33387828|NCT00661713|62766470|FG007|Overall Study|Adverse Event|0|||
33387829|NCT00661713|62766463|FG000|Overall Study|Inappropriate Enrollment|0|||
33387830|NCT00661713|62766464|FG001|Overall Study|Inappropriate Enrollment|0|||
33387831|NCT00661713|62766465|FG002|Overall Study|Inappropriate Enrollment|0|||
33298567|NCT01320722|62674605|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
33298568|NCT01320722|62674606|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
33298569|NCT01320722|62674607|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
33298570|NCT01320722|62674603|FG000|Overall Study|Participant Developed a Rash|0|||
33298571|NCT01320722|62674604|FG001|Overall Study|Participant Developed a Rash|0|||
33298572|NCT01320722|62674605|FG002|Overall Study|Participant Developed a Rash|2|||
33387832|NCT00661713|62766466|FG003|Overall Study|Inappropriate Enrollment|0|||
33387833|NCT00661713|62766467|FG004|Overall Study|Inappropriate Enrollment|0|||
33387834|NCT00661713|62766468|FG005|Overall Study|Inappropriate Enrollment|0|||
33387835|NCT00661713|62766469|FG006|Overall Study|Inappropriate Enrollment|1|||
33387836|NCT00661713|62766470|FG007|Overall Study|Inappropriate Enrollment|0|||
33387837|NCT03835975|62766495|FG000|Overall Study|Lost to Follow-up|1|||
33387838|NCT03835975|62766496|FG001|Overall Study|Lost to Follow-up|1|||
33387839|NCT03835975|62766497|FG002|Overall Study|Lost to Follow-up|0|||
33662634|NCT01587703|63093227|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33662635|NCT01587703|63093228|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33662636|NCT01587703|63093229|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33662637|NCT01587703|63093230|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33298573|NCT01320722|62674606|FG003|Overall Study|Participant Developed a Rash|1|||
33298574|NCT01320722|62674607|FG004|Overall Study|Participant Developed a Rash|1|||
33298575|NCT01320722|62674603|FG000|Overall Study|Non-compliant with Medication|0|||
33298576|NCT01320722|62674604|FG001|Overall Study|Non-compliant with Medication|0|||
33387840|NCT03835975|62766498|FG003|Overall Study|Lost to Follow-up|0|||
33387841|NCT03835975|62766499|FG004|Overall Study|Lost to Follow-up|0|||
33387842|NCT03835975|62766495|FG000|Overall Study|No longer met eligibility criteria|0|||
33387843|NCT03835975|62766496|FG001|Overall Study|No longer met eligibility criteria|1|||
33298577|NCT01320722|62674605|FG002|Overall Study|Non-compliant with Medication|1|||
33387844|NCT03835975|62766497|FG002|Overall Study|No longer met eligibility criteria|0|||
33387845|NCT03835975|62766498|FG003|Overall Study|No longer met eligibility criteria|0|||
33489530|NCT04588480|62867589|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
33662638|NCT01587703|63093231|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33298578|NCT01320722|62674606|FG003|Overall Study|Non-compliant with Medication|0|||
33298579|NCT01320722|62674607|FG004|Overall Study|Non-compliant with Medication|0|||
33298580|NCT01320722|62674603|FG000|Overall Study|Adverse Event|0|||
33298581|NCT01320722|62674604|FG001|Overall Study|Adverse Event|0|||
33298582|NCT01320722|62674605|FG002|Overall Study|Adverse Event|3|||
33298583|NCT01320722|62674606|FG003|Overall Study|Adverse Event|6|||
33298584|NCT01320722|62674607|FG004|Overall Study|Adverse Event|0|||
33298585|NCT01320722|62674603|FG000|Overall Study|Not Compliant with Study Procedures|0|||
33298586|NCT01320722|62674604|FG001|Overall Study|Not Compliant with Study Procedures|0|||
33298587|NCT01320722|62674605|FG002|Overall Study|Not Compliant with Study Procedures|0|||
33298588|NCT01320722|62674606|FG003|Overall Study|Not Compliant with Study Procedures|4|||
33387846|NCT03835975|62766499|FG004|Overall Study|No longer met eligibility criteria|0|||
33387847|NCT03835975|62766495|FG000|Overall Study|Protocol Violation|1|||
33387848|NCT03835975|62766496|FG001|Overall Study|Protocol Violation|1|||
33387849|NCT03835975|62766497|FG002|Overall Study|Protocol Violation|2|||
33387850|NCT03835975|62766498|FG003|Overall Study|Protocol Violation|0|||
33387851|NCT03835975|62766499|FG004|Overall Study|Protocol Violation|0|||
33387852|NCT03835975|62766495|FG000|Overall Study|Withdrawal by Subject|1|||
33387853|NCT03835975|62766496|FG001|Overall Study|Withdrawal by Subject|0|||
33387854|NCT03835975|62766497|FG002|Overall Study|Withdrawal by Subject|1|||
33387855|NCT03835975|62766498|FG003|Overall Study|Withdrawal by Subject|1|||
33387856|NCT03835975|62766499|FG004|Overall Study|Withdrawal by Subject|0|||
33387857|NCT00427921|62766513|FG000|Overall Study|Adverse Event|26|||
33387858|NCT00427921|62766513|FG000|Overall Study|Withdrawal by Subject|4|||
33387859|NCT00427921|62766513|FG000|Overall Study|Lost to Follow-up|2|||
33387860|NCT00427921|62766513|FG000|Overall Study|Other reason not specified|10|||
33387861|NCT00427921|62766513|FG000|Overall Study|Adverse Event + Hospitalization|1|||
33387862|NCT00427921|62766513|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
33387863|NCT00427921|62766513|FG000|Overall Study|Adverse Event + No Response|1|||
33387864|NCT00427921|62766513|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
33387865|NCT00427921|62766513|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
33387866|NCT00427921|62766513|FG000|Overall Study|Adverse Event + Lost Response|1|||
33387867|NCT00427921|62766513|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
33387868|NCT00427921|62766513|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
33387869|NCT00432991|62766519|FG000|Overall Study|Protocol Violation|7|||
33387870|NCT00432991|62766520|FG001|Overall Study|Protocol Violation|12|||
33387871|NCT00432835|62766528|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
33298589|NCT01320722|62674607|FG004|Overall Study|Not Compliant with Study Procedures|0|||
33298590|NCT01320722|62674603|FG000|Overall Study|Pregnancy|0|||
33298591|NCT01320722|62674604|FG001|Overall Study|Pregnancy|0|||
33298592|NCT01320722|62674605|FG002|Overall Study|Pregnancy|0|||
33298593|NCT01320722|62674606|FG003|Overall Study|Pregnancy|1|||
33298594|NCT01320722|62674607|FG004|Overall Study|Pregnancy|0|||
33298595|NCT01320722|62674603|FG000|Overall Study|Started an Exclusionary Medication|0|||
33298596|NCT01320722|62674604|FG001|Overall Study|Started an Exclusionary Medication|0|||
33298597|NCT01320722|62674605|FG002|Overall Study|Started an Exclusionary Medication|0|||
33298598|NCT01320722|62674606|FG003|Overall Study|Started an Exclusionary Medication|0|||
33298599|NCT01320722|62674607|FG004|Overall Study|Started an Exclusionary Medication|1|||
33298600|NCT01320722|62674603|FG000|Overall Study|Withdrew due to Health Condition|0|||
33298601|NCT01320722|62674604|FG001|Overall Study|Withdrew due to Health Condition|0|||
33298602|NCT01320722|62674605|FG002|Overall Study|Withdrew due to Health Condition|0|||
33298603|NCT01320722|62674606|FG003|Overall Study|Withdrew due to Health Condition|0|||
33298604|NCT01320722|62674607|FG004|Overall Study|Withdrew due to Health Condition|1|||
33298605|NCT01313559|62674624|FG000|Overall Study|Withdrawal by Subject|1|||
33298606|NCT01313559|62674625|FG001|Overall Study|Withdrawal by Subject|2|||
33298607|NCT01313559|62674624|FG000|Overall Study|Disease progression|1|||
33298608|NCT01313559|62674625|FG001|Overall Study|Disease progression|0|||
33298609|NCT01313559|62674624|FG000|Overall Study|Rising PSA|2|||
33298610|NCT01313559|62674625|FG001|Overall Study|Rising PSA|0|||
33298611|NCT01312779|62674631|FG000|Overall Study|Withdrawal by Subject|2|||
33298612|NCT01312779|62674631|FG000|Overall Study|Death|3|||
33298613|NCT01312779|62674631|FG000|Overall Study|Not Implanted with Device|27|||
33298614|NCT01312467|62674644|FG000|Overall Study|Adverse Event|4|||
33298615|NCT01312467|62674644|FG000|Overall Study|Lost to Follow-up|1|||
33298616|NCT01312467|62674644|FG000|Overall Study|Withdrawal by Subject|2|||
33298617|NCT01312467|62674644|FG000|Overall Study|Deported to country of origin|1|||
33298618|NCT01312467|62674644|FG000|Overall Study|Another medical condition|1|||
33298619|NCT01312467|62674644|FG000|Overall Study|Ineligible|4|||
33298620|NCT01310127|62674651|FG000|Overall Study|Protocol Violation|1|||
33298621|NCT01310127|62674652|FG001|Overall Study|Protocol Violation|1|||
33298622|NCT01310127|62674651|FG000|Overall Study|advanced psc cataract outlier|1|||
33298623|NCT01310127|62674652|FG001|Overall Study|advanced psc cataract outlier|0|||
33298624|NCT01309893|62674658|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
33298625|NCT01309893|62674659|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
33298626|NCT01309893|62674658|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
33387872|NCT00432835|62766529|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
33298627|NCT01309893|62674659|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
33298628|NCT01318902|62674669|FG000|Overall Study|Symptomatic Deterioration|0|||
33298629|NCT01318902|62674670|FG001|Overall Study|Symptomatic Deterioration|1|||
33298630|NCT01318902|62674671|FG002|Overall Study|Symptomatic Deterioration|1|||
33298631|NCT01318902|62674672|FG003|Overall Study|Symptomatic Deterioration|2|||
33298632|NCT01318902|62674669|FG000|Overall Study|Withdrawal by Patient|0|||
33298633|NCT01318902|62674670|FG001|Overall Study|Withdrawal by Patient|1|||
33298634|NCT01318902|62674671|FG002|Overall Study|Withdrawal by Patient|0|||
33298635|NCT01318902|62674672|FG003|Overall Study|Withdrawal by Patient|3|||
33298636|NCT01318902|62674669|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
33298637|NCT01318902|62674670|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
33298638|NCT01318902|62674671|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
33298639|NCT01318902|62674672|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
33662639|NCT01587703|63093232|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33298640|NCT01318902|62674669|FG000|Overall Study|Adverse Event|0|||
33298641|NCT01318902|62674670|FG001|Overall Study|Adverse Event|1|||
33387873|NCT00580970|62766537|FG000|Pre-treatment|Non-compliance|1|||
33387874|NCT00580970|62766537|FG000|Treatment (Lovastatin)|Non-compliance|6|||
33387875|NCT00580970|62766537|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
33387876|NCT00580970|62766537|FG000|Treatment (Lovastatin)|Physician Decision|4|||
33387877|NCT00580970|62766537|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
33387878|NCT00580970|62766537|FG000|Treatment (Lovastatin)|Death|1|||
33387879|NCT00665925|62766545|FG000|Overall Study|Lack of Efficacy|10|||
33387880|NCT00665925|62766546|FG001|Overall Study|Lack of Efficacy|8|||
33387881|NCT00665925|62766547|FG002|Overall Study|Lack of Efficacy|9|||
33387882|NCT00665925|62766548|FG003|Overall Study|Lack of Efficacy|8|||
33387883|NCT00665925|62766545|FG000|Overall Study|Lost to Follow-up|1|||
33387884|NCT00665925|62766546|FG001|Overall Study|Lost to Follow-up|2|||
33387885|NCT00665925|62766547|FG002|Overall Study|Lost to Follow-up|2|||
33298642|NCT01318902|62674671|FG002|Overall Study|Adverse Event|0|||
33298643|NCT01318902|62674672|FG003|Overall Study|Adverse Event|0|||
33298644|NCT01318902|62674669|FG000|Overall Study|Terminated by Sponsor|0|||
33298645|NCT01318902|62674670|FG001|Overall Study|Terminated by Sponsor|0|||
33298646|NCT01318902|62674671|FG002|Overall Study|Terminated by Sponsor|1|||
33387886|NCT00665925|62766548|FG003|Overall Study|Lost to Follow-up|2|||
33387887|NCT00665925|62766545|FG000|Overall Study|Withdrawal by Subject|2|||
33298647|NCT01318902|62674672|FG003|Overall Study|Terminated by Sponsor|0|||
33298648|NCT01313858|62674687|FG000|Overall Study|Premature Treatment Termination|251|||
33387888|NCT00665925|62766546|FG001|Overall Study|Withdrawal by Subject|2|||
33387889|NCT00665925|62766547|FG002|Overall Study|Withdrawal by Subject|3|||
33387890|NCT00665925|62766548|FG003|Overall Study|Withdrawal by Subject|2|||
33387891|NCT00665925|62766545|FG000|Overall Study|Physician Decision|0|||
33387892|NCT00665925|62766546|FG001|Overall Study|Physician Decision|0|||
33387893|NCT00665925|62766547|FG002|Overall Study|Physician Decision|1|||
33387894|NCT00665925|62766548|FG003|Overall Study|Physician Decision|2|||
33387895|NCT00665925|62766545|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
33387896|NCT00665925|62766546|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
33387897|NCT00665925|62766547|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
33387898|NCT00665925|62766548|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
33387899|NCT00665925|62766545|FG000|Overall Study|Adverse Event|1|||
33387900|NCT00665925|62766546|FG001|Overall Study|Adverse Event|5|||
33387901|NCT00665925|62766547|FG002|Overall Study|Adverse Event|10|||
33387902|NCT00665925|62766548|FG003|Overall Study|Adverse Event|5|||
33298649|NCT01313858|62674688|FG001|Overall Study|Premature Treatment Termination|219|||
33387903|NCT00665925|62766545|FG000|Overall Study|Enrolled by mistake|0|||
33387904|NCT00665925|62766546|FG001|Overall Study|Enrolled by mistake|0|||
33387905|NCT00665925|62766547|FG002|Overall Study|Enrolled by mistake|0|||
33387906|NCT00665925|62766548|FG003|Overall Study|Enrolled by mistake|1|||
33387907|NCT00665925|62766545|FG000|Overall Study|Due to exclusion criteria|1|||
33387908|NCT00665925|62766546|FG001|Overall Study|Due to exclusion criteria|0|||
33387909|NCT00665925|62766547|FG002|Overall Study|Due to exclusion criteria|0|||
33387910|NCT00665925|62766548|FG003|Overall Study|Due to exclusion criteria|0|||
33387911|NCT00426751|62766561|FG000|Overall Study|Adverse Event|8|||
33387912|NCT00426751|62766562|FG001|Overall Study|Adverse Event|1|||
33387913|NCT00426751|62766561|FG000|Overall Study|Lost to Follow-up|7|||
33387914|NCT00426751|62766562|FG001|Overall Study|Lost to Follow-up|6|||
33387915|NCT00426751|62766561|FG000|Overall Study|Consent Withdrawn|0|||
33387916|NCT00426751|62766562|FG001|Overall Study|Consent Withdrawn|1|||
33387917|NCT00426751|62766561|FG000|Overall Study|Other Reasons|7|||
33387918|NCT00426751|62766562|FG001|Overall Study|Other Reasons|12|||
33387919|NCT00440401|62766570|FG000|Overall Study|Adverse Event|2|||
33387920|NCT00440401|62766571|FG001|Overall Study|Adverse Event|1|||
33387921|NCT00440401|62766570|FG000|Overall Study|Other|2|||
33387922|NCT00440401|62766571|FG001|Overall Study|Other|5|||
33387923|NCT02598960|62766590|FG000|Treatment Period|Disease Progression|4|||
33387924|NCT02598960|62766591|FG001|Treatment Period|Disease Progression|4|||
33387925|NCT02598960|62766592|FG002|Treatment Period|Disease Progression|4|||
33387926|NCT02598960|62766593|FG003|Treatment Period|Disease Progression|6|||
33387927|NCT02598960|62766594|FG004|Treatment Period|Disease Progression|8|||
33298650|NCT01313858|62674689|FG002|Overall Study|Premature Treatment Termination|191|||
33298651|NCT01313858|62674687|FG000|Overall Study|Lost to Follow-up|35|||
33298652|NCT01313858|62674688|FG001|Overall Study|Lost to Follow-up|51|||
33298653|NCT01313858|62674689|FG002|Overall Study|Lost to Follow-up|47|||
33298654|NCT01090765|62674701|FG000|Overall Study|Patient withdrew consent|0|||
33387928|NCT02598960|62766595|FG005|Treatment Period|Disease Progression|2|||
33387929|NCT02598960|62766596|FG006|Treatment Period|Disease Progression|2|||
33387930|NCT02598960|62766597|FG007|Treatment Period|Disease Progression|3|||
33387931|NCT02598960|62766598|FG008|Treatment Period|Disease Progression|7|||
33387932|NCT02598960|62766599|FG009|Treatment Period|Disease Progression|9|||
33387933|NCT02598960|62766600|FG010|Treatment Period|Disease Progression|7|||
33387934|NCT02598960|62766601|FG011|Treatment Period|Disease Progression|143|||
33387935|NCT02598960|62766602|FG012|Treatment Period|Disease Progression|23|||
33387936|NCT02598960|62766590|FG000|Treatment Period|Study drug toxicity|0|||
33387937|NCT02598960|62766591|FG001|Treatment Period|Study drug toxicity|0|||
33387938|NCT02598960|62766592|FG002|Treatment Period|Study drug toxicity|0|||
33387939|NCT02598960|62766593|FG003|Treatment Period|Study drug toxicity|0|||
33387940|NCT02598960|62766594|FG004|Treatment Period|Study drug toxicity|0|||
33298655|NCT01090765|62674702|FG001|Overall Study|Patient withdrew consent|0|||
33298656|NCT01090765|62674703|FG002|Overall Study|Patient withdrew consent|0|||
33387941|NCT02598960|62766595|FG005|Treatment Period|Study drug toxicity|0|||
33387942|NCT02598960|62766596|FG006|Treatment Period|Study drug toxicity|0|||
33387943|NCT02598960|62766597|FG007|Treatment Period|Study drug toxicity|0|||
33387944|NCT02598960|62766598|FG008|Treatment Period|Study drug toxicity|0|||
33387945|NCT02598960|62766599|FG009|Treatment Period|Study drug toxicity|1|||
33387946|NCT02598960|62766600|FG010|Treatment Period|Study drug toxicity|0|||
33387947|NCT02598960|62766601|FG011|Treatment Period|Study drug toxicity|3|||
33387948|NCT02598960|62766602|FG012|Treatment Period|Study drug toxicity|0|||
33387949|NCT02598960|62766590|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
33387950|NCT02598960|62766591|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
33387951|NCT02598960|62766592|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
33387952|NCT02598960|62766593|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
33387953|NCT02598960|62766594|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
33298657|NCT01090765|62674704|FG003|Overall Study|Patient withdrew consent|0|||
33298658|NCT01090765|62674705|FG004|Overall Study|Patient withdrew consent|1|||
33298659|NCT01090765|62674706|FG005|Overall Study|Patient withdrew consent|1|||
33298660|NCT01090765|62674701|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
33298661|NCT01090765|62674702|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
33298662|NCT01090765|62674703|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
33387954|NCT02598960|62766595|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
33387955|NCT02598960|62766596|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
33387956|NCT02598960|62766597|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
33387957|NCT02598960|62766598|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
33387958|NCT02598960|62766599|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
33387959|NCT02598960|62766600|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
33387960|NCT02598960|62766601|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
33387961|NCT02598960|62766602|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
33387962|NCT02598960|62766590|FG000|Treatment Period|participant request to discontinue|0|||
33387963|NCT02598960|62766591|FG001|Treatment Period|participant request to discontinue|1|||
33387964|NCT02598960|62766592|FG002|Treatment Period|participant request to discontinue|0|||
33387965|NCT02598960|62766593|FG003|Treatment Period|participant request to discontinue|0|||
33387966|NCT02598960|62766594|FG004|Treatment Period|participant request to discontinue|1|||
33387967|NCT02598960|62766595|FG005|Treatment Period|participant request to discontinue|0|||
33298663|NCT01090765|62674704|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
33298664|NCT01090765|62674705|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
33387968|NCT02598960|62766596|FG006|Treatment Period|participant request to discontinue|0|||
33387969|NCT02598960|62766597|FG007|Treatment Period|participant request to discontinue|0|||
33387970|NCT02598960|62766598|FG008|Treatment Period|participant request to discontinue|0|||
33387971|NCT02598960|62766599|FG009|Treatment Period|participant request to discontinue|0|||
33387972|NCT02598960|62766600|FG010|Treatment Period|participant request to discontinue|1|||
33387973|NCT02598960|62766601|FG011|Treatment Period|participant request to discontinue|4|||
33387974|NCT02598960|62766602|FG012|Treatment Period|participant request to discontinue|0|||
33387975|NCT02598960|62766590|FG000|Treatment Period|participant withdrew consent|0|||
33387976|NCT02598960|62766591|FG001|Treatment Period|participant withdrew consent|0|||
33387977|NCT02598960|62766592|FG002|Treatment Period|participant withdrew consent|0|||
33387978|NCT02598960|62766593|FG003|Treatment Period|participant withdrew consent|0|||
33387979|NCT02598960|62766594|FG004|Treatment Period|participant withdrew consent|0|||
33387980|NCT02598960|62766595|FG005|Treatment Period|participant withdrew consent|0|||
33387981|NCT02598960|62766596|FG006|Treatment Period|participant withdrew consent|0|||
33387982|NCT02598960|62766597|FG007|Treatment Period|participant withdrew consent|0|||
33387983|NCT02598960|62766598|FG008|Treatment Period|participant withdrew consent|0|||
33387984|NCT02598960|62766599|FG009|Treatment Period|participant withdrew consent|0|||
33387985|NCT02598960|62766600|FG010|Treatment Period|participant withdrew consent|0|||
33662640|NCT01587703|63093233|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33662641|NCT01587703|63093234|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
33662642|NCT01587703|63093235|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33298665|NCT01090765|62674706|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
33298666|NCT01090765|62674701|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
33298667|NCT01090765|62674702|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
33298668|NCT01090765|62674703|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
33387986|NCT02598960|62766601|FG011|Treatment Period|participant withdrew consent|3|||
33387987|NCT02598960|62766602|FG012|Treatment Period|participant withdrew consent|0|||
33387988|NCT02598960|62766590|FG000|Treatment Period|No longer meets study criteria|0|||
33387989|NCT02598960|62766591|FG001|Treatment Period|No longer meets study criteria|0|||
33387990|NCT02598960|62766592|FG002|Treatment Period|No longer meets study criteria|0|||
33387991|NCT02598960|62766593|FG003|Treatment Period|No longer meets study criteria|0|||
33387992|NCT02598960|62766594|FG004|Treatment Period|No longer meets study criteria|0|||
33387993|NCT02598960|62766595|FG005|Treatment Period|No longer meets study criteria|0|||
33387994|NCT02598960|62766596|FG006|Treatment Period|No longer meets study criteria|0|||
33387995|NCT02598960|62766597|FG007|Treatment Period|No longer meets study criteria|0|||
33387996|NCT02598960|62766598|FG008|Treatment Period|No longer meets study criteria|0|||
33387997|NCT02598960|62766599|FG009|Treatment Period|No longer meets study criteria|0|||
33387998|NCT02598960|62766600|FG010|Treatment Period|No longer meets study criteria|0|||
33387999|NCT02598960|62766601|FG011|Treatment Period|No longer meets study criteria|1|||
33388000|NCT02598960|62766602|FG012|Treatment Period|No longer meets study criteria|0|||
33388001|NCT02598960|62766590|FG000|Treatment Period|Other Reasons|0|||
33388002|NCT02598960|62766591|FG001|Treatment Period|Other Reasons|0|||
33388003|NCT02598960|62766592|FG002|Treatment Period|Other Reasons|0|||
33388004|NCT02598960|62766593|FG003|Treatment Period|Other Reasons|0|||
33388005|NCT02598960|62766594|FG004|Treatment Period|Other Reasons|0|||
33388006|NCT02598960|62766595|FG005|Treatment Period|Other Reasons|0|||
33388007|NCT02598960|62766596|FG006|Treatment Period|Other Reasons|0|||
33388008|NCT02598960|62766597|FG007|Treatment Period|Other Reasons|0|||
33388009|NCT02598960|62766598|FG008|Treatment Period|Other Reasons|0|||
33388010|NCT02598960|62766599|FG009|Treatment Period|Other Reasons|0|||
33388011|NCT02598960|62766600|FG010|Treatment Period|Other Reasons|0|||
33388012|NCT02598960|62766601|FG011|Treatment Period|Other Reasons|0|||
33388013|NCT02598960|62766602|FG012|Treatment Period|Other Reasons|1|||
33388014|NCT02598960|62766590|FG000|Participants Entering Follow Up Period|Death|1|||
33388015|NCT02598960|62766591|FG001|Participants Entering Follow Up Period|Death|0|||
33388016|NCT02598960|62766592|FG002|Participants Entering Follow Up Period|Death|0|||
33388017|NCT02598960|62766593|FG003|Participants Entering Follow Up Period|Death|0|||
33388018|NCT02598960|62766594|FG004|Participants Entering Follow Up Period|Death|0|||
33388019|NCT02598960|62766595|FG005|Participants Entering Follow Up Period|Death|0|||
33388020|NCT02598960|62766596|FG006|Participants Entering Follow Up Period|Death|0|||
33388021|NCT02598960|62766597|FG007|Participants Entering Follow Up Period|Death|0|||
33388022|NCT02598960|62766598|FG008|Participants Entering Follow Up Period|Death|0|||
33388023|NCT02598960|62766599|FG009|Participants Entering Follow Up Period|Death|1|||
33388024|NCT02598960|62766600|FG010|Participants Entering Follow Up Period|Death|0|||
33388025|NCT02598960|62766601|FG011|Participants Entering Follow Up Period|Death|11|||
33388026|NCT02598960|62766602|FG012|Participants Entering Follow Up Period|Death|2|||
33388027|NCT02598960|62766590|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
33388028|NCT02598960|62766591|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
33388029|NCT02598960|62766592|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
33388030|NCT02598960|62766593|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
33388031|NCT02598960|62766594|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
33388032|NCT02598960|62766595|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
33388033|NCT02598960|62766596|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
33388034|NCT02598960|62766597|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
33388035|NCT02598960|62766598|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
33388036|NCT02598960|62766599|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
33388037|NCT02598960|62766600|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
33388038|NCT02598960|62766601|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
33489531|NCT04588480|62867590|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
33489532|NCT04588480|62867591|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
33489533|NCT02756650|62867598|FG000|Overall Study|Physician Decision|1|||
33489534|NCT02756650|62867598|FG000|Overall Study|Adverse Event|1|||
33388039|NCT02598960|62766602|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
33388040|NCT02598960|62766590|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
33388041|NCT02598960|62766591|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
33388042|NCT02598960|62766592|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
33388043|NCT02598960|62766593|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
33388044|NCT02598960|62766594|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
33388045|NCT02598960|62766595|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
33388046|NCT02598960|62766596|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
33388047|NCT02598960|62766597|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
33489535|NCT00110357|62867604|FG000|Overall Study|Deterioration without progression|2|||
33489536|NCT00110357|62867605|FG001|Overall Study|Deterioration without progression|0|||
33489537|NCT00110357|62867604|FG000|Overall Study|Disease progression/relapse|20|||
33489538|NCT00110357|62867605|FG001|Overall Study|Disease progression/relapse|15|||
33388048|NCT02598960|62766598|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
33388049|NCT02598960|62766599|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
33489539|NCT00110357|62867604|FG000|Overall Study|Study Closure|1|||
33388050|NCT02598960|62766600|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
33388051|NCT02598960|62766601|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
33388052|NCT02598960|62766602|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
33388053|NCT02598960|62766590|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33388054|NCT02598960|62766591|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33388055|NCT02598960|62766592|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33388056|NCT02598960|62766593|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33388057|NCT02598960|62766594|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33388058|NCT02598960|62766595|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33388059|NCT02598960|62766596|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33388060|NCT02598960|62766597|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33388061|NCT02598960|62766598|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33388062|NCT02598960|62766599|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33388063|NCT02598960|62766600|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33388064|NCT02598960|62766601|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
33388065|NCT02598960|62766602|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33388066|NCT02598960|62766590|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
33388067|NCT02598960|62766591|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
33388068|NCT02598960|62766592|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
33388069|NCT02598960|62766593|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
33388070|NCT02598960|62766594|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
33388071|NCT02598960|62766595|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
33388072|NCT02598960|62766596|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
33388073|NCT02598960|62766597|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
33388074|NCT02598960|62766598|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
33298669|NCT01090765|62674704|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
33298670|NCT01090765|62674705|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
33298671|NCT01090765|62674706|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
33298672|NCT01313780|62674723|FG000|Overall Study|Lack of Efficacy|4|||
33298673|NCT01313780|62674724|FG001|Overall Study|Lack of Efficacy|2|||
33298674|NCT01313780|62674723|FG000|Overall Study|Adverse Event|6|||
33388075|NCT02598960|62766599|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
33388076|NCT02598960|62766600|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
33388077|NCT02598960|62766601|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
33388078|NCT02598960|62766602|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
33388079|NCT00426361|62766633|FG000|Overall Study|Lost to Follow-up|3|||
33388080|NCT00426361|62766634|FG001|Overall Study|Lost to Follow-up|2|||
33388081|NCT00426361|62766635|FG002|Overall Study|Lost to Follow-up|5|||
33388082|NCT00426361|62766633|FG000|Overall Study|Withdrawal by Subject|1|||
33388083|NCT00426361|62766634|FG001|Overall Study|Withdrawal by Subject|3|||
33388084|NCT00426361|62766635|FG002|Overall Study|Withdrawal by Subject|0|||
33388085|NCT00665847|62766643|FG000|Overall Study|Adverse Event|8|||
33388086|NCT00665847|62766643|FG000|Overall Study|Withdrawal by Subject|2|||
33388087|NCT00665847|62766643|FG000|Overall Study|Subject non-compliant|8|||
33388088|NCT00665847|62766643|FG000|Overall Study|Subject reached a virologic endpoint|4|||
33388089|NCT00665847|62766643|FG000|Overall Study|Resistance to TMC125|1|||
33388090|NCT00665847|62766643|FG000|Overall Study|Subject ineligible to continue the trial|1|||
33489540|NCT00110357|62867605|FG001|Overall Study|Study Closure|0|||
33298675|NCT01313780|62674724|FG001|Overall Study|Adverse Event|11|||
33298676|NCT01313780|62674723|FG000|Overall Study|Withdrawal by Subject|2|||
33298677|NCT01313780|62674724|FG001|Overall Study|Withdrawal by Subject|8|||
33298678|NCT01313780|62674723|FG000|Overall Study|Protocol Violation|10|||
33298679|NCT01313780|62674724|FG001|Overall Study|Protocol Violation|4|||
33298680|NCT01313780|62674723|FG000|Overall Study|missing data|3|||
33298681|NCT01313780|62674724|FG001|Overall Study|missing data|3|||
33298682|NCT01090453|62674732|FG000|Overall Study|Withdrawal by Subject|1|||
33298683|NCT01090453|62674733|FG001|Overall Study|Withdrawal by Subject|2|||
33298684|NCT01090453|62674732|FG000|Overall Study|Lost to Follow-up|7|||
33298685|NCT01090453|62674733|FG001|Overall Study|Lost to Follow-up|7|||
33298686|NCT01090453|62674732|FG000|Overall Study|Non serious AEs|1|||
33298687|NCT01090453|62674733|FG001|Overall Study|Non serious AEs|0|||
33298688|NCT01090453|62674732|FG000|Overall Study|Protocol Violation|2|||
33298689|NCT01090453|62674733|FG001|Overall Study|Protocol Violation|0|||
33298690|NCT01090453|62674732|FG000|Overall Study|Other|2|||
33298691|NCT01090453|62674733|FG001|Overall Study|Other|4|||
33298692|NCT01090453|62674732|FG000|Overall Study|Eligibility Criteria|0|||
33298693|NCT01090453|62674733|FG001|Overall Study|Eligibility Criteria|1|||
33298694|NCT01171612|62674739|FG000|Overall Study|Lost to Follow-up|51|||
33298695|NCT01171534|62674748|FG000|Overall Study|Lost to Follow-up|0|||
33298696|NCT01171534|62674749|FG001|Overall Study|Lost to Follow-up|2|||
33298697|NCT01171534|62674748|FG000|Overall Study|screen failure|0|||
33298698|NCT01171534|62674749|FG001|Overall Study|screen failure|1|||
33298699|NCT01170598|62674755|FG000|Overall Study|Withdrawal by Subject|1|||
33298700|NCT01170598|62674755|FG000|Overall Study|Death|3|||
33298701|NCT01170598|62674755|FG000|Overall Study|Lost to Follow-up|1|||
33298702|NCT01170598|62674755|FG000|Overall Study|Refused|1|||
33388091|NCT00665847|62766643|FG000|Overall Study|Switch to Commercial Medication|1|||
33388092|NCT00426127|62766647|FG000|Overall Study|Adverse Event|1|||
33298703|NCT01170364|62674761|FG000|Overall Study|Protocol Violation|4|||
33298704|NCT01170364|62674762|FG001|Overall Study|Protocol Violation|1|||
33298705|NCT01076179|62674768|FG000|Overall Study|Withdrawal by Subject|1|||
33298706|NCT01170208|62674776|FG000|Overall Study|Withdrawal by Subject|5|||
33298707|NCT01170208|62674777|FG001|Overall Study|Withdrawal by Subject|0|||
33298708|NCT01170208|62674778|FG002|Overall Study|Withdrawal by Subject|1|||
33298709|NCT01170208|62674776|FG000|Overall Study|Protocol Violation|1|||
33298710|NCT01170208|62674777|FG001|Overall Study|Protocol Violation|0|||
33298711|NCT01170208|62674778|FG002|Overall Study|Protocol Violation|1|||
33298712|NCT01313624|62674791|FG000|Double-Blind Phase|Adverse Event|27|||
33298713|NCT01313624|62674792|FG001|Double-Blind Phase|Adverse Event|4|||
33298714|NCT01313624|62674791|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
33298715|NCT01313624|62674792|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
33298716|NCT01313624|62674791|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33298717|NCT01313624|62674792|FG001|Double-Blind Phase|Lost to Follow-up|2|||
33298718|NCT01313624|62674791|FG000|Double-Blind Phase|Physician Decision|1|||
33298719|NCT01313624|62674792|FG001|Double-Blind Phase|Physician Decision|0|||
33298720|NCT01313624|62674791|FG000|Double-Blind Phase|Lack of Efficacy|1|||
33298721|NCT01313624|62674792|FG001|Double-Blind Phase|Lack of Efficacy|0|||
33298722|NCT01313624|62674791|FG000|Open-Label Phase|Adverse Event|1|||
33298723|NCT01313624|62674792|FG001|Open-Label Phase|Adverse Event|10|||
33298724|NCT01313624|62674791|FG000|Open-Label Phase|Withdrawal by Subject|2|||
33298725|NCT01313624|62674792|FG001|Open-Label Phase|Withdrawal by Subject|2|||
33298726|NCT01313624|62674791|FG000|Open-Label Phase|Lost to Follow-up|1|||
33298727|NCT01313624|62674792|FG001|Open-Label Phase|Lost to Follow-up|1|||
33298728|NCT01169350|62674800|FG000|Overall Study|Physician Decision|3|||
33298729|NCT01169350|62674800|FG000|Overall Study|Lost to Follow-up|2|||
33298730|NCT01169038|62674804|FG000|Overall Study|Death|1|||
33298731|NCT01169038|62674804|FG000|Overall Study|Adverse Event|5|||
33298732|NCT01169038|62674804|FG000|Overall Study|Required antibiotic administration|1|||
33298733|NCT01167634|62674812|FG000|Overall Study|Lost to Follow-up|1|||
33298734|NCT01167634|62674813|FG001|Overall Study|Lost to Follow-up|3|||
33298735|NCT01167634|62674814|FG002|Overall Study|Lost to Follow-up|3|||
33298736|NCT01167634|62674815|FG003|Overall Study|Lost to Follow-up|4|||
33298737|NCT01167634|62674812|FG000|Overall Study|Withdrawal by Subject|1|||
33298738|NCT01167634|62674813|FG001|Overall Study|Withdrawal by Subject|1|||
33298739|NCT01167634|62674814|FG002|Overall Study|Withdrawal by Subject|0|||
33388093|NCT00426127|62766647|FG000|Overall Study|Removed due to disease progression|1|||
33388094|NCT00425503|62766651|FG000|Overall Study|Adverse Event|2|||
33388095|NCT00425503|62766651|FG000|Overall Study|Protocol Violation|1|||
33388096|NCT00425269|62766657|FG000|Overall Study|Pregnancy|5|||
33388097|NCT00425269|62766658|FG001|Overall Study|Pregnancy|7|||
33388098|NCT00425269|62766657|FG000|Overall Study|Lost to Follow-up|9|||
33388099|NCT00425269|62766658|FG001|Overall Study|Lost to Follow-up|9|||
33388100|NCT00425269|62766657|FG000|Overall Study|moved or medical reason|5|||
33388101|NCT00425269|62766658|FG001|Overall Study|moved or medical reason|4|||
33388102|NCT00430573|62766664|FG000|Overall Study|Withdrawal by Subject|5|||
33388103|NCT02075840|62766688|FG000|Overall Study|Withdrawal by Subject|13|||
33388104|NCT02075840|62766689|FG001|Overall Study|Withdrawal by Subject|22|||
33388105|NCT02075840|62766688|FG000|Overall Study|Reason not specified|1|||
33388106|NCT02075840|62766689|FG001|Overall Study|Reason not specified|0|||
33388107|NCT02075840|62766688|FG000|Overall Study|Adverse Event|0|||
33388108|NCT02075840|62766689|FG001|Overall Study|Adverse Event|2|||
33298740|NCT01167634|62674815|FG003|Overall Study|Withdrawal by Subject|0|||
33388109|NCT02075840|62766688|FG000|Overall Study|Death|35|||
33388110|NCT02075840|62766689|FG001|Overall Study|Death|40|||
33388111|NCT02075840|62766688|FG000|Overall Study|Lost to Follow-up|3|||
33298741|NCT01166386|62674827|FG000|Overall Study|Withdrawal by Subject|3|||
33298742|NCT01166386|62674828|FG001|Overall Study|Withdrawal by Subject|5|||
33388112|NCT02075840|62766689|FG001|Overall Study|Lost to Follow-up|2|||
33298743|NCT01114828|62674836|FG000|Overall Study|Adverse Event|1|||
33298744|NCT01114828|62674837|FG001|Overall Study|Adverse Event|1|||
33298745|NCT01114828|62674836|FG000|Overall Study|Lack of Efficacy|0|||
33298746|NCT01114828|62674837|FG001|Overall Study|Lack of Efficacy|2|||
33298747|NCT01114828|62674836|FG000|Overall Study|Protocol Violation|2|||
33388113|NCT02075840|62766688|FG000|Overall Study|Physician Decision|1|||
33388114|NCT02075840|62766689|FG001|Overall Study|Physician Decision|3|||
33388115|NCT02075840|62766688|FG000|Overall Study|Ongoing at CCOD|99|||
33388116|NCT02075840|62766689|FG001|Overall Study|Ongoing at CCOD|82|||
33388117|NCT00430495|62766699|FG000|Overall Study|Adverse Event|2|||
33388118|NCT00430495|62766700|FG001|Overall Study|Adverse Event|3|||
33388119|NCT00430495|62766701|FG002|Overall Study|Adverse Event|2|||
33388120|NCT00430495|62766702|FG003|Overall Study|Adverse Event|0|||
33388121|NCT00430495|62766699|FG000|Overall Study|Death|0|||
33388122|NCT00430495|62766700|FG001|Overall Study|Death|0|||
33388123|NCT00430495|62766701|FG002|Overall Study|Death|1|||
33388124|NCT00430495|62766702|FG003|Overall Study|Death|0|||
33388125|NCT00430495|62766699|FG000|Overall Study|Lost to Follow-up|0|||
33388126|NCT00430495|62766700|FG001|Overall Study|Lost to Follow-up|1|||
33388127|NCT00430495|62766701|FG002|Overall Study|Lost to Follow-up|4|||
33388128|NCT00430495|62766702|FG003|Overall Study|Lost to Follow-up|0|||
33388129|NCT00430495|62766699|FG000|Overall Study|Protocol Violation|1|||
33388130|NCT00430495|62766700|FG001|Overall Study|Protocol Violation|0|||
33388131|NCT00430495|62766701|FG002|Overall Study|Protocol Violation|1|||
33388132|NCT00430495|62766702|FG003|Overall Study|Protocol Violation|0|||
33388133|NCT00430495|62766699|FG000|Overall Study|Disease Progression|1|||
33388134|NCT00430495|62766700|FG001|Overall Study|Disease Progression|1|||
33388135|NCT00430495|62766701|FG002|Overall Study|Disease Progression|0|||
33388136|NCT00430495|62766702|FG003|Overall Study|Disease Progression|0|||
33388137|NCT00430495|62766699|FG000|Overall Study|Other|8|||
33388138|NCT00430495|62766700|FG001|Overall Study|Other|2|||
33388139|NCT00430495|62766701|FG002|Overall Study|Other|5|||
33388140|NCT00430495|62766702|FG003|Overall Study|Other|4|||
33388141|NCT00430495|62766699|FG000|Overall Study|Randomized but not Treated|2|||
33388142|NCT00430495|62766700|FG001|Overall Study|Randomized but not Treated|0|||
33388143|NCT00430495|62766701|FG002|Overall Study|Randomized but not Treated|0|||
33388144|NCT00430495|62766702|FG003|Overall Study|Randomized but not Treated|0|||
33388145|NCT00425113|62766714|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
33388146|NCT00425113|62766715|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
33388147|NCT00425113|62766714|FG000|Overall Study|diagnosis of abdominal TB|0|||
33388148|NCT00425113|62766715|FG001|Overall Study|diagnosis of abdominal TB|1|||
33388149|NCT00425113|62766714|FG000|Overall Study|missing study drug more than 14 days|0|||
33388150|NCT00425113|62766715|FG001|Overall Study|missing study drug more than 14 days|1|||
33388151|NCT00425113|62766714|FG000|Overall Study|Withdrawal by Subject|1|||
33388152|NCT00425113|62766715|FG001|Overall Study|Withdrawal by Subject|0|||
33388153|NCT00440011|62766724|FG000|Overall Study|Adverse Event|2|||
33388154|NCT00440011|62766725|FG001|Overall Study|Adverse Event|0|||
33388155|NCT00440011|62766724|FG000|Overall Study|Lost to Follow-up|0|||
33388156|NCT00440011|62766725|FG001|Overall Study|Lost to Follow-up|2|||
33388157|NCT00440011|62766724|FG000|Overall Study|Protocol Violation|1|||
33388158|NCT00440011|62766725|FG001|Overall Study|Protocol Violation|1|||
33388159|NCT00440011|62766724|FG000|Overall Study|Withdrawal by Subject|1|||
33388160|NCT00440011|62766725|FG001|Overall Study|Withdrawal by Subject|0|||
33388161|NCT00663117|62766762|FG000|Overall Study|Lack of Efficacy|1|||
33388162|NCT00663117|62766763|FG001|Overall Study|Lack of Efficacy|0|||
33388163|NCT00570141|62766784|FG000|Overall Study|Adverse Event|1|||
33388164|NCT00570141|62766784|FG000|Overall Study|Missed visits|1|||
33388165|NCT00570141|62766784|FG000|Overall Study|Lost to Follow-up|1|||
33388166|NCT00579254|62766788|FG000|Overall Study|Lost to Follow-up|39|||
33388167|NCT00579254|62766788|FG000|Overall Study|Discontinued when study terminated|73|||
33388168|NCT00661089|62766794|FG000|Overall Study|1 subject withdrawal|0|||
33298748|NCT01114828|62674837|FG001|Overall Study|Protocol Violation|0|||
33298749|NCT01114828|62674836|FG000|Overall Study|Withdrawal by Subject|0|||
33298750|NCT01114828|62674837|FG001|Overall Study|Withdrawal by Subject|1|||
33298751|NCT01313312|62674843|FG000|Overall Study|Adverse Event|5|||
33298752|NCT01313312|62674843|FG000|Overall Study|Withdrawal by Subject|18|||
33298753|NCT01313312|62674843|FG000|Overall Study|Lack of Efficacy|3|||
33298754|NCT01313312|62674843|FG000|Overall Study|Investigator Decision|1|||
33298755|NCT01313312|62674843|FG000|Overall Study|Observational Phase|1|||
33298756|NCT01313312|62674843|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
33298757|NCT01313312|62674843|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
33298758|NCT01114672|62674849|FG000|Overall Study|Death|0|||
33298759|NCT01114672|62674850|FG001|Overall Study|Death|1|||
33298760|NCT01114672|62674849|FG000|Overall Study|Withdrawal by Subject|2|||
33298761|NCT01114672|62674850|FG001|Overall Study|Withdrawal by Subject|1|||
33298762|NCT01114672|62674849|FG000|Overall Study|Lost to Follow-up|1|||
33298763|NCT01114672|62674850|FG001|Overall Study|Lost to Follow-up|0|||
33388169|NCT00661089|62766795|FG001|Overall Study|1 subject withdrawal|1|||
33388170|NCT00661089|62766794|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
33388171|NCT00661089|62766795|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
33388172|NCT00582426|62766808|FG000|Overall Study|Lost to Follow-up|0|||
33388173|NCT00582426|62766809|FG001|Overall Study|Lost to Follow-up|2|||
33388174|NCT00582426|62766808|FG000|Overall Study|Adverse Event|4|||
33388175|NCT00582426|62766809|FG001|Overall Study|Adverse Event|2|||
33388176|NCT00582426|62766808|FG000|Overall Study|Protocol Violation|6|||
33388177|NCT00582426|62766809|FG001|Overall Study|Protocol Violation|2|||
33388178|NCT00582426|62766808|FG000|Overall Study|Death|4|||
33388179|NCT00582426|62766809|FG001|Overall Study|Death|3|||
33388180|NCT00582426|62766808|FG000|Overall Study|Withdrawal by Subject|3|||
33388181|NCT00582426|62766809|FG001|Overall Study|Withdrawal by Subject|2|||
33298764|NCT01114672|62674849|FG000|Overall Study|transplanted|1|||
33388182|NCT00582426|62766808|FG000|Overall Study|Disease Progression|2|||
33388183|NCT00582426|62766809|FG001|Overall Study|Disease Progression|2|||
33388184|NCT00582426|62766808|FG000|Overall Study|Use of illicit drugs|1|||
33388185|NCT00582426|62766809|FG001|Overall Study|Use of illicit drugs|0|||
33388186|NCT02387970|62766817|FG000|Overall Study|Did not complete 1-year follow up|1|||
33489541|NCT00110357|62867604|FG000|Overall Study|Study Drug Toxicity|1|||
33489542|NCT00110357|62867605|FG001|Overall Study|Study Drug Toxicity|3|||
33489543|NCT00110357|62867604|FG000|Overall Study|Withdrawal by Subject|3|||
33489544|NCT00110357|62867605|FG001|Overall Study|Withdrawal by Subject|1|||
33489545|NCT02752906|62867640|FG000|Overall Study|Protocol Violation|2|||
33489546|NCT02752906|62867641|FG001|Overall Study|Protocol Violation|1|||
33489547|NCT02752906|62867640|FG000|Overall Study|Withdrawal by Subject|2|||
33489548|NCT02752906|62867641|FG001|Overall Study|Withdrawal by Subject|2|||
33489549|NCT02752906|62867640|FG000|Overall Study|Lost to Follow-up|3|||
33489550|NCT02752906|62867641|FG001|Overall Study|Lost to Follow-up|2|||
33489551|NCT02756338|62867647|FG000|Overall Study|Withdrawn by Investigator|1|||
33489552|NCT02756338|62867647|FG000|Overall Study|Device Replaced with Pacemaker|4|||
33489553|NCT00293033|62867651|FG000|Open-label Titration Period|Adverse Event|10|||
33489554|NCT00293033|62867651|FG000|Open-label Titration Period|Death|3|||
33489555|NCT00293033|62867651|FG000|Open-label Titration Period|Lack of Efficacy|5|||
33489556|NCT00293033|62867651|FG000|Open-label Titration Period|Protocol Violation|2|||
33489557|NCT00293033|62867651|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
33489558|NCT00293033|62867651|FG000|Open-label Titration Period|Noncompliance and other|27|||
33489559|NCT00293033|62867651|FG000|Double-blind Treatment Period|Adverse Event|3|||
33489560|NCT00293033|62867651|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
33489561|NCT00293033|62867651|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
33489562|NCT00293033|62867651|FG000|Double-blind Treatment Period|Noncompliance|4|||
33489563|NCT02756182|62867659|FG000|Overall Study|StudyTechnical Difficulties|4|||
33489564|NCT03823703|62867668|FG000|Overall Study|Sponsor request|0|||
33489565|NCT03823703|62867669|FG001|Overall Study|Sponsor request|3|||
33489566|NCT03823703|62867670|FG002|Overall Study|Sponsor request|4|||
33489567|NCT03823703|62867668|FG000|Overall Study|Adverse Event|3|||
33489568|NCT03823703|62867669|FG001|Overall Study|Adverse Event|1|||
33489569|NCT03823703|62867670|FG002|Overall Study|Adverse Event|0|||
33489570|NCT03823703|62867668|FG000|Overall Study|Withdrawal by Subject|0|||
33489571|NCT03823703|62867669|FG001|Overall Study|Withdrawal by Subject|1|||
33489572|NCT03823703|62867670|FG002|Overall Study|Withdrawal by Subject|0|||
33489573|NCT00109577|62867680|FG000|Overall Study|Withdrawal by Subject|3|||
33489574|NCT00109577|62867681|FG001|Overall Study|Withdrawal by Subject|3|||
33489575|NCT02755090|62867689|FG000|Overall Study|equipment malfunction|1|||
33489576|NCT02755090|62867690|FG001|Overall Study|equipment malfunction|0|||
33489577|NCT00109343|62867699|FG000|Overall Study|Adverse Event|1|||
33298765|NCT01114672|62674850|FG001|Overall Study|transplanted|0|||
33298766|NCT01114516|62674858|FG000|Overall Study|Lost to Follow-up|2|||
33298767|NCT01114516|62674859|FG001|Overall Study|Lost to Follow-up|1|||
33298768|NCT01114438|62674865|FG000|Overall Study|Adverse Event|10|||
33298769|NCT01114438|62674865|FG000|Overall Study|concomitant medication|1|||
33298770|NCT01114438|62674865|FG000|Overall Study|Physician Decision|1|||
33298771|NCT01114438|62674865|FG000|Overall Study|Withdrawal by Subject|2|||
33298772|NCT01313078|62674874|FG000|Overall Study|Death|1|||
33298773|NCT01313078|62674874|FG000|Overall Study|Discontinued study drug|1|||
33298774|NCT01313078|62674874|FG000|Overall Study|Withdrawal by Subject|1|||
33298775|NCT01114360|62674878|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
33298776|NCT01114360|62674879|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
33298777|NCT01310036|62674899|FG000|Overall Study|Administrative/other|10|||
33298778|NCT01310036|62674899|FG000|Overall Study|Withdrew Consent|11|||
33298779|NCT01310036|62674899|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
33298780|NCT01310036|62674899|FG000|Overall Study|Progression of Disease|164|||
33489578|NCT00109343|62867700|FG001|Overall Study|Adverse Event|0|||
33489579|NCT00109343|62867701|FG002|Overall Study|Adverse Event|2|||
33489580|NCT00109343|62867699|FG000|Overall Study|Lack of Efficacy|1|||
33489581|NCT00109343|62867700|FG001|Overall Study|Lack of Efficacy|0|||
33489582|NCT00109343|62867701|FG002|Overall Study|Lack of Efficacy|0|||
33489583|NCT00109343|62867699|FG000|Overall Study|Lost to Follow-up|35|||
33298781|NCT01310036|62674899|FG000|Overall Study|Death|1|||
33298782|NCT01310036|62674899|FG000|Overall Study|Adverse event or intercurrent illness|12|||
33298783|NCT01309100|62674903|FG000|Overall Study|Protocol Violation|1|||
33298784|NCT01309100|62674903|FG000|Overall Study|Positive Slit lamp finding|1|||
33388187|NCT02387970|62766818|FG001|Overall Study|Did not complete 1-year follow up|2|||
33489584|NCT00109343|62867700|FG001|Overall Study|Lost to Follow-up|20|||
33489585|NCT00109343|62867701|FG002|Overall Study|Lost to Follow-up|14|||
33489586|NCT00109343|62867699|FG000|Overall Study|Protocol Violation|1|||
33489587|NCT00109343|62867700|FG001|Overall Study|Protocol Violation|2|||
33489588|NCT00109343|62867701|FG002|Overall Study|Protocol Violation|2|||
33489589|NCT00109343|62867699|FG000|Overall Study|Withdrawal by Subject|15|||
33388188|NCT00580034|62766824|FG000|Overall Study|Toxicity|10|||
33388189|NCT00580034|62766825|FG001|Overall Study|Toxicity|0|||
33298785|NCT01308788|62674912|FG000|2-year Treatment|medication change by treating physician|4|||
33298786|NCT01308788|62674913|FG001|2-year Treatment|medication change by treating physician|11|||
33388190|NCT00773513|62766831|FG000|Overall Study|Renal Transplant|254|||
33388191|NCT00773513|62766832|FG001|Overall Study|Renal Transplant|263|||
33388192|NCT00773513|62766831|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
33388193|NCT00773513|62766832|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
33388194|NCT00773513|62766831|FG000|Overall Study|Withdrew Consent|68|||
33388195|NCT00773513|62766832|FG001|Overall Study|Withdrew Consent|69|||
33388196|NCT00773513|62766831|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
33388197|NCT00773513|62766832|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
33388198|NCT00773513|62766831|FG000|Overall Study|Failure to Return|22|||
33388199|NCT00773513|62766832|FG001|Overall Study|Failure to Return|8|||
33388200|NCT00773513|62766831|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33388201|NCT00773513|62766832|FG001|Overall Study|Insufficient Therapeutic Response|18|||
33388202|NCT00773513|62766831|FG000|Overall Study|Reason Not Specified|159|||
33388203|NCT00773513|62766832|FG001|Overall Study|Reason Not Specified|126|||
33388204|NCT00773513|62766831|FG000|Overall Study|Death|531|||
33388205|NCT00773513|62766832|FG001|Overall Study|Death|545|||
33388206|NCT00767039|62766840|FG000|Overall Study|Death|5|||
33388207|NCT00767039|62766841|FG001|Overall Study|Death|2|||
33662643|NCT01587703|63093236|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
33662644|NCT01587703|63093237|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33662645|NCT01587703|63093238|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33662646|NCT01587703|63093239|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33662647|NCT01587703|63093240|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33662648|NCT01587703|63093241|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33662649|NCT01587703|63093242|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33662650|NCT01587703|63093243|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33662651|NCT01587703|63093244|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33298787|NCT01075321|62674919|FG000|Overall Study|Withdrawal by Subject|0|||
33388208|NCT00662649|62766851|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
33489590|NCT00109343|62867700|FG001|Overall Study|Withdrawal by Subject|11|||
33489591|NCT00109343|62867701|FG002|Overall Study|Withdrawal by Subject|10|||
33489592|NCT00109343|62867699|FG000|Overall Study|Subject Moved|6|||
33489593|NCT00109343|62867700|FG001|Overall Study|Subject Moved|2|||
33489594|NCT00109343|62867701|FG002|Overall Study|Subject Moved|1|||
33489595|NCT00109343|62867699|FG000|Overall Study|Other|5|||
33489596|NCT00109343|62867700|FG001|Overall Study|Other|2|||
33489597|NCT00109343|62867701|FG002|Overall Study|Other|1|||
33489598|NCT00108485|62867711|FG000|Overall Study|Withdrawal by Subject|3|||
33489599|NCT00108485|62867712|FG001|Overall Study|Withdrawal by Subject|0|||
33489600|NCT00108485|62867711|FG000|Overall Study|Lost to Follow-up|0|||
33489601|NCT00108485|62867712|FG001|Overall Study|Lost to Follow-up|2|||
33489602|NCT00107783|62867720|FG000|Overall Study|Adverse Event|0|||
33489603|NCT00107783|62867721|FG001|Overall Study|Adverse Event|2|||
33489604|NCT00107783|62867720|FG000|Overall Study|Death|0|||
33489605|NCT00107783|62867721|FG001|Overall Study|Death|1|||
33298788|NCT01075321|62674920|FG001|Overall Study|Withdrawal by Subject|0|||
33298789|NCT01075321|62674921|FG002|Overall Study|Withdrawal by Subject|1|||
33298790|NCT01075321|62674922|FG003|Overall Study|Withdrawal by Subject|1|||
33298791|NCT01075321|62674919|FG000|Overall Study|Protocol Violation|0|||
33298792|NCT01075321|62674920|FG001|Overall Study|Protocol Violation|0|||
33298793|NCT01075321|62674921|FG002|Overall Study|Protocol Violation|1|||
33298794|NCT01075321|62674922|FG003|Overall Study|Protocol Violation|0|||
33388209|NCT00662649|62766852|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
33388210|NCT00662649|62766853|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
33388211|NCT00662649|62766854|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
33388212|NCT00662649|62766855|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
33388213|NCT00662649|62766851|FG000|Core Study (24 Months)|Adverse Event|22|||
33489606|NCT00107783|62867720|FG000|Overall Study|Withdrawal by Subject|2|||
33489607|NCT00107783|62867721|FG001|Overall Study|Withdrawal by Subject|0|||
33489608|NCT00107783|62867720|FG000|Overall Study|Second hip replacement|1|||
33489609|NCT00107783|62867721|FG001|Overall Study|Second hip replacement|1|||
33489610|NCT00095303|62867729|FG000|Main Study|Lost to Follow-up|91|||
33489611|NCT00095303|62867730|FG001|Main Study|Lost to Follow-up|87|||
33489612|NCT00095303|62867729|FG000|Follow Up Study|Lost to Follow-up|59|||
33489613|NCT00095303|62867730|FG001|Follow Up Study|Lost to Follow-up|58|||
33489614|NCT00105521|62867740|FG000|Overall Study|Other|1|||
33298795|NCT01075321|62674919|FG000|Overall Study|Treatment Incomplete due to progression|1|||
33298796|NCT01075321|62674920|FG001|Overall Study|Treatment Incomplete due to progression|0|||
33489615|NCT00105521|62867741|FG001|Overall Study|Other|1|||
33489616|NCT00105521|62867742|FG002|Overall Study|Other|2|||
33489617|NCT00105521|62867743|FG003|Overall Study|Other|0|||
33388214|NCT00662649|62766852|FG001|Core Study (24 Months)|Adverse Event|13|||
33388215|NCT00662649|62766853|FG002|Core Study (24 Months)|Adverse Event|18|||
33388216|NCT00662649|62766854|FG003|Core Study (24 Months)|Adverse Event|0|||
33388217|NCT00662649|62766855|FG004|Core Study (24 Months)|Adverse Event|0|||
33388218|NCT00662649|62766851|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
33388219|NCT00662649|62766852|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
33388220|NCT00662649|62766853|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
33388221|NCT00662649|62766854|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
33388222|NCT00662649|62766855|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
33388223|NCT00662649|62766851|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
33388224|NCT00662649|62766852|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
33388225|NCT00662649|62766853|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
33298797|NCT01075321|62674921|FG002|Overall Study|Treatment Incomplete due to progression|0|||
33298798|NCT01075321|62674922|FG003|Overall Study|Treatment Incomplete due to progression|0|||
33298799|NCT01075321|62674919|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
33298800|NCT01075321|62674920|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
33298801|NCT01075321|62674921|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
33298802|NCT01075321|62674922|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
33298803|NCT01114204|62674936|FG000|Overall Study|Adverse Event|3|||
33298804|NCT01114204|62674937|FG001|Overall Study|Adverse Event|2|||
33298805|NCT01114204|62674936|FG000|Overall Study|Lost to Follow-up|1|||
33298806|NCT01114204|62674937|FG001|Overall Study|Lost to Follow-up|0|||
33298807|NCT01114204|62674936|FG000|Overall Study|Withdrawal by Subject|10|||
33298808|NCT01114204|62674937|FG001|Overall Study|Withdrawal by Subject|6|||
33298809|NCT01114204|62674936|FG000|Overall Study|Death|1|||
33298810|NCT01114204|62674937|FG001|Overall Study|Death|0|||
33298811|NCT01114204|62674936|FG000|Overall Study|Other-Personal reasons|2|||
33298812|NCT01114204|62674937|FG001|Overall Study|Other-Personal reasons|0|||
33298813|NCT01114204|62674936|FG000|Overall Study|Other-Medical monitor request|1|||
33298814|NCT01114204|62674937|FG001|Overall Study|Other-Medical monitor request|0|||
33298815|NCT01114204|62674936|FG000|Overall Study|Other-Participant request|2|||
33298816|NCT01114204|62674937|FG001|Overall Study|Other-Participant request|0|||
33298817|NCT01114204|62674936|FG000|Overall Study|Other-Protocol Violation|1|||
33298818|NCT01114204|62674937|FG001|Overall Study|Other-Protocol Violation|0|||
33298819|NCT01075243|62674946|FG000|Overall Study|Lost to Follow-up|5|||
33298820|NCT01075243|62674947|FG001|Overall Study|Lost to Follow-up|2|||
33298821|NCT01075243|62674948|FG002|Overall Study|Lost to Follow-up|0|||
33298822|NCT01075243|62674946|FG000|Overall Study|Withdrawal by Subject|1|||
33298823|NCT01075243|62674947|FG001|Overall Study|Withdrawal by Subject|1|||
33298824|NCT01075243|62674948|FG002|Overall Study|Withdrawal by Subject|0|||
33298825|NCT01308476|62674960|FG000|Overall Study|Lost to Follow-up|2|||
33298826|NCT01308476|62674961|FG001|Overall Study|Lost to Follow-up|2|||
33298827|NCT01308476|62674960|FG000|Overall Study|Other|1|||
33298828|NCT01308476|62674961|FG001|Overall Study|Other|0|||
33388226|NCT00662649|62766854|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
33388227|NCT00662649|62766855|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
33388228|NCT00662649|62766851|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
33388229|NCT00662649|62766852|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
33388230|NCT00662649|62766853|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
33388231|NCT00662649|62766854|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
33388232|NCT00662649|62766855|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
33388233|NCT00662649|62766851|FG000|Core Study (24 Months)|Protocol Violation|5|||
33388234|NCT00662649|62766852|FG001|Core Study (24 Months)|Protocol Violation|5|||
33388235|NCT00662649|62766853|FG002|Core Study (24 Months)|Protocol Violation|4|||
33388236|NCT00662649|62766854|FG003|Core Study (24 Months)|Protocol Violation|0|||
33388237|NCT00662649|62766855|FG004|Core Study (24 Months)|Protocol Violation|0|||
33388238|NCT00662649|62766851|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
33388239|NCT00662649|62766852|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
33388240|NCT00662649|62766853|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
33388241|NCT00662649|62766854|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
33388242|NCT00662649|62766855|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
33388243|NCT00662649|62766851|FG000|Core Study (24 Months)|Death|1|||
33298829|NCT01078441|62674967|FG000|Overall Study|Withdrawal by Subject|1|||
33298830|NCT01308008|62674973|FG000|4 Weeks|Illness, disinterest, time|9|||
33298831|NCT01308008|62674974|FG001|4 Weeks|Illness, disinterest, time|2|||
33298832|NCT01113892|62674982|FG000|Overall Study|Lost to Follow-up|2|||
33298833|NCT01113892|62674983|FG001|Overall Study|Lost to Follow-up|2|||
33298834|NCT01113892|62674982|FG000|Overall Study|Withdrawal by Subject|1|||
33388244|NCT00662649|62766852|FG001|Core Study (24 Months)|Death|0|||
33388245|NCT00662649|62766853|FG002|Core Study (24 Months)|Death|2|||
33388246|NCT00662649|62766854|FG003|Core Study (24 Months)|Death|0|||
33298835|NCT01113892|62674983|FG001|Overall Study|Withdrawal by Subject|1|||
33298836|NCT01113892|62674982|FG000|Overall Study|Death|2|||
33298837|NCT01113892|62674983|FG001|Overall Study|Death|4|||
33388247|NCT00662649|62766855|FG004|Core Study (24 Months)|Death|0|||
33388248|NCT00662649|62766851|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
33388249|NCT00662649|62766852|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
33388250|NCT00662649|62766853|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
33388251|NCT00662649|62766854|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
33388252|NCT00662649|62766855|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
33388253|NCT00662649|62766851|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
33388254|NCT00662649|62766852|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
33388255|NCT00662649|62766853|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
33388256|NCT00662649|62766854|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
33388257|NCT00662649|62766855|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
33388258|NCT00662649|62766851|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
33388259|NCT00662649|62766852|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
33388260|NCT00662649|62766853|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
33388261|NCT00662649|62766854|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
33388262|NCT00662649|62766855|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
33388263|NCT00662649|62766851|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
33388264|NCT00662649|62766852|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
33388265|NCT00662649|62766853|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
33388266|NCT00662649|62766854|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
33388267|NCT00662649|62766855|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
33388268|NCT00662649|62766851|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
33388269|NCT00662649|62766852|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
33388270|NCT00662649|62766853|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
33388271|NCT00662649|62766854|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
33388272|NCT00662649|62766855|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
33388273|NCT00662649|62766851|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
33388274|NCT00662649|62766852|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
33388275|NCT00662649|62766853|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
33388276|NCT00662649|62766854|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
33298838|NCT01113892|62674982|FG000|Overall Study|Graft no longer evaluable|9|||
33298839|NCT01113892|62674983|FG001|Overall Study|Graft no longer evaluable|9|||
33298840|NCT01090063|62674989|FG000|Screen|Screen Failed|4|||
33298841|NCT01090063|62674989|FG000|Treatment|Withdrawal by Subject|4|||
33298842|NCT01113580|62675005|FG000|Overall Study|Protocol Violation|1|||
33298843|NCT01113580|62675006|FG001|Overall Study|Protocol Violation|0|||
33298844|NCT01306214|62675015|FG000|Overall Study|Death|0|||
33298845|NCT01306214|62675016|FG001|Overall Study|Death|0|||
33388277|NCT00662649|62766855|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
33388278|NCT00662649|62766851|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
33388279|NCT00662649|62766852|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
33388280|NCT00662649|62766853|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
33388281|NCT00662649|62766854|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
33388282|NCT00662649|62766855|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
33388283|NCT00662649|62766851|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
33388284|NCT00662649|62766852|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
33388285|NCT00662649|62766853|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
33388286|NCT00662649|62766854|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
33388287|NCT00662649|62766855|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
33388288|NCT00662649|62766851|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
33388289|NCT00662649|62766852|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
33388290|NCT00662649|62766853|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
33298846|NCT01306214|62675017|FG002|Overall Study|Death|1|||
33298847|NCT01306214|62675015|FG000|Overall Study|Lost to Follow-up|3|||
33298848|NCT01306214|62675016|FG001|Overall Study|Lost to Follow-up|5|||
33298849|NCT01306214|62675017|FG002|Overall Study|Lost to Follow-up|4|||
33298850|NCT01306214|62675015|FG000|Overall Study|Withdrawal by Subject|24|||
33298851|NCT01306214|62675016|FG001|Overall Study|Withdrawal by Subject|22|||
33298852|NCT01306214|62675017|FG002|Overall Study|Withdrawal by Subject|16|||
33388291|NCT00662649|62766854|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
33388292|NCT00662649|62766855|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
33388293|NCT00766493|62766869|FG000|30 Days Post-Procedure|Discontinued|7|||
33298853|NCT01306214|62675015|FG000|Overall Study|Not treated|1|||
33298854|NCT01306214|62675016|FG001|Overall Study|Not treated|1|||
33298855|NCT01306214|62675017|FG002|Overall Study|Not treated|1|||
33298856|NCT01077739|62675027|FG000|Overall Study|Premature withdrawal|1|||
33298857|NCT01077739|62675028|FG001|Overall Study|Premature withdrawal|3|||
33298858|NCT01077739|62675027|FG000|Overall Study|Withdrawal by Subject|1|||
33388294|NCT00766493|62766869|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
33388295|NCT00766493|62766869|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
33388296|NCT03070392|62766875|FG000|Overall Study|Not Treated|7|||
33388297|NCT03070392|62766876|FG001|Overall Study|Not Treated|0|||
33388298|NCT03070392|62766877|FG002|Overall Study|Not Treated|3|||
33388299|NCT03070392|62766878|FG003|Overall Study|Not Treated|12|||
33388300|NCT03070392|62766875|FG000|Overall Study|Death|3|||
33388301|NCT03070392|62766876|FG001|Overall Study|Death|0|||
33388302|NCT03070392|62766877|FG002|Overall Study|Death|0|||
33388303|NCT03070392|62766878|FG003|Overall Study|Death|1|||
33388304|NCT03070392|62766875|FG000|Overall Study|Withdrawal by Subject|7|||
33388305|NCT03070392|62766876|FG001|Overall Study|Withdrawal by Subject|0|||
33388306|NCT03070392|62766877|FG002|Overall Study|Withdrawal by Subject|0|||
33388307|NCT03070392|62766878|FG003|Overall Study|Withdrawal by Subject|3|||
33388308|NCT03070392|62766875|FG000|Overall Study|Physician Decision|1|||
33388309|NCT03070392|62766876|FG001|Overall Study|Physician Decision|0|||
33388310|NCT03070392|62766877|FG002|Overall Study|Physician Decision|0|||
33662652|NCT01587703|63093226|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33662653|NCT01587703|63093227|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33388311|NCT03070392|62766878|FG003|Overall Study|Physician Decision|2|||
33388312|NCT03070392|62766875|FG000|Overall Study|Progressive Disease|154|||
33388313|NCT03070392|62766876|FG001|Overall Study|Progressive Disease|6|||
33388314|NCT03070392|62766877|FG002|Overall Study|Progressive Disease|2|||
33388315|NCT03070392|62766878|FG003|Overall Study|Progressive Disease|70|||
33388316|NCT03070392|62766875|FG000|Overall Study|Adverse Event|6|||
33388317|NCT03070392|62766876|FG001|Overall Study|Adverse Event|1|||
33388318|NCT03070392|62766877|FG002|Overall Study|Adverse Event|1|||
33388319|NCT03070392|62766878|FG003|Overall Study|Adverse Event|3|||
33388320|NCT03070392|62766875|FG000|Overall Study|Alternate anticancer treatment|1|||
33388321|NCT03070392|62766876|FG001|Overall Study|Alternate anticancer treatment|0|||
33388322|NCT03070392|62766877|FG002|Overall Study|Alternate anticancer treatment|0|||
33388323|NCT03070392|62766878|FG003|Overall Study|Alternate anticancer treatment|1|||
33388324|NCT03070392|62766875|FG000|Overall Study|Ongoing|73|||
33388325|NCT03070392|62766876|FG001|Overall Study|Ongoing|0|||
33388326|NCT03070392|62766877|FG002|Overall Study|Ongoing|0|||
33388327|NCT03070392|62766878|FG003|Overall Study|Ongoing|11|||
33388328|NCT00784043|62766886|FG000|Overall Study|Withdrawal by Subject|8|||
33388329|NCT00784043|62766887|FG001|Overall Study|Withdrawal by Subject|5|||
33388330|NCT00784043|62766886|FG000|Overall Study|Protocol Terminated|23|||
33388331|NCT00784043|62766887|FG001|Overall Study|Protocol Terminated|1|||
33388332|NCT00773279|62766893|FG000|Period 1|Adverse Event|2|||
33388333|NCT00773279|62766894|FG001|Period 1|Adverse Event|1|||
33388334|NCT00773279|62766893|FG000|Period 1|Lack of Efficacy|0|||
33388335|NCT00773279|62766894|FG001|Period 1|Lack of Efficacy|2|||
33388336|NCT00773279|62766893|FG000|Period 1|Unclassified|5|||
33388337|NCT00773279|62766894|FG001|Period 1|Unclassified|1|||
33388338|NCT00773279|62766893|FG000|Period 2|Adverse Event|0|||
33388339|NCT00773279|62766894|FG001|Period 2|Adverse Event|1|||
33388340|NCT00773279|62766893|FG000|Period 2|Lack of Efficacy|1|||
33388341|NCT00773279|62766894|FG001|Period 2|Lack of Efficacy|0|||
33388342|NCT00773279|62766893|FG000|Period 2|Protocol Violation|0|||
33388343|NCT00773279|62766894|FG001|Period 2|Protocol Violation|3|||
33298859|NCT01077739|62675028|FG001|Overall Study|Withdrawal by Subject|0|||
33298860|NCT01077739|62675027|FG000|Overall Study|Death|0|||
33298861|NCT01077739|62675028|FG001|Overall Study|Death|3|||
33298862|NCT01077739|62675027|FG000|Overall Study|Unacceptable toxicity|1|||
33298863|NCT01077739|62675028|FG001|Overall Study|Unacceptable toxicity|2|||
33298864|NCT01077739|62675027|FG000|Overall Study|Other|2|||
33298865|NCT01077739|62675028|FG001|Overall Study|Other|2|||
33298866|NCT01306058|62675034|FG000|Overall Study|Death|1|||
33662654|NCT01587703|63093228|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33298867|NCT01306058|62675034|FG000|Overall Study|Enrolled but did not get treatment|1|||
33298868|NCT01305200|62675041|FG000|Overall Study|Physician Decision|4|||
33298869|NCT01305200|62675042|FG001|Overall Study|Physician Decision|6|||
33298870|NCT01305200|62675043|FG002|Overall Study|Physician Decision|1|||
33388344|NCT00773279|62766893|FG000|Period 2|Unclassified|2|||
33388345|NCT00773279|62766894|FG001|Period 2|Unclassified|2|||
33388346|NCT00766415|62766903|FG000|Overall Study|Withdrawal by Subject|0|||
33388347|NCT00766415|62766904|FG001|Overall Study|Withdrawal by Subject|1|||
33388348|NCT00772967|62766910|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
33388349|NCT00772967|62766911|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
33388350|NCT00772967|62766912|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
33388351|NCT00772967|62766913|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
33388352|NCT00772967|62766914|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
33298871|NCT01305200|62675041|FG000|Overall Study|Withdrawal by Subject|24|||
33388353|NCT00772967|62766915|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
33388354|NCT00772967|62766910|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
33388355|NCT00772967|62766911|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
33388356|NCT00772967|62766912|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
33388357|NCT00772967|62766913|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
33388358|NCT00772967|62766914|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
33388359|NCT00772967|62766915|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
33388360|NCT00772967|62766910|FG000|Crossover Treatment 3|Adverse Event|0|||
33388361|NCT00772967|62766911|FG001|Crossover Treatment 3|Adverse Event|0|||
33388362|NCT00772967|62766912|FG002|Crossover Treatment 3|Adverse Event|0|||
33388363|NCT00772967|62766913|FG003|Crossover Treatment 3|Adverse Event|0|||
33388364|NCT00772967|62766914|FG004|Crossover Treatment 3|Adverse Event|1|||
33388365|NCT00772967|62766915|FG005|Crossover Treatment 3|Adverse Event|0|||
33388366|NCT00662259|62766938|FG000|Overall Study|Adverse Event|2|||
33388367|NCT00662259|62766939|FG001|Overall Study|Adverse Event|0|||
33388368|NCT00660699|62766945|FG000|Overall Study|Withdrawal by Subject|2|||
33388369|NCT00582114|62766951|FG000|Overall Study|Death|4|||
33388370|NCT00582114|62766952|FG001|Overall Study|Death|4|||
33388371|NCT00582114|62766951|FG000|Overall Study|Kidney Transplant|3|||
33388372|NCT00582114|62766952|FG001|Overall Study|Kidney Transplant|1|||
33388373|NCT00582114|62766951|FG000|Overall Study|Lost to Follow-up|7|||
33388374|NCT00582114|62766952|FG001|Overall Study|Lost to Follow-up|6|||
33388375|NCT00582114|62766951|FG000|Overall Study|Withdrawal by Subject|8|||
33388376|NCT00582114|62766952|FG001|Overall Study|Withdrawal by Subject|16|||
33388377|NCT00582114|62766951|FG000|Overall Study|Adverse Event|1|||
33388378|NCT00582114|62766952|FG001|Overall Study|Adverse Event|1|||
33388379|NCT00582114|62766951|FG000|Overall Study|Physician Decision|0|||
33388380|NCT00582114|62766952|FG001|Overall Study|Physician Decision|6|||
33388381|NCT00582114|62766951|FG000|Overall Study|Stopped by data safety monitoring board|19|||
33388382|NCT00582114|62766952|FG001|Overall Study|Stopped by data safety monitoring board|20|||
33388383|NCT00582036|62766960|FG000|Overall Study|Withdrawal by Subject|0|||
33388384|NCT00582036|62766961|FG001|Overall Study|Withdrawal by Subject|1|||
33388385|NCT00581360|62766967|FG000|Overall Study|Withdrawal by Subject|1|||
33388386|NCT00660387|62766973|FG000|Overall Study|Adverse Event|1|||
33388387|NCT00660387|62766974|FG001|Overall Study|Adverse Event|2|||
33388388|NCT00660387|62766973|FG000|Overall Study|Lack of Efficacy|0|||
33388389|NCT00660387|62766974|FG001|Overall Study|Lack of Efficacy|1|||
33388390|NCT00660387|62766973|FG000|Overall Study|Protocol Violation|1|||
33388391|NCT00660387|62766974|FG001|Overall Study|Protocol Violation|0|||
33388392|NCT00582738|62766982|FG000|Overall Study|Administrative Problems|7|||
33388393|NCT00582738|62766983|FG001|Overall Study|Administrative Problems|8|||
33388394|NCT00582738|62766982|FG000|Overall Study|Adverse Event|0|||
33388395|NCT00582738|62766983|FG001|Overall Study|Adverse Event|5|||
33388396|NCT00582738|62766982|FG000|Overall Study|Graft Lost|0|||
33388397|NCT00582738|62766983|FG001|Overall Study|Graft Lost|1|||
33388398|NCT00582738|62766982|FG000|Overall Study|Other|1|||
33388399|NCT00582738|62766983|FG001|Overall Study|Other|0|||
33388400|NCT00582738|62766982|FG000|Overall Study|Protocol Violation|1|||
33388401|NCT00582738|62766983|FG001|Overall Study|Protocol Violation|1|||
33388402|NCT00582738|62766982|FG000|Overall Study|Withdrawal by Subject|0|||
33388403|NCT00582738|62766983|FG001|Overall Study|Withdrawal by Subject|3|||
33388404|NCT00772889|62766998|FG000|Overall Study|Adverse Event|7|||
33388405|NCT00772889|62766999|FG001|Overall Study|Adverse Event|4|||
33388406|NCT00772889|62767000|FG002|Overall Study|Adverse Event|0|||
33489618|NCT00105521|62867740|FG000|Overall Study|Adverse Event|10|||
33489619|NCT00105521|62867741|FG001|Overall Study|Adverse Event|4|||
33489620|NCT00105521|62867742|FG002|Overall Study|Adverse Event|10|||
33489621|NCT00105521|62867743|FG003|Overall Study|Adverse Event|8|||
33489622|NCT00105521|62867740|FG000|Overall Study|Withdrawal by Subject|1|||
33489623|NCT00105521|62867741|FG001|Overall Study|Withdrawal by Subject|0|||
33489624|NCT00105521|62867742|FG002|Overall Study|Withdrawal by Subject|1|||
33489625|NCT00105521|62867743|FG003|Overall Study|Withdrawal by Subject|4|||
33298872|NCT01305200|62675042|FG001|Overall Study|Withdrawal by Subject|21|||
33298873|NCT01305200|62675043|FG002|Overall Study|Withdrawal by Subject|1|||
33298874|NCT01305200|62675041|FG000|Overall Study|Ineligible|1|||
33298875|NCT01305200|62675042|FG001|Overall Study|Ineligible|2|||
33298876|NCT01305200|62675043|FG002|Overall Study|Ineligible|1|||
33298877|NCT01305200|62675041|FG000|Overall Study|Death|0|||
33298878|NCT01305200|62675042|FG001|Overall Study|Death|2|||
33298879|NCT01305200|62675043|FG002|Overall Study|Death|0|||
33298880|NCT01077271|62675053|FG000|Overall Study|Parental desire|8|||
33298881|NCT01077271|62675053|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
33298882|NCT01077271|62675053|FG000|Overall Study|Noncompliance|2|||
33298883|NCT01077271|62675053|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
33388407|NCT00772889|62766998|FG000|Overall Study|Withdrawal by Subject|9|||
33388408|NCT00772889|62766999|FG001|Overall Study|Withdrawal by Subject|8|||
33388409|NCT00772889|62767000|FG002|Overall Study|Withdrawal by Subject|9|||
33388410|NCT00772889|62766998|FG000|Overall Study|Lost to Follow-up|6|||
33388411|NCT00772889|62766999|FG001|Overall Study|Lost to Follow-up|6|||
33388412|NCT00772889|62767000|FG002|Overall Study|Lost to Follow-up|7|||
33388413|NCT01247324|62767010|FG000|Overall Study|Death|1|||
33388414|NCT01247324|62767011|FG001|Overall Study|Death|0|||
33388415|NCT01247324|62767010|FG000|Overall Study|Physician Decision|0|||
33388416|NCT01247324|62767011|FG001|Overall Study|Physician Decision|1|||
33388417|NCT01247324|62767010|FG000|Overall Study|Non-compliance with study drug|3|||
33388418|NCT01247324|62767011|FG001|Overall Study|Non-compliance with study drug|0|||
33388419|NCT01247324|62767010|FG000|Overall Study|Lack of Efficacy|12|||
33388420|NCT01247324|62767011|FG001|Overall Study|Lack of Efficacy|8|||
33388421|NCT01247324|62767010|FG000|Overall Study|Non-compliance|2|||
33388422|NCT01247324|62767011|FG001|Overall Study|Non-compliance|0|||
33388423|NCT01247324|62767010|FG000|Overall Study|Pregnancy|2|||
33489626|NCT00105521|62867740|FG000|Overall Study|Lack of Efficacy|0|||
33489627|NCT00105521|62867741|FG001|Overall Study|Lack of Efficacy|0|||
33489628|NCT00105521|62867742|FG002|Overall Study|Lack of Efficacy|0|||
33489629|NCT00105521|62867743|FG003|Overall Study|Lack of Efficacy|1|||
33489630|NCT00105521|62867740|FG000|Overall Study|Protocol Violation|3|||
33489631|NCT00105521|62867741|FG001|Overall Study|Protocol Violation|5|||
33489632|NCT00105521|62867742|FG002|Overall Study|Protocol Violation|4|||
33489633|NCT00105521|62867743|FG003|Overall Study|Protocol Violation|4|||
33489634|NCT00105521|62867740|FG000|Overall Study|Lost to Follow-up|0|||
33489635|NCT00105521|62867741|FG001|Overall Study|Lost to Follow-up|1|||
33489636|NCT00105521|62867742|FG002|Overall Study|Lost to Follow-up|0|||
33489637|NCT00105521|62867743|FG003|Overall Study|Lost to Follow-up|0|||
33489638|NCT00291551|62867753|FG000|Overall Study|Death|7|||
33489639|NCT00291551|62867753|FG000|Overall Study|Withdrawal by Subject|6|||
33489640|NCT02752048|62867782|FG000|Overall Study|Withdrawal by Subject|0|||
33489641|NCT02752048|62867783|FG001|Overall Study|Withdrawal by Subject|0|||
33489642|NCT02752048|62867784|FG002|Overall Study|Withdrawal by Subject|3|||
33489643|NCT00095147|62867799|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
33489644|NCT00095147|62867800|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
33489645|NCT00095147|62867801|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
33489646|NCT00095147|62867802|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
33489647|NCT00095147|62867803|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
33489648|NCT00095147|62867799|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
33489649|NCT00095147|62867800|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
33489650|NCT00095147|62867801|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
33489651|NCT00095147|62867802|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
33489652|NCT00095147|62867803|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
33489653|NCT00095147|62867799|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
33489654|NCT00095147|62867800|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
33489655|NCT00095147|62867801|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
33489656|NCT00095147|62867802|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
33489657|NCT00095147|62867803|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
33489658|NCT00095147|62867799|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
33489659|NCT00095147|62867800|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
33489660|NCT00095147|62867801|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
33489661|NCT00095147|62867802|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
33489662|NCT00095147|62867803|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
33489663|NCT00095147|62867799|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
33489664|NCT00095147|62867800|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
33489665|NCT00095147|62867801|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
33489666|NCT00095147|62867802|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
33489667|NCT00095147|62867803|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
33556800|NCT02339506|62949652|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
33556801|NCT02339506|62949653|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
33556802|NCT02305888|62949662|FG000|Overall Study|Lost to Follow-up|0|||
33556803|NCT02305888|62949663|FG001|Overall Study|Lost to Follow-up|0|||
33556804|NCT02305888|62949664|FG002|Overall Study|Lost to Follow-up|1|||
33556805|NCT02305888|62949662|FG000|Overall Study|Adverse Event|0|||
33556806|NCT02305888|62949663|FG001|Overall Study|Adverse Event|1|||
33556807|NCT02305888|62949664|FG002|Overall Study|Adverse Event|0|||
33388424|NCT01247324|62767011|FG001|Overall Study|Pregnancy|3|||
33489668|NCT00095147|62867799|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
33489669|NCT00095147|62867800|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
33489670|NCT00095147|62867801|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
33489671|NCT00095147|62867802|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
33489672|NCT00095147|62867803|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
33489673|NCT00095147|62867799|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
33489674|NCT00095147|62867800|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
33489675|NCT00095147|62867801|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
33556808|NCT02338882|62949674|FG000|Overall Study|Death|1|||
33489676|NCT00095147|62867802|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
33556809|NCT02338882|62949675|FG001|Overall Study|Death|0|||
33556810|NCT02338882|62949674|FG000|Overall Study|Lost to Follow-up|6|||
33388425|NCT01247324|62767010|FG000|Overall Study|Protocol Violation|1|||
33388426|NCT01247324|62767011|FG001|Overall Study|Protocol Violation|2|||
33388427|NCT01247324|62767010|FG000|Overall Study|Reason not specified|11|||
33388428|NCT01247324|62767011|FG001|Overall Study|Reason not specified|8|||
33388429|NCT01247324|62767010|FG000|Overall Study|Consent withdrawn by participant|13|||
33388430|NCT01247324|62767011|FG001|Overall Study|Consent withdrawn by participant|8|||
33388431|NCT01247324|62767010|FG000|Overall Study|Adverse Event|25|||
33388432|NCT01247324|62767011|FG001|Overall Study|Adverse Event|13|||
33388433|NCT01247324|62767010|FG000|Overall Study|Lost to Follow-up|1|||
33388434|NCT01247324|62767011|FG001|Overall Study|Lost to Follow-up|1|||
33388435|NCT00772577|62767020|FG000|Overall Study|Adverse Event|6|||
33388436|NCT00772577|62767021|FG001|Overall Study|Adverse Event|3|||
33388437|NCT00772577|62767020|FG000|Overall Study|Abnormal laboratory values|0|||
33388438|NCT00772577|62767021|FG001|Overall Study|Abnormal laboratory values|1|||
33388439|NCT00772577|62767020|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33388440|NCT00772577|62767021|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
33388441|NCT00772577|62767020|FG000|Overall Study|Patient withdrew consent|8|||
33388442|NCT00772577|62767021|FG001|Overall Study|Patient withdrew consent|5|||
33388443|NCT00772577|62767020|FG000|Overall Study|Lost to Follow-up|4|||
33388444|NCT00772577|62767021|FG001|Overall Study|Lost to Follow-up|3|||
33388445|NCT00772577|62767020|FG000|Overall Study|Administrative problems|2|||
33489677|NCT00095147|62867803|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
33489678|NCT00095147|62867799|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
33489679|NCT00095147|62867800|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
33489680|NCT00095147|62867801|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
33489681|NCT00095147|62867802|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
33489682|NCT00095147|62867803|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
33489683|NCT00095147|62867799|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
33489684|NCT00095147|62867800|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
33489685|NCT00095147|62867801|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
33489686|NCT00095147|62867802|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
33489687|NCT00095147|62867803|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
33489688|NCT00095147|62867799|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
33489689|NCT00095147|62867800|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
33489690|NCT00095147|62867801|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
33489691|NCT00095147|62867802|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
33489692|NCT00095147|62867803|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
33489693|NCT00095147|62867799|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
33489694|NCT00095147|62867800|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
33489695|NCT00095147|62867801|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
33489696|NCT00095147|62867802|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
33489697|NCT00095147|62867803|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
33489698|NCT00095147|62867799|FG000|Long-term Extension Period|Death|0|||
33489699|NCT00095147|62867800|FG001|Long-term Extension Period|Death|0|||
33489700|NCT00095147|62867801|FG002|Long-term Extension Period|Death|0|||
33489701|NCT00095147|62867802|FG003|Long-term Extension Period|Death|0|||
33489702|NCT00095147|62867803|FG004|Long-term Extension Period|Death|3|||
33489703|NCT00095147|62867799|FG000|Long-term Extension Period|Adverse Event|0|||
33489704|NCT00095147|62867800|FG001|Long-term Extension Period|Adverse Event|0|||
33489705|NCT00095147|62867801|FG002|Long-term Extension Period|Adverse Event|0|||
33489706|NCT00095147|62867802|FG003|Long-term Extension Period|Adverse Event|0|||
33489707|NCT00095147|62867803|FG004|Long-term Extension Period|Adverse Event|11|||
33489708|NCT00095147|62867799|FG000|Long-term Extension Period|Lack of Efficacy|0|||
33489709|NCT00095147|62867800|FG001|Long-term Extension Period|Lack of Efficacy|0|||
33489710|NCT00095147|62867801|FG002|Long-term Extension Period|Lack of Efficacy|0|||
33489711|NCT00095147|62867802|FG003|Long-term Extension Period|Lack of Efficacy|0|||
33489712|NCT00095147|62867803|FG004|Long-term Extension Period|Lack of Efficacy|9|||
33489713|NCT00095147|62867799|FG000|Long-term Extension Period|Lost to Follow-up|0|||
33489714|NCT00095147|62867800|FG001|Long-term Extension Period|Lost to Follow-up|0|||
33489715|NCT00095147|62867801|FG002|Long-term Extension Period|Lost to Follow-up|0|||
33489716|NCT00095147|62867802|FG003|Long-term Extension Period|Lost to Follow-up|0|||
33489717|NCT00095147|62867803|FG004|Long-term Extension Period|Lost to Follow-up|6|||
33489718|NCT00095147|62867799|FG000|Long-term Extension Period|Withdrawal of consent|0|||
33489719|NCT00095147|62867800|FG001|Long-term Extension Period|Withdrawal of consent|0|||
33489720|NCT00095147|62867801|FG002|Long-term Extension Period|Withdrawal of consent|0|||
33388446|NCT00772577|62767021|FG001|Overall Study|Administrative problems|1|||
33388447|NCT00772577|62767020|FG000|Overall Study|Protocol Deviation|3|||
33388448|NCT00772577|62767021|FG001|Overall Study|Protocol Deviation|2|||
33388449|NCT02345850|62767030|FG000|Overall Study|Not transplanted|10|||
33388450|NCT02345850|62767031|FG001|Overall Study|Not transplanted|5|||
33388451|NCT02345850|62767032|FG002|Overall Study|Not transplanted|4|||
33388452|NCT02345850|62767030|FG000|Overall Study|Lost to Follow-up|2|||
33489721|NCT00095147|62867802|FG003|Long-term Extension Period|Withdrawal of consent|0|||
33556811|NCT02338882|62949675|FG001|Overall Study|Lost to Follow-up|3|||
33388453|NCT02345850|62767031|FG001|Overall Study|Lost to Follow-up|3|||
33388454|NCT02345850|62767032|FG002|Overall Study|Lost to Follow-up|2|||
33388455|NCT02345850|62767030|FG000|Overall Study|Withdrawal by Subject|1|||
33388456|NCT02345850|62767031|FG001|Overall Study|Withdrawal by Subject|0|||
33388457|NCT02345850|62767032|FG002|Overall Study|Withdrawal by Subject|0|||
33388458|NCT00659607|62767040|FG000|Overall Study|No blood pressure recorded|147|||
33388459|NCT00659607|62767040|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
33388460|NCT00659607|62767040|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
33388461|NCT00659607|62767040|FG000|Overall Study|No recorded efficacy data|15|||
33388462|NCT00659607|62767040|FG000|Overall Study|Inconsistent BP measuring date|2|||
33388463|NCT02848092|62767048|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
33388464|NCT02848092|62767049|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
33388465|NCT02848092|62767048|FG000|1-month Post-training Follow-up|Adverse Event|2|||
33388466|NCT02848092|62767049|FG001|1-month Post-training Follow-up|Adverse Event|1|||
33388467|NCT02848092|62767048|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
33388468|NCT02848092|62767049|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
33388469|NCT02848092|62767048|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
33388470|NCT02848092|62767049|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
33388471|NCT02848092|62767048|FG000|1-month Post-training Follow-up|fatigue|0|||
33388472|NCT02848092|62767049|FG001|1-month Post-training Follow-up|fatigue|1|||
33388473|NCT02848092|62767048|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
33388474|NCT02848092|62767049|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
33388475|NCT02848092|62767048|FG000|6-month Post-training Follow-up|Adverse Event|1|||
33388476|NCT02848092|62767049|FG001|6-month Post-training Follow-up|Adverse Event|1|||
33388477|NCT02848092|62767048|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
33388478|NCT02848092|62767049|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
33388479|NCT02848092|62767048|FG000|6-month Post-training Follow-up|frustrated with task|1|||
33388480|NCT02848092|62767049|FG001|6-month Post-training Follow-up|frustrated with task|0|||
33388481|NCT02848092|62767048|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
33388482|NCT02848092|62767049|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
33388483|NCT02848092|62767048|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
33388484|NCT02848092|62767049|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
33388485|NCT00660309|62767057|FG000|Overall Study|Adverse Event|2|||
33388486|NCT00660309|62767058|FG001|Overall Study|Adverse Event|0|||
33298884|NCT01077271|62675053|FG000|Overall Study|Changed doctors|2|||
33298885|NCT01077271|62675053|FG000|Overall Study|Parents thought too many injections|2|||
33298886|NCT01077271|62675053|FG000|Overall Study|End of RSV season nearly reached|1|||
33388487|NCT00660309|62767057|FG000|Overall Study|Withdrawal by Subject|0|||
33388488|NCT00660309|62767058|FG001|Overall Study|Withdrawal by Subject|3|||
33388489|NCT00581100|62767067|FG000|Overall Study|Death|1|||
33388490|NCT00581100|62767068|FG001|Overall Study|Death|0|||
33489722|NCT00095147|62867803|FG004|Long-term Extension Period|Withdrawal of consent|12|||
33298887|NCT01077271|62675053|FG000|Overall Study|Mother unconvinced of the necessity|1|||
33298888|NCT01305044|62675067|FG000|Overall Study|Withdrawal by Subject|3|||
33298889|NCT01305044|62675068|FG001|Overall Study|Withdrawal by Subject|6|||
33298890|NCT01304498|62675076|FG000|Overall Study|Adverse Event|1|||
33298891|NCT01304498|62675077|FG001|Overall Study|Adverse Event|1|||
33298892|NCT01304498|62675076|FG000|Overall Study|Withdrawal by Subject|2|||
33298893|NCT01304498|62675077|FG001|Overall Study|Withdrawal by Subject|3|||
33298894|NCT01304498|62675076|FG000|Overall Study|Protocol Violation|1|||
33298895|NCT01304498|62675077|FG001|Overall Study|Protocol Violation|0|||
33298896|NCT01304498|62675076|FG000|Overall Study|Lost to Follow-up|2|||
33298897|NCT01304498|62675077|FG001|Overall Study|Lost to Follow-up|1|||
33298898|NCT01077193|62675083|FG000|Overall Study|Lost to Follow-up|1|||
33298899|NCT01077193|62675083|FG000|Overall Study|Withdrawal by Subject|2|||
33298900|NCT01077193|62675083|FG000|Overall Study|Lack of Efficacy|1|||
33298901|NCT01077193|62675083|FG000|Overall Study|Study Terminated by Sponsor|40|||
33298902|NCT01074931|62675087|FG000|Overall Study|Economic reasons|1|||
33298903|NCT01074931|62675087|FG000|Overall Study|Death|5|||
33298904|NCT01303172|62675097|FG000|Overall Study|Physician Decision|9|||
33298905|NCT01303172|62675098|FG001|Overall Study|Physician Decision|6|||
33298906|NCT01303172|62675097|FG000|Overall Study|Adverse Event|5|||
33388491|NCT00581100|62767067|FG000|Overall Study|Adverse Event|2|||
33388492|NCT00581100|62767068|FG001|Overall Study|Adverse Event|1|||
33388493|NCT00581100|62767067|FG000|Overall Study|Withdrawal by Subject|1|||
33489723|NCT00095147|62867799|FG000|Long-term Extension Period|Pregnancy|0|||
33489724|NCT00095147|62867800|FG001|Long-term Extension Period|Pregnancy|0|||
33489725|NCT00095147|62867801|FG002|Long-term Extension Period|Pregnancy|0|||
33298907|NCT01303172|62675098|FG001|Overall Study|Adverse Event|2|||
33298908|NCT01303172|62675097|FG000|Overall Study|Withdrawal by Subject|4|||
33298909|NCT01303172|62675098|FG001|Overall Study|Withdrawal by Subject|2|||
33298910|NCT01303172|62675097|FG000|Overall Study|Death|20|||
33298911|NCT01303172|62675098|FG001|Overall Study|Death|7|||
33298912|NCT01303172|62675097|FG000|Overall Study|Lack of Efficacy|25|||
33388494|NCT00581100|62767068|FG001|Overall Study|Withdrawal by Subject|4|||
33388495|NCT00581100|62767067|FG000|Overall Study|Other|3|||
33388496|NCT00581100|62767068|FG001|Overall Study|Other|0|||
33388497|NCT00579098|62767076|FG000|Overall Study|Lost to Follow-up|2|||
33388498|NCT00579098|62767077|FG001|Overall Study|Lost to Follow-up|0|||
33388499|NCT00579098|62767076|FG000|Overall Study|Adverse Event|2|||
33388500|NCT00579098|62767077|FG001|Overall Study|Adverse Event|3|||
33388501|NCT00579098|62767076|FG000|Overall Study|Withdrawal by Subject|2|||
33388502|NCT00579098|62767077|FG001|Overall Study|Withdrawal by Subject|3|||
33388503|NCT00579098|62767076|FG000|Overall Study|AF returned after ablation|3|||
33388504|NCT00579098|62767077|FG001|Overall Study|AF returned after ablation|2|||
33388505|NCT00772109|62767087|FG000|Overall Study|Serious adverse event|1|||
33388506|NCT00772109|62767088|FG001|Overall Study|Serious adverse event|0|||
33388507|NCT00772109|62767089|FG002|Overall Study|Serious adverse event|1|||
33388508|NCT00772109|62767090|FG003|Overall Study|Serious adverse event|0|||
33388509|NCT00772109|62767087|FG000|Overall Study|Protocol Violation|5|||
33388510|NCT00772109|62767088|FG001|Overall Study|Protocol Violation|8|||
33388511|NCT00772109|62767089|FG002|Overall Study|Protocol Violation|7|||
33388512|NCT00772109|62767090|FG003|Overall Study|Protocol Violation|6|||
33388513|NCT00772109|62767087|FG000|Overall Study|Lost to Follow-up|7|||
33388514|NCT00772109|62767088|FG001|Overall Study|Lost to Follow-up|3|||
33388515|NCT00772109|62767089|FG002|Overall Study|Lost to Follow-up|5|||
33388516|NCT00772109|62767090|FG003|Overall Study|Lost to Follow-up|9|||
33388517|NCT00772109|62767087|FG000|Overall Study|Withdrawal by Subject|8|||
33388518|NCT00772109|62767088|FG001|Overall Study|Withdrawal by Subject|8|||
33388519|NCT00772109|62767089|FG002|Overall Study|Withdrawal by Subject|6|||
33388520|NCT00772109|62767090|FG003|Overall Study|Withdrawal by Subject|16|||
33388521|NCT00772031|62767102|FG000|Overall Study|Early termination of trial|12|||
33388522|NCT00772031|62767103|FG001|Overall Study|Early termination of trial|10|||
33388523|NCT00772031|62767102|FG000|Overall Study|Lost to Follow-up|20|||
33388524|NCT00772031|62767103|FG001|Overall Study|Lost to Follow-up|33|||
33388525|NCT00580866|62767117|FG000|Overall Study|Lost to Follow-up|2|||
33388526|NCT00580866|62767118|FG001|Overall Study|Lost to Follow-up|2|||
33388527|NCT00771953|62767126|FG000|Overall Study|Adverse Event|5|||
33388528|NCT00771953|62767127|FG001|Overall Study|Adverse Event|3|||
33388529|NCT00771953|62767126|FG000|Overall Study|Death|2|||
33388530|NCT00771953|62767127|FG001|Overall Study|Death|2|||
33388531|NCT00771953|62767126|FG000|Overall Study|Progression before active Tx|1|||
33489726|NCT00095147|62867802|FG003|Long-term Extension Period|Pregnancy|0|||
33489727|NCT00095147|62867803|FG004|Long-term Extension Period|Pregnancy|1|||
33489728|NCT00095147|62867799|FG000|Long-term Extension Period|No longer meets study criteria|0|||
33489729|NCT00095147|62867800|FG001|Long-term Extension Period|No longer meets study criteria|0|||
33489730|NCT00095147|62867801|FG002|Long-term Extension Period|No longer meets study criteria|0|||
33489731|NCT00095147|62867802|FG003|Long-term Extension Period|No longer meets study criteria|0|||
33489732|NCT00095147|62867803|FG004|Long-term Extension Period|No longer meets study criteria|1|||
33489733|NCT00095147|62867799|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
33489734|NCT00095147|62867800|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
33489735|NCT00095147|62867801|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
33489736|NCT00095147|62867802|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
33489737|NCT00095147|62867803|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
33489738|NCT00095147|62867799|FG000|Long-term Extension Period|Leaving country|0|||
33489739|NCT00095147|62867800|FG001|Long-term Extension Period|Leaving country|0|||
33489740|NCT00095147|62867801|FG002|Long-term Extension Period|Leaving country|0|||
33489741|NCT00095147|62867802|FG003|Long-term Extension Period|Leaving country|0|||
33489742|NCT00095147|62867803|FG004|Long-term Extension Period|Leaving country|1|||
33489743|NCT02751580|62867821|FG000|Overall Study|Lost to Follow-up|4|||
33489744|NCT02751580|62867821|FG000|Overall Study|Death|2|||
33489745|NCT02751502|62867825|FG000|Overall Study|Lack of funding|4|||
33489746|NCT02257918|62867832|FG000|Overall Study|Lost to Follow-up|4|||
33489747|NCT02257918|62867833|FG001|Overall Study|Lost to Follow-up|1|||
33388532|NCT00771953|62767127|FG001|Overall Study|Progression before active Tx|2|||
33388533|NCT00771953|62767126|FG000|Overall Study|Sponsor decision|1|||
33388534|NCT00771953|62767127|FG001|Overall Study|Sponsor decision|0|||
33388535|NCT00771953|62767126|FG000|Overall Study|Other complicating disease|1|||
33388536|NCT00771953|62767127|FG001|Overall Study|Other complicating disease|0|||
33388537|NCT00771953|62767126|FG000|Overall Study|Withdrawal by Subject|0|||
33388538|NCT00771953|62767127|FG001|Overall Study|Withdrawal by Subject|3|||
33388539|NCT00621244|62767139|FG000|Overall Study|Withdrawal by Subject|7|||
33489748|NCT02257918|62867834|FG002|Overall Study|Lost to Follow-up|0|||
33388540|NCT00621244|62767140|FG001|Overall Study|Withdrawal by Subject|3|||
33388541|NCT00621244|62767141|FG002|Overall Study|Withdrawal by Subject|3|||
33388542|NCT00621244|62767142|FG003|Overall Study|Withdrawal by Subject|3|||
33388543|NCT00621244|62767139|FG000|Overall Study|Disease progression|44|||
33388544|NCT00621244|62767140|FG001|Overall Study|Disease progression|20|||
33388545|NCT00621244|62767141|FG002|Overall Study|Disease progression|20|||
33388546|NCT00621244|62767142|FG003|Overall Study|Disease progression|15|||
33388547|NCT00621244|62767139|FG000|Overall Study|Death|3|||
33388548|NCT00621244|62767140|FG001|Overall Study|Death|3|||
33388549|NCT00621244|62767141|FG002|Overall Study|Death|1|||
33388550|NCT00621244|62767142|FG003|Overall Study|Death|1|||
33388551|NCT00621244|62767139|FG000|Overall Study|Adverse Event|27|||
33388552|NCT00621244|62767140|FG001|Overall Study|Adverse Event|7|||
33388553|NCT00621244|62767141|FG002|Overall Study|Adverse Event|9|||
33388554|NCT00621244|62767142|FG003|Overall Study|Adverse Event|2|||
33388555|NCT00621244|62767139|FG000|Overall Study|Administrative problems|5|||
33388556|NCT00621244|62767140|FG001|Overall Study|Administrative problems|1|||
33388557|NCT00621244|62767141|FG002|Overall Study|Administrative problems|0|||
33388558|NCT00621244|62767142|FG003|Overall Study|Administrative problems|2|||
33388559|NCT00659529|62767216|FG000|Overall Study|Withdrawal by Subject|4|||
33388560|NCT00659529|62767216|FG000|Overall Study|Protocol Violation|3|||
33388561|NCT00659529|62767216|FG000|Overall Study|Screen failure|9|||
33388562|NCT00578942|62767220|FG000|Overall Study|Lost to Follow-up|1|||
33388563|NCT00765245|62767226|FG000|Overall Study|disease progression|3|||
33388564|NCT00765245|62767227|FG001|Overall Study|disease progression|2|||
33388565|NCT00765245|62767226|FG000|Overall Study|Withdrawal by Subject|3|||
33388566|NCT00765245|62767227|FG001|Overall Study|Withdrawal by Subject|0|||
33388567|NCT00765245|62767226|FG000|Overall Study|Adverse Event|5|||
33388568|NCT00765245|62767227|FG001|Overall Study|Adverse Event|0|||
33388569|NCT00765245|62767226|FG000|Overall Study|Physician Decision|1|||
33388570|NCT00765245|62767227|FG001|Overall Study|Physician Decision|0|||
33388571|NCT00765245|62767226|FG000|Overall Study|Death|1|||
33388572|NCT00765245|62767227|FG001|Overall Study|Death|0|||
33388573|NCT00782795|62767235|FG000|Overall Study|Withdrawal by Subject|1|||
33388574|NCT00782795|62767236|FG001|Overall Study|Withdrawal by Subject|2|||
33388575|NCT00656799|62767242|FG000|Overall Study|Death|2|||
33388576|NCT00764699|62767246|FG000|Overall Study|PI left and study terminated|3|||
33388577|NCT00782717|62767252|FG000|Overall Study|Adverse Event|2|||
33388578|NCT00782717|62767253|FG001|Overall Study|Adverse Event|5|||
33388579|NCT00782717|62767252|FG000|Overall Study|Patient decision unrelated to AE|6|||
33388580|NCT00782717|62767253|FG001|Overall Study|Patient decision unrelated to AE|3|||
33388581|NCT00782717|62767252|FG000|Overall Study|Noncompliance|2|||
33388582|NCT00782717|62767253|FG001|Overall Study|Noncompliance|1|||
33388583|NCT00782717|62767252|FG000|Overall Study|Treatment failure|3|||
33388584|NCT00782717|62767253|FG001|Overall Study|Treatment failure|14|||
33388585|NCT00782717|62767252|FG000|Overall Study|Enrollment close prior to surgery|1|||
33388586|NCT00782717|62767253|FG001|Overall Study|Enrollment close prior to surgery|0|||
33388587|NCT00782717|62767252|FG000|Overall Study|Did not meet entrance criteria|1|||
33388588|NCT00782717|62767253|FG001|Overall Study|Did not meet entrance criteria|3|||
33388589|NCT00782717|62767252|FG000|Overall Study|Exited in error|0|||
33489749|NCT02257918|62867832|FG000|Overall Study|Withdrawal by Subject|0|||
33489750|NCT02257918|62867833|FG001|Overall Study|Withdrawal by Subject|0|||
33489751|NCT02257918|62867834|FG002|Overall Study|Withdrawal by Subject|1|||
33489752|NCT02257918|62867832|FG000|Overall Study|Pregnancy|0|||
33489753|NCT02257918|62867833|FG001|Overall Study|Pregnancy|0|||
33489754|NCT02257918|62867834|FG002|Overall Study|Pregnancy|1|||
33489755|NCT02751424|62867851|FG000|Part 2|Adverse Event|0|||
33489756|NCT02751424|62867852|FG001|Part 2|Adverse Event|0|||
33489757|NCT02751424|62867853|FG002|Part 2|Adverse Event|0|||
33489758|NCT02751424|62867854|FG003|Part 2|Adverse Event|0|||
33489759|NCT02751424|62867855|FG004|Part 2|Adverse Event|0|||
33489760|NCT02751424|62867856|FG005|Part 2|Adverse Event|0|||
33489761|NCT02751424|62867857|FG006|Part 2|Adverse Event|0|||
33489762|NCT02751424|62867858|FG007|Part 2|Adverse Event|5|||
33489763|NCT02751424|62867859|FG008|Part 2|Adverse Event|0|||
33489764|NCT00094835|62867889|FG000|Overall Study|Physician Decision|1|||
33489765|NCT00094835|62867890|FG001|Overall Study|Physician Decision|0|||
33489766|NCT00094835|62867891|FG002|Overall Study|Physician Decision|0|||
33489767|NCT00094835|62867892|FG003|Overall Study|Physician Decision|0|||
33489768|NCT00094835|62867893|FG004|Overall Study|Physician Decision|0|||
33388590|NCT00782717|62767253|FG001|Overall Study|Exited in error|2|||
33388591|NCT00656175|62767261|FG000|Overall Study|Adverse Event|1|||
33388592|NCT00656175|62767262|FG001|Overall Study|Adverse Event|0|||
33388593|NCT00656175|62767261|FG000|Overall Study|Transportation issues|0|||
33489769|NCT00094835|62867894|FG005|Overall Study|Physician Decision|1|||
33662655|NCT01587703|63093229|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33388594|NCT00656175|62767262|FG001|Overall Study|Transportation issues|1|||
33388595|NCT00620776|62767270|FG000|Overall Study|Did not receive treatment|3|||
33388596|NCT00620776|62767271|FG001|Overall Study|Did not receive treatment|5|||
33388597|NCT00620776|62767270|FG000|Overall Study|Adverse Event|2|||
33388598|NCT00620776|62767271|FG001|Overall Study|Adverse Event|3|||
33489770|NCT00094835|62867895|FG006|Overall Study|Physician Decision|0|||
33489771|NCT00094835|62867889|FG000|Overall Study|Withdrawal by Subject|0|||
33489772|NCT00094835|62867890|FG001|Overall Study|Withdrawal by Subject|0|||
33662656|NCT01587703|63093230|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33489773|NCT00094835|62867891|FG002|Overall Study|Withdrawal by Subject|0|||
33388599|NCT00620776|62767270|FG000|Overall Study|Lack of Efficacy|2|||
33388600|NCT00620776|62767271|FG001|Overall Study|Lack of Efficacy|1|||
33388601|NCT00620776|62767270|FG000|Overall Study|Lost to Follow-up|2|||
33388602|NCT00620776|62767271|FG001|Overall Study|Lost to Follow-up|5|||
33388603|NCT00620776|62767270|FG000|Overall Study|Withdrawal by Subject|3|||
33388604|NCT00620776|62767271|FG001|Overall Study|Withdrawal by Subject|2|||
33388605|NCT00656019|62767281|FG000|Overall Study|Not Eligible|10|||
33388606|NCT00656019|62767282|FG001|Overall Study|Not Eligible|0|||
33388607|NCT00656019|62767283|FG002|Overall Study|Not Eligible|0|||
33388608|NCT00656019|62767284|FG003|Overall Study|Not Eligible|0|||
33388609|NCT00656019|62767281|FG000|Overall Study|Withdrawal by Subject|2|||
33388610|NCT00656019|62767282|FG001|Overall Study|Withdrawal by Subject|0|||
33388611|NCT00656019|62767283|FG002|Overall Study|Withdrawal by Subject|0|||
33388612|NCT00656019|62767284|FG003|Overall Study|Withdrawal by Subject|0|||
33388613|NCT00656019|62767281|FG000|Overall Study|Lost to Follow-up|2|||
33388614|NCT00656019|62767282|FG001|Overall Study|Lost to Follow-up|1|||
33388615|NCT00656019|62767283|FG002|Overall Study|Lost to Follow-up|0|||
33388616|NCT00656019|62767284|FG003|Overall Study|Lost to Follow-up|0|||
33388617|NCT00782483|62767294|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
33388618|NCT00782171|62767300|FG000|Overall Study|Lost to Follow-up|2|||
33388619|NCT00782171|62767301|FG001|Overall Study|Lost to Follow-up|2|||
33388620|NCT00782171|62767300|FG000|Overall Study|Withdrawal by Subject|2|||
33388621|NCT00782171|62767301|FG001|Overall Study|Withdrawal by Subject|1|||
33388622|NCT00782171|62767300|FG000|Overall Study|complications|3|||
33388623|NCT00782171|62767301|FG001|Overall Study|complications|1|||
33388624|NCT00782171|62767300|FG000|Overall Study|others|7|||
33388625|NCT00782171|62767301|FG001|Overall Study|others|9|||
33388626|NCT00782171|62767300|FG000|Overall Study|not eligible|8|||
33388627|NCT00782171|62767301|FG001|Overall Study|not eligible|6|||
33388628|NCT00764465|62767313|FG000|Overall Study|Adverse Event|2|||
33298913|NCT01303172|62675098|FG001|Overall Study|Lack of Efficacy|17|||
33298914|NCT01302938|62675107|FG000|Overall Study|Withdrawal by Subject|1|||
33298915|NCT01302938|62675108|FG001|Overall Study|Withdrawal by Subject|0|||
33298916|NCT01302938|62675107|FG000|Overall Study|Adverse Event|1|||
33298917|NCT01302938|62675108|FG001|Overall Study|Adverse Event|0|||
33298918|NCT01302548|62675117|FG000|Overall Study|Lost to Follow-up|2|||
33388629|NCT00764465|62767314|FG001|Overall Study|Adverse Event|0|||
33388630|NCT00764465|62767315|FG002|Overall Study|Adverse Event|0|||
33388631|NCT00764465|62767316|FG003|Overall Study|Adverse Event|1|||
33388632|NCT00764465|62767317|FG004|Overall Study|Adverse Event|1|||
33388633|NCT00764465|62767318|FG005|Overall Study|Adverse Event|1|||
33388634|NCT00764465|62767313|FG000|Overall Study|Withdrawal by Subject|0|||
33388635|NCT00764465|62767314|FG001|Overall Study|Withdrawal by Subject|1|||
33388636|NCT00764465|62767315|FG002|Overall Study|Withdrawal by Subject|1|||
33388637|NCT00764465|62767316|FG003|Overall Study|Withdrawal by Subject|0|||
33388638|NCT00764465|62767317|FG004|Overall Study|Withdrawal by Subject|0|||
33388639|NCT00764465|62767318|FG005|Overall Study|Withdrawal by Subject|0|||
33388640|NCT00655863|62767338|FG000|Overall Study|Lost to Follow-up|0|||
33388641|NCT00655863|62767339|FG001|Overall Study|Lost to Follow-up|0|||
33388642|NCT00655863|62767340|FG002|Overall Study|Lost to Follow-up|1|||
33388643|NCT00781937|62767350|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
33388644|NCT00781937|62767351|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
33388645|NCT00781937|62767350|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
33388646|NCT00781937|62767351|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
33388647|NCT00781937|62767350|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
33388648|NCT00781937|62767351|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
33388649|NCT00781937|62767350|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
33388650|NCT00781937|62767351|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
33388651|NCT00781937|62767350|FG000|Main Trial Period Through Week 56|Unclassified|10|||
33388652|NCT00781937|62767351|FG001|Main Trial Period Through Week 56|Unclassified|15|||
33388653|NCT00781937|62767350|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
33388654|NCT00781937|62767351|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
33388655|NCT00781937|62767350|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
33388656|NCT00781937|62767351|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
33388657|NCT00659373|62767359|FG000|Overall Study|Withdrawal by Subject|3|||
33298919|NCT01302548|62675118|FG001|Overall Study|Lost to Follow-up|1|||
33388658|NCT00659373|62767360|FG001|Overall Study|Withdrawal by Subject|5|||
33388659|NCT00659373|62767359|FG000|Overall Study|Assessment Missed|2|||
33388660|NCT00659373|62767360|FG001|Overall Study|Assessment Missed|2|||
33298920|NCT01076959|62675124|FG000|Overall Study|Adverse Event|767|||
33298921|NCT01076959|62675124|FG000|Overall Study|Lack of Efficacy|849|||
33298922|NCT01076959|62675124|FG000|Overall Study|Non-compliance|274|||
33388661|NCT00439777|62767368|FG000|Treatment Period|Death|29|||
33388662|NCT00439777|62767369|FG001|Treatment Period|Death|21|||
33388663|NCT00439777|62767368|FG000|Treatment Period|Study terminated by sponsor|125|||
33388664|NCT00439777|62767369|FG001|Treatment Period|Study terminated by sponsor|132|||
33298923|NCT01076959|62675124|FG000|Overall Study|Lost to Follow-up|241|||
33388665|NCT00439777|62767368|FG000|Treatment Period|Site closed by investigator|0|||
33388666|NCT00439777|62767369|FG001|Treatment Period|Site closed by investigator|1|||
33388667|NCT00439777|62767368|FG000|Treatment Period|Did not take study treatment|7|||
33388668|NCT00439777|62767369|FG001|Treatment Period|Did not take study treatment|8|||
33388669|NCT00439777|62767368|FG000|Treatment Period|Adverse Event|111|||
33388670|NCT00439777|62767369|FG001|Treatment Period|Adverse Event|92|||
33388671|NCT00439777|62767368|FG000|Treatment Period|Protocol Violation|23|||
33388672|NCT00439777|62767369|FG001|Treatment Period|Protocol Violation|30|||
33388673|NCT00439777|62767368|FG000|Treatment Period|Withdrawal by Subject|66|||
33388674|NCT00439777|62767369|FG001|Treatment Period|Withdrawal by Subject|118|||
33388675|NCT00439777|62767368|FG000|Treatment Period|Lack of Efficacy|1|||
33388676|NCT00439777|62767369|FG001|Treatment Period|Lack of Efficacy|4|||
33388677|NCT00439777|62767368|FG000|Treatment Period|Lost to Follow-up|8|||
33388678|NCT00439777|62767369|FG001|Treatment Period|Lost to Follow-up|10|||
33388679|NCT00439777|62767368|FG000|Treatment Period|Protocol driven decision point|1|||
33388680|NCT00439777|62767369|FG001|Treatment Period|Protocol driven decision point|3|||
33388681|NCT00439777|62767368|FG000|Treatment Period|Physician Decision|7|||
33388682|NCT00439777|62767369|FG001|Treatment Period|Physician Decision|18|||
33388683|NCT00439777|62767368|FG000|Treatment Period|Clinical endpoint reached|26|||
33388684|NCT00439777|62767369|FG001|Treatment Period|Clinical endpoint reached|13|||
33388685|NCT00439777|62767368|FG000|Treatment Period|Technical problems|3|||
33388686|NCT00439777|62767369|FG001|Treatment Period|Technical problems|1|||
33388687|NCT00439777|62767368|FG000|Treatment Period|Participant convenience|12|||
33388688|NCT00439777|62767369|FG001|Treatment Period|Participant convenience|8|||
33388689|NCT00439777|62767368|FG000|Observational Period|Protocol Violation|0|||
33388690|NCT00439777|62767369|FG001|Observational Period|Protocol Violation|2|||
33388691|NCT00439777|62767368|FG000|Observational Period|Withdrawal by Subject|9|||
33388692|NCT00439777|62767369|FG001|Observational Period|Withdrawal by Subject|5|||
33388693|NCT00439777|62767368|FG000|Observational Period|Lost to Follow-up|1|||
33388694|NCT00439777|62767369|FG001|Observational Period|Lost to Follow-up|11|||
33298924|NCT01076959|62675124|FG000|Overall Study|Other|119|||
33298925|NCT01302392|62675143|FG000|Overall Study|Lost to Follow-up|1|||
33298926|NCT01302392|62675144|FG001|Overall Study|Lost to Follow-up|0|||
33298927|NCT01302392|62675143|FG000|Overall Study|Withdrawal by Subject|6|||
33298928|NCT01302392|62675144|FG001|Overall Study|Withdrawal by Subject|1|||
33298929|NCT01076647|62675152|FG000|Overall Study|Adverse Event|4|||
33388695|NCT00439777|62767368|FG000|Observational Period|Death|27|||
33388696|NCT00439777|62767369|FG001|Observational Period|Death|20|||
33388697|NCT00439777|62767368|FG000|Observational Period|Study terminated by sponsor|3|||
33388698|NCT00439777|62767369|FG001|Observational Period|Study terminated by sponsor|1|||
33388699|NCT00439777|62767368|FG000|Observational Period|Protocol driven decision point|0|||
33388700|NCT00439777|62767369|FG001|Observational Period|Protocol driven decision point|1|||
33388701|NCT00439777|62767368|FG000|Observational Period|Lack of Efficacy|1|||
33388702|NCT00439777|62767369|FG001|Observational Period|Lack of Efficacy|0|||
33388703|NCT00439777|62767368|FG000|Observational Period|Technical problems|0|||
33388704|NCT00439777|62767369|FG001|Observational Period|Technical problems|1|||
33388705|NCT00620854|62767381|FG000|Washout 1|Withdrawal by Subject|0|||
33388706|NCT00620854|62767382|FG001|Washout 1|Withdrawal by Subject|0|||
33388707|NCT00620854|62767383|FG002|Washout 1|Withdrawal by Subject|1|||
33388708|NCT00620854|62767384|FG003|Washout 1|Withdrawal by Subject|1|||
33298930|NCT01076647|62675153|FG001|Overall Study|Adverse Event|1|||
33298931|NCT01076647|62675152|FG000|Overall Study|Lack of Efficacy|0|||
33298932|NCT01076647|62675153|FG001|Overall Study|Lack of Efficacy|1|||
33298933|NCT01076647|62675152|FG000|Overall Study|Protocol Violation|7|||
33298934|NCT01076647|62675153|FG001|Overall Study|Protocol Violation|9|||
33298935|NCT01076647|62675152|FG000|Overall Study|Withdrawal criteria|2|||
33298936|NCT01076647|62675153|FG001|Overall Study|Withdrawal criteria|2|||
33298937|NCT01076647|62675152|FG000|Overall Study|Unclassified|12|||
33298938|NCT01076647|62675153|FG001|Overall Study|Unclassified|12|||
33298939|NCT01074307|62675161|FG000|Overall Study|No primary endpoint evaluation|14|||
33298940|NCT01074307|62675162|FG001|Overall Study|No primary endpoint evaluation|6|||
33298941|NCT01074307|62675161|FG000|Overall Study|Exclusion criterion|0|||
33388709|NCT00620854|62767385|FG004|Washout 1|Withdrawal by Subject|0|||
33298942|NCT01074307|62675162|FG001|Overall Study|Exclusion criterion|1|||
33298943|NCT01074307|62675161|FG000|Overall Study|Protocol Violation|8|||
33298944|NCT01074307|62675162|FG001|Overall Study|Protocol Violation|5|||
33298945|NCT01076335|62675168|FG000|Overall Study|Withdrawal by Subject|3|||
33298946|NCT01076335|62675168|FG000|Overall Study|Withdrawal without treatment|1|||
33298947|NCT01309737|62675175|FG000|Week 0 to 16|Death|1|||
33298948|NCT01309737|62675176|FG001|Week 0 to 16|Death|0|||
33298949|NCT01309737|62675177|FG002|Week 0 to 16|Death|1|||
33388710|NCT00620854|62767386|FG005|Washout 1|Withdrawal by Subject|0|||
33388711|NCT00430027|62767397|FG000|Overall Study|Study terminated|8|||
33298950|NCT01309737|62675178|FG003|Week 0 to 16|Death|0|||
33298951|NCT01309737|62675179|FG004|Week 0 to 16|Death|0|||
33388712|NCT00429793|62767401|FG000|Overall Study|Improper pre-protocol treatment|3|||
33388713|NCT00429793|62767401|FG000|Overall Study|Required test not done|1|||
33388714|NCT00429793|62767401|FG000|Overall Study|Never treated|1|||
33388715|NCT00429793|62767401|FG000|Overall Study|Non-measurable|1|||
33388716|NCT00424645|62767412|FG000|Overall Study|Death|1|||
33388717|NCT00424645|62767413|FG001|Overall Study|Death|0|||
33388718|NCT00763451|62767423|FG000|Overall Study|Adverse Event|4|||
33388719|NCT00763451|62767424|FG001|Overall Study|Adverse Event|6|||
33388720|NCT00763451|62767425|FG002|Overall Study|Adverse Event|19|||
33388721|NCT00763451|62767426|FG003|Overall Study|Adverse Event|14|||
33388722|NCT00763451|62767423|FG000|Overall Study|Lack of Efficacy|1|||
33388723|NCT00763451|62767424|FG001|Overall Study|Lack of Efficacy|4|||
33388724|NCT00763451|62767425|FG002|Overall Study|Lack of Efficacy|3|||
33388725|NCT00763451|62767426|FG003|Overall Study|Lack of Efficacy|2|||
33388726|NCT00763451|62767423|FG000|Overall Study|Withdrawal by Subject|1|||
33388727|NCT00763451|62767424|FG001|Overall Study|Withdrawal by Subject|6|||
33388728|NCT00763451|62767425|FG002|Overall Study|Withdrawal by Subject|9|||
33388729|NCT00763451|62767426|FG003|Overall Study|Withdrawal by Subject|7|||
33388730|NCT00763451|62767423|FG000|Overall Study|Protocol Violation|0|||
33388731|NCT00763451|62767424|FG001|Overall Study|Protocol Violation|0|||
33388732|NCT00763451|62767425|FG002|Overall Study|Protocol Violation|1|||
33388733|NCT00763451|62767426|FG003|Overall Study|Protocol Violation|0|||
33388734|NCT00763451|62767423|FG000|Overall Study|Poor Compliance to Protocol|1|||
33388735|NCT00763451|62767424|FG001|Overall Study|Poor Compliance to Protocol|1|||
33388736|NCT00763451|62767425|FG002|Overall Study|Poor Compliance to Protocol|2|||
33388737|NCT00763451|62767426|FG003|Overall Study|Poor Compliance to Protocol|2|||
33388738|NCT00763451|62767423|FG000|Overall Study|Familial and Personal Reasons|5|||
33388739|NCT00763451|62767424|FG001|Overall Study|Familial and Personal Reasons|3|||
33388740|NCT00763451|62767425|FG002|Overall Study|Familial and Personal Reasons|5|||
33388741|NCT00763451|62767426|FG003|Overall Study|Familial and Personal Reasons|4|||
33388742|NCT00763451|62767423|FG000|Overall Study|Randomized but not Treated|1|||
33388743|NCT00763451|62767424|FG001|Overall Study|Randomized but not Treated|1|||
33388744|NCT00763451|62767425|FG002|Overall Study|Randomized but not Treated|0|||
33388745|NCT00763451|62767426|FG003|Overall Study|Randomized but not Treated|0|||
33388746|NCT00763451|62767423|FG000|Overall Study|Study Site Reason|0|||
33388747|NCT00763451|62767424|FG001|Overall Study|Study Site Reason|1|||
33388748|NCT00763451|62767425|FG002|Overall Study|Study Site Reason|1|||
33388749|NCT00763451|62767426|FG003|Overall Study|Study Site Reason|1|||
33388750|NCT00762762|62767439|FG000|Overall Study|Did not return for appointments|6|||
33388751|NCT00762762|62767440|FG001|Overall Study|Did not return for appointments|8|||
33388752|NCT00424489|62767448|FG000|Overall Study|Death|3|||
33388753|NCT00578864|62767454|FG000|Overall Study|Death|1|||
33388754|NCT00578864|62767455|FG001|Overall Study|Death|0|||
33388755|NCT00770315|62767478|FG000|Overall Study|Adverse Event|11|||
33388756|NCT00770315|62767479|FG001|Overall Study|Adverse Event|17|||
33388757|NCT00770315|62767480|FG002|Overall Study|Adverse Event|16|||
33388758|NCT00770315|62767481|FG003|Overall Study|Adverse Event|6|||
33388759|NCT00770315|62767478|FG000|Overall Study|Lost to Follow-up|9|||
33388760|NCT00770315|62767479|FG001|Overall Study|Lost to Follow-up|5|||
33388761|NCT00770315|62767480|FG002|Overall Study|Lost to Follow-up|10|||
33388762|NCT00770315|62767481|FG003|Overall Study|Lost to Follow-up|3|||
33388763|NCT00770315|62767478|FG000|Overall Study|Withdrawal by Subject|13|||
33388764|NCT00770315|62767479|FG001|Overall Study|Withdrawal by Subject|17|||
33388765|NCT00770315|62767480|FG002|Overall Study|Withdrawal by Subject|24|||
33388766|NCT00770315|62767481|FG003|Overall Study|Withdrawal by Subject|20|||
33388767|NCT00770315|62767478|FG000|Overall Study|Noncompliance with Protocol|7|||
33388768|NCT00770315|62767479|FG001|Overall Study|Noncompliance with Protocol|4|||
33388769|NCT00770315|62767480|FG002|Overall Study|Noncompliance with Protocol|7|||
33388770|NCT00770315|62767481|FG003|Overall Study|Noncompliance with Protocol|9|||
33388771|NCT00587171|62767493|FG000|Overall Study|Lost to Follow-up|1|||
33388772|NCT00587171|62767494|FG001|Overall Study|Lost to Follow-up|1|||
33388773|NCT00763139|62767500|FG000|Overall Study|Adverse Event|4|||
33388774|NCT00763139|62767501|FG001|Overall Study|Adverse Event|2|||
33388775|NCT00763139|62767500|FG000|Overall Study|Withdrawal by Subject|0|||
33388776|NCT00763139|62767501|FG001|Overall Study|Withdrawal by Subject|1|||
33388777|NCT00763139|62767500|FG000|Overall Study|med change not allowed by protocol|1|||
33388778|NCT00763139|62767501|FG001|Overall Study|med change not allowed by protocol|0|||
33388779|NCT01366092|62767512|FG000|Overall Study|Progressive cGVHD|2|||
33388780|NCT01366092|62767512|FG000|Overall Study|Physician Decision|1|||
33388781|NCT01366092|62767512|FG000|Overall Study|Withdrawal by Subject|1|||
33388782|NCT00781859|62767518|FG000|Overall Study|Adverse Event|2|||
33556812|NCT01594970|62949687|FG000|Overall Study|Non-Adverse Event Related|4|||
33662657|NCT01587703|63093231|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33388783|NCT00781859|62767519|FG001|Overall Study|Adverse Event|2|||
33388784|NCT00781859|62767518|FG000|Overall Study|Withdrawal by Subject|8|||
33388785|NCT00781859|62767519|FG001|Overall Study|Withdrawal by Subject|4|||
33388786|NCT00781859|62767518|FG000|Overall Study|Lost to Follow-up|6|||
33388787|NCT00781859|62767519|FG001|Overall Study|Lost to Follow-up|3|||
33388788|NCT00781859|62767518|FG000|Overall Study|Death|3|||
33388789|NCT00781859|62767519|FG001|Overall Study|Death|0|||
33388790|NCT00580788|62767529|FG000|Overall Study|Adverse Event|0|||
33388791|NCT00580788|62767530|FG001|Overall Study|Adverse Event|0|||
33388792|NCT00580788|62767531|FG002|Overall Study|Adverse Event|0|||
33388793|NCT00580788|62767532|FG003|Overall Study|Adverse Event|1|||
33388794|NCT00417079|62767551|FG000|Overall Study|Disease progression|267|||
33388795|NCT00417079|62767552|FG001|Overall Study|Disease progression|180|||
33388796|NCT00417079|62767551|FG000|Overall Study|Adverse Event|32|||
33388797|NCT00417079|62767552|FG001|Overall Study|Adverse Event|67|||
33388798|NCT00417079|62767551|FG000|Overall Study|Non-compliance to protocol|0|||
33388799|NCT00417079|62767552|FG001|Overall Study|Non-compliance to protocol|1|||
33388800|NCT00417079|62767551|FG000|Overall Study|Lost to Follow-up|2|||
33388801|NCT00417079|62767552|FG001|Overall Study|Lost to Follow-up|0|||
33388802|NCT00417079|62767551|FG000|Overall Study|Withdrawal by Subject|17|||
33388803|NCT00417079|62767552|FG001|Overall Study|Withdrawal by Subject|8|||
33388804|NCT00417079|62767551|FG000|Overall Study|Not treated|6|||
33388805|NCT00417079|62767552|FG001|Overall Study|Not treated|7|||
33388806|NCT00417079|62767551|FG000|Overall Study|Screened failure|2|||
33388807|NCT00417079|62767552|FG001|Overall Study|Screened failure|1|||
33388808|NCT00417079|62767551|FG000|Overall Study|Investigator's decision|1|||
33388809|NCT00417079|62767552|FG001|Overall Study|Investigator's decision|4|||
33388810|NCT00417079|62767551|FG000|Overall Study|Non-confirmed Disease progression|1|||
33388811|NCT00417079|62767552|FG001|Overall Study|Non-confirmed Disease progression|1|||
33388812|NCT00417079|62767551|FG000|Overall Study|Clinical deterioration|1|||
33388813|NCT00417079|62767552|FG001|Overall Study|Clinical deterioration|0|||
33388814|NCT00417079|62767551|FG000|Overall Study|Screening error|2|||
33388815|NCT00417079|62767552|FG001|Overall Study|Screening error|1|||
33388816|NCT00417079|62767551|FG000|Overall Study|Withdrawal by subject's family|0|||
33388817|NCT00417079|62767552|FG001|Overall Study|Withdrawal by subject's family|1|||
33388818|NCT00417079|62767551|FG000|Overall Study|Patient unable to come to the clinic|0|||
33388819|NCT00417079|62767552|FG001|Overall Study|Patient unable to come to the clinic|1|||
33388820|NCT00417079|62767551|FG000|Overall Study|abnormal liver function tests|0|||
33388821|NCT00417079|62767552|FG001|Overall Study|abnormal liver function tests|1|||
33388822|NCT00429169|62767560|FG000|Overall Study|Lost to Follow-up|0|||
33388823|NCT00429169|62767561|FG001|Overall Study|Lost to Follow-up|1|||
33388824|NCT00429169|62767560|FG000|Overall Study|Ineligibility discovered after entry|2|||
33388825|NCT00429169|62767561|FG001|Overall Study|Ineligibility discovered after entry|1|||
33388826|NCT00416455|62767571|FG000|Overall Study|PET / CT not done|3|||
33388827|NCT00416455|62767572|FG001|Overall Study|PET / CT not done|5|||
33388828|NCT00416455|62767571|FG000|Overall Study|PET / CT poor quality|2|||
33298952|NCT01309737|62675175|FG000|Week 0 to 16|Adverse Event|11|||
33298953|NCT01309737|62675176|FG001|Week 0 to 16|Adverse Event|10|||
33298954|NCT01309737|62675177|FG002|Week 0 to 16|Adverse Event|5|||
33298955|NCT01309737|62675178|FG003|Week 0 to 16|Adverse Event|0|||
33298956|NCT01309737|62675179|FG004|Week 0 to 16|Adverse Event|0|||
33298957|NCT01309737|62675175|FG000|Week 0 to 16|Lack of Efficacy|15|||
33298958|NCT01309737|62675176|FG001|Week 0 to 16|Lack of Efficacy|2|||
33298959|NCT01309737|62675177|FG002|Week 0 to 16|Lack of Efficacy|24|||
33298960|NCT01309737|62675178|FG003|Week 0 to 16|Lack of Efficacy|0|||
33298961|NCT01309737|62675179|FG004|Week 0 to 16|Lack of Efficacy|0|||
33298962|NCT01309737|62675175|FG000|Week 0 to 16|Lost to Follow-up|7|||
33298963|NCT01309737|62675176|FG001|Week 0 to 16|Lost to Follow-up|8|||
33298964|NCT01309737|62675177|FG002|Week 0 to 16|Lost to Follow-up|3|||
33298965|NCT01309737|62675178|FG003|Week 0 to 16|Lost to Follow-up|0|||
33298966|NCT01309737|62675179|FG004|Week 0 to 16|Lost to Follow-up|0|||
33298967|NCT01309737|62675175|FG000|Week 0 to 16|Withdrawal by Subject|7|||
33298968|NCT01309737|62675176|FG001|Week 0 to 16|Withdrawal by Subject|6|||
33298969|NCT01309737|62675177|FG002|Week 0 to 16|Withdrawal by Subject|7|||
33388829|NCT00416455|62767572|FG001|Overall Study|PET / CT poor quality|1|||
33388830|NCT00416455|62767571|FG000|Overall Study|Inadequate pathology|11|||
33388831|NCT00416455|62767572|FG001|Overall Study|Inadequate pathology|2|||
33388832|NCT00415909|62767589|FG000|Overall Study|Withdrawal by Subject|2|||
33388833|NCT00415909|62767589|FG000|Overall Study|Death|1|||
33388834|NCT00415597|62767593|FG000|Enrollment|Withdrawal by Subject|1|||
33298970|NCT01309737|62675178|FG003|Week 0 to 16|Withdrawal by Subject|0|||
33298971|NCT01309737|62675179|FG004|Week 0 to 16|Withdrawal by Subject|0|||
33298972|NCT01309737|62675175|FG000|Week 0 to 16|Other|10|||
33298973|NCT01309737|62675176|FG001|Week 0 to 16|Other|14|||
33298974|NCT01309737|62675177|FG002|Week 0 to 16|Other|4|||
33388835|NCT00415597|62767593|FG000|Enrollment|Protocol Violation|1|||
33388836|NCT00415597|62767593|FG000|Treatment|Adverse Event|110|||
33388837|NCT00415597|62767593|FG000|Treatment|Lack of Efficacy|39|||
33388838|NCT00415597|62767593|FG000|Treatment|Protocol Violation|67|||
33388839|NCT00415597|62767593|FG000|Treatment|Physician Decision|3|||
33388840|NCT00415597|62767593|FG000|Treatment|Withdrawal by Subject|51|||
33388841|NCT00415597|62767593|FG000|Treatment|Lost to Follow-up|28|||
33388842|NCT00415597|62767593|FG000|Treatment|Drug Screen|2|||
33298975|NCT01309737|62675178|FG003|Week 0 to 16|Other|0|||
33298976|NCT01309737|62675179|FG004|Week 0 to 16|Other|0|||
33388843|NCT00415597|62767593|FG000|Treatment|Administrative|3|||
33388844|NCT00415597|62767593|FG000|Treatment|Sponsor Decision|1|||
33388845|NCT00415597|62767593|FG000|Treatment|Multiple Reasons|1|||
33388846|NCT00620542|62767599|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
33388847|NCT00620542|62767600|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
33388848|NCT00620542|62767601|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
33388849|NCT00620542|62767602|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
33388850|NCT00620542|62767599|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
33388851|NCT00620542|62767600|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
33388852|NCT00620542|62767601|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
33388853|NCT00620542|62767602|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
33388854|NCT00620542|62767599|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
33388855|NCT00620542|62767600|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
33388856|NCT00620542|62767601|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
33388857|NCT00620542|62767602|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
33388858|NCT00620542|62767599|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
33489774|NCT00094835|62867892|FG003|Overall Study|Withdrawal by Subject|0|||
33489775|NCT00094835|62867893|FG004|Overall Study|Withdrawal by Subject|0|||
33489776|NCT00094835|62867894|FG005|Overall Study|Withdrawal by Subject|0|||
33489777|NCT00094835|62867895|FG006|Overall Study|Withdrawal by Subject|1|||
33489778|NCT00094835|62867889|FG000|Overall Study|Lost to Follow-up|0|||
33489779|NCT00094835|62867890|FG001|Overall Study|Lost to Follow-up|0|||
33489780|NCT00094835|62867891|FG002|Overall Study|Lost to Follow-up|0|||
33489781|NCT00094835|62867892|FG003|Overall Study|Lost to Follow-up|0|||
33298977|NCT01309737|62675175|FG000|Week 0 to 16|Randomized, but not treated|1|||
33298978|NCT01309737|62675176|FG001|Week 0 to 16|Randomized, but not treated|0|||
33298979|NCT01309737|62675177|FG002|Week 0 to 16|Randomized, but not treated|0|||
33298980|NCT01309737|62675178|FG003|Week 0 to 16|Randomized, but not treated|0|||
33298981|NCT01309737|62675179|FG004|Week 0 to 16|Randomized, but not treated|0|||
33298982|NCT01309737|62675175|FG000|Week 16 to 52|Death|0|||
33298983|NCT01309737|62675176|FG001|Week 16 to 52|Death|0|||
33298984|NCT01309737|62675177|FG002|Week 16 to 52|Death|0|||
33298985|NCT01309737|62675178|FG003|Week 16 to 52|Death|0|||
33298986|NCT01309737|62675179|FG004|Week 16 to 52|Death|1|||
33298987|NCT01309737|62675175|FG000|Week 16 to 52|Adverse Event|7|||
33298988|NCT01309737|62675176|FG001|Week 16 to 52|Adverse Event|7|||
33298989|NCT01309737|62675177|FG002|Week 16 to 52|Adverse Event|0|||
33298990|NCT01309737|62675178|FG003|Week 16 to 52|Adverse Event|6|||
33298991|NCT01309737|62675179|FG004|Week 16 to 52|Adverse Event|5|||
33298992|NCT01309737|62675175|FG000|Week 16 to 52|Lack of Efficacy|107|||
33298993|NCT01309737|62675176|FG001|Week 16 to 52|Lack of Efficacy|76|||
33298994|NCT01309737|62675177|FG002|Week 16 to 52|Lack of Efficacy|0|||
33298995|NCT01309737|62675178|FG003|Week 16 to 52|Lack of Efficacy|25|||
33298996|NCT01309737|62675179|FG004|Week 16 to 52|Lack of Efficacy|21|||
33298997|NCT01309737|62675175|FG000|Week 16 to 52|Lost to Follow-up|4|||
33298998|NCT01309737|62675176|FG001|Week 16 to 52|Lost to Follow-up|2|||
33298999|NCT01309737|62675177|FG002|Week 16 to 52|Lost to Follow-up|0|||
33299000|NCT01309737|62675178|FG003|Week 16 to 52|Lost to Follow-up|1|||
33299001|NCT01309737|62675179|FG004|Week 16 to 52|Lost to Follow-up|4|||
33299002|NCT01309737|62675175|FG000|Week 16 to 52|Withdrawal by Subject|5|||
33299003|NCT01309737|62675176|FG001|Week 16 to 52|Withdrawal by Subject|6|||
33388859|NCT00620542|62767600|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
33388860|NCT00620542|62767601|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
33388861|NCT00620542|62767602|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
33388862|NCT00620542|62767599|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
33299004|NCT01309737|62675177|FG002|Week 16 to 52|Withdrawal by Subject|0|||
33299005|NCT01309737|62675178|FG003|Week 16 to 52|Withdrawal by Subject|0|||
33299006|NCT01309737|62675179|FG004|Week 16 to 52|Withdrawal by Subject|2|||
33299007|NCT01309737|62675175|FG000|Week 16 to 52|Other|10|||
33299008|NCT01309737|62675176|FG001|Week 16 to 52|Other|12|||
33299009|NCT01309737|62675177|FG002|Week 16 to 52|Other|0|||
33299010|NCT01309737|62675178|FG003|Week 16 to 52|Other|2|||
33299011|NCT01309737|62675179|FG004|Week 16 to 52|Other|0|||
33299012|NCT01074229|62675205|FG000|Overall Study|Lost to Follow-up|1|||
33299013|NCT01074229|62675206|FG001|Overall Study|Lost to Follow-up|0|||
33299014|NCT01074229|62675207|FG002|Overall Study|Lost to Follow-up|0|||
33299015|NCT01074229|62675205|FG000|Overall Study|Change to open surgical procedure|1|||
33299016|NCT01074229|62675206|FG001|Overall Study|Change to open surgical procedure|3|||
33299017|NCT01074229|62675207|FG002|Overall Study|Change to open surgical procedure|4|||
33299018|NCT01106014|62675219|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
33388863|NCT00620542|62767600|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
33489782|NCT00094835|62867893|FG004|Overall Study|Lost to Follow-up|1|||
33489783|NCT00094835|62867894|FG005|Overall Study|Lost to Follow-up|0|||
33489784|NCT00094835|62867895|FG006|Overall Study|Lost to Follow-up|0|||
33299019|NCT01106014|62675220|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
33299020|NCT01106014|62675219|FG000|Overall Study|Adverse Event|78|||
33489785|NCT00094835|62867889|FG000|Overall Study|Death|1|||
33299021|NCT01106014|62675220|FG001|Overall Study|Adverse Event|42|||
33388864|NCT00620542|62767601|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
33388865|NCT00620542|62767602|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
33388866|NCT00620542|62767599|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
33388867|NCT00620542|62767600|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
33299022|NCT01106014|62675219|FG000|Overall Study|Withdrawal by Subject|43|||
33299023|NCT01106014|62675220|FG001|Overall Study|Withdrawal by Subject|37|||
33299024|NCT01106014|62675219|FG000|Overall Study|Administrative reason|7|||
33299025|NCT01106014|62675220|FG001|Overall Study|Administrative reason|6|||
33299026|NCT01106014|62675219|FG000|Overall Study|Lost to Follow-up|2|||
33299027|NCT01106014|62675220|FG001|Overall Study|Lost to Follow-up|3|||
33299028|NCT01073605|62675229|FG000|Overall Study|Ongoing at Cutoff Date|1|||
33299029|NCT01073605|62675230|FG001|Overall Study|Ongoing at Cutoff Date|1|||
33299030|NCT01073605|62675231|FG002|Overall Study|Ongoing at Cutoff Date|0|||
33299031|NCT01073605|62675229|FG000|Overall Study|Adverse Event|2|||
33299032|NCT01073605|62675230|FG001|Overall Study|Adverse Event|1|||
33299033|NCT01073605|62675231|FG002|Overall Study|Adverse Event|0|||
33299034|NCT01073605|62675229|FG000|Overall Study|Lost to Follow-up|3|||
33299035|NCT01073605|62675230|FG001|Overall Study|Lost to Follow-up|4|||
33299036|NCT01073605|62675231|FG002|Overall Study|Lost to Follow-up|9|||
33299037|NCT01073605|62675229|FG000|Overall Study|Other|25|||
33299038|NCT01073605|62675230|FG001|Overall Study|Other|21|||
33299039|NCT01073605|62675231|FG002|Overall Study|Other|29|||
33299040|NCT01073605|62675229|FG000|Overall Study|Withdrawal by Subject|31|||
33299041|NCT01073605|62675230|FG001|Overall Study|Withdrawal by Subject|39|||
33299042|NCT01073605|62675231|FG002|Overall Study|Withdrawal by Subject|22|||
33299043|NCT01073605|62675229|FG000|Overall Study|Randomized But Not Treated|0|||
33299044|NCT01073605|62675230|FG001|Overall Study|Randomized But Not Treated|1|||
33299045|NCT01073605|62675231|FG002|Overall Study|Randomized But Not Treated|1|||
33299046|NCT01073293|62675241|FG000|Overall Study|Lost to Follow-up|0|||
33299047|NCT01073293|62675242|FG001|Overall Study|Lost to Follow-up|1|||
33299048|NCT01073293|62675241|FG000|Overall Study|Withdrawal by Subject|5|||
33299049|NCT01073293|62675242|FG001|Overall Study|Withdrawal by Subject|10|||
33299050|NCT01105936|62675248|FG000|Period 1|Adverse Event|0|||
33299051|NCT01105936|62675249|FG001|Period 1|Adverse Event|0|||
33299052|NCT01105936|62675250|FG002|Period 1|Adverse Event|0|||
33299053|NCT01105936|62675251|FG003|Period 1|Adverse Event|1|||
33299054|NCT01105936|62675248|FG000|Period 2|Adverse Event|1|||
33299055|NCT01105936|62675249|FG001|Period 2|Adverse Event|0|||
33388868|NCT00620542|62767601|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
33388869|NCT00620542|62767602|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
33388870|NCT00620542|62767599|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
33388871|NCT00620542|62767600|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
33388872|NCT00620542|62767601|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
33388873|NCT00620542|62767602|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
33388874|NCT00620542|62767599|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
33388875|NCT00620542|62767600|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
33388876|NCT00620542|62767601|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
33388877|NCT00620542|62767602|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
33388878|NCT00620542|62767599|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
33388879|NCT00620542|62767600|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
33388880|NCT00620542|62767601|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
33388881|NCT00620542|62767602|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
33388882|NCT00620542|62767599|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
33388883|NCT00620542|62767600|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
33388884|NCT00620542|62767601|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
33388885|NCT00620542|62767602|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
33388886|NCT00620542|62767599|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
33388887|NCT00620542|62767600|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
33388888|NCT00620542|62767601|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
33388889|NCT00620542|62767602|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
33388890|NCT00620542|62767599|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
33388891|NCT00620542|62767600|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
33388892|NCT00620542|62767601|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
33388893|NCT00620542|62767602|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
33388894|NCT00620542|62767599|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
33388895|NCT00620542|62767600|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
33299056|NCT01105936|62675250|FG002|Period 2|Adverse Event|0|||
33299057|NCT01105936|62675251|FG003|Period 2|Adverse Event|0|||
33299058|NCT01105936|62675248|FG000|Period 3|Protocol Violation|0|||
33299059|NCT01105936|62675249|FG001|Period 3|Protocol Violation|2|||
33388896|NCT00620542|62767601|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
33299060|NCT01105936|62675250|FG002|Period 3|Protocol Violation|0|||
33299061|NCT01105936|62675251|FG003|Period 3|Protocol Violation|0|||
33299062|NCT01309659|62675262|FG000|Overall Study|Protocol Violation|0|||
33299063|NCT01309659|62675263|FG001|Overall Study|Protocol Violation|1|||
33299064|NCT01104766|62675273|FG000|Overall Study|Did not meet inc/exc criteria|1|||
33388897|NCT00620542|62767602|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
33388898|NCT00620542|62767599|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
33388899|NCT00620542|62767600|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
33388900|NCT00620542|62767601|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
33388901|NCT00620542|62767602|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
33388902|NCT00620542|62767599|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
33388903|NCT00620542|62767600|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
33388904|NCT00620542|62767601|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
33388905|NCT00620542|62767602|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
33388906|NCT05096208|62767614|FG000|Overall Study|Lost to Follow-up|3|||
33388907|NCT05096208|62767615|FG001|Overall Study|Lost to Follow-up|5|||
33388908|NCT05096208|62767616|FG002|Overall Study|Lost to Follow-up|5|||
33388909|NCT05096208|62767617|FG003|Overall Study|Lost to Follow-up|2|||
33388910|NCT05096208|62767614|FG000|Overall Study|Withdrawal by Subject|0|||
33388911|NCT05096208|62767615|FG001|Overall Study|Withdrawal by Subject|1|||
33388912|NCT05096208|62767616|FG002|Overall Study|Withdrawal by Subject|2|||
33388913|NCT05096208|62767617|FG003|Overall Study|Withdrawal by Subject|3|||
33388914|NCT05096208|62767614|FG000|Overall Study|No longer met eligibility criteria|1|||
33388915|NCT05096208|62767615|FG001|Overall Study|No longer met eligibility criteria|0|||
33388916|NCT05096208|62767616|FG002|Overall Study|No longer met eligibility criteria|0|||
33388917|NCT05096208|62767617|FG003|Overall Study|No longer met eligibility criteria|0|||
33388918|NCT05096208|62767614|FG000|Overall Study|Other|0|||
33388919|NCT05096208|62767615|FG001|Overall Study|Other|0|||
33388920|NCT05096208|62767616|FG002|Overall Study|Other|1|||
33388921|NCT05096208|62767617|FG003|Overall Study|Other|0|||
33388922|NCT04555616|62767636|FG000|Overall Study|Death|1|||
33388923|NCT04555616|62767637|FG001|Overall Study|Death|0|||
33388924|NCT04555616|62767638|FG002|Overall Study|Death|1|||
33388925|NCT04555616|62767636|FG000|Overall Study|Withdrawal by Subject|2|||
33388926|NCT04555616|62767637|FG001|Overall Study|Withdrawal by Subject|1|||
33388927|NCT04555616|62767638|FG002|Overall Study|Withdrawal by Subject|0|||
33388928|NCT04177758|62767662|FG000|Overall Study|Lost to Follow-up|19|||
33388929|NCT04177758|62767663|FG001|Overall Study|Lost to Follow-up|11|||
33388930|NCT04003103|62767672|FG000|Overall Study|Death|1|||
33388931|NCT04003103|62767673|FG001|Overall Study|Death|0|||
33388932|NCT04003103|62767674|FG002|Overall Study|Death|0|||
33388933|NCT04003103|62767672|FG000|Overall Study|Lost to Follow-up|4|||
33388934|NCT04003103|62767673|FG001|Overall Study|Lost to Follow-up|3|||
33299065|NCT01104766|62675274|FG001|Overall Study|Did not meet inc/exc criteria|0|||
33299066|NCT01104766|62675275|FG002|Overall Study|Did not meet inc/exc criteria|0|||
33299067|NCT01104766|62675276|FG003|Overall Study|Did not meet inc/exc criteria|0|||
33299068|NCT01104766|62675273|FG000|Overall Study|Adverse Event|17|||
33299069|NCT01104766|62675274|FG001|Overall Study|Adverse Event|15|||
33299070|NCT01104766|62675275|FG002|Overall Study|Adverse Event|20|||
33299071|NCT01104766|62675276|FG003|Overall Study|Adverse Event|14|||
33299072|NCT01104766|62675273|FG000|Overall Study|Lack of Efficacy|20|||
33299073|NCT01104766|62675274|FG001|Overall Study|Lack of Efficacy|15|||
33299074|NCT01104766|62675275|FG002|Overall Study|Lack of Efficacy|14|||
33299075|NCT01104766|62675276|FG003|Overall Study|Lack of Efficacy|8|||
33299076|NCT01104766|62675273|FG000|Overall Study|Protocol Violation|2|||
33299077|NCT01104766|62675274|FG001|Overall Study|Protocol Violation|0|||
33299078|NCT01104766|62675275|FG002|Overall Study|Protocol Violation|0|||
33299079|NCT01104766|62675276|FG003|Overall Study|Protocol Violation|0|||
33299080|NCT01104766|62675273|FG000|Overall Study|Withdrawal by Subject|17|||
33299081|NCT01104766|62675274|FG001|Overall Study|Withdrawal by Subject|19|||
33299082|NCT01104766|62675275|FG002|Overall Study|Withdrawal by Subject|25|||
33299083|NCT01104766|62675276|FG003|Overall Study|Withdrawal by Subject|15|||
33299084|NCT01104766|62675273|FG000|Overall Study|Lost to Follow-up|1|||
33299085|NCT01104766|62675274|FG001|Overall Study|Lost to Follow-up|2|||
33299086|NCT01104766|62675275|FG002|Overall Study|Lost to Follow-up|1|||
33299087|NCT01104766|62675276|FG003|Overall Study|Lost to Follow-up|1|||
33299088|NCT01104376|62675286|FG000|Overall Study|Withdrawal by Subject|15|||
33299089|NCT01104376|62675286|FG000|Overall Study|Consented but excluded after labs|13|||
33388935|NCT04003103|62767674|FG002|Overall Study|Lost to Follow-up|2|||
33388936|NCT04003103|62767672|FG000|Overall Study|Withdrawal by Subject|10|||
33388937|NCT04003103|62767673|FG001|Overall Study|Withdrawal by Subject|1|||
33388938|NCT04003103|62767674|FG002|Overall Study|Withdrawal by Subject|1|||
33388939|NCT04003103|62767672|FG000|Overall Study|Status not recorded|0|||
33388940|NCT04003103|62767673|FG001|Overall Study|Status not recorded|2|||
33388941|NCT04003103|62767674|FG002|Overall Study|Status not recorded|0|||
33388942|NCT03921528|62767723|FG000|Overall Study|Withdrawal by Subject|0|||
33388943|NCT03921528|62767724|FG001|Overall Study|Withdrawal by Subject|1|||
33388944|NCT03921528|62767725|FG002|Overall Study|Withdrawal by Subject|0|||
33299090|NCT01072357|62675292|FG000|Overall Study|Lost to Follow-up|0|||
33299091|NCT01072357|62675293|FG001|Overall Study|Lost to Follow-up|1|||
33299092|NCT01072201|62675301|FG000|Overall Study|Lost to Follow-up|0|||
33388945|NCT03921528|62767726|FG003|Overall Study|Withdrawal by Subject|0|||
33299093|NCT01072201|62675302|FG001|Overall Study|Lost to Follow-up|1|||
33299094|NCT01103362|62675308|FG000|Overall Study|study terminated|596|||
33299095|NCT01103284|62675314|FG000|Overall Study|Death|2|||
33299096|NCT01103284|62675315|FG001|Overall Study|Death|0|||
33299097|NCT01103284|62675314|FG000|Overall Study|Lost to Follow-up|9|||
33299098|NCT01103284|62675315|FG001|Overall Study|Lost to Follow-up|10|||
33299099|NCT01103284|62675314|FG000|Overall Study|Pregnancy|3|||
33388946|NCT03921528|62767727|FG004|Overall Study|Withdrawal by Subject|0|||
33388947|NCT03832322|62767745|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
33388948|NCT03832322|62767746|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
33388949|NCT03642990|62767762|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
33388950|NCT03642990|62767762|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
33388951|NCT03639311|62767768|FG000|Overall Study|Ongoing at the time of analysis|88|||
33388952|NCT03639311|62767769|FG001|Overall Study|Ongoing at the time of analysis|0|||
33388953|NCT03639311|62767768|FG000|Overall Study|Lost to Follow-up|1|||
33388954|NCT03639311|62767769|FG001|Overall Study|Lost to Follow-up|0|||
33388955|NCT03639311|62767768|FG000|Overall Study|Adverse Event|1|||
33388956|NCT03639311|62767769|FG001|Overall Study|Adverse Event|0|||
33388957|NCT03633825|62767780|FG000|Enrollment|Did not post on network|5066|||
33388958|NCT03633825|62767781|FG001|Enrollment|Did not post on network|5080|||
33388959|NCT03633825|62767780|FG000|Enrollment|Post not classified as crisis|13967|||
33388960|NCT03633825|62767781|FG001|Enrollment|Post not classified as crisis|13757|||
33388961|NCT03633825|62767780|FG000|Follow up|Lost to Follow-up|478|||
33388962|NCT03633825|62767781|FG001|Follow up|Lost to Follow-up|450|||
33388963|NCT03465540|62767793|FG000|Overall Study|Withdrawal by Subject|0|||
33388964|NCT03465540|62767794|FG001|Overall Study|Withdrawal by Subject|0|||
33388965|NCT03465540|62767795|FG002|Overall Study|Withdrawal by Subject|1|||
33388966|NCT03465540|62767796|FG003|Overall Study|Withdrawal by Subject|1|||
33388967|NCT03465540|62767797|FG004|Overall Study|Withdrawal by Subject|1|||
33388968|NCT03465540|62767798|FG005|Overall Study|Withdrawal by Subject|0|||
33388969|NCT03465540|62767793|FG000|Overall Study|Lost to Follow-up|0|||
33388970|NCT03465540|62767794|FG001|Overall Study|Lost to Follow-up|1|||
33388971|NCT03465540|62767795|FG002|Overall Study|Lost to Follow-up|0|||
33388972|NCT03465540|62767796|FG003|Overall Study|Lost to Follow-up|0|||
33388973|NCT03465540|62767797|FG004|Overall Study|Lost to Follow-up|1|||
33388974|NCT03465540|62767798|FG005|Overall Study|Lost to Follow-up|0|||
33388975|NCT03465540|62767793|FG000|Overall Study|Death|1|||
33388976|NCT03465540|62767794|FG001|Overall Study|Death|1|||
33388977|NCT03465540|62767795|FG002|Overall Study|Death|0|||
33388978|NCT03465540|62767796|FG003|Overall Study|Death|2|||
33388979|NCT03465540|62767797|FG004|Overall Study|Death|0|||
33388980|NCT03465540|62767798|FG005|Overall Study|Death|2|||
33388981|NCT03465540|62767793|FG000|Overall Study|Protocol specified criteria|0|||
33388982|NCT03465540|62767794|FG001|Overall Study|Protocol specified criteria|2|||
33388983|NCT03465540|62767795|FG002|Overall Study|Protocol specified criteria|2|||
33388984|NCT03465540|62767796|FG003|Overall Study|Protocol specified criteria|0|||
33388985|NCT03465540|62767797|FG004|Overall Study|Protocol specified criteria|2|||
33388986|NCT03465540|62767798|FG005|Overall Study|Protocol specified criteria|0|||
33388987|NCT03055832|62767846|FG000|Week 2|Withdrawal by Subject|1|||
33388988|NCT03055832|62767847|FG001|Week 2|Withdrawal by Subject|0|||
33388989|NCT03052049|62767867|FG000|Overall Study|Withdrawal by Subject|2|||
33388990|NCT02771275|62767892|FG000|Overall Study|Reoperation|2|||
33388991|NCT02771275|62767892|FG000|Overall Study|On Study|11|||
33388992|NCT02768870|62767896|FG000|Overall Study|Not Implanted with Device|2|||
33388993|NCT02768870|62767896|FG000|Overall Study|Death|1|||
33388994|NCT02768870|62767896|FG000|Overall Study|Reoperation|4|||
33388995|NCT02768870|62767896|FG000|Overall Study|On Study|19|||
33388996|NCT02750618|62767900|FG000|Overall Study|Withdrawal by Subject|1|||
33388997|NCT02537431|62767904|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
33299100|NCT01103284|62675315|FG001|Overall Study|Pregnancy|1|||
33299101|NCT01103284|62675314|FG000|Overall Study|Protocol Violation|12|||
33299102|NCT01103284|62675315|FG001|Overall Study|Protocol Violation|5|||
33299103|NCT01103284|62675314|FG000|Overall Study|Adverse Event|0|||
33299104|NCT01103284|62675315|FG001|Overall Study|Adverse Event|5|||
33388998|NCT02526160|62767910|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
33388999|NCT02526160|62767911|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
33389000|NCT02526160|62767910|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
33389001|NCT02526160|62767911|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
33389002|NCT02526160|62767910|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
33389003|NCT02526160|62767911|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
33389004|NCT02526160|62767910|FG000|Open-Label Treatment Extension Period I|Death|0|||
33389005|NCT02526160|62767911|FG001|Open-Label Treatment Extension Period I|Death|1|||
33389006|NCT02526160|62767910|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
33299105|NCT01103284|62675314|FG000|Overall Study|Withdrawal by Subject|14|||
33299106|NCT01103284|62675315|FG001|Overall Study|Withdrawal by Subject|18|||
33299107|NCT01103284|62675314|FG000|Overall Study|Dermal Hypersensitivity|0|||
33389007|NCT02526160|62767911|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
33389008|NCT02526160|62767910|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
33389009|NCT02526160|62767911|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
33389010|NCT02526160|62767910|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
33389011|NCT02526160|62767911|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
33389012|NCT02526160|62767910|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
33389013|NCT02526160|62767911|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
33389014|NCT02432196|62767922|FG000|Overall Study|Not Implanted with Device|1|||
33389015|NCT02432196|62767922|FG000|Overall Study|Death|2|||
33389016|NCT02432196|62767922|FG000|Overall Study|Reoperation|3|||
33389017|NCT02432196|62767922|FG000|Overall Study|On Study|20|||
33389018|NCT02157610|62767937|FG000|Overall Study|Death|4|||
33389019|NCT02157610|62767938|FG001|Overall Study|Death|4|||
33389020|NCT01511250|62767972|FG000|Overall Study|Withdrawal of Consent|1|||
33389021|NCT01511250|62767973|FG001|Overall Study|Withdrawal of Consent|0|||
33389022|NCT01511250|62767974|FG002|Overall Study|Withdrawal of Consent|0|||
33389023|NCT01511250|62767975|FG003|Overall Study|Withdrawal of Consent|0|||
33389024|NCT01511250|62767976|FG004|Overall Study|Withdrawal of Consent|0|||
33389025|NCT01511250|62767977|FG005|Overall Study|Withdrawal of Consent|0|||
33389026|NCT01511250|62767978|FG006|Overall Study|Withdrawal of Consent|0|||
33389027|NCT01511250|62767979|FG007|Overall Study|Withdrawal of Consent|1|||
33389028|NCT01511250|62767980|FG008|Overall Study|Withdrawal of Consent|1|||
33299108|NCT01103284|62675315|FG001|Overall Study|Dermal Hypersensitivity|1|||
33299109|NCT01103284|62675314|FG000|Overall Study|Termination by the Sponsor|0|||
33299110|NCT01103284|62675315|FG001|Overall Study|Termination by the Sponsor|1|||
33299111|NCT01103284|62675314|FG000|Overall Study|Not described|2|||
33299112|NCT01103284|62675315|FG001|Overall Study|Not described|1|||
33299113|NCT01103284|62675314|FG000|Overall Study|Missing CRF entries for study completion|0|||
33299114|NCT01103284|62675315|FG001|Overall Study|Missing CRF entries for study completion|2|||
33299115|NCT01070953|62675321|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
33299116|NCT01070953|62675321|FG000|Participants for Safety Evaluation|Off-label use|283|||
33299117|NCT01070953|62675321|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
33299118|NCT01070953|62675321|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
33299119|NCT01070953|62675321|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
33299120|NCT01070953|62675321|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
33299121|NCT01070953|62675321|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
33389029|NCT01511250|62767981|FG009|Overall Study|Withdrawal of Consent|0|||
33389030|NCT01511250|62767972|FG000|Overall Study|Sponsor/Investigator Decision|1|||
33389031|NCT01511250|62767973|FG001|Overall Study|Sponsor/Investigator Decision|0|||
33389032|NCT01511250|62767974|FG002|Overall Study|Sponsor/Investigator Decision|0|||
33389033|NCT01511250|62767975|FG003|Overall Study|Sponsor/Investigator Decision|0|||
33389034|NCT01511250|62767976|FG004|Overall Study|Sponsor/Investigator Decision|0|||
33389035|NCT01511250|62767977|FG005|Overall Study|Sponsor/Investigator Decision|0|||
33389036|NCT01511250|62767978|FG006|Overall Study|Sponsor/Investigator Decision|0|||
33389037|NCT01511250|62767979|FG007|Overall Study|Sponsor/Investigator Decision|0|||
33389038|NCT01511250|62767980|FG008|Overall Study|Sponsor/Investigator Decision|0|||
33389039|NCT01511250|62767981|FG009|Overall Study|Sponsor/Investigator Decision|0|||
33389040|NCT01511250|62767972|FG000|Overall Study|Lost to Follow-up|7|||
33389041|NCT01511250|62767973|FG001|Overall Study|Lost to Follow-up|3|||
33389042|NCT01511250|62767974|FG002|Overall Study|Lost to Follow-up|3|||
33389043|NCT01511250|62767975|FG003|Overall Study|Lost to Follow-up|3|||
33389044|NCT01511250|62767976|FG004|Overall Study|Lost to Follow-up|0|||
33389045|NCT01511250|62767977|FG005|Overall Study|Lost to Follow-up|0|||
33389046|NCT01511250|62767978|FG006|Overall Study|Lost to Follow-up|2|||
33389047|NCT01511250|62767979|FG007|Overall Study|Lost to Follow-up|3|||
33389048|NCT01511250|62767980|FG008|Overall Study|Lost to Follow-up|13|||
33389049|NCT01511250|62767981|FG009|Overall Study|Lost to Follow-up|5|||
33389050|NCT01511250|62767972|FG000|Overall Study|Protocol Violation|0|||
33389051|NCT01511250|62767973|FG001|Overall Study|Protocol Violation|2|||
33389052|NCT01511250|62767974|FG002|Overall Study|Protocol Violation|1|||
33299122|NCT01070953|62675321|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
33299123|NCT01070953|62675321|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
33299124|NCT01070953|62675321|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
33299125|NCT01089361|62675333|FG000|Overall Study|Death|1|||
33299126|NCT01089361|62675334|FG001|Overall Study|Death|0|||
33299127|NCT01102972|62675344|FG000|Overall Study|Adverse Event|8|||
33389053|NCT01511250|62767975|FG003|Overall Study|Protocol Violation|0|||
33389054|NCT01511250|62767976|FG004|Overall Study|Protocol Violation|0|||
33389055|NCT01511250|62767977|FG005|Overall Study|Protocol Violation|0|||
33389056|NCT01511250|62767978|FG006|Overall Study|Protocol Violation|0|||
33389057|NCT01511250|62767979|FG007|Overall Study|Protocol Violation|0|||
33389058|NCT01511250|62767980|FG008|Overall Study|Protocol Violation|0|||
33389059|NCT01511250|62767981|FG009|Overall Study|Protocol Violation|0|||
33389060|NCT01424566|62768003|FG000|Single-blind Treatment|Adverse Event|71|||
33389061|NCT01424566|62768004|FG001|Single-blind Treatment|Adverse Event|0|||
33389062|NCT01424566|62768005|FG002|Single-blind Treatment|Adverse Event|0|||
33389063|NCT01424566|62768003|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
33389064|NCT01424566|62768004|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
33389065|NCT01424566|62768005|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
33389066|NCT01424566|62768003|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
33389067|NCT01424566|62768004|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
33389068|NCT01424566|62768005|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
33389069|NCT01424566|62768003|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
33389070|NCT01424566|62768004|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
33389071|NCT01424566|62768005|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
33389072|NCT01424566|62768003|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
33389073|NCT01424566|62768004|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
33389074|NCT01424566|62768005|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
33389075|NCT01424566|62768003|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
33389076|NCT01424566|62768004|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
33389077|NCT01424566|62768005|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
33389078|NCT01424566|62768003|FG000|Double-blind Treatment|Adverse Event|0|||
33389079|NCT01424566|62768004|FG001|Double-blind Treatment|Adverse Event|21|||
33389080|NCT01424566|62768005|FG002|Double-blind Treatment|Adverse Event|13|||
33389081|NCT01424566|62768003|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
33389082|NCT01424566|62768004|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
33389083|NCT01424566|62768005|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
33389084|NCT01424566|62768003|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
33389085|NCT01424566|62768004|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
33389086|NCT01424566|62768005|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
33389087|NCT01424566|62768003|FG000|Double-blind Treatment|Lack of Efficacy|0|||
33389088|NCT01424566|62768004|FG001|Double-blind Treatment|Lack of Efficacy|1|||
33389089|NCT01424566|62768005|FG002|Double-blind Treatment|Lack of Efficacy|1|||
33389090|NCT01361607|62768014|FG000|Overall Study|Adverse Event|38|||
33389091|NCT01361607|62768015|FG001|Overall Study|Adverse Event|29|||
33389092|NCT01361607|62768014|FG000|Overall Study|Withdrawal by Subject|19|||
33389093|NCT01361607|62768015|FG001|Overall Study|Withdrawal by Subject|8|||
33389094|NCT01361607|62768014|FG000|Overall Study|Withdrawal by Investigator|5|||
33389095|NCT01361607|62768015|FG001|Overall Study|Withdrawal by Investigator|3|||
33389096|NCT01361607|62768014|FG000|Overall Study|Lost to Follow-up|1|||
33389097|NCT01361607|62768015|FG001|Overall Study|Lost to Follow-up|0|||
33389098|NCT01361607|62768014|FG000|Overall Study|Met Withdrawal Criteria|1|||
33389099|NCT01361607|62768015|FG001|Overall Study|Met Withdrawal Criteria|1|||
33389100|NCT01337089|62768022|FG000|Overall Study|Adverse Event|237|||
33389101|NCT01337089|62768022|FG000|Overall Study|Withdrawal by Subject|129|||
33389102|NCT01337089|62768022|FG000|Overall Study|Withdrawal by Investigator|33|||
33389103|NCT01337089|62768022|FG000|Overall Study|Met Withdrawal Criteria|3|||
33389104|NCT01337089|62768022|FG000|Overall Study|Lost to Follow-up|2|||
33389105|NCT00114530|62768036|FG000|Overall Study|Death|3|||
33389106|NCT00114530|62768037|FG001|Overall Study|Death|11|||
33389107|NCT00114530|62768036|FG000|Overall Study|Lost to Follow-up|1|||
33389108|NCT00114530|62768037|FG001|Overall Study|Lost to Follow-up|1|||
33389109|NCT00114530|62768036|FG000|Overall Study|Physician Decision|1|||
33389110|NCT00114530|62768037|FG001|Overall Study|Physician Decision|1|||
33389111|NCT00114530|62768036|FG000|Overall Study|Withdrawal by Subject|2|||
33389112|NCT00114530|62768037|FG001|Overall Study|Withdrawal by Subject|6|||
33389113|NCT00114530|62768036|FG000|Overall Study|Breast Cancer|1|||
33389114|NCT00114530|62768037|FG001|Overall Study|Breast Cancer|0|||
33299128|NCT01102972|62675345|FG001|Overall Study|Adverse Event|2|||
33299129|NCT01102972|62675344|FG000|Overall Study|Lack of Efficacy|2|||
33299130|NCT01102972|62675345|FG001|Overall Study|Lack of Efficacy|1|||
33299131|NCT01102972|62675344|FG000|Overall Study|Protocol Violation|1|||
33299132|NCT01102972|62675345|FG001|Overall Study|Protocol Violation|0|||
33299133|NCT01102972|62675344|FG000|Overall Study|Lost to Follow-up|10|||
33299134|NCT01102972|62675345|FG001|Overall Study|Lost to Follow-up|5|||
33299135|NCT01102972|62675344|FG000|Overall Study|Investigator Discretion|2|||
33299136|NCT01102972|62675345|FG001|Overall Study|Investigator Discretion|0|||
33389115|NCT00114530|62768036|FG000|Overall Study|Subject decision after endpoint failure|0|||
33389116|NCT00114530|62768037|FG001|Overall Study|Subject decision after endpoint failure|1|||
33389117|NCT00114530|62768036|FG000|Overall Study|Ineligible|1|||
33389118|NCT00114530|62768037|FG001|Overall Study|Ineligible|0|||
33389119|NCT00618982|62768060|FG000|Overall Study|Adverse Event|23|||
33299137|NCT01102972|62675344|FG000|Overall Study|Withdrawal by Subject|6|||
33389120|NCT00618982|62768060|FG000|Overall Study|Withdrawal by Subject|1|||
33389121|NCT00618982|62768060|FG000|Overall Study|Protocol Violation|1|||
33389122|NCT00618982|62768060|FG000|Overall Study|ongoing, still treated with study med.|25|||
33299138|NCT01102972|62675345|FG001|Overall Study|Withdrawal by Subject|6|||
33389123|NCT00578786|62768070|FG000|Overall Study|Adverse Event|27|||
33389124|NCT00578786|62768071|FG001|Overall Study|Adverse Event|37|||
33389125|NCT00578786|62768072|FG002|Overall Study|Adverse Event|17|||
33389126|NCT00578786|62768070|FG000|Overall Study|Lack of Efficacy|2|||
33389127|NCT00578786|62768071|FG001|Overall Study|Lack of Efficacy|5|||
33389128|NCT00578786|62768072|FG002|Overall Study|Lack of Efficacy|2|||
33389129|NCT00578786|62768070|FG000|Overall Study|Early Escape from Prior Study|2|||
33389130|NCT00578786|62768071|FG001|Overall Study|Early Escape from Prior Study|1|||
33389131|NCT00578786|62768072|FG002|Overall Study|Early Escape from Prior Study|2|||
33389132|NCT00578786|62768070|FG000|Overall Study|Withdrawal by Subject|7|||
33389133|NCT00578786|62768071|FG001|Overall Study|Withdrawal by Subject|8|||
33389134|NCT00578786|62768072|FG002|Overall Study|Withdrawal by Subject|5|||
33389135|NCT00578786|62768070|FG000|Overall Study|Protocol Violation|0|||
33389136|NCT00578786|62768071|FG001|Overall Study|Protocol Violation|3|||
33389137|NCT00578786|62768072|FG002|Overall Study|Protocol Violation|1|||
33389138|NCT00578786|62768070|FG000|Overall Study|Physician Decision|1|||
33389139|NCT00578786|62768071|FG001|Overall Study|Physician Decision|0|||
33389140|NCT00578786|62768072|FG002|Overall Study|Physician Decision|1|||
33299139|NCT01309269|62675351|FG000|Overall Study|Adverse Event|56|||
33299140|NCT01309269|62675351|FG000|Overall Study|Withdrawal by Subject|25|||
33299141|NCT01309269|62675351|FG000|Overall Study|Lack of Acceptance|15|||
33389141|NCT00578786|62768070|FG000|Overall Study|Sponsor Decision|0|||
33389142|NCT00578786|62768071|FG001|Overall Study|Sponsor Decision|0|||
33389143|NCT00578786|62768072|FG002|Overall Study|Sponsor Decision|1|||
33389144|NCT00578786|62768070|FG000|Overall Study|Lost to Follow-up|0|||
33389145|NCT00578786|62768071|FG001|Overall Study|Lost to Follow-up|4|||
33389146|NCT00578786|62768072|FG002|Overall Study|Lost to Follow-up|0|||
33389147|NCT00578786|62768070|FG000|Overall Study|Pregnancy|0|||
33389148|NCT00578786|62768071|FG001|Overall Study|Pregnancy|1|||
33389149|NCT00578786|62768072|FG002|Overall Study|Pregnancy|0|||
33389150|NCT00578786|62768070|FG000|Overall Study|Not Otherwise Specified|0|||
33389151|NCT00578786|62768071|FG001|Overall Study|Not Otherwise Specified|4|||
33389152|NCT00578786|62768072|FG002|Overall Study|Not Otherwise Specified|1|||
33389153|NCT00578786|62768070|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
33389154|NCT00578786|62768071|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
33299142|NCT01309269|62675351|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
33299143|NCT01309269|62675351|FG000|Overall Study|Kidney Transplant|25|||
33299144|NCT01309269|62675351|FG000|Overall Study|Administrative Problems|141|||
33389155|NCT00578786|62768072|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
33389156|NCT00424255|62768092|FG000|Overall Study|Death|115|||
33389157|NCT00424255|62768093|FG001|Overall Study|Death|111|||
33389158|NCT00424255|62768092|FG000|Overall Study|Lost to Follow-up|26|||
33389159|NCT00424255|62768093|FG001|Overall Study|Lost to Follow-up|20|||
33389160|NCT00424255|62768092|FG000|Overall Study|Protocol Violation|0|||
33389161|NCT00424255|62768093|FG001|Overall Study|Protocol Violation|1|||
33389162|NCT00424255|62768092|FG000|Overall Study|Withdrawal by Subject|34|||
33389163|NCT00424255|62768093|FG001|Overall Study|Withdrawal by Subject|38|||
33299145|NCT01309269|62675351|FG000|Overall Study|Other|256|||
33299146|NCT01309269|62675351|FG000|Overall Study|Other|1|||
33299147|NCT01309269|62675351|FG000|Overall Study|Study Completion Data Not Recorded|95|||
33299148|NCT01309269|62675351|FG000|Overall Study|Enrolled but not Treated|107|||
33299149|NCT01088503|62675358|FG000|Overall Study|Withdrawal by Subject|118|||
33299150|NCT01088503|62675359|FG001|Overall Study|Withdrawal by Subject|327|||
33299151|NCT01088503|62675360|FG002|Overall Study|Withdrawal by Subject|10|||
33299152|NCT01088503|62675358|FG000|Overall Study|Death|64|||
33299153|NCT01088503|62675359|FG001|Overall Study|Death|358|||
33299154|NCT01088503|62675360|FG002|Overall Study|Death|7|||
33299155|NCT01087489|62675366|FG000|Overall Study|enrolled in another VA study|0|||
33299156|NCT01087489|62675367|FG001|Overall Study|enrolled in another VA study|1|||
33299157|NCT01087489|62675366|FG000|Overall Study|Death|0|||
33299158|NCT01087489|62675367|FG001|Overall Study|Death|1|||
33299159|NCT01087489|62675366|FG000|Overall Study|unable to survey by telephone|0|||
33389164|NCT00424255|62768092|FG000|Overall Study|Physician Decision|3|||
33389165|NCT00424255|62768093|FG001|Overall Study|Physician Decision|7|||
33389166|NCT00424255|62768092|FG000|Overall Study|Cognitive Disturbance|1|||
33299160|NCT01087489|62675367|FG001|Overall Study|unable to survey by telephone|1|||
33389167|NCT00424255|62768093|FG001|Overall Study|Cognitive Disturbance|0|||
33389168|NCT00424255|62768092|FG000|Overall Study|Non-compliance by Participants|1|||
33389169|NCT00424255|62768093|FG001|Overall Study|Non-compliance by Participants|0|||
33389170|NCT00424255|62768092|FG000|Overall Study|Fatigue|1|||
33389171|NCT00424255|62768093|FG001|Overall Study|Fatigue|0|||
33389172|NCT00424255|62768092|FG000|Overall Study|Disease Progression|0|||
33299161|NCT01082965|62675375|FG000|Overall Study|Protocol Violation|0|||
33299162|NCT01082965|62675376|FG001|Overall Study|Protocol Violation|1|||
33299163|NCT01082965|62675375|FG000|Overall Study|Other|1|||
33389173|NCT00424255|62768093|FG001|Overall Study|Disease Progression|2|||
33389174|NCT00424255|62768092|FG000|Overall Study|Sponsor Terminated Study|161|||
33389175|NCT00424255|62768093|FG001|Overall Study|Sponsor Terminated Study|167|||
33389176|NCT00620074|62768099|FG000|Overall Study|Adverse Event|1|||
33389177|NCT00424177|62768103|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
33389178|NCT00424177|62768103|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
33389179|NCT00424177|62768103|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
33389180|NCT00424177|62768103|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
33389181|NCT00424177|62768103|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
33389182|NCT00424177|62768103|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
33389183|NCT00424177|62768103|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
33389184|NCT00424177|62768103|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
33389185|NCT00424177|62768103|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
33389186|NCT00424177|62768103|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
33389187|NCT00618826|62768115|FG000|Overall Study|Adverse Event|1|||
33556813|NCT01594970|62949688|FG001|Overall Study|Non-Adverse Event Related|5|||
33556814|NCT01594970|62949689|FG002|Overall Study|Non-Adverse Event Related|6|||
33556815|NCT01594970|62949687|FG000|Overall Study|Adverse Event|17|||
33556816|NCT01594970|62949688|FG001|Overall Study|Adverse Event|23|||
33556817|NCT01594970|62949689|FG002|Overall Study|Adverse Event|23|||
33556818|NCT01594970|62949687|FG000|Overall Study|Lost to Follow-up|54|||
33299164|NCT01082965|62675376|FG001|Overall Study|Other|1|||
33299165|NCT01102426|62675384|FG000|Overall Study|Randomized but not treated|4|||
33299166|NCT01102426|62675385|FG001|Overall Study|Randomized but not treated|1|||
33389188|NCT00578448|62768120|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
33389189|NCT00578448|62768120|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
33389190|NCT00578448|62768120|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
33389191|NCT00578448|62768120|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
33389192|NCT00578318|62768128|FG000|Overall Study|Lost to Follow-up|2|||
33389193|NCT00578318|62768129|FG001|Overall Study|Lost to Follow-up|0|||
33389194|NCT00578318|62768128|FG000|Overall Study|Physician Decision|1|||
33389195|NCT00578318|62768129|FG001|Overall Study|Physician Decision|0|||
33389196|NCT00618748|62768138|FG000|Overall Study|Adverse Event|4|||
33389197|NCT00618748|62768139|FG001|Overall Study|Adverse Event|3|||
33389198|NCT00618748|62768140|FG002|Overall Study|Adverse Event|8|||
33389199|NCT00618748|62768138|FG000|Overall Study|Physician Decision|3|||
33389200|NCT00618748|62768139|FG001|Overall Study|Physician Decision|1|||
33389201|NCT00618748|62768140|FG002|Overall Study|Physician Decision|1|||
33389202|NCT00618748|62768138|FG000|Overall Study|Withdrawal by Subject|4|||
33389203|NCT00618748|62768139|FG001|Overall Study|Withdrawal by Subject|1|||
33389204|NCT00618748|62768140|FG002|Overall Study|Withdrawal by Subject|5|||
33389205|NCT00658359|62768151|FG000|Overall Study|Death|3|||
33389206|NCT00658359|62768152|FG001|Overall Study|Death|1|||
33389207|NCT00658359|62768153|FG002|Overall Study|Death|2|||
33389208|NCT00658359|62768151|FG000|Overall Study|Adverse Event|13|||
33389209|NCT00658359|62768152|FG001|Overall Study|Adverse Event|6|||
33389210|NCT00658359|62768153|FG002|Overall Study|Adverse Event|9|||
33389211|NCT00658359|62768151|FG000|Overall Study|Protocol Violation|1|||
33389212|NCT00658359|62768152|FG001|Overall Study|Protocol Violation|0|||
33389213|NCT00658359|62768153|FG002|Overall Study|Protocol Violation|0|||
33299167|NCT01102426|62675384|FG000|Overall Study|Adverse Events (treatment-related)|15|||
33299168|NCT01102426|62675385|FG001|Overall Study|Adverse Events (treatment-related)|8|||
33299169|NCT01102426|62675384|FG000|Overall Study|Physician Decision|9|||
33299170|NCT01102426|62675385|FG001|Overall Study|Physician Decision|6|||
33299171|NCT01102426|62675384|FG000|Overall Study|Progressive Disease|85|||
33299172|NCT01102426|62675385|FG001|Overall Study|Progressive Disease|44|||
33299173|NCT01102426|62675384|FG000|Overall Study|Adverse Events (unrelated to|9|||
33299174|NCT01102426|62675385|FG001|Overall Study|Adverse Events (unrelated to|1|||
33299175|NCT01102426|62675384|FG000|Overall Study|Patient Refusal|24|||
33299176|NCT01102426|62675385|FG001|Overall Study|Patient Refusal|12|||
33299177|NCT01102426|62675384|FG000|Overall Study|Death (due to adverse events|0|||
33299178|NCT01102426|62675385|FG001|Overall Study|Death (due to adverse events|1|||
33389214|NCT00658359|62768151|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
33389215|NCT00658359|62768152|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
33389216|NCT00658359|62768153|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
33389217|NCT00658359|62768151|FG000|Overall Study|Withdrawal by Subject|7|||
33489786|NCT00094835|62867890|FG001|Overall Study|Death|0|||
33489787|NCT00094835|62867891|FG002|Overall Study|Death|0|||
33389218|NCT00658359|62768152|FG001|Overall Study|Withdrawal by Subject|4|||
33389219|NCT00658359|62768153|FG002|Overall Study|Withdrawal by Subject|2|||
33389220|NCT00658359|62768151|FG000|Overall Study|Lost to Follow-up|2|||
33389221|NCT00658359|62768152|FG001|Overall Study|Lost to Follow-up|2|||
33389222|NCT00658359|62768153|FG002|Overall Study|Lost to Follow-up|4|||
33389223|NCT00658359|62768151|FG000|Overall Study|Lack of Efficacy|0|||
33489788|NCT00094835|62867892|FG003|Overall Study|Death|0|||
33489789|NCT00094835|62867893|FG004|Overall Study|Death|1|||
33556819|NCT01594970|62949688|FG001|Overall Study|Lost to Follow-up|54|||
33556820|NCT01594970|62949689|FG002|Overall Study|Lost to Follow-up|37|||
33299179|NCT01102426|62675384|FG000|Overall Study|Death (non-related to the study|19|||
33299180|NCT01102426|62675385|FG001|Overall Study|Death (non-related to the study|8|||
33299181|NCT01101334|62675393|FG000|Overall Study|Adverse Event|9|||
33299182|NCT01101334|62675394|FG001|Overall Study|Adverse Event|4|||
33299183|NCT01101334|62675393|FG000|Overall Study|Death|7|||
33299184|NCT01101334|62675394|FG001|Overall Study|Death|1|||
33299185|NCT01101334|62675393|FG000|Overall Study|Withdrawal by Subject|4|||
33299186|NCT01101334|62675394|FG001|Overall Study|Withdrawal by Subject|3|||
33299187|NCT01101334|62675393|FG000|Overall Study|Withdrawal by Sponsor|1|||
33299188|NCT01101334|62675394|FG001|Overall Study|Withdrawal by Sponsor|1|||
33299189|NCT01101334|62675393|FG000|Overall Study|Progressive Disease|22|||
33389224|NCT00658359|62768152|FG001|Overall Study|Lack of Efficacy|1|||
33389225|NCT00658359|62768153|FG002|Overall Study|Lack of Efficacy|0|||
33299190|NCT01101334|62675394|FG001|Overall Study|Progressive Disease|35|||
33299191|NCT01101334|62675393|FG000|Overall Study|Other|2|||
33389226|NCT00619918|62768165|FG000|Overall Study|Withdrawal by Subject|4|||
33389227|NCT00619918|62768166|FG001|Overall Study|Withdrawal by Subject|3|||
33389228|NCT00619918|62768165|FG000|Overall Study|Physician Decision|8|||
33389229|NCT00619918|62768166|FG001|Overall Study|Physician Decision|8|||
33389230|NCT00619918|62768165|FG000|Overall Study|Transfer to outside facility|3|||
33389231|NCT00619918|62768166|FG001|Overall Study|Transfer to outside facility|3|||
33389232|NCT00619918|62768165|FG000|Overall Study|Left before receiving first dose|5|||
33389233|NCT00619918|62768166|FG001|Overall Study|Left before receiving first dose|8|||
33389234|NCT01005914|62768172|FG000|Overall Study|Adverse Event|4|||
33389235|NCT01005914|62768172|FG000|Overall Study|Death|4|||
33389236|NCT01005914|62768172|FG000|Overall Study|Lack of Efficacy|1|||
33389237|NCT01005914|62768172|FG000|Overall Study|Withdrawal by Subject|1|||
33389238|NCT00618514|62768183|FG000|Overall Study|Lost to Follow-up|11|||
33389239|NCT00618514|62768184|FG001|Overall Study|Lost to Follow-up|12|||
33389240|NCT00618514|62768185|FG002|Overall Study|Lost to Follow-up|4|||
33489790|NCT00094835|62867894|FG005|Overall Study|Death|0|||
33489791|NCT00094835|62867895|FG006|Overall Study|Death|0|||
33489792|NCT00094835|62867889|FG000|Overall Study|Non-compliance|1|||
33489793|NCT00094835|62867890|FG001|Overall Study|Non-compliance|2|||
33489794|NCT00094835|62867891|FG002|Overall Study|Non-compliance|2|||
33489795|NCT00094835|62867892|FG003|Overall Study|Non-compliance|0|||
33489796|NCT00094835|62867893|FG004|Overall Study|Non-compliance|2|||
33489797|NCT00094835|62867894|FG005|Overall Study|Non-compliance|2|||
33489798|NCT00094835|62867895|FG006|Overall Study|Non-compliance|1|||
33489799|NCT00094835|62867889|FG000|Overall Study|Other|1|||
33489800|NCT00094835|62867890|FG001|Overall Study|Other|1|||
33489801|NCT00094835|62867891|FG002|Overall Study|Other|1|||
33489802|NCT00094835|62867892|FG003|Overall Study|Other|1|||
33489803|NCT00094835|62867893|FG004|Overall Study|Other|0|||
33489804|NCT00094835|62867894|FG005|Overall Study|Other|0|||
33489805|NCT00094835|62867895|FG006|Overall Study|Other|0|||
33489806|NCT00094757|62867919|FG000|Overall Study|Adverse Event|11|||
33489807|NCT00094757|62867920|FG001|Overall Study|Adverse Event|9|||
33489808|NCT00094757|62867921|FG002|Overall Study|Adverse Event|6|||
33489809|NCT00094757|62867919|FG000|Overall Study|Lack of Efficacy|11|||
33489810|NCT00094757|62867920|FG001|Overall Study|Lack of Efficacy|15|||
33489811|NCT00094757|62867921|FG002|Overall Study|Lack of Efficacy|8|||
33489812|NCT00094757|62867919|FG000|Overall Study|Lost to Follow-up|3|||
33489813|NCT00094757|62867920|FG001|Overall Study|Lost to Follow-up|5|||
33489814|NCT00094757|62867921|FG002|Overall Study|Lost to Follow-up|6|||
33489815|NCT00094757|62867919|FG000|Overall Study|Patient Moved|2|||
33489816|NCT00094757|62867920|FG001|Overall Study|Patient Moved|1|||
33489817|NCT00094757|62867921|FG002|Overall Study|Patient Moved|1|||
33489818|NCT00094757|62867919|FG000|Overall Study|Protocol Violation|8|||
33489819|NCT00094757|62867920|FG001|Overall Study|Protocol Violation|5|||
33489820|NCT00094757|62867921|FG002|Overall Study|Protocol Violation|3|||
33299192|NCT01101334|62675394|FG001|Overall Study|Other|1|||
33299193|NCT01327547|62675402|FG000|Overall Study|Adverse Event|4|||
33299194|NCT01327547|62675403|FG001|Overall Study|Adverse Event|1|||
33299195|NCT01327547|62675402|FG000|Overall Study|Death|1|||
33299196|NCT01327547|62675403|FG001|Overall Study|Death|2|||
33299197|NCT01327547|62675402|FG000|Overall Study|Lost to Follow-up|6|||
33389241|NCT00655629|62768193|FG000|Overall Study|Adverse Event|4|||
33389242|NCT00655629|62768194|FG001|Overall Study|Adverse Event|1|||
33389243|NCT00655629|62768193|FG000|Overall Study|Lack of Efficacy|2|||
33389244|NCT00655629|62768194|FG001|Overall Study|Lack of Efficacy|12|||
33389245|NCT00655629|62768193|FG000|Overall Study|Lost to Follow-up|4|||
33489821|NCT00094757|62867919|FG000|Overall Study|Withdrawal by Subject|14|||
33489822|NCT00094757|62867920|FG001|Overall Study|Withdrawal by Subject|21|||
33489823|NCT00094757|62867921|FG002|Overall Study|Withdrawal by Subject|5|||
33489824|NCT00094757|62867919|FG000|Overall Study|Other|3|||
33489825|NCT00094757|62867920|FG001|Overall Study|Other|3|||
33489826|NCT00094757|62867921|FG002|Overall Study|Other|1|||
33489827|NCT00094757|62867919|FG000|Overall Study|Protocol specified discontinuation|1|||
33489828|NCT00094757|62867920|FG001|Overall Study|Protocol specified discontinuation|3|||
33489829|NCT00094757|62867921|FG002|Overall Study|Protocol specified discontinuation|0|||
33489830|NCT04378114|62867929|FG000|Overall Study|Withdrawal by Subject|5|||
33299198|NCT01327547|62675403|FG001|Overall Study|Lost to Follow-up|6|||
33299199|NCT01327547|62675402|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
33299200|NCT01327547|62675403|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
33299201|NCT01327547|62675402|FG000|Overall Study|Withdrawal by Subject|3|||
33389246|NCT00655629|62768194|FG001|Overall Study|Lost to Follow-up|3|||
33389247|NCT00655629|62768193|FG000|Overall Study|Protocol Violation|5|||
33389248|NCT00655629|62768194|FG001|Overall Study|Protocol Violation|3|||
33389249|NCT00655629|62768193|FG000|Overall Study|consent withdrawn|6|||
33389250|NCT00655629|62768194|FG001|Overall Study|consent withdrawn|4|||
33389251|NCT00578292|62768200|FG000|Overall Study|Death|1|||
33389252|NCT00578292|62768200|FG000|Overall Study|Graft failure|2|||
33389253|NCT00570063|62768206|FG000|Overall Study|Adverse Event|4|||
33389254|NCT00570063|62768207|FG001|Overall Study|Adverse Event|1|||
33389255|NCT00570063|62768206|FG000|Overall Study|Lack of Efficacy|0|||
33389256|NCT00570063|62768207|FG001|Overall Study|Lack of Efficacy|1|||
33389257|NCT00570063|62768206|FG000|Overall Study|Withdrawal by Subject|4|||
33389258|NCT00570063|62768207|FG001|Overall Study|Withdrawal by Subject|3|||
33389259|NCT00570063|62768206|FG000|Overall Study|Sponsor's Decision|7|||
33389260|NCT00570063|62768207|FG001|Overall Study|Sponsor's Decision|3|||
33389261|NCT00577772|62768224|FG000|Overall Study|Lost to Follow-up|0|||
33389262|NCT00577772|62768225|FG001|Overall Study|Lost to Follow-up|1|||
33389263|NCT00578136|62768233|FG000|Overall Study|Not given intervention|1|||
33389264|NCT00578136|62768234|FG001|Overall Study|Not given intervention|1|||
33389265|NCT00655551|62768243|FG000|All Periods Combined|Adverse Event|0|||
33389266|NCT00655551|62768244|FG001|All Periods Combined|Adverse Event|3|||
33389267|NCT00655551|62768245|FG002|All Periods Combined|Adverse Event|4|||
33389268|NCT00655551|62768243|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
33389269|NCT00655551|62768244|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
33389270|NCT00655551|62768245|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
33389271|NCT00655551|62768243|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
33389272|NCT00655551|62768244|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
33389273|NCT00655551|62768245|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
33389274|NCT00655551|62768243|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
33389275|NCT00655551|62768244|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
33389276|NCT00655551|62768245|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
33389277|NCT00312728|62768253|FG000|Overall Study|Progressive disease|53|||
33389278|NCT00312728|62768253|FG000|Overall Study|Adverse Event|32|||
33389279|NCT00312728|62768253|FG000|Overall Study|Withdrawal by Subject|10|||
33389280|NCT00312728|62768253|FG000|Overall Study|Required non-protocol cancer treatment|2|||
33389281|NCT00312728|62768253|FG000|Overall Study|Protocol Violation|2|||
33389282|NCT00312728|62768253|FG000|Overall Study|Other|10|||
33389283|NCT00312728|62768253|FG000|Overall Study|Other|1|||
33389284|NCT00577824|62768260|FG000|Overall Study|Adverse Event|6|||
33389285|NCT00577824|62768261|FG001|Overall Study|Adverse Event|18|||
33389286|NCT00577824|62768262|FG002|Overall Study|Adverse Event|1|||
33489831|NCT00082433|62867938|FG000|Overall Study|Adverse Event|12|||
33489832|NCT00082433|62867939|FG001|Overall Study|Adverse Event|17|||
33489833|NCT00082433|62867938|FG000|Overall Study|Death|8|||
33489834|NCT00082433|62867939|FG001|Overall Study|Death|18|||
33489835|NCT00082433|62867938|FG000|Overall Study|Disease Progression/Relapse|270|||
33489836|NCT00082433|62867939|FG001|Overall Study|Disease Progression/Relapse|388|||
33489837|NCT00082433|62867938|FG000|Overall Study|Physician Decision|50|||
33489838|NCT00082433|62867939|FG001|Overall Study|Physician Decision|61|||
33489839|NCT00082433|62867938|FG000|Overall Study|Lost to Follow-up|1|||
33489840|NCT00082433|62867939|FG001|Overall Study|Lost to Follow-up|2|||
33489841|NCT00082433|62867938|FG000|Overall Study|Study Drug Toxicity|179|||
33489842|NCT00082433|62867939|FG001|Overall Study|Study Drug Toxicity|66|||
33489843|NCT00082433|62867938|FG000|Overall Study|Withdrawal by Subject|55|||
33556821|NCT02338492|62949697|FG000|Overall Study|Death|32|||
33556822|NCT02338492|62949697|FG000|Overall Study|Adverse Event|3|||
33299202|NCT01327547|62675403|FG001|Overall Study|Withdrawal by Subject|7|||
33299203|NCT01327547|62675402|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
33389287|NCT00577824|62768260|FG000|Overall Study|Patient decision|0|||
33389288|NCT00577824|62768261|FG001|Overall Study|Patient decision|1|||
33389289|NCT00577824|62768262|FG002|Overall Study|Patient decision|1|||
33389290|NCT00577824|62768260|FG000|Overall Study|Protocol Violation|1|||
33389291|NCT00577824|62768261|FG001|Overall Study|Protocol Violation|1|||
33299204|NCT01327547|62675403|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
33389292|NCT00577824|62768262|FG002|Overall Study|Protocol Violation|0|||
33489844|NCT00082433|62867939|FG001|Overall Study|Withdrawal by Subject|30|||
33299205|NCT01327547|62675402|FG000|Overall Study|Protocol Violation|1|||
33299206|NCT01327547|62675403|FG001|Overall Study|Protocol Violation|0|||
33299207|NCT01327547|62675402|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
33389293|NCT00617344|62768273|FG000|Overall Study|Serious adverse event|1|||
33389294|NCT00617344|62768274|FG001|Overall Study|Serious adverse event|0|||
33489845|NCT00082433|62867938|FG000|Overall Study|Still On Treatment|2|||
33489846|NCT00082433|62867939|FG001|Overall Study|Still On Treatment|1|||
33489847|NCT00082433|62867938|FG000|Overall Study|Not Treated|12|||
33556823|NCT02338492|62949697|FG000|Overall Study|Lost to Follow-up|4|||
33299208|NCT01327547|62675403|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
33299209|NCT01327547|62675402|FG000|Overall Study|Required prohibited medication|2|||
33299210|NCT01327547|62675403|FG001|Overall Study|Required prohibited medication|0|||
33299211|NCT01327547|62675402|FG000|Overall Study|Non-compliance with study procedures|1|||
33299212|NCT01327547|62675403|FG001|Overall Study|Non-compliance with study procedures|0|||
33299213|NCT01327547|62675402|FG000|Overall Study|By investigator in subject's interest|0|||
33299214|NCT01327547|62675403|FG001|Overall Study|By investigator in subject's interest|1|||
33299215|NCT01308567|62675425|FG000|Overall Study|Lost to Follow-up|2|||
33389295|NCT00617344|62768275|FG002|Overall Study|Serious adverse event|0|||
33389296|NCT00617344|62768273|FG000|Overall Study|Other Adverse Event|1|||
33389297|NCT00617344|62768274|FG001|Overall Study|Other Adverse Event|1|||
33389298|NCT00617344|62768275|FG002|Overall Study|Other Adverse Event|0|||
33389299|NCT00617344|62768273|FG000|Overall Study|Protocol Violation|10|||
33389300|NCT00617344|62768274|FG001|Overall Study|Protocol Violation|8|||
33299216|NCT01308567|62675426|FG001|Overall Study|Lost to Follow-up|4|||
33299217|NCT01308567|62675427|FG002|Overall Study|Lost to Follow-up|4|||
33299218|NCT01307319|62675438|FG000|Overall Study|Adverse Event|2|||
33299219|NCT01307319|62675439|FG001|Overall Study|Adverse Event|2|||
33299220|NCT01307319|62675440|FG002|Overall Study|Adverse Event|1|||
33299221|NCT01307319|62675438|FG000|Overall Study|Lost to Follow-up|1|||
33299222|NCT01307319|62675439|FG001|Overall Study|Lost to Follow-up|0|||
33299223|NCT01307319|62675440|FG002|Overall Study|Lost to Follow-up|1|||
33299224|NCT01307319|62675438|FG000|Overall Study|Protocol Violation|1|||
33299225|NCT01307319|62675439|FG001|Overall Study|Protocol Violation|1|||
33299226|NCT01307319|62675440|FG002|Overall Study|Protocol Violation|0|||
33299227|NCT01307319|62675438|FG000|Overall Study|Withdrawal by Subject|0|||
33299228|NCT01307319|62675439|FG001|Overall Study|Withdrawal by Subject|1|||
33389301|NCT00617344|62768275|FG002|Overall Study|Protocol Violation|5|||
33489848|NCT00082433|62867939|FG001|Overall Study|Not Treated|11|||
33489849|NCT00082433|62867938|FG000|Overall Study|Ineligible|2|||
33489850|NCT00082433|62867939|FG001|Overall Study|Ineligible|1|||
33489851|NCT00082433|62867938|FG000|Overall Study|Noncompliance|2|||
33489852|NCT00082433|62867939|FG001|Overall Study|Noncompliance|1|||
33489853|NCT00082433|62867938|FG000|Overall Study|New primary cancer|1|||
33489854|NCT00082433|62867939|FG001|Overall Study|New primary cancer|0|||
33489855|NCT00082433|62867938|FG000|Overall Study|Impending surgery|0|||
33489856|NCT00082433|62867939|FG001|Overall Study|Impending surgery|1|||
33489857|NCT00094445|62867945|FG000|Overall Study|Withdrawal by Subject|3|||
33489858|NCT00094445|62867945|FG000|Overall Study|Lost to Follow-up|1|||
33489859|NCT00094445|62867945|FG000|Overall Study|Progressive Disease|2|||
33489860|NCT00082355|62867949|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
33489861|NCT00082355|62867949|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
33489862|NCT00082355|62867949|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
33489863|NCT00094055|62867953|FG000|Overall Study|Adverse Event|11|||
33489864|NCT00094055|62867953|FG000|Overall Study|Death|4|||
33489865|NCT00094055|62867953|FG000|Overall Study|Lack of Efficacy|17|||
33489866|NCT00094055|62867953|FG000|Overall Study|Lost to Follow-up|2|||
33489867|NCT00094055|62867953|FG000|Overall Study|progressive disease|2|||
33489868|NCT00094055|62867953|FG000|Overall Study|clinical progression|1|||
33489869|NCT00094055|62867953|FG000|Overall Study|roll-over to another study|14|||
33489870|NCT00094055|62867953|FG000|Overall Study|Withdrawal by Subject|9|||
33489871|NCT00099983|62867959|FG000|Overall Study|Lost to Follow-up|2|||
33489872|NCT00099983|62867960|FG001|Overall Study|Lost to Follow-up|3|||
33489873|NCT00099983|62867959|FG000|Overall Study|Missing Source Documents|14|||
33489874|NCT00099983|62867960|FG001|Overall Study|Missing Source Documents|15|||
33489875|NCT00099983|62867959|FG000|Overall Study|Withdrawal by Subject|3|||
33489876|NCT00099983|62867960|FG001|Overall Study|Withdrawal by Subject|2|||
33489877|NCT00099983|62867959|FG000|Overall Study|Adverse Event|1|||
33489878|NCT00099983|62867960|FG001|Overall Study|Adverse Event|1|||
33489879|NCT00099983|62867959|FG000|Overall Study|Lack of Efficacy|0|||
33489880|NCT00099983|62867960|FG001|Overall Study|Lack of Efficacy|1|||
33489881|NCT00099983|62867959|FG000|Overall Study|Unable to return for appointments|1|||
33489882|NCT00099983|62867960|FG001|Overall Study|Unable to return for appointments|1|||
33299229|NCT01307319|62675440|FG002|Overall Study|Withdrawal by Subject|2|||
33489883|NCT00099983|62867959|FG000|Overall Study|Moved|1|||
33489884|NCT00099983|62867960|FG001|Overall Study|Moved|0|||
33489885|NCT00099983|62867959|FG000|Overall Study|Other psychiatric problem|1|||
33489886|NCT00099983|62867960|FG001|Overall Study|Other psychiatric problem|0|||
33299230|NCT01307319|62675438|FG000|Overall Study|Other|0|||
33299231|NCT01307319|62675439|FG001|Overall Study|Other|4|||
33389302|NCT00617344|62768273|FG000|Overall Study|Lost to Follow-up|5|||
33389303|NCT00617344|62768274|FG001|Overall Study|Lost to Follow-up|4|||
33489887|NCT00099983|62867959|FG000|Overall Study|Incarcerated|0|||
33489888|NCT00099983|62867960|FG001|Overall Study|Incarcerated|1|||
33489889|NCT00099983|62867959|FG000|Overall Study|Intolerant of burden of visits|0|||
33489890|NCT00099983|62867960|FG001|Overall Study|Intolerant of burden of visits|1|||
33489891|NCT00099983|62867959|FG000|Overall Study|Other issue|1|||
33489892|NCT00099983|62867960|FG001|Overall Study|Other issue|0|||
33389304|NCT00617344|62768275|FG002|Overall Study|Lost to Follow-up|1|||
33389305|NCT00617344|62768273|FG000|Overall Study|Withdrawal by Subject|8|||
33389306|NCT00617344|62768274|FG001|Overall Study|Withdrawal by Subject|9|||
33389307|NCT00617344|62768275|FG002|Overall Study|Withdrawal by Subject|2|||
33389308|NCT00654381|62768343|FG000|1st Stage|Adverse Event|3|||
33389309|NCT00654381|62768344|FG001|1st Stage|Adverse Event|3|||
33389310|NCT00654381|62768345|FG002|1st Stage|Adverse Event|3|||
33389311|NCT00654381|62768346|FG003|1st Stage|Adverse Event|3|||
33389312|NCT00654381|62768347|FG004|1st Stage|Adverse Event|2|||
33389313|NCT00654381|62768348|FG005|1st Stage|Adverse Event|1|||
33389314|NCT00654381|62768343|FG000|1st Stage|Withdrawal by Subject|0|||
33389315|NCT00654381|62768344|FG001|1st Stage|Withdrawal by Subject|0|||
33389316|NCT00654381|62768345|FG002|1st Stage|Withdrawal by Subject|0|||
33389317|NCT00654381|62768346|FG003|1st Stage|Withdrawal by Subject|1|||
33389318|NCT00654381|62768347|FG004|1st Stage|Withdrawal by Subject|0|||
33389319|NCT00654381|62768348|FG005|1st Stage|Withdrawal by Subject|1|||
33389320|NCT00654381|62768343|FG000|1st Stage|Investigator's decision|0|||
33389321|NCT00654381|62768344|FG001|1st Stage|Investigator's decision|0|||
33389322|NCT00654381|62768345|FG002|1st Stage|Investigator's decision|0|||
33389323|NCT00654381|62768346|FG003|1st Stage|Investigator's decision|1|||
33389324|NCT00654381|62768347|FG004|1st Stage|Investigator's decision|0|||
33389325|NCT00654381|62768348|FG005|1st Stage|Investigator's decision|0|||
33389326|NCT00654381|62768343|FG000|2nd Stage|Adverse Event|2|||
33389327|NCT00654381|62768344|FG001|2nd Stage|Adverse Event|0|||
33389328|NCT00654381|62768345|FG002|2nd Stage|Adverse Event|2|||
33389329|NCT00654381|62768346|FG003|2nd Stage|Adverse Event|3|||
33389330|NCT00654381|62768347|FG004|2nd Stage|Adverse Event|7|||
33389331|NCT00654381|62768348|FG005|2nd Stage|Adverse Event|2|||
33389332|NCT00654381|62768343|FG000|2nd Stage|Withdrawal by Subject|0|||
33389333|NCT00654381|62768344|FG001|2nd Stage|Withdrawal by Subject|0|||
33389334|NCT00654381|62768345|FG002|2nd Stage|Withdrawal by Subject|0|||
33389335|NCT00654381|62768346|FG003|2nd Stage|Withdrawal by Subject|0|||
33389336|NCT00654381|62768347|FG004|2nd Stage|Withdrawal by Subject|1|||
33389337|NCT00654381|62768348|FG005|2nd Stage|Withdrawal by Subject|1|||
33389338|NCT00654381|62768343|FG000|2nd Stage|Investigator's decision|0|||
33389339|NCT00654381|62768344|FG001|2nd Stage|Investigator's decision|0|||
33389340|NCT00654381|62768345|FG002|2nd Stage|Investigator's decision|1|||
33389341|NCT00654381|62768346|FG003|2nd Stage|Investigator's decision|1|||
33389342|NCT00654381|62768347|FG004|2nd Stage|Investigator's decision|0|||
33389343|NCT00654381|62768348|FG005|2nd Stage|Investigator's decision|0|||
33389344|NCT00654381|62768343|FG000|Extension Stage|Adverse Event|1|||
33489893|NCT00099359|62867969|FG000|Overall Study|Death|11|||
33662658|NCT01587703|63093232|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33299232|NCT01307319|62675440|FG002|Overall Study|Other|3|||
33299233|NCT01080391|62675450|FG000|Overall Study|Randomized but not treated|7|||
33299234|NCT01080391|62675451|FG001|Overall Study|Randomized but not treated|4|||
33299235|NCT01070329|62675459|FG000|Overall Study|Adverse Event|13|||
33299236|NCT01070329|62675460|FG001|Overall Study|Adverse Event|10|||
33299237|NCT01070329|62675459|FG000|Overall Study|Lost to Follow-up|22|||
33299238|NCT01070329|62675460|FG001|Overall Study|Lost to Follow-up|12|||
33299239|NCT01070329|62675459|FG000|Overall Study|Withdrawal by Subject|9|||
33299240|NCT01070329|62675460|FG001|Overall Study|Withdrawal by Subject|11|||
33299241|NCT01070329|62675459|FG000|Overall Study|Protocol Violation|3|||
33299242|NCT01070329|62675460|FG001|Overall Study|Protocol Violation|8|||
33299243|NCT01070329|62675459|FG000|Overall Study|Lack of Efficacy|2|||
33299244|NCT01070329|62675460|FG001|Overall Study|Lack of Efficacy|6|||
33389345|NCT00654381|62768344|FG001|Extension Stage|Adverse Event|2|||
33389346|NCT00654381|62768345|FG002|Extension Stage|Adverse Event|9|||
33389347|NCT00654381|62768346|FG003|Extension Stage|Adverse Event|7|||
33389348|NCT00654381|62768347|FG004|Extension Stage|Adverse Event|1|||
33389349|NCT00654381|62768348|FG005|Extension Stage|Adverse Event|1|||
33389350|NCT00654381|62768343|FG000|Extension Stage|Protocol Violation|0|||
33389351|NCT00654381|62768344|FG001|Extension Stage|Protocol Violation|0|||
33662659|NCT01587703|63093233|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33299245|NCT01070329|62675459|FG000|Overall Study|Physician Decision|2|||
33299246|NCT01070329|62675460|FG001|Overall Study|Physician Decision|1|||
33299247|NCT01070329|62675459|FG000|Overall Study|Entry Criteria Not Met|1|||
33299248|NCT01070329|62675460|FG001|Overall Study|Entry Criteria Not Met|0|||
33299249|NCT01070329|62675459|FG000|Overall Study|Sponsor Decision|0|||
33299250|NCT01070329|62675460|FG001|Overall Study|Sponsor Decision|1|||
33299251|NCT01069861|62675466|FG000|Overall Study|Death|1|||
33299252|NCT01069861|62675466|FG000|Overall Study|Adverse Event|1|||
33299253|NCT01069861|62675466|FG000|Overall Study|Did not meet entrance criteria|1|||
33389352|NCT00654381|62768345|FG002|Extension Stage|Protocol Violation|0|||
33299254|NCT01306929|62675470|FG000|Overall Study|Withdrawal by Subject|23|||
33299255|NCT01306929|62675470|FG000|Overall Study|Adverse Event|21|||
33299256|NCT01306929|62675470|FG000|Overall Study|Physician Decision|13|||
33389353|NCT00654381|62768346|FG003|Extension Stage|Protocol Violation|1|||
33389354|NCT00654381|62768347|FG004|Extension Stage|Protocol Violation|0|||
33489894|NCT00099359|62867970|FG001|Overall Study|Death|15|||
33389355|NCT00654381|62768348|FG005|Extension Stage|Protocol Violation|0|||
33389356|NCT00654381|62768343|FG000|Extension Stage|Lack of Efficacy|0|||
33489895|NCT00099359|62867971|FG002|Overall Study|Death|17|||
33489896|NCT00099359|62867969|FG000|Overall Study|Withdrawal by Subject|19|||
33489897|NCT00099359|62867970|FG001|Overall Study|Withdrawal by Subject|19|||
33489898|NCT00099359|62867971|FG002|Overall Study|Withdrawal by Subject|23|||
33489899|NCT00099359|62867969|FG000|Overall Study|Lost to Follow-up|15|||
33489900|NCT00099359|62867970|FG001|Overall Study|Lost to Follow-up|24|||
33489901|NCT00099359|62867971|FG002|Overall Study|Lost to Follow-up|24|||
33489902|NCT00099359|62867969|FG000|Overall Study|moved out of area|9|||
33489903|NCT00099359|62867970|FG001|Overall Study|moved out of area|7|||
33489904|NCT00099359|62867971|FG002|Overall Study|moved out of area|4|||
33489905|NCT00092495|62867993|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
33489906|NCT00092495|62867994|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
33489907|NCT00092495|62867995|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
33489908|NCT00092495|62867996|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
33489909|NCT00092495|62867997|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
33489910|NCT00092495|62867993|FG000|Base Study Vaccination Period|Extended|0|||
33489911|NCT00092495|62867994|FG001|Base Study Vaccination Period|Extended|0|||
33489912|NCT00092495|62867995|FG002|Base Study Vaccination Period|Extended|0|||
33489913|NCT00092495|62867996|FG003|Base Study Vaccination Period|Extended|1|||
33489914|NCT00092495|62867997|FG004|Base Study Vaccination Period|Extended|0|||
33489915|NCT00092495|62867993|FG000|Base Study Vaccination Period|*Clinical AE|1|||
33489916|NCT00092495|62867994|FG001|Base Study Vaccination Period|*Clinical AE|0|||
33489917|NCT00092495|62867995|FG002|Base Study Vaccination Period|*Clinical AE|1|||
33489918|NCT00092495|62867996|FG003|Base Study Vaccination Period|*Clinical AE|2|||
33489919|NCT00092495|62867997|FG004|Base Study Vaccination Period|*Clinical AE|0|||
33489920|NCT00092495|62867993|FG000|Base Study Vaccination Period|*Other reasons|1|||
33489921|NCT00092495|62867994|FG001|Base Study Vaccination Period|*Other reasons|0|||
33489922|NCT00092495|62867995|FG002|Base Study Vaccination Period|*Other reasons|0|||
33489923|NCT00092495|62867996|FG003|Base Study Vaccination Period|*Other reasons|1|||
33489924|NCT00092495|62867997|FG004|Base Study Vaccination Period|*Other reasons|0|||
33489925|NCT00092495|62867993|FG000|Base Study Vaccination Period|*Pregnancy|0|||
33489926|NCT00092495|62867994|FG001|Base Study Vaccination Period|*Pregnancy|2|||
33489927|NCT00092495|62867995|FG002|Base Study Vaccination Period|*Pregnancy|5|||
33489928|NCT00092495|62867996|FG003|Base Study Vaccination Period|*Pregnancy|7|||
33489929|NCT00092495|62867997|FG004|Base Study Vaccination Period|*Pregnancy|0|||
33489930|NCT00092495|62867993|FG000|Base Study Vaccination Period|Adverse Event|1|||
33489931|NCT00092495|62867994|FG001|Base Study Vaccination Period|Adverse Event|0|||
33489932|NCT00092495|62867995|FG002|Base Study Vaccination Period|Adverse Event|0|||
33489933|NCT00092495|62867996|FG003|Base Study Vaccination Period|Adverse Event|3|||
33489934|NCT00092495|62867997|FG004|Base Study Vaccination Period|Adverse Event|0|||
33489935|NCT00092495|62867993|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
33489936|NCT00092495|62867994|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
33489937|NCT00092495|62867995|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
33489938|NCT00092495|62867996|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
33489939|NCT00092495|62867997|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
33489940|NCT00092495|62867993|FG000|Base Study Vaccination Period|Moved|3|||
33489941|NCT00092495|62867994|FG001|Base Study Vaccination Period|Moved|1|||
33489942|NCT00092495|62867995|FG002|Base Study Vaccination Period|Moved|2|||
33489943|NCT00092495|62867996|FG003|Base Study Vaccination Period|Moved|2|||
33489944|NCT00092495|62867997|FG004|Base Study Vaccination Period|Moved|0|||
33299257|NCT01306929|62675470|FG000|Overall Study|Death|8|||
33299258|NCT01306929|62675470|FG000|Overall Study|Withdrawal by parent/guardian|5|||
33299259|NCT01306929|62675470|FG000|Overall Study|Protocol Violation|3|||
33299260|NCT01306929|62675470|FG000|Overall Study|Non-compliance with study drug|2|||
33299261|NCT01306929|62675470|FG000|Overall Study|Lost to Follow-up|2|||
33299262|NCT01306929|62675470|FG000|Overall Study|Various|17|||
33299263|NCT01064401|62675476|FG000|Overall Study|Adverse Event|47|||
33299264|NCT01064401|62675477|FG001|Overall Study|Adverse Event|56|||
33389357|NCT00654381|62768344|FG001|Extension Stage|Lack of Efficacy|0|||
33489945|NCT00092495|62867993|FG000|Base Study Vaccination Period|Other|1|||
33299265|NCT01064401|62675476|FG000|Overall Study|Lack of Efficacy|46|||
33299266|NCT01064401|62675477|FG001|Overall Study|Lack of Efficacy|23|||
33299267|NCT01064401|62675476|FG000|Overall Study|Lost to Follow-up|12|||
33299268|NCT01064401|62675477|FG001|Overall Study|Lost to Follow-up|9|||
33389358|NCT00654381|62768345|FG002|Extension Stage|Lack of Efficacy|1|||
33389359|NCT00654381|62768346|FG003|Extension Stage|Lack of Efficacy|0|||
33489946|NCT00092495|62867994|FG001|Base Study Vaccination Period|Other|1|||
33489947|NCT00092495|62867995|FG002|Base Study Vaccination Period|Other|0|||
33489948|NCT00092495|62867996|FG003|Base Study Vaccination Period|Other|2|||
33489949|NCT00092495|62867997|FG004|Base Study Vaccination Period|Other|0|||
33489950|NCT00092495|62867993|FG000|Base Study Vaccination Period|Pregnancy|2|||
33489951|NCT00092495|62867994|FG001|Base Study Vaccination Period|Pregnancy|0|||
33489952|NCT00092495|62867995|FG002|Base Study Vaccination Period|Pregnancy|0|||
33389360|NCT00654381|62768347|FG004|Extension Stage|Lack of Efficacy|0|||
33389361|NCT00654381|62768348|FG005|Extension Stage|Lack of Efficacy|0|||
33389362|NCT00654381|62768343|FG000|Extension Stage|Withdrawal by Subject|0|||
33389363|NCT00654381|62768344|FG001|Extension Stage|Withdrawal by Subject|0|||
33389364|NCT00654381|62768345|FG002|Extension Stage|Withdrawal by Subject|1|||
33389365|NCT00654381|62768346|FG003|Extension Stage|Withdrawal by Subject|1|||
33389366|NCT00654381|62768347|FG004|Extension Stage|Withdrawal by Subject|1|||
33389367|NCT00654381|62768348|FG005|Extension Stage|Withdrawal by Subject|1|||
33389368|NCT00654381|62768343|FG000|Extension Stage|Closure of the trial site|0|||
33389369|NCT00654381|62768344|FG001|Extension Stage|Closure of the trial site|0|||
33389370|NCT00654381|62768345|FG002|Extension Stage|Closure of the trial site|0|||
33389371|NCT00654381|62768346|FG003|Extension Stage|Closure of the trial site|0|||
33389372|NCT00654381|62768347|FG004|Extension Stage|Closure of the trial site|1|||
33389373|NCT00654381|62768348|FG005|Extension Stage|Closure of the trial site|1|||
33389374|NCT00657267|62768365|FG000|Overall Study|Progressive disease|45|||
33389375|NCT00657267|62768365|FG000|Overall Study|Adverse Event|9|||
33389376|NCT00653991|62768373|FG000|3 Month Follow-up|Participant would not respond|150|||
33389377|NCT00653991|62768374|FG001|3 Month Follow-up|Participant would not respond|157|||
33389378|NCT00653991|62768373|FG000|6 Month Follow-up|Participant would not respond|133|||
33389379|NCT00653991|62768374|FG001|6 Month Follow-up|Participant would not respond|141|||
33389380|NCT00652899|62768382|FG000|Overall Study|Death|1|||
33389381|NCT00652899|62768382|FG000|Overall Study|Treating physician decision|1|||
33389382|NCT00617890|62768394|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
33389383|NCT00617890|62768395|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
33389384|NCT00617890|62768396|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
33389385|NCT00617890|62768397|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
33389386|NCT00617890|62768394|FG000|Overall Study|Lack of Efficacy|23|||
33389387|NCT00617890|62768395|FG001|Overall Study|Lack of Efficacy|26|||
33389388|NCT00617890|62768396|FG002|Overall Study|Lack of Efficacy|30|||
33389389|NCT00617890|62768397|FG003|Overall Study|Lack of Efficacy|97|||
33389390|NCT00617890|62768394|FG000|Overall Study|Lost to Follow-up|0|||
33389391|NCT00617890|62768395|FG001|Overall Study|Lost to Follow-up|0|||
33389392|NCT00617890|62768396|FG002|Overall Study|Lost to Follow-up|1|||
33389393|NCT00617890|62768397|FG003|Overall Study|Lost to Follow-up|2|||
33389394|NCT00617890|62768394|FG000|Overall Study|Withdrawal by Subject|4|||
33389395|NCT00617890|62768395|FG001|Overall Study|Withdrawal by Subject|1|||
33389396|NCT00617890|62768396|FG002|Overall Study|Withdrawal by Subject|0|||
33389397|NCT00617890|62768397|FG003|Overall Study|Withdrawal by Subject|2|||
33389398|NCT00617890|62768394|FG000|Overall Study|Protocol Violation|2|||
33389399|NCT00617890|62768395|FG001|Overall Study|Protocol Violation|1|||
33389400|NCT00617890|62768396|FG002|Overall Study|Protocol Violation|0|||
33389401|NCT00617890|62768397|FG003|Overall Study|Protocol Violation|0|||
33389402|NCT00617890|62768394|FG000|Overall Study|Adverse Event|1|||
33389403|NCT00617890|62768395|FG001|Overall Study|Adverse Event|0|||
33389404|NCT00617890|62768396|FG002|Overall Study|Adverse Event|3|||
33389405|NCT00617890|62768397|FG003|Overall Study|Adverse Event|8|||
33389406|NCT00617890|62768394|FG000|Overall Study|Not treated|1|||
33389407|NCT00617890|62768395|FG001|Overall Study|Not treated|0|||
33389408|NCT00617890|62768396|FG002|Overall Study|Not treated|1|||
33389409|NCT00617890|62768397|FG003|Overall Study|Not treated|1|||
33389410|NCT00712166|62768412|FG000|Overall Study|Noncompliance|0|||
33389411|NCT00712166|62768413|FG001|Overall Study|Noncompliance|1|||
33389412|NCT00652743|62768424|FG000|Months 12-18|Lost to Follow-up|1|||
33299269|NCT01064401|62675476|FG000|Overall Study|Consent Withdrawn|98|||
33299270|NCT01064401|62675477|FG001|Overall Study|Consent Withdrawn|80|||
33299271|NCT01064401|62675476|FG000|Overall Study|Investigator Decision|4|||
33299272|NCT01064401|62675477|FG001|Overall Study|Investigator Decision|6|||
33299273|NCT01064401|62675476|FG000|Overall Study|Death|4|||
33299274|NCT01064401|62675477|FG001|Overall Study|Death|0|||
33299275|NCT01064401|62675476|FG000|Overall Study|Pregnancy|4|||
33299276|NCT01064401|62675477|FG001|Overall Study|Pregnancy|7|||
33389413|NCT00652743|62768425|FG001|Months 12-18|Lost to Follow-up|2|||
33389414|NCT00652743|62768426|FG002|Months 12-18|Lost to Follow-up|7|||
33389415|NCT00652743|62768424|FG000|Months 24-30|Other|5|||
33389416|NCT00652743|62768425|FG001|Months 24-30|Other|1|||
33389417|NCT00652743|62768426|FG002|Months 24-30|Other|11|||
33299277|NCT01064401|62675476|FG000|Overall Study|Noncompliance|7|||
33299278|NCT01064401|62675477|FG001|Overall Study|Noncompliance|8|||
33299279|NCT01064401|62675476|FG000|Overall Study|Site Closure|4|||
33389418|NCT00652743|62768424|FG000|Months 36-42|Serious Adverse Events|0|||
33389419|NCT00652743|62768425|FG001|Months 36-42|Serious Adverse Events|1|||
33389420|NCT00652743|62768426|FG002|Months 36-42|Serious Adverse Events|1|||
33389421|NCT00652743|62768424|FG000|Months 36-42|Withdrawal by Subject|1|||
33389422|NCT00652743|62768425|FG001|Months 36-42|Withdrawal by Subject|1|||
33389423|NCT00652743|62768426|FG002|Months 36-42|Withdrawal by Subject|0|||
33389424|NCT00652743|62768424|FG000|Months 36-42|Lost to Follow-up|0|||
33389425|NCT00652743|62768425|FG001|Months 36-42|Lost to Follow-up|1|||
33389426|NCT00652743|62768426|FG002|Months 36-42|Lost to Follow-up|0|||
33389427|NCT00652743|62768424|FG000|Months 36-42|Migrated/moved from study area|1|||
33299280|NCT01064401|62675477|FG001|Overall Study|Site Closure|5|||
33299281|NCT01064401|62675476|FG000|Overall Study|Other|2|||
33389428|NCT00652743|62768425|FG001|Months 36-42|Migrated/moved from study area|0|||
33389429|NCT00652743|62768426|FG002|Months 36-42|Migrated/moved from study area|0|||
33389430|NCT00652743|62768424|FG000|Months 36-42|Other|4|||
33389431|NCT00652743|62768425|FG001|Months 36-42|Other|2|||
33389432|NCT00652743|62768426|FG002|Months 36-42|Other|8|||
33389433|NCT00712010|62768437|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
33389434|NCT00653523|62768453|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
33389435|NCT00653523|62768453|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
33389436|NCT00653523|62768453|FG000|Overall Study|Adverse Event|7|||
33389437|NCT00653523|62768453|FG000|Overall Study|Withdrawal by Subject|6|||
33389438|NCT00653523|62768453|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
33389439|NCT00653523|62768453|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
33389440|NCT02717442|62768459|FG000|Overall Study|Study Terminated by Sponsor|31|||
33389441|NCT02717442|62768460|FG001|Overall Study|Study Terminated by Sponsor|29|||
33389442|NCT02717442|62768459|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
33389443|NCT02717442|62768460|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
33389444|NCT02717442|62768459|FG000|Overall Study|Other - Not Specified|2|||
33389445|NCT02717442|62768460|FG001|Overall Study|Other - Not Specified|0|||
33389446|NCT00616018|62768473|FG000|Overall Study|Protocol Violation|3|||
33389447|NCT00424021|62768482|FG000|NCT00046319 Study Period|Adverse Event|1|||
33389448|NCT00424021|62768483|FG001|NCT00046319 Study Period|Adverse Event|0|||
33389449|NCT00424021|62768484|FG002|NCT00046319 Study Period|Adverse Event|1|||
33389450|NCT00424021|62768485|FG003|NCT00046319 Study Period|Adverse Event|1|||
33389451|NCT00424021|62768482|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
33389452|NCT00424021|62768483|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
33389453|NCT00424021|62768484|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
33389454|NCT00424021|62768485|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
33389455|NCT00424021|62768482|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
33389456|NCT00424021|62768483|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
33389457|NCT00424021|62768484|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
33389458|NCT00424021|62768485|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
33389459|NCT00424021|62768482|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
33389460|NCT00424021|62768483|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
33389461|NCT00424021|62768484|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
33389462|NCT00424021|62768485|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
33389463|NCT00424021|62768482|FG000|AMB-220-E Study Period|Adverse Event|1|||
33389464|NCT00424021|62768483|FG001|AMB-220-E Study Period|Adverse Event|1|||
33299282|NCT01064401|62675477|FG001|Overall Study|Other|1|||
33299283|NCT01306617|62675487|FG000|Overall Study|Adverse Event|1|||
33299284|NCT01306617|62675488|FG001|Overall Study|Adverse Event|0|||
33299285|NCT01306617|62675489|FG002|Overall Study|Adverse Event|0|||
33299286|NCT01306617|62675487|FG000|Overall Study|Virologic Failure|0|||
33299287|NCT01306617|62675488|FG001|Overall Study|Virologic Failure|0|||
33299288|NCT01306617|62675489|FG002|Overall Study|Virologic Failure|5|||
33299289|NCT01306617|62675487|FG000|Overall Study|Non-compliance|0|||
33299290|NCT01306617|62675488|FG001|Overall Study|Non-compliance|1|||
33299291|NCT01306617|62675489|FG002|Overall Study|Non-compliance|0|||
33299292|NCT01306305|62675499|FG000|Overall Study|Lost to Follow-up|1|||
33299293|NCT01306305|62675500|FG001|Overall Study|Lost to Follow-up|0|||
33299294|NCT01306305|62675499|FG000|Overall Study|Withdrew consent|1|||
33299295|NCT01306305|62675500|FG001|Overall Study|Withdrew consent|0|||
33299296|NCT01038427|62675509|FG000|Overall Study|Lost to follow up|1|||
33299297|NCT01038427|62675510|FG001|Overall Study|Lost to follow up|1|||
33299298|NCT01038427|62675511|FG002|Overall Study|Lost to follow up|0|||
33299299|NCT01038427|62675509|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
33299300|NCT01038427|62675510|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
33299301|NCT01038427|62675511|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
33299302|NCT01038427|62675509|FG000|Overall Study|Withdrew consent|0|||
33299303|NCT01038427|62675510|FG001|Overall Study|Withdrew consent|0|||
33299304|NCT01038427|62675511|FG002|Overall Study|Withdrew consent|1|||
33299305|NCT01038427|62675509|FG000|Overall Study|Adverse Event|2|||
33299306|NCT01038427|62675510|FG001|Overall Study|Adverse Event|2|||
33299307|NCT01038427|62675511|FG002|Overall Study|Adverse Event|1|||
33299308|NCT01038427|62675509|FG000|Overall Study|Enrolled in error|0|||
33299309|NCT01038427|62675510|FG001|Overall Study|Enrolled in error|1|||
33299310|NCT01038427|62675511|FG002|Overall Study|Enrolled in error|1|||
33299311|NCT01038427|62675509|FG000|Overall Study|Other|0|||
33389465|NCT00424021|62768484|FG002|AMB-220-E Study Period|Adverse Event|3|||
33389466|NCT00424021|62768485|FG003|AMB-220-E Study Period|Adverse Event|7|||
33389467|NCT00424021|62768482|FG000|AMB-220-E Study Period|Death|0|||
33389468|NCT00424021|62768483|FG001|AMB-220-E Study Period|Death|0|||
33389469|NCT00424021|62768484|FG002|AMB-220-E Study Period|Death|1|||
33389470|NCT00424021|62768485|FG003|AMB-220-E Study Period|Death|1|||
33489953|NCT00092495|62867996|FG003|Base Study Vaccination Period|Pregnancy|0|||
33489954|NCT00092495|62867997|FG004|Base Study Vaccination Period|Pregnancy|0|||
33489955|NCT00092495|62867993|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
33489956|NCT00092495|62867994|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
33489957|NCT00092495|62867995|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
33489958|NCT00092495|62867996|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
33489959|NCT00092495|62867997|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
33489960|NCT00092495|62867993|FG000|Base Study Vaccination Period|Protocol Violation|1|||
33489961|NCT00092495|62867994|FG001|Base Study Vaccination Period|Protocol Violation|0|||
33489962|NCT00092495|62867995|FG002|Base Study Vaccination Period|Protocol Violation|0|||
33489963|NCT00092495|62867996|FG003|Base Study Vaccination Period|Protocol Violation|0|||
33389471|NCT00424021|62768482|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
33389472|NCT00424021|62768483|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
33489964|NCT00092495|62867997|FG004|Base Study Vaccination Period|Protocol Violation|0|||
33489965|NCT00092495|62867993|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
33489966|NCT00092495|62867994|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
33389473|NCT00424021|62768484|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
33389474|NCT00424021|62768485|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
33489967|NCT00092495|62867995|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
33489968|NCT00092495|62867996|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
33489969|NCT00092495|62867997|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
33489970|NCT00092495|62867993|FG000|Base Study Follow-up Period|Extended|0|||
33489971|NCT00092495|62867994|FG001|Base Study Follow-up Period|Extended|0|||
33489972|NCT00092495|62867995|FG002|Base Study Follow-up Period|Extended|1|||
33489973|NCT00092495|62867996|FG003|Base Study Follow-up Period|Extended|2|||
33489974|NCT00092495|62867997|FG004|Base Study Follow-up Period|Extended|0|||
33489975|NCT00092495|62867993|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
33489976|NCT00092495|62867994|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
33489977|NCT00092495|62867995|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
33489978|NCT00092495|62867996|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
33489979|NCT00092495|62867997|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
33489980|NCT00092495|62867993|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
33489981|NCT00092495|62867994|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
33489982|NCT00092495|62867995|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
33489983|NCT00092495|62867996|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
33489984|NCT00092495|62867997|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
33489985|NCT00092417|62868012|FG000|Overall Study|Lost to Follow-up|2|||
33489986|NCT00092417|62868013|FG001|Overall Study|Lost to Follow-up|0|||
33489987|NCT00092417|62868012|FG000|Overall Study|Withdrawal by Subject|2|||
33489988|NCT00092417|62868013|FG001|Overall Study|Withdrawal by Subject|1|||
33489989|NCT00092417|62868012|FG000|Overall Study|Other|1|||
33489990|NCT00092417|62868013|FG001|Overall Study|Other|0|||
33489991|NCT00091949|62868021|FG000|Overall Study|Withdrawal by Subject|117|||
33489992|NCT00091949|62868022|FG001|Overall Study|Withdrawal by Subject|110|||
33489993|NCT00091949|62868021|FG000|Overall Study|Lost to Follow-up|58|||
33489994|NCT00091949|62868022|FG001|Overall Study|Lost to Follow-up|41|||
33489995|NCT02258542|62868032|FG000|Overall Study|eg. not made to the visit|7|||
33489996|NCT02258542|62868033|FG001|Overall Study|eg. not made to the visit|4|||
33489997|NCT02258542|62868034|FG002|Overall Study|eg. not made to the visit|0|||
33662660|NCT01587703|63093234|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33299312|NCT01038427|62675510|FG001|Overall Study|Other|2|||
33299313|NCT01038427|62675511|FG002|Overall Study|Other|0|||
33299314|NCT01037413|62675519|FG000|Part A: Skin Testing|Adverse Event|1|||
33299315|NCT01037413|62675520|FG001|Part A: Skin Testing|Adverse Event|0|||
33299316|NCT01037413|62675519|FG000|Part A: Skin Testing|Protocol Violation|1|||
33299317|NCT01037413|62675520|FG001|Part A: Skin Testing|Protocol Violation|0|||
33299318|NCT01037413|62675519|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
33299319|NCT01037413|62675520|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
33389475|NCT00424021|62768482|FG000|AMB-220-E Study Period|Physician Decision|0|||
33389476|NCT00424021|62768483|FG001|AMB-220-E Study Period|Physician Decision|0|||
33389477|NCT00424021|62768484|FG002|AMB-220-E Study Period|Physician Decision|0|||
33389478|NCT00424021|62768485|FG003|AMB-220-E Study Period|Physician Decision|1|||
33389479|NCT00617734|62768504|FG000|Overall Study|Withdrew Consent|2|||
33389480|NCT00617734|62768505|FG001|Overall Study|Withdrew Consent|0|||
33389481|NCT00617734|62768504|FG000|Overall Study|Adverse Event|4|||
33389482|NCT00617734|62768505|FG001|Overall Study|Adverse Event|1|||
33389483|NCT00617734|62768504|FG000|Overall Study|Protocol Violation|1|||
33389484|NCT00617734|62768505|FG001|Overall Study|Protocol Violation|0|||
33489998|NCT02258542|62868035|FG003|Overall Study|eg. not made to the visit|1|||
33489999|NCT02258542|62868032|FG000|Overall Study|study specific discount. criteria|1|||
33490000|NCT02258542|62868033|FG001|Overall Study|study specific discount. criteria|1|||
33299320|NCT01037413|62675519|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
33299321|NCT01037413|62675520|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
33490001|NCT02258542|62868034|FG002|Overall Study|study specific discount. criteria|0|||
33490002|NCT02258542|62868035|FG003|Overall Study|study specific discount. criteria|0|||
33490003|NCT02258542|62868032|FG000|Overall Study|Withdrawal by Subject|20|||
33490004|NCT02258542|62868033|FG001|Overall Study|Withdrawal by Subject|20|||
33490005|NCT02258542|62868034|FG002|Overall Study|Withdrawal by Subject|7|||
33490006|NCT02258542|62868035|FG003|Overall Study|Withdrawal by Subject|1|||
33490007|NCT02258542|62868032|FG000|Overall Study|Lost to Follow-up|5|||
33490008|NCT02258542|62868033|FG001|Overall Study|Lost to Follow-up|12|||
33490009|NCT02258542|62868034|FG002|Overall Study|Lost to Follow-up|1|||
33490010|NCT02258542|62868035|FG003|Overall Study|Lost to Follow-up|2|||
33490011|NCT02258542|62868032|FG000|Overall Study|Death|5|||
33490012|NCT02258542|62868033|FG001|Overall Study|Death|4|||
33490013|NCT02258542|62868034|FG002|Overall Study|Death|0|||
33490014|NCT02258542|62868035|FG003|Overall Study|Death|1|||
33490015|NCT02258542|62868032|FG000|Overall Study|Adverse Event|3|||
33490016|NCT02258542|62868033|FG001|Overall Study|Adverse Event|4|||
33490017|NCT02258542|62868034|FG002|Overall Study|Adverse Event|0|||
33490018|NCT02258542|62868035|FG003|Overall Study|Adverse Event|0|||
33490019|NCT02258542|62868032|FG000|Overall Study|Protocol Violation|1|||
33490020|NCT02258542|62868033|FG001|Overall Study|Protocol Violation|2|||
33490021|NCT02258542|62868034|FG002|Overall Study|Protocol Violation|0|||
33490022|NCT02258542|62868035|FG003|Overall Study|Protocol Violation|0|||
33490023|NCT02258542|62868032|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33490024|NCT02258542|62868033|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
33490025|NCT02258542|62868034|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
33490026|NCT02258542|62868035|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
33490027|NCT00091793|62868065|FG000|Overall Study|Adverse Event|1|||
33490028|NCT00091793|62868066|FG001|Overall Study|Adverse Event|2|||
33490029|NCT00091793|62868065|FG000|Overall Study|Withdrawal by Subject|10|||
33490030|NCT00091793|62868066|FG001|Overall Study|Withdrawal by Subject|15|||
33490031|NCT00091793|62868065|FG000|Overall Study|Ineligibility determined|2|||
33490032|NCT00091793|62868066|FG001|Overall Study|Ineligibility determined|0|||
33490033|NCT00091793|62868065|FG000|Overall Study|Lost to Follow-up|7|||
33490034|NCT00091793|62868066|FG001|Overall Study|Lost to Follow-up|5|||
33490035|NCT00091793|62868065|FG000|Overall Study|Noncompliance|2|||
33490036|NCT00091793|62868066|FG001|Overall Study|Noncompliance|0|||
33490037|NCT00091793|62868065|FG000|Overall Study|Other|2|||
33490038|NCT00091793|62868066|FG001|Overall Study|Other|0|||
33490039|NCT00098813|62868072|FG000|Overall Study|Death|8|||
33490040|NCT00098813|62868072|FG000|Overall Study|Protocol Violation|1|||
33490041|NCT00098813|62868072|FG000|Overall Study|Withdrawal by Subject|7|||
33490042|NCT00098813|62868072|FG000|Overall Study|Progression of Disease|1|||
33490043|NCT00098813|62868072|FG000|Overall Study|Other complicating disease|1|||
33490044|NCT00098813|62868072|FG000|Overall Study|Reversal of RAI resistance|1|||
33490045|NCT00090857|62868078|FG000|Overall Study|Lost to Follow-up|0|||
33490046|NCT00090857|62868079|FG001|Overall Study|Lost to Follow-up|1|||
33490047|NCT00090857|62868078|FG000|Overall Study|Withdrawal by Subject|2|||
33490048|NCT00090857|62868079|FG001|Overall Study|Withdrawal by Subject|0|||
33490049|NCT00090857|62868078|FG000|Overall Study|Adverse Event|2|||
33490050|NCT00090857|62868079|FG001|Overall Study|Adverse Event|2|||
33490051|NCT00090779|62868091|FG000|Step 1|Withdrawal by Subject|4|||
33490052|NCT00090779|62868092|FG001|Step 1|Withdrawal by Subject|2|||
33490053|NCT00090779|62868091|FG000|Step 1|Lost to Follow-up|3|||
33490054|NCT00090779|62868092|FG001|Step 1|Lost to Follow-up|2|||
33490055|NCT00090779|62868091|FG000|Step 1|Death|0|||
33490056|NCT00090779|62868092|FG001|Step 1|Death|2|||
33490057|NCT00090779|62868091|FG000|Step 1|Physician Decision|1|||
33490058|NCT00090779|62868092|FG001|Step 1|Physician Decision|0|||
33490059|NCT00090779|62868091|FG000|Step 1|Pregnancy|1|||
33490060|NCT00090779|62868092|FG001|Step 1|Pregnancy|0|||
33490061|NCT00090779|62868091|FG000|Step 1|Non-compliance to study requirements|0|||
33490062|NCT00090779|62868092|FG001|Step 1|Non-compliance to study requirements|1|||
33490063|NCT00090779|62868091|FG000|Step 1|Subject relocated|2|||
33490064|NCT00090779|62868092|FG001|Step 1|Subject relocated|8|||
33490065|NCT00090779|62868091|FG000|Step 2|Off study per study closure|6|||
33490066|NCT00090779|62868092|FG001|Step 2|Off study per study closure|16|||
33490067|NCT00090779|62868091|FG000|Step 2|Subject relocated|0|||
33490068|NCT00090779|62868092|FG001|Step 2|Subject relocated|1|||
33490069|NCT00090779|62868091|FG000|Step 2|Non-compliance to study requirements|0|||
33490070|NCT00090779|62868092|FG001|Step 2|Non-compliance to study requirements|1|||
33490071|NCT00090779|62868091|FG000|Step 3|Initiation of ART and off extended study|3|||
33490072|NCT00090779|62868092|FG001|Step 3|Initiation of ART and off extended study|2|||
33490073|NCT00090779|62868091|FG000|Step 3|Off extended study due to study closure|4|||
33490074|NCT00090779|62868092|FG001|Step 3|Off extended study due to study closure|3|||
33556824|NCT02338492|62949697|FG000|Overall Study|Reason not captured above|6|||
33490075|NCT00098345|62868098|FG000|Overall Study|Adverse Event|7|||
33490076|NCT00098345|62868098|FG000|Overall Study|Withdrawal by Subject|2|||
33490077|NCT00098345|62868098|FG000|Overall Study|progression|4|||
33490078|NCT02224456|62868102|FG000|Overall Study|Lack of Efficacy|1|||
33490079|NCT02224456|62868102|FG000|Overall Study|Lost to Follow-up|15|||
33490080|NCT02224456|62868102|FG000|Overall Study|Withdrawal by Subject|9|||
33490081|NCT02224456|62868102|FG000|Overall Study|Physician Decision|3|||
33490082|NCT02224456|62868102|FG000|Overall Study|Death|2|||
33490083|NCT02224456|62868102|FG000|Overall Study|Pregnancy|4|||
33299322|NCT01326845|62675535|FG000|Overall Study|Administrative Problems|5|||
33299323|NCT01326845|62675536|FG001|Overall Study|Administrative Problems|2|||
33299324|NCT01326845|62675535|FG000|Overall Study|Adverse Event|1|||
33299325|NCT01326845|62675536|FG001|Overall Study|Adverse Event|0|||
33299326|NCT01326845|62675535|FG000|Overall Study|Misisng|1|||
33389485|NCT00617734|62768504|FG000|Overall Study|Found Ineligible After Randomization|1|||
33389486|NCT00617734|62768505|FG001|Overall Study|Found Ineligible After Randomization|4|||
33389487|NCT00617734|62768504|FG000|Overall Study|Lost to Follow-up|0|||
33389488|NCT00617734|62768505|FG001|Overall Study|Lost to Follow-up|1|||
33389489|NCT00577460|62768514|FG000|Overall Study|Adverse Event|11|||
33389490|NCT00577460|62768515|FG001|Overall Study|Adverse Event|7|||
33389491|NCT00577460|62768516|FG002|Overall Study|Adverse Event|14|||
33389492|NCT00577460|62768514|FG000|Overall Study|Protocol Violation|0|||
33389493|NCT00577460|62768515|FG001|Overall Study|Protocol Violation|1|||
33389494|NCT00577460|62768516|FG002|Overall Study|Protocol Violation|1|||
33389495|NCT00577460|62768514|FG000|Overall Study|Lost to Follow-up|0|||
33389496|NCT00577460|62768515|FG001|Overall Study|Lost to Follow-up|3|||
33389497|NCT00577460|62768516|FG002|Overall Study|Lost to Follow-up|4|||
33389498|NCT00577460|62768514|FG000|Overall Study|Withdrawal by Subject|5|||
33389499|NCT00577460|62768515|FG001|Overall Study|Withdrawal by Subject|5|||
33389500|NCT00577460|62768516|FG002|Overall Study|Withdrawal by Subject|6|||
33389501|NCT00577460|62768514|FG000|Overall Study|Other|0|||
33389502|NCT00577460|62768515|FG001|Overall Study|Other|3|||
33389503|NCT00577460|62768516|FG002|Overall Study|Other|2|||
33389504|NCT00415519|62768533|FG000|Overall Study|Adverse Event|1|||
33389505|NCT00415519|62768534|FG001|Overall Study|Adverse Event|0|||
33389506|NCT00415519|62768533|FG000|Overall Study|Withdrawal by Subject|2|||
33389507|NCT00415519|62768534|FG001|Overall Study|Withdrawal by Subject|0|||
33389508|NCT00415519|62768533|FG000|Overall Study|Patient's convenience|1|||
33389509|NCT00415519|62768534|FG001|Overall Study|Patient's convenience|0|||
33389510|NCT00423943|62768542|FG000|Overall Study|Withdrawal by Subject|3|||
33389511|NCT00423943|62768543|FG001|Overall Study|Withdrawal by Subject|1|||
33389512|NCT00428389|62768551|FG000|Core Phase|Adverse Event|6|||
33389513|NCT00428389|62768552|FG001|Core Phase|Adverse Event|4|||
33389514|NCT00428389|62768551|FG000|Core Phase|Lack of Efficacy|2|||
33389515|NCT00428389|62768552|FG001|Core Phase|Lack of Efficacy|0|||
33389516|NCT00428389|62768551|FG000|Core Phase|Abnormal test procedure result(s)|0|||
33389517|NCT00428389|62768552|FG001|Core Phase|Abnormal test procedure result(s)|1|||
33389518|NCT00428389|62768551|FG000|Core Phase|Withdrawal by Subject|3|||
33389519|NCT00428389|62768552|FG001|Core Phase|Withdrawal by Subject|4|||
33389520|NCT00428389|62768551|FG000|Core Phase|Protocol deviation|0|||
33389521|NCT00428389|62768552|FG001|Core Phase|Protocol deviation|2|||
33389522|NCT00428389|62768551|FG000|Extension Phase|Adverse Event|17|||
33389523|NCT00428389|62768552|FG001|Extension Phase|Adverse Event|11|||
33389524|NCT00428389|62768551|FG000|Extension Phase|Lack of Efficacy|4|||
33389525|NCT00428389|62768552|FG001|Extension Phase|Lack of Efficacy|3|||
33389526|NCT00428389|62768551|FG000|Extension Phase|Withdrawal by Subject|6|||
33389527|NCT00428389|62768552|FG001|Extension Phase|Withdrawal by Subject|6|||
33389528|NCT00428389|62768551|FG000|Extension Phase|Lost to Follow-up|0|||
33389529|NCT00428389|62768552|FG001|Extension Phase|Lost to Follow-up|3|||
33490084|NCT02224456|62868102|FG000|Overall Study|Protocol Violation|1|||
33299327|NCT01326845|62675536|FG001|Overall Study|Misisng|3|||
33299328|NCT01062763|62675544|FG000|Overall Study|Adverse Event|3|||
33299329|NCT01062763|62675545|FG001|Overall Study|Adverse Event|4|||
33299330|NCT01048099|62675551|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
33299331|NCT01048099|62675551|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
33389530|NCT00428389|62768551|FG000|Extension Phase|Death|1|||
33389531|NCT00428389|62768552|FG001|Extension Phase|Death|0|||
33389532|NCT00428389|62768551|FG000|Extension Phase|Protocol Violation|3|||
33389533|NCT00428389|62768552|FG001|Extension Phase|Protocol Violation|2|||
33389534|NCT00428389|62768551|FG000|Extension Phase|Administrative problems|1|||
33389535|NCT00428389|62768552|FG001|Extension Phase|Administrative problems|1|||
33490085|NCT02224456|62868102|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
33490086|NCT00097721|62868108|FG000|Overall Study|Adverse Event|8|||
33389536|NCT00616642|62768560|FG000|Overall Study|Withdrawal by Subject|0|||
33389537|NCT00616642|62768561|FG001|Overall Study|Withdrawal by Subject|1|||
33299332|NCT01303965|62675559|FG000|Overall Study|Adverse Event|1|||
33299333|NCT01303965|62675560|FG001|Overall Study|Adverse Event|1|||
33299334|NCT01303965|62675559|FG000|Overall Study|Death|0|||
33389538|NCT00406315|62768567|FG000|Overall Study|Death|1|||
33389539|NCT00406315|62768567|FG000|Overall Study|Adverse Event|39|||
33389540|NCT00406315|62768567|FG000|Overall Study|Laboratory Abnormality|4|||
33389541|NCT00406315|62768567|FG000|Overall Study|Lack of Efficacy|13|||
33490087|NCT00097721|62868109|FG001|Overall Study|Adverse Event|1|||
33299335|NCT01303965|62675560|FG001|Overall Study|Death|3|||
33299336|NCT01303965|62675559|FG000|Overall Study|Withdrawal by Subject|1|||
33299337|NCT01303965|62675560|FG001|Overall Study|Withdrawal by Subject|0|||
33299338|NCT01303965|62675559|FG000|Overall Study|Disease Progression|1|||
33490088|NCT00097721|62868108|FG000|Overall Study|Withdrawal by Subject|6|||
33490089|NCT00097721|62868109|FG001|Overall Study|Withdrawal by Subject|1|||
33490090|NCT00097721|62868108|FG000|Overall Study|Progressive Disease|55|||
33490091|NCT00097721|62868109|FG001|Overall Study|Progressive Disease|27|||
33490092|NCT00097721|62868108|FG000|Overall Study|Physician Decision|1|||
33490093|NCT00097721|62868109|FG001|Overall Study|Physician Decision|3|||
33490094|NCT00097721|62868108|FG000|Overall Study|Reason not given|1|||
33490095|NCT00097721|62868109|FG001|Overall Study|Reason not given|1|||
33490096|NCT03553498|62868117|FG000|Overall Study|Missing primary outcome|1|||
33490097|NCT03553498|62868118|FG001|Overall Study|Missing primary outcome|2|||
33490098|NCT00096941|62868124|FG000|Overall Study|disease progression|3|||
33490099|NCT00096785|62868130|FG000|Overall Study|Lost to Follow-up|1|||
33490100|NCT00096785|62868131|FG001|Overall Study|Lost to Follow-up|0|||
33490101|NCT00096785|62868130|FG000|Overall Study|Withdrawal by Subject|0|||
33490102|NCT00096785|62868131|FG001|Overall Study|Withdrawal by Subject|1|||
33490103|NCT00096785|62868130|FG000|Overall Study|Relocated|1|||
33490104|NCT00096785|62868131|FG001|Overall Study|Relocated|0|||
33490105|NCT03285178|62868166|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
33490106|NCT03285178|62868167|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
33490107|NCT03285178|62868168|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
33490108|NCT03285178|62868169|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
33490109|NCT03285178|62868170|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
33490110|NCT03285178|62868171|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
33490111|NCT03285178|62868172|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
33490112|NCT03285178|62868166|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
33490113|NCT03285178|62868167|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
33490114|NCT03285178|62868168|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
33490115|NCT03285178|62868169|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
33490116|NCT03285178|62868170|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
33490117|NCT03285178|62868171|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
33490118|NCT03285178|62868172|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
33490119|NCT03285178|62868166|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
33490120|NCT03285178|62868167|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
33490121|NCT03285178|62868168|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
33490122|NCT03285178|62868169|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
33490123|NCT03285178|62868170|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
33490124|NCT03285178|62868171|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
33490125|NCT03285178|62868172|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
33490126|NCT03285178|62868166|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
33490127|NCT03285178|62868167|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
33490128|NCT03285178|62868168|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
33490129|NCT03285178|62868169|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
33490130|NCT03285178|62868170|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
33490131|NCT03285178|62868171|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
33490132|NCT03285178|62868172|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
33490133|NCT03285178|62868166|FG000|Single-Blind Run-In Period|Physician Decision|2|||
33490134|NCT03285178|62868167|FG001|Single-Blind Run-In Period|Physician Decision|0|||
33490135|NCT03285178|62868168|FG002|Single-Blind Run-In Period|Physician Decision|0|||
33490136|NCT03285178|62868169|FG003|Single-Blind Run-In Period|Physician Decision|0|||
33490137|NCT03285178|62868170|FG004|Single-Blind Run-In Period|Physician Decision|0|||
33490138|NCT03285178|62868171|FG005|Single-Blind Run-In Period|Physician Decision|0|||
33490139|NCT03285178|62868172|FG006|Single-Blind Run-In Period|Physician Decision|0|||
33490140|NCT03285178|62868166|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
33490141|NCT03285178|62868167|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
33490142|NCT03285178|62868168|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
33490143|NCT03285178|62868169|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
33490144|NCT03285178|62868170|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
33662661|NCT01587703|63093235|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
33299339|NCT01303965|62675560|FG001|Overall Study|Disease Progression|6|||
33299340|NCT01045993|62675570|FG000|Overall Study|Treated-later found eligibility not met|0|||
33490145|NCT03285178|62868171|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
33556825|NCT02337946|62949701|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
33490146|NCT03285178|62868172|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
33490147|NCT03285178|62868166|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33490148|NCT03285178|62868167|FG001|Double-Blind Treatment Period|Adverse Event|0|||
33490149|NCT03285178|62868168|FG002|Double-Blind Treatment Period|Adverse Event|0|||
33490150|NCT03285178|62868169|FG003|Double-Blind Treatment Period|Adverse Event|0|||
33490151|NCT03285178|62868170|FG004|Double-Blind Treatment Period|Adverse Event|0|||
33490152|NCT03285178|62868171|FG005|Double-Blind Treatment Period|Adverse Event|0|||
33490153|NCT03285178|62868172|FG006|Double-Blind Treatment Period|Adverse Event|2|||
33490154|NCT03285178|62868166|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33490155|NCT03285178|62868167|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
33490156|NCT03285178|62868168|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
33490157|NCT03285178|62868169|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
33490158|NCT03285178|62868170|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
33490159|NCT03285178|62868171|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
33490160|NCT03285178|62868172|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
33490161|NCT03285178|62868166|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33490162|NCT03285178|62868167|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33490163|NCT03285178|62868168|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33490164|NCT03285178|62868169|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33490165|NCT03285178|62868170|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33490166|NCT03285178|62868171|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
33490167|NCT03285178|62868172|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33556826|NCT02337946|62949702|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
33556827|NCT02337946|62949703|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
33389542|NCT00406315|62768567|FG000|Overall Study|Other|33|||
33490168|NCT03285178|62868166|FG000|Double-Blind Treatment Period|COVID-19|0|||
33490169|NCT03285178|62868167|FG001|Double-Blind Treatment Period|COVID-19|0|||
33490170|NCT03285178|62868168|FG002|Double-Blind Treatment Period|COVID-19|1|||
33490171|NCT03285178|62868169|FG003|Double-Blind Treatment Period|COVID-19|0|||
33490172|NCT03285178|62868170|FG004|Double-Blind Treatment Period|COVID-19|0|||
33490173|NCT03285178|62868171|FG005|Double-Blind Treatment Period|COVID-19|0|||
33490174|NCT03285178|62868172|FG006|Double-Blind Treatment Period|COVID-19|0|||
33490175|NCT00090545|62868196|FG000|Overall Study|Disease progression on study|21|||
33490176|NCT00090545|62868197|FG001|Overall Study|Disease progression on study|17|||
33490177|NCT00090545|62868196|FG000|Overall Study|Refused further treatment|1|||
33490178|NCT00090545|62868197|FG001|Overall Study|Refused further treatment|4|||
33490179|NCT00090545|62868196|FG000|Overall Study|Death|0|||
33490180|NCT00090545|62868197|FG001|Overall Study|Death|1|||
33490181|NCT00090545|62868196|FG000|Overall Study|Adverse Event|0|||
33490182|NCT00090545|62868197|FG001|Overall Study|Adverse Event|2|||
33490183|NCT03249376|62868207|FG000|Overall Study|Adverse Event|11|||
33490184|NCT03249376|62868208|FG001|Overall Study|Adverse Event|5|||
33490185|NCT03249376|62868207|FG000|Overall Study|Lack of Efficacy|2|||
33490186|NCT03249376|62868208|FG001|Overall Study|Lack of Efficacy|4|||
33490187|NCT03249376|62868207|FG000|Overall Study|Protocol Violation|3|||
33490188|NCT03249376|62868208|FG001|Overall Study|Protocol Violation|2|||
33490189|NCT03249376|62868207|FG000|Overall Study|Physician Decision|0|||
33490190|NCT03249376|62868208|FG001|Overall Study|Physician Decision|2|||
33490191|NCT03249376|62868207|FG000|Overall Study|Withdrawal by Subject|3|||
33490192|NCT03249376|62868208|FG001|Overall Study|Withdrawal by Subject|9|||
33490193|NCT03249376|62868207|FG000|Overall Study|LTFU|2|||
33490194|NCT03249376|62868208|FG001|Overall Study|LTFU|1|||
33490195|NCT00070109|62868219|FG000|Overall Study|Death|1|||
33490196|NCT00070109|62868220|FG001|Overall Study|Death|1|||
33490197|NCT00070109|62868221|FG002|Overall Study|Death|0|||
33490198|NCT00070109|62868222|FG003|Overall Study|Death|0|||
33490199|NCT00070109|62868223|FG004|Overall Study|Death|1|||
33490200|NCT00070109|62868219|FG000|Overall Study|Lack of Efficacy|6|||
33490201|NCT00070109|62868220|FG001|Overall Study|Lack of Efficacy|4|||
33490202|NCT00070109|62868221|FG002|Overall Study|Lack of Efficacy|5|||
33490203|NCT00070109|62868222|FG003|Overall Study|Lack of Efficacy|15|||
33490204|NCT00070109|62868223|FG004|Overall Study|Lack of Efficacy|5|||
33556828|NCT02337946|62949701|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
33556829|NCT02337946|62949702|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
33490205|NCT00070109|62868219|FG000|Overall Study|Physician Decision|1|||
33490206|NCT00070109|62868220|FG001|Overall Study|Physician Decision|0|||
33490207|NCT00070109|62868221|FG002|Overall Study|Physician Decision|0|||
33490208|NCT00070109|62868222|FG003|Overall Study|Physician Decision|0|||
33490209|NCT00070109|62868223|FG004|Overall Study|Physician Decision|0|||
33490210|NCT00070109|62868219|FG000|Overall Study|Withdrawal by Subject|0|||
33490211|NCT00070109|62868220|FG001|Overall Study|Withdrawal by Subject|1|||
33490212|NCT00070109|62868221|FG002|Overall Study|Withdrawal by Subject|1|||
33490213|NCT00070109|62868222|FG003|Overall Study|Withdrawal by Subject|0|||
33490214|NCT00070109|62868223|FG004|Overall Study|Withdrawal by Subject|0|||
33490215|NCT00070109|62868219|FG000|Overall Study|Adverse Event|0|||
33490216|NCT00070109|62868220|FG001|Overall Study|Adverse Event|0|||
33490217|NCT00070109|62868221|FG002|Overall Study|Adverse Event|2|||
33490218|NCT00070109|62868222|FG003|Overall Study|Adverse Event|4|||
33490219|NCT00070109|62868223|FG004|Overall Study|Adverse Event|2|||
33490220|NCT00070109|62868219|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
33490221|NCT00070109|62868220|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
33490222|NCT00070109|62868221|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
33490223|NCT00070109|62868222|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
33490224|NCT00070109|62868223|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
33490225|NCT00090233|62868244|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
33490226|NCT00090233|62868245|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
33490227|NCT00090233|62868244|FG000|Overall Study|Adverse Event|214|||
33490228|NCT00090233|62868245|FG001|Overall Study|Adverse Event|198|||
33490229|NCT00090233|62868244|FG000|Overall Study|Lost to Follow-up|68|||
33490230|NCT00090233|62868245|FG001|Overall Study|Lost to Follow-up|95|||
33490231|NCT00090233|62868244|FG000|Overall Study|Protocol Violation|960|||
33490232|NCT00090233|62868245|FG001|Overall Study|Protocol Violation|1022|||
33490233|NCT00090233|62868244|FG000|Overall Study|Withdrawal by Subject|182|||
33490234|NCT00090233|62868245|FG001|Overall Study|Withdrawal by Subject|211|||
33490235|NCT00090233|62868244|FG000|Overall Study|Moved|203|||
33490236|NCT00090233|62868245|FG001|Overall Study|Moved|189|||
33490237|NCT00090233|62868244|FG000|Overall Study|Other|1211|||
33490238|NCT00090233|62868245|FG001|Overall Study|Other|1160|||
33490239|NCT00090233|62868244|FG000|Overall Study|Data not available at data cut-off point|1552|||
33490240|NCT00090233|62868245|FG001|Overall Study|Data not available at data cut-off point|1563|||
33490241|NCT00069953|62868255|FG000|Overall Study|Protocol Violation|2|||
33490242|NCT02750800|62868265|FG000|Overall Study|Adverse Event|18|||
33490243|NCT02750800|62868265|FG000|Overall Study|Lost to Follow-up|12|||
33490244|NCT02750800|62868265|FG000|Overall Study|Investigator decision|53|||
33490245|NCT02750800|62868265|FG000|Overall Study|Patient request|12|||
33490246|NCT02750800|62868265|FG000|Overall Study|Other, not specified|3|||
33490247|NCT01329562|62868285|FG000|Overall Study|Protocol Violation|5|||
33490248|NCT01329562|62868286|FG001|Overall Study|Protocol Violation|3|||
33490249|NCT01329562|62868285|FG000|Overall Study|Lost to Follow-up|1|||
33490250|NCT01329562|62868286|FG001|Overall Study|Lost to Follow-up|1|||
33490251|NCT01329562|62868285|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
33490252|NCT01329562|62868286|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
33490253|NCT01329562|62868285|FG000|Overall Study|Physician Decision|0|||
33389543|NCT00406315|62768567|FG000|Overall Study|Lost to Follow-up|21|||
33389544|NCT00406315|62768567|FG000|Overall Study|Withdrawal by Subject|30|||
33389545|NCT00711594|62768575|FG000|Overall Study|Progressive disease|2|||
33389546|NCT00711594|62768576|FG001|Overall Study|Progressive disease|2|||
33389547|NCT00711594|62768577|FG002|Overall Study|Progressive disease|6|||
33389548|NCT00711594|62768578|FG003|Overall Study|Progressive disease|44|||
33389549|NCT00711594|62768575|FG000|Overall Study|Other Adverse Event|1|||
33389550|NCT00711594|62768576|FG001|Overall Study|Other Adverse Event|0|||
33389551|NCT00711594|62768577|FG002|Overall Study|Other Adverse Event|0|||
33389552|NCT00711594|62768578|FG003|Overall Study|Other Adverse Event|16|||
33389553|NCT00711594|62768575|FG000|Overall Study|Withdrawal by Subject|0|||
33389554|NCT00711594|62768576|FG001|Overall Study|Withdrawal by Subject|1|||
33389555|NCT00711594|62768577|FG002|Overall Study|Withdrawal by Subject|0|||
33389556|NCT00711594|62768578|FG003|Overall Study|Withdrawal by Subject|2|||
33389557|NCT00710762|62768592|FG000|Overall Study|Progressive disease|27|||
33389558|NCT00710762|62768593|FG001|Overall Study|Progressive disease|30|||
33389559|NCT00710762|62768592|FG000|Overall Study|Adverse Event other disease worsening|2|||
33389560|NCT00710762|62768593|FG001|Overall Study|Adverse Event other disease worsening|1|||
33389561|NCT00710762|62768592|FG000|Overall Study|Other Adverse Event|7|||
33389562|NCT00710762|62768593|FG001|Overall Study|Other Adverse Event|7|||
33389563|NCT00710762|62768592|FG000|Overall Study|Lost to Follow-up|1|||
33389564|NCT00710762|62768593|FG001|Overall Study|Lost to Follow-up|0|||
33389565|NCT00710762|62768592|FG000|Overall Study|Reason other than listed above|2|||
33389566|NCT00710762|62768593|FG001|Overall Study|Reason other than listed above|2|||
33490254|NCT01329562|62868286|FG001|Overall Study|Physician Decision|1|||
33389567|NCT00573430|62768602|FG000|Overall Study|Incorrect enrollment of randomization|0|||
33490255|NCT00069641|62868297|FG000|Overall Study|Death|1|||
33490256|NCT00069641|62868298|FG001|Overall Study|Death|0|||
33490257|NCT00069641|62868299|FG002|Overall Study|Death|1|||
33490258|NCT03653026|62868310|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
33490259|NCT03653026|62868311|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
33490260|NCT03653026|62868312|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
33490261|NCT03653026|62868313|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
33389568|NCT00573430|62768603|FG001|Overall Study|Incorrect enrollment of randomization|4|||
33389569|NCT00573430|62768604|FG002|Overall Study|Incorrect enrollment of randomization|3|||
33389570|NCT00573430|62768602|FG000|Overall Study|Adverse Event|0|||
33389571|NCT00573430|62768603|FG001|Overall Study|Adverse Event|0|||
33389572|NCT00573430|62768604|FG002|Overall Study|Adverse Event|2|||
33389573|NCT00573430|62768602|FG000|Overall Study|Withdrawal by Subject|1|||
33389574|NCT00573430|62768603|FG001|Overall Study|Withdrawal by Subject|0|||
33389575|NCT00573430|62768604|FG002|Overall Study|Withdrawal by Subject|1|||
33389576|NCT00573430|62768602|FG000|Overall Study|Protocol Violation|0|||
33389577|NCT00573430|62768603|FG001|Overall Study|Protocol Violation|1|||
33389578|NCT00573430|62768604|FG002|Overall Study|Protocol Violation|1|||
33389579|NCT00573430|62768602|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33389580|NCT00573430|62768603|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33389581|NCT00573430|62768604|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
33389582|NCT00711516|62768614|FG000|Overall Study|Adverse Event|1|||
33389583|NCT00711516|62768615|FG001|Overall Study|Adverse Event|1|||
33389584|NCT00711516|62768614|FG000|Overall Study|Withdrawal by Subject|0|||
33389585|NCT00711516|62768615|FG001|Overall Study|Withdrawal by Subject|1|||
33389586|NCT00711516|62768614|FG000|Overall Study|Protocol Violation|0|||
33389587|NCT00711516|62768615|FG001|Overall Study|Protocol Violation|1|||
33389588|NCT00615550|62768623|FG000|Overall Study|Lost to Follow-up|6|||
33389589|NCT00615550|62768624|FG001|Overall Study|Lost to Follow-up|1|||
33389590|NCT00186888|62768633|FG000|Overall Study|Toxicity|0|||
33389591|NCT00186888|62768634|FG001|Overall Study|Toxicity|1|||
33389592|NCT00186888|62768635|FG002|Overall Study|Toxicity|0|||
33389593|NCT00186888|62768633|FG000|Overall Study|Relapse or progression of disease|4|||
33389594|NCT00186888|62768634|FG001|Overall Study|Relapse or progression of disease|2|||
33389595|NCT00186888|62768635|FG002|Overall Study|Relapse or progression of disease|0|||
33389596|NCT00577382|62768672|FG000|Overall Study|Adverse Event|0|||
33389597|NCT00577382|62768673|FG001|Overall Study|Adverse Event|6|||
33389598|NCT00577382|62768672|FG000|Overall Study|Withdrawal by Subject|0|||
33389599|NCT00577382|62768673|FG001|Overall Study|Withdrawal by Subject|1|||
33389600|NCT00577382|62768672|FG000|Overall Study|Progressive Disease|17|||
33389601|NCT00577382|62768673|FG001|Overall Study|Progressive Disease|19|||
33389602|NCT00577382|62768672|FG000|Overall Study|Intercurrent Illness|1|||
33389603|NCT00577382|62768673|FG001|Overall Study|Intercurrent Illness|2|||
33389604|NCT00577382|62768672|FG000|Overall Study|Death|1|||
33389605|NCT00577382|62768673|FG001|Overall Study|Death|1|||
33389606|NCT00577382|62768672|FG000|Overall Study|Lost to Follow-up|2|||
33389607|NCT00577382|62768673|FG001|Overall Study|Lost to Follow-up|2|||
33389608|NCT00614926|62768681|FG000|Overall Study|Burden of travel|1|||
33389609|NCT00614926|62768682|FG001|Overall Study|Burden of travel|0|||
33389610|NCT00614926|62768681|FG000|Overall Study|Adverse Event|3|||
33389611|NCT00614926|62768682|FG001|Overall Study|Adverse Event|0|||
33389612|NCT00423319|62768690|FG000|Overall Study|Death|2|||
33389613|NCT00423319|62768691|FG001|Overall Study|Death|0|||
33389614|NCT00423319|62768690|FG000|Overall Study|Adverse Event|93|||
33389615|NCT00423319|62768691|FG001|Overall Study|Adverse Event|112|||
33389616|NCT00423319|62768690|FG000|Overall Study|Withdrawal by Subject|86|||
33389617|NCT00423319|62768691|FG001|Overall Study|Withdrawal by Subject|99|||
33389618|NCT00423319|62768690|FG000|Overall Study|Lost to Follow-up|4|||
33490262|NCT03653026|62868310|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
33490263|NCT03653026|62868311|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
33490264|NCT03653026|62868312|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33490265|NCT03653026|62868313|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33490266|NCT03653026|62868310|FG000|Part 1: Placebo-controlled Period|Other|0|||
33490267|NCT03653026|62868311|FG001|Part 1: Placebo-controlled Period|Other|3|||
33490268|NCT03653026|62868312|FG002|Part 1: Placebo-controlled Period|Other|0|||
33490269|NCT03653026|62868313|FG003|Part 1: Placebo-controlled Period|Other|0|||
33490270|NCT03653026|62868310|FG000|Part 2: Open-label Extension|Adverse Event|0|||
33490271|NCT03653026|62868311|FG001|Part 2: Open-label Extension|Adverse Event|0|||
33490272|NCT03653026|62868312|FG002|Part 2: Open-label Extension|Adverse Event|1|||
33490273|NCT03653026|62868313|FG003|Part 2: Open-label Extension|Adverse Event|1|||
33490274|NCT03653026|62868310|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
33389619|NCT00423319|62768691|FG001|Overall Study|Lost to Follow-up|3|||
33389620|NCT00423319|62768690|FG000|Overall Study|Poor compliance or noncompliance|1|||
33389621|NCT00423319|62768691|FG001|Overall Study|Poor compliance or noncompliance|1|||
33389622|NCT00423319|62768690|FG000|Overall Study|No longer meets study criteria|15|||
33389623|NCT00423319|62768691|FG001|Overall Study|No longer meets study criteria|15|||
33389624|NCT00423319|62768690|FG000|Overall Study|Other|23|||
33389625|NCT00423319|62768691|FG001|Overall Study|Other|22|||
33389626|NCT00710684|62768701|FG000|Overall Study|Adverse Event|11|||
33389627|NCT00710684|62768702|FG001|Overall Study|Adverse Event|19|||
33389628|NCT00710684|62768703|FG002|Overall Study|Adverse Event|16|||
33389629|NCT00710684|62768701|FG000|Overall Study|Lack of Efficacy|4|||
33389630|NCT00710684|62768702|FG001|Overall Study|Lack of Efficacy|3|||
33389631|NCT00710684|62768703|FG002|Overall Study|Lack of Efficacy|5|||
33389632|NCT00710684|62768701|FG000|Overall Study|Protocol Violation|5|||
33389633|NCT00710684|62768702|FG001|Overall Study|Protocol Violation|5|||
33389634|NCT00710684|62768703|FG002|Overall Study|Protocol Violation|5|||
33389635|NCT00710684|62768701|FG000|Overall Study|Lost to Follow-up|4|||
33389636|NCT00710684|62768702|FG001|Overall Study|Lost to Follow-up|6|||
33389637|NCT00710684|62768703|FG002|Overall Study|Lost to Follow-up|7|||
33389638|NCT00710684|62768701|FG000|Overall Study|Physician Decision|0|||
33389639|NCT00710684|62768702|FG001|Overall Study|Physician Decision|2|||
33389640|NCT00710684|62768703|FG002|Overall Study|Physician Decision|4|||
33389641|NCT00710684|62768701|FG000|Overall Study|Withdrawal by Subject|24|||
33389642|NCT00710684|62768702|FG001|Overall Study|Withdrawal by Subject|18|||
33389643|NCT00710684|62768703|FG002|Overall Study|Withdrawal by Subject|11|||
33389644|NCT00710684|62768701|FG000|Overall Study|Missing|1|||
33389645|NCT00710684|62768702|FG001|Overall Study|Missing|0|||
33389646|NCT00710684|62768703|FG002|Overall Study|Missing|0|||
33389647|NCT00710684|62768701|FG000|Overall Study|Did not continue after week 24|25|||
33389648|NCT00710684|62768702|FG001|Overall Study|Did not continue after week 24|21|||
33389649|NCT00710684|62768703|FG002|Overall Study|Did not continue after week 24|16|||
33389650|NCT00710606|62768719|FG000|Overall Study|Adverse Event|0|||
33389651|NCT00710606|62768720|FG001|Overall Study|Adverse Event|2|||
33389652|NCT00713544|62768734|FG000|Overall Study|Adverse Event|5|||
33389653|NCT00713544|62768735|FG001|Overall Study|Adverse Event|3|||
33389654|NCT00713544|62768736|FG002|Overall Study|Adverse Event|7|||
33389655|NCT00713544|62768737|FG003|Overall Study|Adverse Event|7|||
33389656|NCT00713544|62768738|FG004|Overall Study|Adverse Event|3|||
33389657|NCT00713544|62768739|FG005|Overall Study|Adverse Event|5|||
33389658|NCT00713544|62768734|FG000|Overall Study|Withdrawal by Subject|2|||
33389659|NCT00713544|62768735|FG001|Overall Study|Withdrawal by Subject|0|||
33389660|NCT00713544|62768736|FG002|Overall Study|Withdrawal by Subject|3|||
33389661|NCT00713544|62768737|FG003|Overall Study|Withdrawal by Subject|2|||
33389662|NCT00713544|62768738|FG004|Overall Study|Withdrawal by Subject|3|||
33389663|NCT00713544|62768739|FG005|Overall Study|Withdrawal by Subject|1|||
33389664|NCT00713544|62768734|FG000|Overall Study|Protocol Violation|0|||
33389665|NCT00713544|62768735|FG001|Overall Study|Protocol Violation|0|||
33389666|NCT00713544|62768736|FG002|Overall Study|Protocol Violation|0|||
33389667|NCT00713544|62768737|FG003|Overall Study|Protocol Violation|0|||
33389668|NCT00713544|62768738|FG004|Overall Study|Protocol Violation|0|||
33389669|NCT00713544|62768739|FG005|Overall Study|Protocol Violation|1|||
33490275|NCT03653026|62868311|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
33490276|NCT03653026|62868312|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
33490277|NCT03653026|62868313|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
33490278|NCT03653026|62868310|FG000|Part 2: Open-label Extension|Other|0|||
33490279|NCT03653026|62868311|FG001|Part 2: Open-label Extension|Other|0|||
33490280|NCT03653026|62868312|FG002|Part 2: Open-label Extension|Other|1|||
33490281|NCT03653026|62868313|FG003|Part 2: Open-label Extension|Other|2|||
33490282|NCT01329328|62868324|FG000|Overall Study|Withdrawal by Subject|2|||
33490283|NCT01329328|62868325|FG001|Overall Study|Withdrawal by Subject|4|||
33490284|NCT01329328|62868326|FG002|Overall Study|Withdrawal by Subject|3|||
33490285|NCT01337986|62868336|FG000|Overall Study|Adverse Event|2|||
33490286|NCT01337986|62868337|FG001|Overall Study|Adverse Event|2|||
33490287|NCT01337986|62868336|FG000|Overall Study|Lost to Follow-up|1|||
33490288|NCT01337986|62868337|FG001|Overall Study|Lost to Follow-up|0|||
33490289|NCT01337986|62868336|FG000|Overall Study|Protocol Violation|0|||
33490290|NCT01337986|62868337|FG001|Overall Study|Protocol Violation|3|||
33490291|NCT01337674|62868361|FG000|Treatment Period 1|Adverse Event|0|||
33490292|NCT01337674|62868362|FG001|Treatment Period 1|Adverse Event|1|||
33490293|NCT01337674|62868363|FG002|Treatment Period 1|Adverse Event|0|||
33490294|NCT01337674|62868364|FG003|Treatment Period 1|Adverse Event|0|||
33490295|NCT01337674|62868361|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
33490296|NCT01337674|62868362|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
33490297|NCT01337674|62868363|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
33556830|NCT02337946|62949703|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
33389670|NCT00713544|62768734|FG000|Overall Study|Physician Decision|0|||
33389671|NCT00713544|62768735|FG001|Overall Study|Physician Decision|0|||
33389672|NCT00713544|62768736|FG002|Overall Study|Physician Decision|0|||
33389673|NCT00713544|62768737|FG003|Overall Study|Physician Decision|0|||
33389674|NCT00713544|62768738|FG004|Overall Study|Physician Decision|0|||
33389675|NCT00713544|62768739|FG005|Overall Study|Physician Decision|2|||
33389676|NCT00713544|62768734|FG000|Overall Study|Lack of Efficacy|0|||
33389677|NCT00713544|62768735|FG001|Overall Study|Lack of Efficacy|1|||
33389678|NCT00713544|62768736|FG002|Overall Study|Lack of Efficacy|0|||
33389679|NCT00713544|62768737|FG003|Overall Study|Lack of Efficacy|1|||
33490298|NCT01337674|62868364|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
33490299|NCT01337674|62868361|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33389680|NCT00713544|62768738|FG004|Overall Study|Lack of Efficacy|1|||
33389681|NCT00713544|62768739|FG005|Overall Study|Lack of Efficacy|0|||
33389682|NCT00713544|62768734|FG000|Overall Study|Lost to Follow-up|0|||
33490300|NCT01337674|62868362|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33490301|NCT01337674|62868363|FG002|Treatment Period 2|Withdrawal by Subject|1|||
33490302|NCT01337674|62868364|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33490303|NCT02750410|62868379|FG000|Double-Blind Treatment Period|Adverse Event|2|||
33490304|NCT02750410|62868380|FG001|Double-Blind Treatment Period|Adverse Event|2|||
33490305|NCT02750410|62868379|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33490306|NCT02750410|62868380|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33490307|NCT02750410|62868379|FG000|Open-Label Extension Period|Adverse Event|5|||
33490308|NCT02750410|62868380|FG001|Open-Label Extension Period|Adverse Event|3|||
33490309|NCT02750410|62868379|FG000|Open-Label Extension Period|Protocol Violation|0|||
33490310|NCT02750410|62868380|FG001|Open-Label Extension Period|Protocol Violation|1|||
33490311|NCT02750410|62868379|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
33490312|NCT02750410|62868380|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
33490313|NCT02750332|62868390|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33490314|NCT02750332|62868391|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33490315|NCT01337596|62868406|FG000|Overall Study|Withdrawal by Subject|0|||
33490316|NCT01337596|62868407|FG001|Overall Study|Withdrawal by Subject|0|||
33490317|NCT01337596|62868408|FG002|Overall Study|Withdrawal by Subject|0|||
33490318|NCT01337596|62868409|FG003|Overall Study|Withdrawal by Subject|0|||
33490319|NCT01337596|62868410|FG004|Overall Study|Withdrawal by Subject|2|||
33490320|NCT01337596|62868411|FG005|Overall Study|Withdrawal by Subject|0|||
33490321|NCT01337596|62868412|FG006|Overall Study|Withdrawal by Subject|0|||
33490322|NCT01337596|62868413|FG007|Overall Study|Withdrawal by Subject|0|||
33490323|NCT01337596|62868414|FG008|Overall Study|Withdrawal by Subject|0|||
33490324|NCT00069095|62868443|FG000|Primary Treatment Phase|Ongoing|0|||
33490325|NCT00069095|62868444|FG001|Primary Treatment Phase|Ongoing|0|||
33490326|NCT00069095|62868445|FG002|Primary Treatment Phase|Ongoing|5|||
33490327|NCT00069095|62868446|FG003|Primary Treatment Phase|Ongoing|7|||
33490328|NCT00069095|62868447|FG004|Primary Treatment Phase|Ongoing|7|||
33490329|NCT00069095|62868448|FG005|Primary Treatment Phase|Ongoing|4|||
33490330|NCT00069095|62868443|FG000|Primary Treatment Phase|Admin/Other|29|||
33556831|NCT02337946|62949701|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
33556832|NCT02337946|62949702|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
33556833|NCT02337946|62949703|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
33299341|NCT01045993|62675571|FG001|Overall Study|Treated-later found eligibility not met|1|||
33389683|NCT00713544|62768735|FG001|Overall Study|Lost to Follow-up|0|||
33389684|NCT00713544|62768736|FG002|Overall Study|Lost to Follow-up|1|||
33389685|NCT00713544|62768737|FG003|Overall Study|Lost to Follow-up|0|||
33389686|NCT00713544|62768738|FG004|Overall Study|Lost to Follow-up|0|||
33389687|NCT00713544|62768739|FG005|Overall Study|Lost to Follow-up|0|||
33389688|NCT00713544|62768734|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
33389689|NCT00713544|62768735|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
33389690|NCT00713544|62768736|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
33389691|NCT00713544|62768737|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
33389692|NCT00713544|62768738|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
33389693|NCT00713544|62768739|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
33389694|NCT00713544|62768734|FG000|Overall Study|Incorrect enrollment|0|||
33389695|NCT00713544|62768735|FG001|Overall Study|Incorrect enrollment|1|||
33389696|NCT00713544|62768736|FG002|Overall Study|Incorrect enrollment|0|||
33389697|NCT00713544|62768737|FG003|Overall Study|Incorrect enrollment|0|||
33389698|NCT00713544|62768738|FG004|Overall Study|Incorrect enrollment|0|||
33389699|NCT00713544|62768739|FG005|Overall Study|Incorrect enrollment|0|||
33389700|NCT00713544|62768734|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
33389701|NCT00713544|62768735|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
33389702|NCT00713544|62768736|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
33389703|NCT00713544|62768737|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
33389704|NCT00713544|62768738|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
33389705|NCT00713544|62768739|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
33299342|NCT01045993|62675572|FG002|Overall Study|Treated-later found eligibility not met|0|||
33299343|NCT01045993|62675573|FG003|Overall Study|Treated-later found eligibility not met|0|||
33299344|NCT01303419|62675583|FG000|Overall Study|Discontinuation of study|60|||
33299345|NCT01303419|62675583|FG000|Overall Study|Did not complete both imaging methods|5|||
33299346|NCT01303419|62675583|FG000|Overall Study|Did not meet all I/E after screening|31|||
33299347|NCT01326533|62675589|FG000|Overall Study|Lost to Follow-up|2|||
33389706|NCT00415363|62768755|FG000|Overall Study|Withdrawal by Subject|4|||
33389707|NCT00415363|62768756|FG001|Overall Study|Withdrawal by Subject|4|||
33490331|NCT00069095|62868444|FG001|Primary Treatment Phase|Admin/Other|38|||
33490332|NCT00069095|62868445|FG002|Primary Treatment Phase|Admin/Other|31|||
33556834|NCT02337946|62949701|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
33556835|NCT02337946|62949702|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
33299348|NCT01326533|62675590|FG001|Overall Study|Lost to Follow-up|0|||
33389708|NCT00415363|62768755|FG000|Overall Study|Adverse Event|4|||
33389709|NCT00415363|62768756|FG001|Overall Study|Adverse Event|4|||
33389710|NCT00415363|62768755|FG000|Overall Study|Lost to Follow-up|2|||
33389711|NCT00415363|62768756|FG001|Overall Study|Lost to Follow-up|1|||
33490333|NCT00069095|62868446|FG003|Primary Treatment Phase|Admin/Other|45|||
33556836|NCT02337946|62949703|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
33556837|NCT02337946|62949701|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
33556838|NCT02337946|62949702|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
33556839|NCT02337946|62949703|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
33556840|NCT02337946|62949701|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
33556841|NCT02337946|62949702|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
33556842|NCT02337946|62949703|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
33556843|NCT02337946|62949701|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
33556844|NCT02337946|62949702|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
33556845|NCT02337946|62949703|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
33556846|NCT02337946|62949701|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
33556847|NCT02337946|62949702|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
33556848|NCT02337946|62949703|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
33556849|NCT02337946|62949701|FG000|In-between Period|Without Informed Consent|1|||
33556850|NCT02337946|62949702|FG001|In-between Period|Without Informed Consent|0|||
33556851|NCT02337946|62949703|FG002|In-between Period|Without Informed Consent|0|||
33556852|NCT02337946|62949701|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
33556853|NCT02337946|62949702|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
33556854|NCT02337946|62949703|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
33556855|NCT02337946|62949701|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
33556856|NCT02337946|62949702|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
33556857|NCT02337946|62949703|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
33556858|NCT02337946|62949701|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
33556859|NCT02337946|62949702|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
33556860|NCT02337946|62949703|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
33556861|NCT02337946|62949701|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
33556862|NCT02337946|62949702|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
33556863|NCT02337946|62949703|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
33556864|NCT02337946|62949701|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
33556865|NCT02337946|62949702|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
33556866|NCT02337946|62949703|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
33556867|NCT02337946|62949701|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
33556868|NCT02337946|62949702|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
33556869|NCT02337946|62949703|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
33556870|NCT01369199|62949709|FG000|Overall Study|Withdrawal by Subject|1|||
33556871|NCT01369199|62949709|FG000|Overall Study|Lost to Follow-up|2|||
33556872|NCT01368965|62949713|FG000|Overall Study|Lost to Follow-up|12|||
33556873|NCT02610140|62949721|FG000|Randomization and Treatment Period|Radiological progression|23|||
33556874|NCT02610140|62949722|FG001|Randomization and Treatment Period|Radiological progression|15|||
33389712|NCT00415363|62768755|FG000|Overall Study|Physician Decision|3|||
33389713|NCT00415363|62768756|FG001|Overall Study|Physician Decision|1|||
33389714|NCT00415363|62768755|FG000|Overall Study|Death|16|||
33389715|NCT00415363|62768756|FG001|Overall Study|Death|12|||
33389716|NCT00415363|62768755|FG000|Overall Study|Progressive disease|26|||
33389717|NCT00415363|62768756|FG001|Overall Study|Progressive disease|32|||
33389718|NCT00415051|62768763|FG000|Overall Study|Protocol Violation|1|||
33389719|NCT00713258|62768769|FG000|Overall Study|Adverse Event|2|||
33389720|NCT00713258|62768770|FG001|Overall Study|Adverse Event|4|||
33556875|NCT02610140|62949721|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
33556876|NCT02610140|62949722|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
33556877|NCT02610140|62949721|FG000|Randomization and Treatment Period|Protocol Violation|1|||
33556878|NCT02610140|62949722|FG001|Randomization and Treatment Period|Protocol Violation|0|||
33556879|NCT02610140|62949721|FG000|Randomization and Treatment Period|Physician Decision|0|||
33556880|NCT02610140|62949722|FG001|Randomization and Treatment Period|Physician Decision|1|||
33556881|NCT02610140|62949721|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
33556882|NCT02610140|62949722|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
33556883|NCT02610140|62949721|FG000|Randomization and Treatment Period|Death|7|||
33556884|NCT02610140|62949722|FG001|Randomization and Treatment Period|Death|1|||
33556885|NCT02610140|62949721|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
33556886|NCT02610140|62949722|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
33556887|NCT02610140|62949721|FG000|Randomization and Treatment Period|Adverse Event|44|||
33556888|NCT02610140|62949722|FG001|Randomization and Treatment Period|Adverse Event|13|||
33556889|NCT02610140|62949721|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
33389721|NCT00713258|62768769|FG000|Overall Study|Non-Compliance|2|||
33389722|NCT00713258|62768770|FG001|Overall Study|Non-Compliance|1|||
33556890|NCT02610140|62949722|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
33389723|NCT00713258|62768769|FG000|Overall Study|Other|1|||
33389724|NCT00713258|62768770|FG001|Overall Study|Other|1|||
33389725|NCT00710034|62768778|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
33556891|NCT02610140|62949721|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
33556892|NCT02610140|62949722|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
33556893|NCT02610140|62949721|FG000|Randomization and Treatment Period|Not treated|3|||
33556894|NCT02610140|62949722|FG001|Randomization and Treatment Period|Not treated|10|||
33556895|NCT02610140|62949721|FG000|Safety Follow-up|Other|0|||
33556896|NCT02610140|62949722|FG001|Safety Follow-up|Other|2|||
33556897|NCT02610140|62949721|FG000|Safety Follow-up|Lost to Follow-up|1|||
33556898|NCT02610140|62949722|FG001|Safety Follow-up|Lost to Follow-up|0|||
33556899|NCT02610140|62949721|FG000|Safety Follow-up|No follow-up|5|||
33556900|NCT02610140|62949722|FG001|Safety Follow-up|No follow-up|3|||
33556901|NCT02610140|62949721|FG000|Safety Follow-up|Death|12|||
33556902|NCT02610140|62949722|FG001|Safety Follow-up|Death|2|||
33556903|NCT02610140|62949721|FG000|Safety Follow-up|Deterioration of general conditions|15|||
33556904|NCT02610140|62949722|FG001|Safety Follow-up|Deterioration of general conditions|5|||
33556905|NCT02610140|62949721|FG000|Safety Follow-up|Withdrawal by Subject|12|||
33556906|NCT02610140|62949722|FG001|Safety Follow-up|Withdrawal by Subject|12|||
33556907|NCT02610140|62949721|FG000|Active Follow-up|Progressive disease - radiological|30|||
33556908|NCT02610140|62949722|FG001|Active Follow-up|Progressive disease - radiological|22|||
33556909|NCT02610140|62949721|FG000|Active Follow-up|Death|8|||
33556910|NCT02610140|62949722|FG001|Active Follow-up|Death|1|||
33556911|NCT02610140|62949721|FG000|Active Follow-up|Withdrawal by Subject|4|||
33556912|NCT02610140|62949722|FG001|Active Follow-up|Withdrawal by Subject|0|||
33556913|NCT02610140|62949721|FG000|Active Follow-up|Progressive disease - clinical|1|||
33556914|NCT02610140|62949722|FG001|Active Follow-up|Progressive disease - clinical|2|||
33556915|NCT02610140|62949721|FG000|Active Follow-up|Deterioration of general conditions|1|||
33299349|NCT01326533|62675589|FG000|Overall Study|Withdrawal by Subject|1|||
33299350|NCT01326533|62675590|FG001|Overall Study|Withdrawal by Subject|0|||
33299351|NCT01326533|62675589|FG000|Overall Study|Adverse Event|1|||
33299352|NCT01326533|62675590|FG001|Overall Study|Adverse Event|0|||
33299353|NCT01045447|62675598|FG000|Overall Study|Adverse Event|0|||
33299354|NCT01045447|62675599|FG001|Overall Study|Adverse Event|1|||
33389726|NCT00710034|62768779|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
33389727|NCT00710034|62768778|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
33389728|NCT00710034|62768779|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
33389729|NCT00710034|62768778|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
33389730|NCT00710034|62768779|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
33389731|NCT00710034|62768778|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
33389732|NCT00710034|62768779|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
33389733|NCT00710034|62768778|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
33389734|NCT00710034|62768779|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
33389735|NCT00710034|62768778|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
33389736|NCT00710034|62768779|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
33389737|NCT00710034|62768778|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
33389738|NCT00710034|62768779|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
33389739|NCT00710034|62768778|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
33389740|NCT00710034|62768779|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
33389741|NCT00710034|62768778|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
33389742|NCT00710034|62768779|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
33389743|NCT00710034|62768778|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
33389744|NCT00710034|62768779|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
33389745|NCT00710034|62768778|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
33389746|NCT00710034|62768779|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
33389747|NCT00414973|62768789|FG000|Overall Study|Withdrawal by Subject|14|||
33389748|NCT00414973|62768790|FG001|Overall Study|Withdrawal by Subject|4|||
33389749|NCT00414973|62768791|FG002|Overall Study|Withdrawal by Subject|1|||
33389750|NCT00414973|62768792|FG003|Overall Study|Withdrawal by Subject|0|||
33389751|NCT00414973|62768789|FG000|Overall Study|Adverse Event|10|||
33389752|NCT00414973|62768790|FG001|Overall Study|Adverse Event|0|||
33389753|NCT00414973|62768791|FG002|Overall Study|Adverse Event|1|||
33389754|NCT00414973|62768792|FG003|Overall Study|Adverse Event|0|||
33556916|NCT02610140|62949722|FG001|Active Follow-up|Deterioration of general conditions|0|||
33299355|NCT01045447|62675598|FG000|Overall Study|Lack of Efficacy|3|||
33299356|NCT01045447|62675599|FG001|Overall Study|Lack of Efficacy|1|||
33389755|NCT00414973|62768789|FG000|Overall Study|Protocol Violation|3|||
33389756|NCT00414973|62768790|FG001|Overall Study|Protocol Violation|4|||
33389757|NCT00414973|62768791|FG002|Overall Study|Protocol Violation|0|||
33389758|NCT00414973|62768792|FG003|Overall Study|Protocol Violation|0|||
33389759|NCT00414973|62768789|FG000|Overall Study|Lost to Follow-up|0|||
33556917|NCT02610140|62949721|FG000|Active Follow-up|Ongoing but not completed|4|||
33556918|NCT02610140|62949722|FG001|Active Follow-up|Ongoing but not completed|1|||
33556919|NCT02610140|62949721|FG000|Long-term Follow-up|Death|86|||
33556920|NCT02610140|62949722|FG001|Long-term Follow-up|Death|44|||
33299357|NCT01045447|62675598|FG000|Overall Study|Protocol Violation|6|||
33299358|NCT01045447|62675599|FG001|Overall Study|Protocol Violation|3|||
33556921|NCT02610140|62949721|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
33556922|NCT02610140|62949722|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
33556923|NCT02610140|62949721|FG000|Long-term Follow-up|Lost to Follow-up|1|||
33556924|NCT02610140|62949722|FG001|Long-term Follow-up|Lost to Follow-up|2|||
33556925|NCT02610140|62949721|FG000|Long-term Follow-up|Ongoing but not completed|30|||
33556926|NCT02610140|62949722|FG001|Long-term Follow-up|Ongoing but not completed|17|||
33556927|NCT02789657|62949732|FG000|Overall Study|Withdrawal by Subject|2|||
33556928|NCT02789657|62949733|FG001|Overall Study|Withdrawal by Subject|0|||
33556929|NCT02789657|62949734|FG002|Overall Study|Withdrawal by Subject|0|||
33556930|NCT02789657|62949735|FG003|Overall Study|Withdrawal by Subject|0|||
33556931|NCT02609984|62949746|FG000|Overall Study|Death|29|||
33556932|NCT02609984|62949747|FG001|Overall Study|Death|26|||
33556933|NCT02609984|62949746|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
33556934|NCT02609984|62949747|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
33556935|NCT02609984|62949746|FG000|Overall Study|Lost to Follow-up|1|||
33556936|NCT02609984|62949747|FG001|Overall Study|Lost to Follow-up|2|||
33556937|NCT02609984|62949746|FG000|Overall Study|Withdrawal by Subject|0|||
33556938|NCT02609984|62949747|FG001|Overall Study|Withdrawal by Subject|1|||
33556939|NCT02609984|62949746|FG000|Overall Study|Disease Progression|2|||
33556940|NCT02609984|62949747|FG001|Overall Study|Disease Progression|0|||
33389760|NCT00414973|62768790|FG001|Overall Study|Lost to Follow-up|2|||
33389761|NCT00414973|62768791|FG002|Overall Study|Lost to Follow-up|0|||
33556941|NCT02609672|62949755|FG000|Overall Study|Lost to Follow-up|3|||
33389762|NCT00414973|62768792|FG003|Overall Study|Lost to Follow-up|0|||
33556942|NCT02609672|62949756|FG001|Overall Study|Lost to Follow-up|1|||
33556943|NCT02611778|62949764|FG000|Overall Study|Withdrawal by Subject|2|||
33556944|NCT02611778|62949765|FG001|Overall Study|Withdrawal by Subject|8|||
33556945|NCT02611778|62949764|FG000|Overall Study|Adverse Event|1|||
33556946|NCT02611778|62949765|FG001|Overall Study|Adverse Event|2|||
33556947|NCT02611778|62949764|FG000|Overall Study|Death|2|||
33556948|NCT02611778|62949765|FG001|Overall Study|Death|1|||
33556949|NCT02611778|62949764|FG000|Overall Study|Protocol Violation|1|||
33556950|NCT02611778|62949765|FG001|Overall Study|Protocol Violation|0|||
33556951|NCT02611778|62949764|FG000|Overall Study|Lost to Follow-up|3|||
33556952|NCT02611778|62949765|FG001|Overall Study|Lost to Follow-up|1|||
33556953|NCT02611778|62949764|FG000|Overall Study|Need for alternative treatment|1|||
33556954|NCT02611778|62949765|FG001|Overall Study|Need for alternative treatment|0|||
33556955|NCT02611778|62949764|FG000|Overall Study|Other Reason|2|||
33556956|NCT02611778|62949765|FG001|Overall Study|Other Reason|1|||
33556957|NCT02711553|62949776|FG000|Overall Study|Withdrawal by Subject|2|||
33556958|NCT02711553|62949777|FG001|Overall Study|Withdrawal by Subject|1|||
33556959|NCT02711553|62949778|FG002|Overall Study|Withdrawal by Subject|1|||
33556960|NCT02711553|62949779|FG003|Overall Study|Withdrawal by Subject|0|||
33556961|NCT02711553|62949776|FG000|Overall Study|Lost to Follow-up|3|||
33556962|NCT02711553|62949777|FG001|Overall Study|Lost to Follow-up|3|||
33556963|NCT02711553|62949778|FG002|Overall Study|Lost to Follow-up|6|||
33556964|NCT02711553|62949779|FG003|Overall Study|Lost to Follow-up|3|||
33556965|NCT02711553|62949776|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
33556966|NCT02711553|62949777|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
33556967|NCT02711553|62949778|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
33389763|NCT00414973|62768789|FG000|Overall Study|Sponsor Decision|1|||
33389764|NCT00414973|62768790|FG001|Overall Study|Sponsor Decision|0|||
33389765|NCT00414973|62768791|FG002|Overall Study|Sponsor Decision|0|||
33389766|NCT00414973|62768792|FG003|Overall Study|Sponsor Decision|0|||
33389767|NCT00414973|62768789|FG000|Overall Study|Death|0|||
33389768|NCT00414973|62768790|FG001|Overall Study|Death|0|||
33389769|NCT00414973|62768791|FG002|Overall Study|Death|1|||
33389770|NCT00414973|62768792|FG003|Overall Study|Death|0|||
33389771|NCT00423085|62768805|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
33389772|NCT00423085|62768806|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
33389773|NCT00423085|62768807|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
33389774|NCT00423085|62768808|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
33389775|NCT00423085|62768805|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
33389776|NCT00423085|62768806|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
33389777|NCT00423085|62768807|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
33389778|NCT00423085|62768808|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
33556968|NCT02711553|62949779|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
33556969|NCT02709369|62949791|FG000|Overall Study|Lost to Follow-up|15|||
33556970|NCT02709369|62949791|FG000|Overall Study|Withdrawal by Subject|10|||
33556971|NCT02709369|62949791|FG000|Overall Study|Did not received intervention|2|||
33556972|NCT02613182|62949795|FG000|Overall Study|Death|6|||
33556973|NCT02613182|62949795|FG000|Overall Study|Physician Decision|1|||
33556974|NCT02613182|62949795|FG000|Overall Study|Study Terminated by Sponsor|21|||
33556975|NCT02613182|62949795|FG000|Overall Study|Withdrawal by Subject|6|||
33556976|NCT02610842|62949799|FG000|Overall Study|Lost to Follow-up|5|||
33556977|NCT01648582|62949808|FG000|Overall Study|Adverse Event|6|||
33389779|NCT00423085|62768805|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
33389780|NCT00423085|62768806|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
33389781|NCT00423085|62768807|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
33389782|NCT00423085|62768808|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
33389783|NCT00423085|62768805|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
33389784|NCT00423085|62768806|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
33389785|NCT00423085|62768807|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
33389786|NCT00423085|62768808|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
33389787|NCT00423085|62768805|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
33389788|NCT00423085|62768806|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
33556978|NCT01648582|62949809|FG001|Overall Study|Adverse Event|11|||
33556979|NCT01648582|62949810|FG002|Overall Study|Adverse Event|2|||
33556980|NCT01648582|62949808|FG000|Overall Study|Lost to Follow-up|9|||
33556981|NCT01648582|62949809|FG001|Overall Study|Lost to Follow-up|6|||
33556982|NCT01648582|62949810|FG002|Overall Study|Lost to Follow-up|8|||
33556983|NCT01648582|62949808|FG000|Overall Study|Protocol Violation|1|||
33556984|NCT01648582|62949809|FG001|Overall Study|Protocol Violation|2|||
33556985|NCT01648582|62949810|FG002|Overall Study|Protocol Violation|1|||
33556986|NCT01648582|62949808|FG000|Overall Study|Withdrawal by Subject|15|||
33556987|NCT01648582|62949809|FG001|Overall Study|Withdrawal by Subject|17|||
33556988|NCT01648582|62949810|FG002|Overall Study|Withdrawal by Subject|17|||
33556989|NCT01648582|62949808|FG000|Overall Study|Physician Decision|0|||
33556990|NCT01648582|62949809|FG001|Overall Study|Physician Decision|1|||
33556991|NCT01648582|62949810|FG002|Overall Study|Physician Decision|3|||
33556992|NCT01648582|62949808|FG000|Overall Study|Death|1|||
33556993|NCT01648582|62949809|FG001|Overall Study|Death|0|||
33556994|NCT01648582|62949810|FG002|Overall Study|Death|0|||
33556995|NCT01648582|62949808|FG000|Overall Study|Sponsor Decision|0|||
33556996|NCT01648582|62949809|FG001|Overall Study|Sponsor Decision|1|||
33556997|NCT01648582|62949810|FG002|Overall Study|Sponsor Decision|1|||
33299359|NCT01045447|62675598|FG000|Overall Study|Withdrawal Criteria|10|||
33299360|NCT01045447|62675599|FG001|Overall Study|Withdrawal Criteria|10|||
33299361|NCT01045447|62675598|FG000|Overall Study|Unclassified|17|||
33299362|NCT01045447|62675599|FG001|Overall Study|Unclassified|13|||
33299363|NCT01301625|62675605|FG000|Overall Study|Death|5|||
33299364|NCT01301625|62675605|FG000|Overall Study|Not Due|21|||
33299365|NCT01301625|62675605|FG000|Overall Study|Expected|8|||
33299366|NCT01301625|62675605|FG000|Overall Study|Lost to Follow-up|1|||
33299367|NCT01301391|62675609|FG000|Overall Study|Death|13|||
33389789|NCT00423085|62768807|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
33389790|NCT00423085|62768808|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
33389791|NCT00423085|62768805|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
33389792|NCT00423085|62768806|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
33389793|NCT00423085|62768807|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
33389794|NCT00423085|62768808|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
33389795|NCT00423085|62768805|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
33299368|NCT01301391|62675609|FG000|Overall Study|Lost to Follow-up|3|||
33299369|NCT01301391|62675609|FG000|Overall Study|Physician Decision|2|||
33299370|NCT01301391|62675609|FG000|Overall Study|Sponsor's decision|8|||
33299371|NCT01036321|62675615|FG000|Overall Study|Ineligible after randomization|0|||
33299372|NCT01036321|62675616|FG001|Overall Study|Ineligible after randomization|1|||
33299373|NCT01036321|62675615|FG000|Overall Study|Withdrawal by Subject|3|||
33299374|NCT01036321|62675616|FG001|Overall Study|Withdrawal by Subject|2|||
33299375|NCT01036321|62675615|FG000|Overall Study|Adverse Event|2|||
33299376|NCT01036321|62675616|FG001|Overall Study|Adverse Event|1|||
33299377|NCT01061359|62675622|FG000|Overall Study|Death|32|||
33299378|NCT01061359|62675622|FG000|Overall Study|Lost to Follow-up|1072|||
33299379|NCT01061359|62675622|FG000|Overall Study|Relapse|187|||
33299380|NCT01061359|62675622|FG000|Overall Study|Secondary neoplasm|11|||
33299381|NCT01301079|62675628|FG000|Overall Study|Lost to Follow-up|2|||
33299382|NCT01301079|62675629|FG001|Overall Study|Lost to Follow-up|2|||
33299383|NCT01036165|62675639|FG000|Overall Study|Adverse Event|6|||
33389796|NCT00423085|62768806|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
33556998|NCT02607800|62949823|FG000|Overall Study|Lost to Follow-up|7|||
33556999|NCT02607800|62949824|FG001|Overall Study|Lost to Follow-up|10|||
33557000|NCT02607800|62949823|FG000|Overall Study|Withdrew Consent|2|||
33557001|NCT02607800|62949824|FG001|Overall Study|Withdrew Consent|0|||
33557002|NCT02607800|62949823|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
33299384|NCT01036165|62675639|FG000|Overall Study|Lost to Follow-up|2|||
33299385|NCT01036165|62675639|FG000|Overall Study|Withdrawal by Subject|3|||
33299386|NCT01036165|62675639|FG000|Overall Study|Device Related Issues|3|||
33557003|NCT02607800|62949824|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
33299387|NCT01036165|62675639|FG000|Overall Study|Problems finding proper area to inject|1|||
33299388|NCT01301001|62675643|FG000|First Intervention|Lost to Follow-up|4|||
33299389|NCT01301001|62675644|FG001|First Intervention|Lost to Follow-up|4|||
33299390|NCT01301001|62675643|FG000|First Intervention|Withdrawal by Subject|1|||
33557004|NCT02304484|62949831|FG000|Overall Study|Death|9|||
33557005|NCT02304484|62949831|FG000|Overall Study|Withdrawal by Subject|14|||
33557006|NCT02304484|62949831|FG000|Overall Study|Lost to Follow-up|2|||
33557007|NCT02708355|62949838|FG000|Overall Study|Adverse Event|1|||
33557008|NCT02708355|62949839|FG001|Overall Study|Adverse Event|0|||
33557009|NCT02708355|62949840|FG002|Overall Study|Adverse Event|0|||
33557010|NCT02708277|62949850|FG000|Overall Study|Lost to Follow-up|7|||
33557011|NCT02708277|62949851|FG001|Overall Study|Lost to Follow-up|4|||
33557012|NCT02337478|62949857|FG000|Overall Study|Lack of Efficacy|5|||
33557013|NCT02303704|62949863|FG000|Overall Study|Protocol Violation|5|||
33557014|NCT02303704|62949864|FG001|Overall Study|Protocol Violation|9|||
33557015|NCT02608892|62949872|FG000|Overall Study|Lost to Follow-up|1|||
33557016|NCT02608892|62949873|FG001|Overall Study|Lost to Follow-up|0|||
33557017|NCT02706951|62949883|FG000|Overall Study|Adverse Event|1|||
33557018|NCT02706951|62949884|FG001|Overall Study|Adverse Event|5|||
33557019|NCT02706951|62949885|FG002|Overall Study|Adverse Event|3|||
33557020|NCT02706951|62949883|FG000|Overall Study|Withdrawal by Subject|11|||
33557021|NCT02706951|62949884|FG001|Overall Study|Withdrawal by Subject|6|||
33557022|NCT02706951|62949885|FG002|Overall Study|Withdrawal by Subject|6|||
33557023|NCT02706951|62949883|FG000|Overall Study|Lost to Follow-up|0|||
33557024|NCT02706951|62949884|FG001|Overall Study|Lost to Follow-up|4|||
33557025|NCT02706951|62949885|FG002|Overall Study|Lost to Follow-up|1|||
33557026|NCT02706951|62949883|FG000|Overall Study|Other|2|||
33557027|NCT02706951|62949884|FG001|Overall Study|Other|1|||
33557028|NCT02706951|62949885|FG002|Overall Study|Other|0|||
33557029|NCT02708121|62949895|FG000|Overall Study|Withdrawn by Study Team|1|||
33557030|NCT02708121|62949896|FG001|Overall Study|Withdrawn by Study Team|1|||
33557031|NCT02708121|62949895|FG000|Overall Study|Withdrawal by Subject|0|||
33557032|NCT02708121|62949896|FG001|Overall Study|Withdrawal by Subject|4|||
33557033|NCT02707965|62949911|FG000|Overall Study|Withdrawal by Subject|0|||
33557034|NCT02707965|62949912|FG001|Overall Study|Withdrawal by Subject|0|||
33557035|NCT02707965|62949913|FG002|Overall Study|Withdrawal by Subject|1|||
33557036|NCT02707965|62949914|FG003|Overall Study|Withdrawal by Subject|0|||
33557037|NCT02707965|62949915|FG004|Overall Study|Withdrawal by Subject|0|||
33557038|NCT02707965|62949916|FG005|Overall Study|Withdrawal by Subject|0|||
33557039|NCT02707965|62949917|FG006|Overall Study|Withdrawal by Subject|0|||
33557040|NCT02707965|62949918|FG007|Overall Study|Withdrawal by Subject|2|||
33557041|NCT02707965|62949919|FG008|Overall Study|Withdrawal by Subject|0|||
33557042|NCT02707965|62949920|FG009|Overall Study|Withdrawal by Subject|0|||
33557043|NCT02707965|62949921|FG010|Overall Study|Withdrawal by Subject|0|||
33557044|NCT02707965|62949922|FG011|Overall Study|Withdrawal by Subject|0|||
33557045|NCT02707965|62949923|FG012|Overall Study|Withdrawal by Subject|0|||
33557046|NCT02707965|62949924|FG013|Overall Study|Withdrawal by Subject|0|||
33557047|NCT02707965|62949925|FG014|Overall Study|Withdrawal by Subject|0|||
33557048|NCT02707965|62949926|FG015|Overall Study|Withdrawal by Subject|0|||
33557049|NCT02707965|62949911|FG000|Overall Study|PI decisions|0|||
33557050|NCT02707965|62949912|FG001|Overall Study|PI decisions|0|||
33557051|NCT02707965|62949913|FG002|Overall Study|PI decisions|0|||
33557052|NCT02707965|62949914|FG003|Overall Study|PI decisions|0|||
33557053|NCT02707965|62949915|FG004|Overall Study|PI decisions|0|||
33557054|NCT02707965|62949916|FG005|Overall Study|PI decisions|0|||
33557055|NCT02707965|62949917|FG006|Overall Study|PI decisions|0|||
33557056|NCT02707965|62949918|FG007|Overall Study|PI decisions|0|||
33557057|NCT02707965|62949919|FG008|Overall Study|PI decisions|0|||
33557058|NCT02707965|62949920|FG009|Overall Study|PI decisions|0|||
33557059|NCT02707965|62949921|FG010|Overall Study|PI decisions|0|||
33557060|NCT02707965|62949922|FG011|Overall Study|PI decisions|0|||
33557061|NCT02707965|62949923|FG012|Overall Study|PI decisions|0|||
33557062|NCT02707965|62949924|FG013|Overall Study|PI decisions|0|||
33557063|NCT02707965|62949925|FG014|Overall Study|PI decisions|2|||
33557064|NCT02707965|62949926|FG015|Overall Study|PI decisions|0|||
33557065|NCT02707965|62949911|FG000|Overall Study|Protocol deviation|1|||
33557066|NCT02707965|62949912|FG001|Overall Study|Protocol deviation|1|||
33557067|NCT02707965|62949913|FG002|Overall Study|Protocol deviation|0|||
33557068|NCT02707965|62949914|FG003|Overall Study|Protocol deviation|0|||
33557069|NCT02707965|62949915|FG004|Overall Study|Protocol deviation|0|||
33557070|NCT02707965|62949916|FG005|Overall Study|Protocol deviation|0|||
33557071|NCT02707965|62949917|FG006|Overall Study|Protocol deviation|0|||
33557072|NCT02707965|62949918|FG007|Overall Study|Protocol deviation|1|||
33557073|NCT02707965|62949919|FG008|Overall Study|Protocol deviation|0|||
33557074|NCT02707965|62949920|FG009|Overall Study|Protocol deviation|0|||
33557075|NCT02707965|62949921|FG010|Overall Study|Protocol deviation|0|||
33557076|NCT02707965|62949922|FG011|Overall Study|Protocol deviation|0|||
33557077|NCT02707965|62949923|FG012|Overall Study|Protocol deviation|0|||
33557078|NCT02707965|62949924|FG013|Overall Study|Protocol deviation|0|||
33557079|NCT02707965|62949925|FG014|Overall Study|Protocol deviation|0|||
33557080|NCT02707965|62949926|FG015|Overall Study|Protocol deviation|0|||
33557081|NCT01667900|62949964|FG000|Part B|Death|0|||
33557082|NCT01667900|62949965|FG001|Part B|Death|0|||
33557083|NCT01667900|62949966|FG002|Part B|Death|0|||
33557084|NCT01667900|62949967|FG003|Part B|Death|0|||
33557085|NCT01667900|62949968|FG004|Part B|Death|0|||
33557086|NCT01667900|62949969|FG005|Part B|Death|0|||
33557087|NCT01667900|62949970|FG006|Part B|Death|0|||
33557088|NCT01667900|62949971|FG007|Part B|Death|0|||
33557089|NCT01667900|62949972|FG008|Part B|Death|0|||
33557090|NCT01667900|62949973|FG009|Part B|Death|0|||
33557091|NCT01667900|62949974|FG010|Part B|Death|0|||
33557092|NCT01667900|62949975|FG011|Part B|Death|0|||
33557093|NCT01667900|62949976|FG012|Part B|Death|0|||
33557094|NCT01667900|62949977|FG013|Part B|Death|0|||
33557095|NCT01667900|62949978|FG014|Part B|Death|0|||
33557096|NCT01667900|62949979|FG015|Part B|Death|0|||
33557097|NCT01667900|62949980|FG016|Part B|Death|1|||
33557098|NCT01667900|62949981|FG017|Part B|Death|0|||
33557099|NCT01667900|62949982|FG018|Part B|Death|0|||
33557100|NCT01667900|62949983|FG019|Part B|Death|0|||
33557101|NCT02605928|62950012|FG000|Overall Study|Model tuning phase|28|||
33557102|NCT02605928|62950012|FG000|Overall Study|Lack of Efficacy|5|||
33557103|NCT02706717|62950018|FG000|Overall Study|Withdrawal by Subject|1|||
33557104|NCT02706717|62950019|FG001|Overall Study|Withdrawal by Subject|8|||
33557105|NCT02706717|62950018|FG000|Overall Study|Lost to Follow-up|0|||
33557106|NCT02706717|62950019|FG001|Overall Study|Lost to Follow-up|1|||
33557107|NCT02706717|62950018|FG000|Overall Study|Physician Decision|0|||
33557108|NCT02706717|62950019|FG001|Overall Study|Physician Decision|1|||
33557109|NCT02706717|62950018|FG000|Overall Study|Death|0|||
33557110|NCT02706717|62950019|FG001|Overall Study|Death|1|||
33557111|NCT01331837|62950027|FG000|Overall Study|Death|30|||
33557112|NCT01331837|62950028|FG001|Overall Study|Death|34|||
33557113|NCT01331837|62950027|FG000|Overall Study|Lost to Follow-up|3|||
33557114|NCT01331837|62950028|FG001|Overall Study|Lost to Follow-up|1|||
33557115|NCT01331837|62950027|FG000|Overall Study|Info not recorded|10|||
33557116|NCT01331837|62950028|FG001|Overall Study|Info not recorded|16|||
33557117|NCT01331837|62950027|FG000|Overall Study|Withdrawal by Subject|13|||
33557118|NCT01331837|62950028|FG001|Overall Study|Withdrawal by Subject|16|||
33557119|NCT02706483|62950034|FG000|Overall Study|Adverse Event|97|||
33557120|NCT02706483|62950034|FG000|Overall Study|Death|1|||
33557121|NCT02706483|62950034|FG000|Overall Study|Lack of Efficacy|39|||
33557122|NCT02706483|62950034|FG000|Overall Study|Lost to Follow-up|101|||
33557123|NCT02706483|62950034|FG000|Overall Study|Non-compliance with study drug|15|||
33557124|NCT02706483|62950034|FG000|Overall Study|Physician Decision|6|||
33557125|NCT02706483|62950034|FG000|Overall Study|Pregnancy|6|||
33557126|NCT02706483|62950034|FG000|Overall Study|Protocol Violation|18|||
33557127|NCT02706483|62950034|FG000|Overall Study|Withdrawal by Subject|136|||
33557128|NCT02706483|62950034|FG000|Overall Study|Non-compliance with visits|6|||
33557129|NCT02706483|62950034|FG000|Overall Study|Site closure|4|||
33557130|NCT02706483|62950034|FG000|Overall Study|Subject moved|1|||
33557131|NCT01648348|62950041|FG000|Overall Study|Cancel|1|||
33557132|NCT01648348|62950042|FG001|Overall Study|Cancel|0|||
33557133|NCT01648348|62950043|FG002|Overall Study|Cancel|0|||
33557134|NCT01648348|62950044|FG003|Overall Study|Cancel|0|||
33557135|NCT01648348|62950045|FG004|Overall Study|Cancel|3|||
33557136|NCT01648348|62950046|FG005|Overall Study|Cancel|6|||
33557137|NCT01648348|62950041|FG000|Overall Study|Replaced for MTD analysis|1|||
33557138|NCT01648348|62950042|FG001|Overall Study|Replaced for MTD analysis|0|||
33557139|NCT01648348|62950043|FG002|Overall Study|Replaced for MTD analysis|1|||
33557140|NCT01648348|62950044|FG003|Overall Study|Replaced for MTD analysis|0|||
33557141|NCT01648348|62950045|FG004|Overall Study|Replaced for MTD analysis|0|||
33557142|NCT01648348|62950046|FG005|Overall Study|Replaced for MTD analysis|0|||
33557143|NCT01648270|62950059|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
33557144|NCT02302846|62950069|FG000|Overall Study|Withdrawal by Subject|1|||
33557145|NCT02336230|62950073|FG000|Overall Study|Adverse Event|1|||
33557146|NCT02336230|62950073|FG000|Overall Study|Withdrawal of consent|1|||
33299391|NCT01301001|62675644|FG001|First Intervention|Withdrawal by Subject|4|||
33557147|NCT02336230|62950073|FG000|Overall Study|Death|9|||
33557148|NCT02336230|62950073|FG000|Overall Study|Dose not received due to shipping delay|1|||
33557149|NCT02336230|62950073|FG000|Overall Study|Discontinuation of MSC infusion|1|||
33557150|NCT02302222|62950079|FG000|Overall Study|Physician Decision|0|||
33557151|NCT02302222|62950080|FG001|Overall Study|Physician Decision|4|||
33557152|NCT02302222|62950079|FG000|Overall Study|Lost to Follow-up|1|||
33557153|NCT02302222|62950080|FG001|Overall Study|Lost to Follow-up|0|||
33557154|NCT02302222|62950079|FG000|Overall Study|Treatment discontinued before day 5|0|||
33557155|NCT02302222|62950080|FG001|Overall Study|Treatment discontinued before day 5|1|||
33557156|NCT02302222|62950079|FG000|Overall Study|Withdrawn prior to any treatment|0|||
33557157|NCT02302222|62950080|FG001|Overall Study|Withdrawn prior to any treatment|1|||
33557158|NCT02336074|62950088|FG000|Overall Study|Adverse Event|0|||
33557159|NCT02336074|62950089|FG001|Overall Study|Adverse Event|2|||
33557160|NCT02335450|62950100|FG000|Overall Study|Pregnancy|1|||
33557161|NCT02302066|62950114|FG000|Overall Study|Adverse Event|1|||
33557162|NCT02302066|62950115|FG001|Overall Study|Adverse Event|1|||
33557163|NCT02302066|62950116|FG002|Overall Study|Adverse Event|3|||
33557164|NCT02302066|62950117|FG003|Overall Study|Adverse Event|0|||
33299392|NCT01301001|62675643|FG000|First Intervention|Adverse Event|5|||
33299393|NCT01301001|62675644|FG001|First Intervention|Adverse Event|0|||
33299394|NCT01301001|62675643|FG000|First Intervention|Protocol Violation|0|||
33389797|NCT00423085|62768807|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
33389798|NCT00423085|62768808|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
33389799|NCT00423085|62768805|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
33389800|NCT00423085|62768806|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
33389801|NCT00423085|62768807|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
33389802|NCT00423085|62768808|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
33389803|NCT00423085|62768805|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
33389804|NCT00423085|62768806|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
33389805|NCT00423085|62768807|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
33389806|NCT00423085|62768808|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
33389807|NCT00423085|62768805|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
33389808|NCT00423085|62768806|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
33389809|NCT00423085|62768807|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
33389810|NCT00423085|62768808|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
33389811|NCT00423085|62768805|FG000|52-Week Open-Label Extension Phase|Death|0|||
33389812|NCT00423085|62768806|FG001|52-Week Open-Label Extension Phase|Death|0|||
33389813|NCT00423085|62768807|FG002|52-Week Open-Label Extension Phase|Death|0|||
33389814|NCT00423085|62768808|FG003|52-Week Open-Label Extension Phase|Death|2|||
33389815|NCT00414661|62768822|FG000|Overall Study|Death|2|||
33389816|NCT00414661|62768823|FG001|Overall Study|Death|5|||
33389817|NCT00414661|62768824|FG002|Overall Study|Death|0|||
33389818|NCT00414661|62768825|FG003|Overall Study|Death|0|||
33389819|NCT00414661|62768822|FG000|Overall Study|Lost to Follow-up|1|||
33389820|NCT00414661|62768823|FG001|Overall Study|Lost to Follow-up|4|||
33389821|NCT00414661|62768824|FG002|Overall Study|Lost to Follow-up|0|||
33389822|NCT00414661|62768825|FG003|Overall Study|Lost to Follow-up|1|||
33389823|NCT00414661|62768822|FG000|Overall Study|Withdrawal by Subject|5|||
33389824|NCT00414661|62768823|FG001|Overall Study|Withdrawal by Subject|2|||
33389825|NCT00414661|62768824|FG002|Overall Study|Withdrawal by Subject|2|||
33389826|NCT00414661|62768825|FG003|Overall Study|Withdrawal by Subject|2|||
33389827|NCT00414661|62768822|FG000|Overall Study|Other|6|||
33389828|NCT00414661|62768823|FG001|Overall Study|Other|3|||
33389829|NCT00414661|62768824|FG002|Overall Study|Other|0|||
33389830|NCT00414661|62768825|FG003|Overall Study|Other|0|||
33389831|NCT00405067|62768838|FG000|Overall Study|Adverse Event|4|||
33389832|NCT00405067|62768839|FG001|Overall Study|Adverse Event|9|||
33389833|NCT00405067|62768840|FG002|Overall Study|Adverse Event|4|||
33389834|NCT00405067|62768838|FG000|Overall Study|Lost to Follow-up|0|||
33389835|NCT00405067|62768839|FG001|Overall Study|Lost to Follow-up|0|||
33389836|NCT00405067|62768840|FG002|Overall Study|Lost to Follow-up|1|||
33389837|NCT00708708|62768848|FG000|Overall Study|Another therapy instead of Enbrel|141|||
33389838|NCT00708708|62768848|FG000|Overall Study|Lost to Follow-up|52|||
33389839|NCT00708708|62768848|FG000|Overall Study|Withdrawal by Subject|51|||
33389840|NCT00708708|62768848|FG000|Overall Study|Intolerance|42|||
33389841|NCT00708708|62768848|FG000|Overall Study|Another therapy along with Enbrel|15|||
33389842|NCT00708708|62768848|FG000|Overall Study|Other unspecified|11|||
33389843|NCT00708708|62768848|FG000|Overall Study|Good effectiveness|9|||
33389844|NCT00708708|62768848|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
33389845|NCT00708708|62768848|FG000|Overall Study|Administrative reasons|7|||
33389846|NCT00708708|62768848|FG000|Overall Study|Lack of effectiveness|4|||
33389847|NCT00708708|62768848|FG000|Overall Study|Lack of compliance|3|||
33299395|NCT01301001|62675644|FG001|First Intervention|Protocol Violation|1|||
33299396|NCT01301001|62675643|FG000|Second Intervention|Adverse Event|2|||
33299397|NCT01301001|62675644|FG001|Second Intervention|Adverse Event|0|||
33299398|NCT01301001|62675643|FG000|Second Intervention|Withdrawal by Subject|2|||
33389848|NCT00708708|62768848|FG000|Overall Study|Pregnancy|3|||
33389849|NCT00708708|62768848|FG000|Overall Study|Adverse Event|3|||
33389850|NCT00708708|62768848|FG000|Overall Study|Missing values|392|||
33389851|NCT00404755|62768855|FG000|Phase I (Bupropion)|Adverse Event|3|||
33389852|NCT00404755|62768855|FG000|Phase I (Bupropion)|Other|1|||
33389853|NCT00404755|62768855|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
33389854|NCT00614614|62768865|FG000|Primary Vaccination Phase|Adverse Event|6|||
33389855|NCT00614614|62768866|FG001|Primary Vaccination Phase|Adverse Event|0|||
33389856|NCT00614614|62768867|FG002|Primary Vaccination Phase|Adverse Event|0|||
33389857|NCT00614614|62768868|FG003|Primary Vaccination Phase|Adverse Event|0|||
33389858|NCT00614614|62768869|FG004|Primary Vaccination Phase|Adverse Event|0|||
33389859|NCT00614614|62768865|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
33389860|NCT00614614|62768866|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
33299399|NCT01301001|62675644|FG001|Second Intervention|Withdrawal by Subject|0|||
33299400|NCT01035463|62675653|FG000|Overall Study|Adverse Event|0|||
33389861|NCT00614614|62768867|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
33557165|NCT02302066|62950114|FG000|Overall Study|Lost to Follow-up|4|||
33557166|NCT02302066|62950115|FG001|Overall Study|Lost to Follow-up|5|||
33557167|NCT02302066|62950116|FG002|Overall Study|Lost to Follow-up|24|||
33557168|NCT02302066|62950117|FG003|Overall Study|Lost to Follow-up|7|||
33557169|NCT02302066|62950114|FG000|Overall Study|Withdrawal by Subject|25|||
33557170|NCT02302066|62950115|FG001|Overall Study|Withdrawal by Subject|58|||
33557171|NCT02302066|62950116|FG002|Overall Study|Withdrawal by Subject|124|||
33557172|NCT02302066|62950117|FG003|Overall Study|Withdrawal by Subject|33|||
33557173|NCT02302066|62950114|FG000|Overall Study|Pregnancy|2|||
33557174|NCT02302066|62950115|FG001|Overall Study|Pregnancy|10|||
33557175|NCT02302066|62950116|FG002|Overall Study|Pregnancy|12|||
33557176|NCT02302066|62950117|FG003|Overall Study|Pregnancy|0|||
33389862|NCT00614614|62768868|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
33389863|NCT00614614|62768869|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
33389864|NCT00614614|62768865|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
33389865|NCT00614614|62768866|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
33389866|NCT00614614|62768867|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
33389867|NCT00614614|62768868|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
33389868|NCT00614614|62768869|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
33389869|NCT00614614|62768865|FG000|Primary Vaccination Phase|Protocol Violation|9|||
33389870|NCT00614614|62768866|FG001|Primary Vaccination Phase|Protocol Violation|3|||
33389871|NCT00614614|62768867|FG002|Primary Vaccination Phase|Protocol Violation|0|||
33389872|NCT00614614|62768868|FG003|Primary Vaccination Phase|Protocol Violation|0|||
33389873|NCT00614614|62768869|FG004|Primary Vaccination Phase|Protocol Violation|0|||
33389874|NCT00614614|62768865|FG000|Primary Vaccination Phase|Other|4|||
33389875|NCT00614614|62768866|FG001|Primary Vaccination Phase|Other|0|||
33389876|NCT00614614|62768867|FG002|Primary Vaccination Phase|Other|0|||
33389877|NCT00614614|62768868|FG003|Primary Vaccination Phase|Other|0|||
33389878|NCT00614614|62768869|FG004|Primary Vaccination Phase|Other|0|||
33389879|NCT00614614|62768865|FG000|Booster Vaccination Phase|Adverse Event|0|||
33389880|NCT00614614|62768866|FG001|Booster Vaccination Phase|Adverse Event|0|||
33389881|NCT00614614|62768867|FG002|Booster Vaccination Phase|Adverse Event|1|||
33389882|NCT00614614|62768868|FG003|Booster Vaccination Phase|Adverse Event|1|||
33389883|NCT00614614|62768869|FG004|Booster Vaccination Phase|Adverse Event|0|||
33389884|NCT00614614|62768865|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
33389885|NCT00614614|62768866|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
33389886|NCT00614614|62768867|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
33389887|NCT00614614|62768868|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
33389888|NCT00614614|62768869|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
33389889|NCT00614614|62768865|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
33389890|NCT00614614|62768866|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
33389891|NCT00614614|62768867|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
33389892|NCT00614614|62768868|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
33389893|NCT00614614|62768869|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
33389894|NCT00614614|62768865|FG000|Booster Vaccination Phase|Protocol Violation|0|||
33389895|NCT00614614|62768866|FG001|Booster Vaccination Phase|Protocol Violation|0|||
33389896|NCT00614614|62768867|FG002|Booster Vaccination Phase|Protocol Violation|2|||
33389897|NCT00614614|62768868|FG003|Booster Vaccination Phase|Protocol Violation|3|||
33389898|NCT00614614|62768869|FG004|Booster Vaccination Phase|Protocol Violation|0|||
33389899|NCT00614614|62768865|FG000|Booster Vaccination Phase|Other|0|||
33389900|NCT00614614|62768866|FG001|Booster Vaccination Phase|Other|1|||
33389901|NCT00614614|62768867|FG002|Booster Vaccination Phase|Other|3|||
33389902|NCT00614614|62768868|FG003|Booster Vaccination Phase|Other|2|||
33389903|NCT00614614|62768869|FG004|Booster Vaccination Phase|Other|1|||
33389904|NCT00713310|62768886|FG000|Overall Study|Adverse Event|5|||
33389905|NCT00713310|62768887|FG001|Overall Study|Adverse Event|2|||
33557177|NCT02302066|62950114|FG000|Overall Study|Reason Not Specified|1|||
33557178|NCT02302066|62950115|FG001|Overall Study|Reason Not Specified|1|||
33557179|NCT02302066|62950116|FG002|Overall Study|Reason Not Specified|9|||
33299401|NCT01035463|62675654|FG001|Overall Study|Adverse Event|0|||
33299402|NCT01035463|62675655|FG002|Overall Study|Adverse Event|4|||
33299403|NCT01035463|62675656|FG003|Overall Study|Adverse Event|1|||
33299404|NCT01035463|62675657|FG004|Overall Study|Adverse Event|5|||
33299405|NCT01035463|62675658|FG005|Overall Study|Adverse Event|7|||
33299406|NCT01035463|62675653|FG000|Overall Study|Withdrawal by Subject|0|||
33299407|NCT01035463|62675654|FG001|Overall Study|Withdrawal by Subject|2|||
33299408|NCT01035463|62675655|FG002|Overall Study|Withdrawal by Subject|1|||
33389906|NCT00713310|62768886|FG000|Overall Study|Lack of Efficacy|0|||
33389907|NCT00713310|62768887|FG001|Overall Study|Lack of Efficacy|2|||
33389908|NCT00713310|62768886|FG000|Overall Study|Withdrawal by Subject|0|||
33389909|NCT00713310|62768887|FG001|Overall Study|Withdrawal by Subject|2|||
33557180|NCT02302066|62950117|FG003|Overall Study|Reason Not Specified|1|||
33299409|NCT01035463|62675656|FG003|Overall Study|Withdrawal by Subject|0|||
33389910|NCT00422461|62768897|FG000|Overall Study|Adverse Event|1|||
33389911|NCT00422461|62768898|FG001|Overall Study|Adverse Event|2|||
33299410|NCT01035463|62675657|FG004|Overall Study|Withdrawal by Subject|1|||
33389912|NCT00422461|62768899|FG002|Overall Study|Adverse Event|1|||
33557181|NCT02301988|62950139|FG000|Overall Study|Withdrawal by Subject|2|||
33389913|NCT00422461|62768900|FG003|Overall Study|Adverse Event|1|||
33389914|NCT00422461|62768897|FG000|Overall Study|Other|0|||
33389915|NCT00422461|62768898|FG001|Overall Study|Other|0|||
33389916|NCT00422461|62768899|FG002|Overall Study|Other|0|||
33389917|NCT00422461|62768900|FG003|Overall Study|Other|2|||
33389918|NCT00422461|62768897|FG000|Overall Study|Participants no longer willing to participate in study|1|||
33389919|NCT00422461|62768898|FG001|Overall Study|Participants no longer willing to participate in study|0|||
33389920|NCT00422461|62768899|FG002|Overall Study|Participants no longer willing to participate in study|0|||
33389921|NCT00422461|62768900|FG003|Overall Study|Participants no longer willing to participate in study|0|||
33389922|NCT00422461|62768897|FG000|Overall Study|Randomized but not treated|1|||
33389923|NCT00422461|62768898|FG001|Overall Study|Randomized but not treated|1|||
33389924|NCT00422461|62768899|FG002|Overall Study|Randomized but not treated|0|||
33389925|NCT00422461|62768900|FG003|Overall Study|Randomized but not treated|0|||
33389926|NCT00712920|62768913|FG000|Overall Study|Adverse Event|3|||
33389927|NCT00712920|62768914|FG001|Overall Study|Adverse Event|4|||
33389928|NCT00712920|62768915|FG002|Overall Study|Adverse Event|7|||
33389929|NCT00712920|62768913|FG000|Overall Study|Withdrawal by Subject|4|||
33389930|NCT00712920|62768914|FG001|Overall Study|Withdrawal by Subject|2|||
33389931|NCT00712920|62768915|FG002|Overall Study|Withdrawal by Subject|1|||
33389932|NCT00712920|62768913|FG000|Overall Study|Lost to Follow-up|1|||
33389933|NCT00712920|62768914|FG001|Overall Study|Lost to Follow-up|4|||
33389934|NCT00712920|62768915|FG002|Overall Study|Lost to Follow-up|0|||
33389935|NCT00712920|62768913|FG000|Overall Study|Lack of Efficacy|1|||
33389936|NCT00712920|62768914|FG001|Overall Study|Lack of Efficacy|0|||
33389937|NCT00712920|62768915|FG002|Overall Study|Lack of Efficacy|1|||
33389938|NCT00712920|62768913|FG000|Overall Study|Other|5|||
33389939|NCT00712920|62768914|FG001|Overall Study|Other|7|||
33389940|NCT00712920|62768915|FG002|Overall Study|Other|3|||
33389941|NCT00712920|62768913|FG000|Overall Study|Non-compliance|3|||
33389942|NCT00712920|62768914|FG001|Overall Study|Non-compliance|0|||
33389943|NCT00712920|62768915|FG002|Overall Study|Non-compliance|0|||
33389944|NCT00612586|62768934|FG000|Overall Study|Adverse Event|6|||
33389945|NCT00612586|62768935|FG001|Overall Study|Adverse Event|2|||
33389946|NCT00612586|62768934|FG000|Overall Study|Death|1|||
33389947|NCT00612586|62768935|FG001|Overall Study|Death|0|||
33389948|NCT00612586|62768934|FG000|Overall Study|Entry Criteria Not Met|0|||
33389949|NCT00612586|62768935|FG001|Overall Study|Entry Criteria Not Met|2|||
33389950|NCT00612586|62768934|FG000|Overall Study|Withdrawal by Subject|7|||
33389951|NCT00612586|62768935|FG001|Overall Study|Withdrawal by Subject|9|||
33389952|NCT00612586|62768934|FG000|Overall Study|Physician Decision|1|||
33389953|NCT00612586|62768935|FG001|Overall Study|Physician Decision|2|||
33389954|NCT00612586|62768934|FG000|Overall Study|Sponsor Decision|1|||
33389955|NCT00612586|62768935|FG001|Overall Study|Sponsor Decision|1|||
33389956|NCT00612586|62768934|FG000|Overall Study|Progressive Disease|26|||
33389957|NCT00612586|62768935|FG001|Overall Study|Progressive Disease|24|||
33389958|NCT00612586|62768934|FG000|Overall Study|Randomized and Not Treated|1|||
33389959|NCT00612586|62768935|FG001|Overall Study|Randomized and Not Treated|1|||
33389960|NCT00614380|62768946|FG000|Overall Study|Adverse Event|14|||
33389961|NCT00614380|62768947|FG001|Overall Study|Adverse Event|4|||
33389962|NCT00614380|62768948|FG002|Overall Study|Adverse Event|0|||
33389963|NCT00614380|62768949|FG003|Overall Study|Adverse Event|0|||
33389964|NCT00614380|62768946|FG000|Overall Study|Lost to Follow-up|6|||
33389965|NCT00614380|62768947|FG001|Overall Study|Lost to Follow-up|1|||
33389966|NCT00614380|62768948|FG002|Overall Study|Lost to Follow-up|0|||
33389967|NCT00614380|62768949|FG003|Overall Study|Lost to Follow-up|0|||
33389968|NCT00614380|62768946|FG000|Overall Study|Non compliant with the protocol|12|||
33389969|NCT00614380|62768947|FG001|Overall Study|Non compliant with the protocol|2|||
33557182|NCT02301988|62950140|FG001|Overall Study|Withdrawal by Subject|1|||
33299411|NCT01035463|62675658|FG005|Overall Study|Withdrawal by Subject|4|||
33299412|NCT01035463|62675653|FG000|Overall Study|Disease progression|0|||
33299413|NCT01035463|62675654|FG001|Overall Study|Disease progression|0|||
33299414|NCT01035463|62675655|FG002|Overall Study|Disease progression|0|||
33299415|NCT01035463|62675656|FG003|Overall Study|Disease progression|0|||
33299416|NCT01035463|62675657|FG004|Overall Study|Disease progression|0|||
33299417|NCT01035463|62675658|FG005|Overall Study|Disease progression|3|||
33299418|NCT01035463|62675653|FG000|Overall Study|Other Malignancy|0|||
33389970|NCT00614380|62768948|FG002|Overall Study|Non compliant with the protocol|1|||
33389971|NCT00614380|62768949|FG003|Overall Study|Non compliant with the protocol|2|||
33389972|NCT00614380|62768946|FG000|Overall Study|Consent withdrawn|3|||
33389973|NCT00614380|62768947|FG001|Overall Study|Consent withdrawn|1|||
33389974|NCT00614380|62768948|FG002|Overall Study|Consent withdrawn|0|||
33389975|NCT00614380|62768949|FG003|Overall Study|Consent withdrawn|0|||
33557183|NCT02301988|62950139|FG000|Overall Study|Physician Decision|2|||
33299419|NCT01035463|62675654|FG001|Overall Study|Other Malignancy|0|||
33299420|NCT01035463|62675655|FG002|Overall Study|Other Malignancy|0|||
33389976|NCT00612508|62768966|FG000|Overall Study|Withdrawal by Subject|3|||
33389977|NCT00612508|62768967|FG001|Overall Study|Withdrawal by Subject|4|||
33389978|NCT00613834|62768977|FG000|Overall Study|Withdrawal by Subject|0|||
33389979|NCT00613834|62768978|FG001|Overall Study|Withdrawal by Subject|3|||
33389980|NCT00613366|62768992|FG000|Overall Study|Withdrawal by Subject|3|||
33389981|NCT00613366|62768993|FG001|Overall Study|Withdrawal by Subject|2|||
33389982|NCT00612352|62769001|FG000|Overall Study|Adverse Event|1|||
33389983|NCT00612352|62769002|FG001|Overall Study|Adverse Event|0|||
33389984|NCT00612352|62769001|FG000|Overall Study|Withdrawal by Subject|3|||
33389985|NCT00612352|62769002|FG001|Overall Study|Withdrawal by Subject|5|||
33389986|NCT00612352|62769001|FG000|Overall Study|moved out of state|1|||
33389987|NCT00612352|62769002|FG001|Overall Study|moved out of state|0|||
33389988|NCT00612352|62769001|FG000|Overall Study|didn't return calls/show up on test date|4|||
33389989|NCT00612352|62769002|FG001|Overall Study|didn't return calls/show up on test date|1|||
33389990|NCT00704730|62769010|FG000|Overall Study|Adverse Event|35|||
33389991|NCT00704730|62769011|FG001|Overall Study|Adverse Event|9|||
33389992|NCT00704730|62769010|FG000|Overall Study|Death|11|||
33389993|NCT00704730|62769011|FG001|Overall Study|Death|5|||
33389994|NCT00704730|62769010|FG000|Overall Study|Physician Decision|2|||
33389995|NCT00704730|62769011|FG001|Overall Study|Physician Decision|0|||
33389996|NCT00704730|62769010|FG000|Overall Study|Did not receive drug|5|||
33389997|NCT00704730|62769011|FG001|Overall Study|Did not receive drug|2|||
33389998|NCT00704730|62769010|FG000|Overall Study|Disease progression per PI|58|||
33389999|NCT00704730|62769011|FG001|Overall Study|Disease progression per PI|67|||
33390000|NCT00704730|62769010|FG000|Overall Study|data unavailable|1|||
33390001|NCT00704730|62769011|FG001|Overall Study|data unavailable|0|||
33390002|NCT00704730|62769010|FG000|Overall Study|Withdrawal by Subject|9|||
33390003|NCT00704730|62769011|FG001|Overall Study|Withdrawal by Subject|13|||
33390004|NCT00651261|62769020|FG000|Overall Study|Adverse Event|32|||
33390005|NCT00651261|62769021|FG001|Overall Study|Adverse Event|22|||
33390006|NCT00651261|62769020|FG000|Overall Study|Death|18|||
33390007|NCT00651261|62769021|FG001|Overall Study|Death|18|||
33390008|NCT00651261|62769020|FG000|Overall Study|Withdrawal by Subject|22|||
33390009|NCT00651261|62769021|FG001|Overall Study|Withdrawal by Subject|40|||
33390010|NCT00651261|62769020|FG000|Overall Study|Induction failure|24|||
33390011|NCT00651261|62769021|FG001|Overall Study|Induction failure|35|||
33390012|NCT00651261|62769020|FG000|Overall Study|Disease progression|58|||
33390013|NCT00651261|62769021|FG001|Overall Study|Disease progression|58|||
33390014|NCT00651261|62769020|FG000|Overall Study|Alternative therapy|109|||
33390015|NCT00651261|62769021|FG001|Overall Study|Alternative therapy|107|||
33390016|NCT00651261|62769020|FG000|Overall Study|Other disease or participant decisions|23|||
33390017|NCT00651261|62769021|FG001|Overall Study|Other disease or participant decisions|23|||
33390018|NCT00651261|62769020|FG000|Overall Study|Never treated|5|||
33390019|NCT00651261|62769021|FG001|Overall Study|Never treated|3|||
33390020|NCT00651183|62769029|FG000|Overall Study|Lack of Efficacy|1|||
33390021|NCT00651183|62769030|FG001|Overall Study|Lack of Efficacy|0|||
33390022|NCT00651183|62769029|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
33390023|NCT00651183|62769030|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
33390024|NCT00651183|62769029|FG000|Overall Study|Tolerability insufficient|5|||
33390025|NCT00651183|62769030|FG001|Overall Study|Tolerability insufficient|2|||
33390026|NCT00651183|62769029|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
33390027|NCT00651183|62769030|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
33390028|NCT00651183|62769029|FG000|Overall Study|Withdrawal by Subject|6|||
33390029|NCT00651183|62769030|FG001|Overall Study|Withdrawal by Subject|3|||
33390030|NCT00651183|62769029|FG000|Overall Study|Lost to Follow-up|3|||
33390031|NCT00651183|62769030|FG001|Overall Study|Lost to Follow-up|1|||
33390032|NCT00651183|62769029|FG000|Overall Study|Other reasons|4|||
33390033|NCT00651183|62769030|FG001|Overall Study|Other reasons|2|||
33390034|NCT00651183|62769029|FG000|Overall Study|missing|1|||
33390035|NCT00651183|62769030|FG001|Overall Study|missing|0|||
33390036|NCT00699972|62769039|FG000|Overall Study|Adverse Event|7|||
33390037|NCT00699972|62769040|FG001|Overall Study|Adverse Event|9|||
33390038|NCT00699972|62769041|FG002|Overall Study|Adverse Event|24|||
33390039|NCT00699972|62769039|FG000|Overall Study|Lost to Follow-up|0|||
33390040|NCT00699972|62769040|FG001|Overall Study|Lost to Follow-up|2|||
33557184|NCT02301988|62950140|FG001|Overall Study|Physician Decision|2|||
33557185|NCT02301988|62950139|FG000|Overall Study|Unknown Reason|1|||
33390041|NCT00699972|62769041|FG002|Overall Study|Lost to Follow-up|0|||
33390042|NCT00699972|62769039|FG000|Overall Study|Withdrawal by Subject|3|||
33390043|NCT00699972|62769040|FG001|Overall Study|Withdrawal by Subject|7|||
33557186|NCT02301988|62950140|FG001|Overall Study|Unknown Reason|3|||
33390044|NCT00699972|62769041|FG002|Overall Study|Withdrawal by Subject|4|||
33390045|NCT00699972|62769039|FG000|Overall Study|Lack of Efficacy|2|||
33390046|NCT00699972|62769040|FG001|Overall Study|Lack of Efficacy|0|||
33390047|NCT00699972|62769041|FG002|Overall Study|Lack of Efficacy|2|||
33390048|NCT00699972|62769039|FG000|Overall Study|Administrative/Other|3|||
33390049|NCT00699972|62769040|FG001|Overall Study|Administrative/Other|1|||
33390050|NCT00699972|62769041|FG002|Overall Study|Administrative/Other|4|||
33390051|NCT00699972|62769039|FG000|Overall Study|Randomized, Not Treated|1|||
33390052|NCT00699972|62769040|FG001|Overall Study|Randomized, Not Treated|0|||
33557187|NCT02301988|62950139|FG000|Overall Study|Lack of Efficacy|3|||
33390053|NCT00699972|62769041|FG002|Overall Study|Randomized, Not Treated|1|||
33390054|NCT00642759|62769049|FG000|Overall Study|Protocol Violation|1|||
33390055|NCT00611026|62769057|FG000|Randomized to Double-blind Treatment|Not treated|2|||
33390056|NCT00611026|62769058|FG001|Randomized to Double-blind Treatment|Not treated|1|||
33390057|NCT00611026|62769059|FG002|Randomized to Double-blind Treatment|Not treated|3|||
33390058|NCT00611026|62769057|FG000|Double-blind Treatment Period|Death|1|||
33390059|NCT00611026|62769058|FG001|Double-blind Treatment Period|Death|0|||
33390060|NCT00611026|62769059|FG002|Double-blind Treatment Period|Death|0|||
33390061|NCT00611026|62769057|FG000|Double-blind Treatment Period|Adverse Event|9|||
33390062|NCT00611026|62769058|FG001|Double-blind Treatment Period|Adverse Event|28|||
33390063|NCT00611026|62769059|FG002|Double-blind Treatment Period|Adverse Event|46|||
33390064|NCT00611026|62769057|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
33390065|NCT00611026|62769058|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
33390066|NCT00611026|62769059|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
33390067|NCT00611026|62769057|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
33390068|NCT00611026|62769058|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
33390069|NCT00611026|62769059|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
33390070|NCT00611026|62769057|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
33390071|NCT00611026|62769058|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
33390072|NCT00611026|62769059|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
33390073|NCT00611026|62769057|FG000|Double-blind Treatment Period|Other|13|||
33390074|NCT00611026|62769058|FG001|Double-blind Treatment Period|Other|20|||
33390075|NCT00611026|62769059|FG002|Double-blind Treatment Period|Other|18|||
33390076|NCT00646113|62769069|FG000|Overall Study|Lost to Follow-up|5|||
33390077|NCT00646113|62769069|FG000|Overall Study|Adverse Event|3|||
33390078|NCT00422383|62769078|FG000|Overall Study|Adverse Event|5|||
33390079|NCT00422383|62769079|FG001|Overall Study|Adverse Event|3|||
33390080|NCT00422383|62769080|FG002|Overall Study|Adverse Event|1|||
33390081|NCT00422383|62769081|FG003|Overall Study|Adverse Event|1|||
33390082|NCT00422383|62769082|FG004|Overall Study|Adverse Event|0|||
33390083|NCT00422383|62769078|FG000|Overall Study|Lack of Efficacy|4|||
33390084|NCT00422383|62769079|FG001|Overall Study|Lack of Efficacy|4|||
33390085|NCT00422383|62769080|FG002|Overall Study|Lack of Efficacy|2|||
33390086|NCT00422383|62769081|FG003|Overall Study|Lack of Efficacy|1|||
33390087|NCT00422383|62769082|FG004|Overall Study|Lack of Efficacy|1|||
33390088|NCT00422383|62769078|FG000|Overall Study|Lost to Follow-up|0|||
33390089|NCT00422383|62769079|FG001|Overall Study|Lost to Follow-up|1|||
33390090|NCT00422383|62769080|FG002|Overall Study|Lost to Follow-up|0|||
33390091|NCT00422383|62769081|FG003|Overall Study|Lost to Follow-up|0|||
33390092|NCT00422383|62769082|FG004|Overall Study|Lost to Follow-up|1|||
33390093|NCT00422383|62769078|FG000|Overall Study|Protocol Violation|1|||
33390094|NCT00422383|62769079|FG001|Overall Study|Protocol Violation|1|||
33390095|NCT00422383|62769080|FG002|Overall Study|Protocol Violation|1|||
33390096|NCT00422383|62769081|FG003|Overall Study|Protocol Violation|0|||
33390097|NCT00422383|62769082|FG004|Overall Study|Protocol Violation|0|||
33390098|NCT00422383|62769078|FG000|Overall Study|Withdrawal by Subject|5|||
33390099|NCT00422383|62769079|FG001|Overall Study|Withdrawal by Subject|5|||
33390100|NCT00422383|62769080|FG002|Overall Study|Withdrawal by Subject|0|||
33390101|NCT00422383|62769081|FG003|Overall Study|Withdrawal by Subject|0|||
33390102|NCT00422383|62769082|FG004|Overall Study|Withdrawal by Subject|1|||
33390103|NCT00612040|62769103|FG000|Overall Study|Adverse Event|0|||
33390104|NCT00612040|62769104|FG001|Overall Study|Adverse Event|2|||
33390105|NCT00612040|62769105|FG002|Overall Study|Adverse Event|1|||
33390106|NCT00612040|62769103|FG000|Overall Study|Protocol Violation|1|||
33390107|NCT00612040|62769104|FG001|Overall Study|Protocol Violation|2|||
33390108|NCT00612040|62769105|FG002|Overall Study|Protocol Violation|1|||
33390109|NCT00612040|62769103|FG000|Overall Study|Lack of Efficacy|2|||
33390110|NCT00612040|62769104|FG001|Overall Study|Lack of Efficacy|1|||
33390111|NCT00612040|62769105|FG002|Overall Study|Lack of Efficacy|0|||
33390112|NCT00612040|62769103|FG000|Overall Study|Unclassified|2|||
33390113|NCT00612040|62769104|FG001|Overall Study|Unclassified|2|||
33390114|NCT00612040|62769105|FG002|Overall Study|Unclassified|5|||
33390115|NCT00422227|62769115|FG000|Overall Study|Adverse Event|3|||
33390116|NCT00422227|62769116|FG001|Overall Study|Adverse Event|8|||
33390117|NCT00422227|62769115|FG000|Overall Study|Lost to Follow-up|1|||
33390118|NCT00422227|62769116|FG001|Overall Study|Lost to Follow-up|3|||
33390119|NCT00422227|62769115|FG000|Overall Study|Withdrawal by Subject|0|||
33390120|NCT00422227|62769116|FG001|Overall Study|Withdrawal by Subject|4|||
33390121|NCT00421993|62769126|FG000|Overall Study|Withdrawal by Subject|22|||
33390122|NCT00421993|62769127|FG001|Overall Study|Withdrawal by Subject|23|||
33390123|NCT00421993|62769128|FG002|Overall Study|Withdrawal by Subject|23|||
33390124|NCT00421993|62769129|FG003|Overall Study|Withdrawal by Subject|24|||
33390125|NCT00421993|62769126|FG000|Overall Study|Lost to Follow-up|18|||
33390126|NCT00421993|62769127|FG001|Overall Study|Lost to Follow-up|19|||
33390127|NCT00421993|62769128|FG002|Overall Study|Lost to Follow-up|22|||
33390128|NCT00421993|62769129|FG003|Overall Study|Lost to Follow-up|20|||
33390129|NCT00421993|62769126|FG000|Overall Study|Adverse Event|11|||
33390130|NCT00421993|62769127|FG001|Overall Study|Adverse Event|1|||
33390131|NCT00421993|62769128|FG002|Overall Study|Adverse Event|6|||
33390132|NCT00421993|62769129|FG003|Overall Study|Adverse Event|4|||
33390133|NCT00421993|62769126|FG000|Overall Study|Protocol Violation|2|||
33390134|NCT00421993|62769127|FG001|Overall Study|Protocol Violation|2|||
33390135|NCT00421993|62769128|FG002|Overall Study|Protocol Violation|0|||
33390136|NCT00421993|62769129|FG003|Overall Study|Protocol Violation|1|||
33390137|NCT00421993|62769126|FG000|Overall Study|Lack of Efficacy|0|||
33390138|NCT00421993|62769127|FG001|Overall Study|Lack of Efficacy|3|||
33390139|NCT00421993|62769128|FG002|Overall Study|Lack of Efficacy|0|||
33390140|NCT00421993|62769129|FG003|Overall Study|Lack of Efficacy|5|||
33390141|NCT00421993|62769126|FG000|Overall Study|Pregnancy|0|||
33390142|NCT00421993|62769127|FG001|Overall Study|Pregnancy|1|||
33390143|NCT00421993|62769128|FG002|Overall Study|Pregnancy|1|||
33390144|NCT00421993|62769129|FG003|Overall Study|Pregnancy|2|||
33390145|NCT00421993|62769126|FG000|Overall Study|Subject transportation issues|0|||
33390146|NCT00421993|62769127|FG001|Overall Study|Subject transportation issues|0|||
33390147|NCT00421993|62769128|FG002|Overall Study|Subject transportation issues|0|||
33390148|NCT00421993|62769129|FG003|Overall Study|Subject transportation issues|1|||
33390149|NCT00413959|62769139|FG000|Overall Study|Pt had only one cycle.|1|||
33390150|NCT00645567|62769143|FG000|Overall Study|Adverse Event|1|||
33390151|NCT00611884|62769155|FG000|Overall Study|Adverse Event|1|||
33390152|NCT00611884|62769156|FG001|Overall Study|Adverse Event|0|||
33390153|NCT00611884|62769157|FG002|Overall Study|Adverse Event|0|||
33390154|NCT00611884|62769158|FG003|Overall Study|Adverse Event|1|||
33390155|NCT00611884|62769155|FG000|Overall Study|Non-Compliance|1|||
33390156|NCT00611884|62769156|FG001|Overall Study|Non-Compliance|4|||
33557188|NCT02301988|62950140|FG001|Overall Study|Lack of Efficacy|2|||
33557189|NCT02301988|62950139|FG000|Overall Study|Death|1|||
33557190|NCT02301988|62950140|FG001|Overall Study|Death|0|||
33557191|NCT02301988|62950139|FG000|Overall Study|Adverse Event|1|||
33557192|NCT02301988|62950140|FG001|Overall Study|Adverse Event|1|||
33557193|NCT02334748|62950155|FG000|Overall Study|Adverse Event|1|||
33557194|NCT02334748|62950155|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
33557195|NCT02334748|62950155|FG000|Overall Study|Patient no longer required study drug|2|||
33557196|NCT02334748|62950155|FG000|Overall Study|Lack of Efficacy|4|||
33557197|NCT02332876|62950161|FG000|Overall Study|Lost to Follow-up|1|||
33557198|NCT02332876|62950162|FG001|Overall Study|Lost to Follow-up|1|||
33299421|NCT01035463|62675656|FG003|Overall Study|Other Malignancy|0|||
33299422|NCT01035463|62675657|FG004|Overall Study|Other Malignancy|0|||
33299423|NCT01035463|62675658|FG005|Overall Study|Other Malignancy|2|||
33299424|NCT01035463|62675653|FG000|Overall Study|Other|0|||
33299425|NCT01035463|62675654|FG001|Overall Study|Other|0|||
33299426|NCT01035463|62675655|FG002|Overall Study|Other|0|||
33299427|NCT01035463|62675656|FG003|Overall Study|Other|1|||
33299428|NCT01035463|62675657|FG004|Overall Study|Other|0|||
33299429|NCT01035463|62675658|FG005|Overall Study|Other|2|||
33299430|NCT01300923|62675665|FG000|Overall Study|Physician Decision|0|||
33299431|NCT01300923|62675666|FG001|Overall Study|Physician Decision|2|||
33299432|NCT01300767|62675671|FG000|Overall Study|Discomfort|2|||
33299433|NCT01300767|62675671|FG000|Overall Study|Biomicroscopy|1|||
33299434|NCT01300767|62675671|FG000|Overall Study|Unacceptable fit|1|||
33299435|NCT01300455|62675679|FG000|Washout|Withdrawal by Subject|1|||
33299436|NCT01300455|62675680|FG001|Washout|Withdrawal by Subject|0|||
33299437|NCT01107418|62675690|FG000|Overall Study|Disease Progression|45|||
33299438|NCT01107418|62675690|FG000|Overall Study|Adverse Event|3|||
33299439|NCT01107418|62675690|FG000|Overall Study|Withdrawal by Subject|1|||
33299440|NCT01107418|62675690|FG000|Overall Study|Study Closing|1|||
33299441|NCT01107418|62675690|FG000|Overall Study|Started Other Therapy|1|||
33299442|NCT01107418|62675690|FG000|Overall Study|Entered Extension Study|1|||
33299443|NCT01101178|62675705|FG000|Period 1|Withdrawal by Subject|1|||
33299444|NCT01101178|62675706|FG001|Period 1|Withdrawal by Subject|2|||
33299445|NCT01101178|62675705|FG000|Period 1|Positive drug screen|1|||
33299446|NCT01101178|62675706|FG001|Period 1|Positive drug screen|1|||
33299447|NCT01101178|62675705|FG000|Period 1|Adverse Event|2|||
33299448|NCT01101178|62675706|FG001|Period 1|Adverse Event|1|||
33299449|NCT01101178|62675705|FG000|Period 2|Withdrawal by Subject|0|||
33299450|NCT01101178|62675706|FG001|Period 2|Withdrawal by Subject|1|||
33299451|NCT01101022|62675715|FG000|Overall Study|Adverse Event|6|||
33299452|NCT01101022|62675716|FG001|Overall Study|Adverse Event|2|||
33299453|NCT01101022|62675715|FG000|Overall Study|Protocol Violation|4|||
33299454|NCT01101022|62675716|FG001|Overall Study|Protocol Violation|3|||
33299455|NCT01101022|62675715|FG000|Overall Study|Withdrawal by Subject|3|||
33299456|NCT01101022|62675716|FG001|Overall Study|Withdrawal by Subject|8|||
33299457|NCT01101022|62675715|FG000|Overall Study|Lost to Follow-up|1|||
33299458|NCT01101022|62675716|FG001|Overall Study|Lost to Follow-up|4|||
33390157|NCT00611884|62769157|FG002|Overall Study|Non-Compliance|2|||
33390158|NCT00611884|62769158|FG003|Overall Study|Non-Compliance|2|||
33390159|NCT00611884|62769155|FG000|Overall Study|Lack of Efficacy|0|||
33390160|NCT00611884|62769156|FG001|Overall Study|Lack of Efficacy|1|||
33390161|NCT00611884|62769157|FG002|Overall Study|Lack of Efficacy|0|||
33557199|NCT02332798|62950171|FG000|Overall Study|Unwilling to Participate in Study|0|||
33557200|NCT02332798|62950172|FG001|Overall Study|Unwilling to Participate in Study|1|||
33557201|NCT02332798|62950173|FG002|Overall Study|Unwilling to Participate in Study|1|||
33557202|NCT02332798|62950171|FG000|Overall Study|Positive Urine Drug Test|0|||
33557203|NCT02332798|62950172|FG001|Overall Study|Positive Urine Drug Test|1|||
33557204|NCT02332798|62950173|FG002|Overall Study|Positive Urine Drug Test|0|||
33557205|NCT02332798|62950171|FG000|Overall Study|Abnormal Laboratory Findings|1|||
33557206|NCT02332798|62950172|FG001|Overall Study|Abnormal Laboratory Findings|0|||
33557207|NCT02332798|62950173|FG002|Overall Study|Abnormal Laboratory Findings|0|||
33557208|NCT02790437|62950183|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
33557209|NCT02790437|62950184|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
33557210|NCT02790437|62950183|FG000|Overall Study|Adverse Event|1|||
33557211|NCT02790437|62950184|FG001|Overall Study|Adverse Event|0|||
33557212|NCT02790437|62950183|FG000|Overall Study|Withdrawal by Subject|1|||
33557213|NCT02790437|62950184|FG001|Overall Study|Withdrawal by Subject|0|||
33557214|NCT02604212|62950201|FG000|Overall Study|Study Terminated by Sponsor|2|||
33557215|NCT02604212|62950202|FG001|Overall Study|Study Terminated by Sponsor|1|||
33557216|NCT02604212|62950203|FG002|Overall Study|Study Terminated by Sponsor|3|||
33557217|NCT02604212|62950204|FG003|Overall Study|Study Terminated by Sponsor|3|||
33557218|NCT02604212|62950201|FG000|Overall Study|Withdrawal by Subject|0|||
33557219|NCT02604212|62950202|FG001|Overall Study|Withdrawal by Subject|0|||
33557220|NCT02604212|62950203|FG002|Overall Study|Withdrawal by Subject|1|||
33557221|NCT02604212|62950204|FG003|Overall Study|Withdrawal by Subject|0|||
33557222|NCT02789111|62950221|FG000|Overall Study|Withdrawal by Subject|1|||
33557223|NCT02789111|62950222|FG001|Overall Study|Withdrawal by Subject|4|||
33557224|NCT01359644|62950240|FG000|Treatment Period|Lack of Efficacy|0|||
33557225|NCT01359644|62950241|FG001|Treatment Period|Lack of Efficacy|1|||
33557226|NCT01359644|62950242|FG002|Treatment Period|Lack of Efficacy|0|||
33557227|NCT01359644|62950243|FG003|Treatment Period|Lack of Efficacy|0|||
33557228|NCT01359644|62950244|FG004|Treatment Period|Lack of Efficacy|0|||
33557229|NCT01359644|62950245|FG005|Treatment Period|Lack of Efficacy|0|||
33557230|NCT01359644|62950246|FG006|Treatment Period|Lack of Efficacy|0|||
33557231|NCT01359644|62950247|FG007|Treatment Period|Lack of Efficacy|0|||
33557232|NCT01359644|62950248|FG008|Treatment Period|Lack of Efficacy|0|||
33557233|NCT01359644|62950249|FG009|Treatment Period|Lack of Efficacy|0|||
33557234|NCT01359644|62950240|FG000|Treatment Period|Adverse Event|0|||
33557235|NCT01359644|62950241|FG001|Treatment Period|Adverse Event|0|||
33557236|NCT01359644|62950242|FG002|Treatment Period|Adverse Event|1|||
33557237|NCT01359644|62950243|FG003|Treatment Period|Adverse Event|0|||
33557238|NCT01359644|62950244|FG004|Treatment Period|Adverse Event|0|||
33557239|NCT01359644|62950245|FG005|Treatment Period|Adverse Event|1|||
33557240|NCT01359644|62950246|FG006|Treatment Period|Adverse Event|0|||
33557241|NCT01359644|62950247|FG007|Treatment Period|Adverse Event|0|||
33557242|NCT01359644|62950248|FG008|Treatment Period|Adverse Event|0|||
33557243|NCT01359644|62950249|FG009|Treatment Period|Adverse Event|0|||
33557244|NCT01359644|62950240|FG000|Treatment Period|Lost to Follow-up|0|||
33557245|NCT01359644|62950241|FG001|Treatment Period|Lost to Follow-up|0|||
33557246|NCT01359644|62950242|FG002|Treatment Period|Lost to Follow-up|0|||
33557247|NCT01359644|62950243|FG003|Treatment Period|Lost to Follow-up|0|||
33557248|NCT01359644|62950244|FG004|Treatment Period|Lost to Follow-up|0|||
33557249|NCT01359644|62950245|FG005|Treatment Period|Lost to Follow-up|1|||
33557250|NCT01359644|62950246|FG006|Treatment Period|Lost to Follow-up|0|||
33557251|NCT01359644|62950247|FG007|Treatment Period|Lost to Follow-up|0|||
33557252|NCT01359644|62950248|FG008|Treatment Period|Lost to Follow-up|0|||
33557253|NCT01359644|62950249|FG009|Treatment Period|Lost to Follow-up|0|||
33557254|NCT01359644|62950240|FG000|Follow-up Period|Withdrawal by Subject|0|||
33557255|NCT01359644|62950241|FG001|Follow-up Period|Withdrawal by Subject|0|||
33557256|NCT01359644|62950242|FG002|Follow-up Period|Withdrawal by Subject|0|||
33557257|NCT01359644|62950243|FG003|Follow-up Period|Withdrawal by Subject|0|||
33557258|NCT01359644|62950244|FG004|Follow-up Period|Withdrawal by Subject|0|||
33557259|NCT01359644|62950245|FG005|Follow-up Period|Withdrawal by Subject|1|||
33557260|NCT01359644|62950246|FG006|Follow-up Period|Withdrawal by Subject|0|||
33557261|NCT01359644|62950247|FG007|Follow-up Period|Withdrawal by Subject|0|||
33557262|NCT01359644|62950248|FG008|Follow-up Period|Withdrawal by Subject|0|||
33557263|NCT01359644|62950249|FG009|Follow-up Period|Withdrawal by Subject|0|||
33390162|NCT00611884|62769158|FG003|Overall Study|Lack of Efficacy|0|||
33557264|NCT01359644|62950240|FG000|Follow-up Period|Lost to Follow-up|0|||
33557265|NCT01359644|62950241|FG001|Follow-up Period|Lost to Follow-up|0|||
33557266|NCT01359644|62950242|FG002|Follow-up Period|Lost to Follow-up|0|||
33557267|NCT01359644|62950243|FG003|Follow-up Period|Lost to Follow-up|0|||
33557268|NCT01359644|62950244|FG004|Follow-up Period|Lost to Follow-up|0|||
33557269|NCT01359644|62950245|FG005|Follow-up Period|Lost to Follow-up|0|||
33557270|NCT01359644|62950246|FG006|Follow-up Period|Lost to Follow-up|1|||
33557271|NCT01359644|62950247|FG007|Follow-up Period|Lost to Follow-up|2|||
33557272|NCT01359644|62950248|FG008|Follow-up Period|Lost to Follow-up|0|||
33390163|NCT00611884|62769155|FG000|Overall Study|Unclassified|7|||
33557273|NCT01359644|62950249|FG009|Follow-up Period|Lost to Follow-up|0|||
33557274|NCT02603120|62950284|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
33557275|NCT02603120|62950285|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
33557276|NCT02603120|62950284|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
33557277|NCT02603120|62950285|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
33557278|NCT02603120|62950284|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
33557279|NCT02603120|62950285|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
33557280|NCT02603120|62950284|FG000|Double-Blind Treatment Phase|Death|2|||
33557281|NCT02603120|62950285|FG001|Double-Blind Treatment Phase|Death|0|||
33557282|NCT02603120|62950284|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
33557283|NCT02603120|62950285|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
33557284|NCT02603120|62950284|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
33557285|NCT02603120|62950285|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
33557286|NCT02603120|62950284|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
33557287|NCT02603120|62950285|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
33557288|NCT02603120|62950284|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
33557289|NCT02603120|62950285|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
33557290|NCT02603120|62950284|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
33557291|NCT02603120|62950285|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
33557292|NCT02603120|62950284|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
33557293|NCT02603120|62950285|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
33557294|NCT02603120|62950284|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
33390164|NCT00611884|62769156|FG001|Overall Study|Unclassified|4|||
33390165|NCT00611884|62769157|FG002|Overall Study|Unclassified|2|||
33390166|NCT00611884|62769158|FG003|Overall Study|Unclassified|3|||
33390167|NCT00420745|62769170|FG000|Overall Study|Adverse Event|2|||
33390168|NCT00420745|62769171|FG001|Overall Study|Adverse Event|2|||
33390169|NCT00420745|62769170|FG000|Overall Study|Lost to Follow-up|10|||
33390170|NCT00420745|62769171|FG001|Overall Study|Lost to Follow-up|2|||
33390171|NCT00420745|62769170|FG000|Overall Study|Protocol Violation|1|||
33390172|NCT00420745|62769171|FG001|Overall Study|Protocol Violation|0|||
33390173|NCT00420745|62769170|FG000|Overall Study|Physician Decision|1|||
33390174|NCT00420745|62769171|FG001|Overall Study|Physician Decision|1|||
33390175|NCT00420745|62769170|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
33390176|NCT00420745|62769171|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
33390177|NCT00420745|62769170|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
33390178|NCT00420745|62769171|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
33390179|NCT00611806|62769179|FG000|Overall Study|Withdrawal by Subject|8|||
33390180|NCT00611806|62769180|FG001|Overall Study|Withdrawal by Subject|2|||
33390181|NCT00611806|62769179|FG000|Overall Study|Adverse Event|2|||
33390182|NCT00611806|62769180|FG001|Overall Study|Adverse Event|1|||
33390183|NCT00611806|62769179|FG000|Overall Study|Lost to Follow-up|6|||
33390184|NCT00611806|62769180|FG001|Overall Study|Lost to Follow-up|0|||
33390185|NCT00413413|62769189|FG000|Single-Blind|Adverse Event|0|||
33390186|NCT00413413|62769190|FG001|Single-Blind|Adverse Event|9|||
33390187|NCT00413413|62769191|FG002|Single-Blind|Adverse Event|0|||
33557295|NCT02603120|62950285|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
33557296|NCT02603120|62950284|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
33557297|NCT02603120|62950285|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
33557298|NCT02603120|62950284|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
33557299|NCT02603120|62950285|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
33557300|NCT02603120|62950284|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
33299459|NCT01101022|62675715|FG000|Overall Study|Lack of Efficacy|0|||
33299460|NCT01101022|62675716|FG001|Overall Study|Lack of Efficacy|7|||
33299461|NCT01101022|62675715|FG000|Overall Study|Sponsor decision|1|||
33299462|NCT01101022|62675716|FG001|Overall Study|Sponsor decision|1|||
33299463|NCT01101022|62675715|FG000|Overall Study|Non-compliance|1|||
33299464|NCT01101022|62675716|FG001|Overall Study|Non-compliance|0|||
33299465|NCT01101022|62675715|FG000|Overall Study|Work schedule|1|||
33299466|NCT01101022|62675716|FG001|Overall Study|Work schedule|1|||
33299467|NCT01101022|62675715|FG000|Overall Study|Vacation|0|||
33299468|NCT01101022|62675716|FG001|Overall Study|Vacation|1|||
33299469|NCT01299909|62675725|FG000|Overall Study|Lost to Follow-up|22|||
33299470|NCT01299909|62675726|FG001|Overall Study|Lost to Follow-up|18|||
33299471|NCT01299909|62675727|FG002|Overall Study|Lost to Follow-up|17|||
33299472|NCT01298661|62675737|FG000|Overall Study|Withdrawal by Subject|2|||
33299473|NCT01298661|62675738|FG001|Overall Study|Withdrawal by Subject|0|||
33299474|NCT01298661|62675739|FG002|Overall Study|Withdrawal by Subject|2|||
33299475|NCT01100944|62675748|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
33390188|NCT00413413|62769189|FG000|Single-Blind|Lack of Efficacy|0|||
33390189|NCT00413413|62769190|FG001|Single-Blind|Lack of Efficacy|5|||
33390190|NCT00413413|62769191|FG002|Single-Blind|Lack of Efficacy|0|||
33390191|NCT00413413|62769189|FG000|Single-Blind|Subject no longer requires study drug|0|||
33390192|NCT00413413|62769190|FG001|Single-Blind|Subject no longer requires study drug|151|||
33557301|NCT02603120|62950285|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
33557302|NCT02599688|62950293|FG000|Overall Study|Lack of Efficacy|1|||
33557303|NCT02599688|62950293|FG000|Overall Study|Withdrawal by Subject|1|||
33557304|NCT02599688|62950293|FG000|Overall Study|Termination by Sponsor|2|||
33557305|NCT01331681|62950300|FG000|Overall Study|Adverse Event|10|||
33557306|NCT01331681|62950301|FG001|Overall Study|Adverse Event|13|||
33557307|NCT01331681|62950302|FG002|Overall Study|Adverse Event|10|||
33557308|NCT01331681|62950300|FG000|Overall Study|Death|6|||
33557309|NCT01331681|62950301|FG001|Overall Study|Death|6|||
33557310|NCT01331681|62950302|FG002|Overall Study|Death|2|||
33557311|NCT01331681|62950300|FG000|Overall Study|Lack of Efficacy|0|||
33557312|NCT01331681|62950301|FG001|Overall Study|Lack of Efficacy|1|||
33557313|NCT01331681|62950302|FG002|Overall Study|Lack of Efficacy|0|||
33557314|NCT01331681|62950300|FG000|Overall Study|Withdrawal by Subject|12|||
33557315|NCT01331681|62950301|FG001|Overall Study|Withdrawal by Subject|8|||
33557316|NCT01331681|62950302|FG002|Overall Study|Withdrawal by Subject|15|||
33557317|NCT01331681|62950300|FG000|Overall Study|Protocol Violation|1|||
33557318|NCT01331681|62950301|FG001|Overall Study|Protocol Violation|1|||
33390193|NCT00413413|62769191|FG002|Single-Blind|Subject no longer requires study drug|0|||
33390194|NCT00413413|62769189|FG000|Single-Blind|Protocol Violation|0|||
33390195|NCT00413413|62769190|FG001|Single-Blind|Protocol Violation|16|||
33390196|NCT00413413|62769191|FG002|Single-Blind|Protocol Violation|0|||
33390197|NCT00413413|62769189|FG000|Single-Blind|Withdrawal by Subject|0|||
33390198|NCT00413413|62769190|FG001|Single-Blind|Withdrawal by Subject|27|||
33390199|NCT00413413|62769191|FG002|Single-Blind|Withdrawal by Subject|0|||
33390200|NCT00413413|62769189|FG000|Single-Blind|Lost to Follow-up|0|||
33390201|NCT00413413|62769190|FG001|Single-Blind|Lost to Follow-up|8|||
33390202|NCT00413413|62769191|FG002|Single-Blind|Lost to Follow-up|0|||
33390203|NCT00413413|62769189|FG000|Double-Blind|Adverse Event|6|||
33390204|NCT00413413|62769190|FG001|Double-Blind|Adverse Event|0|||
33390205|NCT00413413|62769191|FG002|Double-Blind|Adverse Event|5|||
33390206|NCT00413413|62769189|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
33390207|NCT00413413|62769190|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
33390208|NCT00413413|62769191|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
33390209|NCT00413413|62769189|FG000|Double-Blind|Protocol deviation|1|||
33390210|NCT00413413|62769190|FG001|Double-Blind|Protocol deviation|2|||
33390211|NCT00413413|62769191|FG002|Double-Blind|Protocol deviation|1|||
33390212|NCT00413413|62769189|FG000|Double-Blind|Subject withdrew consent|4|||
33390213|NCT00413413|62769190|FG001|Double-Blind|Subject withdrew consent|6|||
33390214|NCT00413413|62769191|FG002|Double-Blind|Subject withdrew consent|9|||
33390215|NCT00413413|62769189|FG000|Double-Blind|Lost to Follow-up|3|||
33390216|NCT00413413|62769190|FG001|Double-Blind|Lost to Follow-up|4|||
33390217|NCT00413413|62769191|FG002|Double-Blind|Lost to Follow-up|2|||
33390218|NCT00610714|62769201|FG000|Overall Study|Adverse Event|3|||
33390219|NCT00610714|62769202|FG001|Overall Study|Adverse Event|1|||
33390220|NCT00610714|62769201|FG000|Overall Study|Death|12|||
33390221|NCT00610714|62769202|FG001|Overall Study|Death|18|||
33390222|NCT00610714|62769201|FG000|Overall Study|Withdrawal by Subject|9|||
33390223|NCT00610714|62769202|FG001|Overall Study|Withdrawal by Subject|3|||
33390224|NCT00610714|62769201|FG000|Overall Study|Study completion at 120 PFS events|2|||
33390225|NCT00610714|62769202|FG001|Overall Study|Study completion at 120 PFS events|2|||
33390226|NCT00403585|62769208|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
33390227|NCT00403585|62769208|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
33390228|NCT00403585|62769208|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
33390229|NCT00645411|62769216|FG000|Overall Study|Adverse Event|0|||
33390230|NCT00645411|62769217|FG001|Overall Study|Adverse Event|0|||
33390231|NCT00645411|62769218|FG002|Overall Study|Adverse Event|0|||
33390232|NCT00645411|62769219|FG003|Overall Study|Adverse Event|2|||
33390233|NCT00645411|62769216|FG000|Overall Study|Withdrawal by Subject|2|||
33390234|NCT00645411|62769217|FG001|Overall Study|Withdrawal by Subject|1|||
33390235|NCT00645411|62769218|FG002|Overall Study|Withdrawal by Subject|19|||
33390236|NCT00645411|62769219|FG003|Overall Study|Withdrawal by Subject|21|||
33390237|NCT00645411|62769216|FG000|Overall Study|Lost to Follow-up|10|||
33557319|NCT01331681|62950302|FG002|Overall Study|Protocol Violation|0|||
33557320|NCT01331681|62950300|FG000|Overall Study|Lost to Follow-up|2|||
33557321|NCT01331681|62950301|FG001|Overall Study|Lost to Follow-up|4|||
33557322|NCT01331681|62950302|FG002|Overall Study|Lost to Follow-up|1|||
33390238|NCT00645411|62769217|FG001|Overall Study|Lost to Follow-up|5|||
33390239|NCT00645411|62769218|FG002|Overall Study|Lost to Follow-up|124|||
33390240|NCT00645411|62769219|FG003|Overall Study|Lost to Follow-up|75|||
33390241|NCT00645411|62769216|FG000|Overall Study|Protocol Violation|1|||
33390242|NCT00645411|62769217|FG001|Overall Study|Protocol Violation|0|||
33390243|NCT00645411|62769218|FG002|Overall Study|Protocol Violation|1|||
33390244|NCT00645411|62769219|FG003|Overall Study|Protocol Violation|0|||
33557323|NCT01331681|62950300|FG000|Overall Study|Physician Decision|2|||
33557324|NCT01331681|62950301|FG001|Overall Study|Physician Decision|0|||
33557325|NCT01331681|62950302|FG002|Overall Study|Physician Decision|4|||
33557326|NCT01331681|62950300|FG000|Overall Study|Therapeutic procedure required|1|||
33390245|NCT00645411|62769216|FG000|Overall Study|Inappropriate enrollment|0|||
33390246|NCT00645411|62769217|FG001|Overall Study|Inappropriate enrollment|0|||
33557327|NCT01331681|62950301|FG001|Overall Study|Therapeutic procedure required|0|||
33557328|NCT01331681|62950302|FG002|Overall Study|Therapeutic procedure required|0|||
33557329|NCT01331681|62950300|FG000|Overall Study|Sponsor decision|1|||
33557330|NCT01331681|62950301|FG001|Overall Study|Sponsor decision|1|||
33557331|NCT01331681|62950302|FG002|Overall Study|Sponsor decision|0|||
33557332|NCT01331681|62950300|FG000|Overall Study|Switching to other therapy|0|||
33557333|NCT01331681|62950301|FG001|Overall Study|Switching to other therapy|0|||
33557334|NCT01331681|62950302|FG002|Overall Study|Switching to other therapy|1|||
33557335|NCT01331681|62950300|FG000|Overall Study|Not Received Study Treatment|0|||
33557336|NCT01331681|62950301|FG001|Overall Study|Not Received Study Treatment|0|||
33557337|NCT01331681|62950302|FG002|Overall Study|Not Received Study Treatment|2|||
33557338|NCT01331291|62950312|FG000|Overall Study|Lack of Efficacy|2|||
33557339|NCT01331291|62950313|FG001|Overall Study|Lack of Efficacy|8|||
33557340|NCT01331291|62950312|FG000|Overall Study|Death|0|||
33557341|NCT01331291|62950313|FG001|Overall Study|Death|1|||
33557342|NCT02601560|62950326|FG000|Overall Study|Other|0|||
33557343|NCT02601560|62950327|FG001|Overall Study|Other|0|||
33557344|NCT02601560|62950328|FG002|Overall Study|Other|0|||
33557345|NCT02601560|62950329|FG003|Overall Study|Other|0|||
33299476|NCT01100944|62675749|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
33557346|NCT02601560|62950330|FG004|Overall Study|Other|0|||
33557347|NCT02601560|62950331|FG005|Overall Study|Other|0|||
33557348|NCT02601560|62950332|FG006|Overall Study|Other|1|||
33557349|NCT02601560|62950333|FG007|Overall Study|Other|0|||
33557350|NCT02595398|62950364|FG000|Overall Study|Non-compliance|1|||
33557351|NCT02595398|62950365|FG001|Overall Study|Non-compliance|0|||
33557352|NCT02595398|62950364|FG000|Overall Study|Withdrawal by Subject|2|||
33557353|NCT02595398|62950365|FG001|Overall Study|Withdrawal by Subject|1|||
33557354|NCT02595398|62950364|FG000|Overall Study|Lost to Follow-up|1|||
33557355|NCT02595398|62950365|FG001|Overall Study|Lost to Follow-up|0|||
33557356|NCT01368497|62950371|FG000|Overall Study|Lost to Follow-up|2|||
33557357|NCT02595008|62950377|FG000|Overall Study|Enrolled In Error|1|||
33557358|NCT02595008|62950378|FG001|Overall Study|Enrolled In Error|0|||
33557359|NCT02598128|62950384|FG000|Period A: Days -7 to -1|Adverse Event|1|||
33557360|NCT02598128|62950385|FG001|Period A: Days -7 to -1|Adverse Event|0|||
33557361|NCT02598128|62950386|FG002|Period A: Days -7 to -1|Adverse Event|0|||
33557362|NCT02598128|62950387|FG003|Period A: Days -7 to -1|Adverse Event|0|||
33557363|NCT02788175|62950399|FG000|Overall Study|Protocol Violation|3|||
33557364|NCT02788175|62950399|FG000|Overall Study|Withdrawal by Subject|4|||
33557365|NCT02788175|62950399|FG000|Overall Study|Ineligible prior to study agent|6|||
33557366|NCT02787083|62950405|FG000|Overall Study|Adverse Event|1|||
33557367|NCT02787083|62950406|FG001|Overall Study|Adverse Event|0|||
33557368|NCT02787083|62950405|FG000|Overall Study|Withdrawal by Subject|2|||
33557369|NCT02787083|62950406|FG001|Overall Study|Withdrawal by Subject|2|||
33557370|NCT02787863|62950420|FG000|Overall Study|Death|1|||
33557371|NCT02787863|62950421|FG001|Overall Study|Death|0|||
33557372|NCT02787863|62950422|FG002|Overall Study|Death|1|||
33557373|NCT02787863|62950423|FG003|Overall Study|Death|0|||
33557374|NCT02787863|62950424|FG004|Overall Study|Death|0|||
33557375|NCT02787863|62950425|FG005|Overall Study|Death|0|||
33557376|NCT02787863|62950426|FG006|Overall Study|Death|0|||
33557377|NCT02787863|62950427|FG007|Overall Study|Death|0|||
33557378|NCT02787863|62950420|FG000|Overall Study|Withdrawal by Subject|0|||
33557379|NCT02787863|62950421|FG001|Overall Study|Withdrawal by Subject|1|||
33557380|NCT02787863|62950422|FG002|Overall Study|Withdrawal by Subject|1|||
33557381|NCT02787863|62950423|FG003|Overall Study|Withdrawal by Subject|0|||
33557382|NCT02787863|62950424|FG004|Overall Study|Withdrawal by Subject|0|||
33299477|NCT01100944|62675750|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
33299478|NCT01100944|62675748|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
33299479|NCT01100944|62675749|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
33557383|NCT02787863|62950425|FG005|Overall Study|Withdrawal by Subject|0|||
33557384|NCT02787863|62950426|FG006|Overall Study|Withdrawal by Subject|0|||
33299480|NCT01100944|62675750|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
33299481|NCT01100944|62675748|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
33299482|NCT01100944|62675749|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
33299483|NCT01100944|62675750|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
33299484|NCT01100944|62675748|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
33299485|NCT01100944|62675749|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
33557385|NCT02787863|62950427|FG007|Overall Study|Withdrawal by Subject|0|||
33557386|NCT02596958|62950468|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
33557387|NCT02596958|62950468|FG000|Overall Study|Cancer Progression|441|||
33557388|NCT02596958|62950468|FG000|Overall Study|Death From Cancer|112|||
33557389|NCT02596958|62950468|FG000|Overall Study|Death From Other Cause|33|||
33557390|NCT02596958|62950468|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
33390247|NCT00645411|62769218|FG002|Overall Study|Inappropriate enrollment|4|||
33390248|NCT00645411|62769219|FG003|Overall Study|Inappropriate enrollment|1|||
33390249|NCT00645411|62769216|FG000|Overall Study|Unable to classify|0|||
33557391|NCT02596958|62950468|FG000|Overall Study|Administrative Reasons/Other|231|||
33557392|NCT02596958|62950468|FG000|Overall Study|Lost to Follow-up|33|||
33557393|NCT02596958|62950468|FG000|Overall Study|Missing|32|||
33557394|NCT02596958|62950468|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
33557395|NCT01367249|62950474|FG000|Overall Study|Withdrawal by Subject|6|||
33557396|NCT01367249|62950475|FG001|Overall Study|Withdrawal by Subject|6|||
33557397|NCT01367249|62950474|FG000|Overall Study|Other|3|||
33557398|NCT01367249|62950475|FG001|Overall Study|Other|10|||
33557399|NCT02786927|62950481|FG000|Overall Study|Adverse Event|1|||
33557400|NCT02786927|62950481|FG000|Overall Study|Protocol Violation|4|||
33557401|NCT02592434|62950486|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
33557402|NCT02592434|62950487|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
33557403|NCT02592434|62950488|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
33557404|NCT02592434|62950486|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
33557405|NCT02592434|62950487|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
33557406|NCT02592434|62950488|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
33557407|NCT02592434|62950486|FG000|Open-Label Phase (18 Weeks)|Other|3|||
33557408|NCT02592434|62950487|FG001|Open-Label Phase (18 Weeks)|Other|0|||
33557409|NCT02592434|62950488|FG002|Open-Label Phase (18 Weeks)|Other|0|||
33557410|NCT02592434|62950486|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
33390250|NCT00645411|62769217|FG001|Overall Study|Unable to classify|0|||
33390251|NCT00645411|62769218|FG002|Overall Study|Unable to classify|3|||
33390252|NCT00645411|62769219|FG003|Overall Study|Unable to classify|4|||
33390253|NCT00403273|62769238|FG000|Overall Study|Lost to Follow-up|3|||
33390254|NCT00403273|62769239|FG001|Overall Study|Lost to Follow-up|2|||
33390255|NCT00403273|62769238|FG000|Overall Study|Physician Decision|0|||
33390256|NCT00403273|62769239|FG001|Overall Study|Physician Decision|1|||
33390257|NCT00403273|62769238|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
33390258|NCT00403273|62769239|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
33390259|NCT00402727|62769262|FG000|Overall Study|Adverse Event|10|||
33390260|NCT00402727|62769263|FG001|Overall Study|Adverse Event|6|||
33390261|NCT00402727|62769262|FG000|Overall Study|Death|1|||
33299486|NCT01100944|62675750|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
33299487|NCT01100320|62675771|FG000|Period 1|Withdrawal by Subject|2|||
33390262|NCT00402727|62769263|FG001|Overall Study|Death|0|||
33390263|NCT00402727|62769262|FG000|Overall Study|Lack of Efficacy|1|||
33390264|NCT00402727|62769263|FG001|Overall Study|Lack of Efficacy|3|||
33390265|NCT00402727|62769262|FG000|Overall Study|Lost to Follow-up|24|||
33390266|NCT00402727|62769263|FG001|Overall Study|Lost to Follow-up|11|||
33390267|NCT00402727|62769262|FG000|Overall Study|Physician Decision|1|||
33390268|NCT00402727|62769263|FG001|Overall Study|Physician Decision|1|||
33390269|NCT00402727|62769262|FG000|Overall Study|Protocol Violation|0|||
33390270|NCT00402727|62769263|FG001|Overall Study|Protocol Violation|4|||
33390271|NCT00402727|62769262|FG000|Overall Study|Withdrawal by Subject|3|||
33390272|NCT00402727|62769263|FG001|Overall Study|Withdrawal by Subject|7|||
33390273|NCT00402727|62769262|FG000|Overall Study|supply problems|2|||
33390274|NCT00402727|62769263|FG001|Overall Study|supply problems|1|||
33390275|NCT00402727|62769262|FG000|Overall Study|non-compliance|0|||
33390276|NCT00402727|62769263|FG001|Overall Study|non-compliance|1|||
33390277|NCT00402649|62769269|FG000|Overall Study|Lost to Follow-up|1|||
33390278|NCT00402649|62769269|FG000|Overall Study|Withdrawal by Subject|1|||
33390279|NCT00402337|62769278|FG000|Overall Study|Adverse Event|0|||
33390280|NCT00402337|62769279|FG001|Overall Study|Adverse Event|2|||
33390281|NCT00402337|62769280|FG002|Overall Study|Adverse Event|2|||
33390282|NCT00402337|62769281|FG003|Overall Study|Adverse Event|3|||
33390283|NCT00402337|62769282|FG004|Overall Study|Adverse Event|2|||
33390284|NCT00402337|62769278|FG000|Overall Study|Noncompliance|0|||
33390285|NCT00402337|62769279|FG001|Overall Study|Noncompliance|0|||
33557411|NCT02592434|62950487|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
33557412|NCT02592434|62950488|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
33557413|NCT02592434|62950486|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
33557414|NCT02592434|62950487|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
33390286|NCT00402337|62769280|FG002|Overall Study|Noncompliance|0|||
33390287|NCT00402337|62769281|FG003|Overall Study|Noncompliance|0|||
33390288|NCT00402337|62769282|FG004|Overall Study|Noncompliance|2|||
33390289|NCT00402337|62769278|FG000|Overall Study|Withdrawal by Subject|5|||
33557415|NCT02592434|62950488|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
33557416|NCT02592434|62950486|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
33299488|NCT01100320|62675772|FG001|Period 1|Withdrawal by Subject|4|||
33299489|NCT01100320|62675771|FG000|Period 1|Positive Drug Screen|1|||
33299490|NCT01100320|62675772|FG001|Period 1|Positive Drug Screen|1|||
33299491|NCT01100320|62675771|FG000|Period 1|Adverse Event|2|||
33299492|NCT01100320|62675772|FG001|Period 1|Adverse Event|2|||
33299493|NCT01100320|62675771|FG000|Period 2|Withdrawal by Subject|1|||
33557417|NCT02592434|62950487|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
33557418|NCT02592434|62950488|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
33557419|NCT02592434|62950486|FG000|Double Blind Phase (26 Weeks)|Other|0|||
33557420|NCT02592434|62950487|FG001|Double Blind Phase (26 Weeks)|Other|1|||
33557421|NCT02592434|62950488|FG002|Double Blind Phase (26 Weeks)|Other|0|||
33557422|NCT02592434|62950486|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
33557423|NCT02592434|62950487|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
33557424|NCT02592434|62950488|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
33557425|NCT02592434|62950486|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
33557426|NCT02592434|62950487|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
33557427|NCT02592434|62950488|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
33557428|NCT02592434|62950486|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
33557429|NCT02592434|62950487|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
33557430|NCT02592434|62950488|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
33557431|NCT02785913|62950496|FG000|Overall Study|Adverse Event|5|||
33557432|NCT02785913|62950496|FG000|Overall Study|Death|2|||
33557433|NCT02785913|62950496|FG000|Overall Study|Progression|18|||
33557434|NCT02785913|62950496|FG000|Overall Study|Not protocol specified|1|||
33557435|NCT02590562|62950505|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
33557436|NCT02783729|62950532|FG000|Overall Study|Lack of Efficacy|1|||
33557437|NCT02783729|62950533|FG001|Overall Study|Lack of Efficacy|0|||
33557438|NCT02783729|62950534|FG002|Overall Study|Lack of Efficacy|0|||
33557439|NCT02783729|62950535|FG003|Overall Study|Lack of Efficacy|0|||
33557440|NCT02783729|62950532|FG000|Overall Study|Adverse Event|2|||
33557441|NCT02783729|62950533|FG001|Overall Study|Adverse Event|6|||
33557442|NCT02783729|62950534|FG002|Overall Study|Adverse Event|2|||
33557443|NCT02783729|62950535|FG003|Overall Study|Adverse Event|3|||
33557444|NCT02783729|62950532|FG000|Overall Study|Other|1|||
33557445|NCT02783729|62950533|FG001|Overall Study|Other|6|||
33557446|NCT02783729|62950534|FG002|Overall Study|Other|2|||
33557447|NCT02783729|62950535|FG003|Overall Study|Other|3|||
33557448|NCT02783729|62950532|FG000|Overall Study|Withdrawal by Subject|2|||
33557449|NCT02783729|62950533|FG001|Overall Study|Withdrawal by Subject|3|||
33557450|NCT02783729|62950534|FG002|Overall Study|Withdrawal by Subject|1|||
33557451|NCT02783729|62950535|FG003|Overall Study|Withdrawal by Subject|2|||
33557452|NCT02783729|62950532|FG000|Overall Study|Participant's choice|2|||
33557453|NCT02783729|62950533|FG001|Overall Study|Participant's choice|1|||
33557454|NCT02783729|62950534|FG002|Overall Study|Participant's choice|2|||
33557455|NCT02783729|62950535|FG003|Overall Study|Participant's choice|1|||
33557456|NCT02783729|62950532|FG000|Overall Study|Lost to Follow-up|2|||
33557457|NCT02783729|62950533|FG001|Overall Study|Lost to Follow-up|1|||
33557458|NCT02783729|62950534|FG002|Overall Study|Lost to Follow-up|1|||
33557459|NCT02783729|62950535|FG003|Overall Study|Lost to Follow-up|0|||
33557460|NCT02784431|62950557|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
33557461|NCT02784431|62950557|FG000|Overall Study|Early Study Termination|19|||
33557462|NCT02590406|62950563|FG000|Overall Study|Adverse Event|1|||
33557463|NCT02590406|62950564|FG001|Overall Study|Adverse Event|0|||
33557464|NCT02590406|62950563|FG000|Overall Study|Saturometer malfunction|0|||
33557465|NCT02590406|62950564|FG001|Overall Study|Saturometer malfunction|1|||
33557466|NCT01359254|62950572|FG000|Overall Study|Death|1|||
33557467|NCT01359254|62950573|FG001|Overall Study|Death|0|||
33557468|NCT01667432|62950579|FG000|Overall Study|Premature Study Termination|26|||
33557469|NCT01667432|62950579|FG000|Overall Study|Failure to Return|10|||
33662662|NCT01587703|63093236|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
33662663|NCT01587703|63093237|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33662664|NCT01587703|63093238|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33662665|NCT01587703|63093239|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33662666|NCT01587703|63093240|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33662667|NCT01587703|63093241|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33662668|NCT01587703|63093242|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33662669|NCT01587703|63093243|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33662670|NCT01587703|63093244|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33662671|NCT01587703|63093226|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33662672|NCT01587703|63093227|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33662673|NCT01587703|63093228|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33557470|NCT01667432|62950579|FG000|Overall Study|Moved to Another Center|3|||
33557471|NCT01667432|62950579|FG000|Overall Study|Lost to Follow-up|3|||
33557472|NCT01667432|62950579|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
33557473|NCT01667432|62950579|FG000|Overall Study|Insufficient Therapeutic Response|4|||
33557474|NCT01667432|62950579|FG000|Overall Study|Adverse Event|1|||
33557475|NCT01667432|62950579|FG000|Overall Study|Protocol Deviation|2|||
33557476|NCT01667432|62950579|FG000|Overall Study|Principal Investigator Decision|1|||
33557477|NCT01667432|62950579|FG000|Overall Study|Reason Not Specified|2|||
33557478|NCT01667432|62950579|FG000|Overall Study|Missing Information|4|||
33557479|NCT01563107|62950587|FG000|Overall Study|Physician Decision|0|||
33557480|NCT01563107|62950588|FG001|Overall Study|Physician Decision|1|||
33557481|NCT01563107|62950589|FG002|Overall Study|Physician Decision|1|||
33557482|NCT01563107|62950590|FG003|Overall Study|Physician Decision|3|||
33557483|NCT01563107|62950587|FG000|Overall Study|Withdrawal by Subject|1|||
33557484|NCT01563107|62950588|FG001|Overall Study|Withdrawal by Subject|2|||
33557485|NCT01563107|62950589|FG002|Overall Study|Withdrawal by Subject|1|||
33557486|NCT01563107|62950590|FG003|Overall Study|Withdrawal by Subject|2|||
33557487|NCT02589626|62950652|FG000|Overall Study|Other than the reason specified|1|||
33557488|NCT02589626|62950653|FG001|Overall Study|Other than the reason specified|0|||
33557489|NCT02589626|62950652|FG000|Overall Study|Withdrawal by Subject|1|||
33557490|NCT02589626|62950653|FG001|Overall Study|Withdrawal by Subject|1|||
33662674|NCT01587703|63093229|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33299494|NCT01100320|62675772|FG001|Period 2|Withdrawal by Subject|1|||
33299495|NCT01100086|62675778|FG000|Period 1|Withdrawal by Subject|1|||
33299496|NCT01100086|62675779|FG001|Period 1|Withdrawal by Subject|0|||
33299497|NCT01297959|62675787|FG000|Overall Study|Adverse Event|0|||
33390290|NCT00402337|62769279|FG001|Overall Study|Withdrawal by Subject|3|||
33390291|NCT00402337|62769280|FG002|Overall Study|Withdrawal by Subject|1|||
33299498|NCT01297959|62675788|FG001|Overall Study|Adverse Event|1|||
33299499|NCT01297959|62675787|FG000|Overall Study|Protocol Violation|2|||
33299500|NCT01297959|62675788|FG001|Overall Study|Protocol Violation|1|||
33299501|NCT01297959|62675787|FG000|Overall Study|Withdrawal by Subject|5|||
33299502|NCT01297959|62675788|FG001|Overall Study|Withdrawal by Subject|4|||
33299503|NCT01297959|62675787|FG000|Overall Study|Physician Decision|0|||
33299504|NCT01297959|62675788|FG001|Overall Study|Physician Decision|1|||
33299505|NCT01297959|62675787|FG000|Overall Study|Unrelated medical illness / complication|0|||
33299506|NCT01297959|62675788|FG001|Overall Study|Unrelated medical illness / complication|2|||
33299507|NCT01297959|62675787|FG000|Overall Study|Other|13|||
33299508|NCT01297959|62675788|FG001|Overall Study|Other|7|||
33299509|NCT01035229|62675796|FG000|Overall Study|Adverse Event|61|||
33299510|NCT01035229|62675797|FG001|Overall Study|Adverse Event|14|||
33299511|NCT01035229|62675796|FG000|Overall Study|Withdrawal by Subject|20|||
33299512|NCT01035229|62675797|FG001|Overall Study|Withdrawal by Subject|7|||
33299513|NCT01035229|62675796|FG000|Overall Study|Lost to Follow-up|1|||
33299514|NCT01035229|62675797|FG001|Overall Study|Lost to Follow-up|0|||
33299515|NCT01035229|62675796|FG000|Overall Study|Administrative problems|1|||
33299516|NCT01035229|62675797|FG001|Overall Study|Administrative problems|1|||
33299517|NCT01035229|62675796|FG000|Overall Study|Death|13|||
33299518|NCT01035229|62675797|FG001|Overall Study|Death|5|||
33299519|NCT01035229|62675796|FG000|Overall Study|New cancer therapy|2|||
33299520|NCT01035229|62675797|FG001|Overall Study|New cancer therapy|0|||
33299521|NCT01035229|62675796|FG000|Overall Study|Protocol Violation|0|||
33299522|NCT01035229|62675797|FG001|Overall Study|Protocol Violation|2|||
33299523|NCT01035229|62675796|FG000|Overall Study|Sponsor's decision to end study|3|||
33299524|NCT01035229|62675797|FG001|Overall Study|Sponsor's decision to end study|3|||
33299525|NCT01035229|62675796|FG000|Overall Study|Disease Progression|261|||
33299526|NCT01035229|62675797|FG001|Overall Study|Disease Progression|152|||
33299527|NCT01106404|62675807|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
33299528|NCT01106404|62675808|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
33299529|NCT01106404|62675807|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
33390292|NCT00402337|62769281|FG003|Overall Study|Withdrawal by Subject|6|||
33390293|NCT00402337|62769282|FG004|Overall Study|Withdrawal by Subject|4|||
33390294|NCT00402337|62769278|FG000|Overall Study|Lost to Follow-up|0|||
33390295|NCT00402337|62769279|FG001|Overall Study|Lost to Follow-up|0|||
33390296|NCT00402337|62769280|FG002|Overall Study|Lost to Follow-up|1|||
33390297|NCT00402337|62769281|FG003|Overall Study|Lost to Follow-up|2|||
33390298|NCT00402337|62769282|FG004|Overall Study|Lost to Follow-up|0|||
33390299|NCT00402337|62769278|FG000|Overall Study|Physician Decision|0|||
33390300|NCT00402337|62769279|FG001|Overall Study|Physician Decision|0|||
33390301|NCT00402337|62769280|FG002|Overall Study|Physician Decision|0|||
33390302|NCT00402337|62769281|FG003|Overall Study|Physician Decision|1|||
33557491|NCT02589626|62950652|FG000|Overall Study|Adverse Event|1|||
33662675|NCT01587703|63093230|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33662676|NCT01587703|63093231|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33299530|NCT01106404|62675808|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
33299531|NCT01106404|62675807|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
33299532|NCT01106404|62675808|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
33299533|NCT01106404|62675807|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
33299534|NCT01106404|62675808|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
33557492|NCT02589626|62950653|FG001|Overall Study|Adverse Event|1|||
33557493|NCT01666730|62950668|FG000|Overall Study|Adverse Event|16|||
33299535|NCT01059799|62675822|FG000|Overall Study|Adverse Event|2|||
33299536|NCT01059799|62675823|FG001|Overall Study|Adverse Event|3|||
33299537|NCT01059799|62675822|FG000|Overall Study|Lack of Efficacy|1|||
33390303|NCT00402337|62769282|FG004|Overall Study|Physician Decision|0|||
33557494|NCT01666730|62950668|FG000|Overall Study|Death|2|||
33557495|NCT01666730|62950668|FG000|Overall Study|Physician Decision|5|||
33557496|NCT01666730|62950668|FG000|Overall Study|Withdrawal by Subject|9|||
33557497|NCT01666730|62950668|FG000|Overall Study|Disease progression/relapse|18|||
33557498|NCT00103285|62950681|FG000|Induction|Adverse Event|14|||
33557499|NCT00103285|62950682|FG001|Induction|Adverse Event|0|||
33557500|NCT00103285|62950683|FG002|Induction|Adverse Event|0|||
33557501|NCT00103285|62950684|FG003|Induction|Adverse Event|0|||
33557502|NCT00103285|62950685|FG004|Induction|Adverse Event|0|||
33557503|NCT00103285|62950686|FG005|Induction|Adverse Event|0|||
33557504|NCT00103285|62950687|FG006|Induction|Adverse Event|0|||
33557505|NCT00103285|62950688|FG007|Induction|Adverse Event|0|||
33557506|NCT00103285|62950681|FG000|Induction|Death|24|||
33557507|NCT00103285|62950682|FG001|Induction|Death|0|||
33390304|NCT00402337|62769278|FG000|Overall Study|Other Reason|0|||
33390305|NCT00402337|62769279|FG001|Overall Study|Other Reason|1|||
33390306|NCT00402337|62769280|FG002|Overall Study|Other Reason|0|||
33390307|NCT00402337|62769281|FG003|Overall Study|Other Reason|0|||
33390308|NCT00402337|62769282|FG004|Overall Study|Other Reason|0|||
33390309|NCT00650091|62769296|FG000|Amended Study Design|Withdrawal by Subject|12|||
33390310|NCT00650091|62769297|FG001|Amended Study Design|Withdrawal by Subject|11|||
33390311|NCT00650091|62769298|FG002|Amended Study Design|Withdrawal by Subject|0|||
33390312|NCT00650091|62769296|FG000|Amended Study Design|Physician Decision|5|||
33390313|NCT00650091|62769297|FG001|Amended Study Design|Physician Decision|0|||
33390314|NCT00650091|62769298|FG002|Amended Study Design|Physician Decision|0|||
33390315|NCT00650091|62769296|FG000|Amended Study Design|Adverse Event|1|||
33390316|NCT00650091|62769297|FG001|Amended Study Design|Adverse Event|4|||
33557508|NCT00103285|62950683|FG002|Induction|Death|0|||
33557509|NCT00103285|62950684|FG003|Induction|Death|0|||
33557510|NCT00103285|62950685|FG004|Induction|Death|0|||
33557511|NCT00103285|62950686|FG005|Induction|Death|0|||
33557512|NCT00103285|62950687|FG006|Induction|Death|0|||
33557513|NCT00103285|62950688|FG007|Induction|Death|0|||
33557514|NCT00103285|62950681|FG000|Induction|Physician Decision|103|||
33557515|NCT00103285|62950682|FG001|Induction|Physician Decision|0|||
33557516|NCT00103285|62950683|FG002|Induction|Physician Decision|0|||
33557517|NCT00103285|62950684|FG003|Induction|Physician Decision|0|||
33557518|NCT00103285|62950685|FG004|Induction|Physician Decision|0|||
33557519|NCT00103285|62950686|FG005|Induction|Physician Decision|0|||
33557520|NCT00103285|62950687|FG006|Induction|Physician Decision|0|||
33557521|NCT00103285|62950688|FG007|Induction|Physician Decision|0|||
33557522|NCT00103285|62950681|FG000|Induction|Withdrawal by Subject|1|||
33557523|NCT00103285|62950682|FG001|Induction|Withdrawal by Subject|0|||
33557524|NCT00103285|62950683|FG002|Induction|Withdrawal by Subject|0|||
33557525|NCT00103285|62950684|FG003|Induction|Withdrawal by Subject|0|||
33557526|NCT00103285|62950685|FG004|Induction|Withdrawal by Subject|0|||
33557527|NCT00103285|62950686|FG005|Induction|Withdrawal by Subject|0|||
33557528|NCT00103285|62950687|FG006|Induction|Withdrawal by Subject|0|||
33557529|NCT00103285|62950688|FG007|Induction|Withdrawal by Subject|0|||
33557530|NCT00103285|62950681|FG000|Induction|Ineligible|43|||
33557531|NCT00103285|62950682|FG001|Induction|Ineligible|0|||
33557532|NCT00103285|62950683|FG002|Induction|Ineligible|0|||
33557533|NCT00103285|62950684|FG003|Induction|Ineligible|0|||
33557534|NCT00103285|62950685|FG004|Induction|Ineligible|0|||
33557535|NCT00103285|62950686|FG005|Induction|Ineligible|0|||
33557536|NCT00103285|62950687|FG006|Induction|Ineligible|0|||
33557537|NCT00103285|62950688|FG007|Induction|Ineligible|0|||
33557538|NCT00103285|62950681|FG000|Induction|Refusal|906|||
33557539|NCT00103285|62950682|FG001|Induction|Refusal|0|||
33557540|NCT00103285|62950683|FG002|Induction|Refusal|0|||
33557541|NCT00103285|62950684|FG003|Induction|Refusal|0|||
33557542|NCT00103285|62950685|FG004|Induction|Refusal|0|||
33557543|NCT00103285|62950686|FG005|Induction|Refusal|0|||
33557544|NCT00103285|62950687|FG006|Induction|Refusal|0|||
33557545|NCT00103285|62950688|FG007|Induction|Refusal|0|||
33557546|NCT00103285|62950681|FG000|Induction|Other|258|||
33557547|NCT00103285|62950682|FG001|Induction|Other|0|||
33557548|NCT00103285|62950683|FG002|Induction|Other|0|||
33557549|NCT00103285|62950684|FG003|Induction|Other|0|||
33299538|NCT01059799|62675823|FG001|Overall Study|Lack of Efficacy|0|||
33299539|NCT01059799|62675822|FG000|Overall Study|Protocol Violation|3|||
33299540|NCT01059799|62675823|FG001|Overall Study|Protocol Violation|2|||
33299541|NCT01059799|62675822|FG000|Overall Study|Withdrawal criteria|13|||
33299542|NCT01059799|62675823|FG001|Overall Study|Withdrawal criteria|2|||
33299543|NCT01059799|62675822|FG000|Overall Study|Other|12|||
33299544|NCT01059799|62675823|FG001|Overall Study|Other|3|||
33299545|NCT01106248|62675829|FG000|Overall Study|Adverse Event|1|||
33299546|NCT01106248|62675829|FG000|Overall Study|Administrative|2|||
33390317|NCT00650091|62769298|FG002|Amended Study Design|Adverse Event|0|||
33557550|NCT00103285|62950685|FG004|Induction|Other|0|||
33557551|NCT00103285|62950686|FG005|Induction|Other|0|||
33557552|NCT00103285|62950687|FG006|Induction|Other|0|||
33557553|NCT00103285|62950688|FG007|Induction|Other|0|||
33557554|NCT00103285|62950681|FG000|Response Assignment|Adverse Event|0|||
33557555|NCT00103285|62950682|FG001|Response Assignment|Adverse Event|8|||
33557556|NCT00103285|62950683|FG002|Response Assignment|Adverse Event|3|||
33557557|NCT00103285|62950684|FG003|Response Assignment|Adverse Event|2|||
33557558|NCT00103285|62950685|FG004|Response Assignment|Adverse Event|3|||
33557559|NCT00103285|62950686|FG005|Response Assignment|Adverse Event|1|||
33557560|NCT00103285|62950687|FG006|Response Assignment|Adverse Event|1|||
33557561|NCT00103285|62950688|FG007|Response Assignment|Adverse Event|2|||
33557562|NCT00103285|62950681|FG000|Response Assignment|Death|0|||
33557563|NCT00103285|62950682|FG001|Response Assignment|Death|5|||
33557564|NCT00103285|62950683|FG002|Response Assignment|Death|2|||
33557565|NCT00103285|62950684|FG003|Response Assignment|Death|2|||
33557566|NCT00103285|62950685|FG004|Response Assignment|Death|3|||
33557567|NCT00103285|62950686|FG005|Response Assignment|Death|1|||
33557568|NCT00103285|62950687|FG006|Response Assignment|Death|0|||
33557569|NCT00103285|62950688|FG007|Response Assignment|Death|8|||
33557570|NCT00103285|62950681|FG000|Response Assignment|Lost to Follow-up|0|||
33557571|NCT00103285|62950682|FG001|Response Assignment|Lost to Follow-up|9|||
33557572|NCT00103285|62950683|FG002|Response Assignment|Lost to Follow-up|5|||
33557573|NCT00103285|62950684|FG003|Response Assignment|Lost to Follow-up|5|||
33557574|NCT00103285|62950685|FG004|Response Assignment|Lost to Follow-up|1|||
33557575|NCT00103285|62950686|FG005|Response Assignment|Lost to Follow-up|2|||
33557576|NCT00103285|62950687|FG006|Response Assignment|Lost to Follow-up|2|||
33557577|NCT00103285|62950688|FG007|Response Assignment|Lost to Follow-up|5|||
33557578|NCT00103285|62950681|FG000|Response Assignment|Physician Decision|0|||
33557579|NCT00103285|62950682|FG001|Response Assignment|Physician Decision|13|||
33557580|NCT00103285|62950683|FG002|Response Assignment|Physician Decision|14|||
33557581|NCT00103285|62950684|FG003|Response Assignment|Physician Decision|9|||
33557582|NCT00103285|62950685|FG004|Response Assignment|Physician Decision|13|||
33557583|NCT00103285|62950686|FG005|Response Assignment|Physician Decision|7|||
33557584|NCT00103285|62950687|FG006|Response Assignment|Physician Decision|4|||
33557585|NCT00103285|62950688|FG007|Response Assignment|Physician Decision|35|||
33557586|NCT00103285|62950681|FG000|Response Assignment|Protocol Violation|0|||
33557587|NCT00103285|62950682|FG001|Response Assignment|Protocol Violation|2|||
33557588|NCT00103285|62950683|FG002|Response Assignment|Protocol Violation|0|||
33557589|NCT00103285|62950684|FG003|Response Assignment|Protocol Violation|0|||
33557590|NCT00103285|62950685|FG004|Response Assignment|Protocol Violation|0|||
33557591|NCT00103285|62950686|FG005|Response Assignment|Protocol Violation|0|||
33557592|NCT00103285|62950687|FG006|Response Assignment|Protocol Violation|0|||
33557593|NCT00103285|62950688|FG007|Response Assignment|Protocol Violation|0|||
33557594|NCT00103285|62950681|FG000|Response Assignment|Withdrawal by Subject|0|||
33390318|NCT00650091|62769296|FG000|Amended Study Design|Lung transplantation|4|||
33390319|NCT00650091|62769297|FG001|Amended Study Design|Lung transplantation|2|||
33390320|NCT00650091|62769298|FG002|Amended Study Design|Lung transplantation|0|||
33390321|NCT00650091|62769296|FG000|Amended Study Design|Other|1|||
33390322|NCT00650091|62769297|FG001|Amended Study Design|Other|3|||
33557595|NCT00103285|62950682|FG001|Response Assignment|Withdrawal by Subject|4|||
33299547|NCT01059175|62675835|FG000|Overall Study|Death|17|||
33299548|NCT01059175|62675836|FG001|Overall Study|Death|17|||
33299549|NCT01059175|62675835|FG000|Overall Study|Adverse Event|4|||
33299550|NCT01059175|62675836|FG001|Overall Study|Adverse Event|2|||
33299551|NCT01059175|62675835|FG000|Overall Study|Lost to Follow-up|0|||
33299552|NCT01059175|62675836|FG001|Overall Study|Lost to Follow-up|1|||
33299553|NCT01297491|62675844|FG000|Overall Study|Adverse Event|11|||
33557596|NCT00103285|62950683|FG002|Response Assignment|Withdrawal by Subject|1|||
33557597|NCT00103285|62950684|FG003|Response Assignment|Withdrawal by Subject|1|||
33557598|NCT00103285|62950685|FG004|Response Assignment|Withdrawal by Subject|2|||
33557599|NCT00103285|62950686|FG005|Response Assignment|Withdrawal by Subject|2|||
33557600|NCT00103285|62950687|FG006|Response Assignment|Withdrawal by Subject|0|||
33557601|NCT00103285|62950688|FG007|Response Assignment|Withdrawal by Subject|2|||
33299554|NCT01297491|62675845|FG001|Overall Study|Adverse Event|6|||
33299555|NCT01297491|62675844|FG000|Overall Study|Physician Decision|3|||
33299556|NCT01297491|62675845|FG001|Overall Study|Physician Decision|2|||
33299557|NCT01297491|62675844|FG000|Overall Study|Progressive disease|11|||
33299558|NCT01297491|62675845|FG001|Overall Study|Progressive disease|20|||
33299559|NCT01297491|62675844|FG000|Overall Study|Patient/Guardian decision|3|||
33557602|NCT00103285|62950681|FG000|Response Assignment|Ineligible|0|||
33390323|NCT00650091|62769298|FG002|Amended Study Design|Other|0|||
33557603|NCT00103285|62950682|FG001|Response Assignment|Ineligible|8|||
33557604|NCT00103285|62950683|FG002|Response Assignment|Ineligible|6|||
33299560|NCT01297491|62675845|FG001|Overall Study|Patient/Guardian decision|4|||
33299561|NCT01297491|62675844|FG000|Overall Study|Death|2|||
33299562|NCT01297491|62675845|FG001|Overall Study|Death|1|||
33557605|NCT00103285|62950684|FG003|Response Assignment|Ineligible|2|||
33557606|NCT00103285|62950685|FG004|Response Assignment|Ineligible|0|||
33557607|NCT00103285|62950686|FG005|Response Assignment|Ineligible|3|||
33557608|NCT00103285|62950687|FG006|Response Assignment|Ineligible|1|||
33557609|NCT00103285|62950688|FG007|Response Assignment|Ineligible|5|||
33557610|NCT00103285|62950681|FG000|Response Assignment|Refusal|0|||
33557611|NCT00103285|62950682|FG001|Response Assignment|Refusal|53|||
33557612|NCT00103285|62950683|FG002|Response Assignment|Refusal|5|||
33390324|NCT00642369|62769308|FG000|Overall Study|Adverse Event|2|||
33390325|NCT00642369|62769309|FG001|Overall Study|Adverse Event|3|||
33390326|NCT00642369|62769308|FG000|Overall Study|Withdrawal by Subject|1|||
33390327|NCT00642369|62769309|FG001|Overall Study|Withdrawal by Subject|0|||
33390328|NCT00642369|62769308|FG000|Overall Study|misdiagnosis|0|||
33390329|NCT00642369|62769309|FG001|Overall Study|misdiagnosis|1|||
33390330|NCT00642369|62769308|FG000|Overall Study|Lack of Efficacy|2|||
33390331|NCT00642369|62769309|FG001|Overall Study|Lack of Efficacy|2|||
33390332|NCT00645099|62769334|FG000|Overall Study|Lack of Efficacy|15|||
33390333|NCT00645099|62769335|FG001|Overall Study|Lack of Efficacy|6|||
33390334|NCT00645099|62769334|FG000|Overall Study|Withdrawal by Subject|30|||
33390335|NCT00645099|62769335|FG001|Overall Study|Withdrawal by Subject|22|||
33557613|NCT00103285|62950684|FG003|Response Assignment|Refusal|3|||
33557614|NCT00103285|62950685|FG004|Response Assignment|Refusal|25|||
33557615|NCT00103285|62950686|FG005|Response Assignment|Refusal|15|||
33557616|NCT00103285|62950687|FG006|Response Assignment|Refusal|30|||
33557617|NCT00103285|62950688|FG007|Response Assignment|Refusal|10|||
33557618|NCT00103285|62950681|FG000|Response Assignment|Other|0|||
33557619|NCT00103285|62950682|FG001|Response Assignment|Other|30|||
33557620|NCT00103285|62950683|FG002|Response Assignment|Other|48|||
33557621|NCT00103285|62950684|FG003|Response Assignment|Other|38|||
33557622|NCT00103285|62950685|FG004|Response Assignment|Other|37|||
33557623|NCT00103285|62950686|FG005|Response Assignment|Other|17|||
33557624|NCT00103285|62950687|FG006|Response Assignment|Other|11|||
33557625|NCT00103285|62950688|FG007|Response Assignment|Other|53|||
33557626|NCT02783573|62950716|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
33557627|NCT02783573|62950717|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
33557628|NCT02783573|62950718|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
33557629|NCT02783573|62950716|FG000|Placebo-Controlled Treatment Period|Death|4|||
33557630|NCT02783573|62950717|FG001|Placebo-Controlled Treatment Period|Death|2|||
33557631|NCT02783573|62950718|FG002|Placebo-Controlled Treatment Period|Death|3|||
33557632|NCT02783573|62950716|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
33557633|NCT02783573|62950717|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
33557634|NCT02783573|62950718|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
33557635|NCT02783573|62950716|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
33557636|NCT02783573|62950717|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
33557637|NCT02783573|62950718|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
33557638|NCT02783573|62950716|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
33557639|NCT02783573|62950717|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
33557640|NCT02783573|62950718|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
33557641|NCT02783573|62950716|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
33557642|NCT02783573|62950717|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
33557643|NCT02783573|62950718|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
33557644|NCT02783573|62950716|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
33557645|NCT02783573|62950717|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
33557646|NCT02783573|62950718|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
33557647|NCT02783573|62950716|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
33557648|NCT02783573|62950717|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
33557649|NCT02783573|62950718|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
33557650|NCT02783573|62950716|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
33390336|NCT00645099|62769334|FG000|Overall Study|Lost to Follow-up|6|||
33390337|NCT00645099|62769335|FG001|Overall Study|Lost to Follow-up|4|||
33557651|NCT02783573|62950717|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
33557652|NCT02783573|62950718|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
33557653|NCT02783573|62950716|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
33557654|NCT02783573|62950717|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
33557655|NCT02783573|62950718|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
33557656|NCT02783573|62950716|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
33299563|NCT01106092|62675855|FG000|Overall Study|Withdrawal by Subject|0|||
33299564|NCT01106092|62675856|FG001|Overall Study|Withdrawal by Subject|0|||
33299565|NCT01106092|62675857|FG002|Overall Study|Withdrawal by Subject|0|||
33299566|NCT01106092|62675858|FG003|Overall Study|Withdrawal by Subject|1|||
33299567|NCT01097668|62675870|FG000|Overall Study|Withdrawal by Subject|1|||
33299568|NCT01097668|62675871|FG001|Overall Study|Withdrawal by Subject|2|||
33299569|NCT01097668|62675870|FG000|Overall Study|Lost to Follow-up|1|||
33299570|NCT01097668|62675871|FG001|Overall Study|Lost to Follow-up|0|||
33299571|NCT01325207|62675887|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
33299572|NCT01325207|62675888|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
33299573|NCT01325207|62675889|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
33299574|NCT01325207|62675890|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
33299575|NCT01325207|62675891|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
33390338|NCT00645099|62769334|FG000|Overall Study|Adverse Event|11|||
33557657|NCT02783573|62950717|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
33557658|NCT02783573|62950718|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
33557659|NCT02783573|62950716|FG000|Delayed-Start Period|Sponsor Decision|0|||
33557660|NCT02783573|62950717|FG001|Delayed-Start Period|Sponsor Decision|17|||
33557661|NCT02783573|62950718|FG002|Delayed-Start Period|Sponsor Decision|12|||
33557662|NCT01666652|62950734|FG000|Overall Study|Serious Adverse Event|0|||
33557663|NCT01666652|62950735|FG001|Overall Study|Serious Adverse Event|0|||
33557664|NCT01666652|62950736|FG002|Overall Study|Serious Adverse Event|0|||
33557665|NCT01666652|62950737|FG003|Overall Study|Serious Adverse Event|1|||
33557666|NCT01666652|62950738|FG004|Overall Study|Serious Adverse Event|0|||
33557667|NCT01666652|62950734|FG000|Overall Study|Withdrawal by Subject|0|||
33557668|NCT01666652|62950735|FG001|Overall Study|Withdrawal by Subject|0|||
33557669|NCT01666652|62950736|FG002|Overall Study|Withdrawal by Subject|0|||
33557670|NCT01666652|62950737|FG003|Overall Study|Withdrawal by Subject|0|||
33557671|NCT01666652|62950738|FG004|Overall Study|Withdrawal by Subject|1|||
33557672|NCT01666652|62950734|FG000|Overall Study|Moved from study area|1|||
33557673|NCT01666652|62950735|FG001|Overall Study|Moved from study area|0|||
33557674|NCT01666652|62950736|FG002|Overall Study|Moved from study area|0|||
33557675|NCT01666652|62950737|FG003|Overall Study|Moved from study area|2|||
33557676|NCT01666652|62950738|FG004|Overall Study|Moved from study area|0|||
33557677|NCT01666652|62950734|FG000|Overall Study|Lost to Follow-up|1|||
33557678|NCT01666652|62950735|FG001|Overall Study|Lost to Follow-up|1|||
33390339|NCT00645099|62769335|FG001|Overall Study|Adverse Event|5|||
33390340|NCT00645099|62769334|FG000|Overall Study|Other|9|||
33390341|NCT00645099|62769335|FG001|Overall Study|Other|5|||
33390342|NCT00420511|62769343|FG000|Overall Study|Adverse Event|1|||
33390343|NCT00420511|62769344|FG001|Overall Study|Adverse Event|1|||
33390344|NCT00420511|62769343|FG000|Overall Study|Lost to Follow-up|1|||
33390345|NCT00420511|62769344|FG001|Overall Study|Lost to Follow-up|0|||
33390346|NCT00420199|62769354|FG000|Overall Study|Participant no longer met study criteria|1|||
33390347|NCT00420199|62769355|FG001|Overall Study|Participant no longer met study criteria|0|||
33390348|NCT00649389|62769370|FG000|Overall Study|Adverse Event|22|||
33390349|NCT00649389|62769371|FG001|Overall Study|Adverse Event|46|||
33390350|NCT00649389|62769372|FG002|Overall Study|Adverse Event|38|||
33390351|NCT00649389|62769373|FG003|Overall Study|Adverse Event|48|||
33390352|NCT00649389|62769370|FG000|Overall Study|Lost to Follow-up|15|||
33390353|NCT00649389|62769371|FG001|Overall Study|Lost to Follow-up|17|||
33390354|NCT00649389|62769372|FG002|Overall Study|Lost to Follow-up|21|||
33390355|NCT00649389|62769373|FG003|Overall Study|Lost to Follow-up|26|||
33390356|NCT00649389|62769370|FG000|Overall Study|Protocol Violation|11|||
33390357|NCT00649389|62769371|FG001|Overall Study|Protocol Violation|13|||
33390358|NCT00649389|62769372|FG002|Overall Study|Protocol Violation|9|||
33390359|NCT00649389|62769373|FG003|Overall Study|Protocol Violation|8|||
33390360|NCT00649389|62769370|FG000|Overall Study|Withdrawal by Subject|20|||
33390361|NCT00649389|62769371|FG001|Overall Study|Withdrawal by Subject|21|||
33390362|NCT00649389|62769372|FG002|Overall Study|Withdrawal by Subject|19|||
33390363|NCT00649389|62769373|FG003|Overall Study|Withdrawal by Subject|23|||
33390364|NCT00649389|62769370|FG000|Overall Study|Other|3|||
33390365|NCT00649389|62769371|FG001|Overall Study|Other|9|||
33390366|NCT00649389|62769372|FG002|Overall Study|Other|1|||
33390367|NCT00649389|62769373|FG003|Overall Study|Other|6|||
33390368|NCT00402103|62769385|FG000|Overall Study|Adverse Event|60|||
33390369|NCT00402103|62769386|FG001|Overall Study|Adverse Event|7|||
33390370|NCT00402103|62769385|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33557679|NCT01666652|62950736|FG002|Overall Study|Lost to Follow-up|1|||
33557680|NCT01666652|62950737|FG003|Overall Study|Lost to Follow-up|1|||
33557681|NCT01666652|62950738|FG004|Overall Study|Lost to Follow-up|0|||
33557682|NCT00109733|62950752|FG000|Overall Study|Protocol Violation|0|||
33557683|NCT00109733|62950753|FG001|Overall Study|Protocol Violation|1|||
33662677|NCT01587703|63093232|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33299576|NCT01325207|62675892|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
33299577|NCT01325207|62675887|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
33299578|NCT01325207|62675888|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
33299579|NCT01325207|62675889|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
33299580|NCT01325207|62675890|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
33299581|NCT01325207|62675891|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
33299582|NCT01325207|62675892|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
33299583|NCT01325207|62675887|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
33299584|NCT01325207|62675888|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
33299585|NCT01325207|62675889|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
33390371|NCT00402103|62769386|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33390372|NCT00402103|62769385|FG000|Overall Study|Condition no longer requires study drug|2|||
33390373|NCT00402103|62769386|FG001|Overall Study|Condition no longer requires study drug|0|||
33390374|NCT00402103|62769385|FG000|Overall Study|Protocol Deviation|8|||
33390375|NCT00402103|62769386|FG001|Overall Study|Protocol Deviation|0|||
33557684|NCT00109733|62950752|FG000|Overall Study|Stopped taking study drug|1|||
33557685|NCT00109733|62950753|FG001|Overall Study|Stopped taking study drug|1|||
33557686|NCT00109733|62950752|FG000|Overall Study|Non-compliant|0|||
33557687|NCT00109733|62950753|FG001|Overall Study|Non-compliant|1|||
33557688|NCT00109733|62950752|FG000|Overall Study|Could not commit time for study|1|||
33557689|NCT00109733|62950753|FG001|Overall Study|Could not commit time for study|1|||
33557690|NCT02706405|62950767|FG000|Overall Study|Death|3|||
33557691|NCT02706405|62950768|FG001|Overall Study|Death|2|||
33557692|NCT02706405|62950769|FG002|Overall Study|Death|0|||
33557693|NCT02706405|62950770|FG003|Overall Study|Death|1|||
33557694|NCT02706405|62950771|FG004|Overall Study|Death|0|||
33557695|NCT02706405|62950772|FG005|Overall Study|Death|0|||
33557696|NCT02706405|62950773|FG006|Overall Study|Death|3|||
33557697|NCT02706405|62950774|FG007|Overall Study|Death|4|||
33557698|NCT02706405|62950767|FG000|Overall Study|Disease progression|0|||
33557699|NCT02706405|62950768|FG001|Overall Study|Disease progression|0|||
33557700|NCT02706405|62950769|FG002|Overall Study|Disease progression|0|||
33557701|NCT02706405|62950770|FG003|Overall Study|Disease progression|0|||
33557702|NCT02706405|62950771|FG004|Overall Study|Disease progression|0|||
33557703|NCT02706405|62950772|FG005|Overall Study|Disease progression|0|||
33557704|NCT02706405|62950773|FG006|Overall Study|Disease progression|0|||
33557705|NCT02706405|62950774|FG007|Overall Study|Disease progression|1|||
33557706|NCT02706405|62950767|FG000|Overall Study|Pt moved to new therapy|0|||
33557707|NCT02706405|62950768|FG001|Overall Study|Pt moved to new therapy|0|||
33557708|NCT02706405|62950769|FG002|Overall Study|Pt moved to new therapy|0|||
33557709|NCT02706405|62950770|FG003|Overall Study|Pt moved to new therapy|0|||
33557710|NCT02706405|62950771|FG004|Overall Study|Pt moved to new therapy|0|||
33557711|NCT02706405|62950772|FG005|Overall Study|Pt moved to new therapy|1|||
33557712|NCT02706405|62950773|FG006|Overall Study|Pt moved to new therapy|0|||
33557713|NCT02706405|62950774|FG007|Overall Study|Pt moved to new therapy|1|||
33557714|NCT02706405|62950767|FG000|Overall Study|Physician Decision|1|||
33557715|NCT02706405|62950768|FG001|Overall Study|Physician Decision|0|||
33557716|NCT02706405|62950769|FG002|Overall Study|Physician Decision|0|||
33557717|NCT02706405|62950770|FG003|Overall Study|Physician Decision|0|||
33557718|NCT02706405|62950771|FG004|Overall Study|Physician Decision|0|||
33557719|NCT02706405|62950772|FG005|Overall Study|Physician Decision|0|||
33557720|NCT02706405|62950773|FG006|Overall Study|Physician Decision|0|||
33557721|NCT02706405|62950774|FG007|Overall Study|Physician Decision|0|||
33557722|NCT02761993|62950803|FG000|Overall Study|Adverse Event|0|||
33557723|NCT02761993|62950804|FG001|Overall Study|Adverse Event|2|||
33557724|NCT02761993|62950805|FG002|Overall Study|Adverse Event|0|||
33557725|NCT02761993|62950803|FG000|Overall Study|Lost to Follow-up|1|||
33390376|NCT00402103|62769385|FG000|Overall Study|Patient withdrew consent|12|||
33390377|NCT00402103|62769386|FG001|Overall Study|Patient withdrew consent|1|||
33390378|NCT00402103|62769385|FG000|Overall Study|Lost to Follow-up|6|||
33390379|NCT00402103|62769386|FG001|Overall Study|Lost to Follow-up|3|||
33390380|NCT00402103|62769385|FG000|Overall Study|Administrative problems|2|||
33390381|NCT00402103|62769386|FG001|Overall Study|Administrative problems|0|||
33390382|NCT00641667|62769396|FG000|Overall Study|Withdrawal by Subject|1|||
33390383|NCT00641667|62769396|FG000|Overall Study|Adverse Event|1|||
33390384|NCT00641667|62769396|FG000|Overall Study|Physician Decision|1|||
33390385|NCT00641667|62769396|FG000|Overall Study|Worsening of underlying disease|3|||
33390386|NCT00704184|62769405|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
33390387|NCT00704184|62769406|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
33390388|NCT00704184|62769407|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
33390389|NCT00704184|62769408|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
33557726|NCT02761993|62950804|FG001|Overall Study|Lost to Follow-up|3|||
33557727|NCT02761993|62950805|FG002|Overall Study|Lost to Follow-up|2|||
33557728|NCT02761993|62950803|FG000|Overall Study|Withdrawal by Subject|1|||
33557729|NCT02761993|62950804|FG001|Overall Study|Withdrawal by Subject|1|||
33557730|NCT02761993|62950805|FG002|Overall Study|Withdrawal by Subject|2|||
33557731|NCT02766283|62950813|FG000|Overall Study|Lost to Follow-up|27|||
33557732|NCT02761915|62950847|FG000|Overall Study|Death|3|||
33557733|NCT02761915|62950848|FG001|Overall Study|Death|1|||
33557734|NCT02761915|62950849|FG002|Overall Study|Death|1|||
33557735|NCT02761915|62950850|FG003|Overall Study|Death|1|||
33557736|NCT02761915|62950851|FG004|Overall Study|Death|0|||
33299586|NCT01325207|62675890|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
33299587|NCT01325207|62675891|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
33299588|NCT01325207|62675892|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
33299589|NCT01325207|62675887|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
33299590|NCT01325207|62675888|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
33299591|NCT01325207|62675889|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
33299592|NCT01325207|62675890|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
33390390|NCT00704184|62769409|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
33390391|NCT00704184|62769405|FG000|Open-Label Treatment|Adverse Event|0|||
33557737|NCT02761915|62950852|FG005|Overall Study|Death|1|||
33390392|NCT00704184|62769406|FG001|Open-Label Treatment|Adverse Event|0|||
33390393|NCT00704184|62769407|FG002|Open-Label Treatment|Adverse Event|2|||
33390394|NCT00704184|62769408|FG003|Open-Label Treatment|Adverse Event|0|||
33390395|NCT00704184|62769409|FG004|Open-Label Treatment|Adverse Event|1|||
33390396|NCT00704184|62769405|FG000|Open-Label Treatment|Lack of Efficacy|0|||
33390397|NCT00704184|62769406|FG001|Open-Label Treatment|Lack of Efficacy|2|||
33390398|NCT00704184|62769407|FG002|Open-Label Treatment|Lack of Efficacy|2|||
33390399|NCT00704184|62769408|FG003|Open-Label Treatment|Lack of Efficacy|2|||
33390400|NCT00704184|62769409|FG004|Open-Label Treatment|Lack of Efficacy|1|||
33390401|NCT00704184|62769405|FG000|Open-Label Treatment|Physician Decision|0|||
33390402|NCT00704184|62769406|FG001|Open-Label Treatment|Physician Decision|0|||
33390403|NCT00704184|62769407|FG002|Open-Label Treatment|Physician Decision|0|||
33390404|NCT00704184|62769408|FG003|Open-Label Treatment|Physician Decision|0|||
33557738|NCT02761915|62950847|FG000|Overall Study|Withdrawal by Subject|1|||
33557739|NCT02761915|62950848|FG001|Overall Study|Withdrawal by Subject|0|||
33557740|NCT02761915|62950849|FG002|Overall Study|Withdrawal by Subject|0|||
33557741|NCT02761915|62950850|FG003|Overall Study|Withdrawal by Subject|0|||
33557742|NCT02761915|62950851|FG004|Overall Study|Withdrawal by Subject|1|||
33557743|NCT02761915|62950852|FG005|Overall Study|Withdrawal by Subject|2|||
33557744|NCT02761915|62950847|FG000|Overall Study|Disease Progression|0|||
33390405|NCT00704184|62769409|FG004|Open-Label Treatment|Physician Decision|1|||
33390406|NCT00704184|62769405|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
33390407|NCT00704184|62769406|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
33390408|NCT00704184|62769407|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
33390409|NCT00704184|62769408|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
33390410|NCT00704184|62769409|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
33390411|NCT00641043|62769423|FG000|Overall Study|Adverse Event|6|||
33390412|NCT00641043|62769424|FG001|Overall Study|Adverse Event|4|||
33557745|NCT02761915|62950848|FG001|Overall Study|Disease Progression|0|||
33557746|NCT02761915|62950849|FG002|Overall Study|Disease Progression|0|||
33557747|NCT02761915|62950850|FG003|Overall Study|Disease Progression|2|||
33557748|NCT02761915|62950851|FG004|Overall Study|Disease Progression|2|||
33557749|NCT02761915|62950852|FG005|Overall Study|Disease Progression|2|||
33557750|NCT02706327|62950873|FG000|Overall Study|Lost to Follow-up|1|||
33557751|NCT02706327|62950874|FG001|Overall Study|Lost to Follow-up|1|||
33557752|NCT02706327|62950875|FG002|Overall Study|Lost to Follow-up|2|||
33557753|NCT02764333|62950883|FG000|Overall Study|Ineligible|1|||
33557754|NCT02705625|62950890|FG000|Overall Study|Protocol Violation|1|||
33557755|NCT02705625|62950891|FG001|Overall Study|Protocol Violation|0|||
33557756|NCT02705625|62950892|FG002|Overall Study|Protocol Violation|0|||
33557757|NCT02705625|62950890|FG000|Overall Study|Adverse Event|6|||
33557758|NCT02705625|62950891|FG001|Overall Study|Adverse Event|5|||
33557759|NCT02705625|62950892|FG002|Overall Study|Adverse Event|2|||
33299593|NCT01325207|62675891|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
33299594|NCT01325207|62675892|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
33299595|NCT01325207|62675887|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
33557760|NCT02705625|62950890|FG000|Overall Study|Death|0|||
33557761|NCT02705625|62950891|FG001|Overall Study|Death|0|||
33557762|NCT02705625|62950892|FG002|Overall Study|Death|1|||
33557763|NCT02705625|62950890|FG000|Overall Study|Withdrawal by Subject|1|||
33557764|NCT02705625|62950891|FG001|Overall Study|Withdrawal by Subject|4|||
33299596|NCT01325207|62675888|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
33299597|NCT01325207|62675889|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
33299598|NCT01325207|62675890|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
33299599|NCT01325207|62675891|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
33299600|NCT01325207|62675892|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
33299601|NCT01325207|62675887|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
33299602|NCT01325207|62675888|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
33299603|NCT01325207|62675889|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
33299604|NCT01325207|62675890|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
33299605|NCT01325207|62675891|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
33299606|NCT01325207|62675892|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
33299607|NCT01325207|62675887|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
33299608|NCT01325207|62675888|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
33390413|NCT00641043|62769423|FG000|Overall Study|Protocol Violation|2|||
33390414|NCT00641043|62769424|FG001|Overall Study|Protocol Violation|3|||
33390415|NCT00641043|62769423|FG000|Overall Study|Lost to Follow-up|3|||
33557765|NCT02705625|62950892|FG002|Overall Study|Withdrawal by Subject|5|||
33557766|NCT02705625|62950890|FG000|Overall Study|Lost to Follow-up|0|||
33557767|NCT02705625|62950891|FG001|Overall Study|Lost to Follow-up|0|||
33390416|NCT00641043|62769424|FG001|Overall Study|Lost to Follow-up|2|||
33557768|NCT02705625|62950892|FG002|Overall Study|Lost to Follow-up|1|||
33557769|NCT02705625|62950890|FG000|Overall Study|Non-compliance|0|||
33390417|NCT00641043|62769423|FG000|Overall Study|Withdrawal by Subject|4|||
33557770|NCT02705625|62950891|FG001|Overall Study|Non-compliance|1|||
33557771|NCT02705625|62950892|FG002|Overall Study|Non-compliance|1|||
33557772|NCT02705625|62950890|FG000|Overall Study|Overdosing|0|||
33557773|NCT02705625|62950891|FG001|Overall Study|Overdosing|0|||
33557774|NCT02705625|62950892|FG002|Overall Study|Overdosing|1|||
33557775|NCT02588612|62950900|FG000|Overall Study|Physician Decision|1|||
33557776|NCT02588612|62950900|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
33557777|NCT02588612|62950900|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
33557778|NCT02588612|62950900|FG000|Overall Study|Death prior to T-cell infusion|1|||
33557779|NCT02704689|62950913|FG000|Overall Study|Physician Decision|1|||
33557780|NCT02704689|62950913|FG000|Overall Study|Study device not implanted|2|||
33557781|NCT02704143|62950917|FG000|Overall Study|disease progression|10|||
33557782|NCT02586506|62950921|FG000|Overall Study|Protocol Violation|6|||
33557783|NCT02586506|62950921|FG000|Overall Study|Lost to Follow-up|1|||
33557784|NCT02586506|62950921|FG000|Overall Study|Other Reason|2|||
33557785|NCT00109031|62950929|FG000|Overall Study|Adverse Event|0|||
33557786|NCT00109031|62950930|FG001|Overall Study|Adverse Event|0|||
33557787|NCT00109031|62950931|FG002|Overall Study|Adverse Event|1|||
33557788|NCT00109031|62950932|FG003|Overall Study|Adverse Event|0|||
33557789|NCT00109031|62950929|FG000|Overall Study|Withdrawal by Subject|0|||
33557790|NCT00109031|62950930|FG001|Overall Study|Withdrawal by Subject|1|||
33557791|NCT00109031|62950931|FG002|Overall Study|Withdrawal by Subject|0|||
33557792|NCT00109031|62950932|FG003|Overall Study|Withdrawal by Subject|0|||
33557793|NCT00109031|62950929|FG000|Overall Study|Physician Decision|0|||
33557794|NCT00109031|62950930|FG001|Overall Study|Physician Decision|1|||
33557795|NCT00109031|62950931|FG002|Overall Study|Physician Decision|0|||
33557796|NCT00109031|62950932|FG003|Overall Study|Physician Decision|0|||
33557797|NCT00109031|62950929|FG000|Overall Study|Protocol Violation|0|||
33557798|NCT00109031|62950930|FG001|Overall Study|Protocol Violation|0|||
33557799|NCT00109031|62950931|FG002|Overall Study|Protocol Violation|1|||
33557800|NCT00109031|62950932|FG003|Overall Study|Protocol Violation|0|||
33557801|NCT01664624|62950946|FG000|Overall Study|Adverse Event|0|||
33557802|NCT01664624|62950947|FG001|Overall Study|Adverse Event|1|||
33557803|NCT01664624|62950948|FG002|Overall Study|Adverse Event|0|||
33557804|NCT01664624|62950949|FG003|Overall Study|Adverse Event|0|||
33557805|NCT02702193|62950961|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
33557806|NCT02702193|62950962|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
33557807|NCT02702193|62950961|FG000|4 Month Follow up|Withdrawal by Subject|1|||
33557808|NCT02702193|62950962|FG001|4 Month Follow up|Withdrawal by Subject|0|||
33557809|NCT02702193|62950961|FG000|4 Month Follow up|Lost to Follow-up|17|||
33557810|NCT02702193|62950962|FG001|4 Month Follow up|Lost to Follow-up|18|||
33557811|NCT02702193|62950961|FG000|8 Month Follow up|Withdrawal by Subject|1|||
33557812|NCT02702193|62950962|FG001|8 Month Follow up|Withdrawal by Subject|0|||
33557813|NCT02702193|62950961|FG000|8 Month Follow up|Lost to Follow-up|14|||
33557814|NCT02702193|62950962|FG001|8 Month Follow up|Lost to Follow-up|18|||
33557815|NCT02702193|62950961|FG000|12 Month Follow up|Withdrawal by Subject|1|||
33557816|NCT02702193|62950962|FG001|12 Month Follow up|Withdrawal by Subject|0|||
33557817|NCT02702193|62950961|FG000|12 Month Follow up|Lost to Follow-up|16|||
33557818|NCT02702193|62950962|FG001|12 Month Follow up|Lost to Follow-up|18|||
33390418|NCT00641043|62769424|FG001|Overall Study|Withdrawal by Subject|4|||
33390419|NCT00641043|62769423|FG000|Overall Study|Other incl. lack of efficacy|4|||
33390420|NCT00641043|62769424|FG001|Overall Study|Other incl. lack of efficacy|2|||
33390421|NCT00402025|62769433|FG000|Overall Study|Adverse Event|0|||
33390422|NCT00402025|62769434|FG001|Overall Study|Adverse Event|0|||
33390423|NCT00402025|62769435|FG002|Overall Study|Adverse Event|2|||
33390424|NCT00402025|62769433|FG000|Overall Study|Death|0|||
33390425|NCT00402025|62769434|FG001|Overall Study|Death|1|||
33390426|NCT00402025|62769435|FG002|Overall Study|Death|5|||
33390427|NCT00402025|62769433|FG000|Overall Study|Disease Progression|1|||
33390428|NCT00402025|62769434|FG001|Overall Study|Disease Progression|1|||
33557819|NCT02761057|62950972|FG000|Overall Study|Currently On Study Treatment|0|||
33557820|NCT02761057|62950973|FG001|Overall Study|Currently On Study Treatment|3|||
33557821|NCT02761057|62950974|FG002|Overall Study|Currently On Study Treatment|0|||
33557822|NCT02761057|62950975|FG003|Overall Study|Currently On Study Treatment|0|||
33557823|NCT02761057|62950972|FG000|Overall Study|Adverse Event|11|||
33557824|NCT02761057|62950973|FG001|Overall Study|Adverse Event|9|||
33390429|NCT00402025|62769435|FG002|Overall Study|Disease Progression|2|||
33390430|NCT00402025|62769433|FG000|Overall Study|Physician Decision|1|||
33390431|NCT00402025|62769434|FG001|Overall Study|Physician Decision|1|||
33390432|NCT00402025|62769435|FG002|Overall Study|Physician Decision|0|||
33390433|NCT00402025|62769433|FG000|Overall Study|Participant Decision|0|||
33557825|NCT02761057|62950974|FG002|Overall Study|Adverse Event|5|||
33557826|NCT02761057|62950975|FG003|Overall Study|Adverse Event|3|||
33557827|NCT02761057|62950972|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
33557828|NCT02761057|62950973|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
33557829|NCT02761057|62950974|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
33557830|NCT02761057|62950975|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
33557831|NCT02761057|62950972|FG000|Overall Study|Progression/Relapse|29|||
33557832|NCT02761057|62950973|FG001|Overall Study|Progression/Relapse|27|||
33557833|NCT02761057|62950974|FG002|Overall Study|Progression/Relapse|20|||
33557834|NCT02761057|62950975|FG003|Overall Study|Progression/Relapse|23|||
33557835|NCT02761057|62950972|FG000|Overall Study|Death|2|||
33557836|NCT02761057|62950973|FG001|Overall Study|Death|2|||
33557837|NCT02761057|62950974|FG002|Overall Study|Death|1|||
33557838|NCT02761057|62950975|FG003|Overall Study|Death|1|||
33557839|NCT02761057|62950972|FG000|Overall Study|Other - Not Protocol Specified|2|||
33557840|NCT02761057|62950973|FG001|Overall Study|Other - Not Protocol Specified|1|||
33557841|NCT02761057|62950974|FG002|Overall Study|Other - Not Protocol Specified|2|||
33557842|NCT02761057|62950975|FG003|Overall Study|Other - Not Protocol Specified|0|||
33557843|NCT02701413|62950987|FG000|Overall Study|Withdrawal by Subject|7|||
33557844|NCT02701413|62950988|FG001|Overall Study|Withdrawal by Subject|11|||
33557845|NCT02582684|62950994|FG000|Overall Study|Unable to contact subject/parent|4|||
33557846|NCT02582684|62950994|FG000|Overall Study|Subject not able to get to clinic|10|||
33557847|NCT02582684|62950994|FG000|Overall Study|Subject withdrew consent|1|||
33557848|NCT02582684|62950994|FG000|Overall Study|Found to be ineligible after enrollment|2|||
33557849|NCT02585960|62951001|FG000|PK/Safety Assessment Period|Physician Decision|0|||
33557850|NCT02585960|62951002|FG001|PK/Safety Assessment Period|Physician Decision|1|||
33557851|NCT02585960|62951003|FG002|PK/Safety Assessment Period|Physician Decision|0|||
33557852|NCT02585960|62951001|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
33557853|NCT02585960|62951002|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
33557854|NCT02585960|62951003|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
33557855|NCT02585960|62951001|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
33557856|NCT02585960|62951002|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
33557857|NCT02585960|62951003|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
33557858|NCT02585960|62951001|FG000|PK/Safety Assessment Period|Other|4|||
33557859|NCT02585960|62951002|FG001|PK/Safety Assessment Period|Other|4|||
33557860|NCT02585960|62951003|FG002|PK/Safety Assessment Period|Other|0|||
33557861|NCT02585960|62951001|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
33557862|NCT02585960|62951002|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
33557863|NCT02585960|62951003|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
33557864|NCT02585960|62951001|FG000|PK/Safety Assessment Period|Screen Failure|0|||
33557865|NCT02585960|62951002|FG001|PK/Safety Assessment Period|Screen Failure|0|||
33557866|NCT02585960|62951003|FG002|PK/Safety Assessment Period|Screen Failure|1|||
33557867|NCT02585960|62951001|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
33557868|NCT02585960|62951002|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
33662678|NCT01587703|63093233|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33662679|NCT01587703|63093234|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
33662680|NCT01587703|63093235|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33662681|NCT01587703|63093236|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33662682|NCT01587703|63093237|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33662683|NCT01587703|63093238|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33662684|NCT01587703|63093239|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33662685|NCT01587703|63093240|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33662686|NCT01587703|63093241|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33662687|NCT01587703|63093242|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33662688|NCT01587703|63093243|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33662689|NCT01587703|63093244|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33662690|NCT01587703|63093226|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662691|NCT01587703|63093227|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662692|NCT01587703|63093228|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662693|NCT01587703|63093229|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662694|NCT01587703|63093230|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662695|NCT01587703|63093231|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662696|NCT01587703|63093232|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662697|NCT01587703|63093233|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662698|NCT01587703|63093234|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33390434|NCT00402025|62769434|FG001|Overall Study|Participant Decision|0|||
33557869|NCT02585960|62951003|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
33557870|NCT02585960|62951001|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
33557871|NCT02585960|62951002|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
33557872|NCT02585960|62951003|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
33557873|NCT02699463|62951016|FG000|Overall Study|Lost to Follow-up|11|||
33390435|NCT00402025|62769435|FG002|Overall Study|Participant Decision|1|||
33557874|NCT02699463|62951017|FG001|Overall Study|Lost to Follow-up|8|||
33557875|NCT02699463|62951016|FG000|Overall Study|Withdrawal by Subject|4|||
33557876|NCT02699463|62951017|FG001|Overall Study|Withdrawal by Subject|1|||
33557877|NCT00100789|62951023|FG000|Overall Study|Adverse Event|10|||
33557878|NCT00100789|62951023|FG000|Overall Study|Withdrawal by Subject|1|||
33557879|NCT00100789|62951023|FG000|Overall Study|Progression/relapse|42|||
33557880|NCT00100789|62951023|FG000|Overall Study|Death|2|||
33557881|NCT00100789|62951023|FG000|Overall Study|Not protocol specified|5|||
33557882|NCT00100789|62951023|FG000|Overall Study|Ineligible|3|||
33557883|NCT00100789|62951023|FG000|Overall Study|Never received treatment|1|||
33557884|NCT00708123|62951028|FG000|Period 1|Protocol Violation|0|||
33557885|NCT00708123|62951029|FG001|Period 1|Protocol Violation|1|||
33557886|NCT00708123|62951030|FG002|Period 1|Protocol Violation|0|||
33557887|NCT00708123|62951031|FG003|Period 1|Protocol Violation|1|||
33557888|NCT00708123|62951032|FG004|Period 1|Protocol Violation|0|||
33557889|NCT00708123|62951028|FG000|Period 1|Adverse Event|0|||
33557890|NCT00708123|62951029|FG001|Period 1|Adverse Event|0|||
33557891|NCT00708123|62951030|FG002|Period 1|Adverse Event|1|||
33557892|NCT00708123|62951031|FG003|Period 1|Adverse Event|0|||
33557893|NCT00708123|62951032|FG004|Period 1|Adverse Event|0|||
33557894|NCT00708123|62951028|FG000|Period 2|Protocol Violation|0|||
33557895|NCT00708123|62951029|FG001|Period 2|Protocol Violation|0|||
33557896|NCT00708123|62951030|FG002|Period 2|Protocol Violation|0|||
33557897|NCT00708123|62951031|FG003|Period 2|Protocol Violation|1|||
33557898|NCT00708123|62951032|FG004|Period 2|Protocol Violation|0|||
33557899|NCT00708123|62951028|FG000|Period 2|Other Reason|1|||
33557900|NCT00708123|62951029|FG001|Period 2|Other Reason|0|||
33557901|NCT00708123|62951030|FG002|Period 2|Other Reason|0|||
33557902|NCT00708123|62951031|FG003|Period 2|Other Reason|0|||
33557903|NCT00708123|62951032|FG004|Period 2|Other Reason|0|||
33557904|NCT00708123|62951028|FG000|Period 3|Lost to Follow-up|0|||
33557905|NCT00708123|62951029|FG001|Period 3|Lost to Follow-up|0|||
33557906|NCT00708123|62951030|FG002|Period 3|Lost to Follow-up|1|||
33557907|NCT00708123|62951031|FG003|Period 3|Lost to Follow-up|1|||
33557908|NCT00708123|62951032|FG004|Period 3|Lost to Follow-up|0|||
33557909|NCT00708123|62951028|FG000|Period 4|Protocol Violation|0|||
33557910|NCT00708123|62951029|FG001|Period 4|Protocol Violation|1|||
33557911|NCT00708123|62951030|FG002|Period 4|Protocol Violation|0|||
33557912|NCT00708123|62951031|FG003|Period 4|Protocol Violation|0|||
33557913|NCT00708123|62951032|FG004|Period 4|Protocol Violation|0|||
33557914|NCT02165215|62951051|FG000|Induction Phase|Adverse Event|1|||
33557915|NCT02165215|62951052|FG001|Induction Phase|Adverse Event|0|||
33557916|NCT02165215|62951053|FG002|Induction Phase|Adverse Event|0|||
33557917|NCT02165215|62951051|FG000|Induction Phase|Withdrawal by Subject|10|||
33662699|NCT01587703|63093235|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662700|NCT01587703|63093236|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662701|NCT01587703|63093237|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662702|NCT01587703|63093238|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662703|NCT01587703|63093239|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662704|NCT01587703|63093240|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662705|NCT01587703|63093241|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662706|NCT01587703|63093242|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662707|NCT01587703|63093243|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33662708|NCT01587703|63093244|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
33662709|NCT01587703|63093226|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33662710|NCT01587703|63093227|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33662711|NCT01587703|63093228|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33662712|NCT01587703|63093229|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33662713|NCT01587703|63093230|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33662714|NCT01587703|63093231|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33557918|NCT02165215|62951052|FG001|Induction Phase|Withdrawal by Subject|0|||
33557919|NCT02165215|62951053|FG002|Induction Phase|Withdrawal by Subject|0|||
33557920|NCT02165215|62951051|FG000|Induction Phase|Protocol Violation|1|||
33299609|NCT01325207|62675889|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
33299610|NCT01325207|62675890|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
33299611|NCT01325207|62675891|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
33299612|NCT01325207|62675892|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
33299613|NCT01324349|62675909|FG000|Overall Study|Death|1|||
33299614|NCT01324349|62675910|FG001|Overall Study|Death|1|||
33299615|NCT01324349|62675909|FG000|Overall Study|Withdrawal by Subject|0|||
33299616|NCT01324349|62675910|FG001|Overall Study|Withdrawal by Subject|1|||
33299617|NCT01095250|62675920|FG000|Overall Study|administrative reasons|8|||
33557921|NCT02165215|62951052|FG001|Induction Phase|Protocol Violation|0|||
33557922|NCT02165215|62951053|FG002|Induction Phase|Protocol Violation|0|||
33557923|NCT02165215|62951051|FG000|Induction Phase|Physician Decision|1|||
33557924|NCT02165215|62951052|FG001|Induction Phase|Physician Decision|0|||
33557925|NCT02165215|62951053|FG002|Induction Phase|Physician Decision|0|||
33557926|NCT02165215|62951051|FG000|Induction Phase|Lack of Efficacy|2|||
33390436|NCT00609622|62769445|FG000|Overall Study|Adverse Event|14|||
33390437|NCT00609622|62769446|FG001|Overall Study|Adverse Event|10|||
33390438|NCT00609622|62769445|FG000|Overall Study|Withdrawal by Subject|4|||
33390439|NCT00609622|62769446|FG001|Overall Study|Withdrawal by Subject|20|||
33390440|NCT00609622|62769445|FG000|Overall Study|Death|1|||
33390441|NCT00609622|62769446|FG001|Overall Study|Death|4|||
33390442|NCT00609622|62769445|FG000|Overall Study|Protocol Violation|1|||
33390443|NCT00609622|62769446|FG001|Overall Study|Protocol Violation|1|||
33390444|NCT00609622|62769445|FG000|Overall Study|Objective progression or relapse|47|||
33390445|NCT00609622|62769446|FG001|Overall Study|Objective progression or relapse|41|||
33390446|NCT00609622|62769445|FG000|Overall Study|Study terminated by sponsor|16|||
33390447|NCT00609622|62769446|FG001|Overall Study|Study terminated by sponsor|3|||
33390448|NCT00609622|62769445|FG000|Overall Study|Other|7|||
33390449|NCT00609622|62769446|FG001|Overall Study|Other|14|||
33390450|NCT00609622|62769445|FG000|Overall Study|Global deterioration of health status|6|||
33390451|NCT00609622|62769446|FG001|Overall Study|Global deterioration of health status|2|||
33390452|NCT00699660|62769454|FG000|Overall Study|Lost to Follow-up|4|||
33390453|NCT00699660|62769455|FG001|Overall Study|Lost to Follow-up|2|||
33390454|NCT00699660|62769454|FG000|Overall Study|missing reports and recording failures|10|||
33390455|NCT00699660|62769455|FG001|Overall Study|missing reports and recording failures|6|||
33390456|NCT00627705|62769463|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
33390457|NCT00627705|62769464|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
33390458|NCT00627705|62769463|FG000|Overall Study|Adverse Event|1|||
33299618|NCT01095250|62675921|FG001|Overall Study|administrative reasons|10|||
33557927|NCT02165215|62951052|FG001|Induction Phase|Lack of Efficacy|0|||
33557928|NCT02165215|62951053|FG002|Induction Phase|Lack of Efficacy|0|||
33557929|NCT02165215|62951051|FG000|Induction Phase|Non-Compliance|2|||
33299619|NCT01095250|62675922|FG002|Overall Study|administrative reasons|7|||
33299620|NCT01095250|62675923|FG003|Overall Study|administrative reasons|5|||
33390459|NCT00627705|62769464|FG001|Overall Study|Adverse Event|0|||
33390460|NCT00627705|62769463|FG000|Overall Study|Withdrawal by Subject|0|||
33390461|NCT00627705|62769464|FG001|Overall Study|Withdrawal by Subject|2|||
33390462|NCT00627705|62769463|FG000|Overall Study|Lost to Follow-up|0|||
33390463|NCT00627705|62769464|FG001|Overall Study|Lost to Follow-up|1|||
33390464|NCT00610168|62769472|FG000|Overall Study|Withdrawal by Subject|2|||
33390465|NCT00610168|62769473|FG001|Overall Study|Withdrawal by Subject|0|||
33390466|NCT00644787|62769479|FG000|Period 1: Titration Phase|Adverse Event|11|||
33390467|NCT00644787|62769480|FG001|Period 1: Titration Phase|Adverse Event|0|||
33390468|NCT00644787|62769481|FG002|Period 1: Titration Phase|Adverse Event|0|||
33390469|NCT00644787|62769479|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
33390470|NCT00644787|62769480|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
33390471|NCT00644787|62769481|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
33390472|NCT00644787|62769479|FG000|Period 1: Titration Phase|Physician Decision|1|||
33390473|NCT00644787|62769480|FG001|Period 1: Titration Phase|Physician Decision|0|||
33390474|NCT00644787|62769481|FG002|Period 1: Titration Phase|Physician Decision|0|||
33390475|NCT00644787|62769479|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
33390476|NCT00644787|62769480|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
33557930|NCT02165215|62951052|FG001|Induction Phase|Non-Compliance|0|||
33557931|NCT02165215|62951053|FG002|Induction Phase|Non-Compliance|0|||
33557932|NCT02165215|62951051|FG000|Induction Phase|Lost to Follow-up|6|||
33557933|NCT02165215|62951052|FG001|Induction Phase|Lost to Follow-up|0|||
33557934|NCT02165215|62951053|FG002|Induction Phase|Lost to Follow-up|0|||
33557935|NCT02165215|62951051|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33557936|NCT02165215|62951052|FG001|Maintenance Phase|Withdrawal by Subject|7|||
33557937|NCT02165215|62951053|FG002|Maintenance Phase|Withdrawal by Subject|3|||
33557938|NCT02165215|62951051|FG000|Maintenance Phase|Multiple reasons|0|||
33557939|NCT02165215|62951052|FG001|Maintenance Phase|Multiple reasons|2|||
33557940|NCT02165215|62951053|FG002|Maintenance Phase|Multiple reasons|1|||
33299621|NCT01095250|62675920|FG000|Overall Study|Withdrawal by Subject|0|||
33299622|NCT01095250|62675921|FG001|Overall Study|Withdrawal by Subject|0|||
33299623|NCT01095250|62675922|FG002|Overall Study|Withdrawal by Subject|1|||
33299624|NCT01095250|62675923|FG003|Overall Study|Withdrawal by Subject|0|||
33390477|NCT00644787|62769481|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
33390478|NCT00644787|62769479|FG000|Period 1: Titration Phase|Worsening of complications|1|||
33390479|NCT00644787|62769480|FG001|Period 1: Titration Phase|Worsening of complications|0|||
33390480|NCT00644787|62769481|FG002|Period 1: Titration Phase|Worsening of complications|0|||
33557941|NCT02165215|62951051|FG000|Maintenance Phase|Lost to Follow-up|0|||
33390481|NCT00644787|62769479|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
33390482|NCT00644787|62769480|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
33557942|NCT02165215|62951052|FG001|Maintenance Phase|Lost to Follow-up|2|||
33557943|NCT02165215|62951053|FG002|Maintenance Phase|Lost to Follow-up|0|||
33557944|NCT02165215|62951051|FG000|Maintenance Phase|Adverse Event|0|||
33557945|NCT02165215|62951052|FG001|Maintenance Phase|Adverse Event|1|||
33299625|NCT01324271|62675933|FG000|Overall Study|Lost to Follow-up|3|||
33557946|NCT02165215|62951053|FG002|Maintenance Phase|Adverse Event|1|||
33557947|NCT02757625|62951068|FG000|Overall Study|Investigator's discretion|0|||
33557948|NCT02757625|62951069|FG001|Overall Study|Investigator's discretion|0|||
33557949|NCT02757625|62951070|FG002|Overall Study|Investigator's discretion|1|||
33557950|NCT02757625|62951071|FG003|Overall Study|Investigator's discretion|0|||
33557951|NCT02757625|62951068|FG000|Overall Study|Adverse Event|0|||
33557952|NCT02757625|62951069|FG001|Overall Study|Adverse Event|0|||
33557953|NCT02757625|62951070|FG002|Overall Study|Adverse Event|1|||
33557954|NCT02757625|62951071|FG003|Overall Study|Adverse Event|0|||
33557955|NCT02581202|62951083|FG000|Overall Study|Lack of Efficacy|2|||
33557956|NCT02581202|62951083|FG000|Overall Study|Withdrawal by Subject|4|||
33557957|NCT02581202|62951083|FG000|Overall Study|Lost to Follow-up|5|||
33557958|NCT02581202|62951083|FG000|Overall Study|Pregnancy|3|||
33557959|NCT02758171|62951090|FG000|Wash-out|Withdrawal by Subject|1|||
33557960|NCT02758171|62951091|FG001|Wash-out|Withdrawal by Subject|0|||
33557961|NCT02758171|62951090|FG000|Wash-out|Other reason|1|||
33557962|NCT02758171|62951091|FG001|Wash-out|Other reason|0|||
33557963|NCT01664078|62951120|FG000|Overall Study|Death|9|||
33557964|NCT01664078|62951120|FG000|Overall Study|Withdrawal by Subject|4|||
33557965|NCT01664078|62951120|FG000|Overall Study|Lost to Follow-up|2|||
33557966|NCT01664078|62951120|FG000|Overall Study|missed 5 year visit|1|||
33557967|NCT01664078|62951120|FG000|Overall Study|Other|53|||
33557968|NCT03367403|62951173|FG000|Overall Study|Adverse Event|20|||
33557969|NCT03367403|62951174|FG001|Overall Study|Adverse Event|6|||
33557970|NCT03367403|62951175|FG002|Overall Study|Adverse Event|2|||
33557971|NCT03367403|62951173|FG000|Overall Study|Withdrawal by Subject|12|||
33557972|NCT03367403|62951174|FG001|Overall Study|Withdrawal by Subject|13|||
33557973|NCT03367403|62951175|FG002|Overall Study|Withdrawal by Subject|1|||
33557974|NCT03367403|62951173|FG000|Overall Study|Death|1|||
33557975|NCT03367403|62951174|FG001|Overall Study|Death|2|||
33557976|NCT03367403|62951175|FG002|Overall Study|Death|0|||
33557977|NCT03367403|62951173|FG000|Overall Study|Physician Decision|0|||
33557978|NCT03367403|62951174|FG001|Overall Study|Physician Decision|1|||
33557979|NCT03367403|62951175|FG002|Overall Study|Physician Decision|0|||
33557980|NCT03367403|62951173|FG000|Overall Study|Protocol Violation|1|||
33557981|NCT03367403|62951174|FG001|Overall Study|Protocol Violation|1|||
33557982|NCT03367403|62951175|FG002|Overall Study|Protocol Violation|0|||
33557983|NCT03367403|62951173|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
33557984|NCT03367403|62951174|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
33557985|NCT03367403|62951175|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
33557986|NCT03367403|62951173|FG000|Overall Study|COVID-19|3|||
33557987|NCT03367403|62951174|FG001|Overall Study|COVID-19|6|||
33557988|NCT03367403|62951175|FG002|Overall Study|COVID-19|0|||
33557989|NCT03367403|62951173|FG000|Overall Study|Abuse of Alcohol Intake|0|||
33557990|NCT03367403|62951174|FG001|Overall Study|Abuse of Alcohol Intake|1|||
33557991|NCT03367403|62951175|FG002|Overall Study|Abuse of Alcohol Intake|0|||
33557992|NCT03367403|62951173|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
33557993|NCT03367403|62951174|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
33557994|NCT03367403|62951175|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
33557995|NCT02577146|62951183|FG000|Overall Study|Lost to Follow-up|8|||
33557996|NCT02577146|62951183|FG000|Overall Study|Physician Decision|3|||
33557997|NCT02577146|62951183|FG000|Overall Study|Screen Failure|17|||
33557998|NCT00109967|62951189|FG000|Overall Study|Cancel Prior to Treatment|2|||
33557999|NCT00109967|62951190|FG001|Overall Study|Cancel Prior to Treatment|0|||
33558000|NCT00109967|62951189|FG000|Overall Study|Adverse Event|12|||
33558001|NCT00109967|62951190|FG001|Overall Study|Adverse Event|1|||
33558002|NCT00109967|62951189|FG000|Overall Study|Withdrawal by Subject|5|||
33558003|NCT00109967|62951190|FG001|Overall Study|Withdrawal by Subject|0|||
33558004|NCT00109967|62951189|FG000|Overall Study|Physician Decision|1|||
33558005|NCT00109967|62951190|FG001|Overall Study|Physician Decision|3|||
33558006|NCT00109967|62951189|FG000|Overall Study|Death|0|||
33558007|NCT00109967|62951190|FG001|Overall Study|Death|2|||
33558008|NCT02579096|62951198|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
33558009|NCT02579096|62951199|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
33558010|NCT02579096|62951198|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
33558011|NCT02579096|62951199|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
33558012|NCT02579096|62951198|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
33558013|NCT02579096|62951199|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
33558014|NCT02579096|62951198|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
33558015|NCT02579096|62951199|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
33558016|NCT02579096|62951198|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
33558017|NCT02579096|62951199|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
33558018|NCT02579096|62951198|FG000|Phase 2, Weeks 25 - 48|Death|2|||
33558019|NCT02579096|62951199|FG001|Phase 2, Weeks 25 - 48|Death|4|||
33558020|NCT02579096|62951198|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
33558021|NCT02579096|62951199|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
33558022|NCT02579096|62951198|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
33558023|NCT02579096|62951199|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
33558024|NCT02579096|62951198|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
33558025|NCT02579096|62951199|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
33558026|NCT02579096|62951198|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
33558027|NCT02579096|62951199|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
33558028|NCT02579096|62951198|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
33558029|NCT02579096|62951199|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
33558030|NCT02579096|62951198|FG000|Phase 3, Weeks 49 - 72|Death|3|||
33558031|NCT02579096|62951199|FG001|Phase 3, Weeks 49 - 72|Death|2|||
33558032|NCT02579096|62951198|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
33558033|NCT02579096|62951199|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
33558034|NCT02579096|62951198|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
33558035|NCT02579096|62951199|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
33558036|NCT02579096|62951198|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
33558037|NCT02579096|62951199|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
33558038|NCT02579096|62951198|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
33558039|NCT02579096|62951199|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
33558040|NCT02579096|62951198|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
33558041|NCT02579096|62951199|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
33558042|NCT02579096|62951198|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
33558043|NCT02579096|62951199|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
33558044|NCT02578940|62951205|FG000|Overall Study|Screening failure|5|||
33558045|NCT02578940|62951205|FG000|Overall Study|Lost to Follow-up|1|||
33558046|NCT02578862|62951213|FG000|Overall Study|Withdrawal by Subject|0|||
33558047|NCT02578862|62951214|FG001|Overall Study|Withdrawal by Subject|1|||
33558048|NCT02578862|62951213|FG000|Overall Study|Unplanned unilateral procedure|0|||
33558049|NCT02578862|62951214|FG001|Overall Study|Unplanned unilateral procedure|1|||
33558050|NCT02578706|62951223|FG000|Overall Study|Withdrawal by Subject|1|||
33558051|NCT02578706|62951224|FG001|Overall Study|Withdrawal by Subject|0|||
33558052|NCT02578706|62951225|FG002|Overall Study|Withdrawal by Subject|0|||
33558053|NCT02578706|62951223|FG000|Overall Study|Lost to Follow-up|0|||
33558054|NCT02578706|62951224|FG001|Overall Study|Lost to Follow-up|4|||
33558055|NCT02578706|62951225|FG002|Overall Study|Lost to Follow-up|0|||
33558056|NCT02578706|62951223|FG000|Overall Study|Physician Decision|0|||
33558057|NCT02578706|62951224|FG001|Overall Study|Physician Decision|1|||
33558058|NCT02578706|62951225|FG002|Overall Study|Physician Decision|0|||
33558059|NCT00108953|62951235|FG000|Follow-up|Death|18|||
33558060|NCT00108953|62951236|FG001|Follow-up|Death|26|||
33558061|NCT00108953|62951235|FG000|Follow-up|Lost to Follow-up|1|||
33558062|NCT00108953|62951236|FG001|Follow-up|Lost to Follow-up|1|||
33558063|NCT00108953|62951235|FG000|Follow-up|Study terminated by sponsor|10|||
33558064|NCT00108953|62951236|FG001|Follow-up|Study terminated by sponsor|6|||
33558065|NCT02578316|62951244|FG000|Extension Phase|Progression of disease|6|||
33558066|NCT02576678|62951255|FG000|Overall Study|Adverse Event|0|||
33558067|NCT02576678|62951256|FG001|Overall Study|Adverse Event|0|||
33558068|NCT02576678|62951257|FG002|Overall Study|Adverse Event|2|||
33558069|NCT02576678|62951255|FG000|Overall Study|Withdrawal by Subject|3|||
33558070|NCT02576678|62951256|FG001|Overall Study|Withdrawal by Subject|1|||
33558071|NCT02576678|62951257|FG002|Overall Study|Withdrawal by Subject|2|||
33558072|NCT02576678|62951255|FG000|Overall Study|Lost to Follow-up|0|||
33558073|NCT02576678|62951256|FG001|Overall Study|Lost to Follow-up|0|||
33558074|NCT02576678|62951257|FG002|Overall Study|Lost to Follow-up|1|||
33558075|NCT02576678|62951255|FG000|Overall Study|Miscellaneous|2|||
33558076|NCT02576678|62951256|FG001|Overall Study|Miscellaneous|0|||
33558077|NCT02576678|62951257|FG002|Overall Study|Miscellaneous|0|||
33558078|NCT00108745|62951268|FG000|Overall Study|Withdrawal by Subject|19|||
33558079|NCT00108745|62951269|FG001|Overall Study|Withdrawal by Subject|12|||
33558080|NCT00108745|62951270|FG002|Overall Study|Withdrawal by Subject|12|||
33558081|NCT00108745|62951268|FG000|Overall Study|Never Treated|8|||
33558082|NCT00108745|62951269|FG001|Overall Study|Never Treated|10|||
33558083|NCT00108745|62951270|FG002|Overall Study|Never Treated|12|||
33558084|NCT00108745|62951268|FG000|Overall Study|Ineligible|7|||
33558085|NCT00108745|62951269|FG001|Overall Study|Ineligible|13|||
33558086|NCT00108745|62951270|FG002|Overall Study|Ineligible|13|||
33558087|NCT02716805|62951300|FG000|Overall Study|Progressive disease|2|||
33558088|NCT02716805|62951301|FG001|Overall Study|Progressive disease|0|||
33558089|NCT02716805|62951302|FG002|Overall Study|Progressive disease|0|||
33558090|NCT02716805|62951303|FG003|Overall Study|Progressive disease|0|||
33558091|NCT02581982|62951307|FG000|Overall Study|Lack of Efficacy|12|||
33558092|NCT02581982|62951307|FG000|Overall Study|Adverse Event|3|||
33558093|NCT02581982|62951307|FG000|Overall Study|Physician Decision|1|||
33558094|NCT04439201|62951347|FG000|Overall Study|Ineligible|2|||
33558095|NCT04439201|62951347|FG000|Overall Study|Never start protocol therapy|1|||
33558096|NCT04439201|62951347|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
33558097|NCT04439201|62951347|FG000|Overall Study|Mutation status not confirmed|4|||
33558098|NCT04439201|62951347|FG000|Overall Study|Adverse Event|1|||
33558099|NCT04439201|62951347|FG000|Overall Study|Death|7|||
33558100|NCT04439201|62951347|FG000|Overall Study|Withdrawal by Subject|2|||
33558101|NCT04439201|62951347|FG000|Overall Study|Disease progression|20|||
33558102|NCT04439201|62951347|FG000|Overall Study|Alternative therapy|1|||
33558103|NCT04439201|62951347|FG000|Overall Study|Physician Decision|1|||
33558104|NCT04318132|62951365|FG000|Overall Study|Protocol Violation|0|||
33558105|NCT04318132|62951366|FG001|Overall Study|Protocol Violation|0|||
33558106|NCT04318132|62951367|FG002|Overall Study|Protocol Violation|3|||
33558107|NCT04318132|62951368|FG003|Overall Study|Protocol Violation|0|||
33558108|NCT04271254|62951384|FG000|Overall Study|Withdrawal by Subject|3|||
33558109|NCT03938636|62951404|FG000|Overall Study|Protocol Violation|0|||
33558110|NCT03938636|62951405|FG001|Overall Study|Protocol Violation|1|||
33558111|NCT03938636|62951406|FG002|Overall Study|Protocol Violation|1|||
33558112|NCT03938636|62951404|FG000|Overall Study|Subject withdrew due to death in family|0|||
33558113|NCT03938636|62951405|FG001|Overall Study|Subject withdrew due to death in family|1|||
33558114|NCT03938636|62951406|FG002|Overall Study|Subject withdrew due to death in family|0|||
33558115|NCT03938636|62951404|FG000|Overall Study|Missed visit|0|||
33558116|NCT03938636|62951405|FG001|Overall Study|Missed visit|1|||
33558117|NCT03938636|62951406|FG002|Overall Study|Missed visit|0|||
33558118|NCT03938636|62951404|FG000|Overall Study|Adverse Event|0|||
33558119|NCT03938636|62951405|FG001|Overall Study|Adverse Event|0|||
33558120|NCT03938636|62951406|FG002|Overall Study|Adverse Event|1|||
33558121|NCT03938636|62951404|FG000|Overall Study|Lost to Follow-up|0|||
33558122|NCT03938636|62951405|FG001|Overall Study|Lost to Follow-up|0|||
33558123|NCT03938636|62951406|FG002|Overall Study|Lost to Follow-up|1|||
33558124|NCT03836716|62951431|FG000|Overall Study|Adverse Event|3|||
33558125|NCT03836716|62951431|FG000|Overall Study|Death|22|||
33558126|NCT03836716|62951431|FG000|Overall Study|Withdrawal by Subject|8|||
33558127|NCT03836716|62951431|FG000|Overall Study|Study terminated by sponsor|87|||
33558128|NCT03686215|62951438|FG000|Overall Study|Adverse Event|0|||
33558129|NCT03686215|62951439|FG001|Overall Study|Adverse Event|0|||
33558130|NCT03686215|62951440|FG002|Overall Study|Adverse Event|7|||
33558131|NCT03686215|62951438|FG000|Overall Study|Physician Decision|0|||
33558132|NCT03686215|62951439|FG001|Overall Study|Physician Decision|0|||
33558133|NCT03686215|62951440|FG002|Overall Study|Physician Decision|1|||
33558134|NCT03686215|62951438|FG000|Overall Study|Protocol Violation|0|||
33558135|NCT03686215|62951439|FG001|Overall Study|Protocol Violation|0|||
33558136|NCT03686215|62951440|FG002|Overall Study|Protocol Violation|4|||
33558137|NCT03686215|62951438|FG000|Overall Study|Device issue|1|||
33558138|NCT03686215|62951439|FG001|Overall Study|Device issue|0|||
33558139|NCT03686215|62951440|FG002|Overall Study|Device issue|2|||
33558140|NCT03665077|62951448|FG000|Overall Study|Lost to Follow-up|2|||
33558141|NCT03665077|62951448|FG000|Overall Study|Physician Decision|2|||
33558142|NCT03606174|62951463|FG000|Overall Study|Death|37|||
33558143|NCT03606174|62951464|FG001|Overall Study|Death|15|||
33558144|NCT03606174|62951465|FG002|Overall Study|Death|15|||
33558145|NCT03606174|62951466|FG003|Overall Study|Death|7|||
33558146|NCT03606174|62951467|FG004|Overall Study|Death|35|||
33558147|NCT03606174|62951468|FG005|Overall Study|Death|12|||
33558148|NCT03606174|62951469|FG006|Overall Study|Death|35|||
33558149|NCT03606174|62951470|FG007|Overall Study|Death|8|||
33558150|NCT03606174|62951471|FG008|Overall Study|Death|5|||
33558151|NCT03606174|62951472|FG009|Overall Study|Death|3|||
33558152|NCT03606174|62951473|FG010|Overall Study|Death|0|||
33558153|NCT03606174|62951463|FG000|Overall Study|Lost to Follow-up|0|||
33558154|NCT03606174|62951464|FG001|Overall Study|Lost to Follow-up|0|||
33558155|NCT03606174|62951465|FG002|Overall Study|Lost to Follow-up|0|||
33558156|NCT03606174|62951466|FG003|Overall Study|Lost to Follow-up|0|||
33558157|NCT03606174|62951467|FG004|Overall Study|Lost to Follow-up|1|||
33558158|NCT03606174|62951468|FG005|Overall Study|Lost to Follow-up|1|||
33558159|NCT03606174|62951469|FG006|Overall Study|Lost to Follow-up|0|||
33558160|NCT03606174|62951470|FG007|Overall Study|Lost to Follow-up|0|||
33558161|NCT03606174|62951471|FG008|Overall Study|Lost to Follow-up|0|||
33662715|NCT01587703|63093232|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33662716|NCT01587703|63093233|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33299626|NCT01324271|62675934|FG001|Overall Study|Lost to Follow-up|0|||
33558162|NCT03606174|62951472|FG009|Overall Study|Lost to Follow-up|0|||
33662717|NCT01587703|63093234|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33299627|NCT01324271|62675933|FG000|Overall Study|Physician Decision|1|||
33558163|NCT03606174|62951473|FG010|Overall Study|Lost to Follow-up|0|||
33558164|NCT03606174|62951463|FG000|Overall Study|Withdrawal by Subject|6|||
33558165|NCT03606174|62951464|FG001|Overall Study|Withdrawal by Subject|0|||
33558166|NCT03606174|62951465|FG002|Overall Study|Withdrawal by Subject|0|||
33299628|NCT01324271|62675934|FG001|Overall Study|Physician Decision|0|||
33558167|NCT03606174|62951466|FG003|Overall Study|Withdrawal by Subject|1|||
33558168|NCT03606174|62951467|FG004|Overall Study|Withdrawal by Subject|2|||
33558169|NCT03606174|62951468|FG005|Overall Study|Withdrawal by Subject|1|||
33558170|NCT03606174|62951469|FG006|Overall Study|Withdrawal by Subject|4|||
33558171|NCT03606174|62951470|FG007|Overall Study|Withdrawal by Subject|0|||
33558172|NCT03606174|62951471|FG008|Overall Study|Withdrawal by Subject|0|||
33558173|NCT03606174|62951472|FG009|Overall Study|Withdrawal by Subject|0|||
33558174|NCT03606174|62951473|FG010|Overall Study|Withdrawal by Subject|1|||
33558175|NCT03606174|62951463|FG000|Overall Study|Study Terminated by Sponsor|5|||
33558176|NCT03606174|62951464|FG001|Overall Study|Study Terminated by Sponsor|7|||
33558177|NCT03606174|62951465|FG002|Overall Study|Study Terminated by Sponsor|3|||
33558178|NCT03606174|62951466|FG003|Overall Study|Study Terminated by Sponsor|0|||
33558179|NCT03606174|62951467|FG004|Overall Study|Study Terminated by Sponsor|11|||
33558180|NCT03606174|62951468|FG005|Overall Study|Study Terminated by Sponsor|6|||
33558181|NCT03606174|62951469|FG006|Overall Study|Study Terminated by Sponsor|12|||
33558182|NCT03606174|62951470|FG007|Overall Study|Study Terminated by Sponsor|1|||
33558183|NCT03606174|62951471|FG008|Overall Study|Study Terminated by Sponsor|3|||
33558184|NCT03606174|62951472|FG009|Overall Study|Study Terminated by Sponsor|1|||
33558185|NCT03606174|62951473|FG010|Overall Study|Study Terminated by Sponsor|2|||
33558186|NCT03606174|62951463|FG000|Overall Study|Miscellaneous|1|||
33558187|NCT03606174|62951464|FG001|Overall Study|Miscellaneous|1|||
33558188|NCT03606174|62951465|FG002|Overall Study|Miscellaneous|0|||
33558189|NCT03606174|62951466|FG003|Overall Study|Miscellaneous|1|||
33558190|NCT03606174|62951467|FG004|Overall Study|Miscellaneous|4|||
33558191|NCT03606174|62951468|FG005|Overall Study|Miscellaneous|7|||
33558192|NCT03606174|62951469|FG006|Overall Study|Miscellaneous|5|||
33558193|NCT03606174|62951470|FG007|Overall Study|Miscellaneous|0|||
33558194|NCT03606174|62951471|FG008|Overall Study|Miscellaneous|0|||
33558195|NCT03606174|62951472|FG009|Overall Study|Miscellaneous|0|||
33558196|NCT03606174|62951473|FG010|Overall Study|Miscellaneous|1|||
33558197|NCT03450707|62951503|FG000|Overall Study|Outside enrollment window|4|||
33558198|NCT03450707|62951504|FG001|Overall Study|Outside enrollment window|1|||
33558199|NCT03450707|62951503|FG000|Overall Study|Death|1|||
33558200|NCT03450707|62951504|FG001|Overall Study|Death|0|||
33558201|NCT03450707|62951503|FG000|Overall Study|Indication for thiamine|1|||
33558202|NCT03450707|62951504|FG001|Overall Study|Indication for thiamine|1|||
33558203|NCT03450707|62951503|FG000|Overall Study|Evidence of traumatic brain injury|1|||
33558204|NCT03450707|62951504|FG001|Overall Study|Evidence of traumatic brain injury|0|||
33558205|NCT03450707|62951503|FG000|Overall Study|Following commands|0|||
33558206|NCT03450707|62951504|FG001|Overall Study|Following commands|3|||
33558207|NCT03450707|62951503|FG000|Overall Study|Lactate < 3.5|0|||
33558208|NCT03450707|62951504|FG001|Overall Study|Lactate < 3.5|2|||
33558209|NCT03450707|62951503|FG000|Overall Study|Rearrest with ECMO|0|||
33558210|NCT03450707|62951504|FG001|Overall Study|Rearrest with ECMO|1|||
33558211|NCT03450707|62951503|FG000|Overall Study|Indication for thiamine + head CT results|0|||
33558212|NCT03450707|62951504|FG001|Overall Study|Indication for thiamine + head CT results|1|||
33558213|NCT03450707|62951503|FG000|Overall Study|Family/patient goals of care|0|||
33558214|NCT03450707|62951504|FG001|Overall Study|Family/patient goals of care|1|||
33558215|NCT03296527|62951512|FG000|Overall Study|Adverse Event|15|||
33558216|NCT03296527|62951513|FG001|Overall Study|Adverse Event|33|||
33558217|NCT03296527|62951512|FG000|Overall Study|Protocol Deviation|4|||
33558218|NCT03296527|62951513|FG001|Overall Study|Protocol Deviation|0|||
33558219|NCT03296527|62951512|FG000|Overall Study|Participant withdrew consent|3|||
33558220|NCT03296527|62951513|FG001|Overall Study|Participant withdrew consent|1|||
33558221|NCT03296527|62951512|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
33558222|NCT03296527|62951513|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
33558223|NCT03296527|62951512|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
33558224|NCT03296527|62951513|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
33558225|NCT03296527|62951512|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
33558226|NCT03296527|62951513|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
33558227|NCT03296527|62951512|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
33558228|NCT03296527|62951513|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
33558229|NCT03296527|62951512|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
33558230|NCT03296527|62951513|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
33558231|NCT03228680|62951522|FG000|Overall Study|Adverse Event|13|||
33558232|NCT03228680|62951523|FG001|Overall Study|Adverse Event|18|||
33558233|NCT03228680|62951522|FG000|Overall Study|Randomization failure|0|||
33558234|NCT03228680|62951523|FG001|Overall Study|Randomization failure|1|||
33558235|NCT03228680|62951522|FG000|Overall Study|Withdrawal by Subject|1|||
33558236|NCT03228680|62951523|FG001|Overall Study|Withdrawal by Subject|0|||
33558237|NCT03228680|62951522|FG000|Overall Study|Other|9|||
33558238|NCT03228680|62951523|FG001|Overall Study|Other|16|||
33558239|NCT03194542|62951534|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
33558240|NCT03194542|62951535|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
33558241|NCT03194542|62951536|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
33558242|NCT03194542|62951537|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
33558243|NCT03194542|62951534|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
33558244|NCT03194542|62951535|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
33558245|NCT03194542|62951536|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
33558246|NCT03194542|62951537|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
33558247|NCT03194542|62951534|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
33558248|NCT03194542|62951535|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
33558249|NCT03194542|62951536|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
33558250|NCT03194542|62951537|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
33558251|NCT03194542|62951534|FG000|Overall Study|Loss of Response|4|||
33558252|NCT03194542|62951535|FG001|Overall Study|Loss of Response|2|||
33558253|NCT03194542|62951536|FG002|Overall Study|Loss of Response|3|||
33558254|NCT03194542|62951537|FG003|Overall Study|Loss of Response|4|||
33558255|NCT03194542|62951534|FG000|Overall Study|Physician Decision|0|||
33558256|NCT03194542|62951535|FG001|Overall Study|Physician Decision|1|||
33558257|NCT03194542|62951536|FG002|Overall Study|Physician Decision|0|||
33558258|NCT03194542|62951537|FG003|Overall Study|Physician Decision|0|||
33558259|NCT03194542|62951534|FG000|Overall Study|Lack of Efficacy|2|||
33558260|NCT03194542|62951535|FG001|Overall Study|Lack of Efficacy|2|||
33558261|NCT03194542|62951536|FG002|Overall Study|Lack of Efficacy|2|||
33558262|NCT03194542|62951537|FG003|Overall Study|Lack of Efficacy|6|||
33558263|NCT03194542|62951534|FG000|Overall Study|Withdrawal by Subject|2|||
33558264|NCT03194542|62951535|FG001|Overall Study|Withdrawal by Subject|1|||
33558265|NCT03194542|62951536|FG002|Overall Study|Withdrawal by Subject|5|||
33558266|NCT03194542|62951537|FG003|Overall Study|Withdrawal by Subject|4|||
33558267|NCT03194542|62951534|FG000|Overall Study|Progressive Disease|1|||
33558268|NCT03194542|62951535|FG001|Overall Study|Progressive Disease|0|||
33558269|NCT03194542|62951536|FG002|Overall Study|Progressive Disease|1|||
33558270|NCT03194542|62951537|FG003|Overall Study|Progressive Disease|1|||
33558271|NCT03194542|62951534|FG000|Overall Study|Adverse Event|1|||
33558272|NCT03194542|62951535|FG001|Overall Study|Adverse Event|2|||
33558273|NCT03194542|62951536|FG002|Overall Study|Adverse Event|0|||
33558274|NCT03194542|62951537|FG003|Overall Study|Adverse Event|5|||
33558275|NCT03194542|62951534|FG000|Overall Study|Death|1|||
33558276|NCT03194542|62951535|FG001|Overall Study|Death|2|||
33558277|NCT03194542|62951536|FG002|Overall Study|Death|0|||
33558278|NCT03194542|62951537|FG003|Overall Study|Death|5|||
33558279|NCT03194542|62951534|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
33558280|NCT03194542|62951535|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
33558281|NCT03194542|62951536|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
33558282|NCT03194542|62951537|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
33558283|NCT02717611|62951554|FG000|Overall Study|Death|13|||
33558284|NCT02717611|62951554|FG000|Overall Study|Withdrawal by Subject|6|||
33558285|NCT02717611|62951554|FG000|Overall Study|Active, not recruiting|40|||
33558286|NCT02717611|62951554|FG000|Overall Study|Complicating disease|1|||
33558287|NCT02362035|62951558|FG000|Overall Study|Death|67|||
33558288|NCT02362035|62951558|FG000|Overall Study|Lost to Follow-up|3|||
33558289|NCT02362035|62951558|FG000|Overall Study|Adverse Event|1|||
33558290|NCT02362035|62951558|FG000|Overall Study|Physician Decision|1|||
33558291|NCT02362035|62951558|FG000|Overall Study|Subject started another cancer therapy|10|||
33558292|NCT02362035|62951558|FG000|Overall Study|Study terminated by sponsor|45|||
33558293|NCT02362035|62951558|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
33558294|NCT02362035|62951558|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
33558295|NCT02362035|62951558|FG000|Overall Study|Disease progression|11|||
33558296|NCT02362035|62951558|FG000|Overall Study|Withdrawal by Subject|20|||
33558297|NCT02328014|62951566|FG000|Overall Study|Adverse Event|1|||
33558298|NCT02328014|62951567|FG001|Overall Study|Adverse Event|0|||
33558299|NCT02328014|62951568|FG002|Overall Study|Adverse Event|0|||
33558300|NCT02328014|62951569|FG003|Overall Study|Adverse Event|1|||
33558301|NCT02328014|62951566|FG000|Overall Study|Death|0|||
33558302|NCT02328014|62951567|FG001|Overall Study|Death|0|||
33558303|NCT02328014|62951568|FG002|Overall Study|Death|0|||
33558304|NCT02328014|62951569|FG003|Overall Study|Death|4|||
33558305|NCT02328014|62951566|FG000|Overall Study|Physician Decision|0|||
33558306|NCT02328014|62951567|FG001|Overall Study|Physician Decision|0|||
33558307|NCT02328014|62951568|FG002|Overall Study|Physician Decision|0|||
33558308|NCT02328014|62951569|FG003|Overall Study|Physician Decision|1|||
33558309|NCT02328014|62951566|FG000|Overall Study|Disease Progression|1|||
33558310|NCT02328014|62951567|FG001|Overall Study|Disease Progression|0|||
33558311|NCT02328014|62951568|FG002|Overall Study|Disease Progression|1|||
33662718|NCT01587703|63093235|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33558312|NCT02328014|62951569|FG003|Overall Study|Disease Progression|3|||
33558313|NCT02328014|62951566|FG000|Overall Study|Study Terminated by Sponsor|4|||
33662719|NCT01587703|63093236|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33558314|NCT02328014|62951567|FG001|Overall Study|Study Terminated by Sponsor|1|||
33558315|NCT02328014|62951568|FG002|Overall Study|Study Terminated by Sponsor|1|||
33558316|NCT02328014|62951569|FG003|Overall Study|Study Terminated by Sponsor|0|||
33558317|NCT02328014|62951566|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
33558318|NCT02328014|62951567|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
33558319|NCT02328014|62951568|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
33558320|NCT02328014|62951569|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
33558321|NCT02328014|62951566|FG000|Overall Study|Withdrawal by Subject|0|||
33558322|NCT02328014|62951567|FG001|Overall Study|Withdrawal by Subject|0|||
33558323|NCT02328014|62951568|FG002|Overall Study|Withdrawal by Subject|0|||
33558324|NCT02328014|62951569|FG003|Overall Study|Withdrawal by Subject|1|||
33558325|NCT02213926|62951579|FG000|Overall Study|Death|59|||
33558326|NCT02213926|62951579|FG000|Overall Study|Withdrawal by Subject|10|||
33558327|NCT02213926|62951579|FG000|Overall Study|study terminated by sponsor|51|||
33558328|NCT02213926|62951579|FG000|Overall Study|Lost to Follow-up|3|||
33558329|NCT02213926|62951579|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
33558330|NCT02180724|62951585|FG000|Overall Study|Death|26|||
33558331|NCT02180724|62951586|FG001|Overall Study|Death|1|||
33558332|NCT02180724|62951585|FG000|Overall Study|Lost to Follow-up|3|||
33558333|NCT02180724|62951586|FG001|Overall Study|Lost to Follow-up|1|||
33558334|NCT02180724|62951585|FG000|Overall Study|Withdrawal by Subject|4|||
33558335|NCT02180724|62951586|FG001|Overall Study|Withdrawal by Subject|2|||
33558336|NCT02180724|62951585|FG000|Overall Study|PI Decision|5|||
33558337|NCT02180724|62951586|FG001|Overall Study|PI Decision|2|||
33558338|NCT02180724|62951585|FG000|Overall Study|Study terminated by sponsor|54|||
33558339|NCT02180724|62951586|FG001|Overall Study|Study terminated by sponsor|8|||
33558340|NCT01892085|62951601|FG000|Overall Study|Death|4|||
33558341|NCT01892085|62951602|FG001|Overall Study|Death|1|||
33558342|NCT01892085|62951603|FG002|Overall Study|Death|3|||
33558343|NCT01892085|62951601|FG000|Overall Study|Withdrawal by Subject|2|||
33558344|NCT01892085|62951602|FG001|Overall Study|Withdrawal by Subject|0|||
33558345|NCT01892085|62951603|FG002|Overall Study|Withdrawal by Subject|2|||
33558346|NCT01267955|62951611|FG000|Stage 1 (6 Months)|Death|3|||
33558347|NCT01267955|62951611|FG000|Stage 2 (6 Months)|Death|5|||
33558348|NCT01267955|62951611|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
33558349|NCT00381641|62951635|FG000|Overall Study|Withdrawal by Subject|0|||
33558350|NCT00381641|62951636|FG001|Overall Study|Withdrawal by Subject|2|||
33558351|NCT04510285|62951657|FG000|Overall Study|Death|1|||
33558352|NCT02576054|62951661|FG000|Overall Study|Withdrawal by Subject|1|||
33558353|NCT01606202|62951669|FG000|Overall Study|Adverse Event|5|||
33558354|NCT01606202|62951670|FG001|Overall Study|Adverse Event|0|||
33558355|NCT01606202|62951669|FG000|Overall Study|Withdrawal by Subject|2|||
33558356|NCT01606202|62951670|FG001|Overall Study|Withdrawal by Subject|1|||
33558357|NCT01606202|62951669|FG000|Overall Study|Personal problems|0|||
33558358|NCT01606202|62951670|FG001|Overall Study|Personal problems|1|||
33558359|NCT01606202|62951669|FG000|Overall Study|Problems with administration|0|||
33558360|NCT01606202|62951670|FG001|Overall Study|Problems with administration|1|||
33558361|NCT01493960|62951678|FG000|Overall Study|Adverse Event|0|||
33558362|NCT01493960|62951679|FG001|Overall Study|Adverse Event|1|||
33558363|NCT01493960|62951678|FG000|Overall Study|Lack of Efficacy|15|||
33558364|NCT01493960|62951679|FG001|Overall Study|Lack of Efficacy|9|||
33558365|NCT01493960|62951678|FG000|Overall Study|Protocol Violation|3|||
33558366|NCT01493960|62951679|FG001|Overall Study|Protocol Violation|0|||
33662720|NCT01587703|63093237|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33558367|NCT01493960|62951678|FG000|Overall Study|Withdrawal by Subject|10|||
33558368|NCT01493960|62951679|FG001|Overall Study|Withdrawal by Subject|4|||
33558369|NCT01493960|62951678|FG000|Overall Study|Non-specified|4|||
33558370|NCT01493960|62951679|FG001|Overall Study|Non-specified|4|||
33558371|NCT02630459|62951689|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
33558372|NCT02630459|62951690|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
33558373|NCT02630459|62951691|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
33558374|NCT02630459|62951692|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
33558375|NCT02630459|62951693|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
33558376|NCT02630459|62951694|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
33558377|NCT02630459|62951695|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
33558378|NCT02630459|62951696|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
33662721|NCT01587703|63093238|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33662722|NCT01587703|63093239|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33558379|NCT02630459|62951689|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
33558380|NCT02630459|62951690|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
33558381|NCT02630459|62951691|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
33558382|NCT02630459|62951692|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
33558383|NCT02630459|62951693|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
33558384|NCT02630459|62951694|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
33558385|NCT02630459|62951695|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
33662723|NCT01587703|63093240|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33558386|NCT02630459|62951696|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
33558387|NCT02630459|62951689|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
33558388|NCT02630459|62951690|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
33558389|NCT02630459|62951691|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
33390483|NCT00644787|62769481|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
33390484|NCT00644787|62769479|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
33390485|NCT00644787|62769480|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
33390486|NCT00644787|62769481|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
33390487|NCT00644787|62769479|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
33390488|NCT00644787|62769480|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
33390489|NCT00644787|62769481|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
33390490|NCT00644787|62769479|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
33390491|NCT00644787|62769480|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
33390492|NCT00644787|62769481|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
33390493|NCT00644787|62769479|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
33390494|NCT00644787|62769480|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
33390495|NCT00644787|62769481|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
33390496|NCT00644787|62769479|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
33390497|NCT00644787|62769480|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
33390498|NCT00644787|62769481|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
33390499|NCT00644787|62769479|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
33390500|NCT00644787|62769480|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
33390501|NCT00644787|62769481|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
33390502|NCT00699582|62769492|FG000|Overall Study|Adverse Event|4|||
33390503|NCT00699582|62769493|FG001|Overall Study|Adverse Event|11|||
33390504|NCT00699582|62769494|FG002|Overall Study|Adverse Event|23|||
33390505|NCT00699582|62769492|FG000|Overall Study|Withdrawal by Subject|6|||
33390506|NCT00699582|62769493|FG001|Overall Study|Withdrawal by Subject|7|||
33390507|NCT00699582|62769494|FG002|Overall Study|Withdrawal by Subject|4|||
33390508|NCT00699582|62769492|FG000|Overall Study|Lack of Efficacy|1|||
33390509|NCT00699582|62769493|FG001|Overall Study|Lack of Efficacy|0|||
33390510|NCT00699582|62769494|FG002|Overall Study|Lack of Efficacy|1|||
33390511|NCT00699582|62769492|FG000|Overall Study|Progressive Disease|1|||
33390512|NCT00699582|62769493|FG001|Overall Study|Progressive Disease|0|||
33390513|NCT00699582|62769494|FG002|Overall Study|Progressive Disease|0|||
33390514|NCT00699582|62769492|FG000|Overall Study|Administrative/Other|4|||
33390515|NCT00699582|62769493|FG001|Overall Study|Administrative/Other|3|||
33390516|NCT00699582|62769494|FG002|Overall Study|Administrative/Other|0|||
33390517|NCT00699582|62769492|FG000|Overall Study|Randomized, Not Treated|2|||
33390518|NCT00699582|62769493|FG001|Overall Study|Randomized, Not Treated|1|||
33390519|NCT00699582|62769494|FG002|Overall Study|Randomized, Not Treated|0|||
33390520|NCT00640341|62769505|FG000|Overall Study|Adverse Event|0|||
33390521|NCT00640341|62769506|FG001|Overall Study|Adverse Event|0|||
33390522|NCT00640341|62769507|FG002|Overall Study|Adverse Event|1|||
33390523|NCT00640341|62769505|FG000|Overall Study|Positive Slit Lamp Findings|0|||
33390524|NCT00640341|62769506|FG001|Overall Study|Positive Slit Lamp Findings|0|||
33390525|NCT00640341|62769507|FG002|Overall Study|Positive Slit Lamp Findings|1|||
33390526|NCT00640341|62769505|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
33390527|NCT00640341|62769506|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
33390528|NCT00640341|62769507|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
33390529|NCT00640341|62769505|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
33390530|NCT00640341|62769506|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
33390531|NCT00640341|62769507|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
33390532|NCT00640341|62769505|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
33390533|NCT00640341|62769506|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
33390534|NCT00640341|62769507|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
33390535|NCT00640341|62769505|FG000|Overall Study|Lost to Follow-up|2|||
33390536|NCT00640341|62769506|FG001|Overall Study|Lost to Follow-up|0|||
33390537|NCT00640341|62769507|FG002|Overall Study|Lost to Follow-up|0|||
33390538|NCT00640341|62769505|FG000|Overall Study|Withdrawal by Subject|4|||
33390539|NCT00640341|62769506|FG001|Overall Study|Withdrawal by Subject|0|||
33390540|NCT00640341|62769507|FG002|Overall Study|Withdrawal by Subject|1|||
33390541|NCT00640341|62769505|FG000|Overall Study|Unacceptable Lens Movement|1|||
33390542|NCT00640341|62769506|FG001|Overall Study|Unacceptable Lens Movement|0|||
33390543|NCT00640341|62769507|FG002|Overall Study|Unacceptable Lens Movement|0|||
33390544|NCT00640341|62769505|FG000|Overall Study|Poor fit/Uncomfortable|4|||
33390545|NCT00640341|62769506|FG001|Overall Study|Poor fit/Uncomfortable|0|||
33390546|NCT00640341|62769507|FG002|Overall Study|Poor fit/Uncomfortable|0|||
33390547|NCT00640341|62769505|FG000|Overall Study|Ineligable at Baseline|5|||
33390548|NCT00640341|62769506|FG001|Overall Study|Ineligable at Baseline|3|||
33390549|NCT00640341|62769507|FG002|Overall Study|Ineligable at Baseline|2|||
33390550|NCT00640341|62769505|FG000|Overall Study|Adverse event and positive slit lamp|1|||
33390551|NCT00640341|62769506|FG001|Overall Study|Adverse event and positive slit lamp|0|||
33558390|NCT02630459|62951692|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
33558391|NCT02630459|62951693|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
33558392|NCT02630459|62951694|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
33558393|NCT02630459|62951695|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
33558394|NCT02630459|62951696|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
33558395|NCT02630459|62951689|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
33558396|NCT02630459|62951690|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
33558397|NCT02630459|62951691|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
33558398|NCT02630459|62951692|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
33558399|NCT02630459|62951693|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
33558400|NCT02630459|62951694|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
33558401|NCT02630459|62951695|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
33558402|NCT02630459|62951696|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
33558403|NCT02630459|62951689|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
33558404|NCT02630459|62951690|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
33558405|NCT02630459|62951691|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
33558406|NCT02630459|62951692|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
33558407|NCT02630459|62951693|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
33558408|NCT02630459|62951694|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
33558409|NCT02630459|62951695|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
33558410|NCT02630459|62951696|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
33558411|NCT02630459|62951689|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
33558412|NCT02630459|62951690|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
33558413|NCT02630459|62951691|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
33558414|NCT02630459|62951692|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
33558415|NCT02630459|62951693|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
33558416|NCT02630459|62951694|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
33558417|NCT02630459|62951695|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
33558418|NCT02630459|62951696|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
33558419|NCT02630459|62951689|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
33558420|NCT02630459|62951690|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
33558421|NCT02630459|62951691|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
33558422|NCT02630459|62951692|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
33558423|NCT02630459|62951693|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
33558424|NCT02630459|62951694|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
33558425|NCT02630459|62951695|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
33558426|NCT02630459|62951696|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
33558427|NCT02573948|62951721|FG000|Longitudinal Cohort|Death|9|||
33558428|NCT02573948|62951721|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
33558429|NCT02573948|62951721|FG000|Longitudinal Cohort|Incarcerated|25|||
33558430|NCT01464593|62951728|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
33558431|NCT01361711|62951732|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
33558432|NCT01361711|62951732|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
33558433|NCT01361711|62951732|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
33558434|NCT01361711|62951732|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
33558435|NCT01361711|62951732|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
33558436|NCT01361711|62951732|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
33558437|NCT01361711|62951732|FG000|Completed Week 18 of Treatment|Other|9|||
33558438|NCT01361711|62951732|FG000|10 Year Follow-up|Still in follow-up|22|||
33558439|NCT01361711|62951732|FG000|10 Year Follow-up|Death|7|||
33558440|NCT01361711|62951732|FG000|10 Year Follow-up|Developed new cancer|1|||
33558441|NCT01361711|62951732|FG000|10 Year Follow-up|Lost to Follow-up|2|||
33558442|NCT01361711|62951732|FG000|10 Year Follow-up|New treatment started|6|||
33558443|NCT01361711|62951732|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
33558444|NCT01361711|62951732|FG000|10 Year Follow-up|Progressive Disease|1|||
33558445|NCT02572388|62951740|FG000|Overall Study|Withdrawal by Subject|1|||
33558446|NCT02572388|62951741|FG001|Overall Study|Withdrawal by Subject|1|||
33558447|NCT02572388|62951742|FG002|Overall Study|Withdrawal by Subject|2|||
33558448|NCT02572388|62951743|FG003|Overall Study|Withdrawal by Subject|2|||
33558449|NCT02573870|62951755|FG000|Overall Study|Adverse Event|0|||
33558450|NCT02573870|62951756|FG001|Overall Study|Adverse Event|2|||
33558451|NCT02573870|62951755|FG000|Overall Study|Lack of Efficacy|0|||
33558452|NCT02573870|62951756|FG001|Overall Study|Lack of Efficacy|1|||
33558453|NCT02573870|62951755|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
33662724|NCT01587703|63093241|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33662725|NCT01587703|63093242|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33662726|NCT01587703|63093243|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
33558454|NCT02573870|62951756|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
33558455|NCT02573870|62951755|FG000|Overall Study|Lost to Follow-up|0|||
33558456|NCT02573870|62951756|FG001|Overall Study|Lost to Follow-up|1|||
33558457|NCT02573870|62951755|FG000|Overall Study|Other: Fail to Meet Visit|0|||
33558458|NCT02573870|62951756|FG001|Overall Study|Other: Fail to Meet Visit|2|||
33558459|NCT02572076|62951762|FG000|Overall Study|Protocol Violation|1|||
33558460|NCT02571452|62951768|FG000|Overall Study Treatment|Protocol Violation|0|||
33558461|NCT02571452|62951769|FG001|Overall Study Treatment|Protocol Violation|1|||
33558462|NCT02571452|62951768|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
33558463|NCT02571452|62951769|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
33558464|NCT02571452|62951768|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
33558465|NCT02571452|62951769|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
33558466|NCT02574260|62951775|FG000|Overall Study|Disease Progression|1|||
33558467|NCT02570126|62951781|FG000|Overall Study|Lost to Follow-up|2|||
33558468|NCT02570126|62951782|FG001|Overall Study|Lost to Follow-up|0|||
33558469|NCT02570126|62951781|FG000|Overall Study|Unable To Arrange Visit 3|1|||
33558470|NCT02570126|62951782|FG001|Overall Study|Unable To Arrange Visit 3|0|||
33558471|NCT02570126|62951781|FG000|Overall Study|Violation Of Procedures GSK|0|||
33558472|NCT02570126|62951782|FG001|Overall Study|Violation Of Procedures GSK|1|||
33558473|NCT02570126|62951781|FG000|Overall Study|Protocol Violation|0|||
33558474|NCT02570126|62951782|FG001|Overall Study|Protocol Violation|1|||
33558475|NCT02570126|62951781|FG000|Overall Study|Withdrawal by Subject|3|||
33558476|NCT02570126|62951782|FG001|Overall Study|Withdrawal by Subject|7|||
33558477|NCT02755831|62951790|FG000|Overall Study|Lost to Follow-up|3|||
33558478|NCT02755831|62951791|FG001|Overall Study|Lost to Follow-up|3|||
33558479|NCT02573246|62951802|FG000|Overall Study|Lost to Follow-up|2|||
33558480|NCT02573246|62951803|FG001|Overall Study|Lost to Follow-up|0|||
33558481|NCT02573246|62951804|FG002|Overall Study|Lost to Follow-up|0|||
33558482|NCT02573246|62951805|FG003|Overall Study|Lost to Follow-up|0|||
33558483|NCT02573246|62951806|FG004|Overall Study|Lost to Follow-up|1|||
33558484|NCT02573246|62951802|FG000|Overall Study|Withdrawal by Subject|0|||
33558485|NCT02573246|62951803|FG001|Overall Study|Withdrawal by Subject|0|||
33558486|NCT02573246|62951804|FG002|Overall Study|Withdrawal by Subject|0|||
33558487|NCT02573246|62951805|FG003|Overall Study|Withdrawal by Subject|0|||
33558488|NCT02573246|62951806|FG004|Overall Study|Withdrawal by Subject|1|||
33558489|NCT02573246|62951802|FG000|Overall Study|Physician Decision|1|||
33558490|NCT02573246|62951803|FG001|Overall Study|Physician Decision|1|||
33558491|NCT02573246|62951804|FG002|Overall Study|Physician Decision|3|||
33558492|NCT02573246|62951805|FG003|Overall Study|Physician Decision|2|||
33558493|NCT02573246|62951806|FG004|Overall Study|Physician Decision|2|||
33558494|NCT02570750|62951825|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
33558495|NCT02570750|62951826|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
33558496|NCT02570750|62951825|FG000|Overall Study|Protocol deviation|4|||
33558497|NCT02570750|62951826|FG001|Overall Study|Protocol deviation|2|||
33558498|NCT02570750|62951825|FG000|Overall Study|Withdrawal by Subject|5|||
33558499|NCT02570750|62951826|FG001|Overall Study|Withdrawal by Subject|0|||
33558500|NCT02570750|62951825|FG000|Overall Study|Lost to Follow-up|2|||
33558501|NCT02570750|62951826|FG001|Overall Study|Lost to Follow-up|2|||
33558502|NCT02570750|62951825|FG000|Overall Study|Adverse Event|2|||
33558503|NCT02570750|62951826|FG001|Overall Study|Adverse Event|1|||
33558504|NCT02573012|62951834|FG000|Overall Study|Adverse Event|5|||
33558505|NCT02573012|62951835|FG001|Overall Study|Adverse Event|5|||
33558506|NCT02573012|62951834|FG000|Overall Study|Lack of Efficacy|5|||
33558507|NCT02573012|62951835|FG001|Overall Study|Lack of Efficacy|4|||
33558508|NCT02573012|62951834|FG000|Overall Study|Non-compliance|1|||
33558509|NCT02573012|62951835|FG001|Overall Study|Non-compliance|2|||
33299629|NCT01095094|62675940|FG000|Overall Study|Withdrawal by Subject|1|||
33299630|NCT01095094|62675940|FG000|Overall Study|Death|1|||
33299631|NCT01095094|62675940|FG000|Overall Study|Physician Decision|1|||
33558510|NCT02573012|62951834|FG000|Overall Study|Withdrawal by Subject|2|||
33558511|NCT02573012|62951835|FG001|Overall Study|Withdrawal by Subject|2|||
33558512|NCT02573012|62951834|FG000|Overall Study|Study Ended per Protocol|1|||
33558513|NCT02573012|62951835|FG001|Overall Study|Study Ended per Protocol|0|||
33558514|NCT02573012|62951834|FG000|Overall Study|Physician Decision|1|||
33558515|NCT02573012|62951835|FG001|Overall Study|Physician Decision|2|||
33558516|NCT02752633|62951841|FG000|Overall Study|Withdrawal by Subject|1|||
33558517|NCT02752087|62951845|FG000|Washout|Physician Decision|1|||
33299632|NCT01323647|62675946|FG000|Overall Study|Migrated/moved from study area|2|||
33558518|NCT02752087|62951846|FG001|Washout|Physician Decision|0|||
33558519|NCT04766996|62951855|FG000|Overall Study|Withdrawal by Subject|1|||
33558520|NCT04766996|62951856|FG001|Overall Study|Withdrawal by Subject|0|||
33558521|NCT04766996|62951857|FG002|Overall Study|Withdrawal by Subject|13|||
33558522|NCT02563028|62951863|FG000|Overall Study|Lack of equipment|1|||
33558523|NCT02563028|62951863|FG000|Overall Study|Unable to elicit VEP post induction|1|||
33558524|NCT02192827|62951869|FG000|Overall Study|Lost to Follow-up|25|||
33558525|NCT02192827|62951870|FG001|Overall Study|Lost to Follow-up|27|||
33558526|NCT02192827|62951869|FG000|Overall Study|Given additional steroids with admission|13|||
33558527|NCT02192827|62951870|FG001|Overall Study|Given additional steroids with admission|11|||
33558528|NCT02562482|62951878|FG000|Overall Study|Enrolled, but did not receive product|4|||
33558529|NCT02562482|62951879|FG001|Overall Study|Enrolled, but did not receive product|0|||
33558530|NCT02562482|62951878|FG000|Overall Study|Lost to Follow-up|9|||
33558531|NCT02562482|62951879|FG001|Overall Study|Lost to Follow-up|6|||
33558532|NCT02562482|62951878|FG000|Overall Study|Moved from area|2|||
33558533|NCT02562482|62951879|FG001|Overall Study|Moved from area|3|||
33558534|NCT02562482|62951878|FG000|Overall Study|Withdrawal by Subject|5|||
33558535|NCT02562482|62951879|FG001|Overall Study|Withdrawal by Subject|3|||
33558536|NCT02562482|62951878|FG000|Overall Study|Physician Decision|1|||
33558537|NCT02562482|62951879|FG001|Overall Study|Physician Decision|3|||
33558538|NCT02562482|62951878|FG000|Overall Study|Illness/Injury unrelated to product|0|||
33558539|NCT02562482|62951879|FG001|Overall Study|Illness/Injury unrelated to product|1|||
33558540|NCT02568254|62951894|FG000|Period 2|Adverse Event|0|||
33558541|NCT02568254|62951895|FG001|Period 2|Adverse Event|0|||
33558542|NCT02568254|62951896|FG002|Period 2|Adverse Event|1|||
33558543|NCT02568254|62951897|FG003|Period 2|Adverse Event|0|||
33558544|NCT02568254|62951898|FG004|Period 2|Adverse Event|0|||
33558545|NCT02568254|62951899|FG005|Period 2|Adverse Event|0|||
33558546|NCT02568254|62951894|FG000|Period 3|Unstatisfactory Lens fitting|0|||
33558547|NCT02568254|62951895|FG001|Period 3|Unstatisfactory Lens fitting|0|||
33558548|NCT02568254|62951896|FG002|Period 3|Unstatisfactory Lens fitting|0|||
33558549|NCT02568254|62951897|FG003|Period 3|Unstatisfactory Lens fitting|0|||
33558550|NCT02568254|62951898|FG004|Period 3|Unstatisfactory Lens fitting|1|||
33558551|NCT02568254|62951899|FG005|Period 3|Unstatisfactory Lens fitting|0|||
33558552|NCT02567708|62951907|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
33558553|NCT02567708|62951908|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
33558554|NCT02567708|62951907|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
33558555|NCT02567708|62951908|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
33558556|NCT02567708|62951907|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
33558557|NCT02567708|62951908|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
33558558|NCT02567708|62951907|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
33558559|NCT02567708|62951908|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
33558560|NCT02562716|62951917|FG000|Overall Study|Adverse Event|7|||
33299633|NCT01323647|62675947|FG001|Overall Study|Migrated/moved from study area|0|||
33558561|NCT02562716|62951918|FG001|Overall Study|Adverse Event|14|||
33558562|NCT02562716|62951917|FG000|Overall Study|Withdrawal unrelated to AE|7|||
33558563|NCT02562716|62951918|FG001|Overall Study|Withdrawal unrelated to AE|1|||
33558564|NCT02562716|62951917|FG000|Overall Study|Progression|8|||
33558565|NCT02562716|62951918|FG001|Overall Study|Progression|10|||
33558566|NCT02562716|62951917|FG000|Overall Study|Death|2|||
33558567|NCT02562716|62951918|FG001|Overall Study|Death|1|||
33558568|NCT02562716|62951917|FG000|Overall Study|Not protocol specified|4|||
33558569|NCT02562716|62951918|FG001|Overall Study|Not protocol specified|2|||
33558570|NCT02751931|62951928|FG000|Overall Study|Adverse Event|3|||
33558571|NCT02751931|62951929|FG001|Overall Study|Adverse Event|0|||
33558572|NCT02751931|62951928|FG000|Overall Study|Other: Miscelleneous|10|||
33558573|NCT02751931|62951929|FG001|Overall Study|Other: Miscelleneous|8|||
33558574|NCT02561156|62951954|FG000|Part 2|Adverse Event|0|||
33558575|NCT02561156|62951955|FG001|Part 2|Adverse Event|0|||
33558576|NCT02561156|62951956|FG002|Part 2|Adverse Event|0|||
33558577|NCT02561156|62951957|FG003|Part 2|Adverse Event|0|||
33558578|NCT02561156|62951958|FG004|Part 2|Adverse Event|0|||
33558579|NCT02561156|62951959|FG005|Part 2|Adverse Event|0|||
33558580|NCT02561156|62951960|FG006|Part 2|Adverse Event|0|||
33558581|NCT02561156|62951961|FG007|Part 2|Adverse Event|0|||
33558582|NCT02561156|62951962|FG008|Part 2|Adverse Event|0|||
33558583|NCT02561156|62951963|FG009|Part 2|Adverse Event|0|||
33558584|NCT02561156|62951964|FG010|Part 2|Adverse Event|0|||
33299634|NCT01323647|62675946|FG000|Overall Study|Withdrawal by Subject|5|||
33299635|NCT01323647|62675947|FG001|Overall Study|Withdrawal by Subject|0|||
33299636|NCT01323647|62675946|FG000|Overall Study|Lost to Follow-up|2|||
33558585|NCT02561156|62951965|FG011|Part 2|Adverse Event|1|||
33299637|NCT01323647|62675947|FG001|Overall Study|Lost to Follow-up|0|||
33299638|NCT01094782|62675959|FG000|Overall Study|Withdrawal by Subject|5|||
33299639|NCT01094782|62675960|FG001|Overall Study|Withdrawal by Subject|5|||
33299640|NCT01094782|62675961|FG002|Overall Study|Withdrawal by Subject|1|||
33558586|NCT02561156|62951966|FG012|Part 2|Adverse Event|0|||
33558587|NCT02561078|62952012|FG000|Overall Study|Adverse Event|5|||
33558588|NCT02561078|62952013|FG001|Overall Study|Adverse Event|2|||
33558589|NCT02561078|62952012|FG000|Overall Study|Death|2|||
33558590|NCT02561078|62952013|FG001|Overall Study|Death|1|||
33558591|NCT02561078|62952012|FG000|Overall Study|Lost to Follow-up|2|||
33558592|NCT02561078|62952013|FG001|Overall Study|Lost to Follow-up|6|||
33558593|NCT02561078|62952012|FG000|Overall Study|Non-Compliance with Study Drug|6|||
33299641|NCT01094782|62675962|FG003|Overall Study|Withdrawal by Subject|5|||
33558594|NCT02561078|62952013|FG001|Overall Study|Non-Compliance with Study Drug|3|||
33558595|NCT02561078|62952012|FG000|Overall Study|Physician Decision|2|||
33390552|NCT00640341|62769507|FG002|Overall Study|Adverse event and positive slit lamp|0|||
33390553|NCT00699348|62769515|FG000|Overall Study|Death|6|||
33390554|NCT00699348|62769515|FG000|Overall Study|Adverse Event|15|||
33558596|NCT02561078|62952013|FG001|Overall Study|Physician Decision|3|||
33558597|NCT02561078|62952012|FG000|Overall Study|Withdrawal by Subject|13|||
33558598|NCT02561078|62952013|FG001|Overall Study|Withdrawal by Subject|10|||
33558599|NCT04907227|62952021|FG000|Overall Study|Death|10|||
33558600|NCT04907227|62952022|FG001|Overall Study|Death|7|||
33558601|NCT04907227|62952021|FG000|Overall Study|Withdrawal by Subject|1|||
33558602|NCT04907227|62952022|FG001|Overall Study|Withdrawal by Subject|0|||
33299642|NCT01094782|62675963|FG004|Overall Study|Withdrawal by Subject|5|||
33299643|NCT01094782|62675964|FG005|Overall Study|Withdrawal by Subject|0|||
33299644|NCT01094782|62675959|FG000|Overall Study|Lost to Follow-up|1|||
33299645|NCT01094782|62675960|FG001|Overall Study|Lost to Follow-up|0|||
33299646|NCT01094782|62675961|FG002|Overall Study|Lost to Follow-up|0|||
33558603|NCT04907227|62952021|FG000|Overall Study|Participants ongoing in the study|30|||
33558604|NCT04907227|62952022|FG001|Overall Study|Participants ongoing in the study|33|||
33558605|NCT04886596|62952030|FG000|Overall Study|Adverse Event|73|||
33558606|NCT04886596|62952031|FG001|Overall Study|Adverse Event|78|||
33558607|NCT04886596|62952030|FG000|Overall Study|Lost to Follow-up|104|||
33558608|NCT04886596|62952031|FG001|Overall Study|Lost to Follow-up|104|||
33558609|NCT04886596|62952030|FG000|Overall Study|Ongoing|12095|||
33558610|NCT04886596|62952031|FG001|Overall Study|Ongoing|12107|||
33299647|NCT01094782|62675962|FG003|Overall Study|Lost to Follow-up|2|||
33299648|NCT01094782|62675963|FG004|Overall Study|Lost to Follow-up|1|||
33299649|NCT01094782|62675964|FG005|Overall Study|Lost to Follow-up|4|||
33299650|NCT01094782|62675959|FG000|Overall Study|Positive Drug Screen|2|||
33299651|NCT01094782|62675960|FG001|Overall Study|Positive Drug Screen|2|||
33299652|NCT01094782|62675961|FG002|Overall Study|Positive Drug Screen|1|||
33390555|NCT00699348|62769515|FG000|Overall Study|Withdrawal by Subject|11|||
33390556|NCT00699348|62769515|FG000|Overall Study|Protocol Violation|10|||
33390557|NCT00699348|62769515|FG000|Overall Study|Lack of Efficacy|8|||
33390558|NCT00699348|62769515|FG000|Overall Study|Failure to return|1|||
33558611|NCT04886596|62952030|FG000|Overall Study|Consent withdrawal, not due to an (S)AE|162|||
33558612|NCT04886596|62952031|FG001|Overall Study|Consent withdrawal, not due to an (S)AE|173|||
33558613|NCT04886596|62952030|FG000|Overall Study|Migrated / Moved from the study area|17|||
33299653|NCT01094782|62675962|FG003|Overall Study|Positive Drug Screen|1|||
33299654|NCT01094782|62675963|FG004|Overall Study|Positive Drug Screen|3|||
33299655|NCT01094782|62675964|FG005|Overall Study|Positive Drug Screen|2|||
33299656|NCT01094782|62675959|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
33299657|NCT01094782|62675960|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
33299658|NCT01094782|62675961|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
33299659|NCT01094782|62675962|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
33299660|NCT01094782|62675963|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
33299661|NCT01094782|62675964|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
33299662|NCT01094782|62675959|FG000|Overall Study|Unable to Complete Questionnaires|0|||
33299663|NCT01094782|62675960|FG001|Overall Study|Unable to Complete Questionnaires|1|||
33299664|NCT01094782|62675961|FG002|Overall Study|Unable to Complete Questionnaires|0|||
33299665|NCT01094782|62675962|FG003|Overall Study|Unable to Complete Questionnaires|0|||
33299666|NCT01094782|62675963|FG004|Overall Study|Unable to Complete Questionnaires|0|||
33299667|NCT01094782|62675964|FG005|Overall Study|Unable to Complete Questionnaires|0|||
33299668|NCT01094782|62675959|FG000|Overall Study|Healthy Subject Had Pain|0|||
33299669|NCT01094782|62675960|FG001|Overall Study|Healthy Subject Had Pain|1|||
33299670|NCT01094782|62675961|FG002|Overall Study|Healthy Subject Had Pain|0|||
33299671|NCT01094782|62675962|FG003|Overall Study|Healthy Subject Had Pain|0|||
33299672|NCT01094782|62675963|FG004|Overall Study|Healthy Subject Had Pain|0|||
33299673|NCT01094782|62675964|FG005|Overall Study|Healthy Subject Had Pain|0|||
33299674|NCT01094782|62675959|FG000|Overall Study|Hypertension|0|||
33299675|NCT01094782|62675960|FG001|Overall Study|Hypertension|0|||
33299676|NCT01094782|62675961|FG002|Overall Study|Hypertension|1|||
33299677|NCT01094782|62675962|FG003|Overall Study|Hypertension|0|||
33299678|NCT01094782|62675963|FG004|Overall Study|Hypertension|0|||
33299679|NCT01094782|62675964|FG005|Overall Study|Hypertension|0|||
33299680|NCT01094782|62675959|FG000|Overall Study|Wrong Pain Condition|0|||
33299681|NCT01094782|62675960|FG001|Overall Study|Wrong Pain Condition|0|||
33299682|NCT01094782|62675961|FG002|Overall Study|Wrong Pain Condition|0|||
33299683|NCT01094782|62675962|FG003|Overall Study|Wrong Pain Condition|2|||
33390559|NCT00699348|62769515|FG000|Overall Study|Blood transfusion|24|||
33558614|NCT04886596|62952031|FG001|Overall Study|Migrated / Moved from the study area|14|||
33299684|NCT01094782|62675963|FG004|Overall Study|Wrong Pain Condition|1|||
33299685|NCT01094782|62675964|FG005|Overall Study|Wrong Pain Condition|1|||
33299686|NCT01094782|62675959|FG000|Overall Study|Recent Interventional Injection|0|||
33299687|NCT01094782|62675960|FG001|Overall Study|Recent Interventional Injection|0|||
33299688|NCT01094782|62675961|FG002|Overall Study|Recent Interventional Injection|0|||
33299689|NCT01094782|62675962|FG003|Overall Study|Recent Interventional Injection|0|||
33558615|NCT04886596|62952030|FG000|Overall Study|Unknown reason|16|||
33558616|NCT04886596|62952031|FG001|Overall Study|Unknown reason|23|||
33558617|NCT04881448|62952037|FG000|Overall Study|Study cancelled by sponsor|220|||
33558618|NCT04881448|62952037|FG000|Overall Study|Withdrawal by Subject|2|||
33558619|NCT04881448|62952037|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
33558620|NCT04275310|62952068|FG000|Overall Study|Non-randomized due to running out of funding|4|||
33558621|NCT04275310|62952069|FG001|Overall Study|Non-randomized due to running out of funding|0|||
33558622|NCT04157088|62952075|FG000|Overall Study|Study terminated by sponsor|23|||
33558623|NCT04157088|62952075|FG000|Overall Study|Withdrawal by Subject|4|||
33558624|NCT04157088|62952075|FG000|Overall Study|Lost to Follow-up|2|||
33558625|NCT04157088|62952075|FG000|Overall Study|Death|1|||
33558626|NCT04140266|62952083|FG000|Overall Study|Physician Decision|2|||
33558627|NCT04140266|62952084|FG001|Overall Study|Physician Decision|0|||
33558628|NCT04140266|62952083|FG000|Overall Study|Withdrawal by Subject|4|||
33558629|NCT04140266|62952084|FG001|Overall Study|Withdrawal by Subject|2|||
33558630|NCT04034004|62952109|FG000|Overall Study|Withdrawal by Subject|1|||
33558631|NCT04034004|62952110|FG001|Overall Study|Withdrawal by Subject|2|||
33558632|NCT04034004|62952111|FG002|Overall Study|Withdrawal by Subject|2|||
33558633|NCT04034004|62952112|FG003|Overall Study|Withdrawal by Subject|3|||
33558634|NCT04034004|62952109|FG000|Overall Study|could not find vein to administer IV|2|||
33558635|NCT04034004|62952110|FG001|Overall Study|could not find vein to administer IV|1|||
33558636|NCT04034004|62952111|FG002|Overall Study|could not find vein to administer IV|0|||
33558637|NCT04034004|62952112|FG003|Overall Study|could not find vein to administer IV|0|||
33558638|NCT04034004|62952109|FG000|Overall Study|nurse accidentally unblinded subject|0|||
33558639|NCT04034004|62952110|FG001|Overall Study|nurse accidentally unblinded subject|0|||
33558640|NCT04034004|62952111|FG002|Overall Study|nurse accidentally unblinded subject|0|||
33558641|NCT04034004|62952112|FG003|Overall Study|nurse accidentally unblinded subject|1|||
33558642|NCT03926143|62952120|FG000|Overall Study|Physician Decision|3|||
33558643|NCT03926143|62952120|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
33558644|NCT03926143|62952120|FG000|Overall Study|Adverse Event|2|||
33558645|NCT03926143|62952120|FG000|Overall Study|Progressive disease|3|||
33558646|NCT03213691|62952135|FG000|Overall Study|Adverse Event|2|||
33558647|NCT03213691|62952135|FG000|Overall Study|Death|3|||
33558648|NCT03213691|62952135|FG000|Overall Study|Physician Decision|1|||
33558649|NCT03213691|62952135|FG000|Overall Study|Progressive Disease|14|||
33558650|NCT03213691|62952135|FG000|Overall Study|Ineligible|1|||
33558651|NCT03018080|62952141|FG000|Overall Study|Death|12|||
33558652|NCT03018080|62952142|FG001|Overall Study|Death|19|||
33558653|NCT02781090|62952150|FG000|3-Month Follow-Up|Missed Visit|20|||
33558654|NCT02781090|62952151|FG001|3-Month Follow-Up|Missed Visit|20|||
33558655|NCT02781090|62952150|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
33390560|NCT00699348|62769515|FG000|Overall Study|Renal transplantation|10|||
33390561|NCT00699348|62769515|FG000|Overall Study|Other|5|||
33390562|NCT00643851|62769522|FG000|Overall Study|Death|0|||
33390563|NCT00643851|62769523|FG001|Overall Study|Death|1|||
33390564|NCT00643851|62769524|FG002|Overall Study|Death|0|||
33390565|NCT00643851|62769522|FG000|Overall Study|Lack of Efficacy|0|||
33390566|NCT00643851|62769523|FG001|Overall Study|Lack of Efficacy|1|||
33390567|NCT00643851|62769524|FG002|Overall Study|Lack of Efficacy|0|||
33558656|NCT02781090|62952151|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
33558657|NCT02781090|62952150|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
33558658|NCT02781090|62952151|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
33558659|NCT02781090|62952150|FG000|3-Month Follow-Up|Death|1|||
33558660|NCT02781090|62952151|FG001|3-Month Follow-Up|Death|0|||
33558661|NCT02781090|62952150|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
33558662|NCT02781090|62952151|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
33558663|NCT02781090|62952150|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
33558664|NCT02781090|62952151|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
33558665|NCT02781090|62952150|FG000|6-Month Follow-Up|Death|0|||
33558666|NCT02781090|62952151|FG001|6-Month Follow-Up|Death|1|||
33558667|NCT02774291|62952159|FG000|Overall Study|Lost to Follow-up|1|||
33558668|NCT01897571|62952175|FG000|Overall Study|Lost to Follow-up|3|||
33662727|NCT01587703|63093244|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
33558669|NCT01897571|62952176|FG001|Overall Study|Lost to Follow-up|0|||
33558670|NCT01897571|62952177|FG002|Overall Study|Lost to Follow-up|0|||
33558671|NCT01897571|62952178|FG003|Overall Study|Lost to Follow-up|0|||
33558672|NCT01897571|62952179|FG004|Overall Study|Lost to Follow-up|2|||
33558673|NCT01897571|62952180|FG005|Overall Study|Lost to Follow-up|0|||
33558674|NCT01897571|62952181|FG006|Overall Study|Lost to Follow-up|0|||
33558675|NCT01897571|62952182|FG007|Overall Study|Lost to Follow-up|0|||
33558676|NCT01897571|62952183|FG008|Overall Study|Lost to Follow-up|1|||
33558677|NCT01897571|62952184|FG009|Overall Study|Lost to Follow-up|2|||
33558678|NCT01897571|62952185|FG010|Overall Study|Lost to Follow-up|4|||
33558679|NCT01897571|62952175|FG000|Overall Study|Withdrawal by Subject|0|||
33390568|NCT00643851|62769522|FG000|Overall Study|Adverse Event|2|||
33390569|NCT00643851|62769523|FG001|Overall Study|Adverse Event|6|||
33390570|NCT00643851|62769524|FG002|Overall Study|Adverse Event|6|||
33558680|NCT01897571|62952176|FG001|Overall Study|Withdrawal by Subject|0|||
33558681|NCT01897571|62952177|FG002|Overall Study|Withdrawal by Subject|0|||
33558682|NCT01897571|62952178|FG003|Overall Study|Withdrawal by Subject|0|||
33558683|NCT01897571|62952179|FG004|Overall Study|Withdrawal by Subject|0|||
33558684|NCT01897571|62952180|FG005|Overall Study|Withdrawal by Subject|0|||
33558685|NCT01897571|62952181|FG006|Overall Study|Withdrawal by Subject|0|||
33558686|NCT01897571|62952182|FG007|Overall Study|Withdrawal by Subject|1|||
33558687|NCT01897571|62952183|FG008|Overall Study|Withdrawal by Subject|4|||
33558688|NCT01897571|62952184|FG009|Overall Study|Withdrawal by Subject|3|||
33558689|NCT01897571|62952185|FG010|Overall Study|Withdrawal by Subject|1|||
33558690|NCT01897571|62952175|FG000|Overall Study|Other|1|||
33558691|NCT01897571|62952176|FG001|Overall Study|Other|0|||
33558692|NCT01897571|62952177|FG002|Overall Study|Other|0|||
33558693|NCT01897571|62952178|FG003|Overall Study|Other|3|||
33558694|NCT01897571|62952179|FG004|Overall Study|Other|3|||
33558695|NCT01897571|62952180|FG005|Overall Study|Other|4|||
33558696|NCT01897571|62952181|FG006|Overall Study|Other|7|||
33558697|NCT01897571|62952182|FG007|Overall Study|Other|0|||
33558698|NCT01897571|62952183|FG008|Overall Study|Other|0|||
33558699|NCT01897571|62952184|FG009|Overall Study|Other|0|||
33558700|NCT01897571|62952185|FG010|Overall Study|Other|0|||
33558701|NCT01897571|62952175|FG000|Overall Study|Enrolled in rollover study|0|||
33558702|NCT01897571|62952176|FG001|Overall Study|Enrolled in rollover study|0|||
33558703|NCT01897571|62952177|FG002|Overall Study|Enrolled in rollover study|0|||
33558704|NCT01897571|62952178|FG003|Overall Study|Enrolled in rollover study|0|||
33558705|NCT01897571|62952179|FG004|Overall Study|Enrolled in rollover study|0|||
33558706|NCT01897571|62952180|FG005|Overall Study|Enrolled in rollover study|0|||
33558707|NCT01897571|62952181|FG006|Overall Study|Enrolled in rollover study|0|||
33558708|NCT01897571|62952182|FG007|Overall Study|Enrolled in rollover study|9|||
33558709|NCT01897571|62952183|FG008|Overall Study|Enrolled in rollover study|7|||
33558710|NCT01897571|62952184|FG009|Overall Study|Enrolled in rollover study|9|||
33558711|NCT01897571|62952185|FG010|Overall Study|Enrolled in rollover study|1|||
33558712|NCT01897571|62952175|FG000|Overall Study|Death|2|||
33558713|NCT01897571|62952176|FG001|Overall Study|Death|2|||
33558714|NCT01897571|62952177|FG002|Overall Study|Death|3|||
33558715|NCT01897571|62952178|FG003|Overall Study|Death|6|||
33558716|NCT01897571|62952179|FG004|Overall Study|Death|7|||
33558717|NCT01897571|62952180|FG005|Overall Study|Death|9|||
33390571|NCT00643851|62769522|FG000|Overall Study|Lost to Follow-up|4|||
33390572|NCT00643851|62769523|FG001|Overall Study|Lost to Follow-up|6|||
33390573|NCT00643851|62769524|FG002|Overall Study|Lost to Follow-up|9|||
33390574|NCT00643851|62769522|FG000|Overall Study|Withdrawal by Subject|8|||
33390575|NCT00643851|62769523|FG001|Overall Study|Withdrawal by Subject|15|||
33390576|NCT00643851|62769524|FG002|Overall Study|Withdrawal by Subject|9|||
33390577|NCT00643851|62769522|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
33390578|NCT00643851|62769523|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
33390579|NCT00643851|62769524|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
33390580|NCT03667690|62769534|FG000|Overall Study|Adverse Event|0|||
33558718|NCT01897571|62952181|FG006|Overall Study|Death|5|||
33558719|NCT01897571|62952182|FG007|Overall Study|Death|22|||
33558720|NCT01897571|62952183|FG008|Overall Study|Death|23|||
33558721|NCT01897571|62952184|FG009|Overall Study|Death|129|||
33558722|NCT01897571|62952185|FG010|Overall Study|Death|59|||
33558723|NCT01651403|62952206|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
33299690|NCT01094782|62675963|FG004|Overall Study|Recent Interventional Injection|0|||
33299691|NCT01094782|62675964|FG005|Overall Study|Recent Interventional Injection|1|||
33299692|NCT01094782|62675959|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
33299693|NCT01094782|62675960|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
33299694|NCT01094782|62675961|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
33299695|NCT01094782|62675962|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
33299696|NCT01094782|62675963|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
33558724|NCT01651403|62952207|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
33558725|NCT01651403|62952206|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
33558726|NCT01651403|62952207|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
33558727|NCT01651403|62952206|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
33558728|NCT01651403|62952207|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
33558729|NCT01651403|62952206|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
33558730|NCT01651403|62952207|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
33558731|NCT01651403|62952206|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
33558732|NCT01651403|62952207|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
33558733|NCT01651403|62952206|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
33558734|NCT01651403|62952207|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
33558735|NCT01207778|62952221|FG000|Overall Study|Lost to Follow-up|0|||
33390581|NCT03667690|62769535|FG001|Overall Study|Adverse Event|3|||
33390582|NCT03667690|62769534|FG000|Overall Study|Death|22|||
33558736|NCT01207778|62952222|FG001|Overall Study|Lost to Follow-up|3|||
33390583|NCT03667690|62769535|FG001|Overall Study|Death|21|||
33390584|NCT03667690|62769534|FG000|Overall Study|Lost to Follow-up|4|||
33558737|NCT01207778|62952223|FG002|Overall Study|Lost to Follow-up|3|||
33558738|NCT00953771|62952233|FG000|Overall Study|Death|1|||
33558739|NCT00953771|62952234|FG001|Overall Study|Death|0|||
33558740|NCT02567552|62952242|FG000|Overall Study|Adverse Event|0|||
33558741|NCT02567552|62952243|FG001|Overall Study|Adverse Event|1|||
33558742|NCT02561000|62952257|FG000|Overall Study|Withdrawal by Subject|2|||
33558743|NCT02561000|62952258|FG001|Overall Study|Withdrawal by Subject|3|||
33558744|NCT02561000|62952259|FG002|Overall Study|Withdrawal by Subject|0|||
33390585|NCT03667690|62769535|FG001|Overall Study|Lost to Follow-up|5|||
33390586|NCT03667690|62769534|FG000|Overall Study|Withdrawal by Subject|7|||
33390587|NCT03667690|62769535|FG001|Overall Study|Withdrawal by Subject|8|||
33390588|NCT03667690|62769534|FG000|Overall Study|Subject could not return for additional investigational product|1|||
33558745|NCT02561000|62952257|FG000|Overall Study|Adverse Event|0|||
33558746|NCT02561000|62952258|FG001|Overall Study|Adverse Event|1|||
33558747|NCT02561000|62952259|FG002|Overall Study|Adverse Event|0|||
33558748|NCT01663532|62952269|FG000|Overall Study|Lost to Follow-up|9|||
33558749|NCT01663532|62952270|FG001|Overall Study|Lost to Follow-up|10|||
33558750|NCT01663532|62952269|FG000|Overall Study|Adverse Event|7|||
33558751|NCT01663532|62952270|FG001|Overall Study|Adverse Event|13|||
33558752|NCT01663532|62952269|FG000|Overall Study|Met Withdrawal Criteria|7|||
33558753|NCT01663532|62952270|FG001|Overall Study|Met Withdrawal Criteria|6|||
33558754|NCT01663532|62952269|FG000|Overall Study|Physician Decision|1|||
33558755|NCT01663532|62952270|FG001|Overall Study|Physician Decision|1|||
33558756|NCT01663532|62952269|FG000|Overall Study|Withdrawal by Subject|35|||
33558757|NCT01663532|62952270|FG001|Overall Study|Withdrawal by Subject|17|||
33558758|NCT01663532|62952269|FG000|Overall Study|Lack of Efficacy|15|||
33558759|NCT01663532|62952270|FG001|Overall Study|Lack of Efficacy|60|||
33558760|NCT02525939|62952278|FG000|Overall Study|Lost to Follow-up|27|||
33558761|NCT02525939|62952279|FG001|Overall Study|Lost to Follow-up|24|||
33390589|NCT03667690|62769535|FG001|Overall Study|Subject could not return for additional investigational product|0|||
33390590|NCT03667690|62769534|FG000|Overall Study|Subject discharged to hospice care|2|||
33390591|NCT03667690|62769535|FG001|Overall Study|Subject discharged to hospice care|0|||
33390592|NCT03667690|62769534|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
33390593|NCT03667690|62769535|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
33390594|NCT03667690|62769534|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
33390595|NCT03667690|62769535|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
33390596|NCT03667690|62769534|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
33390597|NCT03667690|62769535|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
33390598|NCT03667690|62769534|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
33390599|NCT03667690|62769535|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
33390600|NCT03667690|62769534|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
33390601|NCT03667690|62769535|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
33390602|NCT00627393|62769543|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
33390603|NCT00627393|62769544|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
33390604|NCT00627393|62769543|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
33390605|NCT00627393|62769544|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
33390606|NCT00627393|62769543|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
33390607|NCT00627393|62769544|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
33390608|NCT00627393|62769543|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
33558762|NCT02525939|62952278|FG000|Overall Study|Physician Decision|0|||
33558763|NCT02525939|62952279|FG001|Overall Study|Physician Decision|1|||
33558764|NCT02525939|62952278|FG000|Overall Study|Withdrawal by Subject|24|||
33558765|NCT02525939|62952279|FG001|Overall Study|Withdrawal by Subject|39|||
33558766|NCT02525939|62952278|FG000|Overall Study|Death|180|||
33558767|NCT02525939|62952279|FG001|Overall Study|Death|179|||
33558768|NCT02697591|62952316|FG000|Overall Study|Lost to Follow-up|0|||
33558769|NCT02697591|62952317|FG001|Overall Study|Lost to Follow-up|0|||
33558770|NCT02697591|62952318|FG002|Overall Study|Lost to Follow-up|0|||
33558771|NCT02697591|62952319|FG003|Overall Study|Lost to Follow-up|0|||
33558772|NCT02697591|62952320|FG004|Overall Study|Lost to Follow-up|0|||
33558773|NCT02697591|62952321|FG005|Overall Study|Lost to Follow-up|1|||
33558774|NCT02697591|62952322|FG006|Overall Study|Lost to Follow-up|1|||
33558775|NCT02697591|62952323|FG007|Overall Study|Lost to Follow-up|0|||
33558776|NCT02697591|62952324|FG008|Overall Study|Lost to Follow-up|0|||
33558777|NCT02697591|62952325|FG009|Overall Study|Lost to Follow-up|1|||
33558778|NCT02697591|62952316|FG000|Overall Study|Withdrawal by Subject|1|||
33558779|NCT02697591|62952317|FG001|Overall Study|Withdrawal by Subject|1|||
33558780|NCT02697591|62952318|FG002|Overall Study|Withdrawal by Subject|2|||
33558781|NCT02697591|62952319|FG003|Overall Study|Withdrawal by Subject|1|||
33390609|NCT00627393|62769544|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
33390610|NCT00577122|62769554|FG000|Overall Study|Adverse Event|0|||
33558782|NCT02697591|62952320|FG004|Overall Study|Withdrawal by Subject|7|||
33558783|NCT02697591|62952321|FG005|Overall Study|Withdrawal by Subject|6|||
33390611|NCT00577122|62769555|FG001|Overall Study|Adverse Event|2|||
33390612|NCT00577122|62769554|FG000|Overall Study|Progression, relapse during active trt|6|||
33390613|NCT00577122|62769555|FG001|Overall Study|Progression, relapse during active trt|8|||
33390614|NCT00577122|62769554|FG000|Overall Study|Prog, refract disease during active trt|8|||
33390615|NCT00577122|62769555|FG001|Overall Study|Prog, refract disease during active trt|5|||
33390616|NCT00577122|62769554|FG000|Overall Study|Alternative Therapy|0|||
33390617|NCT00577122|62769555|FG001|Overall Study|Alternative Therapy|1|||
33390618|NCT00696774|62769565|FG000|Period II|Adverse Event|0|||
33390619|NCT00696774|62769566|FG001|Period II|Adverse Event|0|||
33390620|NCT00696774|62769567|FG002|Period II|Adverse Event|15|||
33390621|NCT00696774|62769565|FG000|Period II|Lost to Follow-up|0|||
33390622|NCT00696774|62769566|FG001|Period II|Lost to Follow-up|0|||
33558784|NCT02697591|62952322|FG006|Overall Study|Withdrawal by Subject|9|||
33558785|NCT02697591|62952323|FG007|Overall Study|Withdrawal by Subject|1|||
33558786|NCT02697591|62952324|FG008|Overall Study|Withdrawal by Subject|6|||
33558787|NCT02697591|62952325|FG009|Overall Study|Withdrawal by Subject|10|||
33558788|NCT02697591|62952316|FG000|Overall Study|Physician Decision|1|||
33558789|NCT02697591|62952317|FG001|Overall Study|Physician Decision|0|||
33558790|NCT02697591|62952318|FG002|Overall Study|Physician Decision|0|||
33558791|NCT02697591|62952319|FG003|Overall Study|Physician Decision|0|||
33558792|NCT02697591|62952320|FG004|Overall Study|Physician Decision|1|||
33558793|NCT02697591|62952321|FG005|Overall Study|Physician Decision|2|||
33558794|NCT02697591|62952322|FG006|Overall Study|Physician Decision|0|||
33558795|NCT02697591|62952323|FG007|Overall Study|Physician Decision|0|||
33558796|NCT02697591|62952324|FG008|Overall Study|Physician Decision|1|||
33558797|NCT02697591|62952325|FG009|Overall Study|Physician Decision|1|||
33558798|NCT02697591|62952316|FG000|Overall Study|Death|2|||
33558799|NCT02697591|62952317|FG001|Overall Study|Death|3|||
33558800|NCT02697591|62952318|FG002|Overall Study|Death|1|||
33558801|NCT02697591|62952319|FG003|Overall Study|Death|1|||
33558802|NCT02697591|62952320|FG004|Overall Study|Death|4|||
33558803|NCT02697591|62952321|FG005|Overall Study|Death|5|||
33558804|NCT02697591|62952322|FG006|Overall Study|Death|3|||
33558805|NCT02697591|62952323|FG007|Overall Study|Death|1|||
33558806|NCT02697591|62952324|FG008|Overall Study|Death|1|||
33558807|NCT02697591|62952325|FG009|Overall Study|Death|5|||
33558808|NCT02697591|62952316|FG000|Overall Study|Reason not Specified|0|||
33558809|NCT02697591|62952317|FG001|Overall Study|Reason not Specified|0|||
33558810|NCT02697591|62952318|FG002|Overall Study|Reason not Specified|0|||
33558811|NCT02697591|62952319|FG003|Overall Study|Reason not Specified|1|||
33558812|NCT02697591|62952320|FG004|Overall Study|Reason not Specified|1|||
33558813|NCT02697591|62952321|FG005|Overall Study|Reason not Specified|2|||
33558814|NCT02697591|62952322|FG006|Overall Study|Reason not Specified|3|||
33558815|NCT02697591|62952323|FG007|Overall Study|Reason not Specified|1|||
33558816|NCT02697591|62952324|FG008|Overall Study|Reason not Specified|1|||
33558817|NCT02697591|62952325|FG009|Overall Study|Reason not Specified|3|||
33299697|NCT01094782|62675964|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
33299698|NCT01094782|62675959|FG000|Overall Study|Noncompliance With Study Schedule|0|||
33299699|NCT01094782|62675960|FG001|Overall Study|Noncompliance With Study Schedule|0|||
33299700|NCT01094782|62675961|FG002|Overall Study|Noncompliance With Study Schedule|0|||
33299701|NCT01094782|62675962|FG003|Overall Study|Noncompliance With Study Schedule|1|||
33299702|NCT01094782|62675963|FG004|Overall Study|Noncompliance With Study Schedule|0|||
33299703|NCT01094782|62675964|FG005|Overall Study|Noncompliance With Study Schedule|0|||
33299704|NCT01097044|62675980|FG000|Overall Study|Withdrawal by Subject|4|||
33299705|NCT01097044|62675981|FG001|Overall Study|Withdrawal by Subject|4|||
33299706|NCT01097044|62675980|FG000|Overall Study|Lost to Follow-up|1|||
33299707|NCT01097044|62675981|FG001|Overall Study|Lost to Follow-up|0|||
33390623|NCT00696774|62769567|FG002|Period II|Lost to Follow-up|4|||
33558818|NCT02697435|62952350|FG000|Overall Study|Withdrawal by Subject|1|||
33558819|NCT02697435|62952351|FG001|Overall Study|Withdrawal by Subject|0|||
33558820|NCT02697435|62952350|FG000|Overall Study|Physician Decision|0|||
33558821|NCT02697435|62952351|FG001|Overall Study|Physician Decision|4|||
33558822|NCT02174861|62952358|FG000|Overall Study|Decision by sponsor|8|||
33558823|NCT02174861|62952358|FG000|Overall Study|Withdrawal by Subject|124|||
33558824|NCT02174861|62952358|FG000|Overall Study|Lost to Follow-up|26|||
33390624|NCT00696774|62769565|FG000|Period II|Protocol Violation|0|||
33390625|NCT00696774|62769566|FG001|Period II|Protocol Violation|0|||
33558825|NCT00140855|62952364|FG000|Overall Study|Progressive disease|2|||
33558826|NCT00700635|62952371|FG000|Overall Study|Adverse Event|1|||
33299708|NCT01097044|62675980|FG000|Overall Study|Withdrawal by Sponsor|0|||
33558827|NCT00700635|62952372|FG001|Overall Study|Adverse Event|0|||
33558828|NCT00700635|62952373|FG002|Overall Study|Adverse Event|0|||
33558829|NCT00700635|62952371|FG000|Overall Study|Lost to Follow-up|1|||
33558830|NCT00700635|62952372|FG001|Overall Study|Lost to Follow-up|3|||
33558831|NCT00700635|62952373|FG002|Overall Study|Lost to Follow-up|0|||
33558832|NCT00700635|62952371|FG000|Overall Study|Protocol Violation|2|||
33558833|NCT00700635|62952372|FG001|Overall Study|Protocol Violation|2|||
33558834|NCT00700635|62952373|FG002|Overall Study|Protocol Violation|0|||
33558835|NCT00700635|62952371|FG000|Overall Study|Withdrawal by Subject|7|||
33558836|NCT00700635|62952372|FG001|Overall Study|Withdrawal by Subject|3|||
33558837|NCT00700635|62952373|FG002|Overall Study|Withdrawal by Subject|1|||
33558838|NCT02780687|62952383|FG000|Overall Study|Adverse Event|1|||
33558839|NCT02780687|62952384|FG001|Overall Study|Adverse Event|1|||
33558840|NCT02780687|62952383|FG000|Overall Study|Withdrawal by Subject|2|||
33558841|NCT02780687|62952384|FG001|Overall Study|Withdrawal by Subject|1|||
33558842|NCT02780687|62952383|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
33558843|NCT02780687|62952384|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
33558844|NCT02780687|62952383|FG000|Overall Study|progressive disease|29|||
33558845|NCT02780687|62952384|FG001|Overall Study|progressive disease|6|||
33558846|NCT02698371|62952389|FG000|All Participants Flow|Lost to Follow-up|3|||
33558847|NCT02698371|62952389|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
33558848|NCT02698371|62952389|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
33558849|NCT02698371|62952389|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
33558850|NCT02698371|62952389|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
33558851|NCT02698371|62952389|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
33558852|NCT02698371|62952389|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
33558853|NCT02781311|62952408|FG000|Overall Study|Adverse Event|2|||
33558854|NCT02781311|62952409|FG001|Overall Study|Adverse Event|6|||
33558855|NCT02781311|62952410|FG002|Overall Study|Adverse Event|1|||
33558856|NCT02781311|62952408|FG000|Overall Study|Withdrawal of Consent|11|||
33558857|NCT02781311|62952409|FG001|Overall Study|Withdrawal of Consent|12|||
33558858|NCT02781311|62952410|FG002|Overall Study|Withdrawal of Consent|2|||
33558859|NCT02781311|62952408|FG000|Overall Study|Lost to Follow-up|11|||
33558860|NCT02781311|62952409|FG001|Overall Study|Lost to Follow-up|8|||
33558861|NCT02781311|62952410|FG002|Overall Study|Lost to Follow-up|1|||
33558862|NCT02781311|62952408|FG000|Overall Study|Non-Compliance with Study Drug|2|||
33558863|NCT02781311|62952409|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33558864|NCT02781311|62952410|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33558865|NCT02564198|62952420|FG000|Overall Study|Withdrawal by Subject|2|||
33558866|NCT02564198|62952421|FG001|Overall Study|Withdrawal by Subject|4|||
33558867|NCT02564198|62952422|FG002|Overall Study|Withdrawal by Subject|0|||
33558868|NCT02564198|62952420|FG000|Overall Study|Adverse Event|0|||
33558869|NCT02564198|62952421|FG001|Overall Study|Adverse Event|1|||
33558870|NCT02564198|62952422|FG002|Overall Study|Adverse Event|0|||
33558871|NCT02564120|62952437|FG000|Overall Study|Did not return release forms|160|||
33558872|NCT02564120|62952437|FG000|Overall Study|Death|58|||
33558873|NCT02564120|62952437|FG000|Overall Study|Withdrawal by Subject|204|||
33558874|NCT02564120|62952437|FG000|Overall Study|Other medical condition|24|||
33558875|NCT00705783|62952453|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
33558876|NCT00705783|62952454|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
33558877|NCT00705783|62952455|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
33558878|NCT00705783|62952453|FG000|Conversion Phase|Lost to Follow-up|13|||
33558879|NCT00705783|62952454|FG001|Conversion Phase|Lost to Follow-up|0|||
33558880|NCT00705783|62952455|FG002|Conversion Phase|Lost to Follow-up|0|||
33558881|NCT00705783|62952453|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
33558882|NCT00705783|62952454|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
33558883|NCT00705783|62952455|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
33662728|NCT01587703|63093226|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33662729|NCT01587703|63093227|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33299709|NCT01097044|62675981|FG001|Overall Study|Withdrawal by Sponsor|1|||
33299710|NCT01322009|62675991|FG000|Overall Study|Death|0|||
33299711|NCT01322009|62675992|FG001|Overall Study|Death|1|||
33299712|NCT01322009|62675991|FG000|Overall Study|Adverse Event|0|||
33299713|NCT01322009|62675992|FG001|Overall Study|Adverse Event|1|||
33558884|NCT00705783|62952453|FG000|Conversion Phase|Withdrawn by Investigator|4|||
33558885|NCT00705783|62952454|FG001|Conversion Phase|Withdrawn by Investigator|0|||
33558886|NCT00705783|62952455|FG002|Conversion Phase|Withdrawn by Investigator|0|||
33558887|NCT00705783|62952453|FG000|Conversion Phase|Withdrew Consent|24|||
33558888|NCT00705783|62952454|FG001|Conversion Phase|Withdrew Consent|0|||
33558889|NCT00705783|62952455|FG002|Conversion Phase|Withdrew Consent|0|||
33662730|NCT01587703|63093228|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33299714|NCT01322009|62675991|FG000|Overall Study|ng tube discontinued|0|||
33390626|NCT00696774|62769567|FG002|Period II|Protocol Violation|11|||
33558890|NCT00705783|62952453|FG000|Conversion Phase|Protocol Deviation|2|||
33558891|NCT00705783|62952454|FG001|Conversion Phase|Protocol Deviation|0|||
33558892|NCT00705783|62952455|FG002|Conversion Phase|Protocol Deviation|0|||
33558893|NCT00705783|62952453|FG000|Conversion Phase|Adverse Event|11|||
33558894|NCT00705783|62952454|FG001|Conversion Phase|Adverse Event|0|||
33299715|NCT01322009|62675992|FG001|Overall Study|ng tube discontinued|1|||
33558895|NCT00705783|62952455|FG002|Conversion Phase|Adverse Event|0|||
33558896|NCT00705783|62952453|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
33558897|NCT00705783|62952454|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
33558898|NCT00705783|62952455|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
33558899|NCT00705783|62952453|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
33558900|NCT00705783|62952454|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
33558901|NCT00705783|62952455|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
33558902|NCT00705783|62952453|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
33558903|NCT00705783|62952454|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
33558904|NCT00705783|62952455|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
33558905|NCT00705783|62952453|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
33558906|NCT00705783|62952454|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
33558907|NCT00705783|62952455|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
33558908|NCT00705783|62952453|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
33558909|NCT00705783|62952454|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
33558910|NCT00705783|62952455|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
33558911|NCT00705783|62952453|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
33558912|NCT00705783|62952454|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
33558913|NCT00705783|62952455|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
33558914|NCT00705783|62952453|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
33558915|NCT00705783|62952454|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
33558916|NCT00705783|62952455|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
33558917|NCT00705783|62952453|FG000|Oral Stabilization Phase|Adverse Event|14|||
33558918|NCT00705783|62952454|FG001|Oral Stabilization Phase|Adverse Event|0|||
33558919|NCT00705783|62952455|FG002|Oral Stabilization Phase|Adverse Event|0|||
33558920|NCT00705783|62952453|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
33558921|NCT00705783|62952454|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
33558922|NCT00705783|62952455|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
33558923|NCT00705783|62952453|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
33558924|NCT00705783|62952454|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
33558925|NCT00705783|62952455|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
33558926|NCT00705783|62952453|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
33558927|NCT00705783|62952454|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
33558928|NCT00705783|62952455|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
33558929|NCT00705783|62952453|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
33558930|NCT00705783|62952454|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
33558931|NCT00705783|62952455|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
33558932|NCT00705783|62952453|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
33558933|NCT00705783|62952454|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
33558934|NCT00705783|62952455|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
33558935|NCT00705783|62952453|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
33558936|NCT00705783|62952454|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
33558937|NCT00705783|62952455|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
33558938|NCT00705783|62952453|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
33558939|NCT00705783|62952454|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
33558940|NCT00705783|62952455|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
33558941|NCT00705783|62952453|FG000|Depot Stabilization Phase|Adverse Event|17|||
33558942|NCT00705783|62952454|FG001|Depot Stabilization Phase|Adverse Event|0|||
33558943|NCT00705783|62952455|FG002|Depot Stabilization Phase|Adverse Event|0|||
33558944|NCT00705783|62952453|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
33558945|NCT00705783|62952454|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
33558946|NCT00705783|62952455|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
33558947|NCT00705783|62952453|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
33558948|NCT00705783|62952454|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
33558949|NCT00705783|62952455|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
33558950|NCT00705783|62952453|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
33558951|NCT00705783|62952454|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
33558952|NCT00705783|62952455|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
33558953|NCT00705783|62952453|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
33558954|NCT00705783|62952454|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
33558955|NCT00705783|62952455|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
33558956|NCT00705783|62952453|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
33558957|NCT00705783|62952454|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
33558958|NCT00705783|62952455|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
33558959|NCT00705783|62952453|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
33558960|NCT00705783|62952454|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
33299716|NCT01321697|62675998|FG000|Overall Study|Study Terminated|7|||
33299717|NCT01320683|62676002|FG000|Overall Study|Positive antibody response|1|||
33558961|NCT00705783|62952455|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
33558962|NCT00705783|62952453|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
33558963|NCT00705783|62952454|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
33558964|NCT00705783|62952455|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
33558965|NCT00705783|62952453|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
33558966|NCT00705783|62952454|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
33558967|NCT00705783|62952455|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
33390627|NCT00696774|62769565|FG000|Period II|Withdrawal by Subject|0|||
33390628|NCT00696774|62769566|FG001|Period II|Withdrawal by Subject|0|||
33390629|NCT00696774|62769567|FG002|Period II|Withdrawal by Subject|4|||
33390630|NCT00696774|62769565|FG000|Period II|Sponsor Decision|0|||
33390631|NCT00696774|62769566|FG001|Period II|Sponsor Decision|0|||
33390632|NCT00696774|62769567|FG002|Period II|Sponsor Decision|0|||
33390633|NCT00696774|62769565|FG000|Period II|Lack of Efficacy|0|||
33390634|NCT00696774|62769566|FG001|Period II|Lack of Efficacy|0|||
33558968|NCT00705783|62952453|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
33299718|NCT01320293|62676006|FG000|Overall Study|Lack of Efficacy|1|||
33299719|NCT01320293|62676006|FG000|Overall Study|Adverse Event|1|||
33299720|NCT01318811|62676012|FG000|Overall Study|Physician Decision|1|||
33299721|NCT01318811|62676013|FG001|Overall Study|Physician Decision|1|||
33299722|NCT01318811|62676012|FG000|Overall Study|CRRT stopped for head CT|0|||
33299723|NCT01318811|62676013|FG001|Overall Study|CRRT stopped for head CT|1|||
33299724|NCT01318811|62676012|FG000|Overall Study|Death|0|||
33299725|NCT01318811|62676013|FG001|Overall Study|Death|1|||
33299726|NCT01318811|62676012|FG000|Overall Study|CRRT stopped for head MRI|0|||
33299727|NCT01318811|62676013|FG001|Overall Study|CRRT stopped for head MRI|1|||
33299728|NCT01093846|62676022|FG000|Overall Study|Adverse Event|0|||
33299729|NCT01093846|62676023|FG001|Overall Study|Adverse Event|0|||
33299730|NCT01093846|62676024|FG002|Overall Study|Adverse Event|1|||
33299731|NCT01093846|62676022|FG000|Overall Study|Lack of Efficacy|0|||
33299732|NCT01093846|62676023|FG001|Overall Study|Lack of Efficacy|0|||
33299733|NCT01093846|62676024|FG002|Overall Study|Lack of Efficacy|4|||
33299734|NCT01093846|62676022|FG000|Overall Study|Condition no longer required study drug|1|||
33299735|NCT01093846|62676023|FG001|Overall Study|Condition no longer required study drug|1|||
33299736|NCT01093846|62676024|FG002|Overall Study|Condition no longer required study drug|1|||
33299737|NCT01093846|62676022|FG000|Overall Study|Administrative Problems|18|||
33299738|NCT01093846|62676023|FG001|Overall Study|Administrative Problems|17|||
33299739|NCT01093846|62676024|FG002|Overall Study|Administrative Problems|15|||
33299740|NCT01315847|62676032|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
33299741|NCT01315847|62676033|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
33299742|NCT01315847|62676032|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
33299743|NCT01315847|62676033|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
33299744|NCT01093534|62676042|FG000|Overall Study|Adverse Event|2|||
33299745|NCT01093534|62676043|FG001|Overall Study|Adverse Event|5|||
33299746|NCT01093534|62676044|FG002|Overall Study|Adverse Event|2|||
33299747|NCT01093534|62676042|FG000|Overall Study|Lack of Efficacy|2|||
33299748|NCT01093534|62676043|FG001|Overall Study|Lack of Efficacy|1|||
33299749|NCT01093534|62676044|FG002|Overall Study|Lack of Efficacy|1|||
33299750|NCT01093534|62676042|FG000|Overall Study|Withdrawal by Subject|5|||
33299751|NCT01093534|62676043|FG001|Overall Study|Withdrawal by Subject|7|||
33299752|NCT01093534|62676044|FG002|Overall Study|Withdrawal by Subject|2|||
33299753|NCT01093534|62676042|FG000|Overall Study|Other|1|||
33299754|NCT01093534|62676043|FG001|Overall Study|Other|3|||
33299755|NCT01093534|62676044|FG002|Overall Study|Other|4|||
33299756|NCT01314911|62676055|FG000|Overall Study|Lost to Follow-up|3|||
33299757|NCT01314911|62676056|FG001|Overall Study|Lost to Follow-up|2|||
33299758|NCT01314911|62676055|FG000|Overall Study|Withdrawal by Subject|1|||
33390635|NCT00696774|62769567|FG002|Period II|Lack of Efficacy|2|||
33390636|NCT00696774|62769565|FG000|Period III|Adverse Event|1|||
33390637|NCT00696774|62769566|FG001|Period III|Adverse Event|1|||
33390638|NCT00696774|62769567|FG002|Period III|Adverse Event|0|||
33390639|NCT00696774|62769565|FG000|Period III|Lost to Follow-up|2|||
33390640|NCT00696774|62769566|FG001|Period III|Lost to Follow-up|1|||
33390641|NCT00696774|62769567|FG002|Period III|Lost to Follow-up|0|||
33390642|NCT00696774|62769565|FG000|Period III|Protocol Violation|1|||
33390643|NCT00696774|62769566|FG001|Period III|Protocol Violation|1|||
33558969|NCT00705783|62952454|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
33299759|NCT01314911|62676056|FG001|Overall Study|Withdrawal by Subject|3|||
33299760|NCT01314911|62676055|FG000|Overall Study|Received Non-randomized Study Drug|0|||
33299761|NCT01314911|62676056|FG001|Overall Study|Received Non-randomized Study Drug|1|||
33299762|NCT01314911|62676055|FG000|Overall Study|Never Started Treatment|1|||
33299763|NCT01314911|62676056|FG001|Overall Study|Never Started Treatment|0|||
33299764|NCT01093222|62676062|FG000|Overall Study|Ineligible|6|||
33299765|NCT01093222|62676062|FG000|Overall Study|Adverse Event|7|||
33299766|NCT01093222|62676062|FG000|Overall Study|Progression/relapse|24|||
33299767|NCT01093222|62676062|FG000|Overall Study|Death|2|||
33390644|NCT00696774|62769567|FG002|Period III|Protocol Violation|0|||
33558970|NCT00705783|62952455|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
33558971|NCT00705783|62952453|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
33558972|NCT00705783|62952454|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
33558973|NCT00705783|62952455|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
33558974|NCT00705783|62952453|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
33558975|NCT00705783|62952454|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
33558976|NCT00705783|62952455|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
33558977|NCT02694549|62952464|FG000|Overall Study|screen failures|2|||
33558978|NCT02782325|62952470|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
33558979|NCT02782325|62952471|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
33558980|NCT02782325|62952472|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
33558981|NCT02782325|62952470|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
33558982|NCT02782325|62952471|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
33558983|NCT02782325|62952472|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
33558984|NCT02693691|62952480|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
33558985|NCT02693691|62952480|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
33558986|NCT02693691|62952480|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
33558987|NCT02693691|62952480|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
33558988|NCT02693691|62952480|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
33558989|NCT02693691|62952480|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
33558990|NCT02693691|62952480|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
33558991|NCT04203667|62952484|FG000|Overall Study|Withdrawal by Subject|1|||
33558992|NCT04203667|62952484|FG000|Overall Study|Lost to Follow-up|1|||
33558993|NCT04203667|62952484|FG000|Overall Study|Death|1|||
33558994|NCT04203667|62952484|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
33558995|NCT02782169|62952491|FG000|Overall Study|Lost to Follow-up|1|||
33558996|NCT02782169|62952492|FG001|Overall Study|Lost to Follow-up|2|||
33558997|NCT02564042|62952504|FG000|Overall Study|Adverse Event|4|||
33558998|NCT02564042|62952505|FG001|Overall Study|Adverse Event|4|||
33558999|NCT02564042|62952506|FG002|Overall Study|Adverse Event|3|||
33559000|NCT02564042|62952507|FG003|Overall Study|Adverse Event|0|||
33559001|NCT02564042|62952508|FG004|Overall Study|Adverse Event|0|||
33559002|NCT02564042|62952509|FG005|Overall Study|Adverse Event|1|||
33559003|NCT02564042|62952504|FG000|Overall Study|Lost to Follow-up|1|||
33559004|NCT02564042|62952505|FG001|Overall Study|Lost to Follow-up|1|||
33559005|NCT02564042|62952506|FG002|Overall Study|Lost to Follow-up|1|||
33559006|NCT02564042|62952507|FG003|Overall Study|Lost to Follow-up|0|||
33559007|NCT02564042|62952508|FG004|Overall Study|Lost to Follow-up|1|||
33559008|NCT02564042|62952509|FG005|Overall Study|Lost to Follow-up|1|||
33559009|NCT02564042|62952504|FG000|Overall Study|Physician Decision|1|||
33559010|NCT02564042|62952505|FG001|Overall Study|Physician Decision|0|||
33559011|NCT02564042|62952506|FG002|Overall Study|Physician Decision|0|||
33559012|NCT02564042|62952507|FG003|Overall Study|Physician Decision|1|||
33559013|NCT02564042|62952508|FG004|Overall Study|Physician Decision|0|||
33559014|NCT02564042|62952509|FG005|Overall Study|Physician Decision|0|||
33559015|NCT02564042|62952504|FG000|Overall Study|Withdrawal by Subject|5|||
33559016|NCT02564042|62952505|FG001|Overall Study|Withdrawal by Subject|3|||
33559017|NCT02564042|62952506|FG002|Overall Study|Withdrawal by Subject|2|||
33559018|NCT02564042|62952507|FG003|Overall Study|Withdrawal by Subject|2|||
33559019|NCT02564042|62952508|FG004|Overall Study|Withdrawal by Subject|10|||
33559020|NCT02564042|62952509|FG005|Overall Study|Withdrawal by Subject|12|||
33559021|NCT02695719|62952542|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
33559022|NCT02695719|62952543|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
33559023|NCT02695719|62952542|FG000|Overall Study|Significant Protocol Deviation|0|||
33299768|NCT01093222|62676062|FG000|Overall Study|Not protocol specified|1|||
33559024|NCT02695719|62952543|FG001|Overall Study|Significant Protocol Deviation|1|||
33559025|NCT02695719|62952542|FG000|Overall Study|Voluntary Withdrawal|1|||
33559026|NCT02695719|62952543|FG001|Overall Study|Voluntary Withdrawal|0|||
33559027|NCT02563106|62952560|FG000|Overall Study|Withdrawal by Subject|7|||
33559028|NCT02563106|62952561|FG001|Overall Study|Withdrawal by Subject|8|||
33559029|NCT02563106|62952560|FG000|Overall Study|Adverse Event|17|||
33559030|NCT02563106|62952561|FG001|Overall Study|Adverse Event|15|||
33559031|NCT02563106|62952560|FG000|Overall Study|Protocol Violation|1|||
33559032|NCT02563106|62952561|FG001|Overall Study|Protocol Violation|0|||
33299769|NCT01313663|62676068|FG000|Overall Study|Study Closed/Terminated|2|||
33299770|NCT01313663|62676069|FG001|Overall Study|Study Closed/Terminated|4|||
33299771|NCT01313663|62676068|FG000|Overall Study|Lost to Follow-up|0|||
33299772|NCT01313663|62676069|FG001|Overall Study|Lost to Follow-up|1|||
33299773|NCT01313663|62676068|FG000|Overall Study|Physician Decision|0|||
33299774|NCT01313663|62676069|FG001|Overall Study|Physician Decision|2|||
33299775|NCT01313663|62676068|FG000|Overall Study|Withdrawal by Subject|2|||
33559033|NCT02563106|62952560|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
33559034|NCT02563106|62952561|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
33559035|NCT02563106|62952560|FG000|Overall Study|Lost to Follow-up|3|||
33559036|NCT02563106|62952561|FG001|Overall Study|Lost to Follow-up|2|||
33559037|NCT02563106|62952560|FG000|Overall Study|Physician Decision|3|||
33559038|NCT02563106|62952561|FG001|Overall Study|Physician Decision|1|||
33559039|NCT02563106|62952560|FG000|Overall Study|Other reason - not specified|2|||
33559040|NCT02563106|62952561|FG001|Overall Study|Other reason - not specified|1|||
33559041|NCT02691741|62952569|FG000|Overall Study|Adverse Event|0|||
33559042|NCT02691741|62952570|FG001|Overall Study|Adverse Event|2|||
33559043|NCT02691741|62952569|FG000|Overall Study|Lost to Follow-up|1|||
33559044|NCT02691741|62952570|FG001|Overall Study|Lost to Follow-up|0|||
33559045|NCT02691741|62952569|FG000|Overall Study|Physician Decision|0|||
33559046|NCT02691741|62952570|FG001|Overall Study|Physician Decision|1|||
33559047|NCT02691741|62952569|FG000|Overall Study|Withdrawal by Subject|0|||
33559048|NCT02691741|62952570|FG001|Overall Study|Withdrawal by Subject|4|||
33559049|NCT02691507|62952583|FG000|Overall Study|Missed Visit 3|0|||
33559050|NCT02691507|62952584|FG001|Overall Study|Missed Visit 3|1|||
33559051|NCT04579393|62952592|FG000|Overall Study|Withdrawal by Subject|2|||
33559052|NCT04579393|62952593|FG001|Overall Study|Withdrawal by Subject|2|||
33559053|NCT04579393|62952592|FG000|Overall Study|Death|1|||
33559054|NCT04579393|62952593|FG001|Overall Study|Death|3|||
33559055|NCT02776553|62952602|FG000|Overall Study|Lost to Follow-up|1|||
33559056|NCT02776553|62952603|FG001|Overall Study|Lost to Follow-up|0|||
33559057|NCT02776553|62952602|FG000|Overall Study|got liver transplant|1|||
33559058|NCT02776553|62952603|FG001|Overall Study|got liver transplant|2|||
33559059|NCT02776553|62952602|FG000|Overall Study|had other surgery|1|||
33559060|NCT02776553|62952603|FG001|Overall Study|had other surgery|0|||
33559061|NCT02776553|62952602|FG000|Overall Study|Protocol Violation|0|||
33559062|NCT02776553|62952603|FG001|Overall Study|Protocol Violation|1|||
33559063|NCT02690727|62952609|FG000|Overall Study|Adverse Event|2|||
33559064|NCT02690727|62952610|FG001|Overall Study|Adverse Event|2|||
33559065|NCT02777333|62952620|FG000|Overall Study|Withdrawal by Subject|0|||
33559066|NCT02777333|62952621|FG001|Overall Study|Withdrawal by Subject|1|||
33559067|NCT02777333|62952620|FG000|Overall Study|Lost to Follow-up|0|||
33559068|NCT02777333|62952621|FG001|Overall Study|Lost to Follow-up|1|||
33559069|NCT02695329|62952629|FG000|Overall Study|Adverse Event|1|||
33559070|NCT02695329|62952630|FG001|Overall Study|Adverse Event|0|||
33559071|NCT02695329|62952629|FG000|Overall Study|Poor X-ray quality for measurement|4|||
33559072|NCT02695329|62952630|FG001|Overall Study|Poor X-ray quality for measurement|5|||
33559073|NCT02690649|62952638|FG000|Overall Study|Withdrawal by Subject|1|||
33559074|NCT02690649|62952639|FG001|Overall Study|Withdrawal by Subject|1|||
33559075|NCT02690649|62952638|FG000|Overall Study|Protocol Violation|0|||
33559076|NCT02690649|62952639|FG001|Overall Study|Protocol Violation|3|||
33559077|NCT01358864|62952655|FG000|Overall Study|Adverse Event|0|||
33559078|NCT01358864|62952656|FG001|Overall Study|Adverse Event|6|||
33559079|NCT01358864|62952657|FG002|Overall Study|Adverse Event|9|||
33559080|NCT01358864|62952658|FG003|Overall Study|Adverse Event|0|||
33559081|NCT01358864|62952659|FG004|Overall Study|Adverse Event|4|||
33559082|NCT01358864|62952660|FG005|Overall Study|Adverse Event|8|||
33559083|NCT01358864|62952661|FG006|Overall Study|Adverse Event|12|||
33559084|NCT01358864|62952662|FG007|Overall Study|Adverse Event|7|||
33559085|NCT01358864|62952655|FG000|Overall Study|Lack of Efficacy|26|||
33559086|NCT01358864|62952656|FG001|Overall Study|Lack of Efficacy|3|||
33559087|NCT01358864|62952657|FG002|Overall Study|Lack of Efficacy|4|||
33559088|NCT01358864|62952658|FG003|Overall Study|Lack of Efficacy|19|||
33559089|NCT01358864|62952659|FG004|Overall Study|Lack of Efficacy|7|||
33559090|NCT01358864|62952660|FG005|Overall Study|Lack of Efficacy|4|||
33559091|NCT01358864|62952661|FG006|Overall Study|Lack of Efficacy|49|||
33559092|NCT01358864|62952662|FG007|Overall Study|Lack of Efficacy|44|||
33559093|NCT01358864|62952655|FG000|Overall Study|Lost to Follow-up|0|||
33559094|NCT01358864|62952656|FG001|Overall Study|Lost to Follow-up|0|||
33559095|NCT01358864|62952657|FG002|Overall Study|Lost to Follow-up|1|||
33559096|NCT01358864|62952658|FG003|Overall Study|Lost to Follow-up|0|||
33559097|NCT01358864|62952659|FG004|Overall Study|Lost to Follow-up|0|||
33559098|NCT01358864|62952660|FG005|Overall Study|Lost to Follow-up|0|||
33559099|NCT01358864|62952661|FG006|Overall Study|Lost to Follow-up|0|||
33559100|NCT01358864|62952662|FG007|Overall Study|Lost to Follow-up|1|||
33559101|NCT01358864|62952655|FG000|Overall Study|Withdrawal by Subject|3|||
33559102|NCT01358864|62952656|FG001|Overall Study|Withdrawal by Subject|4|||
33559103|NCT01358864|62952657|FG002|Overall Study|Withdrawal by Subject|2|||
33559104|NCT01358864|62952658|FG003|Overall Study|Withdrawal by Subject|0|||
33559105|NCT01358864|62952659|FG004|Overall Study|Withdrawal by Subject|0|||
33559106|NCT01358864|62952660|FG005|Overall Study|Withdrawal by Subject|1|||
33559107|NCT01358864|62952661|FG006|Overall Study|Withdrawal by Subject|1|||
33559108|NCT01358864|62952662|FG007|Overall Study|Withdrawal by Subject|3|||
33559109|NCT01358864|62952655|FG000|Overall Study|Other reason not defined above|2|||
33559110|NCT01358864|62952656|FG001|Overall Study|Other reason not defined above|0|||
33559111|NCT01358864|62952657|FG002|Overall Study|Other reason not defined above|0|||
33559112|NCT01358864|62952658|FG003|Overall Study|Other reason not defined above|0|||
33559113|NCT01358864|62952659|FG004|Overall Study|Other reason not defined above|0|||
33559114|NCT01358864|62952660|FG005|Overall Study|Other reason not defined above|0|||
33559115|NCT01358864|62952661|FG006|Overall Study|Other reason not defined above|2|||
33559116|NCT01358864|62952662|FG007|Overall Study|Other reason not defined above|0|||
33559117|NCT01358864|62952655|FG000|Overall Study|Not treated|0|||
33559118|NCT01358864|62952656|FG001|Overall Study|Not treated|0|||
33559119|NCT01358864|62952657|FG002|Overall Study|Not treated|0|||
33559120|NCT01358864|62952658|FG003|Overall Study|Not treated|0|||
33559121|NCT01358864|62952659|FG004|Overall Study|Not treated|0|||
33559122|NCT01358864|62952660|FG005|Overall Study|Not treated|0|||
33559123|NCT01358864|62952661|FG006|Overall Study|Not treated|1|||
33559124|NCT01358864|62952662|FG007|Overall Study|Not treated|0|||
33559125|NCT02750761|62952688|FG000|Overall Study|Lost to Follow-up|0|||
33559126|NCT02750761|62952689|FG001|Overall Study|Lost to Follow-up|0|||
33559127|NCT02750761|62952690|FG002|Overall Study|Lost to Follow-up|1|||
33559128|NCT02750761|62952691|FG003|Overall Study|Lost to Follow-up|0|||
33559129|NCT02750761|62952692|FG004|Overall Study|Lost to Follow-up|0|||
33559130|NCT02750761|62952693|FG005|Overall Study|Lost to Follow-up|0|||
33559131|NCT02688933|62952736|FG000|Overall Study|Adverse Event|3|||
33559132|NCT02688933|62952737|FG001|Overall Study|Adverse Event|1|||
33559133|NCT02688933|62952736|FG000|Overall Study|Lack of Efficacy|2|||
33559134|NCT02688933|62952737|FG001|Overall Study|Lack of Efficacy|2|||
33559135|NCT02688933|62952736|FG000|Overall Study|Poor compliance to protocol|7|||
33559136|NCT02688933|62952737|FG001|Overall Study|Poor compliance to protocol|4|||
33559137|NCT02688933|62952736|FG000|Overall Study|Hypoglycemia|2|||
33559138|NCT02688933|62952737|FG001|Overall Study|Hypoglycemia|0|||
33559139|NCT02688933|62952736|FG000|Overall Study|Other than Specified|14|||
33559140|NCT02688933|62952737|FG001|Overall Study|Other than Specified|25|||
33559141|NCT02688933|62952736|FG000|Overall Study|Lost to Follow-up|1|||
33559142|NCT02688933|62952737|FG001|Overall Study|Lost to Follow-up|5|||
33559143|NCT02688621|62952757|FG000|Overall Study|Pregnancy|1|||
33559144|NCT02688621|62952758|FG001|Overall Study|Pregnancy|3|||
33559145|NCT02688621|62952757|FG000|Overall Study|Lost to Follow-up|38|||
33559146|NCT02688621|62952758|FG001|Overall Study|Lost to Follow-up|15|||
33559147|NCT02688621|62952757|FG000|Overall Study|Withdrawal by Subject|1|||
33559148|NCT02688621|62952758|FG001|Overall Study|Withdrawal by Subject|0|||
33559149|NCT04227704|62952770|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
33559150|NCT04227704|62952771|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
33559151|NCT04227704|62952772|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
33559152|NCT04227704|62952770|FG000|Overall Study|due to C/S being cancelled|1|||
33559153|NCT04227704|62952771|FG001|Overall Study|due to C/S being cancelled|0|||
33559154|NCT04227704|62952772|FG002|Overall Study|due to C/S being cancelled|0|||
33559155|NCT03530293|62952782|FG000|Pre-randomization|Adverse Event|12|||
33559156|NCT03530293|62952783|FG001|Pre-randomization|Adverse Event|0|||
33559157|NCT03530293|62952784|FG002|Pre-randomization|Adverse Event|0|||
33559158|NCT03530293|62952782|FG000|Pre-randomization|Protocol Violation|2|||
33559159|NCT03530293|62952783|FG001|Pre-randomization|Protocol Violation|0|||
33559160|NCT03530293|62952784|FG002|Pre-randomization|Protocol Violation|0|||
33559161|NCT03530293|62952782|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
33559162|NCT03530293|62952783|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
33559163|NCT03530293|62952784|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
33299776|NCT01313663|62676069|FG001|Overall Study|Withdrawal by Subject|1|||
33299777|NCT01092832|62676077|FG000|Overall Study|Other|1|||
33299778|NCT01092832|62676078|FG001|Overall Study|Other|0|||
33299779|NCT01313273|62676086|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
33299780|NCT01313273|62676087|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
33559164|NCT03530293|62952782|FG000|Pre-randomization|Withdrawal by Subject|5|||
33299781|NCT01313273|62676086|FG000|Overall Study|Withdrawal by Subject|1|||
33299782|NCT01313273|62676087|FG001|Overall Study|Withdrawal by Subject|0|||
33299783|NCT01313273|62676086|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
33299784|NCT01313273|62676087|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
33299785|NCT01091974|62676097|FG000|Overall Study|Did not start intervention|3|||
33559165|NCT03530293|62952783|FG001|Pre-randomization|Withdrawal by Subject|0|||
33559166|NCT03530293|62952784|FG002|Pre-randomization|Withdrawal by Subject|0|||
33662731|NCT01587703|63093229|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33559167|NCT03530293|62952782|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
33559168|NCT03530293|62952783|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
33559169|NCT03530293|62952784|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
33559170|NCT03530293|62952782|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
33559171|NCT03530293|62952783|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
33559172|NCT03530293|62952784|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
33559173|NCT03530293|62952782|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
33559174|NCT03530293|62952783|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
33299786|NCT01091974|62676098|FG001|Overall Study|Did not start intervention|1|||
33299787|NCT01091974|62676099|FG002|Overall Study|Did not start intervention|3|||
33559175|NCT03530293|62952784|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
33559176|NCT03530293|62952782|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
33559177|NCT03530293|62952783|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
33559178|NCT03530293|62952784|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
33559179|NCT03530293|62952782|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
33559180|NCT03530293|62952783|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
33559181|NCT03530293|62952784|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
33559182|NCT03335371|62952813|FG000|Overall Study|Lost to Follow-up|0|||
33559183|NCT03335371|62952814|FG001|Overall Study|Lost to Follow-up|0|||
33559184|NCT03335371|62952815|FG002|Overall Study|Lost to Follow-up|0|||
33559185|NCT03335371|62952816|FG003|Overall Study|Lost to Follow-up|0|||
33390645|NCT00696774|62769565|FG000|Period III|Withdrawal by Subject|1|||
33390646|NCT00696774|62769566|FG001|Period III|Withdrawal by Subject|2|||
33390647|NCT00696774|62769567|FG002|Period III|Withdrawal by Subject|0|||
33390648|NCT00696774|62769565|FG000|Period III|Sponsor Decision|2|||
33390649|NCT00696774|62769566|FG001|Period III|Sponsor Decision|0|||
33390650|NCT00696774|62769567|FG002|Period III|Sponsor Decision|0|||
33390651|NCT00696774|62769565|FG000|Period III|Lack of Efficacy|0|||
33390652|NCT00696774|62769566|FG001|Period III|Lack of Efficacy|2|||
33390653|NCT00696774|62769567|FG002|Period III|Lack of Efficacy|0|||
33390654|NCT00608842|62769579|FG000|Overall Study|Participant's Request|0|||
33390655|NCT00608842|62769580|FG001|Overall Study|Participant's Request|1|||
33390656|NCT00608842|62769581|FG002|Overall Study|Participant's Request|2|||
33390657|NCT00608842|62769582|FG003|Overall Study|Participant's Request|1|||
33390658|NCT00608842|62769579|FG000|Overall Study|Lost to Follow-up|1|||
33390659|NCT00608842|62769580|FG001|Overall Study|Lost to Follow-up|0|||
33390660|NCT00608842|62769581|FG002|Overall Study|Lost to Follow-up|0|||
33390661|NCT00608842|62769582|FG003|Overall Study|Lost to Follow-up|0|||
33390662|NCT00626925|62769594|FG000|Overall Study|Lost to Follow-up|1|||
33390663|NCT00626925|62769595|FG001|Overall Study|Lost to Follow-up|2|||
33390664|NCT00626925|62769594|FG000|Overall Study|relapse|1|||
33390665|NCT00626925|62769595|FG001|Overall Study|relapse|0|||
33390666|NCT00626925|62769594|FG000|Overall Study|Adverse effect|6|||
33390667|NCT00626925|62769595|FG001|Overall Study|Adverse effect|2|||
33390668|NCT00626925|62769594|FG000|Overall Study|Lack of Efficacy|1|||
33390669|NCT00626925|62769595|FG001|Overall Study|Lack of Efficacy|4|||
33390670|NCT00626925|62769594|FG000|Overall Study|Time constraints|3|||
33390671|NCT00626925|62769595|FG001|Overall Study|Time constraints|1|||
33390672|NCT00698646|62769618|FG000|Overall Study|Adverse Event|8|||
33390673|NCT00698646|62769619|FG001|Overall Study|Adverse Event|7|||
33390674|NCT00698646|62769620|FG002|Overall Study|Adverse Event|8|||
33390675|NCT00698646|62769618|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
33390676|NCT00698646|62769619|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
33390677|NCT00698646|62769620|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
33390678|NCT00698646|62769618|FG000|Overall Study|Protocol Deviation|6|||
33390679|NCT00698646|62769619|FG001|Overall Study|Protocol Deviation|2|||
33390680|NCT00698646|62769620|FG002|Overall Study|Protocol Deviation|3|||
33390681|NCT00698646|62769618|FG000|Overall Study|Withdrawal by Subject|10|||
33390682|NCT00698646|62769619|FG001|Overall Study|Withdrawal by Subject|11|||
33390683|NCT00698646|62769620|FG002|Overall Study|Withdrawal by Subject|8|||
33390684|NCT00698646|62769618|FG000|Overall Study|Lost to Follow-up|0|||
33390685|NCT00698646|62769619|FG001|Overall Study|Lost to Follow-up|0|||
33390686|NCT00698646|62769620|FG002|Overall Study|Lost to Follow-up|2|||
33390687|NCT00698646|62769618|FG000|Overall Study|Administrative problems|1|||
33390688|NCT00698646|62769619|FG001|Overall Study|Administrative problems|0|||
33390689|NCT00698646|62769620|FG002|Overall Study|Administrative problems|1|||
33390690|NCT00609466|62769631|FG000|Overall Study|Withdrawal by Subject|0|||
33390691|NCT00609466|62769632|FG001|Overall Study|Withdrawal by Subject|1|||
33390692|NCT00609466|62769633|FG002|Overall Study|Withdrawal by Subject|1|||
33390693|NCT00609466|62769631|FG000|Overall Study|Adverse Event|2|||
33390694|NCT00609466|62769632|FG001|Overall Study|Adverse Event|3|||
33390695|NCT00609466|62769633|FG002|Overall Study|Adverse Event|1|||
33390696|NCT00609466|62769631|FG000|Overall Study|Lack of Efficacy|0|||
33559186|NCT03335371|62952817|FG004|Overall Study|Lost to Follow-up|1|||
33390697|NCT00609466|62769632|FG001|Overall Study|Lack of Efficacy|2|||
33390698|NCT00609466|62769633|FG002|Overall Study|Lack of Efficacy|2|||
33390699|NCT00608530|62769645|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
33390700|NCT00608530|62769646|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
33390701|NCT00608530|62769647|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
33390702|NCT00608530|62769648|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
33390703|NCT00608530|62769645|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
33559187|NCT03335371|62952813|FG000|Overall Study|Withdrawal by Subject|0|||
33390704|NCT00608530|62769646|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
33390705|NCT00608530|62769647|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
33390706|NCT00608530|62769648|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
33390707|NCT00608530|62769645|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
33390708|NCT00608530|62769646|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
33390709|NCT00608530|62769647|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
33390710|NCT00608530|62769648|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
33390711|NCT00608530|62769645|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
33390712|NCT00608530|62769646|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
33390713|NCT00608530|62769647|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
33390714|NCT00608530|62769648|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
33390715|NCT00608530|62769645|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
33390716|NCT00608530|62769646|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
33559188|NCT03335371|62952814|FG001|Overall Study|Withdrawal by Subject|0|||
33559189|NCT03335371|62952815|FG002|Overall Study|Withdrawal by Subject|0|||
33559190|NCT03335371|62952816|FG003|Overall Study|Withdrawal by Subject|0|||
33559191|NCT03335371|62952817|FG004|Overall Study|Withdrawal by Subject|1|||
33559192|NCT03335371|62952813|FG000|Overall Study|Randomization Error|0|||
33559193|NCT03335371|62952814|FG001|Overall Study|Randomization Error|0|||
33559194|NCT03335371|62952815|FG002|Overall Study|Randomization Error|1|||
33559195|NCT03335371|62952816|FG003|Overall Study|Randomization Error|0|||
33559196|NCT03335371|62952817|FG004|Overall Study|Randomization Error|0|||
33559197|NCT03301051|62952845|FG000|Overall Study|Adverse Event|0|||
33559198|NCT03301051|62952846|FG001|Overall Study|Adverse Event|4|||
33559199|NCT03301051|62952845|FG000|Overall Study|Withdrawal by Subject|59|||
33559200|NCT03301051|62952846|FG001|Overall Study|Withdrawal by Subject|65|||
33559201|NCT03301051|62952845|FG000|Overall Study|Lost to Follow-up|263|||
33559202|NCT03301051|62952846|FG001|Overall Study|Lost to Follow-up|282|||
33559203|NCT03301051|62952845|FG000|Overall Study|Protocol Violation|1|||
33559204|NCT03301051|62952846|FG001|Overall Study|Protocol Violation|3|||
33559205|NCT03301051|62952845|FG000|Overall Study|Physician Decision|1|||
33559206|NCT03301051|62952846|FG001|Overall Study|Physician Decision|3|||
33559207|NCT03301051|62952845|FG000|Overall Study|Death|1|||
33559208|NCT03301051|62952846|FG001|Overall Study|Death|1|||
33559209|NCT03301051|62952845|FG000|Overall Study|Miscellaneous|8|||
33559210|NCT03301051|62952846|FG001|Overall Study|Miscellaneous|4|||
33559211|NCT03301051|62952845|FG000|Overall Study|Randomized, not vaccinated|13|||
33559212|NCT03301051|62952846|FG001|Overall Study|Randomized, not vaccinated|10|||
33559213|NCT01662986|62952854|FG000|Overall Study|Adverse Event|5|||
33559214|NCT01662986|62952855|FG001|Overall Study|Adverse Event|4|||
33559215|NCT01662986|62952854|FG000|Overall Study|Protocol Violation|2|||
33559216|NCT01662986|62952855|FG001|Overall Study|Protocol Violation|3|||
33559217|NCT01662986|62952854|FG000|Overall Study|Lost to Follow-up|5|||
33559218|NCT01662986|62952855|FG001|Overall Study|Lost to Follow-up|4|||
33559219|NCT01662986|62952854|FG000|Overall Study|Withdrawal by Subject|2|||
33559220|NCT01662986|62952855|FG001|Overall Study|Withdrawal by Subject|2|||
33559221|NCT01662986|62952854|FG000|Overall Study|Not Treated|1|||
33390717|NCT00608530|62769647|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
33390718|NCT00608530|62769648|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
33390719|NCT00608530|62769645|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
33390720|NCT00608530|62769646|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
33390721|NCT00608530|62769647|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
33390722|NCT00608530|62769648|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
33390723|NCT00642993|62769665|FG000|Overall Study|Adverse Event|85|||
33390724|NCT00642993|62769666|FG001|Overall Study|Adverse Event|4|||
33390725|NCT00642993|62769665|FG000|Overall Study|Lost to Follow-up|8|||
33390726|NCT00642993|62769666|FG001|Overall Study|Lost to Follow-up|4|||
33390727|NCT00642993|62769665|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
33390728|NCT00642993|62769666|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
33390729|NCT00642993|62769665|FG000|Overall Study|Protocol Violation|1|||
33390730|NCT00642993|62769666|FG001|Overall Study|Protocol Violation|4|||
33390731|NCT00642993|62769665|FG000|Overall Study|Did not meet protocol eligibility|0|||
33559222|NCT01662986|62952855|FG001|Overall Study|Not Treated|0|||
33559223|NCT01662986|62952854|FG000|Overall Study|Other than stated above|3|||
33559224|NCT01662986|62952855|FG001|Overall Study|Other than stated above|0|||
33559225|NCT01337167|62952863|FG000|Infant Series|Adverse Event|1|||
33559226|NCT01337167|62952864|FG001|Infant Series|Adverse Event|1|||
33559227|NCT01337167|62952863|FG000|Infant Series|Death|1|||
33390732|NCT00642993|62769666|FG001|Overall Study|Did not meet protocol eligibility|1|||
33390733|NCT00642993|62769665|FG000|Overall Study|Administrative|1|||
33559228|NCT01337167|62952864|FG001|Infant Series|Death|1|||
33559229|NCT01337167|62952863|FG000|Infant Series|Lost to Follow-up|13|||
33559230|NCT01337167|62952864|FG001|Infant Series|Lost to Follow-up|7|||
33559231|NCT01337167|62952863|FG000|Infant Series|Non-compliance with study drug|2|||
33559232|NCT01337167|62952864|FG001|Infant Series|Non-compliance with study drug|1|||
33559233|NCT01337167|62952863|FG000|Infant Series|Physician Decision|3|||
33559234|NCT01337167|62952864|FG001|Infant Series|Physician Decision|1|||
33559235|NCT01337167|62952863|FG000|Infant Series|Protocol Violation|22|||
33390734|NCT00642993|62769666|FG001|Overall Study|Administrative|0|||
33390735|NCT00696696|62769672|FG000|Overall Study|Adverse Event|5|||
33390736|NCT00696696|62769672|FG000|Overall Study|Withdrawal by Subject|8|||
33390737|NCT00696696|62769672|FG000|Overall Study|Physician Decision|2|||
33390738|NCT00696696|62769672|FG000|Overall Study|Death|3|||
33390739|NCT00699192|62769679|FG000|Overall Study|Missing|1|||
33390740|NCT00699192|62769680|FG001|Overall Study|Missing|1|||
33390741|NCT00699192|62769681|FG002|Overall Study|Missing|1|||
33390742|NCT00699192|62769679|FG000|Overall Study|Adverse Event|9|||
33390743|NCT00699192|62769680|FG001|Overall Study|Adverse Event|4|||
33390744|NCT00699192|62769681|FG002|Overall Study|Adverse Event|3|||
33390745|NCT00699192|62769679|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33390746|NCT00699192|62769680|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33390747|NCT00699192|62769681|FG002|Overall Study|Abnormal test procedure result(s)|1|||
33390748|NCT00699192|62769679|FG000|Overall Study|Lack of Efficacy|0|||
33390749|NCT00699192|62769680|FG001|Overall Study|Lack of Efficacy|0|||
33390750|NCT00699192|62769681|FG002|Overall Study|Lack of Efficacy|1|||
33390751|NCT00699192|62769679|FG000|Overall Study|Withdrawal by Subject|3|||
33390752|NCT00699192|62769680|FG001|Overall Study|Withdrawal by Subject|2|||
33390753|NCT00699192|62769681|FG002|Overall Study|Withdrawal by Subject|4|||
33390754|NCT00699192|62769679|FG000|Overall Study|Administrative problems|1|||
33390755|NCT00699192|62769680|FG001|Overall Study|Administrative problems|3|||
33390756|NCT00699192|62769681|FG002|Overall Study|Administrative problems|1|||
33390757|NCT00699192|62769679|FG000|Overall Study|Protocol Violation|2|||
33390758|NCT00699192|62769680|FG001|Overall Study|Protocol Violation|2|||
33390759|NCT00699192|62769681|FG002|Overall Study|Protocol Violation|0|||
33390760|NCT00401245|62769697|FG000|Double Blind Titration Phase|Adverse Event|3|||
33390761|NCT00401245|62769698|FG001|Double Blind Titration Phase|Adverse Event|2|||
33390762|NCT00401245|62769699|FG002|Double Blind Titration Phase|Adverse Event|5|||
33390763|NCT00401245|62769700|FG003|Double Blind Titration Phase|Adverse Event|12|||
33390764|NCT00401245|62769701|FG004|Double Blind Titration Phase|Adverse Event|0|||
33390765|NCT00401245|62769702|FG005|Double Blind Titration Phase|Adverse Event|0|||
33390766|NCT00401245|62769703|FG006|Double Blind Titration Phase|Adverse Event|0|||
33390767|NCT00401245|62769704|FG007|Double Blind Titration Phase|Adverse Event|0|||
33390768|NCT00401245|62769697|FG000|Double Blind Titration Phase|Other|0|||
33390769|NCT00401245|62769698|FG001|Double Blind Titration Phase|Other|0|||
33390770|NCT00401245|62769699|FG002|Double Blind Titration Phase|Other|1|||
33390771|NCT00401245|62769700|FG003|Double Blind Titration Phase|Other|0|||
33390772|NCT00401245|62769701|FG004|Double Blind Titration Phase|Other|0|||
33390773|NCT00401245|62769702|FG005|Double Blind Titration Phase|Other|0|||
33390774|NCT00401245|62769703|FG006|Double Blind Titration Phase|Other|0|||
33390775|NCT00401245|62769704|FG007|Double Blind Titration Phase|Other|0|||
33390776|NCT00401245|62769697|FG000|Double Blind Titration Phase|Protocol Violation|0|||
33390777|NCT00401245|62769698|FG001|Double Blind Titration Phase|Protocol Violation|0|||
33390778|NCT00401245|62769699|FG002|Double Blind Titration Phase|Protocol Violation|0|||
33390779|NCT00401245|62769700|FG003|Double Blind Titration Phase|Protocol Violation|1|||
33390780|NCT00401245|62769701|FG004|Double Blind Titration Phase|Protocol Violation|0|||
33390781|NCT00401245|62769702|FG005|Double Blind Titration Phase|Protocol Violation|0|||
33390782|NCT00401245|62769703|FG006|Double Blind Titration Phase|Protocol Violation|0|||
33390783|NCT00401245|62769704|FG007|Double Blind Titration Phase|Protocol Violation|0|||
33390784|NCT00401245|62769697|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
33390785|NCT00401245|62769698|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
33390786|NCT00401245|62769699|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
33390787|NCT00401245|62769700|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
33390788|NCT00401245|62769701|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
33390789|NCT00401245|62769702|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
33390790|NCT00401245|62769703|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
33390791|NCT00401245|62769704|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
33390792|NCT00401245|62769697|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
33390793|NCT00401245|62769698|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
33390794|NCT00401245|62769699|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
33390795|NCT00401245|62769700|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
33390796|NCT00401245|62769701|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
33390797|NCT00401245|62769702|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
33390798|NCT00401245|62769703|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
33390799|NCT00401245|62769704|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
33390800|NCT00401245|62769697|FG000|Open Label Phase|Adverse Event|5|||
33390801|NCT00401245|62769698|FG001|Open Label Phase|Adverse Event|14|||
33390802|NCT00401245|62769699|FG002|Open Label Phase|Adverse Event|6|||
33390803|NCT00401245|62769700|FG003|Open Label Phase|Adverse Event|7|||
33390804|NCT00401245|62769701|FG004|Open Label Phase|Adverse Event|0|||
33390805|NCT00401245|62769702|FG005|Open Label Phase|Adverse Event|0|||
33390806|NCT00401245|62769703|FG006|Open Label Phase|Adverse Event|0|||
33390807|NCT00401245|62769704|FG007|Open Label Phase|Adverse Event|0|||
33390808|NCT00401245|62769697|FG000|Open Label Phase|Lost to Follow-up|5|||
33390809|NCT00401245|62769698|FG001|Open Label Phase|Lost to Follow-up|7|||
33390810|NCT00401245|62769699|FG002|Open Label Phase|Lost to Follow-up|5|||
33390811|NCT00401245|62769700|FG003|Open Label Phase|Lost to Follow-up|4|||
33390812|NCT00401245|62769701|FG004|Open Label Phase|Lost to Follow-up|0|||
33390813|NCT00401245|62769702|FG005|Open Label Phase|Lost to Follow-up|0|||
33559236|NCT01337167|62952864|FG001|Infant Series|Protocol Violation|9|||
33559237|NCT01337167|62952863|FG000|Infant Series|Withdrawal by Subject|15|||
33559238|NCT01337167|62952864|FG001|Infant Series|Withdrawal by Subject|4|||
33559239|NCT01337167|62952863|FG000|Infant Series|Randomized but not vaccinated|5|||
33559240|NCT01337167|62952864|FG001|Infant Series|Randomized but not vaccinated|3|||
33559241|NCT01337167|62952863|FG000|Interim Period|Lost to Follow-up|51|||
33559242|NCT01337167|62952864|FG001|Interim Period|Lost to Follow-up|23|||
33559243|NCT01337167|62952863|FG000|Interim Period|Non-compliance with study drug|1|||
33390814|NCT00401245|62769703|FG006|Open Label Phase|Lost to Follow-up|0|||
33390815|NCT00401245|62769704|FG007|Open Label Phase|Lost to Follow-up|0|||
33390816|NCT00401245|62769697|FG000|Open Label Phase|Other|4|||
33559244|NCT01337167|62952864|FG001|Interim Period|Non-compliance with study drug|0|||
33559245|NCT01337167|62952863|FG000|Interim Period|Physician Decision|6|||
33559246|NCT01337167|62952864|FG001|Interim Period|Physician Decision|3|||
33662732|NCT01587703|63093230|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33390817|NCT00401245|62769698|FG001|Open Label Phase|Other|8|||
33390818|NCT00401245|62769699|FG002|Open Label Phase|Other|7|||
33390819|NCT00401245|62769700|FG003|Open Label Phase|Other|8|||
33390820|NCT00401245|62769701|FG004|Open Label Phase|Other|0|||
33559247|NCT01337167|62952863|FG000|Interim Period|Protocol Violation|5|||
33559248|NCT01337167|62952864|FG001|Interim Period|Protocol Violation|3|||
33559249|NCT01337167|62952863|FG000|Interim Period|Withdrawal by Subject|18|||
33559250|NCT01337167|62952864|FG001|Interim Period|Withdrawal by Subject|10|||
33559251|NCT01337167|62952863|FG000|Interim Period|Other protocol criterion not met|0|||
33559252|NCT01337167|62952864|FG001|Interim Period|Other protocol criterion not met|1|||
33559253|NCT01337167|62952863|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
33559254|NCT01337167|62952864|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
33559255|NCT01337167|62952863|FG000|Toddler Vaccinations|Protocol Violation|0|||
33559256|NCT01337167|62952864|FG001|Toddler Vaccinations|Protocol Violation|1|||
33559257|NCT01337167|62952863|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
33559258|NCT01337167|62952864|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
33559259|NCT01338025|62952872|FG000|Overall Study|Unexpected closure of study|10|||
33559260|NCT01338025|62952873|FG001|Overall Study|Unexpected closure of study|9|||
33559261|NCT01338025|62952872|FG000|Overall Study|Withdrawal by Subject|0|||
33559262|NCT01338025|62952873|FG001|Overall Study|Withdrawal by Subject|2|||
33559263|NCT01338025|62952872|FG000|Overall Study|Found ineligible after starting|1|||
33559264|NCT01338025|62952873|FG001|Overall Study|Found ineligible after starting|0|||
33559265|NCT02559206|62952917|FG000|Overall Study|Adverse Event|0|||
33559266|NCT02559206|62952918|FG001|Overall Study|Adverse Event|4|||
33559267|NCT02559206|62952919|FG002|Overall Study|Adverse Event|1|||
33559268|NCT02559206|62952920|FG003|Overall Study|Adverse Event|5|||
33559269|NCT02559206|62952921|FG004|Overall Study|Adverse Event|3|||
33559270|NCT02559206|62952922|FG005|Overall Study|Adverse Event|0|||
33559271|NCT02559206|62952923|FG006|Overall Study|Adverse Event|1|||
33559272|NCT02559206|62952924|FG007|Overall Study|Adverse Event|0|||
33559273|NCT02559206|62952917|FG000|Overall Study|Protocol Violation|1|||
33559274|NCT02559206|62952918|FG001|Overall Study|Protocol Violation|0|||
33559275|NCT02559206|62952919|FG002|Overall Study|Protocol Violation|1|||
33559276|NCT02559206|62952920|FG003|Overall Study|Protocol Violation|0|||
33662733|NCT01587703|63093231|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33390821|NCT00401245|62769702|FG005|Open Label Phase|Other|0|||
33390822|NCT00401245|62769703|FG006|Open Label Phase|Other|0|||
33390823|NCT00401245|62769704|FG007|Open Label Phase|Other|0|||
33390824|NCT00401245|62769697|FG000|Open Label Phase|Protocol Violation|0|||
33390825|NCT00401245|62769698|FG001|Open Label Phase|Protocol Violation|1|||
33390826|NCT00401245|62769699|FG002|Open Label Phase|Protocol Violation|0|||
33559277|NCT02559206|62952921|FG004|Overall Study|Protocol Violation|0|||
33559278|NCT02559206|62952922|FG005|Overall Study|Protocol Violation|2|||
33559279|NCT02559206|62952923|FG006|Overall Study|Protocol Violation|0|||
33559280|NCT02559206|62952924|FG007|Overall Study|Protocol Violation|0|||
33559281|NCT02559206|62952917|FG000|Overall Study|Withdrawal by Subject|3|||
33559282|NCT02559206|62952918|FG001|Overall Study|Withdrawal by Subject|3|||
33559283|NCT02559206|62952919|FG002|Overall Study|Withdrawal by Subject|1|||
33390827|NCT00401245|62769700|FG003|Open Label Phase|Protocol Violation|1|||
33390828|NCT00401245|62769701|FG004|Open Label Phase|Protocol Violation|0|||
33390829|NCT00401245|62769702|FG005|Open Label Phase|Protocol Violation|0|||
33559284|NCT02559206|62952920|FG003|Overall Study|Withdrawal by Subject|3|||
33390830|NCT00401245|62769703|FG006|Open Label Phase|Protocol Violation|0|||
33559285|NCT02559206|62952921|FG004|Overall Study|Withdrawal by Subject|5|||
33559286|NCT02559206|62952922|FG005|Overall Study|Withdrawal by Subject|4|||
33559287|NCT02559206|62952923|FG006|Overall Study|Withdrawal by Subject|1|||
33559288|NCT02559206|62952924|FG007|Overall Study|Withdrawal by Subject|2|||
33559289|NCT02559206|62952917|FG000|Overall Study|Lost to Follow-up|3|||
33559290|NCT02559206|62952918|FG001|Overall Study|Lost to Follow-up|5|||
33559291|NCT02559206|62952919|FG002|Overall Study|Lost to Follow-up|3|||
33559292|NCT02559206|62952920|FG003|Overall Study|Lost to Follow-up|3|||
33559293|NCT02559206|62952921|FG004|Overall Study|Lost to Follow-up|2|||
33559294|NCT02559206|62952922|FG005|Overall Study|Lost to Follow-up|5|||
33559295|NCT02559206|62952923|FG006|Overall Study|Lost to Follow-up|1|||
33559296|NCT02559206|62952924|FG007|Overall Study|Lost to Follow-up|4|||
33559297|NCT02559206|62952917|FG000|Overall Study|Lack of Efficacy|1|||
33559298|NCT02559206|62952918|FG001|Overall Study|Lack of Efficacy|0|||
33559299|NCT02559206|62952919|FG002|Overall Study|Lack of Efficacy|3|||
33559300|NCT02559206|62952920|FG003|Overall Study|Lack of Efficacy|2|||
33559301|NCT02559206|62952921|FG004|Overall Study|Lack of Efficacy|2|||
33559302|NCT02559206|62952922|FG005|Overall Study|Lack of Efficacy|3|||
33559303|NCT02559206|62952923|FG006|Overall Study|Lack of Efficacy|3|||
33559304|NCT02559206|62952924|FG007|Overall Study|Lack of Efficacy|3|||
33559305|NCT02559206|62952917|FG000|Overall Study|Other Not Specified|0|||
33559306|NCT02559206|62952918|FG001|Overall Study|Other Not Specified|0|||
33559307|NCT02559206|62952919|FG002|Overall Study|Other Not Specified|0|||
33559308|NCT02559206|62952920|FG003|Overall Study|Other Not Specified|1|||
33559309|NCT02559206|62952921|FG004|Overall Study|Other Not Specified|0|||
33559310|NCT02559206|62952922|FG005|Overall Study|Other Not Specified|0|||
33390831|NCT00401245|62769704|FG007|Open Label Phase|Protocol Violation|0|||
33390832|NCT00401245|62769697|FG000|Open Label Phase|Withdrawal by Subject|3|||
33390833|NCT00401245|62769698|FG001|Open Label Phase|Withdrawal by Subject|3|||
33390834|NCT00401245|62769699|FG002|Open Label Phase|Withdrawal by Subject|2|||
33390835|NCT00401245|62769700|FG003|Open Label Phase|Withdrawal by Subject|1|||
33390836|NCT00401245|62769701|FG004|Open Label Phase|Withdrawal by Subject|0|||
33559311|NCT02559206|62952923|FG006|Overall Study|Other Not Specified|0|||
33559312|NCT02559206|62952924|FG007|Overall Study|Other Not Specified|0|||
33559313|NCT02558894|62952944|FG000|Overall Study|Death; any cause, entire study duration|28|||
33559314|NCT02558894|62952945|FG001|Overall Study|Death; any cause, entire study duration|31|||
33559315|NCT02558894|62952944|FG000|Overall Study|Withdrawal by Subject|2|||
33559316|NCT02558894|62952945|FG001|Overall Study|Withdrawal by Subject|1|||
33559317|NCT02558894|62952944|FG000|Overall Study|Closure of Part A|2|||
33390837|NCT00401245|62769702|FG005|Open Label Phase|Withdrawal by Subject|0|||
33390838|NCT00401245|62769703|FG006|Open Label Phase|Withdrawal by Subject|0|||
33390839|NCT00401245|62769704|FG007|Open Label Phase|Withdrawal by Subject|0|||
33390840|NCT00401245|62769697|FG000|Open Label Phase|Lack of Efficacy|4|||
33390841|NCT00401245|62769698|FG001|Open Label Phase|Lack of Efficacy|2|||
33390842|NCT00401245|62769699|FG002|Open Label Phase|Lack of Efficacy|3|||
33390843|NCT00401245|62769700|FG003|Open Label Phase|Lack of Efficacy|0|||
33390844|NCT00401245|62769701|FG004|Open Label Phase|Lack of Efficacy|0|||
33390845|NCT00401245|62769702|FG005|Open Label Phase|Lack of Efficacy|0|||
33390846|NCT00401245|62769703|FG006|Open Label Phase|Lack of Efficacy|0|||
33390847|NCT00401245|62769704|FG007|Open Label Phase|Lack of Efficacy|0|||
33390848|NCT00401245|62769697|FG000|Double Blind Tapering Phase|Adverse Event|0|||
33390849|NCT00401245|62769698|FG001|Double Blind Tapering Phase|Adverse Event|0|||
33390850|NCT00401245|62769699|FG002|Double Blind Tapering Phase|Adverse Event|0|||
33390851|NCT00401245|62769700|FG003|Double Blind Tapering Phase|Adverse Event|0|||
33390852|NCT00401245|62769701|FG004|Double Blind Tapering Phase|Adverse Event|1|||
33390853|NCT00401245|62769702|FG005|Double Blind Tapering Phase|Adverse Event|1|||
33390854|NCT00401245|62769703|FG006|Double Blind Tapering Phase|Adverse Event|2|||
33390855|NCT00401245|62769704|FG007|Double Blind Tapering Phase|Adverse Event|4|||
33559318|NCT02558894|62952945|FG001|Overall Study|Closure of Part A|1|||
33559319|NCT02688387|62952955|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559320|NCT02688387|62952956|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559321|NCT02688387|62952957|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
33559322|NCT02688387|62952958|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559323|NCT02688387|62952959|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559324|NCT02688387|62952960|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559325|NCT02688387|62952961|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559326|NCT02688387|62952962|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559327|NCT02688387|62952963|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33390856|NCT00401245|62769697|FG000|Double Blind Tapering Phase|Investigator request|0|||
33390857|NCT00401245|62769698|FG001|Double Blind Tapering Phase|Investigator request|0|||
33390858|NCT00401245|62769699|FG002|Double Blind Tapering Phase|Investigator request|0|||
33559328|NCT02688387|62952964|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559329|NCT02688387|62952965|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33390859|NCT00401245|62769700|FG003|Double Blind Tapering Phase|Investigator request|0|||
33390860|NCT00401245|62769701|FG004|Double Blind Tapering Phase|Investigator request|0|||
33390861|NCT00401245|62769702|FG005|Double Blind Tapering Phase|Investigator request|0|||
33390862|NCT00401245|62769703|FG006|Double Blind Tapering Phase|Investigator request|0|||
33390863|NCT00401245|62769704|FG007|Double Blind Tapering Phase|Investigator request|1|||
33390864|NCT00401245|62769697|FG000|Double Blind Tapering Phase|Other|0|||
33390865|NCT00401245|62769698|FG001|Double Blind Tapering Phase|Other|0|||
33559330|NCT02688387|62952966|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559331|NCT02688387|62952967|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559332|NCT02688387|62952968|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559333|NCT02688387|62952969|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559334|NCT02688387|62952970|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559335|NCT02688387|62952971|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559336|NCT02688387|62952972|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559337|NCT02688387|62952973|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559338|NCT02688387|62952974|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559339|NCT02688387|62952975|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559340|NCT02688387|62952976|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33559341|NCT02688387|62952955|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559342|NCT02688387|62952956|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559343|NCT02688387|62952957|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559344|NCT02688387|62952958|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
33559345|NCT02688387|62952959|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559346|NCT02688387|62952960|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559347|NCT02688387|62952961|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559348|NCT02688387|62952962|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559349|NCT02688387|62952963|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559350|NCT02688387|62952964|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559351|NCT02688387|62952965|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559352|NCT02688387|62952966|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559353|NCT02688387|62952967|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559354|NCT02688387|62952968|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559355|NCT02688387|62952969|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559356|NCT02688387|62952970|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559357|NCT02688387|62952971|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559358|NCT02688387|62952972|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559359|NCT02688387|62952973|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559360|NCT02688387|62952974|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559361|NCT02688387|62952975|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559362|NCT02688387|62952976|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559363|NCT02688387|62952955|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559364|NCT02688387|62952956|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
33559365|NCT02688387|62952957|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559366|NCT02688387|62952958|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559367|NCT02688387|62952959|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559368|NCT02688387|62952960|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559369|NCT02688387|62952961|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559370|NCT02688387|62952962|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559371|NCT02688387|62952963|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559372|NCT02688387|62952964|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559373|NCT02688387|62952965|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559374|NCT02688387|62952966|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559375|NCT02688387|62952967|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559376|NCT02688387|62952968|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559377|NCT02688387|62952969|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559378|NCT02688387|62952970|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559379|NCT02688387|62952971|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559380|NCT02688387|62952972|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33299788|NCT01091974|62676100|FG003|Overall Study|Did not start intervention|1|||
33299789|NCT01091974|62676097|FG000|Overall Study|resumed sleep medication|0|||
33299790|NCT01091974|62676098|FG001|Overall Study|resumed sleep medication|0|||
33299791|NCT01091974|62676099|FG002|Overall Study|resumed sleep medication|1|||
33299792|NCT01091974|62676100|FG003|Overall Study|resumed sleep medication|2|||
33299793|NCT01091974|62676097|FG000|Overall Study|Withdrawal by Subject|1|||
33299794|NCT01091974|62676098|FG001|Overall Study|Withdrawal by Subject|3|||
33299795|NCT01091974|62676099|FG002|Overall Study|Withdrawal by Subject|2|||
33299796|NCT01091974|62676100|FG003|Overall Study|Withdrawal by Subject|2|||
33390866|NCT00401245|62769699|FG002|Double Blind Tapering Phase|Other|0|||
33299797|NCT01091974|62676097|FG000|Overall Study|side-effects|1|||
33299798|NCT01091974|62676098|FG001|Overall Study|side-effects|1|||
33559381|NCT02688387|62952973|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559382|NCT02688387|62952974|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559383|NCT02688387|62952975|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559384|NCT02688387|62952976|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33559385|NCT02688387|62952955|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559386|NCT02688387|62952956|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559387|NCT02688387|62952957|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
33559388|NCT02688387|62952958|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559389|NCT02688387|62952959|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
33559390|NCT02688387|62952960|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559391|NCT02688387|62952961|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559392|NCT02688387|62952962|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559393|NCT02688387|62952963|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559394|NCT02688387|62952964|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559395|NCT02688387|62952965|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559396|NCT02688387|62952966|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559397|NCT02688387|62952967|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559398|NCT02688387|62952968|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559399|NCT02688387|62952969|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559400|NCT02688387|62952970|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559401|NCT02688387|62952971|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559402|NCT02688387|62952972|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559403|NCT02688387|62952973|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559404|NCT02688387|62952974|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559405|NCT02688387|62952975|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559406|NCT02688387|62952976|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33559407|NCT02688387|62952955|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
33559408|NCT02688387|62952956|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559409|NCT02688387|62952957|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559410|NCT02688387|62952958|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559411|NCT02688387|62952959|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559412|NCT02688387|62952960|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559413|NCT02688387|62952961|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559414|NCT02688387|62952962|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559415|NCT02688387|62952963|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559416|NCT02688387|62952964|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559417|NCT02688387|62952965|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559418|NCT02688387|62952966|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559419|NCT02688387|62952967|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559420|NCT02688387|62952968|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559421|NCT02688387|62952969|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559422|NCT02688387|62952970|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559423|NCT02688387|62952971|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559424|NCT02688387|62952972|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559425|NCT02688387|62952973|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559426|NCT02688387|62952974|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559427|NCT02688387|62952975|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559428|NCT02688387|62952976|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33559429|NCT02688387|62952955|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559430|NCT02688387|62952956|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559431|NCT02688387|62952957|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559432|NCT02688387|62952958|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559433|NCT02688387|62952959|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559434|NCT02688387|62952960|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559435|NCT02688387|62952961|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559436|NCT02688387|62952962|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559437|NCT02688387|62952963|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559438|NCT02688387|62952964|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559439|NCT02688387|62952965|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
33559440|NCT02688387|62952966|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559441|NCT02688387|62952967|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559442|NCT02688387|62952968|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559443|NCT02688387|62952969|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559444|NCT02688387|62952970|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559445|NCT02688387|62952971|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559446|NCT02688387|62952972|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559447|NCT02688387|62952973|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559448|NCT02688387|62952974|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559449|NCT02688387|62952975|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559450|NCT02688387|62952976|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33559451|NCT02688387|62952955|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33390867|NCT00401245|62769700|FG003|Double Blind Tapering Phase|Other|0|||
33390868|NCT00401245|62769701|FG004|Double Blind Tapering Phase|Other|1|||
33390869|NCT00401245|62769702|FG005|Double Blind Tapering Phase|Other|0|||
33390870|NCT00401245|62769703|FG006|Double Blind Tapering Phase|Other|2|||
33390871|NCT00401245|62769704|FG007|Double Blind Tapering Phase|Other|2|||
33390872|NCT00401245|62769697|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
33390873|NCT00401245|62769698|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
33390874|NCT00401245|62769699|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
33390875|NCT00401245|62769700|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
33390876|NCT00401245|62769701|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
33390877|NCT00401245|62769702|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
33390878|NCT00401245|62769703|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
33390879|NCT00401245|62769704|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
33390880|NCT00401245|62769697|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
33390881|NCT00401245|62769698|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
33390882|NCT00401245|62769699|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
33559452|NCT02688387|62952956|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559453|NCT02688387|62952957|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559454|NCT02688387|62952958|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559455|NCT02688387|62952959|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559456|NCT02688387|62952960|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559457|NCT02688387|62952961|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559458|NCT02688387|62952962|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559459|NCT02688387|62952963|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559460|NCT02688387|62952964|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559461|NCT02688387|62952965|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559462|NCT02688387|62952966|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559463|NCT02688387|62952967|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559464|NCT02688387|62952968|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559465|NCT02688387|62952969|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
33559466|NCT02688387|62952970|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559467|NCT02688387|62952971|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559468|NCT02688387|62952972|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559469|NCT02688387|62952973|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559470|NCT02688387|62952974|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559471|NCT02688387|62952975|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559472|NCT02688387|62952976|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33559473|NCT02688387|62952955|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33662734|NCT01587703|63093232|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33299799|NCT01091974|62676099|FG002|Overall Study|side-effects|0|||
33299800|NCT01091974|62676100|FG003|Overall Study|side-effects|2|||
33299801|NCT01313117|62676110|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
33299802|NCT01313117|62676110|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
33299803|NCT01313039|62676115|FG000|Overall Study|Physician Decision|1|||
33299804|NCT01313039|62676115|FG000|Overall Study|Adverse Event|1|||
33299805|NCT01091662|62676121|FG000|Overall Study|Adverse Event|1|||
33299806|NCT01091662|62676122|FG001|Overall Study|Adverse Event|9|||
33299807|NCT01091662|62676121|FG000|Overall Study|Physician Decision|1|||
33299808|NCT01091662|62676122|FG001|Overall Study|Physician Decision|1|||
33299809|NCT01091662|62676121|FG000|Overall Study|Withdrawal by Subject|7|||
33299810|NCT01091662|62676122|FG001|Overall Study|Withdrawal by Subject|6|||
33299811|NCT01091662|62676121|FG000|Overall Study|met exit criteria|7|||
33299812|NCT01091662|62676122|FG001|Overall Study|met exit criteria|13|||
33299813|NCT01091662|62676121|FG000|Overall Study|met exclusion criteria|1|||
33299814|NCT01091662|62676122|FG001|Overall Study|met exclusion criteria|0|||
33299815|NCT01091662|62676121|FG000|Overall Study|Lost to Follow-up|0|||
33299816|NCT01091662|62676122|FG001|Overall Study|Lost to Follow-up|1|||
33390883|NCT00401245|62769700|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
33390884|NCT00401245|62769701|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
33390885|NCT00401245|62769702|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
33390886|NCT00401245|62769703|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
33299817|NCT01091662|62676121|FG000|Overall Study|Pregnancy|0|||
33299818|NCT01091662|62676122|FG001|Overall Study|Pregnancy|1|||
33559474|NCT02688387|62952956|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559475|NCT02688387|62952957|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559476|NCT02688387|62952958|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559477|NCT02688387|62952959|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559478|NCT02688387|62952960|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559479|NCT02688387|62952961|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559480|NCT02688387|62952962|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559481|NCT02688387|62952963|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559482|NCT02688387|62952964|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559483|NCT02688387|62952965|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559484|NCT02688387|62952966|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559485|NCT02688387|62952967|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559486|NCT02688387|62952968|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559487|NCT02688387|62952969|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559488|NCT02688387|62952970|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559489|NCT02688387|62952971|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559490|NCT02688387|62952972|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559491|NCT02688387|62952973|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559492|NCT02688387|62952974|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559493|NCT02688387|62952975|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
33559494|NCT02688387|62952976|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33559495|NCT02688387|62952955|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559496|NCT02688387|62952956|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559497|NCT02688387|62952957|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559498|NCT02688387|62952958|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559499|NCT02688387|62952959|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559500|NCT02688387|62952960|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559501|NCT02688387|62952961|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559502|NCT02688387|62952962|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559503|NCT02688387|62952963|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559504|NCT02688387|62952964|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559505|NCT02688387|62952965|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559506|NCT02688387|62952966|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559507|NCT02688387|62952967|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559508|NCT02688387|62952968|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559509|NCT02688387|62952969|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559510|NCT02688387|62952970|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559511|NCT02688387|62952971|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559512|NCT02688387|62952972|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559513|NCT02688387|62952973|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
33559514|NCT02688387|62952974|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559515|NCT02688387|62952975|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
33559516|NCT02688387|62952976|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33559517|NCT02688387|62952955|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559518|NCT02688387|62952956|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559519|NCT02688387|62952957|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559520|NCT02688387|62952958|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559521|NCT02688387|62952959|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559522|NCT02688387|62952960|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559523|NCT02688387|62952961|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559524|NCT02688387|62952962|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559525|NCT02688387|62952963|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559526|NCT02688387|62952964|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559527|NCT02688387|62952965|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559528|NCT02688387|62952966|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559529|NCT02688387|62952967|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559530|NCT02688387|62952968|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559531|NCT02688387|62952969|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559532|NCT02688387|62952970|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559533|NCT02688387|62952971|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33299819|NCT01091662|62676121|FG000|Overall Study|Protocol Violation|0|||
33299820|NCT01091662|62676122|FG001|Overall Study|Protocol Violation|2|||
33299821|NCT01091662|62676121|FG000|Overall Study|unable to swallow capsule|0|||
33299822|NCT01091662|62676122|FG001|Overall Study|unable to swallow capsule|1|||
33299823|NCT01312961|62676135|FG000|Overall Study|Adverse Event|3|||
33299824|NCT01312961|62676136|FG001|Overall Study|Adverse Event|3|||
33390887|NCT00401245|62769704|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
33299825|NCT01312961|62676135|FG000|Overall Study|Lack of Efficacy|11|||
33559534|NCT02688387|62952972|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559535|NCT02688387|62952973|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559536|NCT02688387|62952974|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
33559537|NCT02688387|62952975|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559538|NCT02688387|62952976|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33559539|NCT02476201|62953022|FG000|Overall Study|Unable to program MPP|9|||
33559540|NCT02476201|62953022|FG000|Overall Study|Study echo not performed|5|||
33559541|NCT02476201|62953022|FG000|Overall Study|Adverse Event|4|||
33559542|NCT02476201|62953022|FG000|Overall Study|Death|2|||
33559543|NCT02476201|62953022|FG000|Overall Study|Lost to Follow-up|2|||
33559544|NCT02476201|62953022|FG000|Overall Study|MPP programmed to OFF|2|||
33559545|NCT02476201|62953022|FG000|Overall Study|Withdrawal by Subject|1|||
33559546|NCT02476201|62953022|FG000|Overall Study|Unsuccessful implant|1|||
33559547|NCT02688153|62953029|FG000|Overall Study|Death|7|||
33559548|NCT02688153|62953030|FG001|Overall Study|Death|5|||
33559549|NCT02688153|62953029|FG000|Overall Study|Withdrawal by Subject|4|||
33559550|NCT02688153|62953030|FG001|Overall Study|Withdrawal by Subject|2|||
33559551|NCT02688153|62953029|FG000|Overall Study|Valve Explant|1|||
33559552|NCT02688153|62953030|FG001|Overall Study|Valve Explant|0|||
33559553|NCT02688153|62953029|FG000|Overall Study|Conversion to Commercial Valve|3|||
33559554|NCT02688153|62953030|FG001|Overall Study|Conversion to Commercial Valve|0|||
33559555|NCT02687919|62953039|FG000|Overall Study|Withdrawal by Subject|6|||
33559556|NCT02687919|62953040|FG001|Overall Study|Withdrawal by Subject|6|||
33559557|NCT02687919|62953039|FG000|Overall Study|Protocol Violation|2|||
33559558|NCT02687919|62953040|FG001|Overall Study|Protocol Violation|0|||
33559559|NCT02687451|62953052|FG000|Overall Study|Withdrawal by Subject|1|||
33559560|NCT02687451|62953053|FG001|Overall Study|Withdrawal by Subject|0|||
33559561|NCT02687451|62953054|FG002|Overall Study|Withdrawal by Subject|0|||
33559562|NCT02687451|62953055|FG003|Overall Study|Withdrawal by Subject|0|||
33559563|NCT02687451|62953056|FG004|Overall Study|Withdrawal by Subject|0|||
33559564|NCT02687451|62953057|FG005|Overall Study|Withdrawal by Subject|1|||
33559565|NCT02557646|62953073|FG000|Overall Study|Adverse Event|40|||
33559566|NCT02557646|62953073|FG000|Overall Study|Death|1|||
33559567|NCT02557646|62953073|FG000|Overall Study|Lack of Efficacy|186|||
33559568|NCT02557646|62953073|FG000|Overall Study|Withdrawal by Subject|18|||
33559569|NCT02557646|62953073|FG000|Overall Study|Lost to Follow-up|17|||
33559570|NCT02557646|62953073|FG000|Overall Study|Other|14|||
33559571|NCT02679573|62953079|FG000|Overall Study|Adverse Event|13|||
33559572|NCT02679573|62953080|FG001|Overall Study|Adverse Event|6|||
33559573|NCT02679573|62953079|FG000|Overall Study|Lack of Efficacy|12|||
33559574|NCT02679573|62953080|FG001|Overall Study|Lack of Efficacy|15|||
33559575|NCT02679573|62953079|FG000|Overall Study|Could not complete required study visits|6|||
33559576|NCT02679573|62953080|FG001|Overall Study|Could not complete required study visits|2|||
33559577|NCT02679573|62953079|FG000|Overall Study|Withdrawal by Subject|2|||
33299826|NCT01312961|62676136|FG001|Overall Study|Lack of Efficacy|1|||
33299827|NCT01312961|62676135|FG000|Overall Study|Poor compliance to protocol|1|||
33299828|NCT01312961|62676136|FG001|Overall Study|Poor compliance to protocol|0|||
33299829|NCT01312961|62676135|FG000|Overall Study|Other than specified above|2|||
33299830|NCT01312961|62676136|FG001|Overall Study|Other than specified above|3|||
33299831|NCT01311557|62676145|FG000|Overall Study|Serious adverse event|0|||
33299832|NCT01311557|62676146|FG001|Overall Study|Serious adverse event|1|||
33299833|NCT01311557|62676145|FG000|Overall Study|Protocol Violation|4|||
33299834|NCT01311557|62676146|FG001|Overall Study|Protocol Violation|2|||
33299835|NCT01311557|62676145|FG000|Overall Study|Lost to Follow-up|0|||
33299836|NCT01311557|62676146|FG001|Overall Study|Lost to Follow-up|1|||
33390888|NCT00696384|62769724|FG000|Open Label Phase|Adverse Event|27|||
33390889|NCT00696384|62769725|FG001|Open Label Phase|Adverse Event|0|||
33390890|NCT00696384|62769726|FG002|Open Label Phase|Adverse Event|0|||
33390891|NCT00696384|62769724|FG000|Open Label Phase|Protocol Violation|18|||
33390892|NCT00696384|62769725|FG001|Open Label Phase|Protocol Violation|0|||
33390893|NCT00696384|62769726|FG002|Open Label Phase|Protocol Violation|0|||
33390894|NCT00696384|62769724|FG000|Open Label Phase|Lost to Follow-up|24|||
33390895|NCT00696384|62769725|FG001|Open Label Phase|Lost to Follow-up|0|||
33390896|NCT00696384|62769726|FG002|Open Label Phase|Lost to Follow-up|0|||
33390897|NCT00696384|62769724|FG000|Open Label Phase|Withdrawal by Subject|37|||
33390898|NCT00696384|62769725|FG001|Open Label Phase|Withdrawal by Subject|0|||
33559578|NCT02679573|62953080|FG001|Overall Study|Withdrawal by Subject|9|||
33559579|NCT02679573|62953079|FG000|Overall Study|Death|2|||
33559580|NCT02679573|62953080|FG001|Overall Study|Death|0|||
33559581|NCT02679573|62953079|FG000|Overall Study|Physician Decision|2|||
33559582|NCT02679573|62953080|FG001|Overall Study|Physician Decision|4|||
33559583|NCT02679573|62953079|FG000|Overall Study|Lost to Follow-up|0|||
33559584|NCT02679573|62953080|FG001|Overall Study|Lost to Follow-up|3|||
33559585|NCT02685033|62953088|FG000|Overall Study|Withdrawal of Consent|0|||
33559586|NCT02685033|62953089|FG001|Overall Study|Withdrawal of Consent|1|||
33559587|NCT02685033|62953088|FG000|Overall Study|Lost to Follow-up|2|||
33559588|NCT02685033|62953089|FG001|Overall Study|Lost to Follow-up|1|||
33559589|NCT02685033|62953088|FG000|Overall Study|Adverse Event|1|||
33559590|NCT02685033|62953089|FG001|Overall Study|Adverse Event|0|||
33559591|NCT02684097|62953097|FG000|Overall Study|Lack of Efficacy|13|||
33559592|NCT02684097|62953098|FG001|Overall Study|Lack of Efficacy|6|||
33559593|NCT02555618|62953106|FG000|Overall Study|Sponsor's Circumstances|1|||
33559594|NCT02555618|62953107|FG001|Overall Study|Sponsor's Circumstances|0|||
33559595|NCT02557100|62953133|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
33559596|NCT02557100|62953134|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
33559597|NCT02557100|62953135|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
33559598|NCT02557100|62953133|FG000|Single Blind Treatment Period|Death|0|||
33559599|NCT02557100|62953134|FG001|Single Blind Treatment Period|Death|1|||
33559600|NCT02557100|62953135|FG002|Single Blind Treatment Period|Death|0|||
33559601|NCT02557100|62953133|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
33559602|NCT02557100|62953134|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
33559603|NCT02557100|62953135|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
33559604|NCT02557100|62953133|FG000|Single Blind Treatment Period|Adverse Event|0|||
33559605|NCT02557100|62953134|FG001|Single Blind Treatment Period|Adverse Event|1|||
33559606|NCT02557100|62953135|FG002|Single Blind Treatment Period|Adverse Event|0|||
33559607|NCT02557100|62953133|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
33559608|NCT02557100|62953134|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
33559609|NCT02557100|62953135|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
33559610|NCT02557100|62953133|FG000|Cumulative Abatacept Period|Other Reasons|0|||
33559611|NCT02557100|62953134|FG001|Cumulative Abatacept Period|Other Reasons|0|||
33559612|NCT02557100|62953135|FG002|Cumulative Abatacept Period|Other Reasons|1|||
33299837|NCT01311557|62676145|FG000|Overall Study|Withdrawal by Subject|1|||
33299838|NCT01311557|62676146|FG001|Overall Study|Withdrawal by Subject|2|||
33299839|NCT01310777|62676155|FG000|Overall Study|Adverse Event|23|||
33299840|NCT01310777|62676156|FG001|Overall Study|Adverse Event|1|||
33299841|NCT01310777|62676157|FG002|Overall Study|Adverse Event|15|||
33299842|NCT01310777|62676155|FG000|Overall Study|Lost to Follow-up|0|||
33299843|NCT01310777|62676156|FG001|Overall Study|Lost to Follow-up|4|||
33299844|NCT01310777|62676157|FG002|Overall Study|Lost to Follow-up|1|||
33299845|NCT01310777|62676155|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
33299846|NCT01310777|62676156|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
33299847|NCT01310777|62676157|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
33299848|NCT01310777|62676155|FG000|Overall Study|Inadequate Control of IOP|5|||
33299849|NCT01310777|62676156|FG001|Overall Study|Inadequate Control of IOP|7|||
33299850|NCT01310777|62676157|FG002|Overall Study|Inadequate Control of IOP|10|||
33390899|NCT00696384|62769726|FG002|Open Label Phase|Withdrawal by Subject|0|||
33390900|NCT00696384|62769724|FG000|Open Label Phase|Other|6|||
33390901|NCT00696384|62769725|FG001|Open Label Phase|Other|0|||
33390902|NCT00696384|62769726|FG002|Open Label Phase|Other|0|||
33390903|NCT00696384|62769724|FG000|Open Label Phase|Lack of Efficacy|3|||
33390904|NCT00696384|62769725|FG001|Open Label Phase|Lack of Efficacy|0|||
33390905|NCT00696384|62769726|FG002|Open Label Phase|Lack of Efficacy|0|||
33390906|NCT00696384|62769724|FG000|Open Label Phase|Physician Decision|4|||
33390907|NCT00696384|62769725|FG001|Open Label Phase|Physician Decision|0|||
33390908|NCT00696384|62769726|FG002|Open Label Phase|Physician Decision|0|||
33390909|NCT00696384|62769724|FG000|Double Blind Phase|Adverse Event|0|||
33390910|NCT00696384|62769725|FG001|Double Blind Phase|Adverse Event|2|||
33390911|NCT00696384|62769726|FG002|Double Blind Phase|Adverse Event|2|||
33390912|NCT00696384|62769724|FG000|Double Blind Phase|Lost to Follow-up|0|||
33390913|NCT00696384|62769725|FG001|Double Blind Phase|Lost to Follow-up|2|||
33390914|NCT00696384|62769726|FG002|Double Blind Phase|Lost to Follow-up|1|||
33390915|NCT00696384|62769724|FG000|Double Blind Phase|Withdrawal by Subject|0|||
33390916|NCT00696384|62769725|FG001|Double Blind Phase|Withdrawal by Subject|4|||
33390917|NCT00696384|62769726|FG002|Double Blind Phase|Withdrawal by Subject|3|||
33390918|NCT00696384|62769724|FG000|Double Blind Phase|Lack of Efficacy|0|||
33390919|NCT00696384|62769725|FG001|Double Blind Phase|Lack of Efficacy|1|||
33390920|NCT00696384|62769726|FG002|Double Blind Phase|Lack of Efficacy|0|||
33390921|NCT00696384|62769724|FG000|Double Blind Phase|Physician Decision|0|||
33390922|NCT00696384|62769725|FG001|Double Blind Phase|Physician Decision|2|||
33390923|NCT00696384|62769726|FG002|Double Blind Phase|Physician Decision|0|||
33390924|NCT00636675|62769737|FG000|Overall Study|Lost to Follow-up|121|||
33390925|NCT00636675|62769738|FG001|Overall Study|Lost to Follow-up|31|||
33390926|NCT00636675|62769737|FG000|Overall Study|Withdrawal by Subject|19|||
33390927|NCT00636675|62769738|FG001|Overall Study|Withdrawal by Subject|10|||
33390928|NCT00699998|62769748|FG000|Overall Study|Withdrawal by Subject|194|||
33390929|NCT00699998|62769749|FG001|Overall Study|Withdrawal by Subject|83|||
33390930|NCT00699998|62769750|FG002|Overall Study|Withdrawal by Subject|202|||
33390931|NCT00699998|62769751|FG003|Overall Study|Withdrawal by Subject|80|||
33559613|NCT02557100|62953133|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
33559614|NCT02557100|62953134|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
33559615|NCT02557100|62953135|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
33559616|NCT02557100|62953133|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
33559617|NCT02557100|62953134|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
33559618|NCT02557100|62953135|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
33559619|NCT01337635|62953145|FG000|Overall Study|Lost to Follow-up|0|||
33559620|NCT01337635|62953146|FG001|Overall Study|Lost to Follow-up|1|||
33559621|NCT02556710|62953154|FG000|Overall Study|Surgical treatment|3|||
33559622|NCT02556710|62953155|FG001|Overall Study|Surgical treatment|0|||
33559623|NCT02556710|62953154|FG000|Overall Study|Required proscribed pain medication|2|||
33559624|NCT02556710|62953155|FG001|Overall Study|Required proscribed pain medication|1|||
33559625|NCT02556710|62953154|FG000|Overall Study|Lack of Efficacy|1|||
33559626|NCT02556710|62953155|FG001|Overall Study|Lack of Efficacy|0|||
33559627|NCT02556710|62953154|FG000|Overall Study|Worsening osteoarthritis|1|||
33559628|NCT02556710|62953155|FG001|Overall Study|Worsening osteoarthritis|0|||
33559629|NCT02556710|62953154|FG000|Overall Study|Moved out of state|1|||
33559630|NCT02556710|62953155|FG001|Overall Study|Moved out of state|0|||
33559631|NCT02556710|62953154|FG000|Overall Study|Missing reason|3|||
33559632|NCT02556710|62953155|FG001|Overall Study|Missing reason|1|||
33559633|NCT02556710|62953154|FG000|Overall Study|Pain as lack of efficacy|0|||
33559634|NCT02556710|62953155|FG001|Overall Study|Pain as lack of efficacy|4|||
33559635|NCT02556632|62953166|FG000|Overall Study|Lost to Follow-up|1|||
33559636|NCT02556632|62953167|FG001|Overall Study|Lost to Follow-up|0|||
33559637|NCT02556632|62953168|FG002|Overall Study|Lost to Follow-up|0|||
33559638|NCT02556632|62953166|FG000|Overall Study|Disliked Intervention|1|||
33559639|NCT02556632|62953167|FG001|Overall Study|Disliked Intervention|1|||
33559640|NCT02556632|62953168|FG002|Overall Study|Disliked Intervention|1|||
33559641|NCT02556632|62953166|FG000|Overall Study|No Reason|1|||
33559642|NCT02556632|62953167|FG001|Overall Study|No Reason|0|||
33559643|NCT02556632|62953168|FG002|Overall Study|No Reason|1|||
33559644|NCT02556632|62953166|FG000|Overall Study|Personal Issues|0|||
33559645|NCT02556632|62953167|FG001|Overall Study|Personal Issues|1|||
33559646|NCT02556632|62953168|FG002|Overall Study|Personal Issues|1|||
33559647|NCT02556632|62953166|FG000|Overall Study|Changed Mind|0|||
33559648|NCT02556632|62953167|FG001|Overall Study|Changed Mind|1|||
33559649|NCT02556632|62953168|FG002|Overall Study|Changed Mind|0|||
33559650|NCT02556632|62953166|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
33559651|NCT02556632|62953167|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
33559652|NCT02556632|62953168|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
33559653|NCT02556632|62953166|FG000|Overall Study|Unrelated Adverse Event|1|||
33559654|NCT02556632|62953167|FG001|Overall Study|Unrelated Adverse Event|0|||
33559655|NCT02556632|62953168|FG002|Overall Study|Unrelated Adverse Event|3|||
33559656|NCT02556632|62953166|FG000|Overall Study|Related Adverse Event|0|||
33559657|NCT02556632|62953167|FG001|Overall Study|Related Adverse Event|1|||
33559658|NCT02556632|62953168|FG002|Overall Study|Related Adverse Event|0|||
33559659|NCT02556632|62953166|FG000|Overall Study|Possibly Related Adverse Event|0|||
33559660|NCT02556632|62953167|FG001|Overall Study|Possibly Related Adverse Event|0|||
33559661|NCT02556632|62953168|FG002|Overall Study|Possibly Related Adverse Event|1|||
33559662|NCT02556632|62953166|FG000|Overall Study|Did Not Start RT|0|||
33299851|NCT01310777|62676155|FG000|Overall Study|Other|4|||
33299852|NCT01310777|62676156|FG001|Overall Study|Other|1|||
33559663|NCT02556632|62953167|FG001|Overall Study|Did Not Start RT|1|||
33299853|NCT01310777|62676157|FG002|Overall Study|Other|2|||
33299854|NCT01310699|62676167|FG000|Overall Study|Patients did not complete tandem.|4|||
33299855|NCT01310699|62676168|FG001|Overall Study|Patients did not complete tandem.|6|||
33299856|NCT01310075|62676178|FG000|Overall Study|Lost to Follow-up|1|||
33299857|NCT01310075|62676179|FG001|Overall Study|Lost to Follow-up|0|||
33559664|NCT02556632|62953168|FG002|Overall Study|Did Not Start RT|0|||
33559665|NCT02556632|62953166|FG000|Overall Study|Ineligible|0|||
33559666|NCT02556632|62953167|FG001|Overall Study|Ineligible|1|||
33299858|NCT01310075|62676178|FG000|Overall Study|Physician Decision|10|||
33299859|NCT01310075|62676179|FG001|Overall Study|Physician Decision|7|||
33559667|NCT02556632|62953168|FG002|Overall Study|Ineligible|0|||
33559668|NCT02556632|62953166|FG000|Overall Study|Disliked Study Procedures|0|||
33559669|NCT02556632|62953167|FG001|Overall Study|Disliked Study Procedures|0|||
33559670|NCT02556632|62953168|FG002|Overall Study|Disliked Study Procedures|1|||
33299860|NCT01310075|62676178|FG000|Overall Study|Protocol Violation|2|||
33299861|NCT01310075|62676179|FG001|Overall Study|Protocol Violation|2|||
33299862|NCT01310075|62676178|FG000|Overall Study|Withdrawal by Subject|1|||
33559671|NCT02556632|62953166|FG000|Overall Study|Treatment or Change Delay|0|||
33559672|NCT02556632|62953167|FG001|Overall Study|Treatment or Change Delay|0|||
33559673|NCT02556632|62953168|FG002|Overall Study|Treatment or Change Delay|1|||
33559674|NCT01662440|62953180|FG000|Overall Study|Adverse Event|1|||
33559675|NCT01662440|62953181|FG001|Overall Study|Adverse Event|0|||
33559676|NCT01662440|62953182|FG002|Overall Study|Adverse Event|0|||
33559677|NCT01662440|62953183|FG003|Overall Study|Adverse Event|1|||
33559678|NCT01662440|62953180|FG000|Overall Study|Death|0|||
33559679|NCT01662440|62953181|FG001|Overall Study|Death|1|||
33559680|NCT01662440|62953182|FG002|Overall Study|Death|0|||
33559681|NCT01662440|62953183|FG003|Overall Study|Death|0|||
33559682|NCT01662440|62953180|FG000|Overall Study|Lost to Follow-up|2|||
33559683|NCT01662440|62953181|FG001|Overall Study|Lost to Follow-up|2|||
33559684|NCT01662440|62953182|FG002|Overall Study|Lost to Follow-up|4|||
33559685|NCT01662440|62953183|FG003|Overall Study|Lost to Follow-up|1|||
33559686|NCT01662440|62953180|FG000|Overall Study|Subject moved to another country.|0|||
33559687|NCT01662440|62953181|FG001|Overall Study|Subject moved to another country.|1|||
33559688|NCT01662440|62953182|FG002|Overall Study|Subject moved to another country.|0|||
33559689|NCT01662440|62953183|FG003|Overall Study|Subject moved to another country.|0|||
33559690|NCT01662440|62953180|FG000|Overall Study|Protocol Violation|1|||
33559691|NCT01662440|62953181|FG001|Overall Study|Protocol Violation|0|||
33559692|NCT01662440|62953182|FG002|Overall Study|Protocol Violation|0|||
33559693|NCT01662440|62953183|FG003|Overall Study|Protocol Violation|0|||
33559694|NCT01662440|62953180|FG000|Overall Study|Withdrawal by Subject|5|||
33559695|NCT01662440|62953181|FG001|Overall Study|Withdrawal by Subject|2|||
33559696|NCT01662440|62953182|FG002|Overall Study|Withdrawal by Subject|2|||
33559697|NCT01662440|62953183|FG003|Overall Study|Withdrawal by Subject|2|||
33559698|NCT01662362|62953203|FG000|Overall Study|Lost to Follow-up|38|||
33559699|NCT02554682|62953218|FG000|Overall Study|Lost to Follow-up|11|||
33559700|NCT02554682|62953219|FG001|Overall Study|Lost to Follow-up|9|||
33559701|NCT02554682|62953220|FG002|Overall Study|Lost to Follow-up|4|||
33559702|NCT02554682|62953221|FG003|Overall Study|Lost to Follow-up|3|||
33559703|NCT02554682|62953222|FG004|Overall Study|Lost to Follow-up|2|||
33559704|NCT02554682|62953223|FG005|Overall Study|Lost to Follow-up|1|||
33559705|NCT02554682|62953224|FG006|Overall Study|Lost to Follow-up|6|||
33559706|NCT02554682|62953225|FG007|Overall Study|Lost to Follow-up|6|||
33559707|NCT02554682|62953226|FG008|Overall Study|Lost to Follow-up|2|||
33559708|NCT02554682|62953227|FG009|Overall Study|Lost to Follow-up|2|||
33559709|NCT02554682|62953218|FG000|Overall Study|Withdrawal by Subject|2|||
33559710|NCT02554682|62953219|FG001|Overall Study|Withdrawal by Subject|1|||
33559711|NCT02554682|62953220|FG002|Overall Study|Withdrawal by Subject|0|||
33559712|NCT02554682|62953221|FG003|Overall Study|Withdrawal by Subject|0|||
33559713|NCT02554682|62953222|FG004|Overall Study|Withdrawal by Subject|0|||
33559714|NCT02554682|62953223|FG005|Overall Study|Withdrawal by Subject|0|||
33559715|NCT02554682|62953224|FG006|Overall Study|Withdrawal by Subject|0|||
33559716|NCT02554682|62953225|FG007|Overall Study|Withdrawal by Subject|0|||
33559717|NCT02554682|62953226|FG008|Overall Study|Withdrawal by Subject|0|||
33559718|NCT02554682|62953227|FG009|Overall Study|Withdrawal by Subject|0|||
33559719|NCT02554682|62953218|FG000|Overall Study|Physician Decision|2|||
33559720|NCT02554682|62953219|FG001|Overall Study|Physician Decision|2|||
33559721|NCT02554682|62953220|FG002|Overall Study|Physician Decision|0|||
33559722|NCT02554682|62953221|FG003|Overall Study|Physician Decision|0|||
33559723|NCT02554682|62953222|FG004|Overall Study|Physician Decision|0|||
33559724|NCT02554682|62953223|FG005|Overall Study|Physician Decision|0|||
33559725|NCT02554682|62953224|FG006|Overall Study|Physician Decision|0|||
33559726|NCT02554682|62953225|FG007|Overall Study|Physician Decision|0|||
33559727|NCT02554682|62953226|FG008|Overall Study|Physician Decision|0|||
33559728|NCT02554682|62953227|FG009|Overall Study|Physician Decision|0|||
33559729|NCT00154063|62953263|FG000|Overall Study|Adverse Event|4|||
33559730|NCT00154063|62953264|FG001|Overall Study|Adverse Event|8|||
33559731|NCT00154063|62953263|FG000|Overall Study|Protocol Violation|1|||
33559732|NCT00154063|62953264|FG001|Overall Study|Protocol Violation|1|||
33559733|NCT00154063|62953263|FG000|Overall Study|Investigator or Sponsor Request|0|||
33559734|NCT00154063|62953264|FG001|Overall Study|Investigator or Sponsor Request|1|||
33559735|NCT00154063|62953263|FG000|Overall Study|Withdrawal by Subject|4|||
33559736|NCT00154063|62953264|FG001|Overall Study|Withdrawal by Subject|9|||
33559737|NCT00154063|62953263|FG000|Overall Study|Other|3|||
33559738|NCT00154063|62953264|FG001|Overall Study|Other|3|||
33559739|NCT02683941|62953276|FG000|Double-blind Phase|Adverse Event|0|||
33559740|NCT02683941|62953277|FG001|Double-blind Phase|Adverse Event|1|||
33559741|NCT02683941|62953276|FG000|Double-blind Phase|Withdrawal by Subject|4|||
33559742|NCT02683941|62953277|FG001|Double-blind Phase|Withdrawal by Subject|2|||
33559743|NCT02683941|62953276|FG000|Double-blind Phase|Lost to Follow-up|1|||
33559744|NCT02683941|62953277|FG001|Double-blind Phase|Lost to Follow-up|0|||
33559745|NCT02683941|62953276|FG000|Double-blind Phase|Disease Progression|5|||
33559746|NCT02683941|62953277|FG001|Double-blind Phase|Disease Progression|2|||
33559747|NCT02683941|62953276|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
33559748|NCT02683941|62953277|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
33559749|NCT02683941|62953276|FG000|Open-label Treatment Phase|Disease Progression|1|||
33559750|NCT02683941|62953277|FG001|Open-label Treatment Phase|Disease Progression|2|||
33559751|NCT02683941|62953276|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
33559752|NCT02683941|62953277|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
33559753|NCT02683941|62953276|FG000|Open-label Treatment Phase|Other|1|||
33559754|NCT02683941|62953277|FG001|Open-label Treatment Phase|Other|0|||
33559755|NCT02683941|62953276|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
33559756|NCT02683941|62953277|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
33559757|NCT02683941|62953276|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
33559758|NCT02683941|62953277|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
33559759|NCT02683941|62953276|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
33559760|NCT02683941|62953277|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
33559761|NCT02683941|62953276|FG000|Open-label Follow-up Phase|Other|8|||
33559762|NCT02683941|62953277|FG001|Open-label Follow-up Phase|Other|1|||
33559763|NCT02678247|62953289|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
33559764|NCT02678247|62953290|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
33559765|NCT02678247|62953289|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
33559766|NCT02678247|62953290|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
33559767|NCT02678247|62953289|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
33559768|NCT02678247|62953290|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
33559769|NCT02678247|62953289|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
33559770|NCT02678247|62953290|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
33559771|NCT02678247|62953289|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
33559772|NCT02678247|62953290|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
33559773|NCT02678247|62953289|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
33559774|NCT02678247|62953290|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
33299863|NCT01310075|62676179|FG001|Overall Study|Withdrawal by Subject|1|||
33559775|NCT02683785|62953303|FG000|Overall Study|Withdrawal by Subject|1|||
33559776|NCT02683785|62953304|FG001|Overall Study|Withdrawal by Subject|1|||
33559777|NCT02683785|62953303|FG000|Overall Study|Lost to Follow-up|0|||
33559778|NCT02683785|62953304|FG001|Overall Study|Lost to Follow-up|1|||
33559779|NCT02683785|62953303|FG000|Overall Study|Adverse Event|0|||
33559780|NCT02683785|62953304|FG001|Overall Study|Adverse Event|2|||
33559781|NCT02543294|62953312|FG000|Overall Study|Lost to Follow-up|3|||
33559782|NCT02543294|62953312|FG000|Overall Study|Physician Decision|2|||
33559783|NCT02543294|62953312|FG000|Overall Study|Withdrawal by Subject|7|||
33559784|NCT02728076|62953317|FG000|Overall Study|Physician Decision|4|||
33559785|NCT02551874|62953323|FG000|Overall Study|Lost to Follow-up|0|||
33559786|NCT02551874|62953324|FG001|Overall Study|Lost to Follow-up|2|||
33559787|NCT02551874|62953323|FG000|Overall Study|Pregnancy|0|||
33559788|NCT02551874|62953324|FG001|Overall Study|Pregnancy|1|||
33559789|NCT02551874|62953323|FG000|Overall Study|Reason not reported|10|||
33559790|NCT02551874|62953324|FG001|Overall Study|Reason not reported|4|||
33559791|NCT02551874|62953323|FG000|Overall Study|Did not receive randomized treatment|0|||
33559792|NCT02551874|62953324|FG001|Overall Study|Did not receive randomized treatment|7|||
33559793|NCT02551874|62953323|FG000|Overall Study|Did not enter long-term study|18|||
33559794|NCT02551874|62953324|FG001|Overall Study|Did not enter long-term study|25|||
33559795|NCT02550938|62953347|FG000|Overall Study|Lost to Follow-up|8|||
33559796|NCT02550938|62953348|FG001|Overall Study|Lost to Follow-up|7|||
33559797|NCT02550938|62953349|FG002|Overall Study|Lost to Follow-up|12|||
33559798|NCT02550938|62953350|FG003|Overall Study|Lost to Follow-up|11|||
33559799|NCT02769065|62953390|FG000|Overall Study|Voluntary Withdrawal|1|||
33559800|NCT02769065|62953391|FG001|Overall Study|Voluntary Withdrawal|0|||
33559801|NCT02769065|62953392|FG002|Overall Study|Voluntary Withdrawal|0|||
33559802|NCT02769065|62953393|FG003|Overall Study|Voluntary Withdrawal|0|||
33559803|NCT02769065|62953394|FG004|Overall Study|Voluntary Withdrawal|0|||
33559804|NCT02769065|62953395|FG005|Overall Study|Voluntary Withdrawal|0|||
33559805|NCT02769065|62953396|FG006|Overall Study|Voluntary Withdrawal|0|||
33559806|NCT02769065|62953397|FG007|Overall Study|Voluntary Withdrawal|0|||
33559807|NCT02769065|62953398|FG008|Overall Study|Voluntary Withdrawal|0|||
33299864|NCT01309997|62676187|FG000|Overall Study|Adverse Event|1|||
33299865|NCT01309997|62676188|FG001|Overall Study|Adverse Event|0|||
33299866|NCT01309997|62676187|FG000|Overall Study|Death|1|||
33559808|NCT02769065|62953399|FG009|Overall Study|Voluntary Withdrawal|0|||
33559809|NCT02769065|62953400|FG010|Overall Study|Voluntary Withdrawal|0|||
33559810|NCT02769065|62953401|FG011|Overall Study|Voluntary Withdrawal|0|||
33299867|NCT01309997|62676188|FG001|Overall Study|Death|3|||
33299868|NCT01309997|62676187|FG000|Overall Study|Lack of Efficacy|2|||
33299869|NCT01309997|62676188|FG001|Overall Study|Lack of Efficacy|2|||
33299870|NCT01309997|62676187|FG000|Overall Study|Withdrawal by Subject|1|||
33299871|NCT01309997|62676188|FG001|Overall Study|Withdrawal by Subject|1|||
33299872|NCT01309919|62676207|FG000|Overall Study|Did not receive a postpartum IUD|17|||
33299873|NCT01309919|62676208|FG001|Overall Study|Did not receive a postpartum IUD|48|||
33299874|NCT01309841|62676217|FG000|Overall Study|Other|0|||
33299875|NCT01309841|62676218|FG001|Overall Study|Other|1|||
33299876|NCT01309841|62676219|FG002|Overall Study|Other|1|||
33299877|NCT01309841|62676217|FG000|Overall Study|Lost to Follow-up|7|||
33299878|NCT01309841|62676218|FG001|Overall Study|Lost to Follow-up|6|||
33299879|NCT01309841|62676219|FG002|Overall Study|Lost to Follow-up|4|||
33390932|NCT00699998|62769748|FG000|Overall Study|Physician Decision|3|||
33559811|NCT02769065|62953402|FG012|Overall Study|Voluntary Withdrawal|0|||
33559812|NCT02769065|62953403|FG013|Overall Study|Voluntary Withdrawal|0|||
33559813|NCT02769065|62953404|FG014|Overall Study|Voluntary Withdrawal|0|||
33559814|NCT02769065|62953405|FG015|Overall Study|Voluntary Withdrawal|0|||
33299880|NCT01309841|62676217|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
33299881|NCT01309841|62676218|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
33299882|NCT01309841|62676219|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
33559815|NCT02769065|62953406|FG016|Overall Study|Voluntary Withdrawal|0|||
33559816|NCT02769065|62953407|FG017|Overall Study|Voluntary Withdrawal|0|||
33559817|NCT02769065|62953408|FG018|Overall Study|Voluntary Withdrawal|0|||
33559818|NCT02769065|62953409|FG019|Overall Study|Voluntary Withdrawal|0|||
33390933|NCT00699998|62769749|FG001|Overall Study|Physician Decision|2|||
33559819|NCT02769065|62953410|FG020|Overall Study|Voluntary Withdrawal|0|||
33559820|NCT02769065|62953411|FG021|Overall Study|Voluntary Withdrawal|0|||
33390934|NCT00699998|62769750|FG002|Overall Study|Physician Decision|1|||
33390935|NCT00699998|62769751|FG003|Overall Study|Physician Decision|1|||
33390936|NCT00699998|62769748|FG000|Overall Study|Lost to Follow-up|2|||
33390937|NCT00699998|62769749|FG001|Overall Study|Lost to Follow-up|1|||
33390938|NCT00699998|62769750|FG002|Overall Study|Lost to Follow-up|3|||
33390939|NCT00699998|62769751|FG003|Overall Study|Lost to Follow-up|1|||
33390940|NCT00696072|62769768|FG000|Overall Study|continuing active treatment|10|||
33390941|NCT00696072|62769769|FG001|Overall Study|continuing active treatment|13|||
33559821|NCT02769065|62953412|FG022|Overall Study|Voluntary Withdrawal|0|||
33559822|NCT02769065|62953413|FG023|Overall Study|Voluntary Withdrawal|0|||
33390942|NCT00696072|62769768|FG000|Overall Study|Adverse Event|10|||
33390943|NCT00696072|62769769|FG001|Overall Study|Adverse Event|6|||
33390944|NCT00696072|62769768|FG000|Overall Study|Patient Request|3|||
33390945|NCT00696072|62769769|FG001|Overall Study|Patient Request|7|||
33390946|NCT00696072|62769768|FG000|Overall Study|Investigator Request|1|||
33390947|NCT00696072|62769769|FG001|Overall Study|Investigator Request|4|||
33390948|NCT00696072|62769768|FG000|Overall Study|Sponsor Request|0|||
33559823|NCT02769065|62953414|FG024|Overall Study|Voluntary Withdrawal|0|||
33559824|NCT02769065|62953415|FG025|Overall Study|Voluntary Withdrawal|0|||
33559825|NCT02769065|62953416|FG026|Overall Study|Voluntary Withdrawal|0|||
33559826|NCT02769065|62953417|FG027|Overall Study|Voluntary Withdrawal|0|||
33559827|NCT02769065|62953418|FG028|Overall Study|Voluntary Withdrawal|0|||
33559828|NCT02769065|62953419|FG029|Overall Study|Voluntary Withdrawal|0|||
33559829|NCT02769065|62953390|FG000|Overall Study|Reason Not Specified|0|||
33559830|NCT02769065|62953391|FG001|Overall Study|Reason Not Specified|0|||
33559831|NCT02769065|62953392|FG002|Overall Study|Reason Not Specified|0|||
33559832|NCT02769065|62953393|FG003|Overall Study|Reason Not Specified|0|||
33559833|NCT02769065|62953394|FG004|Overall Study|Reason Not Specified|0|||
33559834|NCT02769065|62953395|FG005|Overall Study|Reason Not Specified|0|||
33559835|NCT02769065|62953396|FG006|Overall Study|Reason Not Specified|1|||
33559836|NCT02769065|62953397|FG007|Overall Study|Reason Not Specified|0|||
33559837|NCT02769065|62953398|FG008|Overall Study|Reason Not Specified|0|||
33559838|NCT02769065|62953399|FG009|Overall Study|Reason Not Specified|0|||
33559839|NCT02769065|62953400|FG010|Overall Study|Reason Not Specified|0|||
33559840|NCT02769065|62953401|FG011|Overall Study|Reason Not Specified|0|||
33559841|NCT02769065|62953402|FG012|Overall Study|Reason Not Specified|0|||
33559842|NCT02769065|62953403|FG013|Overall Study|Reason Not Specified|0|||
33559843|NCT02769065|62953404|FG014|Overall Study|Reason Not Specified|0|||
33559844|NCT02769065|62953405|FG015|Overall Study|Reason Not Specified|0|||
33559845|NCT02769065|62953406|FG016|Overall Study|Reason Not Specified|0|||
33559846|NCT02769065|62953407|FG017|Overall Study|Reason Not Specified|0|||
33559847|NCT02769065|62953408|FG018|Overall Study|Reason Not Specified|0|||
33559848|NCT02769065|62953409|FG019|Overall Study|Reason Not Specified|0|||
33559849|NCT02769065|62953410|FG020|Overall Study|Reason Not Specified|0|||
33559850|NCT02769065|62953411|FG021|Overall Study|Reason Not Specified|0|||
33559851|NCT02769065|62953412|FG022|Overall Study|Reason Not Specified|0|||
33559852|NCT02769065|62953413|FG023|Overall Study|Reason Not Specified|0|||
33559853|NCT02769065|62953414|FG024|Overall Study|Reason Not Specified|0|||
33559854|NCT02769065|62953415|FG025|Overall Study|Reason Not Specified|0|||
33559855|NCT02769065|62953416|FG026|Overall Study|Reason Not Specified|0|||
33299883|NCT01309841|62676217|FG000|Overall Study|Lack of Efficacy|0|||
33299884|NCT01309841|62676218|FG001|Overall Study|Lack of Efficacy|0|||
33299885|NCT01309841|62676219|FG002|Overall Study|Lack of Efficacy|2|||
33299886|NCT01309841|62676217|FG000|Overall Study|Adverse Event|9|||
33299887|NCT01309841|62676218|FG001|Overall Study|Adverse Event|22|||
33299888|NCT01309841|62676219|FG002|Overall Study|Adverse Event|11|||
33299889|NCT01309841|62676217|FG000|Overall Study|Death|1|||
33559856|NCT02769065|62953417|FG027|Overall Study|Reason Not Specified|0|||
33299890|NCT01309841|62676218|FG001|Overall Study|Death|0|||
33299891|NCT01309841|62676219|FG002|Overall Study|Death|0|||
33299892|NCT01309841|62676217|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
33299893|NCT01309841|62676218|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
33390949|NCT00696072|62769769|FG001|Overall Study|Sponsor Request|1|||
33390950|NCT00696072|62769768|FG000|Overall Study|Disease Progression|32|||
33390951|NCT00696072|62769769|FG001|Overall Study|Disease Progression|30|||
33390952|NCT00696072|62769768|FG000|Overall Study|Non-specified|1|||
33559857|NCT02769065|62953418|FG028|Overall Study|Reason Not Specified|0|||
33559858|NCT02769065|62953419|FG029|Overall Study|Reason Not Specified|0|||
33299894|NCT01309841|62676219|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
33299895|NCT01309841|62676217|FG000|Overall Study|Withdrawal by Subject|17|||
33390953|NCT00696072|62769769|FG001|Overall Study|Non-specified|2|||
33559859|NCT02769065|62953390|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559860|NCT02769065|62953391|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559861|NCT02769065|62953392|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559862|NCT02769065|62953393|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
33390954|NCT00634647|62769776|FG000|Overall Study|death on study|3|||
33390955|NCT00634647|62769776|FG000|Overall Study|refused further treatment|3|||
33390956|NCT00634647|62769776|FG000|Overall Study|declined to participate before treatment|1|||
33390957|NCT00576732|62769783|FG000|DOUBLE BLIND|Adverse Event|0|||
33390958|NCT00576732|62769784|FG001|DOUBLE BLIND|Adverse Event|0|||
33390959|NCT00576732|62769785|FG002|DOUBLE BLIND|Adverse Event|1|||
33390960|NCT00576732|62769786|FG003|DOUBLE BLIND|Adverse Event|0|||
33390961|NCT00576732|62769787|FG004|DOUBLE BLIND|Adverse Event|0|||
33390962|NCT00576732|62769788|FG005|DOUBLE BLIND|Adverse Event|0|||
33390963|NCT00576732|62769783|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
33390964|NCT00576732|62769784|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
33390965|NCT00576732|62769785|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
33390966|NCT00576732|62769786|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
33390967|NCT00576732|62769787|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
33390968|NCT00576732|62769788|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
33390969|NCT00576732|62769783|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
33390970|NCT00576732|62769784|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
33390971|NCT00576732|62769785|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
33390972|NCT00576732|62769786|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
33559863|NCT02769065|62953394|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559864|NCT02769065|62953395|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559865|NCT02769065|62953396|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559866|NCT02769065|62953397|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559867|NCT02769065|62953398|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559868|NCT02769065|62953399|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559869|NCT02769065|62953400|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
33559870|NCT02769065|62953401|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559871|NCT02769065|62953402|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559872|NCT02769065|62953403|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559873|NCT02769065|62953404|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559874|NCT02769065|62953405|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
33299896|NCT01309841|62676218|FG001|Overall Study|Withdrawal by Subject|6|||
33299897|NCT01309841|62676219|FG002|Overall Study|Withdrawal by Subject|13|||
33299898|NCT01309841|62676217|FG000|Overall Study|Did Not Receive Treatment|2|||
33299899|NCT01309841|62676218|FG001|Overall Study|Did Not Receive Treatment|0|||
33299900|NCT01309841|62676219|FG002|Overall Study|Did Not Receive Treatment|1|||
33299901|NCT01309841|62676217|FG000|Overall Study|Severe non-compliance with protocol|0|||
33299902|NCT01309841|62676218|FG001|Overall Study|Severe non-compliance with protocol|5|||
33299903|NCT01309841|62676219|FG002|Overall Study|Severe non-compliance with protocol|2|||
33299904|NCT01308749|62676229|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
33299905|NCT01308749|62676230|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
33299906|NCT01308749|62676229|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
33299907|NCT01308749|62676230|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
33299908|NCT01308749|62676229|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
33299909|NCT01308749|62676230|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
33299910|NCT01307891|62676252|FG000|Overall Study|Progressive Disease|3|||
33299911|NCT01307891|62676253|FG001|Overall Study|Progressive Disease|1|||
33299912|NCT01307579|62676261|FG000|Overall Study|Death|3|||
33299913|NCT01307579|62676262|FG001|Overall Study|Death|6|||
33299914|NCT01307579|62676261|FG000|Overall Study|Physician Decision|26|||
33299915|NCT01307579|62676262|FG001|Overall Study|Physician Decision|29|||
33299916|NCT01307579|62676261|FG000|Overall Study|Withdrawal by Subject|7|||
33299917|NCT01307579|62676262|FG001|Overall Study|Withdrawal by Subject|3|||
33299918|NCT01307579|62676261|FG000|Overall Study|Institutional diagnosis of IFD|21|||
33299919|NCT01307579|62676262|FG001|Overall Study|Institutional diagnosis of IFD|36|||
33299920|NCT01307579|62676261|FG000|Overall Study|Begin conditioning for HSCT|42|||
33299921|NCT01307579|62676262|FG001|Overall Study|Begin conditioning for HSCT|44|||
33299922|NCT01307579|62676261|FG000|Overall Study|Refractory or relapsed AML|38|||
33299923|NCT01307579|62676262|FG001|Overall Study|Refractory or relapsed AML|23|||
33299924|NCT01307579|62676261|FG000|Overall Study|Ineligible|3|||
33299925|NCT01307579|62676262|FG001|Overall Study|Ineligible|4|||
33299926|NCT01057693|62676268|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
33390973|NCT00576732|62769787|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
33390974|NCT00576732|62769788|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
33299927|NCT01057693|62676269|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
33299928|NCT01057693|62676270|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
33299929|NCT01057693|62676268|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
33390975|NCT00576732|62769783|FG000|DOUBLE BLIND|OTHER|0|||
33390976|NCT00576732|62769784|FG001|DOUBLE BLIND|OTHER|2|||
33390977|NCT00576732|62769785|FG002|DOUBLE BLIND|OTHER|1|||
33559875|NCT02769065|62953406|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
33390978|NCT00576732|62769786|FG003|DOUBLE BLIND|OTHER|0|||
33390979|NCT00576732|62769787|FG004|DOUBLE BLIND|OTHER|0|||
33559876|NCT02769065|62953407|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559877|NCT02769065|62953408|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559878|NCT02769065|62953409|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559879|NCT02769065|62953410|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559880|NCT02769065|62953411|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559881|NCT02769065|62953412|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559882|NCT02769065|62953413|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559883|NCT02769065|62953414|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559884|NCT02769065|62953415|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559885|NCT02769065|62953416|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559886|NCT02769065|62953417|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559887|NCT02769065|62953418|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559888|NCT02769065|62953419|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
33559889|NCT02681523|62953512|FG000|Overall Study|Adverse Event|1|||
33559890|NCT02681523|62953512|FG000|Overall Study|Patient Non-compliance|1|||
33559891|NCT02540954|62953518|FG000|Overall Study|Physician Decision|3|||
33559892|NCT02540954|62953519|FG001|Overall Study|Physician Decision|1|||
33559893|NCT02540954|62953518|FG000|Overall Study|Withdrawal by Subject|6|||
33559894|NCT02540954|62953519|FG001|Overall Study|Withdrawal by Subject|5|||
33559895|NCT02540954|62953518|FG000|Overall Study|Lost to Follow-up|1|||
33559896|NCT02540954|62953519|FG001|Overall Study|Lost to Follow-up|1|||
33559897|NCT02540954|62953518|FG000|Overall Study|Adverse Event|4|||
33559898|NCT02540954|62953519|FG001|Overall Study|Adverse Event|2|||
33559899|NCT02540954|62953518|FG000|Overall Study|Death|0|||
33559900|NCT02540954|62953519|FG001|Overall Study|Death|3|||
33559901|NCT02540954|62953518|FG000|Overall Study|Treatment failure|1|||
33559902|NCT02540954|62953519|FG001|Overall Study|Treatment failure|0|||
33559903|NCT02540954|62953518|FG000|Overall Study|Other reason|4|||
33559904|NCT02540954|62953519|FG001|Overall Study|Other reason|2|||
33390980|NCT00576732|62769788|FG005|DOUBLE BLIND|OTHER|0|||
33390981|NCT00576732|62769783|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
33390982|NCT00576732|62769784|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
33390983|NCT00576732|62769785|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
33390984|NCT00576732|62769786|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
33390985|NCT00576732|62769787|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
33390986|NCT00576732|62769788|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
33390987|NCT00576732|62769783|FG000|DOUBLE BLIND|Protocol Violation|1|||
33390988|NCT00576732|62769784|FG001|DOUBLE BLIND|Protocol Violation|0|||
33390989|NCT00576732|62769785|FG002|DOUBLE BLIND|Protocol Violation|0|||
33390990|NCT00576732|62769786|FG003|DOUBLE BLIND|Protocol Violation|0|||
33390991|NCT00576732|62769787|FG004|DOUBLE BLIND|Protocol Violation|0|||
33390992|NCT00576732|62769788|FG005|DOUBLE BLIND|Protocol Violation|0|||
33390993|NCT00576732|62769783|FG000|OPEN LABEL|Adverse Event|0|||
33390994|NCT00576732|62769784|FG001|OPEN LABEL|Adverse Event|0|||
33390995|NCT00576732|62769785|FG002|OPEN LABEL|Adverse Event|0|||
33390996|NCT00576732|62769786|FG003|OPEN LABEL|Adverse Event|4|||
33390997|NCT00576732|62769787|FG004|OPEN LABEL|Adverse Event|0|||
33390998|NCT00576732|62769788|FG005|OPEN LABEL|Adverse Event|1|||
33559905|NCT02658812|62953525|FG000|Overall Study|Disease Progression|7|||
33559906|NCT02658812|62953525|FG000|Overall Study|Unrelated to study treatment|1|||
33559907|NCT02658812|62953525|FG000|Overall Study|Adverse Event|1|||
33559908|NCT02680665|62953529|FG000|Overall Study|No visit after the first prescription|5|||
33559909|NCT00154375|62953535|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
33559910|NCT00154375|62953536|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
33559911|NCT00154375|62953535|FG000|Overall Study|Adverse Event|18|||
33559912|NCT00154375|62953536|FG001|Overall Study|Adverse Event|20|||
33559913|NCT00154375|62953535|FG000|Overall Study|Withdrawal by Subject|14|||
33559914|NCT00154375|62953536|FG001|Overall Study|Withdrawal by Subject|10|||
33559915|NCT00154375|62953535|FG000|Overall Study|Death|5|||
33559916|NCT00154375|62953536|FG001|Overall Study|Death|13|||
33559917|NCT00154375|62953535|FG000|Overall Study|Study drug no longer required|5|||
33559918|NCT00154375|62953536|FG001|Overall Study|Study drug no longer required|3|||
33559919|NCT00154375|62953535|FG000|Overall Study|Lost to Follow-up|2|||
33559920|NCT00154375|62953536|FG001|Overall Study|Lost to Follow-up|1|||
33559921|NCT00154375|62953535|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33559922|NCT00154375|62953536|FG001|Overall Study|Abnormal laboratory value(s)|2|||
33662735|NCT01587703|63093233|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33390999|NCT00576732|62769783|FG000|OPEN LABEL|Lost to Follow-up|0|||
33391000|NCT00576732|62769784|FG001|OPEN LABEL|Lost to Follow-up|0|||
33391001|NCT00576732|62769785|FG002|OPEN LABEL|Lost to Follow-up|0|||
33391002|NCT00576732|62769786|FG003|OPEN LABEL|Lost to Follow-up|2|||
33391003|NCT00576732|62769787|FG004|OPEN LABEL|Lost to Follow-up|1|||
33391004|NCT00576732|62769788|FG005|OPEN LABEL|Lost to Follow-up|1|||
33391005|NCT00576732|62769783|FG000|OPEN LABEL|Withdrawal by Subject|0|||
33391006|NCT00576732|62769784|FG001|OPEN LABEL|Withdrawal by Subject|0|||
33559923|NCT00154375|62953535|FG000|Overall Study|Protocol Violation|0|||
33559924|NCT00154375|62953536|FG001|Overall Study|Protocol Violation|1|||
33559925|NCT00154375|62953535|FG000|Overall Study|Suspected progression of disease|44|||
33559926|NCT00154375|62953536|FG001|Overall Study|Suspected progression of disease|30|||
33559927|NCT02765399|62953545|FG000|Overall Study|Nausea|1|||
33559928|NCT02765399|62953546|FG001|Overall Study|Nausea|0|||
33559929|NCT02676765|62953554|FG000|Overall Study|Lost to Follow-up|0|||
33391007|NCT00576732|62769785|FG002|OPEN LABEL|Withdrawal by Subject|0|||
33391008|NCT00576732|62769786|FG003|OPEN LABEL|Withdrawal by Subject|1|||
33391009|NCT00576732|62769787|FG004|OPEN LABEL|Withdrawal by Subject|0|||
33391010|NCT00576732|62769788|FG005|OPEN LABEL|Withdrawal by Subject|1|||
33391011|NCT00576732|62769783|FG000|OPEN LABEL|OTHER|0|||
33391012|NCT00576732|62769784|FG001|OPEN LABEL|OTHER|0|||
33391013|NCT00576732|62769785|FG002|OPEN LABEL|OTHER|0|||
33391014|NCT00576732|62769786|FG003|OPEN LABEL|OTHER|0|||
33559930|NCT02676765|62953555|FG001|Overall Study|Lost to Follow-up|1|||
33559931|NCT02680041|62953561|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
33559932|NCT02680041|62953561|FG000|Overall Study|Lost to Follow-up|2|||
33559933|NCT02547974|62953570|FG000|Overall Study|Withdrawal by Subject|1|||
33559934|NCT02547974|62953571|FG001|Overall Study|Withdrawal by Subject|0|||
33559935|NCT02547974|62953572|FG002|Overall Study|Withdrawal by Subject|0|||
33559936|NCT02547974|62953573|FG003|Overall Study|Withdrawal by Subject|0|||
33559937|NCT00154297|62953588|FG000|Overall Study|Death|5|||
33559938|NCT00154297|62953589|FG001|Overall Study|Death|2|||
33559939|NCT00154297|62953588|FG000|Overall Study|Withdrawal by Subject|0|||
33559940|NCT00154297|62953589|FG001|Overall Study|Withdrawal by Subject|5|||
33559941|NCT00154297|62953588|FG000|Overall Study|Lost to Follow-up|3|||
33559942|NCT00154297|62953589|FG001|Overall Study|Lost to Follow-up|0|||
33559943|NCT02679729|62953604|FG000|Overall Study|Lost to Follow-up|0|||
33559944|NCT02679729|62953605|FG001|Overall Study|Lost to Follow-up|1|||
33559945|NCT02679729|62953606|FG002|Overall Study|Lost to Follow-up|0|||
33559946|NCT02679729|62953607|FG003|Overall Study|Lost to Follow-up|0|||
33559947|NCT02679729|62953608|FG004|Overall Study|Lost to Follow-up|1|||
33559948|NCT02679729|62953609|FG005|Overall Study|Lost to Follow-up|0|||
33559949|NCT02679729|62953610|FG006|Overall Study|Lost to Follow-up|0|||
33559950|NCT02679729|62953611|FG007|Overall Study|Lost to Follow-up|0|||
33559951|NCT02679729|62953612|FG008|Overall Study|Lost to Follow-up|0|||
33559952|NCT02679729|62953604|FG000|Overall Study|Participant decision|0|||
33559953|NCT02679729|62953605|FG001|Overall Study|Participant decision|1|||
33559954|NCT02679729|62953606|FG002|Overall Study|Participant decision|0|||
33559955|NCT02679729|62953607|FG003|Overall Study|Participant decision|0|||
33559956|NCT02679729|62953608|FG004|Overall Study|Participant decision|0|||
33559957|NCT02679729|62953609|FG005|Overall Study|Participant decision|0|||
33559958|NCT02679729|62953610|FG006|Overall Study|Participant decision|1|||
33559959|NCT02679729|62953611|FG007|Overall Study|Participant decision|0|||
33559960|NCT02679729|62953612|FG008|Overall Study|Participant decision|0|||
33559961|NCT02765165|62953651|FG000|Treatment Period|Progressive disease|3|||
33559962|NCT02765165|62953652|FG001|Treatment Period|Progressive disease|2|||
33559963|NCT02765165|62953653|FG002|Treatment Period|Progressive disease|3|||
33559964|NCT02765165|62953654|FG003|Treatment Period|Progressive disease|3|||
33559965|NCT02765165|62953655|FG004|Treatment Period|Progressive disease|4|||
33559966|NCT02765165|62953656|FG005|Treatment Period|Progressive disease|2|||
33559967|NCT02765165|62953657|FG006|Treatment Period|Progressive disease|2|||
33559968|NCT02765165|62953651|FG000|Treatment Period|Physician Decision|0|||
33559969|NCT02765165|62953652|FG001|Treatment Period|Physician Decision|1|||
33559970|NCT02765165|62953653|FG002|Treatment Period|Physician Decision|0|||
33559971|NCT02765165|62953654|FG003|Treatment Period|Physician Decision|0|||
33559972|NCT02765165|62953655|FG004|Treatment Period|Physician Decision|0|||
33559973|NCT02765165|62953656|FG005|Treatment Period|Physician Decision|0|||
33559974|NCT02765165|62953657|FG006|Treatment Period|Physician Decision|0|||
33559975|NCT02765165|62953651|FG000|Treatment Period|Adverse Event|0|||
33559976|NCT02765165|62953652|FG001|Treatment Period|Adverse Event|1|||
33559977|NCT02765165|62953653|FG002|Treatment Period|Adverse Event|0|||
33559978|NCT02765165|62953654|FG003|Treatment Period|Adverse Event|0|||
33391015|NCT00576732|62769787|FG004|OPEN LABEL|OTHER|0|||
33559979|NCT02765165|62953655|FG004|Treatment Period|Adverse Event|0|||
33559980|NCT02765165|62953656|FG005|Treatment Period|Adverse Event|0|||
33559981|NCT02765165|62953657|FG006|Treatment Period|Adverse Event|0|||
33559982|NCT02765165|62953651|FG000|Treatment Period|Withdrawal by Subject|0|||
33559983|NCT02765165|62953652|FG001|Treatment Period|Withdrawal by Subject|0|||
33559984|NCT02765165|62953653|FG002|Treatment Period|Withdrawal by Subject|0|||
33559985|NCT02765165|62953654|FG003|Treatment Period|Withdrawal by Subject|0|||
33559986|NCT02765165|62953655|FG004|Treatment Period|Withdrawal by Subject|2|||
33391016|NCT00576732|62769788|FG005|OPEN LABEL|OTHER|2|||
33391017|NCT00576732|62769783|FG000|OPEN LABEL|Lack of Efficacy|0|||
33559987|NCT02765165|62953656|FG005|Treatment Period|Withdrawal by Subject|0|||
33559988|NCT02765165|62953657|FG006|Treatment Period|Withdrawal by Subject|0|||
33559989|NCT02765165|62953651|FG000|Treatment Period|Study terminated|0|||
33559990|NCT02765165|62953652|FG001|Treatment Period|Study terminated|0|||
33559991|NCT02765165|62953653|FG002|Treatment Period|Study terminated|0|||
33559992|NCT02765165|62953654|FG003|Treatment Period|Study terminated|0|||
33559993|NCT02765165|62953655|FG004|Treatment Period|Study terminated|0|||
33559994|NCT02765165|62953656|FG005|Treatment Period|Study terminated|1|||
33559995|NCT02765165|62953657|FG006|Treatment Period|Study terminated|2|||
33559996|NCT02765165|62953651|FG000|Post-treatment Follow-up|Death|1|||
33559997|NCT02765165|62953652|FG001|Post-treatment Follow-up|Death|2|||
33559998|NCT02765165|62953653|FG002|Post-treatment Follow-up|Death|1|||
33559999|NCT02765165|62953654|FG003|Post-treatment Follow-up|Death|1|||
33560000|NCT02765165|62953655|FG004|Post-treatment Follow-up|Death|1|||
33560001|NCT02765165|62953656|FG005|Post-treatment Follow-up|Death|1|||
33560002|NCT02765165|62953657|FG006|Post-treatment Follow-up|Death|0|||
33560003|NCT02765165|62953651|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
33391018|NCT00576732|62769784|FG001|OPEN LABEL|Lack of Efficacy|0|||
33391019|NCT00576732|62769785|FG002|OPEN LABEL|Lack of Efficacy|0|||
33391020|NCT00576732|62769786|FG003|OPEN LABEL|Lack of Efficacy|2|||
33391021|NCT00576732|62769787|FG004|OPEN LABEL|Lack of Efficacy|2|||
33391022|NCT00576732|62769788|FG005|OPEN LABEL|Lack of Efficacy|3|||
33391023|NCT00576732|62769783|FG000|OPEN LABEL|Protocol Violation|0|||
33391024|NCT00576732|62769784|FG001|OPEN LABEL|Protocol Violation|0|||
33391025|NCT00576732|62769785|FG002|OPEN LABEL|Protocol Violation|0|||
33391026|NCT00576732|62769786|FG003|OPEN LABEL|Protocol Violation|2|||
33560004|NCT02765165|62953652|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
33560005|NCT02765165|62953653|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
33560006|NCT02765165|62953654|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
33560007|NCT02765165|62953655|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
33560008|NCT02765165|62953656|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
33560009|NCT02765165|62953657|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
33662736|NCT01587703|63093234|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33299930|NCT01057693|62676269|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
33299931|NCT01057693|62676270|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
33299932|NCT01057693|62676268|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
33299933|NCT01057693|62676269|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
33299934|NCT01057693|62676270|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
33299935|NCT01057693|62676268|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
33299936|NCT01057693|62676269|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
33299937|NCT01057693|62676270|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
33299938|NCT01057693|62676268|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
33299939|NCT01057693|62676269|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
33299940|NCT01057693|62676270|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
33391027|NCT00576732|62769787|FG004|OPEN LABEL|Protocol Violation|1|||
33391028|NCT00576732|62769788|FG005|OPEN LABEL|Protocol Violation|0|||
33299941|NCT01057693|62676268|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
33299942|NCT01057693|62676269|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
33299943|NCT01057693|62676270|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
33299944|NCT01057693|62676268|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
33299945|NCT01057693|62676269|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
33299946|NCT01057693|62676270|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
33299947|NCT01057693|62676268|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
33299948|NCT01057693|62676269|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
33299949|NCT01057693|62676270|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
33299950|NCT01057693|62676268|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
33299951|NCT01057693|62676269|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
33299952|NCT01057693|62676270|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
33299953|NCT01057693|62676268|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
33299954|NCT01057693|62676269|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
33299955|NCT01057693|62676270|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
33560010|NCT02765165|62953651|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
33560011|NCT02765165|62953652|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
33560012|NCT02765165|62953653|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
33560013|NCT02765165|62953654|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
33560014|NCT02765165|62953655|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
33560015|NCT02765165|62953656|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
33560016|NCT02765165|62953657|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
33560017|NCT02765165|62953651|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
33662737|NCT01587703|63093235|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33662738|NCT01587703|63093236|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33391029|NCT00697788|62769800|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
33391030|NCT00697788|62769801|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
33560018|NCT02765165|62953652|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
33560019|NCT02765165|62953653|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
33560020|NCT02765165|62953654|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
33560021|NCT02765165|62953655|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
33560022|NCT02765165|62953656|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
33560023|NCT02765165|62953657|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
33560024|NCT02765165|62953651|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
33560025|NCT02765165|62953652|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
33560026|NCT02765165|62953653|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
33560027|NCT02765165|62953654|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
33560028|NCT02765165|62953655|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
33560029|NCT02765165|62953656|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
33560030|NCT02765165|62953657|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
33560031|NCT02765165|62953651|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
33560032|NCT02765165|62953652|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
33560033|NCT02765165|62953653|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
33560034|NCT02765165|62953654|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
33560035|NCT02765165|62953655|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
33560036|NCT02765165|62953656|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
33560037|NCT02765165|62953657|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
33560038|NCT02675907|62953679|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
33560039|NCT02675907|62953680|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
33560040|NCT02675907|62953679|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
33560041|NCT02675907|62953680|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
33560042|NCT02675907|62953679|FG000|Study Overall|Lack of Efficacy|1|||
33560043|NCT02675907|62953680|FG001|Study Overall|Lack of Efficacy|0|||
33560044|NCT02675907|62953679|FG000|Study Overall|Withdrawal by Subject|2|||
33560045|NCT02675907|62953680|FG001|Study Overall|Withdrawal by Subject|2|||
33560046|NCT02675907|62953679|FG000|Study Overall|Lost to Follow-up|0|||
33560047|NCT02675907|62953680|FG001|Study Overall|Lost to Follow-up|2|||
33560048|NCT02675517|62953686|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
33560049|NCT02675517|62953686|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
33560050|NCT02764775|62953690|FG000|Overall Study|Death|1|||
33560051|NCT02764775|62953690|FG000|Overall Study|Lost to Follow-up|2|||
33560052|NCT02764775|62953690|FG000|Overall Study|Withdrawal by Subject|3|||
33560053|NCT02774681|62953694|FG000|Treatment on Study|Progressive Disease|7|||
33662739|NCT01587703|63093237|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33662740|NCT01587703|63093238|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33299956|NCT01057693|62676268|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
33299957|NCT01057693|62676269|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
33299958|NCT01057693|62676270|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
33299959|NCT01057693|62676268|FG000|Between Single-Blind and Double-Blind|Other|6|||
33299960|NCT01057693|62676269|FG001|Between Single-Blind and Double-Blind|Other|0|||
33299961|NCT01057693|62676270|FG002|Between Single-Blind and Double-Blind|Other|0|||
33299962|NCT01057693|62676268|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
33299963|NCT01057693|62676269|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
33299964|NCT01057693|62676270|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
33299965|NCT01057693|62676268|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
33299966|NCT01057693|62676269|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
33299967|NCT01057693|62676270|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
33391031|NCT00697788|62769802|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
33560054|NCT02774681|62953694|FG000|Follow-Up for 3 Years|Death|11|||
33560055|NCT02774681|62953694|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
33560056|NCT02547428|62953700|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
33560057|NCT02547428|62953701|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
33560058|NCT02547428|62953700|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
33560059|NCT02547428|62953701|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
33560060|NCT02547428|62953700|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
33560061|NCT02547428|62953701|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
33560062|NCT02547428|62953700|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
33560063|NCT02547428|62953701|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
33560064|NCT02547428|62953700|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
33560065|NCT02547428|62953701|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
33560066|NCT02547428|62953700|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
33560067|NCT02547428|62953701|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
33560068|NCT02547428|62953700|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
33560069|NCT02547428|62953701|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
33662741|NCT01587703|63093239|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33391032|NCT00697788|62769803|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
33391033|NCT00697788|62769804|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
33391034|NCT00697788|62769805|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
33391035|NCT00697788|62769806|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
33391036|NCT00697788|62769807|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
33391037|NCT00697788|62769800|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
33391038|NCT00697788|62769801|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
33391039|NCT00697788|62769802|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
33391040|NCT00697788|62769803|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
33391041|NCT00697788|62769804|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
33391042|NCT00697788|62769805|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
33391043|NCT00697788|62769806|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
33391044|NCT00697788|62769807|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
33391045|NCT00400153|62769837|FG000|Overall Study|AE due to study disease worsening|14|||
33391046|NCT00400153|62769838|FG001|Overall Study|AE due to study disease worsening|19|||
33391047|NCT00400153|62769839|FG002|Overall Study|AE due to study disease worsening|20|||
33391048|NCT00400153|62769837|FG000|Overall Study|AE due to other disease worsening|2|||
33391049|NCT00400153|62769838|FG001|Overall Study|AE due to other disease worsening|1|||
33391050|NCT00400153|62769839|FG002|Overall Study|AE due to other disease worsening|0|||
33391051|NCT00400153|62769837|FG000|Overall Study|AE due to other condition|3|||
33391052|NCT00400153|62769838|FG001|Overall Study|AE due to other condition|14|||
33391053|NCT00400153|62769839|FG002|Overall Study|AE due to other condition|15|||
33391054|NCT00400153|62769837|FG000|Overall Study|Protocol Violation|7|||
33560070|NCT02547428|62953700|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
33560071|NCT02547428|62953701|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
33560072|NCT01374087|62953716|FG000|Overall Study|Adverse Event|1|||
33560073|NCT01374087|62953717|FG001|Overall Study|Adverse Event|0|||
33560074|NCT01374087|62953716|FG000|Overall Study|Disease progression|2|||
33560075|NCT01374087|62953717|FG001|Overall Study|Disease progression|2|||
33560076|NCT01374087|62953716|FG000|Overall Study|Study discontinued|13|||
33560077|NCT01374087|62953717|FG001|Overall Study|Study discontinued|13|||
33560078|NCT00152971|62953726|FG000|Overall Study|Adverse Event|12|||
33560079|NCT00152971|62953727|FG001|Overall Study|Adverse Event|10|||
33560080|NCT00152971|62953728|FG002|Overall Study|Adverse Event|9|||
33560081|NCT00152971|62953726|FG000|Overall Study|Protocol Violation|10|||
33560082|NCT00152971|62953727|FG001|Overall Study|Protocol Violation|11|||
33560083|NCT00152971|62953728|FG002|Overall Study|Protocol Violation|8|||
33560084|NCT00152971|62953726|FG000|Overall Study|Lost to Follow-up|17|||
33560085|NCT00152971|62953727|FG001|Overall Study|Lost to Follow-up|14|||
33560086|NCT00152971|62953728|FG002|Overall Study|Lost to Follow-up|13|||
33560087|NCT00152971|62953726|FG000|Overall Study|Withdrawal by Subject|9|||
33560088|NCT00152971|62953727|FG001|Overall Study|Withdrawal by Subject|8|||
33560089|NCT00152971|62953728|FG002|Overall Study|Withdrawal by Subject|14|||
33560090|NCT00152971|62953726|FG000|Overall Study|Other|3|||
33560091|NCT00152971|62953727|FG001|Overall Study|Other|5|||
33560092|NCT00152971|62953728|FG002|Overall Study|Other|5|||
33560093|NCT00152971|62953726|FG000|Treatment|Adverse Event|49|||
33560094|NCT00152971|62953727|FG001|Treatment|Adverse Event|40|||
33560095|NCT00152971|62953728|FG002|Treatment|Adverse Event|54|||
33560096|NCT00152971|62953726|FG000|Treatment|Protocol Violation|8|||
33560097|NCT00152971|62953727|FG001|Treatment|Protocol Violation|6|||
33560098|NCT00152971|62953728|FG002|Treatment|Protocol Violation|10|||
33560099|NCT00152971|62953726|FG000|Treatment|Lost to Follow-up|1|||
33560100|NCT00152971|62953727|FG001|Treatment|Lost to Follow-up|2|||
33560101|NCT00152971|62953728|FG002|Treatment|Lost to Follow-up|1|||
33560102|NCT00152971|62953726|FG000|Treatment|Withdrawal by Subject|4|||
33560103|NCT00152971|62953727|FG001|Treatment|Withdrawal by Subject|4|||
33560104|NCT00152971|62953728|FG002|Treatment|Withdrawal by Subject|5|||
33560105|NCT00152971|62953726|FG000|Treatment|Other|9|||
33560106|NCT00152971|62953727|FG001|Treatment|Other|11|||
33560107|NCT00152971|62953728|FG002|Treatment|Other|10|||
33560108|NCT02538614|62953736|FG000|Overall Study|Progressive Disease|2|||
33560109|NCT04620135|62953744|FG000|Study Completion|Adverse Event|2|||
33560110|NCT04620135|62953745|FG001|Study Completion|Adverse Event|3|||
33560111|NCT04620135|62953744|FG000|Study Completion|Withdrawal by Subject|2|||
33560112|NCT04620135|62953745|FG001|Study Completion|Withdrawal by Subject|0|||
33560113|NCT02552966|62953751|FG000|Overall Study|Lost to Follow-up|2|||
33560114|NCT02552966|62953751|FG000|Overall Study|Withdrawal by Subject|3|||
33391055|NCT00400153|62769838|FG001|Overall Study|Protocol Violation|4|||
33560115|NCT02552888|62953757|FG000|Overall Study|Lost to Follow-up|1|||
33560116|NCT02552888|62953758|FG001|Overall Study|Lost to Follow-up|1|||
33560117|NCT01373931|62953777|FG000|Lead-in Period|Adverse Event|2|||
33560118|NCT01373931|62953778|FG001|Lead-in Period|Adverse Event|0|||
33560119|NCT01373931|62953777|FG000|Period 1|Adverse Event|2|||
33560120|NCT01373931|62953778|FG001|Period 1|Adverse Event|0|||
33560121|NCT01373931|62953777|FG000|Period 1|Withdrawal by Subject|0|||
33560122|NCT01373931|62953778|FG001|Period 1|Withdrawal by Subject|2|||
33391056|NCT00400153|62769839|FG002|Overall Study|Protocol Violation|9|||
33391057|NCT00400153|62769837|FG000|Overall Study|Lost to Follow-up|2|||
33391058|NCT00400153|62769838|FG001|Overall Study|Lost to Follow-up|1|||
33391059|NCT00400153|62769839|FG002|Overall Study|Lost to Follow-up|4|||
33391060|NCT00400153|62769837|FG000|Overall Study|Withdrawal by Subject|12|||
33560123|NCT02552732|62953785|FG000|Overall Study|Lost to Follow-up|2|||
33560124|NCT02552732|62953785|FG000|Overall Study|Physician Decision|1|||
33560125|NCT02552732|62953785|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
33560126|NCT02552732|62953785|FG000|Overall Study|Withdrawal by Subject|6|||
33560127|NCT02547038|62953792|FG000|Overall Study|Lost to Follow-up|3|||
33560128|NCT02547038|62953793|FG001|Overall Study|Lost to Follow-up|2|||
33560129|NCT02764697|62953799|FG000|Overall Study|Lack of Efficacy|3|||
33560130|NCT02673489|62953805|FG000|Treatment Period|Lost to Follow-up|3|||
33560131|NCT02673489|62953806|FG001|Treatment Period|Lost to Follow-up|0|||
33560132|NCT02673489|62953805|FG000|Treatment Period|Participant request to discontinue|1|||
33560133|NCT02673489|62953806|FG001|Treatment Period|Participant request to discontinue|1|||
33560134|NCT02673489|62953805|FG000|Treatment Period|Participant moved to another province|1|||
33560135|NCT02673489|62953806|FG001|Treatment Period|Participant moved to another province|0|||
33560136|NCT02673489|62953805|FG000|Treatment Period|Participant was incarcerated|0|||
33560137|NCT02673489|62953806|FG001|Treatment Period|Participant was incarcerated|1|||
33560138|NCT02673489|62953805|FG000|Treatment Period|Adverse Event|0|||
33560139|NCT02673489|62953806|FG001|Treatment Period|Adverse Event|1|||
33560140|NCT02673489|62953805|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
33560141|NCT02673489|62953806|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
33560142|NCT02673489|62953805|FG000|Follow Up Period|Unable to return for follow-up|0|||
33560143|NCT02673489|62953806|FG001|Follow Up Period|Unable to return for follow-up|1|||
33560144|NCT02772809|62953813|FG000|Overall Study|not completed some tasks|6|||
33560145|NCT02537678|62953824|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
33560146|NCT02537678|62953825|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
33560147|NCT02537678|62953824|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
33560148|NCT02537678|62953825|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
33560149|NCT02537678|62953824|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
33560150|NCT02537678|62953825|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
33560151|NCT02537678|62953824|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
33560152|NCT02537678|62953825|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
33560153|NCT02537678|62953824|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
33560154|NCT02537678|62953825|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
33560155|NCT02537678|62953824|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
33560156|NCT02537678|62953825|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
33560157|NCT02537678|62953824|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
33560158|NCT02537678|62953825|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
33560159|NCT02766023|62953837|FG000|Overall Study|Lost to Follow-up|23|||
33662742|NCT01587703|63093240|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33662743|NCT01587703|63093241|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
33391061|NCT00400153|62769838|FG001|Overall Study|Withdrawal by Subject|11|||
33391062|NCT00400153|62769839|FG002|Overall Study|Withdrawal by Subject|10|||
33391063|NCT00400153|62769837|FG000|Overall Study|Other reasons - not mentioned above|8|||
33391064|NCT00400153|62769838|FG001|Overall Study|Other reasons - not mentioned above|5|||
33391065|NCT00400153|62769839|FG002|Overall Study|Other reasons - not mentioned above|3|||
33391066|NCT00631917|62769854|FG000|Overall Study|Adverse Event|34|||
33391067|NCT00631917|62769855|FG001|Overall Study|Adverse Event|45|||
33391068|NCT00631917|62769854|FG000|Overall Study|Abnormal laboratory value(s)|2|||
33560160|NCT02766023|62953838|FG001|Overall Study|Lost to Follow-up|11|||
33560161|NCT02766023|62953837|FG000|Overall Study|Pregnancy|1|||
33560162|NCT02766023|62953838|FG001|Overall Study|Pregnancy|0|||
33560163|NCT02766023|62953837|FG000|Overall Study|Adverse Event|1|||
33560164|NCT02766023|62953838|FG001|Overall Study|Adverse Event|0|||
33560165|NCT02766023|62953837|FG000|Overall Study|Withdrawal by Subject|4|||
33560166|NCT02766023|62953838|FG001|Overall Study|Withdrawal by Subject|5|||
33560167|NCT02766023|62953837|FG000|Overall Study|Physician Decision|1|||
33560168|NCT02766023|62953838|FG001|Overall Study|Physician Decision|0|||
33560169|NCT02766023|62953837|FG000|Overall Study|Not Eligible at Enrollment|0|||
33560170|NCT02766023|62953838|FG001|Overall Study|Not Eligible at Enrollment|1|||
33560171|NCT02764229|62953844|FG000|Overall Study|Withdrawal by Subject|15|||
33560172|NCT02764229|62953844|FG000|Overall Study|Adverse Event|9|||
33560173|NCT02764229|62953844|FG000|Overall Study|Physician Decision|5|||
33662744|NCT01587703|63093242|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33391069|NCT00631917|62769855|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33391070|NCT00631917|62769854|FG000|Overall Study|Abnormal test procedure result(s)|3|||
33391071|NCT00631917|62769855|FG001|Overall Study|Abnormal test procedure result(s)|2|||
33560174|NCT02764229|62953844|FG000|Overall Study|Lost to Follow-up|3|||
33560175|NCT02764229|62953844|FG000|Overall Study|Lack of Efficacy|1|||
33560176|NCT02764229|62953844|FG000|Overall Study|Study Stopped by Sponsor|69|||
33560177|NCT02537522|62953848|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
33560178|NCT02537522|62953849|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
33560179|NCT02537522|62953850|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
33560180|NCT02537522|62953851|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
33560181|NCT02537522|62953848|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
33560182|NCT02537522|62953849|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
33560183|NCT02537522|62953850|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
33560184|NCT02537522|62953851|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
33560185|NCT02537522|62953848|FG000|Phase I - Contralateral|incorrect randomization|0|||
33560186|NCT02537522|62953849|FG001|Phase I - Contralateral|incorrect randomization|1|||
33560187|NCT02537522|62953850|FG002|Phase I - Contralateral|incorrect randomization|0|||
33560188|NCT02537522|62953851|FG003|Phase I - Contralateral|incorrect randomization|0|||
33560189|NCT02537522|62953848|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
33560190|NCT02537522|62953849|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
33560191|NCT02537522|62953850|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
33560192|NCT02537522|62953851|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
33560193|NCT02537522|62953848|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
33560194|NCT02537522|62953849|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
33560195|NCT02537522|62953850|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
33560196|NCT02537522|62953851|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
33560197|NCT02536976|62953859|FG000|Overall Study|Physician Decision|0|||
33560198|NCT02536976|62953860|FG001|Overall Study|Physician Decision|1|||
33560199|NCT02672553|62953870|FG000|Overall Study|Death|3|||
33560200|NCT02672553|62953871|FG001|Overall Study|Death|5|||
33560201|NCT02672553|62953870|FG000|Overall Study|Valve Explant|1|||
33560202|NCT02672553|62953871|FG001|Overall Study|Valve Explant|0|||
33560203|NCT02672553|62953870|FG000|Overall Study|Conversion to Commercial Valve|3|||
33560204|NCT02672553|62953871|FG001|Overall Study|Conversion to Commercial Valve|0|||
33560205|NCT02672553|62953870|FG000|Overall Study|Withdrawal by Subject|3|||
33560206|NCT02672553|62953871|FG001|Overall Study|Withdrawal by Subject|3|||
33560207|NCT02672553|62953870|FG000|Overall Study|Intraoperative screen failure|2|||
33560208|NCT02672553|62953871|FG001|Overall Study|Intraoperative screen failure|0|||
33560209|NCT01373229|62953878|FG000|Overall Study|Death|3|||
33560210|NCT01373229|62953878|FG000|Overall Study|Physician Decision|3|||
33560211|NCT02671461|62953885|FG000|Treatment|Adverse Event|0|||
33560212|NCT02671461|62953886|FG001|Treatment|Adverse Event|0|||
33560213|NCT02671461|62953887|FG002|Treatment|Adverse Event|1|||
33560214|NCT02671461|62953885|FG000|Treatment|Administrative Reason by Sponsor|1|||
33560215|NCT02671461|62953886|FG001|Treatment|Administrative Reason by Sponsor|3|||
33560216|NCT02671461|62953887|FG002|Treatment|Administrative Reason by Sponsor|4|||
33560217|NCT02671461|62953885|FG000|Treatment|Randomized, not treated|1|||
33560218|NCT02671461|62953886|FG001|Treatment|Randomized, not treated|0|||
33560219|NCT02671461|62953887|FG002|Treatment|Randomized, not treated|0|||
33560220|NCT02671461|62953885|FG000|Follow-up|Withdrawal by Subject|1|||
33560221|NCT02671461|62953886|FG001|Follow-up|Withdrawal by Subject|0|||
33560222|NCT02671461|62953887|FG002|Follow-up|Withdrawal by Subject|0|||
33560223|NCT02671461|62953885|FG000|Follow-up|Lost to Follow-up|0|||
33560224|NCT02671461|62953886|FG001|Follow-up|Lost to Follow-up|0|||
33560225|NCT02671461|62953887|FG002|Follow-up|Lost to Follow-up|1|||
33560226|NCT02671461|62953885|FG000|Follow-up|Administrative Reason by Sponsor|0|||
33560227|NCT02671461|62953886|FG001|Follow-up|Administrative Reason by Sponsor|1|||
33560228|NCT02671461|62953887|FG002|Follow-up|Administrative Reason by Sponsor|0|||
33560229|NCT02535416|62953904|FG000|Overall Study|Family bereavement overseas|1|||
33560230|NCT02535416|62953905|FG001|Overall Study|Family bereavement overseas|0|||
33560231|NCT02535416|62953906|FG002|Overall Study|Family bereavement overseas|0|||
33560232|NCT02535416|62953907|FG003|Overall Study|Family bereavement overseas|0|||
33560233|NCT02535416|62953908|FG004|Overall Study|Family bereavement overseas|0|||
33560234|NCT02535416|62953909|FG005|Overall Study|Family bereavement overseas|0|||
33560235|NCT02535416|62953910|FG006|Overall Study|Family bereavement overseas|0|||
33560236|NCT02535416|62953911|FG007|Overall Study|Family bereavement overseas|0|||
33560237|NCT02535416|62953912|FG008|Overall Study|Family bereavement overseas|0|||
33560238|NCT02670915|62953962|FG000|Overall Study|Withdrawal by Subject|0|||
33560239|NCT02670915|62953963|FG001|Overall Study|Withdrawal by Subject|1|||
33560240|NCT02670915|62953964|FG002|Overall Study|Withdrawal by Subject|4|||
33560241|NCT02670915|62953962|FG000|Overall Study|Withdrawal by parent/guardian|4|||
33560242|NCT02670915|62953963|FG001|Overall Study|Withdrawal by parent/guardian|4|||
33560243|NCT02670915|62953964|FG002|Overall Study|Withdrawal by parent/guardian|1|||
33560244|NCT02670915|62953962|FG000|Overall Study|Unclassified|0|||
33560245|NCT02670915|62953963|FG001|Overall Study|Unclassified|3|||
33560246|NCT02670915|62953964|FG002|Overall Study|Unclassified|0|||
33560247|NCT02545868|62953975|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33|||
33560248|NCT02545868|62953976|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35|||
33391072|NCT00631917|62769854|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
33391073|NCT00631917|62769855|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
33391074|NCT00631917|62769854|FG000|Overall Study|No longer required study drug|0|||
33391075|NCT00631917|62769855|FG001|Overall Study|No longer required study drug|1|||
33391076|NCT00631917|62769854|FG000|Overall Study|Protocol deviation|6|||
33391077|NCT00631917|62769855|FG001|Overall Study|Protocol deviation|5|||
33391078|NCT00631917|62769854|FG000|Overall Study|Subject withdrew consent|25|||
33391079|NCT00631917|62769855|FG001|Overall Study|Subject withdrew consent|33|||
33391080|NCT00631917|62769854|FG000|Overall Study|Lost to Follow-up|7|||
33391081|NCT00631917|62769855|FG001|Overall Study|Lost to Follow-up|7|||
33560249|NCT02545868|62953977|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34|||
33560250|NCT02764151|62953994|FG000|Overall Study|Subject refused further follow-up|0|||
33560251|NCT02764151|62953995|FG001|Overall Study|Subject refused further follow-up|0|||
33560252|NCT02764151|62953996|FG002|Overall Study|Subject refused further follow-up|0|||
33560253|NCT02764151|62953997|FG003|Overall Study|Subject refused further follow-up|1|||
33560254|NCT02764151|62953994|FG000|Overall Study|Other|0|||
33560255|NCT02764151|62953995|FG001|Overall Study|Other|0|||
33560256|NCT02764151|62953996|FG002|Overall Study|Other|0|||
33560257|NCT02764151|62953997|FG003|Overall Study|Other|2|||
33560258|NCT02545322|62954007|FG000|Overall Study|Withdrawal by Subject|3|||
33560259|NCT02763215|62954011|FG000|Overall Study|Participants withdrew from study|3|||
33560260|NCT02763215|62954011|FG000|Overall Study|Missed visit|1|||
33560261|NCT02763215|62954011|FG000|Overall Study|Visit outside visit-window|1|||
33560262|NCT02763215|62954011|FG000|Overall Study|Death|1|||
33560263|NCT02763215|62954011|FG000|Overall Study|Lost to Follow-up|1|||
33560264|NCT02770547|62954030|FG000|Overall Study|Patient non-compliant|1|||
33560265|NCT02770547|62954031|FG001|Overall Study|Patient non-compliant|0|||
33560266|NCT02770547|62954030|FG000|Overall Study|Adverse Event|0|||
33560267|NCT02770547|62954031|FG001|Overall Study|Adverse Event|1|||
33560268|NCT01661972|62954039|FG000|Overall Study|Adverse Event|1|||
33560269|NCT01661972|62954040|FG001|Overall Study|Adverse Event|2|||
33560270|NCT01661972|62954039|FG000|Overall Study|Death during Treatment period|1|||
33560271|NCT01661972|62954040|FG001|Overall Study|Death during Treatment period|1|||
33560272|NCT01661972|62954039|FG000|Overall Study|Withdrawal by Subject|0|||
33560273|NCT01661972|62954040|FG001|Overall Study|Withdrawal by Subject|1|||
33560274|NCT00888355|62954052|FG000|Overall Study|Adverse Event|10|||
33560275|NCT00888355|62954053|FG001|Overall Study|Adverse Event|0|||
33560276|NCT00888355|62954054|FG002|Overall Study|Adverse Event|3|||
33560277|NCT00888355|62954055|FG003|Overall Study|Adverse Event|3|||
33560278|NCT00888355|62954052|FG000|Overall Study|Lack of Efficacy|9|||
33560279|NCT00888355|62954053|FG001|Overall Study|Lack of Efficacy|2|||
33560280|NCT00888355|62954054|FG002|Overall Study|Lack of Efficacy|5|||
33560281|NCT00888355|62954055|FG003|Overall Study|Lack of Efficacy|2|||
33560282|NCT00888355|62954052|FG000|Overall Study|Lost to Follow-up|0|||
33560283|NCT00888355|62954053|FG001|Overall Study|Lost to Follow-up|2|||
33560284|NCT00888355|62954054|FG002|Overall Study|Lost to Follow-up|2|||
33560285|NCT00888355|62954055|FG003|Overall Study|Lost to Follow-up|0|||
33560286|NCT00888355|62954052|FG000|Overall Study|Protocol Violation|3|||
33560287|NCT00888355|62954053|FG001|Overall Study|Protocol Violation|2|||
33560288|NCT00888355|62954054|FG002|Overall Study|Protocol Violation|1|||
33560289|NCT00888355|62954055|FG003|Overall Study|Protocol Violation|2|||
33560290|NCT00888355|62954052|FG000|Overall Study|Withdrawal by Subject|0|||
33560291|NCT00888355|62954053|FG001|Overall Study|Withdrawal by Subject|3|||
33299968|NCT01057693|62676268|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
33299969|NCT01057693|62676269|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
33299970|NCT01057693|62676270|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
33299971|NCT01057693|62676268|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
33299972|NCT01057693|62676269|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
33299973|NCT01057693|62676270|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
33299974|NCT01057693|62676268|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
33299975|NCT01057693|62676269|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
33299976|NCT01057693|62676270|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
33299977|NCT01057693|62676268|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
33299978|NCT01057693|62676269|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
33299979|NCT01057693|62676270|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
33299980|NCT01057693|62676268|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
33391082|NCT00631917|62769854|FG000|Overall Study|Administrative problems|2|||
33560292|NCT00888355|62954054|FG002|Overall Study|Withdrawal by Subject|1|||
33560293|NCT00888355|62954055|FG003|Overall Study|Withdrawal by Subject|3|||
33560294|NCT00794677|62954063|FG000|First Intervention|Withdrawal by Subject|2|||
33391083|NCT00631917|62769855|FG001|Overall Study|Administrative problems|0|||
33391084|NCT00631917|62769854|FG000|Overall Study|Death|1|||
33560295|NCT00794677|62954064|FG001|First Intervention|Withdrawal by Subject|0|||
33560296|NCT02770391|62954068|FG000|Overall Study|Lost to Follow-up|2|||
33560297|NCT02770391|62954068|FG000|Overall Study|Withdrawal by Subject|1|||
33560298|NCT02770391|62954068|FG000|Overall Study|Surgery delayed unevaluable|2|||
33560299|NCT02770391|62954068|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
33560300|NCT02536508|62954075|FG000|Overall Study|Withdrawal by Subject|18|||
33560301|NCT02536508|62954076|FG001|Overall Study|Withdrawal by Subject|13|||
33560302|NCT02536508|62954077|FG002|Overall Study|Withdrawal by Subject|7|||
33560303|NCT02536508|62954075|FG000|Overall Study|Adverse Event|14|||
33560304|NCT02536508|62954076|FG001|Overall Study|Adverse Event|13|||
33560305|NCT02536508|62954077|FG002|Overall Study|Adverse Event|6|||
33560306|NCT02536508|62954075|FG000|Overall Study|Lost to Follow-up|12|||
33560307|NCT02536508|62954076|FG001|Overall Study|Lost to Follow-up|4|||
33560308|NCT02536508|62954077|FG002|Overall Study|Lost to Follow-up|0|||
33560309|NCT02536508|62954075|FG000|Overall Study|Lack of Efficacy|3|||
33560310|NCT02536508|62954076|FG001|Overall Study|Lack of Efficacy|5|||
33560311|NCT02536508|62954077|FG002|Overall Study|Lack of Efficacy|4|||
33560312|NCT02536508|62954075|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
33560313|NCT02536508|62954076|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
33560314|NCT02536508|62954077|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
33560315|NCT02536508|62954075|FG000|Overall Study|Physician Decision|0|||
33560316|NCT02536508|62954076|FG001|Overall Study|Physician Decision|4|||
33560317|NCT02536508|62954077|FG002|Overall Study|Physician Decision|2|||
33560318|NCT02536508|62954075|FG000|Overall Study|Major Protocol Deviation|2|||
33560319|NCT02536508|62954076|FG001|Overall Study|Major Protocol Deviation|2|||
33560320|NCT02536508|62954077|FG002|Overall Study|Major Protocol Deviation|2|||
33560321|NCT02536508|62954075|FG000|Overall Study|Administrative Reasons|0|||
33560322|NCT02536508|62954076|FG001|Overall Study|Administrative Reasons|1|||
33560323|NCT02536508|62954077|FG002|Overall Study|Administrative Reasons|0|||
33560324|NCT00103259|62954094|FG000|Overall Study|Death|3|||
33560325|NCT00103259|62954095|FG001|Overall Study|Death|2|||
33560326|NCT00103259|62954094|FG000|Overall Study|Withdrawal by Subject|2|||
33299981|NCT01057693|62676269|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
33560327|NCT00103259|62954095|FG001|Overall Study|Withdrawal by Subject|3|||
33560328|NCT00103259|62954094|FG000|Overall Study|alternative therapy|1|||
33560329|NCT00103259|62954095|FG001|Overall Study|alternative therapy|0|||
33560330|NCT00103259|62954094|FG000|Overall Study|other (reasons were not specified)|2|||
33560331|NCT00103259|62954095|FG001|Overall Study|other (reasons were not specified)|1|||
33560332|NCT00103259|62954094|FG000|Overall Study|ineligible/no protocol therapy|4|||
33560333|NCT00103259|62954095|FG001|Overall Study|ineligible/no protocol therapy|6|||
33560334|NCT02544152|62954105|FG000|Overall Study|Adverse Event|0|||
33560335|NCT02544152|62954106|FG001|Overall Study|Adverse Event|4|||
33560336|NCT02544152|62954105|FG000|Overall Study|Withdrawal by Subject|0|||
33560337|NCT02544152|62954106|FG001|Overall Study|Withdrawal by Subject|3|||
33560338|NCT02544152|62954105|FG000|Overall Study|Other|1|||
33560339|NCT02544152|62954106|FG001|Overall Study|Other|0|||
33560340|NCT02534324|62954114|FG000|Overall Study|Protocol Violation|4|||
33560341|NCT02534324|62954115|FG001|Overall Study|Protocol Violation|1|||
33560342|NCT02534324|62954114|FG000|Overall Study|Lost to Follow-up|20|||
33560343|NCT02534324|62954115|FG001|Overall Study|Lost to Follow-up|7|||
33560344|NCT02534324|62954114|FG000|Overall Study|Adverse Event|1|||
33560345|NCT02534324|62954115|FG001|Overall Study|Adverse Event|0|||
33560346|NCT02761733|62954125|FG000|Overall Study|Death|3|||
33560347|NCT02761733|62954126|FG001|Overall Study|Death|5|||
33560348|NCT02761733|62954127|FG002|Overall Study|Death|1|||
33560349|NCT02761733|62954128|FG003|Overall Study|Death|1|||
33560350|NCT02761733|62954125|FG000|Overall Study|Lost to Follow-up|6|||
33560351|NCT02761733|62954126|FG001|Overall Study|Lost to Follow-up|7|||
33560352|NCT02761733|62954127|FG002|Overall Study|Lost to Follow-up|0|||
33560353|NCT02761733|62954128|FG003|Overall Study|Lost to Follow-up|3|||
33560354|NCT02761733|62954125|FG000|Overall Study|Physician Decision|4|||
33560355|NCT02761733|62954126|FG001|Overall Study|Physician Decision|0|||
33560356|NCT02761733|62954127|FG002|Overall Study|Physician Decision|0|||
33560357|NCT02761733|62954128|FG003|Overall Study|Physician Decision|0|||
33560358|NCT02761733|62954125|FG000|Overall Study|Withdrawal by Subject|2|||
33560359|NCT02761733|62954126|FG001|Overall Study|Withdrawal by Subject|0|||
33299982|NCT01057693|62676270|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
33560360|NCT02761733|62954127|FG002|Overall Study|Withdrawal by Subject|0|||
33560361|NCT02761733|62954128|FG003|Overall Study|Withdrawal by Subject|0|||
33560362|NCT02761733|62954125|FG000|Overall Study|Discharged from Study Site|10|||
33560363|NCT02761733|62954126|FG001|Overall Study|Discharged from Study Site|9|||
33560364|NCT02761733|62954127|FG002|Overall Study|Discharged from Study Site|25|||
33560365|NCT02761733|62954128|FG003|Overall Study|Discharged from Study Site|11|||
33560366|NCT02761733|62954125|FG000|Overall Study|Cognitive Impairment|5|||
33560367|NCT02761733|62954126|FG001|Overall Study|Cognitive Impairment|0|||
33560368|NCT02761733|62954127|FG002|Overall Study|Cognitive Impairment|1|||
33560369|NCT02761733|62954128|FG003|Overall Study|Cognitive Impairment|0|||
33560370|NCT03715465|62954140|FG000|Overall Study|Withdrawal by Subject|1|||
33560371|NCT03715465|62954141|FG001|Overall Study|Withdrawal by Subject|2|||
33560372|NCT00840073|62954149|FG000|Second Intervention|Missed 72 hour blood draw|1|||
33560373|NCT00840073|62954150|FG001|Second Intervention|Missed 72 hour blood draw|1|||
33560374|NCT00838279|62954156|FG000|Washout|Protocol Violation|1|||
33560375|NCT00838279|62954157|FG001|Washout|Protocol Violation|0|||
33560376|NCT00838279|62954156|FG000|Washout|Withdrawal by Subject|0|||
33560377|NCT00838279|62954157|FG001|Washout|Withdrawal by Subject|1|||
33560378|NCT02759939|62954165|FG000|Overall Study|Missing data on first outcome assessed|11|||
33560379|NCT02759939|62954166|FG001|Overall Study|Missing data on first outcome assessed|2|||
33560380|NCT02759939|62954167|FG002|Overall Study|Missing data on first outcome assessed|5|||
33560381|NCT02759939|62954168|FG003|Overall Study|Missing data on first outcome assessed|2|||
33560382|NCT02759939|62954165|FG000|Overall Study|Ineligible for T2 and T3|310|||
33560383|NCT02759939|62954166|FG001|Overall Study|Ineligible for T2 and T3|179|||
33560384|NCT02759939|62954167|FG002|Overall Study|Ineligible for T2 and T3|366|||
33560385|NCT02759939|62954168|FG003|Overall Study|Ineligible for T2 and T3|391|||
33560386|NCT02759939|62954165|FG000|Overall Study|Lost to Follow-up|735|||
33560387|NCT02759939|62954166|FG001|Overall Study|Lost to Follow-up|791|||
33560388|NCT02759939|62954167|FG002|Overall Study|Lost to Follow-up|783|||
33560389|NCT02759939|62954168|FG003|Overall Study|Lost to Follow-up|650|||
33560390|NCT00835705|62954187|FG000|First Intervention|Difficulty with vein|1|||
33560391|NCT00835705|62954188|FG001|First Intervention|Difficulty with vein|0|||
33560392|NCT00835705|62954187|FG000|Second Intervention|Difficulty with vein|1|||
33560393|NCT00835705|62954188|FG001|Second Intervention|Difficulty with vein|0|||
33560394|NCT02759471|62954192|FG000|Overall Study|discomfort|2|||
33560395|NCT00835549|62954200|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
33560396|NCT00835549|62954201|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
33560397|NCT03945825|62954211|FG000|Overall Study|Enrolled but treatment not administered|0|||
33560398|NCT03945825|62954212|FG001|Overall Study|Enrolled but treatment not administered|0|||
33560399|NCT03945825|62954213|FG002|Overall Study|Enrolled but treatment not administered|0|||
33560400|NCT03945825|62954214|FG003|Overall Study|Enrolled but treatment not administered|0|||
33560401|NCT03945825|62954215|FG004|Overall Study|Enrolled but treatment not administered|1|||
33560402|NCT03945825|62954216|FG005|Overall Study|Enrolled but treatment not administered|0|||
33560403|NCT03945825|62954211|FG000|Overall Study|Lost to Follow-up|1|||
33560404|NCT03945825|62954212|FG001|Overall Study|Lost to Follow-up|5|||
33560405|NCT03945825|62954213|FG002|Overall Study|Lost to Follow-up|0|||
33560406|NCT03945825|62954214|FG003|Overall Study|Lost to Follow-up|1|||
33560407|NCT03945825|62954215|FG004|Overall Study|Lost to Follow-up|2|||
33560408|NCT03945825|62954216|FG005|Overall Study|Lost to Follow-up|2|||
33560409|NCT03945825|62954211|FG000|Overall Study|Withdrawal by Subject|1|||
33560410|NCT03945825|62954212|FG001|Overall Study|Withdrawal by Subject|0|||
33560411|NCT03945825|62954213|FG002|Overall Study|Withdrawal by Subject|1|||
33560412|NCT03945825|62954214|FG003|Overall Study|Withdrawal by Subject|1|||
33560413|NCT03945825|62954215|FG004|Overall Study|Withdrawal by Subject|0|||
33560414|NCT03945825|62954216|FG005|Overall Study|Withdrawal by Subject|1|||
33560415|NCT02759315|62954244|FG000|Overall Study|Adverse Event|0|||
33560416|NCT02759315|62954245|FG001|Overall Study|Adverse Event|0|||
33560417|NCT02759315|62954246|FG002|Overall Study|Adverse Event|0|||
33560418|NCT02759315|62954247|FG003|Overall Study|Adverse Event|1|||
33560419|NCT02759315|62954248|FG004|Overall Study|Adverse Event|0|||
33560420|NCT02759315|62954244|FG000|Overall Study|Death|0|||
33560421|NCT02759315|62954245|FG001|Overall Study|Death|0|||
33560422|NCT02759315|62954246|FG002|Overall Study|Death|1|||
33560423|NCT02759315|62954247|FG003|Overall Study|Death|0|||
33560424|NCT02759315|62954248|FG004|Overall Study|Death|0|||
33560425|NCT02759315|62954244|FG000|Overall Study|Lost to Follow-up|2|||
33560426|NCT02759315|62954245|FG001|Overall Study|Lost to Follow-up|0|||
33560427|NCT02759315|62954246|FG002|Overall Study|Lost to Follow-up|4|||
33299983|NCT01307501|62676278|FG000|Overall Study|Treatment Failure|1|||
33299984|NCT01307501|62676278|FG000|Overall Study|Death|20|||
33299985|NCT01307501|62676278|FG000|Overall Study|Lost to Follow-up|1|||
33299986|NCT01307501|62676278|FG000|Overall Study|Starting Hospice|1|||
33299987|NCT01034137|62676285|FG000|Overall Study|Adverse Event|9|||
33299988|NCT01034137|62676286|FG001|Overall Study|Adverse Event|10|||
33299989|NCT01034137|62676287|FG002|Overall Study|Adverse Event|8|||
33299990|NCT01034137|62676285|FG000|Overall Study|Withdrawal by Subject|4|||
33299991|NCT01034137|62676286|FG001|Overall Study|Withdrawal by Subject|3|||
33299992|NCT01034137|62676287|FG002|Overall Study|Withdrawal by Subject|3|||
33299993|NCT01034137|62676285|FG000|Overall Study|Lack of Efficacy|9|||
33299994|NCT01034137|62676286|FG001|Overall Study|Lack of Efficacy|4|||
33560428|NCT02759315|62954247|FG003|Overall Study|Lost to Follow-up|0|||
33560429|NCT02759315|62954248|FG004|Overall Study|Lost to Follow-up|0|||
33560430|NCT02759315|62954244|FG000|Overall Study|Protocol Violation|0|||
33560431|NCT02759315|62954245|FG001|Overall Study|Protocol Violation|1|||
33560432|NCT02759315|62954246|FG002|Overall Study|Protocol Violation|0|||
33560433|NCT02759315|62954247|FG003|Overall Study|Protocol Violation|0|||
33560434|NCT02759315|62954248|FG004|Overall Study|Protocol Violation|0|||
33560435|NCT02759315|62954244|FG000|Overall Study|Study terminated prior to completion|2|||
33560436|NCT02759315|62954245|FG001|Overall Study|Study terminated prior to completion|0|||
33560437|NCT02759315|62954246|FG002|Overall Study|Study terminated prior to completion|5|||
33560438|NCT02759315|62954247|FG003|Overall Study|Study terminated prior to completion|0|||
33560439|NCT02759315|62954248|FG004|Overall Study|Study terminated prior to completion|1|||
33560440|NCT00835081|62954264|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
33560441|NCT00835081|62954265|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
33560442|NCT02543918|62954271|FG000|Overall Study|Never treated|0|||
33560443|NCT02543918|62954272|FG001|Overall Study|Never treated|1|||
33560444|NCT02543918|62954271|FG000|Overall Study|Lost to Follow-up|1|||
33560445|NCT02543918|62954272|FG001|Overall Study|Lost to Follow-up|1|||
33560446|NCT02543918|62954271|FG000|Overall Study|Withdrawal by Subject|1|||
33560447|NCT02543918|62954272|FG001|Overall Study|Withdrawal by Subject|1|||
33560448|NCT02543918|62954271|FG000|Overall Study|Adverse Event|1|||
33560449|NCT02543918|62954272|FG001|Overall Study|Adverse Event|1|||
33560450|NCT01372995|62954281|FG000|Overall Study|Spouse withdrew participant from study|0|||
33560451|NCT01372995|62954282|FG001|Overall Study|Spouse withdrew participant from study|1|||
33560452|NCT01372995|62954283|FG002|Overall Study|Spouse withdrew participant from study|0|||
33560453|NCT01372995|62954281|FG000|Overall Study|Physician Decision|0|||
33560454|NCT01372995|62954282|FG001|Overall Study|Physician Decision|0|||
33560455|NCT01372995|62954283|FG002|Overall Study|Physician Decision|1|||
33560456|NCT02757521|62954293|FG000|Overall Study|Adverse Event|1|||
33560457|NCT02757521|62954294|FG001|Overall Study|Adverse Event|0|||
33560458|NCT00834613|62954302|FG000|First Intervention|Protocol Violation|1|||
33560459|NCT00834613|62954303|FG001|First Intervention|Protocol Violation|0|||
33560460|NCT00834067|62954320|FG000|Washout of 21 Days|Protocol Violation|0|||
33560461|NCT00834067|62954321|FG001|Washout of 21 Days|Protocol Violation|1|||
33560462|NCT02758613|62954329|FG000|Treatment|Physician and Sponsor Decision|1|||
33560463|NCT02758613|62954330|FG001|Treatment|Physician and Sponsor Decision|0|||
33560464|NCT02758613|62954331|FG002|Treatment|Physician and Sponsor Decision|0|||
33560465|NCT02758613|62954332|FG003|Treatment|Physician and Sponsor Decision|0|||
33560466|NCT02758613|62954329|FG000|Treatment|Withdrawal by Subject|1|||
33560467|NCT02758613|62954330|FG001|Treatment|Withdrawal by Subject|0|||
33560468|NCT02758613|62954331|FG002|Treatment|Withdrawal by Subject|1|||
33560469|NCT02758613|62954332|FG003|Treatment|Withdrawal by Subject|0|||
33560470|NCT02758301|62954347|FG000|Overall Study|Death|12|||
33560471|NCT02758301|62954348|FG001|Overall Study|Death|0|||
33560472|NCT02758301|62954347|FG000|Overall Study|Physician Decision|10|||
33560473|NCT02758301|62954348|FG001|Overall Study|Physician Decision|1|||
33560474|NCT02758301|62954347|FG000|Overall Study|Withdrawal by Subject|5|||
33560475|NCT02758301|62954348|FG001|Overall Study|Withdrawal by Subject|6|||
33560476|NCT02758301|62954347|FG000|Overall Study|Lost to Follow-up|7|||
33560477|NCT02758301|62954348|FG001|Overall Study|Lost to Follow-up|0|||
33560478|NCT02758301|62954347|FG000|Overall Study|Protocol Violation|0|||
33560479|NCT02758301|62954348|FG001|Overall Study|Protocol Violation|1|||
33560480|NCT02669667|62954368|FG000|Overall Study|Lost to Follow-up|0|||
33560481|NCT02669667|62954369|FG001|Overall Study|Lost to Follow-up|0|||
33560482|NCT02669667|62954370|FG002|Overall Study|Lost to Follow-up|0|||
33560483|NCT02669667|62954371|FG003|Overall Study|Lost to Follow-up|0|||
33560484|NCT02669667|62954372|FG004|Overall Study|Lost to Follow-up|0|||
33560485|NCT02669667|62954373|FG005|Overall Study|Lost to Follow-up|1|||
33560486|NCT02669667|62954374|FG006|Overall Study|Lost to Follow-up|0|||
33560487|NCT02669433|62954399|FG000|Overall Study|Protocol Violation|0|||
33560488|NCT02669433|62954400|FG001|Overall Study|Protocol Violation|4|||
33560489|NCT02669433|62954401|FG002|Overall Study|Protocol Violation|1|||
33560490|NCT02669433|62954399|FG000|Overall Study|Disease Progression|1|||
33560491|NCT02669433|62954400|FG001|Overall Study|Disease Progression|0|||
33560492|NCT02669433|62954401|FG002|Overall Study|Disease Progression|0|||
33560493|NCT02669433|62954399|FG000|Overall Study|Physician Decision|1|||
33560494|NCT02669433|62954400|FG001|Overall Study|Physician Decision|1|||
33560495|NCT02669433|62954401|FG002|Overall Study|Physician Decision|0|||
33560496|NCT02669433|62954399|FG000|Overall Study|Adverse Event|6|||
33560497|NCT02669433|62954400|FG001|Overall Study|Adverse Event|7|||
33560498|NCT02669433|62954401|FG002|Overall Study|Adverse Event|10|||
33560499|NCT02669433|62954399|FG000|Overall Study|Sponsor Termination|1|||
33560500|NCT02669433|62954400|FG001|Overall Study|Sponsor Termination|0|||
33560501|NCT02669433|62954401|FG002|Overall Study|Sponsor Termination|1|||
33560502|NCT02669433|62954399|FG000|Overall Study|Withdrawal by Subject|5|||
33560503|NCT02669433|62954400|FG001|Overall Study|Withdrawal by Subject|1|||
33560504|NCT02669433|62954401|FG002|Overall Study|Withdrawal by Subject|0|||
33560505|NCT02669433|62954399|FG000|Overall Study|Withdrawal by Caregiver|1|||
33560506|NCT02669433|62954400|FG001|Overall Study|Withdrawal by Caregiver|0|||
33560507|NCT02669433|62954401|FG002|Overall Study|Withdrawal by Caregiver|2|||
33560508|NCT02669433|62954399|FG000|Overall Study|Death|0|||
33560509|NCT02669433|62954400|FG001|Overall Study|Death|1|||
33560510|NCT02669433|62954401|FG002|Overall Study|Death|1|||
33560511|NCT02756819|62954409|FG000|Overall Study|Lost for observation|23|||
33560512|NCT02756819|62954409|FG000|Overall Study|Patient's unwillingness|16|||
33560513|NCT02756819|62954409|FG000|Overall Study|Insufficient efficacy|2|||
33560514|NCT02756819|62954409|FG000|Overall Study|Adverse Event|2|||
33560515|NCT02756819|62954409|FG000|Overall Study|Reason not Specified|9|||
33560516|NCT00829309|62954415|FG000|Washout: 7 Days|Protocol Violation|1|||
33560517|NCT00829309|62954416|FG001|Washout: 7 Days|Protocol Violation|0|||
33560518|NCT02669121|62954422|FG000|Overall Study|Adverse Event|4|||
33560519|NCT02669121|62954423|FG001|Overall Study|Adverse Event|5|||
33560520|NCT02669121|62954422|FG000|Overall Study|Lost to Follow-up|15|||
33560521|NCT02669121|62954423|FG001|Overall Study|Lost to Follow-up|27|||
33560522|NCT02669121|62954422|FG000|Overall Study|Withdrawal by Subject|132|||
33560523|NCT02669121|62954423|FG001|Overall Study|Withdrawal by Subject|140|||
33560524|NCT02669121|62954422|FG000|Overall Study|Pregnancy|0|||
33560525|NCT02669121|62954423|FG001|Overall Study|Pregnancy|1|||
33560526|NCT02669121|62954422|FG000|Overall Study|Discharged from US Military Active Service|117|||
33560527|NCT02669121|62954423|FG001|Overall Study|Discharged from US Military Active Service|91|||
33560528|NCT02669121|62954422|FG000|Overall Study|Reason not Specified|22|||
33560529|NCT02669121|62954423|FG001|Overall Study|Reason not Specified|18|||
33560530|NCT02743117|62954431|FG000|Overall Study|Lost to Follow-up|0|||
33560531|NCT02743117|62954432|FG001|Overall Study|Lost to Follow-up|1|||
33560532|NCT02743117|62954431|FG000|Overall Study|Other|1|||
33560533|NCT02743117|62954432|FG001|Overall Study|Other|0|||
33560534|NCT02669043|62954447|FG000|Overall Study|Didn't meet I/E criteria|4|||
33560535|NCT00805129|62954451|FG000|Overall Study|Not treated|1|||
33560536|NCT02668185|62954455|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
33560537|NCT02668185|62954456|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
33560538|NCT02668185|62954455|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
33560539|NCT02668185|62954456|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
33560540|NCT02668185|62954455|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
33560541|NCT02668185|62954456|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
33560542|NCT02668185|62954455|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
33560543|NCT02668185|62954456|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
33560544|NCT02742181|62954467|FG000|Overall Study|Physician Decision|1|||
33560545|NCT02742181|62954468|FG001|Overall Study|Physician Decision|0|||
33560546|NCT02742103|62954476|FG000|Overall Study|Protocol Violation|1|||
33560547|NCT02742103|62954477|FG001|Overall Study|Protocol Violation|0|||
33560548|NCT02742103|62954476|FG000|Overall Study|Death|2|||
33560549|NCT02742103|62954477|FG001|Overall Study|Death|2|||
33560550|NCT02742103|62954476|FG000|Overall Study|Adverse Event|1|||
33560551|NCT02742103|62954477|FG001|Overall Study|Adverse Event|0|||
33560552|NCT02742103|62954476|FG000|Overall Study|Moved to another town|0|||
33560553|NCT02742103|62954477|FG001|Overall Study|Moved to another town|1|||
33560554|NCT02742103|62954476|FG000|Overall Study|Withdrawal by Subject|5|||
33560555|NCT02742103|62954477|FG001|Overall Study|Withdrawal by Subject|2|||
33560556|NCT02741713|62954485|FG000|Overall Study|Surgery type changed intra-operatively|2|||
33662745|NCT01587703|63093243|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33662746|NCT01587703|63093244|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33299995|NCT01034137|62676287|FG002|Overall Study|Lack of Efficacy|13|||
33560557|NCT02741713|62954486|FG001|Overall Study|Surgery type changed intra-operatively|1|||
33560558|NCT02663271|62954493|FG000|Overall Study|Withdrawal by Subject|5|||
33560559|NCT02663271|62954493|FG000|Overall Study|Lack of Efficacy|1|||
33560560|NCT02742649|62954500|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
33560561|NCT02742649|62954501|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
33560562|NCT02742649|62954502|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
33299996|NCT01034137|62676285|FG000|Overall Study|Protocol Violation|2|||
33299997|NCT01034137|62676286|FG001|Overall Study|Protocol Violation|2|||
33299998|NCT01034137|62676287|FG002|Overall Study|Protocol Violation|1|||
33299999|NCT01034137|62676285|FG000|Overall Study|Refused treatment or did not cooperate|2|||
33300000|NCT01034137|62676286|FG001|Overall Study|Refused treatment or did not cooperate|0|||
33300001|NCT01034137|62676287|FG002|Overall Study|Refused treatment or did not cooperate|1|||
33300002|NCT01034137|62676285|FG000|Overall Study|Administrative or other|2|||
33300003|NCT01034137|62676286|FG001|Overall Study|Administrative or other|3|||
33300004|NCT01034137|62676287|FG002|Overall Study|Administrative or other|4|||
33300005|NCT01056289|62676296|FG000|Open-label Phase|Adverse Event|29|||
33300006|NCT01056289|62676297|FG001|Open-label Phase|Adverse Event|0|||
33300007|NCT01056289|62676298|FG002|Open-label Phase|Adverse Event|0|||
33300008|NCT01056289|62676299|FG003|Open-label Phase|Adverse Event|0|||
33300009|NCT01056289|62676296|FG000|Open-label Phase|Lost to Follow-up|30|||
33300010|NCT01056289|62676297|FG001|Open-label Phase|Lost to Follow-up|0|||
33300011|NCT01056289|62676298|FG002|Open-label Phase|Lost to Follow-up|0|||
33300012|NCT01056289|62676299|FG003|Open-label Phase|Lost to Follow-up|0|||
33300013|NCT01056289|62676296|FG000|Open-label Phase|Other|9|||
33300014|NCT01056289|62676297|FG001|Open-label Phase|Other|0|||
33300015|NCT01056289|62676298|FG002|Open-label Phase|Other|0|||
33300016|NCT01056289|62676299|FG003|Open-label Phase|Other|0|||
33300017|NCT01056289|62676296|FG000|Open-label Phase|Protocol Violation|6|||
33300018|NCT01056289|62676297|FG001|Open-label Phase|Protocol Violation|0|||
33300019|NCT01056289|62676298|FG002|Open-label Phase|Protocol Violation|0|||
33300020|NCT01056289|62676299|FG003|Open-label Phase|Protocol Violation|0|||
33391085|NCT00631917|62769855|FG001|Overall Study|Death|0|||
33391086|NCT00419341|62769872|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
33391087|NCT00419341|62769872|FG000|Wash in/Wash Out Period|Adverse Event|2|||
33391088|NCT00419341|62769872|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
33391089|NCT00419341|62769872|FG000|Efficacy Period|Withdrawal by Subject|6|||
33391090|NCT00419341|62769872|FG000|Efficacy Period|Protocol Violation|1|||
33391091|NCT00419341|62769872|FG000|Efficacy Period|Lost to Follow-up|1|||
33391092|NCT00419341|62769872|FG000|Efficacy Period|Non-compliance|1|||
33391093|NCT00419341|62769872|FG000|Efficacy Period|Termination of study site|1|||
33391094|NCT00694122|62769878|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
33391095|NCT00694122|62769879|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
33391096|NCT00694122|62769878|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
33391097|NCT00694122|62769879|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
33391098|NCT00694122|62769878|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
33391099|NCT00694122|62769879|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
33391100|NCT03922620|62769892|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
33391101|NCT03922620|62769893|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
33391102|NCT00419263|62769902|FG000|Overall Study|Lost to Follow-up|2|||
33391103|NCT00419263|62769903|FG001|Overall Study|Lost to Follow-up|1|||
33391104|NCT00419263|62769904|FG002|Overall Study|Lost to Follow-up|1|||
33391105|NCT00419263|62769902|FG000|Overall Study|Randomized in Error, Not Treated|1|||
33391106|NCT00419263|62769903|FG001|Overall Study|Randomized in Error, Not Treated|1|||
33391107|NCT00419263|62769904|FG002|Overall Study|Randomized in Error, Not Treated|0|||
33391108|NCT00419263|62769902|FG000|Overall Study|Adverse Event|0|||
33391109|NCT00419263|62769903|FG001|Overall Study|Adverse Event|0|||
33391110|NCT00419263|62769904|FG002|Overall Study|Adverse Event|1|||
33391111|NCT00419263|62769902|FG000|Overall Study|Withdrawal by Subject|0|||
33391112|NCT00419263|62769903|FG001|Overall Study|Withdrawal by Subject|0|||
33391113|NCT00419263|62769904|FG002|Overall Study|Withdrawal by Subject|1|||
33391114|NCT00399763|62769915|FG000|Overall Study|Lost to Follow-up|2|||
33391115|NCT00399763|62769916|FG001|Overall Study|Lost to Follow-up|3|||
33391116|NCT00699842|62769925|FG000|Overall Study|Death|0|||
33391117|NCT00699842|62769926|FG001|Overall Study|Death|1|||
33391118|NCT00699842|62769927|FG002|Overall Study|Death|0|||
33391119|NCT00399529|62769935|FG000|Overall Study|Off Study Prior to Treatment|2|||
33391120|NCT00712712|62769940|FG000|Overall Study|Protocol Violation|11|||
33391121|NCT00712712|62769940|FG000|Overall Study|Radiofrequency not done|3|||
33391122|NCT00712712|62769940|FG000|Overall Study|Death|8|||
33391123|NCT00712712|62769940|FG000|Overall Study|Withdrawal by Subject|1|||
33391124|NCT00411151|62769944|FG000|Overall Study|Death|38|||
33391125|NCT00411151|62769944|FG000|Overall Study|Withdrawal by Subject|2|||
33391126|NCT00411151|62769944|FG000|Overall Study|Lost to Follow-up|2|||
33391127|NCT00411151|62769944|FG000|Overall Study|Protocol Violation|1|||
33391128|NCT00411151|62769944|FG000|Overall Study|Trial prematurely closed|4|||
33391129|NCT00607048|62769950|FG000|Overall Study|Adverse Event|0|||
33391130|NCT00607048|62769951|FG001|Overall Study|Adverse Event|1|||
33391131|NCT00607048|62769952|FG002|Overall Study|Adverse Event|0|||
33391132|NCT00607048|62769953|FG003|Overall Study|Adverse Event|0|||
33391133|NCT00607048|62769954|FG004|Overall Study|Adverse Event|4|||
33391134|NCT00607048|62769955|FG005|Overall Study|Adverse Event|0|||
33560563|NCT02742649|62954503|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
33560564|NCT02742649|62954504|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
33560565|NCT02742649|62954500|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33560566|NCT02742649|62954501|FG001|Double-Blind Treatment Period|Adverse Event|1|||
33560567|NCT02742649|62954502|FG002|Double-Blind Treatment Period|Adverse Event|0|||
33560568|NCT02742649|62954503|FG003|Double-Blind Treatment Period|Adverse Event|0|||
33560569|NCT02742649|62954504|FG004|Double-Blind Treatment Period|Adverse Event|0|||
33560570|NCT02742649|62954500|FG000|Open-Label Period|Lost to Follow-up|0|||
33560571|NCT02742649|62954501|FG001|Open-Label Period|Lost to Follow-up|0|||
33560572|NCT02742649|62954502|FG002|Open-Label Period|Lost to Follow-up|0|||
33560573|NCT02742649|62954503|FG003|Open-Label Period|Lost to Follow-up|0|||
33560574|NCT02742649|62954504|FG004|Open-Label Period|Lost to Follow-up|1|||
33560575|NCT02665689|62954517|FG000|Overall Study|Adverse Event|1|||
33560576|NCT02665689|62954518|FG001|Overall Study|Adverse Event|0|||
33560577|NCT02665689|62954517|FG000|Overall Study|Trial termination|1|||
33560578|NCT02665689|62954518|FG001|Overall Study|Trial termination|1|||
33391135|NCT00607048|62769950|FG000|Overall Study|Global deterioration of health|1|||
33391136|NCT00607048|62769951|FG001|Overall Study|Global deterioration of health|0|||
33391137|NCT00607048|62769952|FG002|Overall Study|Global deterioration of health|0|||
33391138|NCT00607048|62769953|FG003|Overall Study|Global deterioration of health|0|||
33391139|NCT00607048|62769954|FG004|Overall Study|Global deterioration of health|0|||
33391140|NCT00607048|62769955|FG005|Overall Study|Global deterioration of health|0|||
33391141|NCT00607048|62769950|FG000|Overall Study|Objective disease progression - relapse|1|||
33391142|NCT00607048|62769951|FG001|Overall Study|Objective disease progression - relapse|2|||
33560579|NCT02665689|62954517|FG000|Overall Study|Lost to Follow-up|0|||
33560580|NCT02665689|62954518|FG001|Overall Study|Lost to Follow-up|1|||
33560581|NCT02665455|62954524|FG000|Overall Study|Withdrawal by Subject|6|||
33560582|NCT02665455|62954524|FG000|Overall Study|Lost to Follow-up|1|||
33560583|NCT02665455|62954524|FG000|Overall Study|Adverse Event|1|||
33560584|NCT02665455|62954524|FG000|Overall Study|Protocol Violation|1|||
33560585|NCT02755805|62954530|FG000|Overall Study|Lost to Follow-up|1|||
33560586|NCT02755805|62954531|FG001|Overall Study|Lost to Follow-up|2|||
33560587|NCT02755805|62954530|FG000|Overall Study|Refused assessments|1|||
33560588|NCT02755805|62954531|FG001|Overall Study|Refused assessments|0|||
33560589|NCT02755805|62954530|FG000|Overall Study|Withdrawal by Subject|0|||
33560590|NCT02755805|62954531|FG001|Overall Study|Withdrawal by Subject|2|||
33560591|NCT02755649|62954540|FG000|Overall Study|Transitioned into OLE study|99|||
33560592|NCT02755649|62954541|FG001|Overall Study|Transitioned into OLE study|98|||
33560593|NCT02755649|62954542|FG002|Overall Study|Transitioned into OLE study|100|||
33560594|NCT02755649|62954540|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
33560595|NCT02755649|62954541|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
33560596|NCT02755649|62954542|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
33560597|NCT02755649|62954540|FG000|Overall Study|Physician Decision|0|||
33560598|NCT02755649|62954541|FG001|Overall Study|Physician Decision|0|||
33560599|NCT02755649|62954542|FG002|Overall Study|Physician Decision|2|||
33560600|NCT02755649|62954540|FG000|Overall Study|Withdrawal by Subject|0|||
33560601|NCT02755649|62954541|FG001|Overall Study|Withdrawal by Subject|1|||
33560602|NCT02755649|62954542|FG002|Overall Study|Withdrawal by Subject|0|||
33560603|NCT02755649|62954540|FG000|Overall Study|Undecided|1|||
33560604|NCT02755649|62954541|FG001|Overall Study|Undecided|0|||
33560605|NCT02755649|62954542|FG002|Overall Study|Undecided|0|||
33560606|NCT00151411|62954552|FG000|Overall Study|Lost to Follow-up|15|||
33560607|NCT00151411|62954553|FG001|Overall Study|Lost to Follow-up|19|||
33560608|NCT00151411|62954552|FG000|Overall Study|Withdrawal by Subject|12|||
33560609|NCT00151411|62954553|FG001|Overall Study|Withdrawal by Subject|20|||
33560610|NCT00151411|62954552|FG000|Overall Study|Adverse Event|6|||
33560611|NCT00151411|62954553|FG001|Overall Study|Adverse Event|0|||
33560612|NCT00151411|62954552|FG000|Overall Study|Pregnancy|0|||
33560613|NCT00151411|62954553|FG001|Overall Study|Pregnancy|4|||
33560614|NCT02662569|62954563|FG000|Overall Study|Withdrawal by Subject|6|||
33560615|NCT02662569|62954564|FG001|Overall Study|Withdrawal by Subject|1|||
33560616|NCT02662569|62954565|FG002|Overall Study|Withdrawal by Subject|6|||
33560617|NCT02662569|62954566|FG003|Overall Study|Withdrawal by Subject|4|||
33560618|NCT02662569|62954563|FG000|Overall Study|Lost to Follow-up|1|||
33560619|NCT02662569|62954564|FG001|Overall Study|Lost to Follow-up|0|||
33560620|NCT02662569|62954565|FG002|Overall Study|Lost to Follow-up|0|||
33560621|NCT02662569|62954566|FG003|Overall Study|Lost to Follow-up|0|||
33560622|NCT02741635|62954576|FG000|Overall Study|Withdrawal by Subject|1|||
33560623|NCT02753075|62954584|FG000|Overall Study|Adverse Event|2|||
33560624|NCT02753075|62954585|FG001|Overall Study|Adverse Event|1|||
33560625|NCT02753075|62954586|FG002|Overall Study|Adverse Event|0|||
33560626|NCT02753075|62954584|FG000|Overall Study|Lost to Follow-up|2|||
33560627|NCT02753075|62954585|FG001|Overall Study|Lost to Follow-up|0|||
33560628|NCT02753075|62954586|FG002|Overall Study|Lost to Follow-up|0|||
33560629|NCT02753075|62954584|FG000|Overall Study|Withdrawal of Consent|1|||
33560630|NCT02753075|62954585|FG001|Overall Study|Withdrawal of Consent|1|||
33560631|NCT02753075|62954586|FG002|Overall Study|Withdrawal of Consent|3|||
33560632|NCT02753075|62954584|FG000|Overall Study|Physician Decision|3|||
33560633|NCT02753075|62954585|FG001|Overall Study|Physician Decision|1|||
33560634|NCT02753075|62954586|FG002|Overall Study|Physician Decision|0|||
33560635|NCT02332720|62954618|FG000|Part A and Part B|Lost to Follow-up|1|||
33560636|NCT02332720|62954619|FG001|Part A and Part B|Lost to Follow-up|0|||
33560637|NCT02332720|62954620|FG002|Part A and Part B|Lost to Follow-up|0|||
33560638|NCT02332720|62954621|FG003|Part A and Part B|Lost to Follow-up|0|||
33560639|NCT02332720|62954622|FG004|Part A and Part B|Lost to Follow-up|0|||
33560640|NCT02332720|62954623|FG005|Part A and Part B|Lost to Follow-up|2|||
33560641|NCT02332720|62954624|FG006|Part A and Part B|Lost to Follow-up|1|||
33560642|NCT02332720|62954625|FG007|Part A and Part B|Lost to Follow-up|1|||
33560643|NCT02332720|62954626|FG008|Part A and Part B|Lost to Follow-up|0|||
33560644|NCT02332720|62954627|FG009|Part A and Part B|Lost to Follow-up|0|||
33560645|NCT02332720|62954628|FG010|Part A and Part B|Lost to Follow-up|0|||
33560646|NCT02332720|62954629|FG011|Part A and Part B|Lost to Follow-up|0|||
33560647|NCT02332720|62954630|FG012|Part A and Part B|Lost to Follow-up|0|||
33560648|NCT02332720|62954631|FG013|Part A and Part B|Lost to Follow-up|0|||
33560649|NCT02332720|62954632|FG014|Part A and Part B|Lost to Follow-up|0|||
33560650|NCT02332720|62954633|FG015|Part A and Part B|Lost to Follow-up|1|||
33560651|NCT02332720|62954634|FG016|Part A and Part B|Lost to Follow-up|0|||
33560652|NCT02332720|62954635|FG017|Part A and Part B|Lost to Follow-up|0|||
33560653|NCT02332720|62954636|FG018|Part A and Part B|Lost to Follow-up|0|||
33560654|NCT02332720|62954637|FG019|Part A and Part B|Lost to Follow-up|0|||
33560655|NCT02332720|62954638|FG020|Part A and Part B|Lost to Follow-up|0|||
33560656|NCT02332720|62954639|FG021|Part A and Part B|Lost to Follow-up|0|||
33560657|NCT02332720|62954640|FG022|Part A and Part B|Lost to Follow-up|0|||
33560658|NCT02332720|62954618|FG000|Part A and Part B|Adverse Event|0|||
33560659|NCT02332720|62954619|FG001|Part A and Part B|Adverse Event|0|||
33560660|NCT02332720|62954620|FG002|Part A and Part B|Adverse Event|0|||
33560661|NCT02332720|62954621|FG003|Part A and Part B|Adverse Event|0|||
33560662|NCT02332720|62954622|FG004|Part A and Part B|Adverse Event|0|||
33560663|NCT02332720|62954623|FG005|Part A and Part B|Adverse Event|0|||
33560664|NCT02332720|62954624|FG006|Part A and Part B|Adverse Event|0|||
33560665|NCT02332720|62954625|FG007|Part A and Part B|Adverse Event|0|||
33560666|NCT02332720|62954626|FG008|Part A and Part B|Adverse Event|0|||
33560667|NCT02332720|62954627|FG009|Part A and Part B|Adverse Event|0|||
33560668|NCT02332720|62954628|FG010|Part A and Part B|Adverse Event|0|||
33560669|NCT02332720|62954629|FG011|Part A and Part B|Adverse Event|0|||
33560670|NCT02332720|62954630|FG012|Part A and Part B|Adverse Event|0|||
33560671|NCT02332720|62954631|FG013|Part A and Part B|Adverse Event|0|||
33560672|NCT02332720|62954632|FG014|Part A and Part B|Adverse Event|0|||
33560673|NCT02332720|62954633|FG015|Part A and Part B|Adverse Event|0|||
33560674|NCT02332720|62954634|FG016|Part A and Part B|Adverse Event|0|||
33560675|NCT02332720|62954635|FG017|Part A and Part B|Adverse Event|1|||
33560676|NCT02332720|62954636|FG018|Part A and Part B|Adverse Event|0|||
33560677|NCT02332720|62954637|FG019|Part A and Part B|Adverse Event|0|||
33560678|NCT02332720|62954638|FG020|Part A and Part B|Adverse Event|0|||
33560679|NCT02332720|62954639|FG021|Part A and Part B|Adverse Event|0|||
33560680|NCT02332720|62954640|FG022|Part A and Part B|Adverse Event|0|||
33560681|NCT02332720|62954618|FG000|Part A and Part B|Physician Decision|0|||
33560682|NCT02332720|62954619|FG001|Part A and Part B|Physician Decision|0|||
33560683|NCT02332720|62954620|FG002|Part A and Part B|Physician Decision|0|||
33560684|NCT02332720|62954621|FG003|Part A and Part B|Physician Decision|0|||
33560685|NCT02332720|62954622|FG004|Part A and Part B|Physician Decision|0|||
33560686|NCT02332720|62954623|FG005|Part A and Part B|Physician Decision|0|||
33560687|NCT02332720|62954624|FG006|Part A and Part B|Physician Decision|0|||
33560688|NCT02332720|62954625|FG007|Part A and Part B|Physician Decision|0|||
33560689|NCT02332720|62954626|FG008|Part A and Part B|Physician Decision|0|||
33560690|NCT02332720|62954627|FG009|Part A and Part B|Physician Decision|0|||
33560691|NCT02332720|62954628|FG010|Part A and Part B|Physician Decision|0|||
33560692|NCT02332720|62954629|FG011|Part A and Part B|Physician Decision|0|||
33560693|NCT02332720|62954630|FG012|Part A and Part B|Physician Decision|0|||
33560694|NCT02332720|62954631|FG013|Part A and Part B|Physician Decision|0|||
33560695|NCT02332720|62954632|FG014|Part A and Part B|Physician Decision|0|||
33560696|NCT02332720|62954633|FG015|Part A and Part B|Physician Decision|0|||
33560697|NCT02332720|62954634|FG016|Part A and Part B|Physician Decision|0|||
33560698|NCT02332720|62954635|FG017|Part A and Part B|Physician Decision|0|||
33560699|NCT02332720|62954636|FG018|Part A and Part B|Physician Decision|1|||
33560700|NCT02332720|62954637|FG019|Part A and Part B|Physician Decision|0|||
33560701|NCT02332720|62954638|FG020|Part A and Part B|Physician Decision|0|||
33560702|NCT02332720|62954639|FG021|Part A and Part B|Physician Decision|0|||
33300021|NCT01056289|62676296|FG000|Open-label Phase|Withdrawal by Subject|26|||
33300022|NCT01056289|62676297|FG001|Open-label Phase|Withdrawal by Subject|0|||
33300023|NCT01056289|62676298|FG002|Open-label Phase|Withdrawal by Subject|0|||
33300024|NCT01056289|62676299|FG003|Open-label Phase|Withdrawal by Subject|0|||
33300025|NCT01056289|62676296|FG000|Open-label Phase|Lack of Efficacy|18|||
33300026|NCT01056289|62676297|FG001|Open-label Phase|Lack of Efficacy|0|||
33300027|NCT01056289|62676298|FG002|Open-label Phase|Lack of Efficacy|0|||
33300028|NCT01056289|62676299|FG003|Open-label Phase|Lack of Efficacy|0|||
33300029|NCT01056289|62676296|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
33300030|NCT01056289|62676297|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
33300031|NCT01056289|62676298|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
33560703|NCT02332720|62954640|FG022|Part A and Part B|Physician Decision|0|||
33560704|NCT02332720|62954618|FG000|Part A and Part B|Withdrawal by Subject|0|||
33560705|NCT02332720|62954619|FG001|Part A and Part B|Withdrawal by Subject|0|||
33560706|NCT02332720|62954620|FG002|Part A and Part B|Withdrawal by Subject|0|||
33560707|NCT02332720|62954621|FG003|Part A and Part B|Withdrawal by Subject|0|||
33560708|NCT02332720|62954622|FG004|Part A and Part B|Withdrawal by Subject|0|||
33560709|NCT02332720|62954623|FG005|Part A and Part B|Withdrawal by Subject|1|||
33560710|NCT02332720|62954624|FG006|Part A and Part B|Withdrawal by Subject|0|||
33560711|NCT02332720|62954625|FG007|Part A and Part B|Withdrawal by Subject|0|||
33662747|NCT01587703|63093226|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33300032|NCT01056289|62676299|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
33300033|NCT01056289|62676296|FG000|Double-blind Phase|Adverse Event|0|||
33560712|NCT02332720|62954626|FG008|Part A and Part B|Withdrawal by Subject|0|||
33560713|NCT02332720|62954627|FG009|Part A and Part B|Withdrawal by Subject|0|||
33560714|NCT02332720|62954628|FG010|Part A and Part B|Withdrawal by Subject|0|||
33560715|NCT02332720|62954629|FG011|Part A and Part B|Withdrawal by Subject|0|||
33560716|NCT02332720|62954630|FG012|Part A and Part B|Withdrawal by Subject|0|||
33560717|NCT02332720|62954631|FG013|Part A and Part B|Withdrawal by Subject|0|||
33560718|NCT02332720|62954632|FG014|Part A and Part B|Withdrawal by Subject|0|||
33560719|NCT02332720|62954633|FG015|Part A and Part B|Withdrawal by Subject|0|||
33560720|NCT02332720|62954634|FG016|Part A and Part B|Withdrawal by Subject|0|||
33560721|NCT02332720|62954635|FG017|Part A and Part B|Withdrawal by Subject|0|||
33560722|NCT02332720|62954636|FG018|Part A and Part B|Withdrawal by Subject|0|||
33560723|NCT02332720|62954637|FG019|Part A and Part B|Withdrawal by Subject|1|||
33560724|NCT02332720|62954638|FG020|Part A and Part B|Withdrawal by Subject|0|||
33560725|NCT02332720|62954639|FG021|Part A and Part B|Withdrawal by Subject|0|||
33560726|NCT02332720|62954640|FG022|Part A and Part B|Withdrawal by Subject|0|||
33560727|NCT02331394|62954712|FG000|Overall Study|Disease progression|1|||
33560728|NCT01645930|62954723|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
33560729|NCT01645930|62954723|FG000|Overall Study|Progressive Disease|12|||
33560730|NCT01645930|62954723|FG000|Overall Study|Adverse Event|4|||
33560731|NCT01645930|62954723|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
33560732|NCT01645930|62954723|FG000|Overall Study|Withdrawal by Participant|2|||
33560733|NCT01645930|62954723|FG000|Overall Study|Reason not Defined|1|||
33560734|NCT02299336|62954727|FG000|Overall Study|Withdrawal by Subject|11|||
33560735|NCT02299336|62954727|FG000|Overall Study|Adverse Event|1|||
33560736|NCT02299336|62954727|FG000|Overall Study|Death|1|||
33560737|NCT02299336|62954727|FG000|Overall Study|Lost to Follow-up|1|||
33560738|NCT02664441|62954733|FG000|Randomization|Withdrawal by Subject|0|||
33560739|NCT02664441|62954734|FG001|Randomization|Withdrawal by Subject|1|||
33560740|NCT02664441|62954733|FG000|36-week Randomized Trial|Adverse Event|2|||
33560741|NCT02664441|62954734|FG001|36-week Randomized Trial|Adverse Event|0|||
33560742|NCT02664441|62954733|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
33560743|NCT02664441|62954734|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
33560744|NCT02664441|62954733|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
33560745|NCT02664441|62954734|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
33560746|NCT02664441|62954733|FG000|18-week Open Label Extension|Adverse Event|1|||
33391143|NCT00607048|62769952|FG002|Overall Study|Objective disease progression - relapse|4|||
33391144|NCT00607048|62769953|FG003|Overall Study|Objective disease progression - relapse|2|||
33391145|NCT00607048|62769954|FG004|Overall Study|Objective disease progression - relapse|2|||
33391146|NCT00607048|62769955|FG005|Overall Study|Objective disease progression - relapse|2|||
33391147|NCT00607048|62769950|FG000|Overall Study|Withdrawal by Subject|0|||
33391148|NCT00607048|62769951|FG001|Overall Study|Withdrawal by Subject|0|||
33391149|NCT00607048|62769952|FG002|Overall Study|Withdrawal by Subject|0|||
33391150|NCT00607048|62769953|FG003|Overall Study|Withdrawal by Subject|1|||
33391151|NCT00607048|62769954|FG004|Overall Study|Withdrawal by Subject|0|||
33391152|NCT00607048|62769955|FG005|Overall Study|Withdrawal by Subject|2|||
33560747|NCT02664441|62954734|FG001|18-week Open Label Extension|Adverse Event|0|||
33560748|NCT02664441|62954733|FG000|18-week Open Label Extension|Physician Decision|1|||
33560749|NCT02664441|62954734|FG001|18-week Open Label Extension|Physician Decision|0|||
33560750|NCT02664441|62954733|FG000|18-week Open Label Extension|Death|1|||
33560751|NCT02664441|62954734|FG001|18-week Open Label Extension|Death|0|||
33560752|NCT02664441|62954733|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
33560753|NCT02664441|62954734|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
33560754|NCT02298946|62954743|FG000|Overall Study|Did not receive treatment|2|||
33560755|NCT02298946|62954744|FG001|Overall Study|Did not receive treatment|0|||
33560756|NCT02298946|62954743|FG000|Overall Study|Unevaluable|2|||
33560757|NCT02298946|62954744|FG001|Overall Study|Unevaluable|1|||
33560758|NCT02328040|62954751|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
33560759|NCT02328040|62954752|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
33662748|NCT01587703|63093227|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33662749|NCT01587703|63093228|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33300034|NCT01056289|62676297|FG001|Double-blind Phase|Adverse Event|1|||
33300035|NCT01056289|62676298|FG002|Double-blind Phase|Adverse Event|2|||
33300036|NCT01056289|62676299|FG003|Double-blind Phase|Adverse Event|1|||
33300037|NCT01056289|62676296|FG000|Double-blind Phase|Lost to Follow-up|0|||
33300038|NCT01056289|62676297|FG001|Double-blind Phase|Lost to Follow-up|2|||
33300039|NCT01056289|62676298|FG002|Double-blind Phase|Lost to Follow-up|2|||
33300040|NCT01056289|62676299|FG003|Double-blind Phase|Lost to Follow-up|2|||
33300041|NCT01056289|62676296|FG000|Double-blind Phase|Other|0|||
33300042|NCT01056289|62676297|FG001|Double-blind Phase|Other|0|||
33300043|NCT01056289|62676298|FG002|Double-blind Phase|Other|1|||
33300044|NCT01056289|62676299|FG003|Double-blind Phase|Other|2|||
33300045|NCT01056289|62676296|FG000|Double-blind Phase|Protocol Violation|0|||
33560760|NCT01647958|62954760|FG000|Initial Study|Lost to Follow-up|2|||
33560761|NCT01647958|62954761|FG001|Initial Study|Lost to Follow-up|3|||
33560762|NCT01647958|62954760|FG000|Continuation Phase|treatment received during Overall Study|39|||
33560763|NCT01647958|62954761|FG001|Continuation Phase|treatment received during Overall Study|0|||
33560764|NCT01647958|62954760|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
33560765|NCT01647958|62954761|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
33300046|NCT01056289|62676297|FG001|Double-blind Phase|Protocol Violation|0|||
33300047|NCT01056289|62676298|FG002|Double-blind Phase|Protocol Violation|1|||
33300048|NCT01056289|62676299|FG003|Double-blind Phase|Protocol Violation|1|||
33391153|NCT00607048|62769950|FG000|Overall Study|Other|1|||
33662750|NCT01587703|63093229|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33662751|NCT01587703|63093230|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33662752|NCT01587703|63093231|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33391154|NCT00607048|62769951|FG001|Overall Study|Other|1|||
33391155|NCT00607048|62769952|FG002|Overall Study|Other|0|||
33391156|NCT00607048|62769953|FG003|Overall Study|Other|0|||
33300049|NCT01056289|62676296|FG000|Double-blind Phase|Withdrawal by Subject|0|||
33300050|NCT01056289|62676297|FG001|Double-blind Phase|Withdrawal by Subject|0|||
33300051|NCT01056289|62676298|FG002|Double-blind Phase|Withdrawal by Subject|4|||
33300052|NCT01056289|62676299|FG003|Double-blind Phase|Withdrawal by Subject|2|||
33300053|NCT01056289|62676296|FG000|Double-blind Phase|Discontinuation symptom|0|||
33300054|NCT01056289|62676297|FG001|Double-blind Phase|Discontinuation symptom|1|||
33300055|NCT01056289|62676298|FG002|Double-blind Phase|Discontinuation symptom|2|||
33300056|NCT01056289|62676299|FG003|Double-blind Phase|Discontinuation symptom|2|||
33300057|NCT01056289|62676296|FG000|Double-blind Phase|Physician Decision|0|||
33300058|NCT01056289|62676297|FG001|Double-blind Phase|Physician Decision|0|||
33300059|NCT01056289|62676298|FG002|Double-blind Phase|Physician Decision|1|||
33300060|NCT01056289|62676299|FG003|Double-blind Phase|Physician Decision|0|||
33300061|NCT01039675|62676311|FG000|Overall Study|Adverse Event|0|||
33300062|NCT01039675|62676312|FG001|Overall Study|Adverse Event|2|||
33300063|NCT01039675|62676311|FG000|Overall Study|Lack of Efficacy|0|||
33391157|NCT00607048|62769954|FG004|Overall Study|Other|0|||
33391158|NCT00607048|62769955|FG005|Overall Study|Other|1|||
33391159|NCT00699608|62769971|FG000|First Intervention|Withdrawal by Subject|0|||
33391160|NCT00699608|62769972|FG001|First Intervention|Withdrawal by Subject|0|||
33391161|NCT00699608|62769973|FG002|First Intervention|Withdrawal by Subject|1|||
33560766|NCT02298868|62954776|FG000|Overall Study|Adverse Event|1|||
33560767|NCT02298868|62954776|FG000|Overall Study|Death|1|||
33560768|NCT02298868|62954776|FG000|Overall Study|Patient underwent transplant|1|||
33662753|NCT01587703|63093232|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33662754|NCT01587703|63093233|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33662755|NCT01587703|63093234|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33662756|NCT01587703|63093235|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33662757|NCT01587703|63093236|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33300064|NCT01039675|62676312|FG001|Overall Study|Lack of Efficacy|2|||
33300065|NCT01039675|62676311|FG000|Overall Study|Withdrawal by Subject|0|||
33300066|NCT01039675|62676312|FG001|Overall Study|Withdrawal by Subject|1|||
33300067|NCT01039675|62676311|FG000|Overall Study|Lost to Follow-up|0|||
33300068|NCT01039675|62676312|FG001|Overall Study|Lost to Follow-up|1|||
33300069|NCT01039675|62676311|FG000|Overall Study|Physician Decision|0|||
33391162|NCT00699608|62769974|FG003|First Intervention|Withdrawal by Subject|0|||
33560769|NCT02327260|62954783|FG000|Overall Study|Lost to Follow-up|2|||
33560770|NCT02327260|62954784|FG001|Overall Study|Lost to Follow-up|3|||
33560771|NCT02327260|62954785|FG002|Overall Study|Lost to Follow-up|2|||
33560772|NCT02327260|62954783|FG000|Overall Study|invalid phone number|1|||
33560773|NCT02327260|62954784|FG001|Overall Study|invalid phone number|1|||
33560774|NCT02327260|62954785|FG002|Overall Study|invalid phone number|0|||
33560775|NCT02327260|62954783|FG000|Overall Study|non-adherence to protocol|2|||
33560776|NCT02327260|62954784|FG001|Overall Study|non-adherence to protocol|0|||
33560777|NCT02327260|62954785|FG002|Overall Study|non-adherence to protocol|0|||
33560778|NCT02327260|62954783|FG000|Overall Study|cognitive concerns|1|||
33560779|NCT02327260|62954784|FG001|Overall Study|cognitive concerns|0|||
33560780|NCT02327260|62954785|FG002|Overall Study|cognitive concerns|0|||
33560781|NCT02296840|62954796|FG000|Overall Study|Adverse Event|1|||
33560782|NCT02296840|62954797|FG001|Overall Study|Adverse Event|1|||
33560783|NCT02296840|62954796|FG000|Overall Study|Protocol Violation|2|||
33560784|NCT02296840|62954797|FG001|Overall Study|Protocol Violation|1|||
33560785|NCT02296840|62954796|FG000|Overall Study|Lost to Follow-up|6|||
33560786|NCT02296840|62954797|FG001|Overall Study|Lost to Follow-up|17|||
33560787|NCT02663895|62954806|FG000|Overall Study|Adverse Event|3|||
33560788|NCT02663895|62954806|FG000|Overall Study|Physician Decision|2|||
33560789|NCT02663895|62954806|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
33560790|NCT02663895|62954806|FG000|Overall Study|Withdrawal by Subject|1|||
33560791|NCT02663817|62954811|FG000|Overall Study|Screen failure|2|||
33560792|NCT01372605|62954819|FG000|Overall Study|Death|1|||
33560793|NCT01372605|62954820|FG001|Overall Study|Death|2|||
33560794|NCT01372605|62954819|FG000|Overall Study|Lost to Follow-up|2|||
33560795|NCT01372605|62954820|FG001|Overall Study|Lost to Follow-up|1|||
33560796|NCT01372605|62954819|FG000|Overall Study|Withdrawal by Subject|4|||
33560797|NCT01372605|62954820|FG001|Overall Study|Withdrawal by Subject|7|||
33300070|NCT01039675|62676312|FG001|Overall Study|Physician Decision|1|||
33300071|NCT01033825|62676325|FG000|Overall Study|Withdrawal by Subject|2|||
33300072|NCT01033825|62676326|FG001|Overall Study|Withdrawal by Subject|3|||
33300073|NCT01033825|62676327|FG002|Overall Study|Withdrawal by Subject|2|||
33391163|NCT00699608|62769975|FG004|First Intervention|Withdrawal by Subject|0|||
33560798|NCT01372605|62954819|FG000|Overall Study|Moved|3|||
33560799|NCT01372605|62954820|FG001|Overall Study|Moved|0|||
33560800|NCT01372605|62954819|FG000|Overall Study|Changed medical home|2|||
33560801|NCT01372605|62954820|FG001|Overall Study|Changed medical home|0|||
33560802|NCT02751983|62954828|FG000|Treatment|Stopped ACT, but Remained in study|2|||
33560803|NCT02751983|62954829|FG001|Treatment|Stopped ACT, but Remained in study|0|||
33560804|NCT02751983|62954828|FG000|Treatment|Discharged prior to beginning ACT|2|||
33560805|NCT02751983|62954829|FG001|Treatment|Discharged prior to beginning ACT|0|||
33560806|NCT02751983|62954828|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
33560807|NCT02751983|62954829|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
33560808|NCT02751983|62954828|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
33560809|NCT02751983|62954829|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
33560810|NCT02751983|62954828|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
33560811|NCT02751983|62954829|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
33560812|NCT00232141|62954849|FG000|Overall Study|Adverse Event|9|||
33560813|NCT00232141|62954850|FG001|Overall Study|Adverse Event|4|||
33560814|NCT00232141|62954849|FG000|Overall Study|Lack of Efficacy|0|||
33560815|NCT00232141|62954850|FG001|Overall Study|Lack of Efficacy|3|||
33560816|NCT00232141|62954849|FG000|Overall Study|Lost to Follow-up|9|||
33560817|NCT00232141|62954850|FG001|Overall Study|Lost to Follow-up|6|||
33560818|NCT00232141|62954849|FG000|Overall Study|Other|8|||
33560819|NCT00232141|62954850|FG001|Overall Study|Other|10|||
33560820|NCT00232141|62954849|FG000|Overall Study|Withdrawal by Subject|5|||
33560821|NCT00232141|62954850|FG001|Overall Study|Withdrawal by Subject|3|||
33560822|NCT02741245|62954879|FG000|Overall Study|Adverse Event|0|||
33560823|NCT02741245|62954880|FG001|Overall Study|Adverse Event|0|||
33560824|NCT02741245|62954881|FG002|Overall Study|Adverse Event|0|||
33560825|NCT02741245|62954882|FG003|Overall Study|Adverse Event|2|||
33560826|NCT02741245|62954883|FG004|Overall Study|Adverse Event|2|||
33560827|NCT02741245|62954879|FG000|Overall Study|Protocol Violation|0|||
33560828|NCT02741245|62954880|FG001|Overall Study|Protocol Violation|1|||
33560829|NCT02741245|62954881|FG002|Overall Study|Protocol Violation|0|||
33560830|NCT02741245|62954882|FG003|Overall Study|Protocol Violation|1|||
33560831|NCT02741245|62954883|FG004|Overall Study|Protocol Violation|0|||
33560832|NCT02741245|62954879|FG000|Overall Study|Withdrawal by Subject|0|||
33560833|NCT02741245|62954880|FG001|Overall Study|Withdrawal by Subject|0|||
33560834|NCT02741245|62954881|FG002|Overall Study|Withdrawal by Subject|0|||
33560835|NCT02741245|62954882|FG003|Overall Study|Withdrawal by Subject|1|||
33560836|NCT02741245|62954883|FG004|Overall Study|Withdrawal by Subject|0|||
33560837|NCT03227757|62954895|FG000|Overall Study|Death|7|||
33560838|NCT03227757|62954895|FG000|Overall Study|Withdrawal|5|||
33560839|NCT03227757|62954895|FG000|Overall Study|Missed visits|4|||
33560840|NCT02751827|62954902|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
33560841|NCT02751827|62954903|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
33560842|NCT02751827|62954904|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
33560843|NCT04896593|62954921|FG000|Overall Study|Withdrawal by Subject|2|||
33560844|NCT04896593|62954921|FG000|Overall Study|Lost to Follow-up|1|||
33560845|NCT04896593|62954921|FG000|Overall Study|Did not complete onboarding|2|||
33560846|NCT04601272|62954937|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
33560847|NCT04601272|62954938|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
33560848|NCT04601272|62954939|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
33560849|NCT03965091|62954959|FG000|Overall Study|Adverse Event|0|||
33560850|NCT03965091|62954960|FG001|Overall Study|Adverse Event|2|||
33560851|NCT03965091|62954961|FG002|Overall Study|Adverse Event|3|||
33560852|NCT03965091|62954959|FG000|Overall Study|Withdrawal by Subject|11|||
33560853|NCT03965091|62954960|FG001|Overall Study|Withdrawal by Subject|3|||
33560854|NCT03965091|62954961|FG002|Overall Study|Withdrawal by Subject|5|||
33560855|NCT03965091|62954959|FG000|Overall Study|Non-compliance with study drug|0|||
33560856|NCT03965091|62954960|FG001|Overall Study|Non-compliance with study drug|0|||
33560857|NCT03965091|62954961|FG002|Overall Study|Non-compliance with study drug|1|||
33560858|NCT03965091|62954959|FG000|Overall Study|Lost to Follow-up|1|||
33560859|NCT03965091|62954960|FG001|Overall Study|Lost to Follow-up|1|||
33560860|NCT03965091|62954961|FG002|Overall Study|Lost to Follow-up|1|||
33560861|NCT03965091|62954959|FG000|Overall Study|Lack of Efficacy|2|||
33560862|NCT03965091|62954960|FG001|Overall Study|Lack of Efficacy|0|||
33560863|NCT03965091|62954961|FG002|Overall Study|Lack of Efficacy|0|||
33560864|NCT03965091|62954959|FG000|Overall Study|Other than specified|9|||
33560865|NCT03965091|62954960|FG001|Overall Study|Other than specified|11|||
33662758|NCT01587703|63093237|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
33662759|NCT01587703|63093238|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33560866|NCT03965091|62954961|FG002|Overall Study|Other than specified|8|||
33560867|NCT03359096|62954988|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
33560868|NCT03359096|62954989|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
33560869|NCT03359096|62954988|FG000|First Intervention (4 Weeks)|Death|1|||
33560870|NCT03359096|62954989|FG001|First Intervention (4 Weeks)|Death|0|||
33560871|NCT03359096|62954988|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
33560872|NCT03359096|62954989|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
33560873|NCT03019588|62955006|FG000|Overall Study|Death|44|||
33560874|NCT03019588|62955007|FG001|Overall Study|Death|46|||
33560875|NCT03019588|62955006|FG000|Overall Study|Study terminated by Sponsor|3|||
33560876|NCT03019588|62955007|FG001|Overall Study|Study terminated by Sponsor|1|||
33560877|NCT02455557|62955039|FG000|Overall Study|Withdrawal by Subject|2|||
33560878|NCT02270450|62955047|FG000|Overall Study|Refusal unrelated to adverse event|3|||
33560879|NCT02270450|62955048|FG001|Overall Study|Refusal unrelated to adverse event|1|||
33560880|NCT02270450|62955049|FG002|Overall Study|Refusal unrelated to adverse event|5|||
33560881|NCT02270450|62955050|FG003|Overall Study|Refusal unrelated to adverse event|14|||
33560882|NCT02270450|62955047|FG000|Overall Study|Progression/relapse|1|||
33560883|NCT02270450|62955048|FG001|Overall Study|Progression/relapse|2|||
33560884|NCT02270450|62955049|FG002|Overall Study|Progression/relapse|4|||
33560885|NCT02270450|62955050|FG003|Overall Study|Progression/relapse|9|||
33560886|NCT02270450|62955047|FG000|Overall Study|Death|19|||
33560887|NCT02270450|62955048|FG001|Overall Study|Death|19|||
33560888|NCT02270450|62955049|FG002|Overall Study|Death|31|||
33560889|NCT02270450|62955050|FG003|Overall Study|Death|59|||
33560890|NCT01570868|62955073|FG000|Overall Study|Adverse Event|8|||
33560891|NCT01570868|62955074|FG001|Overall Study|Adverse Event|1|||
33560892|NCT01570868|62955073|FG000|Overall Study|FDA Recommendation|23|||
33560893|NCT01570868|62955074|FG001|Overall Study|FDA Recommendation|3|||
33560894|NCT01570868|62955073|FG000|Overall Study|Physician Decision|10|||
33560895|NCT01570868|62955074|FG001|Overall Study|Physician Decision|4|||
33560896|NCT01570868|62955073|FG000|Overall Study|Lost to Follow-up|1|||
33560897|NCT01570868|62955074|FG001|Overall Study|Lost to Follow-up|0|||
33560898|NCT01570868|62955073|FG000|Overall Study|Withdrawal by Subject|1|||
33560899|NCT01570868|62955074|FG001|Overall Study|Withdrawal by Subject|0|||
33560900|NCT01565499|62955084|FG000|Overall Study|Physician Decision|1|||
33560901|NCT01565499|62955084|FG000|Overall Study|Adverse Event|5|||
33560902|NCT01565499|62955084|FG000|Overall Study|Withdrawal by Subject|2|||
33560903|NCT01036087|62955088|FG000|Overall Study|Adverse Event|2|||
33560904|NCT01036087|62955088|FG000|Overall Study|Lack of Efficacy|1|||
33560905|NCT00572156|62955105|FG000|Overall Study|Adverse Event|3|||
33560906|NCT00572156|62955106|FG001|Overall Study|Adverse Event|1|||
33560907|NCT00572156|62955107|FG002|Overall Study|Adverse Event|5|||
33560908|NCT00572156|62955108|FG003|Overall Study|Adverse Event|1|||
33560909|NCT00572156|62955105|FG000|Overall Study|Lost to Follow-up|1|||
33560910|NCT00572156|62955106|FG001|Overall Study|Lost to Follow-up|1|||
33560911|NCT00572156|62955107|FG002|Overall Study|Lost to Follow-up|1|||
33560912|NCT00572156|62955108|FG003|Overall Study|Lost to Follow-up|0|||
33560913|NCT00572156|62955105|FG000|Overall Study|Protocol Violation|1|||
33560914|NCT00572156|62955106|FG001|Overall Study|Protocol Violation|2|||
33560915|NCT00572156|62955107|FG002|Overall Study|Protocol Violation|0|||
33300074|NCT01033825|62676328|FG003|Overall Study|Withdrawal by Subject|1|||
33300075|NCT01033825|62676329|FG004|Overall Study|Withdrawal by Subject|1|||
33300076|NCT01033825|62676330|FG005|Overall Study|Withdrawal by Subject|0|||
33300077|NCT01033825|62676331|FG006|Overall Study|Withdrawal by Subject|0|||
33300078|NCT01033825|62676325|FG000|Overall Study|Adverse Event|0|||
33300079|NCT01033825|62676326|FG001|Overall Study|Adverse Event|0|||
33300080|NCT01033825|62676327|FG002|Overall Study|Adverse Event|0|||
33300081|NCT01033825|62676328|FG003|Overall Study|Adverse Event|1|||
33300082|NCT01033825|62676329|FG004|Overall Study|Adverse Event|0|||
33300083|NCT01033825|62676330|FG005|Overall Study|Adverse Event|0|||
33300084|NCT01033825|62676331|FG006|Overall Study|Adverse Event|0|||
33300085|NCT01033825|62676325|FG000|Overall Study|Protocol Violation|1|||
33560916|NCT00572156|62955108|FG003|Overall Study|Protocol Violation|2|||
33560917|NCT00572156|62955105|FG000|Overall Study|Patient/Parent Decision|1|||
33560918|NCT00572156|62955106|FG001|Overall Study|Patient/Parent Decision|6|||
33560919|NCT00572156|62955107|FG002|Overall Study|Patient/Parent Decision|4|||
33560920|NCT00572156|62955108|FG003|Overall Study|Patient/Parent Decision|3|||
33560921|NCT00572156|62955105|FG000|Overall Study|Sponsor Decision|20|||
33560922|NCT00572156|62955106|FG001|Overall Study|Sponsor Decision|16|||
33560923|NCT00572156|62955107|FG002|Overall Study|Sponsor Decision|17|||
33560924|NCT00572156|62955108|FG003|Overall Study|Sponsor Decision|19|||
33560925|NCT00447772|62955118|FG000|Overall Study|Lack of Efficacy|3|||
33560926|NCT00447772|62955118|FG000|Overall Study|Insufficient compliance|6|||
33560927|NCT00447772|62955118|FG000|Overall Study|Discontinuation of drug therapy|1|||
33560928|NCT00447772|62955118|FG000|Overall Study|Lost to Follow-up|9|||
33560929|NCT00447772|62955118|FG000|Overall Study|Withdrawal by Subject|1|||
33300086|NCT01033825|62676326|FG001|Overall Study|Protocol Violation|0|||
33300087|NCT01033825|62676327|FG002|Overall Study|Protocol Violation|0|||
33300088|NCT01033825|62676328|FG003|Overall Study|Protocol Violation|0|||
33560930|NCT00447772|62955118|FG000|Overall Study|Unable to attend all study visits|2|||
33560931|NCT00447772|62955118|FG000|Overall Study|Adverse Event|1|||
33560932|NCT00447772|62955118|FG000|Overall Study|Patient relocated|1|||
33560933|NCT00447772|62955118|FG000|Overall Study|Incomplete documentation at visit 1|1|||
33560934|NCT00447772|62955118|FG000|Overall Study|Chemotherapy for lung cancer|1|||
33560935|NCT00447772|62955118|FG000|Overall Study|Premature re-injection required|1|||
33560936|NCT02296138|62955127|FG000|Overall Study|Adverse Event|348|||
33560937|NCT02296138|62955128|FG001|Overall Study|Adverse Event|259|||
33560938|NCT02296138|62955127|FG000|Overall Study|Lack of Efficacy|59|||
33560939|NCT02296138|62955128|FG001|Overall Study|Lack of Efficacy|37|||
33560940|NCT02296138|62955127|FG000|Overall Study|Protocol Violation|35|||
33560941|NCT02296138|62955128|FG001|Overall Study|Protocol Violation|36|||
33560942|NCT02296138|62955127|FG000|Overall Study|Lost to Follow-up|9|||
33560943|NCT02296138|62955128|FG001|Overall Study|Lost to Follow-up|12|||
33560944|NCT02296138|62955127|FG000|Overall Study|Withdrawal by Subject|184|||
33560945|NCT02296138|62955128|FG001|Overall Study|Withdrawal by Subject|131|||
33560946|NCT02296138|62955127|FG000|Overall Study|Not Treated|1|||
33560947|NCT02296138|62955128|FG001|Overall Study|Not Treated|1|||
33560948|NCT02296138|62955127|FG000|Overall Study|Patients with data irregularities|10|||
33560949|NCT02296138|62955128|FG001|Overall Study|Patients with data irregularities|11|||
33560950|NCT02296138|62955127|FG000|Overall Study|Other than specified|15|||
33560951|NCT02296138|62955128|FG001|Overall Study|Other than specified|13|||
33560952|NCT01306942|62955137|FG000|Phase I|Adverse Event|2|||
33560953|NCT01306942|62955138|FG001|Phase I|Adverse Event|2|||
33560954|NCT01306942|62955139|FG002|Phase I|Adverse Event|0|||
33560955|NCT01306942|62955140|FG003|Phase I|Adverse Event|0|||
33560956|NCT01306942|62955137|FG000|Phase I|Physician Decision|3|||
33560957|NCT01306942|62955138|FG001|Phase I|Physician Decision|1|||
33560958|NCT01306942|62955139|FG002|Phase I|Physician Decision|0|||
33560959|NCT01306942|62955140|FG003|Phase I|Physician Decision|0|||
33560960|NCT01306942|62955137|FG000|Phase II|Adverse Event|0|||
33560961|NCT01306942|62955138|FG001|Phase II|Adverse Event|0|||
33560962|NCT01306942|62955139|FG002|Phase II|Adverse Event|0|||
33560963|NCT01306942|62955140|FG003|Phase II|Adverse Event|6|||
33560964|NCT01306942|62955137|FG000|Phase II|Physician Decision|2|||
33560965|NCT01306942|62955138|FG001|Phase II|Physician Decision|0|||
33560966|NCT01306942|62955139|FG002|Phase II|Physician Decision|0|||
33560967|NCT01306942|62955140|FG003|Phase II|Physician Decision|5|||
33560968|NCT01306942|62955137|FG000|Phase II|Withdrawal by Subject|0|||
33560969|NCT01306942|62955138|FG001|Phase II|Withdrawal by Subject|0|||
33560970|NCT01306942|62955139|FG002|Phase II|Withdrawal by Subject|0|||
33560971|NCT01306942|62955140|FG003|Phase II|Withdrawal by Subject|2|||
33560972|NCT01306942|62955137|FG000|Phase II|Death|0|||
33560973|NCT01306942|62955138|FG001|Phase II|Death|0|||
33560974|NCT01306942|62955139|FG002|Phase II|Death|0|||
33560975|NCT01306942|62955140|FG003|Phase II|Death|1|||
33560976|NCT01306942|62955137|FG000|Phase II|Not finished treatment|0|||
33560977|NCT01306942|62955138|FG001|Phase II|Not finished treatment|0|||
33560978|NCT01306942|62955139|FG002|Phase II|Not finished treatment|0|||
33560979|NCT01306942|62955140|FG003|Phase II|Not finished treatment|1|||
33560980|NCT01306942|62955137|FG000|Phase II|Protocol Violation|0|||
33560981|NCT01306942|62955138|FG001|Phase II|Protocol Violation|0|||
33662760|NCT01587703|63093239|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33560982|NCT01306942|62955139|FG002|Phase II|Protocol Violation|0|||
33560983|NCT01306942|62955140|FG003|Phase II|Protocol Violation|1|||
33560984|NCT02324842|62955155|FG000|Overall Study|Lost to Follow-up|1|||
33560985|NCT02324842|62955156|FG001|Overall Study|Lost to Follow-up|1|||
33560986|NCT02324842|62955157|FG002|Overall Study|Lost to Follow-up|2|||
33560987|NCT02295280|62955167|FG000|Overall Study|Adverse Event|0|||
33560988|NCT02295280|62955168|FG001|Overall Study|Adverse Event|1|||
33560989|NCT02294734|62955176|FG000|Overall Study|Adverse Event|5|||
33560990|NCT02294734|62955177|FG001|Overall Study|Adverse Event|5|||
33560991|NCT02294734|62955176|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
33560992|NCT02294734|62955177|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
33391164|NCT00699608|62769976|FG005|First Intervention|Withdrawal by Subject|0|||
33560993|NCT02294734|62955176|FG000|Overall Study|Lost to Follow-up|2|||
33560994|NCT02294734|62955177|FG001|Overall Study|Lost to Follow-up|0|||
33560995|NCT02294734|62955176|FG000|Overall Study|Physician Decision|2|||
33560996|NCT02294734|62955177|FG001|Overall Study|Physician Decision|1|||
33560997|NCT02294734|62955176|FG000|Overall Study|Withdrawal by Subject|4|||
33560998|NCT02294734|62955177|FG001|Overall Study|Withdrawal by Subject|2|||
33560999|NCT02323204|62955198|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
33561000|NCT02323204|62955199|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
33561001|NCT02323204|62955200|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
33561002|NCT02323204|62955201|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
33561003|NCT02323204|62955198|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
33391165|NCT00699608|62769971|FG000|First Intervention|Protocol Violation|0|||
33561004|NCT02323204|62955199|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
33561005|NCT02323204|62955200|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
33561006|NCT02323204|62955201|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
33561007|NCT02323204|62955198|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
33561008|NCT02323204|62955199|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
33561009|NCT02323204|62955200|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
33561010|NCT02323204|62955201|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
33561011|NCT02323204|62955198|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
33561012|NCT02323204|62955199|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
33561013|NCT02323204|62955200|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
33561014|NCT02323204|62955201|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
33561015|NCT02323204|62955198|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
33561016|NCT02323204|62955199|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
33561017|NCT02323204|62955200|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
33561018|NCT02323204|62955201|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
33561019|NCT02323204|62955198|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
33561020|NCT02323204|62955199|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
33561021|NCT02323204|62955200|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
33561022|NCT02323204|62955201|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
33561023|NCT02323204|62955198|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
33561024|NCT02323204|62955199|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
33561025|NCT02323204|62955200|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
33561026|NCT02323204|62955201|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
33561027|NCT02323204|62955198|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
33561028|NCT02323204|62955199|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
33561029|NCT02323204|62955200|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
33561030|NCT02323204|62955201|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
33561031|NCT02323204|62955198|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
33561032|NCT02323204|62955199|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
33561033|NCT02323204|62955200|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
33561034|NCT02323204|62955201|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
33561035|NCT02322892|62955213|FG000|Overall Study|Surgery cancelled|1|||
33561036|NCT02322892|62955214|FG001|Overall Study|Surgery cancelled|2|||
33561037|NCT02322892|62955213|FG000|Overall Study|Met exclusion criteria|0|||
33561038|NCT02322892|62955214|FG001|Overall Study|Met exclusion criteria|1|||
33561039|NCT02322892|62955213|FG000|Overall Study|Protocol Violation|1|||
33561040|NCT02322892|62955214|FG001|Overall Study|Protocol Violation|0|||
33561041|NCT03916081|62955223|FG000|Overall Study|Adverse Event|1|||
33561042|NCT03916081|62955224|FG001|Overall Study|Adverse Event|0|||
33561043|NCT03916081|62955225|FG002|Overall Study|Adverse Event|0|||
33561044|NCT03916081|62955223|FG000|Overall Study|Physician Decision|0|||
33561045|NCT03916081|62955224|FG001|Overall Study|Physician Decision|0|||
33561046|NCT03916081|62955225|FG002|Overall Study|Physician Decision|1|||
33561047|NCT03916081|62955223|FG000|Overall Study|Lost to Follow-up|0|||
33561048|NCT03916081|62955224|FG001|Overall Study|Lost to Follow-up|1|||
33561049|NCT03916081|62955225|FG002|Overall Study|Lost to Follow-up|0|||
33561050|NCT03916081|62955223|FG000|Overall Study|Withdrawal by Subject|3|||
33561051|NCT03916081|62955224|FG001|Overall Study|Withdrawal by Subject|0|||
33561052|NCT03916081|62955225|FG002|Overall Study|Withdrawal by Subject|1|||
33561053|NCT03916081|62955223|FG000|Overall Study|Worsening of AD|0|||
33561054|NCT03916081|62955224|FG001|Overall Study|Worsening of AD|0|||
33561055|NCT03916081|62955225|FG002|Overall Study|Worsening of AD|1|||
33561056|NCT02739997|62955233|FG000|Overall Study|Death|1|||
33561057|NCT02739997|62955233|FG000|Overall Study|Withdrawal by Subject|1|||
33561058|NCT02221037|62955241|FG000|Overall Study|Physician Decision|0|||
33662761|NCT01587703|63093240|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
33391166|NCT00699608|62769972|FG001|First Intervention|Protocol Violation|0|||
33391167|NCT00699608|62769973|FG002|First Intervention|Protocol Violation|0|||
33391168|NCT00699608|62769974|FG003|First Intervention|Protocol Violation|0|||
33391169|NCT00699608|62769975|FG004|First Intervention|Protocol Violation|1|||
33391170|NCT00699608|62769976|FG005|First Intervention|Protocol Violation|0|||
33391171|NCT00699608|62769971|FG000|Second Intervention|Adverse Event|0|||
33391172|NCT00699608|62769972|FG001|Second Intervention|Adverse Event|0|||
33391173|NCT00699608|62769973|FG002|Second Intervention|Adverse Event|1|||
33391174|NCT00699608|62769974|FG003|Second Intervention|Adverse Event|0|||
33391175|NCT00699608|62769975|FG004|Second Intervention|Adverse Event|0|||
33391176|NCT00699608|62769976|FG005|Second Intervention|Adverse Event|0|||
33561059|NCT02221037|62955242|FG001|Overall Study|Physician Decision|0|||
33561060|NCT02221037|62955243|FG002|Overall Study|Physician Decision|1|||
33561061|NCT02221037|62955244|FG003|Overall Study|Physician Decision|0|||
33561062|NCT02704429|62955260|FG000|Part A: 24 Weeks|Adverse Event|3|||
33561063|NCT02704429|62955261|FG001|Part A: 24 Weeks|Adverse Event|0|||
33561064|NCT02704429|62955260|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
33561065|NCT02704429|62955261|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
33561066|NCT02751359|62955268|FG000|Overall Study|Lost to Follow-up|1|||
33662762|NCT01587703|63093241|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33391177|NCT00699608|62769971|FG000|Second Intervention|Withdrawal by Subject|0|||
33391178|NCT00699608|62769972|FG001|Second Intervention|Withdrawal by Subject|0|||
33561067|NCT02750813|62955287|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
33561068|NCT02750813|62955288|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
33391179|NCT00699608|62769973|FG002|Second Intervention|Withdrawal by Subject|0|||
33391180|NCT00699608|62769974|FG003|Second Intervention|Withdrawal by Subject|1|||
33391181|NCT00699608|62769975|FG004|Second Intervention|Withdrawal by Subject|0|||
33391182|NCT00699608|62769976|FG005|Second Intervention|Withdrawal by Subject|0|||
33391183|NCT03823404|62769987|FG000|Overall Study|Lost to Follow-up|1|||
33561069|NCT02750813|62955287|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
33561070|NCT02750813|62955288|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
33561071|NCT00503035|62955304|FG000|Overall Study|Lost to Follow-up|2|||
33561072|NCT00503035|62955304|FG000|Overall Study|Physician Decision|3|||
33561073|NCT00503035|62955304|FG000|Overall Study|Ineligible|15|||
33561074|NCT03137381|62955313|FG000|Overall Study|Adverse Event|3|||
33561075|NCT03137381|62955314|FG001|Overall Study|Adverse Event|0|||
33561076|NCT03137381|62955315|FG002|Overall Study|Adverse Event|2|||
33561077|NCT03137381|62955316|FG003|Overall Study|Adverse Event|0|||
33561078|NCT03137381|62955313|FG000|Overall Study|Lost to Follow-up|2|||
33561079|NCT03137381|62955314|FG001|Overall Study|Lost to Follow-up|1|||
33561080|NCT03137381|62955315|FG002|Overall Study|Lost to Follow-up|1|||
33561081|NCT03137381|62955316|FG003|Overall Study|Lost to Follow-up|0|||
33561082|NCT03137381|62955313|FG000|Overall Study|Protocol deviation|1|||
33561083|NCT03137381|62955314|FG001|Overall Study|Protocol deviation|1|||
33561084|NCT03137381|62955315|FG002|Overall Study|Protocol deviation|0|||
33561085|NCT03137381|62955316|FG003|Overall Study|Protocol deviation|1|||
33561086|NCT03137381|62955313|FG000|Overall Study|Withdrawal by Investigator|0|||
33561087|NCT03137381|62955314|FG001|Overall Study|Withdrawal by Investigator|1|||
33561088|NCT03137381|62955315|FG002|Overall Study|Withdrawal by Investigator|1|||
33561089|NCT03137381|62955316|FG003|Overall Study|Withdrawal by Investigator|0|||
33561090|NCT03137381|62955313|FG000|Overall Study|Withdrawal by Subject|3|||
33561091|NCT03137381|62955314|FG001|Overall Study|Withdrawal by Subject|4|||
33561092|NCT03137381|62955315|FG002|Overall Study|Withdrawal by Subject|3|||
33561093|NCT03137381|62955316|FG003|Overall Study|Withdrawal by Subject|0|||
33561094|NCT03137381|62955313|FG000|Overall Study|Pregnancy|0|||
33561095|NCT03137381|62955314|FG001|Overall Study|Pregnancy|0|||
33561096|NCT03137381|62955315|FG002|Overall Study|Pregnancy|1|||
33561097|NCT03137381|62955316|FG003|Overall Study|Pregnancy|0|||
33561098|NCT03926117|62955330|FG000|Overall Study|Unclassified|1|||
33561099|NCT03926117|62955331|FG001|Overall Study|Unclassified|4|||
33561100|NCT03926117|62955332|FG002|Overall Study|Unclassified|1|||
33561101|NCT03926117|62955333|FG003|Overall Study|Unclassified|4|||
33561102|NCT03926117|62955330|FG000|Overall Study|Withdrawal by Subject|3|||
33561103|NCT03926117|62955331|FG001|Overall Study|Withdrawal by Subject|0|||
33561104|NCT03926117|62955332|FG002|Overall Study|Withdrawal by Subject|1|||
33561105|NCT03926117|62955333|FG003|Overall Study|Withdrawal by Subject|1|||
33561106|NCT03926117|62955330|FG000|Overall Study|Lost to Follow-up|0|||
33561107|NCT03926117|62955331|FG001|Overall Study|Lost to Follow-up|2|||
33561108|NCT03926117|62955332|FG002|Overall Study|Lost to Follow-up|1|||
33561109|NCT03926117|62955333|FG003|Overall Study|Lost to Follow-up|0|||
33561110|NCT03926117|62955330|FG000|Overall Study|Adverse Event|1|||
33561111|NCT03926117|62955331|FG001|Overall Study|Adverse Event|2|||
33561112|NCT03926117|62955332|FG002|Overall Study|Adverse Event|3|||
33561113|NCT03926117|62955333|FG003|Overall Study|Adverse Event|1|||
33300089|NCT01033825|62676329|FG004|Overall Study|Protocol Violation|0|||
33300090|NCT01033825|62676330|FG005|Overall Study|Protocol Violation|0|||
33300091|NCT01033825|62676331|FG006|Overall Study|Protocol Violation|0|||
33300092|NCT01033825|62676325|FG000|Overall Study|Other|0|||
33300093|NCT01033825|62676326|FG001|Overall Study|Other|0|||
33300094|NCT01033825|62676327|FG002|Overall Study|Other|0|||
33300095|NCT01033825|62676328|FG003|Overall Study|Other|0|||
33300096|NCT01033825|62676329|FG004|Overall Study|Other|1|||
33300097|NCT01033825|62676330|FG005|Overall Study|Other|0|||
33300098|NCT01033825|62676331|FG006|Overall Study|Other|0|||
33300099|NCT01033747|62676351|FG000|Overall Study|Adverse Event|9|||
33391184|NCT03823404|62769988|FG001|Overall Study|Lost to Follow-up|2|||
33391185|NCT03823404|62769989|FG002|Overall Study|Lost to Follow-up|3|||
33391186|NCT03823404|62769987|FG000|Overall Study|Protocol Violation|2|||
33391187|NCT03823404|62769988|FG001|Overall Study|Protocol Violation|0|||
33391188|NCT03823404|62769989|FG002|Overall Study|Protocol Violation|2|||
33300100|NCT01033747|62676352|FG001|Overall Study|Adverse Event|4|||
33300101|NCT01033747|62676351|FG000|Overall Study|Abnormal Laboratory Value|1|||
33391189|NCT03823404|62769987|FG000|Overall Study|Adverse Event|35|||
33300102|NCT01033747|62676352|FG001|Overall Study|Abnormal Laboratory Value|0|||
33561114|NCT03926117|62955330|FG000|Overall Study|Randomized but not treated|1|||
33561115|NCT03926117|62955331|FG001|Overall Study|Randomized but not treated|1|||
33561116|NCT03926117|62955332|FG002|Overall Study|Randomized but not treated|0|||
33561117|NCT03926117|62955333|FG003|Overall Study|Randomized but not treated|1|||
33561118|NCT02750501|62955360|FG000|Overall Study|Adverse Event|4|||
33561119|NCT02750501|62955360|FG000|Overall Study|Physician Decision|1|||
33561120|NCT02750501|62955360|FG000|Overall Study|Protocol Violation|1|||
33391190|NCT03823404|62769988|FG001|Overall Study|Adverse Event|38|||
33391191|NCT03823404|62769989|FG002|Overall Study|Adverse Event|8|||
33561121|NCT02750501|62955360|FG000|Overall Study|G-tube came out|1|||
33561122|NCT02750501|62955360|FG000|Overall Study|Non-compliant use of PERT|1|||
33561123|NCT01337297|62955383|FG000|Overall Study|They entered to single anodal tDCS|4|||
33300103|NCT01033747|62676351|FG000|Overall Study|Abnormal test procedure|0|||
33391192|NCT03823404|62769987|FG000|Overall Study|Withdrawal by Subject|38|||
33391193|NCT03823404|62769988|FG001|Overall Study|Withdrawal by Subject|40|||
33391194|NCT03823404|62769989|FG002|Overall Study|Withdrawal by Subject|35|||
33391195|NCT03823404|62769987|FG000|Overall Study|Death|4|||
33391196|NCT03823404|62769988|FG001|Overall Study|Death|0|||
33391197|NCT03823404|62769989|FG002|Overall Study|Death|0|||
33391198|NCT03823404|62769987|FG000|Overall Study|Other: Various reasons provided|5|||
33391199|NCT03823404|62769988|FG001|Overall Study|Other: Various reasons provided|5|||
33391200|NCT03823404|62769989|FG002|Overall Study|Other: Various reasons provided|6|||
33391201|NCT00706706|62769997|FG000|Overall Study|Death|53|||
33391202|NCT00706706|62769997|FG000|Overall Study|Lost to Follow-up|7|||
33391203|NCT00706706|62769997|FG000|Overall Study|Study endpoint had reached|45|||
33391204|NCT00410761|62770003|FG000|Overall Study|Adverse Event|29|||
33391205|NCT00410761|62770004|FG001|Overall Study|Adverse Event|3|||
33391206|NCT00410761|62770003|FG000|Overall Study|objective disease progression|71|||
33391207|NCT00410761|62770004|FG001|Overall Study|objective disease progression|55|||
33300104|NCT01033747|62676352|FG001|Overall Study|Abnormal test procedure|1|||
33300105|NCT01033747|62676351|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
33300106|NCT01033747|62676352|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
33300107|NCT01033747|62676351|FG000|Overall Study|Protocol Violation|1|||
33300108|NCT01033747|62676352|FG001|Overall Study|Protocol Violation|0|||
33300109|NCT01033747|62676351|FG000|Overall Study|Withdrawal by Subject|9|||
33300110|NCT01033747|62676352|FG001|Overall Study|Withdrawal by Subject|6|||
33300111|NCT01033747|62676351|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
33300112|NCT01033747|62676352|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
33300113|NCT01033747|62676351|FG000|Overall Study|Stopped at end of Extension 1|2|||
33300114|NCT01033747|62676352|FG001|Overall Study|Stopped at end of Extension 1|0|||
33300115|NCT01091428|62676362|FG000|Phase 1|Progressive Disease|24|||
33300116|NCT01091428|62676363|FG001|Phase 1|Progressive Disease|8|||
33300117|NCT01091428|62676364|FG002|Phase 1|Progressive Disease|0|||
33300118|NCT01091428|62676365|FG003|Phase 1|Progressive Disease|0|||
33300119|NCT01091428|62676362|FG000|Phase 1|Symptomatic Deterioration|3|||
33300120|NCT01091428|62676363|FG001|Phase 1|Symptomatic Deterioration|2|||
33300121|NCT01091428|62676364|FG002|Phase 1|Symptomatic Deterioration|0|||
33300122|NCT01091428|62676365|FG003|Phase 1|Symptomatic Deterioration|0|||
33300123|NCT01091428|62676362|FG000|Phase 1|Adverse Event|2|||
33300124|NCT01091428|62676363|FG001|Phase 1|Adverse Event|0|||
33300125|NCT01091428|62676364|FG002|Phase 1|Adverse Event|0|||
33300126|NCT01091428|62676365|FG003|Phase 1|Adverse Event|0|||
33300127|NCT01091428|62676362|FG000|Phase 1|Withdrawal by Subject|7|||
33300128|NCT01091428|62676363|FG001|Phase 1|Withdrawal by Subject|0|||
33300129|NCT01091428|62676364|FG002|Phase 1|Withdrawal by Subject|0|||
33300130|NCT01091428|62676365|FG003|Phase 1|Withdrawal by Subject|0|||
33300131|NCT01091428|62676362|FG000|Phase 1|Reason not specified|0|||
33300132|NCT01091428|62676363|FG001|Phase 1|Reason not specified|1|||
33300133|NCT01091428|62676364|FG002|Phase 1|Reason not specified|0|||
33300134|NCT01091428|62676365|FG003|Phase 1|Reason not specified|0|||
33300135|NCT01091428|62676362|FG000|Phase 1|Single-Patient IND|2|||
33300136|NCT01091428|62676363|FG001|Phase 1|Single-Patient IND|0|||
33300137|NCT01091428|62676364|FG002|Phase 1|Single-Patient IND|0|||
33300138|NCT01091428|62676365|FG003|Phase 1|Single-Patient IND|0|||
33300139|NCT01091428|62676362|FG000|Phase 2|Progressive Disease|0|||
33300140|NCT01091428|62676363|FG001|Phase 2|Progressive Disease|0|||
33391208|NCT00410761|62770003|FG000|Overall Study|Withdrawal by Subject|8|||
33391209|NCT00410761|62770004|FG001|Overall Study|Withdrawal by Subject|4|||
33391210|NCT00410761|62770003|FG000|Overall Study|Other|12|||
33391211|NCT00410761|62770004|FG001|Overall Study|Other|9|||
33391212|NCT00410761|62770003|FG000|Overall Study|Never received randomised treatment|0|||
33391213|NCT00410761|62770004|FG001|Overall Study|Never received randomised treatment|1|||
33391214|NCT00410605|62770010|FG000|Overall Study|Adverse Event|12|||
33391215|NCT00410605|62770010|FG000|Overall Study|Physician Decision|3|||
33391216|NCT00410605|62770010|FG000|Overall Study|Withdrawal by Subject|5|||
33300141|NCT01091428|62676364|FG002|Phase 2|Progressive Disease|44|||
33300142|NCT01091428|62676365|FG003|Phase 2|Progressive Disease|46|||
33300143|NCT01091428|62676362|FG000|Phase 2|Symptomatic Deterioration|0|||
33300144|NCT01091428|62676363|FG001|Phase 2|Symptomatic Deterioration|0|||
33300145|NCT01091428|62676364|FG002|Phase 2|Symptomatic Deterioration|1|||
33300146|NCT01091428|62676365|FG003|Phase 2|Symptomatic Deterioration|6|||
33300147|NCT01091428|62676362|FG000|Phase 2|Adverse Event|0|||
33300148|NCT01091428|62676363|FG001|Phase 2|Adverse Event|0|||
33300149|NCT01091428|62676364|FG002|Phase 2|Adverse Event|12|||
33561124|NCT01337297|62955384|FG001|Overall Study|They entered to single anodal tDCS|3|||
33391217|NCT00410605|62770010|FG000|Overall Study|Started Non-Protocol Therapy|3|||
33391218|NCT00410605|62770010|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
33391219|NCT00410605|62770010|FG000|Overall Study|Transferred to another Institution|1|||
33391220|NCT00418717|62770014|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
33391221|NCT00418717|62770014|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
33391222|NCT00572572|62770020|FG000|Overall Study|Withdrawal by Subject|3|||
33391223|NCT00572572|62770021|FG001|Overall Study|Withdrawal by Subject|6|||
33391224|NCT00418561|62770030|FG000|Overall Study|Participant's (guardian's) decision|0|||
33391225|NCT00418561|62770031|FG001|Overall Study|Participant's (guardian's) decision|1|||
33391226|NCT00418561|62770032|FG002|Overall Study|Participant's (guardian's) decision|0|||
33391227|NCT00398047|62770040|FG000|Overall Study|all patient progressed before completion|3|||
33561125|NCT01337297|62955383|FG000|Overall Study|Lost to Follow-up|1|||
33561126|NCT01337297|62955384|FG001|Overall Study|Lost to Follow-up|3|||
33561127|NCT02302963|62955392|FG000|Overall Study|Withdrawal by Subject|2|||
33561128|NCT02302963|62955393|FG001|Overall Study|Withdrawal by Subject|1|||
33561129|NCT02302963|62955392|FG000|Overall Study|Steroid injection|0|||
33561130|NCT02302963|62955393|FG001|Overall Study|Steroid injection|1|||
33561131|NCT02302963|62955392|FG000|Overall Study|Physician Decision|1|||
33561132|NCT02302963|62955393|FG001|Overall Study|Physician Decision|0|||
33561133|NCT04702997|62955401|FG000|Overall Study|Withdrawal by Subject|1|||
33561134|NCT04702997|62955402|FG001|Overall Study|Withdrawal by Subject|1|||
33561135|NCT03507439|62955423|FG000|Overall Study|Other|2|||
33561136|NCT03507439|62955424|FG001|Overall Study|Other|1|||
33561137|NCT03507439|62955423|FG000|Overall Study|Withdrawal by Subject|1|||
33561138|NCT03507439|62955424|FG001|Overall Study|Withdrawal by Subject|0|||
33561139|NCT03507439|62955423|FG000|Overall Study|Death|1|||
33561140|NCT03507439|62955424|FG001|Overall Study|Death|1|||
33561141|NCT03507127|62955432|FG000|Overall Study|Withdrawal by Subject|1|||
33561142|NCT03507127|62955433|FG001|Overall Study|Withdrawal by Subject|0|||
33561143|NCT03507127|62955432|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
33561144|NCT03507127|62955433|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
33561145|NCT02322190|62955456|FG000|Overall Study|Death on study|1|||
33561146|NCT02322190|62955457|FG001|Overall Study|Death on study|0|||
33561147|NCT02321800|62955473|FG000|Overall Study|Withdrawal by Subject|3|||
33561148|NCT02321800|62955474|FG001|Overall Study|Withdrawal by Subject|3|||
33561149|NCT02321800|62955473|FG000|Overall Study|Death|1|||
33561150|NCT02321800|62955474|FG001|Overall Study|Death|0|||
33561151|NCT02321800|62955473|FG000|Overall Study|Protocol Violation|1|||
33561152|NCT02321800|62955474|FG001|Overall Study|Protocol Violation|0|||
33561153|NCT02321800|62955473|FG000|Overall Study|Lost to Follow-up|10|||
33561154|NCT02321800|62955474|FG001|Overall Study|Lost to Follow-up|4|||
33561155|NCT02321800|62955473|FG000|Overall Study|Adverse Event|2|||
33561156|NCT02321800|62955474|FG001|Overall Study|Adverse Event|3|||
33561157|NCT02321800|62955473|FG000|Overall Study|Other, Miscellaneous|3|||
33561158|NCT02321800|62955474|FG001|Overall Study|Other, Miscellaneous|1|||
33662763|NCT01587703|63093242|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33662764|NCT01587703|63093243|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33662765|NCT01587703|63093244|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33662766|NCT01587703|63093226|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33300150|NCT01091428|62676365|FG003|Phase 2|Adverse Event|5|||
33300151|NCT01091428|62676362|FG000|Phase 2|Withdrawal by Subject|0|||
33300152|NCT01091428|62676363|FG001|Phase 2|Withdrawal by Subject|0|||
33300153|NCT01091428|62676364|FG002|Phase 2|Withdrawal by Subject|9|||
33300154|NCT01091428|62676365|FG003|Phase 2|Withdrawal by Subject|8|||
33300155|NCT01091428|62676362|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
33561159|NCT02292784|62955520|FG000|Overall Study|Lost to Follow-up|1|||
33561160|NCT02292784|62955521|FG001|Overall Study|Lost to Follow-up|17|||
33300156|NCT01091428|62676363|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
33300157|NCT01091428|62676364|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
33300158|NCT01091428|62676365|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
33300159|NCT01091428|62676362|FG000|Phase 2|Reason not specified|0|||
33300160|NCT01091428|62676363|FG001|Phase 2|Reason not specified|0|||
33300161|NCT01091428|62676364|FG002|Phase 2|Reason not specified|4|||
33300162|NCT01091428|62676365|FG003|Phase 2|Reason not specified|3|||
33662767|NCT01587703|63093227|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33300163|NCT01091428|62676362|FG000|Phase 2|Physician Decision|0|||
33391228|NCT00631371|62770047|FG000|Overall Study|Lost to Follow-up|24|||
33391229|NCT00631371|62770048|FG001|Overall Study|Lost to Follow-up|19|||
33391230|NCT00631371|62770047|FG000|Overall Study|Other reason|5|||
33391231|NCT00631371|62770048|FG001|Overall Study|Other reason|12|||
33561161|NCT02292784|62955522|FG002|Overall Study|Lost to Follow-up|18|||
33561162|NCT02292784|62955520|FG000|Overall Study|Withdrawal by Subject|0|||
33300164|NCT01091428|62676363|FG001|Phase 2|Physician Decision|0|||
33561163|NCT02292784|62955521|FG001|Overall Study|Withdrawal by Subject|3|||
33561164|NCT02292784|62955522|FG002|Overall Study|Withdrawal by Subject|3|||
33561165|NCT02320396|62955532|FG000|Overall Study|Adverse Event|2|||
33561166|NCT02320396|62955533|FG001|Overall Study|Adverse Event|2|||
33561167|NCT02320396|62955532|FG000|Overall Study|Pregnancy|0|||
33561168|NCT02320396|62955533|FG001|Overall Study|Pregnancy|1|||
33561169|NCT02320396|62955532|FG000|Overall Study|Protocol Violation|0|||
33561170|NCT02320396|62955533|FG001|Overall Study|Protocol Violation|1|||
33561171|NCT02320396|62955532|FG000|Overall Study|Withdrawal by Subject|2|||
33561172|NCT02320396|62955533|FG001|Overall Study|Withdrawal by Subject|0|||
33561173|NCT02292238|62955541|FG000|Overall Study|Protocol Violation|1|||
33561174|NCT02292238|62955542|FG001|Overall Study|Protocol Violation|2|||
33561175|NCT02292238|62955541|FG000|Overall Study|Withdrawal by Subject|2|||
33561176|NCT02292238|62955542|FG001|Overall Study|Withdrawal by Subject|1|||
33561177|NCT02292238|62955541|FG000|Overall Study|Lost to Follow-up|1|||
33561178|NCT02292238|62955542|FG001|Overall Study|Lost to Follow-up|0|||
33561179|NCT02292238|62955541|FG000|Overall Study|Physician Decision|0|||
33561180|NCT02292238|62955542|FG001|Overall Study|Physician Decision|1|||
33561181|NCT02234843|62955579|FG000|Overall Study|Death|1|||
33561182|NCT02234843|62955580|FG001|Overall Study|Death|0|||
33561183|NCT02234843|62955581|FG002|Overall Study|Death|0|||
33561184|NCT02234843|62955582|FG003|Overall Study|Death|0|||
33561185|NCT02234843|62955583|FG004|Overall Study|Death|0|||
33561186|NCT02234843|62955584|FG005|Overall Study|Death|0|||
33561187|NCT02234843|62955585|FG006|Overall Study|Death|0|||
33561188|NCT02234843|62955586|FG007|Overall Study|Death|0|||
33561189|NCT02234843|62955587|FG008|Overall Study|Death|0|||
33561190|NCT02234843|62955588|FG009|Overall Study|Death|0|||
33561191|NCT02234843|62955579|FG000|Overall Study|Protocol Violation|1|||
33561192|NCT02234843|62955580|FG001|Overall Study|Protocol Violation|0|||
33561193|NCT02234843|62955581|FG002|Overall Study|Protocol Violation|1|||
33561194|NCT02234843|62955582|FG003|Overall Study|Protocol Violation|0|||
33561195|NCT02234843|62955583|FG004|Overall Study|Protocol Violation|0|||
33561196|NCT02234843|62955584|FG005|Overall Study|Protocol Violation|0|||
33561197|NCT02234843|62955585|FG006|Overall Study|Protocol Violation|0|||
33561198|NCT02234843|62955586|FG007|Overall Study|Protocol Violation|0|||
33561199|NCT02234843|62955587|FG008|Overall Study|Protocol Violation|0|||
33561200|NCT02234843|62955588|FG009|Overall Study|Protocol Violation|0|||
33561201|NCT02234843|62955579|FG000|Overall Study|Efficacy outcome reached|2|||
33561202|NCT02234843|62955580|FG001|Overall Study|Efficacy outcome reached|0|||
33561203|NCT02234843|62955581|FG002|Overall Study|Efficacy outcome reached|0|||
33561204|NCT02234843|62955582|FG003|Overall Study|Efficacy outcome reached|0|||
33561205|NCT02234843|62955583|FG004|Overall Study|Efficacy outcome reached|0|||
33561206|NCT02234843|62955584|FG005|Overall Study|Efficacy outcome reached|2|||
33561207|NCT02234843|62955585|FG006|Overall Study|Efficacy outcome reached|0|||
33561208|NCT02234843|62955586|FG007|Overall Study|Efficacy outcome reached|0|||
33561209|NCT02234843|62955587|FG008|Overall Study|Efficacy outcome reached|0|||
33561210|NCT02234843|62955588|FG009|Overall Study|Efficacy outcome reached|0|||
33561211|NCT02234843|62955579|FG000|Overall Study|Patient convenience|2|||
33561212|NCT02234843|62955580|FG001|Overall Study|Patient convenience|0|||
33561213|NCT02234843|62955581|FG002|Overall Study|Patient convenience|0|||
33561214|NCT02234843|62955582|FG003|Overall Study|Patient convenience|0|||
33561215|NCT02234843|62955583|FG004|Overall Study|Patient convenience|0|||
33561216|NCT02234843|62955584|FG005|Overall Study|Patient convenience|1|||
33561217|NCT02234843|62955585|FG006|Overall Study|Patient convenience|0|||
33561218|NCT02234843|62955586|FG007|Overall Study|Patient convenience|0|||
33561219|NCT02234843|62955587|FG008|Overall Study|Patient convenience|0|||
33561220|NCT02234843|62955588|FG009|Overall Study|Patient convenience|0|||
33561221|NCT02234843|62955579|FG000|Overall Study|Withdrawal by Subject|5|||
33561222|NCT02234843|62955580|FG001|Overall Study|Withdrawal by Subject|1|||
33561223|NCT02234843|62955581|FG002|Overall Study|Withdrawal by Subject|1|||
33561224|NCT02234843|62955582|FG003|Overall Study|Withdrawal by Subject|0|||
33561225|NCT02234843|62955583|FG004|Overall Study|Withdrawal by Subject|0|||
33561226|NCT02234843|62955584|FG005|Overall Study|Withdrawal by Subject|7|||
33561227|NCT02234843|62955585|FG006|Overall Study|Withdrawal by Subject|0|||
33561228|NCT02234843|62955586|FG007|Overall Study|Withdrawal by Subject|0|||
33561229|NCT02234843|62955587|FG008|Overall Study|Withdrawal by Subject|0|||
33561230|NCT02234843|62955588|FG009|Overall Study|Withdrawal by Subject|0|||
33561231|NCT02234843|62955579|FG000|Overall Study|Recovery|1|||
33561232|NCT02234843|62955580|FG001|Overall Study|Recovery|0|||
33561233|NCT02234843|62955581|FG002|Overall Study|Recovery|0|||
33561234|NCT02234843|62955582|FG003|Overall Study|Recovery|0|||
33561235|NCT02234843|62955583|FG004|Overall Study|Recovery|0|||
33561236|NCT02234843|62955584|FG005|Overall Study|Recovery|0|||
33561237|NCT02234843|62955585|FG006|Overall Study|Recovery|0|||
33561238|NCT02234843|62955586|FG007|Overall Study|Recovery|0|||
33561239|NCT02234843|62955587|FG008|Overall Study|Recovery|0|||
33561240|NCT02234843|62955588|FG009|Overall Study|Recovery|0|||
33561241|NCT02234843|62955579|FG000|Overall Study|Other|0|||
33561242|NCT02234843|62955580|FG001|Overall Study|Other|2|||
33561243|NCT02234843|62955581|FG002|Overall Study|Other|0|||
33561244|NCT02234843|62955582|FG003|Overall Study|Other|1|||
33561245|NCT02234843|62955583|FG004|Overall Study|Other|0|||
33561246|NCT02234843|62955584|FG005|Overall Study|Other|1|||
33561247|NCT02234843|62955585|FG006|Overall Study|Other|0|||
33561248|NCT02234843|62955586|FG007|Overall Study|Other|1|||
33561249|NCT02234843|62955587|FG008|Overall Study|Other|0|||
33561250|NCT02234843|62955588|FG009|Overall Study|Other|0|||
33391232|NCT00631371|62770047|FG000|Overall Study|subject request|38|||
33391233|NCT00631371|62770048|FG001|Overall Study|subject request|45|||
33391234|NCT00631371|62770047|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
33391235|NCT00631371|62770048|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
33391236|NCT00631371|62770047|FG000|Overall Study|Death|263|||
33391237|NCT00631371|62770048|FG001|Overall Study|Death|239|||
33391238|NCT00409747|62770054|FG000|Overall Study|Withdrawal by Subject|1|||
33391239|NCT00630747|62770058|FG000|Overall Study|Death|1|||
33391240|NCT00630747|62770058|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
33391241|NCT00630747|62770058|FG000|Overall Study|Returned to country of origin|1|||
33391242|NCT00397891|62770067|FG000|Overall Study|Withdrawal by Subject|1|||
33391243|NCT00397891|62770068|FG001|Overall Study|Withdrawal by Subject|0|||
33391244|NCT00397891|62770069|FG002|Overall Study|Withdrawal by Subject|0|||
33391245|NCT00397891|62770070|FG003|Overall Study|Withdrawal by Subject|0|||
33391246|NCT00397891|62770071|FG004|Overall Study|Withdrawal by Subject|1|||
33391247|NCT00397189|62770085|FG000|3 Weeks Period|Lost to Follow-up|5|||
33391248|NCT00397189|62770086|FG001|3 Weeks Period|Lost to Follow-up|4|||
33391249|NCT00397189|62770085|FG000|3 Weeks Period|Adverse Event|3|||
33391250|NCT00397189|62770086|FG001|3 Weeks Period|Adverse Event|2|||
33391251|NCT00397189|62770085|FG000|3 Weeks Period|Withdrawal by Subject|13|||
33391252|NCT00397189|62770086|FG001|3 Weeks Period|Withdrawal by Subject|9|||
33391253|NCT00397189|62770085|FG000|3 Weeks Period|Physician Decision|0|||
33391254|NCT00397189|62770086|FG001|3 Weeks Period|Physician Decision|2|||
33391255|NCT00397189|62770085|FG000|3 Weeks Period|Protocol Violation|0|||
33391256|NCT00397189|62770086|FG001|3 Weeks Period|Protocol Violation|3|||
33391257|NCT00397189|62770085|FG000|3 Weeks Period|Other|0|||
33391258|NCT00397189|62770086|FG001|3 Weeks Period|Other|2|||
33391259|NCT00606034|62770094|FG000|Overall Study|incarceration|1|||
33391260|NCT00397033|62770103|FG000|Overall Study|Adverse Event|7|||
33391261|NCT00397033|62770104|FG001|Overall Study|Adverse Event|10|||
33391262|NCT00397033|62770105|FG002|Overall Study|Adverse Event|4|||
33391263|NCT00397033|62770103|FG000|Overall Study|Lack of Efficacy|22|||
33391264|NCT00397033|62770104|FG001|Overall Study|Lack of Efficacy|12|||
33391265|NCT00397033|62770105|FG002|Overall Study|Lack of Efficacy|9|||
33391266|NCT00397033|62770103|FG000|Overall Study|Lost to Follow-up|3|||
33391267|NCT00397033|62770104|FG001|Overall Study|Lost to Follow-up|3|||
33391268|NCT00397033|62770105|FG002|Overall Study|Lost to Follow-up|3|||
33391269|NCT00397033|62770103|FG000|Overall Study|Withdrawal by Subject|12|||
33391270|NCT00397033|62770104|FG001|Overall Study|Withdrawal by Subject|7|||
33391271|NCT00397033|62770105|FG002|Overall Study|Withdrawal by Subject|5|||
33391272|NCT00397033|62770103|FG000|Overall Study|Other|0|||
33391273|NCT00397033|62770104|FG001|Overall Study|Other|5|||
33391274|NCT00397033|62770105|FG002|Overall Study|Other|2|||
33391275|NCT00572728|62770113|FG000|Overall Study|Withdrawal by Subject|10|||
33391276|NCT00572728|62770113|FG000|Overall Study|Ineligible|3|||
33391277|NCT00572728|62770113|FG000|Overall Study|Enrolled under Amendment 4|5|||
33391278|NCT00572728|62770113|FG000|Overall Study|Offstudy due to complicating disease|1|||
33391279|NCT00572728|62770113|FG000|Overall Study|FLT1 not completed|4|||
33391280|NCT00572728|62770113|FG000|Overall Study|First Chemotherapy not initiated|2|||
33391281|NCT00572728|62770113|FG000|Overall Study|FLT2 not completed|5|||
33391282|NCT00572728|62770113|FG000|Overall Study|Second chemotherapy not initiated|1|||
33391283|NCT00572728|62770113|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
33391284|NCT00572728|62770113|FG000|Overall Study|Pathology missing|1|||
33391285|NCT00699374|62770121|FG000|Overall Study|Death|93|||
33391286|NCT00699374|62770122|FG001|Overall Study|Death|83|||
33391287|NCT00699374|62770121|FG000|Overall Study|Adverse Event|70|||
33391288|NCT00699374|62770122|FG001|Overall Study|Adverse Event|67|||
33561251|NCT02234843|62955579|FG000|Overall Study|Physician Decision|4|||
33561252|NCT02234843|62955580|FG001|Overall Study|Physician Decision|1|||
33662768|NCT01587703|63093228|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33662769|NCT01587703|63093229|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33391289|NCT00699374|62770121|FG000|Overall Study|Global deterioration of health status|7|||
33391290|NCT00699374|62770122|FG001|Overall Study|Global deterioration of health status|8|||
33391291|NCT00699374|62770121|FG000|Overall Study|Lost to Follow-up|3|||
33391292|NCT00699374|62770122|FG001|Overall Study|Lost to Follow-up|5|||
33391293|NCT00699374|62770121|FG000|Overall Study|Withdrawal by Subject|34|||
33391294|NCT00699374|62770122|FG001|Overall Study|Withdrawal by Subject|44|||
33391295|NCT00699374|62770121|FG000|Overall Study|Objective progression or relapse|281|||
33391296|NCT00699374|62770122|FG001|Overall Study|Objective progression or relapse|277|||
33391297|NCT00699374|62770121|FG000|Overall Study|Other|18|||
33391298|NCT00699374|62770122|FG001|Overall Study|Other|15|||
33391299|NCT00699374|62770121|FG000|Overall Study|Protocol Violation|2|||
33391300|NCT00699374|62770122|FG001|Overall Study|Protocol Violation|6|||
33391301|NCT00699374|62770121|FG000|Overall Study|Study terminated by sponsor|13|||
33561253|NCT02234843|62955581|FG002|Overall Study|Physician Decision|0|||
33391302|NCT00699374|62770122|FG001|Overall Study|Study terminated by sponsor|28|||
33391303|NCT00699374|62770121|FG000|Overall Study|Randomized but not treated|4|||
33391304|NCT00699374|62770122|FG001|Overall Study|Randomized but not treated|2|||
33391305|NCT00699374|62770121|FG000|Overall Study|Died 28 days after last dose|5|||
33391306|NCT00699374|62770122|FG001|Overall Study|Died 28 days after last dose|9|||
33391307|NCT00606892|62770128|FG000|First Intervention|Protocol Violation|1|||
33391308|NCT00606892|62770129|FG001|First Intervention|Protocol Violation|4|||
33391309|NCT00625443|62770164|FG000|Overall Study|Adverse Event|1|||
33391310|NCT00625443|62770165|FG001|Overall Study|Adverse Event|4|||
33391311|NCT00625443|62770166|FG002|Overall Study|Adverse Event|0|||
33391312|NCT00625443|62770164|FG000|Overall Study|Non-compliance with protocol|0|||
33391313|NCT00625443|62770165|FG001|Overall Study|Non-compliance with protocol|1|||
33391314|NCT00625443|62770166|FG002|Overall Study|Non-compliance with protocol|0|||
33391315|NCT00625443|62770164|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
33391316|NCT00625443|62770165|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
33391317|NCT00625443|62770166|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
33391318|NCT00625443|62770164|FG000|Overall Study|Withdrawal by Subject|0|||
33391319|NCT00625443|62770165|FG001|Overall Study|Withdrawal by Subject|1|||
33391320|NCT00625443|62770166|FG002|Overall Study|Withdrawal by Subject|2|||
33391321|NCT00625443|62770164|FG000|Overall Study|Physician Decision|0|||
33391322|NCT00625443|62770165|FG001|Overall Study|Physician Decision|4|||
33391323|NCT00625443|62770166|FG002|Overall Study|Physician Decision|2|||
33391324|NCT00625443|62770164|FG000|Overall Study|Other|0|||
33391325|NCT00625443|62770165|FG001|Overall Study|Other|1|||
33391326|NCT00625443|62770166|FG002|Overall Study|Other|1|||
33391327|NCT00625365|62770177|FG000|Overall Study|Withdrawal by Subject|1|||
33391328|NCT00625365|62770177|FG000|Overall Study|No IV access|5|||
33391329|NCT00625365|62770177|FG000|Overall Study|VSD|1|||
33391330|NCT00606580|62770184|FG000|Overall Study|Lost to Follow-up|1|||
33391331|NCT00606580|62770185|FG001|Overall Study|Lost to Follow-up|1|||
33391332|NCT00606580|62770186|FG002|Overall Study|Lost to Follow-up|4|||
33391333|NCT00606580|62770184|FG000|Overall Study|Clinical failures|1|||
33391334|NCT00606580|62770185|FG001|Overall Study|Clinical failures|0|||
33391335|NCT00606580|62770186|FG002|Overall Study|Clinical failures|12|||
33391336|NCT00606580|62770184|FG000|Overall Study|Withdrawal by investigator|0|||
33391337|NCT00606580|62770185|FG001|Overall Study|Withdrawal by investigator|1|||
33391338|NCT00606580|62770186|FG002|Overall Study|Withdrawal by investigator|6|||
33391339|NCT00606580|62770184|FG000|Overall Study|Withdrawal by Subject|0|||
33391340|NCT00606580|62770185|FG001|Overall Study|Withdrawal by Subject|1|||
33391341|NCT00606580|62770186|FG002|Overall Study|Withdrawal by Subject|0|||
33391342|NCT00629265|62770196|FG000|Overall Study|Lost to Follow-up|4|||
33391343|NCT00629265|62770197|FG001|Overall Study|Lost to Follow-up|5|||
33391344|NCT00629265|62770196|FG000|Overall Study|Withdrawal by Subject|11|||
33391345|NCT00629265|62770197|FG001|Overall Study|Withdrawal by Subject|8|||
33391346|NCT00629265|62770196|FG000|Overall Study|Death|1|||
33391347|NCT00629265|62770197|FG001|Overall Study|Death|0|||
33391348|NCT00629265|62770196|FG000|Overall Study|Adverse Event|2|||
33391349|NCT00629265|62770197|FG001|Overall Study|Adverse Event|0|||
33391350|NCT00629265|62770196|FG000|Overall Study|HNC Recurrence|4|||
33391351|NCT00629265|62770197|FG001|Overall Study|HNC Recurrence|0|||
33391352|NCT00629265|62770196|FG000|Overall Study|Other CA Requiring Treatment|1|||
33391353|NCT00629265|62770197|FG001|Overall Study|Other CA Requiring Treatment|3|||
33391354|NCT00629265|62770196|FG000|Overall Study|Needed Esophageal Dilation|4|||
33391355|NCT00629265|62770197|FG001|Overall Study|Needed Esophageal Dilation|1|||
33391356|NCT00629265|62770196|FG000|Overall Study|Unrelated Medical Complications|3|||
33300165|NCT01091428|62676364|FG002|Phase 2|Physician Decision|2|||
33300166|NCT01091428|62676365|FG003|Phase 2|Physician Decision|0|||
33300167|NCT01096342|62676384|FG000|Overall Study|Protocol Violation|1|||
33300168|NCT01039519|62676388|FG000|Treatment|Progressive disease|20|||
33300169|NCT01039519|62676388|FG000|Treatment|Treatment failure|2|||
33300170|NCT01039519|62676388|FG000|Treatment|Adverse Event|3|||
33300171|NCT01039519|62676388|FG000|Treatment|Physician Decision|2|||
33300172|NCT01039519|62676388|FG000|Survival Follow-up|Death|23|||
33391357|NCT00629265|62770197|FG001|Overall Study|Unrelated Medical Complications|1|||
33391358|NCT00629265|62770196|FG000|Overall Study|Unknown Reason|2|||
33391359|NCT00629265|62770197|FG001|Overall Study|Unknown Reason|2|||
33391360|NCT00606502|62770205|FG000|Randomization|Randomized but not treated|3|||
33391361|NCT00606502|62770206|FG001|Randomization|Randomized but not treated|0|||
33391362|NCT00606502|62770205|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
33391363|NCT00606502|62770206|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
33391364|NCT00605722|62770212|FG000|Overall Study|Adverse Event|6|||
33391365|NCT00605722|62770212|FG000|Overall Study|Insufficient therapeutic response|44|||
33391366|NCT00605722|62770212|FG000|Overall Study|Failure to return|1|||
33391367|NCT00605566|62770216|FG000|Overall Study|Adverse Event|1|||
33391368|NCT00605566|62770216|FG000|Overall Study|Clinical deterioration|1|||
33391369|NCT00605566|62770216|FG000|Overall Study|Poor compliance in run-in period|1|||
33300173|NCT01039519|62676388|FG000|Survival Follow-up|Sponsor decision|4|||
33391370|NCT00396877|62770222|FG000|Overall Study|Lost to Follow-up|2|||
33391371|NCT00396877|62770223|FG001|Overall Study|Lost to Follow-up|1|||
33391372|NCT00396877|62770222|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
33391373|NCT00396877|62770223|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
33391374|NCT00628251|62770232|FG000|Randomised Part|Withdrawal by Subject|0|||
33391375|NCT00628251|62770233|FG001|Randomised Part|Withdrawal by Subject|0|||
33391376|NCT00628251|62770234|FG002|Randomised Part|Withdrawal by Subject|1|||
33391377|NCT00628251|62770232|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
33391378|NCT00628251|62770233|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
33391379|NCT00628251|62770234|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
33391380|NCT00628251|62770232|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
33391381|NCT00628251|62770233|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
33391382|NCT00628251|62770234|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
33391383|NCT00628251|62770232|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
33391384|NCT00628251|62770233|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
33391385|NCT00628251|62770234|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
33391386|NCT00628251|62770232|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
33391387|NCT00628251|62770233|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
33391388|NCT00628251|62770234|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
33391389|NCT00628251|62770232|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
33391390|NCT00628251|62770233|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
33391391|NCT00628251|62770234|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
33391392|NCT00625131|62770246|FG000|Overall Study|Lost to Follow-up|3|||
33391393|NCT00625131|62770247|FG001|Overall Study|Lost to Follow-up|2|||
33391394|NCT00625131|62770248|FG002|Overall Study|Lost to Follow-up|0|||
33391395|NCT00625131|62770246|FG000|Overall Study|Withdrawal by Subject|1|||
33391396|NCT00625131|62770247|FG001|Overall Study|Withdrawal by Subject|0|||
33391397|NCT00625131|62770248|FG002|Overall Study|Withdrawal by Subject|5|||
33391398|NCT00408499|62770254|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
33391399|NCT00408499|62770255|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
33391400|NCT00408499|62770256|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
33391401|NCT00408499|62770257|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
33391402|NCT00408499|62770258|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
33391403|NCT00408499|62770254|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
33391404|NCT00408499|62770255|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
33391405|NCT00408499|62770256|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
33391406|NCT00408499|62770257|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
33391407|NCT00408499|62770258|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
33391408|NCT00408499|62770254|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
33391409|NCT00408499|62770255|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
33391410|NCT00408499|62770256|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
33391411|NCT00408499|62770257|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
33391412|NCT00408499|62770258|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
33391413|NCT00408499|62770254|FG000|Phase II- MTD Expansion|Adverse Event|0|||
33391414|NCT00408499|62770255|FG001|Phase II- MTD Expansion|Adverse Event|0|||
33391415|NCT00408499|62770256|FG002|Phase II- MTD Expansion|Adverse Event|0|||
33391416|NCT00408499|62770257|FG003|Phase II- MTD Expansion|Adverse Event|0|||
33391417|NCT00408499|62770258|FG004|Phase II- MTD Expansion|Adverse Event|9|||
33391418|NCT00408499|62770254|FG000|Phase II- MTD Expansion|Death|0|||
33391419|NCT00408499|62770255|FG001|Phase II- MTD Expansion|Death|0|||
33391420|NCT00408499|62770256|FG002|Phase II- MTD Expansion|Death|0|||
33300174|NCT01096186|62676392|FG000|Overall Study|Adverse Event|16|||
33300175|NCT01096186|62676392|FG000|Overall Study|Death|4|||
33300176|NCT01096186|62676392|FG000|Overall Study|Lack of Efficacy|4|||
33300177|NCT01096186|62676392|FG000|Overall Study|Lost to Follow-up|2|||
33300178|NCT01096186|62676392|FG000|Overall Study|Withdrawal by Subject|22|||
33300179|NCT01096186|62676392|FG000|Overall Study|Physician Decision|1|||
33300180|NCT01096186|62676392|FG000|Overall Study|Noncompliance with study drug|1|||
33300181|NCT01032889|62676399|FG000|Overall Study|Adverse Event|2|||
33300182|NCT01032889|62676400|FG001|Overall Study|Adverse Event|2|||
33300183|NCT01032889|62676401|FG002|Overall Study|Adverse Event|0|||
33300184|NCT01032889|62676399|FG000|Overall Study|Withdrawal of Consent|1|||
33391421|NCT00408499|62770257|FG003|Phase II- MTD Expansion|Death|0|||
33391422|NCT00408499|62770258|FG004|Phase II- MTD Expansion|Death|2|||
33391423|NCT00408499|62770254|FG000|Phase II- MTD Expansion|Physician Decision|0|||
33391424|NCT00408499|62770255|FG001|Phase II- MTD Expansion|Physician Decision|0|||
33391425|NCT00408499|62770256|FG002|Phase II- MTD Expansion|Physician Decision|0|||
33391426|NCT00408499|62770257|FG003|Phase II- MTD Expansion|Physician Decision|0|||
33561254|NCT02234843|62955582|FG003|Overall Study|Physician Decision|1|||
33300185|NCT01032889|62676400|FG001|Overall Study|Withdrawal of Consent|2|||
33300186|NCT01032889|62676401|FG002|Overall Study|Withdrawal of Consent|1|||
33300187|NCT01032889|62676399|FG000|Overall Study|Patient Request|0|||
33391427|NCT00408499|62770258|FG004|Phase II- MTD Expansion|Physician Decision|1|||
33391428|NCT00408499|62770254|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
33391429|NCT00408499|62770255|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
33391430|NCT00408499|62770256|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
33391431|NCT00408499|62770257|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
33391432|NCT00408499|62770258|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
33391433|NCT00408499|62770254|FG000|Phase II- MTD Expansion|treatment delay|0|||
33391434|NCT00408499|62770255|FG001|Phase II- MTD Expansion|treatment delay|0|||
33391435|NCT00408499|62770256|FG002|Phase II- MTD Expansion|treatment delay|0|||
33391436|NCT00408499|62770257|FG003|Phase II- MTD Expansion|treatment delay|0|||
33391437|NCT00408499|62770258|FG004|Phase II- MTD Expansion|treatment delay|3|||
33391438|NCT00621777|62770278|FG000|Open Phase|Adverse Event|20|||
33561255|NCT02234843|62955583|FG004|Overall Study|Physician Decision|0|||
33561256|NCT02234843|62955584|FG005|Overall Study|Physician Decision|0|||
33561257|NCT02234843|62955585|FG006|Overall Study|Physician Decision|0|||
33561258|NCT02234843|62955586|FG007|Overall Study|Physician Decision|1|||
33561259|NCT02234843|62955587|FG008|Overall Study|Physician Decision|0|||
33561260|NCT02234843|62955588|FG009|Overall Study|Physician Decision|0|||
33561261|NCT02234843|62955579|FG000|Overall Study|Adverse Event|5|||
33561262|NCT02234843|62955580|FG001|Overall Study|Adverse Event|1|||
33561263|NCT02234843|62955581|FG002|Overall Study|Adverse Event|1|||
33300188|NCT01032889|62676400|FG001|Overall Study|Patient Request|1|||
33300189|NCT01032889|62676401|FG002|Overall Study|Patient Request|0|||
33561264|NCT02234843|62955582|FG003|Overall Study|Adverse Event|3|||
33561265|NCT02234843|62955583|FG004|Overall Study|Adverse Event|2|||
33561266|NCT02234843|62955584|FG005|Overall Study|Adverse Event|1|||
33561267|NCT02234843|62955585|FG006|Overall Study|Adverse Event|0|||
33561268|NCT02234843|62955586|FG007|Overall Study|Adverse Event|0|||
33561269|NCT02234843|62955587|FG008|Overall Study|Adverse Event|1|||
33561270|NCT02234843|62955588|FG009|Overall Study|Adverse Event|0|||
33300190|NCT01032889|62676399|FG000|Overall Study|Lost to Follow-up|1|||
33300191|NCT01032889|62676400|FG001|Overall Study|Lost to Follow-up|1|||
33300192|NCT01032889|62676401|FG002|Overall Study|Lost to Follow-up|0|||
33300193|NCT01032889|62676399|FG000|Overall Study|Lack of Submental Fat|2|||
33300194|NCT01032889|62676400|FG001|Overall Study|Lack of Submental Fat|8|||
33300195|NCT01032889|62676401|FG002|Overall Study|Lack of Submental Fat|1|||
33300196|NCT01032889|62676399|FG000|Overall Study|Miscellaneous Reasons|2|||
33300197|NCT01032889|62676400|FG001|Overall Study|Miscellaneous Reasons|1|||
33300198|NCT01032889|62676401|FG002|Overall Study|Miscellaneous Reasons|1|||
33300199|NCT01049503|62676415|FG000|Overall Study|Lost to Follow-up|11|||
33300200|NCT01049503|62676416|FG001|Overall Study|Lost to Follow-up|12|||
33300201|NCT01049503|62676417|FG002|Overall Study|Lost to Follow-up|24|||
33300202|NCT01049503|62676418|FG003|Overall Study|Lost to Follow-up|26|||
33300203|NCT01049503|62676419|FG004|Overall Study|Lost to Follow-up|27|||
33300204|NCT01049503|62676420|FG005|Overall Study|Lost to Follow-up|8|||
33300205|NCT01029925|62676443|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
33300206|NCT01029925|62676443|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
33300207|NCT01029925|62676443|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
33300208|NCT01029691|62676450|FG000|Continued APAP to Delivery|Death|0|||
33300209|NCT01029691|62676451|FG001|Continued APAP to Delivery|Death|0|||
33300210|NCT01029691|62676452|FG002|Continued APAP to Delivery|Death|1|||
33300211|NCT01029535|62676461|FG000|Overall Study|Lost to Follow-up|24|||
33300212|NCT01029535|62676461|FG000|Overall Study|Protocol Violation|2|||
33300213|NCT01029535|62676461|FG000|Overall Study|Participant Withdrew Consent|2|||
33391439|NCT00621777|62770279|FG001|Open Phase|Adverse Event|0|||
33391440|NCT00621777|62770278|FG000|Open Phase|Did not abstain during open phase|56|||
33391441|NCT00621777|62770279|FG001|Open Phase|Did not abstain during open phase|0|||
33561271|NCT02234843|62955579|FG000|Overall Study|Non-compliance with study drug|1|||
33561272|NCT02234843|62955580|FG001|Overall Study|Non-compliance with study drug|0|||
33561273|NCT02234843|62955581|FG002|Overall Study|Non-compliance with study drug|0|||
33561274|NCT02234843|62955582|FG003|Overall Study|Non-compliance with study drug|0|||
33561275|NCT02234843|62955583|FG004|Overall Study|Non-compliance with study drug|0|||
33561276|NCT02234843|62955584|FG005|Overall Study|Non-compliance with study drug|1|||
33391442|NCT00621777|62770278|FG000|Open Phase|Withdrawal by Subject|17|||
33561277|NCT02234843|62955585|FG006|Overall Study|Non-compliance with study drug|1|||
33561278|NCT02234843|62955586|FG007|Overall Study|Non-compliance with study drug|0|||
33561279|NCT02234843|62955587|FG008|Overall Study|Non-compliance with study drug|0|||
33561280|NCT02234843|62955588|FG009|Overall Study|Non-compliance with study drug|0|||
33561281|NCT02234843|62955579|FG000|Overall Study|Lost to Follow-up|0|||
33300214|NCT01029535|62676461|FG000|Overall Study|Adverse Event|1|||
33300215|NCT01029535|62676461|FG000|Overall Study|Use of Another Treatment|1|||
33300216|NCT01029535|62676461|FG000|Overall Study|Death|1|||
33300217|NCT01028053|62676466|FG000|Overall Study|Screen Failure|113|||
33300218|NCT01028053|62676466|FG000|Overall Study|Patient Request|11|||
33391443|NCT00621777|62770279|FG001|Open Phase|Withdrawal by Subject|0|||
33391444|NCT00621777|62770278|FG000|Open Phase|administrative|13|||
33391445|NCT00621777|62770279|FG001|Open Phase|administrative|0|||
33391446|NCT00621777|62770278|FG000|Open Phase|Lost to Follow-up|10|||
33391447|NCT00621777|62770279|FG001|Open Phase|Lost to Follow-up|0|||
33391448|NCT00621777|62770278|FG000|Randomized Phase|Adverse Event|3|||
33391449|NCT00621777|62770279|FG001|Randomized Phase|Adverse Event|3|||
33391450|NCT00621777|62770278|FG000|Randomized Phase|Lost to Follow-up|3|||
33391451|NCT00621777|62770279|FG001|Randomized Phase|Lost to Follow-up|3|||
33391452|NCT00621777|62770278|FG000|Randomized Phase|Withdrawal by Subject|1|||
33391453|NCT00621777|62770279|FG001|Randomized Phase|Withdrawal by Subject|9|||
33391454|NCT00621777|62770278|FG000|Randomized Phase|administrative|0|||
33391455|NCT00621777|62770279|FG001|Randomized Phase|administrative|3|||
33391456|NCT00621777|62770278|FG000|Randomized Phase|Death|0|||
33391457|NCT00621777|62770279|FG001|Randomized Phase|Death|1|||
33391458|NCT00408421|62770289|FG000|Treatment Initial Randomization|Adverse Event|5|||
33391459|NCT00408421|62770290|FG001|Treatment Initial Randomization|Adverse Event|9|||
33391460|NCT00408421|62770291|FG002|Treatment Initial Randomization|Adverse Event|0|||
33391461|NCT00408421|62770289|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
33391462|NCT00408421|62770290|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
33391463|NCT00408421|62770291|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
33391464|NCT00408421|62770289|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
33391465|NCT00408421|62770290|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
33391466|NCT00408421|62770291|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
33391467|NCT00408421|62770289|FG000|Treatment Initial Randomization|Physician Decision|1|||
33391468|NCT00408421|62770290|FG001|Treatment Initial Randomization|Physician Decision|0|||
33391469|NCT00408421|62770291|FG002|Treatment Initial Randomization|Physician Decision|0|||
33391470|NCT00408421|62770289|FG000|Treatment Initial Randomization|Protocol Violation|0|||
33391471|NCT00408421|62770290|FG001|Treatment Initial Randomization|Protocol Violation|1|||
33391472|NCT00408421|62770291|FG002|Treatment Initial Randomization|Protocol Violation|0|||
33391473|NCT00408421|62770289|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
33391474|NCT00408421|62770290|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
33391475|NCT00408421|62770291|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
33391476|NCT00408421|62770289|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
33391477|NCT00408421|62770290|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
33391478|NCT00408421|62770291|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
33391479|NCT00408421|62770289|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
33391480|NCT00408421|62770290|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
33391481|NCT00408421|62770291|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
33391482|NCT00408421|62770289|FG000|Treatment Re-Randomization|Adverse Event|2|||
33391483|NCT00408421|62770290|FG001|Treatment Re-Randomization|Adverse Event|2|||
33391484|NCT00408421|62770291|FG002|Treatment Re-Randomization|Adverse Event|4|||
33391485|NCT00408421|62770289|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
33391486|NCT00408421|62770290|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
33391487|NCT00408421|62770291|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
33391488|NCT00408421|62770289|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
33391489|NCT00408421|62770290|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
33391490|NCT00408421|62770291|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
33300219|NCT01028053|62676466|FG000|Overall Study|Protocol Violation|1|||
33300220|NCT01028053|62676466|FG000|Overall Study|Physician Decision|2|||
33300221|NCT01028053|62676466|FG000|Overall Study|Technical Problem|1|||
33300222|NCT01028053|62676466|FG000|Overall Study|Terminated by Sponsor|1|||
33300223|NCT01028053|62676466|FG000|Overall Study|Various reasons|4|||
33300224|NCT01023217|62676474|FG000|Overall Study|Withdrawal by Subject|1|||
33300225|NCT01023217|62676475|FG001|Overall Study|Withdrawal by Subject|0|||
33300226|NCT01095796|62676483|FG000|Overall Study|Randomized but Not Treated|5|||
33300227|NCT01095796|62676484|FG001|Overall Study|Randomized but Not Treated|2|||
33300228|NCT01095796|62676483|FG000|Overall Study|Adverse Event|9|||
33300229|NCT01095796|62676484|FG001|Overall Study|Adverse Event|19|||
33300230|NCT01095796|62676483|FG000|Overall Study|Death|3|||
33300231|NCT01095796|62676484|FG001|Overall Study|Death|2|||
33300232|NCT01095796|62676483|FG000|Overall Study|Pregnancy|2|||
33300233|NCT01095796|62676484|FG001|Overall Study|Pregnancy|0|||
33300234|NCT01095796|62676483|FG000|Overall Study|Lack of Efficacy|5|||
33300235|NCT01095796|62676484|FG001|Overall Study|Lack of Efficacy|3|||
33300236|NCT01095796|62676483|FG000|Overall Study|Investigator's Discretion|7|||
33391491|NCT00408421|62770289|FG000|Treatment Re-Randomization|Physician Decision|1|||
33391492|NCT00408421|62770290|FG001|Treatment Re-Randomization|Physician Decision|3|||
33391493|NCT00408421|62770291|FG002|Treatment Re-Randomization|Physician Decision|0|||
33391494|NCT00408421|62770289|FG000|Treatment Re-Randomization|Protocol Violation|1|||
33391495|NCT00408421|62770290|FG001|Treatment Re-Randomization|Protocol Violation|1|||
33391496|NCT00408421|62770291|FG002|Treatment Re-Randomization|Protocol Violation|0|||
33300237|NCT01095796|62676484|FG001|Overall Study|Investigator's Discretion|2|||
33300238|NCT01095796|62676483|FG000|Overall Study|Withdrew Consent|16|||
33300239|NCT01095796|62676484|FG001|Overall Study|Withdrew Consent|22|||
33300240|NCT01095796|62676483|FG000|Overall Study|Lost to Follow-up|27|||
33300241|NCT01095796|62676484|FG001|Overall Study|Lost to Follow-up|29|||
33391497|NCT00408421|62770289|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
33391498|NCT00408421|62770290|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
33391499|NCT00408421|62770291|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
33391500|NCT00604786|62770301|FG000|Overall Study|Lost to Follow-up|2|||
33391501|NCT00604786|62770302|FG001|Overall Study|Lost to Follow-up|0|||
33391502|NCT00604708|62770310|FG000|Overall Study|Withdrawal by Subject|9|||
33391503|NCT00604708|62770311|FG001|Overall Study|Withdrawal by Subject|10|||
33391504|NCT00604708|62770310|FG000|Overall Study|Protocol Violation|2|||
33391505|NCT00604708|62770311|FG001|Overall Study|Protocol Violation|8|||
33391506|NCT00604708|62770310|FG000|Overall Study|Lost to Follow-up|5|||
33391507|NCT00604708|62770311|FG001|Overall Study|Lost to Follow-up|5|||
33561282|NCT02234843|62955580|FG001|Overall Study|Lost to Follow-up|1|||
33561283|NCT02234843|62955581|FG002|Overall Study|Lost to Follow-up|0|||
33561284|NCT02234843|62955582|FG003|Overall Study|Lost to Follow-up|0|||
33561285|NCT02234843|62955583|FG004|Overall Study|Lost to Follow-up|0|||
33561286|NCT02234843|62955584|FG005|Overall Study|Lost to Follow-up|0|||
33561287|NCT02234843|62955585|FG006|Overall Study|Lost to Follow-up|1|||
33561288|NCT02234843|62955586|FG007|Overall Study|Lost to Follow-up|0|||
33561289|NCT02234843|62955587|FG008|Overall Study|Lost to Follow-up|0|||
33561290|NCT02234843|62955588|FG009|Overall Study|Lost to Follow-up|0|||
33561291|NCT02740231|62955625|FG000|Overall Study|Withdrawal by Subject|1|||
33561292|NCT02740231|62955626|FG001|Overall Study|Withdrawal by Subject|1|||
33561293|NCT02740231|62955627|FG002|Overall Study|Withdrawal by Subject|1|||
33561294|NCT02740231|62955628|FG003|Overall Study|Withdrawal by Subject|0|||
33561295|NCT02740231|62955625|FG000|Overall Study|Lack of Efficacy|0|||
33561296|NCT02740231|62955626|FG001|Overall Study|Lack of Efficacy|1|||
33561297|NCT02740231|62955627|FG002|Overall Study|Lack of Efficacy|0|||
33561298|NCT02740231|62955628|FG003|Overall Study|Lack of Efficacy|4|||
33561299|NCT02740231|62955625|FG000|Overall Study|Lost to Follow-up|1|||
33561300|NCT02740231|62955626|FG001|Overall Study|Lost to Follow-up|3|||
33561301|NCT02740231|62955627|FG002|Overall Study|Lost to Follow-up|0|||
33561302|NCT02740231|62955628|FG003|Overall Study|Lost to Follow-up|3|||
33561303|NCT02740231|62955625|FG000|Overall Study|Adverse Event|0|||
33561304|NCT02740231|62955626|FG001|Overall Study|Adverse Event|1|||
33561305|NCT02740231|62955627|FG002|Overall Study|Adverse Event|0|||
33561306|NCT02740231|62955628|FG003|Overall Study|Adverse Event|1|||
33561307|NCT02750345|62955638|FG000|Intervention 1|Adverse Event|0|||
33561308|NCT02750345|62955639|FG001|Intervention 1|Adverse Event|0|||
33561309|NCT02750345|62955640|FG002|Intervention 1|Adverse Event|0|||
33561310|NCT02750345|62955641|FG003|Intervention 1|Adverse Event|0|||
33561311|NCT02750345|62955642|FG004|Intervention 1|Adverse Event|1|||
33561312|NCT02750345|62955643|FG005|Intervention 1|Adverse Event|0|||
33561313|NCT02640625|62955653|FG000|Overall Study|Adverse Event|1|||
33561314|NCT01329263|62955660|FG000|Overall Study|Lost to Follow-up|4|||
33561315|NCT01329263|62955661|FG001|Overall Study|Lost to Follow-up|21|||
33561316|NCT01329263|62955660|FG000|Overall Study|Withdrawal by Subject|1|||
33561317|NCT01329263|62955661|FG001|Overall Study|Withdrawal by Subject|2|||
33561318|NCT02474329|62955669|FG000|Overall Study|Withdraw or did not contribute data.|13|||
33561319|NCT01388491|62955676|FG000|Overall Study|Adverse Event|10|||
33561320|NCT01388491|62955677|FG001|Overall Study|Adverse Event|9|||
33561321|NCT01388491|62955676|FG000|Overall Study|Sponsor Request|9|||
33561322|NCT01388491|62955677|FG001|Overall Study|Sponsor Request|7|||
33561323|NCT01388491|62955676|FG000|Overall Study|Withdrawal by Subject|6|||
33561324|NCT01388491|62955677|FG001|Overall Study|Withdrawal by Subject|10|||
33561325|NCT01388491|62955676|FG000|Overall Study|Lost to Follow-up|4|||
33561326|NCT01388491|62955677|FG001|Overall Study|Lost to Follow-up|3|||
33561327|NCT01388491|62955676|FG000|Overall Study|Protocol Violation|2|||
33561328|NCT01388491|62955677|FG001|Overall Study|Protocol Violation|0|||
33561329|NCT01388491|62955676|FG000|Overall Study|Noncompliance|2|||
33561330|NCT01388491|62955677|FG001|Overall Study|Noncompliance|0|||
33662770|NCT01587703|63093230|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33391508|NCT00604708|62770310|FG000|Overall Study|administrative reasons|9|||
33561331|NCT01388491|62955676|FG000|Overall Study|Pregnancy|1|||
33561332|NCT01388491|62955677|FG001|Overall Study|Pregnancy|0|||
33561333|NCT02749799|62955683|FG000|Overall Study|Adverse Event|2|||
33561334|NCT02749799|62955683|FG000|Overall Study|Lost to Follow-up|4|||
33662771|NCT01587703|63093231|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33662772|NCT01587703|63093232|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33391509|NCT00604708|62770311|FG001|Overall Study|administrative reasons|11|||
33391510|NCT00604708|62770310|FG000|Overall Study|Adverse Event|6|||
33561335|NCT02749799|62955683|FG000|Overall Study|Protocol Violation|1|||
33561336|NCT02749799|62955683|FG000|Overall Study|Withdrawal by Subject|1|||
33561337|NCT03253393|62955690|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
33561338|NCT03253393|62955691|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
33561339|NCT03253393|62955692|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
33561340|NCT03128671|62955708|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
33391511|NCT00604708|62770311|FG001|Overall Study|Adverse Event|6|||
33561341|NCT03128671|62955709|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
33561342|NCT03128671|62955708|FG000|Allocation|Death|1|||
33561343|NCT03128671|62955709|FG001|Allocation|Death|0|||
33561344|NCT03128671|62955708|FG000|Allocation|Withdrawal by Subject|4|||
33561345|NCT03128671|62955709|FG001|Allocation|Withdrawal by Subject|0|||
33561346|NCT03128671|62955708|FG000|Intervention|Withdrawal by Subject|11|||
33300242|NCT01095796|62676483|FG000|Overall Study|Participant Noncompliance|5|||
33300243|NCT01095796|62676484|FG001|Overall Study|Participant Noncompliance|10|||
33300244|NCT01095796|62676483|FG000|Overall Study|Protocol Violation|1|||
33300245|NCT01095796|62676484|FG001|Overall Study|Protocol Violation|0|||
33561347|NCT03128671|62955709|FG001|Intervention|Withdrawal by Subject|10|||
33561348|NCT03128671|62955708|FG000|Intervention|Palliative/hospice care initiated|9|||
33561349|NCT03128671|62955709|FG001|Intervention|Palliative/hospice care initiated|10|||
33561350|NCT03128671|62955708|FG000|Intervention|Death|13|||
33561351|NCT03128671|62955709|FG001|Intervention|Death|11|||
33561352|NCT03128671|62955708|FG000|Intervention|Interrupted by hurricane|1|||
33561353|NCT03128671|62955709|FG001|Intervention|Interrupted by hurricane|0|||
33561354|NCT03128671|62955708|FG000|Intervention|Physician Decision|2|||
33561355|NCT03128671|62955709|FG001|Intervention|Physician Decision|3|||
33561356|NCT02925338|62955720|FG000|Overall Study|Death|0|||
33561357|NCT02925338|62955721|FG001|Overall Study|Death|2|||
33561358|NCT02925338|62955722|FG002|Overall Study|Death|1|||
33561359|NCT02925338|62955723|FG003|Overall Study|Death|0|||
33561360|NCT02925338|62955724|FG004|Overall Study|Death|0|||
33561361|NCT02925338|62955720|FG000|Overall Study|Lost to Follow-up|30|||
33561362|NCT02925338|62955721|FG001|Overall Study|Lost to Follow-up|10|||
33561363|NCT02925338|62955722|FG002|Overall Study|Lost to Follow-up|1|||
33561364|NCT02925338|62955723|FG003|Overall Study|Lost to Follow-up|16|||
33561365|NCT02925338|62955724|FG004|Overall Study|Lost to Follow-up|3|||
33561366|NCT02925338|62955720|FG000|Overall Study|Withdrawal by Subject|3|||
33561367|NCT02925338|62955721|FG001|Overall Study|Withdrawal by Subject|0|||
33561368|NCT02925338|62955722|FG002|Overall Study|Withdrawal by Subject|3|||
33561369|NCT02925338|62955723|FG003|Overall Study|Withdrawal by Subject|2|||
33561370|NCT02925338|62955724|FG004|Overall Study|Withdrawal by Subject|2|||
33561371|NCT02925338|62955720|FG000|Overall Study|Missing|38|||
33561372|NCT02925338|62955721|FG001|Overall Study|Missing|27|||
33561373|NCT02925338|62955722|FG002|Overall Study|Missing|0|||
33561374|NCT02925338|62955723|FG003|Overall Study|Missing|3|||
33561375|NCT02925338|62955724|FG004|Overall Study|Missing|2|||
33561376|NCT02925338|62955720|FG000|Overall Study|Participant's Decision|11|||
33561377|NCT02925338|62955721|FG001|Overall Study|Participant's Decision|7|||
33561378|NCT02925338|62955722|FG002|Overall Study|Participant's Decision|3|||
33561379|NCT02925338|62955723|FG003|Overall Study|Participant's Decision|8|||
33561380|NCT02925338|62955724|FG004|Overall Study|Participant's Decision|1|||
33561381|NCT02925338|62955720|FG000|Overall Study|Treatment Discontinuation|144|||
33561382|NCT02925338|62955721|FG001|Overall Study|Treatment Discontinuation|65|||
33561383|NCT02925338|62955722|FG002|Overall Study|Treatment Discontinuation|56|||
33561384|NCT02925338|62955723|FG003|Overall Study|Treatment Discontinuation|131|||
33561385|NCT02925338|62955724|FG004|Overall Study|Treatment Discontinuation|22|||
33561386|NCT02543528|62955742|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
33561387|NCT02543528|62955743|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
33561388|NCT02543528|62955744|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
33561389|NCT02543528|62955745|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
33561390|NCT02543528|62955746|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
33561391|NCT02543528|62955742|FG000|Adaptation Period|Lens Handling Difficultes|0|||
33561392|NCT02543528|62955743|FG001|Adaptation Period|Lens Handling Difficultes|0|||
33561393|NCT02543528|62955744|FG002|Adaptation Period|Lens Handling Difficultes|0|||
33561394|NCT02543528|62955745|FG003|Adaptation Period|Lens Handling Difficultes|0|||
33561395|NCT02543528|62955746|FG004|Adaptation Period|Lens Handling Difficultes|8|||
33561396|NCT02543528|62955742|FG000|Adaptation Period|Lost to Follow-up|0|||
33561397|NCT02543528|62955743|FG001|Adaptation Period|Lost to Follow-up|0|||
33300246|NCT01095796|62676483|FG000|Overall Study|Participant Transferred to Another Study|215|||
33300247|NCT01095796|62676484|FG001|Overall Study|Participant Transferred to Another Study|200|||
33300248|NCT01023061|62676490|FG000|Overall Study|Withdrawal prior to treatment|2|||
33300249|NCT01027897|62676494|FG000|Overall Study|Protocol Violation|1|||
33300250|NCT01027897|62676494|FG000|Overall Study|Withdrawal by Subject|1|||
33300251|NCT01027351|62676504|FG000|Overall Study|Withdrawal by Subject|1|||
33300252|NCT01027351|62676505|FG001|Overall Study|Withdrawal by Subject|0|||
33300253|NCT01027351|62676506|FG002|Overall Study|Withdrawal by Subject|1|||
33561398|NCT02543528|62955744|FG002|Adaptation Period|Lost to Follow-up|0|||
33561399|NCT02543528|62955745|FG003|Adaptation Period|Lost to Follow-up|0|||
33561400|NCT02543528|62955746|FG004|Adaptation Period|Lost to Follow-up|14|||
33561401|NCT02543528|62955742|FG000|Adaptation Period|Adverse Event|0|||
33561402|NCT02543528|62955743|FG001|Adaptation Period|Adverse Event|0|||
33300254|NCT01027351|62676507|FG003|Overall Study|Withdrawal by Subject|0|||
33300255|NCT01027351|62676508|FG004|Overall Study|Withdrawal by Subject|3|||
33300256|NCT01027351|62676509|FG005|Overall Study|Withdrawal by Subject|5|||
33561403|NCT02543528|62955744|FG002|Adaptation Period|Adverse Event|0|||
33561404|NCT02543528|62955745|FG003|Adaptation Period|Adverse Event|0|||
33561405|NCT02543528|62955746|FG004|Adaptation Period|Adverse Event|2|||
33561406|NCT02543528|62955742|FG000|Extended Wear Period|Adverse Event|17|||
33561407|NCT02543528|62955743|FG001|Extended Wear Period|Adverse Event|11|||
33561408|NCT02543528|62955744|FG002|Extended Wear Period|Adverse Event|16|||
33561409|NCT02543528|62955745|FG003|Extended Wear Period|Adverse Event|3|||
33561410|NCT02543528|62955746|FG004|Extended Wear Period|Adverse Event|0|||
33561411|NCT02543528|62955742|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
33561412|NCT02543528|62955743|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
33561413|NCT02543528|62955744|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
33561414|NCT02543528|62955745|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
33561415|NCT02543528|62955746|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
33561416|NCT02543528|62955742|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
33561417|NCT02543528|62955743|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
33561418|NCT02543528|62955744|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
33561419|NCT02543528|62955745|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
33561420|NCT02543528|62955746|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
33561421|NCT02543528|62955742|FG000|Extended Wear Period|Lost to Follow-up|0|||
33561422|NCT02543528|62955743|FG001|Extended Wear Period|Lost to Follow-up|1|||
33561423|NCT02543528|62955744|FG002|Extended Wear Period|Lost to Follow-up|2|||
33561424|NCT02543528|62955745|FG003|Extended Wear Period|Lost to Follow-up|1|||
33561425|NCT02543528|62955746|FG004|Extended Wear Period|Lost to Follow-up|0|||
33561426|NCT02543528|62955742|FG000|Extended Wear Period|Withdrawal by Subject|10|||
33561427|NCT02543528|62955743|FG001|Extended Wear Period|Withdrawal by Subject|9|||
33561428|NCT02543528|62955744|FG002|Extended Wear Period|Withdrawal by Subject|4|||
33561429|NCT02543528|62955745|FG003|Extended Wear Period|Withdrawal by Subject|5|||
33561430|NCT02543528|62955746|FG004|Extended Wear Period|Withdrawal by Subject|0|||
33561431|NCT00156533|62955764|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
33561432|NCT00156533|62955765|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
33561433|NCT00156533|62955766|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
33561434|NCT00156533|62955767|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
33561435|NCT00156533|62955764|FG000|Overall Study|Withdrawal by Subject|1|||
33561436|NCT00156533|62955765|FG001|Overall Study|Withdrawal by Subject|0|||
33561437|NCT00156533|62955766|FG002|Overall Study|Withdrawal by Subject|0|||
33561438|NCT00156533|62955767|FG003|Overall Study|Withdrawal by Subject|1|||
33561439|NCT00156533|62955764|FG000|Overall Study|Failed Screening|1|||
33561440|NCT00156533|62955765|FG001|Overall Study|Failed Screening|0|||
33561441|NCT00156533|62955766|FG002|Overall Study|Failed Screening|1|||
33561442|NCT00156533|62955767|FG003|Overall Study|Failed Screening|1|||
33561443|NCT01660022|62955785|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
33561444|NCT01660022|62955786|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
33561445|NCT01660022|62955787|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
33561446|NCT01660022|62955788|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
33561447|NCT01660022|62955789|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
33561448|NCT01660022|62955790|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
33561449|NCT01660022|62955785|FG000|First Sequence (7 Days)|Adverse Event|0|||
33561450|NCT01660022|62955786|FG001|First Sequence (7 Days)|Adverse Event|0|||
33561451|NCT01660022|62955787|FG002|First Sequence (7 Days)|Adverse Event|0|||
33561452|NCT01660022|62955788|FG003|First Sequence (7 Days)|Adverse Event|0|||
33561453|NCT01660022|62955789|FG004|First Sequence (7 Days)|Adverse Event|1|||
33561454|NCT01660022|62955790|FG005|First Sequence (7 Days)|Adverse Event|3|||
33561455|NCT01660022|62955785|FG000|First Sequence (7 Days)|Protocol Violation|0|||
33561456|NCT01660022|62955786|FG001|First Sequence (7 Days)|Protocol Violation|0|||
33561457|NCT01660022|62955787|FG002|First Sequence (7 Days)|Protocol Violation|0|||
33561458|NCT01660022|62955788|FG003|First Sequence (7 Days)|Protocol Violation|0|||
33561459|NCT01660022|62955789|FG004|First Sequence (7 Days)|Protocol Violation|0|||
33561460|NCT01660022|62955790|FG005|First Sequence (7 Days)|Protocol Violation|1|||
33561461|NCT00156065|62955819|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
33561462|NCT00156065|62955820|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
33561463|NCT00156065|62955821|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
33561464|NCT00156065|62955819|FG000|Overall Study|Adverse Event|8|||
33561465|NCT00156065|62955820|FG001|Overall Study|Adverse Event|11|||
33561466|NCT00156065|62955821|FG002|Overall Study|Adverse Event|4|||
33561467|NCT00156065|62955819|FG000|Overall Study|Lack of Efficacy|2|||
33561468|NCT00156065|62955820|FG001|Overall Study|Lack of Efficacy|9|||
33561469|NCT00156065|62955821|FG002|Overall Study|Lack of Efficacy|3|||
33561470|NCT00156065|62955819|FG000|Overall Study|Withdrawal by Subject|13|||
33561471|NCT00156065|62955820|FG001|Overall Study|Withdrawal by Subject|26|||
33561472|NCT00156065|62955821|FG002|Overall Study|Withdrawal by Subject|16|||
33561473|NCT00156065|62955819|FG000|Overall Study|Lost to Follow-up|5|||
33561474|NCT00156065|62955820|FG001|Overall Study|Lost to Follow-up|7|||
33561475|NCT00156065|62955821|FG002|Overall Study|Lost to Follow-up|1|||
33561476|NCT00156065|62955819|FG000|Overall Study|Other|2|||
33561477|NCT00156065|62955820|FG001|Overall Study|Other|9|||
33561478|NCT00156065|62955821|FG002|Overall Study|Other|3|||
33561479|NCT01554956|62955832|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
33561480|NCT01554956|62955833|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
33561481|NCT01554956|62955834|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
33561482|NCT01554956|62955832|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
33561483|NCT01554956|62955833|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
33561484|NCT01554956|62955834|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
33561485|NCT01554956|62955832|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
33561486|NCT01554956|62955833|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
33561487|NCT01554956|62955834|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
33561488|NCT02138786|62955855|FG000|Overall Study|Adverse Event|0|||
33561489|NCT02138786|62955856|FG001|Overall Study|Adverse Event|2|||
33561490|NCT02138786|62955857|FG002|Overall Study|Adverse Event|1|||
33561491|NCT02138786|62955855|FG000|Overall Study|Death|1|||
33561492|NCT02138786|62955856|FG001|Overall Study|Death|7|||
33561493|NCT02138786|62955857|FG002|Overall Study|Death|2|||
33561494|NCT02138786|62955855|FG000|Overall Study|Disease Progression|1|||
33561495|NCT02138786|62955856|FG001|Overall Study|Disease Progression|1|||
33561496|NCT02138786|62955857|FG002|Overall Study|Disease Progression|3|||
33561497|NCT02138786|62955855|FG000|Overall Study|Withdrawal by Subject|1|||
33561498|NCT02138786|62955856|FG001|Overall Study|Withdrawal by Subject|2|||
33561499|NCT02138786|62955857|FG002|Overall Study|Withdrawal by Subject|0|||
33561500|NCT02138786|62955855|FG000|Overall Study|Patient's Wish|0|||
33662773|NCT01587703|63093233|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33662774|NCT01587703|63093234|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33662775|NCT01587703|63093235|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33662776|NCT01587703|63093236|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33662777|NCT01587703|63093237|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
33662778|NCT01587703|63093238|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
33662779|NCT01587703|63093239|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
33662780|NCT01587703|63093240|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
33662781|NCT01587703|63093241|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
33662782|NCT01587703|63093242|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
33662783|NCT01587703|63093243|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33662784|NCT01587703|63093244|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33662785|NCT01587703|63093226|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
33662786|NCT01587703|63093227|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
33662787|NCT01587703|63093228|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
33662788|NCT01587703|63093229|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
33662789|NCT01587703|63093230|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
33662790|NCT01587703|63093231|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
33662791|NCT01587703|63093232|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
33662792|NCT01587703|63093233|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
33391512|NCT00407797|62770317|FG000|Overall Study|Lost to Follow-up|2|||
33391513|NCT00407797|62770317|FG000|Overall Study|Adverse Event|6|||
33391514|NCT00407797|62770317|FG000|Overall Study|Other|7|||
33391515|NCT00407797|62770317|FG000|Overall Study|Withdrawal by Subject|3|||
33391516|NCT00568126|62770323|FG000|Overall Study|Adverse Event|3|||
33391517|NCT00568126|62770324|FG001|Overall Study|Adverse Event|0|||
33662793|NCT01587703|63093234|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
33662794|NCT01587703|63093235|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
33391518|NCT00568126|62770323|FG000|Overall Study|Withdrawal by Subject|2|||
33391519|NCT00568126|62770324|FG001|Overall Study|Withdrawal by Subject|3|||
33391520|NCT00568126|62770323|FG000|Overall Study|Lost to Follow-up|4|||
33391521|NCT00568126|62770324|FG001|Overall Study|Lost to Follow-up|3|||
33391522|NCT00568126|62770323|FG000|Overall Study|Lack of Efficacy|0|||
33391523|NCT00568126|62770324|FG001|Overall Study|Lack of Efficacy|1|||
33391524|NCT00568126|62770323|FG000|Overall Study|Physician Decision|2|||
33391525|NCT00568126|62770324|FG001|Overall Study|Physician Decision|2|||
33391526|NCT00407563|62770330|FG000|Overall Study|Patient continues on treatment|1|||
33391527|NCT00567892|62770336|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
33391528|NCT00567892|62770337|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
33391529|NCT00567892|62770338|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
33561501|NCT02138786|62955856|FG001|Overall Study|Patient's Wish|2|||
33561502|NCT02138786|62955857|FG002|Overall Study|Patient's Wish|0|||
33662795|NCT01587703|63093236|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
33391530|NCT00567892|62770339|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
33391531|NCT00567892|62770336|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
33391532|NCT00567892|62770337|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
33391533|NCT00567892|62770338|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
33391534|NCT00567892|62770339|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
33391535|NCT00623103|62770353|FG000|Overall Study|Adverse Event|70|||
33561503|NCT02138786|62955855|FG000|Overall Study|Sponsor Terminated Study|0|||
33561504|NCT02138786|62955856|FG001|Overall Study|Sponsor Terminated Study|1|||
33561505|NCT02138786|62955857|FG002|Overall Study|Sponsor Terminated Study|1|||
33561506|NCT02138786|62955855|FG000|Overall Study|Non-Compliance|0|||
33561507|NCT02138786|62955856|FG001|Overall Study|Non-Compliance|0|||
33561508|NCT02138786|62955857|FG002|Overall Study|Non-Compliance|1|||
33662796|NCT01587703|63093237|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
33662797|NCT01587703|63093238|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
33662798|NCT01587703|63093239|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
33662799|NCT01587703|63093240|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
33662800|NCT01587703|63093241|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
33662801|NCT01587703|63093242|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
33662802|NCT01587703|63093243|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
33662803|NCT01587703|63093244|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
33662804|NCT01587703|63093226|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662805|NCT01587703|63093227|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662806|NCT01587703|63093228|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662807|NCT01587703|63093229|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662808|NCT01587703|63093230|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662809|NCT01587703|63093231|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662810|NCT01587703|63093232|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662811|NCT01587703|63093233|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662812|NCT01587703|63093234|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662813|NCT01587703|63093235|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662814|NCT01587703|63093236|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662815|NCT01587703|63093237|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
33662816|NCT01587703|63093238|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662817|NCT01587703|63093239|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662818|NCT01587703|63093240|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662819|NCT01587703|63093241|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662820|NCT01587703|63093242|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662821|NCT01587703|63093243|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662822|NCT01587703|63093244|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33662823|NCT01577381|63093307|FG000|Overall Study|Discontinued|2|||
33662824|NCT01577381|63093308|FG001|Overall Study|Discontinued|1|||
33662825|NCT01577381|63093309|FG002|Overall Study|Discontinued|2|||
33662826|NCT01577381|63093310|FG003|Overall Study|Discontinued|2|||
33662827|NCT01577381|63093307|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
33662828|NCT01577381|63093308|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
33662829|NCT01577381|63093309|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
33662830|NCT01577381|63093310|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
33662831|NCT02686164|63093320|FG000|Overall Study|Adverse Event|1|||
33662832|NCT02686164|63093320|FG000|Overall Study|Withdrawal of consent|1|||
33662833|NCT02686164|63093320|FG000|Overall Study|Clinical progression|1|||
33662834|NCT01691105|63093341|FG000|1 Month Follow-up|Lost to Follow-up|41|||
33662835|NCT01691105|63093342|FG001|1 Month Follow-up|Lost to Follow-up|38|||
33662836|NCT01691105|63093341|FG000|1 Month Follow-up|Death|2|||
33662837|NCT01691105|63093342|FG001|1 Month Follow-up|Death|3|||
33662838|NCT01691105|63093341|FG000|6 Month Follow-up|Lost to Follow-up|39|||
33662839|NCT01691105|63093342|FG001|6 Month Follow-up|Lost to Follow-up|58|||
33662840|NCT01691105|63093341|FG000|6 Month Follow-up|Death|13|||
33662841|NCT01691105|63093342|FG001|6 Month Follow-up|Death|13|||
33391536|NCT00623103|62770354|FG001|Overall Study|Adverse Event|60|||
33391537|NCT00623103|62770353|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33391538|NCT00623103|62770354|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
33391539|NCT00623103|62770353|FG000|Overall Study|Withdrawal by Subject|18|||
33391540|NCT00623103|62770354|FG001|Overall Study|Withdrawal by Subject|24|||
33391541|NCT00623103|62770353|FG000|Overall Study|Lost to Follow-up|4|||
33391542|NCT00623103|62770354|FG001|Overall Study|Lost to Follow-up|1|||
33391543|NCT00623103|62770353|FG000|Overall Study|Administrative problems|2|||
33391544|NCT00623103|62770354|FG001|Overall Study|Administrative problems|4|||
33391545|NCT00623103|62770353|FG000|Overall Study|Death|11|||
33391546|NCT00623103|62770354|FG001|Overall Study|Death|11|||
33391547|NCT00623103|62770353|FG000|Overall Study|Protocol deviation|2|||
33662842|NCT01691105|63093341|FG000|12 Month Follow-up|Lost to Follow-up|50|||
33662843|NCT01691105|63093342|FG001|12 Month Follow-up|Lost to Follow-up|71|||
33662844|NCT01691105|63093341|FG000|12 Month Follow-up|Death|22|||
33662845|NCT01691105|63093342|FG001|12 Month Follow-up|Death|30|||
33662846|NCT01691105|63093341|FG000|12 Month Biochemical Verification|Death|22|||
33391548|NCT00623103|62770354|FG001|Overall Study|Protocol deviation|1|||
33391549|NCT00396565|62770363|FG000|Overall Study|Physician Decision|3|||
33391550|NCT00396565|62770364|FG001|Overall Study|Physician Decision|1|||
33391551|NCT00396565|62770365|FG002|Overall Study|Physician Decision|2|||
33391552|NCT00396565|62770363|FG000|Overall Study|Adverse Event|5|||
33391553|NCT00396565|62770364|FG001|Overall Study|Adverse Event|13|||
33391554|NCT00396565|62770365|FG002|Overall Study|Adverse Event|3|||
33391555|NCT00396565|62770363|FG000|Overall Study|Withdrawal by Subject|8|||
33391556|NCT00396565|62770364|FG001|Overall Study|Withdrawal by Subject|13|||
33391557|NCT00396565|62770365|FG002|Overall Study|Withdrawal by Subject|1|||
33391558|NCT00396565|62770363|FG000|Overall Study|Lack of Efficacy|32|||
33391559|NCT00396565|62770364|FG001|Overall Study|Lack of Efficacy|64|||
33391560|NCT00396565|62770365|FG002|Overall Study|Lack of Efficacy|11|||
33561509|NCT02529488|62955863|FG000|Overall Study|Adverse Event|1|||
33561510|NCT02529488|62955863|FG000|Overall Study|Death|3|||
33561511|NCT01329419|62955871|FG000|Overall Study|Protocol Violation|235|||
33561512|NCT01329341|62955876|FG000|Overall Study|Withdrawal by Subject|44|||
33561513|NCT02532764|62955890|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
33561514|NCT02532764|62955891|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
33561515|NCT02532764|62955892|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
33561516|NCT02532764|62955893|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
33561517|NCT02532764|62955894|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
33561518|NCT02532764|62955895|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
33561519|NCT02532764|62955896|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
33561520|NCT02532764|62955897|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
33561521|NCT02532764|62955898|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
33561522|NCT02532764|62955899|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
33561523|NCT02528942|62955926|FG000|Overall Study|Did not meet imaging criteria|9|||
33561524|NCT02528942|62955926|FG000|Overall Study|Lost to Follow-up|25|||
33561525|NCT02527148|62955932|FG000|Overall Study|Did not receive study intervention|1|||
33561526|NCT02527148|62955933|FG001|Overall Study|Did not receive study intervention|0|||
33561527|NCT02291614|62955952|FG000|Overall Study|Lost to Follow-up|0|||
33561528|NCT02291614|62955953|FG001|Overall Study|Lost to Follow-up|0|||
33561529|NCT02291614|62955954|FG002|Overall Study|Lost to Follow-up|0|||
33561530|NCT02291614|62955955|FG003|Overall Study|Lost to Follow-up|0|||
33561531|NCT02291614|62955956|FG004|Overall Study|Lost to Follow-up|0|||
33561532|NCT02291614|62955957|FG005|Overall Study|Lost to Follow-up|0|||
33561533|NCT02291614|62955958|FG006|Overall Study|Lost to Follow-up|0|||
33561534|NCT02291614|62955959|FG007|Overall Study|Lost to Follow-up|1|||
33561535|NCT02291614|62955960|FG008|Overall Study|Lost to Follow-up|0|||
33561536|NCT02291614|62955961|FG009|Overall Study|Lost to Follow-up|0|||
33561537|NCT02291614|62955962|FG010|Overall Study|Lost to Follow-up|0|||
33561538|NCT02291614|62955952|FG000|Overall Study|Withdrawal by Subject|0|||
33561539|NCT02291614|62955953|FG001|Overall Study|Withdrawal by Subject|1|||
33561540|NCT02291614|62955954|FG002|Overall Study|Withdrawal by Subject|0|||
33561541|NCT02291614|62955955|FG003|Overall Study|Withdrawal by Subject|0|||
33561542|NCT02291614|62955956|FG004|Overall Study|Withdrawal by Subject|0|||
33561543|NCT02291614|62955957|FG005|Overall Study|Withdrawal by Subject|0|||
33561544|NCT02291614|62955958|FG006|Overall Study|Withdrawal by Subject|0|||
33561545|NCT02291614|62955959|FG007|Overall Study|Withdrawal by Subject|0|||
33561546|NCT02291614|62955960|FG008|Overall Study|Withdrawal by Subject|0|||
33561547|NCT02291614|62955961|FG009|Overall Study|Withdrawal by Subject|2|||
33561548|NCT02291614|62955962|FG010|Overall Study|Withdrawal by Subject|2|||
33561549|NCT02291614|62955952|FG000|Overall Study|Decision by sponsor|0|||
33561550|NCT02291614|62955953|FG001|Overall Study|Decision by sponsor|0|||
33561551|NCT02291614|62955954|FG002|Overall Study|Decision by sponsor|0|||
33391561|NCT00394771|62770377|FG000|Overall Study|Did not meet protocol requirements|1|||
33391562|NCT00394771|62770378|FG001|Overall Study|Did not meet protocol requirements|0|||
33391563|NCT00394771|62770379|FG002|Overall Study|Did not meet protocol requirements|2|||
33391564|NCT00394771|62770380|FG003|Overall Study|Did not meet protocol requirements|0|||
33391565|NCT00394771|62770377|FG000|Overall Study|Protocol Violation|2|||
33391566|NCT00394771|62770378|FG001|Overall Study|Protocol Violation|4|||
33391567|NCT00394771|62770379|FG002|Overall Study|Protocol Violation|9|||
33391568|NCT00394771|62770380|FG003|Overall Study|Protocol Violation|7|||
33391569|NCT00394771|62770377|FG000|Overall Study|Withdrawal by Subject|10|||
33391570|NCT00394771|62770378|FG001|Overall Study|Withdrawal by Subject|6|||
33391571|NCT00394771|62770379|FG002|Overall Study|Withdrawal by Subject|8|||
33391572|NCT00394771|62770380|FG003|Overall Study|Withdrawal by Subject|12|||
33391573|NCT00394771|62770377|FG000|Overall Study|Adverse Event|10|||
33391574|NCT00394771|62770378|FG001|Overall Study|Adverse Event|5|||
33391575|NCT00394771|62770379|FG002|Overall Study|Adverse Event|12|||
33561552|NCT02291614|62955955|FG003|Overall Study|Decision by sponsor|1|||
33561553|NCT02291614|62955956|FG004|Overall Study|Decision by sponsor|0|||
33561554|NCT02291614|62955957|FG005|Overall Study|Decision by sponsor|0|||
33391576|NCT00394771|62770380|FG003|Overall Study|Adverse Event|8|||
33391577|NCT00394771|62770377|FG000|Overall Study|Participant pregnant|0|||
33391578|NCT00394771|62770378|FG001|Overall Study|Participant pregnant|1|||
33391579|NCT00394771|62770379|FG002|Overall Study|Participant pregnant|2|||
33391580|NCT00394771|62770380|FG003|Overall Study|Participant pregnant|2|||
33391581|NCT00394771|62770377|FG000|Overall Study|Lost to Follow-up|15|||
33391582|NCT00394771|62770378|FG001|Overall Study|Lost to Follow-up|15|||
33391583|NCT00394771|62770379|FG002|Overall Study|Lost to Follow-up|13|||
33391584|NCT00394771|62770380|FG003|Overall Study|Lost to Follow-up|10|||
33391585|NCT00394771|62770377|FG000|Overall Study|Other|3|||
33391586|NCT00394771|62770378|FG001|Overall Study|Other|3|||
33391587|NCT00394771|62770379|FG002|Overall Study|Other|1|||
33391588|NCT00394771|62770380|FG003|Overall Study|Other|0|||
33391589|NCT00396409|62770392|FG000|Period 1 - 2007|Adverse Event|0|||
33391590|NCT00396409|62770393|FG001|Period 1 - 2007|Adverse Event|1|||
33391591|NCT00396409|62770392|FG000|Period 1 - 2007|Lack of Efficacy|0|||
33391592|NCT00396409|62770393|FG001|Period 1 - 2007|Lack of Efficacy|1|||
33561555|NCT02291614|62955958|FG006|Overall Study|Decision by sponsor|0|||
33561556|NCT02291614|62955959|FG007|Overall Study|Decision by sponsor|0|||
33561557|NCT02291614|62955960|FG008|Overall Study|Decision by sponsor|0|||
33561558|NCT02291614|62955961|FG009|Overall Study|Decision by sponsor|0|||
33561559|NCT02291614|62955962|FG010|Overall Study|Decision by sponsor|0|||
33561560|NCT02291614|62955952|FG000|Overall Study|Death|0|||
33561561|NCT02291614|62955953|FG001|Overall Study|Death|0|||
33561562|NCT02291614|62955954|FG002|Overall Study|Death|1|||
33561563|NCT02291614|62955955|FG003|Overall Study|Death|0|||
33561564|NCT02291614|62955956|FG004|Overall Study|Death|1|||
33561565|NCT02291614|62955957|FG005|Overall Study|Death|1|||
33561566|NCT02291614|62955958|FG006|Overall Study|Death|1|||
33561567|NCT02291614|62955959|FG007|Overall Study|Death|0|||
33561568|NCT02291614|62955960|FG008|Overall Study|Death|0|||
33561569|NCT02291614|62955961|FG009|Overall Study|Death|0|||
33561570|NCT02291614|62955962|FG010|Overall Study|Death|0|||
33561571|NCT02526524|62955998|FG000|Overall Study|Withdrawal by Subject|3|||
33561572|NCT02526524|62955999|FG001|Overall Study|Withdrawal by Subject|3|||
33561573|NCT02526524|62956000|FG002|Overall Study|Withdrawal by Subject|6|||
33561574|NCT02526524|62956001|FG003|Overall Study|Withdrawal by Subject|1|||
33561575|NCT02526524|62956002|FG004|Overall Study|Withdrawal by Subject|9|||
33561576|NCT02526524|62956003|FG005|Overall Study|Withdrawal by Subject|5|||
33662847|NCT01691105|63093342|FG001|12 Month Biochemical Verification|Death|30|||
33662848|NCT01691105|63093341|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
33662849|NCT01691105|63093342|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
33300257|NCT01027351|62676504|FG000|Overall Study|Lost to Follow-up|1|||
33300258|NCT01027351|62676505|FG001|Overall Study|Lost to Follow-up|1|||
33300259|NCT01027351|62676506|FG002|Overall Study|Lost to Follow-up|0|||
33300260|NCT01027351|62676507|FG003|Overall Study|Lost to Follow-up|1|||
33300261|NCT01027351|62676508|FG004|Overall Study|Lost to Follow-up|6|||
33300262|NCT01027351|62676509|FG005|Overall Study|Lost to Follow-up|0|||
33300263|NCT01027351|62676504|FG000|Overall Study|Inappropriate enrollment|0|||
33300264|NCT01027351|62676505|FG001|Overall Study|Inappropriate enrollment|0|||
33300265|NCT01027351|62676506|FG002|Overall Study|Inappropriate enrollment|0|||
33300266|NCT01027351|62676507|FG003|Overall Study|Inappropriate enrollment|0|||
33300267|NCT01027351|62676508|FG004|Overall Study|Inappropriate enrollment|1|||
33300268|NCT01027351|62676509|FG005|Overall Study|Inappropriate enrollment|0|||
33300269|NCT01027351|62676504|FG000|Overall Study|Protocol Violation|1|||
33300270|NCT01027351|62676505|FG001|Overall Study|Protocol Violation|0|||
33300271|NCT01027351|62676506|FG002|Overall Study|Protocol Violation|0|||
33300272|NCT01027351|62676507|FG003|Overall Study|Protocol Violation|1|||
33300273|NCT01027351|62676508|FG004|Overall Study|Protocol Violation|1|||
33300274|NCT01027351|62676509|FG005|Overall Study|Protocol Violation|0|||
33300275|NCT01027273|62676532|FG000|Overall Study|Lost to Follow-up|57|||
33300276|NCT01027273|62676533|FG001|Overall Study|Lost to Follow-up|31|||
33300277|NCT01027273|62676532|FG000|Overall Study|Death|2|||
33300278|NCT01027273|62676533|FG001|Overall Study|Death|2|||
33300279|NCT01022203|62676541|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
33300280|NCT01022203|62676542|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
33300281|NCT01022203|62676541|FG000|Post Treatment Assessment|Physician Decision|2|||
33300282|NCT01022203|62676542|FG001|Post Treatment Assessment|Physician Decision|0|||
33300283|NCT01022203|62676541|FG000|Post Treatment Assessment|Adverse Event|0|||
33300284|NCT01022203|62676542|FG001|Post Treatment Assessment|Adverse Event|2|||
33391593|NCT00396409|62770392|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
33391594|NCT00396409|62770393|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
33561577|NCT02526524|62955998|FG000|Overall Study|Adverse Event|3|||
33300285|NCT01022203|62676541|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
33391595|NCT00396409|62770392|FG000|Period 1 - 2007|Lost to Follow-up|2|||
33300286|NCT01022203|62676542|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
33300287|NCT01296711|62676559|FG000|Overall Study|Adverse Event|3|||
33300288|NCT01296711|62676560|FG001|Overall Study|Adverse Event|1|||
33300289|NCT01296711|62676561|FG002|Overall Study|Adverse Event|4|||
33300290|NCT01296711|62676562|FG003|Overall Study|Adverse Event|3|||
33391596|NCT00396409|62770393|FG001|Period 1 - 2007|Lost to Follow-up|3|||
33391597|NCT00396409|62770392|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
33561578|NCT02526524|62955999|FG001|Overall Study|Adverse Event|2|||
33561579|NCT02526524|62956000|FG002|Overall Study|Adverse Event|4|||
33561580|NCT02526524|62956001|FG003|Overall Study|Adverse Event|2|||
33561581|NCT02526524|62956002|FG004|Overall Study|Adverse Event|6|||
33561582|NCT02526524|62956003|FG005|Overall Study|Adverse Event|8|||
33561583|NCT02526524|62955998|FG000|Overall Study|Lost to Follow-up|2|||
33561584|NCT02526524|62955999|FG001|Overall Study|Lost to Follow-up|3|||
33561585|NCT02526524|62956000|FG002|Overall Study|Lost to Follow-up|8|||
33561586|NCT02526524|62956001|FG003|Overall Study|Lost to Follow-up|1|||
33561587|NCT02526524|62956002|FG004|Overall Study|Lost to Follow-up|2|||
33561588|NCT02526524|62956003|FG005|Overall Study|Lost to Follow-up|5|||
33561589|NCT02526524|62955998|FG000|Overall Study|Protocol Violation|3|||
33300291|NCT01296711|62676563|FG004|Overall Study|Adverse Event|1|||
33300292|NCT01296711|62676564|FG005|Overall Study|Adverse Event|6|||
33300293|NCT01296711|62676565|FG006|Overall Study|Adverse Event|11|||
33300294|NCT01296711|62676566|FG007|Overall Study|Adverse Event|3|||
33300295|NCT01296711|62676559|FG000|Overall Study|Lack of Efficacy|1|||
33300296|NCT01296711|62676560|FG001|Overall Study|Lack of Efficacy|4|||
33300297|NCT01296711|62676561|FG002|Overall Study|Lack of Efficacy|1|||
33300298|NCT01296711|62676562|FG003|Overall Study|Lack of Efficacy|1|||
33300299|NCT01296711|62676563|FG004|Overall Study|Lack of Efficacy|1|||
33300300|NCT01296711|62676564|FG005|Overall Study|Lack of Efficacy|0|||
33300301|NCT01296711|62676565|FG006|Overall Study|Lack of Efficacy|2|||
33300302|NCT01296711|62676566|FG007|Overall Study|Lack of Efficacy|3|||
33300303|NCT01296711|62676559|FG000|Overall Study|Lost to Follow-up|0|||
33300304|NCT01296711|62676560|FG001|Overall Study|Lost to Follow-up|0|||
33300305|NCT01296711|62676561|FG002|Overall Study|Lost to Follow-up|1|||
33300306|NCT01296711|62676562|FG003|Overall Study|Lost to Follow-up|1|||
33300307|NCT01296711|62676563|FG004|Overall Study|Lost to Follow-up|2|||
33300308|NCT01296711|62676564|FG005|Overall Study|Lost to Follow-up|0|||
33300309|NCT01296711|62676565|FG006|Overall Study|Lost to Follow-up|4|||
33300310|NCT01296711|62676566|FG007|Overall Study|Lost to Follow-up|2|||
33300311|NCT01296711|62676559|FG000|Overall Study|Protocol Violation|0|||
33300312|NCT01296711|62676560|FG001|Overall Study|Protocol Violation|0|||
33300313|NCT01296711|62676561|FG002|Overall Study|Protocol Violation|0|||
33300314|NCT01296711|62676562|FG003|Overall Study|Protocol Violation|1|||
33300315|NCT01296711|62676563|FG004|Overall Study|Protocol Violation|1|||
33300316|NCT01296711|62676564|FG005|Overall Study|Protocol Violation|0|||
33300317|NCT01296711|62676565|FG006|Overall Study|Protocol Violation|0|||
33300318|NCT01296711|62676566|FG007|Overall Study|Protocol Violation|0|||
33300319|NCT01296711|62676559|FG000|Overall Study|Withdrawal by Subject|4|||
33300320|NCT01296711|62676560|FG001|Overall Study|Withdrawal by Subject|2|||
33300321|NCT01296711|62676561|FG002|Overall Study|Withdrawal by Subject|2|||
33300322|NCT01296711|62676562|FG003|Overall Study|Withdrawal by Subject|1|||
33300323|NCT01296711|62676563|FG004|Overall Study|Withdrawal by Subject|1|||
33300324|NCT01296711|62676564|FG005|Overall Study|Withdrawal by Subject|1|||
33561590|NCT02526524|62955999|FG001|Overall Study|Protocol Violation|1|||
33561591|NCT02526524|62956000|FG002|Overall Study|Protocol Violation|5|||
33561592|NCT02526524|62956001|FG003|Overall Study|Protocol Violation|3|||
33561593|NCT02526524|62956002|FG004|Overall Study|Protocol Violation|4|||
33561594|NCT02526524|62956003|FG005|Overall Study|Protocol Violation|3|||
33561595|NCT02526524|62955998|FG000|Overall Study|Loss of Glucose Control|0|||
33561596|NCT02526524|62955999|FG001|Overall Study|Loss of Glucose Control|0|||
33561597|NCT02526524|62956000|FG002|Overall Study|Loss of Glucose Control|3|||
33561598|NCT02526524|62956001|FG003|Overall Study|Loss of Glucose Control|0|||
33561599|NCT02526524|62956002|FG004|Overall Study|Loss of Glucose Control|2|||
33561600|NCT02526524|62956003|FG005|Overall Study|Loss of Glucose Control|0|||
33561601|NCT02526524|62955998|FG000|Overall Study|Physician Decision|0|||
33561602|NCT02526524|62955999|FG001|Overall Study|Physician Decision|0|||
33561603|NCT02526524|62956000|FG002|Overall Study|Physician Decision|0|||
33561604|NCT02526524|62956001|FG003|Overall Study|Physician Decision|0|||
33300325|NCT01296711|62676565|FG006|Overall Study|Withdrawal by Subject|2|||
33391598|NCT00396409|62770393|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
33561605|NCT02526524|62956002|FG004|Overall Study|Physician Decision|1|||
33561606|NCT02526524|62956003|FG005|Overall Study|Physician Decision|0|||
33561607|NCT02526524|62955998|FG000|Overall Study|Sponsor Decision|1|||
33561608|NCT02526524|62955999|FG001|Overall Study|Sponsor Decision|0|||
33561609|NCT02526524|62956000|FG002|Overall Study|Sponsor Decision|0|||
33561610|NCT02526524|62956001|FG003|Overall Study|Sponsor Decision|0|||
33300326|NCT01296711|62676566|FG007|Overall Study|Withdrawal by Subject|1|||
33300327|NCT01296711|62676559|FG000|Overall Study|Study termination|8|||
33300328|NCT01296711|62676560|FG001|Overall Study|Study termination|1|||
33300329|NCT01296711|62676561|FG002|Overall Study|Study termination|5|||
33300330|NCT01296711|62676562|FG003|Overall Study|Study termination|4|||
33300331|NCT01296711|62676563|FG004|Overall Study|Study termination|4|||
33300332|NCT01296711|62676564|FG005|Overall Study|Study termination|4|||
33300333|NCT01296711|62676565|FG006|Overall Study|Study termination|8|||
33300334|NCT01296711|62676566|FG007|Overall Study|Study termination|10|||
33300335|NCT01296711|62676559|FG000|Overall Study|Continued elevated liver enzymes|0|||
33561611|NCT02526524|62956002|FG004|Overall Study|Sponsor Decision|0|||
33561612|NCT02526524|62956003|FG005|Overall Study|Sponsor Decision|0|||
33561613|NCT02526290|62956017|FG000|Overall Study|Adverse Event|3|||
33561614|NCT02526290|62956017|FG000|Overall Study|Withdrawal by Subject|4|||
33561615|NCT02526290|62956017|FG000|Overall Study|Physician Decision|1|||
33561616|NCT02319148|62956024|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
33561617|NCT02319148|62956025|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
33561618|NCT02319148|62956026|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
33561619|NCT02319148|62956027|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
33561620|NCT02319148|62956024|FG000|Second Intervention Period|No longer willing to participate|0|||
33561621|NCT02319148|62956025|FG001|Second Intervention Period|No longer willing to participate|1|||
33561622|NCT02319148|62956026|FG002|Second Intervention Period|No longer willing to participate|0|||
33561623|NCT02319148|62956027|FG003|Second Intervention Period|No longer willing to participate|0|||
33561624|NCT02319148|62956024|FG000|Second Intervention Period|Other|0|||
33561625|NCT02319148|62956025|FG001|Second Intervention Period|Other|0|||
33561626|NCT02319148|62956026|FG002|Second Intervention Period|Other|0|||
33561627|NCT02319148|62956027|FG003|Second Intervention Period|Other|1|||
33561628|NCT02526212|62956048|FG000|Overall Study|Incarceration|1|||
33561629|NCT02526212|62956049|FG001|Overall Study|Incarceration|0|||
33561630|NCT02526212|62956048|FG000|Overall Study|Lost to Follow-up|1|||
33561631|NCT02526212|62956049|FG001|Overall Study|Lost to Follow-up|0|||
33561632|NCT02526212|62956048|FG000|Overall Study|Death|0|||
33561633|NCT02526212|62956049|FG001|Overall Study|Death|1|||
33561634|NCT02532374|62956055|FG000|Overall Study|Withdrawal by Subject|1|||
33561635|NCT02532374|62956055|FG000|Overall Study|Physician Decision|1|||
33561636|NCT02525744|62956067|FG000|Period 1|Physician Decision|0|||
33561637|NCT02525744|62956068|FG001|Period 1|Physician Decision|0|||
33561638|NCT02525744|62956069|FG002|Period 1|Physician Decision|1|||
33561639|NCT02525744|62956070|FG003|Period 1|Physician Decision|0|||
33561640|NCT02525744|62956067|FG000|Period 3|Adverse Event|0|||
33561641|NCT02525744|62956068|FG001|Period 3|Adverse Event|1|||
33561642|NCT02525744|62956069|FG002|Period 3|Adverse Event|0|||
33561643|NCT02525744|62956070|FG003|Period 3|Adverse Event|0|||
33561644|NCT02525744|62956067|FG000|Period 4|Withdrawal by Subject|1|||
33561645|NCT02525744|62956068|FG001|Period 4|Withdrawal by Subject|0|||
33561646|NCT02525744|62956069|FG002|Period 4|Withdrawal by Subject|0|||
33561647|NCT02525744|62956070|FG003|Period 4|Withdrawal by Subject|0|||
33561648|NCT02525744|62956067|FG000|Period 5|Physician Decision|1|||
33561649|NCT02525744|62956068|FG001|Period 5|Physician Decision|0|||
33561650|NCT02525744|62956069|FG002|Period 5|Physician Decision|0|||
33561651|NCT02525744|62956070|FG003|Period 5|Physician Decision|0|||
33561652|NCT00152477|62956083|FG000|Chemotherapy Period|Adverse Event|9|||
33561653|NCT00152477|62956084|FG001|Chemotherapy Period|Adverse Event|4|||
33561654|NCT00152477|62956085|FG002|Chemotherapy Period|Adverse Event|5|||
33300336|NCT01296711|62676560|FG001|Overall Study|Continued elevated liver enzymes|0|||
33300337|NCT01296711|62676561|FG002|Overall Study|Continued elevated liver enzymes|0|||
33300338|NCT01296711|62676562|FG003|Overall Study|Continued elevated liver enzymes|1|||
33300339|NCT01296711|62676563|FG004|Overall Study|Continued elevated liver enzymes|0|||
33300340|NCT01296711|62676564|FG005|Overall Study|Continued elevated liver enzymes|0|||
33300341|NCT01296711|62676565|FG006|Overall Study|Continued elevated liver enzymes|0|||
33561655|NCT00152477|62956083|FG000|Chemotherapy Period|Death|1|||
33561656|NCT00152477|62956084|FG001|Chemotherapy Period|Death|3|||
33561657|NCT00152477|62956085|FG002|Chemotherapy Period|Death|3|||
33561658|NCT00152477|62956083|FG000|Chemotherapy Period|Lack of Efficacy|4|||
33561659|NCT00152477|62956084|FG001|Chemotherapy Period|Lack of Efficacy|5|||
33561660|NCT00152477|62956085|FG002|Chemotherapy Period|Lack of Efficacy|6|||
33561661|NCT00152477|62956083|FG000|Chemotherapy Period|Lost to Follow-up|1|||
33561662|NCT00152477|62956084|FG001|Chemotherapy Period|Lost to Follow-up|0|||
33561663|NCT00152477|62956085|FG002|Chemotherapy Period|Lost to Follow-up|1|||
33561664|NCT00152477|62956083|FG000|Chemotherapy Period|Protocol Violation|1|||
33561665|NCT00152477|62956084|FG001|Chemotherapy Period|Protocol Violation|1|||
33561666|NCT00152477|62956085|FG002|Chemotherapy Period|Protocol Violation|0|||
33561667|NCT00152477|62956083|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
33561668|NCT00152477|62956084|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
33561669|NCT00152477|62956085|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
33561670|NCT00152477|62956083|FG000|Chemotherapy Period|Progression of Disease|6|||
33561671|NCT00152477|62956084|FG001|Chemotherapy Period|Progression of Disease|8|||
33561672|NCT00152477|62956085|FG002|Chemotherapy Period|Progression of Disease|4|||
33561673|NCT00152477|62956083|FG000|Chemotherapy Period|Investigator decision|0|||
33561674|NCT00152477|62956084|FG001|Chemotherapy Period|Investigator decision|0|||
33300342|NCT01296711|62676566|FG007|Overall Study|Continued elevated liver enzymes|0|||
33300343|NCT01296711|62676559|FG000|Overall Study|Methotrexate discontinued|0|||
33300344|NCT01296711|62676560|FG001|Overall Study|Methotrexate discontinued|0|||
33561675|NCT00152477|62956085|FG002|Chemotherapy Period|Investigator decision|1|||
33300345|NCT01296711|62676561|FG002|Overall Study|Methotrexate discontinued|0|||
33300346|NCT01296711|62676562|FG003|Overall Study|Methotrexate discontinued|1|||
33561676|NCT00152477|62956083|FG000|Chemotherapy Period|Patient condition worsened|1|||
33300347|NCT01296711|62676563|FG004|Overall Study|Methotrexate discontinued|0|||
33300348|NCT01296711|62676564|FG005|Overall Study|Methotrexate discontinued|0|||
33300349|NCT01296711|62676565|FG006|Overall Study|Methotrexate discontinued|0|||
33561677|NCT00152477|62956084|FG001|Chemotherapy Period|Patient condition worsened|0|||
33561678|NCT00152477|62956085|FG002|Chemotherapy Period|Patient condition worsened|0|||
33561679|NCT00152477|62956083|FG000|Monotherapy Period|Adverse Event|1|||
33561680|NCT00152477|62956084|FG001|Monotherapy Period|Adverse Event|0|||
33561681|NCT00152477|62956085|FG002|Monotherapy Period|Adverse Event|5|||
33561682|NCT00152477|62956083|FG000|Monotherapy Period|Death|2|||
33561683|NCT00152477|62956084|FG001|Monotherapy Period|Death|0|||
33561684|NCT00152477|62956085|FG002|Monotherapy Period|Death|1|||
33561685|NCT00152477|62956083|FG000|Monotherapy Period|Lack of Efficacy|7|||
33561686|NCT00152477|62956084|FG001|Monotherapy Period|Lack of Efficacy|16|||
33561687|NCT00152477|62956085|FG002|Monotherapy Period|Lack of Efficacy|10|||
33561688|NCT00152477|62956083|FG000|Monotherapy Period|Protocol Violation|0|||
33561689|NCT00152477|62956084|FG001|Monotherapy Period|Protocol Violation|1|||
33561690|NCT00152477|62956085|FG002|Monotherapy Period|Protocol Violation|0|||
33561691|NCT00152477|62956083|FG000|Monotherapy Period|Withdrawal by Subject|0|||
33561692|NCT00152477|62956084|FG001|Monotherapy Period|Withdrawal by Subject|0|||
33561693|NCT00152477|62956085|FG002|Monotherapy Period|Withdrawal by Subject|4|||
33561694|NCT00152477|62956083|FG000|Monotherapy Period|Progression of Disease|5|||
33561695|NCT00152477|62956084|FG001|Monotherapy Period|Progression of Disease|11|||
33561696|NCT00152477|62956085|FG002|Monotherapy Period|Progression of Disease|12|||
33561697|NCT00152477|62956083|FG000|Monotherapy Period|Patient decision|0|||
33561698|NCT00152477|62956084|FG001|Monotherapy Period|Patient decision|1|||
33561699|NCT00152477|62956085|FG002|Monotherapy Period|Patient decision|1|||
33561700|NCT00152477|62956083|FG000|Monotherapy Period|Study personel decision|0|||
33561701|NCT00152477|62956084|FG001|Monotherapy Period|Study personel decision|0|||
33561702|NCT00152477|62956085|FG002|Monotherapy Period|Study personel decision|1|||
33561703|NCT02525588|62956098|FG000|Overall Study|Death|3|||
33561704|NCT02525588|62956099|FG001|Overall Study|Death|1|||
33561705|NCT02525588|62956098|FG000|Overall Study|Lost to Follow-up|2|||
33561706|NCT02525588|62956099|FG001|Overall Study|Lost to Follow-up|0|||
33561707|NCT02525588|62956098|FG000|Overall Study|Withdrawal by Subject|1|||
33561708|NCT02525588|62956099|FG001|Overall Study|Withdrawal by Subject|1|||
33561709|NCT02525588|62956098|FG000|Overall Study|Adverse Event|0|||
33561710|NCT02525588|62956099|FG001|Overall Study|Adverse Event|1|||
33561711|NCT00153179|62956107|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
33561712|NCT00153179|62956108|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
33561713|NCT00153179|62956109|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
33561714|NCT00153179|62956110|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
33561715|NCT02743949|62956121|FG000|Overall Study|Adverse Event|0|||
33561716|NCT02743949|62956122|FG001|Overall Study|Adverse Event|0|||
33561717|NCT02743949|62956123|FG002|Overall Study|Adverse Event|2|||
33561718|NCT02743949|62956121|FG000|Overall Study|Significant Protocol Deviation|2|||
33561719|NCT02743949|62956122|FG001|Overall Study|Significant Protocol Deviation|0|||
33561720|NCT02743949|62956123|FG002|Overall Study|Significant Protocol Deviation|1|||
33561721|NCT02743949|62956121|FG000|Overall Study|Voluntary Withdrawal|2|||
33561722|NCT02743949|62956122|FG001|Overall Study|Voluntary Withdrawal|1|||
33561723|NCT02743949|62956123|FG002|Overall Study|Voluntary Withdrawal|0|||
33561724|NCT02531438|62956133|FG000|Overall Study|Adverse Event|7|||
33561725|NCT02531438|62956134|FG001|Overall Study|Adverse Event|9|||
33561726|NCT02531438|62956133|FG000|Overall Study|Lost to Follow-up|0|||
33561727|NCT02531438|62956134|FG001|Overall Study|Lost to Follow-up|3|||
33561728|NCT02531438|62956133|FG000|Overall Study|Withdrawal by Subject|7|||
33561729|NCT02531438|62956134|FG001|Overall Study|Withdrawal by Subject|8|||
33391599|NCT00396409|62770392|FG000|Period 2 - 2008|Protocol Violation|1|||
33561730|NCT02531438|62956133|FG000|Overall Study|Physician Decision|0|||
33561731|NCT02531438|62956134|FG001|Overall Study|Physician Decision|1|||
33561732|NCT02531438|62956133|FG000|Overall Study|Death|6|||
33300350|NCT01296711|62676566|FG007|Overall Study|Methotrexate discontinued|0|||
33300351|NCT01296711|62676559|FG000|Overall Study|Investigator discretion|0|||
33300352|NCT01296711|62676560|FG001|Overall Study|Investigator discretion|0|||
33300353|NCT01296711|62676561|FG002|Overall Study|Investigator discretion|0|||
33300354|NCT01296711|62676562|FG003|Overall Study|Investigator discretion|0|||
33300355|NCT01296711|62676563|FG004|Overall Study|Investigator discretion|0|||
33300356|NCT01296711|62676564|FG005|Overall Study|Investigator discretion|0|||
33391600|NCT00396409|62770393|FG001|Period 2 - 2008|Protocol Violation|0|||
33561733|NCT02531438|62956134|FG001|Overall Study|Death|3|||
33561734|NCT02531438|62956133|FG000|Overall Study|Randomized, but Not Treated|4|||
33561735|NCT02531438|62956134|FG001|Overall Study|Randomized, but Not Treated|0|||
33561736|NCT02531438|62956133|FG000|Overall Study|Missed EOT/PTE Visit|5|||
33561737|NCT02531438|62956134|FG001|Overall Study|Missed EOT/PTE Visit|2|||
33561738|NCT02531438|62956133|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
33561739|NCT02531438|62956134|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
33300357|NCT01296711|62676565|FG006|Overall Study|Investigator discretion|1|||
33300358|NCT01296711|62676566|FG007|Overall Study|Investigator discretion|0|||
33561740|NCT02289898|62956143|FG000|Overall Study|Death|5|||
33561741|NCT02289898|62956144|FG001|Overall Study|Death|4|||
33561742|NCT02289898|62956145|FG002|Overall Study|Death|3|||
33561743|NCT02289898|62956143|FG000|Overall Study|Physician Decision|2|||
33561744|NCT02289898|62956144|FG001|Overall Study|Physician Decision|5|||
33561745|NCT02289898|62956145|FG002|Overall Study|Physician Decision|2|||
33561746|NCT02289898|62956143|FG000|Overall Study|Withdrawal by Subject|0|||
33561747|NCT02289898|62956144|FG001|Overall Study|Withdrawal by Subject|4|||
33561748|NCT02289898|62956145|FG002|Overall Study|Withdrawal by Subject|1|||
33391601|NCT00396409|62770392|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
33391602|NCT00396409|62770393|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
33391603|NCT00396409|62770392|FG000|Period 2 - 2008|Lost to Follow-up|3|||
33391604|NCT00396409|62770393|FG001|Period 2 - 2008|Lost to Follow-up|1|||
33391605|NCT02924376|62770405|FG000|Overall Study|Progressive Disease|4|||
33391606|NCT02924376|62770406|FG001|Overall Study|Progressive Disease|0|||
33561749|NCT02289898|62956143|FG000|Overall Study|Adverse Event|3|||
33561750|NCT02289898|62956144|FG001|Overall Study|Adverse Event|5|||
33561751|NCT02289898|62956145|FG002|Overall Study|Adverse Event|5|||
33561752|NCT02289898|62956143|FG000|Overall Study|Disease progression|34|||
33561753|NCT02289898|62956144|FG001|Overall Study|Disease progression|28|||
33561754|NCT02289898|62956145|FG002|Overall Study|Disease progression|34|||
33561755|NCT02289898|62956143|FG000|Overall Study|Use of another anticancer therapy|0|||
33561756|NCT02289898|62956144|FG001|Overall Study|Use of another anticancer therapy|0|||
33561757|NCT02289898|62956145|FG002|Overall Study|Use of another anticancer therapy|1|||
33561758|NCT02289898|62956143|FG000|Overall Study|Other|8|||
33561759|NCT02289898|62956144|FG001|Overall Study|Other|7|||
33561760|NCT02289898|62956145|FG002|Overall Study|Other|10|||
33561761|NCT01660412|62956152|FG000|Overall Study|Protocol Violation|0|||
33561762|NCT01660412|62956153|FG001|Overall Study|Protocol Violation|3|||
33561763|NCT01659554|62956159|FG000|Overall Study|Study Termination|4|||
33561764|NCT01659320|62956163|FG000|Overall Study|Withdrawal by Subject|2|||
33561765|NCT01659320|62956163|FG000|Overall Study|Physician Decision|1|||
33561766|NCT01660334|62956167|FG000|Overall Study|Lost to Follow-up|1|||
33561767|NCT01660256|62956174|FG000|Overall Study|Adverse Event|4|||
33561768|NCT01660256|62956175|FG001|Overall Study|Adverse Event|0|||
33561769|NCT01660256|62956176|FG002|Overall Study|Adverse Event|2|||
33561770|NCT01660256|62956174|FG000|Overall Study|Withdrawal by Subject|1|||
33391607|NCT02924376|62770407|FG002|Overall Study|Progressive Disease|1|||
33391608|NCT02924376|62770408|FG003|Overall Study|Progressive Disease|0|||
33391609|NCT02924376|62770405|FG000|Overall Study|Death|73|||
33391610|NCT02924376|62770406|FG001|Overall Study|Death|18|||
33391611|NCT02924376|62770407|FG002|Overall Study|Death|15|||
33391612|NCT02924376|62770408|FG003|Overall Study|Death|2|||
33561771|NCT01660256|62956175|FG001|Overall Study|Withdrawal by Subject|0|||
33561772|NCT01660256|62956176|FG002|Overall Study|Withdrawal by Subject|2|||
33561773|NCT02034123|62956202|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33561774|NCT02034123|62956203|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33561775|NCT02034123|62956204|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33561776|NCT02034123|62956205|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33561777|NCT02034123|62956206|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
33561778|NCT02034123|62956207|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33561779|NCT02034123|62956208|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33561780|NCT02034123|62956209|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
33561781|NCT02034123|62956210|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
33561782|NCT02034123|62956211|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33561783|NCT02034123|62956212|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33561784|NCT02034123|62956213|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33300359|NCT01296711|62676559|FG000|Overall Study|Other|0|||
33300360|NCT01296711|62676560|FG001|Overall Study|Other|0|||
33300361|NCT01296711|62676561|FG002|Overall Study|Other|0|||
33300362|NCT01296711|62676562|FG003|Overall Study|Other|0|||
33300363|NCT01296711|62676563|FG004|Overall Study|Other|0|||
33300364|NCT01296711|62676564|FG005|Overall Study|Other|0|||
33300365|NCT01296711|62676565|FG006|Overall Study|Other|1|||
33391613|NCT02924376|62770405|FG000|Overall Study|Lost to Follow-up|3|||
33561785|NCT02034123|62956214|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33561786|NCT02034123|62956215|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33561787|NCT02034123|62956216|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33561788|NCT02034123|62956217|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33300366|NCT01296711|62676566|FG007|Overall Study|Other|0|||
33300367|NCT01296711|62676559|FG000|Overall Study|Required restricted steroid injections|0|||
33300368|NCT01296711|62676560|FG001|Overall Study|Required restricted steroid injections|0|||
33391614|NCT02924376|62770406|FG001|Overall Study|Lost to Follow-up|0|||
33391615|NCT02924376|62770407|FG002|Overall Study|Lost to Follow-up|0|||
33561789|NCT02034123|62956218|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33561790|NCT02034123|62956219|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33561791|NCT02034123|62956202|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33561792|NCT02034123|62956203|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33561793|NCT02034123|62956204|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33561794|NCT02034123|62956205|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
33561795|NCT02034123|62956206|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33561796|NCT02034123|62956207|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33561797|NCT02034123|62956208|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33561798|NCT02034123|62956209|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33561799|NCT02034123|62956210|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33391616|NCT02924376|62770408|FG003|Overall Study|Lost to Follow-up|0|||
33391617|NCT02924376|62770405|FG000|Overall Study|Study Terminated by Sponsor|19|||
33391618|NCT02924376|62770406|FG001|Overall Study|Study Terminated by Sponsor|0|||
33391619|NCT02924376|62770407|FG002|Overall Study|Study Terminated by Sponsor|0|||
33391620|NCT02924376|62770408|FG003|Overall Study|Study Terminated by Sponsor|0|||
33391621|NCT02924376|62770405|FG000|Overall Study|Physician Decision|1|||
33391622|NCT02924376|62770406|FG001|Overall Study|Physician Decision|0|||
33391623|NCT02924376|62770407|FG002|Overall Study|Physician Decision|0|||
33391624|NCT02924376|62770408|FG003|Overall Study|Physician Decision|0|||
33391625|NCT02924376|62770405|FG000|Overall Study|Withdrawal by Subject|7|||
33391626|NCT02924376|62770406|FG001|Overall Study|Withdrawal by Subject|2|||
33391627|NCT02924376|62770407|FG002|Overall Study|Withdrawal by Subject|1|||
33391628|NCT02924376|62770408|FG003|Overall Study|Withdrawal by Subject|0|||
33391629|NCT02924376|62770405|FG000|Overall Study|Rolled Over to Another Study|1|||
33391630|NCT02924376|62770406|FG001|Overall Study|Rolled Over to Another Study|0|||
33391631|NCT02924376|62770407|FG002|Overall Study|Rolled Over to Another Study|0|||
33391632|NCT02924376|62770408|FG003|Overall Study|Rolled Over to Another Study|0|||
33391633|NCT00693420|62770423|FG000|Overall Study|Adverse Event|4|||
33391634|NCT00693420|62770424|FG001|Overall Study|Adverse Event|4|||
33391635|NCT00693420|62770423|FG000|Overall Study|Lost to Follow-up|0|||
33391636|NCT00693420|62770424|FG001|Overall Study|Lost to Follow-up|3|||
33391637|NCT00693420|62770423|FG000|Overall Study|Withdrawal by Subject|1|||
33391638|NCT00693420|62770424|FG001|Overall Study|Withdrawal by Subject|0|||
33391639|NCT00693420|62770423|FG000|Overall Study|Protocol Violation|0|||
33391640|NCT00693420|62770424|FG001|Overall Study|Protocol Violation|2|||
33391641|NCT00693420|62770423|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
33391642|NCT00693420|62770424|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
33391643|NCT00693420|62770423|FG000|Overall Study|Personal Reasons|1|||
33391644|NCT00693420|62770424|FG001|Overall Study|Personal Reasons|4|||
33391645|NCT00695136|62770430|FG000|Overall Study|Withdrawal by Subject|1|||
33391646|NCT00695136|62770430|FG000|Overall Study|unrelated adverse event|1|||
33391647|NCT00605176|62770446|FG000|Overall Study|Adverse Event|2|||
33391648|NCT00605176|62770447|FG001|Overall Study|Adverse Event|1|||
33391649|NCT00605176|62770448|FG002|Overall Study|Adverse Event|3|||
33391650|NCT00605176|62770446|FG000|Overall Study|Withdrawal by Subject|4|||
33391651|NCT00605176|62770447|FG001|Overall Study|Withdrawal by Subject|2|||
33391652|NCT00605176|62770448|FG002|Overall Study|Withdrawal by Subject|4|||
33391653|NCT00605176|62770446|FG000|Overall Study|Lost to Follow-up|2|||
33391654|NCT00605176|62770447|FG001|Overall Study|Lost to Follow-up|2|||
33391655|NCT00605176|62770448|FG002|Overall Study|Lost to Follow-up|1|||
33391656|NCT00605176|62770446|FG000|Overall Study|Non-complicance with study procedures|1|||
33391657|NCT00605176|62770447|FG001|Overall Study|Non-complicance with study procedures|0|||
33391658|NCT00605176|62770448|FG002|Overall Study|Non-complicance with study procedures|0|||
33391659|NCT00605176|62770446|FG000|Overall Study|Use of concomitant therapy|1|||
33561800|NCT02034123|62956211|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33561801|NCT02034123|62956212|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33561802|NCT02034123|62956213|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33561803|NCT02034123|62956214|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33561804|NCT02034123|62956215|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33561805|NCT02034123|62956216|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33561806|NCT02034123|62956217|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33561807|NCT02034123|62956218|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33561808|NCT02034123|62956219|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33391660|NCT00605176|62770447|FG001|Overall Study|Use of concomitant therapy|0|||
33391661|NCT00605176|62770448|FG002|Overall Study|Use of concomitant therapy|1|||
33391662|NCT00605176|62770446|FG000|Overall Study|Other (not due to AE)|1|||
33391663|NCT00605176|62770447|FG001|Overall Study|Other (not due to AE)|1|||
33391664|NCT00605176|62770448|FG002|Overall Study|Other (not due to AE)|0|||
33391665|NCT00694356|62770459|FG000|Overall Study|Adverse Event|1|||
33391666|NCT00694356|62770460|FG001|Overall Study|Adverse Event|0|||
33391667|NCT00694356|62770461|FG002|Overall Study|Adverse Event|0|||
33391668|NCT00694356|62770459|FG000|Overall Study|Progressive Disease|2|||
33391669|NCT00694356|62770460|FG001|Overall Study|Progressive Disease|6|||
33391670|NCT00694356|62770461|FG002|Overall Study|Progressive Disease|6|||
33391671|NCT00692406|62770469|FG000|Overall Study|PI dropped, bad data|57|||
33391672|NCT00567502|62770486|FG000|Overall Study|Lost to Follow-up|91|||
33391673|NCT00567502|62770487|FG001|Overall Study|Lost to Follow-up|14|||
33391674|NCT00567502|62770488|FG002|Overall Study|Lost to Follow-up|351|||
33391675|NCT00567502|62770489|FG003|Overall Study|Lost to Follow-up|2|||
33391676|NCT00567502|62770486|FG000|Overall Study|Death|65|||
33391677|NCT00567502|62770487|FG001|Overall Study|Death|16|||
33391678|NCT00567502|62770488|FG002|Overall Study|Death|360|||
33391679|NCT00567502|62770489|FG003|Overall Study|Death|5|||
33391680|NCT00567502|62770486|FG000|Overall Study|Other|64|||
33391681|NCT00567502|62770487|FG001|Overall Study|Other|2|||
33391682|NCT00567502|62770488|FG002|Overall Study|Other|134|||
33391683|NCT00567502|62770489|FG003|Overall Study|Other|6|||
33391684|NCT00567502|62770486|FG000|Overall Study|Participant request|12|||
33391685|NCT00567502|62770487|FG001|Overall Study|Participant request|1|||
33391686|NCT00567502|62770488|FG002|Overall Study|Participant request|33|||
33391687|NCT00567502|62770489|FG003|Overall Study|Participant request|1|||
33561809|NCT02034123|62956202|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561810|NCT02034123|62956203|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561811|NCT02034123|62956204|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561812|NCT02034123|62956205|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561813|NCT02034123|62956206|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561814|NCT02034123|62956207|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561815|NCT02034123|62956208|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561816|NCT02034123|62956209|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561817|NCT02034123|62956210|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
33561818|NCT02034123|62956211|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561819|NCT02034123|62956212|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561820|NCT02034123|62956213|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561821|NCT02034123|62956214|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561822|NCT02034123|62956215|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561823|NCT02034123|62956216|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561824|NCT02034123|62956217|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561825|NCT02034123|62956218|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561826|NCT02034123|62956219|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33561827|NCT02034123|62956202|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33561828|NCT02034123|62956203|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33561829|NCT02034123|62956204|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33561830|NCT02034123|62956205|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
33561831|NCT02034123|62956206|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
33561832|NCT02034123|62956207|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33561833|NCT02034123|62956208|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33561834|NCT02034123|62956209|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33561835|NCT02034123|62956210|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33561836|NCT02034123|62956211|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33561837|NCT02034123|62956212|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33391688|NCT00567502|62770486|FG000|Overall Study|Sponsor request|9|||
33391689|NCT00567502|62770487|FG001|Overall Study|Sponsor request|0|||
33391690|NCT00567502|62770488|FG002|Overall Study|Sponsor request|30|||
33391691|NCT00567502|62770489|FG003|Overall Study|Sponsor request|1|||
33391692|NCT00567502|62770486|FG000|Overall Study|Never Initiated Treatment|0|||
33391693|NCT00567502|62770487|FG001|Overall Study|Never Initiated Treatment|0|||
33391694|NCT00567502|62770488|FG002|Overall Study|Never Initiated Treatment|0|||
33391695|NCT00567502|62770489|FG003|Overall Study|Never Initiated Treatment|72|||
33391696|NCT00396331|62770514|FG000|Overall Study|Failed to mobilize - no transplant|8|||
33391697|NCT00396331|62770514|FG000|Overall Study|Did not go on to transplant|5|||
33391698|NCT00396331|62770514|FG000|Overall Study|Lost to Follow-up|3|||
33391699|NCT00396331|62770514|FG000|Overall Study|Death|16|||
33391700|NCT00396253|62770526|FG000|Overall Study|Protocol Violation|1|||
33391701|NCT00396253|62770526|FG000|Overall Study|Withdrawal by Subject|7|||
33391702|NCT00396253|62770526|FG000|Overall Study|Death|3|||
33391703|NCT00396253|62770526|FG000|Overall Study|Physician Decision|1|||
33391704|NCT00396253|62770526|FG000|Overall Study|Change in eligibility status|1|||
33391705|NCT00604162|62770530|FG000|Overall Study|Physician Decision|3|||
33391706|NCT00604162|62770530|FG000|Overall Study|Withdrawal by Subject|1|||
33391707|NCT00396097|62770539|FG000|Overall Study|Withdrawal by Subject|17|||
33391708|NCT00396097|62770540|FG001|Overall Study|Withdrawal by Subject|17|||
33391709|NCT00396097|62770539|FG000|Overall Study|Lost to Follow-up|4|||
33391710|NCT00396097|62770540|FG001|Overall Study|Lost to Follow-up|9|||
33391711|NCT00396097|62770539|FG000|Overall Study|Other|3|||
33561838|NCT02034123|62956213|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33561839|NCT02034123|62956214|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33561840|NCT02034123|62956215|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33561841|NCT02034123|62956216|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33561842|NCT02034123|62956217|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33561843|NCT02034123|62956218|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33561844|NCT02034123|62956219|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33561845|NCT02318602|62956265|FG000|Overall Study|Adverse Event|0|||
33561846|NCT02318602|62956266|FG001|Overall Study|Adverse Event|1|||
33561847|NCT02318602|62956267|FG002|Overall Study|Adverse Event|1|||
33561848|NCT02318602|62956265|FG000|Overall Study|Withdrawal by Subject|0|||
33561849|NCT02318602|62956266|FG001|Overall Study|Withdrawal by Subject|3|||
33561850|NCT02318602|62956267|FG002|Overall Study|Withdrawal by Subject|0|||
33561851|NCT02318602|62956265|FG000|Overall Study|Death|1|||
33561852|NCT02318602|62956266|FG001|Overall Study|Death|0|||
33561853|NCT02318602|62956267|FG002|Overall Study|Death|0|||
33561854|NCT02318602|62956265|FG000|Overall Study|Guardian decision to withdraw|0|||
33561855|NCT02318602|62956266|FG001|Overall Study|Guardian decision to withdraw|0|||
33561856|NCT02318602|62956267|FG002|Overall Study|Guardian decision to withdraw|1|||
33561857|NCT02318368|62956283|FG000|Overall Study|Withdrawal by Subject|2|||
33561858|NCT02318368|62956284|FG001|Overall Study|Withdrawal by Subject|0|||
33561859|NCT02318368|62956283|FG000|Overall Study|Study terminated by the sponsor|5|||
33561860|NCT02318368|62956284|FG001|Overall Study|Study terminated by the sponsor|2|||
33561861|NCT02318368|62956283|FG000|Overall Study|Death|0|||
33561862|NCT02318368|62956284|FG001|Overall Study|Death|1|||
33561863|NCT02318134|62956292|FG000|Overall Study|Withdrawal by Subject|2|||
33561864|NCT02318134|62956293|FG001|Overall Study|Withdrawal by Subject|1|||
33561865|NCT02317510|62956303|FG000|Overall Study|Adverse Event|0|||
33561866|NCT02317510|62956304|FG001|Overall Study|Adverse Event|1|||
33561867|NCT02317432|62956315|FG000|Overall Study|Death|4|||
33561868|NCT02317432|62956316|FG001|Overall Study|Death|1|||
33561869|NCT02317432|62956315|FG000|Overall Study|Lost to Follow-up|0|||
33561870|NCT02317432|62956316|FG001|Overall Study|Lost to Follow-up|5|||
33561871|NCT02317432|62956315|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
33561872|NCT02317432|62956316|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
33561873|NCT00494234|62956324|FG000|Overall Study|Lack of Efficacy|12|||
33561874|NCT00494234|62956325|FG001|Overall Study|Lack of Efficacy|9|||
33561875|NCT00494234|62956324|FG000|Overall Study|Withdrawal by Subject|1|||
33561876|NCT00494234|62956325|FG001|Overall Study|Withdrawal by Subject|0|||
33561877|NCT00494234|62956324|FG000|Overall Study|Death|2|||
33561878|NCT00494234|62956325|FG001|Overall Study|Death|1|||
33561879|NCT02289820|62956342|FG000|Overall Study|Withdrawal by Subject|2|||
33561880|NCT02289820|62956343|FG001|Overall Study|Withdrawal by Subject|1|||
33561881|NCT02289820|62956344|FG002|Overall Study|Withdrawal by Subject|2|||
33561882|NCT02289820|62956345|FG003|Overall Study|Withdrawal by Subject|1|||
33561883|NCT02289820|62956346|FG004|Overall Study|Withdrawal by Subject|0|||
33561884|NCT02289820|62956347|FG005|Overall Study|Withdrawal by Subject|0|||
33561885|NCT02289820|62956348|FG006|Overall Study|Withdrawal by Subject|1|||
33561886|NCT02289820|62956342|FG000|Overall Study|Death|0|||
33561887|NCT02289820|62956343|FG001|Overall Study|Death|0|||
33561888|NCT02289820|62956344|FG002|Overall Study|Death|1|||
33561889|NCT02289820|62956345|FG003|Overall Study|Death|0|||
33561890|NCT02289820|62956346|FG004|Overall Study|Death|0|||
33561891|NCT02289820|62956347|FG005|Overall Study|Death|0|||
33561892|NCT02289820|62956348|FG006|Overall Study|Death|0|||
33561893|NCT02289820|62956342|FG000|Overall Study|Lost to Follow-up|0|||
33561894|NCT02289820|62956343|FG001|Overall Study|Lost to Follow-up|0|||
33561895|NCT02289820|62956344|FG002|Overall Study|Lost to Follow-up|3|||
33561896|NCT02289820|62956345|FG003|Overall Study|Lost to Follow-up|1|||
33561897|NCT02289820|62956346|FG004|Overall Study|Lost to Follow-up|0|||
33561898|NCT02289820|62956347|FG005|Overall Study|Lost to Follow-up|1|||
33561899|NCT02289820|62956348|FG006|Overall Study|Lost to Follow-up|1|||
33561900|NCT02289820|62956342|FG000|Overall Study|withdrawal of consent|0|||
33561901|NCT02289820|62956343|FG001|Overall Study|withdrawal of consent|1|||
33561902|NCT02289820|62956344|FG002|Overall Study|withdrawal of consent|0|||
33561903|NCT02289820|62956345|FG003|Overall Study|withdrawal of consent|0|||
33391712|NCT00396097|62770540|FG001|Overall Study|Other|5|||
33561904|NCT02289820|62956346|FG004|Overall Study|withdrawal of consent|0|||
33561905|NCT02289820|62956347|FG005|Overall Study|withdrawal of consent|0|||
33561906|NCT02289820|62956348|FG006|Overall Study|withdrawal of consent|0|||
33561907|NCT02289742|62956370|FG000|First Wear Period|Adverse event prior to treatment|0|||
33561908|NCT02289742|62956371|FG001|First Wear Period|Adverse event prior to treatment|1|||
33561909|NCT02289742|62956372|FG002|First Wear Period|Adverse event prior to treatment|0|||
33561910|NCT02289742|62956373|FG003|First Wear Period|Adverse event prior to treatment|0|||
33561911|NCT02289742|62956370|FG000|First Wear Period|Adverse Event|0|||
33561912|NCT02289742|62956371|FG001|First Wear Period|Adverse Event|0|||
33561913|NCT02289742|62956372|FG002|First Wear Period|Adverse Event|1|||
33561914|NCT02289742|62956373|FG003|First Wear Period|Adverse Event|0|||
33561915|NCT02289742|62956370|FG000|First Wear Period|Other prior to treatment|0|||
33561916|NCT02289742|62956371|FG001|First Wear Period|Other prior to treatment|0|||
33561917|NCT02289742|62956372|FG002|First Wear Period|Other prior to treatment|0|||
33561918|NCT02289742|62956373|FG003|First Wear Period|Other prior to treatment|1|||
33561919|NCT02289742|62956370|FG000|Third Wear Period|Adverse Event|0|||
33561920|NCT02289742|62956371|FG001|Third Wear Period|Adverse Event|1|||
33561921|NCT02289742|62956372|FG002|Third Wear Period|Adverse Event|0|||
33561922|NCT02289742|62956373|FG003|Third Wear Period|Adverse Event|0|||
33561923|NCT02289742|62956370|FG000|Third Wear Period|Reason not given|0|||
33561924|NCT02289742|62956371|FG001|Third Wear Period|Reason not given|0|||
33561925|NCT02289742|62956372|FG002|Third Wear Period|Reason not given|0|||
33561926|NCT02289742|62956373|FG003|Third Wear Period|Reason not given|1|||
33561927|NCT02289352|62956390|FG000|Overall Study|Withdrawal by Subject|1|||
33561928|NCT02289352|62956391|FG001|Overall Study|Withdrawal by Subject|1|||
33561929|NCT02289352|62956392|FG002|Overall Study|Withdrawal by Subject|0|||
33561930|NCT02315560|62956401|FG000|Overall Study|noncompliance by subjects|3|||
33561931|NCT02522624|62956407|FG000|Overall Study|Technical failure|1|||
33561932|NCT02522624|62956408|FG001|Overall Study|Technical failure|0|||
33561933|NCT02287402|62956414|FG000|Treatment Period|Adverse Event|17|||
33561934|NCT02287402|62956414|FG000|Treatment Period|Voluntary Withdrawal|10|||
33561935|NCT02287402|62956414|FG000|Follow-up|Lost to Follow-up|1|||
33561936|NCT02287402|62956414|FG000|Follow-up|Voluntary Withdrawal|2|||
33561937|NCT02314780|62956421|FG000|Overall Study|organizational reasons|0|||
33561938|NCT02314780|62956422|FG001|Overall Study|organizational reasons|2|||
33561939|NCT02314780|62956423|FG002|Overall Study|organizational reasons|0|||
33561940|NCT02314780|62956421|FG000|Overall Study|Adverse Event|0|||
33561941|NCT02314780|62956422|FG001|Overall Study|Adverse Event|1|||
33561942|NCT02314780|62956423|FG002|Overall Study|Adverse Event|0|||
33561943|NCT02288182|62956433|FG000|Overall Study|Adverse Event|0|||
33561944|NCT02288182|62956434|FG001|Overall Study|Adverse Event|1|||
33561945|NCT02288182|62956433|FG000|Overall Study|Lost to Follow-up|0|||
33561946|NCT02288182|62956434|FG001|Overall Study|Lost to Follow-up|1|||
33561947|NCT02286466|62956444|FG000|Overall Study|Death|1|||
33561948|NCT02286466|62956445|FG001|Overall Study|Death|3|||
33561949|NCT02286466|62956444|FG000|Overall Study|Withdrawal by Subject|5|||
33561950|NCT02286466|62956445|FG001|Overall Study|Withdrawal by Subject|2|||
33561951|NCT02286466|62956444|FG000|Overall Study|Lost to Follow-up|1|||
33391713|NCT00396097|62770539|FG000|Overall Study|Protocol Violation|0|||
33391714|NCT00396097|62770540|FG001|Overall Study|Protocol Violation|6|||
33391715|NCT00396097|62770539|FG000|Overall Study|Adverse Event|1|||
33391716|NCT00396097|62770540|FG001|Overall Study|Adverse Event|5|||
33391717|NCT00396097|62770539|FG000|Overall Study|Insufficient Clinical Response|1|||
33391718|NCT00396097|62770540|FG001|Overall Study|Insufficient Clinical Response|4|||
33391719|NCT00375505|62770552|FG000|Overall Study|Adverse Event|1|||
33391720|NCT00375505|62770553|FG001|Overall Study|Adverse Event|2|||
33391721|NCT00375427|62770561|FG000|Overall Study|Adverse Event|21|||
33391722|NCT00375427|62770562|FG001|Overall Study|Adverse Event|27|||
33391723|NCT00375427|62770561|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33391724|NCT00375427|62770562|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33391725|NCT00375427|62770561|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33391726|NCT00375427|62770562|FG001|Overall Study|Abnormal laboratory value(s)|2|||
33561952|NCT02286466|62956445|FG001|Overall Study|Lost to Follow-up|4|||
33561953|NCT02286466|62956444|FG000|Overall Study|Declined Clinician Assessment|0|||
33561954|NCT02286466|62956445|FG001|Overall Study|Declined Clinician Assessment|1|||
33561955|NCT02313766|62956454|FG000|Overall Study|surgery cancelled|1|||
33561956|NCT02313766|62956455|FG001|Overall Study|surgery cancelled|0|||
33561957|NCT02313766|62956456|FG002|Overall Study|surgery cancelled|0|||
33561958|NCT02313766|62956454|FG000|Overall Study|Lost to Follow-up|0|||
33561959|NCT02313766|62956455|FG001|Overall Study|Lost to Follow-up|2|||
33561960|NCT02313766|62956456|FG002|Overall Study|Lost to Follow-up|0|||
33561961|NCT02313766|62956454|FG000|Overall Study|Adverse Event|0|||
33561962|NCT02313766|62956455|FG001|Overall Study|Adverse Event|1|||
33561963|NCT02313766|62956456|FG002|Overall Study|Adverse Event|0|||
33561964|NCT01646398|62956466|FG000|Overall Study|Withdrawal by Subject|1|||
33561965|NCT01646398|62956467|FG001|Overall Study|Withdrawal by Subject|0|||
33561966|NCT01646320|62956475|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
33561967|NCT01646320|62956476|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
33561968|NCT01646320|62956475|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
33561969|NCT01646320|62956476|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
33561970|NCT01646320|62956475|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
33561971|NCT01646320|62956476|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
33561972|NCT01646320|62956475|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
33561973|NCT01646320|62956476|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
33561974|NCT01646320|62956475|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
33561975|NCT01646320|62956476|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
33561976|NCT01646320|62956475|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
33561977|NCT01646320|62956476|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
33561978|NCT01646320|62956475|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
33561979|NCT01646320|62956476|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
33561980|NCT01646320|62956475|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
33561981|NCT01646320|62956476|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
33561982|NCT01646320|62956475|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
33561983|NCT01646320|62956476|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
33561984|NCT01646320|62956475|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
33561985|NCT01646320|62956476|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
33561986|NCT01646320|62956475|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
33561987|NCT01646320|62956476|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
33561988|NCT02524730|62956482|FG000|Overall Study|Lost to Follow-up|5|||
33561989|NCT02524730|62956482|FG000|Overall Study|Withdrawal by Subject|18|||
33561990|NCT02524730|62956482|FG000|Overall Study|Death|10|||
33561991|NCT02524730|62956482|FG000|Overall Study|Adverse Event|8|||
33561992|NCT02524730|62956482|FG000|Overall Study|Protocol Violation|1|||
33561993|NCT02524730|62956482|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
33561994|NCT01658150|62956486|FG000|Overall Study|Withdrawal by Subject|1|||
33561995|NCT02285998|62956493|FG000|Overall Study|Adverse Event|9|||
33561996|NCT02285998|62956494|FG001|Overall Study|Adverse Event|8|||
33561997|NCT02285998|62956493|FG000|Overall Study|Physician Decision|1|||
33561998|NCT02285998|62956494|FG001|Overall Study|Physician Decision|2|||
33561999|NCT02285998|62956493|FG000|Overall Study|Lost to Follow-up|176|||
33562000|NCT02285998|62956494|FG001|Overall Study|Lost to Follow-up|172|||
33562001|NCT02285998|62956493|FG000|Overall Study|Withdrawal by Subject|53|||
33391727|NCT00375427|62770561|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33391728|NCT00375427|62770562|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
33391729|NCT00375427|62770561|FG000|Overall Study|Patient no longer requires study drug|3|||
33391730|NCT00375427|62770562|FG001|Overall Study|Patient no longer requires study drug|7|||
33391731|NCT00375427|62770561|FG000|Overall Study|Protocol Violation|10|||
33391732|NCT00375427|62770562|FG001|Overall Study|Protocol Violation|8|||
33391733|NCT00375427|62770561|FG000|Overall Study|Withdrawal by Subject|9|||
33391734|NCT00375427|62770562|FG001|Overall Study|Withdrawal by Subject|13|||
33391735|NCT00375427|62770561|FG000|Overall Study|Lost to Follow-up|1|||
33391736|NCT00375427|62770562|FG001|Overall Study|Lost to Follow-up|1|||
33391737|NCT00375427|62770561|FG000|Overall Study|Administrative reasons|0|||
33391738|NCT00375427|62770562|FG001|Overall Study|Administrative reasons|1|||
33391739|NCT00375427|62770561|FG000|Overall Study|Death|11|||
33391740|NCT00375427|62770562|FG001|Overall Study|Death|10|||
33391741|NCT00393913|62770568|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
33391742|NCT00393913|62770568|FG000|Initial Assessment|Withdrawal by Subject|16|||
33391743|NCT00393913|62770568|FG000|CPAP|Withdrawal by Subject|3|||
33391744|NCT00393913|62770568|FG000|CPAP|Physician Decision|1|||
33391745|NCT00393913|62770568|FG000|CPAP|TEchnical problem with CPAP|3|||
33391746|NCT00567268|62770573|FG000|Overall Study|Protocol Violation|7|||
33391747|NCT00567268|62770573|FG000|Overall Study|Lost to Follow-up|36|||
33391748|NCT00567268|62770573|FG000|Overall Study|No Visit After First Day of Treatment|2|||
33391749|NCT00567268|62770573|FG000|Overall Study|No Drug Administration|4|||
33391750|NCT00567268|62770573|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
33391751|NCT03976648|62770614|FG000|Overall Study|Adverse Event|0|||
33391752|NCT03976648|62770615|FG001|Overall Study|Adverse Event|2|||
33391753|NCT03976648|62770614|FG000|Overall Study|Study terminated by sponsor|21|||
33391754|NCT03976648|62770615|FG001|Overall Study|Study terminated by sponsor|8|||
33391755|NCT00566254|62770623|FG000|Overall Study|Adverse Event|3|||
33391756|NCT00566254|62770624|FG001|Overall Study|Adverse Event|1|||
33391757|NCT00566254|62770623|FG000|Overall Study|Protocol Violation|1|||
33391758|NCT00566254|62770624|FG001|Overall Study|Protocol Violation|3|||
33391759|NCT00566254|62770623|FG000|Overall Study|Withdrawal by Subject|1|||
33391760|NCT00566254|62770624|FG001|Overall Study|Withdrawal by Subject|2|||
33391761|NCT00566254|62770623|FG000|Overall Study|Lack of Efficacy|5|||
33391762|NCT00566254|62770624|FG001|Overall Study|Lack of Efficacy|6|||
33391763|NCT00566254|62770623|FG000|Overall Study|Other|0|||
33391764|NCT00566254|62770624|FG001|Overall Study|Other|2|||
33391765|NCT00393523|62770635|FG000|Overall Study|Lost to Follow-up|0|||
33391766|NCT00393523|62770636|FG001|Overall Study|Lost to Follow-up|0|||
33391767|NCT00393523|62770637|FG002|Overall Study|Lost to Follow-up|0|||
33391768|NCT00393523|62770638|FG003|Overall Study|Lost to Follow-up|2|||
33391769|NCT00393523|62770639|FG004|Overall Study|Lost to Follow-up|1|||
33391770|NCT00393523|62770635|FG000|Overall Study|Protocol Violation|6|||
33391771|NCT00393523|62770636|FG001|Overall Study|Protocol Violation|2|||
33391772|NCT00393523|62770637|FG002|Overall Study|Protocol Violation|0|||
33562002|NCT02285998|62956494|FG001|Overall Study|Withdrawal by Subject|61|||
33391773|NCT00393523|62770638|FG003|Overall Study|Protocol Violation|1|||
33391774|NCT00393523|62770639|FG004|Overall Study|Protocol Violation|0|||
33391775|NCT00393523|62770635|FG000|Overall Study|Withdrawal by Subject|6|||
33391776|NCT00393523|62770636|FG001|Overall Study|Withdrawal by Subject|7|||
33391777|NCT00393523|62770637|FG002|Overall Study|Withdrawal by Subject|2|||
33391778|NCT00393523|62770638|FG003|Overall Study|Withdrawal by Subject|3|||
33391779|NCT00393523|62770639|FG004|Overall Study|Withdrawal by Subject|0|||
33391780|NCT00393523|62770635|FG000|Overall Study|Difficulties in specimen collection|0|||
33391781|NCT00393523|62770636|FG001|Overall Study|Difficulties in specimen collection|0|||
33391782|NCT00393523|62770637|FG002|Overall Study|Difficulties in specimen collection|1|||
33391783|NCT00393523|62770638|FG003|Overall Study|Difficulties in specimen collection|0|||
33391784|NCT00393523|62770639|FG004|Overall Study|Difficulties in specimen collection|0|||
33391785|NCT00393523|62770635|FG000|Overall Study|Vaccine supply issue|0|||
33391786|NCT00393523|62770636|FG001|Overall Study|Vaccine supply issue|0|||
33391787|NCT00393523|62770637|FG002|Overall Study|Vaccine supply issue|1|||
33391788|NCT00393523|62770638|FG003|Overall Study|Vaccine supply issue|0|||
33391789|NCT00393523|62770639|FG004|Overall Study|Vaccine supply issue|0|||
33391790|NCT00393367|62770652|FG000|Overall Study|Protocol Violation|2|||
33391791|NCT00393367|62770653|FG001|Overall Study|Protocol Violation|5|||
33391792|NCT00393367|62770652|FG000|Overall Study|Withdrawal by Subject|0|||
33391793|NCT00393367|62770653|FG001|Overall Study|Withdrawal by Subject|2|||
33391794|NCT00395863|62770663|FG000|Overall Study|Patients did not complete both exams|2|||
33391795|NCT00395863|62770664|FG001|Overall Study|Patients did not complete both exams|3|||
33391796|NCT00395629|62770676|FG000|Core Study|Adverse Event|0|||
33391797|NCT00395629|62770677|FG001|Core Study|Adverse Event|3|||
33391798|NCT00395629|62770678|FG002|Core Study|Adverse Event|4|||
33391799|NCT00395629|62770676|FG000|Core Study|Abnormal laboratory value(s)|0|||
33391800|NCT00395629|62770677|FG001|Core Study|Abnormal laboratory value(s)|0|||
33391801|NCT00395629|62770678|FG002|Core Study|Abnormal laboratory value(s)|1|||
33391802|NCT00395629|62770676|FG000|Core Study|Protocol Violation|1|||
33391803|NCT00395629|62770677|FG001|Core Study|Protocol Violation|0|||
33391804|NCT00395629|62770678|FG002|Core Study|Protocol Violation|0|||
33391805|NCT00395629|62770676|FG000|Core Study|Withdrawal by Subject|0|||
33391806|NCT00395629|62770677|FG001|Core Study|Withdrawal by Subject|1|||
33391807|NCT00395629|62770678|FG002|Core Study|Withdrawal by Subject|1|||
33391808|NCT00395629|62770676|FG000|Core Study|Lost to Follow-up|0|||
33391809|NCT00395629|62770677|FG001|Core Study|Lost to Follow-up|0|||
33391810|NCT00395629|62770678|FG002|Core Study|Lost to Follow-up|1|||
33391811|NCT00395629|62770676|FG000|Extension Study|Adverse Event|0|||
33391812|NCT00395629|62770677|FG001|Extension Study|Adverse Event|0|||
33391813|NCT00395629|62770678|FG002|Extension Study|Adverse Event|2|||
33391814|NCT00395629|62770676|FG000|Extension Study|Administrative problems|0|||
33391815|NCT00395629|62770677|FG001|Extension Study|Administrative problems|0|||
33391816|NCT00395629|62770678|FG002|Extension Study|Administrative problems|1|||
33391817|NCT00392665|62770691|FG000|Overall Study|Death|16|||
33391818|NCT00392665|62770692|FG001|Overall Study|Death|14|||
33391819|NCT00392665|62770691|FG000|Overall Study|Lost to Follow-up|1|||
33391820|NCT00392665|62770692|FG001|Overall Study|Lost to Follow-up|1|||
33391821|NCT00622869|62770701|FG000|Overall Study|Subject Withdrew Consent|13|||
33391822|NCT00622869|62770702|FG001|Overall Study|Subject Withdrew Consent|17|||
33391823|NCT00622869|62770703|FG002|Overall Study|Subject Withdrew Consent|11|||
33391824|NCT00622869|62770701|FG000|Overall Study|Administrative Problems|11|||
33391825|NCT00622869|62770702|FG001|Overall Study|Administrative Problems|17|||
33391826|NCT00622869|62770703|FG002|Overall Study|Administrative Problems|13|||
33391827|NCT00622869|62770701|FG000|Overall Study|Death|12|||
33391828|NCT00622869|62770702|FG001|Overall Study|Death|15|||
33391829|NCT00622869|62770703|FG002|Overall Study|Death|10|||
33391830|NCT00622869|62770701|FG000|Overall Study|Lost to Follow-up|2|||
33391831|NCT00622869|62770702|FG001|Overall Study|Lost to Follow-up|4|||
33391832|NCT00622869|62770703|FG002|Overall Study|Lost to Follow-up|2|||
33391833|NCT00622869|62770701|FG000|Overall Study|Graft Loss|5|||
33391834|NCT00622869|62770702|FG001|Overall Study|Graft Loss|3|||
33391835|NCT00622869|62770703|FG002|Overall Study|Graft Loss|2|||
33391836|NCT00622869|62770701|FG000|Overall Study|Missing|0|||
33391837|NCT00622869|62770702|FG001|Overall Study|Missing|1|||
33391838|NCT00622869|62770703|FG002|Overall Study|Missing|1|||
33391839|NCT00395083|62770713|FG000|Overall Study|Withdrawal by Subject|6|||
33391840|NCT00395083|62770714|FG001|Overall Study|Withdrawal by Subject|5|||
33391841|NCT00395083|62770713|FG000|Overall Study|Developed another disease|4|||
33391842|NCT00395083|62770714|FG001|Overall Study|Developed another disease|3|||
33391843|NCT00366457|62770720|FG000|Overall Study|never began study therapy|2|||
33391844|NCT00624819|62770728|FG000|Follow-up Period: Year 4|Parents decision|0|||
33391845|NCT00624819|62770729|FG001|Follow-up Period: Year 4|Parents decision|0|||
33391846|NCT00624819|62770730|FG002|Follow-up Period: Year 4|Parents decision|1|||
33391847|NCT00624819|62770731|FG003|Follow-up Period: Year 4|Parents decision|0|||
33391848|NCT00624819|62770728|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
33391849|NCT00624819|62770729|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
33391850|NCT00624819|62770730|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
33391851|NCT00624819|62770731|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
33391852|NCT03832387|62770743|FG000|Overall Study|Protocol Violation|2|||
33391853|NCT03832387|62770744|FG001|Overall Study|Protocol Violation|6|||
33391854|NCT03832387|62770743|FG000|Overall Study|EXCLUSION CRITERIA|3|||
33391855|NCT03832387|62770744|FG001|Overall Study|EXCLUSION CRITERIA|1|||
33391856|NCT00366301|62770754|FG000|Overall Study|Lost to Follow-up|4|||
33391857|NCT00366301|62770755|FG001|Overall Study|Lost to Follow-up|4|||
33391858|NCT00366301|62770756|FG002|Overall Study|Lost to Follow-up|3|||
33391859|NCT00366301|62770757|FG003|Overall Study|Lost to Follow-up|7|||
33391860|NCT00366301|62770754|FG000|Overall Study|Withdrawal by Subject|4|||
33391861|NCT00366301|62770755|FG001|Overall Study|Withdrawal by Subject|2|||
33391862|NCT00366301|62770756|FG002|Overall Study|Withdrawal by Subject|1|||
33391863|NCT00366301|62770757|FG003|Overall Study|Withdrawal by Subject|1|||
33391864|NCT00365989|62770767|FG000|Overall Study|Withdrawal by Subject|1|||
33391865|NCT00365989|62770767|FG000|Overall Study|Non-compliance|1|||
33391866|NCT00622713|62770772|FG000|Overall Study|Adverse Event|35|||
33562003|NCT02285998|62956493|FG000|Overall Study|Other Reasons|7|||
33562004|NCT02285998|62956494|FG001|Overall Study|Other Reasons|10|||
33562005|NCT01658072|62956502|FG000|Overall Study|Protocol Violation|4|||
33562006|NCT01658072|62956503|FG001|Overall Study|Protocol Violation|2|||
33562007|NCT02285920|62956513|FG000|Overall Study|Kidney transplantation|2|||
33562008|NCT02285920|62956514|FG001|Overall Study|Kidney transplantation|2|||
33562009|NCT02285920|62956515|FG002|Overall Study|Kidney transplantation|2|||
33562010|NCT02285920|62956516|FG003|Overall Study|Kidney transplantation|0|||
33562011|NCT02285920|62956513|FG000|Overall Study|Change to peritoneal dialysis|0|||
33562012|NCT02285920|62956514|FG001|Overall Study|Change to peritoneal dialysis|0|||
33562013|NCT02285920|62956515|FG002|Overall Study|Change to peritoneal dialysis|1|||
33562014|NCT02285920|62956516|FG003|Overall Study|Change to peritoneal dialysis|0|||
33562015|NCT02285920|62956513|FG000|Overall Study|Transfer to non-participating unit|0|||
33562016|NCT02285920|62956514|FG001|Overall Study|Transfer to non-participating unit|1|||
33562017|NCT02285920|62956515|FG002|Overall Study|Transfer to non-participating unit|0|||
33562018|NCT02285920|62956516|FG003|Overall Study|Transfer to non-participating unit|0|||
33562019|NCT02285920|62956513|FG000|Overall Study|Dialysis discontinuation|0|||
33562020|NCT02285920|62956514|FG001|Overall Study|Dialysis discontinuation|1|||
33562021|NCT02285920|62956515|FG002|Overall Study|Dialysis discontinuation|0|||
33562022|NCT02285920|62956516|FG003|Overall Study|Dialysis discontinuation|0|||
33562023|NCT02285920|62956513|FG000|Overall Study|Death|2|||
33562024|NCT02285920|62956514|FG001|Overall Study|Death|0|||
33300369|NCT01296711|62676561|FG002|Overall Study|Required restricted steroid injections|0|||
33300370|NCT01296711|62676562|FG003|Overall Study|Required restricted steroid injections|0|||
33300371|NCT01296711|62676563|FG004|Overall Study|Required restricted steroid injections|0|||
33300372|NCT01296711|62676564|FG005|Overall Study|Required restricted steroid injections|0|||
33300373|NCT01296711|62676565|FG006|Overall Study|Required restricted steroid injections|1|||
33300374|NCT01296711|62676566|FG007|Overall Study|Required restricted steroid injections|0|||
33300375|NCT01296711|62676559|FG000|Overall Study|Ongoing missed appointments|0|||
33300376|NCT01296711|62676560|FG001|Overall Study|Ongoing missed appointments|0|||
33391867|NCT00622713|62770772|FG000|Overall Study|Administrative problems|4|||
33391868|NCT00622713|62770772|FG000|Overall Study|Withdrawal by Subject|11|||
33391869|NCT00622713|62770772|FG000|Overall Study|Lost to Follow-up|5|||
33391870|NCT00622713|62770772|FG000|Overall Study|Death|2|||
33562025|NCT02285920|62956515|FG002|Overall Study|Death|2|||
33562026|NCT02285920|62956516|FG003|Overall Study|Death|1|||
33562027|NCT02035137|62956529|FG000|Overall Study|Physician Decision|0|||
33562028|NCT02035137|62956530|FG001|Overall Study|Physician Decision|0|||
33562029|NCT02035137|62956531|FG002|Overall Study|Physician Decision|1|||
33562030|NCT02035137|62956529|FG000|Overall Study|Withdrawal by Subject|0|||
33562031|NCT02035137|62956530|FG001|Overall Study|Withdrawal by Subject|1|||
33562032|NCT02035137|62956531|FG002|Overall Study|Withdrawal by Subject|2|||
33562033|NCT02035137|62956529|FG000|Overall Study|Ineligible|0|||
33562034|NCT02035137|62956530|FG001|Overall Study|Ineligible|1|||
33562035|NCT02035137|62956531|FG002|Overall Study|Ineligible|2|||
33562036|NCT02035137|62956529|FG000|Overall Study|Disease progression prior to treatment start|2|||
33562037|NCT02035137|62956530|FG001|Overall Study|Disease progression prior to treatment start|0|||
33562038|NCT02035137|62956531|FG002|Overall Study|Disease progression prior to treatment start|0|||
33562039|NCT02522780|62956541|FG000|Overall Study|Consent withdrawn by subject|5|||
33562040|NCT02522780|62956542|FG001|Overall Study|Consent withdrawn by subject|7|||
33562041|NCT02522780|62956541|FG000|Overall Study|Protocol deviation|1|||
33562042|NCT02522780|62956542|FG001|Overall Study|Protocol deviation|3|||
33562043|NCT02522780|62956541|FG000|Overall Study|Subject refused endoscopic procedure|0|||
33562044|NCT02522780|62956542|FG001|Overall Study|Subject refused endoscopic procedure|1|||
33300377|NCT01296711|62676561|FG002|Overall Study|Ongoing missed appointments|0|||
33391871|NCT00622713|62770772|FG000|Overall Study|Subject no longer required study drug|1|||
33391872|NCT00622713|62770772|FG000|Overall Study|Did not meet eligibility criteria|1|||
33391873|NCT00392197|62770778|FG000|Overall Study|Adverse Event|4|||
33391874|NCT00392197|62770779|FG001|Overall Study|Adverse Event|12|||
33391875|NCT00392197|62770778|FG000|Overall Study|Lack of Efficacy|3|||
33391876|NCT00392197|62770779|FG001|Overall Study|Lack of Efficacy|4|||
33391877|NCT00392197|62770778|FG000|Overall Study|Lost to Follow-up|0|||
33391878|NCT00392197|62770779|FG001|Overall Study|Lost to Follow-up|1|||
33391879|NCT00392197|62770778|FG000|Overall Study|Physician Decision|3|||
33562045|NCT02522780|62956541|FG000|Overall Study|Adverse event, non-fatal|11|||
33562046|NCT02522780|62956542|FG001|Overall Study|Adverse event, non-fatal|16|||
33562047|NCT02285062|62956562|FG000|Pre-Treatment Period|Protocol Violation|0|||
33562048|NCT02285062|62956563|FG001|Pre-Treatment Period|Protocol Violation|2|||
33562049|NCT02285062|62956562|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
33562050|NCT02285062|62956563|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
33562051|NCT01352741|62956569|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
33562052|NCT01352741|62956570|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
33562053|NCT01352741|62956569|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
33562054|NCT01352741|62956570|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
33562055|NCT01352741|62956569|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
33562056|NCT01352741|62956570|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
33562057|NCT01352741|62956569|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
33562058|NCT01352741|62956570|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
33562059|NCT01352741|62956569|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
33562060|NCT01352741|62956570|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
33562061|NCT01352741|62956569|FG000|Open-label Tapentadol Titration Period|Other|4|||
33662850|NCT01691105|63093341|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
33300378|NCT01296711|62676562|FG003|Overall Study|Ongoing missed appointments|0|||
33300379|NCT01296711|62676563|FG004|Overall Study|Ongoing missed appointments|0|||
33300380|NCT01296711|62676564|FG005|Overall Study|Ongoing missed appointments|0|||
33300381|NCT01296711|62676565|FG006|Overall Study|Ongoing missed appointments|1|||
33300382|NCT01296711|62676566|FG007|Overall Study|Ongoing missed appointments|0|||
33300383|NCT01296711|62676559|FG000|Overall Study|Failure to comply with visits|0|||
33300384|NCT01296711|62676560|FG001|Overall Study|Failure to comply with visits|0|||
33300385|NCT01296711|62676561|FG002|Overall Study|Failure to comply with visits|0|||
33300386|NCT01296711|62676562|FG003|Overall Study|Failure to comply with visits|0|||
33300387|NCT01296711|62676563|FG004|Overall Study|Failure to comply with visits|0|||
33300388|NCT01296711|62676564|FG005|Overall Study|Failure to comply with visits|0|||
33300389|NCT01296711|62676565|FG006|Overall Study|Failure to comply with visits|0|||
33300390|NCT01296711|62676566|FG007|Overall Study|Failure to comply with visits|1|||
33300391|NCT01296711|62676559|FG000|Overall Study|Patient decision due to transport|0|||
33300392|NCT01296711|62676560|FG001|Overall Study|Patient decision due to transport|0|||
33300393|NCT01296711|62676561|FG002|Overall Study|Patient decision due to transport|0|||
33300394|NCT01296711|62676562|FG003|Overall Study|Patient decision due to transport|0|||
33300395|NCT01296711|62676563|FG004|Overall Study|Patient decision due to transport|0|||
33300396|NCT01296711|62676564|FG005|Overall Study|Patient decision due to transport|0|||
33300397|NCT01296711|62676565|FG006|Overall Study|Patient decision due to transport|0|||
33300398|NCT01296711|62676566|FG007|Overall Study|Patient decision due to transport|1|||
33300399|NCT01294917|62676584|FG000|Overall Study|Relocation|5|||
33300400|NCT01294917|62676584|FG000|Overall Study|Inconvenience|1|||
33300401|NCT01294683|62676592|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
33300402|NCT01294683|62676593|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
33300403|NCT01294683|62676592|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
33300404|NCT01294683|62676593|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
33300405|NCT01294683|62676592|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
33391880|NCT00392197|62770779|FG001|Overall Study|Physician Decision|2|||
33391881|NCT00392197|62770778|FG000|Overall Study|Protocol Violation|7|||
33391882|NCT00392197|62770779|FG001|Overall Study|Protocol Violation|5|||
33391883|NCT00392197|62770778|FG000|Overall Study|Withdrawal by Subject|4|||
33391884|NCT00392197|62770779|FG001|Overall Study|Withdrawal by Subject|6|||
33391885|NCT00391807|62770785|FG000|Overall Study|Did not receive study medication|23|||
33391886|NCT00391807|62770785|FG000|Overall Study|Adverse Event|177|||
33391887|NCT00391807|62770785|FG000|Overall Study|Pregnancy|25|||
33562062|NCT01352741|62956570|FG001|Open-label Tapentadol Titration Period|Other|0|||
33562063|NCT01352741|62956569|FG000|Double-blind Comparative Period|Protocol Violation|2|||
33562064|NCT01352741|62956570|FG001|Double-blind Comparative Period|Protocol Violation|0|||
33662851|NCT01691105|63093342|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
33300406|NCT01294683|62676593|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
33300407|NCT01294683|62676592|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
33300408|NCT01294683|62676593|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
33300409|NCT01294683|62676592|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
33391888|NCT00391807|62770785|FG000|Overall Study|Lost to Follow-up|227|||
33391889|NCT00391807|62770785|FG000|Overall Study|Withdrawal by Subject|147|||
33391890|NCT00391807|62770785|FG000|Overall Study|Protocol Violation|20|||
33391891|NCT00391807|62770785|FG000|Overall Study|Various|96|||
33391892|NCT00624585|62770789|FG000|Overall Study|Death|3|||
33391893|NCT00624585|62770789|FG000|Overall Study|Disease Progression|6|||
33391894|NCT00624585|62770789|FG000|Overall Study|Adverse Event|3|||
33391895|NCT00622635|62770793|FG000|Treatment Period 1|Adverse Event|0|||
33391896|NCT00622635|62770794|FG001|Treatment Period 1|Adverse Event|0|||
33391897|NCT00622635|62770795|FG002|Treatment Period 1|Adverse Event|1|||
33391898|NCT00622635|62770796|FG003|Treatment Period 1|Adverse Event|0|||
33391899|NCT00622635|62770797|FG004|Treatment Period 1|Adverse Event|0|||
33391900|NCT00622635|62770798|FG005|Treatment Period 1|Adverse Event|0|||
33391901|NCT00622635|62770793|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33391902|NCT00622635|62770794|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33391903|NCT00622635|62770795|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33391904|NCT00622635|62770796|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33391905|NCT00622635|62770797|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33391906|NCT00622635|62770798|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33391907|NCT00622635|62770793|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
33391908|NCT00622635|62770794|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
33391909|NCT00622635|62770795|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
33391910|NCT00622635|62770796|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
33391911|NCT00622635|62770797|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
33391912|NCT00622635|62770798|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
33391913|NCT00622635|62770793|FG000|Treatment Period 2|Adverse Event|1|||
33391914|NCT00622635|62770794|FG001|Treatment Period 2|Adverse Event|0|||
33391915|NCT00622635|62770795|FG002|Treatment Period 2|Adverse Event|0|||
33391916|NCT00622635|62770796|FG003|Treatment Period 2|Adverse Event|0|||
33391917|NCT00622635|62770797|FG004|Treatment Period 2|Adverse Event|0|||
33391918|NCT00622635|62770798|FG005|Treatment Period 2|Adverse Event|0|||
33562065|NCT01352741|62956569|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
33562066|NCT01352741|62956570|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
33562067|NCT01352741|62956569|FG000|Double-blind Comparative Period|Adverse Event|16|||
33562068|NCT01352741|62956570|FG001|Double-blind Comparative Period|Adverse Event|17|||
33562069|NCT01352741|62956569|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
33562070|NCT01352741|62956570|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
33562071|NCT01352741|62956569|FG000|Double-blind Comparative Period|Death|0|||
33562072|NCT01352741|62956570|FG001|Double-blind Comparative Period|Death|1|||
33562073|NCT01352741|62956569|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
33562074|NCT01352741|62956570|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
33562075|NCT01352741|62956569|FG000|Double-blind Comparative Period|Other|1|||
33562076|NCT01352741|62956570|FG001|Double-blind Comparative Period|Other|2|||
33562077|NCT01352741|62956569|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
33562078|NCT01352741|62956570|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
33562079|NCT01352741|62956569|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
33562080|NCT01352741|62956570|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
33562081|NCT01352741|62956569|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
33562082|NCT01352741|62956570|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
33562083|NCT01352741|62956569|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
33562084|NCT01352741|62956570|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
33562085|NCT01657292|62956590|FG000|Overall Study|Adverse Event|6|||
33562086|NCT01657292|62956590|FG000|Overall Study|Withdrawal by Subject|2|||
33562087|NCT01657292|62956590|FG000|Overall Study|Violation of eligibility criteria|1|||
33562088|NCT01657292|62956590|FG000|Overall Study|Change of therapy|1|||
33562089|NCT00905567|62956606|FG000|Washout|Withdrawal by Subject|0|||
33562090|NCT00905567|62956607|FG001|Washout|Withdrawal by Subject|1|||
33562091|NCT02282020|62956613|FG000|Overall Study|Objective Disease Progression|128|||
33562092|NCT02282020|62956614|FG001|Overall Study|Objective Disease Progression|30|||
33562093|NCT02282020|62956613|FG000|Overall Study|Adverse Event|18|||
33562094|NCT02282020|62956614|FG001|Overall Study|Adverse Event|15|||
33562095|NCT02282020|62956613|FG000|Overall Study|Withdrawal by Subject|7|||
33562096|NCT02282020|62956614|FG001|Overall Study|Withdrawal by Subject|10|||
33562097|NCT02282020|62956613|FG000|Overall Study|Miscellaneous|5|||
33562098|NCT02282020|62956614|FG001|Overall Study|Miscellaneous|19|||
33562099|NCT02282020|62956613|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
33391919|NCT00622635|62770793|FG000|Treatment Period 3|Adverse Event|0|||
33562100|NCT02282020|62956614|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
33562101|NCT02282020|62956613|FG000|Overall Study|Developed Discontinuation Criteria|0|||
33562102|NCT02282020|62956614|FG001|Overall Study|Developed Discontinuation Criteria|2|||
33562103|NCT02282020|62956613|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
33391920|NCT00622635|62770794|FG001|Treatment Period 3|Adverse Event|0|||
33391921|NCT00622635|62770795|FG002|Treatment Period 3|Adverse Event|0|||
33391922|NCT00622635|62770796|FG003|Treatment Period 3|Adverse Event|2|||
33391923|NCT00622635|62770797|FG004|Treatment Period 3|Adverse Event|0|||
33391924|NCT00622635|62770798|FG005|Treatment Period 3|Adverse Event|0|||
33391925|NCT00622635|62770793|FG000|Treatment Period 3|Withdrawal by Subject|0|||
33391926|NCT00622635|62770794|FG001|Treatment Period 3|Withdrawal by Subject|0|||
33562104|NCT02282020|62956614|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
33562105|NCT02281552|62956630|FG000|Overall Study|Medication error|1|||
33562106|NCT02281552|62956631|FG001|Overall Study|Medication error|0|||
33562107|NCT02281552|62956630|FG000|Overall Study|Insufficient clinical response|0|||
33562108|NCT02281552|62956631|FG001|Overall Study|Insufficient clinical response|1|||
33562109|NCT02281552|62956630|FG000|Overall Study|Adverse Event|3|||
33562110|NCT02281552|62956631|FG001|Overall Study|Adverse Event|9|||
33562111|NCT00890591|62956637|FG000|Overall Study|Lack of Efficacy|20|||
33562112|NCT02284906|62956646|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33562113|NCT02284906|62956647|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
33562114|NCT02284906|62956648|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
33562115|NCT02284906|62956646|FG000|Overall Study|Major Protocol Deviation|0|||
33562116|NCT02284906|62956647|FG001|Overall Study|Major Protocol Deviation|1|||
33562117|NCT02284906|62956648|FG002|Overall Study|Major Protocol Deviation|0|||
33562118|NCT02284906|62956646|FG000|Overall Study|Voluntary Withdrawal|2|||
33562119|NCT02284906|62956647|FG001|Overall Study|Voluntary Withdrawal|4|||
33562120|NCT02284906|62956648|FG002|Overall Study|Voluntary Withdrawal|5|||
33562121|NCT02284906|62956646|FG000|Overall Study|Study Termination|0|||
33562122|NCT02284906|62956647|FG001|Overall Study|Study Termination|11|||
33562123|NCT02284906|62956648|FG002|Overall Study|Study Termination|14|||
33562124|NCT02284906|62956646|FG000|Overall Study|Reason not Specified|1|||
33562125|NCT02284906|62956647|FG001|Overall Study|Reason not Specified|1|||
33562126|NCT02284906|62956648|FG002|Overall Study|Reason not Specified|0|||
33562127|NCT02879305|62956658|FG000|Overall Study|Investigator Site Closed|55|||
33562128|NCT02879305|62956659|FG001|Overall Study|Investigator Site Closed|57|||
33562129|NCT02879305|62956658|FG000|Overall Study|Withdrawal by Subject|44|||
33562130|NCT02879305|62956659|FG001|Overall Study|Withdrawal by Subject|42|||
33562131|NCT02879305|62956658|FG000|Overall Study|Lost to Follow-up|17|||
33562132|NCT02879305|62956659|FG001|Overall Study|Lost to Follow-up|12|||
33562133|NCT02879305|62956658|FG000|Overall Study|Other|1|||
33562134|NCT02879305|62956659|FG001|Overall Study|Other|0|||
33562135|NCT02281318|62956667|FG000|Overall Study|Adverse Event|2|||
33562136|NCT02281318|62956668|FG001|Overall Study|Adverse Event|2|||
33562137|NCT02281318|62956667|FG000|Overall Study|Lack of Efficacy|2|||
33562138|NCT02281318|62956668|FG001|Overall Study|Lack of Efficacy|0|||
33562139|NCT02281318|62956667|FG000|Overall Study|Lost to Follow-up|2|||
33562140|NCT02281318|62956668|FG001|Overall Study|Lost to Follow-up|1|||
33562141|NCT02281318|62956667|FG000|Overall Study|Physician Decision|2|||
33562142|NCT02281318|62956668|FG001|Overall Study|Physician Decision|0|||
33562143|NCT02281318|62956667|FG000|Overall Study|Withdrawal by Subject|6|||
33562144|NCT02281318|62956668|FG001|Overall Study|Withdrawal by Subject|2|||
33562145|NCT01657760|62956676|FG000|Overall Study|Withdrawal by Subject|0|||
33562146|NCT01657760|62956677|FG001|Overall Study|Withdrawal by Subject|0|||
33562147|NCT01657760|62956678|FG002|Overall Study|Withdrawal by Subject|0|||
33562148|NCT01657760|62956679|FG003|Overall Study|Withdrawal by Subject|1|||
33562149|NCT01657760|62956676|FG000|Overall Study|Physician Decision|1|||
33562150|NCT01657760|62956677|FG001|Overall Study|Physician Decision|1|||
33562151|NCT01657760|62956678|FG002|Overall Study|Physician Decision|1|||
33562152|NCT01657760|62956679|FG003|Overall Study|Physician Decision|2|||
33562153|NCT02280304|62956706|FG000|Overall Study|Lost to Follow-up|7|||
33562154|NCT02280304|62956707|FG001|Overall Study|Lost to Follow-up|8|||
33562155|NCT02283658|62956727|FG000|Overall Study|Withdrawal by Subject|1|||
33562156|NCT02279524|62956754|FG000|Overall Study|Withdrawal by Subject|3|||
33562157|NCT02279524|62956755|FG001|Overall Study|Withdrawal by Subject|6|||
33562158|NCT02279524|62956756|FG002|Overall Study|Withdrawal by Subject|3|||
33562159|NCT02279524|62956754|FG000|Overall Study|Adverse Event|4|||
33562160|NCT02279524|62956755|FG001|Overall Study|Adverse Event|3|||
33562161|NCT02279524|62956756|FG002|Overall Study|Adverse Event|2|||
33562162|NCT02279524|62956754|FG000|Overall Study|Lost to Follow-up|1|||
33562163|NCT02279524|62956755|FG001|Overall Study|Lost to Follow-up|1|||
33562164|NCT02279524|62956756|FG002|Overall Study|Lost to Follow-up|0|||
33562165|NCT02279524|62956754|FG000|Overall Study|Disallowed medication|1|||
33562166|NCT02279524|62956755|FG001|Overall Study|Disallowed medication|1|||
33562167|NCT02279524|62956756|FG002|Overall Study|Disallowed medication|2|||
33562168|NCT02279524|62956754|FG000|Overall Study|Bariatric surgery|1|||
33562169|NCT02279524|62956755|FG001|Overall Study|Bariatric surgery|0|||
33562170|NCT02279524|62956756|FG002|Overall Study|Bariatric surgery|0|||
33562171|NCT02283268|62956764|FG000|Overall Study|Withdrawal by Subject|1|||
33562172|NCT00857285|62956778|FG000|Overall Study|Adverse Event|4|||
33562173|NCT00857285|62956779|FG001|Overall Study|Adverse Event|2|||
33562174|NCT00857285|62956778|FG000|Overall Study|Lack of Efficacy|0|||
33562175|NCT00857285|62956779|FG001|Overall Study|Lack of Efficacy|2|||
33562176|NCT00857285|62956778|FG000|Overall Study|Protocol Violation|3|||
33562177|NCT00857285|62956779|FG001|Overall Study|Protocol Violation|1|||
33562178|NCT00857285|62956778|FG000|Overall Study|Withdrawal by Subject|4|||
33562179|NCT00857285|62956779|FG001|Overall Study|Withdrawal by Subject|0|||
33562180|NCT00857285|62956778|FG000|Overall Study|Randomization criteria not met|1|||
33562181|NCT00857285|62956779|FG001|Overall Study|Randomization criteria not met|1|||
33562182|NCT02278354|62956785|FG000|Overall Study|Lost to Follow-up|2|||
33562183|NCT02278354|62956786|FG001|Overall Study|Lost to Follow-up|2|||
33562184|NCT02278354|62956785|FG000|Overall Study|Withdrawal by Subject|0|||
33562185|NCT02278354|62956786|FG001|Overall Study|Withdrawal by Subject|1|||
33562186|NCT02278354|62956785|FG000|Overall Study|<10 professional fights|2|||
33562187|NCT02278354|62956786|FG001|Overall Study|<10 professional fights|0|||
33391927|NCT00622635|62770795|FG002|Treatment Period 3|Withdrawal by Subject|0|||
33562188|NCT01657370|62956805|FG000|Overall Study|Withdrawal by Subject|0|||
33562189|NCT01657370|62956806|FG001|Overall Study|Withdrawal by Subject|0|||
33562190|NCT01657370|62956807|FG002|Overall Study|Withdrawal by Subject|1|||
33562191|NCT01657370|62956808|FG003|Overall Study|Withdrawal by Subject|0|||
33562192|NCT01657370|62956809|FG004|Overall Study|Withdrawal by Subject|0|||
33562193|NCT01657370|62956810|FG005|Overall Study|Withdrawal by Subject|1|||
33562194|NCT01657370|62956805|FG000|Overall Study|Physician Decision|2|||
33562195|NCT01657370|62956806|FG001|Overall Study|Physician Decision|3|||
33562196|NCT01657370|62956807|FG002|Overall Study|Physician Decision|1|||
33562197|NCT01657370|62956808|FG003|Overall Study|Physician Decision|2|||
33562198|NCT01657370|62956809|FG004|Overall Study|Physician Decision|5|||
33562199|NCT01657370|62956810|FG005|Overall Study|Physician Decision|0|||
33562200|NCT01657370|62956805|FG000|Overall Study|Lack of Qualifying Event|1|||
33562201|NCT01657370|62956806|FG001|Overall Study|Lack of Qualifying Event|0|||
33562202|NCT01657370|62956807|FG002|Overall Study|Lack of Qualifying Event|3|||
33562203|NCT01657370|62956808|FG003|Overall Study|Lack of Qualifying Event|2|||
33562204|NCT01657370|62956809|FG004|Overall Study|Lack of Qualifying Event|1|||
33562205|NCT01657370|62956810|FG005|Overall Study|Lack of Qualifying Event|2|||
33562206|NCT01657370|62956805|FG000|Overall Study|Adverse Event|0|||
33562207|NCT01657370|62956806|FG001|Overall Study|Adverse Event|0|||
33562208|NCT01657370|62956807|FG002|Overall Study|Adverse Event|0|||
33562209|NCT01657370|62956808|FG003|Overall Study|Adverse Event|0|||
33562210|NCT01657370|62956809|FG004|Overall Study|Adverse Event|1|||
33562211|NCT01657370|62956810|FG005|Overall Study|Adverse Event|0|||
33562212|NCT01657370|62956805|FG000|Overall Study|Protocol Violation|1|||
33562213|NCT01657370|62956806|FG001|Overall Study|Protocol Violation|1|||
33562214|NCT01657370|62956807|FG002|Overall Study|Protocol Violation|1|||
33562215|NCT01657370|62956808|FG003|Overall Study|Protocol Violation|1|||
33562216|NCT01657370|62956809|FG004|Overall Study|Protocol Violation|0|||
33562217|NCT01657370|62956810|FG005|Overall Study|Protocol Violation|0|||
33562218|NCT01657370|62956805|FG000|Overall Study|Lost to Follow-up|2|||
33562219|NCT01657370|62956806|FG001|Overall Study|Lost to Follow-up|0|||
33562220|NCT01657370|62956807|FG002|Overall Study|Lost to Follow-up|1|||
33562221|NCT01657370|62956808|FG003|Overall Study|Lost to Follow-up|0|||
33562222|NCT01657370|62956809|FG004|Overall Study|Lost to Follow-up|0|||
33562223|NCT01657370|62956810|FG005|Overall Study|Lost to Follow-up|1|||
33562224|NCT00849797|62956852|FG000|First Intervention|bad veins|1|||
33562225|NCT00849797|62956853|FG001|First Intervention|bad veins|0|||
33562226|NCT00849797|62956852|FG000|First Intervention|Adverse Event|0|||
33562227|NCT00849797|62956853|FG001|First Intervention|Adverse Event|1|||
33562228|NCT00849797|62956852|FG000|Washout: One Week|Withdrawal by Subject|0|||
33562229|NCT00849797|62956853|FG001|Washout: One Week|Withdrawal by Subject|2|||
33562230|NCT00840203|62956874|FG000|First Intervention|Protocol Violation|1|||
33300410|NCT01294683|62676593|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
33300411|NCT01294683|62676592|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
33300412|NCT01294683|62676593|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
33300413|NCT01294683|62676592|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
33300414|NCT01294683|62676593|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
33300415|NCT01294683|62676592|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
33300416|NCT01294683|62676593|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
33300417|NCT01294683|62676592|FG000|Post Crossover (Period III)|Adverse Event|6|||
33391928|NCT00622635|62770796|FG003|Treatment Period 3|Withdrawal by Subject|1|||
33391929|NCT00622635|62770797|FG004|Treatment Period 3|Withdrawal by Subject|0|||
33391930|NCT00622635|62770798|FG005|Treatment Period 3|Withdrawal by Subject|0|||
33391931|NCT00391027|62770808|FG000|Overall Study|Adverse Event|8|||
33562231|NCT00840203|62956875|FG001|First Intervention|Protocol Violation|1|||
33562232|NCT00840203|62956874|FG000|Washout|Protocol Violation|1|||
33562233|NCT00840203|62956875|FG001|Washout|Protocol Violation|0|||
33562234|NCT00835991|62956881|FG000|First Intervention|Adverse Event|0|||
33562235|NCT00835991|62956882|FG001|First Intervention|Adverse Event|1|||
33562236|NCT00835991|62956881|FG000|Washout|Protocol Violation|0|||
33562237|NCT00835991|62956882|FG001|Washout|Protocol Violation|2|||
33562238|NCT00835991|62956881|FG000|Washout|Withdrawal by Subject|3|||
33562239|NCT00835991|62956882|FG001|Washout|Withdrawal by Subject|1|||
33562240|NCT02276872|62956889|FG000|Overall Study|Adverse Event|1|||
33562241|NCT02276872|62956890|FG001|Overall Study|Adverse Event|0|||
33562242|NCT02276872|62956891|FG002|Overall Study|Adverse Event|0|||
33562243|NCT00835367|62956906|FG000|Washout|Adverse Event|2|||
33391932|NCT00391027|62770809|FG001|Overall Study|Adverse Event|8|||
33562244|NCT00835367|62956907|FG001|Washout|Adverse Event|0|||
33562245|NCT00835367|62956906|FG000|Washout|Withdrawal by Subject|1|||
33391933|NCT00391027|62770808|FG000|Overall Study|Lack of Efficacy|3|||
33391934|NCT00391027|62770809|FG001|Overall Study|Lack of Efficacy|0|||
33391935|NCT00391027|62770808|FG000|Overall Study|Withdrawal by Subject|10|||
33391936|NCT00391027|62770809|FG001|Overall Study|Withdrawal by Subject|1|||
33391937|NCT00391027|62770808|FG000|Overall Study|Other|4|||
33391938|NCT00391027|62770809|FG001|Overall Study|Other|3|||
33391939|NCT00622401|62770818|FG000|Overall Study|Disease progression prior to treatment|3|||
33391940|NCT00622401|62770819|FG001|Overall Study|Disease progression prior to treatment|2|||
33391941|NCT00622401|62770820|FG002|Overall Study|Disease progression prior to treatment|0|||
33391942|NCT00621621|62770830|FG000|Overall Study|Subjects were exited at EP study|30|||
33391943|NCT00621621|62770831|FG001|Overall Study|Subjects were exited at EP study|0|||
33391944|NCT00621543|62770839|FG000|Overall Study|Lost to Follow-up|23|||
33391945|NCT00623805|62770845|FG000|Overall Study|Adverse Event|9|||
33562246|NCT00835367|62956907|FG001|Washout|Withdrawal by Subject|0|||
33562247|NCT00835367|62956906|FG000|Second Intervention|Adverse Event|1|||
33562248|NCT00835367|62956907|FG001|Second Intervention|Adverse Event|1|||
33562249|NCT02276560|62956914|FG000|Overall Study|Adverse Event|1|||
33562250|NCT02276560|62956915|FG001|Overall Study|Adverse Event|0|||
33562251|NCT02276560|62956916|FG002|Overall Study|Adverse Event|0|||
33562252|NCT02276482|62956926|FG000|Overall Study|Adverse Event|1|||
33391946|NCT00623805|62770846|FG001|Overall Study|Adverse Event|6|||
33391947|NCT00623805|62770845|FG000|Overall Study|Death|2|||
33562253|NCT02276482|62956927|FG001|Overall Study|Adverse Event|0|||
33562254|NCT02276482|62956926|FG000|Overall Study|Withdrawal by Subject|1|||
33562255|NCT02276482|62956927|FG001|Overall Study|Withdrawal by Subject|0|||
33562256|NCT02276482|62956926|FG000|Overall Study|Gram-negative infection|1|||
33562257|NCT02276482|62956927|FG001|Overall Study|Gram-negative infection|0|||
33562258|NCT02276482|62956926|FG000|Overall Study|Reason not specified|0|||
33562259|NCT02276482|62956927|FG001|Overall Study|Reason not specified|1|||
33562260|NCT00835211|62956945|FG000|First Intervention|Withdrawal by Subject|0|||
33562261|NCT00835211|62956946|FG001|First Intervention|Withdrawal by Subject|1|||
33562262|NCT00835211|62956945|FG000|Washout: 7 Days|Adverse Event|2|||
33562263|NCT00835211|62956946|FG001|Washout: 7 Days|Adverse Event|1|||
33562264|NCT00835211|62956945|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
33562265|NCT00835211|62956946|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
33562266|NCT00834743|62956959|FG000|Second Intervention|Withdrawal by Subject|1|||
33562267|NCT00834743|62956960|FG001|Second Intervention|Withdrawal by Subject|0|||
33562268|NCT00834587|62956966|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
33562269|NCT00834587|62956967|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
33562270|NCT00834431|62956973|FG000|First Intervention|Adverse Event|0|||
33562271|NCT00834431|62956974|FG001|First Intervention|Adverse Event|1|||
33562272|NCT00834431|62956973|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
33562273|NCT00834431|62956974|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
33562274|NCT00830219|62956994|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
33562275|NCT00830219|62956995|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
33562276|NCT02274766|62957001|FG000|Overall Study|Withdrawal by Subject|3|||
33562277|NCT02274766|62957002|FG001|Overall Study|Withdrawal by Subject|6|||
33562278|NCT02274766|62957001|FG000|Overall Study|Did Not Receive Study Drug|1|||
33562279|NCT02274766|62957002|FG001|Overall Study|Did Not Receive Study Drug|1|||
33562280|NCT02274766|62957001|FG000|Overall Study|Subject Unwilling to Proceed|0|||
33562281|NCT02274766|62957002|FG001|Overall Study|Subject Unwilling to Proceed|1|||
33562282|NCT02274766|62957001|FG000|Overall Study|Adverse Event|0|||
33562283|NCT02274766|62957002|FG001|Overall Study|Adverse Event|1|||
33562284|NCT00829673|62957010|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
33562285|NCT00829673|62957011|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
33562286|NCT02370238|62957017|FG000|Overall Study|Death|42|||
33562287|NCT02370238|62957018|FG001|Overall Study|Death|35|||
33562288|NCT02370238|62957017|FG000|Overall Study|Lost to Follow-up|1|||
33562289|NCT02370238|62957018|FG001|Overall Study|Lost to Follow-up|3|||
33562290|NCT02370238|62957017|FG000|Overall Study|Withdrawal by Subject|2|||
33562291|NCT02370238|62957018|FG001|Overall Study|Withdrawal by Subject|6|||
33562292|NCT02370238|62957017|FG000|Overall Study|Other|2|||
33562293|NCT02370238|62957018|FG001|Overall Study|Other|1|||
33562294|NCT02370160|62957028|FG000|Overall Study|Death|3|||
33562295|NCT02370160|62957029|FG001|Overall Study|Death|4|||
33562296|NCT02370160|62957030|FG002|Overall Study|Death|1|||
33391948|NCT00623805|62770846|FG001|Overall Study|Death|0|||
33391949|NCT00623805|62770845|FG000|Overall Study|Lack of Efficacy|3|||
33391950|NCT00623805|62770846|FG001|Overall Study|Lack of Efficacy|7|||
33391951|NCT00623805|62770845|FG000|Overall Study|Lost to Follow-up|2|||
33391952|NCT00623805|62770846|FG001|Overall Study|Lost to Follow-up|2|||
33391953|NCT00623805|62770845|FG000|Overall Study|Protocol Violation|1|||
33562297|NCT02273908|62957045|FG000|Overall Study|Adverse Event|16|||
33562298|NCT02273908|62957046|FG001|Overall Study|Adverse Event|0|||
33562299|NCT02273908|62957045|FG000|Overall Study|Lost to Follow-up|10|||
33562300|NCT02273908|62957046|FG001|Overall Study|Lost to Follow-up|1|||
33562301|NCT02273908|62957045|FG000|Overall Study|Did not meet entrance criteria|3|||
33562302|NCT02273908|62957046|FG001|Overall Study|Did not meet entrance criteria|2|||
33562303|NCT02273908|62957045|FG000|Overall Study|Withdrawal by Subject|4|||
33562304|NCT02273908|62957046|FG001|Overall Study|Withdrawal by Subject|2|||
33562305|NCT02273752|62957056|FG000|Overall Study|Trial was terminated early|2|||
33562306|NCT05180630|62957060|FG000|First Intervention|Physician Decision|0|||
33562307|NCT05180630|62957061|FG001|First Intervention|Physician Decision|0|||
33562308|NCT05180630|62957062|FG002|First Intervention|Physician Decision|3|||
33562309|NCT02273596|62957071|FG000|24-Week Treatment Period|Adverse Event|3|||
33562310|NCT02273596|62957071|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
33562311|NCT02273596|62957071|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
33562312|NCT02273596|62957071|FG000|24-Week Treatment Period|Physician Decision|1|||
33562313|NCT02273596|62957071|FG000|24-Week Treatment Period|Protocol Deviation|1|||
33562314|NCT02273596|62957071|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
33562315|NCT02273596|62957071|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
33562316|NCT02273596|62957071|FG000|Extension Period|Lost to Follow-up|1|||
33562317|NCT02273596|62957071|FG000|Extension Period|Protocol Deviation|1|||
33562318|NCT01656200|62957081|FG000|Overall Study|Withdrawal by Subject|1|||
33562319|NCT02369848|62957085|FG000|Overall Study|Death|1|||
33562320|NCT02369848|62957085|FG000|Overall Study|Withdrawal by Subject|2|||
33300418|NCT01294683|62676593|FG001|Post Crossover (Period III)|Adverse Event|6|||
33300419|NCT01294683|62676592|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
33300420|NCT01294683|62676593|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
33300421|NCT01294683|62676592|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
33300422|NCT01294683|62676593|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
33300423|NCT01294683|62676592|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
33562321|NCT02369848|62957085|FG000|Overall Study|Lost to Follow-up|1|||
33562322|NCT02368210|62957091|FG000|Overall Study|Withdrawal by Subject|1|||
33562323|NCT02368210|62957092|FG001|Overall Study|Withdrawal by Subject|0|||
33562324|NCT02368210|62957091|FG000|Overall Study|Adverse Event|0|||
33562325|NCT02368210|62957092|FG001|Overall Study|Adverse Event|1|||
33562326|NCT02273050|62957101|FG000|Overall Study|Adverse Event|4|||
33562327|NCT02273050|62957102|FG001|Overall Study|Adverse Event|3|||
33562328|NCT02273050|62957103|FG002|Overall Study|Adverse Event|3|||
33562329|NCT02273050|62957101|FG000|Overall Study|Death|0|||
33562330|NCT02273050|62957102|FG001|Overall Study|Death|0|||
33562331|NCT02273050|62957103|FG002|Overall Study|Death|1|||
33300424|NCT01294683|62676593|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
33300425|NCT01294449|62676607|FG000|Overall Study|Death|11|||
33391954|NCT00623805|62770846|FG001|Overall Study|Protocol Violation|1|||
33391955|NCT00623805|62770845|FG000|Overall Study|Reason not Specified|3|||
33391956|NCT00623805|62770846|FG001|Overall Study|Reason not Specified|6|||
33391957|NCT00621309|62770852|FG000|Overall Study|Withdrawal by Subject|2|||
33391958|NCT00621309|62770853|FG001|Overall Study|Withdrawal by Subject|0|||
33391959|NCT00621309|62770854|FG002|Overall Study|Withdrawal by Subject|1|||
33391960|NCT00621309|62770855|FG003|Overall Study|Withdrawal by Subject|1|||
33391961|NCT00621309|62770856|FG004|Overall Study|Withdrawal by Subject|1|||
33300426|NCT01294449|62676608|FG001|Overall Study|Death|12|||
33300427|NCT01294449|62676607|FG000|Overall Study|Withdrawal by Subject|1|||
33300428|NCT01294449|62676608|FG001|Overall Study|Withdrawal by Subject|3|||
33300429|NCT01294371|62676614|FG000|Overall Study|Adverse Event|1|||
33300430|NCT01294371|62676614|FG000|Overall Study|Withdrawal by Subject|12|||
33300431|NCT01294371|62676614|FG000|Overall Study|Lost to Follow-up|6|||
33300432|NCT01294371|62676614|FG000|Overall Study|Administrative Reason|1|||
33300433|NCT01294371|62676614|FG000|Overall Study|Other|14|||
33300434|NCT01293123|62676623|FG000|Overall Study|Lost to Follow-up|0|||
33300435|NCT01293123|62676624|FG001|Overall Study|Lost to Follow-up|1|||
33300436|NCT01292187|62676632|FG000|Overall Study|Adverse Event|10|||
33300437|NCT01292187|62676633|FG001|Overall Study|Adverse Event|5|||
33300438|NCT01292187|62676632|FG000|Overall Study|Withdrawal by Subject|6|||
33300439|NCT01292187|62676633|FG001|Overall Study|Withdrawal by Subject|5|||
33300440|NCT01292187|62676632|FG000|Overall Study|All other reasons|1|||
33300441|NCT01292187|62676633|FG001|Overall Study|All other reasons|3|||
33300442|NCT01026493|62676648|FG000|Overall Study|Protocol Violation|0|||
33300443|NCT01026493|62676649|FG001|Overall Study|Protocol Violation|1|||
33300444|NCT01026493|62676650|FG002|Overall Study|Protocol Violation|0|||
33391962|NCT00621309|62770857|FG005|Overall Study|Withdrawal by Subject|1|||
33562332|NCT02273050|62957101|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
33562333|NCT02273050|62957102|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
33300445|NCT01026493|62676651|FG003|Overall Study|Protocol Violation|0|||
33300446|NCT01026493|62676652|FG004|Overall Study|Protocol Violation|2|||
33300447|NCT01026493|62676653|FG005|Overall Study|Protocol Violation|3|||
33300448|NCT01026493|62676654|FG006|Overall Study|Protocol Violation|4|||
33300449|NCT01026493|62676655|FG007|Overall Study|Protocol Violation|1|||
33391963|NCT00567190|62770865|FG000|Overall Study|Death|235|||
33391964|NCT00567190|62770866|FG001|Overall Study|Death|280|||
33391965|NCT00567190|62770865|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
33562334|NCT02273050|62957103|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
33391966|NCT00567190|62770866|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
33391967|NCT00691938|62770884|FG000|Overall Study|QTc prolongation|1|||
33391968|NCT00691938|62770885|FG001|Overall Study|QTc prolongation|0|||
33391969|NCT00691938|62770886|FG002|Overall Study|QTc prolongation|0|||
33391970|NCT00691938|62770887|FG003|Overall Study|QTc prolongation|0|||
33391971|NCT00691938|62770888|FG004|Overall Study|QTc prolongation|0|||
33391972|NCT00691938|62770889|FG005|Overall Study|QTc prolongation|0|||
33562335|NCT02273050|62957101|FG000|Overall Study|Lack of Efficacy|0|||
33562336|NCT02273050|62957102|FG001|Overall Study|Lack of Efficacy|1|||
33562337|NCT02273050|62957103|FG002|Overall Study|Lack of Efficacy|1|||
33562338|NCT02273050|62957101|FG000|Overall Study|Withdrawal by Subject|17|||
33562339|NCT02273050|62957102|FG001|Overall Study|Withdrawal by Subject|14|||
33562340|NCT02273050|62957103|FG002|Overall Study|Withdrawal by Subject|16|||
33562341|NCT02273050|62957101|FG000|Overall Study|Lost to Follow-up|0|||
33562342|NCT02273050|62957102|FG001|Overall Study|Lost to Follow-up|2|||
33562343|NCT02273050|62957103|FG002|Overall Study|Lost to Follow-up|3|||
33562344|NCT02273050|62957101|FG000|Overall Study|Protocol Violation|3|||
33562345|NCT02273050|62957102|FG001|Overall Study|Protocol Violation|1|||
33562346|NCT02273050|62957103|FG002|Overall Study|Protocol Violation|4|||
33562347|NCT02272816|62957111|FG000|Overall Study|Adverse Event|1|||
33562348|NCT02271880|62957117|FG000|Overall Study|Premature discontinuation of study|3|||
33300450|NCT01026103|62676673|FG000|Overall Study|Physician Decision|1|||
33300451|NCT01026103|62676673|FG000|Overall Study|did not receive study device bc of error|1|||
33562349|NCT02271880|62957118|FG001|Overall Study|Premature discontinuation of study|4|||
33562350|NCT02367352|62957126|FG000|Overall Study|Progressive disease|7|||
33562351|NCT02367352|62957127|FG001|Overall Study|Progressive disease|0|||
33562352|NCT02367352|62957128|FG002|Overall Study|Progressive disease|0|||
33562353|NCT02367352|62957126|FG000|Overall Study|Participant Received Alternative Therapy|1|||
33562354|NCT02367352|62957127|FG001|Overall Study|Participant Received Alternative Therapy|0|||
33562355|NCT02367352|62957128|FG002|Overall Study|Participant Received Alternative Therapy|0|||
33562356|NCT02367352|62957126|FG000|Overall Study|Adverse Event|1|||
33562357|NCT02367352|62957127|FG001|Overall Study|Adverse Event|0|||
33562358|NCT02367352|62957128|FG002|Overall Study|Adverse Event|0|||
33562359|NCT02365636|62957137|FG000|Overall Study|Adverse Event|3|||
33562360|NCT02365636|62957138|FG001|Overall Study|Adverse Event|3|||
33562361|NCT02365636|62957139|FG002|Overall Study|Adverse Event|2|||
33562362|NCT02365636|62957137|FG000|Overall Study|Protocol Violation|1|||
33562363|NCT02365636|62957138|FG001|Overall Study|Protocol Violation|4|||
33562364|NCT02365636|62957139|FG002|Overall Study|Protocol Violation|0|||
33562365|NCT02365636|62957137|FG000|Overall Study|Lost to Follow-up|0|||
33562366|NCT02365636|62957138|FG001|Overall Study|Lost to Follow-up|0|||
33562367|NCT02365636|62957139|FG002|Overall Study|Lost to Follow-up|1|||
33300452|NCT01291173|62676681|FG000|Overall Study|Adverse Event|0|||
33300453|NCT01291173|62676682|FG001|Overall Study|Adverse Event|3|||
33300454|NCT01291173|62676683|FG002|Overall Study|Adverse Event|1|||
33300455|NCT01291173|62676684|FG003|Overall Study|Adverse Event|3|||
33300456|NCT01291173|62676681|FG000|Overall Study|Protocol Violation|7|||
33300457|NCT01291173|62676682|FG001|Overall Study|Protocol Violation|2|||
33300458|NCT01291173|62676683|FG002|Overall Study|Protocol Violation|2|||
33300459|NCT01291173|62676684|FG003|Overall Study|Protocol Violation|5|||
33300460|NCT01291173|62676681|FG000|Overall Study|Withdrawal by Subject|6|||
33391973|NCT00691938|62770890|FG006|Overall Study|QTc prolongation|0|||
33562368|NCT02365636|62957137|FG000|Overall Study|Other|2|||
33562369|NCT02365636|62957138|FG001|Overall Study|Other|0|||
33562370|NCT02365636|62957139|FG002|Overall Study|Other|0|||
33562371|NCT01655498|62957147|FG000|Overall Study|Unrelated health issue|2|||
33562372|NCT01655498|62957147|FG000|Overall Study|Protocol Violation|2|||
33562373|NCT01655498|62957147|FG000|Overall Study|Withdrawal by Subject|1|||
33562374|NCT02270944|62957156|FG000|Overall Study|Lost to Follow-up|9|||
33562375|NCT02270944|62957157|FG001|Overall Study|Lost to Follow-up|4|||
33562376|NCT02270944|62957156|FG000|Overall Study|Withdrawal by Subject|2|||
33562377|NCT02270944|62957157|FG001|Overall Study|Withdrawal by Subject|1|||
33562378|NCT02365558|62957164|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
33562379|NCT02365558|62957165|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
33562380|NCT02365558|62957164|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
33562381|NCT02365558|62957165|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
33562382|NCT02365480|62957176|FG000|Overall Study|Withdrawal by Subject|2|||
33562383|NCT02365480|62957177|FG001|Overall Study|Withdrawal by Subject|0|||
33300461|NCT01291173|62676682|FG001|Overall Study|Withdrawal by Subject|4|||
33300462|NCT01291173|62676683|FG002|Overall Study|Withdrawal by Subject|4|||
33300463|NCT01291173|62676684|FG003|Overall Study|Withdrawal by Subject|2|||
33300464|NCT01291173|62676681|FG000|Overall Study|Lost to Follow-up|4|||
33300465|NCT01291173|62676682|FG001|Overall Study|Lost to Follow-up|6|||
33300466|NCT01291173|62676683|FG002|Overall Study|Lost to Follow-up|3|||
33391974|NCT00365365|62770904|FG000|Overall Study|Randomized but not treated|0|||
33562384|NCT02270242|62957185|FG000|Overall Study|Withdrawal by Subject|18|||
33562385|NCT02270242|62957186|FG001|Overall Study|Withdrawal by Subject|25|||
33562386|NCT02270242|62957185|FG000|Overall Study|Lost to Follow-up|41|||
33562387|NCT02270242|62957186|FG001|Overall Study|Lost to Follow-up|27|||
33562388|NCT02270242|62957185|FG000|Overall Study|Physician Decision|0|||
33562389|NCT02270242|62957186|FG001|Overall Study|Physician Decision|1|||
33562390|NCT02364388|62957192|FG000|Overall Study|Protocol Violation|1|||
33562391|NCT02364388|62957192|FG000|Overall Study|Technical Failure|3|||
33562392|NCT02364388|62957192|FG000|Overall Study|No OA/US data|2|||
33562393|NCT02364388|62957192|FG000|Overall Study|No Biopsy|2|||
33562394|NCT02363686|62957196|FG000|Overall Study|Withdrawal by Subject|22|||
33562395|NCT02363686|62957196|FG000|Overall Study|incomplete FEES examinations|13|||
33391975|NCT00365365|62770905|FG001|Overall Study|Randomized but not treated|2|||
33391976|NCT00365365|62770906|FG002|Overall Study|Randomized but not treated|0|||
33391977|NCT00365365|62770904|FG000|Overall Study|Poor compliance to protocol|0|||
33391978|NCT00365365|62770905|FG001|Overall Study|Poor compliance to protocol|1|||
33391979|NCT00365365|62770906|FG002|Overall Study|Poor compliance to protocol|0|||
33562396|NCT02268916|62957202|FG000|Overall Study|Lost to Follow-up|1|||
33562397|NCT02268916|62957203|FG001|Overall Study|Lost to Follow-up|1|||
33562398|NCT02268916|62957202|FG000|Overall Study|Withdrawal by Subject|6|||
33562399|NCT02268916|62957203|FG001|Overall Study|Withdrawal by Subject|5|||
33562400|NCT02268916|62957202|FG000|Overall Study|Participant did not have diabetes|1|||
33562401|NCT02268916|62957203|FG001|Overall Study|Participant did not have diabetes|0|||
33562402|NCT02268916|62957202|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
33562403|NCT02268916|62957203|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
33562404|NCT02518490|62957210|FG000|Overall Study|Withdrawal by Subject|1|||
33562405|NCT02518490|62957211|FG001|Overall Study|Withdrawal by Subject|1|||
33562406|NCT01364870|62957221|FG000|Overall Study|Withdrawal by Subject|13|||
33562407|NCT01364870|62957222|FG001|Overall Study|Withdrawal by Subject|24|||
33562408|NCT01364870|62957223|FG002|Overall Study|Withdrawal by Subject|10|||
33562409|NCT01364870|62957221|FG000|Overall Study|Adverse Event|8|||
33562410|NCT01364870|62957222|FG001|Overall Study|Adverse Event|6|||
33562411|NCT01364870|62957223|FG002|Overall Study|Adverse Event|4|||
33562412|NCT01364870|62957221|FG000|Overall Study|Protocol Violation|1|||
33562413|NCT01364870|62957222|FG001|Overall Study|Protocol Violation|0|||
33562414|NCT01364870|62957223|FG002|Overall Study|Protocol Violation|0|||
33562415|NCT02268526|62957234|FG000|Overall Study|Adverse Event|0|||
33562416|NCT02268526|62957235|FG001|Overall Study|Adverse Event|2|||
33562417|NCT02268526|62957236|FG002|Overall Study|Adverse Event|1|||
33562418|NCT02268526|62957234|FG000|Overall Study|Death|1|||
33562419|NCT02268526|62957235|FG001|Overall Study|Death|11|||
33562420|NCT02268526|62957236|FG002|Overall Study|Death|0|||
33562421|NCT02268526|62957234|FG000|Overall Study|protocol deviation|0|||
33562422|NCT02268526|62957235|FG001|Overall Study|protocol deviation|1|||
33562423|NCT02268526|62957236|FG002|Overall Study|protocol deviation|0|||
33562424|NCT02268526|62957234|FG000|Overall Study|Physician Decision|0|||
33562425|NCT02268526|62957235|FG001|Overall Study|Physician Decision|0|||
33562426|NCT02268526|62957236|FG002|Overall Study|Physician Decision|1|||
33562427|NCT02268526|62957234|FG000|Overall Study|Subject/guardian decision|0|||
33562428|NCT02268526|62957235|FG001|Overall Study|Subject/guardian decision|7|||
33662852|NCT02685072|63093350|FG000|Treatment Period|Lost to Follow-up|12|||
33662853|NCT02685072|63093351|FG001|Treatment Period|Lost to Follow-up|6|||
33662854|NCT02685072|63093350|FG000|Treatment Period|Withdrawal by Subject|1|||
33662855|NCT02685072|63093351|FG001|Treatment Period|Withdrawal by Subject|3|||
33662856|NCT02685072|63093350|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
33662857|NCT02685072|63093351|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
33662858|NCT02695524|63093421|FG000|Overall Study|Lost to Follow-up|3|||
33662859|NCT02695524|63093422|FG001|Overall Study|Lost to Follow-up|2|||
33662860|NCT02695524|63093421|FG000|Overall Study|Death|0|||
33662861|NCT02695524|63093422|FG001|Overall Study|Death|1|||
33662862|NCT01576367|63093428|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33662863|NCT01576367|63093428|FG000|Overall Study|Moved to commercial use after 6 months|1|||
33662864|NCT01689857|63093439|FG000|Overall Study|Lost to Follow-up|5|||
33662865|NCT01689857|63093440|FG001|Overall Study|Lost to Follow-up|2|||
33662866|NCT01587079|63093455|FG000|Overall Study|Protocol-specified criteria|9|||
33662867|NCT01587079|63093455|FG000|Overall Study|Protocol Violation|5|||
33662868|NCT01587079|63093455|FG000|Overall Study|Lost to Follow-up|2|||
33662869|NCT01587079|63093455|FG000|Overall Study|Physician Decision|2|||
33662870|NCT01587079|63093455|FG000|Overall Study|Withdrawal by Subject|7|||
33300467|NCT01291173|62676684|FG003|Overall Study|Lost to Follow-up|2|||
33300468|NCT01291173|62676681|FG000|Overall Study|Unable to meet visit schedule|0|||
33300469|NCT01291173|62676682|FG001|Overall Study|Unable to meet visit schedule|0|||
33300470|NCT01291173|62676683|FG002|Overall Study|Unable to meet visit schedule|1|||
33300471|NCT01291173|62676684|FG003|Overall Study|Unable to meet visit schedule|0|||
33300472|NCT01291173|62676681|FG000|Overall Study|Lack of compliance|0|||
33300473|NCT01291173|62676682|FG001|Overall Study|Lack of compliance|0|||
33300474|NCT01291173|62676683|FG002|Overall Study|Lack of compliance|0|||
33300475|NCT01291173|62676684|FG003|Overall Study|Lack of compliance|1|||
33300476|NCT01291173|62676681|FG000|Overall Study|Subject was unblinded|0|||
33391980|NCT00365365|62770904|FG000|Overall Study|Lost to Follow-up|3|||
33562429|NCT02268526|62957236|FG002|Overall Study|Subject/guardian decision|3|||
33562430|NCT02268214|62957249|FG000|Overall Study|Subject no longer meets study criteria|0|||
33562431|NCT02268214|62957250|FG001|Overall Study|Subject no longer meets study criteria|2|||
33562432|NCT02268214|62957251|FG002|Overall Study|Subject no longer meets study criteria|0|||
33562433|NCT02268214|62957249|FG000|Overall Study|Pregnancy|2|||
33562434|NCT02268214|62957250|FG001|Overall Study|Pregnancy|2|||
33562435|NCT02268214|62957251|FG002|Overall Study|Pregnancy|1|||
33562436|NCT02268214|62957249|FG000|Overall Study|Lost to Follow-up|3|||
33562437|NCT02268214|62957250|FG001|Overall Study|Lost to Follow-up|3|||
33562438|NCT02268214|62957251|FG002|Overall Study|Lost to Follow-up|4|||
33391981|NCT00365365|62770905|FG001|Overall Study|Lost to Follow-up|3|||
33562439|NCT02268214|62957249|FG000|Overall Study|Lack of Efficacy|1|||
33562440|NCT02268214|62957250|FG001|Overall Study|Lack of Efficacy|0|||
33562441|NCT02268214|62957251|FG002|Overall Study|Lack of Efficacy|2|||
33562442|NCT02268214|62957249|FG000|Overall Study|Adverse Event|11|||
33562443|NCT02268214|62957250|FG001|Overall Study|Adverse Event|14|||
33562444|NCT02268214|62957251|FG002|Overall Study|Adverse Event|9|||
33562445|NCT02268214|62957249|FG000|Overall Study|Withdrawal by Subject|4|||
33562446|NCT02268214|62957250|FG001|Overall Study|Withdrawal by Subject|5|||
33562447|NCT02268214|62957251|FG002|Overall Study|Withdrawal by Subject|10|||
33562448|NCT02268214|62957249|FG000|Overall Study|Subject request to discontinue treatment|10|||
33562449|NCT02268214|62957250|FG001|Overall Study|Subject request to discontinue treatment|8|||
33562450|NCT02268214|62957251|FG002|Overall Study|Subject request to discontinue treatment|6|||
33562451|NCT02268214|62957249|FG000|Overall Study|Poor/non-compliance|2|||
33562452|NCT02268214|62957250|FG001|Overall Study|Poor/non-compliance|1|||
33562453|NCT02268214|62957251|FG002|Overall Study|Poor/non-compliance|2|||
33562454|NCT02268214|62957249|FG000|Overall Study|Other reasons|7|||
33562455|NCT02268214|62957250|FG001|Overall Study|Other reasons|3|||
33562456|NCT02268214|62957251|FG002|Overall Study|Other reasons|3|||
33562457|NCT02268214|62957249|FG000|Overall Study|Not entering long-term period|2|||
33562458|NCT02268214|62957250|FG001|Overall Study|Not entering long-term period|3|||
33562459|NCT02268214|62957251|FG002|Overall Study|Not entering long-term period|5|||
33562460|NCT02521376|62957263|FG000|Overall Study|Enrolled, But Not Treated|1|||
33562461|NCT02521376|62957264|FG001|Overall Study|Enrolled, But Not Treated|0|||
33562462|NCT02521376|62957265|FG002|Overall Study|Enrolled, But Not Treated|0|||
33562463|NCT02521376|62957266|FG003|Overall Study|Enrolled, But Not Treated|0|||
33562464|NCT02268058|62957288|FG000|Overall Study|Protocol Violation|1|||
33562465|NCT02268058|62957289|FG001|Overall Study|Protocol Violation|0|||
33562466|NCT02268058|62957290|FG002|Overall Study|Protocol Violation|0|||
33562467|NCT02268058|62957291|FG003|Overall Study|Protocol Violation|0|||
33562468|NCT02267824|62957303|FG000|Overall Study|Pregnancy|1|||
33391982|NCT00365365|62770906|FG002|Overall Study|Lost to Follow-up|3|||
33391983|NCT00365365|62770904|FG000|Overall Study|Death|1|||
33391984|NCT00365365|62770905|FG001|Overall Study|Death|3|||
33391985|NCT00365365|62770906|FG002|Overall Study|Death|0|||
33391986|NCT00365365|62770904|FG000|Overall Study|Subject's request|11|||
33391987|NCT00365365|62770905|FG001|Overall Study|Subject's request|13|||
33391988|NCT00365365|62770906|FG002|Overall Study|Subject's request|1|||
33391989|NCT00365365|62770904|FG000|Overall Study|Disease progression/relapse|9|||
33391990|NCT00365365|62770905|FG001|Overall Study|Disease progression/relapse|6|||
33391991|NCT00365365|62770906|FG002|Overall Study|Disease progression/relapse|7|||
33562469|NCT02267824|62957304|FG001|Overall Study|Pregnancy|1|||
33562470|NCT02267824|62957303|FG000|Overall Study|Lost to Follow-up|4|||
33562471|NCT02267824|62957304|FG001|Overall Study|Lost to Follow-up|0|||
33562472|NCT02267824|62957303|FG000|Overall Study|Protocol Violation|3|||
33562473|NCT02267824|62957304|FG001|Overall Study|Protocol Violation|0|||
33562474|NCT02267824|62957303|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
33562475|NCT02267824|62957304|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
33562476|NCT02267746|62957313|FG000|Overall Study|Adverse Event|0|||
33562477|NCT02267746|62957314|FG001|Overall Study|Adverse Event|2|||
33562478|NCT02267746|62957315|FG002|Overall Study|Adverse Event|1|||
33562479|NCT02267746|62957313|FG000|Overall Study|Protocol Violation|8|||
33562480|NCT02267746|62957314|FG001|Overall Study|Protocol Violation|7|||
33562481|NCT02267746|62957315|FG002|Overall Study|Protocol Violation|3|||
33391992|NCT00365365|62770904|FG000|Overall Study|Adverse Event|6|||
33562482|NCT02267746|62957313|FG000|Overall Study|Lack of Efficacy|11|||
33562483|NCT02267746|62957314|FG001|Overall Study|Lack of Efficacy|11|||
33562484|NCT02267746|62957315|FG002|Overall Study|Lack of Efficacy|15|||
33562485|NCT02267746|62957313|FG000|Overall Study|Protocol Violation|1|||
33562486|NCT02267746|62957314|FG001|Overall Study|Protocol Violation|2|||
33562487|NCT02267746|62957315|FG002|Overall Study|Protocol Violation|1|||
33562488|NCT02267746|62957313|FG000|Overall Study|Miscellaneous|1|||
33562489|NCT02267746|62957314|FG001|Overall Study|Miscellaneous|0|||
33391993|NCT00365365|62770905|FG001|Overall Study|Adverse Event|6|||
33391994|NCT00365365|62770906|FG002|Overall Study|Adverse Event|3|||
33391995|NCT00365365|62770904|FG000|Overall Study|Moved|2|||
33562490|NCT02267746|62957315|FG002|Overall Study|Miscellaneous|1|||
33562491|NCT02362360|62957325|FG000|Period 1|Lack of Efficacy|1|||
33562492|NCT02362360|62957326|FG001|Period 1|Lack of Efficacy|0|||
33562493|NCT02362360|62957325|FG000|Period 1|Withdrawal by Subject|2|||
33562494|NCT02362360|62957326|FG001|Period 1|Withdrawal by Subject|1|||
33562495|NCT02362282|62957334|FG000|Overall Study|Withdrawal by Subject|1|||
33562496|NCT02362282|62957335|FG001|Overall Study|Withdrawal by Subject|0|||
33562497|NCT02361580|62957343|FG000|Overall Study|Lost to Follow-up|6|||
33562498|NCT02361580|62957344|FG001|Overall Study|Lost to Follow-up|3|||
33562499|NCT02520284|62957353|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
33562500|NCT02520284|62957354|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
33562501|NCT02520284|62957355|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
33562502|NCT02520284|62957353|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
33562503|NCT02520284|62957354|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
33562504|NCT02520284|62957355|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
33562505|NCT02520284|62957353|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
33562506|NCT02520284|62957354|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
33562507|NCT02520284|62957355|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
33562508|NCT02520284|62957353|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
33562509|NCT02520284|62957354|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
33562510|NCT02520284|62957355|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
33562511|NCT02520284|62957353|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
33562512|NCT02520284|62957354|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
33562513|NCT02520284|62957355|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
33391996|NCT00365365|62770905|FG001|Overall Study|Moved|0|||
33562514|NCT02520284|62957353|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
33562515|NCT02520284|62957354|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
33562516|NCT02520284|62957355|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
33562517|NCT02520284|62957353|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
33562518|NCT02520284|62957354|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
33562519|NCT02520284|62957355|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
33562520|NCT02520284|62957353|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
33562521|NCT02520284|62957354|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
33562522|NCT02520284|62957355|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
33562523|NCT02520284|62957353|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
33562524|NCT02520284|62957354|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
33562525|NCT02520284|62957355|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
33562526|NCT02520284|62957353|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
33562527|NCT02520284|62957354|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
33562528|NCT02520284|62957355|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
33562529|NCT02520284|62957353|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
33562530|NCT02520284|62957354|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
33562531|NCT02520284|62957355|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
33662871|NCT01587079|63093455|FG000|Overall Study|Adverse Event|14|||
33662872|NCT01587001|63093508|FG000|Overall Study|Lost to Follow-up|2|||
33391997|NCT00365365|62770906|FG002|Overall Study|Moved|0|||
33391998|NCT00365365|62770904|FG000|Overall Study|New cancer|1|||
33391999|NCT00365365|62770905|FG001|Overall Study|New cancer|0|||
33392000|NCT00365365|62770906|FG002|Overall Study|New cancer|0|||
33392001|NCT00365365|62770904|FG000|Overall Study|Withdrew consent|1|||
33392002|NCT00365365|62770905|FG001|Overall Study|Withdrew consent|1|||
33392003|NCT00365365|62770906|FG002|Overall Study|Withdrew consent|0|||
33392004|NCT00365365|62770904|FG000|Overall Study|Second malignancy|0|||
33392005|NCT00365365|62770905|FG001|Overall Study|Second malignancy|1|||
33392006|NCT00365365|62770906|FG002|Overall Study|Second malignancy|0|||
33392007|NCT00365365|62770904|FG000|Overall Study|Patient/physician decision|0|||
33562532|NCT02517866|62957369|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
33562533|NCT02517866|62957370|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
33562534|NCT02517866|62957371|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
33562535|NCT02517866|62957369|FG000|Overall Study|Significant Protocol Deviation|4|||
33562536|NCT02517866|62957370|FG001|Overall Study|Significant Protocol Deviation|1|||
33562537|NCT02517866|62957371|FG002|Overall Study|Significant Protocol Deviation|0|||
33562538|NCT02517866|62957369|FG000|Overall Study|Lost to Follow-up|1|||
33662873|NCT01587001|63093509|FG001|Overall Study|Lost to Follow-up|0|||
33392008|NCT00365365|62770905|FG001|Overall Study|Patient/physician decision|0|||
33392009|NCT00365365|62770906|FG002|Overall Study|Patient/physician decision|1|||
33392010|NCT00623727|62770916|FG000|Double Blind (DB)|Adverse Event|1|||
33392011|NCT00623727|62770917|FG001|Double Blind (DB)|Adverse Event|3|||
33392012|NCT00623727|62770916|FG000|Double Blind (DB)|Physician Decision|0|||
33392013|NCT00623727|62770917|FG001|Double Blind (DB)|Physician Decision|1|||
33392014|NCT00623727|62770916|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
33392015|NCT00623727|62770917|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
33562539|NCT02517866|62957370|FG001|Overall Study|Lost to Follow-up|0|||
33562540|NCT02517866|62957371|FG002|Overall Study|Lost to Follow-up|0|||
33562541|NCT02517866|62957369|FG000|Overall Study|Voluntary Withdrawal|2|||
33562542|NCT02517866|62957370|FG001|Overall Study|Voluntary Withdrawal|2|||
33562543|NCT02517866|62957371|FG002|Overall Study|Voluntary Withdrawal|0|||
33562544|NCT02517866|62957369|FG000|Overall Study|Investigator Decision|2|||
33562545|NCT02517866|62957370|FG001|Overall Study|Investigator Decision|1|||
33562546|NCT02517866|62957371|FG002|Overall Study|Investigator Decision|0|||
33562547|NCT02517866|62957369|FG000|Overall Study|Reason not specified|2|||
33562548|NCT02517866|62957370|FG001|Overall Study|Reason not specified|0|||
33562549|NCT02517866|62957371|FG002|Overall Study|Reason not specified|0|||
33562550|NCT02515994|62957383|FG000|Overall Study|Protocol Violation|3|||
33562551|NCT02515994|62957384|FG001|Overall Study|Protocol Violation|5|||
33562552|NCT02515994|62957383|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
33562553|NCT02515994|62957384|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
33562554|NCT02515994|62957383|FG000|Overall Study|Adverse Event|3|||
33562555|NCT02515994|62957384|FG001|Overall Study|Adverse Event|1|||
33562556|NCT02515994|62957383|FG000|Overall Study|Withdrawal by Subject|2|||
33562557|NCT02515994|62957384|FG001|Overall Study|Withdrawal by Subject|0|||
33562558|NCT02516306|62957392|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
33562559|NCT02516306|62957393|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
33300477|NCT01291173|62676682|FG001|Overall Study|Subject was unblinded|0|||
33300478|NCT01291173|62676683|FG002|Overall Study|Subject was unblinded|1|||
33300479|NCT01291173|62676684|FG003|Overall Study|Subject was unblinded|0|||
33300480|NCT01291173|62676681|FG000|Overall Study|Excluded therapy|0|||
33300481|NCT01291173|62676682|FG001|Overall Study|Excluded therapy|0|||
33300482|NCT01291173|62676683|FG002|Overall Study|Excluded therapy|1|||
33300483|NCT01291173|62676684|FG003|Overall Study|Excluded therapy|0|||
33300484|NCT01291017|62676694|FG000|Overall Study|Lost to Follow-up|2|||
33300485|NCT01291017|62676694|FG000|Overall Study|Withdrawal by Subject|3|||
33300486|NCT01290315|62676702|FG000|Overall Study|Adverse Event|0|||
33300487|NCT01290315|62676703|FG001|Overall Study|Adverse Event|0|||
33300488|NCT01290315|62676704|FG002|Overall Study|Adverse Event|0|||
33300489|NCT01290315|62676705|FG003|Overall Study|Adverse Event|3|||
33300490|NCT01290315|62676702|FG000|Overall Study|Selection criteria/compliance|2|||
33300491|NCT01290315|62676703|FG001|Overall Study|Selection criteria/compliance|1|||
33300492|NCT01290315|62676704|FG002|Overall Study|Selection criteria/compliance|0|||
33300493|NCT01290315|62676705|FG003|Overall Study|Selection criteria/compliance|2|||
33300494|NCT01290315|62676702|FG000|Overall Study|Lost to Follow-up|0|||
33300495|NCT01290315|62676703|FG001|Overall Study|Lost to Follow-up|1|||
33300496|NCT01290315|62676704|FG002|Overall Study|Lost to Follow-up|0|||
33300497|NCT01290315|62676705|FG003|Overall Study|Lost to Follow-up|0|||
33300498|NCT01290315|62676702|FG000|Overall Study|Withdrawal by Subject|1|||
33300499|NCT01290315|62676703|FG001|Overall Study|Withdrawal by Subject|1|||
33300500|NCT01290315|62676704|FG002|Overall Study|Withdrawal by Subject|0|||
33300501|NCT01290315|62676705|FG003|Overall Study|Withdrawal by Subject|0|||
33300502|NCT01289847|62676714|FG000|Overall Study|Patient could not comply with visits|1|||
33300503|NCT01079182|62676718|FG000|Overall Study|Lost to Follow-up|1634|||
33300504|NCT01079182|62676718|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
33562560|NCT02516228|62957399|FG000|Overall Study|Lost to Follow-up|1|||
33562561|NCT02516228|62957399|FG000|Overall Study|Withdrawal by Subject|1|||
33562562|NCT02516228|62957399|FG000|Overall Study|Physician Decision|1|||
33562563|NCT02519504|62957405|FG000|Overall Study|Protocol Violation|6|||
33562564|NCT02519504|62957406|FG001|Overall Study|Protocol Violation|5|||
33562565|NCT02519504|62957405|FG000|Overall Study|Ineligible for direct testing|12|||
33562566|NCT02519504|62957406|FG001|Overall Study|Ineligible for direct testing|12|||
33562567|NCT02519504|62957405|FG000|Overall Study|Did not participate in direct testing|95|||
33562568|NCT02519504|62957406|FG001|Overall Study|Did not participate in direct testing|86|||
33562569|NCT02514824|62957414|FG000|Overall Study|Withdrawal by Subject|1|||
33562570|NCT02514824|62957415|FG001|Overall Study|Withdrawal by Subject|0|||
33562571|NCT02514824|62957416|FG002|Overall Study|Withdrawal by Subject|0|||
33562572|NCT02514824|62957417|FG003|Overall Study|Withdrawal by Subject|0|||
33562573|NCT02514824|62957414|FG000|Overall Study|Dose-Limiting Toxicity|0|||
33562574|NCT02514824|62957415|FG001|Overall Study|Dose-Limiting Toxicity|1|||
33300505|NCT01079182|62676718|FG000|Overall Study|Lack of Efficacy|514|||
33300506|NCT01079182|62676718|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
33300507|NCT01079182|62676718|FG000|Overall Study|Reasons not Evaluated|271|||
33562575|NCT02514824|62957416|FG002|Overall Study|Dose-Limiting Toxicity|0|||
33562576|NCT02514824|62957417|FG003|Overall Study|Dose-Limiting Toxicity|0|||
33562577|NCT02514746|62957426|FG000|Overall Study|Chronically Ill|1|||
33562578|NCT02514746|62957427|FG001|Overall Study|Chronically Ill|2|||
33300508|NCT01021813|62676724|FG000|DB Treatment Phase|Adverse Event|60|||
33300509|NCT01021813|62676725|FG001|DB Treatment Phase|Adverse Event|22|||
33300510|NCT01021813|62676726|FG002|DB Treatment Phase|Adverse Event|0|||
33300511|NCT01021813|62676727|FG003|DB Treatment Phase|Adverse Event|0|||
33300512|NCT01021813|62676728|FG004|DB Treatment Phase|Adverse Event|0|||
33562579|NCT02514746|62957426|FG000|Overall Study|Physician Decision|4|||
33562580|NCT02514746|62957427|FG001|Overall Study|Physician Decision|2|||
33562581|NCT02514746|62957426|FG000|Overall Study|Withdrawal by Subject|12|||
33562582|NCT02514746|62957427|FG001|Overall Study|Withdrawal by Subject|10|||
33562583|NCT02514746|62957426|FG000|Overall Study|Other|5|||
33562584|NCT02514746|62957427|FG001|Overall Study|Other|1|||
33562585|NCT02483078|62957437|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
33562586|NCT02483078|62957438|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
33562587|NCT02483078|62957437|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
33562588|NCT02483078|62957438|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
33562589|NCT02483078|62957437|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
33562590|NCT02483078|62957438|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
33562591|NCT02483078|62957437|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
33562592|NCT02483078|62957438|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
33562593|NCT02483078|62957437|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
33562594|NCT02483078|62957438|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
33562595|NCT02483078|62957437|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
33562596|NCT02483078|62957438|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
33562597|NCT02452190|62957452|FG000|Overall Study|Withdrawal by Sponsor|1|||
33562598|NCT02452190|62957453|FG001|Overall Study|Withdrawal by Sponsor|3|||
33562599|NCT02452190|62957452|FG000|Overall Study|Pregnancy|1|||
33562600|NCT02452190|62957453|FG001|Overall Study|Pregnancy|0|||
33562601|NCT02452190|62957452|FG000|Overall Study|Investigator's Decision|2|||
33562602|NCT02452190|62957453|FG001|Overall Study|Investigator's Decision|0|||
33562603|NCT02452190|62957452|FG000|Overall Study|Lack of Efficacy|3|||
33562604|NCT02452190|62957453|FG001|Overall Study|Lack of Efficacy|1|||
33562605|NCT02452190|62957452|FG000|Overall Study|Lost to Follow-up|4|||
33562606|NCT02452190|62957453|FG001|Overall Study|Lost to Follow-up|3|||
33562607|NCT02452190|62957452|FG000|Overall Study|Adverse Event|2|||
33562608|NCT02452190|62957453|FG001|Overall Study|Adverse Event|5|||
33562609|NCT02452190|62957452|FG000|Overall Study|Withdrawal by Subject|20|||
33562610|NCT02452190|62957453|FG001|Overall Study|Withdrawal by Subject|11|||
33562611|NCT02452190|62957452|FG000|Overall Study|Noncompliance with study drug|1|||
33562612|NCT02452190|62957453|FG001|Overall Study|Noncompliance with study drug|0|||
33562613|NCT02452190|62957452|FG000|Overall Study|Participant traveled abroad|1|||
33562614|NCT02452190|62957453|FG001|Overall Study|Participant traveled abroad|0|||
33562615|NCT02452190|62957452|FG000|Overall Study|Death|0|||
33562616|NCT02452190|62957453|FG001|Overall Study|Death|1|||
33562617|NCT02514122|62957461|FG000|Overall Study|Withdrawal by Subject|2|||
33562618|NCT02514122|62957462|FG001|Overall Study|Withdrawal by Subject|0|||
33562619|NCT00730639|62957473|FG000|Overall Study|Adverse Event|3|||
33562620|NCT00730639|62957474|FG001|Overall Study|Adverse Event|0|||
33562621|NCT00730639|62957475|FG002|Overall Study|Adverse Event|9|||
33562622|NCT00730639|62957476|FG003|Overall Study|Adverse Event|8|||
33562623|NCT00730639|62957477|FG004|Overall Study|Adverse Event|23|||
33562624|NCT00730639|62957473|FG000|Overall Study|Complete Response|0|||
33562625|NCT00730639|62957474|FG001|Overall Study|Complete Response|0|||
33562626|NCT00730639|62957475|FG002|Overall Study|Complete Response|2|||
33562627|NCT00730639|62957476|FG003|Overall Study|Complete Response|2|||
33562628|NCT00730639|62957477|FG004|Overall Study|Complete Response|1|||
33562629|NCT00730639|62957473|FG000|Overall Study|Completed Maximum Cycles|0|||
33562630|NCT00730639|62957474|FG001|Overall Study|Completed Maximum Cycles|0|||
33562631|NCT00730639|62957475|FG002|Overall Study|Completed Maximum Cycles|11|||
33562632|NCT00730639|62957476|FG003|Overall Study|Completed Maximum Cycles|3|||
33562633|NCT00730639|62957477|FG004|Overall Study|Completed Maximum Cycles|6|||
33562634|NCT00730639|62957473|FG000|Overall Study|Death|0|||
33562635|NCT00730639|62957474|FG001|Overall Study|Death|0|||
33562636|NCT00730639|62957475|FG002|Overall Study|Death|0|||
33562637|NCT00730639|62957476|FG003|Overall Study|Death|0|||
33562638|NCT00730639|62957477|FG004|Overall Study|Death|2|||
33562639|NCT00730639|62957473|FG000|Overall Study|Disease Progression|12|||
33562640|NCT00730639|62957474|FG001|Overall Study|Disease Progression|13|||
33562641|NCT00730639|62957475|FG002|Overall Study|Disease Progression|48|||
33562642|NCT00730639|62957476|FG003|Overall Study|Disease Progression|32|||
33562643|NCT00730639|62957477|FG004|Overall Study|Disease Progression|88|||
33562644|NCT00730639|62957473|FG000|Overall Study|non-specified|0|||
33562645|NCT00730639|62957474|FG001|Overall Study|non-specified|0|||
33562646|NCT00730639|62957475|FG002|Overall Study|non-specified|4|||
33562647|NCT00730639|62957476|FG003|Overall Study|non-specified|2|||
33562648|NCT00730639|62957477|FG004|Overall Study|non-specified|3|||
33300513|NCT01021813|62676724|FG000|DB Treatment Phase|Lack of Efficacy|44|||
33562649|NCT00730639|62957473|FG000|Overall Study|Protocol Violation|0|||
33562650|NCT00730639|62957474|FG001|Overall Study|Protocol Violation|0|||
33562651|NCT00730639|62957475|FG002|Overall Study|Protocol Violation|1|||
33562652|NCT00730639|62957476|FG003|Overall Study|Protocol Violation|0|||
33562653|NCT00730639|62957477|FG004|Overall Study|Protocol Violation|0|||
33562654|NCT00730639|62957473|FG000|Overall Study|Withdrawal by Subject|0|||
33562655|NCT00730639|62957474|FG001|Overall Study|Withdrawal by Subject|0|||
33562656|NCT00730639|62957475|FG002|Overall Study|Withdrawal by Subject|6|||
33562657|NCT00730639|62957476|FG003|Overall Study|Withdrawal by Subject|3|||
33562658|NCT00730639|62957477|FG004|Overall Study|Withdrawal by Subject|4|||
33562659|NCT00730639|62957473|FG000|Overall Study|Treatment on-going|2|||
33562660|NCT00730639|62957474|FG001|Overall Study|Treatment on-going|5|||
33562661|NCT00730639|62957475|FG002|Overall Study|Treatment on-going|5|||
33300514|NCT01021813|62676725|FG001|DB Treatment Phase|Lack of Efficacy|28|||
33300515|NCT01021813|62676726|FG002|DB Treatment Phase|Lack of Efficacy|0|||
33300516|NCT01021813|62676727|FG003|DB Treatment Phase|Lack of Efficacy|0|||
33300517|NCT01021813|62676728|FG004|DB Treatment Phase|Lack of Efficacy|0|||
33300518|NCT01021813|62676724|FG000|DB Treatment Phase|Lost to Follow-up|14|||
33300519|NCT01021813|62676725|FG001|DB Treatment Phase|Lost to Follow-up|12|||
33392016|NCT00623727|62770916|FG000|Double Blind (DB)|Lack of Efficacy|2|||
33562662|NCT00730639|62957476|FG003|Overall Study|Treatment on-going|4|||
33562663|NCT00730639|62957477|FG004|Overall Study|Treatment on-going|4|||
33562664|NCT02536339|62957500|FG000|Overall Study|Death|20|||
33562665|NCT02536339|62957500|FG000|Overall Study|Withdrawal by Subject|3|||
33562666|NCT02536339|62957500|FG000|Overall Study|Lost to Follow-up|2|||
33562667|NCT02536339|62957500|FG000|Overall Study|Treatment discontinued|2|||
33562668|NCT02536339|62957500|FG000|Overall Study|Physician Decision|1|||
33562669|NCT02743871|62957534|FG000|Overall Study|Lost to Follow-up|0|||
33562670|NCT02743871|62957535|FG001|Overall Study|Lost to Follow-up|0|||
33562671|NCT02743871|62957536|FG002|Overall Study|Lost to Follow-up|0|||
33562672|NCT02743871|62957537|FG003|Overall Study|Lost to Follow-up|1|||
33562673|NCT02743871|62957538|FG004|Overall Study|Lost to Follow-up|0|||
33562674|NCT02743871|62957539|FG005|Overall Study|Lost to Follow-up|0|||
33562675|NCT02743871|62957540|FG006|Overall Study|Lost to Follow-up|1|||
33562676|NCT02743871|62957541|FG007|Overall Study|Lost to Follow-up|0|||
33562677|NCT02743871|62957542|FG008|Overall Study|Lost to Follow-up|0|||
33562678|NCT02743871|62957543|FG009|Overall Study|Lost to Follow-up|0|||
33562679|NCT02743871|62957544|FG010|Overall Study|Lost to Follow-up|0|||
33562680|NCT02743871|62957545|FG011|Overall Study|Lost to Follow-up|2|||
33562681|NCT02743871|62957546|FG012|Overall Study|Lost to Follow-up|0|||
33562682|NCT02743871|62957547|FG013|Overall Study|Lost to Follow-up|0|||
33562683|NCT02743871|62957534|FG000|Overall Study|Withdrawal by Subject|0|||
33562684|NCT02743871|62957535|FG001|Overall Study|Withdrawal by Subject|0|||
33562685|NCT02743871|62957536|FG002|Overall Study|Withdrawal by Subject|0|||
33562686|NCT02743871|62957537|FG003|Overall Study|Withdrawal by Subject|0|||
33562687|NCT02743871|62957538|FG004|Overall Study|Withdrawal by Subject|0|||
33562688|NCT02743871|62957539|FG005|Overall Study|Withdrawal by Subject|0|||
33562689|NCT02743871|62957540|FG006|Overall Study|Withdrawal by Subject|0|||
33562690|NCT02743871|62957541|FG007|Overall Study|Withdrawal by Subject|0|||
33562691|NCT02743871|62957542|FG008|Overall Study|Withdrawal by Subject|0|||
33562692|NCT02743871|62957543|FG009|Overall Study|Withdrawal by Subject|0|||
33562693|NCT02743871|62957544|FG010|Overall Study|Withdrawal by Subject|1|||
33562694|NCT02743871|62957545|FG011|Overall Study|Withdrawal by Subject|0|||
33562695|NCT02743871|62957546|FG012|Overall Study|Withdrawal by Subject|12|||
33392017|NCT00623727|62770917|FG001|Double Blind (DB)|Lack of Efficacy|2|||
33392018|NCT00623727|62770916|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
33392019|NCT00623727|62770917|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
33392020|NCT00623727|62770916|FG000|Double Blind (DB)|Lost to Follow-up|1|||
33392021|NCT00623727|62770917|FG001|Double Blind (DB)|Lost to Follow-up|1|||
33562696|NCT02743871|62957547|FG013|Overall Study|Withdrawal by Subject|6|||
33562697|NCT02743871|62957534|FG000|Overall Study|Adverse Event|1|||
33562698|NCT02743871|62957535|FG001|Overall Study|Adverse Event|0|||
33562699|NCT02743871|62957536|FG002|Overall Study|Adverse Event|0|||
33562700|NCT02743871|62957537|FG003|Overall Study|Adverse Event|0|||
33562701|NCT02743871|62957538|FG004|Overall Study|Adverse Event|0|||
33562702|NCT02743871|62957539|FG005|Overall Study|Adverse Event|0|||
33562703|NCT02743871|62957540|FG006|Overall Study|Adverse Event|0|||
33300520|NCT01021813|62676726|FG002|DB Treatment Phase|Lost to Follow-up|0|||
33300521|NCT01021813|62676727|FG003|DB Treatment Phase|Lost to Follow-up|0|||
33300522|NCT01021813|62676728|FG004|DB Treatment Phase|Lost to Follow-up|0|||
33300523|NCT01021813|62676724|FG000|DB Treatment Phase|Physician Decision|17|||
33392022|NCT00623727|62770916|FG000|Double Blind (DB)|Protocol Violation|2|||
33562704|NCT02743871|62957541|FG007|Overall Study|Adverse Event|0|||
33562705|NCT02743871|62957542|FG008|Overall Study|Adverse Event|0|||
33562706|NCT02743871|62957543|FG009|Overall Study|Adverse Event|0|||
33562707|NCT02743871|62957544|FG010|Overall Study|Adverse Event|0|||
33562708|NCT02743871|62957545|FG011|Overall Study|Adverse Event|0|||
33562709|NCT02743871|62957546|FG012|Overall Study|Adverse Event|0|||
33300524|NCT01021813|62676725|FG001|DB Treatment Phase|Physician Decision|8|||
33300525|NCT01021813|62676726|FG002|DB Treatment Phase|Physician Decision|0|||
33392023|NCT00623727|62770917|FG001|Double Blind (DB)|Protocol Violation|2|||
33562710|NCT02743871|62957547|FG013|Overall Study|Adverse Event|0|||
33562711|NCT02743871|62957534|FG000|Overall Study|Other|0|||
33562712|NCT02743871|62957535|FG001|Overall Study|Other|0|||
33562713|NCT02743871|62957536|FG002|Overall Study|Other|0|||
33562714|NCT02743871|62957537|FG003|Overall Study|Other|0|||
33562715|NCT02743871|62957538|FG004|Overall Study|Other|0|||
33562716|NCT02743871|62957539|FG005|Overall Study|Other|0|||
33562717|NCT02743871|62957540|FG006|Overall Study|Other|0|||
33562718|NCT02743871|62957541|FG007|Overall Study|Other|0|||
33562719|NCT02743871|62957542|FG008|Overall Study|Other|0|||
33562720|NCT02743871|62957543|FG009|Overall Study|Other|0|||
33562721|NCT02743871|62957544|FG010|Overall Study|Other|0|||
33562722|NCT02743871|62957545|FG011|Overall Study|Other|1|||
33562723|NCT02743871|62957546|FG012|Overall Study|Other|1|||
33562724|NCT02743871|62957547|FG013|Overall Study|Other|1|||
33562725|NCT02743871|62957534|FG000|Overall Study|Protocol Violation|0|||
33562726|NCT02743871|62957535|FG001|Overall Study|Protocol Violation|0|||
33562727|NCT02743871|62957536|FG002|Overall Study|Protocol Violation|0|||
33562728|NCT02743871|62957537|FG003|Overall Study|Protocol Violation|0|||
33562729|NCT02743871|62957538|FG004|Overall Study|Protocol Violation|0|||
33562730|NCT02743871|62957539|FG005|Overall Study|Protocol Violation|0|||
33562731|NCT02743871|62957540|FG006|Overall Study|Protocol Violation|0|||
33562732|NCT02743871|62957541|FG007|Overall Study|Protocol Violation|0|||
33562733|NCT02743871|62957542|FG008|Overall Study|Protocol Violation|0|||
33562734|NCT02743871|62957543|FG009|Overall Study|Protocol Violation|0|||
33562735|NCT02743871|62957544|FG010|Overall Study|Protocol Violation|0|||
33562736|NCT02743871|62957545|FG011|Overall Study|Protocol Violation|0|||
33562737|NCT02743871|62957546|FG012|Overall Study|Protocol Violation|2|||
33562738|NCT02743871|62957547|FG013|Overall Study|Protocol Violation|0|||
33562739|NCT01704547|62957589|FG000|Overall Study|Physician Decision|4|||
33562740|NCT01704547|62957589|FG000|Overall Study|Withdrawal by Subject|1|||
33562741|NCT00796523|62957609|FG000|Overall Study|Lost to Follow-up|9|||
33562742|NCT00796523|62957610|FG001|Overall Study|Lost to Follow-up|7|||
33562743|NCT01352585|62957625|FG000|Overall Study|Adverse Event|2|||
33562744|NCT01352585|62957626|FG001|Overall Study|Adverse Event|1|||
33562745|NCT01352585|62957625|FG000|Overall Study|Lost to Follow-up|1|||
33562746|NCT01352585|62957626|FG001|Overall Study|Lost to Follow-up|0|||
33562747|NCT01352585|62957625|FG000|Overall Study|Other|5|||
33562748|NCT01352585|62957626|FG001|Overall Study|Other|2|||
33562749|NCT01352507|62957635|FG000|Treatment Period 1|Adverse Event|3|||
33562750|NCT01352507|62957636|FG001|Treatment Period 1|Adverse Event|0|||
33562751|NCT01352507|62957635|FG000|Treatment Period 1|Lost to Follow-up|3|||
33562752|NCT01352507|62957636|FG001|Treatment Period 1|Lost to Follow-up|4|||
33562753|NCT01352507|62957635|FG000|Treatment Period 1|Withdrawal by Subject|7|||
33562754|NCT01352507|62957636|FG001|Treatment Period 1|Withdrawal by Subject|5|||
33562755|NCT01352507|62957635|FG000|Treatment Period 1|Physician Decision|1|||
33562756|NCT01352507|62957636|FG001|Treatment Period 1|Physician Decision|0|||
33562757|NCT01352507|62957635|FG000|Washout Period|Withdrawal by Subject|0|||
33562758|NCT01352507|62957636|FG001|Washout Period|Withdrawal by Subject|1|||
33562759|NCT01352507|62957635|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
33562760|NCT01352507|62957636|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
33562761|NCT01352507|62957635|FG000|Treatment Period 2|Withdrawal by Subject|4|||
33562762|NCT01352507|62957636|FG001|Treatment Period 2|Withdrawal by Subject|3|||
33562763|NCT01352507|62957635|FG000|Treatment Period 2|Lack of Efficacy|1|||
33562764|NCT01352507|62957636|FG001|Treatment Period 2|Lack of Efficacy|0|||
33562765|NCT02361346|62957657|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
33562766|NCT02361346|62957658|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
33562767|NCT02361346|62957659|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
33562768|NCT02361346|62957660|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
33562769|NCT02361346|62957661|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
33562770|NCT02361346|62957662|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
33562771|NCT02361346|62957663|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
33562772|NCT02361346|62957664|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
33562773|NCT02361346|62957665|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
33562774|NCT02361346|62957657|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33562775|NCT02361346|62957658|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33562776|NCT02361346|62957659|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33562777|NCT02361346|62957660|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33562778|NCT02361346|62957661|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
33562779|NCT02361346|62957662|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33562780|NCT02361346|62957663|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33562781|NCT02361346|62957664|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33562782|NCT02361346|62957665|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33562783|NCT02361346|62957657|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
33562784|NCT02361346|62957658|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
33562785|NCT02361346|62957659|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
33562786|NCT02361346|62957660|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
33562787|NCT02361346|62957661|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
33562788|NCT02361346|62957662|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
33562789|NCT02361346|62957663|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
33562790|NCT02361346|62957664|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
33562791|NCT02361346|62957665|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
33562792|NCT02361346|62957657|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33562793|NCT02361346|62957658|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33562794|NCT02361346|62957659|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33562795|NCT02361346|62957660|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33562796|NCT02361346|62957661|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33562797|NCT02361346|62957662|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33562798|NCT02361346|62957663|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33562799|NCT02361346|62957664|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
33562800|NCT02361346|62957665|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33562801|NCT02361346|62957657|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33562802|NCT02361346|62957658|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33562803|NCT02361346|62957659|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33562804|NCT02361346|62957660|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33562805|NCT02361346|62957661|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33562806|NCT02361346|62957662|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33562807|NCT02361346|62957663|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33562808|NCT02361346|62957664|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
33562809|NCT02361346|62957665|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33562810|NCT02361346|62957657|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33562811|NCT02361346|62957658|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33562812|NCT02361346|62957659|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33562813|NCT02361346|62957660|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33562814|NCT02361346|62957661|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33562815|NCT02361346|62957662|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33562816|NCT02361346|62957663|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33562817|NCT02361346|62957664|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
33562818|NCT02361346|62957665|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33562819|NCT02267278|62957707|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
33562820|NCT02267278|62957707|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
33562821|NCT02267278|62957707|FG000|Overall Study|Developed new cancer diagnoses|2|||
33562822|NCT02267278|62957707|FG000|Overall Study|prescribed prohibited medication|1|||
33562823|NCT02360098|62957713|FG000|Overall Study|Physician Decision|7|||
33562824|NCT02266888|62957724|FG000|Overall Study|Death|2|||
33562825|NCT02266888|62957725|FG001|Overall Study|Death|2|||
33562826|NCT02266888|62957726|FG002|Overall Study|Death|4|||
33562827|NCT02266888|62957727|FG003|Overall Study|Death|2|||
33562828|NCT02266888|62957724|FG000|Overall Study|Physician Decision|0|||
33562829|NCT02266888|62957725|FG001|Overall Study|Physician Decision|1|||
33562830|NCT02266888|62957726|FG002|Overall Study|Physician Decision|2|||
33562831|NCT02266888|62957727|FG003|Overall Study|Physician Decision|2|||
33562832|NCT02266888|62957724|FG000|Overall Study|Study Terminated|5|||
33562833|NCT02266888|62957725|FG001|Overall Study|Study Terminated|1|||
33562834|NCT02266888|62957726|FG002|Overall Study|Study Terminated|0|||
33662874|NCT01587001|63093508|FG000|Overall Study|Insufficient samples to complete testing|4|||
33662875|NCT01587001|63093509|FG001|Overall Study|Insufficient samples to complete testing|1|||
33392024|NCT00623727|62770916|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
33392025|NCT00623727|62770917|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
33392026|NCT00623727|62770916|FG000|Open Label Follow-up|Study termination|0|||
33392027|NCT00623727|62770917|FG001|Open Label Follow-up|Study termination|6|||
33392028|NCT00623727|62770916|FG000|Open Label Follow-up|Participant convenience|0|||
33392029|NCT00623727|62770917|FG001|Open Label Follow-up|Participant convenience|1|||
33562835|NCT02266888|62957727|FG003|Overall Study|Study Terminated|0|||
33662876|NCT01568047|63093539|FG000|Overall Study|Ineligibility|1|||
33662877|NCT01568047|63093540|FG001|Overall Study|Ineligibility|0|||
33662878|NCT01568047|63093541|FG002|Overall Study|Ineligibility|0|||
33300526|NCT01021813|62676727|FG003|DB Treatment Phase|Physician Decision|0|||
33300527|NCT01021813|62676728|FG004|DB Treatment Phase|Physician Decision|0|||
33300528|NCT01021813|62676724|FG000|DB Treatment Phase|Pregnancy|1|||
33300529|NCT01021813|62676725|FG001|DB Treatment Phase|Pregnancy|0|||
33300530|NCT01021813|62676726|FG002|DB Treatment Phase|Pregnancy|0|||
33300531|NCT01021813|62676727|FG003|DB Treatment Phase|Pregnancy|0|||
33300532|NCT01021813|62676728|FG004|DB Treatment Phase|Pregnancy|0|||
33300533|NCT01021813|62676724|FG000|DB Treatment Phase|Protocol Violation|4|||
33300534|NCT01021813|62676725|FG001|DB Treatment Phase|Protocol Violation|3|||
33392030|NCT00372775|62770925|FG000|Overall Study|Adverse Event|8|||
33392031|NCT00372775|62770925|FG000|Overall Study|Death|15|||
33300535|NCT01021813|62676726|FG002|DB Treatment Phase|Protocol Violation|0|||
33300536|NCT01021813|62676727|FG003|DB Treatment Phase|Protocol Violation|0|||
33562836|NCT02266888|62957724|FG000|Overall Study|No Longer Eligible|0|||
33562837|NCT02266888|62957725|FG001|Overall Study|No Longer Eligible|0|||
33562838|NCT02266888|62957726|FG002|Overall Study|No Longer Eligible|0|||
33662879|NCT01568047|63093542|FG003|Overall Study|Ineligibility|0|||
33562839|NCT02266888|62957727|FG003|Overall Study|No Longer Eligible|2|||
33562840|NCT02266888|62957724|FG000|Overall Study|Randomization Closed|0|||
33562841|NCT02266888|62957725|FG001|Overall Study|Randomization Closed|0|||
33562842|NCT02266888|62957726|FG002|Overall Study|Randomization Closed|4|||
33562843|NCT02266888|62957727|FG003|Overall Study|Randomization Closed|0|||
33562844|NCT02266888|62957724|FG000|Overall Study|Personnel unavailable at transplant|0|||
33562845|NCT02266888|62957725|FG001|Overall Study|Personnel unavailable at transplant|0|||
33562846|NCT02266888|62957726|FG002|Overall Study|Personnel unavailable at transplant|0|||
33562847|NCT02266888|62957727|FG003|Overall Study|Personnel unavailable at transplant|1|||
33562848|NCT02266888|62957724|FG000|Overall Study|Transfer of care|0|||
33562849|NCT02266888|62957725|FG001|Overall Study|Transfer of care|0|||
33562850|NCT02266888|62957726|FG002|Overall Study|Transfer of care|1|||
33562851|NCT02266888|62957727|FG003|Overall Study|Transfer of care|0|||
33562852|NCT01641952|62957735|FG000|Overall Study|Lost to Follow-up|28|||
33562853|NCT01641952|62957735|FG000|Overall Study|Adverse Event|6|||
33562854|NCT02359552|62957741|FG000|Overall Study|Lost to Follow-up|3|||
33562855|NCT02359552|62957742|FG001|Overall Study|Lost to Follow-up|4|||
33562856|NCT02743793|62957750|FG000|Overall Study|Death|1|||
33562857|NCT02743793|62957751|FG001|Overall Study|Death|1|||
33562858|NCT02743793|62957750|FG000|Overall Study|Withdrawal by Subject|0|||
33300537|NCT01021813|62676728|FG004|DB Treatment Phase|Protocol Violation|0|||
33300538|NCT01021813|62676724|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
33300539|NCT01021813|62676725|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
33300540|NCT01021813|62676726|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
33300541|NCT01021813|62676727|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
33300542|NCT01021813|62676728|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
33300543|NCT01021813|62676724|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
33300544|NCT01021813|62676725|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
33300545|NCT01021813|62676726|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
33300546|NCT01021813|62676727|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
33300547|NCT01021813|62676728|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
33300548|NCT01021813|62676724|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
33300549|NCT01021813|62676725|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
33300550|NCT01021813|62676726|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
33300551|NCT01021813|62676727|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
33300552|NCT01021813|62676728|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
33300553|NCT01021813|62676724|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
33300554|NCT01021813|62676725|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
33300555|NCT01021813|62676726|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
33300556|NCT01021813|62676727|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
33300557|NCT01021813|62676728|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
33300558|NCT01021813|62676724|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
33300559|NCT01021813|62676725|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
33300560|NCT01021813|62676726|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
33300561|NCT01021813|62676727|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
33300562|NCT01021813|62676728|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
33300563|NCT01021813|62676724|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
33300564|NCT01021813|62676725|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
33300565|NCT01021813|62676726|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
33300566|NCT01021813|62676727|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
33562859|NCT02743793|62957751|FG001|Overall Study|Withdrawal by Subject|1|||
33562860|NCT02743793|62957750|FG000|Overall Study|Screen Failure|4|||
33562861|NCT02743793|62957751|FG001|Overall Study|Screen Failure|0|||
33562862|NCT02743793|62957750|FG000|Overall Study|No Primary Care Physician|0|||
33562863|NCT02743793|62957751|FG001|Overall Study|No Primary Care Physician|1|||
33562864|NCT02743793|62957750|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
33562865|NCT02743793|62957751|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
33562866|NCT02743793|62957750|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
33562867|NCT02743793|62957751|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
33562868|NCT00152009|62957760|FG000|Overall Study|Adverse Event|9|||
33562869|NCT00152009|62957761|FG001|Overall Study|Adverse Event|13|||
33562870|NCT00152009|62957762|FG002|Overall Study|Adverse Event|20|||
33562871|NCT00152009|62957763|FG003|Overall Study|Adverse Event|1|||
33300567|NCT01021813|62676728|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
33562872|NCT00152009|62957760|FG000|Overall Study|Protocol Violation|3|||
33562873|NCT00152009|62957761|FG001|Overall Study|Protocol Violation|0|||
33562874|NCT00152009|62957762|FG002|Overall Study|Protocol Violation|0|||
33662880|NCT01568047|63093539|FG000|Overall Study|Withdrawal by Subject|0|||
33562875|NCT00152009|62957763|FG003|Overall Study|Protocol Violation|1|||
33562876|NCT00152009|62957760|FG000|Overall Study|Withdrawal by Subject|2|||
33300568|NCT01025635|62676747|FG000|Overall Study|Withdrawal by Subject|6|||
33300569|NCT01025635|62676748|FG001|Overall Study|Withdrawal by Subject|7|||
33392032|NCT00372775|62770925|FG000|Overall Study|Objective progression or relapse|30|||
33392033|NCT00372775|62770925|FG000|Overall Study|Global deterioration of health status|6|||
33392034|NCT00372775|62770925|FG000|Overall Study|Withdrawal by Subject|1|||
33392035|NCT00372775|62770925|FG000|Overall Study|Other|1|||
33392036|NCT00372775|62770925|FG000|Overall Study|Not Treated|2|||
33392037|NCT00372697|62770931|FG000|Overall Study|Protocol Violation|1|||
33562877|NCT00152009|62957761|FG001|Overall Study|Withdrawal by Subject|3|||
33562878|NCT00152009|62957762|FG002|Overall Study|Withdrawal by Subject|4|||
33562879|NCT00152009|62957763|FG003|Overall Study|Withdrawal by Subject|9|||
33562880|NCT00152009|62957760|FG000|Overall Study|Lost to Follow-up|2|||
33562881|NCT00152009|62957761|FG001|Overall Study|Lost to Follow-up|4|||
33562882|NCT00152009|62957762|FG002|Overall Study|Lost to Follow-up|3|||
33562883|NCT00152009|62957763|FG003|Overall Study|Lost to Follow-up|3|||
33562884|NCT00152009|62957760|FG000|Overall Study|Lack of Efficacy|8|||
33562885|NCT00152009|62957761|FG001|Overall Study|Lack of Efficacy|6|||
33562886|NCT00152009|62957762|FG002|Overall Study|Lack of Efficacy|7|||
33562887|NCT00152009|62957763|FG003|Overall Study|Lack of Efficacy|15|||
33562888|NCT00152009|62957760|FG000|Overall Study|ECG abnormalities|2|||
33562889|NCT00152009|62957761|FG001|Overall Study|ECG abnormalities|2|||
33562890|NCT00152009|62957762|FG002|Overall Study|ECG abnormalities|2|||
33562891|NCT00152009|62957763|FG003|Overall Study|ECG abnormalities|1|||
33562892|NCT00152009|62957760|FG000|Overall Study|Sponsor's decision|3|||
33562893|NCT00152009|62957761|FG001|Overall Study|Sponsor's decision|3|||
33562894|NCT00152009|62957762|FG002|Overall Study|Sponsor's decision|1|||
33562895|NCT00152009|62957763|FG003|Overall Study|Sponsor's decision|3|||
33562896|NCT02265952|62957773|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
33562897|NCT02265952|62957774|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
33562898|NCT02265952|62957773|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
33562899|NCT02265952|62957774|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
33562900|NCT02265796|62957782|FG000|Overall Study|Death|1|||
33562901|NCT02265796|62957783|FG001|Overall Study|Death|0|||
33562902|NCT02265796|62957782|FG000|Overall Study|started on excluded medication|1|||
33562903|NCT02265796|62957783|FG001|Overall Study|started on excluded medication|0|||
33562904|NCT02265796|62957782|FG000|Overall Study|Withdrawal by Subject|1|||
33562905|NCT02265796|62957783|FG001|Overall Study|Withdrawal by Subject|1|||
33562906|NCT02357368|62957793|FG000|Overall Study|Lost to Follow-up|0|||
33562907|NCT02357368|62957794|FG001|Overall Study|Lost to Follow-up|0|||
33562908|NCT02357368|62957795|FG002|Overall Study|Lost to Follow-up|0|||
33562909|NCT02357368|62957796|FG003|Overall Study|Lost to Follow-up|1|||
33562910|NCT02357368|62957793|FG000|Overall Study|Pregnancy|3|||
33562911|NCT02357368|62957794|FG001|Overall Study|Pregnancy|2|||
33562912|NCT02357368|62957795|FG002|Overall Study|Pregnancy|0|||
33562913|NCT02357368|62957796|FG003|Overall Study|Pregnancy|0|||
33562914|NCT02357368|62957793|FG000|Overall Study|Withdrawal by Subject|3|||
33562915|NCT02357368|62957794|FG001|Overall Study|Withdrawal by Subject|1|||
33562916|NCT02357368|62957795|FG002|Overall Study|Withdrawal by Subject|1|||
33562917|NCT02357368|62957796|FG003|Overall Study|Withdrawal by Subject|2|||
33562918|NCT03287245|62957810|FG000|Overall Study|Study terminated by sponsor|3|||
33562919|NCT03287245|62957811|FG001|Overall Study|Study terminated by sponsor|0|||
33562920|NCT03287245|62957812|FG002|Overall Study|Study terminated by sponsor|3|||
33562921|NCT03287245|62957813|FG003|Overall Study|Study terminated by sponsor|1|||
33562922|NCT03287245|62957810|FG000|Overall Study|Adverse Event|1|||
33562923|NCT03287245|62957811|FG001|Overall Study|Adverse Event|0|||
33562924|NCT03287245|62957812|FG002|Overall Study|Adverse Event|0|||
33562925|NCT03287245|62957813|FG003|Overall Study|Adverse Event|0|||
33562926|NCT03287245|62957810|FG000|Overall Study|Withdrawal by Subject|8|||
33562927|NCT03287245|62957811|FG001|Overall Study|Withdrawal by Subject|3|||
33562928|NCT03287245|62957812|FG002|Overall Study|Withdrawal by Subject|3|||
33562929|NCT03287245|62957813|FG003|Overall Study|Withdrawal by Subject|0|||
33562930|NCT03287245|62957810|FG000|Overall Study|Physician Decision|3|||
33562931|NCT03287245|62957811|FG001|Overall Study|Physician Decision|2|||
33300570|NCT01025635|62676747|FG000|Overall Study|Protocol Violation|4|||
33300571|NCT01025635|62676748|FG001|Overall Study|Protocol Violation|2|||
33300572|NCT01025635|62676747|FG000|Overall Study|Lack of Efficacy|0|||
33300573|NCT01025635|62676748|FG001|Overall Study|Lack of Efficacy|1|||
33300574|NCT01025635|62676747|FG000|Overall Study|Lost to Follow-up|9|||
33300575|NCT01025635|62676748|FG001|Overall Study|Lost to Follow-up|13|||
33300576|NCT01025635|62676747|FG000|Overall Study|Reason not known|4|||
33562932|NCT03287245|62957812|FG002|Overall Study|Physician Decision|0|||
33562933|NCT03287245|62957813|FG003|Overall Study|Physician Decision|0|||
33562934|NCT04495179|62957845|FG000|Overall Study|Lost to Follow-up|0|||
33562935|NCT04495179|62957846|FG001|Overall Study|Lost to Follow-up|1|||
33562936|NCT04495179|62957845|FG000|Overall Study|Withdrawal by Subject|2|||
33562937|NCT04495179|62957846|FG001|Overall Study|Withdrawal by Subject|4|||
33562938|NCT04495179|62957845|FG000|Overall Study|Study terminated by sponsor|0|||
33562939|NCT04495179|62957846|FG001|Overall Study|Study terminated by sponsor|18|||
33562940|NCT04495179|62957845|FG000|Overall Study|Death|0|||
33562941|NCT04495179|62957846|FG001|Overall Study|Death|4|||
33562942|NCT04495179|62957845|FG000|Overall Study|Adverse Event|0|||
33300577|NCT01025635|62676748|FG001|Overall Study|Reason not known|2|||
33300578|NCT01021423|62676756|FG000|Overall Study|Study terminated|4|||
33300579|NCT01021423|62676757|FG001|Overall Study|Study terminated|5|||
33300580|NCT01020877|62676765|FG000|Second Intervention|Withdrawal by Subject|1|||
33300581|NCT01020877|62676766|FG001|Second Intervention|Withdrawal by Subject|0|||
33300582|NCT01020799|62676775|FG000|Overall Study|Adverse Event|4|||
33300583|NCT01020799|62676776|FG001|Overall Study|Adverse Event|3|||
33300584|NCT01020799|62676777|FG002|Overall Study|Adverse Event|2|||
33300585|NCT01020799|62676775|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
33300586|NCT01020799|62676776|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
33300587|NCT01020799|62676777|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
33300588|NCT01020799|62676775|FG000|Overall Study|Protocol Violation|3|||
33300589|NCT01020799|62676776|FG001|Overall Study|Protocol Violation|2|||
33300590|NCT01020799|62676777|FG002|Overall Study|Protocol Violation|0|||
33300591|NCT01020799|62676775|FG000|Overall Study|Withdrawal by Subject|2|||
33300592|NCT01020799|62676776|FG001|Overall Study|Withdrawal by Subject|2|||
33300593|NCT01020799|62676777|FG002|Overall Study|Withdrawal by Subject|3|||
33300594|NCT01020799|62676775|FG000|Overall Study|Lost to Follow-up|6|||
33300595|NCT01020799|62676776|FG001|Overall Study|Lost to Follow-up|4|||
33300596|NCT01020799|62676777|FG002|Overall Study|Lost to Follow-up|2|||
33300597|NCT01288989|62676790|FG000|Overall Study|Death|0|||
33300598|NCT01288989|62676791|FG001|Overall Study|Death|0|||
33300599|NCT01288989|62676792|FG002|Overall Study|Death|0|||
33300600|NCT01288989|62676793|FG003|Overall Study|Death|1|||
33300601|NCT01288989|62676794|FG004|Overall Study|Death|0|||
33300602|NCT01288989|62676790|FG000|Overall Study|Dose limiting toxicity|1|||
33300603|NCT01288989|62676791|FG001|Overall Study|Dose limiting toxicity|0|||
33300604|NCT01288989|62676792|FG002|Overall Study|Dose limiting toxicity|0|||
33300605|NCT01288989|62676793|FG003|Overall Study|Dose limiting toxicity|0|||
33300606|NCT01288989|62676794|FG004|Overall Study|Dose limiting toxicity|0|||
33300607|NCT01288989|62676790|FG000|Overall Study|Adverse Event|0|||
33300608|NCT01288989|62676791|FG001|Overall Study|Adverse Event|0|||
33300609|NCT01288989|62676792|FG002|Overall Study|Adverse Event|0|||
33300610|NCT01288989|62676793|FG003|Overall Study|Adverse Event|0|||
33300611|NCT01288989|62676794|FG004|Overall Study|Adverse Event|2|||
33300612|NCT01288989|62676790|FG000|Overall Study|Physician Decision|0|||
33300613|NCT01288989|62676791|FG001|Overall Study|Physician Decision|0|||
33300614|NCT01288989|62676792|FG002|Overall Study|Physician Decision|0|||
33300615|NCT01288989|62676793|FG003|Overall Study|Physician Decision|0|||
33300616|NCT01288989|62676794|FG004|Overall Study|Physician Decision|1|||
33300617|NCT01288989|62676790|FG000|Overall Study|Withdrawal by Subject|0|||
33300618|NCT01288989|62676791|FG001|Overall Study|Withdrawal by Subject|0|||
33300619|NCT01288989|62676792|FG002|Overall Study|Withdrawal by Subject|0|||
33300620|NCT01288989|62676793|FG003|Overall Study|Withdrawal by Subject|0|||
33300621|NCT01288989|62676794|FG004|Overall Study|Withdrawal by Subject|3|||
33300622|NCT01020487|62676815|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
33300623|NCT01020487|62676816|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
33300624|NCT01020487|62676817|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
33300625|NCT01020487|62676815|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
33300626|NCT01020487|62676816|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
33300627|NCT01020487|62676817|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
33300628|NCT01020487|62676815|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
33300629|NCT01020487|62676816|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
33300630|NCT01020487|62676817|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
33300631|NCT01020487|62676815|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
33300632|NCT01020487|62676816|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
33562943|NCT04495179|62957846|FG001|Overall Study|Adverse Event|1|||
33562944|NCT04201262|62957871|FG000|Overall Study|Adverse Event|1|||
33562945|NCT04201262|62957872|FG001|Overall Study|Adverse Event|2|||
33562946|NCT04201262|62957871|FG000|Overall Study|Continuing in the study|57|||
33562947|NCT04201262|62957872|FG001|Overall Study|Continuing in the study|0|||
33562948|NCT04201262|62957871|FG000|Overall Study|Withdrawal by Subject|0|||
33300633|NCT01020487|62676817|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
33300634|NCT01020487|62676815|FG000|Part 2 Open-label Period|Adverse Event|0|||
33300635|NCT01020487|62676816|FG001|Part 2 Open-label Period|Adverse Event|4|||
33300636|NCT01020487|62676817|FG002|Part 2 Open-label Period|Adverse Event|1|||
33300637|NCT01024855|62676827|FG000|Overall Study|Inclusion/exclusion criteria|1|||
33300638|NCT01014013|62676834|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
33300639|NCT01014013|62676835|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
33300640|NCT01014013|62676834|FG000|Overall Study|Clinical adverse experience|4|||
33300641|NCT01014013|62676835|FG001|Overall Study|Clinical adverse experience|2|||
33300642|NCT01014013|62676834|FG000|Overall Study|Laboratory adverse experience|1|||
33562949|NCT04201262|62957872|FG001|Overall Study|Withdrawal by Subject|1|||
33562950|NCT03831100|62957884|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
33562951|NCT03831100|62957885|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
33562952|NCT03689244|62957904|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
33562953|NCT03689244|62957905|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
33562954|NCT03689244|62957906|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
33562955|NCT03689244|62957907|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
33562956|NCT03689244|62957904|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
33562957|NCT03689244|62957905|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
33562958|NCT03689244|62957906|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
33562959|NCT03689244|62957907|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
33562960|NCT03689244|62957904|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
33562961|NCT03689244|62957905|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
33562962|NCT03689244|62957906|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
33562963|NCT03689244|62957907|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
33562964|NCT03689244|62957904|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
33562965|NCT03689244|62957905|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
33562966|NCT03689244|62957906|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
33562967|NCT03689244|62957907|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
33562968|NCT03689244|62957904|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
33562969|NCT03689244|62957905|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
33562970|NCT03689244|62957906|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
33562971|NCT03689244|62957907|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
33562972|NCT03689244|62957904|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
33562973|NCT03689244|62957905|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
33562974|NCT03689244|62957906|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
33562975|NCT03689244|62957907|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
33562976|NCT03689244|62957904|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
33562977|NCT03689244|62957905|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
33562978|NCT03689244|62957906|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
33392038|NCT00372697|62770932|FG001|Overall Study|Protocol Violation|1|||
33392039|NCT00690378|62770944|FG000|Overall Study|Adverse Event|1|||
33392040|NCT00690378|62770945|FG001|Overall Study|Adverse Event|0|||
33392041|NCT00690378|62770944|FG000|Overall Study|Withdrawal by Subject|2|||
33392042|NCT00690378|62770945|FG001|Overall Study|Withdrawal by Subject|0|||
33392043|NCT00690378|62770944|FG000|Overall Study|Protocol Violation|1|||
33392044|NCT00690378|62770945|FG001|Overall Study|Protocol Violation|0|||
33392045|NCT00690378|62770944|FG000|Overall Study|Lost to Follow-up|2|||
33392046|NCT00690378|62770945|FG001|Overall Study|Lost to Follow-up|3|||
33392047|NCT00690378|62770944|FG000|Overall Study|Did not meet inc/exc criteria|13|||
33392048|NCT00690378|62770945|FG001|Overall Study|Did not meet inc/exc criteria|11|||
33392049|NCT00690378|62770944|FG000|Overall Study|Social problem|1|||
33392050|NCT00690378|62770945|FG001|Overall Study|Social problem|0|||
33392051|NCT00574275|62770953|FG000|Overall Study|Randomized but not treated|2|||
33392052|NCT00574275|62770954|FG001|Overall Study|Randomized but not treated|3|||
33392053|NCT00574275|62770953|FG000|Overall Study|Adverse Event|32|||
33392054|NCT00574275|62770954|FG001|Overall Study|Adverse Event|76|||
33392055|NCT00574275|62770953|FG000|Overall Study|Disease progression|160|||
33392056|NCT00574275|62770954|FG001|Overall Study|Disease progression|146|||
33562979|NCT03689244|62957907|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
33562980|NCT03689244|62957904|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
33562981|NCT03689244|62957905|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
33562982|NCT03689244|62957906|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
33562983|NCT03689244|62957907|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
33392057|NCT00574275|62770953|FG000|Overall Study|Lost to Follow-up|2|||
33392058|NCT00574275|62770954|FG001|Overall Study|Lost to Follow-up|1|||
33392059|NCT00574275|62770953|FG000|Overall Study|Study stopped based on DMC decision|62|||
33392060|NCT00574275|62770954|FG001|Overall Study|Study stopped based on DMC decision|23|||
33392061|NCT00574275|62770953|FG000|Overall Study|Withdrawal by Subject|15|||
33392062|NCT00574275|62770954|FG001|Overall Study|Withdrawal by Subject|17|||
33562984|NCT03649074|62957917|FG000|Overall Study|Lost to Follow-up|2|||
33562985|NCT03649074|62957918|FG001|Overall Study|Lost to Follow-up|1|||
33562986|NCT03649074|62957917|FG000|Overall Study|Adverse Event|1|||
33562987|NCT03649074|62957918|FG001|Overall Study|Adverse Event|0|||
33562988|NCT03649074|62957917|FG000|Overall Study|Physician Decision|1|||
33562989|NCT03649074|62957918|FG001|Overall Study|Physician Decision|0|||
33562990|NCT03649074|62957917|FG000|Overall Study|Withdrawal by Subject|0|||
33562991|NCT03649074|62957918|FG001|Overall Study|Withdrawal by Subject|2|||
33562992|NCT03649074|62957917|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
33562993|NCT03649074|62957918|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
33562994|NCT03649074|62957917|FG000|Overall Study|Other|1|||
33562995|NCT03649074|62957918|FG001|Overall Study|Other|0|||
33562996|NCT02133573|62957935|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
33562997|NCT02133573|62957936|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
33562998|NCT02133573|62957935|FG000|Overall Study|Child Deaths|3|||
33562999|NCT02133573|62957936|FG001|Overall Study|Child Deaths|5|||
33563000|NCT02133573|62957935|FG000|Overall Study|Child Declined Follow Ups|2|||
33563001|NCT02133573|62957936|FG001|Overall Study|Child Declined Follow Ups|1|||
33563002|NCT02133573|62957935|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
33563003|NCT02133573|62957936|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
33563004|NCT00686595|62957971|FG000|Overall Study|Adverse Event|3|||
33563005|NCT00686595|62957971|FG000|Overall Study|Protocol Violation|1|||
33563006|NCT00686595|62957971|FG000|Overall Study|Lost to Follow-up|1|||
33563007|NCT00686595|62957971|FG000|Overall Study|Lack of Efficacy|1|||
33563008|NCT00686595|62957971|FG000|Overall Study|Poor Compliance|1|||
33563009|NCT00640159|62957975|FG000|Overall Study|Lost to Follow-up|2|||
33563010|NCT02262754|62957985|FG000|Overall Study|Adverse Event|3|||
33563011|NCT02262754|62957986|FG001|Overall Study|Adverse Event|4|||
33563012|NCT02262754|62957987|FG002|Overall Study|Adverse Event|0|||
33563013|NCT02262754|62957985|FG000|Overall Study|Lack of Efficacy|2|||
33563014|NCT02262754|62957986|FG001|Overall Study|Lack of Efficacy|0|||
33563015|NCT02262754|62957987|FG002|Overall Study|Lack of Efficacy|1|||
33563016|NCT02262754|62957985|FG000|Overall Study|Lost to Follow-up|0|||
33563017|NCT02262754|62957986|FG001|Overall Study|Lost to Follow-up|0|||
33563018|NCT02262754|62957987|FG002|Overall Study|Lost to Follow-up|1|||
33563019|NCT02262754|62957985|FG000|Overall Study|No longer meets eligibility criteria|0|||
33563020|NCT02262754|62957986|FG001|Overall Study|No longer meets eligibility criteria|1|||
33563021|NCT02262754|62957987|FG002|Overall Study|No longer meets eligibility criteria|0|||
33563022|NCT02262754|62957985|FG000|Overall Study|Study terminated by sponsor|5|||
33563023|NCT02262754|62957986|FG001|Overall Study|Study terminated by sponsor|4|||
33563024|NCT02262754|62957987|FG002|Overall Study|Study terminated by sponsor|4|||
33563025|NCT02262754|62957985|FG000|Overall Study|Protocol Violation|1|||
33563026|NCT02262754|62957986|FG001|Overall Study|Protocol Violation|0|||
33563027|NCT02262754|62957987|FG002|Overall Study|Protocol Violation|0|||
33563028|NCT02262754|62957985|FG000|Overall Study|Withdrawal by Subject|1|||
33563029|NCT02262754|62957986|FG001|Overall Study|Withdrawal by Subject|0|||
33563030|NCT02262754|62957987|FG002|Overall Study|Withdrawal by Subject|1|||
33563031|NCT02262754|62957985|FG000|Overall Study|Other|4|||
33563032|NCT02262754|62957986|FG001|Overall Study|Other|0|||
33563033|NCT02262754|62957987|FG002|Overall Study|Other|2|||
33563034|NCT02262364|62957997|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
33563035|NCT02261974|62958003|FG000|Overall Study|Withdrawal by Subject|3|||
33563036|NCT02261974|62958004|FG001|Overall Study|Withdrawal by Subject|2|||
33662881|NCT01568047|63093540|FG001|Overall Study|Withdrawal by Subject|1|||
33662882|NCT01568047|63093541|FG002|Overall Study|Withdrawal by Subject|0|||
33662883|NCT01568047|63093542|FG003|Overall Study|Withdrawal by Subject|0|||
33662884|NCT01568047|63093539|FG000|Overall Study|Adverse Event|0|||
33662885|NCT01568047|63093540|FG001|Overall Study|Adverse Event|0|||
33662886|NCT01568047|63093541|FG002|Overall Study|Adverse Event|1|||
33662887|NCT01568047|63093542|FG003|Overall Study|Adverse Event|1|||
33662888|NCT01688999|63093555|FG000|Overall Study|Withdrawal by Subject|5|||
33662889|NCT01688999|63093556|FG001|Overall Study|Withdrawal by Subject|1|||
33662890|NCT01688999|63093557|FG002|Overall Study|Withdrawal by Subject|1|||
33662891|NCT01688999|63093555|FG000|Overall Study|Adverse Event|2|||
33662892|NCT01688999|63093556|FG001|Overall Study|Adverse Event|0|||
33662893|NCT01688999|63093557|FG002|Overall Study|Adverse Event|2|||
33662894|NCT01688999|63093555|FG000|Overall Study|Ineligible/Not treated|1|||
33662895|NCT01688999|63093556|FG001|Overall Study|Ineligible/Not treated|0|||
33662896|NCT01688999|63093557|FG002|Overall Study|Ineligible/Not treated|0|||
33300643|NCT01014013|62676835|FG001|Overall Study|Laboratory adverse experience|1|||
33300644|NCT01014013|62676834|FG000|Overall Study|Protocol Violation|1|||
33300645|NCT01014013|62676835|FG001|Overall Study|Protocol Violation|3|||
33300646|NCT01014013|62676834|FG000|Overall Study|Withdrawal by Subject|7|||
33300647|NCT01014013|62676835|FG001|Overall Study|Withdrawal by Subject|4|||
33563037|NCT02261974|62958003|FG000|Overall Study|Pregnancy|0|||
33563038|NCT02261974|62958004|FG001|Overall Study|Pregnancy|1|||
33563039|NCT02261974|62958003|FG000|Overall Study|Missed treatment cut-off date|6|||
33563040|NCT02261974|62958004|FG001|Overall Study|Missed treatment cut-off date|3|||
33563041|NCT02261974|62958003|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
33563042|NCT02261974|62958004|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
33563043|NCT02261974|62958003|FG000|Overall Study|Lost to Follow-up|2|||
33563044|NCT02261974|62958004|FG001|Overall Study|Lost to Follow-up|0|||
33563045|NCT02261974|62958003|FG000|Overall Study|Adverse Event|1|||
33563046|NCT02261974|62958004|FG001|Overall Study|Adverse Event|0|||
33563047|NCT02356588|62958012|FG000|Overall Study|Lack of Efficacy|4|||
33563048|NCT02356588|62958013|FG001|Overall Study|Lack of Efficacy|10|||
33563049|NCT02356588|62958012|FG000|Overall Study|Adverse Event|0|||
33662897|NCT01541917|63093581|FG000|Overall Study|Lost to Follow-up|2|||
33662898|NCT01541917|63093582|FG001|Overall Study|Lost to Follow-up|2|||
33563050|NCT02356588|62958013|FG001|Overall Study|Adverse Event|2|||
33563051|NCT02356588|62958012|FG000|Overall Study|Withdrawal by Subject|1|||
33563052|NCT02356588|62958013|FG001|Overall Study|Withdrawal by Subject|0|||
33563053|NCT02356588|62958012|FG000|Overall Study|Protocol Violation|0|||
33563054|NCT02356588|62958013|FG001|Overall Study|Protocol Violation|1|||
33563055|NCT02355028|62958021|FG000|Overall Study|Adverse Event|2|||
33563056|NCT02355028|62958022|FG001|Overall Study|Adverse Event|0|||
33563057|NCT02355028|62958021|FG000|Overall Study|Withdrawal by Subject|1|||
33563058|NCT02355028|62958022|FG001|Overall Study|Withdrawal by Subject|1|||
33563059|NCT02355028|62958021|FG000|Overall Study|Deemed ineligible after randomization|8|||
33563060|NCT02355028|62958022|FG001|Overall Study|Deemed ineligible after randomization|4|||
33563061|NCT01643668|62958037|FG000|Overall Study|Death|1|||
33563062|NCT02260882|62958043|FG000|Overall Study|Protocol Violation|0|||
33563063|NCT02260882|62958044|FG001|Overall Study|Protocol Violation|1|||
33563064|NCT02260804|62958053|FG000|Induction Study Period|Protocol Violation|2|||
33563065|NCT02260804|62958054|FG001|Induction Study Period|Protocol Violation|0|||
33563066|NCT02260804|62958053|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
33563067|NCT02260804|62958054|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
33563068|NCT02260804|62958053|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
33563069|NCT02260804|62958054|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
33563070|NCT02260804|62958053|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
33563071|NCT02260804|62958054|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
33563072|NCT02260804|62958053|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
33563073|NCT02260804|62958054|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
33563074|NCT02260804|62958053|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
33563075|NCT02260804|62958054|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
33563076|NCT02260804|62958053|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
33563077|NCT02260804|62958054|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
33563078|NCT02260804|62958053|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
33563079|NCT02260804|62958054|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
33563080|NCT02260804|62958053|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
33563081|NCT02260804|62958054|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
33563082|NCT02260804|62958053|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
33563083|NCT02260804|62958054|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
33563084|NCT02260804|62958053|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
33563085|NCT02260804|62958054|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
33563086|NCT02260648|62958063|FG000|Overall Study|Adverse Event|3|||
33563087|NCT02260648|62958064|FG001|Overall Study|Adverse Event|0|||
33563088|NCT02260648|62958065|FG002|Overall Study|Adverse Event|1|||
33563089|NCT02260648|62958063|FG000|Overall Study|Withdrawal by Subject|1|||
33563090|NCT02260648|62958064|FG001|Overall Study|Withdrawal by Subject|1|||
33563091|NCT02260648|62958065|FG002|Overall Study|Withdrawal by Subject|0|||
33563092|NCT02260648|62958063|FG000|Overall Study|Protocol Violation|1|||
33563093|NCT02260648|62958064|FG001|Overall Study|Protocol Violation|0|||
33563094|NCT02260648|62958065|FG002|Overall Study|Protocol Violation|0|||
33563095|NCT02260648|62958063|FG000|Overall Study|Discontinue Due to Study Termination|13|||
33563096|NCT02260648|62958064|FG001|Overall Study|Discontinue Due to Study Termination|12|||
33563097|NCT02260648|62958065|FG002|Overall Study|Discontinue Due to Study Termination|7|||
33563098|NCT02260492|62958076|FG000|Overall Study|Adverse Event|6|||
33563099|NCT02260492|62958077|FG001|Overall Study|Adverse Event|1|||
33563100|NCT02260492|62958078|FG002|Overall Study|Adverse Event|2|||
33563101|NCT02260492|62958076|FG000|Overall Study|Death|0|||
33563102|NCT02260492|62958077|FG001|Overall Study|Death|1|||
33563103|NCT02260492|62958078|FG002|Overall Study|Death|0|||
33563104|NCT02260492|62958076|FG000|Overall Study|Lost to Follow-up|12|||
33563105|NCT02260492|62958077|FG001|Overall Study|Lost to Follow-up|9|||
33563106|NCT02260492|62958078|FG002|Overall Study|Lost to Follow-up|0|||
33563107|NCT02260492|62958076|FG000|Overall Study|Physician Decision|2|||
33563108|NCT02260492|62958077|FG001|Overall Study|Physician Decision|0|||
33563109|NCT02260492|62958078|FG002|Overall Study|Physician Decision|1|||
33563110|NCT02260492|62958076|FG000|Overall Study|Withdrawal by Subject|3|||
33563111|NCT02260492|62958077|FG001|Overall Study|Withdrawal by Subject|2|||
33563112|NCT02260492|62958078|FG002|Overall Study|Withdrawal by Subject|2|||
33662899|NCT01541917|63093581|FG000|Overall Study|Withdrawal by Subject|13|||
33662900|NCT01541917|63093582|FG001|Overall Study|Withdrawal by Subject|7|||
33563113|NCT02260258|62958088|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
33662901|NCT01688921|63093602|FG000|Overall Study|Lost to Follow-up|7|||
33563114|NCT02260258|62958089|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
33563115|NCT02260180|62958099|FG000|Overall Study|Adverse Event|2|||
33563116|NCT02260180|62958100|FG001|Overall Study|Adverse Event|0|||
33563117|NCT02260180|62958101|FG002|Overall Study|Adverse Event|1|||
33563118|NCT02353468|62958109|FG000|Overall Study|Study terminated|3|||
33563119|NCT02349412|62958115|FG000|Overall Study|Withdrawal by Subject|7|||
33563120|NCT02349412|62958116|FG001|Overall Study|Withdrawal by Subject|7|||
33563121|NCT02259400|62958124|FG000|Overall Study|Death|0|||
33563122|NCT02259400|62958125|FG001|Overall Study|Death|2|||
33563123|NCT01530997|62958131|FG000|Overall Study|Physician Decision|1|||
33563124|NCT01530997|62958131|FG000|Overall Study|Withdrawal by Subject|1|||
33563125|NCT02259088|62958144|FG000|Overall Study|Adverse Event|6|||
33563126|NCT02259088|62958145|FG001|Overall Study|Adverse Event|4|||
33563127|NCT02259088|62958144|FG000|Overall Study|Lost to Follow-up|2|||
33563128|NCT02259088|62958145|FG001|Overall Study|Lost to Follow-up|0|||
33563129|NCT02259088|62958144|FG000|Overall Study|Death|2|||
33563130|NCT02259088|62958145|FG001|Overall Study|Death|0|||
33563131|NCT02259088|62958144|FG000|Overall Study|Physician Decision|5|||
33563132|NCT02259088|62958145|FG001|Overall Study|Physician Decision|2|||
33563133|NCT02259088|62958144|FG000|Overall Study|Protocol deviation|5|||
33563134|NCT02259088|62958145|FG001|Overall Study|Protocol deviation|0|||
33563135|NCT02259088|62958144|FG000|Overall Study|Subject/guardian decision|8|||
33563136|NCT02259088|62958145|FG001|Overall Study|Subject/guardian decision|8|||
33563137|NCT02880241|62958157|FG000|Overall Study|Lack of Efficacy|1|||
33563138|NCT02880241|62958158|FG001|Overall Study|Lack of Efficacy|0|||
33563139|NCT02880241|62958159|FG002|Overall Study|Lack of Efficacy|0|||
33563140|NCT02880241|62958160|FG003|Overall Study|Lack of Efficacy|0|||
33563141|NCT02880241|62958161|FG004|Overall Study|Lack of Efficacy|0|||
33563142|NCT02880241|62958162|FG005|Overall Study|Lack of Efficacy|0|||
33563143|NCT02259010|62958178|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
33563144|NCT02021773|62958187|FG000|Overall Study|Adverse Event|1|||
33563145|NCT02021773|62958188|FG001|Overall Study|Adverse Event|4|||
33563146|NCT02021773|62958189|FG002|Overall Study|Adverse Event|3|||
33563147|NCT02021773|62958187|FG000|Overall Study|Lack of Efficacy|2|||
33563148|NCT02021773|62958188|FG001|Overall Study|Lack of Efficacy|2|||
33563149|NCT02021773|62958189|FG002|Overall Study|Lack of Efficacy|2|||
33563150|NCT02021773|62958187|FG000|Overall Study|Protocol Violation|2|||
33563151|NCT02021773|62958188|FG001|Overall Study|Protocol Violation|3|||
33563152|NCT02021773|62958189|FG002|Overall Study|Protocol Violation|1|||
33563153|NCT02021773|62958187|FG000|Overall Study|Withdrawal by Subject|3|||
33300648|NCT01014013|62676834|FG000|Overall Study|Clinical/microbiologic failure|1|||
33300649|NCT01014013|62676835|FG001|Overall Study|Clinical/microbiologic failure|2|||
33300650|NCT01014013|62676834|FG000|Overall Study|Pathogen culture = no growth|26|||
33300651|NCT01014013|62676835|FG001|Overall Study|Pathogen culture = no growth|34|||
33300652|NCT01014013|62676834|FG000|Overall Study|Negative urine culture|2|||
33300653|NCT01014013|62676835|FG001|Overall Study|Negative urine culture|0|||
33300654|NCT01014013|62676834|FG000|Overall Study|Pathogen resistant|7|||
33300655|NCT01014013|62676835|FG001|Overall Study|Pathogen resistant|4|||
33300656|NCT01014013|62676834|FG000|Overall Study|Physician Decision|0|||
33300657|NCT01014013|62676835|FG001|Overall Study|Physician Decision|1|||
33300658|NCT01014013|62676834|FG000|Overall Study|Another antibiotic therapy required|0|||
33300659|NCT01014013|62676835|FG001|Overall Study|Another antibiotic therapy required|1|||
33300660|NCT01014013|62676834|FG000|Overall Study|Appendectomy|1|||
33300661|NCT01014013|62676835|FG001|Overall Study|Appendectomy|0|||
33300662|NCT01014013|62676834|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
33300663|NCT01014013|62676835|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
33300664|NCT01013701|62676843|FG000|Overall Study|study prematurely terminated|7|||
33300665|NCT01020019|62676850|FG000|Overall Study|Lost to Follow-up|21|||
33300666|NCT01020019|62676851|FG001|Overall Study|Lost to Follow-up|18|||
33300667|NCT01020019|62676850|FG000|Overall Study|Adverse Event|1|||
33300668|NCT01020019|62676851|FG001|Overall Study|Adverse Event|5|||
33300669|NCT01020019|62676850|FG000|Overall Study|not interested in treatment|4|||
33300670|NCT01020019|62676851|FG001|Overall Study|not interested in treatment|4|||
33300671|NCT01020019|62676850|FG000|Overall Study|moving|0|||
33300672|NCT01020019|62676851|FG001|Overall Study|moving|2|||
33300673|NCT01024465|62676857|FG000|Overall Study|Adverse Event|2|||
33300674|NCT01024465|62676857|FG000|Overall Study|Physician Decision|1|||
33300675|NCT01024387|62676861|FG000|Overall Study|Radiographic Progression|29|||
33300676|NCT01024387|62676861|FG000|Overall Study|Symptomatic Progression|10|||
33300677|NCT01024387|62676861|FG000|Overall Study|Physician Decision|5|||
33563154|NCT02021773|62958188|FG001|Overall Study|Withdrawal by Subject|4|||
33563155|NCT02021773|62958189|FG002|Overall Study|Withdrawal by Subject|5|||
33300678|NCT01024387|62676861|FG000|Overall Study|Withdrawal by Subject|5|||
33392063|NCT00574275|62770953|FG000|Overall Study|Error calculating tumor measurement|1|||
33563156|NCT02021773|62958187|FG000|Overall Study|Lost to Follow-up|1|||
33300679|NCT01024387|62676861|FG000|Overall Study|Death|2|||
33300680|NCT01024387|62676861|FG000|Overall Study|Prolonged Treatment Delay|1|||
33300681|NCT01024387|62676861|FG000|Overall Study|Adverse Event|3|||
33300682|NCT01024387|62676861|FG000|Overall Study|Other|5|||
33300683|NCT01019317|62676865|FG000|Overall Study|Not Eligible|4|||
33300684|NCT01024309|62676871|FG000|Overall Study|Physician Decision|4|||
33392064|NCT00574275|62770954|FG001|Overall Study|Error calculating tumor measurement|0|||
33563157|NCT02021773|62958188|FG001|Overall Study|Lost to Follow-up|3|||
33563158|NCT02021773|62958189|FG002|Overall Study|Lost to Follow-up|0|||
33563159|NCT02021773|62958187|FG000|Overall Study|Reason not specified|3|||
33563160|NCT02021773|62958188|FG001|Overall Study|Reason not specified|0|||
33563161|NCT02021773|62958189|FG002|Overall Study|Reason not specified|0|||
33563162|NCT00151775|62958202|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
33563163|NCT00151775|62958203|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
33563164|NCT00151775|62958204|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33563165|NCT00151775|62958205|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33563166|NCT00151775|62958206|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33563167|NCT00151775|62958207|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33563168|NCT00151775|62958208|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33563169|NCT00151775|62958209|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33563170|NCT00151775|62958210|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33563171|NCT00151775|62958211|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33563172|NCT00151775|62958212|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33392065|NCT00574275|62770953|FG000|Overall Study|Physician Decision|1|||
33392066|NCT00574275|62770954|FG001|Overall Study|Physician Decision|1|||
33563173|NCT00151775|62958213|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33563174|NCT00151775|62958202|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
33563175|NCT00151775|62958203|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33563176|NCT00151775|62958204|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33563177|NCT00151775|62958205|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33563178|NCT00151775|62958206|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33563179|NCT00151775|62958207|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33563180|NCT00151775|62958208|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
33563181|NCT00151775|62958209|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33563182|NCT00151775|62958210|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33563183|NCT00151775|62958211|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33563184|NCT00151775|62958212|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
33563185|NCT00151775|62958213|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33563186|NCT00151775|62958202|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33563187|NCT00151775|62958203|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
33563188|NCT00151775|62958204|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33563189|NCT00151775|62958205|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33563190|NCT00151775|62958206|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33563191|NCT00151775|62958207|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33563192|NCT00151775|62958208|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33563193|NCT00151775|62958209|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33563194|NCT00151775|62958210|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33563195|NCT00151775|62958211|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33563196|NCT00151775|62958212|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33563197|NCT00151775|62958213|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33563198|NCT00151775|62958202|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
33563199|NCT00151775|62958203|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
33563200|NCT00151775|62958204|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
33563201|NCT00151775|62958205|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
33563202|NCT00151775|62958206|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
33563203|NCT00151775|62958207|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
33563204|NCT00151775|62958208|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
33563205|NCT00151775|62958209|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
33392067|NCT00574275|62770953|FG000|Overall Study|Protocol Violation|0|||
33392068|NCT00574275|62770954|FG001|Overall Study|Protocol Violation|1|||
33392069|NCT00574275|62770953|FG000|Overall Study|Patient and Investigator decision|0|||
33392070|NCT00574275|62770954|FG001|Overall Study|Patient and Investigator decision|1|||
33392071|NCT00574275|62770953|FG000|Overall Study|Insurance change|0|||
33392072|NCT00574275|62770954|FG001|Overall Study|Insurance change|1|||
33392073|NCT00574275|62770953|FG000|Overall Study|Operation for curative intent|0|||
33392074|NCT00574275|62770954|FG001|Overall Study|Operation for curative intent|1|||
33392075|NCT00567112|62770960|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
33392076|NCT00567112|62770961|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
33392077|NCT00567112|62770962|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
33392078|NCT00567112|62770960|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
33392079|NCT00567112|62770961|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
33563206|NCT00151775|62958210|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
33563207|NCT00151775|62958211|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
33563208|NCT00151775|62958212|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
33392080|NCT00567112|62770962|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
33392081|NCT00567112|62770960|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
33563209|NCT00151775|62958213|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
33563210|NCT00151775|62958202|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33563211|NCT00151775|62958203|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33563212|NCT00151775|62958204|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33563213|NCT00151775|62958205|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33563214|NCT00151775|62958206|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33563215|NCT00151775|62958207|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
33563216|NCT00151775|62958208|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33563217|NCT00151775|62958209|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33563218|NCT00151775|62958210|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33563219|NCT00151775|62958211|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33563220|NCT00151775|62958212|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33563221|NCT00151775|62958213|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33563222|NCT00151775|62958202|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33563223|NCT00151775|62958203|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33563224|NCT00151775|62958204|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33563225|NCT00151775|62958205|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33563226|NCT00151775|62958206|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33563227|NCT00151775|62958207|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
33563228|NCT00151775|62958208|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33563229|NCT00151775|62958209|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33563230|NCT00151775|62958210|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33563231|NCT00151775|62958211|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33563232|NCT00151775|62958212|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33563233|NCT00151775|62958213|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33563234|NCT00151775|62958202|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33563235|NCT00151775|62958203|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33563236|NCT00151775|62958204|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33563237|NCT00151775|62958205|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33563238|NCT00151775|62958206|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33563239|NCT00151775|62958207|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33563240|NCT00151775|62958208|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
33563241|NCT00151775|62958209|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33563242|NCT00151775|62958210|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33563243|NCT00151775|62958211|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33563244|NCT00151775|62958212|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33563245|NCT00151775|62958213|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33563246|NCT00151775|62958202|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33563247|NCT00151775|62958203|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33563248|NCT00151775|62958204|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33563249|NCT00151775|62958205|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33563250|NCT00151775|62958206|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33563251|NCT00151775|62958207|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
33563252|NCT00151775|62958208|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33563253|NCT00151775|62958209|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33563254|NCT00151775|62958210|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33563255|NCT00151775|62958211|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33563256|NCT00151775|62958212|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33563257|NCT00151775|62958213|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33563258|NCT00151775|62958202|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
33662902|NCT01688921|63093603|FG001|Overall Study|Lost to Follow-up|13|||
33563259|NCT00151775|62958203|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
33563260|NCT00151775|62958204|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
33563261|NCT00151775|62958205|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
33563262|NCT00151775|62958206|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
33563263|NCT00151775|62958207|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
33563264|NCT00151775|62958208|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
33563265|NCT00151775|62958209|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
33563266|NCT00151775|62958210|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
33563267|NCT00151775|62958211|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
33563268|NCT00151775|62958212|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
33563269|NCT00151775|62958213|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
33662903|NCT01688921|63093602|FG000|Overall Study|Physician Decision|6|||
33662904|NCT01688921|63093603|FG001|Overall Study|Physician Decision|1|||
33392082|NCT00567112|62770961|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
33392083|NCT00567112|62770962|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
33563270|NCT00151775|62958202|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33563271|NCT00151775|62958203|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33563272|NCT00151775|62958204|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33563273|NCT00151775|62958205|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33563274|NCT00151775|62958206|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33563275|NCT00151775|62958207|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33563276|NCT00151775|62958208|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
33563277|NCT00151775|62958209|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33563278|NCT00151775|62958210|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33563279|NCT00151775|62958211|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33563280|NCT00151775|62958212|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33662905|NCT01688921|63093602|FG000|Overall Study|Protocol Violation|0|||
33662906|NCT01688921|63093603|FG001|Overall Study|Protocol Violation|1|||
33662907|NCT01688921|63093602|FG000|Overall Study|informed consent|3|||
33662908|NCT01688921|63093603|FG001|Overall Study|informed consent|0|||
33662909|NCT01541371|63093625|FG000|Overall Study|Withdrawal by Subject|14|||
33662910|NCT01541371|63093625|FG000|Overall Study|Lost to Follow-up|21|||
33662911|NCT01541371|63093625|FG000|Overall Study|Adverse Event|15|||
33662912|NCT01541371|63093625|FG000|Overall Study|Lack of Efficacy|12|||
33662913|NCT01541371|63093625|FG000|Overall Study|Protocol Violation|6|||
33662914|NCT01541371|63093625|FG000|Overall Study|Study medication non-compliance|3|||
33662915|NCT01541371|63093625|FG000|Overall Study|Other|6|||
33662916|NCT01687673|63093658|FG000|Overall Study|Physician Decision|1|||
33662917|NCT01687595|63093738|FG000|Overall Study|Withdrawal by Subject|8|||
33662918|NCT01687595|63093739|FG001|Overall Study|Withdrawal by Subject|0|||
33662919|NCT01687595|63093738|FG000|Overall Study|Lost to Follow-up|3|||
33662920|NCT01687595|63093739|FG001|Overall Study|Lost to Follow-up|1|||
33662921|NCT01687595|63093738|FG000|Overall Study|Investigator's decision|1|||
33662922|NCT01687595|63093739|FG001|Overall Study|Investigator's decision|0|||
33662923|NCT01687595|63093738|FG000|Overall Study|Sponsor's decision|1|||
33662924|NCT01687595|63093739|FG001|Overall Study|Sponsor's decision|0|||
33662925|NCT01687595|63093738|FG000|Overall Study|Noncompliance|1|||
33662926|NCT01687595|63093739|FG001|Overall Study|Noncompliance|2|||
33662927|NCT01687595|63093738|FG000|Overall Study|Other than specified|56|||
33662928|NCT01687595|63093739|FG001|Overall Study|Other than specified|7|||
33662929|NCT01687283|63093747|FG000|Overall Study|Adverse Event|11|||
33662930|NCT01687283|63093748|FG001|Overall Study|Adverse Event|4|||
33662931|NCT01687283|63093747|FG000|Overall Study|Lack of Efficacy|3|||
33662932|NCT01687283|63093748|FG001|Overall Study|Lack of Efficacy|1|||
33662933|NCT01687283|63093747|FG000|Overall Study|Protocol Violation|1|||
33662934|NCT01687283|63093748|FG001|Overall Study|Protocol Violation|3|||
33662935|NCT01687283|63093747|FG000|Overall Study|protocol defined stopping criteria|8|||
33662936|NCT01687283|63093748|FG001|Overall Study|protocol defined stopping criteria|10|||
33662937|NCT01687283|63093747|FG000|Overall Study|Lost to Follow-up|1|||
33662938|NCT01687283|63093748|FG001|Overall Study|Lost to Follow-up|1|||
33662939|NCT01687283|63093747|FG000|Overall Study|Investigator discretion|2|||
33662940|NCT01687283|63093748|FG001|Overall Study|Investigator discretion|0|||
33662941|NCT01687283|63093747|FG000|Overall Study|Withdrawal by Subject|9|||
33662942|NCT01687283|63093748|FG001|Overall Study|Withdrawal by Subject|8|||
33662943|NCT02684370|63093757|FG000|Part A|Adverse Event|2|||
33662944|NCT02684370|63093758|FG001|Part A|Adverse Event|0|||
33662945|NCT02684370|63093759|FG002|Part A|Adverse Event|1|||
33662946|NCT02684370|63093760|FG003|Part A|Adverse Event|0|||
33662947|NCT02684370|63093761|FG004|Part A|Adverse Event|0|||
33662948|NCT02684370|63093762|FG005|Part A|Adverse Event|0|||
33662949|NCT02684370|63093757|FG000|Part A|Lost to Follow-up|1|||
33662950|NCT02684370|63093758|FG001|Part A|Lost to Follow-up|1|||
33662951|NCT02684370|63093759|FG002|Part A|Lost to Follow-up|0|||
33662952|NCT02684370|63093760|FG003|Part A|Lost to Follow-up|0|||
33662953|NCT02684370|63093761|FG004|Part A|Lost to Follow-up|0|||
33662954|NCT02684370|63093762|FG005|Part A|Lost to Follow-up|0|||
33662955|NCT02684370|63093757|FG000|Part A|Subject Withdrawal|1|||
33662956|NCT02684370|63093758|FG001|Part A|Subject Withdrawal|0|||
33563281|NCT00151775|62958213|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33662957|NCT02684370|63093759|FG002|Part A|Subject Withdrawal|3|||
33662958|NCT02684370|63093760|FG003|Part A|Subject Withdrawal|0|||
33662959|NCT02684370|63093761|FG004|Part A|Subject Withdrawal|0|||
33662960|NCT02684370|63093762|FG005|Part A|Subject Withdrawal|0|||
33662961|NCT02684370|63093757|FG000|Part A|Other|0|||
33662962|NCT02684370|63093758|FG001|Part A|Other|0|||
33662963|NCT02684370|63093759|FG002|Part A|Other|1|||
33662964|NCT02684370|63093760|FG003|Part A|Other|0|||
33662965|NCT02684370|63093761|FG004|Part A|Other|0|||
33662966|NCT02684370|63093762|FG005|Part A|Other|0|||
33662967|NCT02684370|63093757|FG000|Part B|Adverse Event|0|||
33662968|NCT02684370|63093758|FG001|Part B|Adverse Event|0|||
33662969|NCT02684370|63093759|FG002|Part B|Adverse Event|0|||
33662970|NCT02684370|63093760|FG003|Part B|Adverse Event|0|||
33662971|NCT02684370|63093761|FG004|Part B|Adverse Event|2|||
33563282|NCT00151775|62958202|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33563283|NCT00151775|62958203|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33563284|NCT00151775|62958204|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
33563285|NCT00151775|62958205|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33563286|NCT00151775|62958206|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33563287|NCT00151775|62958207|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33563288|NCT00151775|62958208|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33563289|NCT00151775|62958209|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33563290|NCT00151775|62958210|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33563291|NCT00151775|62958211|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33563292|NCT00151775|62958212|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33563293|NCT00151775|62958213|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33563294|NCT00151775|62958202|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33563295|NCT00151775|62958203|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33563296|NCT00151775|62958204|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
33563297|NCT00151775|62958205|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33563298|NCT00151775|62958206|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33563299|NCT00151775|62958207|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33563300|NCT00151775|62958208|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33563301|NCT00151775|62958209|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33563302|NCT00151775|62958210|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33563303|NCT00151775|62958211|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33563304|NCT00151775|62958212|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33563305|NCT00151775|62958213|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33563306|NCT00151775|62958202|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33563307|NCT00151775|62958203|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33563308|NCT00151775|62958204|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33563309|NCT00151775|62958205|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33563310|NCT00151775|62958206|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33563311|NCT00151775|62958207|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33563312|NCT00151775|62958208|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33563313|NCT00151775|62958209|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33563314|NCT00151775|62958210|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33563315|NCT00151775|62958211|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33563316|NCT00151775|62958212|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33563317|NCT00151775|62958213|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
33563318|NCT00151775|62958202|FG000|Period 4: Open Label|Increased blood pressure|0|||
33563319|NCT00151775|62958203|FG001|Period 4: Open Label|Increased blood pressure|0|||
33563320|NCT00151775|62958204|FG002|Period 4: Open Label|Increased blood pressure|0|||
33563321|NCT00151775|62958205|FG003|Period 4: Open Label|Increased blood pressure|0|||
33563322|NCT00151775|62958206|FG004|Period 4: Open Label|Increased blood pressure|1|||
33563323|NCT00151775|62958207|FG005|Period 4: Open Label|Increased blood pressure|0|||
33563324|NCT00151775|62958208|FG006|Period 4: Open Label|Increased blood pressure|0|||
33563325|NCT00151775|62958209|FG007|Period 4: Open Label|Increased blood pressure|0|||
33563326|NCT00151775|62958210|FG008|Period 4: Open Label|Increased blood pressure|0|||
33563327|NCT00151775|62958211|FG009|Period 4: Open Label|Increased blood pressure|1|||
33563328|NCT00151775|62958212|FG010|Period 4: Open Label|Increased blood pressure|0|||
33563329|NCT00151775|62958213|FG011|Period 4: Open Label|Increased blood pressure|0|||
33563330|NCT00151775|62958202|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
33563331|NCT00151775|62958203|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
33563332|NCT00151775|62958204|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
33563333|NCT00151775|62958205|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
33662972|NCT02684370|63093762|FG005|Part B|Adverse Event|1|||
33662973|NCT02684370|63093757|FG000|Part B|Lost to Follow-up|0|||
33662974|NCT02684370|63093758|FG001|Part B|Lost to Follow-up|0|||
33662975|NCT02684370|63093759|FG002|Part B|Lost to Follow-up|0|||
33662976|NCT02684370|63093760|FG003|Part B|Lost to Follow-up|1|||
33662977|NCT02684370|63093761|FG004|Part B|Lost to Follow-up|2|||
33662978|NCT02684370|63093762|FG005|Part B|Lost to Follow-up|5|||
33662979|NCT02684370|63093757|FG000|Part B|Subject Withdrawal|0|||
33662980|NCT02684370|63093758|FG001|Part B|Subject Withdrawal|0|||
33563334|NCT00151775|62958206|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
33563335|NCT00151775|62958207|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
33563336|NCT00151775|62958208|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
33662981|NCT02684370|63093759|FG002|Part B|Subject Withdrawal|0|||
33662982|NCT02684370|63093760|FG003|Part B|Subject Withdrawal|1|||
33563337|NCT00151775|62958209|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
33563338|NCT00151775|62958210|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
33563339|NCT00151775|62958211|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
33563340|NCT00151775|62958212|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
33662983|NCT02684370|63093761|FG004|Part B|Subject Withdrawal|1|||
33563341|NCT00151775|62958213|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
33563342|NCT00151775|62958202|FG000|Period 4: Open Label|Adverse Event|0|||
33563343|NCT00151775|62958203|FG001|Period 4: Open Label|Adverse Event|0|||
33392084|NCT01618656|62770982|FG000|Overall Study|Withdrawal by Subject|7|||
33392085|NCT01618656|62770983|FG001|Overall Study|Withdrawal by Subject|3|||
33392086|NCT01618656|62770982|FG000|Overall Study|Physician Decision|1|||
33392087|NCT01618656|62770983|FG001|Overall Study|Physician Decision|1|||
33392088|NCT03978832|62770989|FG000|Overall Study|Adverse Event|1|||
33392089|NCT03978832|62770989|FG000|Overall Study|Lost to Follow-up|1|||
33392090|NCT03978832|62770989|FG000|Overall Study|Withdrawal by Subject|6|||
33392091|NCT03978832|62770989|FG000|Overall Study|Physician Decision|2|||
33392092|NCT03978832|62770989|FG000|Overall Study|did not pass screening criteria|44|||
33392093|NCT00566722|62770996|FG000|Overall Study|Adverse Event|0|||
33392094|NCT00566722|62770997|FG001|Overall Study|Adverse Event|1|||
33392095|NCT00566722|62770998|FG002|Overall Study|Adverse Event|0|||
33392096|NCT00566722|62770996|FG000|Overall Study|Withdrawal by Subject|0|||
33563344|NCT00151775|62958204|FG002|Period 4: Open Label|Adverse Event|0|||
33563345|NCT00151775|62958205|FG003|Period 4: Open Label|Adverse Event|0|||
33563346|NCT00151775|62958206|FG004|Period 4: Open Label|Adverse Event|1|||
33563347|NCT00151775|62958207|FG005|Period 4: Open Label|Adverse Event|0|||
33563348|NCT00151775|62958208|FG006|Period 4: Open Label|Adverse Event|0|||
33563349|NCT00151775|62958209|FG007|Period 4: Open Label|Adverse Event|0|||
33563350|NCT00151775|62958210|FG008|Period 4: Open Label|Adverse Event|0|||
33563351|NCT00151775|62958211|FG009|Period 4: Open Label|Adverse Event|2|||
33563352|NCT00151775|62958212|FG010|Period 4: Open Label|Adverse Event|0|||
33563353|NCT00151775|62958213|FG011|Period 4: Open Label|Adverse Event|0|||
33563354|NCT00151775|62958202|FG000|Period 4: Open Label|Lost to Follow-up|0|||
33563355|NCT00151775|62958203|FG001|Period 4: Open Label|Lost to Follow-up|0|||
33563356|NCT00151775|62958204|FG002|Period 4: Open Label|Lost to Follow-up|0|||
33563357|NCT00151775|62958205|FG003|Period 4: Open Label|Lost to Follow-up|0|||
33563358|NCT00151775|62958206|FG004|Period 4: Open Label|Lost to Follow-up|17|||
33563359|NCT00151775|62958207|FG005|Period 4: Open Label|Lost to Follow-up|0|||
33563360|NCT00151775|62958208|FG006|Period 4: Open Label|Lost to Follow-up|0|||
33563361|NCT00151775|62958209|FG007|Period 4: Open Label|Lost to Follow-up|0|||
33563362|NCT00151775|62958210|FG008|Period 4: Open Label|Lost to Follow-up|0|||
33563363|NCT00151775|62958211|FG009|Period 4: Open Label|Lost to Follow-up|7|||
33563364|NCT00151775|62958212|FG010|Period 4: Open Label|Lost to Follow-up|0|||
33563365|NCT00151775|62958213|FG011|Period 4: Open Label|Lost to Follow-up|0|||
33563366|NCT00151775|62958202|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
33563367|NCT00151775|62958203|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
33563368|NCT00151775|62958204|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
33563369|NCT00151775|62958205|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
33563370|NCT00151775|62958206|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
33563371|NCT00151775|62958207|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
33563372|NCT00151775|62958208|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
33563373|NCT00151775|62958209|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
33563374|NCT00151775|62958210|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
33563375|NCT00151775|62958211|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
33563376|NCT00151775|62958212|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
33563377|NCT00151775|62958213|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
33563378|NCT00151775|62958202|FG000|Period 4: Open Label|Other|0|||
33563379|NCT00151775|62958203|FG001|Period 4: Open Label|Other|0|||
33563380|NCT00151775|62958204|FG002|Period 4: Open Label|Other|0|||
33563381|NCT00151775|62958205|FG003|Period 4: Open Label|Other|0|||
33563382|NCT00151775|62958206|FG004|Period 4: Open Label|Other|1|||
33563383|NCT00151775|62958207|FG005|Period 4: Open Label|Other|0|||
33563384|NCT00151775|62958208|FG006|Period 4: Open Label|Other|0|||
33563385|NCT00151775|62958209|FG007|Period 4: Open Label|Other|0|||
33563386|NCT00151775|62958210|FG008|Period 4: Open Label|Other|0|||
33392097|NCT00566722|62770997|FG001|Overall Study|Withdrawal by Subject|0|||
33392098|NCT00566722|62770998|FG002|Overall Study|Withdrawal by Subject|1|||
33563387|NCT00151775|62958211|FG009|Period 4: Open Label|Other|3|||
33563388|NCT00151775|62958212|FG010|Period 4: Open Label|Other|0|||
33392099|NCT00566722|62770996|FG000|Overall Study|Lost to Follow-up|1|||
33563389|NCT00151775|62958213|FG011|Period 4: Open Label|Other|0|||
33563390|NCT00151775|62958202|FG000|Period 4: Open Label|Physician Decision|0|||
33563391|NCT00151775|62958203|FG001|Period 4: Open Label|Physician Decision|0|||
33563392|NCT00151775|62958204|FG002|Period 4: Open Label|Physician Decision|0|||
33563393|NCT00151775|62958205|FG003|Period 4: Open Label|Physician Decision|0|||
33563394|NCT00151775|62958206|FG004|Period 4: Open Label|Physician Decision|0|||
33563395|NCT00151775|62958207|FG005|Period 4: Open Label|Physician Decision|0|||
33563396|NCT00151775|62958208|FG006|Period 4: Open Label|Physician Decision|0|||
33392100|NCT00566722|62770997|FG001|Overall Study|Lost to Follow-up|1|||
33392101|NCT00566722|62770998|FG002|Overall Study|Lost to Follow-up|1|||
33563397|NCT00151775|62958209|FG007|Period 4: Open Label|Physician Decision|0|||
33392102|NCT00566722|62770996|FG000|Overall Study|Lack of Efficacy|1|||
33392103|NCT00566722|62770997|FG001|Overall Study|Lack of Efficacy|2|||
33392104|NCT00566722|62770998|FG002|Overall Study|Lack of Efficacy|4|||
33392105|NCT00566722|62770996|FG000|Overall Study|Did not meet exclusion criteria|0|||
33392106|NCT00566722|62770997|FG001|Overall Study|Did not meet exclusion criteria|0|||
33392107|NCT00566722|62770998|FG002|Overall Study|Did not meet exclusion criteria|2|||
33392108|NCT00566722|62770996|FG000|Overall Study|Serious adverse event|0|||
33392109|NCT00566722|62770997|FG001|Overall Study|Serious adverse event|1|||
33392110|NCT00566722|62770998|FG002|Overall Study|Serious adverse event|0|||
33392111|NCT00566722|62770996|FG000|Overall Study|Noncompliant with drug administration|0|||
33392112|NCT00566722|62770997|FG001|Overall Study|Noncompliant with drug administration|0|||
33300685|NCT01024309|62676872|FG001|Overall Study|Physician Decision|0|||
33300686|NCT01024309|62676871|FG000|Overall Study|Withdrawal by Subject|4|||
33300687|NCT01024309|62676872|FG001|Overall Study|Withdrawal by Subject|4|||
33300688|NCT01090492|62676886|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
33300689|NCT01090492|62676887|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
33300690|NCT01090492|62676888|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
33300691|NCT01090492|62676889|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
33300692|NCT01090492|62676890|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
33300693|NCT01090492|62676891|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
33300694|NCT01090492|62676892|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
33300695|NCT01090492|62676893|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
33300696|NCT01090492|62676886|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
33300697|NCT01090492|62676887|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
33300698|NCT01090492|62676888|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
33300699|NCT01090492|62676889|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
33300700|NCT01090492|62676890|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
33300701|NCT01090492|62676891|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
33300702|NCT01090492|62676892|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
33300703|NCT01090492|62676893|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
33300704|NCT01090492|62676886|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33300705|NCT01090492|62676887|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33300706|NCT01090492|62676888|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
33300707|NCT01090492|62676889|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33300708|NCT01090492|62676890|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33300709|NCT01090492|62676891|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33300710|NCT01090492|62676892|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33300711|NCT01090492|62676893|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33300712|NCT01090492|62676886|FG000|First Intervention Period (4 Weeks)|Other|0|||
33300713|NCT01090492|62676887|FG001|First Intervention Period (4 Weeks)|Other|0|||
33300714|NCT01090492|62676888|FG002|First Intervention Period (4 Weeks)|Other|1|||
33300715|NCT01090492|62676889|FG003|First Intervention Period (4 Weeks)|Other|1|||
33300716|NCT01090492|62676890|FG004|First Intervention Period (4 Weeks)|Other|2|||
33300717|NCT01090492|62676891|FG005|First Intervention Period (4 Weeks)|Other|0|||
33300718|NCT01090492|62676892|FG006|First Intervention Period (4 Weeks)|Other|0|||
33300719|NCT01090492|62676893|FG007|First Intervention Period (4 Weeks)|Other|0|||
33300720|NCT01090492|62676886|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
33300721|NCT01090492|62676887|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
33300722|NCT01090492|62676888|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
33300723|NCT01090492|62676889|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
33300724|NCT01090492|62676890|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
33300725|NCT01090492|62676891|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
33300726|NCT01090492|62676892|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
33300727|NCT01090492|62676893|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
33300728|NCT01090492|62676886|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
33300729|NCT01090492|62676887|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
33300730|NCT01090492|62676888|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
33300731|NCT01090492|62676889|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
33300732|NCT01090492|62676890|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
33300733|NCT01090492|62676891|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
33392113|NCT00566722|62770998|FG002|Overall Study|Noncompliant with drug administration|1|||
33392114|NCT00691704|62771009|FG000|Induction Therapy|Disease Progression|1|||
33392115|NCT00691704|62771009|FG000|Induction Therapy|Active Hepatitis|1|||
33392116|NCT00691704|62771009|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
33300734|NCT01090492|62676892|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
33300735|NCT01090492|62676893|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
33300736|NCT01090492|62676886|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
33300737|NCT01090492|62676887|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
33300738|NCT01090492|62676888|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
33563398|NCT00151775|62958210|FG008|Period 4: Open Label|Physician Decision|0|||
33563399|NCT00151775|62958211|FG009|Period 4: Open Label|Physician Decision|2|||
33563400|NCT00151775|62958212|FG010|Period 4: Open Label|Physician Decision|0|||
33563401|NCT00151775|62958213|FG011|Period 4: Open Label|Physician Decision|0|||
33563402|NCT00151775|62958202|FG000|Period 4: Open Label|Protocol Violation|0|||
33563403|NCT00151775|62958203|FG001|Period 4: Open Label|Protocol Violation|0|||
33563404|NCT00151775|62958204|FG002|Period 4: Open Label|Protocol Violation|0|||
33563405|NCT00151775|62958205|FG003|Period 4: Open Label|Protocol Violation|0|||
33563406|NCT00151775|62958206|FG004|Period 4: Open Label|Protocol Violation|1|||
33563407|NCT00151775|62958207|FG005|Period 4: Open Label|Protocol Violation|0|||
33563408|NCT00151775|62958208|FG006|Period 4: Open Label|Protocol Violation|0|||
33563409|NCT00151775|62958209|FG007|Period 4: Open Label|Protocol Violation|0|||
33563410|NCT00151775|62958210|FG008|Period 4: Open Label|Protocol Violation|0|||
33563411|NCT00151775|62958211|FG009|Period 4: Open Label|Protocol Violation|0|||
33563412|NCT00151775|62958212|FG010|Period 4: Open Label|Protocol Violation|0|||
33563413|NCT00151775|62958213|FG011|Period 4: Open Label|Protocol Violation|0|||
33563414|NCT02258464|62958256|FG000|Overall Study|Progressive disease (PD)|9|||
33563415|NCT02258464|62958257|FG001|Overall Study|Progressive disease (PD)|17|||
33563416|NCT02258464|62958256|FG000|Overall Study|Study drug never administered|1|||
33563417|NCT02258464|62958257|FG001|Overall Study|Study drug never administered|1|||
33563418|NCT02258464|62958256|FG000|Overall Study|AE not related to clinical PD|1|||
33563419|NCT02258464|62958257|FG001|Overall Study|AE not related to clinical PD|3|||
33563420|NCT02258464|62958256|FG000|Overall Study|Withdrawal by Subject|5|||
33563421|NCT02258464|62958257|FG001|Overall Study|Withdrawal by Subject|4|||
33563422|NCT02258464|62958256|FG000|Overall Study|AE related to clinical PD|1|||
33563423|NCT02258464|62958257|FG001|Overall Study|AE related to clinical PD|0|||
33563424|NCT02682901|62958265|FG000|Overall Study|Adverse Event|10|||
33563425|NCT02682901|62958266|FG001|Overall Study|Adverse Event|3|||
33563426|NCT02682901|62958265|FG000|Overall Study|Lack of Efficacy|0|||
33563427|NCT02682901|62958266|FG001|Overall Study|Lack of Efficacy|1|||
33563428|NCT02258074|62958276|FG000|Overall Study|Withdrawal by Subject|1|||
33563429|NCT02258074|62958277|FG001|Overall Study|Withdrawal by Subject|0|||
33563430|NCT02258074|62958278|FG002|Overall Study|Withdrawal by Subject|0|||
33563431|NCT02258074|62958279|FG003|Overall Study|Withdrawal by Subject|0|||
33563432|NCT01643044|62958291|FG000|Overall Study|Lost to Follow-up|1|||
33563433|NCT01643044|62958292|FG001|Overall Study|Lost to Follow-up|1|||
33563434|NCT01643044|62958291|FG000|Overall Study|Miscarried baby|2|||
33563435|NCT01643044|62958292|FG001|Overall Study|Miscarried baby|2|||
33563436|NCT01643044|62958291|FG000|Overall Study|Delivered outside of hospital|1|||
33563437|NCT01643044|62958292|FG001|Overall Study|Delivered outside of hospital|2|||
33563438|NCT01642732|62958298|FG000|Overall Study|Withdrawal by Subject|1|||
33563439|NCT02257684|62958302|FG000|Overall Study|Adverse Event|2|||
33563440|NCT02257684|62958302|FG000|Overall Study|Lack of Efficacy|1|||
33563441|NCT02257684|62958302|FG000|Overall Study|Sponsor's Decision|1|||
33563442|NCT02190721|62958309|FG000|Overall Study|Patient was out of the city|0|||
33563443|NCT02190721|62958310|FG001|Overall Study|Patient was out of the city|1|||
33563444|NCT02190721|62958311|FG002|Overall Study|Patient was out of the city|0|||
33563445|NCT00581477|62958319|FG000|Overall Study|Physician Decision|2|||
33563446|NCT02348008|62958335|FG000|Overall Study|Adverse Event|2|||
33563447|NCT02348008|62958336|FG001|Overall Study|Adverse Event|3|||
33563448|NCT02348008|62958337|FG002|Overall Study|Adverse Event|3|||
33563449|NCT02348008|62958335|FG000|Overall Study|Disease Progression|1|||
33563450|NCT02348008|62958336|FG001|Overall Study|Disease Progression|5|||
33563451|NCT02348008|62958337|FG002|Overall Study|Disease Progression|16|||
33563452|NCT02348008|62958335|FG000|Overall Study|Withdrawal by Subject|0|||
33563453|NCT02348008|62958336|FG001|Overall Study|Withdrawal by Subject|1|||
33563454|NCT02348008|62958337|FG002|Overall Study|Withdrawal by Subject|0|||
33563455|NCT02348008|62958335|FG000|Overall Study|Symptomatic Deterioration|0|||
33563456|NCT02348008|62958336|FG001|Overall Study|Symptomatic Deterioration|1|||
33563457|NCT02348008|62958337|FG002|Overall Study|Symptomatic Deterioration|0|||
33563458|NCT04962022|62958343|FG000|Period 1|Withdrawal by Subject|1|||
33563459|NCT04962022|62958344|FG001|Period 1|Withdrawal by Subject|0|||
33563460|NCT04210843|62958396|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
33563461|NCT04210843|62958397|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
33563462|NCT04210843|62958396|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
33563463|NCT04210843|62958397|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
33563464|NCT04210843|62958396|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
33563465|NCT04210843|62958397|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
33563466|NCT04210843|62958396|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
33563467|NCT04210843|62958397|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
33563468|NCT04210843|62958396|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
33563469|NCT04210843|62958397|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
33563470|NCT04210843|62958396|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
33662984|NCT02684370|63093762|FG005|Part B|Subject Withdrawal|2|||
33563471|NCT04210843|62958397|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
33563472|NCT04210843|62958396|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
33563473|NCT04210843|62958397|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
33563474|NCT04210843|62958396|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
33563475|NCT04210843|62958397|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
33563476|NCT04210843|62958396|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
33563477|NCT04210843|62958397|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
33563478|NCT04210843|62958396|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
33563479|NCT04210843|62958397|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
33563480|NCT04210843|62958396|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
33563481|NCT04210843|62958397|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
33563482|NCT04210843|62958396|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
33563483|NCT04210843|62958397|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
33563484|NCT04210843|62958396|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
33563485|NCT04210843|62958397|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
33563486|NCT04210843|62958396|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
33563487|NCT04210843|62958397|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
33563488|NCT04210843|62958396|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
33563489|NCT04210843|62958397|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
33563490|NCT04210843|62958396|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
33563491|NCT04210843|62958397|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
33563492|NCT04210843|62958396|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
33563493|NCT04210843|62958397|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
33563494|NCT04210843|62958396|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
33563495|NCT04210843|62958397|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
33563496|NCT04210843|62958396|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
33563497|NCT04210843|62958397|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
33563498|NCT04210843|62958396|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
33563499|NCT04210843|62958397|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
33563500|NCT04210843|62958396|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
33563501|NCT04210843|62958397|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
33563502|NCT04210843|62958396|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
33563503|NCT04210843|62958397|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
33563504|NCT04210843|62958396|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
33563505|NCT04210843|62958397|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
33563506|NCT04210843|62958396|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
33563507|NCT04210843|62958397|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
33563508|NCT03538041|62958415|FG000|12-Week Treatment Period|Adverse Event|1|||
33563509|NCT03538041|62958416|FG001|12-Week Treatment Period|Adverse Event|1|||
33563510|NCT03538041|62958415|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
33563511|NCT03538041|62958416|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
33563512|NCT03538041|62958415|FG000|Treatment Extension Period|Adverse Event|4|||
33563513|NCT03538041|62958416|FG001|Treatment Extension Period|Adverse Event|0|||
33563514|NCT03538041|62958415|FG000|Treatment Extension Period|Physician Decision|1|||
33563515|NCT03538041|62958416|FG001|Treatment Extension Period|Physician Decision|0|||
33563516|NCT03538041|62958415|FG000|Treatment Extension Period|Lack of Efficacy|1|||
33563517|NCT03538041|62958416|FG001|Treatment Extension Period|Lack of Efficacy|3|||
33563518|NCT03538041|62958415|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
33563519|NCT03538041|62958416|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
33392117|NCT00691704|62771009|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
33392118|NCT00691704|62771009|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
33392119|NCT00566020|62771013|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
33392120|NCT00566020|62771014|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
33563520|NCT03091192|62958431|FG000|Overall Study|Study terminated by sponsor|21|||
33563521|NCT03091192|62958432|FG001|Overall Study|Study terminated by sponsor|14|||
33563522|NCT03091192|62958431|FG000|Overall Study|Death|9|||
33563523|NCT03091192|62958432|FG001|Overall Study|Death|13|||
33563524|NCT03091192|62958431|FG000|Overall Study|Withdrawal by Subject|2|||
33563525|NCT03091192|62958432|FG001|Overall Study|Withdrawal by Subject|0|||
33563526|NCT03091192|62958431|FG000|Overall Study|Lost to Follow-up|1|||
33563527|NCT03091192|62958432|FG001|Overall Study|Lost to Follow-up|0|||
33563528|NCT02838420|62958440|FG000|Overall Study|Ongoing in Study|113|||
33563529|NCT02838420|62958441|FG001|Overall Study|Ongoing in Study|45|||
33563530|NCT02838420|62958440|FG000|Overall Study|Lost to Follow-up|1|||
33563531|NCT02838420|62958441|FG001|Overall Study|Lost to Follow-up|0|||
33662985|NCT01686581|63093789|FG000|Overall Study|Side-effects or Health Problems|15|||
33392121|NCT00566020|62771013|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
33392122|NCT00566020|62771014|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
33563532|NCT02838420|62958440|FG000|Overall Study|Withdrawal by Subject|3|||
33563533|NCT02838420|62958441|FG001|Overall Study|Withdrawal by Subject|4|||
33563534|NCT02838420|62958440|FG000|Overall Study|Death|8|||
33563535|NCT02838420|62958441|FG001|Overall Study|Death|13|||
33563536|NCT02651675|62958450|FG000|Overall Study|Death|0|||
33563537|NCT02651675|62958451|FG001|Overall Study|Death|0|||
33563538|NCT02651675|62958452|FG002|Overall Study|Death|1|||
33563539|NCT02611960|62958462|FG000|Overall Study|Adverse Event|7|||
33563540|NCT02611960|62958463|FG001|Overall Study|Adverse Event|8|||
33563541|NCT02611960|62958462|FG000|Overall Study|Death|98|||
33563542|NCT02611960|62958463|FG001|Overall Study|Death|92|||
33563543|NCT02611960|62958462|FG000|Overall Study|Withdrawal by Subject|1|||
33563544|NCT02611960|62958463|FG001|Overall Study|Withdrawal by Subject|5|||
33563545|NCT02611960|62958462|FG000|Overall Study|Sponsor Decision|11|||
33563546|NCT02611960|62958463|FG001|Overall Study|Sponsor Decision|11|||
33563547|NCT01845597|62958470|FG000|Overall Study|Death|8|||
33563548|NCT01845597|62958470|FG000|Overall Study|Lost to Follow-up|22|||
33563549|NCT00713206|62958498|FG000|Overall Study|Lost to Follow-up|4|||
33563550|NCT00713206|62958499|FG001|Overall Study|Lost to Follow-up|4|||
33563551|NCT00713206|62958498|FG000|Overall Study|Death|1|||
33563552|NCT00713206|62958499|FG001|Overall Study|Death|0|||
33563553|NCT00495131|62958507|FG000|Overall Study|Adverse Event|6|||
33563554|NCT00495131|62958508|FG001|Overall Study|Adverse Event|2|||
33563555|NCT00495131|62958507|FG000|Overall Study|Lack of Efficacy|0|||
33563556|NCT00495131|62958508|FG001|Overall Study|Lack of Efficacy|2|||
33563557|NCT00495131|62958507|FG000|Overall Study|Lost to Follow-up|0|||
33563558|NCT00495131|62958508|FG001|Overall Study|Lost to Follow-up|2|||
33563559|NCT00495131|62958507|FG000|Overall Study|Withdrawal by Subject|1|||
33563560|NCT00495131|62958508|FG001|Overall Study|Withdrawal by Subject|0|||
33563561|NCT02257372|62958514|FG000|Overall Study|Adverse Event|3|||
33563562|NCT02257372|62958515|FG001|Overall Study|Adverse Event|7|||
33563563|NCT02257372|62958514|FG000|Overall Study|Lack of Efficacy|2|||
33563564|NCT02257372|62958515|FG001|Overall Study|Lack of Efficacy|1|||
33563565|NCT02257372|62958514|FG000|Overall Study|Protocol Violation|1|||
33563566|NCT02257372|62958515|FG001|Overall Study|Protocol Violation|1|||
33563567|NCT02257372|62958514|FG000|Overall Study|Lost to Follow-up|0|||
33563568|NCT02257372|62958515|FG001|Overall Study|Lost to Follow-up|1|||
33563569|NCT02257372|62958514|FG000|Overall Study|Withdrew consent|1|||
33563570|NCT02257372|62958515|FG001|Overall Study|Withdrew consent|0|||
33563571|NCT02256982|62958523|FG000|Overall Study|Disease Progression|0|||
33563572|NCT02256982|62958524|FG001|Overall Study|Disease Progression|1|||
33563573|NCT02736721|62958530|FG000|Overall Study|Adverse Event|8|||
33563574|NCT02736721|62958530|FG000|Overall Study|Lost to Follow-up|3|||
33563575|NCT02736721|62958530|FG000|Overall Study|Other|5|||
33563576|NCT04176445|62958534|FG000|Overall Study|Adverse Event|0|||
33563577|NCT04176445|62958535|FG001|Overall Study|Adverse Event|1|||
33563578|NCT04176445|62958534|FG000|Overall Study|change plans weaning after first intervention|0|||
33563579|NCT04176445|62958535|FG001|Overall Study|change plans weaning after first intervention|1|||
33563580|NCT02738203|62958543|FG000|Overall Study|Failed IUD Insertion|2|||
33563581|NCT02738203|62958544|FG001|Overall Study|Failed IUD Insertion|2|||
33563582|NCT02738203|62958543|FG000|Overall Study|Protocol Violation|0|||
33563583|NCT02738203|62958544|FG001|Overall Study|Protocol Violation|1|||
33563584|NCT02452034|62958556|FG000|Overall Study|Adverse Event|0|||
33563585|NCT02452034|62958557|FG001|Overall Study|Adverse Event|0|||
33563586|NCT02452034|62958558|FG002|Overall Study|Adverse Event|0|||
33563587|NCT02452034|62958559|FG003|Overall Study|Adverse Event|0|||
33563588|NCT02452034|62958560|FG004|Overall Study|Adverse Event|0|||
33563589|NCT02452034|62958561|FG005|Overall Study|Adverse Event|1|||
33563590|NCT02452034|62958556|FG000|Overall Study|Death|0|||
33563591|NCT02452034|62958557|FG001|Overall Study|Death|0|||
33563592|NCT02452034|62958558|FG002|Overall Study|Death|0|||
33563593|NCT02452034|62958559|FG003|Overall Study|Death|0|||
33563594|NCT02452034|62958560|FG004|Overall Study|Death|1|||
33563595|NCT02452034|62958561|FG005|Overall Study|Death|1|||
33563596|NCT02452034|62958556|FG000|Overall Study|Physician Decision|0|||
33563597|NCT02452034|62958557|FG001|Overall Study|Physician Decision|1|||
33563598|NCT02452034|62958558|FG002|Overall Study|Physician Decision|1|||
33563599|NCT02452034|62958559|FG003|Overall Study|Physician Decision|0|||
33563600|NCT02452034|62958560|FG004|Overall Study|Physician Decision|0|||
33563601|NCT02452034|62958561|FG005|Overall Study|Physician Decision|0|||
33563602|NCT02452034|62958556|FG000|Overall Study|Protocol Violation|0|||
33563603|NCT02452034|62958557|FG001|Overall Study|Protocol Violation|0|||
33563604|NCT02452034|62958558|FG002|Overall Study|Protocol Violation|0|||
33563605|NCT02452034|62958559|FG003|Overall Study|Protocol Violation|0|||
33563606|NCT02452034|62958560|FG004|Overall Study|Protocol Violation|0|||
33563607|NCT02452034|62958561|FG005|Overall Study|Protocol Violation|1|||
33563608|NCT02452034|62958556|FG000|Overall Study|Screen Failure|1|||
33563609|NCT02452034|62958557|FG001|Overall Study|Screen Failure|0|||
33563610|NCT02452034|62958558|FG002|Overall Study|Screen Failure|0|||
33563611|NCT02452034|62958559|FG003|Overall Study|Screen Failure|1|||
33563612|NCT02452034|62958560|FG004|Overall Study|Screen Failure|0|||
33563613|NCT02452034|62958561|FG005|Overall Study|Screen Failure|0|||
33563614|NCT02452034|62958556|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
33563615|NCT02452034|62958557|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
33563616|NCT02452034|62958558|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
33563617|NCT02452034|62958559|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
33563618|NCT02452034|62958560|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
33563619|NCT02452034|62958561|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
33563620|NCT02482298|62958588|FG000|Overall Study|Withdrawal by Subject|2|||
33563621|NCT02482298|62958589|FG001|Overall Study|Withdrawal by Subject|1|||
33563622|NCT02482298|62958590|FG002|Overall Study|Withdrawal by Subject|2|||
33563623|NCT02482298|62958588|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
33563624|NCT02482298|62958589|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
33563625|NCT02482298|62958590|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
33563626|NCT02482298|62958588|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
33563627|NCT02482298|62958589|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
33563628|NCT02482298|62958590|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
33563629|NCT02482298|62958588|FG000|Overall Study|Lost to Follow-up|0|||
33563630|NCT02482298|62958589|FG001|Overall Study|Lost to Follow-up|1|||
33563631|NCT02482298|62958590|FG002|Overall Study|Lost to Follow-up|0|||
33563632|NCT00440531|62958601|FG000|Overall Study|Adverse Event|1|||
33563633|NCT00440531|62958602|FG001|Overall Study|Adverse Event|0|||
33563634|NCT00440531|62958603|FG002|Overall Study|Adverse Event|2|||
33563635|NCT00440531|62958601|FG000|Overall Study|Withdrawal by Subject|2|||
33563636|NCT00440531|62958602|FG001|Overall Study|Withdrawal by Subject|0|||
33563637|NCT00440531|62958603|FG002|Overall Study|Withdrawal by Subject|0|||
33563638|NCT00440531|62958601|FG000|Overall Study|Protocol Violation|1|||
33563639|NCT00440531|62958602|FG001|Overall Study|Protocol Violation|2|||
33563640|NCT00440531|62958603|FG002|Overall Study|Protocol Violation|0|||
33563641|NCT00440531|62958601|FG000|Overall Study|Lost to Follow-up|4|||
33563642|NCT00440531|62958602|FG001|Overall Study|Lost to Follow-up|3|||
33563643|NCT00440531|62958603|FG002|Overall Study|Lost to Follow-up|5|||
33563644|NCT00440531|62958601|FG000|Overall Study|see pre-assignment details|2|||
33563645|NCT00440531|62958602|FG001|Overall Study|see pre-assignment details|0|||
33563646|NCT00440531|62958603|FG002|Overall Study|see pre-assignment details|0|||
33563647|NCT02513732|62958609|FG000|Overall Study|Lost to Follow-up|11|||
33563648|NCT02513732|62958609|FG000|Overall Study|Death|9|||
33563649|NCT02513732|62958609|FG000|Overall Study|Changing hospital|2|||
33563650|NCT00429923|62958616|FG000|Overall Study|Adverse Event|0|||
33563651|NCT00429923|62958617|FG001|Overall Study|Adverse Event|2|||
33563652|NCT00429923|62958618|FG002|Overall Study|Adverse Event|3|||
33563653|NCT00429923|62958616|FG000|Overall Study|Lack of Efficacy|4|||
33563654|NCT00429923|62958617|FG001|Overall Study|Lack of Efficacy|1|||
33563655|NCT00429923|62958618|FG002|Overall Study|Lack of Efficacy|33|||
33563656|NCT00429923|62958616|FG000|Overall Study|Lost to Follow-up|0|||
33563657|NCT00429923|62958617|FG001|Overall Study|Lost to Follow-up|0|||
33563658|NCT00429923|62958618|FG002|Overall Study|Lost to Follow-up|2|||
33563659|NCT00429923|62958616|FG000|Overall Study|Withdrew Consent|1|||
33563660|NCT00429923|62958617|FG001|Overall Study|Withdrew Consent|0|||
33563661|NCT00429923|62958618|FG002|Overall Study|Withdrew Consent|1|||
33563662|NCT00429923|62958616|FG000|Overall Study|Early Termination|0|||
33563663|NCT00429923|62958617|FG001|Overall Study|Early Termination|1|||
33563664|NCT00429923|62958618|FG002|Overall Study|Early Termination|0|||
33563665|NCT02256436|62958625|FG000|Overall Study|Adverse Event|9|||
33563666|NCT02256436|62958626|FG001|Overall Study|Adverse Event|14|||
33300739|NCT01090492|62676889|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
33300740|NCT01090492|62676890|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
33300741|NCT01090492|62676891|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
33300742|NCT01090492|62676892|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
33300743|NCT01090492|62676893|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
33300744|NCT01090492|62676886|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
33300745|NCT01090492|62676887|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
33563667|NCT02256436|62958625|FG000|Overall Study|Death|216|||
33563668|NCT02256436|62958626|FG001|Overall Study|Death|208|||
33563669|NCT02256436|62958625|FG000|Overall Study|Lost to Follow-up|1|||
33563670|NCT02256436|62958626|FG001|Overall Study|Lost to Follow-up|2|||
33563671|NCT02256436|62958625|FG000|Overall Study|Physician Decision|1|||
33563672|NCT02256436|62958626|FG001|Overall Study|Physician Decision|0|||
33563673|NCT02256436|62958625|FG000|Overall Study|Protocol Violation|0|||
33563674|NCT02256436|62958626|FG001|Overall Study|Protocol Violation|1|||
33563675|NCT02256436|62958625|FG000|Overall Study|Withdrawal by Subject|26|||
33563676|NCT02256436|62958626|FG001|Overall Study|Withdrawal by Subject|10|||
33563677|NCT02256436|62958625|FG000|Overall Study|Transferred to Extension Study|11|||
33563678|NCT02256436|62958626|FG001|Overall Study|Transferred to Extension Study|23|||
33563679|NCT02256436|62958625|FG000|Overall Study|Did Not Continue on Extension Study|8|||
33563680|NCT02256436|62958626|FG001|Overall Study|Did Not Continue on Extension Study|12|||
33300746|NCT01090492|62676888|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
33563681|NCT00326183|62958635|FG000|Overall Study|Lost to Follow-up|104|||
33563682|NCT00326183|62958636|FG001|Overall Study|Lost to Follow-up|56|||
33563683|NCT00326183|62958635|FG000|Overall Study|Protocol Violation|6|||
33563684|NCT00326183|62958636|FG001|Overall Study|Protocol Violation|3|||
33563685|NCT00326183|62958635|FG000|Overall Study|Withdrawal by Subject|35|||
33563686|NCT00326183|62958636|FG001|Overall Study|Withdrawal by Subject|7|||
33563687|NCT00326183|62958635|FG000|Overall Study|Subject Moved|7|||
33563688|NCT00326183|62958636|FG001|Overall Study|Subject Moved|4|||
33563689|NCT00326183|62958635|FG000|Overall Study|Other|47|||
33563690|NCT00326183|62958636|FG001|Overall Study|Other|13|||
33563691|NCT00326183|62958635|FG000|Overall Study|Adverse Event|1|||
33563692|NCT00326183|62958636|FG001|Overall Study|Adverse Event|0|||
33563693|NCT02481050|62958640|FG000|Overall Study|Adverse Event|1|||
33563694|NCT02481050|62958640|FG000|Overall Study|Disease Progression|47|||
33563695|NCT02481050|62958640|FG000|Overall Study|Withdrawal by Subject|7|||
33563696|NCT02481050|62958640|FG000|Overall Study|Other|3|||
33563697|NCT02511782|62958647|FG000|Overall Study|Withdrawal by Subject|1|||
33563698|NCT02511782|62958648|FG001|Overall Study|Withdrawal by Subject|0|||
33563699|NCT02511782|62958649|FG002|Overall Study|Withdrawal by Subject|0|||
33563700|NCT02480114|62958659|FG000|Overall Study|Not completing surveys|3|||
33563701|NCT02480114|62958660|FG001|Overall Study|Not completing surveys|2|||
33563702|NCT02480114|62958659|FG000|Overall Study|Withdrawal by Subject|2|||
33563703|NCT02480114|62958660|FG001|Overall Study|Withdrawal by Subject|4|||
33563704|NCT02480114|62958659|FG000|Overall Study|Disease progression|3|||
33563705|NCT02480114|62958660|FG001|Overall Study|Disease progression|0|||
33563706|NCT02480114|62958659|FG000|Overall Study|Improper completion of survey|1|||
33563707|NCT02480114|62958660|FG001|Overall Study|Improper completion of survey|1|||
33563708|NCT02480114|62958659|FG000|Overall Study|Not eligible|0|||
33563709|NCT02480114|62958660|FG001|Overall Study|Not eligible|1|||
33563710|NCT02479880|62958668|FG000|Overall Study|Study Terminated by Sponsor|13|||
33563711|NCT02479880|62958669|FG001|Overall Study|Study Terminated by Sponsor|12|||
33563712|NCT02479880|62958668|FG000|Overall Study|Pregnancy|0|||
33563713|NCT02479880|62958669|FG001|Overall Study|Pregnancy|1|||
33563714|NCT02479802|62958675|FG000|Overall Study|Lost to Follow-up|1|||
33563715|NCT02479802|62958675|FG000|Overall Study|Adverse Event|1|||
33563716|NCT02479412|62958688|FG000|Overall Study|Adverse Event|0|||
33563717|NCT02479412|62958689|FG001|Overall Study|Adverse Event|0|||
33563718|NCT02479412|62958690|FG002|Overall Study|Adverse Event|1|||
33563719|NCT02479412|62958691|FG003|Overall Study|Adverse Event|0|||
33563720|NCT02479412|62958692|FG004|Overall Study|Adverse Event|0|||
33563721|NCT02479412|62958693|FG005|Overall Study|Adverse Event|0|||
33563722|NCT02479412|62958694|FG006|Overall Study|Adverse Event|0|||
33563723|NCT02479412|62958695|FG007|Overall Study|Adverse Event|0|||
33563724|NCT02479412|62958696|FG008|Overall Study|Adverse Event|0|||
33563725|NCT02479412|62958688|FG000|Overall Study|Study-specific withdrawal criteria|0|||
33563726|NCT02479412|62958689|FG001|Overall Study|Study-specific withdrawal criteria|0|||
33563727|NCT02479412|62958690|FG002|Overall Study|Study-specific withdrawal criteria|1|||
33563728|NCT02479412|62958691|FG003|Overall Study|Study-specific withdrawal criteria|1|||
33563729|NCT02479412|62958692|FG004|Overall Study|Study-specific withdrawal criteria|0|||
33563730|NCT02479412|62958693|FG005|Overall Study|Study-specific withdrawal criteria|0|||
33563731|NCT02479412|62958694|FG006|Overall Study|Study-specific withdrawal criteria|0|||
33563732|NCT02479412|62958695|FG007|Overall Study|Study-specific withdrawal criteria|1|||
33563733|NCT02479412|62958696|FG008|Overall Study|Study-specific withdrawal criteria|1|||
33563734|NCT02479412|62958688|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
33563735|NCT02479412|62958689|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
33563736|NCT02479412|62958690|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
33563737|NCT02479412|62958691|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
33563738|NCT02479412|62958692|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
33563739|NCT02479412|62958693|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
33563740|NCT02479412|62958694|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
33563741|NCT02479412|62958695|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
33563742|NCT02479412|62958696|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
33563743|NCT00224003|62958712|FG000|Overall Study|Adverse Event|1|||
33563744|NCT00224003|62958712|FG000|Overall Study|Protocol Violation|2|||
33563745|NCT00224003|62958712|FG000|Overall Study|Withdrawal by Subject|1|||
33563746|NCT00224003|62958712|FG000|Overall Study|unk|3|||
33563747|NCT02450552|62958718|FG000|Overall Study|Withdrawal by Subject|4|||
33563748|NCT02450552|62958719|FG001|Overall Study|Withdrawal by Subject|0|||
33563749|NCT02450552|62958720|FG002|Overall Study|Withdrawal by Subject|4|||
33563750|NCT02450552|62958718|FG000|Overall Study|Physician Decision|1|||
33563751|NCT02450552|62958719|FG001|Overall Study|Physician Decision|0|||
33563752|NCT02450552|62958720|FG002|Overall Study|Physician Decision|1|||
33563753|NCT02508428|62958730|FG000|Overall Study|Death|32|||
33563754|NCT02508428|62958731|FG001|Overall Study|Death|33|||
33563755|NCT02508428|62958730|FG000|Overall Study|Liner revised|3|||
33563756|NCT02508428|62958731|FG001|Overall Study|Liner revised|19|||
33563757|NCT02508428|62958730|FG000|Overall Study|Incomplete follow-up|17|||
33563758|NCT02508428|62958731|FG001|Overall Study|Incomplete follow-up|15|||
33563759|NCT02448680|62958739|FG000|Overall Study|Physician Decision|1|||
33563760|NCT02448680|62958740|FG001|Overall Study|Physician Decision|1|||
33563761|NCT02448680|62958739|FG000|Overall Study|Withdrawal by Subject|0|||
33563762|NCT02448680|62958740|FG001|Overall Study|Withdrawal by Subject|2|||
33563763|NCT02448446|62958750|FG000|Overall Study|Withdrawal by Subject|1|||
33563764|NCT02448446|62958751|FG001|Overall Study|Withdrawal by Subject|0|||
33563765|NCT02447744|62958759|FG000|Overall Study|Withdrawal by Subject|3|||
33563766|NCT02447744|62958760|FG001|Overall Study|Withdrawal by Subject|1|||
33563767|NCT02447744|62958759|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
33563768|NCT02447744|62958760|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
33563769|NCT02478632|62958768|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
33563770|NCT02478632|62958769|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
33563771|NCT02478632|62958768|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
33563772|NCT02478632|62958769|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
33563773|NCT02478632|62958768|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
33563774|NCT02478632|62958769|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
33563775|NCT02478398|62958780|FG000|Overall Study|Adverse Event|20|||
33563776|NCT02478398|62958781|FG001|Overall Study|Adverse Event|5|||
33563777|NCT02478398|62958780|FG000|Overall Study|Lost to Follow-up|5|||
33563778|NCT02478398|62958781|FG001|Overall Study|Lost to Follow-up|4|||
33563779|NCT02478398|62958780|FG000|Overall Study|Non-Compliance With Study Drug|5|||
33563780|NCT02478398|62958781|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33563781|NCT02478398|62958780|FG000|Overall Study|Protocol Violation|3|||
33563782|NCT02478398|62958781|FG001|Overall Study|Protocol Violation|1|||
33563783|NCT02478398|62958780|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
33563784|NCT02478398|62958781|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
33563785|NCT02478398|62958780|FG000|Overall Study|Withdrawal By Participant|10|||
33563786|NCT02478398|62958781|FG001|Overall Study|Withdrawal By Participant|4|||
33563787|NCT02478164|62958788|FG000|Overall Study|Lack of Efficacy|13|||
33563788|NCT02478164|62958788|FG000|Overall Study|Adverse Event|1|||
33563789|NCT02478164|62958788|FG000|Overall Study|Withdrawal by Subject|1|||
33563790|NCT02476994|62958794|FG000|Overall Study|Based on feedback from FDA|1|||
33563791|NCT02476994|62958795|FG001|Overall Study|Based on feedback from FDA|0|||
33563792|NCT02508194|62958803|FG000|Overall Study|Death|5|||
33563793|NCT02508194|62958804|FG001|Overall Study|Death|3|||
33563794|NCT02508194|62958803|FG000|Overall Study|Lost to Follow-up|25|||
33563795|NCT02508194|62958804|FG001|Overall Study|Lost to Follow-up|18|||
33563796|NCT02508194|62958803|FG000|Overall Study|Withdrawal by Subject|20|||
33563797|NCT02508194|62958804|FG001|Overall Study|Withdrawal by Subject|18|||
33563798|NCT02508194|62958803|FG000|Overall Study|Error in Randomization|1|||
33563799|NCT02508194|62958804|FG001|Overall Study|Error in Randomization|3|||
33563800|NCT02508194|62958803|FG000|Overall Study|Principal Investigator Decision|1|||
33563801|NCT02508194|62958804|FG001|Overall Study|Principal Investigator Decision|2|||
33563802|NCT02508116|62958812|FG000|Overall Study|Lost to Follow-up|2|||
33563803|NCT02508116|62958813|FG001|Overall Study|Lost to Follow-up|3|||
33563804|NCT02508116|62958812|FG000|Overall Study|Withdrawal by Subject|3|||
33563805|NCT02508116|62958813|FG001|Overall Study|Withdrawal by Subject|2|||
33563806|NCT02508116|62958812|FG000|Overall Study|Protocol Violation|1|||
33563807|NCT02508116|62958813|FG001|Overall Study|Protocol Violation|2|||
33563808|NCT02508116|62958812|FG000|Overall Study|Physician Decision|2|||
33563809|NCT02508116|62958813|FG001|Overall Study|Physician Decision|0|||
33563810|NCT01653782|62958822|FG000|Overall Study|Withdrawal by Subject|9|||
33563811|NCT01653782|62958823|FG001|Overall Study|Withdrawal by Subject|15|||
33563812|NCT01653782|62958824|FG002|Overall Study|Withdrawal by Subject|4|||
33563813|NCT01653782|62958822|FG000|Overall Study|Lost to Follow-up|7|||
33563814|NCT01653782|62958823|FG001|Overall Study|Lost to Follow-up|3|||
33563815|NCT01653782|62958824|FG002|Overall Study|Lost to Follow-up|2|||
33563816|NCT02318329|62958842|FG000|Overall Study|Progressive Disease|2|||
33563817|NCT02318329|62958843|FG001|Overall Study|Progressive Disease|3|||
33563818|NCT02318329|62958844|FG002|Overall Study|Progressive Disease|2|||
33563819|NCT02318329|62958845|FG003|Overall Study|Progressive Disease|3|||
33563820|NCT02318329|62958846|FG004|Overall Study|Progressive Disease|3|||
33662986|NCT01686581|63093789|FG000|Overall Study|Lack of Efficacy|90|||
33662987|NCT01686581|63093789|FG000|Overall Study|Participant Concerned about Risks|6|||
33563821|NCT02318329|62958847|FG005|Overall Study|Progressive Disease|3|||
33563822|NCT02318329|62958848|FG006|Overall Study|Progressive Disease|1|||
33563823|NCT02318329|62958849|FG007|Overall Study|Progressive Disease|1|||
33563824|NCT02318329|62958850|FG008|Overall Study|Progressive Disease|5|||
33563825|NCT02318329|62958851|FG009|Overall Study|Progressive Disease|39|||
33563826|NCT02318329|62958842|FG000|Overall Study|Death|0|||
33563827|NCT02318329|62958843|FG001|Overall Study|Death|0|||
33662988|NCT01686581|63093789|FG000|Overall Study|Thinks Injections Too Painful|8|||
33563828|NCT02318329|62958844|FG002|Overall Study|Death|0|||
33563829|NCT02318329|62958845|FG003|Overall Study|Death|0|||
33563830|NCT02318329|62958846|FG004|Overall Study|Death|0|||
33563831|NCT02318329|62958847|FG005|Overall Study|Death|0|||
33563832|NCT02318329|62958848|FG006|Overall Study|Death|0|||
33563833|NCT02318329|62958849|FG007|Overall Study|Death|0|||
33563834|NCT02318329|62958850|FG008|Overall Study|Death|0|||
33563835|NCT02318329|62958851|FG009|Overall Study|Death|5|||
33563836|NCT02318329|62958842|FG000|Overall Study|Lost to Follow-up|0|||
33563837|NCT02318329|62958843|FG001|Overall Study|Lost to Follow-up|0|||
33563838|NCT02318329|62958844|FG002|Overall Study|Lost to Follow-up|0|||
33563839|NCT02318329|62958845|FG003|Overall Study|Lost to Follow-up|0|||
33563840|NCT02318329|62958846|FG004|Overall Study|Lost to Follow-up|0|||
33563841|NCT02318329|62958847|FG005|Overall Study|Lost to Follow-up|0|||
33563842|NCT02318329|62958848|FG006|Overall Study|Lost to Follow-up|0|||
33563843|NCT02318329|62958849|FG007|Overall Study|Lost to Follow-up|0|||
33563844|NCT02318329|62958850|FG008|Overall Study|Lost to Follow-up|0|||
33563845|NCT02318329|62958851|FG009|Overall Study|Lost to Follow-up|1|||
33563846|NCT02318329|62958842|FG000|Overall Study|Withdrawal by Subject|0|||
33563847|NCT02318329|62958843|FG001|Overall Study|Withdrawal by Subject|0|||
33563848|NCT02318329|62958844|FG002|Overall Study|Withdrawal by Subject|0|||
33563849|NCT02318329|62958845|FG003|Overall Study|Withdrawal by Subject|0|||
33563850|NCT02318329|62958846|FG004|Overall Study|Withdrawal by Subject|0|||
33563851|NCT02318329|62958847|FG005|Overall Study|Withdrawal by Subject|0|||
33563852|NCT02318329|62958848|FG006|Overall Study|Withdrawal by Subject|0|||
33563853|NCT02318329|62958849|FG007|Overall Study|Withdrawal by Subject|0|||
33563854|NCT02318329|62958850|FG008|Overall Study|Withdrawal by Subject|0|||
33563855|NCT02318329|62958851|FG009|Overall Study|Withdrawal by Subject|6|||
33563856|NCT02318329|62958842|FG000|Overall Study|Other|1|||
33563857|NCT02318329|62958843|FG001|Overall Study|Other|1|||
33563858|NCT02318329|62958844|FG002|Overall Study|Other|1|||
33563859|NCT02318329|62958845|FG003|Overall Study|Other|0|||
33563860|NCT02318329|62958846|FG004|Overall Study|Other|0|||
33563861|NCT02318329|62958847|FG005|Overall Study|Other|0|||
33563862|NCT02318329|62958848|FG006|Overall Study|Other|0|||
33563863|NCT02318329|62958849|FG007|Overall Study|Other|0|||
33563864|NCT02318329|62958850|FG008|Overall Study|Other|1|||
33563865|NCT02318329|62958851|FG009|Overall Study|Other|1|||
33563866|NCT02255656|62958892|FG000|Overall Study|Adverse Event|11|||
33563867|NCT02255656|62958892|FG000|Overall Study|Poor compliance to protocol|3|||
33563868|NCT02255656|62958892|FG000|Overall Study|Lost to Follow-up|30|||
33563869|NCT02255656|62958892|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
33563870|NCT02255656|62958892|FG000|Overall Study|Other|126|||
33563871|NCT02255500|62958905|FG000|Overall Study|Withdrawal by Subject|1|||
33563872|NCT02255500|62958906|FG001|Overall Study|Withdrawal by Subject|0|||
33563873|NCT02505542|62958912|FG000|Part A: Open-Label Period|Adverse Event|31|||
33563874|NCT02505542|62958913|FG001|Part A: Open-Label Period|Adverse Event|0|||
33563875|NCT02505542|62958914|FG002|Part A: Open-Label Period|Adverse Event|0|||
33563876|NCT02505542|62958915|FG003|Part A: Open-Label Period|Adverse Event|0|||
33563877|NCT02505542|62958912|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
33563878|NCT02505542|62958913|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
33563879|NCT02505542|62958914|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
33563880|NCT02505542|62958915|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
33563881|NCT02505542|62958912|FG000|Part A: Open-Label Period|Protocol Violation|1|||
33563882|NCT02505542|62958913|FG001|Part A: Open-Label Period|Protocol Violation|0|||
33563883|NCT02505542|62958914|FG002|Part A: Open-Label Period|Protocol Violation|0|||
33563884|NCT02505542|62958915|FG003|Part A: Open-Label Period|Protocol Violation|0|||
33563885|NCT02505542|62958912|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
33563886|NCT02505542|62958913|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
33563887|NCT02505542|62958914|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
33563888|NCT02505542|62958915|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
33563889|NCT02505542|62958912|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
33563890|NCT02505542|62958913|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
33563891|NCT02505542|62958914|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
33563892|NCT02505542|62958915|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
33563893|NCT02505542|62958912|FG000|Part A: Open-Label Period|New medical history available|1|||
33563894|NCT02505542|62958913|FG001|Part A: Open-Label Period|New medical history available|0|||
33563895|NCT02505542|62958914|FG002|Part A: Open-Label Period|New medical history available|0|||
33563896|NCT02505542|62958915|FG003|Part A: Open-Label Period|New medical history available|0|||
33563897|NCT02505542|62958912|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
33563898|NCT02505542|62958913|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
33563899|NCT02505542|62958914|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
33563900|NCT02505542|62958915|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
33563901|NCT02505542|62958912|FG000|Part A: Open-Label Period|Pregnancy|2|||
33563902|NCT02505542|62958913|FG001|Part A: Open-Label Period|Pregnancy|0|||
33563903|NCT02505542|62958914|FG002|Part A: Open-Label Period|Pregnancy|0|||
33563904|NCT02505542|62958915|FG003|Part A: Open-Label Period|Pregnancy|0|||
33563905|NCT02505542|62958912|FG000|Part A: Open-Label Period|Sponsor directive|1|||
33563906|NCT02505542|62958913|FG001|Part A: Open-Label Period|Sponsor directive|0|||
33563907|NCT02505542|62958914|FG002|Part A: Open-Label Period|Sponsor directive|0|||
33563908|NCT02505542|62958915|FG003|Part A: Open-Label Period|Sponsor directive|0|||
33563909|NCT02505542|62958912|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
33563910|NCT02505542|62958913|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
33563911|NCT02505542|62958914|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
33563912|NCT02505542|62958915|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
33563913|NCT02505542|62958912|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
33563914|NCT02505542|62958913|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
33563915|NCT02505542|62958914|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
33563916|NCT02505542|62958915|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
33563917|NCT02505542|62958912|FG000|Part A: Open-Label Period|Non-compliance|1|||
33563918|NCT02505542|62958913|FG001|Part A: Open-Label Period|Non-compliance|0|||
33563919|NCT02505542|62958914|FG002|Part A: Open-Label Period|Non-compliance|0|||
33563920|NCT02505542|62958915|FG003|Part A: Open-Label Period|Non-compliance|0|||
33563921|NCT02505542|62958912|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
33563922|NCT02505542|62958913|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
33563923|NCT02505542|62958914|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
33563924|NCT02505542|62958915|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
33563925|NCT02505542|62958912|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
33563926|NCT02505542|62958913|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
33563927|NCT02505542|62958914|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
33563928|NCT02505542|62958915|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
33563929|NCT02505542|62958912|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
33563930|NCT02505542|62958913|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
33563931|NCT02505542|62958914|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
33563932|NCT02505542|62958915|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
33563933|NCT02505542|62958912|FG000|Part B: Double-Blind Period|Adverse Event|0|||
33563934|NCT02505542|62958913|FG001|Part B: Double-Blind Period|Adverse Event|0|||
33563935|NCT02505542|62958914|FG002|Part B: Double-Blind Period|Adverse Event|1|||
33563936|NCT02505542|62958915|FG003|Part B: Double-Blind Period|Adverse Event|3|||
33563937|NCT02505542|62958912|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
33563938|NCT02505542|62958913|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
33563939|NCT02505542|62958914|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
33563940|NCT02505542|62958915|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
33563941|NCT02505542|62958912|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
33563942|NCT02505542|62958913|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
33563943|NCT02505542|62958914|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
33563944|NCT02505542|62958915|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
33563945|NCT02505542|62958912|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
33563946|NCT02505542|62958913|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
33563947|NCT02505542|62958914|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
33563948|NCT02505542|62958915|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
33563949|NCT02505542|62958912|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
33563950|NCT02505542|62958913|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
33563951|NCT02505542|62958914|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
33563952|NCT02505542|62958915|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
33563953|NCT02505542|62958912|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
33563954|NCT02505542|62958913|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
33563955|NCT02505542|62958914|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
33563956|NCT02505542|62958915|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
33563957|NCT02505542|62958912|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
33563958|NCT02505542|62958913|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
33563959|NCT02505542|62958914|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
33563960|NCT02505542|62958915|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
33563961|NCT02505542|62958912|FG000|Part B: Double-Blind Period|Miscalculation|0|||
33563962|NCT02505542|62958913|FG001|Part B: Double-Blind Period|Miscalculation|1|||
33563963|NCT02505542|62958914|FG002|Part B: Double-Blind Period|Miscalculation|0|||
33563964|NCT02505542|62958915|FG003|Part B: Double-Blind Period|Miscalculation|0|||
33563965|NCT02505542|62958912|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
33563966|NCT02505542|62958913|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
33563967|NCT02505542|62958914|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
33563968|NCT02505542|62958915|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
33563969|NCT02475980|62958964|FG000|Overall Study|Lost to Follow-up|4|||
33563970|NCT02475980|62958964|FG000|Overall Study|Withdrawal by Subject|1|||
33563971|NCT02447432|62958970|FG000|Epoch 001|Adverse Event|1|||
33392123|NCT00566020|62771013|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
33563972|NCT02447432|62958971|FG001|Epoch 001|Adverse Event|1|||
33563973|NCT02447432|62958970|FG000|Epoch 001|Withdrawal by Subject|0|||
33563974|NCT02447432|62958971|FG001|Epoch 001|Withdrawal by Subject|4|||
33563975|NCT02447432|62958970|FG000|Epoch 001|Migrated/moved from study area|3|||
33563976|NCT02447432|62958971|FG001|Epoch 001|Migrated/moved from study area|5|||
33563977|NCT02447432|62958970|FG000|Epoch 001|Lost to Follow-up|1|||
33563978|NCT02447432|62958971|FG001|Epoch 001|Lost to Follow-up|3|||
33563979|NCT02446886|62958979|FG000|Overall Study|Adverse Event|1|||
33563980|NCT02446886|62958980|FG001|Overall Study|Adverse Event|3|||
33563981|NCT02446886|62958979|FG000|Overall Study|Withdrawal by Subject|1|||
33563982|NCT02446886|62958980|FG001|Overall Study|Withdrawal by Subject|1|||
33563983|NCT03448939|62958998|FG000|Overall Study|Adverse Event|5|||
33563984|NCT03448939|62958999|FG001|Overall Study|Adverse Event|1|||
33563985|NCT03448939|62958998|FG000|Overall Study|Lost to Follow-up|6|||
33563986|NCT03448939|62958999|FG001|Overall Study|Lost to Follow-up|6|||
33563987|NCT03448939|62958998|FG000|Overall Study|Pregnancy|1|||
33563988|NCT03448939|62958999|FG001|Overall Study|Pregnancy|1|||
33563989|NCT03448939|62958998|FG000|Overall Study|Withdrawal by Subject|9|||
33563990|NCT03448939|62958999|FG001|Overall Study|Withdrawal by Subject|3|||
33563991|NCT02504294|62959017|FG000|Overall Study|Adverse Event|15|||
33563992|NCT02504294|62959018|FG001|Overall Study|Adverse Event|12|||
33563993|NCT02504294|62959017|FG000|Overall Study|Withdrawal by Subject|7|||
33563994|NCT02504294|62959018|FG001|Overall Study|Withdrawal by Subject|1|||
33563995|NCT02504294|62959017|FG000|Overall Study|Protocol Violation|27|||
33563996|NCT02504294|62959018|FG001|Overall Study|Protocol Violation|26|||
33563997|NCT02504294|62959017|FG000|Overall Study|Physician Decision|1|||
33563998|NCT02504294|62959018|FG001|Overall Study|Physician Decision|2|||
33563999|NCT02504294|62959017|FG000|Overall Study|Lost to Follow-up|6|||
33564000|NCT02504294|62959018|FG001|Overall Study|Lost to Follow-up|7|||
33564001|NCT02446418|62959026|FG000|Overall Study|Adverse Event|4|||
33564002|NCT02446418|62959027|FG001|Overall Study|Adverse Event|8|||
33564003|NCT02446418|62959026|FG000|Overall Study|Physician Decision|5|||
33564004|NCT02446418|62959027|FG001|Overall Study|Physician Decision|1|||
33564005|NCT02446418|62959026|FG000|Overall Study|Withdrawal by Subject|3|||
33564006|NCT02446418|62959027|FG001|Overall Study|Withdrawal by Subject|3|||
33564007|NCT02446418|62959026|FG000|Overall Study|Lost to Follow-up|2|||
33564008|NCT02446418|62959027|FG001|Overall Study|Lost to Follow-up|2|||
33564009|NCT02446418|62959026|FG000|Overall Study|Protocol Violation|1|||
33564010|NCT02446418|62959027|FG001|Overall Study|Protocol Violation|2|||
33564011|NCT02446418|62959026|FG000|Overall Study|Lack of Efficacy|2|||
33564012|NCT02446418|62959027|FG001|Overall Study|Lack of Efficacy|0|||
33564013|NCT02446418|62959026|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
33564014|NCT02446418|62959027|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
33564015|NCT02255422|62959040|FG000|Overall Study|Withdrawal by Subject|0|||
33564016|NCT02255422|62959041|FG001|Overall Study|Withdrawal by Subject|0|||
33564017|NCT02255422|62959042|FG002|Overall Study|Withdrawal by Subject|0|||
33564018|NCT02255422|62959043|FG003|Overall Study|Withdrawal by Subject|0|||
33564019|NCT02255422|62959044|FG004|Overall Study|Withdrawal by Subject|0|||
33564020|NCT02255422|62959045|FG005|Overall Study|Withdrawal by Subject|0|||
33564021|NCT02255422|62959046|FG006|Overall Study|Withdrawal by Subject|2|||
33564022|NCT02255422|62959040|FG000|Overall Study|Lost to Follow-up|0|||
33564023|NCT02255422|62959041|FG001|Overall Study|Lost to Follow-up|0|||
33564024|NCT02255422|62959042|FG002|Overall Study|Lost to Follow-up|1|||
33564025|NCT02255422|62959043|FG003|Overall Study|Lost to Follow-up|0|||
33564026|NCT02255422|62959044|FG004|Overall Study|Lost to Follow-up|0|||
33564027|NCT02255422|62959045|FG005|Overall Study|Lost to Follow-up|0|||
33564028|NCT02255422|62959046|FG006|Overall Study|Lost to Follow-up|0|||
33564029|NCT02445794|62959066|FG000|Overall Study|Adverse Event|0|||
33564030|NCT02445794|62959067|FG001|Overall Study|Adverse Event|0|||
33564031|NCT02445794|62959068|FG002|Overall Study|Adverse Event|2|||
33564032|NCT02445794|62959069|FG003|Overall Study|Adverse Event|0|||
33564033|NCT02475278|62959084|FG000|Overall Study|Lost to Follow-up|1|||
33564034|NCT02475278|62959084|FG000|Overall Study|Reason Not Specified|1|||
33564035|NCT02254486|62959090|FG000|Overall Study|Adverse Event|1|||
33564036|NCT02254486|62959091|FG001|Overall Study|Adverse Event|1|||
33564037|NCT02254486|62959090|FG000|Overall Study|Lack of Efficacy|1|||
33564038|NCT02254486|62959091|FG001|Overall Study|Lack of Efficacy|0|||
33564039|NCT02254486|62959090|FG000|Overall Study|Lost to Follow-up|2|||
33564040|NCT02254486|62959091|FG001|Overall Study|Lost to Follow-up|4|||
33564041|NCT02254486|62959090|FG000|Overall Study|Protocol Violation|1|||
33564042|NCT02254486|62959091|FG001|Overall Study|Protocol Violation|2|||
33564043|NCT02254486|62959090|FG000|Overall Study|Withdrawal by Subject|17|||
33564044|NCT02254486|62959091|FG001|Overall Study|Withdrawal by Subject|15|||
33564045|NCT02254486|62959090|FG000|Overall Study|GFR<60mL/min|16|||
33564046|NCT02254486|62959091|FG001|Overall Study|GFR<60mL/min|21|||
33564047|NCT02254486|62959090|FG000|Overall Study|Various|12|||
33564048|NCT02254486|62959091|FG001|Overall Study|Various|12|||
33564049|NCT01641640|62959097|FG000|Overall Study|Enrolled but not treated|1|||
33564050|NCT01641640|62959097|FG000|Overall Study|Efficacy failure|29|||
33564051|NCT01641640|62959097|FG000|Overall Study|Lost to Follow-up|3|||
33564052|NCT01641640|62959097|FG000|Overall Study|Withdrawal by Subject|2|||
33564053|NCT01641640|62959097|FG000|Overall Study|Adverse Event|1|||
33300747|NCT01090492|62676889|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
33300748|NCT01090492|62676890|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
33300749|NCT01090492|62676891|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
33300750|NCT01090492|62676892|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
33300751|NCT01090492|62676893|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
33300752|NCT01090492|62676886|FG000|Second Intervention Period (4 Weeks)|Other|0|||
33300753|NCT01090492|62676887|FG001|Second Intervention Period (4 Weeks)|Other|1|||
33300754|NCT01090492|62676888|FG002|Second Intervention Period (4 Weeks)|Other|1|||
33300755|NCT01090492|62676889|FG003|Second Intervention Period (4 Weeks)|Other|0|||
33300756|NCT01090492|62676890|FG004|Second Intervention Period (4 Weeks)|Other|0|||
33300757|NCT01090492|62676891|FG005|Second Intervention Period (4 Weeks)|Other|0|||
33300758|NCT01090492|62676892|FG006|Second Intervention Period (4 Weeks)|Other|0|||
33300759|NCT01090492|62676893|FG007|Second Intervention Period (4 Weeks)|Other|0|||
33300760|NCT01090492|62676886|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
33300761|NCT01090492|62676887|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
33300762|NCT01090492|62676888|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
33300763|NCT01090492|62676889|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
33300764|NCT01090492|62676890|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
33300765|NCT01090492|62676891|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
33300766|NCT01090492|62676892|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
33300767|NCT01090492|62676893|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
33300768|NCT01090492|62676886|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33300769|NCT01090492|62676887|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33300770|NCT01090492|62676888|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33300771|NCT01090492|62676889|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33300772|NCT01090492|62676890|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33300773|NCT01090492|62676891|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33300774|NCT01090492|62676892|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
33300775|NCT01090492|62676893|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33300776|NCT01288911|62676914|FG000|Double-blind Period|Death|11|||
33300777|NCT01288911|62676915|FG001|Double-blind Period|Death|7|||
33300778|NCT01288911|62676914|FG000|Double-blind Period|Lost to Follow-up|0|||
33300779|NCT01288911|62676915|FG001|Double-blind Period|Lost to Follow-up|2|||
33300780|NCT01288911|62676914|FG000|Double-blind Period|Progressive Disease|75|||
33300781|NCT01288911|62676915|FG001|Double-blind Period|Progressive Disease|103|||
33300782|NCT01288911|62676914|FG000|Double-blind Period|Protocol Violation|1|||
33300783|NCT01288911|62676915|FG001|Double-blind Period|Protocol Violation|0|||
33300784|NCT01288911|62676914|FG000|Double-blind Period|Withdrawal by Subject|25|||
33300785|NCT01288911|62676915|FG001|Double-blind Period|Withdrawal by Subject|26|||
33300786|NCT01288911|62676914|FG000|Double-blind Period|Miscellaneous Reason|29|||
33300787|NCT01288911|62676915|FG001|Double-blind Period|Miscellaneous Reason|42|||
33300788|NCT01288911|62676914|FG000|Double-blind Period|Randomized but never received study drug|1|||
33300789|NCT01288911|62676915|FG001|Double-blind Period|Randomized but never received study drug|2|||
33300790|NCT01288911|62676914|FG000|Open-label Period (All Enzalutamide)|Death|0|||
33300791|NCT01288911|62676915|FG001|Open-label Period (All Enzalutamide)|Death|1|||
33300792|NCT01288911|62676914|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
33300793|NCT01288911|62676915|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
33300794|NCT01288911|62676914|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
33300795|NCT01288911|62676915|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
33300796|NCT01288911|62676914|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
33300797|NCT01288911|62676915|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
33300798|NCT01288911|62676914|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
33564054|NCT01639144|62959103|FG000|Overall Study|Withdrawal by Subject|4|||
33564055|NCT01639144|62959104|FG001|Overall Study|Withdrawal by Subject|2|||
33564056|NCT01639144|62959103|FG000|Overall Study|Physician Decision|2|||
33564057|NCT01639144|62959104|FG001|Overall Study|Physician Decision|0|||
33564058|NCT01639144|62959103|FG000|Overall Study|Met postoperative exclusion criteria|4|||
33564059|NCT01639144|62959104|FG001|Overall Study|Met postoperative exclusion criteria|3|||
33564060|NCT01601626|62959113|FG000|Overall Study|Death|1|||
33662989|NCT01686581|63093789|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
33300799|NCT01288911|62676915|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
33300800|NCT01288911|62676914|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
33300801|NCT01288911|62676915|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
33392124|NCT00566020|62771014|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
33564061|NCT01601626|62959114|FG001|Overall Study|Death|1|||
33564062|NCT01601626|62959115|FG002|Overall Study|Death|1|||
33564063|NCT01601626|62959113|FG000|Overall Study|Lost to Follow-up|1|||
33564064|NCT01601626|62959114|FG001|Overall Study|Lost to Follow-up|2|||
33564065|NCT01601626|62959115|FG002|Overall Study|Lost to Follow-up|0|||
33564066|NCT01601626|62959113|FG000|Overall Study|Unable to Get to Clinic|0|||
33564067|NCT01601626|62959114|FG001|Overall Study|Unable to Get to Clinic|1|||
33564068|NCT01601626|62959115|FG002|Overall Study|Unable to Get to Clinic|0|||
33564069|NCT01601626|62959113|FG000|Overall Study|Withdrawal by Subject|0|||
33564070|NCT01601626|62959114|FG001|Overall Study|Withdrawal by Subject|1|||
33564071|NCT01601626|62959115|FG002|Overall Study|Withdrawal by Subject|1|||
33564072|NCT01601626|62959113|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
33564073|NCT01601626|62959114|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
33564074|NCT01601626|62959115|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
33564075|NCT02737501|62959125|FG000|Randomized Phase|Died|41|||
33564076|NCT02737501|62959126|FG001|Randomized Phase|Died|29|||
33564077|NCT02737501|62959127|FG002|Randomized Phase|Died|0|||
33564078|NCT02737501|62959125|FG000|Randomized Phase|Withdrawal by Subject|16|||
33564079|NCT02737501|62959126|FG001|Randomized Phase|Withdrawal by Subject|6|||
33564080|NCT02737501|62959127|FG002|Randomized Phase|Withdrawal by Subject|0|||
33564081|NCT02737501|62959125|FG000|Randomized Phase|Lost to Follow-up|0|||
33564082|NCT02737501|62959126|FG001|Randomized Phase|Lost to Follow-up|1|||
33564083|NCT02737501|62959127|FG002|Randomized Phase|Lost to Follow-up|0|||
33564084|NCT02737501|62959125|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
33564085|NCT02737501|62959126|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
33564086|NCT02737501|62959127|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
33564087|NCT02737501|62959125|FG000|Randomized Phase|Reason not Specified|1|||
33564088|NCT02737501|62959126|FG001|Randomized Phase|Reason not Specified|1|||
33564089|NCT02737501|62959127|FG002|Randomized Phase|Reason not Specified|0|||
33564090|NCT02737501|62959125|FG000|Randomized Phase|Never Treated|1|||
33564091|NCT02737501|62959126|FG001|Randomized Phase|Never Treated|1|||
33564092|NCT02737501|62959127|FG002|Randomized Phase|Never Treated|0|||
33564093|NCT02737501|62959125|FG000|Crossover Phase|Died|0|||
33564094|NCT02737501|62959126|FG001|Crossover Phase|Died|0|||
33564095|NCT02737501|62959127|FG002|Crossover Phase|Died|22|||
33564096|NCT02737501|62959125|FG000|Crossover Phase|Withdrew Consent|0|||
33564097|NCT02737501|62959126|FG001|Crossover Phase|Withdrew Consent|0|||
33564098|NCT02737501|62959127|FG002|Crossover Phase|Withdrew Consent|9|||
33564099|NCT02737501|62959125|FG000|Crossover Phase|Physician Decision|0|||
33564100|NCT02737501|62959126|FG001|Crossover Phase|Physician Decision|0|||
33564101|NCT02737501|62959127|FG002|Crossover Phase|Physician Decision|1|||
33564102|NCT02737501|62959125|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
33564103|NCT02737501|62959126|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
33564104|NCT02737501|62959127|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
33564105|NCT01640314|62959137|FG000|Overall Study|Protocol Violation|0|||
33564106|NCT01640314|62959138|FG001|Overall Study|Protocol Violation|1|||
33564107|NCT02740049|62959220|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
33564108|NCT01601704|62959226|FG000|Overall Study|Randomized but not dispensed study med|1|||
33564109|NCT01601704|62959227|FG001|Overall Study|Randomized but not dispensed study med|4|||
33564110|NCT04969276|62959236|FG000|Overall Study|Protocol Deviation|0|||
33564111|NCT04969276|62959237|FG001|Overall Study|Protocol Deviation|1|||
33564112|NCT04969276|62959238|FG002|Overall Study|Protocol Deviation|0|||
33564113|NCT04969276|62959236|FG000|Overall Study|Withdrawal by Subject|1|||
33564114|NCT04969276|62959237|FG001|Overall Study|Withdrawal by Subject|10|||
33564115|NCT04969276|62959238|FG002|Overall Study|Withdrawal by Subject|0|||
33564116|NCT04969276|62959236|FG000|Overall Study|Lost to Follow-up|0|||
33564117|NCT04969276|62959237|FG001|Overall Study|Lost to Follow-up|1|||
33564118|NCT04969276|62959238|FG002|Overall Study|Lost to Follow-up|0|||
33564119|NCT01601470|62959246|FG000|Period 2 - LCZ696|Physician Decision|1|||
33662990|NCT01686581|63093789|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
33662991|NCT01686581|63093789|FG000|Overall Study|Thinks it is Inconvenient|17|||
33662992|NCT01686581|63093789|FG000|Overall Study|Other Miscellaneous Reasons|36|||
33662993|NCT01686581|63093789|FG000|Overall Study|Reason Missing|1|||
33662994|NCT02691936|63093807|FG000|Overall Study|Withdrawal by Subject|2|||
33662995|NCT02691936|63093808|FG001|Overall Study|Withdrawal by Subject|5|||
33564120|NCT03248375|62959270|FG000|Overall Study|Lost to Follow-up|5|||
33564121|NCT01637272|62959274|FG000|Overall Study|Adverse Event|6|||
33564122|NCT01637272|62959274|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33564123|NCT01637272|62959274|FG000|Overall Study|Withdrawal by Subject|3|||
33564124|NCT01637272|62959274|FG000|Overall Study|Lost to Follow-up|2|||
33564125|NCT01637272|62959274|FG000|Overall Study|completed core, did not enter ext. phase|4|||
33564126|NCT01637272|62959274|FG000|Overall Study|Administrative problems|1|||
33564127|NCT01637272|62959274|FG000|Overall Study|Protocol Violation|2|||
33564128|NCT01636960|62959293|FG000|Induction Phase|Adverse Event|2|||
33564129|NCT01636960|62959293|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
33564130|NCT01636960|62959293|FG000|Maintenance Phase|Adverse Event|3|||
33564131|NCT01636960|62959293|FG000|Maintenance Phase|Progressive disease|1|||
33662996|NCT01685801|63093855|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
33564132|NCT01636258|62959299|FG000|Overall Study|Lost to Follow-up|1|||
33564133|NCT01636258|62959300|FG001|Overall Study|Lost to Follow-up|0|||
33564134|NCT02504216|62959309|FG000|Overall Study|Lost to Follow-up|3|||
33564135|NCT02504216|62959310|FG001|Overall Study|Lost to Follow-up|3|||
33564136|NCT02504216|62959309|FG000|Overall Study|Withdrawal by Subject|8|||
33564137|NCT02504216|62959310|FG001|Overall Study|Withdrawal by Subject|12|||
33564138|NCT04354870|62959318|FG000|Overall Study|Lost to Follow-up|32|||
33564139|NCT04354870|62959319|FG001|Overall Study|Lost to Follow-up|12|||
33564140|NCT04354870|62959318|FG000|Overall Study|Withdrawal by Subject|10|||
33564141|NCT04354870|62959319|FG001|Overall Study|Withdrawal by Subject|16|||
33564142|NCT04354870|62959318|FG000|Overall Study|Did not complete all study visits|6|||
33564143|NCT04354870|62959319|FG001|Overall Study|Did not complete all study visits|5|||
33564144|NCT02473952|62959327|FG000|Overall Study|Adverse Event|2|||
33564145|NCT02473952|62959328|FG001|Overall Study|Adverse Event|2|||
33564146|NCT02473952|62959327|FG000|Overall Study|Withdrawal by Subject|0|||
33564147|NCT02473952|62959328|FG001|Overall Study|Withdrawal by Subject|6|||
33564148|NCT02473640|62959334|FG000|Treatment Period 1|Adverse Event|1|||
33564149|NCT01637584|62959343|FG000|Overall Study|Withdrawal by Subject|1|||
33564150|NCT01637584|62959344|FG001|Overall Study|Withdrawal by Subject|3|||
33564151|NCT03883906|62959351|FG000|Overall Study|Withdrawal by Subject|2|||
33564152|NCT03883906|62959351|FG000|Overall Study|Physician Decision|5|||
33564153|NCT03875092|62959357|FG000|Overall Study|Adverse Event|2|||
33564154|NCT03875092|62959358|FG001|Overall Study|Adverse Event|5|||
33564155|NCT03875092|62959357|FG000|Overall Study|Death|28|||
33564156|NCT03875092|62959358|FG001|Overall Study|Death|41|||
33564157|NCT03875092|62959357|FG000|Overall Study|Ongoing in Study|35|||
33564158|NCT03875092|62959358|FG001|Overall Study|Ongoing in Study|14|||
33564159|NCT02503202|62959369|FG000|Base Study: Up to Month 6|Death|1|||
33564160|NCT02503202|62959370|FG001|Base Study: Up to Month 6|Death|1|||
33564161|NCT02503202|62959371|FG002|Base Study: Up to Month 6|Death|0|||
33564162|NCT02503202|62959372|FG003|Base Study: Up to Month 6|Death|0|||
33564163|NCT02503202|62959373|FG004|Base Study: Up to Month 6|Death|0|||
33564164|NCT02503202|62959369|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
33564165|NCT02503202|62959370|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
33564166|NCT02503202|62959371|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
33564167|NCT02503202|62959372|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
33564168|NCT02503202|62959373|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
33564169|NCT02503202|62959369|FG000|Base Study: Up to Month 6|Physician Decision|0|||
33564170|NCT02503202|62959370|FG001|Base Study: Up to Month 6|Physician Decision|0|||
33564171|NCT02503202|62959371|FG002|Base Study: Up to Month 6|Physician Decision|0|||
33564172|NCT02503202|62959372|FG003|Base Study: Up to Month 6|Physician Decision|0|||
33564173|NCT02503202|62959373|FG004|Base Study: Up to Month 6|Physician Decision|1|||
33564174|NCT02503202|62959369|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
33564175|NCT02503202|62959370|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
33564176|NCT02503202|62959371|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
33564177|NCT02503202|62959372|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
33564178|NCT02503202|62959373|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
33564179|NCT02503202|62959369|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
33564180|NCT02503202|62959370|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
33564181|NCT02503202|62959371|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
33564182|NCT02503202|62959372|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
33564183|NCT02503202|62959373|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
33564184|NCT02503202|62959369|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
33564185|NCT02503202|62959370|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
33564186|NCT02503202|62959371|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
33564187|NCT02503202|62959372|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
33564188|NCT02503202|62959373|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
33564189|NCT02503202|62959369|FG000|Extension: Month 6 to 24|Death|1|||
33564190|NCT02503202|62959370|FG001|Extension: Month 6 to 24|Death|0|||
33564191|NCT02503202|62959371|FG002|Extension: Month 6 to 24|Death|0|||
33564192|NCT02503202|62959372|FG003|Extension: Month 6 to 24|Death|0|||
33564193|NCT02503202|62959373|FG004|Extension: Month 6 to 24|Death|0|||
33564194|NCT02503202|62959369|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
33564195|NCT02503202|62959370|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
33564196|NCT02503202|62959371|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
33564197|NCT02503202|62959372|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
33564198|NCT02503202|62959373|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
33564199|NCT02503202|62959369|FG000|Extension: Month 6 to 24|Physician Decision|1|||
33564200|NCT02503202|62959370|FG001|Extension: Month 6 to 24|Physician Decision|0|||
33564201|NCT02503202|62959371|FG002|Extension: Month 6 to 24|Physician Decision|1|||
33564202|NCT02503202|62959372|FG003|Extension: Month 6 to 24|Physician Decision|3|||
33564203|NCT02503202|62959373|FG004|Extension: Month 6 to 24|Physician Decision|0|||
33564204|NCT02503202|62959369|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
33564205|NCT02503202|62959370|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
33564206|NCT02503202|62959371|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
33564207|NCT02503202|62959372|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
33564208|NCT02503202|62959373|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
33564209|NCT02728102|62959388|FG000|Overall Study|Death|3|||
33564210|NCT02728102|62959389|FG001|Overall Study|Death|0|||
33564211|NCT02728102|62959390|FG002|Overall Study|Death|1|||
33564212|NCT02728102|62959388|FG000|Overall Study|Withdrawal by Subject|0|||
33564213|NCT02728102|62959389|FG001|Overall Study|Withdrawal by Subject|2|||
33564214|NCT02728102|62959390|FG002|Overall Study|Withdrawal by Subject|3|||
33564215|NCT02728102|62959388|FG000|Overall Study|Physician Decision|1|||
33564216|NCT02728102|62959389|FG001|Overall Study|Physician Decision|1|||
33564217|NCT02728102|62959390|FG002|Overall Study|Physician Decision|0|||
33564218|NCT02728102|62959388|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
33564219|NCT02728102|62959389|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
33564220|NCT02728102|62959390|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
33564221|NCT02728102|62959388|FG000|Overall Study|Covid|0|||
33564222|NCT02728102|62959389|FG001|Overall Study|Covid|0|||
33564223|NCT02728102|62959390|FG002|Overall Study|Covid|1|||
33564224|NCT02502734|62959399|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
33564225|NCT02502734|62959400|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
33564226|NCT02502734|62959399|FG000|Washout Period|Adverse Event|1|||
33564227|NCT02502734|62959400|FG001|Washout Period|Adverse Event|0|||
33564228|NCT02473250|62959408|FG000|Overall Study|Lost to Follow-up|10|||
33564229|NCT02473250|62959408|FG000|Overall Study|Physician Decision|5|||
33564230|NCT02473250|62959408|FG000|Overall Study|Did not tolerate medication washout|3|||
33564231|NCT02473250|62959408|FG000|Overall Study|Antidepressant effect of divalproex|2|||
33564232|NCT02706730|62959413|FG000|Overall Study|Adverse Event|3|||
33564233|NCT02706730|62959413|FG000|Overall Study|Lack of Efficacy|5|||
33564234|NCT02706730|62959413|FG000|Overall Study|Withdrawal by Subject|11|||
33564235|NCT02706730|62959413|FG000|Overall Study|Study Terminated by Sponsor|11|||
33564236|NCT02706730|62959413|FG000|Overall Study|Subject chose not to receive injection|3|||
33564237|NCT02443688|62959420|FG000|Overall Study|Adverse Event|2|||
33564238|NCT02443688|62959421|FG001|Overall Study|Adverse Event|3|||
33564239|NCT02443688|62959422|FG002|Overall Study|Adverse Event|2|||
33564240|NCT02443688|62959420|FG000|Overall Study|Lost to Follow-up|1|||
33564241|NCT02443688|62959421|FG001|Overall Study|Lost to Follow-up|0|||
33564242|NCT02443688|62959422|FG002|Overall Study|Lost to Follow-up|0|||
33564243|NCT02443688|62959420|FG000|Overall Study|Physician Decision|3|||
33564244|NCT02443688|62959421|FG001|Overall Study|Physician Decision|0|||
33564245|NCT02443688|62959422|FG002|Overall Study|Physician Decision|1|||
33564246|NCT02443688|62959420|FG000|Overall Study|Pregnancy|0|||
33564247|NCT02443688|62959421|FG001|Overall Study|Pregnancy|0|||
33564248|NCT02443688|62959422|FG002|Overall Study|Pregnancy|1|||
33564249|NCT02443688|62959420|FG000|Overall Study|Withdrawal by Subject|3|||
33564250|NCT02443688|62959421|FG001|Overall Study|Withdrawal by Subject|3|||
33564251|NCT02443688|62959422|FG002|Overall Study|Withdrawal by Subject|4|||
33564252|NCT02443688|62959420|FG000|Overall Study|Non-compliance with study drug|1|||
33564253|NCT02443688|62959421|FG001|Overall Study|Non-compliance with study drug|2|||
33564254|NCT02443688|62959422|FG002|Overall Study|Non-compliance with study drug|4|||
33564255|NCT02443688|62959420|FG000|Overall Study|Sponsor Request|2|||
33564256|NCT02443688|62959421|FG001|Overall Study|Sponsor Request|1|||
33564257|NCT02443688|62959422|FG002|Overall Study|Sponsor Request|0|||
33564258|NCT02443298|62959436|FG000|Overall Study|Adverse Event|3|||
33564259|NCT02443298|62959437|FG001|Overall Study|Adverse Event|3|||
33564260|NCT02443298|62959436|FG000|Overall Study|Withdrawal by Subject|1|||
33564261|NCT02443298|62959437|FG001|Overall Study|Withdrawal by Subject|2|||
33564262|NCT02500706|62959446|FG000|Overall Study|Adverse Event|0|||
33564263|NCT02500706|62959447|FG001|Overall Study|Adverse Event|0|||
33564264|NCT02500706|62959448|FG002|Overall Study|Adverse Event|1|||
33564265|NCT02500706|62959446|FG000|Overall Study|Lost to Follow-up|0|||
33564266|NCT02500706|62959447|FG001|Overall Study|Lost to Follow-up|1|||
33392125|NCT00566020|62771013|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
33564267|NCT02500706|62959448|FG002|Overall Study|Lost to Follow-up|1|||
33564268|NCT02500706|62959446|FG000|Overall Study|Withdrawal by Subject|4|||
33564269|NCT02500706|62959447|FG001|Overall Study|Withdrawal by Subject|6|||
33564270|NCT02500706|62959448|FG002|Overall Study|Withdrawal by Subject|4|||
33564271|NCT02500706|62959446|FG000|Overall Study|Unclassified|0|||
33564272|NCT02500706|62959447|FG001|Overall Study|Unclassified|0|||
33564273|NCT02500706|62959448|FG002|Overall Study|Unclassified|1|||
33564274|NCT02442830|62959458|FG000|Overall Study|Technical Failure|0|||
33564275|NCT02442830|62959459|FG001|Overall Study|Technical Failure|1|||
33564276|NCT02471612|62959466|FG000|Overall Study|Lost to Follow-up|2|||
33564277|NCT02500550|62959483|FG000|Overall Study|Death|7|||
33564278|NCT02499770|62959489|FG000|Overall Study|Death|17|||
33564279|NCT02499770|62959490|FG001|Overall Study|Death|56|||
33564280|NCT02499770|62959489|FG000|Overall Study|Study completion|1|||
33564281|NCT02499770|62959490|FG001|Overall Study|Study completion|10|||
33564282|NCT02499770|62959489|FG000|Overall Study|Withdrawal by Subject|0|||
33564283|NCT02499770|62959490|FG001|Overall Study|Withdrawal by Subject|7|||
33564284|NCT02499770|62959489|FG000|Overall Study|Lost to Follow-up|0|||
33564285|NCT02499770|62959490|FG001|Overall Study|Lost to Follow-up|2|||
33564286|NCT02499770|62959489|FG000|Overall Study|Subject declined further treatment|1|||
33564287|NCT02499770|62959490|FG001|Overall Study|Subject declined further treatment|0|||
33564288|NCT02499770|62959489|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
33564289|NCT02499770|62959490|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
33564290|NCT02499770|62959489|FG000|Overall Study|Randomized but not enrolled|0|||
33564291|NCT02499770|62959490|FG001|Overall Study|Randomized but not enrolled|1|||
33564292|NCT02442284|62959502|FG000|Overall Study|Adverse Event|1|||
33564293|NCT02442284|62959502|FG000|Overall Study|Withdrew Consent|2|||
33564294|NCT02442284|62959502|FG000|Overall Study|Lost to Follow-up|3|||
33564295|NCT02442284|62959502|FG000|Overall Study|Other|1|||
33564296|NCT02442206|62959512|FG000|Period 1|Adverse Event|1|||
33564297|NCT02442206|62959513|FG001|Period 1|Adverse Event|1|||
33564298|NCT02442206|62959512|FG000|Period 1|withdrew consent|0|||
33564299|NCT02442206|62959513|FG001|Period 1|withdrew consent|1|||
33564300|NCT02442206|62959512|FG000|Period 1|COPD exacerbation|0|||
33564301|NCT02442206|62959513|FG001|Period 1|COPD exacerbation|1|||
33564302|NCT02442206|62959512|FG000|Period 2|Adverse Event|1|||
33564303|NCT02442206|62959513|FG001|Period 2|Adverse Event|0|||
33564304|NCT02499146|62959520|FG000|Overall Study|Lost to Follow-up|1|||
33564305|NCT02499146|62959520|FG000|Overall Study|Withdrawal by Subject|1|||
33564306|NCT02499146|62959520|FG000|Overall Study|Other|2|||
33564307|NCT02499146|62959520|FG000|Overall Study|Ongoing at date of cut-off|9|||
33564308|NCT02499146|62959520|FG000|Overall Study|Began other treatment/therapy|13|||
33564309|NCT03544138|62959524|FG000|Overall Study|Lost to Follow-up|29|||
33564310|NCT01634854|62959530|FG000|Overall Study|Cesarean delivery|2|||
33564311|NCT01634854|62959531|FG001|Overall Study|Cesarean delivery|7|||
33662997|NCT01685801|63093856|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
33662998|NCT01685801|63093857|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
33662999|NCT01685801|63093858|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
33663000|NCT01685801|63093855|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
33663001|NCT01685801|63093856|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
33663002|NCT01685801|63093857|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
33663003|NCT01685801|63093858|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
33663004|NCT01353222|63093877|FG000|Overall Study|Death|30|||
33663005|NCT01353222|63093878|FG001|Overall Study|Death|30|||
33663006|NCT01353222|63093877|FG000|Overall Study|Withdrawal by Subject|8|||
33663007|NCT01353222|63093878|FG001|Overall Study|Withdrawal by Subject|5|||
33663008|NCT01353222|63093877|FG000|Overall Study|Study Terminated|31|||
33663009|NCT01353222|63093878|FG001|Overall Study|Study Terminated|37|||
33663010|NCT01353222|63093877|FG000|Overall Study|Site closed research department|1|||
33663011|NCT01353222|63093878|FG001|Overall Study|Site closed research department|0|||
33663012|NCT01684943|63093908|FG000|Overall Study|Inadequate Venous Access|3|||
33663013|NCT01684943|63093909|FG001|Overall Study|Inadequate Venous Access|0|||
33663014|NCT01684943|63093910|FG002|Overall Study|Inadequate Venous Access|0|||
33663015|NCT01684943|63093908|FG000|Overall Study|Principal Investigator Determination|1|||
33663016|NCT01684943|63093909|FG001|Overall Study|Principal Investigator Determination|0|||
33663017|NCT01684943|63093910|FG002|Overall Study|Principal Investigator Determination|0|||
33663018|NCT01684943|63093908|FG000|Overall Study|Excluded from Analysis|1|||
33663019|NCT01684943|63093909|FG001|Overall Study|Excluded from Analysis|1|||
33663020|NCT01684943|63093910|FG002|Overall Study|Excluded from Analysis|1|||
33663021|NCT01684943|63093908|FG000|Overall Study|Lost to Follow-up|3|||
33663022|NCT01684943|63093909|FG001|Overall Study|Lost to Follow-up|0|||
33663023|NCT01684943|63093910|FG002|Overall Study|Lost to Follow-up|0|||
33663024|NCT01684943|63093908|FG000|Overall Study|Planning Pregnancy|1|||
33663025|NCT01684943|63093909|FG001|Overall Study|Planning Pregnancy|0|||
33663026|NCT01684943|63093910|FG002|Overall Study|Planning Pregnancy|0|||
33663027|NCT01683383|63093925|FG000|Overall Study|Infant was not transported|1|||
33663028|NCT01683383|63093926|FG001|Overall Study|Infant was not transported|0|||
33663029|NCT02694744|63093934|FG000|Overall Study|Adverse Event|2|||
33663030|NCT02694744|63093935|FG001|Overall Study|Adverse Event|1|||
33663031|NCT02694744|63093934|FG000|Overall Study|Withdrawal by Subject|2|||
33663032|NCT02694744|63093935|FG001|Overall Study|Withdrawal by Subject|1|||
33663033|NCT02694744|63093934|FG000|Overall Study|Physician Decision|1|||
33663034|NCT02694744|63093935|FG001|Overall Study|Physician Decision|2|||
33663035|NCT02694744|63093934|FG000|Overall Study|Lost to Follow-up|1|||
33663036|NCT02694744|63093935|FG001|Overall Study|Lost to Follow-up|0|||
33663037|NCT02694744|63093934|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
33564312|NCT02469896|62959539|FG000|Overall Study|Withdrawal by Subject|2|||
33564313|NCT02469896|62959540|FG001|Overall Study|Withdrawal by Subject|0|||
33564314|NCT02441114|62959550|FG000|Washout2|Withdrawal by Subject|4|||
33564315|NCT02498678|62959556|FG000|Overall Study|interference from the surgical team|0|||
33564316|NCT02498678|62959557|FG001|Overall Study|interference from the surgical team|2|||
33564317|NCT02441036|62959568|FG000|Overall Study|No tissue resected|0|||
33564318|NCT02441036|62959569|FG001|Overall Study|No tissue resected|1|||
33564319|NCT02441036|62959570|FG002|Overall Study|No tissue resected|0|||
33564320|NCT02441036|62959571|FG003|Overall Study|No tissue resected|1|||
33564321|NCT02441036|62959572|FG004|Overall Study|No tissue resected|0|||
33564322|NCT02498444|62959587|FG000|Overall Study|Withdrawal by Subject|3|||
33564323|NCT02498444|62959588|FG001|Overall Study|Withdrawal by Subject|0|||
33564324|NCT02498444|62959587|FG000|Overall Study|Physician Decision|1|||
33564325|NCT02498444|62959588|FG001|Overall Study|Physician Decision|0|||
33564326|NCT02497976|62959596|FG000|Overall Study|Withdrawal by Subject|2|||
33564327|NCT02497976|62959597|FG001|Overall Study|Withdrawal by Subject|0|||
33564328|NCT02497976|62959596|FG000|Overall Study|Moved out of area|0|||
33564329|NCT02497976|62959597|FG001|Overall Study|Moved out of area|1|||
33564330|NCT03347188|62959605|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
33564331|NCT03347188|62959606|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
33564332|NCT03347188|62959605|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
33564333|NCT03347188|62959606|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
33564334|NCT03347188|62959605|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
33564335|NCT03347188|62959606|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
33564336|NCT03347188|62959605|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
33564337|NCT03347188|62959606|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
33564338|NCT03347188|62959605|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
33564339|NCT03347188|62959606|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
33564340|NCT03347188|62959605|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
33564341|NCT03347188|62959606|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
33564342|NCT03347188|62959605|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
33564343|NCT03347188|62959606|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
33564344|NCT03347188|62959605|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
33564345|NCT03347188|62959606|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
33564346|NCT02440568|62959616|FG000|Overall Study|Death|1|||
33564347|NCT02440568|62959617|FG001|Overall Study|Death|3|||
33564348|NCT02440568|62959618|FG002|Overall Study|Death|4|||
33564349|NCT02440568|62959619|FG003|Overall Study|Death|2|||
33564350|NCT02440568|62959616|FG000|Overall Study|Lack of Efficacy|2|||
33663038|NCT02694744|63093935|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
33663039|NCT01683071|63093949|FG000|Part 1|Lack of Efficacy|1|||
33663040|NCT01683071|63093950|FG001|Part 1|Lack of Efficacy|0|||
33663041|NCT01683071|63093951|FG002|Part 1|Lack of Efficacy|0|||
33663042|NCT01683071|63093952|FG003|Part 1|Lack of Efficacy|3|||
33663043|NCT01683071|63093953|FG004|Part 1|Lack of Efficacy|0|||
33663044|NCT01683071|63093954|FG005|Part 1|Lack of Efficacy|0|||
33663045|NCT01683071|63093949|FG000|Part 1|Withdrawal by Subject|1|||
33663046|NCT01683071|63093950|FG001|Part 1|Withdrawal by Subject|2|||
33663047|NCT01683071|63093951|FG002|Part 1|Withdrawal by Subject|2|||
33663048|NCT01683071|63093952|FG003|Part 1|Withdrawal by Subject|1|||
33663049|NCT01683071|63093953|FG004|Part 1|Withdrawal by Subject|0|||
33663050|NCT01683071|63093954|FG005|Part 1|Withdrawal by Subject|0|||
33663051|NCT01683071|63093949|FG000|Part 1|Surgery Cancelled|1|||
33663052|NCT01683071|63093950|FG001|Part 1|Surgery Cancelled|0|||
33663053|NCT01683071|63093951|FG002|Part 1|Surgery Cancelled|0|||
33663054|NCT01683071|63093952|FG003|Part 1|Surgery Cancelled|0|||
33663055|NCT01683071|63093953|FG004|Part 1|Surgery Cancelled|0|||
33663056|NCT01683071|63093954|FG005|Part 1|Surgery Cancelled|0|||
33663057|NCT01683071|63093949|FG000|Part 1|Did not receive study drug|1|||
33663058|NCT01683071|63093950|FG001|Part 1|Did not receive study drug|0|||
33663059|NCT01683071|63093951|FG002|Part 1|Did not receive study drug|0|||
33663060|NCT01683071|63093952|FG003|Part 1|Did not receive study drug|1|||
33663061|NCT01683071|63093953|FG004|Part 1|Did not receive study drug|0|||
33663062|NCT01683071|63093954|FG005|Part 1|Did not receive study drug|0|||
33663063|NCT01683071|63093949|FG000|Part 1|Early termination; met exclusion criteria|0|||
33564351|NCT02440568|62959617|FG001|Overall Study|Lack of Efficacy|0|||
33564352|NCT02440568|62959618|FG002|Overall Study|Lack of Efficacy|1|||
33564353|NCT02440568|62959619|FG003|Overall Study|Lack of Efficacy|0|||
33564354|NCT02440568|62959616|FG000|Overall Study|Lost to Follow-up|1|||
33564355|NCT02440568|62959617|FG001|Overall Study|Lost to Follow-up|0|||
33564356|NCT02440568|62959618|FG002|Overall Study|Lost to Follow-up|0|||
33564357|NCT02440568|62959619|FG003|Overall Study|Lost to Follow-up|0|||
33564358|NCT03090191|62959632|FG000|Overall Study|Adverse Event|90|||
33663064|NCT01683071|63093950|FG001|Part 1|Early termination; met exclusion criteria|2|||
33663065|NCT01683071|63093951|FG002|Part 1|Early termination; met exclusion criteria|1|||
33663066|NCT01683071|63093952|FG003|Part 1|Early termination; met exclusion criteria|0|||
33663067|NCT01683071|63093953|FG004|Part 1|Early termination; met exclusion criteria|0|||
33663068|NCT01683071|63093954|FG005|Part 1|Early termination; met exclusion criteria|0|||
33564359|NCT03090191|62959633|FG001|Overall Study|Adverse Event|72|||
33564360|NCT03090191|62959632|FG000|Overall Study|Death|365|||
33564361|NCT03090191|62959633|FG001|Overall Study|Death|358|||
33663069|NCT01683071|63093949|FG000|Part 2|Lack of Efficacy|0|||
33663070|NCT01683071|63093950|FG001|Part 2|Lack of Efficacy|0|||
33564362|NCT03090191|62959632|FG000|Overall Study|Lost to Follow-up|382|||
33564363|NCT03090191|62959633|FG001|Overall Study|Lost to Follow-up|394|||
33564364|NCT03090191|62959632|FG000|Overall Study|Physician Decision|77|||
33564365|NCT03090191|62959633|FG001|Overall Study|Physician Decision|66|||
33564366|NCT03090191|62959632|FG000|Overall Study|Protocol Violation|43|||
33564367|NCT03090191|62959633|FG001|Overall Study|Protocol Violation|52|||
33300802|NCT01288443|62676930|FG000|Overall Study|Adverse Event|0|||
33300803|NCT01288443|62676931|FG001|Overall Study|Adverse Event|0|||
33300804|NCT01288443|62676932|FG002|Overall Study|Adverse Event|1|||
33564368|NCT03090191|62959632|FG000|Overall Study|Withdrawal by Subject|2160|||
33564369|NCT03090191|62959633|FG001|Overall Study|Withdrawal by Subject|2133|||
33564370|NCT03090191|62959632|FG000|Overall Study|Site terminated|7|||
33564371|NCT03090191|62959633|FG001|Overall Study|Site terminated|8|||
33564372|NCT03090191|62959632|FG000|Overall Study|Other|66|||
33564373|NCT03090191|62959633|FG001|Overall Study|Other|60|||
33564374|NCT03090191|62959632|FG000|Overall Study|Withdrawn before any study vaccination|43|||
33564375|NCT03090191|62959633|FG001|Overall Study|Withdrawn before any study vaccination|52|||
33564376|NCT02439320|62959655|FG000|Overall Study|Adverse Event|0|||
33564377|NCT02439320|62959656|FG001|Overall Study|Adverse Event|2|||
33564378|NCT02439320|62959657|FG002|Overall Study|Adverse Event|0|||
33564379|NCT02439320|62959655|FG000|Overall Study|Lost to Follow-up|37|||
33564380|NCT02439320|62959656|FG001|Overall Study|Lost to Follow-up|34|||
33300805|NCT01288443|62676933|FG003|Overall Study|Adverse Event|1|||
33300806|NCT01288443|62676934|FG004|Overall Study|Adverse Event|3|||
33300807|NCT01288443|62676935|FG005|Overall Study|Adverse Event|1|||
33300808|NCT01288443|62676930|FG000|Overall Study|Poor compliance to protocol|0|||
33300809|NCT01288443|62676931|FG001|Overall Study|Poor compliance to protocol|0|||
33300810|NCT01288443|62676932|FG002|Overall Study|Poor compliance to protocol|0|||
33300811|NCT01288443|62676933|FG003|Overall Study|Poor compliance to protocol|0|||
33300812|NCT01288443|62676934|FG004|Overall Study|Poor compliance to protocol|0|||
33300813|NCT01288443|62676935|FG005|Overall Study|Poor compliance to protocol|1|||
33300814|NCT01288443|62676930|FG000|Overall Study|Participant Moved|0|||
33300815|NCT01288443|62676931|FG001|Overall Study|Participant Moved|0|||
33300816|NCT01288443|62676932|FG002|Overall Study|Participant Moved|0|||
33300817|NCT01288443|62676933|FG003|Overall Study|Participant Moved|1|||
33300818|NCT01288443|62676934|FG004|Overall Study|Participant Moved|2|||
33300819|NCT01288443|62676935|FG005|Overall Study|Participant Moved|1|||
33300820|NCT01288443|62676930|FG000|Overall Study|Consent withdrawn by Participant|0|||
33300821|NCT01288443|62676931|FG001|Overall Study|Consent withdrawn by Participant|0|||
33300822|NCT01288443|62676932|FG002|Overall Study|Consent withdrawn by Participant|0|||
33300823|NCT01288443|62676933|FG003|Overall Study|Consent withdrawn by Participant|0|||
33300824|NCT01288443|62676934|FG004|Overall Study|Consent withdrawn by Participant|0|||
33300825|NCT01288443|62676935|FG005|Overall Study|Consent withdrawn by Participant|1|||
33300826|NCT01288443|62676930|FG000|Overall Study|Lost to Follow-up|0|||
33300827|NCT01288443|62676931|FG001|Overall Study|Lost to Follow-up|1|||
33300828|NCT01288443|62676932|FG002|Overall Study|Lost to Follow-up|0|||
33300829|NCT01288443|62676933|FG003|Overall Study|Lost to Follow-up|0|||
33300830|NCT01288443|62676934|FG004|Overall Study|Lost to Follow-up|0|||
33300831|NCT01288443|62676935|FG005|Overall Study|Lost to Follow-up|0|||
33300832|NCT01288443|62676930|FG000|Overall Study|Study drug auto-injector administration|0|||
33300833|NCT01288443|62676931|FG001|Overall Study|Study drug auto-injector administration|0|||
33300834|NCT01288443|62676932|FG002|Overall Study|Study drug auto-injector administration|0|||
33300835|NCT01288443|62676933|FG003|Overall Study|Study drug auto-injector administration|0|||
33300836|NCT01288443|62676934|FG004|Overall Study|Study drug auto-injector administration|1|||
33300837|NCT01288443|62676935|FG005|Overall Study|Study drug auto-injector administration|1|||
33300838|NCT01288443|62676930|FG000|Overall Study|Other than above|0|||
33300839|NCT01288443|62676931|FG001|Overall Study|Other than above|0|||
33300840|NCT01288443|62676932|FG002|Overall Study|Other than above|0|||
33300841|NCT01288443|62676933|FG003|Overall Study|Other than above|2|||
33300842|NCT01288443|62676934|FG004|Overall Study|Other than above|1|||
33300843|NCT01288443|62676935|FG005|Overall Study|Other than above|0|||
33564381|NCT02439320|62959657|FG002|Overall Study|Lost to Follow-up|42|||
33564382|NCT02439320|62959655|FG000|Overall Study|Death|0|||
33564383|NCT02439320|62959656|FG001|Overall Study|Death|1|||
33564384|NCT02439320|62959657|FG002|Overall Study|Death|0|||
33564385|NCT02439320|62959655|FG000|Overall Study|Noncompliance with Protocol|10|||
33564386|NCT02439320|62959656|FG001|Overall Study|Noncompliance with Protocol|11|||
33564387|NCT02439320|62959657|FG002|Overall Study|Noncompliance with Protocol|7|||
33564388|NCT02439320|62959655|FG000|Overall Study|Pregnancy|0|||
33663071|NCT01683071|63093951|FG002|Part 2|Lack of Efficacy|0|||
33300844|NCT01288287|62676949|FG000|Overall Study|Lost to Follow-up|8|||
33300845|NCT01288287|62676949|FG000|Overall Study|Withdrawal by Subject|4|||
33300846|NCT01288287|62676949|FG000|Overall Study|Lack of Efficacy|13|||
33300847|NCT01288287|62676949|FG000|Overall Study|Other Reason|13|||
33564389|NCT02439320|62959656|FG001|Overall Study|Pregnancy|1|||
33564390|NCT02439320|62959657|FG002|Overall Study|Pregnancy|1|||
33564391|NCT02439320|62959655|FG000|Overall Study|Withdrawal by Subject|12|||
33564392|NCT02439320|62959656|FG001|Overall Study|Withdrawal by Subject|16|||
33564393|NCT02439320|62959657|FG002|Overall Study|Withdrawal by Subject|14|||
33564394|NCT02439320|62959655|FG000|Overall Study|Physician Decision|2|||
33564395|NCT02439320|62959656|FG001|Overall Study|Physician Decision|1|||
33564396|NCT02439320|62959657|FG002|Overall Study|Physician Decision|0|||
33564397|NCT02439320|62959655|FG000|Overall Study|Sponsor Request|0|||
33564398|NCT02439320|62959656|FG001|Overall Study|Sponsor Request|2|||
33564399|NCT02439320|62959657|FG002|Overall Study|Sponsor Request|1|||
33564400|NCT02439320|62959655|FG000|Overall Study|Randomization Failure|35|||
33564401|NCT02439320|62959656|FG001|Overall Study|Randomization Failure|46|||
33564402|NCT02439320|62959657|FG002|Overall Study|Randomization Failure|34|||
33564403|NCT02469038|62959673|FG000|Overall Study|Physician Decision|4|||
33564404|NCT02469038|62959674|FG001|Overall Study|Physician Decision|5|||
33564405|NCT02468648|62959680|FG000|Overall Study|Death|1|||
33564406|NCT02468414|62959686|FG000|Overall Study|Early Study Termination by Sponsor|1|||
33564407|NCT02468414|62959687|FG001|Overall Study|Early Study Termination by Sponsor|0|||
33564408|NCT02468414|62959686|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
33564409|NCT02468414|62959687|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
33564410|NCT02468414|62959686|FG000|Overall Study|Screen Failure|1|||
33564411|NCT02468414|62959687|FG001|Overall Study|Screen Failure|0|||
33564412|NCT02466386|62959693|FG000|Overall Study|Adverse Event|5|||
33564413|NCT02466386|62959693|FG000|Overall Study|Protocol Violation|2|||
33564414|NCT02466386|62959693|FG000|Overall Study|Withdrawal by Subject|14|||
33564415|NCT02466386|62959693|FG000|Overall Study|Lost to Follow-up|5|||
33564416|NCT02466386|62959693|FG000|Overall Study|Lack of Efficacy|8|||
33564417|NCT02466386|62959693|FG000|Overall Study|Other|10|||
33564418|NCT01633060|62959699|FG000|Randomization Phase|Protocol deviation|1|||
33564419|NCT01633060|62959700|FG001|Randomization Phase|Protocol deviation|2|||
33564420|NCT01633060|62959699|FG000|Randomization Phase|Technical problem|0|||
33564421|NCT01633060|62959700|FG001|Randomization Phase|Technical problem|1|||
33564422|NCT01633060|62959699|FG000|Treatment Phase|Adverse Event|24|||
33564423|NCT01633060|62959700|FG001|Treatment Phase|Adverse Event|3|||
33564424|NCT01633060|62959699|FG000|Treatment Phase|Lost to Follow-up|1|||
33564425|NCT01633060|62959700|FG001|Treatment Phase|Lost to Follow-up|0|||
33564426|NCT01633060|62959699|FG000|Treatment Phase|Physician Decision|16|||
33564427|NCT01633060|62959700|FG001|Treatment Phase|Physician Decision|7|||
33564428|NCT01633060|62959699|FG000|Treatment Phase|Progressive Disease|210|||
33564429|NCT01633060|62959700|FG001|Treatment Phase|Progressive Disease|120|||
33564430|NCT01633060|62959699|FG000|Treatment Phase|Protocol Deviation|1|||
33564431|NCT01633060|62959700|FG001|Treatment Phase|Protocol Deviation|0|||
33564432|NCT01633060|62959699|FG000|Treatment Phase|Study Terminated by sponsor|7|||
33564433|NCT01633060|62959700|FG001|Treatment Phase|Study Terminated by sponsor|3|||
33564434|NCT01633060|62959699|FG000|Treatment Phase|Subject/guardian decision|25|||
33564435|NCT01633060|62959700|FG001|Treatment Phase|Subject/guardian decision|4|||
33564436|NCT01633060|62959699|FG000|Treatment Phase|Death|4|||
33564437|NCT01633060|62959700|FG001|Treatment Phase|Death|3|||
33564438|NCT01633060|62959699|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
33564439|NCT01633060|62959700|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33564440|NCT01633060|62959699|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
33564441|NCT01633060|62959700|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
33564442|NCT01633060|62959699|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
33564443|NCT01633060|62959700|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
33564444|NCT01633060|62959699|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
33564445|NCT01633060|62959700|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
33564446|NCT01633060|62959699|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
33564447|NCT01633060|62959700|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
33300848|NCT01288287|62676949|FG000|Overall Study|Unknown Reason|1|||
33564448|NCT01633060|62959699|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
33564449|NCT01633060|62959700|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
33564450|NCT01632904|62959709|FG000|Overall Study|Adverse Event|4|||
33564451|NCT01632904|62959710|FG001|Overall Study|Adverse Event|1|||
33564452|NCT01632904|62959709|FG000|Overall Study|Physician Decision|0|||
33564453|NCT01632904|62959710|FG001|Overall Study|Physician Decision|1|||
33564454|NCT01632904|62959709|FG000|Overall Study|Subject decision|3|||
33564455|NCT01632904|62959710|FG001|Overall Study|Subject decision|2|||
33564456|NCT01632904|62959709|FG000|Overall Study|Disease Progression|0|||
33564457|NCT01632904|62959710|FG001|Overall Study|Disease Progression|1|||
33564458|NCT01632904|62959709|FG000|Overall Study|Reason for discontinuation not available|0|||
33564459|NCT01632904|62959710|FG001|Overall Study|Reason for discontinuation not available|1|||
33564460|NCT03834779|62959718|FG000|Overall Study|Death|1|||
33564461|NCT03834779|62959719|FG001|Overall Study|Death|2|||
33564462|NCT03834779|62959718|FG000|Overall Study|Lost to Follow-up|6|||
33564463|NCT03834779|62959719|FG001|Overall Study|Lost to Follow-up|4|||
33564464|NCT03726437|62959728|FG000|Overall Study|Lost to Follow-up|85|||
33564465|NCT03726437|62959729|FG001|Overall Study|Lost to Follow-up|76|||
33564466|NCT02465528|62959739|FG000|Overall Study|Progressive disease|0|||
33564467|NCT02465528|62959740|FG001|Overall Study|Progressive disease|2|||
33564468|NCT02465528|62959741|FG002|Overall Study|Progressive disease|9|||
33564469|NCT02465528|62959742|FG003|Overall Study|Progressive disease|4|||
33564470|NCT02465528|62959739|FG000|Overall Study|Study terminated by sponsor|1|||
33564471|NCT02465528|62959740|FG001|Overall Study|Study terminated by sponsor|2|||
33564472|NCT02465528|62959741|FG002|Overall Study|Study terminated by sponsor|0|||
33564473|NCT02465528|62959742|FG003|Overall Study|Study terminated by sponsor|0|||
33564474|NCT02465528|62959739|FG000|Overall Study|Withdrawal by Subject|0|||
33564475|NCT02465528|62959740|FG001|Overall Study|Withdrawal by Subject|0|||
33564476|NCT02465528|62959741|FG002|Overall Study|Withdrawal by Subject|2|||
33564477|NCT02465528|62959742|FG003|Overall Study|Withdrawal by Subject|0|||
33564478|NCT02465528|62959739|FG000|Overall Study|Adverse Event|0|||
33564479|NCT02465528|62959740|FG001|Overall Study|Adverse Event|0|||
33564480|NCT02465528|62959741|FG002|Overall Study|Adverse Event|0|||
33564481|NCT02465528|62959742|FG003|Overall Study|Adverse Event|1|||
33564482|NCT02465528|62959739|FG000|Overall Study|Physician Decision|0|||
33564483|NCT02465528|62959740|FG001|Overall Study|Physician Decision|0|||
33564484|NCT02465528|62959741|FG002|Overall Study|Physician Decision|1|||
33564485|NCT02465528|62959742|FG003|Overall Study|Physician Decision|0|||
33564486|NCT02438384|62959757|FG000|Overall Study|Lost to Follow-up|8|||
33564487|NCT02438384|62959758|FG001|Overall Study|Lost to Follow-up|6|||
33564488|NCT02438384|62959759|FG002|Overall Study|Lost to Follow-up|4|||
33564489|NCT02463032|62959769|FG000|Overall Study|Lack of Efficacy|61|||
33564490|NCT02463032|62959770|FG001|Overall Study|Lack of Efficacy|50|||
33564491|NCT02463032|62959769|FG000|Overall Study|Death|8|||
33564492|NCT02463032|62959770|FG001|Overall Study|Death|8|||
33564493|NCT02463032|62959769|FG000|Overall Study|Adverse Event|2|||
33564494|NCT02463032|62959770|FG001|Overall Study|Adverse Event|6|||
33564495|NCT02496884|62959780|FG000|Overall Study|Counted twice as enrolled|2|||
33564496|NCT02496884|62959781|FG001|Overall Study|Counted twice as enrolled|0|||
33564497|NCT02496884|62959782|FG002|Overall Study|Counted twice as enrolled|0|||
33564498|NCT02496884|62959783|FG003|Overall Study|Counted twice as enrolled|0|||
33564499|NCT02496884|62959780|FG000|Overall Study|Withdrawal by Subject|0|||
33564500|NCT02496884|62959781|FG001|Overall Study|Withdrawal by Subject|3|||
33564501|NCT02496884|62959782|FG002|Overall Study|Withdrawal by Subject|0|||
33564502|NCT02496884|62959783|FG003|Overall Study|Withdrawal by Subject|0|||
33564503|NCT02462876|62959793|FG000|Overall Study|Death|3|||
33564504|NCT02462876|62959793|FG000|Overall Study|Lost to Follow-up|7|||
33564505|NCT02462876|62959793|FG000|Overall Study|Surgical Bypass|9|||
33564506|NCT02462876|62959793|FG000|Overall Study|Amputation Above the Metatarsals|1|||
33564507|NCT02462876|62959793|FG000|Overall Study|36 months follow-up visit missed|1|||
33564508|NCT02462876|62959793|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
33564509|NCT02462876|62959793|FG000|Overall Study|Patient did not come back to the vascular department|1|||
33564510|NCT02462876|62959793|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
33564511|NCT02462876|62959793|FG000|Overall Study|Patient refused to come back|1|||
33564512|NCT02462876|62959793|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
33564513|NCT02462876|62959793|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
33564514|NCT03386721|62959812|FG000|Overall Study|Death|12|||
33564515|NCT03386721|62959813|FG001|Overall Study|Death|21|||
33564516|NCT03386721|62959814|FG002|Overall Study|Death|2|||
33564517|NCT03386721|62959815|FG003|Overall Study|Death|5|||
33564518|NCT03386721|62959816|FG004|Overall Study|Death|1|||
33564519|NCT03386721|62959817|FG005|Overall Study|Death|12|||
33564520|NCT03386721|62959818|FG006|Overall Study|Death|1|||
33564521|NCT03386721|62959819|FG007|Overall Study|Death|1|||
33564522|NCT03386721|62959820|FG008|Overall Study|Death|12|||
33564523|NCT03386721|62959821|FG009|Overall Study|Death|20|||
33564524|NCT03386721|62959822|FG010|Overall Study|Death|21|||
33564525|NCT03386721|62959823|FG011|Overall Study|Death|21|||
33564526|NCT03386721|62959824|FG012|Overall Study|Death|14|||
33564527|NCT03386721|62959825|FG013|Overall Study|Death|2|||
33564528|NCT03386721|62959826|FG014|Overall Study|Death|1|||
33564529|NCT03386721|62959812|FG000|Overall Study|Lost to Follow-up|1|||
33564530|NCT03386721|62959813|FG001|Overall Study|Lost to Follow-up|3|||
33663072|NCT01683071|63093952|FG003|Part 2|Lack of Efficacy|0|||
33564531|NCT03386721|62959814|FG002|Overall Study|Lost to Follow-up|0|||
33564532|NCT03386721|62959815|FG003|Overall Study|Lost to Follow-up|0|||
33564533|NCT03386721|62959816|FG004|Overall Study|Lost to Follow-up|0|||
33564534|NCT03386721|62959817|FG005|Overall Study|Lost to Follow-up|2|||
33564535|NCT03386721|62959818|FG006|Overall Study|Lost to Follow-up|1|||
33564536|NCT03386721|62959819|FG007|Overall Study|Lost to Follow-up|0|||
33564537|NCT03386721|62959820|FG008|Overall Study|Lost to Follow-up|1|||
33564538|NCT03386721|62959821|FG009|Overall Study|Lost to Follow-up|2|||
33564539|NCT03386721|62959822|FG010|Overall Study|Lost to Follow-up|1|||
33564540|NCT03386721|62959823|FG011|Overall Study|Lost to Follow-up|0|||
33564541|NCT03386721|62959824|FG012|Overall Study|Lost to Follow-up|0|||
33564542|NCT03386721|62959825|FG013|Overall Study|Lost to Follow-up|0|||
33564543|NCT03386721|62959826|FG014|Overall Study|Lost to Follow-up|0|||
33663073|NCT01683071|63093953|FG004|Part 2|Lack of Efficacy|3|||
33564544|NCT03386721|62959812|FG000|Overall Study|Reason not specified|3|||
33564545|NCT03386721|62959813|FG001|Overall Study|Reason not specified|0|||
33564546|NCT03386721|62959814|FG002|Overall Study|Reason not specified|0|||
33564547|NCT03386721|62959815|FG003|Overall Study|Reason not specified|0|||
33564548|NCT03386721|62959816|FG004|Overall Study|Reason not specified|0|||
33564549|NCT03386721|62959817|FG005|Overall Study|Reason not specified|3|||
33564550|NCT03386721|62959818|FG006|Overall Study|Reason not specified|1|||
33564551|NCT03386721|62959819|FG007|Overall Study|Reason not specified|0|||
33564552|NCT03386721|62959820|FG008|Overall Study|Reason not specified|0|||
33564553|NCT03386721|62959821|FG009|Overall Study|Reason not specified|1|||
33564554|NCT03386721|62959822|FG010|Overall Study|Reason not specified|2|||
33564555|NCT03386721|62959823|FG011|Overall Study|Reason not specified|6|||
33564556|NCT03386721|62959824|FG012|Overall Study|Reason not specified|1|||
33564557|NCT03386721|62959825|FG013|Overall Study|Reason not specified|0|||
33564558|NCT03386721|62959826|FG014|Overall Study|Reason not specified|0|||
33564559|NCT03386721|62959812|FG000|Overall Study|Progressive Disease|0|||
33564560|NCT03386721|62959813|FG001|Overall Study|Progressive Disease|0|||
33564561|NCT03386721|62959814|FG002|Overall Study|Progressive Disease|1|||
33564562|NCT03386721|62959815|FG003|Overall Study|Progressive Disease|0|||
33564563|NCT03386721|62959816|FG004|Overall Study|Progressive Disease|0|||
33564564|NCT03386721|62959817|FG005|Overall Study|Progressive Disease|1|||
33564565|NCT03386721|62959818|FG006|Overall Study|Progressive Disease|0|||
33564566|NCT03386721|62959819|FG007|Overall Study|Progressive Disease|0|||
33300849|NCT01288287|62676949|FG000|Overall Study|Unknown Status|7|||
33300850|NCT01288209|62676956|FG000|Overall Study|Withdrawal by Subject|1|||
33300851|NCT01288209|62676957|FG001|Overall Study|Withdrawal by Subject|3|||
33300852|NCT01288209|62676956|FG000|Overall Study|Other|1|||
33300853|NCT01288209|62676957|FG001|Overall Study|Other|0|||
33300854|NCT01288053|62676963|FG000|Overall Study|Death|1|||
33300855|NCT01287195|62676967|FG000|Overall Study|Withdrawal by Subject|2|||
33300856|NCT01287117|62676975|FG000|Overall Study|Adverse Event|2|||
33300857|NCT01287117|62676976|FG001|Overall Study|Adverse Event|1|||
33300858|NCT01287117|62676977|FG002|Overall Study|Adverse Event|1|||
33300859|NCT01287117|62676978|FG003|Overall Study|Adverse Event|1|||
33300860|NCT01287117|62676975|FG000|Overall Study|Lost to Follow-up|1|||
33300861|NCT01287117|62676976|FG001|Overall Study|Lost to Follow-up|1|||
33300862|NCT01287117|62676977|FG002|Overall Study|Lost to Follow-up|0|||
33300863|NCT01287117|62676978|FG003|Overall Study|Lost to Follow-up|0|||
33300864|NCT01287117|62676975|FG000|Overall Study|Physician Decision|0|||
33300865|NCT01287117|62676976|FG001|Overall Study|Physician Decision|1|||
33300866|NCT01287117|62676977|FG002|Overall Study|Physician Decision|1|||
33300867|NCT01287117|62676978|FG003|Overall Study|Physician Decision|1|||
33300868|NCT01287117|62676975|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
33300869|NCT01287117|62676976|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
33300870|NCT01287117|62676977|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
33300871|NCT01287117|62676978|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
33300872|NCT01287117|62676975|FG000|Overall Study|Disease Progression|10|||
33300873|NCT01287117|62676976|FG001|Overall Study|Disease Progression|5|||
33300874|NCT01287117|62676977|FG002|Overall Study|Disease Progression|6|||
33300875|NCT01287117|62676978|FG003|Overall Study|Disease Progression|5|||
33300876|NCT01287039|62676990|FG000|Overall Study|Noncompliance with study procedures|0|||
33300877|NCT01287039|62676991|FG001|Overall Study|Noncompliance with study procedures|1|||
33300878|NCT01287039|62676990|FG000|Overall Study|Change of location/residence|0|||
33300879|NCT01287039|62676991|FG001|Overall Study|Change of location/residence|3|||
33300880|NCT01287039|62676990|FG000|Overall Study|Elective surgery|0|||
33300881|NCT01287039|62676991|FG001|Overall Study|Elective surgery|1|||
33300882|NCT01287039|62676990|FG000|Overall Study|Protocol Violation|2|||
33300883|NCT01287039|62676991|FG001|Overall Study|Protocol Violation|3|||
33300884|NCT01287039|62676990|FG000|Overall Study|Excluded medication taken|1|||
33300885|NCT01287039|62676991|FG001|Overall Study|Excluded medication taken|0|||
33300886|NCT01287039|62676990|FG000|Overall Study|Noncompliance with study medication|0|||
33300887|NCT01287039|62676991|FG001|Overall Study|Noncompliance with study medication|1|||
33300888|NCT01287039|62676990|FG000|Overall Study|Problem with travel|0|||
33300889|NCT01287039|62676991|FG001|Overall Study|Problem with travel|1|||
33300890|NCT01287039|62676990|FG000|Overall Study|Death|1|||
33300891|NCT01287039|62676991|FG001|Overall Study|Death|0|||
33564567|NCT03386721|62959820|FG008|Overall Study|Progressive Disease|2|||
33564568|NCT03386721|62959821|FG009|Overall Study|Progressive Disease|1|||
33564569|NCT03386721|62959822|FG010|Overall Study|Progressive Disease|1|||
33564570|NCT03386721|62959823|FG011|Overall Study|Progressive Disease|0|||
33564571|NCT03386721|62959824|FG012|Overall Study|Progressive Disease|1|||
33300892|NCT01287039|62676990|FG000|Overall Study|Change of residence|1|||
33300893|NCT01287039|62676991|FG001|Overall Study|Change of residence|0|||
33564572|NCT03386721|62959825|FG013|Overall Study|Progressive Disease|0|||
33564573|NCT03386721|62959826|FG014|Overall Study|Progressive Disease|0|||
33564574|NCT03386721|62959812|FG000|Overall Study|Site Terminated by Sponsor|5|||
33564575|NCT03386721|62959813|FG001|Overall Study|Site Terminated by Sponsor|5|||
33564576|NCT03386721|62959814|FG002|Overall Study|Site Terminated by Sponsor|0|||
33564577|NCT03386721|62959815|FG003|Overall Study|Site Terminated by Sponsor|0|||
33564578|NCT03386721|62959816|FG004|Overall Study|Site Terminated by Sponsor|1|||
33564579|NCT03386721|62959817|FG005|Overall Study|Site Terminated by Sponsor|3|||
33564580|NCT03386721|62959818|FG006|Overall Study|Site Terminated by Sponsor|0|||
33564581|NCT03386721|62959819|FG007|Overall Study|Site Terminated by Sponsor|1|||
33564582|NCT03386721|62959820|FG008|Overall Study|Site Terminated by Sponsor|4|||
33564583|NCT03386721|62959821|FG009|Overall Study|Site Terminated by Sponsor|5|||
33564584|NCT03386721|62959822|FG010|Overall Study|Site Terminated by Sponsor|3|||
33564585|NCT03386721|62959823|FG011|Overall Study|Site Terminated by Sponsor|11|||
33564586|NCT03386721|62959824|FG012|Overall Study|Site Terminated by Sponsor|6|||
33564587|NCT03386721|62959825|FG013|Overall Study|Site Terminated by Sponsor|0|||
33564588|NCT03386721|62959826|FG014|Overall Study|Site Terminated by Sponsor|0|||
33564589|NCT03386721|62959812|FG000|Overall Study|Symptomatic Deterioration|0|||
33564590|NCT03386721|62959813|FG001|Overall Study|Symptomatic Deterioration|0|||
33564591|NCT03386721|62959814|FG002|Overall Study|Symptomatic Deterioration|0|||
33564592|NCT03386721|62959815|FG003|Overall Study|Symptomatic Deterioration|0|||
33564593|NCT03386721|62959816|FG004|Overall Study|Symptomatic Deterioration|0|||
33564594|NCT03386721|62959817|FG005|Overall Study|Symptomatic Deterioration|0|||
33564595|NCT03386721|62959818|FG006|Overall Study|Symptomatic Deterioration|0|||
33564596|NCT03386721|62959819|FG007|Overall Study|Symptomatic Deterioration|0|||
33564597|NCT03386721|62959820|FG008|Overall Study|Symptomatic Deterioration|1|||
33564598|NCT03386721|62959821|FG009|Overall Study|Symptomatic Deterioration|0|||
33564599|NCT03386721|62959822|FG010|Overall Study|Symptomatic Deterioration|0|||
33564600|NCT03386721|62959823|FG011|Overall Study|Symptomatic Deterioration|1|||
33564601|NCT03386721|62959824|FG012|Overall Study|Symptomatic Deterioration|0|||
33564602|NCT03386721|62959825|FG013|Overall Study|Symptomatic Deterioration|0|||
33564603|NCT03386721|62959826|FG014|Overall Study|Symptomatic Deterioration|0|||
33564604|NCT03386721|62959812|FG000|Overall Study|Withdrawal by Subject|1|||
33564605|NCT03386721|62959813|FG001|Overall Study|Withdrawal by Subject|2|||
33564606|NCT03386721|62959814|FG002|Overall Study|Withdrawal by Subject|0|||
33564607|NCT03386721|62959815|FG003|Overall Study|Withdrawal by Subject|0|||
33564608|NCT03386721|62959816|FG004|Overall Study|Withdrawal by Subject|0|||
33564609|NCT03386721|62959817|FG005|Overall Study|Withdrawal by Subject|0|||
33564610|NCT03386721|62959818|FG006|Overall Study|Withdrawal by Subject|0|||
33564611|NCT03386721|62959819|FG007|Overall Study|Withdrawal by Subject|0|||
33564612|NCT03386721|62959820|FG008|Overall Study|Withdrawal by Subject|2|||
33564613|NCT03386721|62959821|FG009|Overall Study|Withdrawal by Subject|1|||
33564614|NCT03386721|62959822|FG010|Overall Study|Withdrawal by Subject|3|||
33564615|NCT03386721|62959823|FG011|Overall Study|Withdrawal by Subject|2|||
33564616|NCT03386721|62959824|FG012|Overall Study|Withdrawal by Subject|3|||
33564617|NCT03386721|62959825|FG013|Overall Study|Withdrawal by Subject|0|||
33564618|NCT03386721|62959826|FG014|Overall Study|Withdrawal by Subject|0|||
33564619|NCT02462720|62959858|FG000|Part 2|Withdrawal by Subject|1|||
33564620|NCT02462720|62959859|FG001|Part 2|Withdrawal by Subject|0|||
33564621|NCT02462720|62959858|FG000|Part 2|Protocol Violation|0|||
33564622|NCT02462720|62959859|FG001|Part 2|Protocol Violation|1|||
33564623|NCT02246218|62959869|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33564624|NCT02246218|62959870|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33564625|NCT02246218|62959869|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
33564626|NCT02246218|62959870|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
33564627|NCT02246218|62959869|FG000|Overall Study|Adverse Event|1|||
33564628|NCT02246218|62959870|FG001|Overall Study|Adverse Event|1|||
33564629|NCT02246218|62959869|FG000|Overall Study|Lost to Follow-up|1|||
33564630|NCT02246218|62959870|FG001|Overall Study|Lost to Follow-up|0|||
33564631|NCT02244580|62959876|FG000|Overall Study|No cancer tissues available|241|||
33564632|NCT02244424|62959886|FG000|Overall Study|Lost to Follow-up|20|||
33564633|NCT02244424|62959887|FG001|Overall Study|Lost to Follow-up|10|||
33564634|NCT00159783|62959896|FG000|Overall Study|Adverse Event|5|||
33564635|NCT00159783|62959897|FG001|Overall Study|Adverse Event|7|||
33564636|NCT00159783|62959898|FG002|Overall Study|Adverse Event|9|||
33564637|NCT00159783|62959896|FG000|Overall Study|Lack of Efficacy|1|||
33564638|NCT00159783|62959897|FG001|Overall Study|Lack of Efficacy|2|||
33564639|NCT00159783|62959898|FG002|Overall Study|Lack of Efficacy|3|||
33663074|NCT01683071|63093954|FG005|Part 2|Lack of Efficacy|4|||
33663075|NCT01683071|63093949|FG000|Part 2|Lost to Follow-up|0|||
33663076|NCT01683071|63093950|FG001|Part 2|Lost to Follow-up|0|||
33300894|NCT01287039|62676990|FG000|Overall Study|Adverse Event|7|||
33663077|NCT01683071|63093951|FG002|Part 2|Lost to Follow-up|0|||
33300895|NCT01287039|62676991|FG001|Overall Study|Adverse Event|4|||
33300896|NCT01287039|62676990|FG000|Overall Study|Withdrawal by Subject|14|||
33300897|NCT01287039|62676991|FG001|Overall Study|Withdrawal by Subject|11|||
33300898|NCT01287039|62676990|FG000|Overall Study|Lost to Follow-up|3|||
33564640|NCT00159783|62959896|FG000|Overall Study|Withdrawal by Subject|7|||
33564641|NCT00159783|62959897|FG001|Overall Study|Withdrawal by Subject|11|||
33564642|NCT00159783|62959898|FG002|Overall Study|Withdrawal by Subject|12|||
33564643|NCT00159783|62959896|FG000|Overall Study|Lost to Follow-up|6|||
33564644|NCT00159783|62959897|FG001|Overall Study|Lost to Follow-up|5|||
33564645|NCT00159783|62959898|FG002|Overall Study|Lost to Follow-up|11|||
33564646|NCT00159783|62959896|FG000|Overall Study|Other|0|||
33564647|NCT00159783|62959897|FG001|Overall Study|Other|2|||
33564648|NCT00159783|62959898|FG002|Overall Study|Other|4|||
33564649|NCT00646204|62959909|FG000|Overall Study|Adverse Event|3|||
33564650|NCT00646204|62959910|FG001|Overall Study|Adverse Event|0|||
33564651|NCT00646204|62959909|FG000|Overall Study|Withdrawal by Subject|1|||
33564652|NCT00646204|62959910|FG001|Overall Study|Withdrawal by Subject|0|||
33564653|NCT02936323|62959927|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
33564654|NCT02936323|62959928|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
33564655|NCT02936323|62959929|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
33564656|NCT02936323|62959930|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
33564657|NCT02936323|62959931|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
33564658|NCT02936323|62959932|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
33564659|NCT02936323|62959933|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
33564660|NCT02936323|62959934|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
33564661|NCT02936323|62959935|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
33564662|NCT02936323|62959936|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
33564663|NCT02936323|62959927|FG000|Phase 1 Dose Escalation|Death|2|||
33564664|NCT02936323|62959928|FG001|Phase 1 Dose Escalation|Death|1|||
33564665|NCT02936323|62959929|FG002|Phase 1 Dose Escalation|Death|3|||
33564666|NCT02936323|62959930|FG003|Phase 1 Dose Escalation|Death|1|||
33564667|NCT02936323|62959931|FG004|Phase 1 Dose Escalation|Death|2|||
33564668|NCT02936323|62959932|FG005|Phase 1 Dose Escalation|Death|3|||
33564669|NCT02936323|62959933|FG006|Phase 1 Dose Escalation|Death|3|||
33564670|NCT02936323|62959934|FG007|Phase 1 Dose Escalation|Death|0|||
33564671|NCT02936323|62959935|FG008|Phase 1 Dose Escalation|Death|0|||
33564672|NCT02936323|62959936|FG009|Phase 1 Dose Escalation|Death|0|||
33564673|NCT02936323|62959927|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33564674|NCT02936323|62959928|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33564675|NCT02936323|62959929|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33564676|NCT02936323|62959930|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33564677|NCT02936323|62959931|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33564678|NCT02936323|62959932|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
33564679|NCT02936323|62959933|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33564680|NCT02936323|62959934|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33564681|NCT02936323|62959935|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33564682|NCT02936323|62959936|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33564683|NCT02936323|62959927|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
33564684|NCT02936323|62959928|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
33564685|NCT02936323|62959929|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
33564686|NCT02936323|62959930|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
33564687|NCT02936323|62959931|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
33564688|NCT02936323|62959932|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
33564689|NCT02936323|62959933|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
33564690|NCT02936323|62959934|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
33564691|NCT02936323|62959935|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
33564692|NCT02936323|62959936|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
33564693|NCT02936323|62959927|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
33564694|NCT02936323|62959928|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
33564695|NCT02936323|62959929|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
33564696|NCT02936323|62959930|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
33564697|NCT02936323|62959931|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
33564698|NCT02936323|62959932|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
33564699|NCT02936323|62959933|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
33564700|NCT02936323|62959934|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
33564701|NCT02936323|62959935|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
33564702|NCT02936323|62959936|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
33564703|NCT02936323|62959927|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33564704|NCT02936323|62959928|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33564705|NCT02936323|62959929|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33564706|NCT02936323|62959930|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33564707|NCT02936323|62959931|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33564708|NCT02936323|62959932|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33564709|NCT02936323|62959933|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33564710|NCT02936323|62959934|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
33564711|NCT02936323|62959935|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
33564712|NCT02936323|62959936|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33663078|NCT01683071|63093952|FG003|Part 2|Lost to Follow-up|0|||
33564713|NCT02936323|62959927|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33564714|NCT02936323|62959928|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33564715|NCT02936323|62959929|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33564716|NCT02936323|62959930|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33564717|NCT02936323|62959931|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33564718|NCT02936323|62959932|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33564719|NCT02936323|62959933|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33564720|NCT02936323|62959934|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33564721|NCT02936323|62959935|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33564722|NCT02936323|62959936|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
33564723|NCT02936323|62959927|FG000|Phase 2a Dose Expansion|Death|0|||
33564724|NCT02936323|62959928|FG001|Phase 2a Dose Expansion|Death|0|||
33564725|NCT02936323|62959929|FG002|Phase 2a Dose Expansion|Death|0|||
33564726|NCT02936323|62959930|FG003|Phase 2a Dose Expansion|Death|0|||
33564727|NCT02936323|62959931|FG004|Phase 2a Dose Expansion|Death|0|||
33564728|NCT02936323|62959932|FG005|Phase 2a Dose Expansion|Death|0|||
33564729|NCT02936323|62959933|FG006|Phase 2a Dose Expansion|Death|0|||
33564730|NCT02936323|62959934|FG007|Phase 2a Dose Expansion|Death|4|||
33564731|NCT02936323|62959935|FG008|Phase 2a Dose Expansion|Death|8|||
33564732|NCT02936323|62959936|FG009|Phase 2a Dose Expansion|Death|10|||
33564733|NCT02243176|62959970|FG000|Overall Study|Other reason|1|||
33564734|NCT02243176|62959971|FG001|Overall Study|Other reason|2|||
33564735|NCT02243176|62959970|FG000|Overall Study|protocol specified withdrawal critera|1|||
33564736|NCT02243176|62959971|FG001|Overall Study|protocol specified withdrawal critera|3|||
33564737|NCT02243176|62959970|FG000|Overall Study|Protocol Violation|2|||
33564738|NCT02243176|62959971|FG001|Overall Study|Protocol Violation|1|||
33564739|NCT02243176|62959970|FG000|Overall Study|Withdrawal by Subject|8|||
33564740|NCT02243176|62959971|FG001|Overall Study|Withdrawal by Subject|7|||
33564741|NCT02243176|62959970|FG000|Overall Study|Adverse Event|2|||
33564742|NCT02243176|62959971|FG001|Overall Study|Adverse Event|2|||
33564743|NCT00002663|62959982|FG000|Overall Study|Death|4|||
33564744|NCT00002663|62959983|FG001|Overall Study|Death|1|||
33564745|NCT00002663|62959984|FG002|Overall Study|Death|1|||
33564746|NCT00002663|62959985|FG003|Overall Study|Death|0|||
33564747|NCT00002663|62959986|FG004|Overall Study|Death|0|||
33564748|NCT00002663|62959987|FG005|Overall Study|Death|13|||
33564749|NCT00002663|62959988|FG006|Overall Study|Death|0|||
33564750|NCT00002663|62959989|FG007|Overall Study|Death|1|||
33564751|NCT00002663|62959990|FG008|Overall Study|Death|1|||
33564752|NCT00002663|62959991|FG009|Overall Study|Death|1|||
33564753|NCT00002663|62959982|FG000|Overall Study|Lost to Follow-up|3|||
33564754|NCT00002663|62959983|FG001|Overall Study|Lost to Follow-up|0|||
33564755|NCT00002663|62959984|FG002|Overall Study|Lost to Follow-up|0|||
33564756|NCT00002663|62959985|FG003|Overall Study|Lost to Follow-up|1|||
33564757|NCT00002663|62959986|FG004|Overall Study|Lost to Follow-up|0|||
33564758|NCT00002663|62959987|FG005|Overall Study|Lost to Follow-up|1|||
33564759|NCT00002663|62959988|FG006|Overall Study|Lost to Follow-up|0|||
33564760|NCT00002663|62959989|FG007|Overall Study|Lost to Follow-up|0|||
33564761|NCT00002663|62959990|FG008|Overall Study|Lost to Follow-up|0|||
33564762|NCT00002663|62959991|FG009|Overall Study|Lost to Follow-up|0|||
33564763|NCT00002663|62959982|FG000|Overall Study|Other|0|||
33564764|NCT00002663|62959983|FG001|Overall Study|Other|1|||
33564765|NCT00002663|62959984|FG002|Overall Study|Other|0|||
33564766|NCT00002663|62959985|FG003|Overall Study|Other|0|||
33564767|NCT00002663|62959986|FG004|Overall Study|Other|0|||
33564768|NCT00002663|62959987|FG005|Overall Study|Other|1|||
33564769|NCT00002663|62959988|FG006|Overall Study|Other|1|||
33564770|NCT00002663|62959989|FG007|Overall Study|Other|0|||
33564771|NCT00002663|62959990|FG008|Overall Study|Other|0|||
33564772|NCT00002663|62959991|FG009|Overall Study|Other|0|||
33564773|NCT00002663|62959982|FG000|Overall Study|Physician Decision|0|||
33564774|NCT00002663|62959983|FG001|Overall Study|Physician Decision|0|||
33564775|NCT00002663|62959984|FG002|Overall Study|Physician Decision|0|||
33564776|NCT00002663|62959985|FG003|Overall Study|Physician Decision|0|||
33564777|NCT00002663|62959986|FG004|Overall Study|Physician Decision|1|||
33564778|NCT00002663|62959987|FG005|Overall Study|Physician Decision|0|||
33564779|NCT00002663|62959988|FG006|Overall Study|Physician Decision|0|||
33564780|NCT00002663|62959989|FG007|Overall Study|Physician Decision|0|||
33564781|NCT00002663|62959990|FG008|Overall Study|Physician Decision|1|||
33564782|NCT00002663|62959991|FG009|Overall Study|Physician Decision|1|||
33300899|NCT01287039|62676991|FG001|Overall Study|Lost to Follow-up|2|||
33564783|NCT00002663|62959982|FG000|Overall Study|Adverse Event|0|||
33564784|NCT00002663|62959983|FG001|Overall Study|Adverse Event|0|||
33564785|NCT00002663|62959984|FG002|Overall Study|Adverse Event|0|||
33564786|NCT00002663|62959985|FG003|Overall Study|Adverse Event|1|||
33564787|NCT00002663|62959986|FG004|Overall Study|Adverse Event|0|||
33564788|NCT00002663|62959987|FG005|Overall Study|Adverse Event|0|||
33564789|NCT00002663|62959988|FG006|Overall Study|Adverse Event|0|||
33564790|NCT00002663|62959989|FG007|Overall Study|Adverse Event|1|||
33564791|NCT00002663|62959990|FG008|Overall Study|Adverse Event|0|||
33564792|NCT00002663|62959991|FG009|Overall Study|Adverse Event|0|||
33564793|NCT02240680|62960002|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
33564794|NCT02240680|62960003|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
33564795|NCT02240680|62960004|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
33564796|NCT02240680|62960005|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
33564797|NCT02240680|62960002|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
33564798|NCT02240680|62960003|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
33564799|NCT02240680|62960004|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
33564800|NCT02240680|62960005|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
33564801|NCT02240680|62960002|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
33564802|NCT02240680|62960003|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
33564803|NCT02240680|62960004|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
33564804|NCT02240680|62960005|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
33564805|NCT02240680|62960002|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
33564806|NCT02240680|62960003|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
33564807|NCT02240680|62960004|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
33564808|NCT02240680|62960005|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
33564809|NCT02240680|62960002|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
33564810|NCT02240680|62960003|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
33564811|NCT02240680|62960004|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
33564812|NCT02240680|62960005|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
33564813|NCT02240680|62960002|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
33564814|NCT02240680|62960003|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
33564815|NCT02240680|62960004|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
33564816|NCT02240680|62960005|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
33564817|NCT02240680|62960002|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
33564818|NCT02240680|62960003|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
33564819|NCT02240680|62960004|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
33564820|NCT02240680|62960005|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
33564821|NCT02240680|62960002|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
33564822|NCT02240680|62960003|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
33300900|NCT01285401|62676999|FG000|Overall Study|Prematurely withdrawn from the study|17|||
33300901|NCT01285401|62677000|FG001|Overall Study|Prematurely withdrawn from the study|29|||
33300902|NCT01285323|62677008|FG000|Overall Study|Adverse Event|9|||
33300903|NCT01285323|62677009|FG001|Overall Study|Adverse Event|8|||
33300904|NCT01285323|62677008|FG000|Overall Study|Lack of Efficacy|4|||
33392126|NCT00566020|62771014|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
33392127|NCT00566020|62771013|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
33392128|NCT00566020|62771014|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
33392129|NCT00566020|62771013|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
33392130|NCT00566020|62771014|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
33392131|NCT00564070|62771021|FG000|Overall Study|Lost to Follow-up|9|||
33392132|NCT00564070|62771022|FG001|Overall Study|Lost to Follow-up|7|||
33392133|NCT00564070|62771021|FG000|Overall Study|Worsening depression, referred to care|3|||
33392134|NCT00564070|62771022|FG001|Overall Study|Worsening depression, referred to care|0|||
33392135|NCT00690612|62771028|FG000|Overall Study|Adverse Event|1|||
33392136|NCT00690612|62771028|FG000|Overall Study|Withdrawal by Subject|2|||
33392137|NCT00621153|62771034|FG000|Overall Study|Safety Reason|8|||
33392138|NCT00621153|62771035|FG001|Overall Study|Safety Reason|7|||
33392139|NCT00621153|62771034|FG000|Overall Study|Adverse Event|3|||
33392140|NCT00621153|62771035|FG001|Overall Study|Adverse Event|2|||
33392141|NCT00621153|62771034|FG000|Overall Study|Lost to Follow-up|5|||
33392142|NCT00621153|62771035|FG001|Overall Study|Lost to Follow-up|1|||
33392143|NCT00621153|62771034|FG000|Overall Study|Withdrawal by Subject|4|||
33392144|NCT00621153|62771035|FG001|Overall Study|Withdrawal by Subject|5|||
33392145|NCT00574119|62771041|FG000|Overall Study|Adverse Event|1|||
33392146|NCT00574119|62771041|FG000|Overall Study|Protocol Violation|1|||
33392147|NCT00574119|62771041|FG000|Overall Study|Withdrawal by Subject|1|||
33392148|NCT00574119|62771041|FG000|Overall Study|Physician Decision|1|||
33392149|NCT00705614|62771047|FG000|Initial Intervention|Adverse Event|40|||
33392150|NCT00705614|62771048|FG001|Initial Intervention|Adverse Event|21|||
33392151|NCT00705614|62771047|FG000|Initial Intervention|Lost to Follow-up|310|||
33392152|NCT00705614|62771048|FG001|Initial Intervention|Lost to Follow-up|191|||
33392153|NCT00705614|62771047|FG000|Initial Intervention|Withdrawal by Subject|114|||
33392154|NCT00705614|62771048|FG001|Initial Intervention|Withdrawal by Subject|71|||
33392155|NCT00705614|62771047|FG000|Initial Intervention|Administrative Reason|51|||
33564823|NCT02240680|62960004|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
33564824|NCT02240680|62960005|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
33564825|NCT02240368|62960016|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
33564826|NCT02240368|62960017|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
33300905|NCT01285323|62677009|FG001|Overall Study|Lack of Efficacy|2|||
33300906|NCT01285323|62677008|FG000|Overall Study|Withdrawal by Subject|15|||
33300907|NCT01285323|62677009|FG001|Overall Study|Withdrawal by Subject|11|||
33564827|NCT02240368|62960018|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
33564828|NCT02240368|62960016|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
33564829|NCT02240368|62960017|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
33564830|NCT02240368|62960018|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
33564831|NCT02239978|62960028|FG000|Overall Study|Withdrawal by Subject|2|||
33564832|NCT02239978|62960029|FG001|Overall Study|Withdrawal by Subject|0|||
33564833|NCT02239510|62960039|FG000|Overall Study|Lost to Follow-up|2|||
33564834|NCT02239510|62960040|FG001|Overall Study|Lost to Follow-up|1|||
33564835|NCT02462486|62960049|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
33564836|NCT02462486|62960050|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
33564837|NCT02462486|62960051|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
33564838|NCT02462486|62960049|FG000|Overall Study|Adverse Event|53|||
33564839|NCT02462486|62960050|FG001|Overall Study|Adverse Event|48|||
33564840|NCT02462486|62960051|FG002|Overall Study|Adverse Event|21|||
33564841|NCT02462486|62960049|FG000|Overall Study|Lack of Efficacy|6|||
33564842|NCT02462486|62960050|FG001|Overall Study|Lack of Efficacy|12|||
33564843|NCT02462486|62960051|FG002|Overall Study|Lack of Efficacy|3|||
33564844|NCT02462486|62960049|FG000|Overall Study|Lost to Follow-up|3|||
33564845|NCT02462486|62960050|FG001|Overall Study|Lost to Follow-up|4|||
33564846|NCT02462486|62960051|FG002|Overall Study|Lost to Follow-up|2|||
33564847|NCT02462486|62960049|FG000|Overall Study|Withdrawal by Subject|25|||
33564848|NCT02462486|62960050|FG001|Overall Study|Withdrawal by Subject|22|||
33564849|NCT02462486|62960051|FG002|Overall Study|Withdrawal by Subject|19|||
33564850|NCT02462486|62960049|FG000|Overall Study|Protocol Violation|3|||
33564851|NCT02462486|62960050|FG001|Overall Study|Protocol Violation|1|||
33564852|NCT02462486|62960051|FG002|Overall Study|Protocol Violation|1|||
33564853|NCT02462486|62960049|FG000|Overall Study|Reason not Specified|3|||
33564854|NCT02462486|62960050|FG001|Overall Study|Reason not Specified|4|||
33564855|NCT02462486|62960051|FG002|Overall Study|Reason not Specified|3|||
33564856|NCT02495948|62960059|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
33564857|NCT02495948|62960060|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
33564858|NCT02495948|62960059|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
33564859|NCT02495948|62960060|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
33564860|NCT02461628|62960069|FG000|Overall Study|Refused to complete survey|4|||
33564861|NCT02461628|62960070|FG001|Overall Study|Refused to complete survey|7|||
33564862|NCT02429791|62960078|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
33564863|NCT02429791|62960079|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
33564864|NCT02429791|62960078|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
33564865|NCT02429791|62960079|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
33564866|NCT02429791|62960078|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
33564867|NCT02429791|62960079|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
33564868|NCT02429791|62960078|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
33564869|NCT02429791|62960079|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
33564870|NCT02429791|62960078|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
33564871|NCT02429791|62960079|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
33564872|NCT02429791|62960078|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
33564873|NCT02429791|62960079|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
33564874|NCT02429791|62960078|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
33564875|NCT02429791|62960079|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
33564876|NCT02429791|62960078|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
33564877|NCT02429791|62960079|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
33564878|NCT02429791|62960078|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
33564879|NCT02429791|62960079|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
33564880|NCT02429791|62960078|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
33564881|NCT02429791|62960079|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
33564882|NCT02429791|62960078|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
33564883|NCT02429791|62960079|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
33564884|NCT02429791|62960078|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
33564885|NCT02429791|62960079|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
33564886|NCT02461160|62960105|FG000|Overall Study|Lost to Follow-up|0|||
33564887|NCT02461160|62960106|FG001|Overall Study|Lost to Follow-up|0|||
33564888|NCT02461160|62960107|FG002|Overall Study|Lost to Follow-up|0|||
33564889|NCT02461160|62960108|FG003|Overall Study|Lost to Follow-up|0|||
33564890|NCT02461160|62960109|FG004|Overall Study|Lost to Follow-up|0|||
33564891|NCT02461160|62960110|FG005|Overall Study|Lost to Follow-up|0|||
33564892|NCT02461160|62960111|FG006|Overall Study|Lost to Follow-up|0|||
33564893|NCT02461160|62960112|FG007|Overall Study|Lost to Follow-up|1|||
33663079|NCT01683071|63093953|FG004|Part 2|Lost to Follow-up|2|||
33564894|NCT02461160|62960113|FG008|Overall Study|Lost to Follow-up|0|||
33564895|NCT02461160|62960114|FG009|Overall Study|Lost to Follow-up|0|||
33564896|NCT02461160|62960115|FG010|Overall Study|Lost to Follow-up|0|||
33564897|NCT02461160|62960116|FG011|Overall Study|Lost to Follow-up|0|||
33564898|NCT02461160|62960117|FG012|Overall Study|Lost to Follow-up|0|||
33300908|NCT01285323|62677008|FG000|Overall Study|Protocol Violation|1|||
33300909|NCT01285323|62677009|FG001|Overall Study|Protocol Violation|2|||
33300910|NCT01285323|62677008|FG000|Overall Study|Non-compliance with study procedures|2|||
33300911|NCT01285323|62677009|FG001|Overall Study|Non-compliance with study procedures|3|||
33300912|NCT01285323|62677008|FG000|Overall Study|Lost to Follow-up|1|||
33300913|NCT01285323|62677009|FG001|Overall Study|Lost to Follow-up|1|||
33300914|NCT01285323|62677008|FG000|Overall Study|Other|1|||
33300915|NCT01285323|62677009|FG001|Overall Study|Other|3|||
33300916|NCT01284621|62677015|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
33300917|NCT01284621|62677016|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
33300918|NCT01284621|62677017|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
33300919|NCT01284621|62677018|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
33300920|NCT01284621|62677019|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
33300921|NCT01284621|62677020|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
33300922|NCT01283139|62677034|FG000|Overall Study|Lost to Follow-up|5|||
33300923|NCT01283139|62677035|FG001|Overall Study|Lost to Follow-up|2|||
33300924|NCT01283139|62677036|FG002|Overall Study|Lost to Follow-up|3|||
33300925|NCT01283139|62677037|FG003|Overall Study|Lost to Follow-up|1|||
33300926|NCT01283139|62677034|FG000|Overall Study|Withdrawal by Subject|8|||
33300927|NCT01283139|62677035|FG001|Overall Study|Withdrawal by Subject|8|||
33300928|NCT01283139|62677036|FG002|Overall Study|Withdrawal by Subject|6|||
33300929|NCT01283139|62677037|FG003|Overall Study|Withdrawal by Subject|8|||
33300930|NCT01283139|62677034|FG000|Overall Study|Death|2|||
33300931|NCT01283139|62677035|FG001|Overall Study|Death|0|||
33300932|NCT01283139|62677036|FG002|Overall Study|Death|2|||
33300933|NCT01283139|62677037|FG003|Overall Study|Death|2|||
33300934|NCT01283139|62677034|FG000|Overall Study|Lack of Efficacy|1|||
33300935|NCT01283139|62677035|FG001|Overall Study|Lack of Efficacy|2|||
33300936|NCT01283139|62677036|FG002|Overall Study|Lack of Efficacy|2|||
33300937|NCT01283139|62677037|FG003|Overall Study|Lack of Efficacy|1|||
33300938|NCT01283139|62677034|FG000|Overall Study|Early termination due to AE/SAE|1|||
33300939|NCT01283139|62677035|FG001|Overall Study|Early termination due to AE/SAE|1|||
33300940|NCT01283139|62677036|FG002|Overall Study|Early termination due to AE/SAE|0|||
33300941|NCT01283139|62677037|FG003|Overall Study|Early termination due to AE/SAE|0|||
33300942|NCT01283139|62677034|FG000|Overall Study|Participant's refusal to continue|0|||
33300943|NCT01283139|62677035|FG001|Overall Study|Participant's refusal to continue|3|||
33300944|NCT01283139|62677036|FG002|Overall Study|Participant's refusal to continue|1|||
33300945|NCT01283139|62677037|FG003|Overall Study|Participant's refusal to continue|1|||
33300946|NCT01283139|62677034|FG000|Overall Study|Pregnancy|0|||
33300947|NCT01283139|62677035|FG001|Overall Study|Pregnancy|1|||
33300948|NCT01283139|62677036|FG002|Overall Study|Pregnancy|1|||
33300949|NCT01283139|62677037|FG003|Overall Study|Pregnancy|0|||
33300950|NCT01283139|62677034|FG000|Overall Study|Missed follow-up visit|0|||
33300951|NCT01283139|62677035|FG001|Overall Study|Missed follow-up visit|1|||
33300952|NCT01283139|62677036|FG002|Overall Study|Missed follow-up visit|2|||
33300953|NCT01283139|62677037|FG003|Overall Study|Missed follow-up visit|2|||
33300954|NCT01283139|62677034|FG000|Overall Study|Participant randomized in error|0|||
33300955|NCT01283139|62677035|FG001|Overall Study|Participant randomized in error|0|||
33300956|NCT01283139|62677036|FG002|Overall Study|Participant randomized in error|1|||
33300957|NCT01283139|62677037|FG003|Overall Study|Participant randomized in error|0|||
33300958|NCT01282203|62677047|FG000|Overall Study|Adverse Event|1|||
33300959|NCT01281969|62677056|FG000|Overall Study|not randomized didn't meet criteria|0|||
33300960|NCT01281969|62677057|FG001|Overall Study|not randomized didn't meet criteria|0|||
33300961|NCT01281969|62677058|FG002|Overall Study|not randomized didn't meet criteria|7|||
33300962|NCT01281969|62677056|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
33300963|NCT01281969|62677057|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
33300964|NCT01281969|62677058|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
33300965|NCT01281969|62677056|FG000|Overall Study|not randomized, child consent not given|0|||
33300966|NCT01281969|62677057|FG001|Overall Study|not randomized, child consent not given|0|||
33300967|NCT01281969|62677058|FG002|Overall Study|not randomized, child consent not given|2|||
33300968|NCT01281813|62677069|FG000|Overall Study|Adverse Event|0|||
33300969|NCT01281813|62677070|FG001|Overall Study|Adverse Event|0|||
33392156|NCT00705614|62771048|FG001|Initial Intervention|Administrative Reason|38|||
33564899|NCT01653704|62960168|FG000|Overall Study|Technical failure during recording|1|||
33564900|NCT01653704|62960169|FG001|Overall Study|Technical failure during recording|1|||
33564901|NCT01653704|62960168|FG000|Overall Study|Performance not reflective of training|1|||
33564902|NCT01653704|62960169|FG001|Overall Study|Performance not reflective of training|0|||
33564903|NCT02495168|62960178|FG000|Overall Study|Other than Specified|18|||
33564904|NCT02495168|62960179|FG001|Overall Study|Other than Specified|22|||
33564905|NCT02495168|62960180|FG002|Overall Study|Other than Specified|5|||
33564906|NCT02495168|62960178|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
33300970|NCT01281813|62677071|FG002|Overall Study|Adverse Event|10|||
33392157|NCT00705614|62771047|FG000|Initial Intervention|Status completion unknown|3|||
33564907|NCT02495168|62960179|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
33564908|NCT02495168|62960180|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
33564909|NCT02495168|62960178|FG000|Overall Study|Physician Decision|1|||
33564910|NCT02495168|62960179|FG001|Overall Study|Physician Decision|1|||
33564911|NCT02495168|62960180|FG002|Overall Study|Physician Decision|0|||
33564912|NCT02495168|62960178|FG000|Overall Study|Lost to Follow-up|10|||
33564913|NCT02495168|62960179|FG001|Overall Study|Lost to Follow-up|6|||
33564914|NCT02495168|62960180|FG002|Overall Study|Lost to Follow-up|1|||
33564915|NCT02495168|62960178|FG000|Overall Study|Withdrawal by Subject|1|||
33564916|NCT02495168|62960179|FG001|Overall Study|Withdrawal by Subject|4|||
33564917|NCT02495168|62960180|FG002|Overall Study|Withdrawal by Subject|2|||
33564918|NCT02495168|62960178|FG000|Overall Study|Protocol Violation|0|||
33564919|NCT02495168|62960179|FG001|Overall Study|Protocol Violation|10|||
33564920|NCT02495168|62960180|FG002|Overall Study|Protocol Violation|1|||
33564921|NCT02495168|62960178|FG000|Overall Study|Adverse Event|4|||
33564922|NCT02495168|62960179|FG001|Overall Study|Adverse Event|8|||
33564923|NCT02495168|62960180|FG002|Overall Study|Adverse Event|3|||
33564924|NCT02495168|62960178|FG000|Overall Study|Lack of Efficacy|0|||
33564925|NCT02495168|62960179|FG001|Overall Study|Lack of Efficacy|0|||
33564926|NCT02495168|62960180|FG002|Overall Study|Lack of Efficacy|3|||
33564927|NCT02494778|62960188|FG000|Overall Study|Death|3|||
33564928|NCT02494778|62960188|FG000|Overall Study|Other|173|||
33564929|NCT02494778|62960188|FG000|Overall Study|Lack of Efficacy|4|||
33564930|NCT02494778|62960188|FG000|Overall Study|Adverse Event|18|||
33564931|NCT02494778|62960188|FG000|Overall Study|Withdrawal by Subject|20|||
33564932|NCT02494778|62960188|FG000|Overall Study|Lost to Follow-up|2|||
33564933|NCT02494778|62960188|FG000|Overall Study|Noncompliant with study drug admin.|1|||
33564934|NCT02493764|62960194|FG000|Overall Study|Adverse Event|2|||
33564935|NCT02493764|62960195|FG001|Overall Study|Adverse Event|2|||
33564936|NCT02493764|62960194|FG000|Overall Study|Death|44|||
33564937|NCT02493764|62960195|FG001|Overall Study|Death|58|||
33564938|NCT02493764|62960194|FG000|Overall Study|Lost to Follow-up|2|||
33564939|NCT02493764|62960195|FG001|Overall Study|Lost to Follow-up|1|||
33564940|NCT02493764|62960194|FG000|Overall Study|Protocol Violation|6|||
33564941|NCT02493764|62960195|FG001|Overall Study|Protocol Violation|7|||
33564942|NCT02493764|62960194|FG000|Overall Study|Physician Decision|1|||
33564943|NCT02493764|62960195|FG001|Overall Study|Physician Decision|1|||
33564944|NCT02493764|62960194|FG000|Overall Study|Participant moved|17|||
33564945|NCT02493764|62960195|FG001|Overall Study|Participant moved|5|||
33564946|NCT02493764|62960194|FG000|Overall Study|Withdrawal parent/guardian|0|||
33564947|NCT02493764|62960195|FG001|Overall Study|Withdrawal parent/guardian|1|||
33564948|NCT02493764|62960194|FG000|Overall Study|Withdrawal by Subject|11|||
33564949|NCT02493764|62960195|FG001|Overall Study|Withdrawal by Subject|7|||
33564950|NCT02460380|62960203|FG000|Overall Study|Withdrawal by Subject|10|||
33564951|NCT02460380|62960204|FG001|Overall Study|Withdrawal by Subject|5|||
33564952|NCT02493062|62960211|FG000|Overall Study|Physician Decision|12|||
33564953|NCT02492984|62960217|FG000|Overall Study|Adverse Event|1|||
33564954|NCT02492984|62960218|FG001|Overall Study|Adverse Event|0|||
33564955|NCT02492984|62960217|FG000|Overall Study|Protocol Violation|1|||
33564956|NCT02492984|62960218|FG001|Overall Study|Protocol Violation|0|||
33564957|NCT02492984|62960217|FG000|Overall Study|Withdrawal by Subject|1|||
33564958|NCT02492984|62960218|FG001|Overall Study|Withdrawal by Subject|0|||
33564959|NCT01680159|62960231|FG000|Screening Period|Not meet criteria for dose-up period|7|||
33564960|NCT01680159|62960231|FG000|Increased Dose Period|Adverse Event|6|||
33564961|NCT01680159|62960231|FG000|Increased Dose Period|Withdrawal by Subject|2|||
33564962|NCT02491892|62960253|FG000|Overall Study|Adverse Event|1|||
33564963|NCT02491892|62960254|FG001|Overall Study|Adverse Event|1|||
33564964|NCT02491892|62960253|FG000|Overall Study|Death|1|||
33564965|NCT02491892|62960254|FG001|Overall Study|Death|1|||
33564966|NCT02491892|62960253|FG000|Overall Study|Lack of Efficacy|37|||
33663080|NCT01683071|63093954|FG005|Part 2|Lost to Follow-up|0|||
33663081|NCT01683071|63093949|FG000|Part 2|Withdrawal by Subject|0|||
33564967|NCT02491892|62960254|FG001|Overall Study|Lack of Efficacy|36|||
33564968|NCT02491892|62960253|FG000|Overall Study|Refused Treatment|1|||
33564969|NCT02491892|62960254|FG001|Overall Study|Refused Treatment|0|||
33663082|NCT01683071|63093950|FG001|Part 2|Withdrawal by Subject|0|||
33564970|NCT02491892|62960253|FG000|Overall Study|Lost to Follow-up|1|||
33564971|NCT02491892|62960254|FG001|Overall Study|Lost to Follow-up|0|||
33564972|NCT02436356|62960270|FG000|Overall Study|Excluded by MRI Screening|0|||
33564973|NCT02436356|62960271|FG001|Overall Study|Excluded by MRI Screening|0|||
33564974|NCT02436356|62960272|FG002|Overall Study|Excluded by MRI Screening|2|||
33564975|NCT02436356|62960270|FG000|Overall Study|Lost to Follow-up|0|||
33564976|NCT02436356|62960271|FG001|Overall Study|Lost to Follow-up|1|||
33564977|NCT02436356|62960272|FG002|Overall Study|Lost to Follow-up|0|||
33564978|NCT02436356|62960270|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
33564979|NCT02436356|62960271|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
33564980|NCT02436356|62960272|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
33663083|NCT01683071|63093951|FG002|Part 2|Withdrawal by Subject|0|||
33663084|NCT01683071|63093952|FG003|Part 2|Withdrawal by Subject|0|||
33564981|NCT02436356|62960270|FG000|Overall Study|Excluded due to other medical conditions|3|||
33564982|NCT02436356|62960271|FG001|Overall Study|Excluded due to other medical conditions|0|||
33564983|NCT02436356|62960272|FG002|Overall Study|Excluded due to other medical conditions|0|||
33564984|NCT02436356|62960270|FG000|Overall Study|Withdrawal by Subject|1|||
33564985|NCT02436356|62960271|FG001|Overall Study|Withdrawal by Subject|0|||
33564986|NCT02436356|62960272|FG002|Overall Study|Withdrawal by Subject|0|||
33564987|NCT02436200|62960285|FG000|Overall Study|Significant outlier|1|||
33564988|NCT01679613|62960289|FG000|Overall Study|other than stated above|0|||
33564989|NCT01679613|62960290|FG001|Overall Study|other than stated above|1|||
33564990|NCT01679613|62960291|FG002|Overall Study|other than stated above|2|||
33564991|NCT01679613|62960292|FG003|Overall Study|other than stated above|2|||
33564992|NCT02489630|62960301|FG000|Overall Study|Oversedation|1|||
33564993|NCT02489630|62960302|FG001|Overall Study|Oversedation|1|||
33564994|NCT02489630|62960301|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
33564995|NCT02489630|62960302|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
33564996|NCT02739347|62960310|FG000|Overall Study|Adverse Event|3|||
33564997|NCT02739347|62960311|FG001|Overall Study|Adverse Event|0|||
33564998|NCT02739347|62960310|FG000|Overall Study|Protocol Violation|0|||
33564999|NCT02739347|62960311|FG001|Overall Study|Protocol Violation|1|||
33565000|NCT02739347|62960310|FG000|Overall Study|Lost to Follow-up|0|||
33565001|NCT02739347|62960311|FG001|Overall Study|Lost to Follow-up|2|||
33565002|NCT02435966|62960320|FG000|Overall Study|Withdrawal by Subject|0|||
33565003|NCT02435966|62960321|FG001|Overall Study|Withdrawal by Subject|1|||
33565004|NCT02435966|62960322|FG002|Overall Study|Withdrawal by Subject|0|||
33565005|NCT01679301|62960330|FG000|Screening Period|screen failure|3|||
33565006|NCT01679301|62960331|FG001|Screening Period|screen failure|0|||
33565007|NCT01679301|62960332|FG002|Screening Period|screen failure|0|||
33565008|NCT01678911|62960338|FG000|Second Intervention|Lost to Follow-up|2|||
33565009|NCT01678911|62960339|FG001|Second Intervention|Lost to Follow-up|0|||
33565010|NCT02487446|62960345|FG000|Period 1|Physician Decision|0|||
33565011|NCT02487446|62960346|FG001|Period 1|Physician Decision|1|||
33565012|NCT02487446|62960345|FG000|Period 1|Lack of Efficacy|1|||
33565013|NCT02487446|62960346|FG001|Period 1|Lack of Efficacy|0|||
33565014|NCT02487446|62960345|FG000|Period 1|Protocol deviation|3|||
33565015|NCT02487446|62960346|FG001|Period 1|Protocol deviation|2|||
33565016|NCT02487446|62960345|FG000|Period 1|Lost to Follow-up|2|||
33565017|NCT02487446|62960346|FG001|Period 1|Lost to Follow-up|0|||
33565018|NCT02487446|62960345|FG000|Period 1|Withdrawal by Subject|2|||
33565019|NCT02487446|62960346|FG001|Period 1|Withdrawal by Subject|0|||
33565020|NCT02487446|62960345|FG000|Period 1|Adverse Event|5|||
33565021|NCT02487446|62960346|FG001|Period 1|Adverse Event|5|||
33565022|NCT02487446|62960345|FG000|Washout|Lost to Follow-up|0|||
33565023|NCT02487446|62960346|FG001|Washout|Lost to Follow-up|2|||
33565024|NCT02487446|62960345|FG000|Washout|Withdrawal by Subject|1|||
33565025|NCT02487446|62960346|FG001|Washout|Withdrawal by Subject|4|||
33565026|NCT02487446|62960345|FG000|Washout|Adverse Event|2|||
33565027|NCT02487446|62960346|FG001|Washout|Adverse Event|2|||
33565028|NCT02487446|62960345|FG000|Period 2|Protocol deviation|0|||
33565029|NCT02487446|62960346|FG001|Period 2|Protocol deviation|1|||
33565030|NCT02487446|62960345|FG000|Period 2|Lost to Follow-up|1|||
33300971|NCT01281813|62677069|FG000|Overall Study|Lost to Follow-up|0|||
33300972|NCT01281813|62677070|FG001|Overall Study|Lost to Follow-up|0|||
33300973|NCT01281813|62677071|FG002|Overall Study|Lost to Follow-up|31|||
33300974|NCT01281813|62677069|FG000|Overall Study|Withdrawal by Subject|0|||
33300975|NCT01281813|62677070|FG001|Overall Study|Withdrawal by Subject|0|||
33392158|NCT00705614|62771048|FG001|Initial Intervention|Status completion unknown|0|||
33392159|NCT00705614|62771047|FG000|Switch to Remicade|Adverse Event|0|||
33300976|NCT01281813|62677071|FG002|Overall Study|Withdrawal by Subject|13|||
33300977|NCT01281813|62677069|FG000|Overall Study|Subject Non-Compliant|0|||
33300978|NCT01281813|62677070|FG001|Overall Study|Subject Non-Compliant|0|||
33300979|NCT01281813|62677071|FG002|Overall Study|Subject Non-Compliant|6|||
33300980|NCT01281813|62677069|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
33300981|NCT01281813|62677070|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
33565031|NCT02487446|62960346|FG001|Period 2|Lost to Follow-up|1|||
33300982|NCT01281813|62677071|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
33565032|NCT02487446|62960345|FG000|Period 2|Withdrawal by Subject|1|||
33565033|NCT02487446|62960346|FG001|Period 2|Withdrawal by Subject|1|||
33565034|NCT02487446|62960345|FG000|Period 2|Adverse Event|6|||
33300983|NCT01281813|62677069|FG000|Overall Study|Sponsor's Decision|4|||
33300984|NCT01281813|62677070|FG001|Overall Study|Sponsor's Decision|3|||
33300985|NCT01281813|62677071|FG002|Overall Study|Sponsor's Decision|7|||
33565035|NCT02487446|62960346|FG001|Period 2|Adverse Event|2|||
33565036|NCT02739269|62960355|FG000|Overall Study|Protocol Violation|5|||
33565037|NCT02739269|62960356|FG001|Overall Study|Protocol Violation|0|||
33565038|NCT02739269|62960355|FG000|Overall Study|Cycle cancellation|2|||
33565039|NCT02739269|62960356|FG001|Overall Study|Cycle cancellation|2|||
33565040|NCT02739269|62960355|FG000|Overall Study|Withdrawal by Subject|0|||
33565041|NCT02739269|62960356|FG001|Overall Study|Withdrawal by Subject|2|||
33565042|NCT03318523|62960366|FG000|PC Period: Up to Year 1|Adverse Event|1|||
33565043|NCT03318523|62960367|FG001|PC Period: Up to Year 1|Adverse Event|0|||
33565044|NCT03318523|62960368|FG002|PC Period: Up to Year 1|Adverse Event|2|||
33565045|NCT03318523|62960369|FG003|PC Period: Up to Year 1|Adverse Event|0|||
33565046|NCT03318523|62960370|FG004|PC Period: Up to Year 1|Adverse Event|0|||
33565047|NCT03318523|62960371|FG005|PC Period: Up to Year 1|Adverse Event|0|||
33565048|NCT03318523|62960372|FG006|PC Period: Up to Year 1|Adverse Event|0|||
33565049|NCT03318523|62960373|FG007|PC Period: Up to Year 1|Adverse Event|0|||
33565050|NCT03318523|62960374|FG008|PC Period: Up to Year 1|Adverse Event|0|||
33565051|NCT03318523|62960375|FG009|PC Period: Up to Year 1|Adverse Event|0|||
33565052|NCT03318523|62960366|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
33565053|NCT03318523|62960367|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
33565054|NCT03318523|62960368|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
33565055|NCT03318523|62960369|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
33565056|NCT03318523|62960370|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
33300986|NCT01281813|62677069|FG000|Overall Study|Switched to Commercially Available Medication|0|||
33300987|NCT01281813|62677070|FG001|Overall Study|Switched to Commercially Available Medication|0|||
33300988|NCT01281813|62677071|FG002|Overall Study|Switched to Commercially Available Medication|26|||
33300989|NCT01281813|62677069|FG000|Overall Study|Other|0|||
33300990|NCT01281813|62677070|FG001|Overall Study|Other|1|||
33300991|NCT01281813|62677071|FG002|Overall Study|Other|39|||
33300992|NCT01090414|62677083|FG000|Study 101-99|Progressive Disease|28|||
33300993|NCT01090414|62677084|FG001|Study 101-99|Progressive Disease|48|||
33300994|NCT01090414|62677085|FG002|Study 101-99|Progressive Disease|10|||
33300995|NCT01090414|62677086|FG003|Study 101-99|Progressive Disease|4|||
33300996|NCT01090414|62677083|FG000|Study 101-99|Adverse Event|10|||
33300997|NCT01090414|62677084|FG001|Study 101-99|Adverse Event|28|||
33300998|NCT01090414|62677085|FG002|Study 101-99|Adverse Event|18|||
33300999|NCT01090414|62677086|FG003|Study 101-99|Adverse Event|0|||
33301000|NCT01090414|62677083|FG000|Study 101-99|Investigator Request|1|||
33301001|NCT01090414|62677084|FG001|Study 101-99|Investigator Request|11|||
33301002|NCT01090414|62677085|FG002|Study 101-99|Investigator Request|4|||
33301003|NCT01090414|62677086|FG003|Study 101-99|Investigator Request|0|||
33301004|NCT01090414|62677083|FG000|Study 101-99|Death|3|||
33301005|NCT01090414|62677084|FG001|Study 101-99|Death|8|||
33301006|NCT01090414|62677085|FG002|Study 101-99|Death|1|||
33301007|NCT01090414|62677086|FG003|Study 101-99|Death|0|||
33301008|NCT01090414|62677083|FG000|Study 101-99|Sponsor Discontinued Study|0|||
33301009|NCT01090414|62677084|FG001|Study 101-99|Sponsor Discontinued Study|7|||
33301010|NCT01090414|62677085|FG002|Study 101-99|Sponsor Discontinued Study|5|||
33301011|NCT01090414|62677086|FG003|Study 101-99|Sponsor Discontinued Study|0|||
33301012|NCT01090414|62677083|FG000|Study 101-99|Other (Unknown Reasons)|3|||
33301013|NCT01090414|62677084|FG001|Study 101-99|Other (Unknown Reasons)|3|||
33301014|NCT01090414|62677085|FG002|Study 101-99|Other (Unknown Reasons)|0|||
33301015|NCT01090414|62677086|FG003|Study 101-99|Other (Unknown Reasons)|0|||
33301016|NCT01090414|62677083|FG000|Study 101-99|Withdrew Consent|0|||
33301017|NCT01090414|62677084|FG001|Study 101-99|Withdrew Consent|2|||
33301018|NCT01090414|62677085|FG002|Study 101-99|Withdrew Consent|3|||
33301019|NCT01090414|62677086|FG003|Study 101-99|Withdrew Consent|1|||
33301020|NCT01090414|62677083|FG000|Study 101-99|Participant Request|3|||
33301021|NCT01090414|62677084|FG001|Study 101-99|Participant Request|1|||
33301022|NCT01090414|62677085|FG002|Study 101-99|Participant Request|0|||
33301023|NCT01090414|62677086|FG003|Study 101-99|Participant Request|0|||
33301024|NCT01090102|62677110|FG000|First 12 Weeks|Withdrawal by Subject|1|||
33301025|NCT01090102|62677111|FG001|First 12 Weeks|Withdrawal by Subject|1|||
33301026|NCT01090102|62677110|FG000|First 12 Weeks|Adverse Event|2|||
33301027|NCT01090102|62677111|FG001|First 12 Weeks|Adverse Event|0|||
33301028|NCT01090102|62677110|FG000|First 12 Weeks|Death|1|||
33301029|NCT01090102|62677111|FG001|First 12 Weeks|Death|1|||
33301030|NCT01090102|62677110|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
33301031|NCT01090102|62677111|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
33301032|NCT01287897|62677121|FG000|Overall Study|Adverse Event|5|||
33301033|NCT01287897|62677122|FG001|Overall Study|Adverse Event|3|||
33301034|NCT01287897|62677123|FG002|Overall Study|Adverse Event|6|||
33301035|NCT01287897|62677124|FG003|Overall Study|Adverse Event|4|||
33301036|NCT01287897|62677121|FG000|Overall Study|Lack of Efficacy|2|||
33301037|NCT01287897|62677122|FG001|Overall Study|Lack of Efficacy|0|||
33301038|NCT01287897|62677123|FG002|Overall Study|Lack of Efficacy|0|||
33301039|NCT01287897|62677124|FG003|Overall Study|Lack of Efficacy|0|||
33565057|NCT03318523|62960371|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
33565058|NCT03318523|62960372|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
33565059|NCT03318523|62960373|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
33301040|NCT01287897|62677121|FG000|Overall Study|Protocol Violation|1|||
33301041|NCT01287897|62677122|FG001|Overall Study|Protocol Violation|1|||
33301042|NCT01287897|62677123|FG002|Overall Study|Protocol Violation|0|||
33301043|NCT01287897|62677124|FG003|Overall Study|Protocol Violation|1|||
33301044|NCT01287897|62677121|FG000|Overall Study|Lost to Follow-up|0|||
33301045|NCT01287897|62677122|FG001|Overall Study|Lost to Follow-up|0|||
33663085|NCT01683071|63093953|FG004|Part 2|Withdrawal by Subject|3|||
33565060|NCT03318523|62960374|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
33565061|NCT03318523|62960375|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
33565062|NCT03318523|62960366|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
33565063|NCT03318523|62960367|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
33565064|NCT03318523|62960368|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
33565065|NCT03318523|62960369|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
33565066|NCT03318523|62960370|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
33565067|NCT03318523|62960371|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
33565068|NCT03318523|62960372|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
33565069|NCT03318523|62960373|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
33565070|NCT03318523|62960374|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
33565071|NCT03318523|62960375|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
33565072|NCT03318523|62960366|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
33565073|NCT03318523|62960367|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
33565074|NCT03318523|62960368|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
33565075|NCT03318523|62960369|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
33565076|NCT03318523|62960370|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
33565077|NCT03318523|62960371|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
33565078|NCT03318523|62960372|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
33565079|NCT03318523|62960373|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
33565080|NCT03318523|62960374|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
33565081|NCT03318523|62960375|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
33565082|NCT03318523|62960366|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33565083|NCT03318523|62960367|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33565084|NCT03318523|62960368|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33565085|NCT03318523|62960369|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33565086|NCT03318523|62960370|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33565087|NCT03318523|62960371|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
33565088|NCT03318523|62960372|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33565089|NCT03318523|62960373|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33565090|NCT03318523|62960374|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33565091|NCT03318523|62960375|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33565092|NCT03318523|62960366|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33565093|NCT03318523|62960367|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33565094|NCT03318523|62960368|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33565095|NCT03318523|62960369|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33565096|NCT03318523|62960370|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33565097|NCT03318523|62960371|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33565098|NCT03318523|62960372|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33565099|NCT03318523|62960373|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33565100|NCT03318523|62960374|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33565101|NCT03318523|62960375|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
33565102|NCT03318523|62960366|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
33565103|NCT03318523|62960367|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
33565104|NCT03318523|62960368|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
33565105|NCT03318523|62960369|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
33565106|NCT03318523|62960370|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
33565107|NCT03318523|62960371|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
33565108|NCT03318523|62960372|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
33565109|NCT03318523|62960373|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
33565110|NCT03318523|62960374|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
33565111|NCT03318523|62960375|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
33565112|NCT03318523|62960366|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
33565113|NCT03318523|62960367|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
33565114|NCT03318523|62960368|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
33565115|NCT03318523|62960369|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
33565116|NCT03318523|62960370|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
33565117|NCT03318523|62960371|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
33565118|NCT03318523|62960372|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
33565119|NCT03318523|62960373|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
33565120|NCT03318523|62960374|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
33565121|NCT03318523|62960375|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
33565122|NCT01678209|62960402|FG000|Overall Study|could not scan twice|1|||
33565123|NCT01678209|62960403|FG001|Overall Study|could not scan twice|1|||
33565124|NCT01678209|62960404|FG002|Overall Study|could not scan twice|1|||
33565125|NCT01678209|62960402|FG000|Overall Study|scheduling conflicts|0|||
33565126|NCT01678209|62960403|FG001|Overall Study|scheduling conflicts|0|||
33565127|NCT01678209|62960404|FG002|Overall Study|scheduling conflicts|1|||
33565128|NCT01678209|62960402|FG000|Overall Study|screen fail|16|||
33565129|NCT01678209|62960403|FG001|Overall Study|screen fail|17|||
33565130|NCT01678209|62960404|FG002|Overall Study|screen fail|16|||
33565131|NCT02239120|62960414|FG000|Overall Study|Death|56|||
33565132|NCT02239120|62960415|FG001|Overall Study|Death|58|||
33565133|NCT02239120|62960414|FG000|Overall Study|Lost to Follow-up|19|||
33565134|NCT02239120|62960415|FG001|Overall Study|Lost to Follow-up|14|||
33565135|NCT01603407|62960424|FG000|Overall Study|Adverse Event|1|||
33565136|NCT01603407|62960425|FG001|Overall Study|Adverse Event|1|||
33565137|NCT01603407|62960426|FG002|Overall Study|Adverse Event|1|||
33565138|NCT01603407|62960424|FG000|Overall Study|Protocol Violation|2|||
33565139|NCT01603407|62960425|FG001|Overall Study|Protocol Violation|2|||
33565140|NCT01603407|62960426|FG002|Overall Study|Protocol Violation|0|||
33565141|NCT01603407|62960424|FG000|Overall Study|Withdrawal by Subject|8|||
33565142|NCT01603407|62960425|FG001|Overall Study|Withdrawal by Subject|5|||
33565143|NCT01603407|62960426|FG002|Overall Study|Withdrawal by Subject|7|||
33565144|NCT01603407|62960424|FG000|Overall Study|Lost to Follow-up|0|||
33565145|NCT01603407|62960425|FG001|Overall Study|Lost to Follow-up|3|||
33565146|NCT01603407|62960426|FG002|Overall Study|Lost to Follow-up|2|||
33565147|NCT02235454|62960456|FG000|Overall Study|Withdrawal by Subject|2|||
33663086|NCT01683071|63093954|FG005|Part 2|Withdrawal by Subject|3|||
33663087|NCT01683071|63093949|FG000|Part 2|Surgery cancelled|0|||
33663088|NCT01683071|63093950|FG001|Part 2|Surgery cancelled|0|||
33663089|NCT01683071|63093951|FG002|Part 2|Surgery cancelled|0|||
33663090|NCT01683071|63093952|FG003|Part 2|Surgery cancelled|0|||
33663091|NCT01683071|63093953|FG004|Part 2|Surgery cancelled|4|||
33663092|NCT01683071|63093954|FG005|Part 2|Surgery cancelled|2|||
33663093|NCT01683071|63093949|FG000|Part 2|Did not receive study drug|0|||
33663094|NCT01683071|63093950|FG001|Part 2|Did not receive study drug|0|||
33663095|NCT01683071|63093951|FG002|Part 2|Did not receive study drug|0|||
33663096|NCT01683071|63093952|FG003|Part 2|Did not receive study drug|0|||
33663097|NCT01683071|63093953|FG004|Part 2|Did not receive study drug|2|||
33663098|NCT01683071|63093954|FG005|Part 2|Did not receive study drug|1|||
33663099|NCT01683071|63093949|FG000|Part 2|Met exclusion criterion|0|||
33663100|NCT01683071|63093950|FG001|Part 2|Met exclusion criterion|0|||
33663101|NCT01683071|63093951|FG002|Part 2|Met exclusion criterion|0|||
33663102|NCT01683071|63093952|FG003|Part 2|Met exclusion criterion|0|||
33663103|NCT01683071|63093953|FG004|Part 2|Met exclusion criterion|1|||
33663104|NCT01683071|63093954|FG005|Part 2|Met exclusion criterion|1|||
33663105|NCT01683071|63093949|FG000|Part 2|Protocol deviation|0|||
33663106|NCT01683071|63093950|FG001|Part 2|Protocol deviation|0|||
33663107|NCT01683071|63093951|FG002|Part 2|Protocol deviation|0|||
33663108|NCT01683071|63093952|FG003|Part 2|Protocol deviation|0|||
33663109|NCT01683071|63093953|FG004|Part 2|Protocol deviation|1|||
33663110|NCT01683071|63093954|FG005|Part 2|Protocol deviation|2|||
33663111|NCT01683071|63093949|FG000|Part 2|Withdrawal by investigator decision|0|||
33663112|NCT01683071|63093950|FG001|Part 2|Withdrawal by investigator decision|0|||
33663113|NCT01683071|63093951|FG002|Part 2|Withdrawal by investigator decision|0|||
33663114|NCT01683071|63093952|FG003|Part 2|Withdrawal by investigator decision|0|||
33663115|NCT01683071|63093953|FG004|Part 2|Withdrawal by investigator decision|1|||
33663116|NCT01683071|63093954|FG005|Part 2|Withdrawal by investigator decision|2|||
33663117|NCT01567865|63093978|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
33565148|NCT02235298|62960462|FG000|Overall Study|Lost to Follow-up|6|||
33565149|NCT02235298|62960463|FG001|Overall Study|Lost to Follow-up|5|||
33565150|NCT02235298|62960462|FG000|Overall Study|Adverse Event|2|||
33565151|NCT02235298|62960463|FG001|Overall Study|Adverse Event|2|||
33565152|NCT02235298|62960462|FG000|Overall Study|Withdrawal by Subject|0|||
33565153|NCT02235298|62960463|FG001|Overall Study|Withdrawal by Subject|1|||
33565154|NCT02234596|62960469|FG000|Overall Study|Participant not treated|2|||
33565155|NCT02234362|62960473|FG000|Overall Study|Not eligible after first screening visit|17|||
33565156|NCT02234362|62960473|FG000|Overall Study|Lost to Follow-up|6|||
33565157|NCT02234362|62960473|FG000|Overall Study|Withdrawal by Subject|3|||
33565158|NCT02234284|62960479|FG000|Overall Study|Death|4|||
33565159|NCT02234284|62960480|FG001|Overall Study|Death|2|||
33565160|NCT02234284|62960479|FG000|Overall Study|Withdrawal by Subject|1|||
33565161|NCT02234284|62960480|FG001|Overall Study|Withdrawal by Subject|0|||
33565162|NCT02234284|62960479|FG000|Overall Study|Lost to Follow-up|20|||
33565163|NCT02234284|62960480|FG001|Overall Study|Lost to Follow-up|7|||
33565164|NCT02232880|62960490|FG000|Overall Study|study stopped prior to randomization|1|||
33663118|NCT01567865|63093979|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
33663119|NCT01567865|63093980|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
33663120|NCT01567865|63093981|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
33663121|NCT01567865|63093978|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
33663122|NCT01567865|63093979|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
33663123|NCT01567865|63093980|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
33565165|NCT02896855|62960496|FG000|Overall Study|Death|50|||
33565166|NCT02896855|62960497|FG001|Overall Study|Death|40|||
33565167|NCT02896855|62960496|FG000|Overall Study|Lost to Follow-up|15|||
33565168|NCT02896855|62960497|FG001|Overall Study|Lost to Follow-up|9|||
33565169|NCT02896855|62960496|FG000|Overall Study|Withdrawal by Subject|7|||
33565170|NCT02896855|62960497|FG001|Overall Study|Withdrawal by Subject|4|||
33565171|NCT02232802|62960508|FG000|Period 1|Sponsor request|1|||
33565172|NCT02232802|62960509|FG001|Period 1|Sponsor request|0|||
33565173|NCT02232802|62960508|FG000|Period 1|Adverse Event|1|||
33565174|NCT02232802|62960509|FG001|Period 1|Adverse Event|1|||
33565175|NCT02434328|62960517|FG000|Overall Study|Adverse Event|9|||
33565176|NCT02434328|62960518|FG001|Overall Study|Adverse Event|4|||
33565177|NCT02434328|62960517|FG000|Overall Study|Lack of Efficacy|0|||
33565178|NCT02434328|62960518|FG001|Overall Study|Lack of Efficacy|2|||
33565179|NCT02434328|62960517|FG000|Overall Study|Physician Decision|0|||
33565180|NCT02434328|62960518|FG001|Overall Study|Physician Decision|1|||
33565181|NCT02434328|62960517|FG000|Overall Study|Withdrawal by Subject|12|||
33565182|NCT02434328|62960518|FG001|Overall Study|Withdrawal by Subject|21|||
33565183|NCT02434328|62960517|FG000|Overall Study|Death|4|||
33565184|NCT02434328|62960518|FG001|Overall Study|Death|7|||
33565185|NCT02434328|62960517|FG000|Overall Study|Lost to Follow-up|1|||
33565186|NCT02434328|62960518|FG001|Overall Study|Lost to Follow-up|6|||
33565187|NCT02434328|62960517|FG000|Overall Study|Other|4|||
33565188|NCT02434328|62960518|FG001|Overall Study|Other|1|||
33565189|NCT02660229|62960527|FG000|Overall Study|Adverse Event|2|||
33565190|NCT02660229|62960528|FG001|Overall Study|Adverse Event|0|||
33565191|NCT02660229|62960527|FG000|Overall Study|Withdrawal by Subject|0|||
33565192|NCT02660229|62960528|FG001|Overall Study|Withdrawal by Subject|1|||
33565193|NCT02232178|62960537|FG000|Overall Study|Lost to Follow-up|0|||
33565194|NCT02232178|62960538|FG001|Overall Study|Lost to Follow-up|1|||
33565195|NCT02232178|62960539|FG002|Overall Study|Lost to Follow-up|0|||
33565196|NCT02232178|62960537|FG000|Overall Study|ineligibility|0|||
33565197|NCT02232178|62960538|FG001|Overall Study|ineligibility|0|||
33565198|NCT02232178|62960539|FG002|Overall Study|ineligibility|1|||
33565199|NCT02232178|62960537|FG000|Overall Study|surgical complication|1|||
33565200|NCT02232178|62960538|FG001|Overall Study|surgical complication|0|||
33565201|NCT02232178|62960539|FG002|Overall Study|surgical complication|0|||
33565202|NCT01678131|62960550|FG000|Overall Study|Adverse Event|0|||
33565203|NCT01678131|62960551|FG001|Overall Study|Adverse Event|1|||
33565204|NCT01678131|62960552|FG002|Overall Study|Adverse Event|0|||
33565205|NCT01678131|62960550|FG000|Overall Study|Withdrawal by Subject|0|||
33565206|NCT01678131|62960551|FG001|Overall Study|Withdrawal by Subject|0|||
33565207|NCT01678131|62960552|FG002|Overall Study|Withdrawal by Subject|2|||
33565208|NCT02231164|62960562|FG000|Overall Study|Adverse Event|1|||
33565209|NCT02231164|62960563|FG001|Overall Study|Adverse Event|1|||
33565210|NCT02231164|62960562|FG000|Overall Study|Lack of Efficacy|4|||
33565211|NCT02231164|62960563|FG001|Overall Study|Lack of Efficacy|3|||
33565212|NCT02231164|62960562|FG000|Overall Study|Withdrawal by Subject|1|||
33565213|NCT02231164|62960563|FG001|Overall Study|Withdrawal by Subject|2|||
33565214|NCT02457182|62960571|FG000|Overall Study|Lost to Follow-up|1|||
33565215|NCT02457182|62960572|FG001|Overall Study|Lost to Follow-up|0|||
33565216|NCT02230384|62960580|FG000|Phase 1|Lost to Follow-up|1|||
33565217|NCT02230384|62960581|FG001|Phase 1|Lost to Follow-up|0|||
33565218|NCT02230384|62960580|FG000|Phase 1|Physician Decision|0|||
33565219|NCT02230384|62960581|FG001|Phase 1|Physician Decision|1|||
33565220|NCT02230384|62960580|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
33565221|NCT02230384|62960581|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
33565222|NCT02230384|62960580|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
33565223|NCT02230384|62960581|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
33565224|NCT02230384|62960580|FG000|Phase 2 - Switch|Adverse Event|2|||
33565225|NCT02230384|62960581|FG001|Phase 2 - Switch|Adverse Event|0|||
33565226|NCT02738801|62960597|FG000|Overall Study|Adverse Event|1|||
33565227|NCT02738801|62960598|FG001|Overall Study|Adverse Event|1|||
33565228|NCT02738801|62960597|FG000|Overall Study|Withdrawal by Subject|0|||
33565229|NCT02738801|62960598|FG001|Overall Study|Withdrawal by Subject|1|||
33565230|NCT02230306|62960614|FG000|Overall Study|Did not receive study treatment|1|||
33565231|NCT01680861|62960620|FG000|Early Post-transplant Period|Protocol Violation|1|||
33565232|NCT01680861|62960621|FG001|Early Post-transplant Period|Protocol Violation|1|||
33565233|NCT02229214|62960631|FG000|Overall Study|Adverse Event|2|||
33565234|NCT02229214|62960632|FG001|Overall Study|Adverse Event|0|||
33565235|NCT02229214|62960631|FG000|Overall Study|Withdrawal by Subject|4|||
33565236|NCT02229214|62960632|FG001|Overall Study|Withdrawal by Subject|0|||
33565237|NCT02228980|62960644|FG000|Overall Study|Adverse Event|14|||
33565238|NCT02228980|62960645|FG001|Overall Study|Adverse Event|0|||
33565239|NCT02228980|62960646|FG002|Overall Study|Adverse Event|0|||
33565240|NCT02228980|62960647|FG003|Overall Study|Adverse Event|0|||
33565241|NCT02228980|62960644|FG000|Overall Study|Protocol Violation|7|||
33565242|NCT02228980|62960645|FG001|Overall Study|Protocol Violation|0|||
33565243|NCT02228980|62960646|FG002|Overall Study|Protocol Violation|0|||
33565244|NCT02228980|62960647|FG003|Overall Study|Protocol Violation|0|||
33565245|NCT02228980|62960644|FG000|Overall Study|Withdrawal by Subject|3|||
33565246|NCT02228980|62960645|FG001|Overall Study|Withdrawal by Subject|3|||
33565247|NCT02228980|62960646|FG002|Overall Study|Withdrawal by Subject|2|||
33565248|NCT02228980|62960647|FG003|Overall Study|Withdrawal by Subject|3|||
33565249|NCT02228590|62960661|FG000|Overall Study|Withdrawal by Subject|1|||
33565250|NCT02227108|62960666|FG000|Overall Study|Did not receive treatment|2|||
33565251|NCT02227108|62960666|FG000|Overall Study|Other|3|||
33565252|NCT02227108|62960666|FG000|Overall Study|Progressive disease|17|||
33565253|NCT02227108|62960666|FG000|Overall Study|Initiation of alternative therapy|2|||
33565254|NCT02227108|62960666|FG000|Overall Study|Investigator discretion|1|||
33565255|NCT02227108|62960666|FG000|Overall Study|Adverse Event|6|||
33565256|NCT03564145|62960670|FG000|Overall Study|Adverse Event|4|||
33565257|NCT03564145|62960670|FG000|Overall Study|Lost to Follow-up|21|||
33565258|NCT03564145|62960670|FG000|Overall Study|Protocol Violation|2|||
33565259|NCT03564145|62960670|FG000|Overall Study|Withdrawal by Subject|48|||
33565260|NCT03564145|62960670|FG000|Overall Study|Study Terminated by Sponsor|146|||
33565261|NCT03564145|62960670|FG000|Overall Study|Physician Decision|1|||
33565262|NCT03564145|62960670|FG000|Overall Study|Other Than Specified|1|||
33565263|NCT03564145|62960670|FG000|Overall Study|Pregnancy|1|||
33565264|NCT02226562|62960676|FG000|Overall Study|Lost to Follow-up|0|||
33565265|NCT02226562|62960677|FG001|Overall Study|Lost to Follow-up|1|||
33565266|NCT02456636|62960711|FG000|Overall Study|Death|0|||
33565267|NCT02456636|62960712|FG001|Overall Study|Death|3|||
33565268|NCT02456636|62960713|FG002|Overall Study|Death|0|||
33565269|NCT02456636|62960711|FG000|Overall Study|Pregnancy|1|||
33565270|NCT02456636|62960712|FG001|Overall Study|Pregnancy|3|||
33565271|NCT02456636|62960713|FG002|Overall Study|Pregnancy|5|||
33565272|NCT02456636|62960711|FG000|Overall Study|Physician Decision|4|||
33565273|NCT02456636|62960712|FG001|Overall Study|Physician Decision|5|||
33565274|NCT02456636|62960713|FG002|Overall Study|Physician Decision|4|||
33565275|NCT02456636|62960711|FG000|Overall Study|Withdrawal by Subject|13|||
33565276|NCT02456636|62960712|FG001|Overall Study|Withdrawal by Subject|14|||
33565277|NCT02456636|62960713|FG002|Overall Study|Withdrawal by Subject|16|||
33565278|NCT02456636|62960711|FG000|Overall Study|Lost to Follow-up|50|||
33565279|NCT02456636|62960712|FG001|Overall Study|Lost to Follow-up|44|||
33565280|NCT02456636|62960713|FG002|Overall Study|Lost to Follow-up|50|||
33565281|NCT02226172|62960721|FG000|Overall Study|Participant refused further follow-up|4|||
33565282|NCT02226172|62960721|FG000|Overall Study|Other|5|||
33565283|NCT02226172|62960721|FG000|Overall Study|Death|1|||
33565284|NCT02226172|62960721|FG000|Overall Study|Study terminated by sponsor|1|||
33565285|NCT02226172|62960721|FG000|Overall Study|Adverse Event|6|||
33565286|NCT01676961|62960725|FG000|Overall Study|Death|3|||
33565287|NCT01676961|62960725|FG000|Overall Study|Lost to Follow-up|1|||
33565288|NCT01676961|62960725|FG000|Overall Study|Withdrawal by Subject|1|||
33565289|NCT01676727|62960747|FG000|Overall Study|Death|18|||
33565290|NCT01676727|62960747|FG000|Overall Study|Withdrawal by Subject|6|||
33565291|NCT01676727|62960747|FG000|Overall Study|Screening failure|5|||
33565292|NCT01676727|62960747|FG000|Overall Study|Not willing to attend 1-year visit|2|||
33565293|NCT01676727|62960747|FG000|Overall Study|Valve explanted|1|||
33565294|NCT02738879|62960754|FG000|Overall Study|Adverse Event|1|||
33565295|NCT02738879|62960755|FG001|Overall Study|Adverse Event|1|||
33565296|NCT02738879|62960754|FG000|Overall Study|Death|0|||
33565297|NCT02738879|62960755|FG001|Overall Study|Death|2|||
33565298|NCT02738879|62960754|FG000|Overall Study|Lost to Follow-up|1|||
33565299|NCT02738879|62960755|FG001|Overall Study|Lost to Follow-up|5|||
33565300|NCT02738879|62960754|FG000|Overall Study|Protocol Violation|1|||
33565301|NCT02738879|62960755|FG001|Overall Study|Protocol Violation|3|||
33565302|NCT02738879|62960754|FG000|Overall Study|Physician Decision|3|||
33565303|NCT02738879|62960755|FG001|Overall Study|Physician Decision|4|||
33565304|NCT02738879|62960754|FG000|Overall Study|Pregnancy|0|||
33565305|NCT02738879|62960755|FG001|Overall Study|Pregnancy|1|||
33565306|NCT02738879|62960754|FG000|Overall Study|Screen Failure|1|||
33565307|NCT02738879|62960755|FG001|Overall Study|Screen Failure|2|||
33663124|NCT01567865|63093981|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
33663125|NCT01567163|63093992|FG000|Overall Study|Progressive Disease|2|||
33565308|NCT02738879|62960754|FG000|Overall Study|Site Discontinued Study Participation|1|||
33565309|NCT02738879|62960755|FG001|Overall Study|Site Discontinued Study Participation|0|||
33565310|NCT02738879|62960754|FG000|Overall Study|Withdrawal by Subject|5|||
33565311|NCT02738879|62960755|FG001|Overall Study|Withdrawal by Subject|7|||
33663126|NCT01567163|63093992|FG000|Overall Study|Lost to Follow-up|2|||
33565312|NCT03502811|62960761|FG000|Overall Study|Death|157|||
33565313|NCT03502811|62960761|FG000|Overall Study|Withdrawal by Subject|105|||
33565314|NCT03502811|62960761|FG000|Overall Study|Lost to Follow-up|26|||
33565315|NCT03502811|62960761|FG000|Overall Study|No Visits (Missed)|31|||
33565316|NCT00515671|62960773|FG000|Overall Study|Lost to Follow-up|13|||
33565317|NCT00515671|62960774|FG001|Overall Study|Lost to Follow-up|10|||
33565318|NCT00515671|62960773|FG000|Overall Study|Withdrawal by Subject|3|||
33565319|NCT00515671|62960774|FG001|Overall Study|Withdrawal by Subject|5|||
33565320|NCT00515671|62960773|FG000|Overall Study|incarcerated|1|||
33663127|NCT01567085|63094001|FG000|Overall Study|Death|6|||
33565321|NCT00515671|62960774|FG001|Overall Study|incarcerated|2|||
33565322|NCT01677195|62960783|FG000|Overall Study|Lost to Follow-up|14|||
33565323|NCT01677195|62960784|FG001|Overall Study|Lost to Follow-up|22|||
33565324|NCT01677195|62960785|FG002|Overall Study|Lost to Follow-up|22|||
33565325|NCT01677195|62960783|FG000|Overall Study|Withdrawal by Subject|1|||
33565326|NCT01677195|62960784|FG001|Overall Study|Withdrawal by Subject|0|||
33565327|NCT01677195|62960785|FG002|Overall Study|Withdrawal by Subject|1|||
33565328|NCT01677195|62960783|FG000|Overall Study|Adverse Event|6|||
33565329|NCT01677195|62960784|FG001|Overall Study|Adverse Event|4|||
33565330|NCT01677195|62960785|FG002|Overall Study|Adverse Event|1|||
33565331|NCT01677195|62960783|FG000|Overall Study|Physician Decision|1|||
33565332|NCT01677195|62960784|FG001|Overall Study|Physician Decision|2|||
33565333|NCT01677195|62960785|FG002|Overall Study|Physician Decision|2|||
33565334|NCT01677195|62960783|FG000|Overall Study|Pregnancy|0|||
33565335|NCT01677195|62960784|FG001|Overall Study|Pregnancy|1|||
33565336|NCT01677195|62960785|FG002|Overall Study|Pregnancy|0|||
33565337|NCT01677195|62960783|FG000|Overall Study|Protocol Violation|7|||
33565338|NCT01677195|62960784|FG001|Overall Study|Protocol Violation|3|||
33565339|NCT01677195|62960785|FG002|Overall Study|Protocol Violation|4|||
33565340|NCT00928447|62960797|FG000|Overall Study|Withdrawal by Subject|1|||
33565341|NCT00928447|62960797|FG000|Overall Study|Investigator's decision|1|||
33565342|NCT02224846|62960803|FG000|Period 1 (Month 3)|Adverse Event|2|||
33565343|NCT02224846|62960804|FG001|Period 1 (Month 3)|Adverse Event|1|||
33565344|NCT02224846|62960803|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
33565345|NCT02224846|62960804|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
33565346|NCT02224846|62960803|FG000|Period 1 (Month 3)|Protocol Violation|4|||
33565347|NCT02224846|62960804|FG001|Period 1 (Month 3)|Protocol Violation|8|||
33565348|NCT02224846|62960803|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
33565349|NCT02224846|62960804|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
33565350|NCT02224846|62960803|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
33565351|NCT02224846|62960804|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
33565352|NCT02224846|62960803|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
33565353|NCT02224846|62960804|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
33565354|NCT02224846|62960803|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
33565355|NCT02224846|62960804|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
33565356|NCT02224846|62960803|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
33565357|NCT02224846|62960804|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
33565358|NCT02224846|62960803|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
33565359|NCT02224846|62960804|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
33565360|NCT02224846|62960803|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
33565361|NCT02224846|62960804|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
33565362|NCT02224846|62960803|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
33565363|NCT02224846|62960804|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
33565364|NCT02224846|62960803|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
33565365|NCT02224846|62960804|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
33565366|NCT02224846|62960803|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
33565367|NCT02224846|62960804|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
33565368|NCT02224846|62960803|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
33565369|NCT02224846|62960804|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
33565370|NCT02224846|62960803|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
33565371|NCT02224846|62960804|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
33565372|NCT02224846|62960803|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
33565373|NCT02224846|62960804|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
33565374|NCT02224846|62960803|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
33565375|NCT02224846|62960804|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
33565376|NCT01632280|62960812|FG000|Overall Study|Withdrawal by Subject|1|||
33565377|NCT01632280|62960813|FG001|Overall Study|Withdrawal by Subject|0|||
33565378|NCT02224690|62960821|FG000|Overall Study|Adverse Event|8|||
33565379|NCT02224690|62960822|FG001|Overall Study|Adverse Event|1|||
33565380|NCT02224690|62960821|FG000|Overall Study|Met Withdrawal Criteria|4|||
33565381|NCT02224690|62960822|FG001|Overall Study|Met Withdrawal Criteria|0|||
33565382|NCT02224690|62960821|FG000|Overall Study|Use of G-tube|1|||
33565383|NCT02224690|62960822|FG001|Overall Study|Use of G-tube|0|||
33565384|NCT02224690|62960821|FG000|Overall Study|Did not meet eligibility criteria|1|||
33565385|NCT02224690|62960822|FG001|Overall Study|Did not meet eligibility criteria|0|||
33565386|NCT01634152|62960831|FG000|Overall Study|Adverse Event|2|||
33565387|NCT01634152|62960832|FG001|Overall Study|Adverse Event|0|||
33565388|NCT01634152|62960833|FG002|Overall Study|Adverse Event|2|||
33565389|NCT01634152|62960831|FG000|Overall Study|Consent withdrawn not due to AE|1|||
33565390|NCT01634152|62960832|FG001|Overall Study|Consent withdrawn not due to AE|0|||
33565391|NCT01634152|62960833|FG002|Overall Study|Consent withdrawn not due to AE|1|||
33565392|NCT01634152|62960831|FG000|Overall Study|Not treated|0|||
33565393|NCT01634152|62960832|FG001|Overall Study|Not treated|1|||
33565394|NCT01634152|62960833|FG002|Overall Study|Not treated|0|||
33565395|NCT01634152|62960831|FG000|Overall Study|Other reason not defined above|1|||
33565396|NCT01634152|62960832|FG001|Overall Study|Other reason not defined above|0|||
33565397|NCT01634152|62960833|FG002|Overall Study|Other reason not defined above|1|||
33565398|NCT03862807|62960841|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
33565399|NCT01378429|62960865|FG000|Overall Study|Noncompliance with study drug|1|||
33565400|NCT01378429|62960866|FG001|Overall Study|Noncompliance with study drug|0|||
33565401|NCT01599754|62960877|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
33565402|NCT01599754|62960878|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
33565403|NCT01599754|62960877|FG000|Overall Study|Participant noncompliance|4|||
33565404|NCT01599754|62960878|FG001|Overall Study|Participant noncompliance|4|||
33565405|NCT01599754|62960877|FG000|Overall Study|Lost to Follow-up|13|||
33565406|NCT01599754|62960878|FG001|Overall Study|Lost to Follow-up|6|||
33565407|NCT01599754|62960877|FG000|Overall Study|Death|31|||
33565408|NCT01599754|62960878|FG001|Overall Study|Death|33|||
33565409|NCT01599754|62960877|FG000|Overall Study|Adverse Event|3|||
33565410|NCT01599754|62960878|FG001|Overall Study|Adverse Event|2|||
33565411|NCT01599754|62960877|FG000|Overall Study|Investigator decision|1|||
33565412|NCT01599754|62960878|FG001|Overall Study|Investigator decision|3|||
33565413|NCT01599754|62960877|FG000|Overall Study|Withdrawal by Subject|24|||
33565414|NCT01599754|62960878|FG001|Overall Study|Withdrawal by Subject|25|||
33565415|NCT01599754|62960877|FG000|Overall Study|Study terminated by sponsor|282|||
33565416|NCT01599754|62960878|FG001|Overall Study|Study terminated by sponsor|285|||
33565417|NCT02138110|62960884|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
33565418|NCT02138110|62960884|FG000|Overall Scaffold Implantation|Death|3|||
33565419|NCT02223754|62960890|FG000|Period 1|Adverse Event|1|||
33565420|NCT02223754|62960891|FG001|Period 1|Adverse Event|0|||
33565421|NCT02223754|62960890|FG000|Period 1|Lost to Follow-up|0|||
33565422|NCT02223754|62960891|FG001|Period 1|Lost to Follow-up|1|||
33565423|NCT02223754|62960890|FG000|Period 1|Protocol Violation|2|||
33565424|NCT02223754|62960891|FG001|Period 1|Protocol Violation|4|||
33565425|NCT02223754|62960890|FG000|Period 1|Withdrawal by Subject|0|||
33565426|NCT02223754|62960891|FG001|Period 1|Withdrawal by Subject|4|||
33565427|NCT02223754|62960890|FG000|Period 1|Test Article No Longer Available|1|||
33565428|NCT02223754|62960891|FG001|Period 1|Test Article No Longer Available|5|||
33565429|NCT02223754|62960890|FG000|Period 1|Unsatisfactory Visual Response|0|||
33565430|NCT02223754|62960891|FG001|Period 1|Unsatisfactory Visual Response|1|||
33565431|NCT02223754|62960890|FG000|Period 2|Adverse Event|0|||
33565432|NCT02223754|62960891|FG001|Period 2|Adverse Event|1|||
33565433|NCT02223754|62960890|FG000|Period 2|Protocol Violation|1|||
33565434|NCT02223754|62960891|FG001|Period 2|Protocol Violation|0|||
33565435|NCT02223754|62960890|FG000|Period 2|Lens Discomfort|1|||
33565436|NCT02223754|62960891|FG001|Period 2|Lens Discomfort|1|||
33565437|NCT02223754|62960890|FG000|Period 2|Lost to Follow-up|1|||
33565438|NCT02223754|62960891|FG001|Period 2|Lost to Follow-up|0|||
33565439|NCT02223754|62960890|FG000|Period 2|Test Article No Longer Available|0|||
33565440|NCT02223754|62960891|FG001|Period 2|Test Article No Longer Available|1|||
33565441|NCT02223364|62960901|FG000|Overall Study|Protocol Violation|3|||
33565442|NCT02223364|62960902|FG001|Overall Study|Protocol Violation|0|||
33565443|NCT02223364|62960903|FG002|Overall Study|Protocol Violation|3|||
33565444|NCT02223364|62960901|FG000|Overall Study|subject expired before surgery|1|||
33565445|NCT02223364|62960902|FG001|Overall Study|subject expired before surgery|0|||
33565446|NCT02223364|62960903|FG002|Overall Study|subject expired before surgery|0|||
33565447|NCT02223364|62960901|FG000|Overall Study|Physician Decision|1|||
33565448|NCT02223364|62960902|FG001|Overall Study|Physician Decision|0|||
33565449|NCT02223364|62960903|FG002|Overall Study|Physician Decision|0|||
33565450|NCT01378975|62960913|FG000|Overall Study|Death|77|||
33565451|NCT01378975|62960914|FG001|Overall Study|Death|46|||
33565452|NCT01378975|62960913|FG000|Overall Study|Investigator Request|1|||
33565453|NCT01378975|62960914|FG001|Overall Study|Investigator Request|0|||
33565454|NCT01378975|62960913|FG000|Overall Study|Lost to Follow-up|4|||
33565455|NCT01378975|62960914|FG001|Overall Study|Lost to Follow-up|1|||
33565456|NCT01378975|62960913|FG000|Overall Study|Withdrew Consent|4|||
33565457|NCT01378975|62960914|FG001|Overall Study|Withdrew Consent|3|||
33565458|NCT02222896|62960921|FG000|Abdomen|Did not qualify|34|||
33565459|NCT02222896|62960922|FG001|Abdomen|Did not qualify|10|||
33565460|NCT02222896|62960923|FG002|Abdomen|Did not qualify|32|||
33565461|NCT02222896|62960921|FG000|Groin|Did not qualify|43|||
33565462|NCT02222896|62960922|FG001|Groin|Did not qualify|9|||
33565463|NCT02222896|62960923|FG002|Groin|Did not qualify|40|||
33565464|NCT02222818|62960936|FG000|Period 1|Eligibility criteria not met|0|||
33565465|NCT02222818|62960937|FG001|Period 1|Eligibility criteria not met|3|||
33565466|NCT01378195|62960948|FG000|Overall Study|Lost to Follow-up|29|||
33565467|NCT01378195|62960949|FG001|Overall Study|Lost to Follow-up|18|||
33663128|NCT01567085|63094001|FG000|Overall Study|Adverse Event|6|||
33565468|NCT01378117|62960958|FG000|Overall Study|withdrawal|2|||
33565469|NCT01378117|62960959|FG001|Overall Study|withdrawal|1|||
33565470|NCT01378117|62960960|FG002|Overall Study|withdrawal|2|||
33565471|NCT01378117|62960958|FG000|Overall Study|discharged before med given|2|||
33565472|NCT01378117|62960959|FG001|Overall Study|discharged before med given|0|||
33565473|NCT01378117|62960960|FG002|Overall Study|discharged before med given|1|||
33565474|NCT04254809|62960995|FG000|Overall Study|Lost to Follow-up|5|||
33565475|NCT04254809|62960996|FG001|Overall Study|Lost to Follow-up|10|||
33565476|NCT02736409|62961006|FG000|Overall Study|Withdrawal by Subject|4|||
33565477|NCT02736409|62961007|FG001|Overall Study|Withdrawal by Subject|2|||
33565478|NCT02736409|62961008|FG002|Overall Study|Withdrawal by Subject|17|||
33565479|NCT02736409|62961009|FG003|Overall Study|Withdrawal by Subject|3|||
33565480|NCT02736409|62961006|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33565481|NCT02736409|62961007|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33565482|NCT02736409|62961008|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33565483|NCT02736409|62961009|FG003|Overall Study|Non-Compliance with Study Drug|1|||
33565484|NCT02736409|62961006|FG000|Overall Study|Adverse Event|0|||
33565485|NCT02736409|62961007|FG001|Overall Study|Adverse Event|1|||
33565486|NCT02736409|62961008|FG002|Overall Study|Adverse Event|5|||
33565487|NCT02736409|62961009|FG003|Overall Study|Adverse Event|4|||
33565488|NCT02736409|62961006|FG000|Overall Study|Other|0|||
33565489|NCT02736409|62961007|FG001|Overall Study|Other|0|||
33565490|NCT02736409|62961008|FG002|Overall Study|Other|1|||
33565491|NCT02736409|62961009|FG003|Overall Study|Other|1|||
33565492|NCT02736409|62961006|FG000|Overall Study|Pregnancy|0|||
33565493|NCT02736409|62961007|FG001|Overall Study|Pregnancy|0|||
33565494|NCT02736409|62961008|FG002|Overall Study|Pregnancy|1|||
33565495|NCT02736409|62961009|FG003|Overall Study|Pregnancy|0|||
33565496|NCT02736409|62961006|FG000|Overall Study|Lost to Follow-up|0|||
33565497|NCT02736409|62961007|FG001|Overall Study|Lost to Follow-up|0|||
33565498|NCT02736409|62961008|FG002|Overall Study|Lost to Follow-up|2|||
33565499|NCT02736409|62961009|FG003|Overall Study|Lost to Follow-up|1|||
33565500|NCT02736409|62961006|FG000|Overall Study|Physician Decision|0|||
33565501|NCT02736409|62961007|FG001|Overall Study|Physician Decision|0|||
33565502|NCT02736409|62961008|FG002|Overall Study|Physician Decision|0|||
33565503|NCT02736409|62961009|FG003|Overall Study|Physician Decision|2|||
33565504|NCT03099707|62961022|FG000|Overall Study|Withdrawal by Subject|0|||
33565505|NCT03099707|62961023|FG001|Overall Study|Withdrawal by Subject|3|||
33565506|NCT03099707|62961022|FG000|Overall Study|Lost to Follow-up|0|||
33565507|NCT03099707|62961023|FG001|Overall Study|Lost to Follow-up|1|||
33565508|NCT02906033|62961031|FG000|Baseline|Protocol Violation|37|||
33565509|NCT02906033|62961032|FG001|Baseline|Protocol Violation|33|||
33565510|NCT02906033|62961031|FG000|Follow-up|Lost to Follow-up|46|||
33565511|NCT02906033|62961032|FG001|Follow-up|Lost to Follow-up|62|||
33565512|NCT02221882|62961044|FG000|Overall Study|Withdrawal by Subject|0|||
33565513|NCT02221882|62961045|FG001|Overall Study|Withdrawal by Subject|0|||
33565514|NCT02221882|62961046|FG002|Overall Study|Withdrawal by Subject|4|||
33565515|NCT02221882|62961047|FG003|Overall Study|Withdrawal by Subject|2|||
33565516|NCT02221882|62961048|FG004|Overall Study|Withdrawal by Subject|2|||
33565517|NCT02221882|62961049|FG005|Overall Study|Withdrawal by Subject|2|||
33565518|NCT02221882|62961044|FG000|Overall Study|Death|0|||
33565519|NCT02221882|62961045|FG001|Overall Study|Death|1|||
33565520|NCT02221882|62961046|FG002|Overall Study|Death|0|||
33565521|NCT02221882|62961047|FG003|Overall Study|Death|0|||
33565522|NCT02221882|62961048|FG004|Overall Study|Death|0|||
33565523|NCT02221882|62961049|FG005|Overall Study|Death|0|||
33565524|NCT02837783|62961070|FG000|Overall Study|Adverse Event|1|||
33565525|NCT02837783|62961071|FG001|Overall Study|Adverse Event|0|||
33565526|NCT02837783|62961070|FG000|Overall Study|Other, Not Specified|1|||
33565527|NCT02837783|62961071|FG001|Overall Study|Other, Not Specified|2|||
33565528|NCT02221648|62961079|FG000|Overall Study|Withdrawal by Subject|3|||
33565529|NCT02221648|62961080|FG001|Overall Study|Withdrawal by Subject|3|||
33565530|NCT02220712|62961090|FG000|Overall Study|Adverse Event|1|||
33565531|NCT02220712|62961090|FG000|Overall Study|Withdrawal by Subject|2|||
33565532|NCT02220712|62961090|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
33565533|NCT02219932|62961100|FG000|Overall Study|Other|5|||
33565534|NCT02219932|62961101|FG001|Overall Study|Other|11|||
33565535|NCT02219932|62961100|FG000|Overall Study|Death|1|||
33565536|NCT02219932|62961101|FG001|Overall Study|Death|1|||
33565537|NCT02219932|62961100|FG000|Overall Study|Investigator Decision|0|||
33565538|NCT02219932|62961101|FG001|Overall Study|Investigator Decision|1|||
33301046|NCT01287897|62677123|FG002|Overall Study|Lost to Follow-up|2|||
33301047|NCT01287897|62677124|FG003|Overall Study|Lost to Follow-up|0|||
33301048|NCT01287897|62677121|FG000|Overall Study|Withdrawal by Subject|1|||
33301049|NCT01287897|62677122|FG001|Overall Study|Withdrawal by Subject|5|||
33301050|NCT01287897|62677123|FG002|Overall Study|Withdrawal by Subject|3|||
33301051|NCT01287897|62677124|FG003|Overall Study|Withdrawal by Subject|2|||
33565539|NCT02219932|62961100|FG000|Overall Study|Consent Withdrawn|11|||
33565540|NCT02219932|62961101|FG001|Overall Study|Consent Withdrawn|7|||
33565541|NCT02219932|62961100|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
33565542|NCT02219932|62961101|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
33565543|NCT02219932|62961100|FG000|Overall Study|Protocol Violation|10|||
33565544|NCT02219932|62961101|FG001|Overall Study|Protocol Violation|6|||
33565545|NCT02219932|62961100|FG000|Overall Study|Pregnancy|1|||
33565546|NCT02219932|62961101|FG001|Overall Study|Pregnancy|0|||
33565547|NCT02219932|62961100|FG000|Overall Study|Lost to Follow-up|4|||
33565548|NCT02219932|62961101|FG001|Overall Study|Lost to Follow-up|2|||
33565549|NCT02219932|62961100|FG000|Overall Study|Adverse Event|23|||
33565550|NCT02219932|62961101|FG001|Overall Study|Adverse Event|21|||
33565551|NCT02219464|62961113|FG000|Overall Study|Withdrawal by Subject|1|||
33565552|NCT02219464|62961114|FG001|Overall Study|Withdrawal by Subject|0|||
33565553|NCT02219464|62961113|FG000|Overall Study|case cancelled|1|||
33565554|NCT02219464|62961114|FG001|Overall Study|case cancelled|0|||
33565555|NCT02219464|62961113|FG000|Overall Study|catheter malfunction|1|||
33565556|NCT02219464|62961114|FG001|Overall Study|catheter malfunction|0|||
33565557|NCT02219308|62961122|FG000|Overall Study|Withdrawal by Subject|1|||
33565558|NCT02219308|62961123|FG001|Overall Study|Withdrawal by Subject|2|||
33565559|NCT02218372|62961131|FG000|Overall Study|Adverse Event|1|||
33565560|NCT02218372|62961132|FG001|Overall Study|Adverse Event|1|||
33565561|NCT02218372|62961131|FG000|Overall Study|Miscellaneous|2|||
33565562|NCT02218372|62961132|FG001|Overall Study|Miscellaneous|1|||
33565563|NCT02218372|62961131|FG000|Overall Study|Randomized but did not receive treatment|2|||
33565564|NCT02218372|62961132|FG001|Overall Study|Randomized but did not receive treatment|3|||
33565565|NCT02218372|62961131|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33565566|NCT02218372|62961132|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33565567|NCT02218216|62961145|FG000|Overall Study|Study terminated before completed|6|||
33565568|NCT02218216|62961146|FG001|Overall Study|Study terminated before completed|0|||
33565569|NCT02218216|62961147|FG002|Overall Study|Study terminated before completed|0|||
33565570|NCT02217982|62961157|FG000|Overall Study|Trial discontinued|1|||
33565571|NCT02217982|62961158|FG001|Overall Study|Trial discontinued|0|||
33565572|NCT02217982|62961157|FG000|Overall Study|Adverse Event|0|||
33565573|NCT02217982|62961158|FG001|Overall Study|Adverse Event|1|||
33565574|NCT02254408|62961166|FG000|Overall Study|Randomized But Not Treated|1|||
33565575|NCT02254408|62961167|FG001|Overall Study|Randomized But Not Treated|3|||
33565576|NCT02254408|62961166|FG000|Overall Study|Adverse Event|1|||
33565577|NCT02254408|62961167|FG001|Overall Study|Adverse Event|0|||
33565578|NCT02254408|62961166|FG000|Overall Study|Death|2|||
33565579|NCT02254408|62961167|FG001|Overall Study|Death|3|||
33565580|NCT02254408|62961166|FG000|Overall Study|Investigator's Discretion|0|||
33565581|NCT02254408|62961167|FG001|Overall Study|Investigator's Discretion|1|||
33565582|NCT02254408|62961166|FG000|Overall Study|Withdrawal by Subject|3|||
33565583|NCT02254408|62961167|FG001|Overall Study|Withdrawal by Subject|3|||
33565584|NCT02254408|62961166|FG000|Overall Study|Lost to Follow-up|1|||
33565585|NCT02254408|62961167|FG001|Overall Study|Lost to Follow-up|0|||
33565586|NCT02207608|62961175|FG000|Overall Study|Adverse Event|1|||
33565587|NCT02207608|62961176|FG001|Overall Study|Adverse Event|0|||
33565588|NCT03530995|62961184|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
33565589|NCT03530995|62961185|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
33565590|NCT03530995|62961184|FG000|Part 1 Period 3|Protocol Violation|1|||
33565591|NCT03530995|62961185|FG001|Part 1 Period 3|Protocol Violation|0|||
33565592|NCT03530995|62961184|FG000|Part 1 Period 4|Physician Decision|1|||
33565593|NCT03530995|62961185|FG001|Part 1 Period 4|Physician Decision|0|||
33565594|NCT03530995|62961184|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
33565595|NCT03530995|62961185|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
33565596|NCT02217436|62961209|FG000|Overall Study|Protocol Violation|1|||
33565597|NCT02217436|62961210|FG001|Overall Study|Protocol Violation|1|||
33565598|NCT02217436|62961209|FG000|Overall Study|Incomplete data|0|||
33565599|NCT02217436|62961210|FG001|Overall Study|Incomplete data|1|||
33565600|NCT02207530|62961216|FG000|Overall Study|Worsening condition under investigation|78|||
33565601|NCT02207530|62961216|FG000|Overall Study|Patient decision to stop study treatment|5|||
33565602|NCT02207530|62961216|FG000|Overall Study|Adverse Event|8|||
33565603|NCT02207374|62961223|FG000|Overall Study|Withdrawal by Subject|5|||
33565604|NCT02207374|62961224|FG001|Overall Study|Withdrawal by Subject|9|||
33565605|NCT02207374|62961225|FG002|Overall Study|Withdrawal by Subject|4|||
33565606|NCT02207374|62961223|FG000|Overall Study|Death|1|||
33565607|NCT02207374|62961224|FG001|Overall Study|Death|0|||
33565608|NCT02207374|62961225|FG002|Overall Study|Death|1|||
33565609|NCT02207374|62961223|FG000|Overall Study|Missing follow-up information|0|||
33565610|NCT02207374|62961224|FG001|Overall Study|Missing follow-up information|1|||
33565611|NCT02207374|62961225|FG002|Overall Study|Missing follow-up information|1|||
33565612|NCT02217280|62961233|FG000|Overall Study|Withdrawal by Subject|2|||
33565613|NCT02217280|62961233|FG000|Overall Study|Post-consent sceen fail|2|||
33565614|NCT02786537|62961244|FG000|As Randomized|Adverse Event|0|||
33565615|NCT02786537|62961245|FG001|As Randomized|Adverse Event|11|||
33565616|NCT02786537|62961246|FG002|As Randomized|Adverse Event|0|||
33565617|NCT02786537|62961247|FG003|As Randomized|Adverse Event|4|||
33565618|NCT02786537|62961248|FG004|As Randomized|Adverse Event|6|||
33565619|NCT02786537|62961249|FG005|As Randomized|Adverse Event|2|||
33565620|NCT02786537|62961244|FG000|As Randomized|Lack of Efficacy|0|||
33565621|NCT02786537|62961245|FG001|As Randomized|Lack of Efficacy|0|||
33565622|NCT02786537|62961246|FG002|As Randomized|Lack of Efficacy|0|||
33392160|NCT00705614|62771048|FG001|Switch to Remicade|Adverse Event|5|||
33565623|NCT02786537|62961247|FG003|As Randomized|Lack of Efficacy|1|||
33565624|NCT02786537|62961248|FG004|As Randomized|Lack of Efficacy|0|||
33565625|NCT02786537|62961249|FG005|As Randomized|Lack of Efficacy|0|||
33565626|NCT02786537|62961244|FG000|As Randomized|Withdrawal by Subject|1|||
33565627|NCT02786537|62961245|FG001|As Randomized|Withdrawal by Subject|2|||
33565628|NCT02786537|62961246|FG002|As Randomized|Withdrawal by Subject|0|||
33565629|NCT02786537|62961247|FG003|As Randomized|Withdrawal by Subject|1|||
33565630|NCT02786537|62961248|FG004|As Randomized|Withdrawal by Subject|1|||
33565631|NCT02786537|62961249|FG005|As Randomized|Withdrawal by Subject|0|||
33565632|NCT02786537|62961244|FG000|As Randomized|Death|0|||
33565633|NCT02786537|62961245|FG001|As Randomized|Death|2|||
33565634|NCT02786537|62961246|FG002|As Randomized|Death|0|||
33565635|NCT02786537|62961247|FG003|As Randomized|Death|3|||
33565636|NCT02786537|62961248|FG004|As Randomized|Death|1|||
33565637|NCT02786537|62961249|FG005|As Randomized|Death|0|||
33565638|NCT02786537|62961244|FG000|As Randomized|Non-compliance with study drug|1|||
33565639|NCT02786537|62961245|FG001|As Randomized|Non-compliance with study drug|11|||
33565640|NCT02786537|62961246|FG002|As Randomized|Non-compliance with study drug|0|||
33565641|NCT02786537|62961247|FG003|As Randomized|Non-compliance with study drug|1|||
33565642|NCT02786537|62961248|FG004|As Randomized|Non-compliance with study drug|0|||
33565643|NCT02786537|62961249|FG005|As Randomized|Non-compliance with study drug|1|||
33565644|NCT02786537|62961244|FG000|As Randomized|Lost to treatment follow-up|4|||
33565645|NCT02786537|62961245|FG001|As Randomized|Lost to treatment follow-up|32|||
33565646|NCT02786537|62961246|FG002|As Randomized|Lost to treatment follow-up|0|||
33565647|NCT02786537|62961247|FG003|As Randomized|Lost to treatment follow-up|24|||
33565648|NCT02786537|62961248|FG004|As Randomized|Lost to treatment follow-up|4|||
33565649|NCT02786537|62961249|FG005|As Randomized|Lost to treatment follow-up|4|||
33565650|NCT02786537|62961244|FG000|As Randomized|Incarceration|0|||
33565651|NCT02786537|62961245|FG001|As Randomized|Incarceration|1|||
33565652|NCT02786537|62961246|FG002|As Randomized|Incarceration|0|||
33565653|NCT02786537|62961247|FG003|As Randomized|Incarceration|0|||
33565654|NCT02786537|62961248|FG004|As Randomized|Incarceration|0|||
33565655|NCT02786537|62961249|FG005|As Randomized|Incarceration|0|||
33565656|NCT02786537|62961244|FG000|As Randomized|Opiate Dependency Relapse|0|||
33565657|NCT02786537|62961245|FG001|As Randomized|Opiate Dependency Relapse|1|||
33565658|NCT02786537|62961246|FG002|As Randomized|Opiate Dependency Relapse|0|||
33565659|NCT02786537|62961247|FG003|As Randomized|Opiate Dependency Relapse|0|||
33565660|NCT02786537|62961248|FG004|As Randomized|Opiate Dependency Relapse|0|||
33565661|NCT02786537|62961249|FG005|As Randomized|Opiate Dependency Relapse|0|||
33565662|NCT02786537|62961244|FG000|As Randomized|HCV drugs stolen from pt|0|||
33565663|NCT02786537|62961245|FG001|As Randomized|HCV drugs stolen from pt|1|||
33565664|NCT02786537|62961246|FG002|As Randomized|HCV drugs stolen from pt|0|||
33565665|NCT02786537|62961247|FG003|As Randomized|HCV drugs stolen from pt|0|||
33565666|NCT02786537|62961248|FG004|As Randomized|HCV drugs stolen from pt|0|||
33565667|NCT02786537|62961249|FG005|As Randomized|HCV drugs stolen from pt|0|||
33565668|NCT02786537|62961244|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
33565669|NCT02786537|62961245|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
33565670|NCT02786537|62961246|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
33565671|NCT02786537|62961247|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
33565672|NCT02786537|62961248|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
33565673|NCT02786537|62961249|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
33565674|NCT02786537|62961244|FG000|As Randomized|Subject lost insurance|0|||
33565675|NCT02786537|62961245|FG001|As Randomized|Subject lost insurance|0|||
33565676|NCT02786537|62961246|FG002|As Randomized|Subject lost insurance|0|||
33565677|NCT02786537|62961247|FG003|As Randomized|Subject lost insurance|1|||
33565678|NCT02786537|62961248|FG004|As Randomized|Subject lost insurance|0|||
33565679|NCT02786537|62961249|FG005|As Randomized|Subject lost insurance|0|||
33565680|NCT02786537|62961244|FG000|As Treated|Adverse Event|0|||
33565681|NCT02786537|62961245|FG001|As Treated|Adverse Event|11|||
33301052|NCT01287897|62677121|FG000|Overall Study|Not consented properly|0|||
33301053|NCT01287897|62677122|FG001|Overall Study|Not consented properly|1|||
33301054|NCT01287897|62677123|FG002|Overall Study|Not consented properly|0|||
33301055|NCT01287897|62677124|FG003|Overall Study|Not consented properly|0|||
33301056|NCT01287897|62677121|FG000|Overall Study|Not meeting entrance criteria|1|||
33565682|NCT02786537|62961246|FG002|As Treated|Adverse Event|0|||
33565683|NCT02786537|62961247|FG003|As Treated|Adverse Event|4|||
33565684|NCT02786537|62961248|FG004|As Treated|Adverse Event|6|||
33565685|NCT02786537|62961249|FG005|As Treated|Adverse Event|2|||
33565686|NCT02786537|62961244|FG000|As Treated|Death|0|||
33565687|NCT02786537|62961245|FG001|As Treated|Death|2|||
33565688|NCT02786537|62961246|FG002|As Treated|Death|0|||
33565689|NCT02786537|62961247|FG003|As Treated|Death|3|||
33565690|NCT02786537|62961248|FG004|As Treated|Death|1|||
33565691|NCT02786537|62961249|FG005|As Treated|Death|0|||
33565692|NCT02786537|62961244|FG000|As Treated|Lack of Efficacy|0|||
33565693|NCT02786537|62961245|FG001|As Treated|Lack of Efficacy|0|||
33301057|NCT01287897|62677122|FG001|Overall Study|Not meeting entrance criteria|1|||
33301058|NCT01287897|62677123|FG002|Overall Study|Not meeting entrance criteria|0|||
33565694|NCT02786537|62961246|FG002|As Treated|Lack of Efficacy|0|||
33565695|NCT02786537|62961247|FG003|As Treated|Lack of Efficacy|1|||
33565696|NCT02786537|62961248|FG004|As Treated|Lack of Efficacy|0|||
33565697|NCT02786537|62961249|FG005|As Treated|Lack of Efficacy|0|||
33565698|NCT02786537|62961244|FG000|As Treated|Lost to Follow-up|4|||
33565699|NCT02786537|62961245|FG001|As Treated|Lost to Follow-up|32|||
33565700|NCT02786537|62961246|FG002|As Treated|Lost to Follow-up|0|||
33565701|NCT02786537|62961247|FG003|As Treated|Lost to Follow-up|25|||
33565702|NCT02786537|62961248|FG004|As Treated|Lost to Follow-up|4|||
33565703|NCT02786537|62961249|FG005|As Treated|Lost to Follow-up|4|||
33565704|NCT02786537|62961244|FG000|As Treated|Non-compliance with study drug|1|||
33565705|NCT02786537|62961245|FG001|As Treated|Non-compliance with study drug|11|||
33565706|NCT02786537|62961246|FG002|As Treated|Non-compliance with study drug|0|||
33565707|NCT02786537|62961247|FG003|As Treated|Non-compliance with study drug|1|||
33565708|NCT02786537|62961248|FG004|As Treated|Non-compliance with study drug|0|||
33565709|NCT02786537|62961249|FG005|As Treated|Non-compliance with study drug|1|||
33565710|NCT02786537|62961244|FG000|As Treated|Lost insurance|0|||
33565711|NCT02786537|62961245|FG001|As Treated|Lost insurance|0|||
33565712|NCT02786537|62961246|FG002|As Treated|Lost insurance|0|||
33565713|NCT02786537|62961247|FG003|As Treated|Lost insurance|1|||
33565714|NCT02786537|62961248|FG004|As Treated|Lost insurance|0|||
33565715|NCT02786537|62961249|FG005|As Treated|Lost insurance|0|||
33565716|NCT02786537|62961244|FG000|As Treated|Withdrawal by Subject|1|||
33565717|NCT02786537|62961245|FG001|As Treated|Withdrawal by Subject|2|||
33565718|NCT02786537|62961246|FG002|As Treated|Withdrawal by Subject|0|||
33565719|NCT02786537|62961247|FG003|As Treated|Withdrawal by Subject|0|||
33565720|NCT02786537|62961248|FG004|As Treated|Withdrawal by Subject|1|||
33565721|NCT02786537|62961249|FG005|As Treated|Withdrawal by Subject|0|||
33565722|NCT02786537|62961244|FG000|As Treated|Incarceration|0|||
33565723|NCT02786537|62961245|FG001|As Treated|Incarceration|1|||
33565724|NCT02786537|62961246|FG002|As Treated|Incarceration|0|||
33565725|NCT02786537|62961247|FG003|As Treated|Incarceration|0|||
33565726|NCT02786537|62961248|FG004|As Treated|Incarceration|0|||
33565727|NCT02786537|62961249|FG005|As Treated|Incarceration|0|||
33565728|NCT02786537|62961244|FG000|As Treated|Opiate dependency relapse|0|||
33565729|NCT02786537|62961245|FG001|As Treated|Opiate dependency relapse|1|||
33565730|NCT02786537|62961246|FG002|As Treated|Opiate dependency relapse|0|||
33565731|NCT02786537|62961247|FG003|As Treated|Opiate dependency relapse|0|||
33565732|NCT02786537|62961248|FG004|As Treated|Opiate dependency relapse|0|||
33565733|NCT02786537|62961249|FG005|As Treated|Opiate dependency relapse|0|||
33565734|NCT02786537|62961244|FG000|As Treated|Drugs stolen from patient|0|||
33565735|NCT02786537|62961245|FG001|As Treated|Drugs stolen from patient|1|||
33565736|NCT02786537|62961246|FG002|As Treated|Drugs stolen from patient|0|||
33565737|NCT02786537|62961247|FG003|As Treated|Drugs stolen from patient|0|||
33565738|NCT02786537|62961248|FG004|As Treated|Drugs stolen from patient|0|||
33565739|NCT02786537|62961249|FG005|As Treated|Drugs stolen from patient|0|||
33565740|NCT02786537|62961244|FG000|As Treated|Advised to stop tx after loss of meds|0|||
33565741|NCT02786537|62961245|FG001|As Treated|Advised to stop tx after loss of meds|1|||
33565742|NCT02786537|62961246|FG002|As Treated|Advised to stop tx after loss of meds|0|||
33565743|NCT02786537|62961247|FG003|As Treated|Advised to stop tx after loss of meds|0|||
33565744|NCT02786537|62961248|FG004|As Treated|Advised to stop tx after loss of meds|0|||
33565745|NCT02786537|62961249|FG005|As Treated|Advised to stop tx after loss of meds|0|||
33565746|NCT02216812|62961357|FG000|Overall Study|Lost to Follow-up|10|||
33565747|NCT02216812|62961358|FG001|Overall Study|Lost to Follow-up|5|||
33565748|NCT02252536|62961366|FG000|Overall Study|Lost to Follow-up|5|||
33565749|NCT02252536|62961367|FG001|Overall Study|Lost to Follow-up|3|||
33565750|NCT02206828|62961373|FG000|Overall Study|Lost to Follow-up|7|||
33565751|NCT01209767|62961400|FG000|Overall Study|Withdrawal by Subject|1|||
33565752|NCT01209767|62961400|FG000|Overall Study|Lost to Follow-up|3|||
33565753|NCT02252146|62961408|FG000|Overall Study|Lack of Efficacy|4|||
33565754|NCT02252146|62961408|FG000|Overall Study|Entered hospice care|1|||
33565755|NCT02252146|62961408|FG000|Overall Study|Inability to travel to study site|1|||
33392161|NCT00705614|62771047|FG000|Switch to Remicade|Lost to Follow-up|0|||
33565756|NCT02251990|62961414|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
33565757|NCT02251990|62961415|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
33565758|NCT02251990|62961414|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
33565759|NCT02251990|62961415|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
33565760|NCT02251990|62961414|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
33565761|NCT02251990|62961415|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
33565762|NCT02251990|62961414|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
33565763|NCT02251990|62961415|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
33565764|NCT02251990|62961414|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
33565765|NCT02251990|62961415|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
33565766|NCT02251990|62961414|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
33565767|NCT02251990|62961415|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
33565768|NCT02251912|62961424|FG000|Overall Study|Withdrawal by Subject|2|||
33565769|NCT02251912|62961425|FG001|Overall Study|Withdrawal by Subject|3|||
33565770|NCT02251912|62961424|FG000|Overall Study|Adverse Event|0|||
33565771|NCT02251912|62961425|FG001|Overall Study|Adverse Event|2|||
33565772|NCT02206048|62961440|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
33663129|NCT01567085|63094001|FG000|Overall Study|Lost to Follow-up|3|||
33663130|NCT01567085|63094001|FG000|Overall Study|Graft loss|2|||
33663131|NCT01567085|63094001|FG000|Overall Study|Renal transplantectomy|1|||
33663132|NCT01567085|63094001|FG000|Overall Study|Returned to chronic dialysis|1|||
33663133|NCT01567085|63094001|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
33663134|NCT01566773|63094005|FG000|Overall Study|Protocol specified criteria|4|||
33663135|NCT01566773|63094005|FG000|Overall Study|Protocol Violation|4|||
33663136|NCT01566773|63094005|FG000|Overall Study|Withdrawal by Subject|9|||
33663137|NCT01566773|63094005|FG000|Overall Study|Administrative reason|1|||
33663138|NCT01566773|63094005|FG000|Overall Study|Adverse Event|10|||
33663139|NCT01566773|63094005|FG000|Overall Study|Physician Decision|2|||
33663140|NCT01566149|63094027|FG000|Overall Study|Adverse Event|0|||
33663141|NCT01566149|63094028|FG001|Overall Study|Adverse Event|1|||
33663142|NCT01566149|63094027|FG000|Overall Study|Non-compliance with study medication|2|||
33663143|NCT01566149|63094028|FG001|Overall Study|Non-compliance with study medication|0|||
33663144|NCT01566149|63094027|FG000|Overall Study|Protocol Violation|0|||
33663145|NCT01566149|63094028|FG001|Overall Study|Protocol Violation|1|||
33663146|NCT01566149|63094027|FG000|Overall Study|Withdrawal by Subject|1|||
33663147|NCT01566149|63094028|FG001|Overall Study|Withdrawal by Subject|0|||
33663148|NCT01565993|63094036|FG000|Overall Study|Physician Decision|0|||
33663149|NCT01565993|63094037|FG001|Overall Study|Physician Decision|3|||
33663150|NCT01565291|63094045|FG000|Overall Study|Withdrawal by Subject|1|||
33663151|NCT01565291|63094046|FG001|Overall Study|Withdrawal by Subject|0|||
33392162|NCT00705614|62771048|FG001|Switch to Remicade|Lost to Follow-up|23|||
33392163|NCT00705614|62771047|FG000|Switch to Remicade|Withdrawal by Subject|0|||
33392164|NCT00705614|62771048|FG001|Switch to Remicade|Withdrawal by Subject|12|||
33392165|NCT00705614|62771047|FG000|Switch to Remicade|Administrative Reason|0|||
33392166|NCT00705614|62771048|FG001|Switch to Remicade|Administrative Reason|9|||
33392167|NCT00620763|62771056|FG000|Period: First Intervention|Withdrawal by Subject|0|||
33392168|NCT00620763|62771057|FG001|Period: First Intervention|Withdrawal by Subject|2|||
33392169|NCT00620763|62771056|FG000|Period: First Intervention|Protocol Violation|0|||
33392170|NCT00620763|62771057|FG001|Period: First Intervention|Protocol Violation|3|||
33392171|NCT00620763|62771056|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
33392172|NCT00620763|62771057|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
33392173|NCT00562978|62771065|FG000|Overall Study|Patient had imaging dose only|1|||
33392174|NCT00562978|62771066|FG001|Overall Study|Patient had imaging dose only|11|||
33565773|NCT02205814|62961452|FG000|Overall Study|Lost to Follow-up|0|||
33565774|NCT02205814|62961453|FG001|Overall Study|Lost to Follow-up|0|||
33663152|NCT02691702|63094063|FG000|Overall Study|Adverse Event|1|||
33663153|NCT02691702|63094064|FG001|Overall Study|Adverse Event|0|||
33663154|NCT02691702|63094065|FG002|Overall Study|Adverse Event|0|||
33663155|NCT02691702|63094066|FG003|Overall Study|Adverse Event|0|||
33663156|NCT02691702|63094067|FG004|Overall Study|Adverse Event|0|||
33663157|NCT02691702|63094068|FG005|Overall Study|Adverse Event|0|||
33663158|NCT02691702|63094069|FG006|Overall Study|Adverse Event|0|||
33663159|NCT02691702|63094070|FG007|Overall Study|Adverse Event|0|||
33663160|NCT02691702|63094071|FG008|Overall Study|Adverse Event|1|||
33663161|NCT02691702|63094072|FG009|Overall Study|Adverse Event|0|||
33663162|NCT02691702|63094073|FG010|Overall Study|Adverse Event|1|||
33663163|NCT02691702|63094063|FG000|Overall Study|Lost to Follow-up|0|||
33663164|NCT02691702|63094064|FG001|Overall Study|Lost to Follow-up|0|||
33565775|NCT02205814|62961454|FG002|Overall Study|Lost to Follow-up|0|||
33565776|NCT02205814|62961455|FG003|Overall Study|Lost to Follow-up|1|||
33565777|NCT02205814|62961452|FG000|Overall Study|Lack of Efficacy|1|||
33565778|NCT02205814|62961453|FG001|Overall Study|Lack of Efficacy|0|||
33565779|NCT02205814|62961454|FG002|Overall Study|Lack of Efficacy|1|||
33565780|NCT02205814|62961455|FG003|Overall Study|Lack of Efficacy|1|||
33565781|NCT02205814|62961452|FG000|Overall Study|Physician Decision|0|||
33565782|NCT02205814|62961453|FG001|Overall Study|Physician Decision|0|||
33565783|NCT02205814|62961454|FG002|Overall Study|Physician Decision|1|||
33565784|NCT02205814|62961455|FG003|Overall Study|Physician Decision|0|||
33565785|NCT02205814|62961452|FG000|Overall Study|Protocol Violation|1|||
33663165|NCT02691702|63094065|FG002|Overall Study|Lost to Follow-up|1|||
33663166|NCT02691702|63094066|FG003|Overall Study|Lost to Follow-up|0|||
33392175|NCT00620373|62771072|FG000|Overall Study|Unverified cancer status|33|||
33392176|NCT00372619|62771086|FG000|Overall Study|Ineligible|0|||
33565786|NCT02205814|62961453|FG001|Overall Study|Protocol Violation|0|||
33565787|NCT02205814|62961454|FG002|Overall Study|Protocol Violation|0|||
33565788|NCT02205814|62961455|FG003|Overall Study|Protocol Violation|1|||
33663167|NCT02691702|63094067|FG004|Overall Study|Lost to Follow-up|0|||
33663168|NCT02691702|63094068|FG005|Overall Study|Lost to Follow-up|2|||
33663169|NCT02691702|63094069|FG006|Overall Study|Lost to Follow-up|0|||
33663170|NCT02691702|63094070|FG007|Overall Study|Lost to Follow-up|0|||
33663171|NCT02691702|63094071|FG008|Overall Study|Lost to Follow-up|0|||
33663172|NCT02691702|63094072|FG009|Overall Study|Lost to Follow-up|0|||
33565789|NCT02205814|62961452|FG000|Overall Study|Withdrawal by Subject|0|||
33565790|NCT02205814|62961453|FG001|Overall Study|Withdrawal by Subject|1|||
33565791|NCT02205814|62961454|FG002|Overall Study|Withdrawal by Subject|2|||
33565792|NCT02205814|62961455|FG003|Overall Study|Withdrawal by Subject|1|||
33565793|NCT02205814|62961452|FG000|Overall Study|not compliant with study procedures|0|||
33565794|NCT02205814|62961453|FG001|Overall Study|not compliant with study procedures|0|||
33565795|NCT02205814|62961454|FG002|Overall Study|not compliant with study procedures|1|||
33565796|NCT02205814|62961455|FG003|Overall Study|not compliant with study procedures|0|||
33565797|NCT02662985|62961467|FG000|Treatment Period 1|Adverse Event|0|||
33565798|NCT02662985|62961468|FG001|Treatment Period 1|Adverse Event|2|||
33565799|NCT02662985|62961467|FG000|Treatment Period 1|Protocol Violation|0|||
33565800|NCT02662985|62961468|FG001|Treatment Period 1|Protocol Violation|1|||
33565801|NCT02662985|62961467|FG000|Treatment Period 1|Physician Decision|1|||
33565802|NCT02662985|62961468|FG001|Treatment Period 1|Physician Decision|0|||
33565803|NCT02662985|62961467|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33565804|NCT02662985|62961468|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33565805|NCT02662985|62961467|FG000|Treatment Period 2|Lack of Efficacy|0|||
33565806|NCT02662985|62961468|FG001|Treatment Period 2|Lack of Efficacy|1|||
33565807|NCT02662985|62961467|FG000|Treatment Period 2|Lost to Follow-up|1|||
33565808|NCT02662985|62961468|FG001|Treatment Period 2|Lost to Follow-up|0|||
33565809|NCT02662985|62961467|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
33565810|NCT02662985|62961468|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
33565811|NCT02662985|62961467|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
33565812|NCT02662985|62961468|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
33565813|NCT02662985|62961467|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
33565814|NCT02662985|62961468|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
33565815|NCT02662985|62961467|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
33565816|NCT02662985|62961468|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
33565817|NCT02662985|62961467|FG000|Treatment Period 3 (Extension Period)|Death|0|||
33565818|NCT02662985|62961468|FG001|Treatment Period 3 (Extension Period)|Death|1|||
33565819|NCT01631812|62961474|FG000|Overall Study|Adverse Event|25|||
33565820|NCT01631812|62961474|FG000|Overall Study|Lack of Efficacy|5|||
33565821|NCT01631812|62961474|FG000|Overall Study|Withdrawal by Subject|4|||
33565822|NCT01631812|62961474|FG000|Overall Study|Physician Decision|3|||
33565823|NCT02323295|62961480|FG000|Overall Study|Adverse Event|0|||
33565824|NCT02323295|62961481|FG001|Overall Study|Adverse Event|1|||
33565825|NCT02323295|62961480|FG000|Overall Study|Withdrawal by Subject|0|||
33565826|NCT02323295|62961481|FG001|Overall Study|Withdrawal by Subject|1|||
33565827|NCT02323295|62961480|FG000|Overall Study|Patient did not have surgery as planned.|0|||
33565828|NCT02323295|62961481|FG001|Overall Study|Patient did not have surgery as planned.|1|||
33565829|NCT02215954|62961490|FG000|Overall Study|Adverse Event|0|||
33565830|NCT02215954|62961491|FG001|Overall Study|Adverse Event|0|||
33565831|NCT02215954|62961492|FG002|Overall Study|Adverse Event|1|||
33565832|NCT02215954|62961490|FG000|Overall Study|Withdrawal by Subject|0|||
33565833|NCT02215954|62961491|FG001|Overall Study|Withdrawal by Subject|0|||
33565834|NCT02215954|62961492|FG002|Overall Study|Withdrawal by Subject|2|||
33565835|NCT02215954|62961490|FG000|Overall Study|Not exposed|1|||
33565836|NCT02215954|62961491|FG001|Overall Study|Not exposed|1|||
33565837|NCT02215954|62961492|FG002|Overall Study|Not exposed|3|||
33565838|NCT01941719|62961503|FG000|Overall Study|Lost to Follow-up|20|||
33565839|NCT01941719|62961504|FG001|Overall Study|Lost to Follow-up|19|||
33565840|NCT02215252|62961514|FG000|Overall Study|Adverse Event|1|||
33565841|NCT02215252|62961515|FG001|Overall Study|Adverse Event|5|||
33565842|NCT02215252|62961516|FG002|Overall Study|Adverse Event|2|||
33565843|NCT02215252|62961514|FG000|Overall Study|Lost to Follow-up|0|||
33565844|NCT02215252|62961515|FG001|Overall Study|Lost to Follow-up|0|||
33565845|NCT02215252|62961516|FG002|Overall Study|Lost to Follow-up|1|||
33565846|NCT02215252|62961514|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
33565847|NCT02215252|62961515|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
33565848|NCT02215252|62961516|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
33565849|NCT02215252|62961514|FG000|Overall Study|Protocol Violation|0|||
33565850|NCT02215252|62961515|FG001|Overall Study|Protocol Violation|1|||
33565851|NCT02215252|62961516|FG002|Overall Study|Protocol Violation|0|||
33565852|NCT02215252|62961514|FG000|Overall Study|Withdrawal by Subject|1|||
33565853|NCT02215252|62961515|FG001|Overall Study|Withdrawal by Subject|0|||
33565854|NCT02215252|62961516|FG002|Overall Study|Withdrawal by Subject|0|||
33565855|NCT02215252|62961514|FG000|Overall Study|Other|0|||
33565856|NCT02215252|62961515|FG001|Overall Study|Other|1|||
33565857|NCT02215252|62961516|FG002|Overall Study|Other|1|||
33565858|NCT02204410|62961524|FG000|Overall Study|Lost to Follow-up|5|||
33565859|NCT02204410|62961524|FG000|Overall Study|Physician Decision|2|||
33565860|NCT02204410|62961524|FG000|Overall Study|Protocol Violation|1|||
33565861|NCT02204410|62961524|FG000|Overall Study|Withdrawal by Subject|3|||
33565862|NCT02250274|62961530|FG000|Overall Study|Insufficient blood draw amount|7|||
33565863|NCT02250274|62961531|FG001|Overall Study|Insufficient blood draw amount|6|||
33565864|NCT02213458|62961545|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
33565865|NCT02213458|62961546|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
33565866|NCT02213458|62961545|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
33565867|NCT02213458|62961546|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
33565868|NCT02213458|62961545|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
33565869|NCT02213458|62961546|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
33565870|NCT02213458|62961545|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
33565871|NCT02213458|62961546|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
33565872|NCT02213458|62961545|FG000|Overall Study|Refused re-consent|6|||
33565873|NCT02213458|62961546|FG001|Overall Study|Refused re-consent|0|||
33565874|NCT02213458|62961545|FG000|Overall Study|Lost to Follow-up|2|||
33565875|NCT02213458|62961546|FG001|Overall Study|Lost to Follow-up|2|||
33565876|NCT02213458|62961545|FG000|Overall Study|Withdrawal by Subject|26|||
33565877|NCT02213458|62961546|FG001|Overall Study|Withdrawal by Subject|8|||
33565878|NCT02213380|62961554|FG000|Underwent Randomization|Withdrawal by Subject|2|||
33565879|NCT02213380|62961555|FG001|Underwent Randomization|Withdrawal by Subject|0|||
33565880|NCT02213380|62961554|FG000|Underwent Randomization|Not treated|3|||
33565881|NCT02213380|62961555|FG001|Underwent Randomization|Not treated|3|||
33565882|NCT02213380|62961554|FG000|Per-protocol Analysis|Protocol Violation|32|||
33565883|NCT02213380|62961555|FG001|Per-protocol Analysis|Protocol Violation|36|||
33565884|NCT02202850|62961563|FG000|Overall Study|Other|2|||
33565885|NCT02202850|62961564|FG001|Overall Study|Other|2|||
33565886|NCT02202850|62961563|FG000|Overall Study|Enbrel treatment discontinued|15|||
33565887|NCT02202850|62961564|FG001|Overall Study|Enbrel treatment discontinued|3|||
33565888|NCT02202850|62961563|FG000|Overall Study|Lost to Follow-up|7|||
33565889|NCT02202850|62961564|FG001|Overall Study|Lost to Follow-up|1|||
33565890|NCT02212678|62961570|FG000|Overall Study|Adverse Event|1|||
33565891|NCT03104075|62961576|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
33565892|NCT03104075|62961577|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
33565893|NCT03038087|62961584|FG000|Overall Study|lost data|1|||
33565894|NCT02249182|62961595|FG000|Treatment Phase|Lost to Follow-up|4|||
33565895|NCT02249182|62961596|FG001|Treatment Phase|Lost to Follow-up|0|||
33565896|NCT02249182|62961597|FG002|Treatment Phase|Lost to Follow-up|0|||
33565897|NCT02249182|62961598|FG003|Treatment Phase|Lost to Follow-up|0|||
33565898|NCT02249182|62961599|FG004|Treatment Phase|Lost to Follow-up|0|||
33565899|NCT03641339|62961630|FG000|Overall Study|Physician Decision|1|||
33565900|NCT03641339|62961631|FG001|Overall Study|Physician Decision|0|||
33565901|NCT03641339|62961632|FG002|Overall Study|Physician Decision|0|||
33565902|NCT03641339|62961633|FG003|Overall Study|Physician Decision|0|||
33565903|NCT03641339|62961634|FG004|Overall Study|Physician Decision|0|||
33565904|NCT03641339|62961635|FG005|Overall Study|Physician Decision|0|||
33565905|NCT03641339|62961630|FG000|Overall Study|Withdrawal by Subject|0|||
33565906|NCT03641339|62961631|FG001|Overall Study|Withdrawal by Subject|2|||
33565907|NCT03641339|62961632|FG002|Overall Study|Withdrawal by Subject|0|||
33565908|NCT03641339|62961633|FG003|Overall Study|Withdrawal by Subject|2|||
33565909|NCT03641339|62961634|FG004|Overall Study|Withdrawal by Subject|0|||
33565910|NCT03641339|62961635|FG005|Overall Study|Withdrawal by Subject|1|||
33565911|NCT02248480|62961651|FG000|Overall Study|Lack of Efficacy|4|||
33565912|NCT02248480|62961652|FG001|Overall Study|Lack of Efficacy|6|||
33565913|NCT02248480|62961651|FG000|Overall Study|Adverse Event|11|||
33565914|NCT02248480|62961652|FG001|Overall Study|Adverse Event|2|||
33565915|NCT02248480|62961651|FG000|Overall Study|Withdrawal by Subject|2|||
33565916|NCT02248480|62961652|FG001|Overall Study|Withdrawal by Subject|4|||
33565917|NCT02248480|62961651|FG000|Overall Study|Entry Criteria Not Met|0|||
33565918|NCT02248480|62961652|FG001|Overall Study|Entry Criteria Not Met|1|||
33565919|NCT02248480|62961651|FG000|Overall Study|Other:Physician Decision|0|||
33565920|NCT02248480|62961652|FG001|Overall Study|Other:Physician Decision|1|||
33565921|NCT01653158|62961659|FG000|Overall Study|Death|0|||
33565922|NCT01653158|62961660|FG001|Overall Study|Death|0|||
33565923|NCT01653158|62961661|FG002|Overall Study|Death|0|||
33565924|NCT01653158|62961662|FG003|Overall Study|Death|1|||
33565925|NCT01653158|62961663|FG004|Overall Study|Death|0|||
33565926|NCT01653158|62961664|FG005|Overall Study|Death|0|||
33565927|NCT01653158|62961665|FG006|Overall Study|Death|0|||
33301059|NCT01287897|62677124|FG003|Overall Study|Not meeting entrance criteria|0|||
33301060|NCT01287897|62677121|FG000|Overall Study|Other|1|||
33565928|NCT01653158|62961666|FG007|Overall Study|Death|2|||
33565929|NCT01653158|62961659|FG000|Overall Study|Adverse Event|0|||
33565930|NCT01653158|62961660|FG001|Overall Study|Adverse Event|0|||
33565931|NCT01653158|62961661|FG002|Overall Study|Adverse Event|0|||
33565932|NCT01653158|62961662|FG003|Overall Study|Adverse Event|1|||
33565933|NCT01653158|62961663|FG004|Overall Study|Adverse Event|0|||
33565934|NCT01653158|62961664|FG005|Overall Study|Adverse Event|0|||
33565935|NCT01653158|62961665|FG006|Overall Study|Adverse Event|0|||
33565936|NCT01653158|62961666|FG007|Overall Study|Adverse Event|3|||
33565937|NCT01653158|62961659|FG000|Overall Study|Other|0|||
33565938|NCT01653158|62961660|FG001|Overall Study|Other|0|||
33565939|NCT01653158|62961661|FG002|Overall Study|Other|0|||
33565940|NCT01653158|62961662|FG003|Overall Study|Other|0|||
33565941|NCT01653158|62961663|FG004|Overall Study|Other|0|||
33565942|NCT01653158|62961664|FG005|Overall Study|Other|0|||
33565943|NCT01653158|62961665|FG006|Overall Study|Other|0|||
33565944|NCT01653158|62961666|FG007|Overall Study|Other|1|||
33565945|NCT01653158|62961659|FG000|Overall Study|Progressive disease|0|||
33565946|NCT01653158|62961660|FG001|Overall Study|Progressive disease|0|||
33565947|NCT01653158|62961661|FG002|Overall Study|Progressive disease|0|||
33565948|NCT01653158|62961662|FG003|Overall Study|Progressive disease|0|||
33565949|NCT01653158|62961663|FG004|Overall Study|Progressive disease|1|||
33565950|NCT01653158|62961664|FG005|Overall Study|Progressive disease|1|||
33565951|NCT01653158|62961665|FG006|Overall Study|Progressive disease|2|||
33565952|NCT01653158|62961666|FG007|Overall Study|Progressive disease|9|||
33565953|NCT01653158|62961659|FG000|Overall Study|Withdrawal by Subject|1|||
33565954|NCT01653158|62961660|FG001|Overall Study|Withdrawal by Subject|0|||
33565955|NCT01653158|62961661|FG002|Overall Study|Withdrawal by Subject|0|||
33565956|NCT01653158|62961662|FG003|Overall Study|Withdrawal by Subject|0|||
33565957|NCT01653158|62961663|FG004|Overall Study|Withdrawal by Subject|0|||
33565958|NCT01653158|62961664|FG005|Overall Study|Withdrawal by Subject|0|||
33565959|NCT01653158|62961665|FG006|Overall Study|Withdrawal by Subject|0|||
33565960|NCT01653158|62961666|FG007|Overall Study|Withdrawal by Subject|0|||
33565961|NCT02247466|62961691|FG000|Overall Study|Procedure changed to open surgery|0|||
33565962|NCT02247466|62961692|FG001|Overall Study|Procedure changed to open surgery|3|||
33565963|NCT03317795|62961700|FG000|Overall Study|IUD Expulsion|1|||
33565964|NCT03317795|62961701|FG001|Overall Study|IUD Expulsion|0|||
33565965|NCT03317795|62961700|FG000|Overall Study|Lost to Follow-up|1|||
33565966|NCT03317795|62961701|FG001|Overall Study|Lost to Follow-up|3|||
33565967|NCT03317795|62961700|FG000|Overall Study|Treatment change|0|||
33565968|NCT03317795|62961701|FG001|Overall Study|Treatment change|3|||
33565969|NCT03317795|62961700|FG000|Overall Study|Intolerance of medication|0|||
33565970|NCT03317795|62961701|FG001|Overall Study|Intolerance of medication|1|||
33565971|NCT02202616|62961707|FG000|Overall Study|Screen failed|24|||
33565972|NCT02202616|62961707|FG000|Overall Study|Adverse Event|32|||
33565973|NCT02202616|62961707|FG000|Overall Study|Protocol deviation|18|||
33565974|NCT02202616|62961707|FG000|Overall Study|Patient withdrew consent|12|||
33565975|NCT02202616|62961707|FG000|Overall Study|Lost to Follow-up|6|||
33565976|NCT02202616|62961707|FG000|Overall Study|Administrative problems|6|||
33565977|NCT02202616|62961707|FG000|Overall Study|Abnormal test procedure result|1|||
33565978|NCT02202616|62961707|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33565979|NCT02455388|62961714|FG000|Overall Study|Protocol Violation|1|||
33565980|NCT02455388|62961715|FG001|Overall Study|Protocol Violation|0|||
33565981|NCT02455388|62961716|FG002|Overall Study|Protocol Violation|4|||
33565982|NCT02455388|62961714|FG000|Overall Study|Withdrawal by Subject|0|||
33565983|NCT02455388|62961715|FG001|Overall Study|Withdrawal by Subject|0|||
33565984|NCT02455388|62961716|FG002|Overall Study|Withdrawal by Subject|7|||
33565985|NCT02455076|62961729|FG000|Inpatient|Withdrawal by Subject|1|||
33565986|NCT02455076|62961730|FG001|Inpatient|Withdrawal by Subject|0|||
33565987|NCT02455076|62961731|FG002|Inpatient|Withdrawal by Subject|0|||
33565988|NCT02455076|62961732|FG003|Inpatient|Withdrawal by Subject|0|||
33565989|NCT02455076|62961733|FG004|Inpatient|Withdrawal by Subject|0|||
33301061|NCT01287897|62677122|FG001|Overall Study|Other|0|||
33301062|NCT01287897|62677123|FG002|Overall Study|Other|1|||
33301063|NCT01287897|62677124|FG003|Overall Study|Other|0|||
33301064|NCT01090024|62677138|FG000|Period 1|Met exclusion criteria|0|||
33301065|NCT01090024|62677139|FG001|Period 1|Met exclusion criteria|0|||
33301066|NCT01090024|62677140|FG002|Period 1|Met exclusion criteria|0|||
33301067|NCT01090024|62677141|FG003|Period 1|Met exclusion criteria|0|||
33301068|NCT01090024|62677142|FG004|Period 1|Met exclusion criteria|0|||
33301069|NCT01090024|62677143|FG005|Period 1|Met exclusion criteria|0|||
33301070|NCT01090024|62677144|FG006|Period 1|Met exclusion criteria|0|||
33301071|NCT01090024|62677145|FG007|Period 1|Met exclusion criteria|0|||
33392177|NCT00372619|62771087|FG001|Overall Study|Ineligible|0|||
33392178|NCT00372619|62771088|FG002|Overall Study|Ineligible|0|||
33565990|NCT02455076|62961729|FG000|Inpatient|Discharged <24 h after admission|0|||
33565991|NCT02455076|62961730|FG001|Inpatient|Discharged <24 h after admission|1|||
33565992|NCT02455076|62961731|FG002|Inpatient|Discharged <24 h after admission|0|||
33565993|NCT02455076|62961732|FG003|Inpatient|Discharged <24 h after admission|0|||
33565994|NCT02455076|62961733|FG004|Inpatient|Discharged <24 h after admission|0|||
33565995|NCT02455076|62961729|FG000|Inpatient|Adverse Event|3|||
33565996|NCT02455076|62961730|FG001|Inpatient|Adverse Event|0|||
33565997|NCT02455076|62961731|FG002|Inpatient|Adverse Event|0|||
33565998|NCT02455076|62961732|FG003|Inpatient|Adverse Event|0|||
33565999|NCT02455076|62961733|FG004|Inpatient|Adverse Event|0|||
33566000|NCT02455076|62961729|FG000|Outpatient|Adverse Event|0|||
33301072|NCT01090024|62677146|FG008|Period 1|Met exclusion criteria|0|||
33301073|NCT01090024|62677147|FG009|Period 1|Met exclusion criteria|0|||
33301074|NCT01090024|62677148|FG010|Period 1|Met exclusion criteria|0|||
33566001|NCT02455076|62961730|FG001|Outpatient|Adverse Event|0|||
33663173|NCT02691702|63094073|FG010|Overall Study|Lost to Follow-up|1|||
33663174|NCT02691702|63094063|FG000|Overall Study|Withdrawal by Subject|1|||
33663175|NCT02691702|63094064|FG001|Overall Study|Withdrawal by Subject|1|||
33663176|NCT02691702|63094065|FG002|Overall Study|Withdrawal by Subject|0|||
33663177|NCT02691702|63094066|FG003|Overall Study|Withdrawal by Subject|0|||
33663178|NCT02691702|63094067|FG004|Overall Study|Withdrawal by Subject|0|||
33663179|NCT02691702|63094068|FG005|Overall Study|Withdrawal by Subject|1|||
33663180|NCT02691702|63094069|FG006|Overall Study|Withdrawal by Subject|2|||
33663181|NCT02691702|63094070|FG007|Overall Study|Withdrawal by Subject|0|||
33663182|NCT02691702|63094071|FG008|Overall Study|Withdrawal by Subject|0|||
33663183|NCT02691702|63094072|FG009|Overall Study|Withdrawal by Subject|0|||
33663184|NCT02691702|63094073|FG010|Overall Study|Withdrawal by Subject|0|||
33663185|NCT02691702|63094063|FG000|Overall Study|Other|0|||
33663186|NCT02691702|63094064|FG001|Overall Study|Other|0|||
33663187|NCT02691702|63094065|FG002|Overall Study|Other|0|||
33663188|NCT02691702|63094066|FG003|Overall Study|Other|0|||
33663189|NCT02691702|63094067|FG004|Overall Study|Other|0|||
33663190|NCT02691702|63094068|FG005|Overall Study|Other|0|||
33663191|NCT02691702|63094069|FG006|Overall Study|Other|1|||
33663192|NCT02691702|63094070|FG007|Overall Study|Other|0|||
33663193|NCT02691702|63094071|FG008|Overall Study|Other|1|||
33663194|NCT02691702|63094072|FG009|Overall Study|Other|0|||
33663195|NCT02691702|63094073|FG010|Overall Study|Other|0|||
33663196|NCT02691702|63094063|FG000|Overall Study|Protocol Violation|0|||
33663197|NCT02691702|63094064|FG001|Overall Study|Protocol Violation|0|||
33663198|NCT02691702|63094065|FG002|Overall Study|Protocol Violation|0|||
33663199|NCT02691702|63094066|FG003|Overall Study|Protocol Violation|0|||
33663200|NCT02691702|63094067|FG004|Overall Study|Protocol Violation|0|||
33663201|NCT02691702|63094068|FG005|Overall Study|Protocol Violation|0|||
33663202|NCT02691702|63094069|FG006|Overall Study|Protocol Violation|0|||
33663203|NCT02691702|63094070|FG007|Overall Study|Protocol Violation|0|||
33301075|NCT01090024|62677149|FG011|Period 1|Met exclusion criteria|0|||
33301076|NCT01090024|62677150|FG012|Period 1|Met exclusion criteria|0|||
33301077|NCT01090024|62677151|FG013|Period 1|Met exclusion criteria|0|||
33301078|NCT01090024|62677152|FG014|Period 1|Met exclusion criteria|1|||
33301079|NCT01090024|62677153|FG015|Period 1|Met exclusion criteria|0|||
33392179|NCT00372619|62771089|FG003|Overall Study|Ineligible|0|||
33392180|NCT00372619|62771090|FG004|Overall Study|Ineligible|0|||
33392181|NCT00372619|62771091|FG005|Overall Study|Ineligible|2|||
33392182|NCT00372619|62771092|FG006|Overall Study|Ineligible|0|||
33392183|NCT00372619|62771086|FG000|Overall Study|Inevaluable|0|||
33392184|NCT00372619|62771087|FG001|Overall Study|Inevaluable|0|||
33392185|NCT00372619|62771088|FG002|Overall Study|Inevaluable|0|||
33392186|NCT00372619|62771089|FG003|Overall Study|Inevaluable|0|||
33392187|NCT00372619|62771090|FG004|Overall Study|Inevaluable|0|||
33392188|NCT00372619|62771091|FG005|Overall Study|Inevaluable|1|||
33392189|NCT00372619|62771092|FG006|Overall Study|Inevaluable|0|||
33392190|NCT00562588|62771110|FG000|Overall Study|Adverse Event|40|||
33392191|NCT00562588|62771111|FG001|Overall Study|Adverse Event|58|||
33392192|NCT00562588|62771110|FG000|Overall Study|Protocol Violation|30|||
33392193|NCT00562588|62771111|FG001|Overall Study|Protocol Violation|26|||
33663204|NCT02691702|63094071|FG008|Overall Study|Protocol Violation|0|||
33301080|NCT01090024|62677154|FG016|Period 1|Met exclusion criteria|0|||
33301081|NCT01090024|62677155|FG017|Period 1|Met exclusion criteria|0|||
33301082|NCT01090024|62677138|FG000|Period 1|Adverse Event|0|||
33301083|NCT01090024|62677139|FG001|Period 1|Adverse Event|0|||
33301084|NCT01090024|62677140|FG002|Period 1|Adverse Event|0|||
33301085|NCT01090024|62677141|FG003|Period 1|Adverse Event|0|||
33301086|NCT01090024|62677142|FG004|Period 1|Adverse Event|0|||
33301087|NCT01090024|62677143|FG005|Period 1|Adverse Event|0|||
33301088|NCT01090024|62677144|FG006|Period 1|Adverse Event|0|||
33301089|NCT01090024|62677145|FG007|Period 1|Adverse Event|0|||
33301090|NCT01090024|62677146|FG008|Period 1|Adverse Event|0|||
33301091|NCT01090024|62677147|FG009|Period 1|Adverse Event|1|||
33663205|NCT02691702|63094072|FG009|Overall Study|Protocol Violation|2|||
33663206|NCT02691702|63094073|FG010|Overall Study|Protocol Violation|0|||
33663207|NCT01564277|63094107|FG000|Overall Study|Protocol Violation|0|||
33663208|NCT01564277|63094108|FG001|Overall Study|Protocol Violation|1|||
33301092|NCT01090024|62677148|FG010|Period 1|Adverse Event|0|||
33301093|NCT01090024|62677149|FG011|Period 1|Adverse Event|1|||
33301094|NCT01090024|62677150|FG012|Period 1|Adverse Event|0|||
33301095|NCT01090024|62677151|FG013|Period 1|Adverse Event|0|||
33301096|NCT01090024|62677152|FG014|Period 1|Adverse Event|0|||
33392194|NCT00562588|62771110|FG000|Overall Study|Lost to Follow-up|12|||
33392195|NCT00562588|62771111|FG001|Overall Study|Lost to Follow-up|4|||
33392196|NCT00562588|62771110|FG000|Overall Study|Withdrawal by Subject|10|||
33566002|NCT02455076|62961731|FG002|Outpatient|Adverse Event|0|||
33663209|NCT01564277|63094107|FG000|Overall Study|Physician Decision|1|||
33663210|NCT01564277|63094108|FG001|Overall Study|Physician Decision|0|||
33663211|NCT02679222|63094114|FG000|Overall Study|No time for project|1|||
33663212|NCT01563185|63094126|FG000|Overall Study|Withdrawal by Subject|1|||
33663213|NCT01563185|63094126|FG000|Overall Study|Non-Compliance with study drug|1|||
33663214|NCT03305848|63094130|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
33663215|NCT03305848|63094130|FG000|Overall Study|Physician Decision|2|||
33663216|NCT01563029|63094139|FG000|Overall Study|Adverse Event|1|||
33663217|NCT01563029|63094140|FG001|Overall Study|Adverse Event|0|||
33663218|NCT01563029|63094141|FG002|Overall Study|Adverse Event|1|||
33663219|NCT01563029|63094142|FG003|Overall Study|Adverse Event|2|||
33663220|NCT01563029|63094143|FG004|Overall Study|Adverse Event|1|||
33663221|NCT01563029|63094139|FG000|Overall Study|Lack of Efficacy|42|||
33566003|NCT02455076|62961732|FG003|Outpatient|Adverse Event|5|||
33566004|NCT02455076|62961733|FG004|Outpatient|Adverse Event|0|||
33566005|NCT02455076|62961729|FG000|Outpatient|Lost to Follow-up|0|||
33566006|NCT02455076|62961730|FG001|Outpatient|Lost to Follow-up|0|||
33663222|NCT01563029|63094140|FG001|Overall Study|Lack of Efficacy|16|||
33663223|NCT01563029|63094141|FG002|Overall Study|Lack of Efficacy|23|||
33663224|NCT01563029|63094142|FG003|Overall Study|Lack of Efficacy|21|||
33663225|NCT01563029|63094143|FG004|Overall Study|Lack of Efficacy|19|||
33663226|NCT01563029|63094139|FG000|Overall Study|Protocol Violation|1|||
33663227|NCT01563029|63094140|FG001|Overall Study|Protocol Violation|2|||
33663228|NCT01563029|63094141|FG002|Overall Study|Protocol Violation|3|||
33663229|NCT01563029|63094142|FG003|Overall Study|Protocol Violation|1|||
33663230|NCT01563029|63094143|FG004|Overall Study|Protocol Violation|3|||
33663231|NCT01563029|63094139|FG000|Overall Study|Protocol defined stopping criteria|1|||
33663232|NCT01563029|63094140|FG001|Overall Study|Protocol defined stopping criteria|0|||
33663233|NCT01563029|63094141|FG002|Overall Study|Protocol defined stopping criteria|0|||
33663234|NCT01563029|63094142|FG003|Overall Study|Protocol defined stopping criteria|0|||
33663235|NCT01563029|63094143|FG004|Overall Study|Protocol defined stopping criteria|0|||
33663236|NCT01563029|63094139|FG000|Overall Study|Lost to Follow-up|1|||
33663237|NCT01563029|63094140|FG001|Overall Study|Lost to Follow-up|0|||
33663238|NCT01563029|63094141|FG002|Overall Study|Lost to Follow-up|1|||
33663239|NCT01563029|63094142|FG003|Overall Study|Lost to Follow-up|1|||
33663240|NCT01563029|63094143|FG004|Overall Study|Lost to Follow-up|1|||
33663241|NCT01563029|63094139|FG000|Overall Study|Physician Decision|3|||
33663242|NCT01563029|63094140|FG001|Overall Study|Physician Decision|5|||
33663243|NCT01563029|63094141|FG002|Overall Study|Physician Decision|2|||
33663244|NCT01563029|63094142|FG003|Overall Study|Physician Decision|4|||
33663245|NCT01563029|63094143|FG004|Overall Study|Physician Decision|2|||
33663246|NCT01563029|63094139|FG000|Overall Study|Withdrawal by Subject|4|||
33663247|NCT01563029|63094140|FG001|Overall Study|Withdrawal by Subject|1|||
33663248|NCT01563029|63094141|FG002|Overall Study|Withdrawal by Subject|3|||
33663249|NCT01563029|63094142|FG003|Overall Study|Withdrawal by Subject|4|||
33663250|NCT01563029|63094143|FG004|Overall Study|Withdrawal by Subject|3|||
33663251|NCT01562873|63094156|FG000|Overall Study|Disease Progression per RECIST|10|||
33663252|NCT01562873|63094157|FG001|Overall Study|Disease Progression per RECIST|0|||
33663253|NCT01562873|63094156|FG000|Overall Study|Adverse Event|1|||
33663254|NCT01562873|63094157|FG001|Overall Study|Adverse Event|0|||
33663255|NCT01562873|63094156|FG000|Overall Study|Clinical Disease Progression|9|||
33663256|NCT01562873|63094157|FG001|Overall Study|Clinical Disease Progression|0|||
33663257|NCT01562873|63094156|FG000|Overall Study|Clinical PD and adverse event|1|||
33663258|NCT01562873|63094157|FG001|Overall Study|Clinical PD and adverse event|0|||
33663259|NCT03273712|63094161|FG000|Overall Study|Death|5|||
33663260|NCT03273712|63094161|FG000|Overall Study|Adverse Event|1|||
33663261|NCT03273712|63094161|FG000|Overall Study|Disease Progression|1|||
33663262|NCT01562327|63094166|FG000|Overall Study|Adverse Event|2|||
33663263|NCT01562327|63094166|FG000|Overall Study|Lack of Efficacy|1|||
33663264|NCT01562327|63094166|FG000|Overall Study|Participant drop-out|1|||
33663265|NCT01562327|63094166|FG000|Overall Study|Infusion not received at 6 month window|4|||
33663266|NCT01561313|63094173|FG000|Overall Study|Withdrawal by Subject|1|||
33663267|NCT01561313|63094174|FG001|Overall Study|Withdrawal by Subject|0|||
33663268|NCT01561313|63094173|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
33663269|NCT01561313|63094174|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
33663270|NCT01561079|63094180|FG000|Overall Study|Physician Decision|17|||
33663271|NCT01561079|63094180|FG000|Overall Study|Withdrawal by Subject|59|||
33301097|NCT01090024|62677153|FG015|Period 1|Adverse Event|0|||
33301098|NCT01090024|62677154|FG016|Period 1|Adverse Event|0|||
33566007|NCT02455076|62961731|FG002|Outpatient|Lost to Follow-up|0|||
33663272|NCT01561079|63094180|FG000|Overall Study|Protocol Violation|2|||
33663273|NCT01559675|63094225|FG000|Overall Study|Protocol Violation|1|||
33663274|NCT01559675|63094226|FG001|Overall Study|Protocol Violation|2|||
33663275|NCT01559675|63094225|FG000|Overall Study|2nd operation on same patient excluded|14|||
33663276|NCT01559675|63094226|FG001|Overall Study|2nd operation on same patient excluded|12|||
33663277|NCT01374906|63094234|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33663278|NCT01374906|63094235|FG001|Overall Study|Abnormal laboratory value(s)|3|||
33663279|NCT01374906|63094234|FG000|Overall Study|Administrative problems|2|||
33663280|NCT01374906|63094235|FG001|Overall Study|Administrative problems|2|||
33301099|NCT01090024|62677155|FG017|Period 1|Adverse Event|1|||
33301100|NCT01090024|62677138|FG000|Period 1|Withdrawal by Subject|0|||
33566008|NCT02455076|62961732|FG003|Outpatient|Lost to Follow-up|1|||
33566009|NCT02455076|62961733|FG004|Outpatient|Lost to Follow-up|12|||
33566010|NCT02433080|62961747|FG000|Overall Study|Lost to Follow-up|1|||
33566011|NCT02433080|62961748|FG001|Overall Study|Lost to Follow-up|2|||
33566012|NCT02433080|62961747|FG000|Overall Study|Withdrawal by Subject|0|||
33566013|NCT02433080|62961748|FG001|Overall Study|Withdrawal by Subject|2|||
33566014|NCT03092219|62961757|FG000|Overall Study|Protocol Violation|7|||
33566015|NCT03092219|62961758|FG001|Overall Study|Protocol Violation|4|||
33566016|NCT02432846|62961773|FG000|Overall Study (4 Arms/Strata)|Death|3|||
33566017|NCT02432846|62961774|FG001|Overall Study (4 Arms/Strata)|Death|2|||
33566018|NCT02432846|62961775|FG002|Overall Study (4 Arms/Strata)|Death|4|||
33566019|NCT02432846|62961776|FG003|Overall Study (4 Arms/Strata)|Death|3|||
33566020|NCT02432846|62961777|FG004|Overall Study (4 Arms/Strata)|Death|0|||
33566021|NCT02432846|62961778|FG005|Overall Study (4 Arms/Strata)|Death|0|||
33566022|NCT02432846|62961773|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
33566023|NCT02432846|62961774|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
33566024|NCT02432846|62961775|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
33566025|NCT02432846|62961776|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
33566026|NCT02432846|62961777|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
33566027|NCT02432846|62961778|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
33566028|NCT02432846|62961773|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
33566029|NCT02432846|62961774|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
33566030|NCT02432846|62961775|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
33566031|NCT02432846|62961776|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
33566032|NCT02432846|62961777|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
33566033|NCT02432846|62961778|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
33566034|NCT02432846|62961773|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
33566035|NCT02432846|62961774|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
33566036|NCT02432846|62961775|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
33566037|NCT02432846|62961776|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
33566038|NCT02432846|62961777|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
33566039|NCT02432846|62961778|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
33566040|NCT02432846|62961773|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
33566041|NCT02432846|62961774|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
33566042|NCT02432846|62961775|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
33566043|NCT02432846|62961776|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
33566044|NCT02432846|62961777|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
33566045|NCT02432846|62961778|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
33566046|NCT02432846|62961773|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
33566047|NCT02432846|62961774|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
33566048|NCT02432846|62961775|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
33566049|NCT02432846|62961776|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
33566050|NCT02432846|62961777|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
33566051|NCT02432846|62961778|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
33566052|NCT02432846|62961773|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
33566053|NCT02432846|62961774|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
33566054|NCT02432846|62961775|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
33566055|NCT02432846|62961776|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
33566056|NCT02432846|62961777|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
33566057|NCT02432846|62961778|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
33566058|NCT02432846|62961773|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
33566059|NCT02432846|62961774|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
33566060|NCT02432846|62961775|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
33566061|NCT02432846|62961776|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
33566062|NCT02432846|62961777|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
33566063|NCT02432846|62961778|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
33566064|NCT02432846|62961773|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
33566065|NCT02432846|62961774|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
33566066|NCT02432846|62961775|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
33566067|NCT02432846|62961776|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
33566068|NCT02432846|62961777|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
33566069|NCT02432846|62961778|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
33566070|NCT02432846|62961773|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
33566071|NCT02432846|62961774|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
33566072|NCT02432846|62961775|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
33301101|NCT01090024|62677139|FG001|Period 1|Withdrawal by Subject|0|||
33566073|NCT02432846|62961776|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
33566074|NCT02432846|62961777|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
33566075|NCT02432846|62961778|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
33566076|NCT02432846|62961773|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
33663281|NCT01374906|63094234|FG000|Overall Study|Adverse Event|10|||
33663282|NCT01374906|63094235|FG001|Overall Study|Adverse Event|11|||
33663283|NCT01374906|63094234|FG000|Overall Study|Death|0|||
33663284|NCT01374906|63094235|FG001|Overall Study|Death|2|||
33663285|NCT01374906|63094234|FG000|Overall Study|Protocol Violation|2|||
33663286|NCT01374906|63094235|FG001|Overall Study|Protocol Violation|2|||
33663287|NCT01374906|63094234|FG000|Overall Study|Withdrawal by Subject|15|||
33663288|NCT01374906|63094235|FG001|Overall Study|Withdrawal by Subject|9|||
33663289|NCT01374906|63094234|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
33663290|NCT01374906|63094235|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
33663291|NCT02683746|63094265|FG000|Overall Study|Adverse Event|3|||
33663292|NCT02683746|63094266|FG001|Overall Study|Adverse Event|2|||
33663293|NCT02683746|63094265|FG000|Overall Study|Lost to Follow-up|5|||
33663294|NCT02683746|63094266|FG001|Overall Study|Lost to Follow-up|6|||
33663295|NCT02683746|63094265|FG000|Overall Study|Withdrawal by Subject|6|||
33663296|NCT02683746|63094266|FG001|Overall Study|Withdrawal by Subject|5|||
33663297|NCT02683746|63094265|FG000|Overall Study|Physician Decision|2|||
33663298|NCT02683746|63094266|FG001|Overall Study|Physician Decision|1|||
33663299|NCT01559129|63094274|FG000|Treatment Phase|Adverse Event|0|||
33663300|NCT01559129|63094275|FG001|Treatment Phase|Adverse Event|2|||
33663301|NCT01559129|63094274|FG000|Treatment Phase|Progressive Disease|1|||
33663302|NCT01559129|63094275|FG001|Treatment Phase|Progressive Disease|1|||
33663303|NCT01559129|63094274|FG000|Treatment Phase|Lack of Efficacy|0|||
33663304|NCT01559129|63094275|FG001|Treatment Phase|Lack of Efficacy|1|||
33663305|NCT01559129|63094274|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
33663306|NCT01559129|63094275|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
33663307|NCT01559129|63094274|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
33663308|NCT01559129|63094275|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
33663309|NCT01559129|63094274|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
33663310|NCT01559129|63094275|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
33663311|NCT01559129|63094274|FG000|Open-label Extension Period|Adverse Event|1|||
33663312|NCT01559129|63094275|FG001|Open-label Extension Period|Adverse Event|0|||
33663313|NCT01559129|63094274|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
33566077|NCT02432846|62961774|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
33566078|NCT02432846|62961775|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
33566079|NCT02432846|62961776|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
33566080|NCT02432846|62961777|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
33566081|NCT02432846|62961778|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
33566082|NCT02432846|62961773|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
33566083|NCT02432846|62961774|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
33566084|NCT02432846|62961775|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
33566085|NCT02432846|62961776|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
33566086|NCT02432846|62961777|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
33566087|NCT02432846|62961778|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
33566088|NCT02432846|62961773|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
33663314|NCT01559129|63094275|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
33663315|NCT02691468|63094289|FG000|Overall Study|Bronchial blocker use|2|||
33663316|NCT02691468|63094290|FG001|Overall Study|Bronchial blocker use|1|||
33663317|NCT02691468|63094289|FG000|Overall Study|Lost to Follow-up|2|||
33663318|NCT02691468|63094290|FG001|Overall Study|Lost to Follow-up|1|||
33663319|NCT02691468|63094289|FG000|Overall Study|Failure to advance FOB|2|||
33663320|NCT02691468|63094290|FG001|Overall Study|Failure to advance FOB|0|||
33663321|NCT02678676|63094298|FG000|Overall Study|Death|619|||
33663322|NCT02678676|63094299|FG001|Overall Study|Death|649|||
33663323|NCT02678676|63094298|FG000|Overall Study|Withdrawal by Subject|13|||
33663324|NCT02678676|63094299|FG001|Overall Study|Withdrawal by Subject|5|||
33663325|NCT02678676|63094298|FG000|Overall Study|Lost to Follow-up|171|||
33663326|NCT02678676|63094299|FG001|Overall Study|Lost to Follow-up|151|||
33663327|NCT02678676|63094298|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
33663328|NCT02678676|63094299|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
33566089|NCT02432846|62961774|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
33566090|NCT02432846|62961775|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
33663329|NCT01558739|63094305|FG000|Overall Study|Adverse Event|7|||
33663330|NCT01558739|63094305|FG000|Overall Study|Withdrawal by Subject|2|||
33663331|NCT01558739|63094305|FG000|Overall Study|Death|3|||
33663332|NCT01558739|63094305|FG000|Overall Study|Disease Progression|4|||
33663333|NCT01558739|63094305|FG000|Overall Study|Protocol Violation|1|||
33663334|NCT02683668|63094309|FG000|Period 2|Withdrawal by Subject|0|||
33663335|NCT02683668|63094310|FG001|Period 2|Withdrawal by Subject|1|||
33663336|NCT02683668|63094311|FG002|Period 2|Withdrawal by Subject|0|||
33663337|NCT02678286|63094319|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
33663338|NCT02678286|63094320|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
33663339|NCT02678286|63094319|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
33663340|NCT02678286|63094320|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
33663341|NCT02678286|63094319|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
33663342|NCT02678286|63094320|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
33663343|NCT02678286|63094319|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
33663344|NCT02678286|63094320|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
33663345|NCT02678286|63094319|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
33663346|NCT02678286|63094320|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
33663347|NCT02682264|63094328|FG000|Overall Study|Withdrawal by Subject|56|||
33663348|NCT02682264|63094329|FG001|Overall Study|Withdrawal by Subject|45|||
33663349|NCT02682264|63094328|FG000|Overall Study|Lost to Follow-up|49|||
33663350|NCT02682264|63094329|FG001|Overall Study|Lost to Follow-up|41|||
33663351|NCT02682264|63094328|FG000|Overall Study|Lack of Efficacy|14|||
33663352|NCT02682264|63094329|FG001|Overall Study|Lack of Efficacy|16|||
33663353|NCT02682264|63094328|FG000|Overall Study|Withdrawal by Parent|6|||
33663354|NCT02682264|63094329|FG001|Overall Study|Withdrawal by Parent|7|||
33663355|NCT02682264|63094328|FG000|Overall Study|Adverse Event|9|||
33663356|NCT02682264|63094329|FG001|Overall Study|Adverse Event|0|||
33663357|NCT02682264|63094328|FG000|Overall Study|Noncompliance with study drug|1|||
33663358|NCT02682264|63094329|FG001|Overall Study|Noncompliance with study drug|4|||
33663359|NCT02682264|63094328|FG000|Overall Study|Pregnancy|1|||
33663360|NCT02682264|63094329|FG001|Overall Study|Pregnancy|2|||
33663361|NCT02682264|63094328|FG000|Overall Study|Recovery|1|||
33663362|NCT02682264|63094329|FG001|Overall Study|Recovery|2|||
33663363|NCT02682264|63094328|FG000|Overall Study|Progressive Disease|1|||
33663364|NCT02682264|63094329|FG001|Overall Study|Progressive Disease|0|||
33663365|NCT02682264|63094328|FG000|Overall Study|Technical Problems|0|||
33663366|NCT02682264|63094329|FG001|Overall Study|Technical Problems|1|||
33663367|NCT02682264|63094328|FG000|Overall Study|Moved abroad and unable to continue|0|||
33663368|NCT02682264|63094329|FG001|Overall Study|Moved abroad and unable to continue|3|||
33663369|NCT02682264|63094328|FG000|Overall Study|Stopped test article application|0|||
33663370|NCT02682264|63094329|FG001|Overall Study|Stopped test article application|1|||
33663371|NCT01566721|63094337|FG000|Treatment Period|Withdrawal by Subject|35|||
33663372|NCT01566721|63094338|FG001|Treatment Period|Withdrawal by Subject|9|||
33663373|NCT01566721|63094337|FG000|Treatment Period|Disease Progression/Recurrence|37|||
33663374|NCT01566721|63094338|FG001|Treatment Period|Disease Progression/Recurrence|13|||
33392197|NCT00562588|62771111|FG001|Overall Study|Withdrawal by Subject|9|||
33392198|NCT00562588|62771110|FG000|Overall Study|Other|0|||
33566091|NCT02432846|62961776|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
33566092|NCT02432846|62961777|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
33566093|NCT02432846|62961778|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
33566094|NCT02432846|62961773|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
33566095|NCT02432846|62961774|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
33566096|NCT02432846|62961775|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
33566097|NCT02432846|62961776|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
33566098|NCT02432846|62961777|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
33566099|NCT02432846|62961778|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
33566100|NCT02432144|62961791|FG000|Overall Study|Participant Non-Compliance|1|||
33566101|NCT02246998|62961799|FG000|Overall Study|Adverse Event|0|||
33566102|NCT02246998|62961800|FG001|Overall Study|Adverse Event|1|||
33566103|NCT02246998|62961801|FG002|Overall Study|Adverse Event|1|||
33566104|NCT02246998|62961802|FG003|Overall Study|Adverse Event|0|||
33566105|NCT02246998|62961799|FG000|Overall Study|Lost to Follow-up|1|||
33566106|NCT02246998|62961800|FG001|Overall Study|Lost to Follow-up|0|||
33566107|NCT02246998|62961801|FG002|Overall Study|Lost to Follow-up|0|||
33566108|NCT02246998|62961802|FG003|Overall Study|Lost to Follow-up|1|||
33566109|NCT02246998|62961799|FG000|Overall Study|Randomized but Never Dosed|1|||
33566110|NCT02246998|62961800|FG001|Overall Study|Randomized but Never Dosed|2|||
33566111|NCT02246998|62961801|FG002|Overall Study|Randomized but Never Dosed|2|||
33566112|NCT02246998|62961802|FG003|Overall Study|Randomized but Never Dosed|1|||
33566113|NCT02486588|62961821|FG000|Overall Study|Randomized in error- ineligible|738|||
33566114|NCT02486588|62961822|FG001|Overall Study|Randomized in error- ineligible|750|||
33566115|NCT02486588|62961823|FG002|Overall Study|Randomized in error- ineligible|755|||
33566116|NCT02486588|62961824|FG003|Overall Study|Randomized in error- ineligible|738|||
33566117|NCT02486588|62961825|FG004|Overall Study|Randomized in error- ineligible|746|||
33663375|NCT01566721|63094337|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
33663376|NCT01566721|63094338|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
33663377|NCT01566721|63094337|FG000|Treatment Period|Other|13|||
33663378|NCT01566721|63094338|FG001|Treatment Period|Other|2|||
33392199|NCT00562588|62771111|FG001|Overall Study|Other|2|||
33566118|NCT02486588|62961826|FG005|Overall Study|Randomized in error- ineligible|746|||
33566119|NCT00805961|62961845|FG000|Modality Therapy|Withdrawal by Subject|1|||
33566120|NCT00805961|62961845|FG000|Modality Therapy|Adverse Event|1|||
33566121|NCT00805961|62961845|FG000|Modality Therapy|Disease Progression|2|||
33566122|NCT00805961|62961845|FG000|Treatment-Free Interval|Adverse Event|3|||
33663379|NCT01566721|63094337|FG000|Treatment Period|Lack of Compliance|5|||
33663380|NCT01566721|63094338|FG001|Treatment Period|Lack of Compliance|1|||
33663381|NCT01566721|63094337|FG000|Treatment Period|Adverse Event|100|||
33663382|NCT01566721|63094338|FG001|Treatment Period|Adverse Event|30|||
33663383|NCT01566721|63094337|FG000|Treatment Period|Pregnancy|1|||
33663384|NCT01566721|63094338|FG001|Treatment Period|Pregnancy|0|||
33663385|NCT01566721|63094337|FG000|Safety Follow-up|Physician Decision|6|||
33663386|NCT01566721|63094338|FG001|Safety Follow-up|Physician Decision|4|||
33663387|NCT01566721|63094337|FG000|Safety Follow-up|Lost to Follow-up|101|||
33663388|NCT01566721|63094338|FG001|Safety Follow-up|Lost to Follow-up|48|||
33663389|NCT01566721|63094337|FG000|Safety Follow-up|Withdrawal by Subject|155|||
33663390|NCT01566721|63094338|FG001|Safety Follow-up|Withdrawal by Subject|49|||
33663391|NCT01566721|63094337|FG000|Safety Follow-up|Death|28|||
33663392|NCT01566721|63094338|FG001|Safety Follow-up|Death|4|||
33663393|NCT01566721|63094337|FG000|Safety Follow-up|Non-compliance|7|||
33663394|NCT01566721|63094338|FG001|Safety Follow-up|Non-compliance|3|||
33663395|NCT01566721|63094337|FG000|Safety Follow-up|Protocol Violation|7|||
33663396|NCT01566721|63094338|FG001|Safety Follow-up|Protocol Violation|0|||
33663397|NCT01566721|63094337|FG000|Safety Follow-up|Site closure|2|||
33663398|NCT01566721|63094338|FG001|Safety Follow-up|Site closure|3|||
33663399|NCT01566721|63094337|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
33663400|NCT01566721|63094338|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
33663401|NCT01566721|63094337|FG000|Safety Follow-up|Missing|7|||
33663402|NCT01566721|63094338|FG001|Safety Follow-up|Missing|2|||
33663403|NCT01566721|63094337|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
33663404|NCT01566721|63094338|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
33663405|NCT01566721|63094337|FG000|Safety Follow-up|Sponsor decision|1|||
33663406|NCT01566721|63094338|FG001|Safety Follow-up|Sponsor decision|0|||
33663407|NCT01566721|63094337|FG000|Safety Follow-up|Adverse Event|8|||
33663408|NCT01566721|63094338|FG001|Safety Follow-up|Adverse Event|4|||
33663409|NCT01541215|63094353|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
33663410|NCT01541215|63094354|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
33663411|NCT01541215|63094353|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
33663412|NCT01541215|63094354|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
33663413|NCT01541215|63094353|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
33663414|NCT01541215|63094354|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
33663415|NCT01541215|63094353|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
33663416|NCT01541215|63094354|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
33663417|NCT01541215|63094353|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
33663418|NCT01541215|63094354|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
33663419|NCT01541215|63094353|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
33663420|NCT01541215|63094354|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
33663421|NCT01540981|63094366|FG000|Overall Study|Withdrawal by Subject|1|||
33663422|NCT01540981|63094367|FG001|Overall Study|Withdrawal by Subject|0|||
33663423|NCT01585987|63094375|FG000|Randomized|Withdrawal by Subject|0|||
33663424|NCT01585987|63094376|FG001|Randomized|Withdrawal by Subject|4|||
33663425|NCT01585987|63094375|FG000|Randomized|No longer met criteria|0|||
33663426|NCT01585987|63094376|FG001|Randomized|No longer met criteria|2|||
33663427|NCT01585987|63094375|FG000|Treated|Disease Progression|39|||
33663428|NCT01585987|63094376|FG001|Treated|Disease Progression|36|||
33663429|NCT01585987|63094375|FG000|Treated|Study Drug Toxicity|9|||
33663430|NCT01585987|63094376|FG001|Treated|Study Drug Toxicity|5|||
33663431|NCT01585987|63094375|FG000|Treated|Adverse Event|3|||
33663432|NCT01585987|63094376|FG001|Treated|Adverse Event|0|||
33663433|NCT01585987|63094375|FG000|Treated|Withdrawal by Subject|1|||
33663434|NCT01585987|63094376|FG001|Treated|Withdrawal by Subject|2|||
33663435|NCT01585987|63094375|FG000|Treated|Death|1|||
33663436|NCT01585987|63094376|FG001|Treated|Death|0|||
33663437|NCT01585987|63094375|FG000|Treated|Lost to Follow-up|0|||
33663438|NCT01585987|63094376|FG001|Treated|Lost to Follow-up|1|||
33663439|NCT01585987|63094375|FG000|Treated|Maximum Clinical Benefit|0|||
33663440|NCT01585987|63094376|FG001|Treated|Maximum Clinical Benefit|1|||
33663441|NCT01585987|63094375|FG000|Treated|Non-Specified|1|||
33663442|NCT01585987|63094376|FG001|Treated|Non-Specified|2|||
33663443|NCT01585987|63094375|FG000|Treated|Subject Request|0|||
33663444|NCT01585987|63094376|FG001|Treated|Subject Request|1|||
33663445|NCT01585987|63094375|FG000|Treated|Poor/Non-Compliance|0|||
33663446|NCT01585987|63094376|FG001|Treated|Poor/Non-Compliance|1|||
33663447|NCT01585831|63094385|FG000|Overall Study|Physician Decision|0|||
33663448|NCT01585831|63094386|FG001|Overall Study|Physician Decision|1|||
33663449|NCT01585831|63094385|FG000|Overall Study|Withdrawal by Subject|2|||
33663450|NCT01585831|63094386|FG001|Overall Study|Withdrawal by Subject|1|||
33663451|NCT01565941|63094394|FG000|Overall Study|Withdrawn by parent/guardian|3|||
33663452|NCT01565941|63094395|FG001|Overall Study|Withdrawn by parent/guardian|2|||
33663453|NCT01565941|63094394|FG000|Overall Study|Randomized; did not receive intevention|8|||
33663454|NCT01565941|63094395|FG001|Overall Study|Randomized; did not receive intevention|2|||
33663455|NCT01558271|63094406|FG000|Overall Study|Adverse Event|6|||
33663456|NCT01558271|63094407|FG001|Overall Study|Adverse Event|3|||
33663457|NCT01558271|63094408|FG002|Overall Study|Adverse Event|4|||
33663458|NCT01558271|63094406|FG000|Overall Study|Lost to Follow-up|1|||
33663459|NCT01558271|63094407|FG001|Overall Study|Lost to Follow-up|0|||
33663460|NCT01558271|63094408|FG002|Overall Study|Lost to Follow-up|0|||
33663461|NCT01558271|63094406|FG000|Overall Study|Protocol Violation|1|||
33663462|NCT01558271|63094407|FG001|Overall Study|Protocol Violation|0|||
33663463|NCT01558271|63094408|FG002|Overall Study|Protocol Violation|0|||
33663464|NCT01558271|63094406|FG000|Overall Study|Withdrawal by Subject|10|||
33663465|NCT01558271|63094407|FG001|Overall Study|Withdrawal by Subject|6|||
33663466|NCT01558271|63094408|FG002|Overall Study|Withdrawal by Subject|12|||
33663467|NCT01558271|63094406|FG000|Overall Study|Physician Decision|0|||
33663468|NCT01558271|63094407|FG001|Overall Study|Physician Decision|2|||
33663469|NCT01558271|63094408|FG002|Overall Study|Physician Decision|1|||
33663470|NCT01565707|63094424|FG000|Overall Study|Adverse Event|1|||
33663471|NCT01565707|63094425|FG001|Overall Study|Adverse Event|6|||
33663472|NCT01565707|63094426|FG002|Overall Study|Adverse Event|2|||
33663473|NCT01565707|63094427|FG003|Overall Study|Adverse Event|1|||
33663474|NCT01565707|63094424|FG000|Overall Study|Lost to Follow-up|1|||
33663475|NCT01565707|63094425|FG001|Overall Study|Lost to Follow-up|0|||
33663476|NCT01565707|63094426|FG002|Overall Study|Lost to Follow-up|0|||
33663477|NCT01565707|63094427|FG003|Overall Study|Lost to Follow-up|0|||
33663478|NCT01565707|63094424|FG000|Overall Study|Protocol Violation|1|||
33663479|NCT01565707|63094425|FG001|Overall Study|Protocol Violation|0|||
33663480|NCT01565707|63094426|FG002|Overall Study|Protocol Violation|0|||
33663481|NCT01565707|63094427|FG003|Overall Study|Protocol Violation|1|||
33663482|NCT01565707|63094424|FG000|Overall Study|Withdrawal by Subject|3|||
33663483|NCT01565707|63094425|FG001|Overall Study|Withdrawal by Subject|1|||
33663484|NCT01565707|63094426|FG002|Overall Study|Withdrawal by Subject|1|||
33663485|NCT01565707|63094427|FG003|Overall Study|Withdrawal by Subject|1|||
33663486|NCT01565707|63094424|FG000|Overall Study|Randomized but not evaluable|2|||
33663487|NCT01565707|63094425|FG001|Overall Study|Randomized but not evaluable|0|||
33663488|NCT01565707|63094426|FG002|Overall Study|Randomized but not evaluable|0|||
33663489|NCT01565707|63094427|FG003|Overall Study|Randomized but not evaluable|0|||
33663490|NCT01565707|63094424|FG000|Overall Study|Miscellaneous|1|||
33663491|NCT01565707|63094425|FG001|Overall Study|Miscellaneous|1|||
33663492|NCT01565707|63094426|FG002|Overall Study|Miscellaneous|0|||
33566123|NCT00805961|62961845|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
33566124|NCT00805961|62961845|FG000|Treatment-Free Interval|Physician Decision|1|||
33566125|NCT00805961|62961845|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
33566126|NCT00805961|62961845|FG000|Maintenance Treatment|Lack of Efficacy|13|||
33566127|NCT00805961|62961845|FG000|Maintenance Treatment|Intercurrent Illness|7|||
33566128|NCT00805961|62961845|FG000|Maintenance Treatment|Adverse Event|6|||
33566129|NCT00805961|62961845|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
33566130|NCT00805961|62961845|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
33566131|NCT00805961|62961845|FG000|Maintenance Treatment|Withdrawn Consent|1|||
33566132|NCT02202538|62961849|FG000|Overall Study|Withdrawal by Subject|5|||
33566133|NCT02202538|62961849|FG000|Overall Study|Did not meet all inclusion criteria|2|||
33566134|NCT02202538|62961849|FG000|Overall Study|Investigator Decision|1|||
33566135|NCT02454608|62961856|FG000|Double-Blind Period|Lack of Efficacy|0|||
33566136|NCT02454608|62961857|FG001|Double-Blind Period|Lack of Efficacy|2|||
33566137|NCT02454608|62961858|FG002|Double-Blind Period|Lack of Efficacy|0|||
33566138|NCT02454608|62961856|FG000|Open Label Period|Lost to Follow-up|0|||
33566139|NCT02454608|62961857|FG001|Open Label Period|Lost to Follow-up|0|||
33566140|NCT02454608|62961858|FG002|Open Label Period|Lost to Follow-up|11|||
33566141|NCT02454608|62961856|FG000|Open Label Period|Withdrawal by Subject|0|||
33566142|NCT02454608|62961857|FG001|Open Label Period|Withdrawal by Subject|0|||
33566143|NCT02454608|62961858|FG002|Open Label Period|Withdrawal by Subject|8|||
33566144|NCT02246764|62961869|FG000|Overall Study|Adverse Event|15|||
33566145|NCT02246764|62961870|FG001|Overall Study|Adverse Event|29|||
33566146|NCT02246764|62961871|FG002|Overall Study|Adverse Event|1|||
33566147|NCT02246764|62961869|FG000|Overall Study|Withdrawal by Subject|0|||
33566148|NCT02246764|62961870|FG001|Overall Study|Withdrawal by Subject|0|||
33663493|NCT01565707|63094427|FG003|Overall Study|Miscellaneous|2|||
33663494|NCT01557569|63094446|FG000|Overall Study|Adverse Event|2|||
33663495|NCT01557569|63094447|FG001|Overall Study|Adverse Event|0|||
33663496|NCT01557569|63094446|FG000|Overall Study|high blood pressure|0|||
33663497|NCT01557569|63094447|FG001|Overall Study|high blood pressure|1|||
33566149|NCT02246764|62961871|FG002|Overall Study|Withdrawal by Subject|1|||
33566150|NCT02246764|62961869|FG000|Overall Study|Disallowed Concomitant Medication|1|||
33663498|NCT01557569|63094446|FG000|Overall Study|Withdrawal by Subject|3|||
33566151|NCT02246764|62961870|FG001|Overall Study|Disallowed Concomitant Medication|0|||
33663499|NCT01557569|63094447|FG001|Overall Study|Withdrawal by Subject|5|||
33663500|NCT01557569|63094446|FG000|Overall Study|noncompliance with rules of residential|0|||
33663501|NCT01557569|63094447|FG001|Overall Study|noncompliance with rules of residential|1|||
33663502|NCT01538719|63094455|FG000|Overall Study|Lost to Follow-up|2|||
33663503|NCT01538719|63094456|FG001|Overall Study|Lost to Follow-up|0|||
33663504|NCT01537783|63094464|FG000|Overall Study|Lost to Follow-up|11|||
33663505|NCT01537783|63094465|FG001|Overall Study|Lost to Follow-up|2|||
33663506|NCT01556165|63094473|FG000|Overall Study|Adverse Event|5|||
33663507|NCT01556165|63094474|FG001|Overall Study|Adverse Event|3|||
33663508|NCT01556165|63094473|FG000|Overall Study|Protocol Violation|0|||
33663509|NCT01556165|63094474|FG001|Overall Study|Protocol Violation|3|||
33663510|NCT01556165|63094473|FG000|Overall Study|Withdrawal of Consent|7|||
33663511|NCT01556165|63094474|FG001|Overall Study|Withdrawal of Consent|1|||
33663512|NCT01537549|63094480|FG000|Overall Study|Lost to Follow-up|1|||
33663513|NCT01537549|63094480|FG000|Overall Study|Withdrawal by Subject|2|||
33663514|NCT01555931|63094488|FG000|Overall Study|Lost to Follow-up|2|||
33663515|NCT01555931|63094489|FG001|Overall Study|Lost to Follow-up|5|||
33663516|NCT01583179|63094497|FG000|Overall Study|Screen failure|1|||
33663517|NCT01583179|63094498|FG001|Overall Study|Screen failure|2|||
33663518|NCT01582945|63094504|FG000|Overall Study|Intolerable side-effects|1|||
33663519|NCT01582945|63094504|FG000|Overall Study|Scheduling conflicts|1|||
33663520|NCT01565083|63094510|FG000|Overall Study|Withdrawal by Subject|6|||
33663521|NCT01565083|63094511|FG001|Overall Study|Withdrawal by Subject|4|||
33663522|NCT01565083|63094510|FG000|Overall Study|Lost to Follow-up|2|||
33663523|NCT01565083|63094511|FG001|Overall Study|Lost to Follow-up|7|||
33663524|NCT01565083|63094510|FG000|Overall Study|Death|22|||
33663525|NCT01565083|63094511|FG001|Overall Study|Death|23|||
33663526|NCT01565083|63094510|FG000|Overall Study|Other|3|||
33663527|NCT01565083|63094511|FG001|Overall Study|Other|5|||
33663528|NCT01582789|63094517|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
33663529|NCT01582789|63094518|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
33663530|NCT01537393|63094528|FG000|Overall Study|Exclude prior to study|32|||
33663531|NCT01537393|63094529|FG001|Overall Study|Exclude prior to study|44|||
33663532|NCT01537393|63094528|FG000|Overall Study|Death|20|||
33663533|NCT01537393|63094529|FG001|Overall Study|Death|32|||
33663534|NCT01537393|63094528|FG000|Overall Study|Withdrawal by Subject|18|||
33663535|NCT01537393|63094529|FG001|Overall Study|Withdrawal by Subject|17|||
33663536|NCT01537393|63094528|FG000|Overall Study|Lost to Follow-up|53|||
33663537|NCT01537393|63094529|FG001|Overall Study|Lost to Follow-up|48|||
33663538|NCT01537393|63094528|FG000|Overall Study|Failure - Regrafted|28|||
33663539|NCT01537393|63094529|FG001|Overall Study|Failure - Regrafted|43|||
33663540|NCT01537393|63094528|FG000|Overall Study|Failure - Not regrafted|2|||
33663541|NCT01537393|63094529|FG001|Overall Study|Failure - Not regrafted|6|||
33663542|NCT01537393|63094528|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
33663543|NCT01537393|63094529|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
33663544|NCT01555151|63094539|FG000|Overall Study|Withdrawal by Subject|6|||
33663545|NCT01555151|63094540|FG001|Overall Study|Withdrawal by Subject|2|||
33663546|NCT01555151|63094541|FG002|Overall Study|Withdrawal by Subject|0|||
33663547|NCT01555151|63094542|FG003|Overall Study|Withdrawal by Subject|2|||
33663548|NCT01555151|63094539|FG000|Overall Study|Administrative|3|||
33663549|NCT01555151|63094540|FG001|Overall Study|Administrative|1|||
33663550|NCT01555151|63094541|FG002|Overall Study|Administrative|2|||
33663551|NCT01555151|63094542|FG003|Overall Study|Administrative|0|||
33663552|NCT01555151|63094539|FG000|Overall Study|Protocol Violation|3|||
33663553|NCT01555151|63094540|FG001|Overall Study|Protocol Violation|3|||
33663554|NCT01555151|63094541|FG002|Overall Study|Protocol Violation|3|||
33663555|NCT01555151|63094542|FG003|Overall Study|Protocol Violation|5|||
33663556|NCT01555151|63094539|FG000|Overall Study|Adverse Event|1|||
33663557|NCT01555151|63094540|FG001|Overall Study|Adverse Event|2|||
33663558|NCT01555151|63094541|FG002|Overall Study|Adverse Event|1|||
33663559|NCT01555151|63094542|FG003|Overall Study|Adverse Event|2|||
33663560|NCT01555151|63094539|FG000|Overall Study|Lost to Follow-up|0|||
33663561|NCT01555151|63094540|FG001|Overall Study|Lost to Follow-up|0|||
33663562|NCT01555151|63094541|FG002|Overall Study|Lost to Follow-up|0|||
33663563|NCT01555151|63094542|FG003|Overall Study|Lost to Follow-up|1|||
33663564|NCT01537081|63094556|FG000|Overall Study|Adverse Event|5|||
33663565|NCT01537081|63094557|FG001|Overall Study|Adverse Event|2|||
33663566|NCT01537081|63094558|FG002|Overall Study|Adverse Event|2|||
33663567|NCT01537081|63094556|FG000|Overall Study|Lack of Efficacy|2|||
33663568|NCT01537081|63094557|FG001|Overall Study|Lack of Efficacy|1|||
33663569|NCT01537081|63094558|FG002|Overall Study|Lack of Efficacy|0|||
33663570|NCT01537081|63094556|FG000|Overall Study|Lost to Follow-up|17|||
33663571|NCT01537081|63094557|FG001|Overall Study|Lost to Follow-up|15|||
33663572|NCT01537081|63094558|FG002|Overall Study|Lost to Follow-up|9|||
33663573|NCT01537081|63094556|FG000|Overall Study|Protocol Violation|3|||
33663574|NCT01537081|63094557|FG001|Overall Study|Protocol Violation|2|||
33663575|NCT01537081|63094558|FG002|Overall Study|Protocol Violation|2|||
33663576|NCT01537081|63094556|FG000|Overall Study|Withdrawal by Subject|6|||
33663577|NCT01537081|63094557|FG001|Overall Study|Withdrawal by Subject|11|||
33663578|NCT01537081|63094558|FG002|Overall Study|Withdrawal by Subject|3|||
33663579|NCT01537081|63094556|FG000|Overall Study|Physician Decision|5|||
33663580|NCT01537081|63094557|FG001|Overall Study|Physician Decision|6|||
33663581|NCT01537081|63094558|FG002|Overall Study|Physician Decision|0|||
33663582|NCT01537081|63094556|FG000|Overall Study|Sponsor decision|0|||
33663583|NCT01537081|63094557|FG001|Overall Study|Sponsor decision|1|||
33663584|NCT01537081|63094558|FG002|Overall Study|Sponsor decision|0|||
33663585|NCT01537081|63094556|FG000|Overall Study|Assigned but never dosed|1|||
33663586|NCT01537081|63094557|FG001|Overall Study|Assigned but never dosed|0|||
33663587|NCT01537081|63094558|FG002|Overall Study|Assigned but never dosed|0|||
33663588|NCT01564459|63094570|FG000|Run-In|Adverse Event|7|||
33663589|NCT01564459|63094571|FG001|Run-In|Adverse Event|0|||
33663590|NCT01564459|63094572|FG002|Run-In|Adverse Event|0|||
33663591|NCT01564459|63094570|FG000|Run-In|Lost to Follow-up|1|||
33663592|NCT01564459|63094571|FG001|Run-In|Lost to Follow-up|0|||
33663593|NCT01564459|63094572|FG002|Run-In|Lost to Follow-up|0|||
33663594|NCT01564459|63094570|FG000|Run-In|Non-compliance with study drug|2|||
33663595|NCT01564459|63094571|FG001|Run-In|Non-compliance with study drug|0|||
33663596|NCT01564459|63094572|FG002|Run-In|Non-compliance with study drug|0|||
33663597|NCT01564459|63094570|FG000|Run-In|Protocol Violation|1|||
33663598|NCT01564459|63094571|FG001|Run-In|Protocol Violation|0|||
33663599|NCT01564459|63094572|FG002|Run-In|Protocol Violation|0|||
33663600|NCT01564459|63094570|FG000|Run-In|Withdrawal by Subject|1|||
33663601|NCT01564459|63094571|FG001|Run-In|Withdrawal by Subject|0|||
33663602|NCT01564459|63094572|FG002|Run-In|Withdrawal by Subject|0|||
33663603|NCT01564459|63094570|FG000|Double-blind Treatment|Adverse Event|0|||
33663604|NCT01564459|63094571|FG001|Double-blind Treatment|Adverse Event|0|||
33663605|NCT01564459|63094572|FG002|Double-blind Treatment|Adverse Event|1|||
33663606|NCT01555073|63094587|FG000|Overall Study|Lost to Follow-up|1|||
33663607|NCT01555073|63094588|FG001|Overall Study|Lost to Follow-up|2|||
33663608|NCT01555073|63094589|FG002|Overall Study|Lost to Follow-up|0|||
33663609|NCT01555073|63094590|FG003|Overall Study|Lost to Follow-up|5|||
33663610|NCT01582243|63094600|FG000|Overall Study|Withdrawal by Subject|1|||
33663611|NCT01582243|63094600|FG000|Overall Study|Adverse Event|1|||
33663612|NCT01582243|63094600|FG000|Overall Study|Lost to Follow-up|1|||
33663613|NCT01536535|63094606|FG000|Overall Study|Withdrawal by Subject|10|||
33663614|NCT01536535|63094607|FG001|Overall Study|Withdrawal by Subject|5|||
33663615|NCT01536535|63094606|FG000|Overall Study|Lost to Follow-up|4|||
33663616|NCT01536535|63094607|FG001|Overall Study|Lost to Follow-up|6|||
33663617|NCT01536535|63094606|FG000|Overall Study|Physician Decision|1|||
33663618|NCT01536535|63094607|FG001|Overall Study|Physician Decision|1|||
33663619|NCT01536535|63094606|FG000|Overall Study|Participant moved|0|||
33663620|NCT01536535|63094607|FG001|Overall Study|Participant moved|1|||
33663621|NCT01554527|63094617|FG000|Overall Study|Withdrawal by Subject|1|||
33663622|NCT01554527|63094618|FG001|Overall Study|Withdrawal by Subject|0|||
33663623|NCT01554527|63094619|FG002|Overall Study|Withdrawal by Subject|3|||
33663624|NCT01554527|63094617|FG000|Overall Study|Lost to Follow-up|0|||
33663625|NCT01554527|63094618|FG001|Overall Study|Lost to Follow-up|0|||
33663626|NCT01554527|63094619|FG002|Overall Study|Lost to Follow-up|4|||
33663627|NCT01554527|63094617|FG000|Overall Study|Physician Decision|0|||
33663628|NCT01554527|63094618|FG001|Overall Study|Physician Decision|0|||
33663629|NCT01554527|63094619|FG002|Overall Study|Physician Decision|1|||
33663630|NCT01563913|63094630|FG000|Overall Study|Physician Decision|1|||
33663631|NCT01563913|63094631|FG001|Overall Study|Physician Decision|0|||
33663632|NCT01563913|63094630|FG000|Overall Study|Spouse Passed Away|1|||
33663633|NCT01563913|63094631|FG001|Overall Study|Spouse Passed Away|0|||
33663634|NCT01553747|63094640|FG000|Overall Study|Protocol Violation|0|||
33663635|NCT01553747|63094641|FG001|Overall Study|Protocol Violation|2|||
33663636|NCT01553747|63094642|FG002|Overall Study|Protocol Violation|0|||
33663637|NCT01553747|63094640|FG000|Overall Study|Voluntarily withdrew|70|||
33663638|NCT01553747|63094641|FG001|Overall Study|Voluntarily withdrew|66|||
33663639|NCT01553747|63094642|FG002|Overall Study|Voluntarily withdrew|74|||
33663640|NCT01553747|63094640|FG000|Overall Study|Adverse event or SAE|32|||
33663641|NCT01553747|63094641|FG001|Overall Study|Adverse event or SAE|28|||
33663642|NCT01553747|63094642|FG002|Overall Study|Adverse event or SAE|19|||
33663643|NCT01553747|63094640|FG000|Overall Study|Physician decision: other|10|||
33663644|NCT01553747|63094641|FG001|Overall Study|Physician decision: other|8|||
33663645|NCT01553747|63094642|FG002|Overall Study|Physician decision: other|7|||
33663646|NCT01553747|63094640|FG000|Overall Study|Lost to Follow-up|11|||
33663647|NCT01553747|63094641|FG001|Overall Study|Lost to Follow-up|5|||
33663648|NCT01553747|63094642|FG002|Overall Study|Lost to Follow-up|6|||
33663649|NCT01553747|63094640|FG000|Overall Study|Sponsor decision, specify|7|||
33663650|NCT01553747|63094641|FG001|Overall Study|Sponsor decision, specify|5|||
33663651|NCT01553747|63094642|FG002|Overall Study|Sponsor decision, specify|0|||
33663652|NCT01553747|63094640|FG000|Overall Study|Physician decision: lack of efficacy|1|||
33663653|NCT01553747|63094641|FG001|Overall Study|Physician decision: lack of efficacy|5|||
33663654|NCT01553747|63094642|FG002|Overall Study|Physician decision: lack of efficacy|3|||
33566152|NCT02246764|62961871|FG002|Overall Study|Disallowed Concomitant Medication|0|||
33663655|NCT01536379|63094655|FG000|Overall Study|Adverse Event|1|||
33663656|NCT01536379|63094656|FG001|Overall Study|Adverse Event|2|||
33663657|NCT01536379|63094655|FG000|Overall Study|Withdrawal by Subject|1|||
33663658|NCT01536379|63094656|FG001|Overall Study|Withdrawal by Subject|1|||
33663659|NCT01536145|63094662|FG000|Overall Study|Progressive disease|3|||
33663660|NCT01536145|63094663|FG001|Overall Study|Progressive disease|4|||
33663661|NCT01536145|63094664|FG002|Overall Study|Progressive disease|1|||
33663662|NCT01536145|63094665|FG003|Overall Study|Progressive disease|2|||
33663663|NCT01536145|63094666|FG004|Overall Study|Progressive disease|1|||
33663664|NCT01536145|63094667|FG005|Overall Study|Progressive disease|2|||
33663665|NCT01536145|63094668|FG006|Overall Study|Progressive disease|1|||
33663666|NCT01536145|63094669|FG007|Overall Study|Progressive disease|2|||
33663667|NCT01536145|63094670|FG008|Overall Study|Progressive disease|1|||
33663668|NCT01536145|63094671|FG009|Overall Study|Progressive disease|3|||
33663669|NCT01536145|63094672|FG010|Overall Study|Progressive disease|3|||
33663670|NCT01536145|63094662|FG000|Overall Study|Withdrawal by Subject|0|||
33663671|NCT01536145|63094663|FG001|Overall Study|Withdrawal by Subject|0|||
33663672|NCT01536145|63094664|FG002|Overall Study|Withdrawal by Subject|1|||
33663673|NCT01536145|63094665|FG003|Overall Study|Withdrawal by Subject|0|||
33663674|NCT01536145|63094666|FG004|Overall Study|Withdrawal by Subject|0|||
33663675|NCT01536145|63094667|FG005|Overall Study|Withdrawal by Subject|1|||
33663676|NCT01536145|63094668|FG006|Overall Study|Withdrawal by Subject|0|||
33663677|NCT01536145|63094669|FG007|Overall Study|Withdrawal by Subject|0|||
33663678|NCT01536145|63094670|FG008|Overall Study|Withdrawal by Subject|2|||
33663679|NCT01536145|63094671|FG009|Overall Study|Withdrawal by Subject|0|||
33663680|NCT01536145|63094672|FG010|Overall Study|Withdrawal by Subject|2|||
33663681|NCT01536145|63094662|FG000|Overall Study|Other|0|||
33663682|NCT01536145|63094663|FG001|Overall Study|Other|0|||
33663683|NCT01536145|63094664|FG002|Overall Study|Other|0|||
33663684|NCT01536145|63094665|FG003|Overall Study|Other|0|||
33663685|NCT01536145|63094666|FG004|Overall Study|Other|1|||
33663686|NCT01536145|63094667|FG005|Overall Study|Other|0|||
33663687|NCT01536145|63094668|FG006|Overall Study|Other|0|||
33663688|NCT01536145|63094669|FG007|Overall Study|Other|0|||
33663689|NCT01536145|63094670|FG008|Overall Study|Other|0|||
33663690|NCT01536145|63094671|FG009|Overall Study|Other|3|||
33663691|NCT01536145|63094672|FG010|Overall Study|Other|2|||
33663692|NCT01536145|63094662|FG000|Overall Study|Death|0|||
33663693|NCT01536145|63094663|FG001|Overall Study|Death|0|||
33663694|NCT01536145|63094664|FG002|Overall Study|Death|0|||
33663695|NCT01536145|63094665|FG003|Overall Study|Death|0|||
33663696|NCT01536145|63094666|FG004|Overall Study|Death|0|||
33663697|NCT01536145|63094667|FG005|Overall Study|Death|0|||
33663698|NCT01536145|63094668|FG006|Overall Study|Death|1|||
33663699|NCT01536145|63094669|FG007|Overall Study|Death|0|||
33663700|NCT01536145|63094670|FG008|Overall Study|Death|0|||
33663701|NCT01536145|63094671|FG009|Overall Study|Death|0|||
33663702|NCT01536145|63094672|FG010|Overall Study|Death|0|||
33663703|NCT01536145|63094662|FG000|Overall Study|Adverse Event|0|||
33663704|NCT01536145|63094663|FG001|Overall Study|Adverse Event|0|||
33663705|NCT01536145|63094664|FG002|Overall Study|Adverse Event|0|||
33663706|NCT01536145|63094665|FG003|Overall Study|Adverse Event|0|||
33663707|NCT01536145|63094666|FG004|Overall Study|Adverse Event|0|||
33663708|NCT01536145|63094667|FG005|Overall Study|Adverse Event|0|||
33663709|NCT01536145|63094668|FG006|Overall Study|Adverse Event|0|||
33663710|NCT01536145|63094669|FG007|Overall Study|Adverse Event|2|||
33663711|NCT01536145|63094670|FG008|Overall Study|Adverse Event|0|||
33663712|NCT01536145|63094671|FG009|Overall Study|Adverse Event|0|||
33663713|NCT01536145|63094672|FG010|Overall Study|Adverse Event|3|||
33663714|NCT01536067|63094703|FG000|Overall Study|Disease Progression|1|||
33663715|NCT01582009|63094707|FG000|Overall Study|Withdrawal by Subject|1|||
33663716|NCT01582009|63094707|FG000|Overall Study|Physician Decision|1|||
33663717|NCT01553591|63094714|FG000|Overall Study|Voluntarily withdrew|94|||
33663718|NCT01553591|63094715|FG001|Overall Study|Voluntarily withdrew|79|||
33663719|NCT01553591|63094716|FG002|Overall Study|Voluntarily withdrew|96|||
33663720|NCT01553591|63094714|FG000|Overall Study|Adverse Event|36|||
33663721|NCT01553591|63094715|FG001|Overall Study|Adverse Event|45|||
33663722|NCT01553591|63094716|FG002|Overall Study|Adverse Event|16|||
33663723|NCT01553591|63094714|FG000|Overall Study|Lost to Follow-up|25|||
33663724|NCT01553591|63094715|FG001|Overall Study|Lost to Follow-up|23|||
33663725|NCT01553591|63094716|FG002|Overall Study|Lost to Follow-up|16|||
33663726|NCT01553591|63094714|FG000|Overall Study|Physician decision: other|11|||
33663727|NCT01553591|63094715|FG001|Overall Study|Physician decision: other|14|||
33663728|NCT01553591|63094716|FG002|Overall Study|Physician decision: other|16|||
33663729|NCT01553591|63094714|FG000|Overall Study|Physician decision: lack of efficacy|2|||
33663730|NCT01553591|63094715|FG001|Overall Study|Physician decision: lack of efficacy|3|||
33663731|NCT01553591|63094716|FG002|Overall Study|Physician decision: lack of efficacy|7|||
33663732|NCT01553591|63094714|FG000|Overall Study|Protocol Violation|3|||
33663733|NCT01553591|63094715|FG001|Overall Study|Protocol Violation|4|||
33663734|NCT01553591|63094716|FG002|Overall Study|Protocol Violation|4|||
33663735|NCT01553591|63094714|FG000|Overall Study|Sponsor decision|1|||
33663736|NCT01553591|63094715|FG001|Overall Study|Sponsor decision|0|||
33663737|NCT01553591|63094716|FG002|Overall Study|Sponsor decision|3|||
33663738|NCT01553591|63094714|FG000|Overall Study|Randomized and never dispensed drug|0|||
33663739|NCT01553591|63094715|FG001|Overall Study|Randomized and never dispensed drug|1|||
33663740|NCT01553591|63094716|FG002|Overall Study|Randomized and never dispensed drug|0|||
33663741|NCT01581931|63094724|FG000|Washout|Adverse Event|0|||
33663742|NCT01581931|63094725|FG001|Washout|Adverse Event|1|||
33663743|NCT01581619|63094731|FG000|Overall Study|Withdrawal by Subject|1|||
33663744|NCT01581619|63094731|FG000|Overall Study|Lost to Follow-up|1|||
33663745|NCT01581307|63094737|FG000|Overall Study|Withdrawal by Subject|1|||
33663746|NCT01580995|63094743|FG000|Overall Study|Lost to Follow-up|2|||
33663747|NCT01580995|63094744|FG001|Overall Study|Lost to Follow-up|2|||
33663748|NCT01535599|63094752|FG000|Overall Study|Adverse Event|6|||
33663749|NCT01535599|63094753|FG001|Overall Study|Adverse Event|15|||
33663750|NCT01535599|63094752|FG000|Overall Study|Lost to Follow-up|3|||
33663751|NCT01535599|63094753|FG001|Overall Study|Lost to Follow-up|4|||
33663752|NCT01535599|63094752|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
33663753|NCT01535599|63094753|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
33663754|NCT01535599|63094752|FG000|Overall Study|Treatment Failure|33|||
33663755|NCT01535599|63094753|FG001|Overall Study|Treatment Failure|66|||
33663756|NCT01535599|63094752|FG000|Overall Study|BL Culture + for Group A Strep|0|||
33663757|NCT01535599|63094753|FG001|Overall Study|BL Culture + for Group A Strep|1|||
33663758|NCT01535599|63094752|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
33663759|NCT01535599|63094753|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
33663760|NCT01535599|63094752|FG000|Overall Study|Randomized in Error|2|||
33663761|NCT01535599|63094753|FG001|Overall Study|Randomized in Error|4|||
33663762|NCT01535599|63094752|FG000|Overall Study|Did not use product|1|||
33663763|NCT01535599|63094753|FG001|Overall Study|Did not use product|0|||
33663764|NCT01535599|63094752|FG000|Overall Study|Other|1|||
33663765|NCT01535599|63094753|FG001|Overall Study|Other|0|||
33663766|NCT01535599|63094752|FG000|Overall Study|Stopped medication|0|||
33663767|NCT01535599|63094753|FG001|Overall Study|Stopped medication|1|||
33663768|NCT01535599|63094752|FG000|Overall Study|Noncompliance|0|||
33663769|NCT01535599|63094753|FG001|Overall Study|Noncompliance|1|||
33663770|NCT01553279|63094761|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
33663771|NCT01553279|63094762|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
33663772|NCT01553279|63094761|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
33663773|NCT01553279|63094762|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
33663774|NCT01553279|63094761|FG000|Interim Period|Withdrawal by Subject|2|||
33663775|NCT01553279|63094762|FG001|Interim Period|Withdrawal by Subject|2|||
33663776|NCT01553279|63094761|FG000|Interim Period|Lost to Follow-up|1|||
33663777|NCT01553279|63094762|FG001|Interim Period|Lost to Follow-up|0|||
33663778|NCT01553279|63094761|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
33301102|NCT01090024|62677140|FG002|Period 1|Withdrawal by Subject|0|||
33301103|NCT01090024|62677141|FG003|Period 1|Withdrawal by Subject|1|||
33301104|NCT01090024|62677142|FG004|Period 1|Withdrawal by Subject|0|||
33301105|NCT01090024|62677143|FG005|Period 1|Withdrawal by Subject|0|||
33301106|NCT01090024|62677144|FG006|Period 1|Withdrawal by Subject|0|||
33301107|NCT01090024|62677145|FG007|Period 1|Withdrawal by Subject|0|||
33301108|NCT01090024|62677146|FG008|Period 1|Withdrawal by Subject|0|||
33301109|NCT01090024|62677147|FG009|Period 1|Withdrawal by Subject|0|||
33301110|NCT01090024|62677148|FG010|Period 1|Withdrawal by Subject|0|||
33301111|NCT01090024|62677149|FG011|Period 1|Withdrawal by Subject|0|||
33301112|NCT01090024|62677150|FG012|Period 1|Withdrawal by Subject|0|||
33301113|NCT01090024|62677151|FG013|Period 1|Withdrawal by Subject|0|||
33301114|NCT01090024|62677152|FG014|Period 1|Withdrawal by Subject|0|||
33301115|NCT01090024|62677153|FG015|Period 1|Withdrawal by Subject|0|||
33301116|NCT01090024|62677154|FG016|Period 1|Withdrawal by Subject|0|||
33301117|NCT01090024|62677155|FG017|Period 1|Withdrawal by Subject|0|||
33301118|NCT01090024|62677138|FG000|Period 1|Lost to Follow-up|0|||
33301119|NCT01090024|62677139|FG001|Period 1|Lost to Follow-up|1|||
33301120|NCT01090024|62677140|FG002|Period 1|Lost to Follow-up|0|||
33301121|NCT01090024|62677141|FG003|Period 1|Lost to Follow-up|0|||
33301122|NCT01090024|62677142|FG004|Period 1|Lost to Follow-up|0|||
33301123|NCT01090024|62677143|FG005|Period 1|Lost to Follow-up|0|||
33301124|NCT01090024|62677144|FG006|Period 1|Lost to Follow-up|0|||
33301125|NCT01090024|62677145|FG007|Period 1|Lost to Follow-up|0|||
33566153|NCT02246764|62961869|FG000|Overall Study|Physician Decision|0|||
33566154|NCT02246764|62961870|FG001|Overall Study|Physician Decision|2|||
33566155|NCT02246764|62961871|FG002|Overall Study|Physician Decision|1|||
33566156|NCT02246764|62961869|FG000|Overall Study|Protocol Violation|2|||
33301126|NCT01090024|62677146|FG008|Period 1|Lost to Follow-up|0|||
33301127|NCT01090024|62677147|FG009|Period 1|Lost to Follow-up|0|||
33663779|NCT01553279|63094762|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
33663780|NCT01553279|63094761|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
33663781|NCT01553279|63094762|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
33663782|NCT01562743|63094769|FG000|Overall Study|Adverse Event|29|||
33301128|NCT01090024|62677148|FG010|Period 1|Lost to Follow-up|0|||
33301129|NCT01090024|62677149|FG011|Period 1|Lost to Follow-up|0|||
33392200|NCT00622167|62771117|FG000|Overall Study|Did not meet angiographic criteria|20|||
33566157|NCT02246764|62961870|FG001|Overall Study|Protocol Violation|1|||
33566158|NCT02246764|62961871|FG002|Overall Study|Protocol Violation|1|||
33663783|NCT01562743|63094769|FG000|Overall Study|Lack of Efficacy|3|||
33663784|NCT01562743|63094769|FG000|Overall Study|Withdrawal by Subject|13|||
33663785|NCT01562743|63094769|FG000|Overall Study|Protocol Violation|1|||
33663786|NCT01562743|63094769|FG000|Overall Study|Discontinuation criteria|2|||
33663787|NCT01562743|63094769|FG000|Overall Study|Lost to Follow-up|2|||
33663788|NCT01562743|63094769|FG000|Overall Study|Physician Decision|2|||
33663789|NCT01535443|63094773|FG000|Overall Study|Physician Decision|3|||
33663790|NCT01535287|63094780|FG000|Overall Study|drug not prepared in time|5|||
33663791|NCT01535287|63094781|FG001|Overall Study|drug not prepared in time|6|||
33663792|NCT01551173|63094789|FG000|Overall Study|Withdrawal by Subject|11|||
33663793|NCT01551173|63094790|FG001|Overall Study|Withdrawal by Subject|16|||
33663794|NCT01551173|63094789|FG000|Overall Study|Adverse Event|7|||
33663795|NCT01551173|63094790|FG001|Overall Study|Adverse Event|6|||
33663796|NCT01551173|63094789|FG000|Overall Study|Lost to Follow-up|5|||
33663797|NCT01551173|63094790|FG001|Overall Study|Lost to Follow-up|7|||
33663798|NCT01551173|63094789|FG000|Overall Study|Other|5|||
33663799|NCT01551173|63094790|FG001|Overall Study|Other|3|||
33663800|NCT01549613|63094799|FG000|Overall Study|Lost to Follow-up|11|||
33663801|NCT01549613|63094800|FG001|Overall Study|Lost to Follow-up|11|||
33663802|NCT01548599|63094808|FG000|Overall Study|Lost to Follow-up|0|||
33663803|NCT01548599|63094809|FG001|Overall Study|Lost to Follow-up|1|||
33663804|NCT01548599|63094808|FG000|Overall Study|Withdrawal by Subject|4|||
33663805|NCT01548599|63094809|FG001|Overall Study|Withdrawal by Subject|0|||
33663806|NCT01548599|63094808|FG000|Overall Study|Death|2|||
33663807|NCT01548599|63094809|FG001|Overall Study|Death|1|||
33663808|NCT01548287|63094822|FG000|Screening|No reason provided|0|||
33663809|NCT01548287|63094823|FG001|Screening|No reason provided|0|||
33663810|NCT01548287|63094824|FG002|Screening|No reason provided|0|||
33663811|NCT01548287|63094825|FG003|Screening|No reason provided|0|||
33663812|NCT01548287|63094826|FG004|Screening|No reason provided|9|||
33663813|NCT01548287|63094822|FG000|Screening|Did not meet eligibility criteria|0|||
33663814|NCT01548287|63094823|FG001|Screening|Did not meet eligibility criteria|0|||
33663815|NCT01548287|63094824|FG002|Screening|Did not meet eligibility criteria|0|||
33663816|NCT01548287|63094825|FG003|Screening|Did not meet eligibility criteria|0|||
33663817|NCT01548287|63094826|FG004|Screening|Did not meet eligibility criteria|74|||
33663818|NCT01548287|63094822|FG000|Randomized Period|Did not meet inclusion criteria|0|||
33663819|NCT01548287|63094823|FG001|Randomized Period|Did not meet inclusion criteria|0|||
33663820|NCT01548287|63094824|FG002|Randomized Period|Did not meet inclusion criteria|2|||
33663821|NCT01548287|63094825|FG003|Randomized Period|Did not meet inclusion criteria|0|||
33663822|NCT01548287|63094826|FG004|Randomized Period|Did not meet inclusion criteria|0|||
33663823|NCT01548287|63094822|FG000|Randomized Period|Adverse Event|0|||
33663824|NCT01548287|63094823|FG001|Randomized Period|Adverse Event|2|||
33663825|NCT01548287|63094824|FG002|Randomized Period|Adverse Event|5|||
33663826|NCT01548287|63094825|FG003|Randomized Period|Adverse Event|0|||
33663827|NCT01548287|63094826|FG004|Randomized Period|Adverse Event|0|||
33663828|NCT01546883|63094836|FG000|Overall Study|Withdrawal by Subject|3|||
33663829|NCT01546883|63094836|FG000|Overall Study|Adverse Event|4|||
33663830|NCT01546883|63094836|FG000|Overall Study|Lost to Follow-up|2|||
33663831|NCT01546883|63094836|FG000|Overall Study|early closure of study|2|||
33663832|NCT01546883|63094836|FG000|Overall Study|other unrelated illness|1|||
33663833|NCT01580293|63094847|FG000|Part A_Main Trial|Adverse Event|0|||
33663834|NCT01580293|63094848|FG001|Part A_Main Trial|Adverse Event|2|||
33663835|NCT01580293|63094849|FG002|Part A_Main Trial|Adverse Event|0|||
33663836|NCT01580293|63094847|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
33301130|NCT01090024|62677150|FG012|Period 1|Lost to Follow-up|0|||
33301131|NCT01090024|62677151|FG013|Period 1|Lost to Follow-up|0|||
33301132|NCT01090024|62677152|FG014|Period 1|Lost to Follow-up|0|||
33566159|NCT02454530|62961881|FG000|Overall Study|Other|8|||
33566160|NCT02454530|62961882|FG001|Overall Study|Other|13|||
33566161|NCT02454530|62961881|FG000|Overall Study|Missing information|56|||
33566162|NCT02454530|62961882|FG001|Overall Study|Missing information|69|||
33566163|NCT02454530|62961881|FG000|Overall Study|Death|2|||
33566164|NCT02454530|62961882|FG001|Overall Study|Death|41|||
33663837|NCT01580293|63094848|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
33663838|NCT01580293|63094849|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
33663839|NCT01580293|63094847|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
33663840|NCT01580293|63094848|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
33663841|NCT01580293|63094849|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
33301133|NCT01090024|62677153|FG015|Period 1|Lost to Follow-up|0|||
33301134|NCT01090024|62677154|FG016|Period 1|Lost to Follow-up|0|||
33301135|NCT01090024|62677155|FG017|Period 1|Lost to Follow-up|0|||
33663842|NCT01580293|63094847|FG000|Part A_Extension|Adverse Event|0|||
33663843|NCT01580293|63094848|FG001|Part A_Extension|Adverse Event|2|||
33663844|NCT01580293|63094849|FG002|Part A_Extension|Adverse Event|0|||
33301136|NCT01090024|62677138|FG000|Period 2|Lost to Follow-up|0|||
33566165|NCT02454530|62961881|FG000|Overall Study|Lost to Follow-up|4|||
33566166|NCT02454530|62961882|FG001|Overall Study|Lost to Follow-up|4|||
33663845|NCT01580293|63094847|FG000|Part A_Extension|Withdrawal by Subject|0|||
33663846|NCT01580293|63094848|FG001|Part A_Extension|Withdrawal by Subject|3|||
33663847|NCT01580293|63094849|FG002|Part A_Extension|Withdrawal by Subject|0|||
33663848|NCT01580293|63094847|FG000|Part A_Extension|Lost to Follow-up|0|||
33663849|NCT01580293|63094848|FG001|Part A_Extension|Lost to Follow-up|1|||
33663850|NCT01580293|63094849|FG002|Part A_Extension|Lost to Follow-up|0|||
33663851|NCT01580293|63094847|FG000|Part A_Extension|Other Reason|0|||
33663852|NCT01580293|63094848|FG001|Part A_Extension|Other Reason|1|||
33663853|NCT01580293|63094849|FG002|Part A_Extension|Other Reason|0|||
33663854|NCT01580293|63094847|FG000|Part A_Extension|Completed Japan only|0|||
33663855|NCT01580293|63094848|FG001|Part A_Extension|Completed Japan only|5|||
33663856|NCT01580293|63094849|FG002|Part A_Extension|Completed Japan only|0|||
33663857|NCT01580293|63094847|FG000|Part B|Withdrawal by Subject|0|||
33663858|NCT01580293|63094848|FG001|Part B|Withdrawal by Subject|0|||
33663859|NCT01580293|63094849|FG002|Part B|Withdrawal by Subject|1|||
33663860|NCT01580293|63094847|FG000|Part B|Other reason|0|||
33663861|NCT01580293|63094848|FG001|Part B|Other reason|0|||
33663862|NCT01580293|63094849|FG002|Part B|Other reason|1|||
33663863|NCT01546649|63094878|FG000|Overall Study|Adverse Event|4|||
33663864|NCT01546649|63094879|FG001|Overall Study|Adverse Event|5|||
33663865|NCT01546649|63094878|FG000|Overall Study|Protocol Violation|1|||
33663866|NCT01546649|63094879|FG001|Overall Study|Protocol Violation|0|||
33663867|NCT01546649|63094878|FG000|Overall Study|Lack of Efficacy|1|||
33663868|NCT01546649|63094879|FG001|Overall Study|Lack of Efficacy|0|||
33663869|NCT01546649|63094878|FG000|Overall Study|Recurrence|1|||
33663870|NCT01546649|63094879|FG001|Overall Study|Recurrence|1|||
33663871|NCT01546649|63094878|FG000|Overall Study|Discovery of secondary cancer|0|||
33663872|NCT01546649|63094879|FG001|Overall Study|Discovery of secondary cancer|1|||
33663873|NCT01546649|63094878|FG000|Overall Study|Withdrawal by Subject|1|||
33663874|NCT01546649|63094879|FG001|Overall Study|Withdrawal by Subject|2|||
33663875|NCT01544309|63094887|FG000|Overall Study|Withdrawal by Subject|12|||
33663876|NCT01544309|63094888|FG001|Overall Study|Withdrawal by Subject|7|||
33663877|NCT01544309|63094887|FG000|Overall Study|Protocol Violation|2|||
33663878|NCT01544309|63094888|FG001|Overall Study|Protocol Violation|1|||
33663879|NCT01544309|63094887|FG000|Overall Study|Physician Decision|4|||
33663880|NCT01544309|63094888|FG001|Overall Study|Physician Decision|1|||
33663881|NCT01544309|63094887|FG000|Overall Study|Not performed pre-dose examination|1|||
33663882|NCT01544309|63094888|FG001|Overall Study|Not performed pre-dose examination|2|||
33663883|NCT01544309|63094887|FG000|Overall Study|Administered prohibit prior medication|1|||
33663884|NCT01544309|63094888|FG001|Overall Study|Administered prohibit prior medication|0|||
33663885|NCT01544153|63094900|FG000|Overall Study|Under 18|0|||
33663886|NCT01544153|63094901|FG001|Overall Study|Under 18|1|||
33663887|NCT01544153|63094902|FG002|Overall Study|Under 18|0|||
33663888|NCT01544153|63094903|FG003|Overall Study|Under 18|0|||
33663889|NCT01544153|63094900|FG000|Overall Study|Non-smoker|0|||
33663890|NCT01544153|63094901|FG001|Overall Study|Non-smoker|0|||
33663891|NCT01544153|63094902|FG002|Overall Study|Non-smoker|1|||
33663892|NCT01544153|63094903|FG003|Overall Study|Non-smoker|0|||
33663893|NCT01543685|63094918|FG000|Overall Study|Lack of Efficacy|1|||
33663894|NCT01543685|63094919|FG001|Overall Study|Lack of Efficacy|2|||
33663895|NCT01543685|63094920|FG002|Overall Study|Lack of Efficacy|2|||
33663896|NCT01543685|63094921|FG003|Overall Study|Lack of Efficacy|0|||
33663897|NCT01543685|63094922|FG004|Overall Study|Lack of Efficacy|2|||
33663898|NCT01543685|63094918|FG000|Overall Study|Adverse Event|2|||
33663899|NCT01543685|63094919|FG001|Overall Study|Adverse Event|1|||
33663900|NCT01543685|63094920|FG002|Overall Study|Adverse Event|0|||
33663901|NCT01543685|63094921|FG003|Overall Study|Adverse Event|0|||
33663902|NCT01543685|63094922|FG004|Overall Study|Adverse Event|2|||
33663903|NCT01541969|63094936|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
33663904|NCT01541969|63094937|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
33663905|NCT01541969|63094936|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
33663906|NCT01541969|63094937|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
33663907|NCT01541969|63094936|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
33663908|NCT01541969|63094937|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
33663909|NCT01541969|63094936|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
33663910|NCT01541969|63094937|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
33663911|NCT01541969|63094936|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
33663912|NCT01541969|63094937|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
33566167|NCT02431676|62961892|FG000|Overall Study|no lab obtained|0|||
33663913|NCT01541969|63094936|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
33663914|NCT01541969|63094937|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
33566168|NCT02431676|62961893|FG001|Overall Study|no lab obtained|1|||
33663915|NCT01541969|63094936|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
33663916|NCT01541969|63094937|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
33663917|NCT01541969|63094936|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
33663918|NCT01541969|63094937|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
33663919|NCT01541969|63094936|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
33663920|NCT01541969|63094937|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
33301137|NCT01090024|62677139|FG001|Period 2|Lost to Follow-up|0|||
33663921|NCT01541969|63094936|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
33663922|NCT01541969|63094937|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
33663923|NCT01540565|63094946|FG000|Overall Study|Ineligible|2|||
33663924|NCT01540487|63094952|FG000|Overall Study|Protocol Violation|1|||
33663925|NCT01540487|63094953|FG001|Overall Study|Protocol Violation|0|||
33663926|NCT01539863|63094965|FG000|Overall Study|Lost to Follow-up|5|||
33663927|NCT01539863|63094966|FG001|Overall Study|Lost to Follow-up|4|||
33663928|NCT01539317|63094974|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
33663929|NCT01539317|63094975|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
33663930|NCT01539239|63094986|FG000|Overall Study|Death|5|||
33663931|NCT01539239|63094987|FG001|Overall Study|Death|5|||
33663932|NCT01539239|63094986|FG000|Overall Study|Lost to Follow-up|7|||
33663933|NCT01539239|63094987|FG001|Overall Study|Lost to Follow-up|12|||
33663934|NCT01539083|63094993|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
33663935|NCT01539083|63094994|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
33663936|NCT01539083|63094995|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
33663937|NCT01539083|63094993|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
33663938|NCT01539083|63094994|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
33663939|NCT01539083|63094995|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
33663940|NCT01539083|63094993|FG000|Before Randomization (VCD Induction)|Death|6|||
33663941|NCT01539083|63094994|FG001|Before Randomization (VCD Induction)|Death|0|||
33663942|NCT01539083|63094995|FG002|Before Randomization (VCD Induction)|Death|0|||
33663943|NCT01539083|63094993|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
33663944|NCT01539083|63094994|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
33663945|NCT01539083|63094995|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
33663946|NCT01539083|63094993|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
33663947|NCT01539083|63094994|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
33663948|NCT01539083|63094995|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
33663949|NCT01539083|63094993|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
33663950|NCT01539083|63094994|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
33663951|NCT01539083|63094995|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
33663952|NCT01539083|63094993|FG000|Before Randomization (VCD Induction)|Other|5|||
33663953|NCT01539083|63094994|FG001|Before Randomization (VCD Induction)|Other|0|||
33663954|NCT01539083|63094995|FG002|Before Randomization (VCD Induction)|Other|0|||
33663955|NCT01539083|63094993|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
33663956|NCT01539083|63094994|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
33663957|NCT01539083|63094995|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
33663958|NCT01539083|63094993|FG000|After Randomization (TP and VTP)|Other|0|||
33663959|NCT01539083|63094994|FG001|After Randomization (TP and VTP)|Other|1|||
33663960|NCT01539083|63094995|FG002|After Randomization (TP and VTP)|Other|1|||
33663961|NCT01539083|63094993|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
33663962|NCT01539083|63094994|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
33663963|NCT01539083|63094995|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
33663964|NCT01539083|63094993|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
33663965|NCT01539083|63094994|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
33663966|NCT01539083|63094995|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
33663967|NCT01539083|63094993|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
33663968|NCT01539083|63094994|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
33663969|NCT01539083|63094995|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
33663970|NCT01539083|63094993|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
33663971|NCT01539083|63094994|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
33663972|NCT01539083|63094995|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
33663973|NCT01539083|63094993|FG000|After Randomization (TP and VTP)|Death|0|||
33663974|NCT01539083|63094994|FG001|After Randomization (TP and VTP)|Death|6|||
33663975|NCT01539083|63094995|FG002|After Randomization (TP and VTP)|Death|11|||
33663976|NCT01537211|63095004|FG000|Overall Study|Lost to Follow-up|0|||
33663977|NCT01537211|63095005|FG001|Overall Study|Lost to Follow-up|1|||
33566169|NCT02431676|62961894|FG002|Overall Study|no lab obtained|2|||
33566170|NCT01654250|62961904|FG000|Overall Study|Lost to Follow-up|1|||
33566171|NCT01654250|62961905|FG001|Overall Study|Lost to Follow-up|0|||
33566172|NCT01652690|62961914|FG000|Overall Study|Withdrawal by Subject|16|||
33663978|NCT01537133|63095019|FG000|Overall Study|Withdrawal by Subject|2|||
33663979|NCT01537133|63095020|FG001|Overall Study|Withdrawal by Subject|0|||
33663980|NCT01537133|63095021|FG002|Overall Study|Withdrawal by Subject|0|||
33663981|NCT01537133|63095022|FG003|Overall Study|Withdrawal by Subject|0|||
33663982|NCT01537133|63095019|FG000|Overall Study|Lost to Follow-up|1|||
33663983|NCT01537133|63095020|FG001|Overall Study|Lost to Follow-up|0|||
33663984|NCT01537133|63095021|FG002|Overall Study|Lost to Follow-up|0|||
33663985|NCT01537133|63095022|FG003|Overall Study|Lost to Follow-up|0|||
33663986|NCT01536587|63095030|FG000|Overall Study|Adverse Event|2|||
33566173|NCT01652690|62961915|FG001|Overall Study|Withdrawal by Subject|4|||
33663987|NCT01536119|63095036|FG000|Overall Study|Lost to Follow-up|17|||
33663988|NCT01536119|63095037|FG001|Overall Study|Lost to Follow-up|14|||
33663989|NCT01535729|63095043|FG000|Overall Study|Withdrawal by Subject|2|||
33663990|NCT01535729|63095043|FG000|Overall Study|Disease progression|230|||
33663991|NCT01535729|63095043|FG000|Overall Study|Discontinued treatment|25|||
33663992|NCT01535729|63095043|FG000|Overall Study|Lost to Follow-up|8|||
33663993|NCT01535729|63095043|FG000|Overall Study|Death|52|||
33663994|NCT01535729|63095043|FG000|Overall Study|Other|19|||
33663995|NCT01535729|63095043|FG000|Overall Study|Did not sign informed consent|1|||
33663996|NCT01535729|63095043|FG000|Overall Study|No previous chemotherapy|33|||
33663997|NCT01535729|63095043|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
33663998|NCT01535729|63095043|FG000|Overall Study|Protocol Violation|11|||
33663999|NCT01535729|63095043|FG000|Overall Study|Screening failure|1|||
33664000|NCT01535729|63095043|FG000|Overall Study|Not treated|9|||
33664001|NCT01535729|63095043|FG000|Overall Study|No participant record available|5|||
33664002|NCT01535261|63095047|FG000|Overall Study|Physician Decision|8|||
33664003|NCT01535261|63095047|FG000|Overall Study|Protocol Violation|3|||
33664004|NCT01535261|63095047|FG000|Overall Study|Death|5|||
33664005|NCT01535261|63095047|FG000|Overall Study|Lost to Follow-up|8|||
33664006|NCT01535261|63095047|FG000|Overall Study|Withdrawal by Subject|14|||
33664007|NCT01535261|63095047|FG000|Overall Study|Adverse Event|12|||
33664008|NCT01534637|63095051|FG000|Overall Study|Physician Decision|3|||
33664009|NCT01534637|63095051|FG000|Overall Study|Lack of Efficacy|3|||
33664010|NCT01534637|63095051|FG000|Overall Study|Withdrawal by Subject|1|||
33664011|NCT01534637|63095051|FG000|Overall Study|Adverse Event|1|||
33664012|NCT01534637|63095051|FG000|Overall Study|Liver Mets before treatment|1|||
33664013|NCT02655016|63095057|FG000|Overall Study|Disease progression|6|||
33664014|NCT02655016|63095058|FG001|Overall Study|Disease progression|4|||
33664015|NCT02655016|63095057|FG000|Overall Study|Site closed|0|||
33664016|NCT02655016|63095058|FG001|Overall Study|Site closed|1|||
33664017|NCT02655016|63095057|FG000|Overall Study|Death|30|||
33664018|NCT02655016|63095058|FG001|Overall Study|Death|48|||
33664019|NCT02655016|63095057|FG000|Overall Study|Lost to Follow-up|1|||
33664020|NCT02655016|63095058|FG001|Overall Study|Lost to Follow-up|1|||
33664021|NCT02655016|63095057|FG000|Overall Study|Withdrawal by Subject|18|||
33664022|NCT02655016|63095058|FG001|Overall Study|Withdrawal by Subject|36|||
33664023|NCT01533935|63095065|FG000|Overall Study|Adverse Event|5|||
33664024|NCT01533935|63095066|FG001|Overall Study|Adverse Event|7|||
33664025|NCT01533935|63095067|FG002|Overall Study|Adverse Event|1|||
33664026|NCT01533935|63095068|FG003|Overall Study|Adverse Event|5|||
33664027|NCT01533935|63095069|FG004|Overall Study|Adverse Event|3|||
33664028|NCT01533935|63095065|FG000|Overall Study|Protocol Violation|0|||
33664029|NCT01533935|63095066|FG001|Overall Study|Protocol Violation|2|||
33664030|NCT01533935|63095067|FG002|Overall Study|Protocol Violation|0|||
33664031|NCT01533935|63095068|FG003|Overall Study|Protocol Violation|0|||
33664032|NCT01533935|63095069|FG004|Overall Study|Protocol Violation|0|||
33664033|NCT01533935|63095065|FG000|Overall Study|Lost to Follow-up|0|||
33664034|NCT01533935|63095066|FG001|Overall Study|Lost to Follow-up|0|||
33664035|NCT01533935|63095067|FG002|Overall Study|Lost to Follow-up|1|||
33664036|NCT01533935|63095068|FG003|Overall Study|Lost to Follow-up|0|||
33664037|NCT01533935|63095069|FG004|Overall Study|Lost to Follow-up|0|||
33664038|NCT01533935|63095065|FG000|Overall Study|Withdrawal by Subject|0|||
33664039|NCT01533935|63095066|FG001|Overall Study|Withdrawal by Subject|4|||
33664040|NCT01533935|63095067|FG002|Overall Study|Withdrawal by Subject|5|||
33664041|NCT01533935|63095068|FG003|Overall Study|Withdrawal by Subject|2|||
33664042|NCT01533935|63095069|FG004|Overall Study|Withdrawal by Subject|4|||
33664043|NCT01533935|63095065|FG000|Overall Study|Other reason not defined above|1|||
33664044|NCT01533935|63095066|FG001|Overall Study|Other reason not defined above|0|||
33664045|NCT01533935|63095067|FG002|Overall Study|Other reason not defined above|1|||
33664046|NCT01533935|63095068|FG003|Overall Study|Other reason not defined above|0|||
33664047|NCT01533935|63095069|FG004|Overall Study|Other reason not defined above|1|||
33664048|NCT01532999|63095083|FG000|Overall Study|Lost to Follow-up|14|||
33301138|NCT01090024|62677140|FG002|Period 2|Lost to Follow-up|0|||
33301139|NCT01090024|62677141|FG003|Period 2|Lost to Follow-up|1|||
33301140|NCT01090024|62677142|FG004|Period 2|Lost to Follow-up|0|||
33301141|NCT01090024|62677143|FG005|Period 2|Lost to Follow-up|0|||
33664049|NCT01532999|63095084|FG001|Overall Study|Lost to Follow-up|8|||
33664050|NCT01532999|63095083|FG000|Overall Study|Physician Decision|1|||
33664051|NCT01532999|63095084|FG001|Overall Study|Physician Decision|2|||
33664052|NCT01532999|63095083|FG000|Overall Study|Withdrawal by Subject|5|||
33664053|NCT01532999|63095084|FG001|Overall Study|Withdrawal by Subject|0|||
33664054|NCT01532999|63095083|FG000|Overall Study|Relocated|2|||
33301142|NCT01090024|62677144|FG006|Period 2|Lost to Follow-up|0|||
33566174|NCT01652690|62961914|FG000|Overall Study|Other|8|||
33664055|NCT01532999|63095084|FG001|Overall Study|Relocated|0|||
33664056|NCT01532999|63095083|FG000|Overall Study|should not have been randomized|1|||
33664057|NCT01532999|63095084|FG001|Overall Study|should not have been randomized|0|||
33664058|NCT01532999|63095083|FG000|Overall Study|substantial noncompliance|2|||
33664059|NCT01532999|63095084|FG001|Overall Study|substantial noncompliance|0|||
33664060|NCT01532999|63095083|FG000|Overall Study|no show for week 9 assessments|6|||
33664061|NCT01532999|63095084|FG001|Overall Study|no show for week 9 assessments|4|||
33664062|NCT01532999|63095083|FG000|Overall Study|Adverse Event|0|||
33664063|NCT01532999|63095084|FG001|Overall Study|Adverse Event|1|||
33664064|NCT01532999|63095083|FG000|Overall Study|incarcerated|0|||
33664065|NCT01532999|63095084|FG001|Overall Study|incarcerated|1|||
33664066|NCT01532999|63095083|FG000|Overall Study|New job|0|||
33664067|NCT01532999|63095084|FG001|Overall Study|New job|2|||
33664068|NCT01532921|63095090|FG000|Overall Study|Death|3|||
33664069|NCT01532921|63095090|FG000|Overall Study|Withdrawal by Subject|2|||
33664070|NCT01532921|63095090|FG000|Overall Study|Lost to Follow-up|3|||
33664071|NCT01532921|63095090|FG000|Overall Study|Physician Decision|7|||
33664072|NCT01532921|63095090|FG000|Overall Study|Device was explanted during procedure|1|||
33664073|NCT01532687|63095100|FG000|Overall Study|Death|2|||
33664074|NCT01532687|63095101|FG001|Overall Study|Death|0|||
33664075|NCT01532687|63095100|FG000|Overall Study|Adverse Event|6|||
33664076|NCT01532687|63095101|FG001|Overall Study|Adverse Event|1|||
33664077|NCT01532687|63095100|FG000|Overall Study|Withdrawal by Subject|1|||
33664078|NCT01532687|63095101|FG001|Overall Study|Withdrawal by Subject|0|||
33664079|NCT01532687|63095100|FG000|Overall Study|Physician Decision|2|||
33664080|NCT01532687|63095101|FG001|Overall Study|Physician Decision|1|||
33664081|NCT01532687|63095100|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
33664082|NCT01532687|63095101|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
33664083|NCT02677116|63095118|FG000|Overall Study|Adverse Event|0|||
33664084|NCT02677116|63095119|FG001|Overall Study|Adverse Event|1|||
33664085|NCT02677116|63095120|FG002|Overall Study|Adverse Event|0|||
33664086|NCT02677116|63095121|FG003|Overall Study|Adverse Event|0|||
33664087|NCT02677116|63095122|FG004|Overall Study|Adverse Event|0|||
33664088|NCT02677116|63095123|FG005|Overall Study|Adverse Event|1|||
33664089|NCT02677116|63095124|FG006|Overall Study|Adverse Event|1|||
33664090|NCT02677116|63095125|FG007|Overall Study|Adverse Event|0|||
33664091|NCT02677116|63095126|FG008|Overall Study|Adverse Event|0|||
33664092|NCT02677116|63095118|FG000|Overall Study|Physician Decision|0|||
33301143|NCT01090024|62677145|FG007|Period 2|Lost to Follow-up|0|||
33301144|NCT01090024|62677146|FG008|Period 2|Lost to Follow-up|0|||
33301145|NCT01090024|62677147|FG009|Period 2|Lost to Follow-up|0|||
33301146|NCT01090024|62677148|FG010|Period 2|Lost to Follow-up|0|||
33301147|NCT01090024|62677149|FG011|Period 2|Lost to Follow-up|0|||
33301148|NCT01090024|62677150|FG012|Period 2|Lost to Follow-up|0|||
33301149|NCT01090024|62677151|FG013|Period 2|Lost to Follow-up|0|||
33301150|NCT01090024|62677152|FG014|Period 2|Lost to Follow-up|0|||
33301151|NCT01090024|62677153|FG015|Period 2|Lost to Follow-up|0|||
33301152|NCT01090024|62677154|FG016|Period 2|Lost to Follow-up|0|||
33301153|NCT01090024|62677155|FG017|Period 2|Lost to Follow-up|0|||
33301154|NCT01090024|62677138|FG000|Period 2|Adverse Event|1|||
33301155|NCT01090024|62677139|FG001|Period 2|Adverse Event|0|||
33301156|NCT01090024|62677140|FG002|Period 2|Adverse Event|0|||
33301157|NCT01090024|62677141|FG003|Period 2|Adverse Event|0|||
33301158|NCT01090024|62677142|FG004|Period 2|Adverse Event|0|||
33301159|NCT01090024|62677143|FG005|Period 2|Adverse Event|0|||
33301160|NCT01090024|62677144|FG006|Period 2|Adverse Event|0|||
33301161|NCT01090024|62677145|FG007|Period 2|Adverse Event|0|||
33301162|NCT01090024|62677146|FG008|Period 2|Adverse Event|0|||
33301163|NCT01090024|62677147|FG009|Period 2|Adverse Event|0|||
33301164|NCT01090024|62677148|FG010|Period 2|Adverse Event|0|||
33301165|NCT01090024|62677149|FG011|Period 2|Adverse Event|0|||
33301166|NCT01090024|62677150|FG012|Period 2|Adverse Event|0|||
33301167|NCT01090024|62677151|FG013|Period 2|Adverse Event|0|||
33301168|NCT01090024|62677152|FG014|Period 2|Adverse Event|0|||
33301169|NCT01090024|62677153|FG015|Period 2|Adverse Event|0|||
33664093|NCT02677116|63095119|FG001|Overall Study|Physician Decision|2|||
33664094|NCT02677116|63095120|FG002|Overall Study|Physician Decision|3|||
33664095|NCT02677116|63095121|FG003|Overall Study|Physician Decision|2|||
33664096|NCT02677116|63095122|FG004|Overall Study|Physician Decision|1|||
33301170|NCT01090024|62677154|FG016|Period 2|Adverse Event|0|||
33301171|NCT01090024|62677155|FG017|Period 2|Adverse Event|0|||
33301172|NCT01090024|62677138|FG000|Period 3|Withdrawal by Subject|0|||
33301173|NCT01090024|62677139|FG001|Period 3|Withdrawal by Subject|0|||
33301174|NCT01090024|62677140|FG002|Period 3|Withdrawal by Subject|0|||
33301175|NCT01090024|62677141|FG003|Period 3|Withdrawal by Subject|0|||
33301176|NCT01090024|62677142|FG004|Period 3|Withdrawal by Subject|0|||
33664097|NCT02677116|63095123|FG005|Overall Study|Physician Decision|3|||
33664098|NCT02677116|63095124|FG006|Overall Study|Physician Decision|1|||
33664099|NCT02677116|63095125|FG007|Overall Study|Physician Decision|1|||
33664100|NCT02677116|63095126|FG008|Overall Study|Physician Decision|2|||
33664101|NCT02677116|63095118|FG000|Overall Study|Withdrawal by parent or guardian|2|||
33664102|NCT02677116|63095119|FG001|Overall Study|Withdrawal by parent or guardian|1|||
33301177|NCT01090024|62677143|FG005|Period 3|Withdrawal by Subject|0|||
33301178|NCT01090024|62677144|FG006|Period 3|Withdrawal by Subject|0|||
33301179|NCT01090024|62677145|FG007|Period 3|Withdrawal by Subject|0|||
33301180|NCT01090024|62677146|FG008|Period 3|Withdrawal by Subject|0|||
33301181|NCT01090024|62677147|FG009|Period 3|Withdrawal by Subject|0|||
33664103|NCT02677116|63095120|FG002|Overall Study|Withdrawal by parent or guardian|0|||
33301182|NCT01090024|62677148|FG010|Period 3|Withdrawal by Subject|0|||
33301183|NCT01090024|62677149|FG011|Period 3|Withdrawal by Subject|0|||
33301184|NCT01090024|62677150|FG012|Period 3|Withdrawal by Subject|0|||
33301185|NCT01090024|62677151|FG013|Period 3|Withdrawal by Subject|0|||
33301186|NCT01090024|62677152|FG014|Period 3|Withdrawal by Subject|0|||
33301187|NCT01090024|62677153|FG015|Period 3|Withdrawal by Subject|1|||
33301188|NCT01090024|62677154|FG016|Period 3|Withdrawal by Subject|0|||
33301189|NCT01090024|62677155|FG017|Period 3|Withdrawal by Subject|0|||
33301190|NCT01090024|62677138|FG000|Period 3|Protocol Violation|0|||
33301191|NCT01090024|62677139|FG001|Period 3|Protocol Violation|0|||
33301192|NCT01090024|62677140|FG002|Period 3|Protocol Violation|0|||
33301193|NCT01090024|62677141|FG003|Period 3|Protocol Violation|0|||
33301194|NCT01090024|62677142|FG004|Period 3|Protocol Violation|0|||
33301195|NCT01090024|62677143|FG005|Period 3|Protocol Violation|0|||
33301196|NCT01090024|62677144|FG006|Period 3|Protocol Violation|0|||
33301197|NCT01090024|62677145|FG007|Period 3|Protocol Violation|0|||
33301198|NCT01090024|62677146|FG008|Period 3|Protocol Violation|1|||
33301199|NCT01090024|62677147|FG009|Period 3|Protocol Violation|0|||
33301200|NCT01090024|62677148|FG010|Period 3|Protocol Violation|0|||
33301201|NCT01090024|62677149|FG011|Period 3|Protocol Violation|0|||
33301202|NCT01090024|62677150|FG012|Period 3|Protocol Violation|0|||
33301203|NCT01090024|62677151|FG013|Period 3|Protocol Violation|0|||
33301204|NCT01090024|62677152|FG014|Period 3|Protocol Violation|0|||
33301205|NCT01090024|62677153|FG015|Period 3|Protocol Violation|0|||
33301206|NCT01090024|62677154|FG016|Period 3|Protocol Violation|0|||
33301207|NCT01090024|62677155|FG017|Period 3|Protocol Violation|0|||
33301208|NCT01090024|62677138|FG000|Period 3|Adverse Event|0|||
33301209|NCT01090024|62677139|FG001|Period 3|Adverse Event|0|||
33301210|NCT01090024|62677140|FG002|Period 3|Adverse Event|0|||
33301211|NCT01090024|62677141|FG003|Period 3|Adverse Event|0|||
33301212|NCT01090024|62677142|FG004|Period 3|Adverse Event|0|||
33301213|NCT01090024|62677143|FG005|Period 3|Adverse Event|1|||
33301214|NCT01090024|62677144|FG006|Period 3|Adverse Event|0|||
33301215|NCT01090024|62677145|FG007|Period 3|Adverse Event|0|||
33301216|NCT01090024|62677146|FG008|Period 3|Adverse Event|0|||
33301217|NCT01090024|62677147|FG009|Period 3|Adverse Event|0|||
33301218|NCT01090024|62677148|FG010|Period 3|Adverse Event|0|||
33301219|NCT01090024|62677149|FG011|Period 3|Adverse Event|0|||
33301220|NCT01090024|62677150|FG012|Period 3|Adverse Event|0|||
33301221|NCT01090024|62677151|FG013|Period 3|Adverse Event|0|||
33301222|NCT01090024|62677152|FG014|Period 3|Adverse Event|0|||
33301223|NCT01090024|62677153|FG015|Period 3|Adverse Event|0|||
33301224|NCT01090024|62677154|FG016|Period 3|Adverse Event|0|||
33301225|NCT01090024|62677155|FG017|Period 3|Adverse Event|0|||
33301226|NCT04868890|62677167|FG000|Overall Study|Death|2|||
33301227|NCT04868890|62677168|FG001|Overall Study|Death|1|||
33301228|NCT04868890|62677167|FG000|Overall Study|Withdrawal by Subject|1|||
33301229|NCT04868890|62677168|FG001|Overall Study|Withdrawal by Subject|5|||
33301230|NCT01281189|62677176|FG000|Overall Study|Adverse Event|7|||
33301231|NCT01281189|62677177|FG001|Overall Study|Adverse Event|9|||
33301232|NCT01281189|62677176|FG000|Overall Study|Lost to Follow-up|6|||
33301233|NCT01281189|62677177|FG001|Overall Study|Lost to Follow-up|4|||
33301234|NCT01281189|62677176|FG000|Overall Study|Withdrawal by Subject|21|||
33301235|NCT01281189|62677177|FG001|Overall Study|Withdrawal by Subject|24|||
33301236|NCT01281189|62677176|FG000|Overall Study|Physician Decision|2|||
33301237|NCT01281189|62677177|FG001|Overall Study|Physician Decision|3|||
33301238|NCT01281189|62677176|FG000|Overall Study|Death|103|||
33301239|NCT01281189|62677177|FG001|Overall Study|Death|91|||
33301240|NCT01281189|62677176|FG000|Overall Study|Other|8|||
33301241|NCT01281189|62677177|FG001|Overall Study|Other|12|||
33392201|NCT00562354|62771123|FG000|Overall Study|Physician Decision|0|||
33566175|NCT01652690|62961915|FG001|Overall Study|Other|9|||
33301242|NCT01280955|62677183|FG000|Overall Study|Death|2|||
33301243|NCT01280955|62677183|FG000|Overall Study|Withdrawal by Subject|1|||
33301244|NCT01280721|62677189|FG000|Overall Study|Adverse Event|4|||
33301245|NCT01280721|62677189|FG000|Overall Study|Physician Decision|3|||
33301246|NCT01280721|62677189|FG000|Overall Study|Withdrawal by Subject|6|||
33301247|NCT01280721|62677189|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
33301248|NCT01280721|62677189|FG000|Overall Study|No tolerability for the lowest dose|2|||
33301249|NCT01087762|62677207|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
33301250|NCT01087762|62677208|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
33301251|NCT01087762|62677209|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
33301252|NCT01087762|62677210|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
33301253|NCT01087762|62677211|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
33301254|NCT01087762|62677207|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
33301255|NCT01087762|62677208|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
33301256|NCT01087762|62677209|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
33301257|NCT01087762|62677210|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
33301258|NCT01087762|62677211|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
33301259|NCT01087762|62677207|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
33301260|NCT01087762|62677208|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
33301261|NCT01087762|62677209|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
33301262|NCT01087762|62677210|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
33566176|NCT01652690|62961914|FG000|Overall Study|Lost to Follow-up|6|||
33566177|NCT01652690|62961915|FG001|Overall Study|Lost to Follow-up|6|||
33566178|NCT01652690|62961914|FG000|Overall Study|Death|5|||
33566179|NCT01652690|62961915|FG001|Overall Study|Death|2|||
33566180|NCT02429258|62961923|FG000|Overall Study|Withdrawal by Subject|2|||
33566181|NCT02429258|62961924|FG001|Overall Study|Withdrawal by Subject|0|||
33566182|NCT02429258|62961923|FG000|Overall Study|Protocol Violation|0|||
33566183|NCT02429258|62961924|FG001|Overall Study|Protocol Violation|1|||
33566184|NCT02201524|62961934|FG000|Overall Study|Adverse Event|0|||
33566185|NCT02201524|62961935|FG001|Overall Study|Adverse Event|2|||
33566186|NCT02201524|62961936|FG002|Overall Study|Adverse Event|1|||
33566187|NCT02201524|62961937|FG003|Overall Study|Adverse Event|0|||
33566188|NCT02201524|62961934|FG000|Overall Study|Insufficient clinical response|1|||
33566189|NCT02201524|62961935|FG001|Overall Study|Insufficient clinical response|0|||
33566190|NCT02201524|62961936|FG002|Overall Study|Insufficient clinical response|0|||
33566191|NCT02201524|62961937|FG003|Overall Study|Insufficient clinical response|0|||
33566192|NCT02201524|62961934|FG000|Overall Study|Lost to Follow-up|0|||
33566193|NCT02201524|62961935|FG001|Overall Study|Lost to Follow-up|0|||
33566194|NCT02201524|62961936|FG002|Overall Study|Lost to Follow-up|2|||
33566195|NCT02201524|62961937|FG003|Overall Study|Lost to Follow-up|0|||
33566196|NCT02201524|62961934|FG000|Overall Study|No longer meets eligibility criteria|0|||
33566197|NCT02201524|62961935|FG001|Overall Study|No longer meets eligibility criteria|0|||
33566198|NCT02201524|62961936|FG002|Overall Study|No longer meets eligibility criteria|0|||
33566199|NCT02201524|62961937|FG003|Overall Study|No longer meets eligibility criteria|2|||
33566200|NCT02201524|62961934|FG000|Overall Study|Protocol Violation|0|||
33566201|NCT02201524|62961935|FG001|Overall Study|Protocol Violation|0|||
33566202|NCT02201524|62961936|FG002|Overall Study|Protocol Violation|0|||
33566203|NCT02201524|62961937|FG003|Overall Study|Protocol Violation|1|||
33566204|NCT02201524|62961934|FG000|Overall Study|Withdrawal by Subject|0|||
33566205|NCT02201524|62961935|FG001|Overall Study|Withdrawal by Subject|0|||
33566206|NCT02201524|62961936|FG002|Overall Study|Withdrawal by Subject|1|||
33566207|NCT02201524|62961937|FG003|Overall Study|Withdrawal by Subject|1|||
33566208|NCT02201524|62961934|FG000|Overall Study|Other|1|||
33566209|NCT02201524|62961935|FG001|Overall Study|Other|1|||
33566210|NCT02201524|62961936|FG002|Overall Study|Other|0|||
33566211|NCT02201524|62961937|FG003|Overall Study|Other|0|||
33566212|NCT02453048|62961952|FG000|Overall Study|Only part of initial 6 mo. study|0|||
33566213|NCT02453048|62961953|FG001|Overall Study|Only part of initial 6 mo. study|0|||
33566214|NCT02453048|62961954|FG002|Overall Study|Only part of initial 6 mo. study|0|||
33566215|NCT02453048|62961955|FG003|Overall Study|Only part of initial 6 mo. study|0|||
33566216|NCT02453048|62961956|FG004|Overall Study|Only part of initial 6 mo. study|6|||
33566217|NCT02453048|62961952|FG000|Overall Study|Lost to Follow-up|0|||
33566218|NCT02453048|62961953|FG001|Overall Study|Lost to Follow-up|1|||
33566219|NCT02453048|62961954|FG002|Overall Study|Lost to Follow-up|2|||
33566220|NCT02453048|62961955|FG003|Overall Study|Lost to Follow-up|0|||
33566221|NCT02453048|62961956|FG004|Overall Study|Lost to Follow-up|0|||
33566222|NCT02137252|62961970|FG000|Overall Study|trial terminated early|2|||
33566223|NCT02137252|62961971|FG001|Overall Study|trial terminated early|1|||
33566224|NCT02201290|62961977|FG000|Overall Study|Withdrawal by Subject|2|||
33566225|NCT02201290|62961977|FG000|Overall Study|Lack of Efficacy|2|||
33566226|NCT02201290|62961977|FG000|Overall Study|Adverse Event|1|||
33566227|NCT02200510|62961983|FG000|Overall Study|Death|1|||
33566228|NCT02200510|62961984|FG001|Overall Study|Death|1|||
33566229|NCT02200510|62961983|FG000|Overall Study|Protocol Violation|0|||
33566230|NCT02200510|62961984|FG001|Overall Study|Protocol Violation|1|||
33566231|NCT02200510|62961983|FG000|Overall Study|Lost to Follow-up|7|||
33566232|NCT02200510|62961984|FG001|Overall Study|Lost to Follow-up|1|||
33566233|NCT02200510|62961983|FG000|Overall Study|potential COI - joined study team|1|||
33566234|NCT02200510|62961984|FG001|Overall Study|potential COI - joined study team|0|||
33566235|NCT02452892|62961994|FG000|Week 1 Initial Randommization|Adverse Event|1|||
33566236|NCT02452892|62961995|FG001|Week 1 Initial Randommization|Adverse Event|0|||
33301263|NCT01087762|62677211|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
33566237|NCT02452892|62961996|FG002|Week 1 Initial Randommization|Adverse Event|0|||
33566238|NCT02452892|62961997|FG003|Week 1 Initial Randommization|Adverse Event|0|||
33566239|NCT02452892|62961994|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
33566240|NCT02452892|62961995|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
33566241|NCT02452892|62961996|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
33566242|NCT02452892|62961997|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
33566243|NCT02452892|62961994|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
33566244|NCT02452892|62961995|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
33566245|NCT02452892|62961996|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
33566246|NCT02452892|62961997|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
33301264|NCT01087762|62677207|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
33301265|NCT01087762|62677208|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
33301266|NCT01087762|62677209|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
33301267|NCT01087762|62677210|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
33301268|NCT01087762|62677211|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
33301269|NCT01087762|62677207|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
33301270|NCT01087762|62677208|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
33301271|NCT01087762|62677209|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
33301272|NCT01087762|62677210|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
33301273|NCT01087762|62677211|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
33301274|NCT01087762|62677207|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
33301275|NCT01087762|62677208|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
33301276|NCT01087762|62677209|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
33301277|NCT01087762|62677210|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
33301278|NCT01087762|62677211|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
33301279|NCT01087762|62677207|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
33301280|NCT01087762|62677208|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
33301281|NCT01087762|62677209|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
33301282|NCT01087762|62677210|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
33301283|NCT01087762|62677211|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
33301284|NCT01087762|62677207|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
33301285|NCT01087762|62677208|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
33301286|NCT01087762|62677209|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
33301287|NCT01087762|62677210|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
33301288|NCT01087762|62677211|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
33301289|NCT01087762|62677207|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
33301290|NCT01087762|62677208|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
33301291|NCT01087762|62677209|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
33301292|NCT01087762|62677210|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
33301293|NCT01087762|62677211|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
33301294|NCT01087762|62677207|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
33301295|NCT01087762|62677208|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
33301296|NCT01087762|62677209|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
33392202|NCT00562354|62771124|FG001|Overall Study|Physician Decision|1|||
33392203|NCT00562354|62771123|FG000|Overall Study|Lost to Follow-up|0|||
33392204|NCT00562354|62771124|FG001|Overall Study|Lost to Follow-up|1|||
33392205|NCT00372385|62771136|FG000|Overall Study|Adverse Event|6|||
33392206|NCT00372385|62771137|FG001|Overall Study|Adverse Event|11|||
33392207|NCT00372385|62771138|FG002|Overall Study|Adverse Event|9|||
33392208|NCT00372385|62771139|FG003|Overall Study|Adverse Event|7|||
33392209|NCT00372385|62771136|FG000|Overall Study|Noncompliance|0|||
33392210|NCT00372385|62771137|FG001|Overall Study|Noncompliance|1|||
33392211|NCT00372385|62771138|FG002|Overall Study|Noncompliance|1|||
33392212|NCT00372385|62771139|FG003|Overall Study|Noncompliance|1|||
33392213|NCT00372385|62771136|FG000|Overall Study|Physician Decision|1|||
33392214|NCT00372385|62771137|FG001|Overall Study|Physician Decision|0|||
33392215|NCT00372385|62771138|FG002|Overall Study|Physician Decision|0|||
33392216|NCT00372385|62771139|FG003|Overall Study|Physician Decision|0|||
33392217|NCT00372385|62771136|FG000|Overall Study|Lost to Follow-up|2|||
33392218|NCT00372385|62771137|FG001|Overall Study|Lost to Follow-up|0|||
33392219|NCT00372385|62771138|FG002|Overall Study|Lost to Follow-up|0|||
33392220|NCT00372385|62771139|FG003|Overall Study|Lost to Follow-up|0|||
33392221|NCT00372385|62771136|FG000|Overall Study|Withdrawal by Subject|2|||
33392222|NCT00372385|62771137|FG001|Overall Study|Withdrawal by Subject|1|||
33392223|NCT00372385|62771138|FG002|Overall Study|Withdrawal by Subject|0|||
33392224|NCT00372385|62771139|FG003|Overall Study|Withdrawal by Subject|0|||
33392225|NCT00372385|62771136|FG000|Overall Study|Refusal of Treatment|3|||
33392226|NCT00372385|62771137|FG001|Overall Study|Refusal of Treatment|6|||
33392227|NCT00372385|62771138|FG002|Overall Study|Refusal of Treatment|0|||
33392228|NCT00372385|62771139|FG003|Overall Study|Refusal of Treatment|0|||
33392229|NCT00372385|62771136|FG000|Overall Study|No Response|1|||
33392230|NCT00372385|62771137|FG001|Overall Study|No Response|1|||
33392231|NCT00372385|62771138|FG002|Overall Study|No Response|0|||
33392232|NCT00372385|62771139|FG003|Overall Study|No Response|0|||
33392233|NCT00372385|62771136|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
33392234|NCT00372385|62771137|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
33392235|NCT00372385|62771138|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
33301297|NCT01087762|62677210|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
33301298|NCT01087762|62677211|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
33301299|NCT01087762|62677207|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
33301300|NCT01087762|62677208|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
33392236|NCT00372385|62771139|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
33392237|NCT00372385|62771136|FG000|Overall Study|Virologic Stopping Rule|17|||
33301301|NCT01087762|62677209|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
33301302|NCT01087762|62677210|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
33301303|NCT01087762|62677211|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
33301304|NCT01087762|62677207|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
33301305|NCT01087762|62677208|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
33301306|NCT01087762|62677209|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
33301307|NCT01087762|62677210|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
33301308|NCT01087762|62677211|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
33301309|NCT01087762|62677207|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
33301310|NCT01087762|62677208|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
33301311|NCT01087762|62677209|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
33301312|NCT01087762|62677210|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
33301313|NCT01087762|62677211|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
33301314|NCT01078168|62677223|FG000|Overall Study|Physician Decision|0|||
33301315|NCT01078168|62677224|FG001|Overall Study|Physician Decision|1|||
33301316|NCT01086358|62677230|FG000|First Intervention|Lost to Follow-up|9|||
33301317|NCT01086358|62677231|FG001|First Intervention|Lost to Follow-up|4|||
33301318|NCT01086358|62677230|FG000|First Intervention|Withdrawal by Subject|0|||
33301319|NCT01086358|62677231|FG001|First Intervention|Withdrawal by Subject|1|||
33301320|NCT01086358|62677230|FG000|Second Intervention|Lost to Follow-up|4|||
33301321|NCT01086358|62677231|FG001|Second Intervention|Lost to Follow-up|4|||
33301322|NCT01277601|62677241|FG000|Overall Study|Adverse Event|5|||
33301323|NCT01277601|62677242|FG001|Overall Study|Adverse Event|3|||
33301324|NCT01277601|62677243|FG002|Overall Study|Adverse Event|0|||
33301325|NCT01277601|62677244|FG003|Overall Study|Adverse Event|7|||
33301326|NCT01277601|62677241|FG000|Overall Study|Withdrawal by Subject|18|||
33301327|NCT01277601|62677242|FG001|Overall Study|Withdrawal by Subject|21|||
33301328|NCT01277601|62677243|FG002|Overall Study|Withdrawal by Subject|8|||
33301329|NCT01277601|62677244|FG003|Overall Study|Withdrawal by Subject|17|||
33301330|NCT01277601|62677241|FG000|Overall Study|Lost to Follow-up|7|||
33301331|NCT01277601|62677242|FG001|Overall Study|Lost to Follow-up|9|||
33301332|NCT01277601|62677243|FG002|Overall Study|Lost to Follow-up|4|||
33301333|NCT01277601|62677244|FG003|Overall Study|Lost to Follow-up|2|||
33301334|NCT01277601|62677241|FG000|Overall Study|Physician Decision|3|||
33301335|NCT01277601|62677242|FG001|Overall Study|Physician Decision|5|||
33301336|NCT01277601|62677243|FG002|Overall Study|Physician Decision|1|||
33301337|NCT01277601|62677244|FG003|Overall Study|Physician Decision|6|||
33301338|NCT01277601|62677241|FG000|Overall Study|Pregnancy|2|||
33301339|NCT01277601|62677242|FG001|Overall Study|Pregnancy|2|||
33301340|NCT01277601|62677243|FG002|Overall Study|Pregnancy|4|||
33301341|NCT01277601|62677244|FG003|Overall Study|Pregnancy|1|||
33301342|NCT01277601|62677241|FG000|Overall Study|Noncompliance with Study Drug|1|||
33301343|NCT01277601|62677242|FG001|Overall Study|Noncompliance with Study Drug|3|||
33301344|NCT01277601|62677243|FG002|Overall Study|Noncompliance with Study Drug|2|||
33301345|NCT01277601|62677244|FG003|Overall Study|Noncompliance with Study Drug|0|||
33301346|NCT01277601|62677241|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
33301347|NCT01277601|62677242|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
33301348|NCT01277601|62677243|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
33301349|NCT01277601|62677244|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
33301350|NCT01277601|62677241|FG000|Overall Study|Protocol Violation|0|||
33301351|NCT01277601|62677242|FG001|Overall Study|Protocol Violation|2|||
33301352|NCT01277601|62677243|FG002|Overall Study|Protocol Violation|5|||
33301353|NCT01277601|62677244|FG003|Overall Study|Protocol Violation|0|||
33301354|NCT01277601|62677241|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
33301355|NCT01277601|62677242|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
33301356|NCT01277601|62677243|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
33301357|NCT01277601|62677244|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
33301358|NCT01277523|62677274|FG000|Overall Study|Adverse Event|1|||
33301359|NCT01277523|62677275|FG001|Overall Study|Adverse Event|0|||
33301360|NCT01277523|62677276|FG002|Overall Study|Adverse Event|0|||
33301361|NCT01277523|62677274|FG000|Overall Study|Protocol Violation|2|||
33301362|NCT01277523|62677275|FG001|Overall Study|Protocol Violation|0|||
33301363|NCT01277523|62677276|FG002|Overall Study|Protocol Violation|0|||
33301364|NCT01277523|62677274|FG000|Overall Study|Other Reason not Defined|0|||
33566247|NCT02452892|62961994|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
33301365|NCT01277523|62677275|FG001|Overall Study|Other Reason not Defined|1|||
33301366|NCT01277523|62677276|FG002|Overall Study|Other Reason not Defined|0|||
33301367|NCT01081834|62677289|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
33301368|NCT01081834|62677290|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
33301369|NCT01081834|62677291|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
33301370|NCT01081834|62677292|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
33301371|NCT01081834|62677293|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
33301372|NCT01081834|62677289|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
33301373|NCT01081834|62677290|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
33301374|NCT01081834|62677291|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
33301375|NCT01081834|62677292|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
33301376|NCT01081834|62677293|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
33301377|NCT01081834|62677289|FG000|Core Period: Baseline to Week 26|Death|1|||
33301378|NCT01081834|62677290|FG001|Core Period: Baseline to Week 26|Death|0|||
33301379|NCT01081834|62677291|FG002|Core Period: Baseline to Week 26|Death|0|||
33301380|NCT01081834|62677292|FG003|Core Period: Baseline to Week 26|Death|0|||
33301381|NCT01081834|62677293|FG004|Core Period: Baseline to Week 26|Death|0|||
33301382|NCT01081834|62677289|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
33301383|NCT01081834|62677290|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
33301384|NCT01081834|62677291|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
33301385|NCT01081834|62677292|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
33301386|NCT01081834|62677293|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
33301387|NCT01081834|62677289|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
33301388|NCT01081834|62677290|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
33301389|NCT01081834|62677291|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
33301390|NCT01081834|62677292|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
33301391|NCT01081834|62677293|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
33301392|NCT01081834|62677289|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
33301393|NCT01081834|62677290|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
33301394|NCT01081834|62677291|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
33301395|NCT01081834|62677292|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
33301396|NCT01081834|62677293|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
33301397|NCT01081834|62677289|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
33301398|NCT01081834|62677290|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
33301399|NCT01081834|62677291|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
33301400|NCT01081834|62677292|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
33301401|NCT01081834|62677293|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33301402|NCT01081834|62677289|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
33301403|NCT01081834|62677290|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
33301404|NCT01081834|62677291|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
33301405|NCT01081834|62677292|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
33301406|NCT01081834|62677293|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
33301407|NCT01081834|62677289|FG000|Core Period: Baseline to Week 26|Other|4|||
33301408|NCT01081834|62677290|FG001|Core Period: Baseline to Week 26|Other|4|||
33301409|NCT01081834|62677291|FG002|Core Period: Baseline to Week 26|Other|3|||
33301410|NCT01081834|62677292|FG003|Core Period: Baseline to Week 26|Other|1|||
33301411|NCT01081834|62677293|FG004|Core Period: Baseline to Week 26|Other|0|||
33301412|NCT01081834|62677289|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
33301413|NCT01081834|62677290|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
33301414|NCT01081834|62677291|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
33301415|NCT01081834|62677292|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
33301416|NCT01081834|62677293|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
33301417|NCT01081834|62677289|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
33301418|NCT01081834|62677290|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
33301419|NCT01081834|62677291|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
33301420|NCT01081834|62677292|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
33301421|NCT01081834|62677293|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
33301422|NCT01081834|62677289|FG000|Extension Period: Week 26 to Week 52|Death|1|||
33301423|NCT01081834|62677290|FG001|Extension Period: Week 26 to Week 52|Death|0|||
33392238|NCT00372385|62771137|FG001|Overall Study|Virologic Stopping Rule|0|||
33392239|NCT00372385|62771138|FG002|Overall Study|Virologic Stopping Rule|0|||
33392240|NCT00372385|62771139|FG003|Overall Study|Virologic Stopping Rule|0|||
33392241|NCT03830281|62771152|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
33392242|NCT03830281|62771153|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
33392243|NCT03830281|62771152|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
33392244|NCT03830281|62771153|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
33392245|NCT03830281|62771152|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
33392246|NCT03830281|62771153|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
33392247|NCT03830281|62771152|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
33392248|NCT03830281|62771153|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
33392249|NCT03830281|62771152|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
33392250|NCT03830281|62771153|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
33566248|NCT02452892|62961995|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
33566249|NCT02452892|62961996|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
33566250|NCT02452892|62961997|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
33301424|NCT01081834|62677291|FG002|Extension Period: Week 26 to Week 52|Death|0|||
33301425|NCT01081834|62677292|FG003|Extension Period: Week 26 to Week 52|Death|0|||
33301426|NCT01081834|62677293|FG004|Extension Period: Week 26 to Week 52|Death|0|||
33301427|NCT01081834|62677289|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
33301428|NCT01081834|62677290|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
33301429|NCT01081834|62677291|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33301430|NCT01081834|62677292|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33301431|NCT01081834|62677293|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33301432|NCT01081834|62677289|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33301433|NCT01081834|62677290|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
33301434|NCT01081834|62677291|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33301435|NCT01081834|62677292|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33301436|NCT01081834|62677293|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33301437|NCT01081834|62677289|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33301438|NCT01081834|62677290|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
33566251|NCT02452892|62961994|FG000|Follow-up|Withdrawal by Subject|0|||
33566252|NCT02452892|62961995|FG001|Follow-up|Withdrawal by Subject|0|||
33566253|NCT02452892|62961996|FG002|Follow-up|Withdrawal by Subject|0|||
33566254|NCT02452892|62961997|FG003|Follow-up|Withdrawal by Subject|1|||
33566255|NCT02452892|62961994|FG000|Follow-up|Subject left town on Day 42|1|||
33566256|NCT02452892|62961995|FG001|Follow-up|Subject left town on Day 42|0|||
33566257|NCT02452892|62961996|FG002|Follow-up|Subject left town on Day 42|0|||
33566258|NCT02452892|62961997|FG003|Follow-up|Subject left town on Day 42|0|||
33566259|NCT02135848|62962012|FG000|Overall Study|Adverse Event|2|||
33566260|NCT02135848|62962013|FG001|Overall Study|Adverse Event|0|||
33566261|NCT02135848|62962012|FG000|Overall Study|Withdrawal by Subject|1|||
33566262|NCT02135848|62962013|FG001|Overall Study|Withdrawal by Subject|1|||
33566263|NCT02738333|62962033|FG000|Overall Study|Death|1|||
33566264|NCT02738333|62962034|FG001|Overall Study|Death|0|||
33566265|NCT02738333|62962035|FG002|Overall Study|Death|0|||
33566266|NCT02738333|62962033|FG000|Overall Study|Lost to Follow-up|1|||
33566267|NCT02738333|62962034|FG001|Overall Study|Lost to Follow-up|0|||
33566268|NCT02738333|62962035|FG002|Overall Study|Lost to Follow-up|0|||
33566269|NCT02135692|62962043|FG000|Overall Study|Adverse Event|3|||
33566270|NCT02135692|62962043|FG000|Overall Study|Lack of Efficacy|2|||
33566271|NCT02135692|62962043|FG000|Overall Study|Protocol Violation|2|||
33566272|NCT02135692|62962043|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
33566273|NCT02135692|62962043|FG000|Overall Study|Product commercially available|159|||
33566274|NCT02135692|62962043|FG000|Overall Study|Study closed/terminated|153|||
33566275|NCT02135692|62962043|FG000|Overall Study|Lost to Follow-up|4|||
33566276|NCT02135692|62962043|FG000|Overall Study|Withdrawal by Subject|15|||
33566277|NCT02429414|62962049|FG000|Overall Study|Physician Decision|0|||
33566278|NCT02429414|62962050|FG001|Overall Study|Physician Decision|1|||
33566279|NCT02135614|62962058|FG000|Overall Study|Randomized but Not Treated|2|||
33566280|NCT02135614|62962059|FG001|Overall Study|Randomized but Not Treated|1|||
33566281|NCT02135614|62962058|FG000|Overall Study|Adverse Event|0|||
33566282|NCT02135614|62962059|FG001|Overall Study|Adverse Event|1|||
33566283|NCT02135614|62962058|FG000|Overall Study|Death|1|||
33566284|NCT02135614|62962059|FG001|Overall Study|Death|0|||
33566285|NCT02135614|62962058|FG000|Overall Study|Investigator's Discretion|0|||
33301439|NCT01081834|62677291|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
33301440|NCT01081834|62677292|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
33301441|NCT01081834|62677293|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
33301442|NCT01081834|62677289|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
33301443|NCT01081834|62677290|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
33301444|NCT01081834|62677291|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
33301445|NCT01081834|62677292|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
33301446|NCT01081834|62677293|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
33566286|NCT02135614|62962059|FG001|Overall Study|Investigator's Discretion|1|||
33566287|NCT02135614|62962058|FG000|Overall Study|Withdrew Consent|2|||
33566288|NCT02135614|62962059|FG001|Overall Study|Withdrew Consent|2|||
33301447|NCT01081834|62677289|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
33301448|NCT01081834|62677290|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
33566289|NCT02135614|62962058|FG000|Overall Study|Lost to Follow-up|3|||
33566290|NCT02135614|62962059|FG001|Overall Study|Lost to Follow-up|0|||
33566291|NCT02168842|62962067|FG000|Overall Study|Withdrawal by Subject|5|||
33566292|NCT02168842|62962068|FG001|Overall Study|Withdrawal by Subject|3|||
33566293|NCT02168842|62962067|FG000|Overall Study|Lost to Follow-up|0|||
33566294|NCT02168842|62962068|FG001|Overall Study|Lost to Follow-up|2|||
33566295|NCT02168842|62962067|FG000|Overall Study|Death|2|||
33566296|NCT02168842|62962068|FG001|Overall Study|Death|1|||
33566297|NCT02168842|62962067|FG000|Overall Study|Physician Decision|1|||
33566298|NCT02168842|62962068|FG001|Overall Study|Physician Decision|2|||
33301449|NCT01081834|62677291|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
33301450|NCT01081834|62677292|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
33301451|NCT01081834|62677293|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
33301452|NCT01081834|62677289|FG000|Extension Period: Week 26 to Week 52|Other|4|||
33301453|NCT01081834|62677290|FG001|Extension Period: Week 26 to Week 52|Other|5|||
33301454|NCT01081834|62677291|FG002|Extension Period: Week 26 to Week 52|Other|4|||
33301455|NCT01081834|62677292|FG003|Extension Period: Week 26 to Week 52|Other|0|||
33301456|NCT01081834|62677293|FG004|Extension Period: Week 26 to Week 52|Other|0|||
33301457|NCT01081834|62677289|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
33301458|NCT01081834|62677290|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
33301459|NCT01081834|62677291|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
33301460|NCT01081834|62677292|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
33301461|NCT01081834|62677293|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
33301462|NCT01081834|62677289|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33301463|NCT01081834|62677290|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
33301464|NCT01081834|62677291|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33301465|NCT01081834|62677292|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33301466|NCT01081834|62677293|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33301467|NCT01276509|62677316|FG000|Overall Study|Adverse Event|9|||
33301468|NCT01276509|62677317|FG001|Overall Study|Adverse Event|8|||
33301469|NCT01276509|62677318|FG002|Overall Study|Adverse Event|4|||
33301470|NCT01276509|62677319|FG003|Overall Study|Adverse Event|3|||
33301471|NCT01276509|62677316|FG000|Overall Study|Lack of Efficacy|2|||
33301472|NCT01276509|62677317|FG001|Overall Study|Lack of Efficacy|1|||
33301473|NCT01276509|62677318|FG002|Overall Study|Lack of Efficacy|1|||
33301474|NCT01276509|62677319|FG003|Overall Study|Lack of Efficacy|2|||
33301475|NCT01276509|62677316|FG000|Overall Study|Pregnancy|1|||
33301476|NCT01276509|62677317|FG001|Overall Study|Pregnancy|0|||
33301477|NCT01276509|62677318|FG002|Overall Study|Pregnancy|0|||
33301478|NCT01276509|62677319|FG003|Overall Study|Pregnancy|0|||
33301479|NCT01276509|62677316|FG000|Overall Study|Withdrawal by Subject|1|||
33301480|NCT01276509|62677317|FG001|Overall Study|Withdrawal by Subject|2|||
33301481|NCT01276509|62677318|FG002|Overall Study|Withdrawal by Subject|0|||
33301482|NCT01276509|62677319|FG003|Overall Study|Withdrawal by Subject|0|||
33301483|NCT01276509|62677316|FG000|Overall Study|Other|0|||
33301484|NCT01276509|62677317|FG001|Overall Study|Other|1|||
33301485|NCT01276509|62677318|FG002|Overall Study|Other|0|||
33301486|NCT01276509|62677319|FG003|Overall Study|Other|0|||
33301487|NCT01079962|62677331|FG000|Overall Study|Adverse Event|2|||
33301488|NCT01079962|62677332|FG001|Overall Study|Adverse Event|2|||
33301489|NCT01079962|62677331|FG000|Overall Study|Withdrawal by Subject|5|||
33301490|NCT01079962|62677332|FG001|Overall Study|Withdrawal by Subject|7|||
33301491|NCT01079962|62677331|FG000|Overall Study|Protocol Violation|2|||
33301492|NCT01079962|62677332|FG001|Overall Study|Protocol Violation|2|||
33301493|NCT01079962|62677331|FG000|Overall Study|No blood pressure (BP) control|3|||
33301494|NCT01079962|62677332|FG001|Overall Study|No blood pressure (BP) control|0|||
33301495|NCT01079962|62677331|FG000|Overall Study|Inclusion/exclusion criteria|1|||
33301496|NCT01079962|62677332|FG001|Overall Study|Inclusion/exclusion criteria|3|||
33301497|NCT01079962|62677331|FG000|Overall Study|Participant not returning for next visit|1|||
33301498|NCT01079962|62677332|FG001|Overall Study|Participant not returning for next visit|0|||
33301499|NCT01079962|62677331|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
33301500|NCT01079962|62677332|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
33301501|NCT01274637|62677340|FG000|Overall Study|Withdrawal by Subject|0|||
33301502|NCT01274637|62677341|FG001|Overall Study|Withdrawal by Subject|1|||
33301503|NCT01274637|62677340|FG000|Overall Study|Lost to Follow-up|0|||
33301504|NCT01274637|62677341|FG001|Overall Study|Lost to Follow-up|1|||
33301505|NCT01079806|62677349|FG000|Day 1 to Week 96|Adverse Event|0|||
33301506|NCT01079806|62677350|FG001|Day 1 to Week 96|Adverse Event|3|||
33301507|NCT01079806|62677349|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
33301508|NCT01079806|62677350|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
33301509|NCT01079806|62677349|FG000|Day 1 to Week 96|Pregnancy|0|||
33301510|NCT01079806|62677350|FG001|Day 1 to Week 96|Pregnancy|1|||
33301511|NCT01079806|62677349|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
33301512|NCT01079806|62677350|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
33301513|NCT01079806|62677349|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
33301514|NCT01079806|62677350|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
33301515|NCT01079806|62677349|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
33301516|NCT01079806|62677350|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
33301517|NCT01079806|62677349|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
33301518|NCT01079806|62677350|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
33301519|NCT01079806|62677349|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
33301520|NCT01079806|62677350|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
33301521|NCT01079806|62677349|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
33301522|NCT01079806|62677350|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
33301523|NCT01079806|62677349|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
33301524|NCT01079806|62677350|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
33301525|NCT01078090|62677358|FG000|Overall Study|Lost to Follow-up|2363|||
33301526|NCT01078090|62677358|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
33301527|NCT01078090|62677358|FG000|Overall Study|Lack of Efficacy|1193|||
33301528|NCT01078090|62677358|FG000|Overall Study|ADR and lack of efficacy|61|||
33301529|NCT01078090|62677358|FG000|Overall Study|Other|523|||
33301530|NCT01077622|62677376|FG000|Overall Study|Physician Decision|2|||
33301531|NCT01077622|62677376|FG000|Overall Study|Withdrawal by Subject|1|||
33301532|NCT01313676|62677384|FG000|Overall Study|Adverse Event|395|||
33301533|NCT01313676|62677385|FG001|Overall Study|Adverse Event|365|||
33301534|NCT01313676|62677386|FG002|Overall Study|Adverse Event|372|||
33301535|NCT01313676|62677387|FG003|Overall Study|Adverse Event|333|||
33301536|NCT01313676|62677384|FG000|Overall Study|Lack of Efficacy|98|||
33301537|NCT01313676|62677385|FG001|Overall Study|Lack of Efficacy|90|||
33301538|NCT01313676|62677386|FG002|Overall Study|Lack of Efficacy|65|||
33301539|NCT01313676|62677387|FG003|Overall Study|Lack of Efficacy|46|||
33301540|NCT01313676|62677384|FG000|Overall Study|Protocol Violation|37|||
33301541|NCT01313676|62677385|FG001|Overall Study|Protocol Violation|44|||
33301542|NCT01313676|62677386|FG002|Overall Study|Protocol Violation|46|||
33301543|NCT01313676|62677387|FG003|Overall Study|Protocol Violation|44|||
33301544|NCT01313676|62677384|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
33301545|NCT01313676|62677385|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
33301546|NCT01313676|62677386|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
33301547|NCT01313676|62677387|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
33301548|NCT01313676|62677384|FG000|Overall Study|Study Closed/terminated|7|||
33301549|NCT01313676|62677385|FG001|Overall Study|Study Closed/terminated|6|||
33301550|NCT01313676|62677386|FG002|Overall Study|Study Closed/terminated|9|||
33301551|NCT01313676|62677387|FG003|Overall Study|Study Closed/terminated|9|||
33301552|NCT01313676|62677384|FG000|Overall Study|Lost to Follow-up|0|||
33301553|NCT01313676|62677385|FG001|Overall Study|Lost to Follow-up|0|||
33301554|NCT01313676|62677386|FG002|Overall Study|Lost to Follow-up|1|||
33301555|NCT01313676|62677387|FG003|Overall Study|Lost to Follow-up|0|||
33301556|NCT01313676|62677384|FG000|Overall Study|Physician Decision|53|||
33301557|NCT01313676|62677385|FG001|Overall Study|Physician Decision|64|||
33301558|NCT01313676|62677386|FG002|Overall Study|Physician Decision|62|||
33301559|NCT01313676|62677387|FG003|Overall Study|Physician Decision|48|||
33301560|NCT01313676|62677384|FG000|Overall Study|Decision by Participant or Proxy|643|||
33301561|NCT01313676|62677385|FG001|Overall Study|Decision by Participant or Proxy|527|||
33301562|NCT01313676|62677386|FG002|Overall Study|Decision by Participant or Proxy|515|||
33301563|NCT01313676|62677387|FG003|Overall Study|Decision by Participant or Proxy|492|||
33301564|NCT01313676|62677384|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
33301565|NCT01313676|62677385|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
33301566|NCT01313676|62677386|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
33301567|NCT01313676|62677387|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
33301568|NCT01313676|62677384|FG000|Overall Study|Investigator Site Closed|12|||
33301569|NCT01313676|62677385|FG001|Overall Study|Investigator Site Closed|11|||
33301570|NCT01313676|62677386|FG002|Overall Study|Investigator Site Closed|15|||
33301571|NCT01313676|62677387|FG003|Overall Study|Investigator Site Closed|10|||
33392251|NCT03830281|62771152|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
33392252|NCT03830281|62771153|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
33392253|NCT03830281|62771152|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
33392254|NCT03830281|62771153|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
33392255|NCT03830281|62771152|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
33392256|NCT03830281|62771153|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
33392257|NCT03830281|62771152|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
33392258|NCT03830281|62771153|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
33392259|NCT00563368|62771167|FG000|Overall Study|Lost to Follow-up|14|||
33392260|NCT00563368|62771168|FG001|Overall Study|Lost to Follow-up|14|||
33392261|NCT00563368|62771169|FG002|Overall Study|Lost to Follow-up|12|||
33392262|NCT00563368|62771170|FG003|Overall Study|Lost to Follow-up|6|||
33392263|NCT00563368|62771171|FG004|Overall Study|Lost to Follow-up|9|||
33392264|NCT00563368|62771172|FG005|Overall Study|Lost to Follow-up|8|||
33301572|NCT01313676|62677384|FG000|Overall Study|Missing|1|||
33301573|NCT01313676|62677385|FG001|Overall Study|Missing|1|||
33301574|NCT01313676|62677386|FG002|Overall Study|Missing|1|||
33301575|NCT01313676|62677387|FG003|Overall Study|Missing|0|||
33301576|NCT01313286|62677398|FG000|Period 1|Withdrawal by Subject|2|||
33301577|NCT01313286|62677399|FG001|Period 1|Withdrawal by Subject|0|||
33301578|NCT01313208|62677407|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
33392265|NCT00563368|62771173|FG006|Overall Study|Lost to Follow-up|9|||
33392266|NCT00563368|62771167|FG000|Overall Study|Adverse Event|3|||
33392267|NCT00563368|62771168|FG001|Overall Study|Adverse Event|4|||
33301579|NCT01313208|62677408|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
33301580|NCT01313208|62677407|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
33301581|NCT01313208|62677408|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
33301582|NCT01313208|62677407|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
33301583|NCT01313208|62677408|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
33301584|NCT01313208|62677407|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
33301585|NCT01313208|62677408|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
33301586|NCT01313208|62677407|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
33301587|NCT01313208|62677408|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
33301588|NCT01313208|62677407|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
33301589|NCT01313208|62677408|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
33566299|NCT02200042|62962078|FG000|Overall Study|Withdrawal by Subject|0|||
33566300|NCT02200042|62962079|FG001|Overall Study|Withdrawal by Subject|1|||
33566301|NCT02199028|62962087|FG000|Week 1|Adverse Event|1|||
33301590|NCT01313208|62677407|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
33301591|NCT01313208|62677408|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
33301592|NCT01313208|62677407|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
33301593|NCT01313208|62677408|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
33301594|NCT01313208|62677407|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
33301595|NCT01313208|62677408|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
33301596|NCT01312428|62677418|FG000|Overall Study|Study Termination|3|||
33301597|NCT01312428|62677419|FG001|Overall Study|Study Termination|4|||
33301598|NCT01075984|62677432|FG000|Treatment Phase|Adverse Event|0|||
33301599|NCT01075984|62677433|FG001|Treatment Phase|Adverse Event|1|||
33301600|NCT01075984|62677434|FG002|Treatment Phase|Adverse Event|3|||
33301601|NCT01075984|62677435|FG003|Treatment Phase|Adverse Event|7|||
33301602|NCT01075984|62677436|FG004|Treatment Phase|Adverse Event|35|||
33301603|NCT01075984|62677432|FG000|Treatment Phase|Protocol Violation|0|||
33301604|NCT01075984|62677433|FG001|Treatment Phase|Protocol Violation|0|||
33301605|NCT01075984|62677434|FG002|Treatment Phase|Protocol Violation|1|||
33301606|NCT01075984|62677435|FG003|Treatment Phase|Protocol Violation|0|||
33301607|NCT01075984|62677436|FG004|Treatment Phase|Protocol Violation|3|||
33301608|NCT01075984|62677432|FG000|Treatment Phase|Withdrawal by Subject|0|||
33301609|NCT01075984|62677433|FG001|Treatment Phase|Withdrawal by Subject|0|||
33301610|NCT01075984|62677434|FG002|Treatment Phase|Withdrawal by Subject|2|||
33301611|NCT01075984|62677435|FG003|Treatment Phase|Withdrawal by Subject|0|||
33301612|NCT01075984|62677436|FG004|Treatment Phase|Withdrawal by Subject|15|||
33301613|NCT01075984|62677432|FG000|Treatment Phase|Treatment Failure|0|||
33301614|NCT01075984|62677433|FG001|Treatment Phase|Treatment Failure|0|||
33301615|NCT01075984|62677434|FG002|Treatment Phase|Treatment Failure|1|||
33301616|NCT01075984|62677435|FG003|Treatment Phase|Treatment Failure|0|||
33301617|NCT01075984|62677436|FG004|Treatment Phase|Treatment Failure|5|||
33301618|NCT01075984|62677432|FG000|Treatment Phase|Progression of disease|0|||
33301619|NCT01075984|62677433|FG001|Treatment Phase|Progression of disease|0|||
33301620|NCT01075984|62677434|FG002|Treatment Phase|Progression of disease|0|||
33301621|NCT01075984|62677435|FG003|Treatment Phase|Progression of disease|0|||
33301622|NCT01075984|62677436|FG004|Treatment Phase|Progression of disease|2|||
33301623|NCT01075984|62677432|FG000|Follow-up Phase|Protocol Violation|0|||
33301624|NCT01075984|62677433|FG001|Follow-up Phase|Protocol Violation|0|||
33301625|NCT01075984|62677434|FG002|Follow-up Phase|Protocol Violation|1|||
33301626|NCT01075984|62677435|FG003|Follow-up Phase|Protocol Violation|0|||
33301627|NCT01075984|62677436|FG004|Follow-up Phase|Protocol Violation|3|||
33301628|NCT01075984|62677432|FG000|Follow-up Phase|Adverse Event|0|||
33301629|NCT01075984|62677433|FG001|Follow-up Phase|Adverse Event|0|||
33301630|NCT01075984|62677434|FG002|Follow-up Phase|Adverse Event|0|||
33301631|NCT01075984|62677435|FG003|Follow-up Phase|Adverse Event|2|||
33301632|NCT01075984|62677436|FG004|Follow-up Phase|Adverse Event|27|||
33301633|NCT01075984|62677432|FG000|Follow-up Phase|Administrative|0|||
33301634|NCT01075984|62677433|FG001|Follow-up Phase|Administrative|0|||
33301635|NCT01075984|62677434|FG002|Follow-up Phase|Administrative|0|||
33301636|NCT01075984|62677435|FG003|Follow-up Phase|Administrative|0|||
33301637|NCT01075984|62677436|FG004|Follow-up Phase|Administrative|1|||
33566302|NCT02199028|62962088|FG001|Week 1|Adverse Event|0|||
33566303|NCT02199028|62962087|FG000|Week 3|Adverse Event|1|||
33301638|NCT01075984|62677432|FG000|Follow-up Phase|Withdrawal by Subject|0|||
33301639|NCT01075984|62677433|FG001|Follow-up Phase|Withdrawal by Subject|0|||
33301640|NCT01075984|62677434|FG002|Follow-up Phase|Withdrawal by Subject|0|||
33301641|NCT01075984|62677435|FG003|Follow-up Phase|Withdrawal by Subject|0|||
33301642|NCT01075984|62677436|FG004|Follow-up Phase|Withdrawal by Subject|10|||
33301643|NCT01075984|62677432|FG000|Follow-up Phase|Progression of disease|0|||
33301644|NCT01075984|62677433|FG001|Follow-up Phase|Progression of disease|0|||
33301645|NCT01075984|62677434|FG002|Follow-up Phase|Progression of disease|0|||
33301646|NCT01075984|62677435|FG003|Follow-up Phase|Progression of disease|0|||
33301647|NCT01075984|62677436|FG004|Follow-up Phase|Progression of disease|2|||
33566304|NCT02199028|62962088|FG001|Week 3|Adverse Event|0|||
33566305|NCT03347123|62962097|FG000|Overall Study|Death|1|||
33301648|NCT01075984|62677432|FG000|Follow-up Phase|Treatment failure|0|||
33301649|NCT01075984|62677433|FG001|Follow-up Phase|Treatment failure|0|||
33301650|NCT01075984|62677434|FG002|Follow-up Phase|Treatment failure|0|||
33301651|NCT01075984|62677435|FG003|Follow-up Phase|Treatment failure|0|||
33301652|NCT01075984|62677436|FG004|Follow-up Phase|Treatment failure|4|||
33301653|NCT01024231|62677455|FG000|Overall Study|Other Reasons|1|||
33301654|NCT01024231|62677456|FG001|Overall Study|Other Reasons|2|||
33301655|NCT01024231|62677457|FG002|Overall Study|Other Reasons|0|||
33301656|NCT01024231|62677458|FG003|Overall Study|Other Reasons|0|||
33301657|NCT01024231|62677459|FG004|Overall Study|Other Reasons|2|||
33301658|NCT01024231|62677460|FG005|Overall Study|Other Reasons|0|||
33301659|NCT01024231|62677461|FG006|Overall Study|Other Reasons|1|||
33301660|NCT01024231|62677455|FG000|Overall Study|Maximum Clinical Benefit|1|||
33301661|NCT01024231|62677456|FG001|Overall Study|Maximum Clinical Benefit|2|||
33301662|NCT01024231|62677457|FG002|Overall Study|Maximum Clinical Benefit|0|||
33301663|NCT01024231|62677458|FG003|Overall Study|Maximum Clinical Benefit|1|||
33301664|NCT01024231|62677459|FG004|Overall Study|Maximum Clinical Benefit|1|||
33301665|NCT01024231|62677460|FG005|Overall Study|Maximum Clinical Benefit|0|||
33301666|NCT01024231|62677461|FG006|Overall Study|Maximum Clinical Benefit|0|||
33301667|NCT01024231|62677455|FG000|Overall Study|Disease Progression|3|||
33301668|NCT01024231|62677456|FG001|Overall Study|Disease Progression|1|||
33301669|NCT01024231|62677457|FG002|Overall Study|Disease Progression|3|||
33301670|NCT01024231|62677458|FG003|Overall Study|Disease Progression|0|||
33301671|NCT01024231|62677459|FG004|Overall Study|Disease Progression|4|||
33301672|NCT01024231|62677460|FG005|Overall Study|Disease Progression|11|||
33301673|NCT01024231|62677461|FG006|Overall Study|Disease Progression|6|||
33301674|NCT01024231|62677455|FG000|Overall Study|AE unrelated to Study Drug|0|||
33301675|NCT01024231|62677456|FG001|Overall Study|AE unrelated to Study Drug|1|||
33301676|NCT01024231|62677457|FG002|Overall Study|AE unrelated to Study Drug|0|||
33301677|NCT01024231|62677458|FG003|Overall Study|AE unrelated to Study Drug|0|||
33301678|NCT01024231|62677459|FG004|Overall Study|AE unrelated to Study Drug|0|||
33301679|NCT01024231|62677460|FG005|Overall Study|AE unrelated to Study Drug|0|||
33301680|NCT01024231|62677461|FG006|Overall Study|AE unrelated to Study Drug|0|||
33301681|NCT01024231|62677455|FG000|Overall Study|No longer meets criteria|0|||
33301682|NCT01024231|62677456|FG001|Overall Study|No longer meets criteria|0|||
33301683|NCT01024231|62677457|FG002|Overall Study|No longer meets criteria|0|||
33301684|NCT01024231|62677458|FG003|Overall Study|No longer meets criteria|0|||
33301685|NCT01024231|62677459|FG004|Overall Study|No longer meets criteria|1|||
33301686|NCT01024231|62677460|FG005|Overall Study|No longer meets criteria|0|||
33301687|NCT01024231|62677461|FG006|Overall Study|No longer meets criteria|1|||
33301688|NCT01024231|62677455|FG000|Overall Study|Study Drug Toxicity|1|||
33301689|NCT01024231|62677456|FG001|Overall Study|Study Drug Toxicity|6|||
33301690|NCT01024231|62677457|FG002|Overall Study|Study Drug Toxicity|6|||
33301691|NCT01024231|62677458|FG003|Overall Study|Study Drug Toxicity|4|||
33301692|NCT01024231|62677459|FG004|Overall Study|Study Drug Toxicity|2|||
33301693|NCT01024231|62677460|FG005|Overall Study|Study Drug Toxicity|0|||
33301694|NCT01024231|62677461|FG006|Overall Study|Study Drug Toxicity|7|||
33301695|NCT01024231|62677455|FG000|Overall Study|Death|6|||
33301696|NCT01024231|62677456|FG001|Overall Study|Death|2|||
33301697|NCT01024231|62677457|FG002|Overall Study|Death|1|||
33301698|NCT01024231|62677458|FG003|Overall Study|Death|0|||
33301699|NCT01024231|62677459|FG004|Overall Study|Death|4|||
33301700|NCT01024231|62677460|FG005|Overall Study|Death|3|||
33301701|NCT01024231|62677461|FG006|Overall Study|Death|5|||
33301702|NCT01024231|62677455|FG000|Overall Study|Lost to Follow-up|0|||
33301703|NCT01024231|62677456|FG001|Overall Study|Lost to Follow-up|0|||
33301704|NCT01024231|62677457|FG002|Overall Study|Lost to Follow-up|0|||
33301705|NCT01024231|62677458|FG003|Overall Study|Lost to Follow-up|0|||
33301706|NCT01024231|62677459|FG004|Overall Study|Lost to Follow-up|0|||
33301707|NCT01024231|62677460|FG005|Overall Study|Lost to Follow-up|0|||
33301708|NCT01024231|62677461|FG006|Overall Study|Lost to Follow-up|1|||
33301709|NCT01024231|62677455|FG000|Overall Study|Withdrew Consent|0|||
33301710|NCT01024231|62677456|FG001|Overall Study|Withdrew Consent|1|||
33392268|NCT00563368|62771169|FG002|Overall Study|Adverse Event|5|||
33566306|NCT03347123|62962098|FG001|Overall Study|Death|2|||
33301711|NCT01024231|62677457|FG002|Overall Study|Withdrew Consent|0|||
33301712|NCT01024231|62677458|FG003|Overall Study|Withdrew Consent|0|||
33566307|NCT03347123|62962099|FG002|Overall Study|Death|0|||
33301713|NCT01024231|62677459|FG004|Overall Study|Withdrew Consent|0|||
33301714|NCT01024231|62677460|FG005|Overall Study|Withdrew Consent|0|||
33301715|NCT01024231|62677461|FG006|Overall Study|Withdrew Consent|0|||
33301716|NCT01024231|62677455|FG000|Overall Study|Continuing on Treatment|0|||
33301717|NCT01024231|62677456|FG001|Overall Study|Continuing on Treatment|0|||
33301718|NCT01024231|62677457|FG002|Overall Study|Continuing on Treatment|0|||
33301719|NCT01024231|62677458|FG003|Overall Study|Continuing on Treatment|0|||
33301720|NCT01024231|62677459|FG004|Overall Study|Continuing on Treatment|3|||
33301721|NCT01024231|62677460|FG005|Overall Study|Continuing on Treatment|2|||
33301722|NCT01024231|62677461|FG006|Overall Study|Continuing on Treatment|0|||
33301723|NCT01077544|62677484|FG000|Overall Study|New Cancer Therapy|3|||
33566308|NCT03347123|62962100|FG003|Overall Study|Death|0|||
33301724|NCT01077544|62677485|FG001|Overall Study|New Cancer Therapy|3|||
33301725|NCT01077544|62677484|FG000|Overall Study|Adverse Event|0|||
33301726|NCT01077544|62677485|FG001|Overall Study|Adverse Event|1|||
33301727|NCT01077544|62677484|FG000|Overall Study|Disease Progression|0|||
33301728|NCT01077544|62677485|FG001|Overall Study|Disease Progression|1|||
33301729|NCT01075516|62677493|FG000|Overall Study|Death|5|||
33301730|NCT01075516|62677494|FG001|Overall Study|Death|9|||
33301731|NCT01075516|62677493|FG000|Overall Study|Lost to Follow-up|10|||
33301732|NCT01075516|62677494|FG001|Overall Study|Lost to Follow-up|2|||
33301733|NCT01075516|62677493|FG000|Overall Study|Withdrawal by Subject|3|||
33301734|NCT01075516|62677494|FG001|Overall Study|Withdrawal by Subject|5|||
33301735|NCT01012999|62677500|FG000|Overall Study|Protocol Violation|1|||
33301736|NCT01017601|62677506|FG000|Overall Study|Disease Progression|12|||
33301737|NCT01017601|62677507|FG001|Overall Study|Disease Progression|12|||
33301738|NCT01017601|62677506|FG000|Overall Study|Withdrawal by Subject|0|||
33301739|NCT01017601|62677507|FG001|Overall Study|Withdrawal by Subject|1|||
33301740|NCT01016977|62677515|FG000|Overall Study|Lost to Follow-up|1|||
33301741|NCT01016977|62677516|FG001|Overall Study|Lost to Follow-up|0|||
33301742|NCT01016977|62677515|FG000|Overall Study|Withdrawal by Subject|2|||
33301743|NCT01016977|62677516|FG001|Overall Study|Withdrawal by Subject|2|||
33301744|NCT01012765|62677525|FG000|Treatment Period 1|Adverse Event|1|||
33301745|NCT01012765|62677526|FG001|Treatment Period 1|Adverse Event|0|||
33301746|NCT01012765|62677527|FG002|Treatment Period 1|Adverse Event|1|||
33301747|NCT01012765|62677528|FG003|Treatment Period 1|Adverse Event|0|||
33301748|NCT01012765|62677529|FG004|Treatment Period 1|Adverse Event|0|||
33301749|NCT01012765|62677530|FG005|Treatment Period 1|Adverse Event|0|||
33301750|NCT01012765|62677525|FG000|Treatment Period 1|Withdrawal by Subject|2|||
33301751|NCT01012765|62677526|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33301752|NCT01012765|62677527|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33301753|NCT01012765|62677528|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33301754|NCT01012765|62677529|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33301755|NCT01012765|62677530|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33301756|NCT01012765|62677525|FG000|Treatment Period 1|Administrative problems|0|||
33301757|NCT01012765|62677526|FG001|Treatment Period 1|Administrative problems|0|||
33301758|NCT01012765|62677527|FG002|Treatment Period 1|Administrative problems|1|||
33301759|NCT01012765|62677528|FG003|Treatment Period 1|Administrative problems|1|||
33301760|NCT01012765|62677529|FG004|Treatment Period 1|Administrative problems|1|||
33301761|NCT01012765|62677530|FG005|Treatment Period 1|Administrative problems|0|||
33301762|NCT01012765|62677525|FG000|Treatment Period 1|Protocol Violation|0|||
33301763|NCT01012765|62677526|FG001|Treatment Period 1|Protocol Violation|0|||
33301764|NCT01012765|62677527|FG002|Treatment Period 1|Protocol Violation|0|||
33301765|NCT01012765|62677528|FG003|Treatment Period 1|Protocol Violation|2|||
33301766|NCT01012765|62677529|FG004|Treatment Period 1|Protocol Violation|1|||
33301767|NCT01012765|62677530|FG005|Treatment Period 1|Protocol Violation|0|||
33301768|NCT01012765|62677525|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
33301769|NCT01012765|62677526|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
33301770|NCT01012765|62677527|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
33301771|NCT01012765|62677528|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
33301772|NCT01012765|62677529|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
33301773|NCT01012765|62677530|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
33301774|NCT01012765|62677525|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33301775|NCT01012765|62677526|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33301776|NCT01012765|62677527|FG002|Treatment Period 2|Withdrawal by Subject|1|||
33301777|NCT01012765|62677528|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33301778|NCT01012765|62677529|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33301779|NCT01012765|62677530|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33301780|NCT01012765|62677525|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
33301781|NCT01012765|62677526|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
33301782|NCT01012765|62677527|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
33301783|NCT01012765|62677528|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
33301784|NCT01012765|62677529|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
33301785|NCT01012765|62677530|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
33301786|NCT01012765|62677525|FG000|Treatment Period 2|Adverse Event|0|||
33301787|NCT01012765|62677526|FG001|Treatment Period 2|Adverse Event|1|||
33301788|NCT01012765|62677527|FG002|Treatment Period 2|Adverse Event|1|||
33301789|NCT01012765|62677528|FG003|Treatment Period 2|Adverse Event|0|||
33392269|NCT00563368|62771170|FG003|Overall Study|Adverse Event|9|||
33392270|NCT00563368|62771171|FG004|Overall Study|Adverse Event|6|||
33301790|NCT01012765|62677529|FG004|Treatment Period 2|Adverse Event|0|||
33566309|NCT03347123|62962101|FG004|Overall Study|Death|0|||
33301791|NCT01012765|62677530|FG005|Treatment Period 2|Adverse Event|0|||
33301792|NCT01012765|62677525|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
33301793|NCT01012765|62677526|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
33301794|NCT01012765|62677527|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
33301795|NCT01012765|62677528|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
33301796|NCT01012765|62677529|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
33301797|NCT01012765|62677530|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
33301798|NCT01010503|62677538|FG000|Overall Study|Adverse Event|1|||
33301799|NCT01010503|62677538|FG000|Overall Study|Death|1|||
33301800|NCT01009645|62677546|FG000|Overall Study|Lost to Follow-up|2|||
33301801|NCT01009645|62677547|FG001|Overall Study|Lost to Follow-up|8|||
33301802|NCT01009645|62677548|FG002|Overall Study|Lost to Follow-up|4|||
33301803|NCT01009645|62677549|FG003|Overall Study|Lost to Follow-up|5|||
33301804|NCT01006291|62677562|FG000|Overall Study|Adverse Event|2|||
33301805|NCT01006291|62677563|FG001|Overall Study|Adverse Event|1|||
33301806|NCT01006291|62677564|FG002|Overall Study|Adverse Event|2|||
33301807|NCT01006291|62677562|FG000|Overall Study|Lack of Efficacy|2|||
33301808|NCT01006291|62677563|FG001|Overall Study|Lack of Efficacy|2|||
33301809|NCT01006291|62677564|FG002|Overall Study|Lack of Efficacy|1|||
33301810|NCT01006291|62677562|FG000|Overall Study|Protocol Violation|3|||
33301811|NCT01006291|62677563|FG001|Overall Study|Protocol Violation|3|||
33301812|NCT01006291|62677564|FG002|Overall Study|Protocol Violation|3|||
33301813|NCT01006291|62677562|FG000|Overall Study|Withdrawal criteria|5|||
33301814|NCT01006291|62677563|FG001|Overall Study|Withdrawal criteria|4|||
33301815|NCT01006291|62677564|FG002|Overall Study|Withdrawal criteria|4|||
33301816|NCT01006291|62677562|FG000|Overall Study|Other|14|||
33301817|NCT01006291|62677563|FG001|Overall Study|Other|14|||
33301818|NCT01006291|62677564|FG002|Overall Study|Other|17|||
33301819|NCT01006135|62677572|FG000|Overall Study|Adverse Event|22|||
33301820|NCT01006135|62677572|FG000|Overall Study|Protocol Violation|14|||
33301821|NCT01006135|62677572|FG000|Overall Study|Lost to Follow-up|32|||
33301822|NCT01006135|62677572|FG000|Overall Study|Other|72|||
33301823|NCT01012609|62677578|FG000|Overall Study|Withdrawal by Subject|1|||
33301824|NCT01012609|62677579|FG001|Overall Study|Withdrawal by Subject|1|||
33301825|NCT01012219|62677586|FG000|Period 1|Withdrawal by Subject|1|||
33301826|NCT01012219|62677586|FG000|Period 2|Withdrawal by Subject|1|||
33301827|NCT01011907|62677595|FG000|Overall Study|Withdrawal by Subject|13|||
33301828|NCT01011907|62677596|FG001|Overall Study|Withdrawal by Subject|11|||
33301829|NCT01011907|62677595|FG000|Overall Study|Adverse Event|1|||
33301830|NCT01011907|62677596|FG001|Overall Study|Adverse Event|4|||
33301831|NCT01011673|62677604|FG000|Randomized|Secondary headache|2|||
33301832|NCT01011673|62677605|FG001|Randomized|Secondary headache|1|||
33301833|NCT01011673|62677604|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
33301834|NCT01011673|62677605|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
33301835|NCT01311648|62677614|FG000|Main Study|Protocol Violation|0|||
33301836|NCT01311648|62677615|FG001|Main Study|Protocol Violation|1|||
33301837|NCT01311648|62677614|FG000|Main Study|Adverse Event|0|||
33301838|NCT01311648|62677615|FG001|Main Study|Adverse Event|1|||
33301839|NCT01311648|62677614|FG000|Main Study|Inhibitor management|0|||
33301840|NCT01311648|62677615|FG001|Main Study|Inhibitor management|17|||
33301841|NCT01311648|62677614|FG000|Main Study|Withdrawal by Subject|0|||
33301842|NCT01311648|62677615|FG001|Main Study|Withdrawal by Subject|2|||
33301843|NCT01311648|62677614|FG000|Extension Study|Physician Decision|0|||
33301844|NCT01311648|62677615|FG001|Extension Study|Physician Decision|1|||
33301845|NCT01311648|62677614|FG000|Extension Study|ITI therapy with marketed product|0|||
33301846|NCT01311648|62677615|FG001|Extension Study|ITI therapy with marketed product|1|||
33301847|NCT01311648|62677614|FG000|Extension Study|Incorrect visit planning|0|||
33301848|NCT01311648|62677615|FG001|Extension Study|Incorrect visit planning|1|||
33301849|NCT01311648|62677614|FG000|Extension Study|Family's decision|0|||
33301850|NCT01311648|62677615|FG001|Extension Study|Family's decision|1|||
33301851|NCT01311648|62677614|FG000|Extension Study|Failure of ITI therapy|0|||
33301852|NCT01311648|62677615|FG001|Extension Study|Failure of ITI therapy|3|||
33301853|NCT01311648|62677614|FG000|Extension Study|Long travel|0|||
33301854|NCT01311648|62677615|FG001|Extension Study|Long travel|1|||
33301855|NCT01311648|62677614|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
33301856|NCT01311648|62677615|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
33392271|NCT00563368|62771172|FG005|Overall Study|Adverse Event|10|||
33392272|NCT00563368|62771173|FG006|Overall Study|Adverse Event|17|||
33392273|NCT00563368|62771167|FG000|Overall Study|Withdrawal by Subject|11|||
33301857|NCT01311648|62677614|FG000|Extension Study|Withdrawal by Subject|0|||
33301858|NCT01311648|62677615|FG001|Extension Study|Withdrawal by Subject|1|||
33301859|NCT01311648|62677614|FG000|Extension Study|Inhibitor management|0|||
33301860|NCT01311648|62677615|FG001|Extension Study|Inhibitor management|2|||
33301861|NCT01011439|62677628|FG000|Overall Study|Death|37|||
33301862|NCT01011439|62677628|FG000|Overall Study|Lost to Follow-up|4|||
33301863|NCT01011439|62677628|FG000|Overall Study|Withdrawal by Subject|1|||
33301864|NCT01011439|62677628|FG000|Overall Study|Sponsor's decision|15|||
33301865|NCT01311024|62677635|FG000|Overall Study|Protocol Violation|35|||
33301866|NCT01311024|62677636|FG001|Overall Study|Protocol Violation|22|||
33301867|NCT01310868|62677642|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
33301868|NCT01273155|62677650|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
33301869|NCT01273155|62677651|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
33301870|NCT01273155|62677652|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
33301871|NCT01273155|62677653|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
33301872|NCT01273155|62677654|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
33301873|NCT01273155|62677655|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
33301874|NCT01273155|62677656|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
33301875|NCT01273155|62677650|FG000|Overall Study|Change in liver function/no longer eval.|0|||
33301876|NCT01273155|62677651|FG001|Overall Study|Change in liver function/no longer eval.|1|||
33301877|NCT01273155|62677652|FG002|Overall Study|Change in liver function/no longer eval.|0|||
33301878|NCT01273155|62677653|FG003|Overall Study|Change in liver function/no longer eval.|0|||
33301879|NCT01273155|62677654|FG004|Overall Study|Change in liver function/no longer eval.|1|||
33301880|NCT01273155|62677655|FG005|Overall Study|Change in liver function/no longer eval.|0|||
33301881|NCT01273155|62677656|FG006|Overall Study|Change in liver function/no longer eval.|0|||
33301882|NCT01273155|62677650|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
33301883|NCT01273155|62677651|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
33301884|NCT01273155|62677652|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
33301885|NCT01273155|62677653|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
33301886|NCT01273155|62677654|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
33301887|NCT01273155|62677655|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
33301888|NCT01273155|62677656|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
33301889|NCT01273155|62677650|FG000|Overall Study|Died during Cycle 1|0|||
33301890|NCT01273155|62677651|FG001|Overall Study|Died during Cycle 1|0|||
33301891|NCT01273155|62677652|FG002|Overall Study|Died during Cycle 1|1|||
33301892|NCT01273155|62677653|FG003|Overall Study|Died during Cycle 1|1|||
33301893|NCT01273155|62677654|FG004|Overall Study|Died during Cycle 1|0|||
33301894|NCT01273155|62677655|FG005|Overall Study|Died during Cycle 1|2|||
33301895|NCT01273155|62677656|FG006|Overall Study|Died during Cycle 1|2|||
33301896|NCT01273155|62677650|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
33301897|NCT01273155|62677651|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
33301898|NCT01273155|62677652|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
33301899|NCT01273155|62677653|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
33301900|NCT01273155|62677654|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
33301901|NCT01273155|62677655|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
33301902|NCT01273155|62677656|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
33301903|NCT01005901|62677681|FG000|Overall Study|Withdrawal by Subject|38|||
33301904|NCT01005901|62677682|FG001|Overall Study|Withdrawal by Subject|14|||
33301905|NCT01005901|62677681|FG000|Overall Study|Adverse Event|30|||
33301906|NCT01005901|62677682|FG001|Overall Study|Adverse Event|16|||
33301907|NCT01005901|62677681|FG000|Overall Study|Administrative problems|21|||
33301908|NCT01005901|62677682|FG001|Overall Study|Administrative problems|13|||
33301909|NCT01005901|62677681|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
33301910|NCT01005901|62677682|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
33301911|NCT01005901|62677681|FG000|Overall Study|Protocol Violation|4|||
33301912|NCT01005901|62677682|FG001|Overall Study|Protocol Violation|3|||
33301913|NCT01005901|62677681|FG000|Overall Study|Death|2|||
33301914|NCT01005901|62677682|FG001|Overall Study|Death|3|||
33301915|NCT01005901|62677681|FG000|Overall Study|Lost to Follow-up|1|||
33301916|NCT01005901|62677682|FG001|Overall Study|Lost to Follow-up|2|||
33301917|NCT01005901|62677681|FG000|Overall Study|Patient's inability to use the device|1|||
33301918|NCT01005901|62677682|FG001|Overall Study|Patient's inability to use the device|1|||
33301919|NCT01005901|62677681|FG000|Overall Study|No longer requires study drug|0|||
33301920|NCT01005901|62677682|FG001|Overall Study|No longer requires study drug|1|||
33301921|NCT04968925|62677690|FG000|Phase I- Period 1|COVID-19 related|0|||
33301922|NCT04968925|62677691|FG001|Phase I- Period 1|COVID-19 related|1|||
33301923|NCT04968925|62677692|FG002|Phase I- Period 1|COVID-19 related|0|||
33301924|NCT04968925|62677693|FG003|Phase I- Period 1|COVID-19 related|0|||
33301925|NCT04968925|62677690|FG000|Phase I- Period 1|Subject enrolled in error|1|||
33301926|NCT04968925|62677691|FG001|Phase I- Period 1|Subject enrolled in error|1|||
33301927|NCT04968925|62677692|FG002|Phase I- Period 1|Subject enrolled in error|0|||
33301928|NCT04968925|62677693|FG003|Phase I- Period 1|Subject enrolled in error|0|||
33301929|NCT04968925|62677690|FG000|Phase II- Period 1|COVID-19 Related|0|||
33301930|NCT04968925|62677691|FG001|Phase II- Period 1|COVID-19 Related|0|||
33301931|NCT04968925|62677692|FG002|Phase II- Period 1|COVID-19 Related|6|||
33301932|NCT04968925|62677693|FG003|Phase II- Period 1|COVID-19 Related|6|||
33392274|NCT00563368|62771168|FG001|Overall Study|Withdrawal by Subject|6|||
33566310|NCT03347123|62962102|FG005|Overall Study|Death|0|||
33664104|NCT02677116|63095121|FG003|Overall Study|Withdrawal by parent or guardian|1|||
33301933|NCT04968925|62677690|FG000|Phase II- Period 1|Subject enrolled in error|0|||
33301934|NCT04968925|62677691|FG001|Phase II- Period 1|Subject enrolled in error|0|||
33301935|NCT04968925|62677692|FG002|Phase II- Period 1|Subject enrolled in error|1|||
33301936|NCT04968925|62677693|FG003|Phase II- Period 1|Subject enrolled in error|0|||
33301937|NCT04968925|62677690|FG000|Phase II -Period 2|COVID-19 related|0|||
33301938|NCT04968925|62677691|FG001|Phase II -Period 2|COVID-19 related|0|||
33566311|NCT03347123|62962103|FG006|Overall Study|Death|0|||
33301939|NCT04968925|62677692|FG002|Phase II -Period 2|COVID-19 related|4|||
33301940|NCT04968925|62677693|FG003|Phase II -Period 2|COVID-19 related|3|||
33301941|NCT04968925|62677690|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
33301942|NCT04968925|62677691|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
33301943|NCT04968925|62677692|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
33301944|NCT04968925|62677693|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
33301945|NCT01266993|62677705|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
33301946|NCT01266993|62677706|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
33301947|NCT01266993|62677705|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
33301948|NCT01266993|62677706|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
33301949|NCT01309386|62677714|FG000|Overall Study|Other|2|||
33301950|NCT01309386|62677715|FG001|Overall Study|Other|0|||
33301951|NCT01309386|62677714|FG000|Overall Study|Withdrawal by Subject|2|||
33301952|NCT01309386|62677715|FG001|Overall Study|Withdrawal by Subject|0|||
33301953|NCT01309386|62677714|FG000|Overall Study|Progressive disease|9|||
33301954|NCT01309386|62677715|FG001|Overall Study|Progressive disease|11|||
33301955|NCT01309386|62677714|FG000|Overall Study|Physician Decision|1|||
33301956|NCT01309386|62677715|FG001|Overall Study|Physician Decision|1|||
33301957|NCT01309386|62677714|FG000|Overall Study|Lack of Efficacy|3|||
33301958|NCT01309386|62677715|FG001|Overall Study|Lack of Efficacy|1|||
33301959|NCT01309386|62677714|FG000|Overall Study|Adverse Event|5|||
33301960|NCT01309386|62677715|FG001|Overall Study|Adverse Event|8|||
33301961|NCT01266603|62677721|FG000|Overall Study|Adverse Event|1|||
33301962|NCT01266603|62677721|FG000|Overall Study|Lack of Efficacy|14|||
33301963|NCT01266603|62677721|FG000|Overall Study|Withdrawal by Subject|1|||
33301964|NCT01266603|62677721|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
33301965|NCT01309308|62677727|FG000|Overall Study|Lost to Follow-up|6|||
33301966|NCT01309308|62677728|FG001|Overall Study|Lost to Follow-up|4|||
33301967|NCT01266291|62677734|FG000|Overall Study|Adverse Event|1|||
33301968|NCT01004263|62677738|FG000|Overall Study|Adverse Event|15|||
33301969|NCT01004263|62677738|FG000|Overall Study|Withdrawal by Subject|58|||
33566312|NCT03347123|62962097|FG000|Overall Study|Withdrawal by Subject|1|||
33566313|NCT03347123|62962098|FG001|Overall Study|Withdrawal by Subject|0|||
33566314|NCT03347123|62962099|FG002|Overall Study|Withdrawal by Subject|0|||
33566315|NCT03347123|62962100|FG003|Overall Study|Withdrawal by Subject|0|||
33566316|NCT03347123|62962101|FG004|Overall Study|Withdrawal by Subject|0|||
33566317|NCT03347123|62962102|FG005|Overall Study|Withdrawal by Subject|0|||
33566318|NCT03347123|62962103|FG006|Overall Study|Withdrawal by Subject|0|||
33566319|NCT03347123|62962097|FG000|Overall Study|Reason not Specified|3|||
33566320|NCT03347123|62962098|FG001|Overall Study|Reason not Specified|4|||
33566321|NCT03347123|62962099|FG002|Overall Study|Reason not Specified|0|||
33566322|NCT03347123|62962100|FG003|Overall Study|Reason not Specified|0|||
33566323|NCT03347123|62962101|FG004|Overall Study|Reason not Specified|0|||
33566324|NCT03347123|62962102|FG005|Overall Study|Reason not Specified|0|||
33566325|NCT03347123|62962103|FG006|Overall Study|Reason not Specified|0|||
33566326|NCT02198794|62962114|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
33566327|NCT02198794|62962115|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
33566328|NCT02198794|62962116|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
33566329|NCT02198794|62962117|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
33566330|NCT02198794|62962114|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
33566331|NCT02198794|62962115|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
33566332|NCT02198794|62962116|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
33566333|NCT02198794|62962117|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
33566334|NCT02198794|62962114|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
33566335|NCT02198794|62962115|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
33566336|NCT02198794|62962116|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
33566337|NCT02198794|62962117|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
33566338|NCT02198794|62962114|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
33566339|NCT02198794|62962115|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
33566340|NCT02198794|62962116|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
33301970|NCT01004263|62677738|FG000|Overall Study|Protocol Violation|10|||
33301971|NCT01004263|62677738|FG000|Overall Study|Lost to Follow-up|64|||
33566341|NCT02198794|62962117|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
33301972|NCT01004263|62677738|FG000|Overall Study|Lack of Efficacy|13|||
33566342|NCT02198794|62962114|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
33566343|NCT02198794|62962115|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
33566344|NCT02198794|62962116|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
33566345|NCT02198794|62962117|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
33301973|NCT01004263|62677738|FG000|Overall Study|Pregnancy|2|||
33301974|NCT01004263|62677738|FG000|Overall Study|Physician Decision|15|||
33301975|NCT01004263|62677738|FG000|Overall Study|Lack of Qualifying Event|2|||
33301976|NCT01308762|62677745|FG000|Overall Study|Protocol Violation|0|||
33301977|NCT01308762|62677746|FG001|Overall Study|Protocol Violation|1|||
33301978|NCT01308762|62677747|FG002|Overall Study|Protocol Violation|0|||
33301979|NCT01265823|62677758|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
33301980|NCT01265823|62677758|FG000|Overall Study|Failure to Return|4|||
33301981|NCT01265823|62677758|FG000|Overall Study|Protocol Violation|1|||
33301982|NCT01265823|62677758|FG000|Overall Study|Participant Request|1|||
33301983|NCT01004185|62677768|FG000|Overall Study|Adverse Event|1|||
33301984|NCT01004185|62677769|FG001|Overall Study|Adverse Event|1|||
33301985|NCT01004185|62677768|FG000|Overall Study|Lost to Follow-up|0|||
33301986|NCT01004185|62677769|FG001|Overall Study|Lost to Follow-up|1|||
33301987|NCT01004185|62677768|FG000|Overall Study|Lack of Efficacy|2|||
33301988|NCT01004185|62677769|FG001|Overall Study|Lack of Efficacy|1|||
33301989|NCT01004185|62677768|FG000|Overall Study|Sponsor Terminated Study|4|||
33301990|NCT01004185|62677769|FG001|Overall Study|Sponsor Terminated Study|5|||
33301991|NCT01004185|62677768|FG000|Overall Study|Withdrawal by Subject|2|||
33301992|NCT01004185|62677769|FG001|Overall Study|Withdrawal by Subject|1|||
33301993|NCT01265511|62677777|FG000|Overall Study|Lack of Efficacy|2|||
33301994|NCT01265511|62677778|FG001|Overall Study|Lack of Efficacy|1|||
33301995|NCT01265511|62677777|FG000|Overall Study|Met stopping rules|0|||
33301996|NCT01265511|62677778|FG001|Overall Study|Met stopping rules|2|||
33301997|NCT01264965|62677784|FG000|Overall Study|Withdrawal by Subject|10|||
33301998|NCT01264887|62677788|FG000|Overall Study|Adverse Event|5|||
33301999|NCT01264887|62677788|FG000|Overall Study|Death|7|||
33302000|NCT01264887|62677788|FG000|Overall Study|Lack of Efficacy|5|||
33302001|NCT01264887|62677788|FG000|Overall Study|Physician Decision|4|||
33302002|NCT01264887|62677788|FG000|Overall Study|Withdrawal by Subject|6|||
33302003|NCT01264887|62677788|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
33302004|NCT01264887|62677788|FG000|Overall Study|Other|2|||
33302005|NCT01306968|62677798|FG000|Overall Study|Lost to Follow-up|1|||
33302006|NCT01306968|62677799|FG001|Overall Study|Lost to Follow-up|1|||
33302007|NCT01306968|62677800|FG002|Overall Study|Lost to Follow-up|0|||
33302008|NCT01306968|62677801|FG003|Overall Study|Lost to Follow-up|0|||
33302009|NCT01306968|62677798|FG000|Overall Study|Physician Decision|0|||
33302010|NCT01306968|62677799|FG001|Overall Study|Physician Decision|1|||
33302011|NCT01306968|62677800|FG002|Overall Study|Physician Decision|0|||
33302012|NCT01306968|62677801|FG003|Overall Study|Physician Decision|0|||
33302013|NCT01306968|62677798|FG000|Overall Study|Relocated and left active duty|0|||
33302014|NCT01306968|62677799|FG001|Overall Study|Relocated and left active duty|1|||
33302015|NCT01306968|62677800|FG002|Overall Study|Relocated and left active duty|1|||
33302016|NCT01306968|62677801|FG003|Overall Study|Relocated and left active duty|1|||
33302017|NCT01306968|62677798|FG000|Overall Study|Withdrew - time commitment|0|||
33302018|NCT01306968|62677799|FG001|Overall Study|Withdrew - time commitment|0|||
33302019|NCT01306968|62677800|FG002|Overall Study|Withdrew - time commitment|0|||
33302020|NCT01306968|62677801|FG003|Overall Study|Withdrew - time commitment|2|||
33302021|NCT01306968|62677798|FG000|Overall Study|Withdrew over privacy concerns|0|||
33302022|NCT01306968|62677799|FG001|Overall Study|Withdrew over privacy concerns|0|||
33302023|NCT01306968|62677800|FG002|Overall Study|Withdrew over privacy concerns|0|||
33302024|NCT01306968|62677801|FG003|Overall Study|Withdrew over privacy concerns|1|||
33302025|NCT01264419|62677813|FG000|Overall Study|Lost to Follow-up|3|||
33302026|NCT01263873|62677819|FG000|Overall Study|One provider unable to complete numbers|1|||
33302027|NCT01263873|62677820|FG001|Overall Study|One provider unable to complete numbers|1|||
33302028|NCT01263639|62677828|FG000|Overall Study|Lost to Follow-up|66|||
33302029|NCT01263639|62677829|FG001|Overall Study|Lost to Follow-up|70|||
33302030|NCT01263639|62677828|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
33302031|NCT01263639|62677829|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
33302032|NCT01011283|62677837|FG000|Overall Study|Adverse Event|4|||
33302033|NCT01011283|62677838|FG001|Overall Study|Adverse Event|2|||
33302034|NCT01011283|62677837|FG000|Overall Study|Progressive Disease|0|||
33302035|NCT01011283|62677838|FG001|Overall Study|Progressive Disease|2|||
33302036|NCT01011283|62677837|FG000|Overall Study|Terminated by Sponsor|5|||
33302037|NCT01011283|62677838|FG001|Overall Study|Terminated by Sponsor|5|||
33302038|NCT01011283|62677837|FG000|Overall Study|Other|2|||
33566346|NCT02198794|62962114|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
33566347|NCT02198794|62962115|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
33302039|NCT01011283|62677838|FG001|Overall Study|Other|2|||
33302040|NCT01263561|62677846|FG000|Overall Study|Death|1|||
33392275|NCT00563368|62771169|FG002|Overall Study|Withdrawal by Subject|5|||
33566348|NCT02198794|62962116|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
33302041|NCT01263561|62677847|FG001|Overall Study|Death|2|||
33392276|NCT00563368|62771170|FG003|Overall Study|Withdrawal by Subject|7|||
33302042|NCT01009099|62677855|FG000|Overall Study|Lost to Follow-up|1|||
33302043|NCT01009099|62677856|FG001|Overall Study|Lost to Follow-up|0|||
33302044|NCT01009099|62677855|FG000|Overall Study|Physician Decision|3|||
33302045|NCT01009099|62677856|FG001|Overall Study|Physician Decision|2|||
33302046|NCT01009099|62677855|FG000|Overall Study|Withdrawal by Subject|1|||
33302047|NCT01009099|62677856|FG001|Overall Study|Withdrawal by Subject|1|||
33302048|NCT01009099|62677855|FG000|Overall Study|Death|0|||
33302049|NCT01009099|62677856|FG001|Overall Study|Death|1|||
33302050|NCT01263483|62677865|FG000|Overall Study|Adverse Event|4|||
33302051|NCT01263483|62677866|FG001|Overall Study|Adverse Event|0|||
33302052|NCT01263483|62677867|FG002|Overall Study|Adverse Event|3|||
33302053|NCT01263483|62677865|FG000|Overall Study|Withdrawal by Subject|1|||
33302054|NCT01263483|62677866|FG001|Overall Study|Withdrawal by Subject|0|||
33302055|NCT01263483|62677867|FG002|Overall Study|Withdrawal by Subject|0|||
33302056|NCT01263483|62677865|FG000|Overall Study|Lack of Efficacy|2|||
33302057|NCT01263483|62677866|FG001|Overall Study|Lack of Efficacy|0|||
33302058|NCT01263483|62677867|FG002|Overall Study|Lack of Efficacy|0|||
33302059|NCT01263483|62677865|FG000|Overall Study|Protocol Violation|0|||
33302060|NCT01263483|62677866|FG001|Overall Study|Protocol Violation|1|||
33302061|NCT01263483|62677867|FG002|Overall Study|Protocol Violation|1|||
33302062|NCT01263483|62677865|FG000|Overall Study|Participant Unavailability|0|||
33302063|NCT01263483|62677866|FG001|Overall Study|Participant Unavailability|1|||
33302064|NCT01263483|62677867|FG002|Overall Study|Participant Unavailability|1|||
33302065|NCT01306890|62677875|FG000|Overall Study|Adverse Event|2|||
33302066|NCT01306890|62677875|FG000|Overall Study|Death|1223|||
33302067|NCT01306890|62677875|FG000|Overall Study|Lost to Follow-up|58|||
33302068|NCT01306890|62677875|FG000|Overall Study|Withdrawal by Subject|88|||
33392277|NCT00563368|62771171|FG004|Overall Study|Withdrawal by Subject|8|||
33566349|NCT02198794|62962117|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
33566350|NCT02198794|62962114|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
33392278|NCT00563368|62771172|FG005|Overall Study|Withdrawal by Subject|5|||
33392279|NCT00563368|62771173|FG006|Overall Study|Withdrawal by Subject|4|||
33392280|NCT00563368|62771167|FG000|Overall Study|protocol non-compliance|1|||
33392281|NCT00563368|62771168|FG001|Overall Study|protocol non-compliance|1|||
33392282|NCT00563368|62771169|FG002|Overall Study|protocol non-compliance|2|||
33392283|NCT00563368|62771170|FG003|Overall Study|protocol non-compliance|1|||
33392284|NCT00563368|62771171|FG004|Overall Study|protocol non-compliance|0|||
33392285|NCT00563368|62771172|FG005|Overall Study|protocol non-compliance|1|||
33392286|NCT00563368|62771173|FG006|Overall Study|protocol non-compliance|3|||
33392287|NCT00563368|62771167|FG000|Overall Study|Pregnancy|1|||
33392288|NCT00563368|62771168|FG001|Overall Study|Pregnancy|0|||
33392289|NCT00563368|62771169|FG002|Overall Study|Pregnancy|1|||
33392290|NCT00563368|62771170|FG003|Overall Study|Pregnancy|2|||
33392291|NCT00563368|62771171|FG004|Overall Study|Pregnancy|1|||
33392292|NCT00563368|62771172|FG005|Overall Study|Pregnancy|2|||
33392293|NCT00563368|62771173|FG006|Overall Study|Pregnancy|0|||
33392294|NCT00563368|62771167|FG000|Overall Study|requirement for restricted medication|0|||
33392295|NCT00563368|62771168|FG001|Overall Study|requirement for restricted medication|0|||
33392296|NCT00563368|62771169|FG002|Overall Study|requirement for restricted medication|2|||
33392297|NCT00563368|62771170|FG003|Overall Study|requirement for restricted medication|0|||
33392298|NCT00563368|62771171|FG004|Overall Study|requirement for restricted medication|0|||
33392299|NCT00563368|62771172|FG005|Overall Study|requirement for restricted medication|0|||
33392300|NCT00563368|62771173|FG006|Overall Study|requirement for restricted medication|0|||
33392301|NCT00563368|62771167|FG000|Overall Study|Other|5|||
33392302|NCT00563368|62771168|FG001|Overall Study|Other|5|||
33392303|NCT00563368|62771169|FG002|Overall Study|Other|3|||
33392304|NCT00563368|62771170|FG003|Overall Study|Other|4|||
33392305|NCT00563368|62771171|FG004|Overall Study|Other|4|||
33392306|NCT00563368|62771172|FG005|Overall Study|Other|4|||
33392307|NCT00563368|62771173|FG006|Overall Study|Other|0|||
33392308|NCT00390013|62771192|FG000|Phase 1|tired|0|||
33392309|NCT00390013|62771193|FG001|Phase 1|tired|0|||
33566351|NCT02198794|62962115|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
33566352|NCT02198794|62962116|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
33566353|NCT02198794|62962117|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
33566354|NCT02198794|62962114|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
33566355|NCT02198794|62962115|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
33566356|NCT02198794|62962116|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
33566357|NCT02198794|62962117|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
33566358|NCT02198794|62962114|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
33566359|NCT02198794|62962115|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
33566360|NCT02198794|62962116|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
33566361|NCT02198794|62962117|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
33566362|NCT02198794|62962114|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
33302069|NCT01306890|62677875|FG000|Overall Study|Unspecified reasons|104|||
33302070|NCT01306890|62677875|FG000|Overall Study|Study Termination|3|||
33392310|NCT00390013|62771194|FG002|Phase 1|tired|0|||
33392311|NCT00390013|62771195|FG003|Phase 1|tired|1|||
33392312|NCT00390013|62771192|FG000|Phase 2 First Treatment|tired|1|||
33392313|NCT00390013|62771193|FG001|Phase 2 First Treatment|tired|0|||
33302071|NCT01306890|62677875|FG000|Overall Study|No discontinuation documentation|41|||
33302072|NCT01011049|62677883|FG000|Overall Study|Protocol Violation|0|||
33302073|NCT01011049|62677884|FG001|Overall Study|Protocol Violation|0|||
33392314|NCT00390013|62771194|FG002|Phase 2 First Treatment|tired|0|||
33392315|NCT00390013|62771195|FG003|Phase 2 First Treatment|tired|0|||
33566363|NCT02198794|62962115|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
33392316|NCT00390013|62771192|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
33392317|NCT00390013|62771193|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
33392318|NCT00390013|62771194|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
33392319|NCT00390013|62771195|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
33392320|NCT00561652|62771203|FG000|Overall Study|Withdrawal by Subject|0|||
33392321|NCT00561652|62771204|FG001|Overall Study|Withdrawal by Subject|1|||
33392322|NCT00697346|62771213|FG000|Overall Study|Adverse Event|4|||
33392323|NCT00697346|62771214|FG001|Overall Study|Adverse Event|5|||
33392324|NCT00697346|62771215|FG002|Overall Study|Adverse Event|0|||
33392325|NCT00697346|62771213|FG000|Overall Study|Progressive Disease|19|||
33392326|NCT00697346|62771214|FG001|Overall Study|Progressive Disease|18|||
33392327|NCT00697346|62771215|FG002|Overall Study|Progressive Disease|0|||
33392328|NCT00697346|62771213|FG000|Overall Study|Symptomatic Deterioration|0|||
33392329|NCT00697346|62771214|FG001|Overall Study|Symptomatic Deterioration|1|||
33392330|NCT00697346|62771215|FG002|Overall Study|Symptomatic Deterioration|0|||
33392331|NCT00697346|62771213|FG000|Overall Study|Withdrawal by Subject|2|||
33392332|NCT00697346|62771214|FG001|Overall Study|Withdrawal by Subject|2|||
33392333|NCT00697346|62771215|FG002|Overall Study|Withdrawal by Subject|0|||
33392334|NCT00697346|62771213|FG000|Overall Study|Reason not Specified|3|||
33392335|NCT00697346|62771214|FG001|Overall Study|Reason not Specified|0|||
33392336|NCT00697346|62771215|FG002|Overall Study|Reason not Specified|1|||
33392337|NCT00562120|62771242|FG000|First Intervention Period|Adverse Event|1|||
33392338|NCT00562120|62771243|FG001|First Intervention Period|Adverse Event|0|||
33392339|NCT00562120|62771244|FG002|First Intervention Period|Adverse Event|0|||
33392340|NCT00562120|62771245|FG003|First Intervention Period|Adverse Event|0|||
33566364|NCT02198794|62962116|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
33566365|NCT02198794|62962117|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
33566366|NCT02198794|62962114|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
33566367|NCT02198794|62962115|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
33566368|NCT02198794|62962116|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
33566369|NCT02198794|62962117|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
33566370|NCT02198794|62962114|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
33566371|NCT02198794|62962115|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
33566372|NCT02198794|62962116|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
33566373|NCT02198794|62962117|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
33566374|NCT02198794|62962114|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
33566375|NCT02198794|62962115|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
33566376|NCT02198794|62962116|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
33566377|NCT02198794|62962117|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
33566378|NCT02198794|62962114|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
33566379|NCT02198794|62962115|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
33566380|NCT02198794|62962116|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
33392341|NCT00562120|62771242|FG000|First Intervention Period|Randomized but not Treated|1|||
33392342|NCT00562120|62771243|FG001|First Intervention Period|Randomized but not Treated|0|||
33566381|NCT02198794|62962117|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
33566382|NCT02198794|62962114|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
33566383|NCT02198794|62962115|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
33566384|NCT02198794|62962116|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
33566385|NCT02198794|62962117|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
33566386|NCT02133664|62962128|FG000|Overall Study|Lost to Follow-up|2|||
33566387|NCT02133664|62962129|FG001|Overall Study|Lost to Follow-up|1|||
33566388|NCT02133664|62962128|FG000|Overall Study|Adverse Event|3|||
33566389|NCT02133664|62962129|FG001|Overall Study|Adverse Event|6|||
33566390|NCT02133508|62962135|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
33566391|NCT02133508|62962135|FG000|Overall Study|Death|12|||
33566392|NCT02133508|62962135|FG000|Overall Study|Lost to Follow-up|2|||
33566393|NCT02133352|62962139|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
33664105|NCT02677116|63095122|FG004|Overall Study|Withdrawal by parent or guardian|0|||
33392343|NCT00562120|62771244|FG002|First Intervention Period|Randomized but not Treated|0|||
33392344|NCT00562120|62771245|FG003|First Intervention Period|Randomized but not Treated|0|||
33392345|NCT00561730|62771255|FG000|Overall Study|Adverse Event|2|||
33566394|NCT02167594|62962146|FG000|Overall Study|Withdrawal by Subject|2|||
33566395|NCT02167594|62962147|FG001|Overall Study|Withdrawal by Subject|0|||
33566396|NCT02167594|62962148|FG002|Overall Study|Withdrawal by Subject|0|||
33566397|NCT02167594|62962146|FG000|Overall Study|Death|0|||
33566398|NCT02167594|62962147|FG001|Overall Study|Death|1|||
33566399|NCT02167594|62962148|FG002|Overall Study|Death|0|||
33566400|NCT02555657|62962159|FG000|Overall Study|Death|274|||
33566401|NCT02555657|62962160|FG001|Overall Study|Death|262|||
33566402|NCT02555657|62962159|FG000|Overall Study|Physician Decision|0|||
33566403|NCT02555657|62962160|FG001|Overall Study|Physician Decision|1|||
33566404|NCT02555657|62962159|FG000|Overall Study|Sponsor Decision|27|||
33566405|NCT02555657|62962160|FG001|Overall Study|Sponsor Decision|15|||
33392346|NCT00561730|62771255|FG000|Overall Study|Handling of the drug|1|||
33392347|NCT00561730|62771255|FG000|Overall Study|Lost to Follow-up|5|||
33392348|NCT00561730|62771255|FG000|Overall Study|Not specified reasons|1|||
33392349|NCT00697112|62771261|FG000|Overall Study|Adverse Event|8|||
33392350|NCT00697112|62771261|FG000|Overall Study|Lost to Follow-up|1|||
33392351|NCT00697112|62771261|FG000|Overall Study|Did not meet inclusion criteria|1|||
33392352|NCT00621855|62771270|FG000|Overall Study|Adverse Event|32|||
33392353|NCT00621855|62771271|FG001|Overall Study|Adverse Event|31|||
33392354|NCT00621855|62771272|FG002|Overall Study|Adverse Event|48|||
33392355|NCT00621855|62771273|FG003|Overall Study|Adverse Event|34|||
33392356|NCT00621855|62771274|FG004|Overall Study|Adverse Event|31|||
33392357|NCT00621855|62771270|FG000|Overall Study|Lost to Follow-up|0|||
33392358|NCT00621855|62771271|FG001|Overall Study|Lost to Follow-up|1|||
33392359|NCT00621855|62771272|FG002|Overall Study|Lost to Follow-up|3|||
33392360|NCT00621855|62771273|FG003|Overall Study|Lost to Follow-up|4|||
33392361|NCT00621855|62771274|FG004|Overall Study|Lost to Follow-up|1|||
33392362|NCT00621855|62771270|FG000|Overall Study|Protocol Violation|16|||
33392363|NCT00621855|62771271|FG001|Overall Study|Protocol Violation|8|||
33392364|NCT00621855|62771272|FG002|Overall Study|Protocol Violation|6|||
33392365|NCT00621855|62771273|FG003|Overall Study|Protocol Violation|7|||
33392366|NCT00621855|62771274|FG004|Overall Study|Protocol Violation|8|||
33392367|NCT00621855|62771270|FG000|Overall Study|Withdrawal by Subject|16|||
33392368|NCT00621855|62771271|FG001|Overall Study|Withdrawal by Subject|11|||
33392369|NCT00621855|62771272|FG002|Overall Study|Withdrawal by Subject|13|||
33392370|NCT00621855|62771273|FG003|Overall Study|Withdrawal by Subject|13|||
33392371|NCT00621855|62771274|FG004|Overall Study|Withdrawal by Subject|9|||
33392372|NCT00621855|62771270|FG000|Overall Study|Other|9|||
33392373|NCT00621855|62771271|FG001|Overall Study|Other|7|||
33392374|NCT00621855|62771272|FG002|Overall Study|Other|6|||
33392375|NCT00621855|62771273|FG003|Overall Study|Other|5|||
33392376|NCT00621855|62771274|FG004|Overall Study|Other|4|||
33392377|NCT00621855|62771270|FG000|Overall Study|Patients did not receive study drug|3|||
33392378|NCT00621855|62771271|FG001|Overall Study|Patients did not receive study drug|3|||
33392379|NCT00621855|62771272|FG002|Overall Study|Patients did not receive study drug|5|||
33392380|NCT00621855|62771273|FG003|Overall Study|Patients did not receive study drug|4|||
33392381|NCT00621855|62771274|FG004|Overall Study|Patients did not receive study drug|2|||
33392382|NCT00561574|62771288|FG000|Overall Study|Adverse Event|21|||
33392383|NCT00561574|62771289|FG001|Overall Study|Adverse Event|24|||
33392384|NCT00561574|62771288|FG000|Overall Study|Lack of Efficacy|11|||
33392385|NCT00561574|62771289|FG001|Overall Study|Lack of Efficacy|21|||
33392386|NCT00561574|62771288|FG000|Overall Study|Withdrawal by Subject|4|||
33392387|NCT00561574|62771289|FG001|Overall Study|Withdrawal by Subject|4|||
33392388|NCT00561574|62771288|FG000|Overall Study|Reason Unrelated to Trial|6|||
33392389|NCT00561574|62771289|FG001|Overall Study|Reason Unrelated to Trial|2|||
33392390|NCT00561574|62771288|FG000|Overall Study|Lost to Follow-up|1|||
33392391|NCT00561574|62771289|FG001|Overall Study|Lost to Follow-up|0|||
33392392|NCT00561574|62771288|FG000|Overall Study|Other|5|||
33392393|NCT00561574|62771289|FG001|Overall Study|Other|7|||
33392394|NCT00619827|62771297|FG000|Overall Study|Adverse Event|1|||
33392395|NCT00619827|62771298|FG001|Overall Study|Adverse Event|2|||
33392396|NCT00619827|62771297|FG000|Overall Study|Withdrawal by Subject|2|||
33392397|NCT00619827|62771298|FG001|Overall Study|Withdrawal by Subject|2|||
33664106|NCT02677116|63095123|FG005|Overall Study|Withdrawal by parent or guardian|0|||
33664107|NCT02677116|63095124|FG006|Overall Study|Withdrawal by parent or guardian|2|||
33302074|NCT01011049|62677885|FG002|Overall Study|Protocol Violation|2|||
33302075|NCT01011049|62677886|FG003|Overall Study|Protocol Violation|0|||
33302076|NCT01011049|62677883|FG000|Overall Study|Lost to Follow-up|1|||
33302077|NCT01011049|62677884|FG001|Overall Study|Lost to Follow-up|2|||
33302078|NCT01011049|62677885|FG002|Overall Study|Lost to Follow-up|1|||
33302079|NCT01011049|62677886|FG003|Overall Study|Lost to Follow-up|0|||
33302080|NCT01011049|62677883|FG000|Overall Study|Withdrawal by Subject|0|||
33302081|NCT01011049|62677884|FG001|Overall Study|Withdrawal by Subject|0|||
33302082|NCT01011049|62677885|FG002|Overall Study|Withdrawal by Subject|1|||
33302083|NCT01011049|62677886|FG003|Overall Study|Withdrawal by Subject|0|||
33302084|NCT01263093|62677898|FG000|Washout|Physician Decision|1|||
33392398|NCT00687804|62771307|FG000|Core Study|Adverse Event|5|||
33392399|NCT00687804|62771308|FG001|Core Study|Adverse Event|3|||
33392400|NCT00687804|62771309|FG002|Core Study|Adverse Event|3|||
33392401|NCT00687804|62771307|FG000|Core Study|Abnormal laboratory value(s)|1|||
33392402|NCT00687804|62771308|FG001|Core Study|Abnormal laboratory value(s)|0|||
33664108|NCT02677116|63095125|FG007|Overall Study|Withdrawal by parent or guardian|1|||
33302085|NCT01263093|62677899|FG001|Washout|Physician Decision|0|||
33302086|NCT01263093|62677898|FG000|Period 2|Adverse Event|1|||
33302087|NCT01263093|62677899|FG001|Period 2|Adverse Event|0|||
33392403|NCT00687804|62771309|FG002|Core Study|Abnormal laboratory value(s)|0|||
33392404|NCT00687804|62771307|FG000|Core Study|Lack of Efficacy|1|||
33392405|NCT00687804|62771308|FG001|Core Study|Lack of Efficacy|1|||
33392406|NCT00687804|62771309|FG002|Core Study|Lack of Efficacy|1|||
33392407|NCT00687804|62771307|FG000|Core Study|Withdrawal by Subject|4|||
33392408|NCT00687804|62771308|FG001|Core Study|Withdrawal by Subject|7|||
33392409|NCT00687804|62771309|FG002|Core Study|Withdrawal by Subject|7|||
33392410|NCT00687804|62771307|FG000|Core Study|Lost to Follow-up|0|||
33392411|NCT00687804|62771308|FG001|Core Study|Lost to Follow-up|1|||
33392412|NCT00687804|62771309|FG002|Core Study|Lost to Follow-up|0|||
33392413|NCT00687804|62771307|FG000|Core Study|Death|2|||
33392414|NCT00687804|62771308|FG001|Core Study|Death|2|||
33392415|NCT00687804|62771309|FG002|Core Study|Death|2|||
33392416|NCT00687804|62771307|FG000|Core Study|Protocol Violation|1|||
33392417|NCT00687804|62771308|FG001|Core Study|Protocol Violation|1|||
33392418|NCT00687804|62771309|FG002|Core Study|Protocol Violation|0|||
33392419|NCT00687804|62771307|FG000|Open-Label Extension Study|Adverse Event|2|||
33392420|NCT00687804|62771308|FG001|Open-Label Extension Study|Adverse Event|2|||
33392421|NCT00687804|62771309|FG002|Open-Label Extension Study|Adverse Event|2|||
33392422|NCT00687804|62771307|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
33392423|NCT00687804|62771308|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
33392424|NCT00687804|62771309|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
33392425|NCT00687804|62771307|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
33392426|NCT00687804|62771308|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
33392427|NCT00687804|62771309|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
33392428|NCT00687804|62771307|FG000|Open-Label Extension Study|Administrative problems|1|||
33392429|NCT00687804|62771308|FG001|Open-Label Extension Study|Administrative problems|1|||
33392430|NCT00687804|62771309|FG002|Open-Label Extension Study|Administrative problems|0|||
33392431|NCT00687804|62771307|FG000|Open-Label Extension Study|Death|2|||
33392432|NCT00687804|62771308|FG001|Open-Label Extension Study|Death|3|||
33392433|NCT00687804|62771309|FG002|Open-Label Extension Study|Death|3|||
33392434|NCT00689052|62771336|FG000|Overall Study|Adverse Event|4|||
33392435|NCT00689052|62771337|FG001|Overall Study|Adverse Event|6|||
33392436|NCT00689052|62771336|FG000|Overall Study|Protocol Violation|1|||
33392437|NCT00689052|62771337|FG001|Overall Study|Protocol Violation|0|||
33392438|NCT00689052|62771336|FG000|Overall Study|Lost to Follow-up|2|||
33392439|NCT00689052|62771337|FG001|Overall Study|Lost to Follow-up|0|||
33392440|NCT00689052|62771336|FG000|Overall Study|Withdrawal by Subject|2|||
33392441|NCT00689052|62771337|FG001|Overall Study|Withdrawal by Subject|0|||
33392442|NCT00689052|62771336|FG000|Overall Study|Early termination of the trial|22|||
33392443|NCT00689052|62771337|FG001|Overall Study|Early termination of the trial|24|||
33392444|NCT00560950|62771347|FG000|Overall Study|Lost to Follow-up|1|||
33392445|NCT00560950|62771348|FG001|Overall Study|Lost to Follow-up|0|||
33392446|NCT00576758|62771358|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
33302088|NCT01010971|62677909|FG000|Overall Study|Adverse Event|2|||
33302089|NCT01010971|62677910|FG001|Overall Study|Adverse Event|4|||
33302090|NCT01010971|62677911|FG002|Overall Study|Adverse Event|3|||
33302091|NCT01010971|62677909|FG000|Overall Study|Withdrawal by Subject|0|||
33302092|NCT01010971|62677910|FG001|Overall Study|Withdrawal by Subject|2|||
33302093|NCT01010971|62677911|FG002|Overall Study|Withdrawal by Subject|5|||
33302094|NCT01010971|62677909|FG000|Overall Study|Lost to Follow-up|0|||
33302095|NCT01010971|62677910|FG001|Overall Study|Lost to Follow-up|2|||
33302096|NCT01010971|62677911|FG002|Overall Study|Lost to Follow-up|3|||
33302097|NCT01010971|62677909|FG000|Overall Study|Other|1|||
33302098|NCT01010971|62677910|FG001|Overall Study|Other|0|||
33302099|NCT01010971|62677911|FG002|Overall Study|Other|2|||
33302100|NCT01306656|62677921|FG000|Overall Study|Lost to Follow-up|1|||
33392447|NCT00576758|62771359|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
33392448|NCT00576758|62771358|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
33392449|NCT00576758|62771359|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
33392450|NCT00576758|62771358|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
33392451|NCT00576758|62771359|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
33392452|NCT00576758|62771358|FG000|Induction Treatment Period|Death|1|||
33392453|NCT00576758|62771359|FG001|Induction Treatment Period|Death|0|||
33392454|NCT00576758|62771358|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
33392455|NCT00576758|62771359|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
33392456|NCT00576758|62771358|FG000|Induction Treatment Period|Withdrew consent|1|||
33392457|NCT00576758|62771359|FG001|Induction Treatment Period|Withdrew consent|0|||
33392458|NCT00576758|62771358|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
33392459|NCT00576758|62771359|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
33392460|NCT00576758|62771358|FG000|Extension Treatment Period|Death|1|||
33392461|NCT00576758|62771359|FG001|Extension Treatment Period|Death|1|||
33392462|NCT00576758|62771358|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
33392463|NCT00576758|62771359|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
33392464|NCT00576758|62771358|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
33302101|NCT01306656|62677922|FG001|Overall Study|Lost to Follow-up|0|||
33302102|NCT01008943|62677930|FG000|Overall Study|Withdrawal by Subject|1|||
33392465|NCT00576758|62771359|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
33302103|NCT01003639|62677936|FG000|Overall Study|Lost to Follow-up|6|||
33392466|NCT00576758|62771358|FG000|Extension Treatment Period|Administrative/Other|3|||
33392467|NCT00576758|62771359|FG001|Extension Treatment Period|Administrative/Other|1|||
33392468|NCT00576758|62771358|FG000|Follow-up Period|Administrative/Other|6|||
33392469|NCT00576758|62771359|FG001|Follow-up Period|Administrative/Other|8|||
33392470|NCT00576758|62771358|FG000|Follow-up Period|Death|3|||
33392471|NCT00576758|62771359|FG001|Follow-up Period|Death|3|||
33392472|NCT00576758|62771358|FG000|Follow-up Period|Insufficient therapeutic response|16|||
33392473|NCT00576758|62771359|FG001|Follow-up Period|Insufficient therapeutic response|5|||
33392474|NCT00576758|62771358|FG000|Follow-up Period|Withdrew consent|2|||
33392475|NCT00576758|62771359|FG001|Follow-up Period|Withdrew consent|1|||
33392476|NCT00560794|62771366|FG000|Overall Study|Adverse Event|2|||
33392477|NCT00560794|62771366|FG000|Overall Study|Patient was not Compliant|1|||
33392478|NCT00560794|62771366|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
33392479|NCT00560794|62771366|FG000|Overall Study|Hematological Relapse|1|||
33392480|NCT00560794|62771366|FG000|Overall Study|Received Bone Marrow Transplant|6|||
33392481|NCT00619359|62771374|FG000|Overall Study|Adverse Event|32|||
33392482|NCT00619359|62771375|FG001|Overall Study|Adverse Event|36|||
33392483|NCT00619359|62771374|FG000|Overall Study|Lost to Follow-up|12|||
33392484|NCT00619359|62771375|FG001|Overall Study|Lost to Follow-up|16|||
33392485|NCT00619359|62771374|FG000|Overall Study|Physician Decision|0|||
33392486|NCT00619359|62771375|FG001|Overall Study|Physician Decision|7|||
33392487|NCT00619359|62771374|FG000|Overall Study|Protocol Violation|1|||
33392488|NCT00619359|62771375|FG001|Overall Study|Protocol Violation|1|||
33392489|NCT00619359|62771374|FG000|Overall Study|Withdrawal by Subject|19|||
33392490|NCT00619359|62771375|FG001|Overall Study|Withdrawal by Subject|20|||
33392491|NCT00619359|62771374|FG000|Overall Study|Progressive Disease|3|||
33392492|NCT00619359|62771375|FG001|Overall Study|Progressive Disease|1|||
33392493|NCT00372229|62771383|FG000|Study Phase|Graft loss|0|||
33392494|NCT00372229|62771384|FG001|Study Phase|Graft loss|3|||
33392495|NCT00372229|62771383|FG000|Study Phase|Protocol Violation|3|||
33392496|NCT00372229|62771384|FG001|Study Phase|Protocol Violation|4|||
33392497|NCT00372229|62771383|FG000|Study Phase|Consent withdrawn|16|||
33392498|NCT00372229|62771384|FG001|Study Phase|Consent withdrawn|14|||
33392499|NCT00372229|62771383|FG000|Study Phase|Refused treatment/did not cooperate|3|||
33392500|NCT00372229|62771384|FG001|Study Phase|Refused treatment/did not cooperate|1|||
33392501|NCT00372229|62771383|FG000|Study Phase|Death|3|||
33392502|NCT00372229|62771384|FG001|Study Phase|Death|2|||
33392503|NCT00372229|62771383|FG000|Study Phase|Reason not specified|3|||
33392504|NCT00372229|62771384|FG001|Study Phase|Reason not specified|2|||
33392505|NCT00372229|62771383|FG000|Study Phase|Lost to Follow-up|3|||
33392506|NCT00372229|62771384|FG001|Study Phase|Lost to Follow-up|3|||
33392507|NCT00372229|62771383|FG000|Follow-Up Phase|Graft loss|8|||
33392508|NCT00372229|62771384|FG001|Follow-Up Phase|Graft loss|7|||
33392509|NCT00372229|62771383|FG000|Follow-Up Phase|Consent withdrawn|13|||
33392510|NCT00372229|62771384|FG001|Follow-Up Phase|Consent withdrawn|19|||
33392511|NCT00372229|62771383|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
33392512|NCT00372229|62771384|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
33392513|NCT00372229|62771383|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
33392514|NCT00372229|62771384|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
33392515|NCT00372229|62771383|FG000|Follow-Up Phase|Death|9|||
33392516|NCT00372229|62771384|FG001|Follow-Up Phase|Death|12|||
33392517|NCT00372229|62771383|FG000|Follow-Up Phase|Administrative|1|||
33392518|NCT00372229|62771384|FG001|Follow-Up Phase|Administrative|0|||
33392519|NCT00372229|62771383|FG000|Follow-Up Phase|Reason not specified|2|||
33392520|NCT00372229|62771384|FG001|Follow-Up Phase|Reason not specified|3|||
33392521|NCT00372229|62771383|FG000|Follow-Up Phase|Lost to Follow-up|12|||
33566406|NCT02555657|62962159|FG000|Overall Study|Withdrawal by Subject|11|||
33664109|NCT02677116|63095126|FG008|Overall Study|Withdrawal by parent or guardian|0|||
33392522|NCT00372229|62771384|FG001|Follow-Up Phase|Lost to Follow-up|10|||
33392523|NCT00698828|62771397|FG000|Overall Study|Adverse Event|3|||
33392524|NCT00698828|62771398|FG001|Overall Study|Adverse Event|4|||
33392525|NCT00698828|62771399|FG002|Overall Study|Adverse Event|4|||
33392526|NCT00698828|62771397|FG000|Overall Study|Death|0|||
33566407|NCT02555657|62962160|FG001|Overall Study|Withdrawal by Subject|32|||
33664110|NCT02677116|63095118|FG000|Overall Study|Withdrawal by Subject|1|||
33392527|NCT00698828|62771398|FG001|Overall Study|Death|0|||
33392528|NCT00698828|62771399|FG002|Overall Study|Death|1|||
33392529|NCT00698828|62771397|FG000|Overall Study|Exacerbation of COPD|1|||
33392530|NCT00698828|62771398|FG001|Overall Study|Exacerbation of COPD|3|||
33392531|NCT00698828|62771399|FG002|Overall Study|Exacerbation of COPD|0|||
33392532|NCT00698828|62771397|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
33392533|NCT00698828|62771398|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
33392534|NCT00698828|62771399|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
33566408|NCT02195518|62962192|FG000|Overall Study|Adverse Event|1|||
33392535|NCT00698828|62771397|FG000|Overall Study|Investigator/Sponsor decision|1|||
33392536|NCT00698828|62771398|FG001|Overall Study|Investigator/Sponsor decision|0|||
33392537|NCT00698828|62771399|FG002|Overall Study|Investigator/Sponsor decision|2|||
33392538|NCT00698828|62771397|FG000|Overall Study|Lost to Follow-up|1|||
33392539|NCT00698828|62771398|FG001|Overall Study|Lost to Follow-up|1|||
33392540|NCT00698828|62771399|FG002|Overall Study|Lost to Follow-up|0|||
33392541|NCT00698828|62771397|FG000|Overall Study|Withdrew consent|0|||
33392542|NCT00698828|62771398|FG001|Overall Study|Withdrew consent|7|||
33392543|NCT00698828|62771399|FG002|Overall Study|Withdrew consent|4|||
33566409|NCT02195518|62962192|FG000|Overall Study|Protocol Violation|4|||
33566410|NCT02195518|62962192|FG000|Overall Study|Pregnancy|2|||
33566411|NCT02195518|62962192|FG000|Overall Study|Withdrawal by Subject|1|||
33566412|NCT02195518|62962192|FG000|Overall Study|Lost to Follow-up|1|||
33392544|NCT00698828|62771397|FG000|Overall Study|Withdrew consent (not treated)|2|||
33392545|NCT00698828|62771398|FG001|Overall Study|Withdrew consent (not treated)|0|||
33392546|NCT00698828|62771399|FG002|Overall Study|Withdrew consent (not treated)|0|||
33392547|NCT00619515|62771407|FG000|Overall Study|Study Termination by IRB|73|||
33392548|NCT03167606|62771413|FG000|Overall Study|Lost to Follow-up|73|||
33392549|NCT03167606|62771414|FG001|Overall Study|Lost to Follow-up|64|||
33392550|NCT03167606|62771413|FG000|Overall Study|Withdrawal by Subject|6|||
33392551|NCT03167606|62771414|FG001|Overall Study|Withdrawal by Subject|5|||
33392552|NCT03167606|62771413|FG000|Overall Study|Withdrawal by Investigator|0|||
33392553|NCT03167606|62771414|FG001|Overall Study|Withdrawal by Investigator|2|||
33392554|NCT00688740|62771422|FG000|Overall Study|Adverse Event|45|||
33392555|NCT00688740|62771423|FG001|Overall Study|Adverse Event|8|||
33392556|NCT00688740|62771422|FG000|Overall Study|Death|2|||
33392557|NCT00688740|62771423|FG001|Overall Study|Death|2|||
33392558|NCT00688740|62771422|FG000|Overall Study|Lost to Follow-up|0|||
33392559|NCT00688740|62771423|FG001|Overall Study|Lost to Follow-up|1|||
33392560|NCT00688740|62771422|FG000|Overall Study|Consent Withdrawn|17|||
33392561|NCT00688740|62771423|FG001|Overall Study|Consent Withdrawn|17|||
33392562|NCT00688740|62771422|FG000|Overall Study|Breast Cancer Relapse|1|||
33392563|NCT00688740|62771423|FG001|Overall Study|Breast Cancer Relapse|4|||
33392564|NCT00688740|62771422|FG000|Overall Study|Violation of Inclusion Criteria|1|||
33392565|NCT00688740|62771423|FG001|Overall Study|Violation of Inclusion Criteria|3|||
33566413|NCT02133742|62962222|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
33566414|NCT02133742|62962222|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
33566415|NCT02133742|62962222|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
33566416|NCT02133742|62962222|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
33566417|NCT02133742|62962222|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
33566418|NCT03032705|62962230|FG000|Overall Study|Lost to Follow-up|16|||
33566419|NCT03032705|62962231|FG001|Overall Study|Lost to Follow-up|17|||
33566420|NCT03032705|62962230|FG000|Overall Study|did not quality|6|||
33566421|NCT03032705|62962231|FG001|Overall Study|did not quality|6|||
33566422|NCT04476251|62962237|FG000|Overall Study|Not treated|1|||
33566423|NCT03795233|62962243|FG000|Overall Study|Withdrawal by Subject|2|||
33566424|NCT03795233|62962244|FG001|Overall Study|Withdrawal by Subject|1|||
33566425|NCT03795233|62962243|FG000|Overall Study|Lost to Follow-up|1|||
33566426|NCT03795233|62962244|FG001|Overall Study|Lost to Follow-up|0|||
33566427|NCT03795233|62962243|FG000|Overall Study|Death|1|||
33566428|NCT03795233|62962244|FG001|Overall Study|Death|0|||
33566429|NCT03645863|62962253|FG000|Overall Study|Withdrawal by Subject|1|||
33566430|NCT03645863|62962254|FG001|Overall Study|Withdrawal by Subject|0|||
33566431|NCT03645863|62962255|FG002|Overall Study|Withdrawal by Subject|0|||
33566432|NCT03564119|62962265|FG000|Overall Study|Adverse Event|4|||
33566433|NCT03564119|62962266|FG001|Overall Study|Adverse Event|0|||
33566434|NCT03564119|62962265|FG000|Overall Study|Lost to Follow-up|1|||
33566435|NCT03564119|62962266|FG001|Overall Study|Lost to Follow-up|4|||
33566436|NCT03564119|62962265|FG000|Overall Study|Protocol Violation|1|||
33566437|NCT03564119|62962266|FG001|Overall Study|Protocol Violation|0|||
33566438|NCT03564119|62962265|FG000|Overall Study|Withdrawal by Subject|9|||
33566439|NCT03564119|62962266|FG001|Overall Study|Withdrawal by Subject|4|||
33566440|NCT03564119|62962265|FG000|Overall Study|Other Than Specified|0|||
33566441|NCT03564119|62962266|FG001|Overall Study|Other Than Specified|1|||
33392566|NCT00552760|62771431|FG000|Overall Study|Adverse Event|3|||
33392567|NCT00552760|62771432|FG001|Overall Study|Adverse Event|5|||
33392568|NCT00552760|62771431|FG000|Overall Study|Relapsed- Depressed Event|10|||
33392569|NCT00552760|62771432|FG001|Overall Study|Relapsed- Depressed Event|16|||
33392570|NCT00552760|62771431|FG000|Overall Study|Relapse- Manic Event|3|||
33392571|NCT00552760|62771432|FG001|Overall Study|Relapse- Manic Event|3|||
33392572|NCT00552760|62771431|FG000|Overall Study|Relapsed- Mixed Event|3|||
33392573|NCT00552760|62771432|FG001|Overall Study|Relapsed- Mixed Event|5|||
33566442|NCT04531241|62962272|FG000|Period 1|Withdrawal by Subject|2|||
33566443|NCT04531241|62962273|FG001|Period 1|Withdrawal by Subject|0|||
33566444|NCT04531241|62962272|FG000|Period 1|Dispesed incorrect lens power|1|||
33566445|NCT04531241|62962273|FG001|Period 1|Dispesed incorrect lens power|0|||
33566446|NCT04531241|62962272|FG000|Period 1|Protocol Violation|1|||
33566447|NCT04531241|62962273|FG001|Period 1|Protocol Violation|0|||
33566448|NCT04531241|62962272|FG000|Period 1|No longer eligible|0|||
33566449|NCT04531241|62962273|FG001|Period 1|No longer eligible|1|||
33566450|NCT04531241|62962272|FG000|Period 1|Lens Discomfort|0|||
33392574|NCT00552760|62771431|FG000|Overall Study|Protocol Violation|0|||
33392575|NCT00552760|62771432|FG001|Overall Study|Protocol Violation|1|||
33392576|NCT00552760|62771431|FG000|Overall Study|Lost to Follow-up|1|||
33392577|NCT00552760|62771432|FG001|Overall Study|Lost to Follow-up|1|||
33392578|NCT00552760|62771431|FG000|Overall Study|Non-compliance|1|||
33392579|NCT00552760|62771432|FG001|Overall Study|Non-compliance|1|||
33392580|NCT00552760|62771431|FG000|Overall Study|Medical Condition|1|||
33392581|NCT00552760|62771432|FG001|Overall Study|Medical Condition|1|||
33392582|NCT00552760|62771431|FG000|Overall Study|Withdrawal by Subject|3|||
33392583|NCT00552760|62771432|FG001|Overall Study|Withdrawal by Subject|0|||
33392584|NCT00552760|62771431|FG000|Overall Study|Medication Change|1|||
33392585|NCT00552760|62771432|FG001|Overall Study|Medication Change|0|||
33392586|NCT00686790|62771438|FG000|Overall Study|Adverse Event|2|||
33392587|NCT00686790|62771438|FG000|Overall Study|Withdrawal by Subject|1|||
33392588|NCT00686790|62771438|FG000|Overall Study|Death|1|||
33392589|NCT00686790|62771438|FG000|Overall Study|Lost to Follow-up|12|||
33392590|NCT00686712|62771445|FG000|Overall Study|Protocol Violation|8|||
33392591|NCT00686712|62771446|FG001|Overall Study|Protocol Violation|8|||
33392592|NCT00686712|62771447|FG002|Overall Study|Protocol Violation|10|||
33392593|NCT00686712|62771445|FG000|Overall Study|Lost to Follow-up|1|||
33392594|NCT00686712|62771446|FG001|Overall Study|Lost to Follow-up|2|||
33392595|NCT00686712|62771447|FG002|Overall Study|Lost to Follow-up|3|||
33392596|NCT00686712|62771445|FG000|Overall Study|Adverse Event|1|||
33392597|NCT00686712|62771446|FG001|Overall Study|Adverse Event|1|||
33392598|NCT00686712|62771447|FG002|Overall Study|Adverse Event|0|||
33392599|NCT00686634|62771458|FG000|Overall Study|Protocol Violation|6|||
33392600|NCT00560404|62771465|FG000|Overall Study|Adverse Event|2|||
33392601|NCT00560404|62771466|FG001|Overall Study|Adverse Event|3|||
33392602|NCT00560404|62771465|FG000|Overall Study|Death|3|||
33392603|NCT00560404|62771466|FG001|Overall Study|Death|3|||
33392604|NCT00560404|62771465|FG000|Overall Study|Protocol Violation|12|||
33392605|NCT00560404|62771466|FG001|Overall Study|Protocol Violation|7|||
33392606|NCT00560404|62771465|FG000|Overall Study|Administrative Reasons|1|||
33392607|NCT00560404|62771466|FG001|Overall Study|Administrative Reasons|1|||
33392608|NCT00560404|62771465|FG000|Overall Study|Withdrew Consent|4|||
33392609|NCT00560404|62771466|FG001|Overall Study|Withdrew Consent|0|||
33392610|NCT00560404|62771465|FG000|Overall Study|Failure to return|1|||
33392611|NCT00560404|62771466|FG001|Overall Study|Failure to return|2|||
33392612|NCT00560404|62771465|FG000|Overall Study|Other withdrawal reason|13|||
33392613|NCT00560404|62771466|FG001|Overall Study|Other withdrawal reason|5|||
33392614|NCT03967444|62771474|FG000|Overall Study|Lost to Follow-up|1|||
33392615|NCT03967444|62771475|FG001|Overall Study|Lost to Follow-up|2|||
33392616|NCT00619983|62771485|FG000|Test Drug Alone|Withdrawal by Subject|1|||
33392617|NCT00619983|62771486|FG001|Test Drug Alone|Withdrawal by Subject|0|||
33392618|NCT00619983|62771487|FG002|Test Drug Alone|Withdrawal by Subject|0|||
33392619|NCT00619983|62771488|FG003|Test Drug Alone|Withdrawal by Subject|1|||
33392620|NCT00619983|62771485|FG000|Test Drug Alone|Failure of daily diary device|1|||
33392621|NCT00619983|62771486|FG001|Test Drug Alone|Failure of daily diary device|1|||
33392622|NCT00619983|62771487|FG002|Test Drug Alone|Failure of daily diary device|2|||
33392623|NCT00619983|62771488|FG003|Test Drug Alone|Failure of daily diary device|2|||
33392624|NCT00576420|62771501|FG000|Overall Study|Death|0|||
33392625|NCT00576420|62771502|FG001|Overall Study|Death|0|||
33392626|NCT00576420|62771503|FG002|Overall Study|Death|1|||
33392627|NCT03961204|62771552|FG000|Overall Study|Withdrawal by Subject|2|||
33392628|NCT03961204|62771552|FG000|Overall Study|Lost to Follow-up|3|||
33392629|NCT03961204|62771552|FG000|Overall Study|Other|1|||
33392630|NCT03961204|62771552|FG000|Overall Study|Missing|1|||
33392631|NCT00364351|62771558|FG000|Overall Study|Adverse Event|90|||
33392632|NCT00364351|62771559|FG001|Overall Study|Adverse Event|44|||
33392633|NCT00364351|62771558|FG000|Overall Study|Condition under investigation worsened|469|||
33392634|NCT00364351|62771559|FG001|Overall Study|Condition under investigation worsened|497|||
33392635|NCT00364351|62771558|FG000|Overall Study|Prohibited concomitant medication|0|||
33392636|NCT00364351|62771559|FG001|Overall Study|Prohibited concomitant medication|2|||
33392637|NCT00364351|62771558|FG000|Overall Study|Lost to Follow-up|1|||
33392638|NCT00364351|62771559|FG001|Overall Study|Lost to Follow-up|1|||
33392639|NCT00364351|62771558|FG000|Overall Study|Withdrawal by Subject|30|||
33392640|NCT00364351|62771559|FG001|Overall Study|Withdrawal by Subject|29|||
33392641|NCT00364351|62771558|FG000|Overall Study|Incorrect enrollment|1|||
33392642|NCT00364351|62771559|FG001|Overall Study|Incorrect enrollment|1|||
33392643|NCT00364351|62771558|FG000|Overall Study|Sponsor decision|1|||
33392644|NCT00364351|62771559|FG001|Overall Study|Sponsor decision|0|||
33392645|NCT00364351|62771558|FG000|Overall Study|Poor treatment compliance|0|||
33392646|NCT00364351|62771559|FG001|Overall Study|Poor treatment compliance|3|||
33392647|NCT00364351|62771558|FG000|Overall Study|Investigator error|0|||
33392648|NCT00364351|62771559|FG001|Overall Study|Investigator error|2|||
33392649|NCT00364351|62771558|FG000|Overall Study|Patient could not travel to site|0|||
33392650|NCT00364351|62771559|FG001|Overall Study|Patient could not travel to site|1|||
33392651|NCT00364351|62771558|FG000|Overall Study|Randomised treatment not started|0|||
33392652|NCT00364351|62771559|FG001|Overall Study|Randomised treatment not started|3|||
33392653|NCT00388297|62771569|FG000|Overall Study|Lost to Follow-up|16|||
33392654|NCT00388297|62771570|FG001|Overall Study|Lost to Follow-up|12|||
33392655|NCT00388297|62771571|FG002|Overall Study|Lost to Follow-up|11|||
33392656|NCT00388297|62771572|FG003|Overall Study|Lost to Follow-up|8|||
33392657|NCT00686166|62771582|FG000|Overall Study|Adverse Event|7|||
33566451|NCT04531241|62962273|FG001|Period 1|Lens Discomfort|1|||
33566452|NCT04531241|62962272|FG000|Period 2|Covid-19 Related|1|||
33566453|NCT04531241|62962273|FG001|Period 2|Covid-19 Related|1|||
33566454|NCT03181529|62962281|FG000|Overall Study|Withdrawal by Subject|1|||
33566455|NCT03181529|62962282|FG001|Overall Study|Withdrawal by Subject|1|||
33566456|NCT03181529|62962281|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
33566457|NCT03181529|62962282|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
33566458|NCT03470441|62962296|FG000|Overall Study|Death|0|||
33566459|NCT03470441|62962297|FG001|Overall Study|Death|1|||
33566460|NCT03470441|62962298|FG002|Overall Study|Death|1|||
33566461|NCT03470441|62962299|FG003|Overall Study|Death|0|||
33566462|NCT03470441|62962296|FG000|Overall Study|Adverse Event|0|||
33566463|NCT03470441|62962297|FG001|Overall Study|Adverse Event|0|||
33566464|NCT03470441|62962298|FG002|Overall Study|Adverse Event|0|||
33566465|NCT03470441|62962299|FG003|Overall Study|Adverse Event|1|||
33566466|NCT03470441|62962296|FG000|Overall Study|Withdrawal by Subject|1|||
33566467|NCT03470441|62962297|FG001|Overall Study|Withdrawal by Subject|4|||
33566468|NCT03470441|62962298|FG002|Overall Study|Withdrawal by Subject|1|||
33566469|NCT03470441|62962299|FG003|Overall Study|Withdrawal by Subject|3|||
33566470|NCT03361865|62962311|FG000|Overall Study|Death|17|||
33566471|NCT03361865|62962312|FG001|Overall Study|Death|18|||
33566472|NCT03361865|62962311|FG000|Overall Study|Physician Decision|1|||
33566473|NCT03361865|62962312|FG001|Overall Study|Physician Decision|9|||
33566474|NCT03361865|62962311|FG000|Overall Study|Withdrawal by Subject|1|||
33566475|NCT03361865|62962312|FG001|Overall Study|Withdrawal by Subject|0|||
33566476|NCT02149121|62962326|FG000|Main Study Period|Lack of Efficacy|2|||
33566477|NCT02149121|62962327|FG001|Main Study Period|Lack of Efficacy|2|||
33566478|NCT02149121|62962328|FG002|Main Study Period|Lack of Efficacy|1|||
33566479|NCT02149121|62962329|FG003|Main Study Period|Lack of Efficacy|0|||
33566480|NCT02149121|62962330|FG004|Main Study Period|Lack of Efficacy|0|||
33566481|NCT02149121|62962331|FG005|Main Study Period|Lack of Efficacy|0|||
33566482|NCT02149121|62962332|FG006|Main Study Period|Lack of Efficacy|0|||
33566483|NCT02149121|62962326|FG000|Main Study Period|Withdrawal by Subject|9|||
33566484|NCT02149121|62962327|FG001|Main Study Period|Withdrawal by Subject|5|||
33566485|NCT02149121|62962328|FG002|Main Study Period|Withdrawal by Subject|1|||
33566486|NCT02149121|62962329|FG003|Main Study Period|Withdrawal by Subject|0|||
33566487|NCT02149121|62962330|FG004|Main Study Period|Withdrawal by Subject|0|||
33566488|NCT02149121|62962331|FG005|Main Study Period|Withdrawal by Subject|0|||
33566489|NCT02149121|62962332|FG006|Main Study Period|Withdrawal by Subject|0|||
33566490|NCT02149121|62962326|FG000|Main Study Period|Adverse Event|2|||
33566491|NCT02149121|62962327|FG001|Main Study Period|Adverse Event|5|||
33566492|NCT02149121|62962328|FG002|Main Study Period|Adverse Event|1|||
33566493|NCT02149121|62962329|FG003|Main Study Period|Adverse Event|0|||
33566494|NCT02149121|62962330|FG004|Main Study Period|Adverse Event|0|||
33566495|NCT02149121|62962331|FG005|Main Study Period|Adverse Event|0|||
33566496|NCT02149121|62962332|FG006|Main Study Period|Adverse Event|0|||
33566497|NCT02149121|62962326|FG000|Main Study Period|Protocol Violation|2|||
33566498|NCT02149121|62962327|FG001|Main Study Period|Protocol Violation|0|||
33566499|NCT02149121|62962328|FG002|Main Study Period|Protocol Violation|0|||
33566500|NCT02149121|62962329|FG003|Main Study Period|Protocol Violation|0|||
33566501|NCT02149121|62962330|FG004|Main Study Period|Protocol Violation|0|||
33566502|NCT02149121|62962331|FG005|Main Study Period|Protocol Violation|0|||
33566503|NCT02149121|62962332|FG006|Main Study Period|Protocol Violation|0|||
33566504|NCT02149121|62962326|FG000|Main Study Period|Lost to Follow-up|2|||
33566505|NCT02149121|62962327|FG001|Main Study Period|Lost to Follow-up|1|||
33566506|NCT02149121|62962328|FG002|Main Study Period|Lost to Follow-up|0|||
33566507|NCT02149121|62962329|FG003|Main Study Period|Lost to Follow-up|0|||
33566508|NCT02149121|62962330|FG004|Main Study Period|Lost to Follow-up|0|||
33392658|NCT00686166|62771582|FG000|Overall Study|Withdrawal by Subject|1|||
33566509|NCT02149121|62962331|FG005|Main Study Period|Lost to Follow-up|0|||
33566510|NCT02149121|62962332|FG006|Main Study Period|Lost to Follow-up|0|||
33566511|NCT02149121|62962326|FG000|Main Study Period|Death|1|||
33566512|NCT02149121|62962327|FG001|Main Study Period|Death|0|||
33566513|NCT02149121|62962328|FG002|Main Study Period|Death|0|||
33566514|NCT02149121|62962329|FG003|Main Study Period|Death|0|||
33566515|NCT02149121|62962330|FG004|Main Study Period|Death|0|||
33392659|NCT00686166|62771582|FG000|Overall Study|Progression/Relapse|1|||
33566516|NCT02149121|62962331|FG005|Main Study Period|Death|0|||
33566517|NCT02149121|62962332|FG006|Main Study Period|Death|0|||
33566518|NCT02149121|62962326|FG000|Main Study Period|Physician Decision|1|||
33566519|NCT02149121|62962327|FG001|Main Study Period|Physician Decision|0|||
33392660|NCT00686166|62771582|FG000|Overall Study|Death|1|||
33392661|NCT00686166|62771582|FG000|Overall Study|Not Protocol Specified|1|||
33392662|NCT00686166|62771582|FG000|Overall Study|Ineligible|5|||
33392663|NCT00686166|62771582|FG000|Overall Study|Did not begin protocol therapy|4|||
33392664|NCT00363649|62771593|FG000|Overall Study|Withdrawal by Subject|1|||
33392665|NCT00363649|62771594|FG001|Overall Study|Withdrawal by Subject|1|||
33392666|NCT00363649|62771593|FG000|Overall Study|Adverse Event|6|||
33392667|NCT00363649|62771594|FG001|Overall Study|Adverse Event|0|||
33392668|NCT00684060|62771602|FG000|Overall Study|Lost to Follow-up|1|||
33392669|NCT00684060|62771603|FG001|Overall Study|Lost to Follow-up|0|||
33392670|NCT00684060|62771602|FG000|Overall Study|New stenosis identified|1|||
33392671|NCT00684060|62771603|FG001|Overall Study|New stenosis identified|0|||
33392672|NCT00684060|62771602|FG000|Overall Study|Unable to collect MRI|1|||
33392673|NCT00684060|62771603|FG001|Overall Study|Unable to collect MRI|2|||
33392674|NCT00684060|62771602|FG000|Overall Study|Death|0|||
33392675|NCT00684060|62771603|FG001|Overall Study|Death|1|||
33392676|NCT03131648|62771611|FG000|Initial Treatment Period|Not dosed|2|||
33392677|NCT03131648|62771612|FG001|Initial Treatment Period|Not dosed|2|||
33392678|NCT03131648|62771613|FG002|Initial Treatment Period|Not dosed|0|||
33392679|NCT03131648|62771614|FG003|Initial Treatment Period|Not dosed|0|||
33392680|NCT03131648|62771615|FG004|Initial Treatment Period|Not dosed|0|||
33392681|NCT03131648|62771616|FG005|Initial Treatment Period|Not dosed|0|||
33392682|NCT03131648|62771617|FG006|Initial Treatment Period|Not dosed|0|||
33392683|NCT03131648|62771618|FG007|Initial Treatment Period|Not dosed|0|||
33392684|NCT03131648|62771611|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
33392685|NCT03131648|62771612|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
33392686|NCT03131648|62771613|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33392687|NCT03131648|62771614|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33392688|NCT03131648|62771615|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33392689|NCT03131648|62771616|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33392690|NCT03131648|62771617|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33392691|NCT03131648|62771618|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33302104|NCT01003639|62677937|FG001|Overall Study|Lost to Follow-up|9|||
33302105|NCT01003639|62677936|FG000|Overall Study|Withdrawal by Subject|9|||
33302106|NCT01003639|62677937|FG001|Overall Study|Withdrawal by Subject|5|||
33302107|NCT01003639|62677936|FG000|Overall Study|Lack of Efficacy|1|||
33302108|NCT01003639|62677937|FG001|Overall Study|Lack of Efficacy|6|||
33302109|NCT01003639|62677936|FG000|Overall Study|Adverse Event|0|||
33302110|NCT01003639|62677937|FG001|Overall Study|Adverse Event|1|||
33302111|NCT01003639|62677936|FG000|Overall Study|Protocol Violation|0|||
33302112|NCT01003639|62677937|FG001|Overall Study|Protocol Violation|1|||
33302113|NCT01003639|62677936|FG000|Overall Study|Physician Decision|1|||
33302114|NCT01003639|62677937|FG001|Overall Study|Physician Decision|0|||
33302115|NCT01003249|62677943|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
33302116|NCT01003249|62677944|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
33302117|NCT01003249|62677943|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
33302118|NCT01003249|62677944|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
33302119|NCT01003249|62677943|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
33302120|NCT01003249|62677944|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
33302121|NCT01003249|62677943|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
33302122|NCT01003249|62677944|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
33302123|NCT01001767|62677956|FG000|Overall Study|no baseline study performed|1|||
33302124|NCT01001767|62677957|FG001|Overall Study|no baseline study performed|0|||
33302125|NCT01001767|62677956|FG000|Overall Study|Protocol Violation|1|||
33302126|NCT01001767|62677957|FG001|Overall Study|Protocol Violation|0|||
33302127|NCT01001767|62677956|FG000|Overall Study|Lost to Follow-up|1|||
33302128|NCT01001767|62677957|FG001|Overall Study|Lost to Follow-up|0|||
33302129|NCT01001767|62677956|FG000|Overall Study|Physician Decision|1|||
33302130|NCT01001767|62677957|FG001|Overall Study|Physician Decision|0|||
33302131|NCT01306032|62677969|FG000|First Intervention|Adverse Event|1|||
33302132|NCT01306032|62677970|FG001|First Intervention|Adverse Event|0|||
33302133|NCT01306032|62677971|FG002|First Intervention|Adverse Event|1|||
33302134|NCT01306032|62677972|FG003|First Intervention|Adverse Event|0|||
33302135|NCT01306032|62677973|FG004|First Intervention|Adverse Event|0|||
33302136|NCT01306032|62677974|FG005|First Intervention|Adverse Event|1|||
33302137|NCT01306032|62677969|FG000|First Intervention|Withdrawal by Subject|0|||
33302138|NCT01306032|62677970|FG001|First Intervention|Withdrawal by Subject|2|||
33302139|NCT01306032|62677971|FG002|First Intervention|Withdrawal by Subject|0|||
33302140|NCT01306032|62677972|FG003|First Intervention|Withdrawal by Subject|1|||
33302141|NCT01306032|62677973|FG004|First Intervention|Withdrawal by Subject|0|||
33302142|NCT01306032|62677974|FG005|First Intervention|Withdrawal by Subject|0|||
33302143|NCT01306032|62677969|FG000|First Intervention|Death|0|||
33392692|NCT03131648|62771611|FG000|Open-label Treatment|Discontinued IMP|0|||
33392693|NCT03131648|62771612|FG001|Open-label Treatment|Discontinued IMP|0|||
33392694|NCT03131648|62771613|FG002|Open-label Treatment|Discontinued IMP|0|||
33392695|NCT03131648|62771614|FG003|Open-label Treatment|Discontinued IMP|0|||
33392696|NCT03131648|62771615|FG004|Open-label Treatment|Discontinued IMP|0|||
33392697|NCT03131648|62771616|FG005|Open-label Treatment|Discontinued IMP|0|||
33392698|NCT03131648|62771617|FG006|Open-label Treatment|Discontinued IMP|112|||
33392699|NCT03131648|62771618|FG007|Open-label Treatment|Discontinued IMP|0|||
33392700|NCT03131648|62771611|FG000|Open-label Treatment|Completed Week 50|0|||
33392701|NCT03131648|62771612|FG001|Open-label Treatment|Completed Week 50|0|||
33392702|NCT03131648|62771613|FG002|Open-label Treatment|Completed Week 50|0|||
33392703|NCT03131648|62771614|FG003|Open-label Treatment|Completed Week 50|0|||
33392704|NCT03131648|62771615|FG004|Open-label Treatment|Completed Week 50|0|||
33392705|NCT03131648|62771616|FG005|Open-label Treatment|Completed Week 50|0|||
33392706|NCT03131648|62771617|FG006|Open-label Treatment|Completed Week 50|6|||
33392707|NCT03131648|62771618|FG007|Open-label Treatment|Completed Week 50|0|||
33392708|NCT03131648|62771611|FG000|Maintenance Treatment Period|Not dosed|0|||
33392709|NCT03131648|62771612|FG001|Maintenance Treatment Period|Not dosed|0|||
33392710|NCT03131648|62771613|FG002|Maintenance Treatment Period|Not dosed|3|||
33392711|NCT03131648|62771614|FG003|Maintenance Treatment Period|Not dosed|2|||
33392712|NCT03131648|62771615|FG004|Maintenance Treatment Period|Not dosed|1|||
33392713|NCT03131648|62771616|FG005|Maintenance Treatment Period|Not dosed|0|||
33392714|NCT03131648|62771617|FG006|Maintenance Treatment Period|Not dosed|0|||
33392715|NCT03131648|62771618|FG007|Maintenance Treatment Period|Not dosed|0|||
33392716|NCT03131648|62771611|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
33392717|NCT03131648|62771612|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
33392718|NCT03131648|62771613|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
33392719|NCT03131648|62771614|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
33392720|NCT03131648|62771615|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
33392721|NCT03131648|62771616|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
33392722|NCT03131648|62771617|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
33392723|NCT03131648|62771618|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
33392724|NCT03131648|62771611|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
33392725|NCT03131648|62771612|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
33392726|NCT03131648|62771613|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
33392727|NCT03131648|62771614|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
33392728|NCT03131648|62771615|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
33392729|NCT03131648|62771616|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
33392730|NCT03131648|62771617|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
33392731|NCT03131648|62771618|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
33392732|NCT03131648|62771611|FG000|Maintenance Treatment Period|Completed Week 50|0|||
33392733|NCT03131648|62771612|FG001|Maintenance Treatment Period|Completed Week 50|0|||
33392734|NCT03131648|62771613|FG002|Maintenance Treatment Period|Completed Week 50|0|||
33392735|NCT03131648|62771614|FG003|Maintenance Treatment Period|Completed Week 50|0|||
33392736|NCT03131648|62771615|FG004|Maintenance Treatment Period|Completed Week 50|1|||
33392737|NCT03131648|62771616|FG005|Maintenance Treatment Period|Completed Week 50|0|||
33302144|NCT01306032|62677970|FG001|First Intervention|Death|0|||
33302145|NCT01306032|62677971|FG002|First Intervention|Death|1|||
33302146|NCT01306032|62677972|FG003|First Intervention|Death|0|||
33302147|NCT01306032|62677973|FG004|First Intervention|Death|0|||
33302148|NCT01306032|62677974|FG005|First Intervention|Death|0|||
33302149|NCT01306032|62677969|FG000|First Intervention|Ineligible|0|||
33302150|NCT01306032|62677970|FG001|First Intervention|Ineligible|0|||
33302151|NCT01306032|62677971|FG002|First Intervention|Ineligible|0|||
33302152|NCT01306032|62677972|FG003|First Intervention|Ineligible|0|||
33302153|NCT01306032|62677973|FG004|First Intervention|Ineligible|0|||
33302154|NCT01306032|62677974|FG005|First Intervention|Ineligible|1|||
33302155|NCT01306032|62677969|FG000|First Intervention|Progressive disease|0|||
33302156|NCT01306032|62677970|FG001|First Intervention|Progressive disease|0|||
33302157|NCT01306032|62677971|FG002|First Intervention|Progressive disease|0|||
33302158|NCT01306032|62677972|FG003|First Intervention|Progressive disease|0|||
33302159|NCT01306032|62677973|FG004|First Intervention|Progressive disease|2|||
33302160|NCT01306032|62677974|FG005|First Intervention|Progressive disease|0|||
33302161|NCT01306032|62677969|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
33302162|NCT01306032|62677970|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
33302163|NCT01306032|62677971|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
33302164|NCT01306032|62677972|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
33302165|NCT01306032|62677973|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
33392738|NCT03131648|62771617|FG006|Maintenance Treatment Period|Completed Week 50|0|||
33392739|NCT03131648|62771618|FG007|Maintenance Treatment Period|Completed Week 50|0|||
33392740|NCT03131648|62771611|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
33302166|NCT01306032|62677974|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
33302167|NCT01306032|62677969|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
33302168|NCT01306032|62677970|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
33302169|NCT01306032|62677971|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
33664111|NCT02677116|63095119|FG001|Overall Study|Withdrawal by Subject|0|||
33302170|NCT01306032|62677972|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
33302171|NCT01306032|62677973|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
33302172|NCT01306032|62677974|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
33302173|NCT01263015|62678002|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
33302174|NCT01263015|62678003|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
33302175|NCT01263015|62678002|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
33302176|NCT01263015|62678003|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
33302177|NCT01263015|62678002|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
33302178|NCT01263015|62678003|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
33302179|NCT01263015|62678002|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
33302180|NCT01263015|62678003|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
33302181|NCT01263015|62678002|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
33302182|NCT01263015|62678003|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
33302183|NCT01263015|62678002|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
33302184|NCT01263015|62678003|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
33302185|NCT01263015|62678002|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
33302186|NCT01263015|62678003|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
33302187|NCT01263015|62678002|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
33302188|NCT01263015|62678003|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
33302189|NCT01263015|62678002|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
33302190|NCT01263015|62678003|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
33302191|NCT01263015|62678002|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
33302192|NCT01263015|62678003|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
33302193|NCT01263015|62678002|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
33302194|NCT01263015|62678003|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
33302195|NCT01263015|62678002|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
33302196|NCT01263015|62678003|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
33302197|NCT01305564|62678009|FG000|Overall Study|Death|21|||
33302198|NCT01305564|62678009|FG000|Overall Study|Lost to Follow-up|12|||
33302199|NCT01305564|62678009|FG000|Overall Study|Withdrawal by Subject|1|||
33302200|NCT01305564|62678009|FG000|Overall Study|Physician Decision|3|||
33302201|NCT01305408|62678026|FG000|Overall Study|Adverse Event|10|||
33302202|NCT01305408|62678027|FG001|Overall Study|Adverse Event|7|||
33302203|NCT01305408|62678026|FG000|Overall Study|Lack of Efficacy|3|||
33302204|NCT01305408|62678027|FG001|Overall Study|Lack of Efficacy|4|||
33302205|NCT01305408|62678026|FG000|Overall Study|Withdrawal by Subject|9|||
33302206|NCT01305408|62678027|FG001|Overall Study|Withdrawal by Subject|9|||
33302207|NCT01305408|62678026|FG000|Overall Study|Protocol Violation|4|||
33302208|NCT01305408|62678027|FG001|Overall Study|Protocol Violation|6|||
33302209|NCT01305408|62678026|FG000|Overall Study|Lost to Follow-up|5|||
33302210|NCT01305408|62678027|FG001|Overall Study|Lost to Follow-up|3|||
33302211|NCT01305408|62678026|FG000|Overall Study|Noncompliance with study medication|0|||
33302212|NCT01305408|62678027|FG001|Overall Study|Noncompliance with study medication|1|||
33302213|NCT01305408|62678026|FG000|Overall Study|Noncompliance with study procedures|0|||
33302214|NCT01305408|62678027|FG001|Overall Study|Noncompliance with study procedures|1|||
33302215|NCT01305408|62678026|FG000|Overall Study|Other|1|||
33302216|NCT01305408|62678027|FG001|Overall Study|Other|0|||
33302217|NCT01304940|62678035|FG000|Overall Study|not meet symptom severity requirement|3|||
33302218|NCT01304940|62678036|FG001|Overall Study|not meet symptom severity requirement|0|||
33302219|NCT01261611|62678045|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
33302220|NCT01261611|62678046|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
33302221|NCT01261611|62678047|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
33302222|NCT01261611|62678045|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
33302223|NCT01261611|62678046|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
33302224|NCT01261611|62678047|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
33302225|NCT01261611|62678045|FG000|Treatment Cycle 1|Adverse Event|0|||
33302226|NCT01261611|62678046|FG001|Treatment Cycle 1|Adverse Event|1|||
33302227|NCT01261611|62678047|FG002|Treatment Cycle 1|Adverse Event|0|||
33302228|NCT01261611|62678045|FG000|Treatment Cycle 1|Protocol Violation|0|||
33302229|NCT01261611|62678046|FG001|Treatment Cycle 1|Protocol Violation|0|||
33302230|NCT01261611|62678047|FG002|Treatment Cycle 1|Protocol Violation|2|||
33302231|NCT01261611|62678045|FG000|Treatment Cycle 2|Completed study|4|||
33302232|NCT01261611|62678046|FG001|Treatment Cycle 2|Completed study|0|||
33302233|NCT01261611|62678047|FG002|Treatment Cycle 2|Completed study|0|||
33302234|NCT01261611|62678045|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
33302235|NCT01261611|62678046|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
33302236|NCT01261611|62678047|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
33302237|NCT01261611|62678045|FG000|Treatment Cycle 2|Adverse Event|1|||
33302238|NCT01261611|62678046|FG001|Treatment Cycle 2|Adverse Event|0|||
33302239|NCT01261611|62678047|FG002|Treatment Cycle 2|Adverse Event|0|||
33566520|NCT02149121|62962328|FG002|Main Study Period|Physician Decision|0|||
33392741|NCT03131648|62771612|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
33392742|NCT03131648|62771613|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
33392743|NCT03131648|62771614|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
33392744|NCT03131648|62771615|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
33392745|NCT03131648|62771616|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
33392746|NCT03131648|62771617|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
33392747|NCT03131648|62771618|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
33392748|NCT00618813|62771635|FG000|Overall Study|Lack of Efficacy|1|||
33392749|NCT00618813|62771635|FG000|Overall Study|Physician Decision|2|||
33392750|NCT00618813|62771635|FG000|Overall Study|Withdrawal by Subject|1|||
33392751|NCT00554788|62771642|FG000|Overall Study|Adverse Event|0|||
33392752|NCT00554788|62771643|FG001|Overall Study|Adverse Event|1|||
33392753|NCT00554788|62771644|FG002|Overall Study|Adverse Event|2|||
33392754|NCT00554788|62771642|FG000|Overall Study|Lost to Follow-up|4|||
33392755|NCT00554788|62771643|FG001|Overall Study|Lost to Follow-up|3|||
33392756|NCT00554788|62771644|FG002|Overall Study|Lost to Follow-up|3|||
33392757|NCT00554788|62771642|FG000|Overall Study|Physician Decision|1|||
33392758|NCT00554788|62771643|FG001|Overall Study|Physician Decision|1|||
33392759|NCT00554788|62771644|FG002|Overall Study|Physician Decision|3|||
33392760|NCT00554788|62771642|FG000|Overall Study|Withdrawal by Subject|0|||
33392761|NCT00554788|62771643|FG001|Overall Study|Withdrawal by Subject|0|||
33392762|NCT00554788|62771644|FG002|Overall Study|Withdrawal by Subject|1|||
33392763|NCT00554788|62771642|FG000|Overall Study|Refusal of further protocol therapy|0|||
33392764|NCT00554788|62771643|FG001|Overall Study|Refusal of further protocol therapy|1|||
33392765|NCT00554788|62771644|FG002|Overall Study|Refusal of further protocol therapy|1|||
33392766|NCT00554788|62771642|FG000|Overall Study|Progressive disease|0|||
33392767|NCT00554788|62771643|FG001|Overall Study|Progressive disease|0|||
33392768|NCT00554788|62771644|FG002|Overall Study|Progressive disease|3|||
33392769|NCT00554788|62771642|FG000|Overall Study|Ineligible|2|||
33392770|NCT00554788|62771643|FG001|Overall Study|Ineligible|0|||
33392771|NCT00554788|62771644|FG002|Overall Study|Ineligible|1|||
33392772|NCT00685698|62771653|FG000|Overall Study|Withdrawal by Subject|1|||
33392773|NCT00685698|62771653|FG000|Overall Study|Protocol Violation|6|||
33392774|NCT00685698|62771653|FG000|Overall Study|Adverse Event|3|||
33392775|NCT00685698|62771653|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
33392776|NCT00685698|62771653|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
33392777|NCT00685698|62771653|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
33392778|NCT00549328|62771669|FG000|Overall Study|Adverse Event|2|||
33392779|NCT00549328|62771669|FG000|Overall Study|Disease Progression|10|||
33392780|NCT00549328|62771669|FG000|Overall Study|Death|1|||
33392781|NCT00549328|62771669|FG000|Overall Study|Use of Prohibited Medication|1|||
33392782|NCT00696410|62771675|FG000|Overall Study|Lost to Follow-up|2|||
33392783|NCT00696410|62771676|FG001|Overall Study|Lost to Follow-up|0|||
33392784|NCT00696410|62771675|FG000|Overall Study|Withdrawal by Subject|8|||
33392785|NCT00696410|62771676|FG001|Overall Study|Withdrawal by Subject|0|||
33392786|NCT00696410|62771675|FG000|Overall Study|Physician Decision|3|||
33392787|NCT00696410|62771676|FG001|Overall Study|Physician Decision|0|||
33392788|NCT00683904|62771689|FG000|Dose Level 1|Disease progression|2|||
33392789|NCT00683904|62771690|FG001|Dose Level 1|Disease progression|0|||
33392790|NCT00683904|62771689|FG000|Dose Level 1|Adverse Event|1|||
33392791|NCT00683904|62771690|FG001|Dose Level 1|Adverse Event|0|||
33392792|NCT00683904|62771689|FG000|Dose Level 2|Adverse Event|0|||
33392793|NCT00683904|62771690|FG001|Dose Level 2|Adverse Event|2|||
33392794|NCT00363415|62771704|FG000|Overall Study|Progressive Disease|196|||
33392795|NCT00363415|62771705|FG001|Overall Study|Progressive Disease|107|||
33392796|NCT00363415|62771704|FG000|Overall Study|Sponsor Decision|67|||
33392797|NCT00363415|62771705|FG001|Overall Study|Sponsor Decision|31|||
33392798|NCT00363415|62771704|FG000|Overall Study|Death|32|||
33392799|NCT00363415|62771705|FG001|Overall Study|Death|29|||
33392800|NCT00363415|62771704|FG000|Overall Study|Adverse Event|24|||
33392801|NCT00363415|62771705|FG001|Overall Study|Adverse Event|15|||
33392802|NCT00363415|62771704|FG000|Overall Study|Physician Decision|18|||
33392803|NCT00363415|62771705|FG001|Overall Study|Physician Decision|35|||
33392804|NCT00363415|62771704|FG000|Overall Study|Entry Criteria Not Met|11|||
33392805|NCT00363415|62771705|FG001|Overall Study|Entry Criteria Not Met|10|||
33392806|NCT00363415|62771704|FG000|Overall Study|Withdrawal by Subject|9|||
33392807|NCT00363415|62771705|FG001|Overall Study|Withdrawal by Subject|15|||
33664112|NCT02677116|63095120|FG002|Overall Study|Withdrawal by Subject|0|||
33664113|NCT02677116|63095121|FG003|Overall Study|Withdrawal by Subject|0|||
33392808|NCT00363415|62771704|FG000|Overall Study|Lost to Follow-up|3|||
33392809|NCT00363415|62771705|FG001|Overall Study|Lost to Follow-up|3|||
33392810|NCT00363415|62771704|FG000|Overall Study|Protocol Violation|1|||
33392811|NCT00363415|62771705|FG001|Overall Study|Protocol Violation|4|||
33392812|NCT00696020|62771715|FG000|Overall Study|Adverse Event|3|||
33392813|NCT00696020|62771716|FG001|Overall Study|Adverse Event|1|||
33392814|NCT00696020|62771717|FG002|Overall Study|Adverse Event|2|||
33392815|NCT00696020|62771718|FG003|Overall Study|Adverse Event|1|||
33392816|NCT00696020|62771715|FG000|Overall Study|Lack of Efficacy|1|||
33392817|NCT00696020|62771716|FG001|Overall Study|Lack of Efficacy|0|||
33392818|NCT00696020|62771717|FG002|Overall Study|Lack of Efficacy|0|||
33392819|NCT00696020|62771718|FG003|Overall Study|Lack of Efficacy|0|||
33392820|NCT00696020|62771715|FG000|Overall Study|Protocol Violation|0|||
33392821|NCT00696020|62771716|FG001|Overall Study|Protocol Violation|0|||
33392822|NCT00696020|62771717|FG002|Overall Study|Protocol Violation|0|||
33392823|NCT00696020|62771718|FG003|Overall Study|Protocol Violation|1|||
33392824|NCT00696020|62771715|FG000|Overall Study|Withdrawal by Subject|0|||
33392825|NCT00696020|62771716|FG001|Overall Study|Withdrawal by Subject|1|||
33392826|NCT00696020|62771717|FG002|Overall Study|Withdrawal by Subject|0|||
33392827|NCT00696020|62771718|FG003|Overall Study|Withdrawal by Subject|1|||
33392828|NCT00696020|62771715|FG000|Overall Study|Other not stated above|0|||
33392829|NCT00696020|62771716|FG001|Overall Study|Other not stated above|0|||
33392830|NCT00696020|62771717|FG002|Overall Study|Other not stated above|1|||
33392831|NCT00696020|62771718|FG003|Overall Study|Other not stated above|1|||
33392832|NCT00576576|62771730|FG000|Overall Study|Lost to Follow-up|6|||
33392833|NCT00576576|62771730|FG000|Overall Study|Protocol Violation|1|||
33392834|NCT00695864|62771749|FG000|Placebo|Withdrawal by Subject|1|||
33392835|NCT00695864|62771749|FG000|Placebo|Physician Decision|4|||
33392836|NCT00684996|62771755|FG000|Overall Study|Adverse Event|1|||
33392837|NCT00684996|62771755|FG000|Overall Study|Refusal unrelated to adverse event|1|||
33392838|NCT00684996|62771755|FG000|Overall Study|Progression/relapse|2|||
33392839|NCT00684996|62771755|FG000|Overall Study|Other reasons not protocol specified|1|||
33392840|NCT00684762|62771762|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
33392841|NCT00684762|62771763|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
33392842|NCT00695786|62771773|FG000|Overall Study|Adverse Event|0|||
33392843|NCT00695786|62771774|FG001|Overall Study|Adverse Event|3|||
33392844|NCT00695786|62771775|FG002|Overall Study|Adverse Event|4|||
33392845|NCT00695786|62771776|FG003|Overall Study|Adverse Event|2|||
33392846|NCT00695786|62771773|FG000|Overall Study|Lost to Follow-up|0|||
33392847|NCT00695786|62771774|FG001|Overall Study|Lost to Follow-up|5|||
33392848|NCT00695786|62771775|FG002|Overall Study|Lost to Follow-up|1|||
33392849|NCT00695786|62771776|FG003|Overall Study|Lost to Follow-up|1|||
33392850|NCT00695786|62771773|FG000|Overall Study|Withdrawal by Subject|0|||
33392851|NCT00695786|62771774|FG001|Overall Study|Withdrawal by Subject|4|||
33392852|NCT00695786|62771775|FG002|Overall Study|Withdrawal by Subject|3|||
33392853|NCT00695786|62771776|FG003|Overall Study|Withdrawal by Subject|1|||
33392854|NCT00695786|62771773|FG000|Overall Study|Deemed Ineligible|1|||
33392855|NCT00695786|62771774|FG001|Overall Study|Deemed Ineligible|0|||
33392856|NCT00695786|62771775|FG002|Overall Study|Deemed Ineligible|0|||
33392857|NCT00695786|62771776|FG003|Overall Study|Deemed Ineligible|0|||
33392858|NCT00695786|62771773|FG000|Overall Study|Lack of Efficacy|0|||
33392859|NCT00695786|62771774|FG001|Overall Study|Lack of Efficacy|0|||
33392860|NCT00695786|62771775|FG002|Overall Study|Lack of Efficacy|0|||
33392861|NCT00695786|62771776|FG003|Overall Study|Lack of Efficacy|4|||
33392862|NCT00387127|62771788|FG000|Overall Study|Lost to Follow-up|0|||
33392863|NCT00387127|62771789|FG001|Overall Study|Lost to Follow-up|4|||
33392864|NCT00387127|62771788|FG000|Overall Study|Death|16|||
33392865|NCT00387127|62771789|FG001|Overall Study|Death|16|||
33392866|NCT00387127|62771788|FG000|Overall Study|Physician Decision|0|||
33392867|NCT00387127|62771789|FG001|Overall Study|Physician Decision|1|||
33392868|NCT00387127|62771788|FG000|Overall Study|Withdrawal by Subject|3|||
33392869|NCT00387127|62771789|FG001|Overall Study|Withdrawal by Subject|2|||
33392870|NCT00387127|62771788|FG000|Overall Study|Required by Protocol Amendment #4|12|||
33392871|NCT00387127|62771789|FG001|Overall Study|Required by Protocol Amendment #4|10|||
33392872|NCT00387127|62771788|FG000|Overall Study|Serious Adverse Event|1|||
33392873|NCT00387127|62771789|FG001|Overall Study|Serious Adverse Event|1|||
33392874|NCT00387127|62771788|FG000|Overall Study|Sponsor Unblinded|1|||
33392875|NCT00387127|62771789|FG001|Overall Study|Sponsor Unblinded|0|||
33392876|NCT00683592|62771799|FG000|Overall Study|Adverse Event|12|||
33392877|NCT00683592|62771800|FG001|Overall Study|Adverse Event|4|||
33392878|NCT00683592|62771799|FG000|Overall Study|Withdrawal by Subject|11|||
33392879|NCT00683592|62771800|FG001|Overall Study|Withdrawal by Subject|11|||
33392880|NCT00683592|62771799|FG000|Overall Study|Lost to Follow-up|17|||
33392881|NCT00683592|62771800|FG001|Overall Study|Lost to Follow-up|17|||
33392882|NCT00683592|62771799|FG000|Overall Study|Lack of Efficacy|3|||
33392883|NCT00683592|62771800|FG001|Overall Study|Lack of Efficacy|7|||
33392884|NCT00683592|62771799|FG000|Overall Study|Physician Decision|0|||
33392885|NCT00683592|62771800|FG001|Overall Study|Physician Decision|1|||
33392886|NCT00683592|62771799|FG000|Overall Study|Non-compliance|3|||
33392887|NCT00683592|62771800|FG001|Overall Study|Non-compliance|5|||
33392888|NCT00683592|62771799|FG000|Overall Study|Other|1|||
33392889|NCT00683592|62771800|FG001|Overall Study|Other|1|||
33392890|NCT00695396|62771809|FG000|Overall Study|Study Closed Prematurely|5|||
33392891|NCT00695396|62771810|FG001|Overall Study|Study Closed Prematurely|6|||
33392892|NCT00695396|62771811|FG002|Overall Study|Study Closed Prematurely|8|||
33392893|NCT00695396|62771809|FG000|Overall Study|Withdrawal by Subject|2|||
33392894|NCT00695396|62771810|FG001|Overall Study|Withdrawal by Subject|2|||
33392895|NCT00695396|62771811|FG002|Overall Study|Withdrawal by Subject|0|||
33392896|NCT02656706|62771819|FG000|Overall Study|Insurance Denial|1|||
33392897|NCT00575328|62771825|FG000|Overall Study|Adverse Event|1|||
33392898|NCT00575328|62771826|FG001|Overall Study|Adverse Event|1|||
33392899|NCT00575328|62771825|FG000|Overall Study|Lost to Follow-up|2|||
33392900|NCT00575328|62771826|FG001|Overall Study|Lost to Follow-up|1|||
33392901|NCT00575094|62771832|FG000|Overall Study|Adverse Event|2|||
33392902|NCT00575094|62771832|FG000|Overall Study|Withdrawal by Subject|1|||
33392903|NCT00553696|62771840|FG000|Overall Study|Adverse Event|2|||
33392904|NCT00553696|62771841|FG001|Overall Study|Adverse Event|4|||
33392905|NCT00553696|62771842|FG002|Overall Study|Adverse Event|0|||
33392906|NCT00553696|62771843|FG003|Overall Study|Adverse Event|1|||
33392907|NCT00553696|62771840|FG000|Overall Study|Global deterioration of health status|0|||
33392908|NCT00553696|62771841|FG001|Overall Study|Global deterioration of health status|2|||
33392909|NCT00553696|62771842|FG002|Overall Study|Global deterioration of health status|0|||
33392910|NCT00553696|62771843|FG003|Overall Study|Global deterioration of health status|0|||
33392911|NCT00553696|62771840|FG000|Overall Study|Objective progression or relapse|2|||
33392912|NCT00553696|62771841|FG001|Overall Study|Objective progression or relapse|9|||
33392913|NCT00553696|62771842|FG002|Overall Study|Objective progression or relapse|6|||
33392914|NCT00553696|62771843|FG003|Overall Study|Objective progression or relapse|0|||
33392915|NCT00553696|62771840|FG000|Overall Study|Withdrawal by Subject|0|||
33392916|NCT00553696|62771841|FG001|Overall Study|Withdrawal by Subject|1|||
33392917|NCT00553696|62771842|FG002|Overall Study|Withdrawal by Subject|0|||
33392918|NCT00553696|62771843|FG003|Overall Study|Withdrawal by Subject|0|||
33392919|NCT00553540|62771858|FG000|Overall Study|discharged after first visit|2|||
33392920|NCT00553540|62771859|FG001|Overall Study|discharged after first visit|5|||
33392921|NCT00617409|62771868|FG000|Overall Study|Withdrawal by Subject|4|||
33392922|NCT00617409|62771869|FG001|Overall Study|Withdrawal by Subject|1|||
33392923|NCT00617409|62771870|FG002|Overall Study|Withdrawal by Subject|2|||
33392924|NCT00617409|62771868|FG000|Overall Study|Adverse Event|0|||
33392925|NCT00617409|62771869|FG001|Overall Study|Adverse Event|2|||
33392926|NCT00617409|62771870|FG002|Overall Study|Adverse Event|3|||
33392927|NCT00617409|62771868|FG000|Overall Study|Disease Progression|8|||
33392928|NCT00617409|62771869|FG001|Overall Study|Disease Progression|8|||
33392929|NCT00617409|62771870|FG002|Overall Study|Disease Progression|18|||
33392930|NCT00617409|62771868|FG000|Overall Study|Death|3|||
33392931|NCT00617409|62771869|FG001|Overall Study|Death|5|||
33392932|NCT00617409|62771870|FG002|Overall Study|Death|4|||
33392933|NCT00617409|62771868|FG000|Overall Study|Alternative Therapy|1|||
33392934|NCT00617409|62771869|FG001|Overall Study|Alternative Therapy|2|||
33392935|NCT00617409|62771870|FG002|Overall Study|Alternative Therapy|0|||
33392936|NCT00695318|62771881|FG000|Overall Study|Lost to Follow-up|1|||
33392937|NCT00695318|62771882|FG001|Overall Study|Lost to Follow-up|0|||
33392938|NCT00695318|62771881|FG000|Overall Study|Withdrawal by Subject|2|||
33392939|NCT00695318|62771882|FG001|Overall Study|Withdrawal by Subject|0|||
33392940|NCT00695318|62771881|FG000|Overall Study|Death|1|||
33392941|NCT00695318|62771882|FG001|Overall Study|Death|1|||
33392942|NCT00695318|62771881|FG000|Overall Study|Study Terminated|1|||
33392943|NCT00695318|62771882|FG001|Overall Study|Study Terminated|0|||
33392944|NCT00386425|62771896|FG000|Overall Study|Physician Decision|3|||
33392945|NCT00386425|62771897|FG001|Overall Study|Physician Decision|0|||
33392946|NCT00386425|62771898|FG002|Overall Study|Physician Decision|0|||
33392947|NCT00386425|62771896|FG000|Overall Study|Withdrawal by Subject|0|||
33392948|NCT00386425|62771897|FG001|Overall Study|Withdrawal by Subject|1|||
33392949|NCT00386425|62771898|FG002|Overall Study|Withdrawal by Subject|0|||
33392950|NCT00694304|62771910|FG000|Overall Study|Adverse Event|42|||
33392951|NCT00694304|62771910|FG000|Overall Study|Lack of Efficacy|35|||
33392952|NCT00694304|62771910|FG000|Overall Study|Non-compliance With Study Product|16|||
33392953|NCT00694304|62771910|FG000|Overall Study|Protocol Violation|6|||
33392954|NCT00694304|62771910|FG000|Overall Study|Withdrawal of Consent|61|||
33392955|NCT00694304|62771910|FG000|Overall Study|Lost to Follow-up|15|||
33392956|NCT00694304|62771910|FG000|Overall Study|Administrative or Other Reasons|32|||
33302240|NCT01261611|62678045|FG000|Treatment Cycle 2|Protocol Violation|2|||
33302241|NCT01261611|62678046|FG001|Treatment Cycle 2|Protocol Violation|0|||
33302242|NCT01261611|62678047|FG002|Treatment Cycle 2|Protocol Violation|0|||
33302243|NCT01261611|62678045|FG000|Treatment Cycle 2|Not otherwise specified|2|||
33302244|NCT01261611|62678046|FG001|Treatment Cycle 2|Not otherwise specified|0|||
33302245|NCT01261611|62678047|FG002|Treatment Cycle 2|Not otherwise specified|0|||
33302246|NCT01261611|62678045|FG000|Treatment Cycle 3|Completed study|24|||
33302247|NCT01261611|62678046|FG001|Treatment Cycle 3|Completed study|0|||
33302248|NCT01261611|62678047|FG002|Treatment Cycle 3|Completed study|0|||
33302249|NCT01261611|62678045|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
33302250|NCT01261611|62678046|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
33302251|NCT01261611|62678047|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
33392957|NCT00371839|62771917|FG000|Overall Study|Death|4|||
33392958|NCT00371839|62771918|FG001|Overall Study|Death|0|||
33392959|NCT00371839|62771919|FG002|Overall Study|Death|0|||
33392960|NCT00371839|62771917|FG000|Overall Study|Withdrawal by Subject|7|||
33392961|NCT00371839|62771918|FG001|Overall Study|Withdrawal by Subject|4|||
33392962|NCT00371839|62771919|FG002|Overall Study|Withdrawal by Subject|0|||
33392963|NCT00371839|62771917|FG000|Overall Study|Lost to Follow-up|6|||
33392964|NCT00371839|62771918|FG001|Overall Study|Lost to Follow-up|3|||
33392965|NCT00371839|62771919|FG002|Overall Study|Lost to Follow-up|2|||
33392966|NCT00682890|62771927|FG000|Overall Study|Lost to Follow-up|1|||
33392967|NCT00682890|62771928|FG001|Overall Study|Lost to Follow-up|1|||
33392968|NCT00682890|62771927|FG000|Overall Study|subject moved away|0|||
33392969|NCT00682890|62771928|FG001|Overall Study|subject moved away|1|||
33392970|NCT00682890|62771927|FG000|Overall Study|heavy menstrual bleeding|1|||
33392971|NCT00682890|62771928|FG001|Overall Study|heavy menstrual bleeding|0|||
33392972|NCT00385723|62771937|FG000|Overall Study|Lost to Follow-up|1|||
33392973|NCT00385723|62771938|FG001|Overall Study|Lost to Follow-up|1|||
33392974|NCT00385723|62771939|FG002|Overall Study|Lost to Follow-up|0|||
33392975|NCT00385723|62771937|FG000|Overall Study|Withdrawal by Subject|1|||
33392976|NCT00385723|62771938|FG001|Overall Study|Withdrawal by Subject|0|||
33392977|NCT00385723|62771939|FG002|Overall Study|Withdrawal by Subject|2|||
33392978|NCT00698516|62771947|FG000|Overall Study|Study Termination|2|||
33392979|NCT00698516|62771947|FG000|Overall Study|Withdrawal by Subject|3|||
33392980|NCT00679302|62771957|FG000|Overall Study|Lost to Follow-up|8|||
33392981|NCT00679302|62771958|FG001|Overall Study|Lost to Follow-up|4|||
33392982|NCT00690482|62771987|FG000|Overall Study|Adverse Event|2|||
33392983|NCT00690482|62771988|FG001|Overall Study|Adverse Event|1|||
33392984|NCT00690482|62771987|FG000|Overall Study|Incorrect enrolment|0|||
33392985|NCT00690482|62771988|FG001|Overall Study|Incorrect enrolment|1|||
33392986|NCT00690482|62771987|FG000|Overall Study|Study-specific discontinuation criteria|1|||
33392987|NCT00690482|62771988|FG001|Overall Study|Study-specific discontinuation criteria|0|||
33392988|NCT00690482|62771987|FG000|Overall Study|Intake of prohibited medicine|1|||
33392989|NCT00690482|62771988|FG001|Overall Study|Intake of prohibited medicine|0|||
33392990|NCT00690482|62771987|FG000|Overall Study|withdrew consent at rand.day|0|||
33392991|NCT00690482|62771988|FG001|Overall Study|withdrew consent at rand.day|1|||
33392992|NCT00385255|62771996|FG000|Overall Study|Serious Adverse Event|1|||
33392993|NCT00385255|62771997|FG001|Overall Study|Serious Adverse Event|2|||
33392994|NCT00385255|62771996|FG000|Overall Study|Protocol Violation|0|||
33392995|NCT00385255|62771997|FG001|Overall Study|Protocol Violation|4|||
33392996|NCT00385255|62771996|FG000|Overall Study|Withdrawal by Subject|0|||
33392997|NCT00385255|62771997|FG001|Overall Study|Withdrawal by Subject|8|||
33392998|NCT00385255|62771996|FG000|Overall Study|Migrated/moved from study area|0|||
33392999|NCT00385255|62771997|FG001|Overall Study|Migrated/moved from study area|1|||
33393000|NCT00385255|62771996|FG000|Overall Study|Lost to Follow-up|20|||
33393001|NCT00385255|62771997|FG001|Overall Study|Lost to Follow-up|58|||
33393002|NCT00571662|62772007|FG000|Overall Study|Withdrawal by Subject|2|||
33393003|NCT00571662|62772007|FG000|Overall Study|psychiatric instability|1|||
33393004|NCT00571662|62772007|FG000|Overall Study|Adverse Event|5|||
33393005|NCT00698204|62772015|FG000|Overall Study|Withdrawal by Subject|1|||
33393006|NCT00698204|62772016|FG001|Overall Study|Withdrawal by Subject|0|||
33393007|NCT00549718|62772028|FG000|Overall Study|Insufficient clinical response|20|||
33393008|NCT00549718|62772029|FG001|Overall Study|Insufficient clinical response|7|||
33393009|NCT00549718|62772030|FG002|Overall Study|Insufficient clinical response|18|||
33393010|NCT00549718|62772031|FG003|Overall Study|Insufficient clinical response|32|||
33393011|NCT00549718|62772028|FG000|Overall Study|Adverse Event|6|||
33393012|NCT00549718|62772029|FG001|Overall Study|Adverse Event|8|||
33393013|NCT00549718|62772030|FG002|Overall Study|Adverse Event|7|||
33393014|NCT00549718|62772031|FG003|Overall Study|Adverse Event|3|||
33393015|NCT00549718|62772028|FG000|Overall Study|Lost to Follow-up|4|||
33393016|NCT00549718|62772029|FG001|Overall Study|Lost to Follow-up|2|||
33393017|NCT00549718|62772030|FG002|Overall Study|Lost to Follow-up|0|||
33393018|NCT00549718|62772031|FG003|Overall Study|Lost to Follow-up|6|||
33393019|NCT00549718|62772028|FG000|Overall Study|Withdrawal by Subject|9|||
33393020|NCT00549718|62772029|FG001|Overall Study|Withdrawal by Subject|18|||
33393021|NCT00549718|62772030|FG002|Overall Study|Withdrawal by Subject|12|||
33393022|NCT00549718|62772031|FG003|Overall Study|Withdrawal by Subject|13|||
33393023|NCT00549718|62772028|FG000|Overall Study|Administrative|2|||
33393024|NCT00549718|62772029|FG001|Overall Study|Administrative|2|||
33393025|NCT00549718|62772030|FG002|Overall Study|Administrative|2|||
33393026|NCT00549718|62772031|FG003|Overall Study|Administrative|1|||
33393027|NCT00371761|62772043|FG000|Overall Study|Adverse Event|1|||
33393028|NCT00371761|62772044|FG001|Overall Study|Adverse Event|1|||
33664114|NCT02677116|63095122|FG004|Overall Study|Withdrawal by Subject|0|||
33664115|NCT02677116|63095123|FG005|Overall Study|Withdrawal by Subject|0|||
33393029|NCT00371761|62772043|FG000|Overall Study|Withdrawal by Subject|1|||
33393030|NCT00371761|62772044|FG001|Overall Study|Withdrawal by Subject|3|||
33393031|NCT00371761|62772043|FG000|Overall Study|Investigator Judgment|2|||
33664116|NCT02677116|63095124|FG006|Overall Study|Withdrawal by Subject|0|||
33393032|NCT00371761|62772044|FG001|Overall Study|Investigator Judgment|3|||
33393033|NCT00371761|62772043|FG000|Overall Study|Study termination|4|||
33393034|NCT00371761|62772044|FG001|Overall Study|Study termination|3|||
33393035|NCT00549640|62772052|FG000|Overall Study|Withdrawal by Subject|6|||
33393036|NCT00549640|62772053|FG001|Overall Study|Withdrawal by Subject|12|||
33393037|NCT00549640|62772052|FG000|Overall Study|Adverse Event|5|||
33393038|NCT00549640|62772053|FG001|Overall Study|Adverse Event|0|||
33393039|NCT00549640|62772052|FG000|Overall Study|Lost to Follow-up|7|||
33393040|NCT00549640|62772053|FG001|Overall Study|Lost to Follow-up|4|||
33393041|NCT00549562|62772075|FG000|Overall Study|Adverse Event|1|||
33393042|NCT00549562|62772075|FG000|Overall Study|Lack of Efficacy|1|||
33393043|NCT00681564|62772081|FG000|Overall Study|Lost to Follow-up|6|||
33393044|NCT00681564|62772082|FG001|Overall Study|Lost to Follow-up|6|||
33393045|NCT00681564|62772081|FG000|Overall Study|Withdrawal by Subject|0|||
33393046|NCT00681564|62772082|FG001|Overall Study|Withdrawal by Subject|1|||
33393047|NCT00681564|62772081|FG000|Overall Study|Death|0|||
33393048|NCT00681564|62772082|FG001|Overall Study|Death|1|||
33393049|NCT00677352|62772090|FG000|Treatment Phase|Adverse Event|14|||
33393050|NCT00677352|62772091|FG001|Treatment Phase|Adverse Event|22|||
33393051|NCT00677352|62772090|FG000|Treatment Phase|Lack of Efficacy|2|||
33393052|NCT00677352|62772091|FG001|Treatment Phase|Lack of Efficacy|3|||
33393053|NCT00677352|62772090|FG000|Treatment Phase|Lost to Follow-up|0|||
33393054|NCT00677352|62772091|FG001|Treatment Phase|Lost to Follow-up|1|||
33393055|NCT00677352|62772090|FG000|Treatment Phase|Withdrawal by Subject|7|||
33393056|NCT00677352|62772091|FG001|Treatment Phase|Withdrawal by Subject|7|||
33393057|NCT00677352|62772090|FG000|Treatment Phase|Physician Decision|1|||
33393058|NCT00677352|62772091|FG001|Treatment Phase|Physician Decision|0|||
33393059|NCT00677352|62772090|FG000|Treatment Phase|Pregnancy|0|||
33393060|NCT00677352|62772091|FG001|Treatment Phase|Pregnancy|1|||
33393061|NCT00677352|62772090|FG000|Treatment Phase|Protocol Violation|1|||
33393062|NCT00677352|62772091|FG001|Treatment Phase|Protocol Violation|1|||
33393063|NCT00677352|62772090|FG000|Treatment Phase|Transference or work related matter|0|||
33393064|NCT00677352|62772091|FG001|Treatment Phase|Transference or work related matter|5|||
33393065|NCT00677352|62772090|FG000|Treatment Phase|Not treated|0|||
33393066|NCT00677352|62772091|FG001|Treatment Phase|Not treated|2|||
33393067|NCT00677352|62772090|FG000|Tapering Phase|Adverse Event|1|||
33393068|NCT00677352|62772091|FG001|Tapering Phase|Adverse Event|5|||
33393069|NCT00677352|62772090|FG000|Tapering Phase|Withdrawal by Subject|5|||
33393070|NCT00677352|62772091|FG001|Tapering Phase|Withdrawal by Subject|3|||
33393071|NCT00677352|62772090|FG000|Tapering Phase|Pregnancy|0|||
33393072|NCT00677352|62772091|FG001|Tapering Phase|Pregnancy|1|||
33393073|NCT00677352|62772090|FG000|Tapering Phase|Job transfer|0|||
33393074|NCT00677352|62772091|FG001|Tapering Phase|Job transfer|1|||
33393075|NCT00371683|62772104|FG000|DB Treatment Period-Randomized Patients|Death|1|||
33393076|NCT00371683|62772105|FG001|DB Treatment Period-Randomized Patients|Death|1|||
33393077|NCT00371683|62772104|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
33393078|NCT00371683|62772105|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
33393079|NCT00371683|62772104|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
33393080|NCT00371683|62772105|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
33393081|NCT00371683|62772104|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
33393082|NCT00371683|62772105|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
33393083|NCT00371683|62772104|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
33393084|NCT00371683|62772105|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
33393085|NCT00371683|62772104|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
33393086|NCT00371683|62772105|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
33393087|NCT00371683|62772104|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
33393088|NCT00371683|62772105|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
33393089|NCT00371683|62772104|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
33393090|NCT00371683|62772105|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
33393091|NCT00371683|62772104|FG000|Follow-Up Period - Randomized Patients|Death|0|||
33393092|NCT00371683|62772105|FG001|Follow-Up Period - Randomized Patients|Death|2|||
33393093|NCT00371683|62772104|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
33393094|NCT00371683|62772105|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
33393095|NCT00371683|62772104|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
33393096|NCT00371683|62772105|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
33393097|NCT03951766|62772121|FG000|Treatment Phase|Lost to Follow-up|1|||
33566521|NCT02149121|62962329|FG003|Main Study Period|Physician Decision|0|||
33566522|NCT02149121|62962330|FG004|Main Study Period|Physician Decision|0|||
33566523|NCT02149121|62962331|FG005|Main Study Period|Physician Decision|0|||
33393098|NCT03951766|62772121|FG000|Follow-up Phase|Lost to Follow-up|10|||
33393099|NCT00371137|62772130|FG000|Overall Study|Adverse Event|20|||
33393100|NCT00371137|62772131|FG001|Overall Study|Adverse Event|35|||
33393101|NCT00371137|62772132|FG002|Overall Study|Adverse Event|42|||
33393102|NCT00371137|62772130|FG000|Overall Study|Withdrawal by Subject|11|||
33393103|NCT00371137|62772131|FG001|Overall Study|Withdrawal by Subject|10|||
33393104|NCT00371137|62772132|FG002|Overall Study|Withdrawal by Subject|15|||
33393105|NCT00371137|62772130|FG000|Overall Study|Lost to Follow-up|6|||
33566524|NCT02149121|62962332|FG006|Main Study Period|Physician Decision|0|||
33393106|NCT00371137|62772131|FG001|Overall Study|Lost to Follow-up|3|||
33393107|NCT00371137|62772132|FG002|Overall Study|Lost to Follow-up|5|||
33393108|NCT00371137|62772130|FG000|Overall Study|Lack of Efficacy|30|||
33393109|NCT00371137|62772131|FG001|Overall Study|Lack of Efficacy|12|||
33393110|NCT00371137|62772132|FG002|Overall Study|Lack of Efficacy|13|||
33393111|NCT00371137|62772130|FG000|Overall Study|Sponsor Decision|2|||
33393112|NCT00371137|62772131|FG001|Overall Study|Sponsor Decision|1|||
33393113|NCT00371137|62772132|FG002|Overall Study|Sponsor Decision|2|||
33393114|NCT00371137|62772130|FG000|Overall Study|Physician Decision|1|||
33393115|NCT00371137|62772131|FG001|Overall Study|Physician Decision|1|||
33393116|NCT00371137|62772132|FG002|Overall Study|Physician Decision|1|||
33393117|NCT00371137|62772130|FG000|Overall Study|Protocol Violation|2|||
33393118|NCT00371137|62772131|FG001|Overall Study|Protocol Violation|1|||
33393119|NCT00371137|62772132|FG002|Overall Study|Protocol Violation|1|||
33393120|NCT00616239|62772140|FG000|Overall Study|Withdrawal by Subject|2|||
33393121|NCT00547534|62772144|FG000|Overall Study|Adverse Event|7|||
33393122|NCT00547534|62772144|FG000|Overall Study|Disease Progression|4|||
33393123|NCT00384397|62772152|FG000|Overall Study|Adverse Event|0|||
33393124|NCT00384397|62772153|FG001|Overall Study|Adverse Event|1|||
33393125|NCT00384397|62772154|FG002|Overall Study|Adverse Event|2|||
33566525|NCT02149121|62962326|FG000|Main Study Period|Developed any malignancy|0|||
33566526|NCT02149121|62962327|FG001|Main Study Period|Developed any malignancy|1|||
33566527|NCT02149121|62962328|FG002|Main Study Period|Developed any malignancy|1|||
33393126|NCT00384397|62772152|FG000|Overall Study|Protocol Violation|7|||
33393127|NCT00384397|62772153|FG001|Overall Study|Protocol Violation|15|||
33393128|NCT00384397|62772154|FG002|Overall Study|Protocol Violation|13|||
33393129|NCT00384397|62772152|FG000|Overall Study|Lost to Follow-up|11|||
33393130|NCT00384397|62772153|FG001|Overall Study|Lost to Follow-up|13|||
33393131|NCT00384397|62772154|FG002|Overall Study|Lost to Follow-up|3|||
33393132|NCT00384397|62772152|FG000|Overall Study|Withdrawal by Subject|14|||
33393133|NCT00384397|62772153|FG001|Overall Study|Withdrawal by Subject|17|||
33393134|NCT00384397|62772154|FG002|Overall Study|Withdrawal by Subject|15|||
33393135|NCT00384085|62772165|FG000|Overall Study|Adverse Event|5|||
33393136|NCT00384085|62772166|FG001|Overall Study|Adverse Event|5|||
33393137|NCT00384085|62772167|FG002|Overall Study|Adverse Event|4|||
33393138|NCT00384085|62772165|FG000|Overall Study|Lack of Efficacy|0|||
33393139|NCT00384085|62772166|FG001|Overall Study|Lack of Efficacy|3|||
33393140|NCT00384085|62772167|FG002|Overall Study|Lack of Efficacy|2|||
33393141|NCT00384085|62772165|FG000|Overall Study|No longer Requires Study Treatment|1|||
33393142|NCT00384085|62772166|FG001|Overall Study|No longer Requires Study Treatment|0|||
33393143|NCT00384085|62772167|FG002|Overall Study|No longer Requires Study Treatment|1|||
33393144|NCT00384085|62772165|FG000|Overall Study|Protocol Violation|2|||
33566528|NCT02149121|62962329|FG003|Main Study Period|Developed any malignancy|0|||
33566529|NCT02149121|62962330|FG004|Main Study Period|Developed any malignancy|0|||
33566530|NCT02149121|62962331|FG005|Main Study Period|Developed any malignancy|0|||
33566531|NCT02149121|62962332|FG006|Main Study Period|Developed any malignancy|0|||
33566532|NCT02149121|62962326|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
33566533|NCT02149121|62962327|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
33393145|NCT00384085|62772166|FG001|Overall Study|Protocol Violation|2|||
33393146|NCT00384085|62772167|FG002|Overall Study|Protocol Violation|2|||
33393147|NCT00384085|62772165|FG000|Overall Study|Lost to Follow-up|9|||
33393148|NCT00384085|62772166|FG001|Overall Study|Lost to Follow-up|9|||
33393149|NCT00384085|62772167|FG002|Overall Study|Lost to Follow-up|10|||
33566534|NCT02149121|62962328|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
33393150|NCT00384085|62772165|FG000|Overall Study|Progressive Disease|0|||
33393151|NCT00384085|62772166|FG001|Overall Study|Progressive Disease|1|||
33393152|NCT00384085|62772167|FG002|Overall Study|Progressive Disease|0|||
33393153|NCT00384085|62772165|FG000|Overall Study|Withdrawal by Subject|14|||
33393154|NCT00384085|62772166|FG001|Overall Study|Withdrawal by Subject|19|||
33393155|NCT00384085|62772167|FG002|Overall Study|Withdrawal by Subject|29|||
33393156|NCT00384085|62772165|FG000|Overall Study|Patient non-compliant|4|||
33566535|NCT02149121|62962329|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
33566536|NCT02149121|62962330|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
33566537|NCT02149121|62962331|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
33566538|NCT02149121|62962332|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
33566539|NCT02149121|62962326|FG000|Main Study Period|Disease progression|0|||
33566540|NCT02149121|62962327|FG001|Main Study Period|Disease progression|1|||
33566541|NCT02149121|62962328|FG002|Main Study Period|Disease progression|0|||
33566542|NCT02149121|62962329|FG003|Main Study Period|Disease progression|0|||
33566543|NCT02149121|62962330|FG004|Main Study Period|Disease progression|0|||
33566544|NCT02149121|62962331|FG005|Main Study Period|Disease progression|0|||
33566545|NCT02149121|62962332|FG006|Main Study Period|Disease progression|0|||
33566546|NCT02149121|62962326|FG000|Extension Study Period|Withdrawal by Subject|0|||
33393157|NCT00384085|62772166|FG001|Overall Study|Patient non-compliant|4|||
33393158|NCT00384085|62772167|FG002|Overall Study|Patient non-compliant|5|||
33393159|NCT00384085|62772165|FG000|Overall Study|Physician Decision|1|||
33393160|NCT00384085|62772166|FG001|Overall Study|Physician Decision|0|||
33393161|NCT00384085|62772167|FG002|Overall Study|Physician Decision|0|||
33393162|NCT00384085|62772165|FG000|Overall Study|Loss of site personnel|1|||
33393163|NCT00384085|62772166|FG001|Overall Study|Loss of site personnel|0|||
33393164|NCT00384085|62772167|FG002|Overall Study|Loss of site personnel|1|||
33393165|NCT00384085|62772165|FG000|Overall Study|Sponsor decision|1|||
33393166|NCT00384085|62772166|FG001|Overall Study|Sponsor decision|2|||
33393167|NCT00384085|62772167|FG002|Overall Study|Sponsor decision|1|||
33393168|NCT00384085|62772165|FG000|Overall Study|Patient moved|1|||
33393169|NCT00384085|62772166|FG001|Overall Study|Patient moved|0|||
33393170|NCT00384085|62772167|FG002|Overall Study|Patient moved|1|||
33393171|NCT00384085|62772165|FG000|Overall Study|Patient required surgery|0|||
33393172|NCT00384085|62772166|FG001|Overall Study|Patient required surgery|1|||
33393173|NCT00384085|62772167|FG002|Overall Study|Patient required surgery|0|||
33393174|NCT00361231|62772177|FG000|Overall Study|Physician Decision|3|||
33393175|NCT00361231|62772177|FG000|Overall Study|Symptomatic deterioration|5|||
33393176|NCT00361231|62772177|FG000|Overall Study|Radiographic disease progression|16|||
33393177|NCT00361231|62772177|FG000|Overall Study|Withdrawal by Subject|4|||
33393178|NCT00361231|62772177|FG000|Overall Study|Adverse Event|6|||
33393179|NCT00676650|62772183|FG000|Overall Study|Death|45|||
33393180|NCT00676650|62772184|FG001|Overall Study|Death|14|||
33393181|NCT00676650|62772183|FG000|Overall Study|Adverse Event|159|||
33393182|NCT00676650|62772184|FG001|Overall Study|Adverse Event|21|||
33393183|NCT00676650|62772183|FG000|Overall Study|Global deterioration of health status|66|||
33393184|NCT00676650|62772184|FG001|Overall Study|Global deterioration of health status|31|||
33393185|NCT00676650|62772183|FG000|Overall Study|Lost to Follow-up|0|||
33393186|NCT00676650|62772184|FG001|Overall Study|Lost to Follow-up|1|||
33393187|NCT00676650|62772183|FG000|Overall Study|Objective progression or relapse|189|||
33393188|NCT00676650|62772184|FG001|Overall Study|Objective progression or relapse|140|||
33393189|NCT00676650|62772183|FG000|Overall Study|Other|14|||
33393190|NCT00676650|62772184|FG001|Overall Study|Other|10|||
33393191|NCT00676650|62772183|FG000|Overall Study|Protocol Violation|3|||
33393192|NCT00676650|62772184|FG001|Overall Study|Protocol Violation|1|||
33393193|NCT00676650|62772183|FG000|Overall Study|Study terminated by sponsor|57|||
33393194|NCT00676650|62772184|FG001|Overall Study|Study terminated by sponsor|43|||
33393195|NCT00676650|62772183|FG000|Overall Study|Withdrawal by Subject|48|||
33393196|NCT00676650|62772184|FG001|Overall Study|Withdrawal by Subject|24|||
33393197|NCT00676650|62772183|FG000|Overall Study|Randomized but not treated|3|||
33393198|NCT00676650|62772184|FG001|Overall Study|Randomized but not treated|4|||
33393199|NCT00573183|62772192|FG000|Overall Study|Lost to Follow-up|52|||
33393200|NCT00573183|62772193|FG001|Overall Study|Lost to Follow-up|50|||
33393201|NCT00573183|62772192|FG000|Overall Study|Withdrawal by Subject|8|||
33393202|NCT00573183|62772193|FG001|Overall Study|Withdrawal by Subject|2|||
33393203|NCT00573183|62772192|FG000|Overall Study|Death|0|||
33393204|NCT00573183|62772193|FG001|Overall Study|Death|1|||
33393205|NCT00573183|62772192|FG000|Overall Study|Adverse Event|2|||
33393206|NCT00573183|62772193|FG001|Overall Study|Adverse Event|0|||
33393207|NCT00573183|62772192|FG000|Overall Study|Incarceration|5|||
33393208|NCT00573183|62772193|FG001|Overall Study|Incarceration|8|||
33393209|NCT00573183|62772192|FG000|Overall Study|Other|5|||
33393210|NCT00573183|62772193|FG001|Overall Study|Other|2|||
33393211|NCT00615459|62772201|FG000|Period I|Adverse Event|2|||
33393212|NCT00615459|62772202|FG001|Period I|Adverse Event|0|||
33393213|NCT00615459|62772203|FG002|Period I|Adverse Event|1|||
33393214|NCT00615459|62772204|FG003|Period I|Adverse Event|0|||
33393215|NCT00615459|62772201|FG000|Period I|Subject withdrew consent|1|||
33566547|NCT02149121|62962327|FG001|Extension Study Period|Withdrawal by Subject|0|||
33393216|NCT00615459|62772202|FG001|Period I|Subject withdrew consent|0|||
33393217|NCT00615459|62772203|FG002|Period I|Subject withdrew consent|0|||
33393218|NCT00615459|62772204|FG003|Period I|Subject withdrew consent|1|||
33393219|NCT00615459|62772201|FG000|Period I|Abnormal test procedure results|1|||
33393220|NCT00615459|62772202|FG001|Period I|Abnormal test procedure results|1|||
33393221|NCT00615459|62772203|FG002|Period I|Abnormal test procedure results|1|||
33393222|NCT00615459|62772204|FG003|Period I|Abnormal test procedure results|0|||
33393223|NCT00615459|62772201|FG000|Period II|Adverse Event|1|||
33393224|NCT00615459|62772202|FG001|Period II|Adverse Event|0|||
33393225|NCT00615459|62772203|FG002|Period II|Adverse Event|0|||
33393226|NCT00615459|62772204|FG003|Period II|Adverse Event|0|||
33566548|NCT02149121|62962328|FG002|Extension Study Period|Withdrawal by Subject|0|||
33566549|NCT02149121|62962329|FG003|Extension Study Period|Withdrawal by Subject|1|||
33393227|NCT00615459|62772201|FG000|Period II|Lost to Follow-up|0|||
33393228|NCT00615459|62772202|FG001|Period II|Lost to Follow-up|0|||
33393229|NCT00615459|62772203|FG002|Period II|Lost to Follow-up|0|||
33393230|NCT00615459|62772204|FG003|Period II|Lost to Follow-up|1|||
33393231|NCT00615459|62772201|FG000|Period III|Adverse Event|0|||
33393232|NCT00615459|62772202|FG001|Period III|Adverse Event|1|||
33393233|NCT00615459|62772203|FG002|Period III|Adverse Event|0|||
33393234|NCT00615459|62772204|FG003|Period III|Adverse Event|0|||
33393235|NCT00615459|62772201|FG000|Period III|Administrative problems|0|||
33393236|NCT00615459|62772202|FG001|Period III|Administrative problems|1|||
33393237|NCT00615459|62772203|FG002|Period III|Administrative problems|1|||
33393238|NCT00615459|62772204|FG003|Period III|Administrative problems|0|||
33393239|NCT00615459|62772201|FG000|Period III|Unsatisfactory therapeutic effect|0|||
33393240|NCT00615459|62772202|FG001|Period III|Unsatisfactory therapeutic effect|1|||
33393241|NCT00615459|62772203|FG002|Period III|Unsatisfactory therapeutic effect|0|||
33393242|NCT00615459|62772204|FG003|Period III|Unsatisfactory therapeutic effect|0|||
33393243|NCT00383149|62772218|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
33393244|NCT00383149|62772218|FG000|Overall Study|Death|2|||
33393245|NCT00383149|62772218|FG000|Overall Study|Disease Progression|38|||
33393246|NCT00383149|62772218|FG000|Overall Study|Lost to Follow-up|1|||
33393247|NCT00383149|62772218|FG000|Overall Study|Other|1|||
33393248|NCT00383149|62772218|FG000|Overall Study|Study Drug Toxicity|4|||
33393249|NCT00383149|62772218|FG000|Overall Study|Request to Discontinue Treatment|4|||
33393250|NCT00383149|62772218|FG000|Overall Study|Participant Withdrew Consent|1|||
33393251|NCT00382993|62772224|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
33393252|NCT00382993|62772225|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
33393253|NCT00382993|62772224|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
33393254|NCT00382993|62772225|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
33393255|NCT00382993|62772224|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
33393256|NCT00382993|62772225|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
33393257|NCT00382993|62772224|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
33393258|NCT00382993|62772225|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
33393259|NCT00382993|62772224|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
33393260|NCT00382993|62772225|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
33393261|NCT00382993|62772224|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
33393262|NCT00382993|62772225|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
33393263|NCT00382993|62772224|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
33393264|NCT00382993|62772225|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
33393265|NCT00382993|62772224|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
33393266|NCT00382993|62772225|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
33393267|NCT00382993|62772224|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
33393268|NCT00382993|62772225|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
33393269|NCT00382993|62772224|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
33393270|NCT00382993|62772225|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
33393271|NCT00369967|62772233|FG000|Overall Study|Lost to Follow-up|23|||
33393272|NCT00369967|62772234|FG001|Overall Study|Lost to Follow-up|12|||
33393273|NCT00616629|62772249|FG000|Overall Study|Protocol Violation|1|||
33393274|NCT00616629|62772250|FG001|Overall Study|Protocol Violation|2|||
33393275|NCT00616629|62772251|FG002|Overall Study|Protocol Violation|1|||
33393276|NCT00616629|62772252|FG003|Overall Study|Protocol Violation|0|||
33393277|NCT00616629|62772253|FG004|Overall Study|Protocol Violation|0|||
33393278|NCT00616629|62772249|FG000|Overall Study|AV-block|1|||
33393279|NCT00616629|62772250|FG001|Overall Study|AV-block|0|||
33393280|NCT00616629|62772251|FG002|Overall Study|AV-block|0|||
33393281|NCT00616629|62772252|FG003|Overall Study|AV-block|0|||
33393282|NCT00616629|62772253|FG004|Overall Study|AV-block|0|||
33393283|NCT00369655|62772265|FG000|Overall Study|Refusal of further treatment|2|||
33393284|NCT00615069|62772269|FG000|Overall Study|Death|10|||
33393285|NCT00615069|62772269|FG000|Overall Study|Physician Decision|2|||
33566550|NCT02149121|62962330|FG004|Extension Study Period|Withdrawal by Subject|0|||
33566551|NCT02149121|62962331|FG005|Extension Study Period|Withdrawal by Subject|2|||
33566552|NCT02149121|62962332|FG006|Extension Study Period|Withdrawal by Subject|0|||
33302252|NCT01261611|62678045|FG000|Treatment Cycle 3|Adverse Event|1|||
33302253|NCT01261611|62678046|FG001|Treatment Cycle 3|Adverse Event|0|||
33302254|NCT01261611|62678047|FG002|Treatment Cycle 3|Adverse Event|0|||
33302255|NCT01261611|62678045|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
33302256|NCT01261611|62678046|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
33302257|NCT01261611|62678047|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
33302258|NCT01261611|62678045|FG000|Treatment Cycle 4|Completed study|87|||
33302259|NCT01261611|62678046|FG001|Treatment Cycle 4|Completed study|0|||
33302260|NCT01261611|62678047|FG002|Treatment Cycle 4|Completed study|0|||
33393286|NCT00615069|62772269|FG000|Overall Study|Withdrawal by Subject|4|||
33393287|NCT00676338|62772277|FG000|Overall Study|Adverse Event|6|||
33393288|NCT00676338|62772278|FG001|Overall Study|Adverse Event|6|||
33393289|NCT00676338|62772279|FG002|Overall Study|Adverse Event|5|||
33393290|NCT00676338|62772280|FG003|Overall Study|Adverse Event|1|||
33393291|NCT00676338|62772277|FG000|Overall Study|Lost to Follow-up|4|||
33393292|NCT00676338|62772278|FG001|Overall Study|Lost to Follow-up|1|||
33393293|NCT00676338|62772279|FG002|Overall Study|Lost to Follow-up|3|||
33302261|NCT01261611|62678045|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
33393294|NCT00676338|62772280|FG003|Overall Study|Lost to Follow-up|4|||
33393295|NCT00676338|62772277|FG000|Overall Study|Physician Decision|3|||
33393296|NCT00676338|62772278|FG001|Overall Study|Physician Decision|3|||
33393297|NCT00676338|62772279|FG002|Overall Study|Physician Decision|2|||
33393298|NCT00676338|62772280|FG003|Overall Study|Physician Decision|3|||
33393299|NCT00676338|62772277|FG000|Overall Study|Protocol Violation|5|||
33393300|NCT00676338|62772278|FG001|Overall Study|Protocol Violation|9|||
33393301|NCT00676338|62772279|FG002|Overall Study|Protocol Violation|2|||
33393302|NCT00676338|62772280|FG003|Overall Study|Protocol Violation|5|||
33393303|NCT00676338|62772277|FG000|Overall Study|Withdrawal by Subject|17|||
33393304|NCT00676338|62772278|FG001|Overall Study|Withdrawal by Subject|9|||
33393305|NCT00676338|62772279|FG002|Overall Study|Withdrawal by Subject|12|||
33393306|NCT00676338|62772280|FG003|Overall Study|Withdrawal by Subject|6|||
33393307|NCT00676338|62772277|FG000|Overall Study|Entry Criteria Not Met|0|||
33393308|NCT00676338|62772278|FG001|Overall Study|Entry Criteria Not Met|2|||
33393309|NCT00676338|62772279|FG002|Overall Study|Entry Criteria Not Met|1|||
33393310|NCT00676338|62772280|FG003|Overall Study|Entry Criteria Not Met|1|||
33393311|NCT00676338|62772277|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
33393312|NCT00676338|62772278|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
33393313|NCT00676338|62772279|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
33393314|NCT00676338|62772280|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
33393315|NCT00382291|62772293|FG000|Overall Study|Adverse Event|1|||
33393316|NCT00382291|62772294|FG001|Overall Study|Adverse Event|2|||
33393317|NCT00382291|62772295|FG002|Overall Study|Adverse Event|2|||
33393318|NCT00382291|62772293|FG000|Overall Study|Protocol Violation|1|||
33393319|NCT00382291|62772294|FG001|Overall Study|Protocol Violation|0|||
33393320|NCT00382291|62772295|FG002|Overall Study|Protocol Violation|0|||
33393321|NCT00382291|62772293|FG000|Overall Study|Temporary study suspension|2|||
33393322|NCT00382291|62772294|FG001|Overall Study|Temporary study suspension|2|||
33393323|NCT00382291|62772295|FG002|Overall Study|Temporary study suspension|5|||
33393324|NCT00382291|62772293|FG000|Overall Study|Withdrawal by Subject|0|||
33393325|NCT00382291|62772294|FG001|Overall Study|Withdrawal by Subject|2|||
33393326|NCT00382291|62772295|FG002|Overall Study|Withdrawal by Subject|0|||
33393327|NCT00382291|62772293|FG000|Overall Study|Physician Decision|0|||
33393328|NCT00382291|62772294|FG001|Overall Study|Physician Decision|1|||
33393329|NCT00382291|62772295|FG002|Overall Study|Physician Decision|0|||
33393330|NCT00382291|62772293|FG000|Overall Study|Lack of Efficacy|0|||
33393331|NCT00382291|62772294|FG001|Overall Study|Lack of Efficacy|0|||
33393332|NCT00382291|62772295|FG002|Overall Study|Lack of Efficacy|1|||
33393333|NCT00547378|62772317|FG000|Randomized Cohort|Withdrawal by Subject|7|||
33393334|NCT00547378|62772318|FG001|Randomized Cohort|Withdrawal by Subject|5|||
33393335|NCT00547378|62772319|FG002|Randomized Cohort|Withdrawal by Subject|0|||
33393336|NCT00547378|62772317|FG000|Randomized Cohort|Death|0|||
33393337|NCT00547378|62772318|FG001|Randomized Cohort|Death|1|||
33393338|NCT00547378|62772319|FG002|Randomized Cohort|Death|0|||
33393339|NCT00547378|62772317|FG000|Randomized Cohort|Lost to Follow-up|1|||
33393340|NCT00547378|62772318|FG001|Randomized Cohort|Lost to Follow-up|0|||
33566553|NCT01865617|62962384|FG000|Overall Study|Death|27|||
33566554|NCT01865617|62962385|FG001|Overall Study|Death|3|||
33566555|NCT01865617|62962386|FG002|Overall Study|Death|1|||
33566556|NCT01865617|62962387|FG003|Overall Study|Death|1|||
33566557|NCT01865617|62962388|FG004|Overall Study|Death|5|||
33566558|NCT01865617|62962389|FG005|Overall Study|Death|1|||
33566559|NCT01865617|62962390|FG006|Overall Study|Death|11|||
33566560|NCT01865617|62962391|FG007|Overall Study|Death|1|||
33566561|NCT01865617|62962392|FG008|Overall Study|Death|11|||
33566562|NCT01865617|62962393|FG009|Overall Study|Death|3|||
33664117|NCT02677116|63095125|FG007|Overall Study|Withdrawal by Subject|0|||
33664118|NCT02677116|63095126|FG008|Overall Study|Withdrawal by Subject|0|||
33664119|NCT02689518|63095169|FG000|Overall Study|Withdrawal by Subject|3|||
33664120|NCT02681094|63095176|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
33393341|NCT00547378|62772319|FG002|Randomized Cohort|Lost to Follow-up|0|||
33393342|NCT00547378|62772317|FG000|Randomized Cohort|Adverse Event|1|||
33393343|NCT00547378|62772318|FG001|Randomized Cohort|Adverse Event|0|||
33393344|NCT00547378|62772319|FG002|Randomized Cohort|Adverse Event|0|||
33393345|NCT00547378|62772317|FG000|Randomized Cohort|Other reasons|2|||
33393346|NCT00547378|62772318|FG001|Randomized Cohort|Other reasons|0|||
33393347|NCT00547378|62772319|FG002|Randomized Cohort|Other reasons|0|||
33393348|NCT00547378|62772317|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
33393349|NCT00547378|62772318|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
33393350|NCT00547378|62772319|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
33393351|NCT00547378|62772317|FG000|All Implanted Cohort|Adverse Event|4|||
33393352|NCT00547378|62772318|FG001|All Implanted Cohort|Adverse Event|10|||
33393353|NCT00547378|62772319|FG002|All Implanted Cohort|Adverse Event|17|||
33393354|NCT00547378|62772317|FG000|All Implanted Cohort|Lost to Follow-up|0|||
33393355|NCT00547378|62772318|FG001|All Implanted Cohort|Lost to Follow-up|1|||
33393356|NCT00547378|62772319|FG002|All Implanted Cohort|Lost to Follow-up|14|||
33393357|NCT00547378|62772317|FG000|All Implanted Cohort|Death|3|||
33393358|NCT00547378|62772318|FG001|All Implanted Cohort|Death|1|||
33393359|NCT00547378|62772319|FG002|All Implanted Cohort|Death|4|||
33566563|NCT01865617|62962394|FG010|Overall Study|Death|32|||
33566564|NCT01865617|62962395|FG011|Overall Study|Death|6|||
33393360|NCT00547378|62772317|FG000|All Implanted Cohort|Physician Decision|0|||
33393361|NCT00547378|62772318|FG001|All Implanted Cohort|Physician Decision|2|||
33393362|NCT00547378|62772319|FG002|All Implanted Cohort|Physician Decision|6|||
33566565|NCT01865617|62962396|FG012|Overall Study|Death|13|||
33566566|NCT01865617|62962384|FG000|Overall Study|Lost to Follow-up|2|||
33566567|NCT01865617|62962385|FG001|Overall Study|Lost to Follow-up|0|||
33566568|NCT01865617|62962386|FG002|Overall Study|Lost to Follow-up|0|||
33566569|NCT01865617|62962387|FG003|Overall Study|Lost to Follow-up|0|||
33566570|NCT01865617|62962388|FG004|Overall Study|Lost to Follow-up|0|||
33566571|NCT01865617|62962389|FG005|Overall Study|Lost to Follow-up|0|||
33566572|NCT01865617|62962390|FG006|Overall Study|Lost to Follow-up|0|||
33566573|NCT01865617|62962391|FG007|Overall Study|Lost to Follow-up|0|||
33566574|NCT01865617|62962392|FG008|Overall Study|Lost to Follow-up|0|||
33566575|NCT01865617|62962393|FG009|Overall Study|Lost to Follow-up|0|||
33566576|NCT01865617|62962394|FG010|Overall Study|Lost to Follow-up|0|||
33566577|NCT01865617|62962395|FG011|Overall Study|Lost to Follow-up|0|||
33393363|NCT00547378|62772317|FG000|All Implanted Cohort|Site closure|2|||
33393364|NCT00547378|62772318|FG001|All Implanted Cohort|Site closure|0|||
33393365|NCT00547378|62772319|FG002|All Implanted Cohort|Site closure|1|||
33393366|NCT00547378|62772317|FG000|All Implanted Cohort|Other reasons|1|||
33393367|NCT00547378|62772318|FG001|All Implanted Cohort|Other reasons|0|||
33393368|NCT00547378|62772319|FG002|All Implanted Cohort|Other reasons|1|||
33393369|NCT00381043|62772329|FG000|Overall Study|Lost to Follow-up|8|||
33393370|NCT00381043|62772330|FG001|Overall Study|Lost to Follow-up|6|||
33393371|NCT00381043|62772329|FG000|Overall Study|Withdrawal by Subject|3|||
33393372|NCT00381043|62772330|FG001|Overall Study|Withdrawal by Subject|1|||
33393373|NCT00381043|62772329|FG000|Overall Study|wanted more care|0|||
33393374|NCT00381043|62772330|FG001|Overall Study|wanted more care|1|||
33393375|NCT00381043|62772329|FG000|Overall Study|incarcerated|1|||
33393376|NCT00381043|62772330|FG001|Overall Study|incarcerated|0|||
33393377|NCT00614991|62772342|FG000|Overall Study|Adverse Event|3|||
33393378|NCT00614991|62772343|FG001|Overall Study|Adverse Event|3|||
33393379|NCT00614991|62772344|FG002|Overall Study|Adverse Event|0|||
33393380|NCT00614991|62772345|FG003|Overall Study|Adverse Event|0|||
33393381|NCT00614991|62772346|FG004|Overall Study|Adverse Event|1|||
33393382|NCT00614991|62772347|FG005|Overall Study|Adverse Event|0|||
33393383|NCT00360529|62772369|FG000|Overall Study|Adverse Event|10|||
33393384|NCT00360529|62772370|FG001|Overall Study|Adverse Event|23|||
33393385|NCT00360529|62772371|FG002|Overall Study|Adverse Event|33|||
33393386|NCT00360529|62772369|FG000|Overall Study|Protocol Violation|3|||
33393387|NCT00360529|62772370|FG001|Overall Study|Protocol Violation|3|||
33393388|NCT00360529|62772371|FG002|Overall Study|Protocol Violation|11|||
33393389|NCT00360529|62772369|FG000|Overall Study|Lost to Follow-up|14|||
33393390|NCT00360529|62772370|FG001|Overall Study|Lost to Follow-up|10|||
33393391|NCT00360529|62772371|FG002|Overall Study|Lost to Follow-up|13|||
33393392|NCT00360529|62772369|FG000|Overall Study|Withdrawal by Subject|22|||
33393393|NCT00360529|62772370|FG001|Overall Study|Withdrawal by Subject|14|||
33566578|NCT01865617|62962396|FG012|Overall Study|Lost to Follow-up|0|||
33566579|NCT01865617|62962384|FG000|Overall Study|Withdrawal by Subject|1|||
33566580|NCT01865617|62962385|FG001|Overall Study|Withdrawal by Subject|0|||
33566581|NCT01865617|62962386|FG002|Overall Study|Withdrawal by Subject|0|||
33566582|NCT01865617|62962387|FG003|Overall Study|Withdrawal by Subject|0|||
33566583|NCT01865617|62962388|FG004|Overall Study|Withdrawal by Subject|0|||
33566584|NCT01865617|62962389|FG005|Overall Study|Withdrawal by Subject|0|||
33566585|NCT01865617|62962390|FG006|Overall Study|Withdrawal by Subject|0|||
33566586|NCT01865617|62962391|FG007|Overall Study|Withdrawal by Subject|0|||
33566587|NCT01865617|62962392|FG008|Overall Study|Withdrawal by Subject|0|||
33566588|NCT01865617|62962393|FG009|Overall Study|Withdrawal by Subject|0|||
33566589|NCT01865617|62962394|FG010|Overall Study|Withdrawal by Subject|0|||
33566590|NCT01865617|62962395|FG011|Overall Study|Withdrawal by Subject|0|||
33566591|NCT01865617|62962396|FG012|Overall Study|Withdrawal by Subject|0|||
33566592|NCT01865617|62962384|FG000|Overall Study|Patient proceeded to new therapy|0|||
33566593|NCT01865617|62962385|FG001|Overall Study|Patient proceeded to new therapy|0|||
33566594|NCT01865617|62962386|FG002|Overall Study|Patient proceeded to new therapy|0|||
33566595|NCT01865617|62962387|FG003|Overall Study|Patient proceeded to new therapy|0|||
33566596|NCT01865617|62962388|FG004|Overall Study|Patient proceeded to new therapy|2|||
33566597|NCT01865617|62962389|FG005|Overall Study|Patient proceeded to new therapy|0|||
33566598|NCT01865617|62962390|FG006|Overall Study|Patient proceeded to new therapy|0|||
33566599|NCT01865617|62962391|FG007|Overall Study|Patient proceeded to new therapy|0|||
33566600|NCT01865617|62962392|FG008|Overall Study|Patient proceeded to new therapy|0|||
33566601|NCT01865617|62962393|FG009|Overall Study|Patient proceeded to new therapy|0|||
33566602|NCT01865617|62962394|FG010|Overall Study|Patient proceeded to new therapy|0|||
33566603|NCT01865617|62962395|FG011|Overall Study|Patient proceeded to new therapy|0|||
33393394|NCT00360529|62772371|FG002|Overall Study|Withdrawal by Subject|18|||
33393395|NCT00360529|62772369|FG000|Overall Study|Lack of Efficacy|8|||
33393396|NCT00360529|62772370|FG001|Overall Study|Lack of Efficacy|6|||
33393397|NCT00360529|62772371|FG002|Overall Study|Lack of Efficacy|5|||
33393398|NCT00360529|62772369|FG000|Overall Study|Reason discontinued not explained above|4|||
33393399|NCT00360529|62772370|FG001|Overall Study|Reason discontinued not explained above|9|||
33393400|NCT00360529|62772371|FG002|Overall Study|Reason discontinued not explained above|11|||
33393401|NCT00369577|62772382|FG000|Overall Study|Withdrawal by Subject|0|||
33393402|NCT00369577|62772383|FG001|Overall Study|Withdrawal by Subject|0|||
33393403|NCT00369577|62772384|FG002|Overall Study|Withdrawal by Subject|1|||
33393404|NCT00678288|62772394|FG000|Overall Study|Adverse Event|0|||
33393405|NCT00678288|62772395|FG001|Overall Study|Adverse Event|2|||
33393406|NCT00678288|62772394|FG000|Overall Study|Withdrawal by Subject|1|||
33393407|NCT00678288|62772395|FG001|Overall Study|Withdrawal by Subject|1|||
33393408|NCT00678288|62772394|FG000|Overall Study|Study terminated by the sponsor|2|||
33393409|NCT00678288|62772395|FG001|Overall Study|Study terminated by the sponsor|0|||
33393410|NCT00678288|62772394|FG000|Overall Study|Not compliant with study medication|0|||
33393411|NCT00678288|62772395|FG001|Overall Study|Not compliant with study medication|1|||
33393412|NCT00678288|62772394|FG000|Overall Study|Switch to commercial drug|0|||
33393413|NCT00678288|62772395|FG001|Overall Study|Switch to commercial drug|1|||
33393414|NCT00678288|62772394|FG000|Overall Study|Reason not reported|1|||
33393415|NCT00678288|62772395|FG001|Overall Study|Reason not reported|0|||
33393416|NCT00678288|62772394|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
33393417|NCT00678288|62772395|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
33393418|NCT00369343|62772403|FG000|Double-blind Phase|Adverse Event|19|||
33393419|NCT00369343|62772404|FG001|Double-blind Phase|Adverse Event|4|||
33393420|NCT00369343|62772403|FG000|Double-blind Phase|Failed to return|2|||
33393421|NCT00369343|62772404|FG001|Double-blind Phase|Failed to return|0|||
33393422|NCT00369343|62772403|FG000|Double-blind Phase|Lost to Follow-up|9|||
33393423|NCT00369343|62772404|FG001|Double-blind Phase|Lost to Follow-up|2|||
33393424|NCT00369343|62772403|FG000|Double-blind Phase|Protocol Violation|2|||
33393425|NCT00369343|62772404|FG001|Double-blind Phase|Protocol Violation|0|||
33393426|NCT00369343|62772403|FG000|Double-blind Phase|Withdrawal by Subject|8|||
33393427|NCT00369343|62772404|FG001|Double-blind Phase|Withdrawal by Subject|6|||
33393428|NCT00369343|62772403|FG000|Double-blind Phase|Lack of Efficacy|0|||
33393429|NCT00369343|62772404|FG001|Double-blind Phase|Lack of Efficacy|4|||
33393430|NCT00369343|62772403|FG000|Double-blind Phase|Protocol deviation|4|||
33393431|NCT00369343|62772404|FG001|Double-blind Phase|Protocol deviation|0|||
33393432|NCT00369343|62772403|FG000|Open-label Phase|Adverse Event|19|||
33393433|NCT00369343|62772404|FG001|Open-label Phase|Adverse Event|7|||
33393434|NCT00369343|62772403|FG000|Open-label Phase|Failed to return|4|||
33393435|NCT00369343|62772404|FG001|Open-label Phase|Failed to return|0|||
33393436|NCT00369343|62772403|FG000|Open-label Phase|Physician Decision|2|||
33393437|NCT00369343|62772404|FG001|Open-label Phase|Physician Decision|0|||
33393438|NCT00369343|62772403|FG000|Open-label Phase|Lost to Follow-up|5|||
33393439|NCT00369343|62772404|FG001|Open-label Phase|Lost to Follow-up|3|||
33393440|NCT00369343|62772403|FG000|Open-label Phase|inadvertently reported study completers|3|||
33393441|NCT00369343|62772404|FG001|Open-label Phase|inadvertently reported study completers|2|||
33393442|NCT00369343|62772403|FG000|Open-label Phase|Protocol Violation|1|||
33393443|NCT00369343|62772404|FG001|Open-label Phase|Protocol Violation|3|||
33393444|NCT00369343|62772403|FG000|Open-label Phase|Withdrawal by Subject|15|||
33393445|NCT00369343|62772404|FG001|Open-label Phase|Withdrawal by Subject|6|||
33393446|NCT00369343|62772403|FG000|Open-label Phase|Lack of Efficacy|4|||
33393447|NCT00369343|62772404|FG001|Open-label Phase|Lack of Efficacy|3|||
33393448|NCT00369343|62772403|FG000|Open-label Phase|Lack of continuance tolerability|3|||
33393449|NCT00369343|62772404|FG001|Open-label Phase|Lack of continuance tolerability|4|||
33393450|NCT00369343|62772403|FG000|Open-label Phase|did not take study drug|1|||
33393451|NCT00369343|62772404|FG001|Open-label Phase|did not take study drug|2|||
33393452|NCT00369265|62772419|FG000|Overall Study|Study terminated|4|||
33393453|NCT00369265|62772420|FG001|Overall Study|Study terminated|7|||
33393454|NCT00368875|62772426|FG000|Overall Study|Adverse Event|0|||
33393455|NCT00368875|62772427|FG001|Overall Study|Adverse Event|12|||
33393456|NCT00368875|62772426|FG000|Overall Study|Progressive disease|3|||
33393457|NCT00368875|62772427|FG001|Overall Study|Progressive disease|27|||
33393458|NCT00368875|62772426|FG000|Overall Study|Withdrawal by Subject|2|||
33393459|NCT00368875|62772427|FG001|Overall Study|Withdrawal by Subject|6|||
33393460|NCT00368875|62772426|FG000|Overall Study|Other Reason|0|||
33393461|NCT00368875|62772427|FG001|Overall Study|Other Reason|2|||
33393462|NCT00368875|62772426|FG000|Overall Study|Alternative Therapy|1|||
33393463|NCT00368875|62772427|FG001|Overall Study|Alternative Therapy|1|||
33393464|NCT00614055|62772436|FG000|Overall Study|Adverse Event|1|||
33393465|NCT00614055|62772437|FG001|Overall Study|Adverse Event|0|||
33393466|NCT00614055|62772438|FG002|Overall Study|Adverse Event|0|||
33393467|NCT00614055|62772436|FG000|Overall Study|Protocol Violation|2|||
33393468|NCT00614055|62772437|FG001|Overall Study|Protocol Violation|2|||
33393469|NCT00614055|62772438|FG002|Overall Study|Protocol Violation|1|||
33393470|NCT00614055|62772436|FG000|Overall Study|Lack of Efficacy|0|||
33566604|NCT01865617|62962396|FG012|Overall Study|Patient proceeded to new therapy|0|||
33393471|NCT00614055|62772437|FG001|Overall Study|Lack of Efficacy|0|||
33393472|NCT00614055|62772438|FG002|Overall Study|Lack of Efficacy|2|||
33393473|NCT00614055|62772436|FG000|Overall Study|Unclassified|1|||
33393474|NCT00614055|62772437|FG001|Overall Study|Unclassified|4|||
33393475|NCT00614055|62772438|FG002|Overall Study|Unclassified|2|||
33393476|NCT00613821|62772451|FG000|Overall Study|Withdrawal by Subject|1|||
33393477|NCT00613821|62772452|FG001|Overall Study|Withdrawal by Subject|0|||
33393478|NCT00613821|62772451|FG000|Overall Study|Physician Decision|1|||
33393479|NCT00613821|62772452|FG001|Overall Study|Physician Decision|1|||
33393480|NCT00548548|62772460|FG000|Overall Study|Death|345|||
33393481|NCT00548548|62772461|FG001|Overall Study|Death|348|||
33393482|NCT00548548|62772460|FG000|Overall Study|Lost to Follow-up|17|||
33393483|NCT00548548|62772461|FG001|Overall Study|Lost to Follow-up|18|||
33393484|NCT00613509|62772469|FG000|Cycle 1|Adverse Event|2|||
33393485|NCT00613509|62772470|FG001|Cycle 1|Adverse Event|1|||
33393486|NCT00613509|62772469|FG000|Cycle 1|Disease Progression|2|||
33393487|NCT00613509|62772470|FG001|Cycle 1|Disease Progression|6|||
33393488|NCT00613509|62772469|FG000|Cycle 1|Unacceptable Toxicity|1|||
33393489|NCT00613509|62772470|FG001|Cycle 1|Unacceptable Toxicity|0|||
33393490|NCT00613509|62772469|FG000|Cycle 1|Other administrative reason|0|||
33393491|NCT00613509|62772470|FG001|Cycle 1|Other administrative reason|1|||
33393492|NCT00547300|62772495|FG000|Overall Study|Study was Administratively Terminated|25|||
33393493|NCT00547300|62772496|FG001|Overall Study|Study was Administratively Terminated|24|||
33393494|NCT00547300|62772495|FG000|Overall Study|Did not Meet Entry Criteria|0|||
33393495|NCT00547300|62772496|FG001|Overall Study|Did not Meet Entry Criteria|2|||
33393496|NCT00612807|62772504|FG000|Overall Study|Withdrawal by Subject|2|||
33393497|NCT00612807|62772505|FG001|Overall Study|Withdrawal by Subject|0|||
33393498|NCT00678210|62772515|FG000|Overall Study|Adverse Event|1|||
33393499|NCT00678210|62772516|FG001|Overall Study|Adverse Event|2|||
33393500|NCT00678210|62772517|FG002|Overall Study|Adverse Event|3|||
33393501|NCT00678210|62772518|FG003|Overall Study|Adverse Event|3|||
33393502|NCT00678210|62772515|FG000|Overall Study|Lack of Efficacy|2|||
33393503|NCT00678210|62772516|FG001|Overall Study|Lack of Efficacy|3|||
33393504|NCT00678210|62772517|FG002|Overall Study|Lack of Efficacy|1|||
33393505|NCT00678210|62772518|FG003|Overall Study|Lack of Efficacy|9|||
33393506|NCT00678210|62772515|FG000|Overall Study|Lost to Follow-up|4|||
33393507|NCT00678210|62772516|FG001|Overall Study|Lost to Follow-up|2|||
33393508|NCT00678210|62772517|FG002|Overall Study|Lost to Follow-up|0|||
33393509|NCT00678210|62772518|FG003|Overall Study|Lost to Follow-up|1|||
33393510|NCT00678210|62772515|FG000|Overall Study|Withdrawal by Subject|3|||
33393511|NCT00678210|62772516|FG001|Overall Study|Withdrawal by Subject|4|||
33393512|NCT00678210|62772517|FG002|Overall Study|Withdrawal by Subject|1|||
33393513|NCT00678210|62772518|FG003|Overall Study|Withdrawal by Subject|7|||
33393514|NCT00678210|62772515|FG000|Overall Study|Other|1|||
33393515|NCT00678210|62772516|FG001|Overall Study|Other|0|||
33393516|NCT00678210|62772517|FG002|Overall Study|Other|1|||
33393517|NCT00678210|62772518|FG003|Overall Study|Other|0|||
33393518|NCT00611715|62772530|FG000|Overall Study|Disease Progression|24|||
33393519|NCT00611715|62772531|FG001|Overall Study|Disease Progression|4|||
33393520|NCT00611715|62772530|FG000|Overall Study|Withdrawal by Subject|5|||
33393521|NCT00611715|62772531|FG001|Overall Study|Withdrawal by Subject|1|||
33393522|NCT00611715|62772530|FG000|Overall Study|Adverse Event|9|||
33393523|NCT00611715|62772531|FG001|Overall Study|Adverse Event|1|||
33393524|NCT00611715|62772530|FG000|Overall Study|Death|1|||
33393525|NCT00611715|62772531|FG001|Overall Study|Death|0|||
33393526|NCT00611715|62772530|FG000|Overall Study|two patients are still on treatment|2|||
33393527|NCT00611715|62772531|FG001|Overall Study|two patients are still on treatment|0|||
33664121|NCT02681094|63095177|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
33393528|NCT00677820|62772545|FG000|Overall Study|Lost to Follow-up|1|||
33393529|NCT00677820|62772546|FG001|Overall Study|Lost to Follow-up|0|||
33393530|NCT00611559|62772555|FG000|Overall Study|Lost to Follow-up|0|||
33393531|NCT00611559|62772556|FG001|Overall Study|Lost to Follow-up|1|||
33393532|NCT00611559|62772557|FG002|Overall Study|Lost to Follow-up|0|||
33393533|NCT00611559|62772555|FG000|Overall Study|Protocol Violation|1|||
33393534|NCT00611559|62772556|FG001|Overall Study|Protocol Violation|0|||
33393535|NCT00611559|62772557|FG002|Overall Study|Protocol Violation|1|||
33490334|NCT00069095|62868447|FG004|Primary Treatment Phase|Admin/Other|48|||
33490335|NCT00069095|62868448|FG005|Primary Treatment Phase|Admin/Other|42|||
33490336|NCT00069095|62868443|FG000|Primary Treatment Phase|Adverse Event|99|||
33490337|NCT00069095|62868444|FG001|Primary Treatment Phase|Adverse Event|92|||
33490338|NCT00069095|62868445|FG002|Primary Treatment Phase|Adverse Event|71|||
33490339|NCT00069095|62868446|FG003|Primary Treatment Phase|Adverse Event|72|||
33490340|NCT00069095|62868447|FG004|Primary Treatment Phase|Adverse Event|109|||
33490341|NCT00069095|62868448|FG005|Primary Treatment Phase|Adverse Event|101|||
33490342|NCT00069095|62868443|FG000|Primary Treatment Phase|Death|14|||
33490343|NCT00069095|62868444|FG001|Primary Treatment Phase|Death|8|||
33490344|NCT00069095|62868445|FG002|Primary Treatment Phase|Death|2|||
33490345|NCT00069095|62868446|FG003|Primary Treatment Phase|Death|5|||
33490346|NCT00069095|62868447|FG004|Primary Treatment Phase|Death|8|||
33490347|NCT00069095|62868448|FG005|Primary Treatment Phase|Death|8|||
33490348|NCT00069095|62868443|FG000|Primary Treatment Phase|Failure to return|5|||
33393536|NCT00611247|62772567|FG000|Overall Study|Death|1|||
33393537|NCT00611247|62772568|FG001|Overall Study|Death|5|||
33393538|NCT00611247|62772567|FG000|Overall Study|Lack of Efficacy|1|||
33393539|NCT00611247|62772568|FG001|Overall Study|Lack of Efficacy|16|||
33393540|NCT00675948|62772577|FG000|Overall Study|Adverse Event|23|||
33393541|NCT00675948|62772578|FG001|Overall Study|Adverse Event|1|||
33393542|NCT00675948|62772577|FG000|Overall Study|Lack of Efficacy|3|||
33393543|NCT00675948|62772578|FG001|Overall Study|Lack of Efficacy|0|||
33393544|NCT00675948|62772577|FG000|Overall Study|Withdrawal by Subject|7|||
33393545|NCT00675948|62772578|FG001|Overall Study|Withdrawal by Subject|0|||
33393546|NCT00675948|62772577|FG000|Overall Study|Lost to Follow-up|2|||
33393547|NCT00675948|62772578|FG001|Overall Study|Lost to Follow-up|0|||
33393548|NCT00675948|62772577|FG000|Overall Study|Protocol Violation|1|||
33393549|NCT00675948|62772578|FG001|Overall Study|Protocol Violation|0|||
33393550|NCT00675948|62772577|FG000|Overall Study|Pain under control|1|||
33393551|NCT00675948|62772578|FG001|Overall Study|Pain under control|0|||
33393552|NCT00675948|62772577|FG000|Overall Study|Sponsor decision|0|||
33393553|NCT00675948|62772578|FG001|Overall Study|Sponsor decision|1|||
33393554|NCT00675948|62772577|FG000|Overall Study|Patient died|1|||
33393555|NCT00675948|62772578|FG001|Overall Study|Patient died|0|||
33393556|NCT00675948|62772577|FG000|Overall Study|Patient unable to comply with diaries|1|||
33393557|NCT00675948|62772578|FG001|Overall Study|Patient unable to comply with diaries|0|||
33393558|NCT00675948|62772577|FG000|Overall Study|Patient feels unable to take medication|0|||
33393559|NCT00675948|62772578|FG001|Overall Study|Patient feels unable to take medication|1|||
33393560|NCT00610935|62772587|FG000|Overall Study|Lost to Follow-up|0|||
33393561|NCT00610935|62772588|FG001|Overall Study|Lost to Follow-up|1|||
33393562|NCT00610935|62772587|FG000|Overall Study|Withdrawal by Subject|0|||
33393563|NCT00610935|62772588|FG001|Overall Study|Withdrawal by Subject|2|||
33393564|NCT00610935|62772587|FG000|Overall Study|Sponsor Discontinuation|1|||
33393565|NCT00610935|62772588|FG001|Overall Study|Sponsor Discontinuation|0|||
33393566|NCT00610857|62772603|FG000|Overall Study|Not evaluable for response|2|||
33393567|NCT00672984|62772610|FG000|First Intervention|Adverse Event|5|||
33393568|NCT00672984|62772611|FG001|First Intervention|Adverse Event|0|||
33393569|NCT00672984|62772612|FG002|First Intervention|Adverse Event|0|||
33566605|NCT01865617|62962384|FG000|Overall Study|Other|0|||
33566606|NCT01865617|62962385|FG001|Overall Study|Other|0|||
33566607|NCT01865617|62962386|FG002|Overall Study|Other|0|||
33566608|NCT01865617|62962387|FG003|Overall Study|Other|0|||
33566609|NCT01865617|62962388|FG004|Overall Study|Other|0|||
33566610|NCT01865617|62962389|FG005|Overall Study|Other|0|||
33566611|NCT01865617|62962390|FG006|Overall Study|Other|1|||
33566612|NCT01865617|62962391|FG007|Overall Study|Other|0|||
33302262|NCT01261611|62678046|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
33302263|NCT01261611|62678047|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
33302264|NCT01261611|62678045|FG000|Treatment Cycle 4|Adverse Event|1|||
33302265|NCT01261611|62678046|FG001|Treatment Cycle 4|Adverse Event|0|||
33302266|NCT01261611|62678047|FG002|Treatment Cycle 4|Adverse Event|0|||
33302267|NCT01261611|62678045|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
33302268|NCT01261611|62678046|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
33302269|NCT01261611|62678047|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
33302270|NCT01261611|62678045|FG000|Treatment Cycle 4|Not otherwise specified|3|||
33302271|NCT01261611|62678046|FG001|Treatment Cycle 4|Not otherwise specified|0|||
33302272|NCT01261611|62678047|FG002|Treatment Cycle 4|Not otherwise specified|0|||
33302273|NCT01261611|62678045|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
33302274|NCT01261611|62678046|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
33302275|NCT01261611|62678047|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
33302276|NCT01261611|62678045|FG000|Treatment Cycle 5|Adverse Event|1|||
33302277|NCT01261611|62678046|FG001|Treatment Cycle 5|Adverse Event|0|||
33302278|NCT01261611|62678047|FG002|Treatment Cycle 5|Adverse Event|0|||
33302279|NCT01261611|62678045|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
33302280|NCT01261611|62678046|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
33302281|NCT01261611|62678047|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
33302282|NCT01304706|62678059|FG000|Overall Study|Adverse Event|2|||
33302283|NCT01304706|62678059|FG000|Overall Study|Lack of Efficacy|1|||
33302284|NCT01304706|62678059|FG000|Overall Study|Death|3|||
33302285|NCT01304706|62678059|FG000|Overall Study|Withdrawal by Subject|3|||
33302286|NCT01304706|62678059|FG000|Overall Study|Lost to Follow-up|7|||
33302287|NCT01304706|62678059|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
33302288|NCT01303380|62678063|FG000|Overall Study|Lack of compliance to study procedures|1|||
33302289|NCT01008553|62678067|FG000|Period 1 (Titration Period)|Physician Decision|2|||
33302290|NCT01008553|62678068|FG001|Period 1 (Titration Period)|Physician Decision|0|||
33302291|NCT01008553|62678069|FG002|Period 1 (Titration Period)|Physician Decision|0|||
33302292|NCT01008553|62678067|FG000|Period 1 (Titration Period)|Adverse Event|33|||
33302293|NCT01008553|62678068|FG001|Period 1 (Titration Period)|Adverse Event|0|||
33302294|NCT01008553|62678069|FG002|Period 1 (Titration Period)|Adverse Event|0|||
33302295|NCT01008553|62678067|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
33302296|NCT01008553|62678068|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
33566613|NCT01865617|62962392|FG008|Overall Study|Other|0|||
33393570|NCT00672984|62772610|FG000|First Intervention|Withdrawal by Subject|1|||
33393571|NCT00672984|62772611|FG001|First Intervention|Withdrawal by Subject|2|||
33393572|NCT00672984|62772612|FG002|First Intervention|Withdrawal by Subject|2|||
33393573|NCT00672984|62772610|FG000|First Intervention|Sponsor decision|3|||
33393574|NCT00672984|62772611|FG001|First Intervention|Sponsor decision|0|||
33393575|NCT00672984|62772612|FG002|First Intervention|Sponsor decision|0|||
33393576|NCT00672984|62772610|FG000|Second Intervention|Non-compliance with facility policies|0|||
33393577|NCT00672984|62772611|FG001|Second Intervention|Non-compliance with facility policies|2|||
33393578|NCT00672984|62772612|FG002|Second Intervention|Non-compliance with facility policies|0|||
33393579|NCT00672984|62772610|FG000|Second Intervention|Withdrawal by Subject|0|||
33393580|NCT00672984|62772611|FG001|Second Intervention|Withdrawal by Subject|3|||
33393581|NCT00672984|62772612|FG002|Second Intervention|Withdrawal by Subject|0|||
33393582|NCT00672984|62772610|FG000|Second Intervention|Protocol Violation|0|||
33393583|NCT00672984|62772611|FG001|Second Intervention|Protocol Violation|1|||
33393584|NCT00672984|62772612|FG002|Second Intervention|Protocol Violation|1|||
33393585|NCT00672984|62772610|FG000|Third Intervention|Adverse Event|1|||
33393586|NCT00672984|62772611|FG001|Third Intervention|Adverse Event|0|||
33393587|NCT00672984|62772612|FG002|Third Intervention|Adverse Event|1|||
33393588|NCT00546364|62772625|FG000|Overall Study|Disease progression|5|||
33393589|NCT00546364|62772626|FG001|Overall Study|Disease progression|11|||
33393590|NCT00546364|62772627|FG002|Overall Study|Disease progression|8|||
33393591|NCT00546364|62772625|FG000|Overall Study|Completed and off treatment|1|||
33393592|NCT00546364|62772626|FG001|Overall Study|Completed and off treatment|0|||
33393593|NCT00546364|62772627|FG002|Overall Study|Completed and off treatment|2|||
33393594|NCT00546364|62772625|FG000|Overall Study|Administrative reason by sponsor|1|||
33393595|NCT00546364|62772626|FG001|Overall Study|Administrative reason by sponsor|0|||
33393596|NCT00546364|62772627|FG002|Overall Study|Administrative reason by sponsor|0|||
33393597|NCT00546364|62772625|FG000|Overall Study|Poor compliance/noncompliance|0|||
33393598|NCT00546364|62772626|FG001|Overall Study|Poor compliance/noncompliance|0|||
33393599|NCT00546364|62772627|FG002|Overall Study|Poor compliance/noncompliance|1|||
33393600|NCT00546364|62772625|FG000|Overall Study|No longer meets study criteria|1|||
33393601|NCT00546364|62772626|FG001|Overall Study|No longer meets study criteria|1|||
33393602|NCT00546364|62772627|FG002|Overall Study|No longer meets study criteria|0|||
33393603|NCT00546364|62772625|FG000|Overall Study|Withdrawal by Subject|5|||
33393604|NCT00546364|62772626|FG001|Overall Study|Withdrawal by Subject|6|||
33393605|NCT00546364|62772627|FG002|Overall Study|Withdrawal by Subject|3|||
33393606|NCT00546364|62772625|FG000|Overall Study|Prior taxotere|1|||
33393607|NCT00546364|62772626|FG001|Overall Study|Prior taxotere|0|||
33393608|NCT00546364|62772627|FG002|Overall Study|Prior taxotere|0|||
33393609|NCT00546364|62772625|FG000|Overall Study|Mixed response|1|||
33393610|NCT00546364|62772626|FG001|Overall Study|Mixed response|0|||
33393611|NCT00546364|62772627|FG002|Overall Study|Mixed response|0|||
33393612|NCT00546364|62772625|FG000|Overall Study|Palliative treatment|1|||
33393613|NCT00546364|62772626|FG001|Overall Study|Palliative treatment|0|||
33393614|NCT00546364|62772627|FG002|Overall Study|Palliative treatment|1|||
33393615|NCT00546364|62772625|FG000|Overall Study|Target lesions resected|1|||
33393616|NCT00546364|62772626|FG001|Overall Study|Target lesions resected|0|||
33393617|NCT00546364|62772627|FG002|Overall Study|Target lesions resected|0|||
33393618|NCT00546364|62772625|FG000|Overall Study|Physician Decision|0|||
33393619|NCT00546364|62772626|FG001|Overall Study|Physician Decision|0|||
33393620|NCT00546364|62772627|FG002|Overall Study|Physician Decision|1|||
33393621|NCT00546364|62772625|FG000|Overall Study|Sponsor decision|0|||
33393622|NCT00546364|62772626|FG001|Overall Study|Sponsor decision|0|||
33393623|NCT00546364|62772627|FG002|Overall Study|Sponsor decision|1|||
33393624|NCT05020327|62772646|FG000|Overall Study|Physician Decision|3|||
33393625|NCT05020327|62772647|FG001|Overall Study|Physician Decision|0|||
33393626|NCT05020327|62772648|FG002|Overall Study|Physician Decision|0|||
33393627|NCT05020327|62772646|FG000|Overall Study|Withdrawal by Subject|1|||
33393628|NCT05020327|62772647|FG001|Overall Study|Withdrawal by Subject|1|||
33393629|NCT05020327|62772648|FG002|Overall Study|Withdrawal by Subject|0|||
33393630|NCT05020327|62772646|FG000|Overall Study|personal/cultural, ineligible|12|||
33393631|NCT05020327|62772647|FG001|Overall Study|personal/cultural, ineligible|0|||
33393632|NCT05020327|62772648|FG002|Overall Study|personal/cultural, ineligible|0|||
33393633|NCT04907032|62772662|FG000|Overall Study|Withdrawal by Subject|7|||
33393634|NCT04907032|62772663|FG001|Overall Study|Withdrawal by Subject|1|||
33393635|NCT04739709|62772684|FG000|Overall Study|Physician Decision|1|||
33393636|NCT04739709|62772685|FG001|Overall Study|Physician Decision|0|||
33566614|NCT01865617|62962393|FG009|Overall Study|Other|0|||
33566615|NCT01865617|62962394|FG010|Overall Study|Other|0|||
33664122|NCT02681094|63095178|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
33393637|NCT04710927|62772702|FG000|Overall Study|Lost to Follow-up|7|||
33664123|NCT02681094|63095176|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
33393638|NCT04710927|62772703|FG001|Overall Study|Lost to Follow-up|6|||
33393639|NCT04710927|62772704|FG002|Overall Study|Lost to Follow-up|5|||
33393640|NCT04657666|62772715|FG000|Period 1|Withdrawal of participant consent|2|||
33566616|NCT01865617|62962395|FG011|Overall Study|Other|0|||
33393641|NCT04657666|62772716|FG001|Period 1|Withdrawal of participant consent|1|||
33393642|NCT04657666|62772715|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
33393643|NCT04657666|62772716|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
33393644|NCT04657666|62772715|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
33393645|NCT04657666|62772716|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
33393646|NCT04657666|62772715|FG000|Period 2|Other|2|||
33566617|NCT01865617|62962396|FG012|Overall Study|Other|0|||
33566618|NCT02458313|62962429|FG000|Overall Study|Withdrawal by Subject|6|||
33566619|NCT02458313|62962430|FG001|Overall Study|Withdrawal by Subject|8|||
33302297|NCT01008553|62678069|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
33302298|NCT01008553|62678067|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
33302299|NCT01008553|62678068|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
33302300|NCT01008553|62678069|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
33302301|NCT01008553|62678067|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
33302302|NCT01008553|62678068|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
33302303|NCT01008553|62678069|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
33302304|NCT01008553|62678067|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
33302305|NCT01008553|62678068|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
33302306|NCT01008553|62678069|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
33302307|NCT01008553|62678067|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
33302308|NCT01008553|62678068|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
33302309|NCT01008553|62678069|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
33302310|NCT01008553|62678067|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
33302311|NCT01008553|62678068|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
33302312|NCT01008553|62678069|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
33302313|NCT01008553|62678067|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
33302314|NCT01008553|62678068|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
33302315|NCT01008553|62678069|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
33302316|NCT01008553|62678067|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
33302317|NCT01008553|62678068|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
33302318|NCT01008553|62678069|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
33302319|NCT01008553|62678067|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
33302320|NCT01008553|62678068|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
33302321|NCT01008553|62678069|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
33302322|NCT01008553|62678067|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
33302323|NCT01008553|62678068|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
33302324|NCT01008553|62678069|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
33302325|NCT01008553|62678067|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
33302326|NCT01008553|62678068|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
33302327|NCT01008553|62678069|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
33302328|NCT01008553|62678067|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
33302329|NCT01008553|62678068|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
33302330|NCT01008553|62678069|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
33302331|NCT01302834|62678080|FG000|Overall Study|Protocol Violation|17|||
33302332|NCT01302834|62678081|FG001|Overall Study|Protocol Violation|23|||
33302333|NCT01302834|62678080|FG000|Overall Study|HIV positive|1|||
33302334|NCT01302834|62678081|FG001|Overall Study|HIV positive|3|||
33302335|NCT01259115|62678087|FG000|Period 1|Adverse Event|1|||
33302336|NCT01259115|62678088|FG001|Period 1|Adverse Event|0|||
33302337|NCT01259115|62678087|FG000|Period 1|Protocol Violation|2|||
33302338|NCT01259115|62678088|FG001|Period 1|Protocol Violation|0|||
33302339|NCT01259115|62678087|FG000|Period 1|Lost to Follow-up|0|||
33302340|NCT01259115|62678088|FG001|Period 1|Lost to Follow-up|1|||
33302341|NCT01259115|62678087|FG000|Period 2|Adverse Event|1|||
33302342|NCT01259115|62678088|FG001|Period 2|Adverse Event|0|||
33302343|NCT01302366|62678099|FG000|Overall Study|patient choice or noncompliance|5|||
33302344|NCT01302054|62678103|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
33302345|NCT01302054|62678104|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
33302346|NCT01302054|62678105|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
33302347|NCT01302054|62678103|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
33302348|NCT01302054|62678104|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
33302349|NCT01302054|62678105|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
33302350|NCT01302054|62678103|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
33302351|NCT01302054|62678104|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
33302352|NCT01302054|62678105|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
33566620|NCT02458313|62962429|FG000|Overall Study|Excluded for motion during MRI|1|||
33664124|NCT02681094|63095177|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
33393647|NCT04657666|62772716|FG001|Period 2|Other|0|||
33393648|NCT04657666|62772715|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
33393649|NCT04657666|62772716|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
33393650|NCT04495829|62772735|FG000|Overall Study|Lost to Follow-up|2|||
33393651|NCT04495829|62772735|FG000|Overall Study|Inclusion criterion not met|3|||
33393652|NCT04101721|62772750|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
33393653|NCT04101721|62772751|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
33393654|NCT04101721|62772750|FG000|Overall Study|Death|0|||
33393655|NCT04101721|62772751|FG001|Overall Study|Death|1|||
33393656|NCT04101721|62772750|FG000|Overall Study|Lost to Follow-up|0|||
33393657|NCT04101721|62772751|FG001|Overall Study|Lost to Follow-up|3|||
33393658|NCT03864926|62772759|FG000|Overall Study|Death|0|||
33393659|NCT03864926|62772760|FG001|Overall Study|Death|2|||
33393660|NCT03623243|62772775|FG000|Overall Study|Adverse Event|15|||
33393661|NCT03623243|62772775|FG000|Overall Study|Guardian Decision|1|||
33393662|NCT03623243|62772775|FG000|Overall Study|New Therapy for Study Indication|1|||
33393663|NCT03623243|62772775|FG000|Overall Study|Protocol Deviation|3|||
33393664|NCT03623243|62772775|FG000|Overall Study|Physician Decision|4|||
33393665|NCT03623243|62772775|FG000|Overall Study|Patient Decision|15|||
33393666|NCT03258853|62772781|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
33393667|NCT03258853|62772782|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
33393668|NCT03246347|62772788|FG000|Overall Study|On Study|23|||
33393669|NCT03089606|62772827|FG000|Overall Study|Progression after Cycle 1|1|||
33393670|NCT03006848|62772850|FG000|Overall Study|Adverse Event|1|||
33393671|NCT03006848|62772850|FG000|Overall Study|Physician Decision|1|||
33393672|NCT03006848|62772850|FG000|Overall Study|Lack of Efficacy|16|||
33393673|NCT02828358|62772890|FG000|Overall Study|Physician Decision|7|||
33393674|NCT02828358|62772891|FG001|Overall Study|Physician Decision|1|||
33393675|NCT02828358|62772890|FG000|Overall Study|Treatment Failure|6|||
33393676|NCT02828358|62772891|FG001|Overall Study|Treatment Failure|0|||
33393677|NCT02828358|62772890|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
33393678|NCT02828358|62772891|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
33393679|NCT02828358|62772890|FG000|Overall Study|Refusal of further protocol therapy|2|||
33393680|NCT02828358|62772891|FG001|Overall Study|Refusal of further protocol therapy|0|||
33393681|NCT02828358|62772890|FG000|Overall Study|Relapse|25|||
33393682|NCT02828358|62772891|FG001|Overall Study|Relapse|0|||
33393683|NCT02828358|62772890|FG000|Overall Study|Still on therapy|5|||
33566621|NCT02458313|62962430|FG001|Overall Study|Excluded for motion during MRI|2|||
33566622|NCT01328431|62962447|FG000|Baseline|Protocol Violation|0|||
33566623|NCT01328431|62962448|FG001|Baseline|Protocol Violation|2|||
33566624|NCT01328431|62962447|FG000|1 Month (1M)|Lost to Follow-up|55|||
33566625|NCT01328431|62962448|FG001|1 Month (1M)|Lost to Follow-up|58|||
33566626|NCT01328431|62962447|FG000|3 Month (3M)|Death|2|||
33566627|NCT01328431|62962448|FG001|3 Month (3M)|Death|2|||
33566628|NCT01328431|62962447|FG000|3 Month (3M)|Lost to Follow-up|75|||
33566629|NCT01328431|62962448|FG001|3 Month (3M)|Lost to Follow-up|70|||
33566630|NCT01328431|62962447|FG000|12 Month (12M)|Death|2|||
33566631|NCT01328431|62962448|FG001|12 Month (12M)|Death|6|||
33566632|NCT01328431|62962447|FG000|12 Month (12M)|Lost to Follow-up|82|||
33566633|NCT01328431|62962448|FG001|12 Month (12M)|Lost to Follow-up|91|||
33566634|NCT00893789|62962458|FG000|Overall Study|Withdrawal by Subject|3|||
33566635|NCT00893789|62962459|FG001|Overall Study|Withdrawal by Subject|1|||
33566636|NCT00893789|62962460|FG002|Overall Study|Withdrawal by Subject|3|||
33566637|NCT00893789|62962461|FG003|Overall Study|Withdrawal by Subject|1|||
33566638|NCT00893789|62962458|FG000|Overall Study|Noncompliance With Study Drug|1|||
33566639|NCT00893789|62962459|FG001|Overall Study|Noncompliance With Study Drug|0|||
33566640|NCT00893789|62962460|FG002|Overall Study|Noncompliance With Study Drug|1|||
33566641|NCT00893789|62962461|FG003|Overall Study|Noncompliance With Study Drug|2|||
33566642|NCT00893789|62962458|FG000|Overall Study|Noncompliance With Study Procedures|1|||
33566643|NCT00893789|62962459|FG001|Overall Study|Noncompliance With Study Procedures|0|||
33566644|NCT00893789|62962460|FG002|Overall Study|Noncompliance With Study Procedures|0|||
33664125|NCT02681094|63095178|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
33664126|NCT02681094|63095176|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
33664127|NCT02681094|63095177|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
33664128|NCT02681094|63095178|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
33393684|NCT02828358|62772891|FG001|Overall Study|Still on therapy|0|||
33393685|NCT02810444|62772896|FG000|Overall Study|Screen Failures|14|||
33393686|NCT02810444|62772896|FG000|Overall Study|Withdrawal by Subject|4|||
33393687|NCT02810444|62772896|FG000|Overall Study|Adverse Event|3|||
33393688|NCT02501096|62772922|FG000|Overall Study|Lost to Follow-up|0|||
33393689|NCT02501096|62772923|FG001|Overall Study|Lost to Follow-up|0|||
33393690|NCT02501096|62772924|FG002|Overall Study|Lost to Follow-up|0|||
33566645|NCT00893789|62962461|FG003|Overall Study|Noncompliance With Study Procedures|0|||
33566646|NCT00893789|62962458|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
33393691|NCT02501096|62772925|FG003|Overall Study|Lost to Follow-up|0|||
33393692|NCT02501096|62772926|FG004|Overall Study|Lost to Follow-up|1|||
33393693|NCT02501096|62772927|FG005|Overall Study|Lost to Follow-up|1|||
33393694|NCT02501096|62772928|FG006|Overall Study|Lost to Follow-up|3|||
33393695|NCT02501096|62772929|FG007|Overall Study|Lost to Follow-up|0|||
33393696|NCT02501096|62772930|FG008|Overall Study|Lost to Follow-up|0|||
33393697|NCT02501096|62772922|FG000|Overall Study|Withdrawal by Subject|1|||
33393698|NCT02501096|62772923|FG001|Overall Study|Withdrawal by Subject|0|||
33393699|NCT02501096|62772924|FG002|Overall Study|Withdrawal by Subject|7|||
33393700|NCT02501096|62772925|FG003|Overall Study|Withdrawal by Subject|13|||
33393701|NCT02501096|62772926|FG004|Overall Study|Withdrawal by Subject|2|||
33393702|NCT02501096|62772927|FG005|Overall Study|Withdrawal by Subject|2|||
33393703|NCT02501096|62772928|FG006|Overall Study|Withdrawal by Subject|2|||
33393704|NCT02501096|62772929|FG007|Overall Study|Withdrawal by Subject|3|||
33393705|NCT02501096|62772930|FG008|Overall Study|Withdrawal by Subject|0|||
33393706|NCT02501096|62772922|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
33393707|NCT02501096|62772923|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
33393708|NCT02501096|62772924|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
33393709|NCT02501096|62772925|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
33393710|NCT02501096|62772926|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
33393711|NCT02501096|62772927|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
33393712|NCT02501096|62772928|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
33393713|NCT02501096|62772929|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
33393714|NCT02501096|62772930|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
33393715|NCT02501096|62772922|FG000|Overall Study|Death|1|||
33393716|NCT02501096|62772923|FG001|Overall Study|Death|1|||
33393717|NCT02501096|62772924|FG002|Overall Study|Death|88|||
33393718|NCT02501096|62772925|FG003|Overall Study|Death|74|||
33393719|NCT02501096|62772926|FG004|Overall Study|Death|15|||
33393720|NCT02501096|62772927|FG005|Overall Study|Death|16|||
33393721|NCT02501096|62772928|FG006|Overall Study|Death|15|||
33393722|NCT02501096|62772929|FG007|Overall Study|Death|16|||
33393723|NCT02501096|62772930|FG008|Overall Study|Death|1|||
33393724|NCT01991977|62772962|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
33393725|NCT01991977|62772962|FG000|Overall Study|Withdrew after start of treatment|5|||
33393726|NCT01633541|62772968|FG000|Overall Study|Death|1|||
33393727|NCT01633541|62772969|FG001|Overall Study|Death|0|||
33393728|NCT01466036|62772979|FG000|Overall Study|Death|1|||
33393729|NCT01466036|62772980|FG001|Overall Study|Death|1|||
33566647|NCT00893789|62962459|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
33302353|NCT01302054|62678103|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
33302354|NCT01302054|62678104|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
33302355|NCT01302054|62678105|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
33302356|NCT01302054|62678103|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
33302357|NCT01302054|62678104|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
33302358|NCT01302054|62678105|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
33302359|NCT01302054|62678103|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
33302360|NCT01302054|62678104|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
33302361|NCT01302054|62678105|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
33302362|NCT01302054|62678103|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
33302363|NCT01302054|62678104|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
33302364|NCT01302054|62678105|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
33302365|NCT01302054|62678103|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
33302366|NCT01302054|62678104|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
33302367|NCT01302054|62678105|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
33302368|NCT01302054|62678103|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
33302369|NCT01302054|62678104|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
33302370|NCT01302054|62678105|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
33302371|NCT01302054|62678103|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33302372|NCT01302054|62678104|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
33302373|NCT01302054|62678105|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
33302374|NCT01302054|62678103|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
33302375|NCT01302054|62678104|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
33302376|NCT01302054|62678105|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
33302377|NCT01302054|62678103|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
33393730|NCT01466036|62772979|FG000|Overall Study|Physician Decision|0|||
33393731|NCT01466036|62772980|FG001|Overall Study|Physician Decision|4|||
33393732|NCT01466036|62772979|FG000|Overall Study|Adverse Event|2|||
33393733|NCT01466036|62772980|FG001|Overall Study|Adverse Event|6|||
33393734|NCT01466036|62772979|FG000|Overall Study|Withdrawal by Subject|2|||
33566648|NCT00893789|62962460|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
33393735|NCT01466036|62772980|FG001|Overall Study|Withdrawal by Subject|8|||
33393736|NCT01466036|62772979|FG000|Overall Study|progression/relapse|14|||
33393737|NCT01466036|62772980|FG001|Overall Study|progression/relapse|21|||
33393738|NCT01466036|62772979|FG000|Overall Study|prolonged treatment delay|1|||
33393739|NCT01466036|62772980|FG001|Overall Study|prolonged treatment delay|1|||
33393740|NCT01399372|62772989|FG000|Overall Study|Protocol Violation|3|||
33393741|NCT01399372|62772990|FG001|Overall Study|Protocol Violation|1|||
33393742|NCT01063517|62772998|FG000|Overall Study|Consent withdrawal|1|||
33393743|NCT01063517|62772999|FG001|Overall Study|Consent withdrawal|0|||
33393744|NCT01063517|62772998|FG000|Overall Study|Study reached data cut-off|19|||
33393745|NCT01063517|62772999|FG001|Overall Study|Study reached data cut-off|7|||
33393746|NCT01063517|62772998|FG000|Overall Study|Lost to Follow-up|4|||
33393747|NCT01063517|62772999|FG001|Overall Study|Lost to Follow-up|3|||
33393748|NCT01063517|62772998|FG000|Overall Study|Withdrawal by Subject|1|||
33393749|NCT01063517|62772999|FG001|Overall Study|Withdrawal by Subject|2|||
33393750|NCT01063517|62772998|FG000|Overall Study|Death|33|||
33393751|NCT01063517|62772999|FG001|Overall Study|Death|48|||
33393752|NCT00920621|62773009|FG000|Overall Study|Lost to Follow-up|16|||
33393753|NCT00920621|62773010|FG001|Overall Study|Lost to Follow-up|17|||
33393754|NCT00920621|62773011|FG002|Overall Study|Lost to Follow-up|19|||
33393755|NCT00920621|62773012|FG003|Overall Study|Lost to Follow-up|21|||
33393756|NCT00920621|62773009|FG000|Overall Study|Fetal/neonatal deaths|16|||
33302378|NCT01302054|62678104|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
33393757|NCT00920621|62773010|FG001|Overall Study|Fetal/neonatal deaths|14|||
33393758|NCT00920621|62773011|FG002|Overall Study|Fetal/neonatal deaths|16|||
33393759|NCT00920621|62773012|FG003|Overall Study|Fetal/neonatal deaths|14|||
33393760|NCT00920621|62773009|FG000|Overall Study|Blood sample not collected|22|||
33393761|NCT00920621|62773010|FG001|Overall Study|Blood sample not collected|14|||
33393762|NCT00920621|62773011|FG002|Overall Study|Blood sample not collected|0|||
33393763|NCT00920621|62773012|FG003|Overall Study|Blood sample not collected|0|||
33393764|NCT00612105|62773025|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
33393765|NCT00612105|62773026|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
33393766|NCT00612105|62773025|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
33393767|NCT00612105|62773026|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
33393768|NCT00612105|62773025|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
33393769|NCT00612105|62773026|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
33393770|NCT00612105|62773025|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
33393771|NCT00612105|62773026|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
33393772|NCT00612105|62773025|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
33393773|NCT00612105|62773026|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
33393774|NCT00612105|62773025|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
33393775|NCT00612105|62773026|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
33393776|NCT00612105|62773025|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
33393777|NCT00612105|62773026|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
33393778|NCT00612105|62773025|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
33393779|NCT00612105|62773026|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
33393780|NCT00612105|62773025|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
33393781|NCT00612105|62773026|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
33393782|NCT00612105|62773025|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
33302379|NCT01302054|62678105|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
33302380|NCT01302054|62678103|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
33302381|NCT01302054|62678104|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
33302382|NCT01302054|62678105|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
33302383|NCT01302054|62678103|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
33302384|NCT01302054|62678104|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
33302385|NCT01302054|62678105|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
33302386|NCT01302054|62678103|FG000|Double-Blind Treatment Phase|Other|0|||
33302387|NCT01302054|62678104|FG001|Double-Blind Treatment Phase|Other|4|||
33302388|NCT01302054|62678105|FG002|Double-Blind Treatment Phase|Other|9|||
33302389|NCT01301508|62678116|FG000|Overall Study|Withdrawal by Subject|1|||
33302390|NCT01301508|62678117|FG001|Overall Study|Withdrawal by Subject|2|||
33302391|NCT01301508|62678116|FG000|Overall Study|Lost to Follow-up|0|||
33302392|NCT01301508|62678117|FG001|Overall Study|Lost to Follow-up|1|||
33302393|NCT01301274|62678125|FG000|Overall Study|Physician Decision|2|||
33302394|NCT01301274|62678126|FG001|Overall Study|Physician Decision|1|||
33393783|NCT00612105|62773026|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
33393784|NCT00612105|62773025|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
33302395|NCT01300650|62678137|FG000|Overall Study|Adverse Event|1|||
33393785|NCT00612105|62773026|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
33393786|NCT00612105|62773025|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
33393787|NCT00612105|62773026|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
33302396|NCT01300572|62678142|FG000|Overall Study|HAMA + post dosimetry|1|||
33302397|NCT01077154|62678149|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
33302398|NCT01077154|62678150|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
33302399|NCT01077154|62678149|FG000|Overall Study|Withdrawal by Subject|369|||
33393788|NCT00546052|62773032|FG000|Overall Study|Adverse Event|47|||
33393789|NCT00546052|62773032|FG000|Overall Study|Lost to Follow-up|144|||
33393790|NCT00546052|62773032|FG000|Overall Study|Protocol Violation|9|||
33393791|NCT00546052|62773032|FG000|Overall Study|Withdrawal by Subject|20|||
33393792|NCT00546052|62773032|FG000|Overall Study|Non Compliance|7|||
33393793|NCT00673920|62773047|FG000|Baseline up to Week 48|Withdrew consent|1|||
33393794|NCT00673920|62773048|FG001|Baseline up to Week 48|Withdrew consent|0|||
33393795|NCT00673920|62773049|FG002|Baseline up to Week 48|Withdrew consent|2|||
33393796|NCT00673920|62773050|FG003|Baseline up to Week 48|Withdrew consent|0|||
33393797|NCT00673920|62773051|FG004|Baseline up to Week 48|Withdrew consent|0|||
33393798|NCT00673920|62773052|FG005|Baseline up to Week 48|Withdrew consent|0|||
33393799|NCT00673920|62773053|FG006|Baseline up to Week 48|Withdrew consent|0|||
33393800|NCT00673920|62773054|FG007|Baseline up to Week 48|Withdrew consent|0|||
33393801|NCT00673920|62773047|FG000|Baseline up to Week 48|Refused treatment|1|||
33393802|NCT00673920|62773048|FG001|Baseline up to Week 48|Refused treatment|0|||
33393803|NCT00673920|62773049|FG002|Baseline up to Week 48|Refused treatment|0|||
33393804|NCT00673920|62773050|FG003|Baseline up to Week 48|Refused treatment|0|||
33393805|NCT00673920|62773051|FG004|Baseline up to Week 48|Refused treatment|0|||
33393806|NCT00673920|62773052|FG005|Baseline up to Week 48|Refused treatment|0|||
33393807|NCT00673920|62773053|FG006|Baseline up to Week 48|Refused treatment|0|||
33393808|NCT00673920|62773054|FG007|Baseline up to Week 48|Refused treatment|0|||
33393809|NCT00673920|62773047|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
33393810|NCT00673920|62773048|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
33393811|NCT00673920|62773049|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
33393812|NCT00673920|62773050|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
33393813|NCT00673920|62773051|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
33393814|NCT00673920|62773052|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
33393815|NCT00673920|62773053|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
33393816|NCT00673920|62773054|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
33393817|NCT00673920|62773047|FG000|Baseline up to Week 48|Protocol Violation|0|||
33393818|NCT00673920|62773048|FG001|Baseline up to Week 48|Protocol Violation|0|||
33393819|NCT00673920|62773049|FG002|Baseline up to Week 48|Protocol Violation|1|||
33393820|NCT00673920|62773050|FG003|Baseline up to Week 48|Protocol Violation|0|||
33393821|NCT00673920|62773051|FG004|Baseline up to Week 48|Protocol Violation|0|||
33393822|NCT00673920|62773052|FG005|Baseline up to Week 48|Protocol Violation|0|||
33393823|NCT00673920|62773053|FG006|Baseline up to Week 48|Protocol Violation|0|||
33393824|NCT00673920|62773054|FG007|Baseline up to Week 48|Protocol Violation|0|||
33393825|NCT00673920|62773047|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
33393826|NCT00673920|62773048|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
33393827|NCT00673920|62773049|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
33393828|NCT00673920|62773050|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
33393829|NCT00673920|62773051|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
33393830|NCT00673920|62773052|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
33393831|NCT00673920|62773053|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
33393832|NCT00673920|62773054|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
33393833|NCT00673920|62773047|FG000|Baseline up to Week 48|Administrative/Other|0|||
33393834|NCT00673920|62773048|FG001|Baseline up to Week 48|Administrative/Other|1|||
33393835|NCT00673920|62773049|FG002|Baseline up to Week 48|Administrative/Other|2|||
33393836|NCT00673920|62773050|FG003|Baseline up to Week 48|Administrative/Other|0|||
33393837|NCT00673920|62773051|FG004|Baseline up to Week 48|Administrative/Other|0|||
33393838|NCT00673920|62773052|FG005|Baseline up to Week 48|Administrative/Other|0|||
33393839|NCT00673920|62773053|FG006|Baseline up to Week 48|Administrative/Other|0|||
33393840|NCT00673920|62773054|FG007|Baseline up to Week 48|Administrative/Other|0|||
33393841|NCT00673920|62773047|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
33566649|NCT00893789|62962461|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
33566650|NCT00893789|62962458|FG000|Overall Study|Adverse Event|0|||
33566651|NCT00893789|62962459|FG001|Overall Study|Adverse Event|2|||
33566652|NCT00893789|62962460|FG002|Overall Study|Adverse Event|1|||
33566653|NCT00893789|62962461|FG003|Overall Study|Adverse Event|5|||
33566654|NCT00893789|62962458|FG000|Overall Study|Protocol Violation|0|||
33566655|NCT00893789|62962459|FG001|Overall Study|Protocol Violation|1|||
33566656|NCT00893789|62962460|FG002|Overall Study|Protocol Violation|1|||
33566657|NCT00893789|62962461|FG003|Overall Study|Protocol Violation|4|||
33566658|NCT00893789|62962458|FG000|Overall Study|Lost to Follow-up|0|||
33566659|NCT00893789|62962459|FG001|Overall Study|Lost to Follow-up|0|||
33566660|NCT00893789|62962460|FG002|Overall Study|Lost to Follow-up|0|||
33566661|NCT00893789|62962461|FG003|Overall Study|Lost to Follow-up|1|||
33566662|NCT02164864|62962474|FG000|Overall Study|Trial disease worsening|7|||
33566663|NCT02164864|62962475|FG001|Overall Study|Trial disease worsening|5|||
33393842|NCT00673920|62773048|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
33566664|NCT02164864|62962476|FG002|Overall Study|Trial disease worsening|1|||
33566665|NCT02164864|62962474|FG000|Overall Study|Other pre-existing disease worsening|6|||
33393843|NCT00673920|62773049|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
33393844|NCT00673920|62773050|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
33393845|NCT00673920|62773051|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
33393846|NCT00673920|62773052|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
33393847|NCT00673920|62773053|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
33393848|NCT00673920|62773054|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
33393849|NCT00673920|62773047|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
33393850|NCT00673920|62773048|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
33393851|NCT00673920|62773049|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
33393852|NCT00673920|62773050|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
33393853|NCT00673920|62773051|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
33393854|NCT00673920|62773052|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
33393855|NCT00673920|62773053|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
33393856|NCT00673920|62773054|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
33393857|NCT00673920|62773047|FG000|Week 24 to Week 48|Failure to return|0|||
33393858|NCT00673920|62773048|FG001|Week 24 to Week 48|Failure to return|0|||
33393859|NCT00673920|62773049|FG002|Week 24 to Week 48|Failure to return|0|||
33393860|NCT00673920|62773050|FG003|Week 24 to Week 48|Failure to return|0|||
33393861|NCT00673920|62773051|FG004|Week 24 to Week 48|Failure to return|0|||
33393862|NCT00673920|62773052|FG005|Week 24 to Week 48|Failure to return|1|||
33393863|NCT00673920|62773053|FG006|Week 24 to Week 48|Failure to return|0|||
33393864|NCT00673920|62773054|FG007|Week 24 to Week 48|Failure to return|0|||
33393865|NCT00673920|62773047|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
33393866|NCT00673920|62773048|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
33393867|NCT00673920|62773049|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
33393868|NCT00673920|62773050|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
33393869|NCT00673920|62773051|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
33393870|NCT00673920|62773052|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
33393871|NCT00673920|62773053|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
33393872|NCT00673920|62773054|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
33393873|NCT00673920|62773047|FG000|Week 24 to Week 48|Death|0|||
33393874|NCT00673920|62773048|FG001|Week 24 to Week 48|Death|0|||
33393875|NCT00673920|62773049|FG002|Week 24 to Week 48|Death|0|||
33393876|NCT00673920|62773050|FG003|Week 24 to Week 48|Death|0|||
33393877|NCT00673920|62773051|FG004|Week 24 to Week 48|Death|0|||
33393878|NCT00673920|62773052|FG005|Week 24 to Week 48|Death|1|||
33393879|NCT00673920|62773053|FG006|Week 24 to Week 48|Death|0|||
33393880|NCT00673920|62773054|FG007|Week 24 to Week 48|Death|0|||
33393881|NCT00673920|62773047|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
33393882|NCT00673920|62773048|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
33393883|NCT00673920|62773049|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
33393884|NCT00673920|62773050|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
33393885|NCT00673920|62773051|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
33393886|NCT00673920|62773052|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
33393887|NCT00673920|62773053|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
33566666|NCT02164864|62962475|FG001|Overall Study|Other pre-existing disease worsening|4|||
33566667|NCT02164864|62962476|FG002|Overall Study|Other pre-existing disease worsening|9|||
33566668|NCT02164864|62962474|FG000|Overall Study|Other Adverse Event (AE)|52|||
33566669|NCT02164864|62962475|FG001|Overall Study|Other Adverse Event (AE)|32|||
33566670|NCT02164864|62962476|FG002|Overall Study|Other Adverse Event (AE)|49|||
33566671|NCT02164864|62962474|FG000|Overall Study|Protocol Violation|2|||
33566672|NCT02164864|62962475|FG001|Overall Study|Protocol Violation|4|||
33566673|NCT02164864|62962476|FG002|Overall Study|Protocol Violation|1|||
33566674|NCT02164864|62962474|FG000|Overall Study|Lost to Follow-up|4|||
33566675|NCT02164864|62962475|FG001|Overall Study|Lost to Follow-up|3|||
33566676|NCT02164864|62962476|FG002|Overall Study|Lost to Follow-up|2|||
33566677|NCT02164864|62962474|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
33566678|NCT02164864|62962475|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
33566679|NCT02164864|62962476|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
33566680|NCT02164864|62962474|FG000|Overall Study|Other than stated|3|||
33566681|NCT02164864|62962475|FG001|Overall Study|Other than stated|4|||
33566682|NCT02164864|62962476|FG002|Overall Study|Other than stated|14|||
33566683|NCT02419807|62962487|FG000|Overall Study|Withdrawal by Subject|4|||
33566684|NCT02419807|62962487|FG000|Overall Study|Physician Decision|1|||
33566685|NCT02419807|62962487|FG000|Overall Study|Protocol Violation|5|||
33393888|NCT00673920|62773054|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
33393889|NCT00379795|62773081|FG000|Overall Study|Death|31|||
33393890|NCT00379795|62773082|FG001|Overall Study|Death|8|||
33393891|NCT00379795|62773083|FG002|Overall Study|Death|6|||
33393892|NCT00379795|62773084|FG003|Overall Study|Death|4|||
33393893|NCT00379795|62773085|FG004|Overall Study|Death|7|||
33393894|NCT00379795|62773081|FG000|Overall Study|Adverse Event|17|||
33393895|NCT00379795|62773082|FG001|Overall Study|Adverse Event|3|||
33566686|NCT03857867|62962491|FG000|Overall Study|Physician Decision|1|||
33393896|NCT00379795|62773083|FG002|Overall Study|Adverse Event|3|||
33393897|NCT00379795|62773084|FG003|Overall Study|Adverse Event|1|||
33393898|NCT00379795|62773085|FG004|Overall Study|Adverse Event|4|||
33566687|NCT01628926|62962499|FG000|Overall Study|Adverse Event|13|||
33566688|NCT01628926|62962500|FG001|Overall Study|Adverse Event|11|||
33566689|NCT01628926|62962501|FG002|Overall Study|Adverse Event|9|||
33566690|NCT01628926|62962499|FG000|Overall Study|Lack of Efficacy|2|||
33566691|NCT01628926|62962500|FG001|Overall Study|Lack of Efficacy|1|||
33566692|NCT01628926|62962501|FG002|Overall Study|Lack of Efficacy|5|||
33566693|NCT01628926|62962499|FG000|Overall Study|Withdrawal by Subject|6|||
33566694|NCT01628926|62962500|FG001|Overall Study|Withdrawal by Subject|4|||
33566695|NCT01628926|62962501|FG002|Overall Study|Withdrawal by Subject|2|||
33566696|NCT01628926|62962499|FG000|Overall Study|Protocol Violation|0|||
33566697|NCT01628926|62962500|FG001|Overall Study|Protocol Violation|1|||
33566698|NCT01628926|62962501|FG002|Overall Study|Protocol Violation|0|||
33566699|NCT01628926|62962499|FG000|Overall Study|Discontinuation criteria|3|||
33566700|NCT01628926|62962500|FG001|Overall Study|Discontinuation criteria|4|||
33566701|NCT01628926|62962501|FG002|Overall Study|Discontinuation criteria|0|||
33566702|NCT01628926|62962499|FG000|Overall Study|Physician Decision|2|||
33566703|NCT01628926|62962500|FG001|Overall Study|Physician Decision|2|||
33566704|NCT01628926|62962501|FG002|Overall Study|Physician Decision|1|||
33566705|NCT01628848|62962512|FG000|Overall Study|Adverse Event|9|||
33393899|NCT00379795|62773081|FG000|Overall Study|Lost to Follow-up|8|||
33393900|NCT00379795|62773082|FG001|Overall Study|Lost to Follow-up|1|||
33393901|NCT00379795|62773083|FG002|Overall Study|Lost to Follow-up|2|||
33393902|NCT00379795|62773084|FG003|Overall Study|Lost to Follow-up|1|||
33393903|NCT00379795|62773085|FG004|Overall Study|Lost to Follow-up|4|||
33393904|NCT00379795|62773081|FG000|Overall Study|Physician Decision|25|||
33393905|NCT00379795|62773082|FG001|Overall Study|Physician Decision|0|||
33393906|NCT00379795|62773083|FG002|Overall Study|Physician Decision|2|||
33393907|NCT00379795|62773084|FG003|Overall Study|Physician Decision|2|||
33393908|NCT00379795|62773085|FG004|Overall Study|Physician Decision|2|||
33393909|NCT00379795|62773081|FG000|Overall Study|Withdrawal by Subject|94|||
33393910|NCT00379795|62773082|FG001|Overall Study|Withdrawal by Subject|11|||
33393911|NCT00379795|62773083|FG002|Overall Study|Withdrawal by Subject|19|||
33393912|NCT00379795|62773084|FG003|Overall Study|Withdrawal by Subject|7|||
33566706|NCT01628848|62962513|FG001|Overall Study|Adverse Event|7|||
33566707|NCT01628848|62962512|FG000|Overall Study|Lack of Efficacy|0|||
33566708|NCT01628848|62962513|FG001|Overall Study|Lack of Efficacy|4|||
33566709|NCT01628848|62962512|FG000|Overall Study|Withdrawal by Subject|0|||
33566710|NCT01628848|62962513|FG001|Overall Study|Withdrawal by Subject|2|||
33566711|NCT01628848|62962512|FG000|Overall Study|Physician Decision|3|||
33566712|NCT01628848|62962513|FG001|Overall Study|Physician Decision|1|||
33566713|NCT02164318|62962523|FG000|Overall Study|Withdrawal by Subject|0|||
33566714|NCT02164318|62962524|FG001|Overall Study|Withdrawal by Subject|1|||
33566715|NCT02164318|62962525|FG002|Overall Study|Withdrawal by Subject|0|||
33566716|NCT02164318|62962526|FG003|Overall Study|Withdrawal by Subject|1|||
33566717|NCT03436199|62962539|FG000|Overall Study|Adverse Event|15|||
33566718|NCT03436199|62962540|FG001|Overall Study|Adverse Event|40|||
33566719|NCT03436199|62962541|FG002|Overall Study|Adverse Event|7|||
33566720|NCT03436199|62962539|FG000|Overall Study|Withdrawal by Subject|4|||
33566721|NCT03436199|62962540|FG001|Overall Study|Withdrawal by Subject|10|||
33566722|NCT03436199|62962541|FG002|Overall Study|Withdrawal by Subject|3|||
33566723|NCT03436199|62962539|FG000|Overall Study|Lost to Follow-up|1|||
33566724|NCT03436199|62962540|FG001|Overall Study|Lost to Follow-up|0|||
33566725|NCT03436199|62962541|FG002|Overall Study|Lost to Follow-up|2|||
33566726|NCT03436199|62962539|FG000|Overall Study|Protocol Violation|1|||
33566727|NCT03436199|62962540|FG001|Overall Study|Protocol Violation|1|||
33566728|NCT03436199|62962541|FG002|Overall Study|Protocol Violation|0|||
33566729|NCT03436199|62962539|FG000|Overall Study|Physician Decision|0|||
33566730|NCT03436199|62962540|FG001|Overall Study|Physician Decision|1|||
33566731|NCT03436199|62962541|FG002|Overall Study|Physician Decision|0|||
33393913|NCT00379795|62773085|FG004|Overall Study|Withdrawal by Subject|14|||
33393914|NCT00379795|62773081|FG000|Overall Study|Subject non-compliance|7|||
33393915|NCT00379795|62773082|FG001|Overall Study|Subject non-compliance|2|||
33393916|NCT00379795|62773083|FG002|Overall Study|Subject non-compliance|0|||
33566732|NCT03436199|62962539|FG000|Overall Study|Could not return to clinic|1|||
33566733|NCT03436199|62962540|FG001|Overall Study|Could not return to clinic|0|||
33566734|NCT03436199|62962541|FG002|Overall Study|Could not return to clinic|0|||
33566735|NCT03436199|62962539|FG000|Overall Study|Withdrawn per physician|0|||
33566736|NCT03436199|62962540|FG001|Overall Study|Withdrawn per physician|1|||
33566737|NCT03436199|62962541|FG002|Overall Study|Withdrawn per physician|0|||
33566738|NCT02131636|62962551|FG000|Overall Study|Personal Reasons|4|||
33566739|NCT02131636|62962552|FG001|Overall Study|Personal Reasons|4|||
33566740|NCT02131636|62962551|FG000|Overall Study|Lost to Follow-up|4|||
33566741|NCT02131636|62962552|FG001|Overall Study|Lost to Follow-up|0|||
33566742|NCT02131636|62962551|FG000|Overall Study|Adverse Event|4|||
33566743|NCT02131636|62962552|FG001|Overall Study|Adverse Event|1|||
33393917|NCT00379795|62773084|FG003|Overall Study|Subject non-compliance|0|||
33393918|NCT00379795|62773085|FG004|Overall Study|Subject non-compliance|1|||
33393919|NCT00379795|62773081|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
33393920|NCT00379795|62773082|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
33393921|NCT00379795|62773083|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
33393922|NCT00379795|62773084|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
33393923|NCT00379795|62773085|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
33393924|NCT00379795|62773081|FG000|Overall Study|Subjects condition mandated intervention|34|||
33393925|NCT00379795|62773082|FG001|Overall Study|Subjects condition mandated intervention|9|||
33393926|NCT00379795|62773083|FG002|Overall Study|Subjects condition mandated intervention|7|||
33393927|NCT00379795|62773084|FG003|Overall Study|Subjects condition mandated intervention|5|||
33566744|NCT02131324|62962560|FG000|Overall Study|Withdrawal by Subject|1|||
33566745|NCT02131324|62962561|FG001|Overall Study|Withdrawal by Subject|2|||
33566746|NCT02131324|62962560|FG000|Overall Study|Lost to Follow-up|1|||
33566747|NCT02131324|62962561|FG001|Overall Study|Lost to Follow-up|1|||
33566748|NCT02734693|62962570|FG000|Overall Study|Adverse Event|1|||
33566749|NCT02734693|62962571|FG001|Overall Study|Adverse Event|3|||
33566750|NCT02734693|62962572|FG002|Overall Study|Adverse Event|3|||
33566751|NCT02734693|62962570|FG000|Overall Study|Lack of Efficacy|1|||
33566752|NCT02734693|62962571|FG001|Overall Study|Lack of Efficacy|0|||
33566753|NCT02734693|62962572|FG002|Overall Study|Lack of Efficacy|0|||
33566754|NCT02734693|62962570|FG000|Overall Study|Lost to Follow-up|2|||
33566755|NCT02734693|62962571|FG001|Overall Study|Lost to Follow-up|0|||
33566756|NCT02734693|62962572|FG002|Overall Study|Lost to Follow-up|0|||
33566757|NCT02734693|62962570|FG000|Overall Study|Protocol Violation|1|||
33566758|NCT02734693|62962571|FG001|Overall Study|Protocol Violation|0|||
33566759|NCT02734693|62962572|FG002|Overall Study|Protocol Violation|0|||
33566760|NCT02734693|62962570|FG000|Overall Study|Withdrawal by Subject|1|||
33566761|NCT02734693|62962571|FG001|Overall Study|Withdrawal by Subject|0|||
33566762|NCT02734693|62962572|FG002|Overall Study|Withdrawal by Subject|0|||
33566763|NCT02193880|62962580|FG000|Overall Study|patients did not collect enough HPC|3|||
33566764|NCT01378325|62962586|FG000|Overall Study|Protocol Violation|0|||
33566765|NCT01378325|62962587|FG001|Overall Study|Protocol Violation|1|||
33302400|NCT01077154|62678150|FG001|Overall Study|Withdrawal by Subject|385|||
33302401|NCT01077154|62678149|FG000|Overall Study|Death|215|||
33302402|NCT01077154|62678150|FG001|Overall Study|Death|214|||
33302403|NCT01077154|62678149|FG000|Overall Study|Lost to Follow-up|43|||
33302404|NCT01077154|62678150|FG001|Overall Study|Lost to Follow-up|35|||
33302405|NCT01077154|62678149|FG000|Overall Study|Noncompliance|22|||
33302406|NCT01077154|62678150|FG001|Overall Study|Noncompliance|20|||
33302407|NCT01077154|62678149|FG000|Overall Study|Disease Progression|18|||
33302408|NCT01077154|62678150|FG001|Overall Study|Disease Progression|20|||
33302409|NCT01077154|62678149|FG000|Overall Study|Ineligibility Determined|10|||
33302410|NCT01077154|62678150|FG001|Overall Study|Ineligibility Determined|14|||
33302411|NCT01077154|62678149|FG000|Overall Study|Other|14|||
33302412|NCT01077154|62678150|FG001|Overall Study|Other|11|||
33302413|NCT01077154|62678149|FG000|Overall Study|Adverse Event|9|||
33302414|NCT01077154|62678150|FG001|Overall Study|Adverse Event|9|||
33302415|NCT01077154|62678149|FG000|Overall Study|Administrative Decision|1|||
33302416|NCT01077154|62678150|FG001|Overall Study|Administrative Decision|6|||
33302417|NCT01077154|62678149|FG000|Overall Study|Protocol Deviation|1|||
33302418|NCT01077154|62678150|FG001|Overall Study|Protocol Deviation|0|||
33302419|NCT01258101|62678160|FG000|Overall Study|Adverse Event|5|||
33302420|NCT01258101|62678161|FG001|Overall Study|Adverse Event|6|||
33302421|NCT01258101|62678162|FG002|Overall Study|Adverse Event|0|||
33302422|NCT01258101|62678163|FG003|Overall Study|Adverse Event|0|||
33302423|NCT01258101|62678160|FG000|Overall Study|Extra exclusion criterion amended|2|||
33302424|NCT01258101|62678161|FG001|Overall Study|Extra exclusion criterion amended|1|||
33302425|NCT01258101|62678162|FG002|Overall Study|Extra exclusion criterion amended|1|||
33302426|NCT01258101|62678163|FG003|Overall Study|Extra exclusion criterion amended|1|||
33302427|NCT01258101|62678160|FG000|Overall Study|Informed consent has been withdrawn|2|||
33302428|NCT01258101|62678161|FG001|Overall Study|Informed consent has been withdrawn|2|||
33302429|NCT01258101|62678162|FG002|Overall Study|Informed consent has been withdrawn|1|||
33302430|NCT01258101|62678163|FG003|Overall Study|Informed consent has been withdrawn|1|||
33393928|NCT00379795|62773085|FG004|Overall Study|Subjects condition mandated intervention|7|||
33393929|NCT00379795|62773081|FG000|Overall Study|Sponsor's decision|257|||
33393930|NCT00379795|62773082|FG001|Overall Study|Sponsor's decision|17|||
33393931|NCT00379795|62773083|FG002|Overall Study|Sponsor's decision|54|||
33566766|NCT01093573|62962596|FG000|Overall Study|Physician Decision|0|||
33566767|NCT01093573|62962597|FG001|Overall Study|Physician Decision|0|||
33566768|NCT01093573|62962598|FG002|Overall Study|Physician Decision|1|||
33566769|NCT01093573|62962596|FG000|Overall Study|Insurance Denied|0|||
33566770|NCT01093573|62962597|FG001|Overall Study|Insurance Denied|0|||
33566771|NCT01093573|62962598|FG002|Overall Study|Insurance Denied|1|||
33566772|NCT02733367|62962626|FG000|Overall Study|Withdrawal by Subject|6|||
33566773|NCT03688555|62962633|FG000|Treatment Period|Adverse Event|0|||
33566774|NCT03688555|62962634|FG001|Treatment Period|Adverse Event|0|||
33566775|NCT03688555|62962635|FG002|Treatment Period|Adverse Event|1|||
33566776|NCT01328951|62962677|FG000|Overall Study|Disease Progression|17|||
33566777|NCT01328951|62962678|FG001|Overall Study|Disease Progression|14|||
33566778|NCT01328951|62962677|FG000|Overall Study|Adverse Event|2|||
33566779|NCT01328951|62962678|FG001|Overall Study|Adverse Event|0|||
33566780|NCT01328951|62962677|FG000|Overall Study|Death|243|||
33566781|NCT01328951|62962678|FG001|Overall Study|Death|258|||
33566782|NCT01328951|62962677|FG000|Overall Study|Lost to Follow-up|6|||
33566783|NCT01328951|62962678|FG001|Overall Study|Lost to Follow-up|7|||
33566784|NCT01328951|62962677|FG000|Overall Study|Withdrawal by Subject|6|||
33566785|NCT01328951|62962678|FG001|Overall Study|Withdrawal by Subject|6|||
33566786|NCT01328951|62962677|FG000|Overall Study|Study Closed by the Sponsor|36|||
33566787|NCT01328951|62962678|FG001|Overall Study|Study Closed by the Sponsor|31|||
33566788|NCT01328951|62962677|FG000|Overall Study|Other|11|||
33566789|NCT01328951|62962678|FG001|Overall Study|Other|6|||
33566790|NCT02611817|62962691|FG000|Open-label Induction Phase|Reason not Specified|9|||
33566791|NCT02611817|62962692|FG001|Open-label Induction Phase|Reason not Specified|0|||
33566792|NCT02611817|62962693|FG002|Open-label Induction Phase|Reason not Specified|0|||
33566793|NCT02611817|62962691|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
33566794|NCT02611817|62962692|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
33566795|NCT02611817|62962693|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
33566796|NCT02611817|62962691|FG000|Open-label Induction Phase|Pregnancy|1|||
33566797|NCT02611817|62962692|FG001|Open-label Induction Phase|Pregnancy|0|||
33566798|NCT02611817|62962693|FG002|Open-label Induction Phase|Pregnancy|0|||
33566799|NCT02611817|62962691|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
33566800|NCT02611817|62962692|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
33566801|NCT02611817|62962693|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
33566802|NCT02611817|62962691|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
33566803|NCT02611817|62962692|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
33566804|NCT02611817|62962693|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
33566805|NCT02611817|62962691|FG000|Open-label Induction Phase|Protocol Violation|5|||
33566806|NCT02611817|62962692|FG001|Open-label Induction Phase|Protocol Violation|0|||
33566807|NCT02611817|62962693|FG002|Open-label Induction Phase|Protocol Violation|0|||
33566808|NCT02611817|62962691|FG000|Open-label Induction Phase|Adverse Event|16|||
33566809|NCT02611817|62962692|FG001|Open-label Induction Phase|Adverse Event|0|||
33566810|NCT02611817|62962693|FG002|Open-label Induction Phase|Adverse Event|0|||
33566811|NCT02611817|62962691|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
33566812|NCT02611817|62962692|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
33566813|NCT02611817|62962693|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
33566814|NCT02611817|62962691|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
33566815|NCT02611817|62962692|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
33566816|NCT02611817|62962693|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
33566817|NCT02611817|62962691|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
33566818|NCT02611817|62962692|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
33566819|NCT02611817|62962693|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
33566820|NCT02611817|62962691|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
33566821|NCT02611817|62962692|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
33566822|NCT02611817|62962693|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
33566823|NCT02611817|62962691|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
33566824|NCT02611817|62962692|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
33566825|NCT02611817|62962693|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
33566826|NCT02611817|62962691|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
33566827|NCT02611817|62962692|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
33566828|NCT02611817|62962693|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
33566829|NCT02611817|62962691|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
33566830|NCT02611817|62962692|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
33566831|NCT02611817|62962693|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
33566832|NCT02735915|62962700|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
33566833|NCT02735915|62962700|FG000|Overall Study|Withdrawal following SAE|2|||
33566834|NCT02735915|62962700|FG000|Overall Study|Withdrawal by Subject|1|||
33566835|NCT02557139|62962709|FG000|Overall Study|Significant liver elevation|1|||
33566836|NCT02557139|62962710|FG001|Overall Study|Significant liver elevation|0|||
33566837|NCT02557139|62962711|FG002|Overall Study|Significant liver elevation|1|||
33566838|NCT02557139|62962709|FG000|Overall Study|Withdrawal by Subject|1|||
33566839|NCT02557139|62962710|FG001|Overall Study|Withdrawal by Subject|0|||
33566840|NCT02557139|62962711|FG002|Overall Study|Withdrawal by Subject|0|||
33566841|NCT02557139|62962709|FG000|Overall Study|Illness of prohibited medication|0|||
33664129|NCT02681094|63095176|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
33664130|NCT02681094|63095177|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
33566842|NCT02557139|62962710|FG001|Overall Study|Illness of prohibited medication|0|||
33566843|NCT02557139|62962711|FG002|Overall Study|Illness of prohibited medication|1|||
33566844|NCT01328717|62962728|FG000|Overall Study|Adverse Event|1|||
33393932|NCT00379795|62773084|FG003|Overall Study|Sponsor's decision|47|||
33393933|NCT00379795|62773085|FG004|Overall Study|Sponsor's decision|10|||
33393934|NCT00610155|62773100|FG000|Period 1|Withdrawal by Subject|0|||
33393935|NCT00610155|62773101|FG001|Period 1|Withdrawal by Subject|0|||
33393936|NCT00610155|62773102|FG002|Period 1|Withdrawal by Subject|1|||
33393937|NCT00610155|62773103|FG003|Period 1|Withdrawal by Subject|0|||
33393938|NCT00610155|62773104|FG004|Period 1|Withdrawal by Subject|0|||
33393939|NCT00610155|62773105|FG005|Period 1|Withdrawal by Subject|0|||
33393940|NCT00610155|62773100|FG000|Period 3|Adverse Event|1|||
33393941|NCT00610155|62773101|FG001|Period 3|Adverse Event|0|||
33393942|NCT00610155|62773102|FG002|Period 3|Adverse Event|0|||
33393943|NCT00610155|62773103|FG003|Period 3|Adverse Event|0|||
33393944|NCT00610155|62773104|FG004|Period 3|Adverse Event|0|||
33393945|NCT00610155|62773105|FG005|Period 3|Adverse Event|0|||
33393946|NCT00674700|62773116|FG000|Year 1|Adverse Event|17|||
33393947|NCT00674700|62773117|FG001|Year 1|Adverse Event|20|||
33393948|NCT00674700|62773118|FG002|Year 1|Adverse Event|5|||
33393949|NCT00674700|62773116|FG000|Year 1|Withdrawal by Subject|7|||
33393950|NCT00674700|62773117|FG001|Year 1|Withdrawal by Subject|7|||
33393951|NCT00674700|62773118|FG002|Year 1|Withdrawal by Subject|6|||
33393952|NCT00674700|62773116|FG000|Year 1|Any other reason not above-mentioned|7|||
33393953|NCT00674700|62773117|FG001|Year 1|Any other reason not above-mentioned|7|||
33393954|NCT00674700|62773118|FG002|Year 1|Any other reason not above-mentioned|6|||
33393955|NCT00674700|62773116|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
33393956|NCT00674700|62773117|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
33393957|NCT00674700|62773118|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
33393958|NCT00674700|62773116|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
33393959|NCT00674700|62773117|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
33393960|NCT00674700|62773118|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
33393961|NCT00674700|62773116|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
33393962|NCT00674700|62773117|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
33393963|NCT00674700|62773118|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
33393964|NCT00546910|62773128|FG000|Overall Study|Adverse Event|2|||
33393965|NCT00546910|62773129|FG001|Overall Study|Adverse Event|3|||
33393966|NCT00546910|62773128|FG000|Overall Study|Lack of Efficacy|5|||
33393967|NCT00546910|62773129|FG001|Overall Study|Lack of Efficacy|7|||
33393968|NCT00546910|62773128|FG000|Overall Study|Physician Decision|0|||
33393969|NCT00546910|62773129|FG001|Overall Study|Physician Decision|1|||
33393970|NCT00546910|62773128|FG000|Overall Study|Withdrawal by Subject|2|||
33393971|NCT00546910|62773129|FG001|Overall Study|Withdrawal by Subject|0|||
33393972|NCT00379639|62773140|FG000|Overall Study|Disease Progression|3|||
33393973|NCT00379639|62773141|FG001|Overall Study|Disease Progression|3|||
33393974|NCT00379639|62773142|FG002|Overall Study|Disease Progression|3|||
33393975|NCT00379639|62773143|FG003|Overall Study|Disease Progression|4|||
33393976|NCT00379639|62773144|FG004|Overall Study|Disease Progression|4|||
33393977|NCT00379639|62773140|FG000|Overall Study|Physician Decision|0|||
33393978|NCT00379639|62773141|FG001|Overall Study|Physician Decision|2|||
33393979|NCT00379639|62773142|FG002|Overall Study|Physician Decision|1|||
33393980|NCT00379639|62773143|FG003|Overall Study|Physician Decision|1|||
33393981|NCT00379639|62773144|FG004|Overall Study|Physician Decision|0|||
33393982|NCT00379639|62773140|FG000|Overall Study|Symptomatic Deterioration|0|||
33393983|NCT00379639|62773141|FG001|Overall Study|Symptomatic Deterioration|0|||
33393984|NCT00379639|62773142|FG002|Overall Study|Symptomatic Deterioration|1|||
33393985|NCT00379639|62773143|FG003|Overall Study|Symptomatic Deterioration|0|||
33393986|NCT00379639|62773144|FG004|Overall Study|Symptomatic Deterioration|1|||
33664131|NCT02681094|63095178|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
33302431|NCT01258101|62678160|FG000|Overall Study|Patient is not able to attend visits|8|||
33302432|NCT01258101|62678161|FG001|Overall Study|Patient is not able to attend visits|9|||
33302433|NCT01258101|62678162|FG002|Overall Study|Patient is not able to attend visits|7|||
33302434|NCT01258101|62678163|FG003|Overall Study|Patient is not able to attend visits|6|||
33302435|NCT01258101|62678160|FG000|Overall Study|Patient´s compliance|4|||
33302436|NCT01258101|62678161|FG001|Overall Study|Patient´s compliance|3|||
33302437|NCT01258101|62678162|FG002|Overall Study|Patient´s compliance|1|||
33393987|NCT00379639|62773140|FG000|Overall Study|Adverse Event|0|||
33393988|NCT00379639|62773141|FG001|Overall Study|Adverse Event|0|||
33393989|NCT00379639|62773142|FG002|Overall Study|Adverse Event|1|||
33393990|NCT00379639|62773143|FG003|Overall Study|Adverse Event|0|||
33393991|NCT00379639|62773144|FG004|Overall Study|Adverse Event|1|||
33664132|NCT02681094|63095176|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
33393992|NCT00379639|62773140|FG000|Overall Study|Lost to Follow-up|0|||
33393993|NCT00379639|62773141|FG001|Overall Study|Lost to Follow-up|0|||
33393994|NCT00379639|62773142|FG002|Overall Study|Lost to Follow-up|0|||
33393995|NCT00379639|62773143|FG003|Overall Study|Lost to Follow-up|1|||
33393996|NCT00379639|62773144|FG004|Overall Study|Lost to Follow-up|0|||
33393997|NCT00379639|62773140|FG000|Overall Study|Other|0|||
33393998|NCT00379639|62773141|FG001|Overall Study|Other|0|||
33393999|NCT00379639|62773142|FG002|Overall Study|Other|3|||
33394000|NCT00379639|62773143|FG003|Overall Study|Other|0|||
33394001|NCT00379639|62773144|FG004|Overall Study|Other|0|||
33394002|NCT03948334|62773158|FG000|Overall Study|Adverse Event|1|||
33394003|NCT03948334|62773159|FG001|Overall Study|Adverse Event|4|||
33394004|NCT03948334|62773158|FG000|Overall Study|Lack of Efficacy|2|||
33394005|NCT03948334|62773159|FG001|Overall Study|Lack of Efficacy|0|||
33394006|NCT03948334|62773158|FG000|Overall Study|Lost to Follow-up|1|||
33394007|NCT03948334|62773159|FG001|Overall Study|Lost to Follow-up|0|||
33394008|NCT03948334|62773158|FG000|Overall Study|Physician Decision|1|||
33394009|NCT03948334|62773159|FG001|Overall Study|Physician Decision|0|||
33394010|NCT03948334|62773158|FG000|Overall Study|Pregnancy|0|||
33394011|NCT03948334|62773159|FG001|Overall Study|Pregnancy|1|||
33394012|NCT03948334|62773158|FG000|Overall Study|Protocol Deviation|1|||
33394013|NCT03948334|62773159|FG001|Overall Study|Protocol Deviation|0|||
33394014|NCT03948334|62773158|FG000|Overall Study|Study terminated by Sponsor|50|||
33394015|NCT03948334|62773159|FG001|Overall Study|Study terminated by Sponsor|51|||
33394016|NCT03948334|62773158|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
33394017|NCT03948334|62773159|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
33394018|NCT00609765|62773173|FG000|Overall Study|Study ended prior to 12 months|1|||
33394019|NCT00608829|62773177|FG000|Overall Study|Death|6|||
33394020|NCT00608829|62773177|FG000|Overall Study|Withdrawal by Subject|4|||
33394021|NCT00608829|62773177|FG000|Overall Study|Subject refuses to follow up or return.|5|||
33394022|NCT00545818|62773183|FG000|Overall Study|Protocol Violation|1|||
33394023|NCT00545818|62773184|FG001|Overall Study|Protocol Violation|0|||
33394024|NCT00545818|62773183|FG000|Overall Study|Adverse Event|1|||
33394025|NCT00545818|62773184|FG001|Overall Study|Adverse Event|1|||
33394026|NCT00545818|62773183|FG000|Overall Study|Lost to Follow-up|1|||
33394027|NCT00545818|62773184|FG001|Overall Study|Lost to Follow-up|6|||
33394028|NCT00674154|62773192|FG000|Overall Study|Withdrawal by Subject|3|||
33394029|NCT00674154|62773193|FG001|Overall Study|Withdrawal by Subject|1|||
33394030|NCT00674154|62773192|FG000|Overall Study|Did not want parathyroidectomy|0|||
33394031|NCT00674154|62773193|FG001|Overall Study|Did not want parathyroidectomy|2|||
33394032|NCT00608517|62773202|FG000|Overall Study|Death|1|||
33394033|NCT00608517|62773203|FG001|Overall Study|Death|0|||
33394034|NCT00608517|62773204|FG002|Overall Study|Death|0|||
33394035|NCT00608205|62773215|FG000|Overall Study|Adverse Event|3|||
33394036|NCT00608205|62773216|FG001|Overall Study|Adverse Event|2|||
33394037|NCT00608205|62773215|FG000|Overall Study|Patient non-compliant|0|||
33394038|NCT00608205|62773216|FG001|Overall Study|Patient non-compliant|1|||
33394039|NCT00670800|62773226|FG000|Overall Study|2 controls were insulin resistant|0|||
33394040|NCT00670800|62773227|FG001|Overall Study|2 controls were insulin resistant|2|||
33394041|NCT00607893|62773237|FG000|Overall Study|Lost to Follow-up|4|||
33394042|NCT00607893|62773238|FG001|Overall Study|Lost to Follow-up|0|||
33394043|NCT00607893|62773237|FG000|Overall Study|withdrew due to loss of interest|0|||
33394044|NCT00607893|62773238|FG001|Overall Study|withdrew due to loss of interest|1|||
33394045|NCT00607893|62773237|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
33394046|NCT00607893|62773238|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
33394047|NCT00607893|62773237|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
33394048|NCT00607893|62773238|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
33394049|NCT00607893|62773237|FG000|Overall Study|Declined to be treated|1|||
33394050|NCT00607893|62773238|FG001|Overall Study|Declined to be treated|0|||
33394051|NCT00607893|62773237|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
33394052|NCT00607893|62773238|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
33394053|NCT00571038|62773248|FG000|Overall Study|Lost to Follow-up|1|||
33394054|NCT00571038|62773249|FG001|Overall Study|Lost to Follow-up|4|||
33394055|NCT00571038|62773248|FG000|Overall Study|Death|7|||
33394056|NCT00571038|62773249|FG001|Overall Study|Death|5|||
33394057|NCT00571038|62773248|FG000|Overall Study|Withdrawal by Subject|1|||
33394058|NCT00571038|62773249|FG001|Overall Study|Withdrawal by Subject|3|||
33394059|NCT00571038|62773248|FG000|Overall Study|Moved out of state|2|||
33394060|NCT00571038|62773249|FG001|Overall Study|Moved out of state|2|||
33394061|NCT00545740|62773259|FG000|Overall Study|Lack of Efficacy|34|||
33394062|NCT00545740|62773260|FG001|Overall Study|Lack of Efficacy|35|||
33394063|NCT00545740|62773261|FG002|Overall Study|Lack of Efficacy|47|||
33394064|NCT00545740|62773262|FG003|Overall Study|Lack of Efficacy|36|||
33394065|NCT00545740|62773259|FG000|Overall Study|Withdrawal by Subject|17|||
33394066|NCT00545740|62773260|FG001|Overall Study|Withdrawal by Subject|15|||
33394067|NCT00545740|62773261|FG002|Overall Study|Withdrawal by Subject|16|||
33394068|NCT00545740|62773262|FG003|Overall Study|Withdrawal by Subject|18|||
33566845|NCT01677741|62962740|FG000|Overall Study|Death|0|||
33566846|NCT01677741|62962741|FG001|Overall Study|Death|0|||
33394069|NCT00545740|62773259|FG000|Overall Study|Adverse Event|10|||
33394070|NCT00545740|62773260|FG001|Overall Study|Adverse Event|18|||
33394071|NCT00545740|62773261|FG002|Overall Study|Adverse Event|19|||
33566847|NCT01677741|62962742|FG002|Overall Study|Death|0|||
33394072|NCT00545740|62773262|FG003|Overall Study|Adverse Event|9|||
33394073|NCT00545740|62773259|FG000|Overall Study|Lost to Follow-up|7|||
33394074|NCT00545740|62773260|FG001|Overall Study|Lost to Follow-up|5|||
33394075|NCT00545740|62773261|FG002|Overall Study|Lost to Follow-up|5|||
33394076|NCT00545740|62773262|FG003|Overall Study|Lost to Follow-up|6|||
33394077|NCT00545740|62773259|FG000|Overall Study|Protocol Violation|1|||
33394078|NCT00545740|62773260|FG001|Overall Study|Protocol Violation|3|||
33394079|NCT00545740|62773261|FG002|Overall Study|Protocol Violation|1|||
33394080|NCT00545740|62773262|FG003|Overall Study|Protocol Violation|0|||
33394081|NCT00545740|62773259|FG000|Overall Study|Non-compliance|0|||
33394082|NCT00545740|62773260|FG001|Overall Study|Non-compliance|2|||
33394083|NCT00545740|62773261|FG002|Overall Study|Non-compliance|1|||
33394084|NCT00545740|62773262|FG003|Overall Study|Non-compliance|0|||
33394085|NCT00545740|62773259|FG000|Overall Study|Moved|2|||
33394086|NCT00545740|62773260|FG001|Overall Study|Moved|0|||
33394087|NCT00545740|62773261|FG002|Overall Study|Moved|1|||
33394088|NCT00545740|62773262|FG003|Overall Study|Moved|0|||
33394089|NCT00545740|62773259|FG000|Overall Study|Diverticulitis attack|0|||
33394090|NCT00545740|62773260|FG001|Overall Study|Diverticulitis attack|0|||
33394091|NCT00545740|62773261|FG002|Overall Study|Diverticulitis attack|1|||
33394092|NCT00545740|62773262|FG003|Overall Study|Diverticulitis attack|1|||
33394093|NCT00545740|62773259|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
33566848|NCT01677741|62962743|FG003|Overall Study|Death|1|||
33566849|NCT01677741|62962744|FG004|Overall Study|Death|0|||
33566850|NCT01677741|62962745|FG005|Overall Study|Death|1|||
33566851|NCT01677741|62962746|FG006|Overall Study|Death|0|||
33566852|NCT01677741|62962747|FG007|Overall Study|Death|0|||
33566853|NCT01677741|62962740|FG000|Overall Study|Withdrawal by Subject|2|||
33566854|NCT01677741|62962741|FG001|Overall Study|Withdrawal by Subject|7|||
33566855|NCT01677741|62962742|FG002|Overall Study|Withdrawal by Subject|5|||
33566856|NCT01677741|62962743|FG003|Overall Study|Withdrawal by Subject|4|||
33566857|NCT01677741|62962744|FG004|Overall Study|Withdrawal by Subject|11|||
33566858|NCT01677741|62962745|FG005|Overall Study|Withdrawal by Subject|20|||
33566859|NCT01677741|62962746|FG006|Overall Study|Withdrawal by Subject|4|||
33566860|NCT01677741|62962747|FG007|Overall Study|Withdrawal by Subject|2|||
33566861|NCT01677741|62962740|FG000|Overall Study|Enrolled in a rollover study|0|||
33566862|NCT01677741|62962741|FG001|Overall Study|Enrolled in a rollover study|3|||
33566863|NCT01677741|62962742|FG002|Overall Study|Enrolled in a rollover study|2|||
33566864|NCT01677741|62962743|FG003|Overall Study|Enrolled in a rollover study|1|||
33566865|NCT01677741|62962744|FG004|Overall Study|Enrolled in a rollover study|6|||
33566866|NCT01677741|62962745|FG005|Overall Study|Enrolled in a rollover study|6|||
33566867|NCT01677741|62962746|FG006|Overall Study|Enrolled in a rollover study|7|||
33566868|NCT01677741|62962747|FG007|Overall Study|Enrolled in a rollover study|0|||
33566869|NCT01677741|62962740|FG000|Overall Study|Progressive disease|1|||
33566870|NCT01677741|62962741|FG001|Overall Study|Progressive disease|0|||
33566871|NCT01677741|62962742|FG002|Overall Study|Progressive disease|1|||
33566872|NCT01677741|62962743|FG003|Overall Study|Progressive disease|0|||
33566873|NCT01677741|62962744|FG004|Overall Study|Progressive disease|0|||
33566874|NCT01677741|62962745|FG005|Overall Study|Progressive disease|1|||
33566875|NCT01677741|62962746|FG006|Overall Study|Progressive disease|0|||
33566876|NCT01677741|62962747|FG007|Overall Study|Progressive disease|0|||
33566877|NCT01677507|62962799|FG000|Initial Assignment|Adverse Event|0|||
33566878|NCT01677507|62962800|FG001|Initial Assignment|Adverse Event|1|||
33566879|NCT01677507|62962799|FG000|Initial Assignment|Protocol Violation|0|||
33566880|NCT01677507|62962800|FG001|Initial Assignment|Protocol Violation|1|||
33566881|NCT01677507|62962799|FG000|Second Assigment|Withdrawal by Subject|2|||
33566882|NCT01677507|62962800|FG001|Second Assigment|Withdrawal by Subject|2|||
33566883|NCT01677507|62962799|FG000|Second Assigment|Adverse Event|1|||
33566884|NCT01677507|62962800|FG001|Second Assigment|Adverse Event|3|||
33566885|NCT02732951|62962810|FG000|Overall Study|Other than listed|1|||
33566886|NCT02732951|62962811|FG001|Overall Study|Other than listed|0|||
33566887|NCT02732951|62962810|FG000|Overall Study|Lost to Follow-up|0|||
33566888|NCT02732951|62962811|FG001|Overall Study|Lost to Follow-up|1|||
33566889|NCT02732951|62962810|FG000|Overall Study|Adverse Event|4|||
33566890|NCT02732951|62962811|FG001|Overall Study|Adverse Event|4|||
33566891|NCT02732951|62962810|FG000|Overall Study|Protocol Violation|0|||
33566892|NCT02732951|62962811|FG001|Overall Study|Protocol Violation|1|||
33566893|NCT01377233|62962822|FG000|Open-label|Adverse Event|1|||
33566894|NCT01377233|62962823|FG001|Open-label|Adverse Event|0|||
33566895|NCT01377233|62962824|FG002|Open-label|Adverse Event|0|||
33566896|NCT01377233|62962825|FG003|Open-label|Adverse Event|0|||
33566897|NCT01377233|62962826|FG004|Open-label|Adverse Event|0|||
33566898|NCT01377233|62962822|FG000|Open-label|Withdrawal by Subject|3|||
33566899|NCT01377233|62962823|FG001|Open-label|Withdrawal by Subject|0|||
33394094|NCT00545740|62773260|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
33394095|NCT00545740|62773261|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
33394096|NCT00545740|62773262|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
33394097|NCT00545740|62773259|FG000|Overall Study|Site closure|1|||
33566900|NCT01377233|62962824|FG002|Open-label|Withdrawal by Subject|0|||
33566901|NCT01377233|62962825|FG003|Open-label|Withdrawal by Subject|0|||
33566902|NCT01377233|62962826|FG004|Open-label|Withdrawal by Subject|0|||
33566903|NCT01377233|62962822|FG000|Double-blind|Adverse Event|0|||
33566904|NCT01377233|62962823|FG001|Double-blind|Adverse Event|1|||
33566905|NCT01377233|62962824|FG002|Double-blind|Adverse Event|2|||
33566906|NCT01377233|62962825|FG003|Double-blind|Adverse Event|2|||
33566907|NCT01377233|62962826|FG004|Double-blind|Adverse Event|0|||
33566908|NCT01377233|62962822|FG000|Double-blind|Protocol Violation|0|||
33566909|NCT01377233|62962823|FG001|Double-blind|Protocol Violation|0|||
33566910|NCT01377233|62962824|FG002|Double-blind|Protocol Violation|0|||
33566911|NCT01377233|62962825|FG003|Double-blind|Protocol Violation|0|||
33566912|NCT01377233|62962826|FG004|Double-blind|Protocol Violation|1|||
33566913|NCT01377233|62962822|FG000|Double-blind|Withdrawal by Subject|0|||
33566914|NCT01377233|62962823|FG001|Double-blind|Withdrawal by Subject|0|||
33566915|NCT01377233|62962824|FG002|Double-blind|Withdrawal by Subject|0|||
33566916|NCT01377233|62962825|FG003|Double-blind|Withdrawal by Subject|1|||
33566917|NCT01377233|62962826|FG004|Double-blind|Withdrawal by Subject|0|||
33566918|NCT01377233|62962822|FG000|Double-blind|Administrative or other|0|||
33566919|NCT01377233|62962823|FG001|Double-blind|Administrative or other|0|||
33566920|NCT01377233|62962824|FG002|Double-blind|Administrative or other|0|||
33566921|NCT01377233|62962825|FG003|Double-blind|Administrative or other|1|||
33566922|NCT01377233|62962826|FG004|Double-blind|Administrative or other|1|||
33566923|NCT03248531|62962845|FG000|Overall Study|Adverse Event|0|||
33566924|NCT03248531|62962846|FG001|Overall Study|Adverse Event|0|||
33566925|NCT03248531|62962847|FG002|Overall Study|Adverse Event|1|||
33566926|NCT03248531|62962845|FG000|Overall Study|Lost to Follow-up|1|||
33566927|NCT03248531|62962846|FG001|Overall Study|Lost to Follow-up|0|||
33566928|NCT03248531|62962847|FG002|Overall Study|Lost to Follow-up|5|||
33566929|NCT03248531|62962845|FG000|Overall Study|Withdrawal by Subject|3|||
33566930|NCT03248531|62962846|FG001|Overall Study|Withdrawal by Subject|3|||
33664133|NCT02681094|63095177|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
33302438|NCT01258101|62678163|FG003|Overall Study|Patient´s compliance|2|||
33302439|NCT01258101|62678160|FG000|Overall Study|Lost to Follow-up|5|||
33394098|NCT00545740|62773260|FG001|Overall Study|Site closure|0|||
33394099|NCT00545740|62773261|FG002|Overall Study|Site closure|0|||
33394100|NCT00545740|62773262|FG003|Overall Study|Site closure|0|||
33394101|NCT00545740|62773259|FG000|Overall Study|Missed visit|1|||
33394102|NCT00545740|62773260|FG001|Overall Study|Missed visit|0|||
33566931|NCT03248531|62962847|FG002|Overall Study|Withdrawal by Subject|2|||
33566932|NCT03248531|62962845|FG000|Overall Study|Sponsor Request|0|||
33566933|NCT03248531|62962846|FG001|Overall Study|Sponsor Request|2|||
33566934|NCT03248531|62962847|FG002|Overall Study|Sponsor Request|0|||
33566935|NCT02656329|62962864|FG000|Overall Study|Lost to Follow-up|2|||
33566936|NCT02656329|62962865|FG001|Overall Study|Lost to Follow-up|3|||
33566937|NCT02656329|62962864|FG000|Overall Study|Withdrawal by Subject|7|||
33566938|NCT02656329|62962865|FG001|Overall Study|Withdrawal by Subject|6|||
33566939|NCT02656329|62962864|FG000|Overall Study|Study termination by Sponsor|150|||
33566940|NCT02656329|62962865|FG001|Overall Study|Study termination by Sponsor|142|||
33566941|NCT02656329|62962864|FG000|Overall Study|Other than specified above|5|||
33302440|NCT01258101|62678161|FG001|Overall Study|Lost to Follow-up|5|||
33302441|NCT01258101|62678162|FG002|Overall Study|Lost to Follow-up|0|||
33302442|NCT01258101|62678163|FG003|Overall Study|Lost to Follow-up|6|||
33566942|NCT02656329|62962865|FG001|Overall Study|Other than specified above|6|||
33566943|NCT02712905|62962890|FG000|Monotherapy|Death|2|||
33566944|NCT02712905|62962891|FG001|Monotherapy|Death|5|||
33566945|NCT02712905|62962892|FG002|Monotherapy|Death|0|||
33566946|NCT02712905|62962893|FG003|Monotherapy|Death|3|||
33566947|NCT02712905|62962894|FG004|Monotherapy|Death|15|||
33566948|NCT02712905|62962895|FG005|Monotherapy|Death|1|||
33566949|NCT02712905|62962896|FG006|Monotherapy|Death|3|||
33302443|NCT01258101|62678160|FG000|Overall Study|PCR positive at week 24|0|||
33302444|NCT01258101|62678161|FG001|Overall Study|PCR positive at week 24|0|||
33302445|NCT01258101|62678162|FG002|Overall Study|PCR positive at week 24|0|||
33302446|NCT01258101|62678163|FG003|Overall Study|PCR positive at week 24|1|||
33302447|NCT01258101|62678160|FG000|Overall Study|Other reason|7|||
33302448|NCT01258101|62678161|FG001|Overall Study|Other reason|8|||
33302449|NCT01258101|62678162|FG002|Overall Study|Other reason|1|||
33302450|NCT01258101|62678163|FG003|Overall Study|Other reason|8|||
33302451|NCT01300338|62678175|FG000|Overall Study|Lost to Follow-up|5|||
33302452|NCT01300338|62678176|FG001|Overall Study|Lost to Follow-up|0|||
33302453|NCT01300260|62678184|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
33302454|NCT01300260|62678185|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
33302455|NCT01300260|62678184|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
33302456|NCT01300260|62678185|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
33302457|NCT01300260|62678184|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
33394103|NCT00545740|62773261|FG002|Overall Study|Missed visit|0|||
33566950|NCT02712905|62962897|FG007|Monotherapy|Death|3|||
33566951|NCT02712905|62962898|FG008|Monotherapy|Death|0|||
33566952|NCT02712905|62962899|FG009|Monotherapy|Death|27|||
33566953|NCT02712905|62962900|FG010|Monotherapy|Death|2|||
33566954|NCT02712905|62962901|FG011|Monotherapy|Death|5|||
33566955|NCT02712905|62962902|FG012|Monotherapy|Death|0|||
33394104|NCT00545740|62773262|FG003|Overall Study|Missed visit|0|||
33394105|NCT00545740|62773259|FG000|Overall Study|Physician Decision|0|||
33394106|NCT00545740|62773260|FG001|Overall Study|Physician Decision|0|||
33394107|NCT00545740|62773261|FG002|Overall Study|Physician Decision|3|||
33394108|NCT00545740|62773262|FG003|Overall Study|Physician Decision|0|||
33394109|NCT00545740|62773259|FG000|Overall Study|Accepted only monthly telephone calls|1|||
33394110|NCT00545740|62773260|FG001|Overall Study|Accepted only monthly telephone calls|0|||
33394111|NCT00545740|62773261|FG002|Overall Study|Accepted only monthly telephone calls|0|||
33394112|NCT00545740|62773262|FG003|Overall Study|Accepted only monthly telephone calls|0|||
33394113|NCT00545740|62773259|FG000|Overall Study|Sponsor decision|0|||
33394114|NCT00545740|62773260|FG001|Overall Study|Sponsor decision|1|||
33394115|NCT00545740|62773261|FG002|Overall Study|Sponsor decision|0|||
33394116|NCT00545740|62773262|FG003|Overall Study|Sponsor decision|0|||
33394117|NCT00545740|62773259|FG000|Overall Study|Lack of time|0|||
33566956|NCT02712905|62962903|FG013|Monotherapy|Death|0|||
33566957|NCT02712905|62962904|FG014|Monotherapy|Death|0|||
33566958|NCT02712905|62962905|FG015|Monotherapy|Death|0|||
33566959|NCT02712905|62962906|FG016|Monotherapy|Death|0|||
33566960|NCT02712905|62962907|FG017|Monotherapy|Death|0|||
33566961|NCT02712905|62962890|FG000|Monotherapy|Lost to Follow-up|0|||
33566962|NCT02712905|62962891|FG001|Monotherapy|Lost to Follow-up|1|||
33566963|NCT02712905|62962892|FG002|Monotherapy|Lost to Follow-up|0|||
33566964|NCT02712905|62962893|FG003|Monotherapy|Lost to Follow-up|1|||
33566965|NCT02712905|62962894|FG004|Monotherapy|Lost to Follow-up|0|||
33566966|NCT02712905|62962895|FG005|Monotherapy|Lost to Follow-up|0|||
33566967|NCT02712905|62962896|FG006|Monotherapy|Lost to Follow-up|0|||
33566968|NCT02712905|62962897|FG007|Monotherapy|Lost to Follow-up|0|||
33566969|NCT02712905|62962898|FG008|Monotherapy|Lost to Follow-up|0|||
33566970|NCT02712905|62962899|FG009|Monotherapy|Lost to Follow-up|2|||
33566971|NCT02712905|62962900|FG010|Monotherapy|Lost to Follow-up|0|||
33566972|NCT02712905|62962901|FG011|Monotherapy|Lost to Follow-up|0|||
33566973|NCT02712905|62962902|FG012|Monotherapy|Lost to Follow-up|0|||
33566974|NCT02712905|62962903|FG013|Monotherapy|Lost to Follow-up|0|||
33566975|NCT02712905|62962904|FG014|Monotherapy|Lost to Follow-up|0|||
33566976|NCT02712905|62962905|FG015|Monotherapy|Lost to Follow-up|0|||
33566977|NCT02712905|62962906|FG016|Monotherapy|Lost to Follow-up|0|||
33566978|NCT02712905|62962907|FG017|Monotherapy|Lost to Follow-up|0|||
33566979|NCT02712905|62962890|FG000|Monotherapy|Physician Decision|1|||
33566980|NCT02712905|62962891|FG001|Monotherapy|Physician Decision|0|||
33566981|NCT02712905|62962892|FG002|Monotherapy|Physician Decision|0|||
33566982|NCT02712905|62962893|FG003|Monotherapy|Physician Decision|1|||
33566983|NCT02712905|62962894|FG004|Monotherapy|Physician Decision|0|||
33566984|NCT02712905|62962895|FG005|Monotherapy|Physician Decision|0|||
33566985|NCT02712905|62962896|FG006|Monotherapy|Physician Decision|0|||
33566986|NCT02712905|62962897|FG007|Monotherapy|Physician Decision|0|||
33566987|NCT02712905|62962898|FG008|Monotherapy|Physician Decision|0|||
33566988|NCT02712905|62962899|FG009|Monotherapy|Physician Decision|1|||
33566989|NCT02712905|62962900|FG010|Monotherapy|Physician Decision|0|||
33566990|NCT02712905|62962901|FG011|Monotherapy|Physician Decision|0|||
33566991|NCT02712905|62962902|FG012|Monotherapy|Physician Decision|0|||
33566992|NCT02712905|62962903|FG013|Monotherapy|Physician Decision|0|||
33566993|NCT02712905|62962904|FG014|Monotherapy|Physician Decision|0|||
33566994|NCT02712905|62962905|FG015|Monotherapy|Physician Decision|0|||
33566995|NCT02712905|62962906|FG016|Monotherapy|Physician Decision|0|||
33566996|NCT02712905|62962907|FG017|Monotherapy|Physician Decision|0|||
33566997|NCT02712905|62962890|FG000|Monotherapy|Study Terminated by Sponsor|0|||
33664134|NCT02681094|63095178|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
33664135|NCT02681094|63095176|FG000|1 -Modified Enrolled Participants Set|Other|6|||
33664136|NCT02681094|63095177|FG001|1 -Modified Enrolled Participants Set|Other|6|||
33664137|NCT02681094|63095178|FG002|1 -Modified Enrolled Participants Set|Other|7|||
33664138|NCT02681094|63095176|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
33394118|NCT00545740|62773260|FG001|Overall Study|Lack of time|1|||
33566998|NCT02712905|62962891|FG001|Monotherapy|Study Terminated by Sponsor|0|||
33566999|NCT02712905|62962892|FG002|Monotherapy|Study Terminated by Sponsor|0|||
33567000|NCT02712905|62962893|FG003|Monotherapy|Study Terminated by Sponsor|0|||
33567001|NCT02712905|62962894|FG004|Monotherapy|Study Terminated by Sponsor|1|||
33567002|NCT02712905|62962895|FG005|Monotherapy|Study Terminated by Sponsor|0|||
33567003|NCT02712905|62962896|FG006|Monotherapy|Study Terminated by Sponsor|0|||
33567004|NCT02712905|62962897|FG007|Monotherapy|Study Terminated by Sponsor|0|||
33567005|NCT02712905|62962898|FG008|Monotherapy|Study Terminated by Sponsor|0|||
33567006|NCT02712905|62962899|FG009|Monotherapy|Study Terminated by Sponsor|2|||
33567007|NCT02712905|62962900|FG010|Monotherapy|Study Terminated by Sponsor|0|||
33567008|NCT02712905|62962901|FG011|Monotherapy|Study Terminated by Sponsor|0|||
33567009|NCT02712905|62962902|FG012|Monotherapy|Study Terminated by Sponsor|0|||
33567010|NCT02712905|62962903|FG013|Monotherapy|Study Terminated by Sponsor|0|||
33567011|NCT02712905|62962904|FG014|Monotherapy|Study Terminated by Sponsor|0|||
33567012|NCT02712905|62962905|FG015|Monotherapy|Study Terminated by Sponsor|0|||
33567013|NCT02712905|62962906|FG016|Monotherapy|Study Terminated by Sponsor|0|||
33394119|NCT00545740|62773261|FG002|Overall Study|Lack of time|0|||
33394120|NCT00545740|62773262|FG003|Overall Study|Lack of time|0|||
33394121|NCT00545740|62773259|FG000|Overall Study|Non-adherence to visits|0|||
33394122|NCT00545740|62773260|FG001|Overall Study|Non-adherence to visits|1|||
33394123|NCT00545740|62773261|FG002|Overall Study|Non-adherence to visits|0|||
33394124|NCT00545740|62773262|FG003|Overall Study|Non-adherence to visits|0|||
33394125|NCT00545740|62773259|FG000|Overall Study|Patient difficulties|0|||
33394126|NCT00545740|62773260|FG001|Overall Study|Patient difficulties|1|||
33394127|NCT00545740|62773261|FG002|Overall Study|Patient difficulties|0|||
33394128|NCT00545740|62773262|FG003|Overall Study|Patient difficulties|0|||
33394129|NCT00545740|62773259|FG000|Overall Study|Husband against study|0|||
33394130|NCT00545740|62773260|FG001|Overall Study|Husband against study|0|||
33394131|NCT00545740|62773261|FG002|Overall Study|Husband against study|1|||
33394132|NCT00545740|62773262|FG003|Overall Study|Husband against study|0|||
33394133|NCT00609609|62773274|FG000|Overall Study|Withdrawal by Subject|2|||
33394134|NCT00609609|62773275|FG001|Overall Study|Withdrawal by Subject|0|||
33394135|NCT00609609|62773274|FG000|Overall Study|Progression|4|||
33394136|NCT00609609|62773275|FG001|Overall Study|Progression|2|||
33394137|NCT00673452|62773283|FG000|Acute Double-Blind Phase|Adverse Event|41|||
33567014|NCT02712905|62962907|FG017|Monotherapy|Study Terminated by Sponsor|0|||
33567015|NCT02712905|62962890|FG000|Monotherapy|Withdrawal by Subject|0|||
33567016|NCT02712905|62962891|FG001|Monotherapy|Withdrawal by Subject|0|||
33567017|NCT02712905|62962892|FG002|Monotherapy|Withdrawal by Subject|1|||
33567018|NCT02712905|62962893|FG003|Monotherapy|Withdrawal by Subject|0|||
33567019|NCT02712905|62962894|FG004|Monotherapy|Withdrawal by Subject|2|||
33567020|NCT02712905|62962895|FG005|Monotherapy|Withdrawal by Subject|0|||
33567021|NCT02712905|62962896|FG006|Monotherapy|Withdrawal by Subject|0|||
33567022|NCT02712905|62962897|FG007|Monotherapy|Withdrawal by Subject|0|||
33567023|NCT02712905|62962898|FG008|Monotherapy|Withdrawal by Subject|0|||
33567024|NCT02712905|62962899|FG009|Monotherapy|Withdrawal by Subject|4|||
33567025|NCT02712905|62962900|FG010|Monotherapy|Withdrawal by Subject|1|||
33567026|NCT02712905|62962901|FG011|Monotherapy|Withdrawal by Subject|2|||
33567027|NCT02712905|62962902|FG012|Monotherapy|Withdrawal by Subject|0|||
33567028|NCT02712905|62962903|FG013|Monotherapy|Withdrawal by Subject|0|||
33567029|NCT02712905|62962904|FG014|Monotherapy|Withdrawal by Subject|0|||
33567030|NCT02712905|62962905|FG015|Monotherapy|Withdrawal by Subject|0|||
33567031|NCT02712905|62962906|FG016|Monotherapy|Withdrawal by Subject|0|||
33567032|NCT02712905|62962907|FG017|Monotherapy|Withdrawal by Subject|0|||
33567033|NCT02712905|62962890|FG000|Monotherapy|Started New Cancer Drug|0|||
33567034|NCT02712905|62962891|FG001|Monotherapy|Started New Cancer Drug|0|||
33567035|NCT02712905|62962892|FG002|Monotherapy|Started New Cancer Drug|0|||
33567036|NCT02712905|62962893|FG003|Monotherapy|Started New Cancer Drug|0|||
33567037|NCT02712905|62962894|FG004|Monotherapy|Started New Cancer Drug|0|||
33567038|NCT02712905|62962895|FG005|Monotherapy|Started New Cancer Drug|1|||
33567039|NCT02712905|62962896|FG006|Monotherapy|Started New Cancer Drug|0|||
33567040|NCT02712905|62962897|FG007|Monotherapy|Started New Cancer Drug|0|||
33567041|NCT02712905|62962898|FG008|Monotherapy|Started New Cancer Drug|0|||
33567042|NCT02712905|62962899|FG009|Monotherapy|Started New Cancer Drug|0|||
33567043|NCT02712905|62962900|FG010|Monotherapy|Started New Cancer Drug|0|||
33567044|NCT02712905|62962901|FG011|Monotherapy|Started New Cancer Drug|0|||
33567045|NCT02712905|62962902|FG012|Monotherapy|Started New Cancer Drug|0|||
33567046|NCT02712905|62962903|FG013|Monotherapy|Started New Cancer Drug|0|||
33567047|NCT02712905|62962904|FG014|Monotherapy|Started New Cancer Drug|0|||
33567048|NCT02712905|62962905|FG015|Monotherapy|Started New Cancer Drug|0|||
33567049|NCT02712905|62962906|FG016|Monotherapy|Started New Cancer Drug|0|||
33567050|NCT02712905|62962907|FG017|Monotherapy|Started New Cancer Drug|0|||
33567051|NCT02712905|62962890|FG000|Monotherapy|Adverse Event|0|||
33567052|NCT02712905|62962891|FG001|Monotherapy|Adverse Event|0|||
33567053|NCT02712905|62962892|FG002|Monotherapy|Adverse Event|0|||
33567054|NCT02712905|62962893|FG003|Monotherapy|Adverse Event|0|||
33567055|NCT02712905|62962894|FG004|Monotherapy|Adverse Event|0|||
33567056|NCT02712905|62962895|FG005|Monotherapy|Adverse Event|0|||
33567057|NCT02712905|62962896|FG006|Monotherapy|Adverse Event|0|||
33302458|NCT01300260|62678185|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
33302459|NCT01256385|62678204|FG000|Overall Study|Physician Decision|1|||
33302460|NCT01256385|62678205|FG001|Overall Study|Physician Decision|1|||
33302461|NCT01256385|62678204|FG000|Overall Study|Withdrawal by Subject|2|||
33567058|NCT02712905|62962897|FG007|Monotherapy|Adverse Event|0|||
33567059|NCT02712905|62962898|FG008|Monotherapy|Adverse Event|1|||
33567060|NCT02712905|62962899|FG009|Monotherapy|Adverse Event|0|||
33567061|NCT02712905|62962900|FG010|Monotherapy|Adverse Event|0|||
33567062|NCT02712905|62962901|FG011|Monotherapy|Adverse Event|0|||
33567063|NCT02712905|62962902|FG012|Monotherapy|Adverse Event|0|||
33302462|NCT01256385|62678205|FG001|Overall Study|Withdrawal by Subject|2|||
33302463|NCT01298778|62678213|FG000|Overall Study|Lost to Follow-up|2|||
33302464|NCT01298778|62678214|FG001|Overall Study|Lost to Follow-up|3|||
33302465|NCT01298778|62678213|FG000|Overall Study|Incorrect use of VAS|1|||
33302466|NCT01298778|62678214|FG001|Overall Study|Incorrect use of VAS|0|||
33567064|NCT02712905|62962903|FG013|Monotherapy|Adverse Event|0|||
33302467|NCT01298778|62678213|FG000|Overall Study|Withdrawal by Subject|0|||
33302468|NCT01298778|62678214|FG001|Overall Study|Withdrawal by Subject|1|||
33302469|NCT01298778|62678213|FG000|Overall Study|Protocol Violation|0|||
33394138|NCT00673452|62773284|FG001|Acute Double-Blind Phase|Adverse Event|24|||
33394139|NCT00673452|62773283|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
33394140|NCT00673452|62773284|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
33394141|NCT00673452|62773283|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
33394142|NCT00673452|62773284|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
33394143|NCT00673452|62773283|FG000|Acute Double-Blind Phase|Physician Decision|0|||
33394144|NCT00673452|62773284|FG001|Acute Double-Blind Phase|Physician Decision|6|||
33394145|NCT00673452|62773283|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
33394146|NCT00673452|62773284|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
33394147|NCT00673452|62773283|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
33394148|NCT00673452|62773284|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
33394149|NCT00673452|62773283|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
33394150|NCT00673452|62773284|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
33394151|NCT00673452|62773283|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
33394152|NCT00673452|62773284|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
33394153|NCT00673452|62773283|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
33394154|NCT00673452|62773284|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
33394155|NCT00673452|62773283|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
33394156|NCT00673452|62773284|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
33394157|NCT00673452|62773283|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
33394158|NCT00673452|62773284|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
33394159|NCT00673452|62773283|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
33394160|NCT00673452|62773284|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
33394161|NCT00673452|62773283|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
33394162|NCT00673452|62773284|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
33394163|NCT00673452|62773283|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
33394164|NCT00673452|62773284|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
33394165|NCT00673452|62773283|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
33394166|NCT00673452|62773284|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
33394167|NCT00545584|62773293|FG000|Overall Study|Only one reason for discontinuation|62|||
33394168|NCT00545584|62773294|FG001|Overall Study|Only one reason for discontinuation|61|||
33394169|NCT00545584|62773295|FG002|Overall Study|Only one reason for discontinuation|48|||
33394170|NCT00545584|62773293|FG000|Overall Study|Two or more reasons for discontinuation|17|||
33394171|NCT00545584|62773294|FG001|Overall Study|Two or more reasons for discontinuation|19|||
33394172|NCT00545584|62773295|FG002|Overall Study|Two or more reasons for discontinuation|8|||
33394173|NCT00378703|62773307|FG000|Overall Study|Disease progression|59|||
33394174|NCT00378703|62773308|FG001|Overall Study|Disease progression|43|||
33394175|NCT00378703|62773309|FG002|Overall Study|Disease progression|48|||
33394176|NCT00378703|62773310|FG003|Overall Study|Disease progression|49|||
33394177|NCT00378703|62773307|FG000|Overall Study|Adverse Event|11|||
33394178|NCT00378703|62773308|FG001|Overall Study|Adverse Event|17|||
33394179|NCT00378703|62773309|FG002|Overall Study|Adverse Event|20|||
33394180|NCT00378703|62773310|FG003|Overall Study|Adverse Event|18|||
33394181|NCT00378703|62773307|FG000|Overall Study|Death|2|||
33394182|NCT00378703|62773308|FG001|Overall Study|Death|2|||
33302470|NCT01298778|62678214|FG001|Overall Study|Protocol Violation|1|||
33302471|NCT01298778|62678213|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
33302472|NCT01298778|62678214|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
33302473|NCT01298700|62678224|FG000|Overall Study|Adverse Event|50|||
33302474|NCT01298700|62678225|FG001|Overall Study|Adverse Event|51|||
33302475|NCT01298700|62678224|FG000|Overall Study|Lack of Efficacy|9|||
33302476|NCT01298700|62678225|FG001|Overall Study|Lack of Efficacy|14|||
33302477|NCT01298700|62678224|FG000|Overall Study|Lost to Follow-up|5|||
33302478|NCT01298700|62678225|FG001|Overall Study|Lost to Follow-up|2|||
33302479|NCT01298700|62678224|FG000|Overall Study|Withdrawal by Subject|12|||
33302480|NCT01298700|62678225|FG001|Overall Study|Withdrawal by Subject|9|||
33302481|NCT01298700|62678224|FG000|Overall Study|Protocol Violation|6|||
33302482|NCT01298700|62678225|FG001|Overall Study|Protocol Violation|4|||
33302483|NCT01298700|62678224|FG000|Overall Study|Other Miscellaneous Reasons|16|||
33302484|NCT01298700|62678225|FG001|Overall Study|Other Miscellaneous Reasons|15|||
33302485|NCT01298700|62678224|FG000|Overall Study|Did not Receive Study Drug|3|||
33302486|NCT01298700|62678225|FG001|Overall Study|Did not Receive Study Drug|5|||
33394183|NCT00378703|62773309|FG002|Overall Study|Death|4|||
33394184|NCT00378703|62773310|FG003|Overall Study|Death|3|||
33302487|NCT01297920|62678234|FG000|Overall Study|Adverse Event|42|||
33302488|NCT01297920|62678235|FG001|Overall Study|Adverse Event|10|||
33302489|NCT01297920|62678236|FG002|Overall Study|Adverse Event|38|||
33302490|NCT01297920|62678234|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
33302491|NCT01297920|62678235|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
33302492|NCT01297920|62678236|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
33394185|NCT00378703|62773307|FG000|Overall Study|Withdrawal by Subject|4|||
33394186|NCT00378703|62773308|FG001|Overall Study|Withdrawal by Subject|8|||
33394187|NCT00378703|62773309|FG002|Overall Study|Withdrawal by Subject|5|||
33394188|NCT00378703|62773310|FG003|Overall Study|Withdrawal by Subject|7|||
33394189|NCT00378703|62773307|FG000|Overall Study|Physician Decision|1|||
33394190|NCT00378703|62773308|FG001|Overall Study|Physician Decision|4|||
33394191|NCT00378703|62773309|FG002|Overall Study|Physician Decision|1|||
33394192|NCT00378703|62773310|FG003|Overall Study|Physician Decision|0|||
33394193|NCT00378703|62773307|FG000|Overall Study|Alternative therapy|4|||
33394194|NCT00378703|62773308|FG001|Overall Study|Alternative therapy|2|||
33394195|NCT00378703|62773309|FG002|Overall Study|Alternative therapy|0|||
33394196|NCT00378703|62773310|FG003|Overall Study|Alternative therapy|0|||
33394197|NCT00378703|62773307|FG000|Overall Study|Other complicated disease|0|||
33394198|NCT00378703|62773308|FG001|Overall Study|Other complicated disease|2|||
33394199|NCT00378703|62773309|FG002|Overall Study|Other complicated disease|2|||
33394200|NCT00378703|62773310|FG003|Overall Study|Other complicated disease|0|||
33394201|NCT00378703|62773307|FG000|Overall Study|Symptomatic deterioration|0|||
33394202|NCT00378703|62773308|FG001|Overall Study|Symptomatic deterioration|1|||
33394203|NCT00378703|62773309|FG002|Overall Study|Symptomatic deterioration|0|||
33394204|NCT00378703|62773310|FG003|Overall Study|Symptomatic deterioration|2|||
33394205|NCT00378703|62773307|FG000|Overall Study|Surgery|1|||
33394206|NCT00378703|62773308|FG001|Overall Study|Surgery|0|||
33394207|NCT00378703|62773309|FG002|Overall Study|Surgery|0|||
33394208|NCT00378703|62773310|FG003|Overall Study|Surgery|1|||
33394209|NCT00378703|62773307|FG000|Overall Study|Joint decision of physician and patient|1|||
33394210|NCT00378703|62773308|FG001|Overall Study|Joint decision of physician and patient|0|||
33394211|NCT00378703|62773309|FG002|Overall Study|Joint decision of physician and patient|0|||
33394212|NCT00378703|62773310|FG003|Overall Study|Joint decision of physician and patient|0|||
33394213|NCT00378703|62773307|FG000|Overall Study|Adverse events and progressive disease|0|||
33394214|NCT00378703|62773308|FG001|Overall Study|Adverse events and progressive disease|0|||
33394215|NCT00378703|62773309|FG002|Overall Study|Adverse events and progressive disease|0|||
33394216|NCT00378703|62773310|FG003|Overall Study|Adverse events and progressive disease|1|||
33394217|NCT00378703|62773307|FG000|Overall Study|Relocation|0|||
33394218|NCT00378703|62773308|FG001|Overall Study|Relocation|0|||
33394219|NCT00378703|62773309|FG002|Overall Study|Relocation|1|||
33394220|NCT00378703|62773310|FG003|Overall Study|Relocation|0|||
33394221|NCT00378703|62773307|FG000|Overall Study|Ineligible|4|||
33394222|NCT00378703|62773308|FG001|Overall Study|Ineligible|7|||
33394223|NCT00378703|62773309|FG002|Overall Study|Ineligible|7|||
33394224|NCT00378703|62773310|FG003|Overall Study|Ineligible|7|||
33394225|NCT00378703|62773307|FG000|Overall Study|Never started treatment|1|||
33394226|NCT00378703|62773308|FG001|Overall Study|Never started treatment|4|||
33394227|NCT00378703|62773309|FG002|Overall Study|Never started treatment|0|||
33394228|NCT00378703|62773310|FG003|Overall Study|Never started treatment|0|||
33394229|NCT00378703|62773307|FG000|Overall Study|Other|1|||
33394230|NCT00378703|62773308|FG001|Overall Study|Other|1|||
33394231|NCT00378703|62773309|FG002|Overall Study|Other|2|||
33394232|NCT00378703|62773310|FG003|Overall Study|Other|3|||
33394233|NCT00368641|62773326|FG000|Overall Study|Adverse Event|2|||
33394234|NCT00368641|62773327|FG001|Overall Study|Adverse Event|1|||
33394235|NCT00368641|62773326|FG000|Overall Study|Death|1|||
33394236|NCT00368641|62773327|FG001|Overall Study|Death|0|||
33394237|NCT00368641|62773326|FG000|Overall Study|Withdrawal by Subject|1|||
33394238|NCT00368641|62773327|FG001|Overall Study|Withdrawal by Subject|0|||
33394239|NCT00368641|62773326|FG000|Overall Study|Sponsor decision to terminate study|2|||
33394240|NCT00368641|62773327|FG001|Overall Study|Sponsor decision to terminate study|5|||
33394241|NCT00608985|62773337|FG000|Overall Study|Adverse Event|2|||
33394242|NCT00608985|62773338|FG001|Overall Study|Adverse Event|7|||
33567065|NCT02712905|62962904|FG014|Monotherapy|Adverse Event|0|||
33567066|NCT02712905|62962905|FG015|Monotherapy|Adverse Event|0|||
33302493|NCT01297920|62678234|FG000|Overall Study|Noncompliance|1|||
33302494|NCT01297920|62678235|FG001|Overall Study|Noncompliance|0|||
33302495|NCT01297920|62678236|FG002|Overall Study|Noncompliance|0|||
33302496|NCT01297920|62678234|FG000|Overall Study|Protocol Violation|1|||
33302497|NCT01297920|62678235|FG001|Overall Study|Protocol Violation|3|||
33302498|NCT01297920|62678236|FG002|Overall Study|Protocol Violation|0|||
33302499|NCT01297920|62678234|FG000|Overall Study|Inadequate Control of IOP|7|||
33302500|NCT01297920|62678235|FG001|Overall Study|Inadequate Control of IOP|9|||
33394243|NCT00608985|62773339|FG002|Overall Study|Adverse Event|4|||
33394244|NCT00608985|62773340|FG003|Overall Study|Adverse Event|6|||
33394245|NCT00608985|62773337|FG000|Overall Study|Administrative/Other|7|||
33394246|NCT00608985|62773338|FG001|Overall Study|Administrative/Other|4|||
33394247|NCT00608985|62773339|FG002|Overall Study|Administrative/Other|1|||
33394248|NCT00608985|62773340|FG003|Overall Study|Administrative/Other|2|||
33394249|NCT00608985|62773337|FG000|Overall Study|Withdrawal of Consent|5|||
33394250|NCT00608985|62773338|FG001|Overall Study|Withdrawal of Consent|1|||
33394251|NCT00608985|62773339|FG002|Overall Study|Withdrawal of Consent|1|||
33394252|NCT00608985|62773340|FG003|Overall Study|Withdrawal of Consent|1|||
33394253|NCT00608985|62773337|FG000|Overall Study|Lost to Follow-up|2|||
33394254|NCT00608985|62773338|FG001|Overall Study|Lost to Follow-up|1|||
33394255|NCT00608985|62773339|FG002|Overall Study|Lost to Follow-up|0|||
33394256|NCT00608985|62773340|FG003|Overall Study|Lost to Follow-up|0|||
33394257|NCT00368251|62773353|FG000|Overall Study|SAE, non-fatal|1|||
33394258|NCT00368251|62773354|FG001|Overall Study|SAE, non-fatal|0|||
33394259|NCT00368251|62773355|FG002|Overall Study|SAE, non-fatal|0|||
33394260|NCT00368251|62773353|FG000|Overall Study|AE, non-serious non-fatal|0|||
33394261|NCT00368251|62773354|FG001|Overall Study|AE, non-serious non-fatal|0|||
33394262|NCT00368251|62773355|FG002|Overall Study|AE, non-serious non-fatal|1|||
33394263|NCT00378079|62773366|FG000|Overall Study|Lost to Follow-up|6|||
33394264|NCT00378079|62773367|FG001|Overall Study|Lost to Follow-up|1|||
33394265|NCT00378079|62773368|FG002|Overall Study|Lost to Follow-up|0|||
33394266|NCT03936244|62773378|FG000|Overall Study|Lost to Follow-up|5|||
33394267|NCT03936244|62773379|FG001|Overall Study|Lost to Follow-up|1|||
33394268|NCT03936244|62773378|FG000|Overall Study|Physician Decision|7|||
33394269|NCT03936244|62773379|FG001|Overall Study|Physician Decision|3|||
33394270|NCT03923530|62773386|FG000|Overall Study|Withdrawal by Subject|1|||
33394271|NCT03923530|62773386|FG000|Overall Study|screen failure|3|||
33394272|NCT00608907|62773393|FG000|Overall Study|Adverse Event|6|||
33394273|NCT00608907|62773394|FG001|Overall Study|Adverse Event|0|||
33394274|NCT00608907|62773395|FG002|Overall Study|Adverse Event|1|||
33394275|NCT00608907|62773393|FG000|Overall Study|Death|1|||
33394276|NCT00608907|62773394|FG001|Overall Study|Death|0|||
33664139|NCT02681094|63095177|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
33664140|NCT02681094|63095178|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
33302501|NCT01297920|62678236|FG002|Overall Study|Inadequate Control of IOP|17|||
33302502|NCT01297920|62678234|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
33302503|NCT01297920|62678235|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
33302504|NCT01297920|62678236|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
33302505|NCT01255761|62678246|FG000|Overall Study|Adverse Event|29|||
33302506|NCT01255761|62678247|FG001|Overall Study|Adverse Event|43|||
33302507|NCT01255761|62678246|FG000|Overall Study|Lack of Efficacy|86|||
33302508|NCT01255761|62678247|FG001|Overall Study|Lack of Efficacy|74|||
33302509|NCT01255761|62678246|FG000|Overall Study|Protocol Violation|9|||
33302510|NCT01255761|62678247|FG001|Overall Study|Protocol Violation|5|||
33302511|NCT01255761|62678246|FG000|Overall Study|Lost to Follow-up|10|||
33302512|NCT01255761|62678247|FG001|Overall Study|Lost to Follow-up|8|||
33302513|NCT01255761|62678246|FG000|Overall Study|Withdrawal by Subject|11|||
33302514|NCT01255761|62678247|FG001|Overall Study|Withdrawal by Subject|27|||
33302515|NCT01255761|62678246|FG000|Overall Study|Other Reasons|37|||
33302516|NCT01255761|62678247|FG001|Overall Study|Other Reasons|18|||
33302517|NCT01297062|62678259|FG000|Overall Study|Adverse Event|2|||
33302518|NCT01297062|62678260|FG001|Overall Study|Adverse Event|0|||
33302519|NCT01297062|62678261|FG002|Overall Study|Adverse Event|1|||
33302520|NCT01297062|62678262|FG003|Overall Study|Adverse Event|0|||
33302521|NCT01297062|62678263|FG004|Overall Study|Adverse Event|0|||
33302522|NCT01297062|62678264|FG005|Overall Study|Adverse Event|0|||
33302523|NCT01297062|62678265|FG006|Overall Study|Adverse Event|0|||
33302524|NCT01297062|62678259|FG000|Overall Study|Physician Decision|1|||
33302525|NCT01297062|62678260|FG001|Overall Study|Physician Decision|0|||
33302526|NCT01297062|62678261|FG002|Overall Study|Physician Decision|1|||
33302527|NCT01297062|62678262|FG003|Overall Study|Physician Decision|0|||
33302528|NCT01297062|62678263|FG004|Overall Study|Physician Decision|0|||
33302529|NCT01297062|62678264|FG005|Overall Study|Physician Decision|0|||
33302530|NCT01297062|62678265|FG006|Overall Study|Physician Decision|6|||
33302531|NCT01297062|62678259|FG000|Overall Study|Protocol Violation|0|||
33302532|NCT01297062|62678260|FG001|Overall Study|Protocol Violation|0|||
33302533|NCT01297062|62678261|FG002|Overall Study|Protocol Violation|0|||
33302534|NCT01297062|62678262|FG003|Overall Study|Protocol Violation|0|||
33302535|NCT01297062|62678263|FG004|Overall Study|Protocol Violation|1|||
33302536|NCT01297062|62678264|FG005|Overall Study|Protocol Violation|0|||
33302537|NCT01297062|62678265|FG006|Overall Study|Protocol Violation|0|||
33302538|NCT01297062|62678259|FG000|Overall Study|Subject Decision|1|||
33302539|NCT01297062|62678260|FG001|Overall Study|Subject Decision|1|||
33302540|NCT01297062|62678261|FG002|Overall Study|Subject Decision|0|||
33302541|NCT01297062|62678262|FG003|Overall Study|Subject Decision|1|||
33302542|NCT01297062|62678263|FG004|Overall Study|Subject Decision|1|||
33302543|NCT01297062|62678264|FG005|Overall Study|Subject Decision|1|||
33302544|NCT01297062|62678265|FG006|Overall Study|Subject Decision|2|||
33302545|NCT01254747|62678277|FG000|Overall Study|Unacceptable subjective vision|0|||
33302546|NCT01254747|62678278|FG001|Overall Study|Unacceptable subjective vision|0|||
33302547|NCT01254747|62678279|FG002|Overall Study|Unacceptable subjective vision|0|||
33302548|NCT01254747|62678280|FG003|Overall Study|Unacceptable subjective vision|2|||
33394277|NCT00608907|62773395|FG002|Overall Study|Death|0|||
33394278|NCT00608907|62773393|FG000|Overall Study|Withdrawal by Subject|4|||
33394279|NCT00608907|62773394|FG001|Overall Study|Withdrawal by Subject|0|||
33394280|NCT00608907|62773395|FG002|Overall Study|Withdrawal by Subject|0|||
33394281|NCT00608907|62773393|FG000|Overall Study|Progressive Disease|1|||
33394282|NCT00608907|62773394|FG001|Overall Study|Progressive Disease|0|||
33394283|NCT00608907|62773395|FG002|Overall Study|Progressive Disease|0|||
33394284|NCT00377611|62773405|FG000|Overall Study|Adverse Event|2|||
33394285|NCT00377611|62773406|FG001|Overall Study|Adverse Event|9|||
33394286|NCT00377611|62773405|FG000|Overall Study|Protocol Violation|2|||
33394287|NCT00377611|62773406|FG001|Overall Study|Protocol Violation|0|||
33394288|NCT00377611|62773405|FG000|Overall Study|Withdrawal by Subject|0|||
33394289|NCT00377611|62773406|FG001|Overall Study|Withdrawal by Subject|5|||
33394290|NCT00377611|62773405|FG000|Overall Study|Lost to Follow-up|18|||
33394291|NCT00377611|62773406|FG001|Overall Study|Lost to Follow-up|16|||
33394292|NCT00377611|62773405|FG000|Overall Study|Other|0|||
33394293|NCT00377611|62773406|FG001|Overall Study|Other|3|||
33394294|NCT00545272|62773419|FG000|Overall Study|Protocol deviation|0|||
33394295|NCT00545272|62773420|FG001|Overall Study|Protocol deviation|1|||
33394296|NCT00545272|62773421|FG002|Overall Study|Protocol deviation|0|||
33394297|NCT00545272|62773422|FG003|Overall Study|Protocol deviation|1|||
33394298|NCT00545272|62773423|FG004|Overall Study|Protocol deviation|0|||
33394299|NCT00545272|62773424|FG005|Overall Study|Protocol deviation|1|||
33394300|NCT00545272|62773419|FG000|Overall Study|Adverse Event|0|||
33394301|NCT00545272|62773420|FG001|Overall Study|Adverse Event|0|||
33394302|NCT00545272|62773421|FG002|Overall Study|Adverse Event|1|||
33394303|NCT00545272|62773422|FG003|Overall Study|Adverse Event|0|||
33394304|NCT00545272|62773423|FG004|Overall Study|Adverse Event|0|||
33394305|NCT00545272|62773424|FG005|Overall Study|Adverse Event|1|||
33394306|NCT00545272|62773419|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33394307|NCT00545272|62773420|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33394308|NCT00545272|62773421|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33394309|NCT00545272|62773422|FG003|Overall Study|Abnormal laboratory value(s)|0|||
33394310|NCT00545272|62773423|FG004|Overall Study|Abnormal laboratory value(s)|0|||
33394311|NCT00545272|62773424|FG005|Overall Study|Abnormal laboratory value(s)|1|||
33394312|NCT00545272|62773419|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33394313|NCT00545272|62773420|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33394314|NCT00545272|62773421|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33394315|NCT00545272|62773422|FG003|Overall Study|Abnormal test procedure result(s)|0|||
33394316|NCT00545272|62773423|FG004|Overall Study|Abnormal test procedure result(s)|1|||
33394317|NCT00545272|62773424|FG005|Overall Study|Abnormal test procedure result(s)|0|||
33394318|NCT00545272|62773419|FG000|Overall Study|Lost to Follow-up|0|||
33394319|NCT00545272|62773420|FG001|Overall Study|Lost to Follow-up|0|||
33394320|NCT00545272|62773421|FG002|Overall Study|Lost to Follow-up|0|||
33394321|NCT00545272|62773422|FG003|Overall Study|Lost to Follow-up|0|||
33394322|NCT00545272|62773423|FG004|Overall Study|Lost to Follow-up|1|||
33394323|NCT00545272|62773424|FG005|Overall Study|Lost to Follow-up|0|||
33394324|NCT00377455|62773438|FG000|Overall Study|Withdrawal by Subject|1|||
33394325|NCT00377299|62773444|FG000|Overall Study|Lost to Follow-up|14|||
33394326|NCT00377299|62773445|FG001|Overall Study|Lost to Follow-up|19|||
33394327|NCT00377299|62773444|FG000|Overall Study|Adverse Event|0|||
33394328|NCT00377299|62773445|FG001|Overall Study|Adverse Event|1|||
33394329|NCT00377299|62773444|FG000|Overall Study|Withdrawal by Subject|5|||
33394330|NCT00377299|62773445|FG001|Overall Study|Withdrawal by Subject|4|||
33394331|NCT00376675|62773454|FG000|Overall Study|Withdrawal by Subject|9|||
33394332|NCT00376675|62773455|FG001|Overall Study|Withdrawal by Subject|2|||
33394333|NCT00376675|62773454|FG000|Overall Study|Adverse Event|10|||
33394334|NCT00376675|62773455|FG001|Overall Study|Adverse Event|5|||
33394335|NCT00376675|62773454|FG000|Overall Study|Other Reason|1|||
33394336|NCT00376675|62773455|FG001|Overall Study|Other Reason|7|||
33394337|NCT03931330|62773461|FG000|Overall Study|Physician Decision|1|||
33394338|NCT00367237|62773468|FG000|Overall Study|Adverse Event|7|||
33394339|NCT00367237|62773469|FG001|Overall Study|Adverse Event|2|||
33394340|NCT00367237|62773468|FG000|Overall Study|Lost to Follow-up|1|||
33394341|NCT00367237|62773469|FG001|Overall Study|Lost to Follow-up|0|||
33394342|NCT00367237|62773468|FG000|Overall Study|Withdrawal by Subject|0|||
33394343|NCT00367237|62773469|FG001|Overall Study|Withdrawal by Subject|4|||
33394344|NCT00367237|62773468|FG000|Overall Study|Protocol Violation|2|||
33394345|NCT00367237|62773469|FG001|Overall Study|Protocol Violation|5|||
33394346|NCT00544882|62773477|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
33394347|NCT00544882|62773478|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
33394348|NCT00544882|62773479|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
33394349|NCT00544882|62773477|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
33394350|NCT00544882|62773478|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
33394351|NCT00544882|62773479|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
33394352|NCT00544882|62773477|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
33394353|NCT00544882|62773478|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
33394354|NCT00544882|62773479|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
33394355|NCT00544882|62773477|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
33394356|NCT00544882|62773478|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
33394357|NCT00544882|62773479|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
33394358|NCT00544882|62773477|FG000|Cycle 3: Follow-up|Noncompliance|0|||
33394359|NCT00544882|62773478|FG001|Cycle 3: Follow-up|Noncompliance|1|||
33394360|NCT00544882|62773479|FG002|Cycle 3: Follow-up|Noncompliance|0|||
33394361|NCT00544882|62773477|FG000|Cycle 3: Follow-up|Pregnancy|0|||
33394362|NCT00544882|62773478|FG001|Cycle 3: Follow-up|Pregnancy|1|||
33394363|NCT00544882|62773479|FG002|Cycle 3: Follow-up|Pregnancy|0|||
33394364|NCT00606801|62773487|FG000|Intervention|Protocol Violation|3|||
33394365|NCT00606801|62773488|FG001|Intervention|Protocol Violation|3|||
33394366|NCT00606177|62773500|FG000|Overall Study|Adverse Event|9|||
33394367|NCT00606177|62773501|FG001|Overall Study|Adverse Event|5|||
33394368|NCT00606177|62773500|FG000|Overall Study|Lack of Efficacy|3|||
33394369|NCT00606177|62773501|FG001|Overall Study|Lack of Efficacy|7|||
33394370|NCT00606177|62773500|FG000|Overall Study|Physician Decision|1|||
33394371|NCT00606177|62773501|FG001|Overall Study|Physician Decision|0|||
33394372|NCT00606177|62773500|FG000|Overall Study|Protocol Violation|1|||
33394373|NCT00606177|62773501|FG001|Overall Study|Protocol Violation|4|||
33394374|NCT00606177|62773500|FG000|Overall Study|Withdrawal by Subject|5|||
33394375|NCT00606177|62773501|FG001|Overall Study|Withdrawal by Subject|6|||
33394376|NCT00606177|62773500|FG000|Overall Study|Progression to depressive phase|6|||
33394377|NCT00606177|62773501|FG001|Overall Study|Progression to depressive phase|1|||
33394378|NCT00606177|62773500|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
33394379|NCT00606177|62773501|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
33394380|NCT00606177|62773500|FG000|Overall Study|Change of residence or other commitments|1|||
33394381|NCT00606177|62773501|FG001|Overall Study|Change of residence or other commitments|1|||
33394382|NCT00359281|62773516|FG000|Overall Study|Adverse Event|1|||
33394383|NCT00359281|62773517|FG001|Overall Study|Adverse Event|0|||
33394384|NCT00359281|62773518|FG002|Overall Study|Adverse Event|0|||
33394385|NCT00359281|62773519|FG003|Overall Study|Adverse Event|0|||
33394386|NCT00359281|62773520|FG004|Overall Study|Adverse Event|0|||
33394387|NCT00359281|62773521|FG005|Overall Study|Adverse Event|0|||
33394388|NCT00359281|62773522|FG006|Overall Study|Adverse Event|1|||
33394389|NCT00359281|62773523|FG007|Overall Study|Adverse Event|0|||
33394390|NCT00359281|62773524|FG008|Overall Study|Adverse Event|0|||
33394391|NCT00359281|62773516|FG000|Overall Study|Withdrawal by Subject|0|||
33394392|NCT00359281|62773517|FG001|Overall Study|Withdrawal by Subject|0|||
33394393|NCT00359281|62773518|FG002|Overall Study|Withdrawal by Subject|0|||
33394394|NCT00359281|62773519|FG003|Overall Study|Withdrawal by Subject|0|||
33394395|NCT00359281|62773520|FG004|Overall Study|Withdrawal by Subject|0|||
33394396|NCT00359281|62773521|FG005|Overall Study|Withdrawal by Subject|0|||
33394397|NCT00359281|62773522|FG006|Overall Study|Withdrawal by Subject|1|||
33394398|NCT00359281|62773523|FG007|Overall Study|Withdrawal by Subject|0|||
33394399|NCT00359281|62773524|FG008|Overall Study|Withdrawal by Subject|0|||
33394400|NCT00366535|62773553|FG000|First Phase: 12 Weeks|Adverse Event|1|||
33394401|NCT00366535|62773554|FG001|First Phase: 12 Weeks|Adverse Event|3|||
33394402|NCT00366535|62773553|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
33394403|NCT00366535|62773554|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
33394404|NCT00366535|62773553|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
33394405|NCT00366535|62773554|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
33394406|NCT00366535|62773553|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
33394407|NCT00366535|62773554|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
33394408|NCT00350545|62773568|FG000|Overall Study|Withdrawal by Subject|2|||
33394409|NCT00349921|62773576|FG000|First Spinal Injection|Physician Decision|1|||
33394410|NCT00349921|62773577|FG001|First Spinal Injection|Physician Decision|0|||
33302549|NCT01254747|62678277|FG000|Overall Study|Difficult removal handling|0|||
33302550|NCT01254747|62678278|FG001|Overall Study|Difficult removal handling|0|||
33302551|NCT01254747|62678279|FG002|Overall Study|Difficult removal handling|1|||
33302552|NCT01254747|62678280|FG003|Overall Study|Difficult removal handling|0|||
33302553|NCT01254747|62678277|FG000|Overall Study|Symptoms and problems|0|||
33302554|NCT01254747|62678278|FG001|Overall Study|Symptoms and problems|2|||
33302555|NCT01254747|62678279|FG002|Overall Study|Symptoms and problems|1|||
33302556|NCT01254747|62678280|FG003|Overall Study|Symptoms and problems|0|||
33302557|NCT01254747|62678277|FG000|Overall Study|Lost to Follow-up|0|||
33302558|NCT01254747|62678278|FG001|Overall Study|Lost to Follow-up|0|||
33302559|NCT01254747|62678279|FG002|Overall Study|Lost to Follow-up|1|||
33394411|NCT00349921|62773578|FG002|First Spinal Injection|Physician Decision|0|||
33394412|NCT00349921|62773579|FG003|First Spinal Injection|Physician Decision|0|||
33394413|NCT00349921|62773576|FG000|First Spinal Injection|Adverse Event|0|||
33394414|NCT00349921|62773577|FG001|First Spinal Injection|Adverse Event|0|||
33394415|NCT00349921|62773578|FG002|First Spinal Injection|Adverse Event|1|||
33394416|NCT00349921|62773579|FG003|First Spinal Injection|Adverse Event|0|||
33394417|NCT00606021|62773590|FG000|Induction Phase|Death|73|||
33394418|NCT00606021|62773591|FG001|Induction Phase|Death|0|||
33394419|NCT00606021|62773592|FG002|Induction Phase|Death|0|||
33394420|NCT00606021|62773590|FG000|Induction Phase|Physician Decision|2|||
33394421|NCT00606021|62773591|FG001|Induction Phase|Physician Decision|0|||
33302560|NCT01254747|62678280|FG003|Overall Study|Lost to Follow-up|0|||
33394422|NCT00606021|62773592|FG002|Induction Phase|Physician Decision|0|||
33394423|NCT00606021|62773590|FG000|Induction Phase|Withdrawal by Subject|2|||
33394424|NCT00606021|62773591|FG001|Induction Phase|Withdrawal by Subject|0|||
33394425|NCT00606021|62773592|FG002|Induction Phase|Withdrawal by Subject|0|||
33394426|NCT00606021|62773590|FG000|Induction Phase|Lost to Follow-up|10|||
33394427|NCT00606021|62773591|FG001|Induction Phase|Lost to Follow-up|0|||
33394428|NCT00606021|62773592|FG002|Induction Phase|Lost to Follow-up|0|||
33394429|NCT00606021|62773590|FG000|Maintenance Phase|Death|0|||
33394430|NCT00606021|62773591|FG001|Maintenance Phase|Death|17|||
33394431|NCT00606021|62773592|FG002|Maintenance Phase|Death|15|||
33394432|NCT00606021|62773590|FG000|Maintenance Phase|Physician Decision|0|||
33394433|NCT00606021|62773591|FG001|Maintenance Phase|Physician Decision|1|||
33394434|NCT00606021|62773592|FG002|Maintenance Phase|Physician Decision|0|||
33394435|NCT00606021|62773590|FG000|Maintenance Phase|Lost to Follow-up|0|||
33394436|NCT00606021|62773591|FG001|Maintenance Phase|Lost to Follow-up|5|||
33394437|NCT00606021|62773592|FG002|Maintenance Phase|Lost to Follow-up|2|||
33394438|NCT00337675|62773603|FG000|Overall Study|Adverse Event|10|||
33394439|NCT00337675|62773604|FG001|Overall Study|Adverse Event|9|||
33394440|NCT00337675|62773605|FG002|Overall Study|Adverse Event|19|||
33394441|NCT00337675|62773603|FG000|Overall Study|Lack of Efficacy|10|||
33394442|NCT00337675|62773604|FG001|Overall Study|Lack of Efficacy|7|||
33394443|NCT00337675|62773605|FG002|Overall Study|Lack of Efficacy|9|||
33394444|NCT00337675|62773603|FG000|Overall Study|Lost to Follow-up|22|||
33394445|NCT00337675|62773604|FG001|Overall Study|Lost to Follow-up|19|||
33394446|NCT00337675|62773605|FG002|Overall Study|Lost to Follow-up|17|||
33394447|NCT00337675|62773603|FG000|Overall Study|Physician Decision|9|||
33394448|NCT00337675|62773604|FG001|Overall Study|Physician Decision|17|||
33394449|NCT00337675|62773605|FG002|Overall Study|Physician Decision|14|||
33394450|NCT00337675|62773603|FG000|Overall Study|Protocol Violation|21|||
33394451|NCT00337675|62773604|FG001|Overall Study|Protocol Violation|24|||
33394452|NCT00337675|62773605|FG002|Overall Study|Protocol Violation|19|||
33394453|NCT00337675|62773603|FG000|Overall Study|Withdrawal by Subject|25|||
33394454|NCT00337675|62773604|FG001|Overall Study|Withdrawal by Subject|25|||
33394455|NCT00337675|62773605|FG002|Overall Study|Withdrawal by Subject|19|||
33394456|NCT00337675|62773603|FG000|Overall Study|Progressive Disease|0|||
33394457|NCT00337675|62773604|FG001|Overall Study|Progressive Disease|2|||
33394458|NCT00337675|62773605|FG002|Overall Study|Progressive Disease|0|||
33394459|NCT00337675|62773603|FG000|Overall Study|Trial Terminated|0|||
33394460|NCT00337675|62773604|FG001|Overall Study|Trial Terminated|0|||
33394461|NCT00337675|62773605|FG002|Overall Study|Trial Terminated|2|||
33394462|NCT00337285|62773613|FG000|Overall Study|Withdrawal by Subject|42|||
33394463|NCT00337285|62773613|FG000|Overall Study|Lost to Follow-up|41|||
33394464|NCT00337285|62773613|FG000|Overall Study|Adverse Event|28|||
33394465|NCT00337285|62773613|FG000|Overall Study|Protocol Violation|27|||
33394466|NCT00337285|62773613|FG000|Overall Study|Lack of Efficacy|11|||
33394467|NCT00337285|62773613|FG000|Overall Study|Death|1|||
33394468|NCT00337285|62773613|FG000|Overall Study|Physician Decision|1|||
33394469|NCT00337285|62773613|FG000|Overall Study|Lack of protocol compliance|7|||
33394470|NCT00605865|62773617|FG000|Overall Study|Protocol Violation|115|||
33394471|NCT00348673|62773657|FG000|Stage 1|Randomized but not Treated|0|||
33394472|NCT00348673|62773658|FG001|Stage 1|Randomized but not Treated|0|||
33394473|NCT00348673|62773659|FG002|Stage 1|Randomized but not Treated|1|||
33394474|NCT00348673|62773660|FG003|Stage 1|Randomized but not Treated|0|||
33394475|NCT00348673|62773661|FG004|Stage 1|Randomized but not Treated|0|||
33394476|NCT00348673|62773662|FG005|Stage 1|Randomized but not Treated|0|||
33394477|NCT00348673|62773663|FG006|Stage 1|Randomized but not Treated|0|||
33394478|NCT00348673|62773664|FG007|Stage 1|Randomized but not Treated|0|||
33394479|NCT00348673|62773665|FG008|Stage 1|Randomized but not Treated|0|||
33394480|NCT00337207|62773683|FG000|Overall Study|Withdrawal by Subject|3|||
33394481|NCT00604695|62773690|FG000|Overall Study|Did not receive first bolus.|0|||
33394482|NCT00604695|62773691|FG001|Overall Study|Did not receive first bolus.|4|||
33394483|NCT00348595|62773699|FG000|Overall Study|Adverse Event|5|||
33394484|NCT00348595|62773700|FG001|Overall Study|Adverse Event|8|||
33394485|NCT00337129|62773706|FG000|Overall Study|Adverse Event|4|||
33394486|NCT00337129|62773706|FG000|Overall Study|Withdrawal by Subject|1|||
33394487|NCT00337129|62773706|FG000|Overall Study|Lack of Efficacy|32|||
33394488|NCT00337129|62773706|FG000|Overall Study|Death|2|||
33394489|NCT00337129|62773706|FG000|Overall Study|not protocol specified|1|||
33394490|NCT00605085|62773712|FG000|Overall Study|Withdrawal by Subject|8|||
33394491|NCT00605085|62773713|FG001|Overall Study|Withdrawal by Subject|5|||
33394492|NCT00605085|62773712|FG000|Overall Study|Adverse Event|9|||
33394493|NCT00605085|62773713|FG001|Overall Study|Adverse Event|5|||
33394494|NCT00605085|62773712|FG000|Overall Study|Pregnancy|2|||
33394495|NCT00605085|62773713|FG001|Overall Study|Pregnancy|0|||
33394496|NCT00605085|62773712|FG000|Overall Study|Protocol Violation|3|||
33394497|NCT00605085|62773713|FG001|Overall Study|Protocol Violation|2|||
33394498|NCT00605085|62773712|FG000|Overall Study|Lost to Follow-up|10|||
33394499|NCT00605085|62773713|FG001|Overall Study|Lost to Follow-up|5|||
33394500|NCT00605085|62773712|FG000|Overall Study|administrative reasons|18|||
33394501|NCT00605085|62773713|FG001|Overall Study|administrative reasons|8|||
33394502|NCT00348283|62773721|FG000|Induction|Adverse Event|0|||
33394503|NCT00348283|62773722|FG001|Induction|Adverse Event|2|||
33394504|NCT00348283|62773721|FG000|Induction|Protocol Violation|0|||
33394505|NCT00348283|62773722|FG001|Induction|Protocol Violation|4|||
33394506|NCT00348283|62773721|FG000|Double Blind|Adverse Event|2|||
33394507|NCT00348283|62773722|FG001|Double Blind|Adverse Event|5|||
33394508|NCT00348283|62773721|FG000|Double Blind|Withdrawal by Subject|1|||
33394509|NCT00348283|62773722|FG001|Double Blind|Withdrawal by Subject|1|||
33394510|NCT00348283|62773721|FG000|Double Blind|Protocol Violation|0|||
33394511|NCT00348283|62773722|FG001|Double Blind|Protocol Violation|1|||
33394512|NCT00348283|62773721|FG000|Double Blind|Lack of Efficacy|2|||
33394513|NCT00348283|62773722|FG001|Double Blind|Lack of Efficacy|2|||
33394514|NCT00348283|62773721|FG000|Double Blind|Pregnancy|0|||
33394515|NCT00348283|62773722|FG001|Double Blind|Pregnancy|1|||
33394516|NCT00348283|62773721|FG000|Open Label|Adverse Event|0|||
33394517|NCT00348283|62773722|FG001|Open Label|Adverse Event|8|||
33394518|NCT00348283|62773721|FG000|Open Label|Withdrawal by Subject|0|||
33394519|NCT00348283|62773722|FG001|Open Label|Withdrawal by Subject|4|||
33394520|NCT00348283|62773721|FG000|Open Label|Lost to Follow-up|0|||
33394521|NCT00348283|62773722|FG001|Open Label|Lost to Follow-up|1|||
33394522|NCT00348283|62773721|FG000|Open Label|Lack of Efficacy|0|||
33394523|NCT00348283|62773722|FG001|Open Label|Lack of Efficacy|13|||
33394524|NCT00348283|62773721|FG000|Open Label|Administrative reasons|0|||
33394525|NCT00348283|62773722|FG001|Open Label|Administrative reasons|5|||
33394526|NCT00348283|62773721|FG000|Open Label|Subject moved to the United States|0|||
33394527|NCT00348283|62773722|FG001|Open Label|Subject moved to the United States|1|||
33394528|NCT00348283|62773721|FG000|Open Label|Pregnancy|0|||
33394529|NCT00348283|62773722|FG001|Open Label|Pregnancy|1|||
33394530|NCT00348283|62773721|FG000|Open Label|Sponsor decision|0|||
33394531|NCT00348283|62773722|FG001|Open Label|Sponsor decision|1|||
33394532|NCT00336895|62773728|FG000|Overall Study|diarrhea|1|||
33394533|NCT00336895|62773728|FG000|Overall Study|nausea and upset stomach|1|||
33394534|NCT00336895|62773728|FG000|Overall Study|Physician Decision|1|||
33394535|NCT00336895|62773728|FG000|Overall Study|screen failed|1|||
33394536|NCT00336583|62773732|FG000|Overall Study|Lost to Follow-up|1|||
33394537|NCT00336583|62773732|FG000|Overall Study|Death|1|||
33394538|NCT00336505|62773738|FG000|Overall Study|Adverse Event|10|||
33394539|NCT00336505|62773739|FG001|Overall Study|Adverse Event|9|||
33394540|NCT00336505|62773738|FG000|Overall Study|Lack of Efficacy|8|||
33302561|NCT01254747|62678277|FG000|Overall Study|Biomicroscopy|0|||
33302562|NCT01254747|62678278|FG001|Overall Study|Biomicroscopy|0|||
33302563|NCT01254747|62678279|FG002|Overall Study|Biomicroscopy|1|||
33302564|NCT01254747|62678280|FG003|Overall Study|Biomicroscopy|0|||
33302565|NCT01254747|62678277|FG000|Overall Study|Discomfort|0|||
33302566|NCT01254747|62678278|FG001|Overall Study|Discomfort|4|||
33302567|NCT01254747|62678279|FG002|Overall Study|Discomfort|0|||
33302568|NCT01254747|62678280|FG003|Overall Study|Discomfort|0|||
33302569|NCT01296672|62678292|FG000|Overall Study|Lost to Follow-up|73|||
33302570|NCT01296672|62678293|FG001|Overall Study|Lost to Follow-up|18|||
33302571|NCT01254669|62678303|FG000|Overall Study|Withdrawal by Subject|0|||
33302572|NCT01254669|62678304|FG001|Overall Study|Withdrawal by Subject|1|||
33302573|NCT01254669|62678303|FG000|Overall Study|time constraint|2|||
33302574|NCT01254669|62678304|FG001|Overall Study|time constraint|2|||
33302575|NCT01254669|62678303|FG000|Overall Study|called to clinic during intervention|1|||
33302576|NCT01254669|62678304|FG001|Overall Study|called to clinic during intervention|1|||
33302577|NCT01295814|62678314|FG000|Overall Study|Lack of Efficacy|0|||
33302578|NCT01295814|62678315|FG001|Overall Study|Lack of Efficacy|2|||
33302579|NCT01295814|62678314|FG000|Overall Study|Withdrawal by Subject|2|||
33302580|NCT01295814|62678315|FG001|Overall Study|Withdrawal by Subject|0|||
33302581|NCT01254045|62678321|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
33302582|NCT01254045|62678322|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
33302583|NCT01254045|62678323|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
33394541|NCT00336505|62773739|FG001|Overall Study|Lack of Efficacy|4|||
33394542|NCT00336505|62773738|FG000|Overall Study|Lost to Follow-up|7|||
33394543|NCT00336505|62773739|FG001|Overall Study|Lost to Follow-up|4|||
33394544|NCT00336505|62773738|FG000|Overall Study|Withdrawal by Subject|5|||
33394545|NCT00336505|62773739|FG001|Overall Study|Withdrawal by Subject|3|||
33394546|NCT00336505|62773738|FG000|Overall Study|Other|7|||
33394547|NCT00336505|62773739|FG001|Overall Study|Other|7|||
33394548|NCT00357877|62773747|FG000|Overall Study|Death|2|||
33394549|NCT00357877|62773748|FG001|Overall Study|Death|1|||
33394550|NCT00357877|62773747|FG000|Overall Study|Lost to Follow-up|20|||
33394551|NCT00357877|62773748|FG001|Overall Study|Lost to Follow-up|23|||
33394552|NCT00357877|62773747|FG000|Overall Study|Withdrawal by Subject|3|||
33394553|NCT00357877|62773748|FG001|Overall Study|Withdrawal by Subject|3|||
33302584|NCT01254045|62678324|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
33302585|NCT01254045|62678325|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
33394554|NCT00357877|62773747|FG000|Overall Study|Administrative withdrawal|1|||
33394555|NCT00357877|62773748|FG001|Overall Study|Administrative withdrawal|1|||
33394556|NCT00357877|62773747|FG000|Overall Study|Other|0|||
33394557|NCT00357877|62773748|FG001|Overall Study|Other|2|||
33394558|NCT00335959|62773756|FG000|Overall Study|Adverse Event|2|||
33394559|NCT00335959|62773756|FG000|Overall Study|Ineligible|1|||
33394560|NCT00670488|62773771|FG000|Overall Study|Adverse Event|0|||
33567067|NCT02712905|62962906|FG016|Monotherapy|Adverse Event|0|||
33567068|NCT02712905|62962907|FG017|Monotherapy|Adverse Event|0|||
33567069|NCT02712905|62962890|FG000|Combination Therapy|Death|0|||
33567070|NCT02712905|62962891|FG001|Combination Therapy|Death|0|||
33567071|NCT02712905|62962892|FG002|Combination Therapy|Death|0|||
33567072|NCT02712905|62962893|FG003|Combination Therapy|Death|0|||
33567073|NCT02712905|62962894|FG004|Combination Therapy|Death|0|||
33567074|NCT02712905|62962895|FG005|Combination Therapy|Death|0|||
33567075|NCT02712905|62962896|FG006|Combination Therapy|Death|0|||
33567076|NCT02712905|62962897|FG007|Combination Therapy|Death|0|||
33567077|NCT02712905|62962898|FG008|Combination Therapy|Death|0|||
33567078|NCT02712905|62962899|FG009|Combination Therapy|Death|0|||
33567079|NCT02712905|62962900|FG010|Combination Therapy|Death|0|||
33567080|NCT02712905|62962901|FG011|Combination Therapy|Death|0|||
33567081|NCT02712905|62962902|FG012|Combination Therapy|Death|5|||
33567082|NCT02712905|62962903|FG013|Combination Therapy|Death|6|||
33567083|NCT02712905|62962904|FG014|Combination Therapy|Death|1|||
33567084|NCT02712905|62962905|FG015|Combination Therapy|Death|3|||
33567085|NCT02712905|62962906|FG016|Combination Therapy|Death|1|||
33567086|NCT02712905|62962907|FG017|Combination Therapy|Death|3|||
33567087|NCT02712905|62962890|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
33567088|NCT02712905|62962891|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
33567089|NCT02712905|62962892|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
33567090|NCT02712905|62962893|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
33567091|NCT02712905|62962894|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
33567092|NCT02712905|62962895|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
33567093|NCT02712905|62962896|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
33567094|NCT02712905|62962897|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
33567095|NCT02712905|62962898|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
33567096|NCT02712905|62962899|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
33567097|NCT02712905|62962900|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
33567098|NCT02712905|62962901|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
33567099|NCT02712905|62962902|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
33567100|NCT02712905|62962903|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
33567101|NCT02712905|62962904|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
33567102|NCT02712905|62962905|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
33567103|NCT02712905|62962906|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
33567104|NCT02712905|62962907|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
33567105|NCT02712905|62962890|FG000|Combination Therapy|Withdrawal by Subject|0|||
33567106|NCT02712905|62962891|FG001|Combination Therapy|Withdrawal by Subject|0|||
33567107|NCT02712905|62962892|FG002|Combination Therapy|Withdrawal by Subject|0|||
33567108|NCT02712905|62962893|FG003|Combination Therapy|Withdrawal by Subject|0|||
33567109|NCT02712905|62962894|FG004|Combination Therapy|Withdrawal by Subject|0|||
33567110|NCT02712905|62962895|FG005|Combination Therapy|Withdrawal by Subject|0|||
33567111|NCT02712905|62962896|FG006|Combination Therapy|Withdrawal by Subject|0|||
33567112|NCT02712905|62962897|FG007|Combination Therapy|Withdrawal by Subject|0|||
33567113|NCT02712905|62962898|FG008|Combination Therapy|Withdrawal by Subject|0|||
33567114|NCT02712905|62962899|FG009|Combination Therapy|Withdrawal by Subject|0|||
33567115|NCT02712905|62962900|FG010|Combination Therapy|Withdrawal by Subject|0|||
33567116|NCT02712905|62962901|FG011|Combination Therapy|Withdrawal by Subject|0|||
33567117|NCT02712905|62962902|FG012|Combination Therapy|Withdrawal by Subject|0|||
33567118|NCT02712905|62962903|FG013|Combination Therapy|Withdrawal by Subject|0|||
33567119|NCT02712905|62962904|FG014|Combination Therapy|Withdrawal by Subject|0|||
33567120|NCT02712905|62962905|FG015|Combination Therapy|Withdrawal by Subject|1|||
33567121|NCT02712905|62962906|FG016|Combination Therapy|Withdrawal by Subject|0|||
33567122|NCT02712905|62962907|FG017|Combination Therapy|Withdrawal by Subject|2|||
33567123|NCT02712905|62962890|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33567124|NCT02712905|62962891|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33567125|NCT02712905|62962892|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33567126|NCT02712905|62962893|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33567127|NCT02712905|62962894|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33567128|NCT02712905|62962895|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33394561|NCT00670488|62773772|FG001|Overall Study|Adverse Event|7|||
33394562|NCT00670488|62773773|FG002|Overall Study|Adverse Event|0|||
33394563|NCT00670488|62773774|FG003|Overall Study|Adverse Event|3|||
33394564|NCT00670488|62773775|FG004|Overall Study|Adverse Event|1|||
33567129|NCT02712905|62962896|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33580966|NCT01268150|62978110|FG000|Treatment Phase|Withdrawal by Subject|3|||
33394565|NCT00670488|62773776|FG005|Overall Study|Adverse Event|1|||
33394566|NCT00670488|62773777|FG006|Overall Study|Adverse Event|5|||
33394567|NCT00670488|62773778|FG007|Overall Study|Adverse Event|1|||
33394568|NCT00670488|62773779|FG008|Overall Study|Adverse Event|0|||
33394569|NCT00670488|62773780|FG009|Overall Study|Adverse Event|1|||
33394570|NCT00670488|62773771|FG000|Overall Study|Physician Decision|1|||
33394571|NCT00670488|62773772|FG001|Overall Study|Physician Decision|9|||
33394572|NCT00670488|62773773|FG002|Overall Study|Physician Decision|0|||
33567130|NCT02712905|62962897|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33567131|NCT02712905|62962898|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33567132|NCT02712905|62962899|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33567133|NCT02712905|62962900|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33567134|NCT02712905|62962901|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33567135|NCT02712905|62962902|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33567136|NCT02712905|62962903|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33567137|NCT02712905|62962904|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33567138|NCT02712905|62962905|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
33567139|NCT02712905|62962906|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33567140|NCT02712905|62962907|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33567141|NCT03776357|62962945|FG000|Overall Study|Lost to Follow-up|3|||
33567142|NCT04520997|62962951|FG000|Overall Study|Lost to Follow-up|1|||
33567143|NCT04520997|62962952|FG001|Overall Study|Lost to Follow-up|1|||
33567144|NCT04520997|62962951|FG000|Overall Study|Withdrawal by Subject|1|||
33567145|NCT04520997|62962952|FG001|Overall Study|Withdrawal by Subject|0|||
33567146|NCT04520997|62962951|FG000|Overall Study|Not Treated|0|||
33567147|NCT04520997|62962952|FG001|Overall Study|Not Treated|1|||
33567148|NCT02734433|62962963|FG000|Overall Study|Disease progression|1|||
33567149|NCT02734433|62962964|FG001|Overall Study|Disease progression|5|||
33567150|NCT02734433|62962963|FG000|Overall Study|Clinical progression|0|||
33567151|NCT02734433|62962964|FG001|Overall Study|Clinical progression|1|||
33567152|NCT02734433|62962963|FG000|Overall Study|Withdrawal by Subject|1|||
33567153|NCT02734433|62962964|FG001|Overall Study|Withdrawal by Subject|2|||
33567154|NCT02452424|62962990|FG000|Overall Study|Death|2|||
33567155|NCT02452424|62962991|FG001|Overall Study|Death|2|||
33567156|NCT02452424|62962992|FG002|Overall Study|Death|2|||
33567157|NCT02452424|62962993|FG003|Overall Study|Death|6|||
33567158|NCT02452424|62962994|FG004|Overall Study|Death|2|||
33567159|NCT02452424|62962995|FG005|Overall Study|Death|0|||
33567160|NCT02452424|62962996|FG006|Overall Study|Death|5|||
33567161|NCT02452424|62962997|FG007|Overall Study|Death|1|||
33567162|NCT02452424|62962998|FG008|Overall Study|Death|3|||
33567163|NCT02452424|62962999|FG009|Overall Study|Death|1|||
33567164|NCT02452424|62963000|FG010|Overall Study|Death|0|||
33567165|NCT02452424|62962990|FG000|Overall Study|Lost to Follow-up|0|||
33567166|NCT02452424|62962991|FG001|Overall Study|Lost to Follow-up|1|||
33394573|NCT00670488|62773774|FG003|Overall Study|Physician Decision|1|||
33394574|NCT00670488|62773775|FG004|Overall Study|Physician Decision|0|||
33394575|NCT00670488|62773776|FG005|Overall Study|Physician Decision|0|||
33567167|NCT02452424|62962992|FG002|Overall Study|Lost to Follow-up|1|||
33394576|NCT00670488|62773777|FG006|Overall Study|Physician Decision|0|||
33394577|NCT00670488|62773778|FG007|Overall Study|Physician Decision|0|||
33394578|NCT00670488|62773779|FG008|Overall Study|Physician Decision|0|||
33394579|NCT00670488|62773780|FG009|Overall Study|Physician Decision|0|||
33394580|NCT00670488|62773771|FG000|Overall Study|Progressive Disease|2|||
33394581|NCT00670488|62773772|FG001|Overall Study|Progressive Disease|41|||
33394582|NCT00670488|62773773|FG002|Overall Study|Progressive Disease|3|||
33394583|NCT00670488|62773774|FG003|Overall Study|Progressive Disease|2|||
33394584|NCT00670488|62773775|FG004|Overall Study|Progressive Disease|2|||
33394585|NCT00670488|62773776|FG005|Overall Study|Progressive Disease|4|||
33394586|NCT00670488|62773777|FG006|Overall Study|Progressive Disease|11|||
33394587|NCT00670488|62773778|FG007|Overall Study|Progressive Disease|2|||
33394588|NCT00670488|62773779|FG008|Overall Study|Progressive Disease|2|||
33394589|NCT00670488|62773780|FG009|Overall Study|Progressive Disease|1|||
33394590|NCT00670488|62773771|FG000|Overall Study|Withdrawal by Subject|0|||
33394591|NCT00670488|62773772|FG001|Overall Study|Withdrawal by Subject|1|||
33394592|NCT00670488|62773773|FG002|Overall Study|Withdrawal by Subject|0|||
33394593|NCT00670488|62773774|FG003|Overall Study|Withdrawal by Subject|1|||
33394594|NCT00670488|62773775|FG004|Overall Study|Withdrawal by Subject|0|||
33394595|NCT00670488|62773776|FG005|Overall Study|Withdrawal by Subject|0|||
33394596|NCT00670488|62773777|FG006|Overall Study|Withdrawal by Subject|1|||
33394597|NCT00670488|62773778|FG007|Overall Study|Withdrawal by Subject|0|||
33394598|NCT00670488|62773779|FG008|Overall Study|Withdrawal by Subject|1|||
33394599|NCT00670488|62773780|FG009|Overall Study|Withdrawal by Subject|0|||
33394600|NCT00671658|62773802|FG000|Overall Study|Physician Decision|5|||
33394601|NCT00542386|62773812|FG000|Overall Study|Adverse Event|1|||
33394602|NCT00542386|62773813|FG001|Overall Study|Adverse Event|7|||
33567168|NCT02452424|62962993|FG003|Overall Study|Lost to Follow-up|0|||
33394603|NCT00542386|62773814|FG002|Overall Study|Adverse Event|7|||
33394604|NCT00542386|62773815|FG003|Overall Study|Adverse Event|8|||
33394605|NCT00542386|62773816|FG004|Overall Study|Adverse Event|13|||
33394606|NCT00542386|62773817|FG005|Overall Study|Adverse Event|4|||
33394607|NCT00542386|62773812|FG000|Overall Study|Death|0|||
33567169|NCT02452424|62962994|FG004|Overall Study|Lost to Follow-up|0|||
33567170|NCT02452424|62962995|FG005|Overall Study|Lost to Follow-up|0|||
33567171|NCT02452424|62962996|FG006|Overall Study|Lost to Follow-up|0|||
33567172|NCT02452424|62962997|FG007|Overall Study|Lost to Follow-up|0|||
33567173|NCT02452424|62962998|FG008|Overall Study|Lost to Follow-up|0|||
33567174|NCT02452424|62962999|FG009|Overall Study|Lost to Follow-up|0|||
33567175|NCT02452424|62963000|FG010|Overall Study|Lost to Follow-up|0|||
33567176|NCT02452424|62962990|FG000|Overall Study|Withdrawal by Subject|0|||
33567177|NCT02452424|62962991|FG001|Overall Study|Withdrawal by Subject|0|||
33567178|NCT02452424|62962992|FG002|Overall Study|Withdrawal by Subject|3|||
33567179|NCT02452424|62962993|FG003|Overall Study|Withdrawal by Subject|2|||
33567180|NCT02452424|62962994|FG004|Overall Study|Withdrawal by Subject|0|||
33567181|NCT02452424|62962995|FG005|Overall Study|Withdrawal by Subject|0|||
33567182|NCT02452424|62962996|FG006|Overall Study|Withdrawal by Subject|1|||
33567183|NCT02452424|62962997|FG007|Overall Study|Withdrawal by Subject|0|||
33567184|NCT02452424|62962998|FG008|Overall Study|Withdrawal by Subject|1|||
33567185|NCT02452424|62962999|FG009|Overall Study|Withdrawal by Subject|1|||
33567186|NCT02452424|62963000|FG010|Overall Study|Withdrawal by Subject|0|||
33567187|NCT02452424|62962990|FG000|Overall Study|Other|0|||
33567188|NCT02452424|62962991|FG001|Overall Study|Other|0|||
33567189|NCT02452424|62962992|FG002|Overall Study|Other|1|||
33567190|NCT02452424|62962993|FG003|Overall Study|Other|0|||
33567191|NCT02452424|62962994|FG004|Overall Study|Other|0|||
33567192|NCT02452424|62962995|FG005|Overall Study|Other|1|||
33567193|NCT02452424|62962996|FG006|Overall Study|Other|4|||
33567194|NCT02452424|62962997|FG007|Overall Study|Other|3|||
33567195|NCT02452424|62962998|FG008|Overall Study|Other|0|||
33567196|NCT02452424|62962999|FG009|Overall Study|Other|0|||
33567197|NCT02452424|62963000|FG010|Overall Study|Other|1|||
33567198|NCT02452424|62962990|FG000|Overall Study|Progressive disease (per RECIST)|0|||
33567199|NCT02452424|62962991|FG001|Overall Study|Progressive disease (per RECIST)|0|||
33567200|NCT02452424|62962992|FG002|Overall Study|Progressive disease (per RECIST)|0|||
33567201|NCT02452424|62962993|FG003|Overall Study|Progressive disease (per RECIST)|0|||
33567202|NCT02452424|62962994|FG004|Overall Study|Progressive disease (per RECIST)|0|||
33567203|NCT02452424|62962995|FG005|Overall Study|Progressive disease (per RECIST)|0|||
33567204|NCT02452424|62962996|FG006|Overall Study|Progressive disease (per RECIST)|0|||
33567205|NCT02452424|62962997|FG007|Overall Study|Progressive disease (per RECIST)|0|||
33567206|NCT02452424|62962998|FG008|Overall Study|Progressive disease (per RECIST)|2|||
33567207|NCT02452424|62962999|FG009|Overall Study|Progressive disease (per RECIST)|0|||
33567208|NCT02452424|62963000|FG010|Overall Study|Progressive disease (per RECIST)|0|||
33567209|NCT02452424|62962990|FG000|Overall Study|Adverse Event|0|||
33567210|NCT02452424|62962991|FG001|Overall Study|Adverse Event|0|||
33567211|NCT02452424|62962992|FG002|Overall Study|Adverse Event|0|||
33567212|NCT02452424|62962993|FG003|Overall Study|Adverse Event|0|||
33567213|NCT02452424|62962994|FG004|Overall Study|Adverse Event|0|||
33567214|NCT02452424|62962995|FG005|Overall Study|Adverse Event|0|||
33567215|NCT02452424|62962996|FG006|Overall Study|Adverse Event|0|||
33567216|NCT02452424|62962997|FG007|Overall Study|Adverse Event|0|||
33567217|NCT02452424|62962998|FG008|Overall Study|Adverse Event|0|||
33567218|NCT02452424|62962999|FG009|Overall Study|Adverse Event|0|||
33567219|NCT02452424|62963000|FG010|Overall Study|Adverse Event|1|||
33567220|NCT02419508|62963028|FG000|Overall Study|Adverse Event|9|||
33567221|NCT02419508|62963029|FG001|Overall Study|Adverse Event|3|||
33567222|NCT02419508|62963028|FG000|Overall Study|Withdrawal by Subject|1|||
33567223|NCT02419508|62963029|FG001|Overall Study|Withdrawal by Subject|0|||
33567224|NCT02419508|62963028|FG000|Overall Study|Other - Reason not specified|0|||
33567225|NCT02419508|62963029|FG001|Overall Study|Other - Reason not specified|1|||
33567226|NCT01328249|62963037|FG000|Overall Study|Adverse Event|3|||
33567227|NCT01328249|62963038|FG001|Overall Study|Adverse Event|0|||
33567228|NCT01328249|62963037|FG000|Overall Study|Disease progression|1|||
33567229|NCT01328249|62963038|FG001|Overall Study|Disease progression|0|||
33567230|NCT01328249|62963037|FG000|Overall Study|Withdrawal by Subject|1|||
33394608|NCT00542386|62773813|FG001|Overall Study|Death|0|||
33567231|NCT01328249|62963038|FG001|Overall Study|Withdrawal by Subject|1|||
33567232|NCT01328249|62963037|FG000|Overall Study|Moved before end of treatment visit|1|||
33567233|NCT01328249|62963038|FG001|Overall Study|Moved before end of treatment visit|0|||
33567234|NCT01328249|62963037|FG000|Overall Study|Subject choice|1|||
33567235|NCT01328249|62963038|FG001|Overall Study|Subject choice|1|||
33567236|NCT01328249|62963037|FG000|Overall Study|Protocol Violation|0|||
33567237|NCT01328249|62963038|FG001|Overall Study|Protocol Violation|1|||
33567238|NCT01651052|62963046|FG000|Overall Study|Death|21|||
33394609|NCT00542386|62773814|FG002|Overall Study|Death|1|||
33394610|NCT00542386|62773815|FG003|Overall Study|Death|2|||
33567239|NCT01651052|62963046|FG000|Overall Study|Explant|1|||
33394611|NCT00542386|62773816|FG004|Overall Study|Death|1|||
33394612|NCT00542386|62773817|FG005|Overall Study|Death|2|||
33394613|NCT00542386|62773812|FG000|Overall Study|Lack of Efficacy|32|||
33394614|NCT00542386|62773813|FG001|Overall Study|Lack of Efficacy|12|||
33394615|NCT00542386|62773814|FG002|Overall Study|Lack of Efficacy|10|||
33394616|NCT00542386|62773815|FG003|Overall Study|Lack of Efficacy|13|||
33394617|NCT00542386|62773816|FG004|Overall Study|Lack of Efficacy|7|||
33394618|NCT00542386|62773817|FG005|Overall Study|Lack of Efficacy|31|||
33394619|NCT00542386|62773812|FG000|Overall Study|Physician Decision|1|||
33394620|NCT00542386|62773813|FG001|Overall Study|Physician Decision|0|||
33394621|NCT00542386|62773814|FG002|Overall Study|Physician Decision|0|||
33394622|NCT00542386|62773815|FG003|Overall Study|Physician Decision|1|||
33394623|NCT00542386|62773816|FG004|Overall Study|Physician Decision|0|||
33394624|NCT00542386|62773817|FG005|Overall Study|Physician Decision|0|||
33394625|NCT00542386|62773812|FG000|Overall Study|Protocol Violation|0|||
33394626|NCT00542386|62773813|FG001|Overall Study|Protocol Violation|0|||
33394627|NCT00542386|62773814|FG002|Overall Study|Protocol Violation|1|||
33394628|NCT00542386|62773815|FG003|Overall Study|Protocol Violation|0|||
33394629|NCT00542386|62773816|FG004|Overall Study|Protocol Violation|0|||
33394630|NCT00542386|62773817|FG005|Overall Study|Protocol Violation|4|||
33394631|NCT00542386|62773812|FG000|Overall Study|Withdrawal by Subject|5|||
33394632|NCT00542386|62773813|FG001|Overall Study|Withdrawal by Subject|8|||
33394633|NCT00542386|62773814|FG002|Overall Study|Withdrawal by Subject|10|||
33394634|NCT00542386|62773815|FG003|Overall Study|Withdrawal by Subject|11|||
33394635|NCT00542386|62773816|FG004|Overall Study|Withdrawal by Subject|15|||
33394636|NCT00542386|62773817|FG005|Overall Study|Withdrawal by Subject|7|||
33394637|NCT00542386|62773812|FG000|Overall Study|Other Reasons|4|||
33394638|NCT00542386|62773813|FG001|Overall Study|Other Reasons|1|||
33394639|NCT00542386|62773814|FG002|Overall Study|Other Reasons|4|||
33394640|NCT00542386|62773815|FG003|Overall Study|Other Reasons|3|||
33394641|NCT00542386|62773816|FG004|Overall Study|Other Reasons|4|||
33394642|NCT00542386|62773817|FG005|Overall Study|Other Reasons|2|||
33394643|NCT00604383|62773833|FG000|Overall Study|Withdrawal by Subject|33|||
33394644|NCT00604383|62773834|FG001|Overall Study|Withdrawal by Subject|31|||
33394645|NCT00604383|62773833|FG000|Overall Study|Lost to Follow-up|24|||
33394646|NCT00604383|62773834|FG001|Overall Study|Lost to Follow-up|19|||
33394647|NCT00604383|62773833|FG000|Overall Study|Death|14|||
33394648|NCT00604383|62773834|FG001|Overall Study|Death|22|||
33394649|NCT00604383|62773833|FG000|Overall Study|Adverse Event|16|||
33394650|NCT00604383|62773834|FG001|Overall Study|Adverse Event|9|||
33394651|NCT00604383|62773833|FG000|Overall Study|Physician Decision|0|||
33394652|NCT00604383|62773834|FG001|Overall Study|Physician Decision|3|||
33567240|NCT01651052|62963046|FG000|Overall Study|Withdrawal by Subject|1|||
33567241|NCT01651052|62963046|FG000|Overall Study|Lost to Follow-up|3|||
33567242|NCT02388074|62963050|FG000|Overall Study|Lost in Transit|2|||
33567243|NCT02388074|62963050|FG000|Overall Study|Sample Not Returned|1|||
33567244|NCT01602549|62963056|FG000|Overall Study|Protocol Violation|0|||
33567245|NCT01602549|62963057|FG001|Overall Study|Protocol Violation|1|||
33567246|NCT01602549|62963056|FG000|Overall Study|Withdrawal by Subject|1|||
33567247|NCT01602549|62963057|FG001|Overall Study|Withdrawal by Subject|0|||
33567248|NCT02427464|62963067|FG000|Overall Study|Adverse Event|6|||
33567249|NCT02427464|62963068|FG001|Overall Study|Adverse Event|1|||
33567250|NCT02427464|62963067|FG000|Overall Study|Lost to Follow-up|16|||
33567251|NCT02427464|62963068|FG001|Overall Study|Lost to Follow-up|5|||
33567252|NCT02427464|62963067|FG000|Overall Study|Physician Decision|2|||
33567253|NCT02427464|62963068|FG001|Overall Study|Physician Decision|0|||
33567254|NCT02427464|62963067|FG000|Overall Study|Withdrawal by Subject|10|||
33567255|NCT02427464|62963068|FG001|Overall Study|Withdrawal by Subject|8|||
33394653|NCT00333775|62773843|FG000|Overall Study|Death|144|||
33394654|NCT00333775|62773844|FG001|Overall Study|Death|149|||
33394655|NCT00333775|62773845|FG002|Overall Study|Death|143|||
33394656|NCT00333775|62773843|FG000|Overall Study|In Follow-up When Study Stopped|87|||
33394657|NCT00333775|62773844|FG001|Overall Study|In Follow-up When Study Stopped|92|||
33567256|NCT02427464|62963067|FG000|Overall Study|Noncompliance|16|||
33567257|NCT02427464|62963068|FG001|Overall Study|Noncompliance|10|||
33567258|NCT02426918|62963077|FG000|Overall Study|Adverse Event|2|||
33567259|NCT02426918|62963078|FG001|Overall Study|Adverse Event|2|||
33394658|NCT00333775|62773845|FG002|Overall Study|In Follow-up When Study Stopped|96|||
33394659|NCT00333775|62773843|FG000|Overall Study|Lost to Follow-up|10|||
33394660|NCT00333775|62773844|FG001|Overall Study|Lost to Follow-up|7|||
33394661|NCT00333775|62773845|FG002|Overall Study|Lost to Follow-up|8|||
33394662|NCT00605475|62773863|FG000|Overall Study|Abnormal Laboratory Values|0|||
33394663|NCT00605475|62773864|FG001|Overall Study|Abnormal Laboratory Values|0|||
33394664|NCT00605475|62773865|FG002|Overall Study|Abnormal Laboratory Values|0|||
33394665|NCT00605475|62773866|FG003|Overall Study|Abnormal Laboratory Values|0|||
33394666|NCT00605475|62773867|FG004|Overall Study|Abnormal Laboratory Values|0|||
33394667|NCT00605475|62773868|FG005|Overall Study|Abnormal Laboratory Values|0|||
33567260|NCT02426918|62963079|FG002|Overall Study|Adverse Event|0|||
33567261|NCT02426918|62963077|FG000|Overall Study|Physician Decision|1|||
33394668|NCT00605475|62773869|FG006|Overall Study|Abnormal Laboratory Values|0|||
33394669|NCT00605475|62773870|FG007|Overall Study|Abnormal Laboratory Values|0|||
33394670|NCT00605475|62773871|FG008|Overall Study|Abnormal Laboratory Values|1|||
33394671|NCT00605475|62773872|FG009|Overall Study|Abnormal Laboratory Values|0|||
33394672|NCT00605475|62773863|FG000|Overall Study|Administrative problems|0|||
33394673|NCT00605475|62773864|FG001|Overall Study|Administrative problems|0|||
33394674|NCT00605475|62773865|FG002|Overall Study|Administrative problems|0|||
33394675|NCT00605475|62773866|FG003|Overall Study|Administrative problems|0|||
33394676|NCT00605475|62773867|FG004|Overall Study|Administrative problems|0|||
33394677|NCT00605475|62773868|FG005|Overall Study|Administrative problems|0|||
33394678|NCT00605475|62773869|FG006|Overall Study|Administrative problems|1|||
33394679|NCT00605475|62773870|FG007|Overall Study|Administrative problems|0|||
33394680|NCT00605475|62773871|FG008|Overall Study|Administrative problems|0|||
33394681|NCT00605475|62773872|FG009|Overall Study|Administrative problems|0|||
33394682|NCT00605475|62773863|FG000|Overall Study|Lost to Follow-up|0|||
33394683|NCT00605475|62773864|FG001|Overall Study|Lost to Follow-up|0|||
33394684|NCT00605475|62773865|FG002|Overall Study|Lost to Follow-up|0|||
33394685|NCT00605475|62773866|FG003|Overall Study|Lost to Follow-up|0|||
33394686|NCT00605475|62773867|FG004|Overall Study|Lost to Follow-up|0|||
33394687|NCT00605475|62773868|FG005|Overall Study|Lost to Follow-up|0|||
33394688|NCT00605475|62773869|FG006|Overall Study|Lost to Follow-up|0|||
33394689|NCT00605475|62773870|FG007|Overall Study|Lost to Follow-up|0|||
33394690|NCT00605475|62773871|FG008|Overall Study|Lost to Follow-up|1|||
33394691|NCT00605475|62773872|FG009|Overall Study|Lost to Follow-up|1|||
33394692|NCT00605475|62773863|FG000|Overall Study|Protocol Violation|0|||
33394693|NCT00605475|62773864|FG001|Overall Study|Protocol Violation|0|||
33394694|NCT00605475|62773865|FG002|Overall Study|Protocol Violation|0|||
33394695|NCT00605475|62773866|FG003|Overall Study|Protocol Violation|0|||
33394696|NCT00605475|62773867|FG004|Overall Study|Protocol Violation|1|||
33394697|NCT00605475|62773868|FG005|Overall Study|Protocol Violation|0|||
33394698|NCT00605475|62773869|FG006|Overall Study|Protocol Violation|0|||
33394699|NCT00605475|62773870|FG007|Overall Study|Protocol Violation|0|||
33394700|NCT00605475|62773871|FG008|Overall Study|Protocol Violation|0|||
33394701|NCT00605475|62773872|FG009|Overall Study|Protocol Violation|0|||
33394702|NCT00605475|62773863|FG000|Overall Study|Withdrawal by Subject|0|||
33394703|NCT00605475|62773864|FG001|Overall Study|Withdrawal by Subject|0|||
33394704|NCT00605475|62773865|FG002|Overall Study|Withdrawal by Subject|0|||
33394705|NCT00605475|62773866|FG003|Overall Study|Withdrawal by Subject|0|||
33394706|NCT00605475|62773867|FG004|Overall Study|Withdrawal by Subject|0|||
33394707|NCT00605475|62773868|FG005|Overall Study|Withdrawal by Subject|2|||
33394708|NCT00605475|62773869|FG006|Overall Study|Withdrawal by Subject|0|||
33394709|NCT00605475|62773870|FG007|Overall Study|Withdrawal by Subject|0|||
33394710|NCT00605475|62773871|FG008|Overall Study|Withdrawal by Subject|0|||
33394711|NCT00605475|62773872|FG009|Overall Study|Withdrawal by Subject|1|||
33394712|NCT00333619|62773917|FG000|Overall Study|Death|12|||
33394713|NCT00333619|62773918|FG001|Overall Study|Death|6|||
33394714|NCT00333619|62773917|FG000|Overall Study|Withdrawal by Subject|6|||
33394715|NCT00333619|62773918|FG001|Overall Study|Withdrawal by Subject|1|||
33394716|NCT00333619|62773917|FG000|Overall Study|Lost to Follow-up|3|||
33394717|NCT00333619|62773918|FG001|Overall Study|Lost to Follow-up|3|||
33394718|NCT00605319|62773926|FG000|Overall Study|Adverse Event|6|||
33394719|NCT00333229|62773938|FG000|Overall Study|Lack of Efficacy|0|||
33394720|NCT00333229|62773939|FG001|Overall Study|Lack of Efficacy|1|||
33394721|NCT00332839|62773947|FG000|Core (Months 0 - 12)|Administrative problems|1|||
33394722|NCT00332839|62773948|FG001|Core (Months 0 - 12)|Administrative problems|1|||
33394723|NCT00332839|62773947|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
33394724|NCT00332839|62773948|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
33394725|NCT00332839|62773947|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
33394726|NCT00332839|62773948|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
33394727|NCT00332839|62773947|FG000|Core (Months 0 - 12)|Adverse Event|5|||
33394728|NCT00332839|62773948|FG001|Core (Months 0 - 12)|Adverse Event|15|||
33567262|NCT02426918|62963078|FG001|Overall Study|Physician Decision|1|||
33567263|NCT02426918|62963079|FG002|Overall Study|Physician Decision|1|||
33394729|NCT00332839|62773947|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
33394730|NCT00332839|62773948|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
33394731|NCT00332839|62773947|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
33394732|NCT00332839|62773948|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
33394733|NCT00332839|62773947|FG000|Follow-up (Months 12 - 60)|Death|1|||
33394734|NCT00332839|62773948|FG001|Follow-up (Months 12 - 60)|Death|1|||
33394735|NCT00357097|62773956|FG000|Overall Study|Did not meet inclusion criteria|5|||
33394736|NCT00357097|62773957|FG001|Overall Study|Did not meet inclusion criteria|3|||
33394737|NCT00357097|62773956|FG000|Overall Study|Adverse Event|34|||
33394738|NCT00357097|62773957|FG001|Overall Study|Adverse Event|6|||
33394739|NCT00357097|62773956|FG000|Overall Study|Withdrawal by Subject|8|||
33567264|NCT02426918|62963077|FG000|Overall Study|Withdrawal by Subject|5|||
33567265|NCT02426918|62963078|FG001|Overall Study|Withdrawal by Subject|5|||
33567266|NCT02426918|62963079|FG002|Overall Study|Withdrawal by Subject|4|||
33394740|NCT00357097|62773957|FG001|Overall Study|Withdrawal by Subject|7|||
33394741|NCT00357097|62773956|FG000|Overall Study|Non-compliance|1|||
33394742|NCT00357097|62773957|FG001|Overall Study|Non-compliance|2|||
33394743|NCT00357097|62773956|FG000|Overall Study|Lack of Efficacy|2|||
33394744|NCT00357097|62773957|FG001|Overall Study|Lack of Efficacy|8|||
33394745|NCT00357097|62773956|FG000|Overall Study|Met Exclusion Criteria|3|||
33394746|NCT00357097|62773957|FG001|Overall Study|Met Exclusion Criteria|1|||
33394747|NCT00357097|62773956|FG000|Overall Study|Other|1|||
33567267|NCT02426918|62963077|FG000|Overall Study|Other|9|||
33567268|NCT02426918|62963078|FG001|Overall Study|Other|11|||
33567269|NCT02426918|62963079|FG002|Overall Study|Other|9|||
33567270|NCT02387840|62963093|FG000|Overall Study|Death|0|||
33567271|NCT02387840|62963094|FG001|Overall Study|Death|0|||
33567272|NCT02387840|62963095|FG002|Overall Study|Death|0|||
33567273|NCT02387840|62963096|FG003|Overall Study|Death|0|||
33567274|NCT02387840|62963097|FG004|Overall Study|Death|0|||
33567275|NCT02387840|62963098|FG005|Overall Study|Death|1|||
33567276|NCT02387762|62963120|FG000|Overall Study|Withdrawal by Subject|1|||
33567277|NCT02387762|62963121|FG001|Overall Study|Withdrawal by Subject|0|||
33567278|NCT02418182|62963129|FG000|Overall Study|Unable to re-consent|18|||
33567279|NCT02418182|62963130|FG001|Overall Study|Unable to re-consent|15|||
33567280|NCT02418182|62963129|FG000|Overall Study|Lost to Follow-up|0|||
33567281|NCT02418182|62963130|FG001|Overall Study|Lost to Follow-up|2|||
33567282|NCT02387372|62963151|FG000|Overall Study|Not Treated|1|||
33567283|NCT02387372|62963152|FG001|Overall Study|Not Treated|0|||
33567284|NCT02426138|62963168|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
33567285|NCT02426138|62963169|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
33567286|NCT02426684|62963182|FG000|Overall Study|Physician Decision|1|||
33567287|NCT02656173|62963188|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
33567288|NCT02656173|62963189|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
33567289|NCT02656173|62963188|FG000|Overall Study|Adverse Event|7|||
33567290|NCT02656173|62963189|FG001|Overall Study|Adverse Event|5|||
33567291|NCT02656173|62963188|FG000|Overall Study|Withdrawal by Subject|1|||
33567292|NCT02656173|62963189|FG001|Overall Study|Withdrawal by Subject|3|||
33567293|NCT02656173|62963188|FG000|Overall Study|Protocol Violation|0|||
33567294|NCT02656173|62963189|FG001|Overall Study|Protocol Violation|1|||
33567295|NCT02656173|62963188|FG000|Overall Study|Miscellaneous|2|||
33567296|NCT02656173|62963189|FG001|Overall Study|Miscellaneous|0|||
33567297|NCT02656017|62963199|FG000|Overall Study|Study burden|3|||
33567298|NCT02656017|62963200|FG001|Overall Study|Study burden|3|||
33567299|NCT02656017|62963199|FG000|Overall Study|Adverse Event|2|||
33567300|NCT02656017|62963200|FG001|Overall Study|Adverse Event|1|||
33567301|NCT02656017|62963199|FG000|Overall Study|Unable/unwilling to take study medication|2|||
33567302|NCT02656017|62963200|FG001|Overall Study|Unable/unwilling to take study medication|1|||
33567303|NCT02656017|62963199|FG000|Overall Study|Began Tolvaptan|1|||
33567304|NCT02656017|62963200|FG001|Overall Study|Began Tolvaptan|1|||
33567305|NCT02656017|62963199|FG000|Overall Study|Withdrawal by Subject|1|||
33567306|NCT02656017|62963200|FG001|Overall Study|Withdrawal by Subject|0|||
33567307|NCT02657343|62963212|FG000|Overall Study|Death|0|||
33567308|NCT02657343|62963213|FG001|Overall Study|Death|2|||
33567309|NCT02657343|62963214|FG002|Overall Study|Death|0|||
33567310|NCT02657343|62963215|FG003|Overall Study|Death|0|||
33567311|NCT02657343|62963216|FG004|Overall Study|Death|0|||
33567312|NCT02657343|62963217|FG005|Overall Study|Death|0|||
33567313|NCT02657343|62963212|FG000|Overall Study|Patient went to hospice|1|||
33567314|NCT02657343|62963213|FG001|Overall Study|Patient went to hospice|0|||
33567315|NCT02657343|62963214|FG002|Overall Study|Patient went to hospice|0|||
33567316|NCT02657343|62963215|FG003|Overall Study|Patient went to hospice|0|||
33567317|NCT02657343|62963216|FG004|Overall Study|Patient went to hospice|0|||
33567318|NCT02657343|62963217|FG005|Overall Study|Patient went to hospice|0|||
33567319|NCT02657343|62963212|FG000|Overall Study|Withdrawal by Subject|0|||
33567320|NCT02657343|62963213|FG001|Overall Study|Withdrawal by Subject|0|||
33567321|NCT02657343|62963214|FG002|Overall Study|Withdrawal by Subject|0|||
33567322|NCT02657343|62963215|FG003|Overall Study|Withdrawal by Subject|0|||
33567323|NCT02657343|62963216|FG004|Overall Study|Withdrawal by Subject|1|||
33567324|NCT02657343|62963217|FG005|Overall Study|Withdrawal by Subject|0|||
33567325|NCT02655237|62963233|FG000|Overall Study|Adverse Event|10|||
33567326|NCT02655237|62963234|FG001|Overall Study|Adverse Event|7|||
33567327|NCT02655237|62963233|FG000|Overall Study|Protocol Deviation|2|||
33567328|NCT02655237|62963234|FG001|Overall Study|Protocol Deviation|0|||
33394748|NCT00357097|62773957|FG001|Overall Study|Other|1|||
33394749|NCT00357097|62773956|FG000|Overall Study|Increase of RLS Symptoms|0|||
33567329|NCT02655237|62963233|FG000|Overall Study|Withdrawal by Participant|1|||
33567330|NCT02655237|62963234|FG001|Overall Study|Withdrawal by Participant|2|||
33567331|NCT02655237|62963233|FG000|Overall Study|Lack of Efficacy|0|||
33567332|NCT02655237|62963234|FG001|Overall Study|Lack of Efficacy|1|||
33567333|NCT02655237|62963233|FG000|Overall Study|Recovery Leading to Surgery|2|||
33567334|NCT02655237|62963234|FG001|Overall Study|Recovery Leading to Surgery|1|||
33567335|NCT02655237|62963233|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
33394750|NCT00357097|62773957|FG001|Overall Study|Increase of RLS Symptoms|1|||
33394751|NCT00356863|62773965|FG000|Overall Study|Death|16|||
33394752|NCT00356863|62773966|FG001|Overall Study|Death|32|||
33394753|NCT00356863|62773965|FG000|Overall Study|Lost to Follow-up|76|||
33394754|NCT00356863|62773966|FG001|Overall Study|Lost to Follow-up|43|||
33394755|NCT00355615|62773989|FG000|Randomized Double Blind Period|Adverse Event|1|||
33394756|NCT00355615|62773990|FG001|Randomized Double Blind Period|Adverse Event|0|||
33394757|NCT00355615|62773991|FG002|Randomized Double Blind Period|Adverse Event|0|||
33394758|NCT00355615|62773992|FG003|Randomized Double Blind Period|Adverse Event|0|||
33394759|NCT00355615|62773993|FG004|Randomized Double Blind Period|Adverse Event|0|||
33394760|NCT00355615|62773989|FG000|Randomized Double Blind Period|Protocol Violation|0|||
33394761|NCT00355615|62773990|FG001|Randomized Double Blind Period|Protocol Violation|0|||
33394762|NCT00355615|62773991|FG002|Randomized Double Blind Period|Protocol Violation|1|||
33394763|NCT00355615|62773992|FG003|Randomized Double Blind Period|Protocol Violation|1|||
33394764|NCT00355615|62773993|FG004|Randomized Double Blind Period|Protocol Violation|0|||
33394765|NCT00355615|62773989|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
33394766|NCT00355615|62773990|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
33394767|NCT00355615|62773991|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
33394768|NCT00355615|62773992|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
33394769|NCT00355615|62773993|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
33394770|NCT00355615|62773989|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
33394771|NCT00355615|62773990|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
33394772|NCT00355615|62773991|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
33394773|NCT00355615|62773992|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
33394774|NCT00355615|62773993|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
33394775|NCT00355615|62773989|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
33394776|NCT00355615|62773990|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
33394777|NCT00355615|62773991|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
33394778|NCT00355615|62773992|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
33394779|NCT00355615|62773993|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
33394780|NCT00355615|62773989|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
33394781|NCT00355615|62773990|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
33394782|NCT00355615|62773991|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
33394783|NCT00355615|62773992|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
33394784|NCT00355615|62773993|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
33394785|NCT00347269|62774006|FG000|Overall Study|Lost to Follow-up|74|||
33394786|NCT00347269|62774007|FG001|Overall Study|Lost to Follow-up|65|||
33394787|NCT00347269|62774006|FG000|Overall Study|Withdrawal by Subject|18|||
33394788|NCT00347269|62774007|FG001|Overall Study|Withdrawal by Subject|38|||
33394789|NCT00347269|62774006|FG000|Overall Study|Death|2|||
33394790|NCT00347269|62774007|FG001|Overall Study|Death|3|||
33394791|NCT00544648|62774015|FG000|Overall Study|Withdrawal by Subject|1|||
33394792|NCT00544648|62774016|FG001|Overall Study|Withdrawal by Subject|0|||
33394793|NCT00544648|62774015|FG000|Overall Study|Adverse Event|1|||
33394794|NCT00544648|62774016|FG001|Overall Study|Adverse Event|1|||
33394795|NCT00544648|62774015|FG000|Overall Study|progression of disease|1|||
33394796|NCT00544648|62774016|FG001|Overall Study|progression of disease|0|||
33394797|NCT00346333|62774026|FG000|Overall Study|Death|1|||
33394798|NCT00346333|62774027|FG001|Overall Study|Death|0|||
33394799|NCT00346333|62774026|FG000|Overall Study|unwilling or unable to continue|4|||
33394800|NCT00346333|62774027|FG001|Overall Study|unwilling or unable to continue|8|||
33394801|NCT00330967|62774037|FG000|Overall Study|Withdrawal by Subject|0|||
33394802|NCT00330967|62774038|FG001|Overall Study|Withdrawal by Subject|5|||
33394803|NCT00330967|62774037|FG000|Overall Study|Physician Decision|0|||
33394804|NCT00330967|62774038|FG001|Overall Study|Physician Decision|9|||
33394805|NCT00330343|62774044|FG000|Overall Study|Lost to Follow-up|5|||
33394806|NCT00330187|62774052|FG000|Overall Study|Lost to Follow-up|12|||
33394807|NCT00330187|62774053|FG001|Overall Study|Lost to Follow-up|13|||
33567336|NCT02655237|62963234|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
33567337|NCT02655237|62963233|FG000|Overall Study|Randomized but Not Treated|1|||
33567338|NCT02655237|62963234|FG001|Overall Study|Randomized but Not Treated|0|||
33567339|NCT02657031|62963242|FG000|Overall Study|Adverse Event|1|||
33567340|NCT02657031|62963243|FG001|Overall Study|Adverse Event|2|||
33567341|NCT04375397|62963271|FG000|Overall Study|Death|1|||
33394808|NCT00330187|62774054|FG002|Overall Study|Lost to Follow-up|14|||
33394809|NCT00330187|62774055|FG003|Overall Study|Lost to Follow-up|10|||
33394810|NCT00330187|62774052|FG000|Overall Study|Withdrawal by Subject|8|||
33394811|NCT00330187|62774053|FG001|Overall Study|Withdrawal by Subject|5|||
33394812|NCT00330187|62774054|FG002|Overall Study|Withdrawal by Subject|4|||
33394813|NCT00330187|62774055|FG003|Overall Study|Withdrawal by Subject|4|||
33394814|NCT03914950|62774065|FG000|Overall Study|Physician Decision|54|||
33567342|NCT04375397|62963272|FG001|Overall Study|Death|1|||
33394815|NCT00329797|62774077|FG000|Overall Study|Protocol Violation|1|||
33394816|NCT00329797|62774078|FG001|Overall Study|Protocol Violation|0|||
33394817|NCT00329797|62774077|FG000|Overall Study|Withdrawal by Subject|6|||
33394818|NCT00329797|62774078|FG001|Overall Study|Withdrawal by Subject|6|||
33394819|NCT00541450|62774086|FG000|Phase A|Adverse Event|3|||
33394820|NCT00541450|62774087|FG001|Phase A|Adverse Event|0|||
33394821|NCT00541450|62774086|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
33394822|NCT00541450|62774087|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
33394823|NCT00541450|62774086|FG000|Phase A|Hyperglycemia|0|||
33394824|NCT00541450|62774087|FG001|Phase A|Hyperglycemia|1|||
33394825|NCT00541450|62774086|FG000|Phase A|Lost to Follow-up|6|||
33394826|NCT00541450|62774087|FG001|Phase A|Lost to Follow-up|4|||
33394827|NCT00541450|62774086|FG000|Phase A|Physician Decision|2|||
33394828|NCT00541450|62774087|FG001|Phase A|Physician Decision|0|||
33394829|NCT00541450|62774086|FG000|Phase A|Protocol Violation|2|||
33394830|NCT00541450|62774087|FG001|Phase A|Protocol Violation|3|||
33394831|NCT00541450|62774086|FG000|Phase A|Withdrawal by Subject|7|||
33394832|NCT00541450|62774087|FG001|Phase A|Withdrawal by Subject|7|||
33394833|NCT00541450|62774086|FG000|Phase B|Adverse Event|6|||
33394834|NCT00541450|62774087|FG001|Phase B|Adverse Event|6|||
33394835|NCT00541450|62774086|FG000|Phase B|Hyperglycemia|10|||
33394836|NCT00541450|62774087|FG001|Phase B|Hyperglycemia|9|||
33394837|NCT00541450|62774086|FG000|Phase B|Lost to Follow-up|6|||
33394838|NCT00541450|62774087|FG001|Phase B|Lost to Follow-up|4|||
33394839|NCT00541450|62774086|FG000|Phase B|Physician Decision|4|||
33394840|NCT00541450|62774087|FG001|Phase B|Physician Decision|2|||
33394841|NCT00541450|62774086|FG000|Phase B|Pregnancy|0|||
33394842|NCT00541450|62774087|FG001|Phase B|Pregnancy|1|||
33394843|NCT00541450|62774086|FG000|Phase B|Protocol Violation|3|||
33394844|NCT00541450|62774087|FG001|Phase B|Protocol Violation|3|||
33394845|NCT00541450|62774086|FG000|Phase B|Withdrawal by Subject|8|||
33394846|NCT00541450|62774087|FG001|Phase B|Withdrawal by Subject|6|||
33394847|NCT00355147|62774099|FG000|Overall Study|Lost to Follow-up|10|||
33394848|NCT00355147|62774100|FG001|Overall Study|Lost to Follow-up|8|||
33394849|NCT00355147|62774099|FG000|Overall Study|Withdrawal by Subject|8|||
33394850|NCT00355147|62774100|FG001|Overall Study|Withdrawal by Subject|12|||
33394851|NCT00540124|62774113|FG000|Overall Study|Adverse Event|0|||
33394852|NCT00540124|62774114|FG001|Overall Study|Adverse Event|2|||
33394853|NCT00540124|62774115|FG002|Overall Study|Adverse Event|1|||
33394854|NCT00540124|62774113|FG000|Overall Study|Entry Criteria Not Met|2|||
33394855|NCT00540124|62774114|FG001|Overall Study|Entry Criteria Not Met|0|||
33394856|NCT00540124|62774115|FG002|Overall Study|Entry Criteria Not Met|0|||
33394857|NCT00540124|62774113|FG000|Overall Study|Lack of Efficacy|1|||
33394858|NCT00540124|62774114|FG001|Overall Study|Lack of Efficacy|0|||
33394859|NCT00540124|62774115|FG002|Overall Study|Lack of Efficacy|0|||
33394860|NCT00540124|62774113|FG000|Overall Study|Withdrawal by Subject|1|||
33394861|NCT00540124|62774114|FG001|Overall Study|Withdrawal by Subject|1|||
33394862|NCT00540124|62774115|FG002|Overall Study|Withdrawal by Subject|0|||
33394863|NCT00540046|62774125|FG000|Overall Study|Lost to Follow-up|33|||
33394864|NCT00540046|62774126|FG001|Overall Study|Lost to Follow-up|23|||
33394865|NCT00689936|62774137|FG000|Active Treatment Phase|Adverse Event|68|||
33394866|NCT00689936|62774138|FG001|Active Treatment Phase|Adverse Event|71|||
33394867|NCT00689936|62774139|FG002|Active Treatment Phase|Adverse Event|76|||
33394868|NCT00689936|62774137|FG000|Active Treatment Phase|Disease Progression|273|||
33394869|NCT00689936|62774138|FG001|Active Treatment Phase|Disease Progression|362|||
33394870|NCT00689936|62774139|FG002|Active Treatment Phase|Disease Progression|339|||
33394871|NCT00689936|62774137|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
33394872|NCT00689936|62774138|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
33394873|NCT00689936|62774139|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
33394874|NCT00689936|62774137|FG000|Active Treatment Phase|Death|60|||
33567343|NCT04375397|62963271|FG000|Overall Study|Withdrew consent|2|||
33567344|NCT04375397|62963272|FG001|Overall Study|Withdrew consent|0|||
33394875|NCT00689936|62774138|FG001|Active Treatment Phase|Death|28|||
33394876|NCT00689936|62774139|FG002|Active Treatment Phase|Death|37|||
33394877|NCT00689936|62774137|FG000|Active Treatment Phase|Lost to Follow-up|0|||
33394878|NCT00689936|62774138|FG001|Active Treatment Phase|Lost to Follow-up|2|||
33394879|NCT00689936|62774139|FG002|Active Treatment Phase|Lost to Follow-up|2|||
33394880|NCT00689936|62774137|FG000|Active Treatment Phase|Protocol Violation|2|||
33394881|NCT00689936|62774138|FG001|Active Treatment Phase|Protocol Violation|2|||
33394882|NCT00689936|62774139|FG002|Active Treatment Phase|Protocol Violation|4|||
33394883|NCT00689936|62774137|FG000|Active Treatment Phase|Study Close Out|64|||
33394884|NCT00689936|62774138|FG001|Active Treatment Phase|Study Close Out|26|||
33394885|NCT00689936|62774139|FG002|Active Treatment Phase|Study Close Out|21|||
33394886|NCT00689936|62774137|FG000|Active Treatment Phase|Miscellaneous|52|||
33394887|NCT00689936|62774138|FG001|Active Treatment Phase|Miscellaneous|34|||
33394888|NCT00689936|62774139|FG002|Active Treatment Phase|Miscellaneous|47|||
33394889|NCT00689936|62774137|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
33394890|NCT00689936|62774138|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
33567345|NCT04375397|62963271|FG000|Overall Study|Lost to Follow-up|6|||
33394891|NCT00689936|62774139|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
33394892|NCT00671034|62774150|FG000|Overall Study|Adverse Event|5|||
33394893|NCT00671034|62774151|FG001|Overall Study|Adverse Event|7|||
33394894|NCT00671034|62774152|FG002|Overall Study|Adverse Event|1|||
33394895|NCT00671034|62774150|FG000|Overall Study|Death|3|||
33394896|NCT00671034|62774151|FG001|Overall Study|Death|2|||
33394897|NCT00671034|62774152|FG002|Overall Study|Death|1|||
33394898|NCT00671034|62774150|FG000|Overall Study|Physician Decision|12|||
33394899|NCT00671034|62774151|FG001|Overall Study|Physician Decision|4|||
33394900|NCT00671034|62774152|FG002|Overall Study|Physician Decision|5|||
33394901|NCT00671034|62774150|FG000|Overall Study|VHR ALL feature|8|||
33394902|NCT00671034|62774151|FG001|Overall Study|VHR ALL feature|3|||
33394903|NCT00671034|62774152|FG002|Overall Study|VHR ALL feature|5|||
33394904|NCT00671034|62774150|FG000|Overall Study|Refusal|5|||
33394905|NCT00671034|62774151|FG001|Overall Study|Refusal|3|||
33394906|NCT00671034|62774152|FG002|Overall Study|Refusal|5|||
33394907|NCT00671034|62774150|FG000|Overall Study|includes Alternative therapy, etc.|6|||
33394908|NCT00671034|62774151|FG001|Overall Study|includes Alternative therapy, etc.|1|||
33394909|NCT00671034|62774152|FG002|Overall Study|includes Alternative therapy, etc.|7|||
33394910|NCT04404478|62774163|FG000|Overall Study|Withdrawal by Subject|1|||
33394911|NCT04404478|62774164|FG001|Overall Study|Withdrawal by Subject|3|||
33394912|NCT00539734|62774172|FG000|Overall Study|Protocol Violation|1|||
33394913|NCT03907072|62774179|FG000|Overall Study|Study Terminated by Sponsor|2|||
33394914|NCT03907072|62774180|FG001|Overall Study|Study Terminated by Sponsor|2|||
33394915|NCT03907072|62774181|FG002|Overall Study|Study Terminated by Sponsor|2|||
33394916|NCT00329719|62774206|FG000|Overall Study|Lost to Follow-up|0|||
33394917|NCT00329719|62774207|FG001|Overall Study|Lost to Follow-up|0|||
33394918|NCT00329719|62774208|FG002|Overall Study|Lost to Follow-up|0|||
33394919|NCT00329719|62774209|FG003|Overall Study|Lost to Follow-up|1|||
33394920|NCT00329641|62774219|FG000|Overall Study|Did not start treatment|1|||
33567346|NCT04375397|62963272|FG001|Overall Study|Lost to Follow-up|4|||
33567347|NCT04375397|62963271|FG000|Overall Study|Other, not specified|0|||
33394921|NCT00329641|62774219|FG000|Overall Study|Not eligible|1|||
33394922|NCT00329641|62774219|FG000|Overall Study|Adverse Event|3|||
33394923|NCT00329641|62774219|FG000|Overall Study|Other reason, not protocol specified|1|||
33394924|NCT00329407|62774233|FG000|Overall Study|Withdrawal by Subject|1|||
33394925|NCT00328783|62774237|FG000|Overall Study|Could not tolerate ABC|21|||
33394926|NCT00328783|62774237|FG000|Overall Study|No heart in RT field|4|||
33394927|NCT00328783|62774237|FG000|Overall Study|Withdrawal by Subject|1|||
33394928|NCT00567489|62774245|FG000|Overall Study|Adverse Event|6|||
33394929|NCT00567489|62774246|FG001|Overall Study|Adverse Event|14|||
33567348|NCT04375397|62963272|FG001|Overall Study|Other, not specified|1|||
33567349|NCT02387216|62963280|FG000|Overall Study|Progressive disease|2|||
33567350|NCT02387216|62963281|FG001|Overall Study|Progressive disease|0|||
33567351|NCT02387216|62963280|FG000|Overall Study|Withdrawal by Subject|3|||
33394930|NCT00567489|62774245|FG000|Overall Study|Physician Decision|0|||
33394931|NCT00567489|62774246|FG001|Overall Study|Physician Decision|4|||
33394932|NCT00567489|62774245|FG000|Overall Study|Withdrawal by Subject|0|||
33394933|NCT00567489|62774246|FG001|Overall Study|Withdrawal by Subject|2|||
33394934|NCT00567489|62774245|FG000|Overall Study|Renal Transplantation|0|||
33394935|NCT00567489|62774246|FG001|Overall Study|Renal Transplantation|3|||
33394936|NCT00567489|62774245|FG000|Overall Study|Other|1|||
33394937|NCT00567489|62774246|FG001|Overall Study|Other|0|||
33567352|NCT02387216|62963281|FG001|Overall Study|Withdrawal by Subject|5|||
33567353|NCT02387216|62963280|FG000|Overall Study|Physician Decision|2|||
33567354|NCT02387216|62963281|FG001|Overall Study|Physician Decision|0|||
33567355|NCT02387216|62963280|FG000|Overall Study|Sponsor Decision|28|||
33394938|NCT00669942|62774264|FG000|Parts 2 and 3|Adverse Event|0|||
33394939|NCT00669942|62774265|FG001|Parts 2 and 3|Adverse Event|0|||
33394940|NCT00669942|62774266|FG002|Parts 2 and 3|Adverse Event|0|||
33394941|NCT00669942|62774267|FG003|Parts 2 and 3|Adverse Event|0|||
33394942|NCT00669942|62774268|FG004|Parts 2 and 3|Adverse Event|0|||
33567356|NCT02387216|62963281|FG001|Overall Study|Sponsor Decision|12|||
33567357|NCT02387216|62963280|FG000|Overall Study|Death|60|||
33567358|NCT02387216|62963281|FG001|Overall Study|Death|23|||
33567359|NCT02387216|62963280|FG000|Overall Study|Other|5|||
33567360|NCT02387216|62963281|FG001|Overall Study|Other|4|||
33567361|NCT02387216|62963280|FG000|Overall Study|Lost to Follow-up|0|||
33567362|NCT02387216|62963281|FG001|Overall Study|Lost to Follow-up|3|||
33567363|NCT02417246|62963289|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
33567364|NCT02417246|62963290|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
33567365|NCT02417246|62963289|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
33567366|NCT02417246|62963290|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
33394943|NCT00669942|62774269|FG005|Parts 2 and 3|Adverse Event|0|||
33394944|NCT00669942|62774270|FG006|Parts 2 and 3|Adverse Event|0|||
33394945|NCT00669942|62774271|FG007|Parts 2 and 3|Adverse Event|2|||
33394946|NCT00669942|62774272|FG008|Parts 2 and 3|Adverse Event|1|||
33394947|NCT00669942|62774273|FG009|Parts 2 and 3|Adverse Event|0|||
33567367|NCT02417246|62963289|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
33394948|NCT00669942|62774274|FG010|Parts 2 and 3|Adverse Event|0|||
33394949|NCT00669942|62774275|FG011|Parts 2 and 3|Adverse Event|0|||
33394950|NCT00669942|62774264|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
33394951|NCT00669942|62774265|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
33394952|NCT00669942|62774266|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
33394953|NCT00669942|62774267|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
33394954|NCT00669942|62774268|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
33394955|NCT00669942|62774269|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
33394956|NCT00669942|62774270|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
33394957|NCT00669942|62774271|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
33394958|NCT00669942|62774272|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
33394959|NCT00669942|62774273|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
33394960|NCT00669942|62774274|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
33394961|NCT00669942|62774275|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
33394962|NCT00669942|62774264|FG000|Parts 2 and 3|Protocol Violation|0|||
33394963|NCT00669942|62774265|FG001|Parts 2 and 3|Protocol Violation|0|||
33394964|NCT00669942|62774266|FG002|Parts 2 and 3|Protocol Violation|0|||
33394965|NCT00669942|62774267|FG003|Parts 2 and 3|Protocol Violation|0|||
33394966|NCT00669942|62774268|FG004|Parts 2 and 3|Protocol Violation|0|||
33394967|NCT00669942|62774269|FG005|Parts 2 and 3|Protocol Violation|1|||
33394968|NCT00669942|62774270|FG006|Parts 2 and 3|Protocol Violation|0|||
33394969|NCT00669942|62774271|FG007|Parts 2 and 3|Protocol Violation|0|||
33394970|NCT00669942|62774272|FG008|Parts 2 and 3|Protocol Violation|0|||
33394971|NCT00669942|62774273|FG009|Parts 2 and 3|Protocol Violation|0|||
33394972|NCT00669942|62774274|FG010|Parts 2 and 3|Protocol Violation|0|||
33394973|NCT00669942|62774275|FG011|Parts 2 and 3|Protocol Violation|0|||
33394974|NCT00669864|62774298|FG000|Overall Study|Lost to Follow-up|2|||
33394975|NCT00669864|62774298|FG000|Overall Study|Protocol Violation|2|||
33394976|NCT00669864|62774298|FG000|Overall Study|Withdrawal by Subject|3|||
33394977|NCT00669864|62774298|FG000|Overall Study|Other|2|||
33394978|NCT00668148|62774302|FG000|Overall Study|Adverse Event|5|||
33394979|NCT00668148|62774302|FG000|Overall Study|Subject Non-compliance|1|||
33394980|NCT00668148|62774302|FG000|Overall Study|Progressive Disease Before Treatment|2|||
33394981|NCT00668148|62774302|FG000|Overall Study|Withdrawal of Consent|2|||
33394982|NCT00667992|62774319|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
33394983|NCT00667992|62774320|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
33567368|NCT02417246|62963290|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
33567369|NCT02417246|62963289|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
33567370|NCT02417246|62963290|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
33567371|NCT02424734|62963301|FG000|Overall Study|Treatment stopped to be discharged home|2|||
33567372|NCT02424734|62963302|FG001|Overall Study|Treatment stopped to be discharged home|2|||
33567373|NCT02424734|62963303|FG002|Overall Study|Treatment stopped to be discharged home|0|||
33567374|NCT02424578|62963314|FG000|Overall Study|Withdrawal by Subject|0|||
33567375|NCT02424578|62963315|FG001|Overall Study|Withdrawal by Subject|1|||
33567376|NCT02416934|62963323|FG000|Overall Study|given steroids|1|||
33567377|NCT02416934|62963324|FG001|Overall Study|given steroids|2|||
33567378|NCT02416934|62963323|FG000|Overall Study|Lost to Follow-up|0|||
33567379|NCT02416934|62963324|FG001|Overall Study|Lost to Follow-up|2|||
33567380|NCT02416934|62963323|FG000|Overall Study|Withdrawal by Subject|1|||
33567381|NCT02416934|62963324|FG001|Overall Study|Withdrawal by Subject|0|||
33567382|NCT02416934|62963323|FG000|Overall Study|recruited during continuing renewal proc|0|||
33567383|NCT02416934|62963324|FG001|Overall Study|recruited during continuing renewal proc|1|||
33567384|NCT02416934|62963323|FG000|Overall Study|Protocol Violation|0|||
33567385|NCT02416934|62963324|FG001|Overall Study|Protocol Violation|1|||
33302586|NCT01254045|62678326|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
33302587|NCT01075282|62678339|FG000|Overall Study|Withdrawal by Subject|11|||
33302588|NCT01075282|62678340|FG001|Overall Study|Withdrawal by Subject|7|||
33302589|NCT01075282|62678341|FG002|Overall Study|Withdrawal by Subject|11|||
33302590|NCT01075282|62678339|FG000|Overall Study|Adverse Event|9|||
33302591|NCT01075282|62678340|FG001|Overall Study|Adverse Event|8|||
33302592|NCT01075282|62678341|FG002|Overall Study|Adverse Event|5|||
33302593|NCT01075282|62678339|FG000|Overall Study|Entry Criteria Not Met|3|||
33302594|NCT01075282|62678340|FG001|Overall Study|Entry Criteria Not Met|2|||
33302595|NCT01075282|62678341|FG002|Overall Study|Entry Criteria Not Met|0|||
33302596|NCT01075282|62678339|FG000|Overall Study|Lost to Follow-up|3|||
33302597|NCT01075282|62678340|FG001|Overall Study|Lost to Follow-up|3|||
33302598|NCT01075282|62678341|FG002|Overall Study|Lost to Follow-up|3|||
33302599|NCT01075282|62678339|FG000|Overall Study|Physician Decision|3|||
33302600|NCT01075282|62678340|FG001|Overall Study|Physician Decision|3|||
33302601|NCT01075282|62678341|FG002|Overall Study|Physician Decision|3|||
33302602|NCT01075282|62678339|FG000|Overall Study|Lack of Efficacy|1|||
33302603|NCT01075282|62678340|FG001|Overall Study|Lack of Efficacy|1|||
33302604|NCT01075282|62678341|FG002|Overall Study|Lack of Efficacy|0|||
33302605|NCT01075282|62678339|FG000|Overall Study|Treatment Non-compliance|1|||
33394984|NCT00667992|62774319|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
33394985|NCT00667992|62774320|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
33394986|NCT00667992|62774319|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
33394987|NCT00667992|62774320|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
33394988|NCT00667992|62774319|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
33394989|NCT00667992|62774320|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
33394990|NCT00667992|62774319|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
33394991|NCT00667992|62774320|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
33394992|NCT00667992|62774319|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
33394993|NCT00667992|62774320|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
33567386|NCT02416934|62963323|FG000|Overall Study|surgery started late|0|||
33567387|NCT02416934|62963324|FG001|Overall Study|surgery started late|1|||
33567388|NCT02416934|62963323|FG000|Overall Study|re-operation|1|||
33567389|NCT02416934|62963324|FG001|Overall Study|re-operation|0|||
33567390|NCT02819635|62963344|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
33567391|NCT02819635|62963345|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
33567392|NCT02819635|62963346|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
33567393|NCT02819635|62963347|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
33567394|NCT02819635|62963348|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
33567395|NCT02819635|62963349|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
33567396|NCT02819635|62963350|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
33567397|NCT02819635|62963351|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
33567398|NCT02819635|62963352|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
33567399|NCT02819635|62963353|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
33567400|NCT02819635|62963354|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
33567401|NCT02819635|62963355|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
33567402|NCT02819635|62963344|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33567403|NCT02819635|62963345|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33567404|NCT02819635|62963346|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33567405|NCT02819635|62963347|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33567406|NCT02819635|62963348|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
33567407|NCT02819635|62963349|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
33567408|NCT02819635|62963350|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
33567409|NCT02819635|62963351|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33567410|NCT02819635|62963352|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33567411|NCT02819635|62963353|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33394994|NCT00667992|62774319|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
33394995|NCT00667992|62774320|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
33567412|NCT02819635|62963354|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33567413|NCT02819635|62963355|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33567414|NCT02819635|62963344|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33567415|NCT02819635|62963345|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33567416|NCT02819635|62963346|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33567417|NCT02819635|62963347|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33567418|NCT02819635|62963348|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33567419|NCT02819635|62963349|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
33567420|NCT02819635|62963350|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
33567421|NCT02819635|62963351|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33394996|NCT00667992|62774319|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
33394997|NCT00667992|62774320|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
33394998|NCT00667992|62774319|FG000|Wash-out|Not within one doubling dilution|4|||
33394999|NCT00667992|62774320|FG001|Wash-out|Not within one doubling dilution|3|||
33395000|NCT00667992|62774319|FG000|Wash-out|Failure to wash-out|2|||
33395001|NCT00667992|62774320|FG001|Wash-out|Failure to wash-out|2|||
33395002|NCT00667992|62774319|FG000|Wash-out|Withdrawal by Subject|1|||
33395003|NCT00667992|62774320|FG001|Wash-out|Withdrawal by Subject|0|||
33395004|NCT00667992|62774319|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
33395005|NCT00667992|62774320|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
33395006|NCT00667992|62774319|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
33395007|NCT00667992|62774320|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
33395008|NCT00669396|62774338|FG000|Overall Study|Lost to Follow-up|10|||
33395009|NCT00669396|62774339|FG001|Overall Study|Lost to Follow-up|12|||
33395010|NCT00669318|62774345|FG000|Overall Study|Withdrawal by Subject|2|||
33395011|NCT00669240|62774349|FG000|Overall Study|Lack of Efficacy|33|||
33395012|NCT00669240|62774349|FG000|Overall Study|Withdrawal by Subject|42|||
33395013|NCT00669240|62774349|FG000|Overall Study|Lost to Follow-up|34|||
33395014|NCT00669240|62774349|FG000|Overall Study|Adverse Event|21|||
33580967|NCT01268150|62978110|FG000|Treatment Phase|Other|4|||
33664141|NCT02681094|63095176|FG000|2 - Enrolled Participants Set|Participant decision|7|||
33395015|NCT00669240|62774349|FG000|Overall Study|Other|19|||
33395016|NCT00669240|62774349|FG000|Overall Study|Enrolled but not treated|15|||
33395017|NCT00669240|62774349|FG000|Overall Study|Enrolled but no dosing record|1|||
33395018|NCT00669162|62774353|FG000|Overall Study|Withdrawal by Subject|1|||
33395019|NCT00400946|62774362|FG000|Overall Study|Ineligible|0|||
33395020|NCT00400946|62774363|FG001|Overall Study|Ineligible|0|||
33395021|NCT00400946|62774364|FG002|Overall Study|Ineligible|0|||
33395022|NCT00400946|62774365|FG003|Overall Study|Ineligible|5|||
33395023|NCT00400946|62774366|FG004|Overall Study|Ineligible|1|||
33395024|NCT00400946|62774362|FG000|Overall Study|Induction Failure|0|||
33395025|NCT00400946|62774363|FG001|Overall Study|Induction Failure|0|||
33395026|NCT00400946|62774364|FG002|Overall Study|Induction Failure|0|||
33395027|NCT00400946|62774365|FG003|Overall Study|Induction Failure|11|||
33395028|NCT00400946|62774366|FG004|Overall Study|Induction Failure|8|||
33395029|NCT00400946|62774362|FG000|Overall Study|Induction Death|0|||
33395030|NCT00400946|62774363|FG001|Overall Study|Induction Death|0|||
33395031|NCT00400946|62774364|FG002|Overall Study|Induction Death|0|||
33395032|NCT00400946|62774365|FG003|Overall Study|Induction Death|13|||
33395033|NCT00400946|62774366|FG004|Overall Study|Induction Death|3|||
33395034|NCT00400946|62774362|FG000|Overall Study|Lost to Follow-up|1|||
33395035|NCT00400946|62774363|FG001|Overall Study|Lost to Follow-up|1|||
33395036|NCT00400946|62774364|FG002|Overall Study|Lost to Follow-up|0|||
33395037|NCT00400946|62774365|FG003|Overall Study|Lost to Follow-up|0|||
33395038|NCT00400946|62774366|FG004|Overall Study|Lost to Follow-up|1|||
33395039|NCT00400946|62774362|FG000|Overall Study|Remission Death|1|||
33395040|NCT00400946|62774363|FG001|Overall Study|Remission Death|1|||
33395041|NCT00400946|62774364|FG002|Overall Study|Remission Death|0|||
33395042|NCT00400946|62774365|FG003|Overall Study|Remission Death|0|||
33395043|NCT00400946|62774366|FG004|Overall Study|Remission Death|1|||
33395044|NCT00400946|62774362|FG000|Overall Study|Relapse|9|||
33395045|NCT00400946|62774363|FG001|Overall Study|Relapse|2|||
33395046|NCT00400946|62774364|FG002|Overall Study|Relapse|1|||
33395047|NCT00400946|62774365|FG003|Overall Study|Relapse|1|||
33395048|NCT00400946|62774366|FG004|Overall Study|Relapse|5|||
33395049|NCT00400946|62774362|FG000|Overall Study|Transplant in CR1|0|||
33395050|NCT00400946|62774363|FG001|Overall Study|Transplant in CR1|0|||
33395051|NCT00400946|62774364|FG002|Overall Study|Transplant in CR1|0|||
33395052|NCT00400946|62774365|FG003|Overall Study|Transplant in CR1|10|||
33395053|NCT00400946|62774366|FG004|Overall Study|Transplant in CR1|1|||
33395054|NCT00400946|62774362|FG000|Overall Study|Withdrawal by Subject|2|||
33395055|NCT00400946|62774363|FG001|Overall Study|Withdrawal by Subject|5|||
33395056|NCT00400946|62774364|FG002|Overall Study|Withdrawal by Subject|1|||
33395057|NCT00400946|62774365|FG003|Overall Study|Withdrawal by Subject|5|||
33395058|NCT00400946|62774366|FG004|Overall Study|Withdrawal by Subject|8|||
33395059|NCT00400946|62774362|FG000|Overall Study|Clinical|1|||
33395060|NCT00400946|62774363|FG001|Overall Study|Clinical|2|||
33395061|NCT00400946|62774364|FG002|Overall Study|Clinical|0|||
33395062|NCT00400946|62774365|FG003|Overall Study|Clinical|2|||
33395063|NCT00400946|62774366|FG004|Overall Study|Clinical|9|||
33395064|NCT00400946|62774362|FG000|Overall Study|Other|0|||
33395065|NCT00400946|62774363|FG001|Overall Study|Other|0|||
33395066|NCT00400946|62774364|FG002|Overall Study|Other|0|||
33567422|NCT02819635|62963352|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33567423|NCT02819635|62963353|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33567424|NCT02819635|62963354|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33567425|NCT02819635|62963355|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33580968|NCT01268150|62978110|FG000|Extension Phase|Adverse Event|3|||
33302606|NCT01075282|62678340|FG001|Overall Study|Treatment Non-compliance|2|||
33302607|NCT01075282|62678341|FG002|Overall Study|Treatment Non-compliance|2|||
33302608|NCT01075282|62678339|FG000|Overall Study|Protocol Violation|0|||
33302609|NCT01075282|62678340|FG001|Overall Study|Protocol Violation|2|||
33302610|NCT01075282|62678341|FG002|Overall Study|Protocol Violation|1|||
33302611|NCT01075282|62678339|FG000|Overall Study|Death|0|||
33302612|NCT01075282|62678340|FG001|Overall Study|Death|1|||
33302613|NCT01075282|62678341|FG002|Overall Study|Death|2|||
33302614|NCT01253811|62678350|FG000|Overall Study|Withdrawal criteria|1|||
33395067|NCT00400946|62774365|FG003|Overall Study|Other|0|||
33395068|NCT00400946|62774366|FG004|Overall Study|Other|1|||
33395069|NCT00666588|62774397|FG000|Overall Study|ineligible|2|||
33395070|NCT00666588|62774398|FG001|Overall Study|ineligible|0|||
33395071|NCT00666588|62774399|FG002|Overall Study|ineligible|0|||
33395072|NCT00666588|62774400|FG003|Overall Study|ineligible|2|||
33395073|NCT00666588|62774397|FG000|Overall Study|inevaluable|2|||
33395074|NCT00666588|62774398|FG001|Overall Study|inevaluable|0|||
33302615|NCT01295580|62678356|FG000|Overall Study|Protocol Violation|4|||
33395075|NCT00666588|62774399|FG002|Overall Study|inevaluable|0|||
33395076|NCT00666588|62774400|FG003|Overall Study|inevaluable|0|||
33395077|NCT00689390|62774412|FG000|Overall Study|Adverse Event|19|||
33395078|NCT00689390|62774413|FG001|Overall Study|Adverse Event|0|||
33395079|NCT00689390|62774412|FG000|Overall Study|Lost to Follow-up|179|||
33395080|NCT00689390|62774413|FG001|Overall Study|Lost to Follow-up|7|||
33395081|NCT00689390|62774412|FG000|Overall Study|Withdrawal by Subject|117|||
33395082|NCT00689390|62774413|FG001|Overall Study|Withdrawal by Subject|3|||
33395083|NCT00689390|62774412|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
33395084|NCT00689390|62774413|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
33395085|NCT00689390|62774412|FG000|Overall Study|Non-Compliance With Protocol|21|||
33395086|NCT00689390|62774413|FG001|Overall Study|Non-Compliance With Protocol|0|||
33395087|NCT00689390|62774412|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
33395088|NCT00689390|62774413|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
33395089|NCT00689390|62774412|FG000|Overall Study|Administrative|37|||
33395090|NCT00689390|62774413|FG001|Overall Study|Administrative|0|||
33395091|NCT00567879|62774430|FG000|Overall Study|Adverse Event|2|||
33395092|NCT00567879|62774431|FG001|Overall Study|Adverse Event|0|||
33395093|NCT00567879|62774432|FG002|Overall Study|Adverse Event|1|||
33395094|NCT00567879|62774433|FG003|Overall Study|Adverse Event|0|||
33395095|NCT00567879|62774434|FG004|Overall Study|Adverse Event|1|||
33395096|NCT00567879|62774435|FG005|Overall Study|Adverse Event|0|||
33395097|NCT00567879|62774430|FG000|Overall Study|Abnormal test procedure(s)|0|||
33395098|NCT00567879|62774431|FG001|Overall Study|Abnormal test procedure(s)|0|||
33395099|NCT00567879|62774432|FG002|Overall Study|Abnormal test procedure(s)|1|||
33395100|NCT00567879|62774433|FG003|Overall Study|Abnormal test procedure(s)|0|||
33567426|NCT02819635|62963344|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33567427|NCT02819635|62963345|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33567428|NCT02819635|62963346|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33567429|NCT02819635|62963347|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33567430|NCT02819635|62963348|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33567431|NCT02819635|62963349|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33567432|NCT02819635|62963350|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
33567433|NCT02819635|62963351|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33567434|NCT02819635|62963352|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33567435|NCT02819635|62963353|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33567436|NCT02819635|62963354|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33567437|NCT02819635|62963355|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33567438|NCT02819635|62963344|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
33567439|NCT02819635|62963345|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
33567440|NCT02819635|62963346|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
33567441|NCT02819635|62963347|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
33567442|NCT02819635|62963348|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
33567443|NCT02819635|62963349|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
33567444|NCT02819635|62963350|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
33567445|NCT02819635|62963351|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
33567446|NCT02819635|62963352|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
33395101|NCT00567879|62774434|FG004|Overall Study|Abnormal test procedure(s)|0|||
33395102|NCT00567879|62774435|FG005|Overall Study|Abnormal test procedure(s)|0|||
33395103|NCT00567879|62774430|FG000|Overall Study|Withdrawal by Subject|0|||
33395104|NCT00567879|62774431|FG001|Overall Study|Withdrawal by Subject|0|||
33395105|NCT00567879|62774432|FG002|Overall Study|Withdrawal by Subject|3|||
33567447|NCT02819635|62963353|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
33567448|NCT02819635|62963354|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
33567449|NCT02819635|62963355|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
33567450|NCT02819635|62963344|FG000|Substudy 2, Part 2|Adverse Event|0|||
33567451|NCT02819635|62963345|FG001|Substudy 2, Part 2|Adverse Event|0|||
33567452|NCT02819635|62963346|FG002|Substudy 2, Part 2|Adverse Event|0|||
33567453|NCT02819635|62963347|FG003|Substudy 2, Part 2|Adverse Event|0|||
33567454|NCT02819635|62963348|FG004|Substudy 2, Part 2|Adverse Event|0|||
33567455|NCT02819635|62963349|FG005|Substudy 2, Part 2|Adverse Event|4|||
33302616|NCT01295580|62678357|FG001|Overall Study|Protocol Violation|2|||
33302617|NCT01295580|62678356|FG000|Overall Study|Withdrawal by Subject|1|||
33302618|NCT01295580|62678357|FG001|Overall Study|Withdrawal by Subject|4|||
33302619|NCT01295580|62678356|FG000|Overall Study|Adverse Event|2|||
33302620|NCT01295580|62678357|FG001|Overall Study|Adverse Event|1|||
33302621|NCT01295580|62678356|FG000|Overall Study|Lost to Follow-up|1|||
33302622|NCT01295580|62678357|FG001|Overall Study|Lost to Follow-up|0|||
33302623|NCT01295580|62678356|FG000|Overall Study|Lack of Efficacy|1|||
33302624|NCT01295580|62678357|FG001|Overall Study|Lack of Efficacy|0|||
33302625|NCT01295580|62678356|FG000|Overall Study|Other: inconvenience|1|||
33302626|NCT01295580|62678357|FG001|Overall Study|Other: inconvenience|0|||
33395106|NCT00567879|62774433|FG003|Overall Study|Withdrawal by Subject|1|||
33395107|NCT00567879|62774434|FG004|Overall Study|Withdrawal by Subject|0|||
33395108|NCT00567879|62774435|FG005|Overall Study|Withdrawal by Subject|0|||
33395109|NCT00567879|62774430|FG000|Overall Study|New cancer therapy|0|||
33302627|NCT01295580|62678356|FG000|Overall Study|Other: family objection|0|||
33302628|NCT01295580|62678357|FG001|Overall Study|Other: family objection|1|||
33395110|NCT00567879|62774431|FG001|Overall Study|New cancer therapy|0|||
33395111|NCT00567879|62774432|FG002|Overall Study|New cancer therapy|1|||
33395112|NCT00567879|62774433|FG003|Overall Study|New cancer therapy|0|||
33395113|NCT00567879|62774434|FG004|Overall Study|New cancer therapy|0|||
33395114|NCT00567879|62774435|FG005|Overall Study|New cancer therapy|0|||
33395115|NCT00567879|62774430|FG000|Overall Study|Disease progression|5|||
33395116|NCT00567879|62774431|FG001|Overall Study|Disease progression|7|||
33395117|NCT00567879|62774432|FG002|Overall Study|Disease progression|15|||
33395118|NCT00567879|62774433|FG003|Overall Study|Disease progression|5|||
33395119|NCT00567879|62774434|FG004|Overall Study|Disease progression|11|||
33395120|NCT00567879|62774435|FG005|Overall Study|Disease progression|3|||
33395121|NCT00603915|62774453|FG000|Overall Study|Physician Decision|1|||
33395122|NCT00603837|62774459|FG000|Overall Study|Physician Decision|3|||
33395123|NCT00603837|62774460|FG001|Overall Study|Physician Decision|0|||
33395124|NCT00667602|62774469|FG000|Overall Study|Withdrawal by Subject|4|||
33395125|NCT00667602|62774470|FG001|Overall Study|Withdrawal by Subject|9|||
33395126|NCT00667602|62774471|FG002|Overall Study|Withdrawal by Subject|10|||
33395127|NCT00667602|62774469|FG000|Overall Study|Lost to Follow-up|4|||
33395128|NCT00667602|62774470|FG001|Overall Study|Lost to Follow-up|5|||
33395129|NCT00667602|62774471|FG002|Overall Study|Lost to Follow-up|6|||
33395130|NCT00667602|62774469|FG000|Overall Study|Administrative reason|0|||
33395131|NCT00667602|62774470|FG001|Overall Study|Administrative reason|0|||
33395132|NCT00667602|62774471|FG002|Overall Study|Administrative reason|2|||
33395133|NCT00667602|62774469|FG000|Overall Study|Protocol Violation|0|||
33395134|NCT00667602|62774470|FG001|Overall Study|Protocol Violation|1|||
33395135|NCT00667602|62774471|FG002|Overall Study|Protocol Violation|0|||
33395136|NCT00691028|62774487|FG000|Open-label Period|Adverse Event|0|||
33395137|NCT00691028|62774488|FG001|Open-label Period|Adverse Event|0|||
33395138|NCT00691028|62774489|FG002|Open-label Period|Adverse Event|0|||
33395139|NCT00691028|62774490|FG003|Open-label Period|Adverse Event|16|||
33395140|NCT00691028|62774487|FG000|Open-label Period|Withdrawal by Subject|0|||
33395141|NCT00691028|62774488|FG001|Open-label Period|Withdrawal by Subject|0|||
33395142|NCT00691028|62774489|FG002|Open-label Period|Withdrawal by Subject|0|||
33395143|NCT00691028|62774490|FG003|Open-label Period|Withdrawal by Subject|3|||
33395144|NCT00691028|62774487|FG000|Open-label Period|not come to a hospital|0|||
33395145|NCT00691028|62774488|FG001|Open-label Period|not come to a hospital|0|||
33395146|NCT00691028|62774489|FG002|Open-label Period|not come to a hospital|0|||
33395147|NCT00691028|62774490|FG003|Open-label Period|not come to a hospital|1|||
33395148|NCT00691028|62774487|FG000|Double-blind Period|Adverse Event|8|||
33395149|NCT00691028|62774488|FG001|Double-blind Period|Adverse Event|9|||
33395150|NCT00691028|62774489|FG002|Double-blind Period|Adverse Event|6|||
33395151|NCT00691028|62774490|FG003|Double-blind Period|Adverse Event|0|||
33395152|NCT00691028|62774487|FG000|Double-blind Period|Lack of Efficacy|4|||
33395153|NCT00691028|62774488|FG001|Double-blind Period|Lack of Efficacy|3|||
33395154|NCT00691028|62774489|FG002|Double-blind Period|Lack of Efficacy|2|||
33395155|NCT00691028|62774490|FG003|Double-blind Period|Lack of Efficacy|0|||
33395156|NCT00691028|62774487|FG000|Double-blind Period|Withdrawal by Subject|1|||
33395157|NCT00691028|62774488|FG001|Double-blind Period|Withdrawal by Subject|0|||
33395158|NCT00691028|62774489|FG002|Double-blind Period|Withdrawal by Subject|1|||
33395159|NCT00691028|62774490|FG003|Double-blind Period|Withdrawal by Subject|0|||
33395160|NCT00691028|62774487|FG000|Double-blind Period|not come to a hospital.|0|||
33395161|NCT00691028|62774488|FG001|Double-blind Period|not come to a hospital.|1|||
33395162|NCT00691028|62774489|FG002|Double-blind Period|not come to a hospital.|0|||
33395163|NCT00691028|62774490|FG003|Double-blind Period|not come to a hospital.|0|||
33395164|NCT00690794|62774504|FG000|Overall Study|Adverse Event|12|||
33395165|NCT00690794|62774505|FG001|Overall Study|Adverse Event|10|||
33395166|NCT00690794|62774504|FG000|Overall Study|Lost to Follow-up|1|||
33395167|NCT00690794|62774505|FG001|Overall Study|Lost to Follow-up|4|||
33395168|NCT00690794|62774504|FG000|Overall Study|Withdrawal by Subject|0|||
33395169|NCT00690794|62774505|FG001|Overall Study|Withdrawal by Subject|9|||
33395170|NCT00690794|62774504|FG000|Overall Study|Protocol Violation|6|||
33395171|NCT00690794|62774505|FG001|Overall Study|Protocol Violation|7|||
33395172|NCT00690794|62774504|FG000|Overall Study|Noncompliance|1|||
33395173|NCT00690794|62774505|FG001|Overall Study|Noncompliance|2|||
33395174|NCT00690794|62774504|FG000|Overall Study|Other not specified|1|||
33395175|NCT00690794|62774505|FG001|Overall Study|Other not specified|3|||
33567456|NCT02819635|62963350|FG006|Substudy 2, Part 2|Adverse Event|0|||
33567457|NCT02819635|62963351|FG007|Substudy 2, Part 2|Adverse Event|0|||
33567458|NCT02819635|62963352|FG008|Substudy 2, Part 2|Adverse Event|0|||
33395176|NCT00666276|62774511|FG000|Overall Study|Protocol Violation|34|||
33395177|NCT00567255|62774536|FG000|Overall Study|Adverse Event|241|||
33395178|NCT00567255|62774537|FG001|Overall Study|Adverse Event|68|||
33395179|NCT00567255|62774536|FG000|Overall Study|Lost to Follow-up|77|||
33395180|NCT00567255|62774537|FG001|Overall Study|Lost to Follow-up|48|||
33395181|NCT00567255|62774536|FG000|Overall Study|Withdrawal by Subject|75|||
33395182|NCT00567255|62774537|FG001|Overall Study|Withdrawal by Subject|56|||
33395183|NCT00567255|62774536|FG000|Overall Study|Lack of Efficacy|19|||
33395184|NCT00567255|62774537|FG001|Overall Study|Lack of Efficacy|33|||
33395185|NCT00567255|62774536|FG000|Overall Study|Protocol Violation|20|||
33395186|NCT00567255|62774537|FG001|Overall Study|Protocol Violation|8|||
33395187|NCT00567255|62774536|FG000|Overall Study|Pregnancy|6|||
33395188|NCT00567255|62774537|FG001|Overall Study|Pregnancy|0|||
33395189|NCT00567255|62774536|FG000|Overall Study|Drug noncompliance,moved,other|25|||
33395190|NCT00567255|62774537|FG001|Overall Study|Drug noncompliance,moved,other|15|||
33395191|NCT00667446|62774545|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
33395192|NCT00667446|62774546|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
33395193|NCT00667446|62774545|FG000|Treatment Period (36 Months)|Other|2|||
33395194|NCT00667446|62774546|FG001|Treatment Period (36 Months)|Other|2|||
33395195|NCT00667446|62774545|FG000|Treatment Period (36 Months)|Personal reasons|2|||
33395196|NCT00667446|62774546|FG001|Treatment Period (36 Months)|Personal reasons|2|||
33395197|NCT00667446|62774545|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
33395198|NCT00667446|62774546|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
33567459|NCT02819635|62963353|FG009|Substudy 2, Part 2|Adverse Event|0|||
33567460|NCT02819635|62963354|FG010|Substudy 2, Part 2|Adverse Event|0|||
33567461|NCT02819635|62963355|FG011|Substudy 2, Part 2|Adverse Event|0|||
33567462|NCT02819635|62963344|FG000|Substudy 2, Part 2|Withdrew consent|0|||
33567463|NCT02819635|62963345|FG001|Substudy 2, Part 2|Withdrew consent|0|||
33567464|NCT02819635|62963346|FG002|Substudy 2, Part 2|Withdrew consent|0|||
33567465|NCT02819635|62963347|FG003|Substudy 2, Part 2|Withdrew consent|0|||
33567466|NCT02819635|62963348|FG004|Substudy 2, Part 2|Withdrew consent|0|||
33567467|NCT02819635|62963349|FG005|Substudy 2, Part 2|Withdrew consent|3|||
33567468|NCT02819635|62963350|FG006|Substudy 2, Part 2|Withdrew consent|1|||
33567469|NCT02819635|62963351|FG007|Substudy 2, Part 2|Withdrew consent|0|||
33664142|NCT02681094|63095177|FG001|2 - Enrolled Participants Set|Participant decision|10|||
33664143|NCT02681094|63095178|FG002|2 - Enrolled Participants Set|Participant decision|9|||
33664144|NCT02681094|63095176|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
33664145|NCT02681094|63095177|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
33664146|NCT02681094|63095178|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
33664147|NCT02681094|63095176|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
33302629|NCT01253577|62678363|FG000|Overall Study|Lost to Follow-up|3|||
33302630|NCT01295034|62678371|FG000|Overall Study|Lost to Follow-up|5|||
33567470|NCT02819635|62963352|FG008|Substudy 2, Part 2|Withdrew consent|0|||
33567471|NCT02819635|62963353|FG009|Substudy 2, Part 2|Withdrew consent|0|||
33567472|NCT02819635|62963354|FG010|Substudy 2, Part 2|Withdrew consent|0|||
33567473|NCT02819635|62963355|FG011|Substudy 2, Part 2|Withdrew consent|0|||
33567474|NCT02819635|62963344|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
33567475|NCT02819635|62963345|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
33567476|NCT02819635|62963346|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
33567477|NCT02819635|62963347|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
33567478|NCT02819635|62963348|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
33302631|NCT01295034|62678372|FG001|Overall Study|Lost to Follow-up|5|||
33302632|NCT01253421|62678383|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
33302633|NCT01253421|62678384|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
33302634|NCT01253421|62678385|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
33302635|NCT01253421|62678386|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
33302636|NCT01253421|62678387|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
33302637|NCT01253421|62678383|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
33302638|NCT01253421|62678384|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
33302639|NCT01253421|62678385|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
33302640|NCT01253421|62678386|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
33302641|NCT01253421|62678387|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
33302642|NCT01253421|62678383|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
33302643|NCT01253421|62678384|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
33302644|NCT01253421|62678385|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
33302645|NCT01253421|62678386|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
33302646|NCT01253421|62678387|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
33302647|NCT01253421|62678383|FG000|Assessment and Scheduling|Physician Decision|1|||
33302648|NCT01253421|62678384|FG001|Assessment and Scheduling|Physician Decision|0|||
33302649|NCT01253421|62678385|FG002|Assessment and Scheduling|Physician Decision|0|||
33302650|NCT01253421|62678386|FG003|Assessment and Scheduling|Physician Decision|0|||
33302651|NCT01253421|62678387|FG004|Assessment and Scheduling|Physician Decision|0|||
33302652|NCT01253421|62678383|FG000|Drug+Scanning Visit|Physician Decision|0|||
33302653|NCT01253421|62678384|FG001|Drug+Scanning Visit|Physician Decision|0|||
33567479|NCT02819635|62963349|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
33567480|NCT02819635|62963350|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
33664148|NCT02681094|63095177|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
33664149|NCT02681094|63095178|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
33302654|NCT01253421|62678385|FG002|Drug+Scanning Visit|Physician Decision|0|||
33302655|NCT01253421|62678386|FG003|Drug+Scanning Visit|Physician Decision|0|||
33395199|NCT00667446|62774545|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
33395200|NCT00667446|62774546|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
33395201|NCT00667446|62774545|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
33395202|NCT00667446|62774546|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
33395203|NCT00667446|62774545|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
33395204|NCT00667446|62774546|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
33395205|NCT00667446|62774545|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
33395206|NCT00667446|62774546|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
33395207|NCT00667446|62774545|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
33395208|NCT00667446|62774546|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
33395209|NCT00688844|62774552|FG000|Overall Study|Lost to Follow-up|10|||
33395210|NCT00667368|62774558|FG000|Overall Study|Lost to Follow-up|176|||
33395211|NCT00667368|62774559|FG001|Overall Study|Lost to Follow-up|155|||
33395212|NCT00667368|62774558|FG000|Overall Study|Discontinued early|24|||
33395213|NCT00667368|62774559|FG001|Overall Study|Discontinued early|17|||
33395214|NCT00567567|62774568|FG000|Overall Study|Adverse Event|0|||
33395215|NCT00567567|62774569|FG001|Overall Study|Adverse Event|2|||
33395216|NCT00567567|62774570|FG002|Overall Study|Adverse Event|5|||
33302656|NCT01253421|62678387|FG004|Drug+Scanning Visit|Physician Decision|1|||
33302657|NCT01077076|62678397|FG000|First Intervention|Withdrawal by Subject|1|||
33302658|NCT01077076|62678398|FG001|First Intervention|Withdrawal by Subject|0|||
33302659|NCT01077076|62678399|FG002|First Intervention|Withdrawal by Subject|0|||
33302660|NCT01077076|62678400|FG003|First Intervention|Withdrawal by Subject|0|||
33302661|NCT01077076|62678401|FG004|First Intervention|Withdrawal by Subject|0|||
33302662|NCT01077076|62678402|FG005|First Intervention|Withdrawal by Subject|0|||
33302663|NCT01077076|62678397|FG000|Third Intervention|Death in the participant's family|0|||
33302664|NCT01077076|62678398|FG001|Third Intervention|Death in the participant's family|0|||
33302665|NCT01077076|62678399|FG002|Third Intervention|Death in the participant's family|0|||
33302666|NCT01077076|62678400|FG003|Third Intervention|Death in the participant's family|0|||
33302667|NCT01077076|62678401|FG004|Third Intervention|Death in the participant's family|0|||
33302668|NCT01077076|62678402|FG005|Third Intervention|Death in the participant's family|1|||
33302669|NCT01294800|62678414|FG000|Overall Study|Adverse Event|7|||
33302670|NCT01294800|62678415|FG001|Overall Study|Adverse Event|6|||
33302671|NCT01294800|62678416|FG002|Overall Study|Adverse Event|12|||
33302672|NCT01294800|62678417|FG003|Overall Study|Adverse Event|5|||
33302673|NCT01294800|62678414|FG000|Overall Study|Subject Withdrew Consent|2|||
33302674|NCT01294800|62678415|FG001|Overall Study|Subject Withdrew Consent|2|||
33302675|NCT01294800|62678416|FG002|Overall Study|Subject Withdrew Consent|2|||
33302676|NCT01294800|62678417|FG003|Overall Study|Subject Withdrew Consent|11|||
33302677|NCT01294800|62678414|FG000|Overall Study|Lost to Follow-up|0|||
33302678|NCT01294800|62678415|FG001|Overall Study|Lost to Follow-up|0|||
33302679|NCT01294800|62678416|FG002|Overall Study|Lost to Follow-up|1|||
33302680|NCT01294800|62678417|FG003|Overall Study|Lost to Follow-up|0|||
33302681|NCT01294800|62678414|FG000|Overall Study|Non-compliance With Protocol|0|||
33302682|NCT01294800|62678415|FG001|Overall Study|Non-compliance With Protocol|1|||
33302683|NCT01294800|62678416|FG002|Overall Study|Non-compliance With Protocol|1|||
33302684|NCT01294800|62678417|FG003|Overall Study|Non-compliance With Protocol|0|||
33302685|NCT01294800|62678414|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
33302686|NCT01294800|62678415|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
33302687|NCT01294800|62678416|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
33302688|NCT01294800|62678417|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
33302689|NCT01294644|62678430|FG000|Overall Study|Adverse Event|2|||
33302690|NCT01294644|62678431|FG001|Overall Study|Adverse Event|0|||
33302691|NCT01294644|62678432|FG002|Overall Study|Adverse Event|1|||
33302692|NCT01294644|62678430|FG000|Overall Study|Withdrawal by Subject|3|||
33395217|NCT00567567|62774568|FG000|Overall Study|Death|8|||
33302693|NCT01294644|62678431|FG001|Overall Study|Withdrawal by Subject|7|||
33302694|NCT01294644|62678432|FG002|Overall Study|Withdrawal by Subject|4|||
33302695|NCT01294644|62678430|FG000|Overall Study|Lost to Follow-up|3|||
33302696|NCT01294644|62678431|FG001|Overall Study|Lost to Follow-up|2|||
33302697|NCT01294644|62678432|FG002|Overall Study|Lost to Follow-up|5|||
33302698|NCT01294644|62678430|FG000|Overall Study|Miscellaneous Reason|2|||
33302699|NCT01294644|62678431|FG001|Overall Study|Miscellaneous Reason|1|||
33302700|NCT01294644|62678432|FG002|Overall Study|Miscellaneous Reason|4|||
33302701|NCT01293240|62678440|FG000|Overall Study|Noncompliance|2|||
33302702|NCT01253265|62678449|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
33302703|NCT01253265|62678450|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
33302704|NCT01253265|62678451|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
33302705|NCT01253265|62678452|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
33302706|NCT01253265|62678453|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
33302707|NCT01253265|62678449|FG000|Overall Study|Withdrawal by Subject|0|||
33302708|NCT01253265|62678450|FG001|Overall Study|Withdrawal by Subject|0|||
33302709|NCT01253265|62678451|FG002|Overall Study|Withdrawal by Subject|0|||
33302710|NCT01253265|62678452|FG003|Overall Study|Withdrawal by Subject|0|||
33395218|NCT00567567|62774569|FG001|Overall Study|Death|1|||
33395219|NCT00567567|62774570|FG002|Overall Study|Death|5|||
33395220|NCT00567567|62774568|FG000|Overall Study|Lack of Efficacy|16|||
33395221|NCT00567567|62774569|FG001|Overall Study|Lack of Efficacy|17|||
33395222|NCT00567567|62774570|FG002|Overall Study|Lack of Efficacy|48|||
33395223|NCT00567567|62774568|FG000|Overall Study|Lost to Follow-up|0|||
33395224|NCT00567567|62774569|FG001|Overall Study|Lost to Follow-up|0|||
33395225|NCT00567567|62774570|FG002|Overall Study|Lost to Follow-up|1|||
33395226|NCT00567567|62774568|FG000|Overall Study|Physician Decision|16|||
33395227|NCT00567567|62774569|FG001|Overall Study|Physician Decision|18|||
33395228|NCT00567567|62774570|FG002|Overall Study|Physician Decision|84|||
33395229|NCT00567567|62774568|FG000|Overall Study|Withdrawal by Subject|0|||
33395230|NCT00567567|62774569|FG001|Overall Study|Withdrawal by Subject|0|||
33395231|NCT00567567|62774570|FG002|Overall Study|Withdrawal by Subject|2|||
33395232|NCT00567567|62774568|FG000|Overall Study|Ineligible|4|||
33395233|NCT00567567|62774569|FG001|Overall Study|Ineligible|0|||
33395234|NCT00567567|62774570|FG002|Overall Study|Ineligible|9|||
33395235|NCT00567567|62774568|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
33395236|NCT00567567|62774569|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
33395237|NCT00567567|62774570|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
33395238|NCT00567567|62774568|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
33395239|NCT00567567|62774569|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
33395240|NCT00567567|62774570|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
33395241|NCT00567567|62774568|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
33395242|NCT00567567|62774569|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
33395243|NCT00567567|62774570|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
33395244|NCT00666198|62774580|FG000|Overall Study|Protocol Violation|10|||
33395245|NCT00666198|62774580|FG000|Overall Study|No Visit After First Day of Treatment|13|||
33395246|NCT00666198|62774580|FG000|Overall Study|Safety Not Assessable|6|||
33395247|NCT00666198|62774580|FG000|Overall Study|No Drug Administration|4|||
33395248|NCT00664560|62774587|FG000|Overall Study|Adverse Event|19|||
33395249|NCT00664560|62774588|FG001|Overall Study|Adverse Event|16|||
33395250|NCT00664560|62774589|FG002|Overall Study|Adverse Event|7|||
33395251|NCT00664560|62774587|FG000|Overall Study|Withdrawal by Subject|9|||
33395252|NCT00664560|62774588|FG001|Overall Study|Withdrawal by Subject|13|||
33395253|NCT00664560|62774589|FG002|Overall Study|Withdrawal by Subject|7|||
33395254|NCT00664560|62774587|FG000|Overall Study|Lost to Follow-up|0|||
33395255|NCT00664560|62774588|FG001|Overall Study|Lost to Follow-up|2|||
33395256|NCT00664560|62774589|FG002|Overall Study|Lost to Follow-up|0|||
33395257|NCT00664560|62774587|FG000|Overall Study|Other|11|||
33395258|NCT00664560|62774588|FG001|Overall Study|Other|4|||
33395259|NCT00664560|62774589|FG002|Overall Study|Other|5|||
33395260|NCT00566709|62774599|FG000|Overall Study|Protocol Violation|5|||
33395261|NCT00566709|62774600|FG001|Overall Study|Protocol Violation|0|||
33395262|NCT00688688|62774609|FG000|Overall Study|Eligibility criterion not met|7|||
33395263|NCT00688688|62774610|FG001|Overall Study|Eligibility criterion not met|7|||
33395264|NCT00688688|62774611|FG002|Overall Study|Eligibility criterion not met|10|||
33395265|NCT00688688|62774609|FG000|Overall Study|Adverse Event|52|||
33395266|NCT00688688|62774610|FG001|Overall Study|Adverse Event|51|||
33395267|NCT00688688|62774611|FG002|Overall Study|Adverse Event|50|||
33395268|NCT00688688|62774609|FG000|Overall Study|Lack of Efficacy|34|||
33395269|NCT00688688|62774610|FG001|Overall Study|Lack of Efficacy|25|||
33395270|NCT00688688|62774611|FG002|Overall Study|Lack of Efficacy|45|||
33395271|NCT00688688|62774609|FG000|Overall Study|Withdrawal by Subject|66|||
33395272|NCT00688688|62774610|FG001|Overall Study|Withdrawal by Subject|75|||
33395273|NCT00688688|62774611|FG002|Overall Study|Withdrawal by Subject|65|||
33395274|NCT00688688|62774609|FG000|Overall Study|Lost to Follow-up|14|||
33395275|NCT00688688|62774610|FG001|Overall Study|Lost to Follow-up|7|||
33395276|NCT00688688|62774611|FG002|Overall Study|Lost to Follow-up|7|||
33395277|NCT00688688|62774609|FG000|Overall Study|Protocol Violation|6|||
33302711|NCT01253265|62678453|FG004|Overall Study|Withdrawal by Subject|1|||
33302712|NCT01293084|62678465|FG000|Overall Study|Physician Decision|3|||
33302713|NCT01293084|62678465|FG000|Overall Study|Withdrawal by Subject|2|||
33302714|NCT01293006|62678475|FG000|Period 2|Lost to Follow-up|1|||
33302715|NCT01293006|62678476|FG001|Period 2|Lost to Follow-up|0|||
33302716|NCT01293006|62678477|FG002|Period 2|Lost to Follow-up|0|||
33302717|NCT01293006|62678478|FG003|Period 2|Lost to Follow-up|0|||
33395278|NCT00688688|62774610|FG001|Overall Study|Protocol Violation|9|||
33395279|NCT00688688|62774611|FG002|Overall Study|Protocol Violation|11|||
33395280|NCT00688688|62774609|FG000|Overall Study|Randomized but never received study drug|1|||
33395281|NCT00688688|62774610|FG001|Overall Study|Randomized but never received study drug|0|||
33395282|NCT00688688|62774611|FG002|Overall Study|Randomized but never received study drug|0|||
33302718|NCT01253187|62678497|FG000|Period 2|Withdrawal by Subject|0|||
33302719|NCT01253187|62678498|FG001|Period 2|Withdrawal by Subject|0|||
33302720|NCT01253187|62678499|FG002|Period 2|Withdrawal by Subject|0|||
33302721|NCT01253187|62678500|FG003|Period 2|Withdrawal by Subject|0|||
33395283|NCT00688688|62774609|FG000|Overall Study|Non-compliance with study procedures|5|||
33395284|NCT00688688|62774610|FG001|Overall Study|Non-compliance with study procedures|3|||
33395285|NCT00688688|62774611|FG002|Overall Study|Non-compliance with study procedures|4|||
33395286|NCT00688688|62774609|FG000|Overall Study|Taking exclusionary medications|1|||
33395287|NCT00688688|62774610|FG001|Overall Study|Taking exclusionary medications|0|||
33395288|NCT00688688|62774611|FG002|Overall Study|Taking exclusionary medications|0|||
33395289|NCT00688688|62774609|FG000|Overall Study|Site closure|0|||
33395290|NCT00688688|62774610|FG001|Overall Study|Site closure|1|||
33395291|NCT00688688|62774611|FG002|Overall Study|Site closure|0|||
33395292|NCT00688688|62774609|FG000|Overall Study|Violation of exclusion criterion|0|||
33395293|NCT00688688|62774610|FG001|Overall Study|Violation of exclusion criterion|1|||
33395294|NCT00688688|62774611|FG002|Overall Study|Violation of exclusion criterion|0|||
33395295|NCT00664326|62774619|FG000|Overall Study|Adverse Event|14|||
33395296|NCT00664326|62774619|FG000|Overall Study|Noncompliance with study medication|3|||
33395297|NCT00664326|62774619|FG000|Overall Study|Withdrawal by Subject|1|||
33395298|NCT00664326|62774619|FG000|Overall Study|Physician Decision|1|||
33395299|NCT00664326|62774619|FG000|Overall Study|Other Reasons|3|||
33395300|NCT00664326|62774619|FG000|Overall Study|Death|2|||
33395301|NCT00664326|62774619|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
33395302|NCT00686972|62774623|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
33395303|NCT00665652|62774627|FG000|Overall Study|Adverse Event|4|||
33395304|NCT00665652|62774627|FG000|Overall Study|Death|1|||
33395305|NCT00665652|62774627|FG000|Overall Study|No longer met inclusion criteria.|1|||
33567481|NCT02819635|62963351|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
33567482|NCT02819635|62963352|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
33567483|NCT02819635|62963353|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
33567484|NCT02819635|62963354|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
33567485|NCT02819635|62963355|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
33567486|NCT02819635|62963344|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33567487|NCT02819635|62963345|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33567488|NCT02819635|62963346|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33567489|NCT02819635|62963347|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33567490|NCT02819635|62963348|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33567491|NCT02819635|62963349|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33567492|NCT02819635|62963350|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
33567493|NCT02819635|62963351|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33567494|NCT02819635|62963352|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33567495|NCT02819635|62963353|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33567496|NCT02819635|62963354|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33567497|NCT02819635|62963355|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33567498|NCT02819635|62963344|FG000|Substudy 2, Part 2|Other, not specified|0|||
33567499|NCT02819635|62963345|FG001|Substudy 2, Part 2|Other, not specified|0|||
33567500|NCT02819635|62963346|FG002|Substudy 2, Part 2|Other, not specified|0|||
33567501|NCT02819635|62963347|FG003|Substudy 2, Part 2|Other, not specified|0|||
33567502|NCT02819635|62963348|FG004|Substudy 2, Part 2|Other, not specified|0|||
33567503|NCT02819635|62963349|FG005|Substudy 2, Part 2|Other, not specified|4|||
33567504|NCT02819635|62963350|FG006|Substudy 2, Part 2|Other, not specified|8|||
33567505|NCT02819635|62963351|FG007|Substudy 2, Part 2|Other, not specified|0|||
33567506|NCT02819635|62963352|FG008|Substudy 2, Part 2|Other, not specified|0|||
33567507|NCT02819635|62963353|FG009|Substudy 2, Part 2|Other, not specified|0|||
33567508|NCT02819635|62963354|FG010|Substudy 2, Part 2|Other, not specified|0|||
33567509|NCT02819635|62963355|FG011|Substudy 2, Part 2|Other, not specified|0|||
33567510|NCT02819635|62963344|FG000|Substudy 3|Adverse Event|0|||
33567511|NCT02819635|62963345|FG001|Substudy 3|Adverse Event|0|||
33567512|NCT02819635|62963346|FG002|Substudy 3|Adverse Event|0|||
33567513|NCT02819635|62963347|FG003|Substudy 3|Adverse Event|0|||
33567514|NCT02819635|62963348|FG004|Substudy 3|Adverse Event|0|||
33567515|NCT02819635|62963349|FG005|Substudy 3|Adverse Event|0|||
33567516|NCT02819635|62963350|FG006|Substudy 3|Adverse Event|0|||
33567517|NCT02819635|62963351|FG007|Substudy 3|Adverse Event|0|||
33567518|NCT02819635|62963352|FG008|Substudy 3|Adverse Event|32|||
33567519|NCT02819635|62963353|FG009|Substudy 3|Adverse Event|3|||
33567520|NCT02819635|62963354|FG010|Substudy 3|Adverse Event|12|||
33567521|NCT02819635|62963355|FG011|Substudy 3|Adverse Event|18|||
33567522|NCT02819635|62963344|FG000|Substudy 3|Withdrew consent|0|||
33567523|NCT02819635|62963345|FG001|Substudy 3|Withdrew consent|0|||
33567524|NCT02819635|62963346|FG002|Substudy 3|Withdrew consent|0|||
33567525|NCT02819635|62963347|FG003|Substudy 3|Withdrew consent|0|||
33567526|NCT02819635|62963348|FG004|Substudy 3|Withdrew consent|0|||
33395306|NCT00566631|62774631|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
33395307|NCT00566631|62774631|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
33395308|NCT00566631|62774631|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
33567527|NCT02819635|62963349|FG005|Substudy 3|Withdrew consent|0|||
33567528|NCT02819635|62963350|FG006|Substudy 3|Withdrew consent|0|||
33567529|NCT02819635|62963351|FG007|Substudy 3|Withdrew consent|0|||
33567530|NCT02819635|62963352|FG008|Substudy 3|Withdrew consent|11|||
33567531|NCT02819635|62963353|FG009|Substudy 3|Withdrew consent|1|||
33567532|NCT02819635|62963354|FG010|Substudy 3|Withdrew consent|4|||
33395309|NCT00566631|62774631|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
33395310|NCT00566631|62774631|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
33395311|NCT00566631|62774631|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
33395312|NCT00566631|62774631|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
33395313|NCT00566631|62774631|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
33395314|NCT00566631|62774631|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
33395315|NCT00566631|62774631|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
33395316|NCT00566631|62774631|FG000|Part 2: Extension Phase|Adverse Event|11|||
33395317|NCT00566631|62774631|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
33395318|NCT00566631|62774631|FG000|Part 2: Extension Phase|Death|1|||
33395319|NCT00566631|62774631|FG000|Part 2: Extension Phase|Other|5|||
33395320|NCT00661830|62774637|FG000|Overall Study|Death|37|||
33395321|NCT00661830|62774638|FG001|Overall Study|Death|33|||
33395322|NCT00661830|62774637|FG000|Overall Study|Lost to Follow-up|1|||
33395323|NCT00661830|62774638|FG001|Overall Study|Lost to Follow-up|3|||
33395324|NCT00661830|62774637|FG000|Overall Study|Withdrawal by Subject|1|||
33395325|NCT00661830|62774638|FG001|Overall Study|Withdrawal by Subject|1|||
33395326|NCT00661830|62774637|FG000|Overall Study|Other reason|1|||
33395327|NCT00661830|62774638|FG001|Overall Study|Other reason|5|||
33395328|NCT00540592|62774654|FG000|Overall Study|Adverse Event|0|||
33395329|NCT00540592|62774655|FG001|Overall Study|Adverse Event|1|||
33395330|NCT00540592|62774656|FG002|Overall Study|Adverse Event|0|||
33395331|NCT00540592|62774657|FG003|Overall Study|Adverse Event|0|||
33395332|NCT00540592|62774658|FG004|Overall Study|Adverse Event|1|||
33395333|NCT00540592|62774659|FG005|Overall Study|Adverse Event|0|||
33395334|NCT00540592|62774660|FG006|Overall Study|Adverse Event|0|||
33395335|NCT00540592|62774661|FG007|Overall Study|Adverse Event|1|||
33395336|NCT00540592|62774662|FG008|Overall Study|Adverse Event|1|||
33395337|NCT00540592|62774663|FG009|Overall Study|Adverse Event|2|||
33395338|NCT00540592|62774654|FG000|Overall Study|Lost to Follow-up|2|||
33395339|NCT00540592|62774655|FG001|Overall Study|Lost to Follow-up|0|||
33395340|NCT00540592|62774656|FG002|Overall Study|Lost to Follow-up|0|||
33395341|NCT00540592|62774657|FG003|Overall Study|Lost to Follow-up|0|||
33395342|NCT00540592|62774658|FG004|Overall Study|Lost to Follow-up|0|||
33395343|NCT00540592|62774659|FG005|Overall Study|Lost to Follow-up|0|||
33395344|NCT00540592|62774660|FG006|Overall Study|Lost to Follow-up|0|||
33395345|NCT00540592|62774661|FG007|Overall Study|Lost to Follow-up|0|||
33395346|NCT00540592|62774662|FG008|Overall Study|Lost to Follow-up|0|||
33395347|NCT00540592|62774663|FG009|Overall Study|Lost to Follow-up|0|||
33395348|NCT00540592|62774654|FG000|Overall Study|Withdrawal by Subject|0|||
33395349|NCT00540592|62774655|FG001|Overall Study|Withdrawal by Subject|0|||
33395350|NCT00540592|62774656|FG002|Overall Study|Withdrawal by Subject|1|||
33395351|NCT00540592|62774657|FG003|Overall Study|Withdrawal by Subject|1|||
33395352|NCT00540592|62774658|FG004|Overall Study|Withdrawal by Subject|0|||
33395353|NCT00540592|62774659|FG005|Overall Study|Withdrawal by Subject|0|||
33395354|NCT00540592|62774660|FG006|Overall Study|Withdrawal by Subject|0|||
33395355|NCT00540592|62774661|FG007|Overall Study|Withdrawal by Subject|0|||
33395356|NCT00540592|62774662|FG008|Overall Study|Withdrawal by Subject|0|||
33395357|NCT00540592|62774663|FG009|Overall Study|Withdrawal by Subject|0|||
33395358|NCT03970395|62774687|FG000|Overall Study|Withdrawal by Subject|3|||
33395359|NCT03970395|62774688|FG001|Overall Study|Withdrawal by Subject|4|||
33395360|NCT03970395|62774687|FG000|Overall Study|Lost to Follow-up|4|||
33395361|NCT03970395|62774688|FG001|Overall Study|Lost to Follow-up|8|||
33395362|NCT00565773|62774698|FG000|Overall Study|Withdrawal by Subject|1|||
33395363|NCT00565773|62774698|FG000|Overall Study|Physician Decision|1|||
33395364|NCT00570492|62774704|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
33395365|NCT00570492|62774705|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
33395366|NCT00570492|62774706|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
33395367|NCT00570492|62774704|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
33395368|NCT00570492|62774705|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
33395369|NCT00570492|62774706|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
33567533|NCT02819635|62963355|FG011|Substudy 3|Withdrew consent|9|||
33567534|NCT02819635|62963344|FG000|Substudy 3|Lost to Follow-up|0|||
33395370|NCT00570492|62774704|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
33395371|NCT00570492|62774705|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
33395372|NCT00570492|62774706|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
33395373|NCT00570492|62774704|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
33395374|NCT00570492|62774705|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
33395375|NCT00570492|62774706|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
33395376|NCT00570492|62774704|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
33395377|NCT00570492|62774705|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
33395378|NCT00570492|62774706|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
33395379|NCT00570492|62774704|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
33395380|NCT00570492|62774705|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
33395381|NCT00570492|62774706|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
33395382|NCT00570492|62774704|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
33395383|NCT00570492|62774705|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
33395384|NCT00570492|62774706|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
33395385|NCT00570492|62774704|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33395386|NCT00570492|62774705|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
33395387|NCT00570492|62774706|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
33395388|NCT00570492|62774704|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
33395389|NCT00570492|62774705|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
33395390|NCT00570492|62774706|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
33395391|NCT00570492|62774704|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
33395392|NCT00570492|62774705|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
33567535|NCT02819635|62963345|FG001|Substudy 3|Lost to Follow-up|0|||
33567536|NCT02819635|62963346|FG002|Substudy 3|Lost to Follow-up|0|||
33567537|NCT02819635|62963347|FG003|Substudy 3|Lost to Follow-up|0|||
33567538|NCT02819635|62963348|FG004|Substudy 3|Lost to Follow-up|0|||
33567539|NCT02819635|62963349|FG005|Substudy 3|Lost to Follow-up|0|||
33567540|NCT02819635|62963350|FG006|Substudy 3|Lost to Follow-up|0|||
33567541|NCT02819635|62963351|FG007|Substudy 3|Lost to Follow-up|0|||
33567542|NCT02819635|62963352|FG008|Substudy 3|Lost to Follow-up|1|||
33567543|NCT02819635|62963353|FG009|Substudy 3|Lost to Follow-up|0|||
33567544|NCT02819635|62963354|FG010|Substudy 3|Lost to Follow-up|1|||
33567545|NCT02819635|62963355|FG011|Substudy 3|Lost to Follow-up|1|||
33567546|NCT02819635|62963344|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
33567547|NCT02819635|62963345|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
33567548|NCT02819635|62963346|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
33567549|NCT02819635|62963347|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
33567550|NCT02819635|62963348|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
33567551|NCT02819635|62963349|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
33567552|NCT02819635|62963350|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
33567553|NCT02819635|62963351|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
33567554|NCT02819635|62963352|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
33567555|NCT02819635|62963353|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
33567556|NCT02819635|62963354|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
33567557|NCT02819635|62963355|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
33567558|NCT02819635|62963344|FG000|Substudy 3|Other, not specified|0|||
33567559|NCT02819635|62963345|FG001|Substudy 3|Other, not specified|0|||
33567560|NCT02819635|62963346|FG002|Substudy 3|Other, not specified|0|||
33567561|NCT02819635|62963347|FG003|Substudy 3|Other, not specified|0|||
33567562|NCT02819635|62963348|FG004|Substudy 3|Other, not specified|0|||
33567563|NCT02819635|62963349|FG005|Substudy 3|Other, not specified|0|||
33567564|NCT02819635|62963350|FG006|Substudy 3|Other, not specified|0|||
33567565|NCT02819635|62963351|FG007|Substudy 3|Other, not specified|0|||
33567566|NCT02819635|62963352|FG008|Substudy 3|Other, not specified|202|||
33567567|NCT02819635|62963353|FG009|Substudy 3|Other, not specified|5|||
33567568|NCT02819635|62963354|FG010|Substudy 3|Other, not specified|89|||
33567569|NCT02819635|62963355|FG011|Substudy 3|Other, not specified|39|||
33567570|NCT02424344|62963390|FG000|Overall Study|Lack of Efficacy|0|||
33567571|NCT02424344|62963391|FG001|Overall Study|Lack of Efficacy|1|||
33567572|NCT02424344|62963390|FG000|Overall Study|Withdrawal by Subject|2|||
33567573|NCT02424344|62963391|FG001|Overall Study|Withdrawal by Subject|1|||
33567574|NCT02424344|62963390|FG000|Overall Study|Lost to Follow-up|1|||
33567575|NCT02424344|62963391|FG001|Overall Study|Lost to Follow-up|0|||
33567576|NCT02424344|62963390|FG000|Overall Study|Adverse Event|4|||
33567577|NCT02424344|62963391|FG001|Overall Study|Adverse Event|8|||
33395393|NCT00570492|62774706|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
33395394|NCT00570492|62774704|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
33395395|NCT00570492|62774705|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
33395396|NCT00570492|62774706|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
33395397|NCT00570492|62774704|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
33567578|NCT02423798|62963397|FG000|Overall Study|Withdrawal by Subject|3|||
33567579|NCT01651208|62963420|FG000|Overall Study|Lost to Follow-up|14|||
33664150|NCT02681094|63095176|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
33664151|NCT02681094|63095177|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
33567580|NCT01651208|62963421|FG001|Overall Study|Lost to Follow-up|16|||
33567581|NCT02383940|62963430|FG000|Overall Study|Adverse Event|1|||
33395398|NCT00570492|62774705|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
33395399|NCT00570492|62774706|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
33567582|NCT02383940|62963431|FG001|Overall Study|Adverse Event|0|||
33567583|NCT02383940|62963430|FG000|Overall Study|Lost to Follow-up|2|||
33567584|NCT02383940|62963431|FG001|Overall Study|Lost to Follow-up|2|||
33567585|NCT02383940|62963430|FG000|Overall Study|Physician Decision|2|||
33395400|NCT00570492|62774704|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
33395401|NCT00570492|62774705|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
33395402|NCT00570492|62774706|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
33395403|NCT00570492|62774704|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
33395404|NCT00570492|62774705|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
33395405|NCT00570492|62774706|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
33395406|NCT00571922|62774714|FG000|Overall Study|Completion unknown|36|||
33395407|NCT00571922|62774715|FG001|Overall Study|Completion unknown|36|||
33395408|NCT00686894|62774721|FG000|Overall Study|Relapse|2|||
33395409|NCT00686894|62774721|FG000|Overall Study|Protocol Violation|4|||
33395410|NCT00328627|62774737|FG000|Overall Study|Hyperglycemic Rescue|41|||
33395411|NCT00328627|62774738|FG001|Overall Study|Hyperglycemic Rescue|18|||
33395412|NCT00328627|62774739|FG002|Overall Study|Hyperglycemic Rescue|16|||
33395413|NCT00328627|62774740|FG003|Overall Study|Hyperglycemic Rescue|13|||
33395414|NCT00328627|62774741|FG004|Overall Study|Hyperglycemic Rescue|6|||
33395415|NCT00328627|62774742|FG005|Overall Study|Hyperglycemic Rescue|5|||
33395416|NCT00328627|62774743|FG006|Overall Study|Hyperglycemic Rescue|19|||
33395417|NCT00328627|62774744|FG007|Overall Study|Hyperglycemic Rescue|6|||
33395418|NCT00328627|62774745|FG008|Overall Study|Hyperglycemic Rescue|6|||
33395419|NCT00328627|62774746|FG009|Overall Study|Hyperglycemic Rescue|11|||
33395420|NCT00328627|62774747|FG010|Overall Study|Hyperglycemic Rescue|3|||
33395421|NCT00328627|62774748|FG011|Overall Study|Hyperglycemic Rescue|2|||
33395422|NCT00328627|62774737|FG000|Overall Study|Adverse Event|3|||
33395423|NCT00328627|62774738|FG001|Overall Study|Adverse Event|1|||
33395424|NCT00328627|62774739|FG002|Overall Study|Adverse Event|2|||
33395425|NCT00328627|62774740|FG003|Overall Study|Adverse Event|3|||
33395426|NCT00328627|62774741|FG004|Overall Study|Adverse Event|1|||
33395427|NCT00328627|62774742|FG005|Overall Study|Adverse Event|2|||
33395428|NCT00328627|62774743|FG006|Overall Study|Adverse Event|1|||
33395429|NCT00328627|62774744|FG007|Overall Study|Adverse Event|2|||
33395430|NCT00328627|62774745|FG008|Overall Study|Adverse Event|0|||
33395431|NCT00328627|62774746|FG009|Overall Study|Adverse Event|7|||
33395432|NCT00328627|62774747|FG010|Overall Study|Adverse Event|5|||
33395433|NCT00328627|62774748|FG011|Overall Study|Adverse Event|4|||
33395434|NCT00328627|62774737|FG000|Overall Study|Protocol Violation|2|||
33395435|NCT00328627|62774738|FG001|Overall Study|Protocol Violation|2|||
33395436|NCT00328627|62774739|FG002|Overall Study|Protocol Violation|2|||
33395437|NCT00328627|62774740|FG003|Overall Study|Protocol Violation|8|||
33395438|NCT00328627|62774741|FG004|Overall Study|Protocol Violation|5|||
33395439|NCT00328627|62774742|FG005|Overall Study|Protocol Violation|5|||
33395440|NCT00328627|62774743|FG006|Overall Study|Protocol Violation|6|||
33395441|NCT00328627|62774744|FG007|Overall Study|Protocol Violation|2|||
33395442|NCT00328627|62774745|FG008|Overall Study|Protocol Violation|1|||
33395443|NCT00328627|62774746|FG009|Overall Study|Protocol Violation|4|||
33395444|NCT00328627|62774747|FG010|Overall Study|Protocol Violation|6|||
33395445|NCT00328627|62774748|FG011|Overall Study|Protocol Violation|2|||
33395446|NCT00328627|62774737|FG000|Overall Study|Lost to Follow-up|4|||
33395447|NCT00328627|62774738|FG001|Overall Study|Lost to Follow-up|2|||
33395448|NCT00328627|62774739|FG002|Overall Study|Lost to Follow-up|2|||
33395449|NCT00328627|62774740|FG003|Overall Study|Lost to Follow-up|4|||
33395450|NCT00328627|62774741|FG004|Overall Study|Lost to Follow-up|0|||
33567586|NCT02383940|62963431|FG001|Overall Study|Physician Decision|0|||
33567587|NCT02383940|62963430|FG000|Overall Study|Withdrawal by Subject|1|||
33567588|NCT02383940|62963431|FG001|Overall Study|Withdrawal by Subject|1|||
33567589|NCT02383940|62963430|FG000|Overall Study|Randomized but not treated|2|||
33567590|NCT02383940|62963431|FG001|Overall Study|Randomized but not treated|0|||
33567591|NCT02383940|62963430|FG000|Overall Study|Other than specified above|1|||
33567592|NCT02383940|62963431|FG001|Overall Study|Other than specified above|0|||
33567593|NCT02383862|62963439|FG000|3 Month Follow up|Lost to Follow-up|23|||
33567594|NCT02383862|62963440|FG001|3 Month Follow up|Lost to Follow-up|21|||
33567595|NCT02383472|62963455|FG000|Overall Study|Withdrawal by Subject|1|||
33395451|NCT00328627|62774742|FG005|Overall Study|Lost to Follow-up|2|||
33395452|NCT00328627|62774743|FG006|Overall Study|Lost to Follow-up|3|||
33395453|NCT00328627|62774744|FG007|Overall Study|Lost to Follow-up|0|||
33567596|NCT02383472|62963456|FG001|Overall Study|Withdrawal by Subject|1|||
33567597|NCT02234323|62963464|FG000|All Enrolled|Not Treated: Completed study in database|2|||
33567598|NCT02234323|62963464|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
33664152|NCT02681094|63095178|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
33395454|NCT00328627|62774745|FG008|Overall Study|Lost to Follow-up|3|||
33395455|NCT00328627|62774746|FG009|Overall Study|Lost to Follow-up|2|||
33395456|NCT00328627|62774747|FG010|Overall Study|Lost to Follow-up|0|||
33395457|NCT00328627|62774748|FG011|Overall Study|Lost to Follow-up|1|||
33395458|NCT00328627|62774737|FG000|Overall Study|Withdrawal by Subject|5|||
33395459|NCT00328627|62774738|FG001|Overall Study|Withdrawal by Subject|4|||
33395460|NCT00328627|62774739|FG002|Overall Study|Withdrawal by Subject|5|||
33395461|NCT00328627|62774740|FG003|Overall Study|Withdrawal by Subject|6|||
33395462|NCT00328627|62774741|FG004|Overall Study|Withdrawal by Subject|2|||
33395463|NCT00328627|62774742|FG005|Overall Study|Withdrawal by Subject|5|||
33395464|NCT00328627|62774743|FG006|Overall Study|Withdrawal by Subject|4|||
33395465|NCT00328627|62774744|FG007|Overall Study|Withdrawal by Subject|4|||
33395466|NCT00328627|62774745|FG008|Overall Study|Withdrawal by Subject|4|||
33395467|NCT00328627|62774746|FG009|Overall Study|Withdrawal by Subject|5|||
33395468|NCT00328627|62774747|FG010|Overall Study|Withdrawal by Subject|2|||
33395469|NCT00328627|62774748|FG011|Overall Study|Withdrawal by Subject|7|||
33395470|NCT00328627|62774737|FG000|Overall Study|Pregnancy|0|||
33395471|NCT00328627|62774738|FG001|Overall Study|Pregnancy|1|||
33395472|NCT00328627|62774739|FG002|Overall Study|Pregnancy|0|||
33395473|NCT00328627|62774740|FG003|Overall Study|Pregnancy|0|||
33395474|NCT00328627|62774741|FG004|Overall Study|Pregnancy|0|||
33395475|NCT00328627|62774742|FG005|Overall Study|Pregnancy|0|||
33395476|NCT00328627|62774743|FG006|Overall Study|Pregnancy|0|||
33395477|NCT00328627|62774744|FG007|Overall Study|Pregnancy|0|||
33395478|NCT00328627|62774745|FG008|Overall Study|Pregnancy|0|||
33395479|NCT00328627|62774746|FG009|Overall Study|Pregnancy|0|||
33395480|NCT00328627|62774747|FG010|Overall Study|Pregnancy|0|||
33395481|NCT00328627|62774748|FG011|Overall Study|Pregnancy|0|||
33395482|NCT00328627|62774737|FG000|Overall Study|Physician Decision|4|||
33395483|NCT00328627|62774738|FG001|Overall Study|Physician Decision|3|||
33395484|NCT00328627|62774739|FG002|Overall Study|Physician Decision|1|||
33395485|NCT00328627|62774740|FG003|Overall Study|Physician Decision|2|||
33395486|NCT00328627|62774741|FG004|Overall Study|Physician Decision|1|||
33395487|NCT00328627|62774742|FG005|Overall Study|Physician Decision|1|||
33395488|NCT00328627|62774743|FG006|Overall Study|Physician Decision|1|||
33395489|NCT00328627|62774744|FG007|Overall Study|Physician Decision|0|||
33395490|NCT00328627|62774745|FG008|Overall Study|Physician Decision|3|||
33395491|NCT00328627|62774746|FG009|Overall Study|Physician Decision|2|||
33395492|NCT00328627|62774747|FG010|Overall Study|Physician Decision|1|||
33395493|NCT00328627|62774748|FG011|Overall Study|Physician Decision|0|||
33395494|NCT00328627|62774737|FG000|Overall Study|Other|0|||
33395495|NCT00328627|62774738|FG001|Overall Study|Other|0|||
33395496|NCT00328627|62774739|FG002|Overall Study|Other|0|||
33395497|NCT00328627|62774740|FG003|Overall Study|Other|1|||
33395498|NCT00328627|62774741|FG004|Overall Study|Other|0|||
33395499|NCT00328627|62774742|FG005|Overall Study|Other|0|||
33395500|NCT00328627|62774743|FG006|Overall Study|Other|1|||
33395501|NCT00328627|62774744|FG007|Overall Study|Other|0|||
33395502|NCT00328627|62774745|FG008|Overall Study|Other|0|||
33395503|NCT00328627|62774746|FG009|Overall Study|Other|1|||
33395504|NCT00328627|62774747|FG010|Overall Study|Other|1|||
33395505|NCT00328627|62774748|FG011|Overall Study|Other|0|||
33395506|NCT03977727|62774784|FG000|Second Treatment|Lost to Follow-up|0|||
33395507|NCT03977727|62774785|FG001|Second Treatment|Lost to Follow-up|3|||
33395508|NCT00663858|62774794|FG000|Overall Study|Adverse Event|9|||
33395509|NCT00663858|62774795|FG001|Overall Study|Adverse Event|1|||
33395510|NCT00663858|62774796|FG002|Overall Study|Adverse Event|6|||
33395511|NCT00663858|62774794|FG000|Overall Study|Lack of Efficacy|5|||
33395512|NCT00663858|62774795|FG001|Overall Study|Lack of Efficacy|1|||
33395513|NCT00663858|62774796|FG002|Overall Study|Lack of Efficacy|3|||
33395514|NCT00663858|62774794|FG000|Overall Study|Withdrawal by Subject|7|||
33395515|NCT00663858|62774795|FG001|Overall Study|Withdrawal by Subject|3|||
33395516|NCT00663858|62774796|FG002|Overall Study|Withdrawal by Subject|3|||
33567599|NCT02234323|62963464|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
33567600|NCT02234323|62963464|FG000|All Treated|Death|1|||
33567601|NCT02234323|62963464|FG000|All Treated|Physician Decision|5|||
33567602|NCT02234323|62963464|FG000|All Treated|Lack of Efficacy|3|||
33567603|NCT02234323|62963464|FG000|All Treated|Exceeded lab value limit|2|||
33567604|NCT02234323|62963464|FG000|All Treated|Other|7|||
33567605|NCT02414828|62963474|FG000|Overall Study|Lost to Follow-up|0|||
33567606|NCT02414828|62963475|FG001|Overall Study|Lost to Follow-up|1|||
33395517|NCT00663858|62774794|FG000|Overall Study|Protocol Violation|5|||
33395518|NCT00663858|62774795|FG001|Overall Study|Protocol Violation|3|||
33567607|NCT02414828|62963476|FG002|Overall Study|Lost to Follow-up|1|||
33567608|NCT02414828|62963477|FG003|Overall Study|Lost to Follow-up|2|||
33395519|NCT00663858|62774796|FG002|Overall Study|Protocol Violation|4|||
33395520|NCT00663858|62774794|FG000|Overall Study|Other|8|||
33395521|NCT00663858|62774795|FG001|Overall Study|Other|2|||
33395522|NCT00663858|62774796|FG002|Overall Study|Other|4|||
33395523|NCT00659880|62774804|FG000|Overall Study|Lost to Follow-up|5|||
33395524|NCT00683774|62774811|FG000|Overall Study|Withdrawal by Subject|0|||
33395525|NCT00683774|62774812|FG001|Overall Study|Withdrawal by Subject|1|||
33395526|NCT00683774|62774811|FG000|Overall Study|Physician Decision|3|||
33395527|NCT00683774|62774812|FG001|Overall Study|Physician Decision|0|||
33395528|NCT00354679|62774818|FG000|Overall Study|Patient Not Treated|1|||
33395529|NCT00683696|62774824|FG000|Overall Study|Withdrawn due to study closure|337|||
33395530|NCT00683696|62774825|FG001|Overall Study|Withdrawn due to study closure|338|||
33395531|NCT00683696|62774824|FG000|Overall Study|Withdrawn prior to study closure|13|||
33395532|NCT00683696|62774825|FG001|Overall Study|Withdrawn prior to study closure|28|||
33395533|NCT00683696|62774824|FG000|Overall Study|Lost to Follow-up|5|||
33395534|NCT00683696|62774825|FG001|Overall Study|Lost to Follow-up|6|||
33395535|NCT00683696|62774824|FG000|Overall Study|Vital status follow-up only|3|||
33395536|NCT00683696|62774825|FG001|Overall Study|Vital status follow-up only|3|||
33395537|NCT00683696|62774824|FG000|Overall Study|Death|46|||
33395538|NCT00683696|62774825|FG001|Overall Study|Death|30|||
33395539|NCT00345631|62774835|FG000|Overall Study|Withdrawal by Subject|1|||
33395540|NCT00345631|62774836|FG001|Overall Study|Withdrawal by Subject|0|||
33395541|NCT00345631|62774837|FG002|Overall Study|Withdrawal by Subject|1|||
33395542|NCT00345631|62774835|FG000|Overall Study|Adverse Event|0|||
33395543|NCT00345631|62774836|FG001|Overall Study|Adverse Event|1|||
33395544|NCT00345631|62774837|FG002|Overall Study|Adverse Event|0|||
33395545|NCT00345631|62774835|FG000|Overall Study|Lost to Follow-up|3|||
33395546|NCT00345631|62774836|FG001|Overall Study|Lost to Follow-up|7|||
33395547|NCT00345631|62774837|FG002|Overall Study|Lost to Follow-up|4|||
33395548|NCT00345631|62774835|FG000|Overall Study|Other reasons|0|||
33395549|NCT00345631|62774836|FG001|Overall Study|Other reasons|0|||
33395550|NCT00345631|62774837|FG002|Overall Study|Other reasons|1|||
33395551|NCT00540514|62774849|FG000|Overall Study|Still on treatment|3|||
33395552|NCT00540514|62774850|FG001|Overall Study|Still on treatment|0|||
33395553|NCT00540514|62774849|FG000|Overall Study|Unacceptable Toxicity|61|||
33395554|NCT00540514|62774850|FG001|Overall Study|Unacceptable Toxicity|62|||
33395555|NCT00540514|62774849|FG000|Overall Study|Adverse Event|20|||
33395556|NCT00540514|62774850|FG001|Overall Study|Adverse Event|24|||
33395557|NCT00540514|62774849|FG000|Overall Study|Physician Decision|86|||
33395558|NCT00540514|62774850|FG001|Overall Study|Physician Decision|99|||
33395559|NCT00540514|62774849|FG000|Overall Study|Protocol Deviation|3|||
33395560|NCT00540514|62774850|FG001|Overall Study|Protocol Deviation|4|||
33395561|NCT00540514|62774849|FG000|Overall Study|Lost to Follow-up|1|||
33395562|NCT00540514|62774850|FG001|Overall Study|Lost to Follow-up|1|||
33395563|NCT00540514|62774849|FG000|Overall Study|Withdrawal by Subject|65|||
33395564|NCT00540514|62774850|FG001|Overall Study|Withdrawal by Subject|67|||
33395565|NCT00540514|62774849|FG000|Overall Study|Excluded prior to treatment|7|||
33395566|NCT00540514|62774850|FG001|Overall Study|Excluded prior to treatment|7|||
33395567|NCT00540514|62774849|FG000|Overall Study|Paclitaxel not available|0|||
33395568|NCT00540514|62774850|FG001|Overall Study|Paclitaxel not available|2|||
33395569|NCT00663702|62774859|FG000|Overall Study|Adverse Event|8|||
33395570|NCT00663702|62774860|FG001|Overall Study|Adverse Event|4|||
33395571|NCT00663702|62774859|FG000|Overall Study|Withdrawal by Subject|3|||
33395572|NCT00663702|62774860|FG001|Overall Study|Withdrawal by Subject|1|||
33395573|NCT00663702|62774859|FG000|Overall Study|Pregnancy|0|||
33395574|NCT00663702|62774860|FG001|Overall Study|Pregnancy|1|||
33395575|NCT00663702|62774859|FG000|Overall Study|Lost to Follow-up|3|||
33395576|NCT00663702|62774860|FG001|Overall Study|Lost to Follow-up|0|||
33395577|NCT00663702|62774859|FG000|Overall Study|Death|1|||
33395578|NCT00663702|62774860|FG001|Overall Study|Death|1|||
33395579|NCT00663702|62774859|FG000|Overall Study|Lack of Efficacy|3|||
33395580|NCT00663702|62774860|FG001|Overall Study|Lack of Efficacy|3|||
33395581|NCT00683618|62774869|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
33395582|NCT00683618|62774870|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
33395583|NCT00683618|62774871|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
33395584|NCT00683618|62774869|FG000|Randomised Treatment Period|Protocol Violation|0|||
33395585|NCT00683618|62774870|FG001|Randomised Treatment Period|Protocol Violation|1|||
33395586|NCT00683618|62774871|FG002|Randomised Treatment Period|Protocol Violation|0|||
33395587|NCT00683618|62774869|FG000|Randomised Treatment Period|Adverse Event|2|||
33302722|NCT01253187|62678501|FG004|Period 2|Withdrawal by Subject|1|||
33302723|NCT01253187|62678502|FG005|Period 2|Withdrawal by Subject|0|||
33302724|NCT01253187|62678497|FG000|Period 3|Pregnancy|1|||
33302725|NCT01253187|62678498|FG001|Period 3|Pregnancy|0|||
33302726|NCT01253187|62678499|FG002|Period 3|Pregnancy|0|||
33302727|NCT01253187|62678500|FG003|Period 3|Pregnancy|0|||
33302728|NCT01253187|62678501|FG004|Period 3|Pregnancy|0|||
33302729|NCT01253187|62678502|FG005|Period 3|Pregnancy|0|||
33395588|NCT00683618|62774870|FG001|Randomised Treatment Period|Adverse Event|0|||
33395589|NCT00683618|62774871|FG002|Randomised Treatment Period|Adverse Event|2|||
33395590|NCT00683618|62774869|FG000|Randomised Treatment Period|Reason not provided|0|||
33395591|NCT00683618|62774870|FG001|Randomised Treatment Period|Reason not provided|0|||
33395592|NCT00683618|62774871|FG002|Randomised Treatment Period|Reason not provided|2|||
33395593|NCT00683618|62774869|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
33395594|NCT00683618|62774870|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
33395595|NCT00683618|62774871|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
33395596|NCT00683618|62774869|FG000|Extension Treatment Period|Adverse Event|1|||
33395597|NCT00683618|62774870|FG001|Extension Treatment Period|Adverse Event|0|||
33567609|NCT02413346|62963490|FG000|Overall Study|Adverse Event|6|||
33302730|NCT01253187|62678497|FG000|Period 3|difficulty with blood sampling|0|||
33302731|NCT01253187|62678498|FG001|Period 3|difficulty with blood sampling|1|||
33302732|NCT01253187|62678499|FG002|Period 3|difficulty with blood sampling|0|||
33395598|NCT00683618|62774871|FG002|Extension Treatment Period|Adverse Event|0|||
33302733|NCT01253187|62678500|FG003|Period 3|difficulty with blood sampling|0|||
33302734|NCT01253187|62678501|FG004|Period 3|difficulty with blood sampling|0|||
33302735|NCT01253187|62678502|FG005|Period 3|difficulty with blood sampling|0|||
33302736|NCT01253187|62678497|FG000|Period 3|non-compliance|0|||
33302737|NCT01253187|62678498|FG001|Period 3|non-compliance|0|||
33302738|NCT01253187|62678499|FG002|Period 3|non-compliance|0|||
33302739|NCT01253187|62678500|FG003|Period 3|non-compliance|0|||
33302740|NCT01253187|62678501|FG004|Period 3|non-compliance|1|||
33302741|NCT01253187|62678502|FG005|Period 3|non-compliance|0|||
33395599|NCT00683618|62774869|FG000|Extension Treatment Period|Protocol Violation|1|||
33395600|NCT00683618|62774870|FG001|Extension Treatment Period|Protocol Violation|0|||
33395601|NCT00683618|62774871|FG002|Extension Treatment Period|Protocol Violation|0|||
33395602|NCT00688064|62774883|FG000|Overall Study|Protocol Violation|0|||
33395603|NCT00688064|62774884|FG001|Overall Study|Protocol Violation|1|||
33395604|NCT00688064|62774883|FG000|Overall Study|Adverse Event|2|||
33395605|NCT00688064|62774884|FG001|Overall Study|Adverse Event|4|||
33395606|NCT00688064|62774883|FG000|Overall Study|Withdrawal by Subject|7|||
33395607|NCT00688064|62774884|FG001|Overall Study|Withdrawal by Subject|7|||
33395608|NCT00688064|62774883|FG000|Overall Study|Lost to Follow-up|10|||
33395609|NCT00688064|62774884|FG001|Overall Study|Lost to Follow-up|10|||
33395610|NCT00688064|62774883|FG000|Overall Study|Lack of Efficacy|0|||
33395611|NCT00688064|62774884|FG001|Overall Study|Lack of Efficacy|1|||
33395612|NCT00688064|62774883|FG000|Overall Study|Pregnancy|1|||
33395613|NCT00688064|62774884|FG001|Overall Study|Pregnancy|0|||
33395614|NCT00688064|62774883|FG000|Overall Study|Any other reasons|1|||
33395615|NCT00688064|62774884|FG001|Overall Study|Any other reasons|3|||
33395616|NCT00663234|62774890|FG000|Overall Study|Not willing to adhere to requirements|1|||
33395617|NCT00683384|62774898|FG000|Overall Study|Death|1|||
33395618|NCT00683384|62774898|FG000|Overall Study|Adverse Event|1|||
33395619|NCT00326911|62774904|FG000|Overall Study|Hospitalization prior to treatment|0|||
33395620|NCT00326911|62774905|FG001|Overall Study|Hospitalization prior to treatment|1|||
33395621|NCT00326911|62774904|FG000|Overall Study|Physician decision prior to treatment|1|||
33395622|NCT00326911|62774905|FG001|Overall Study|Physician decision prior to treatment|0|||
33395623|NCT00326911|62774904|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
33395624|NCT00326911|62774905|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
33395625|NCT00540436|62774911|FG000|First 12-Week Treatment Period|Adverse Event|1|||
33395626|NCT00540436|62774911|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
33395627|NCT00540436|62774911|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
33395628|NCT00540436|62774911|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
33395629|NCT00687440|62774915|FG000|Overall Study|Adverse Event|3|||
33567610|NCT02413346|62963491|FG001|Overall Study|Adverse Event|6|||
33567611|NCT02413346|62963490|FG000|Overall Study|Withdrawal by Subject|30|||
33567612|NCT02413346|62963491|FG001|Overall Study|Withdrawal by Subject|40|||
33567613|NCT02413346|62963490|FG000|Overall Study|Lost to Follow-up|17|||
33395630|NCT00687440|62774915|FG000|Overall Study|Lost to Follow-up|3|||
33395631|NCT00687440|62774915|FG000|Overall Study|Lack of Efficacy|2|||
33567614|NCT02413346|62963491|FG001|Overall Study|Lost to Follow-up|21|||
33567615|NCT02413346|62963490|FG000|Overall Study|Protocol Violation|2|||
33567616|NCT02413346|62963491|FG001|Overall Study|Protocol Violation|0|||
33567617|NCT02413346|62963490|FG000|Overall Study|Other Miscellaneous Reasons|4|||
33567618|NCT02413346|62963491|FG001|Overall Study|Other Miscellaneous Reasons|3|||
33567619|NCT03390101|62963504|FG000|Weeks 0-12|Withdrawal by Subject|0|||
33567620|NCT03390101|62963505|FG001|Weeks 0-12|Withdrawal by Subject|1|||
33567621|NCT03390101|62963506|FG002|Weeks 0-12|Withdrawal by Subject|1|||
33567622|NCT03390101|62963504|FG000|Weeks 0-12|Lost to Follow-up|0|||
33567623|NCT03390101|62963505|FG001|Weeks 0-12|Lost to Follow-up|1|||
33395632|NCT00687440|62774915|FG000|Overall Study|Death|2|||
33395633|NCT00687440|62774915|FG000|Overall Study|Other|1|||
33395634|NCT00687440|62774915|FG000|Overall Study|Missing|1|||
33395635|NCT00659490|62774922|FG000|Overall Study|Lost to Follow-up|2|||
33395636|NCT00659490|62774923|FG001|Overall Study|Lost to Follow-up|0|||
33395637|NCT00659490|62774924|FG002|Overall Study|Lost to Follow-up|1|||
33395638|NCT00539500|62774932|FG000|Overall Study|Disease Progression|1|||
33395639|NCT00539500|62774932|FG000|Overall Study|Lost to Follow-up|2|||
33395640|NCT00662532|62774938|FG000|Overall Study|Adverse Event|0|||
33567624|NCT03390101|62963506|FG002|Weeks 0-12|Lost to Follow-up|0|||
33567625|NCT03390101|62963504|FG000|Weeks 12-54|Withdrawal by Subject|0|||
33567626|NCT03390101|62963505|FG001|Weeks 12-54|Withdrawal by Subject|3|||
33395641|NCT00662532|62774939|FG001|Overall Study|Adverse Event|1|||
33395642|NCT00662532|62774938|FG000|Overall Study|Lost to Follow-up|0|||
33567627|NCT03390101|62963506|FG002|Weeks 12-54|Withdrawal by Subject|1|||
33567628|NCT03390101|62963504|FG000|Weeks 12-54|Pregnancy|1|||
33567629|NCT03390101|62963505|FG001|Weeks 12-54|Pregnancy|0|||
33567630|NCT03390101|62963506|FG002|Weeks 12-54|Pregnancy|0|||
33302742|NCT01252563|62678513|FG000|Overall Study|Contract Deviation|41|||
33302743|NCT01252563|62678513|FG000|Overall Study|Centralized Registration Deviation|30|||
33302744|NCT01252563|62678513|FG000|Overall Study|Lost to Follow-up|161|||
33567631|NCT03390101|62963504|FG000|Weeks 12-54|Adverse Event|2|||
33567632|NCT03390101|62963505|FG001|Weeks 12-54|Adverse Event|1|||
33395643|NCT00662532|62774939|FG001|Overall Study|Lost to Follow-up|1|||
33395644|NCT00686036|62774947|FG000|Overall Study|Adverse Event|3|||
33395645|NCT00686036|62774948|FG001|Overall Study|Adverse Event|0|||
33395646|NCT00686036|62774947|FG000|Overall Study|Withdrawal by Subject|3|||
33395647|NCT00686036|62774948|FG001|Overall Study|Withdrawal by Subject|1|||
33395648|NCT00686036|62774947|FG000|Overall Study|Study terminated by AstraZeneca|2|||
33395649|NCT00686036|62774948|FG001|Overall Study|Study terminated by AstraZeneca|1|||
33395650|NCT00686036|62774947|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
33395651|NCT00686036|62774948|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
33395652|NCT00686036|62774947|FG000|Overall Study|Other reasons not identified|0|||
33395653|NCT00686036|62774948|FG001|Overall Study|Other reasons not identified|4|||
33395654|NCT00682448|62774956|FG000|Overall Study|Adverse Event|1|||
33395655|NCT00682448|62774957|FG001|Overall Study|Adverse Event|2|||
33395656|NCT00682448|62774956|FG000|Overall Study|Lack of Efficacy|1|||
33395657|NCT00682448|62774957|FG001|Overall Study|Lack of Efficacy|0|||
33395658|NCT00682448|62774956|FG000|Overall Study|Lost to Follow-up|1|||
33395659|NCT00682448|62774957|FG001|Overall Study|Lost to Follow-up|3|||
33395660|NCT00682448|62774956|FG000|Overall Study|Pregnancy|0|||
33395661|NCT00682448|62774957|FG001|Overall Study|Pregnancy|1|||
33395662|NCT00682448|62774956|FG000|Overall Study|Withdrawal by Subject|2|||
33395663|NCT00682448|62774957|FG001|Overall Study|Withdrawal by Subject|0|||
33395664|NCT00681824|62774966|FG000|Overall Study|withdrawn by investigator|0|||
33395665|NCT00681824|62774967|FG001|Overall Study|withdrawn by investigator|0|||
33395666|NCT00681824|62774968|FG002|Overall Study|withdrawn by investigator|1|||
33395667|NCT00681824|62774966|FG000|Overall Study|scheduling conflict|1|||
33395668|NCT00681824|62774967|FG001|Overall Study|scheduling conflict|0|||
33395669|NCT00681824|62774968|FG002|Overall Study|scheduling conflict|0|||
33395670|NCT00681824|62774966|FG000|Overall Study|Death|0|||
33395671|NCT00681824|62774967|FG001|Overall Study|Death|1|||
33395672|NCT00681824|62774968|FG002|Overall Study|Death|0|||
33395673|NCT00681668|62774976|FG000|Overall Study|Protocol Violation|1|||
33395674|NCT00681668|62774976|FG000|Overall Study|Withdrawal by Subject|1|||
33395675|NCT00539188|62774982|FG000|Overall Study|Withdrawal by Subject|1|||
33395676|NCT00539188|62774983|FG001|Overall Study|Withdrawal by Subject|0|||
33395677|NCT00539188|62774982|FG000|Overall Study|Lost to Follow-up|2|||
33395678|NCT00539188|62774983|FG001|Overall Study|Lost to Follow-up|1|||
33395679|NCT00681590|62774991|FG000|Overall Study|Withdrawal by Subject|2|||
33395680|NCT00681590|62774992|FG001|Overall Study|Withdrawal by Subject|12|||
33395681|NCT04980456|62775000|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
33395682|NCT04980456|62775001|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
33395683|NCT04980456|62775000|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
33395684|NCT04980456|62775001|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
33395685|NCT04980456|62775000|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
33395686|NCT04980456|62775001|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
33395687|NCT04980456|62775000|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
33395688|NCT04980456|62775001|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
33395689|NCT00326599|62775014|FG000|Overall Study|Withdrawal by Subject|1|||
33395690|NCT00326599|62775015|FG001|Overall Study|Withdrawal by Subject|0|||
33395691|NCT00326599|62775016|FG002|Overall Study|Withdrawal by Subject|5|||
33395692|NCT00326599|62775017|FG003|Overall Study|Withdrawal by Subject|2|||
33395693|NCT00326599|62775014|FG000|Overall Study|Adverse Event|1|||
33395694|NCT00326599|62775015|FG001|Overall Study|Adverse Event|0|||
33395695|NCT00326599|62775016|FG002|Overall Study|Adverse Event|32|||
33395696|NCT00326599|62775017|FG003|Overall Study|Adverse Event|3|||
33395697|NCT00326599|62775014|FG000|Overall Study|Disease Progression|3|||
33395698|NCT00326599|62775015|FG001|Overall Study|Disease Progression|1|||
33395699|NCT00326599|62775016|FG002|Overall Study|Disease Progression|13|||
33395700|NCT00326599|62775017|FG003|Overall Study|Disease Progression|11|||
33395701|NCT00326599|62775014|FG000|Overall Study|Alternate Treatment|1|||
33395702|NCT00326599|62775015|FG001|Overall Study|Alternate Treatment|0|||
33395703|NCT00326599|62775016|FG002|Overall Study|Alternate Treatment|0|||
33664153|NCT02681094|63095176|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
33395704|NCT00326599|62775017|FG003|Overall Study|Alternate Treatment|0|||
33395705|NCT00326599|62775014|FG000|Overall Study|Death|0|||
33395706|NCT00326599|62775015|FG001|Overall Study|Death|0|||
33395707|NCT00326599|62775016|FG002|Overall Study|Death|1|||
33395708|NCT00326599|62775017|FG003|Overall Study|Death|2|||
33395709|NCT00326599|62775014|FG000|Overall Study|Other Unspecified Reason|0|||
33395710|NCT00326599|62775015|FG001|Overall Study|Other Unspecified Reason|0|||
33395711|NCT00326599|62775016|FG002|Overall Study|Other Unspecified Reason|2|||
33395712|NCT00326599|62775017|FG003|Overall Study|Other Unspecified Reason|1|||
33395713|NCT00539032|62775028|FG000|Overall Study|Withdrawal by Subject|2|||
33395714|NCT00539032|62775029|FG001|Overall Study|Withdrawal by Subject|1|||
33395715|NCT00685802|62775035|FG000|Washout Period of 7 Days|Protocol Violation|2|||
33395716|NCT00685802|62775036|FG001|Washout Period of 7 Days|Protocol Violation|0|||
33395717|NCT00685802|62775035|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
33395718|NCT00685802|62775036|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33395719|NCT00354601|62775042|FG000|Overall Study|Protocol Violation|1|||
33395720|NCT00354601|62775042|FG000|Overall Study|progression|1|||
33395721|NCT03827473|62775048|FG000|Overall Study|Withdrawal by Subject|1|||
33395722|NCT03827473|62775049|FG001|Overall Study|Withdrawal by Subject|0|||
33395723|NCT00345397|62775055|FG000|Overall Study|Death|1|||
33395724|NCT00326209|62775060|FG000|Overall Study|Adverse Event|28|||
33395725|NCT00326209|62775060|FG000|Overall Study|Withdrawal by Subject|22|||
33395726|NCT00326209|62775060|FG000|Overall Study|Lack of Efficacy|31|||
33395727|NCT00326209|62775060|FG000|Overall Study|Lost to Follow-up|18|||
33395728|NCT00326209|62775060|FG000|Overall Study|Participant non-compliant|6|||
33395729|NCT00326209|62775060|FG000|Overall Study|Sponsor closed study|173|||
33395730|NCT00326209|62775060|FG000|Overall Study|Prohibited medication use|1|||
33395731|NCT00326209|62775060|FG000|Overall Study|Violation of entry criteria|1|||
33395732|NCT00326209|62775060|FG000|Overall Study|Withdrawn in error|1|||
33395733|NCT00326209|62775060|FG000|Overall Study|Pregnancy|1|||
33395734|NCT00537940|62775066|FG000|Overall Study|Adverse Event|20|||
33395735|NCT00537940|62775067|FG001|Overall Study|Adverse Event|19|||
33395736|NCT00537940|62775066|FG000|Overall Study|Lack of Efficacy|8|||
33395737|NCT00537940|62775067|FG001|Overall Study|Lack of Efficacy|16|||
33395738|NCT00537940|62775066|FG000|Overall Study|Lost to Follow-up|23|||
33395739|NCT00537940|62775067|FG001|Overall Study|Lost to Follow-up|29|||
33395740|NCT00537940|62775066|FG000|Overall Study|Withdrawal by Subject|113|||
33395741|NCT00537940|62775067|FG001|Overall Study|Withdrawal by Subject|95|||
33395742|NCT00537940|62775066|FG000|Overall Study|Protocol Violation|6|||
33395743|NCT00537940|62775067|FG001|Overall Study|Protocol Violation|4|||
33395744|NCT00537940|62775066|FG000|Overall Study|Pregnancy|1|||
33395745|NCT00537940|62775067|FG001|Overall Study|Pregnancy|1|||
33395746|NCT00537940|62775066|FG000|Overall Study|Study terminated by sponsor|2|||
33395747|NCT00537940|62775067|FG001|Overall Study|Study terminated by sponsor|3|||
33395748|NCT00537940|62775066|FG000|Overall Study|Other|10|||
33395749|NCT00537940|62775067|FG001|Overall Study|Other|12|||
33395750|NCT00661362|62775075|FG000|Overall Study|Adverse Event|5|||
33395751|NCT00661362|62775076|FG001|Overall Study|Adverse Event|4|||
33395752|NCT00661362|62775075|FG000|Overall Study|Incorrect enrollment|2|||
33395753|NCT00661362|62775076|FG001|Overall Study|Incorrect enrollment|0|||
33395754|NCT00661362|62775075|FG000|Overall Study|Study specific discontinuation criteria|4|||
33395755|NCT00661362|62775076|FG001|Overall Study|Study specific discontinuation criteria|11|||
33395756|NCT00661362|62775075|FG000|Overall Study|Withdrawal by Subject|13|||
33395757|NCT00661362|62775076|FG001|Overall Study|Withdrawal by Subject|23|||
33395758|NCT00661362|62775075|FG000|Overall Study|Lost to Follow-up|3|||
33395759|NCT00661362|62775076|FG001|Overall Study|Lost to Follow-up|1|||
33395760|NCT00661362|62775075|FG000|Overall Study|Severe non-compliance to protocol|0|||
33395761|NCT00661362|62775076|FG001|Overall Study|Severe non-compliance to protocol|1|||
33395762|NCT00661362|62775075|FG000|Overall Study|Safety reasons|1|||
33395763|NCT00661362|62775076|FG001|Overall Study|Safety reasons|0|||
33395764|NCT00661362|62775075|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
33395765|NCT00661362|62775076|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
33395766|NCT00325897|62775084|FG000|Overall Study|Lost to Follow-up|12|||
33395767|NCT00325897|62775085|FG001|Overall Study|Lost to Follow-up|13|||
33395768|NCT00344773|62775094|FG000|Overall Study|Adverse Event|2|||
33395769|NCT00344773|62775094|FG000|Overall Study|Objective Disease Progression|16|||
33395770|NCT00344773|62775094|FG000|Overall Study|Withdrawal by Subject|1|||
33395771|NCT00344773|62775094|FG000|Overall Study|Not Eligible for the study|2|||
33395772|NCT00325819|62775100|FG000|Overall Study|Study product lost in mail|2|||
33395773|NCT00325819|62775101|FG001|Overall Study|Study product lost in mail|1|||
33395774|NCT00325819|62775100|FG000|Overall Study|Did not take a dose of study product|4|||
33395775|NCT00325819|62775101|FG001|Overall Study|Did not take a dose of study product|9|||
33395776|NCT00325819|62775100|FG000|Overall Study|Lost to Follow-up|3|||
33395777|NCT00325819|62775101|FG001|Overall Study|Lost to Follow-up|3|||
33395778|NCT00687362|62775109|FG000|Overall Study|Protocol Violation|2|||
33395779|NCT00687362|62775109|FG000|Overall Study|Withdrawal by Subject|1|||
33395780|NCT00325195|62775116|FG000|Randomized|Not dosed|5|||
33395781|NCT00325195|62775117|FG001|Randomized|Not dosed|5|||
33395782|NCT00325195|62775118|FG002|Randomized|Not dosed|3|||
33395783|NCT00325195|62775116|FG000|Received Intervention: ITT Population|Adverse Event|15|||
33395784|NCT00325195|62775117|FG001|Received Intervention: ITT Population|Adverse Event|17|||
33395785|NCT00325195|62775118|FG002|Received Intervention: ITT Population|Adverse Event|1|||
33395786|NCT00325195|62775116|FG000|Received Intervention: ITT Population|Death|3|||
33395787|NCT00325195|62775117|FG001|Received Intervention: ITT Population|Death|1|||
33395788|NCT00325195|62775118|FG002|Received Intervention: ITT Population|Death|0|||
33395789|NCT00325195|62775116|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
33395790|NCT00325195|62775117|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
33395791|NCT00325195|62775118|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
33395792|NCT00325195|62775116|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
33395793|NCT00325195|62775117|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
33395794|NCT00325195|62775118|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
33395795|NCT00325195|62775116|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
33395796|NCT00325195|62775117|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
33395797|NCT00325195|62775118|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
33395798|NCT03976401|62775132|FG000|Overall Study|Adverse Event|2|||
33395799|NCT03976401|62775133|FG001|Overall Study|Adverse Event|0|||
33395800|NCT03976401|62775134|FG002|Overall Study|Adverse Event|4|||
33395801|NCT03976401|62775135|FG003|Overall Study|Adverse Event|1|||
33395802|NCT03976401|62775136|FG004|Overall Study|Adverse Event|1|||
33395803|NCT03976401|62775137|FG005|Overall Study|Adverse Event|0|||
33395804|NCT03976401|62775132|FG000|Overall Study|Withdrawal by Subject|0|||
33395805|NCT03976401|62775133|FG001|Overall Study|Withdrawal by Subject|1|||
33395806|NCT03976401|62775134|FG002|Overall Study|Withdrawal by Subject|0|||
33395807|NCT03976401|62775135|FG003|Overall Study|Withdrawal by Subject|0|||
33395808|NCT03976401|62775136|FG004|Overall Study|Withdrawal by Subject|0|||
33395809|NCT03976401|62775137|FG005|Overall Study|Withdrawal by Subject|1|||
33395810|NCT03976401|62775132|FG000|Overall Study|Physician Decision|0|||
33395811|NCT03976401|62775133|FG001|Overall Study|Physician Decision|0|||
33395812|NCT03976401|62775134|FG002|Overall Study|Physician Decision|1|||
33395813|NCT03976401|62775135|FG003|Overall Study|Physician Decision|0|||
33395814|NCT03976401|62775136|FG004|Overall Study|Physician Decision|0|||
33395815|NCT03976401|62775137|FG005|Overall Study|Physician Decision|0|||
33395816|NCT03976401|62775132|FG000|Overall Study|Lost to Follow-up|1|||
33395817|NCT03976401|62775133|FG001|Overall Study|Lost to Follow-up|2|||
33395818|NCT03976401|62775134|FG002|Overall Study|Lost to Follow-up|0|||
33395819|NCT03976401|62775135|FG003|Overall Study|Lost to Follow-up|0|||
33395820|NCT03976401|62775136|FG004|Overall Study|Lost to Follow-up|0|||
33395821|NCT03976401|62775137|FG005|Overall Study|Lost to Follow-up|0|||
33395822|NCT03976401|62775132|FG000|Overall Study|Protocol Violation|0|||
33395823|NCT03976401|62775133|FG001|Overall Study|Protocol Violation|1|||
33395824|NCT03976401|62775134|FG002|Overall Study|Protocol Violation|0|||
33395825|NCT03976401|62775135|FG003|Overall Study|Protocol Violation|0|||
33395826|NCT03976401|62775136|FG004|Overall Study|Protocol Violation|0|||
33395827|NCT03976401|62775137|FG005|Overall Study|Protocol Violation|0|||
33395828|NCT03976401|62775132|FG000|Overall Study|Withdrew Consent|0|||
33395829|NCT03976401|62775133|FG001|Overall Study|Withdrew Consent|0|||
33395830|NCT03976401|62775134|FG002|Overall Study|Withdrew Consent|0|||
33395831|NCT03976401|62775135|FG003|Overall Study|Withdrew Consent|1|||
33395832|NCT03976401|62775136|FG004|Overall Study|Withdrew Consent|0|||
33395833|NCT03976401|62775137|FG005|Overall Study|Withdrew Consent|0|||
33395834|NCT00685334|62775153|FG000|Overall Study|Withdrawal by Subject|5|||
33395835|NCT00685334|62775154|FG001|Overall Study|Withdrawal by Subject|6|||
33395836|NCT00685334|62775153|FG000|Overall Study|Lost to Follow-up|4|||
33395837|NCT00685334|62775154|FG001|Overall Study|Lost to Follow-up|0|||
33395838|NCT00685334|62775153|FG000|Overall Study|Chose to enter hospital|1|||
33395839|NCT00685334|62775154|FG001|Overall Study|Chose to enter hospital|1|||
33395840|NCT00325039|62775162|FG000|Overall Study|Lost to Follow-up|18|||
33395841|NCT00325039|62775163|FG001|Overall Study|Lost to Follow-up|14|||
33395842|NCT00344461|62775169|FG000|Overall Study|Adverse Event|6|||
33395843|NCT00344461|62775169|FG000|Overall Study|Death|1|||
33395844|NCT00344461|62775169|FG000|Overall Study|Lack of Efficacy|2|||
33395845|NCT00344461|62775169|FG000|Overall Study|Lost to Follow-up|2|||
33395846|NCT00344461|62775169|FG000|Overall Study|Physician Decision|2|||
33395847|NCT00344461|62775169|FG000|Overall Study|Protocol Violation|6|||
33395848|NCT00344461|62775169|FG000|Overall Study|Withdrawal by Subject|2|||
33395849|NCT00685178|62775178|FG000|Overall Study|Adverse Event|1|||
33395850|NCT00685178|62775179|FG001|Overall Study|Adverse Event|5|||
33395851|NCT00685178|62775180|FG002|Overall Study|Adverse Event|2|||
33395852|NCT00685178|62775181|FG003|Overall Study|Adverse Event|4|||
33395853|NCT00685178|62775178|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
33395854|NCT00685178|62775179|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
33395855|NCT00685178|62775180|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
33395856|NCT00685178|62775181|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
33395857|NCT00685178|62775178|FG000|Overall Study|voluntary study discharge|4|||
33395858|NCT00685178|62775179|FG001|Overall Study|voluntary study discharge|5|||
33567633|NCT03390101|62963506|FG002|Weeks 12-54|Adverse Event|1|||
33567634|NCT02732639|62963514|FG000|Overall Study|Lost to Follow-up|1|||
33567635|NCT02732561|62963520|FG000|Overall Study|Lost to Follow-up|1|||
33567636|NCT02732561|62963521|FG001|Overall Study|Lost to Follow-up|1|||
33567637|NCT02732561|62963520|FG000|Overall Study|Withdrawal by Subject|1|||
33567638|NCT02732561|62963521|FG001|Overall Study|Withdrawal by Subject|0|||
33567639|NCT02412878|62963529|FG000|Overall Study|Withdrawal by Subject|19|||
33395859|NCT00685178|62775180|FG002|Overall Study|voluntary study discharge|1|||
33395860|NCT00685178|62775181|FG003|Overall Study|voluntary study discharge|1|||
33395861|NCT00685178|62775178|FG000|Overall Study|incarcerated|1|||
33567640|NCT02412878|62963530|FG001|Overall Study|Withdrawal by Subject|10|||
33395862|NCT00685178|62775179|FG001|Overall Study|incarcerated|3|||
33395863|NCT00685178|62775180|FG002|Overall Study|incarcerated|7|||
33567641|NCT02412878|62963529|FG000|Overall Study|Lost to Follow-up|2|||
33395864|NCT00685178|62775181|FG003|Overall Study|incarcerated|0|||
33395865|NCT00685178|62775178|FG000|Overall Study|administrative (disciplinary) discharge|0|||
33395866|NCT00685178|62775179|FG001|Overall Study|administrative (disciplinary) discharge|1|||
33395867|NCT00685178|62775180|FG002|Overall Study|administrative (disciplinary) discharge|0|||
33395868|NCT00685178|62775181|FG003|Overall Study|administrative (disciplinary) discharge|2|||
33395869|NCT00685178|62775178|FG000|Overall Study|Pregnancy|0|||
33395870|NCT00685178|62775179|FG001|Overall Study|Pregnancy|0|||
33395871|NCT00685178|62775180|FG002|Overall Study|Pregnancy|0|||
33395872|NCT00685178|62775181|FG003|Overall Study|Pregnancy|1|||
33395873|NCT00537394|62775194|FG000|First Year of Follow-up|Death|7|||
33395874|NCT00537394|62775195|FG001|First Year of Follow-up|Death|0|||
33395875|NCT00537394|62775196|FG002|First Year of Follow-up|Death|0|||
33395876|NCT00537394|62775194|FG000|First Year of Follow-up|Severe debilitation|1|||
33395877|NCT00537394|62775195|FG001|First Year of Follow-up|Severe debilitation|0|||
33395878|NCT00537394|62775196|FG002|First Year of Follow-up|Severe debilitation|1|||
33395879|NCT00537394|62775194|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
33395880|NCT00537394|62775195|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
33395881|NCT00537394|62775196|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
33395882|NCT00537394|62775194|FG000|First Year of Follow-up|Lost to Follow-up|1|||
33395883|NCT00537394|62775195|FG001|First Year of Follow-up|Lost to Follow-up|5|||
33395884|NCT00537394|62775196|FG002|First Year of Follow-up|Lost to Follow-up|1|||
33395885|NCT00537394|62775194|FG000|2nd Year of Follow-up|Death|4|||
33395886|NCT00537394|62775195|FG001|2nd Year of Follow-up|Death|1|||
33395887|NCT00537394|62775196|FG002|2nd Year of Follow-up|Death|2|||
33395888|NCT00537394|62775194|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
33395889|NCT00537394|62775195|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
33395890|NCT00537394|62775196|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
33395891|NCT00537394|62775194|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
33395892|NCT00537394|62775195|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
33395893|NCT00537394|62775196|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
33395894|NCT00537394|62775194|FG000|2nd Year of Follow-up|Clinic site closure|1|||
33395895|NCT00537394|62775195|FG001|2nd Year of Follow-up|Clinic site closure|0|||
33395896|NCT00537394|62775196|FG002|2nd Year of Follow-up|Clinic site closure|0|||
33395897|NCT00352885|62775204|FG000|Overall Study|Withdrawal by Subject|0|||
33395898|NCT00352885|62775205|FG001|Overall Study|Withdrawal by Subject|3|||
33395899|NCT00352885|62775204|FG000|Overall Study|Development of major depression|0|||
33395900|NCT00352885|62775205|FG001|Overall Study|Development of major depression|1|||
33395901|NCT00352885|62775204|FG000|Overall Study|Progression of metastatic melanoma|5|||
33395902|NCT00352885|62775205|FG001|Overall Study|Progression of metastatic melanoma|3|||
33395903|NCT00352885|62775204|FG000|Overall Study|Side effects of IL-2 administration|1|||
33395904|NCT00352885|62775205|FG001|Overall Study|Side effects of IL-2 administration|0|||
33395905|NCT00660660|62775213|FG000|Overall Study|Adverse Event|1|||
33395906|NCT00660660|62775214|FG001|Overall Study|Adverse Event|0|||
33395907|NCT00660660|62775213|FG000|Overall Study|Lost to Follow-up|0|||
33395908|NCT00660660|62775214|FG001|Overall Study|Lost to Follow-up|6|||
33395909|NCT00660660|62775213|FG000|Overall Study|Lack of Efficacy|0|||
33395910|NCT00660660|62775214|FG001|Overall Study|Lack of Efficacy|2|||
33395911|NCT00660660|62775213|FG000|Overall Study|Withdrawal by Subject|3|||
33395912|NCT00660660|62775214|FG001|Overall Study|Withdrawal by Subject|0|||
33395913|NCT00660660|62775213|FG000|Overall Study|Incorrect enrollment and other|0|||
33395914|NCT00660660|62775214|FG001|Overall Study|Incorrect enrollment and other|1|||
33395915|NCT00660660|62775213|FG000|Overall Study|New medication after randomization|1|||
33395916|NCT00660660|62775214|FG001|Overall Study|New medication after randomization|0|||
33395917|NCT00344305|62775222|FG000|Overall Study|Lost to Follow-up|2|||
33395918|NCT00344305|62775223|FG001|Overall Study|Lost to Follow-up|0|||
33395919|NCT00344305|62775222|FG000|Overall Study|Participant was not contacted in window|0|||
33395920|NCT00344305|62775223|FG001|Overall Study|Participant was not contacted in window|1|||
33395921|NCT00660816|62775232|FG000|Overall Study|Adverse Event|1|||
33395922|NCT00660816|62775233|FG001|Overall Study|Adverse Event|2|||
33395923|NCT00660816|62775232|FG000|Overall Study|Withdrawal by Subject|1|||
33395924|NCT00660816|62775233|FG001|Overall Study|Withdrawal by Subject|0|||
33395925|NCT00660816|62775232|FG000|Overall Study|Death|0|||
33395926|NCT00660816|62775233|FG001|Overall Study|Death|2|||
33395927|NCT00660816|62775232|FG000|Overall Study|Lack of Efficacy|1|||
33395928|NCT00660816|62775233|FG001|Overall Study|Lack of Efficacy|0|||
33395929|NCT00660816|62775232|FG000|Overall Study|Physician Decision|0|||
33395930|NCT00660816|62775233|FG001|Overall Study|Physician Decision|2|||
33395931|NCT00660816|62775232|FG000|Overall Study|Protocol Violation|1|||
33395932|NCT00660816|62775233|FG001|Overall Study|Protocol Violation|0|||
33395933|NCT00660816|62775232|FG000|Overall Study|Disease Progression|16|||
33395934|NCT00660816|62775233|FG001|Overall Study|Disease Progression|12|||
33395935|NCT00660816|62775232|FG000|Overall Study|Complicating Disease|0|||
33395936|NCT00660816|62775233|FG001|Overall Study|Complicating Disease|1|||
33395937|NCT00576056|62775239|FG000|Overall Study|Adverse Event|1|||
33395938|NCT00576056|62775239|FG000|Overall Study|Death|1|||
33395939|NCT00576056|62775239|FG000|Overall Study|Lack of Efficacy|1|||
33395940|NCT00576056|62775239|FG000|Overall Study|Withdrawal by Subject|2|||
33395941|NCT00576056|62775239|FG000|Overall Study|did not meet eligibility criteria|8|||
33395942|NCT00576056|62775239|FG000|Overall Study|Physician Decision|1|||
33395943|NCT00575510|62775246|FG000|Overall Study|Lost to Follow-up|4|||
33395944|NCT00575510|62775247|FG001|Overall Study|Lost to Follow-up|6|||
33395945|NCT00575510|62775248|FG002|Overall Study|Lost to Follow-up|9|||
33395946|NCT00575510|62775246|FG000|Overall Study|Withdrawal by Subject|1|||
33395947|NCT00575510|62775247|FG001|Overall Study|Withdrawal by Subject|0|||
33395948|NCT00575510|62775248|FG002|Overall Study|Withdrawal by Subject|0|||
33395949|NCT00575510|62775246|FG000|Overall Study|Clinic Called Patient|7|||
33395950|NCT00575510|62775247|FG001|Overall Study|Clinic Called Patient|7|||
33395951|NCT00575510|62775248|FG002|Overall Study|Clinic Called Patient|7|||
33395952|NCT00575510|62775246|FG000|Overall Study|Pregnancy|0|||
33395953|NCT00575510|62775247|FG001|Overall Study|Pregnancy|0|||
33395954|NCT00575510|62775248|FG002|Overall Study|Pregnancy|1|||
33395955|NCT02636439|62775259|FG000|Overall Study|Adverse Event|2|||
33395956|NCT02636439|62775260|FG001|Overall Study|Adverse Event|2|||
33395957|NCT02636439|62775259|FG000|Overall Study|Lost to Follow-up|1|||
33395958|NCT02636439|62775260|FG001|Overall Study|Lost to Follow-up|0|||
33395959|NCT02636439|62775259|FG000|Overall Study|Non-compliance|1|||
33395960|NCT02636439|62775260|FG001|Overall Study|Non-compliance|1|||
33395961|NCT02636439|62775259|FG000|Overall Study|Personal reasons|2|||
33395962|NCT02636439|62775260|FG001|Overall Study|Personal reasons|0|||
33395963|NCT00343915|62775268|FG000|Primary Study|Withdrawal by Subject|1|||
33395964|NCT00343915|62775269|FG001|Primary Study|Withdrawal by Subject|0|||
33395965|NCT00343915|62775268|FG000|Primary Study|Lost to Follow-up|2|||
33395966|NCT00343915|62775269|FG001|Primary Study|Lost to Follow-up|3|||
33395967|NCT00343915|62775268|FG000|Primary Study|Other|1|||
33395968|NCT00343915|62775269|FG001|Primary Study|Other|0|||
33395969|NCT00575666|62775280|FG000|Overall Study|Withdrawal by Subject|3|||
33395970|NCT00575666|62775281|FG001|Overall Study|Withdrawal by Subject|2|||
33395971|NCT00575666|62775280|FG000|Overall Study|Physician Decision|1|||
33395972|NCT00575666|62775281|FG001|Overall Study|Physician Decision|1|||
33395973|NCT00658632|62775289|FG000|Overall Study|Adverse Event|13|||
33302745|NCT01252563|62678513|FG000|Overall Study|No visit after first day of treatment|194|||
33302746|NCT01252563|62678513|FG000|Overall Study|No drug administration|6|||
33302747|NCT01292226|62678548|FG000|Overall Study|Adverse Event|5|||
33302748|NCT01292226|62678548|FG000|Overall Study|Death|1|||
33302749|NCT01292226|62678548|FG000|Overall Study|Graft loss|1|||
33302750|NCT01292226|62678548|FG000|Overall Study|Protocol Violation|3|||
33302751|NCT01292226|62678548|FG000|Overall Study|Withdrawal by Subject|1|||
33302752|NCT01292226|62678548|FG000|Overall Study|Other|2|||
33302753|NCT01290822|62678552|FG000|Overall Study|Withdrawal by Subject|1|||
33302754|NCT01290822|62678552|FG000|Overall Study|Physician Decision|10|||
33302755|NCT01075048|62678559|FG000|Overall Study|Death|4|||
33302756|NCT01075048|62678560|FG001|Overall Study|Death|17|||
33302757|NCT01075048|62678561|FG002|Overall Study|Death|12|||
33302758|NCT01075048|62678559|FG000|Overall Study|Start of other or new therapy|4|||
33302759|NCT01075048|62678560|FG001|Overall Study|Start of other or new therapy|36|||
33302760|NCT01075048|62678561|FG002|Overall Study|Start of other or new therapy|46|||
33302761|NCT01075048|62678559|FG000|Overall Study|Withdrawal by Subject|1|||
33302762|NCT01075048|62678560|FG001|Overall Study|Withdrawal by Subject|6|||
33302763|NCT01075048|62678561|FG002|Overall Study|Withdrawal by Subject|3|||
33302764|NCT01075048|62678559|FG000|Overall Study|Lost to Follow-up|0|||
33302765|NCT01075048|62678560|FG001|Overall Study|Lost to Follow-up|1|||
33395974|NCT00658632|62775290|FG001|Overall Study|Adverse Event|11|||
33395975|NCT00658632|62775289|FG000|Overall Study|Lost to Follow-up|25|||
33395976|NCT00658632|62775290|FG001|Overall Study|Lost to Follow-up|23|||
33395977|NCT00658632|62775289|FG000|Overall Study|Withdrawal by Subject|10|||
33395978|NCT00658632|62775290|FG001|Overall Study|Withdrawal by Subject|7|||
33395979|NCT00658632|62775289|FG000|Overall Study|Lack of Efficacy|0|||
33395980|NCT00658632|62775290|FG001|Overall Study|Lack of Efficacy|1|||
33395981|NCT00658632|62775289|FG000|Overall Study|Withdrawal of consent|8|||
33395982|NCT00658632|62775290|FG001|Overall Study|Withdrawal of consent|14|||
33567642|NCT02412878|62963530|FG001|Overall Study|Lost to Follow-up|3|||
33664154|NCT02681094|63095177|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
33664155|NCT02681094|63095178|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
33302766|NCT01075048|62678561|FG002|Overall Study|Lost to Follow-up|1|||
33302767|NCT01290666|62678572|FG000|Overall Study|Lost to Follow-up|11|||
33302768|NCT01290666|62678572|FG000|Overall Study|Withdrawal by Subject|23|||
33302769|NCT01290666|62678572|FG000|Overall Study|Early Termination of Study|4|||
33302770|NCT01252251|62678576|FG000|Overall Study|Withdrawal by Subject|1|||
33302771|NCT01289574|62678583|FG000|Overall Study|Lack of Efficacy|4|||
33302772|NCT01289574|62678584|FG001|Overall Study|Lack of Efficacy|0|||
33302773|NCT01289574|62678585|FG002|Overall Study|Lack of Efficacy|1|||
33302774|NCT01289574|62678583|FG000|Overall Study|Lost to Follow-up|2|||
33302775|NCT01289574|62678584|FG001|Overall Study|Lost to Follow-up|0|||
33395983|NCT00658632|62775289|FG000|Overall Study|Pregnancy|1|||
33395984|NCT00658632|62775290|FG001|Overall Study|Pregnancy|1|||
33567643|NCT02380742|62963538|FG000|Overall Study|Withdrawal by Subject|1|||
33395985|NCT00658632|62775289|FG000|Overall Study|Other|7|||
33395986|NCT00658632|62775290|FG001|Overall Study|Other|8|||
33395987|NCT00677534|62775296|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
33395988|NCT00677534|62775296|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
33395989|NCT00677534|62775296|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
33395990|NCT00660348|62775302|FG000|Overall Study|Withdrawal by Subject|1|||
33395991|NCT00660348|62775303|FG001|Overall Study|Withdrawal by Subject|0|||
33395992|NCT00660192|62775311|FG000|Overall Study|Lost to Follow-up|2|||
33395993|NCT00660192|62775312|FG001|Overall Study|Lost to Follow-up|3|||
33395994|NCT00571688|62775320|FG000|Overall Study|Lost to Follow-up|3|||
33395995|NCT00571688|62775321|FG001|Overall Study|Lost to Follow-up|6|||
33395996|NCT00571688|62775320|FG000|Overall Study|subject did not tolerate Consta|1|||
33395997|NCT00571688|62775321|FG001|Overall Study|subject did not tolerate Consta|0|||
33395998|NCT00571688|62775320|FG000|Overall Study|subject moved out of the area|1|||
33395999|NCT00571688|62775321|FG001|Overall Study|subject moved out of the area|0|||
33396000|NCT00343291|62775329|FG000|Overall Study|Adverse Event|13|||
33396001|NCT00343291|62775330|FG001|Overall Study|Adverse Event|13|||
33396002|NCT00343291|62775329|FG000|Overall Study|Death|3|||
33396003|NCT00343291|62775330|FG001|Overall Study|Death|2|||
33396004|NCT00343291|62775329|FG000|Overall Study|Progressive disease|33|||
33396005|NCT00343291|62775330|FG001|Overall Study|Progressive disease|34|||
33396006|NCT00343291|62775329|FG000|Overall Study|Withdrawal by Subject|0|||
33396007|NCT00343291|62775330|FG001|Overall Study|Withdrawal by Subject|2|||
33396008|NCT00343291|62775329|FG000|Overall Study|Other|8|||
33396009|NCT00343291|62775330|FG001|Overall Study|Other|5|||
33396010|NCT00658788|62775336|FG000|Overall Study|Adverse Event|11|||
33396011|NCT00658788|62775336|FG000|Overall Study|Withdrawal by Subject|13|||
33396012|NCT00658788|62775336|FG000|Overall Study|Lost to Follow-up|18|||
33396013|NCT00658788|62775336|FG000|Overall Study|Treatment Discontinuation|32|||
33396014|NCT04829214|62775351|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
33396015|NCT04829214|62775352|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
33396016|NCT04829214|62775351|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
33396017|NCT04829214|62775352|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
33396018|NCT00562965|62775362|FG000|Overall Study|Withdrawal by Subject|0|||
33396019|NCT00562965|62775363|FG001|Overall Study|Withdrawal by Subject|1|||
33396020|NCT00562965|62775362|FG000|Overall Study|Death|2|||
33396021|NCT00562965|62775363|FG001|Overall Study|Death|4|||
33396022|NCT00562965|62775362|FG000|Overall Study|Lost to Follow-up|1|||
33396023|NCT00562965|62775363|FG001|Overall Study|Lost to Follow-up|0|||
33396024|NCT00562965|62775362|FG000|Overall Study|Other|0|||
33396025|NCT00562965|62775363|FG001|Overall Study|Other|1|||
33396026|NCT00537082|62775372|FG000|Overall Study|Adverse Event|6|||
33396027|NCT00537082|62775373|FG001|Overall Study|Adverse Event|6|||
33396028|NCT00537082|62775374|FG002|Overall Study|Adverse Event|3|||
33396029|NCT00537082|62775372|FG000|Overall Study|Protocol Violation|0|||
33396030|NCT00537082|62775373|FG001|Overall Study|Protocol Violation|2|||
33396031|NCT00537082|62775374|FG002|Overall Study|Protocol Violation|1|||
33396032|NCT00537082|62775372|FG000|Overall Study|Lack of Efficacy|0|||
33396033|NCT00537082|62775373|FG001|Overall Study|Lack of Efficacy|0|||
33396034|NCT00537082|62775374|FG002|Overall Study|Lack of Efficacy|2|||
33567644|NCT02380742|62963539|FG001|Overall Study|Withdrawal by Subject|0|||
33567645|NCT02922725|62963548|FG000|Overall Study|Withdrawal by Subject|1|||
33567646|NCT02922725|62963549|FG001|Overall Study|Withdrawal by Subject|0|||
33567647|NCT02922725|62963550|FG002|Overall Study|Withdrawal by Subject|0|||
33567648|NCT02805257|62963559|FG000|Overall Study|Lost to Follow-up|7|||
33396035|NCT00537082|62775372|FG000|Overall Study|Withdrawal by Subject|0|||
33396036|NCT00537082|62775373|FG001|Overall Study|Withdrawal by Subject|1|||
33567649|NCT02805257|62963560|FG001|Overall Study|Lost to Follow-up|6|||
33567650|NCT02805257|62963559|FG000|Overall Study|Death|0|||
33567651|NCT02805257|62963560|FG001|Overall Study|Death|1|||
33567652|NCT04794803|62963568|FG000|Overall Study|Death|1|||
33567653|NCT04794803|62963569|FG001|Overall Study|Death|3|||
33567654|NCT04794803|62963568|FG000|Overall Study|Lost to Follow-up|2|||
33396037|NCT00537082|62775374|FG002|Overall Study|Withdrawal by Subject|0|||
33396038|NCT00537082|62775372|FG000|Overall Study|Discontinued before initiating treatment|3|||
33567655|NCT04794803|62963569|FG001|Overall Study|Lost to Follow-up|2|||
33567656|NCT04794803|62963568|FG000|Overall Study|Withdrawal by Subject|1|||
33567657|NCT04794803|62963569|FG001|Overall Study|Withdrawal by Subject|0|||
33396039|NCT00537082|62775373|FG001|Overall Study|Discontinued before initiating treatment|0|||
33396040|NCT00537082|62775374|FG002|Overall Study|Discontinued before initiating treatment|0|||
33396041|NCT03828487|62775382|FG000|Overall Study|Physician Decision|1|||
33396042|NCT00324961|62775386|FG000|Overall Study|Adverse Event|5|||
33396043|NCT00324961|62775386|FG000|Overall Study|Consent Withdrawn|11|||
33396044|NCT00324961|62775386|FG000|Overall Study|Lost to Follow-up|22|||
33396045|NCT00324961|62775386|FG000|Overall Study|Protocol Violation|3|||
33396046|NCT00324961|62775386|FG000|Overall Study|Other|2|||
33396047|NCT00324649|62775394|FG000|Overall Study|Adverse Event|1|||
33396048|NCT00324649|62775395|FG001|Overall Study|Adverse Event|4|||
33396049|NCT00324649|62775394|FG000|Overall Study|Withdrawal by Subject|0|||
33396050|NCT00324649|62775395|FG001|Overall Study|Withdrawal by Subject|1|||
33396051|NCT00324649|62775394|FG000|Overall Study|Noncompliance|1|||
33396052|NCT00324649|62775395|FG001|Overall Study|Noncompliance|0|||
33396053|NCT00656370|62775401|FG000|Overall Study|Screen Failures|7|||
33396054|NCT00656370|62775401|FG000|Overall Study|Alternates|3|||
33396055|NCT00680186|62775409|FG000|Overall Study|Adverse Event|47|||
33396056|NCT00680186|62775410|FG001|Overall Study|Adverse Event|44|||
33396057|NCT00680186|62775409|FG000|Overall Study|Protocol Violation|31|||
33396058|NCT00680186|62775410|FG001|Overall Study|Protocol Violation|26|||
33396059|NCT00680186|62775409|FG000|Overall Study|Lost to Follow-up|11|||
33396060|NCT00680186|62775410|FG001|Overall Study|Lost to Follow-up|6|||
33396061|NCT00680186|62775409|FG000|Overall Study|Withdrawal by Subject|32|||
33396062|NCT00680186|62775410|FG001|Overall Study|Withdrawal by Subject|39|||
33396063|NCT00680186|62775409|FG000|Overall Study|Other|4|||
33396064|NCT00680186|62775410|FG001|Overall Study|Other|1|||
33396065|NCT00656292|62775418|FG000|Overall Study|Withdrawal by Subject|2|||
33396066|NCT00656292|62775419|FG001|Overall Study|Withdrawal by Subject|3|||
33396067|NCT00656292|62775418|FG000|Overall Study|Screen failure|1|||
33396068|NCT00656292|62775419|FG001|Overall Study|Screen failure|2|||
33396069|NCT00352417|62775427|FG000|Overall Study|Adverse Event|1|||
33396070|NCT00352417|62775428|FG001|Overall Study|Adverse Event|0|||
33396071|NCT00352417|62775427|FG000|Overall Study|Protocol Violation|0|||
33396072|NCT00352417|62775428|FG001|Overall Study|Protocol Violation|2|||
33396073|NCT00352417|62775427|FG000|Overall Study|Withdrawal by Subject|1|||
33396074|NCT00352417|62775428|FG001|Overall Study|Withdrawal by Subject|2|||
33396075|NCT00352417|62775427|FG000|Overall Study|Lost to Follow-up|1|||
33396076|NCT00352417|62775428|FG001|Overall Study|Lost to Follow-up|0|||
33396077|NCT00352417|62775427|FG000|Overall Study|Schedule Change|2|||
33396078|NCT00352417|62775428|FG001|Overall Study|Schedule Change|1|||
33396079|NCT00323869|62775434|FG000|Overall Study|Death|1|||
33396080|NCT00323557|62775440|FG000|Overall Study|Physician Decision|1|||
33396081|NCT00323557|62775441|FG001|Overall Study|Physician Decision|0|||
33396082|NCT00558363|62775450|FG000|Overall Study|Physician Decision|18|||
33396083|NCT00558363|62775451|FG001|Overall Study|Physician Decision|4|||
33396084|NCT00558363|62775450|FG000|Overall Study|Withdrawal by Subject|11|||
33396085|NCT00558363|62775451|FG001|Overall Study|Withdrawal by Subject|4|||
33396086|NCT00558363|62775450|FG000|Overall Study|Adverse Event|5|||
33396087|NCT00558363|62775451|FG001|Overall Study|Adverse Event|5|||
33396088|NCT00558363|62775450|FG000|Overall Study|Lack of Efficacy|2|||
33396089|NCT00558363|62775451|FG001|Overall Study|Lack of Efficacy|2|||
33396090|NCT00558363|62775450|FG000|Overall Study|Protocol Violation|2|||
33396091|NCT00558363|62775451|FG001|Overall Study|Protocol Violation|1|||
33396092|NCT00558363|62775450|FG000|Overall Study|Lost to Follow-up|0|||
33396093|NCT00558363|62775451|FG001|Overall Study|Lost to Follow-up|1|||
33396094|NCT00558363|62775450|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
33396095|NCT00558363|62775451|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
33396096|NCT00558363|62775450|FG000|Overall Study|Randomized in Error|1|||
33396097|NCT00558363|62775451|FG001|Overall Study|Randomized in Error|2|||
33396098|NCT00558363|62775450|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
33396099|NCT00558363|62775451|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
33396100|NCT00323479|62775457|FG000|Overall Study|Adverse Event|2|||
33396101|NCT00323479|62775457|FG000|Overall Study|Withdrawal by Subject|2|||
33396102|NCT00323479|62775457|FG000|Overall Study|Protocol Violation|3|||
33396103|NCT00323479|62775457|FG000|Overall Study|house moving|1|||
33396104|NCT00352105|62775461|FG000|Overall Study|Death|5|||
33396105|NCT00352105|62775461|FG000|Overall Study|Withdrawal by Subject|5|||
33396106|NCT00352105|62775461|FG000|Overall Study|Lack of Efficacy|9|||
33396107|NCT00352105|62775461|FG000|Overall Study|Adverse Event|19|||
33396108|NCT00352105|62775461|FG000|Overall Study|Protocol Violation|2|||
33396109|NCT00350779|62775467|FG000|Overall Study|Adverse Event|4|||
33396110|NCT00350779|62775468|FG001|Overall Study|Adverse Event|2|||
33396111|NCT00350779|62775467|FG000|Overall Study|Lack of Efficacy|0|||
33567658|NCT04794803|62963568|FG000|Overall Study|Physician Decision|1|||
33396112|NCT00350779|62775468|FG001|Overall Study|Lack of Efficacy|4|||
33396113|NCT00350779|62775467|FG000|Overall Study|Lost to Follow-up|2|||
33396114|NCT00350779|62775468|FG001|Overall Study|Lost to Follow-up|0|||
33396115|NCT00350779|62775467|FG000|Overall Study|Physician Decision|2|||
33396116|NCT00350779|62775468|FG001|Overall Study|Physician Decision|4|||
33396117|NCT00350779|62775467|FG000|Overall Study|Protocol Violation|3|||
33396118|NCT00350779|62775468|FG001|Overall Study|Protocol Violation|1|||
33396119|NCT00350779|62775467|FG000|Overall Study|Withdrawal by Subject|9|||
33396120|NCT00350779|62775468|FG001|Overall Study|Withdrawal by Subject|8|||
33396121|NCT00350779|62775467|FG000|Overall Study|Patient Moved|2|||
33396122|NCT00350779|62775468|FG001|Overall Study|Patient Moved|1|||
33396123|NCT00350779|62775467|FG000|Overall Study|Non-compliance with study procedures|0|||
33396124|NCT00350779|62775468|FG001|Overall Study|Non-compliance with study procedures|1|||
33396125|NCT00350623|62775479|FG000|Overall Study|Lost to Follow-up|8|||
33396126|NCT00350623|62775480|FG001|Overall Study|Lost to Follow-up|3|||
33396127|NCT00350623|62775481|FG002|Overall Study|Lost to Follow-up|4|||
33396128|NCT00350623|62775479|FG000|Overall Study|Withdrawal by Subject|0|||
33396129|NCT00350623|62775480|FG001|Overall Study|Withdrawal by Subject|1|||
33396130|NCT00350623|62775481|FG002|Overall Study|Withdrawal by Subject|1|||
33396131|NCT00350623|62775479|FG000|Overall Study|patient traveling outside the country|0|||
33396132|NCT00350623|62775480|FG001|Overall Study|patient traveling outside the country|0|||
33396133|NCT00350623|62775481|FG002|Overall Study|patient traveling outside the country|1|||
33396134|NCT00656136|62775491|FG000|Overall Study|Progressive disease|177|||
33396135|NCT00656136|62775492|FG001|Overall Study|Progressive disease|322|||
33396136|NCT00656136|62775491|FG000|Overall Study|Other Adverse Event|5|||
33396137|NCT00656136|62775492|FG001|Overall Study|Other Adverse Event|51|||
33396138|NCT00656136|62775491|FG000|Overall Study|Protocol Violation|2|||
33396139|NCT00656136|62775492|FG001|Overall Study|Protocol Violation|3|||
33396140|NCT00656136|62775491|FG000|Overall Study|Patient refused to take study medication|7|||
33396141|NCT00656136|62775492|FG001|Overall Study|Patient refused to take study medication|10|||
33396142|NCT00656136|62775491|FG000|Overall Study|Unknown and others|4|||
33396143|NCT00656136|62775492|FG001|Overall Study|Unknown and others|4|||
33396144|NCT00676520|62775498|FG000|Overall Study|Withdrawal by Subject|163|||
33396145|NCT00676520|62775498|FG000|Overall Study|Lost to Follow-up|162|||
33396146|NCT00676520|62775498|FG000|Overall Study|Death|159|||
33396147|NCT00676520|62775498|FG000|Overall Study|Physician Decision|20|||
33396148|NCT00676520|62775498|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
33396149|NCT00676520|62775498|FG000|Overall Study|Other Reason|18|||
33396150|NCT00652938|62775510|FG000|Overall Study|Adverse Event|1|||
33396151|NCT00652938|62775511|FG001|Overall Study|Adverse Event|0|||
33396152|NCT00652938|62775512|FG002|Overall Study|Adverse Event|2|||
33396153|NCT00652938|62775510|FG000|Overall Study|Withdrawal by Subject|0|||
33396154|NCT00652938|62775511|FG001|Overall Study|Withdrawal by Subject|6|||
33396155|NCT00652938|62775512|FG002|Overall Study|Withdrawal by Subject|1|||
33396156|NCT00652938|62775510|FG000|Overall Study|Lost to Follow-up|0|||
33396157|NCT00652938|62775511|FG001|Overall Study|Lost to Follow-up|0|||
33396158|NCT00652938|62775512|FG002|Overall Study|Lost to Follow-up|2|||
33396159|NCT00652938|62775510|FG000|Overall Study|fear of blood sampling|0|||
33396160|NCT00652938|62775511|FG001|Overall Study|fear of blood sampling|1|||
33396161|NCT00652938|62775512|FG002|Overall Study|fear of blood sampling|0|||
33396162|NCT00322621|62775520|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
33396163|NCT00322621|62775521|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
33396164|NCT00322621|62775522|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
33396165|NCT00322621|62775520|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
33396166|NCT00322621|62775521|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
33396167|NCT00322621|62775522|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
33396168|NCT00322621|62775520|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
33396169|NCT00322621|62775521|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
33396170|NCT00322621|62775522|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
33396171|NCT00322621|62775520|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
33396172|NCT00322621|62775521|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
33396173|NCT00322621|62775522|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
33396174|NCT00322621|62775520|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
33396175|NCT00322621|62775521|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
33396176|NCT00322621|62775522|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
33396177|NCT00322621|62775520|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
33396178|NCT00322621|62775521|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
33396179|NCT00322621|62775522|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
33396180|NCT00322621|62775520|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
33396181|NCT00322621|62775521|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
33396182|NCT00322621|62775522|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
33396183|NCT00322621|62775520|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
33396184|NCT00322621|62775521|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
33396185|NCT00322621|62775522|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
33396186|NCT00322621|62775520|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
33396187|NCT00322621|62775521|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
33396188|NCT00322621|62775522|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
33396189|NCT00322621|62775520|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
33396190|NCT00322621|62775521|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
33396191|NCT00322621|62775522|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
33396192|NCT00322621|62775520|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
33567659|NCT04794803|62963569|FG001|Overall Study|Physician Decision|1|||
33567660|NCT04794803|62963568|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
33567661|NCT04794803|62963569|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
33664156|NCT02681094|63095176|FG000|2 - Enrolled Participants Set|Other|6|||
33396193|NCT00322621|62775521|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
33302776|NCT01289574|62678585|FG002|Overall Study|Lost to Follow-up|1|||
33302777|NCT01289574|62678583|FG000|Overall Study|Withdrawal by Subject|1|||
33302778|NCT01289574|62678584|FG001|Overall Study|Withdrawal by Subject|1|||
33302779|NCT01289574|62678585|FG002|Overall Study|Withdrawal by Subject|1|||
33302780|NCT01289574|62678583|FG000|Overall Study|Adverse Event|0|||
33302781|NCT01289574|62678584|FG001|Overall Study|Adverse Event|1|||
33396194|NCT00322621|62775522|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
33396195|NCT00575042|62775535|FG000|Overall Study|Adverse Event|2|||
33396196|NCT00575042|62775535|FG000|Overall Study|Lost to Follow-up|1|||
33396197|NCT00676208|62775542|FG000|Overall Study|Lost to Follow-up|0|||
33396198|NCT00676208|62775543|FG001|Overall Study|Lost to Follow-up|2|||
33396199|NCT00676208|62775542|FG000|Overall Study|Incomplete data|2|||
33396200|NCT00676208|62775543|FG001|Overall Study|Incomplete data|4|||
33396201|NCT00656058|62775551|FG000|Overall Study|Withdrawal by Subject|2|||
33396202|NCT00656058|62775551|FG000|Overall Study|Withdrawal by Subject|4|||
33396203|NCT00537316|62775561|FG000|Part 1|Adverse Event|7|||
33396204|NCT00537316|62775562|FG001|Part 1|Adverse Event|11|||
33396205|NCT00537316|62775563|FG002|Part 1|Adverse Event|8|||
33396206|NCT00537316|62775564|FG003|Part 1|Adverse Event|0|||
33396207|NCT00537316|62775565|FG004|Part 1|Adverse Event|0|||
33396208|NCT00537316|62775566|FG005|Part 1|Adverse Event|0|||
33396209|NCT00537316|62775567|FG006|Part 1|Adverse Event|0|||
33396210|NCT00537316|62775561|FG000|Part 1|Protocol defined clinical event|1|||
33396211|NCT00537316|62775562|FG001|Part 1|Protocol defined clinical event|0|||
33396212|NCT00537316|62775563|FG002|Part 1|Protocol defined clinical event|0|||
33396213|NCT00537316|62775564|FG003|Part 1|Protocol defined clinical event|0|||
33396214|NCT00537316|62775565|FG004|Part 1|Protocol defined clinical event|0|||
33396215|NCT00537316|62775566|FG005|Part 1|Protocol defined clinical event|0|||
33396216|NCT00537316|62775567|FG006|Part 1|Protocol defined clinical event|0|||
33396217|NCT00537316|62775561|FG000|Part 1|Lost to Follow-up|1|||
33396218|NCT00537316|62775562|FG001|Part 1|Lost to Follow-up|0|||
33396219|NCT00537316|62775563|FG002|Part 1|Lost to Follow-up|0|||
33396220|NCT00537316|62775564|FG003|Part 1|Lost to Follow-up|0|||
33396221|NCT00537316|62775565|FG004|Part 1|Lost to Follow-up|0|||
33396222|NCT00537316|62775566|FG005|Part 1|Lost to Follow-up|0|||
33396223|NCT00537316|62775567|FG006|Part 1|Lost to Follow-up|0|||
33396224|NCT00537316|62775561|FG000|Part 1|Withdrawal by Subject|3|||
33396225|NCT00537316|62775562|FG001|Part 1|Withdrawal by Subject|8|||
33396226|NCT00537316|62775563|FG002|Part 1|Withdrawal by Subject|4|||
33396227|NCT00537316|62775564|FG003|Part 1|Withdrawal by Subject|0|||
33396228|NCT00537316|62775565|FG004|Part 1|Withdrawal by Subject|0|||
33396229|NCT00537316|62775566|FG005|Part 1|Withdrawal by Subject|0|||
33396230|NCT00537316|62775567|FG006|Part 1|Withdrawal by Subject|0|||
33396231|NCT00537316|62775561|FG000|Part 1|Protocol Violation|1|||
33396232|NCT00537316|62775562|FG001|Part 1|Protocol Violation|5|||
33567662|NCT04794803|62963568|FG000|Overall Study|Refused to continue the treatment|1|||
33567663|NCT04794803|62963569|FG001|Overall Study|Refused to continue the treatment|0|||
33567664|NCT04794803|62963568|FG000|Overall Study|Patient admitted to ICU|0|||
33567665|NCT04794803|62963569|FG001|Overall Study|Patient admitted to ICU|1|||
33567666|NCT01791595|62963582|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
33567667|NCT01791595|62963583|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
33567668|NCT01791595|62963584|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
33567669|NCT01791595|62963585|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
33567670|NCT01791595|62963586|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
33567671|NCT01791595|62963587|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
33396233|NCT00537316|62775563|FG002|Part 1|Protocol Violation|1|||
33396234|NCT00537316|62775564|FG003|Part 1|Protocol Violation|0|||
33567672|NCT01791595|62963588|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
33567673|NCT01791595|62963582|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
33567674|NCT01791595|62963583|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
33567675|NCT01791595|62963584|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
33567676|NCT01791595|62963585|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
33567677|NCT01791595|62963586|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
33567678|NCT01791595|62963587|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
33567679|NCT01791595|62963588|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
33567680|NCT01791595|62963582|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
33302782|NCT01289574|62678585|FG002|Overall Study|Adverse Event|0|||
33302783|NCT01289574|62678583|FG000|Overall Study|Subject wanted alternate treatment|0|||
33302784|NCT01289574|62678584|FG001|Overall Study|Subject wanted alternate treatment|1|||
33567681|NCT01791595|62963583|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
33302785|NCT01289574|62678585|FG002|Overall Study|Subject wanted alternate treatment|0|||
33396235|NCT00537316|62775565|FG004|Part 1|Protocol Violation|0|||
33396236|NCT00537316|62775566|FG005|Part 1|Protocol Violation|0|||
33396237|NCT00537316|62775567|FG006|Part 1|Protocol Violation|0|||
33396238|NCT00537316|62775561|FG000|Part 1|Did not meet protocol eligibility|1|||
33396239|NCT00537316|62775562|FG001|Part 1|Did not meet protocol eligibility|3|||
33396240|NCT00537316|62775563|FG002|Part 1|Did not meet protocol eligibility|2|||
33396241|NCT00537316|62775564|FG003|Part 1|Did not meet protocol eligibility|0|||
33396242|NCT00537316|62775565|FG004|Part 1|Did not meet protocol eligibility|0|||
33396243|NCT00537316|62775566|FG005|Part 1|Did not meet protocol eligibility|0|||
33396244|NCT00537316|62775567|FG006|Part 1|Did not meet protocol eligibility|0|||
33396245|NCT00537316|62775561|FG000|Part 1|Administrative|0|||
33396246|NCT00537316|62775562|FG001|Part 1|Administrative|0|||
33396247|NCT00537316|62775563|FG002|Part 1|Administrative|2|||
33396248|NCT00537316|62775564|FG003|Part 1|Administrative|0|||
33396249|NCT00537316|62775565|FG004|Part 1|Administrative|0|||
33396250|NCT00537316|62775566|FG005|Part 1|Administrative|0|||
33396251|NCT00537316|62775567|FG006|Part 1|Administrative|0|||
33396252|NCT00537316|62775561|FG000|Part 2|Never entered follow-up|0|||
33396253|NCT00537316|62775562|FG001|Part 2|Never entered follow-up|0|||
33396254|NCT00537316|62775563|FG002|Part 2|Never entered follow-up|0|||
33396255|NCT00537316|62775564|FG003|Part 2|Never entered follow-up|0|||
33396256|NCT00537316|62775565|FG004|Part 2|Never entered follow-up|0|||
33396257|NCT00537316|62775566|FG005|Part 2|Never entered follow-up|0|||
33396258|NCT00537316|62775567|FG006|Part 2|Never entered follow-up|1|||
33396259|NCT00537316|62775561|FG000|Part 2|Adverse Event|4|||
33396260|NCT00537316|62775562|FG001|Part 2|Adverse Event|0|||
33567682|NCT01791595|62963584|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
33567683|NCT01791595|62963585|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
33567684|NCT01791595|62963586|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
33567685|NCT01791595|62963587|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
33567686|NCT01791595|62963588|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
33302786|NCT01252095|62678596|FG000|Overall Study|Disease progression|1|||
33302787|NCT01252095|62678597|FG001|Overall Study|Disease progression|0|||
33302788|NCT01289418|62678606|FG000|Day 8 Survey|email address invalid|283|||
33302789|NCT01289418|62678606|FG000|Day 8 Survey|participants did not complete the survey|1935|||
33302790|NCT01289418|62678606|FG000|Day 29 Survey|email address invalid|283|||
33302791|NCT01289418|62678606|FG000|Day 29 Survey|participants did not complete the survey|2185|||
33302792|NCT01074658|62678612|FG000|Overall Study|No implant attempted|19|||
33302793|NCT01074502|62678616|FG000|Overall Study|Withdrawal by Subject|1|||
33302794|NCT01289028|62678620|FG000|Overall Study|Progressive Disease|49|||
33302795|NCT01289028|62678620|FG000|Overall Study|Adverse Event|14|||
33302796|NCT01289028|62678620|FG000|Overall Study|Withdrawal by Subject|6|||
33302797|NCT01289028|62678620|FG000|Overall Study|Death|4|||
33302798|NCT01289028|62678620|FG000|Overall Study|Lack of Efficacy|2|||
33302799|NCT01289028|62678620|FG000|Overall Study|No longer required|2|||
33302800|NCT01289028|62678620|FG000|Overall Study|Lost to Follow-up|2|||
33302801|NCT01289028|62678620|FG000|Overall Study|New Cancer Therapy|2|||
33302802|NCT01289028|62678620|FG000|Overall Study|Abnormal Lab Value|1|||
33302803|NCT01289028|62678620|FG000|Overall Study|Missing reason for discon|1|||
33302804|NCT01250925|62678629|FG000|Overall Study|Lost to Follow-up|1|||
33302805|NCT01250925|62678630|FG001|Overall Study|Lost to Follow-up|1|||
33302806|NCT01250925|62678631|FG002|Overall Study|Lost to Follow-up|0|||
33302807|NCT01250925|62678629|FG000|Overall Study|Withdrawal by Subject|2|||
33567687|NCT01791595|62963582|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
33567688|NCT01791595|62963583|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
33567689|NCT01791595|62963584|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
33567690|NCT01791595|62963585|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
33567691|NCT01791595|62963586|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
33567692|NCT01791595|62963587|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
33567693|NCT01791595|62963588|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
33567694|NCT01791595|62963582|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
33567695|NCT01791595|62963583|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
33567696|NCT01791595|62963584|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
33567697|NCT01791595|62963585|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
33567698|NCT01791595|62963586|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
33567699|NCT01791595|62963587|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
33567700|NCT01791595|62963588|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
33396261|NCT00537316|62775563|FG002|Part 2|Adverse Event|2|||
33396262|NCT00537316|62775564|FG003|Part 2|Adverse Event|0|||
33396263|NCT00537316|62775565|FG004|Part 2|Adverse Event|0|||
33396264|NCT00537316|62775566|FG005|Part 2|Adverse Event|0|||
33302808|NCT01250925|62678630|FG001|Overall Study|Withdrawal by Subject|0|||
33302809|NCT01250925|62678631|FG002|Overall Study|Withdrawal by Subject|0|||
33302810|NCT01250925|62678629|FG000|Overall Study|Protocol Violation|2|||
33302811|NCT01250925|62678630|FG001|Overall Study|Protocol Violation|0|||
33302812|NCT01250925|62678631|FG002|Overall Study|Protocol Violation|0|||
33396265|NCT00537316|62775567|FG006|Part 2|Adverse Event|0|||
33396266|NCT00537316|62775561|FG000|Part 2|Lost to Follow-up|1|||
33396267|NCT00537316|62775562|FG001|Part 2|Lost to Follow-up|0|||
33396268|NCT00537316|62775563|FG002|Part 2|Lost to Follow-up|2|||
33396269|NCT00537316|62775564|FG003|Part 2|Lost to Follow-up|0|||
33396270|NCT00537316|62775565|FG004|Part 2|Lost to Follow-up|0|||
33396271|NCT00537316|62775566|FG005|Part 2|Lost to Follow-up|0|||
33396272|NCT00537316|62775567|FG006|Part 2|Lost to Follow-up|0|||
33396273|NCT00537316|62775561|FG000|Part 2|Withdrawal by Subject|5|||
33396274|NCT00537316|62775562|FG001|Part 2|Withdrawal by Subject|1|||
33396275|NCT00537316|62775563|FG002|Part 2|Withdrawal by Subject|4|||
33396276|NCT00537316|62775564|FG003|Part 2|Withdrawal by Subject|0|||
33396277|NCT00537316|62775565|FG004|Part 2|Withdrawal by Subject|0|||
33396278|NCT00537316|62775566|FG005|Part 2|Withdrawal by Subject|0|||
33396279|NCT00537316|62775567|FG006|Part 2|Withdrawal by Subject|0|||
33396280|NCT00537316|62775561|FG000|Part 2|Administrative|16|||
33396281|NCT00537316|62775562|FG001|Part 2|Administrative|8|||
33396282|NCT00537316|62775563|FG002|Part 2|Administrative|24|||
33396283|NCT00537316|62775564|FG003|Part 2|Administrative|3|||
33396284|NCT00537316|62775565|FG004|Part 2|Administrative|1|||
33396285|NCT00537316|62775566|FG005|Part 2|Administrative|4|||
33396286|NCT00537316|62775567|FG006|Part 2|Administrative|1|||
33396287|NCT03827395|62775588|FG000|Overall Study|Lost to Follow-up|1|||
33396288|NCT03827395|62775589|FG001|Overall Study|Lost to Follow-up|0|||
33396289|NCT03827395|62775588|FG000|Overall Study|Protocol Violation|1|||
33396290|NCT03827395|62775589|FG001|Overall Study|Protocol Violation|0|||
33396291|NCT03827395|62775588|FG000|Overall Study|Became ineligible after enrollment|1|||
33396292|NCT03827395|62775589|FG001|Overall Study|Became ineligible after enrollment|2|||
33396293|NCT00655980|62775598|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
33396294|NCT00655980|62775599|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
33396295|NCT00655980|62775600|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
33396296|NCT00679172|62775616|FG000|Overall Study|Non-compliance|1|||
33396297|NCT00679172|62775617|FG001|Overall Study|Non-compliance|1|||
33396298|NCT00679172|62775618|FG002|Overall Study|Non-compliance|0|||
33396299|NCT00679172|62775619|FG003|Overall Study|Non-compliance|1|||
33396300|NCT00679172|62775620|FG004|Overall Study|Non-compliance|0|||
33396301|NCT00679172|62775616|FG000|Overall Study|Other not specified|0|||
33396302|NCT00679172|62775617|FG001|Overall Study|Other not specified|0|||
33396303|NCT00679172|62775618|FG002|Overall Study|Other not specified|1|||
33396304|NCT00679172|62775619|FG003|Overall Study|Other not specified|0|||
33396305|NCT00679172|62775620|FG004|Overall Study|Other not specified|0|||
33396306|NCT00676130|62775637|FG000|Overall Study|Lost to Follow-up|0|||
33396307|NCT00676130|62775638|FG001|Overall Study|Lost to Follow-up|1|||
33396308|NCT00676130|62775637|FG000|Overall Study|Found ineligible|3|||
33396309|NCT00676130|62775638|FG001|Overall Study|Found ineligible|2|||
33396310|NCT00676130|62775637|FG000|Overall Study|Withdrawal by Subject|0|||
33396311|NCT00676130|62775638|FG001|Overall Study|Withdrawal by Subject|1|||
33396312|NCT00676052|62775650|FG000|Overall Study|Adverse Event|0|||
33396313|NCT00676052|62775651|FG001|Overall Study|Adverse Event|1|||
33396314|NCT00676052|62775652|FG002|Overall Study|Adverse Event|1|||
33396315|NCT00676052|62775653|FG003|Overall Study|Adverse Event|2|||
33396316|NCT00676052|62775654|FG004|Overall Study|Adverse Event|2|||
33396317|NCT00676052|62775655|FG005|Overall Study|Adverse Event|2|||
33396318|NCT00676052|62775650|FG000|Overall Study|Lack of Efficacy|2|||
33396319|NCT00676052|62775651|FG001|Overall Study|Lack of Efficacy|2|||
33396320|NCT00676052|62775652|FG002|Overall Study|Lack of Efficacy|1|||
33396321|NCT00676052|62775653|FG003|Overall Study|Lack of Efficacy|1|||
33396322|NCT00676052|62775654|FG004|Overall Study|Lack of Efficacy|2|||
33396323|NCT00676052|62775655|FG005|Overall Study|Lack of Efficacy|1|||
33396324|NCT00676052|62775650|FG000|Overall Study|Protocol Violation|5|||
33396325|NCT00676052|62775651|FG001|Overall Study|Protocol Violation|3|||
33396326|NCT00676052|62775652|FG002|Overall Study|Protocol Violation|2|||
33396327|NCT00676052|62775653|FG003|Overall Study|Protocol Violation|2|||
33396328|NCT00676052|62775654|FG004|Overall Study|Protocol Violation|1|||
33396329|NCT00676052|62775655|FG005|Overall Study|Protocol Violation|2|||
33567701|NCT01791595|62963582|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
33396330|NCT00676052|62775650|FG000|Overall Study|Lost to Follow-up|0|||
33396331|NCT00676052|62775651|FG001|Overall Study|Lost to Follow-up|0|||
33396332|NCT00676052|62775652|FG002|Overall Study|Lost to Follow-up|0|||
33396333|NCT00676052|62775653|FG003|Overall Study|Lost to Follow-up|0|||
33396334|NCT00676052|62775654|FG004|Overall Study|Lost to Follow-up|1|||
33396335|NCT00676052|62775655|FG005|Overall Study|Lost to Follow-up|0|||
33396336|NCT00676052|62775650|FG000|Overall Study|Physician Decision|1|||
33396337|NCT00676052|62775651|FG001|Overall Study|Physician Decision|1|||
33567702|NCT01791595|62963583|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
33567703|NCT01791595|62963584|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
33396338|NCT00676052|62775652|FG002|Overall Study|Physician Decision|1|||
33396339|NCT00676052|62775653|FG003|Overall Study|Physician Decision|0|||
33396340|NCT00676052|62775654|FG004|Overall Study|Physician Decision|0|||
33396341|NCT00676052|62775655|FG005|Overall Study|Physician Decision|1|||
33396342|NCT00676052|62775650|FG000|Overall Study|Withdrawal by Subject|1|||
33396343|NCT00676052|62775651|FG001|Overall Study|Withdrawal by Subject|0|||
33396344|NCT00676052|62775652|FG002|Overall Study|Withdrawal by Subject|1|||
33396345|NCT00676052|62775653|FG003|Overall Study|Withdrawal by Subject|0|||
33396346|NCT00676052|62775654|FG004|Overall Study|Withdrawal by Subject|0|||
33396347|NCT00676052|62775655|FG005|Overall Study|Withdrawal by Subject|0|||
33396348|NCT00535288|62775674|FG000|Overall Study|Adverse Event|20|||
33396349|NCT00535288|62775675|FG001|Overall Study|Adverse Event|19|||
33396350|NCT00535288|62775676|FG002|Overall Study|Adverse Event|25|||
33396351|NCT00535288|62775677|FG003|Overall Study|Adverse Event|20|||
33396352|NCT00535288|62775678|FG004|Overall Study|Adverse Event|30|||
33396353|NCT00535288|62775674|FG000|Overall Study|Lost to Follow-up|0|||
33396354|NCT00535288|62775675|FG001|Overall Study|Lost to Follow-up|3|||
33396355|NCT00535288|62775676|FG002|Overall Study|Lost to Follow-up|0|||
33396356|NCT00535288|62775677|FG003|Overall Study|Lost to Follow-up|0|||
33396357|NCT00535288|62775678|FG004|Overall Study|Lost to Follow-up|0|||
33396358|NCT00535288|62775674|FG000|Overall Study|Lack of Efficacy|26|||
33396359|NCT00535288|62775675|FG001|Overall Study|Lack of Efficacy|3|||
33396360|NCT00535288|62775676|FG002|Overall Study|Lack of Efficacy|4|||
33396361|NCT00535288|62775677|FG003|Overall Study|Lack of Efficacy|4|||
33396362|NCT00535288|62775678|FG004|Overall Study|Lack of Efficacy|7|||
33396363|NCT00535288|62775674|FG000|Overall Study|Unwilling to cooperate|6|||
33396364|NCT00535288|62775675|FG001|Overall Study|Unwilling to cooperate|6|||
33396365|NCT00535288|62775676|FG002|Overall Study|Unwilling to cooperate|3|||
33396366|NCT00535288|62775677|FG003|Overall Study|Unwilling to cooperate|3|||
33396367|NCT00535288|62775678|FG004|Overall Study|Unwilling to cooperate|4|||
33396368|NCT00535288|62775674|FG000|Overall Study|Other|2|||
33396369|NCT00535288|62775675|FG001|Overall Study|Other|1|||
33396370|NCT00535288|62775676|FG002|Overall Study|Other|1|||
33396371|NCT00535288|62775677|FG003|Overall Study|Other|2|||
33396372|NCT00535288|62775678|FG004|Overall Study|Other|1|||
33396373|NCT03904420|62775697|FG000|Overall Study|Study terminated|2|||
33567704|NCT01791595|62963585|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
33567705|NCT01791595|62963586|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
33567706|NCT01791595|62963587|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
33567707|NCT01791595|62963588|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
33567708|NCT01791595|62963582|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
33567709|NCT01791595|62963583|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
33567710|NCT01791595|62963584|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
33567711|NCT01791595|62963585|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
33567712|NCT01791595|62963586|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
33567713|NCT01791595|62963587|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
33567714|NCT01791595|62963588|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
33567715|NCT01791595|62963582|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
33664157|NCT02681094|63095177|FG001|2 - Enrolled Participants Set|Other|6|||
33664158|NCT02681094|63095178|FG002|2 - Enrolled Participants Set|Other|7|||
33302813|NCT01250925|62678629|FG000|Overall Study|Physician Decision|0|||
33302814|NCT01250925|62678630|FG001|Overall Study|Physician Decision|2|||
33302815|NCT01250925|62678631|FG002|Overall Study|Physician Decision|1|||
33302816|NCT01250925|62678629|FG000|Overall Study|Adverse Event|0|||
33302817|NCT01250925|62678630|FG001|Overall Study|Adverse Event|0|||
33302818|NCT01250925|62678631|FG002|Overall Study|Adverse Event|1|||
33302819|NCT01285908|62678639|FG000|Baseline Measurement|unable to insert catheter|1|||
33302820|NCT01285908|62678640|FG001|Baseline Measurement|unable to insert catheter|0|||
33302821|NCT01285908|62678641|FG002|Baseline Measurement|unable to insert catheter|0|||
33396374|NCT03904420|62775698|FG001|Overall Study|Study terminated|2|||
33396375|NCT00675506|62775706|FG000|Overall Study|Lost to Follow-up|1|||
33396376|NCT00675506|62775707|FG001|Overall Study|Lost to Follow-up|5|||
33396377|NCT00675506|62775706|FG000|Overall Study|Lost interest|3|||
33396378|NCT00675506|62775707|FG001|Overall Study|Lost interest|5|||
33396379|NCT00675506|62775706|FG000|Overall Study|Elevated fasting glucose|2|||
33396380|NCT00675506|62775707|FG001|Overall Study|Elevated fasting glucose|1|||
33396381|NCT00675506|62775706|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
33396382|NCT00675506|62775707|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
33396383|NCT00675506|62775706|FG000|Overall Study|Elevated IGF-1|2|||
33396384|NCT00675506|62775707|FG001|Overall Study|Elevated IGF-1|0|||
33567716|NCT01791595|62963583|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
33567717|NCT01791595|62963584|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
33567718|NCT01791595|62963585|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
33567719|NCT01791595|62963586|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
33567720|NCT01791595|62963587|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
33567721|NCT01791595|62963588|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
33567722|NCT01791595|62963582|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
33396385|NCT00675506|62775706|FG000|Overall Study|Hypersensitivity Reaction|1|||
33396386|NCT00675506|62775707|FG001|Overall Study|Hypersensitivity Reaction|0|||
33396387|NCT00675506|62775706|FG000|Overall Study|Disclosed history of cancer|1|||
33396388|NCT00675506|62775707|FG001|Overall Study|Disclosed history of cancer|0|||
33396389|NCT00675506|62775706|FG000|Overall Study|Declined participation|1|||
33396390|NCT00675506|62775707|FG001|Overall Study|Declined participation|0|||
33396391|NCT00675506|62775706|FG000|Overall Study|Schedule conflict|0|||
33396392|NCT00675506|62775707|FG001|Overall Study|Schedule conflict|1|||
33396393|NCT03895840|62775714|FG000|Overall Study|Withdrawal by Subject|21|||
33396394|NCT00310375|62775720|FG000|Primary Reporting Phase|Adverse Event|28|||
33396395|NCT00310375|62775721|FG001|Primary Reporting Phase|Adverse Event|22|||
33396396|NCT00310375|62775722|FG002|Primary Reporting Phase|Adverse Event|0|||
33396397|NCT00310375|62775720|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
33396398|NCT00310375|62775721|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
33396399|NCT00310375|62775722|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
33396400|NCT00310375|62775720|FG000|Primary Reporting Phase|Pregnancy|2|||
33396401|NCT00310375|62775721|FG001|Primary Reporting Phase|Pregnancy|2|||
33396402|NCT00310375|62775722|FG002|Primary Reporting Phase|Pregnancy|0|||
33396403|NCT00310375|62775720|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
33567723|NCT01791595|62963583|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
33567724|NCT01791595|62963584|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
33567725|NCT01791595|62963585|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
33567726|NCT01791595|62963586|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
33567727|NCT01791595|62963587|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
33567728|NCT01791595|62963588|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
33567729|NCT01791595|62963582|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
33567730|NCT01791595|62963583|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
33567731|NCT01791595|62963584|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
33567732|NCT01791595|62963585|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
33567733|NCT01791595|62963586|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
33567734|NCT01791595|62963587|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
33567735|NCT01791595|62963588|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
33567736|NCT01791595|62963582|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
33567737|NCT01791595|62963583|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
33567738|NCT01791595|62963584|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
33567739|NCT01791595|62963585|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
33567740|NCT01791595|62963586|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
33567741|NCT01791595|62963587|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
33567742|NCT01791595|62963588|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
33567743|NCT01791595|62963582|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
33567744|NCT01791595|62963583|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
33567745|NCT01791595|62963584|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
33567746|NCT01791595|62963585|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
33567747|NCT01791595|62963586|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
33567748|NCT01791595|62963587|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
33567749|NCT01791595|62963588|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
33567750|NCT01791595|62963582|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
33567751|NCT01791595|62963583|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
33567752|NCT01791595|62963584|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
33567753|NCT01791595|62963585|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
33302822|NCT01285908|62678639|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
33302823|NCT01285908|62678640|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
33302824|NCT01285908|62678641|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
33302825|NCT01285908|62678639|FG000|Baseline Measurement|unable to tolerate procedure|1|||
33302826|NCT01285908|62678640|FG001|Baseline Measurement|unable to tolerate procedure|0|||
33302827|NCT01285908|62678641|FG002|Baseline Measurement|unable to tolerate procedure|0|||
33302828|NCT01250769|62678675|FG000|Overall Study|Withdrawal by Subject|0|||
33302829|NCT01250769|62678676|FG001|Overall Study|Withdrawal by Subject|1|||
33302830|NCT01250769|62678677|FG002|Overall Study|Withdrawal by Subject|1|||
33567754|NCT01791595|62963586|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
33567755|NCT01791595|62963587|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
33567756|NCT01791595|62963588|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
33567757|NCT01791595|62963582|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
33567758|NCT01791595|62963583|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
33567759|NCT01791595|62963584|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
33567760|NCT01791595|62963585|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
33396404|NCT00310375|62775721|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
33396405|NCT00310375|62775722|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
33396406|NCT00310375|62775720|FG000|Primary Reporting Phase|Protocol Violation|8|||
33396407|NCT00310375|62775721|FG001|Primary Reporting Phase|Protocol Violation|5|||
33396408|NCT00310375|62775722|FG002|Primary Reporting Phase|Protocol Violation|0|||
33567761|NCT01791595|62963586|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
33567762|NCT01791595|62963587|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
33567763|NCT01791595|62963588|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
33567764|NCT01791595|62963582|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
33567765|NCT01791595|62963583|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
33567766|NCT01791595|62963584|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
33567767|NCT01791595|62963585|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
33567768|NCT01791595|62963586|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
33567769|NCT01791595|62963587|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
33567770|NCT01791595|62963588|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
33567771|NCT01791595|62963582|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
33567772|NCT01791595|62963583|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
33567773|NCT01791595|62963584|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
33567774|NCT01791595|62963585|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
33567775|NCT01791595|62963586|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
33567776|NCT01791595|62963587|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
33567777|NCT01791595|62963588|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
33567778|NCT01791595|62963582|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
33567779|NCT01791595|62963583|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
33567780|NCT01791595|62963584|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
33567781|NCT01791595|62963585|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
33567782|NCT01791595|62963586|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
33567783|NCT01791595|62963587|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
33567784|NCT01791595|62963588|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
33567785|NCT01791595|62963582|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
33567786|NCT01791595|62963583|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
33567787|NCT01791595|62963584|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
33567788|NCT01791595|62963585|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
33567789|NCT01791595|62963586|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
33567790|NCT01791595|62963587|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
33567791|NCT01791595|62963588|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
33567792|NCT01559363|62963641|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
33567793|NCT01559363|62963642|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
33567794|NCT01559363|62963643|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
33567795|NCT01559363|62963644|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
33567796|NCT01559363|62963645|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
33567797|NCT01559363|62963646|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
33567798|NCT01559363|62963641|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
33567799|NCT01559363|62963642|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
33567800|NCT01559363|62963643|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
33567801|NCT01559363|62963644|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
33567802|NCT01559363|62963645|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
33567803|NCT01559363|62963646|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
33567804|NCT01559363|62963641|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
33567805|NCT01559363|62963642|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
33567806|NCT01559363|62963643|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
33567807|NCT01559363|62963644|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
33567808|NCT01559363|62963645|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
33567809|NCT01559363|62963646|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
33567810|NCT01559363|62963641|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
33567811|NCT01559363|62963642|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
33567812|NCT01559363|62963643|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
33567813|NCT01559363|62963644|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
33567814|NCT01559363|62963645|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
33567815|NCT01559363|62963646|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
33567816|NCT01559363|62963641|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
33567817|NCT01559363|62963642|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
33567818|NCT01559363|62963643|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
33567819|NCT01559363|62963644|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
33567820|NCT01559363|62963645|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
33567821|NCT01559363|62963646|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
33567822|NCT01559363|62963641|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
33567823|NCT01559363|62963642|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
33567824|NCT01559363|62963643|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
33567825|NCT01559363|62963644|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
33396409|NCT00310375|62775720|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
33396410|NCT00310375|62775721|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
33396411|NCT00310375|62775722|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
33396412|NCT00310375|62775720|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
33396413|NCT00310375|62775721|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
33396414|NCT00310375|62775722|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
33396415|NCT00310375|62775720|FG000|Primary Reporting Phase|Physician Decision|5|||
33396416|NCT00310375|62775721|FG001|Primary Reporting Phase|Physician Decision|3|||
33396417|NCT00310375|62775722|FG002|Primary Reporting Phase|Physician Decision|0|||
33396418|NCT00310375|62775720|FG000|Primary Reporting Phase|Request of the sponsor|2|||
33396419|NCT00310375|62775721|FG001|Primary Reporting Phase|Request of the sponsor|2|||
33396420|NCT00310375|62775722|FG002|Primary Reporting Phase|Request of the sponsor|0|||
33396421|NCT00310375|62775720|FG000|Primary Reporting Phase|Failed to return|1|||
33396422|NCT00310375|62775721|FG001|Primary Reporting Phase|Failed to return|3|||
33396423|NCT00310375|62775722|FG002|Primary Reporting Phase|Failed to return|0|||
33396424|NCT00310375|62775720|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
33396425|NCT00310375|62775721|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
33396426|NCT00310375|62775722|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
33396427|NCT00310375|62775720|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
33396428|NCT00310375|62775721|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
33396429|NCT00310375|62775722|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
33396430|NCT00310375|62775720|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
33396431|NCT00310375|62775721|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
33396432|NCT00310375|62775722|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
33396433|NCT00310375|62775720|FG000|Primary Reporting Phase|Site closure|3|||
33396434|NCT00310375|62775721|FG001|Primary Reporting Phase|Site closure|0|||
33396435|NCT00310375|62775722|FG002|Primary Reporting Phase|Site closure|0|||
33396436|NCT00310375|62775720|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
33396437|NCT00310375|62775721|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
33396438|NCT00310375|62775722|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
33396439|NCT00310375|62775720|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
33396440|NCT00310375|62775721|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
33396441|NCT00310375|62775722|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
33396442|NCT00310375|62775720|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
33396443|NCT00310375|62775721|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
33396444|NCT00310375|62775722|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
33396445|NCT00310375|62775720|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
33396446|NCT00310375|62775721|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
33396447|NCT00310375|62775722|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
33396448|NCT00309907|62775731|FG000|Overall Study|Death|4|||
33396449|NCT00309907|62775731|FG000|Overall Study|Physician Decision|1|||
33396450|NCT00309907|62775731|FG000|Overall Study|Ineligible|11|||
33396451|NCT00309907|62775731|FG000|Overall Study|Major infectious event|4|||
33396452|NCT00655824|62775736|FG000|Overall Study|Adverse Event|3|||
33396453|NCT00655824|62775736|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
33396454|NCT00655824|62775736|FG000|Overall Study|Protocol Violation|1|||
33396455|NCT00655824|62775736|FG000|Overall Study|Withdrawal by Subject|4|||
33396456|NCT00655824|62775736|FG000|Overall Study|Deterioration of Trial Disease|2|||
33396457|NCT00575588|62775742|FG000|Overall Study|Adverse Event|11|||
33396458|NCT00575588|62775743|FG001|Overall Study|Adverse Event|13|||
33396459|NCT00575588|62775742|FG000|Overall Study|Withdrawal by Subject|27|||
33396460|NCT00575588|62775743|FG001|Overall Study|Withdrawal by Subject|31|||
33396461|NCT00575588|62775742|FG000|Overall Study|Lost to Follow-up|1|||
33396462|NCT00575588|62775743|FG001|Overall Study|Lost to Follow-up|3|||
33396463|NCT00575588|62775742|FG000|Overall Study|Death|4|||
33396464|NCT00575588|62775743|FG001|Overall Study|Death|2|||
33396465|NCT00575588|62775742|FG000|Overall Study|Incorrect enrollment|8|||
33396466|NCT00575588|62775743|FG001|Overall Study|Incorrect enrollment|4|||
33396467|NCT00575588|62775742|FG000|Overall Study|Study specific discontinuation criteria|203|||
33396468|NCT00575588|62775743|FG001|Overall Study|Study specific discontinuation criteria|218|||
33396469|NCT00575588|62775742|FG000|Overall Study|Severe non-compliance to protocol|5|||
33396470|NCT00575588|62775743|FG001|Overall Study|Severe non-compliance to protocol|7|||
33396471|NCT00575588|62775742|FG000|Overall Study|Safety reasons|2|||
33396472|NCT00575588|62775743|FG001|Overall Study|Safety reasons|1|||
33396473|NCT00575588|62775742|FG000|Overall Study|Elevated triglyceride|1|||
33567826|NCT01559363|62963645|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
33567827|NCT01559363|62963646|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
33567828|NCT01559363|62963641|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
33396474|NCT00575588|62775743|FG001|Overall Study|Elevated triglyceride|0|||
33396475|NCT00575588|62775742|FG000|Overall Study|Patient moved|1|||
33396476|NCT00575588|62775743|FG001|Overall Study|Patient moved|3|||
33396477|NCT00575588|62775742|FG000|Overall Study|Impossible to determine HbA1c|0|||
33396478|NCT00575588|62775743|FG001|Overall Study|Impossible to determine HbA1c|1|||
33396479|NCT00675428|62775751|FG000|Overall Study|Disease Progression|2|||
33396480|NCT00675428|62775752|FG001|Overall Study|Disease Progression|2|||
33396481|NCT00675428|62775751|FG000|Overall Study|No Disease Response After Cycle 6|0|||
33396482|NCT00675428|62775752|FG001|Overall Study|No Disease Response After Cycle 6|1|||
33396483|NCT00675428|62775751|FG000|Overall Study|Physician Decision|1|||
33396484|NCT00675428|62775752|FG001|Overall Study|Physician Decision|0|||
33396485|NCT00557505|62775776|FG000|Overall Study|Death|0|||
33396486|NCT00557505|62775777|FG001|Overall Study|Death|0|||
33396487|NCT00557505|62775778|FG002|Overall Study|Death|0|||
33396488|NCT00557505|62775779|FG003|Overall Study|Death|0|||
33396489|NCT00557505|62775780|FG004|Overall Study|Death|0|||
33396490|NCT00557505|62775781|FG005|Overall Study|Death|0|||
33396491|NCT00557505|62775782|FG006|Overall Study|Death|0|||
33396492|NCT00557505|62775783|FG007|Overall Study|Death|0|||
33396493|NCT00557505|62775784|FG008|Overall Study|Death|1|||
33396494|NCT00557505|62775776|FG000|Overall Study|Adverse Event|0|||
33396495|NCT00557505|62775777|FG001|Overall Study|Adverse Event|0|||
33396496|NCT00557505|62775778|FG002|Overall Study|Adverse Event|1|||
33396497|NCT00557505|62775779|FG003|Overall Study|Adverse Event|0|||
33396498|NCT00557505|62775780|FG004|Overall Study|Adverse Event|0|||
33396499|NCT00557505|62775781|FG005|Overall Study|Adverse Event|0|||
33396500|NCT00557505|62775782|FG006|Overall Study|Adverse Event|1|||
33396501|NCT00557505|62775783|FG007|Overall Study|Adverse Event|0|||
33396502|NCT00557505|62775784|FG008|Overall Study|Adverse Event|0|||
33396503|NCT00557505|62775776|FG000|Overall Study|Global deterioration of health|1|||
33396504|NCT00557505|62775777|FG001|Overall Study|Global deterioration of health|0|||
33396505|NCT00557505|62775778|FG002|Overall Study|Global deterioration of health|0|||
33396506|NCT00557505|62775779|FG003|Overall Study|Global deterioration of health|0|||
33396507|NCT00557505|62775780|FG004|Overall Study|Global deterioration of health|0|||
33396508|NCT00557505|62775781|FG005|Overall Study|Global deterioration of health|0|||
33396509|NCT00557505|62775782|FG006|Overall Study|Global deterioration of health|0|||
33396510|NCT00557505|62775783|FG007|Overall Study|Global deterioration of health|0|||
33567829|NCT01559363|62963642|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
33567830|NCT01559363|62963643|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
33567831|NCT01559363|62963644|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
33567832|NCT01559363|62963645|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
33567833|NCT01559363|62963646|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
33567834|NCT02732327|62963668|FG000|Overall Study|Protocol Violation|0|||
33567835|NCT02732327|62963669|FG001|Overall Study|Protocol Violation|1|||
33567836|NCT03179605|62963675|FG000|Overall Study|Withdrawal by Subject|1|||
33567837|NCT02412722|62963685|FG000|Overall Study|Adverse Event|0|||
33567838|NCT02412722|62963686|FG001|Overall Study|Adverse Event|2|||
33567839|NCT02412722|62963687|FG002|Overall Study|Adverse Event|0|||
33567840|NCT02412722|62963688|FG003|Overall Study|Adverse Event|3|||
33567841|NCT02412722|62963689|FG004|Overall Study|Adverse Event|0|||
33567842|NCT02412722|62963690|FG005|Overall Study|Adverse Event|3|||
33567843|NCT02412722|62963685|FG000|Overall Study|Progressive Disease|6|||
33567844|NCT02412722|62963686|FG001|Overall Study|Progressive Disease|4|||
33567845|NCT02412722|62963687|FG002|Overall Study|Progressive Disease|4|||
33567846|NCT02412722|62963688|FG003|Overall Study|Progressive Disease|9|||
33567847|NCT02412722|62963689|FG004|Overall Study|Progressive Disease|3|||
33567848|NCT02412722|62963690|FG005|Overall Study|Progressive Disease|3|||
33567849|NCT02412722|62963685|FG000|Overall Study|Withdrawal by Subject|2|||
33567850|NCT02412722|62963686|FG001|Overall Study|Withdrawal by Subject|0|||
33567851|NCT02412722|62963687|FG002|Overall Study|Withdrawal by Subject|1|||
33567852|NCT02412722|62963688|FG003|Overall Study|Withdrawal by Subject|2|||
33567853|NCT02412722|62963689|FG004|Overall Study|Withdrawal by Subject|1|||
33567854|NCT02412722|62963690|FG005|Overall Study|Withdrawal by Subject|1|||
33567855|NCT02412722|62963685|FG000|Overall Study|Lost to Follow-up|0|||
33567856|NCT02412722|62963686|FG001|Overall Study|Lost to Follow-up|0|||
33567857|NCT02412722|62963687|FG002|Overall Study|Lost to Follow-up|0|||
33396511|NCT00557505|62775784|FG008|Overall Study|Global deterioration of health|0|||
33396512|NCT00557505|62775776|FG000|Overall Study|Objective progression or relapse|2|||
33396513|NCT00557505|62775777|FG001|Overall Study|Objective progression or relapse|3|||
33396514|NCT00557505|62775778|FG002|Overall Study|Objective progression or relapse|3|||
33396515|NCT00557505|62775779|FG003|Overall Study|Objective progression or relapse|2|||
33396516|NCT00557505|62775780|FG004|Overall Study|Objective progression or relapse|2|||
33396517|NCT00557505|62775781|FG005|Overall Study|Objective progression or relapse|3|||
33567858|NCT02412722|62963688|FG003|Overall Study|Lost to Follow-up|0|||
33567859|NCT02412722|62963689|FG004|Overall Study|Lost to Follow-up|1|||
33567860|NCT02412722|62963690|FG005|Overall Study|Lost to Follow-up|0|||
33567861|NCT02412722|62963685|FG000|Overall Study|Received drug in run-in and discontinued|0|||
33567862|NCT02412722|62963686|FG001|Overall Study|Received drug in run-in and discontinued|2|||
33396518|NCT00557505|62775782|FG006|Overall Study|Objective progression or relapse|2|||
33396519|NCT00557505|62775783|FG007|Overall Study|Objective progression or relapse|5|||
33396520|NCT00557505|62775784|FG008|Overall Study|Objective progression or relapse|15|||
33396521|NCT00557505|62775776|FG000|Overall Study|Withdrawal by Subject|0|||
33396522|NCT00557505|62775777|FG001|Overall Study|Withdrawal by Subject|0|||
33396523|NCT00557505|62775778|FG002|Overall Study|Withdrawal by Subject|0|||
33396524|NCT00557505|62775779|FG003|Overall Study|Withdrawal by Subject|1|||
33396525|NCT00557505|62775780|FG004|Overall Study|Withdrawal by Subject|0|||
33396526|NCT00557505|62775781|FG005|Overall Study|Withdrawal by Subject|0|||
33396527|NCT00557505|62775782|FG006|Overall Study|Withdrawal by Subject|0|||
33396528|NCT00557505|62775783|FG007|Overall Study|Withdrawal by Subject|0|||
33396529|NCT00557505|62775784|FG008|Overall Study|Withdrawal by Subject|1|||
33396530|NCT00674570|62775810|FG000|Overall Study|Withdrawal by Subject|0|||
33396531|NCT00674570|62775811|FG001|Overall Study|Withdrawal by Subject|2|||
33396532|NCT00674570|62775812|FG002|Overall Study|Withdrawal by Subject|0|||
33396533|NCT00561951|62775823|FG000|Overall Study|Adverse Event|11|||
33396534|NCT00561951|62775824|FG001|Overall Study|Adverse Event|14|||
33396535|NCT00561951|62775825|FG002|Overall Study|Adverse Event|14|||
33396536|NCT00561951|62775823|FG000|Overall Study|Lack of Efficacy|5|||
33396537|NCT00561951|62775824|FG001|Overall Study|Lack of Efficacy|3|||
33396538|NCT00561951|62775825|FG002|Overall Study|Lack of Efficacy|2|||
33396539|NCT00561951|62775823|FG000|Overall Study|Lost to Follow-up|1|||
33396540|NCT00561951|62775824|FG001|Overall Study|Lost to Follow-up|1|||
33396541|NCT00561951|62775825|FG002|Overall Study|Lost to Follow-up|0|||
33396542|NCT00561951|62775823|FG000|Overall Study|Withdrawal by Subject|10|||
33396543|NCT00561951|62775824|FG001|Overall Study|Withdrawal by Subject|9|||
33396544|NCT00561951|62775825|FG002|Overall Study|Withdrawal by Subject|10|||
33396545|NCT00561951|62775823|FG000|Overall Study|Protocol Violation|4|||
33396546|NCT00561951|62775824|FG001|Overall Study|Protocol Violation|3|||
33396547|NCT00561951|62775825|FG002|Overall Study|Protocol Violation|4|||
33396548|NCT00561951|62775823|FG000|Overall Study|Physician Decision|1|||
33396549|NCT00561951|62775824|FG001|Overall Study|Physician Decision|0|||
33396550|NCT00561951|62775825|FG002|Overall Study|Physician Decision|0|||
33396551|NCT00561951|62775823|FG000|Overall Study|Pregnancy|0|||
33396552|NCT00561951|62775824|FG001|Overall Study|Pregnancy|1|||
33396553|NCT00561951|62775825|FG002|Overall Study|Pregnancy|0|||
33396554|NCT00561951|62775823|FG000|Overall Study|Meet Withdrawal Criterion|0|||
33396555|NCT00561951|62775824|FG001|Overall Study|Meet Withdrawal Criterion|1|||
33396556|NCT00561951|62775825|FG002|Overall Study|Meet Withdrawal Criterion|1|||
33396557|NCT00561951|62775823|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
33396558|NCT00561951|62775824|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
33396559|NCT00561951|62775825|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
33567863|NCT02412722|62963687|FG002|Overall Study|Received drug in run-in and discontinued|0|||
33567864|NCT02412722|62963688|FG003|Overall Study|Received drug in run-in and discontinued|0|||
33302831|NCT01250769|62678678|FG003|Overall Study|Withdrawal by Subject|0|||
33302832|NCT01250769|62678675|FG000|Overall Study|Adverse Event|0|||
33302833|NCT01250769|62678676|FG001|Overall Study|Adverse Event|0|||
33302834|NCT01250769|62678677|FG002|Overall Study|Adverse Event|1|||
33302835|NCT01250769|62678678|FG003|Overall Study|Adverse Event|0|||
33302836|NCT01074268|62678690|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
33302837|NCT01074268|62678691|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
33302838|NCT01074268|62678690|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
33302839|NCT01074268|62678691|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
33302840|NCT01074268|62678690|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
33396560|NCT00322387|62775835|FG000|Treatment Period|Adverse Event|0|||
33302841|NCT01074268|62678691|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
33302842|NCT01074268|62678690|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
33302843|NCT01074268|62678691|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
33302844|NCT01074268|62678690|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
33302845|NCT01074268|62678691|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
33396561|NCT00322387|62775836|FG001|Treatment Period|Adverse Event|1|||
33396562|NCT00322387|62775835|FG000|Follow-up Period|Final assessment not done|1|||
33567865|NCT02412722|62963689|FG004|Overall Study|Received drug in run-in and discontinued|0|||
33567866|NCT02412722|62963690|FG005|Overall Study|Received drug in run-in and discontinued|0|||
33567867|NCT02412722|62963685|FG000|Overall Study|Reason not Specified|3|||
33567868|NCT02412722|62963686|FG001|Overall Study|Reason not Specified|0|||
33567869|NCT02412722|62963687|FG002|Overall Study|Reason not Specified|2|||
33567870|NCT02412722|62963688|FG003|Overall Study|Reason not Specified|1|||
33567871|NCT02412722|62963689|FG004|Overall Study|Reason not Specified|2|||
33567872|NCT02412722|62963690|FG005|Overall Study|Reason not Specified|6|||
33567873|NCT03074695|62963726|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
33567874|NCT03074695|62963727|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
33302846|NCT01074268|62678690|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
33396563|NCT00322387|62775836|FG001|Follow-up Period|Final assessment not done|3|||
33396564|NCT00322387|62775835|FG000|Follow-up Period|Death|1|||
33396565|NCT00322387|62775836|FG001|Follow-up Period|Death|0|||
33396566|NCT00561015|62775859|FG000|Overall Study|Adverse Event|0|||
33396567|NCT00561015|62775860|FG001|Overall Study|Adverse Event|0|||
33396568|NCT00561015|62775861|FG002|Overall Study|Adverse Event|0|||
33396569|NCT00561015|62775862|FG003|Overall Study|Adverse Event|0|||
33396570|NCT00561015|62775863|FG004|Overall Study|Adverse Event|1|||
33396571|NCT00561015|62775864|FG005|Overall Study|Adverse Event|0|||
33396572|NCT00561015|62775859|FG000|Overall Study|Lost to Follow-up|2|||
33396573|NCT00561015|62775860|FG001|Overall Study|Lost to Follow-up|0|||
33396574|NCT00561015|62775861|FG002|Overall Study|Lost to Follow-up|0|||
33396575|NCT00561015|62775862|FG003|Overall Study|Lost to Follow-up|1|||
33396576|NCT00561015|62775863|FG004|Overall Study|Lost to Follow-up|0|||
33396577|NCT00561015|62775864|FG005|Overall Study|Lost to Follow-up|3|||
33396578|NCT00561015|62775859|FG000|Overall Study|Participant non-compliance|2|||
33396579|NCT00561015|62775860|FG001|Overall Study|Participant non-compliance|0|||
33396580|NCT00561015|62775861|FG002|Overall Study|Participant non-compliance|0|||
33396581|NCT00561015|62775862|FG003|Overall Study|Participant non-compliance|0|||
33396582|NCT00561015|62775863|FG004|Overall Study|Participant non-compliance|0|||
33396583|NCT00561015|62775864|FG005|Overall Study|Participant non-compliance|0|||
33396584|NCT00560937|62775884|FG000|Overall Study|Withdrawal by Subject|0|||
33396585|NCT00560937|62775885|FG001|Overall Study|Withdrawal by Subject|1|||
33396586|NCT00560937|62775884|FG000|Overall Study|Physician Decision|1|||
33396587|NCT00560937|62775885|FG001|Overall Study|Physician Decision|1|||
33396588|NCT00561795|62775893|FG000|Overall Study|Adverse Event|3|||
33396589|NCT00561795|62775894|FG001|Overall Study|Adverse Event|3|||
33396590|NCT00561795|62775895|FG002|Overall Study|Adverse Event|0|||
33396591|NCT00561795|62775896|FG003|Overall Study|Adverse Event|0|||
33396592|NCT00561795|62775893|FG000|Overall Study|Study Closed/Terminated|0|||
33396593|NCT00561795|62775894|FG001|Overall Study|Study Closed/Terminated|3|||
33396594|NCT00561795|62775895|FG002|Overall Study|Study Closed/Terminated|0|||
33396595|NCT00561795|62775896|FG003|Overall Study|Study Closed/Terminated|0|||
33396596|NCT00561795|62775893|FG000|Overall Study|Physician Decision|1|||
33396597|NCT00561795|62775894|FG001|Overall Study|Physician Decision|0|||
33396598|NCT00561795|62775895|FG002|Overall Study|Physician Decision|0|||
33396599|NCT00561795|62775896|FG003|Overall Study|Physician Decision|0|||
33396600|NCT00652626|62775911|FG000|Initial Treatment Phase|Adverse Event|0|||
33396601|NCT00652626|62775912|FG001|Initial Treatment Phase|Adverse Event|0|||
33396602|NCT00652626|62775913|FG002|Initial Treatment Phase|Adverse Event|0|||
33396603|NCT00652626|62775914|FG003|Initial Treatment Phase|Adverse Event|0|||
33396604|NCT00652626|62775915|FG004|Initial Treatment Phase|Adverse Event|1|||
33396605|NCT00652626|62775916|FG005|Initial Treatment Phase|Adverse Event|0|||
33396606|NCT00652626|62775917|FG006|Initial Treatment Phase|Adverse Event|0|||
33396607|NCT00652626|62775911|FG000|Initial Treatment Phase|Protocol Violation|0|||
33396608|NCT00652626|62775912|FG001|Initial Treatment Phase|Protocol Violation|0|||
33396609|NCT00652626|62775913|FG002|Initial Treatment Phase|Protocol Violation|0|||
33396610|NCT00652626|62775914|FG003|Initial Treatment Phase|Protocol Violation|1|||
33396611|NCT00652626|62775915|FG004|Initial Treatment Phase|Protocol Violation|0|||
33396612|NCT00652626|62775916|FG005|Initial Treatment Phase|Protocol Violation|0|||
33396613|NCT00652626|62775917|FG006|Initial Treatment Phase|Protocol Violation|0|||
33396614|NCT00652626|62775911|FG000|Initial Treatment Phase|Physician Decision|0|||
33396615|NCT00652626|62775912|FG001|Initial Treatment Phase|Physician Decision|0|||
33396616|NCT00652626|62775913|FG002|Initial Treatment Phase|Physician Decision|0|||
33396617|NCT00652626|62775914|FG003|Initial Treatment Phase|Physician Decision|0|||
33396618|NCT00652626|62775915|FG004|Initial Treatment Phase|Physician Decision|1|||
33396619|NCT00652626|62775916|FG005|Initial Treatment Phase|Physician Decision|0|||
33396620|NCT00652626|62775917|FG006|Initial Treatment Phase|Physician Decision|0|||
33396621|NCT00652626|62775911|FG000|Initial Treatment Phase|Sponsor Request|0|||
33396622|NCT00652626|62775912|FG001|Initial Treatment Phase|Sponsor Request|0|||
33396623|NCT00652626|62775913|FG002|Initial Treatment Phase|Sponsor Request|1|||
33396624|NCT00652626|62775914|FG003|Initial Treatment Phase|Sponsor Request|0|||
33396625|NCT00652626|62775915|FG004|Initial Treatment Phase|Sponsor Request|0|||
33396626|NCT00652626|62775916|FG005|Initial Treatment Phase|Sponsor Request|0|||
33396627|NCT00652626|62775917|FG006|Initial Treatment Phase|Sponsor Request|0|||
33396628|NCT00652626|62775911|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
33396629|NCT00652626|62775912|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
33396630|NCT00652626|62775913|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
33396631|NCT00652626|62775914|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
33396632|NCT00652626|62775915|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
33396633|NCT00652626|62775916|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
33396634|NCT00652626|62775917|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
33396635|NCT00652626|62775911|FG000|Extension Phase|Withdrawal by Subject|0|||
33396636|NCT00652626|62775912|FG001|Extension Phase|Withdrawal by Subject|0|||
33396637|NCT00652626|62775913|FG002|Extension Phase|Withdrawal by Subject|0|||
33396638|NCT00652626|62775914|FG003|Extension Phase|Withdrawal by Subject|0|||
33396639|NCT00652626|62775915|FG004|Extension Phase|Withdrawal by Subject|0|||
33396640|NCT00652626|62775916|FG005|Extension Phase|Withdrawal by Subject|2|||
33396641|NCT00652626|62775917|FG006|Extension Phase|Withdrawal by Subject|0|||
33396642|NCT00652626|62775911|FG000|Extension Phase|Adverse Event|0|||
33396643|NCT00652626|62775912|FG001|Extension Phase|Adverse Event|0|||
33396644|NCT00652626|62775913|FG002|Extension Phase|Adverse Event|0|||
33396645|NCT00652626|62775914|FG003|Extension Phase|Adverse Event|0|||
33396646|NCT00652626|62775915|FG004|Extension Phase|Adverse Event|0|||
33396647|NCT00652626|62775916|FG005|Extension Phase|Adverse Event|2|||
33396648|NCT00652626|62775917|FG006|Extension Phase|Adverse Event|1|||
33396649|NCT00652626|62775911|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
33396650|NCT00652626|62775912|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
33396651|NCT00652626|62775913|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
33567875|NCT03074695|62963726|FG000|Overall Study|Research staff not available|1|||
33567876|NCT03074695|62963727|FG001|Overall Study|Research staff not available|2|||
33567877|NCT03074695|62963726|FG000|Overall Study|Did not receive neuraxial block|2|||
33567878|NCT03074695|62963727|FG001|Overall Study|Did not receive neuraxial block|2|||
33567879|NCT03469999|62963733|FG000|Overall Study|Lost to Follow-up|2|||
33567880|NCT02379728|62963740|FG000|Overall Study|Lost to Follow-up|1|||
33567881|NCT02379728|62963741|FG001|Overall Study|Lost to Follow-up|0|||
33567882|NCT02379728|62963742|FG002|Overall Study|Lost to Follow-up|3|||
33567883|NCT02379728|62963743|FG003|Overall Study|Lost to Follow-up|0|||
33567884|NCT02379728|62963740|FG000|Overall Study|Withdrawal by Subject|5|||
33567885|NCT02379728|62963741|FG001|Overall Study|Withdrawal by Subject|0|||
33567886|NCT02379728|62963742|FG002|Overall Study|Withdrawal by Subject|5|||
33567887|NCT02379728|62963743|FG003|Overall Study|Withdrawal by Subject|3|||
33567888|NCT02379728|62963740|FG000|Overall Study|Protocol Violation|0|||
33567889|NCT02379728|62963741|FG001|Overall Study|Protocol Violation|0|||
33567890|NCT02379728|62963742|FG002|Overall Study|Protocol Violation|2|||
33567891|NCT02379728|62963743|FG003|Overall Study|Protocol Violation|0|||
33567892|NCT03463993|62963754|FG000|Overall Study|Lost to Follow-up|7|||
33567893|NCT03463993|62963755|FG001|Overall Study|Lost to Follow-up|8|||
33567894|NCT03463993|62963754|FG000|Overall Study|Withdrawal by Subject|2|||
33567895|NCT03463993|62963755|FG001|Overall Study|Withdrawal by Subject|0|||
33567896|NCT03463993|62963754|FG000|Overall Study|Protocol Violation|4|||
33567897|NCT03463993|62963755|FG001|Overall Study|Protocol Violation|1|||
33567898|NCT03463993|62963754|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
33567899|NCT03463993|62963755|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
33567900|NCT03463993|62963754|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
33567901|NCT03463993|62963755|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
33567902|NCT02412488|62963770|FG000|Overall Study|Lost to Follow-up|10|||
33567903|NCT02412488|62963770|FG000|Overall Study|Withdrawal by Subject|5|||
33567904|NCT02412488|62963770|FG000|Overall Study|Physician Decision|1|||
33567905|NCT02412488|62963770|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
33567906|NCT02412488|62963770|FG000|Overall Study|Reveal LINQ explant|1|||
33567907|NCT02378480|62963776|FG000|Overall Study|Physician Decision|1|||
33567908|NCT02378480|62963777|FG001|Overall Study|Physician Decision|1|||
33567909|NCT02378480|62963776|FG000|Overall Study|Death|1|||
33567910|NCT02378480|62963777|FG001|Overall Study|Death|2|||
33567911|NCT02378480|62963776|FG000|Overall Study|Randomized, but Not Treated|6|||
33567912|NCT02378480|62963777|FG001|Overall Study|Randomized, but Not Treated|4|||
33567913|NCT02378480|62963776|FG000|Overall Study|Adverse Event|0|||
33567914|NCT02378480|62963777|FG001|Overall Study|Adverse Event|1|||
33567915|NCT02378480|62963776|FG000|Overall Study|Missed EOT/PTE Visit|1|||
33567916|NCT02378480|62963777|FG001|Overall Study|Missed EOT/PTE Visit|2|||
33567917|NCT02378480|62963776|FG000|Overall Study|Withdrawal by Subject|9|||
33567918|NCT02378480|62963777|FG001|Overall Study|Withdrawal by Subject|4|||
33567919|NCT02378480|62963776|FG000|Overall Study|Lost to Follow-up|10|||
33567920|NCT02378480|62963777|FG001|Overall Study|Lost to Follow-up|18|||
33567921|NCT02411396|62963783|FG000|Overall Study|Lost to Follow-up|31|||
33567922|NCT02411396|62963783|FG000|Overall Study|Death|10|||
33567923|NCT02345252|62963804|FG000|Double-Blind Phase|Adverse Event|2|||
33302847|NCT01074268|62678691|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
33302848|NCT01074268|62678690|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
33302849|NCT01074268|62678691|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
33396652|NCT00652626|62775914|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
33567924|NCT02345252|62963805|FG001|Double-Blind Phase|Adverse Event|3|||
33567925|NCT02345252|62963804|FG000|Double-Blind Phase|Death|1|||
33567926|NCT02345252|62963805|FG001|Double-Blind Phase|Death|2|||
33567927|NCT02345252|62963804|FG000|Double-Blind Phase|Lack of Efficacy|1|||
33567928|NCT02345252|62963805|FG001|Double-Blind Phase|Lack of Efficacy|0|||
33567929|NCT02345252|62963804|FG000|Double-Blind Phase|Investigator's Discretion|4|||
33567930|NCT02345252|62963805|FG001|Double-Blind Phase|Investigator's Discretion|6|||
33567931|NCT02345252|62963804|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
33567932|NCT02345252|62963805|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
33567933|NCT02345252|62963804|FG000|Double-Blind Phase|Protocol Violation|2|||
33396653|NCT00652626|62775915|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
33567934|NCT02345252|62963805|FG001|Double-Blind Phase|Protocol Violation|1|||
33567935|NCT02345252|62963804|FG000|Double-Blind Phase|Withdrew Consent|21|||
33567936|NCT02345252|62963805|FG001|Double-Blind Phase|Withdrew Consent|23|||
33567937|NCT02345252|62963804|FG000|Double-Blind Phase|Lost to Follow-up|8|||
33567938|NCT02345252|62963805|FG001|Double-Blind Phase|Lost to Follow-up|10|||
33567939|NCT02345252|62963804|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
33567940|NCT02345252|62963805|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
33567941|NCT01239797|62963815|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
33567942|NCT01239797|62963816|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
33567943|NCT01239797|62963815|FG000|Randomized Participants|Participant withdrew consent|1|||
33567944|NCT01239797|62963816|FG001|Randomized Participants|Participant withdrew consent|7|||
33567945|NCT01239797|62963815|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
33567946|NCT01239797|62963816|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
33567947|NCT01239797|62963815|FG000|Treated Participants|Disease progression|185|||
33567948|NCT01239797|62963816|FG001|Treated Participants|Disease progression|185|||
33567949|NCT01239797|62963815|FG000|Treated Participants|Study drug toxicity|39|||
33567950|NCT01239797|62963816|FG001|Treated Participants|Study drug toxicity|45|||
33567951|NCT01239797|62963815|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
33567952|NCT01239797|62963816|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
33567953|NCT01239797|62963815|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
33567954|NCT01239797|62963816|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
33567955|NCT01239797|62963815|FG000|Treated Participants|Administrative reason by sponsor|13|||
33567956|NCT01239797|62963816|FG001|Treated Participants|Administrative reason by sponsor|4|||
33567957|NCT01239797|62963815|FG000|Treated Participants|Other reasons|14|||
33567958|NCT01239797|62963816|FG001|Treated Participants|Other reasons|14|||
33567959|NCT01239797|62963815|FG000|Treated Participants|Participant withdrew consent|6|||
33567960|NCT01239797|62963816|FG001|Treated Participants|Participant withdrew consent|11|||
33567961|NCT01239797|62963815|FG000|Treated Participants|Death|1|||
33567962|NCT01239797|62963816|FG001|Treated Participants|Death|1|||
33567963|NCT01239797|62963815|FG000|Treated Participants|Participant no longer meets study criteria|1|||
33567964|NCT01239797|62963816|FG001|Treated Participants|Participant no longer meets study criteria|1|||
33567965|NCT01239797|62963815|FG000|Treated Participants|Poor/non-compliance|0|||
33567966|NCT01239797|62963816|FG001|Treated Participants|Poor/non-compliance|1|||
33567967|NCT01092143|62963827|FG000|Overall Study|Adverse Event|10|||
33567968|NCT01092143|62963828|FG001|Overall Study|Adverse Event|5|||
33567969|NCT01092143|62963829|FG002|Overall Study|Adverse Event|1|||
33567970|NCT01092143|62963830|FG003|Overall Study|Adverse Event|4|||
33567971|NCT01092143|62963831|FG004|Overall Study|Adverse Event|3|||
33567972|NCT01092143|62963827|FG000|Overall Study|Lost to Follow-up|1|||
33567973|NCT01092143|62963828|FG001|Overall Study|Lost to Follow-up|0|||
33567974|NCT01092143|62963829|FG002|Overall Study|Lost to Follow-up|1|||
33567975|NCT01092143|62963830|FG003|Overall Study|Lost to Follow-up|0|||
33567976|NCT01092143|62963831|FG004|Overall Study|Lost to Follow-up|0|||
33567977|NCT01092143|62963827|FG000|Overall Study|Consent withdrawn|2|||
33567978|NCT01092143|62963828|FG001|Overall Study|Consent withdrawn|1|||
33567979|NCT01092143|62963829|FG002|Overall Study|Consent withdrawn|0|||
33567980|NCT01092143|62963830|FG003|Overall Study|Consent withdrawn|1|||
33567981|NCT01092143|62963831|FG004|Overall Study|Consent withdrawn|3|||
33567982|NCT01092143|62963827|FG000|Overall Study|Not treated|0|||
33567983|NCT01092143|62963828|FG001|Overall Study|Not treated|0|||
33567984|NCT01092143|62963829|FG002|Overall Study|Not treated|1|||
33567985|NCT01092143|62963830|FG003|Overall Study|Not treated|0|||
33567986|NCT01092143|62963831|FG004|Overall Study|Not treated|0|||
33567987|NCT01092143|62963827|FG000|Overall Study|did not reversibility criteria|0|||
33567988|NCT01092143|62963828|FG001|Overall Study|did not reversibility criteria|0|||
33567989|NCT01092143|62963829|FG002|Overall Study|did not reversibility criteria|1|||
33567990|NCT01092143|62963830|FG003|Overall Study|did not reversibility criteria|0|||
33567991|NCT01092143|62963831|FG004|Overall Study|did not reversibility criteria|0|||
33567992|NCT01092143|62963827|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
33567993|NCT01092143|62963828|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
33567994|NCT01092143|62963829|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
33567995|NCT01092143|62963830|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
33567996|NCT01092143|62963831|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
33567997|NCT01092143|62963827|FG000|Overall Study|Ineligible patient|1|||
33567998|NCT01092143|62963828|FG001|Overall Study|Ineligible patient|0|||
33567999|NCT01092143|62963829|FG002|Overall Study|Ineligible patient|0|||
33568000|NCT01092143|62963830|FG003|Overall Study|Ineligible patient|0|||
33568001|NCT01092143|62963831|FG004|Overall Study|Ineligible patient|0|||
33568002|NCT01092143|62963827|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
33568003|NCT01092143|62963828|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
33568004|NCT01092143|62963829|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
33568005|NCT01092143|62963830|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
33568006|NCT01092143|62963831|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
33568007|NCT01092143|62963827|FG000|Overall Study|Patient travel|0|||
33568008|NCT01092143|62963828|FG001|Overall Study|Patient travel|0|||
33568009|NCT01092143|62963829|FG002|Overall Study|Patient travel|0|||
33568010|NCT01092143|62963830|FG003|Overall Study|Patient travel|0|||
33568011|NCT01092143|62963831|FG004|Overall Study|Patient travel|1|||
33568012|NCT01092143|62963827|FG000|Overall Study|Non compliance with study medication|0|||
33568013|NCT01092143|62963828|FG001|Overall Study|Non compliance with study medication|0|||
33568014|NCT01092143|62963829|FG002|Overall Study|Non compliance with study medication|0|||
33568015|NCT01092143|62963830|FG003|Overall Study|Non compliance with study medication|0|||
33568016|NCT01092143|62963831|FG004|Overall Study|Non compliance with study medication|1|||
33568017|NCT01092143|62963827|FG000|Overall Study|Randomized by mistake|0|||
33568018|NCT01092143|62963828|FG001|Overall Study|Randomized by mistake|0|||
33568019|NCT01092143|62963829|FG002|Overall Study|Randomized by mistake|0|||
33568020|NCT01092143|62963830|FG003|Overall Study|Randomized by mistake|1|||
33568021|NCT01092143|62963831|FG004|Overall Study|Randomized by mistake|0|||
33568022|NCT01092143|62963827|FG000|Overall Study|Pregnancy|0|||
33568023|NCT01092143|62963828|FG001|Overall Study|Pregnancy|0|||
33568024|NCT01092143|62963829|FG002|Overall Study|Pregnancy|0|||
33568025|NCT01092143|62963830|FG003|Overall Study|Pregnancy|1|||
33568026|NCT01092143|62963831|FG004|Overall Study|Pregnancy|0|||
33568027|NCT02377466|62963845|FG000|Overall Study|Other: Randomized and not treated|0|||
33568028|NCT02377466|62963846|FG001|Overall Study|Other: Randomized and not treated|2|||
33568029|NCT00950989|62963863|FG000|Overall Study|Death|0|||
33568030|NCT00950989|62963864|FG001|Overall Study|Death|0|||
33568031|NCT00950989|62963865|FG002|Overall Study|Death|1|||
33568032|NCT00950989|62963866|FG003|Overall Study|Death|0|||
33568033|NCT00950989|62963863|FG000|Overall Study|Administrative Decision|0|||
33568034|NCT00950989|62963864|FG001|Overall Study|Administrative Decision|1|||
33568035|NCT00950989|62963865|FG002|Overall Study|Administrative Decision|0|||
33568036|NCT00950989|62963866|FG003|Overall Study|Administrative Decision|0|||
33568037|NCT00950989|62963863|FG000|Overall Study|Disease Progression|0|||
33568038|NCT00950989|62963864|FG001|Overall Study|Disease Progression|0|||
33568039|NCT00950989|62963865|FG002|Overall Study|Disease Progression|1|||
33568040|NCT00950989|62963866|FG003|Overall Study|Disease Progression|0|||
33568041|NCT00950989|62963863|FG000|Overall Study|Withdrawal by Subject|2|||
33568042|NCT00950989|62963864|FG001|Overall Study|Withdrawal by Subject|1|||
33568043|NCT00950989|62963865|FG002|Overall Study|Withdrawal by Subject|0|||
33568044|NCT00950989|62963866|FG003|Overall Study|Withdrawal by Subject|0|||
33568045|NCT00950989|62963863|FG000|Overall Study|Adverse Event|2|||
33568046|NCT00950989|62963864|FG001|Overall Study|Adverse Event|1|||
33396654|NCT00652626|62775916|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
33396655|NCT00652626|62775917|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
33396656|NCT00652626|62775911|FG000|Extension Phase|Physician Decision|0|||
33396657|NCT00652626|62775912|FG001|Extension Phase|Physician Decision|0|||
33396658|NCT00652626|62775913|FG002|Extension Phase|Physician Decision|0|||
33396659|NCT00652626|62775914|FG003|Extension Phase|Physician Decision|0|||
33396660|NCT00652626|62775915|FG004|Extension Phase|Physician Decision|0|||
33396661|NCT00652626|62775916|FG005|Extension Phase|Physician Decision|1|||
33396662|NCT00652626|62775917|FG006|Extension Phase|Physician Decision|1|||
33396663|NCT00652626|62775911|FG000|Extension Phase|Death|0|||
33568047|NCT00950989|62963865|FG002|Overall Study|Adverse Event|1|||
33568048|NCT00950989|62963866|FG003|Overall Study|Adverse Event|0|||
33568049|NCT00593567|62963881|FG000|Overall Study|Adverse Event|2|||
33568050|NCT00593567|62963882|FG001|Overall Study|Adverse Event|0|||
33568051|NCT00593567|62963881|FG000|Overall Study|Physician Decision|2|||
33568052|NCT00593567|62963882|FG001|Overall Study|Physician Decision|0|||
33568053|NCT00593567|62963881|FG000|Overall Study|Protocol Violation|13|||
33568054|NCT00593567|62963882|FG001|Overall Study|Protocol Violation|7|||
33568055|NCT00593567|62963881|FG000|Overall Study|Lack of Efficacy|2|||
33568056|NCT00593567|62963882|FG001|Overall Study|Lack of Efficacy|1|||
33568057|NCT00593567|62963881|FG000|Overall Study|Withdrawal by Subject|1|||
33568058|NCT00593567|62963882|FG001|Overall Study|Withdrawal by Subject|2|||
33568059|NCT02411084|62963890|FG000|Overall Study|Lack of Efficacy|6|||
33568060|NCT02411084|62963891|FG001|Overall Study|Lack of Efficacy|3|||
33568061|NCT02411084|62963890|FG000|Overall Study|Death|5|||
33568062|NCT02411084|62963891|FG001|Overall Study|Death|4|||
33568063|NCT02411084|62963890|FG000|Overall Study|Adverse Event|2|||
33568064|NCT02411084|62963891|FG001|Overall Study|Adverse Event|1|||
33568065|NCT02411084|62963890|FG000|Overall Study|Other reasons|0|||
33568066|NCT02411084|62963891|FG001|Overall Study|Other reasons|5|||
33568067|NCT01602315|62963904|FG000|Overall Study|Protocol Violation|0|||
33568068|NCT01602315|62963905|FG001|Overall Study|Protocol Violation|0|||
33568069|NCT01602315|62963906|FG002|Overall Study|Protocol Violation|0|||
33396664|NCT00652626|62775912|FG001|Extension Phase|Death|0|||
33396665|NCT00652626|62775913|FG002|Extension Phase|Death|0|||
33396666|NCT00652626|62775914|FG003|Extension Phase|Death|0|||
33568070|NCT01602315|62963907|FG003|Overall Study|Protocol Violation|0|||
33568071|NCT01602315|62963908|FG004|Overall Study|Protocol Violation|0|||
33396667|NCT00652626|62775915|FG004|Extension Phase|Death|0|||
33396668|NCT00652626|62775916|FG005|Extension Phase|Death|1|||
33396669|NCT00652626|62775917|FG006|Extension Phase|Death|1|||
33396670|NCT00560703|62775937|FG000|Overall Study|Adverse Event|0|||
33568072|NCT01602315|62963909|FG005|Overall Study|Protocol Violation|1|||
33568073|NCT01602315|62963910|FG006|Overall Study|Protocol Violation|0|||
33568074|NCT01602315|62963904|FG000|Overall Study|Physician Decision|2|||
33568075|NCT01602315|62963905|FG001|Overall Study|Physician Decision|0|||
33568076|NCT01602315|62963906|FG002|Overall Study|Physician Decision|0|||
33568077|NCT01602315|62963907|FG003|Overall Study|Physician Decision|0|||
33568078|NCT01602315|62963908|FG004|Overall Study|Physician Decision|2|||
33568079|NCT01602315|62963909|FG005|Overall Study|Physician Decision|1|||
33568080|NCT01602315|62963910|FG006|Overall Study|Physician Decision|1|||
33568081|NCT01602315|62963904|FG000|Overall Study|Disease progression|6|||
33568082|NCT01602315|62963905|FG001|Overall Study|Disease progression|3|||
33568083|NCT01602315|62963906|FG002|Overall Study|Disease progression|10|||
33568084|NCT01602315|62963907|FG003|Overall Study|Disease progression|1|||
33568085|NCT01602315|62963908|FG004|Overall Study|Disease progression|41|||
33568086|NCT01602315|62963909|FG005|Overall Study|Disease progression|12|||
33568087|NCT01602315|62963910|FG006|Overall Study|Disease progression|15|||
33568088|NCT01602315|62963904|FG000|Overall Study|Death|1|||
33568089|NCT01602315|62963905|FG001|Overall Study|Death|1|||
33568090|NCT01602315|62963906|FG002|Overall Study|Death|1|||
33568091|NCT01602315|62963907|FG003|Overall Study|Death|1|||
33568092|NCT01602315|62963908|FG004|Overall Study|Death|7|||
33568093|NCT01602315|62963909|FG005|Overall Study|Death|2|||
33568094|NCT01602315|62963910|FG006|Overall Study|Death|2|||
33568095|NCT01602315|62963904|FG000|Overall Study|Withdrawal by Subject|2|||
33568096|NCT01602315|62963905|FG001|Overall Study|Withdrawal by Subject|0|||
33568097|NCT01602315|62963906|FG002|Overall Study|Withdrawal by Subject|2|||
33568098|NCT01602315|62963907|FG003|Overall Study|Withdrawal by Subject|0|||
33568099|NCT01602315|62963908|FG004|Overall Study|Withdrawal by Subject|6|||
33568100|NCT01602315|62963909|FG005|Overall Study|Withdrawal by Subject|0|||
33568101|NCT01602315|62963910|FG006|Overall Study|Withdrawal by Subject|1|||
33568102|NCT01602315|62963904|FG000|Overall Study|Adverse Event|5|||
33568103|NCT01602315|62963905|FG001|Overall Study|Adverse Event|1|||
33568104|NCT01602315|62963906|FG002|Overall Study|Adverse Event|5|||
33568105|NCT01602315|62963907|FG003|Overall Study|Adverse Event|4|||
33568106|NCT01602315|62963908|FG004|Overall Study|Adverse Event|15|||
33568107|NCT01602315|62963909|FG005|Overall Study|Adverse Event|3|||
33568108|NCT01602315|62963910|FG006|Overall Study|Adverse Event|9|||
33568109|NCT01602315|62963904|FG000|Overall Study|Subject/guardian decision|0|||
33568110|NCT01602315|62963905|FG001|Overall Study|Subject/guardian decision|0|||
33568111|NCT01602315|62963906|FG002|Overall Study|Subject/guardian decision|0|||
33568112|NCT01602315|62963907|FG003|Overall Study|Subject/guardian decision|0|||
33568113|NCT01602315|62963908|FG004|Overall Study|Subject/guardian decision|0|||
33568114|NCT01602315|62963909|FG005|Overall Study|Subject/guardian decision|0|||
33568115|NCT01602315|62963910|FG006|Overall Study|Subject/guardian decision|1|||
33568116|NCT01602315|62963904|FG000|Overall Study|Cross-over patients to combo treatment|0|||
33568117|NCT01602315|62963905|FG001|Overall Study|Cross-over patients to combo treatment|0|||
33568118|NCT01602315|62963906|FG002|Overall Study|Cross-over patients to combo treatment|0|||
33568119|NCT01602315|62963907|FG003|Overall Study|Cross-over patients to combo treatment|0|||
33664159|NCT02681094|63095176|FG000|2 - Enrolled Participants Set|No treatment given|0|||
33664160|NCT02681094|63095177|FG001|2 - Enrolled Participants Set|No treatment given|1|||
33664161|NCT02681094|63095178|FG002|2 - Enrolled Participants Set|No treatment given|1|||
33664162|NCT02689284|63095189|FG000|Overall Study|Adverse Event|1|||
33664163|NCT02689284|63095190|FG001|Overall Study|Adverse Event|8|||
33664164|NCT02689284|63095189|FG000|Overall Study|Death|0|||
33664165|NCT02689284|63095190|FG001|Overall Study|Death|1|||
33664166|NCT02689284|63095189|FG000|Overall Study|Physician Decision|1|||
33664167|NCT02689284|63095190|FG001|Overall Study|Physician Decision|2|||
33664168|NCT02689284|63095189|FG000|Overall Study|Withdrawal by Subject|0|||
33664169|NCT02689284|63095190|FG001|Overall Study|Withdrawal by Subject|1|||
33664170|NCT02689284|63095189|FG000|Overall Study|progression of cancer|1|||
33664171|NCT02689284|63095190|FG001|Overall Study|progression of cancer|72|||
33568120|NCT01602315|62963908|FG004|Overall Study|Cross-over patients to combo treatment|0|||
33664172|NCT02689284|63095189|FG000|Overall Study|decreased heart function|0|||
33664173|NCT02689284|63095190|FG001|Overall Study|decreased heart function|1|||
33664174|NCT02689284|63095189|FG000|Overall Study|concern for anemia|0|||
33396671|NCT00560703|62775938|FG001|Overall Study|Adverse Event|2|||
33568121|NCT01602315|62963909|FG005|Overall Study|Cross-over patients to combo treatment|16|||
33568122|NCT01602315|62963910|FG006|Overall Study|Cross-over patients to combo treatment|0|||
33568123|NCT02344004|62963957|FG000|Overall Study|Adverse Event|11|||
33568124|NCT02344004|62963958|FG001|Overall Study|Adverse Event|1|||
33568125|NCT02344004|62963957|FG000|Overall Study|Death|9|||
33568126|NCT02344004|62963958|FG001|Overall Study|Death|7|||
33568127|NCT02344004|62963957|FG000|Overall Study|Physician Decision|4|||
33568128|NCT02344004|62963958|FG001|Overall Study|Physician Decision|1|||
33664175|NCT02689284|63095190|FG001|Overall Study|concern for anemia|1|||
33568129|NCT02344004|62963957|FG000|Overall Study|Withdrawal by Subject|22|||
33568130|NCT02344004|62963958|FG001|Overall Study|Withdrawal by Subject|5|||
33568131|NCT02344004|62963957|FG000|Overall Study|Rescue Medication|2|||
33568132|NCT02344004|62963958|FG001|Overall Study|Rescue Medication|0|||
33568133|NCT02344004|62963957|FG000|Overall Study|Other Not Specified|12|||
33568134|NCT02344004|62963958|FG001|Overall Study|Other Not Specified|0|||
33568135|NCT02344004|62963957|FG000|Overall Study|Protocol Violation|1|||
33568136|NCT02344004|62963958|FG001|Overall Study|Protocol Violation|0|||
33568137|NCT01328093|62963967|FG000|Double-Blind Phase|Adverse Event|78|||
33568138|NCT01328093|62963968|FG001|Double-Blind Phase|Adverse Event|15|||
33568139|NCT01328093|62963967|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
33568140|NCT01328093|62963968|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
33568141|NCT01328093|62963967|FG000|Double-Blind Phase|Lost to Follow-up|39|||
33568142|NCT01328093|62963968|FG001|Double-Blind Phase|Lost to Follow-up|14|||
33568143|NCT01328093|62963967|FG000|Double-Blind Phase|Protocol Violation|30|||
33568144|NCT01328093|62963968|FG001|Double-Blind Phase|Protocol Violation|10|||
33568145|NCT01328093|62963967|FG000|Double-Blind Phase|Lack of Efficacy|55|||
33568146|NCT01328093|62963968|FG001|Double-Blind Phase|Lack of Efficacy|13|||
33568147|NCT01328093|62963967|FG000|Double-Blind Phase|Sponsor Decision|17|||
33568148|NCT01328093|62963968|FG001|Double-Blind Phase|Sponsor Decision|3|||
33568149|NCT01328093|62963967|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
33568150|NCT01328093|62963968|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
33568151|NCT01328093|62963967|FG000|Double-Blind Phase|Scheduling conflict|8|||
33568152|NCT01328093|62963968|FG001|Double-Blind Phase|Scheduling conflict|3|||
33568153|NCT01328093|62963967|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
33568154|NCT01328093|62963968|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
33568155|NCT01328093|62963967|FG000|Double-Blind Phase|Death|1|||
33568156|NCT01328093|62963968|FG001|Double-Blind Phase|Death|0|||
33568157|NCT01328093|62963967|FG000|Open-Label Phase|Sponsor Decision|98|||
33568158|NCT01328093|62963968|FG001|Open-Label Phase|Sponsor Decision|34|||
33568159|NCT01328093|62963967|FG000|Open-Label Phase|Protocol Violation|8|||
33568160|NCT01328093|62963968|FG001|Open-Label Phase|Protocol Violation|3|||
33568161|NCT01328093|62963967|FG000|Open-Label Phase|Lost to Follow-up|10|||
33568162|NCT01328093|62963968|FG001|Open-Label Phase|Lost to Follow-up|1|||
33568163|NCT01328093|62963967|FG000|Open-Label Phase|Adverse Event|10|||
33568164|NCT01328093|62963968|FG001|Open-Label Phase|Adverse Event|4|||
33568165|NCT01328093|62963967|FG000|Open-Label Phase|Lack of Efficacy|5|||
33568166|NCT01328093|62963968|FG001|Open-Label Phase|Lack of Efficacy|6|||
33568167|NCT01328093|62963967|FG000|Open-Label Phase|Withdrawal by Subject|4|||
33568168|NCT01328093|62963968|FG001|Open-Label Phase|Withdrawal by Subject|1|||
33568169|NCT01328093|62963967|FG000|Open-Label Phase|Scheduling conflict|2|||
33568170|NCT01328093|62963968|FG001|Open-Label Phase|Scheduling conflict|1|||
33568171|NCT01328093|62963967|FG000|Open-Label Phase|Subject is moving or has moved|2|||
33568172|NCT01328093|62963968|FG001|Open-Label Phase|Subject is moving or has moved|0|||
33568173|NCT01328093|62963967|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
33568174|NCT01328093|62963968|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
33568175|NCT02654145|62963975|FG000|Overall Study|Lack of Efficacy|1|||
33568176|NCT02654145|62963975|FG000|Overall Study|Protocol Violation|1|||
33568177|NCT02654145|62963975|FG000|Overall Study|Withdrawal by Subject|5|||
33568178|NCT01111565|62963979|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
33568179|NCT01111565|62963980|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
33568180|NCT01111565|62963981|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
33568181|NCT01111565|62963982|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
33568182|NCT01111565|62963983|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
33568183|NCT01111565|62963979|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
33568184|NCT01111565|62963980|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
33568185|NCT01111565|62963981|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
33568186|NCT01111565|62963982|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
33568187|NCT01111565|62963983|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
33568188|NCT01111565|62963979|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
33568189|NCT01111565|62963980|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
33568190|NCT01111565|62963981|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
33568191|NCT01111565|62963982|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
33568192|NCT01111565|62963983|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
33568193|NCT01111565|62963979|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
33568194|NCT01111565|62963980|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
33568195|NCT01111565|62963981|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
33568196|NCT01111565|62963982|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
33568197|NCT01111565|62963983|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
33568198|NCT01111565|62963979|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
33568199|NCT01111565|62963980|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
33568200|NCT01111565|62963981|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
33664176|NCT02689284|63095189|FG000|Overall Study|no measurable cancer for evaluation|0|||
33568201|NCT01111565|62963982|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
33568202|NCT01111565|62963983|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
33568203|NCT01111565|62963979|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
33568204|NCT01111565|62963980|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
33568205|NCT01111565|62963981|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
33568206|NCT01111565|62963982|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
33568207|NCT01111565|62963983|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
33568208|NCT01111565|62963979|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
33568209|NCT01111565|62963980|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
33568210|NCT01111565|62963981|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
33568211|NCT01111565|62963982|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
33568212|NCT01111565|62963983|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
33568213|NCT01111565|62963979|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
33568214|NCT01111565|62963980|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
33568215|NCT01111565|62963981|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
33568216|NCT01111565|62963982|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
33568217|NCT01111565|62963983|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
33568218|NCT01111565|62963979|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33568219|NCT01111565|62963980|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33568220|NCT01111565|62963981|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
33568221|NCT01111565|62963982|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33568222|NCT01111565|62963983|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33568223|NCT01111565|62963979|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
33568224|NCT01111565|62963980|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
33568225|NCT01111565|62963981|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
33568226|NCT01111565|62963982|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
33568227|NCT01111565|62963983|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
33568228|NCT01111565|62963979|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
33568229|NCT01111565|62963980|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
33568230|NCT01111565|62963981|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
33568231|NCT01111565|62963982|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
33568232|NCT01111565|62963983|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
33568233|NCT01111565|62963979|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
33568234|NCT01111565|62963980|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
33568235|NCT01111565|62963981|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
33568236|NCT01111565|62963982|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
33568237|NCT01111565|62963983|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
33568238|NCT02343458|62963997|FG000|Overall Study|Adverse Event|15|||
33568239|NCT02343458|62963998|FG001|Overall Study|Adverse Event|14|||
33568240|NCT02343458|62963999|FG002|Overall Study|Adverse Event|15|||
33568241|NCT02343458|62964000|FG003|Overall Study|Adverse Event|3|||
33568242|NCT02343458|62963997|FG000|Overall Study|Lack of Efficacy|3|||
33568243|NCT02343458|62963998|FG001|Overall Study|Lack of Efficacy|8|||
33568244|NCT02343458|62963999|FG002|Overall Study|Lack of Efficacy|4|||
33568245|NCT02343458|62964000|FG003|Overall Study|Lack of Efficacy|8|||
33568246|NCT02343458|62963997|FG000|Overall Study|Withdrawal by Subject|18|||
33568247|NCT02343458|62963998|FG001|Overall Study|Withdrawal by Subject|17|||
33568248|NCT02343458|62963999|FG002|Overall Study|Withdrawal by Subject|23|||
33568249|NCT02343458|62964000|FG003|Overall Study|Withdrawal by Subject|14|||
33568250|NCT02343458|62963997|FG000|Overall Study|Physician Decision|1|||
33568251|NCT02343458|62963998|FG001|Overall Study|Physician Decision|4|||
33568252|NCT02343458|62963999|FG002|Overall Study|Physician Decision|2|||
33568253|NCT02343458|62964000|FG003|Overall Study|Physician Decision|2|||
33568254|NCT02343458|62963997|FG000|Overall Study|Lost to Follow-up|5|||
33568255|NCT02343458|62963998|FG001|Overall Study|Lost to Follow-up|5|||
33568256|NCT02343458|62963999|FG002|Overall Study|Lost to Follow-up|3|||
33568257|NCT02343458|62964000|FG003|Overall Study|Lost to Follow-up|1|||
33568258|NCT02343458|62963997|FG000|Overall Study|Protocol Violation|2|||
33568259|NCT02343458|62963998|FG001|Overall Study|Protocol Violation|5|||
33568260|NCT02343458|62963999|FG002|Overall Study|Protocol Violation|2|||
33568261|NCT02343458|62964000|FG003|Overall Study|Protocol Violation|2|||
33568262|NCT02343458|62963997|FG000|Overall Study|Protocol Specified Criteria|17|||
33568263|NCT02343458|62963998|FG001|Overall Study|Protocol Specified Criteria|13|||
33568264|NCT02343458|62963999|FG002|Overall Study|Protocol Specified Criteria|14|||
33568265|NCT02343458|62964000|FG003|Overall Study|Protocol Specified Criteria|8|||
33568266|NCT01328041|62964023|FG000|Overall Study|Adverse Event|7|||
33568267|NCT01328041|62964023|FG000|Overall Study|Lack of Efficacy|27|||
33568268|NCT01328041|62964023|FG000|Overall Study|Protocol Violation|7|||
33568269|NCT01328041|62964023|FG000|Overall Study|Lost to Follow-up|7|||
33568270|NCT01328041|62964023|FG000|Overall Study|Physician Decision|2|||
33568271|NCT01328041|62964023|FG000|Overall Study|Withdrawal by Subject|7|||
33568272|NCT02410772|62964030|FG000|Overall Study|Death|3|||
33568273|NCT02410772|62964031|FG001|Overall Study|Death|4|||
33568274|NCT02410772|62964032|FG002|Overall Study|Death|8|||
33568275|NCT02410772|62964030|FG000|Overall Study|Lost to Follow-up|31|||
33568276|NCT02410772|62964031|FG001|Overall Study|Lost to Follow-up|23|||
33568277|NCT02410772|62964032|FG002|Overall Study|Lost to Follow-up|22|||
33568278|NCT02410772|62964030|FG000|Overall Study|Pregnancy|8|||
33568279|NCT02410772|62964031|FG001|Overall Study|Pregnancy|4|||
33568280|NCT02410772|62964032|FG002|Overall Study|Pregnancy|5|||
33568281|NCT02410772|62964030|FG000|Overall Study|Protocol Violation|8|||
33568282|NCT02410772|62964031|FG001|Overall Study|Protocol Violation|8|||
33568283|NCT02410772|62964032|FG002|Overall Study|Protocol Violation|4|||
33568284|NCT02410772|62964030|FG000|Overall Study|Baseline Drug Resistance|49|||
33568285|NCT02410772|62964031|FG001|Overall Study|Baseline Drug Resistance|40|||
33568286|NCT02410772|62964032|FG002|Overall Study|Baseline Drug Resistance|51|||
33568287|NCT02410772|62964030|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
33568288|NCT02410772|62964031|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
33568289|NCT02410772|62964032|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
33568290|NCT02410772|62964030|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
33568291|NCT02410772|62964031|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
33568292|NCT02410772|62964032|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
33568293|NCT01648790|62964049|FG000|Treatment 3|Withdrawal by Subject|0|||
33568294|NCT01648790|62964050|FG001|Treatment 3|Withdrawal by Subject|0|||
33568295|NCT01648790|62964051|FG002|Treatment 3|Withdrawal by Subject|0|||
33568296|NCT01648790|62964052|FG003|Treatment 3|Withdrawal by Subject|1|||
33568297|NCT01648790|62964053|FG004|Treatment 3|Withdrawal by Subject|0|||
33568298|NCT01936857|62964076|FG000|Overall Study|Sent to prison or 06 center|11|||
33568299|NCT01936857|62964077|FG001|Overall Study|Sent to prison or 06 center|12|||
33568300|NCT01936857|62964076|FG000|Overall Study|Lost to Follow-up|10|||
33568301|NCT01936857|62964077|FG001|Overall Study|Lost to Follow-up|7|||
33568302|NCT01936857|62964076|FG000|Overall Study|Death|7|||
33568303|NCT01936857|62964077|FG001|Overall Study|Death|3|||
33568304|NCT01936857|62964076|FG000|Overall Study|Moved|2|||
33568305|NCT01936857|62964077|FG001|Overall Study|Moved|1|||
33568306|NCT01936857|62964076|FG000|Overall Study|Withdrawal by Subject|1|||
33568307|NCT01936857|62964077|FG001|Overall Study|Withdrawal by Subject|0|||
33568308|NCT01936857|62964076|FG000|Overall Study|Side effect of medication|1|||
33568309|NCT01936857|62964077|FG001|Overall Study|Side effect of medication|0|||
33568310|NCT01936857|62964076|FG000|Overall Study|Other|2|||
33568311|NCT01936857|62964077|FG001|Overall Study|Other|2|||
33568312|NCT01602224|62964086|FG000|Overall Study|Adverse Event|0|||
33568313|NCT01602224|62964087|FG001|Overall Study|Adverse Event|1|||
33568314|NCT01602224|62964088|FG002|Overall Study|Adverse Event|0|||
33568315|NCT01602224|62964086|FG000|Overall Study|Investigator Decison|1|||
33568316|NCT01602224|62964087|FG001|Overall Study|Investigator Decison|0|||
33568317|NCT01602224|62964088|FG002|Overall Study|Investigator Decison|0|||
33568318|NCT01602224|62964086|FG000|Overall Study|Lost to Follow-up|0|||
33568319|NCT01602224|62964087|FG001|Overall Study|Lost to Follow-up|0|||
33568320|NCT01602224|62964088|FG002|Overall Study|Lost to Follow-up|1|||
33568321|NCT01602224|62964086|FG000|Overall Study|Protocol Violation|0|||
33568322|NCT01602224|62964087|FG001|Overall Study|Protocol Violation|1|||
33568323|NCT01602224|62964088|FG002|Overall Study|Protocol Violation|0|||
33568324|NCT01602224|62964086|FG000|Overall Study|Sponsor Decision|2|||
33568325|NCT01602224|62964087|FG001|Overall Study|Sponsor Decision|3|||
33568326|NCT01602224|62964088|FG002|Overall Study|Sponsor Decision|2|||
33568327|NCT01602224|62964086|FG000|Overall Study|Withdrawal by Subject|5|||
33568328|NCT01602224|62964087|FG001|Overall Study|Withdrawal by Subject|3|||
33568329|NCT01602224|62964088|FG002|Overall Study|Withdrawal by Subject|3|||
33568330|NCT04498247|62964106|FG000|Overall Study|Lost to Follow-up|0|||
33568331|NCT04498247|62964107|FG001|Overall Study|Lost to Follow-up|0|||
33568332|NCT04498247|62964108|FG002|Overall Study|Lost to Follow-up|0|||
33568333|NCT04498247|62964109|FG003|Overall Study|Lost to Follow-up|1|||
33568334|NCT04498247|62964110|FG004|Overall Study|Lost to Follow-up|0|||
33568335|NCT04498247|62964111|FG005|Overall Study|Lost to Follow-up|0|||
33568336|NCT04498247|62964112|FG006|Overall Study|Lost to Follow-up|0|||
33568337|NCT04498247|62964113|FG007|Overall Study|Lost to Follow-up|0|||
33568338|NCT04498247|62964106|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
33568339|NCT04498247|62964107|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
33568340|NCT04498247|62964108|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
33568341|NCT04498247|62964109|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
33568342|NCT04498247|62964110|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
33568343|NCT04498247|62964111|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
33568344|NCT04498247|62964112|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
33568345|NCT04498247|62964113|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
33664177|NCT02689284|63095190|FG001|Overall Study|no measurable cancer for evaluation|1|||
33568346|NCT04498247|62964106|FG000|Overall Study|Withdrawal by Subject|0|||
33568347|NCT04498247|62964107|FG001|Overall Study|Withdrawal by Subject|8|||
33568348|NCT04498247|62964108|FG002|Overall Study|Withdrawal by Subject|0|||
33568349|NCT04498247|62964109|FG003|Overall Study|Withdrawal by Subject|7|||
33568350|NCT04498247|62964110|FG004|Overall Study|Withdrawal by Subject|0|||
33568351|NCT04498247|62964111|FG005|Overall Study|Withdrawal by Subject|0|||
33568352|NCT04498247|62964112|FG006|Overall Study|Withdrawal by Subject|1|||
33568353|NCT04498247|62964113|FG007|Overall Study|Withdrawal by Subject|0|||
33568354|NCT04498247|62964106|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
33568355|NCT04498247|62964107|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
33568356|NCT04498247|62964108|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
33568357|NCT04498247|62964109|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
33568358|NCT04498247|62964110|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
33568359|NCT04498247|62964111|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
33568360|NCT04498247|62964112|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
33568361|NCT04498247|62964113|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
33568362|NCT03887117|62964141|FG000|Overall Study|Discontinued prematurely|0|||
33568363|NCT03887117|62964142|FG001|Overall Study|Discontinued prematurely|1|||
33568364|NCT03887117|62964143|FG002|Overall Study|Discontinued prematurely|1|||
33568365|NCT03887117|62964144|FG003|Overall Study|Discontinued prematurely|2|||
33568366|NCT04038385|62964165|FG000|Overall Study|Completed baseline assessment only|7|||
33568367|NCT04038385|62964166|FG001|Overall Study|Completed baseline assessment only|4|||
33568368|NCT04038385|62964165|FG000|Overall Study|Moved out of area|4|||
33568369|NCT04038385|62964166|FG001|Overall Study|Moved out of area|2|||
33568370|NCT04038385|62964165|FG000|Overall Study|Discontinued study involvement|6|||
33568371|NCT04038385|62964166|FG001|Overall Study|Discontinued study involvement|1|||
33568372|NCT00783263|62964176|FG000|Overall Study|Adverse Event|3|||
33568373|NCT00783263|62964177|FG001|Overall Study|Adverse Event|0|||
33568374|NCT00783263|62964178|FG002|Overall Study|Adverse Event|2|||
33568375|NCT00783263|62964179|FG003|Overall Study|Adverse Event|1|||
33568376|NCT00783263|62964176|FG000|Overall Study|Lost to Follow-up|1|||
33568377|NCT00783263|62964177|FG001|Overall Study|Lost to Follow-up|1|||
33568378|NCT00783263|62964178|FG002|Overall Study|Lost to Follow-up|0|||
33568379|NCT00783263|62964179|FG003|Overall Study|Lost to Follow-up|0|||
33568380|NCT00783263|62964176|FG000|Overall Study|Withdrawal by Subject|0|||
33568381|NCT00783263|62964177|FG001|Overall Study|Withdrawal by Subject|1|||
33568382|NCT00783263|62964178|FG002|Overall Study|Withdrawal by Subject|1|||
33568383|NCT00783263|62964179|FG003|Overall Study|Withdrawal by Subject|2|||
33568384|NCT03987919|62964206|FG000|Overall Study|Adverse Event|1|||
33568385|NCT03987919|62964207|FG001|Overall Study|Adverse Event|4|||
33568386|NCT03987919|62964208|FG002|Overall Study|Adverse Event|1|||
33568387|NCT03987919|62964209|FG003|Overall Study|Adverse Event|3|||
33568388|NCT03987919|62964206|FG000|Overall Study|Death|4|||
33568389|NCT03987919|62964207|FG001|Overall Study|Death|4|||
33568390|NCT03987919|62964208|FG002|Overall Study|Death|4|||
33568391|NCT03987919|62964209|FG003|Overall Study|Death|1|||
33568392|NCT03987919|62964206|FG000|Overall Study|Lost to Follow-up|5|||
33568393|NCT03987919|62964207|FG001|Overall Study|Lost to Follow-up|6|||
33568394|NCT03987919|62964208|FG002|Overall Study|Lost to Follow-up|8|||
33568395|NCT03987919|62964209|FG003|Overall Study|Lost to Follow-up|12|||
33568396|NCT03987919|62964206|FG000|Overall Study|Physician Decision|0|||
33568397|NCT03987919|62964207|FG001|Overall Study|Physician Decision|2|||
33568398|NCT03987919|62964208|FG002|Overall Study|Physician Decision|0|||
33568399|NCT03987919|62964209|FG003|Overall Study|Physician Decision|4|||
33568400|NCT03987919|62964206|FG000|Overall Study|Pregnancy|1|||
33568401|NCT03987919|62964207|FG001|Overall Study|Pregnancy|0|||
33568402|NCT03987919|62964208|FG002|Overall Study|Pregnancy|1|||
33568403|NCT03987919|62964209|FG003|Overall Study|Pregnancy|1|||
33568404|NCT03987919|62964206|FG000|Overall Study|Protocol Violation|0|||
33568405|NCT03987919|62964207|FG001|Overall Study|Protocol Violation|1|||
33568406|NCT03987919|62964208|FG002|Overall Study|Protocol Violation|0|||
33568407|NCT03987919|62964209|FG003|Overall Study|Protocol Violation|0|||
33568408|NCT03987919|62964206|FG000|Overall Study|Site terminated by Sponsor|0|||
33568409|NCT03987919|62964207|FG001|Overall Study|Site terminated by Sponsor|0|||
33568410|NCT03987919|62964208|FG002|Overall Study|Site terminated by Sponsor|0|||
33568411|NCT03987919|62964209|FG003|Overall Study|Site terminated by Sponsor|1|||
33568412|NCT03987919|62964206|FG000|Overall Study|Withdrawal by Subject|7|||
33568413|NCT03987919|62964207|FG001|Overall Study|Withdrawal by Subject|7|||
33568414|NCT03987919|62964208|FG002|Overall Study|Withdrawal by Subject|8|||
33568415|NCT03987919|62964209|FG003|Overall Study|Withdrawal by Subject|4|||
33568416|NCT03987919|62964206|FG000|Overall Study|Other - as reported by the investigator|1|||
33568417|NCT03987919|62964207|FG001|Overall Study|Other - as reported by the investigator|3|||
33568418|NCT03987919|62964208|FG002|Overall Study|Other - as reported by the investigator|2|||
33568419|NCT03987919|62964209|FG003|Overall Study|Other - as reported by the investigator|0|||
33568420|NCT00535405|62964229|FG000|Overall Study|Adverse Event|6|||
33568421|NCT00535405|62964230|FG001|Overall Study|Adverse Event|8|||
33568422|NCT00535405|62964231|FG002|Overall Study|Adverse Event|3|||
33568423|NCT00535405|62964232|FG003|Overall Study|Adverse Event|8|||
33568424|NCT00535405|62964233|FG004|Overall Study|Adverse Event|6|||
33568425|NCT00535405|62964229|FG000|Overall Study|Lost to Follow-up|1|||
33568426|NCT00535405|62964230|FG001|Overall Study|Lost to Follow-up|3|||
33568427|NCT00535405|62964231|FG002|Overall Study|Lost to Follow-up|3|||
33568428|NCT00535405|62964232|FG003|Overall Study|Lost to Follow-up|2|||
33568429|NCT00535405|62964233|FG004|Overall Study|Lost to Follow-up|1|||
33568430|NCT00535405|62964229|FG000|Overall Study|Physician Decision|3|||
33568431|NCT00535405|62964230|FG001|Overall Study|Physician Decision|2|||
33568432|NCT00535405|62964231|FG002|Overall Study|Physician Decision|0|||
33568433|NCT00535405|62964232|FG003|Overall Study|Physician Decision|1|||
33664178|NCT02676882|63095199|FG000|Overall Study|Adverse Event|1|||
33664179|NCT02676882|63095200|FG001|Overall Study|Adverse Event|0|||
33664180|NCT02676882|63095199|FG000|Overall Study|Lost to Follow-up|1|||
33664181|NCT02676882|63095200|FG001|Overall Study|Lost to Follow-up|0|||
33664182|NCT02676882|63095199|FG000|Overall Study|Withdrawal by Subject|1|||
33664183|NCT02676882|63095200|FG001|Overall Study|Withdrawal by Subject|2|||
33664184|NCT02674386|63095209|FG000|Overall Study|Lost to Follow-up|0|||
33664185|NCT02674386|63095210|FG001|Overall Study|Lost to Follow-up|1|||
33664186|NCT02674386|63095211|FG002|Overall Study|Lost to Follow-up|1|||
33664187|NCT02674386|63095209|FG000|Overall Study|Withdrawal by Subject|0|||
33664188|NCT02674386|63095210|FG001|Overall Study|Withdrawal by Subject|4|||
33664189|NCT02674386|63095211|FG002|Overall Study|Withdrawal by Subject|0|||
33664190|NCT02674386|63095209|FG000|Overall Study|Other|0|||
33664191|NCT02674386|63095210|FG001|Overall Study|Other|1|||
33664192|NCT02674386|63095211|FG002|Overall Study|Other|0|||
33664193|NCT02674386|63095209|FG000|Overall Study|Enrolled but not evaluated|0|||
33664194|NCT02674386|63095210|FG001|Overall Study|Enrolled but not evaluated|4|||
33664195|NCT02674386|63095211|FG002|Overall Study|Enrolled but not evaluated|0|||
33664196|NCT02680002|63095230|FG000|Overall Study|Lost to Follow-up|5|||
33664197|NCT02680002|63095231|FG001|Overall Study|Lost to Follow-up|1|||
33664198|NCT02680002|63095232|FG002|Overall Study|Lost to Follow-up|4|||
33664199|NCT02680002|63095233|FG003|Overall Study|Lost to Follow-up|2|||
33664200|NCT02680002|63095234|FG004|Overall Study|Lost to Follow-up|0|||
33664201|NCT02680002|63095235|FG005|Overall Study|Lost to Follow-up|2|||
33664202|NCT02680002|63095230|FG000|Overall Study|Physician Decision|5|||
33664203|NCT02680002|63095231|FG001|Overall Study|Physician Decision|1|||
33664204|NCT02680002|63095232|FG002|Overall Study|Physician Decision|1|||
33664205|NCT02680002|63095233|FG003|Overall Study|Physician Decision|1|||
33664206|NCT02680002|63095234|FG004|Overall Study|Physician Decision|1|||
33664207|NCT02680002|63095235|FG005|Overall Study|Physician Decision|1|||
33664208|NCT02680002|63095230|FG000|Overall Study|Protocol Violation|1|||
33664209|NCT02680002|63095231|FG001|Overall Study|Protocol Violation|0|||
33664210|NCT02680002|63095232|FG002|Overall Study|Protocol Violation|1|||
33664211|NCT02680002|63095233|FG003|Overall Study|Protocol Violation|0|||
33664212|NCT02680002|63095234|FG004|Overall Study|Protocol Violation|1|||
33664213|NCT02680002|63095235|FG005|Overall Study|Protocol Violation|2|||
33664214|NCT02680002|63095230|FG000|Overall Study|Withdrawal by Subject|0|||
33664215|NCT02680002|63095231|FG001|Overall Study|Withdrawal by Subject|0|||
33664216|NCT02680002|63095232|FG002|Overall Study|Withdrawal by Subject|1|||
33664217|NCT02680002|63095233|FG003|Overall Study|Withdrawal by Subject|0|||
33664218|NCT02680002|63095234|FG004|Overall Study|Withdrawal by Subject|2|||
33664219|NCT02680002|63095235|FG005|Overall Study|Withdrawal by Subject|2|||
33664220|NCT02680002|63095230|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
33664221|NCT02680002|63095231|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
33664222|NCT02680002|63095232|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
33664223|NCT02680002|63095233|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
33664224|NCT02680002|63095234|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
33664225|NCT02680002|63095235|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
33568434|NCT00535405|62964233|FG004|Overall Study|Physician Decision|1|||
33664226|NCT02680002|63095230|FG000|Overall Study|Other|0|||
33664227|NCT02680002|63095231|FG001|Overall Study|Other|1|||
33664228|NCT02680002|63095232|FG002|Overall Study|Other|0|||
33664229|NCT02680002|63095233|FG003|Overall Study|Other|0|||
33664230|NCT02680002|63095234|FG004|Overall Study|Other|1|||
33664231|NCT02680002|63095235|FG005|Overall Study|Other|0|||
33664232|NCT02680002|63095230|FG000|Overall Study|Adverse Event|0|||
33664233|NCT02680002|63095231|FG001|Overall Study|Adverse Event|0|||
33664234|NCT02680002|63095232|FG002|Overall Study|Adverse Event|0|||
33664235|NCT02680002|63095233|FG003|Overall Study|Adverse Event|0|||
33664236|NCT02680002|63095234|FG004|Overall Study|Adverse Event|1|||
33664237|NCT02680002|63095235|FG005|Overall Study|Adverse Event|2|||
33664238|NCT04557384|63095252|FG000|Overall Study|Study Terminated by Sponsor|1|||
33664239|NCT04557384|63095252|FG000|Overall Study|Death|1|||
33664240|NCT02673684|63095258|FG000|Overall Study|Study not completed d/t loss of funding|9|||
33664241|NCT02673684|63095259|FG001|Overall Study|Study not completed d/t loss of funding|8|||
33664242|NCT02675634|63095267|FG000|Test Period 1|Adverse Event|0|||
33664243|NCT02675634|63095268|FG001|Test Period 1|Adverse Event|1|||
33664244|NCT02675634|63095269|FG002|Test Period 1|Adverse Event|0|||
33664245|NCT02675634|63095270|FG003|Test Period 1|Adverse Event|1|||
33664246|NCT02675634|63095271|FG004|Test Period 1|Adverse Event|0|||
33664247|NCT02675634|63095272|FG005|Test Period 1|Adverse Event|0|||
33568435|NCT00535405|62964229|FG000|Overall Study|Protocol Violation|2|||
33568436|NCT00535405|62964230|FG001|Overall Study|Protocol Violation|2|||
33568437|NCT00535405|62964231|FG002|Overall Study|Protocol Violation|2|||
33568438|NCT00535405|62964232|FG003|Overall Study|Protocol Violation|1|||
33568439|NCT00535405|62964233|FG004|Overall Study|Protocol Violation|0|||
33568440|NCT00535405|62964229|FG000|Overall Study|Withdrawal by Subject|5|||
33568441|NCT00535405|62964230|FG001|Overall Study|Withdrawal by Subject|11|||
33568442|NCT00535405|62964231|FG002|Overall Study|Withdrawal by Subject|10|||
33568443|NCT00535405|62964232|FG003|Overall Study|Withdrawal by Subject|10|||
33568444|NCT00535405|62964233|FG004|Overall Study|Withdrawal by Subject|8|||
33568445|NCT00271817|62964248|FG000|Part 1|Adverse Event|68|||
33568446|NCT00271817|62964249|FG001|Part 1|Adverse Event|25|||
33568447|NCT00271817|62964250|FG002|Part 1|Adverse Event|156|||
33568448|NCT00271817|62964248|FG000|Part 1|Lost to Follow-up|6|||
33568449|NCT00271817|62964249|FG001|Part 1|Lost to Follow-up|8|||
33568450|NCT00271817|62964250|FG002|Part 1|Lost to Follow-up|24|||
33568451|NCT00271817|62964248|FG000|Part 1|Protocol Violation|5|||
33568452|NCT00271817|62964249|FG001|Part 1|Protocol Violation|4|||
33568453|NCT00271817|62964250|FG002|Part 1|Protocol Violation|7|||
33568454|NCT00271817|62964248|FG000|Part 1|Patient Moved|3|||
33568455|NCT00271817|62964249|FG001|Part 1|Patient Moved|1|||
33568456|NCT00271817|62964250|FG002|Part 1|Patient Moved|5|||
33568457|NCT00271817|62964248|FG000|Part 1|Withdrawal by Subject|23|||
33568458|NCT00271817|62964249|FG001|Part 1|Withdrawal by Subject|17|||
33568459|NCT00271817|62964250|FG002|Part 1|Withdrawal by Subject|45|||
33568460|NCT00271817|62964248|FG000|Part 1|LDL < 50 mg/dL|1|||
33568461|NCT00271817|62964249|FG001|Part 1|LDL < 50 mg/dL|4|||
33568462|NCT00271817|62964250|FG002|Part 1|LDL < 50 mg/dL|48|||
33568463|NCT00271817|62964248|FG000|Part 2|Adverse Event|0|||
33568464|NCT00271817|62964249|FG001|Part 2|Adverse Event|17|||
33568465|NCT00271817|62964250|FG002|Part 2|Adverse Event|33|||
33568466|NCT00271817|62964248|FG000|Part 2|Lack of Efficacy|0|||
33568467|NCT00271817|62964249|FG001|Part 2|Lack of Efficacy|1|||
33568468|NCT00271817|62964250|FG002|Part 2|Lack of Efficacy|6|||
33568469|NCT00271817|62964248|FG000|Part 2|Lost to Follow-up|0|||
33568470|NCT00271817|62964249|FG001|Part 2|Lost to Follow-up|6|||
33568471|NCT00271817|62964250|FG002|Part 2|Lost to Follow-up|18|||
33568472|NCT00271817|62964248|FG000|Part 2|Protocol Violation|0|||
33568473|NCT00271817|62964249|FG001|Part 2|Protocol Violation|3|||
33568474|NCT00271817|62964250|FG002|Part 2|Protocol Violation|5|||
33568475|NCT00271817|62964248|FG000|Part 2|Patient Moved|0|||
33568476|NCT00271817|62964249|FG001|Part 2|Patient Moved|0|||
33568477|NCT00271817|62964250|FG002|Part 2|Patient Moved|5|||
33568478|NCT00271817|62964248|FG000|Part 2|Withdrawal by Subject|0|||
33568479|NCT00271817|62964249|FG001|Part 2|Withdrawal by Subject|2|||
33664248|NCT02675634|63095267|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
33664249|NCT02675634|63095268|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
33664250|NCT02675634|63095269|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
33664251|NCT02675634|63095270|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
33664252|NCT02675634|63095271|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
33396672|NCT00560703|62775937|FG000|Overall Study|Protocol Violation|0|||
33568480|NCT00271817|62964250|FG002|Part 2|Withdrawal by Subject|13|||
33568481|NCT00271817|62964248|FG000|Part 2|LDL < 50 mg/dL|0|||
33568482|NCT00271817|62964249|FG001|Part 2|LDL < 50 mg/dL|3|||
33568483|NCT00271817|62964250|FG002|Part 2|LDL < 50 mg/dL|4|||
33568484|NCT02731157|62964262|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
33568485|NCT03268811|62964270|FG000|Overall Study|Adverse Event|0|||
33568486|NCT03268811|62964271|FG001|Overall Study|Adverse Event|1|||
33568487|NCT02732015|62964280|FG000|Overall Study|Lost to Follow-up|0|||
33568488|NCT02732015|62964281|FG001|Overall Study|Lost to Follow-up|1|||
33568489|NCT01441115|62964301|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
33568490|NCT02006147|62964312|FG000|Overall Study|Protocol Violation|1|||
33568491|NCT02006147|62964313|FG001|Overall Study|Protocol Violation|1|||
33568492|NCT02006147|62964314|FG002|Overall Study|Protocol Violation|0|||
33568493|NCT02006147|62964315|FG003|Overall Study|Protocol Violation|0|||
33568494|NCT02006147|62964312|FG000|Overall Study|Withdrawal by Subject|0|||
33568495|NCT02006147|62964313|FG001|Overall Study|Withdrawal by Subject|1|||
33568496|NCT02006147|62964314|FG002|Overall Study|Withdrawal by Subject|0|||
33568497|NCT02006147|62964315|FG003|Overall Study|Withdrawal by Subject|0|||
33568498|NCT02006147|62964312|FG000|Overall Study|Withdrawal by Sponsor|1|||
33664253|NCT02675634|63095272|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
33664254|NCT02675634|63095267|FG000|Test Period 2|Lack of Efficacy|1|||
33568499|NCT02006147|62964313|FG001|Overall Study|Withdrawal by Sponsor|0|||
33568500|NCT02006147|62964314|FG002|Overall Study|Withdrawal by Sponsor|0|||
33568501|NCT02006147|62964315|FG003|Overall Study|Withdrawal by Sponsor|0|||
33568502|NCT02732119|62964326|FG000|Phase I|Adverse Event|1|||
33568503|NCT02732119|62964327|FG001|Phase I|Adverse Event|3|||
33568504|NCT02732119|62964328|FG002|Phase I|Adverse Event|1|||
33568505|NCT02732119|62964329|FG003|Phase I|Adverse Event|0|||
33568506|NCT02732119|62964330|FG004|Phase I|Adverse Event|0|||
33568507|NCT02732119|62964326|FG000|Phase I|Progressive disease|7|||
33568508|NCT02732119|62964327|FG001|Phase I|Progressive disease|3|||
33568509|NCT02732119|62964328|FG002|Phase I|Progressive disease|2|||
33568510|NCT02732119|62964329|FG003|Phase I|Progressive disease|0|||
33568511|NCT02732119|62964330|FG004|Phase I|Progressive disease|0|||
33568512|NCT02732119|62964326|FG000|Phase I|Protocol deviation|0|||
33568513|NCT02732119|62964327|FG001|Phase I|Protocol deviation|1|||
33568514|NCT02732119|62964328|FG002|Phase I|Protocol deviation|0|||
33568515|NCT02732119|62964329|FG003|Phase I|Protocol deviation|0|||
33568516|NCT02732119|62964330|FG004|Phase I|Protocol deviation|0|||
33568517|NCT02732119|62964326|FG000|Phase I|Physician Decision|0|||
33568518|NCT02732119|62964327|FG001|Phase I|Physician Decision|3|||
33568519|NCT02732119|62964328|FG002|Phase I|Physician Decision|4|||
33568520|NCT02732119|62964329|FG003|Phase I|Physician Decision|0|||
33568521|NCT02732119|62964330|FG004|Phase I|Physician Decision|0|||
33568522|NCT02732119|62964326|FG000|Phase II|Adverse Event|0|||
33568523|NCT02732119|62964327|FG001|Phase II|Adverse Event|0|||
33568524|NCT02732119|62964328|FG002|Phase II|Adverse Event|0|||
33568525|NCT02732119|62964329|FG003|Phase II|Adverse Event|3|||
33568526|NCT02732119|62964330|FG004|Phase II|Adverse Event|3|||
33568527|NCT02732119|62964326|FG000|Phase II|Death|0|||
33568528|NCT02732119|62964327|FG001|Phase II|Death|0|||
33568529|NCT02732119|62964328|FG002|Phase II|Death|0|||
33568530|NCT02732119|62964329|FG003|Phase II|Death|1|||
33568531|NCT02732119|62964330|FG004|Phase II|Death|0|||
33568532|NCT02732119|62964326|FG000|Phase II|Progressive dissease|0|||
33568533|NCT02732119|62964327|FG001|Phase II|Progressive dissease|0|||
33568534|NCT02732119|62964328|FG002|Phase II|Progressive dissease|0|||
33568535|NCT02732119|62964329|FG003|Phase II|Progressive dissease|30|||
33568536|NCT02732119|62964330|FG004|Phase II|Progressive dissease|23|||
33568537|NCT02732119|62964326|FG000|Phase II|Study terminated by sponsor|0|||
33568538|NCT02732119|62964327|FG001|Phase II|Study terminated by sponsor|0|||
33568539|NCT02732119|62964328|FG002|Phase II|Study terminated by sponsor|0|||
33568540|NCT02732119|62964329|FG003|Phase II|Study terminated by sponsor|2|||
33568541|NCT02732119|62964330|FG004|Phase II|Study terminated by sponsor|2|||
33568542|NCT02732119|62964326|FG000|Phase II|Other|0|||
33568543|NCT02732119|62964327|FG001|Phase II|Other|0|||
33568544|NCT02732119|62964328|FG002|Phase II|Other|0|||
33568545|NCT02732119|62964329|FG003|Phase II|Other|2|||
33568546|NCT02732119|62964330|FG004|Phase II|Other|0|||
33568547|NCT02732119|62964326|FG000|Phase II|Physician Decision|0|||
33568548|NCT02732119|62964327|FG001|Phase II|Physician Decision|0|||
33568549|NCT02732119|62964328|FG002|Phase II|Physician Decision|0|||
33568550|NCT02732119|62964329|FG003|Phase II|Physician Decision|8|||
33568551|NCT02732119|62964330|FG004|Phase II|Physician Decision|5|||
33568552|NCT03252925|62964353|FG000|Overall Study|Withdrawal by Subject|1|||
33396673|NCT00560703|62775938|FG001|Overall Study|Protocol Violation|2|||
33396674|NCT00560703|62775937|FG000|Overall Study|Withdrawal by Subject|0|||
33396675|NCT00560703|62775938|FG001|Overall Study|Withdrawal by Subject|1|||
33396676|NCT00560703|62775937|FG000|Overall Study|non-compliance|0|||
33396677|NCT00560703|62775938|FG001|Overall Study|non-compliance|1|||
33396678|NCT00308737|62775947|FG000|Overall Study|Adverse Event|104|||
33396679|NCT00308737|62775948|FG001|Overall Study|Adverse Event|9|||
33396680|NCT00308737|62775949|FG002|Overall Study|Adverse Event|0|||
33396681|NCT00308737|62775947|FG000|Overall Study|Death|4|||
33396682|NCT00308737|62775948|FG001|Overall Study|Death|3|||
33568553|NCT03252925|62964354|FG001|Overall Study|Withdrawal by Subject|0|||
33568554|NCT03252925|62964353|FG000|Overall Study|Protocol Violation|6|||
33568555|NCT03252925|62964354|FG001|Overall Study|Protocol Violation|0|||
33568556|NCT03252925|62964353|FG000|Overall Study|Adverse Event|1|||
33568557|NCT03252925|62964354|FG001|Overall Study|Adverse Event|0|||
33568558|NCT03252925|62964353|FG000|Overall Study|Lost to Follow-up|6|||
33568559|NCT03252925|62964354|FG001|Overall Study|Lost to Follow-up|6|||
33568560|NCT01327885|62964362|FG000|Overall Study|Disease progression-according to RECIST|173|||
33568561|NCT01327885|62964363|FG001|Overall Study|Disease progression-according to RECIST|165|||
33568562|NCT01327885|62964362|FG000|Overall Study|Clinical progression|24|||
33568563|NCT01327885|62964363|FG001|Overall Study|Clinical progression|27|||
33568564|NCT01327885|62964362|FG000|Overall Study|Adverse Event|14|||
33568565|NCT01327885|62964363|FG001|Overall Study|Adverse Event|10|||
33568566|NCT01327885|62964362|FG000|Overall Study|Subject choice|5|||
33664255|NCT02675634|63095268|FG001|Test Period 2|Lack of Efficacy|0|||
33664256|NCT02675634|63095269|FG002|Test Period 2|Lack of Efficacy|0|||
33664257|NCT02675634|63095270|FG003|Test Period 2|Lack of Efficacy|0|||
33396683|NCT00308737|62775949|FG002|Overall Study|Death|0|||
33396684|NCT00308737|62775947|FG000|Overall Study|Lost to Follow-up|56|||
33568567|NCT01327885|62964363|FG001|Overall Study|Subject choice|10|||
33568568|NCT01327885|62964362|FG000|Overall Study|Other|8|||
33568569|NCT01327885|62964363|FG001|Overall Study|Other|6|||
33568570|NCT01327885|62964362|FG000|Overall Study|Withdrawal of consent from study|3|||
33568571|NCT01327885|62964363|FG001|Overall Study|Withdrawal of consent from study|4|||
33568572|NCT01327885|62964362|FG000|Overall Study|Not treated|1|||
33568573|NCT01327885|62964363|FG001|Overall Study|Not treated|1|||
33568574|NCT01327885|62964362|FG000|Overall Study|Administrative decision|0|||
33568575|NCT01327885|62964363|FG001|Overall Study|Administrative decision|1|||
33568576|NCT03420781|62964381|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
33568577|NCT03420781|62964382|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
33568578|NCT03420781|62964383|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
33568579|NCT03420781|62964384|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
33568580|NCT03420781|62964385|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
33568581|NCT03420781|62964381|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
33568582|NCT03420781|62964382|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
33568583|NCT03420781|62964383|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
33568584|NCT03420781|62964384|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
33568585|NCT03420781|62964385|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
33568586|NCT03420781|62964381|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
33568587|NCT03420781|62964382|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
33568588|NCT03420781|62964383|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
33568589|NCT03420781|62964384|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
33568590|NCT03420781|62964385|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
33568591|NCT03420781|62964381|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
33568592|NCT03420781|62964382|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
33568593|NCT03420781|62964383|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
33568594|NCT03420781|62964384|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
33568595|NCT03420781|62964385|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
33568596|NCT03420781|62964381|FG000|Treatment Period (40 Weeks)|Death|2|||
33568597|NCT03420781|62964382|FG001|Treatment Period (40 Weeks)|Death|2|||
33568598|NCT03420781|62964383|FG002|Treatment Period (40 Weeks)|Death|0|||
33568599|NCT03420781|62964384|FG003|Treatment Period (40 Weeks)|Death|0|||
33568600|NCT03420781|62964385|FG004|Treatment Period (40 Weeks)|Death|0|||
33568601|NCT03420781|62964381|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
33568602|NCT03420781|62964382|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
33568603|NCT03420781|62964383|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
33568604|NCT03420781|62964384|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
33568605|NCT03420781|62964385|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
33568606|NCT03420781|62964381|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
33568607|NCT03420781|62964382|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
33568608|NCT03420781|62964383|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
33568609|NCT03420781|62964384|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
33568610|NCT03420781|62964385|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
33568611|NCT03420781|62964381|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
33568612|NCT03420781|62964382|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
33568613|NCT03420781|62964383|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
33568614|NCT03420781|62964384|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
33568615|NCT03420781|62964385|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
33568616|NCT03420781|62964381|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
33568617|NCT03420781|62964382|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
33568618|NCT03420781|62964383|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
33568619|NCT03420781|62964384|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
33568620|NCT03420781|62964385|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
33568621|NCT03420781|62964381|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
33568622|NCT03420781|62964382|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
33568623|NCT03420781|62964383|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
33568624|NCT03420781|62964384|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
33568625|NCT03420781|62964385|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
33568626|NCT03420781|62964381|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
33568627|NCT03420781|62964382|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
33568628|NCT03420781|62964383|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
33568629|NCT03420781|62964384|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
33568630|NCT03420781|62964385|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
33568631|NCT03420781|62964381|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
33568632|NCT03420781|62964382|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
33568633|NCT03420781|62964383|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
33568634|NCT03420781|62964384|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
33568635|NCT03420781|62964385|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
33568636|NCT03420781|62964381|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
33568637|NCT03420781|62964382|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
33568638|NCT03420781|62964383|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
33568639|NCT03420781|62964384|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
33568640|NCT03420781|62964385|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
33568641|NCT03269695|62964403|FG000|Overall Study|Adverse Event|2|||
33568642|NCT03269695|62964404|FG001|Overall Study|Adverse Event|1|||
33568643|NCT03269695|62964403|FG000|Overall Study|Lack of Efficacy|0|||
33568644|NCT03269695|62964404|FG001|Overall Study|Lack of Efficacy|1|||
33568645|NCT03269695|62964403|FG000|Overall Study|Withdrawal by Subject|0|||
33568646|NCT03269695|62964404|FG001|Overall Study|Withdrawal by Subject|1|||
33568647|NCT00462943|62964414|FG000|Overall Study|Failure to achieve a response|5|||
33568648|NCT00462943|62964415|FG001|Overall Study|Failure to achieve a response|5|||
33568649|NCT00462943|62964416|FG002|Overall Study|Failure to achieve a response|1|||
33568650|NCT00462943|62964414|FG000|Overall Study|Adverse Event|6|||
33568651|NCT00462943|62964415|FG001|Overall Study|Adverse Event|4|||
33568652|NCT00462943|62964416|FG002|Overall Study|Adverse Event|1|||
33568653|NCT00462943|62964414|FG000|Overall Study|Protocol Violation|1|||
33568654|NCT00462943|62964415|FG001|Overall Study|Protocol Violation|0|||
33568655|NCT00462943|62964416|FG002|Overall Study|Protocol Violation|0|||
33568656|NCT00462943|62964414|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
33568657|NCT00462943|62964415|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
33568658|NCT00462943|62964416|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
33568659|NCT00462943|62964414|FG000|Overall Study|Disease Progression|15|||
33568660|NCT00462943|62964415|FG001|Overall Study|Disease Progression|15|||
33568661|NCT00462943|62964416|FG002|Overall Study|Disease Progression|9|||
33568662|NCT00462943|62964414|FG000|Overall Study|Death|5|||
33568663|NCT00462943|62964415|FG001|Overall Study|Death|2|||
33568664|NCT00462943|62964416|FG002|Overall Study|Death|7|||
33568665|NCT00462943|62964414|FG000|Overall Study|Stem Cell Transplant|1|||
33568666|NCT00462943|62964415|FG001|Overall Study|Stem Cell Transplant|1|||
33568667|NCT00462943|62964416|FG002|Overall Study|Stem Cell Transplant|0|||
33568668|NCT00462943|62964414|FG000|Overall Study|Bone Marrow Transplant|1|||
33568669|NCT00462943|62964415|FG001|Overall Study|Bone Marrow Transplant|0|||
33568670|NCT00462943|62964416|FG002|Overall Study|Bone Marrow Transplant|0|||
33568671|NCT00462943|62964414|FG000|Overall Study|Required Lymphocyte Infusion|1|||
33568672|NCT00462943|62964415|FG001|Overall Study|Required Lymphocyte Infusion|0|||
33568673|NCT00462943|62964416|FG002|Overall Study|Required Lymphocyte Infusion|0|||
33568674|NCT00462943|62964414|FG000|Overall Study|Transplant - not specified|1|||
33568675|NCT00462943|62964415|FG001|Overall Study|Transplant - not specified|0|||
33568676|NCT00462943|62964416|FG002|Overall Study|Transplant - not specified|1|||
33568677|NCT00462943|62964414|FG000|Overall Study|Physician Decision|1|||
33568678|NCT00462943|62964415|FG001|Overall Study|Physician Decision|0|||
33568679|NCT00462943|62964416|FG002|Overall Study|Physician Decision|0|||
33568680|NCT00462943|62964414|FG000|Overall Study|Withdrawal by Subject|0|||
33568681|NCT00462943|62964415|FG001|Overall Study|Withdrawal by Subject|1|||
33568682|NCT00462943|62964416|FG002|Overall Study|Withdrawal by Subject|0|||
33568683|NCT02730793|62964440|FG000|Overall Study|Physician Decision|0|||
33568684|NCT02730793|62964441|FG001|Overall Study|Physician Decision|1|||
33568685|NCT02730793|62964440|FG000|Overall Study|Withdrawal by Subject|0|||
33568686|NCT02730793|62964441|FG001|Overall Study|Withdrawal by Subject|1|||
33568687|NCT02855125|62964449|FG000|Overall Study|Withdrawal by Subject|2|||
33568688|NCT02855125|62964450|FG001|Overall Study|Withdrawal by Subject|2|||
33568689|NCT02855125|62964449|FG000|Overall Study|Clinical Disease Progression|5|||
33568690|NCT02855125|62964450|FG001|Overall Study|Clinical Disease Progression|4|||
33568691|NCT02855125|62964449|FG000|Overall Study|Radiologic Disease Progression|36|||
33568692|NCT02855125|62964450|FG001|Overall Study|Radiologic Disease Progression|39|||
33568693|NCT02855125|62964449|FG000|Overall Study|Adverse Event|11|||
33568694|NCT02855125|62964450|FG001|Overall Study|Adverse Event|7|||
33568695|NCT02855125|62964449|FG000|Overall Study|Physician Decision|1|||
33568696|NCT02855125|62964450|FG001|Overall Study|Physician Decision|0|||
33568697|NCT02855125|62964449|FG000|Overall Study|On Treatment|9|||
33568698|NCT02855125|62964450|FG001|Overall Study|On Treatment|11|||
33568699|NCT02855125|62964449|FG000|Overall Study|Randomized but not treated|0|||
33568700|NCT02855125|62964450|FG001|Overall Study|Randomized but not treated|1|||
33568701|NCT02730871|62964473|FG000|Overall Study|Adverse Event|6|||
33568702|NCT02730871|62964474|FG001|Overall Study|Adverse Event|0|||
33568703|NCT03376789|62964482|FG000|Overall Study|Withdrawal by Subject|3|||
33568704|NCT03376789|62964483|FG001|Overall Study|Withdrawal by Subject|5|||
33568705|NCT03376789|62964482|FG000|Overall Study|Protocol Violation|0|||
33568706|NCT03376789|62964483|FG001|Overall Study|Protocol Violation|1|||
33568707|NCT03376789|62964482|FG000|Overall Study|Adverse Event|0|||
33568708|NCT03376789|62964483|FG001|Overall Study|Adverse Event|1|||
33568709|NCT03376789|62964482|FG000|Overall Study|Lost to Follow-up|1|||
33568710|NCT03376789|62964483|FG001|Overall Study|Lost to Follow-up|1|||
33568711|NCT03376789|62964482|FG000|Overall Study|Per sponsor due to noncompliance|1|||
33568712|NCT03376789|62964483|FG001|Overall Study|Per sponsor due to noncompliance|0|||
33568713|NCT03376789|62964482|FG000|Overall Study|Subject off study medication|0|||
33568714|NCT03376789|62964483|FG001|Overall Study|Subject off study medication|1|||
33568715|NCT04032093|62964499|FG000|Overall Study|Lost to Follow-up|7|||
33568716|NCT04032093|62964500|FG001|Overall Study|Lost to Follow-up|7|||
33568717|NCT04032093|62964501|FG002|Overall Study|Lost to Follow-up|6|||
33568718|NCT04032093|62964502|FG003|Overall Study|Lost to Follow-up|10|||
33568719|NCT04032093|62964503|FG004|Overall Study|Lost to Follow-up|13|||
33568720|NCT04032093|62964504|FG005|Overall Study|Lost to Follow-up|7|||
33568721|NCT04032093|62964505|FG006|Overall Study|Lost to Follow-up|7|||
33568722|NCT04032093|62964506|FG007|Overall Study|Lost to Follow-up|5|||
33568723|NCT04032093|62964507|FG008|Overall Study|Lost to Follow-up|9|||
33568724|NCT04032093|62964508|FG009|Overall Study|Lost to Follow-up|12|||
33568725|NCT04032093|62964499|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33568726|NCT04032093|62964500|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33568727|NCT04032093|62964501|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
33568728|NCT04032093|62964502|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
33568729|NCT04032093|62964503|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
33568730|NCT04032093|62964504|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
33568731|NCT04032093|62964505|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
33568732|NCT04032093|62964506|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
33568733|NCT04032093|62964507|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
33568734|NCT04032093|62964508|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
33568735|NCT04032093|62964499|FG000|Overall Study|Other|1|||
33568736|NCT04032093|62964500|FG001|Overall Study|Other|0|||
33568737|NCT04032093|62964501|FG002|Overall Study|Other|0|||
33568738|NCT04032093|62964502|FG003|Overall Study|Other|1|||
33568739|NCT04032093|62964503|FG004|Overall Study|Other|1|||
33568740|NCT04032093|62964504|FG005|Overall Study|Other|0|||
33568741|NCT04032093|62964505|FG006|Overall Study|Other|0|||
33568742|NCT04032093|62964506|FG007|Overall Study|Other|0|||
33568743|NCT04032093|62964507|FG008|Overall Study|Other|0|||
33568744|NCT04032093|62964508|FG009|Overall Study|Other|1|||
33568745|NCT04032093|62964499|FG000|Overall Study|Withdrawal by Subject|1|||
33568746|NCT04032093|62964500|FG001|Overall Study|Withdrawal by Subject|3|||
33568747|NCT04032093|62964501|FG002|Overall Study|Withdrawal by Subject|2|||
33568748|NCT04032093|62964502|FG003|Overall Study|Withdrawal by Subject|2|||
33568749|NCT04032093|62964503|FG004|Overall Study|Withdrawal by Subject|3|||
33568750|NCT04032093|62964504|FG005|Overall Study|Withdrawal by Subject|0|||
33568751|NCT04032093|62964505|FG006|Overall Study|Withdrawal by Subject|0|||
33568752|NCT04032093|62964506|FG007|Overall Study|Withdrawal by Subject|0|||
33568753|NCT04032093|62964507|FG008|Overall Study|Withdrawal by Subject|0|||
33568754|NCT04032093|62964508|FG009|Overall Study|Withdrawal by Subject|0|||
33568755|NCT04032093|62964499|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33568756|NCT04032093|62964500|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33568757|NCT04032093|62964501|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
33568758|NCT04032093|62964502|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
33568759|NCT04032093|62964503|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
33568760|NCT04032093|62964504|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
33568761|NCT04032093|62964505|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
33568762|NCT04032093|62964506|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
33568763|NCT04032093|62964507|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
33568764|NCT04032093|62964508|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
33568765|NCT04032093|62964499|FG000|Overall Study|Adverse Event|0|||
33568766|NCT04032093|62964500|FG001|Overall Study|Adverse Event|0|||
33568767|NCT04032093|62964501|FG002|Overall Study|Adverse Event|0|||
33568768|NCT04032093|62964502|FG003|Overall Study|Adverse Event|0|||
33568769|NCT04032093|62964503|FG004|Overall Study|Adverse Event|0|||
33568770|NCT04032093|62964504|FG005|Overall Study|Adverse Event|0|||
33568771|NCT04032093|62964505|FG006|Overall Study|Adverse Event|0|||
33568772|NCT04032093|62964506|FG007|Overall Study|Adverse Event|0|||
33568773|NCT04032093|62964507|FG008|Overall Study|Adverse Event|0|||
33568774|NCT04032093|62964508|FG009|Overall Study|Adverse Event|1|||
33568775|NCT04032093|62964499|FG000|Overall Study|Physician Decision|0|||
33568776|NCT04032093|62964500|FG001|Overall Study|Physician Decision|0|||
33568777|NCT04032093|62964501|FG002|Overall Study|Physician Decision|0|||
33568778|NCT04032093|62964502|FG003|Overall Study|Physician Decision|0|||
33568779|NCT04032093|62964503|FG004|Overall Study|Physician Decision|0|||
33568780|NCT04032093|62964504|FG005|Overall Study|Physician Decision|1|||
33568781|NCT04032093|62964505|FG006|Overall Study|Physician Decision|0|||
33568782|NCT04032093|62964506|FG007|Overall Study|Physician Decision|0|||
33568783|NCT04032093|62964507|FG008|Overall Study|Physician Decision|0|||
33568784|NCT04032093|62964508|FG009|Overall Study|Physician Decision|0|||
33568785|NCT01675167|62964532|FG000|Open-label Titration Phase|Adverse Event|81|||
33568786|NCT01675167|62964533|FG001|Open-label Titration Phase|Adverse Event|0|||
33568787|NCT01675167|62964534|FG002|Open-label Titration Phase|Adverse Event|0|||
33568788|NCT01675167|62964532|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
33568789|NCT01675167|62964533|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
33568790|NCT01675167|62964534|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
33568791|NCT01675167|62964532|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
33568792|NCT01675167|62964533|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
33568793|NCT01675167|62964534|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
33568794|NCT01675167|62964532|FG000|Open-label Titration Phase|Protocol Violation|43|||
33568795|NCT01675167|62964533|FG001|Open-label Titration Phase|Protocol Violation|0|||
33664258|NCT02675634|63095271|FG004|Test Period 2|Lack of Efficacy|0|||
33396685|NCT00308737|62775948|FG001|Overall Study|Lost to Follow-up|80|||
33568796|NCT01675167|62964534|FG002|Open-label Titration Phase|Protocol Violation|0|||
33568797|NCT01675167|62964532|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
33568798|NCT01675167|62964533|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
33568799|NCT01675167|62964534|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
33568800|NCT01675167|62964532|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
33568801|NCT01675167|62964533|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
33568802|NCT01675167|62964534|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
33568803|NCT01675167|62964532|FG000|Open-label Titration Phase|Other|55|||
33568804|NCT01675167|62964533|FG001|Open-label Titration Phase|Other|0|||
33568805|NCT01675167|62964534|FG002|Open-label Titration Phase|Other|0|||
33568806|NCT01675167|62964532|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
33568807|NCT01675167|62964533|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
33568808|NCT01675167|62964534|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
33568809|NCT01675167|62964532|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33568810|NCT01675167|62964533|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
33568811|NCT01675167|62964534|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
33568812|NCT01675167|62964532|FG000|Double-blind Treatment Phase|Adverse Event|0|||
33568813|NCT01675167|62964533|FG001|Double-blind Treatment Phase|Adverse Event|5|||
33568814|NCT01675167|62964534|FG002|Double-blind Treatment Phase|Adverse Event|13|||
33568815|NCT01675167|62964532|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
33568816|NCT01675167|62964533|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
33568817|NCT01675167|62964534|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
33568818|NCT01675167|62964532|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
33568819|NCT01675167|62964533|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
33568820|NCT01675167|62964534|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
33568821|NCT01675167|62964532|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
33568822|NCT01675167|62964533|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
33568823|NCT01675167|62964534|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
33568824|NCT01675167|62964532|FG000|Double-blind Treatment Phase|Other|0|||
33568825|NCT01675167|62964533|FG001|Double-blind Treatment Phase|Other|7|||
33568826|NCT01675167|62964534|FG002|Double-blind Treatment Phase|Other|5|||
33568827|NCT01675011|62964544|FG000|Overall Study|Trial terminated by Sponsor|3|||
33568828|NCT01675011|62964545|FG001|Overall Study|Trial terminated by Sponsor|1|||
33568829|NCT04109547|62964573|FG000|Overall Study|Withdrawal by Subject|3|||
33568830|NCT04109547|62964574|FG001|Overall Study|Withdrawal by Subject|2|||
33568831|NCT04109547|62964575|FG002|Overall Study|Withdrawal by Subject|6|||
33568832|NCT04109547|62964576|FG003|Overall Study|Withdrawal by Subject|6|||
33568833|NCT04109547|62964573|FG000|Overall Study|Lost to Follow-up|0|||
33568834|NCT04109547|62964574|FG001|Overall Study|Lost to Follow-up|0|||
33568835|NCT04109547|62964575|FG002|Overall Study|Lost to Follow-up|0|||
33568836|NCT04109547|62964576|FG003|Overall Study|Lost to Follow-up|1|||
33568837|NCT04109547|62964573|FG000|Overall Study|Physician Decision|1|||
33568838|NCT04109547|62964574|FG001|Overall Study|Physician Decision|2|||
33568839|NCT04109547|62964575|FG002|Overall Study|Physician Decision|0|||
33568840|NCT04109547|62964576|FG003|Overall Study|Physician Decision|0|||
33568841|NCT02649231|62964599|FG000|Overall Study|Adverse Event|0|||
33568842|NCT02649231|62964600|FG001|Overall Study|Adverse Event|0|||
33568843|NCT02649231|62964601|FG002|Overall Study|Adverse Event|0|||
33568844|NCT02649231|62964602|FG003|Overall Study|Adverse Event|1|||
33568845|NCT02649231|62964599|FG000|Overall Study|Lost to Follow-up|2|||
33568846|NCT02649231|62964600|FG001|Overall Study|Lost to Follow-up|1|||
33568847|NCT02649231|62964601|FG002|Overall Study|Lost to Follow-up|1|||
33568848|NCT02649231|62964602|FG003|Overall Study|Lost to Follow-up|0|||
33568849|NCT02649231|62964599|FG000|Overall Study|Withdrawal by Subject|0|||
33568850|NCT02649231|62964600|FG001|Overall Study|Withdrawal by Subject|1|||
33568851|NCT02649231|62964601|FG002|Overall Study|Withdrawal by Subject|0|||
33568852|NCT02649231|62964602|FG003|Overall Study|Withdrawal by Subject|1|||
33568853|NCT02649231|62964599|FG000|Overall Study|Protocol Violation|2|||
33568854|NCT02649231|62964600|FG001|Overall Study|Protocol Violation|1|||
33568855|NCT02649231|62964601|FG002|Overall Study|Protocol Violation|1|||
33568856|NCT02649231|62964602|FG003|Overall Study|Protocol Violation|0|||
33568857|NCT01376245|62964616|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
33568858|NCT01376245|62964617|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
33568859|NCT01376245|62964618|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
33568860|NCT01376245|62964619|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
33568861|NCT01376245|62964620|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
33568862|NCT01376245|62964616|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
33568863|NCT01376245|62964617|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
33568864|NCT01376245|62964618|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
33568865|NCT01376245|62964619|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
33568866|NCT01376245|62964620|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
33568867|NCT01376245|62964616|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
33568868|NCT01376245|62964617|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
33568869|NCT01376245|62964618|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
33568870|NCT01376245|62964619|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
33568871|NCT01376245|62964620|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
33568872|NCT01376245|62964616|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
33568873|NCT01376245|62964617|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
33568874|NCT01376245|62964618|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
33568875|NCT01376245|62964619|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
33568876|NCT01376245|62964620|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
33568877|NCT01376245|62964616|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
33568878|NCT01376245|62964617|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
33568879|NCT01376245|62964618|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
33568880|NCT01376245|62964619|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
33568881|NCT01376245|62964620|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
33568882|NCT01376245|62964616|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
33568883|NCT01376245|62964617|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
33568884|NCT01376245|62964618|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
33568885|NCT01376245|62964619|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
33568886|NCT01376245|62964620|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
33568887|NCT01376245|62964616|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
33568888|NCT01376245|62964617|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
33568889|NCT01376245|62964618|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
33568890|NCT01376245|62964619|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
33568891|NCT01376245|62964620|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
33568892|NCT01376245|62964616|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
33568893|NCT01376245|62964617|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
33568894|NCT01376245|62964618|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
33568895|NCT01376245|62964619|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
33568896|NCT01376245|62964620|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
33568897|NCT01376245|62964616|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
33568898|NCT01376245|62964617|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
33568899|NCT01376245|62964618|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
33568900|NCT01376245|62964619|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
33568901|NCT01376245|62964620|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
33568902|NCT01376245|62964616|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33568903|NCT01376245|62964617|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
33568904|NCT01376245|62964618|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33396686|NCT00308737|62775949|FG002|Overall Study|Lost to Follow-up|5|||
33396687|NCT00308737|62775947|FG000|Overall Study|Physician Decision|15|||
33396688|NCT00308737|62775948|FG001|Overall Study|Physician Decision|2|||
33396689|NCT00308737|62775949|FG002|Overall Study|Physician Decision|1|||
33396690|NCT00308737|62775947|FG000|Overall Study|Protocol Violation|34|||
33396691|NCT00308737|62775948|FG001|Overall Study|Protocol Violation|9|||
33396692|NCT00308737|62775949|FG002|Overall Study|Protocol Violation|5|||
33568905|NCT01376245|62964619|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
33568906|NCT01376245|62964620|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
33568907|NCT01376245|62964616|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
33568908|NCT01376245|62964617|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
33568909|NCT01376245|62964618|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
33568910|NCT01376245|62964619|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
33568911|NCT01376245|62964620|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
33568912|NCT01376245|62964616|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
33568913|NCT01376245|62964617|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
33568914|NCT01376245|62964618|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
33568915|NCT01376245|62964619|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
33568916|NCT01376245|62964620|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
33568917|NCT01674621|62964635|FG000|Overall Study|Adverse Event|3|||
33568918|NCT01674621|62964636|FG001|Overall Study|Adverse Event|2|||
33568919|NCT01674621|62964637|FG002|Overall Study|Adverse Event|5|||
33568920|NCT01674621|62964638|FG003|Overall Study|Adverse Event|5|||
33568921|NCT01674621|62964639|FG004|Overall Study|Adverse Event|1|||
33568922|NCT01674621|62964635|FG000|Overall Study|Inability to Complete Study Procedures|0|||
33664259|NCT02675634|63095272|FG005|Test Period 2|Lack of Efficacy|0|||
33396693|NCT00308737|62775947|FG000|Overall Study|Withdrawal by Subject|218|||
33396694|NCT00308737|62775948|FG001|Overall Study|Withdrawal by Subject|166|||
33568923|NCT01674621|62964636|FG001|Overall Study|Inability to Complete Study Procedures|0|||
33568924|NCT01674621|62964637|FG002|Overall Study|Inability to Complete Study Procedures|0|||
33568925|NCT01674621|62964638|FG003|Overall Study|Inability to Complete Study Procedures|0|||
33568926|NCT01674621|62964639|FG004|Overall Study|Inability to Complete Study Procedures|2|||
33568927|NCT01674621|62964635|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
33568928|NCT01674621|62964636|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
33568929|NCT01674621|62964637|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
33568930|NCT01674621|62964638|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
33568931|NCT01674621|62964639|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
33568932|NCT01674621|62964635|FG000|Overall Study|Withdrawal by Subject|2|||
33568933|NCT01674621|62964636|FG001|Overall Study|Withdrawal by Subject|5|||
33568934|NCT01674621|62964637|FG002|Overall Study|Withdrawal by Subject|2|||
33568935|NCT01674621|62964638|FG003|Overall Study|Withdrawal by Subject|0|||
33568936|NCT01674621|62964639|FG004|Overall Study|Withdrawal by Subject|1|||
33568937|NCT01674621|62964635|FG000|Overall Study|Other than specified|0|||
33568938|NCT01674621|62964636|FG001|Overall Study|Other than specified|1|||
33568939|NCT01674621|62964637|FG002|Overall Study|Other than specified|0|||
33568940|NCT01674621|62964638|FG003|Overall Study|Other than specified|0|||
33568941|NCT01674621|62964639|FG004|Overall Study|Other than specified|2|||
33568942|NCT02730169|62964656|FG000|Overall Study|Protocol Violation|1|||
33568943|NCT02730169|62964657|FG001|Overall Study|Protocol Violation|0|||
33568944|NCT02730169|62964658|FG002|Overall Study|Protocol Violation|0|||
33568945|NCT02730169|62964659|FG003|Overall Study|Protocol Violation|1|||
33568946|NCT02730169|62964656|FG000|Overall Study|Adverse Event|2|||
33568947|NCT02730169|62964657|FG001|Overall Study|Adverse Event|3|||
33568948|NCT02730169|62964658|FG002|Overall Study|Adverse Event|3|||
33568949|NCT02730169|62964659|FG003|Overall Study|Adverse Event|0|||
33568950|NCT02730169|62964656|FG000|Overall Study|Adverse Event of Special Interest|0|||
33568951|NCT02730169|62964657|FG001|Overall Study|Adverse Event of Special Interest|1|||
33568952|NCT02730169|62964658|FG002|Overall Study|Adverse Event of Special Interest|2|||
33568953|NCT02730169|62964659|FG003|Overall Study|Adverse Event of Special Interest|0|||
33568954|NCT02730169|62964656|FG000|Overall Study|Withdrawal by Subject|6|||
33568955|NCT02730169|62964657|FG001|Overall Study|Withdrawal by Subject|11|||
33568956|NCT02730169|62964658|FG002|Overall Study|Withdrawal by Subject|6|||
33568957|NCT02730169|62964659|FG003|Overall Study|Withdrawal by Subject|8|||
33568958|NCT02730169|62964656|FG000|Overall Study|Lost to Follow-up|5|||
33568959|NCT02730169|62964657|FG001|Overall Study|Lost to Follow-up|6|||
33568960|NCT02730169|62964658|FG002|Overall Study|Lost to Follow-up|5|||
33568961|NCT02730169|62964659|FG003|Overall Study|Lost to Follow-up|6|||
33568962|NCT02730169|62964656|FG000|Overall Study|Other|0|||
33568963|NCT02730169|62964657|FG001|Overall Study|Other|0|||
33568964|NCT02730169|62964658|FG002|Overall Study|Other|1|||
33568965|NCT02730169|62964659|FG003|Overall Study|Other|1|||
33568966|NCT02648217|62964671|FG000|Overall Study|Adverse Event|0|||
33568967|NCT02648217|62964672|FG001|Overall Study|Adverse Event|1|||
33568968|NCT02648217|62964671|FG000|Overall Study|Lost to Follow-up|1|||
33568969|NCT02648217|62964672|FG001|Overall Study|Lost to Follow-up|1|||
33568970|NCT02648217|62964671|FG000|Overall Study|Withdrawal by Subject|4|||
33568971|NCT02648217|62964672|FG001|Overall Study|Withdrawal by Subject|3|||
33568972|NCT02648217|62964671|FG000|Overall Study|Unclassified|5|||
33568973|NCT02648217|62964672|FG001|Overall Study|Unclassified|0|||
33568974|NCT00709735|62964680|FG000|Overall Study|Lost to Follow-up|1|||
33568975|NCT00709735|62964681|FG001|Overall Study|Lost to Follow-up|1|||
33568976|NCT00709735|62964680|FG000|Overall Study|Relapse into Opioid Abuse|0|||
33568977|NCT00709735|62964681|FG001|Overall Study|Relapse into Opioid Abuse|1|||
33568978|NCT00709735|62964680|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
33568979|NCT00709735|62964681|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
33568980|NCT02647905|62964687|FG000|Overall Study|Lost to Follow-up|1|||
33568981|NCT02647905|62964687|FG000|Overall Study|Withdrawal by Subject|2|||
33568982|NCT04185909|62964700|FG000|Overall Study|Lost to Follow-up|1|||
33568983|NCT04076943|62964704|FG000|Overall Study|Withdrawal by Subject|12|||
33568984|NCT04076943|62964704|FG000|Overall Study|Adverse Event|1|||
33568985|NCT04076943|62964704|FG000|Overall Study|Progressive Disease|2|||
33568986|NCT04076943|62964704|FG000|Overall Study|Death|13|||
33568987|NCT04076943|62964704|FG000|Overall Study|Other than specified|6|||
33568988|NCT00708643|62964710|FG000|Overall Study|Adverse Event|0|||
33568989|NCT00708643|62964711|FG001|Overall Study|Adverse Event|1|||
33568990|NCT01285557|62964774|FG000|Overall Study|Death|173|||
33396695|NCT00308737|62775949|FG002|Overall Study|Withdrawal by Subject|18|||
33568991|NCT01285557|62964775|FG001|Overall Study|Death|90|||
33568992|NCT01285557|62964774|FG000|Overall Study|Lost to Follow-up|6|||
33568993|NCT01285557|62964775|FG001|Overall Study|Lost to Follow-up|2|||
33568994|NCT01285557|62964774|FG000|Overall Study|Withdrew Consent|6|||
33568995|NCT01285557|62964775|FG001|Overall Study|Withdrew Consent|1|||
33568996|NCT01285557|62964774|FG000|Overall Study|Sponsor Study Termination|23|||
33568997|NCT01285557|62964775|FG001|Overall Study|Sponsor Study Termination|13|||
33664260|NCT02675634|63095267|FG000|Test Period 2|Adverse Event|0|||
33568998|NCT01285557|62964774|FG000|Overall Study|Randomized but not treated|1|||
33568999|NCT01285557|62964775|FG001|Overall Study|Randomized but not treated|1|||
33569000|NCT01285557|62964774|FG000|Overall Study|Study follow-up ongoing|28|||
33569001|NCT01285557|62964775|FG001|Overall Study|Study follow-up ongoing|14|||
33569002|NCT01285557|62964774|FG000|Overall Study|Sponsor Decision|2|||
33569003|NCT01285557|62964775|FG001|Overall Study|Sponsor Decision|1|||
33569004|NCT01376167|62964837|FG000|Overall Study|Lost to Follow-up|2|||
33569005|NCT01376167|62964838|FG001|Overall Study|Lost to Follow-up|4|||
33569006|NCT01376167|62964839|FG002|Overall Study|Lost to Follow-up|2|||
33569007|NCT01376167|62964837|FG000|Overall Study|Physician Decision|1|||
33569008|NCT01376167|62964838|FG001|Overall Study|Physician Decision|1|||
33569009|NCT01376167|62964839|FG002|Overall Study|Physician Decision|0|||
33569010|NCT01376167|62964837|FG000|Overall Study|Withdrawal by Subject|1|||
33569011|NCT01376167|62964838|FG001|Overall Study|Withdrawal by Subject|5|||
33569012|NCT01376167|62964839|FG002|Overall Study|Withdrawal by Subject|4|||
33569013|NCT02647281|62964859|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33396696|NCT00308737|62775947|FG000|Overall Study|Various|32|||
33396697|NCT00308737|62775948|FG001|Overall Study|Various|20|||
33396698|NCT00308737|62775949|FG002|Overall Study|Various|8|||
33569014|NCT02647281|62964860|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33569015|NCT02647281|62964861|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33569016|NCT02647281|62964862|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33569017|NCT02647281|62964863|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33569018|NCT02647281|62964864|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33569019|NCT02647281|62964865|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33569020|NCT02647281|62964866|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33569021|NCT02647281|62964867|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
33569022|NCT02729545|62964898|FG000|Overall Study|Pregnancy|1|||
33569023|NCT02729545|62964899|FG001|Overall Study|Pregnancy|1|||
33569024|NCT02729545|62964898|FG000|Overall Study|Lost to Follow-up|0|||
33569025|NCT02729545|62964899|FG001|Overall Study|Lost to Follow-up|1|||
33569026|NCT02729545|62964898|FG000|Overall Study|Withdrawal by Subject|2|||
33569027|NCT02729545|62964899|FG001|Overall Study|Withdrawal by Subject|3|||
33569028|NCT01376089|62964907|FG000|Overall Study|Patient received no contrast media|3|||
33569029|NCT01376089|62964908|FG001|Overall Study|Patient received no contrast media|4|||
33569030|NCT00706849|62964920|FG000|Treatment Period|Adverse Event|0|||
33569031|NCT00706849|62964921|FG001|Treatment Period|Adverse Event|9|||
33569032|NCT00706849|62964920|FG000|Treatment Period|Other|0|||
33569033|NCT00706849|62964921|FG001|Treatment Period|Other|1|||
33569034|NCT00706849|62964920|FG000|Follow-up Period|Withdrawal by Subject|0|||
33569035|NCT00706849|62964921|FG001|Follow-up Period|Withdrawal by Subject|2|||
33569036|NCT00706849|62964920|FG000|Follow-up Period|Protocol non-compliance|0|||
33569037|NCT00706849|62964921|FG001|Follow-up Period|Protocol non-compliance|1|||
33569038|NCT00707161|62964927|FG000|Overall Study|Physician Decision|6|||
33569039|NCT02130466|62964945|FG000|Overall Study|Death|4|||
33569040|NCT02130466|62964946|FG001|Overall Study|Death|1|||
33569041|NCT02130466|62964947|FG002|Overall Study|Death|1|||
33569042|NCT02130466|62964948|FG003|Overall Study|Death|3|||
33569043|NCT02130466|62964949|FG004|Overall Study|Death|2|||
33569044|NCT02130466|62964950|FG005|Overall Study|Death|30|||
33569045|NCT02130466|62964951|FG006|Overall Study|Death|45|||
33569046|NCT02130466|62964952|FG007|Overall Study|Death|2|||
33569047|NCT02130466|62964953|FG008|Overall Study|Death|3|||
33569048|NCT02130466|62964954|FG009|Overall Study|Death|4|||
33569049|NCT02130466|62964955|FG010|Overall Study|Death|5|||
33569050|NCT02130466|62964956|FG011|Overall Study|Death|3|||
33569051|NCT02130466|62964957|FG012|Overall Study|Death|11|||
33569052|NCT02130466|62964958|FG013|Overall Study|Death|7|||
33569053|NCT02130466|62964945|FG000|Overall Study|Lost to Follow-up|1|||
33569054|NCT02130466|62964946|FG001|Overall Study|Lost to Follow-up|0|||
33569055|NCT02130466|62964947|FG002|Overall Study|Lost to Follow-up|0|||
33569056|NCT02130466|62964948|FG003|Overall Study|Lost to Follow-up|0|||
33569057|NCT02130466|62964949|FG004|Overall Study|Lost to Follow-up|0|||
33569058|NCT02130466|62964950|FG005|Overall Study|Lost to Follow-up|1|||
33396699|NCT00655746|62775957|FG000|Overall Study|Withdrawal by Subject|1|||
33569059|NCT02130466|62964951|FG006|Overall Study|Lost to Follow-up|0|||
33569060|NCT02130466|62964952|FG007|Overall Study|Lost to Follow-up|0|||
33569061|NCT02130466|62964953|FG008|Overall Study|Lost to Follow-up|0|||
33396700|NCT00338455|62775967|FG000|Overall Study|Death|2|||
33569062|NCT02130466|62964954|FG009|Overall Study|Lost to Follow-up|0|||
33569063|NCT02130466|62964955|FG010|Overall Study|Lost to Follow-up|0|||
33569064|NCT02130466|62964956|FG011|Overall Study|Lost to Follow-up|0|||
33569065|NCT02130466|62964957|FG012|Overall Study|Lost to Follow-up|1|||
33569066|NCT02130466|62964958|FG013|Overall Study|Lost to Follow-up|0|||
33569067|NCT02130466|62964945|FG000|Overall Study|Physician Decision|0|||
33569068|NCT02130466|62964946|FG001|Overall Study|Physician Decision|0|||
33569069|NCT02130466|62964947|FG002|Overall Study|Physician Decision|0|||
33396701|NCT00338455|62775968|FG001|Overall Study|Death|1|||
33569070|NCT02130466|62964948|FG003|Overall Study|Physician Decision|0|||
33569071|NCT02130466|62964949|FG004|Overall Study|Physician Decision|0|||
33569072|NCT02130466|62964950|FG005|Overall Study|Physician Decision|1|||
33569073|NCT02130466|62964951|FG006|Overall Study|Physician Decision|1|||
33569074|NCT02130466|62964952|FG007|Overall Study|Physician Decision|0|||
33569075|NCT02130466|62964953|FG008|Overall Study|Physician Decision|0|||
33569076|NCT02130466|62964954|FG009|Overall Study|Physician Decision|0|||
33569077|NCT02130466|62964955|FG010|Overall Study|Physician Decision|0|||
33569078|NCT02130466|62964956|FG011|Overall Study|Physician Decision|0|||
33569079|NCT02130466|62964957|FG012|Overall Study|Physician Decision|0|||
33569080|NCT02130466|62964958|FG013|Overall Study|Physician Decision|0|||
33569081|NCT02130466|62964945|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
33569082|NCT02130466|62964946|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
33569083|NCT02130466|62964947|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
33569084|NCT02130466|62964948|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
33569085|NCT02130466|62964949|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
33569086|NCT02130466|62964950|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
33569087|NCT02130466|62964951|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
33569088|NCT02130466|62964952|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
33569089|NCT02130466|62964953|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
33569090|NCT02130466|62964954|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
33569091|NCT02130466|62964955|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
33569092|NCT02130466|62964956|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
33569093|NCT02130466|62964957|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
33569094|NCT02130466|62964958|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
33569095|NCT02130466|62964945|FG000|Overall Study|Withdrawal by Subject|1|||
33569096|NCT02130466|62964946|FG001|Overall Study|Withdrawal by Subject|0|||
33569097|NCT02130466|62964947|FG002|Overall Study|Withdrawal by Subject|0|||
33569098|NCT02130466|62964948|FG003|Overall Study|Withdrawal by Subject|0|||
33569099|NCT02130466|62964949|FG004|Overall Study|Withdrawal by Subject|0|||
33569100|NCT02130466|62964950|FG005|Overall Study|Withdrawal by Subject|1|||
33569101|NCT02130466|62964951|FG006|Overall Study|Withdrawal by Subject|0|||
33569102|NCT02130466|62964952|FG007|Overall Study|Withdrawal by Subject|0|||
33569103|NCT02130466|62964953|FG008|Overall Study|Withdrawal by Subject|1|||
33569104|NCT02130466|62964954|FG009|Overall Study|Withdrawal by Subject|0|||
33569105|NCT02130466|62964955|FG010|Overall Study|Withdrawal by Subject|0|||
33569106|NCT02130466|62964956|FG011|Overall Study|Withdrawal by Subject|0|||
33569107|NCT02130466|62964957|FG012|Overall Study|Withdrawal by Subject|0|||
33569108|NCT02130466|62964958|FG013|Overall Study|Withdrawal by Subject|0|||
33569109|NCT02163538|62965007|FG000|Overall Study|Protocol Violation|1|||
33569110|NCT02163538|62965008|FG001|Overall Study|Protocol Violation|0|||
33569111|NCT02163538|62965007|FG000|Overall Study|Physician Decision|0|||
33569112|NCT02163538|62965008|FG001|Overall Study|Physician Decision|1|||
33569113|NCT02163226|62965016|FG000|Overall Study|Death|2|||
33569114|NCT02163226|62965017|FG001|Overall Study|Death|1|||
33569115|NCT02163226|62965016|FG000|Overall Study|Withdrawal by Subject|5|||
33569116|NCT02163226|62965017|FG001|Overall Study|Withdrawal by Subject|2|||
33569117|NCT02163226|62965016|FG000|Overall Study|Returned home, local radiotherapy|3|||
33569118|NCT02163226|62965017|FG001|Overall Study|Returned home, local radiotherapy|0|||
33569119|NCT02163226|62965016|FG000|Overall Study|Repeat imaging showed no disease|2|||
33569120|NCT02163226|62965017|FG001|Overall Study|Repeat imaging showed no disease|0|||
33569121|NCT02163226|62965016|FG000|Overall Study|Incomplete radiotherapy|3|||
33569122|NCT02163226|62965017|FG001|Overall Study|Incomplete radiotherapy|0|||
33569123|NCT02163226|62965016|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
33569124|NCT02163226|62965017|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
33569125|NCT02163226|62965016|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
33569126|NCT02163226|62965017|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
33569127|NCT02163226|62965016|FG000|Overall Study|ineligible|0|||
33569128|NCT02163226|62965017|FG001|Overall Study|ineligible|3|||
33569129|NCT02193178|62965023|FG000|Overall Study|Lost to Follow-up|1|||
33569130|NCT02193178|62965023|FG000|Overall Study|Dry eyes|1|||
33569131|NCT02129608|62965044|FG000|Overall Study|Lost to Follow-up|0|||
33569132|NCT02129608|62965045|FG001|Overall Study|Lost to Follow-up|1|||
33569133|NCT02129608|62965046|FG002|Overall Study|Lost to Follow-up|1|||
33569134|NCT02129608|62965044|FG000|Overall Study|Withdrawal by Subject|0|||
33569135|NCT02129608|62965045|FG001|Overall Study|Withdrawal by Subject|0|||
33569136|NCT02129608|62965046|FG002|Overall Study|Withdrawal by Subject|2|||
33569137|NCT01631188|62965054|FG000|Overall Study|Physician Decision|75|||
33569138|NCT02129062|62965058|FG000|Overall Study|Death|1|||
33569139|NCT02129062|62965058|FG000|Overall Study|Disease Progression|2|||
33569140|NCT02162758|62965064|FG000|Overall Study|Study termination|0|||
33569141|NCT02162758|62965065|FG001|Overall Study|Study termination|1|||
33569142|NCT02192164|62965071|FG000|Overall Study|Other|8|||
33569143|NCT02192164|62965071|FG000|Overall Study|Withdrawal by Subject|1|||
33569144|NCT02192164|62965071|FG000|Overall Study|Physician Decision|4|||
33569145|NCT02192164|62965071|FG000|Overall Study|Did not meet the exclusion criteria|1|||
33569146|NCT02191618|62965078|FG000|Overall Study|Withdrawal by Subject|3|||
33569147|NCT02191618|62965078|FG000|Overall Study|Missed Visit|4|||
33569148|NCT02646891|62965092|FG000|Overall Study|Adverse Event|0|||
33569149|NCT02646891|62965093|FG001|Overall Study|Adverse Event|1|||
33569150|NCT02646891|62965094|FG002|Overall Study|Adverse Event|0|||
33569151|NCT02646891|62965095|FG003|Overall Study|Adverse Event|0|||
33569152|NCT02646891|62965096|FG004|Overall Study|Adverse Event|0|||
33569153|NCT02646891|62965097|FG005|Overall Study|Adverse Event|0|||
33569154|NCT02646891|62965098|FG006|Overall Study|Adverse Event|0|||
33569155|NCT02646891|62965099|FG007|Overall Study|Adverse Event|0|||
33569156|NCT02646891|62965100|FG008|Overall Study|Adverse Event|0|||
33569157|NCT02646891|62965101|FG009|Overall Study|Adverse Event|0|||
33569158|NCT02646891|62965092|FG000|Overall Study|Lost to Follow-up|0|||
33569159|NCT02646891|62965093|FG001|Overall Study|Lost to Follow-up|0|||
33569160|NCT02646891|62965094|FG002|Overall Study|Lost to Follow-up|0|||
33569161|NCT02646891|62965095|FG003|Overall Study|Lost to Follow-up|0|||
33569162|NCT02646891|62965096|FG004|Overall Study|Lost to Follow-up|0|||
33569163|NCT02646891|62965097|FG005|Overall Study|Lost to Follow-up|0|||
33569164|NCT02646891|62965098|FG006|Overall Study|Lost to Follow-up|2|||
33569165|NCT02646891|62965099|FG007|Overall Study|Lost to Follow-up|2|||
33569166|NCT02646891|62965100|FG008|Overall Study|Lost to Follow-up|2|||
33569167|NCT02646891|62965101|FG009|Overall Study|Lost to Follow-up|2|||
33569168|NCT02646891|62965092|FG000|Overall Study|Protocol Violation|0|||
33569169|NCT02646891|62965093|FG001|Overall Study|Protocol Violation|0|||
33569170|NCT02646891|62965094|FG002|Overall Study|Protocol Violation|0|||
33569171|NCT02646891|62965095|FG003|Overall Study|Protocol Violation|0|||
33569172|NCT02646891|62965096|FG004|Overall Study|Protocol Violation|0|||
33569173|NCT02646891|62965097|FG005|Overall Study|Protocol Violation|0|||
33569174|NCT02646891|62965098|FG006|Overall Study|Protocol Violation|1|||
33569175|NCT02646891|62965099|FG007|Overall Study|Protocol Violation|1|||
33569176|NCT02646891|62965100|FG008|Overall Study|Protocol Violation|0|||
33569177|NCT02646891|62965101|FG009|Overall Study|Protocol Violation|0|||
33569178|NCT02646891|62965092|FG000|Overall Study|Withdrawal by Subject|2|||
33569179|NCT02646891|62965093|FG001|Overall Study|Withdrawal by Subject|0|||
33569180|NCT02646891|62965094|FG002|Overall Study|Withdrawal by Subject|1|||
33569181|NCT02646891|62965095|FG003|Overall Study|Withdrawal by Subject|0|||
33569182|NCT02646891|62965096|FG004|Overall Study|Withdrawal by Subject|0|||
33569183|NCT02646891|62965097|FG005|Overall Study|Withdrawal by Subject|0|||
33569184|NCT02646891|62965098|FG006|Overall Study|Withdrawal by Subject|5|||
33569185|NCT02646891|62965099|FG007|Overall Study|Withdrawal by Subject|9|||
33569186|NCT02646891|62965100|FG008|Overall Study|Withdrawal by Subject|7|||
33569187|NCT02646891|62965101|FG009|Overall Study|Withdrawal by Subject|3|||
33569188|NCT02646891|62965092|FG000|Overall Study|Death|0|||
33569189|NCT02646891|62965093|FG001|Overall Study|Death|0|||
33569190|NCT02646891|62965094|FG002|Overall Study|Death|0|||
33569191|NCT02646891|62965095|FG003|Overall Study|Death|0|||
33569192|NCT02646891|62965096|FG004|Overall Study|Death|0|||
33569193|NCT02646891|62965097|FG005|Overall Study|Death|0|||
33569194|NCT02646891|62965098|FG006|Overall Study|Death|1|||
33569195|NCT02646891|62965099|FG007|Overall Study|Death|1|||
33569196|NCT02646891|62965100|FG008|Overall Study|Death|1|||
33569197|NCT02646891|62965101|FG009|Overall Study|Death|0|||
33569198|NCT02646423|62965137|FG000|Overall Study|Adverse Event|5|||
33569199|NCT02646423|62965138|FG001|Overall Study|Adverse Event|7|||
33569200|NCT02646423|62965137|FG000|Overall Study|Ineligible|2|||
33569201|NCT02646423|62965138|FG001|Overall Study|Ineligible|1|||
33569202|NCT02647359|62965164|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
33569203|NCT02647359|62965165|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
33569204|NCT02647359|62965164|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
33569205|NCT02647359|62965165|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
33569206|NCT02647359|62965164|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
33569207|NCT02647359|62965165|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
33569208|NCT02647359|62965164|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
33569209|NCT02647359|62965165|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
33569210|NCT02647359|62965164|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
33569211|NCT02647359|62965165|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
33569212|NCT02647359|62965164|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
33569213|NCT02647359|62965165|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
33396702|NCT00338455|62775967|FG000|Overall Study|Physician Decision|1|||
33569214|NCT02645409|62965177|FG000|Overall Study|Withdrawal by Subject|3|||
33569215|NCT02645409|62965178|FG001|Overall Study|Withdrawal by Subject|0|||
33569216|NCT02645409|62965177|FG000|Overall Study|Physician Decision|1|||
33569217|NCT02645409|62965178|FG001|Overall Study|Physician Decision|0|||
33569218|NCT01597479|62965185|FG000|Overall Study|Protocol Violation|1|||
33569219|NCT01597479|62965186|FG001|Overall Study|Protocol Violation|0|||
33569220|NCT01597479|62965185|FG000|Overall Study|Lost to Follow-up|1|||
33569221|NCT01597479|62965186|FG001|Overall Study|Lost to Follow-up|0|||
33569222|NCT04248465|62965195|FG000|Randomized-Controlled Period|Death|12|||
33569223|NCT04248465|62965196|FG001|Randomized-Controlled Period|Death|5|||
33569224|NCT04248465|62965195|FG000|Randomized-Controlled Period|Adverse Event|2|||
33569225|NCT04248465|62965196|FG001|Randomized-Controlled Period|Adverse Event|0|||
33569226|NCT04248465|62965195|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
33569227|NCT04248465|62965196|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
33569228|NCT04248465|62965195|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
33569229|NCT04248465|62965196|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
33569230|NCT04248465|62965195|FG000|Randomized-Controlled Period|Physician Decision|1|||
33569231|NCT04248465|62965196|FG001|Randomized-Controlled Period|Physician Decision|1|||
33569232|NCT04248465|62965195|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
33569233|NCT04248465|62965196|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
33569234|NCT04248465|62965195|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
33569235|NCT04248465|62965196|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
33569236|NCT04248465|62965195|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
33569237|NCT04248465|62965196|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
33569238|NCT02643693|62965204|FG000|Overall Study|Physician Decision|0|||
33569239|NCT02643693|62965205|FG001|Overall Study|Physician Decision|1|||
33569240|NCT02643693|62965206|FG002|Overall Study|Physician Decision|0|||
33569241|NCT02643693|62965207|FG003|Overall Study|Physician Decision|0|||
33569242|NCT02643693|62965208|FG004|Overall Study|Physician Decision|0|||
33569243|NCT02643693|62965209|FG005|Overall Study|Physician Decision|0|||
33569244|NCT02643693|62965204|FG000|Overall Study|Withdrawal by Subject|0|||
33569245|NCT02643693|62965205|FG001|Overall Study|Withdrawal by Subject|1|||
33569246|NCT02643693|62965206|FG002|Overall Study|Withdrawal by Subject|0|||
33569247|NCT02643693|62965207|FG003|Overall Study|Withdrawal by Subject|0|||
33569248|NCT02643693|62965208|FG004|Overall Study|Withdrawal by Subject|0|||
33569249|NCT02643693|62965209|FG005|Overall Study|Withdrawal by Subject|0|||
33569250|NCT02643693|62965204|FG000|Overall Study|Protocol Adherence Issues|2|||
33569251|NCT02643693|62965205|FG001|Overall Study|Protocol Adherence Issues|0|||
33569252|NCT02643693|62965206|FG002|Overall Study|Protocol Adherence Issues|1|||
33569253|NCT02643693|62965207|FG003|Overall Study|Protocol Adherence Issues|0|||
33569254|NCT02643693|62965208|FG004|Overall Study|Protocol Adherence Issues|0|||
33569255|NCT02643693|62965209|FG005|Overall Study|Protocol Adherence Issues|1|||
33569256|NCT02726113|62965219|FG000|Total Enrollment|Physician Decision|0|||
33569257|NCT02726113|62965220|FG001|Total Enrollment|Physician Decision|1|||
33569258|NCT02726113|62965219|FG000|Total Enrollment|Protocol Violation|1|||
33569259|NCT02726113|62965220|FG001|Total Enrollment|Protocol Violation|0|||
33569260|NCT02726113|62965219|FG000|Total Enrollment|Withdrawal by Subject|2|||
33569261|NCT02726113|62965220|FG001|Total Enrollment|Withdrawal by Subject|1|||
33569262|NCT02726113|62965219|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
33569263|NCT02726113|62965220|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
33569264|NCT02726113|62965219|FG000|Genomic Analysis|Protocol Violation|1|||
33569265|NCT02726113|62965220|FG001|Genomic Analysis|Protocol Violation|0|||
33569266|NCT02726113|62965219|FG000|Genomic Analysis|Withdrawal by Subject|2|||
33569267|NCT02726113|62965220|FG001|Genomic Analysis|Withdrawal by Subject|1|||
33569268|NCT02726113|62965219|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
33569269|NCT02726113|62965220|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
33569270|NCT01361919|62965238|FG000|Overall Study|technical issues|10|||
33569271|NCT01361919|62965239|FG001|Overall Study|technical issues|12|||
33569272|NCT01361919|62965240|FG002|Overall Study|technical issues|10|||
33569273|NCT02642679|62965248|FG000|Overall Study|Withdrawal by Subject|1|||
33569274|NCT02642679|62965248|FG000|Overall Study|Physician Decision|1|||
33569275|NCT02642679|62965248|FG000|Overall Study|Physician Decision|1|||
33569276|NCT00705523|62965254|FG000|Overall Study|Lost to Follow-up|2|||
33569277|NCT00705523|62965255|FG001|Overall Study|Lost to Follow-up|3|||
33569278|NCT02725411|62965264|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
33569279|NCT02725411|62965265|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
33569280|NCT02725411|62965266|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
33569281|NCT02725411|62965264|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
33569282|NCT02725411|62965265|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
33569283|NCT02725411|62965266|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
33569284|NCT02725411|62965264|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
33569285|NCT02725411|62965265|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
33302850|NCT01074268|62678690|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
33302851|NCT01074268|62678691|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
33302852|NCT01074268|62678690|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
33302853|NCT01074268|62678691|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
33302854|NCT01074190|62678700|FG000|Overall Study|Emergency Cesarean Delivery|1|||
33569286|NCT02725411|62965266|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
33569287|NCT02725411|62965264|FG000|Treatment Period (56 Weeks)|Other|1|||
33569288|NCT02725411|62965265|FG001|Treatment Period (56 Weeks)|Other|4|||
33569289|NCT02725411|62965266|FG002|Treatment Period (56 Weeks)|Other|5|||
33569290|NCT02725411|62965264|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
33569291|NCT02725411|62965265|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
33569292|NCT02725411|62965266|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
33569293|NCT02725411|62965264|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
33569294|NCT02725411|62965265|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
33569295|NCT02725411|62965266|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
33569296|NCT02725411|62965264|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
33569297|NCT02725411|62965265|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
33569298|NCT02725411|62965266|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
33569299|NCT02725411|62965264|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
33569300|NCT02725411|62965265|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
33569301|NCT02725411|62965266|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
33569302|NCT02725411|62965264|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
33569303|NCT02725411|62965265|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
33569304|NCT02725411|62965266|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
33569305|NCT02725411|62965264|FG000|Follow-up Period (24 Weeks)|Other|1|||
33569306|NCT02725411|62965265|FG001|Follow-up Period (24 Weeks)|Other|4|||
33569307|NCT02725411|62965266|FG002|Follow-up Period (24 Weeks)|Other|2|||
33569308|NCT02725411|62965264|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
33569309|NCT02725411|62965265|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
33569310|NCT02725411|62965266|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
33569311|NCT02190604|62965302|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569312|NCT02190604|62965303|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569313|NCT02190604|62965304|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569314|NCT02190604|62965305|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569315|NCT02190604|62965306|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569316|NCT02190604|62965307|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569317|NCT02190604|62965308|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569318|NCT02190604|62965309|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569319|NCT02190604|62965310|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569320|NCT02190604|62965311|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569321|NCT02190604|62965312|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569322|NCT02190604|62965313|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569323|NCT02190604|62965314|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569324|NCT02190604|62965315|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569325|NCT02190604|62965316|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
33569326|NCT02190604|62965317|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569327|NCT02190604|62965318|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569328|NCT02190604|62965319|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569329|NCT02190604|62965320|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33569330|NCT02190604|62965302|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569331|NCT02190604|62965303|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569332|NCT02190604|62965304|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569333|NCT02190604|62965305|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569334|NCT02190604|62965306|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569335|NCT02190604|62965307|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569336|NCT02190604|62965308|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569337|NCT02190604|62965309|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569338|NCT02190604|62965310|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569339|NCT02190604|62965311|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569340|NCT02190604|62965312|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569341|NCT02190604|62965313|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569342|NCT02190604|62965314|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569343|NCT02190604|62965315|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
33569344|NCT02190604|62965316|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569345|NCT02190604|62965317|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569346|NCT02190604|62965318|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569347|NCT02190604|62965319|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569348|NCT02190604|62965320|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33569349|NCT02127970|62965379|FG000|Overall Study|Adverse Event|2|||
33569350|NCT02127970|62965380|FG001|Overall Study|Adverse Event|1|||
33569351|NCT02127970|62965379|FG000|Overall Study|Death|1|||
33569352|NCT02127970|62965380|FG001|Overall Study|Death|1|||
33664261|NCT02675634|63095268|FG001|Test Period 2|Adverse Event|0|||
33302855|NCT01074190|62678701|FG001|Overall Study|Emergency Cesarean Delivery|2|||
33569353|NCT02127970|62965379|FG000|Overall Study|Lost to Follow-up|14|||
33569354|NCT02127970|62965380|FG001|Overall Study|Lost to Follow-up|14|||
33569355|NCT02127970|62965379|FG000|Overall Study|Reason not Specified|4|||
33569356|NCT02127970|62965380|FG001|Overall Study|Reason not Specified|7|||
33569357|NCT02127970|62965379|FG000|Overall Study|Pregnancy|0|||
33569358|NCT02127970|62965380|FG001|Overall Study|Pregnancy|1|||
33569359|NCT02127970|62965379|FG000|Overall Study|Subject Withdrew Consent|5|||
33569360|NCT02127970|62965380|FG001|Overall Study|Subject Withdrew Consent|3|||
33569361|NCT03549871|62965388|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
33569362|NCT03549871|62965389|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
33569363|NCT03549871|62965388|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
33569364|NCT03549871|62965389|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
33569365|NCT03549871|62965388|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
33569366|NCT03549871|62965389|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
33569367|NCT03549871|62965388|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
33569368|NCT03549871|62965389|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
33569369|NCT03549871|62965388|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
33569370|NCT03549871|62965389|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
33569371|NCT03549871|62965388|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
33569372|NCT03549871|62965389|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
33569373|NCT03549871|62965388|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
33569374|NCT03549871|62965389|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
33569375|NCT03549871|62965388|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
33569376|NCT03549871|62965389|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
33569377|NCT03549871|62965388|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
33569378|NCT03549871|62965389|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
33569379|NCT03549871|62965388|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
33302856|NCT01074190|62678702|FG002|Overall Study|Emergency Cesarean Delivery|1|||
33396703|NCT00338455|62775968|FG001|Overall Study|Physician Decision|0|||
33569380|NCT03549871|62965389|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
33569381|NCT03549871|62965388|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
33569382|NCT03549871|62965389|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
33569383|NCT00705367|62965412|FG000|Long-term Extension Period|Adverse Event|2|||
33569384|NCT00705367|62965413|FG001|Long-term Extension Period|Adverse Event|0|||
33569385|NCT00705367|62965412|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
33569386|NCT00705367|62965413|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
33569387|NCT00705367|62965412|FG000|Long-term Extension Period|Lack of Efficacy|1|||
33569388|NCT00705367|62965413|FG001|Long-term Extension Period|Lack of Efficacy|0|||
33569389|NCT00705367|62965412|FG000|Long-term Extension Period|No longer met study criteria|1|||
33569390|NCT00705367|62965413|FG001|Long-term Extension Period|No longer met study criteria|0|||
33569391|NCT00705367|62965412|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
33569392|NCT00705367|62965413|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
33569393|NCT00705289|62965421|FG000|Overall Study|Subject or treating physician's choice|131|||
33569394|NCT02038777|62965450|FG000|Overall Study|Death|0|||
33569395|NCT02038777|62965451|FG001|Overall Study|Death|2|||
33569396|NCT02038777|62965452|FG002|Overall Study|Death|0|||
33569397|NCT02038777|62965453|FG003|Overall Study|Death|1|||
33569398|NCT02038777|62965454|FG004|Overall Study|Death|2|||
33569399|NCT02038777|62965455|FG005|Overall Study|Death|4|||
33569400|NCT02038777|62965456|FG006|Overall Study|Death|0|||
33569401|NCT02038777|62965457|FG007|Overall Study|Death|10|||
33569402|NCT02038777|62965450|FG000|Overall Study|Lost to Follow-up|0|||
33569403|NCT02038777|62965451|FG001|Overall Study|Lost to Follow-up|0|||
33569404|NCT02038777|62965452|FG002|Overall Study|Lost to Follow-up|0|||
33569405|NCT02038777|62965453|FG003|Overall Study|Lost to Follow-up|1|||
33396704|NCT00651924|62775976|FG000|Overall Study|Withdrawal by PI|0|||
33396705|NCT00651924|62775977|FG001|Overall Study|Withdrawal by PI|2|||
33569406|NCT02038777|62965454|FG004|Overall Study|Lost to Follow-up|0|||
33569407|NCT02038777|62965455|FG005|Overall Study|Lost to Follow-up|0|||
33569408|NCT02038777|62965456|FG006|Overall Study|Lost to Follow-up|0|||
33569409|NCT02038777|62965457|FG007|Overall Study|Lost to Follow-up|0|||
33569410|NCT02038777|62965450|FG000|Overall Study|Other|0|||
33569411|NCT02038777|62965451|FG001|Overall Study|Other|1|||
33569412|NCT02038777|62965452|FG002|Overall Study|Other|0|||
33569413|NCT02038777|62965453|FG003|Overall Study|Other|2|||
33569414|NCT02038777|62965454|FG004|Overall Study|Other|1|||
33569415|NCT02038777|62965455|FG005|Overall Study|Other|0|||
33569416|NCT02038777|62965456|FG006|Overall Study|Other|0|||
33569417|NCT02038777|62965457|FG007|Overall Study|Other|0|||
33569418|NCT02038777|62965450|FG000|Overall Study|Randomized but not treated|0|||
33569419|NCT02038777|62965451|FG001|Overall Study|Randomized but not treated|1|||
33569420|NCT02038777|62965452|FG002|Overall Study|Randomized but not treated|0|||
33569421|NCT02038777|62965453|FG003|Overall Study|Randomized but not treated|0|||
33569422|NCT02038777|62965454|FG004|Overall Study|Randomized but not treated|0|||
33569423|NCT02038777|62965455|FG005|Overall Study|Randomized but not treated|0|||
33664262|NCT02675634|63095269|FG002|Test Period 2|Adverse Event|0|||
33664263|NCT02675634|63095270|FG003|Test Period 2|Adverse Event|0|||
33302857|NCT01074190|62678700|FG000|Overall Study|Protocol Violation|2|||
33569424|NCT02038777|62965456|FG006|Overall Study|Randomized but not treated|0|||
33569425|NCT02038777|62965457|FG007|Overall Study|Randomized but not treated|0|||
33569426|NCT02038777|62965450|FG000|Overall Study|Started Chemotherapy|1|||
33569427|NCT02038777|62965451|FG001|Overall Study|Started Chemotherapy|0|||
33569428|NCT02038777|62965452|FG002|Overall Study|Started Chemotherapy|3|||
33569429|NCT02038777|62965453|FG003|Overall Study|Started Chemotherapy|0|||
33569430|NCT02038777|62965454|FG004|Overall Study|Started Chemotherapy|0|||
33569431|NCT02038777|62965455|FG005|Overall Study|Started Chemotherapy|0|||
33569432|NCT02038777|62965456|FG006|Overall Study|Started Chemotherapy|0|||
33569433|NCT02038777|62965457|FG007|Overall Study|Started Chemotherapy|0|||
33569434|NCT00703963|62965476|FG000|Overall Study|Withdrawal by Subject|7|||
33569435|NCT00703963|62965477|FG001|Overall Study|Withdrawal by Subject|13|||
33569436|NCT00703963|62965476|FG000|Overall Study|Physician Decision|0|||
33569437|NCT00703963|62965477|FG001|Overall Study|Physician Decision|1|||
33569438|NCT02721355|62965485|FG000|Overall Study|Lost to Follow-up|6|||
33569439|NCT02721355|62965486|FG001|Overall Study|Lost to Follow-up|1|||
33569440|NCT02733991|62965494|FG000|Overall Study|Adverse Event|1|||
33569441|NCT02733991|62965495|FG001|Overall Study|Adverse Event|0|||
33569442|NCT02733991|62965494|FG000|Overall Study|Withdrawal by Subject|0|||
33569443|NCT02733991|62965495|FG001|Overall Study|Withdrawal by Subject|5|||
33569444|NCT00702949|62965504|FG000|Overall Study|Refusal|3|||
33569445|NCT00702949|62965505|FG001|Overall Study|Refusal|2|||
33569446|NCT00702949|62965506|FG002|Overall Study|Refusal|2|||
33569447|NCT00702949|62965504|FG000|Overall Study|Adverse Event|1|||
33569448|NCT00702949|62965505|FG001|Overall Study|Adverse Event|6|||
33569449|NCT00702949|62965506|FG002|Overall Study|Adverse Event|3|||
33569450|NCT00702949|62965504|FG000|Overall Study|Other Medical Reason/unknown|1|||
33569451|NCT00702949|62965505|FG001|Overall Study|Other Medical Reason/unknown|1|||
33569452|NCT00702949|62965506|FG002|Overall Study|Other Medical Reason/unknown|3|||
33569453|NCT00702715|62965518|FG000|Overall Study|Lost to Follow-up|1|||
33569454|NCT00702715|62965519|FG001|Overall Study|Lost to Follow-up|0|||
33569455|NCT00702403|62965525|FG000|From Consent to Engraftment|Progressive leukemia|6|||
33569456|NCT00702403|62965525|FG000|From Consent to Engraftment|Critically ill|2|||
33569457|NCT00702403|62965525|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
33569458|NCT00702403|62965525|FG000|From Consent to Engraftment|Myocardial infarction|1|||
33569459|NCT00702403|62965525|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
33569460|NCT00702403|62965525|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
33569461|NCT00702403|62965525|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
33569462|NCT00702403|62965525|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
33569463|NCT00702403|62965525|FG000|From Engraftment to Study Completion|Non-compliance|2|||
33569464|NCT00702403|62965525|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
33569465|NCT00702403|62965525|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
33569466|NCT00702403|62965525|FG000|From Engraftment to Study Completion|Suicide|1|||
33569467|NCT00702403|62965525|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
33569468|NCT00702403|62965525|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
33569469|NCT00702403|62965525|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
33569470|NCT00702325|62965534|FG000|Overall Study|Adverse Event|1|||
33569471|NCT00702325|62965535|FG001|Overall Study|Adverse Event|0|||
33569472|NCT00702325|62965534|FG000|Overall Study|Withdrawal by Subject|7|||
33569473|NCT00702325|62965535|FG001|Overall Study|Withdrawal by Subject|7|||
33569474|NCT00702325|62965534|FG000|Overall Study|Lost to Follow-up|3|||
33569475|NCT00702325|62965535|FG001|Overall Study|Lost to Follow-up|4|||
33569476|NCT00702325|62965534|FG000|Overall Study|Incorrect enrollment|5|||
33569477|NCT00702325|62965535|FG001|Overall Study|Incorrect enrollment|7|||
33569478|NCT00702325|62965534|FG000|Overall Study|Developed study discontinuation criteria|18|||
33569479|NCT00702325|62965535|FG001|Overall Study|Developed study discontinuation criteria|28|||
33569480|NCT00702325|62965534|FG000|Overall Study|Severe noncompliance to protocol|3|||
33569481|NCT00702325|62965535|FG001|Overall Study|Severe noncompliance to protocol|3|||
33569482|NCT00702325|62965534|FG000|Overall Study|Termination due to lab results|1|||
33569483|NCT00702325|62965535|FG001|Overall Study|Termination due to lab results|0|||
33569484|NCT00702325|62965534|FG000|Overall Study|Didn't follow study medication dosage|0|||
33569485|NCT00702325|62965535|FG001|Overall Study|Didn't follow study medication dosage|2|||
33302858|NCT01074190|62678701|FG001|Overall Study|Protocol Violation|1|||
33302859|NCT01074190|62678702|FG002|Overall Study|Protocol Violation|0|||
33396706|NCT00651924|62775976|FG000|Overall Study|Withdrawal by Subject|0|||
33569486|NCT00702325|62965534|FG000|Overall Study|Withdrew consent|0|||
33569487|NCT00702325|62965535|FG001|Overall Study|Withdrew consent|1|||
33569488|NCT00702325|62965534|FG000|Overall Study|Incorrectly Discontinued|0|||
33569489|NCT00702325|62965535|FG001|Overall Study|Incorrectly Discontinued|1|||
33569490|NCT02719171|62965546|FG000|Overall Study|Adverse Event|1|||
33569491|NCT02719171|62965547|FG001|Overall Study|Adverse Event|2|||
33569492|NCT02719171|62965548|FG002|Overall Study|Adverse Event|0|||
33569493|NCT02719171|62965549|FG003|Overall Study|Adverse Event|0|||
33569494|NCT02719171|62965550|FG004|Overall Study|Adverse Event|2|||
33569495|NCT02719171|62965546|FG000|Overall Study|Lost to Follow-up|0|||
33569496|NCT02719171|62965547|FG001|Overall Study|Lost to Follow-up|0|||
33569497|NCT02719171|62965548|FG002|Overall Study|Lost to Follow-up|1|||
33569498|NCT02719171|62965549|FG003|Overall Study|Lost to Follow-up|0|||
33569499|NCT02719171|62965550|FG004|Overall Study|Lost to Follow-up|0|||
33569500|NCT02719171|62965546|FG000|Overall Study|Subject Withdrawal|0|||
33569501|NCT02719171|62965547|FG001|Overall Study|Subject Withdrawal|2|||
33569502|NCT02719171|62965548|FG002|Overall Study|Subject Withdrawal|2|||
33569503|NCT02719171|62965549|FG003|Overall Study|Subject Withdrawal|1|||
33569504|NCT02719171|62965550|FG004|Overall Study|Subject Withdrawal|0|||
33569505|NCT02719171|62965546|FG000|Overall Study|Other|0|||
33569506|NCT02719171|62965547|FG001|Overall Study|Other|0|||
33569507|NCT02719171|62965548|FG002|Overall Study|Other|0|||
33569508|NCT02719171|62965549|FG003|Overall Study|Other|1|||
33569509|NCT02719171|62965550|FG004|Overall Study|Other|0|||
33569510|NCT02718625|62965567|FG000|Overall Study|Adverse Event|0|||
33569511|NCT02718625|62965568|FG001|Overall Study|Adverse Event|1|||
33569512|NCT02718625|62965567|FG000|Overall Study|Termination of Study by Sponsor|0|||
33569513|NCT02718625|62965568|FG001|Overall Study|Termination of Study by Sponsor|1|||
33569514|NCT02716987|62965580|FG000|Overall Study|Ligand synthesis failure|0|||
33569515|NCT02716987|62965581|FG001|Overall Study|Ligand synthesis failure|0|||
33569516|NCT02716987|62965582|FG002|Overall Study|Ligand synthesis failure|1|||
33569517|NCT02716987|62965583|FG003|Overall Study|Ligand synthesis failure|0|||
33569518|NCT02716987|62965584|FG004|Overall Study|Ligand synthesis failure|0|||
33569519|NCT02716987|62965585|FG005|Overall Study|Ligand synthesis failure|0|||
33569520|NCT02716987|62965580|FG000|Overall Study|Withdrawal by Subject|0|||
33569521|NCT02716987|62965581|FG001|Overall Study|Withdrawal by Subject|0|||
33569522|NCT02716987|62965582|FG002|Overall Study|Withdrawal by Subject|0|||
33569523|NCT02716987|62965583|FG003|Overall Study|Withdrawal by Subject|0|||
33569524|NCT02716987|62965584|FG004|Overall Study|Withdrawal by Subject|1|||
33569525|NCT02716987|62965585|FG005|Overall Study|Withdrawal by Subject|1|||
33569526|NCT00701779|62965610|FG000|Overall Study|Adverse Event|6|||
33569527|NCT00701779|62965610|FG000|Overall Study|Lost to Follow-up|1|||
33569528|NCT00701779|62965610|FG000|Overall Study|Withdrawal by Subject|2|||
33569529|NCT03707977|62965633|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
33569530|NCT03707977|62965634|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
33569531|NCT03707977|62965635|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
33569532|NCT03707977|62965633|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
33569533|NCT03707977|62965634|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
33569534|NCT03707977|62965635|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
33569535|NCT03332095|62965651|FG000|Overall Study|Lost to Follow-up|1|||
33569536|NCT03332095|62965652|FG001|Overall Study|Lost to Follow-up|0|||
33569537|NCT03332095|62965651|FG000|Overall Study|Pregnancy|0|||
33569538|NCT03332095|62965652|FG001|Overall Study|Pregnancy|1|||
33569539|NCT02764489|62965659|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
33569540|NCT02764489|62965660|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
33569541|NCT02764489|62965659|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
33569542|NCT02764489|62965660|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
33569543|NCT02764489|62965659|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
33569544|NCT02764489|62965660|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
33569545|NCT02764489|62965659|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
33569546|NCT02764489|62965660|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
33569547|NCT02001623|62965685|FG000|Overall Study|Disease Progression|2|||
33569548|NCT02001623|62965686|FG001|Overall Study|Disease Progression|2|||
33569549|NCT02001623|62965687|FG002|Overall Study|Disease Progression|3|||
33569550|NCT02001623|62965688|FG003|Overall Study|Disease Progression|2|||
33569551|NCT02001623|62965689|FG004|Overall Study|Disease Progression|3|||
33569552|NCT02001623|62965690|FG005|Overall Study|Disease Progression|2|||
33569553|NCT02001623|62965691|FG006|Overall Study|Disease Progression|3|||
33569554|NCT02001623|62965692|FG007|Overall Study|Disease Progression|3|||
33569555|NCT02001623|62965693|FG008|Overall Study|Disease Progression|7|||
33569556|NCT02001623|62965694|FG009|Overall Study|Disease Progression|40|||
33569557|NCT02001623|62965695|FG010|Overall Study|Disease Progression|5|||
33569558|NCT02001623|62965696|FG011|Overall Study|Disease Progression|9|||
33569559|NCT02001623|62965697|FG012|Overall Study|Disease Progression|9|||
33569560|NCT02001623|62965698|FG013|Overall Study|Disease Progression|20|||
33569561|NCT02001623|62965699|FG014|Overall Study|Disease Progression|9|||
33569562|NCT02001623|62965685|FG000|Overall Study|Physician Decision|0|||
33569563|NCT02001623|62965686|FG001|Overall Study|Physician Decision|0|||
33569564|NCT02001623|62965687|FG002|Overall Study|Physician Decision|0|||
33569565|NCT02001623|62965688|FG003|Overall Study|Physician Decision|0|||
33569566|NCT02001623|62965689|FG004|Overall Study|Physician Decision|0|||
33569567|NCT02001623|62965690|FG005|Overall Study|Physician Decision|0|||
33569568|NCT02001623|62965691|FG006|Overall Study|Physician Decision|0|||
33569569|NCT02001623|62965692|FG007|Overall Study|Physician Decision|0|||
33569570|NCT02001623|62965693|FG008|Overall Study|Physician Decision|3|||
33569571|NCT02001623|62965694|FG009|Overall Study|Physician Decision|2|||
33569572|NCT02001623|62965695|FG010|Overall Study|Physician Decision|3|||
33569573|NCT02001623|62965696|FG011|Overall Study|Physician Decision|3|||
33569574|NCT02001623|62965697|FG012|Overall Study|Physician Decision|1|||
33569575|NCT02001623|62965698|FG013|Overall Study|Physician Decision|2|||
33569576|NCT02001623|62965699|FG014|Overall Study|Physician Decision|1|||
33569577|NCT02001623|62965685|FG000|Overall Study|Death|0|||
33569578|NCT02001623|62965686|FG001|Overall Study|Death|1|||
33569579|NCT02001623|62965687|FG002|Overall Study|Death|0|||
33569580|NCT02001623|62965688|FG003|Overall Study|Death|0|||
33569581|NCT02001623|62965689|FG004|Overall Study|Death|0|||
33569582|NCT02001623|62965690|FG005|Overall Study|Death|0|||
33569583|NCT02001623|62965691|FG006|Overall Study|Death|0|||
33569584|NCT02001623|62965692|FG007|Overall Study|Death|0|||
33569585|NCT02001623|62965693|FG008|Overall Study|Death|0|||
33569586|NCT02001623|62965694|FG009|Overall Study|Death|0|||
33569587|NCT02001623|62965695|FG010|Overall Study|Death|0|||
33569588|NCT02001623|62965696|FG011|Overall Study|Death|0|||
33569589|NCT02001623|62965697|FG012|Overall Study|Death|0|||
33569590|NCT02001623|62965698|FG013|Overall Study|Death|0|||
33569591|NCT02001623|62965699|FG014|Overall Study|Death|0|||
33569592|NCT02001623|62965685|FG000|Overall Study|Adverse Event|0|||
33569593|NCT02001623|62965686|FG001|Overall Study|Adverse Event|0|||
33569594|NCT02001623|62965687|FG002|Overall Study|Adverse Event|0|||
33569595|NCT02001623|62965688|FG003|Overall Study|Adverse Event|0|||
33569596|NCT02001623|62965689|FG004|Overall Study|Adverse Event|0|||
33569597|NCT02001623|62965690|FG005|Overall Study|Adverse Event|1|||
33569598|NCT02001623|62965691|FG006|Overall Study|Adverse Event|0|||
33569599|NCT02001623|62965692|FG007|Overall Study|Adverse Event|3|||
33569600|NCT02001623|62965693|FG008|Overall Study|Adverse Event|4|||
33569601|NCT02001623|62965694|FG009|Overall Study|Adverse Event|6|||
33569602|NCT02001623|62965695|FG010|Overall Study|Adverse Event|4|||
33569603|NCT02001623|62965696|FG011|Overall Study|Adverse Event|0|||
33569604|NCT02001623|62965697|FG012|Overall Study|Adverse Event|3|||
33569605|NCT02001623|62965698|FG013|Overall Study|Adverse Event|5|||
33569606|NCT02001623|62965699|FG014|Overall Study|Adverse Event|6|||
33569607|NCT02001623|62965685|FG000|Overall Study|Other - Miscellaneous|0|||
33569608|NCT02001623|62965686|FG001|Overall Study|Other - Miscellaneous|0|||
33569609|NCT02001623|62965687|FG002|Overall Study|Other - Miscellaneous|0|||
33569610|NCT02001623|62965688|FG003|Overall Study|Other - Miscellaneous|0|||
33569611|NCT02001623|62965689|FG004|Overall Study|Other - Miscellaneous|0|||
33569612|NCT02001623|62965690|FG005|Overall Study|Other - Miscellaneous|0|||
33569613|NCT02001623|62965691|FG006|Overall Study|Other - Miscellaneous|0|||
33569614|NCT02001623|62965692|FG007|Overall Study|Other - Miscellaneous|0|||
33569615|NCT02001623|62965693|FG008|Overall Study|Other - Miscellaneous|0|||
33569616|NCT02001623|62965694|FG009|Overall Study|Other - Miscellaneous|1|||
33569617|NCT02001623|62965695|FG010|Overall Study|Other - Miscellaneous|0|||
33569618|NCT02001623|62965696|FG011|Overall Study|Other - Miscellaneous|0|||
33569619|NCT02001623|62965697|FG012|Overall Study|Other - Miscellaneous|0|||
33569620|NCT02001623|62965698|FG013|Overall Study|Other - Miscellaneous|1|||
33569621|NCT02001623|62965699|FG014|Overall Study|Other - Miscellaneous|0|||
33569622|NCT02001623|62965685|FG000|Overall Study|Withdrawal by Subject|1|||
33569623|NCT02001623|62965686|FG001|Overall Study|Withdrawal by Subject|0|||
33569624|NCT02001623|62965687|FG002|Overall Study|Withdrawal by Subject|0|||
33569625|NCT02001623|62965688|FG003|Overall Study|Withdrawal by Subject|0|||
33569626|NCT02001623|62965689|FG004|Overall Study|Withdrawal by Subject|0|||
33569627|NCT02001623|62965690|FG005|Overall Study|Withdrawal by Subject|0|||
33569628|NCT02001623|62965691|FG006|Overall Study|Withdrawal by Subject|0|||
33569629|NCT02001623|62965692|FG007|Overall Study|Withdrawal by Subject|0|||
33569630|NCT02001623|62965693|FG008|Overall Study|Withdrawal by Subject|1|||
33569631|NCT02001623|62965694|FG009|Overall Study|Withdrawal by Subject|3|||
33569632|NCT02001623|62965695|FG010|Overall Study|Withdrawal by Subject|2|||
33569633|NCT02001623|62965696|FG011|Overall Study|Withdrawal by Subject|2|||
33569634|NCT02001623|62965697|FG012|Overall Study|Withdrawal by Subject|1|||
33569635|NCT02001623|62965698|FG013|Overall Study|Withdrawal by Subject|5|||
33569636|NCT02001623|62965699|FG014|Overall Study|Withdrawal by Subject|2|||
33569637|NCT02001623|62965685|FG000|Overall Study|Lost to Follow-up|0|||
33569638|NCT02001623|62965686|FG001|Overall Study|Lost to Follow-up|0|||
33569639|NCT02001623|62965687|FG002|Overall Study|Lost to Follow-up|0|||
33569640|NCT02001623|62965688|FG003|Overall Study|Lost to Follow-up|0|||
33569641|NCT02001623|62965689|FG004|Overall Study|Lost to Follow-up|0|||
33569642|NCT02001623|62965690|FG005|Overall Study|Lost to Follow-up|0|||
33569643|NCT02001623|62965691|FG006|Overall Study|Lost to Follow-up|0|||
33569644|NCT02001623|62965692|FG007|Overall Study|Lost to Follow-up|0|||
33569645|NCT02001623|62965693|FG008|Overall Study|Lost to Follow-up|0|||
33569646|NCT02001623|62965694|FG009|Overall Study|Lost to Follow-up|1|||
33569647|NCT02001623|62965695|FG010|Overall Study|Lost to Follow-up|0|||
33569648|NCT02001623|62965696|FG011|Overall Study|Lost to Follow-up|0|||
33569649|NCT02001623|62965697|FG012|Overall Study|Lost to Follow-up|0|||
33569650|NCT02001623|62965698|FG013|Overall Study|Lost to Follow-up|0|||
33569651|NCT02001623|62965699|FG014|Overall Study|Lost to Follow-up|0|||
33569652|NCT02001623|62965685|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
33569653|NCT02001623|62965686|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
33569654|NCT02001623|62965687|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
33569655|NCT02001623|62965688|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
33569656|NCT02001623|62965689|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
33569657|NCT02001623|62965690|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
33569658|NCT02001623|62965691|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
33569659|NCT02001623|62965692|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
33569660|NCT02001623|62965693|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
33569661|NCT02001623|62965694|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
33569662|NCT02001623|62965695|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
33569663|NCT02001623|62965696|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
33569664|NCT02001623|62965697|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
33569665|NCT02001623|62965698|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
33569666|NCT02001623|62965699|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
33569667|NCT02001623|62965685|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
33569668|NCT02001623|62965686|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
33569669|NCT02001623|62965687|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
33569670|NCT02001623|62965688|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
33569671|NCT02001623|62965689|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
33569672|NCT02001623|62965690|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
33569673|NCT02001623|62965691|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
33569674|NCT02001623|62965692|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
33569675|NCT02001623|62965693|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
33569676|NCT02001623|62965694|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
33569677|NCT02001623|62965695|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
33569678|NCT02001623|62965696|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
33569679|NCT02001623|62965697|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
33569680|NCT02001623|62965698|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
33569681|NCT02001623|62965699|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
33569682|NCT02713867|62965750|FG000|Randomization|Other Reason|2|||
33569683|NCT02713867|62965751|FG001|Randomization|Other Reason|1|||
33569684|NCT02713867|62965750|FG000|Randomization|Participant Withdrew consent|0|||
33569685|NCT02713867|62965751|FG001|Randomization|Participant Withdrew consent|2|||
33569686|NCT02713867|62965750|FG000|Treatment Period|Other Reasons|22|||
33569687|NCT02713867|62965751|FG001|Treatment Period|Other Reasons|28|||
33569688|NCT02713867|62965750|FG000|Treatment Period|Administrative reason by sponsor|21|||
33569689|NCT02713867|62965751|FG001|Treatment Period|Administrative reason by sponsor|16|||
33569690|NCT02713867|62965750|FG000|Treatment Period|No longer meets study criteria|2|||
33569691|NCT02713867|62965751|FG001|Treatment Period|No longer meets study criteria|1|||
33569692|NCT02713867|62965750|FG000|Treatment Period|Poor/Non Compliance|1|||
33569693|NCT02713867|62965751|FG001|Treatment Period|Poor/Non Compliance|0|||
33569694|NCT02713867|62965750|FG000|Treatment Period|Maximum Clinical Benefit|5|||
33569695|NCT02713867|62965751|FG001|Treatment Period|Maximum Clinical Benefit|6|||
33569696|NCT02713867|62965750|FG000|Treatment Period|Withdrew consent|3|||
33569697|NCT02713867|62965751|FG001|Treatment Period|Withdrew consent|6|||
33569698|NCT02713867|62965750|FG000|Treatment Period|Requested to Discontinue|8|||
33569699|NCT02713867|62965751|FG001|Treatment Period|Requested to Discontinue|8|||
33569700|NCT02713867|62965750|FG000|Treatment Period|AE unrelated to Study Drug|11|||
33569701|NCT02713867|62965751|FG001|Treatment Period|AE unrelated to Study Drug|10|||
33569702|NCT02713867|62965750|FG000|Treatment Period|Death|7|||
33569703|NCT02713867|62965751|FG001|Treatment Period|Death|3|||
33569704|NCT02713867|62965750|FG000|Treatment Period|Study Drug Toxicity|16|||
33569705|NCT02713867|62965751|FG001|Treatment Period|Study Drug Toxicity|19|||
33569706|NCT02713867|62965750|FG000|Treatment Period|Disease Progression|82|||
33569707|NCT02713867|62965751|FG001|Treatment Period|Disease Progression|83|||
33569708|NCT02730455|62965760|FG000|Overall Study|Death|5|||
33569709|NCT02730455|62965761|FG001|Overall Study|Death|6|||
33569710|NCT02730455|62965762|FG002|Overall Study|Death|4|||
33569711|NCT02730455|62965760|FG000|Overall Study|Consent withdrawn|2|||
33569712|NCT02730455|62965761|FG001|Overall Study|Consent withdrawn|4|||
33569713|NCT02730455|62965762|FG002|Overall Study|Consent withdrawn|1|||
33569714|NCT02730455|62965760|FG000|Overall Study|Lost to Follow-up|3|||
33569715|NCT02730455|62965761|FG001|Overall Study|Lost to Follow-up|1|||
33569716|NCT02730455|62965762|FG002|Overall Study|Lost to Follow-up|4|||
33569717|NCT02730455|62965760|FG000|Overall Study|Other|1|||
33569718|NCT02730455|62965761|FG001|Overall Study|Other|1|||
33569719|NCT02730455|62965762|FG002|Overall Study|Other|2|||
33569720|NCT02730455|62965760|FG000|Overall Study|Other|2|||
33569721|NCT02730455|62965761|FG001|Overall Study|Other|2|||
33569722|NCT02730455|62965762|FG002|Overall Study|Other|0|||
33569723|NCT04440449|62965772|FG000|Overall Study|Lost to Follow-up|2|||
33569724|NCT04440449|62965773|FG001|Overall Study|Lost to Follow-up|0|||
33569725|NCT00701311|62965780|FG000|Overall Study|Lack of Efficacy|3|||
33569726|NCT00701311|62965780|FG000|Overall Study|Adverse Event|3|||
33569727|NCT00701311|62965780|FG000|Overall Study|Withdrawal by Subject|2|||
33569728|NCT02730377|62965790|FG000|Overall Study|Other|5|||
33569729|NCT02730377|62965791|FG001|Overall Study|Other|4|||
33569730|NCT02730377|62965790|FG000|Overall Study|Death|1|||
33569731|NCT02730377|62965791|FG001|Overall Study|Death|8|||
33569732|NCT02730377|62965790|FG000|Overall Study|Inadequate glycaemic control|368|||
33569733|NCT02730377|62965791|FG001|Overall Study|Inadequate glycaemic control|473|||
33569734|NCT02730377|62965790|FG000|Overall Study|Adverse Event|79|||
33569735|NCT02730377|62965791|FG001|Overall Study|Adverse Event|41|||
33569736|NCT02730377|62965790|FG000|Overall Study|Protocol Violation|23|||
33569737|NCT02730377|62965791|FG001|Overall Study|Protocol Violation|30|||
33569738|NCT02730377|62965790|FG000|Overall Study|Lack of Efficacy|4|||
33569739|NCT02730377|62965791|FG001|Overall Study|Lack of Efficacy|13|||
33569740|NCT02730377|62965790|FG000|Overall Study|Pregnancy|0|||
33569741|NCT02730377|62965791|FG001|Overall Study|Pregnancy|1|||
33569742|NCT02730377|62965790|FG000|Overall Study|Withdrawal by Subject|45|||
33569743|NCT02730377|62965791|FG001|Overall Study|Withdrawal by Subject|42|||
33569744|NCT02730377|62965790|FG000|Overall Study|Lost to Follow-up|25|||
33569745|NCT02730377|62965791|FG001|Overall Study|Lost to Follow-up|21|||
33569746|NCT02714569|62965808|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
33569747|NCT02714569|62965809|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
33569748|NCT02714569|62965810|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
33569749|NCT02714569|62965811|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
33569750|NCT02714569|62965812|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
33569751|NCT02714569|62965813|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
33569752|NCT02714569|62965814|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
33569753|NCT02714569|62965815|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
33569754|NCT02714569|62965816|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
33569755|NCT02714569|62965817|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
33569756|NCT02714569|62965818|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
33569757|NCT02714569|62965808|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33569758|NCT02714569|62965809|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33569759|NCT02714569|62965810|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33569760|NCT02714569|62965811|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
33569761|NCT02714569|62965812|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33569762|NCT02714569|62965813|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33569763|NCT02714569|62965814|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33569764|NCT02714569|62965815|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33569765|NCT02714569|62965816|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33569766|NCT02714569|62965817|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33569767|NCT02714569|62965818|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33569768|NCT02714569|62965808|FG000|Part A Third Intervention|Adverse Event|0|||
33569769|NCT02714569|62965809|FG001|Part A Third Intervention|Adverse Event|0|||
33569770|NCT02714569|62965810|FG002|Part A Third Intervention|Adverse Event|1|||
33569771|NCT02714569|62965811|FG003|Part A Third Intervention|Adverse Event|0|||
33569772|NCT02714569|62965812|FG004|Part A Third Intervention|Adverse Event|0|||
33569773|NCT02714569|62965813|FG005|Part A Third Intervention|Adverse Event|0|||
33569774|NCT02714569|62965814|FG006|Part A Third Intervention|Adverse Event|0|||
33569775|NCT02714569|62965815|FG007|Part A Third Intervention|Adverse Event|0|||
33569776|NCT02714569|62965816|FG008|Part A Third Intervention|Adverse Event|0|||
33569777|NCT02714569|62965817|FG009|Part A Third Intervention|Adverse Event|0|||
33569778|NCT02714569|62965818|FG010|Part A Third Intervention|Adverse Event|0|||
33569779|NCT02714569|62965808|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
33569780|NCT02714569|62965809|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33569781|NCT02714569|62965810|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33569782|NCT02714569|62965811|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33569783|NCT02714569|62965812|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33569784|NCT02714569|62965813|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
33569785|NCT02714569|62965814|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33569786|NCT02714569|62965815|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33569787|NCT02714569|62965816|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33569788|NCT02714569|62965817|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33569789|NCT02714569|62965818|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33569790|NCT02714569|62965808|FG000|Part B (Overall)|Lost to Follow-up|0|||
33569791|NCT02714569|62965809|FG001|Part B (Overall)|Lost to Follow-up|0|||
33569792|NCT02714569|62965810|FG002|Part B (Overall)|Lost to Follow-up|0|||
33569793|NCT02714569|62965811|FG003|Part B (Overall)|Lost to Follow-up|0|||
33569794|NCT02714569|62965812|FG004|Part B (Overall)|Lost to Follow-up|0|||
33569795|NCT02714569|62965813|FG005|Part B (Overall)|Lost to Follow-up|0|||
33664264|NCT02675634|63095271|FG004|Test Period 2|Adverse Event|0|||
33569796|NCT02714569|62965814|FG006|Part B (Overall)|Lost to Follow-up|1|||
33569797|NCT02714569|62965815|FG007|Part B (Overall)|Lost to Follow-up|0|||
33569798|NCT02714569|62965816|FG008|Part B (Overall)|Lost to Follow-up|0|||
33569799|NCT02714569|62965817|FG009|Part B (Overall)|Lost to Follow-up|0|||
33569800|NCT02714569|62965818|FG010|Part B (Overall)|Lost to Follow-up|0|||
33569801|NCT02714569|62965808|FG000|Part B (Overall)|Withdrawal by Subject|0|||
33569802|NCT02714569|62965809|FG001|Part B (Overall)|Withdrawal by Subject|0|||
33569803|NCT02714569|62965810|FG002|Part B (Overall)|Withdrawal by Subject|0|||
33569804|NCT02714569|62965811|FG003|Part B (Overall)|Withdrawal by Subject|0|||
33569805|NCT02714569|62965812|FG004|Part B (Overall)|Withdrawal by Subject|0|||
33569806|NCT02714569|62965813|FG005|Part B (Overall)|Withdrawal by Subject|0|||
33569807|NCT02714569|62965814|FG006|Part B (Overall)|Withdrawal by Subject|0|||
33569808|NCT02714569|62965815|FG007|Part B (Overall)|Withdrawal by Subject|1|||
33569809|NCT02714569|62965816|FG008|Part B (Overall)|Withdrawal by Subject|0|||
33569810|NCT02714569|62965817|FG009|Part B (Overall)|Withdrawal by Subject|1|||
33569811|NCT02714569|62965818|FG010|Part B (Overall)|Withdrawal by Subject|0|||
33569812|NCT02714569|62965808|FG000|Part B (Overall)|Adverse Event|0|||
33569813|NCT02714569|62965809|FG001|Part B (Overall)|Adverse Event|0|||
33569814|NCT02714569|62965810|FG002|Part B (Overall)|Adverse Event|0|||
33569815|NCT02714569|62965811|FG003|Part B (Overall)|Adverse Event|0|||
33569816|NCT02714569|62965812|FG004|Part B (Overall)|Adverse Event|0|||
33569817|NCT02714569|62965813|FG005|Part B (Overall)|Adverse Event|0|||
33569818|NCT02714569|62965814|FG006|Part B (Overall)|Adverse Event|0|||
33569819|NCT02714569|62965815|FG007|Part B (Overall)|Adverse Event|0|||
33569820|NCT02714569|62965816|FG008|Part B (Overall)|Adverse Event|0|||
33569821|NCT02714569|62965817|FG009|Part B (Overall)|Adverse Event|1|||
33569822|NCT02714569|62965818|FG010|Part B (Overall)|Adverse Event|0|||
33569823|NCT02713789|62965881|FG000|Overall Study|Lost to Follow-up|0|||
33569824|NCT02713789|62965882|FG001|Overall Study|Lost to Follow-up|1|||
33569825|NCT02713789|62965883|FG002|Overall Study|Lost to Follow-up|1|||
33569826|NCT04445051|62965893|FG000|Overall Study|Adverse Event|0|||
33569827|NCT04445051|62965894|FG001|Overall Study|Adverse Event|0|||
33569828|NCT04445051|62965895|FG002|Overall Study|Adverse Event|1|||
33569829|NCT04445051|62965896|FG003|Overall Study|Adverse Event|0|||
33569830|NCT04445051|62965897|FG004|Overall Study|Adverse Event|0|||
33569831|NCT04445051|62965898|FG005|Overall Study|Adverse Event|0|||
33569832|NCT04086121|62965912|FG000|Overall Study|Other than listed|8|||
33569833|NCT04086121|62965912|FG000|Overall Study|Withdrawal by Subject|3|||
33569834|NCT04086121|62965912|FG000|Overall Study|Lost to Follow-up|2|||
33569835|NCT04086121|62965912|FG000|Overall Study|Adverse Event|1|||
33569836|NCT02729909|62965919|FG000|Overall Study|Lost to Follow-up|0|||
33569837|NCT02729909|62965920|FG001|Overall Study|Lost to Follow-up|1|||
33569838|NCT02729909|62965919|FG000|Overall Study|Lack of Efficacy|0|||
33569839|NCT02729909|62965920|FG001|Overall Study|Lack of Efficacy|2|||
33569840|NCT02729909|62965919|FG000|Overall Study|Significant Protocol Deviation|0|||
33569841|NCT02729909|62965920|FG001|Overall Study|Significant Protocol Deviation|2|||
33569842|NCT02729909|62965919|FG000|Overall Study|Voluntary Withdrawal|1|||
33569843|NCT02729909|62965920|FG001|Overall Study|Voluntary Withdrawal|0|||
33569844|NCT02713243|62965928|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
33569845|NCT02713243|62965929|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
33569846|NCT02713243|62965928|FG000|Overall Study|Administrative problems|0|||
33569847|NCT02713243|62965929|FG001|Overall Study|Administrative problems|1|||
33569848|NCT02713243|62965928|FG000|Overall Study|Protocol deviation|0|||
33569849|NCT02713243|62965929|FG001|Overall Study|Protocol deviation|1|||
33569850|NCT03434041|62965937|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
33569851|NCT03434041|62965938|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
33569852|NCT03434041|62965937|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
33569853|NCT03434041|62965938|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
33569854|NCT03434041|62965937|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
33569855|NCT03434041|62965938|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
33569856|NCT03434041|62965937|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
33569857|NCT03434041|62965938|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
33569858|NCT03434041|62965937|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
33302860|NCT01074190|62678700|FG000|Overall Study|Delivered in under 90 minutes|0|||
33396707|NCT00651924|62775977|FG001|Overall Study|Withdrawal by Subject|5|||
33569859|NCT03434041|62965938|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
33569860|NCT03434041|62965937|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
33569861|NCT03434041|62965938|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
33569862|NCT03434041|62965937|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
33569863|NCT03434041|62965938|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
33569864|NCT03434041|62965937|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
33569865|NCT03434041|62965938|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
33569866|NCT03434041|62965937|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
33569867|NCT03434041|62965938|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
33569868|NCT03434041|62965937|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
33569869|NCT03434041|62965938|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
33569870|NCT03434041|62965937|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
33569871|NCT03434041|62965938|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
33569872|NCT00708461|62965953|FG000|Overall Study|Lost to Follow-up|18|||
33569873|NCT00708461|62965954|FG001|Overall Study|Lost to Follow-up|11|||
33569874|NCT00708461|62965953|FG000|Overall Study|Withdrawal by Subject|8|||
33569875|NCT00708461|62965954|FG001|Overall Study|Withdrawal by Subject|9|||
33569876|NCT00708461|62965953|FG000|Overall Study|left workforce|115|||
33569877|NCT00708461|62965954|FG001|Overall Study|left workforce|180|||
33569878|NCT00700999|62965962|FG000|Overall Study|Lost to Follow-up|7|||
33569879|NCT00700999|62965963|FG001|Overall Study|Lost to Follow-up|7|||
33569880|NCT00700999|62965962|FG000|Overall Study|Excluded - did not meet study criteria|0|||
33569881|NCT00700999|62965963|FG001|Overall Study|Excluded - did not meet study criteria|1|||
33569882|NCT00700999|62965962|FG000|Overall Study|Withdrawal by Subject|8|||
33569883|NCT00700999|62965963|FG001|Overall Study|Withdrawal by Subject|1|||
33569884|NCT02729831|62965973|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
33569885|NCT02729831|62965974|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
33569886|NCT02729831|62965975|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
33569887|NCT02729831|62965976|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
33569888|NCT02729831|62965973|FG000|1 Week Post-visit|Lost to Follow-up|43|||
33569889|NCT02729831|62965974|FG001|1 Week Post-visit|Lost to Follow-up|40|||
33569890|NCT02729831|62965975|FG002|1 Week Post-visit|Lost to Follow-up|38|||
33569891|NCT02729831|62965976|FG003|1 Week Post-visit|Lost to Follow-up|36|||
33569892|NCT02729831|62965973|FG000|6 Month Follow-up|Lost to Follow-up|54|||
33569893|NCT02729831|62965974|FG001|6 Month Follow-up|Lost to Follow-up|51|||
33569894|NCT02729831|62965975|FG002|6 Month Follow-up|Lost to Follow-up|48|||
33569895|NCT02729831|62965976|FG003|6 Month Follow-up|Lost to Follow-up|42|||
33569896|NCT02729831|62965973|FG000|6 Month Follow-up|Death|1|||
33569897|NCT02729831|62965974|FG001|6 Month Follow-up|Death|3|||
33569898|NCT02729831|62965975|FG002|6 Month Follow-up|Death|0|||
33569899|NCT02729831|62965976|FG003|6 Month Follow-up|Death|1|||
33569900|NCT02729753|62965988|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
33569901|NCT02729753|62965989|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
33569902|NCT00709319|62965998|FG000|Overall Study|Death|4|||
33569903|NCT00709319|62965998|FG000|Overall Study|Withdrawal by Subject|2|||
33569904|NCT02729051|62966043|FG000|Overall Study|Adverse Event|21|||
33569905|NCT02729051|62966044|FG001|Overall Study|Adverse Event|11|||
33569906|NCT02729051|62966043|FG000|Overall Study|Lack of Efficacy|1|||
33569907|NCT02729051|62966044|FG001|Overall Study|Lack of Efficacy|1|||
33569908|NCT02729051|62966043|FG000|Overall Study|Lost to Follow-up|1|||
33569909|NCT02729051|62966044|FG001|Overall Study|Lost to Follow-up|2|||
33569910|NCT02729051|62966043|FG000|Overall Study|Physician Decision|1|||
33569911|NCT02729051|62966044|FG001|Overall Study|Physician Decision|1|||
33569912|NCT02729051|62966043|FG000|Overall Study|Withdrawal by Subject|6|||
33569913|NCT02729051|62966044|FG001|Overall Study|Withdrawal by Subject|17|||
33569914|NCT00707993|62966052|FG000|Overall Study|Adverse Event|16|||
33569915|NCT00707993|62966053|FG001|Overall Study|Adverse Event|20|||
33569916|NCT00707993|62966052|FG000|Overall Study|Protocol Violation|4|||
33569917|NCT00707993|62966053|FG001|Overall Study|Protocol Violation|7|||
33569918|NCT00707993|62966052|FG000|Overall Study|Lost to Follow-up|0|||
33569919|NCT00707993|62966053|FG001|Overall Study|Lost to Follow-up|4|||
33569920|NCT00707993|62966052|FG000|Overall Study|Withdrawal by Subject|12|||
33569921|NCT00707993|62966053|FG001|Overall Study|Withdrawal by Subject|16|||
33569922|NCT00707993|62966052|FG000|Overall Study|Hyperglycemic Rescue|55|||
33569923|NCT00707993|62966053|FG001|Overall Study|Hyperglycemic Rescue|47|||
33569924|NCT00707993|62966052|FG000|Overall Study|Other|2|||
33569925|NCT00707993|62966053|FG001|Overall Study|Other|0|||
33569926|NCT00708227|62966063|FG000|Overall Study|Physician Decision|0|||
33569927|NCT00708227|62966064|FG001|Overall Study|Physician Decision|3|||
33569928|NCT00708227|62966065|FG002|Overall Study|Physician Decision|1|||
33569929|NCT00708227|62966066|FG003|Overall Study|Physician Decision|2|||
33569930|NCT00708227|62966063|FG000|Overall Study|Withdrawal by Subject|1|||
33569931|NCT00708227|62966064|FG001|Overall Study|Withdrawal by Subject|2|||
33569932|NCT00708227|62966065|FG002|Overall Study|Withdrawal by Subject|0|||
33569933|NCT00708227|62966066|FG003|Overall Study|Withdrawal by Subject|1|||
33569934|NCT02425891|62966098|FG000|Overall Study|Death|333|||
33569935|NCT02425891|62966099|FG001|Overall Study|Death|314|||
33569936|NCT02425891|62966098|FG000|Overall Study|Lost to Follow-up|4|||
33569937|NCT02425891|62966099|FG001|Overall Study|Lost to Follow-up|6|||
33569938|NCT02425891|62966098|FG000|Overall Study|Non-Compliance|1|||
33569939|NCT02425891|62966099|FG001|Overall Study|Non-Compliance|1|||
33569940|NCT02425891|62966098|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
33569941|NCT02425891|62966099|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
33569942|NCT02425891|62966098|FG000|Overall Study|Physician Decision|0|||
33569943|NCT02425891|62966099|FG001|Overall Study|Physician Decision|1|||
33569944|NCT02425891|62966098|FG000|Overall Study|Protocol Violation|1|||
33569945|NCT02425891|62966099|FG001|Overall Study|Protocol Violation|1|||
33569946|NCT02425891|62966098|FG000|Overall Study|Study Terminated By Sponsor|85|||
33569947|NCT02425891|62966099|FG001|Overall Study|Study Terminated By Sponsor|95|||
33569948|NCT02425891|62966098|FG000|Overall Study|Withdrawal by Subject|27|||
33569949|NCT02425891|62966099|FG001|Overall Study|Withdrawal by Subject|32|||
33569950|NCT03241225|62966109|FG000|Overall Study|Lost to Follow-up|2|||
33569951|NCT03241225|62966110|FG001|Overall Study|Lost to Follow-up|1|||
33569952|NCT03241225|62966109|FG000|Overall Study|Protocol Violation|4|||
33569953|NCT03241225|62966110|FG001|Overall Study|Protocol Violation|1|||
33569954|NCT03241225|62966109|FG000|Overall Study|Withdrawal by Subject|1|||
33569955|NCT03241225|62966110|FG001|Overall Study|Withdrawal by Subject|0|||
33569956|NCT01597245|62966120|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
33569957|NCT01597245|62966121|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
33569958|NCT01597245|62966122|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
33569959|NCT01597245|62966123|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
33569960|NCT01597245|62966124|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569961|NCT01597245|62966125|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569962|NCT01597245|62966126|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569963|NCT01597245|62966127|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569964|NCT01597245|62966128|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569965|NCT01597245|62966129|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569966|NCT01597245|62966130|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569967|NCT01597245|62966131|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569968|NCT01597245|62966132|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569969|NCT01597245|62966133|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569970|NCT01597245|62966134|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569971|NCT01597245|62966135|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569972|NCT01597245|62966136|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569973|NCT01597245|62966137|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569974|NCT01597245|62966138|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569975|NCT01597245|62966139|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569976|NCT01597245|62966140|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33569977|NCT01597245|62966120|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
33569978|NCT01597245|62966121|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
33569979|NCT01597245|62966122|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
33569980|NCT01597245|62966123|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
33569981|NCT01597245|62966124|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569982|NCT01597245|62966125|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569983|NCT01597245|62966126|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569984|NCT01597245|62966127|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569985|NCT01597245|62966128|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569986|NCT01597245|62966129|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569987|NCT01597245|62966130|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569988|NCT01597245|62966131|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569989|NCT01597245|62966132|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569990|NCT01597245|62966133|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569991|NCT01597245|62966134|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569992|NCT01597245|62966135|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569993|NCT01597245|62966136|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569994|NCT01597245|62966137|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569995|NCT01597245|62966138|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569996|NCT01597245|62966139|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569997|NCT01597245|62966140|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33569998|NCT01597245|62966120|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
33569999|NCT01597245|62966121|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
33570000|NCT01597245|62966122|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
33570001|NCT01597245|62966123|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
33570002|NCT01597245|62966124|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570003|NCT01597245|62966125|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570004|NCT01597245|62966126|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570005|NCT01597245|62966127|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570006|NCT01597245|62966128|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570007|NCT01597245|62966129|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570008|NCT01597245|62966130|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33664265|NCT02675634|63095272|FG005|Test Period 2|Adverse Event|1|||
33396708|NCT00678392|62775985|FG000|Overall Study|Adverse Event|0|||
33570009|NCT01597245|62966131|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570010|NCT01597245|62966132|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570011|NCT01597245|62966133|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570012|NCT01597245|62966134|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570013|NCT01597245|62966135|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570014|NCT01597245|62966136|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570015|NCT01597245|62966137|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570016|NCT01597245|62966138|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570017|NCT01597245|62966139|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570018|NCT01597245|62966140|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33570019|NCT01597245|62966120|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
33570020|NCT01597245|62966121|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
33570021|NCT01597245|62966122|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
33570022|NCT01597245|62966123|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570023|NCT01597245|62966124|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570024|NCT01597245|62966125|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570025|NCT01597245|62966126|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570026|NCT01597245|62966127|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570027|NCT01597245|62966128|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570028|NCT01597245|62966129|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570029|NCT01597245|62966130|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570030|NCT01597245|62966131|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570031|NCT01597245|62966132|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570032|NCT01597245|62966133|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570033|NCT01597245|62966134|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570034|NCT01597245|62966135|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570035|NCT01597245|62966136|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570036|NCT01597245|62966137|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570037|NCT01597245|62966138|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570038|NCT01597245|62966139|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570039|NCT01597245|62966140|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33570040|NCT01597245|62966120|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
33570041|NCT01597245|62966121|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570042|NCT01597245|62966122|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570043|NCT01597245|62966123|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
33570044|NCT01597245|62966124|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570045|NCT01597245|62966125|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570046|NCT01597245|62966126|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570047|NCT01597245|62966127|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570048|NCT01597245|62966128|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570049|NCT01597245|62966129|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570050|NCT01597245|62966130|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570051|NCT01597245|62966131|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570052|NCT01597245|62966132|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570053|NCT01597245|62966133|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570054|NCT01597245|62966134|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570055|NCT01597245|62966135|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570056|NCT01597245|62966136|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570057|NCT01597245|62966137|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570058|NCT01597245|62966138|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570059|NCT01597245|62966139|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570060|NCT01597245|62966140|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33570061|NCT01597245|62966120|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
33570062|NCT01597245|62966121|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
33570063|NCT01597245|62966122|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
33570064|NCT01597245|62966123|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570065|NCT01597245|62966124|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570066|NCT01597245|62966125|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570067|NCT01597245|62966126|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570068|NCT01597245|62966127|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570069|NCT01597245|62966128|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570070|NCT01597245|62966129|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570071|NCT01597245|62966130|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570072|NCT01597245|62966131|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570073|NCT01597245|62966132|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570074|NCT01597245|62966133|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33664266|NCT02671500|63095280|FG000|Overall Study|Lack of Efficacy|12|||
33570075|NCT01597245|62966134|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570076|NCT01597245|62966135|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570077|NCT01597245|62966136|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570078|NCT01597245|62966137|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570079|NCT01597245|62966138|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570080|NCT01597245|62966139|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570081|NCT01597245|62966140|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33570082|NCT01597245|62966120|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570083|NCT01597245|62966121|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570084|NCT01597245|62966122|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570085|NCT01597245|62966123|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570086|NCT01597245|62966124|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570087|NCT01597245|62966125|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
33570088|NCT01597245|62966126|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
33570089|NCT01597245|62966127|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570090|NCT01597245|62966128|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570091|NCT01597245|62966129|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570092|NCT01597245|62966130|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570093|NCT01597245|62966131|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570094|NCT01597245|62966132|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570095|NCT01597245|62966133|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570096|NCT01597245|62966134|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570097|NCT01597245|62966135|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570098|NCT01597245|62966136|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570099|NCT01597245|62966137|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570100|NCT01597245|62966138|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570101|NCT01597245|62966139|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570102|NCT01597245|62966140|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33570103|NCT01597245|62966120|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570104|NCT01597245|62966121|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570105|NCT01597245|62966122|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570106|NCT01597245|62966123|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570107|NCT01597245|62966124|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
33570108|NCT01597245|62966125|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
33570109|NCT01597245|62966126|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
33570110|NCT01597245|62966127|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
33570111|NCT01597245|62966128|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570112|NCT01597245|62966129|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
33570113|NCT01597245|62966130|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570114|NCT01597245|62966131|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570115|NCT01597245|62966132|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570116|NCT01597245|62966133|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570117|NCT01597245|62966134|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570118|NCT01597245|62966135|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570119|NCT01597245|62966136|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570120|NCT01597245|62966137|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570121|NCT01597245|62966138|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570122|NCT01597245|62966139|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570123|NCT01597245|62966140|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33570124|NCT01597245|62966120|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570125|NCT01597245|62966121|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570126|NCT01597245|62966122|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570127|NCT01597245|62966123|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570128|NCT01597245|62966124|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570129|NCT01597245|62966125|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
33664267|NCT02671500|63095280|FG000|Overall Study|Lost to Follow-up|2|||
33396709|NCT00678392|62775986|FG001|Overall Study|Adverse Event|6|||
33396710|NCT00678392|62775985|FG000|Overall Study|Death|280|||
33396711|NCT00678392|62775986|FG001|Overall Study|Death|269|||
33396712|NCT00678392|62775985|FG000|Overall Study|Lost to Follow-up|15|||
33396713|NCT00678392|62775986|FG001|Overall Study|Lost to Follow-up|13|||
33396714|NCT00678392|62775985|FG000|Overall Study|Objective Progression or Relapse|3|||
33396715|NCT00678392|62775986|FG001|Overall Study|Objective Progression or Relapse|8|||
33396716|NCT00678392|62775985|FG000|Overall Study|Sponsor's Decision|1|||
33396717|NCT00678392|62775986|FG001|Overall Study|Sponsor's Decision|2|||
33396718|NCT00678392|62775985|FG000|Overall Study|Withdrawal by Subject|4|||
33396719|NCT00678392|62775986|FG001|Overall Study|Withdrawal by Subject|4|||
33570130|NCT01597245|62966126|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570131|NCT01597245|62966127|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570132|NCT01597245|62966128|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
33570133|NCT01597245|62966129|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570134|NCT01597245|62966130|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
33570135|NCT01597245|62966131|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
33570136|NCT01597245|62966132|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
33570137|NCT01597245|62966133|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570138|NCT01597245|62966134|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570139|NCT01597245|62966135|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570140|NCT01597245|62966136|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570141|NCT01597245|62966137|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570142|NCT01597245|62966138|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570143|NCT01597245|62966139|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570144|NCT01597245|62966140|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33570145|NCT01597245|62966120|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33570146|NCT01597245|62966121|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33570147|NCT01597245|62966122|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33570148|NCT01597245|62966123|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33570149|NCT01597245|62966124|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
33570150|NCT01597245|62966125|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
33570151|NCT01597245|62966126|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
33570152|NCT01597245|62966127|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
33570153|NCT01597245|62966128|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
33570154|NCT01597245|62966129|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
33570155|NCT01597245|62966130|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
33570156|NCT01597245|62966131|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
33570157|NCT01597245|62966132|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
33570158|NCT01597245|62966133|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33570159|NCT01597245|62966134|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33570160|NCT01597245|62966135|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33570161|NCT01597245|62966136|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33570162|NCT01597245|62966137|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33570163|NCT01597245|62966138|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33570164|NCT01597245|62966139|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33570165|NCT01597245|62966140|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33570166|NCT01597245|62966120|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33570167|NCT01597245|62966121|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33570168|NCT01597245|62966122|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33570169|NCT01597245|62966123|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33570170|NCT01597245|62966124|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
33570171|NCT01597245|62966125|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
33570172|NCT01597245|62966126|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
33570173|NCT01597245|62966127|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33570174|NCT01597245|62966128|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
33570175|NCT01597245|62966129|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
33570176|NCT01597245|62966130|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
33570177|NCT01597245|62966131|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
33570178|NCT01597245|62966132|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
33570179|NCT01597245|62966133|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33570180|NCT01597245|62966134|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33570181|NCT01597245|62966135|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33570182|NCT01597245|62966136|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33570183|NCT01597245|62966137|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33570184|NCT01597245|62966138|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33570185|NCT01597245|62966139|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33570186|NCT01597245|62966140|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33570187|NCT01597245|62966120|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570188|NCT01597245|62966121|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570189|NCT01597245|62966122|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570190|NCT01597245|62966123|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570191|NCT01597245|62966124|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
33570192|NCT01597245|62966125|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570193|NCT01597245|62966126|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570194|NCT01597245|62966127|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570195|NCT01597245|62966128|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
33570196|NCT01597245|62966129|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
33570197|NCT01597245|62966130|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
33570198|NCT01597245|62966131|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570199|NCT01597245|62966132|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
33570200|NCT01597245|62966133|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570201|NCT01597245|62966134|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570202|NCT01597245|62966135|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570203|NCT01597245|62966136|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570204|NCT01597245|62966137|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570205|NCT01597245|62966138|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570206|NCT01597245|62966139|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570207|NCT01597245|62966140|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33570208|NCT01597245|62966120|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33570209|NCT01597245|62966121|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33570210|NCT01597245|62966122|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33570211|NCT01597245|62966123|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33570212|NCT01597245|62966124|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
33570213|NCT01597245|62966125|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
33570214|NCT01597245|62966126|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
33570215|NCT01597245|62966127|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33570216|NCT01597245|62966128|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
33570217|NCT01597245|62966129|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
33570218|NCT01597245|62966130|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
33570219|NCT01597245|62966131|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
33570220|NCT01597245|62966132|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
33570221|NCT01597245|62966133|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33570222|NCT01597245|62966134|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33570223|NCT01597245|62966135|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33570224|NCT01597245|62966136|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33570225|NCT01597245|62966137|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33570226|NCT01597245|62966138|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33570227|NCT01597245|62966139|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33570228|NCT01597245|62966140|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33570229|NCT01597245|62966120|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33570230|NCT01597245|62966121|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33570231|NCT01597245|62966122|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33570232|NCT01597245|62966123|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33570233|NCT01597245|62966124|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33570234|NCT01597245|62966125|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
33570235|NCT01597245|62966126|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33570236|NCT01597245|62966127|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33570237|NCT01597245|62966128|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
33570238|NCT01597245|62966129|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
33570239|NCT01597245|62966130|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
33570240|NCT01597245|62966131|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
33570241|NCT01597245|62966132|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33570242|NCT01597245|62966133|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33570243|NCT01597245|62966134|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33664268|NCT02671422|63095288|FG000|Overall Study|Lost to Follow-up|1|||
33664269|NCT02671422|63095288|FG000|Overall Study|Adverse Event|68|||
33664270|NCT02671422|63095288|FG000|Overall Study|Lack of Efficacy|1|||
33664271|NCT02671422|63095288|FG000|Overall Study|Lost to Follow-up|4|||
33664272|NCT02671422|63095288|FG000|Overall Study|Withdrawal by Subject|7|||
33664273|NCT02671422|63095288|FG000|Overall Study|Progressive Disease|156|||
33664274|NCT02671422|63095288|FG000|Overall Study|Worsening of Disease|4|||
33664275|NCT02671422|63095288|FG000|Overall Study|Sponsor decision|5|||
33664276|NCT02671422|63095288|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
33664277|NCT02671422|63095288|FG000|Overall Study|Not treated with Vargatef®|3|||
33664278|NCT02671422|63095288|FG000|Overall Study|Other not defined above|3|||
33664279|NCT02671266|63095294|FG000|Overall Study|Withdrawal by Subject|1|||
33396720|NCT00678392|62775985|FG000|Overall Study|Randomized But Not Treated|2|||
33396721|NCT00678392|62775986|FG001|Overall Study|Randomized But Not Treated|7|||
33396722|NCT00678392|62775985|FG000|Overall Study|Other|56|||
33396723|NCT00678392|62775986|FG001|Overall Study|Other|53|||
33570244|NCT01597245|62966135|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33570245|NCT01597245|62966136|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33570246|NCT01597245|62966137|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33570247|NCT01597245|62966138|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33570248|NCT01597245|62966139|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33570249|NCT01597245|62966140|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33570250|NCT01597245|62966120|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570251|NCT01597245|62966121|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570252|NCT01597245|62966122|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570253|NCT01597245|62966123|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570254|NCT01597245|62966124|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570255|NCT01597245|62966125|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570256|NCT01597245|62966126|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570257|NCT01597245|62966127|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570258|NCT01597245|62966128|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570259|NCT01597245|62966129|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570260|NCT01597245|62966130|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
33570261|NCT01597245|62966131|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570262|NCT01597245|62966132|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570263|NCT01597245|62966133|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570264|NCT01597245|62966134|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570265|NCT01597245|62966135|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570266|NCT01597245|62966136|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570267|NCT01597245|62966137|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570268|NCT01597245|62966138|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570269|NCT01597245|62966139|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570270|NCT01597245|62966140|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33570271|NCT01597245|62966120|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570272|NCT01597245|62966121|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570273|NCT01597245|62966122|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570274|NCT01597245|62966123|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570275|NCT01597245|62966124|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570276|NCT01597245|62966125|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570277|NCT01597245|62966126|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570278|NCT01597245|62966127|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570279|NCT01597245|62966128|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570280|NCT01597245|62966129|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570281|NCT01597245|62966130|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570282|NCT01597245|62966131|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570283|NCT01597245|62966132|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570284|NCT01597245|62966133|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
33570285|NCT01597245|62966134|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
33570286|NCT01597245|62966135|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
33570287|NCT01597245|62966136|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570288|NCT01597245|62966137|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570289|NCT01597245|62966138|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570290|NCT01597245|62966139|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570291|NCT01597245|62966140|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33570292|NCT01597245|62966120|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570293|NCT01597245|62966121|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570294|NCT01597245|62966122|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570295|NCT01597245|62966123|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570296|NCT01597245|62966124|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570297|NCT01597245|62966125|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570298|NCT01597245|62966126|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570299|NCT01597245|62966127|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570300|NCT01597245|62966128|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570301|NCT01597245|62966129|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570302|NCT01597245|62966130|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570303|NCT01597245|62966131|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570304|NCT01597245|62966132|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570305|NCT01597245|62966133|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
33570306|NCT01597245|62966134|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
33570307|NCT01597245|62966135|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
33570308|NCT01597245|62966136|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570309|NCT01597245|62966137|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570310|NCT01597245|62966138|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570311|NCT01597245|62966139|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570312|NCT01597245|62966140|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33570313|NCT01597245|62966120|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570314|NCT01597245|62966121|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570315|NCT01597245|62966122|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570316|NCT01597245|62966123|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570317|NCT01597245|62966124|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570318|NCT01597245|62966125|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570319|NCT01597245|62966126|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570320|NCT01597245|62966127|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570321|NCT01597245|62966128|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570322|NCT01597245|62966129|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570323|NCT01597245|62966130|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570324|NCT01597245|62966131|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570325|NCT01597245|62966132|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570326|NCT01597245|62966133|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570327|NCT01597245|62966134|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
33570328|NCT01597245|62966135|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
33570329|NCT01597245|62966136|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570330|NCT01597245|62966137|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570331|NCT01597245|62966138|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570332|NCT01597245|62966139|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570333|NCT01597245|62966140|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33570334|NCT01597245|62966120|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570335|NCT01597245|62966121|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570336|NCT01597245|62966122|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570337|NCT01597245|62966123|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570338|NCT01597245|62966124|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33396724|NCT00308581|62775992|FG000|Induction Phase|Adverse Event|0|||
33396725|NCT00308581|62775993|FG001|Induction Phase|Adverse Event|0|||
33396726|NCT00308581|62775994|FG002|Induction Phase|Adverse Event|37|||
33396727|NCT00308581|62775992|FG000|Induction Phase|Lack of Efficacy|0|||
33396728|NCT00308581|62775993|FG001|Induction Phase|Lack of Efficacy|0|||
33396729|NCT00308581|62775994|FG002|Induction Phase|Lack of Efficacy|121|||
33396730|NCT00308581|62775992|FG000|Induction Phase|Withdrawal by Subject|0|||
33396731|NCT00308581|62775993|FG001|Induction Phase|Withdrawal by Subject|0|||
33396732|NCT00308581|62775994|FG002|Induction Phase|Withdrawal by Subject|5|||
33396733|NCT00308581|62775992|FG000|Induction Phase|Unknown reason|0|||
33396734|NCT00308581|62775993|FG001|Induction Phase|Unknown reason|0|||
33570339|NCT01597245|62966125|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570340|NCT01597245|62966126|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570341|NCT01597245|62966127|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570342|NCT01597245|62966128|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570343|NCT01597245|62966129|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570344|NCT01597245|62966130|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570345|NCT01597245|62966131|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570346|NCT01597245|62966132|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570347|NCT01597245|62966133|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570348|NCT01597245|62966134|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
33570349|NCT01597245|62966135|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
33570350|NCT01597245|62966136|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570351|NCT01597245|62966137|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570352|NCT01597245|62966138|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570353|NCT01597245|62966139|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570354|NCT01597245|62966140|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33570355|NCT01597245|62966120|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570356|NCT01597245|62966121|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570357|NCT01597245|62966122|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570358|NCT01597245|62966123|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33664280|NCT02671266|63095295|FG001|Overall Study|Withdrawal by Subject|1|||
33396735|NCT00308581|62775994|FG002|Induction Phase|Unknown reason|3|||
33396736|NCT00308581|62775992|FG000|Randomized Maintenance Phase|Adverse Event|10|||
33570359|NCT01597245|62966124|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570360|NCT01597245|62966125|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570361|NCT01597245|62966126|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570362|NCT01597245|62966127|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570363|NCT01597245|62966128|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570364|NCT01597245|62966129|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570365|NCT01597245|62966130|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570366|NCT01597245|62966131|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570367|NCT01597245|62966132|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570368|NCT01597245|62966133|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
33570369|NCT01597245|62966134|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
33570370|NCT01597245|62966135|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
33570371|NCT01597245|62966136|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570372|NCT01597245|62966137|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570373|NCT01597245|62966138|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570374|NCT01597245|62966139|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570375|NCT01597245|62966140|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33570376|NCT01597245|62966120|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570377|NCT01597245|62966121|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570378|NCT01597245|62966122|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570379|NCT01597245|62966123|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570380|NCT01597245|62966124|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570381|NCT01597245|62966125|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570382|NCT01597245|62966126|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570383|NCT01597245|62966127|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570384|NCT01597245|62966128|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570385|NCT01597245|62966129|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570386|NCT01597245|62966130|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570387|NCT01597245|62966131|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570388|NCT01597245|62966132|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570389|NCT01597245|62966133|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570390|NCT01597245|62966134|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
33570391|NCT01597245|62966135|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
33570392|NCT01597245|62966136|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570393|NCT01597245|62966137|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570394|NCT01597245|62966138|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570395|NCT01597245|62966139|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570396|NCT01597245|62966140|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
33570397|NCT01597245|62966120|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570398|NCT01597245|62966121|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570399|NCT01597245|62966122|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570400|NCT01597245|62966123|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570401|NCT01597245|62966124|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570402|NCT01597245|62966125|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570403|NCT01597245|62966126|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570404|NCT01597245|62966127|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570405|NCT01597245|62966128|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570406|NCT01597245|62966129|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570407|NCT01597245|62966130|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570408|NCT01597245|62966131|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570409|NCT01597245|62966132|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570410|NCT01597245|62966133|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570411|NCT01597245|62966134|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
33570412|NCT01597245|62966135|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
33570413|NCT01597245|62966136|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570414|NCT01597245|62966137|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570415|NCT01597245|62966138|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570416|NCT01597245|62966139|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570417|NCT01597245|62966140|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33570418|NCT01597245|62966120|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570419|NCT01597245|62966121|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570420|NCT01597245|62966122|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570421|NCT01597245|62966123|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570422|NCT01597245|62966124|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570423|NCT01597245|62966125|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570424|NCT01597245|62966126|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570425|NCT01597245|62966127|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570426|NCT01597245|62966128|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570427|NCT01597245|62966129|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570428|NCT01597245|62966130|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570429|NCT01597245|62966131|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570430|NCT01597245|62966132|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570431|NCT01597245|62966133|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570432|NCT01597245|62966134|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
33570433|NCT01597245|62966135|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
33570434|NCT01597245|62966136|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570435|NCT01597245|62966137|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570436|NCT01597245|62966138|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570437|NCT01597245|62966139|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570438|NCT01597245|62966140|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33570439|NCT01597245|62966120|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570440|NCT01597245|62966121|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570441|NCT01597245|62966122|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570442|NCT01597245|62966123|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570443|NCT01597245|62966124|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570444|NCT01597245|62966125|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570445|NCT01597245|62966126|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570446|NCT01597245|62966127|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570447|NCT01597245|62966128|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570448|NCT01597245|62966129|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570449|NCT01597245|62966130|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570450|NCT01597245|62966131|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570451|NCT01597245|62966132|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570452|NCT01597245|62966133|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570453|NCT01597245|62966134|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
33570454|NCT01597245|62966135|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
33570455|NCT01597245|62966136|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570456|NCT01597245|62966137|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570457|NCT01597245|62966138|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570458|NCT01597245|62966139|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570459|NCT01597245|62966140|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33570460|NCT01597245|62966120|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570461|NCT01597245|62966121|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570462|NCT01597245|62966122|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570463|NCT01597245|62966123|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570464|NCT01597245|62966124|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570465|NCT01597245|62966125|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570466|NCT01597245|62966126|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570467|NCT01597245|62966127|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570468|NCT01597245|62966128|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570469|NCT01597245|62966129|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570470|NCT01597245|62966130|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570471|NCT01597245|62966131|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570472|NCT01597245|62966132|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570473|NCT01597245|62966133|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
33570474|NCT01597245|62966134|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570475|NCT01597245|62966135|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570476|NCT01597245|62966136|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570477|NCT01597245|62966137|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570478|NCT01597245|62966138|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570479|NCT01597245|62966139|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570480|NCT01597245|62966140|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33570481|NCT01597245|62966120|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33570482|NCT01597245|62966121|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33570483|NCT01597245|62966122|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33570484|NCT01597245|62966123|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33302861|NCT01074190|62678701|FG001|Overall Study|Delivered in under 90 minutes|2|||
33302862|NCT01074190|62678702|FG002|Overall Study|Delivered in under 90 minutes|1|||
33570485|NCT01597245|62966124|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33570486|NCT01597245|62966125|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33570487|NCT01597245|62966126|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33570488|NCT01597245|62966127|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33570489|NCT01597245|62966128|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33570490|NCT01597245|62966129|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33570491|NCT01597245|62966130|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33570492|NCT01597245|62966131|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33570493|NCT01597245|62966132|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33570494|NCT01597245|62966133|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33570495|NCT01597245|62966134|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33570496|NCT01597245|62966135|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33570497|NCT01597245|62966136|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
33570498|NCT01597245|62966137|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
33570499|NCT01597245|62966138|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
33570500|NCT01597245|62966139|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
33570501|NCT01597245|62966140|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
33570502|NCT01597245|62966120|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570503|NCT01597245|62966121|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570504|NCT01597245|62966122|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570505|NCT01597245|62966123|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570506|NCT01597245|62966124|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570507|NCT01597245|62966125|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570508|NCT01597245|62966126|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570509|NCT01597245|62966127|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570510|NCT01597245|62966128|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570511|NCT01597245|62966129|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570512|NCT01597245|62966130|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570513|NCT01597245|62966131|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570514|NCT01597245|62966132|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570515|NCT01597245|62966133|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570516|NCT01597245|62966134|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570517|NCT01597245|62966135|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570518|NCT01597245|62966136|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33570519|NCT01597245|62966137|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
33570520|NCT01597245|62966138|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
33570521|NCT01597245|62966139|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
33570522|NCT01597245|62966140|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
33570523|NCT01597245|62966120|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570524|NCT01597245|62966121|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570525|NCT01597245|62966122|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570526|NCT01597245|62966123|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570527|NCT01597245|62966124|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570528|NCT01597245|62966125|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570529|NCT01597245|62966126|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570530|NCT01597245|62966127|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570531|NCT01597245|62966128|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570532|NCT01597245|62966129|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570533|NCT01597245|62966130|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570534|NCT01597245|62966131|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570535|NCT01597245|62966132|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570536|NCT01597245|62966133|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570537|NCT01597245|62966134|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570538|NCT01597245|62966135|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570539|NCT01597245|62966136|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
33570540|NCT01597245|62966137|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570541|NCT01597245|62966138|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33570542|NCT01597245|62966139|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
33570543|NCT01597245|62966140|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
33570544|NCT01597245|62966120|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570545|NCT01597245|62966121|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33664281|NCT03320070|63095303|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
33664282|NCT03320070|63095304|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
33396737|NCT00308581|62775993|FG001|Randomized Maintenance Phase|Adverse Event|17|||
33570546|NCT01597245|62966122|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570547|NCT01597245|62966123|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570548|NCT01597245|62966124|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570549|NCT01597245|62966125|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570550|NCT01597245|62966126|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570551|NCT01597245|62966127|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570552|NCT01597245|62966128|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570553|NCT01597245|62966129|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570554|NCT01597245|62966130|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570555|NCT01597245|62966131|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570556|NCT01597245|62966132|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570557|NCT01597245|62966133|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570558|NCT01597245|62966134|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570559|NCT01597245|62966135|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570560|NCT01597245|62966136|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570561|NCT01597245|62966137|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33570562|NCT01597245|62966138|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
33570563|NCT01597245|62966139|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
33570564|NCT01597245|62966140|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
33570565|NCT01597245|62966120|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570566|NCT01597245|62966121|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570567|NCT01597245|62966122|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570568|NCT01597245|62966123|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570569|NCT01597245|62966124|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570570|NCT01597245|62966125|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570571|NCT01597245|62966126|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570572|NCT01597245|62966127|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570573|NCT01597245|62966128|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570574|NCT01597245|62966129|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570575|NCT01597245|62966130|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570576|NCT01597245|62966131|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570577|NCT01597245|62966132|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570578|NCT01597245|62966133|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570579|NCT01597245|62966134|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570580|NCT01597245|62966135|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570581|NCT01597245|62966136|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
33570582|NCT01597245|62966137|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570583|NCT01597245|62966138|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33570584|NCT01597245|62966139|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
33570585|NCT01597245|62966140|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
33570586|NCT01597245|62966120|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570587|NCT01597245|62966121|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570588|NCT01597245|62966122|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570589|NCT01597245|62966123|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570590|NCT01597245|62966124|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570591|NCT01597245|62966125|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570592|NCT01597245|62966126|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570593|NCT01597245|62966127|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570594|NCT01597245|62966128|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570595|NCT01597245|62966129|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570596|NCT01597245|62966130|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570597|NCT01597245|62966131|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570598|NCT01597245|62966132|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570599|NCT01597245|62966133|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570600|NCT01597245|62966134|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570601|NCT01597245|62966135|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570602|NCT01597245|62966136|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
33570603|NCT01597245|62966137|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570604|NCT01597245|62966138|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33570605|NCT01597245|62966139|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
33396738|NCT00308581|62775994|FG002|Randomized Maintenance Phase|Adverse Event|0|||
33570606|NCT01597245|62966140|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
33570607|NCT01597245|62966120|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570608|NCT01597245|62966121|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570609|NCT01597245|62966122|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570610|NCT01597245|62966123|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570611|NCT01597245|62966124|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570612|NCT01597245|62966125|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570613|NCT01597245|62966126|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570614|NCT01597245|62966127|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570615|NCT01597245|62966128|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570616|NCT01597245|62966129|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570617|NCT01597245|62966130|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570618|NCT01597245|62966131|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570619|NCT01597245|62966132|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570620|NCT01597245|62966133|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570621|NCT01597245|62966134|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570622|NCT01597245|62966135|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570623|NCT01597245|62966136|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
33570624|NCT01597245|62966137|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570625|NCT01597245|62966138|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570626|NCT01597245|62966139|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
33570627|NCT01597245|62966140|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33570628|NCT01597245|62966120|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570629|NCT01597245|62966121|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570630|NCT01597245|62966122|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570631|NCT01597245|62966123|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570632|NCT01597245|62966124|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570633|NCT01597245|62966125|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570634|NCT01597245|62966126|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570635|NCT01597245|62966127|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570636|NCT01597245|62966128|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570637|NCT01597245|62966129|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570638|NCT01597245|62966130|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570639|NCT01597245|62966131|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570640|NCT01597245|62966132|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570641|NCT01597245|62966133|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570642|NCT01597245|62966134|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570643|NCT01597245|62966135|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570644|NCT01597245|62966136|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
33570645|NCT01597245|62966137|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570646|NCT01597245|62966138|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570647|NCT01597245|62966139|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
33570648|NCT01597245|62966140|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33570649|NCT01597245|62966120|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570650|NCT01597245|62966121|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570651|NCT01597245|62966122|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570652|NCT01597245|62966123|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570653|NCT01597245|62966124|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570654|NCT01597245|62966125|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570655|NCT01597245|62966126|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570656|NCT01597245|62966127|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570657|NCT01597245|62966128|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570658|NCT01597245|62966129|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570659|NCT01597245|62966130|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570660|NCT01597245|62966131|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570661|NCT01597245|62966132|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33396739|NCT00308581|62775992|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
33396740|NCT00308581|62775993|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
33570662|NCT01597245|62966133|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570663|NCT01597245|62966134|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570664|NCT01597245|62966135|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570665|NCT01597245|62966136|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570666|NCT01597245|62966137|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570667|NCT01597245|62966138|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570668|NCT01597245|62966139|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
33570669|NCT01597245|62966140|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33570670|NCT00707057|62966175|FG000|Overall Study|Withdrawal by Subject|8|||
33570671|NCT00707057|62966176|FG001|Overall Study|Withdrawal by Subject|3|||
33570672|NCT00707057|62966175|FG000|Overall Study|Dosed incorrectly|0|||
33570673|NCT00707057|62966176|FG001|Overall Study|Dosed incorrectly|1|||
33570674|NCT02639247|62966184|FG000|Overall Study|Lost to Follow-up|2|||
33570675|NCT02639247|62966185|FG001|Overall Study|Lost to Follow-up|1|||
33570676|NCT02639247|62966184|FG000|Overall Study|Death|2|||
33570677|NCT02639247|62966185|FG001|Overall Study|Death|0|||
33570678|NCT02639247|62966184|FG000|Overall Study|Withdrew Consent|0|||
33570679|NCT02639247|62966185|FG001|Overall Study|Withdrew Consent|1|||
33570680|NCT02639247|62966184|FG000|Overall Study|Protocol Violation|1|||
33570681|NCT02639247|62966185|FG001|Overall Study|Protocol Violation|0|||
33570682|NCT00706901|62966194|FG000|Overall Study|Lost to Follow-up|2|||
33570683|NCT00706901|62966195|FG001|Overall Study|Lost to Follow-up|3|||
33570684|NCT00706901|62966196|FG002|Overall Study|Lost to Follow-up|2|||
33570685|NCT00706901|62966194|FG000|Overall Study|Withdrawal by Subject|4|||
33570686|NCT00706901|62966195|FG001|Overall Study|Withdrawal by Subject|2|||
33570687|NCT00706901|62966196|FG002|Overall Study|Withdrawal by Subject|5|||
33570688|NCT00706901|62966194|FG000|Overall Study|In Jail|1|||
33570689|NCT00706901|62966195|FG001|Overall Study|In Jail|0|||
33570690|NCT00706901|62966196|FG002|Overall Study|In Jail|1|||
33570691|NCT00706901|62966194|FG000|Overall Study|Death|1|||
33570692|NCT00706901|62966195|FG001|Overall Study|Death|0|||
33570693|NCT00706901|62966196|FG002|Overall Study|Death|0|||
33570694|NCT01673373|62966205|FG000|Overall Study|Death|2|||
33570695|NCT01236547|62966214|FG000|Overall Study|Protocol Violation|0|||
33570696|NCT01236547|62966215|FG001|Overall Study|Protocol Violation|1|||
33570697|NCT01236547|62966216|FG002|Overall Study|Protocol Violation|1|||
33570698|NCT01236547|62966217|FG003|Overall Study|Protocol Violation|6|||
33570699|NCT01236547|62966218|FG004|Overall Study|Protocol Violation|12|||
33570700|NCT02167945|62966231|FG000|Overall Study|Adverse Event|16|||
33570701|NCT02167945|62966231|FG000|Overall Study|Withdrew Consent|42|||
33570702|NCT02167945|62966231|FG000|Overall Study|Lost to Follow-up|122|||
33570703|NCT02167945|62966231|FG000|Overall Study|COVID-19 logistical restrictions|6|||
33570704|NCT02167945|62966231|FG000|Overall Study|Other, not specified|63|||
33570705|NCT01375075|62966249|FG000|Overall Study|Adverse Event|0|||
33570706|NCT01375075|62966250|FG001|Overall Study|Adverse Event|0|||
33570707|NCT01375075|62966251|FG002|Overall Study|Adverse Event|3|||
33570708|NCT01375075|62966252|FG003|Overall Study|Adverse Event|1|||
33570709|NCT01375075|62966253|FG004|Overall Study|Adverse Event|0|||
33570710|NCT01375075|62966254|FG005|Overall Study|Adverse Event|1|||
33570711|NCT01375075|62966249|FG000|Overall Study|Entry Criterion Not Met|1|||
33570712|NCT01375075|62966250|FG001|Overall Study|Entry Criterion Not Met|0|||
33570713|NCT01375075|62966251|FG002|Overall Study|Entry Criterion Not Met|0|||
33570714|NCT01375075|62966252|FG003|Overall Study|Entry Criterion Not Met|0|||
33570715|NCT01375075|62966253|FG004|Overall Study|Entry Criterion Not Met|0|||
33570716|NCT01375075|62966254|FG005|Overall Study|Entry Criterion Not Met|1|||
33570717|NCT01375075|62966249|FG000|Overall Study|Withdrawal by Subject|0|||
33570718|NCT01375075|62966250|FG001|Overall Study|Withdrawal by Subject|1|||
33570719|NCT01375075|62966251|FG002|Overall Study|Withdrawal by Subject|0|||
33570720|NCT01375075|62966252|FG003|Overall Study|Withdrawal by Subject|0|||
33570721|NCT01375075|62966253|FG004|Overall Study|Withdrawal by Subject|0|||
33570722|NCT01375075|62966254|FG005|Overall Study|Withdrawal by Subject|1|||
33570723|NCT00706433|62966276|FG000|Overall Study|Lost to Follow-up|3|||
33570724|NCT00706433|62966277|FG001|Overall Study|Lost to Follow-up|1|||
33570725|NCT00706433|62966278|FG002|Overall Study|Lost to Follow-up|6|||
33570726|NCT00706433|62966279|FG003|Overall Study|Lost to Follow-up|0|||
33570727|NCT00706433|62966276|FG000|Overall Study|Withdrawal by Subject|1|||
33570728|NCT00706433|62966277|FG001|Overall Study|Withdrawal by Subject|2|||
33570729|NCT00706433|62966278|FG002|Overall Study|Withdrawal by Subject|3|||
33570730|NCT00706433|62966279|FG003|Overall Study|Withdrawal by Subject|1|||
33570731|NCT00706433|62966276|FG000|Overall Study|Adverse Event|0|||
33570732|NCT00706433|62966277|FG001|Overall Study|Adverse Event|0|||
33570733|NCT00706433|62966278|FG002|Overall Study|Adverse Event|1|||
33570734|NCT00706433|62966279|FG003|Overall Study|Adverse Event|0|||
33570735|NCT00706433|62966276|FG000|Overall Study|Protocol Violation|1|||
33570736|NCT00706433|62966277|FG001|Overall Study|Protocol Violation|0|||
33570737|NCT00706433|62966278|FG002|Overall Study|Protocol Violation|0|||
33570738|NCT00706433|62966279|FG003|Overall Study|Protocol Violation|0|||
33570739|NCT00706433|62966276|FG000|Overall Study|new job|0|||
33570740|NCT00706433|62966277|FG001|Overall Study|new job|0|||
33570741|NCT00706433|62966278|FG002|Overall Study|new job|0|||
33570742|NCT00706433|62966279|FG003|Overall Study|new job|1|||
33570743|NCT02638623|62966291|FG000|Overall Study|Surgery timing|5|||
33570744|NCT02638623|62966292|FG001|Overall Study|Surgery timing|6|||
33570745|NCT02638623|62966291|FG000|Overall Study|Not given intervention|2|||
33570746|NCT02638623|62966292|FG001|Overall Study|Not given intervention|0|||
33570747|NCT02637141|62966301|FG000|Overall Study|Adverse Event|1|||
33570748|NCT02637141|62966302|FG001|Overall Study|Adverse Event|1|||
33570749|NCT02637141|62966303|FG002|Overall Study|Adverse Event|0|||
33570750|NCT02637141|62966301|FG000|Overall Study|Withdrawal by Subject|1|||
33570751|NCT02637141|62966302|FG001|Overall Study|Withdrawal by Subject|1|||
33570752|NCT02637141|62966303|FG002|Overall Study|Withdrawal by Subject|1|||
33570753|NCT02637063|62966314|FG000|Overall Study|Lost to Follow-up|3|||
33570754|NCT02637063|62966315|FG001|Overall Study|Lost to Follow-up|2|||
33570755|NCT02637063|62966316|FG002|Overall Study|Lost to Follow-up|3|||
33570756|NCT02637063|62966314|FG000|Overall Study|Withdrawal by Subject|2|||
33570757|NCT02637063|62966315|FG001|Overall Study|Withdrawal by Subject|2|||
33570758|NCT02637063|62966316|FG002|Overall Study|Withdrawal by Subject|3|||
33570759|NCT02635737|62966324|FG000|Overall Study|Protocol Violation|1|||
33570760|NCT02636907|62966328|FG000|Autoinjector Assessment Period|Adverse Event|2|||
33570761|NCT02636907|62966328|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
33570762|NCT02636907|62966328|FG000|Extension Phase|Adverse Event|2|||
33570763|NCT02636907|62966328|FG000|Extension Phase|Withdrawal by Subject|4|||
33570764|NCT02636907|62966328|FG000|Extension Phase|Physician Decision|1|||
33570765|NCT02636907|62966328|FG000|Extension Phase|Lost to Follow-up|2|||
33570766|NCT02636907|62966328|FG000|Extension Phase|Lack of Efficacy|1|||
33570767|NCT01374919|62966332|FG000|Overall Study|Withdrawal by Subject|2|||
33570768|NCT02726945|62966343|FG000|Overall Study|Withdrawal by Subject|0|||
33570769|NCT02726945|62966344|FG001|Overall Study|Withdrawal by Subject|0|||
33570770|NCT02726945|62966345|FG002|Overall Study|Withdrawal by Subject|1|||
33570771|NCT02726945|62966343|FG000|Overall Study|Elected to have total knee replacement|0|||
33570772|NCT02726945|62966344|FG001|Overall Study|Elected to have total knee replacement|1|||
33570773|NCT02726945|62966345|FG002|Overall Study|Elected to have total knee replacement|0|||
33570774|NCT02635347|62966355|FG000|Overall Study|Failed screening|20|||
33570775|NCT02635347|62966356|FG001|Overall Study|Failed screening|7|||
33570776|NCT02726399|62966376|FG000|Overall Study|Participant Non-Compliance|1|||
33570777|NCT02726399|62966376|FG000|Overall Study|Adverse Event|2|||
33570778|NCT02726399|62966376|FG000|Overall Study|Progression of disease|4|||
33570779|NCT02634801|62966383|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
33570780|NCT02634801|62966384|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
33570781|NCT02634801|62966385|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
33570782|NCT02634801|62966383|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
33570783|NCT02634801|62966384|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
33570784|NCT02634801|62966385|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
33570785|NCT02634801|62966383|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
33570786|NCT02634801|62966384|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
33570787|NCT02634801|62966385|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
33570788|NCT02634801|62966383|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
33570789|NCT02634801|62966384|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
33570790|NCT02634801|62966385|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
33570791|NCT02634801|62966383|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
33570792|NCT02634801|62966384|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
33664283|NCT03320070|63095303|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
33664284|NCT03320070|63095304|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
33664285|NCT03320070|63095303|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
33664286|NCT03320070|63095304|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
33664287|NCT03320070|63095303|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
33664288|NCT03320070|63095304|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
33664289|NCT03320070|63095303|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
33664290|NCT03320070|63095304|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
33664291|NCT03320070|63095303|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
33664292|NCT03320070|63095304|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
33664293|NCT02667912|63095315|FG000|Overall Study|Death|3|||
33664294|NCT02667912|63095316|FG001|Overall Study|Death|1|||
33664295|NCT02667912|63095315|FG000|Overall Study|Withdrawal by Subject|1|||
33664296|NCT02667912|63095316|FG001|Overall Study|Withdrawal by Subject|2|||
33664297|NCT02667912|63095315|FG000|Overall Study|Withdrawal by Subject|1|||
33664298|NCT02667912|63095316|FG001|Overall Study|Withdrawal by Subject|0|||
33664299|NCT01373346|63095322|FG000|Overall Study|Death|1|||
33664300|NCT03284424|63095333|FG000|Overall Study|Death|56|||
33664301|NCT03284424|63095334|FG001|Overall Study|Death|13|||
33664302|NCT03284424|63095333|FG000|Overall Study|Lost to Follow-up|1|||
33664303|NCT03284424|63095334|FG001|Overall Study|Lost to Follow-up|0|||
33664304|NCT03284424|63095333|FG000|Overall Study|Physician Decision|1|||
33664305|NCT03284424|63095334|FG001|Overall Study|Physician Decision|0|||
33664306|NCT03284424|63095333|FG000|Overall Study|Withdrawal by Subject|3|||
33664307|NCT03284424|63095334|FG001|Overall Study|Withdrawal by Subject|2|||
33664308|NCT03284424|63095333|FG000|Overall Study|Ongoing in study|44|||
33664309|NCT03284424|63095334|FG001|Overall Study|Ongoing in study|39|||
33664310|NCT02674854|63095342|FG000|Overall Study|Adverse Event|17|||
33570793|NCT02634801|62966385|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
33570794|NCT02634801|62966383|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
33570795|NCT02634801|62966384|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
33570796|NCT02634801|62966385|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
33570797|NCT02634801|62966383|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
33570798|NCT02634801|62966384|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
33570799|NCT02634801|62966385|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
33570800|NCT02634801|62966383|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
33570801|NCT02634801|62966384|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
33570802|NCT02634801|62966385|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
33570803|NCT02634801|62966383|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
33570804|NCT02634801|62966384|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
33570805|NCT02634801|62966385|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
33570806|NCT02634801|62966383|FG000|Follow-up Period|Lost to Follow-up|3|||
33570807|NCT02634801|62966384|FG001|Follow-up Period|Lost to Follow-up|1|||
33570808|NCT02634801|62966385|FG002|Follow-up Period|Lost to Follow-up|2|||
33570809|NCT02634801|62966383|FG000|Follow-up Period|Physician Decision|0|||
33570810|NCT02634801|62966384|FG001|Follow-up Period|Physician Decision|0|||
33570811|NCT02634801|62966385|FG002|Follow-up Period|Physician Decision|1|||
33570812|NCT02634801|62966383|FG000|Follow-up Period|Withdrawal by Subject|1|||
33570813|NCT02634801|62966384|FG001|Follow-up Period|Withdrawal by Subject|2|||
33570814|NCT02634801|62966385|FG002|Follow-up Period|Withdrawal by Subject|5|||
33570815|NCT02634801|62966383|FG000|Follow-up Period|Adverse Event|1|||
33570816|NCT02634801|62966384|FG001|Follow-up Period|Adverse Event|5|||
33570817|NCT02634801|62966385|FG002|Follow-up Period|Adverse Event|0|||
33570818|NCT02724839|62966400|FG000|Overall Study|Withdrawal by Subject|1|||
33570819|NCT02724839|62966401|FG001|Overall Study|Withdrawal by Subject|1|||
33570820|NCT02724839|62966402|FG002|Overall Study|Withdrawal by Subject|0|||
33570821|NCT02724839|62966400|FG000|Overall Study|Lost to Follow-up|0|||
33570822|NCT02724839|62966401|FG001|Overall Study|Lost to Follow-up|3|||
33570823|NCT02724839|62966402|FG002|Overall Study|Lost to Follow-up|2|||
33570824|NCT02724839|62966400|FG000|Overall Study|Physician Decision|0|||
33570825|NCT02724839|62966401|FG001|Overall Study|Physician Decision|0|||
33570826|NCT02724839|62966402|FG002|Overall Study|Physician Decision|3|||
33570827|NCT01375751|62966420|FG000|Overall Study|Other|0|||
33570828|NCT01375751|62966421|FG001|Overall Study|Other|1|||
33570829|NCT01375751|62966422|FG002|Overall Study|Other|0|||
33570830|NCT00705575|62966432|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33570831|NCT00705575|62966433|FG001|Overall Study|Abnormal laboratory value(s)|3|||
33570832|NCT00705575|62966432|FG000|Overall Study|Abnormal test procedure result(s)|2|||
33570833|NCT00705575|62966433|FG001|Overall Study|Abnormal test procedure result(s)|12|||
33570834|NCT00705575|62966432|FG000|Overall Study|Adverse Event|11|||
33570835|NCT00705575|62966433|FG001|Overall Study|Adverse Event|15|||
33570836|NCT00705575|62966432|FG000|Overall Study|Lost to Follow-up|3|||
33570837|NCT00705575|62966433|FG001|Overall Study|Lost to Follow-up|4|||
33570838|NCT00705575|62966432|FG000|Overall Study|Protocol Violation|2|||
33570839|NCT00705575|62966433|FG001|Overall Study|Protocol Violation|2|||
33570840|NCT00705575|62966432|FG000|Overall Study|Withdrawal by Subject|5|||
33570841|NCT00705575|62966433|FG001|Overall Study|Withdrawal by Subject|10|||
33570842|NCT02636595|62966439|FG000|Overall Study|Lost to Follow-up|1|||
33570843|NCT02636595|62966439|FG000|Overall Study|Other|1|||
33570844|NCT02636361|62966443|FG000|Period 4|Physician Decision|0|||
33570845|NCT02636361|62966444|FG001|Period 4|Physician Decision|0|||
33570846|NCT02636361|62966445|FG002|Period 4|Physician Decision|0|||
33570847|NCT02636361|62966446|FG003|Period 4|Physician Decision|1|||
33570848|NCT02636361|62966447|FG004|Period 4|Physician Decision|0|||
33570849|NCT02636283|62966463|FG000|Overall Study|Adverse Event|2|||
33570850|NCT02636283|62966464|FG001|Overall Study|Adverse Event|0|||
33570851|NCT02636283|62966463|FG000|Overall Study|Trial Terminated Prematurely|0|||
33570852|NCT02636283|62966464|FG001|Overall Study|Trial Terminated Prematurely|3|||
33570853|NCT04430855|62966472|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
33570854|NCT04430855|62966473|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
33396741|NCT00308581|62775994|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
33570855|NCT04430855|62966472|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
33570856|NCT04430855|62966473|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
33570857|NCT04430855|62966472|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
33570858|NCT04430855|62966473|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
33570859|NCT04430855|62966472|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
33570860|NCT04430855|62966473|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
33570861|NCT04430855|62966472|FG000|Period 1 (Weeks 1-12)|Other|0|||
33570862|NCT04430855|62966473|FG001|Period 1 (Weeks 1-12)|Other|1|||
33570863|NCT04430855|62966472|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
33570864|NCT04430855|62966473|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
33570865|NCT04430855|62966472|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
33570866|NCT04430855|62966473|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
33570867|NCT04430855|62966472|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
33570868|NCT04430855|62966473|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
33570869|NCT01375673|62966483|FG000|Overall Study|Withdrawal by Subject|0|||
33570870|NCT01375673|62966484|FG001|Overall Study|Withdrawal by Subject|1|||
33570871|NCT03652961|62966490|FG000|Overall Study|Lost to Follow-up|3|||
33570872|NCT03652961|62966490|FG000|Overall Study|Screen Failure|1|||
33570873|NCT02723591|62966496|FG000|Overall Study|Adverse Event|48|||
33570874|NCT02723591|62966497|FG001|Overall Study|Adverse Event|40|||
33570875|NCT02723591|62966496|FG000|Overall Study|Death|2|||
33570876|NCT02723591|62966497|FG001|Overall Study|Death|2|||
33570877|NCT02723591|62966496|FG000|Overall Study|Lack of Efficacy|4|||
33570878|NCT02723591|62966497|FG001|Overall Study|Lack of Efficacy|3|||
33570879|NCT02723591|62966496|FG000|Overall Study|Lost to Follow-up|1|||
33570880|NCT02723591|62966497|FG001|Overall Study|Lost to Follow-up|7|||
33570881|NCT02723591|62966496|FG000|Overall Study|Protocol Violation|20|||
33570882|NCT02723591|62966497|FG001|Overall Study|Protocol Violation|23|||
33570883|NCT02723591|62966496|FG000|Overall Study|Withdrawal by Subject|4|||
33570884|NCT02723591|62966497|FG001|Overall Study|Withdrawal by Subject|8|||
33570885|NCT02723591|62966496|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
33570886|NCT02723591|62966497|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
33570887|NCT02723591|62966496|FG000|Overall Study|Miscellaneous|5|||
33570888|NCT02723591|62966497|FG001|Overall Study|Miscellaneous|6|||
33570889|NCT00705341|62966505|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
33570890|NCT00705341|62966506|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
33570891|NCT00705341|62966507|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
33570892|NCT00705341|62966508|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
33570893|NCT00705341|62966505|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
33570894|NCT00705341|62966506|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
33570895|NCT00705341|62966507|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
33570896|NCT00705341|62966508|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
33570897|NCT02723201|62966519|FG000|Second Intervention Period|Protocol Violation|1|||
33570898|NCT02723201|62966520|FG001|Second Intervention Period|Protocol Violation|0|||
33570899|NCT02723201|62966521|FG002|Second Intervention Period|Protocol Violation|0|||
33570900|NCT02723201|62966519|FG000|Second Intervention Period|Adverse Event|1|||
33570901|NCT02723201|62966520|FG001|Second Intervention Period|Adverse Event|0|||
33570902|NCT02723201|62966521|FG002|Second Intervention Period|Adverse Event|0|||
33570903|NCT03846479|62966535|FG000|Overall Study|Death|8|||
33570904|NCT03846479|62966535|FG000|Overall Study|Lost to Follow-up|1|||
33570905|NCT00705263|62966539|FG000|Overall Study|Withdrawal by Subject|2|||
33570906|NCT00704405|62966557|FG000|Overall Study (NC Population)|Adverse Event|1|||
33570907|NCT00704405|62966558|FG001|Overall Study (NC Population)|Adverse Event|0|||
33570908|NCT00704405|62966559|FG002|Overall Study (NC Population)|Adverse Event|0|||
33570909|NCT00704405|62966560|FG003|Overall Study (NC Population)|Adverse Event|0|||
33570910|NCT00704405|62966561|FG004|Overall Study (NC Population)|Adverse Event|0|||
33570911|NCT00704405|62966557|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
33570912|NCT00704405|62966558|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
33570913|NCT00704405|62966559|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
33570914|NCT00704405|62966560|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
33570915|NCT00704405|62966561|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
33570916|NCT00704405|62966557|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
33570917|NCT00704405|62966558|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
33570918|NCT00704405|62966559|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
33570919|NCT00704405|62966560|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
33570920|NCT00704405|62966561|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
33570921|NCT00704405|62966557|FG000|Overall Study (NC Population)|Other|0|||
33570922|NCT00704405|62966558|FG001|Overall Study (NC Population)|Other|0|||
33570923|NCT00704405|62966559|FG002|Overall Study (NC Population)|Other|0|||
33570924|NCT00704405|62966560|FG003|Overall Study (NC Population)|Other|0|||
33570925|NCT00704405|62966561|FG004|Overall Study (NC Population)|Other|1|||
33570926|NCT00704405|62966557|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
33570927|NCT00704405|62966558|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
33570928|NCT00704405|62966559|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
33570929|NCT00704405|62966560|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
33302863|NCT01074190|62678700|FG000|Overall Study|Subject withdrew consent|1|||
33570930|NCT00704405|62966561|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
33570931|NCT00704405|62966557|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
33570932|NCT00704405|62966558|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
33570933|NCT00704405|62966559|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
33570934|NCT00704405|62966560|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
33570935|NCT00704405|62966561|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
33570936|NCT01534481|62966581|FG000|Overall Study|Lost to Follow-up|29|||
33570937|NCT01534481|62966582|FG001|Overall Study|Lost to Follow-up|24|||
33570938|NCT01534481|62966581|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
33570939|NCT01534481|62966582|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
33570940|NCT00704171|62966590|FG000|Overall Study|Withdrawal by Subject|1|||
33570941|NCT00704171|62966591|FG001|Overall Study|Withdrawal by Subject|0|||
33570942|NCT00703781|62966599|FG000|Overall Study|Withdrawal by Subject|1|||
33570943|NCT00703781|62966600|FG001|Overall Study|Withdrawal by Subject|2|||
33570944|NCT00703781|62966599|FG000|Overall Study|Cancelled surgery|1|||
33570945|NCT00703781|62966600|FG001|Overall Study|Cancelled surgery|0|||
33570946|NCT00703157|62966608|FG000|Overall Study|Lost to Follow-up|0|||
33570947|NCT00703157|62966609|FG001|Overall Study|Lost to Follow-up|1|||
33570948|NCT00703157|62966608|FG000|Overall Study|source data permanently lost/ other|4|||
33570949|NCT00703157|62966609|FG001|Overall Study|source data permanently lost/ other|1|||
33570950|NCT03307967|62966617|FG000|Overall Study|Lost to Follow-up|4|||
33570951|NCT02722967|62966624|FG000|Overall Study|Adverse Event|1|||
33570952|NCT02722967|62966625|FG001|Overall Study|Adverse Event|0|||
33570953|NCT02722967|62966626|FG002|Overall Study|Adverse Event|0|||
33570954|NCT02722967|62966624|FG000|Overall Study|Lost to Follow-up|0|||
33570955|NCT02722967|62966625|FG001|Overall Study|Lost to Follow-up|1|||
33570956|NCT02722967|62966626|FG002|Overall Study|Lost to Follow-up|0|||
33570957|NCT02722967|62966624|FG000|Overall Study|Non-compliance with patch wearing|2|||
33570958|NCT02722967|62966625|FG001|Overall Study|Non-compliance with patch wearing|1|||
33570959|NCT02722967|62966626|FG002|Overall Study|Non-compliance with patch wearing|1|||
33570960|NCT02722967|62966624|FG000|Overall Study|Withdrawal by Subject|1|||
33570961|NCT02722967|62966625|FG001|Overall Study|Withdrawal by Subject|0|||
33570962|NCT02722967|62966626|FG002|Overall Study|Withdrawal by Subject|1|||
33570963|NCT02722967|62966624|FG000|Overall Study|Physician Decision|1|||
33570964|NCT02722967|62966625|FG001|Overall Study|Physician Decision|0|||
33570965|NCT02722967|62966626|FG002|Overall Study|Physician Decision|0|||
33570966|NCT02722967|62966624|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
33570967|NCT02722967|62966625|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
33570968|NCT02722967|62966626|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
33570969|NCT02722499|62966637|FG000|Overall Study|Lost to Follow-up|2|||
33570970|NCT02722499|62966638|FG001|Overall Study|Lost to Follow-up|0|||
33570971|NCT02722499|62966639|FG002|Overall Study|Lost to Follow-up|1|||
33570972|NCT02721875|62966649|FG000|Overall Study|Progressive disease/relapse|1|||
33570973|NCT02721875|62966650|FG001|Overall Study|Progressive disease/relapse|0|||
33570974|NCT02721251|62966659|FG000|Overall Study|Withdrawal by Subject|8|||
33570975|NCT02721251|62966660|FG001|Overall Study|Withdrawal by Subject|7|||
33570976|NCT02721251|62966661|FG002|Overall Study|Withdrawal by Subject|9|||
33570977|NCT02721251|62966659|FG000|Overall Study|poor adherence|2|||
33570978|NCT02721251|62966660|FG001|Overall Study|poor adherence|2|||
33570979|NCT02721251|62966661|FG002|Overall Study|poor adherence|2|||
33570980|NCT00702221|62966672|FG000|Overall Study|Adverse Event|4|||
33570981|NCT00702221|62966673|FG001|Overall Study|Adverse Event|3|||
33570982|NCT00702143|62966682|FG000|Overall Study|Lost to Follow-up|0|||
33570983|NCT00702143|62966683|FG001|Overall Study|Lost to Follow-up|0|||
33570984|NCT00702143|62966684|FG002|Overall Study|Lost to Follow-up|1|||
33570985|NCT00702923|62966690|FG000|Overall Study|Adverse Event|1|||
33570986|NCT02633787|62966695|FG000|Overall Study|Withdrawal by Subject|1|||
33570987|NCT02719691|62966706|FG000|Overall Study|Physician Decision|0|||
33570988|NCT02719691|62966707|FG001|Overall Study|Physician Decision|0|||
33570989|NCT02719691|62966708|FG002|Overall Study|Physician Decision|1|||
33570990|NCT02719691|62966709|FG003|Overall Study|Physician Decision|0|||
33570991|NCT02719691|62966710|FG004|Overall Study|Physician Decision|0|||
33570992|NCT02719691|62966711|FG005|Overall Study|Physician Decision|0|||
33570993|NCT02719691|62966712|FG006|Overall Study|Physician Decision|0|||
33570994|NCT02719691|62966706|FG000|Overall Study|Withdrawal by Subject|0|||
33570995|NCT02719691|62966707|FG001|Overall Study|Withdrawal by Subject|0|||
33570996|NCT02719691|62966708|FG002|Overall Study|Withdrawal by Subject|0|||
33570997|NCT02719691|62966709|FG003|Overall Study|Withdrawal by Subject|0|||
33570998|NCT02719691|62966710|FG004|Overall Study|Withdrawal by Subject|0|||
33570999|NCT02719691|62966711|FG005|Overall Study|Withdrawal by Subject|1|||
33571000|NCT02719691|62966712|FG006|Overall Study|Withdrawal by Subject|0|||
33571001|NCT02720081|62966731|FG000|Overall Study|Adverse Event|0|||
33571002|NCT02720081|62966732|FG001|Overall Study|Adverse Event|3|||
33571003|NCT02720081|62966731|FG000|Overall Study|Protocol Violation|4|||
33571004|NCT02720081|62966732|FG001|Overall Study|Protocol Violation|1|||
33571005|NCT04248933|62966738|FG000|Overall Study|Lost to Follow-up|9|||
33571006|NCT04248933|62966738|FG000|Overall Study|Withdrawal by Subject|2|||
33571007|NCT02718131|62966744|FG000|Overall Study|Withdrawal by Subject|1|||
33571008|NCT02718131|62966745|FG001|Overall Study|Withdrawal by Subject|0|||
33571009|NCT02718131|62966744|FG000|Overall Study|Adverse Event|1|||
33571010|NCT02718131|62966745|FG001|Overall Study|Adverse Event|0|||
33571011|NCT02718131|62966744|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
33571012|NCT02718131|62966745|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
33571013|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
33571014|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
33571015|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
33571016|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
33571017|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
33571018|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
33571019|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
33571020|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
33571021|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
33571022|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
33571023|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
33571024|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
33571025|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
33571026|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
33571027|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
33571028|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
33571029|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
33571030|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
33571031|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
33571032|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
33571033|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
33571034|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
33571035|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
33571036|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
33571037|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
33571038|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
33571039|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
33571040|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
33571041|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
33571042|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
33571043|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
33571044|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
33571045|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
33571046|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
33571047|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
33571048|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
33571049|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
33571050|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
33571051|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
33571052|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
33571053|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
33571054|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
33571055|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
33571056|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
33571057|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
33571058|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
33571059|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
33571060|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
33571061|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
33571062|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
33571063|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
33571064|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
33571065|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
33571066|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
33571067|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
33571068|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
33571069|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
33571070|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
33571071|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
33571072|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
33571073|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
33571074|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
33396742|NCT00308581|62775992|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
33396743|NCT00308581|62775993|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
33396744|NCT00308581|62775994|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
33571075|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
33571076|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
33571077|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
33571078|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
33571079|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
33571080|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
33571081|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
33571082|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
33571083|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
33571084|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
33571085|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
33571086|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
33571087|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
33571088|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
33571089|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
33571090|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
33571091|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
33571092|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
33571093|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
33571094|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
33571095|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
33571096|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
33571097|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
33571098|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
33571099|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
33571100|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
33571101|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
33571102|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
33571103|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
33571104|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
33571105|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
33571106|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
33571107|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
33571108|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
33571109|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
33571110|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
33571111|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
33571112|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
33571113|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
33571114|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
33571115|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
33571116|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
33571117|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
33571118|NCT02717195|62966780|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
33571119|NCT02717195|62966781|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
33571120|NCT02717195|62966782|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
33571121|NCT02717195|62966783|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
33571122|NCT02717195|62966784|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
33571123|NCT02717195|62966780|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
33396745|NCT00308581|62775992|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
33396746|NCT00308581|62775993|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
33571124|NCT02717195|62966781|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
33571125|NCT02717195|62966782|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
33571126|NCT02717195|62966783|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
33571127|NCT02717195|62966784|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
33571128|NCT02717195|62966780|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
33571129|NCT02717195|62966781|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
33571130|NCT02717195|62966782|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
33571131|NCT02717195|62966783|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
33571132|NCT02717195|62966784|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
33571133|NCT02717195|62966780|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
33396747|NCT00308581|62775994|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
33571134|NCT02717195|62966781|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
33571135|NCT02717195|62966782|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
33571136|NCT02717195|62966783|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
33571137|NCT02717195|62966784|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
33571138|NCT02717195|62966780|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
33571139|NCT02717195|62966781|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
33571140|NCT02717195|62966782|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
33571141|NCT02717195|62966783|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
33571142|NCT02717195|62966784|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
33571143|NCT02717195|62966780|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
33571144|NCT02717195|62966781|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
33571145|NCT02717195|62966782|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
33571146|NCT02717195|62966783|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
33571147|NCT02717195|62966784|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
33571148|NCT02717195|62966780|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
33571149|NCT02717195|62966781|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
33571150|NCT02717195|62966782|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
33571151|NCT02717195|62966783|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
33571152|NCT02717195|62966784|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
33571153|NCT02717195|62966780|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
33571154|NCT02717195|62966781|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
33571155|NCT02717195|62966782|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
33571156|NCT02717195|62966783|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
33571157|NCT02717195|62966784|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
33571158|NCT02717195|62966780|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
33571159|NCT02717195|62966781|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
33571160|NCT02717195|62966782|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
33571161|NCT02717195|62966783|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
33571162|NCT02717195|62966784|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
33571163|NCT02717195|62966780|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
33571164|NCT02717195|62966781|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
33571165|NCT02717195|62966782|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
33571166|NCT02717195|62966783|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
33571167|NCT02717195|62966784|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
33571168|NCT02717195|62966780|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
33571169|NCT02717195|62966781|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
33571170|NCT02717195|62966782|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
33571171|NCT02717195|62966783|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
33571172|NCT02717195|62966784|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
33571173|NCT02717195|62966780|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
33571174|NCT02717195|62966781|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
33571175|NCT02717195|62966782|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
33571176|NCT02717195|62966783|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
33571177|NCT02717195|62966784|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
33571178|NCT02717195|62966780|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
33571179|NCT02717195|62966781|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
33571180|NCT02717195|62966782|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
33571181|NCT02717195|62966783|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
33571182|NCT02717195|62966784|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
33571183|NCT02717195|62966780|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
33571184|NCT02717195|62966781|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
33571185|NCT02717195|62966782|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
33571186|NCT02717195|62966783|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
33571187|NCT02717195|62966784|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
33571188|NCT02717195|62966780|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
33571189|NCT02717195|62966781|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
33571190|NCT02717195|62966782|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
33571191|NCT02717195|62966783|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
33571192|NCT02717195|62966784|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
33571193|NCT00701441|62966799|FG000|Overall Study|failure in cpap compliance|0|||
33571194|NCT00701441|62966800|FG001|Overall Study|failure in cpap compliance|4|||
33571195|NCT02628873|62966812|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
33571196|NCT02628873|62966813|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
33571197|NCT02628873|62966812|FG000|Second Test (1 Hour)|Physician Decision|1|||
33571198|NCT02628873|62966813|FG001|Second Test (1 Hour)|Physician Decision|0|||
33571199|NCT02629965|62966823|FG000|Period 1|Adverse Event|1|||
33571200|NCT02629965|62966824|FG001|Period 1|Adverse Event|0|||
33571201|NCT02629965|62966823|FG000|Period 1|Unexpected worsening of disease|2|||
33571202|NCT02629965|62966824|FG001|Period 1|Unexpected worsening of disease|0|||
33571203|NCT02629965|62966823|FG000|Period 1|Other than listed above|1|||
33571204|NCT02629965|62966824|FG001|Period 1|Other than listed above|2|||
33571205|NCT02629965|62966823|FG000|Period 2|Adverse Event|1|||
33571206|NCT02629965|62966824|FG001|Period 2|Adverse Event|0|||
33571207|NCT01671111|62966830|FG000|Overall Study|Adverse Event|2|||
33571208|NCT01671111|62966830|FG000|Overall Study|Lack of Efficacy|1|||
33571209|NCT01671111|62966830|FG000|Overall Study|Withdrawal by Subject|2|||
33571210|NCT01671111|62966830|FG000|Overall Study|Physician Decision|1|||
33571211|NCT01671111|62966830|FG000|Overall Study|Other|24|||
33571212|NCT01671345|62966836|FG000|Overall Study|Lost to Follow-up|10|||
33571213|NCT01671345|62966837|FG001|Overall Study|Lost to Follow-up|6|||
33571214|NCT01671345|62966836|FG000|Overall Study|visit with non-participating physician|3|||
33571215|NCT01671345|62966837|FG001|Overall Study|visit with non-participating physician|3|||
33571216|NCT04338321|62966859|FG000|Overall Study|Adverse Event|4|||
33571217|NCT04338321|62966860|FG001|Overall Study|Adverse Event|10|||
33571218|NCT04338321|62966859|FG000|Overall Study|Death|1|||
33571219|NCT04338321|62966860|FG001|Overall Study|Death|1|||
33571220|NCT04338321|62966859|FG000|Overall Study|Lost to Follow-up|4|||
33571221|NCT04338321|62966860|FG001|Overall Study|Lost to Follow-up|9|||
33571222|NCT04338321|62966859|FG000|Overall Study|Withdrawal by Subject|45|||
33571223|NCT04338321|62966860|FG001|Overall Study|Withdrawal by Subject|69|||
33571224|NCT04338321|62966859|FG000|Overall Study|Physician Decision|5|||
33571225|NCT04338321|62966860|FG001|Overall Study|Physician Decision|9|||
33571226|NCT04338321|62966859|FG000|Overall Study|Other|3|||
33571227|NCT04338321|62966860|FG001|Overall Study|Other|10|||
33571228|NCT02487095|62966876|FG000|Dose Expansion|Unable to scan/restage participant|0|||
33571229|NCT02487095|62966877|FG001|Dose Expansion|Unable to scan/restage participant|0|||
33571230|NCT02487095|62966878|FG002|Dose Expansion|Unable to scan/restage participant|0|||
33571231|NCT02487095|62966879|FG003|Dose Expansion|Unable to scan/restage participant|0|||
33571232|NCT02487095|62966880|FG004|Dose Expansion|Unable to scan/restage participant|1|||
33571233|NCT03855137|62966903|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
33571234|NCT03855137|62966904|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
33571235|NCT03855137|62966905|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
33571236|NCT03855137|62966903|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
33571237|NCT03855137|62966904|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
33571238|NCT03855137|62966905|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
33571239|NCT03855137|62966903|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
33571240|NCT03855137|62966904|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
33571241|NCT03855137|62966905|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
33571242|NCT03855137|62966903|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
33571243|NCT03855137|62966904|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
33571244|NCT03855137|62966905|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
33571245|NCT03855137|62966903|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
33571246|NCT03855137|62966904|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
33571247|NCT03855137|62966905|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
33571248|NCT03855137|62966903|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
33571249|NCT03855137|62966904|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
33571250|NCT03855137|62966905|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
33571251|NCT03855137|62966903|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
33571252|NCT03855137|62966904|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
33571253|NCT03855137|62966905|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
33571254|NCT03855137|62966903|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
33571255|NCT03855137|62966904|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
33571256|NCT03855137|62966905|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
33571257|NCT03855137|62966903|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
33571258|NCT03855137|62966904|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
33571259|NCT03855137|62966905|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
33571260|NCT03855137|62966903|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
33571261|NCT03855137|62966904|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
33571262|NCT03855137|62966905|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
33302864|NCT01074190|62678701|FG001|Overall Study|Subject withdrew consent|1|||
33302865|NCT01074190|62678702|FG002|Overall Study|Subject withdrew consent|1|||
33571263|NCT00701363|62966927|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
33664311|NCT02674854|63095343|FG001|Overall Study|Adverse Event|15|||
33302866|NCT01073566|62678715|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
33664312|NCT02674854|63095344|FG002|Overall Study|Adverse Event|5|||
33664313|NCT02674854|63095342|FG000|Overall Study|Withdrawal by Subject|1|||
33571264|NCT00701363|62966928|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
33571265|NCT00701363|62966929|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
33571266|NCT00701363|62966930|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
33571267|NCT00701363|62966927|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
33571268|NCT00701363|62966928|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
33571269|NCT00701363|62966929|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
33571270|NCT00701363|62966930|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
33571271|NCT00701363|62966927|FG000|Treatment Phase 1|Adverse Event|7|||
33571272|NCT00701363|62966928|FG001|Treatment Phase 1|Adverse Event|0|||
33571273|NCT00701363|62966929|FG002|Treatment Phase 1|Adverse Event|0|||
33571274|NCT00701363|62966930|FG003|Treatment Phase 1|Adverse Event|0|||
33571275|NCT00701363|62966927|FG000|Treatment Phase 1|Protocol Violation|1|||
33571276|NCT00701363|62966928|FG001|Treatment Phase 1|Protocol Violation|0|||
33571277|NCT00701363|62966929|FG002|Treatment Phase 1|Protocol Violation|0|||
33571278|NCT00701363|62966930|FG003|Treatment Phase 1|Protocol Violation|0|||
33571279|NCT00701363|62966927|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
33571280|NCT00701363|62966928|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
33571281|NCT00701363|62966929|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
33571282|NCT00701363|62966930|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
33571283|NCT00701363|62966927|FG000|Treatment Phase 1|Lack of Efficacy|1|||
33571284|NCT00701363|62966928|FG001|Treatment Phase 1|Lack of Efficacy|0|||
33571285|NCT00701363|62966929|FG002|Treatment Phase 1|Lack of Efficacy|0|||
33571286|NCT00701363|62966930|FG003|Treatment Phase 1|Lack of Efficacy|0|||
33571287|NCT00701363|62966927|FG000|Treatment Phase 2|Adverse Event|0|||
33571288|NCT00701363|62966928|FG001|Treatment Phase 2|Adverse Event|0|||
33571289|NCT00701363|62966929|FG002|Treatment Phase 2|Adverse Event|1|||
33571290|NCT00701363|62966930|FG003|Treatment Phase 2|Adverse Event|0|||
33571291|NCT00701363|62966927|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
33571292|NCT00701363|62966928|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
33571293|NCT00701363|62966929|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
33571294|NCT00701363|62966930|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
33571295|NCT01670877|62966954|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
33571296|NCT01670877|62966955|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
33571297|NCT01670877|62966956|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
33571298|NCT01670877|62966957|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
33571299|NCT01670877|62966958|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
33571300|NCT01670877|62966959|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
33571301|NCT01670877|62966954|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
33571302|NCT01670877|62966955|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
33571303|NCT01670877|62966956|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
33571304|NCT01670877|62966957|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
33571305|NCT01670877|62966958|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
33571306|NCT01670877|62966959|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
33571307|NCT01670877|62966954|FG000|Part I and Part 2|Grade 2 vomiting|0|||
33571308|NCT01670877|62966955|FG001|Part I and Part 2|Grade 2 vomiting|0|||
33571309|NCT01670877|62966956|FG002|Part I and Part 2|Grade 2 vomiting|0|||
33571310|NCT01670877|62966957|FG003|Part I and Part 2|Grade 2 vomiting|1|||
33571311|NCT01670877|62966958|FG004|Part I and Part 2|Grade 2 vomiting|0|||
33571312|NCT01670877|62966959|FG005|Part I and Part 2|Grade 2 vomiting|0|||
33571313|NCT01670877|62966954|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
33571314|NCT01670877|62966955|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
33571315|NCT01670877|62966956|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
33571316|NCT01670877|62966957|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
33571317|NCT01670877|62966958|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
33571318|NCT01670877|62966959|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
33571319|NCT01670877|62966954|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
33571320|NCT01670877|62966955|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
33571321|NCT01670877|62966956|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
33571322|NCT01670877|62966957|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
33571323|NCT01670877|62966958|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
33571324|NCT01670877|62966959|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
33571325|NCT00701129|62966973|FG000|Overall Study|Death|2|||
33571326|NCT01670721|62966977|FG000|Overall Study|Participant's decision|15|||
33571327|NCT01670721|62966977|FG000|Overall Study|Other than specified above|38|||
33396748|NCT00308581|62775992|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
33571328|NCT02711137|62966996|FG000|Overall Study|Death|1|||
33571329|NCT02711137|62966997|FG001|Overall Study|Death|4|||
33571330|NCT02711137|62966998|FG002|Overall Study|Death|5|||
33571331|NCT02711137|62966999|FG003|Overall Study|Death|5|||
33571332|NCT02711137|62967000|FG004|Overall Study|Death|3|||
33664314|NCT02674854|63095343|FG001|Overall Study|Withdrawal by Subject|5|||
33571333|NCT02711137|62967001|FG005|Overall Study|Death|1|||
33571334|NCT02711137|62967002|FG006|Overall Study|Death|61|||
33571335|NCT02711137|62967003|FG007|Overall Study|Death|3|||
33571336|NCT02711137|62967004|FG008|Overall Study|Death|0|||
33571337|NCT02711137|62967005|FG009|Overall Study|Death|1|||
33571338|NCT02711137|62967006|FG010|Overall Study|Death|1|||
33571339|NCT02711137|62967007|FG011|Overall Study|Death|1|||
33571340|NCT02711137|62967008|FG012|Overall Study|Death|0|||
33571341|NCT02711137|62967009|FG013|Overall Study|Death|0|||
33571342|NCT02711137|62967010|FG014|Overall Study|Death|0|||
33571343|NCT02711137|62966996|FG000|Overall Study|Study Terminated by Sponsor|0|||
33571344|NCT02711137|62966997|FG001|Overall Study|Study Terminated by Sponsor|0|||
33571345|NCT02711137|62966998|FG002|Overall Study|Study Terminated by Sponsor|1|||
33571346|NCT02711137|62966999|FG003|Overall Study|Study Terminated by Sponsor|0|||
33571347|NCT02711137|62967000|FG004|Overall Study|Study Terminated by Sponsor|0|||
33571348|NCT02711137|62967001|FG005|Overall Study|Study Terminated by Sponsor|0|||
33571349|NCT02711137|62967002|FG006|Overall Study|Study Terminated by Sponsor|1|||
33571350|NCT02711137|62967003|FG007|Overall Study|Study Terminated by Sponsor|0|||
33571351|NCT02711137|62967004|FG008|Overall Study|Study Terminated by Sponsor|0|||
33571352|NCT02711137|62967005|FG009|Overall Study|Study Terminated by Sponsor|0|||
33571353|NCT02711137|62967006|FG010|Overall Study|Study Terminated by Sponsor|0|||
33571354|NCT02711137|62967007|FG011|Overall Study|Study Terminated by Sponsor|0|||
33571355|NCT02711137|62967008|FG012|Overall Study|Study Terminated by Sponsor|0|||
33571356|NCT02711137|62967009|FG013|Overall Study|Study Terminated by Sponsor|0|||
33571357|NCT02711137|62967010|FG014|Overall Study|Study Terminated by Sponsor|0|||
33571358|NCT02711137|62966996|FG000|Overall Study|Physician Decision|1|||
33571359|NCT02711137|62966997|FG001|Overall Study|Physician Decision|0|||
33571360|NCT02711137|62966998|FG002|Overall Study|Physician Decision|2|||
33571361|NCT02711137|62966999|FG003|Overall Study|Physician Decision|1|||
33571362|NCT02711137|62967000|FG004|Overall Study|Physician Decision|1|||
33571363|NCT02711137|62967001|FG005|Overall Study|Physician Decision|0|||
33571364|NCT02711137|62967002|FG006|Overall Study|Physician Decision|12|||
33571365|NCT02711137|62967003|FG007|Overall Study|Physician Decision|2|||
33571366|NCT02711137|62967004|FG008|Overall Study|Physician Decision|1|||
33571367|NCT02711137|62967005|FG009|Overall Study|Physician Decision|1|||
33571368|NCT02711137|62967006|FG010|Overall Study|Physician Decision|3|||
33571369|NCT02711137|62967007|FG011|Overall Study|Physician Decision|2|||
33571370|NCT02711137|62967008|FG012|Overall Study|Physician Decision|1|||
33571371|NCT02711137|62967009|FG013|Overall Study|Physician Decision|1|||
33571372|NCT02711137|62967010|FG014|Overall Study|Physician Decision|2|||
33571373|NCT02711137|62966996|FG000|Overall Study|Other|0|||
33571374|NCT02711137|62966997|FG001|Overall Study|Other|1|||
33571375|NCT02711137|62966998|FG002|Overall Study|Other|0|||
33571376|NCT02711137|62966999|FG003|Overall Study|Other|0|||
33571377|NCT02711137|62967000|FG004|Overall Study|Other|0|||
33571378|NCT02711137|62967001|FG005|Overall Study|Other|0|||
33571379|NCT02711137|62967002|FG006|Overall Study|Other|3|||
33571380|NCT02711137|62967003|FG007|Overall Study|Other|0|||
33571381|NCT02711137|62967004|FG008|Overall Study|Other|0|||
33571382|NCT02711137|62967005|FG009|Overall Study|Other|0|||
33571383|NCT02711137|62967006|FG010|Overall Study|Other|0|||
33571384|NCT02711137|62967007|FG011|Overall Study|Other|0|||
33571385|NCT02711137|62967008|FG012|Overall Study|Other|0|||
33571386|NCT02711137|62967009|FG013|Overall Study|Other|0|||
33571387|NCT02711137|62967010|FG014|Overall Study|Other|1|||
33571388|NCT02711137|62966996|FG000|Overall Study|Withdrawal by Subject|1|||
33571389|NCT02711137|62966997|FG001|Overall Study|Withdrawal by Subject|0|||
33571390|NCT02711137|62966998|FG002|Overall Study|Withdrawal by Subject|0|||
33571391|NCT02711137|62966999|FG003|Overall Study|Withdrawal by Subject|1|||
33571392|NCT02711137|62967000|FG004|Overall Study|Withdrawal by Subject|1|||
33571393|NCT02711137|62967001|FG005|Overall Study|Withdrawal by Subject|0|||
33571394|NCT02711137|62967002|FG006|Overall Study|Withdrawal by Subject|7|||
33571395|NCT02711137|62967003|FG007|Overall Study|Withdrawal by Subject|0|||
33571396|NCT02711137|62967004|FG008|Overall Study|Withdrawal by Subject|0|||
33571397|NCT02711137|62967005|FG009|Overall Study|Withdrawal by Subject|0|||
33571398|NCT02711137|62967006|FG010|Overall Study|Withdrawal by Subject|0|||
33571399|NCT02711137|62967007|FG011|Overall Study|Withdrawal by Subject|0|||
33571400|NCT02711137|62967008|FG012|Overall Study|Withdrawal by Subject|0|||
33571401|NCT02711137|62967009|FG013|Overall Study|Withdrawal by Subject|1|||
33571402|NCT02711137|62967010|FG014|Overall Study|Withdrawal by Subject|0|||
33571403|NCT02711137|62966996|FG000|Overall Study|Lost to Follow-up|1|||
33571404|NCT02711137|62966997|FG001|Overall Study|Lost to Follow-up|0|||
33571405|NCT02711137|62966998|FG002|Overall Study|Lost to Follow-up|0|||
33571406|NCT02711137|62966999|FG003|Overall Study|Lost to Follow-up|0|||
33571407|NCT02711137|62967000|FG004|Overall Study|Lost to Follow-up|0|||
33571408|NCT02711137|62967001|FG005|Overall Study|Lost to Follow-up|0|||
33571409|NCT02711137|62967002|FG006|Overall Study|Lost to Follow-up|2|||
33571410|NCT02711137|62967003|FG007|Overall Study|Lost to Follow-up|0|||
33571411|NCT02711137|62967004|FG008|Overall Study|Lost to Follow-up|0|||
33571412|NCT02711137|62967005|FG009|Overall Study|Lost to Follow-up|0|||
33571413|NCT02711137|62967006|FG010|Overall Study|Lost to Follow-up|0|||
33571414|NCT02711137|62967007|FG011|Overall Study|Lost to Follow-up|0|||
33571415|NCT02711137|62967008|FG012|Overall Study|Lost to Follow-up|0|||
33571416|NCT02711137|62967009|FG013|Overall Study|Lost to Follow-up|0|||
33571417|NCT02711137|62967010|FG014|Overall Study|Lost to Follow-up|0|||
33571418|NCT02710045|62967050|FG000|Overall Study|Death|1|||
33571419|NCT02710045|62967051|FG001|Overall Study|Death|2|||
33571420|NCT02710045|62967052|FG002|Overall Study|Death|0|||
33571421|NCT02710045|62967050|FG000|Overall Study|Withdrawal by Subject|6|||
33571422|NCT02710045|62967051|FG001|Overall Study|Withdrawal by Subject|6|||
33571423|NCT02710045|62967052|FG002|Overall Study|Withdrawal by Subject|2|||
33571424|NCT02710045|62967050|FG000|Overall Study|Protocol Violation|1|||
33571425|NCT02710045|62967051|FG001|Overall Study|Protocol Violation|2|||
33571426|NCT02710045|62967052|FG002|Overall Study|Protocol Violation|3|||
33571427|NCT02710045|62967050|FG000|Overall Study|Lost to Follow-up|3|||
33571428|NCT02710045|62967051|FG001|Overall Study|Lost to Follow-up|6|||
33571429|NCT02710045|62967052|FG002|Overall Study|Lost to Follow-up|7|||
33571430|NCT02710045|62967050|FG000|Overall Study|Physician Decision|0|||
33571431|NCT02710045|62967051|FG001|Overall Study|Physician Decision|0|||
33571432|NCT02710045|62967052|FG002|Overall Study|Physician Decision|1|||
33571433|NCT02710045|62967050|FG000|Overall Study|Poor Attendance|0|||
33571434|NCT02710045|62967051|FG001|Overall Study|Poor Attendance|1|||
33571435|NCT02710045|62967052|FG002|Overall Study|Poor Attendance|0|||
33571436|NCT02714153|62967060|FG000|Overall Study|Death|1|||
33571437|NCT04369469|62967066|FG000|Overall Study|Lost to Follow-up|2|||
33571438|NCT04369469|62967067|FG001|Overall Study|Lost to Follow-up|4|||
33571439|NCT04369469|62967066|FG000|Overall Study|Physician Decision|2|||
33571440|NCT04369469|62967067|FG001|Overall Study|Physician Decision|1|||
33571441|NCT04369469|62967066|FG000|Overall Study|Withdrawal by Subject|2|||
33571442|NCT04369469|62967067|FG001|Overall Study|Withdrawal by Subject|3|||
33571443|NCT04369469|62967066|FG000|Overall Study|Adverse Event|1|||
33571444|NCT04369469|62967067|FG001|Overall Study|Adverse Event|0|||
33571445|NCT04369469|62967066|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
33571446|NCT04369469|62967067|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
33571447|NCT04369469|62967066|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
33571448|NCT04369469|62967067|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
33571449|NCT04369469|62967066|FG000|Overall Study|Unable to Provide Consent|0|||
33571450|NCT04369469|62967067|FG001|Overall Study|Unable to Provide Consent|1|||
33571451|NCT01670097|62967088|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
33571452|NCT01670097|62967089|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
33571453|NCT01670097|62967088|FG000|Overall Study|Study burden|1|||
33571454|NCT01670097|62967089|FG001|Overall Study|Study burden|0|||
33571455|NCT01670097|62967088|FG000|Overall Study|COPD exacerbation|0|||
33571456|NCT01670097|62967089|FG001|Overall Study|COPD exacerbation|1|||
33571457|NCT01670097|62967088|FG000|Overall Study|Neutropenia|0|||
33571458|NCT01670097|62967089|FG001|Overall Study|Neutropenia|1|||
33571459|NCT01670097|62967088|FG000|Overall Study|Clinical deterioration|0|||
33571460|NCT01670097|62967089|FG001|Overall Study|Clinical deterioration|1|||
33571461|NCT01670097|62967088|FG000|Overall Study|Disease progression|0|||
33571462|NCT01670097|62967089|FG001|Overall Study|Disease progression|1|||
33571463|NCT01670019|62967097|FG000|Overall Study|Adverse Event|3|||
33571464|NCT01670019|62967098|FG001|Overall Study|Adverse Event|0|||
33571465|NCT01670019|62967097|FG000|Overall Study|Withdrawal by Subject|6|||
33571466|NCT01670019|62967098|FG001|Overall Study|Withdrawal by Subject|0|||
33571467|NCT01669629|62967104|FG000|Period 1|protocol deviation|1|||
33571468|NCT01669629|62967105|FG001|Period 1|protocol deviation|2|||
33571469|NCT00701051|62967113|FG000|Screening|Failed Screening|40|||
33571470|NCT00701051|62967114|FG001|Screening|Failed Screening|0|||
33571471|NCT00701051|62967115|FG002|Screening|Failed Screening|0|||
33571472|NCT00701051|62967113|FG000|Screening|Time conflicts|19|||
33571473|NCT00701051|62967114|FG001|Screening|Time conflicts|0|||
33571474|NCT00701051|62967115|FG002|Screening|Time conflicts|0|||
33571475|NCT00701051|62967113|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
33571476|NCT00701051|62967114|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
33571477|NCT00701051|62967115|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
33571478|NCT00700817|62967126|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
33571479|NCT00700817|62967127|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
33571480|NCT00700817|62967128|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
33571481|NCT00700817|62967129|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
33664315|NCT02674854|63095344|FG002|Overall Study|Withdrawal by Subject|4|||
33664316|NCT02674854|63095342|FG000|Overall Study|No-compliant subject|1|||
33571482|NCT00700817|62967130|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
33571483|NCT00700817|62967126|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
33571484|NCT00700817|62967127|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
33571485|NCT00700817|62967128|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
33571486|NCT00700817|62967129|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
33571487|NCT00700817|62967130|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
33664317|NCT02674854|63095343|FG001|Overall Study|No-compliant subject|0|||
33302867|NCT01073566|62678716|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
33571488|NCT00700817|62967126|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
33571489|NCT00700817|62967127|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
33571490|NCT00700817|62967128|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
33571491|NCT00700817|62967129|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
33571492|NCT00700817|62967130|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
33571493|NCT00700817|62967126|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
33571494|NCT00700817|62967127|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
33571495|NCT00700817|62967128|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
33571496|NCT00700817|62967129|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
33571497|NCT00700817|62967130|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
33571498|NCT00700817|62967126|FG000|Week 0-26 (Main Period)|Unclassified|14|||
33571499|NCT00700817|62967127|FG001|Week 0-26 (Main Period)|Unclassified|4|||
33571500|NCT00700817|62967128|FG002|Week 0-26 (Main Period)|Unclassified|8|||
33571501|NCT00700817|62967129|FG003|Week 0-26 (Main Period)|Unclassified|0|||
33571502|NCT00700817|62967130|FG004|Week 0-26 (Main Period)|Unclassified|0|||
33571503|NCT00700817|62967126|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
33571504|NCT00700817|62967127|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
33571505|NCT00700817|62967128|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
33571506|NCT00700817|62967129|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
33571507|NCT00700817|62967130|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
33571508|NCT00700817|62967126|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
33571509|NCT00700817|62967127|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
33571510|NCT00700817|62967128|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
33571511|NCT00700817|62967129|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
33571512|NCT00700817|62967130|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
33571513|NCT00700817|62967126|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
33571514|NCT00700817|62967127|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
33571515|NCT00700817|62967128|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
33571516|NCT00700817|62967129|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
33571517|NCT00700817|62967130|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
33571518|NCT00700817|62967126|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
33571519|NCT00700817|62967127|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
33571520|NCT00700817|62967128|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
33571521|NCT00700817|62967129|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
33571522|NCT00700817|62967130|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
33571523|NCT00700817|62967126|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
33571524|NCT00700817|62967127|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
33571525|NCT00700817|62967128|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
33571526|NCT00700817|62967129|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
33571527|NCT00700817|62967130|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
33571528|NCT00700817|62967126|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
33571529|NCT00700817|62967127|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
33571530|NCT00700817|62967128|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
33571531|NCT00700817|62967129|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
33571532|NCT00700817|62967130|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
33571533|NCT00700817|62967126|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
33571534|NCT00700817|62967127|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
33571535|NCT00700817|62967128|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
33571536|NCT00700817|62967129|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
33571537|NCT00700817|62967130|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
33571538|NCT00700817|62967126|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
33571539|NCT00700817|62967127|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
33571540|NCT00700817|62967128|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
33571541|NCT00700817|62967129|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
33571542|NCT00700817|62967130|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
33571543|NCT00700817|62967126|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
33571544|NCT00700817|62967127|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
33571545|NCT00700817|62967128|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
33571546|NCT00700817|62967129|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
33571547|NCT00700817|62967130|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
33571548|NCT00700817|62967126|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
33571549|NCT00700817|62967127|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
33571550|NCT00700817|62967128|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
33571551|NCT00700817|62967129|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
33571552|NCT00700817|62967130|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
33571553|NCT02625909|62967142|FG000|Overall Study|Death|2|||
33664318|NCT02674854|63095344|FG002|Overall Study|No-compliant subject|1|||
33664319|NCT02674854|63095342|FG000|Overall Study|Lost to Follow-up|1|||
33664320|NCT02674854|63095343|FG001|Overall Study|Lost to Follow-up|0|||
33664321|NCT02674854|63095344|FG002|Overall Study|Lost to Follow-up|2|||
33571554|NCT02625909|62967143|FG001|Overall Study|Death|0|||
33571555|NCT02625909|62967142|FG000|Overall Study|Lost to Follow-up|3|||
33571556|NCT02625909|62967143|FG001|Overall Study|Lost to Follow-up|5|||
33571557|NCT02625909|62967142|FG000|Overall Study|Lack of Efficacy|9|||
33571558|NCT02625909|62967143|FG001|Overall Study|Lack of Efficacy|2|||
33571559|NCT02625909|62967142|FG000|Overall Study|Reinfection|3|||
33571560|NCT02625909|62967143|FG001|Overall Study|Reinfection|2|||
33571561|NCT02623959|62967151|FG000|Overall Study|Progression|0|||
33571562|NCT02623959|62967152|FG001|Overall Study|Progression|1|||
33571563|NCT00700739|62967162|FG000|Overall Study|Lost to Follow-up|4|||
33571564|NCT00700739|62967163|FG001|Overall Study|Lost to Follow-up|4|||
33571565|NCT02623335|62967172|FG000|Overall Study|Death|8|||
33571566|NCT02623335|62967173|FG001|Overall Study|Death|7|||
33571567|NCT02623335|62967172|FG000|Overall Study|Lost to Follow-up|15|||
33571568|NCT02623335|62967173|FG001|Overall Study|Lost to Follow-up|23|||
33571569|NCT02623335|62967172|FG000|Overall Study|Withdrawal by Subject|2|||
33571570|NCT02623335|62967173|FG001|Overall Study|Withdrawal by Subject|5|||
33571571|NCT02623335|62967172|FG000|Overall Study|Protocol Violation|2|||
33571572|NCT02623335|62967173|FG001|Overall Study|Protocol Violation|1|||
33571573|NCT00700427|62967183|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
33571574|NCT00700427|62967184|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
33571575|NCT00700427|62967185|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
33571576|NCT00700427|62967186|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
33571577|NCT00700427|62967187|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
33571578|NCT00700427|62967183|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
33571579|NCT00700427|62967184|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
33571580|NCT00700427|62967185|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
33571581|NCT00700427|62967186|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
33571582|NCT00700427|62967187|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
33571583|NCT00700427|62967183|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
33571584|NCT00700427|62967184|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
33571585|NCT00700427|62967185|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
33571586|NCT00700427|62967186|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
33571587|NCT00700427|62967187|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
33571588|NCT00700427|62967183|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
33571589|NCT00700427|62967184|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
33571590|NCT00700427|62967185|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
33571591|NCT00700427|62967186|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
33571592|NCT00700427|62967187|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
33571593|NCT00700427|62967183|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
33571594|NCT00700427|62967184|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
33571595|NCT00700427|62967185|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
33571596|NCT00700427|62967186|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
33571597|NCT00700427|62967187|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
33571598|NCT00700427|62967183|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
33571599|NCT00700427|62967184|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
33396749|NCT00308581|62775993|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
33396750|NCT00308581|62775994|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
33396751|NCT00308581|62775992|FG000|Randomized Maintenance Phase|Unknown reason|3|||
33571600|NCT00700427|62967185|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
33571601|NCT00700427|62967186|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
33571602|NCT00700427|62967187|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
33571603|NCT00700427|62967183|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
33571604|NCT00700427|62967184|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
33571605|NCT00700427|62967185|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
33571606|NCT00700427|62967186|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
33571607|NCT00700427|62967187|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
33571608|NCT00700427|62967183|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
33571609|NCT00700427|62967184|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
33571610|NCT00700427|62967185|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
33571611|NCT00700427|62967186|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
33571612|NCT00700427|62967187|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
33571613|NCT00700427|62967183|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
33571614|NCT00700427|62967184|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
33571615|NCT00700427|62967185|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
33571616|NCT00700427|62967186|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
33571617|NCT00700427|62967187|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
33571618|NCT00700427|62967183|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
33571619|NCT00700427|62967184|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
33571620|NCT00700427|62967185|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
33571621|NCT00700427|62967186|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
33571622|NCT00700427|62967187|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
33571623|NCT00700427|62967183|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
33571624|NCT00700427|62967184|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
33571625|NCT00700427|62967185|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
33571626|NCT00700427|62967186|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
33571627|NCT00700427|62967187|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
33571628|NCT00700427|62967183|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
33571629|NCT00700427|62967184|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
33571630|NCT00700427|62967185|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
33571631|NCT00700427|62967186|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
33571632|NCT00700427|62967187|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
33571633|NCT00700427|62967183|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
33571634|NCT00700427|62967184|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
33571635|NCT00700427|62967185|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
33571636|NCT00700427|62967186|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
33571637|NCT00700427|62967187|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
33571638|NCT00700427|62967183|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
33571639|NCT00700427|62967184|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
33571640|NCT00700427|62967185|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
33571641|NCT00700427|62967186|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
33571642|NCT00700427|62967187|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
33571643|NCT00700427|62967183|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
33571644|NCT00700427|62967184|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
33571645|NCT00700427|62967185|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
33571646|NCT00700427|62967186|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
33571647|NCT00700427|62967187|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
33571648|NCT00700427|62967183|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
33571649|NCT00700427|62967184|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
33571650|NCT00700427|62967185|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
33571651|NCT00700427|62967186|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
33571652|NCT00700427|62967187|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
33571653|NCT00700427|62967183|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
33571654|NCT00700427|62967184|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
33571655|NCT00700427|62967185|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
33571656|NCT00700427|62967186|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
33571657|NCT00700427|62967187|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
33571658|NCT00700427|62967183|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
33571659|NCT00700427|62967184|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
33571660|NCT00700427|62967185|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
33571661|NCT00700427|62967186|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
33571662|NCT00700427|62967187|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
33571663|NCT00700427|62967183|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
33571664|NCT00700427|62967184|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
33571665|NCT00700427|62967185|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
33571666|NCT00700427|62967186|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
33571667|NCT00700427|62967187|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
33571668|NCT00700427|62967183|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
33571669|NCT00700427|62967184|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
33571670|NCT00700427|62967185|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
33571671|NCT00700427|62967186|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
33571672|NCT00700427|62967187|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
33571673|NCT00700427|62967183|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
33571674|NCT00700427|62967184|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
33571675|NCT00700427|62967185|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
33571676|NCT00700427|62967186|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
33571677|NCT00700427|62967187|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
33571678|NCT00700427|62967183|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
33571679|NCT00700427|62967184|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
33571680|NCT00700427|62967185|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
33571681|NCT00700427|62967186|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
33571682|NCT00700427|62967187|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
33571683|NCT00700427|62967183|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
33571684|NCT00700427|62967184|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
33571685|NCT00700427|62967185|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
33571686|NCT00700427|62967186|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
33571687|NCT00700427|62967187|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
33571688|NCT00700427|62967183|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
33571689|NCT00700427|62967184|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
33571690|NCT00700427|62967185|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
33571691|NCT00700427|62967186|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
33571692|NCT00700427|62967187|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
33571693|NCT00700427|62967183|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
33571694|NCT00700427|62967184|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
33571695|NCT00700427|62967185|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
33571696|NCT00700427|62967186|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
33571697|NCT00700427|62967187|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
33571698|NCT00700427|62967183|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
33571699|NCT00700427|62967184|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
33571700|NCT00700427|62967185|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
33571701|NCT00700427|62967186|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
33571702|NCT00700427|62967187|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
33571703|NCT00700427|62967183|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
33571704|NCT00700427|62967184|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
33571705|NCT00700427|62967185|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
33571706|NCT00700427|62967186|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
33571707|NCT00700427|62967187|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
33571708|NCT00700427|62967183|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
33571709|NCT00700427|62967184|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
33571710|NCT00700427|62967185|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
33571711|NCT00700427|62967186|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
33571712|NCT00700427|62967187|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
33571713|NCT00700427|62967183|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
33571714|NCT00700427|62967184|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
33571715|NCT00700427|62967185|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
33571716|NCT00700427|62967186|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
33571717|NCT00700427|62967187|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
33571718|NCT00700427|62967183|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
33571719|NCT00700427|62967184|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
33571720|NCT00700427|62967185|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
33571721|NCT00700427|62967186|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
33571722|NCT00700427|62967187|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
33571723|NCT00700427|62967183|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
33571724|NCT00700427|62967184|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
33571725|NCT00700427|62967185|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
33571726|NCT00700427|62967186|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
33571727|NCT00700427|62967187|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
33571728|NCT00700427|62967183|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
33571729|NCT00700427|62967184|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
33571730|NCT00700427|62967185|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
33571731|NCT00700427|62967186|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
33571732|NCT00700427|62967187|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
33571733|NCT00700427|62967183|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
33571734|NCT00700427|62967184|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
33571735|NCT00700427|62967185|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
33571736|NCT00700427|62967186|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
33571737|NCT00700427|62967187|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
33571738|NCT00700427|62967183|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
33571739|NCT00700427|62967184|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
33571740|NCT00700427|62967185|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
33571741|NCT00700427|62967186|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
33571742|NCT00700427|62967187|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
33571743|NCT00700427|62967183|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
33664322|NCT02674854|63095342|FG000|Overall Study|Lack of Efficacy|0|||
33302868|NCT01072396|62678724|FG000|Period One|Adverse Event|1|||
33664323|NCT02674854|63095343|FG001|Overall Study|Lack of Efficacy|3|||
33664324|NCT02674854|63095344|FG002|Overall Study|Lack of Efficacy|0|||
33571744|NCT00700427|62967184|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
33571745|NCT00700427|62967185|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
33571746|NCT00700427|62967186|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
33571747|NCT00700427|62967187|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
33571748|NCT00700427|62967183|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
33571749|NCT00700427|62967184|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
33571750|NCT00700427|62967185|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
33571751|NCT00700427|62967186|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
33571752|NCT00700427|62967187|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
33571753|NCT00700427|62967183|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
33571754|NCT00700427|62967184|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
33571755|NCT00700427|62967185|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
33571756|NCT00700427|62967186|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
33571757|NCT00700427|62967187|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
33571758|NCT00700427|62967183|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
33571759|NCT00700427|62967184|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
33571760|NCT00700427|62967185|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
33571761|NCT00700427|62967186|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
33571762|NCT00700427|62967187|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
33571763|NCT02128763|62967197|FG000|Overall Study|Death|1|||
33571764|NCT02128763|62967198|FG001|Overall Study|Death|0|||
33571765|NCT02128763|62967197|FG000|Overall Study|Lost to Follow-up|19|||
33571766|NCT02128763|62967198|FG001|Overall Study|Lost to Follow-up|16|||
33571767|NCT02124772|62967220|FG000|Overall Study|Lack of Efficacy|2|||
33571768|NCT02124772|62967221|FG001|Overall Study|Lack of Efficacy|0|||
33571769|NCT02124772|62967222|FG002|Overall Study|Lack of Efficacy|0|||
33571770|NCT02124772|62967223|FG003|Overall Study|Lack of Efficacy|1|||
33571771|NCT02124772|62967224|FG004|Overall Study|Lack of Efficacy|2|||
33571772|NCT02124772|62967225|FG005|Overall Study|Lack of Efficacy|3|||
33571773|NCT02124772|62967226|FG006|Overall Study|Lack of Efficacy|0|||
33571774|NCT02124772|62967227|FG007|Overall Study|Lack of Efficacy|2|||
33571775|NCT02124772|62967228|FG008|Overall Study|Lack of Efficacy|0|||
33571776|NCT02124772|62967229|FG009|Overall Study|Lack of Efficacy|1|||
33571777|NCT02124772|62967230|FG010|Overall Study|Lack of Efficacy|0|||
33571778|NCT02124772|62967231|FG011|Overall Study|Lack of Efficacy|0|||
33571779|NCT02124772|62967232|FG012|Overall Study|Lack of Efficacy|1|||
33571780|NCT02124772|62967220|FG000|Overall Study|Adverse Event|1|||
33571781|NCT02124772|62967221|FG001|Overall Study|Adverse Event|4|||
33571782|NCT02124772|62967222|FG002|Overall Study|Adverse Event|1|||
33571783|NCT02124772|62967223|FG003|Overall Study|Adverse Event|5|||
33571784|NCT02124772|62967224|FG004|Overall Study|Adverse Event|2|||
33571785|NCT02124772|62967225|FG005|Overall Study|Adverse Event|1|||
33571786|NCT02124772|62967226|FG006|Overall Study|Adverse Event|1|||
33571787|NCT02124772|62967227|FG007|Overall Study|Adverse Event|5|||
33571788|NCT02124772|62967228|FG008|Overall Study|Adverse Event|0|||
33571789|NCT02124772|62967229|FG009|Overall Study|Adverse Event|3|||
33571790|NCT02124772|62967230|FG010|Overall Study|Adverse Event|1|||
33571791|NCT02124772|62967231|FG011|Overall Study|Adverse Event|3|||
33571792|NCT02124772|62967232|FG012|Overall Study|Adverse Event|1|||
33571793|NCT02124772|62967220|FG000|Overall Study|Withdrawal consent|0|||
33571794|NCT02124772|62967221|FG001|Overall Study|Withdrawal consent|1|||
33571795|NCT02124772|62967222|FG002|Overall Study|Withdrawal consent|1|||
33571796|NCT02124772|62967223|FG003|Overall Study|Withdrawal consent|1|||
33571797|NCT02124772|62967224|FG004|Overall Study|Withdrawal consent|0|||
33571798|NCT02124772|62967225|FG005|Overall Study|Withdrawal consent|1|||
33571799|NCT02124772|62967226|FG006|Overall Study|Withdrawal consent|1|||
33571800|NCT02124772|62967227|FG007|Overall Study|Withdrawal consent|0|||
33571801|NCT02124772|62967228|FG008|Overall Study|Withdrawal consent|0|||
33571802|NCT02124772|62967229|FG009|Overall Study|Withdrawal consent|1|||
33571803|NCT02124772|62967230|FG010|Overall Study|Withdrawal consent|0|||
33571804|NCT02124772|62967231|FG011|Overall Study|Withdrawal consent|1|||
33571805|NCT02124772|62967232|FG012|Overall Study|Withdrawal consent|0|||
33571806|NCT02124772|62967220|FG000|Overall Study|Investigator discretion|0|||
33571807|NCT02124772|62967221|FG001|Overall Study|Investigator discretion|2|||
33302869|NCT01072396|62678725|FG001|Period One|Adverse Event|1|||
33302870|NCT01072396|62678724|FG000|Period One|Protocol Violation|2|||
33302871|NCT01072396|62678725|FG001|Period One|Protocol Violation|1|||
33302872|NCT01072396|62678724|FG000|Period One|Withdrawal by Subject|2|||
33302873|NCT01072396|62678725|FG001|Period One|Withdrawal by Subject|0|||
33302874|NCT01072396|62678724|FG000|Washout Period|Missing termination information|0|||
33396752|NCT00308581|62775993|FG001|Randomized Maintenance Phase|Unknown reason|0|||
33571808|NCT02124772|62967222|FG002|Overall Study|Investigator discretion|2|||
33571809|NCT02124772|62967223|FG003|Overall Study|Investigator discretion|1|||
33571810|NCT02124772|62967224|FG004|Overall Study|Investigator discretion|1|||
33571811|NCT02124772|62967225|FG005|Overall Study|Investigator discretion|0|||
33302875|NCT01072396|62678725|FG001|Washout Period|Missing termination information|1|||
33571812|NCT02124772|62967226|FG006|Overall Study|Investigator discretion|1|||
33571813|NCT02124772|62967227|FG007|Overall Study|Investigator discretion|0|||
33571814|NCT02124772|62967228|FG008|Overall Study|Investigator discretion|0|||
33571815|NCT02124772|62967229|FG009|Overall Study|Investigator discretion|1|||
33571816|NCT02124772|62967230|FG010|Overall Study|Investigator discretion|0|||
33571817|NCT02124772|62967231|FG011|Overall Study|Investigator discretion|1|||
33571818|NCT02124772|62967232|FG012|Overall Study|Investigator discretion|0|||
33571819|NCT02124772|62967220|FG000|Overall Study|Progressive disease|0|||
33571820|NCT02124772|62967221|FG001|Overall Study|Progressive disease|0|||
33571821|NCT02124772|62967222|FG002|Overall Study|Progressive disease|0|||
33571822|NCT02124772|62967223|FG003|Overall Study|Progressive disease|0|||
33571823|NCT02124772|62967224|FG004|Overall Study|Progressive disease|0|||
33571824|NCT02124772|62967225|FG005|Overall Study|Progressive disease|0|||
33571825|NCT02124772|62967226|FG006|Overall Study|Progressive disease|1|||
33571826|NCT02124772|62967227|FG007|Overall Study|Progressive disease|1|||
33571827|NCT02124772|62967228|FG008|Overall Study|Progressive disease|0|||
33571828|NCT02124772|62967229|FG009|Overall Study|Progressive disease|0|||
33571829|NCT02124772|62967230|FG010|Overall Study|Progressive disease|0|||
33571830|NCT02124772|62967231|FG011|Overall Study|Progressive disease|0|||
33571831|NCT02124772|62967232|FG012|Overall Study|Progressive disease|0|||
33571832|NCT02124772|62967220|FG000|Overall Study|Other|0|||
33571833|NCT02124772|62967221|FG001|Overall Study|Other|7|||
33571834|NCT02124772|62967222|FG002|Overall Study|Other|2|||
33571835|NCT02124772|62967223|FG003|Overall Study|Other|5|||
33571836|NCT02124772|62967224|FG004|Overall Study|Other|4|||
33571837|NCT02124772|62967225|FG005|Overall Study|Other|3|||
33571838|NCT02124772|62967226|FG006|Overall Study|Other|4|||
33571839|NCT02124772|62967227|FG007|Overall Study|Other|1|||
33571840|NCT02124772|62967228|FG008|Overall Study|Other|1|||
33571841|NCT02124772|62967229|FG009|Overall Study|Other|1|||
33571842|NCT02124772|62967230|FG010|Overall Study|Other|1|||
33571843|NCT02124772|62967231|FG011|Overall Study|Other|1|||
33571844|NCT02124772|62967232|FG012|Overall Study|Other|0|||
33571845|NCT02159482|62967284|FG000|Overall Study|Withdrawal by Subject|2|||
33571846|NCT02159482|62967284|FG000|Overall Study|Physician Decision|3|||
33571847|NCT02622321|62967292|FG000|Overall Study|Withdrawal by Subject|2|||
33571848|NCT02622321|62967293|FG001|Overall Study|Withdrawal by Subject|0|||
33571849|NCT02622321|62967294|FG002|Overall Study|Withdrawal by Subject|0|||
33571850|NCT02622321|62967295|FG003|Overall Study|Withdrawal by Subject|0|||
33571851|NCT02622321|62967292|FG000|Overall Study|Death|0|||
33571852|NCT02622321|62967293|FG001|Overall Study|Death|0|||
33571853|NCT02622321|62967294|FG002|Overall Study|Death|1|||
33571854|NCT02622321|62967295|FG003|Overall Study|Death|0|||
33571855|NCT02622321|62967292|FG000|Overall Study|Physician Decision|1|||
33571856|NCT02622321|62967293|FG001|Overall Study|Physician Decision|0|||
33571857|NCT02622321|62967294|FG002|Overall Study|Physician Decision|0|||
33571858|NCT02622321|62967295|FG003|Overall Study|Physician Decision|0|||
33571859|NCT02187172|62967321|FG000|Overall Study|Lost to Follow-up|1|||
33571860|NCT02187172|62967322|FG001|Overall Study|Lost to Follow-up|2|||
33571861|NCT02187172|62967321|FG000|Overall Study|Lack of Efficacy|1|||
33571862|NCT02187172|62967322|FG001|Overall Study|Lack of Efficacy|2|||
33571863|NCT02187172|62967321|FG000|Overall Study|Adverse Event|0|||
33571864|NCT02187172|62967322|FG001|Overall Study|Adverse Event|1|||
33571865|NCT02187172|62967321|FG000|Overall Study|Physician Decision|1|||
33571866|NCT02187172|62967322|FG001|Overall Study|Physician Decision|1|||
33571867|NCT02621931|62967333|FG000|Overall Study|Death|0|||
33571868|NCT02621931|62967334|FG001|Overall Study|Death|1|||
33571869|NCT02621931|62967335|FG002|Overall Study|Death|0|||
33571870|NCT02621931|62967333|FG000|Overall Study|Adverse Event|8|||
33571871|NCT02621931|62967334|FG001|Overall Study|Adverse Event|5|||
33571872|NCT02621931|62967335|FG002|Overall Study|Adverse Event|7|||
33571873|NCT02621931|62967333|FG000|Overall Study|Withdrawal by Subject|12|||
33571874|NCT02621931|62967334|FG001|Overall Study|Withdrawal by Subject|10|||
33396753|NCT00308581|62775994|FG002|Randomized Maintenance Phase|Unknown reason|0|||
33396754|NCT00678080|62776004|FG000|Overall Study|Physician Decision|2|||
33571875|NCT02621931|62967335|FG002|Overall Study|Withdrawal by Subject|11|||
33571876|NCT02621931|62967333|FG000|Overall Study|Protocol Violation|2|||
33571877|NCT02621931|62967334|FG001|Overall Study|Protocol Violation|2|||
33396755|NCT00678080|62776005|FG001|Overall Study|Physician Decision|0|||
33571878|NCT02621931|62967335|FG002|Overall Study|Protocol Violation|2|||
33571879|NCT02621931|62967333|FG000|Overall Study|Pregnancy|2|||
33571880|NCT02621931|62967334|FG001|Overall Study|Pregnancy|0|||
33571881|NCT02621931|62967335|FG002|Overall Study|Pregnancy|0|||
33571882|NCT02621931|62967333|FG000|Overall Study|Noncompliance to study procedures|0|||
33571883|NCT02621931|62967334|FG001|Overall Study|Noncompliance to study procedures|1|||
33571884|NCT02621931|62967335|FG002|Overall Study|Noncompliance to study procedures|2|||
33571885|NCT02621931|62967333|FG000|Overall Study|Lost to Follow-up|8|||
33571886|NCT02621931|62967334|FG001|Overall Study|Lost to Follow-up|7|||
33571887|NCT02621931|62967335|FG002|Overall Study|Lost to Follow-up|10|||
33571888|NCT02621931|62967333|FG000|Overall Study|Lack of Efficacy|0|||
33571889|NCT02621931|62967334|FG001|Overall Study|Lack of Efficacy|0|||
33571890|NCT02621931|62967335|FG002|Overall Study|Lack of Efficacy|1|||
33571891|NCT02621931|62967333|FG000|Overall Study|Other|1|||
33571892|NCT02621931|62967334|FG001|Overall Study|Other|1|||
33571893|NCT02621931|62967335|FG002|Overall Study|Other|3|||
33571894|NCT02621073|62967347|FG000|Overall Study|Lost to Follow-up|0|||
33571895|NCT02621073|62967348|FG001|Overall Study|Lost to Follow-up|1|||
33571896|NCT02621073|62967347|FG000|Overall Study|Physician Decision|3|||
33571897|NCT02621073|62967348|FG001|Overall Study|Physician Decision|2|||
33571898|NCT02158936|62967356|FG000|Overall Study|Study closed/ terminated|57|||
33571899|NCT02158936|62967357|FG001|Overall Study|Study closed/ terminated|77|||
33571900|NCT02158936|62967356|FG000|Overall Study|Azacitidine tx discontinued|53|||
33571901|NCT02158936|62967357|FG001|Overall Study|Azacitidine tx discontinued|46|||
33571902|NCT02158936|62967356|FG000|Overall Study|Adverse Event|39|||
33571903|NCT02158936|62967357|FG001|Overall Study|Adverse Event|24|||
33571904|NCT02158936|62967356|FG000|Overall Study|Withdrawal by Subject|15|||
33571905|NCT02158936|62967357|FG001|Overall Study|Withdrawal by Subject|16|||
33571906|NCT02158936|62967356|FG000|Overall Study|Physician Decision|15|||
33571907|NCT02158936|62967357|FG001|Overall Study|Physician Decision|13|||
33571908|NCT02158936|62967356|FG000|Overall Study|Lost to Follow-up|0|||
33571909|NCT02158936|62967357|FG001|Overall Study|Lost to Follow-up|1|||
33571910|NCT02158546|62967367|FG000|Overall Study|Physician Decision|0|||
33571911|NCT02158546|62967368|FG001|Overall Study|Physician Decision|1|||
33571912|NCT02158546|62967369|FG002|Overall Study|Physician Decision|0|||
33571913|NCT02158546|62967370|FG003|Overall Study|Physician Decision|0|||
33571914|NCT02158546|62967367|FG000|Overall Study|Non-compliance|0|||
33571915|NCT02158546|62967368|FG001|Overall Study|Non-compliance|1|||
33571916|NCT02158546|62967369|FG002|Overall Study|Non-compliance|0|||
33571917|NCT02158546|62967370|FG003|Overall Study|Non-compliance|1|||
33571918|NCT02158546|62967367|FG000|Overall Study|Failure to meet eligibility criteria|0|||
33571919|NCT02158546|62967368|FG001|Overall Study|Failure to meet eligibility criteria|1|||
33571920|NCT02158546|62967369|FG002|Overall Study|Failure to meet eligibility criteria|0|||
33571921|NCT02158546|62967370|FG003|Overall Study|Failure to meet eligibility criteria|0|||
33571922|NCT02158546|62967367|FG000|Overall Study|Lack of Efficacy|1|||
33571923|NCT02158546|62967368|FG001|Overall Study|Lack of Efficacy|1|||
33571924|NCT02158546|62967369|FG002|Overall Study|Lack of Efficacy|0|||
33571925|NCT02158546|62967370|FG003|Overall Study|Lack of Efficacy|0|||
33571926|NCT02158546|62967367|FG000|Overall Study|Adverse Event|2|||
33571927|NCT02158546|62967368|FG001|Overall Study|Adverse Event|2|||
33571928|NCT02158546|62967369|FG002|Overall Study|Adverse Event|0|||
33571929|NCT02158546|62967370|FG003|Overall Study|Adverse Event|0|||
33571930|NCT02158546|62967367|FG000|Overall Study|Withdrawal by Subject|6|||
33571931|NCT02158546|62967368|FG001|Overall Study|Withdrawal by Subject|2|||
33571932|NCT02158546|62967369|FG002|Overall Study|Withdrawal by Subject|1|||
33571933|NCT02158546|62967370|FG003|Overall Study|Withdrawal by Subject|0|||
33571934|NCT02158546|62967367|FG000|Overall Study|Lost to Follow-up|5|||
33571935|NCT02158546|62967368|FG001|Overall Study|Lost to Follow-up|4|||
33571936|NCT02158546|62967369|FG002|Overall Study|Lost to Follow-up|0|||
33571937|NCT02158546|62967370|FG003|Overall Study|Lost to Follow-up|1|||
33571938|NCT02158546|62967367|FG000|Overall Study|Site Excluded|5|||
33571939|NCT02158546|62967368|FG001|Overall Study|Site Excluded|5|||
33571940|NCT02158546|62967369|FG002|Overall Study|Site Excluded|3|||
33571941|NCT02158546|62967370|FG003|Overall Study|Site Excluded|4|||
33571942|NCT02123446|62967380|FG000|Washout Period (1 Day)|Physician Decision|1|||
33571943|NCT02123446|62967381|FG001|Washout Period (1 Day)|Physician Decision|0|||
33571944|NCT02123134|62967389|FG000|Overall Study|Withdrawal of consent|3|||
33571945|NCT02123134|62967390|FG001|Overall Study|Withdrawal of consent|2|||
33571946|NCT02123134|62967389|FG000|Overall Study|Administrative decision|0|||
33571947|NCT02123134|62967390|FG001|Overall Study|Administrative decision|1|||
33571948|NCT02185534|62967402|FG000|First Period|Withdrawal by Subject|0|||
33571949|NCT02185534|62967403|FG001|First Period|Withdrawal by Subject|0|||
33571950|NCT02185534|62967404|FG002|First Period|Withdrawal by Subject|0|||
33571951|NCT02185534|62967405|FG003|First Period|Withdrawal by Subject|1|||
33571952|NCT02185534|62967406|FG004|First Period|Withdrawal by Subject|0|||
33571953|NCT02185534|62967407|FG005|First Period|Withdrawal by Subject|0|||
33571954|NCT02185534|62967402|FG000|First Washout Period|Withdrawal by Subject|1|||
33571955|NCT02185534|62967403|FG001|First Washout Period|Withdrawal by Subject|0|||
33571956|NCT02185534|62967404|FG002|First Washout Period|Withdrawal by Subject|0|||
33571957|NCT02185534|62967405|FG003|First Washout Period|Withdrawal by Subject|0|||
33571958|NCT02185534|62967406|FG004|First Washout Period|Withdrawal by Subject|1|||
33571959|NCT02185534|62967407|FG005|First Washout Period|Withdrawal by Subject|0|||
33571960|NCT02185534|62967402|FG000|First Washout Period|Protocol Violation|0|||
33571961|NCT02185534|62967403|FG001|First Washout Period|Protocol Violation|0|||
33571962|NCT02185534|62967404|FG002|First Washout Period|Protocol Violation|0|||
33571963|NCT02185534|62967405|FG003|First Washout Period|Protocol Violation|0|||
33571964|NCT02185534|62967406|FG004|First Washout Period|Protocol Violation|0|||
33571965|NCT02185534|62967407|FG005|First Washout Period|Protocol Violation|1|||
33571966|NCT02121808|62967416|FG000|Overall Study|Technical problem|3|||
33571967|NCT02157376|62967427|FG000|Overall Study|Death|10|||
33571968|NCT02157376|62967428|FG001|Overall Study|Death|4|||
33571969|NCT02157376|62967427|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33571970|NCT02157376|62967428|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33571971|NCT02157376|62967427|FG000|Overall Study|Withdrawal by Subject|3|||
33571972|NCT02157376|62967428|FG001|Overall Study|Withdrawal by Subject|8|||
33571973|NCT02157376|62967427|FG000|Overall Study|Not treated|8|||
33571974|NCT02157376|62967428|FG001|Overall Study|Not treated|3|||
33571975|NCT02157376|62967427|FG000|Overall Study|Investigator's misjudgement|1|||
33571976|NCT02157376|62967428|FG001|Overall Study|Investigator's misjudgement|2|||
33571977|NCT02157298|62967436|FG000|Overall Study|Adverse Event|1|||
33571978|NCT02157298|62967437|FG001|Overall Study|Adverse Event|0|||
33571979|NCT02157298|62967436|FG000|Overall Study|Subject no longer meets study criteria|1|||
33571980|NCT02157298|62967437|FG001|Overall Study|Subject no longer meets study criteria|2|||
33571981|NCT02157298|62967436|FG000|Overall Study|Poor/Non-compliance|1|||
33571982|NCT02157298|62967437|FG001|Overall Study|Poor/Non-compliance|0|||
33571983|NCT02157298|62967436|FG000|Overall Study|Withdrawal by Subject|1|||
33571984|NCT02157298|62967437|FG001|Overall Study|Withdrawal by Subject|0|||
33571985|NCT02184988|62967443|FG000|Overall Study|Pregnancy|2|||
33571986|NCT02184988|62967443|FG000|Overall Study|Adverse Event|2|||
33571987|NCT02184988|62967443|FG000|Overall Study|moving away/travelling/unable to complet|6|||
33571988|NCT02184988|62967443|FG000|Overall Study|work scheduling issues|4|||
33571989|NCT02184988|62967443|FG000|Overall Study|various other reasons|9|||
33571990|NCT02184988|62967443|FG000|Overall Study|Lost to Follow-up|32|||
33571991|NCT02121262|62967449|FG000|Overall Study|Adverse Event|6|||
33571992|NCT02121262|62967450|FG001|Overall Study|Adverse Event|3|||
33571993|NCT02121262|62967449|FG000|Overall Study|Lack of Efficacy|3|||
33571994|NCT02121262|62967450|FG001|Overall Study|Lack of Efficacy|0|||
33571995|NCT02121262|62967449|FG000|Overall Study|Personal Reasons|19|||
33571996|NCT02121262|62967450|FG001|Overall Study|Personal Reasons|5|||
33571997|NCT02121262|62967449|FG000|Overall Study|Protocol Violation|1|||
33571998|NCT02121262|62967450|FG001|Overall Study|Protocol Violation|1|||
33571999|NCT02121262|62967449|FG000|Overall Study|Participant Dropped-out|0|||
33572000|NCT02121262|62967450|FG001|Overall Study|Participant Dropped-out|1|||
33572001|NCT02121262|62967449|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
33572002|NCT02121262|62967450|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
33572003|NCT02121262|62967449|FG000|Overall Study|Consent Withdrawn|1|||
33572004|NCT02121262|62967450|FG001|Overall Study|Consent Withdrawn|0|||
33572005|NCT02120950|62967458|FG000|Overall Study|Adverse Event|5|||
33572006|NCT02120950|62967459|FG001|Overall Study|Adverse Event|4|||
33572007|NCT02120950|62967460|FG002|Overall Study|Adverse Event|3|||
33572008|NCT02120950|62967458|FG000|Overall Study|Death|3|||
33572009|NCT02120950|62967459|FG001|Overall Study|Death|0|||
33572010|NCT02120950|62967460|FG002|Overall Study|Death|1|||
33572011|NCT02120950|62967458|FG000|Overall Study|Withdrawal by Subject|6|||
33572012|NCT02120950|62967459|FG001|Overall Study|Withdrawal by Subject|3|||
33572013|NCT02120950|62967460|FG002|Overall Study|Withdrawal by Subject|2|||
33572014|NCT02120950|62967458|FG000|Overall Study|Protocol Violation|1|||
33572015|NCT02120950|62967459|FG001|Overall Study|Protocol Violation|1|||
33572016|NCT02120950|62967460|FG002|Overall Study|Protocol Violation|7|||
33572017|NCT02120950|62967458|FG000|Overall Study|Other reasons|5|||
33572018|NCT02120950|62967459|FG001|Overall Study|Other reasons|4|||
33572019|NCT02120950|62967460|FG002|Overall Study|Other reasons|1|||
33572020|NCT02120950|62967458|FG000|Overall Study|Lost to Follow-up|0|||
33572021|NCT02120950|62967459|FG001|Overall Study|Lost to Follow-up|2|||
33572022|NCT02120950|62967460|FG002|Overall Study|Lost to Follow-up|1|||
33572023|NCT02120794|62967467|FG000|Overall Study|Withdrawal by Subject|43|||
33572024|NCT02120794|62967467|FG000|Overall Study|Adverse Event|10|||
33572025|NCT02120794|62967467|FG000|Overall Study|Physician Decision|4|||
33572026|NCT02120794|62967467|FG000|Overall Study|Due to insurance coverage|1|||
33572027|NCT02184442|62967473|FG000|Overall Study|Death|61|||
33572028|NCT02184442|62967474|FG001|Overall Study|Death|65|||
33572029|NCT02184442|62967473|FG000|Overall Study|Withdrawal by Subject|3|||
33572030|NCT02184442|62967474|FG001|Overall Study|Withdrawal by Subject|11|||
33572031|NCT02155738|62967484|FG000|Overall Study|Missing critical information|1|||
33572032|NCT02155738|62967485|FG001|Overall Study|Missing critical information|0|||
33572033|NCT02155738|62967486|FG002|Overall Study|Missing critical information|0|||
33572034|NCT02155738|62967487|FG003|Overall Study|Missing critical information|1|||
33572035|NCT02181790|62967499|FG000|Overall Study|study terminated|2|||
33572036|NCT02181790|62967500|FG001|Overall Study|study terminated|0|||
33572037|NCT02618967|62967516|FG000|Overall Study|Lost to Follow-up|0|||
33572038|NCT02618967|62967517|FG001|Overall Study|Lost to Follow-up|0|||
33572039|NCT02618967|62967518|FG002|Overall Study|Lost to Follow-up|1|||
33572040|NCT02618967|62967519|FG003|Overall Study|Lost to Follow-up|0|||
33572041|NCT02618967|62967520|FG004|Overall Study|Lost to Follow-up|2|||
33302876|NCT01072396|62678724|FG000|Period Two|Adverse Event|0|||
33572042|NCT02618967|62967521|FG005|Overall Study|Lost to Follow-up|0|||
33572043|NCT02618967|62967522|FG006|Overall Study|Lost to Follow-up|0|||
33572044|NCT02618967|62967523|FG007|Overall Study|Lost to Follow-up|0|||
33572045|NCT02618967|62967516|FG000|Overall Study|Withdrawal by Subject|1|||
33572046|NCT02618967|62967517|FG001|Overall Study|Withdrawal by Subject|0|||
33572047|NCT02618967|62967518|FG002|Overall Study|Withdrawal by Subject|0|||
33572048|NCT02618967|62967519|FG003|Overall Study|Withdrawal by Subject|0|||
33572049|NCT02618967|62967520|FG004|Overall Study|Withdrawal by Subject|0|||
33572050|NCT02618967|62967521|FG005|Overall Study|Withdrawal by Subject|0|||
33572051|NCT02618967|62967522|FG006|Overall Study|Withdrawal by Subject|0|||
33572052|NCT02618967|62967523|FG007|Overall Study|Withdrawal by Subject|0|||
33572053|NCT02616783|62967543|FG000|Overall Study|Randomized but Not Treated|1|||
33572054|NCT02616783|62967544|FG001|Overall Study|Randomized but Not Treated|0|||
33572055|NCT02616783|62967543|FG000|Overall Study|Adverse Event|1|||
33572056|NCT02616783|62967544|FG001|Overall Study|Adverse Event|0|||
33572057|NCT02616783|62967543|FG000|Overall Study|Death|1|||
33572058|NCT02616783|62967544|FG001|Overall Study|Death|0|||
33572059|NCT02616783|62967543|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33572060|NCT02616783|62967544|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33572061|NCT02616783|62967543|FG000|Overall Study|Protocol Violation|1|||
33572062|NCT02616783|62967544|FG001|Overall Study|Protocol Violation|1|||
33572063|NCT02616783|62967543|FG000|Overall Study|Withdrew Consent|1|||
33572064|NCT02616783|62967544|FG001|Overall Study|Withdrew Consent|1|||
33572065|NCT02616393|62967553|FG000|Overall Study|Death|5|||
33572066|NCT02616393|62967554|FG001|Overall Study|Death|12|||
33572067|NCT02616393|62967555|FG002|Overall Study|Death|1|||
33572068|NCT02616393|62967553|FG000|Overall Study|Termination by Sponsor|4|||
33572069|NCT02616393|62967554|FG001|Overall Study|Termination by Sponsor|5|||
33572070|NCT02616393|62967555|FG002|Overall Study|Termination by Sponsor|2|||
33572071|NCT02616393|62967553|FG000|Overall Study|Other|3|||
33572072|NCT02616393|62967554|FG001|Overall Study|Other|0|||
33572073|NCT02616393|62967555|FG002|Overall Study|Other|0|||
33572074|NCT02616393|62967553|FG000|Overall Study|Withdrawal by Subject|1|||
33572075|NCT02616393|62967554|FG001|Overall Study|Withdrawal by Subject|1|||
33572076|NCT02616393|62967555|FG002|Overall Study|Withdrawal by Subject|0|||
33572077|NCT02616393|62967553|FG000|Overall Study|Lost to Follow-up|0|||
33572078|NCT02616393|62967554|FG001|Overall Study|Lost to Follow-up|2|||
33572079|NCT02616393|62967555|FG002|Overall Study|Lost to Follow-up|0|||
33572080|NCT02155660|62967583|FG000|Overall Study|Other Reason|8|||
33572081|NCT02155660|62967584|FG001|Overall Study|Other Reason|6|||
33572082|NCT02155660|62967585|FG002|Overall Study|Other Reason|10|||
33572083|NCT02155660|62967586|FG003|Overall Study|Other Reason|10|||
33572084|NCT02155660|62967583|FG000|Overall Study|Study-specific withdrawal criteria|0|||
33572085|NCT02155660|62967584|FG001|Overall Study|Study-specific withdrawal criteria|1|||
33572086|NCT02155660|62967585|FG002|Overall Study|Study-specific withdrawal criteria|1|||
33572087|NCT02155660|62967586|FG003|Overall Study|Study-specific withdrawal criteria|1|||
33572088|NCT02155660|62967583|FG000|Overall Study|Severe non-compliance|0|||
33572089|NCT02155660|62967584|FG001|Overall Study|Severe non-compliance|4|||
33572090|NCT02155660|62967585|FG002|Overall Study|Severe non-compliance|0|||
33572091|NCT02155660|62967586|FG003|Overall Study|Severe non-compliance|1|||
33572092|NCT02155660|62967583|FG000|Overall Study|Adverse Event|2|||
33572093|NCT02155660|62967584|FG001|Overall Study|Adverse Event|6|||
33572094|NCT02155660|62967585|FG002|Overall Study|Adverse Event|3|||
33572095|NCT02155660|62967586|FG003|Overall Study|Adverse Event|1|||
33572096|NCT02155660|62967583|FG000|Overall Study|Lost to Follow-up|3|||
33572097|NCT02155660|62967584|FG001|Overall Study|Lost to Follow-up|6|||
33572098|NCT02155660|62967585|FG002|Overall Study|Lost to Follow-up|5|||
33572099|NCT02155660|62967586|FG003|Overall Study|Lost to Follow-up|8|||
33572100|NCT02155660|62967583|FG000|Overall Study|Death|17|||
33572101|NCT02155660|62967584|FG001|Overall Study|Death|19|||
33572102|NCT02155660|62967585|FG002|Overall Study|Death|17|||
33572103|NCT02155660|62967586|FG003|Overall Study|Death|19|||
33572104|NCT02155660|62967583|FG000|Overall Study|Withdrawal by Subject|28|||
33572105|NCT02155660|62967584|FG001|Overall Study|Withdrawal by Subject|31|||
33572106|NCT02155660|62967585|FG002|Overall Study|Withdrawal by Subject|24|||
33572107|NCT02155660|62967586|FG003|Overall Study|Withdrawal by Subject|21|||
33572108|NCT02119936|62967596|FG000|Overall Study|Lost to Follow-up|10|||
33572109|NCT02181634|62967600|FG000|Overall Study|Lack of Efficacy|33|||
33572110|NCT02181634|62967600|FG000|Overall Study|Adverse Event|17|||
33572111|NCT02181634|62967600|FG000|Overall Study|Physician Decision|8|||
33572112|NCT02181634|62967600|FG000|Overall Study|Withdrawal by Subject|5|||
33572113|NCT02181634|62967600|FG000|Overall Study|Death|2|||
33572114|NCT02181634|62967600|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
33572115|NCT02181634|62967600|FG000|Overall Study|Ineligible|1|||
33572116|NCT02181634|62967600|FG000|Overall Study|Max number of dose reduction|1|||
33572117|NCT02181634|62967600|FG000|Overall Study|Symptomatic progression|1|||
33572118|NCT02181634|62967600|FG000|Overall Study|Patient opted to proceed to surgery|1|||
33572119|NCT01595529|62967606|FG000|Overall Study|Adverse Event|2|||
33572120|NCT01595529|62967607|FG001|Overall Study|Adverse Event|0|||
33572121|NCT01595529|62967606|FG000|Overall Study|Subject Non-Compliant|2|||
33572122|NCT01595529|62967607|FG001|Overall Study|Subject Non-Compliant|0|||
33572123|NCT01595529|62967606|FG000|Overall Study|Lost to Follow-up|8|||
33572124|NCT01595529|62967607|FG001|Overall Study|Lost to Follow-up|14|||
33572125|NCT01595529|62967606|FG000|Overall Study|Protocol Violation|1|||
33572126|NCT01595529|62967607|FG001|Overall Study|Protocol Violation|2|||
33572127|NCT01595529|62967606|FG000|Overall Study|Physician Decision|1|||
33572128|NCT01595529|62967607|FG001|Overall Study|Physician Decision|0|||
33572129|NCT01595529|62967606|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
33572130|NCT01595529|62967607|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
33572131|NCT01595529|62967606|FG000|Overall Study|Administrative Decision|1|||
33572132|NCT01595529|62967607|FG001|Overall Study|Administrative Decision|0|||
33572133|NCT01595529|62967606|FG000|Overall Study|Entry Failure/Screening Failure|6|||
33572134|NCT01595529|62967607|FG001|Overall Study|Entry Failure/Screening Failure|1|||
33572135|NCT02615145|62967616|FG000|Overall Study|Did Not Start Treatment|0|||
33572136|NCT02615145|62967617|FG001|Overall Study|Did Not Start Treatment|0|||
33572137|NCT02615145|62967618|FG002|Overall Study|Did Not Start Treatment|1|||
33572138|NCT02615145|62967619|FG003|Overall Study|Did Not Start Treatment|1|||
33572139|NCT02615145|62967616|FG000|Overall Study|Failure to Return|20|||
33572140|NCT02615145|62967617|FG001|Overall Study|Failure to Return|10|||
33572141|NCT02615145|62967618|FG002|Overall Study|Failure to Return|7|||
33572142|NCT02615145|62967619|FG003|Overall Study|Failure to Return|0|||
33572143|NCT02615145|62967616|FG000|Overall Study|Death|2|||
33572144|NCT02615145|62967617|FG001|Overall Study|Death|3|||
33572145|NCT02615145|62967618|FG002|Overall Study|Death|0|||
33572146|NCT02615145|62967619|FG003|Overall Study|Death|0|||
33572147|NCT02615145|62967616|FG000|Overall Study|Other, Not Specified|5|||
33572148|NCT02615145|62967617|FG001|Overall Study|Other, Not Specified|2|||
33572149|NCT02615145|62967618|FG002|Overall Study|Other, Not Specified|0|||
33572150|NCT02615145|62967619|FG003|Overall Study|Other, Not Specified|0|||
33572151|NCT02119156|62967648|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
33572152|NCT02119156|62967649|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
33572153|NCT02119156|62967650|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
33572154|NCT02119156|62967648|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
33572155|NCT02119156|62967649|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
33572156|NCT02119156|62967650|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
33572157|NCT02119156|62967648|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
33572158|NCT02119156|62967649|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
33572159|NCT02119156|62967650|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
33572160|NCT02119156|62967648|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
33572161|NCT02119156|62967649|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
33572162|NCT02119156|62967650|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
33572163|NCT02119156|62967648|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
33572164|NCT02119156|62967649|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
33572165|NCT02119156|62967650|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
33572166|NCT02181556|62967665|FG000|Overall Study|Withdrawal by Subject|1|||
33572167|NCT02614131|62967676|FG000|Overall Study|Withdrawal by Subject|1|||
33572168|NCT02614131|62967677|FG001|Overall Study|Withdrawal by Subject|0|||
33572169|NCT02614131|62967678|FG002|Overall Study|Withdrawal by Subject|0|||
33572170|NCT02614131|62967679|FG003|Overall Study|Withdrawal by Subject|0|||
33572171|NCT02614131|62967680|FG004|Overall Study|Withdrawal by Subject|0|||
33572172|NCT02614131|62967681|FG005|Overall Study|Withdrawal by Subject|0|||
33572173|NCT02614131|62967682|FG006|Overall Study|Withdrawal by Subject|0|||
33572174|NCT02614131|62967676|FG000|Overall Study|Adverse Event|0|||
33572175|NCT02614131|62967677|FG001|Overall Study|Adverse Event|0|||
33572176|NCT02614131|62967678|FG002|Overall Study|Adverse Event|0|||
33572177|NCT02614131|62967679|FG003|Overall Study|Adverse Event|0|||
33572178|NCT02614131|62967680|FG004|Overall Study|Adverse Event|0|||
33572179|NCT02614131|62967681|FG005|Overall Study|Adverse Event|0|||
33572180|NCT02614131|62967682|FG006|Overall Study|Adverse Event|1|||
33572181|NCT01903733|62967708|FG000|Overall Study|Death|23|||
33572182|NCT01903733|62967709|FG001|Overall Study|Death|54|||
33572183|NCT01903733|62967710|FG002|Overall Study|Death|30|||
33572184|NCT01903733|62967711|FG003|Overall Study|Death|98|||
33572185|NCT01903733|62967708|FG000|Overall Study|Participant refused further follow-up|35|||
33572186|NCT01903733|62967709|FG001|Overall Study|Participant refused further follow-up|38|||
33572187|NCT01903733|62967710|FG002|Overall Study|Participant refused further follow-up|13|||
33572188|NCT01903733|62967711|FG003|Overall Study|Participant refused further follow-up|9|||
33572189|NCT01903733|62967708|FG000|Overall Study|Lost to Follow-up|18|||
33572190|NCT01903733|62967709|FG001|Overall Study|Lost to Follow-up|19|||
33572191|NCT01903733|62967710|FG002|Overall Study|Lost to Follow-up|6|||
33572192|NCT01903733|62967711|FG003|Overall Study|Lost to Follow-up|9|||
33572193|NCT01903733|62967708|FG000|Overall Study|Other|10|||
33664325|NCT02674854|63095342|FG000|Overall Study|Disallowed Concurrent Medication|2|||
33396756|NCT00678080|62776004|FG000|Overall Study|Lost to Follow-up|1|||
33572194|NCT01903733|62967709|FG001|Overall Study|Other|15|||
33664326|NCT02674854|63095343|FG001|Overall Study|Disallowed Concurrent Medication|2|||
33572195|NCT01903733|62967710|FG002|Overall Study|Other|12|||
33572196|NCT01903733|62967711|FG003|Overall Study|Other|3|||
33572197|NCT01903733|62967708|FG000|Overall Study|Missing|2|||
33572198|NCT01903733|62967709|FG001|Overall Study|Missing|0|||
33572199|NCT01903733|62967710|FG002|Overall Study|Missing|0|||
33572200|NCT01903733|62967711|FG003|Overall Study|Missing|0|||
33572201|NCT01903733|62967708|FG000|Overall Study|Investigator request|18|||
33572202|NCT01903733|62967709|FG001|Overall Study|Investigator request|0|||
33572203|NCT01903733|62967710|FG002|Overall Study|Investigator request|0|||
33572204|NCT01903733|62967711|FG003|Overall Study|Investigator request|0|||
33572205|NCT01375205|62967733|FG000|Overall Study|Lost to Follow-up|15|||
33572206|NCT01375205|62967734|FG001|Overall Study|Lost to Follow-up|12|||
33572207|NCT01375205|62967733|FG000|Overall Study|Withdrawal by Subject|6|||
33572208|NCT01375205|62967734|FG001|Overall Study|Withdrawal by Subject|1|||
33572209|NCT00700271|62967742|FG000|Overall Study|Adverse Event|4|||
33572210|NCT00700271|62967743|FG001|Overall Study|Adverse Event|6|||
33572211|NCT00700271|62967742|FG000|Overall Study|Protocol Violation|1|||
33572212|NCT00700271|62967743|FG001|Overall Study|Protocol Violation|0|||
33572213|NCT00700271|62967742|FG000|Overall Study|Administrative Reasons|1|||
33572214|NCT00700271|62967743|FG001|Overall Study|Administrative Reasons|0|||
33572215|NCT00700271|62967742|FG000|Overall Study|Withdrawal by Subject|6|||
33572216|NCT00700271|62967743|FG001|Overall Study|Withdrawal by Subject|4|||
33572217|NCT00700271|62967742|FG000|Overall Study|Lost to Follow-up|2|||
33572218|NCT00700271|62967743|FG001|Overall Study|Lost to Follow-up|2|||
33572219|NCT01375049|62967749|FG000|Overall Study|Adverse Event|2|||
33572220|NCT01375049|62967749|FG000|Overall Study|Lost to Follow-up|1|||
33572221|NCT01375049|62967749|FG000|Overall Study|Withdrawal by Subject|2|||
33572222|NCT01375049|62967749|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
33572223|NCT01594749|62967759|FG000|Overall Study|Adverse Event|2|||
33572224|NCT01594749|62967760|FG001|Overall Study|Adverse Event|1|||
33572225|NCT01594749|62967759|FG000|Overall Study|Withdrawal by Subject|2|||
33572226|NCT01594749|62967760|FG001|Overall Study|Withdrawal by Subject|2|||
33572227|NCT01594749|62967759|FG000|Overall Study|Protocol Violation|2|||
33572228|NCT01594749|62967760|FG001|Overall Study|Protocol Violation|0|||
33572229|NCT01594749|62967759|FG000|Overall Study|Physician Decision|1|||
33572230|NCT01594749|62967760|FG001|Overall Study|Physician Decision|1|||
33572231|NCT01594749|62967759|FG000|Overall Study|Non-compliance with Protocol|0|||
33572232|NCT01594749|62967760|FG001|Overall Study|Non-compliance with Protocol|1|||
33572233|NCT01594749|62967759|FG000|Overall Study|Lost to Follow-up|1|||
33572234|NCT01594749|62967760|FG001|Overall Study|Lost to Follow-up|0|||
33572235|NCT01594749|62967759|FG000|Overall Study|Death|9|||
33572236|NCT01594749|62967760|FG001|Overall Study|Death|3|||
33572237|NCT01594749|62967759|FG000|Overall Study|Not Treated|4|||
33572238|NCT01594749|62967760|FG001|Overall Study|Not Treated|10|||
33572239|NCT01594749|62967759|FG000|Overall Study|Lost Source Documentation|1|||
33572240|NCT01594749|62967760|FG001|Overall Study|Lost Source Documentation|0|||
33572241|NCT02179918|62967771|FG000|Overall Study|Death|0|||
33572242|NCT02179918|62967772|FG001|Overall Study|Death|0|||
33572243|NCT02179918|62967773|FG002|Overall Study|Death|0|||
33572244|NCT02179918|62967774|FG003|Overall Study|Death|1|||
33572245|NCT02179918|62967775|FG004|Overall Study|Death|0|||
33572246|NCT02179918|62967771|FG000|Overall Study|Lost to Follow-up|0|||
33572247|NCT02179918|62967772|FG001|Overall Study|Lost to Follow-up|0|||
33572248|NCT02179918|62967773|FG002|Overall Study|Lost to Follow-up|1|||
33572249|NCT02179918|62967774|FG003|Overall Study|Lost to Follow-up|0|||
33572250|NCT02179918|62967775|FG004|Overall Study|Lost to Follow-up|0|||
33572251|NCT02179918|62967771|FG000|Overall Study|Progressive Disease|4|||
33572252|NCT02179918|62967772|FG001|Overall Study|Progressive Disease|1|||
33572253|NCT02179918|62967773|FG002|Overall Study|Progressive Disease|1|||
33572254|NCT02179918|62967774|FG003|Overall Study|Progressive Disease|2|||
33572255|NCT02179918|62967775|FG004|Overall Study|Progressive Disease|6|||
33572256|NCT02179918|62967771|FG000|Overall Study|Other|0|||
33572257|NCT02179918|62967772|FG001|Overall Study|Other|1|||
33664327|NCT02674854|63095344|FG002|Overall Study|Disallowed Concurrent Medication|0|||
33572258|NCT02179918|62967773|FG002|Overall Study|Other|0|||
33572259|NCT02179918|62967774|FG003|Overall Study|Other|0|||
33572260|NCT02179918|62967775|FG004|Overall Study|Other|1|||
33572261|NCT02179918|62967771|FG000|Overall Study|Subject refused further follow-up|0|||
33572262|NCT02179918|62967772|FG001|Overall Study|Subject refused further follow-up|1|||
33572263|NCT02179918|62967773|FG002|Overall Study|Subject refused further follow-up|0|||
33572264|NCT02179918|62967774|FG003|Overall Study|Subject refused further follow-up|0|||
33572265|NCT02179918|62967775|FG004|Overall Study|Subject refused further follow-up|1|||
33572266|NCT02611479|62967788|FG000|Baseline Enrollment|Exited study|13|||
33572267|NCT02611479|62967788|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
33572268|NCT02611479|62967788|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
33572269|NCT02611479|62967788|FG000|Data Cleaning|No baseline function or pain metrics|2|||
33572270|NCT02153788|62967794|FG000|Overall Study|Physician Decision|2|||
33572271|NCT02153788|62967795|FG001|Overall Study|Physician Decision|1|||
33572272|NCT02153398|62967806|FG000|Overall Study|Withdrawal by Subject|1|||
33572273|NCT02153398|62967807|FG001|Overall Study|Withdrawal by Subject|0|||
33572274|NCT02153398|62967808|FG002|Overall Study|Withdrawal by Subject|0|||
33572275|NCT02153398|62967809|FG003|Overall Study|Withdrawal by Subject|0|||
33572276|NCT02153398|62967810|FG004|Overall Study|Withdrawal by Subject|0|||
33572277|NCT02153398|62967806|FG000|Overall Study|Adverse Event|0|||
33572278|NCT02153398|62967807|FG001|Overall Study|Adverse Event|0|||
33572279|NCT02153398|62967808|FG002|Overall Study|Adverse Event|1|||
33572280|NCT02153398|62967809|FG003|Overall Study|Adverse Event|1|||
33572281|NCT02153398|62967810|FG004|Overall Study|Adverse Event|0|||
33572282|NCT02118766|62967824|FG000|Overall Study|Adverse Event|7|||
33572283|NCT02118766|62967825|FG001|Overall Study|Adverse Event|2|||
33572284|NCT02118766|62967824|FG000|Overall Study|Withdrawal by Subject|3|||
33572285|NCT02118766|62967825|FG001|Overall Study|Withdrawal by Subject|6|||
33572286|NCT02118766|62967824|FG000|Overall Study|Lost to Follow-up|5|||
33572287|NCT02118766|62967825|FG001|Overall Study|Lost to Follow-up|4|||
33572288|NCT02118766|62967824|FG000|Overall Study|Withdrawal by parent/guardian|12|||
33572289|NCT02118766|62967825|FG001|Overall Study|Withdrawal by parent/guardian|18|||
33572290|NCT02118766|62967824|FG000|Overall Study|Other|3|||
33572291|NCT02118766|62967825|FG001|Overall Study|Other|1|||
33572292|NCT02614287|62967833|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
33572293|NCT02614287|62967834|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
33572294|NCT02614287|62967833|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
33572295|NCT02614287|62967834|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
33572296|NCT02614287|62967833|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
33572297|NCT02614287|62967834|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
33572298|NCT02614287|62967833|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
33572299|NCT02614287|62967834|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
33572300|NCT02614287|62967833|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
33572301|NCT02614287|62967834|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
33572302|NCT02614287|62967833|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
33572303|NCT02614287|62967834|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
33572304|NCT02614287|62967833|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
33572305|NCT02614287|62967834|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
33572306|NCT02614287|62967833|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
33572307|NCT02614287|62967834|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
33572308|NCT01374971|62967845|FG000|Overall Study|Withdrawal by Subject|1|||
33572309|NCT02178592|62967851|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
33572310|NCT02178592|62967852|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
33572311|NCT02178592|62967851|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
33572312|NCT02178592|62967852|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
33572313|NCT02178592|62967851|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
33572314|NCT02178592|62967852|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
33572315|NCT02178592|62967851|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
33572316|NCT02178592|62967852|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
33572317|NCT02178592|62967851|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
33572318|NCT02178592|62967852|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
33572319|NCT02178592|62967851|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
33572320|NCT02178592|62967852|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
33572321|NCT02178592|62967851|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
33572322|NCT02178592|62967852|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
33572323|NCT02178592|62967851|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
33572324|NCT02178592|62967852|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
33572325|NCT02178592|62967851|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
33572326|NCT02178592|62967852|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
33572327|NCT02178592|62967851|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
33572328|NCT02178592|62967852|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
33572329|NCT02178592|62967851|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
33572330|NCT02178592|62967852|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
33572331|NCT02178592|62967851|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
33572332|NCT02178592|62967852|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
33572333|NCT02610777|62967863|FG000|Overall Study|Lost to Follow-up|1|||
33572334|NCT02610777|62967864|FG001|Overall Study|Lost to Follow-up|0|||
33572335|NCT02610777|62967863|FG000|Overall Study|Site Terminated by Sponsor|9|||
33572336|NCT02610777|62967864|FG001|Overall Study|Site Terminated by Sponsor|8|||
33302877|NCT01072396|62678725|FG001|Period Two|Adverse Event|3|||
33572337|NCT02610777|62967863|FG000|Overall Study|Withdrawal by Subject|2|||
33572338|NCT02610777|62967864|FG001|Overall Study|Withdrawal by Subject|2|||
33572339|NCT02610777|62967863|FG000|Overall Study|Reason not Specified|0|||
33572340|NCT02610777|62967864|FG001|Overall Study|Reason not Specified|1|||
33572341|NCT02610777|62967863|FG000|Overall Study|Death|50|||
33302878|NCT01072396|62678724|FG000|Period Two|Lost to Follow-up|1|||
33572342|NCT02610777|62967864|FG001|Overall Study|Death|47|||
33572343|NCT01628692|62967878|FG000|Overall Study|Lack of Efficacy|4|||
33572344|NCT01628692|62967879|FG001|Overall Study|Lack of Efficacy|4|||
33572345|NCT01628692|62967880|FG002|Overall Study|Lack of Efficacy|5|||
33572346|NCT01628692|62967881|FG003|Overall Study|Lack of Efficacy|1|||
33572347|NCT01628692|62967882|FG004|Overall Study|Lack of Efficacy|4|||
33572348|NCT01628692|62967883|FG005|Overall Study|Lack of Efficacy|7|||
33572349|NCT01628692|62967878|FG000|Overall Study|Adverse Event|2|||
33572350|NCT01628692|62967879|FG001|Overall Study|Adverse Event|0|||
33572351|NCT01628692|62967880|FG002|Overall Study|Adverse Event|2|||
33572352|NCT01628692|62967881|FG003|Overall Study|Adverse Event|0|||
33572353|NCT01628692|62967882|FG004|Overall Study|Adverse Event|0|||
33572354|NCT01628692|62967883|FG005|Overall Study|Adverse Event|0|||
33572355|NCT01628692|62967878|FG000|Overall Study|Withdrawal by Subject|0|||
33572356|NCT01628692|62967879|FG001|Overall Study|Withdrawal by Subject|1|||
33572357|NCT01628692|62967880|FG002|Overall Study|Withdrawal by Subject|1|||
33572358|NCT01628692|62967881|FG003|Overall Study|Withdrawal by Subject|0|||
33572359|NCT01628692|62967882|FG004|Overall Study|Withdrawal by Subject|0|||
33572360|NCT01628692|62967883|FG005|Overall Study|Withdrawal by Subject|0|||
33572361|NCT01628692|62967878|FG000|Overall Study|Death|0|||
33572362|NCT01628692|62967879|FG001|Overall Study|Death|1|||
33572363|NCT01628692|62967880|FG002|Overall Study|Death|0|||
33572364|NCT01628692|62967881|FG003|Overall Study|Death|0|||
33572365|NCT01628692|62967882|FG004|Overall Study|Death|0|||
33572366|NCT01628692|62967883|FG005|Overall Study|Death|0|||
33572367|NCT01628692|62967878|FG000|Overall Study|Poor compliance/noncompliance|1|||
33572368|NCT01628692|62967879|FG001|Overall Study|Poor compliance/noncompliance|0|||
33572369|NCT01628692|62967880|FG002|Overall Study|Poor compliance/noncompliance|0|||
33572370|NCT01628692|62967881|FG003|Overall Study|Poor compliance/noncompliance|0|||
33572371|NCT01628692|62967882|FG004|Overall Study|Poor compliance/noncompliance|0|||
33572372|NCT01628692|62967883|FG005|Overall Study|Poor compliance/noncompliance|0|||
33572373|NCT01628692|62967878|FG000|Overall Study|Administrative reason by sponsor|0|||
33572374|NCT01628692|62967879|FG001|Overall Study|Administrative reason by sponsor|0|||
33572375|NCT01628692|62967880|FG002|Overall Study|Administrative reason by sponsor|0|||
33572376|NCT01628692|62967881|FG003|Overall Study|Administrative reason by sponsor|0|||
33572377|NCT01628692|62967882|FG004|Overall Study|Administrative reason by sponsor|0|||
33572378|NCT01628692|62967883|FG005|Overall Study|Administrative reason by sponsor|1|||
33572379|NCT01628692|62967878|FG000|Overall Study|Completed 12 Week only|0|||
33572380|NCT01628692|62967879|FG001|Overall Study|Completed 12 Week only|0|||
33572381|NCT01628692|62967880|FG002|Overall Study|Completed 12 Week only|0|||
33572382|NCT01628692|62967881|FG003|Overall Study|Completed 12 Week only|0|||
33572383|NCT01628692|62967882|FG004|Overall Study|Completed 12 Week only|0|||
33572384|NCT01628692|62967883|FG005|Overall Study|Completed 12 Week only|1|||
33572385|NCT02612727|62967902|FG000|Overall Study|Parent request|4|||
33572386|NCT02612727|62967903|FG001|Overall Study|Parent request|1|||
33572387|NCT02612727|62967902|FG000|Overall Study|Needed treatment incompatible with PT|1|||
33572388|NCT02612727|62967903|FG001|Overall Study|Needed treatment incompatible with PT|1|||
33572389|NCT02612727|62967902|FG000|Overall Study|Direct hyperbilirubinemia|0|||
33572390|NCT02612727|62967903|FG001|Overall Study|Direct hyperbilirubinemia|2|||
33572391|NCT01594827|62967911|FG000|Overall Study|Adverse Event|1|||
33572392|NCT01594827|62967912|FG001|Overall Study|Adverse Event|0|||
33572393|NCT01594827|62967911|FG000|Overall Study|Physician Decision|3|||
33572394|NCT01594827|62967912|FG001|Overall Study|Physician Decision|0|||
33572395|NCT02610231|62967920|FG000|Overall Study|Withdrawal by Subject|27|||
33572396|NCT02610231|62967920|FG000|Overall Study|Adverse Event|20|||
33572397|NCT02610231|62967920|FG000|Overall Study|Death|5|||
33572398|NCT02610231|62967920|FG000|Overall Study|Surgery|2|||
33572399|NCT02610231|62967920|FG000|Overall Study|Physician Decision|1|||
33572400|NCT02610231|62967920|FG000|Overall Study|Non Compliance|2|||
33572401|NCT02610231|62967920|FG000|Overall Study|Other|3|||
33572402|NCT02178358|62967930|FG000|Overall Study|Withdrawal by Subject|0|||
33572403|NCT02178358|62967931|FG001|Overall Study|Withdrawal by Subject|2|||
33572404|NCT02178358|62967932|FG002|Overall Study|Withdrawal by Subject|2|||
33572405|NCT02178358|62967930|FG000|Overall Study|Lost to Follow-up|1|||
33572406|NCT02178358|62967931|FG001|Overall Study|Lost to Follow-up|0|||
33664328|NCT02674854|63095342|FG000|Overall Study|Protocol Violation|1|||
33664329|NCT02674854|63095343|FG001|Overall Study|Protocol Violation|1|||
33664330|NCT02674854|63095344|FG002|Overall Study|Protocol Violation|2|||
33396757|NCT00678080|62776005|FG001|Overall Study|Lost to Follow-up|0|||
33572407|NCT02178358|62967932|FG002|Overall Study|Lost to Follow-up|0|||
33572408|NCT01598896|62967943|FG000|Overall Study|Withdrawal by Subject|0|||
33572409|NCT01598896|62967944|FG001|Overall Study|Withdrawal by Subject|1|||
33572410|NCT01598896|62967943|FG000|Overall Study|Lack of Efficacy|0|||
33572411|NCT01598896|62967944|FG001|Overall Study|Lack of Efficacy|1|||
33572412|NCT01598662|62967952|FG000|Overall Study|Lost to Follow-up|10|||
33572413|NCT01598662|62967953|FG001|Overall Study|Lost to Follow-up|17|||
33572414|NCT01598662|62967952|FG000|Overall Study|Physician Decision|1|||
33664331|NCT02674854|63095342|FG000|Overall Study|Death|0|||
33572415|NCT01598662|62967953|FG001|Overall Study|Physician Decision|2|||
33572416|NCT01598662|62967952|FG000|Overall Study|IUD expelled before month 6|0|||
33572417|NCT01598662|62967953|FG001|Overall Study|IUD expelled before month 6|2|||
33572418|NCT01629706|62967959|FG000|Phase 1 PureVision|Screen Failure|4|||
33572419|NCT01629706|62967959|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
33572420|NCT01629706|62967959|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
33572421|NCT01629706|62967959|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
33572422|NCT01629706|62967959|FG000|Phase 2 Habitual|Screen Failure|6|||
33572423|NCT01629706|62967959|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
33572424|NCT01629706|62967959|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
33572425|NCT01629706|62967959|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
33572426|NCT01629706|62967959|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
33572427|NCT02153086|62967967|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
33572428|NCT02153086|62967967|FG000|Overall Study|Other|2|||
33572429|NCT02117050|62967971|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
33572430|NCT02728895|62967978|FG000|Overall Study|Other|1|||
33572431|NCT02728895|62967979|FG001|Overall Study|Other|2|||
33572432|NCT02728895|62967978|FG000|Overall Study|Withdrawal by Subject|0|||
33572433|NCT02728895|62967979|FG001|Overall Study|Withdrawal by Subject|3|||
33572434|NCT02606877|62967987|FG000|Overall Study|Adverse Event|3|||
33572435|NCT02606877|62967988|FG001|Overall Study|Adverse Event|0|||
33572436|NCT02606877|62967987|FG000|Overall Study|Non-compliance with protocol|0|||
33572437|NCT02606877|62967988|FG001|Overall Study|Non-compliance with protocol|1|||
33572438|NCT02606877|62967987|FG000|Overall Study|Other than listed above|1|||
33572439|NCT02606877|62967988|FG001|Overall Study|Other than listed above|0|||
33572440|NCT02606643|62967998|FG000|Overall Study|did not meet inclusion criteria|1|||
33572441|NCT02606643|62967999|FG001|Overall Study|did not meet inclusion criteria|3|||
33572442|NCT02609607|62968030|FG000|Overall Study|Lost to Follow-up|0|||
33572443|NCT02609607|62968031|FG001|Overall Study|Lost to Follow-up|1|||
33572444|NCT02606253|62968040|FG000|Overall Study|Adverse Event|2|||
33572445|NCT02606253|62968041|FG001|Overall Study|Adverse Event|0|||
33572446|NCT02606253|62968042|FG002|Overall Study|Adverse Event|0|||
33572447|NCT02606253|62968040|FG000|Overall Study|Protocol Violation|2|||
33572448|NCT02606253|62968041|FG001|Overall Study|Protocol Violation|1|||
33572449|NCT02606253|62968042|FG002|Overall Study|Protocol Violation|0|||
33572450|NCT02606253|62968040|FG000|Overall Study|Physician Decision|1|||
33572451|NCT02606253|62968041|FG001|Overall Study|Physician Decision|1|||
33572452|NCT02606253|62968042|FG002|Overall Study|Physician Decision|0|||
33572453|NCT02607735|62968052|FG000|Primary Study|Randomized but Never Treated|1|||
33572454|NCT02607735|62968053|FG001|Primary Study|Randomized but Never Treated|0|||
33572455|NCT02607735|62968054|FG002|Primary Study|Randomized but Never Treated|0|||
33572456|NCT02607735|62968052|FG000|Primary Study|Lost to Follow-up|4|||
33572457|NCT02607735|62968053|FG001|Primary Study|Lost to Follow-up|0|||
33572458|NCT02607735|62968054|FG002|Primary Study|Lost to Follow-up|0|||
33572459|NCT02607735|62968052|FG000|Primary Study|Withdrew Consent|2|||
33572460|NCT02607735|62968053|FG001|Primary Study|Withdrew Consent|0|||
33572461|NCT02607735|62968054|FG002|Primary Study|Withdrew Consent|0|||
33572462|NCT02607735|62968052|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
33572463|NCT02607735|62968053|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
33572464|NCT02607735|62968054|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
33572465|NCT02607735|62968052|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
33572466|NCT02607735|62968053|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
33572467|NCT02607735|62968054|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
33572468|NCT01668537|62968064|FG000|Overall Study|Request to Discontinue Prematurely|1|||
33572469|NCT01668537|62968065|FG001|Overall Study|Request to Discontinue Prematurely|1|||
33572470|NCT01668537|62968064|FG000|Overall Study|Subject unwilling/unable to comply|5|||
33572471|NCT01668537|62968065|FG001|Overall Study|Subject unwilling/unable to comply|0|||
33572472|NCT01668537|62968064|FG000|Overall Study|Reason Precludes Participation|1|||
33572473|NCT01668537|62968065|FG001|Overall Study|Reason Precludes Participation|0|||
33572474|NCT01668537|62968064|FG000|Overall Study|Lost to Follow-up|13|||
33572475|NCT01668537|62968065|FG001|Overall Study|Lost to Follow-up|6|||
33572476|NCT01668537|62968064|FG000|Overall Study|Other|2|||
33572477|NCT01668537|62968065|FG001|Overall Study|Other|3|||
33572478|NCT01668147|62968071|FG000|Overall Study|Withdrawal by Subject|6|||
33664332|NCT02674854|63095343|FG001|Overall Study|Death|1|||
33664333|NCT02674854|63095344|FG002|Overall Study|Death|0|||
33572479|NCT02600559|62968088|FG000|Overall Study|Withdrawal by Subject|3|||
33572480|NCT02600559|62968088|FG000|Overall Study|Lost to Follow-up|20|||
33572481|NCT02601573|62968097|FG000|Overall Study|Lost to Follow-up|0|||
33572482|NCT02601573|62968098|FG001|Overall Study|Lost to Follow-up|3|||
33572483|NCT02601573|62968099|FG002|Overall Study|Lost to Follow-up|1|||
33572484|NCT02601573|62968100|FG003|Overall Study|Lost to Follow-up|0|||
33572485|NCT02601573|62968101|FG004|Overall Study|Lost to Follow-up|2|||
33572486|NCT02601573|62968097|FG000|Overall Study|Withdrawal by Subject|0|||
33572487|NCT02601573|62968098|FG001|Overall Study|Withdrawal by Subject|1|||
33664334|NCT02674854|63095342|FG000|Overall Study|Subject missed V6.2|1|||
33572488|NCT02601573|62968099|FG002|Overall Study|Withdrawal by Subject|0|||
33572489|NCT02601573|62968100|FG003|Overall Study|Withdrawal by Subject|1|||
33572490|NCT02601573|62968101|FG004|Overall Study|Withdrawal by Subject|0|||
33572491|NCT02601027|62968115|FG000|Registration to Surgery|Withdrawal by Subject|20|||
33572492|NCT02601027|62968116|FG001|Registration to Surgery|Withdrawal by Subject|10|||
33572493|NCT02600871|62968124|FG000|Overall Study|Lost to Follow-up|13|||
33572494|NCT02600871|62968125|FG001|Overall Study|Lost to Follow-up|10|||
33572495|NCT02598297|62968134|FG000|Overall Study|Study terminated by Sponsor|21|||
33572496|NCT02598297|62968135|FG001|Overall Study|Study terminated by Sponsor|23|||
33572497|NCT02598297|62968134|FG000|Overall Study|Adverse Event|1|||
33572498|NCT02598297|62968135|FG001|Overall Study|Adverse Event|1|||
33572499|NCT02598297|62968134|FG000|Overall Study|Physician Decision|1|||
33572500|NCT02598297|62968135|FG001|Overall Study|Physician Decision|0|||
33572501|NCT02598297|62968134|FG000|Overall Study|Subject/guardian decision|1|||
33572502|NCT02598297|62968135|FG001|Overall Study|Subject/guardian decision|0|||
33572503|NCT02598297|62968134|FG000|Overall Study|Followed for survival|1|||
33572504|NCT02598297|62968135|FG001|Overall Study|Followed for survival|0|||
33572505|NCT02596893|62968145|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
33572506|NCT02596893|62968146|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
33572507|NCT02596893|62968147|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
33572508|NCT02596893|62968148|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
33572509|NCT02596893|62968145|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
33572510|NCT02596893|62968146|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
33572511|NCT02596893|62968147|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
33572512|NCT02596893|62968148|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
33572513|NCT02596893|62968145|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
33572514|NCT02596893|62968146|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
33572515|NCT02596893|62968147|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
33572516|NCT02596893|62968148|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
33572517|NCT02596893|62968145|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
33572518|NCT02596893|62968146|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
33572519|NCT02596893|62968147|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
33572520|NCT02596893|62968148|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
33572521|NCT02596893|62968145|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
33572522|NCT02596893|62968146|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
33572523|NCT02596893|62968147|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
33572524|NCT02596893|62968148|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
33572525|NCT02596893|62968145|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
33572526|NCT02596893|62968146|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
33572527|NCT02596893|62968147|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
33572528|NCT02596893|62968148|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
33572529|NCT02596893|62968145|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
33572530|NCT02596893|62968146|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
33572531|NCT02596893|62968147|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
33572532|NCT02596893|62968148|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
33572533|NCT02596893|62968145|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
33572534|NCT02596893|62968146|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
33572535|NCT02596893|62968147|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
33572536|NCT02596893|62968148|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
33572537|NCT02596893|62968145|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
33572538|NCT02596893|62968146|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
33572539|NCT02596893|62968147|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
33572540|NCT02596893|62968148|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
33572541|NCT02596893|62968145|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
33572542|NCT02596893|62968146|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
33572543|NCT02596893|62968147|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
33572544|NCT02596893|62968148|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
33572545|NCT02596893|62968145|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
33572546|NCT02596893|62968146|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
33572547|NCT02596893|62968147|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
33572548|NCT02596893|62968148|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
33572549|NCT02592447|62968164|FG000|Overall Study|Lost to Follow-up|1|||
33572550|NCT02592447|62968165|FG001|Overall Study|Lost to Follow-up|0|||
33572551|NCT02592447|62968164|FG000|Overall Study|Ineligible after randomization|1|||
33572552|NCT02592447|62968165|FG001|Overall Study|Ineligible after randomization|0|||
33396758|NCT00678080|62776004|FG000|Overall Study|Withdrawal by Subject|0|||
33572553|NCT02592447|62968164|FG000|Overall Study|Withdrawal by Subject|0|||
33572554|NCT02592447|62968165|FG001|Overall Study|Withdrawal by Subject|1|||
33572555|NCT02595723|62968174|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
33572556|NCT02595723|62968175|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
33572557|NCT02595723|62968176|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
33572558|NCT02595723|62968174|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
33572559|NCT02595723|62968175|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
33572560|NCT02595723|62968176|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
33572561|NCT01667679|62968186|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
33572562|NCT01667679|62968187|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
33572563|NCT01667679|62968186|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
33572564|NCT01667679|62968187|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
33572565|NCT01667679|62968186|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
33572566|NCT01667679|62968187|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
33572567|NCT01667679|62968186|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
33572568|NCT01667679|62968187|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
33572569|NCT01667679|62968186|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
33572570|NCT01667679|62968187|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
33572571|NCT01667679|62968186|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
33572572|NCT01667679|62968187|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
33572573|NCT01667679|62968186|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
33572574|NCT01667679|62968187|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
33572575|NCT01667679|62968186|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
33572576|NCT01667679|62968187|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
33572577|NCT01667679|62968186|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
33572578|NCT01667679|62968187|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
33572579|NCT01667679|62968186|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
33572580|NCT01667679|62968187|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
33572581|NCT01667679|62968186|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
33572582|NCT01667679|62968187|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
33572583|NCT01667679|62968186|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
33572584|NCT01667679|62968187|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
33572585|NCT01667679|62968186|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
33572586|NCT01667679|62968187|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
33572587|NCT01667679|62968186|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
33572588|NCT01667679|62968187|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
33572589|NCT01667679|62968186|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
33572590|NCT01667679|62968187|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
33572591|NCT01667679|62968186|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
33572592|NCT01667679|62968187|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
33572593|NCT01667679|62968186|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
33572594|NCT01667679|62968187|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
33572595|NCT01667679|62968186|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
33572596|NCT01667679|62968187|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
33572597|NCT01667679|62968186|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
33572598|NCT01667679|62968187|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
33572599|NCT01667679|62968186|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
33572600|NCT01667679|62968187|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
33572601|NCT01667679|62968186|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
33572602|NCT01667679|62968187|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
33572603|NCT02597049|62968198|FG000|Overall Study|Lost to Follow-up|0|||
33572604|NCT02597049|62968199|FG001|Overall Study|Lost to Follow-up|3|||
33572605|NCT02597049|62968200|FG002|Overall Study|Lost to Follow-up|2|||
33572606|NCT02597049|62968198|FG000|Overall Study|Withdrawal by Subject|2|||
33572607|NCT02597049|62968199|FG001|Overall Study|Withdrawal by Subject|2|||
33572608|NCT02597049|62968200|FG002|Overall Study|Withdrawal by Subject|1|||
33572609|NCT02597049|62968198|FG000|Overall Study|Adverse Event|2|||
33572610|NCT02597049|62968199|FG001|Overall Study|Adverse Event|0|||
33572611|NCT02597049|62968200|FG002|Overall Study|Adverse Event|0|||
33572612|NCT02597049|62968198|FG000|Overall Study|Death|2|||
33572613|NCT02597049|62968199|FG001|Overall Study|Death|0|||
33572614|NCT02597049|62968200|FG002|Overall Study|Death|0|||
33572615|NCT02597049|62968198|FG000|Overall Study|Noncompliant with Study Visits|1|||
33572616|NCT02597049|62968199|FG001|Overall Study|Noncompliant with Study Visits|0|||
33572617|NCT02597049|62968200|FG002|Overall Study|Noncompliant with Study Visits|0|||
33572618|NCT02594163|62968210|FG000|Treatment Period|Progressive disease|2|||
33572619|NCT02594163|62968211|FG001|Treatment Period|Progressive disease|3|||
33396759|NCT00678080|62776005|FG001|Overall Study|Withdrawal by Subject|1|||
33572620|NCT02594163|62968210|FG000|Treatment Period|Adverse Event|1|||
33572621|NCT02594163|62968211|FG001|Treatment Period|Adverse Event|5|||
33572622|NCT02594163|62968210|FG000|Treatment Period|Physician Decision|1|||
33572623|NCT02594163|62968211|FG001|Treatment Period|Physician Decision|3|||
33572624|NCT02594163|62968210|FG000|Treatment Period|Study termination by sponsor|2|||
33572625|NCT02594163|62968211|FG001|Treatment Period|Study termination by sponsor|1|||
33572626|NCT02594163|62968210|FG000|Treatment Period|Other, Non-AE|1|||
33572627|NCT02594163|62968211|FG001|Treatment Period|Other, Non-AE|0|||
33572628|NCT02594163|62968210|FG000|Follow-up Period|Withdrawal by Subject|0|||
33572629|NCT02594163|62968211|FG001|Follow-up Period|Withdrawal by Subject|1|||
33572630|NCT02594163|62968210|FG000|Follow-up Period|Study Termination by Sponsor|6|||
33572631|NCT02594163|62968211|FG001|Follow-up Period|Study Termination by Sponsor|4|||
33572632|NCT02594163|62968210|FG000|Follow-up Period|Lost to Follow-up|1|||
33572633|NCT02594163|62968211|FG001|Follow-up Period|Lost to Follow-up|0|||
33572634|NCT02594163|62968210|FG000|Follow-up Period|Death|2|||
33572635|NCT02594163|62968211|FG001|Follow-up Period|Death|5|||
33572636|NCT02594163|62968210|FG000|Follow-up Period|Adverse Event|0|||
33572637|NCT02594163|62968211|FG001|Follow-up Period|Adverse Event|1|||
33572638|NCT02594163|62968210|FG000|Follow-up Period|Progressive Disease|2|||
33572639|NCT02594163|62968211|FG001|Follow-up Period|Progressive Disease|0|||
33396760|NCT00658320|62776013|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
33396761|NCT00658320|62776014|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
33396762|NCT00658320|62776013|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
33396763|NCT00658320|62776014|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
33572640|NCT02594163|62968210|FG000|Follow-up Period|Physician Decision|0|||
33572641|NCT02594163|62968211|FG001|Follow-up Period|Physician Decision|1|||
33572642|NCT02712983|62968226|FG000|Treatment Phase|Adverse Event|3|||
33572643|NCT02712983|62968227|FG001|Treatment Phase|Adverse Event|1|||
33572644|NCT02712983|62968228|FG002|Treatment Phase|Adverse Event|1|||
33572645|NCT02712983|62968229|FG003|Treatment Phase|Adverse Event|4|||
33572646|NCT02712983|62968230|FG004|Treatment Phase|Adverse Event|3|||
33572647|NCT02712983|62968231|FG005|Treatment Phase|Adverse Event|0|||
33572648|NCT02712983|62968232|FG006|Treatment Phase|Adverse Event|6|||
33572649|NCT02712983|62968233|FG007|Treatment Phase|Adverse Event|6|||
33572650|NCT02712983|62968234|FG008|Treatment Phase|Adverse Event|1|||
33572651|NCT02712983|62968226|FG000|Treatment Phase|Protocol Deviation|0|||
33572652|NCT02712983|62968227|FG001|Treatment Phase|Protocol Deviation|0|||
33572653|NCT02712983|62968228|FG002|Treatment Phase|Protocol Deviation|0|||
33572654|NCT02712983|62968229|FG003|Treatment Phase|Protocol Deviation|2|||
33572655|NCT02712983|62968230|FG004|Treatment Phase|Protocol Deviation|0|||
33572656|NCT02712983|62968231|FG005|Treatment Phase|Protocol Deviation|0|||
33572657|NCT02712983|62968232|FG006|Treatment Phase|Protocol Deviation|1|||
33572658|NCT02712983|62968233|FG007|Treatment Phase|Protocol Deviation|0|||
33572659|NCT02712983|62968234|FG008|Treatment Phase|Protocol Deviation|0|||
33572660|NCT02712983|62968226|FG000|Treatment Phase|Technical Problems|0|||
33572661|NCT02712983|62968227|FG001|Treatment Phase|Technical Problems|0|||
33572662|NCT02712983|62968228|FG002|Treatment Phase|Technical Problems|0|||
33572663|NCT02712983|62968229|FG003|Treatment Phase|Technical Problems|0|||
33572664|NCT02712983|62968230|FG004|Treatment Phase|Technical Problems|0|||
33572665|NCT02712983|62968231|FG005|Treatment Phase|Technical Problems|0|||
33572666|NCT02712983|62968232|FG006|Treatment Phase|Technical Problems|1|||
33572667|NCT02712983|62968233|FG007|Treatment Phase|Technical Problems|0|||
33572668|NCT02712983|62968234|FG008|Treatment Phase|Technical Problems|0|||
33572669|NCT02712983|62968226|FG000|Treatment Phase|Physician Decision|0|||
33572670|NCT02712983|62968227|FG001|Treatment Phase|Physician Decision|0|||
33572671|NCT02712983|62968228|FG002|Treatment Phase|Physician Decision|0|||
33572672|NCT02712983|62968229|FG003|Treatment Phase|Physician Decision|0|||
33572673|NCT02712983|62968230|FG004|Treatment Phase|Physician Decision|0|||
33572674|NCT02712983|62968231|FG005|Treatment Phase|Physician Decision|0|||
33572675|NCT02712983|62968232|FG006|Treatment Phase|Physician Decision|0|||
33572676|NCT02712983|62968233|FG007|Treatment Phase|Physician Decision|1|||
33572677|NCT02712983|62968234|FG008|Treatment Phase|Physician Decision|1|||
33572678|NCT02712983|62968226|FG000|Treatment Phase|Subject Decision|2|||
33572679|NCT02712983|62968227|FG001|Treatment Phase|Subject Decision|0|||
33572680|NCT02712983|62968228|FG002|Treatment Phase|Subject Decision|0|||
33572681|NCT02712983|62968229|FG003|Treatment Phase|Subject Decision|2|||
33572682|NCT02712983|62968230|FG004|Treatment Phase|Subject Decision|1|||
33572683|NCT02712983|62968231|FG005|Treatment Phase|Subject Decision|0|||
33572684|NCT02712983|62968232|FG006|Treatment Phase|Subject Decision|1|||
33572685|NCT02712983|62968233|FG007|Treatment Phase|Subject Decision|2|||
33572686|NCT02712983|62968234|FG008|Treatment Phase|Subject Decision|0|||
33572687|NCT02712983|62968226|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33572688|NCT02712983|62968227|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
33572689|NCT02712983|62968228|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33572690|NCT02712983|62968229|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33572691|NCT02712983|62968230|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33572692|NCT02712983|62968231|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33572693|NCT02712983|62968232|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
33572694|NCT02712983|62968233|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
33572695|NCT02712983|62968234|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33572696|NCT02712983|62968226|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33572697|NCT02712983|62968227|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33572698|NCT02712983|62968228|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33572699|NCT02712983|62968229|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
33572700|NCT02712983|62968230|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33572701|NCT02712983|62968231|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33572702|NCT02712983|62968232|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33572703|NCT02712983|62968233|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33572704|NCT02712983|62968234|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33572705|NCT02712983|62968226|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
33572706|NCT02712983|62968227|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
33572707|NCT02712983|62968228|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
33572708|NCT02712983|62968229|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
33572709|NCT02712983|62968230|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
33572710|NCT02712983|62968231|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
33572711|NCT02712983|62968232|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
33572712|NCT02712983|62968233|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
33572713|NCT02712983|62968234|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
33572714|NCT02596971|62968257|FG000|Overall Study|Death|5|||
33572715|NCT02596971|62968258|FG001|Overall Study|Death|1|||
33572716|NCT02596971|62968259|FG002|Overall Study|Death|5|||
33572717|NCT02596971|62968257|FG000|Overall Study|Withdrawal by Subject|5|||
33572718|NCT02596971|62968258|FG001|Overall Study|Withdrawal by Subject|1|||
33572719|NCT02596971|62968259|FG002|Overall Study|Withdrawal by Subject|4|||
33572720|NCT02593773|62968270|FG000|Overall Study|Voluntary Withdrawal|3|||
33572721|NCT02593773|62968270|FG000|Overall Study|Study Terminated by Sponsor|31|||
33572722|NCT02593773|62968270|FG000|Overall Study|Death|1|||
33572723|NCT02593539|62968274|FG000|Overall Study|Adverse Event|1|||
33572724|NCT00919763|62968283|FG000|Overall Study|Adverse Event|7|||
33572725|NCT00919763|62968284|FG001|Overall Study|Adverse Event|1|||
33572726|NCT00919763|62968283|FG000|Overall Study|Lost to Follow-up|1|||
33572727|NCT00919763|62968284|FG001|Overall Study|Lost to Follow-up|0|||
33572728|NCT00919763|62968283|FG000|Overall Study|Protocol Violation|1|||
33572729|NCT00919763|62968284|FG001|Overall Study|Protocol Violation|1|||
33572730|NCT00919763|62968283|FG000|Overall Study|Withdrawal by Subject|3|||
33572731|NCT00919763|62968284|FG001|Overall Study|Withdrawal by Subject|1|||
33572732|NCT00919763|62968283|FG000|Overall Study|Non-compliance|0|||
33572733|NCT00919763|62968284|FG001|Overall Study|Non-compliance|1|||
33572734|NCT02593305|62968302|FG000|Post 1|Comparison only group. No intervention.|0|||
33572735|NCT02593305|62968303|FG001|Post 1|Comparison only group. No intervention.|0|||
33572736|NCT02593305|62968304|FG002|Post 1|Comparison only group. No intervention.|10|||
33572737|NCT02593149|62968315|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
33572738|NCT02593149|62968316|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
33572739|NCT02593149|62968315|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
33572740|NCT02593149|62968316|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
33572741|NCT02177812|62968331|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
33572742|NCT02177812|62968332|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
33572743|NCT02177812|62968333|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
33572744|NCT02177812|62968334|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
33572745|NCT02177812|62968335|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
33572746|NCT02177812|62968336|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
33572747|NCT02177812|62968337|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
33572748|NCT02177812|62968338|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
33572749|NCT02177812|62968339|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
33572750|NCT02177812|62968331|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
33572751|NCT02177812|62968332|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
33572752|NCT02177812|62968333|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
33572753|NCT02177812|62968334|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
33572754|NCT02177812|62968335|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
33572755|NCT02177812|62968336|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
33572756|NCT02177812|62968337|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
33572757|NCT02177812|62968338|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
33572758|NCT02177812|62968339|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
33572759|NCT02177812|62968331|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
33572760|NCT02177812|62968332|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
33572761|NCT02177812|62968333|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
33572762|NCT02177812|62968334|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
33572763|NCT02177812|62968335|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
33572764|NCT02177812|62968336|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
33572765|NCT02177812|62968337|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
33572766|NCT02177812|62968338|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
33572767|NCT02177812|62968339|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
33572768|NCT01626352|62968383|FG000|Overall Study|Disease Progression|3|||
33572769|NCT01626352|62968383|FG000|Overall Study|Intercurrent Illness|2|||
33572770|NCT01626352|62968383|FG000|Overall Study|Death|2|||
33572771|NCT01626352|62968383|FG000|Overall Study|Withdrawal by Subject|1|||
33572772|NCT01626352|62968383|FG000|Overall Study|Non-Compliance|1|||
33572773|NCT01626352|62968383|FG000|Overall Study|Never Treated|1|||
33664335|NCT02674854|63095343|FG001|Overall Study|Subject missed V6.2|0|||
33664336|NCT02674854|63095344|FG002|Overall Study|Subject missed V6.2|0|||
33572774|NCT01626118|62968394|FG000|Overall Study|Lack of Efficacy|1|||
33572775|NCT01626118|62968395|FG001|Overall Study|Lack of Efficacy|0|||
33572776|NCT01626118|62968396|FG002|Overall Study|Lack of Efficacy|1|||
33572777|NCT01626118|62968397|FG003|Overall Study|Lack of Efficacy|3|||
33572778|NCT01626118|62968394|FG000|Overall Study|Lost to Follow-up|1|||
33572779|NCT01626118|62968395|FG001|Overall Study|Lost to Follow-up|0|||
33572780|NCT01626118|62968396|FG002|Overall Study|Lost to Follow-up|0|||
33572781|NCT01626118|62968397|FG003|Overall Study|Lost to Follow-up|0|||
33572782|NCT01626118|62968394|FG000|Overall Study|Adverse Event|0|||
33572783|NCT01626118|62968395|FG001|Overall Study|Adverse Event|1|||
33572784|NCT01626118|62968396|FG002|Overall Study|Adverse Event|1|||
33572785|NCT01626118|62968397|FG003|Overall Study|Adverse Event|0|||
33572786|NCT01626118|62968394|FG000|Overall Study|Investigator Decision|0|||
33572787|NCT01626118|62968395|FG001|Overall Study|Investigator Decision|1|||
33572788|NCT01626118|62968396|FG002|Overall Study|Investigator Decision|0|||
33572789|NCT01626118|62968397|FG003|Overall Study|Investigator Decision|0|||
33572790|NCT02152384|62968407|FG000|Period 1|Withdrawal by Subject|0|||
33572791|NCT02152384|62968408|FG001|Period 1|Withdrawal by Subject|1|||
33572792|NCT02152384|62968407|FG000|Period 1|Adverse Event|1|||
33572793|NCT02152384|62968408|FG001|Period 1|Adverse Event|1|||
33572794|NCT02177266|62968420|FG000|Overall Study|Adverse Event|0|||
33572795|NCT02177266|62968421|FG001|Overall Study|Adverse Event|1|||
33572796|NCT02177266|62968420|FG000|Overall Study|Withdrawal by Subject|1|||
33572797|NCT02177266|62968421|FG001|Overall Study|Withdrawal by Subject|0|||
33572798|NCT02177032|62968431|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
33572799|NCT02177032|62968432|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
33572800|NCT02177032|62968433|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
33572801|NCT02177032|62968434|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
33572802|NCT02177032|62968431|FG000|Overall Study|Lost to Follow-up|0|||
33572803|NCT02177032|62968432|FG001|Overall Study|Lost to Follow-up|2|||
33572804|NCT02177032|62968433|FG002|Overall Study|Lost to Follow-up|0|||
33572805|NCT02177032|62968434|FG003|Overall Study|Lost to Follow-up|0|||
33572806|NCT02177032|62968431|FG000|Overall Study|OTHER|2|||
33572807|NCT02177032|62968432|FG001|Overall Study|OTHER|0|||
33572808|NCT02177032|62968433|FG002|Overall Study|OTHER|1|||
33572809|NCT02177032|62968434|FG003|Overall Study|OTHER|0|||
33572810|NCT02177032|62968431|FG000|Overall Study|Withdrawal by Subject|1|||
33572811|NCT02177032|62968432|FG001|Overall Study|Withdrawal by Subject|0|||
33572812|NCT02177032|62968433|FG002|Overall Study|Withdrawal by Subject|1|||
33572813|NCT02177032|62968434|FG003|Overall Study|Withdrawal by Subject|0|||
33572814|NCT02116972|62968458|FG000|Overall Study|Adverse Event|4|||
33572815|NCT02116972|62968459|FG001|Overall Study|Adverse Event|4|||
33572816|NCT02116972|62968460|FG002|Overall Study|Adverse Event|1|||
33572817|NCT02116972|62968458|FG000|Overall Study|Withdrawal by Subject|1|||
33572818|NCT02116972|62968459|FG001|Overall Study|Withdrawal by Subject|1|||
33572819|NCT02116972|62968460|FG002|Overall Study|Withdrawal by Subject|5|||
33572820|NCT02116972|62968458|FG000|Overall Study|Protocol Violation|1|||
33572821|NCT02116972|62968459|FG001|Overall Study|Protocol Violation|0|||
33664337|NCT02667288|63095352|FG000|Overall Study|Protocol Violation|5|||
33664338|NCT02667288|63095352|FG000|Overall Study|Lost to Follow-up|3|||
33572822|NCT02116972|62968460|FG002|Overall Study|Protocol Violation|1|||
33572823|NCT02116972|62968458|FG000|Overall Study|Lost to Follow-up|4|||
33572824|NCT02116972|62968459|FG001|Overall Study|Lost to Follow-up|3|||
33572825|NCT02116972|62968460|FG002|Overall Study|Lost to Follow-up|1|||
33572826|NCT02116972|62968458|FG000|Overall Study|Lack of Efficacy|6|||
33572827|NCT02116972|62968459|FG001|Overall Study|Lack of Efficacy|6|||
33572828|NCT02116972|62968460|FG002|Overall Study|Lack of Efficacy|5|||
33572829|NCT02116972|62968458|FG000|Overall Study|scheduling conflicts and relocation|3|||
33572830|NCT02116972|62968459|FG001|Overall Study|scheduling conflicts and relocation|3|||
33572831|NCT02116972|62968460|FG002|Overall Study|scheduling conflicts and relocation|6|||
33572832|NCT02176642|62968472|FG000|Overall Study|Withdrawal by Subject|0|||
33572833|NCT02176642|62968473|FG001|Overall Study|Withdrawal by Subject|1|||
33572834|NCT02116660|62968481|FG000|Overall Study|Deteriorating renal function|0|||
33572835|NCT02116660|62968482|FG001|Overall Study|Deteriorating renal function|1|||
33572836|NCT02116660|62968481|FG000|Overall Study|Adverse Event|1|||
33572837|NCT02116660|62968482|FG001|Overall Study|Adverse Event|1|||
33572838|NCT02116660|62968481|FG000|Overall Study|Withdrawal by Subject|0|||
33572839|NCT02116660|62968482|FG001|Overall Study|Withdrawal by Subject|2|||
33572840|NCT02116660|62968481|FG000|Overall Study|Organization reason|1|||
33572841|NCT02116660|62968482|FG001|Overall Study|Organization reason|0|||
33572842|NCT02589405|62968490|FG000|Overall Study|Adverse Event|3|||
33572843|NCT02589405|62968490|FG000|Overall Study|Withdrawal by Subject|1|||
33572844|NCT02176018|62968496|FG000|Overall Study|Adverse Event|0|||
33572845|NCT02176018|62968497|FG001|Overall Study|Adverse Event|2|||
33572846|NCT02176018|62968496|FG000|Overall Study|Lost to Follow-up|3|||
33572847|NCT02176018|62968497|FG001|Overall Study|Lost to Follow-up|1|||
33572848|NCT02176018|62968496|FG000|Overall Study|Protocol Violation|1|||
33572849|NCT02176018|62968497|FG001|Overall Study|Protocol Violation|1|||
33572850|NCT02176018|62968496|FG000|Overall Study|Withdrawal by Subject|1|||
33572851|NCT02176018|62968497|FG001|Overall Study|Withdrawal by Subject|2|||
33572852|NCT02116582|62968503|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
33572853|NCT02116582|62968503|FG000|Overall Study|Adverse Event|22|||
33572854|NCT02116582|62968503|FG000|Overall Study|Death|9|||
33572855|NCT02116582|62968503|FG000|Overall Study|Progressive Disease|148|||
33572856|NCT02116582|62968503|FG000|Overall Study|Protocol Violation|3|||
33572857|NCT02116582|62968503|FG000|Overall Study|Withdrawal by Subject|8|||
33572858|NCT02116582|62968503|FG000|Overall Study|Other: Miscellaneous|11|||
33572859|NCT02116582|62968503|FG000|Overall Study|Lost to Follow-up|1|||
33572860|NCT02116582|62968503|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
33572861|NCT02589639|62968510|FG000|Overall Study|Lost to Follow-up|1|||
33572862|NCT02589639|62968511|FG001|Overall Study|Lost to Follow-up|0|||
33572863|NCT02589639|62968512|FG002|Overall Study|Lost to Follow-up|0|||
33572864|NCT02589639|62968510|FG000|Overall Study|Protocol Violation|1|||
33572865|NCT02589639|62968511|FG001|Overall Study|Protocol Violation|0|||
33572866|NCT02589639|62968512|FG002|Overall Study|Protocol Violation|0|||
33572867|NCT02589639|62968510|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
33572868|NCT02589639|62968511|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
33572869|NCT02589639|62968512|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
33572870|NCT02589639|62968510|FG000|Overall Study|Adverse Event|4|||
33572871|NCT02589639|62968511|FG001|Overall Study|Adverse Event|5|||
33572872|NCT02589639|62968512|FG002|Overall Study|Adverse Event|3|||
33572873|NCT02589639|62968510|FG000|Overall Study|Other reason than specified above|1|||
33572874|NCT02589639|62968511|FG001|Overall Study|Other reason than specified above|2|||
33572875|NCT02589639|62968512|FG002|Overall Study|Other reason than specified above|1|||
33572876|NCT02589639|62968510|FG000|Overall Study|Not Treated|0|||
33572877|NCT02589639|62968511|FG001|Overall Study|Not Treated|3|||
33572878|NCT02589639|62968512|FG002|Overall Study|Not Treated|0|||
33572879|NCT02151682|62968522|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
33572880|NCT02151682|62968523|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
33572881|NCT02151682|62968524|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
33572882|NCT02151682|62968525|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
33572883|NCT02151682|62968526|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
33572884|NCT02151682|62968527|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
33572885|NCT02151682|62968522|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
33572886|NCT02151682|62968523|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
33572887|NCT02151682|62968524|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
33572888|NCT02151682|62968525|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
33572889|NCT02151682|62968526|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
33572890|NCT02151682|62968527|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
33572891|NCT02151682|62968522|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
33572892|NCT02151682|62968523|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
33572893|NCT02151682|62968524|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
33572894|NCT02151682|62968525|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
33572895|NCT02151682|62968526|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
33572896|NCT02151682|62968527|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
33572897|NCT02151682|62968522|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
33572898|NCT02151682|62968523|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
33572899|NCT02151682|62968524|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
33572900|NCT02151682|62968525|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
33572901|NCT02151682|62968526|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
33572902|NCT02151682|62968527|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
33572903|NCT02151682|62968522|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
33572904|NCT02151682|62968523|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
33572905|NCT02151682|62968524|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
33572906|NCT02151682|62968525|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
33572907|NCT02151682|62968526|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
33572908|NCT02151682|62968527|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
33572909|NCT02151682|62968522|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
33572910|NCT02151682|62968523|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
33572911|NCT02151682|62968524|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
33572912|NCT02151682|62968525|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
33572913|NCT02151682|62968526|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
33572914|NCT02151682|62968527|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
33572915|NCT02151682|62968522|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
33572916|NCT02151682|62968523|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
33572917|NCT02151682|62968524|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
33572918|NCT02151682|62968525|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
33572919|NCT02151682|62968526|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
33572920|NCT02151682|62968527|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
33572921|NCT02151682|62968522|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
33572922|NCT02151682|62968523|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
33572923|NCT02151682|62968524|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
33572924|NCT02151682|62968525|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
33572925|NCT02151682|62968526|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
33572926|NCT02151682|62968527|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
33572927|NCT02151682|62968522|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
33572928|NCT02151682|62968523|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
33572929|NCT02151682|62968524|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
33572930|NCT02151682|62968525|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
33572931|NCT02151682|62968526|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
33572932|NCT02151682|62968527|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
33572933|NCT02151682|62968522|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
33572934|NCT02151682|62968523|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
33572935|NCT02151682|62968524|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
33572936|NCT02151682|62968525|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
33572937|NCT02151682|62968526|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
33572938|NCT02151682|62968527|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
33572939|NCT02151682|62968522|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
33572940|NCT02151682|62968523|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
33572941|NCT02151682|62968524|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
33572942|NCT02151682|62968525|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
33572943|NCT02151682|62968526|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
33572944|NCT02151682|62968527|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
33572945|NCT02151682|62968522|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
33572946|NCT02151682|62968523|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
33572947|NCT02151682|62968524|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
33572948|NCT02151682|62968525|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
33572949|NCT02151682|62968526|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
33572950|NCT02151682|62968527|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
33572951|NCT02151682|62968522|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
33572952|NCT02151682|62968523|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
33572953|NCT02151682|62968524|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
33572954|NCT02151682|62968525|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
33572955|NCT02151682|62968526|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
33572956|NCT02151682|62968527|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
33572957|NCT02151682|62968522|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
33572958|NCT02151682|62968523|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
33572959|NCT02151682|62968524|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
33572960|NCT02151682|62968525|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
33572961|NCT02151682|62968526|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
33572962|NCT02151682|62968527|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
33572963|NCT02151682|62968522|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
33572964|NCT02151682|62968523|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
33572965|NCT02151682|62968524|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
33572966|NCT02151682|62968525|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
33572967|NCT02151682|62968526|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
33572968|NCT02151682|62968527|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
33572969|NCT02151682|62968522|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
33572970|NCT02151682|62968523|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
33572971|NCT02151682|62968524|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
33572972|NCT02151682|62968525|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
33572973|NCT02151682|62968526|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
33572974|NCT02151682|62968527|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
33572975|NCT02151682|62968522|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
33572976|NCT02151682|62968523|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
33572977|NCT02151682|62968524|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
33572978|NCT02151682|62968525|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
33572979|NCT02151682|62968526|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
33572980|NCT02151682|62968527|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
33572981|NCT02151682|62968522|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
33572982|NCT02151682|62968523|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
33572983|NCT02151682|62968524|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
33572984|NCT02151682|62968525|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
33572985|NCT02151682|62968526|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
33572986|NCT02151682|62968527|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
33572987|NCT02174848|62968547|FG000|Overall Study|Adverse Event|2|||
33572988|NCT02174848|62968548|FG001|Overall Study|Adverse Event|1|||
33572989|NCT02174848|62968547|FG000|Overall Study|Withdrawal by Subject|3|||
33572990|NCT02174848|62968548|FG001|Overall Study|Withdrawal by Subject|3|||
33572991|NCT02174848|62968547|FG000|Overall Study|Lost to Follow-up|0|||
33572992|NCT02174848|62968548|FG001|Overall Study|Lost to Follow-up|1|||
33572993|NCT02174848|62968547|FG000|Overall Study|Worsening of disease|1|||
33572994|NCT02174848|62968548|FG001|Overall Study|Worsening of disease|1|||
33572995|NCT02174848|62968547|FG000|Overall Study|Unable to comply with study requirements|1|||
33572996|NCT02174848|62968548|FG001|Overall Study|Unable to comply with study requirements|0|||
33572997|NCT02151058|62968562|FG000|Overall Study|Withdrawal by Subject|1|||
33572998|NCT02151058|62968563|FG001|Overall Study|Withdrawal by Subject|1|||
33572999|NCT02151058|62968564|FG002|Overall Study|Withdrawal by Subject|3|||
33573000|NCT02151058|62968562|FG000|Overall Study|Lost to Follow-up|1|||
33573001|NCT02151058|62968563|FG001|Overall Study|Lost to Follow-up|0|||
33573002|NCT02151058|62968564|FG002|Overall Study|Lost to Follow-up|2|||
33573003|NCT02149810|62968574|FG000|Overall Study|Physician Decision|1|||
33573004|NCT02149810|62968575|FG001|Overall Study|Physician Decision|2|||
33573005|NCT02149810|62968574|FG000|Overall Study|Lost to Follow-up|2|||
33573006|NCT02149810|62968575|FG001|Overall Study|Lost to Follow-up|1|||
33573007|NCT02149810|62968574|FG000|Overall Study|Withdrawal by Subject|5|||
33573008|NCT02149810|62968575|FG001|Overall Study|Withdrawal by Subject|1|||
33573009|NCT02149420|62968584|FG000|Core Study|Administrative problems|0|||
33573010|NCT02149420|62968585|FG001|Core Study|Administrative problems|1|||
33573011|NCT02149420|62968586|FG002|Core Study|Administrative problems|2|||
33573012|NCT02149420|62968584|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
33573013|NCT02149420|62968585|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
33573014|NCT02149420|62968586|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
33573015|NCT02149264|62968599|FG000|Overall Study|Withdrawal by Subject|9|||
33573016|NCT02149264|62968599|FG000|Overall Study|Adverse Event|7|||
33573017|NCT02149264|62968599|FG000|Overall Study|Physician Decision|3|||
33573018|NCT02149264|62968599|FG000|Overall Study|Protocol Violation|1|||
33573019|NCT02115256|62968605|FG000|Overall Study|Withdrawal by Subject|0|||
33573020|NCT02115256|62968606|FG001|Overall Study|Withdrawal by Subject|1|||
33573021|NCT02173054|62968615|FG000|Overall Study|lack of compliance|1|||
33573022|NCT02173054|62968616|FG001|Overall Study|lack of compliance|0|||
33573023|NCT02173054|62968617|FG002|Overall Study|lack of compliance|0|||
33573024|NCT02173054|62968615|FG000|Overall Study|Withdrawal by Subject|0|||
33573025|NCT02173054|62968616|FG001|Overall Study|Withdrawal by Subject|0|||
33573026|NCT02173054|62968617|FG002|Overall Study|Withdrawal by Subject|1|||
33573027|NCT02149108|62968662|FG000|Overall Study|Not treated|1|||
33573028|NCT02149108|62968663|FG001|Overall Study|Not treated|2|||
33573029|NCT02149108|62968662|FG000|Overall Study|Progressive Disease (PD)|324|||
33573030|NCT02149108|62968663|FG001|Overall Study|Progressive Disease (PD)|318|||
33573031|NCT02149108|62968662|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
33573032|NCT02149108|62968663|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
33573033|NCT02149108|62968662|FG000|Overall Study|Other Adverse Event (AE)|8|||
33573034|NCT02149108|62968663|FG001|Overall Study|Other Adverse Event (AE)|18|||
33573035|NCT02149108|62968662|FG000|Overall Study|Other not defined above|0|||
33573036|NCT02149108|62968663|FG001|Overall Study|Other not defined above|2|||
33573037|NCT02149108|62968662|FG000|Overall Study|Refusal to continue trial medication|15|||
33573038|NCT02149108|62968663|FG001|Overall Study|Refusal to continue trial medication|11|||
33573039|NCT02149108|62968662|FG000|Overall Study|Lost to Follow-up|1|||
33573040|NCT02149108|62968663|FG001|Overall Study|Lost to Follow-up|0|||
33573041|NCT02148952|62968671|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
33573042|NCT02148952|62968672|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
33573043|NCT02148952|62968671|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
33573044|NCT02148952|62968672|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
33573045|NCT02148952|62968671|FG000|Follow-Up|Lost to Follow-up|219|||
33573046|NCT02148952|62968672|FG001|Follow-Up|Lost to Follow-up|231|||
33573047|NCT02148952|62968671|FG000|Follow-Up|Withdrawal by Subject|46|||
33573048|NCT02148952|62968672|FG001|Follow-Up|Withdrawal by Subject|48|||
33573049|NCT02148718|62968696|FG000|Overall Study|Protocol Violation|26|||
33573050|NCT02148718|62968696|FG000|Overall Study|Discontinued Study Prematurely|5|||
33573051|NCT02148250|62968700|FG000|Screening|Withdrawal by Subject|5|||
33573052|NCT02148250|62968701|FG001|Screening|Withdrawal by Subject|0|||
33573053|NCT02147626|62968710|FG000|Overall Study|Lost to Follow-up|4|||
33573054|NCT02147626|62968711|FG001|Overall Study|Lost to Follow-up|4|||
33573055|NCT02147626|62968710|FG000|Overall Study|Pregnancy|1|||
33573056|NCT02147626|62968711|FG001|Overall Study|Pregnancy|2|||
33573057|NCT02147626|62968710|FG000|Overall Study|Withdrawal by Subject|0|||
33573058|NCT02147626|62968711|FG001|Overall Study|Withdrawal by Subject|1|||
33573059|NCT02172664|62968717|FG000|Overall Study|Lost to Follow-up|4|||
33573060|NCT02172664|62968718|FG001|Overall Study|Lost to Follow-up|4|||
33573061|NCT02172664|62968717|FG000|Overall Study|Death|1|||
33573062|NCT02172664|62968718|FG001|Overall Study|Death|1|||
33573063|NCT02172664|62968717|FG000|Overall Study|Moved out of area|1|||
33573064|NCT02172664|62968718|FG001|Overall Study|Moved out of area|1|||
33573065|NCT02172040|62968727|FG000|Overall Study|Adverse Event|0|||
33573066|NCT02172040|62968728|FG001|Overall Study|Adverse Event|2|||
33573067|NCT02172040|62968729|FG002|Overall Study|Adverse Event|0|||
33573068|NCT02172040|62968730|FG003|Overall Study|Adverse Event|0|||
33573069|NCT02172040|62968727|FG000|Overall Study|Protocol Violation|0|||
33573070|NCT02172040|62968728|FG001|Overall Study|Protocol Violation|1|||
33573071|NCT02172040|62968729|FG002|Overall Study|Protocol Violation|0|||
33573072|NCT02172040|62968730|FG003|Overall Study|Protocol Violation|0|||
33573073|NCT02172040|62968727|FG000|Overall Study|Withdrawal by Subject|0|||
33573074|NCT02172040|62968728|FG001|Overall Study|Withdrawal by Subject|0|||
33573075|NCT02172040|62968729|FG002|Overall Study|Withdrawal by Subject|1|||
33573076|NCT02172040|62968730|FG003|Overall Study|Withdrawal by Subject|0|||
33573077|NCT02172040|62968727|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
33573078|NCT02172040|62968728|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
33573079|NCT02172040|62968729|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
33573080|NCT02172040|62968730|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
33573081|NCT02172040|62968727|FG000|Overall Study|Family emergency abroad|0|||
33573082|NCT02172040|62968728|FG001|Overall Study|Family emergency abroad|0|||
33573083|NCT02172040|62968729|FG002|Overall Study|Family emergency abroad|0|||
33573084|NCT02172040|62968730|FG003|Overall Study|Family emergency abroad|1|||
33573085|NCT02112994|62968756|FG000|Overall Study|Progressive Disease|0|||
33573086|NCT02112994|62968757|FG001|Overall Study|Progressive Disease|0|||
33573087|NCT02112994|62968758|FG002|Overall Study|Progressive Disease|1|||
33573088|NCT02112994|62968756|FG000|Overall Study|Pregnancy|0|||
33573089|NCT02112994|62968757|FG001|Overall Study|Pregnancy|1|||
33573090|NCT02112994|62968758|FG002|Overall Study|Pregnancy|1|||
33573091|NCT02112994|62968756|FG000|Overall Study|Liver Transplant|0|||
33573092|NCT02112994|62968757|FG001|Overall Study|Liver Transplant|1|||
33573093|NCT02112994|62968758|FG002|Overall Study|Liver Transplant|0|||
33573094|NCT02112994|62968756|FG000|Overall Study|Withdrawal by Subject|0|||
33573095|NCT02112994|62968757|FG001|Overall Study|Withdrawal by Subject|0|||
33573096|NCT02112994|62968758|FG002|Overall Study|Withdrawal by Subject|1|||
33573097|NCT02147158|62968776|FG000|Treatment Course 1|Adverse Event|1|||
33573098|NCT02147158|62968777|FG001|Treatment Course 1|Adverse Event|4|||
33573099|NCT02147158|62968778|FG002|Treatment Course 1|Adverse Event|3|||
33573100|NCT02147158|62968779|FG003|Treatment Course 1|Adverse Event|4|||
33573101|NCT02147158|62968780|FG004|Treatment Course 1|Adverse Event|1|||
33302879|NCT01072396|62678725|FG001|Period Two|Lost to Follow-up|0|||
33302880|NCT01045096|62678734|FG000|Overall Study|Withdrawal by Subject|2|||
33573102|NCT02147158|62968781|FG005|Treatment Course 1|Adverse Event|2|||
33573103|NCT02147158|62968776|FG000|Treatment Course 1|Lost to Follow-up|2|||
33573104|NCT02147158|62968777|FG001|Treatment Course 1|Lost to Follow-up|4|||
33573105|NCT02147158|62968778|FG002|Treatment Course 1|Lost to Follow-up|3|||
33573106|NCT02147158|62968779|FG003|Treatment Course 1|Lost to Follow-up|3|||
33573107|NCT02147158|62968780|FG004|Treatment Course 1|Lost to Follow-up|2|||
33573108|NCT02147158|62968781|FG005|Treatment Course 1|Lost to Follow-up|4|||
33573109|NCT02147158|62968776|FG000|Treatment Course 1|Protocol Violation|0|||
33573110|NCT02147158|62968777|FG001|Treatment Course 1|Protocol Violation|0|||
33573111|NCT02147158|62968778|FG002|Treatment Course 1|Protocol Violation|1|||
33573112|NCT02147158|62968779|FG003|Treatment Course 1|Protocol Violation|1|||
33573113|NCT02147158|62968780|FG004|Treatment Course 1|Protocol Violation|0|||
33573114|NCT02147158|62968781|FG005|Treatment Course 1|Protocol Violation|0|||
33573115|NCT02147158|62968776|FG000|Treatment Course 1|Withdrawal of Consent|1|||
33573116|NCT02147158|62968777|FG001|Treatment Course 1|Withdrawal of Consent|1|||
33573117|NCT02147158|62968778|FG002|Treatment Course 1|Withdrawal of Consent|1|||
33573118|NCT02147158|62968779|FG003|Treatment Course 1|Withdrawal of Consent|5|||
33573119|NCT02147158|62968780|FG004|Treatment Course 1|Withdrawal of Consent|3|||
33573120|NCT02147158|62968781|FG005|Treatment Course 1|Withdrawal of Consent|2|||
33573121|NCT02147158|62968776|FG000|Off-Treatment Interval 1|Adverse Event|1|||
33573122|NCT02147158|62968777|FG001|Off-Treatment Interval 1|Adverse Event|0|||
33573123|NCT02147158|62968778|FG002|Off-Treatment Interval 1|Adverse Event|0|||
33573124|NCT02147158|62968779|FG003|Off-Treatment Interval 1|Adverse Event|1|||
33573125|NCT02147158|62968780|FG004|Off-Treatment Interval 1|Adverse Event|0|||
33573126|NCT02147158|62968781|FG005|Off-Treatment Interval 1|Adverse Event|0|||
33573127|NCT02147158|62968776|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
33573128|NCT02147158|62968777|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
33573129|NCT02147158|62968778|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
33573130|NCT02147158|62968779|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
33573131|NCT02147158|62968780|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
33573132|NCT02147158|62968781|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
33573133|NCT02147158|62968776|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
33573134|NCT02147158|62968777|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
33573135|NCT02147158|62968778|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
33573136|NCT02147158|62968779|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
33573137|NCT02147158|62968780|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
33573138|NCT02147158|62968781|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
33573139|NCT02147158|62968776|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
33573140|NCT02147158|62968777|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
33302881|NCT01045096|62678735|FG001|Overall Study|Withdrawal by Subject|0|||
33490349|NCT00069095|62868444|FG001|Primary Treatment Phase|Failure to return|5|||
33490350|NCT00069095|62868445|FG002|Primary Treatment Phase|Failure to return|0|||
33490351|NCT00069095|62868446|FG003|Primary Treatment Phase|Failure to return|0|||
33490352|NCT00069095|62868447|FG004|Primary Treatment Phase|Failure to return|0|||
33490353|NCT00069095|62868448|FG005|Primary Treatment Phase|Failure to return|2|||
33490354|NCT00069095|62868443|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
33490355|NCT00069095|62868444|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
33490356|NCT00069095|62868445|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
33490357|NCT00069095|62868446|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
33490358|NCT00069095|62868447|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
33490359|NCT00069095|62868448|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
33490360|NCT00069095|62868443|FG000|Primary Treatment Phase|Refused treatment|15|||
33490361|NCT00069095|62868444|FG001|Primary Treatment Phase|Refused treatment|26|||
33490362|NCT00069095|62868445|FG002|Primary Treatment Phase|Refused treatment|17|||
33490363|NCT00069095|62868446|FG003|Primary Treatment Phase|Refused treatment|31|||
33490364|NCT00069095|62868447|FG004|Primary Treatment Phase|Refused treatment|24|||
33490365|NCT00069095|62868448|FG005|Primary Treatment Phase|Refused treatment|27|||
33490366|NCT00069095|62868443|FG000|Primary Treatment Phase|Withdrew|2|||
33490367|NCT00069095|62868444|FG001|Primary Treatment Phase|Withdrew|3|||
33490368|NCT00069095|62868445|FG002|Primary Treatment Phase|Withdrew|8|||
33490369|NCT00069095|62868446|FG003|Primary Treatment Phase|Withdrew|2|||
33490370|NCT00069095|62868447|FG004|Primary Treatment Phase|Withdrew|4|||
33490371|NCT00069095|62868448|FG005|Primary Treatment Phase|Withdrew|9|||
33490372|NCT00069095|62868443|FG000|Primary Treatment Phase|Other Violation|0|||
33490373|NCT00069095|62868444|FG001|Primary Treatment Phase|Other Violation|1|||
33490374|NCT00069095|62868445|FG002|Primary Treatment Phase|Other Violation|1|||
33490375|NCT00069095|62868446|FG003|Primary Treatment Phase|Other Violation|1|||
33490376|NCT00069095|62868447|FG004|Primary Treatment Phase|Other Violation|0|||
33490377|NCT00069095|62868448|FG005|Primary Treatment Phase|Other Violation|1|||
33490378|NCT00069095|62868443|FG000|Primary Treatment Phase|Violation criteria|0|||
33490379|NCT00069095|62868444|FG001|Primary Treatment Phase|Violation criteria|2|||
33490380|NCT00069095|62868445|FG002|Primary Treatment Phase|Violation criteria|4|||
33490381|NCT00069095|62868446|FG003|Primary Treatment Phase|Violation criteria|3|||
33490382|NCT00069095|62868447|FG004|Primary Treatment Phase|Violation criteria|1|||
33490383|NCT00069095|62868448|FG005|Primary Treatment Phase|Violation criteria|5|||
33490384|NCT00069095|62868443|FG000|Post-study Treatment Phase|Missing reason|1|||
33490385|NCT00069095|62868444|FG001|Post-study Treatment Phase|Missing reason|3|||
33490386|NCT00069095|62868445|FG002|Post-study Treatment Phase|Missing reason|12|||
33490387|NCT00069095|62868446|FG003|Post-study Treatment Phase|Missing reason|8|||
33490388|NCT00069095|62868447|FG004|Post-study Treatment Phase|Missing reason|18|||
33490389|NCT00069095|62868448|FG005|Post-study Treatment Phase|Missing reason|17|||
33490390|NCT00069095|62868443|FG000|Post-study Treatment Phase|Adverse Event|2|||
33490391|NCT00069095|62868444|FG001|Post-study Treatment Phase|Adverse Event|3|||
33490392|NCT00069095|62868445|FG002|Post-study Treatment Phase|Adverse Event|1|||
33490393|NCT00069095|62868446|FG003|Post-study Treatment Phase|Adverse Event|0|||
33490394|NCT00069095|62868447|FG004|Post-study Treatment Phase|Adverse Event|5|||
33490395|NCT00069095|62868448|FG005|Post-study Treatment Phase|Adverse Event|1|||
33490396|NCT00069095|62868443|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
33490397|NCT00069095|62868444|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
33490398|NCT00069095|62868445|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
33490399|NCT00069095|62868446|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
33490400|NCT00069095|62868447|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
33490401|NCT00069095|62868448|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
33490402|NCT00069095|62868443|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
33573141|NCT02147158|62968778|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
33573142|NCT02147158|62968779|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
33573143|NCT02147158|62968780|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
33573144|NCT02147158|62968781|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
33573145|NCT02147158|62968776|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
33573146|NCT02147158|62968777|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
33573147|NCT02147158|62968778|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
33573148|NCT02147158|62968779|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
33573149|NCT02147158|62968780|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
33573150|NCT02147158|62968781|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
33573151|NCT02147158|62968776|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
33573152|NCT02147158|62968777|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
33573153|NCT02147158|62968778|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
33573154|NCT02147158|62968779|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
33573155|NCT02147158|62968780|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
33573156|NCT02147158|62968781|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
33573157|NCT02147158|62968776|FG000|Treatment Course 2|Adverse Event|0|||
33573158|NCT02147158|62968777|FG001|Treatment Course 2|Adverse Event|4|||
33573159|NCT02147158|62968778|FG002|Treatment Course 2|Adverse Event|2|||
33573160|NCT02147158|62968779|FG003|Treatment Course 2|Adverse Event|1|||
33573161|NCT02147158|62968780|FG004|Treatment Course 2|Adverse Event|0|||
33573162|NCT02147158|62968781|FG005|Treatment Course 2|Adverse Event|1|||
33573163|NCT02147158|62968776|FG000|Treatment Course 2|Withdrawal of Consent|0|||
33573164|NCT02147158|62968777|FG001|Treatment Course 2|Withdrawal of Consent|1|||
33573165|NCT02147158|62968778|FG002|Treatment Course 2|Withdrawal of Consent|2|||
33573166|NCT02147158|62968779|FG003|Treatment Course 2|Withdrawal of Consent|3|||
33573167|NCT02147158|62968780|FG004|Treatment Course 2|Withdrawal of Consent|0|||
33573168|NCT02147158|62968781|FG005|Treatment Course 2|Withdrawal of Consent|0|||
33573169|NCT02147158|62968776|FG000|Treatment Course 2|Lost to Follow-up|1|||
33573170|NCT02147158|62968777|FG001|Treatment Course 2|Lost to Follow-up|0|||
33573171|NCT02147158|62968778|FG002|Treatment Course 2|Lost to Follow-up|1|||
33573172|NCT02147158|62968779|FG003|Treatment Course 2|Lost to Follow-up|1|||
33573173|NCT02147158|62968780|FG004|Treatment Course 2|Lost to Follow-up|0|||
33573174|NCT02147158|62968781|FG005|Treatment Course 2|Lost to Follow-up|1|||
33573175|NCT02147158|62968776|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
33573176|NCT02147158|62968777|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
33573177|NCT02147158|62968778|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
33573178|NCT02147158|62968779|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
33573179|NCT02147158|62968780|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
33573180|NCT02147158|62968781|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
33573181|NCT02147158|62968776|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
33573182|NCT02147158|62968777|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
33573183|NCT02147158|62968778|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
33573184|NCT02147158|62968779|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
33573185|NCT02147158|62968780|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
33573186|NCT02147158|62968781|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
33573187|NCT02147158|62968776|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
33573188|NCT02147158|62968777|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
33573189|NCT02147158|62968778|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
33573190|NCT02147158|62968779|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
33573191|NCT02147158|62968780|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
33573192|NCT02147158|62968781|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
33573193|NCT02147158|62968776|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
33573194|NCT02147158|62968777|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
33573195|NCT02147158|62968778|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
33573196|NCT02147158|62968779|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
33573197|NCT02147158|62968780|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
33573198|NCT02147158|62968781|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
33573199|NCT02147158|62968776|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
33573200|NCT02147158|62968777|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
33573201|NCT02147158|62968778|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
33573202|NCT02147158|62968779|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
33573203|NCT02147158|62968780|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
33573204|NCT02147158|62968781|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
33573205|NCT02112448|62968800|FG000|Overall Study|lab values precluding use of ketorolac|2|||
33573206|NCT02112448|62968801|FG001|Overall Study|lab values precluding use of ketorolac|2|||
33573207|NCT02112448|62968800|FG000|Overall Study|Protocol Violation|1|||
33573208|NCT02112448|62968801|FG001|Overall Study|Protocol Violation|2|||
33573209|NCT02112448|62968800|FG000|Overall Study|Physician Decision|4|||
33573210|NCT02112448|62968801|FG001|Overall Study|Physician Decision|6|||
33573211|NCT02112448|62968800|FG000|Overall Study|required heparin so could not use ketoro|1|||
33573212|NCT02112448|62968801|FG001|Overall Study|required heparin so could not use ketoro|0|||
33573213|NCT02171260|62968813|FG000|Overall Study|Death|0|||
33573214|NCT02171260|62968814|FG001|Overall Study|Death|0|||
33573215|NCT02171260|62968815|FG002|Overall Study|Death|0|||
33573216|NCT02171260|62968816|FG003|Overall Study|Death|1|||
33573217|NCT02171260|62968813|FG000|Overall Study|Physician Decision|1|||
33573218|NCT02171260|62968814|FG001|Overall Study|Physician Decision|0|||
33573219|NCT02171260|62968815|FG002|Overall Study|Physician Decision|1|||
33573220|NCT02171260|62968816|FG003|Overall Study|Physician Decision|0|||
33573221|NCT02171260|62968813|FG000|Overall Study|Withdrawal by Subject|1|||
33573222|NCT02171260|62968814|FG001|Overall Study|Withdrawal by Subject|0|||
33573223|NCT02171260|62968815|FG002|Overall Study|Withdrawal by Subject|0|||
33573224|NCT02171260|62968816|FG003|Overall Study|Withdrawal by Subject|0|||
33573225|NCT02171260|62968813|FG000|Overall Study|Evidence of progressive disease|4|||
33573226|NCT02171260|62968814|FG001|Overall Study|Evidence of progressive disease|6|||
33573227|NCT02171260|62968815|FG002|Overall Study|Evidence of progressive disease|4|||
33573228|NCT02171260|62968816|FG003|Overall Study|Evidence of progressive disease|4|||
33573229|NCT02110732|62968834|FG000|Overall Study|Physician Decision|5|||
33573230|NCT02110732|62968835|FG001|Overall Study|Physician Decision|2|||
33573231|NCT02110732|62968834|FG000|Overall Study|Lost to Follow-up|1|||
33573232|NCT02110732|62968835|FG001|Overall Study|Lost to Follow-up|1|||
33573233|NCT02109562|62968844|FG000|Overall Study|Insufficient clinical response|2|||
33573234|NCT02109562|62968845|FG001|Overall Study|Insufficient clinical response|0|||
33573235|NCT02109562|62968846|FG002|Overall Study|Insufficient clinical response|4|||
33573236|NCT02109562|62968844|FG000|Overall Study|Adverse Event|0|||
33573237|NCT02109562|62968845|FG001|Overall Study|Adverse Event|2|||
33573238|NCT02109562|62968846|FG002|Overall Study|Adverse Event|3|||
33573239|NCT02109562|62968844|FG000|Overall Study|Lost to Follow-up|1|||
33573240|NCT02109562|62968845|FG001|Overall Study|Lost to Follow-up|0|||
33573241|NCT02109562|62968846|FG002|Overall Study|Lost to Follow-up|1|||
33573242|NCT02109562|62968844|FG000|Overall Study|Protocol Violation|0|||
33573243|NCT02109562|62968845|FG001|Overall Study|Protocol Violation|3|||
33573244|NCT02109562|62968846|FG002|Overall Study|Protocol Violation|1|||
33573245|NCT02109562|62968844|FG000|Overall Study|Withdrawal by Subject|20|||
33573246|NCT02109562|62968845|FG001|Overall Study|Withdrawal by Subject|25|||
33573247|NCT02109562|62968846|FG002|Overall Study|Withdrawal by Subject|21|||
33573248|NCT02109562|62968844|FG000|Overall Study|Physician Decision|3|||
33573249|NCT02109562|62968845|FG001|Overall Study|Physician Decision|4|||
33573250|NCT02109562|62968846|FG002|Overall Study|Physician Decision|5|||
33573251|NCT02109484|62968862|FG000|Overall Study|Lost to Follow-up|0|||
33573252|NCT02109484|62968863|FG001|Overall Study|Lost to Follow-up|0|||
33573253|NCT02109484|62968864|FG002|Overall Study|Lost to Follow-up|0|||
33573254|NCT02109484|62968865|FG003|Overall Study|Lost to Follow-up|1|||
33573255|NCT02109484|62968866|FG004|Overall Study|Lost to Follow-up|1|||
33573256|NCT02109484|62968867|FG005|Overall Study|Lost to Follow-up|0|||
33573257|NCT02109484|62968868|FG006|Overall Study|Lost to Follow-up|1|||
33573258|NCT02109484|62968869|FG007|Overall Study|Lost to Follow-up|0|||
33573259|NCT02109484|62968862|FG000|Overall Study|Withdrawal by Subject|0|||
33573260|NCT02109484|62968863|FG001|Overall Study|Withdrawal by Subject|0|||
33573261|NCT02109484|62968864|FG002|Overall Study|Withdrawal by Subject|0|||
33573262|NCT02109484|62968865|FG003|Overall Study|Withdrawal by Subject|0|||
33573263|NCT02109484|62968866|FG004|Overall Study|Withdrawal by Subject|1|||
33573264|NCT02109484|62968867|FG005|Overall Study|Withdrawal by Subject|1|||
33573265|NCT02109484|62968868|FG006|Overall Study|Withdrawal by Subject|1|||
33573266|NCT02109484|62968869|FG007|Overall Study|Withdrawal by Subject|0|||
33573267|NCT02109484|62968862|FG000|Overall Study|Physician Decision|0|||
33573268|NCT02109484|62968863|FG001|Overall Study|Physician Decision|0|||
33573269|NCT02109484|62968864|FG002|Overall Study|Physician Decision|0|||
33573270|NCT02109484|62968865|FG003|Overall Study|Physician Decision|0|||
33573271|NCT02109484|62968866|FG004|Overall Study|Physician Decision|2|||
33573272|NCT02109484|62968867|FG005|Overall Study|Physician Decision|0|||
33573273|NCT02109484|62968868|FG006|Overall Study|Physician Decision|0|||
33573274|NCT02109484|62968869|FG007|Overall Study|Physician Decision|0|||
33573275|NCT02109484|62968862|FG000|Overall Study|Death|0|||
33573276|NCT02109484|62968863|FG001|Overall Study|Death|0|||
33573277|NCT02109484|62968864|FG002|Overall Study|Death|0|||
33573278|NCT02109484|62968865|FG003|Overall Study|Death|0|||
33573279|NCT02109484|62968866|FG004|Overall Study|Death|0|||
33573280|NCT02109484|62968867|FG005|Overall Study|Death|0|||
33573281|NCT02109484|62968868|FG006|Overall Study|Death|0|||
33664339|NCT02667288|63095352|FG000|Overall Study|Withdrawal by Subject|5|||
33664340|NCT02670330|63095358|FG000|Overall Study|Protocol Deviation|1|||
33573282|NCT02109484|62968869|FG007|Overall Study|Death|2|||
33573283|NCT02109484|62968862|FG000|Overall Study|Moved away from study area|0|||
33573284|NCT02109484|62968863|FG001|Overall Study|Moved away from study area|0|||
33573285|NCT02109484|62968864|FG002|Overall Study|Moved away from study area|0|||
33573286|NCT02109484|62968865|FG003|Overall Study|Moved away from study area|0|||
33573287|NCT02109484|62968866|FG004|Overall Study|Moved away from study area|0|||
33573288|NCT02109484|62968867|FG005|Overall Study|Moved away from study area|0|||
33664341|NCT02670330|63095359|FG001|Overall Study|Protocol Deviation|0|||
33573289|NCT02109484|62968868|FG006|Overall Study|Moved away from study area|1|||
33573290|NCT02109484|62968869|FG007|Overall Study|Moved away from study area|1|||
33573291|NCT02105974|62968906|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
33573292|NCT02105974|62968907|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
33573293|NCT02105974|62968908|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
33573294|NCT02105974|62968906|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
33573295|NCT02105974|62968907|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
33573296|NCT02105974|62968908|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
33573297|NCT02105974|62968906|FG000|2 Week Run-in Period|Adverse Event|6|||
33573298|NCT02105974|62968907|FG001|2 Week Run-in Period|Adverse Event|0|||
33573299|NCT02105974|62968908|FG002|2 Week Run-in Period|Adverse Event|0|||
33573300|NCT02105974|62968906|FG000|2 Week Run-in Period|Study closed/terminated|1|||
33573301|NCT02105974|62968907|FG001|2 Week Run-in Period|Study closed/terminated|0|||
33573302|NCT02105974|62968908|FG002|2 Week Run-in Period|Study closed/terminated|0|||
33573303|NCT02105974|62968906|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
33573304|NCT02105974|62968907|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
33573305|NCT02105974|62968908|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
33573306|NCT02105974|62968906|FG000|2 Week Run-in Period|Withdrew consent|23|||
33573307|NCT02105974|62968907|FG001|2 Week Run-in Period|Withdrew consent|0|||
33573308|NCT02105974|62968908|FG002|2 Week Run-in Period|Withdrew consent|0|||
33573309|NCT02105974|62968906|FG000|2 Week Run-in Period|Investigator discretion|8|||
33573310|NCT02105974|62968907|FG001|2 Week Run-in Period|Investigator discretion|0|||
33573311|NCT02105974|62968908|FG002|2 Week Run-in Period|Investigator discretion|0|||
33573312|NCT02105974|62968906|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
33573313|NCT02105974|62968907|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
33573314|NCT02105974|62968908|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
33573315|NCT02105974|62968906|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
33573316|NCT02105974|62968907|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
33573317|NCT02105974|62968908|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
33573318|NCT02105974|62968906|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
33573319|NCT02105974|62968907|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
33573320|NCT02105974|62968908|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
33573321|NCT02105974|62968906|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
33573322|NCT02105974|62968907|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
33573323|NCT02105974|62968908|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
33573324|NCT02105974|62968906|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
33573325|NCT02105974|62968907|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
33573326|NCT02105974|62968908|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
33573327|NCT02105974|62968906|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
33573328|NCT02105974|62968907|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
33573329|NCT02105974|62968908|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
33573330|NCT02105974|62968906|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
33573331|NCT02105974|62968907|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
33573332|NCT02105974|62968908|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
33573333|NCT02105662|62968914|FG000|Overall Study|Lost to Follow-up|5|||
33573334|NCT02105662|62968914|FG000|Overall Study|Withdrawal by Subject|1|||
33573335|NCT02143102|62968920|FG000|Overall Study|Lost to Follow-up|11|||
33573336|NCT02143102|62968921|FG001|Overall Study|Lost to Follow-up|0|||
33573337|NCT02143024|62968929|FG000|Overall Study|Lost to Follow-up|1|||
33573338|NCT02143024|62968930|FG001|Overall Study|Lost to Follow-up|1|||
33573339|NCT02143024|62968929|FG000|Overall Study|Withdrawal by Subject|1|||
33573340|NCT02143024|62968930|FG001|Overall Study|Withdrawal by Subject|0|||
33573341|NCT02142712|62968939|FG000|Overall Study|Lost to Follow-up|1|||
33573342|NCT02142712|62968940|FG001|Overall Study|Lost to Follow-up|1|||
33573343|NCT02142712|62968941|FG002|Overall Study|Lost to Follow-up|1|||
33573344|NCT02142712|62968942|FG003|Overall Study|Lost to Follow-up|0|||
33573345|NCT02105272|62968953|FG000|Overall Study|Adverse Event|1|||
33573346|NCT02105272|62968954|FG001|Overall Study|Adverse Event|2|||
33573347|NCT02105272|62968953|FG000|Overall Study|Physician Decision|0|||
33573348|NCT02105272|62968954|FG001|Overall Study|Physician Decision|1|||
33573349|NCT02105272|62968953|FG000|Overall Study|Protocol Violation|2|||
33573350|NCT02105272|62968954|FG001|Overall Study|Protocol Violation|0|||
33573351|NCT02105272|62968953|FG000|Overall Study|Withdrawal by Subject|2|||
33573352|NCT02105272|62968954|FG001|Overall Study|Withdrawal by Subject|0|||
33573353|NCT02141854|62968965|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
33664342|NCT02670330|63095358|FG000|Overall Study|Study Terminated By Sponsor|36|||
33664343|NCT02670330|63095359|FG001|Overall Study|Study Terminated By Sponsor|43|||
33664344|NCT02670330|63095358|FG000|Overall Study|Adverse Event|1|||
33573354|NCT02141854|62968966|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33664345|NCT02670330|63095359|FG001|Overall Study|Adverse Event|3|||
33664346|NCT02670330|63095358|FG000|Overall Study|Withdrawal by Subject|34|||
33573355|NCT02141854|62968967|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33573356|NCT02141854|62968968|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33573357|NCT02141854|62968969|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33573358|NCT02141854|62968970|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33573359|NCT02141854|62968965|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
33573360|NCT02141854|62968966|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33573361|NCT02141854|62968967|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33573362|NCT02141854|62968968|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33573363|NCT02141854|62968969|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33573364|NCT02141854|62968970|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33573365|NCT02141854|62968965|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
33573366|NCT02141854|62968966|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33573367|NCT02141854|62968967|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33573368|NCT02141854|62968968|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33573369|NCT02141854|62968969|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33573370|NCT02141854|62968970|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33573371|NCT02141854|62968965|FG000|Run-In Period (Pre-assignment)|Other|14|||
33573372|NCT02141854|62968966|FG001|Run-In Period (Pre-assignment)|Other|0|||
33573373|NCT02141854|62968967|FG002|Run-In Period (Pre-assignment)|Other|0|||
33573374|NCT02141854|62968968|FG003|Run-In Period (Pre-assignment)|Other|0|||
33573375|NCT02141854|62968969|FG004|Run-In Period (Pre-assignment)|Other|0|||
33573376|NCT02141854|62968970|FG005|Run-In Period (Pre-assignment)|Other|0|||
33573377|NCT02141854|62968965|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
33573378|NCT02141854|62968966|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
33573379|NCT02141854|62968967|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
33573380|NCT02141854|62968968|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
33573381|NCT02141854|62968969|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
33573382|NCT02141854|62968970|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
33573383|NCT02141854|62968965|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
33573384|NCT02141854|62968966|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33573385|NCT02141854|62968967|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33573386|NCT02141854|62968968|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33573387|NCT02141854|62968969|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33573388|NCT02141854|62968970|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33573389|NCT02141854|62968965|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
33573390|NCT02141854|62968966|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33573391|NCT02141854|62968967|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33573392|NCT02141854|62968968|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33573393|NCT02141854|62968969|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33573394|NCT02141854|62968970|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33573395|NCT02141854|62968965|FG000|Treatment Period|Protocol Violation|0|||
33573396|NCT02141854|62968966|FG001|Treatment Period|Protocol Violation|1|||
33573397|NCT02141854|62968967|FG002|Treatment Period|Protocol Violation|0|||
33573398|NCT02141854|62968968|FG003|Treatment Period|Protocol Violation|2|||
33573399|NCT02141854|62968969|FG004|Treatment Period|Protocol Violation|2|||
33573400|NCT02141854|62968970|FG005|Treatment Period|Protocol Violation|1|||
33573401|NCT02141854|62968965|FG000|Treatment Period|Noncompliance|0|||
33573402|NCT02141854|62968966|FG001|Treatment Period|Noncompliance|0|||
33573403|NCT02141854|62968967|FG002|Treatment Period|Noncompliance|0|||
33573404|NCT02141854|62968968|FG003|Treatment Period|Noncompliance|1|||
33573405|NCT02141854|62968969|FG004|Treatment Period|Noncompliance|0|||
33573406|NCT02141854|62968970|FG005|Treatment Period|Noncompliance|0|||
33573407|NCT02141854|62968965|FG000|Treatment Period|Lack of Efficacy|0|||
33573408|NCT02141854|62968966|FG001|Treatment Period|Lack of Efficacy|0|||
33573409|NCT02141854|62968967|FG002|Treatment Period|Lack of Efficacy|0|||
33573410|NCT02141854|62968968|FG003|Treatment Period|Lack of Efficacy|1|||
33573411|NCT02141854|62968969|FG004|Treatment Period|Lack of Efficacy|1|||
33573412|NCT02141854|62968970|FG005|Treatment Period|Lack of Efficacy|7|||
33573413|NCT02141854|62968965|FG000|Treatment Period|Pregnancy|0|||
33573414|NCT02141854|62968966|FG001|Treatment Period|Pregnancy|1|||
33573415|NCT02141854|62968967|FG002|Treatment Period|Pregnancy|0|||
33573416|NCT02141854|62968968|FG003|Treatment Period|Pregnancy|0|||
33573417|NCT02141854|62968969|FG004|Treatment Period|Pregnancy|0|||
33573418|NCT02141854|62968970|FG005|Treatment Period|Pregnancy|0|||
33573419|NCT02141854|62968965|FG000|Treatment Period|Other|0|||
33573420|NCT02141854|62968966|FG001|Treatment Period|Other|1|||
33573421|NCT02141854|62968967|FG002|Treatment Period|Other|2|||
33573422|NCT02141854|62968968|FG003|Treatment Period|Other|0|||
33573423|NCT02141854|62968969|FG004|Treatment Period|Other|1|||
33573424|NCT02141854|62968970|FG005|Treatment Period|Other|2|||
33573425|NCT02141854|62968965|FG000|Treatment Period|Adverse Event|0|||
33573426|NCT02141854|62968966|FG001|Treatment Period|Adverse Event|2|||
33573427|NCT02141854|62968967|FG002|Treatment Period|Adverse Event|2|||
33573428|NCT02141854|62968968|FG003|Treatment Period|Adverse Event|0|||
33573429|NCT02141854|62968969|FG004|Treatment Period|Adverse Event|2|||
33573430|NCT02141854|62968970|FG005|Treatment Period|Adverse Event|2|||
33573431|NCT02141854|62968965|FG000|Treatment Period|Withdrawal by Subject|0|||
33573432|NCT02141854|62968966|FG001|Treatment Period|Withdrawal by Subject|2|||
33573433|NCT02141854|62968967|FG002|Treatment Period|Withdrawal by Subject|3|||
33573434|NCT02141854|62968968|FG003|Treatment Period|Withdrawal by Subject|3|||
33573435|NCT02141854|62968969|FG004|Treatment Period|Withdrawal by Subject|4|||
33573436|NCT02141854|62968970|FG005|Treatment Period|Withdrawal by Subject|7|||
33573437|NCT02141854|62968965|FG000|Treatment Period|Disease progression|0|||
33573438|NCT02141854|62968966|FG001|Treatment Period|Disease progression|2|||
33573439|NCT02141854|62968967|FG002|Treatment Period|Disease progression|1|||
33573440|NCT02141854|62968968|FG003|Treatment Period|Disease progression|3|||
33573441|NCT02141854|62968969|FG004|Treatment Period|Disease progression|0|||
33573442|NCT02141854|62968970|FG005|Treatment Period|Disease progression|18|||
33573443|NCT02141854|62968965|FG000|Treatment Period|Lost to Follow-up|0|||
33573444|NCT02141854|62968966|FG001|Treatment Period|Lost to Follow-up|1|||
33573445|NCT02141854|62968967|FG002|Treatment Period|Lost to Follow-up|1|||
33573446|NCT02141854|62968968|FG003|Treatment Period|Lost to Follow-up|1|||
33573447|NCT02141854|62968969|FG004|Treatment Period|Lost to Follow-up|0|||
33573448|NCT02141854|62968970|FG005|Treatment Period|Lost to Follow-up|1|||
33573449|NCT02587221|62968984|FG000|Overall Study|Adverse Event|3|||
33573450|NCT02587221|62968985|FG001|Overall Study|Adverse Event|3|||
33573451|NCT02587221|62968984|FG000|Overall Study|Death|33|||
33573452|NCT02587221|62968985|FG001|Overall Study|Death|34|||
33573453|NCT02587221|62968984|FG000|Overall Study|Withdrawal by Subject|66|||
33573454|NCT02587221|62968985|FG001|Overall Study|Withdrawal by Subject|61|||
33573455|NCT02587221|62968984|FG000|Overall Study|Lost to Follow-up|21|||
33573456|NCT02587221|62968985|FG001|Overall Study|Lost to Follow-up|19|||
33573457|NCT02587221|62968984|FG000|Overall Study|Protocol Violation|6|||
33573458|NCT02587221|62968985|FG001|Overall Study|Protocol Violation|5|||
33573459|NCT02587221|62968984|FG000|Overall Study|Other Reason or Unspecified|2|||
33573460|NCT02587221|62968985|FG001|Overall Study|Other Reason or Unspecified|1|||
33573461|NCT02141620|62968991|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
33573462|NCT02141620|62968992|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
33573463|NCT02106910|62969000|FG000|Overall Study|Lost to Follow-up|1|||
33573464|NCT02106910|62969001|FG001|Overall Study|Lost to Follow-up|1|||
33573465|NCT01664949|62969010|FG000|Overall Study|Adverse Event|11|||
33573466|NCT01664949|62969011|FG001|Overall Study|Adverse Event|12|||
33573467|NCT01664949|62969010|FG000|Overall Study|Lack of Efficacy|1|||
33573468|NCT01664949|62969011|FG001|Overall Study|Lack of Efficacy|1|||
33573469|NCT01664949|62969010|FG000|Overall Study|Lost to Follow-up|1|||
33573470|NCT01664949|62969011|FG001|Overall Study|Lost to Follow-up|2|||
33664347|NCT02670330|63095359|FG001|Overall Study|Withdrawal by Subject|29|||
33664348|NCT02670330|63095358|FG000|Overall Study|Lost to Follow-up|3|||
33664349|NCT02670330|63095359|FG001|Overall Study|Lost to Follow-up|2|||
33664350|NCT02669940|63095367|FG000|Overall Study|Failure to return|0|||
33664351|NCT02669940|63095368|FG001|Overall Study|Failure to return|3|||
33664352|NCT02669940|63095367|FG000|Overall Study|Insufficient follow-up data|1|||
33664353|NCT02669940|63095368|FG001|Overall Study|Insufficient follow-up data|0|||
33664354|NCT02669862|63095384|FG000|Overall Study|Lost to Follow-up|0|||
33664355|NCT02669862|63095385|FG001|Overall Study|Lost to Follow-up|2|||
33664356|NCT02669862|63095386|FG002|Overall Study|Lost to Follow-up|1|||
33664357|NCT02669862|63095384|FG000|Overall Study|Withdrawal by Subject|2|||
33664358|NCT02669862|63095385|FG001|Overall Study|Withdrawal by Subject|2|||
33664359|NCT02669862|63095386|FG002|Overall Study|Withdrawal by Subject|3|||
33664360|NCT02669862|63095384|FG000|Overall Study|moved|0|||
33664361|NCT02669862|63095385|FG001|Overall Study|moved|1|||
33664362|NCT02669862|63095386|FG002|Overall Study|moved|0|||
33664363|NCT02669862|63095384|FG000|Overall Study|Protocol Violation|0|||
33664364|NCT02669862|63095385|FG001|Overall Study|Protocol Violation|0|||
33664365|NCT02669862|63095386|FG002|Overall Study|Protocol Violation|1|||
33664366|NCT01531673|63095410|FG000|Overall Study|Non-Compliance|0|||
33664367|NCT01531673|63095411|FG001|Overall Study|Non-Compliance|0|||
33573471|NCT01664949|62969010|FG000|Overall Study|Personal Reasons|3|||
33573472|NCT01664949|62969011|FG001|Overall Study|Personal Reasons|4|||
33573473|NCT01664949|62969010|FG000|Overall Study|Protocol Violation|5|||
33573474|NCT01664949|62969011|FG001|Overall Study|Protocol Violation|5|||
33573475|NCT01664949|62969010|FG000|Overall Study|Other Miscellaneous Reasons|3|||
33573476|NCT01664949|62969011|FG001|Overall Study|Other Miscellaneous Reasons|1|||
33573477|NCT02587143|62969019|FG000|Overall Study|Adverse Event|1|||
33664368|NCT01531673|63095412|FG002|Overall Study|Non-Compliance|0|||
33664369|NCT01531673|63095413|FG003|Overall Study|Non-Compliance|0|||
33664370|NCT01531673|63095414|FG004|Overall Study|Non-Compliance|0|||
33664371|NCT01531673|63095415|FG005|Overall Study|Non-Compliance|1|||
33664372|NCT01531673|63095416|FG006|Overall Study|Non-Compliance|0|||
33664373|NCT01531673|63095417|FG007|Overall Study|Non-Compliance|0|||
33573478|NCT02587143|62969020|FG001|Overall Study|Adverse Event|0|||
33664374|NCT01531673|63095418|FG008|Overall Study|Non-Compliance|0|||
33573479|NCT02106832|62969030|FG000|Overall Study|Adverse Event|1|||
33573480|NCT02106832|62969031|FG001|Overall Study|Adverse Event|2|||
33573481|NCT02106832|62969032|FG002|Overall Study|Adverse Event|3|||
33573482|NCT02106832|62969033|FG003|Overall Study|Adverse Event|0|||
33573483|NCT02106832|62969030|FG000|Overall Study|Death|4|||
33573484|NCT02106832|62969031|FG001|Overall Study|Death|4|||
33573485|NCT02106832|62969032|FG002|Overall Study|Death|1|||
33573486|NCT02106832|62969033|FG003|Overall Study|Death|4|||
33573487|NCT02106832|62969030|FG000|Overall Study|Deterioration of general conditions|0|||
33573488|NCT02106832|62969031|FG001|Overall Study|Deterioration of general conditions|0|||
33573489|NCT02106832|62969032|FG002|Overall Study|Deterioration of general conditions|1|||
33573490|NCT02106832|62969033|FG003|Overall Study|Deterioration of general conditions|0|||
33573491|NCT02106832|62969030|FG000|Overall Study|Lost to Follow-up|0|||
33573492|NCT02106832|62969031|FG001|Overall Study|Lost to Follow-up|1|||
33573493|NCT02106832|62969032|FG002|Overall Study|Lost to Follow-up|1|||
33573494|NCT02106832|62969033|FG003|Overall Study|Lost to Follow-up|3|||
33573495|NCT02106832|62969030|FG000|Overall Study|Physician Decision|1|||
33573496|NCT02106832|62969031|FG001|Overall Study|Physician Decision|0|||
33573497|NCT02106832|62969032|FG002|Overall Study|Physician Decision|0|||
33573498|NCT02106832|62969033|FG003|Overall Study|Physician Decision|0|||
33573499|NCT02106832|62969030|FG000|Overall Study|Protocol Violation|0|||
33573500|NCT02106832|62969031|FG001|Overall Study|Protocol Violation|0|||
33573501|NCT02106832|62969032|FG002|Overall Study|Protocol Violation|0|||
33573502|NCT02106832|62969033|FG003|Overall Study|Protocol Violation|1|||
33573503|NCT02106832|62969030|FG000|Overall Study|Withdrawal by Subject|17|||
33573504|NCT02106832|62969031|FG001|Overall Study|Withdrawal by Subject|17|||
33573505|NCT02106832|62969032|FG002|Overall Study|Withdrawal by Subject|10|||
33573506|NCT02106832|62969033|FG003|Overall Study|Withdrawal by Subject|7|||
33573507|NCT02106832|62969030|FG000|Overall Study|Technical problems|0|||
33573508|NCT02106832|62969031|FG001|Overall Study|Technical problems|1|||
33573509|NCT02106832|62969032|FG002|Overall Study|Technical problems|0|||
33573510|NCT02106832|62969033|FG003|Overall Study|Technical problems|0|||
33573511|NCT02106442|62969045|FG000|Overall Study|Case Report Forms Uncollected|7|||
33573512|NCT02106442|62969045|FG000|Overall Study|Protocol Deviation|30|||
33573513|NCT02105116|62969049|FG000|Overall Study|not eligible for step 2 of trial|5|||
33573514|NCT02105116|62969049|FG000|Overall Study|Death|1|||
33573515|NCT02104804|62969055|FG000|Overall Study|Did not take study medication|0|||
33573516|NCT02104804|62969056|FG001|Overall Study|Did not take study medication|1|||
33573517|NCT02104804|62969055|FG000|Overall Study|Study specific discontinuation criteria|6|||
33573518|NCT02104804|62969056|FG001|Overall Study|Study specific discontinuation criteria|1|||
33573519|NCT02104804|62969055|FG000|Overall Study|Other listed|2|||
33573520|NCT02104804|62969056|FG001|Overall Study|Other listed|1|||
33573521|NCT02104804|62969055|FG000|Overall Study|Protocol Violation|0|||
33573522|NCT02104804|62969056|FG001|Overall Study|Protocol Violation|1|||
33573523|NCT02104804|62969055|FG000|Overall Study|Adverse Event|4|||
33573524|NCT02104804|62969056|FG001|Overall Study|Adverse Event|3|||
33573525|NCT02104804|62969055|FG000|Overall Study|Withdrawal by Subject|4|||
33573526|NCT02104804|62969056|FG001|Overall Study|Withdrawal by Subject|12|||
33573527|NCT02075008|62969062|FG000|Overall Study|Technical problems|1|||
33573528|NCT02075008|62969062|FG000|Overall Study|Pregnancy|1|||
33573529|NCT02075008|62969062|FG000|Overall Study|Physician Decision|1|||
33573530|NCT02075008|62969062|FG000|Overall Study|Lost to Follow-up|1|||
33573531|NCT02075008|62969062|FG000|Overall Study|Lack of Efficacy|1|||
33573532|NCT02075008|62969062|FG000|Overall Study|Death|1|||
33573533|NCT02075008|62969062|FG000|Overall Study|Adverse Event|5|||
33573534|NCT02075008|62969062|FG000|Overall Study|Withdrawal by Subject|6|||
33573535|NCT02075008|62969062|FG000|Overall Study|Study terminated by Sponsor|159|||
33573536|NCT01666119|62969093|FG000|Overall Study|Adverse Event|6|||
33573537|NCT01666119|62969093|FG000|Overall Study|Withdrawal by Subject|16|||
33573538|NCT01666119|62969093|FG000|Overall Study|Lost to Follow-up|7|||
33573539|NCT01666119|62969093|FG000|Overall Study|non compliance with study medication, pa|18|||
33573540|NCT01666119|62969093|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
33664375|NCT01531673|63095419|FG009|Overall Study|Non-Compliance|0|||
33573541|NCT05128773|62969097|FG000|Overall Study|Sponsor decision to terminate study|3|||
33573542|NCT01665807|62969105|FG000|Overall Study|Withdrawal by Subject|2|||
33573543|NCT01665807|62969106|FG001|Overall Study|Withdrawal by Subject|0|||
33573544|NCT01665807|62969107|FG002|Overall Study|Withdrawal by Subject|1|||
33573545|NCT02584959|62969118|FG000|Period 1|Withdrawn from study|3|||
33573546|NCT02584959|62969119|FG001|Period 1|Withdrawn from study|4|||
33573547|NCT02584959|62969120|FG002|Period 1|Withdrawn from study|0|||
33573548|NCT02584959|62969118|FG000|Period 2|Withdrawn from study|6|||
33573549|NCT02584959|62969119|FG001|Period 2|Withdrawn from study|1|||
33573550|NCT02584959|62969120|FG002|Period 2|Withdrawn from study|2|||
33573551|NCT02584257|62969137|FG000|Period 1|Withdrawal by Subject|0|||
33573552|NCT02584257|62969138|FG001|Period 1|Withdrawal by Subject|0|||
33573553|NCT02584257|62969139|FG002|Period 1|Withdrawal by Subject|0|||
33573554|NCT02584257|62969140|FG003|Period 1|Withdrawal by Subject|0|||
33573555|NCT02584257|62969141|FG004|Period 1|Withdrawal by Subject|0|||
33573556|NCT02584257|62969142|FG005|Period 1|Withdrawal by Subject|0|||
33573557|NCT02584257|62969143|FG006|Period 1|Withdrawal by Subject|1|||
33573558|NCT02584257|62969144|FG007|Period 1|Withdrawal by Subject|0|||
33573559|NCT02584257|62969145|FG008|Period 1|Withdrawal by Subject|0|||
33573560|NCT02584257|62969137|FG000|Period 2|Physician Decision|1|||
33573561|NCT02584257|62969138|FG001|Period 2|Physician Decision|0|||
33573562|NCT02584257|62969139|FG002|Period 2|Physician Decision|0|||
33573563|NCT02584257|62969140|FG003|Period 2|Physician Decision|0|||
33573564|NCT02584257|62969141|FG004|Period 2|Physician Decision|0|||
33573565|NCT02584257|62969142|FG005|Period 2|Physician Decision|0|||
33573566|NCT02584257|62969143|FG006|Period 2|Physician Decision|0|||
33573567|NCT02584257|62969144|FG007|Period 2|Physician Decision|0|||
33573568|NCT02584257|62969145|FG008|Period 2|Physician Decision|0|||
33573569|NCT02584257|62969137|FG000|Period 2|Adverse Event|0|||
33573570|NCT02584257|62969138|FG001|Period 2|Adverse Event|1|||
33573571|NCT02584257|62969139|FG002|Period 2|Adverse Event|0|||
33573572|NCT02584257|62969140|FG003|Period 2|Adverse Event|0|||
33573573|NCT02584257|62969141|FG004|Period 2|Adverse Event|0|||
33573574|NCT02584257|62969142|FG005|Period 2|Adverse Event|0|||
33573575|NCT02584257|62969143|FG006|Period 2|Adverse Event|0|||
33573576|NCT02584257|62969144|FG007|Period 2|Adverse Event|0|||
33573577|NCT02584257|62969145|FG008|Period 2|Adverse Event|0|||
33573578|NCT02583711|62969160|FG000|Overall Study|Withdrawal by Subject|0|||
33573579|NCT02583711|62969161|FG001|Overall Study|Withdrawal by Subject|10|||
33573580|NCT02583711|62969162|FG002|Overall Study|Withdrawal by Subject|0|||
33573581|NCT02583477|62969174|FG000|Overall Study|Adverse Event|0|||
33573582|NCT02583477|62969175|FG001|Overall Study|Adverse Event|2|||
33573583|NCT02583477|62969174|FG000|Overall Study|Death|1|||
33573584|NCT02583477|62969175|FG001|Overall Study|Death|16|||
33573585|NCT02583477|62969174|FG000|Overall Study|Study terminated|2|||
33573586|NCT02583477|62969175|FG001|Overall Study|Study terminated|2|||
33573587|NCT02583399|62969182|FG000|Overall Study|Able to be discharged|3|||
33573588|NCT02583399|62969182|FG000|Overall Study|Wanted to use a restricted medication|3|||
33573589|NCT02580591|62969190|FG000|Overall Study|Adverse Event|0|||
33573590|NCT02580591|62969191|FG001|Overall Study|Adverse Event|1|||
33573591|NCT02580591|62969192|FG002|Overall Study|Adverse Event|2|||
33573592|NCT02580591|62969193|FG003|Overall Study|Adverse Event|5|||
33573593|NCT02580591|62969190|FG000|Overall Study|Protocol Violation|3|||
33573594|NCT02580591|62969191|FG001|Overall Study|Protocol Violation|2|||
33573595|NCT02580591|62969192|FG002|Overall Study|Protocol Violation|1|||
33573596|NCT02580591|62969193|FG003|Overall Study|Protocol Violation|1|||
33573597|NCT02580591|62969190|FG000|Overall Study|Lost to Follow-up|5|||
33573598|NCT02580591|62969191|FG001|Overall Study|Lost to Follow-up|3|||
33573599|NCT02580591|62969192|FG002|Overall Study|Lost to Follow-up|3|||
33573600|NCT02580591|62969193|FG003|Overall Study|Lost to Follow-up|1|||
33573601|NCT02580591|62969190|FG000|Overall Study|Withdrawal by Subject|6|||
33573602|NCT02580591|62969191|FG001|Overall Study|Withdrawal by Subject|1|||
33573603|NCT02580591|62969192|FG002|Overall Study|Withdrawal by Subject|2|||
33573604|NCT02580591|62969193|FG003|Overall Study|Withdrawal by Subject|3|||
33573605|NCT02580591|62969190|FG000|Overall Study|Not treated|1|||
33573606|NCT02580591|62969191|FG001|Overall Study|Not treated|1|||
33573607|NCT02580591|62969192|FG002|Overall Study|Not treated|0|||
33573608|NCT02580591|62969193|FG003|Overall Study|Not treated|0|||
33573609|NCT02580591|62969190|FG000|Overall Study|Other than specified|3|||
33573610|NCT02580591|62969191|FG001|Overall Study|Other than specified|2|||
33573611|NCT02580591|62969192|FG002|Overall Study|Other than specified|5|||
33573612|NCT02580591|62969193|FG003|Overall Study|Other than specified|2|||
33573613|NCT02580357|62969206|FG000|Overall Study|Lost to Follow-up|2|||
33573614|NCT02580357|62969207|FG001|Overall Study|Lost to Follow-up|0|||
33573615|NCT02580357|62969208|FG002|Overall Study|Lost to Follow-up|0|||
33573616|NCT02580357|62969206|FG000|Overall Study|Protocol Violation|1|||
33573617|NCT02580357|62969207|FG001|Overall Study|Protocol Violation|0|||
33573618|NCT02580357|62969208|FG002|Overall Study|Protocol Violation|0|||
33573619|NCT01664091|62969216|FG000|Overall Study|Death|1|||
33573620|NCT01664091|62969216|FG000|Overall Study|Disease Progression|2|||
33573621|NCT01664091|62969216|FG000|Overall Study|Lost to Follow-up|2|||
33573622|NCT01664091|62969216|FG000|Overall Study|Withdrawal by Subject|1|||
33573623|NCT02577315|62969223|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
33573624|NCT02577315|62969224|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
33573625|NCT02711345|62969240|FG000|Overall Study|Adverse Event|0|||
33573626|NCT02711345|62969241|FG001|Overall Study|Adverse Event|0|||
33573627|NCT02711345|62969242|FG002|Overall Study|Adverse Event|0|||
33573628|NCT02711345|62969243|FG003|Overall Study|Adverse Event|1|||
33573629|NCT02711345|62969244|FG004|Overall Study|Adverse Event|1|||
33573630|NCT02711345|62969245|FG005|Overall Study|Adverse Event|2|||
33573631|NCT02711345|62969246|FG006|Overall Study|Adverse Event|1|||
33573632|NCT02711345|62969247|FG007|Overall Study|Adverse Event|0|||
33573633|NCT02711345|62969248|FG008|Overall Study|Adverse Event|0|||
33573634|NCT02711345|62969249|FG009|Overall Study|Adverse Event|2|||
33573635|NCT02711345|62969240|FG000|Overall Study|Physician Decision|0|||
33573636|NCT02711345|62969241|FG001|Overall Study|Physician Decision|0|||
33573637|NCT02711345|62969242|FG002|Overall Study|Physician Decision|1|||
33573638|NCT02711345|62969243|FG003|Overall Study|Physician Decision|0|||
33573639|NCT02711345|62969244|FG004|Overall Study|Physician Decision|0|||
33573640|NCT02711345|62969245|FG005|Overall Study|Physician Decision|0|||
33573641|NCT02711345|62969246|FG006|Overall Study|Physician Decision|0|||
33573642|NCT02711345|62969247|FG007|Overall Study|Physician Decision|0|||
33573643|NCT02711345|62969248|FG008|Overall Study|Physician Decision|1|||
33573644|NCT02711345|62969249|FG009|Overall Study|Physician Decision|0|||
33573645|NCT02711345|62969240|FG000|Overall Study|Progressive disease|1|||
33573646|NCT02711345|62969241|FG001|Overall Study|Progressive disease|3|||
33573647|NCT02711345|62969242|FG002|Overall Study|Progressive disease|5|||
33573648|NCT02711345|62969243|FG003|Overall Study|Progressive disease|3|||
33573649|NCT02711345|62969244|FG004|Overall Study|Progressive disease|7|||
33573650|NCT02711345|62969245|FG005|Overall Study|Progressive disease|2|||
33573651|NCT02711345|62969246|FG006|Overall Study|Progressive disease|8|||
33573652|NCT02711345|62969247|FG007|Overall Study|Progressive disease|4|||
33573653|NCT02711345|62969248|FG008|Overall Study|Progressive disease|5|||
33573654|NCT02711345|62969249|FG009|Overall Study|Progressive disease|6|||
33573655|NCT02711345|62969240|FG000|Overall Study|Subject/guardian decision|0|||
33573656|NCT02711345|62969241|FG001|Overall Study|Subject/guardian decision|0|||
33573657|NCT02711345|62969242|FG002|Overall Study|Subject/guardian decision|0|||
33573658|NCT02711345|62969243|FG003|Overall Study|Subject/guardian decision|0|||
33573659|NCT02711345|62969244|FG004|Overall Study|Subject/guardian decision|0|||
33573660|NCT02711345|62969245|FG005|Overall Study|Subject/guardian decision|2|||
33573661|NCT02711345|62969246|FG006|Overall Study|Subject/guardian decision|3|||
33573662|NCT02711345|62969247|FG007|Overall Study|Subject/guardian decision|1|||
33573663|NCT02711345|62969248|FG008|Overall Study|Subject/guardian decision|0|||
33573664|NCT02711345|62969249|FG009|Overall Study|Subject/guardian decision|4|||
33573665|NCT02711345|62969240|FG000|Overall Study|Death|1|||
33573666|NCT02711345|62969241|FG001|Overall Study|Death|0|||
33573667|NCT02711345|62969242|FG002|Overall Study|Death|0|||
33573668|NCT02711345|62969243|FG003|Overall Study|Death|0|||
33573669|NCT02711345|62969244|FG004|Overall Study|Death|0|||
33573670|NCT02711345|62969245|FG005|Overall Study|Death|0|||
33573671|NCT02711345|62969246|FG006|Overall Study|Death|0|||
33573672|NCT02711345|62969247|FG007|Overall Study|Death|1|||
33573673|NCT02711345|62969248|FG008|Overall Study|Death|0|||
33573674|NCT02711345|62969249|FG009|Overall Study|Death|0|||
33573675|NCT02581995|62969286|FG000|Overall Study|Unspecified other|3|||
33573676|NCT02581995|62969286|FG000|Overall Study|Adverse Event|6|||
33573677|NCT02581995|62969286|FG000|Overall Study|Lost to Follow-up|5|||
33573678|NCT02581995|62969286|FG000|Overall Study|Withdrawal by participant|12|||
33573679|NCT02581995|62969286|FG000|Overall Study|Physician Decision|1|||
33573680|NCT02581995|62969286|FG000|Overall Study|Death|4|||
33573681|NCT02577003|62969292|FG000|Overall Study|Adverse Event|2|||
33573682|NCT02577003|62969293|FG001|Overall Study|Adverse Event|4|||
33573683|NCT02577003|62969292|FG000|Overall Study|Withdrawal by Subject|0|||
33573684|NCT02577003|62969293|FG001|Overall Study|Withdrawal by Subject|1|||
33573685|NCT02446899|62969301|FG000|Overall Study|Adverse Event|4|||
33573686|NCT02446899|62969302|FG001|Overall Study|Adverse Event|7|||
33573687|NCT02446899|62969301|FG000|Overall Study|Condition Under Investigation Worsened|1|||
33573688|NCT02446899|62969302|FG001|Overall Study|Condition Under Investigation Worsened|4|||
33573689|NCT02446899|62969301|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
33573690|NCT02446899|62969302|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
33573691|NCT02446899|62969301|FG000|Overall Study|Lack of Efficacy|2|||
33573692|NCT02446899|62969302|FG001|Overall Study|Lack of Efficacy|8|||
33573693|NCT02446899|62969301|FG000|Overall Study|Lost to Follow-up|1|||
33573694|NCT02446899|62969302|FG001|Overall Study|Lost to Follow-up|3|||
33573695|NCT02446899|62969301|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
33573696|NCT02446899|62969302|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
33573697|NCT02446899|62969301|FG000|Overall Study|Withdrawal by Subject|11|||
33573698|NCT02446899|62969302|FG001|Overall Study|Withdrawal by Subject|19|||
33573699|NCT02446899|62969301|FG000|Overall Study|Miscellaneous|5|||
33573700|NCT02446899|62969302|FG001|Overall Study|Miscellaneous|4|||
33573701|NCT02446899|62969301|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
33573702|NCT02446899|62969302|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
33573703|NCT02709785|62969311|FG000|Overall Study|Withdrawal by Subject|1|||
33573704|NCT02709785|62969312|FG001|Overall Study|Withdrawal by Subject|2|||
33573705|NCT02709785|62969313|FG002|Overall Study|Withdrawal by Subject|1|||
33573706|NCT02356887|62969321|FG000|Overall Study|poor compliance|2|||
33573707|NCT01604265|62969333|FG000|Overall Study|Adverse Event|1|||
33573708|NCT01604265|62969334|FG001|Overall Study|Adverse Event|0|||
33573709|NCT01604265|62969333|FG000|Overall Study|Withdrawal by Subject|1|||
33573710|NCT01604265|62969334|FG001|Overall Study|Withdrawal by Subject|0|||
33573711|NCT01664247|62969342|FG000|Overall Study|Adverse Event|5|||
33302882|NCT01045096|62678736|FG002|Overall Study|Withdrawal by Subject|0|||
33573712|NCT01664247|62969343|FG001|Overall Study|Adverse Event|3|||
33302883|NCT01045096|62678734|FG000|Overall Study|Other|1|||
33573713|NCT01664247|62969342|FG000|Overall Study|Protocol Violation|3|||
33573714|NCT01664247|62969343|FG001|Overall Study|Protocol Violation|5|||
33573715|NCT01664247|62969342|FG000|Overall Study|Withdrawal Criteria|1|||
33573716|NCT01664247|62969343|FG001|Overall Study|Withdrawal Criteria|4|||
33573717|NCT01664247|62969342|FG000|Overall Study|Unclassified|5|||
33573718|NCT01664247|62969343|FG001|Overall Study|Unclassified|29|||
33573719|NCT03191903|62969367|FG000|Overall Study|Withdrawal by Subject|6|||
33573720|NCT03191903|62969368|FG001|Overall Study|Withdrawal by Subject|5|||
33573721|NCT03191903|62969369|FG002|Overall Study|Withdrawal by Subject|4|||
33573722|NCT03191903|62969367|FG000|Overall Study|Adverse Event|1|||
33573723|NCT03191903|62969368|FG001|Overall Study|Adverse Event|0|||
33573724|NCT03191903|62969369|FG002|Overall Study|Adverse Event|0|||
33573725|NCT02576535|62969382|FG000|Overall Study|Withdrawal by Subject|2|||
33573726|NCT02576145|62969388|FG000|Overall Study|Adverse Event|1|||
33573727|NCT02576145|62969389|FG001|Overall Study|Adverse Event|0|||
33573728|NCT02576145|62969388|FG000|Overall Study|Withdrawal by Subject|1|||
33573729|NCT02576145|62969389|FG001|Overall Study|Withdrawal by Subject|0|||
33573730|NCT02576145|62969388|FG000|Overall Study|Acute rejection|1|||
33573731|NCT02576145|62969389|FG001|Overall Study|Acute rejection|0|||
33573732|NCT02576145|62969388|FG000|Overall Study|Tetanus Titers Decreased|0|||
33573733|NCT02576145|62969389|FG001|Overall Study|Tetanus Titers Decreased|1|||
33573734|NCT02576067|62969434|FG000|Overall Study|Death|0|||
33573735|NCT02576067|62969435|FG001|Overall Study|Death|1|||
33573736|NCT02576067|62969434|FG000|Overall Study|Lack of Efficacy|1|||
33573737|NCT02576067|62969435|FG001|Overall Study|Lack of Efficacy|0|||
33573738|NCT02576067|62969434|FG000|Overall Study|Lost to Follow-up|11|||
33573739|NCT02576067|62969435|FG001|Overall Study|Lost to Follow-up|0|||
33573740|NCT02576067|62969434|FG000|Overall Study|Withdrawal by Subject|11|||
33573741|NCT02576067|62969435|FG001|Overall Study|Withdrawal by Subject|2|||
33573742|NCT02576067|62969434|FG000|Overall Study|study closure of main CIRT trial)|0|||
33573743|NCT02576067|62969435|FG001|Overall Study|study closure of main CIRT trial)|8|||
33573744|NCT02576067|62969434|FG000|Overall Study|not randomized, failed run-in|7|||
33573745|NCT02576067|62969435|FG001|Overall Study|not randomized, failed run-in|0|||
33573746|NCT02576067|62969434|FG000|Overall Study|screen failure/ re-enrolled|0|||
33573747|NCT02576067|62969435|FG001|Overall Study|screen failure/ re-enrolled|25|||
33573748|NCT02576067|62969434|FG000|Overall Study|Physician Decision|4|||
33573749|NCT02576067|62969435|FG001|Overall Study|Physician Decision|0|||
33573750|NCT02575911|62969441|FG000|Overall Study|Lost to Follow-up|1|||
33573751|NCT02575833|62969455|FG000|Overall Study|Withdrawal by Subject|0|||
33573752|NCT02575833|62969456|FG001|Overall Study|Withdrawal by Subject|1|||
33573753|NCT02575833|62969455|FG000|Overall Study|Lost to Follow-up|1|||
33573754|NCT02575833|62969456|FG001|Overall Study|Lost to Follow-up|0|||
33573755|NCT02709083|62969462|FG000|Overall Study|Original PI left institution|7|||
33573756|NCT02709005|62969468|FG000|Overall Study|Lost to Follow-up|1|||
33573757|NCT02709005|62969469|FG001|Overall Study|Lost to Follow-up|1|||
33573758|NCT02709005|62969468|FG000|Overall Study|Withdrawal by Subject|3|||
33573759|NCT02709005|62969469|FG001|Overall Study|Withdrawal by Subject|0|||
33573760|NCT02573883|62969477|FG000|Six Month Follow Up|Lost to Follow-up|1|||
33573761|NCT02573883|62969478|FG001|Six Month Follow Up|Lost to Follow-up|0|||
33573762|NCT02573883|62969479|FG002|Six Month Follow Up|Lost to Follow-up|0|||
33573763|NCT02573883|62969480|FG003|Six Month Follow Up|Lost to Follow-up|0|||
33573764|NCT02573883|62969477|FG000|One Year Follow Up|Lost to Follow-up|2|||
33573765|NCT02573883|62969478|FG001|One Year Follow Up|Lost to Follow-up|1|||
33573766|NCT02573883|62969479|FG002|One Year Follow Up|Lost to Follow-up|0|||
33573767|NCT02573883|62969480|FG003|One Year Follow Up|Lost to Follow-up|0|||
33573768|NCT02575365|62969495|FG000|Overall Study|Lost to Follow-up|4|||
33573769|NCT02707991|62969501|FG000|Overall Study|Protocol Violation|1|||
33573770|NCT02707991|62969502|FG001|Overall Study|Protocol Violation|0|||
33573771|NCT02707991|62969501|FG000|Overall Study|Became ineligible|0|||
33573772|NCT02707991|62969502|FG001|Overall Study|Became ineligible|1|||
33573773|NCT02707757|62969510|FG000|Overall Study|Protocol Violation|3|||
33573774|NCT02707757|62969511|FG001|Overall Study|Protocol Violation|2|||
33573775|NCT02707757|62969510|FG000|Overall Study|Withdrawal by Subject|2|||
33573776|NCT02707757|62969511|FG001|Overall Study|Withdrawal by Subject|0|||
33573777|NCT02707757|62969510|FG000|Overall Study|Death|0|||
33573778|NCT02707757|62969511|FG001|Overall Study|Death|1|||
33573779|NCT02707757|62969510|FG000|Overall Study|Adverse Event|6|||
33573780|NCT02707757|62969511|FG001|Overall Study|Adverse Event|4|||
33573781|NCT02707757|62969510|FG000|Overall Study|Renal transplant/elective operation|1|||
33573782|NCT02707757|62969511|FG001|Overall Study|Renal transplant/elective operation|5|||
33573783|NCT02572401|62969521|FG000|Overall Study|Lost to Follow-up|5|||
33573784|NCT02572401|62969522|FG001|Overall Study|Lost to Follow-up|8|||
33573785|NCT02572401|62969523|FG002|Overall Study|Lost to Follow-up|9|||
33573786|NCT02572401|62969524|FG003|Overall Study|Lost to Follow-up|9|||
33573787|NCT02572401|62969521|FG000|Overall Study|Death|0|||
33573788|NCT02572401|62969522|FG001|Overall Study|Death|0|||
33573789|NCT02572401|62969523|FG002|Overall Study|Death|0|||
33573790|NCT02572401|62969524|FG003|Overall Study|Death|1|||
33573791|NCT02431325|62969536|FG000|Overall Study|Adverse Event|3|||
33573792|NCT02431325|62969537|FG001|Overall Study|Adverse Event|0|||
33573793|NCT02431325|62969536|FG000|Overall Study|Lost to Follow-up|0|||
33573794|NCT02431325|62969537|FG001|Overall Study|Lost to Follow-up|1|||
33573795|NCT02431325|62969536|FG000|Overall Study|Withdrawal by Subject|1|||
33573796|NCT02431325|62969537|FG001|Overall Study|Withdrawal by Subject|2|||
33573797|NCT02431325|62969536|FG000|Overall Study|Declined to take study medication|1|||
33573798|NCT02431325|62969537|FG001|Overall Study|Declined to take study medication|0|||
33573799|NCT02431325|62969536|FG000|Overall Study|Withdrew before starting study medication|1|||
33573800|NCT02431325|62969537|FG001|Overall Study|Withdrew before starting study medication|0|||
33573801|NCT02431325|62969536|FG000|Overall Study|Placebo shortage|2|||
33573802|NCT02431325|62969537|FG001|Overall Study|Placebo shortage|0|||
33573803|NCT02103478|62969550|FG000|Overall Study|Adverse Event|0|||
33573804|NCT02103478|62969551|FG001|Overall Study|Adverse Event|0|||
33573805|NCT02103478|62969552|FG002|Overall Study|Adverse Event|1|||
33573806|NCT02103478|62969553|FG003|Overall Study|Adverse Event|1|||
33573807|NCT02103478|62969554|FG004|Overall Study|Adverse Event|2|||
33573808|NCT02103478|62969555|FG005|Overall Study|Adverse Event|1|||
33573809|NCT02103478|62969556|FG006|Overall Study|Adverse Event|0|||
33573810|NCT02103478|62969557|FG007|Overall Study|Adverse Event|0|||
33573811|NCT02103478|62969558|FG008|Overall Study|Adverse Event|0|||
33573812|NCT02103478|62969550|FG000|Overall Study|Death|2|||
33573813|NCT02103478|62969551|FG001|Overall Study|Death|2|||
33573814|NCT02103478|62969552|FG002|Overall Study|Death|1|||
33573815|NCT02103478|62969553|FG003|Overall Study|Death|1|||
33573816|NCT02103478|62969554|FG004|Overall Study|Death|5|||
33573817|NCT02103478|62969555|FG005|Overall Study|Death|15|||
33573818|NCT02103478|62969556|FG006|Overall Study|Death|14|||
33573819|NCT02103478|62969557|FG007|Overall Study|Death|10|||
33573820|NCT02103478|62969558|FG008|Overall Study|Death|11|||
33573821|NCT02103478|62969550|FG000|Overall Study|Progressive Disease|2|||
33573822|NCT02103478|62969551|FG001|Overall Study|Progressive Disease|1|||
33573823|NCT02103478|62969552|FG002|Overall Study|Progressive Disease|2|||
33573824|NCT02103478|62969553|FG003|Overall Study|Progressive Disease|0|||
33573825|NCT02103478|62969554|FG004|Overall Study|Progressive Disease|9|||
33573826|NCT02103478|62969555|FG005|Overall Study|Progressive Disease|1|||
33573827|NCT02103478|62969556|FG006|Overall Study|Progressive Disease|2|||
33573828|NCT02103478|62969557|FG007|Overall Study|Progressive Disease|0|||
33573829|NCT02103478|62969558|FG008|Overall Study|Progressive Disease|1|||
33573830|NCT02103478|62969550|FG000|Overall Study|Withdrawal by Subject|2|||
33573831|NCT02103478|62969551|FG001|Overall Study|Withdrawal by Subject|0|||
33573832|NCT02103478|62969552|FG002|Overall Study|Withdrawal by Subject|0|||
33573833|NCT02103478|62969553|FG003|Overall Study|Withdrawal by Subject|4|||
33573834|NCT02103478|62969554|FG004|Overall Study|Withdrawal by Subject|0|||
33573835|NCT02103478|62969555|FG005|Overall Study|Withdrawal by Subject|0|||
33573836|NCT02103478|62969556|FG006|Overall Study|Withdrawal by Subject|1|||
33573837|NCT02103478|62969557|FG007|Overall Study|Withdrawal by Subject|1|||
33573838|NCT02103478|62969558|FG008|Overall Study|Withdrawal by Subject|0|||
33573839|NCT02103478|62969550|FG000|Overall Study|Lost to Follow-up|0|||
33573840|NCT02103478|62969551|FG001|Overall Study|Lost to Follow-up|0|||
33573841|NCT02103478|62969552|FG002|Overall Study|Lost to Follow-up|0|||
33573842|NCT02103478|62969553|FG003|Overall Study|Lost to Follow-up|0|||
33573843|NCT02103478|62969554|FG004|Overall Study|Lost to Follow-up|0|||
33573844|NCT02103478|62969555|FG005|Overall Study|Lost to Follow-up|0|||
33573845|NCT02103478|62969556|FG006|Overall Study|Lost to Follow-up|0|||
33573846|NCT02103478|62969557|FG007|Overall Study|Lost to Follow-up|1|||
33573847|NCT02103478|62969558|FG008|Overall Study|Lost to Follow-up|0|||
33396764|NCT00658320|62776013|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
33396765|NCT00658320|62776014|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
33573848|NCT02103478|62969550|FG000|Overall Study|Other|1|||
33573849|NCT02103478|62969551|FG001|Overall Study|Other|3|||
33573850|NCT02103478|62969552|FG002|Overall Study|Other|2|||
33573851|NCT02103478|62969553|FG003|Overall Study|Other|0|||
33396766|NCT00658320|62776013|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
33396767|NCT00658320|62776014|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
33664376|NCT01531673|63095420|FG010|Overall Study|Non-Compliance|0|||
33396768|NCT00322153|62776024|FG000|Overall Study|Adverse Event|21|||
33396769|NCT00322153|62776025|FG001|Overall Study|Adverse Event|34|||
33573852|NCT02103478|62969554|FG004|Overall Study|Other|3|||
33573853|NCT02103478|62969555|FG005|Overall Study|Other|8|||
33573854|NCT02103478|62969556|FG006|Overall Study|Other|8|||
33573855|NCT02103478|62969557|FG007|Overall Study|Other|4|||
33573856|NCT02103478|62969558|FG008|Overall Study|Other|2|||
33573857|NCT02102464|62969590|FG000|Randomized Study|Withdrawal by Subject|0|||
33573858|NCT02102464|62969591|FG001|Randomized Study|Withdrawal by Subject|1|||
33573859|NCT02102464|62969592|FG002|Randomized Study|Withdrawal by Subject|0|||
33573860|NCT02707601|62969603|FG000|Overall Study|Death|0|||
33573861|NCT02707601|62969604|FG001|Overall Study|Death|1|||
33573862|NCT02707601|62969603|FG000|Overall Study|Lack of Efficacy|0|||
33573863|NCT02707601|62969604|FG001|Overall Study|Lack of Efficacy|1|||
33573864|NCT02707601|62969603|FG000|Overall Study|Investigator's Discretion|1|||
33573865|NCT02707601|62969604|FG001|Overall Study|Investigator's Discretion|0|||
33573866|NCT02707601|62969603|FG000|Overall Study|Withdrew Consent|0|||
33573867|NCT02707601|62969604|FG001|Overall Study|Withdrew Consent|1|||
33573868|NCT02707601|62969603|FG000|Overall Study|Lost to Follow-up|1|||
33573869|NCT02707601|62969604|FG001|Overall Study|Lost to Follow-up|1|||
33573870|NCT02707601|62969603|FG000|Overall Study|Participants Randomized but Not Treated|2|||
33573871|NCT02707601|62969604|FG001|Overall Study|Participants Randomized but Not Treated|0|||
33573872|NCT02707055|62969616|FG000|Phase 1|Withdrawal by Subject|1|||
33573873|NCT02707055|62969617|FG001|Phase 1|Withdrawal by Subject|2|||
33573874|NCT02707055|62969616|FG000|Phase 1|Physician Decision|0|||
33573875|NCT02707055|62969617|FG001|Phase 1|Physician Decision|1|||
33573876|NCT02707055|62969616|FG000|Phase 2|Adverse Event|1|||
33573877|NCT02707055|62969617|FG001|Phase 2|Adverse Event|2|||
33573878|NCT02073682|62969625|FG000|Overall Study|Low Creatinine Clearance|1|||
33573879|NCT02073682|62969626|FG001|Overall Study|Low Creatinine Clearance|2|||
33573880|NCT02073682|62969625|FG000|Overall Study|Death|86|||
33573881|NCT02073682|62969626|FG001|Overall Study|Death|100|||
33573882|NCT02073682|62969625|FG000|Overall Study|Cancer Cured|10|||
33573883|NCT02073682|62969626|FG001|Overall Study|Cancer Cured|15|||
33573884|NCT02073682|62969625|FG000|Overall Study|ID: Patient Noncompliance|1|||
33573885|NCT02073682|62969626|FG001|Overall Study|ID: Patient Noncompliance|2|||
33573886|NCT02073682|62969625|FG000|Overall Study|ID: Palliative Treatment Only|10|||
33573887|NCT02073682|62969626|FG001|Overall Study|ID: Palliative Treatment Only|7|||
33573888|NCT02073682|62969625|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
33573889|NCT02073682|62969626|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
33573890|NCT02073682|62969625|FG000|Overall Study|Platelet Count <50,000/mL|1|||
33573891|NCT02073682|62969626|FG001|Overall Study|Platelet Count <50,000/mL|2|||
33573892|NCT02073682|62969625|FG000|Overall Study|Surgery/Medical Procedure|3|||
33573893|NCT02073682|62969626|FG001|Overall Study|Surgery/Medical Procedure|1|||
33573894|NCT02073682|62969625|FG000|Overall Study|Withdrawal by Subject|6|||
33573895|NCT02073682|62969626|FG001|Overall Study|Withdrawal by Subject|8|||
33573896|NCT02073682|62969625|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
33573897|NCT02073682|62969626|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
33573898|NCT02073682|62969625|FG000|Overall Study|Cancer Progression|53|||
33573899|NCT02073682|62969626|FG001|Overall Study|Cancer Progression|33|||
33573900|NCT02073682|62969625|FG000|Overall Study|Protocol Violation|1|||
33573901|NCT02073682|62969626|FG001|Overall Study|Protocol Violation|0|||
33573902|NCT02073682|62969625|FG000|Overall Study|Adverse Event|79|||
33573903|NCT02073682|62969626|FG001|Overall Study|Adverse Event|62|||
33573904|NCT02073682|62969625|FG000|Overall Study|No reason provided|11|||
33573905|NCT02073682|62969626|FG001|Overall Study|No reason provided|9|||
33573906|NCT02073682|62969625|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
33573907|NCT02073682|62969626|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
33573908|NCT02073682|62969625|FG000|Overall Study|Lost to Follow-up|1|||
33573909|NCT02073682|62969626|FG001|Overall Study|Lost to Follow-up|1|||
33573910|NCT02073682|62969625|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
33573911|NCT02073682|62969626|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
33573912|NCT02072980|62969632|FG000|Period 2, Second Wear|Adverse Event|0|||
33573913|NCT02072980|62969633|FG001|Period 2, Second Wear|Adverse Event|1|||
33573914|NCT02706899|62969641|FG000|Overall Study|Withdrawal by Subject|1|||
33573915|NCT02706899|62969642|FG001|Overall Study|Withdrawal by Subject|0|||
33573916|NCT02706899|62969641|FG000|Overall Study|Death|8|||
33573917|NCT02706899|62969642|FG001|Overall Study|Death|0|||
33573918|NCT02706899|62969641|FG000|Overall Study|Study Termination by Sponsor|4|||
33573919|NCT02706899|62969642|FG001|Overall Study|Study Termination by Sponsor|6|||
33573920|NCT02072824|62969651|FG000|Overall Study|Insufficient clinical response|1|||
33573921|NCT02072824|62969652|FG001|Overall Study|Insufficient clinical response|0|||
33573922|NCT02072824|62969653|FG002|Overall Study|Insufficient clinical response|1|||
33573923|NCT02072824|62969651|FG000|Overall Study|No longer willing to participate|1|||
33573924|NCT02072824|62969652|FG001|Overall Study|No longer willing to participate|0|||
33573925|NCT02072824|62969653|FG002|Overall Study|No longer willing to participate|1|||
33573926|NCT02072824|62969651|FG000|Overall Study|Medication error|0|||
33573927|NCT02072824|62969652|FG001|Overall Study|Medication error|1|||
33573928|NCT02072824|62969653|FG002|Overall Study|Medication error|0|||
33664377|NCT01531673|63095421|FG011|Overall Study|Non-Compliance|0|||
33664378|NCT01531673|63095422|FG012|Overall Study|Non-Compliance|0|||
33573929|NCT02072824|62969651|FG000|Overall Study|Adverse Event|0|||
33573930|NCT02072824|62969652|FG001|Overall Study|Adverse Event|0|||
33573931|NCT02072824|62969653|FG002|Overall Study|Adverse Event|1|||
33573932|NCT02072668|62969661|FG000|Second Intervention|Lost to Follow-up|1|||
33573933|NCT02072668|62969662|FG001|Second Intervention|Lost to Follow-up|0|||
33573934|NCT02140762|62969672|FG000|Overall Study|Adverse Event|1|||
33573935|NCT02140762|62969673|FG001|Overall Study|Adverse Event|1|||
33573936|NCT02140762|62969672|FG000|Overall Study|Lost to Follow-up|9|||
33573937|NCT02140762|62969673|FG001|Overall Study|Lost to Follow-up|5|||
33573938|NCT02140762|62969672|FG000|Overall Study|Protocol Violation|1|||
33573939|NCT02140762|62969673|FG001|Overall Study|Protocol Violation|1|||
33573940|NCT02140762|62969672|FG000|Overall Study|Withdrawal by Subject|6|||
33573941|NCT02140762|62969673|FG001|Overall Study|Withdrawal by Subject|4|||
33573942|NCT02140762|62969672|FG000|Overall Study|Other|0|||
33573943|NCT02140762|62969673|FG001|Overall Study|Other|1|||
33573944|NCT02101294|62969684|FG000|Overall Study|Withdrawal by Subject|5|||
33573945|NCT02101294|62969684|FG000|Overall Study|Lost to Follow-up|6|||
33573946|NCT01598506|62969691|FG000|Overall Study|Withdrawal by Subject|2|||
33573947|NCT02140060|62969702|FG000|Overall Study|Adverse Event|0|||
33573948|NCT02140060|62969703|FG001|Overall Study|Adverse Event|0|||
33573949|NCT02140060|62969704|FG002|Overall Study|Adverse Event|0|||
33573950|NCT02140060|62969705|FG003|Overall Study|Adverse Event|1|||
33573951|NCT02140060|62969706|FG004|Overall Study|Adverse Event|1|||
33573952|NCT02140060|62969707|FG005|Overall Study|Adverse Event|1|||
33573953|NCT02140060|62969702|FG000|Overall Study|Lack of Efficacy|0|||
33573954|NCT02140060|62969703|FG001|Overall Study|Lack of Efficacy|0|||
33573955|NCT02140060|62969704|FG002|Overall Study|Lack of Efficacy|0|||
33573956|NCT02140060|62969705|FG003|Overall Study|Lack of Efficacy|1|||
33573957|NCT02140060|62969706|FG004|Overall Study|Lack of Efficacy|0|||
33573958|NCT02140060|62969707|FG005|Overall Study|Lack of Efficacy|0|||
33573959|NCT02139982|62969732|FG000|Overall Study|Lack of Efficacy|0|||
33573960|NCT02139982|62969733|FG001|Overall Study|Lack of Efficacy|1|||
33573961|NCT02139982|62969734|FG002|Overall Study|Lack of Efficacy|0|||
33573962|NCT02139982|62969735|FG003|Overall Study|Lack of Efficacy|1|||
33573963|NCT02139982|62969736|FG004|Overall Study|Lack of Efficacy|0|||
33573964|NCT02139982|62969737|FG005|Overall Study|Lack of Efficacy|0|||
33573965|NCT02139982|62969738|FG006|Overall Study|Lack of Efficacy|0|||
33573966|NCT02139982|62969739|FG007|Overall Study|Lack of Efficacy|0|||
33573967|NCT02139982|62969740|FG008|Overall Study|Lack of Efficacy|0|||
33573968|NCT02139982|62969741|FG009|Overall Study|Lack of Efficacy|0|||
33573969|NCT02139826|62969763|FG000|Overall Study|Adverse Event|1|||
33573970|NCT02139592|62969773|FG000|Overall Study|Case Report Forms Uncollected|8|||
33573971|NCT02139280|62969779|FG000|Overall Study|No longer eligible|2|||
33573972|NCT02139280|62969780|FG001|Overall Study|No longer eligible|0|||
33573973|NCT02072434|62969788|FG000|Overall Study|Protocol Violation|10|||
33573974|NCT02072434|62969789|FG001|Overall Study|Protocol Violation|9|||
33573975|NCT02072434|62969788|FG000|Overall Study|Physician Decision|5|||
33573976|NCT02072434|62969789|FG001|Overall Study|Physician Decision|10|||
33573977|NCT02072434|62969788|FG000|Overall Study|Adverse event, serious fatal|1|||
33573978|NCT02072434|62969789|FG001|Overall Study|Adverse event, serious fatal|6|||
33573979|NCT02072434|62969788|FG000|Overall Study|Adverse Event|7|||
33573980|NCT02072434|62969789|FG001|Overall Study|Adverse Event|6|||
33573981|NCT02072434|62969788|FG000|Overall Study|Withdrawal by Subject|17|||
33573982|NCT02072434|62969789|FG001|Overall Study|Withdrawal by Subject|29|||
33573983|NCT02072434|62969788|FG000|Overall Study|Other|14|||
33573984|NCT02072434|62969789|FG001|Overall Study|Other|29|||
33573985|NCT02072434|62969788|FG000|Overall Study|Lost to Follow-up|0|||
33573986|NCT02072434|62969789|FG001|Overall Study|Lost to Follow-up|1|||
33573987|NCT02101060|62969797|FG000|Overall Study|Adverse Event|1|||
33573988|NCT02101060|62969798|FG001|Overall Study|Adverse Event|0|||
33573989|NCT02101060|62969797|FG000|Overall Study|Withdrawal by Subject|1|||
33573990|NCT02101060|62969798|FG001|Overall Study|Withdrawal by Subject|1|||
33573991|NCT02101060|62969797|FG000|Overall Study|Lost to Follow-up|3|||
33573992|NCT02101060|62969798|FG001|Overall Study|Lost to Follow-up|3|||
33573993|NCT02139124|62969809|FG000|Overall Study|Adverse Event|2|||
33573994|NCT02139124|62969810|FG001|Overall Study|Adverse Event|0|||
33573995|NCT02139124|62969811|FG002|Overall Study|Adverse Event|1|||
33573996|NCT02139124|62969812|FG003|Overall Study|Adverse Event|2|||
33573997|NCT02139124|62969813|FG004|Overall Study|Adverse Event|5|||
33573998|NCT02139124|62969809|FG000|Overall Study|Withdrawal by Subject|2|||
33573999|NCT02139124|62969810|FG001|Overall Study|Withdrawal by Subject|2|||
33574000|NCT02139124|62969811|FG002|Overall Study|Withdrawal by Subject|2|||
33574001|NCT02139124|62969812|FG003|Overall Study|Withdrawal by Subject|2|||
33574002|NCT02139124|62969813|FG004|Overall Study|Withdrawal by Subject|3|||
33574003|NCT02139124|62969809|FG000|Overall Study|Protocol Violation|0|||
33574004|NCT02139124|62969810|FG001|Overall Study|Protocol Violation|0|||
33574005|NCT02139124|62969811|FG002|Overall Study|Protocol Violation|0|||
33574006|NCT02139124|62969812|FG003|Overall Study|Protocol Violation|1|||
33574007|NCT02139124|62969813|FG004|Overall Study|Protocol Violation|1|||
33664379|NCT01531673|63095410|FG000|Overall Study|Adverse Event|0|||
33664380|NCT01531673|63095411|FG001|Overall Study|Adverse Event|1|||
33664381|NCT01531673|63095412|FG002|Overall Study|Adverse Event|0|||
33574008|NCT02139124|62969809|FG000|Overall Study|non-compliant|1|||
33574009|NCT02139124|62969810|FG001|Overall Study|non-compliant|0|||
33574010|NCT02139124|62969811|FG002|Overall Study|non-compliant|0|||
33574011|NCT02139124|62969812|FG003|Overall Study|non-compliant|2|||
33574012|NCT02139124|62969813|FG004|Overall Study|non-compliant|0|||
33574013|NCT02139124|62969809|FG000|Overall Study|incarceration|0|||
33302884|NCT01045096|62678735|FG001|Overall Study|Other|0|||
33574014|NCT02139124|62969810|FG001|Overall Study|incarceration|0|||
33574015|NCT02139124|62969811|FG002|Overall Study|incarceration|1|||
33574016|NCT02139124|62969812|FG003|Overall Study|incarceration|0|||
33574017|NCT02139124|62969813|FG004|Overall Study|incarceration|0|||
33574018|NCT02139124|62969809|FG000|Overall Study|subject moved|1|||
33574019|NCT02139124|62969810|FG001|Overall Study|subject moved|0|||
33574020|NCT02139124|62969811|FG002|Overall Study|subject moved|0|||
33574021|NCT02139124|62969812|FG003|Overall Study|subject moved|0|||
33574022|NCT02139124|62969813|FG004|Overall Study|subject moved|0|||
33574023|NCT02139124|62969809|FG000|Overall Study|Lost to Follow-up|3|||
33574024|NCT02139124|62969810|FG001|Overall Study|Lost to Follow-up|2|||
33574025|NCT02139124|62969811|FG002|Overall Study|Lost to Follow-up|0|||
33574026|NCT02139124|62969812|FG003|Overall Study|Lost to Follow-up|5|||
33574027|NCT02139124|62969813|FG004|Overall Study|Lost to Follow-up|4|||
33574028|NCT02139046|62969830|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
33574029|NCT02139046|62969831|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
33574030|NCT02139046|62969832|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
33574031|NCT02139046|62969833|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
33574032|NCT02139046|62969834|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
33574033|NCT02139046|62969830|FG000|Overall Study|Major Protocol Deviation|9|||
33574034|NCT02139046|62969831|FG001|Overall Study|Major Protocol Deviation|10|||
33574035|NCT02139046|62969832|FG002|Overall Study|Major Protocol Deviation|16|||
33574036|NCT02139046|62969833|FG003|Overall Study|Major Protocol Deviation|12|||
33574037|NCT02139046|62969834|FG004|Overall Study|Major Protocol Deviation|6|||
33574038|NCT02139046|62969830|FG000|Overall Study|Lost to Follow-up|13|||
33574039|NCT02139046|62969831|FG001|Overall Study|Lost to Follow-up|16|||
33574040|NCT02139046|62969832|FG002|Overall Study|Lost to Follow-up|16|||
33574041|NCT02139046|62969833|FG003|Overall Study|Lost to Follow-up|18|||
33574042|NCT02139046|62969834|FG004|Overall Study|Lost to Follow-up|13|||
33574043|NCT02139046|62969830|FG000|Overall Study|Voluntary Withdrawal|20|||
33574044|NCT02139046|62969831|FG001|Overall Study|Voluntary Withdrawal|8|||
33574045|NCT02139046|62969832|FG002|Overall Study|Voluntary Withdrawal|10|||
33574046|NCT02139046|62969833|FG003|Overall Study|Voluntary Withdrawal|15|||
33574047|NCT02139046|62969834|FG004|Overall Study|Voluntary Withdrawal|16|||
33574048|NCT02139046|62969830|FG000|Overall Study|Lack of Efficacy|0|||
33574049|NCT02139046|62969831|FG001|Overall Study|Lack of Efficacy|1|||
33574050|NCT02139046|62969832|FG002|Overall Study|Lack of Efficacy|2|||
33574051|NCT02139046|62969833|FG003|Overall Study|Lack of Efficacy|1|||
33574052|NCT02139046|62969834|FG004|Overall Study|Lack of Efficacy|2|||
33574053|NCT02139046|62969830|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
33574054|NCT02139046|62969831|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
33574055|NCT02139046|62969832|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
33574056|NCT02139046|62969833|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
33574057|NCT02139046|62969834|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
33574058|NCT02139046|62969830|FG000|Overall Study|Other Miscellaneous Reasons|10|||
33574059|NCT02139046|62969831|FG001|Overall Study|Other Miscellaneous Reasons|9|||
33574060|NCT02139046|62969832|FG002|Overall Study|Other Miscellaneous Reasons|4|||
33574061|NCT02139046|62969833|FG003|Overall Study|Other Miscellaneous Reasons|9|||
33574062|NCT02139046|62969834|FG004|Overall Study|Other Miscellaneous Reasons|12|||
33574063|NCT02138890|62969848|FG000|Overall Study|Adverse Event|1|||
33574064|NCT02138890|62969849|FG001|Overall Study|Adverse Event|0|||
33574065|NCT02100670|62969860|FG000|Overall Study|Adverse Event|10|||
33574066|NCT02100670|62969861|FG001|Overall Study|Adverse Event|3|||
33574067|NCT02100670|62969862|FG002|Overall Study|Adverse Event|3|||
33574068|NCT02100670|62969863|FG003|Overall Study|Adverse Event|0|||
33574069|NCT02100670|62969860|FG000|Overall Study|Lost to Follow-up|1|||
33574070|NCT02100670|62969861|FG001|Overall Study|Lost to Follow-up|0|||
33574071|NCT02100670|62969862|FG002|Overall Study|Lost to Follow-up|0|||
33574072|NCT02100670|62969863|FG003|Overall Study|Lost to Follow-up|0|||
33574073|NCT02100670|62969860|FG000|Overall Study|Protocol Violation|0|||
33574074|NCT02100670|62969861|FG001|Overall Study|Protocol Violation|1|||
33574075|NCT02100670|62969862|FG002|Overall Study|Protocol Violation|0|||
33574076|NCT02100670|62969863|FG003|Overall Study|Protocol Violation|1|||
33574077|NCT02100670|62969860|FG000|Overall Study|Withdrawal of Consent|0|||
33302885|NCT01045096|62678736|FG002|Overall Study|Other|0|||
33396770|NCT00322153|62776024|FG000|Overall Study|Protocol Violation|6|||
33396771|NCT00322153|62776025|FG001|Overall Study|Protocol Violation|14|||
33396772|NCT00322153|62776024|FG000|Overall Study|Withdrawal by Subject|18|||
33574078|NCT02100670|62969861|FG001|Overall Study|Withdrawal of Consent|1|||
33574079|NCT02100670|62969862|FG002|Overall Study|Withdrawal of Consent|1|||
33574080|NCT02100670|62969863|FG003|Overall Study|Withdrawal of Consent|0|||
33396773|NCT00322153|62776025|FG001|Overall Study|Withdrawal by Subject|10|||
33574081|NCT02100670|62969860|FG000|Overall Study|No swelling no pain|1|||
33574082|NCT02100670|62969861|FG001|Overall Study|No swelling no pain|0|||
33574083|NCT02100670|62969862|FG002|Overall Study|No swelling no pain|0|||
33574084|NCT02100670|62969863|FG003|Overall Study|No swelling no pain|0|||
33574085|NCT02100670|62969860|FG000|Overall Study|Poor Efficacy|0|||
33574086|NCT02100670|62969861|FG001|Overall Study|Poor Efficacy|1|||
33574087|NCT02100670|62969862|FG002|Overall Study|Poor Efficacy|0|||
33574088|NCT02100670|62969863|FG003|Overall Study|Poor Efficacy|0|||
33574089|NCT02100670|62969860|FG000|Overall Study|Physician Decision|0|||
33574090|NCT02100670|62969861|FG001|Overall Study|Physician Decision|1|||
33574091|NCT02100670|62969862|FG002|Overall Study|Physician Decision|0|||
33574092|NCT02100670|62969863|FG003|Overall Study|Physician Decision|0|||
33574093|NCT02100670|62969860|FG000|Overall Study|Withdrawal by Subject|1|||
33574094|NCT02100670|62969861|FG001|Overall Study|Withdrawal by Subject|0|||
33574095|NCT02100670|62969862|FG002|Overall Study|Withdrawal by Subject|0|||
33574096|NCT02100670|62969863|FG003|Overall Study|Withdrawal by Subject|0|||
33574097|NCT02070484|62969882|FG000|Overall Study|Withdrawal by Subject|1|||
33574098|NCT02070484|62969883|FG001|Overall Study|Withdrawal by Subject|0|||
33574099|NCT02100514|62969891|FG000|Treatment Period|Adverse Event|0|||
33574100|NCT02100514|62969892|FG001|Treatment Period|Adverse Event|5|||
33574101|NCT02100514|62969893|FG002|Treatment Period|Adverse Event|0|||
33574102|NCT02100514|62969894|FG003|Treatment Period|Adverse Event|0|||
33574103|NCT02100514|62969895|FG004|Treatment Period|Adverse Event|0|||
33574104|NCT02100514|62969891|FG000|Treatment Period|Death|2|||
33574105|NCT02100514|62969892|FG001|Treatment Period|Death|2|||
33574106|NCT02100514|62969893|FG002|Treatment Period|Death|0|||
33574107|NCT02100514|62969894|FG003|Treatment Period|Death|0|||
33574108|NCT02100514|62969895|FG004|Treatment Period|Death|0|||
33574109|NCT02100514|62969891|FG000|Treatment Period|Lost to Follow-up|5|||
33574110|NCT02100514|62969892|FG001|Treatment Period|Lost to Follow-up|17|||
33574111|NCT02100514|62969893|FG002|Treatment Period|Lost to Follow-up|0|||
33574112|NCT02100514|62969894|FG003|Treatment Period|Lost to Follow-up|0|||
33574113|NCT02100514|62969895|FG004|Treatment Period|Lost to Follow-up|0|||
33574114|NCT02100514|62969891|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
33574115|NCT02100514|62969892|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
33574116|NCT02100514|62969893|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
33574117|NCT02100514|62969894|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
33574118|NCT02100514|62969895|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
33574119|NCT02100514|62969891|FG000|Treatment Period|Protocol Violation|1|||
33574120|NCT02100514|62969892|FG001|Treatment Period|Protocol Violation|1|||
33574121|NCT02100514|62969893|FG002|Treatment Period|Protocol Violation|0|||
33574122|NCT02100514|62969894|FG003|Treatment Period|Protocol Violation|0|||
33574123|NCT02100514|62969895|FG004|Treatment Period|Protocol Violation|0|||
33574124|NCT02100514|62969891|FG000|Treatment Period|Withdrawal by Subject|12|||
33574125|NCT02100514|62969892|FG001|Treatment Period|Withdrawal by Subject|37|||
33574126|NCT02100514|62969893|FG002|Treatment Period|Withdrawal by Subject|0|||
33574127|NCT02100514|62969894|FG003|Treatment Period|Withdrawal by Subject|0|||
33574128|NCT02100514|62969895|FG004|Treatment Period|Withdrawal by Subject|0|||
33574129|NCT02100514|62969891|FG000|Treatment Period|Other|9|||
33574130|NCT02100514|62969892|FG001|Treatment Period|Other|11|||
33574131|NCT02100514|62969893|FG002|Treatment Period|Other|0|||
33574132|NCT02100514|62969894|FG003|Treatment Period|Other|0|||
33574133|NCT02100514|62969895|FG004|Treatment Period|Other|0|||
33574134|NCT02100514|62969891|FG000|Extension Period|Withdrew consent|0|||
33574135|NCT02100514|62969892|FG001|Extension Period|Withdrew consent|0|||
33574136|NCT02100514|62969893|FG002|Extension Period|Withdrew consent|2|||
33574137|NCT02100514|62969894|FG003|Extension Period|Withdrew consent|0|||
33574138|NCT02100514|62969895|FG004|Extension Period|Withdrew consent|0|||
33574139|NCT02069392|62969911|FG000|Overall Study|Withdrawal by Subject|4|||
33574140|NCT02069392|62969912|FG001|Overall Study|Withdrawal by Subject|2|||
33574141|NCT02047318|62969920|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
33574142|NCT02047318|62969920|FG000|Core Study Period|Adverse Event|1|||
33574143|NCT02047318|62969920|FG000|Core Study Period|Withdrawal by caregiver|3|||
33574144|NCT02047318|62969920|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
33574145|NCT02100124|62969938|FG000|Overall Study|Lost to Follow-up|5|||
33574146|NCT02100124|62969939|FG001|Overall Study|Lost to Follow-up|11|||
33574147|NCT02100124|62969940|FG002|Overall Study|Lost to Follow-up|3|||
33574148|NCT02100124|62969938|FG000|Overall Study|Withdrawal by Subject|1|||
33574149|NCT02100124|62969939|FG001|Overall Study|Withdrawal by Subject|0|||
33574150|NCT02100124|62969940|FG002|Overall Study|Withdrawal by Subject|0|||
33574151|NCT02068768|62969948|FG000|Overall Study|Lost to Follow-up|5|||
33574152|NCT02068768|62969948|FG000|Overall Study|Early Termination by Sponsor|2|||
33574153|NCT02046616|62969952|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
33574154|NCT02046616|62969952|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
33574155|NCT02046616|62969952|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
33574156|NCT02046616|62969952|FG000|24-Week Treatment Period|Physician Decision|3|||
33574157|NCT02046616|62969952|FG000|24-Week Treatment Period|Other|1|||
33574158|NCT02046616|62969952|FG000|8-Week FU Period|Lost to Follow-up|1|||
33574159|NCT02099344|62969958|FG000|Overall Study|Physician Decision|1|||
33574160|NCT02099344|62969959|FG001|Overall Study|Physician Decision|0|||
33574161|NCT02068222|62969967|FG000|Overall Study|Lost to Follow-up|1|||
33574162|NCT02099110|62969976|FG000|Overall Study|Protocol Violation|2|||
33574163|NCT02099110|62969977|FG001|Overall Study|Protocol Violation|1|||
33574164|NCT02099110|62969978|FG002|Overall Study|Protocol Violation|0|||
33574165|NCT02099110|62969979|FG003|Overall Study|Protocol Violation|3|||
33574166|NCT02099110|62969980|FG004|Overall Study|Protocol Violation|1|||
33574167|NCT02099110|62969976|FG000|Overall Study|Participant moved|1|||
33574168|NCT02099110|62969977|FG001|Overall Study|Participant moved|1|||
33574169|NCT02099110|62969978|FG002|Overall Study|Participant moved|1|||
33574170|NCT02099110|62969979|FG003|Overall Study|Participant moved|0|||
33574171|NCT02099110|62969980|FG004|Overall Study|Participant moved|2|||
33574172|NCT02099110|62969976|FG000|Overall Study|Withdrawal by Subject|7|||
33574173|NCT02099110|62969977|FG001|Overall Study|Withdrawal by Subject|11|||
33574174|NCT02099110|62969978|FG002|Overall Study|Withdrawal by Subject|13|||
33574175|NCT02099110|62969979|FG003|Overall Study|Withdrawal by Subject|9|||
33574176|NCT02099110|62969980|FG004|Overall Study|Withdrawal by Subject|13|||
33574177|NCT02099110|62969976|FG000|Overall Study|Adverse Event|3|||
33574178|NCT02099110|62969977|FG001|Overall Study|Adverse Event|5|||
33574179|NCT02099110|62969978|FG002|Overall Study|Adverse Event|2|||
33574180|NCT02099110|62969979|FG003|Overall Study|Adverse Event|3|||
33574181|NCT02099110|62969980|FG004|Overall Study|Adverse Event|2|||
33574182|NCT02099110|62969976|FG000|Overall Study|Lost to Follow-up|6|||
33574183|NCT02099110|62969977|FG001|Overall Study|Lost to Follow-up|12|||
33574184|NCT02099110|62969978|FG002|Overall Study|Lost to Follow-up|11|||
33574185|NCT02099110|62969979|FG003|Overall Study|Lost to Follow-up|5|||
33574186|NCT02099110|62969980|FG004|Overall Study|Lost to Follow-up|6|||
33574187|NCT02099110|62969976|FG000|Overall Study|Death|0|||
33574188|NCT02099110|62969977|FG001|Overall Study|Death|1|||
33574189|NCT02099110|62969978|FG002|Overall Study|Death|0|||
33574190|NCT02099110|62969979|FG003|Overall Study|Death|0|||
33574191|NCT02099110|62969980|FG004|Overall Study|Death|0|||
33574192|NCT02099110|62969976|FG000|Overall Study|Screen failure|0|||
33574193|NCT02099110|62969977|FG001|Overall Study|Screen failure|0|||
33574194|NCT02099110|62969978|FG002|Overall Study|Screen failure|0|||
33574195|NCT02099110|62969979|FG003|Overall Study|Screen failure|0|||
33574196|NCT02099110|62969980|FG004|Overall Study|Screen failure|1|||
33574197|NCT02099110|62969976|FG000|Overall Study|Non-compliance with study drug|2|||
33574198|NCT02099110|62969977|FG001|Overall Study|Non-compliance with study drug|0|||
33574199|NCT02099110|62969978|FG002|Overall Study|Non-compliance with study drug|0|||
33574200|NCT02099110|62969979|FG003|Overall Study|Non-compliance with study drug|0|||
33574201|NCT02099110|62969980|FG004|Overall Study|Non-compliance with study drug|1|||
33574202|NCT02099110|62969976|FG000|Overall Study|Physician Decision|3|||
33574203|NCT02099110|62969977|FG001|Overall Study|Physician Decision|0|||
33574204|NCT02099110|62969978|FG002|Overall Study|Physician Decision|1|||
33574205|NCT02099110|62969979|FG003|Overall Study|Physician Decision|2|||
33574206|NCT02099110|62969980|FG004|Overall Study|Physician Decision|1|||
33574207|NCT02098876|62969994|FG000|Overall Study|Withdrawal by Subject|5|||
33574208|NCT02098876|62969995|FG001|Overall Study|Withdrawal by Subject|5|||
33574209|NCT01624090|62970005|FG000|Overall Study|DLT, taken off therapy|0|||
33574210|NCT01624090|62970006|FG001|Overall Study|DLT, taken off therapy|1|||
33574211|NCT01624090|62970007|FG002|Overall Study|DLT, taken off therapy|0|||
33574212|NCT01624090|62970008|FG003|Overall Study|DLT, taken off therapy|0|||
33574213|NCT01624090|62970005|FG000|Overall Study|Withdrew prior to treatment|0|||
33574214|NCT01624090|62970006|FG001|Overall Study|Withdrew prior to treatment|1|||
33574215|NCT01624090|62970007|FG002|Overall Study|Withdrew prior to treatment|0|||
33574216|NCT01624090|62970008|FG003|Overall Study|Withdrew prior to treatment|0|||
33574217|NCT01624090|62970005|FG000|Overall Study|Died on study|0|||
33574218|NCT01624090|62970006|FG001|Overall Study|Died on study|0|||
33574219|NCT01624090|62970007|FG002|Overall Study|Died on study|2|||
33574220|NCT01624090|62970008|FG003|Overall Study|Died on study|0|||
33574221|NCT01624090|62970005|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
33574222|NCT01624090|62970006|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
33574223|NCT01624090|62970007|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
33574224|NCT01624090|62970008|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
33574225|NCT01624090|62970005|FG000|Overall Study|Dose escalated|0|||
33574226|NCT01624090|62970006|FG001|Overall Study|Dose escalated|0|||
33574227|NCT01624090|62970007|FG002|Overall Study|Dose escalated|3|||
33664382|NCT01531673|63095413|FG003|Overall Study|Adverse Event|0|||
33664383|NCT01531673|63095414|FG004|Overall Study|Adverse Event|0|||
33574228|NCT01624090|62970008|FG003|Overall Study|Dose escalated|0|||
33574229|NCT02571777|62970023|FG000|Overall Study|Subject/guardian decision|34|||
33664384|NCT01531673|63095415|FG005|Overall Study|Adverse Event|0|||
33664385|NCT01531673|63095416|FG006|Overall Study|Adverse Event|0|||
33574230|NCT02571777|62970024|FG001|Overall Study|Subject/guardian decision|26|||
33574231|NCT02571777|62970025|FG002|Overall Study|Subject/guardian decision|26|||
33574232|NCT02571777|62970026|FG003|Overall Study|Subject/guardian decision|25|||
33664386|NCT01531673|63095417|FG007|Overall Study|Adverse Event|0|||
33664387|NCT01531673|63095418|FG008|Overall Study|Adverse Event|0|||
33574233|NCT02571777|62970027|FG004|Overall Study|Subject/guardian decision|27|||
33574234|NCT02571777|62970023|FG000|Overall Study|Protocol Deviation|2|||
33574235|NCT02571777|62970024|FG001|Overall Study|Protocol Deviation|3|||
33574236|NCT02571777|62970025|FG002|Overall Study|Protocol Deviation|4|||
33574237|NCT02571777|62970026|FG003|Overall Study|Protocol Deviation|8|||
33664388|NCT01531673|63095419|FG009|Overall Study|Adverse Event|0|||
33574238|NCT02571777|62970027|FG004|Overall Study|Protocol Deviation|4|||
33574239|NCT02571777|62970023|FG000|Overall Study|Death|1|||
33574240|NCT02571777|62970024|FG001|Overall Study|Death|1|||
33574241|NCT02571777|62970025|FG002|Overall Study|Death|4|||
33574242|NCT02571777|62970026|FG003|Overall Study|Death|0|||
33574243|NCT02571777|62970027|FG004|Overall Study|Death|0|||
33574244|NCT02571777|62970023|FG000|Overall Study|Lost to Follow-up|1|||
33574245|NCT02571777|62970024|FG001|Overall Study|Lost to Follow-up|1|||
33574246|NCT02571777|62970025|FG002|Overall Study|Lost to Follow-up|2|||
33574247|NCT02571777|62970026|FG003|Overall Study|Lost to Follow-up|0|||
33574248|NCT02571777|62970027|FG004|Overall Study|Lost to Follow-up|1|||
33574249|NCT02571777|62970023|FG000|Overall Study|Physician Decision|1|||
33574250|NCT02571777|62970024|FG001|Overall Study|Physician Decision|7|||
33574251|NCT02571777|62970025|FG002|Overall Study|Physician Decision|5|||
33574252|NCT02571777|62970026|FG003|Overall Study|Physician Decision|2|||
33574253|NCT02571777|62970027|FG004|Overall Study|Physician Decision|4|||
33574254|NCT02571777|62970023|FG000|Overall Study|Pregnancy|0|||
33574255|NCT02571777|62970024|FG001|Overall Study|Pregnancy|0|||
33574256|NCT02571777|62970025|FG002|Overall Study|Pregnancy|0|||
33574257|NCT02571777|62970026|FG003|Overall Study|Pregnancy|2|||
33574258|NCT02571777|62970027|FG004|Overall Study|Pregnancy|0|||
33574259|NCT02571075|62970041|FG000|Overall Study|Lost to Follow-up|20|||
33574260|NCT02571075|62970042|FG001|Overall Study|Lost to Follow-up|24|||
33574261|NCT02705105|62970056|FG000|Treatment|Objective Disease Progression|1|||
33574262|NCT02705105|62970057|FG001|Treatment|Objective Disease Progression|50|||
33574263|NCT02705105|62970056|FG000|Treatment|Withdrawal by Subject|3|||
33574264|NCT02705105|62970057|FG001|Treatment|Withdrawal by Subject|5|||
33574265|NCT02705105|62970056|FG000|Treatment|Adverse Event|0|||
33574266|NCT02705105|62970057|FG001|Treatment|Adverse Event|17|||
33574267|NCT02705105|62970056|FG000|Treatment|Clinical Disease Progression|0|||
33574268|NCT02705105|62970057|FG001|Treatment|Clinical Disease Progression|32|||
33574269|NCT02705105|62970056|FG000|Treatment|Physician Decision|0|||
33574270|NCT02705105|62970057|FG001|Treatment|Physician Decision|3|||
33574271|NCT02705105|62970056|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
33574272|NCT02705105|62970057|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
33574273|NCT02705105|62970056|FG000|Follow-Up|Death|3|||
33574274|NCT02705105|62970057|FG001|Follow-Up|Death|68|||
33574275|NCT02705105|62970056|FG000|Follow-Up|Withdrawal by Subject|1|||
33574276|NCT02705105|62970057|FG001|Follow-Up|Withdrawal by Subject|14|||
33574277|NCT02705105|62970056|FG000|Follow-Up|Study Terminated|0|||
33574278|NCT02705105|62970057|FG001|Follow-Up|Study Terminated|26|||
33574279|NCT02705105|62970056|FG000|Follow-Up|Discontinued per Amendment 3|0|||
33574280|NCT02705105|62970057|FG001|Follow-Up|Discontinued per Amendment 3|2|||
33574281|NCT02097472|62970083|FG000|Received Vaccination 2|Adverse Event|0|||
33574282|NCT02097472|62970084|FG001|Received Vaccination 2|Adverse Event|0|||
33574283|NCT02097472|62970085|FG002|Received Vaccination 2|Adverse Event|0|||
33574284|NCT02097472|62970086|FG003|Received Vaccination 2|Adverse Event|0|||
33574285|NCT02097472|62970087|FG004|Received Vaccination 2|Adverse Event|0|||
33574286|NCT02097472|62970088|FG005|Received Vaccination 2|Adverse Event|0|||
33574287|NCT02097472|62970089|FG006|Received Vaccination 2|Adverse Event|1|||
33574288|NCT02097472|62970090|FG007|Received Vaccination 2|Adverse Event|0|||
33574289|NCT01623310|62970174|FG000|Overall Study|Adverse Event|21|||
33574290|NCT01623310|62970174|FG000|Overall Study|Lost to Follow-up|18|||
33574291|NCT01623310|62970174|FG000|Overall Study|Lack of Efficacy|6|||
33574292|NCT01623310|62970174|FG000|Overall Study|Protocol Violation|6|||
33574293|NCT01623310|62970174|FG000|Overall Study|Withdrawal by Subject|25|||
33574294|NCT01623310|62970174|FG000|Overall Study|Became potentially child-bearing|1|||
33574295|NCT01623310|62970174|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
33574296|NCT01623310|62970174|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
33574297|NCT02046226|62970178|FG000|Overall Study|Lost to Follow-up|7|||
33664389|NCT01531673|63095420|FG010|Overall Study|Adverse Event|0|||
33574298|NCT02046148|62970185|FG000|Overall Study|Lost to Follow-up|1|||
33574299|NCT02046148|62970186|FG001|Overall Study|Lost to Follow-up|1|||
33574300|NCT02046148|62970185|FG000|Overall Study|Withdrawal by Subject|0|||
33574301|NCT02046148|62970186|FG001|Overall Study|Withdrawal by Subject|2|||
33574302|NCT02097238|62970192|FG000|Overall Study|Death|1|||
33574303|NCT02097238|62970192|FG000|Overall Study|Physician Decision|1|||
33574304|NCT02097238|62970192|FG000|Overall Study|Progressive Disease|17|||
33574305|NCT02704091|62970199|FG000|Overall Study|Adverse Event|4|||
33574306|NCT02704091|62970200|FG001|Overall Study|Adverse Event|3|||
33574307|NCT02704091|62970199|FG000|Overall Study|Protocol Violation|5|||
33574308|NCT02704091|62970200|FG001|Overall Study|Protocol Violation|3|||
33574309|NCT02704091|62970199|FG000|Overall Study|Consent withdrawn|4|||
33574310|NCT02704091|62970200|FG001|Overall Study|Consent withdrawn|4|||
33574311|NCT02704091|62970199|FG000|Overall Study|Lost to Follow-up|13|||
33574312|NCT02704091|62970200|FG001|Overall Study|Lost to Follow-up|5|||
33574313|NCT02704091|62970199|FG000|Overall Study|Other|2|||
33574314|NCT02704091|62970200|FG001|Overall Study|Other|8|||
33574315|NCT02702609|62970208|FG000|Overall Study|Lost to Follow-up|8|||
33574316|NCT02702609|62970209|FG001|Overall Study|Lost to Follow-up|4|||
33574317|NCT02702609|62970208|FG000|Overall Study|Physician Decision|1|||
33574318|NCT02702609|62970209|FG001|Overall Study|Physician Decision|0|||
33574319|NCT02046070|62970218|FG000|Overall Study|Progressive Disease|18|||
33574320|NCT02046070|62970219|FG001|Overall Study|Progressive Disease|11|||
33574321|NCT02046070|62970220|FG002|Overall Study|Progressive Disease|40|||
33574322|NCT02046070|62970218|FG000|Overall Study|Adverse Event|8|||
33574323|NCT02046070|62970219|FG001|Overall Study|Adverse Event|10|||
33574324|NCT02046070|62970220|FG002|Overall Study|Adverse Event|17|||
33574325|NCT02046070|62970218|FG000|Overall Study|Withdrawal by Subject|1|||
33574326|NCT02046070|62970219|FG001|Overall Study|Withdrawal by Subject|2|||
33574327|NCT02046070|62970220|FG002|Overall Study|Withdrawal by Subject|6|||
33574328|NCT02046070|62970218|FG000|Overall Study|Study Terminated by Sponsor|1|||
33574329|NCT02046070|62970219|FG001|Overall Study|Study Terminated by Sponsor|1|||
33574330|NCT02046070|62970220|FG002|Overall Study|Study Terminated by Sponsor|1|||
33574331|NCT02046070|62970218|FG000|Overall Study|Reason not Specified|4|||
33574332|NCT02046070|62970219|FG001|Overall Study|Reason not Specified|4|||
33574333|NCT02046070|62970220|FG002|Overall Study|Reason not Specified|6|||
33574334|NCT01663857|62970232|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
33574335|NCT01663857|62970233|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
33574336|NCT01663857|62970234|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
33574337|NCT01663857|62970235|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
33574338|NCT01663857|62970232|FG000|Overall Study|Lost to Follow-up|0|||
33574339|NCT01663857|62970233|FG001|Overall Study|Lost to Follow-up|0|||
33574340|NCT01663857|62970234|FG002|Overall Study|Lost to Follow-up|3|||
33574341|NCT01663857|62970235|FG003|Overall Study|Lost to Follow-up|1|||
33574342|NCT02094898|62970251|FG000|Overall Study|Clinical Worsening|2|||
33574343|NCT02094898|62970251|FG000|Overall Study|Adverse Event|2|||
33574344|NCT02094898|62970251|FG000|Overall Study|Lack of Efficacy|1|||
33580969|NCT01268150|62978110|FG000|Extension Phase|Disease progression|18|||
33580970|NCT01268150|62978110|FG000|Extension Phase|Other|6|||
33580971|NCT01267175|62978114|FG000|Overall Study|Withdrawal by Subject|1|||
33580972|NCT01267175|62978114|FG000|Overall Study|Lost to Follow-up|1|||
33580973|NCT01133756|62978125|FG000|Overall Study|Adverse Event|1|||
33580974|NCT01133756|62978126|FG001|Overall Study|Adverse Event|2|||
33580975|NCT01133756|62978127|FG002|Overall Study|Adverse Event|1|||
33580976|NCT01133756|62978125|FG000|Overall Study|Investigator Decision|1|||
33580977|NCT01133756|62978126|FG001|Overall Study|Investigator Decision|0|||
33580978|NCT01133756|62978127|FG002|Overall Study|Investigator Decision|0|||
33580979|NCT01133756|62978125|FG000|Overall Study|Withdrawal by Subject|0|||
33580980|NCT01133756|62978126|FG001|Overall Study|Withdrawal by Subject|1|||
33580981|NCT01133756|62978127|FG002|Overall Study|Withdrawal by Subject|0|||
33580982|NCT01133756|62978125|FG000|Overall Study|Progression of Disease|0|||
33580983|NCT01133756|62978126|FG001|Overall Study|Progression of Disease|0|||
33580984|NCT01133756|62978127|FG002|Overall Study|Progression of Disease|1|||
33580985|NCT01126736|62978140|FG000|Overall Study|Death|2|||
33580986|NCT01126736|62978141|FG001|Overall Study|Death|2|||
33580987|NCT01126736|62978142|FG002|Overall Study|Death|1|||
33580988|NCT01126736|62978143|FG003|Overall Study|Death|19|||
33580989|NCT01126736|62978144|FG004|Overall Study|Death|19|||
33580990|NCT01126736|62978140|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
33580991|NCT01126736|62978141|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
33580992|NCT01126736|62978142|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
33580993|NCT01126736|62978143|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
33580994|NCT01126736|62978144|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
33580995|NCT01126736|62978140|FG000|Overall Study|Lost to Follow-up|0|||
33580996|NCT01126736|62978141|FG001|Overall Study|Lost to Follow-up|0|||
33580997|NCT01126736|62978142|FG002|Overall Study|Lost to Follow-up|0|||
33580998|NCT01126736|62978143|FG003|Overall Study|Lost to Follow-up|1|||
33580999|NCT01126736|62978144|FG004|Overall Study|Lost to Follow-up|1|||
33581000|NCT01126736|62978140|FG000|Overall Study|Administrative reasons|0|||
33581001|NCT01126736|62978141|FG001|Overall Study|Administrative reasons|0|||
33581002|NCT01126736|62978142|FG002|Overall Study|Administrative reasons|0|||
33581003|NCT01126736|62978143|FG003|Overall Study|Administrative reasons|0|||
33581004|NCT01126736|62978144|FG004|Overall Study|Administrative reasons|1|||
33581005|NCT01126736|62978140|FG000|Overall Study|Progressive disease|0|||
33581006|NCT01126736|62978141|FG001|Overall Study|Progressive disease|0|||
33581007|NCT01126736|62978142|FG002|Overall Study|Progressive disease|0|||
33581008|NCT01126736|62978143|FG003|Overall Study|Progressive disease|2|||
33581009|NCT01126736|62978144|FG004|Overall Study|Progressive disease|1|||
33581010|NCT01126736|62978140|FG000|Overall Study|Withdrawal by Subject|0|||
33581011|NCT01126736|62978141|FG001|Overall Study|Withdrawal by Subject|0|||
33581012|NCT01126736|62978142|FG002|Overall Study|Withdrawal by Subject|0|||
33581013|NCT01126736|62978143|FG003|Overall Study|Withdrawal by Subject|1|||
33581014|NCT01126736|62978144|FG004|Overall Study|Withdrawal by Subject|1|||
33581015|NCT01126736|62978140|FG000|Overall Study|Other|2|||
33581016|NCT01126736|62978141|FG001|Overall Study|Other|4|||
33581017|NCT01126736|62978142|FG002|Overall Study|Other|4|||
33574345|NCT02045836|62970259|FG000|Overall Study|Adverse Event|4|||
33574346|NCT02045836|62970260|FG001|Overall Study|Adverse Event|4|||
33574347|NCT02045836|62970259|FG000|Overall Study|Withdrawal by Subject|1|||
33574348|NCT02045836|62970260|FG001|Overall Study|Withdrawal by Subject|1|||
33574349|NCT02045836|62970259|FG000|Overall Study|Lost to Follow-up|4|||
33574350|NCT02045836|62970260|FG001|Overall Study|Lost to Follow-up|7|||
33574351|NCT02045836|62970259|FG000|Overall Study|Migrated from study area|0|||
33574352|NCT02045836|62970260|FG001|Overall Study|Migrated from study area|2|||
33574353|NCT02569437|62970269|FG000|Overall Study|Lost to Follow-up|12|||
33574354|NCT02569437|62970270|FG001|Overall Study|Lost to Follow-up|14|||
33574355|NCT02045212|62970278|FG000|Overall Study|Adverse Event|0|||
33574356|NCT02045212|62970279|FG001|Overall Study|Adverse Event|1|||
33574357|NCT02045212|62970278|FG000|Overall Study|Withdrawal by Subject|1|||
33574358|NCT02045212|62970279|FG001|Overall Study|Withdrawal by Subject|0|||
33574359|NCT02045212|62970278|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
33574360|NCT02045212|62970279|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
33574361|NCT02044822|62970289|FG000|Overall Study|Study Terminated by Sponsor|77|||
33664390|NCT01531673|63095421|FG011|Overall Study|Adverse Event|0|||
33664391|NCT01531673|63095422|FG012|Overall Study|Adverse Event|0|||
33664392|NCT01531673|63095410|FG000|Overall Study|Lost to Follow-up|0|||
33664393|NCT01531673|63095411|FG001|Overall Study|Lost to Follow-up|0|||
33664394|NCT01531673|63095412|FG002|Overall Study|Lost to Follow-up|0|||
33664395|NCT01531673|63095413|FG003|Overall Study|Lost to Follow-up|0|||
33664396|NCT01531673|63095414|FG004|Overall Study|Lost to Follow-up|1|||
33664397|NCT01531673|63095415|FG005|Overall Study|Lost to Follow-up|0|||
33664398|NCT01531673|63095416|FG006|Overall Study|Lost to Follow-up|0|||
33664399|NCT01531673|63095417|FG007|Overall Study|Lost to Follow-up|0|||
33664400|NCT01531673|63095418|FG008|Overall Study|Lost to Follow-up|0|||
33664401|NCT01531673|63095419|FG009|Overall Study|Lost to Follow-up|0|||
33664402|NCT01531673|63095420|FG010|Overall Study|Lost to Follow-up|0|||
33664403|NCT01531673|63095421|FG011|Overall Study|Lost to Follow-up|0|||
33664404|NCT01531673|63095422|FG012|Overall Study|Lost to Follow-up|0|||
33664405|NCT01531673|63095410|FG000|Overall Study|Other|0|||
33664406|NCT01531673|63095411|FG001|Overall Study|Other|0|||
33664407|NCT01531673|63095412|FG002|Overall Study|Other|0|||
33664408|NCT01531673|63095413|FG003|Overall Study|Other|1|||
33664409|NCT01531673|63095414|FG004|Overall Study|Other|0|||
33664410|NCT01531673|63095415|FG005|Overall Study|Other|0|||
33664411|NCT01531673|63095416|FG006|Overall Study|Other|0|||
33664412|NCT01531673|63095417|FG007|Overall Study|Other|0|||
33664413|NCT01531673|63095418|FG008|Overall Study|Other|0|||
33574362|NCT02044822|62970289|FG000|Overall Study|Investigator's Discretion|10|||
33574363|NCT02044822|62970289|FG000|Overall Study|Withdrew Consent|3|||
33574364|NCT02044822|62970289|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
33574365|NCT02044822|62970289|FG000|Overall Study|Lost to Follow-up|1|||
33574366|NCT02044510|62970295|FG000|Overall Study|Adverse Event|1|||
33574367|NCT02044510|62970296|FG001|Overall Study|Adverse Event|2|||
33574368|NCT02067676|62970308|FG000|Overall Study|Withdrawal by Subject|1|||
33574369|NCT02067676|62970309|FG001|Overall Study|Withdrawal by Subject|0|||
33574370|NCT02067676|62970310|FG002|Overall Study|Withdrawal by Subject|0|||
33574371|NCT02067676|62970311|FG003|Overall Study|Withdrawal by Subject|0|||
33574372|NCT02067676|62970312|FG004|Overall Study|Withdrawal by Subject|0|||
33574373|NCT02067676|62970313|FG005|Overall Study|Withdrawal by Subject|0|||
33574374|NCT01623154|62970332|FG000|Overall Study|Did not drink Pranactin Citric|4|||
33574375|NCT00702689|62970338|FG000|Overall Study|Withdrawal by Subject|4|||
33574376|NCT00702689|62970338|FG000|Overall Study|Recurrent malignancy|1|||
33574377|NCT00702689|62970338|FG000|Overall Study|Adverse Event|1|||
33574378|NCT02065570|62970344|FG000|Induction Study|Adverse Event|5|||
33574379|NCT02065570|62970345|FG001|Induction Study|Adverse Event|12|||
33574380|NCT02065570|62970346|FG002|Induction Study|Adverse Event|0|||
33574381|NCT02065570|62970347|FG003|Induction Study|Adverse Event|0|||
33664414|NCT01531673|63095419|FG009|Overall Study|Other|1|||
33664415|NCT01531673|63095420|FG010|Overall Study|Other|0|||
33574382|NCT02065570|62970344|FG000|Induction Study|Withdrawal by Subject|2|||
33574383|NCT02065570|62970345|FG001|Induction Study|Withdrawal by Subject|3|||
33574384|NCT02065570|62970346|FG002|Induction Study|Withdrawal by Subject|0|||
33574385|NCT02065570|62970347|FG003|Induction Study|Withdrawal by Subject|0|||
33574386|NCT02065570|62970344|FG000|Induction Study|Lost to Follow-up|1|||
33574387|NCT02065570|62970345|FG001|Induction Study|Lost to Follow-up|1|||
33574388|NCT02065570|62970346|FG002|Induction Study|Lost to Follow-up|0|||
33574389|NCT02065570|62970347|FG003|Induction Study|Lost to Follow-up|0|||
33664416|NCT01531673|63095421|FG011|Overall Study|Other|0|||
33574390|NCT02065570|62970344|FG000|Induction Study|Other, Not Specified|6|||
33574391|NCT02065570|62970345|FG001|Induction Study|Other, Not Specified|5|||
33574392|NCT02065570|62970346|FG002|Induction Study|Other, Not Specified|0|||
33574393|NCT02065570|62970347|FG003|Induction Study|Other, Not Specified|0|||
33664417|NCT01531673|63095422|FG012|Overall Study|Other|0|||
33664418|NCT01531205|63095474|FG000|Overall Study|Did not proceed to surgery|1|||
33664419|NCT01529645|63095490|FG000|Overall Study|Lost to Follow-up|0|||
33574394|NCT02065570|62970344|FG000|Maintenance Study|Adverse Event|0|||
33574395|NCT02065570|62970345|FG001|Maintenance Study|Adverse Event|0|||
33574396|NCT02065570|62970346|FG002|Maintenance Study|Adverse Event|8|||
33574397|NCT02065570|62970347|FG003|Maintenance Study|Adverse Event|8|||
33574398|NCT02065570|62970344|FG000|Maintenance Study|Withdrawal by Subject|0|||
33574399|NCT02065570|62970345|FG001|Maintenance Study|Withdrawal by Subject|0|||
33574400|NCT02065570|62970346|FG002|Maintenance Study|Withdrawal by Subject|1|||
33574401|NCT02065570|62970347|FG003|Maintenance Study|Withdrawal by Subject|4|||
33574402|NCT02065570|62970344|FG000|Maintenance Study|Lost to Follow-up|0|||
33574403|NCT02065570|62970345|FG001|Maintenance Study|Lost to Follow-up|0|||
33574404|NCT02065570|62970346|FG002|Maintenance Study|Lost to Follow-up|2|||
33574405|NCT02065570|62970347|FG003|Maintenance Study|Lost to Follow-up|2|||
33574406|NCT02065570|62970344|FG000|Maintenance Study|Other, Not Specified|0|||
33574407|NCT02065570|62970345|FG001|Maintenance Study|Other, Not Specified|0|||
33574408|NCT02065570|62970346|FG002|Maintenance Study|Other, Not Specified|11|||
33574409|NCT02065570|62970347|FG003|Maintenance Study|Other, Not Specified|5|||
33574410|NCT02566005|62970360|FG000|Overall Study|vaginal bleeding|0|||
33574411|NCT02566005|62970361|FG001|Overall Study|vaginal bleeding|1|||
33574412|NCT02566005|62970360|FG000|Overall Study|received foley|8|||
33574413|NCT02566005|62970361|FG001|Overall Study|received foley|0|||
33574414|NCT02566005|62970360|FG000|Overall Study|did not receive foley|0|||
33574415|NCT02566005|62970361|FG001|Overall Study|did not receive foley|1|||
33574416|NCT02566005|62970360|FG000|Overall Study|labor after randomization|0|||
33574417|NCT02566005|62970361|FG001|Overall Study|labor after randomization|4|||
33574418|NCT02065336|62970379|FG000|Extension Phase|Study Terminated by Sponsor|0|||
33574419|NCT02065336|62970380|FG001|Extension Phase|Study Terminated by Sponsor|0|||
33574420|NCT02065336|62970381|FG002|Extension Phase|Study Terminated by Sponsor|0|||
33574421|NCT02065336|62970382|FG003|Extension Phase|Study Terminated by Sponsor|0|||
33574422|NCT02065336|62970383|FG004|Extension Phase|Study Terminated by Sponsor|0|||
33574423|NCT02065336|62970384|FG005|Extension Phase|Study Terminated by Sponsor|0|||
33574424|NCT02065336|62970385|FG006|Extension Phase|Study Terminated by Sponsor|0|||
33574425|NCT02065336|62970386|FG007|Extension Phase|Study Terminated by Sponsor|0|||
33574426|NCT02065336|62970387|FG008|Extension Phase|Study Terminated by Sponsor|2|||
33574427|NCT02065336|62970388|FG009|Extension Phase|Study Terminated by Sponsor|8|||
33574428|NCT02701985|62970421|FG000|Overall Study|Withdrawal by Subject|1|||
33574429|NCT02701985|62970422|FG001|Overall Study|Withdrawal by Subject|1|||
33574430|NCT02701985|62970421|FG000|Overall Study|Lost to Follow-up|1|||
33574431|NCT02701985|62970422|FG001|Overall Study|Lost to Follow-up|0|||
33574432|NCT02701985|62970421|FG000|Overall Study|Death|1|||
33574433|NCT02701985|62970422|FG001|Overall Study|Death|0|||
33574434|NCT02701985|62970421|FG000|Overall Study|Adverse Event|0|||
33574435|NCT02701985|62970422|FG001|Overall Study|Adverse Event|5|||
33574436|NCT02064868|62970431|FG000|Overall Study|Lost to Follow-up|14|||
33574437|NCT02064868|62970432|FG001|Overall Study|Lost to Follow-up|8|||
33574438|NCT02064868|62970431|FG000|Overall Study|Physician Decision|1|||
33574439|NCT02064868|62970432|FG001|Overall Study|Physician Decision|0|||
33574440|NCT02064868|62970431|FG000|Overall Study|Withdrawal by Subject|14|||
33574441|NCT02064868|62970432|FG001|Overall Study|Withdrawal by Subject|3|||
33574442|NCT02064868|62970431|FG000|Overall Study|Technical Problems or Missing|5|||
33574443|NCT02064868|62970432|FG001|Overall Study|Technical Problems or Missing|2|||
33574444|NCT02064166|62970440|FG000|Overall Study|Adverse Event|1|||
33574445|NCT02064166|62970441|FG001|Overall Study|Adverse Event|0|||
33574446|NCT02565615|62970474|FG000|Overall Study|Death|0|||
33574447|NCT02565615|62970475|FG001|Overall Study|Death|1|||
33574448|NCT02565615|62970476|FG002|Overall Study|Death|0|||
33574449|NCT02565615|62970477|FG003|Overall Study|Death|0|||
33574450|NCT02565615|62970478|FG004|Overall Study|Death|4|||
33574451|NCT02565615|62970474|FG000|Overall Study|Not willing to participate in study|2|||
33574452|NCT02565615|62970475|FG001|Overall Study|Not willing to participate in study|21|||
33574453|NCT02565615|62970476|FG002|Overall Study|Not willing to participate in study|0|||
33574454|NCT02565615|62970477|FG003|Overall Study|Not willing to participate in study|1|||
33574455|NCT02565615|62970478|FG004|Overall Study|Not willing to participate in study|169|||
33574456|NCT02565615|62970474|FG000|Overall Study|Lost to Follow-up|0|||
33574457|NCT02565615|62970475|FG001|Overall Study|Lost to Follow-up|4|||
33574458|NCT02565615|62970476|FG002|Overall Study|Lost to Follow-up|0|||
33574459|NCT02565615|62970477|FG003|Overall Study|Lost to Follow-up|1|||
33574460|NCT02565615|62970478|FG004|Overall Study|Lost to Follow-up|765|||
33574461|NCT02565615|62970474|FG000|Overall Study|Not meeting eligibility criteria|0|||
33664420|NCT01529645|63095491|FG001|Overall Study|Lost to Follow-up|1|||
33574462|NCT02565615|62970475|FG001|Overall Study|Not meeting eligibility criteria|7|||
33574463|NCT02565615|62970476|FG002|Overall Study|Not meeting eligibility criteria|0|||
33574464|NCT02565615|62970477|FG003|Overall Study|Not meeting eligibility criteria|0|||
33574465|NCT02565615|62970478|FG004|Overall Study|Not meeting eligibility criteria|25|||
33574466|NCT02565615|62970474|FG000|Overall Study|Reason not defined|0|||
33574467|NCT02565615|62970475|FG001|Overall Study|Reason not defined|2|||
33574468|NCT02565615|62970476|FG002|Overall Study|Reason not defined|0|||
33574469|NCT02565615|62970477|FG003|Overall Study|Reason not defined|1|||
33574470|NCT02565615|62970478|FG004|Overall Study|Reason not defined|62|||
33574471|NCT02565615|62970474|FG000|Overall Study|Adverse Event|1|||
33574472|NCT02565615|62970475|FG001|Overall Study|Adverse Event|1|||
33574473|NCT02565615|62970476|FG002|Overall Study|Adverse Event|0|||
33574474|NCT02565615|62970477|FG003|Overall Study|Adverse Event|0|||
33574475|NCT02565615|62970478|FG004|Overall Study|Adverse Event|9|||
33574476|NCT02565615|62970474|FG000|Overall Study|Untreated|0|||
33574477|NCT02565615|62970475|FG001|Overall Study|Untreated|0|||
33574478|NCT02565615|62970476|FG002|Overall Study|Untreated|0|||
33574479|NCT02565615|62970477|FG003|Overall Study|Untreated|0|||
33574480|NCT02565615|62970478|FG004|Overall Study|Untreated|567|||
33574481|NCT02701361|62970493|FG000|Overall Study|Lost to Follow-up|5|||
33574482|NCT02701361|62970494|FG001|Overall Study|Lost to Follow-up|2|||
33574483|NCT02701361|62970495|FG002|Overall Study|Lost to Follow-up|1|||
33574484|NCT02701361|62970493|FG000|Overall Study|Withdrawal by Subject|4|||
33574485|NCT02701361|62970494|FG001|Overall Study|Withdrawal by Subject|0|||
33574486|NCT02701361|62970495|FG002|Overall Study|Withdrawal by Subject|0|||
33574487|NCT02701361|62970493|FG000|Overall Study|timed out in rehab center|0|||
33574488|NCT02701361|62970494|FG001|Overall Study|timed out in rehab center|1|||
33574489|NCT02701361|62970495|FG002|Overall Study|timed out in rehab center|0|||
33574490|NCT02701361|62970493|FG000|Overall Study|incarceration|0|||
33574491|NCT02701361|62970494|FG001|Overall Study|incarceration|0|||
33574492|NCT02701361|62970495|FG002|Overall Study|incarceration|1|||
33574493|NCT01662999|62970520|FG000|Period 3|Withdrawal by Subject|0|||
33574494|NCT01662999|62970521|FG001|Period 3|Withdrawal by Subject|1|||
33574495|NCT01662999|62970522|FG002|Period 3|Withdrawal by Subject|0|||
33574496|NCT01662999|62970523|FG003|Period 3|Withdrawal by Subject|0|||
33574497|NCT01662999|62970524|FG004|Period 3|Withdrawal by Subject|0|||
33574498|NCT01662999|62970525|FG005|Period 3|Withdrawal by Subject|0|||
33574499|NCT02565381|62970558|FG000|Overall Study|Lost to Follow-up|1|||
33574500|NCT02565381|62970559|FG001|Overall Study|Lost to Follow-up|0|||
33574501|NCT02565381|62970560|FG002|Overall Study|Lost to Follow-up|1|||
33574502|NCT02063854|62970575|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
33574503|NCT02063854|62970576|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
33574504|NCT02063854|62970577|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
33574505|NCT02063854|62970578|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
33574506|NCT02063854|62970579|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
33574507|NCT02063854|62970580|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
33574508|NCT02063854|62970581|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
33574509|NCT02063854|62970575|FG000|Overall Study|Major Protocol Deviation|0|||
33574510|NCT02063854|62970576|FG001|Overall Study|Major Protocol Deviation|0|||
33574511|NCT02063854|62970577|FG002|Overall Study|Major Protocol Deviation|3|||
33574512|NCT02063854|62970578|FG003|Overall Study|Major Protocol Deviation|0|||
33574513|NCT02063854|62970579|FG004|Overall Study|Major Protocol Deviation|0|||
33574514|NCT02063854|62970580|FG005|Overall Study|Major Protocol Deviation|0|||
33574515|NCT02063854|62970581|FG006|Overall Study|Major Protocol Deviation|0|||
33574516|NCT02063854|62970575|FG000|Overall Study|Voluntary Withdrawal|2|||
33574517|NCT02063854|62970576|FG001|Overall Study|Voluntary Withdrawal|0|||
33574518|NCT02063854|62970577|FG002|Overall Study|Voluntary Withdrawal|8|||
33574519|NCT02063854|62970578|FG003|Overall Study|Voluntary Withdrawal|1|||
33574520|NCT02063854|62970579|FG004|Overall Study|Voluntary Withdrawal|3|||
33574521|NCT02063854|62970580|FG005|Overall Study|Voluntary Withdrawal|6|||
33396774|NCT00322153|62776024|FG000|Overall Study|Lack of Efficacy|8|||
33396775|NCT00322153|62776025|FG001|Overall Study|Lack of Efficacy|3|||
33574522|NCT02063854|62970581|FG006|Overall Study|Voluntary Withdrawal|1|||
33574523|NCT02063854|62970575|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
33574524|NCT02063854|62970576|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
33574525|NCT02063854|62970577|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
33574526|NCT02063854|62970578|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
33574527|NCT02063854|62970579|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
33574528|NCT02063854|62970580|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
33574529|NCT02063854|62970581|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
33574530|NCT02063854|62970575|FG000|Overall Study|Reason Not Specified|1|||
33574531|NCT02063854|62970576|FG001|Overall Study|Reason Not Specified|0|||
33574532|NCT02063854|62970577|FG002|Overall Study|Reason Not Specified|0|||
33574533|NCT02063854|62970578|FG003|Overall Study|Reason Not Specified|0|||
33574534|NCT02063854|62970579|FG004|Overall Study|Reason Not Specified|0|||
33574535|NCT02063854|62970580|FG005|Overall Study|Reason Not Specified|0|||
33574536|NCT02063854|62970581|FG006|Overall Study|Reason Not Specified|0|||
33574537|NCT02063854|62970575|FG000|Overall Study|Did Not Receive Study Drug|0|||
33574538|NCT02063854|62970576|FG001|Overall Study|Did Not Receive Study Drug|0|||
33574539|NCT02063854|62970577|FG002|Overall Study|Did Not Receive Study Drug|0|||
33574540|NCT02063854|62970578|FG003|Overall Study|Did Not Receive Study Drug|0|||
33396776|NCT00322153|62776024|FG000|Overall Study|Lost to Follow-up|5|||
33574541|NCT02063854|62970579|FG004|Overall Study|Did Not Receive Study Drug|0|||
33574542|NCT02063854|62970580|FG005|Overall Study|Did Not Receive Study Drug|1|||
33574543|NCT02063854|62970581|FG006|Overall Study|Did Not Receive Study Drug|0|||
33574544|NCT02063698|62970601|FG000|Overall Study|did not complete booklet for days 2-8|1|||
33574545|NCT02063698|62970602|FG001|Overall Study|did not complete booklet for days 2-8|2|||
33574546|NCT04701333|62970610|FG000|Overall Study|Lost to Follow-up|3|||
33574547|NCT04701333|62970611|FG001|Overall Study|Lost to Follow-up|7|||
33574548|NCT04701333|62970610|FG000|Overall Study|Withdrawal by Subject|0|||
33574549|NCT04701333|62970611|FG001|Overall Study|Withdrawal by Subject|1|||
33574550|NCT02062450|62970619|FG000|Overall Study|No follow-up visit|124|||
33574551|NCT02561247|62970627|FG000|Overall Study|Protocol Violation|1|||
33574552|NCT02561247|62970627|FG000|Overall Study|Withdrawal by Subject|1|||
33574553|NCT02561247|62970627|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
33574554|NCT02061592|62970633|FG000|Period 1|Withdrawal by Subject|1|||
33574555|NCT02061592|62970634|FG001|Period 1|Withdrawal by Subject|0|||
33574556|NCT02061592|62970633|FG000|Period 1|Protocol Violation|1|||
33574557|NCT02061592|62970634|FG001|Period 1|Protocol Violation|0|||
33574558|NCT02061592|62970633|FG000|Period 2|Lost to Follow-up|0|||
33574559|NCT02061592|62970634|FG001|Period 2|Lost to Follow-up|1|||
33574560|NCT01663623|62970644|FG000|Overall Study|Adverse Event|3|||
33574561|NCT01663623|62970645|FG001|Overall Study|Adverse Event|7|||
33574562|NCT01663623|62970644|FG000|Overall Study|Lack of Efficacy|5|||
33574563|NCT01663623|62970645|FG001|Overall Study|Lack of Efficacy|6|||
33574564|NCT01663623|62970644|FG000|Overall Study|Protocol Violation|0|||
33574565|NCT01663623|62970645|FG001|Overall Study|Protocol Violation|1|||
33574566|NCT01663623|62970644|FG000|Overall Study|Other-Study closed/terminated|1|||
33574567|NCT01663623|62970645|FG001|Overall Study|Other-Study closed/terminated|1|||
33574568|NCT01663623|62970644|FG000|Overall Study|Physician Decision|1|||
33574569|NCT01663623|62970645|FG001|Overall Study|Physician Decision|4|||
33574570|NCT01663623|62970644|FG000|Overall Study|Withdrawal by Subject|2|||
33574571|NCT01663623|62970645|FG001|Overall Study|Withdrawal by Subject|1|||
33574572|NCT02042950|62970651|FG000|Overall Study|Progressive Disease|4|||
33574573|NCT02042404|62970655|FG000|Overall Study|Death|1|||
33574574|NCT02042404|62970656|FG001|Overall Study|Death|0|||
33574575|NCT02042404|62970655|FG000|Overall Study|Unrelated Adverse Event|3|||
33574576|NCT02042404|62970656|FG001|Overall Study|Unrelated Adverse Event|0|||
33574577|NCT02042404|62970655|FG000|Overall Study|Inability to meet time requirements|1|||
33574578|NCT02042404|62970656|FG001|Overall Study|Inability to meet time requirements|0|||
33574579|NCT02042014|62970663|FG000|Overall Study|Adverse Event|1|||
33574580|NCT02042014|62970663|FG000|Overall Study|Physician Decision|7|||
33574581|NCT02041702|62970669|FG000|Overall Study|Lost to Follow-up|1|||
33574582|NCT02041702|62970670|FG001|Overall Study|Lost to Follow-up|6|||
33574583|NCT02041702|62970669|FG000|Overall Study|Death|4|||
33574584|NCT02041702|62970670|FG001|Overall Study|Death|0|||
33574585|NCT02041702|62970669|FG000|Overall Study|Withdrawal by Subject|4|||
33574586|NCT02041702|62970670|FG001|Overall Study|Withdrawal by Subject|3|||
33574587|NCT02041702|62970669|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
33574588|NCT02041702|62970670|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
33574589|NCT02041702|62970669|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
33574590|NCT02041702|62970670|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
33574591|NCT02565147|62970678|FG000|Overall Study|Withdrawal by Subject|5|||
33574592|NCT02565147|62970679|FG001|Overall Study|Withdrawal by Subject|1|||
33664421|NCT01529645|63095492|FG002|Overall Study|Lost to Follow-up|1|||
33664422|NCT01529645|63095493|FG003|Overall Study|Lost to Follow-up|1|||
33664423|NCT01529645|63095494|FG004|Overall Study|Lost to Follow-up|1|||
33664424|NCT01529645|63095495|FG005|Overall Study|Lost to Follow-up|0|||
33664425|NCT01529645|63095496|FG006|Overall Study|Lost to Follow-up|2|||
33664426|NCT01529645|63095497|FG007|Overall Study|Lost to Follow-up|0|||
33664427|NCT01529645|63095498|FG008|Overall Study|Lost to Follow-up|1|||
33664428|NCT01529645|63095499|FG009|Overall Study|Lost to Follow-up|0|||
33664429|NCT01529645|63095490|FG000|Overall Study|SAE - Premature contractions|0|||
33396777|NCT00322153|62776025|FG001|Overall Study|Lost to Follow-up|4|||
33574593|NCT02565147|62970678|FG000|Overall Study|Lost to Follow-up|0|||
33574594|NCT02565147|62970679|FG001|Overall Study|Lost to Follow-up|1|||
33574595|NCT02565147|62970678|FG000|Overall Study|Death|1|||
33574596|NCT02565147|62970679|FG001|Overall Study|Death|1|||
33574597|NCT02061280|62970687|FG000|Overall Study|Protocol Violation|12|||
33574598|NCT02061280|62970688|FG001|Overall Study|Protocol Violation|8|||
33574599|NCT02061280|62970687|FG000|Overall Study|moved out of state|0|||
33574600|NCT02061280|62970688|FG001|Overall Study|moved out of state|1|||
33574601|NCT02061280|62970687|FG000|Overall Study|Withdrawal by Subject|1|||
33664430|NCT01529645|63095491|FG001|Overall Study|SAE - Premature contractions|0|||
33574602|NCT02061280|62970688|FG001|Overall Study|Withdrawal by Subject|2|||
33574603|NCT02061280|62970687|FG000|Overall Study|Lost to Follow-up|5|||
33574604|NCT02061280|62970688|FG001|Overall Study|Lost to Follow-up|1|||
33574605|NCT02061202|62970699|FG000|Overall Study|Lost to Follow-up|1|||
33574606|NCT02061202|62970700|FG001|Overall Study|Lost to Follow-up|1|||
33574607|NCT02059408|62970709|FG000|Overall Study|Did not get tested|0|||
33574608|NCT02059408|62970710|FG001|Overall Study|Did not get tested|330|||
33574609|NCT02059408|62970711|FG002|Overall Study|Did not get tested|358|||
33574610|NCT01625338|62970724|FG000|Overall Study|Enrolled but not Treated|0|||
33574611|NCT01625338|62970725|FG001|Overall Study|Enrolled but not Treated|0|||
33574612|NCT01625338|62970726|FG002|Overall Study|Enrolled but not Treated|1|||
33574613|NCT01625338|62970724|FG000|Overall Study|Efficacy Failure|27|||
33574614|NCT01625338|62970725|FG001|Overall Study|Efficacy Failure|39|||
33574615|NCT01625338|62970726|FG002|Overall Study|Efficacy Failure|31|||
33574616|NCT01625338|62970724|FG000|Overall Study|Lost to Follow-up|3|||
33574617|NCT01625338|62970725|FG001|Overall Study|Lost to Follow-up|3|||
33574618|NCT01625338|62970726|FG002|Overall Study|Lost to Follow-up|2|||
33574619|NCT01625338|62970724|FG000|Overall Study|Investigator Decision|0|||
33574620|NCT01625338|62970725|FG001|Overall Study|Investigator Decision|2|||
33574621|NCT01625338|62970726|FG002|Overall Study|Investigator Decision|1|||
33574622|NCT01625338|62970724|FG000|Overall Study|Subject Withdrew Consent|1|||
33574623|NCT01625338|62970725|FG001|Overall Study|Subject Withdrew Consent|0|||
33574624|NCT01625338|62970726|FG002|Overall Study|Subject Withdrew Consent|2|||
33574625|NCT01625338|62970724|FG000|Overall Study|Adverse Event|1|||
33574626|NCT01625338|62970725|FG001|Overall Study|Adverse Event|0|||
33574627|NCT01625338|62970726|FG002|Overall Study|Adverse Event|1|||
33574628|NCT01625338|62970724|FG000|Overall Study|Study Discontinued by Sponsor|0|||
33574629|NCT01625338|62970725|FG001|Overall Study|Study Discontinued by Sponsor|0|||
33574630|NCT01625338|62970726|FG002|Overall Study|Study Discontinued by Sponsor|1|||
33574631|NCT02560623|62970738|FG000|Overall Study|Unable to swallow sponge|0|||
33574632|NCT02560623|62970739|FG001|Overall Study|Unable to swallow sponge|1|||
33574633|NCT02560623|62970740|FG002|Overall Study|Unable to swallow sponge|0|||
33574634|NCT02560623|62970741|FG003|Overall Study|Unable to swallow sponge|0|||
33574635|NCT02560623|62970738|FG000|Overall Study|Intervention prior to sponge administration|0|||
33574636|NCT02560623|62970739|FG001|Overall Study|Intervention prior to sponge administration|1|||
33574637|NCT02560623|62970740|FG002|Overall Study|Intervention prior to sponge administration|0|||
33574638|NCT02560623|62970741|FG003|Overall Study|Intervention prior to sponge administration|0|||
33574639|NCT02560389|62970754|FG000|Overall Study|Lost to Follow-up|1|||
33574640|NCT02560389|62970755|FG001|Overall Study|Lost to Follow-up|2|||
33574641|NCT02560389|62970756|FG002|Overall Study|Lost to Follow-up|2|||
33574642|NCT02560389|62970754|FG000|Overall Study|Tested positive for illicit substance|0|||
33574643|NCT02560389|62970755|FG001|Overall Study|Tested positive for illicit substance|1|||
33574644|NCT02560389|62970756|FG002|Overall Study|Tested positive for illicit substance|0|||
33574645|NCT02564211|62970764|FG000|Overall Study|Adverse Event|4|||
33574646|NCT02093026|62970768|FG000|Overall Study|Adverse Event|26|||
33574647|NCT02093026|62970768|FG000|Overall Study|Death|10|||
33574648|NCT02093026|62970768|FG000|Overall Study|Other|157|||
33574649|NCT02040844|62970776|FG000|Overall Study|Adverse Event|0|||
33574650|NCT02040844|62970777|FG001|Overall Study|Adverse Event|0|||
33574651|NCT02040844|62970778|FG002|Overall Study|Adverse Event|1|||
33574652|NCT02040844|62970776|FG000|Overall Study|Withdrawal by Subject|16|||
33574653|NCT02040844|62970777|FG001|Overall Study|Withdrawal by Subject|22|||
33574654|NCT02040844|62970778|FG002|Overall Study|Withdrawal by Subject|25|||
33574655|NCT02040844|62970776|FG000|Overall Study|Lost to Follow-up|12|||
33574656|NCT02040844|62970777|FG001|Overall Study|Lost to Follow-up|9|||
33574657|NCT02040844|62970778|FG002|Overall Study|Lost to Follow-up|13|||
33574658|NCT02040844|62970776|FG000|Overall Study|Missing|13|||
33574659|NCT02040844|62970777|FG001|Overall Study|Missing|3|||
33574660|NCT02040844|62970778|FG002|Overall Study|Missing|2|||
33302886|NCT01285518|62678752|FG000|Overall Study|Lost to Follow-up|0|||
33302887|NCT01285518|62678753|FG001|Overall Study|Lost to Follow-up|0|||
33302888|NCT01285518|62678754|FG002|Overall Study|Lost to Follow-up|0|||
33302889|NCT01285518|62678755|FG003|Overall Study|Lost to Follow-up|0|||
33302890|NCT01285518|62678756|FG004|Overall Study|Lost to Follow-up|0|||
33302891|NCT01285518|62678757|FG005|Overall Study|Lost to Follow-up|1|||
33302892|NCT01285518|62678758|FG006|Overall Study|Lost to Follow-up|0|||
33302893|NCT01285518|62678759|FG007|Overall Study|Lost to Follow-up|0|||
33302894|NCT01073020|62678782|FG000|Overall Study|Withdrawal by Subject|6|||
33302895|NCT01073020|62678783|FG001|Overall Study|Withdrawal by Subject|4|||
33302896|NCT01073020|62678784|FG002|Overall Study|Withdrawal by Subject|1|||
33396778|NCT00322153|62776024|FG000|Overall Study|Withdrawn for other reasons|5|||
33302897|NCT01073020|62678785|FG003|Overall Study|Withdrawal by Subject|2|||
33396779|NCT00322153|62776025|FG001|Overall Study|Withdrawn for other reasons|4|||
33574661|NCT02040844|62970776|FG000|Overall Study|Non-specified|8|||
33574662|NCT02040844|62970777|FG001|Overall Study|Non-specified|2|||
33574663|NCT02040844|62970778|FG002|Overall Study|Non-specified|5|||
33574664|NCT02040844|62970776|FG000|Overall Study|Concomitant medication|1|||
33574665|NCT02040844|62970777|FG001|Overall Study|Concomitant medication|3|||
33574666|NCT02040844|62970778|FG002|Overall Study|Concomitant medication|1|||
33574667|NCT02059174|62970786|FG000|Period 1|Withdrawal by Subject|0|||
33302898|NCT01073020|62678782|FG000|Overall Study|Physician Decision|1|||
33302899|NCT01073020|62678783|FG001|Overall Study|Physician Decision|0|||
33302900|NCT01073020|62678784|FG002|Overall Study|Physician Decision|2|||
33574668|NCT02059174|62970787|FG001|Period 1|Withdrawal by Subject|2|||
33574669|NCT02059174|62970786|FG000|Period 2|Withdrawal by Subject|0|||
33574670|NCT02059174|62970787|FG001|Period 2|Withdrawal by Subject|2|||
33574671|NCT02059174|62970786|FG000|Period 2|Protocol Violation|1|||
33574672|NCT02059174|62970787|FG001|Period 2|Protocol Violation|0|||
33574673|NCT02059174|62970786|FG000|Period 3|Physician Decision|1|||
33574674|NCT02059174|62970787|FG001|Period 3|Physician Decision|0|||
33574675|NCT02092324|62970795|FG000|Overall Study|Adverse Event|1|||
33574676|NCT02092324|62970795|FG000|Overall Study|Lack of Efficacy|6|||
33574677|NCT02092324|62970795|FG000|Overall Study|Proceed to Transplant|3|||
33574678|NCT02092324|62970795|FG000|Overall Study|Physician Decision|7|||
33574679|NCT02092324|62970795|FG000|Overall Study|Misdiagnosis|2|||
33574680|NCT02040766|62970807|FG000|Overall Study|Adverse Event|1|||
33574681|NCT02040766|62970808|FG001|Overall Study|Adverse Event|1|||
33574682|NCT02040766|62970809|FG002|Overall Study|Adverse Event|1|||
33574683|NCT02040766|62970810|FG003|Overall Study|Adverse Event|0|||
33574684|NCT02040766|62970811|FG004|Overall Study|Adverse Event|2|||
33574685|NCT02040766|62970807|FG000|Overall Study|Withdrawal by Subject|4|||
33574686|NCT02040766|62970808|FG001|Overall Study|Withdrawal by Subject|3|||
33574687|NCT02040766|62970809|FG002|Overall Study|Withdrawal by Subject|2|||
33574688|NCT02040766|62970810|FG003|Overall Study|Withdrawal by Subject|3|||
33574689|NCT02040766|62970811|FG004|Overall Study|Withdrawal by Subject|2|||
33574690|NCT02040766|62970807|FG000|Overall Study|Non-compliance|0|||
33574691|NCT02040766|62970808|FG001|Overall Study|Non-compliance|1|||
33574692|NCT02040766|62970809|FG002|Overall Study|Non-compliance|0|||
33574693|NCT02040766|62970810|FG003|Overall Study|Non-compliance|0|||
33574694|NCT02040766|62970811|FG004|Overall Study|Non-compliance|0|||
33574695|NCT02040766|62970807|FG000|Overall Study|Protocol Violation|2|||
33574696|NCT02040766|62970808|FG001|Overall Study|Protocol Violation|1|||
33574697|NCT02040766|62970809|FG002|Overall Study|Protocol Violation|2|||
33574698|NCT02040766|62970810|FG003|Overall Study|Protocol Violation|3|||
33574699|NCT02040766|62970811|FG004|Overall Study|Protocol Violation|0|||
33574700|NCT02040766|62970807|FG000|Overall Study|Lost to Follow-up|4|||
33574701|NCT02040766|62970808|FG001|Overall Study|Lost to Follow-up|1|||
33574702|NCT02040766|62970809|FG002|Overall Study|Lost to Follow-up|3|||
33574703|NCT02040766|62970810|FG003|Overall Study|Lost to Follow-up|1|||
33574704|NCT02040766|62970811|FG004|Overall Study|Lost to Follow-up|4|||
33574705|NCT02040766|62970807|FG000|Overall Study|Not reported|1|||
33574706|NCT02040766|62970808|FG001|Overall Study|Not reported|0|||
33574707|NCT02040766|62970809|FG002|Overall Study|Not reported|0|||
33574708|NCT02040766|62970810|FG003|Overall Study|Not reported|0|||
33574709|NCT02040766|62970811|FG004|Overall Study|Not reported|0|||
33574710|NCT02040766|62970807|FG000|Overall Study|Lack of Efficacy|6|||
33574711|NCT02040766|62970808|FG001|Overall Study|Lack of Efficacy|3|||
33574712|NCT02040766|62970809|FG002|Overall Study|Lack of Efficacy|4|||
33574713|NCT02040766|62970810|FG003|Overall Study|Lack of Efficacy|6|||
33574714|NCT02040766|62970811|FG004|Overall Study|Lack of Efficacy|5|||
33574715|NCT02040532|62970824|FG000|Overall Study|Lost to Follow-up|1|||
33574716|NCT02040532|62970824|FG000|Overall Study|Physician Decision|4|||
33574717|NCT02040532|62970824|FG000|Overall Study|Adverse Event|4|||
33574718|NCT02040532|62970824|FG000|Overall Study|Withdrawal by Subject|3|||
33574719|NCT02039908|62970828|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
33574720|NCT02039908|62970829|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
33574721|NCT02039908|62970830|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
33574722|NCT02039908|62970831|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
33574723|NCT02039908|62970828|FG000|Phase 1-Summer|Protocol Violation|6|||
33574724|NCT02039908|62970829|FG001|Phase 1-Summer|Protocol Violation|0|||
33574725|NCT02039908|62970830|FG002|Phase 1-Summer|Protocol Violation|0|||
33574726|NCT02039908|62970831|FG003|Phase 1-Summer|Protocol Violation|0|||
33574727|NCT02039908|62970828|FG000|Phase 2-School Year|Lost to Follow-up|0|||
33574728|NCT02039908|62970829|FG001|Phase 2-School Year|Lost to Follow-up|0|||
33574729|NCT02039908|62970830|FG002|Phase 2-School Year|Lost to Follow-up|1|||
33574730|NCT02039908|62970831|FG003|Phase 2-School Year|Lost to Follow-up|3|||
33574731|NCT02039908|62970828|FG000|Phase 2-School Year|Protocol Violation|0|||
33574732|NCT02039908|62970829|FG001|Phase 2-School Year|Protocol Violation|0|||
33574733|NCT02039908|62970830|FG002|Phase 2-School Year|Protocol Violation|3|||
33574734|NCT02039908|62970831|FG003|Phase 2-School Year|Protocol Violation|0|||
33574735|NCT02039908|62970828|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
33574736|NCT02039908|62970829|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
33574737|NCT02039908|62970830|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
33574738|NCT02039908|62970831|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
33574739|NCT02058940|62970839|FG000|Overall Study|Discharged from Critical Care Unit|1|||
33574740|NCT02058628|62970845|FG000|Overall Study|Adverse Event|1|||
33574741|NCT02058628|62970846|FG001|Overall Study|Adverse Event|0|||
33574742|NCT02058628|62970845|FG000|Overall Study|Withdrawal by Subject|2|||
33574743|NCT02058628|62970846|FG001|Overall Study|Withdrawal by Subject|2|||
33574744|NCT02058628|62970845|FG000|Overall Study|Lost to Follow-up|2|||
33574745|NCT02058628|62970846|FG001|Overall Study|Lost to Follow-up|4|||
33574746|NCT02058628|62970845|FG000|Overall Study|Not in time schedule|0|||
33574747|NCT02058628|62970846|FG001|Overall Study|Not in time schedule|1|||
33574748|NCT02058628|62970845|FG000|Overall Study|The visit date was not in timeline|0|||
33574749|NCT02058628|62970846|FG001|Overall Study|The visit date was not in timeline|1|||
33574750|NCT02058628|62970845|FG000|Overall Study|A lot of time for study for participant|1|||
33574751|NCT02058628|62970846|FG001|Overall Study|A lot of time for study for participant|0|||
33574752|NCT02058628|62970845|FG000|Overall Study|Non compliance|1|||
33574753|NCT02058628|62970846|FG001|Overall Study|Non compliance|0|||
33574754|NCT02058160|62970857|FG000|Overall Study|Randomized but not treated|2|||
33574755|NCT02058160|62970858|FG001|Overall Study|Randomized but not treated|4|||
33574756|NCT02058160|62970857|FG000|Overall Study|Poor compliance to protocol|4|||
33574757|NCT02058160|62970858|FG001|Overall Study|Poor compliance to protocol|1|||
33574758|NCT02058160|62970857|FG000|Overall Study|Adverse Event|12|||
33574759|NCT02058160|62970858|FG001|Overall Study|Adverse Event|3|||
33574760|NCT02058160|62970857|FG000|Overall Study|Lost to Follow-up|1|||
33574761|NCT02058160|62970858|FG001|Overall Study|Lost to Follow-up|0|||
33574762|NCT02058160|62970857|FG000|Overall Study|Other than specified above|12|||
33574763|NCT02058160|62970858|FG001|Overall Study|Other than specified above|6|||
33574764|NCT02090764|62970866|FG000|Overall Study|Adverse Event|1|||
33574765|NCT02090764|62970867|FG001|Overall Study|Adverse Event|3|||
33574766|NCT02090764|62970866|FG000|Overall Study|Lack of Efficacy|0|||
33574767|NCT02090764|62970867|FG001|Overall Study|Lack of Efficacy|13|||
33574768|NCT02090764|62970866|FG000|Overall Study|Withdrawal by Subject|2|||
33574769|NCT02090764|62970867|FG001|Overall Study|Withdrawal by Subject|1|||
33574770|NCT02090764|62970866|FG000|Overall Study|Intercurrent illness and other|1|||
33574771|NCT02090764|62970867|FG001|Overall Study|Intercurrent illness and other|1|||
33574772|NCT02090764|62970866|FG000|Overall Study|Lost to Follow-up|2|||
33574773|NCT02090764|62970867|FG001|Overall Study|Lost to Follow-up|2|||
33574774|NCT02057692|62970877|FG000|Overall Study|Adverse Event|1|||
33574775|NCT02057692|62970878|FG001|Overall Study|Adverse Event|0|||
33574776|NCT02057692|62970879|FG002|Overall Study|Adverse Event|0|||
33574777|NCT02057692|62970880|FG003|Overall Study|Adverse Event|0|||
33574778|NCT02057692|62970877|FG000|Overall Study|Lost to Follow-up|0|||
33574779|NCT02057692|62970878|FG001|Overall Study|Lost to Follow-up|0|||
33574780|NCT02057692|62970879|FG002|Overall Study|Lost to Follow-up|0|||
33574781|NCT02057692|62970880|FG003|Overall Study|Lost to Follow-up|1|||
33574782|NCT02038036|62970898|FG000|Core Study|Adverse Event|7|||
33574783|NCT02038036|62970899|FG001|Core Study|Adverse Event|7|||
33574784|NCT02038036|62970898|FG000|Core Study|Death|1|||
33574785|NCT02038036|62970899|FG001|Core Study|Death|1|||
33574786|NCT02038036|62970898|FG000|Core Study|Disease progression|2|||
33574787|NCT02038036|62970899|FG001|Core Study|Disease progression|2|||
33574788|NCT02038036|62970898|FG000|Core Study|Lost to Follow-up|0|||
33574789|NCT02038036|62970899|FG001|Core Study|Lost to Follow-up|1|||
33574790|NCT02038036|62970898|FG000|Core Study|Physician Decision|2|||
33574791|NCT02038036|62970899|FG001|Core Study|Physician Decision|1|||
33574792|NCT02038036|62970898|FG000|Core Study|Subject/guardian decision|0|||
33574793|NCT02038036|62970899|FG001|Core Study|Subject/guardian decision|1|||
33574794|NCT02038036|62970898|FG000|Core Study|Withdrawal by Subject|3|||
33574795|NCT02038036|62970899|FG001|Core Study|Withdrawal by Subject|1|||
33574796|NCT02038036|62970898|FG000|Crossover Period|Withdrawal by Subject|0|||
33574797|NCT02038036|62970899|FG001|Crossover Period|Withdrawal by Subject|3|||
33574798|NCT02038036|62970898|FG000|Crossover Period|Adverse Event|0|||
33574799|NCT02038036|62970899|FG001|Crossover Period|Adverse Event|9|||
33574800|NCT02038036|62970898|FG000|Crossover Period|Death|0|||
33574801|NCT02038036|62970899|FG001|Crossover Period|Death|2|||
33574802|NCT02038036|62970898|FG000|Crossover Period|Disease progression|0|||
33574803|NCT02038036|62970899|FG001|Crossover Period|Disease progression|3|||
33574804|NCT02038036|62970898|FG000|Crossover Period|Lost to Follow-up|0|||
33574805|NCT02038036|62970899|FG001|Crossover Period|Lost to Follow-up|1|||
33574806|NCT02038036|62970898|FG000|Crossover Period|Physician Decision|0|||
33574807|NCT02038036|62970899|FG001|Crossover Period|Physician Decision|2|||
33574808|NCT02037568|62970910|FG000|Overall Study|Withdrawal by Subject|17|||
33574809|NCT02037568|62970911|FG001|Overall Study|Withdrawal by Subject|24|||
33574810|NCT02037568|62970910|FG000|Overall Study|Lost to Follow-up|16|||
33574811|NCT02037568|62970911|FG001|Overall Study|Lost to Follow-up|13|||
33574812|NCT02037568|62970910|FG000|Overall Study|Screen Failure|3|||
33574813|NCT02037568|62970911|FG001|Overall Study|Screen Failure|1|||
33574814|NCT02037568|62970910|FG000|Overall Study|Patient did not receive transplant|0|||
33574815|NCT02037568|62970911|FG001|Overall Study|Patient did not receive transplant|1|||
33574816|NCT02088034|62970920|FG000|Overall Study|Lost to Follow-up|1|||
33574817|NCT02088034|62970921|FG001|Overall Study|Lost to Follow-up|1|||
33574818|NCT02088034|62970922|FG002|Overall Study|Lost to Follow-up|0|||
33574819|NCT02088034|62970920|FG000|Overall Study|Pregnancy|2|||
33574820|NCT02088034|62970921|FG001|Overall Study|Pregnancy|1|||
33574821|NCT02088034|62970922|FG002|Overall Study|Pregnancy|2|||
33574822|NCT02037256|62970932|FG000|Overall Study|Protocol Violation|0|||
33574823|NCT02037256|62970933|FG001|Overall Study|Protocol Violation|1|||
33574824|NCT02037256|62970932|FG000|Overall Study|Withdrawn prior to Velcade|0|||
33574825|NCT02037256|62970933|FG001|Overall Study|Withdrawn prior to Velcade|2|||
33574826|NCT02035696|62970945|FG000|Overall Study|Lost to Follow-up|0|||
33574827|NCT02035696|62970946|FG001|Overall Study|Lost to Follow-up|3|||
33574828|NCT02035696|62970947|FG002|Overall Study|Lost to Follow-up|1|||
33574829|NCT02035696|62970948|FG003|Overall Study|Lost to Follow-up|2|||
33574830|NCT02035696|62970945|FG000|Overall Study|Withdrawal by Subject|3|||
33574831|NCT02035696|62970946|FG001|Overall Study|Withdrawal by Subject|0|||
33574832|NCT02035696|62970947|FG002|Overall Study|Withdrawal by Subject|2|||
33574833|NCT02035696|62970948|FG003|Overall Study|Withdrawal by Subject|1|||
33574834|NCT02057458|62970962|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
33574835|NCT02057458|62970963|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
33574836|NCT02057458|62970964|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
33574837|NCT02057458|62970962|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
33574838|NCT02057458|62970963|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
33574839|NCT02057458|62970964|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
33574840|NCT02057458|62970962|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
33574841|NCT02057458|62970963|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
33574842|NCT02057458|62970964|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
33574843|NCT02057068|62970996|FG000|Overall Study|Withdrawal by Subject|2|||
33574844|NCT02057068|62970997|FG001|Overall Study|Withdrawal by Subject|2|||
33574845|NCT02057068|62970996|FG000|Overall Study|Caregiver (CG) Health|0|||
33574846|NCT02057068|62970997|FG001|Overall Study|Caregiver (CG) Health|2|||
33574847|NCT02057068|62970996|FG000|Overall Study|Carepartner (CP) Health|4|||
33574848|NCT02057068|62970997|FG001|Overall Study|Carepartner (CP) Health|2|||
33574849|NCT02057068|62970996|FG000|Overall Study|Lost to Follow-up|2|||
33574850|NCT02057068|62970997|FG001|Overall Study|Lost to Follow-up|2|||
33574851|NCT02056834|62971005|FG000|Overall Study|Lost to Follow-up|7|||
33574852|NCT02087176|62971010|FG000|Overall Study|Withdrawal by Subject|1|||
33574853|NCT02087176|62971010|FG000|Overall Study|Death|10|||
33574854|NCT02087176|62971010|FG000|Overall Study|Censored|19|||
33574855|NCT02087176|62971010|FG000|Overall Study|Study Terminated by Sponsor|2|||
33574856|NCT02056288|62971016|FG000|In-Hospital Data|Surgery cancelled|1|||
33574857|NCT02056288|62971017|FG001|In-Hospital Data|Surgery cancelled|0|||
33574858|NCT02056288|62971016|FG000|In-Hospital Data|Protocol Violation|3|||
33574859|NCT02056288|62971017|FG001|In-Hospital Data|Protocol Violation|0|||
33574860|NCT02056288|62971016|FG000|In-Hospital Data|Physician Decision|1|||
33574861|NCT02056288|62971017|FG001|In-Hospital Data|Physician Decision|0|||
33574862|NCT02056288|62971016|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
33574863|NCT02056288|62971017|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
33574864|NCT02086162|62971025|FG000|Overall Study|Withdrawal by Subject|4|||
33574865|NCT02086162|62971026|FG001|Overall Study|Withdrawal by Subject|4|||
33574866|NCT02086162|62971025|FG000|Overall Study|moved|1|||
33574867|NCT02086162|62971026|FG001|Overall Study|moved|1|||
33574868|NCT02086162|62971025|FG000|Overall Study|Lost to Follow-up|4|||
33574869|NCT02086162|62971026|FG001|Overall Study|Lost to Follow-up|2|||
33574870|NCT02086162|62971025|FG000|Overall Study|Death|1|||
33574871|NCT02086162|62971026|FG001|Overall Study|Death|0|||
33574872|NCT02700815|62971040|FG000|Overall Study|Adverse Event|0|||
33574873|NCT02700815|62971041|FG001|Overall Study|Adverse Event|6|||
33574874|NCT02700815|62971042|FG002|Overall Study|Adverse Event|2|||
33574875|NCT02700815|62971043|FG003|Overall Study|Adverse Event|3|||
33574876|NCT02700815|62971040|FG000|Overall Study|Lack of Efficacy|0|||
33574877|NCT02700815|62971041|FG001|Overall Study|Lack of Efficacy|0|||
33574878|NCT02700815|62971042|FG002|Overall Study|Lack of Efficacy|1|||
33574879|NCT02700815|62971043|FG003|Overall Study|Lack of Efficacy|2|||
33574880|NCT02700815|62971040|FG000|Overall Study|Lost to Follow-up|1|||
33574881|NCT02700815|62971041|FG001|Overall Study|Lost to Follow-up|0|||
33574882|NCT02700815|62971042|FG002|Overall Study|Lost to Follow-up|0|||
33574883|NCT02700815|62971043|FG003|Overall Study|Lost to Follow-up|1|||
33574884|NCT02700815|62971040|FG000|Overall Study|Refusal to continue medication|0|||
33574885|NCT02700815|62971041|FG001|Overall Study|Refusal to continue medication|1|||
33574886|NCT02700815|62971042|FG002|Overall Study|Refusal to continue medication|0|||
33574887|NCT02700815|62971043|FG003|Overall Study|Refusal to continue medication|1|||
33302901|NCT01073020|62678785|FG003|Overall Study|Physician Decision|0|||
33396780|NCT00657618|62776031|FG000|Overall Study|Adverse Event|32|||
33574888|NCT02700815|62971040|FG000|Overall Study|Withdrawal by Subject|0|||
33574889|NCT02700815|62971041|FG001|Overall Study|Withdrawal by Subject|0|||
33574890|NCT02700815|62971042|FG002|Overall Study|Withdrawal by Subject|1|||
33574891|NCT02700815|62971043|FG003|Overall Study|Withdrawal by Subject|0|||
33574892|NCT00708305|62971053|FG000|Period 1|Protocol Violation|1|||
33574893|NCT00708305|62971054|FG001|Period 1|Protocol Violation|0|||
33574894|NCT00708305|62971055|FG002|Period 1|Protocol Violation|1|||
33574895|NCT00708305|62971056|FG003|Period 1|Protocol Violation|0|||
33574896|NCT00708305|62971053|FG000|Period 1|Other Reason|0|||
33574897|NCT00708305|62971054|FG001|Period 1|Other Reason|0|||
33574898|NCT00708305|62971055|FG002|Period 1|Other Reason|0|||
33574899|NCT00708305|62971056|FG003|Period 1|Other Reason|2|||
33574900|NCT00708305|62971053|FG000|Period 2|Lost to Follow-up|0|||
33574901|NCT00708305|62971054|FG001|Period 2|Lost to Follow-up|1|||
33574902|NCT00708305|62971055|FG002|Period 2|Lost to Follow-up|0|||
33574903|NCT00708305|62971056|FG003|Period 2|Lost to Follow-up|0|||
33574904|NCT00708305|62971053|FG000|Period 2|Protocol Violation|0|||
33574905|NCT00708305|62971054|FG001|Period 2|Protocol Violation|1|||
33574906|NCT00708305|62971055|FG002|Period 2|Protocol Violation|0|||
33574907|NCT00708305|62971056|FG003|Period 2|Protocol Violation|0|||
33574908|NCT00708305|62971053|FG000|Period 2|Other Reason|1|||
33574909|NCT00708305|62971054|FG001|Period 2|Other Reason|0|||
33574910|NCT00708305|62971055|FG002|Period 2|Other Reason|0|||
33574911|NCT00708305|62971056|FG003|Period 2|Other Reason|1|||
33574912|NCT00708305|62971053|FG000|Period 3|Protocol Violation|0|||
33574913|NCT00708305|62971054|FG001|Period 3|Protocol Violation|2|||
33396781|NCT00657618|62776031|FG000|Overall Study|Withdrawal by Subject|8|||
33396782|NCT00657618|62776031|FG000|Overall Study|negative for leishmaniasis|2|||
33396783|NCT00657618|62776031|FG000|Overall Study|didn't start due to schedule conflicts|1|||
33396784|NCT00657540|62776037|FG000|Overall Study|Lost to Follow-up|1|||
33574914|NCT00708305|62971055|FG002|Period 3|Protocol Violation|0|||
33574915|NCT00708305|62971056|FG003|Period 3|Protocol Violation|0|||
33574916|NCT00708305|62971053|FG000|Period 3|Other Reason|1|||
33574917|NCT00708305|62971054|FG001|Period 3|Other Reason|0|||
33574918|NCT00708305|62971055|FG002|Period 3|Other Reason|0|||
33574919|NCT00708305|62971056|FG003|Period 3|Other Reason|0|||
33574920|NCT02055976|62971078|FG000|Overall Study|Other|0|||
33574921|NCT02055976|62971079|FG001|Overall Study|Other|0|||
33574922|NCT02055976|62971080|FG002|Overall Study|Other|1|||
33574923|NCT02055976|62971081|FG003|Overall Study|Other|0|||
33574924|NCT02055976|62971082|FG004|Overall Study|Other|0|||
33574925|NCT02055976|62971083|FG005|Overall Study|Other|0|||
33574926|NCT02055976|62971084|FG006|Overall Study|Other|0|||
33574927|NCT02055976|62971085|FG007|Overall Study|Other|0|||
33574928|NCT02055976|62971086|FG008|Overall Study|Other|0|||
33574929|NCT02055976|62971078|FG000|Overall Study|Adverse Event|0|||
33302902|NCT01073020|62678782|FG000|Overall Study|Death|0|||
33302903|NCT01073020|62678783|FG001|Overall Study|Death|1|||
33302904|NCT01073020|62678784|FG002|Overall Study|Death|0|||
33302905|NCT01073020|62678785|FG003|Overall Study|Death|0|||
33396785|NCT00657540|62776038|FG001|Overall Study|Lost to Follow-up|4|||
33574930|NCT02055976|62971079|FG001|Overall Study|Adverse Event|0|||
33574931|NCT02055976|62971080|FG002|Overall Study|Adverse Event|0|||
33574932|NCT02055976|62971081|FG003|Overall Study|Adverse Event|0|||
33574933|NCT02055976|62971082|FG004|Overall Study|Adverse Event|0|||
33574934|NCT02055976|62971083|FG005|Overall Study|Adverse Event|1|||
33574935|NCT02055976|62971084|FG006|Overall Study|Adverse Event|1|||
33574936|NCT02055976|62971085|FG007|Overall Study|Adverse Event|0|||
33574937|NCT02055976|62971086|FG008|Overall Study|Adverse Event|0|||
33574938|NCT02055976|62971078|FG000|Overall Study|Does not meet entrance criteria|0|||
33574939|NCT02055976|62971079|FG001|Overall Study|Does not meet entrance criteria|0|||
33574940|NCT02055976|62971080|FG002|Overall Study|Does not meet entrance criteria|0|||
33574941|NCT02055976|62971081|FG003|Overall Study|Does not meet entrance criteria|0|||
33574942|NCT02055976|62971082|FG004|Overall Study|Does not meet entrance criteria|0|||
33574943|NCT02055976|62971083|FG005|Overall Study|Does not meet entrance criteria|0|||
33574944|NCT02055976|62971084|FG006|Overall Study|Does not meet entrance criteria|1|||
33574945|NCT02055976|62971085|FG007|Overall Study|Does not meet entrance criteria|0|||
33574946|NCT02055976|62971086|FG008|Overall Study|Does not meet entrance criteria|0|||
33574947|NCT02055976|62971078|FG000|Overall Study|Lost to Follow-up|0|||
33574948|NCT02055976|62971079|FG001|Overall Study|Lost to Follow-up|0|||
33574949|NCT02055976|62971080|FG002|Overall Study|Lost to Follow-up|0|||
33574950|NCT02055976|62971081|FG003|Overall Study|Lost to Follow-up|1|||
33574951|NCT02055976|62971082|FG004|Overall Study|Lost to Follow-up|0|||
33574952|NCT02055976|62971083|FG005|Overall Study|Lost to Follow-up|0|||
33574953|NCT02055976|62971084|FG006|Overall Study|Lost to Follow-up|0|||
33302906|NCT01284114|62678795|FG000|Overall Study|viral infection|1|||
33302907|NCT01284114|62678795|FG000|Overall Study|From the results of ALLTITUDE study|1|||
33302908|NCT01284114|62678795|FG000|Overall Study|Symptomatic hypotension|1|||
33396786|NCT00672620|62776048|FG000|Overall Study|Adverse Event|7|||
33574954|NCT02055976|62971085|FG007|Overall Study|Lost to Follow-up|0|||
33574955|NCT02055976|62971086|FG008|Overall Study|Lost to Follow-up|0|||
33574956|NCT02055898|62971115|FG000|First Intervention (5 Days)|Physician Decision|2|||
33574957|NCT02055898|62971116|FG001|First Intervention (5 Days)|Physician Decision|0|||
33574958|NCT02055898|62971115|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
33574959|NCT02055898|62971116|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
33574960|NCT02564055|62971128|FG000|Overall Study|Adverse Event|1|||
33574961|NCT02564055|62971129|FG001|Overall Study|Adverse Event|0|||
33574962|NCT02564055|62971130|FG002|Overall Study|Adverse Event|4|||
33574963|NCT02564055|62971131|FG003|Overall Study|Adverse Event|1|||
33574964|NCT02564055|62971132|FG004|Overall Study|Adverse Event|4|||
33574965|NCT02564055|62971133|FG005|Overall Study|Adverse Event|1|||
33574966|NCT02564055|62971128|FG000|Overall Study|Protocol Violation|1|||
33574967|NCT02564055|62971129|FG001|Overall Study|Protocol Violation|0|||
33574968|NCT02564055|62971130|FG002|Overall Study|Protocol Violation|0|||
33574969|NCT02564055|62971131|FG003|Overall Study|Protocol Violation|0|||
33574970|NCT02564055|62971132|FG004|Overall Study|Protocol Violation|0|||
33574971|NCT02564055|62971133|FG005|Overall Study|Protocol Violation|0|||
33574972|NCT02564055|62971128|FG000|Overall Study|Reached stopping criteria|0|||
33574973|NCT02564055|62971129|FG001|Overall Study|Reached stopping criteria|0|||
33574974|NCT02564055|62971130|FG002|Overall Study|Reached stopping criteria|0|||
33574975|NCT02564055|62971131|FG003|Overall Study|Reached stopping criteria|0|||
33574976|NCT02564055|62971132|FG004|Overall Study|Reached stopping criteria|0|||
33574977|NCT02564055|62971133|FG005|Overall Study|Reached stopping criteria|1|||
33574978|NCT02564055|62971128|FG000|Overall Study|Lost to Follow-up|0|||
33574979|NCT02564055|62971129|FG001|Overall Study|Lost to Follow-up|1|||
33574980|NCT02564055|62971130|FG002|Overall Study|Lost to Follow-up|4|||
33574981|NCT02564055|62971131|FG003|Overall Study|Lost to Follow-up|2|||
33574982|NCT02564055|62971132|FG004|Overall Study|Lost to Follow-up|1|||
33574983|NCT02564055|62971133|FG005|Overall Study|Lost to Follow-up|0|||
33574984|NCT02564055|62971128|FG000|Overall Study|Physician Decision|0|||
33574985|NCT02564055|62971129|FG001|Overall Study|Physician Decision|0|||
33574986|NCT02564055|62971130|FG002|Overall Study|Physician Decision|1|||
33574987|NCT02564055|62971131|FG003|Overall Study|Physician Decision|0|||
33574988|NCT02564055|62971132|FG004|Overall Study|Physician Decision|0|||
33574989|NCT02564055|62971133|FG005|Overall Study|Physician Decision|0|||
33574990|NCT02564055|62971128|FG000|Overall Study|Withdrawal by Subject|4|||
33574991|NCT02564055|62971129|FG001|Overall Study|Withdrawal by Subject|4|||
33574992|NCT02564055|62971130|FG002|Overall Study|Withdrawal by Subject|3|||
33574993|NCT02564055|62971131|FG003|Overall Study|Withdrawal by Subject|3|||
33574994|NCT02564055|62971132|FG004|Overall Study|Withdrawal by Subject|10|||
33574995|NCT02564055|62971133|FG005|Overall Study|Withdrawal by Subject|10|||
33574996|NCT02563899|62971151|FG000|Overall Study|Protocol Violation|1|||
33574997|NCT02563899|62971152|FG001|Overall Study|Protocol Violation|0|||
33574998|NCT02563899|62971153|FG002|Overall Study|Protocol Violation|0|||
33574999|NCT02563899|62971154|FG003|Overall Study|Protocol Violation|0|||
33575000|NCT02563899|62971151|FG000|Overall Study|Withdrawal by Subject|0|||
33575001|NCT02563899|62971152|FG001|Overall Study|Withdrawal by Subject|0|||
33575002|NCT02563899|62971153|FG002|Overall Study|Withdrawal by Subject|1|||
33575003|NCT02563899|62971154|FG003|Overall Study|Withdrawal by Subject|0|||
33575004|NCT02699099|62971168|FG000|Overall Study|Adverse Event|1|||
33575005|NCT02699099|62971169|FG001|Overall Study|Adverse Event|0|||
33575006|NCT02699099|62971170|FG002|Overall Study|Adverse Event|2|||
33575007|NCT02699099|62971168|FG000|Overall Study|Lost to Follow-up|0|||
33575008|NCT02699099|62971169|FG001|Overall Study|Lost to Follow-up|1|||
33575009|NCT02699099|62971170|FG002|Overall Study|Lost to Follow-up|0|||
33575010|NCT02699099|62971168|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
33575011|NCT02699099|62971169|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
33575012|NCT02699099|62971170|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
33575013|NCT04399551|62971180|FG000|Overall Study|Adverse Event|12|||
33575014|NCT04399551|62971180|FG000|Overall Study|Withdrawal by Subject|6|||
33575015|NCT04399551|62971180|FG000|Overall Study|Physician Decision|3|||
33575016|NCT04399551|62971180|FG000|Overall Study|Lost to Follow-up|1|||
33575017|NCT04399551|62971180|FG000|Overall Study|Protocol Deviation|2|||
33575018|NCT04399551|62971180|FG000|Overall Study|Ongoing|100|||
33575019|NCT02698865|62971194|FG000|Overall Study|Other|11|||
33575020|NCT02698865|62971195|FG001|Overall Study|Other|11|||
33575021|NCT02698865|62971194|FG000|Overall Study|Withdrawal by Subject|20|||
33575022|NCT02698865|62971195|FG001|Overall Study|Withdrawal by Subject|16|||
33575023|NCT02698865|62971194|FG000|Overall Study|Physician Decision|0|||
33575024|NCT02698865|62971195|FG001|Overall Study|Physician Decision|4|||
33575025|NCT02698865|62971194|FG000|Overall Study|Lost to Follow-up|4|||
33575026|NCT02698865|62971195|FG001|Overall Study|Lost to Follow-up|2|||
33575027|NCT02698787|62971203|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
33575028|NCT02698787|62971204|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
33575029|NCT02698475|62971211|FG000|Main Study Period|Lack of Efficacy|1|||
33664431|NCT01529645|63095492|FG002|Overall Study|SAE - Premature contractions|1|||
33302909|NCT01284114|62678795|FG000|Overall Study|dizziness|1|||
33575030|NCT02698475|62971211|FG000|Main Study Period|Protocol Violation|2|||
33575031|NCT02698475|62971211|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
33575032|NCT02698475|62971211|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
33575033|NCT02698475|62971211|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
33575034|NCT02698475|62971211|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
33575035|NCT02698475|62971211|FG000|Long-Term Extension Period|Other|1|||
33575036|NCT02559687|62971218|FG000|Overall Study|Death|112|||
33575037|NCT02559687|62971218|FG000|Overall Study|Sponsor Decision|5|||
33575038|NCT02559687|62971218|FG000|Overall Study|Withdrawal by Subject|4|||
33575039|NCT04294719|62971232|FG000|Overall Study|Withdrawal by Subject|1|||
33575040|NCT02703311|62971240|FG000|Overall Study|Death|5|||
33575041|NCT02703311|62971240|FG000|Overall Study|Withdrawal by Subject|3|||
33575042|NCT02697617|62971244|FG000|Overall Study|Withdrawal by Subject|0|||
33575043|NCT02697617|62971245|FG001|Overall Study|Withdrawal by Subject|2|||
33575044|NCT02697617|62971244|FG000|Overall Study|Pregnancy|1|||
33575045|NCT02697617|62971245|FG001|Overall Study|Pregnancy|0|||
33575046|NCT02698241|62971255|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
33575047|NCT02698241|62971255|FG000|Overall Study|Screening not met|7|||
33575048|NCT02698241|62971255|FG000|Overall Study|Withdrawal by Subject|7|||
33575049|NCT02698241|62971255|FG000|Overall Study|Physician Decision|2|||
33575050|NCT02698241|62971255|FG000|Overall Study|Subject underwent system modification|2|||
33575051|NCT02698241|62971255|FG000|Overall Study|Lost to Follow-up|3|||
33575052|NCT02698241|62971255|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
33575053|NCT02698241|62971255|FG000|Overall Study|geographic and licensing issue|1|||
33575054|NCT02698241|62971255|FG000|Overall Study|Death|2|||
33575055|NCT01663233|62971261|FG000|Overall Study|Withdrawal by Subject|3|||
33575056|NCT01663233|62971262|FG001|Overall Study|Withdrawal by Subject|2|||
33575057|NCT01663233|62971261|FG000|Overall Study|Protocol Deviation|1|||
33575058|NCT01663233|62971262|FG001|Overall Study|Protocol Deviation|4|||
33575059|NCT01663233|62971261|FG000|Overall Study|Lost to Follow-up|0|||
33575060|NCT01663233|62971262|FG001|Overall Study|Lost to Follow-up|1|||
33575061|NCT02556255|62971281|FG000|Overall Study|Lost to Follow-up|4|||
33575062|NCT02556801|62971289|FG000|Overall Study|Lost to Follow-up|1|||
33575063|NCT02556801|62971290|FG001|Overall Study|Lost to Follow-up|0|||
33575064|NCT02556801|62971291|FG002|Overall Study|Lost to Follow-up|2|||
33575065|NCT02556801|62971292|FG003|Overall Study|Lost to Follow-up|0|||
33575066|NCT02556801|62971289|FG000|Overall Study|Withdrawal by Subject|1|||
33575067|NCT02556801|62971290|FG001|Overall Study|Withdrawal by Subject|1|||
33575068|NCT02556801|62971291|FG002|Overall Study|Withdrawal by Subject|1|||
33575069|NCT02556801|62971292|FG003|Overall Study|Withdrawal by Subject|0|||
33575070|NCT02556801|62971289|FG000|Overall Study|Protocol Violation|0|||
33575071|NCT02556801|62971290|FG001|Overall Study|Protocol Violation|3|||
33575072|NCT02556801|62971291|FG002|Overall Study|Protocol Violation|1|||
33575073|NCT02556801|62971292|FG003|Overall Study|Protocol Violation|1|||
33575074|NCT02556801|62971289|FG000|Overall Study|Adverse Event|0|||
33575075|NCT02556801|62971290|FG001|Overall Study|Adverse Event|2|||
33575076|NCT02556801|62971291|FG002|Overall Study|Adverse Event|0|||
33575077|NCT02556801|62971292|FG003|Overall Study|Adverse Event|3|||
33575078|NCT02556801|62971289|FG000|Overall Study|Pregnancy|0|||
33575079|NCT02556801|62971290|FG001|Overall Study|Pregnancy|1|||
33575080|NCT02556801|62971291|FG002|Overall Study|Pregnancy|0|||
33575081|NCT02556801|62971292|FG003|Overall Study|Pregnancy|0|||
33575082|NCT02556801|62971289|FG000|Overall Study|Personal reasons patient|0|||
33575083|NCT02556801|62971290|FG001|Overall Study|Personal reasons patient|0|||
33575084|NCT02556801|62971291|FG002|Overall Study|Personal reasons patient|0|||
33575085|NCT02556801|62971292|FG003|Overall Study|Personal reasons patient|1|||
33575086|NCT02556177|62971304|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
33575087|NCT02556177|62971305|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
33575088|NCT02554929|62971313|FG000|Overall Study|Lost to Follow-up|4|||
33575089|NCT02554929|62971314|FG001|Overall Study|Lost to Follow-up|4|||
33575090|NCT02554929|62971313|FG000|Overall Study|Withdrawal by Subject|2|||
33575091|NCT02554929|62971314|FG001|Overall Study|Withdrawal by Subject|8|||
33575092|NCT02697773|62971332|FG000|Overall Study|Adverse Event|2|||
33575093|NCT02697773|62971333|FG001|Overall Study|Adverse Event|1|||
33575094|NCT02697773|62971334|FG002|Overall Study|Adverse Event|2|||
33575095|NCT02697773|62971332|FG000|Overall Study|Death|0|||
33575096|NCT02697773|62971333|FG001|Overall Study|Death|0|||
33575097|NCT02697773|62971334|FG002|Overall Study|Death|2|||
33575098|NCT02697773|62971332|FG000|Overall Study|Lack of Efficacy|4|||
33575099|NCT02697773|62971333|FG001|Overall Study|Lack of Efficacy|6|||
33575100|NCT02697773|62971334|FG002|Overall Study|Lack of Efficacy|6|||
33575101|NCT02697773|62971332|FG000|Overall Study|Lost to Follow-up|5|||
33575102|NCT02697773|62971333|FG001|Overall Study|Lost to Follow-up|5|||
33575103|NCT02697773|62971334|FG002|Overall Study|Lost to Follow-up|7|||
33575104|NCT02697773|62971332|FG000|Overall Study|Other|15|||
33575105|NCT02697773|62971333|FG001|Overall Study|Other|11|||
33575106|NCT02697773|62971334|FG002|Overall Study|Other|10|||
33575107|NCT02697773|62971332|FG000|Overall Study|Protocol Violation|1|||
33575108|NCT02697773|62971333|FG001|Overall Study|Protocol Violation|1|||
33575109|NCT02697773|62971334|FG002|Overall Study|Protocol Violation|0|||
33575110|NCT02697773|62971332|FG000|Overall Study|Withdrawal by Subject|10|||
33575111|NCT02697773|62971333|FG001|Overall Study|Withdrawal by Subject|13|||
33575112|NCT02697773|62971334|FG002|Overall Study|Withdrawal by Subject|13|||
33575113|NCT02697773|62971332|FG000|Overall Study|Randomized but not treated|1|||
33575114|NCT02697773|62971333|FG001|Overall Study|Randomized but not treated|1|||
33575115|NCT02697773|62971334|FG002|Overall Study|Randomized but not treated|0|||
33575116|NCT02693171|62971342|FG000|Overall Study|Adverse Event|1|||
33575117|NCT02693171|62971342|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
33575118|NCT02692703|62971346|FG000|Overall Study|Lost to Follow-up|1|||
33575119|NCT02692703|62971346|FG000|Overall Study|Other|1|||
33575120|NCT02692235|62971352|FG000|Overall Study|Withdrawal by Subject|2|||
33575121|NCT02692235|62971353|FG001|Overall Study|Withdrawal by Subject|1|||
33575122|NCT02692235|62971352|FG000|Overall Study|Adverse Event|1|||
33575123|NCT02692235|62971353|FG001|Overall Study|Adverse Event|2|||
33575124|NCT02552121|62971367|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
33575125|NCT02552121|62971368|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
33575126|NCT02552121|62971369|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
33575127|NCT02552121|62971370|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
33575128|NCT02552121|62971371|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
33575129|NCT02552121|62971372|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
33575130|NCT02552121|62971373|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
33575131|NCT02552121|62971374|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
33575132|NCT02552121|62971367|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
33575133|NCT02552121|62971368|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
33575134|NCT02552121|62971369|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
33575135|NCT02552121|62971370|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
33575136|NCT02552121|62971371|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
33575137|NCT02552121|62971372|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
33575138|NCT02552121|62971373|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
33575139|NCT02552121|62971374|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
33575140|NCT02552121|62971367|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
33575141|NCT02552121|62971368|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
33575142|NCT02552121|62971369|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
33575143|NCT02552121|62971370|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
33575144|NCT02552121|62971371|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
33575145|NCT02552121|62971372|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
33575146|NCT02552121|62971373|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
33575147|NCT02552121|62971374|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
33575148|NCT02552121|62971367|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
33575149|NCT02552121|62971368|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
33575150|NCT02552121|62971369|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
33575151|NCT02552121|62971370|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
33575152|NCT02552121|62971371|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
33575153|NCT02552121|62971372|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
33575154|NCT02552121|62971373|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
33575155|NCT02552121|62971374|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
33575156|NCT02552121|62971367|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
33575157|NCT02552121|62971368|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
33575158|NCT02552121|62971369|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
33575159|NCT02552121|62971370|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
33575160|NCT02552121|62971371|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
33575161|NCT02552121|62971372|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
33575162|NCT02552121|62971373|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
33575163|NCT02552121|62971374|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
33575164|NCT02552121|62971367|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
33575165|NCT02552121|62971368|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
33575166|NCT02552121|62971369|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
33575167|NCT02552121|62971370|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
33575168|NCT02552121|62971371|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
33575169|NCT02552121|62971372|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
33575170|NCT02552121|62971373|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
33575171|NCT02552121|62971374|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
33575172|NCT02552121|62971367|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
33575173|NCT02552121|62971368|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
33575174|NCT02552121|62971369|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
33575175|NCT02552121|62971370|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
33575176|NCT02552121|62971371|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
33575177|NCT02552121|62971372|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
33575178|NCT02552121|62971373|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
33575179|NCT02552121|62971374|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
33575180|NCT02552121|62971367|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
33575181|NCT02552121|62971368|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
33575182|NCT02552121|62971369|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
33575183|NCT02552121|62971370|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
33575184|NCT02552121|62971371|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
33575185|NCT02552121|62971372|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
33575186|NCT02552121|62971373|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
33575187|NCT02552121|62971374|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
33575188|NCT02552121|62971367|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
33575189|NCT02552121|62971368|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
33575190|NCT02552121|62971369|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
33575191|NCT02552121|62971370|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
33575192|NCT02552121|62971371|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
33575193|NCT02552121|62971372|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
33575194|NCT02552121|62971373|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
33575195|NCT02552121|62971374|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
33575196|NCT02552121|62971367|FG000|Part 2: Cohort Expansion|Death|0|||
33575197|NCT02552121|62971368|FG001|Part 2: Cohort Expansion|Death|0|||
33575198|NCT02552121|62971369|FG002|Part 2: Cohort Expansion|Death|1|||
33575199|NCT02552121|62971370|FG003|Part 2: Cohort Expansion|Death|0|||
33575200|NCT02552121|62971371|FG004|Part 2: Cohort Expansion|Death|0|||
33575201|NCT02552121|62971372|FG005|Part 2: Cohort Expansion|Death|0|||
33575202|NCT02552121|62971373|FG006|Part 2: Cohort Expansion|Death|0|||
33575203|NCT02552121|62971374|FG007|Part 2: Cohort Expansion|Death|0|||
33575204|NCT02552355|62971419|FG000|Overall Study|Adverse Event|0|||
33575205|NCT02552355|62971420|FG001|Overall Study|Adverse Event|2|||
33575206|NCT02552355|62971421|FG002|Overall Study|Adverse Event|2|||
33575207|NCT02552355|62971422|FG003|Overall Study|Adverse Event|0|||
33575208|NCT02552355|62971419|FG000|Overall Study|Withdrawal by Subject|0|||
33575209|NCT02552355|62971420|FG001|Overall Study|Withdrawal by Subject|0|||
33575210|NCT02552355|62971421|FG002|Overall Study|Withdrawal by Subject|0|||
33575211|NCT02552355|62971422|FG003|Overall Study|Withdrawal by Subject|1|||
33575212|NCT02551731|62971432|FG000|Overall Study|Withdrawal by Subject|2|||
33575213|NCT02542605|62971436|FG000|Part B: Challenge Phase|Sponsor decision|1|||
33575214|NCT02542605|62971437|FG001|Part B: Challenge Phase|Sponsor decision|0|||
33575215|NCT02542605|62971438|FG002|Part B: Challenge Phase|Sponsor decision|0|||
33575216|NCT02542605|62971436|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
33575217|NCT02542605|62971437|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
33575218|NCT02542605|62971438|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
33575219|NCT02550873|62971449|FG000|Randomized Double Blind|Adverse Event|3|||
33575220|NCT02550873|62971450|FG001|Randomized Double Blind|Adverse Event|1|||
33575221|NCT02550873|62971451|FG002|Randomized Double Blind|Adverse Event|0|||
33575222|NCT02550873|62971449|FG000|Randomized Double Blind|Disease progression|1|||
33575223|NCT02550873|62971450|FG001|Randomized Double Blind|Disease progression|1|||
33575224|NCT02550873|62971451|FG002|Randomized Double Blind|Disease progression|0|||
33575225|NCT02550873|62971449|FG000|Open Label Extension|Study ongoing|0|||
33575226|NCT02550873|62971450|FG001|Open Label Extension|Study ongoing|0|||
33575227|NCT02550873|62971451|FG002|Open Label Extension|Study ongoing|111|||
33575228|NCT02535741|62971473|FG000|Overall Study|Adverse Event|3|||
33575229|NCT02535741|62971473|FG000|Overall Study|Withdrawal by Subject|9|||
33575230|NCT02535741|62971473|FG000|Overall Study|Lost to Follow-up|10|||
33575231|NCT02535741|62971473|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
33575232|NCT02535741|62971473|FG000|Overall Study|Missing data|6|||
33575233|NCT02550795|62971494|FG000|Overall Study|Physician Decision|0|||
33575234|NCT02550795|62971495|FG001|Overall Study|Physician Decision|1|||
33575235|NCT02550795|62971496|FG002|Overall Study|Physician Decision|0|||
33575236|NCT02541903|62971504|FG000|Overall Study|Death|1|||
33575237|NCT02541669|62971513|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
33575238|NCT02541669|62971514|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
33575239|NCT02541669|62971515|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
33575240|NCT02541669|62971516|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
33575241|NCT02541669|62971517|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
33575242|NCT02549859|62971528|FG000|Long-term 60 Hz DBS|Study Closed|1|||
33575243|NCT02688647|62971538|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
33575244|NCT02688647|62971539|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
33575245|NCT02688647|62971538|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
33575246|NCT02688647|62971539|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
33575247|NCT02688647|62971538|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
33575248|NCT02688647|62971539|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
33575249|NCT02688647|62971538|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
33575250|NCT02688647|62971539|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
33575251|NCT02688647|62971538|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
33575252|NCT02688647|62971539|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
33575253|NCT02688647|62971538|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
33575254|NCT02688647|62971539|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
33575255|NCT02688647|62971538|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
33575256|NCT02688647|62971539|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
33575257|NCT02687711|62971557|FG000|Overall Study|Adverse Event|89|||
33575258|NCT02687711|62971557|FG000|Overall Study|Lack of Efficacy|70|||
33575259|NCT02687711|62971557|FG000|Overall Study|Lost to Follow-up|20|||
33575260|NCT02687711|62971557|FG000|Overall Study|Consent withdrawn|15|||
33575261|NCT02687711|62971557|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
33575262|NCT02687711|62971557|FG000|Overall Study|Too expensive|4|||
33575263|NCT02687711|62971557|FG000|Overall Study|Participant moved abroad|1|||
33575264|NCT02687711|62971557|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
33575265|NCT02687711|62971557|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
33575266|NCT02687711|62971557|FG000|Overall Study|Disliked taste|1|||
33575267|NCT02687711|62971557|FG000|Overall Study|Low mood|1|||
33575268|NCT02687711|62971557|FG000|Overall Study|Side effects|1|||
33575269|NCT02687711|62971557|FG000|Overall Study|Change of Hospital|1|||
33575270|NCT02687711|62971557|FG000|Overall Study|Liver Encephalopathy|1|||
33575271|NCT02687711|62971557|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
33575272|NCT02687711|62971557|FG000|Overall Study|Withdrawn due to intake interruption|1|||
33575273|NCT02687711|62971557|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
33575274|NCT02687711|62971557|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
33575275|NCT02687711|62971557|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
33575276|NCT01662063|62971563|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
33575277|NCT01662063|62971564|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
33575278|NCT01662063|62971565|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
33575279|NCT01662063|62971563|FG000|Overall Study|Lack of Efficacy|1|||
33575280|NCT01662063|62971564|FG001|Overall Study|Lack of Efficacy|6|||
33575281|NCT01662063|62971565|FG002|Overall Study|Lack of Efficacy|0|||
33575282|NCT01662063|62971563|FG000|Overall Study|Lost to Follow-up|0|||
33575283|NCT01662063|62971564|FG001|Overall Study|Lost to Follow-up|4|||
33575284|NCT01662063|62971565|FG002|Overall Study|Lost to Follow-up|0|||
33575285|NCT01662063|62971563|FG000|Overall Study|Protocol Violation|1|||
33575286|NCT01662063|62971564|FG001|Overall Study|Protocol Violation|0|||
33575287|NCT01662063|62971565|FG002|Overall Study|Protocol Violation|0|||
33575288|NCT01662063|62971563|FG000|Overall Study|Withdrawal by Subject|2|||
33575289|NCT01662063|62971564|FG001|Overall Study|Withdrawal by Subject|4|||
33575290|NCT01662063|62971565|FG002|Overall Study|Withdrawal by Subject|1|||
33575291|NCT01662063|62971563|FG000|Overall Study|Physician Decision|0|||
33575292|NCT01662063|62971564|FG001|Overall Study|Physician Decision|2|||
33575293|NCT01662063|62971565|FG002|Overall Study|Physician Decision|0|||
33575294|NCT01662063|62971563|FG000|Overall Study|Other|0|||
33575295|NCT01662063|62971564|FG001|Overall Study|Other|1|||
33575296|NCT01662063|62971565|FG002|Overall Study|Other|0|||
33575297|NCT02548455|62971573|FG000|Overall Study|Withdrawal by Subject|27|||
33575298|NCT02548455|62971573|FG000|Overall Study|Death|26|||
33575299|NCT02548455|62971573|FG000|Overall Study|Lost to Follow-up|14|||
33575300|NCT02548455|62971573|FG000|Overall Study|Visit not completed|173|||
33396787|NCT00672620|62776049|FG001|Overall Study|Adverse Event|7|||
33396788|NCT00672620|62776050|FG002|Overall Study|Adverse Event|12|||
33396789|NCT00672620|62776051|FG003|Overall Study|Adverse Event|17|||
33396790|NCT00672620|62776048|FG000|Overall Study|Lack of Efficacy|1|||
33396791|NCT00672620|62776049|FG001|Overall Study|Lack of Efficacy|2|||
33396792|NCT00672620|62776050|FG002|Overall Study|Lack of Efficacy|2|||
33575301|NCT02691455|62971579|FG000|Overall Study|Withdrawal by Subject|1|||
33575302|NCT02691455|62971580|FG001|Overall Study|Withdrawal by Subject|2|||
33575303|NCT02691455|62971579|FG000|Overall Study|Lost to Follow-up|15|||
33575304|NCT02691455|62971580|FG001|Overall Study|Lost to Follow-up|15|||
33575305|NCT02534883|62971588|FG000|Overall Study|Early Termination|8|||
33575306|NCT02534883|62971589|FG001|Overall Study|Early Termination|3|||
33575307|NCT02685995|62971597|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
33575308|NCT02685995|62971598|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
33575309|NCT02548143|62971606|FG000|Overall Study|Adverse Event|1|||
33575310|NCT02548143|62971607|FG001|Overall Study|Adverse Event|0|||
33575311|NCT02548143|62971606|FG000|Overall Study|Withdrawal by Subject|0|||
33575312|NCT02548143|62971607|FG001|Overall Study|Withdrawal by Subject|1|||
33575313|NCT02547441|62971615|FG000|Double-Blind Study Period|Adverse Event|4|||
33575314|NCT02547441|62971616|FG001|Double-Blind Study Period|Adverse Event|9|||
33575315|NCT02547441|62971615|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
33575316|NCT02547441|62971616|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
33575317|NCT02547441|62971615|FG000|Double-Blind Study Period|Physician Decision|1|||
33575318|NCT02547441|62971616|FG001|Double-Blind Study Period|Physician Decision|0|||
33575319|NCT02547441|62971615|FG000|Double-Blind Study Period|Protocol Violation|1|||
33575320|NCT02547441|62971616|FG001|Double-Blind Study Period|Protocol Violation|2|||
33575321|NCT02547441|62971615|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
33575322|NCT02547441|62971616|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
33575323|NCT02547441|62971615|FG000|Double-Blind Study Period|Sponsor Decision|1|||
33575324|NCT02547441|62971616|FG001|Double-Blind Study Period|Sponsor Decision|0|||
33575325|NCT02547441|62971615|FG000|Open-Label Study Period|Adverse Event|10|||
33575326|NCT02547441|62971616|FG001|Open-Label Study Period|Adverse Event|11|||
33575327|NCT02547441|62971615|FG000|Open-Label Study Period|Lack of Efficacy|3|||
33575328|NCT02547441|62971616|FG001|Open-Label Study Period|Lack of Efficacy|2|||
33575329|NCT02547441|62971615|FG000|Open-Label Study Period|Lost to Follow-up|7|||
33581018|NCT01126736|62978143|FG003|Overall Study|Other|16|||
33664432|NCT01529645|63095493|FG003|Overall Study|SAE - Premature contractions|0|||
33575330|NCT02547441|62971616|FG001|Open-Label Study Period|Lost to Follow-up|8|||
33575331|NCT02547441|62971615|FG000|Open-Label Study Period|Physician Decision|1|||
33575332|NCT02547441|62971616|FG001|Open-Label Study Period|Physician Decision|0|||
33575333|NCT02547441|62971615|FG000|Open-Label Study Period|Protocol Violation|2|||
33575334|NCT02547441|62971616|FG001|Open-Label Study Period|Protocol Violation|0|||
33575335|NCT02547441|62971615|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
33575336|NCT02547441|62971616|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
33575337|NCT02547441|62971615|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
33575338|NCT02547441|62971616|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
33575339|NCT02540265|62971626|FG000|Overall Study|Lost to Follow-up|0|||
33575340|NCT02540265|62971627|FG001|Overall Study|Lost to Follow-up|0|||
33575341|NCT02540265|62971628|FG002|Overall Study|Lost to Follow-up|1|||
33575342|NCT02547363|62971638|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
33575343|NCT02547363|62971639|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
33575344|NCT02547363|62971638|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
33575345|NCT02547363|62971639|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
33575346|NCT02547363|62971638|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
33575347|NCT02547363|62971639|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
33575348|NCT02547363|62971638|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
33575349|NCT02547363|62971639|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
33575350|NCT02547363|62971638|FG000|12-month Follow-up|Withdrawal by Subject|4|||
33575351|NCT02547363|62971639|FG001|12-month Follow-up|Withdrawal by Subject|3|||
33575352|NCT02547363|62971638|FG000|12-month Follow-up|Lost to Follow-up|4|||
33575353|NCT02547363|62971639|FG001|12-month Follow-up|Lost to Follow-up|1|||
33575354|NCT02547363|62971638|FG000|12-month Follow-up|Lack of Efficacy|1|||
33575355|NCT02547363|62971639|FG001|12-month Follow-up|Lack of Efficacy|1|||
33575356|NCT02547363|62971638|FG000|12-month Follow-up|Other|1|||
33575357|NCT02547363|62971639|FG001|12-month Follow-up|Other|0|||
33575358|NCT02539797|62971647|FG000|Overall Study|Lost to Follow-up|0|||
33575359|NCT02539797|62971648|FG001|Overall Study|Lost to Follow-up|1|||
33575360|NCT02539797|62971649|FG002|Overall Study|Lost to Follow-up|0|||
33575361|NCT02684357|62971660|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
33575362|NCT02684357|62971661|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
33575363|NCT02684357|62971662|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
33575364|NCT02684357|62971663|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
33575365|NCT02684357|62971664|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
33575366|NCT02684357|62971665|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
33575367|NCT02684357|62971660|FG000|Part A|Lost to Follow-up|0|||
33575368|NCT02684357|62971661|FG001|Part A|Lost to Follow-up|2|||
33575369|NCT02684357|62971662|FG002|Part A|Lost to Follow-up|2|||
33575370|NCT02684357|62971663|FG003|Part A|Lost to Follow-up|0|||
33575371|NCT02684357|62971664|FG004|Part A|Lost to Follow-up|0|||
33575372|NCT02684357|62971665|FG005|Part A|Lost to Follow-up|0|||
33575373|NCT02684357|62971660|FG000|Part A|Withdrawal by Subject|3|||
33575374|NCT02684357|62971661|FG001|Part A|Withdrawal by Subject|0|||
33575375|NCT02684357|62971662|FG002|Part A|Withdrawal by Subject|0|||
33575376|NCT02684357|62971663|FG003|Part A|Withdrawal by Subject|0|||
33575377|NCT02684357|62971664|FG004|Part A|Withdrawal by Subject|0|||
33575378|NCT02684357|62971665|FG005|Part A|Withdrawal by Subject|0|||
33575379|NCT02684357|62971660|FG000|Part A|Other|0|||
33575380|NCT02684357|62971661|FG001|Part A|Other|1|||
33575381|NCT02684357|62971662|FG002|Part A|Other|0|||
33575382|NCT02684357|62971663|FG003|Part A|Other|0|||
33575383|NCT02684357|62971664|FG004|Part A|Other|0|||
33575384|NCT02684357|62971665|FG005|Part A|Other|0|||
33575385|NCT02684357|62971660|FG000|Part B|Adverse Event (Other)|0|||
33575386|NCT02684357|62971661|FG001|Part B|Adverse Event (Other)|0|||
33575387|NCT02684357|62971662|FG002|Part B|Adverse Event (Other)|0|||
33575388|NCT02684357|62971663|FG003|Part B|Adverse Event (Other)|1|||
33575389|NCT02684357|62971664|FG004|Part B|Adverse Event (Other)|1|||
33575390|NCT02684357|62971665|FG005|Part B|Adverse Event (Other)|1|||
33302910|NCT01283334|62678800|FG000|Overall Study|Withdrawal by Subject|1|||
33302911|NCT01283334|62678800|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
33575391|NCT02684357|62971660|FG000|Part B|Lost to Follow-up|0|||
33575392|NCT02684357|62971661|FG001|Part B|Lost to Follow-up|0|||
33575393|NCT02684357|62971662|FG002|Part B|Lost to Follow-up|0|||
33575394|NCT02684357|62971663|FG003|Part B|Lost to Follow-up|1|||
33575395|NCT02684357|62971664|FG004|Part B|Lost to Follow-up|1|||
33575396|NCT02684357|62971665|FG005|Part B|Lost to Follow-up|7|||
33575397|NCT02684357|62971660|FG000|Part B|Withdrawal by Subject|0|||
33575398|NCT02684357|62971661|FG001|Part B|Withdrawal by Subject|0|||
33302912|NCT01283334|62678800|FG000|Overall Study|Adverse Event|4|||
33302913|NCT01283334|62678800|FG000|Overall Study|Physician Decision|1|||
33575399|NCT02684357|62971662|FG002|Part B|Withdrawal by Subject|0|||
33575400|NCT02684357|62971663|FG003|Part B|Withdrawal by Subject|0|||
33575401|NCT02684357|62971664|FG004|Part B|Withdrawal by Subject|2|||
33575402|NCT02684357|62971665|FG005|Part B|Withdrawal by Subject|4|||
33575403|NCT02684357|62971660|FG000|Part B|Other|0|||
33575404|NCT02684357|62971661|FG001|Part B|Other|0|||
33575405|NCT02684357|62971662|FG002|Part B|Other|0|||
33575406|NCT02684357|62971663|FG003|Part B|Other|1|||
33575407|NCT02684357|62971664|FG004|Part B|Other|0|||
33575408|NCT02684357|62971665|FG005|Part B|Other|1|||
33575409|NCT02684279|62971678|FG000|Overall Study|Adverse Event|87|||
33575410|NCT02684279|62971678|FG000|Overall Study|Lack of Efficacy|4|||
33575411|NCT02684279|62971678|FG000|Overall Study|Lost to Follow-up|61|||
33575412|NCT02684279|62971678|FG000|Overall Study|Protocol Violation|6|||
33575413|NCT02684279|62971678|FG000|Overall Study|Pregnancy|8|||
33575414|NCT02684279|62971678|FG000|Overall Study|Withdrawal by Subject|92|||
33575415|NCT02684279|62971678|FG000|Overall Study|non-compliance with study drug|9|||
33575416|NCT02684279|62971678|FG000|Overall Study|non compliance with study visits|2|||
33575417|NCT02684279|62971678|FG000|Overall Study|subject to have surgery|1|||
33575418|NCT02684279|62971678|FG000|Overall Study|family emergency|1|||
33575419|NCT02684279|62971678|FG000|Overall Study|Site closures|7|||
33575420|NCT02684279|62971678|FG000|Overall Study|Physician Decision|1|||
33575421|NCT03206073|62971686|FG000|Overall Study|Participant Noncompliance|0|||
33575422|NCT03206073|62971687|FG001|Overall Study|Participant Noncompliance|1|||
33575423|NCT03206073|62971688|FG002|Overall Study|Participant Noncompliance|0|||
33575424|NCT03206073|62971689|FG003|Overall Study|Participant Noncompliance|0|||
33575425|NCT03206073|62971686|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
33575426|NCT03206073|62971687|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
33575427|NCT03206073|62971688|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
33575428|NCT03206073|62971689|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
33575429|NCT03206073|62971686|FG000|Overall Study|Death|0|||
33575430|NCT03206073|62971687|FG001|Overall Study|Death|0|||
33575431|NCT03206073|62971688|FG002|Overall Study|Death|1|||
33575432|NCT03206073|62971689|FG003|Overall Study|Death|0|||
33575433|NCT03206073|62971686|FG000|Overall Study|Taken off active treatment|0|||
33664433|NCT01529645|63095494|FG004|Overall Study|SAE - Premature contractions|0|||
33664434|NCT01529645|63095495|FG005|Overall Study|SAE - Premature contractions|0|||
33575434|NCT03206073|62971687|FG001|Overall Study|Taken off active treatment|0|||
33575435|NCT03206073|62971688|FG002|Overall Study|Taken off active treatment|3|||
33575436|NCT03206073|62971689|FG003|Overall Study|Taken off active treatment|0|||
33575437|NCT02534493|62971699|FG000|Overall Study|Lost to Follow-up|1|||
33575438|NCT02534493|62971699|FG000|Overall Study|Withdrawal by Subject|1|||
33575439|NCT02547129|62971707|FG000|Overall Study|Difficulty with ongoing infection|1|||
33575440|NCT02547129|62971708|FG001|Overall Study|Difficulty with ongoing infection|0|||
33575441|NCT02546193|62971716|FG000|Overall Study|Withdrawal by Subject|2|||
33575442|NCT02546193|62971717|FG001|Overall Study|Withdrawal by Subject|0|||
33575443|NCT02546193|62971718|FG002|Overall Study|Withdrawal by Subject|1|||
33575444|NCT02546193|62971719|FG003|Overall Study|Withdrawal by Subject|0|||
33575445|NCT02546193|62971716|FG000|Overall Study|Not eligible at time of induction|4|||
33575446|NCT02546193|62971717|FG001|Overall Study|Not eligible at time of induction|6|||
33575447|NCT02546193|62971718|FG002|Overall Study|Not eligible at time of induction|1|||
33575448|NCT02546193|62971719|FG003|Overall Study|Not eligible at time of induction|0|||
33575449|NCT02538471|62971725|FG000|Overall Study|Progression of disease|2|||
33575450|NCT01661595|62971733|FG000|Phase 1: Week 0-4|Adverse Event|1|||
33575451|NCT01661595|62971734|FG001|Phase 1: Week 0-4|Adverse Event|0|||
33575452|NCT01661595|62971735|FG002|Phase 1: Week 0-4|Adverse Event|0|||
33575453|NCT01661595|62971736|FG003|Phase 1: Week 0-4|Adverse Event|0|||
33575454|NCT01661595|62971733|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
33575455|NCT01661595|62971734|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
33575456|NCT01661595|62971735|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
33575457|NCT01661595|62971736|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
33575458|NCT02213133|62971756|FG000|Overall Study|Participant discontinued study therapy|2|||
33575459|NCT02213133|62971757|FG001|Overall Study|Participant discontinued study therapy|0|||
33575460|NCT02213133|62971758|FG002|Overall Study|Participant discontinued study therapy|0|||
33575461|NCT02213133|62971756|FG000|Overall Study|Participant withdrew informed consent|2|||
33575462|NCT02213133|62971757|FG001|Overall Study|Participant withdrew informed consent|1|||
33575463|NCT02213133|62971758|FG002|Overall Study|Participant withdrew informed consent|2|||
33575464|NCT02213133|62971756|FG000|Overall Study|Disease progression|11|||
33575465|NCT02213133|62971757|FG001|Overall Study|Disease progression|2|||
33575466|NCT02213133|62971758|FG002|Overall Study|Disease progression|0|||
33575467|NCT02213133|62971756|FG000|Overall Study|Adverse Event (AE)|1|||
33575468|NCT02213133|62971757|FG001|Overall Study|Adverse Event (AE)|0|||
33575469|NCT02213133|62971758|FG002|Overall Study|Adverse Event (AE)|0|||
33575470|NCT02213133|62971756|FG000|Overall Study|Death|16|||
33575471|NCT02213133|62971757|FG001|Overall Study|Death|2|||
33575472|NCT02213133|62971758|FG002|Overall Study|Death|1|||
33575473|NCT02213133|62971756|FG000|Overall Study|Other|5|||
33664435|NCT01529645|63095496|FG006|Overall Study|SAE - Premature contractions|0|||
33575474|NCT02213133|62971757|FG001|Overall Study|Other|0|||
33575475|NCT02213133|62971758|FG002|Overall Study|Other|0|||
33575476|NCT02684981|62971770|FG000|Overall Study|Permanently discontinued the treatment|157|||
33664436|NCT01529645|63095497|FG007|Overall Study|SAE - Premature contractions|0|||
33575477|NCT02684981|62971771|FG001|Overall Study|Permanently discontinued the treatment|161|||
33575478|NCT02684981|62971772|FG002|Overall Study|Permanently discontinued the treatment|110|||
33575479|NCT02684981|62971770|FG000|Overall Study|Other|83|||
33575480|NCT02684981|62971771|FG001|Overall Study|Other|49|||
33575481|NCT02684981|62971772|FG002|Overall Study|Other|17|||
33575482|NCT02146833|62971786|FG000|Overall Study|Death|10|||
33575483|NCT02146833|62971786|FG000|Overall Study|No longer consented to study treatment|1|||
33575484|NCT02690207|62971790|FG000|Overall Study|Lost to Follow-up|48|||
33575485|NCT02690207|62971790|FG000|Overall Study|Withdrawal by Subject|46|||
33575486|NCT02690207|62971790|FG000|Overall Study|Protocol Violation|2|||
33575487|NCT02690207|62971790|FG000|Overall Study|Serious adverse event|110|||
33575488|NCT02690207|62971790|FG000|Overall Study|Non-serious Adverse Event|18|||
33575489|NCT02690207|62971790|FG000|Overall Study|Migrated/moved from study area|5|||
33575490|NCT02690207|62971790|FG000|Overall Study|Suspected HZ Episode|1|||
33575491|NCT02690207|62971790|FG000|Overall Study|Other reasons for withdrawal|23|||
33575492|NCT02689349|62971796|FG000|Overall Study|Not implanted|4|||
33575493|NCT02689349|62971797|FG001|Overall Study|Not implanted|0|||
33575494|NCT02689349|62971796|FG000|Overall Study|Withdrawal by Subject|9|||
33575495|NCT02689349|62971797|FG001|Overall Study|Withdrawal by Subject|0|||
33575496|NCT02679287|62971808|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
33575497|NCT02679287|62971809|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
33575498|NCT02679287|62971808|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
33575499|NCT02679287|62971809|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
33575500|NCT02679287|62971808|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
33575501|NCT02679287|62971809|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
33575502|NCT02679287|62971808|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
33575503|NCT02679287|62971809|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
33575504|NCT02679287|62971808|FG000|Period 2|Work/Scheduling Conflict|1|||
33575505|NCT02679287|62971809|FG001|Period 2|Work/Scheduling Conflict|0|||
33575506|NCT02679287|62971808|FG000|Period 2|Disliked Mobile System|2|||
33575507|NCT02679287|62971809|FG001|Period 2|Disliked Mobile System|0|||
33575508|NCT02679287|62971808|FG000|Period 3|Work/Scheduling Conflict|0|||
33575509|NCT02679287|62971809|FG001|Period 3|Work/Scheduling Conflict|1|||
33575510|NCT02544633|62971825|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
33575511|NCT02544633|62971826|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
33575512|NCT02544633|62971827|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
33575513|NCT02544633|62971828|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
33575514|NCT02544633|62971825|FG000|Treatment Period|Adverse Event|7|||
33575515|NCT02544633|62971826|FG001|Treatment Period|Adverse Event|4|||
33575516|NCT02544633|62971827|FG002|Treatment Period|Adverse Event|0|||
33575517|NCT02544633|62971828|FG003|Treatment Period|Adverse Event|5|||
33575518|NCT02544633|62971825|FG000|Treatment Period|Lack of Efficacy|17|||
33575519|NCT02544633|62971826|FG001|Treatment Period|Lack of Efficacy|11|||
33575520|NCT02544633|62971827|FG002|Treatment Period|Lack of Efficacy|5|||
33575521|NCT02544633|62971828|FG003|Treatment Period|Lack of Efficacy|5|||
33575522|NCT02544633|62971825|FG000|Treatment Period|Global Deterioration of Health|3|||
33575523|NCT02544633|62971826|FG001|Treatment Period|Global Deterioration of Health|3|||
33575524|NCT02544633|62971827|FG002|Treatment Period|Global Deterioration of Health|0|||
33575525|NCT02544633|62971828|FG003|Treatment Period|Global Deterioration of Health|1|||
33575526|NCT02544633|62971825|FG000|Treatment Period|Withdrawal by Subject|1|||
33575527|NCT02544633|62971826|FG001|Treatment Period|Withdrawal by Subject|0|||
33575528|NCT02544633|62971827|FG002|Treatment Period|Withdrawal by Subject|0|||
33575529|NCT02544633|62971828|FG003|Treatment Period|Withdrawal by Subject|0|||
33575530|NCT02544633|62971825|FG000|Treatment Period|Lost to Follow-up|0|||
33575531|NCT02544633|62971826|FG001|Treatment Period|Lost to Follow-up|1|||
33575532|NCT02544633|62971827|FG002|Treatment Period|Lost to Follow-up|0|||
33575533|NCT02544633|62971828|FG003|Treatment Period|Lost to Follow-up|0|||
33575534|NCT02544633|62971825|FG000|Treatment Period|Death|0|||
33575535|NCT02544633|62971826|FG001|Treatment Period|Death|0|||
33575536|NCT02544633|62971827|FG002|Treatment Period|Death|1|||
33575537|NCT02544633|62971828|FG003|Treatment Period|Death|0|||
33575538|NCT02544633|62971825|FG000|Treatment Period|Non-compliance|0|||
33575539|NCT02544633|62971826|FG001|Treatment Period|Non-compliance|0|||
33575540|NCT02544633|62971827|FG002|Treatment Period|Non-compliance|1|||
33575541|NCT02544633|62971828|FG003|Treatment Period|Non-compliance|0|||
33575542|NCT02544633|62971825|FG000|Treatment Period|Clinical Disease Progression|0|||
33575543|NCT02544633|62971826|FG001|Treatment Period|Clinical Disease Progression|0|||
33575544|NCT02544633|62971827|FG002|Treatment Period|Clinical Disease Progression|0|||
33575545|NCT02544633|62971828|FG003|Treatment Period|Clinical Disease Progression|1|||
33575546|NCT02544633|62971825|FG000|Survival Follow-up Period|Death|12|||
33575547|NCT02544633|62971826|FG001|Survival Follow-up Period|Death|14|||
33575548|NCT02544633|62971827|FG002|Survival Follow-up Period|Death|3|||
33575549|NCT02544633|62971828|FG003|Survival Follow-up Period|Death|9|||
33575550|NCT02544633|62971825|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
33575551|NCT02544633|62971826|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
33575552|NCT02544633|62971827|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
33575553|NCT02544633|62971828|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
33575554|NCT02544633|62971825|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
33575555|NCT02544633|62971826|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
33575556|NCT02544633|62971827|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
33575557|NCT02544633|62971828|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
33575558|NCT02544633|62971825|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
33575559|NCT02544633|62971826|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
33575560|NCT02544633|62971827|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
33575561|NCT02544633|62971828|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
33575562|NCT02678351|62971850|FG000|Overall Study|Withdrawal by Subject|1|||
33575563|NCT02683187|62971854|FG000|Overall Study|Failed IV access|3|||
33575564|NCT02683187|62971854|FG000|Overall Study|Withdrawal by Subject|5|||
33575565|NCT02683109|62971864|FG000|Overall Study|Adverse Event|1|||
33575566|NCT02683109|62971865|FG001|Overall Study|Adverse Event|0|||
33575567|NCT02544321|62971874|FG000|Overall Study|Withdrawal by Subject|1|||
33575568|NCT02544321|62971875|FG001|Overall Study|Withdrawal by Subject|2|||
33575569|NCT02544321|62971874|FG000|Overall Study|Adverse Event|1|||
33575570|NCT02544321|62971875|FG001|Overall Study|Adverse Event|1|||
33575571|NCT02544321|62971874|FG000|Overall Study|Protocol Violation|0|||
33575572|NCT02544321|62971875|FG001|Overall Study|Protocol Violation|1|||
33575573|NCT02533401|62971890|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
33575574|NCT02533401|62971890|FG000|Overall Study|Death|5|||
33575575|NCT02533401|62971890|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
33575576|NCT02533401|62971890|FG000|Overall Study|Lost to Follow-up|1|||
33575577|NCT02533401|62971890|FG000|Overall Study|Violation of Selection Criteria|1|||
33575578|NCT02536833|62971898|FG000|Overall Study|Discontinued Before Treatment|0|||
33575579|NCT02536833|62971899|FG001|Overall Study|Discontinued Before Treatment|0|||
33575580|NCT02536833|62971900|FG002|Overall Study|Discontinued Before Treatment|1|||
33575581|NCT02536833|62971901|FG003|Overall Study|Discontinued Before Treatment|2|||
33575582|NCT02536833|62971898|FG000|Overall Study|Adverse Event|1|||
33575583|NCT02536833|62971899|FG001|Overall Study|Adverse Event|3|||
33575584|NCT02536833|62971900|FG002|Overall Study|Adverse Event|4|||
33575585|NCT02536833|62971901|FG003|Overall Study|Adverse Event|1|||
33575586|NCT02536833|62971898|FG000|Overall Study|Lost to Follow-up|2|||
33575587|NCT02536833|62971899|FG001|Overall Study|Lost to Follow-up|1|||
33575588|NCT02536833|62971900|FG002|Overall Study|Lost to Follow-up|2|||
33575589|NCT02536833|62971901|FG003|Overall Study|Lost to Follow-up|2|||
33575590|NCT02536833|62971898|FG000|Overall Study|Physician Decision|0|||
33575591|NCT02536833|62971899|FG001|Overall Study|Physician Decision|0|||
33575592|NCT02536833|62971900|FG002|Overall Study|Physician Decision|0|||
33575593|NCT02536833|62971901|FG003|Overall Study|Physician Decision|1|||
33575594|NCT02536833|62971898|FG000|Overall Study|Site Terminated by Sponsor|2|||
33575595|NCT02536833|62971899|FG001|Overall Study|Site Terminated by Sponsor|2|||
33575596|NCT02536833|62971900|FG002|Overall Study|Site Terminated by Sponsor|2|||
33575597|NCT02536833|62971901|FG003|Overall Study|Site Terminated by Sponsor|2|||
33575598|NCT02536833|62971898|FG000|Overall Study|Subject Non-Compliance|0|||
33575599|NCT02536833|62971899|FG001|Overall Study|Subject Non-Compliance|1|||
33575600|NCT02536833|62971900|FG002|Overall Study|Subject Non-Compliance|1|||
33575601|NCT02536833|62971901|FG003|Overall Study|Subject Non-Compliance|0|||
33575602|NCT02536833|62971898|FG000|Overall Study|Withdrawal by Subject|4|||
33575603|NCT02536833|62971899|FG001|Overall Study|Withdrawal by Subject|3|||
33575604|NCT02536833|62971900|FG002|Overall Study|Withdrawal by Subject|5|||
33575605|NCT02536833|62971901|FG003|Overall Study|Withdrawal by Subject|11|||
33575606|NCT02680847|62971915|FG000|Overall Study|Other|2|||
33575607|NCT02680847|62971916|FG001|Overall Study|Other|0|||
33575608|NCT02680847|62971917|FG002|Overall Study|Other|0|||
33575609|NCT02680847|62971915|FG000|Overall Study|No longer met eligibility criteria|2|||
33575610|NCT02680847|62971916|FG001|Overall Study|No longer met eligibility criteria|2|||
33575611|NCT02680847|62971917|FG002|Overall Study|No longer met eligibility criteria|0|||
33575612|NCT02680847|62971915|FG000|Overall Study|Unwilling to participate in study|1|||
33575613|NCT02680847|62971916|FG001|Overall Study|Unwilling to participate in study|1|||
33575614|NCT02680847|62971917|FG002|Overall Study|Unwilling to participate in study|0|||
33575615|NCT02680847|62971915|FG000|Overall Study|Lack of Efficacy|0|||
33575616|NCT02680847|62971916|FG001|Overall Study|Lack of Efficacy|0|||
33575617|NCT02680847|62971917|FG002|Overall Study|Lack of Efficacy|2|||
33575618|NCT02680847|62971915|FG000|Overall Study|Adverse Event|0|||
33575619|NCT02680847|62971916|FG001|Overall Study|Adverse Event|0|||
33575620|NCT02680847|62971917|FG002|Overall Study|Adverse Event|1|||
33575621|NCT02532855|62971927|FG000|Overall Study|Lost to Follow-up|4|||
33575622|NCT02532855|62971928|FG001|Overall Study|Lost to Follow-up|3|||
33575623|NCT02532855|62971927|FG000|Overall Study|Withdrawal by Subject|4|||
33575624|NCT02532855|62971928|FG001|Overall Study|Withdrawal by Subject|8|||
33575625|NCT02530125|62971934|FG000|Completed Treatment|Early termination of study|1|||
33575626|NCT02530125|62971934|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
33575627|NCT01661205|62971938|FG000|Overall Study|Physician Decision|2|||
33575628|NCT02055820|62971952|FG000|Phase I: Dose-Finding|Death|1|||
33575629|NCT02055820|62971953|FG001|Phase I: Dose-Finding|Death|0|||
33575630|NCT02055820|62971954|FG002|Phase I: Dose-Finding|Death|1|||
33575631|NCT02055820|62971955|FG003|Phase I: Dose-Finding|Death|2|||
33575632|NCT02055820|62971956|FG004|Phase I: Dose-Finding|Death|0|||
33575633|NCT02055820|62971957|FG005|Phase I: Dose-Finding|Death|1|||
33575634|NCT02055820|62971958|FG006|Phase I: Dose-Finding|Death|1|||
33575635|NCT02055820|62971959|FG007|Phase I: Dose-Finding|Death|0|||
33575636|NCT02055820|62971960|FG008|Phase I: Dose-Finding|Death|0|||
33575637|NCT02055820|62971961|FG009|Phase I: Dose-Finding|Death|0|||
33575638|NCT02055820|62971952|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33575639|NCT02055820|62971953|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33575640|NCT02055820|62971954|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33575641|NCT02055820|62971955|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33575642|NCT02055820|62971956|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33575643|NCT02055820|62971957|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
33575644|NCT02055820|62971958|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33575645|NCT02055820|62971959|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33575646|NCT02055820|62971960|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33575647|NCT02055820|62971961|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33575648|NCT02055820|62971952|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
33575649|NCT02055820|62971953|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
33575650|NCT02055820|62971954|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
33575651|NCT02055820|62971955|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
33575652|NCT02055820|62971956|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
33575653|NCT02055820|62971957|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
33575654|NCT02055820|62971958|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
33575655|NCT02055820|62971959|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
33575656|NCT02055820|62971960|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
33575657|NCT02055820|62971961|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
33575658|NCT02055820|62971952|FG000|Phase II: Expansion|Death|0|||
33575659|NCT02055820|62971953|FG001|Phase II: Expansion|Death|0|||
33575660|NCT02055820|62971954|FG002|Phase II: Expansion|Death|0|||
33575661|NCT02055820|62971955|FG003|Phase II: Expansion|Death|0|||
33575662|NCT02055820|62971956|FG004|Phase II: Expansion|Death|33|||
33575663|NCT02055820|62971957|FG005|Phase II: Expansion|Death|0|||
33575664|NCT02055820|62971958|FG006|Phase II: Expansion|Death|0|||
33575665|NCT02055820|62971959|FG007|Phase II: Expansion|Death|0|||
33575666|NCT02055820|62971960|FG008|Phase II: Expansion|Death|0|||
33575667|NCT02055820|62971961|FG009|Phase II: Expansion|Death|0|||
33575668|NCT02055820|62971952|FG000|Phase II: Expansion|Lost to Follow-up|0|||
33575669|NCT02055820|62971953|FG001|Phase II: Expansion|Lost to Follow-up|0|||
33575670|NCT02055820|62971954|FG002|Phase II: Expansion|Lost to Follow-up|0|||
33575671|NCT02055820|62971955|FG003|Phase II: Expansion|Lost to Follow-up|0|||
33575672|NCT02055820|62971956|FG004|Phase II: Expansion|Lost to Follow-up|4|||
33575673|NCT02055820|62971957|FG005|Phase II: Expansion|Lost to Follow-up|0|||
33575674|NCT02055820|62971958|FG006|Phase II: Expansion|Lost to Follow-up|0|||
33664437|NCT01529645|63095498|FG008|Overall Study|SAE - Premature contractions|0|||
33664438|NCT01529645|63095499|FG009|Overall Study|SAE - Premature contractions|0|||
33664439|NCT01529645|63095490|FG000|Overall Study|Withdrawal by Subject|2|||
33664440|NCT01529645|63095491|FG001|Overall Study|Withdrawal by Subject|0|||
33664441|NCT01529645|63095492|FG002|Overall Study|Withdrawal by Subject|0|||
33664442|NCT01529645|63095493|FG003|Overall Study|Withdrawal by Subject|1|||
33575675|NCT02055820|62971959|FG007|Phase II: Expansion|Lost to Follow-up|0|||
33575676|NCT02055820|62971960|FG008|Phase II: Expansion|Lost to Follow-up|0|||
33575677|NCT02055820|62971961|FG009|Phase II: Expansion|Lost to Follow-up|0|||
33575678|NCT02055820|62971952|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
33575679|NCT02055820|62971953|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
33575680|NCT02055820|62971954|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
33575681|NCT02055820|62971955|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
33575682|NCT02055820|62971956|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
33575683|NCT02055820|62971957|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
33575684|NCT02055820|62971958|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
33575685|NCT02055820|62971959|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
33575686|NCT02055820|62971960|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
33575687|NCT02055820|62971961|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
33575688|NCT02055352|62972005|FG000|Overall Study|Adverse Event|0|||
33575689|NCT02055352|62972006|FG001|Overall Study|Adverse Event|1|||
33575690|NCT02055352|62972005|FG000|Overall Study|Non-eligible|0|||
33575691|NCT02055352|62972006|FG001|Overall Study|Non-eligible|1|||
33575692|NCT02055352|62972005|FG000|Overall Study|Poor compliance|1|||
33575693|NCT02055352|62972006|FG001|Overall Study|Poor compliance|1|||
33575694|NCT02055352|62972005|FG000|Overall Study|Death|1|||
33664443|NCT01529645|63095494|FG004|Overall Study|Withdrawal by Subject|1|||
33575695|NCT02055352|62972006|FG001|Overall Study|Death|2|||
33664444|NCT01529645|63095495|FG005|Overall Study|Withdrawal by Subject|1|||
33664445|NCT01529645|63095496|FG006|Overall Study|Withdrawal by Subject|0|||
33664446|NCT01529645|63095497|FG007|Overall Study|Withdrawal by Subject|0|||
33664447|NCT01529645|63095498|FG008|Overall Study|Withdrawal by Subject|0|||
33664448|NCT01529645|63095499|FG009|Overall Study|Withdrawal by Subject|0|||
33664449|NCT01528787|63095533|FG000|Overall Study|Withdrawal by Subject|0|||
33664450|NCT01528787|63095534|FG001|Overall Study|Withdrawal by Subject|0|||
33664451|NCT01528787|63095535|FG002|Overall Study|Withdrawal by Subject|0|||
33664452|NCT01528787|63095536|FG003|Overall Study|Withdrawal by Subject|1|||
33664453|NCT01528787|63095533|FG000|Overall Study|Family Emergency|0|||
33664454|NCT01528787|63095534|FG001|Overall Study|Family Emergency|0|||
33664455|NCT01528787|63095535|FG002|Overall Study|Family Emergency|1|||
33664456|NCT01528787|63095536|FG003|Overall Study|Family Emergency|0|||
33664457|NCT01528709|63095548|FG000|Overall Study|Death|2|||
33664458|NCT01528709|63095549|FG001|Overall Study|Death|0|||
33664459|NCT01528709|63095548|FG000|Overall Study|Withdrawal by Subject|10|||
33664460|NCT01528709|63095549|FG001|Overall Study|Withdrawal by Subject|15|||
33664461|NCT01528709|63095548|FG000|Overall Study|allergy|1|||
33664462|NCT01528709|63095549|FG001|Overall Study|allergy|0|||
33664463|NCT01527383|63095557|FG000|Overall Study|Adverse Event|5|||
33664464|NCT01527383|63095558|FG001|Overall Study|Adverse Event|0|||
33664465|NCT01527383|63095557|FG000|Overall Study|Lost to Follow-up|3|||
33664466|NCT01527383|63095558|FG001|Overall Study|Lost to Follow-up|0|||
33664467|NCT01527383|63095557|FG000|Overall Study|Physician Decision|2|||
33664468|NCT01527383|63095558|FG001|Overall Study|Physician Decision|0|||
33664469|NCT01527383|63095557|FG000|Overall Study|Pregnancy|1|||
33664470|NCT01527383|63095558|FG001|Overall Study|Pregnancy|0|||
33664471|NCT01527383|63095557|FG000|Overall Study|Protocol Violation|1|||
33664472|NCT01527383|63095558|FG001|Overall Study|Protocol Violation|0|||
33664473|NCT01527383|63095557|FG000|Overall Study|Screen failure|1|||
33664474|NCT01527383|63095558|FG001|Overall Study|Screen failure|0|||
33664475|NCT01527383|63095557|FG000|Overall Study|Participant moved|0|||
33664476|NCT01527383|63095558|FG001|Overall Study|Participant moved|1|||
33664477|NCT01527383|63095557|FG000|Overall Study|Withdrawal by Subject|2|||
33664478|NCT01527383|63095558|FG001|Overall Study|Withdrawal by Subject|3|||
33664479|NCT01526057|63095567|FG000|Overall Study|Withdrawal by Subject|3|||
33664480|NCT01526057|63095568|FG001|Overall Study|Withdrawal by Subject|2|||
33664481|NCT01526057|63095569|FG002|Overall Study|Withdrawal by Subject|2|||
33664482|NCT01526057|63095567|FG000|Overall Study|Adverse Event|3|||
33664483|NCT01526057|63095568|FG001|Overall Study|Adverse Event|1|||
33664484|NCT01526057|63095569|FG002|Overall Study|Adverse Event|1|||
33664485|NCT01526057|63095567|FG000|Overall Study|Death|1|||
33664486|NCT01526057|63095568|FG001|Overall Study|Death|0|||
33664487|NCT01526057|63095569|FG002|Overall Study|Death|0|||
33302914|NCT01282866|62678806|FG000|Overall Study|Adverse Event|1|||
33302915|NCT01071070|62678812|FG000|Overall Study|Adverse Event|0|||
33302916|NCT01071070|62678813|FG001|Overall Study|Adverse Event|3|||
33575696|NCT02055352|62972005|FG000|Overall Study|Patient decision|1|||
33575697|NCT02055352|62972006|FG001|Overall Study|Patient decision|1|||
33575698|NCT02055352|62972005|FG000|Overall Study|Use of prohibited treatment|0|||
33575699|NCT02055352|62972006|FG001|Overall Study|Use of prohibited treatment|3|||
33575700|NCT02055352|62972005|FG000|Overall Study|AE, study drug would be detrimental|1|||
33575701|NCT02055352|62972006|FG001|Overall Study|AE, study drug would be detrimental|3|||
33575702|NCT02055352|62972005|FG000|Overall Study|Withdrawal of informed consent|1|||
33575703|NCT02055352|62972006|FG001|Overall Study|Withdrawal of informed consent|0|||
33575704|NCT02055352|62972005|FG000|Overall Study|Reason unknown|1|||
33575705|NCT02055352|62972006|FG001|Overall Study|Reason unknown|5|||
33575706|NCT02034916|62972014|FG000|Overall Study|Death|39|||
33575707|NCT02034916|62972015|FG001|Overall Study|Death|28|||
33575708|NCT02034916|62972014|FG000|Overall Study|Withdrawal by Subject|2|||
33664488|NCT01526057|63095567|FG000|Overall Study|Lost to Follow-up|1|||
33664489|NCT01526057|63095568|FG001|Overall Study|Lost to Follow-up|0|||
33664490|NCT01526057|63095569|FG002|Overall Study|Lost to Follow-up|1|||
33664491|NCT01526057|63095567|FG000|Overall Study|Other|1|||
33664492|NCT01526057|63095568|FG001|Overall Study|Other|0|||
33664493|NCT01526057|63095569|FG002|Overall Study|Other|1|||
33664494|NCT01526057|63095567|FG000|Overall Study|Protocol Violation|0|||
33664495|NCT01526057|63095568|FG001|Overall Study|Protocol Violation|0|||
33664496|NCT01526057|63095569|FG002|Overall Study|Protocol Violation|1|||
33664497|NCT01525901|63095581|FG000|Period 2: 12 Weeks|Adverse Event|0|||
33664498|NCT01525901|63095582|FG001|Period 2: 12 Weeks|Adverse Event|1|||
33664499|NCT01525901|63095583|FG002|Period 2: 12 Weeks|Adverse Event|0|||
33664500|NCT01525901|63095584|FG003|Period 2: 12 Weeks|Adverse Event|0|||
33664501|NCT01525589|63095697|FG000|Overall Study|Non-treatment-related AE|1|||
33664502|NCT01525589|63095698|FG001|Overall Study|Non-treatment-related AE|0|||
33664503|NCT01525589|63095699|FG002|Overall Study|Non-treatment-related AE|0|||
33664504|NCT01525589|63095697|FG000|Overall Study|Progressive disease|48|||
33664505|NCT01525589|63095698|FG001|Overall Study|Progressive disease|15|||
33664506|NCT01525589|63095699|FG002|Overall Study|Progressive disease|29|||
33664507|NCT01525589|63095697|FG000|Overall Study|Never treated|2|||
33664508|NCT01525589|63095698|FG001|Overall Study|Never treated|0|||
33664509|NCT01525589|63095699|FG002|Overall Study|Never treated|0|||
33664510|NCT01525589|63095697|FG000|Overall Study|Physician Decision|4|||
33664511|NCT01525589|63095698|FG001|Overall Study|Physician Decision|2|||
33664512|NCT01525589|63095699|FG002|Overall Study|Physician Decision|2|||
33664513|NCT01525589|63095697|FG000|Overall Study|Death|0|||
33664514|NCT01525589|63095698|FG001|Overall Study|Death|0|||
33664515|NCT01525589|63095699|FG002|Overall Study|Death|2|||
33664516|NCT01525589|63095697|FG000|Overall Study|Treatment-related AE|1|||
33664517|NCT01525589|63095698|FG001|Overall Study|Treatment-related AE|1|||
33664518|NCT01525589|63095699|FG002|Overall Study|Treatment-related AE|2|||
33664519|NCT01525589|63095697|FG000|Overall Study|Other reasons|0|||
33664520|NCT01525589|63095698|FG001|Overall Study|Other reasons|1|||
33664521|NCT01525589|63095699|FG002|Overall Study|Other reasons|0|||
33664522|NCT01525589|63095697|FG000|Overall Study|Withdrawal by Subject|0|||
33664523|NCT01525589|63095698|FG001|Overall Study|Withdrawal by Subject|1|||
33664524|NCT01525589|63095699|FG002|Overall Study|Withdrawal by Subject|0|||
33664525|NCT01524887|63095710|FG000|Overall Study|Withdrawal by Subject|6|||
33664526|NCT01524887|63095711|FG001|Overall Study|Withdrawal by Subject|2|||
33664527|NCT01524887|63095712|FG002|Overall Study|Withdrawal by Subject|3|||
33664528|NCT01524887|63095710|FG000|Overall Study|Adverse Event|5|||
33664529|NCT01524887|63095711|FG001|Overall Study|Adverse Event|1|||
33664530|NCT01524887|63095712|FG002|Overall Study|Adverse Event|1|||
33664531|NCT01524887|63095710|FG000|Overall Study|Protocol Violation|0|||
33664532|NCT01524887|63095711|FG001|Overall Study|Protocol Violation|0|||
33664533|NCT01524887|63095712|FG002|Overall Study|Protocol Violation|1|||
33664534|NCT01524887|63095710|FG000|Overall Study|Study termination|73|||
33664535|NCT01524887|63095711|FG001|Overall Study|Study termination|87|||
33664536|NCT01524887|63095712|FG002|Overall Study|Study termination|79|||
33664537|NCT01524887|63095710|FG000|Overall Study|Withdrawal by Caregiver|0|||
33664538|NCT01524887|63095711|FG001|Overall Study|Withdrawal by Caregiver|0|||
33664539|NCT01524887|63095712|FG002|Overall Study|Withdrawal by Caregiver|2|||
33664540|NCT01524887|63095710|FG000|Overall Study|Use of prohibited medication|1|||
33664541|NCT01524887|63095711|FG001|Overall Study|Use of prohibited medication|0|||
33664542|NCT01524887|63095712|FG002|Overall Study|Use of prohibited medication|0|||
33664543|NCT01523873|63095738|FG000|Overall Study|Protocol Violation|422|||
33664544|NCT01522235|63095763|FG000|Overall Study|Physician Decision|1|||
33664545|NCT01522235|63095764|FG001|Overall Study|Physician Decision|1|||
33664546|NCT01521923|63095801|FG000|Overall Study|AE, serious fatal|1|||
33664547|NCT01521923|63095802|FG001|Overall Study|AE, serious fatal|0|||
33664548|NCT01521923|63095803|FG002|Overall Study|AE, serious fatal|0|||
33302917|NCT01071070|62678812|FG000|Overall Study|Withdrawal by Subject|1|||
33575709|NCT02034916|62972015|FG001|Overall Study|Withdrawal by Subject|1|||
33575710|NCT02034916|62972014|FG000|Overall Study|Lost to Follow-up|4|||
33575711|NCT02034916|62972015|FG001|Overall Study|Lost to Follow-up|1|||
33575712|NCT02034916|62972014|FG000|Overall Study|Study terminated by sponsor|4|||
33575713|NCT02034916|62972015|FG001|Overall Study|Study terminated by sponsor|5|||
33575714|NCT01374425|62972024|FG000|Overall Study|Radiographic Disease Progression|86|||
33575715|NCT01374425|62972025|FG001|Overall Study|Radiographic Disease Progression|81|||
33575716|NCT01374425|62972024|FG000|Overall Study|Clinical Disease Progression|9|||
33575717|NCT01374425|62972025|FG001|Overall Study|Clinical Disease Progression|6|||
33575718|NCT01374425|62972024|FG000|Overall Study|Adverse Event|29|||
33575719|NCT01374425|62972025|FG001|Overall Study|Adverse Event|18|||
33575720|NCT01374425|62972024|FG000|Overall Study|Death (Progression of Disease)|1|||
33575721|NCT01374425|62972025|FG001|Overall Study|Death (Progression of Disease)|0|||
33575722|NCT01374425|62972024|FG000|Overall Study|Death (Adverse Event)|2|||
33575723|NCT01374425|62972025|FG001|Overall Study|Death (Adverse Event)|4|||
33664549|NCT01521923|63095804|FG003|Overall Study|AE, serious fatal|0|||
33664550|NCT01521923|63095801|FG000|Overall Study|SAE, non-fatal|0|||
33664551|NCT01521923|63095802|FG001|Overall Study|SAE, non-fatal|2|||
33664552|NCT01521923|63095803|FG002|Overall Study|SAE, non-fatal|2|||
33664553|NCT01521923|63095804|FG003|Overall Study|SAE, non-fatal|0|||
33664554|NCT01521923|63095801|FG000|Overall Study|AE, non-serious, non-fatal|1|||
33664555|NCT01521923|63095802|FG001|Overall Study|AE, non-serious, non-fatal|3|||
33664556|NCT01521923|63095803|FG002|Overall Study|AE, non-serious, non-fatal|6|||
33664557|NCT01521923|63095804|FG003|Overall Study|AE, non-serious, non-fatal|2|||
33664558|NCT01521923|63095801|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
33664559|NCT01521923|63095802|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
33664560|NCT01521923|63095803|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
33664561|NCT01521923|63095804|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
33664562|NCT01521923|63095801|FG000|Overall Study|Lack of Efficacy|1|||
33664563|NCT01521923|63095802|FG001|Overall Study|Lack of Efficacy|1|||
33664564|NCT01521923|63095803|FG002|Overall Study|Lack of Efficacy|0|||
33664565|NCT01521923|63095804|FG003|Overall Study|Lack of Efficacy|0|||
33664566|NCT01521923|63095801|FG000|Overall Study|Protocol Violation|0|||
33664567|NCT01521923|63095802|FG001|Overall Study|Protocol Violation|0|||
33664568|NCT01521923|63095803|FG002|Overall Study|Protocol Violation|1|||
33664569|NCT01521923|63095804|FG003|Overall Study|Protocol Violation|0|||
33664570|NCT01521923|63095801|FG000|Overall Study|Lost to Follow-up|1|||
33664571|NCT01521923|63095802|FG001|Overall Study|Lost to Follow-up|0|||
33664572|NCT01521923|63095803|FG002|Overall Study|Lost to Follow-up|2|||
33664573|NCT01521923|63095804|FG003|Overall Study|Lost to Follow-up|1|||
33664574|NCT01521923|63095801|FG000|Overall Study|Withdrawal by Subject|1|||
33664575|NCT01521923|63095802|FG001|Overall Study|Withdrawal by Subject|1|||
33664576|NCT01521923|63095803|FG002|Overall Study|Withdrawal by Subject|1|||
33664577|NCT01521923|63095804|FG003|Overall Study|Withdrawal by Subject|2|||
33664578|NCT01521923|63095801|FG000|Overall Study|Other|2|||
33664579|NCT01521923|63095802|FG001|Overall Study|Other|1|||
33664580|NCT01521923|63095803|FG002|Overall Study|Other|3|||
33664581|NCT01521923|63095804|FG003|Overall Study|Other|6|||
33664582|NCT01521923|63095801|FG000|Overall Study|AE, captured in Period 1|0|||
33664583|NCT01521923|63095802|FG001|Overall Study|AE, captured in Period 1|1|||
33664584|NCT01521923|63095803|FG002|Overall Study|AE, captured in Period 1|0|||
33664585|NCT01521923|63095804|FG003|Overall Study|AE, captured in Period 1|1|||
33664586|NCT01520987|63095928|FG000|Overall Study|Withdrawal by Subject|1|||
33664587|NCT01520987|63095929|FG001|Overall Study|Withdrawal by Subject|0|||
33664588|NCT01520987|63095930|FG002|Overall Study|Withdrawal by Subject|0|||
33664589|NCT01520987|63095931|FG003|Overall Study|Withdrawal by Subject|0|||
33664590|NCT01520987|63095932|FG004|Overall Study|Withdrawal by Subject|0|||
33664591|NCT01520987|63095933|FG005|Overall Study|Withdrawal by Subject|1|||
33664592|NCT01520987|63095934|FG006|Overall Study|Withdrawal by Subject|0|||
33575724|NCT01374425|62972024|FG000|Overall Study|Withdrawal by Subject|6|||
33575725|NCT01374425|62972025|FG001|Overall Study|Withdrawal by Subject|7|||
33575726|NCT01374425|62972024|FG000|Overall Study|Refused Treatment|10|||
33575727|NCT01374425|62972025|FG001|Overall Study|Refused Treatment|24|||
33575728|NCT01374425|62972024|FG000|Overall Study|Protocol Violation|2|||
33575729|NCT01374425|62972025|FG001|Overall Study|Protocol Violation|3|||
33664593|NCT01520987|63095935|FG007|Overall Study|Withdrawal by Subject|0|||
33664594|NCT01562275|63096009|FG000|Stage 1|Adverse Event|0|||
33664595|NCT01562275|63096010|FG001|Stage 1|Adverse Event|0|||
33664596|NCT01562275|63096011|FG002|Stage 1|Adverse Event|0|||
33664597|NCT01562275|63096012|FG003|Stage 1|Adverse Event|1|||
33664598|NCT01562275|63096013|FG004|Stage 1|Adverse Event|1|||
33396793|NCT00672620|62776051|FG003|Overall Study|Lack of Efficacy|0|||
33396794|NCT00672620|62776048|FG000|Overall Study|Noncompliance with Study Drug|3|||
33396795|NCT00672620|62776049|FG001|Overall Study|Noncompliance with Study Drug|4|||
33575730|NCT01374425|62972024|FG000|Overall Study|Sponsor Decision|0|||
33575731|NCT01374425|62972025|FG001|Overall Study|Sponsor Decision|1|||
33302918|NCT01071070|62678813|FG001|Overall Study|Withdrawal by Subject|0|||
33396796|NCT00672620|62776050|FG002|Overall Study|Noncompliance with Study Drug|0|||
33396797|NCT00672620|62776051|FG003|Overall Study|Noncompliance with Study Drug|2|||
33575732|NCT01374425|62972024|FG000|Overall Study|Lost to Follow-up|2|||
33575733|NCT01374425|62972025|FG001|Overall Study|Lost to Follow-up|1|||
33575734|NCT01374425|62972024|FG000|Overall Study|Other|41|||
33575735|NCT01374425|62972025|FG001|Overall Study|Other|43|||
33575736|NCT02085460|62972055|FG000|Overall Study|Adverse Event|2|||
33575737|NCT02085460|62972056|FG001|Overall Study|Adverse Event|2|||
33575738|NCT02085460|62972057|FG002|Overall Study|Adverse Event|1|||
33575739|NCT02085460|62972055|FG000|Overall Study|Physician Decision|1|||
33575740|NCT02085460|62972056|FG001|Overall Study|Physician Decision|1|||
33575741|NCT02085460|62972057|FG002|Overall Study|Physician Decision|2|||
33575742|NCT02085460|62972055|FG000|Overall Study|Withdrawal by Subject|11|||
33575743|NCT02085460|62972056|FG001|Overall Study|Withdrawal by Subject|5|||
33575744|NCT02085460|62972057|FG002|Overall Study|Withdrawal by Subject|7|||
33575745|NCT02084134|62972067|FG000|Overall Study|Protocol Violation|4|||
33575746|NCT02084134|62972068|FG001|Overall Study|Protocol Violation|2|||
33575747|NCT02084134|62972067|FG000|Overall Study|Death|0|||
33575748|NCT02084134|62972068|FG001|Overall Study|Death|1|||
33575749|NCT02034058|62972074|FG000|Overall Study|Death|3|||
33575750|NCT01374269|62972080|FG000|Overall Study|Withdrawal by Subject|4|||
33575751|NCT01374269|62972081|FG001|Overall Study|Withdrawal by Subject|0|||
33575752|NCT01374269|62972080|FG000|Overall Study|Lost to Follow-up|1|||
33664599|NCT01562275|63096014|FG005|Stage 1|Adverse Event|0|||
33664600|NCT01562275|63096015|FG006|Stage 1|Adverse Event|0|||
33664601|NCT01562275|63096016|FG007|Stage 1|Adverse Event|0|||
33664602|NCT01562275|63096017|FG008|Stage 1|Adverse Event|0|||
33664603|NCT01562275|63096018|FG009|Stage 1|Adverse Event|1|||
33664604|NCT01562275|63096019|FG010|Stage 1|Adverse Event|0|||
33664605|NCT01562275|63096020|FG011|Stage 1|Adverse Event|0|||
33664606|NCT01562275|63096021|FG012|Stage 1|Adverse Event|0|||
33575753|NCT01374269|62972081|FG001|Overall Study|Lost to Follow-up|3|||
33575754|NCT01374269|62972080|FG000|Overall Study|closed research|1|||
33575755|NCT01374269|62972081|FG001|Overall Study|closed research|2|||
33575756|NCT02679755|62972089|FG000|Overall Study|Death|0|||
33575757|NCT02679755|62972090|FG001|Overall Study|Death|3|||
33575758|NCT02679755|62972089|FG000|Overall Study|Global deterioration of health status|1|||
33575759|NCT02679755|62972090|FG001|Overall Study|Global deterioration of health status|8|||
33664607|NCT01562275|63096009|FG000|Stage 1|Death|1|||
33664608|NCT01562275|63096010|FG001|Stage 1|Death|0|||
33664609|NCT01562275|63096011|FG002|Stage 1|Death|0|||
33664610|NCT01562275|63096012|FG003|Stage 1|Death|0|||
33664611|NCT01562275|63096013|FG004|Stage 1|Death|0|||
33664612|NCT01562275|63096014|FG005|Stage 1|Death|0|||
33664613|NCT01562275|63096015|FG006|Stage 1|Death|0|||
33664614|NCT01562275|63096016|FG007|Stage 1|Death|0|||
33664615|NCT01562275|63096017|FG008|Stage 1|Death|0|||
33664616|NCT01562275|63096018|FG009|Stage 1|Death|0|||
33664617|NCT01562275|63096019|FG010|Stage 1|Death|0|||
33664618|NCT01562275|63096020|FG011|Stage 1|Death|0|||
33664619|NCT01562275|63096021|FG012|Stage 1|Death|0|||
33664620|NCT01562275|63096009|FG000|Stage 1|Non Compliance|0|||
33664621|NCT01562275|63096010|FG001|Stage 1|Non Compliance|0|||
33664622|NCT01562275|63096011|FG002|Stage 1|Non Compliance|1|||
33664623|NCT01562275|63096012|FG003|Stage 1|Non Compliance|0|||
33664624|NCT01562275|63096013|FG004|Stage 1|Non Compliance|0|||
33664625|NCT01562275|63096014|FG005|Stage 1|Non Compliance|0|||
33664626|NCT01562275|63096015|FG006|Stage 1|Non Compliance|0|||
33664627|NCT01562275|63096016|FG007|Stage 1|Non Compliance|0|||
33664628|NCT01562275|63096017|FG008|Stage 1|Non Compliance|0|||
33664629|NCT01562275|63096018|FG009|Stage 1|Non Compliance|0|||
33664630|NCT01562275|63096019|FG010|Stage 1|Non Compliance|0|||
33664631|NCT01562275|63096020|FG011|Stage 1|Non Compliance|0|||
33664632|NCT01562275|63096021|FG012|Stage 1|Non Compliance|0|||
33664633|NCT01562275|63096009|FG000|Stage 1|Physician Decision|0|||
33664634|NCT01562275|63096010|FG001|Stage 1|Physician Decision|0|||
33664635|NCT01562275|63096011|FG002|Stage 1|Physician Decision|0|||
33664636|NCT01562275|63096012|FG003|Stage 1|Physician Decision|0|||
33664637|NCT01562275|63096013|FG004|Stage 1|Physician Decision|1|||
33664638|NCT01562275|63096014|FG005|Stage 1|Physician Decision|0|||
33664639|NCT01562275|63096015|FG006|Stage 1|Physician Decision|1|||
33664640|NCT01562275|63096016|FG007|Stage 1|Physician Decision|0|||
33664641|NCT01562275|63096017|FG008|Stage 1|Physician Decision|1|||
33664642|NCT01562275|63096018|FG009|Stage 1|Physician Decision|0|||
33664643|NCT01562275|63096019|FG010|Stage 1|Physician Decision|0|||
33664644|NCT01562275|63096020|FG011|Stage 1|Physician Decision|0|||
33664645|NCT01562275|63096021|FG012|Stage 1|Physician Decision|0|||
33664646|NCT01562275|63096009|FG000|Stage 1|Progression of Disease|2|||
33664647|NCT01562275|63096010|FG001|Stage 1|Progression of Disease|6|||
33664648|NCT01562275|63096011|FG002|Stage 1|Progression of Disease|2|||
33664649|NCT01562275|63096012|FG003|Stage 1|Progression of Disease|1|||
33664650|NCT01562275|63096013|FG004|Stage 1|Progression of Disease|2|||
33664651|NCT01562275|63096014|FG005|Stage 1|Progression of Disease|4|||
33664652|NCT01562275|63096015|FG006|Stage 1|Progression of Disease|1|||
33664653|NCT01562275|63096016|FG007|Stage 1|Progression of Disease|7|||
33664654|NCT01562275|63096017|FG008|Stage 1|Progression of Disease|2|||
33664655|NCT01562275|63096018|FG009|Stage 1|Progression of Disease|5|||
33664656|NCT01562275|63096019|FG010|Stage 1|Progression of Disease|3|||
33575760|NCT02679755|62972089|FG000|Overall Study|Lost to Follow-up|1|||
33575761|NCT02679755|62972090|FG001|Overall Study|Lost to Follow-up|0|||
33575762|NCT02679755|62972089|FG000|Overall Study|Objective progression or relapse|24|||
33575763|NCT02679755|62972090|FG001|Overall Study|Objective progression or relapse|83|||
33575764|NCT02679755|62972089|FG000|Overall Study|Not defined|0|||
33575765|NCT02679755|62972090|FG001|Overall Study|Not defined|2|||
33575766|NCT02679755|62972089|FG000|Overall Study|Withdrawal by participant|6|||
33575767|NCT02679755|62972090|FG001|Overall Study|Withdrawal by participant|3|||
33575768|NCT02679755|62972089|FG000|Overall Study|Adverse Event|1|||
33575769|NCT02679755|62972090|FG001|Overall Study|Adverse Event|4|||
33575770|NCT02679755|62972089|FG000|Overall Study|Adverse events not related to study drug|1|||
33575771|NCT02679755|62972090|FG001|Overall Study|Adverse events not related to study drug|2|||
33575772|NCT02675075|62972101|FG000|Overall Study|Lost to Follow-up|3|||
33664657|NCT01562275|63096020|FG011|Stage 1|Progression of Disease|0|||
33664658|NCT01562275|63096021|FG012|Stage 1|Progression of Disease|0|||
33664659|NCT01562275|63096009|FG000|Stage 1|Withdrawal by Subject|0|||
33664660|NCT01562275|63096010|FG001|Stage 1|Withdrawal by Subject|1|||
33664661|NCT01562275|63096011|FG002|Stage 1|Withdrawal by Subject|0|||
33664662|NCT01562275|63096012|FG003|Stage 1|Withdrawal by Subject|2|||
33664663|NCT01562275|63096013|FG004|Stage 1|Withdrawal by Subject|0|||
33664664|NCT01562275|63096014|FG005|Stage 1|Withdrawal by Subject|0|||
33664665|NCT01562275|63096015|FG006|Stage 1|Withdrawal by Subject|1|||
33664666|NCT01562275|63096016|FG007|Stage 1|Withdrawal by Subject|0|||
33664667|NCT01562275|63096017|FG008|Stage 1|Withdrawal by Subject|0|||
33664668|NCT01562275|63096018|FG009|Stage 1|Withdrawal by Subject|1|||
33664669|NCT01562275|63096019|FG010|Stage 1|Withdrawal by Subject|0|||
33575773|NCT02675075|62972102|FG001|Overall Study|Lost to Follow-up|0|||
33575774|NCT02673515|62972112|FG000|Overall Study|Lack of motivation|2|||
33664670|NCT01562275|63096020|FG011|Stage 1|Withdrawal by Subject|0|||
33664671|NCT01562275|63096021|FG012|Stage 1|Withdrawal by Subject|0|||
33664672|NCT01562275|63096009|FG000|Stage 2|Death|0|||
33664673|NCT01562275|63096010|FG001|Stage 2|Death|0|||
33664674|NCT01562275|63096011|FG002|Stage 2|Death|0|||
33664675|NCT01562275|63096012|FG003|Stage 2|Death|0|||
33664676|NCT01562275|63096013|FG004|Stage 2|Death|0|||
33664677|NCT01562275|63096014|FG005|Stage 2|Death|0|||
33664678|NCT01562275|63096015|FG006|Stage 2|Death|0|||
33664679|NCT01562275|63096016|FG007|Stage 2|Death|0|||
33664680|NCT01562275|63096017|FG008|Stage 2|Death|0|||
33664681|NCT01562275|63096018|FG009|Stage 2|Death|0|||
33664682|NCT01562275|63096019|FG010|Stage 2|Death|0|||
33664683|NCT01562275|63096020|FG011|Stage 2|Death|2|||
33664684|NCT01562275|63096021|FG012|Stage 2|Death|1|||
33664685|NCT01562275|63096009|FG000|Stage 2|Progression of Disease|0|||
33664686|NCT01562275|63096010|FG001|Stage 2|Progression of Disease|0|||
33664687|NCT01562275|63096011|FG002|Stage 2|Progression of Disease|0|||
33664688|NCT01562275|63096012|FG003|Stage 2|Progression of Disease|0|||
33664689|NCT01562275|63096013|FG004|Stage 2|Progression of Disease|0|||
33664690|NCT01562275|63096014|FG005|Stage 2|Progression of Disease|0|||
33664691|NCT01562275|63096015|FG006|Stage 2|Progression of Disease|0|||
33664692|NCT01562275|63096016|FG007|Stage 2|Progression of Disease|0|||
33664693|NCT01562275|63096017|FG008|Stage 2|Progression of Disease|0|||
33664694|NCT01562275|63096018|FG009|Stage 2|Progression of Disease|0|||
33664695|NCT01562275|63096019|FG010|Stage 2|Progression of Disease|0|||
33664696|NCT01562275|63096020|FG011|Stage 2|Progression of Disease|12|||
33664697|NCT01562275|63096021|FG012|Stage 2|Progression of Disease|4|||
33664698|NCT01535053|63096053|FG000|Overall Study|Ineligible|1|||
33664699|NCT01535053|63096054|FG001|Overall Study|Ineligible|2|||
33664700|NCT01534663|63096062|FG000|Overall Study|Lost to Follow-up|0|||
33664701|NCT01534663|63096063|FG001|Overall Study|Lost to Follow-up|2|||
33664702|NCT01534663|63096062|FG000|Overall Study|Adverse Event|2|||
33664703|NCT01534663|63096063|FG001|Overall Study|Adverse Event|1|||
33664704|NCT01520909|63096071|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
33664705|NCT01520909|63096072|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
33664706|NCT01520909|63096073|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
33664707|NCT01520909|63096071|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
33664708|NCT01520909|63096072|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
33664709|NCT01520909|63096073|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
33664710|NCT01520909|63096071|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
33664711|NCT01520909|63096072|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
33664712|NCT01520909|63096073|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
33664713|NCT01520909|63096071|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
33664714|NCT01520909|63096072|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
33664715|NCT01520909|63096073|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
33664716|NCT01520363|63096095|FG000|Overall Study|Withdrawal by Subject|2|||
33664717|NCT01520363|63096096|FG001|Overall Study|Withdrawal by Subject|0|||
33664718|NCT01578499|63096128|FG000|Overall Study|Reason not Specified|0|||
33664719|NCT01578499|63096129|FG001|Overall Study|Reason not Specified|1|||
33664720|NCT01578499|63096128|FG000|Overall Study|Lost to Follow-up|2|||
33664721|NCT01578499|63096129|FG001|Overall Study|Lost to Follow-up|1|||
33664722|NCT01578499|63096128|FG000|Overall Study|Withdrawal by Subject|10|||
33664723|NCT01578499|63096129|FG001|Overall Study|Withdrawal by Subject|16|||
33664724|NCT01578499|63096128|FG000|Overall Study|Death|20|||
33664725|NCT01578499|63096129|FG001|Overall Study|Death|25|||
33664726|NCT01578499|63096128|FG000|Overall Study|Died and End of Study Page not Completed|2|||
33664727|NCT01578499|63096129|FG001|Overall Study|Died and End of Study Page not Completed|0|||
33664728|NCT01578187|63096139|FG000|Usability Phase|Withdrawal by Subject|1|||
33664729|NCT01561963|63096145|FG000|Overall Study|Adverse Event|1|||
33664730|NCT01576783|63096156|FG000|Overall Study|Change in Medical Care|1|||
33664731|NCT01576783|63096157|FG001|Overall Study|Change in Medical Care|0|||
33664732|NCT01576783|63096156|FG000|Overall Study|Lost to Follow-up|14|||
33664733|NCT01576783|63096157|FG001|Overall Study|Lost to Follow-up|16|||
33664734|NCT01576783|63096156|FG000|Overall Study|Withdrawal by Subject|5|||
33664735|NCT01576783|63096157|FG001|Overall Study|Withdrawal by Subject|1|||
33664736|NCT01534351|63096166|FG000|Overall Study|Study Terminated Early|1|||
33664737|NCT01534351|63096167|FG001|Overall Study|Study Terminated Early|0|||
33664738|NCT01534351|63096168|FG002|Overall Study|Study Terminated Early|0|||
33664739|NCT01534273|63096180|FG000|Period 1|Physician Decision|0|||
33664740|NCT01534273|63096181|FG001|Period 1|Physician Decision|0|||
33664741|NCT01534273|63096182|FG002|Period 1|Physician Decision|0|||
33664742|NCT01534273|63096183|FG003|Period 1|Physician Decision|1|||
33664743|NCT01534273|63096184|FG004|Period 1|Physician Decision|0|||
33664744|NCT01534273|63096185|FG005|Period 1|Physician Decision|0|||
33664745|NCT01534273|63096186|FG006|Period 1|Physician Decision|0|||
33664746|NCT01534195|63096209|FG000|Overall Study|Withdrawal by Subject|1|||
33664747|NCT01534195|63096210|FG001|Overall Study|Withdrawal by Subject|1|||
33664748|NCT01560949|63096216|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
33664749|NCT01560949|63096216|FG000|Surgery Phase|Physician Decision|3|||
33664750|NCT01372878|63096224|FG000|Overall Study|Withdrawal by Subject|63|||
33664751|NCT01372878|63096224|FG000|Overall Study|Protocol Violation|17|||
33664752|NCT01372878|63096224|FG000|Overall Study|incomplete study procedure|104|||
33664753|NCT01533493|63096230|FG000|Overall Study|Adverse Event|2|||
33302919|NCT01071070|62678812|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
33302920|NCT01071070|62678813|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
33302921|NCT01071070|62678812|FG000|Overall Study|Hypercalcemia|1|||
33302922|NCT01071070|62678813|FG001|Overall Study|Hypercalcemia|0|||
33302923|NCT01282476|62678819|FG000|Overall Study|Death|11|||
33302924|NCT01282164|62678825|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
33302925|NCT01282164|62678826|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
33302926|NCT01250379|62678842|FG000|Overall Study|Death|141|||
33302927|NCT01250379|62678843|FG001|Overall Study|Death|148|||
33575775|NCT02673515|62972113|FG001|Overall Study|Lack of motivation|1|||
33575776|NCT02667275|62972121|FG000|Overall Study|Protocol Violation|11|||
33575777|NCT02667275|62972122|FG001|Overall Study|Protocol Violation|7|||
33575778|NCT02667275|62972121|FG000|Overall Study|Lost to Follow-up|0|||
33575779|NCT02667275|62972122|FG001|Overall Study|Lost to Follow-up|2|||
33575780|NCT02667275|62972121|FG000|Overall Study|Withdrawal by Subject|0|||
33575781|NCT02667275|62972122|FG001|Overall Study|Withdrawal by Subject|5|||
33575782|NCT02667275|62972121|FG000|Overall Study|Discontinued early without completing|0|||
33575783|NCT02667275|62972122|FG001|Overall Study|Discontinued early without completing|1|||
33575784|NCT02672423|62972131|FG000|Period 1|Adverse Event|0|||
33575785|NCT02672423|62972132|FG001|Period 1|Adverse Event|0|||
33575786|NCT02672423|62972133|FG002|Period 1|Adverse Event|0|||
33575787|NCT02672423|62972134|FG003|Period 1|Adverse Event|0|||
33575788|NCT02672423|62972135|FG004|Period 1|Adverse Event|1|||
33575789|NCT02672423|62972136|FG005|Period 1|Adverse Event|0|||
33575790|NCT02672423|62972137|FG006|Period 1|Adverse Event|0|||
33575791|NCT02672423|62972138|FG007|Period 1|Adverse Event|0|||
33575792|NCT02672423|62972139|FG008|Period 1|Adverse Event|0|||
33575793|NCT02672423|62972140|FG009|Period 1|Adverse Event|0|||
33575794|NCT02672423|62972131|FG000|Period 2|Withdrawal by Subject|0|||
33575795|NCT02672423|62972132|FG001|Period 2|Withdrawal by Subject|0|||
33575796|NCT02672423|62972133|FG002|Period 2|Withdrawal by Subject|1|||
33575797|NCT02672423|62972134|FG003|Period 2|Withdrawal by Subject|0|||
33575798|NCT02672423|62972135|FG004|Period 2|Withdrawal by Subject|0|||
33575799|NCT02672423|62972136|FG005|Period 2|Withdrawal by Subject|0|||
33575800|NCT02672423|62972137|FG006|Period 2|Withdrawal by Subject|0|||
33575801|NCT02672423|62972138|FG007|Period 2|Withdrawal by Subject|0|||
33575802|NCT02672423|62972139|FG008|Period 2|Withdrawal by Subject|0|||
33575803|NCT02672423|62972140|FG009|Period 2|Withdrawal by Subject|0|||
33575804|NCT02672423|62972131|FG000|Period 3|Withdrawal by Subject|0|||
33575805|NCT02672423|62972132|FG001|Period 3|Withdrawal by Subject|0|||
33575806|NCT02672423|62972133|FG002|Period 3|Withdrawal by Subject|0|||
33575807|NCT02672423|62972134|FG003|Period 3|Withdrawal by Subject|0|||
33575808|NCT02672423|62972135|FG004|Period 3|Withdrawal by Subject|0|||
33575809|NCT02672423|62972136|FG005|Period 3|Withdrawal by Subject|0|||
33575810|NCT02672423|62972137|FG006|Period 3|Withdrawal by Subject|0|||
33575811|NCT02672423|62972138|FG007|Period 3|Withdrawal by Subject|1|||
33575812|NCT02672423|62972139|FG008|Period 3|Withdrawal by Subject|0|||
33575813|NCT02672423|62972140|FG009|Period 3|Withdrawal by Subject|0|||
33575814|NCT02672423|62972131|FG000|Period 3|Physician Decision|0|||
33575815|NCT02672423|62972132|FG001|Period 3|Physician Decision|0|||
33575816|NCT02672423|62972133|FG002|Period 3|Physician Decision|0|||
33575817|NCT02672423|62972134|FG003|Period 3|Physician Decision|0|||
33575818|NCT02672423|62972135|FG004|Period 3|Physician Decision|0|||
33575819|NCT02672423|62972136|FG005|Period 3|Physician Decision|1|||
33575820|NCT02672423|62972137|FG006|Period 3|Physician Decision|0|||
33575821|NCT02672423|62972138|FG007|Period 3|Physician Decision|0|||
33575822|NCT02672423|62972139|FG008|Period 3|Physician Decision|0|||
33575823|NCT02672423|62972140|FG009|Period 3|Physician Decision|0|||
33575824|NCT02670551|62972164|FG000|Overall Study|Adverse Event|4|||
33575825|NCT02670551|62972165|FG001|Overall Study|Adverse Event|7|||
33575826|NCT02670551|62972166|FG002|Overall Study|Adverse Event|9|||
33575827|NCT02670551|62972164|FG000|Overall Study|Lack of Efficacy|2|||
33575828|NCT02670551|62972165|FG001|Overall Study|Lack of Efficacy|0|||
33575829|NCT02670551|62972166|FG002|Overall Study|Lack of Efficacy|3|||
33575830|NCT02670551|62972164|FG000|Overall Study|Withdrawal of Consent|6|||
33575831|NCT02670551|62972165|FG001|Overall Study|Withdrawal of Consent|3|||
33575832|NCT02670551|62972166|FG002|Overall Study|Withdrawal of Consent|8|||
33575833|NCT02670551|62972164|FG000|Overall Study|Lost to Follow-up|5|||
33575834|NCT02670551|62972165|FG001|Overall Study|Lost to Follow-up|7|||
33575835|NCT02670551|62972166|FG002|Overall Study|Lost to Follow-up|6|||
33575836|NCT02670551|62972164|FG000|Overall Study|Protocol Violation|1|||
33575837|NCT02670551|62972165|FG001|Overall Study|Protocol Violation|0|||
33575838|NCT02670551|62972166|FG002|Overall Study|Protocol Violation|0|||
33664754|NCT01533493|63096231|FG001|Overall Study|Adverse Event|1|||
33302928|NCT01250379|62678842|FG000|Overall Study|Withdrawal by Subject|32|||
33302929|NCT01250379|62678843|FG001|Overall Study|Withdrawal by Subject|20|||
33302930|NCT01250379|62678842|FG000|Overall Study|Physician Decision|11|||
33575839|NCT02670551|62972164|FG000|Overall Study|Noncompliance with study drug|3|||
33575840|NCT02670551|62972165|FG001|Overall Study|Noncompliance with study drug|3|||
33575841|NCT02670551|62972166|FG002|Overall Study|Noncompliance with study drug|2|||
33302931|NCT01250379|62678843|FG001|Overall Study|Physician Decision|3|||
33302932|NCT01250379|62678842|FG000|Overall Study|Protocol Violation|2|||
33302933|NCT01250379|62678843|FG001|Overall Study|Protocol Violation|8|||
33302934|NCT01250379|62678842|FG000|Overall Study|Lost to Follow-up|9|||
33302935|NCT01250379|62678843|FG001|Overall Study|Lost to Follow-up|6|||
33302936|NCT01250379|62678842|FG000|Overall Study|Adverse Event|5|||
33302937|NCT01250379|62678843|FG001|Overall Study|Adverse Event|4|||
33302938|NCT01250379|62678842|FG000|Overall Study|Other|0|||
33302939|NCT01250379|62678843|FG001|Overall Study|Other|4|||
33302940|NCT01250379|62678842|FG000|Overall Study|Participant noncompliance|2|||
33302941|NCT01250379|62678843|FG001|Overall Study|Participant noncompliance|0|||
33302942|NCT01072630|62678852|FG000|Overall Study|Adverse Event|11|||
33302943|NCT01072630|62678853|FG001|Overall Study|Adverse Event|19|||
33302944|NCT01072630|62678854|FG002|Overall Study|Adverse Event|2|||
33302945|NCT01072630|62678852|FG000|Overall Study|Lack of Efficacy|10|||
33302946|NCT01072630|62678853|FG001|Overall Study|Lack of Efficacy|10|||
33302947|NCT01072630|62678854|FG002|Overall Study|Lack of Efficacy|1|||
33302948|NCT01072630|62678852|FG000|Overall Study|Withdrawal by Subject|8|||
33302949|NCT01072630|62678853|FG001|Overall Study|Withdrawal by Subject|7|||
33302950|NCT01072630|62678854|FG002|Overall Study|Withdrawal by Subject|2|||
33302951|NCT01072630|62678852|FG000|Overall Study|Protocol Violation|10|||
33302952|NCT01072630|62678853|FG001|Overall Study|Protocol Violation|8|||
33302953|NCT01072630|62678854|FG002|Overall Study|Protocol Violation|4|||
33302954|NCT01072630|62678852|FG000|Overall Study|Lost to Follow-up|11|||
33302955|NCT01072630|62678853|FG001|Overall Study|Lost to Follow-up|11|||
33302956|NCT01072630|62678854|FG002|Overall Study|Lost to Follow-up|1|||
33302957|NCT01072630|62678852|FG000|Overall Study|Noncompliance with study medication|1|||
33302958|NCT01072630|62678853|FG001|Overall Study|Noncompliance with study medication|1|||
33302959|NCT01072630|62678854|FG002|Overall Study|Noncompliance with study medication|1|||
33302960|NCT01072630|62678852|FG000|Overall Study|Noncompliance with study procedures|1|||
33302961|NCT01072630|62678853|FG001|Overall Study|Noncompliance with study procedures|2|||
33302962|NCT01072630|62678854|FG002|Overall Study|Noncompliance with study procedures|1|||
33302963|NCT01072630|62678852|FG000|Overall Study|Other|3|||
33302964|NCT01072630|62678853|FG001|Overall Study|Other|2|||
33302965|NCT01072630|62678854|FG002|Overall Study|Other|1|||
33302966|NCT01281306|62678870|FG000|Overall Study|Lack of Efficacy|0|||
33302967|NCT01281306|62678871|FG001|Overall Study|Lack of Efficacy|1|||
33302968|NCT01281306|62678872|FG002|Overall Study|Lack of Efficacy|3|||
33302969|NCT01281306|62678873|FG003|Overall Study|Lack of Efficacy|0|||
33302970|NCT01281306|62678874|FG004|Overall Study|Lack of Efficacy|2|||
33302971|NCT01281306|62678875|FG005|Overall Study|Lack of Efficacy|0|||
33302972|NCT01281306|62678876|FG006|Overall Study|Lack of Efficacy|1|||
33302973|NCT01281306|62678870|FG000|Overall Study|Withdrawal by Subject|1|||
33302974|NCT01281306|62678871|FG001|Overall Study|Withdrawal by Subject|0|||
33302975|NCT01281306|62678872|FG002|Overall Study|Withdrawal by Subject|2|||
33302976|NCT01281306|62678873|FG003|Overall Study|Withdrawal by Subject|4|||
33302977|NCT01281306|62678874|FG004|Overall Study|Withdrawal by Subject|1|||
33302978|NCT01281306|62678875|FG005|Overall Study|Withdrawal by Subject|3|||
33302979|NCT01281306|62678876|FG006|Overall Study|Withdrawal by Subject|1|||
33302980|NCT01281306|62678870|FG000|Overall Study|Protocol deviation|0|||
33302981|NCT01281306|62678871|FG001|Overall Study|Protocol deviation|1|||
33302982|NCT01281306|62678872|FG002|Overall Study|Protocol deviation|1|||
33575842|NCT02670551|62972164|FG000|Overall Study|Other Miscellaneous Reasons|2|||
33575843|NCT02670551|62972165|FG001|Overall Study|Other Miscellaneous Reasons|3|||
33575844|NCT02670551|62972166|FG002|Overall Study|Other Miscellaneous Reasons|3|||
33302983|NCT01281306|62678873|FG003|Overall Study|Protocol deviation|1|||
33302984|NCT01281306|62678874|FG004|Overall Study|Protocol deviation|1|||
33302985|NCT01281306|62678875|FG005|Overall Study|Protocol deviation|0|||
33302986|NCT01281306|62678876|FG006|Overall Study|Protocol deviation|0|||
33302987|NCT01281306|62678870|FG000|Overall Study|Condition no longer requires study drug|1|||
33302988|NCT01281306|62678871|FG001|Overall Study|Condition no longer requires study drug|0|||
33302989|NCT01281306|62678872|FG002|Overall Study|Condition no longer requires study drug|0|||
33302990|NCT01281306|62678873|FG003|Overall Study|Condition no longer requires study drug|0|||
33302991|NCT01281306|62678874|FG004|Overall Study|Condition no longer requires study drug|0|||
33302992|NCT01281306|62678875|FG005|Overall Study|Condition no longer requires study drug|1|||
33302993|NCT01281306|62678876|FG006|Overall Study|Condition no longer requires study drug|1|||
33302994|NCT01281306|62678870|FG000|Overall Study|Lost to Follow-up|1|||
33302995|NCT01281306|62678871|FG001|Overall Study|Lost to Follow-up|0|||
33302996|NCT01281306|62678872|FG002|Overall Study|Lost to Follow-up|0|||
33302997|NCT01281306|62678873|FG003|Overall Study|Lost to Follow-up|2|||
33302998|NCT01281306|62678874|FG004|Overall Study|Lost to Follow-up|0|||
33302999|NCT01281306|62678875|FG005|Overall Study|Lost to Follow-up|0|||
33303000|NCT01281306|62678876|FG006|Overall Study|Lost to Follow-up|1|||
33303001|NCT01281306|62678870|FG000|Overall Study|Death|1|||
33303002|NCT01281306|62678871|FG001|Overall Study|Death|0|||
33303003|NCT01281306|62678872|FG002|Overall Study|Death|0|||
33303004|NCT01281306|62678873|FG003|Overall Study|Death|0|||
33303005|NCT01281306|62678874|FG004|Overall Study|Death|0|||
33303006|NCT01281306|62678875|FG005|Overall Study|Death|0|||
33303007|NCT01281306|62678876|FG006|Overall Study|Death|0|||
33303008|NCT01281306|62678870|FG000|Overall Study|Adverse Event|3|||
33303009|NCT01281306|62678871|FG001|Overall Study|Adverse Event|2|||
33303010|NCT01281306|62678872|FG002|Overall Study|Adverse Event|2|||
33303011|NCT01281306|62678873|FG003|Overall Study|Adverse Event|3|||
33303012|NCT01281306|62678874|FG004|Overall Study|Adverse Event|5|||
33303013|NCT01281306|62678875|FG005|Overall Study|Adverse Event|3|||
33303014|NCT01281306|62678876|FG006|Overall Study|Adverse Event|3|||
33303015|NCT01281306|62678870|FG000|Overall Study|Randomized in error|1|||
33303016|NCT01281306|62678871|FG001|Overall Study|Randomized in error|0|||
33303017|NCT01281306|62678872|FG002|Overall Study|Randomized in error|0|||
33303018|NCT01281306|62678873|FG003|Overall Study|Randomized in error|1|||
33303019|NCT01281306|62678874|FG004|Overall Study|Randomized in error|0|||
33303020|NCT01281306|62678875|FG005|Overall Study|Randomized in error|0|||
33303021|NCT01281306|62678876|FG006|Overall Study|Randomized in error|0|||
33303022|NCT01250145|62678894|FG000|Overall Study|Adverse Event|2|||
33303023|NCT01250145|62678895|FG001|Overall Study|Adverse Event|1|||
33303024|NCT01250145|62678894|FG000|Overall Study|Withdrawal by Subject|0|||
33303025|NCT01250145|62678895|FG001|Overall Study|Withdrawal by Subject|4|||
33303026|NCT01067326|62678917|FG000|Overall Study|Adverse Event|0|||
33303027|NCT01067326|62678918|FG001|Overall Study|Adverse Event|2|||
33303028|NCT01067326|62678917|FG000|Overall Study|Withdrawal by Subject|1|||
33303029|NCT01067326|62678918|FG001|Overall Study|Withdrawal by Subject|0|||
33303030|NCT01067326|62678917|FG000|Overall Study|Early Study Termination|1|||
33303031|NCT01067326|62678918|FG001|Overall Study|Early Study Termination|1|||
33303032|NCT01279200|62678926|FG000|Overall Study|Withdrawal by Subject|1|||
33303033|NCT01279200|62678927|FG001|Overall Study|Withdrawal by Subject|3|||
33303034|NCT01279200|62678926|FG000|Overall Study|Patient withdrawal due to high cost|0|||
33303035|NCT01279200|62678927|FG001|Overall Study|Patient withdrawal due to high cost|1|||
33303036|NCT01279200|62678926|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
33303037|NCT01279200|62678927|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
33303038|NCT01279200|62678926|FG000|Overall Study|ultrasound screening failure|0|||
33303039|NCT01279200|62678927|FG001|Overall Study|ultrasound screening failure|1|||
33303040|NCT01279200|62678926|FG000|Overall Study|Lost to Follow-up|0|||
33303041|NCT01279200|62678927|FG001|Overall Study|Lost to Follow-up|1|||
33303042|NCT01279200|62678926|FG000|Overall Study|Adverse Event|1|||
33303043|NCT01279200|62678927|FG001|Overall Study|Adverse Event|0|||
33303044|NCT01273818|62678936|FG000|Overall Study|Physician Decision|13|||
33303045|NCT01273818|62678937|FG001|Overall Study|Physician Decision|2|||
33303046|NCT01273818|62678938|FG002|Overall Study|Physician Decision|9|||
33303047|NCT01245387|62678946|FG000|Overall Study|Lost to Follow-up|106|||
33303048|NCT01245387|62678946|FG000|Overall Study|Lack of Efficacy|195|||
33303049|NCT01245387|62678946|FG000|Overall Study|Adverse Event|9|||
33303050|NCT01245387|62678946|FG000|Overall Study|Death|3|||
33303051|NCT01245387|62678946|FG000|Overall Study|Other|131|||
33303052|NCT01245387|62678946|FG000|Overall Study|Missing discontinuation status|369|||
33303053|NCT01037218|62678954|FG000|Overall Study|Adverse Event|4|||
33303054|NCT01037218|62678955|FG001|Overall Study|Adverse Event|2|||
33303055|NCT01037218|62678956|FG002|Overall Study|Adverse Event|2|||
33303056|NCT01037218|62678957|FG003|Overall Study|Adverse Event|1|||
33303057|NCT01037218|62678954|FG000|Overall Study|Lack of Efficacy|0|||
33303058|NCT01037218|62678955|FG001|Overall Study|Lack of Efficacy|2|||
33303059|NCT01037218|62678956|FG002|Overall Study|Lack of Efficacy|1|||
33303060|NCT01037218|62678957|FG003|Overall Study|Lack of Efficacy|5|||
33303061|NCT01037218|62678954|FG000|Overall Study|Lost to Follow-up|3|||
33303062|NCT01037218|62678955|FG001|Overall Study|Lost to Follow-up|5|||
33303063|NCT01037218|62678956|FG002|Overall Study|Lost to Follow-up|4|||
33303064|NCT01037218|62678957|FG003|Overall Study|Lost to Follow-up|2|||
33303065|NCT01037218|62678954|FG000|Overall Study|Withdrawal by Subject|6|||
33303066|NCT01037218|62678955|FG001|Overall Study|Withdrawal by Subject|7|||
33303067|NCT01037218|62678956|FG002|Overall Study|Withdrawal by Subject|7|||
33575845|NCT02670551|62972164|FG000|Overall Study|Did Not Receive Treatment|5|||
33303068|NCT01037218|62678957|FG003|Overall Study|Withdrawal by Subject|4|||
33303069|NCT01037218|62678954|FG000|Overall Study|Partner Withdrew Consent|0|||
33303070|NCT01037218|62678955|FG001|Overall Study|Partner Withdrew Consent|3|||
33303071|NCT01037218|62678956|FG002|Overall Study|Partner Withdrew Consent|2|||
33303072|NCT01037218|62678957|FG003|Overall Study|Partner Withdrew Consent|1|||
33303073|NCT01037218|62678954|FG000|Overall Study|Protocol Violation|0|||
33303074|NCT01037218|62678955|FG001|Overall Study|Protocol Violation|0|||
33303075|NCT01037218|62678956|FG002|Overall Study|Protocol Violation|2|||
33303076|NCT01037218|62678957|FG003|Overall Study|Protocol Violation|2|||
33303077|NCT01037218|62678954|FG000|Overall Study|Various|3|||
33303078|NCT01037218|62678955|FG001|Overall Study|Various|2|||
33303079|NCT01037218|62678956|FG002|Overall Study|Various|3|||
33303080|NCT01037218|62678957|FG003|Overall Study|Various|1|||
33303081|NCT01038856|62678967|FG000|Overall Study|Adverse Event|2|||
33303082|NCT01066546|62678973|FG000|Overall Study|Study terminated by sponsor|5|||
33303083|NCT01272804|62678983|FG000|Overall Study|Adverse Event|1|||
33303084|NCT01272804|62678984|FG001|Overall Study|Adverse Event|0|||
33303085|NCT01272804|62678985|FG002|Overall Study|Adverse Event|0|||
33303086|NCT01272804|62678986|FG003|Overall Study|Adverse Event|0|||
33303087|NCT01272804|62678987|FG004|Overall Study|Adverse Event|2|||
33396798|NCT00672620|62776048|FG000|Overall Study|Protocol Deviations|5|||
33396799|NCT00672620|62776049|FG001|Overall Study|Protocol Deviations|7|||
33396800|NCT00672620|62776050|FG002|Overall Study|Protocol Deviations|2|||
33396801|NCT00672620|62776051|FG003|Overall Study|Protocol Deviations|5|||
33396802|NCT00672620|62776048|FG000|Overall Study|Withdrawal of Consent|6|||
33396803|NCT00672620|62776049|FG001|Overall Study|Withdrawal of Consent|12|||
33396804|NCT00672620|62776050|FG002|Overall Study|Withdrawal of Consent|5|||
33396805|NCT00672620|62776051|FG003|Overall Study|Withdrawal of Consent|6|||
33396806|NCT00672620|62776048|FG000|Overall Study|Lost to Follow-up|8|||
33396807|NCT00672620|62776049|FG001|Overall Study|Lost to Follow-up|19|||
33396808|NCT00672620|62776050|FG002|Overall Study|Lost to Follow-up|8|||
33396809|NCT00672620|62776051|FG003|Overall Study|Lost to Follow-up|11|||
33396810|NCT00672620|62776048|FG000|Overall Study|Reason not Specified|3|||
33396811|NCT00672620|62776049|FG001|Overall Study|Reason not Specified|3|||
33396812|NCT00672620|62776050|FG002|Overall Study|Reason not Specified|2|||
33396813|NCT00672620|62776051|FG003|Overall Study|Reason not Specified|1|||
33396814|NCT00673790|62776064|FG000|Overall Study|Adverse Event|23|||
33396815|NCT00673790|62776065|FG001|Overall Study|Adverse Event|14|||
33396816|NCT00673790|62776066|FG002|Overall Study|Adverse Event|2|||
33396817|NCT00673790|62776064|FG000|Overall Study|Lack of Efficacy|2|||
33396818|NCT00673790|62776065|FG001|Overall Study|Lack of Efficacy|2|||
33396819|NCT00673790|62776066|FG002|Overall Study|Lack of Efficacy|2|||
33396820|NCT00673790|62776064|FG000|Overall Study|Protocol Violation|6|||
33396821|NCT00673790|62776065|FG001|Overall Study|Protocol Violation|9|||
33396822|NCT00673790|62776066|FG002|Overall Study|Protocol Violation|1|||
33396823|NCT00673790|62776064|FG000|Overall Study|Withdrawal by Subject|7|||
33396824|NCT00673790|62776065|FG001|Overall Study|Withdrawal by Subject|4|||
33396825|NCT00673790|62776066|FG002|Overall Study|Withdrawal by Subject|1|||
33396826|NCT00673790|62776064|FG000|Overall Study|Lost to Follow-up|6|||
33396827|NCT00673790|62776065|FG001|Overall Study|Lost to Follow-up|6|||
33396828|NCT00673790|62776066|FG002|Overall Study|Lost to Follow-up|5|||
33396829|NCT00673790|62776064|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
33396830|NCT00673790|62776065|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
33396831|NCT00673790|62776066|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
33396832|NCT00673790|62776064|FG000|Overall Study|Poor compliance|1|||
33396833|NCT00673790|62776065|FG001|Overall Study|Poor compliance|0|||
33396834|NCT00673790|62776066|FG002|Overall Study|Poor compliance|0|||
33396835|NCT00673790|62776064|FG000|Overall Study|Participated in two Nebivolol studies|0|||
33396836|NCT00673790|62776065|FG001|Overall Study|Participated in two Nebivolol studies|0|||
33396837|NCT00673790|62776066|FG002|Overall Study|Participated in two Nebivolol studies|1|||
33396838|NCT00673790|62776064|FG000|Overall Study|Unconfirmed pregnancy|0|||
33396839|NCT00673790|62776065|FG001|Overall Study|Unconfirmed pregnancy|1|||
33396840|NCT00673790|62776066|FG002|Overall Study|Unconfirmed pregnancy|0|||
33396841|NCT00673790|62776064|FG000|Overall Study|Randomization criteria not met|0|||
33396842|NCT00673790|62776065|FG001|Overall Study|Randomization criteria not met|1|||
33396843|NCT00673790|62776066|FG002|Overall Study|Randomization criteria not met|0|||
33396844|NCT00657150|62776077|FG000|Overall Study|Adverse Event|19|||
33396845|NCT00657150|62776078|FG001|Overall Study|Adverse Event|10|||
33396846|NCT00657150|62776077|FG000|Overall Study|Non-compliant with protocol|5|||
33396847|NCT00657150|62776078|FG001|Overall Study|Non-compliant with protocol|9|||
33396848|NCT00657150|62776077|FG000|Overall Study|Lost to Follow-up|2|||
33396849|NCT00657150|62776078|FG001|Overall Study|Lost to Follow-up|0|||
33396850|NCT00657150|62776077|FG000|Overall Study|Withdrawal by Subject|51|||
33396851|NCT00657150|62776078|FG001|Overall Study|Withdrawal by Subject|36|||
33396852|NCT00657150|62776077|FG000|Overall Study|Other|38|||
33396853|NCT00657150|62776078|FG001|Overall Study|Other|38|||
33396854|NCT00657150|62776077|FG000|Treatment|Adverse Event|60|||
33396855|NCT00657150|62776078|FG001|Treatment|Adverse Event|53|||
33396856|NCT00657150|62776077|FG000|Treatment|Non-compliant with protocol|10|||
33575846|NCT02670551|62972165|FG001|Overall Study|Did Not Receive Treatment|3|||
33575847|NCT02670551|62972166|FG002|Overall Study|Did Not Receive Treatment|0|||
33303088|NCT01272804|62678988|FG005|Overall Study|Adverse Event|1|||
33396857|NCT00657150|62776078|FG001|Treatment|Non-compliant with protocol|9|||
33396858|NCT00657150|62776077|FG000|Treatment|Lost to Follow-up|1|||
33396859|NCT00657150|62776078|FG001|Treatment|Lost to Follow-up|0|||
33396860|NCT00657150|62776077|FG000|Treatment|Withdrawal by Subject|23|||
33396861|NCT00657150|62776078|FG001|Treatment|Withdrawal by Subject|20|||
33396862|NCT00657150|62776077|FG000|Treatment|Other|13|||
33396863|NCT00657150|62776078|FG001|Treatment|Other|15|||
33396864|NCT00670748|62776088|FG000|Overall Study|Death during treatment|1|||
33396865|NCT00670748|62776089|FG001|Overall Study|Death during treatment|1|||
33396866|NCT00670748|62776090|FG002|Overall Study|Death during treatment|1|||
33396867|NCT00670748|62776091|FG003|Overall Study|Death during treatment|0|||
33396868|NCT00670748|62776088|FG000|Overall Study|Not off study|2|||
33303089|NCT01269918|62679004|FG000|Overall Study|Did not receive study drug|0|||
33303090|NCT01269918|62679005|FG001|Overall Study|Did not receive study drug|3|||
33303091|NCT01036594|62679011|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
33303092|NCT01036594|62679012|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
33303093|NCT01036594|62679011|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
33303094|NCT01036594|62679012|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
33303095|NCT01036594|62679011|FG000|Week 12 Evaluation|Adverse Event|5|||
33303096|NCT01036594|62679012|FG001|Week 12 Evaluation|Adverse Event|0|||
33303097|NCT01036594|62679011|FG000|Week 12 Evaluation|Physician Decision|1|||
33303098|NCT01036594|62679012|FG001|Week 12 Evaluation|Physician Decision|0|||
33303099|NCT01036594|62679011|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
33303100|NCT01036594|62679012|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
33303101|NCT01036594|62679011|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
33303102|NCT01036594|62679012|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
33303103|NCT01036594|62679011|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
33303104|NCT01036594|62679012|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
33303105|NCT01036594|62679011|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
33303106|NCT01036594|62679012|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
33303107|NCT01036594|62679011|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
33303108|NCT01036594|62679012|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
33303109|NCT01036438|62679020|FG000|Overall Study|Adverse Event|7|||
33303110|NCT01036438|62679021|FG001|Overall Study|Adverse Event|8|||
33303111|NCT01036438|62679020|FG000|Overall Study|Death|0|||
33303112|NCT01036438|62679021|FG001|Overall Study|Death|1|||
33303113|NCT01036438|62679020|FG000|Overall Study|No effect of study treatment|3|||
33303114|NCT01036438|62679021|FG001|Overall Study|No effect of study treatment|1|||
33303115|NCT01268514|62679027|FG000|Overall Study|Adverse Event|20|||
33303116|NCT01268514|62679027|FG000|Overall Study|Death|8|||
33303117|NCT01268514|62679027|FG000|Overall Study|Lost to Follow-up|5|||
33303118|NCT01268514|62679027|FG000|Overall Study|Withdrawal by Subject|3|||
33303119|NCT01268514|62679027|FG000|Overall Study|Withdrawal by Surgeon|5|||
33303120|NCT01268046|62679037|FG000|Overall Study|Withdrawal by Subject|1|||
33303121|NCT01268046|62679038|FG001|Overall Study|Withdrawal by Subject|0|||
33303122|NCT01268046|62679039|FG002|Overall Study|Withdrawal by Subject|0|||
33303123|NCT01268046|62679040|FG003|Overall Study|Withdrawal by Subject|1|||
33303124|NCT01268046|62679037|FG000|Overall Study|Lost to Follow-up|0|||
33303125|NCT01268046|62679038|FG001|Overall Study|Lost to Follow-up|0|||
33303126|NCT01268046|62679039|FG002|Overall Study|Lost to Follow-up|1|||
33303127|NCT01268046|62679040|FG003|Overall Study|Lost to Follow-up|0|||
33303128|NCT01267266|62679050|FG000|Enrollment Phase|Withdrawal by Subject|2|||
33303129|NCT01267266|62679051|FG001|Enrollment Phase|Withdrawal by Subject|0|||
33303130|NCT01267266|62679050|FG000|Lead-in Phase|Lack of Efficacy|20|||
33303131|NCT01267266|62679051|FG001|Lead-in Phase|Lack of Efficacy|0|||
33303132|NCT01267266|62679050|FG000|Lead-in Phase|Adverse Event|2|||
33303133|NCT01267266|62679051|FG001|Lead-in Phase|Adverse Event|0|||
33303134|NCT01267266|62679050|FG000|Lead-in Phase|Withdrawal by Subject|1|||
33303135|NCT01267266|62679051|FG001|Lead-in Phase|Withdrawal by Subject|0|||
33303136|NCT01034176|62679062|FG000|Overall Study|Physician Decision|2|||
33303137|NCT01034176|62679063|FG001|Overall Study|Physician Decision|0|||
33303138|NCT01034176|62679062|FG000|Overall Study|Withdrawal by Subject|0|||
33303139|NCT01034176|62679063|FG001|Overall Study|Withdrawal by Subject|1|||
33303140|NCT01034176|62679062|FG000|Overall Study|Lost to Follow-up|0|||
33303141|NCT01034176|62679063|FG001|Overall Study|Lost to Follow-up|1|||
33303142|NCT01033942|62679072|FG000|Overall Study|Withdrawal by Subject|1|||
33303143|NCT01033942|62679073|FG001|Overall Study|Withdrawal by Subject|1|||
33303144|NCT01033942|62679074|FG002|Overall Study|Withdrawal by Subject|1|||
33303145|NCT01033942|62679072|FG000|Overall Study|Lost to Follow-up|1|||
33303146|NCT01033942|62679073|FG001|Overall Study|Lost to Follow-up|0|||
33303147|NCT01033942|62679074|FG002|Overall Study|Lost to Follow-up|0|||
33303148|NCT01033942|62679072|FG000|Overall Study|Enrolled in Extension Study|0|||
33303149|NCT01033942|62679073|FG001|Overall Study|Enrolled in Extension Study|3|||
33303150|NCT01033942|62679074|FG002|Overall Study|Enrolled in Extension Study|0|||
33303151|NCT01062256|62679087|FG000|Overall Study|Adverse Event|1|||
33303152|NCT01062256|62679088|FG001|Overall Study|Adverse Event|0|||
33303153|NCT01062256|62679089|FG002|Overall Study|Adverse Event|0|||
33303154|NCT01062256|62679087|FG000|Overall Study|Withdrawal by Subject|1|||
33303155|NCT01062256|62679088|FG001|Overall Study|Withdrawal by Subject|1|||
33303156|NCT01062256|62679089|FG002|Overall Study|Withdrawal by Subject|1|||
33303157|NCT01062256|62679087|FG000|Overall Study|Ineligible|1|||
33303158|NCT01062256|62679088|FG001|Overall Study|Ineligible|4|||
33303159|NCT01062256|62679089|FG002|Overall Study|Ineligible|3|||
33303160|NCT01062256|62679087|FG000|Overall Study|Administrative|0|||
33303161|NCT01062256|62679088|FG001|Overall Study|Administrative|2|||
33303162|NCT01062256|62679089|FG002|Overall Study|Administrative|0|||
33303163|NCT01029886|62679099|FG000|Overall Study|Adverse Event|12|||
33303164|NCT01029886|62679100|FG001|Overall Study|Adverse Event|25|||
33303165|NCT01029886|62679099|FG000|Overall Study|Lost to Follow-up|1|||
33303166|NCT01029886|62679100|FG001|Overall Study|Lost to Follow-up|0|||
33303167|NCT01029886|62679099|FG000|Overall Study|Physician Decision|2|||
33303168|NCT01029886|62679100|FG001|Overall Study|Physician Decision|6|||
33303169|NCT01029886|62679099|FG000|Overall Study|Protocol Violation|17|||
33303170|NCT01029886|62679100|FG001|Overall Study|Protocol Violation|5|||
33303171|NCT01029886|62679099|FG000|Overall Study|Withdrawal by Subject|8|||
33303172|NCT01029886|62679100|FG001|Overall Study|Withdrawal by Subject|18|||
33303173|NCT01029886|62679099|FG000|Overall Study|Entry Criteria Not Met|13|||
33303174|NCT01029886|62679100|FG001|Overall Study|Entry Criteria Not Met|5|||
33303175|NCT01029886|62679099|FG000|Overall Study|Sponsor Decision|1|||
33303176|NCT01029886|62679100|FG001|Overall Study|Sponsor Decision|0|||
33303177|NCT01029886|62679099|FG000|Overall Study|Loss Glucose Control|7|||
33303178|NCT01029886|62679100|FG001|Overall Study|Loss Glucose Control|1|||
33303179|NCT01244763|62679116|FG000|Overall Study|Adverse Event|1|||
33303180|NCT01244763|62679117|FG001|Overall Study|Adverse Event|0|||
33303181|NCT01244763|62679118|FG002|Overall Study|Adverse Event|0|||
33303182|NCT01244763|62679119|FG003|Overall Study|Adverse Event|0|||
33303183|NCT01244763|62679120|FG004|Overall Study|Adverse Event|0|||
33303184|NCT01244763|62679121|FG005|Overall Study|Adverse Event|1|||
33303185|NCT01244763|62679116|FG000|Overall Study|Death|1|||
33303186|NCT01244763|62679117|FG001|Overall Study|Death|0|||
33303187|NCT01244763|62679118|FG002|Overall Study|Death|1|||
33303188|NCT01244763|62679119|FG003|Overall Study|Death|0|||
33303189|NCT01244763|62679120|FG004|Overall Study|Death|2|||
33303190|NCT01244763|62679121|FG005|Overall Study|Death|0|||
33303191|NCT01244763|62679116|FG000|Overall Study|Physician Decision|0|||
33303192|NCT01244763|62679117|FG001|Overall Study|Physician Decision|0|||
33303193|NCT01244763|62679118|FG002|Overall Study|Physician Decision|1|||
33303194|NCT01244763|62679119|FG003|Overall Study|Physician Decision|0|||
33303195|NCT01244763|62679120|FG004|Overall Study|Physician Decision|0|||
33303196|NCT01244763|62679121|FG005|Overall Study|Physician Decision|0|||
33396869|NCT00670748|62776089|FG001|Overall Study|Not off study|1|||
33396870|NCT00670748|62776090|FG002|Overall Study|Not off study|1|||
33396871|NCT00670748|62776091|FG003|Overall Study|Not off study|1|||
33396872|NCT00646776|62776103|FG000|Overall Study|Adverse Event|1|||
33396873|NCT00646776|62776104|FG001|Overall Study|Adverse Event|9|||
33396874|NCT00646776|62776103|FG000|Overall Study|Investigator discretion|0|||
33396875|NCT00646776|62776104|FG001|Overall Study|Investigator discretion|4|||
33396876|NCT00655668|62776113|FG000|Overall Study|Adverse Event|6|||
33396877|NCT00655668|62776113|FG000|Overall Study|Death|5|||
33396878|NCT00655668|62776113|FG000|Overall Study|Disease Progression|27|||
33396879|NCT00655668|62776113|FG000|Overall Study|Study Terminated|9|||
33396880|NCT00655668|62776113|FG000|Overall Study|Other|1|||
33396881|NCT00655668|62776113|FG000|Overall Study|New Lymphoma Treatment Started|4|||
33396882|NCT00655668|62776113|FG000|Overall Study|Withdrawal by Subject|2|||
33396883|NCT00569166|62776120|FG000|Overall Study|Withdrawal by Subject|7|||
33396884|NCT00569166|62776121|FG001|Overall Study|Withdrawal by Subject|5|||
33664755|NCT01533493|63096230|FG000|Overall Study|Withdrawal by Subject|1|||
33664756|NCT01533493|63096231|FG001|Overall Study|Withdrawal by Subject|2|||
33664757|NCT01533493|63096230|FG000|Overall Study|Lost to Follow-up|2|||
33664758|NCT01533493|63096231|FG001|Overall Study|Lost to Follow-up|0|||
33664759|NCT01533181|63096307|FG000|Overall Study|Disease progression pre-active treatment|0|||
33664760|NCT01533181|63096308|FG001|Overall Study|Disease progression pre-active treatment|1|||
33664761|NCT01533181|63096307|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
33664762|NCT01533181|63096308|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
33664763|NCT02669082|63096314|FG000|Overall Study|Adverse Event|1|||
33664764|NCT02668692|63096378|FG000|Overall Study|Adverse Event|1|||
33664765|NCT02668692|63096379|FG001|Overall Study|Adverse Event|0|||
33664766|NCT02662764|63096393|FG000|Overall Study|Adverse Event|6|||
33664767|NCT02662764|63096393|FG000|Overall Study|Lack of Efficacy|8|||
33664768|NCT02662764|63096393|FG000|Overall Study|Protocol Violation|1|||
33664769|NCT02662764|63096393|FG000|Overall Study|Withdrawal by Subject|5|||
33664770|NCT02662764|63096393|FG000|Overall Study|Device failure|4|||
33664771|NCT02662764|63096393|FG000|Overall Study|Patient changed treatment|1|||
33664772|NCT02662764|63096393|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
33664773|NCT01519817|63096402|FG000|Overall Study|Withdrawal by Subject|1|||
33303197|NCT01244763|62679116|FG000|Overall Study|Withdrawal by Subject|1|||
33303198|NCT01244763|62679117|FG001|Overall Study|Withdrawal by Subject|2|||
33303199|NCT01244763|62679118|FG002|Overall Study|Withdrawal by Subject|0|||
33303200|NCT01244763|62679119|FG003|Overall Study|Withdrawal by Subject|1|||
33303201|NCT01244763|62679120|FG004|Overall Study|Withdrawal by Subject|1|||
33303202|NCT01244763|62679121|FG005|Overall Study|Withdrawal by Subject|2|||
33303203|NCT01244763|62679116|FG000|Overall Study|Lost to Follow-up|0|||
33303204|NCT01244763|62679117|FG001|Overall Study|Lost to Follow-up|1|||
33396885|NCT00569166|62776122|FG002|Overall Study|Withdrawal by Subject|3|||
33396886|NCT00569166|62776120|FG000|Overall Study|Lost to Follow-up|2|||
33396887|NCT00569166|62776121|FG001|Overall Study|Lost to Follow-up|1|||
33396888|NCT00569166|62776122|FG002|Overall Study|Lost to Follow-up|1|||
33664774|NCT01519817|63096403|FG001|Overall Study|Withdrawal by Subject|0|||
33664775|NCT01519817|63096404|FG002|Overall Study|Withdrawal by Subject|0|||
33664776|NCT01519817|63096405|FG003|Overall Study|Withdrawal by Subject|0|||
33664777|NCT01519817|63096402|FG000|Overall Study|Off study due to infection|0|||
33664778|NCT01519817|63096403|FG001|Overall Study|Off study due to infection|0|||
33664779|NCT01519817|63096404|FG002|Overall Study|Off study due to infection|0|||
33664780|NCT01519817|63096405|FG003|Overall Study|Off study due to infection|1|||
33664781|NCT01519661|63096415|FG000|Overall Study|Protocol deviation|6|||
33664782|NCT01519661|63096415|FG000|Overall Study|Lost to Follow-up|3|||
33664783|NCT01519661|63096415|FG000|Overall Study|Withdrawal by Subject|17|||
33664784|NCT01519661|63096415|FG000|Overall Study|Lack of Efficacy|6|||
33664785|NCT01519661|63096415|FG000|Overall Study|Adverse Event|29|||
33664786|NCT01519427|63096420|FG000|Overall Study|disease progression|2|||
33664787|NCT01518257|63096426|FG000|Overall Study|Lost to Follow-up|1|||
33664788|NCT01518257|63096427|FG001|Overall Study|Lost to Follow-up|0|||
33664789|NCT01518257|63096426|FG000|Overall Study|Other Miscellaneous Reason|1|||
33664790|NCT01518257|63096427|FG001|Overall Study|Other Miscellaneous Reason|0|||
33664791|NCT02668302|63096435|FG000|Overall Study|Withdrawal by Subject|1|||
33664792|NCT02668302|63096436|FG001|Overall Study|Withdrawal by Subject|0|||
33664793|NCT01517867|63096444|FG000|Overall Study|never started treatment|29|||
33664794|NCT01517867|63096445|FG001|Overall Study|never started treatment|32|||
33664795|NCT01517867|63096444|FG000|Overall Study|Withdrawal by Subject|34|||
33664796|NCT01517867|63096445|FG001|Overall Study|Withdrawal by Subject|30|||
33664797|NCT01517867|63096444|FG000|Overall Study|Still in treatment at study end|0|||
33664798|NCT01517867|63096445|FG001|Overall Study|Still in treatment at study end|3|||
33664799|NCT01514357|63096453|FG000|Overall Study|Screen failure|2|||
33664800|NCT01514357|63096454|FG001|Overall Study|Screen failure|0|||
33664801|NCT01514357|63096453|FG000|Overall Study|Withdrawal by Subject|2|||
33664802|NCT01514357|63096454|FG001|Overall Study|Withdrawal by Subject|0|||
33664803|NCT01532869|63096462|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
33664804|NCT01532869|63096463|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
33664805|NCT01532869|63096462|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
33664806|NCT01532869|63096463|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
33664807|NCT01532869|63096462|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
33664808|NCT01532869|63096463|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
33664809|NCT01532869|63096462|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
33664810|NCT01532869|63096463|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
33664811|NCT01532869|63096462|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
33664812|NCT01532869|63096463|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
33664813|NCT01532869|63096462|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
33664814|NCT01532869|63096463|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
33664815|NCT01532869|63096462|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
33664816|NCT01532869|63096463|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
33664817|NCT01532869|63096462|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
33664818|NCT01532869|63096463|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
33664819|NCT01532869|63096462|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
33664820|NCT01532869|63096463|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
33664821|NCT01532869|63096462|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
33664822|NCT01532869|63096463|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
33664823|NCT01532869|63096462|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
33664824|NCT01532869|63096463|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
33664825|NCT01532869|63096462|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
33664826|NCT01532869|63096463|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
33664827|NCT01532869|63096462|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
33664828|NCT01532869|63096463|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
33664829|NCT01532869|63096462|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
33664830|NCT01532869|63096463|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
33664831|NCT01532869|63096462|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
33664832|NCT01532869|63096463|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
33664833|NCT01532869|63096462|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
33664834|NCT01532869|63096463|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
33664835|NCT01532869|63096462|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
33664836|NCT01532869|63096463|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
33396889|NCT00655356|62776132|FG000|Overall Study|Withdrawal by Subject|3|||
33396890|NCT00655356|62776133|FG001|Overall Study|Withdrawal by Subject|4|||
33664837|NCT01531387|63096476|FG000|Overall Study|Early termination of study|11|||
33664838|NCT01531387|63096477|FG001|Overall Study|Early termination of study|11|||
33664839|NCT01531153|63096486|FG000|Overall Study|Withdrawal by Subject|10|||
33396891|NCT00655356|62776132|FG000|Overall Study|Sponsor Request|10|||
33396892|NCT00655356|62776133|FG001|Overall Study|Sponsor Request|4|||
33664840|NCT01531153|63096487|FG001|Overall Study|Withdrawal by Subject|9|||
33664841|NCT01531153|63096488|FG002|Overall Study|Withdrawal by Subject|15|||
33664842|NCT01529749|63096503|FG000|Overall Study|Lost to Follow-up|0|||
33664843|NCT01529749|63096504|FG001|Overall Study|Lost to Follow-up|1|||
33664844|NCT01529749|63096505|FG002|Overall Study|Lost to Follow-up|1|||
33664845|NCT01529749|63096506|FG003|Overall Study|Lost to Follow-up|0|||
33664846|NCT01529749|63096503|FG000|Overall Study|Physician Decision|0|||
33664847|NCT01529749|63096504|FG001|Overall Study|Physician Decision|0|||
33664848|NCT01529749|63096505|FG002|Overall Study|Physician Decision|0|||
33664849|NCT01529749|63096506|FG003|Overall Study|Physician Decision|1|||
33664850|NCT01529749|63096503|FG000|Overall Study|Withdrawal by Subject|0|||
33664851|NCT01529749|63096504|FG001|Overall Study|Withdrawal by Subject|1|||
33664852|NCT01529749|63096505|FG002|Overall Study|Withdrawal by Subject|1|||
33664853|NCT01529749|63096506|FG003|Overall Study|Withdrawal by Subject|0|||
33664854|NCT01529749|63096503|FG000|Overall Study|Protocol Violation|0|||
33664855|NCT01529749|63096504|FG001|Overall Study|Protocol Violation|0|||
33664856|NCT01529749|63096505|FG002|Overall Study|Protocol Violation|0|||
33664857|NCT01529749|63096506|FG003|Overall Study|Protocol Violation|1|||
33664858|NCT01529515|63096518|FG000|TRANSITION PHASE|Adverse Event|16|||
33664859|NCT01529515|63096519|FG001|TRANSITION PHASE|Adverse Event|0|||
33664860|NCT01529515|63096520|FG002|TRANSITION PHASE|Adverse Event|0|||
33664861|NCT01529515|63096521|FG003|TRANSITION PHASE|Adverse Event|0|||
33664862|NCT01529515|63096518|FG000|TRANSITION PHASE|Death|1|||
33664863|NCT01529515|63096519|FG001|TRANSITION PHASE|Death|0|||
33664864|NCT01529515|63096520|FG002|TRANSITION PHASE|Death|0|||
33664865|NCT01529515|63096521|FG003|TRANSITION PHASE|Death|0|||
33664866|NCT01529515|63096518|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
33664867|NCT01529515|63096519|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
33664868|NCT01529515|63096520|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
33664869|NCT01529515|63096521|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
33664870|NCT01529515|63096518|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
33664871|NCT01529515|63096519|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
33664872|NCT01529515|63096520|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
33664873|NCT01529515|63096521|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
33664874|NCT01529515|63096518|FG000|TRANSITION PHASE|Protocol Violation|4|||
33664875|NCT01529515|63096519|FG001|TRANSITION PHASE|Protocol Violation|0|||
33664876|NCT01529515|63096520|FG002|TRANSITION PHASE|Protocol Violation|0|||
33664877|NCT01529515|63096521|FG003|TRANSITION PHASE|Protocol Violation|0|||
33664878|NCT01529515|63096518|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
33664879|NCT01529515|63096519|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
33664880|NCT01529515|63096520|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
33664881|NCT01529515|63096521|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
33664882|NCT01529515|63096518|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
33664883|NCT01529515|63096519|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
33664884|NCT01529515|63096520|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
33664885|NCT01529515|63096521|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
33664886|NCT01529515|63096518|FG000|TRANSITION PHASE|Other|9|||
33664887|NCT01529515|63096519|FG001|TRANSITION PHASE|Other|0|||
33664888|NCT01529515|63096520|FG002|TRANSITION PHASE|Other|0|||
33664889|NCT01529515|63096521|FG003|TRANSITION PHASE|Other|0|||
33664890|NCT01529515|63096518|FG000|MAINTENANCE PHASE|Adverse Event|0|||
33664891|NCT01529515|63096519|FG001|MAINTENANCE PHASE|Adverse Event|10|||
33664892|NCT01529515|63096520|FG002|MAINTENANCE PHASE|Adverse Event|0|||
33664893|NCT01529515|63096521|FG003|MAINTENANCE PHASE|Adverse Event|0|||
33664894|NCT01529515|63096518|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
33664895|NCT01529515|63096519|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
33664896|NCT01529515|63096520|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
33664897|NCT01529515|63096521|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
33664898|NCT01529515|63096518|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
33664899|NCT01529515|63096519|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
33664900|NCT01529515|63096520|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
33664901|NCT01529515|63096521|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
33664902|NCT01529515|63096518|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
33664903|NCT01529515|63096519|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
33664904|NCT01529515|63096520|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
33664905|NCT01529515|63096521|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
33664906|NCT01529515|63096518|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
33664907|NCT01529515|63096519|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
33664908|NCT01529515|63096520|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
33664909|NCT01529515|63096521|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
33664910|NCT01529515|63096518|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
33303205|NCT01244763|62679118|FG002|Overall Study|Lost to Follow-up|0|||
33303206|NCT01244763|62679119|FG003|Overall Study|Lost to Follow-up|0|||
33664911|NCT01529515|63096519|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
33664912|NCT01529515|63096520|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
33664913|NCT01529515|63096521|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
33664914|NCT01529515|63096518|FG000|MAINTENANCE PHASE|Other|0|||
33664915|NCT01529515|63096519|FG001|MAINTENANCE PHASE|Other|10|||
33664916|NCT01529515|63096520|FG002|MAINTENANCE PHASE|Other|0|||
33664917|NCT01529515|63096521|FG003|MAINTENANCE PHASE|Other|0|||
33664918|NCT01529515|63096518|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
33664919|NCT01529515|63096519|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
33664920|NCT01529515|63096520|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
33664921|NCT01529515|63096521|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
33664922|NCT01529515|63096518|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
33664923|NCT01529515|63096519|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
33664924|NCT01529515|63096520|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
33664925|NCT01529515|63096521|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
33664926|NCT01529515|63096518|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
33664927|NCT01529515|63096519|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
33664928|NCT01529515|63096520|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
33664929|NCT01529515|63096521|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
33664930|NCT01529515|63096518|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
33664931|NCT01529515|63096519|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
33664932|NCT01529515|63096520|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
33664933|NCT01529515|63096521|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
33664934|NCT01529515|63096518|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
33664935|NCT01529515|63096519|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
33664936|NCT01529515|63096520|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
33664937|NCT01529515|63096521|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
33664938|NCT01529515|63096518|FG000|DOUBLE BLIND PHASE|Other|0|||
33664939|NCT01529515|63096519|FG001|DOUBLE BLIND PHASE|Other|0|||
33664940|NCT01529515|63096520|FG002|DOUBLE BLIND PHASE|Other|9|||
33664941|NCT01529515|63096521|FG003|DOUBLE BLIND PHASE|Other|2|||
33664942|NCT01528969|63096530|FG000|Overall Study|absent from the school at baseline|2|||
33664943|NCT01528969|63096531|FG001|Overall Study|absent from the school at baseline|0|||
33664944|NCT01514201|63096541|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
33664945|NCT01514201|63096542|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
33664946|NCT01514201|63096543|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
33664947|NCT01514201|63096544|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
33664948|NCT01514201|63096541|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
33664949|NCT01514201|63096542|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
33664950|NCT01514201|63096543|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
33664951|NCT01514201|63096544|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
33664952|NCT01514201|63096541|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
33664953|NCT01514201|63096542|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
33664954|NCT01514201|63096543|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
33664955|NCT01514201|63096544|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
33303207|NCT01244763|62679120|FG004|Overall Study|Lost to Follow-up|0|||
33303208|NCT01244763|62679121|FG005|Overall Study|Lost to Follow-up|0|||
33303209|NCT01244763|62679116|FG000|Overall Study|Enrolled into the Extension Study|0|||
33303210|NCT01244763|62679117|FG001|Overall Study|Enrolled into the Extension Study|0|||
33303211|NCT01244763|62679118|FG002|Overall Study|Enrolled into the Extension Study|0|||
33303212|NCT01244763|62679119|FG003|Overall Study|Enrolled into the Extension Study|0|||
33575848|NCT02670473|62972174|FG000|Overall Study|Withdrawal by Subject|1|||
33575849|NCT02667119|62972189|FG000|Overall Study|Lost to Follow-up|3|||
33575850|NCT02667119|62972190|FG001|Overall Study|Lost to Follow-up|0|||
33575851|NCT02670083|62972198|FG000|Overall Study|Adverse Event|16|||
33575852|NCT02670083|62972199|FG001|Overall Study|Adverse Event|13|||
33575853|NCT02670083|62972198|FG000|Overall Study|Death|4|||
33575854|NCT02670083|62972199|FG001|Overall Study|Death|6|||
33575855|NCT02670083|62972198|FG000|Overall Study|Lost to Follow-up|2|||
33575856|NCT02670083|62972199|FG001|Overall Study|Lost to Follow-up|2|||
33575857|NCT02670083|62972198|FG000|Overall Study|Multiple Reasons|9|||
33575858|NCT02670083|62972199|FG001|Overall Study|Multiple Reasons|9|||
33575859|NCT02670083|62972198|FG000|Overall Study|Physician Decision|0|||
33575860|NCT02670083|62972199|FG001|Overall Study|Physician Decision|2|||
33575861|NCT02670083|62972198|FG000|Overall Study|Study Terminated By Sponsor|257|||
33575862|NCT02670083|62972199|FG001|Overall Study|Study Terminated By Sponsor|254|||
33575863|NCT02670083|62972198|FG000|Overall Study|Symptomatic Deterioration|0|||
33575864|NCT02670083|62972199|FG001|Overall Study|Symptomatic Deterioration|2|||
33575865|NCT02670083|62972198|FG000|Overall Study|Withdrawal by Subject|32|||
33303213|NCT01244763|62679120|FG004|Overall Study|Enrolled into the Extension Study|0|||
33303214|NCT01244763|62679121|FG005|Overall Study|Enrolled into the Extension Study|1|||
33303215|NCT01244061|62679137|FG000|Overall Study|Death|1|||
33303216|NCT01244061|62679138|FG001|Overall Study|Death|0|||
33575866|NCT02670083|62972199|FG001|Overall Study|Withdrawal by Subject|31|||
33575867|NCT02670083|62972198|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33575868|NCT02670083|62972199|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33396893|NCT00655356|62776132|FG000|Overall Study|Adverse Event|1|||
33575869|NCT02669849|62972209|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
33303217|NCT01244061|62679137|FG000|Overall Study|Did not meet entrance criteria|1|||
33575870|NCT02669849|62972210|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
33303218|NCT01244061|62679138|FG001|Overall Study|Did not meet entrance criteria|0|||
33303219|NCT01244061|62679137|FG000|Overall Study|Lack of Efficacy|1|||
33303220|NCT01244061|62679138|FG001|Overall Study|Lack of Efficacy|3|||
33303221|NCT01244061|62679137|FG000|Overall Study|Lost to Follow-up|34|||
33303222|NCT01244061|62679138|FG001|Overall Study|Lost to Follow-up|30|||
33664956|NCT01514201|63096541|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
33664957|NCT01514201|63096542|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
33664958|NCT01514201|63096543|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
33664959|NCT01514201|63096544|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
33664960|NCT01514201|63096541|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
33664961|NCT01514201|63096542|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
33664962|NCT01514201|63096543|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
33664963|NCT01514201|63096544|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
33664964|NCT01514201|63096541|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
33664965|NCT01514201|63096542|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
33664966|NCT01514201|63096543|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
33396894|NCT00655356|62776133|FG001|Overall Study|Adverse Event|1|||
33575871|NCT02669849|62972211|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
33575872|NCT02669849|62972209|FG000|Overall Study|Lost to Follow-up|1|||
33575873|NCT02669849|62972210|FG001|Overall Study|Lost to Follow-up|0|||
33575874|NCT02669849|62972211|FG002|Overall Study|Lost to Follow-up|3|||
33575875|NCT02669849|62972209|FG000|Overall Study|Death|1|||
33575876|NCT02669849|62972210|FG001|Overall Study|Death|1|||
33575877|NCT02669849|62972211|FG002|Overall Study|Death|2|||
33575878|NCT02669849|62972209|FG000|Overall Study|Study terminated by sponsor|16|||
33575879|NCT02669849|62972210|FG001|Overall Study|Study terminated by sponsor|1|||
33575880|NCT02669849|62972211|FG002|Overall Study|Study terminated by sponsor|14|||
33575881|NCT02669849|62972209|FG000|Overall Study|Other|0|||
33575882|NCT02669849|62972210|FG001|Overall Study|Other|0|||
33575883|NCT02669849|62972211|FG002|Overall Study|Other|2|||
33575884|NCT03625895|62972219|FG000|Overall Study|Protocol Violation|585|||
33575885|NCT02663687|62972228|FG000|Overall Study|Adverse Event|1|||
33575886|NCT02663687|62972229|FG001|Overall Study|Adverse Event|0|||
33575887|NCT02663687|62972230|FG002|Overall Study|Adverse Event|0|||
33575888|NCT02663687|62972231|FG003|Overall Study|Adverse Event|0|||
33575889|NCT02663687|62972232|FG004|Overall Study|Adverse Event|0|||
33575890|NCT02663687|62972228|FG000|Overall Study|Other|1|||
33575891|NCT02663687|62972229|FG001|Overall Study|Other|0|||
33575892|NCT02663687|62972230|FG002|Overall Study|Other|1|||
33575893|NCT02663687|62972231|FG003|Overall Study|Other|0|||
33575894|NCT02663687|62972232|FG004|Overall Study|Other|0|||
33575895|NCT02663453|62972263|FG000|Overall Study|Death|4|||
33575896|NCT02663453|62972264|FG001|Overall Study|Death|4|||
33575897|NCT02663453|62972263|FG000|Overall Study|Withdrawal by Subject|1|||
33575898|NCT02663453|62972264|FG001|Overall Study|Withdrawal by Subject|0|||
33575899|NCT02055118|62972273|FG000|Overall Study|Withdrawal by Subject|0|||
33575900|NCT02055118|62972274|FG001|Overall Study|Withdrawal by Subject|2|||
33575901|NCT02055118|62972275|FG002|Overall Study|Withdrawal by Subject|0|||
33575902|NCT02084056|62972286|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
33575903|NCT02084056|62972287|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
33575904|NCT02084056|62972288|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
33575905|NCT02084056|62972289|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
33575906|NCT02084056|62972286|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
33575907|NCT02084056|62972287|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
33575908|NCT02084056|62972288|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
33575909|NCT02084056|62972289|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
33575910|NCT01625182|62972301|FG000|Overall Study|Administrative problems|1|||
33575911|NCT01625182|62972302|FG001|Overall Study|Administrative problems|0|||
33575912|NCT01625182|62972301|FG000|Overall Study|Protocol deviation|0|||
33575913|NCT01625182|62972302|FG001|Overall Study|Protocol deviation|2|||
33575914|NCT01625182|62972301|FG000|Overall Study|Adverse Event|2|||
33575915|NCT01625182|62972302|FG001|Overall Study|Adverse Event|0|||
33575916|NCT01625182|62972301|FG000|Overall Study|Withdrawal by Subject|5|||
33575917|NCT01625182|62972302|FG001|Overall Study|Withdrawal by Subject|1|||
33303223|NCT01244061|62679137|FG000|Overall Study|Withdrawal by Subject|29|||
33575918|NCT01625182|62972301|FG000|Overall Study|Lack of Efficacy|12|||
33575919|NCT01625182|62972302|FG001|Overall Study|Lack of Efficacy|8|||
33575920|NCT02661815|62972313|FG000|Overall Study|Withdrawal by Subject|1|||
33575921|NCT02661815|62972314|FG001|Overall Study|Withdrawal by Subject|0|||
33575922|NCT02661815|62972315|FG002|Overall Study|Withdrawal by Subject|0|||
33575923|NCT02661815|62972316|FG003|Overall Study|Withdrawal by Subject|0|||
33575924|NCT02053792|62972332|FG000|Overall Study|Physician Decision|0|||
33575925|NCT02053792|62972333|FG001|Overall Study|Physician Decision|1|||
33575926|NCT02053792|62972332|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
33575927|NCT02053792|62972333|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
33664967|NCT01514201|63096544|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
33664968|NCT01514201|63096541|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
33664969|NCT01514201|63096542|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
33664970|NCT01514201|63096543|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
33664971|NCT01514201|63096544|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
33664972|NCT01514201|63096541|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
33664973|NCT01514201|63096542|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
33664974|NCT01514201|63096543|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
33664975|NCT01514201|63096544|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
33664976|NCT01514201|63096541|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
33664977|NCT01514201|63096542|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
33664978|NCT01514201|63096543|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
33664979|NCT01514201|63096544|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
33664980|NCT01514201|63096541|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
33664981|NCT01514201|63096542|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
33664982|NCT01514201|63096543|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
33664983|NCT01514201|63096544|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
33664984|NCT01514201|63096541|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
33664985|NCT01514201|63096542|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
33664986|NCT01514201|63096543|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
33664987|NCT01514201|63096544|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
33664988|NCT01514201|63096541|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
33664989|NCT01514201|63096542|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
33664990|NCT01514201|63096543|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
33664991|NCT01514201|63096544|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
33664992|NCT02666664|63096566|FG000|Overall Study|Physician Decision|0|||
33664993|NCT02666664|63096567|FG001|Overall Study|Physician Decision|1|||
33664994|NCT02666664|63096566|FG000|Overall Study|Protocol Violation|0|||
33664995|NCT02666664|63096567|FG001|Overall Study|Protocol Violation|2|||
33664996|NCT02666664|63096566|FG000|Overall Study|Other|0|||
33664997|NCT02666664|63096567|FG001|Overall Study|Other|1|||
33664998|NCT02666664|63096566|FG000|Overall Study|Adverse Event|12|||
33664999|NCT02666664|63096567|FG001|Overall Study|Adverse Event|37|||
33665000|NCT02666664|63096566|FG000|Overall Study|Withdrawal by participant|23|||
33665001|NCT02666664|63096567|FG001|Overall Study|Withdrawal by participant|40|||
33665002|NCT02666664|63096566|FG000|Overall Study|Sponsor decision|0|||
33665003|NCT02666664|63096567|FG001|Overall Study|Sponsor decision|1|||
33575928|NCT02053792|62972332|FG000|Overall Study|Lack of Efficacy|1|||
33575929|NCT02053792|62972333|FG001|Overall Study|Lack of Efficacy|0|||
33575930|NCT02053792|62972332|FG000|Overall Study|Adverse Event|1|||
33575931|NCT02053792|62972333|FG001|Overall Study|Adverse Event|0|||
33575932|NCT02053792|62972332|FG000|Overall Study|Withdrawal by Subject|2|||
33575933|NCT02053792|62972333|FG001|Overall Study|Withdrawal by Subject|2|||
33575934|NCT02053792|62972332|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
33575935|NCT02053792|62972333|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
33575936|NCT02053792|62972332|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
33575937|NCT02053792|62972333|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
33575938|NCT02082340|62972341|FG000|Overall Study|Lost to Follow-up|1|||
33575939|NCT02082340|62972342|FG001|Overall Study|Lost to Follow-up|1|||
33575940|NCT02053246|62972348|FG000|Overall Study|Withdrawal by Subject|3|||
33575941|NCT02053246|62972348|FG000|Overall Study|Physician Decision|1|||
33575942|NCT02053168|62972352|FG000|Overall Study|Withdrawal by Subject|1|||
33575943|NCT02053168|62972352|FG000|Overall Study|Physician Decision|1|||
33575944|NCT02053168|62972352|FG000|Overall Study|Lost to Follow-up|1|||
33575945|NCT02052466|62972356|FG000|Overall Study|Withdrawal by Subject|1|||
33575946|NCT02052466|62972356|FG000|Overall Study|Acromial fracture|1|||
33575947|NCT02032888|62972363|FG000|Treatment Period|Poor compliance/noncompliance|1|||
33575948|NCT02032888|62972364|FG001|Treatment Period|Poor compliance/noncompliance|1|||
33575949|NCT02032888|62972365|FG002|Treatment Period|Poor compliance/noncompliance|0|||
33575950|NCT02032888|62972363|FG000|Treatment Period|Other|1|||
33575951|NCT02032888|62972364|FG001|Treatment Period|Other|1|||
33575952|NCT02032888|62972365|FG002|Treatment Period|Other|0|||
33575953|NCT02032888|62972363|FG000|Follow-up Period|Lost to Follow-up|1|||
33575954|NCT02032888|62972364|FG001|Follow-up Period|Lost to Follow-up|1|||
33575955|NCT02032888|62972365|FG002|Follow-up Period|Lost to Follow-up|0|||
33575956|NCT02032888|62972363|FG000|Follow-up Period|Death|1|||
33575957|NCT02032888|62972364|FG001|Follow-up Period|Death|1|||
33575958|NCT02032888|62972365|FG002|Follow-up Period|Death|0|||
33575959|NCT02032888|62972363|FG000|Follow-up Period|Other|1|||
33575960|NCT02032888|62972364|FG001|Follow-up Period|Other|0|||
33575961|NCT02032888|62972365|FG002|Follow-up Period|Other|0|||
33575962|NCT02082262|62972382|FG000|Overall Study|Withdrawal by Subject|3|||
33665004|NCT02666664|63096566|FG000|Overall Study|Lost to Follow-up|1|||
33665005|NCT02666664|63096567|FG001|Overall Study|Lost to Follow-up|2|||
33665006|NCT01528735|63096575|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
33665007|NCT01528735|63096576|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
33665008|NCT01528735|63096575|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
33665009|NCT01528735|63096576|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
33665010|NCT02661594|63096588|FG000|Overall Study|Protocol Violation|1|||
33665011|NCT02661594|63096589|FG001|Overall Study|Protocol Violation|0|||
33665012|NCT02661594|63096590|FG002|Overall Study|Protocol Violation|1|||
33665013|NCT02661594|63096591|FG003|Overall Study|Protocol Violation|0|||
33665014|NCT01528345|63096603|FG000|Overall Study|Adverse Event|10|||
33665015|NCT01528345|63096604|FG001|Overall Study|Adverse Event|1|||
33665016|NCT01528345|63096603|FG000|Overall Study|Death|1|||
33665017|NCT01528345|63096604|FG001|Overall Study|Death|1|||
33665018|NCT01528345|63096603|FG000|Overall Study|Non-compliance with study treatment|1|||
33665019|NCT01528345|63096604|FG001|Overall Study|Non-compliance with study treatment|0|||
33665020|NCT01528345|63096603|FG000|Overall Study|Progressive Disease|26|||
33665021|NCT01528345|63096604|FG001|Overall Study|Progressive Disease|40|||
33665022|NCT01528345|63096603|FG000|Overall Study|Study Terminated by Sponsor|4|||
33665023|NCT01528345|63096604|FG001|Overall Study|Study Terminated by Sponsor|8|||
33665024|NCT01528345|63096603|FG000|Overall Study|Subject/Guardian Decision|5|||
33665025|NCT01528345|63096604|FG001|Overall Study|Subject/Guardian Decision|0|||
33665026|NCT01513967|63096618|FG000|Overall Study|Pregnancy|0|||
33665027|NCT01513967|63096619|FG001|Overall Study|Pregnancy|0|||
33665028|NCT01513967|63096620|FG002|Overall Study|Pregnancy|0|||
33665029|NCT01513967|63096621|FG003|Overall Study|Pregnancy|0|||
33665030|NCT01513967|63096622|FG004|Overall Study|Pregnancy|0|||
33665031|NCT01513967|63096623|FG005|Overall Study|Pregnancy|0|||
33665032|NCT01513967|63096624|FG006|Overall Study|Pregnancy|1|||
33665033|NCT01513967|63096625|FG007|Overall Study|Pregnancy|0|||
33665034|NCT01513967|63096618|FG000|Overall Study|missed a study visit|0|||
33665035|NCT01513967|63096619|FG001|Overall Study|missed a study visit|0|||
33665036|NCT01513967|63096620|FG002|Overall Study|missed a study visit|0|||
33665037|NCT01513967|63096621|FG003|Overall Study|missed a study visit|0|||
33665038|NCT01513967|63096622|FG004|Overall Study|missed a study visit|0|||
33665039|NCT01513967|63096623|FG005|Overall Study|missed a study visit|0|||
33665040|NCT01513967|63096624|FG006|Overall Study|missed a study visit|1|||
33665041|NCT01513967|63096625|FG007|Overall Study|missed a study visit|0|||
33665042|NCT01513967|63096618|FG000|Overall Study|excluded due to positive drug screen|0|||
33665043|NCT01513967|63096619|FG001|Overall Study|excluded due to positive drug screen|0|||
33665044|NCT01513967|63096620|FG002|Overall Study|excluded due to positive drug screen|0|||
33665045|NCT01513967|63096621|FG003|Overall Study|excluded due to positive drug screen|0|||
33665046|NCT01513967|63096622|FG004|Overall Study|excluded due to positive drug screen|0|||
33665047|NCT01513967|63096623|FG005|Overall Study|excluded due to positive drug screen|0|||
33665048|NCT01513967|63096624|FG006|Overall Study|excluded due to positive drug screen|0|||
33665049|NCT01513967|63096625|FG007|Overall Study|excluded due to positive drug screen|2|||
33665050|NCT01513967|63096618|FG000|Overall Study|Physician Decision|0|||
33665051|NCT01513967|63096619|FG001|Overall Study|Physician Decision|0|||
33665052|NCT01513967|63096620|FG002|Overall Study|Physician Decision|0|||
33665053|NCT01513967|63096621|FG003|Overall Study|Physician Decision|0|||
33665054|NCT01513967|63096622|FG004|Overall Study|Physician Decision|0|||
33665055|NCT01513967|63096623|FG005|Overall Study|Physician Decision|1|||
33665056|NCT01513967|63096624|FG006|Overall Study|Physician Decision|0|||
33665057|NCT01513967|63096625|FG007|Overall Study|Physician Decision|0|||
33665058|NCT01511939|63096669|FG000|Overall Study|Withdrawal by Subject|2|||
33303224|NCT01244061|62679138|FG001|Overall Study|Withdrawal by Subject|46|||
33575963|NCT02082262|62972382|FG000|Overall Study|Adverse Event|48|||
33575964|NCT04697069|62972388|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
33575965|NCT04697069|62972389|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
33575966|NCT04697069|62972388|FG000|Overall Study|Study termination|2|||
33575967|NCT04697069|62972389|FG001|Overall Study|Study termination|1|||
33575968|NCT02082184|62972397|FG000|Overall Study|Adverse Event|1|||
33575969|NCT02082184|62972398|FG001|Overall Study|Adverse Event|0|||
33575970|NCT02082184|62972397|FG000|Overall Study|Medical diagnosis|1|||
33575971|NCT02082184|62972398|FG001|Overall Study|Medical diagnosis|2|||
33575972|NCT02082184|62972397|FG000|Overall Study|Device associated symptoms|5|||
33575973|NCT02082184|62972398|FG001|Overall Study|Device associated symptoms|0|||
33575974|NCT02082184|62972397|FG000|Overall Study|Withdrawal by Subject|3|||
33575975|NCT02082184|62972398|FG001|Overall Study|Withdrawal by Subject|2|||
33575976|NCT02082184|62972397|FG000|Overall Study|Protocol Violation|0|||
33575977|NCT02082184|62972398|FG001|Overall Study|Protocol Violation|6|||
33575978|NCT02082184|62972397|FG000|Overall Study|Lost to Follow-up|0|||
33665059|NCT01511939|63096670|FG001|Overall Study|Withdrawal by Subject|1|||
33665060|NCT01511939|63096671|FG002|Overall Study|Withdrawal by Subject|0|||
33575979|NCT02082184|62972398|FG001|Overall Study|Lost to Follow-up|2|||
33575980|NCT02082184|62972397|FG000|Overall Study|Subject non-compliance|0|||
33665061|NCT01576705|63096683|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
33665062|NCT01576705|63096684|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
33665063|NCT01576705|63096685|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
33665064|NCT01576705|63096686|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
33665065|NCT01576705|63096683|FG000|Overall Study|invalid ICF|0|||
33665066|NCT01576705|63096684|FG001|Overall Study|invalid ICF|1|||
33665067|NCT01576705|63096685|FG002|Overall Study|invalid ICF|0|||
33303225|NCT01244061|62679137|FG000|Overall Study|Other|8|||
33303226|NCT01244061|62679138|FG001|Overall Study|Other|19|||
33303227|NCT01244061|62679137|FG000|Overall Study|Protocol Violation|1|||
33303228|NCT01244061|62679138|FG001|Overall Study|Protocol Violation|1|||
33303229|NCT01244061|62679137|FG000|Overall Study|Adverse Event|5|||
33303230|NCT01244061|62679138|FG001|Overall Study|Adverse Event|2|||
33303231|NCT01244061|62679137|FG000|Overall Study|Randomized but not treated|2|||
33303232|NCT01244061|62679138|FG001|Overall Study|Randomized but not treated|2|||
33303233|NCT01243671|62679144|FG000|Overall Study|Adverse Event|3|||
33303234|NCT01243671|62679144|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
33303235|NCT01243671|62679144|FG000|Overall Study|Other|1|||
33303236|NCT01240785|62679150|FG000|Overall Study|Lost to Follow-up|1|||
33575981|NCT02082184|62972398|FG001|Overall Study|Subject non-compliance|1|||
33575982|NCT01624870|62972404|FG000|Overall Study|Death|19|||
33575983|NCT01624870|62972404|FG000|Overall Study|Withdrawal by Subject|1|||
33575984|NCT01624870|62972404|FG000|Overall Study|CoreValve not implanted|6|||
33575985|NCT01624870|62972404|FG000|Overall Study|Lost to follow up|1|||
33575986|NCT02031640|62972415|FG000|Screening Period|Adverse Event|1|||
33575987|NCT02031640|62972416|FG001|Screening Period|Adverse Event|0|||
33575988|NCT02031640|62972417|FG002|Screening Period|Adverse Event|0|||
33575989|NCT02031640|62972418|FG003|Screening Period|Adverse Event|0|||
33575990|NCT02031640|62972419|FG004|Screening Period|Adverse Event|0|||
33575991|NCT02031640|62972420|FG005|Screening Period|Adverse Event|0|||
33575992|NCT02031640|62972415|FG000|Screening Period|Withdrawal by Subject|29|||
33575993|NCT02031640|62972416|FG001|Screening Period|Withdrawal by Subject|0|||
33575994|NCT02031640|62972417|FG002|Screening Period|Withdrawal by Subject|0|||
33575995|NCT02031640|62972418|FG003|Screening Period|Withdrawal by Subject|0|||
33575996|NCT02031640|62972419|FG004|Screening Period|Withdrawal by Subject|0|||
33575997|NCT02031640|62972420|FG005|Screening Period|Withdrawal by Subject|0|||
33575998|NCT02031640|62972415|FG000|Screening Period|Inclusion criteria not met|312|||
33575999|NCT02031640|62972416|FG001|Screening Period|Inclusion criteria not met|0|||
33576000|NCT02031640|62972417|FG002|Screening Period|Inclusion criteria not met|0|||
33576001|NCT02031640|62972418|FG003|Screening Period|Inclusion criteria not met|0|||
33576002|NCT02031640|62972419|FG004|Screening Period|Inclusion criteria not met|0|||
33576003|NCT02031640|62972420|FG005|Screening Period|Inclusion criteria not met|0|||
33576004|NCT02031640|62972415|FG000|Screening Period|Exclusion criteria met|30|||
33576005|NCT02031640|62972416|FG001|Screening Period|Exclusion criteria met|0|||
33576006|NCT02031640|62972417|FG002|Screening Period|Exclusion criteria met|0|||
33576007|NCT02031640|62972418|FG003|Screening Period|Exclusion criteria met|0|||
33576008|NCT02031640|62972419|FG004|Screening Period|Exclusion criteria met|0|||
33576009|NCT02031640|62972420|FG005|Screening Period|Exclusion criteria met|0|||
33576010|NCT02031640|62972415|FG000|Screening Period|Lost to Follow-up|14|||
33576011|NCT02031640|62972416|FG001|Screening Period|Lost to Follow-up|0|||
33576012|NCT02031640|62972417|FG002|Screening Period|Lost to Follow-up|0|||
33576013|NCT02031640|62972418|FG003|Screening Period|Lost to Follow-up|0|||
33576014|NCT02031640|62972419|FG004|Screening Period|Lost to Follow-up|0|||
33576015|NCT02031640|62972420|FG005|Screening Period|Lost to Follow-up|0|||
33576016|NCT02031640|62972415|FG000|Screening Period|Enrollment closed|26|||
33576017|NCT02031640|62972416|FG001|Screening Period|Enrollment closed|0|||
33576018|NCT02031640|62972417|FG002|Screening Period|Enrollment closed|0|||
33576019|NCT02031640|62972418|FG003|Screening Period|Enrollment closed|0|||
33576020|NCT02031640|62972419|FG004|Screening Period|Enrollment closed|0|||
33576021|NCT02031640|62972420|FG005|Screening Period|Enrollment closed|0|||
33576022|NCT02031640|62972415|FG000|Run-In Period|Adverse Event|4|||
33576023|NCT02031640|62972416|FG001|Run-In Period|Adverse Event|0|||
33576024|NCT02031640|62972417|FG002|Run-In Period|Adverse Event|0|||
33576025|NCT02031640|62972418|FG003|Run-In Period|Adverse Event|0|||
33665068|NCT01576705|63096686|FG003|Overall Study|invalid ICF|0|||
33665069|NCT02666430|63096698|FG000|Period 1|Lost to Follow-up|1|||
33303237|NCT01240785|62679151|FG001|Overall Study|Lost to Follow-up|0|||
33303238|NCT01240785|62679150|FG000|Overall Study|Protocol Violation|0|||
33303239|NCT01240785|62679151|FG001|Overall Study|Protocol Violation|3|||
33303240|NCT01240551|62679159|FG000|Overall Study|Refused further treatment|3|||
33303241|NCT01240551|62679160|FG001|Overall Study|Refused further treatment|2|||
33303242|NCT01240551|62679159|FG000|Overall Study|Lost to Follow-up|1|||
33303243|NCT01240551|62679160|FG001|Overall Study|Lost to Follow-up|1|||
33303244|NCT01239381|62679166|FG000|Overall Study|Protocol Violation|1|||
33665070|NCT02666430|63096699|FG001|Period 1|Lost to Follow-up|0|||
33303245|NCT01239381|62679166|FG000|Overall Study|Withdrawal by Subject|1|||
33303246|NCT01266876|62679176|FG000|Overall Study|Adverse Event|0|||
33576026|NCT02031640|62972419|FG004|Run-In Period|Adverse Event|0|||
33303247|NCT01266876|62679177|FG001|Overall Study|Adverse Event|0|||
33303248|NCT01266876|62679178|FG002|Overall Study|Adverse Event|0|||
33303249|NCT01266876|62679179|FG003|Overall Study|Adverse Event|1|||
33303250|NCT01266876|62679180|FG004|Overall Study|Adverse Event|0|||
33303251|NCT01033240|62679195|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
33303252|NCT01033240|62679196|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
33303253|NCT01033240|62679197|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
33303254|NCT01033240|62679195|FG000|Overall Study|Death|2|||
33303255|NCT01033240|62679196|FG001|Overall Study|Death|0|||
33303256|NCT01033240|62679197|FG002|Overall Study|Death|0|||
33303257|NCT01033240|62679195|FG000|Overall Study|Withdrew Consent|2|||
33303258|NCT01033240|62679196|FG001|Overall Study|Withdrew Consent|9|||
33303259|NCT01033240|62679197|FG002|Overall Study|Withdrew Consent|2|||
33303260|NCT01033240|62679195|FG000|Overall Study|Disease Progression|35|||
33303261|NCT01033240|62679196|FG001|Overall Study|Disease Progression|32|||
33303262|NCT01033240|62679197|FG002|Overall Study|Disease Progression|41|||
33303263|NCT01033240|62679195|FG000|Overall Study|Investigator Discretion|0|||
33303264|NCT01033240|62679196|FG001|Overall Study|Investigator Discretion|0|||
33303265|NCT01033240|62679197|FG002|Overall Study|Investigator Discretion|2|||
33303266|NCT01033240|62679195|FG000|Overall Study|Other|0|||
33303267|NCT01033240|62679196|FG001|Overall Study|Other|1|||
33303268|NCT01033240|62679197|FG002|Overall Study|Other|2|||
33303269|NCT01266018|62679205|FG000|Overall Study|Physician Decision|1|||
33303270|NCT01266018|62679206|FG001|Overall Study|Physician Decision|0|||
33303271|NCT01266018|62679205|FG000|Overall Study|Progressive disease|0|||
33303272|NCT01266018|62679206|FG001|Overall Study|Progressive disease|1|||
33303273|NCT01032382|62679214|FG000|Overall Study|Disease dissemination|1|||
33303274|NCT01032382|62679215|FG001|Overall Study|Disease dissemination|1|||
33303275|NCT01032382|62679214|FG000|Overall Study|Treatment failure|3|||
33303276|NCT01032382|62679215|FG001|Overall Study|Treatment failure|1|||
33303277|NCT01032382|62679214|FG000|Overall Study|Index lesion relapse|1|||
33303278|NCT01032382|62679215|FG001|Overall Study|Index lesion relapse|3|||
33303279|NCT01029652|62679223|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
33303280|NCT01029652|62679224|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
33303281|NCT01029652|62679223|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
33303282|NCT01029652|62679224|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
33303283|NCT01029652|62679223|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
33303284|NCT01029652|62679224|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
33303285|NCT01029652|62679223|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
33303286|NCT01029652|62679224|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
33303287|NCT01029652|62679223|FG000|Core Study (0-12 Weeks)|Death|0|||
33303288|NCT01029652|62679224|FG001|Core Study (0-12 Weeks)|Death|1|||
33303289|NCT01029652|62679223|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
33303290|NCT01029652|62679224|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
33303291|NCT01029652|62679223|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
33303292|NCT01029652|62679224|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
33303293|NCT01029652|62679223|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
33303294|NCT01029652|62679224|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
33303295|NCT01029652|62679223|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
33303296|NCT01029652|62679224|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
33303297|NCT01029652|62679223|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
33303298|NCT01029652|62679224|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
33303299|NCT01029652|62679223|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
33303300|NCT01029652|62679224|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
33303301|NCT01029652|62679223|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
33303302|NCT01029652|62679224|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
33303303|NCT01029340|62679253|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
33303304|NCT01029340|62679254|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
33303305|NCT01029340|62679255|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
33303306|NCT01029340|62679256|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
33303307|NCT01029340|62679257|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
33303308|NCT01029340|62679258|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
33303309|NCT01029340|62679253|FG000|Part B Treatment Period|Protocol Violation|0|||
33303310|NCT01029340|62679254|FG001|Part B Treatment Period|Protocol Violation|0|||
33303311|NCT01029340|62679255|FG002|Part B Treatment Period|Protocol Violation|1|||
33303312|NCT01029340|62679256|FG003|Part B Treatment Period|Protocol Violation|0|||
33303313|NCT01029340|62679257|FG004|Part B Treatment Period|Protocol Violation|0|||
33303314|NCT01029340|62679258|FG005|Part B Treatment Period|Protocol Violation|0|||
33396895|NCT00655356|62776132|FG000|Overall Study|Protocol Violation|2|||
33303315|NCT01029340|62679253|FG000|Extension Period|Adverse Event|0|||
33303316|NCT01029340|62679254|FG001|Extension Period|Adverse Event|0|||
33303317|NCT01029340|62679255|FG002|Extension Period|Adverse Event|0|||
33303318|NCT01029340|62679256|FG003|Extension Period|Adverse Event|0|||
33303319|NCT01029340|62679257|FG004|Extension Period|Adverse Event|0|||
33303320|NCT01029340|62679258|FG005|Extension Period|Adverse Event|1|||
33303321|NCT01029340|62679253|FG000|Extension Period|starting another study|0|||
33303322|NCT01029340|62679254|FG001|Extension Period|starting another study|0|||
33303323|NCT01029340|62679255|FG002|Extension Period|starting another study|0|||
33303324|NCT01029340|62679256|FG003|Extension Period|starting another study|0|||
33303325|NCT01029340|62679257|FG004|Extension Period|starting another study|0|||
33303326|NCT01029340|62679258|FG005|Extension Period|starting another study|8|||
33665071|NCT02666430|63096698|FG000|Period 1|Adverse Event|0|||
33665072|NCT02666430|63096699|FG001|Period 1|Adverse Event|1|||
33665073|NCT02666430|63096698|FG000|Period 2|Withdrawal by Subject|1|||
33665074|NCT02666430|63096699|FG001|Period 2|Withdrawal by Subject|4|||
33665075|NCT02666430|63096698|FG000|Period 3|Lost to Follow-up|1|||
33665076|NCT02666430|63096699|FG001|Period 3|Lost to Follow-up|0|||
33665077|NCT01576549|63096705|FG000|Overall Study|Sponsor Decision|2|||
33665078|NCT01576159|63096718|FG000|Overall Study|Withdrawal by Subject|0|||
33665079|NCT01576159|63096719|FG001|Overall Study|Withdrawal by Subject|1|||
33665080|NCT01576159|63096720|FG002|Overall Study|Withdrawal by Subject|0|||
33303327|NCT01029340|62679253|FG000|Extension Period|non-compliance|0|||
33303328|NCT01029340|62679254|FG001|Extension Period|non-compliance|0|||
33303329|NCT01029340|62679255|FG002|Extension Period|non-compliance|0|||
33303330|NCT01029340|62679256|FG003|Extension Period|non-compliance|0|||
33303331|NCT01029340|62679257|FG004|Extension Period|non-compliance|0|||
33303332|NCT01029340|62679258|FG005|Extension Period|non-compliance|1|||
33303333|NCT01029340|62679253|FG000|Extension Period|Withdrawal by Subject|0|||
33303334|NCT01029340|62679254|FG001|Extension Period|Withdrawal by Subject|0|||
33303335|NCT01029340|62679255|FG002|Extension Period|Withdrawal by Subject|0|||
33303336|NCT01029340|62679256|FG003|Extension Period|Withdrawal by Subject|0|||
33303337|NCT01029340|62679257|FG004|Extension Period|Withdrawal by Subject|0|||
33303338|NCT01029340|62679258|FG005|Extension Period|Withdrawal by Subject|1|||
33303339|NCT01029340|62679253|FG000|Extension Period|Physician Decision|0|||
33303340|NCT01029340|62679254|FG001|Extension Period|Physician Decision|0|||
33303341|NCT01029340|62679255|FG002|Extension Period|Physician Decision|0|||
33303342|NCT01029340|62679256|FG003|Extension Period|Physician Decision|0|||
33303343|NCT01029340|62679257|FG004|Extension Period|Physician Decision|0|||
33303344|NCT01029340|62679258|FG005|Extension Period|Physician Decision|1|||
33303345|NCT01265550|62679275|FG000|Pre Randomization|Withdrawal by Subject|0|||
33303346|NCT01265550|62679276|FG001|Pre Randomization|Withdrawal by Subject|0|||
33303347|NCT01265550|62679277|FG002|Pre Randomization|Withdrawal by Subject|0|||
33303348|NCT01265550|62679278|FG003|Pre Randomization|Withdrawal by Subject|70|||
33303349|NCT01265550|62679275|FG000|Pre Randomization|Technical Exclusions|0|||
33303350|NCT01265550|62679276|FG001|Pre Randomization|Technical Exclusions|0|||
33303351|NCT01265550|62679277|FG002|Pre Randomization|Technical Exclusions|0|||
33303352|NCT01265550|62679278|FG003|Pre Randomization|Technical Exclusions|54|||
33303353|NCT01265550|62679275|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
33303354|NCT01265550|62679276|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
33303355|NCT01265550|62679277|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
33303356|NCT01265550|62679278|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
33303357|NCT01265550|62679275|FG000|Pre Randomization|Non-GERD organic disorders|0|||
33303358|NCT01265550|62679276|FG001|Pre Randomization|Non-GERD organic disorders|0|||
33303359|NCT01265550|62679277|FG002|Pre Randomization|Non-GERD organic disorders|0|||
33303360|NCT01265550|62679278|FG003|Pre Randomization|Non-GERD organic disorders|23|||
33303361|NCT01265550|62679275|FG000|Pre Randomization|Functional heartburn|0|||
33303362|NCT01265550|62679276|FG001|Pre Randomization|Functional heartburn|0|||
33303363|NCT01265550|62679277|FG002|Pre Randomization|Functional heartburn|0|||
33303364|NCT01265550|62679278|FG003|Pre Randomization|Functional heartburn|99|||
33303365|NCT01265394|62679292|FG000|Overall Study|Subjects withdrawn|37|||
33303366|NCT01029262|62679299|FG000|Overall Study|Adverse Event|9|||
33303367|NCT01029262|62679300|FG001|Overall Study|Adverse Event|52|||
33303368|NCT01029262|62679299|FG000|Overall Study|Lack of therapeutic effect|57|||
33303369|NCT01029262|62679300|FG001|Overall Study|Lack of therapeutic effect|76|||
33303370|NCT01029262|62679299|FG000|Overall Study|Withdrawal by Subject|10|||
33303371|NCT01029262|62679300|FG001|Overall Study|Withdrawal by Subject|17|||
33303372|NCT01029262|62679299|FG000|Overall Study|Protocol Violation|2|||
33303373|NCT01029262|62679300|FG001|Overall Study|Protocol Violation|3|||
33303374|NCT01029262|62679299|FG000|Overall Study|Miscellaneous|1|||
33303375|NCT01029262|62679300|FG001|Overall Study|Miscellaneous|9|||
33303376|NCT01029262|62679299|FG000|Overall Study|Death|0|||
33303377|NCT01029262|62679300|FG001|Overall Study|Death|3|||
33303378|NCT01028560|62679313|FG000|Overall Study|Lack of Efficacy|3|||
33303379|NCT01028560|62679314|FG001|Overall Study|Lack of Efficacy|6|||
33303380|NCT01028560|62679313|FG000|Overall Study|Withdrawal by Subject|7|||
33303381|NCT01028560|62679314|FG001|Overall Study|Withdrawal by Subject|12|||
33303382|NCT01061710|62679321|FG000|Overall Study|Protocol Violation|14|||
33303383|NCT01028014|62679331|FG000|Overall Study|Lost to Follow-up|1|||
33303384|NCT01028014|62679332|FG001|Overall Study|Lost to Follow-up|2|||
33665081|NCT01576159|63096721|FG003|Overall Study|Withdrawal by Subject|0|||
33303385|NCT01028014|62679333|FG002|Overall Study|Lost to Follow-up|0|||
33303386|NCT01028014|62679334|FG003|Overall Study|Lost to Follow-up|1|||
33303387|NCT01028014|62679335|FG004|Overall Study|Lost to Follow-up|1|||
33303388|NCT01028014|62679336|FG005|Overall Study|Lost to Follow-up|2|||
33303389|NCT01264770|62679356|FG000|Overall Study|Not reported|0|||
33303390|NCT01264770|62679357|FG001|Overall Study|Not reported|0|||
33303391|NCT01264770|62679358|FG002|Overall Study|Not reported|1|||
33303392|NCT01264770|62679359|FG003|Overall Study|Not reported|0|||
33303393|NCT01264770|62679360|FG004|Overall Study|Not reported|0|||
33303394|NCT01264770|62679361|FG005|Overall Study|Not reported|0|||
33303395|NCT01264770|62679356|FG000|Overall Study|e.g., change in circumstances|8|||
33303396|NCT01264770|62679357|FG001|Overall Study|e.g., change in circumstances|3|||
33303397|NCT01264770|62679358|FG002|Overall Study|e.g., change in circumstances|3|||
33303398|NCT01264770|62679359|FG003|Overall Study|e.g., change in circumstances|3|||
33303399|NCT01264770|62679360|FG004|Overall Study|e.g., change in circumstances|4|||
33303400|NCT01264770|62679361|FG005|Overall Study|e.g., change in circumstances|4|||
33303401|NCT01264770|62679356|FG000|Overall Study|Severe non-compliance to protocol|0|||
33303402|NCT01264770|62679357|FG001|Overall Study|Severe non-compliance to protocol|0|||
33303403|NCT01264770|62679358|FG002|Overall Study|Severe non-compliance to protocol|1|||
33303404|NCT01264770|62679359|FG003|Overall Study|Severe non-compliance to protocol|1|||
33303405|NCT01264770|62679360|FG004|Overall Study|Severe non-compliance to protocol|0|||
33303406|NCT01264770|62679361|FG005|Overall Study|Severe non-compliance to protocol|0|||
33303407|NCT01264770|62679356|FG000|Overall Study|Lack of therapeutic response|1|||
33303408|NCT01264770|62679357|FG001|Overall Study|Lack of therapeutic response|0|||
33303409|NCT01264770|62679358|FG002|Overall Study|Lack of therapeutic response|2|||
33303410|NCT01264770|62679359|FG003|Overall Study|Lack of therapeutic response|1|||
33303411|NCT01264770|62679360|FG004|Overall Study|Lack of therapeutic response|1|||
33303412|NCT01264770|62679361|FG005|Overall Study|Lack of therapeutic response|0|||
33303413|NCT01264770|62679356|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
33303414|NCT01264770|62679357|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
33303415|NCT01264770|62679358|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
33303416|NCT01264770|62679359|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
33303417|NCT01264770|62679360|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
33303418|NCT01264770|62679361|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
33303419|NCT01264770|62679356|FG000|Overall Study|Lost to Follow-up|0|||
33303420|NCT01264770|62679357|FG001|Overall Study|Lost to Follow-up|0|||
33303421|NCT01264770|62679358|FG002|Overall Study|Lost to Follow-up|1|||
33303422|NCT01264770|62679359|FG003|Overall Study|Lost to Follow-up|1|||
33303423|NCT01264770|62679360|FG004|Overall Study|Lost to Follow-up|0|||
33303424|NCT01264770|62679361|FG005|Overall Study|Lost to Follow-up|0|||
33303425|NCT01264770|62679356|FG000|Overall Study|Adverse Event|7|||
33303426|NCT01264770|62679357|FG001|Overall Study|Adverse Event|7|||
33303427|NCT01264770|62679358|FG002|Overall Study|Adverse Event|8|||
33303428|NCT01264770|62679359|FG003|Overall Study|Adverse Event|0|||
33303429|NCT01264770|62679360|FG004|Overall Study|Adverse Event|2|||
33303430|NCT01264770|62679361|FG005|Overall Study|Adverse Event|1|||
33303431|NCT01027702|62679381|FG000|Overall Study|Received subsequent therapy|1|||
33303432|NCT01027702|62679382|FG001|Overall Study|Received subsequent therapy|2|||
33665082|NCT01576159|63096718|FG000|Overall Study|Physician Decision|0|||
33665083|NCT01576159|63096719|FG001|Overall Study|Physician Decision|0|||
33665084|NCT01576159|63096720|FG002|Overall Study|Physician Decision|1|||
33303433|NCT01027702|62679383|FG002|Overall Study|Received subsequent therapy|0|||
33303434|NCT01027702|62679384|FG003|Overall Study|Received subsequent therapy|4|||
33303435|NCT01027702|62679385|FG004|Overall Study|Received subsequent therapy|1|||
33303436|NCT01027702|62679386|FG005|Overall Study|Received subsequent therapy|0|||
33303437|NCT01027702|62679387|FG006|Overall Study|Received subsequent therapy|1|||
33303438|NCT01027702|62679381|FG000|Overall Study|Death|0|||
33303439|NCT01027702|62679382|FG001|Overall Study|Death|0|||
33303440|NCT01027702|62679383|FG002|Overall Study|Death|1|||
33303441|NCT01027702|62679384|FG003|Overall Study|Death|0|||
33303442|NCT01027702|62679385|FG004|Overall Study|Death|0|||
33303443|NCT01027702|62679386|FG005|Overall Study|Death|0|||
33303444|NCT01027702|62679387|FG006|Overall Study|Death|0|||
33303445|NCT01302080|62679401|FG000|Overall Study|Withdrew Consent|92|||
33303446|NCT01302080|62679402|FG001|Overall Study|Withdrew Consent|39|||
33396896|NCT00655356|62776133|FG001|Overall Study|Protocol Violation|1|||
33665085|NCT01576159|63096721|FG003|Overall Study|Physician Decision|0|||
33303447|NCT01302080|62679401|FG000|Overall Study|Patient/Family Moved|28|||
33303448|NCT01302080|62679402|FG001|Overall Study|Patient/Family Moved|3|||
33303449|NCT01302080|62679401|FG000|Overall Study|Lost to Follow-up|192|||
33303450|NCT01302080|62679402|FG001|Overall Study|Lost to Follow-up|93|||
33303451|NCT01302080|62679401|FG000|Overall Study|Death|1|||
33303452|NCT01302080|62679402|FG001|Overall Study|Death|0|||
33303453|NCT01302080|62679401|FG000|Overall Study|Other|52|||
33303454|NCT01302080|62679402|FG001|Overall Study|Other|8|||
33303455|NCT01302080|62679401|FG000|Overall Study|Reason Missing For Discontinuation|1|||
33303456|NCT01302080|62679402|FG001|Overall Study|Reason Missing For Discontinuation|0|||
33665086|NCT01576159|63096718|FG000|Overall Study|Lost to Follow-up|0|||
33303457|NCT01238991|62679442|FG000|Overall Study|Adverse Event|1|||
33303458|NCT01238991|62679443|FG001|Overall Study|Adverse Event|0|||
33303459|NCT01238991|62679444|FG002|Overall Study|Adverse Event|3|||
33303460|NCT01238991|62679445|FG003|Overall Study|Adverse Event|1|||
33303461|NCT01238991|62679446|FG004|Overall Study|Adverse Event|1|||
33303462|NCT01238991|62679447|FG005|Overall Study|Adverse Event|0|||
33303463|NCT01238991|62679448|FG006|Overall Study|Adverse Event|1|||
33303464|NCT01238991|62679449|FG007|Overall Study|Adverse Event|1|||
33303465|NCT01238991|62679450|FG008|Overall Study|Adverse Event|0|||
33303466|NCT01238991|62679451|FG009|Overall Study|Adverse Event|0|||
33303467|NCT01238991|62679442|FG000|Overall Study|Death|0|||
33303468|NCT01238991|62679443|FG001|Overall Study|Death|0|||
33303469|NCT01238991|62679444|FG002|Overall Study|Death|0|||
33303470|NCT01238991|62679445|FG003|Overall Study|Death|1|||
33303471|NCT01238991|62679446|FG004|Overall Study|Death|0|||
33303472|NCT01238991|62679447|FG005|Overall Study|Death|0|||
33303473|NCT01238991|62679448|FG006|Overall Study|Death|0|||
33303474|NCT01238991|62679449|FG007|Overall Study|Death|0|||
33303475|NCT01238991|62679450|FG008|Overall Study|Death|0|||
33303476|NCT01238991|62679451|FG009|Overall Study|Death|0|||
33303477|NCT01238991|62679442|FG000|Overall Study|Lack of Efficacy|0|||
33303478|NCT01238991|62679443|FG001|Overall Study|Lack of Efficacy|0|||
33303479|NCT01238991|62679444|FG002|Overall Study|Lack of Efficacy|1|||
33303480|NCT01238991|62679445|FG003|Overall Study|Lack of Efficacy|0|||
33303481|NCT01238991|62679446|FG004|Overall Study|Lack of Efficacy|0|||
33303482|NCT01238991|62679447|FG005|Overall Study|Lack of Efficacy|0|||
33303483|NCT01238991|62679448|FG006|Overall Study|Lack of Efficacy|0|||
33303484|NCT01238991|62679449|FG007|Overall Study|Lack of Efficacy|0|||
33303485|NCT01238991|62679450|FG008|Overall Study|Lack of Efficacy|1|||
33303486|NCT01238991|62679451|FG009|Overall Study|Lack of Efficacy|0|||
33303487|NCT01238991|62679442|FG000|Overall Study|Withdrawal by Subject|0|||
33303488|NCT01238991|62679443|FG001|Overall Study|Withdrawal by Subject|0|||
33303489|NCT01238991|62679444|FG002|Overall Study|Withdrawal by Subject|1|||
33303490|NCT01238991|62679445|FG003|Overall Study|Withdrawal by Subject|0|||
33303491|NCT01238991|62679446|FG004|Overall Study|Withdrawal by Subject|0|||
33303492|NCT01238991|62679447|FG005|Overall Study|Withdrawal by Subject|0|||
33303493|NCT01238991|62679448|FG006|Overall Study|Withdrawal by Subject|0|||
33303494|NCT01238991|62679449|FG007|Overall Study|Withdrawal by Subject|0|||
33303495|NCT01238991|62679450|FG008|Overall Study|Withdrawal by Subject|0|||
33303496|NCT01238991|62679451|FG009|Overall Study|Withdrawal by Subject|0|||
33303497|NCT01238991|62679442|FG000|Overall Study|Study Terminated by Sponsor|0|||
33303498|NCT01238991|62679443|FG001|Overall Study|Study Terminated by Sponsor|0|||
33303499|NCT01238991|62679444|FG002|Overall Study|Study Terminated by Sponsor|0|||
33303500|NCT01238991|62679445|FG003|Overall Study|Study Terminated by Sponsor|0|||
33303501|NCT01238991|62679446|FG004|Overall Study|Study Terminated by Sponsor|1|||
33303502|NCT01238991|62679447|FG005|Overall Study|Study Terminated by Sponsor|0|||
33303503|NCT01238991|62679448|FG006|Overall Study|Study Terminated by Sponsor|7|||
33303504|NCT01238991|62679449|FG007|Overall Study|Study Terminated by Sponsor|4|||
33303505|NCT01238991|62679450|FG008|Overall Study|Study Terminated by Sponsor|2|||
33303506|NCT01238991|62679451|FG009|Overall Study|Study Terminated by Sponsor|2|||
33303507|NCT01238991|62679442|FG000|Overall Study|Caregiver's request|0|||
33303508|NCT01238991|62679443|FG001|Overall Study|Caregiver's request|0|||
33303509|NCT01238991|62679444|FG002|Overall Study|Caregiver's request|0|||
33303510|NCT01238991|62679445|FG003|Overall Study|Caregiver's request|0|||
33303511|NCT01238991|62679446|FG004|Overall Study|Caregiver's request|0|||
33303512|NCT01238991|62679447|FG005|Overall Study|Caregiver's request|0|||
33303513|NCT01238991|62679448|FG006|Overall Study|Caregiver's request|0|||
33303514|NCT01238991|62679449|FG007|Overall Study|Caregiver's request|0|||
33303515|NCT01238991|62679450|FG008|Overall Study|Caregiver's request|1|||
33303516|NCT01238991|62679451|FG009|Overall Study|Caregiver's request|0|||
33303517|NCT01238991|62679442|FG000|Overall Study|Admission to a nursing home|1|||
33303518|NCT01238991|62679443|FG001|Overall Study|Admission to a nursing home|0|||
33303519|NCT01238991|62679444|FG002|Overall Study|Admission to a nursing home|1|||
33303520|NCT01238991|62679445|FG003|Overall Study|Admission to a nursing home|0|||
33303521|NCT01238991|62679446|FG004|Overall Study|Admission to a nursing home|0|||
33303522|NCT01238991|62679447|FG005|Overall Study|Admission to a nursing home|0|||
33303523|NCT01238991|62679448|FG006|Overall Study|Admission to a nursing home|0|||
33303524|NCT01238991|62679449|FG007|Overall Study|Admission to a nursing home|0|||
33303525|NCT01238991|62679450|FG008|Overall Study|Admission to a nursing home|0|||
33303526|NCT01238991|62679451|FG009|Overall Study|Admission to a nursing home|0|||
33303527|NCT01238835|62679476|FG000|Overall Study|Death|124|||
33303528|NCT01238835|62679476|FG000|Overall Study|Withdrawal by Subject|9|||
33303529|NCT01238835|62679476|FG000|Overall Study|Lost to Follow-up|1|||
33303530|NCT01238835|62679476|FG000|Overall Study|Site early discontinuation|2|||
33303531|NCT01032070|62679482|FG000|Overall Study|Disease progression|13|||
33303532|NCT01032070|62679483|FG001|Overall Study|Disease progression|8|||
33303533|NCT01032070|62679482|FG000|Overall Study|Medical or ethical reasons|0|||
33303534|NCT01032070|62679483|FG001|Overall Study|Medical or ethical reasons|2|||
33303535|NCT01032070|62679482|FG000|Overall Study|Withdrawal by Subject|0|||
33303536|NCT01032070|62679483|FG001|Overall Study|Withdrawal by Subject|2|||
33303537|NCT01237899|62679500|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
33303538|NCT01237899|62679501|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
33303539|NCT01237899|62679502|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
33303540|NCT01237899|62679503|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
33303541|NCT01237899|62679504|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
33303542|NCT01237899|62679505|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
33303543|NCT01237899|62679506|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
33303544|NCT01237899|62679507|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
33303545|NCT01237899|62679508|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
33303546|NCT01237899|62679509|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
33303547|NCT01237899|62679510|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
33303548|NCT01264380|62679528|FG000|Period C|Disease Progression|0|||
33303549|NCT01264380|62679529|FG001|Period C|Disease Progression|0|||
33303550|NCT01264380|62679530|FG002|Period C|Disease Progression|4|||
33303551|NCT01264380|62679528|FG000|Period C|Death|0|||
33303552|NCT01264380|62679529|FG001|Period C|Death|0|||
33303553|NCT01264380|62679530|FG002|Period C|Death|2|||
33303554|NCT01264380|62679528|FG000|Period C|Follow-up for survival status|0|||
33303555|NCT01264380|62679529|FG001|Period C|Follow-up for survival status|0|||
33303556|NCT01264380|62679530|FG002|Period C|Follow-up for survival status|6|||
33303557|NCT01264380|62679528|FG000|Period C|Withdrawal by Subject|0|||
33303558|NCT01264380|62679529|FG001|Period C|Withdrawal by Subject|0|||
33303559|NCT01264380|62679530|FG002|Period C|Withdrawal by Subject|1|||
33303560|NCT01264380|62679528|FG000|Period C|Adverse Event|0|||
33303561|NCT01264380|62679529|FG001|Period C|Adverse Event|0|||
33303562|NCT01264380|62679530|FG002|Period C|Adverse Event|1|||
33303563|NCT01263444|62679538|FG000|Overall Study|Adverse Event|8|||
33303564|NCT01263444|62679538|FG000|Overall Study|Withdrawal by Subject|1|||
33303565|NCT01263444|62679538|FG000|Overall Study|Protocol Violation|1|||
33303566|NCT01263054|62679544|FG000|Overall Study|Death|1|||
33303567|NCT01263054|62679545|FG001|Overall Study|Death|0|||
33303568|NCT01263054|62679544|FG000|Overall Study|Lost to Follow-up|2|||
33303569|NCT01263054|62679545|FG001|Overall Study|Lost to Follow-up|2|||
33303570|NCT01263054|62679544|FG000|Overall Study|Withdrawal by Subject|1|||
33303571|NCT01263054|62679545|FG001|Overall Study|Withdrawal by Subject|3|||
33303572|NCT01263054|62679544|FG000|Overall Study|Qualification Violation|1|||
33303573|NCT01263054|62679545|FG001|Overall Study|Qualification Violation|0|||
33303574|NCT01263054|62679544|FG000|Overall Study|Other|0|||
33303575|NCT01263054|62679545|FG001|Overall Study|Other|1|||
33303576|NCT01031836|62679557|FG000|Stage I|Adverse Event|1|||
33303577|NCT01031836|62679558|FG001|Stage I|Adverse Event|1|||
33303578|NCT01031836|62679559|FG002|Stage I|Adverse Event|0|||
33303579|NCT01031836|62679560|FG003|Stage I|Adverse Event|0|||
33303580|NCT01031836|62679561|FG004|Stage I|Adverse Event|0|||
33303581|NCT01031836|62679562|FG005|Stage I|Adverse Event|0|||
33303582|NCT01031836|62679557|FG000|Stage I|Other|0|||
33303583|NCT01031836|62679558|FG001|Stage I|Other|1|||
33303584|NCT01031836|62679559|FG002|Stage I|Other|0|||
33303585|NCT01031836|62679560|FG003|Stage I|Other|0|||
33303586|NCT01031836|62679561|FG004|Stage I|Other|0|||
33303587|NCT01031836|62679562|FG005|Stage I|Other|1|||
33303588|NCT01031836|62679557|FG000|Stage II|Adverse Event|0|||
33303589|NCT01031836|62679558|FG001|Stage II|Adverse Event|0|||
33303590|NCT01031836|62679559|FG002|Stage II|Adverse Event|2|||
33303591|NCT01031836|62679560|FG003|Stage II|Adverse Event|2|||
33303592|NCT01031836|62679561|FG004|Stage II|Adverse Event|1|||
33303593|NCT01031836|62679562|FG005|Stage II|Adverse Event|1|||
33303594|NCT01031836|62679557|FG000|Stage II|Other|2|||
33303595|NCT01031836|62679558|FG001|Stage II|Other|0|||
33303596|NCT01031836|62679559|FG002|Stage II|Other|0|||
33303597|NCT01031836|62679560|FG003|Stage II|Other|1|||
33303598|NCT01031836|62679561|FG004|Stage II|Other|1|||
33303599|NCT01031836|62679562|FG005|Stage II|Other|0|||
33303600|NCT01237587|62679578|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
33303601|NCT01237587|62679579|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
33303602|NCT01237587|62679578|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
33303603|NCT01237587|62679579|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
33303604|NCT01237587|62679578|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
33303605|NCT01237587|62679579|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
33303606|NCT01237587|62679578|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
33303607|NCT01237587|62679579|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
33303608|NCT01237587|62679578|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
33303609|NCT01237587|62679579|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
33303610|NCT01237587|62679578|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
33303611|NCT01237587|62679579|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
33303612|NCT01237587|62679578|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
33303613|NCT01237587|62679579|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
33303614|NCT01237587|62679578|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
33303615|NCT01237587|62679579|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
33303616|NCT01237587|62679578|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
33303617|NCT01237587|62679579|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
33303618|NCT01237587|62679578|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
33303619|NCT01237587|62679579|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
33303620|NCT01237587|62679578|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
33303621|NCT01237587|62679579|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
33303622|NCT01237587|62679578|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
33303623|NCT01237587|62679579|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
33303624|NCT01237587|62679578|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
33303625|NCT01237587|62679579|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
33303626|NCT01237587|62679578|FG000|Taper Phase|Adverse Event|0|||
33303627|NCT01237587|62679579|FG001|Taper Phase|Adverse Event|2|||
33303628|NCT01237587|62679578|FG000|Taper Phase|Protocol Violation|2|||
33303629|NCT01237587|62679579|FG001|Taper Phase|Protocol Violation|0|||
33303630|NCT01237587|62679578|FG000|Taper Phase|Lack of Efficacy|2|||
33303631|NCT01237587|62679579|FG001|Taper Phase|Lack of Efficacy|5|||
33396897|NCT00655356|62776132|FG000|Overall Study|Other Reason|1|||
33396898|NCT00655356|62776133|FG001|Overall Study|Other Reason|0|||
33303632|NCT01237587|62679578|FG000|Taper Phase|Parent/Guardian Decision|0|||
33303633|NCT01237587|62679579|FG001|Taper Phase|Parent/Guardian Decision|2|||
33303634|NCT01237587|62679578|FG000|Taper Phase|Sponsor Decision|1|||
33303635|NCT01237587|62679579|FG001|Taper Phase|Sponsor Decision|0|||
33303636|NCT01237587|62679578|FG000|Taper Phase|Withdrawal by Subject|0|||
33303637|NCT01237587|62679579|FG001|Taper Phase|Withdrawal by Subject|1|||
33303638|NCT01031680|62679594|FG000|Overall Study|Adverse Event|8|||
33303639|NCT01031680|62679595|FG001|Overall Study|Adverse Event|3|||
33303640|NCT01031680|62679594|FG000|Overall Study|Lost to Follow-up|2|||
33303641|NCT01031680|62679595|FG001|Overall Study|Lost to Follow-up|10|||
33303642|NCT01031680|62679594|FG000|Overall Study|Withdrawal by Subject|12|||
33303643|NCT01031680|62679595|FG001|Overall Study|Withdrawal by Subject|16|||
33303644|NCT01031680|62679594|FG000|Overall Study|Death|2|||
33303645|NCT01031680|62679595|FG001|Overall Study|Death|1|||
33303646|NCT01031680|62679594|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
33303647|NCT01031680|62679595|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
33303648|NCT01031680|62679594|FG000|Overall Study|Poor/Non-compliance|5|||
33303649|NCT01031680|62679595|FG001|Overall Study|Poor/Non-compliance|6|||
33303650|NCT01031680|62679594|FG000|Overall Study|Safety|1|||
33303651|NCT01031680|62679595|FG001|Overall Study|Safety|0|||
33303652|NCT01031680|62679594|FG000|Overall Study|Incorrect Enrolment|1|||
33303653|NCT01031680|62679595|FG001|Overall Study|Incorrect Enrolment|2|||
33303654|NCT01031680|62679594|FG000|Overall Study|Administrative Reason by Sponsor|0|||
33303655|NCT01031680|62679595|FG001|Overall Study|Administrative Reason by Sponsor|1|||
33303656|NCT01031680|62679594|FG000|Overall Study|Various|0|||
33303657|NCT01031680|62679595|FG001|Overall Study|Various|2|||
33303658|NCT01031446|62679601|FG000|Overall Study|Disease Progression|38|||
33303659|NCT01031446|62679601|FG000|Overall Study|Adverse Event|9|||
33303660|NCT01031446|62679601|FG000|Overall Study|Physician Decision|4|||
33303661|NCT01031446|62679601|FG000|Overall Study|Withdrawal by Subject|3|||
33303662|NCT01031446|62679601|FG000|Overall Study|Still on treatment|1|||
33303663|NCT01030900|62679607|FG000|Overall Study|Not treated due to congestive heart failure|1|||
33303664|NCT01030900|62679607|FG000|Overall Study|Not treated due to rapid disease|1|||
33303665|NCT01030822|62679614|FG000|Overall Study|Moved/migrated from study area|6|||
33303666|NCT01030822|62679615|FG001|Overall Study|Moved/migrated from study area|7|||
33303667|NCT01030822|62679616|FG002|Overall Study|Moved/migrated from study area|3|||
33303668|NCT01030822|62679614|FG000|Overall Study|Withdrawal by Subject|16|||
33303669|NCT01030822|62679615|FG001|Overall Study|Withdrawal by Subject|13|||
33303670|NCT01030822|62679616|FG002|Overall Study|Withdrawal by Subject|16|||
33303671|NCT01030822|62679614|FG000|Overall Study|Lost to Follow-up|9|||
33303672|NCT01030822|62679615|FG001|Overall Study|Lost to Follow-up|4|||
33303673|NCT01030822|62679616|FG002|Overall Study|Lost to Follow-up|7|||
33303674|NCT01026454|62679627|FG000|Second Intervention|Pregnancy|1|||
33303675|NCT01026454|62679628|FG001|Second Intervention|Pregnancy|1|||
33303676|NCT01026220|62679634|FG000|Induction|Death|1|||
33303677|NCT01026220|62679635|FG001|Induction|Death|0|||
33303678|NCT01026220|62679636|FG002|Induction|Death|0|||
33303679|NCT01026220|62679634|FG000|Induction|Lack of Efficacy|2|||
33303680|NCT01026220|62679635|FG001|Induction|Lack of Efficacy|0|||
33303681|NCT01026220|62679636|FG002|Induction|Lack of Efficacy|0|||
33303682|NCT01026220|62679634|FG000|Induction|Physician Decision|12|||
33303683|NCT01026220|62679635|FG001|Induction|Physician Decision|0|||
33303684|NCT01026220|62679636|FG002|Induction|Physician Decision|0|||
33303685|NCT01026220|62679634|FG000|Induction|Withdrawal by Subject|9|||
33303686|NCT01026220|62679635|FG001|Induction|Withdrawal by Subject|0|||
33303687|NCT01026220|62679636|FG002|Induction|Withdrawal by Subject|0|||
33303688|NCT01026220|62679634|FG000|Induction|Ineligible|1|||
33303689|NCT01026220|62679635|FG001|Induction|Ineligible|0|||
33303690|NCT01026220|62679636|FG002|Induction|Ineligible|0|||
33303691|NCT01026220|62679634|FG000|Consolidation Maintenance|Death|0|||
33303692|NCT01026220|62679635|FG001|Consolidation Maintenance|Death|1|||
33303693|NCT01026220|62679636|FG002|Consolidation Maintenance|Death|0|||
33303694|NCT01026220|62679634|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
33303695|NCT01026220|62679635|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
33303696|NCT01026220|62679636|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
33303697|NCT01026220|62679634|FG000|Consolidation Maintenance|Physician Decision|0|||
33303698|NCT01026220|62679635|FG001|Consolidation Maintenance|Physician Decision|2|||
33303699|NCT01026220|62679636|FG002|Consolidation Maintenance|Physician Decision|7|||
33303700|NCT01026220|62679634|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
33303701|NCT01026220|62679635|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
33303702|NCT01026220|62679636|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
33303703|NCT01026142|62679653|FG000|Overall Study|Death|136|||
33303704|NCT01026142|62679654|FG001|Overall Study|Death|134|||
33303705|NCT01026142|62679653|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
33303706|NCT01026142|62679654|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
33303707|NCT04615403|62679669|FG000|Overall Study|Death|1|||
33303708|NCT04368429|62679679|FG000|Overall Study|Adverse Event|1|||
33303709|NCT04368429|62679680|FG001|Overall Study|Adverse Event|0|||
33303710|NCT04091438|62679697|FG000|Treatment Period 1 (1 Day)|Other|1|||
33303711|NCT04091438|62679698|FG001|Treatment Period 1 (1 Day)|Other|0|||
33303712|NCT04091438|62679697|FG000|Washout Period (1 Day)|Protocol deviation|0|||
33303713|NCT04091438|62679698|FG001|Washout Period (1 Day)|Protocol deviation|1|||
33303714|NCT04091438|62679697|FG000|Washout Period (1 Day)|Other|0|||
33303715|NCT04091438|62679698|FG001|Washout Period (1 Day)|Other|1|||
33303716|NCT04084769|62679710|FG000|Overall Study|Protocol Violation|1|||
33303717|NCT04084769|62679711|FG001|Overall Study|Protocol Violation|3|||
33303718|NCT04084769|62679712|FG002|Overall Study|Protocol Violation|0|||
33303719|NCT04084769|62679713|FG003|Overall Study|Protocol Violation|1|||
33303720|NCT04084769|62679710|FG000|Overall Study|Withdrawal by Subject|0|||
33303721|NCT04084769|62679711|FG001|Overall Study|Withdrawal by Subject|1|||
33303722|NCT04084769|62679712|FG002|Overall Study|Withdrawal by Subject|0|||
33303723|NCT04084769|62679713|FG003|Overall Study|Withdrawal by Subject|0|||
33303724|NCT04084769|62679710|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33303725|NCT04084769|62679711|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33303726|NCT04084769|62679712|FG002|Overall Study|Withdrawal by parent/guardian|0|||
33303727|NCT04084769|62679713|FG003|Overall Study|Withdrawal by parent/guardian|1|||
33303728|NCT04084769|62679710|FG000|Overall Study|Lost to Follow-up|2|||
33303729|NCT04084769|62679711|FG001|Overall Study|Lost to Follow-up|0|||
33303730|NCT04084769|62679712|FG002|Overall Study|Lost to Follow-up|0|||
33303731|NCT04084769|62679713|FG003|Overall Study|Lost to Follow-up|0|||
33303732|NCT03890367|62679731|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33303733|NCT03890367|62679732|FG001|Overall Study|Withdrawal by parent/guardian|3|||
33303734|NCT03890367|62679733|FG002|Overall Study|Withdrawal by parent/guardian|0|||
33303735|NCT03890367|62679731|FG000|Overall Study|Protocol deviation|2|||
33303736|NCT03890367|62679732|FG001|Overall Study|Protocol deviation|2|||
33303737|NCT03890367|62679733|FG002|Overall Study|Protocol deviation|1|||
33303738|NCT03890367|62679731|FG000|Overall Study|Lost to Follow-up|1|||
33303739|NCT03890367|62679732|FG001|Overall Study|Lost to Follow-up|1|||
33303740|NCT03890367|62679733|FG002|Overall Study|Lost to Follow-up|0|||
33303741|NCT03868124|62679744|FG000|Overall Study|Withdrawal by Subject|4|||
33303742|NCT03868124|62679745|FG001|Overall Study|Withdrawal by Subject|0|||
33303743|NCT03868124|62679746|FG002|Overall Study|Withdrawal by Subject|1|||
33303744|NCT03868124|62679744|FG000|Overall Study|Physician Decision|1|||
33303745|NCT03868124|62679745|FG001|Overall Study|Physician Decision|0|||
33303746|NCT03868124|62679746|FG002|Overall Study|Physician Decision|1|||
33303747|NCT03868124|62679744|FG000|Overall Study|Lost to Follow-up|1|||
33303748|NCT03868124|62679745|FG001|Overall Study|Lost to Follow-up|1|||
33303749|NCT03868124|62679746|FG002|Overall Study|Lost to Follow-up|2|||
33303750|NCT03868124|62679744|FG000|Overall Study|Death|1|||
33303751|NCT03868124|62679745|FG001|Overall Study|Death|1|||
33303752|NCT03868124|62679746|FG002|Overall Study|Death|2|||
33303753|NCT03868124|62679744|FG000|Overall Study|Adverse Event|0|||
33303754|NCT03868124|62679745|FG001|Overall Study|Adverse Event|0|||
33303755|NCT03868124|62679746|FG002|Overall Study|Adverse Event|3|||
33576027|NCT02031640|62972420|FG005|Run-In Period|Adverse Event|0|||
33303756|NCT03868124|62679744|FG000|Overall Study|Explanted|2|||
33303757|NCT03868124|62679745|FG001|Overall Study|Explanted|1|||
33303758|NCT03868124|62679746|FG002|Overall Study|Explanted|0|||
33303759|NCT03868124|62679744|FG000|Overall Study|Ongoing in study|176|||
33303760|NCT03868124|62679745|FG001|Overall Study|Ongoing in study|180|||
33303761|NCT03868124|62679746|FG002|Overall Study|Ongoing in study|183|||
33303762|NCT03733249|62679754|FG000|Overall Study|Death|7|||
33665087|NCT01576159|63096719|FG001|Overall Study|Lost to Follow-up|0|||
33303763|NCT03733249|62679754|FG000|Overall Study|Disease relapse|16|||
33303764|NCT03733249|62679754|FG000|Overall Study|Lost to Follow-up|4|||
33303765|NCT03733249|62679754|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
33303766|NCT03733249|62679754|FG000|Overall Study|Withdrawal by Subject|1|||
33303767|NCT03469271|62679766|FG000|Overall Study|Withdrawal by Subject|2|||
33303768|NCT03469271|62679767|FG001|Overall Study|Withdrawal by Subject|0|||
33303769|NCT03469271|62679768|FG002|Overall Study|Withdrawal by Subject|0|||
33303770|NCT03469271|62679769|FG003|Overall Study|Withdrawal by Subject|1|||
33303771|NCT03302234|62679785|FG000|Overall Study|Death|191|||
33303772|NCT03302234|62679786|FG001|Overall Study|Death|192|||
33303773|NCT03302234|62679785|FG000|Overall Study|Withdrawal by Subject|2|||
33303774|NCT03302234|62679786|FG001|Overall Study|Withdrawal by Subject|2|||
33303775|NCT03302234|62679785|FG000|Overall Study|Sponsor Decision|90|||
33303776|NCT03302234|62679786|FG001|Overall Study|Sponsor Decision|89|||
33303777|NCT03302234|62679785|FG000|Overall Study|Laryngeal carcinoma|0|||
33303778|NCT03302234|62679786|FG001|Overall Study|Laryngeal carcinoma|1|||
33303779|NCT03302234|62679785|FG000|Overall Study|Not Reported|1|||
33303780|NCT03302234|62679786|FG001|Overall Study|Not Reported|0|||
33303781|NCT02754596|62679818|FG000|Overall Study|Withdrawal by Subject|3|||
33303782|NCT02754596|62679819|FG001|Overall Study|Withdrawal by Subject|4|||
33303783|NCT02754596|62679820|FG002|Overall Study|Withdrawal by Subject|0|||
33303784|NCT02754596|62679818|FG000|Overall Study|Physician Decision|1|||
33303785|NCT02754596|62679819|FG001|Overall Study|Physician Decision|1|||
33303786|NCT02754596|62679820|FG002|Overall Study|Physician Decision|1|||
33303787|NCT02754596|62679818|FG000|Overall Study|Lost to Follow-up|1|||
33303788|NCT02754596|62679819|FG001|Overall Study|Lost to Follow-up|1|||
33303789|NCT02754596|62679820|FG002|Overall Study|Lost to Follow-up|2|||
33303790|NCT02754596|62679818|FG000|Overall Study|Death|0|||
33303791|NCT02754596|62679819|FG001|Overall Study|Death|2|||
33303792|NCT02754596|62679820|FG002|Overall Study|Death|0|||
33303793|NCT02754596|62679818|FG000|Overall Study|Adverse Event|1|||
33303794|NCT02754596|62679819|FG001|Overall Study|Adverse Event|0|||
33303795|NCT02754596|62679820|FG002|Overall Study|Adverse Event|1|||
33303796|NCT02754596|62679818|FG000|Overall Study|Other|1|||
33303797|NCT02754596|62679819|FG001|Overall Study|Other|0|||
33303798|NCT02754596|62679820|FG002|Overall Study|Other|0|||
33303799|NCT02744898|62679828|FG000|Overall Study|Progressive Disease|2|||
33303800|NCT02744898|62679828|FG000|Overall Study|Physician Decision|1|||
33303801|NCT02744898|62679828|FG000|Overall Study|Toxicity|1|||
33303802|NCT02685826|62679835|FG000|Overall Study|Adverse Event|2|||
33303803|NCT02685826|62679836|FG001|Overall Study|Adverse Event|0|||
33303804|NCT02685826|62679837|FG002|Overall Study|Adverse Event|1|||
33303805|NCT02685826|62679835|FG000|Overall Study|Progressive Disease|2|||
33303806|NCT02685826|62679836|FG001|Overall Study|Progressive Disease|1|||
33303807|NCT02685826|62679837|FG002|Overall Study|Progressive Disease|0|||
33303808|NCT02685826|62679835|FG000|Overall Study|Withdrawal by Subject|2|||
33303809|NCT02685826|62679836|FG001|Overall Study|Withdrawal by Subject|0|||
33303810|NCT02685826|62679837|FG002|Overall Study|Withdrawal by Subject|0|||
33303811|NCT02685826|62679835|FG000|Overall Study|Full Clinical Hold by FDA|19|||
33303812|NCT02685826|62679836|FG001|Overall Study|Full Clinical Hold by FDA|9|||
33303813|NCT02685826|62679837|FG002|Overall Study|Full Clinical Hold by FDA|20|||
33303814|NCT02095132|62679854|FG000|Overall Study|Adverse Event|0|||
33303815|NCT02095132|62679855|FG001|Overall Study|Adverse Event|0|||
33303816|NCT02095132|62679856|FG002|Overall Study|Adverse Event|0|||
33303817|NCT02095132|62679857|FG003|Overall Study|Adverse Event|0|||
33303818|NCT02095132|62679858|FG004|Overall Study|Adverse Event|1|||
33303819|NCT02095132|62679859|FG005|Overall Study|Adverse Event|0|||
33303820|NCT02095132|62679860|FG006|Overall Study|Adverse Event|1|||
33303821|NCT02095132|62679861|FG007|Overall Study|Adverse Event|0|||
33303822|NCT02095132|62679862|FG008|Overall Study|Adverse Event|0|||
33303823|NCT02095132|62679854|FG000|Overall Study|Death|0|||
33303824|NCT02095132|62679855|FG001|Overall Study|Death|0|||
33303825|NCT02095132|62679856|FG002|Overall Study|Death|0|||
33303826|NCT02095132|62679857|FG003|Overall Study|Death|0|||
33303827|NCT02095132|62679858|FG004|Overall Study|Death|0|||
33303828|NCT02095132|62679859|FG005|Overall Study|Death|0|||
33303829|NCT02095132|62679860|FG006|Overall Study|Death|1|||
33303830|NCT02095132|62679861|FG007|Overall Study|Death|0|||
33303831|NCT02095132|62679862|FG008|Overall Study|Death|0|||
33303832|NCT02095132|62679854|FG000|Overall Study|Lack of Efficacy|3|||
33303833|NCT02095132|62679855|FG001|Overall Study|Lack of Efficacy|5|||
33303834|NCT02095132|62679856|FG002|Overall Study|Lack of Efficacy|2|||
33303835|NCT02095132|62679857|FG003|Overall Study|Lack of Efficacy|8|||
33303836|NCT02095132|62679858|FG004|Overall Study|Lack of Efficacy|3|||
33303837|NCT02095132|62679859|FG005|Overall Study|Lack of Efficacy|6|||
33303838|NCT02095132|62679860|FG006|Overall Study|Lack of Efficacy|10|||
33303839|NCT02095132|62679861|FG007|Overall Study|Lack of Efficacy|9|||
33303840|NCT02095132|62679862|FG008|Overall Study|Lack of Efficacy|8|||
33303841|NCT02095132|62679854|FG000|Overall Study|Physician Decision|1|||
33303842|NCT02095132|62679855|FG001|Overall Study|Physician Decision|0|||
33303843|NCT02095132|62679856|FG002|Overall Study|Physician Decision|0|||
33576028|NCT02031640|62972415|FG000|Run-In Period|Withdrawal by Subject|17|||
33303844|NCT02095132|62679857|FG003|Overall Study|Physician Decision|0|||
33303845|NCT02095132|62679858|FG004|Overall Study|Physician Decision|0|||
33303846|NCT02095132|62679859|FG005|Overall Study|Physician Decision|0|||
33303847|NCT02095132|62679860|FG006|Overall Study|Physician Decision|1|||
33303848|NCT02095132|62679861|FG007|Overall Study|Physician Decision|0|||
33303849|NCT02095132|62679862|FG008|Overall Study|Physician Decision|2|||
33303850|NCT02095132|62679854|FG000|Overall Study|Withdrawal by Subject|0|||
33303851|NCT02095132|62679855|FG001|Overall Study|Withdrawal by Subject|0|||
33303852|NCT02095132|62679856|FG002|Overall Study|Withdrawal by Subject|2|||
33303853|NCT02095132|62679857|FG003|Overall Study|Withdrawal by Subject|2|||
33303854|NCT02095132|62679858|FG004|Overall Study|Withdrawal by Subject|3|||
33303855|NCT02095132|62679859|FG005|Overall Study|Withdrawal by Subject|0|||
33303856|NCT02095132|62679860|FG006|Overall Study|Withdrawal by Subject|5|||
33303857|NCT02095132|62679861|FG007|Overall Study|Withdrawal by Subject|0|||
33303858|NCT02095132|62679862|FG008|Overall Study|Withdrawal by Subject|0|||
33303859|NCT02025010|62679885|FG000|Overall Study|Symptomatic or radiographic progression|36|||
33303860|NCT02025010|62679885|FG000|Overall Study|Adverse Event|6|||
33303861|NCT02025010|62679885|FG000|Overall Study|Physician Decision|7|||
33303862|NCT02025010|62679885|FG000|Overall Study|Withdrawal by Subject|3|||
33303863|NCT02025010|62679885|FG000|Overall Study|Intercurrent illness|3|||
33303864|NCT02025010|62679885|FG000|Overall Study|Patients still on treatment|3|||
33303865|NCT02025010|62679885|FG000|Overall Study|Never initiate the treatment|2|||
33303866|NCT01867333|62679893|FG000|Overall Study|Withdrawal by Subject|1|||
33303867|NCT01867333|62679894|FG001|Overall Study|Withdrawal by Subject|0|||
33303868|NCT01867333|62679893|FG000|Overall Study|Adverse Event|1|||
33303869|NCT01867333|62679894|FG001|Overall Study|Adverse Event|0|||
33303870|NCT01867333|62679893|FG000|Overall Study|Participant choice|1|||
33303871|NCT01867333|62679894|FG001|Overall Study|Participant choice|2|||
33303872|NCT01867333|62679893|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
33303873|NCT01867333|62679894|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
33303874|NCT01867333|62679893|FG000|Overall Study|Death|0|||
33303875|NCT01867333|62679894|FG001|Overall Study|Death|1|||
33303876|NCT01867333|62679893|FG000|Overall Study|Physician Decision|3|||
33303877|NCT01867333|62679894|FG001|Overall Study|Physician Decision|2|||
33303878|NCT01867333|62679893|FG000|Overall Study|Switched to alternative treatment|1|||
33303879|NCT01867333|62679894|FG001|Overall Study|Switched to alternative treatment|0|||
33303880|NCT01534494|62679900|FG000|Overall Study|Withdrawal by Subject|1|||
33303881|NCT00788671|62679913|FG000|Overall Study|Death|2|||
33303882|NCT00788671|62679913|FG000|Overall Study|Unable to biopsy|1|||
33396899|NCT00571064|62776139|FG000|Overall Study|Adverse Event|13|||
33396900|NCT00571064|62776139|FG000|Overall Study|Protocol Violation|4|||
33396901|NCT00571064|62776139|FG000|Overall Study|Withdrawal by Subject|2|||
33396902|NCT00571064|62776139|FG000|Overall Study|Other|2|||
33396903|NCT03895372|62776152|FG000|Investigational Treatment Period|Adverse Event|1|||
33396904|NCT03895372|62776153|FG001|Investigational Treatment Period|Adverse Event|0|||
33396905|NCT03895372|62776154|FG002|Investigational Treatment Period|Adverse Event|0|||
33396906|NCT03895372|62776155|FG003|Investigational Treatment Period|Adverse Event|0|||
33396907|NCT03895372|62776156|FG004|Investigational Treatment Period|Adverse Event|0|||
33396908|NCT03895372|62776157|FG005|Investigational Treatment Period|Adverse Event|0|||
33396909|NCT03895372|62776158|FG006|Investigational Treatment Period|Adverse Event|4|||
33396910|NCT03895372|62776159|FG007|Investigational Treatment Period|Adverse Event|3|||
33396911|NCT03895372|62776152|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
33396912|NCT03895372|62776153|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
33396913|NCT03895372|62776154|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
33396914|NCT03895372|62776155|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
33396915|NCT03895372|62776156|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
33396916|NCT03895372|62776157|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
33396917|NCT03895372|62776158|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
33396918|NCT03895372|62776159|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
33396919|NCT03895372|62776152|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
33396920|NCT03895372|62776153|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
33396921|NCT03895372|62776154|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
33396922|NCT03895372|62776155|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
33396923|NCT03895372|62776156|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
33396924|NCT03895372|62776157|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
33396925|NCT03895372|62776158|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
33396926|NCT03895372|62776159|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
33303883|NCT00788671|62679913|FG000|Overall Study|Withdrawal by Subject|4|||
33303884|NCT00788671|62679913|FG000|Overall Study|IUD expulsed|1|||
33303885|NCT00788671|62679913|FG000|Overall Study|Lost to follow up|2|||
33303886|NCT00602797|62679917|FG000|Overall Study|Adverse Event|1|||
33303887|NCT00550615|62679924|FG000|Overall Study|Withdrawal by Subject|0|||
33303888|NCT00550615|62679925|FG001|Overall Study|Withdrawal by Subject|0|||
33303889|NCT00550615|62679926|FG002|Overall Study|Withdrawal by Subject|2|||
33303890|NCT00550615|62679927|FG003|Overall Study|Withdrawal by Subject|3|||
33303891|NCT00550615|62679924|FG000|Overall Study|Not evaluable|0|||
33303892|NCT00550615|62679925|FG001|Overall Study|Not evaluable|0|||
33303893|NCT00550615|62679926|FG002|Overall Study|Not evaluable|2|||
33303894|NCT00550615|62679927|FG003|Overall Study|Not evaluable|7|||
33303895|NCT00006721|62679940|FG000|Overall Study|Adverse Event|0|||
33303896|NCT00006721|62679941|FG001|Overall Study|Adverse Event|4|||
33303897|NCT00006721|62679942|FG002|Overall Study|Adverse Event|4|||
33303898|NCT00006721|62679940|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
33303899|NCT00006721|62679941|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
33303900|NCT00006721|62679942|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
33303901|NCT00006721|62679940|FG000|Overall Study|Progression/Relapse|0|||
33303902|NCT00006721|62679941|FG001|Overall Study|Progression/Relapse|1|||
33303903|NCT00006721|62679942|FG002|Overall Study|Progression/Relapse|2|||
33303904|NCT00006721|62679940|FG000|Overall Study|Death|0|||
33303905|NCT00006721|62679941|FG001|Overall Study|Death|1|||
33303906|NCT00006721|62679942|FG002|Overall Study|Death|2|||
33303907|NCT00006721|62679940|FG000|Overall Study|Other - Not Protocol Specified|0|||
33303908|NCT00006721|62679941|FG001|Overall Study|Other - Not Protocol Specified|7|||
33303909|NCT00006721|62679942|FG002|Overall Study|Other - Not Protocol Specified|7|||
33303910|NCT00006721|62679940|FG000|Overall Study|Ineligible|2|||
33303911|NCT00006721|62679941|FG001|Overall Study|Ineligible|12|||
33303912|NCT00006721|62679942|FG002|Overall Study|Ineligible|10|||
33303913|NCT00006721|62679940|FG000|Overall Study|Eligible but no Treatment Received|1|||
33303914|NCT00006721|62679941|FG001|Overall Study|Eligible but no Treatment Received|0|||
33303915|NCT00006721|62679942|FG002|Overall Study|Eligible but no Treatment Received|0|||
33396927|NCT03895372|62776152|FG000|Investigational Treatment Period|Other|0|||
33396928|NCT03895372|62776153|FG001|Investigational Treatment Period|Other|0|||
33396929|NCT03895372|62776154|FG002|Investigational Treatment Period|Other|0|||
33396930|NCT03895372|62776155|FG003|Investigational Treatment Period|Other|0|||
33396931|NCT03895372|62776156|FG004|Investigational Treatment Period|Other|0|||
33396932|NCT03895372|62776157|FG005|Investigational Treatment Period|Other|1|||
33396933|NCT03895372|62776158|FG006|Investigational Treatment Period|Other|0|||
33396934|NCT03895372|62776159|FG007|Investigational Treatment Period|Other|2|||
33396935|NCT03895372|62776152|FG000|Investigational Treatment Period|Protocol Violation|0|||
33396936|NCT03895372|62776153|FG001|Investigational Treatment Period|Protocol Violation|0|||
33396937|NCT03895372|62776154|FG002|Investigational Treatment Period|Protocol Violation|0|||
33396938|NCT03895372|62776155|FG003|Investigational Treatment Period|Protocol Violation|1|||
33396939|NCT03895372|62776156|FG004|Investigational Treatment Period|Protocol Violation|0|||
33396940|NCT03895372|62776157|FG005|Investigational Treatment Period|Protocol Violation|0|||
33396941|NCT03895372|62776158|FG006|Investigational Treatment Period|Protocol Violation|0|||
33396942|NCT03895372|62776159|FG007|Investigational Treatment Period|Protocol Violation|0|||
33396943|NCT03895372|62776152|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
33396944|NCT03895372|62776153|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
33396945|NCT03895372|62776154|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
33396946|NCT03895372|62776155|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
33396947|NCT03895372|62776156|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
33396948|NCT03895372|62776157|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
33396949|NCT03895372|62776158|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
33396950|NCT03895372|62776159|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
33396951|NCT03895372|62776152|FG000|Extension Treatment Period|Adverse Event|0|||
33396952|NCT03895372|62776153|FG001|Extension Treatment Period|Adverse Event|1|||
33396953|NCT03895372|62776154|FG002|Extension Treatment Period|Adverse Event|0|||
33396954|NCT03895372|62776155|FG003|Extension Treatment Period|Adverse Event|1|||
33396955|NCT03895372|62776156|FG004|Extension Treatment Period|Adverse Event|0|||
33396956|NCT03895372|62776157|FG005|Extension Treatment Period|Adverse Event|0|||
33396957|NCT03895372|62776158|FG006|Extension Treatment Period|Adverse Event|3|||
33396958|NCT03895372|62776159|FG007|Extension Treatment Period|Adverse Event|3|||
33396959|NCT03895372|62776152|FG000|Extension Treatment Period|Other|1|||
33396960|NCT03895372|62776153|FG001|Extension Treatment Period|Other|3|||
33396961|NCT03895372|62776154|FG002|Extension Treatment Period|Other|0|||
33396962|NCT03895372|62776155|FG003|Extension Treatment Period|Other|0|||
33396963|NCT03895372|62776156|FG004|Extension Treatment Period|Other|1|||
33396964|NCT03895372|62776157|FG005|Extension Treatment Period|Other|0|||
33396965|NCT03895372|62776158|FG006|Extension Treatment Period|Other|0|||
33396966|NCT03895372|62776159|FG007|Extension Treatment Period|Other|2|||
33396967|NCT03895372|62776152|FG000|Extension Treatment Period|Pregnancy|0|||
33396968|NCT03895372|62776153|FG001|Extension Treatment Period|Pregnancy|0|||
33396969|NCT03895372|62776154|FG002|Extension Treatment Period|Pregnancy|0|||
33396970|NCT03895372|62776155|FG003|Extension Treatment Period|Pregnancy|0|||
33396971|NCT03895372|62776156|FG004|Extension Treatment Period|Pregnancy|1|||
33396972|NCT03895372|62776157|FG005|Extension Treatment Period|Pregnancy|0|||
33396973|NCT03895372|62776158|FG006|Extension Treatment Period|Pregnancy|0|||
33396974|NCT03895372|62776159|FG007|Extension Treatment Period|Pregnancy|0|||
33396975|NCT03895372|62776152|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
33396976|NCT03895372|62776153|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
33303916|NCT01030666|62679954|FG000|Overall Study|Lost to Follow-up|3|||
33303917|NCT01030666|62679955|FG001|Overall Study|Lost to Follow-up|2|||
33303918|NCT01025752|62679964|FG000|Overall Study|Lost to Follow-up|7|||
33303919|NCT01025752|62679965|FG001|Overall Study|Lost to Follow-up|10|||
33303920|NCT01025752|62679964|FG000|Overall Study|Physician Decision|1|||
33303921|NCT01025752|62679965|FG001|Overall Study|Physician Decision|3|||
33303922|NCT01030198|62679973|FG000|Overall Study|Could not measure efficacy accurately|0|||
33303923|NCT01030198|62679974|FG001|Overall Study|Could not measure efficacy accurately|7|||
33303924|NCT01301456|62679992|FG000|Stage 1|Withdrawal by Subject|0|||
33303925|NCT01301456|62679993|FG001|Stage 1|Withdrawal by Subject|0|||
33303926|NCT01301456|62679994|FG002|Stage 1|Withdrawal by Subject|1|||
33303927|NCT01301456|62679995|FG003|Stage 1|Withdrawal by Subject|0|||
33303928|NCT01301456|62679996|FG004|Stage 1|Withdrawal by Subject|1|||
33303929|NCT01301456|62679997|FG005|Stage 1|Withdrawal by Subject|0|||
33303930|NCT01301456|62679998|FG006|Stage 1|Withdrawal by Subject|0|||
33303931|NCT01301456|62679999|FG007|Stage 1|Withdrawal by Subject|0|||
33303932|NCT01301456|62680000|FG008|Stage 1|Withdrawal by Subject|0|||
33303933|NCT01301456|62680001|FG009|Stage 1|Withdrawal by Subject|0|||
33303934|NCT01301456|62680002|FG010|Stage 1|Withdrawal by Subject|0|||
33303935|NCT01301456|62680003|FG011|Stage 1|Withdrawal by Subject|0|||
33303936|NCT01301456|62679992|FG000|Stage 1|Randomized but not treated|0|||
33303937|NCT01301456|62679993|FG001|Stage 1|Randomized but not treated|0|||
33303938|NCT01301456|62679994|FG002|Stage 1|Randomized but not treated|0|||
33303939|NCT01301456|62679995|FG003|Stage 1|Randomized but not treated|0|||
33303940|NCT01301456|62679996|FG004|Stage 1|Randomized but not treated|0|||
33303941|NCT01301456|62679997|FG005|Stage 1|Randomized but not treated|0|||
33303942|NCT01301456|62679998|FG006|Stage 1|Randomized but not treated|1|||
33303943|NCT01301456|62679999|FG007|Stage 1|Randomized but not treated|0|||
33303944|NCT01301456|62680000|FG008|Stage 1|Randomized but not treated|0|||
33303945|NCT01301456|62680001|FG009|Stage 1|Randomized but not treated|0|||
33303946|NCT01301456|62680002|FG010|Stage 1|Randomized but not treated|0|||
33303947|NCT01301456|62680003|FG011|Stage 1|Randomized but not treated|0|||
33303948|NCT01301456|62679992|FG000|Stage 2|Adverse Event|0|||
33303949|NCT01301456|62679993|FG001|Stage 2|Adverse Event|0|||
33303950|NCT01301456|62679994|FG002|Stage 2|Adverse Event|0|||
33303951|NCT01301456|62679995|FG003|Stage 2|Adverse Event|0|||
33303952|NCT01301456|62679996|FG004|Stage 2|Adverse Event|0|||
33303953|NCT01301456|62679997|FG005|Stage 2|Adverse Event|0|||
33303954|NCT01301456|62679998|FG006|Stage 2|Adverse Event|0|||
33303955|NCT01301456|62679999|FG007|Stage 2|Adverse Event|0|||
33303956|NCT01301456|62680000|FG008|Stage 2|Adverse Event|0|||
33303957|NCT01301456|62680001|FG009|Stage 2|Adverse Event|0|||
33303958|NCT01301456|62680002|FG010|Stage 2|Adverse Event|1|||
33303959|NCT01301456|62680003|FG011|Stage 2|Adverse Event|0|||
33303960|NCT01023256|62680051|FG000|Overall Study|Protocol Violation|2|||
33303961|NCT01023256|62680052|FG001|Overall Study|Protocol Violation|3|||
33303962|NCT01023256|62680053|FG002|Overall Study|Protocol Violation|0|||
33303963|NCT01023256|62680054|FG003|Overall Study|Protocol Violation|0|||
33303964|NCT01023256|62680051|FG000|Overall Study|Randomized but not treated|1|||
33303965|NCT01023256|62680052|FG001|Overall Study|Randomized but not treated|0|||
33303966|NCT01023256|62680053|FG002|Overall Study|Randomized but not treated|1|||
33303967|NCT01023256|62680054|FG003|Overall Study|Randomized but not treated|0|||
33303968|NCT01023256|62680051|FG000|Overall Study|Other|1|||
33303969|NCT01023256|62680052|FG001|Overall Study|Other|0|||
33303970|NCT01023256|62680053|FG002|Overall Study|Other|0|||
33303971|NCT01023256|62680054|FG003|Overall Study|Other|2|||
33303972|NCT01023256|62680051|FG000|Overall Study|Adverse Event|0|||
33303973|NCT01023256|62680052|FG001|Overall Study|Adverse Event|0|||
33303974|NCT01023256|62680053|FG002|Overall Study|Adverse Event|0|||
33303975|NCT01023256|62680054|FG003|Overall Study|Adverse Event|1|||
33303976|NCT01023256|62680051|FG000|Overall Study|Withdrawal by Subject|0|||
33303977|NCT01023256|62680052|FG001|Overall Study|Withdrawal by Subject|0|||
33303978|NCT01023256|62680053|FG002|Overall Study|Withdrawal by Subject|0|||
33303979|NCT01023256|62680054|FG003|Overall Study|Withdrawal by Subject|2|||
33303980|NCT01023022|62680067|FG000|Overall Study|Death|5|||
33303981|NCT01023022|62680067|FG000|Overall Study|Lost to Follow-up|7|||
33303982|NCT01023022|62680067|FG000|Overall Study|due to technical issues|2|||
33303983|NCT01058668|62680074|FG000|Double-blind Treatment Phase|Adverse Event|8|||
33303984|NCT01058668|62680075|FG001|Double-blind Treatment Phase|Adverse Event|15|||
33303985|NCT01058668|62680076|FG002|Double-blind Treatment Phase|Adverse Event|25|||
33303986|NCT01058668|62680074|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
33303987|NCT01058668|62680075|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
33303988|NCT01058668|62680076|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
33303989|NCT01058668|62680074|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
33303990|NCT01058668|62680075|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
33303991|NCT01058668|62680076|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
33303992|NCT01058668|62680074|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
33303993|NCT01058668|62680075|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
33303994|NCT01058668|62680076|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
33303995|NCT01058668|62680074|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
33303996|NCT01058668|62680075|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
33303997|NCT01058668|62680076|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
33303998|NCT01058668|62680074|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
33303999|NCT01058668|62680075|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
33304000|NCT01058668|62680076|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
33304001|NCT01301066|62680086|FG000|Overall Study|Lost to Follow-up|5|||
33304002|NCT01301066|62680087|FG001|Overall Study|Lost to Follow-up|11|||
33304003|NCT01301066|62680086|FG000|Overall Study|Protocol Violation|8|||
33304004|NCT01301066|62680087|FG001|Overall Study|Protocol Violation|7|||
33304005|NCT01301066|62680086|FG000|Overall Study|Withdrawal by Subject|4|||
33304006|NCT01301066|62680087|FG001|Overall Study|Withdrawal by Subject|9|||
33304007|NCT01301066|62680086|FG000|Overall Study|Adverse Event|6|||
33304008|NCT01301066|62680087|FG001|Overall Study|Adverse Event|6|||
33304009|NCT01301066|62680086|FG000|Overall Study|Sponsor Decision|2|||
33304010|NCT01301066|62680087|FG001|Overall Study|Sponsor Decision|1|||
33304011|NCT01301066|62680086|FG000|Overall Study|Physician Decision|0|||
33304012|NCT01301066|62680087|FG001|Overall Study|Physician Decision|1|||
33304013|NCT01301066|62680086|FG000|Overall Study|Other|2|||
33304014|NCT01301066|62680087|FG001|Overall Study|Other|0|||
33304015|NCT01022398|62680095|FG000|Overall Study|Study terminated|2|||
33304016|NCT01022398|62680096|FG001|Overall Study|Study terminated|2|||
33304017|NCT01262976|62680107|FG000|Up to Month 2|Serious Adverse Event|0|||
33304018|NCT01262976|62680108|FG001|Up to Month 2|Serious Adverse Event|0|||
33304019|NCT01262976|62680109|FG002|Up to Month 2|Serious Adverse Event|1|||
33304020|NCT01262976|62680110|FG003|Up to Month 2|Serious Adverse Event|0|||
33304021|NCT01262976|62680111|FG004|Up to Month 2|Serious Adverse Event|0|||
33304022|NCT01262976|62680112|FG005|Up to Month 2|Serious Adverse Event|0|||
33304023|NCT01262976|62680107|FG000|Up to Month 2|Withdrawal by Subject|1|||
33304024|NCT01262976|62680108|FG001|Up to Month 2|Withdrawal by Subject|0|||
33304025|NCT01262976|62680109|FG002|Up to Month 2|Withdrawal by Subject|0|||
33304026|NCT01262976|62680110|FG003|Up to Month 2|Withdrawal by Subject|0|||
33304027|NCT01262976|62680111|FG004|Up to Month 2|Withdrawal by Subject|0|||
33304028|NCT01262976|62680112|FG005|Up to Month 2|Withdrawal by Subject|0|||
33304029|NCT01262976|62680107|FG000|Up to Month 2|Migrated/moved from study area|0|||
33304030|NCT01262976|62680108|FG001|Up to Month 2|Migrated/moved from study area|1|||
33304031|NCT01262976|62680109|FG002|Up to Month 2|Migrated/moved from study area|0|||
33304032|NCT01262976|62680110|FG003|Up to Month 2|Migrated/moved from study area|0|||
33304033|NCT01262976|62680111|FG004|Up to Month 2|Migrated/moved from study area|1|||
33304034|NCT01262976|62680112|FG005|Up to Month 2|Migrated/moved from study area|1|||
33304035|NCT01262976|62680107|FG000|Up to Month 2|Lost to Follow-up|1|||
33304036|NCT01262976|62680108|FG001|Up to Month 2|Lost to Follow-up|0|||
33304037|NCT01262976|62680109|FG002|Up to Month 2|Lost to Follow-up|0|||
33304038|NCT01262976|62680110|FG003|Up to Month 2|Lost to Follow-up|1|||
33304039|NCT01262976|62680111|FG004|Up to Month 2|Lost to Follow-up|1|||
33304040|NCT01262976|62680112|FG005|Up to Month 2|Lost to Follow-up|1|||
33304041|NCT01262976|62680107|FG000|Up to Month 2|Other|1|||
33304042|NCT01262976|62680108|FG001|Up to Month 2|Other|0|||
33304043|NCT01262976|62680109|FG002|Up to Month 2|Other|0|||
33304044|NCT01262976|62680110|FG003|Up to Month 2|Other|1|||
33304045|NCT01262976|62680111|FG004|Up to Month 2|Other|0|||
33304046|NCT01262976|62680112|FG005|Up to Month 2|Other|2|||
33304047|NCT01262976|62680107|FG000|Up to Month 7|Serious Adverse Event|0|||
33304048|NCT01262976|62680108|FG001|Up to Month 7|Serious Adverse Event|0|||
33304049|NCT01262976|62680109|FG002|Up to Month 7|Serious Adverse Event|2|||
33304050|NCT01262976|62680110|FG003|Up to Month 7|Serious Adverse Event|0|||
33304051|NCT01262976|62680111|FG004|Up to Month 7|Serious Adverse Event|0|||
33304052|NCT01262976|62680112|FG005|Up to Month 7|Serious Adverse Event|0|||
33304053|NCT01262976|62680107|FG000|Up to Month 7|Withdrawal by Subject|1|||
33304054|NCT01262976|62680108|FG001|Up to Month 7|Withdrawal by Subject|0|||
33304055|NCT01262976|62680109|FG002|Up to Month 7|Withdrawal by Subject|0|||
33304056|NCT01262976|62680110|FG003|Up to Month 7|Withdrawal by Subject|0|||
33304057|NCT01262976|62680111|FG004|Up to Month 7|Withdrawal by Subject|0|||
33304058|NCT01262976|62680112|FG005|Up to Month 7|Withdrawal by Subject|0|||
33304059|NCT01262976|62680107|FG000|Up to Month 7|Migrated/moved from study area|0|||
33304060|NCT01262976|62680108|FG001|Up to Month 7|Migrated/moved from study area|0|||
33304061|NCT01262976|62680109|FG002|Up to Month 7|Migrated/moved from study area|1|||
33304062|NCT01262976|62680110|FG003|Up to Month 7|Migrated/moved from study area|3|||
33304063|NCT01262976|62680111|FG004|Up to Month 7|Migrated/moved from study area|1|||
33304064|NCT01262976|62680112|FG005|Up to Month 7|Migrated/moved from study area|1|||
33304065|NCT01262976|62680107|FG000|Up to Month 7|Lost to Follow-up|1|||
33581019|NCT01126736|62978144|FG004|Overall Study|Other|15|||
33304066|NCT01262976|62680108|FG001|Up to Month 7|Lost to Follow-up|0|||
33304067|NCT01262976|62680109|FG002|Up to Month 7|Lost to Follow-up|1|||
33304068|NCT01262976|62680110|FG003|Up to Month 7|Lost to Follow-up|3|||
33304069|NCT01262976|62680111|FG004|Up to Month 7|Lost to Follow-up|1|||
33304070|NCT01262976|62680112|FG005|Up to Month 7|Lost to Follow-up|3|||
33304071|NCT01262976|62680107|FG000|Up to Month 7|Other|3|||
33304072|NCT01262976|62680108|FG001|Up to Month 7|Other|0|||
33304073|NCT01262976|62680109|FG002|Up to Month 7|Other|2|||
33304074|NCT01262976|62680110|FG003|Up to Month 7|Other|0|||
33304075|NCT01262976|62680111|FG004|Up to Month 7|Other|0|||
33304076|NCT01262976|62680112|FG005|Up to Month 7|Other|0|||
33304077|NCT01262976|62680107|FG000|Up to Year 1|Serious Adverse Event|0|||
33304078|NCT01262976|62680108|FG001|Up to Year 1|Serious Adverse Event|0|||
33304079|NCT01262976|62680109|FG002|Up to Year 1|Serious Adverse Event|2|||
33304080|NCT01262976|62680110|FG003|Up to Year 1|Serious Adverse Event|0|||
33304081|NCT01262976|62680111|FG004|Up to Year 1|Serious Adverse Event|0|||
33304082|NCT01262976|62680112|FG005|Up to Year 1|Serious Adverse Event|0|||
33304083|NCT01262976|62680107|FG000|Up to Year 1|Withdrawal by Subject|1|||
33304084|NCT01262976|62680108|FG001|Up to Year 1|Withdrawal by Subject|0|||
33304085|NCT01262976|62680109|FG002|Up to Year 1|Withdrawal by Subject|0|||
33304086|NCT01262976|62680110|FG003|Up to Year 1|Withdrawal by Subject|0|||
33304087|NCT01262976|62680111|FG004|Up to Year 1|Withdrawal by Subject|0|||
33304088|NCT01262976|62680112|FG005|Up to Year 1|Withdrawal by Subject|0|||
33304089|NCT01262976|62680107|FG000|Up to Year 1|Migrated/moved from study area|1|||
33304090|NCT01262976|62680108|FG001|Up to Year 1|Migrated/moved from study area|0|||
33304091|NCT01262976|62680109|FG002|Up to Year 1|Migrated/moved from study area|0|||
33304092|NCT01262976|62680110|FG003|Up to Year 1|Migrated/moved from study area|3|||
33304093|NCT01262976|62680111|FG004|Up to Year 1|Migrated/moved from study area|3|||
33304094|NCT01262976|62680112|FG005|Up to Year 1|Migrated/moved from study area|2|||
33304095|NCT01262976|62680107|FG000|Up to Year 1|Lost to Follow-up|4|||
33304096|NCT01262976|62680108|FG001|Up to Year 1|Lost to Follow-up|0|||
33304097|NCT01262976|62680109|FG002|Up to Year 1|Lost to Follow-up|0|||
33304098|NCT01262976|62680110|FG003|Up to Year 1|Lost to Follow-up|1|||
33304099|NCT01262976|62680111|FG004|Up to Year 1|Lost to Follow-up|6|||
33304100|NCT01262976|62680112|FG005|Up to Year 1|Lost to Follow-up|5|||
33304101|NCT01262976|62680107|FG000|Up to Year 1|Other|3|||
33304102|NCT01262976|62680108|FG001|Up to Year 1|Other|1|||
33304103|NCT01262976|62680109|FG002|Up to Year 1|Other|0|||
33304104|NCT01262976|62680110|FG003|Up to Year 1|Other|0|||
33304105|NCT01262976|62680111|FG004|Up to Year 1|Other|2|||
33304106|NCT01262976|62680112|FG005|Up to Year 1|Other|1|||
33304107|NCT01262976|62680107|FG000|Up to Year 1|Subjects with unknown completion status|0|||
33304108|NCT01262976|62680108|FG001|Up to Year 1|Subjects with unknown completion status|0|||
33304109|NCT01262976|62680109|FG002|Up to Year 1|Subjects with unknown completion status|1|||
33304110|NCT01262976|62680110|FG003|Up to Year 1|Subjects with unknown completion status|0|||
33304111|NCT01262976|62680111|FG004|Up to Year 1|Subjects with unknown completion status|0|||
33304112|NCT01262976|62680112|FG005|Up to Year 1|Subjects with unknown completion status|1|||
33304113|NCT01262976|62680107|FG000|Up to Year 2|Serious Adverse Event|0|||
33304114|NCT01262976|62680108|FG001|Up to Year 2|Serious Adverse Event|0|||
33304115|NCT01262976|62680109|FG002|Up to Year 2|Serious Adverse Event|2|||
33576029|NCT02031640|62972416|FG001|Run-In Period|Withdrawal by Subject|0|||
33576030|NCT02031640|62972417|FG002|Run-In Period|Withdrawal by Subject|0|||
33576031|NCT02031640|62972418|FG003|Run-In Period|Withdrawal by Subject|0|||
33576032|NCT02031640|62972419|FG004|Run-In Period|Withdrawal by Subject|0|||
33576033|NCT02031640|62972420|FG005|Run-In Period|Withdrawal by Subject|0|||
33576034|NCT02031640|62972415|FG000|Run-In Period|Inclusion criteria not met|38|||
33576035|NCT02031640|62972416|FG001|Run-In Period|Inclusion criteria not met|0|||
33576036|NCT02031640|62972417|FG002|Run-In Period|Inclusion criteria not met|0|||
33304116|NCT01262976|62680110|FG003|Up to Year 2|Serious Adverse Event|0|||
33304117|NCT01262976|62680111|FG004|Up to Year 2|Serious Adverse Event|0|||
33304118|NCT01262976|62680112|FG005|Up to Year 2|Serious Adverse Event|0|||
33304119|NCT01262976|62680107|FG000|Up to Year 2|Withdrawal by Subject|1|||
33304120|NCT01262976|62680108|FG001|Up to Year 2|Withdrawal by Subject|0|||
33304121|NCT01262976|62680109|FG002|Up to Year 2|Withdrawal by Subject|0|||
33304122|NCT01262976|62680110|FG003|Up to Year 2|Withdrawal by Subject|0|||
33304123|NCT01262976|62680111|FG004|Up to Year 2|Withdrawal by Subject|0|||
33304124|NCT01262976|62680112|FG005|Up to Year 2|Withdrawal by Subject|0|||
33304125|NCT01262976|62680107|FG000|Up to Year 2|Migrated/moved from study area|0|||
33304126|NCT01262976|62680108|FG001|Up to Year 2|Migrated/moved from study area|0|||
33304127|NCT01262976|62680109|FG002|Up to Year 2|Migrated/moved from study area|0|||
33304128|NCT01262976|62680110|FG003|Up to Year 2|Migrated/moved from study area|2|||
33304129|NCT01262976|62680111|FG004|Up to Year 2|Migrated/moved from study area|1|||
33396977|NCT03895372|62776154|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
33396978|NCT03895372|62776155|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
33304130|NCT01262976|62680112|FG005|Up to Year 2|Migrated/moved from study area|2|||
33304131|NCT01262976|62680107|FG000|Up to Year 2|Lost to Follow-up|1|||
33304132|NCT01262976|62680108|FG001|Up to Year 2|Lost to Follow-up|1|||
33304133|NCT01262976|62680109|FG002|Up to Year 2|Lost to Follow-up|2|||
33576037|NCT02031640|62972418|FG003|Run-In Period|Inclusion criteria not met|0|||
33576038|NCT02031640|62972419|FG004|Run-In Period|Inclusion criteria not met|0|||
33304134|NCT01262976|62680110|FG003|Up to Year 2|Lost to Follow-up|2|||
33304135|NCT01262976|62680111|FG004|Up to Year 2|Lost to Follow-up|3|||
33304136|NCT01262976|62680112|FG005|Up to Year 2|Lost to Follow-up|3|||
33304137|NCT01262976|62680107|FG000|Up to Year 2|Subjects with unknown completion status|0|||
33304138|NCT01262976|62680108|FG001|Up to Year 2|Subjects with unknown completion status|0|||
33304139|NCT01262976|62680109|FG002|Up to Year 2|Subjects with unknown completion status|1|||
33304140|NCT01262976|62680110|FG003|Up to Year 2|Subjects with unknown completion status|0|||
33304141|NCT01262976|62680111|FG004|Up to Year 2|Subjects with unknown completion status|0|||
33304142|NCT01262976|62680112|FG005|Up to Year 2|Subjects with unknown completion status|0|||
33304143|NCT01262976|62680107|FG000|Up to Year 2|Other|3|||
33304144|NCT01262976|62680108|FG001|Up to Year 2|Other|0|||
33304145|NCT01262976|62680109|FG002|Up to Year 2|Other|0|||
33304146|NCT01262976|62680110|FG003|Up to Year 2|Other|0|||
33304147|NCT01262976|62680111|FG004|Up to Year 2|Other|0|||
33304148|NCT01262976|62680112|FG005|Up to Year 2|Other|0|||
33304149|NCT01262976|62680107|FG000|Up to Year 3|Serious Adverse Event|0|||
33304150|NCT01262976|62680108|FG001|Up to Year 3|Serious Adverse Event|0|||
33304151|NCT01262976|62680109|FG002|Up to Year 3|Serious Adverse Event|2|||
33304152|NCT01262976|62680110|FG003|Up to Year 3|Serious Adverse Event|0|||
33304153|NCT01262976|62680111|FG004|Up to Year 3|Serious Adverse Event|0|||
33304154|NCT01262976|62680112|FG005|Up to Year 3|Serious Adverse Event|0|||
33304155|NCT01262976|62680107|FG000|Up to Year 3|Withdrawal by Subject|1|||
33304156|NCT01262976|62680108|FG001|Up to Year 3|Withdrawal by Subject|0|||
33304157|NCT01262976|62680109|FG002|Up to Year 3|Withdrawal by Subject|0|||
33304158|NCT01262976|62680110|FG003|Up to Year 3|Withdrawal by Subject|0|||
33304159|NCT01262976|62680111|FG004|Up to Year 3|Withdrawal by Subject|0|||
33304160|NCT01262976|62680112|FG005|Up to Year 3|Withdrawal by Subject|0|||
33304161|NCT01262976|62680107|FG000|Up to Year 3|Migrated/moved from study area|0|||
33304162|NCT01262976|62680108|FG001|Up to Year 3|Migrated/moved from study area|0|||
33304163|NCT01262976|62680109|FG002|Up to Year 3|Migrated/moved from study area|0|||
33304164|NCT01262976|62680110|FG003|Up to Year 3|Migrated/moved from study area|2|||
33304165|NCT01262976|62680111|FG004|Up to Year 3|Migrated/moved from study area|1|||
33304166|NCT01262976|62680112|FG005|Up to Year 3|Migrated/moved from study area|1|||
33304167|NCT01262976|62680107|FG000|Up to Year 3|Lost to Follow-up|2|||
33304168|NCT01262976|62680108|FG001|Up to Year 3|Lost to Follow-up|2|||
33304169|NCT01262976|62680109|FG002|Up to Year 3|Lost to Follow-up|4|||
33304170|NCT01262976|62680110|FG003|Up to Year 3|Lost to Follow-up|3|||
33304171|NCT01262976|62680111|FG004|Up to Year 3|Lost to Follow-up|1|||
33304172|NCT01262976|62680112|FG005|Up to Year 3|Lost to Follow-up|3|||
33304173|NCT01262976|62680107|FG000|Up to Year 3|Subjects with unknown completion status|0|||
33304174|NCT01262976|62680108|FG001|Up to Year 3|Subjects with unknown completion status|0|||
33304175|NCT01262976|62680109|FG002|Up to Year 3|Subjects with unknown completion status|1|||
33304176|NCT01262976|62680110|FG003|Up to Year 3|Subjects with unknown completion status|0|||
33304177|NCT01262976|62680111|FG004|Up to Year 3|Subjects with unknown completion status|0|||
33304178|NCT01262976|62680112|FG005|Up to Year 3|Subjects with unknown completion status|0|||
33304179|NCT01262976|62680107|FG000|Up to Year 3|Other|3|||
33304180|NCT01262976|62680108|FG001|Up to Year 3|Other|0|||
33304181|NCT01262976|62680109|FG002|Up to Year 3|Other|0|||
33304182|NCT01262976|62680110|FG003|Up to Year 3|Other|0|||
33304183|NCT01262976|62680111|FG004|Up to Year 3|Other|0|||
33304184|NCT01262976|62680112|FG005|Up to Year 3|Other|0|||
33304185|NCT01300286|62680127|FG000|Overall Study|did not get dosed|1|||
33304186|NCT01300052|62680134|FG000|Overall Study|Adverse Event|3|||
33304187|NCT01300052|62680135|FG001|Overall Study|Adverse Event|0|||
33304188|NCT01300052|62680134|FG000|Overall Study|Withdrawal by Subject|2|||
33304189|NCT01300052|62680135|FG001|Overall Study|Withdrawal by Subject|2|||
33304190|NCT01300052|62680134|FG000|Overall Study|Protocol Violation|1|||
33304191|NCT01300052|62680135|FG001|Overall Study|Protocol Violation|1|||
33304192|NCT01299896|62680143|FG000|Overall Study|Withdrawal by Subject|1|||
33304193|NCT01299896|62680144|FG001|Overall Study|Withdrawal by Subject|7|||
33304194|NCT01299896|62680143|FG000|Overall Study|Lost to Follow-up|0|||
33304195|NCT01299896|62680144|FG001|Overall Study|Lost to Follow-up|11|||
33396979|NCT03895372|62776156|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
33396980|NCT03895372|62776157|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
33396981|NCT03895372|62776158|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
33304196|NCT01299584|62680150|FG000|Overall Study|Protocol Violation|9|||
33304197|NCT01236573|62680165|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33304198|NCT01236573|62680166|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33304199|NCT01236573|62680167|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33304200|NCT01236573|62680168|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33304201|NCT01236573|62680169|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33304202|NCT01236573|62680170|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33304203|NCT01236573|62680171|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
33304204|NCT01236573|62680172|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33304205|NCT01236573|62680173|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
33304206|NCT01236573|62680174|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
33304207|NCT01236573|62680175|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33304208|NCT01236573|62680165|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33304209|NCT01236573|62680166|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33304210|NCT01236573|62680167|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33304211|NCT01236573|62680168|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33304212|NCT01236573|62680169|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33304213|NCT01236573|62680170|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33304214|NCT01236573|62680171|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33304215|NCT01236573|62680172|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33304216|NCT01236573|62680173|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
33304217|NCT01236573|62680174|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33304218|NCT01236573|62680175|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33304219|NCT01236573|62680165|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33304220|NCT01236573|62680166|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33304221|NCT01236573|62680167|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33304222|NCT01236573|62680168|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33304223|NCT01236573|62680169|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33304224|NCT01236573|62680170|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33304225|NCT01236573|62680171|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33304226|NCT01236573|62680172|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33304227|NCT01236573|62680173|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33304228|NCT01236573|62680174|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33304229|NCT01236573|62680175|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
33304230|NCT01236339|62680202|FG000|Overall Study|Termination of study by sponsor|11|||
33304231|NCT01236339|62680203|FG001|Overall Study|Termination of study by sponsor|13|||
33304232|NCT01262898|62680214|FG000|Overall Study|Protocol Violation|1|||
33304233|NCT01262898|62680215|FG001|Overall Study|Protocol Violation|1|||
33304234|NCT01262898|62680216|FG002|Overall Study|Protocol Violation|0|||
33304235|NCT01262898|62680217|FG003|Overall Study|Protocol Violation|0|||
33304236|NCT01262898|62680214|FG000|Overall Study|Lost to Follow-up|1|||
33304237|NCT01262898|62680215|FG001|Overall Study|Lost to Follow-up|0|||
33304238|NCT01262898|62680216|FG002|Overall Study|Lost to Follow-up|0|||
33304239|NCT01262898|62680217|FG003|Overall Study|Lost to Follow-up|0|||
33304240|NCT01262898|62680214|FG000|Overall Study|Withdrawal by Subject|1|||
33304241|NCT01262898|62680215|FG001|Overall Study|Withdrawal by Subject|1|||
33304242|NCT01262898|62680216|FG002|Overall Study|Withdrawal by Subject|0|||
33304243|NCT01262898|62680217|FG003|Overall Study|Withdrawal by Subject|0|||
33304244|NCT01262820|62680230|FG000|Overall Study|Adverse Event|5|||
33304245|NCT01262820|62680230|FG000|Overall Study|Lack of Efficacy|9|||
33304246|NCT01262820|62680230|FG000|Overall Study|Drug held for 21+ days|1|||
33304247|NCT01057810|62680236|FG000|Overall Study|Disease progression|156|||
33304248|NCT01057810|62680237|FG001|Overall Study|Disease progression|197|||
33304249|NCT01057810|62680236|FG000|Overall Study|Study drug toxicity|5|||
33304250|NCT01057810|62680237|FG001|Overall Study|Study drug toxicity|114|||
33304251|NCT01057810|62680236|FG000|Overall Study|Adverse event unrelated to study drug|13|||
33304252|NCT01057810|62680237|FG001|Overall Study|Adverse event unrelated to study drug|29|||
33304253|NCT01057810|62680236|FG000|Overall Study|Withdrawal by Subject|10|||
33304254|NCT01057810|62680237|FG001|Overall Study|Withdrawal by Subject|25|||
33304255|NCT01057810|62680236|FG000|Overall Study|Death|2|||
33304256|NCT01057810|62680237|FG001|Overall Study|Death|12|||
33304257|NCT01057810|62680236|FG000|Overall Study|Maximum clinical benefit|5|||
33304258|NCT01057810|62680237|FG001|Overall Study|Maximum clinical benefit|5|||
33304259|NCT01057810|62680236|FG000|Overall Study|Poor/non-compliance|0|||
33304260|NCT01057810|62680237|FG001|Overall Study|Poor/non-compliance|1|||
33304261|NCT01057810|62680236|FG000|Overall Study|No longer met study criteria|0|||
33304262|NCT01057810|62680237|FG001|Overall Study|No longer met study criteria|1|||
33304263|NCT01057810|62680236|FG000|Overall Study|Other|7|||
33304264|NCT01057810|62680237|FG001|Overall Study|Other|14|||
33304265|NCT01262352|62680245|FG000|Period 1|Illness after randomization|1|||
33304266|NCT01262352|62680246|FG001|Period 1|Illness after randomization|0|||
33304267|NCT01262352|62680245|FG000|Washout|Adverse Event|1|||
33304268|NCT01262352|62680246|FG001|Washout|Adverse Event|1|||
33304269|NCT01262352|62680245|FG000|Washout|Extended Washout|0|||
33304270|NCT01262352|62680246|FG001|Washout|Extended Washout|1|||
33304271|NCT01299272|62680252|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
33304272|NCT01299272|62680253|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
33304273|NCT01299272|62680254|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
33304274|NCT01299272|62680255|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
33304275|NCT01299272|62680252|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
33304276|NCT01299272|62680253|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
33304277|NCT01299272|62680254|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
33304278|NCT01299272|62680255|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
33304279|NCT01299272|62680252|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
33304280|NCT01299272|62680253|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
33304281|NCT01299272|62680254|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
33304282|NCT01299272|62680255|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
33304283|NCT01299272|62680252|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
33304284|NCT01299272|62680253|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
33304285|NCT01299272|62680254|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
33304286|NCT01299272|62680255|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
33304287|NCT01299272|62680252|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
33304288|NCT01299272|62680253|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
33304289|NCT01299272|62680254|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
33304290|NCT01299272|62680255|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
33304291|NCT01299272|62680252|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
33304292|NCT01299272|62680253|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
33304293|NCT01299272|62680254|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
33304294|NCT01299272|62680255|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
33304295|NCT01299272|62680252|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
33304296|NCT01299272|62680253|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
33304297|NCT01299272|62680254|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
33304298|NCT01299272|62680255|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
33304299|NCT01299272|62680252|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
33304300|NCT01299272|62680253|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
33304301|NCT01299272|62680254|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
33304302|NCT01299272|62680255|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
33304303|NCT01299272|62680252|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
33304304|NCT01299272|62680253|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
33304305|NCT01299272|62680254|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
33304306|NCT01299272|62680255|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
33304307|NCT01299272|62680252|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
33304308|NCT01299272|62680253|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
33304309|NCT01299272|62680254|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
33304310|NCT01299272|62680255|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
33304311|NCT01299272|62680252|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
33304312|NCT01299272|62680253|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
33304313|NCT01299272|62680254|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
33304314|NCT01299272|62680255|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
33304315|NCT01299272|62680252|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
33304316|NCT01299272|62680253|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
33304317|NCT01299272|62680254|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
33304318|NCT01299272|62680255|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
33304319|NCT01299272|62680252|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
33304320|NCT01299272|62680253|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
33304321|NCT01299272|62680254|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
33304322|NCT01299272|62680255|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
33304323|NCT01299272|62680252|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
33304324|NCT01299272|62680253|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
33304325|NCT01299272|62680254|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
33304326|NCT01299272|62680255|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
33304327|NCT01299272|62680252|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
33304328|NCT01299272|62680253|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
33304329|NCT01299272|62680254|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
33304330|NCT01299272|62680255|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
33304331|NCT01299272|62680252|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
33304332|NCT01299272|62680253|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
33304333|NCT01299272|62680254|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
33304334|NCT01299272|62680255|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
33304335|NCT01299272|62680252|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
33304336|NCT01299272|62680253|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
33304337|NCT01299272|62680254|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
33304338|NCT01299272|62680255|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
33304339|NCT01299272|62680252|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
33304340|NCT01299272|62680253|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
33576039|NCT02031640|62972420|FG005|Run-In Period|Inclusion criteria not met|0|||
33576040|NCT02031640|62972415|FG000|Run-In Period|Exclusion criteria met|8|||
33304341|NCT01299272|62680254|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
33304342|NCT01299272|62680255|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
33304343|NCT01299272|62680252|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
33304344|NCT01299272|62680253|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
33304345|NCT01299272|62680254|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
33304346|NCT01299272|62680255|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
33304347|NCT01299272|62680252|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
33304348|NCT01299272|62680253|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
33304349|NCT01299272|62680254|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
33304350|NCT01299272|62680255|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
33304351|NCT01299272|62680252|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
33304352|NCT01299272|62680253|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
33304353|NCT01299272|62680254|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
33304354|NCT01299272|62680255|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
33304355|NCT01299272|62680252|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
33304356|NCT01299272|62680253|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
33304357|NCT01299272|62680254|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
33304358|NCT01299272|62680255|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
33304359|NCT01299272|62680252|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
33304360|NCT01299272|62680253|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
33304361|NCT01299272|62680254|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
33304362|NCT01299272|62680255|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
33304363|NCT01299272|62680252|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
33304364|NCT01299272|62680253|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
33304365|NCT01299272|62680254|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
33304366|NCT01299272|62680255|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
33304367|NCT01299272|62680252|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
33304368|NCT01299272|62680253|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
33304369|NCT01299272|62680254|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
33304370|NCT01299272|62680255|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
33304371|NCT01299116|62680272|FG000|Overall Study|Lost to Follow-up|65|||
33304372|NCT01299116|62680273|FG001|Overall Study|Lost to Follow-up|9|||
33304373|NCT01299116|62680274|FG002|Overall Study|Lost to Follow-up|11|||
33304374|NCT01299038|62680287|FG000|Overall Study|Withdrawal by Subject|1|||
33304375|NCT01299038|62680288|FG001|Overall Study|Withdrawal by Subject|0|||
33304376|NCT01298648|62680294|FG000|Overall Study|Withdrawal by Subject|2|||
33304377|NCT01298648|62680294|FG000|Overall Study|Lost to Follow-up|21|||
33304378|NCT01261338|62680300|FG000|Overall Study|Withdrawal by Subject|3|||
33304379|NCT01261338|62680301|FG001|Overall Study|Withdrawal by Subject|2|||
33304380|NCT01260948|62680309|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
33304381|NCT01260948|62680310|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
33304382|NCT01260948|62680309|FG000|Second Intervention|Emesis|0|||
33304383|NCT01260948|62680310|FG001|Second Intervention|Emesis|1|||
33304384|NCT01025284|62680319|FG000|Overall Study|Investigator Decision|0|||
33304385|NCT01025284|62680320|FG001|Overall Study|Investigator Decision|1|||
33304386|NCT01025284|62680321|FG002|Overall Study|Investigator Decision|0|||
33304387|NCT01025284|62680319|FG000|Overall Study|Withdrawal by Subject|0|||
33304388|NCT01025284|62680320|FG001|Overall Study|Withdrawal by Subject|1|||
33304389|NCT01025284|62680321|FG002|Overall Study|Withdrawal by Subject|0|||
33304390|NCT01021852|62680339|FG000|Treatment Period 1|Adverse Event|3|||
33304391|NCT01021852|62680340|FG001|Treatment Period 1|Adverse Event|1|||
33304392|NCT01021852|62680341|FG002|Treatment Period 1|Adverse Event|1|||
33304393|NCT01021852|62680342|FG003|Treatment Period 1|Adverse Event|0|||
33304394|NCT01021852|62680343|FG004|Treatment Period 1|Adverse Event|2|||
33304395|NCT01021852|62680344|FG005|Treatment Period 1|Adverse Event|2|||
33304396|NCT01021852|62680345|FG006|Treatment Period 1|Adverse Event|0|||
33304397|NCT01021852|62680346|FG007|Treatment Period 1|Adverse Event|0|||
33304398|NCT01021852|62680339|FG000|Treatment Period 1|Pregnancy|0|||
33304399|NCT01021852|62680340|FG001|Treatment Period 1|Pregnancy|0|||
33304400|NCT01021852|62680341|FG002|Treatment Period 1|Pregnancy|1|||
33304401|NCT01021852|62680342|FG003|Treatment Period 1|Pregnancy|0|||
33304402|NCT01021852|62680343|FG004|Treatment Period 1|Pregnancy|0|||
33304403|NCT01021852|62680344|FG005|Treatment Period 1|Pregnancy|0|||
33304404|NCT01021852|62680345|FG006|Treatment Period 1|Pregnancy|0|||
33304405|NCT01021852|62680346|FG007|Treatment Period 1|Pregnancy|0|||
33304406|NCT01021852|62680339|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33304407|NCT01021852|62680340|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33304408|NCT01021852|62680341|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33304409|NCT01021852|62680342|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33304410|NCT01021852|62680343|FG004|Treatment Period 1|Withdrawal by Subject|1|||
33576041|NCT02031640|62972416|FG001|Run-In Period|Exclusion criteria met|0|||
33576042|NCT02031640|62972417|FG002|Run-In Period|Exclusion criteria met|0|||
33304411|NCT01021852|62680344|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33304412|NCT01021852|62680345|FG006|Treatment Period 1|Withdrawal by Subject|0|||
33304413|NCT01021852|62680346|FG007|Treatment Period 1|Withdrawal by Subject|1|||
33304414|NCT01021852|62680339|FG000|Treatment Period 1|Not Treated|0|||
33304415|NCT01021852|62680340|FG001|Treatment Period 1|Not Treated|0|||
33304416|NCT01021852|62680341|FG002|Treatment Period 1|Not Treated|0|||
33304417|NCT01021852|62680342|FG003|Treatment Period 1|Not Treated|2|||
33304418|NCT01021852|62680343|FG004|Treatment Period 1|Not Treated|0|||
33304419|NCT01021852|62680344|FG005|Treatment Period 1|Not Treated|0|||
33304420|NCT01021852|62680345|FG006|Treatment Period 1|Not Treated|0|||
33304421|NCT01021852|62680346|FG007|Treatment Period 1|Not Treated|0|||
33304422|NCT01021852|62680339|FG000|Washout Period-Placebo|Adverse Event|0|||
33304423|NCT01021852|62680340|FG001|Washout Period-Placebo|Adverse Event|0|||
33304424|NCT01021852|62680341|FG002|Washout Period-Placebo|Adverse Event|0|||
33304425|NCT01021852|62680342|FG003|Washout Period-Placebo|Adverse Event|1|||
33304426|NCT01021852|62680343|FG004|Washout Period-Placebo|Adverse Event|0|||
33304427|NCT01021852|62680344|FG005|Washout Period-Placebo|Adverse Event|1|||
33304428|NCT01021852|62680345|FG006|Washout Period-Placebo|Adverse Event|0|||
33304429|NCT01021852|62680346|FG007|Washout Period-Placebo|Adverse Event|0|||
33304430|NCT01021852|62680339|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
33304431|NCT01021852|62680340|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
33304432|NCT01021852|62680341|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
33304433|NCT01021852|62680342|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
33304434|NCT01021852|62680343|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
33304435|NCT01021852|62680344|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
33304436|NCT01021852|62680345|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
33304437|NCT01021852|62680346|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
33304438|NCT01021852|62680339|FG000|Washout Period-Placebo|Protocol Violation|0|||
33304439|NCT01021852|62680340|FG001|Washout Period-Placebo|Protocol Violation|0|||
33304440|NCT01021852|62680341|FG002|Washout Period-Placebo|Protocol Violation|0|||
33304441|NCT01021852|62680342|FG003|Washout Period-Placebo|Protocol Violation|0|||
33304442|NCT01021852|62680343|FG004|Washout Period-Placebo|Protocol Violation|0|||
33304443|NCT01021852|62680344|FG005|Washout Period-Placebo|Protocol Violation|0|||
33304444|NCT01021852|62680345|FG006|Washout Period-Placebo|Protocol Violation|1|||
33304445|NCT01021852|62680346|FG007|Washout Period-Placebo|Protocol Violation|0|||
33304446|NCT01021852|62680339|FG000|Washout Period-No Drug|Adverse Event|1|||
33304447|NCT01021852|62680340|FG001|Washout Period-No Drug|Adverse Event|0|||
33304448|NCT01021852|62680341|FG002|Washout Period-No Drug|Adverse Event|0|||
33304449|NCT01021852|62680342|FG003|Washout Period-No Drug|Adverse Event|0|||
33304450|NCT01021852|62680343|FG004|Washout Period-No Drug|Adverse Event|0|||
33304451|NCT01021852|62680344|FG005|Washout Period-No Drug|Adverse Event|1|||
33304452|NCT01021852|62680345|FG006|Washout Period-No Drug|Adverse Event|0|||
33304453|NCT01021852|62680346|FG007|Washout Period-No Drug|Adverse Event|0|||
33304454|NCT01021852|62680339|FG000|Treatment Period 2|Adverse Event|0|||
33304455|NCT01021852|62680340|FG001|Treatment Period 2|Adverse Event|1|||
33304456|NCT01021852|62680341|FG002|Treatment Period 2|Adverse Event|0|||
33304457|NCT01021852|62680342|FG003|Treatment Period 2|Adverse Event|0|||
33304458|NCT01021852|62680343|FG004|Treatment Period 2|Adverse Event|1|||
33304459|NCT01021852|62680344|FG005|Treatment Period 2|Adverse Event|0|||
33304460|NCT01021852|62680345|FG006|Treatment Period 2|Adverse Event|1|||
33304461|NCT01021852|62680346|FG007|Treatment Period 2|Adverse Event|0|||
33304462|NCT01021852|62680339|FG000|Treatment Period 2|Lack of Efficacy|0|||
33304463|NCT01021852|62680340|FG001|Treatment Period 2|Lack of Efficacy|0|||
33304464|NCT01021852|62680341|FG002|Treatment Period 2|Lack of Efficacy|0|||
33304465|NCT01021852|62680342|FG003|Treatment Period 2|Lack of Efficacy|0|||
33304466|NCT01021852|62680343|FG004|Treatment Period 2|Lack of Efficacy|0|||
33304467|NCT01021852|62680344|FG005|Treatment Period 2|Lack of Efficacy|1|||
33304468|NCT01021852|62680345|FG006|Treatment Period 2|Lack of Efficacy|0|||
33304469|NCT01021852|62680346|FG007|Treatment Period 2|Lack of Efficacy|0|||
33304470|NCT01021852|62680339|FG000|Treatment Period 2|Physician Decision|0|||
33304471|NCT01021852|62680340|FG001|Treatment Period 2|Physician Decision|0|||
33396982|NCT03895372|62776159|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
33396983|NCT00669110|62776184|FG000|Overall Study|Adverse Event|4|||
33396984|NCT00669110|62776185|FG001|Overall Study|Adverse Event|3|||
33396985|NCT00669110|62776184|FG000|Overall Study|Caregiver request|3|||
33304472|NCT01021852|62680341|FG002|Treatment Period 2|Physician Decision|1|||
33304473|NCT01021852|62680342|FG003|Treatment Period 2|Physician Decision|0|||
33304474|NCT01021852|62680343|FG004|Treatment Period 2|Physician Decision|0|||
33304475|NCT01021852|62680344|FG005|Treatment Period 2|Physician Decision|0|||
33304476|NCT01021852|62680345|FG006|Treatment Period 2|Physician Decision|0|||
33304477|NCT01021852|62680346|FG007|Treatment Period 2|Physician Decision|0|||
33304478|NCT01021852|62680339|FG000|Treatment Period 2|Protocol Violation|0|||
33304479|NCT01021852|62680340|FG001|Treatment Period 2|Protocol Violation|0|||
33304480|NCT01021852|62680341|FG002|Treatment Period 2|Protocol Violation|0|||
33304481|NCT01021852|62680342|FG003|Treatment Period 2|Protocol Violation|0|||
33396986|NCT00669110|62776185|FG001|Overall Study|Caregiver request|2|||
33396987|NCT00669110|62776184|FG000|Overall Study|Physician Decision|0|||
33304482|NCT01021852|62680343|FG004|Treatment Period 2|Protocol Violation|1|||
33304483|NCT01021852|62680344|FG005|Treatment Period 2|Protocol Violation|0|||
33304484|NCT01021852|62680345|FG006|Treatment Period 2|Protocol Violation|1|||
33304485|NCT01021852|62680346|FG007|Treatment Period 2|Protocol Violation|0|||
33304486|NCT01021852|62680339|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33304487|NCT01021852|62680340|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33304488|NCT01021852|62680341|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33304489|NCT01021852|62680342|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33304490|NCT01021852|62680343|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33304491|NCT01021852|62680344|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33304492|NCT01021852|62680345|FG006|Treatment Period 2|Withdrawal by Subject|1|||
33304493|NCT01021852|62680346|FG007|Treatment Period 2|Withdrawal by Subject|2|||
33304494|NCT01056718|62680360|FG000|Overall Study|Withdrawal by Subject|2|||
33304495|NCT01056718|62680360|FG000|Overall Study|Ischemia on baseline stress test|1|||
33304496|NCT01298570|62680367|FG000|Overall Study|Disease progression, relapse during acti|64|||
33304497|NCT01298570|62680368|FG001|Overall Study|Disease progression, relapse during acti|40|||
33304498|NCT01298570|62680367|FG000|Overall Study|Adverse Event|20|||
33304499|NCT01298570|62680368|FG001|Overall Study|Adverse Event|2|||
33304500|NCT01298570|62680367|FG000|Overall Study|Withdrawal by Subject|21|||
33304501|NCT01298570|62680368|FG001|Overall Study|Withdrawal by Subject|6|||
33304502|NCT01298570|62680367|FG000|Overall Study|Treatment delay > 4 weeks|4|||
33304503|NCT01298570|62680368|FG001|Overall Study|Treatment delay > 4 weeks|5|||
33304504|NCT01298570|62680367|FG000|Overall Study|Physician Decision|4|||
33304505|NCT01298570|62680368|FG001|Overall Study|Physician Decision|2|||
33304506|NCT01298570|62680367|FG000|Overall Study|Other complicating disease|2|||
33304507|NCT01298570|62680368|FG001|Overall Study|Other complicating disease|1|||
33304508|NCT01298570|62680367|FG000|Overall Study|Surgery|2|||
33304509|NCT01298570|62680368|FG001|Overall Study|Surgery|1|||
33304510|NCT01298570|62680367|FG000|Overall Study|Symptomatic progression/deterioration|3|||
33304511|NCT01298570|62680368|FG001|Overall Study|Symptomatic progression/deterioration|2|||
33304512|NCT01298570|62680367|FG000|Overall Study|Death|0|||
33304513|NCT01298570|62680368|FG001|Overall Study|Death|1|||
33304514|NCT01298570|62680367|FG000|Overall Study|Ineligibility|0|||
33304515|NCT01298570|62680368|FG001|Overall Study|Ineligibility|1|||
33304516|NCT01259856|62680376|FG000|Overall Study|Adverse Event|12|||
33304517|NCT01259856|62680377|FG001|Overall Study|Adverse Event|9|||
33304518|NCT01259856|62680376|FG000|Overall Study|Death|0|||
33304519|NCT01259856|62680377|FG001|Overall Study|Death|1|||
33304520|NCT01259856|62680376|FG000|Overall Study|Lack of Efficacy|3|||
33304521|NCT01259856|62680377|FG001|Overall Study|Lack of Efficacy|1|||
33304522|NCT01259856|62680376|FG000|Overall Study|Lost to Follow-up|1|||
33304523|NCT01259856|62680377|FG001|Overall Study|Lost to Follow-up|1|||
33304524|NCT01259856|62680376|FG000|Overall Study|Physician Decision|2|||
33304525|NCT01259856|62680377|FG001|Overall Study|Physician Decision|1|||
33304526|NCT01259856|62680376|FG000|Overall Study|Withdrawal by Subject|9|||
33304527|NCT01259856|62680377|FG001|Overall Study|Withdrawal by Subject|10|||
33304528|NCT01259856|62680376|FG000|Overall Study|Treatment never started|0|||
33304529|NCT01259856|62680377|FG001|Overall Study|Treatment never started|6|||
33304530|NCT01259856|62680376|FG000|Overall Study|Study closure by sponsor|40|||
33304531|NCT01259856|62680377|FG001|Overall Study|Study closure by sponsor|41|||
33304532|NCT01259856|62680376|FG000|Overall Study|Patient developed other disease|0|||
33304533|NCT01259856|62680377|FG001|Overall Study|Patient developed other disease|1|||
33304534|NCT01259856|62680376|FG000|Overall Study|Transfer to another study|0|||
33304535|NCT01259856|62680377|FG001|Overall Study|Transfer to another study|1|||
33304536|NCT01259856|62680376|FG000|Overall Study|Unknown/missing|2|||
33304537|NCT01259856|62680377|FG001|Overall Study|Unknown/missing|2|||
33304538|NCT01020838|62680383|FG000|Overall Study|Death|90|||
33304539|NCT01020838|62680383|FG000|Overall Study|Adverse Event|1|||
33304540|NCT01020838|62680383|FG000|Overall Study|Withdrawal by Subject|9|||
33304541|NCT01020838|62680383|FG000|Overall Study|Lost to Follow-up|6|||
33304542|NCT01020838|62680383|FG000|Overall Study|Most common: Study ended by sponsor|77|||
33304543|NCT01259466|62680398|FG000|Overall Study|Withdrawal by Subject|1|||
33304544|NCT01259466|62680399|FG001|Overall Study|Withdrawal by Subject|9|||
33304545|NCT01259388|62680407|FG000|Overall Study|Adverse Event|3|||
33304546|NCT01259388|62680408|FG001|Overall Study|Adverse Event|0|||
33304547|NCT01259388|62680407|FG000|Overall Study|Withdrawal by Subject|1|||
33396988|NCT00669110|62776185|FG001|Overall Study|Physician Decision|1|||
33396989|NCT00669110|62776184|FG000|Overall Study|Lost to Follow-up|1|||
33396990|NCT00669110|62776185|FG001|Overall Study|Lost to Follow-up|0|||
33396991|NCT00669110|62776184|FG000|Overall Study|Protocol Violation|0|||
33396992|NCT00669110|62776185|FG001|Overall Study|Protocol Violation|5|||
33396993|NCT00669110|62776184|FG000|Overall Study|Withdrawal by Subject|0|||
33396994|NCT00669110|62776185|FG001|Overall Study|Withdrawal by Subject|2|||
33396995|NCT00654732|62776193|FG000|Overall Study|Adverse Event|4|||
33396996|NCT00654732|62776194|FG001|Overall Study|Adverse Event|6|||
33396997|NCT00649428|62776202|FG000|Overall Study|Adverse Event|2|||
33304548|NCT01259388|62680408|FG001|Overall Study|Withdrawal by Subject|1|||
33304549|NCT01259388|62680407|FG000|Overall Study|Physician Decision|1|||
33304550|NCT01259388|62680408|FG001|Overall Study|Physician Decision|0|||
33304551|NCT01298492|62680414|FG000|Overall Study|Death|2|||
33304552|NCT01298492|62680414|FG000|Overall Study|Insufficient Clinical Response|22|||
33304553|NCT01298492|62680414|FG000|Overall Study|Lost to Follow-up|12|||
33304554|NCT01298492|62680414|FG000|Overall Study|Withdrawal by Subject|47|||
33304555|NCT01298492|62680414|FG000|Overall Study|Other (Unspecified)|7|||
33304556|NCT01298492|62680414|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
33304557|NCT01298492|62680414|FG000|Overall Study|Protocol Violation|2|||
33304558|NCT01298492|62680414|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
33304559|NCT01298492|62680414|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
33304560|NCT01297322|62680420|FG000|Overall Study|Lost to Follow-up|1|||
33304561|NCT01297322|62680421|FG001|Overall Study|Lost to Follow-up|0|||
33304562|NCT01297322|62680420|FG000|Overall Study|Withdrawal by Subject|0|||
33304563|NCT01297322|62680421|FG001|Overall Study|Withdrawal by Subject|1|||
33304564|NCT01297322|62680420|FG000|Overall Study|Protocol Violation|0|||
33304565|NCT01297322|62680421|FG001|Overall Study|Protocol Violation|3|||
33304566|NCT01297244|62680430|FG000|Overall Study|Progressive disease|22|||
33304567|NCT01297244|62680431|FG001|Overall Study|Progressive disease|3|||
33304568|NCT01297244|62680430|FG000|Overall Study|Adverse Event|9|||
33304569|NCT01297244|62680431|FG001|Overall Study|Adverse Event|1|||
33304570|NCT01297244|62680430|FG000|Overall Study|Death|1|||
33304571|NCT01297244|62680431|FG001|Overall Study|Death|1|||
33304572|NCT01297244|62680430|FG000|Overall Study|Clinical progression|1|||
33304573|NCT01297244|62680431|FG001|Overall Study|Clinical progression|1|||
33304574|NCT01297244|62680430|FG000|Overall Study|Withdrawal by Subject|2|||
33304575|NCT01297244|62680431|FG001|Overall Study|Withdrawal by Subject|0|||
33304576|NCT03456726|62680444|FG000|Overall Study|Disease Progression|6|||
33304577|NCT03456726|62680445|FG001|Overall Study|Disease Progression|1|||
33304578|NCT03456726|62680444|FG000|Overall Study|Adverse Event|4|||
33304579|NCT03456726|62680445|FG001|Overall Study|Adverse Event|2|||
33304580|NCT03456726|62680444|FG000|Overall Study|Withdrawal by Subject|1|||
33304581|NCT03456726|62680445|FG001|Overall Study|Withdrawal by Subject|0|||
33304582|NCT03456726|62680444|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
33304583|NCT03456726|62680445|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
33304584|NCT03181932|62680453|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
33304585|NCT03181932|62680454|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
33304586|NCT03181932|62680453|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
33304587|NCT03181932|62680454|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
33304588|NCT03181932|62680453|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
33304589|NCT03181932|62680454|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
33304590|NCT03181932|62680453|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
33304591|NCT03181932|62680454|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
33304592|NCT03181932|62680453|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
33304593|NCT03181932|62680454|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
33304594|NCT03181932|62680453|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
33304595|NCT03181932|62680454|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
33304596|NCT03181932|62680453|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
33304597|NCT03181932|62680454|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
33304598|NCT03181932|62680453|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
33304599|NCT03181932|62680454|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
33304600|NCT03181932|62680453|FG000|Period 2 (Open-label Period)|Reason missing|2|||
33304601|NCT03181932|62680454|FG001|Period 2 (Open-label Period)|Reason missing|0|||
33304602|NCT02864862|62680464|FG000|Overall Study|Lost to Follow-up|1|||
33304603|NCT02864862|62680465|FG001|Overall Study|Lost to Follow-up|0|||
33304604|NCT02864862|62680466|FG002|Overall Study|Lost to Follow-up|1|||
33304605|NCT02864862|62680464|FG000|Overall Study|Protocol Violation|0|||
33304606|NCT02864862|62680465|FG001|Overall Study|Protocol Violation|0|||
33304607|NCT02864862|62680466|FG002|Overall Study|Protocol Violation|1|||
33304608|NCT01598298|62680478|FG000|Overall Study|Not eligible|5|||
33304609|NCT01598298|62680479|FG001|Overall Study|Not eligible|5|||
33304610|NCT01598298|62680478|FG000|Overall Study|Adverse Event|21|||
33304611|NCT01598298|62680479|FG001|Overall Study|Adverse Event|19|||
33304612|NCT01598298|62680478|FG000|Overall Study|Progression/relapse|0|||
33304613|NCT01598298|62680479|FG001|Overall Study|Progression/relapse|2|||
33304614|NCT01598298|62680478|FG000|Overall Study|Withdrawal by Subject|10|||
33304615|NCT01598298|62680479|FG001|Overall Study|Withdrawal by Subject|15|||
33304616|NCT01598298|62680478|FG000|Overall Study|Other reason (not protocol specified)|4|||
33304617|NCT01598298|62680479|FG001|Overall Study|Other reason (not protocol specified)|0|||
33304618|NCT01235949|62680503|FG000|Primary Phase|Migrated/moved from study area|1|||
33581020|NCT01111461|62978156|FG000|Overall Study|Adverse Event|32|||
33304619|NCT01235949|62680504|FG001|Primary Phase|Migrated/moved from study area|1|||
33304620|NCT01235949|62680505|FG002|Primary Phase|Migrated/moved from study area|0|||
33304621|NCT01235949|62680506|FG003|Primary Phase|Migrated/moved from study area|0|||
33396998|NCT00649428|62776203|FG001|Overall Study|Adverse Event|2|||
33304622|NCT01235949|62680507|FG004|Primary Phase|Migrated/moved from study area|1|||
33304623|NCT01235949|62680508|FG005|Primary Phase|Migrated/moved from study area|2|||
33304624|NCT01235949|62680509|FG006|Primary Phase|Migrated/moved from study area|0|||
33304625|NCT01235949|62680510|FG007|Primary Phase|Migrated/moved from study area|0|||
33304626|NCT01235949|62680511|FG008|Primary Phase|Migrated/moved from study area|0|||
33304627|NCT01235949|62680512|FG009|Primary Phase|Migrated/moved from study area|0|||
33304628|NCT01235949|62680513|FG010|Primary Phase|Migrated/moved from study area|0|||
33304629|NCT01235949|62680514|FG011|Primary Phase|Migrated/moved from study area|0|||
33304630|NCT01235949|62680515|FG012|Primary Phase|Migrated/moved from study area|0|||
33304631|NCT01235949|62680516|FG013|Primary Phase|Migrated/moved from study area|0|||
33304632|NCT01235949|62680517|FG014|Primary Phase|Migrated/moved from study area|0|||
33304633|NCT01235949|62680518|FG015|Primary Phase|Migrated/moved from study area|0|||
33304634|NCT01235949|62680519|FG016|Primary Phase|Migrated/moved from study area|0|||
33304635|NCT01235949|62680520|FG017|Primary Phase|Migrated/moved from study area|0|||
33304636|NCT01235949|62680503|FG000|Primary Phase|Adverse Event|0|||
33304637|NCT01235949|62680504|FG001|Primary Phase|Adverse Event|0|||
33304638|NCT01235949|62680505|FG002|Primary Phase|Adverse Event|0|||
33304639|NCT01235949|62680506|FG003|Primary Phase|Adverse Event|1|||
33304640|NCT01235949|62680507|FG004|Primary Phase|Adverse Event|0|||
33304641|NCT01235949|62680508|FG005|Primary Phase|Adverse Event|0|||
33304642|NCT01235949|62680509|FG006|Primary Phase|Adverse Event|0|||
33304643|NCT01235949|62680510|FG007|Primary Phase|Adverse Event|0|||
33304644|NCT01235949|62680511|FG008|Primary Phase|Adverse Event|0|||
33304645|NCT01235949|62680512|FG009|Primary Phase|Adverse Event|0|||
33304646|NCT01235949|62680513|FG010|Primary Phase|Adverse Event|0|||
33304647|NCT01235949|62680514|FG011|Primary Phase|Adverse Event|0|||
33304648|NCT01235949|62680515|FG012|Primary Phase|Adverse Event|0|||
33304649|NCT01235949|62680516|FG013|Primary Phase|Adverse Event|0|||
33304650|NCT01235949|62680517|FG014|Primary Phase|Adverse Event|0|||
33304651|NCT01235949|62680518|FG015|Primary Phase|Adverse Event|0|||
33304652|NCT01235949|62680519|FG016|Primary Phase|Adverse Event|0|||
33304653|NCT01235949|62680520|FG017|Primary Phase|Adverse Event|0|||
33304654|NCT01235949|62680503|FG000|Primary Phase|Withdrawal by Subject|3|||
33304655|NCT01235949|62680504|FG001|Primary Phase|Withdrawal by Subject|2|||
33304656|NCT01235949|62680505|FG002|Primary Phase|Withdrawal by Subject|2|||
33304657|NCT01235949|62680506|FG003|Primary Phase|Withdrawal by Subject|0|||
33304658|NCT01235949|62680507|FG004|Primary Phase|Withdrawal by Subject|0|||
33304659|NCT01235949|62680508|FG005|Primary Phase|Withdrawal by Subject|3|||
33304660|NCT01235949|62680509|FG006|Primary Phase|Withdrawal by Subject|0|||
33304661|NCT01235949|62680510|FG007|Primary Phase|Withdrawal by Subject|0|||
33304662|NCT01235949|62680511|FG008|Primary Phase|Withdrawal by Subject|0|||
33304663|NCT01235949|62680512|FG009|Primary Phase|Withdrawal by Subject|0|||
33304664|NCT01235949|62680513|FG010|Primary Phase|Withdrawal by Subject|0|||
33304665|NCT01235949|62680514|FG011|Primary Phase|Withdrawal by Subject|0|||
33304666|NCT01235949|62680515|FG012|Primary Phase|Withdrawal by Subject|0|||
33304667|NCT01235949|62680516|FG013|Primary Phase|Withdrawal by Subject|0|||
33304668|NCT01235949|62680517|FG014|Primary Phase|Withdrawal by Subject|0|||
33304669|NCT01235949|62680518|FG015|Primary Phase|Withdrawal by Subject|0|||
33304670|NCT01235949|62680519|FG016|Primary Phase|Withdrawal by Subject|0|||
33304671|NCT01235949|62680520|FG017|Primary Phase|Withdrawal by Subject|0|||
33304672|NCT01235949|62680503|FG000|Primary Phase|Lost to Follow-up|0|||
33304673|NCT01235949|62680504|FG001|Primary Phase|Lost to Follow-up|0|||
33304674|NCT01235949|62680505|FG002|Primary Phase|Lost to Follow-up|1|||
33304675|NCT01235949|62680506|FG003|Primary Phase|Lost to Follow-up|1|||
33304676|NCT01235949|62680507|FG004|Primary Phase|Lost to Follow-up|0|||
33304677|NCT01235949|62680508|FG005|Primary Phase|Lost to Follow-up|2|||
33304678|NCT01235949|62680509|FG006|Primary Phase|Lost to Follow-up|0|||
33304679|NCT01235949|62680510|FG007|Primary Phase|Lost to Follow-up|0|||
33304680|NCT01235949|62680511|FG008|Primary Phase|Lost to Follow-up|0|||
33304681|NCT01235949|62680512|FG009|Primary Phase|Lost to Follow-up|0|||
33304682|NCT01235949|62680513|FG010|Primary Phase|Lost to Follow-up|0|||
33304683|NCT01235949|62680514|FG011|Primary Phase|Lost to Follow-up|0|||
33304684|NCT01235949|62680515|FG012|Primary Phase|Lost to Follow-up|0|||
33304685|NCT01235949|62680516|FG013|Primary Phase|Lost to Follow-up|0|||
33304686|NCT01235949|62680517|FG014|Primary Phase|Lost to Follow-up|0|||
33304687|NCT01235949|62680518|FG015|Primary Phase|Lost to Follow-up|0|||
33304688|NCT01235949|62680519|FG016|Primary Phase|Lost to Follow-up|0|||
33304689|NCT01235949|62680520|FG017|Primary Phase|Lost to Follow-up|0|||
33304690|NCT01235949|62680503|FG000|Booster Phase|Migrated/moved from study area|0|||
33304691|NCT01235949|62680504|FG001|Booster Phase|Migrated/moved from study area|0|||
33304692|NCT01235949|62680505|FG002|Booster Phase|Migrated/moved from study area|0|||
33304693|NCT01235949|62680506|FG003|Booster Phase|Migrated/moved from study area|0|||
33304694|NCT01235949|62680507|FG004|Booster Phase|Migrated/moved from study area|0|||
33304695|NCT01235949|62680508|FG005|Booster Phase|Migrated/moved from study area|0|||
33304696|NCT01235949|62680509|FG006|Booster Phase|Migrated/moved from study area|0|||
33304697|NCT01235949|62680510|FG007|Booster Phase|Migrated/moved from study area|0|||
33304698|NCT01235949|62680511|FG008|Booster Phase|Migrated/moved from study area|0|||
33304699|NCT01235949|62680512|FG009|Booster Phase|Migrated/moved from study area|0|||
33304700|NCT01235949|62680513|FG010|Booster Phase|Migrated/moved from study area|0|||
33304701|NCT01235949|62680514|FG011|Booster Phase|Migrated/moved from study area|1|||
33304702|NCT01235949|62680515|FG012|Booster Phase|Migrated/moved from study area|1|||
33304703|NCT01235949|62680516|FG013|Booster Phase|Migrated/moved from study area|0|||
33304704|NCT01235949|62680517|FG014|Booster Phase|Migrated/moved from study area|0|||
33304705|NCT01235949|62680518|FG015|Booster Phase|Migrated/moved from study area|0|||
33304706|NCT01235949|62680519|FG016|Booster Phase|Migrated/moved from study area|0|||
33304707|NCT01235949|62680520|FG017|Booster Phase|Migrated/moved from study area|1|||
33304708|NCT01235949|62680503|FG000|Booster Phase|Adverse Event|0|||
33304709|NCT01235949|62680504|FG001|Booster Phase|Adverse Event|0|||
33304710|NCT01235949|62680505|FG002|Booster Phase|Adverse Event|0|||
33304711|NCT01235949|62680506|FG003|Booster Phase|Adverse Event|0|||
33304712|NCT01235949|62680507|FG004|Booster Phase|Adverse Event|0|||
33304713|NCT01235949|62680508|FG005|Booster Phase|Adverse Event|0|||
33304714|NCT01235949|62680509|FG006|Booster Phase|Adverse Event|0|||
33304715|NCT01235949|62680510|FG007|Booster Phase|Adverse Event|0|||
33304716|NCT01235949|62680511|FG008|Booster Phase|Adverse Event|0|||
33304717|NCT01235949|62680512|FG009|Booster Phase|Adverse Event|0|||
33304718|NCT01235949|62680513|FG010|Booster Phase|Adverse Event|0|||
33304719|NCT01235949|62680514|FG011|Booster Phase|Adverse Event|0|||
33304720|NCT01235949|62680515|FG012|Booster Phase|Adverse Event|0|||
33304721|NCT01235949|62680516|FG013|Booster Phase|Adverse Event|0|||
33304722|NCT01235949|62680517|FG014|Booster Phase|Adverse Event|0|||
33304723|NCT01235949|62680518|FG015|Booster Phase|Adverse Event|1|||
33304724|NCT01235949|62680519|FG016|Booster Phase|Adverse Event|0|||
33304725|NCT01235949|62680520|FG017|Booster Phase|Adverse Event|0|||
33304726|NCT01235949|62680503|FG000|Booster Phase|Withdrawal by Subject|0|||
33304727|NCT01235949|62680504|FG001|Booster Phase|Withdrawal by Subject|0|||
33304728|NCT01235949|62680505|FG002|Booster Phase|Withdrawal by Subject|0|||
33304729|NCT01235949|62680506|FG003|Booster Phase|Withdrawal by Subject|0|||
33304730|NCT01235949|62680507|FG004|Booster Phase|Withdrawal by Subject|0|||
33304731|NCT01235949|62680508|FG005|Booster Phase|Withdrawal by Subject|0|||
33304732|NCT01235949|62680509|FG006|Booster Phase|Withdrawal by Subject|0|||
33304733|NCT01235949|62680510|FG007|Booster Phase|Withdrawal by Subject|1|||
33304734|NCT01235949|62680511|FG008|Booster Phase|Withdrawal by Subject|1|||
33304735|NCT01235949|62680512|FG009|Booster Phase|Withdrawal by Subject|0|||
33304736|NCT01235949|62680513|FG010|Booster Phase|Withdrawal by Subject|1|||
33304737|NCT01235949|62680514|FG011|Booster Phase|Withdrawal by Subject|1|||
33304738|NCT01235949|62680515|FG012|Booster Phase|Withdrawal by Subject|2|||
33304739|NCT01235949|62680516|FG013|Booster Phase|Withdrawal by Subject|0|||
33304740|NCT01235949|62680517|FG014|Booster Phase|Withdrawal by Subject|2|||
33304741|NCT01235949|62680518|FG015|Booster Phase|Withdrawal by Subject|0|||
33304742|NCT01235949|62680519|FG016|Booster Phase|Withdrawal by Subject|0|||
33304743|NCT01235949|62680520|FG017|Booster Phase|Withdrawal by Subject|0|||
33304744|NCT01235949|62680503|FG000|Booster Phase|Lost to Follow-up|0|||
33304745|NCT01235949|62680504|FG001|Booster Phase|Lost to Follow-up|0|||
33304746|NCT01235949|62680505|FG002|Booster Phase|Lost to Follow-up|0|||
33304747|NCT01235949|62680506|FG003|Booster Phase|Lost to Follow-up|0|||
33304748|NCT01235949|62680507|FG004|Booster Phase|Lost to Follow-up|0|||
33304749|NCT01235949|62680508|FG005|Booster Phase|Lost to Follow-up|0|||
33304750|NCT01235949|62680509|FG006|Booster Phase|Lost to Follow-up|0|||
33304751|NCT01235949|62680510|FG007|Booster Phase|Lost to Follow-up|0|||
33304752|NCT01235949|62680511|FG008|Booster Phase|Lost to Follow-up|1|||
33304753|NCT01235949|62680512|FG009|Booster Phase|Lost to Follow-up|1|||
33304754|NCT01235949|62680513|FG010|Booster Phase|Lost to Follow-up|1|||
33304755|NCT01235949|62680514|FG011|Booster Phase|Lost to Follow-up|1|||
33304756|NCT01235949|62680515|FG012|Booster Phase|Lost to Follow-up|0|||
33304757|NCT01235949|62680516|FG013|Booster Phase|Lost to Follow-up|0|||
33304758|NCT01235949|62680517|FG014|Booster Phase|Lost to Follow-up|0|||
33304759|NCT01235949|62680518|FG015|Booster Phase|Lost to Follow-up|0|||
33304760|NCT01235949|62680519|FG016|Booster Phase|Lost to Follow-up|0|||
33304761|NCT01235949|62680520|FG017|Booster Phase|Lost to Follow-up|1|||
33304762|NCT01235793|62680558|FG000|Overall Study|Death|6|||
33304763|NCT01258998|62680563|FG000|Overall Study|Ineligible|1|||
33304764|NCT01235715|62680569|FG000|Overall Study|Physician Decision|0|||
33304765|NCT01235715|62680570|FG001|Overall Study|Physician Decision|2|||
33304766|NCT01235403|62680577|FG000|Overall Study|Adverse Event|14|||
33304767|NCT01235403|62680577|FG000|Overall Study|Lost to Follow-up|2|||
33304768|NCT01235403|62680577|FG000|Overall Study|Withdrawal by Subject|4|||
33304769|NCT01235403|62680577|FG000|Overall Study|Lack of Efficacy|2|||
33304770|NCT01235403|62680577|FG000|Overall Study|Other reasons for premature termination|4|||
33304771|NCT01024036|62680583|FG000|Blinded Treatment|Adverse Event|1|||
33304772|NCT01024036|62680584|FG001|Blinded Treatment|Adverse Event|1|||
33304773|NCT01024036|62680583|FG000|Blinded Treatment|Lack of Efficacy|16|||
33304774|NCT01024036|62680584|FG001|Blinded Treatment|Lack of Efficacy|14|||
33304775|NCT01024036|62680583|FG000|Blinded Treatment|Physician Decision|1|||
33304776|NCT01024036|62680584|FG001|Blinded Treatment|Physician Decision|0|||
33304777|NCT01024036|62680583|FG000|Blinded Treatment|Death|0|||
33304778|NCT01024036|62680584|FG001|Blinded Treatment|Death|2|||
33304779|NCT01024036|62680583|FG000|Blinded Treatment|Withdrawal by Subject|4|||
33304780|NCT01024036|62680584|FG001|Blinded Treatment|Withdrawal by Subject|3|||
33304781|NCT01024036|62680583|FG000|Unblinded Treatment|Adverse Event|0|||
33304782|NCT01024036|62680584|FG001|Unblinded Treatment|Adverse Event|1|||
33304783|NCT01024036|62680583|FG000|Unblinded Treatment|Lack of Efficacy|0|||
33304784|NCT01024036|62680584|FG001|Unblinded Treatment|Lack of Efficacy|2|||
33304785|NCT01024036|62680583|FG000|Follow-Up Period|Lost to Follow-up|1|||
33304786|NCT01024036|62680584|FG001|Follow-Up Period|Lost to Follow-up|1|||
33304787|NCT01024036|62680583|FG000|Follow-Up Period|Withdrawal by Subject|0|||
33304788|NCT01024036|62680584|FG001|Follow-Up Period|Withdrawal by Subject|1|||
33304789|NCT01024036|62680583|FG000|Follow-Up Period|Adverse Event|4|||
33304790|NCT01024036|62680584|FG001|Follow-Up Period|Adverse Event|1|||
33304791|NCT01234467|62680593|FG000|Overall Study|Adverse Event|3|||
33304792|NCT01234467|62680593|FG000|Overall Study|Death|2|||
33304793|NCT01234467|62680593|FG000|Overall Study|Withdrawal by Subject|2|||
33304794|NCT01234467|62680593|FG000|Overall Study|Disease Progression|2|||
33304795|NCT01234467|62680593|FG000|Overall Study|Clinical deterioration|1|||
33304796|NCT01234467|62680593|FG000|Overall Study|Physician Decision|1|||
33304797|NCT01234467|62680593|FG000|Overall Study|Other complicating disease (stroke)|1|||
33304798|NCT01233999|62680597|FG000|Overall Study|Withdrawal by Subject|1|||
33304799|NCT01233999|62680597|FG000|Overall Study|Lost to Follow-up|1|||
33304800|NCT01233687|62680601|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
33304801|NCT01233687|62680601|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
33304802|NCT01233687|62680601|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
33304803|NCT01023958|62680605|FG000|Overall Study|Progressive disease|48|||
33304804|NCT01023958|62680605|FG000|Overall Study|Other adverse event|1|||
33304805|NCT01023958|62680605|FG000|Overall Study|Refused to continue medication|1|||
33304806|NCT01233609|62680611|FG000|Overall Study|Death|1|||
33304807|NCT01233609|62680612|FG001|Overall Study|Death|0|||
33396999|NCT00649428|62776202|FG000|Overall Study|Withdrawal by Subject|6|||
33397000|NCT00649428|62776203|FG001|Overall Study|Withdrawal by Subject|6|||
33397001|NCT00649428|62776202|FG000|Overall Study|Lost to Follow-up|1|||
33397002|NCT00649428|62776203|FG001|Overall Study|Lost to Follow-up|3|||
33397003|NCT00649428|62776202|FG000|Overall Study|Insufficient manufacturing yield|5|||
33397004|NCT00649428|62776203|FG001|Overall Study|Insufficient manufacturing yield|1|||
33397005|NCT00649428|62776202|FG000|Overall Study|Protocol Violation|6|||
33397006|NCT00649428|62776203|FG001|Overall Study|Protocol Violation|2|||
33397007|NCT00649428|62776202|FG000|Overall Study|Physician Decision|0|||
33397008|NCT00649428|62776203|FG001|Overall Study|Physician Decision|1|||
33397009|NCT00669032|62776212|FG000|Overall Study|Lost to Follow-up|6|||
33397010|NCT00669032|62776213|FG001|Overall Study|Lost to Follow-up|5|||
33397011|NCT00669032|62776212|FG000|Overall Study|Lack of Efficacy|8|||
33397012|NCT00669032|62776213|FG001|Overall Study|Lack of Efficacy|19|||
33397013|NCT00669032|62776212|FG000|Overall Study|Withdrawal by Subject|12|||
33397014|NCT00669032|62776213|FG001|Overall Study|Withdrawal by Subject|13|||
33397015|NCT00669032|62776212|FG000|Overall Study|Adverse Event|12|||
33397016|NCT00669032|62776213|FG001|Overall Study|Adverse Event|16|||
33397017|NCT00669032|62776212|FG000|Overall Study|Physician Decision|1|||
33397018|NCT00669032|62776213|FG001|Overall Study|Physician Decision|1|||
33397019|NCT00669032|62776212|FG000|Overall Study|No fulfilment of the selection criteria|5|||
33397020|NCT00669032|62776213|FG001|Overall Study|No fulfilment of the selection criteria|5|||
33397021|NCT00654498|62776221|FG000|Overall Study|Not Treated|1|||
33397022|NCT00654498|62776222|FG001|Overall Study|Not Treated|0|||
33397023|NCT00654498|62776221|FG000|Overall Study|Adverse Event|6|||
33397024|NCT00654498|62776222|FG001|Overall Study|Adverse Event|1|||
33397025|NCT00654498|62776221|FG000|Overall Study|Protocol Violation|1|||
33397026|NCT00654498|62776222|FG001|Overall Study|Protocol Violation|1|||
33397027|NCT00654498|62776221|FG000|Overall Study|Lost to Follow-up|1|||
33397028|NCT00654498|62776222|FG001|Overall Study|Lost to Follow-up|5|||
33397029|NCT00654498|62776221|FG000|Overall Study|Withdrawal by Subject|1|||
33397030|NCT00654498|62776222|FG001|Overall Study|Withdrawal by Subject|0|||
33304808|NCT01233609|62680611|FG000|Overall Study|Lost to Follow-up|3|||
33304809|NCT01233609|62680612|FG001|Overall Study|Lost to Follow-up|1|||
33304810|NCT01233609|62680611|FG000|Overall Study|Adverse Event|2|||
33304811|NCT01233609|62680612|FG001|Overall Study|Adverse Event|1|||
33304812|NCT01233609|62680611|FG000|Overall Study|Withdrawal by Subject|3|||
33304813|NCT01233609|62680612|FG001|Overall Study|Withdrawal by Subject|0|||
33304814|NCT01232283|62680628|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
33304815|NCT01232283|62680629|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
33397031|NCT00654498|62776221|FG000|Overall Study|Other reason not defined above|4|||
33397032|NCT00654498|62776222|FG001|Overall Study|Other reason not defined above|5|||
33397033|NCT00670046|62776230|FG000|Overall Study|Lost to Follow-up|1|||
33397034|NCT00670046|62776231|FG001|Overall Study|Lost to Follow-up|1|||
33397035|NCT00670046|62776230|FG000|Overall Study|Withdrawal by Subject|0|||
33397036|NCT00670046|62776231|FG001|Overall Study|Withdrawal by Subject|1|||
33397037|NCT00560391|62776242|FG000|Overall Study|Still on treatment|0|||
33397038|NCT00560391|62776243|FG001|Overall Study|Still on treatment|0|||
33397039|NCT00560391|62776244|FG002|Overall Study|Still on treatment|0|||
33397040|NCT00560391|62776245|FG003|Overall Study|Still on treatment|1|||
33397041|NCT00560391|62776246|FG004|Overall Study|Still on treatment|2|||
33397042|NCT00537238|62776261|FG000|Overall Study|Death|1|||
33397043|NCT00537238|62776262|FG001|Overall Study|Death|2|||
33397044|NCT00537238|62776261|FG000|Overall Study|Adverse Event|31|||
33397045|NCT00537238|62776262|FG001|Overall Study|Adverse Event|22|||
33397046|NCT00537238|62776261|FG000|Overall Study|Lack of Efficacy|20|||
33397047|NCT00537238|62776262|FG001|Overall Study|Lack of Efficacy|21|||
33397048|NCT00537238|62776261|FG000|Overall Study|Lost to Follow-up|12|||
33397049|NCT00537238|62776262|FG001|Overall Study|Lost to Follow-up|8|||
33397050|NCT00537238|62776261|FG000|Overall Study|Withdrawal by Subject|51|||
33397051|NCT00537238|62776262|FG001|Overall Study|Withdrawal by Subject|47|||
33397052|NCT00537238|62776261|FG000|Overall Study|Protocol Violation|15|||
33397053|NCT00537238|62776262|FG001|Overall Study|Protocol Violation|19|||
33397054|NCT00537238|62776261|FG000|Overall Study|Does not meet entrance criteria|0|||
33397055|NCT00537238|62776262|FG001|Overall Study|Does not meet entrance criteria|2|||
33397056|NCT00537238|62776261|FG000|Overall Study|Other|44|||
33397057|NCT00537238|62776262|FG001|Overall Study|Other|52|||
33397058|NCT03966885|62776270|FG000|Overall Study|Death|1|||
33397059|NCT03966885|62776271|FG001|Overall Study|Death|0|||
33397060|NCT03966885|62776270|FG000|Overall Study|Lost to Follow-up|1|||
33397061|NCT03966885|62776271|FG001|Overall Study|Lost to Follow-up|2|||
33397062|NCT03966885|62776270|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
33397063|NCT03966885|62776271|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
33397064|NCT03966885|62776270|FG000|Overall Study|Moved from study area.|0|||
33397065|NCT03966885|62776271|FG001|Overall Study|Moved from study area.|2|||
33397066|NCT03965403|62776278|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
33397067|NCT00552669|62776284|FG000|Overall Study|Death|3|||
33397068|NCT00552669|62776285|FG001|Overall Study|Death|7|||
33397069|NCT00552513|62776293|FG000|Overall Study|Lost to Follow-up|5|||
33397070|NCT00552513|62776294|FG001|Overall Study|Lost to Follow-up|1|||
33397071|NCT00560313|62776302|FG000|Overall Study|Adverse Events or Death|2|||
33397072|NCT00560313|62776302|FG000|Overall Study|Withdrawal by Subject|2|||
33397073|NCT00560313|62776302|FG000|Overall Study|Lost to Follow-up|1|||
33397074|NCT00560313|62776302|FG000|Overall Study|Protocol Violation|1|||
33397075|NCT00667862|62776321|FG000|Overall Study|Adverse Event|9|||
33397076|NCT00667862|62776321|FG000|Overall Study|Death|1|||
33397077|NCT00667862|62776321|FG000|Overall Study|Disease Progression|22|||
33397078|NCT00667862|62776321|FG000|Overall Study|Withdrawal by Subject|3|||
33397079|NCT00535132|62776327|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
33397080|NCT00535132|62776328|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
33397081|NCT00535132|62776327|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
33397082|NCT00535132|62776328|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
33397083|NCT00570908|62776336|FG000|Overall Study|Adverse Event|5|||
33397084|NCT00570908|62776336|FG000|Overall Study|Withdrawal by Subject|2|||
33397085|NCT00321919|62776342|FG000|Overall Study|Adverse Event|17|||
33397086|NCT00321919|62776343|FG001|Overall Study|Adverse Event|10|||
33304816|NCT01232283|62680630|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33304817|NCT01232283|62680631|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33304818|NCT01232283|62680632|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33304819|NCT01232283|62680633|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33304820|NCT01232283|62680634|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33304821|NCT01232283|62680635|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33304822|NCT01232283|62680636|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33304823|NCT01232283|62680637|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33304824|NCT01232283|62680628|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
33304825|NCT01232283|62680629|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
33304826|NCT01232283|62680630|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33304827|NCT01232283|62680631|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33397087|NCT00321919|62776342|FG000|Overall Study|Death|21|||
33397088|NCT00321919|62776343|FG001|Overall Study|Death|17|||
33397089|NCT00321919|62776342|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33397090|NCT00321919|62776343|FG001|Overall Study|Insufficient Therapeutic Response|0|||
33397091|NCT00321919|62776342|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
33397092|NCT00321919|62776343|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
33397093|NCT00321919|62776342|FG000|Overall Study|Refused Treatment|23|||
33304828|NCT01232283|62680632|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33397094|NCT00321919|62776343|FG001|Overall Study|Refused Treatment|14|||
33397095|NCT00321919|62776342|FG000|Overall Study|Other Protocol Violation|2|||
33397096|NCT00321919|62776343|FG001|Overall Study|Other Protocol Violation|3|||
33397097|NCT00321919|62776342|FG000|Overall Study|Failure to Return|3|||
33397098|NCT00321919|62776343|FG001|Overall Study|Failure to Return|1|||
33397099|NCT00321919|62776342|FG000|Overall Study|Other withdrawal reason|7|||
33397100|NCT00321919|62776343|FG001|Overall Study|Other withdrawal reason|6|||
33397101|NCT00781391|62776353|FG000|Overall Study|never received study drug|24|||
33397102|NCT00781391|62776354|FG001|Overall Study|never received study drug|23|||
33397103|NCT00781391|62776355|FG002|Overall Study|never received study drug|32|||
33397104|NCT00781391|62776353|FG000|Overall Study|Protocol Violation|19|||
33397105|NCT00781391|62776354|FG001|Overall Study|Protocol Violation|17|||
33397106|NCT00781391|62776355|FG002|Overall Study|Protocol Violation|20|||
33397107|NCT00781391|62776353|FG000|Overall Study|Death|789|||
33397108|NCT00781391|62776354|FG001|Overall Study|Death|730|||
33397109|NCT00781391|62776355|FG002|Overall Study|Death|706|||
33397110|NCT00781391|62776353|FG000|Overall Study|Withdrawal by Subject|47|||
33397111|NCT00781391|62776354|FG001|Overall Study|Withdrawal by Subject|37|||
33397112|NCT00781391|62776355|FG002|Overall Study|Withdrawal by Subject|25|||
33397113|NCT00781391|62776353|FG000|Overall Study|Lost to Follow-up|0|||
33397114|NCT00781391|62776354|FG001|Overall Study|Lost to Follow-up|0|||
33397115|NCT00781391|62776355|FG002|Overall Study|Lost to Follow-up|1|||
33397116|NCT00534976|62776365|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
33397117|NCT00534976|62776366|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
33397118|NCT00534976|62776365|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
33397119|NCT00534976|62776366|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
33397120|NCT00534976|62776365|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
33397121|NCT00534976|62776366|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
33397122|NCT00321763|62776376|FG000|Overall Study|Adverse Event|1|||
33397123|NCT00321763|62776377|FG001|Overall Study|Adverse Event|1|||
33397124|NCT00321763|62776378|FG002|Overall Study|Adverse Event|0|||
33397125|NCT00321763|62776379|FG003|Overall Study|Adverse Event|1|||
33397126|NCT00321763|62776376|FG000|Overall Study|Withdrawal by Subject|2|||
33397127|NCT00321763|62776377|FG001|Overall Study|Withdrawal by Subject|0|||
33397128|NCT00321763|62776378|FG002|Overall Study|Withdrawal by Subject|1|||
33397129|NCT00321763|62776379|FG003|Overall Study|Withdrawal by Subject|0|||
33397130|NCT00321763|62776376|FG000|Overall Study|Lost to Follow-up|3|||
33397131|NCT00321763|62776377|FG001|Overall Study|Lost to Follow-up|1|||
33397132|NCT00321763|62776378|FG002|Overall Study|Lost to Follow-up|5|||
33397133|NCT00321763|62776379|FG003|Overall Study|Lost to Follow-up|4|||
33397134|NCT00308113|62776395|FG000|Overall Study|Protocol closure|0|||
33397135|NCT00308113|62776396|FG001|Overall Study|Protocol closure|0|||
33397136|NCT00308113|62776397|FG002|Overall Study|Protocol closure|0|||
33397137|NCT00308113|62776398|FG003|Overall Study|Protocol closure|1|||
33397138|NCT00307801|62776414|FG000|Overall Study|Adverse Event|12|||
33397139|NCT00307801|62776415|FG001|Overall Study|Adverse Event|4|||
33397140|NCT00307801|62776414|FG000|Overall Study|Withdrawal by Subject|9|||
33397141|NCT00307801|62776415|FG001|Overall Study|Withdrawal by Subject|4|||
33397142|NCT00307801|62776414|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
33397143|NCT00307801|62776415|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
33397144|NCT00307801|62776414|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
33304829|NCT01232283|62680633|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33304830|NCT01232283|62680634|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33304831|NCT01232283|62680635|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33304832|NCT01232283|62680636|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33304833|NCT01232283|62680637|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33304834|NCT01232283|62680628|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
33304835|NCT01232283|62680629|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33304836|NCT01232283|62680630|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33304837|NCT01232283|62680631|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33304838|NCT01232283|62680632|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33304839|NCT01232283|62680633|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33304840|NCT01232283|62680634|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33304841|NCT01232283|62680635|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33304842|NCT01232283|62680636|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33304843|NCT01232283|62680637|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33304844|NCT01232283|62680628|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
33304845|NCT01232283|62680629|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
33304846|NCT01232283|62680630|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33397145|NCT00307801|62776415|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
33397146|NCT00307801|62776414|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
33397147|NCT00307801|62776415|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
33576043|NCT02031640|62972418|FG003|Run-In Period|Exclusion criteria met|0|||
33576044|NCT02031640|62972419|FG004|Run-In Period|Exclusion criteria met|0|||
33576045|NCT02031640|62972420|FG005|Run-In Period|Exclusion criteria met|0|||
33581021|NCT01111461|62978156|FG000|Overall Study|Participant choice|11|||
33397148|NCT00307801|62776414|FG000|Overall Study|Wrong Randomization|1|||
33397149|NCT00307801|62776415|FG001|Overall Study|Wrong Randomization|0|||
33397150|NCT00307801|62776414|FG000|Overall Study|Lack of Efficacy|0|||
33397151|NCT00307801|62776415|FG001|Overall Study|Lack of Efficacy|2|||
33397152|NCT00307801|62776414|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
33397153|NCT00307801|62776415|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
33397154|NCT00307801|62776414|FG000|Overall Study|Frustration with e-diary|1|||
33397155|NCT00307801|62776415|FG001|Overall Study|Frustration with e-diary|0|||
33397156|NCT00307801|62776414|FG000|Overall Study|Protocol Violation|3|||
33397157|NCT00307801|62776415|FG001|Overall Study|Protocol Violation|2|||
33397158|NCT00307801|62776414|FG000|Overall Study|No reason specified|2|||
33397159|NCT00307801|62776415|FG001|Overall Study|No reason specified|0|||
33397160|NCT00307801|62776414|FG000|Overall Study|Pregnancy|0|||
33397161|NCT00307801|62776415|FG001|Overall Study|Pregnancy|1|||
33397162|NCT00671060|62776424|FG000|Overall Study|Protocol Violation|1|||
33397163|NCT00671060|62776425|FG001|Overall Study|Protocol Violation|0|||
33397164|NCT00671060|62776424|FG000|Overall Study|Physician Decision|0|||
33397165|NCT00671060|62776425|FG001|Overall Study|Physician Decision|1|||
33397166|NCT00654420|62776435|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
33397167|NCT00654420|62776436|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
33397168|NCT00654420|62776437|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
33397169|NCT00654420|62776438|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
33397170|NCT00654420|62776435|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
33397171|NCT00654420|62776436|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
33397172|NCT00654420|62776437|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
33397173|NCT00654420|62776438|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
33397174|NCT00654420|62776435|FG000|Phase II|Adverse Event|0|||
33397175|NCT00654420|62776436|FG001|Phase II|Adverse Event|0|||
33397176|NCT00654420|62776437|FG002|Phase II|Adverse Event|3|||
33397177|NCT00654420|62776438|FG003|Phase II|Adverse Event|3|||
33397178|NCT00654420|62776435|FG000|Phase II|Lost to Follow-up|0|||
33397179|NCT00654420|62776436|FG001|Phase II|Lost to Follow-up|0|||
33397180|NCT00654420|62776437|FG002|Phase II|Lost to Follow-up|0|||
33397181|NCT00654420|62776438|FG003|Phase II|Lost to Follow-up|1|||
33397182|NCT00654420|62776435|FG000|Phase II|Physician Decision|0|||
33397183|NCT00654420|62776436|FG001|Phase II|Physician Decision|0|||
33397184|NCT00654420|62776437|FG002|Phase II|Physician Decision|0|||
33397185|NCT00654420|62776438|FG003|Phase II|Physician Decision|4|||
33397186|NCT00654420|62776435|FG000|Phase II|Progressive Disease|0|||
33397187|NCT00654420|62776436|FG001|Phase II|Progressive Disease|0|||
33397188|NCT00654420|62776437|FG002|Phase II|Progressive Disease|29|||
33397189|NCT00654420|62776438|FG003|Phase II|Progressive Disease|29|||
33397190|NCT00654420|62776435|FG000|Phase II|Withdrawal by Subject|0|||
33397191|NCT00654420|62776436|FG001|Phase II|Withdrawal by Subject|0|||
33397192|NCT00654420|62776437|FG002|Phase II|Withdrawal by Subject|4|||
33397193|NCT00654420|62776438|FG003|Phase II|Withdrawal by Subject|1|||
33397194|NCT00654420|62776435|FG000|Phase II|Missing Disposition Record|0|||
33397195|NCT00654420|62776436|FG001|Phase II|Missing Disposition Record|0|||
33397196|NCT00654420|62776437|FG002|Phase II|Missing Disposition Record|1|||
33576046|NCT02031640|62972415|FG000|Run-In Period|Randomization criteria not met|85|||
33576047|NCT02031640|62972416|FG001|Run-In Period|Randomization criteria not met|0|||
33576048|NCT02031640|62972417|FG002|Run-In Period|Randomization criteria not met|0|||
33576049|NCT02031640|62972418|FG003|Run-In Period|Randomization criteria not met|0|||
33576050|NCT02031640|62972419|FG004|Run-In Period|Randomization criteria not met|0|||
33576051|NCT02031640|62972420|FG005|Run-In Period|Randomization criteria not met|0|||
33576052|NCT02031640|62972415|FG000|Run-In Period|Various administrative reasons|17|||
33576053|NCT02031640|62972416|FG001|Run-In Period|Various administrative reasons|0|||
33576054|NCT02031640|62972417|FG002|Run-In Period|Various administrative reasons|0|||
33576055|NCT02031640|62972418|FG003|Run-In Period|Various administrative reasons|0|||
33576056|NCT02031640|62972419|FG004|Run-In Period|Various administrative reasons|0|||
33576057|NCT02031640|62972420|FG005|Run-In Period|Various administrative reasons|0|||
33576058|NCT02031640|62972415|FG000|Double-blind Treatment Period|Protocol deviation|0|||
33576059|NCT02031640|62972416|FG001|Double-blind Treatment Period|Protocol deviation|2|||
33576060|NCT02031640|62972417|FG002|Double-blind Treatment Period|Protocol deviation|0|||
33576061|NCT02031640|62972418|FG003|Double-blind Treatment Period|Protocol deviation|1|||
33576062|NCT02031640|62972419|FG004|Double-blind Treatment Period|Protocol deviation|3|||
33397197|NCT00654420|62776438|FG003|Phase II|Missing Disposition Record|0|||
33397198|NCT00307489|62776450|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
33397199|NCT00307489|62776451|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
33397200|NCT00307489|62776450|FG000|Baseline Through Week 48|Physician Decision|1|||
33397201|NCT00307489|62776451|FG001|Baseline Through Week 48|Physician Decision|0|||
33397202|NCT00307489|62776450|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
33397203|NCT00307489|62776451|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
33397204|NCT00307489|62776450|FG000|Week 48 Through Week 168|Adverse Event|1|||
33397205|NCT00307489|62776451|FG001|Week 48 Through Week 168|Adverse Event|0|||
33397206|NCT00307489|62776450|FG000|Week 48 Through Week 168|Physician Decision|1|||
33397207|NCT00307489|62776451|FG001|Week 48 Through Week 168|Physician Decision|0|||
33397208|NCT00307489|62776450|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
33397209|NCT00307489|62776451|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
33397210|NCT00307489|62776450|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
33397211|NCT00307489|62776451|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
33397212|NCT00307489|62776450|FG000|Week 48 Through Week 168|Death|0|||
33397213|NCT00307489|62776451|FG001|Week 48 Through Week 168|Death|1|||
33397214|NCT00307489|62776450|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
33397215|NCT00307489|62776451|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
33397216|NCT00307489|62776450|FG000|Week 48 Through Week 168|Seroconversion|1|||
33397217|NCT00307489|62776451|FG001|Week 48 Through Week 168|Seroconversion|0|||
33397218|NCT00645840|62776457|FG000|Overall Study|Protocol Violation|3|||
33397219|NCT00307333|62776463|FG000|Overall Study|Lost to Follow-up|11|||
33397220|NCT00307333|62776464|FG001|Overall Study|Lost to Follow-up|3|||
33397221|NCT00762359|62776472|FG000|Overall Study|Adverse Event|20|||
33397222|NCT00762359|62776473|FG001|Overall Study|Adverse Event|23|||
33397223|NCT00762359|62776472|FG000|Overall Study|Protocol Violation|21|||
33397224|NCT00762359|62776473|FG001|Overall Study|Protocol Violation|13|||
33397225|NCT00762359|62776472|FG000|Overall Study|Withdrawal by Subject|13|||
33397226|NCT00762359|62776473|FG001|Overall Study|Withdrawal by Subject|10|||
33397227|NCT00762359|62776472|FG000|Overall Study|Lack of Efficacy|0|||
33397228|NCT00762359|62776473|FG001|Overall Study|Lack of Efficacy|4|||
33397229|NCT00762359|62776472|FG000|Overall Study|Institution closed|2|||
33397230|NCT00762359|62776473|FG001|Overall Study|Institution closed|3|||
33397231|NCT00762359|62776472|FG000|Overall Study|Physician Decision|2|||
33397232|NCT00762359|62776473|FG001|Overall Study|Physician Decision|3|||
33397233|NCT00762359|62776472|FG000|Overall Study|Removal|0|||
33397234|NCT00762359|62776473|FG001|Overall Study|Removal|1|||
33397235|NCT00762359|62776472|FG000|Overall Study|Withdrew consent|1|||
33397236|NCT00762359|62776473|FG001|Overall Study|Withdrew consent|0|||
33397237|NCT00654186|62776479|FG000|Overall Study|Withdrawal by Subject|5|||
33397238|NCT00761969|62776485|FG000|Overall Study|Death|112|||
33397239|NCT00761969|62776486|FG001|Overall Study|Death|47|||
33397240|NCT00761969|62776485|FG000|Overall Study|Lost to Follow-up|88|||
33397241|NCT00761969|62776486|FG001|Overall Study|Lost to Follow-up|93|||
33397242|NCT00761891|62776497|FG000|Overall Study|Withdrawal by Subject|10|||
33397243|NCT00321685|62776502|FG000|Overall Study|Adverse Event|18|||
33397244|NCT00321685|62776502|FG000|Overall Study|Death|2|||
33397245|NCT00321685|62776502|FG000|Overall Study|Withdrawal by Subject|8|||
33397246|NCT00321685|62776502|FG000|Overall Study|Alternative therapy|1|||
33397247|NCT00321685|62776502|FG000|Overall Study|Complicating disese|1|||
33397248|NCT00321685|62776502|FG000|Overall Study|Other|5|||
33397249|NCT00321685|62776502|FG000|Overall Study|Not start protocol therapy|2|||
33397250|NCT00321685|62776502|FG000|Overall Study|Ineligible|2|||
33397251|NCT03902392|62776508|FG000|Overall Study|Lost to Follow-up|7|||
33397252|NCT03902392|62776509|FG001|Overall Study|Lost to Follow-up|7|||
33397253|NCT00306787|62776517|FG000|Overall Study|Discontinued without taking study drug|208|||
33397254|NCT00306787|62776518|FG001|Overall Study|Discontinued without taking study drug|215|||
33397255|NCT00306787|62776517|FG000|Overall Study|Adverse Event|1|||
33397256|NCT00306787|62776518|FG001|Overall Study|Adverse Event|1|||
33397257|NCT00306787|62776517|FG000|Overall Study|Lack of Efficacy|1|||
33397258|NCT00306787|62776518|FG001|Overall Study|Lack of Efficacy|0|||
33397259|NCT00306787|62776517|FG000|Overall Study|Protocol Violation|8|||
33397260|NCT00306787|62776518|FG001|Overall Study|Protocol Violation|10|||
33397261|NCT00306787|62776517|FG000|Overall Study|Withdrawal by Subject|2|||
33397262|NCT00306787|62776518|FG001|Overall Study|Withdrawal by Subject|9|||
33397263|NCT00306787|62776517|FG000|Overall Study|Lost to Follow-up|9|||
33397264|NCT00306787|62776518|FG001|Overall Study|Lost to Follow-up|6|||
33397265|NCT00306787|62776517|FG000|Overall Study|Administrative problems|4|||
33397266|NCT00306787|62776518|FG001|Overall Study|Administrative problems|0|||
33397267|NCT00306787|62776517|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33397268|NCT00306787|62776518|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33397269|NCT00769067|62776526|FG000|Overall Study|Death|89|||
33397270|NCT00769067|62776527|FG001|Overall Study|Death|86|||
33397271|NCT00769067|62776526|FG000|Overall Study|Lost to Follow-up|3|||
33397272|NCT00769067|62776527|FG001|Overall Study|Lost to Follow-up|1|||
33397273|NCT00769067|62776526|FG000|Overall Study|Study terminated by sponsor|1|||
33397274|NCT00769067|62776527|FG001|Overall Study|Study terminated by sponsor|3|||
33397275|NCT00769067|62776526|FG000|Overall Study|Other|1|||
33576063|NCT02031640|62972420|FG005|Double-blind Treatment Period|Protocol deviation|1|||
33397276|NCT00769067|62776527|FG001|Overall Study|Other|3|||
33397277|NCT00769067|62776526|FG000|Overall Study|Withdrawal by Subject|0|||
33397278|NCT00769067|62776527|FG001|Overall Study|Withdrawal by Subject|1|||
33397279|NCT00321373|62776537|FG000|Overall Study|Adverse Event|0|||
33397280|NCT00321373|62776538|FG001|Overall Study|Adverse Event|0|||
33397281|NCT00321373|62776539|FG002|Overall Study|Adverse Event|1|||
33397282|NCT00321373|62776537|FG000|Overall Study|Lost to Follow-up|1|||
33397283|NCT00321373|62776538|FG001|Overall Study|Lost to Follow-up|0|||
33397284|NCT00321373|62776539|FG002|Overall Study|Lost to Follow-up|1|||
33397285|NCT00321373|62776537|FG000|Overall Study|Withdrawal by Subject|1|||
33397286|NCT00321373|62776538|FG001|Overall Study|Withdrawal by Subject|0|||
33397287|NCT00321373|62776539|FG002|Overall Study|Withdrawal by Subject|0|||
33397288|NCT00321373|62776537|FG000|Overall Study|Other|0|||
33397289|NCT00321373|62776538|FG001|Overall Study|Other|0|||
33397290|NCT00321373|62776539|FG002|Overall Study|Other|1|||
33397291|NCT00667394|62776549|FG000|Overall Study|Adverse Event|3|||
33397292|NCT00667394|62776550|FG001|Overall Study|Adverse Event|0|||
33397293|NCT00667394|62776549|FG000|Overall Study|Progressive disease|1|||
33397294|NCT00667394|62776550|FG001|Overall Study|Progressive disease|0|||
33397295|NCT00761735|62776556|FG000|Overall Study|Lost to Follow-up|6|||
33397296|NCT00761735|62776556|FG000|Overall Study|Withdrawal by Subject|6|||
33397297|NCT00761735|62776556|FG000|Overall Study|Non-compliance with protocol|1|||
33397298|NCT00761735|62776556|FG000|Overall Study|Administrative|1|||
33397299|NCT00569946|62776564|FG000|Overall Study|Adverse Event|16|||
33397300|NCT00569946|62776564|FG000|Overall Study|Objective Progression or Relapse|42|||
33397301|NCT00569946|62776564|FG000|Overall Study|Global Deterioration of Health Status|1|||
33397302|NCT00645528|62776568|FG000|Overall Study|Did not show up for Visit 2|7|||
33397303|NCT00295633|62776575|FG000|Overall Study|Lack of Efficacy|19|||
33397304|NCT00295633|62776576|FG001|Overall Study|Lack of Efficacy|7|||
33397305|NCT00295633|62776577|FG002|Overall Study|Lack of Efficacy|16|||
33397306|NCT00295633|62776575|FG000|Overall Study|Withdrawal of consent by subject|16|||
33397307|NCT00295633|62776576|FG001|Overall Study|Withdrawal of consent by subject|16|||
33397308|NCT00295633|62776577|FG002|Overall Study|Withdrawal of consent by subject|26|||
33397309|NCT00295633|62776575|FG000|Overall Study|Adverse Event|9|||
33397310|NCT00295633|62776576|FG001|Overall Study|Adverse Event|17|||
33397311|NCT00295633|62776577|FG002|Overall Study|Adverse Event|9|||
33397312|NCT00295633|62776575|FG000|Overall Study|Lost to Follow-up|6|||
33397313|NCT00295633|62776576|FG001|Overall Study|Lost to Follow-up|11|||
33397314|NCT00295633|62776577|FG002|Overall Study|Lost to Follow-up|7|||
33397315|NCT00295633|62776575|FG000|Overall Study|Physician Decision|9|||
33397316|NCT00295633|62776576|FG001|Overall Study|Physician Decision|10|||
33397317|NCT00295633|62776577|FG002|Overall Study|Physician Decision|8|||
33397318|NCT00295633|62776575|FG000|Overall Study|Poor/Noncompliance|2|||
33397319|NCT00295633|62776576|FG001|Overall Study|Poor/Noncompliance|2|||
33397320|NCT00295633|62776577|FG002|Overall Study|Poor/Noncompliance|6|||
33397321|NCT00295633|62776575|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
33397322|NCT00295633|62776576|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
33397323|NCT00295633|62776577|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
33397324|NCT00295633|62776575|FG000|Overall Study|Death|1|||
33397325|NCT00295633|62776576|FG001|Overall Study|Death|1|||
33397326|NCT00295633|62776577|FG002|Overall Study|Death|0|||
33397327|NCT00295633|62776575|FG000|Overall Study|Administrative reason by sponsor|0|||
33397328|NCT00295633|62776576|FG001|Overall Study|Administrative reason by sponsor|0|||
33397329|NCT00295633|62776577|FG002|Overall Study|Administrative reason by sponsor|1|||
33397330|NCT00570674|62776585|FG000|Overall Study|Withdrawal by Subject|0|||
33397331|NCT00570674|62776586|FG001|Overall Study|Withdrawal by Subject|0|||
33397332|NCT00570674|62776587|FG002|Overall Study|Withdrawal by Subject|1|||
33397333|NCT00570674|62776588|FG003|Overall Study|Withdrawal by Subject|0|||
33397334|NCT00570674|62776589|FG004|Overall Study|Withdrawal by Subject|0|||
33397335|NCT00570674|62776590|FG005|Overall Study|Withdrawal by Subject|0|||
33397336|NCT00570674|62776591|FG006|Overall Study|Withdrawal by Subject|0|||
33397337|NCT00768989|62776604|FG000|Prior to Week 24|Withdrawal by Subject|1|||
33397338|NCT00768989|62776605|FG001|Prior to Week 24|Withdrawal by Subject|0|||
33397339|NCT00768989|62776604|FG000|Prior to Week 24|Adverse Event|3|||
33397340|NCT00768989|62776605|FG001|Prior to Week 24|Adverse Event|0|||
33397341|NCT00768989|62776604|FG000|Prior to Week 24|Lost to Follow-up|0|||
33397342|NCT00768989|62776605|FG001|Prior to Week 24|Lost to Follow-up|1|||
33397343|NCT00768989|62776604|FG000|Prior to Week 24|Protocol Violation|0|||
33397344|NCT00768989|62776605|FG001|Prior to Week 24|Protocol Violation|2|||
33397345|NCT00768989|62776604|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
33397346|NCT00768989|62776605|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
33397347|NCT00768989|62776604|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
33397348|NCT00768989|62776605|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
33397349|NCT00768989|62776604|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
33397350|NCT00768989|62776605|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
33397351|NCT00768989|62776604|FG000|On or After Week 36|Lack of Efficacy|1|||
33304847|NCT01232283|62680631|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33397352|NCT00768989|62776605|FG001|On or After Week 36|Lack of Efficacy|0|||
33397353|NCT00768989|62776604|FG000|On or After Week 36|Adverse Event|0|||
33397354|NCT00768989|62776605|FG001|On or After Week 36|Adverse Event|1|||
33397355|NCT00768989|62776604|FG000|On or After Week 36|Lost to Follow-up|1|||
33397356|NCT00768989|62776605|FG001|On or After Week 36|Lost to Follow-up|0|||
33397357|NCT00768989|62776604|FG000|On or After Week 36|Poor Compliance|1|||
33397358|NCT00768989|62776605|FG001|On or After Week 36|Poor Compliance|0|||
33397359|NCT00768989|62776604|FG000|On or After Week 36|Protocol Violation|1|||
33397360|NCT00768989|62776605|FG001|On or After Week 36|Protocol Violation|0|||
33397361|NCT00768989|62776604|FG000|On or After Week 36|Did not attend termination visit|2|||
33397362|NCT00768989|62776605|FG001|On or After Week 36|Did not attend termination visit|0|||
33397363|NCT00768989|62776604|FG000|On or After Week 36|Sponsor Termination|45|||
33397364|NCT00768989|62776605|FG001|On or After Week 36|Sponsor Termination|26|||
33397365|NCT00305773|62776615|FG000|Overall Study|Death|3|||
33397366|NCT00305773|62776616|FG001|Overall Study|Death|2|||
33397367|NCT00305773|62776615|FG000|Overall Study|Adverse Event|1|||
33397368|NCT00305773|62776616|FG001|Overall Study|Adverse Event|2|||
33397369|NCT00305773|62776615|FG000|Overall Study|Alternative Treatment|4|||
33397370|NCT00305773|62776616|FG001|Overall Study|Alternative Treatment|4|||
33397371|NCT00305773|62776615|FG000|Overall Study|Physician Decision|1|||
33397372|NCT00305773|62776616|FG001|Overall Study|Physician Decision|1|||
33397373|NCT00305773|62776615|FG000|Overall Study|Withdrawal by Subject|1|||
33397374|NCT00305773|62776616|FG001|Overall Study|Withdrawal by Subject|4|||
33397375|NCT00305773|62776615|FG000|Overall Study|Disease Progression|1|||
33397376|NCT00305773|62776616|FG001|Overall Study|Disease Progression|3|||
33397377|NCT00305773|62776615|FG000|Overall Study|All other reasons|3|||
33397378|NCT00305773|62776616|FG001|Overall Study|All other reasons|2|||
33397379|NCT00305695|62776624|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
33397380|NCT00305695|62776625|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
33397381|NCT00305695|62776624|FG000|Overall Study|Did not have baseline scan|1|||
33397382|NCT00305695|62776625|FG001|Overall Study|Did not have baseline scan|1|||
33397383|NCT00647556|62776633|FG000|Overall Study|Adverse Event|0|||
33397384|NCT00647556|62776634|FG001|Overall Study|Adverse Event|1|||
33397385|NCT00647556|62776633|FG000|Overall Study|Lost to Follow-up|1|||
33397386|NCT00647556|62776634|FG001|Overall Study|Lost to Follow-up|0|||
33397387|NCT00647556|62776633|FG000|Overall Study|Protocol Violation|0|||
33397388|NCT00647556|62776634|FG001|Overall Study|Protocol Violation|1|||
33397389|NCT00647556|62776633|FG000|Overall Study|Withdrawal by Subject|1|||
33397390|NCT00647556|62776634|FG001|Overall Study|Withdrawal by Subject|0|||
33397391|NCT00647556|62776633|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
33397392|NCT00647556|62776634|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
33397393|NCT00320593|62776642|FG000|Overall Study|Lost to Follow-up|3|||
33397394|NCT00320593|62776643|FG001|Overall Study|Lost to Follow-up|0|||
33397395|NCT00320593|62776642|FG000|Overall Study|Moved to another state|1|||
33397396|NCT00320593|62776643|FG001|Overall Study|Moved to another state|0|||
33397397|NCT00320593|62776642|FG000|Overall Study|Withdrawal by Subject|2|||
33397398|NCT00320593|62776643|FG001|Overall Study|Withdrawal by Subject|1|||
33397399|NCT00320593|62776642|FG000|Overall Study|Withdrawal by clinical center|1|||
33397400|NCT00320593|62776643|FG001|Overall Study|Withdrawal by clinical center|0|||
33397401|NCT00320515|62776649|FG000|Overall Study|Death|33|||
33397402|NCT00320515|62776649|FG000|Overall Study|Lost to Follow-up|6|||
33397403|NCT00320515|62776649|FG000|Overall Study|Physician Decision|2|||
33397404|NCT00320515|62776649|FG000|Overall Study|Withdrawal by Subject|8|||
33397405|NCT00662012|62776653|FG000|Overall Study|Lost to Follow-up|85|||
33397406|NCT00662012|62776653|FG000|Overall Study|Death|1|||
33397407|NCT00662012|62776653|FG000|Overall Study|Withdrawal by Subject|1|||
33397408|NCT00661778|62776657|FG000|Overall Study|Disease Progression|23|||
33397409|NCT00661778|62776657|FG000|Overall Study|Adverse Event|18|||
33397410|NCT00661778|62776657|FG000|Overall Study|Reason not Specified|6|||
33397411|NCT00661778|62776657|FG000|Overall Study|Protocol Violation|2|||
33397412|NCT00661778|62776657|FG000|Overall Study|Withdrawal of Consent|1|||
33397413|NCT00319735|62776661|FG000|Overall Study|Death|2|||
33397414|NCT00653328|62776666|FG000|Overall Study|Withdrawal by Subject|1|||
33397415|NCT00653328|62776666|FG000|Overall Study|Adverse Event|2|||
33397416|NCT00653328|62776666|FG000|Overall Study|Disease progression|10|||
33397417|NCT00653328|62776666|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
33304848|NCT01232283|62680632|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33304849|NCT01232283|62680633|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33304850|NCT01232283|62680634|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33304851|NCT01232283|62680635|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33304852|NCT01232283|62680636|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33304853|NCT01232283|62680637|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33304854|NCT01232283|62680628|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
33304855|NCT01232283|62680629|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
33304856|NCT01232283|62680630|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33304857|NCT01232283|62680631|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33397418|NCT00642642|62776679|FG000|Treatment & Follow Up|Adverse Event|2|||
33304858|NCT01232283|62680632|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33397419|NCT00642642|62776679|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
33397420|NCT00642642|62776679|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
33397421|NCT00534352|62776689|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
33397422|NCT00534352|62776689|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
33397423|NCT00534352|62776689|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
33397424|NCT00534352|62776689|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
33397425|NCT00534352|62776689|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
33397426|NCT00534352|62776689|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
33397427|NCT00642174|62776704|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
33397428|NCT00642174|62776705|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
33397429|NCT00665366|62776713|FG000|Overall Study|Lack of Efficacy|11|||
33397430|NCT00665366|62776714|FG001|Overall Study|Lack of Efficacy|10|||
33397431|NCT00665366|62776713|FG000|Overall Study|Adverse Event|25|||
33397432|NCT00665366|62776714|FG001|Overall Study|Adverse Event|23|||
33397433|NCT00665366|62776713|FG000|Overall Study|Withdrawal by Subject|11|||
33397434|NCT00665366|62776714|FG001|Overall Study|Withdrawal by Subject|14|||
33397435|NCT00665366|62776713|FG000|Overall Study|Lost to Follow-up|3|||
33397436|NCT00665366|62776714|FG001|Overall Study|Lost to Follow-up|5|||
33397437|NCT00665366|62776713|FG000|Overall Study|Poor compliance/noncompliance|3|||
33397438|NCT00665366|62776714|FG001|Overall Study|Poor compliance/noncompliance|5|||
33397439|NCT00665366|62776713|FG000|Overall Study|Pregnancy|1|||
33397440|NCT00665366|62776714|FG001|Overall Study|Pregnancy|0|||
33397441|NCT00665366|62776713|FG000|Overall Study|No longer meets study criteria|0|||
33397442|NCT00665366|62776714|FG001|Overall Study|No longer meets study criteria|1|||
33397443|NCT00665366|62776713|FG000|Overall Study|Other reasons|4|||
33397444|NCT00665366|62776714|FG001|Overall Study|Other reasons|1|||
33397445|NCT00642018|62776744|FG000|Overall Study|Adverse Event|11|||
33397446|NCT00642018|62776745|FG001|Overall Study|Adverse Event|36|||
33397447|NCT00642018|62776744|FG000|Overall Study|Withdrawal by Subject|4|||
33397448|NCT00642018|62776745|FG001|Overall Study|Withdrawal by Subject|10|||
33397449|NCT00642018|62776744|FG000|Overall Study|Progressive Disease|13|||
33397450|NCT00642018|62776745|FG001|Overall Study|Progressive Disease|18|||
33397451|NCT00642018|62776744|FG000|Overall Study|Physician Decision|0|||
33397452|NCT00642018|62776745|FG001|Overall Study|Physician Decision|10|||
33397453|NCT00642018|62776744|FG000|Overall Study|Protocol Violation|0|||
33397454|NCT00642018|62776745|FG001|Overall Study|Protocol Violation|1|||
33397455|NCT00642018|62776744|FG000|Overall Study|Death|0|||
33397456|NCT00642018|62776745|FG001|Overall Study|Death|3|||
33397457|NCT00642018|62776744|FG000|Overall Study|Entry Criteria Not Met|0|||
33397458|NCT00642018|62776745|FG001|Overall Study|Entry Criteria Not Met|1|||
33397459|NCT00532948|62776755|FG000|Overall Study|Protocol Violation|1|||
33397460|NCT00532948|62776756|FG001|Overall Study|Protocol Violation|0|||
33397461|NCT00532948|62776757|FG002|Overall Study|Protocol Violation|0|||
33397462|NCT00532948|62776755|FG000|Overall Study|Death|3|||
33397463|NCT00532948|62776756|FG001|Overall Study|Death|3|||
33397464|NCT00532948|62776757|FG002|Overall Study|Death|4|||
33397465|NCT00532948|62776755|FG000|Overall Study|Violation of selection criteria at entry|0|||
33397466|NCT00532948|62776756|FG001|Overall Study|Violation of selection criteria at entry|1|||
33397467|NCT00532948|62776757|FG002|Overall Study|Violation of selection criteria at entry|0|||
33397468|NCT00532948|62776755|FG000|Overall Study|Failure to return|0|||
33397469|NCT00532948|62776756|FG001|Overall Study|Failure to return|1|||
33397470|NCT00532948|62776757|FG002|Overall Study|Failure to return|0|||
33397471|NCT00641706|62776771|FG000|Overall Study|Adverse Event|2|||
33397472|NCT00641706|62776772|FG001|Overall Study|Adverse Event|1|||
33397473|NCT00641706|62776771|FG000|Overall Study|Withdrawal by Subject|6|||
33397474|NCT00641706|62776772|FG001|Overall Study|Withdrawal by Subject|1|||
33397475|NCT00641706|62776771|FG000|Overall Study|Clinical Decline|1|||
33397476|NCT00641706|62776772|FG001|Overall Study|Clinical Decline|0|||
33397477|NCT00641706|62776771|FG000|Overall Study|Lead Investigator Decision|0|||
33397478|NCT00641706|62776772|FG001|Overall Study|Lead Investigator Decision|1|||
33397479|NCT00644358|62776778|FG000|Overall Study|Adverse Event|124|||
33397480|NCT00644358|62776778|FG000|Overall Study|Lost to Follow-up|105|||
33397481|NCT00644358|62776778|FG000|Overall Study|Consent Withdrawal|64|||
33397482|NCT00644358|62776778|FG000|Overall Study|Lack of Effectiveness|39|||
33397483|NCT00644358|62776778|FG000|Overall Study|Protocol Violation|5|||
33397484|NCT00644358|62776778|FG000|Overall Study|Noncompliance|14|||
33397485|NCT00644358|62776778|FG000|Overall Study|Other Unspecified|11|||
33397486|NCT00640926|62776785|FG000|Overall Study|Adverse Event|2|||
33397487|NCT00640926|62776786|FG001|Overall Study|Adverse Event|3|||
33397488|NCT00640926|62776787|FG002|Overall Study|Adverse Event|2|||
33397489|NCT00640926|62776785|FG000|Overall Study|Lack of Efficacy|0|||
33397490|NCT00640926|62776786|FG001|Overall Study|Lack of Efficacy|2|||
33397491|NCT00640926|62776787|FG002|Overall Study|Lack of Efficacy|1|||
33397492|NCT00640926|62776785|FG000|Overall Study|Protocol Violation|2|||
33397493|NCT00640926|62776786|FG001|Overall Study|Protocol Violation|0|||
33397494|NCT00640926|62776787|FG002|Overall Study|Protocol Violation|2|||
33397495|NCT00640926|62776785|FG000|Overall Study|Lost to Follow-up|3|||
33397496|NCT00640926|62776786|FG001|Overall Study|Lost to Follow-up|1|||
33397497|NCT00640926|62776787|FG002|Overall Study|Lost to Follow-up|2|||
33397498|NCT00640926|62776785|FG000|Overall Study|Withdrawal by Subject|1|||
33397499|NCT00640926|62776786|FG001|Overall Study|Withdrawal by Subject|0|||
33397500|NCT00640926|62776787|FG002|Overall Study|Withdrawal by Subject|1|||
33397501|NCT03892564|62776795|FG000|Overall Study|Withdrawal by Subject|2|||
33397502|NCT03891862|62776802|FG000|Open-label Period|Adverse Event|2|||
33397503|NCT03891862|62776803|FG001|Open-label Period|Adverse Event|0|||
33397504|NCT03891862|62776804|FG002|Open-label Period|Adverse Event|0|||
33397505|NCT03891862|62776802|FG000|Open-label Period|Protocol Violation|5|||
33397506|NCT03891862|62776803|FG001|Open-label Period|Protocol Violation|0|||
33397507|NCT03891862|62776804|FG002|Open-label Period|Protocol Violation|0|||
33397508|NCT03891862|62776802|FG000|Open-label Period|Withdrawal by Subject|6|||
33397509|NCT03891862|62776803|FG001|Open-label Period|Withdrawal by Subject|0|||
33397510|NCT03891862|62776804|FG002|Open-label Period|Withdrawal by Subject|0|||
33397511|NCT03891862|62776802|FG000|Open-label Period|Death|1|||
33397512|NCT03891862|62776803|FG001|Open-label Period|Death|0|||
33397513|NCT03891862|62776804|FG002|Open-label Period|Death|0|||
33397514|NCT03891862|62776802|FG000|Open-label Period|Lost to Follow-up|2|||
33397515|NCT03891862|62776803|FG001|Open-label Period|Lost to Follow-up|0|||
33397516|NCT03891862|62776804|FG002|Open-label Period|Lost to Follow-up|0|||
33397517|NCT03891862|62776802|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
33397518|NCT03891862|62776803|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
33397519|NCT03891862|62776804|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
33397520|NCT03891862|62776802|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
33397521|NCT03891862|62776803|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
33397522|NCT03891862|62776804|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
33397523|NCT03891862|62776802|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
33397524|NCT03891862|62776803|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
33397525|NCT03891862|62776804|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
33397526|NCT03891862|62776802|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
33397527|NCT03891862|62776803|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
33397528|NCT03891862|62776804|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
33397529|NCT00640614|62776813|FG000|Overall Study|Lost to Follow-up|1|||
33397530|NCT00640614|62776814|FG001|Overall Study|Lost to Follow-up|0|||
33397531|NCT00761657|62776852|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
33397532|NCT00761657|62776853|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
33397533|NCT00761657|62776854|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
33397534|NCT00761657|62776855|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
33397535|NCT00761657|62776856|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
33397536|NCT00761657|62776857|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
33397537|NCT00761657|62776858|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
33397538|NCT00761657|62776859|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
33397539|NCT00761657|62776860|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
33397540|NCT00761657|62776852|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
33397541|NCT00761657|62776853|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
33397542|NCT00761657|62776854|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
33397543|NCT00761657|62776855|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
33397544|NCT00761657|62776856|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
33397545|NCT00761657|62776857|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
33397546|NCT00761657|62776858|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
33397547|NCT00761657|62776859|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
33397548|NCT00761657|62776860|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
33397549|NCT00761657|62776852|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
33397550|NCT00761657|62776853|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
33397551|NCT00761657|62776854|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
33397552|NCT00761657|62776855|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
33397553|NCT00761657|62776856|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
33397554|NCT00761657|62776857|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
33397555|NCT00761657|62776858|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
33397556|NCT00761657|62776859|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
33397557|NCT00761657|62776860|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
33397558|NCT00761657|62776852|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
33397559|NCT00761657|62776853|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
33397560|NCT00761657|62776854|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
33397561|NCT00761657|62776855|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
33397562|NCT00761657|62776856|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
33397563|NCT00761657|62776857|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
33397564|NCT00761657|62776858|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
33397565|NCT00761657|62776859|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
33397566|NCT00761657|62776860|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
33397567|NCT00319501|62776892|FG000|Double-blind Period|Withdrawal by Subject|0|||
33397568|NCT00319501|62776893|FG001|Double-blind Period|Withdrawal by Subject|3|||
33397569|NCT00319501|62776892|FG000|Double-blind Period|Sponsor Request|1|||
33397570|NCT00319501|62776893|FG001|Double-blind Period|Sponsor Request|0|||
33397571|NCT00319501|62776892|FG000|Double-blind Period|Did not receive treatment|42|||
33397572|NCT00319501|62776893|FG001|Double-blind Period|Did not receive treatment|29|||
33397573|NCT00319501|62776892|FG000|Open-label Period|Adverse Event|5|||
33397574|NCT00319501|62776893|FG001|Open-label Period|Adverse Event|0|||
33397575|NCT00319501|62776892|FG000|Open-label Period|Protocol Violation|6|||
33576064|NCT02031640|62972415|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
33576065|NCT02031640|62972416|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
33576066|NCT02031640|62972417|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
33576067|NCT02031640|62972418|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
33576068|NCT02031640|62972419|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
33576069|NCT02031640|62972420|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
33576070|NCT02031640|62972415|FG000|Double-blind Treatment Period|Non-compliance|0|||
33576071|NCT02031640|62972416|FG001|Double-blind Treatment Period|Non-compliance|1|||
33576072|NCT02031640|62972417|FG002|Double-blind Treatment Period|Non-compliance|0|||
33576073|NCT02031640|62972418|FG003|Double-blind Treatment Period|Non-compliance|1|||
33576074|NCT02031640|62972419|FG004|Double-blind Treatment Period|Non-compliance|1|||
33576075|NCT02031640|62972420|FG005|Double-blind Treatment Period|Non-compliance|0|||
33576076|NCT02031640|62972415|FG000|Double-blind Treatment Period|Adverse Event|0|||
33576077|NCT02031640|62972416|FG001|Double-blind Treatment Period|Adverse Event|0|||
33576078|NCT02031640|62972417|FG002|Double-blind Treatment Period|Adverse Event|0|||
33576079|NCT02031640|62972418|FG003|Double-blind Treatment Period|Adverse Event|2|||
33576080|NCT02031640|62972419|FG004|Double-blind Treatment Period|Adverse Event|0|||
33576081|NCT02031640|62972420|FG005|Double-blind Treatment Period|Adverse Event|0|||
33576082|NCT02031640|62972415|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
33576083|NCT02031640|62972416|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
33576084|NCT02031640|62972417|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
33576085|NCT02031640|62972418|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
33576086|NCT02031640|62972419|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
33576087|NCT02031640|62972420|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
33576088|NCT02031640|62972415|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
33576089|NCT02031640|62972416|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
33576090|NCT02031640|62972417|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
33576091|NCT02031640|62972418|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
33576092|NCT02031640|62972419|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
33576093|NCT02031640|62972420|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
33576094|NCT02370173|62972441|FG000|Overall Study|Protocol Violation|1|||
33576095|NCT02370173|62972442|FG001|Overall Study|Protocol Violation|1|||
33576096|NCT02370173|62972441|FG000|Overall Study|Withdrawal by Subject|2|||
33576097|NCT02370173|62972442|FG001|Overall Study|Withdrawal by Subject|2|||
33576098|NCT02660489|62972452|FG000|Overall Study|Lost to Follow-up|1|||
33576099|NCT02660489|62972453|FG001|Overall Study|Lost to Follow-up|1|||
33576100|NCT02660489|62972452|FG000|Overall Study|Adverse Event|1|||
33576101|NCT02660489|62972453|FG001|Overall Study|Adverse Event|3|||
33397576|NCT00319501|62776893|FG001|Open-label Period|Protocol Violation|0|||
33397577|NCT00319501|62776892|FG000|Open-label Period|Withdrawal by Subject|38|||
33397578|NCT00319501|62776893|FG001|Open-label Period|Withdrawal by Subject|0|||
33397579|NCT00319501|62776892|FG000|Open-label Period|Principal Investigator decision|6|||
33397580|NCT00319501|62776893|FG001|Open-label Period|Principal Investigator decision|0|||
33397581|NCT00319501|62776892|FG000|Open-label Period|Sponsor request|12|||
33397582|NCT00319501|62776893|FG001|Open-label Period|Sponsor request|0|||
33397583|NCT00319501|62776892|FG000|Open-label Period|Lost to Follow-up|5|||
33397584|NCT00319501|62776893|FG001|Open-label Period|Lost to Follow-up|0|||
33397585|NCT00319501|62776892|FG000|Open-label Period|Did not receive treatment|33|||
33397586|NCT00319501|62776893|FG001|Open-label Period|Did not receive treatment|0|||
33397587|NCT00319501|62776892|FG000|Open-label Period|Other|11|||
33397588|NCT00319501|62776893|FG001|Open-label Period|Other|0|||
33397589|NCT00319501|62776892|FG000|Open-label Extension Period|Adverse Event|2|||
33397590|NCT00319501|62776893|FG001|Open-label Extension Period|Adverse Event|0|||
33397591|NCT00319501|62776892|FG000|Open-label Extension Period|Did not receive treatment|18|||
33397592|NCT00319501|62776893|FG001|Open-label Extension Period|Did not receive treatment|0|||
33397593|NCT00319501|62776892|FG000|Open-label Extension Period|Other|1|||
33397594|NCT00319501|62776893|FG001|Open-label Extension Period|Other|0|||
33397595|NCT00319501|62776892|FG000|Open-label Extension Period|Principal investigator decision|2|||
33397596|NCT00319501|62776893|FG001|Open-label Extension Period|Principal investigator decision|0|||
33397597|NCT00319501|62776892|FG000|Open-label Extension Period|Sponsor request|26|||
33397598|NCT00319501|62776893|FG001|Open-label Extension Period|Sponsor request|0|||
33397599|NCT00319501|62776892|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
33397600|NCT00319501|62776893|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
33397601|NCT00761579|62776904|FG000|Overall Study|Adverse Event|10|||
33397602|NCT00761579|62776904|FG000|Overall Study|Death|2|||
33576102|NCT02660489|62972452|FG000|Overall Study|no rhinovirus infection|4|||
33397603|NCT00761579|62776904|FG000|Overall Study|Lack of Efficacy|21|||
33397604|NCT00761579|62776904|FG000|Overall Study|Lost to Follow-up|16|||
33397605|NCT00761579|62776904|FG000|Overall Study|Pregnancy|1|||
33576103|NCT02660489|62972453|FG001|Overall Study|no rhinovirus infection|4|||
33576104|NCT02052310|62972461|FG000|Overall Study|Death|64|||
33397606|NCT00761579|62776904|FG000|Overall Study|Withdrawal by Subject|34|||
33397607|NCT00761579|62776904|FG000|Overall Study|Lack of compliance|2|||
33397608|NCT00761579|62776904|FG000|Overall Study|Protocol deviation|1|||
33397609|NCT00761579|62776904|FG000|Overall Study|Drug overdose|1|||
33397610|NCT00761579|62776904|FG000|Overall Study|Aggravation of depression|1|||
33397611|NCT00761579|62776904|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
33397612|NCT00761579|62776904|FG000|Overall Study|Lost survey form|1|||
33397613|NCT00761579|62776904|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
33397614|NCT00627042|62776910|FG000|Overall Study|Withdrawal by Subject|2|||
33397615|NCT00319111|62776914|FG000|Overall Study|Adverse Event|20|||
33397616|NCT00319111|62776914|FG000|Overall Study|Withdrawal of consent|11|||
33397617|NCT00319111|62776914|FG000|Overall Study|Death|9|||
33397618|NCT00319111|62776914|FG000|Overall Study|Lack of clinical improvement|4|||
33397619|NCT00319111|62776914|FG000|Overall Study|Administrative|2|||
33397620|NCT00319111|62776914|FG000|Overall Study|Treatment failure|1|||
33397621|NCT00640224|62776922|FG000|Overall Study|Lost to Follow-up|5|||
33397622|NCT00640224|62776923|FG001|Overall Study|Lost to Follow-up|2|||
33397623|NCT00640224|62776924|FG002|Overall Study|Lost to Follow-up|0|||
33397624|NCT00640224|62776925|FG003|Overall Study|Lost to Follow-up|0|||
33397625|NCT00640224|62776922|FG000|Overall Study|Withdrawal by Subject|1|||
33397626|NCT00640224|62776923|FG001|Overall Study|Withdrawal by Subject|0|||
33397627|NCT00640224|62776924|FG002|Overall Study|Withdrawal by Subject|0|||
33397628|NCT00640224|62776925|FG003|Overall Study|Withdrawal by Subject|0|||
33397629|NCT00640224|62776922|FG000|Overall Study|Headaches|0|||
33397630|NCT00640224|62776923|FG001|Overall Study|Headaches|1|||
33397631|NCT00640224|62776924|FG002|Overall Study|Headaches|0|||
33397632|NCT00640224|62776925|FG003|Overall Study|Headaches|0|||
33397633|NCT00318643|62776940|FG000|Overall Study|Adverse Event|0|||
33397634|NCT00318643|62776941|FG001|Overall Study|Adverse Event|0|||
33397635|NCT00318643|62776942|FG002|Overall Study|Adverse Event|0|||
33397636|NCT00318643|62776943|FG003|Overall Study|Adverse Event|0|||
33397637|NCT00318643|62776944|FG004|Overall Study|Adverse Event|1|||
33397638|NCT00318643|62776940|FG000|Overall Study|Participant's Decision|0|||
33397639|NCT00318643|62776941|FG001|Overall Study|Participant's Decision|0|||
33397640|NCT00318643|62776942|FG002|Overall Study|Participant's Decision|0|||
33397641|NCT00318643|62776943|FG003|Overall Study|Participant's Decision|0|||
33397642|NCT00318643|62776944|FG004|Overall Study|Participant's Decision|1|||
33397643|NCT00318643|62776940|FG000|Overall Study|Investigator's Decision|0|||
33397644|NCT00318643|62776941|FG001|Overall Study|Investigator's Decision|0|||
33397645|NCT00318643|62776942|FG002|Overall Study|Investigator's Decision|0|||
33397646|NCT00318643|62776943|FG003|Overall Study|Investigator's Decision|0|||
33397647|NCT00318643|62776944|FG004|Overall Study|Investigator's Decision|1|||
33397648|NCT00318565|62776957|FG000|Overall Study|Excluded per protocol|24|||
33397649|NCT00304915|62776963|FG000|Overall Study|Lost to Follow-up|11|||
33397650|NCT00304915|62776964|FG001|Overall Study|Lost to Follow-up|11|||
33397651|NCT00304915|62776963|FG000|Overall Study|Death|4|||
33397652|NCT00304915|62776964|FG001|Overall Study|Death|5|||
33397653|NCT00304915|62776963|FG000|Overall Study|Withdrawal by Subject|3|||
33397654|NCT00304915|62776964|FG001|Overall Study|Withdrawal by Subject|0|||
33397655|NCT03687970|62776972|FG000|Overall Study|visit scheduling conflicts|2|||
33397656|NCT03687970|62776973|FG001|Overall Study|visit scheduling conflicts|0|||
33397657|NCT00530920|62776984|FG000|Overall Study|Randomized but not treated|0|||
33397658|NCT00530920|62776985|FG001|Overall Study|Randomized but not treated|2|||
33397659|NCT00530920|62776986|FG002|Overall Study|Randomized but not treated|0|||
33397660|NCT00530920|62776984|FG000|Overall Study|Adverse Event|0|||
33397661|NCT00530920|62776985|FG001|Overall Study|Adverse Event|0|||
33397662|NCT00530920|62776986|FG002|Overall Study|Adverse Event|3|||
33397663|NCT00530920|62776984|FG000|Overall Study|Withdrawal by Subject|0|||
33397664|NCT00530920|62776985|FG001|Overall Study|Withdrawal by Subject|0|||
33304859|NCT01232283|62680633|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33304860|NCT01232283|62680634|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33304861|NCT01232283|62680635|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33304862|NCT01232283|62680636|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33304863|NCT01232283|62680637|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33304864|NCT01232283|62680628|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
33304865|NCT01232283|62680629|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
33304866|NCT01232283|62680630|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33304867|NCT01232283|62680631|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33304868|NCT01232283|62680632|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33304869|NCT01232283|62680633|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33304870|NCT01232283|62680634|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33304871|NCT01232283|62680635|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33304872|NCT01232283|62680636|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33304873|NCT01232283|62680637|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33397665|NCT00530920|62776986|FG002|Overall Study|Withdrawal by Subject|1|||
33304874|NCT01232283|62680628|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
33304875|NCT01232283|62680629|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
33304876|NCT01232283|62680630|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33304877|NCT01232283|62680631|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33304878|NCT01232283|62680632|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33304879|NCT01232283|62680633|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33304880|NCT01232283|62680634|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33304881|NCT01232283|62680635|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33304882|NCT01232283|62680636|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33304883|NCT01232283|62680637|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33304884|NCT01232283|62680628|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33304885|NCT01232283|62680629|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33304886|NCT01232283|62680630|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
33304887|NCT01232283|62680631|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
33304888|NCT01232283|62680632|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33304889|NCT01232283|62680633|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33304890|NCT01232283|62680634|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33304891|NCT01232283|62680635|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33304892|NCT01232283|62680636|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33304893|NCT01232283|62680637|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33304894|NCT01232283|62680628|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33304895|NCT01232283|62680629|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33304896|NCT01232283|62680630|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
33304897|NCT01232283|62680631|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
33304898|NCT01232283|62680632|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33304899|NCT01232283|62680633|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33304900|NCT01232283|62680634|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33304901|NCT01232283|62680635|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33304902|NCT01232283|62680636|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33304903|NCT01232283|62680637|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33397666|NCT03878758|62776995|FG000|Overall Study|Withdrawal by Subject|1|||
33397667|NCT03878758|62776995|FG000|Overall Study|Protocol defined|2|||
33397668|NCT03878758|62776995|FG000|Overall Study|Improper consent documentation|1|||
33397669|NCT03878602|62777010|FG000|Overall Study|cord blood donation|7|||
33397670|NCT03878602|62777011|FG001|Overall Study|cord blood donation|1|||
33397671|NCT03878602|62777010|FG000|Overall Study|incomplete data collection|2|||
33397672|NCT03878602|62777011|FG001|Overall Study|incomplete data collection|0|||
33397673|NCT00768755|62777023|FG000|Phase 1|Death|6|||
33397674|NCT00768755|62777024|FG001|Phase 1|Death|0|||
33397675|NCT00768755|62777025|FG002|Phase 1|Death|0|||
33397676|NCT00768755|62777026|FG003|Phase 1|Death|0|||
33397677|NCT00768755|62777023|FG000|Phase 1|Other|4|||
33397678|NCT00768755|62777024|FG001|Phase 1|Other|0|||
33397679|NCT00768755|62777025|FG002|Phase 1|Other|0|||
33397680|NCT00768755|62777026|FG003|Phase 1|Other|0|||
33397681|NCT00768755|62777023|FG000|Phase 2|Death|0|||
33397682|NCT00768755|62777024|FG001|Phase 2|Death|37|||
33397683|NCT00768755|62777025|FG002|Phase 2|Death|48|||
33397684|NCT00768755|62777026|FG003|Phase 2|Death|31|||
33397685|NCT00768755|62777023|FG000|Phase 2|Protocol Violation|0|||
33397686|NCT00768755|62777024|FG001|Phase 2|Protocol Violation|2|||
33397687|NCT00768755|62777025|FG002|Phase 2|Protocol Violation|0|||
33397688|NCT00768755|62777026|FG003|Phase 2|Protocol Violation|1|||
33397689|NCT00768755|62777023|FG000|Phase 2|Lost to Follow-up|0|||
33397690|NCT00768755|62777024|FG001|Phase 2|Lost to Follow-up|1|||
33397691|NCT00768755|62777025|FG002|Phase 2|Lost to Follow-up|1|||
33397692|NCT00768755|62777026|FG003|Phase 2|Lost to Follow-up|4|||
33397693|NCT00768755|62777023|FG000|Phase 2|Withdrawal by Subject|0|||
33397694|NCT00768755|62777024|FG001|Phase 2|Withdrawal by Subject|1|||
33397695|NCT00768755|62777025|FG002|Phase 2|Withdrawal by Subject|0|||
33397696|NCT00768755|62777026|FG003|Phase 2|Withdrawal by Subject|1|||
33397697|NCT00768755|62777023|FG000|Phase 2|Other|0|||
33397698|NCT00768755|62777024|FG001|Phase 2|Other|1|||
33397699|NCT00768755|62777025|FG002|Phase 2|Other|2|||
33397700|NCT00768755|62777026|FG003|Phase 2|Other|4|||
33397701|NCT00768755|62777023|FG000|Phase 2|Study Terminated by Sponsor|0|||
33576105|NCT02052310|62972462|FG001|Overall Study|Death|54|||
33397702|NCT00768755|62777024|FG001|Phase 2|Study Terminated by Sponsor|13|||
33397703|NCT00768755|62777025|FG002|Phase 2|Study Terminated by Sponsor|7|||
33304904|NCT01232283|62680628|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33397704|NCT00768755|62777026|FG003|Phase 2|Study Terminated by Sponsor|14|||
33397705|NCT00768755|62777023|FG000|Phase 2|Randomized but not treated|0|||
33397706|NCT00768755|62777024|FG001|Phase 2|Randomized but not treated|0|||
33397707|NCT00768755|62777025|FG002|Phase 2|Randomized but not treated|0|||
33397708|NCT00768755|62777026|FG003|Phase 2|Randomized but not treated|2|||
33397709|NCT00530842|62777037|FG000|Overall Study|Adverse Event|10|||
33397710|NCT00530842|62777038|FG001|Overall Study|Adverse Event|6|||
33397711|NCT00530842|62777037|FG000|Overall Study|Lack of Efficacy|2|||
33397712|NCT00530842|62777038|FG001|Overall Study|Lack of Efficacy|1|||
33397713|NCT00530842|62777037|FG000|Overall Study|Lost to Follow-up|0|||
33397714|NCT00530842|62777038|FG001|Overall Study|Lost to Follow-up|4|||
33397715|NCT00530842|62777037|FG000|Overall Study|Protocol Violation|3|||
33397716|NCT00530842|62777038|FG001|Overall Study|Protocol Violation|2|||
33397717|NCT00530842|62777037|FG000|Overall Study|Withdrawal by Subject|4|||
33397718|NCT00530842|62777038|FG001|Overall Study|Withdrawal by Subject|5|||
33397719|NCT00530842|62777037|FG000|Overall Study|Individual different reasons|4|||
33397720|NCT00530842|62777038|FG001|Overall Study|Individual different reasons|3|||
33397721|NCT00530842|62777037|FG000|Period 1|Adverse Event|7|||
33397722|NCT00530842|62777038|FG001|Period 1|Adverse Event|3|||
33397723|NCT00530842|62777037|FG000|Period 1|Lack of Efficacy|1|||
33397724|NCT00530842|62777038|FG001|Period 1|Lack of Efficacy|1|||
33397725|NCT00530842|62777037|FG000|Period 1|Protocol Violation|2|||
33397726|NCT00530842|62777038|FG001|Period 1|Protocol Violation|1|||
33397727|NCT00530842|62777037|FG000|Period 1|Withdrawal by Subject|2|||
33397728|NCT00530842|62777038|FG001|Period 1|Withdrawal by Subject|3|||
33397729|NCT00530842|62777037|FG000|Period 1|Individual different reasons|2|||
33397730|NCT00530842|62777038|FG001|Period 1|Individual different reasons|3|||
33397731|NCT00530842|62777037|FG000|Period 2|Adverse Event|3|||
33397732|NCT00530842|62777038|FG001|Period 2|Adverse Event|3|||
33397733|NCT00530842|62777037|FG000|Period 2|Lack of Efficacy|1|||
33397734|NCT00530842|62777038|FG001|Period 2|Lack of Efficacy|0|||
33397735|NCT00530842|62777037|FG000|Period 2|Lost to Follow-up|0|||
33397736|NCT00530842|62777038|FG001|Period 2|Lost to Follow-up|4|||
33397737|NCT00530842|62777037|FG000|Period 2|Protocol Violation|1|||
33397738|NCT00530842|62777038|FG001|Period 2|Protocol Violation|0|||
33397739|NCT00530842|62777037|FG000|Period 2|Withdrawal by Subject|1|||
33397740|NCT00530842|62777038|FG001|Period 2|Withdrawal by Subject|2|||
33397741|NCT00530842|62777037|FG000|Period 2|Individual different reasons|2|||
33397742|NCT00530842|62777038|FG001|Period 2|Individual different reasons|0|||
33397743|NCT03882424|62777049|FG000|Overall Study|Lost to Follow-up|3|||
33397744|NCT03882424|62777050|FG001|Overall Study|Lost to Follow-up|0|||
33397745|NCT03882424|62777051|FG002|Overall Study|Lost to Follow-up|0|||
33397746|NCT03882424|62777049|FG000|Overall Study|schedule conflict|1|||
33397747|NCT03882424|62777050|FG001|Overall Study|schedule conflict|0|||
33397748|NCT03882424|62777051|FG002|Overall Study|schedule conflict|0|||
33397749|NCT03879772|62777064|FG000|Overall Study|Adverse Event|2|||
33397750|NCT03879772|62777065|FG001|Overall Study|Adverse Event|2|||
33397751|NCT03879772|62777066|FG002|Overall Study|Adverse Event|3|||
33397752|NCT03879772|62777067|FG003|Overall Study|Adverse Event|4|||
33397753|NCT03879772|62777068|FG004|Overall Study|Adverse Event|3|||
33397754|NCT03879772|62777064|FG000|Overall Study|Treatment Failure|1|||
33397755|NCT03879772|62777065|FG001|Overall Study|Treatment Failure|0|||
33397756|NCT03879772|62777066|FG002|Overall Study|Treatment Failure|0|||
33397757|NCT03879772|62777067|FG003|Overall Study|Treatment Failure|2|||
33397758|NCT03879772|62777068|FG004|Overall Study|Treatment Failure|1|||
33397759|NCT03879772|62777064|FG000|Overall Study|Lost to Follow-up|0|||
33397760|NCT03879772|62777065|FG001|Overall Study|Lost to Follow-up|0|||
33397761|NCT03879772|62777066|FG002|Overall Study|Lost to Follow-up|0|||
33397762|NCT03879772|62777067|FG003|Overall Study|Lost to Follow-up|0|||
33397763|NCT03879772|62777068|FG004|Overall Study|Lost to Follow-up|1|||
33397764|NCT03879772|62777064|FG000|Overall Study|Withdrawal by Subject|0|||
33397765|NCT03879772|62777065|FG001|Overall Study|Withdrawal by Subject|1|||
33397766|NCT03879772|62777066|FG002|Overall Study|Withdrawal by Subject|3|||
33397767|NCT03879772|62777067|FG003|Overall Study|Withdrawal by Subject|1|||
33397768|NCT03879772|62777068|FG004|Overall Study|Withdrawal by Subject|1|||
33397769|NCT03879772|62777064|FG000|Overall Study|Protocol Violation|0|||
33397770|NCT03879772|62777065|FG001|Overall Study|Protocol Violation|0|||
33397771|NCT03879772|62777066|FG002|Overall Study|Protocol Violation|3|||
33397772|NCT03879772|62777067|FG003|Overall Study|Protocol Violation|1|||
33397773|NCT03879772|62777068|FG004|Overall Study|Protocol Violation|2|||
33397774|NCT03879772|62777064|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
33397775|NCT03879772|62777065|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
33397776|NCT03879772|62777066|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
33397777|NCT03879772|62777067|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
33397778|NCT03879772|62777068|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
33397779|NCT00642954|62777085|FG000|Overall Study|Progressive Disease|3|||
33397780|NCT00642954|62777086|FG001|Overall Study|Progressive Disease|3|||
33397781|NCT00642954|62777087|FG002|Overall Study|Progressive Disease|3|||
33397782|NCT00642954|62777088|FG003|Overall Study|Progressive Disease|3|||
33397783|NCT00642954|62777089|FG004|Overall Study|Progressive Disease|9|||
33397784|NCT00642954|62777085|FG000|Overall Study|Withdrawal by Subject|0|||
33397785|NCT00642954|62777086|FG001|Overall Study|Withdrawal by Subject|0|||
33397786|NCT00642954|62777087|FG002|Overall Study|Withdrawal by Subject|0|||
33397787|NCT00642954|62777088|FG003|Overall Study|Withdrawal by Subject|0|||
33397788|NCT00642954|62777089|FG004|Overall Study|Withdrawal by Subject|1|||
33397789|NCT00642954|62777085|FG000|Overall Study|Adverse Event|1|||
33397790|NCT00642954|62777086|FG001|Overall Study|Adverse Event|1|||
33397791|NCT00642954|62777087|FG002|Overall Study|Adverse Event|0|||
33397792|NCT00642954|62777088|FG003|Overall Study|Adverse Event|0|||
33397793|NCT00642954|62777089|FG004|Overall Study|Adverse Event|6|||
33397794|NCT00640146|62777103|FG000|Overall Study|Adverse Event|2|||
33397795|NCT00640146|62777104|FG001|Overall Study|Adverse Event|0|||
33397796|NCT00640146|62777103|FG000|Overall Study|Lost to Follow-up|0|||
33397797|NCT00640146|62777104|FG001|Overall Study|Lost to Follow-up|1|||
33397798|NCT00640146|62777103|FG000|Overall Study|Lack of Efficacy|0|||
33397799|NCT00640146|62777104|FG001|Overall Study|Lack of Efficacy|1|||
33397800|NCT00640146|62777103|FG000|Overall Study|Withdrawal by Subject|1|||
33397801|NCT00640146|62777104|FG001|Overall Study|Withdrawal by Subject|1|||
33397802|NCT00640146|62777103|FG000|Overall Study|Randomized but not treated|1|||
33397803|NCT00640146|62777104|FG001|Overall Study|Randomized but not treated|3|||
33397804|NCT00317473|62777116|FG000|Overall Study|Withdrawal by Subject|2|||
33397805|NCT00317473|62777117|FG001|Overall Study|Withdrawal by Subject|1|||
33397806|NCT00317473|62777118|FG002|Overall Study|Withdrawal by Subject|2|||
33397807|NCT00317473|62777119|FG003|Overall Study|Withdrawal by Subject|1|||
33397808|NCT00317473|62777120|FG004|Overall Study|Withdrawal by Subject|3|||
33397809|NCT00317473|62777121|FG005|Overall Study|Withdrawal by Subject|1|||
33397810|NCT00317473|62777116|FG000|Overall Study|Relocation|1|||
33397811|NCT00317473|62777117|FG001|Overall Study|Relocation|0|||
33397812|NCT00317473|62777118|FG002|Overall Study|Relocation|1|||
33397813|NCT00317473|62777119|FG003|Overall Study|Relocation|1|||
33397814|NCT00317473|62777120|FG004|Overall Study|Relocation|5|||
33397815|NCT00317473|62777121|FG005|Overall Study|Relocation|2|||
33397816|NCT00317473|62777116|FG000|Overall Study|Death|1|||
33397817|NCT00317473|62777117|FG001|Overall Study|Death|0|||
33397818|NCT00317473|62777118|FG002|Overall Study|Death|0|||
33397819|NCT00317473|62777119|FG003|Overall Study|Death|0|||
33397820|NCT00317473|62777120|FG004|Overall Study|Death|0|||
33397821|NCT00317473|62777121|FG005|Overall Study|Death|0|||
33397822|NCT00317473|62777116|FG000|Overall Study|Other|0|||
33397823|NCT00317473|62777117|FG001|Overall Study|Other|2|||
33397824|NCT00317473|62777118|FG002|Overall Study|Other|0|||
33397825|NCT00317473|62777119|FG003|Overall Study|Other|0|||
33397826|NCT00317473|62777120|FG004|Overall Study|Other|0|||
33576106|NCT02052310|62972461|FG000|Overall Study|Withdrawal by Subject|37|||
33576107|NCT02052310|62972462|FG001|Overall Study|Withdrawal by Subject|49|||
33576108|NCT02052310|62972461|FG000|Overall Study|Other than specified|32|||
33576109|NCT02052310|62972462|FG001|Overall Study|Other than specified|29|||
33576110|NCT02052310|62972461|FG000|Overall Study|Adverse Event|29|||
33576111|NCT02052310|62972462|FG001|Overall Study|Adverse Event|22|||
33576112|NCT02052310|62972461|FG000|Overall Study|Kidney Transplant|23|||
33576113|NCT02052310|62972462|FG001|Overall Study|Kidney Transplant|29|||
33576114|NCT02052310|62972461|FG000|Overall Study|Physician Decision|14|||
33576115|NCT02052310|62972462|FG001|Overall Study|Physician Decision|7|||
33576116|NCT02052310|62972461|FG000|Overall Study|Lack of Efficacy|6|||
33576117|NCT02052310|62972462|FG001|Overall Study|Lack of Efficacy|1|||
33576118|NCT02052310|62972461|FG000|Overall Study|Site Terminated by Sponsor|5|||
33576119|NCT02052310|62972462|FG001|Overall Study|Site Terminated by Sponsor|13|||
33576120|NCT02052310|62972461|FG000|Overall Study|Lost to Follow-up|4|||
33576121|NCT02052310|62972462|FG001|Overall Study|Lost to Follow-up|2|||
33576122|NCT02052310|62972461|FG000|Overall Study|Protocol Violation|1|||
33576123|NCT02052310|62972462|FG001|Overall Study|Protocol Violation|6|||
33576124|NCT02051764|62972470|FG000|Overall Study|Study terminated by sponsor|0|||
33576125|NCT02051764|62972471|FG001|Overall Study|Study terminated by sponsor|7|||
33576126|NCT02051296|62972479|FG000|Overall Study|Lost to Follow-up|1|||
33576127|NCT02051296|62972480|FG001|Overall Study|Lost to Follow-up|2|||
33576128|NCT02051296|62972479|FG000|Overall Study|withdraw prior to treatment|7|||
33576129|NCT02051296|62972480|FG001|Overall Study|withdraw prior to treatment|7|||
33576130|NCT02050048|62972488|FG000|Overall Study|Lost to Follow-up|0|||
33576131|NCT02050048|62972489|FG001|Overall Study|Lost to Follow-up|1|||
33576132|NCT02050048|62972488|FG000|Overall Study|Death|1|||
33576133|NCT02050048|62972489|FG001|Overall Study|Death|0|||
33576134|NCT02050048|62972488|FG000|Overall Study|Ineligible after ERCP|4|||
33576135|NCT02050048|62972489|FG001|Overall Study|Ineligible after ERCP|1|||
33576136|NCT02049814|62972497|FG000|Overall Study|Reason not Specified|4|||
33576137|NCT02049814|62972498|FG001|Overall Study|Reason not Specified|3|||
33397827|NCT00317473|62777121|FG005|Overall Study|Other|0|||
33397828|NCT00530218|62777145|FG000|Overall Study|CMV Not Detected|13|||
33397829|NCT00530218|62777145|FG000|Overall Study|Death|12|||
33397830|NCT00761267|62777155|FG000|Overall Study|Death|1|||
33397831|NCT00761267|62777156|FG001|Overall Study|Death|2|||
33397832|NCT00761267|62777157|FG002|Overall Study|Death|5|||
33397833|NCT00761267|62777155|FG000|Overall Study|Lost to Follow-up|0|||
33397834|NCT00761267|62777156|FG001|Overall Study|Lost to Follow-up|0|||
33397835|NCT00761267|62777157|FG002|Overall Study|Lost to Follow-up|1|||
33576138|NCT02049814|62972497|FG000|Overall Study|Pregnancy|1|||
33576139|NCT02049814|62972498|FG001|Overall Study|Pregnancy|0|||
33576140|NCT02049814|62972497|FG000|Overall Study|Lost to Follow-up|2|||
33576141|NCT02049814|62972498|FG001|Overall Study|Lost to Follow-up|3|||
33576142|NCT02049814|62972497|FG000|Overall Study|Serious Protocol Violation|5|||
33576143|NCT02049814|62972498|FG001|Overall Study|Serious Protocol Violation|7|||
33576144|NCT02049814|62972497|FG000|Overall Study|Study Termination|0|||
33576145|NCT02049814|62972498|FG001|Overall Study|Study Termination|1|||
33576146|NCT02049814|62972497|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
33576147|NCT02049814|62972498|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
33576148|NCT02049814|62972497|FG000|Overall Study|Voluntary withdrawal|9|||
33576149|NCT02049814|62972498|FG001|Overall Study|Voluntary withdrawal|8|||
33576150|NCT02079844|62972516|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
33576151|NCT02079844|62972517|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
33576152|NCT02079844|62972518|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
33576153|NCT02079844|62972516|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
33576154|NCT02079844|62972517|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
33576155|NCT02079844|62972518|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
33576156|NCT02048722|62972538|FG000|2 Cycles of Treatment|Adverse Event|2|||
33576157|NCT02048722|62972538|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
33576158|NCT02048722|62972538|FG000|2 Cycles of Treatment|Progressive Disease|2|||
33576159|NCT02048722|62972538|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
33576160|NCT02048722|62972538|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
33576161|NCT02048722|62972538|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
33576162|NCT02030002|62972542|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
33576163|NCT02030002|62972542|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
33576164|NCT02030002|62972542|FG000|Follow-up|Lost to Follow-up|2|||
33576165|NCT02079610|62972550|FG000|Overall Study|Withdrawal by Subject|1|||
33576166|NCT02079610|62972551|FG001|Overall Study|Withdrawal by Subject|1|||
33576167|NCT02079532|62972557|FG000|Overall Study|Adverse Event|7|||
33576168|NCT02079532|62972557|FG000|Overall Study|Additional or changed therapy|2|||
33576169|NCT02079532|62972557|FG000|Overall Study|Lack of Efficacy|9|||
33576170|NCT02079532|62972557|FG000|Overall Study|Protocol Violation|3|||
33576171|NCT02079532|62972557|FG000|Overall Study|Withdrawal by Subject|1|||
33576172|NCT02079532|62972557|FG000|Overall Study|Administrative problems|1|||
33576173|NCT02079532|62972557|FG000|Overall Study|Inclusion into ReFIRST|3|||
33576174|NCT02079532|62972557|FG000|Overall Study|Other|3|||
33576175|NCT02709889|62972610|FG000|Overall Study|Withdrawal by Subject|11|||
33576176|NCT02709889|62972611|FG001|Overall Study|Withdrawal by Subject|10|||
33576177|NCT02709889|62972612|FG002|Overall Study|Withdrawal by Subject|2|||
33576178|NCT02709889|62972613|FG003|Overall Study|Withdrawal by Subject|12|||
33576179|NCT02709889|62972610|FG000|Overall Study|Death|25|||
33576180|NCT02709889|62972611|FG001|Overall Study|Death|38|||
33576181|NCT02709889|62972612|FG002|Overall Study|Death|4|||
33576182|NCT02709889|62972613|FG003|Overall Study|Death|44|||
33576183|NCT02709889|62972610|FG000|Overall Study|Physician Decision|1|||
33576184|NCT02709889|62972611|FG001|Overall Study|Physician Decision|2|||
33576185|NCT02709889|62972612|FG002|Overall Study|Physician Decision|3|||
33576186|NCT02709889|62972613|FG003|Overall Study|Physician Decision|5|||
33576187|NCT02709889|62972610|FG000|Overall Study|Lost to Follow-up|2|||
33576188|NCT02709889|62972611|FG001|Overall Study|Lost to Follow-up|0|||
33576189|NCT02709889|62972612|FG002|Overall Study|Lost to Follow-up|0|||
33665088|NCT01576159|63096720|FG002|Overall Study|Lost to Follow-up|0|||
33397836|NCT00761267|62777155|FG000|Overall Study|Randomized but not treated|1|||
33397837|NCT00761267|62777156|FG001|Overall Study|Randomized but not treated|1|||
33397838|NCT00761267|62777157|FG002|Overall Study|Randomized but not treated|0|||
33397839|NCT00761267|62777155|FG000|Overall Study|Withdrawal by Subject|0|||
33397840|NCT00761267|62777156|FG001|Overall Study|Withdrawal by Subject|1|||
33397841|NCT00761267|62777157|FG002|Overall Study|Withdrawal by Subject|0|||
33397842|NCT00303667|62777178|FG000|Overall Study|Death|0|||
33397843|NCT00303667|62777179|FG001|Overall Study|Death|4|||
33576190|NCT02709889|62972613|FG003|Overall Study|Lost to Follow-up|4|||
33576191|NCT02709889|62972610|FG000|Overall Study|Study Terminated by Sponsor|4|||
33576192|NCT02709889|62972611|FG001|Overall Study|Study Terminated by Sponsor|6|||
33576193|NCT02709889|62972612|FG002|Overall Study|Study Terminated by Sponsor|2|||
33576194|NCT02709889|62972613|FG003|Overall Study|Study Terminated by Sponsor|17|||
33576195|NCT02709889|62972610|FG000|Overall Study|Other, Not Specified|0|||
33576196|NCT02709889|62972611|FG001|Overall Study|Other, Not Specified|1|||
33576197|NCT02709889|62972612|FG002|Overall Study|Other, Not Specified|1|||
33576198|NCT02709889|62972613|FG003|Overall Study|Other, Not Specified|6|||
33576199|NCT02711995|62972658|FG000|Washout (90 Days)|Conflicting medication|1|||
33576200|NCT02514239|62972696|FG000|Overall Study|Refused to continue trial medication|0|||
33576201|NCT02514239|62972697|FG001|Overall Study|Refused to continue trial medication|0|||
33576202|NCT02514239|62972698|FG002|Overall Study|Refused to continue trial medication|0|||
33576203|NCT02514239|62972699|FG003|Overall Study|Refused to continue trial medication|0|||
33576204|NCT02514239|62972700|FG004|Overall Study|Refused to continue trial medication|0|||
33576205|NCT02514239|62972701|FG005|Overall Study|Refused to continue trial medication|0|||
33576206|NCT02514239|62972702|FG006|Overall Study|Refused to continue trial medication|0|||
33665089|NCT01576159|63096721|FG003|Overall Study|Lost to Follow-up|1|||
33665090|NCT01576159|63096718|FG000|Overall Study|Protocol Violation|1|||
33665091|NCT01576159|63096719|FG001|Overall Study|Protocol Violation|0|||
33665092|NCT01576159|63096720|FG002|Overall Study|Protocol Violation|0|||
33665093|NCT01576159|63096721|FG003|Overall Study|Protocol Violation|0|||
33665094|NCT01510769|63096752|FG000|Overall Study|Adverse Event|7|||
33665095|NCT01510769|63096753|FG001|Overall Study|Adverse Event|6|||
33665096|NCT01510769|63096754|FG002|Overall Study|Adverse Event|4|||
33665097|NCT01510769|63096752|FG000|Overall Study|Gout Flare|0|||
33665098|NCT01510769|63096753|FG001|Overall Study|Gout Flare|3|||
33665099|NCT01510769|63096754|FG002|Overall Study|Gout Flare|1|||
33665100|NCT01510769|63096752|FG000|Overall Study|Protocol Violation|11|||
33665101|NCT01510769|63096753|FG001|Overall Study|Protocol Violation|10|||
33665102|NCT01510769|63096754|FG002|Overall Study|Protocol Violation|9|||
33665103|NCT01510769|63096752|FG000|Overall Study|Lost to Follow-up|5|||
33665104|NCT01510769|63096753|FG001|Overall Study|Lost to Follow-up|1|||
33665105|NCT01510769|63096754|FG002|Overall Study|Lost to Follow-up|5|||
33665106|NCT01510769|63096752|FG000|Overall Study|Withdrawal by Subject|3|||
33665107|NCT01510769|63096753|FG001|Overall Study|Withdrawal by Subject|4|||
33665108|NCT01510769|63096754|FG002|Overall Study|Withdrawal by Subject|3|||
33665109|NCT01510769|63096752|FG000|Overall Study|Death|1|||
33665110|NCT01510769|63096753|FG001|Overall Study|Death|1|||
33665111|NCT01510769|63096754|FG002|Overall Study|Death|0|||
33397844|NCT00761189|62777185|FG000|Overall Study|Adverse Event|42|||
33397845|NCT00761189|62777185|FG000|Overall Study|Lack of Efficacy|45|||
33397846|NCT00761189|62777185|FG000|Overall Study|Lost to Follow-up|36|||
33397847|NCT00761189|62777185|FG000|Overall Study|Withdrawal by Subject|49|||
33665112|NCT01575769|63096762|FG000|Overall Study|Adverse Event|1|||
33665113|NCT01575769|63096762|FG000|Overall Study|Study terminated by sponsor|40|||
33665114|NCT01510145|63096768|FG000|Overall Study|Adverse Event|6|||
33665115|NCT01510145|63096768|FG000|Overall Study|Lost to Follow-up|5|||
33665116|NCT01510145|63096768|FG000|Overall Study|Withdrawal by Subject|6|||
33665117|NCT01510145|63096768|FG000|Overall Study|Relative reported subject withdrew|1|||
33665118|NCT01528033|63096774|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
33665119|NCT01528033|63096775|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
33665120|NCT01528033|63096774|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
33665121|NCT01528033|63096775|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
33665122|NCT01528033|63096774|FG000|Primary Endpoint Assessment ITT|Death|2|||
33665123|NCT01528033|63096775|FG001|Primary Endpoint Assessment ITT|Death|2|||
33665124|NCT01528033|63096774|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
33665125|NCT01528033|63096775|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
33665126|NCT01528033|63096774|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
33665127|NCT01528033|63096775|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
33665128|NCT01528033|63096774|FG000|Follow Up|No data available|46|||
33665129|NCT01528033|63096775|FG001|Follow Up|No data available|44|||
33665130|NCT01560871|63096792|FG000|Overall Study|transportation issues|2|||
33665131|NCT01560871|63096793|FG001|Overall Study|transportation issues|1|||
33665132|NCT01560871|63096792|FG000|Overall Study|relocation|1|||
33665133|NCT01560871|63096793|FG001|Overall Study|relocation|0|||
33665134|NCT01560871|63096792|FG000|Overall Study|readmission to a hospital|2|||
33576207|NCT02514239|62972703|FG007|Overall Study|Refused to continue trial medication|0|||
33576208|NCT02514239|62972704|FG008|Overall Study|Refused to continue trial medication|0|||
33576209|NCT02514239|62972705|FG009|Overall Study|Refused to continue trial medication|1|||
33576210|NCT02514239|62972696|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
33576211|NCT02514239|62972697|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
33576212|NCT02514239|62972698|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
33576213|NCT02514239|62972699|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
33576214|NCT02514239|62972700|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
33576215|NCT02514239|62972701|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
33576216|NCT02514239|62972702|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
33576217|NCT02514239|62972703|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
33576218|NCT02514239|62972704|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
33576219|NCT02514239|62972705|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
33576220|NCT02514239|62972696|FG000|Overall Study|Not treated|0|||
33576221|NCT02514239|62972697|FG001|Overall Study|Not treated|1|||
33576222|NCT02514239|62972698|FG002|Overall Study|Not treated|0|||
33576223|NCT02514239|62972699|FG003|Overall Study|Not treated|0|||
33576224|NCT02514239|62972700|FG004|Overall Study|Not treated|0|||
33576225|NCT02514239|62972701|FG005|Overall Study|Not treated|0|||
33576226|NCT02514239|62972702|FG006|Overall Study|Not treated|0|||
33576227|NCT02514239|62972703|FG007|Overall Study|Not treated|0|||
33665135|NCT01560871|63096793|FG001|Overall Study|readmission to a hospital|1|||
33665136|NCT01560871|63096792|FG000|Overall Study|Lost to Follow-up|1|||
33665137|NCT01560871|63096793|FG001|Overall Study|Lost to Follow-up|0|||
33665138|NCT01509053|63096800|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
33576228|NCT02514239|62972704|FG008|Overall Study|Not treated|0|||
33665139|NCT01509053|63096800|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
33665140|NCT01509053|63096800|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
33665141|NCT01509053|63096800|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
33665142|NCT01509053|63096800|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
33665143|NCT01509053|63096800|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
33665144|NCT01560403|63096814|FG000|Overall Study|Lost to Follow-up|0|||
33665145|NCT01560403|63096815|FG001|Overall Study|Lost to Follow-up|1|||
33665146|NCT01527487|63096862|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
33665147|NCT01527487|63096863|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
33665148|NCT01527487|63096862|FG000|Overall Study|Disease Progression|4|||
33665149|NCT01527487|63096863|FG001|Overall Study|Disease Progression|1|||
33665150|NCT01527487|63096862|FG000|Overall Study|Adverse Event|1|||
33665151|NCT01527487|63096863|FG001|Overall Study|Adverse Event|1|||
33665152|NCT01527487|63096862|FG000|Overall Study|Death|0|||
33665153|NCT01527487|63096863|FG001|Overall Study|Death|1|||
33665154|NCT01506947|63096874|FG000|Overall Study|Lost to Follow-up|7|||
33665155|NCT01506947|63096874|FG000|Overall Study|Adverse Event|5|||
33665156|NCT01506947|63096874|FG000|Overall Study|Death|1|||
33665157|NCT01506947|63096874|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
33665158|NCT02665338|63096891|FG000|Overall Study|Withdrawal by Subject|0|||
33665159|NCT02665338|63096892|FG001|Overall Study|Withdrawal by Subject|1|||
33665160|NCT01506479|63096901|FG000|Overall Study|Lost to Follow-up|1|||
33665161|NCT01506479|63096902|FG001|Overall Study|Lost to Follow-up|2|||
33665162|NCT01506479|63096903|FG002|Overall Study|Lost to Follow-up|2|||
33665163|NCT01506479|63096901|FG000|Overall Study|Withdrawal by Subject|1|||
33665164|NCT01506479|63096902|FG001|Overall Study|Withdrawal by Subject|2|||
33665165|NCT01506479|63096903|FG002|Overall Study|Withdrawal by Subject|1|||
33665166|NCT01506479|63096901|FG000|Overall Study|Missing assessment|1|||
33665167|NCT01506479|63096902|FG001|Overall Study|Missing assessment|0|||
33665168|NCT01506479|63096903|FG002|Overall Study|Missing assessment|0|||
33665169|NCT01506479|63096901|FG000|Overall Study|Adverse Event|0|||
33665170|NCT01506479|63096902|FG001|Overall Study|Adverse Event|1|||
33665171|NCT01506479|63096903|FG002|Overall Study|Adverse Event|0|||
33665172|NCT01506323|63096927|FG000|Overall Study|Lost to Follow-up|5|||
33665173|NCT01506323|63096928|FG001|Overall Study|Lost to Follow-up|4|||
33665174|NCT01506323|63096927|FG000|Overall Study|Withdrawal by Subject|4|||
33665175|NCT01506323|63096928|FG001|Overall Study|Withdrawal by Subject|4|||
33665176|NCT01506323|63096927|FG000|Overall Study|Lack of Efficacy|1|||
33665177|NCT01506323|63096928|FG001|Overall Study|Lack of Efficacy|3|||
33665178|NCT01506323|63096927|FG000|Overall Study|Moved out of area|5|||
33665179|NCT01506323|63096928|FG001|Overall Study|Moved out of area|2|||
33665180|NCT01506323|63096927|FG000|Overall Study|Schedule or Transportation conflict|8|||
33665181|NCT01506323|63096928|FG001|Overall Study|Schedule or Transportation conflict|0|||
33665182|NCT01506323|63096927|FG000|Overall Study|Started another treatment|1|||
33665183|NCT01506323|63096928|FG001|Overall Study|Started another treatment|0|||
33665184|NCT01505387|63096941|FG000|Overall Study|Protocol Violation|1|||
33665185|NCT01505387|63096942|FG001|Overall Study|Protocol Violation|0|||
33665186|NCT01505387|63096941|FG000|Overall Study|Withdrawal by Subject|1|||
33665187|NCT01505387|63096942|FG001|Overall Study|Withdrawal by Subject|1|||
33665188|NCT01504841|63097030|FG000|Overall Study|Withdrawal by Subject|1|||
33665189|NCT01504841|63097031|FG001|Overall Study|Withdrawal by Subject|1|||
33665190|NCT01504841|63097032|FG002|Overall Study|Withdrawal by Subject|0|||
33665191|NCT01502423|63097045|FG000|Overall Study|Withdrawal by Subject|0|||
33665192|NCT01502423|63097046|FG001|Overall Study|Withdrawal by Subject|1|||
33665193|NCT01502033|63097052|FG000|Overall Study|1 participant had scalp discomfort|1|||
33665194|NCT01502033|63097052|FG000|Overall Study|1 participant had worsening depression|1|||
33665195|NCT01502033|63097052|FG000|Overall Study|1 participant went back to school|1|||
33665196|NCT01500629|63097060|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
33665197|NCT01500629|63097061|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
33665198|NCT01500317|63097077|FG000|Overall Study|Withdrawal by Subject|3|||
33665199|NCT01500317|63097078|FG001|Overall Study|Withdrawal by Subject|2|||
33665200|NCT01500317|63097079|FG002|Overall Study|Withdrawal by Subject|0|||
33665201|NCT01500083|63097134|FG000|Overall Study|Adverse Event|4|||
33665202|NCT01500083|63097135|FG001|Overall Study|Adverse Event|17|||
33665203|NCT01500083|63097134|FG000|Overall Study|Death|0|||
33665204|NCT01500083|63097135|FG001|Overall Study|Death|2|||
33665205|NCT01500083|63097134|FG000|Overall Study|Lost to Follow-up|1|||
33665206|NCT01500083|63097135|FG001|Overall Study|Lost to Follow-up|0|||
33665207|NCT01500083|63097134|FG000|Overall Study|Withdrawal of Consent|0|||
33665208|NCT01500083|63097135|FG001|Overall Study|Withdrawal of Consent|1|||
33665209|NCT01500083|63097134|FG000|Overall Study|Disease Progression|2|||
33665210|NCT01500083|63097135|FG001|Overall Study|Disease Progression|10|||
33665211|NCT01500083|63097134|FG000|Overall Study|Investigator Discretion|3|||
33665212|NCT01500083|63097135|FG001|Overall Study|Investigator Discretion|8|||
33665213|NCT01500083|63097134|FG000|Overall Study|Other Reasons|2|||
33665214|NCT01500083|63097135|FG001|Overall Study|Other Reasons|5|||
33665215|NCT01499849|63097165|FG000|Overall Study|Adverse Event|28|||
33665216|NCT01499849|63097166|FG001|Overall Study|Adverse Event|32|||
33665217|NCT01499849|63097165|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
33665218|NCT01499849|63097166|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
33665219|NCT01499849|63097165|FG000|Overall Study|Withdrawal by Subject|43|||
33665220|NCT01499849|63097166|FG001|Overall Study|Withdrawal by Subject|43|||
33665221|NCT01499849|63097165|FG000|Overall Study|Death|5|||
33665222|NCT01499849|63097166|FG001|Overall Study|Death|7|||
33665223|NCT01499849|63097165|FG000|Overall Study|Disease Progression|11|||
33665224|NCT01499849|63097166|FG001|Overall Study|Disease Progression|10|||
33665225|NCT01499849|63097165|FG000|Overall Study|Protocol Violation|11|||
33665226|NCT01499849|63097166|FG001|Overall Study|Protocol Violation|11|||
33665227|NCT01499849|63097165|FG000|Overall Study|Physician Decision|20|||
33665228|NCT01499849|63097166|FG001|Overall Study|Physician Decision|19|||
33665229|NCT01499849|63097165|FG000|Overall Study|Lack of Efficacy|3|||
33665230|NCT01499849|63097166|FG001|Overall Study|Lack of Efficacy|4|||
33304905|NCT01232283|62680629|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33304906|NCT01232283|62680630|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
33304907|NCT01232283|62680631|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33304908|NCT01232283|62680632|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33304909|NCT01232283|62680633|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33304910|NCT01232283|62680634|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33304911|NCT01232283|62680635|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33304912|NCT01232283|62680636|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33304913|NCT01232283|62680637|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33304914|NCT01232283|62680628|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33304915|NCT01232283|62680629|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33304916|NCT01232283|62680630|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
33304917|NCT01232283|62680631|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
33304918|NCT01232283|62680632|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33304919|NCT01232283|62680633|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33304920|NCT01232283|62680634|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33304921|NCT01232283|62680635|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33304922|NCT01232283|62680636|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33304923|NCT01232283|62680637|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33304924|NCT01232283|62680628|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33304925|NCT01232283|62680629|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33304926|NCT01232283|62680630|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
33304927|NCT01232283|62680631|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
33304928|NCT01232283|62680632|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33304929|NCT01232283|62680633|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33304930|NCT01232283|62680634|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33304931|NCT01232283|62680635|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33304932|NCT01232283|62680636|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33304933|NCT01232283|62680637|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33304934|NCT01232283|62680628|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
33304935|NCT01232283|62680629|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
33304936|NCT01232283|62680630|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
33304937|NCT01232283|62680631|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
33304938|NCT01232283|62680632|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
33304939|NCT01232283|62680633|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
33304940|NCT01232283|62680634|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
33304941|NCT01232283|62680635|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
33304942|NCT01232283|62680636|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
33304943|NCT01232283|62680637|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
33304944|NCT01232283|62680628|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
33304945|NCT01232283|62680629|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
33304946|NCT01232283|62680630|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
33304947|NCT01232283|62680631|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
33304948|NCT01232283|62680632|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
33304949|NCT01232283|62680633|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
33304950|NCT01232283|62680634|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
33304951|NCT01232283|62680635|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
33304952|NCT01232283|62680636|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
33304953|NCT01232283|62680637|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
33304954|NCT01232283|62680628|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
33304955|NCT01232283|62680629|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
33304956|NCT01232283|62680630|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
33304957|NCT01232283|62680631|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
33665231|NCT01499849|63097165|FG000|Overall Study|Lost to Follow-up|6|||
33665232|NCT01499849|63097166|FG001|Overall Study|Lost to Follow-up|3|||
33665233|NCT01499849|63097165|FG000|Overall Study|Other Reasons|27|||
33304958|NCT01232283|62680632|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
33304959|NCT01232283|62680633|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
33665234|NCT01499849|63097166|FG001|Overall Study|Other Reasons|30|||
33665235|NCT01499303|63097185|FG000|Overall Study|Ongoing|2|||
33665236|NCT01499303|63097186|FG001|Overall Study|Ongoing|1|||
33665237|NCT01499303|63097185|FG000|Overall Study|Withdrawal by Subject|0|||
33665238|NCT01499303|63097186|FG001|Overall Study|Withdrawal by Subject|1|||
33665239|NCT01499303|63097185|FG000|Overall Study|Adverse Event|1|||
33665240|NCT01499303|63097186|FG001|Overall Study|Adverse Event|4|||
33665241|NCT01499303|63097185|FG000|Overall Study|Other|0|||
33665242|NCT01499303|63097186|FG001|Overall Study|Other|1|||
33665243|NCT01498679|63097207|FG000|Overall Study|Adverse Event|1|||
33665244|NCT01498679|63097208|FG001|Overall Study|Adverse Event|4|||
33665245|NCT01498679|63097207|FG000|Overall Study|Lack of Efficacy|72|||
33665246|NCT01498679|63097208|FG001|Overall Study|Lack of Efficacy|12|||
33665247|NCT01498679|63097207|FG000|Overall Study|Protocol Violation|4|||
33665248|NCT01498679|63097208|FG001|Overall Study|Protocol Violation|0|||
33665249|NCT01498679|63097207|FG000|Overall Study|Physician Decision|0|||
33665250|NCT01498679|63097208|FG001|Overall Study|Physician Decision|2|||
33665251|NCT01498679|63097207|FG000|Overall Study|Withdrawal by Subject|12|||
33665252|NCT01498679|63097208|FG001|Overall Study|Withdrawal by Subject|4|||
33665253|NCT01526785|63097231|FG000|Overall Study|Study Terminated by Sponsor|8|||
33665254|NCT01526785|63097231|FG000|Overall Study|Death|2|||
33665255|NCT01526785|63097231|FG000|Overall Study|Physician Decision|1|||
33665256|NCT01526785|63097231|FG000|Overall Study|Withdrawal by Subject|2|||
33665257|NCT01559389|63097237|FG000|Overall Study|Withdrawal by Subject|20|||
33665258|NCT01559389|63097238|FG001|Overall Study|Withdrawal by Subject|20|||
33665259|NCT01526551|63097248|FG000|Overall Study|Lack of returned parental consent form|424|||
33665260|NCT01559311|63097326|FG000|Overall Study|Protocol Violation|0|||
33665261|NCT01559311|63097327|FG001|Overall Study|Protocol Violation|0|||
33665262|NCT01559311|63097328|FG002|Overall Study|Protocol Violation|2|||
33665263|NCT01559311|63097326|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
33665264|NCT01559311|63097327|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
33665265|NCT01559311|63097328|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
33665266|NCT01559311|63097326|FG000|Overall Study|Withdrawal by Subject|2|||
33665267|NCT01559311|63097327|FG001|Overall Study|Withdrawal by Subject|1|||
33665268|NCT01559311|63097328|FG002|Overall Study|Withdrawal by Subject|0|||
33665269|NCT01559311|63097326|FG000|Overall Study|Death|0|||
33665270|NCT01559311|63097327|FG001|Overall Study|Death|2|||
33665271|NCT01559311|63097328|FG002|Overall Study|Death|3|||
33665272|NCT01559311|63097326|FG000|Overall Study|Lost to Follow-up|0|||
33665273|NCT01559311|63097327|FG001|Overall Study|Lost to Follow-up|3|||
33665274|NCT01559311|63097328|FG002|Overall Study|Lost to Follow-up|2|||
33665275|NCT01559311|63097326|FG000|Overall Study|Adverse Event|0|||
33665276|NCT01559311|63097327|FG001|Overall Study|Adverse Event|0|||
33665277|NCT01559311|63097328|FG002|Overall Study|Adverse Event|1|||
33665278|NCT01498445|63097351|FG000|Overall Study|Lack of Efficacy|0|||
33665279|NCT01498445|63097352|FG001|Overall Study|Lack of Efficacy|0|||
33665280|NCT01498445|63097353|FG002|Overall Study|Lack of Efficacy|1|||
33665281|NCT01498445|63097354|FG003|Overall Study|Lack of Efficacy|2|||
33665282|NCT01498445|63097355|FG004|Overall Study|Lack of Efficacy|0|||
33665283|NCT01498445|63097356|FG005|Overall Study|Lack of Efficacy|0|||
33665284|NCT01498445|63097351|FG000|Overall Study|Screen Failure|0|||
33665285|NCT01498445|63097352|FG001|Overall Study|Screen Failure|0|||
33665286|NCT01498445|63097353|FG002|Overall Study|Screen Failure|0|||
33665287|NCT01498445|63097354|FG003|Overall Study|Screen Failure|0|||
33665288|NCT01498445|63097355|FG004|Overall Study|Screen Failure|1|||
33665289|NCT01498445|63097356|FG005|Overall Study|Screen Failure|1|||
33665290|NCT01558297|63097373|FG000|Overall Study|Withdrawal by Subject|2|||
33665291|NCT01558297|63097374|FG001|Overall Study|Withdrawal by Subject|2|||
33665292|NCT01558297|63097375|FG002|Overall Study|Withdrawal by Subject|1|||
33665293|NCT01525849|63097385|FG000|Overall Study|Lost to Follow-up|3|||
33665294|NCT01525849|63097386|FG001|Overall Study|Lost to Follow-up|2|||
33665295|NCT01525849|63097385|FG000|Overall Study|Withdrawal by Subject|1|||
33665296|NCT01525849|63097386|FG001|Overall Study|Withdrawal by Subject|9|||
33665297|NCT01525849|63097385|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
33665298|NCT01525849|63097386|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
33665299|NCT01525849|63097385|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
33665300|NCT01525849|63097386|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
33665301|NCT01525615|63097405|FG000|Overall Study|Adverse Event|11|||
33665302|NCT01525615|63097406|FG001|Overall Study|Adverse Event|7|||
33665303|NCT01525615|63097407|FG002|Overall Study|Adverse Event|5|||
33665304|NCT01525615|63097405|FG000|Overall Study|Lost to Follow-up|1|||
33665305|NCT01525615|63097406|FG001|Overall Study|Lost to Follow-up|0|||
33665306|NCT01525615|63097407|FG002|Overall Study|Lost to Follow-up|0|||
33665307|NCT01525615|63097405|FG000|Overall Study|Withdrawal by Subject|1|||
33665308|NCT01525615|63097406|FG001|Overall Study|Withdrawal by Subject|0|||
33665309|NCT01525615|63097407|FG002|Overall Study|Withdrawal by Subject|0|||
33665310|NCT01525615|63097405|FG000|Overall Study|Other reason not described above|1|||
33665311|NCT01525615|63097406|FG001|Overall Study|Other reason not described above|0|||
33665312|NCT01525615|63097407|FG002|Overall Study|Other reason not described above|1|||
33665313|NCT01525225|63097449|FG000|Enrollment|No longer met study criteria|1|||
33665314|NCT01525225|63097449|FG000|Enrollment|Other|1|||
33665315|NCT02660580|63097468|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
33665316|NCT02660580|63097469|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
33665317|NCT02660580|63097470|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
33665318|NCT02660580|63097471|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
33665319|NCT02660580|63097472|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
33665320|NCT02660580|63097468|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
33665321|NCT02660580|63097469|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
33665322|NCT02660580|63097470|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
33665323|NCT02660580|63097471|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
33665324|NCT02660580|63097472|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
33665325|NCT02660580|63097468|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
33665326|NCT02660580|63097469|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
33665327|NCT02660580|63097470|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
33665328|NCT02660580|63097471|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
33665329|NCT02660580|63097472|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
33665330|NCT02660580|63097468|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
33665331|NCT02660580|63097469|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
33665332|NCT02660580|63097470|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
33665333|NCT02660580|63097471|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
33665334|NCT02660580|63097472|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
33665335|NCT02660580|63097468|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
33665336|NCT02660580|63097469|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
33665337|NCT02660580|63097470|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
33665338|NCT02660580|63097471|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
33665339|NCT02660580|63097472|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
33665340|NCT02660580|63097468|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
33665341|NCT02660580|63097469|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
33665342|NCT02660580|63097470|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
33665343|NCT02660580|63097471|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
33665344|NCT02660580|63097472|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
33665345|NCT02660580|63097468|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
33665346|NCT02660580|63097469|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
33665347|NCT02660580|63097470|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
33665348|NCT02660580|63097471|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
33665349|NCT02660580|63097472|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
33665350|NCT02660580|63097468|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
33665351|NCT02660580|63097469|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
33665352|NCT02660580|63097470|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
33665353|NCT02660580|63097471|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
33665354|NCT02660580|63097472|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
33665355|NCT02660580|63097468|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
33665356|NCT02660580|63097469|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
33665357|NCT02660580|63097470|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
33665358|NCT02660580|63097471|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
33665359|NCT02660580|63097472|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
33665360|NCT02660580|63097468|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
33665361|NCT02660580|63097469|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
33665362|NCT02660580|63097470|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
33665363|NCT02660580|63097471|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
33665364|NCT02660580|63097472|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
33665365|NCT02660580|63097468|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
33665366|NCT02660580|63097469|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
33665367|NCT02660580|63097470|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
33665368|NCT02660580|63097471|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
33665369|NCT02660580|63097472|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
33665370|NCT02660580|63097468|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
33665371|NCT02660580|63097469|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
33665372|NCT02660580|63097470|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
33665373|NCT02660580|63097471|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
33665374|NCT02660580|63097472|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
33397848|NCT00761189|62777185|FG000|Overall Study|Other|13|||
33397849|NCT00529516|62777192|FG000|Overall Study|Adverse Event|2|||
33397850|NCT00529516|62777193|FG001|Overall Study|Adverse Event|1|||
33397851|NCT00529516|62777194|FG002|Overall Study|Adverse Event|0|||
33665375|NCT02660580|63097468|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
33665376|NCT02660580|63097469|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
33665377|NCT02660580|63097470|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
33665378|NCT02660580|63097471|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
33665379|NCT02660580|63097472|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
33665380|NCT01524991|63097491|FG000|Overall Study|Adverse Event|12|||
33665381|NCT01524991|63097491|FG000|Overall Study|Death|1|||
33665382|NCT01524991|63097491|FG000|Overall Study|Disease ProgressionDu|17|||
33665383|NCT01524991|63097491|FG000|Overall Study|Other complicating disease|1|||
33665384|NCT01524991|63097491|FG000|Overall Study|Withdrawal by Subject|2|||
33665385|NCT01524991|63097491|FG000|Overall Study|Symptomatic Deterioration|1|||
33665386|NCT01524913|63097498|FG000|Overall Study|Lost to Follow-up|4|||
33665387|NCT01524913|63097499|FG001|Overall Study|Lost to Follow-up|0|||
33665388|NCT01524913|63097500|FG002|Overall Study|Lost to Follow-up|0|||
33665389|NCT01524679|63097510|FG000|Overall Study|Lost to Follow-up|1|||
33665390|NCT01524679|63097511|FG001|Overall Study|Lost to Follow-up|4|||
33665391|NCT01524679|63097510|FG000|Overall Study|Withdrawal by Subject|4|||
33665392|NCT01524679|63097511|FG001|Overall Study|Withdrawal by Subject|4|||
33665393|NCT01524679|63097510|FG000|Overall Study|Adverse Event|9|||
33665394|NCT01524679|63097511|FG001|Overall Study|Adverse Event|0|||
33665395|NCT01524679|63097510|FG000|Overall Study|Protocol Violation|1|||
33665396|NCT01524679|63097511|FG001|Overall Study|Protocol Violation|0|||
33665397|NCT01524679|63097510|FG000|Overall Study|Lack of Efficacy|2|||
33665398|NCT01524679|63097511|FG001|Overall Study|Lack of Efficacy|0|||
33665399|NCT01524679|63097510|FG000|Overall Study|e.g.wish for children, relocation|6|||
33665400|NCT01524679|63097511|FG001|Overall Study|e.g.wish for children, relocation|1|||
33665401|NCT01524289|63097528|FG000|Overall Study|Lost to Follow-up|0|||
33665402|NCT01524289|63097529|FG001|Overall Study|Lost to Follow-up|1|||
33665403|NCT01524289|63097528|FG000|Overall Study|Physician Decision|1|||
33665404|NCT01524289|63097529|FG001|Overall Study|Physician Decision|0|||
33665405|NCT01524289|63097528|FG000|Overall Study|Protocol Violation|5|||
33665406|NCT01524289|63097529|FG001|Overall Study|Protocol Violation|1|||
33665407|NCT01524289|63097528|FG000|Overall Study|Withdrawal by Subject|11|||
33665408|NCT01524289|63097529|FG001|Overall Study|Withdrawal by Subject|7|||
33665409|NCT01524289|63097528|FG000|Overall Study|Adverse Event|12|||
33665410|NCT01524289|63097529|FG001|Overall Study|Adverse Event|5|||
33665411|NCT01524289|63097528|FG000|Overall Study|Did not take study medication|1|||
33665412|NCT01524289|63097529|FG001|Overall Study|Did not take study medication|0|||
33665413|NCT01498289|63097539|FG000|Overall Study|Adverse Event|16|||
33665414|NCT01498289|63097540|FG001|Overall Study|Adverse Event|18|||
33665415|NCT01498289|63097539|FG000|Overall Study|Death|6|||
33665416|NCT01498289|63097540|FG001|Overall Study|Death|8|||
33665417|NCT01498289|63097539|FG000|Overall Study|Withdrawal unrelated to AE|16|||
33665418|NCT01498289|63097540|FG001|Overall Study|Withdrawal unrelated to AE|16|||
33665419|NCT01498289|63097539|FG000|Overall Study|Progression/relapse|53|||
33665420|NCT01498289|63097540|FG001|Overall Study|Progression/relapse|59|||
33665421|NCT01498289|63097539|FG000|Overall Study|Not protocol specified|7|||
33665422|NCT01498289|63097540|FG001|Overall Study|Not protocol specified|2|||
33665423|NCT01498289|63097539|FG000|Overall Study|Reason under review|0|||
33665424|NCT01498289|63097540|FG001|Overall Study|Reason under review|1|||
33665425|NCT01524133|63097553|FG000|Treatment Phase|Withdrawal by Subject|13|||
33665426|NCT01524133|63097554|FG001|Treatment Phase|Withdrawal by Subject|28|||
33665427|NCT01524133|63097555|FG002|Treatment Phase|Withdrawal by Subject|31|||
33665428|NCT01524133|63097553|FG000|Treatment Phase|Physician Decision|6|||
33665429|NCT01524133|63097554|FG001|Treatment Phase|Physician Decision|3|||
33665430|NCT01524133|63097555|FG002|Treatment Phase|Physician Decision|3|||
33665431|NCT01524133|63097553|FG000|Treatment Phase|Lost to Follow-up|0|||
33665432|NCT01524133|63097554|FG001|Treatment Phase|Lost to Follow-up|1|||
33665433|NCT01524133|63097555|FG002|Treatment Phase|Lost to Follow-up|2|||
33665434|NCT01524133|63097553|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
33397852|NCT00529516|62777192|FG000|Overall Study|Withdrawal by Subject|1|||
33665435|NCT01524133|63097554|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
33397853|NCT00529516|62777193|FG001|Overall Study|Withdrawal by Subject|1|||
33397854|NCT00529516|62777194|FG002|Overall Study|Withdrawal by Subject|0|||
33576229|NCT02514239|62972705|FG009|Overall Study|Not treated|0|||
33576230|NCT02514239|62972696|FG000|Overall Study|Other Adverse Events|2|||
33576231|NCT02514239|62972697|FG001|Overall Study|Other Adverse Events|0|||
33576232|NCT02514239|62972698|FG002|Overall Study|Other Adverse Events|0|||
33576233|NCT02514239|62972699|FG003|Overall Study|Other Adverse Events|1|||
33576234|NCT02514239|62972700|FG004|Overall Study|Other Adverse Events|0|||
33576235|NCT02514239|62972701|FG005|Overall Study|Other Adverse Events|1|||
33576236|NCT02514239|62972702|FG006|Overall Study|Other Adverse Events|0|||
33576237|NCT02514239|62972703|FG007|Overall Study|Other Adverse Events|1|||
33576238|NCT02514239|62972704|FG008|Overall Study|Other Adverse Events|2|||
33665436|NCT01524133|63097555|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
33576239|NCT02514239|62972705|FG009|Overall Study|Other Adverse Events|0|||
33665437|NCT01524133|63097553|FG000|Overall Study 52 Weeks|Physician Decision|1|||
33665438|NCT01524133|63097554|FG001|Overall Study 52 Weeks|Physician Decision|0|||
33665439|NCT01524133|63097555|FG002|Overall Study 52 Weeks|Physician Decision|2|||
33665440|NCT01524133|63097553|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
33665441|NCT01524133|63097554|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
33665442|NCT01524133|63097555|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
33665443|NCT04304534|63097589|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
33665444|NCT04304534|63097590|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
33665445|NCT04304534|63097591|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
33665446|NCT04304534|63097592|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
33665447|NCT04304534|63097589|FG000|Overall Study|Non-Compliance with study drug|0|||
33665448|NCT04304534|63097590|FG001|Overall Study|Non-Compliance with study drug|1|||
33665449|NCT04304534|63097591|FG002|Overall Study|Non-Compliance with study drug|1|||
33665450|NCT04304534|63097592|FG003|Overall Study|Non-Compliance with study drug|1|||
33665451|NCT04304534|63097589|FG000|Overall Study|Lost to Follow-up|0|||
33665452|NCT04304534|63097590|FG001|Overall Study|Lost to Follow-up|1|||
33665453|NCT04304534|63097591|FG002|Overall Study|Lost to Follow-up|2|||
33665454|NCT04304534|63097592|FG003|Overall Study|Lost to Follow-up|3|||
33665455|NCT04304534|63097589|FG000|Overall Study|Unspecific|4|||
33665456|NCT04304534|63097590|FG001|Overall Study|Unspecific|2|||
33665457|NCT04304534|63097591|FG002|Overall Study|Unspecific|2|||
33665458|NCT04304534|63097592|FG003|Overall Study|Unspecific|2|||
33665459|NCT04304534|63097589|FG000|Overall Study|Technical Problems|2|||
33665460|NCT04304534|63097590|FG001|Overall Study|Technical Problems|2|||
33665461|NCT04304534|63097591|FG002|Overall Study|Technical Problems|3|||
33665462|NCT04304534|63097592|FG003|Overall Study|Technical Problems|4|||
33665463|NCT04304534|63097589|FG000|Overall Study|Death|7|||
33665464|NCT04304534|63097590|FG001|Overall Study|Death|2|||
33665465|NCT04304534|63097591|FG002|Overall Study|Death|4|||
33665466|NCT04304534|63097592|FG003|Overall Study|Death|3|||
33665467|NCT04304534|63097589|FG000|Overall Study|Withdrawal by Subject|7|||
33665468|NCT04304534|63097590|FG001|Overall Study|Withdrawal by Subject|2|||
33665469|NCT04304534|63097591|FG002|Overall Study|Withdrawal by Subject|7|||
33665470|NCT04304534|63097592|FG003|Overall Study|Withdrawal by Subject|4|||
33665471|NCT04304534|63097589|FG000|Overall Study|Physician Decision|4|||
33665472|NCT04304534|63097590|FG001|Overall Study|Physician Decision|9|||
33665473|NCT04304534|63097591|FG002|Overall Study|Physician Decision|9|||
33665474|NCT04304534|63097592|FG003|Overall Study|Physician Decision|5|||
33665475|NCT04304534|63097589|FG000|Overall Study|Subject Decision|34|||
33665476|NCT04304534|63097590|FG001|Overall Study|Subject Decision|25|||
33665477|NCT04304534|63097591|FG002|Overall Study|Subject Decision|25|||
33665478|NCT04304534|63097592|FG003|Overall Study|Subject Decision|26|||
33665479|NCT04304534|63097589|FG000|Overall Study|Adverse Event|35|||
33665480|NCT04304534|63097590|FG001|Overall Study|Adverse Event|40|||
33665481|NCT04304534|63097591|FG002|Overall Study|Adverse Event|39|||
33665482|NCT04304534|63097592|FG003|Overall Study|Adverse Event|44|||
33665483|NCT04223609|63097605|FG000|Overall Study|Adverse Event|0|||
33665484|NCT04223609|63097606|FG001|Overall Study|Adverse Event|1|||
33665485|NCT04223609|63097605|FG000|Overall Study|Missed last visit|0|||
33665486|NCT04223609|63097606|FG001|Overall Study|Missed last visit|1|||
33665487|NCT04176458|63097612|FG000|Overall Study|Covid 19|4|||
33665488|NCT03941548|63097618|FG000|Overall Study|Adverse Event|0|||
33665489|NCT03941548|63097619|FG001|Overall Study|Adverse Event|1|||
33665490|NCT03941548|63097618|FG000|Overall Study|Lost to Follow-up|0|||
33665491|NCT03941548|63097619|FG001|Overall Study|Lost to Follow-up|1|||
33665492|NCT03941548|63097618|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
33665493|NCT03941548|63097619|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
33665494|NCT03925727|63097628|FG000|Overall Study|Adverse Event|4|||
33665495|NCT03925727|63097629|FG001|Overall Study|Adverse Event|0|||
33665496|NCT03925727|63097630|FG002|Overall Study|Adverse Event|3|||
33665497|NCT03925727|63097628|FG000|Overall Study|Protocol Violation|1|||
33665498|NCT03925727|63097629|FG001|Overall Study|Protocol Violation|2|||
33665499|NCT03925727|63097630|FG002|Overall Study|Protocol Violation|2|||
33665500|NCT03925727|63097628|FG000|Overall Study|Withdrawal by Subject|3|||
33665501|NCT03925727|63097629|FG001|Overall Study|Withdrawal by Subject|2|||
33665502|NCT03925727|63097630|FG002|Overall Study|Withdrawal by Subject|4|||
33665503|NCT03925727|63097628|FG000|Overall Study|Administrative Reasons|3|||
33665504|NCT03925727|63097629|FG001|Overall Study|Administrative Reasons|1|||
33665505|NCT03925727|63097630|FG002|Overall Study|Administrative Reasons|2|||
33665506|NCT03925727|63097628|FG000|Overall Study|Randomized in error or Disqualified|8|||
33665507|NCT03925727|63097629|FG001|Overall Study|Randomized in error or Disqualified|1|||
33397855|NCT00529516|62777192|FG000|Overall Study|Lost to Follow-up|0|||
33665508|NCT03925727|63097630|FG002|Overall Study|Randomized in error or Disqualified|7|||
33665509|NCT03387150|63097647|FG000|Overall Study|Withdrawal by Subject|3|||
33665510|NCT03387150|63097648|FG001|Overall Study|Withdrawal by Subject|0|||
33665511|NCT03387150|63097649|FG002|Overall Study|Withdrawal by Subject|3|||
33665512|NCT03387150|63097650|FG003|Overall Study|Withdrawal by Subject|4|||
33665513|NCT03387150|63097651|FG004|Overall Study|Withdrawal by Subject|1|||
33665514|NCT03387150|63097652|FG005|Overall Study|Withdrawal by Subject|2|||
33665515|NCT03387150|63097653|FG006|Overall Study|Withdrawal by Subject|0|||
33665516|NCT03387150|63097647|FG000|Overall Study|Lost to Follow-up|3|||
33665517|NCT03387150|63097648|FG001|Overall Study|Lost to Follow-up|2|||
33576240|NCT02514239|62972696|FG000|Overall Study|Progressive disease|3|||
33576241|NCT02514239|62972697|FG001|Overall Study|Progressive disease|3|||
33576242|NCT02514239|62972698|FG002|Overall Study|Progressive disease|2|||
33576243|NCT02514239|62972699|FG003|Overall Study|Progressive disease|2|||
33576244|NCT02514239|62972700|FG004|Overall Study|Progressive disease|3|||
33576245|NCT02514239|62972701|FG005|Overall Study|Progressive disease|3|||
33576246|NCT02514239|62972702|FG006|Overall Study|Progressive disease|4|||
33576247|NCT02514239|62972703|FG007|Overall Study|Progressive disease|2|||
33576248|NCT02514239|62972704|FG008|Overall Study|Progressive disease|5|||
33576249|NCT02514239|62972705|FG009|Overall Study|Progressive disease|0|||
33576250|NCT02709109|62972749|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
33576251|NCT02709109|62972750|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
33576252|NCT02709109|62972751|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
33576253|NCT02709109|62972752|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
33576254|NCT02709109|62972749|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
33576255|NCT02709109|62972750|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
33576256|NCT02709109|62972751|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
33576257|NCT02709109|62972752|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
33576258|NCT02709109|62972749|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
33576259|NCT02709109|62972750|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
33576260|NCT02709109|62972751|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
33576261|NCT02709109|62972752|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
33576262|NCT02709109|62972749|FG000|Washout Period (28 Days)|Other|2|||
33576263|NCT02709109|62972750|FG001|Washout Period (28 Days)|Other|2|||
33576264|NCT02709109|62972751|FG002|Washout Period (28 Days)|Other|3|||
33576265|NCT02709109|62972752|FG003|Washout Period (28 Days)|Other|0|||
33576266|NCT02709109|62972749|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
33576267|NCT02709109|62972750|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
33576268|NCT02709109|62972751|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
33576269|NCT02709109|62972752|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
33576270|NCT02709109|62972749|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
33576271|NCT02709109|62972750|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
33576272|NCT02709109|62972751|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
33576273|NCT02709109|62972752|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
33576274|NCT02709109|62972749|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
33576275|NCT02709109|62972750|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
33576276|NCT02709109|62972751|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
33576277|NCT02709109|62972752|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
33576278|NCT02709109|62972749|FG000|Treatment Period 2 (28 Days)|Other|0|||
33576279|NCT02709109|62972750|FG001|Treatment Period 2 (28 Days)|Other|0|||
33576280|NCT02709109|62972751|FG002|Treatment Period 2 (28 Days)|Other|1|||
33576281|NCT02709109|62972752|FG003|Treatment Period 2 (28 Days)|Other|0|||
33576282|NCT04289051|62972767|FG000|Overall Study|Lost to Follow-up|0|||
33576283|NCT04289051|62972768|FG001|Overall Study|Lost to Follow-up|0|||
33576284|NCT04289051|62972769|FG002|Overall Study|Lost to Follow-up|2|||
33576285|NCT02709655|62972777|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
33576286|NCT02709655|62972778|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
33576287|NCT02709655|62972779|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
33576288|NCT02709655|62972780|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
33576289|NCT02709655|62972781|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
33576290|NCT02709655|62972777|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
33576291|NCT02709655|62972778|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
33576292|NCT02709655|62972779|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
33576293|NCT02709655|62972780|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
33576294|NCT02709655|62972781|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
33576295|NCT02709655|62972777|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
33576296|NCT02709655|62972778|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
33576297|NCT02709655|62972779|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
33576298|NCT02709655|62972780|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
33576299|NCT02709655|62972781|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
33576300|NCT02709655|62972777|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
33576301|NCT02709655|62972778|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
33576302|NCT02709655|62972779|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
33576303|NCT02709655|62972780|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
33576304|NCT02709655|62972781|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
33665518|NCT03387150|63097649|FG002|Overall Study|Lost to Follow-up|2|||
33576305|NCT02709655|62972777|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
33576306|NCT02709655|62972778|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
33576307|NCT02709655|62972779|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
33576308|NCT02709655|62972780|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
33576309|NCT02709655|62972781|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
33576310|NCT02709655|62972777|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
33576311|NCT02709655|62972778|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
33576312|NCT02709655|62972779|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
33576313|NCT02709655|62972780|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
33576314|NCT02709655|62972781|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
33576315|NCT02709655|62972777|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
33576316|NCT02709655|62972778|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
33665519|NCT03387150|63097650|FG003|Overall Study|Lost to Follow-up|3|||
33665520|NCT03387150|63097651|FG004|Overall Study|Lost to Follow-up|3|||
33665521|NCT03387150|63097652|FG005|Overall Study|Lost to Follow-up|3|||
33665522|NCT03387150|63097653|FG006|Overall Study|Lost to Follow-up|0|||
33665523|NCT03387150|63097647|FG000|Overall Study|Participant unable to adhere to visit|0|||
33665524|NCT03387150|63097648|FG001|Overall Study|Participant unable to adhere to visit|1|||
33665525|NCT03387150|63097649|FG002|Overall Study|Participant unable to adhere to visit|0|||
33665526|NCT03387150|63097650|FG003|Overall Study|Participant unable to adhere to visit|0|||
33665527|NCT03387150|63097651|FG004|Overall Study|Participant unable to adhere to visit|2|||
33665528|NCT03387150|63097652|FG005|Overall Study|Participant unable to adhere to visit|2|||
33665529|NCT03387150|63097653|FG006|Overall Study|Participant unable to adhere to visit|0|||
33665530|NCT03289208|63097685|FG000|Overall Study|Adverse Event|1|||
33665531|NCT03289208|63097686|FG001|Overall Study|Adverse Event|0|||
33665532|NCT03289208|63097687|FG002|Overall Study|Adverse Event|0|||
33665533|NCT03244059|63097697|FG000|Specific Aim 1|Physician Decision|1|||
33665534|NCT03244059|63097698|FG001|Specific Aim 1|Physician Decision|0|||
33665535|NCT03244059|63097697|FG000|Specific Aim 2|Physician Decision|1|||
33665536|NCT03244059|63097698|FG001|Specific Aim 2|Physician Decision|0|||
33665537|NCT03036566|63097704|FG000|Overall Study|Lost to Follow-up|3|||
33665538|NCT02754141|63097735|FG000|Overall Study|Disease progression|11|||
33665539|NCT02754141|63097736|FG001|Overall Study|Disease progression|7|||
33665540|NCT02754141|63097737|FG002|Overall Study|Disease progression|8|||
33665541|NCT02754141|63097738|FG003|Overall Study|Disease progression|5|||
33665542|NCT02754141|63097739|FG004|Overall Study|Disease progression|7|||
33665543|NCT02754141|63097740|FG005|Overall Study|Disease progression|7|||
33665544|NCT02754141|63097741|FG006|Overall Study|Disease progression|7|||
33665545|NCT02754141|63097742|FG007|Overall Study|Disease progression|6|||
33665546|NCT02754141|63097743|FG008|Overall Study|Disease progression|11|||
33665547|NCT02754141|63097744|FG009|Overall Study|Disease progression|16|||
33665548|NCT02754141|63097745|FG010|Overall Study|Disease progression|18|||
33665549|NCT02754141|63097746|FG011|Overall Study|Disease progression|13|||
33665550|NCT02754141|63097747|FG012|Overall Study|Disease progression|10|||
33665551|NCT02754141|63097748|FG013|Overall Study|Disease progression|12|||
33665552|NCT02754141|63097749|FG014|Overall Study|Disease progression|12|||
33665553|NCT02754141|63097750|FG015|Overall Study|Disease progression|14|||
33665554|NCT02754141|63097751|FG016|Overall Study|Disease progression|0|||
33665555|NCT02754141|63097752|FG017|Overall Study|Disease progression|1|||
33665556|NCT02754141|63097735|FG000|Overall Study|Study drug toxicity|1|||
33665557|NCT02754141|63097736|FG001|Overall Study|Study drug toxicity|1|||
33665558|NCT02754141|63097737|FG002|Overall Study|Study drug toxicity|0|||
33665559|NCT02754141|63097738|FG003|Overall Study|Study drug toxicity|0|||
33665560|NCT02754141|63097739|FG004|Overall Study|Study drug toxicity|0|||
33665561|NCT02754141|63097740|FG005|Overall Study|Study drug toxicity|0|||
33665562|NCT02754141|63097741|FG006|Overall Study|Study drug toxicity|0|||
33665563|NCT02754141|63097742|FG007|Overall Study|Study drug toxicity|0|||
33665564|NCT02754141|63097743|FG008|Overall Study|Study drug toxicity|0|||
33665565|NCT02754141|63097744|FG009|Overall Study|Study drug toxicity|0|||
33665566|NCT02754141|63097745|FG010|Overall Study|Study drug toxicity|2|||
33665567|NCT02754141|63097746|FG011|Overall Study|Study drug toxicity|1|||
33665568|NCT02754141|63097747|FG012|Overall Study|Study drug toxicity|1|||
33665569|NCT02754141|63097748|FG013|Overall Study|Study drug toxicity|0|||
33665570|NCT02754141|63097749|FG014|Overall Study|Study drug toxicity|0|||
33665571|NCT02754141|63097750|FG015|Overall Study|Study drug toxicity|0|||
33576317|NCT02709655|62972779|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
33665572|NCT02754141|63097751|FG016|Overall Study|Study drug toxicity|0|||
33665573|NCT02754141|63097752|FG017|Overall Study|Study drug toxicity|0|||
33665574|NCT02754141|63097735|FG000|Overall Study|AE unrelated to study drug|1|||
33665575|NCT02754141|63097736|FG001|Overall Study|AE unrelated to study drug|1|||
33665576|NCT02754141|63097737|FG002|Overall Study|AE unrelated to study drug|0|||
33665577|NCT02754141|63097738|FG003|Overall Study|AE unrelated to study drug|1|||
33665578|NCT02754141|63097739|FG004|Overall Study|AE unrelated to study drug|3|||
33665579|NCT02754141|63097740|FG005|Overall Study|AE unrelated to study drug|2|||
33665580|NCT02754141|63097741|FG006|Overall Study|AE unrelated to study drug|1|||
33665581|NCT02754141|63097742|FG007|Overall Study|AE unrelated to study drug|0|||
33665582|NCT02754141|63097743|FG008|Overall Study|AE unrelated to study drug|0|||
33665583|NCT02754141|63097744|FG009|Overall Study|AE unrelated to study drug|0|||
33665584|NCT02754141|63097745|FG010|Overall Study|AE unrelated to study drug|0|||
33665585|NCT02754141|63097746|FG011|Overall Study|AE unrelated to study drug|0|||
33665586|NCT02754141|63097747|FG012|Overall Study|AE unrelated to study drug|0|||
33665587|NCT02754141|63097748|FG013|Overall Study|AE unrelated to study drug|0|||
33665588|NCT02754141|63097749|FG014|Overall Study|AE unrelated to study drug|0|||
33665589|NCT02754141|63097750|FG015|Overall Study|AE unrelated to study drug|0|||
33665590|NCT02754141|63097751|FG016|Overall Study|AE unrelated to study drug|0|||
33665591|NCT02754141|63097752|FG017|Overall Study|AE unrelated to study drug|0|||
33665592|NCT02754141|63097735|FG000|Overall Study|Request to discontinue|0|||
33665593|NCT02754141|63097736|FG001|Overall Study|Request to discontinue|0|||
33576318|NCT02709655|62972780|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
33576319|NCT02709655|62972781|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
33576320|NCT02709655|62972777|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
33576321|NCT02709655|62972778|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
33576322|NCT02709655|62972779|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
33576323|NCT02709655|62972780|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
33576324|NCT02709655|62972781|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
33665594|NCT02754141|63097737|FG002|Overall Study|Request to discontinue|0|||
33665595|NCT02754141|63097738|FG003|Overall Study|Request to discontinue|0|||
33665596|NCT02754141|63097739|FG004|Overall Study|Request to discontinue|0|||
33665597|NCT02754141|63097740|FG005|Overall Study|Request to discontinue|0|||
33665598|NCT02754141|63097741|FG006|Overall Study|Request to discontinue|0|||
33665599|NCT02754141|63097742|FG007|Overall Study|Request to discontinue|0|||
33665600|NCT02754141|63097743|FG008|Overall Study|Request to discontinue|1|||
33665601|NCT02754141|63097744|FG009|Overall Study|Request to discontinue|0|||
33665602|NCT02754141|63097745|FG010|Overall Study|Request to discontinue|0|||
33665603|NCT02754141|63097746|FG011|Overall Study|Request to discontinue|0|||
33665604|NCT02754141|63097747|FG012|Overall Study|Request to discontinue|0|||
33665605|NCT02754141|63097748|FG013|Overall Study|Request to discontinue|1|||
33665606|NCT02754141|63097749|FG014|Overall Study|Request to discontinue|1|||
33665607|NCT02754141|63097750|FG015|Overall Study|Request to discontinue|0|||
33665608|NCT02754141|63097751|FG016|Overall Study|Request to discontinue|0|||
33665609|NCT02754141|63097752|FG017|Overall Study|Request to discontinue|0|||
33665610|NCT02754141|63097735|FG000|Overall Study|Withdrew consent|0|||
33665611|NCT02754141|63097736|FG001|Overall Study|Withdrew consent|0|||
33665612|NCT02754141|63097737|FG002|Overall Study|Withdrew consent|0|||
33665613|NCT02754141|63097738|FG003|Overall Study|Withdrew consent|0|||
33304960|NCT01232283|62680634|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
33304961|NCT01232283|62680635|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
33304962|NCT01232283|62680636|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
33304963|NCT01232283|62680637|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
33304964|NCT01232283|62680628|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
33304965|NCT01232283|62680629|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
33304966|NCT01232283|62680630|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
33304967|NCT01232283|62680631|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
33304968|NCT01232283|62680632|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
33304969|NCT01232283|62680633|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
33304970|NCT01232283|62680634|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
33304971|NCT01232283|62680635|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
33304972|NCT01232283|62680636|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
33304973|NCT01232283|62680637|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
33304974|NCT01232283|62680628|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33304975|NCT01232283|62680629|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33304976|NCT01232283|62680630|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33304977|NCT01232283|62680631|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33304978|NCT01232283|62680632|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
33304979|NCT01232283|62680633|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33304980|NCT01232283|62680634|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33576325|NCT02709655|62972777|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
33576326|NCT02709655|62972778|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
33665614|NCT02754141|63097739|FG004|Overall Study|Withdrew consent|0|||
33665615|NCT02754141|63097740|FG005|Overall Study|Withdrew consent|0|||
33665616|NCT02754141|63097741|FG006|Overall Study|Withdrew consent|0|||
33665617|NCT02754141|63097742|FG007|Overall Study|Withdrew consent|0|||
33665618|NCT02754141|63097743|FG008|Overall Study|Withdrew consent|0|||
33665619|NCT02754141|63097744|FG009|Overall Study|Withdrew consent|1|||
33665620|NCT02754141|63097745|FG010|Overall Study|Withdrew consent|0|||
33665621|NCT02754141|63097746|FG011|Overall Study|Withdrew consent|0|||
33304981|NCT01232283|62680635|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33304982|NCT01232283|62680636|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33304983|NCT01232283|62680637|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33304984|NCT01232283|62680628|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
33304985|NCT01232283|62680629|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
33304986|NCT01232283|62680630|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
33304987|NCT01232283|62680631|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
33304988|NCT01232283|62680632|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
33304989|NCT01232283|62680633|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
33304990|NCT01232283|62680634|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
33304991|NCT01232283|62680635|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
33304992|NCT01232283|62680636|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
33304993|NCT01232283|62680637|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
33304994|NCT01232283|62680628|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33304995|NCT01232283|62680629|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33304996|NCT01232283|62680630|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33304997|NCT01232283|62680631|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33304998|NCT01232283|62680632|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33304999|NCT01232283|62680633|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33305000|NCT01232283|62680634|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33305001|NCT01232283|62680635|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
33305002|NCT01232283|62680636|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33305003|NCT01232283|62680637|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33305004|NCT01232283|62680628|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33305005|NCT01232283|62680629|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33305006|NCT01232283|62680630|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33305007|NCT01232283|62680631|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33305008|NCT01232283|62680632|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33305009|NCT01232283|62680633|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
33305010|NCT01232283|62680634|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33305011|NCT01232283|62680635|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33305012|NCT01232283|62680636|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33305013|NCT01232283|62680637|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33305014|NCT01232283|62680628|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33305015|NCT01232283|62680629|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33305016|NCT01232283|62680630|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33305017|NCT01232283|62680631|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33305018|NCT01232283|62680632|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33305019|NCT01232283|62680633|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33305020|NCT01232283|62680634|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33305021|NCT01232283|62680635|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33305022|NCT01232283|62680636|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
33305023|NCT01232283|62680637|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
33305024|NCT01232283|62680628|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33305025|NCT01232283|62680629|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33305026|NCT01232283|62680630|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33305027|NCT01232283|62680631|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33305028|NCT01232283|62680632|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33305029|NCT01232283|62680633|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33305030|NCT01232283|62680634|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33305031|NCT01232283|62680635|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33305032|NCT01232283|62680636|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
33305033|NCT01232283|62680637|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
33305034|NCT01232283|62680628|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33305035|NCT01232283|62680629|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33305036|NCT01232283|62680630|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33305037|NCT01232283|62680631|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33305038|NCT01232283|62680632|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33305039|NCT01232283|62680633|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33305040|NCT01232283|62680634|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33305041|NCT01232283|62680635|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33305042|NCT01232283|62680636|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
33305043|NCT01232283|62680637|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
33397856|NCT00529516|62777193|FG001|Overall Study|Lost to Follow-up|0|||
33665622|NCT02754141|63097747|FG012|Overall Study|Withdrew consent|0|||
33665623|NCT02754141|63097748|FG013|Overall Study|Withdrew consent|0|||
33665624|NCT02754141|63097749|FG014|Overall Study|Withdrew consent|0|||
33305044|NCT01232283|62680628|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33305045|NCT01232283|62680629|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33305046|NCT01232283|62680630|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33305047|NCT01232283|62680631|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33305048|NCT01232283|62680632|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33305049|NCT01232283|62680633|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33305050|NCT01232283|62680634|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33305051|NCT01232283|62680635|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33305052|NCT01232283|62680636|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
33305053|NCT01232283|62680637|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
33305054|NCT01232283|62680628|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33305055|NCT01232283|62680629|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33305056|NCT01232283|62680630|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33305057|NCT01232283|62680631|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33305058|NCT01232283|62680632|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33305059|NCT01232283|62680633|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33305060|NCT01232283|62680634|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33305061|NCT01232283|62680635|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33305062|NCT01232283|62680636|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
33305063|NCT01232283|62680637|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
33305064|NCT01232283|62680628|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33305065|NCT01232283|62680629|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33305066|NCT01232283|62680630|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33305067|NCT01232283|62680631|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33305068|NCT01232283|62680632|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33305069|NCT01232283|62680633|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33305070|NCT01232283|62680634|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33305071|NCT01232283|62680635|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33305072|NCT01232283|62680636|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
33305073|NCT01232283|62680637|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33305074|NCT01232283|62680628|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33305075|NCT01232283|62680629|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33305076|NCT01232283|62680630|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33305077|NCT01232283|62680631|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33305078|NCT01232283|62680632|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33305079|NCT01232283|62680633|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33305080|NCT01232283|62680634|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33305081|NCT01232283|62680635|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33305082|NCT01232283|62680636|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
33305083|NCT01232283|62680637|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33305084|NCT01232283|62680628|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33305085|NCT01232283|62680629|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33305086|NCT01232283|62680630|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33305087|NCT01232283|62680631|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33305088|NCT01232283|62680632|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33305089|NCT01232283|62680633|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33305090|NCT01232283|62680634|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33305091|NCT01232283|62680635|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33305092|NCT01232283|62680636|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
33305093|NCT01232283|62680637|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
33305094|NCT01232127|62680659|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
33305095|NCT01232127|62680660|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
33305096|NCT01232127|62680661|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
33305097|NCT01258608|62680675|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
33305098|NCT01258608|62680676|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
33305099|NCT01258608|62680675|FG000|Overall Study|Clinical progression|1|||
33305100|NCT01258608|62680676|FG001|Overall Study|Clinical progression|0|||
33305101|NCT01258608|62680675|FG000|Overall Study|Sponsor decision|0|||
33305102|NCT01258608|62680676|FG001|Overall Study|Sponsor decision|1|||
33305103|NCT01258608|62680675|FG000|Overall Study|Physician Decision|6|||
33305104|NCT01258608|62680676|FG001|Overall Study|Physician Decision|1|||
33305105|NCT01258608|62680675|FG000|Overall Study|Lost to Follow-up|0|||
33305106|NCT01258608|62680676|FG001|Overall Study|Lost to Follow-up|1|||
33305107|NCT01258608|62680675|FG000|Overall Study|Lack of compliance|1|||
33305108|NCT01258608|62680676|FG001|Overall Study|Lack of compliance|0|||
33305109|NCT01258608|62680675|FG000|Overall Study|Lack of Efficacy|0|||
33305110|NCT01258608|62680676|FG001|Overall Study|Lack of Efficacy|1|||
33305111|NCT01258608|62680675|FG000|Overall Study|Adverse Event|6|||
33305112|NCT01258608|62680676|FG001|Overall Study|Adverse Event|10|||
33305113|NCT01258608|62680675|FG000|Overall Study|Withdrawal by Subject|6|||
33305114|NCT01258608|62680676|FG001|Overall Study|Withdrawal by Subject|5|||
33305115|NCT01015612|62680683|FG000|Overall Study|Death|113|||
33305116|NCT01015612|62680683|FG000|Overall Study|Withdrawal by Subject|40|||
33305117|NCT01231659|62680687|FG000|Overall Study|Adverse Event|9|||
33305118|NCT01231659|62680687|FG000|Overall Study|Disease Progression|48|||
33305119|NCT01231659|62680687|FG000|Overall Study|Death|2|||
33305120|NCT01231659|62680687|FG000|Overall Study|Patient refused to complete study visit|1|||
33305121|NCT01231659|62680687|FG000|Overall Study|Other protocol defined criteria|12|||
33305122|NCT01054222|62680691|FG000|Overall Study|Lack of Efficacy|1|||
33305123|NCT01054222|62680691|FG000|Overall Study|Lost to Follow-up|4|||
33305124|NCT01054222|62680691|FG000|Overall Study|Withdrawal by Subject|6|||
33305125|NCT01052428|62680697|FG000|Overall Study|Death|1|||
33305126|NCT01052428|62680698|FG001|Overall Study|Death|0|||
33305127|NCT01052428|62680697|FG000|Overall Study|Withdrawal by Subject|0|||
33305128|NCT01052428|62680698|FG001|Overall Study|Withdrawal by Subject|1|||
33305129|NCT01052272|62680708|FG000|Overall Study|Death|0|||
33305130|NCT01052272|62680709|FG001|Overall Study|Death|0|||
33305131|NCT01052272|62680710|FG002|Overall Study|Death|1|||
33305132|NCT01052272|62680711|FG003|Overall Study|Death|1|||
33305133|NCT01052272|62680708|FG000|Overall Study|Physician Decision|0|||
33305134|NCT01052272|62680709|FG001|Overall Study|Physician Decision|1|||
33305135|NCT01052272|62680710|FG002|Overall Study|Physician Decision|0|||
33305136|NCT01052272|62680711|FG003|Overall Study|Physician Decision|0|||
33305137|NCT01052272|62680708|FG000|Overall Study|patient refuses follow-up|5|||
33305138|NCT01052272|62680709|FG001|Overall Study|patient refuses follow-up|4|||
33305139|NCT01052272|62680710|FG002|Overall Study|patient refuses follow-up|2|||
33305140|NCT01052272|62680711|FG003|Overall Study|patient refuses follow-up|4|||
33305141|NCT01052272|62680708|FG000|Overall Study|Withdrawal by Subject|0|||
33305142|NCT01052272|62680709|FG001|Overall Study|Withdrawal by Subject|2|||
33305143|NCT01052272|62680710|FG002|Overall Study|Withdrawal by Subject|3|||
33305144|NCT01052272|62680711|FG003|Overall Study|Withdrawal by Subject|2|||
33305145|NCT01052272|62680708|FG000|Overall Study|placed in long-term care|0|||
33305146|NCT01052272|62680709|FG001|Overall Study|placed in long-term care|0|||
33305147|NCT01052272|62680710|FG002|Overall Study|placed in long-term care|1|||
33305148|NCT01052272|62680711|FG003|Overall Study|placed in long-term care|0|||
33305149|NCT01052272|62680708|FG000|Overall Study|decline in health|0|||
33305150|NCT01052272|62680709|FG001|Overall Study|decline in health|0|||
33305151|NCT01052272|62680710|FG002|Overall Study|decline in health|1|||
33305152|NCT01052272|62680711|FG003|Overall Study|decline in health|0|||
33305153|NCT01257204|62680724|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
33305154|NCT01257204|62680725|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
33305155|NCT01257204|62680726|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
33305156|NCT01257204|62680724|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
33305157|NCT01257204|62680725|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
33305158|NCT01257204|62680726|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
33305159|NCT01257204|62680724|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
33305160|NCT01257204|62680725|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
33305161|NCT01257204|62680726|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
33305162|NCT01257204|62680724|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
33305163|NCT01257204|62680725|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
33305164|NCT01257204|62680726|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
33305165|NCT01257204|62680724|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
33305166|NCT01257204|62680725|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
33305167|NCT01257204|62680726|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
33305168|NCT01257204|62680724|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
33305169|NCT01257204|62680725|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
33305170|NCT01257204|62680726|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
33305171|NCT01257204|62680724|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
33305172|NCT01257204|62680725|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
33305173|NCT01257204|62680726|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
33305174|NCT01257204|62680724|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
33305175|NCT01257204|62680725|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
33305176|NCT01257204|62680726|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
33305177|NCT01257204|62680724|FG000|Follow-up Period (up to Week 48)|Other|0|||
33305178|NCT01257204|62680725|FG001|Follow-up Period (up to Week 48)|Other|0|||
33305179|NCT01257204|62680726|FG002|Follow-up Period (up to Week 48)|Other|5|||
33305180|NCT01231581|62680748|FG000|Overall Study|Lost to Follow-up|2|||
33305181|NCT01231581|62680749|FG001|Overall Study|Lost to Follow-up|2|||
33305182|NCT01231581|62680748|FG000|Overall Study|Withdrawal by Subject|6|||
33305183|NCT01231581|62680749|FG001|Overall Study|Withdrawal by Subject|9|||
33305184|NCT01231581|62680748|FG000|Overall Study|Study Closed/Terminated|6|||
33305185|NCT01231581|62680749|FG001|Overall Study|Study Closed/Terminated|5|||
33305186|NCT01231581|62680748|FG000|Overall Study|Death|65|||
33305187|NCT01231581|62680749|FG001|Overall Study|Death|64|||
33305188|NCT01231581|62680748|FG000|Overall Study|Ongoing|1|||
33305189|NCT01231581|62680749|FG001|Overall Study|Ongoing|0|||
33305190|NCT01050634|62680755|FG000|Overall Study|Enrolled, but Not Treated|56|||
33305191|NCT01050634|62680755|FG000|Overall Study|Death|2|||
33305192|NCT01050634|62680755|FG000|Overall Study|Adverse Event|42|||
33305193|NCT01050634|62680755|FG000|Overall Study|Lost to Follow-up|2|||
33305194|NCT01050634|62680755|FG000|Overall Study|Other|21|||
33305195|NCT01050634|62680755|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
33305196|NCT01020526|62680759|FG000|Overall Study|Withdrawal by Subject|5|||
33305197|NCT01020526|62680759|FG000|Overall Study|Other reasons|3|||
33305198|NCT01020526|62680759|FG000|Overall Study|Insufficient clinical response|3|||
33305199|NCT01020526|62680759|FG000|Overall Study|Lost to Follow-up|1|||
33305200|NCT01020526|62680759|FG000|Overall Study|Adverse Event|2|||
33305201|NCT01020448|62680763|FG000|Pre-assignment|Adverse Event|6|||
33305202|NCT01020448|62680763|FG000|Pre-assignment|Withdrawal by Subject|5|||
33305203|NCT01020448|62680763|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
33305204|NCT01020448|62680763|FG000|Treatment|Adverse Event|11|||
33305205|NCT01020448|62680763|FG000|Treatment|Consent Withdrawn|3|||
33305206|NCT01020448|62680763|FG000|Treatment|Disease Progression|2|||
33305207|NCT01020448|62680763|FG000|Treatment|Lack of Efficacy|8|||
33305208|NCT01020448|62680763|FG000|Treatment|Lost to Follow-up|2|||
33305209|NCT01256658|62680770|FG000|Period 1|Lost to Follow-up|837|||
33305210|NCT01256658|62680771|FG001|Period 1|Lost to Follow-up|661|||
33305211|NCT01256658|62680770|FG000|Period 1|Withdrawal by Subject|35|||
33305212|NCT01256658|62680771|FG001|Period 1|Withdrawal by Subject|43|||
33305213|NCT01256658|62680770|FG000|Period 1|Death|48|||
33305214|NCT01256658|62680771|FG001|Period 1|Death|44|||
33305215|NCT01256502|62680780|FG000|Overall Study|Had scaffold removed|4|||
33305216|NCT01256502|62680780|FG000|Overall Study|Personal reasons|5|||
33305217|NCT01256502|62680780|FG000|Overall Study|Protocol deviation|1|||
33305218|NCT01256190|62680791|FG000|Overall Study|Lost to Follow-up|2|||
33305219|NCT01256190|62680792|FG001|Overall Study|Lost to Follow-up|0|||
33305220|NCT01255722|62680801|FG000|Overall Study|Adverse Event|0|||
33305221|NCT01255722|62680802|FG001|Overall Study|Adverse Event|1|||
33305222|NCT01255722|62680803|FG002|Overall Study|Adverse Event|1|||
33305223|NCT01255722|62680801|FG000|Overall Study|asymptomatic patient|1|||
33305224|NCT01255722|62680802|FG001|Overall Study|asymptomatic patient|0|||
33305225|NCT01255722|62680803|FG002|Overall Study|asymptomatic patient|0|||
33305226|NCT01255722|62680801|FG000|Overall Study|beta-blocker contraindicated|2|||
33305227|NCT01255722|62680802|FG001|Overall Study|beta-blocker contraindicated|0|||
33305228|NCT01255722|62680803|FG002|Overall Study|beta-blocker contraindicated|0|||
33305229|NCT01231503|62680820|FG000|Overall Study|Adverse Event|0|||
33305230|NCT01231503|62680821|FG001|Overall Study|Adverse Event|0|||
33305231|NCT01231503|62680822|FG002|Overall Study|Adverse Event|0|||
33305232|NCT01231503|62680823|FG003|Overall Study|Adverse Event|0|||
33305233|NCT01231503|62680824|FG004|Overall Study|Adverse Event|0|||
33305234|NCT01231503|62680825|FG005|Overall Study|Adverse Event|1|||
33305235|NCT01231503|62680826|FG006|Overall Study|Adverse Event|0|||
33305236|NCT01231503|62680827|FG007|Overall Study|Adverse Event|0|||
33305237|NCT01231503|62680820|FG000|Overall Study|Adverse event, serious fatal|0|||
33305238|NCT01231503|62680821|FG001|Overall Study|Adverse event, serious fatal|0|||
33305239|NCT01231503|62680822|FG002|Overall Study|Adverse event, serious fatal|1|||
33305240|NCT01231503|62680823|FG003|Overall Study|Adverse event, serious fatal|1|||
33305241|NCT01231503|62680824|FG004|Overall Study|Adverse event, serious fatal|0|||
33305242|NCT01231503|62680825|FG005|Overall Study|Adverse event, serious fatal|1|||
33305243|NCT01231503|62680826|FG006|Overall Study|Adverse event, serious fatal|0|||
33305244|NCT01231503|62680827|FG007|Overall Study|Adverse event, serious fatal|0|||
33305245|NCT01231503|62680820|FG000|Overall Study|Withdrawal by Subject|6|||
33305246|NCT01231503|62680821|FG001|Overall Study|Withdrawal by Subject|3|||
33305247|NCT01231503|62680822|FG002|Overall Study|Withdrawal by Subject|3|||
33305248|NCT01231503|62680823|FG003|Overall Study|Withdrawal by Subject|1|||
33305249|NCT01231503|62680824|FG004|Overall Study|Withdrawal by Subject|3|||
33305250|NCT01231503|62680825|FG005|Overall Study|Withdrawal by Subject|5|||
33305251|NCT01231503|62680826|FG006|Overall Study|Withdrawal by Subject|1|||
33305252|NCT01231503|62680827|FG007|Overall Study|Withdrawal by Subject|2|||
33305253|NCT01231503|62680820|FG000|Overall Study|Lost to Follow-up|8|||
33305254|NCT01231503|62680821|FG001|Overall Study|Lost to Follow-up|10|||
33305255|NCT01231503|62680822|FG002|Overall Study|Lost to Follow-up|8|||
33305256|NCT01231503|62680823|FG003|Overall Study|Lost to Follow-up|5|||
33397857|NCT00529516|62777194|FG002|Overall Study|Lost to Follow-up|1|||
33305257|NCT01231503|62680824|FG004|Overall Study|Lost to Follow-up|7|||
33305258|NCT01231503|62680825|FG005|Overall Study|Lost to Follow-up|9|||
33305259|NCT01231503|62680826|FG006|Overall Study|Lost to Follow-up|6|||
33305260|NCT01231503|62680827|FG007|Overall Study|Lost to Follow-up|6|||
33397858|NCT00316693|62777204|FG000|Overall Study|Adverse Event|6|||
33305261|NCT01231503|62680820|FG000|Overall Study|Protocol Violation|0|||
33305262|NCT01231503|62680821|FG001|Overall Study|Protocol Violation|0|||
33305263|NCT01231503|62680822|FG002|Overall Study|Protocol Violation|0|||
33305264|NCT01231503|62680823|FG003|Overall Study|Protocol Violation|1|||
33305265|NCT01231503|62680824|FG004|Overall Study|Protocol Violation|0|||
33305266|NCT01231503|62680825|FG005|Overall Study|Protocol Violation|0|||
33305267|NCT01231503|62680826|FG006|Overall Study|Protocol Violation|0|||
33305268|NCT01231503|62680827|FG007|Overall Study|Protocol Violation|0|||
33305269|NCT01230489|62680855|FG000|Overall Study|Death|2|||
33305270|NCT01230489|62680855|FG000|Overall Study|Adverse Event|2|||
33305271|NCT01230489|62680855|FG000|Overall Study|Treatment modality changed|1|||
33305272|NCT01229397|62680861|FG000|Overall Study|Withdrawal by Subject|3|||
33305273|NCT01229397|62680862|FG001|Overall Study|Withdrawal by Subject|3|||
33305274|NCT01229397|62680861|FG000|Overall Study|Lost to Follow-up|7|||
33305275|NCT01229397|62680862|FG001|Overall Study|Lost to Follow-up|6|||
33305276|NCT01229397|62680861|FG000|Overall Study|Migrated/moved from study area|1|||
33305277|NCT01229397|62680862|FG001|Overall Study|Migrated/moved from study area|0|||
33305278|NCT01228071|62680872|FG000|Overall Study|Protocol Violation|1|||
33305279|NCT01228071|62680872|FG000|Overall Study|Withdrawal by Subject|1|||
33305280|NCT01008475|62680883|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
33305281|NCT01008475|62680884|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
33305282|NCT01008475|62680885|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
33305283|NCT01008475|62680886|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
33305284|NCT01008475|62680887|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
33305285|NCT01008475|62680888|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
33305286|NCT01008475|62680889|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
33305287|NCT01226745|62680911|FG000|Overall Study|Did not complete schedule of assessments|8|||
33305288|NCT01226745|62680912|FG001|Overall Study|Did not complete schedule of assessments|3|||
33305289|NCT01226745|62680913|FG002|Overall Study|Did not complete schedule of assessments|6|||
33305290|NCT01226745|62680914|FG003|Overall Study|Did not complete schedule of assessments|0|||
33305291|NCT01226745|62680915|FG004|Overall Study|Did not complete schedule of assessments|0|||
33305292|NCT01226745|62680916|FG005|Overall Study|Did not complete schedule of assessments|1|||
33305293|NCT01226745|62680911|FG000|Overall Study|Lost to Follow-up|2|||
33305294|NCT01226745|62680912|FG001|Overall Study|Lost to Follow-up|6|||
33305295|NCT01226745|62680913|FG002|Overall Study|Lost to Follow-up|6|||
33305296|NCT01226745|62680914|FG003|Overall Study|Lost to Follow-up|1|||
33305297|NCT01226745|62680915|FG004|Overall Study|Lost to Follow-up|1|||
33305298|NCT01226745|62680916|FG005|Overall Study|Lost to Follow-up|2|||
33305299|NCT01226745|62680911|FG000|Overall Study|Death|1|||
33305300|NCT01226745|62680912|FG001|Overall Study|Death|0|||
33305301|NCT01226745|62680913|FG002|Overall Study|Death|0|||
33305302|NCT01226745|62680914|FG003|Overall Study|Death|0|||
33305303|NCT01226745|62680915|FG004|Overall Study|Death|0|||
33305304|NCT01226745|62680916|FG005|Overall Study|Death|1|||
33305305|NCT01226745|62680911|FG000|Overall Study|Other|6|||
33305306|NCT01226745|62680912|FG001|Overall Study|Other|7|||
33305307|NCT01226745|62680913|FG002|Overall Study|Other|8|||
33305308|NCT01226745|62680914|FG003|Overall Study|Other|4|||
33305309|NCT01226745|62680915|FG004|Overall Study|Other|3|||
33305310|NCT01226745|62680916|FG005|Overall Study|Other|1|||
33305311|NCT01226511|62680933|FG000|Acute Treatment Period|Adverse Event|7|||
33305312|NCT01226511|62680934|FG001|Acute Treatment Period|Adverse Event|6|||
33305313|NCT01226511|62680933|FG000|Acute Treatment Period|Lack of Efficacy|2|||
33305314|NCT01226511|62680934|FG001|Acute Treatment Period|Lack of Efficacy|1|||
33305315|NCT01226511|62680933|FG000|Acute Treatment Period|Lost to Follow-up|3|||
33305316|NCT01226511|62680934|FG001|Acute Treatment Period|Lost to Follow-up|6|||
33305317|NCT01226511|62680933|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
33305318|NCT01226511|62680934|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
33305319|NCT01226511|62680933|FG000|Acute Treatment Period|Protocol Violation|5|||
33305320|NCT01226511|62680934|FG001|Acute Treatment Period|Protocol Violation|5|||
33305321|NCT01226511|62680933|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
33305322|NCT01226511|62680934|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
33305323|NCT01226511|62680933|FG000|Extension Treatment Period|Adverse Event|8|||
33305324|NCT01226511|62680934|FG001|Extension Treatment Period|Adverse Event|8|||
33305325|NCT01226511|62680933|FG000|Extension Treatment Period|Lack of Efficacy|3|||
33305326|NCT01226511|62680934|FG001|Extension Treatment Period|Lack of Efficacy|2|||
33305327|NCT01226511|62680933|FG000|Extension Treatment Period|Lost to Follow-up|4|||
33665625|NCT02754141|63097750|FG015|Overall Study|Withdrew consent|0|||
33305328|NCT01226511|62680934|FG001|Extension Treatment Period|Lost to Follow-up|3|||
33305329|NCT01226511|62680933|FG000|Extension Treatment Period|Protocol Violation|2|||
33305330|NCT01226511|62680934|FG001|Extension Treatment Period|Protocol Violation|2|||
33397859|NCT00316693|62777205|FG001|Overall Study|Adverse Event|1|||
33305331|NCT01226511|62680933|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
33305332|NCT01226511|62680934|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
33305333|NCT01226511|62680933|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
33305334|NCT01226511|62680934|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
33305335|NCT01226511|62680933|FG000|Extension Treatment Period|Sponsor Decision|1|||
33305336|NCT01226511|62680934|FG001|Extension Treatment Period|Sponsor Decision|1|||
33305337|NCT01226511|62680933|FG000|Taper Period|Adverse Event|1|||
33305338|NCT01226511|62680934|FG001|Taper Period|Adverse Event|0|||
33305339|NCT01226511|62680933|FG000|Taper Period|Lost to Follow-up|2|||
33305340|NCT01226511|62680934|FG001|Taper Period|Lost to Follow-up|2|||
33305341|NCT01226511|62680933|FG000|Taper Period|Protocol Violation|1|||
33305342|NCT01226511|62680934|FG001|Taper Period|Protocol Violation|0|||
33305343|NCT01226511|62680933|FG000|Taper Period|Parent/Caregiver Decision|1|||
33305344|NCT01226511|62680934|FG001|Taper Period|Parent/Caregiver Decision|1|||
33305345|NCT01226121|62680949|FG000|Overall Study|Lost to Follow-up|2|||
33305346|NCT01226121|62680950|FG001|Overall Study|Lost to Follow-up|0|||
33305347|NCT01226121|62680951|FG002|Overall Study|Lost to Follow-up|1|||
33305348|NCT01226043|62680961|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
33305349|NCT01226043|62680962|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
33305350|NCT01226043|62680963|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
33305351|NCT01226043|62680964|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
33305352|NCT01226043|62680961|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
33305353|NCT01226043|62680962|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
33305354|NCT01226043|62680963|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
33305355|NCT01226043|62680964|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
33305356|NCT01226043|62680961|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
33305357|NCT01226043|62680962|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
33305358|NCT01226043|62680963|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
33305359|NCT01226043|62680964|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
33305360|NCT01226043|62680961|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
33305361|NCT01226043|62680962|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
33305362|NCT01226043|62680963|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
33305363|NCT01226043|62680964|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
33305364|NCT01226043|62680961|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
33305365|NCT01226043|62680962|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
33305366|NCT01226043|62680963|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
33305367|NCT01226043|62680964|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
33305368|NCT01226043|62680961|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
33305369|NCT01226043|62680962|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
33305370|NCT01226043|62680963|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
33305371|NCT01226043|62680964|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
33305372|NCT01226043|62680961|FG000|6-week Re-randomization Phase|Adverse Event|0|||
33305373|NCT01226043|62680962|FG001|6-week Re-randomization Phase|Adverse Event|0|||
33305374|NCT01226043|62680963|FG002|6-week Re-randomization Phase|Adverse Event|1|||
33305375|NCT01226043|62680964|FG003|6-week Re-randomization Phase|Adverse Event|1|||
33305376|NCT01226043|62680961|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
33305377|NCT01226043|62680962|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
33305378|NCT01226043|62680963|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
33305379|NCT01226043|62680964|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
33305380|NCT01226043|62680961|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
33305381|NCT01226043|62680962|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
33305382|NCT01226043|62680963|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
33305383|NCT01226043|62680964|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
33305384|NCT01226043|62680961|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
33305385|NCT01226043|62680962|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
33305386|NCT01226043|62680963|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
33305387|NCT01226043|62680964|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
33305388|NCT01226043|62680961|FG000|6-week Re-randomization Phase|Physician Decision|0|||
33305389|NCT01226043|62680962|FG001|6-week Re-randomization Phase|Physician Decision|0|||
33305390|NCT01226043|62680963|FG002|6-week Re-randomization Phase|Physician Decision|3|||
33305391|NCT01226043|62680964|FG003|6-week Re-randomization Phase|Physician Decision|2|||
33305392|NCT01226043|62680961|FG000|6-week Re-randomization Phase|completed in error|0|||
33305393|NCT01226043|62680962|FG001|6-week Re-randomization Phase|completed in error|0|||
33305394|NCT01226043|62680963|FG002|6-week Re-randomization Phase|completed in error|0|||
33305395|NCT01226043|62680964|FG003|6-week Re-randomization Phase|completed in error|1|||
33305396|NCT01226043|62680961|FG000|30-week Observational Phase|Adverse Event|0|||
33305397|NCT01226043|62680962|FG001|30-week Observational Phase|Adverse Event|0|||
33305398|NCT01226043|62680963|FG002|30-week Observational Phase|Adverse Event|1|||
33305399|NCT01226043|62680964|FG003|30-week Observational Phase|Adverse Event|1|||
33305400|NCT01226043|62680961|FG000|30-week Observational Phase|Protocol Violation|0|||
33305401|NCT01226043|62680962|FG001|30-week Observational Phase|Protocol Violation|0|||
33305402|NCT01226043|62680963|FG002|30-week Observational Phase|Protocol Violation|0|||
33305403|NCT01226043|62680964|FG003|30-week Observational Phase|Protocol Violation|1|||
33305404|NCT01226043|62680961|FG000|30-week Observational Phase|Lost to Follow-up|0|||
33305405|NCT01226043|62680962|FG001|30-week Observational Phase|Lost to Follow-up|0|||
33305406|NCT01226043|62680963|FG002|30-week Observational Phase|Lost to Follow-up|2|||
33305407|NCT01226043|62680964|FG003|30-week Observational Phase|Lost to Follow-up|2|||
33305408|NCT01226043|62680961|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
33305409|NCT01226043|62680962|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
33305410|NCT01226043|62680963|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
33305411|NCT01226043|62680964|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
33305412|NCT01226043|62680961|FG000|30-week Observational Phase|Physician Decision|0|||
33305413|NCT01226043|62680962|FG001|30-week Observational Phase|Physician Decision|0|||
33305414|NCT01226043|62680963|FG002|30-week Observational Phase|Physician Decision|2|||
33305415|NCT01226043|62680964|FG003|30-week Observational Phase|Physician Decision|2|||
33305416|NCT01001377|62680996|FG000|Overall Study|Ineligibility determined|2|||
33305417|NCT01001377|62680997|FG001|Overall Study|Ineligibility determined|0|||
33305418|NCT01001377|62680996|FG000|Overall Study|Withdrawal by Subject|19|||
33305419|NCT01001377|62680997|FG001|Overall Study|Withdrawal by Subject|20|||
33305420|NCT01001377|62680996|FG000|Overall Study|Lost to Follow-up|14|||
33305421|NCT01001377|62680997|FG001|Overall Study|Lost to Follow-up|17|||
33305422|NCT01001377|62680996|FG000|Overall Study|Death|391|||
33305423|NCT01001377|62680997|FG001|Overall Study|Death|384|||
33305424|NCT01225887|62681003|FG000|Overall Study|Ineligible:required test not done|2|||
33305425|NCT01225887|62681003|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
33305426|NCT01225887|62681003|FG000|Overall Study|Ineligible:inadequate pathology|2|||
33305427|NCT01001299|62681007|FG000|Overall Study|Insufficient Therapeutic Response|20|||
33305428|NCT01001299|62681007|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
33305429|NCT01001299|62681007|FG000|Overall Study|Death|1|||
33305430|NCT01001299|62681007|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
33305431|NCT01001299|62681007|FG000|Overall Study|Withdrew Consent|1|||
33305432|NCT01296932|62681020|FG000|Overall Study|Dose limiting toxicity|0|||
33305433|NCT01296932|62681021|FG001|Overall Study|Dose limiting toxicity|0|||
33305434|NCT01296932|62681022|FG002|Overall Study|Dose limiting toxicity|0|||
33305435|NCT01296932|62681023|FG003|Overall Study|Dose limiting toxicity|0|||
33305436|NCT01296932|62681024|FG004|Overall Study|Dose limiting toxicity|0|||
33305437|NCT01296932|62681025|FG005|Overall Study|Dose limiting toxicity|0|||
33305438|NCT01296932|62681026|FG006|Overall Study|Dose limiting toxicity|1|||
33305439|NCT01296932|62681027|FG007|Overall Study|Dose limiting toxicity|0|||
33305440|NCT01296932|62681028|FG008|Overall Study|Dose limiting toxicity|1|||
33305441|NCT01296932|62681020|FG000|Overall Study|Progressive disease|2|||
33305442|NCT01296932|62681021|FG001|Overall Study|Progressive disease|0|||
33305443|NCT01296932|62681022|FG002|Overall Study|Progressive disease|1|||
33305444|NCT01296932|62681023|FG003|Overall Study|Progressive disease|1|||
33305445|NCT01296932|62681024|FG004|Overall Study|Progressive disease|2|||
33305446|NCT01296932|62681025|FG005|Overall Study|Progressive disease|3|||
33305447|NCT01296932|62681026|FG006|Overall Study|Progressive disease|1|||
33305448|NCT01296932|62681027|FG007|Overall Study|Progressive disease|0|||
33305449|NCT01296932|62681028|FG008|Overall Study|Progressive disease|0|||
33305450|NCT01296932|62681020|FG000|Overall Study|Withdrawal by Subject|0|||
33305451|NCT01296932|62681021|FG001|Overall Study|Withdrawal by Subject|0|||
33305452|NCT01296932|62681022|FG002|Overall Study|Withdrawal by Subject|1|||
33305453|NCT01296932|62681023|FG003|Overall Study|Withdrawal by Subject|1|||
33305454|NCT01296932|62681024|FG004|Overall Study|Withdrawal by Subject|0|||
33305455|NCT01296932|62681025|FG005|Overall Study|Withdrawal by Subject|0|||
33305456|NCT01296932|62681026|FG006|Overall Study|Withdrawal by Subject|3|||
33305457|NCT01296932|62681027|FG007|Overall Study|Withdrawal by Subject|0|||
33305458|NCT01296932|62681028|FG008|Overall Study|Withdrawal by Subject|0|||
33305459|NCT01296932|62681020|FG000|Overall Study|Adverse Event|1|||
33305460|NCT01296932|62681021|FG001|Overall Study|Adverse Event|1|||
33305461|NCT01296932|62681022|FG002|Overall Study|Adverse Event|1|||
33305462|NCT01296932|62681023|FG003|Overall Study|Adverse Event|2|||
33305463|NCT01296932|62681024|FG004|Overall Study|Adverse Event|1|||
33305464|NCT01296932|62681025|FG005|Overall Study|Adverse Event|0|||
33305465|NCT01296932|62681026|FG006|Overall Study|Adverse Event|0|||
33305466|NCT01296932|62681027|FG007|Overall Study|Adverse Event|0|||
33305467|NCT01296932|62681028|FG008|Overall Study|Adverse Event|1|||
33305468|NCT01296932|62681020|FG000|Overall Study|Investigator decision|0|||
33305469|NCT01296932|62681021|FG001|Overall Study|Investigator decision|1|||
33305470|NCT01296932|62681022|FG002|Overall Study|Investigator decision|0|||
33305471|NCT01296932|62681023|FG003|Overall Study|Investigator decision|1|||
33305472|NCT01296932|62681024|FG004|Overall Study|Investigator decision|0|||
33305473|NCT01296932|62681025|FG005|Overall Study|Investigator decision|0|||
33305474|NCT01296932|62681026|FG006|Overall Study|Investigator decision|1|||
33305475|NCT01296932|62681027|FG007|Overall Study|Investigator decision|0|||
33305476|NCT01296932|62681028|FG008|Overall Study|Investigator decision|1|||
33305477|NCT01296932|62681020|FG000|Overall Study|No clinical benefit anymore|0|||
33305478|NCT01296932|62681021|FG001|Overall Study|No clinical benefit anymore|1|||
33305479|NCT01296932|62681022|FG002|Overall Study|No clinical benefit anymore|0|||
33305480|NCT01296932|62681023|FG003|Overall Study|No clinical benefit anymore|0|||
33305481|NCT01296932|62681024|FG004|Overall Study|No clinical benefit anymore|0|||
33305482|NCT01296932|62681025|FG005|Overall Study|No clinical benefit anymore|0|||
33305483|NCT01296932|62681026|FG006|Overall Study|No clinical benefit anymore|0|||
33305484|NCT01296932|62681027|FG007|Overall Study|No clinical benefit anymore|0|||
33305485|NCT01296932|62681028|FG008|Overall Study|No clinical benefit anymore|0|||
33305486|NCT01296932|62681020|FG000|Overall Study|Physician Decision|0|||
33305487|NCT01296932|62681021|FG001|Overall Study|Physician Decision|0|||
33305488|NCT01296932|62681022|FG002|Overall Study|Physician Decision|1|||
33305489|NCT01296932|62681023|FG003|Overall Study|Physician Decision|0|||
33305490|NCT01296932|62681024|FG004|Overall Study|Physician Decision|0|||
33305491|NCT01296932|62681025|FG005|Overall Study|Physician Decision|0|||
33305492|NCT01296932|62681026|FG006|Overall Study|Physician Decision|0|||
33305493|NCT01296932|62681027|FG007|Overall Study|Physician Decision|0|||
33305494|NCT01296932|62681028|FG008|Overall Study|Physician Decision|0|||
33305495|NCT01296932|62681020|FG000|Overall Study|IV problems, administration not possible|0|||
33397860|NCT00316693|62777204|FG000|Overall Study|Protocol Violation|1|||
33397861|NCT00316693|62777205|FG001|Overall Study|Protocol Violation|0|||
33397862|NCT00316693|62777204|FG000|Overall Study|Withdrawal by Subject|6|||
33397863|NCT00316693|62777205|FG001|Overall Study|Withdrawal by Subject|6|||
33397864|NCT00316693|62777204|FG000|Overall Study|Lost to Follow-up|26|||
33397865|NCT00316693|62777205|FG001|Overall Study|Lost to Follow-up|34|||
33397866|NCT00316693|62777204|FG000|Overall Study|Other|38|||
33397867|NCT00316693|62777205|FG001|Overall Study|Other|44|||
33397868|NCT00316303|62777213|FG000|Overall Study|Lost to Follow-up|11|||
33397869|NCT00316303|62777214|FG001|Overall Study|Lost to Follow-up|16|||
33397870|NCT00760877|62777225|FG000|Overall Study|Protocol Violation|1|||
33397871|NCT00760877|62777226|FG001|Overall Study|Protocol Violation|0|||
33397872|NCT00760877|62777225|FG000|Overall Study|Non-compliance with protocol treatment|2|||
33397873|NCT00760877|62777226|FG001|Overall Study|Non-compliance with protocol treatment|1|||
33397874|NCT00760877|62777225|FG000|Overall Study|Pregnancy|1|||
33397875|NCT00760877|62777226|FG001|Overall Study|Pregnancy|4|||
33397876|NCT00760877|62777225|FG000|Overall Study|Death|2|||
33397877|NCT00760877|62777226|FG001|Overall Study|Death|1|||
33397878|NCT00760877|62777225|FG000|Overall Study|Withdrawal by Subject|7|||
33397879|NCT00760877|62777226|FG001|Overall Study|Withdrawal by Subject|3|||
33397880|NCT00760877|62777225|FG000|Overall Study|Adverse Event|19|||
33397881|NCT00760877|62777226|FG001|Overall Study|Adverse Event|12|||
33397882|NCT00760877|62777225|FG000|Overall Study|Participant diagnosed with AML|0|||
33397883|NCT00760877|62777226|FG001|Overall Study|Participant diagnosed with AML|1|||
33397884|NCT00760877|62777225|FG000|Overall Study|Participant not eligible to cross-over|0|||
33397885|NCT00760877|62777226|FG001|Overall Study|Participant not eligible to cross-over|1|||
33397886|NCT00760877|62777225|FG000|Overall Study|Physician Decision|1|||
33397887|NCT00760877|62777226|FG001|Overall Study|Physician Decision|2|||
33397888|NCT00760877|62777225|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
33397889|NCT00760877|62777226|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
33397890|NCT00760877|62777225|FG000|Overall Study|Treatment failure|1|||
33397891|NCT00760877|62777226|FG001|Overall Study|Treatment failure|0|||
33397892|NCT00302731|62777237|FG000|Overall Study|Lost to Follow-up|1|||
33397893|NCT00302731|62777238|FG001|Overall Study|Lost to Follow-up|2|||
33397894|NCT00302731|62777239|FG002|Overall Study|Lost to Follow-up|0|||
33397895|NCT00302731|62777240|FG003|Overall Study|Lost to Follow-up|0|||
33397896|NCT00302731|62777237|FG000|Overall Study|Adverse Event|0|||
33397897|NCT00302731|62777238|FG001|Overall Study|Adverse Event|2|||
33397898|NCT00302731|62777239|FG002|Overall Study|Adverse Event|2|||
33397899|NCT00302731|62777240|FG003|Overall Study|Adverse Event|0|||
33397900|NCT00302731|62777237|FG000|Overall Study|Withdrawal by Subject|1|||
33397901|NCT00302731|62777238|FG001|Overall Study|Withdrawal by Subject|1|||
33397902|NCT00302731|62777239|FG002|Overall Study|Withdrawal by Subject|0|||
33397903|NCT00302731|62777240|FG003|Overall Study|Withdrawal by Subject|0|||
33665626|NCT02754141|63097751|FG016|Overall Study|Withdrew consent|0|||
33665627|NCT02754141|63097752|FG017|Overall Study|Withdrew consent|0|||
33305496|NCT01296932|62681021|FG001|Overall Study|IV problems, administration not possible|0|||
33305497|NCT01296932|62681022|FG002|Overall Study|IV problems, administration not possible|1|||
33305498|NCT01296932|62681023|FG003|Overall Study|IV problems, administration not possible|0|||
33305499|NCT01296932|62681024|FG004|Overall Study|IV problems, administration not possible|0|||
33305500|NCT01296932|62681025|FG005|Overall Study|IV problems, administration not possible|0|||
33305501|NCT01296932|62681026|FG006|Overall Study|IV problems, administration not possible|0|||
33305502|NCT01296932|62681027|FG007|Overall Study|IV problems, administration not possible|0|||
33397904|NCT00302731|62777237|FG000|Overall Study|Protocol Violation|1|||
33397905|NCT00302731|62777238|FG001|Overall Study|Protocol Violation|0|||
33397906|NCT00302731|62777239|FG002|Overall Study|Protocol Violation|0|||
33397907|NCT00302731|62777240|FG003|Overall Study|Protocol Violation|0|||
33397908|NCT00302731|62777237|FG000|Overall Study|cancer unrelated to study discovered|1|||
33397909|NCT00302731|62777238|FG001|Overall Study|cancer unrelated to study discovered|0|||
33397910|NCT00302731|62777239|FG002|Overall Study|cancer unrelated to study discovered|1|||
33397911|NCT00302731|62777240|FG003|Overall Study|cancer unrelated to study discovered|0|||
33397912|NCT00780143|62777250|FG000|Overall Study|Progressive disease|1|||
33397913|NCT00780143|62777250|FG000|Overall Study|Toxicity|1|||
33397914|NCT00780143|62777250|FG000|Overall Study|Adverse Event|1|||
33397915|NCT00779909|62777258|FG000|Overall Study|Lost to Follow-up|1|||
33397916|NCT00779909|62777259|FG001|Overall Study|Lost to Follow-up|0|||
33397917|NCT00779909|62777260|FG002|Overall Study|Lost to Follow-up|0|||
33397918|NCT00779909|62777261|FG003|Overall Study|Lost to Follow-up|1|||
33397919|NCT00779909|62777258|FG000|Overall Study|Withdrawal by Subject|0|||
33397920|NCT00779909|62777259|FG001|Overall Study|Withdrawal by Subject|1|||
33397921|NCT00779909|62777260|FG002|Overall Study|Withdrawal by Subject|0|||
33397922|NCT00779909|62777261|FG003|Overall Study|Withdrawal by Subject|0|||
33397923|NCT00302107|62777280|FG000|Overall Study|Lost to Follow-up|6|||
33397924|NCT00302107|62777281|FG001|Overall Study|Lost to Follow-up|5|||
33397925|NCT00302107|62777280|FG000|Overall Study|Protocol Violation|1|||
33397926|NCT00302107|62777281|FG001|Overall Study|Protocol Violation|0|||
33397927|NCT00302107|62777280|FG000|Overall Study|Relocation|0|||
33397928|NCT00302107|62777281|FG001|Overall Study|Relocation|1|||
33397929|NCT00302107|62777280|FG000|Overall Study|Withdrawal by Subject|0|||
33397930|NCT00302107|62777281|FG001|Overall Study|Withdrawal by Subject|3|||
33397931|NCT00302107|62777280|FG000|Overall Study|Adverse Event|1|||
33397932|NCT00302107|62777281|FG001|Overall Study|Adverse Event|0|||
33397933|NCT00760487|62777287|FG000|Overall Study|Unilateral implantation|3|||
33397934|NCT00316225|62777291|FG000|Overall Study|Adverse Event|2|||
33397935|NCT00316225|62777291|FG000|Overall Study|Physician Decision|3|||
33397936|NCT00316225|62777291|FG000|Overall Study|Progressive Disease|15|||
33397937|NCT00316225|62777291|FG000|Overall Study|Withdrawal by Subject|3|||
33397938|NCT00316225|62777291|FG000|Overall Study|Death|2|||
33397939|NCT00586703|62777295|FG000|Overall Study|Death|12|||
33397940|NCT00586625|62777301|FG000|Overall Study|Adverse Event|6|||
33397941|NCT00586625|62777302|FG001|Overall Study|Adverse Event|6|||
33397942|NCT00586625|62777301|FG000|Overall Study|Protocol Violation|3|||
33397943|NCT00586625|62777302|FG001|Overall Study|Protocol Violation|0|||
33397944|NCT00586625|62777301|FG000|Overall Study|Withdrawal by Subject|32|||
33397945|NCT00586625|62777302|FG001|Overall Study|Withdrawal by Subject|10|||
33397946|NCT00586625|62777301|FG000|Overall Study|Subject non-compliance|0|||
33397947|NCT00586625|62777302|FG001|Overall Study|Subject non-compliance|1|||
33397948|NCT00586625|62777301|FG000|Overall Study|Subject unable to return for visit|2|||
33397949|NCT00586625|62777302|FG001|Overall Study|Subject unable to return for visit|0|||
33397950|NCT00636168|62777310|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
33397951|NCT00636168|62777311|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
33397952|NCT00636168|62777310|FG000|Randomized to Study Drug|Adverse Event|1|||
33397953|NCT00636168|62777311|FG001|Randomized to Study Drug|Adverse Event|0|||
33397954|NCT00636168|62777310|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
33397955|NCT00636168|62777311|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
33397956|NCT00636168|62777310|FG000|Treated With Study Drug|Recurrence of disease|135|||
33397957|NCT00636168|62777311|FG001|Treated With Study Drug|Recurrence of disease|282|||
33397958|NCT00636168|62777310|FG000|Treated With Study Drug|Adverse Event|250|||
33397959|NCT00636168|62777311|FG001|Treated With Study Drug|Adverse Event|22|||
33397960|NCT00636168|62777310|FG000|Treated With Study Drug|Participant withdrew consent|16|||
33397961|NCT00636168|62777311|FG001|Treated With Study Drug|Participant withdrew consent|21|||
33397962|NCT00636168|62777310|FG000|Treated With Study Drug|Poor/non-compliance|1|||
33397963|NCT00636168|62777311|FG001|Treated With Study Drug|Poor/non-compliance|3|||
33397964|NCT00636168|62777310|FG000|Treated With Study Drug|Death|3|||
33397965|NCT00636168|62777311|FG001|Treated With Study Drug|Death|0|||
33397966|NCT00636168|62777310|FG000|Treated With Study Drug|Pregnancy|1|||
33397967|NCT00636168|62777311|FG001|Treated With Study Drug|Pregnancy|0|||
33397968|NCT00636168|62777310|FG000|Treated With Study Drug|No longer meets study criteria|1|||
33397969|NCT00636168|62777311|FG001|Treated With Study Drug|No longer meets study criteria|0|||
33397970|NCT00636168|62777310|FG000|Treated With Study Drug|Other reason|1|||
33397971|NCT00636168|62777311|FG001|Treated With Study Drug|Other reason|3|||
33397972|NCT00636168|62777310|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
33397973|NCT00636168|62777311|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
33397974|NCT00636168|62777310|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
33397975|NCT00636168|62777311|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
33397976|NCT00636168|62777310|FG000|Long Term Follow-Up|Death|8|||
33397977|NCT00636168|62777311|FG001|Long Term Follow-Up|Death|9|||
33397978|NCT00759941|62777319|FG000|Overall Study|Use of medication|1|||
33397979|NCT00759941|62777320|FG001|Overall Study|Use of medication|0|||
33397980|NCT00759941|62777319|FG000|Overall Study|Adverse Event|1|||
33397981|NCT00759941|62777320|FG001|Overall Study|Adverse Event|0|||
33397982|NCT00759941|62777319|FG000|Overall Study|Exited in error by site|1|||
33397983|NCT00759941|62777320|FG001|Overall Study|Exited in error by site|1|||
33397984|NCT00528424|62777326|FG000|Overall Study|Lost to Follow-up|13|||
33397985|NCT00528424|62777326|FG000|Overall Study|Withdrew consent|2|||
33397986|NCT00528424|62777326|FG000|Overall Study|Administrative reason|2|||
33397987|NCT00528424|62777326|FG000|Overall Study|Other|12|||
33397988|NCT00315445|62777333|FG000|Overall Study|Adverse Event|7|||
33397989|NCT00315445|62777334|FG001|Overall Study|Adverse Event|12|||
33397990|NCT00315445|62777335|FG002|Overall Study|Adverse Event|15|||
33397991|NCT00315445|62777333|FG000|Overall Study|Lack of Efficacy|16|||
33397992|NCT00315445|62777334|FG001|Overall Study|Lack of Efficacy|1|||
33397993|NCT00315445|62777335|FG002|Overall Study|Lack of Efficacy|7|||
33397994|NCT00315445|62777333|FG000|Overall Study|Lost to Follow-up|1|||
33397995|NCT00315445|62777334|FG001|Overall Study|Lost to Follow-up|0|||
33397996|NCT00315445|62777335|FG002|Overall Study|Lost to Follow-up|1|||
33397997|NCT00315445|62777333|FG000|Overall Study|Protocol Violation|2|||
33397998|NCT00315445|62777334|FG001|Overall Study|Protocol Violation|0|||
33397999|NCT00315445|62777335|FG002|Overall Study|Protocol Violation|1|||
33398000|NCT00315445|62777333|FG000|Overall Study|Other|1|||
33398001|NCT00315445|62777334|FG001|Overall Study|Other|3|||
33398002|NCT00315445|62777335|FG002|Overall Study|Other|0|||
33398003|NCT03687736|62777343|FG000|Overall Study|Lost to Follow-up|7|||
33398004|NCT03687736|62777343|FG000|Overall Study|Withdrawal by Subject|3|||
33398005|NCT00779675|62777349|FG000|Treatment Period|Adverse Event|87|||
33398006|NCT00779675|62777349|FG000|Treatment Period|Treatment Failure|80|||
33398007|NCT00779675|62777349|FG000|Treatment Period|Transferred to Another Study|38|||
33398008|NCT00779675|62777349|FG000|Treatment Period|Lost to Follow-up|23|||
33398009|NCT00779675|62777349|FG000|Treatment Period|Withdrawal by Subject|46|||
33398010|NCT00779675|62777349|FG000|Treatment Period|Protocol Violation|54|||
33398011|NCT00779675|62777349|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
33398012|NCT00779675|62777349|FG000|Treatment Period|Administrative|3|||
33398013|NCT00779675|62777349|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
33398014|NCT00779675|62777349|FG000|Extended Treatment Period|Protocol Violation|13|||
33398015|NCT00779675|62777349|FG000|Extended Treatment Period|Adverse Event|6|||
33398016|NCT00779675|62777349|FG000|Extended Treatment Period|Treatment Failure|11|||
33398017|NCT00779675|62777349|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
33398018|NCT00779675|62777349|FG000|Extended Treatment Period|Lost to Follow-up|6|||
33398019|NCT00759863|62777359|FG000|Overall Study|Death, moved, or lost contact|20|||
33398020|NCT00759863|62777360|FG001|Overall Study|Death, moved, or lost contact|18|||
33398021|NCT00759785|62777368|FG000|Overall Study|Participant sample not evaluable|11|||
33398022|NCT00759785|62777369|FG001|Overall Study|Participant sample not evaluable|2|||
33398023|NCT00759785|62777368|FG000|Overall Study|Participant sample lost|0|||
33398024|NCT00759785|62777369|FG001|Overall Study|Participant sample lost|1|||
33398025|NCT00759785|62777368|FG000|Overall Study|Protocol Violation|1|||
33398026|NCT00759785|62777369|FG001|Overall Study|Protocol Violation|0|||
33398027|NCT00759785|62777368|FG000|Overall Study|Physician Decision|0|||
33398028|NCT00759785|62777369|FG001|Overall Study|Physician Decision|1|||
33398029|NCT00759785|62777368|FG000|Overall Study|Withdrawal by Subject|0|||
33398030|NCT00759785|62777369|FG001|Overall Study|Withdrawal by Subject|1|||
33398031|NCT00300781|62777377|FG000|Overall Study|Disease Progression|55|||
33398032|NCT00300781|62777378|FG001|Overall Study|Disease Progression|52|||
33398033|NCT00300781|62777377|FG000|Overall Study|Adverse Event|5|||
33398034|NCT00300781|62777378|FG001|Overall Study|Adverse Event|6|||
33398035|NCT00300781|62777377|FG000|Overall Study|Withdrawal by Subject|1|||
33398036|NCT00300781|62777378|FG001|Overall Study|Withdrawal by Subject|2|||
33398037|NCT00300781|62777377|FG000|Overall Study|Physician Decision|1|||
33398038|NCT00300781|62777378|FG001|Overall Study|Physician Decision|0|||
33398039|NCT00300781|62777377|FG000|Overall Study|Not Recorded|0|||
33398040|NCT00300781|62777378|FG001|Overall Study|Not Recorded|1|||
33398041|NCT00300781|62777377|FG000|Overall Study|Symptomatic Deterioration|1|||
33398042|NCT00300781|62777378|FG001|Overall Study|Symptomatic Deterioration|0|||
33398043|NCT00300781|62777377|FG000|Overall Study|Lost to Follow-up|0|||
33398044|NCT00300781|62777378|FG001|Overall Study|Lost to Follow-up|1|||
33398045|NCT00315055|62777386|FG000|Overall Study|Protocol Violation|2|||
33398046|NCT00315055|62777387|FG001|Overall Study|Protocol Violation|4|||
33398047|NCT00315055|62777386|FG000|Overall Study|Lost to Follow-up|1|||
33398048|NCT00315055|62777387|FG001|Overall Study|Lost to Follow-up|1|||
33398049|NCT00528970|62777399|FG000|Overall Study|Adverse Event|6|||
33398050|NCT00528970|62777400|FG001|Overall Study|Adverse Event|8|||
33398051|NCT00528970|62777401|FG002|Overall Study|Adverse Event|5|||
33398052|NCT00528970|62777399|FG000|Overall Study|Lost to Follow-up|0|||
33398053|NCT00528970|62777400|FG001|Overall Study|Lost to Follow-up|0|||
33398054|NCT00528970|62777401|FG002|Overall Study|Lost to Follow-up|1|||
33398055|NCT00528970|62777399|FG000|Overall Study|Other than specified|2|||
33398056|NCT00528970|62777400|FG001|Overall Study|Other than specified|3|||
33398057|NCT00528970|62777401|FG002|Overall Study|Other than specified|3|||
33398058|NCT00528970|62777399|FG000|Overall Study|Protocol Violation|2|||
33398059|NCT00528970|62777400|FG001|Overall Study|Protocol Violation|1|||
33398060|NCT00528970|62777401|FG002|Overall Study|Protocol Violation|4|||
33665628|NCT02754141|63097735|FG000|Overall Study|Maximum clinical benefit|0|||
33398061|NCT00528970|62777399|FG000|Overall Study|Lack of Efficacy|0|||
33398062|NCT00528970|62777400|FG001|Overall Study|Lack of Efficacy|0|||
33398063|NCT00528970|62777401|FG002|Overall Study|Lack of Efficacy|1|||
33398064|NCT00528970|62777399|FG000|Overall Study|Withdrawal by Subject|4|||
33398065|NCT00528970|62777400|FG001|Overall Study|Withdrawal by Subject|3|||
33398066|NCT00528970|62777401|FG002|Overall Study|Withdrawal by Subject|5|||
33398067|NCT00528970|62777399|FG000|Overall Study|Randomized but not treated|0|||
33398068|NCT00528970|62777400|FG001|Overall Study|Randomized but not treated|0|||
33398069|NCT00528970|62777401|FG002|Overall Study|Randomized but not treated|1|||
33398070|NCT00759395|62777411|FG000|Overall Study|Adverse Event|1|||
33398071|NCT00759395|62777412|FG001|Overall Study|Adverse Event|0|||
33398072|NCT00759395|62777411|FG000|Overall Study|Withdrawal by Subject|1|||
33398073|NCT00759395|62777412|FG001|Overall Study|Withdrawal by Subject|0|||
33398074|NCT00759395|62777411|FG000|Overall Study|Lack of Efficacy|0|||
33576327|NCT02709655|62972779|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
33576328|NCT02709655|62972780|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
33576329|NCT02709655|62972781|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
33576330|NCT02709655|62972777|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
33576331|NCT02709655|62972778|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
33576332|NCT02709655|62972779|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
33576333|NCT02709655|62972780|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
33576334|NCT02709655|62972781|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
33576335|NCT02709655|62972777|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
33576336|NCT02709655|62972778|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
33576337|NCT02709655|62972779|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
33576338|NCT02709655|62972780|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
33576339|NCT02709655|62972781|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
33576340|NCT02709655|62972777|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
33576341|NCT02709655|62972778|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
33576342|NCT02709655|62972779|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
33576343|NCT02709655|62972780|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
33576344|NCT02709655|62972781|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
33576345|NCT02709655|62972777|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
33576346|NCT02709655|62972778|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
33576347|NCT02709655|62972779|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
33576348|NCT02709655|62972780|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
33576349|NCT02709655|62972781|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
33576350|NCT02709655|62972777|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
33576351|NCT02709655|62972778|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
33576352|NCT02709655|62972779|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
33576353|NCT02709655|62972780|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
33576354|NCT02709655|62972781|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
33576355|NCT02709655|62972777|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
33576356|NCT02709655|62972778|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
33576357|NCT02709655|62972779|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
33576358|NCT02709655|62972780|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
33576359|NCT02709655|62972781|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
33576360|NCT02709655|62972777|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
33576361|NCT02709655|62972778|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
33576362|NCT02709655|62972779|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
33576363|NCT02709655|62972780|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
33305503|NCT01296932|62681028|FG008|Overall Study|IV problems, administration not possible|0|||
33305504|NCT01296932|62681020|FG000|Overall Study|per protocol|0|||
33305505|NCT01296932|62681021|FG001|Overall Study|per protocol|0|||
33305506|NCT01296932|62681022|FG002|Overall Study|per protocol|1|||
33305507|NCT01296932|62681023|FG003|Overall Study|per protocol|1|||
33305508|NCT01296932|62681024|FG004|Overall Study|per protocol|0|||
33305509|NCT01296932|62681025|FG005|Overall Study|per protocol|0|||
33305510|NCT01296932|62681026|FG006|Overall Study|per protocol|0|||
33305511|NCT01296932|62681027|FG007|Overall Study|per protocol|0|||
33305512|NCT01296932|62681028|FG008|Overall Study|per protocol|0|||
33305513|NCT01296932|62681020|FG000|Overall Study|Low benefit and too many side effects|0|||
33305514|NCT01296932|62681021|FG001|Overall Study|Low benefit and too many side effects|0|||
33305515|NCT01296932|62681022|FG002|Overall Study|Low benefit and too many side effects|0|||
33305516|NCT01296932|62681023|FG003|Overall Study|Low benefit and too many side effects|0|||
33305517|NCT01296932|62681024|FG004|Overall Study|Low benefit and too many side effects|0|||
33305518|NCT01296932|62681025|FG005|Overall Study|Low benefit and too many side effects|0|||
33305519|NCT01296932|62681026|FG006|Overall Study|Low benefit and too many side effects|0|||
33305520|NCT01296932|62681027|FG007|Overall Study|Low benefit and too many side effects|1|||
33305521|NCT01296932|62681028|FG008|Overall Study|Low benefit and too many side effects|0|||
33305522|NCT01296932|62681020|FG000|Overall Study|No adequate treatment response|0|||
33398075|NCT00759395|62777412|FG001|Overall Study|Lack of Efficacy|2|||
33576364|NCT02709655|62972781|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
33665629|NCT02754141|63097736|FG001|Overall Study|Maximum clinical benefit|0|||
33576365|NCT02708485|62972795|FG000|Overall Study|Withdrawal by Subject|3|||
33576366|NCT02708485|62972796|FG001|Overall Study|Withdrawal by Subject|2|||
33576367|NCT02709577|62972808|FG000|Overall Study|non-accommodating anatomy|0|||
33576368|NCT02709577|62972809|FG001|Overall Study|non-accommodating anatomy|1|||
33576369|NCT02709577|62972810|FG002|Overall Study|non-accommodating anatomy|0|||
33576370|NCT02709577|62972811|FG003|Overall Study|non-accommodating anatomy|0|||
33576371|NCT02709577|62972808|FG000|Overall Study|procedural complication|0|||
33576372|NCT02709577|62972809|FG001|Overall Study|procedural complication|1|||
33576373|NCT02709577|62972810|FG002|Overall Study|procedural complication|0|||
33576374|NCT02709577|62972811|FG003|Overall Study|procedural complication|0|||
33576375|NCT02709577|62972808|FG000|Overall Study|Withdrawal by Subject|2|||
33576376|NCT02709577|62972809|FG001|Overall Study|Withdrawal by Subject|3|||
33576377|NCT02709577|62972810|FG002|Overall Study|Withdrawal by Subject|2|||
33576378|NCT02709577|62972811|FG003|Overall Study|Withdrawal by Subject|0|||
33576379|NCT02078752|62972832|FG000|Overall Study|Death|0|||
33576380|NCT02078752|62972833|FG001|Overall Study|Death|3|||
33576381|NCT02078752|62972834|FG002|Overall Study|Death|0|||
33576382|NCT02078752|62972835|FG003|Overall Study|Death|0|||
33576383|NCT02078752|62972836|FG004|Overall Study|Death|0|||
33576384|NCT02078752|62972837|FG005|Overall Study|Death|1|||
33576385|NCT02078752|62972838|FG006|Overall Study|Death|0|||
33576386|NCT02078752|62972839|FG007|Overall Study|Death|1|||
33576387|NCT02078752|62972840|FG008|Overall Study|Death|0|||
33576388|NCT02078752|62972841|FG009|Overall Study|Death|4|||
33576389|NCT02078752|62972832|FG000|Overall Study|Lost to Follow-up|1|||
33576390|NCT02078752|62972833|FG001|Overall Study|Lost to Follow-up|0|||
33576391|NCT02078752|62972834|FG002|Overall Study|Lost to Follow-up|0|||
33576392|NCT02078752|62972835|FG003|Overall Study|Lost to Follow-up|1|||
33576393|NCT02078752|62972836|FG004|Overall Study|Lost to Follow-up|0|||
33576394|NCT02078752|62972837|FG005|Overall Study|Lost to Follow-up|0|||
33576395|NCT02078752|62972838|FG006|Overall Study|Lost to Follow-up|0|||
33576396|NCT02078752|62972839|FG007|Overall Study|Lost to Follow-up|0|||
33576397|NCT02078752|62972840|FG008|Overall Study|Lost to Follow-up|0|||
33576398|NCT02078752|62972841|FG009|Overall Study|Lost to Follow-up|0|||
33576399|NCT02078752|62972832|FG000|Overall Study|Withdrawal by Subject|1|||
33576400|NCT02078752|62972833|FG001|Overall Study|Withdrawal by Subject|1|||
33576401|NCT02078752|62972834|FG002|Overall Study|Withdrawal by Subject|1|||
33576402|NCT02078752|62972835|FG003|Overall Study|Withdrawal by Subject|1|||
33576403|NCT02078752|62972836|FG004|Overall Study|Withdrawal by Subject|0|||
33576404|NCT02078752|62972837|FG005|Overall Study|Withdrawal by Subject|3|||
33576405|NCT02078752|62972838|FG006|Overall Study|Withdrawal by Subject|2|||
33576406|NCT02078752|62972839|FG007|Overall Study|Withdrawal by Subject|1|||
33576407|NCT02078752|62972840|FG008|Overall Study|Withdrawal by Subject|0|||
33576408|NCT02078752|62972841|FG009|Overall Study|Withdrawal by Subject|1|||
33576409|NCT02078752|62972832|FG000|Overall Study|Other|0|||
33576410|NCT02078752|62972833|FG001|Overall Study|Other|3|||
33576411|NCT02078752|62972834|FG002|Overall Study|Other|0|||
33576412|NCT02078752|62972835|FG003|Overall Study|Other|0|||
33576413|NCT02078752|62972836|FG004|Overall Study|Other|1|||
33576414|NCT02078752|62972837|FG005|Overall Study|Other|0|||
33576415|NCT02078752|62972838|FG006|Overall Study|Other|0|||
33576416|NCT02078752|62972839|FG007|Overall Study|Other|1|||
33576417|NCT02078752|62972840|FG008|Overall Study|Other|0|||
33576418|NCT02078752|62972841|FG009|Overall Study|Other|0|||
33576419|NCT02078752|62972832|FG000|Overall Study|Study terminated by sponsor|0|||
33576420|NCT02078752|62972833|FG001|Overall Study|Study terminated by sponsor|0|||
33576421|NCT02078752|62972834|FG002|Overall Study|Study terminated by sponsor|0|||
33576422|NCT02078752|62972835|FG003|Overall Study|Study terminated by sponsor|0|||
33576423|NCT02078752|62972836|FG004|Overall Study|Study terminated by sponsor|0|||
33576424|NCT02078752|62972837|FG005|Overall Study|Study terminated by sponsor|0|||
33576425|NCT02078752|62972838|FG006|Overall Study|Study terminated by sponsor|0|||
33576426|NCT02078752|62972839|FG007|Overall Study|Study terminated by sponsor|0|||
33576427|NCT02078752|62972840|FG008|Overall Study|Study terminated by sponsor|0|||
33576428|NCT02078752|62972841|FG009|Overall Study|Study terminated by sponsor|5|||
33576429|NCT02022748|62972874|FG000|Overall Study|Adverse Event|1|||
33576430|NCT02022748|62972875|FG001|Overall Study|Adverse Event|1|||
33576431|NCT02022748|62972876|FG002|Overall Study|Adverse Event|0|||
33576432|NCT02022748|62972874|FG000|Overall Study|Withdrawal by Subject|0|||
33576433|NCT02022748|62972875|FG001|Overall Study|Withdrawal by Subject|1|||
33576434|NCT02022748|62972876|FG002|Overall Study|Withdrawal by Subject|0|||
33576435|NCT02022670|62972887|FG000|Overall Study|Adverse Event|1|||
33576436|NCT02022670|62972888|FG001|Overall Study|Adverse Event|0|||
33576437|NCT02022670|62972889|FG002|Overall Study|Adverse Event|1|||
33576438|NCT02076334|62972902|FG000|Overall Study|Protocol Violation|1|||
33576439|NCT02076334|62972903|FG001|Overall Study|Protocol Violation|0|||
33576440|NCT02076334|62972904|FG002|Overall Study|Protocol Violation|0|||
33576441|NCT02076334|62972905|FG003|Overall Study|Protocol Violation|0|||
33576442|NCT02076334|62972902|FG000|Overall Study|Lost to Follow-up|0|||
33576443|NCT02076334|62972903|FG001|Overall Study|Lost to Follow-up|1|||
33576444|NCT02076334|62972904|FG002|Overall Study|Lost to Follow-up|1|||
33576445|NCT02076334|62972905|FG003|Overall Study|Lost to Follow-up|0|||
33576446|NCT02076334|62972902|FG000|Overall Study|muscle soreness|0|||
33576447|NCT02076334|62972903|FG001|Overall Study|muscle soreness|0|||
33576448|NCT02076334|62972904|FG002|Overall Study|muscle soreness|0|||
33576449|NCT02076334|62972905|FG003|Overall Study|muscle soreness|1|||
33576450|NCT02021812|62972915|FG000|Overall Study|Death|8|||
33576451|NCT02021812|62972915|FG000|Overall Study|Withdrawal by Subject|3|||
33576452|NCT02021812|62972915|FG000|Overall Study|Lost to Follow-up|2|||
33576453|NCT02021812|62972915|FG000|Overall Study|Refuse to return, COVD 19|2|||
33576454|NCT02021656|62972919|FG000|Overall Study|Adverse Event|1|||
33576455|NCT02021656|62972919|FG000|Overall Study|Lack of Efficacy|2|||
33576456|NCT02021656|62972919|FG000|Overall Study|Lost to Follow-up|1|||
33576457|NCT02021656|62972919|FG000|Overall Study|Withdrew Consent|2|||
33576458|NCT02076022|62972929|FG000|Overall Study|Withdrawal by Subject|2|||
33576459|NCT02076022|62972930|FG001|Overall Study|Withdrawal by Subject|0|||
33576460|NCT02075632|62972938|FG000|Overall Study|Adverse Event|1|||
33576461|NCT02075632|62972939|FG001|Overall Study|Adverse Event|1|||
33576462|NCT02075632|62972938|FG000|Overall Study|Lost to Follow-up|0|||
33576463|NCT02075632|62972939|FG001|Overall Study|Lost to Follow-up|3|||
33576464|NCT02075632|62972938|FG000|Overall Study|Withdrawal by Subject|0|||
33576465|NCT02075632|62972939|FG001|Overall Study|Withdrawal by Subject|1|||
33576466|NCT02075554|62972945|FG000|Overall Study|Lost to Follow-up|7|||
33576467|NCT02075554|62972945|FG000|Overall Study|Withdrawal by Subject|5|||
33576468|NCT02075554|62972945|FG000|Overall Study|Physician Decision|3|||
33576469|NCT02075476|62972951|FG000|Overall Study|Death|2|||
33576470|NCT02075476|62972952|FG001|Overall Study|Death|2|||
33576471|NCT02075476|62972951|FG000|Overall Study|Lost to Follow-up|1|||
33576472|NCT02075476|62972952|FG001|Overall Study|Lost to Follow-up|3|||
33576473|NCT02075320|62972958|FG000|Overall Study|Withdrawal by Subject|2|||
33576474|NCT02708095|62972965|FG000|Overall Study|Adverse Event|4|||
33576475|NCT02708095|62972966|FG001|Overall Study|Adverse Event|10|||
33576476|NCT02708095|62972967|FG002|Overall Study|Adverse Event|11|||
33576477|NCT02708095|62972965|FG000|Overall Study|Lack of Efficacy|9|||
33576478|NCT02708095|62972966|FG001|Overall Study|Lack of Efficacy|3|||
33576479|NCT02708095|62972967|FG002|Overall Study|Lack of Efficacy|0|||
33576480|NCT02708095|62972965|FG000|Overall Study|Lost to Follow-up|2|||
33576481|NCT02708095|62972966|FG001|Overall Study|Lost to Follow-up|0|||
33576482|NCT02708095|62972967|FG002|Overall Study|Lost to Follow-up|0|||
33576483|NCT02708095|62972965|FG000|Overall Study|Physician Decision|2|||
33576484|NCT02708095|62972966|FG001|Overall Study|Physician Decision|3|||
33576485|NCT02708095|62972967|FG002|Overall Study|Physician Decision|2|||
33576486|NCT02708095|62972965|FG000|Overall Study|Protocol Violation|0|||
33576487|NCT02708095|62972966|FG001|Overall Study|Protocol Violation|0|||
33576488|NCT02708095|62972967|FG002|Overall Study|Protocol Violation|1|||
33576489|NCT02708095|62972965|FG000|Overall Study|Withdrawal by Subject|5|||
33576490|NCT02708095|62972966|FG001|Overall Study|Withdrawal by Subject|3|||
33576491|NCT02708095|62972967|FG002|Overall Study|Withdrawal by Subject|4|||
33576492|NCT02707861|62972979|FG000|Overall Study|Went onto commercial drug|30|||
33576493|NCT02707861|62972980|FG001|Overall Study|Went onto commercial drug|23|||
33576494|NCT02707861|62972979|FG000|Overall Study|Adverse Event|2|||
33576495|NCT02707861|62972980|FG001|Overall Study|Adverse Event|3|||
33576496|NCT02707861|62972979|FG000|Overall Study|Death|5|||
33576497|NCT02707861|62972980|FG001|Overall Study|Death|2|||
33576498|NCT02707861|62972979|FG000|Overall Study|Lack of Efficacy|0|||
33665630|NCT02754141|63097737|FG002|Overall Study|Maximum clinical benefit|0|||
33665631|NCT02754141|63097738|FG003|Overall Study|Maximum clinical benefit|1|||
33665632|NCT02754141|63097739|FG004|Overall Study|Maximum clinical benefit|0|||
33665633|NCT02754141|63097740|FG005|Overall Study|Maximum clinical benefit|0|||
33665634|NCT02754141|63097741|FG006|Overall Study|Maximum clinical benefit|0|||
33665635|NCT02754141|63097742|FG007|Overall Study|Maximum clinical benefit|0|||
33665636|NCT02754141|63097743|FG008|Overall Study|Maximum clinical benefit|0|||
33665637|NCT02754141|63097744|FG009|Overall Study|Maximum clinical benefit|0|||
33665638|NCT02754141|63097745|FG010|Overall Study|Maximum clinical benefit|0|||
33665639|NCT02754141|63097746|FG011|Overall Study|Maximum clinical benefit|0|||
33665640|NCT02754141|63097747|FG012|Overall Study|Maximum clinical benefit|0|||
33576499|NCT02707861|62972980|FG001|Overall Study|Lack of Efficacy|2|||
33576500|NCT02707861|62972979|FG000|Overall Study|Physician Decision|1|||
33665641|NCT02754141|63097748|FG013|Overall Study|Maximum clinical benefit|0|||
33576501|NCT02707861|62972980|FG001|Overall Study|Physician Decision|4|||
33576502|NCT02707861|62972979|FG000|Overall Study|Withdrawal by Subject|2|||
33576503|NCT02707861|62972980|FG001|Overall Study|Withdrawal by Subject|1|||
33576504|NCT02707861|62972979|FG000|Overall Study|Lost to Follow-up|1|||
33576505|NCT02707861|62972980|FG001|Overall Study|Lost to Follow-up|3|||
33576506|NCT02027428|62972988|FG000|Induction|Never treated|7|||
33576507|NCT02027428|62972989|FG001|Induction|Never treated|0|||
33576508|NCT02027428|62972990|FG002|Induction|Never treated|0|||
33576509|NCT02027428|62972988|FG000|Induction|Progressive disease|77|||
33576510|NCT02027428|62972989|FG001|Induction|Progressive disease|0|||
33576511|NCT02027428|62972990|FG002|Induction|Progressive disease|0|||
33576512|NCT02027428|62972988|FG000|Induction|Adverse Event|51|||
33665642|NCT02754141|63097749|FG014|Overall Study|Maximum clinical benefit|0|||
33665643|NCT02754141|63097750|FG015|Overall Study|Maximum clinical benefit|0|||
33665644|NCT02754141|63097751|FG016|Overall Study|Maximum clinical benefit|0|||
33665645|NCT02754141|63097752|FG017|Overall Study|Maximum clinical benefit|0|||
33665646|NCT02754141|63097735|FG000|Overall Study|No longer meets study criteria|0|||
33665647|NCT02754141|63097736|FG001|Overall Study|No longer meets study criteria|0|||
33665648|NCT02754141|63097737|FG002|Overall Study|No longer meets study criteria|0|||
33665649|NCT02754141|63097738|FG003|Overall Study|No longer meets study criteria|1|||
33665650|NCT02754141|63097739|FG004|Overall Study|No longer meets study criteria|0|||
33665651|NCT02754141|63097740|FG005|Overall Study|No longer meets study criteria|0|||
33665652|NCT02754141|63097741|FG006|Overall Study|No longer meets study criteria|0|||
33665653|NCT02754141|63097742|FG007|Overall Study|No longer meets study criteria|0|||
33665654|NCT02754141|63097743|FG008|Overall Study|No longer meets study criteria|0|||
33665655|NCT02754141|63097744|FG009|Overall Study|No longer meets study criteria|0|||
33665656|NCT02754141|63097745|FG010|Overall Study|No longer meets study criteria|0|||
33665657|NCT02754141|63097746|FG011|Overall Study|No longer meets study criteria|0|||
33665658|NCT02754141|63097747|FG012|Overall Study|No longer meets study criteria|0|||
33665659|NCT02754141|63097748|FG013|Overall Study|No longer meets study criteria|0|||
33665660|NCT02754141|63097749|FG014|Overall Study|No longer meets study criteria|0|||
33665661|NCT02754141|63097750|FG015|Overall Study|No longer meets study criteria|0|||
33665662|NCT02754141|63097751|FG016|Overall Study|No longer meets study criteria|0|||
33665663|NCT02754141|63097752|FG017|Overall Study|No longer meets study criteria|0|||
33665664|NCT02754141|63097735|FG000|Overall Study|Other reasons|0|||
33665665|NCT02754141|63097736|FG001|Overall Study|Other reasons|0|||
33665666|NCT02754141|63097737|FG002|Overall Study|Other reasons|0|||
33665667|NCT02754141|63097738|FG003|Overall Study|Other reasons|0|||
33665668|NCT02754141|63097739|FG004|Overall Study|Other reasons|0|||
33665669|NCT02754141|63097740|FG005|Overall Study|Other reasons|0|||
33665670|NCT02754141|63097741|FG006|Overall Study|Other reasons|0|||
33665671|NCT02754141|63097742|FG007|Overall Study|Other reasons|1|||
33665672|NCT02754141|63097743|FG008|Overall Study|Other reasons|0|||
33665673|NCT02754141|63097744|FG009|Overall Study|Other reasons|0|||
33665674|NCT02754141|63097745|FG010|Overall Study|Other reasons|0|||
33665675|NCT02754141|63097746|FG011|Overall Study|Other reasons|0|||
33665676|NCT02754141|63097747|FG012|Overall Study|Other reasons|2|||
33665677|NCT02754141|63097748|FG013|Overall Study|Other reasons|0|||
33665678|NCT02754141|63097749|FG014|Overall Study|Other reasons|0|||
33665679|NCT02754141|63097750|FG015|Overall Study|Other reasons|0|||
33665680|NCT02754141|63097751|FG016|Overall Study|Other reasons|0|||
33665681|NCT02754141|63097752|FG017|Overall Study|Other reasons|0|||
33665682|NCT02754141|63097735|FG000|Overall Study|Completed treatment as per protocol|0|||
33665683|NCT02754141|63097736|FG001|Overall Study|Completed treatment as per protocol|1|||
33665684|NCT02754141|63097737|FG002|Overall Study|Completed treatment as per protocol|0|||
33665685|NCT02754141|63097738|FG003|Overall Study|Completed treatment as per protocol|0|||
33665686|NCT02754141|63097739|FG004|Overall Study|Completed treatment as per protocol|0|||
33665687|NCT02754141|63097740|FG005|Overall Study|Completed treatment as per protocol|0|||
33665688|NCT02754141|63097741|FG006|Overall Study|Completed treatment as per protocol|0|||
33665689|NCT02754141|63097742|FG007|Overall Study|Completed treatment as per protocol|0|||
33665690|NCT02754141|63097743|FG008|Overall Study|Completed treatment as per protocol|0|||
33665691|NCT02754141|63097744|FG009|Overall Study|Completed treatment as per protocol|0|||
33665692|NCT02754141|63097745|FG010|Overall Study|Completed treatment as per protocol|0|||
33665693|NCT02754141|63097746|FG011|Overall Study|Completed treatment as per protocol|0|||
33665694|NCT02754141|63097747|FG012|Overall Study|Completed treatment as per protocol|1|||
33665695|NCT02754141|63097748|FG013|Overall Study|Completed treatment as per protocol|0|||
33665696|NCT02754141|63097749|FG014|Overall Study|Completed treatment as per protocol|0|||
33665697|NCT02754141|63097750|FG015|Overall Study|Completed treatment as per protocol|0|||
33665698|NCT02754141|63097751|FG016|Overall Study|Completed treatment as per protocol|0|||
33665699|NCT02754141|63097752|FG017|Overall Study|Completed treatment as per protocol|0|||
33665700|NCT02754141|63097735|FG000|Overall Study|Not completing monotherapy|0|||
33665701|NCT02754141|63097736|FG001|Overall Study|Not completing monotherapy|0|||
33665702|NCT02754141|63097737|FG002|Overall Study|Not completing monotherapy|0|||
33665703|NCT02754141|63097738|FG003|Overall Study|Not completing monotherapy|0|||
33665704|NCT02754141|63097739|FG004|Overall Study|Not completing monotherapy|0|||
33665705|NCT02754141|63097740|FG005|Overall Study|Not completing monotherapy|0|||
33665706|NCT02754141|63097741|FG006|Overall Study|Not completing monotherapy|0|||
33665707|NCT02754141|63097742|FG007|Overall Study|Not completing monotherapy|0|||
33665708|NCT02754141|63097743|FG008|Overall Study|Not completing monotherapy|0|||
33665709|NCT02754141|63097744|FG009|Overall Study|Not completing monotherapy|0|||
33665710|NCT02754141|63097745|FG010|Overall Study|Not completing monotherapy|0|||
33665711|NCT02754141|63097746|FG011|Overall Study|Not completing monotherapy|0|||
33665712|NCT02754141|63097747|FG012|Overall Study|Not completing monotherapy|0|||
33665713|NCT02754141|63097748|FG013|Overall Study|Not completing monotherapy|1|||
33665714|NCT02754141|63097749|FG014|Overall Study|Not completing monotherapy|0|||
33665715|NCT02754141|63097750|FG015|Overall Study|Not completing monotherapy|0|||
33665716|NCT02754141|63097751|FG016|Overall Study|Not completing monotherapy|0|||
33665717|NCT02754141|63097752|FG017|Overall Study|Not completing monotherapy|0|||
33665718|NCT02659059|63097831|FG000|Overall Study|Other reasons|6|||
33665719|NCT02659059|63097832|FG001|Overall Study|Other reasons|1|||
33665720|NCT02659059|63097831|FG000|Overall Study|Disease Progression|143|||
33665721|NCT02659059|63097832|FG001|Overall Study|Disease Progression|16|||
33665722|NCT02659059|63097831|FG000|Overall Study|Study Drug toxicity|56|||
33665723|NCT02659059|63097832|FG001|Overall Study|Study Drug toxicity|9|||
33665724|NCT02659059|63097831|FG000|Overall Study|Death|3|||
33665725|NCT02659059|63097832|FG001|Overall Study|Death|1|||
33665726|NCT02659059|63097831|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
33665727|NCT02659059|63097832|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
33665728|NCT02659059|63097831|FG000|Overall Study|Participant request to discontinue study treatment|5|||
33665729|NCT02659059|63097832|FG001|Overall Study|Participant request to discontinue study treatment|0|||
33665730|NCT02659059|63097831|FG000|Overall Study|Participant withdrew consent|6|||
33665731|NCT02659059|63097832|FG001|Overall Study|Participant withdrew consent|1|||
33665732|NCT01164891|63097847|FG000|Overall Study|Disease Progression|5|||
33665733|NCT01164891|63097847|FG000|Overall Study|Adverse Event|1|||
33665734|NCT01497899|63097856|FG000|Double-Blind Phase|Randomized but not Treated|1|||
33665735|NCT01497899|63097857|FG001|Double-Blind Phase|Randomized but not Treated|0|||
33665736|NCT01497899|63097858|FG002|Double-Blind Phase|Randomized but not Treated|0|||
33665737|NCT01497899|63097859|FG003|Double-Blind Phase|Randomized but not Treated|0|||
33665738|NCT01497899|63097856|FG000|Double-Blind Phase|Adverse Event|1|||
33665739|NCT01497899|63097857|FG001|Double-Blind Phase|Adverse Event|0|||
33665740|NCT01497899|63097858|FG002|Double-Blind Phase|Adverse Event|0|||
33665741|NCT01497899|63097859|FG003|Double-Blind Phase|Adverse Event|0|||
33665742|NCT01497899|63097856|FG000|Double-Blind Phase|Lack of Efficacy|0|||
33665743|NCT01497899|63097857|FG001|Double-Blind Phase|Lack of Efficacy|1|||
33665744|NCT01497899|63097858|FG002|Double-Blind Phase|Lack of Efficacy|0|||
33665745|NCT01497899|63097859|FG003|Double-Blind Phase|Lack of Efficacy|0|||
33665746|NCT01497899|63097856|FG000|Double-Blind Phase|Investigator's Discretion|1|||
33665747|NCT01497899|63097857|FG001|Double-Blind Phase|Investigator's Discretion|0|||
33665748|NCT01497899|63097858|FG002|Double-Blind Phase|Investigator's Discretion|0|||
33665749|NCT01497899|63097859|FG003|Double-Blind Phase|Investigator's Discretion|0|||
33665750|NCT01497899|63097856|FG000|Double-Blind Phase|Withdrew Consent|0|||
33665751|NCT01497899|63097857|FG001|Double-Blind Phase|Withdrew Consent|1|||
33665752|NCT01497899|63097858|FG002|Double-Blind Phase|Withdrew Consent|0|||
33665753|NCT01497899|63097859|FG003|Double-Blind Phase|Withdrew Consent|0|||
33665754|NCT01497899|63097856|FG000|Double-Blind Phase|Lost to Follow-up|3|||
33665755|NCT01497899|63097857|FG001|Double-Blind Phase|Lost to Follow-up|2|||
33665756|NCT01497899|63097858|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33665757|NCT01497899|63097859|FG003|Double-Blind Phase|Lost to Follow-up|0|||
33665758|NCT01497899|63097856|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
33665759|NCT01497899|63097857|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
33665760|NCT01497899|63097858|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
33665761|NCT01497899|63097859|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
33665762|NCT01497899|63097856|FG000|Open-Label Extension Phase|Adverse Event|1|||
33665763|NCT01497899|63097857|FG001|Open-Label Extension Phase|Adverse Event|0|||
33665764|NCT01497899|63097858|FG002|Open-Label Extension Phase|Adverse Event|0|||
33665765|NCT01497899|63097859|FG003|Open-Label Extension Phase|Adverse Event|0|||
33665766|NCT01497899|63097856|FG000|Open-Label Extension Phase|Death|1|||
33665767|NCT01497899|63097857|FG001|Open-Label Extension Phase|Death|0|||
33665768|NCT01497899|63097858|FG002|Open-Label Extension Phase|Death|0|||
33665769|NCT01497899|63097859|FG003|Open-Label Extension Phase|Death|0|||
33665770|NCT01497899|63097856|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
33665771|NCT01497899|63097857|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
33665772|NCT01497899|63097858|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
33576513|NCT02027428|62972989|FG001|Induction|Adverse Event|0|||
33576514|NCT02027428|62972990|FG002|Induction|Adverse Event|0|||
33576515|NCT02027428|62972988|FG000|Induction|Withdrawal by Subject|22|||
33576516|NCT02027428|62972989|FG001|Induction|Withdrawal by Subject|0|||
33576517|NCT02027428|62972990|FG002|Induction|Withdrawal by Subject|0|||
33576518|NCT02027428|62972988|FG000|Induction|Death|21|||
33576519|NCT02027428|62972989|FG001|Induction|Death|0|||
33576520|NCT02027428|62972990|FG002|Induction|Death|0|||
33576521|NCT02027428|62972988|FG000|Induction|Symptomatic deterioration|16|||
33576522|NCT02027428|62972989|FG001|Induction|Symptomatic deterioration|0|||
33576523|NCT02027428|62972990|FG002|Induction|Symptomatic deterioration|0|||
33665773|NCT01497899|63097859|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
33665774|NCT01497899|63097856|FG000|Open-Label Extension Phase|Pregnancy|0|||
33665775|NCT01497899|63097857|FG001|Open-Label Extension Phase|Pregnancy|1|||
33665776|NCT01497899|63097858|FG002|Open-Label Extension Phase|Pregnancy|1|||
33665777|NCT01497899|63097859|FG003|Open-Label Extension Phase|Pregnancy|0|||
33576524|NCT02027428|62972988|FG000|Induction|Study terminated by sponsor|12|||
33576525|NCT02027428|62972989|FG001|Induction|Study terminated by sponsor|0|||
33576526|NCT02027428|62972990|FG002|Induction|Study terminated by sponsor|0|||
33665778|NCT01497899|63097856|FG000|Open-Label Extension Phase|Protocol Violation|0|||
33665779|NCT01497899|63097857|FG001|Open-Label Extension Phase|Protocol Violation|0|||
33665780|NCT01497899|63097858|FG002|Open-Label Extension Phase|Protocol Violation|1|||
33665781|NCT01497899|63097859|FG003|Open-Label Extension Phase|Protocol Violation|0|||
33665782|NCT01497899|63097856|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
33665783|NCT01497899|63097857|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
33665784|NCT01497899|63097858|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
33665785|NCT01497899|63097859|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
33665786|NCT01497275|63097866|FG000|Overall Study|Death|1|||
33665787|NCT01497275|63097866|FG000|Overall Study|Adverse Event|1|||
33665788|NCT01557517|63097872|FG000|Overall Study|Death|1|||
33665789|NCT01557517|63097873|FG001|Overall Study|Death|0|||
33665790|NCT01557517|63097872|FG000|Overall Study|Refused further treatment|0|||
33665791|NCT01557517|63097873|FG001|Overall Study|Refused further treatment|2|||
33665792|NCT01557517|63097872|FG000|Overall Study|Adverse Event|0|||
33665793|NCT01557517|63097873|FG001|Overall Study|Adverse Event|2|||
33665794|NCT01557517|63097872|FG000|Overall Study|Pt declined before treatment started|1|||
33665795|NCT01557517|63097873|FG001|Overall Study|Pt declined before treatment started|0|||
33665796|NCT01497197|63097888|FG000|Overall Study|Lost to Follow-up|1|||
33665797|NCT01497197|63097889|FG001|Overall Study|Lost to Follow-up|0|||
33665798|NCT01497197|63097888|FG000|Overall Study|Protocol Violation|0|||
33665799|NCT01497197|63097889|FG001|Overall Study|Protocol Violation|2|||
33665800|NCT01497197|63097888|FG000|Overall Study|Withdrawal by Subject|2|||
33665801|NCT01497197|63097889|FG001|Overall Study|Withdrawal by Subject|1|||
33665802|NCT01497197|63097888|FG000|Overall Study|Excessive/lack of response to treatment|1|||
33665803|NCT01497197|63097889|FG001|Overall Study|Excessive/lack of response to treatment|0|||
33665804|NCT01497197|63097888|FG000|Overall Study|Risk of OHSS|1|||
33665805|NCT01497197|63097889|FG001|Overall Study|Risk of OHSS|0|||
33665806|NCT01497197|63097888|FG000|Overall Study|No oocytes retrieved|3|||
33665807|NCT01497197|63097889|FG001|Overall Study|No oocytes retrieved|2|||
33665808|NCT01497197|63097888|FG000|Overall Study|No fertilisation|6|||
33665809|NCT01497197|63097889|FG001|Overall Study|No fertilisation|5|||
33665810|NCT01497197|63097888|FG000|Overall Study|Intention to freeze all embryos|0|||
33665811|NCT01497197|63097889|FG001|Overall Study|Intention to freeze all embryos|1|||
33665812|NCT01497197|63097888|FG000|Overall Study|All embryos discarded|0|||
33665813|NCT01497197|63097889|FG001|Overall Study|All embryos discarded|3|||
33665814|NCT01497197|63097888|FG000|Overall Study|Other|3|||
33576527|NCT02027428|62972988|FG000|Induction|Protocol Violation|1|||
33576528|NCT02027428|62972989|FG001|Induction|Protocol Violation|0|||
33576529|NCT02027428|62972990|FG002|Induction|Protocol Violation|0|||
33576530|NCT02027428|62972988|FG000|Induction|Miscellaneous|14|||
33576531|NCT02027428|62972989|FG001|Induction|Miscellaneous|0|||
33576532|NCT02027428|62972990|FG002|Induction|Miscellaneous|0|||
33576533|NCT02027428|62972988|FG000|Induction|Induction Treatment Ongoing|4|||
33576534|NCT02027428|62972989|FG001|Induction|Induction Treatment Ongoing|0|||
33576535|NCT02027428|62972990|FG002|Induction|Induction Treatment Ongoing|0|||
33576536|NCT02027428|62972988|FG000|Maintenance|Death|0|||
33576537|NCT02027428|62972989|FG001|Maintenance|Death|3|||
33576538|NCT02027428|62972990|FG002|Maintenance|Death|2|||
33576539|NCT02027428|62972988|FG000|Maintenance|Adverse Event|0|||
33576540|NCT02027428|62972989|FG001|Maintenance|Adverse Event|21|||
33576541|NCT02027428|62972990|FG002|Maintenance|Adverse Event|1|||
33576542|NCT02027428|62972988|FG000|Maintenance|Progressive disease|0|||
33576543|NCT02027428|62972989|FG001|Maintenance|Progressive disease|84|||
33576544|NCT02027428|62972990|FG002|Maintenance|Progressive disease|47|||
33665815|NCT01497197|63097889|FG001|Overall Study|Other|1|||
33665816|NCT01496885|63097895|FG000|Overall Study|Lost to Follow-up|13|||
33305523|NCT01296932|62681021|FG001|Overall Study|No adequate treatment response|0|||
33305524|NCT01296932|62681022|FG002|Overall Study|No adequate treatment response|0|||
33305525|NCT01296932|62681023|FG003|Overall Study|No adequate treatment response|0|||
33305526|NCT01296932|62681024|FG004|Overall Study|No adequate treatment response|0|||
33305527|NCT01296932|62681025|FG005|Overall Study|No adequate treatment response|0|||
33305528|NCT01296932|62681026|FG006|Overall Study|No adequate treatment response|0|||
33305529|NCT01296932|62681027|FG007|Overall Study|No adequate treatment response|1|||
33305530|NCT01296932|62681028|FG008|Overall Study|No adequate treatment response|0|||
33576545|NCT02027428|62972988|FG000|Maintenance|Symptomatic deterioration|0|||
33576546|NCT02027428|62972989|FG001|Maintenance|Symptomatic deterioration|4|||
33576547|NCT02027428|62972990|FG002|Maintenance|Symptomatic deterioration|1|||
33576548|NCT02027428|62972988|FG000|Maintenance|Withdrawal by Subject|0|||
33576549|NCT02027428|62972989|FG001|Maintenance|Withdrawal by Subject|6|||
33576550|NCT02027428|62972990|FG002|Maintenance|Withdrawal by Subject|5|||
33665817|NCT01496885|63097895|FG000|Overall Study|Withdrawal by Subject|7|||
33665818|NCT01496885|63097895|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
33665819|NCT01496885|63097895|FG000|Overall Study|Death|1|||
33665820|NCT01557283|63097899|FG000|Overall Study|Lost to Follow-up|7|||
33665821|NCT01557283|63097899|FG000|Overall Study|Non-responder|19|||
33665822|NCT01557283|63097899|FG000|Overall Study|Adverse Event|7|||
33576551|NCT02027428|62972988|FG000|Maintenance|Protocol Violation|0|||
33576552|NCT02027428|62972989|FG001|Maintenance|Protocol Violation|0|||
33576553|NCT02027428|62972990|FG002|Maintenance|Protocol Violation|1|||
33576554|NCT02027428|62972988|FG000|Maintenance|Other|0|||
33576555|NCT02027428|62972989|FG001|Maintenance|Other|6|||
33576556|NCT02027428|62972990|FG002|Maintenance|Other|3|||
33576557|NCT02027428|62972988|FG000|Survival Follow-up|Death|0|||
33576558|NCT02027428|62972989|FG001|Survival Follow-up|Death|78|||
33576559|NCT02027428|62972990|FG002|Survival Follow-up|Death|45|||
33576560|NCT02027428|62972988|FG000|Survival Follow-up|Lost to Follow-up|0|||
33576561|NCT02027428|62972989|FG001|Survival Follow-up|Lost to Follow-up|1|||
33576562|NCT02027428|62972990|FG002|Survival Follow-up|Lost to Follow-up|1|||
33576563|NCT01995136|62973013|FG000|Overall Study|Change in residence|1|||
33576564|NCT01994902|62973017|FG000|Test Period 1|Withdrawal by Subject|3|||
33576565|NCT01994902|62973018|FG001|Test Period 1|Withdrawal by Subject|0|||
33576566|NCT01994902|62973017|FG000|Test Period 1|device deficiency with adverse event|0|||
33576567|NCT01994902|62973018|FG001|Test Period 1|device deficiency with adverse event|1|||
33576568|NCT01994902|62973017|FG000|Test Period 1|Adverse Event|2|||
33576569|NCT01994902|62973018|FG001|Test Period 1|Adverse Event|1|||
33576570|NCT01994902|62973017|FG000|Test Period 1|Lack of Efficacy|0|||
33576571|NCT01994902|62973018|FG001|Test Period 1|Lack of Efficacy|1|||
33576572|NCT01994902|62973017|FG000|Test Period 1|bag too small|1|||
33576573|NCT01994902|62973018|FG001|Test Period 1|bag too small|0|||
33576574|NCT01994902|62973017|FG000|Test Period 2|Withdrawal by Subject|0|||
33576575|NCT01994902|62973018|FG001|Test Period 2|Withdrawal by Subject|2|||
33576576|NCT01994902|62973017|FG000|Test Period 2|Lack of Efficacy|0|||
33576577|NCT01994902|62973018|FG001|Test Period 2|Lack of Efficacy|1|||
33576578|NCT01994902|62973017|FG000|Test Period 2|Other|0|||
33576579|NCT01994902|62973018|FG001|Test Period 2|Other|3|||
33576580|NCT02026258|62973026|FG000|Randomized|Did not start treatment|2|||
33576581|NCT02026258|62973027|FG001|Randomized|Did not start treatment|1|||
33576582|NCT02026258|62973026|FG000|Randomized|Change in treatment plan|1|||
33576583|NCT02026258|62973027|FG001|Randomized|Change in treatment plan|0|||
33576584|NCT02026258|62973026|FG000|Randomized|Presence of periodontal disease|1|||
33576585|NCT02026258|62973027|FG001|Randomized|Presence of periodontal disease|1|||
33576586|NCT02026258|62973026|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
33576587|NCT02026258|62973027|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
33576588|NCT02026258|62973026|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
33576589|NCT02026258|62973027|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
33576590|NCT01994590|62973034|FG000|Overall Study|Adverse Event|1|||
33576591|NCT01994590|62973034|FG000|Overall Study|Trial Terminated|1|||
33576592|NCT02019550|62973040|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
33576593|NCT02019550|62973041|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
33576594|NCT02019472|62973052|FG000|Overall Study|Adverse Event|14|||
33576595|NCT02019472|62973053|FG001|Overall Study|Adverse Event|23|||
33576596|NCT02019472|62973054|FG002|Overall Study|Adverse Event|17|||
33576597|NCT02019472|62973052|FG000|Overall Study|Death|0|||
33576598|NCT02019472|62973053|FG001|Overall Study|Death|1|||
33576599|NCT02019472|62973054|FG002|Overall Study|Death|1|||
33576600|NCT02019472|62973052|FG000|Overall Study|Lack of Efficacy|7|||
33576601|NCT02019472|62973053|FG001|Overall Study|Lack of Efficacy|4|||
33576602|NCT02019472|62973054|FG002|Overall Study|Lack of Efficacy|4|||
33665823|NCT01557283|63097899|FG000|Overall Study|Lack of Efficacy|1|||
33665824|NCT01557283|63097899|FG000|Overall Study|Non-compliance|1|||
33665825|NCT01557283|63097899|FG000|Overall Study|Withdrawal by Subject|1|||
33665826|NCT01557283|63097899|FG000|Overall Study|Participant's weight too high for dose|1|||
33665827|NCT01557283|63097899|FG000|Overall Study|Worsening of psoriasis|1|||
33665828|NCT01557283|63097899|FG000|Overall Study|Other|6|||
33665829|NCT01523743|63097916|FG000|Period 1|Adverse Event|1|||
33665830|NCT01523743|63097917|FG001|Period 1|Adverse Event|0|||
33576603|NCT02019472|62973052|FG000|Overall Study|Lost to Follow-up|0|||
33576604|NCT02019472|62973053|FG001|Overall Study|Lost to Follow-up|2|||
33576605|NCT02019472|62973054|FG002|Overall Study|Lost to Follow-up|1|||
33576606|NCT02019472|62973052|FG000|Overall Study|Physician Decision|1|||
33576607|NCT02019472|62973053|FG001|Overall Study|Physician Decision|2|||
33665831|NCT01523743|63097916|FG000|Period 1|Withdrawal by Subject|6|||
33665832|NCT01523743|63097917|FG001|Period 1|Withdrawal by Subject|2|||
33665833|NCT01523743|63097916|FG000|Period 1|Lost to Follow-up|1|||
33665834|NCT01523743|63097917|FG001|Period 1|Lost to Follow-up|0|||
33576608|NCT02019472|62973054|FG002|Overall Study|Physician Decision|0|||
33576609|NCT02019472|62973052|FG000|Overall Study|Pregnancy|1|||
33665835|NCT01523743|63097916|FG000|Period 1|Lack of Efficacy|1|||
33576610|NCT02019472|62973053|FG001|Overall Study|Pregnancy|2|||
33576611|NCT02019472|62973054|FG002|Overall Study|Pregnancy|2|||
33576612|NCT02019472|62973052|FG000|Overall Study|Withdrawal by Subject|11|||
33576613|NCT02019472|62973053|FG001|Overall Study|Withdrawal by Subject|10|||
33576614|NCT02019472|62973054|FG002|Overall Study|Withdrawal by Subject|11|||
33576615|NCT02019472|62973052|FG000|Overall Study|Other|3|||
33576616|NCT02019472|62973053|FG001|Overall Study|Other|8|||
33576617|NCT02019472|62973054|FG002|Overall Study|Other|6|||
33665836|NCT01523743|63097917|FG001|Period 1|Lack of Efficacy|0|||
33665837|NCT01523743|63097916|FG000|Period 1|Felt unable to empty bladder|1|||
33665838|NCT01523743|63097917|FG001|Period 1|Felt unable to empty bladder|0|||
33665839|NCT01523743|63097916|FG000|Period 2|Withdrawal by Subject|0|||
33665840|NCT01523743|63097917|FG001|Period 2|Withdrawal by Subject|2|||
33665841|NCT01523743|63097916|FG000|Period 2|Adverse Event|1|||
33665842|NCT01523743|63097917|FG001|Period 2|Adverse Event|0|||
33665843|NCT01496807|63097932|FG000|Overall Study|Progressive Disease|21|||
33665844|NCT01496807|63097932|FG000|Overall Study|Participant preference/toxicity|8|||
33665845|NCT01496807|63097932|FG000|Overall Study|Change in diagnosis|1|||
33665846|NCT01496183|63097938|FG000|Overall Study|Physician Decision|3|||
33665847|NCT01496183|63097939|FG001|Overall Study|Physician Decision|1|||
33665848|NCT01496183|63097938|FG000|Overall Study|Withdrawal by Subject|0|||
33665849|NCT01496183|63097939|FG001|Overall Study|Withdrawal by Subject|1|||
33665850|NCT01495793|63097946|FG000|Overall Study|Lost to Follow-up|1|||
33665851|NCT01495793|63097946|FG000|Overall Study|Violation of inclusion criteria|1|||
33665852|NCT01494467|63097952|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
33665853|NCT01494467|63097953|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
33665854|NCT01494467|63097952|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
33665855|NCT01494467|63097953|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
33665856|NCT01494467|63097952|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
33665857|NCT01494467|63097953|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
33665858|NCT01494467|63097952|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
33665859|NCT01494467|63097953|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
33665860|NCT01494467|63097952|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
33665861|NCT01494467|63097953|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
33665862|NCT01494467|63097952|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
33665863|NCT01494467|63097953|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
33665864|NCT01494467|63097952|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
33665865|NCT01494467|63097953|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
33665866|NCT01494467|63097952|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
33665867|NCT01494467|63097953|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
33665868|NCT01494467|63097952|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
33665869|NCT01494467|63097953|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
33665870|NCT01494467|63097952|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
33665871|NCT01494467|63097953|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
33665872|NCT01494467|63097952|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
33665873|NCT01494467|63097953|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
33665874|NCT01494467|63097952|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
33665875|NCT01494467|63097953|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
33665876|NCT01494467|63097952|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
33665877|NCT01494467|63097953|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
33665878|NCT01494467|63097952|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
33665879|NCT01494467|63097953|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
33665880|NCT01493687|63097967|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
33665881|NCT01493687|63097968|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
33665882|NCT01493687|63097967|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
33665883|NCT01493687|63097968|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
33665884|NCT01493687|63097967|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
33665885|NCT01493687|63097968|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
33665886|NCT01493687|63097967|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
33665887|NCT01493687|63097968|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
33665888|NCT01493687|63097967|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
33665889|NCT01493687|63097968|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
33665890|NCT01493687|63097967|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
33665891|NCT01493687|63097968|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
33665892|NCT01493687|63097967|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
33665893|NCT01493687|63097968|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
33665894|NCT01493687|63097967|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
33665895|NCT01493687|63097968|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
33665896|NCT01493687|63097967|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
33665897|NCT01493687|63097968|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
33665898|NCT01493687|63097967|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
33665899|NCT01493687|63097968|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
33665900|NCT01493687|63097967|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
33665901|NCT01493687|63097968|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
33665902|NCT01493687|63097967|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
33665903|NCT01493687|63097968|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
33665904|NCT01493687|63097967|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
33665905|NCT01493687|63097968|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
33665906|NCT01493687|63097967|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
33665907|NCT01493687|63097968|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
33665908|NCT01493687|63097967|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
33665909|NCT01493687|63097968|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
33665910|NCT01523587|63098000|FG000|Overall Study|Other than listed|5|||
33665911|NCT01523587|63098001|FG001|Overall Study|Other than listed|5|||
33665912|NCT01523587|63098000|FG000|Overall Study|Worsening of underlying cancer disease|19|||
33665913|NCT01523587|63098001|FG001|Overall Study|Worsening of underlying cancer disease|34|||
33665914|NCT01523587|63098000|FG000|Overall Study|Adverse Event|68|||
33665915|NCT01523587|63098001|FG001|Overall Study|Adverse Event|52|||
33665916|NCT01523587|63098000|FG000|Overall Study|Protocol Violation|5|||
33665917|NCT01523587|63098001|FG001|Overall Study|Protocol Violation|3|||
33665918|NCT01523587|63098000|FG000|Overall Study|Lost to Follow-up|2|||
33665919|NCT01523587|63098001|FG001|Overall Study|Lost to Follow-up|2|||
33665920|NCT01523587|63098000|FG000|Overall Study|Withdrawal by Subject|28|||
33665921|NCT01523587|63098001|FG001|Overall Study|Withdrawal by Subject|20|||
33665922|NCT01523587|63098000|FG000|Overall Study|Withdrew due to Progressive disease|265|||
33665923|NCT01523587|63098001|FG001|Overall Study|Withdrew due to Progressive disease|279|||
33665924|NCT01523587|63098000|FG000|Overall Study|Randomised but bot treated|6|||
33665925|NCT01523587|63098001|FG001|Overall Study|Randomised but bot treated|2|||
33665926|NCT01493531|63098030|FG000|Overall Study|Adverse Event|4|||
33665927|NCT01493531|63098031|FG001|Overall Study|Adverse Event|12|||
33665928|NCT01493531|63098032|FG002|Overall Study|Adverse Event|9|||
33665929|NCT01493531|63098030|FG000|Overall Study|Gout flare|3|||
33665930|NCT01493531|63098031|FG001|Overall Study|Gout flare|0|||
33665931|NCT01493531|63098032|FG002|Overall Study|Gout flare|2|||
33665932|NCT01493531|63098030|FG000|Overall Study|Protocol Violation|8|||
33665933|NCT01493531|63098031|FG001|Overall Study|Protocol Violation|15|||
33665934|NCT01493531|63098032|FG002|Overall Study|Protocol Violation|12|||
33665935|NCT01493531|63098030|FG000|Overall Study|Sponsor terminated study|5|||
33665936|NCT01493531|63098031|FG001|Overall Study|Sponsor terminated study|2|||
33665937|NCT01493531|63098032|FG002|Overall Study|Sponsor terminated study|3|||
33665938|NCT01493531|63098030|FG000|Overall Study|Lost to Follow-up|5|||
33665939|NCT01493531|63098031|FG001|Overall Study|Lost to Follow-up|7|||
33665940|NCT01493531|63098032|FG002|Overall Study|Lost to Follow-up|11|||
33665941|NCT01493531|63098030|FG000|Overall Study|Withdrawal by Subject|16|||
33665942|NCT01493531|63098031|FG001|Overall Study|Withdrawal by Subject|13|||
33665943|NCT01493531|63098032|FG002|Overall Study|Withdrawal by Subject|11|||
33665944|NCT01493531|63098030|FG000|Overall Study|Death|0|||
33665945|NCT01493531|63098031|FG001|Overall Study|Death|1|||
33665946|NCT01493531|63098032|FG002|Overall Study|Death|0|||
33665947|NCT01523275|63098056|FG000|Overall Study|Lost to Follow-up|1|||
33665948|NCT01523275|63098057|FG001|Overall Study|Lost to Follow-up|2|||
33665949|NCT01523275|63098056|FG000|Overall Study|Withdrawal by Subject|1|||
33665950|NCT01523275|63098057|FG001|Overall Study|Withdrawal by Subject|0|||
33665951|NCT01492439|63098074|FG000|Overall Study|Withdrew from RTE|4|||
33665952|NCT01492439|63098075|FG001|Overall Study|Withdrew from RTE|9|||
33576618|NCT02705755|62973066|FG000|Part A (6 Days)|Adverse Event|1|||
33576619|NCT02705755|62973067|FG001|Part A (6 Days)|Adverse Event|0|||
33576620|NCT02705755|62973068|FG002|Part A (6 Days)|Adverse Event|0|||
33576621|NCT02705755|62973069|FG003|Part A (6 Days)|Adverse Event|0|||
33576622|NCT02705755|62973066|FG000|Part A (6 Days)|Physician Decision|3|||
33576623|NCT02705755|62973067|FG001|Part A (6 Days)|Physician Decision|0|||
33576624|NCT02705755|62973068|FG002|Part A (6 Days)|Physician Decision|0|||
33665953|NCT01572727|63098110|FG000|Overall Study|Adverse Event|43|||
33665954|NCT01572727|63098111|FG001|Overall Study|Adverse Event|15|||
33665955|NCT01572727|63098110|FG000|Overall Study|Lost to Follow-up|1|||
33665956|NCT01572727|63098111|FG001|Overall Study|Lost to Follow-up|1|||
33665957|NCT01572727|63098110|FG000|Overall Study|Physician Decision|23|||
33665958|NCT01572727|63098111|FG001|Overall Study|Physician Decision|9|||
33665959|NCT01572727|63098110|FG000|Overall Study|Progressive disease|59|||
33665960|NCT01572727|63098111|FG001|Overall Study|Progressive disease|82|||
33665961|NCT01572727|63098110|FG000|Overall Study|Protocol Violation|0|||
33576625|NCT02705755|62973069|FG003|Part A (6 Days)|Physician Decision|0|||
33665962|NCT01572727|63098111|FG001|Overall Study|Protocol Violation|1|||
33665963|NCT01572727|63098110|FG000|Overall Study|Study terminated by sponsor|61|||
33665964|NCT01572727|63098111|FG001|Overall Study|Study terminated by sponsor|83|||
33665965|NCT01572727|63098110|FG000|Overall Study|Parent/guardian decision|14|||
33665966|NCT01572727|63098111|FG001|Overall Study|Parent/guardian decision|9|||
33665967|NCT01572727|63098110|FG000|Overall Study|Death|2|||
33665968|NCT01572727|63098111|FG001|Overall Study|Death|2|||
33581022|NCT01111461|62978156|FG000|Overall Study|Lost to Follow-up|1|||
33665969|NCT01572727|63098110|FG000|Overall Study|Untreated|4|||
33665970|NCT01572727|63098111|FG001|Overall Study|Untreated|7|||
33665971|NCT01522651|63098158|FG000|Overall Study|Adverse Event|3|||
33665972|NCT01522651|63098159|FG001|Overall Study|Adverse Event|4|||
33576626|NCT02705755|62973066|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
33576627|NCT02705755|62973067|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
33576628|NCT02705755|62973068|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
33576629|NCT02705755|62973069|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
33576630|NCT02705755|62973066|FG000|Part C (20 Weeks)|Physician Decision|0|||
33576631|NCT02705755|62973067|FG001|Part C (20 Weeks)|Physician Decision|0|||
33576632|NCT02705755|62973068|FG002|Part C (20 Weeks)|Physician Decision|0|||
33576633|NCT02705755|62973069|FG003|Part C (20 Weeks)|Physician Decision|2|||
33576634|NCT02705755|62973066|FG000|Part C (20 Weeks)|Adverse Event|0|||
33576635|NCT02705755|62973067|FG001|Part C (20 Weeks)|Adverse Event|0|||
33576636|NCT02705755|62973068|FG002|Part C (20 Weeks)|Adverse Event|0|||
33576637|NCT02705755|62973069|FG003|Part C (20 Weeks)|Adverse Event|6|||
33576638|NCT02705755|62973066|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
33576639|NCT02705755|62973067|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
33576640|NCT02705755|62973068|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
33576641|NCT02705755|62973069|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
33576642|NCT02024932|62973102|FG000|Overall Study|Adverse Event|2|||
33576643|NCT02024932|62973103|FG001|Overall Study|Adverse Event|3|||
33576644|NCT02024932|62973104|FG002|Overall Study|Adverse Event|0|||
33576645|NCT02024932|62973105|FG003|Overall Study|Adverse Event|0|||
33576646|NCT02024932|62973106|FG004|Overall Study|Adverse Event|2|||
33576647|NCT02024932|62973107|FG005|Overall Study|Adverse Event|0|||
33576648|NCT02024932|62973102|FG000|Overall Study|Abnormal laboratory value|0|||
33576649|NCT02024932|62973103|FG001|Overall Study|Abnormal laboratory value|0|||
33576650|NCT02024932|62973104|FG002|Overall Study|Abnormal laboratory value|0|||
33576651|NCT02024932|62973105|FG003|Overall Study|Abnormal laboratory value|2|||
33576652|NCT02024932|62973106|FG004|Overall Study|Abnormal laboratory value|0|||
33576653|NCT02024932|62973107|FG005|Overall Study|Abnormal laboratory value|0|||
33576654|NCT01993888|62973138|FG000|Overall Study|Death|1|||
33576655|NCT01993888|62973139|FG001|Overall Study|Death|1|||
33576656|NCT01993888|62973138|FG000|Overall Study|Lost to Follow-up|1|||
33576657|NCT01993888|62973139|FG001|Overall Study|Lost to Follow-up|1|||
33576658|NCT01993888|62973138|FG000|Overall Study|Withdrawal by Subject|0|||
33576659|NCT01993888|62973139|FG001|Overall Study|Withdrawal by Subject|1|||
33576660|NCT02024698|62973145|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
33576661|NCT02024698|62973146|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
33576662|NCT02018458|62973152|FG000|Overall Study|Death|4|||
33576663|NCT02017522|62973156|FG000|Overall Study|Withdrawal by Subject|1|||
33576664|NCT02017444|62973163|FG000|Overall Study|Physician Decision|1|||
33576665|NCT02017444|62973164|FG001|Overall Study|Physician Decision|0|||
33576666|NCT02017444|62973163|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
33576667|NCT02017444|62973164|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
33576668|NCT01993186|62973172|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
33576669|NCT01993186|62973173|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
33576670|NCT01993186|62973172|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
33576671|NCT01993186|62973173|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
33576672|NCT01993186|62973172|FG000|Open-Label Extension Period|Other, Not Specified|0|||
33576673|NCT01993186|62973173|FG001|Open-Label Extension Period|Other, Not Specified|1|||
33576674|NCT01993186|62973172|FG000|Open-Label Extension Period|Adverse Event|1|||
33576675|NCT01993186|62973173|FG001|Open-Label Extension Period|Adverse Event|0|||
33576676|NCT01993186|62973172|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
33576677|NCT01993186|62973173|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
33576678|NCT01993186|62973172|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
33576679|NCT01993186|62973173|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
33576680|NCT01993186|62973172|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
33576681|NCT01993186|62973173|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
33576682|NCT02016898|62973182|FG000|Overall Study|Death|1|||
33576683|NCT02016898|62973183|FG001|Overall Study|Death|1|||
33576684|NCT02016898|62973182|FG000|Overall Study|Lost to Follow-up|4|||
33576685|NCT02016898|62973183|FG001|Overall Study|Lost to Follow-up|4|||
33576686|NCT01993030|62973191|FG000|Overall Study|Adverse Event|0|||
33576687|NCT01993030|62973192|FG001|Overall Study|Adverse Event|4|||
33576688|NCT01992094|62973201|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
33576689|NCT01992094|62973202|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
33576690|NCT01992094|62973203|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
33576691|NCT01992094|62973201|FG000|Overall Study|Adverse Event|1|||
33576692|NCT01992094|62973202|FG001|Overall Study|Adverse Event|0|||
33576693|NCT01992094|62973203|FG002|Overall Study|Adverse Event|0|||
33576694|NCT01992094|62973201|FG000|Overall Study|Death|5|||
33576695|NCT01992094|62973202|FG001|Overall Study|Death|5|||
33576696|NCT01992094|62973203|FG002|Overall Study|Death|2|||
33576697|NCT01992094|62973201|FG000|Overall Study|Lost to Follow-up|26|||
33576698|NCT01992094|62973202|FG001|Overall Study|Lost to Follow-up|9|||
33576699|NCT01992094|62973203|FG002|Overall Study|Lost to Follow-up|13|||
33576700|NCT01992094|62973201|FG000|Overall Study|OTHER|4|||
33576701|NCT01992094|62973202|FG001|Overall Study|OTHER|0|||
33576702|NCT01992094|62973203|FG002|Overall Study|OTHER|0|||
33576703|NCT01992094|62973201|FG000|Overall Study|Protocol Violation|1|||
33576704|NCT01992094|62973202|FG001|Overall Study|Protocol Violation|0|||
33576705|NCT01992094|62973203|FG002|Overall Study|Protocol Violation|1|||
33576706|NCT01992094|62973201|FG000|Overall Study|Withdrawal by Subject|7|||
33576707|NCT01992094|62973202|FG001|Overall Study|Withdrawal by Subject|3|||
33576708|NCT01992094|62973203|FG002|Overall Study|Withdrawal by Subject|4|||
33576709|NCT02706691|62973227|FG000|Overall Study|Adverse Event|1|||
33576710|NCT01991470|62973232|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
33576711|NCT01991470|62973232|FG000|Enlite 1 Period|Adverse Event|1|||
33576712|NCT01991470|62973232|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
33576713|NCT01991470|62973232|FG000|Enlite 3 Period|Lost to Follow-up|1|||
33576714|NCT01991470|62973232|FG000|Enlite 3 Period|Physician Decision|2|||
33576715|NCT01991470|62973232|FG000|Enlite 3 Period|Physician Decision|8|||
33576716|NCT01991470|62973232|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
33576717|NCT01991314|62973246|FG000|Overall Study|Adverse Event|5|||
33576718|NCT01991314|62973247|FG001|Overall Study|Adverse Event|1|||
33576719|NCT01991314|62973246|FG000|Overall Study|Lost to Follow-up|6|||
33576720|NCT01991314|62973247|FG001|Overall Study|Lost to Follow-up|10|||
33576721|NCT01990768|62973256|FG000|Intervention Started|Found to be ineligible|14|||
33576722|NCT01990768|62973257|FG001|Intervention Started|Found to be ineligible|13|||
33576723|NCT01990768|62973258|FG002|Intervention Started|Found to be ineligible|11|||
33576724|NCT01990768|62973256|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
33576725|NCT01990768|62973257|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
33576726|NCT01990768|62973258|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
33576727|NCT01990768|62973256|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
33576728|NCT01990768|62973257|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
33576729|NCT01990768|62973258|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
33576730|NCT01990768|62973256|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
33576731|NCT01990768|62973257|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
33576732|NCT01990768|62973258|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
33576733|NCT01990768|62973256|FG000|Intervention Started|Patient care priority|1|||
33576734|NCT01990768|62973257|FG001|Intervention Started|Patient care priority|2|||
33576735|NCT01990768|62973258|FG002|Intervention Started|Patient care priority|3|||
33576736|NCT01990768|62973256|FG000|Intervention Started|IV lost|2|||
33576737|NCT01990768|62973257|FG001|Intervention Started|IV lost|2|||
33576738|NCT01990768|62973258|FG002|Intervention Started|IV lost|2|||
33576739|NCT01990768|62973256|FG000|Intervention Started|Required CPR|1|||
33576740|NCT01990768|62973257|FG001|Intervention Started|Required CPR|1|||
33576741|NCT01990768|62973258|FG002|Intervention Started|Required CPR|0|||
33576742|NCT01990768|62973256|FG000|Intervention Started|Seizure or hx of seizure|0|||
33576743|NCT01990768|62973257|FG001|Intervention Started|Seizure or hx of seizure|0|||
33576744|NCT01990768|62973258|FG002|Intervention Started|Seizure or hx of seizure|2|||
33576745|NCT01990768|62973256|FG000|Intervention Started|Discovered to be pregnant|0|||
33576746|NCT01990768|62973257|FG001|Intervention Started|Discovered to be pregnant|1|||
33576747|NCT01990768|62973258|FG002|Intervention Started|Discovered to be pregnant|0|||
33576748|NCT01990768|62973256|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
33576749|NCT01990768|62973257|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
33576750|NCT01990768|62973258|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
33576751|NCT01990768|62973256|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
33576752|NCT01990768|62973257|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
33576753|NCT01990768|62973258|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
33576754|NCT01990768|62973256|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
33576755|NCT01990768|62973257|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
33576756|NCT01990768|62973258|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
33576757|NCT01990768|62973256|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
33576758|NCT01990768|62973257|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
33576759|NCT01990768|62973258|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
33576760|NCT01990768|62973256|FG000|Prehospital Study Drug Infusion|Death|3|||
33576761|NCT01990768|62973257|FG001|Prehospital Study Drug Infusion|Death|1|||
33576762|NCT01990768|62973258|FG002|Prehospital Study Drug Infusion|Death|1|||
33576763|NCT01990768|62973256|FG000|Prehospital Study Drug Infusion|Discharged|2|||
33576764|NCT01990768|62973257|FG001|Prehospital Study Drug Infusion|Discharged|1|||
33576765|NCT01990768|62973258|FG002|Prehospital Study Drug Infusion|Discharged|0|||
33576766|NCT01990768|62973256|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
33576767|NCT01990768|62973257|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
33576768|NCT01990768|62973258|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
33576769|NCT01990768|62973256|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
33576770|NCT01990768|62973257|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
33576771|NCT01990768|62973258|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
33576772|NCT01990768|62973256|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
33576773|NCT01990768|62973257|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
33576774|NCT01990768|62973258|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
33576775|NCT01990768|62973256|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
33576776|NCT01990768|62973257|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
33576777|NCT01990768|62973258|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
33576778|NCT01990768|62973256|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
33576779|NCT01990768|62973257|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
33576780|NCT01990768|62973258|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
33576781|NCT01990768|62973256|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
33576782|NCT01990768|62973257|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
33576783|NCT01990768|62973258|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
33576784|NCT01990768|62973256|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
33576785|NCT01990768|62973257|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
33576786|NCT01990768|62973258|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
33576787|NCT01990768|62973256|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
33576788|NCT01990768|62973257|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
33576789|NCT01990768|62973258|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
33576790|NCT01990768|62973256|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
33576791|NCT01990768|62973257|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
33576792|NCT01990768|62973258|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
33576793|NCT01990768|62973256|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
33576794|NCT01990768|62973257|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
33576795|NCT01990768|62973258|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
33576796|NCT01990768|62973256|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
33576797|NCT01990768|62973257|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
33576798|NCT01990768|62973258|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
33576799|NCT01990768|62973256|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
33576800|NCT01990768|62973257|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
33576801|NCT01990768|62973258|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
33576802|NCT01990768|62973256|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
33576803|NCT01990768|62973257|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
33576804|NCT01990768|62973258|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
33576805|NCT01990768|62973256|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
33576806|NCT01990768|62973257|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
33576807|NCT01990768|62973258|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
33576808|NCT01990768|62973256|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
33576809|NCT01990768|62973257|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
33576810|NCT01990768|62973258|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
33576811|NCT01990768|62973256|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
33576812|NCT01990768|62973257|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
33576813|NCT01990768|62973258|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
33576814|NCT01990768|62973256|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
33576815|NCT01990768|62973257|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
33576816|NCT01990768|62973258|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
33576817|NCT01990768|62973256|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
33576818|NCT01990768|62973257|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
33576819|NCT01990768|62973258|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
33576820|NCT01990768|62973256|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
33576821|NCT01990768|62973257|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
33576822|NCT01990768|62973258|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
33576823|NCT01990768|62973256|FG000|6-Month Follow-up|No contact information|5|||
33576824|NCT01990768|62973257|FG001|6-Month Follow-up|No contact information|6|||
33576825|NCT01990768|62973258|FG002|6-Month Follow-up|No contact information|5|||
33576826|NCT01990768|62973256|FG000|6-Month Follow-up|Homeless|4|||
33576827|NCT01990768|62973257|FG001|6-Month Follow-up|Homeless|3|||
33576828|NCT01990768|62973258|FG002|6-Month Follow-up|Homeless|6|||
33576829|NCT01990768|62973256|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
33576830|NCT01990768|62973257|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
33576831|NCT01990768|62973258|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
33576832|NCT01990768|62973256|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
33576833|NCT01990768|62973257|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
33576834|NCT01990768|62973258|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
33576835|NCT01990768|62973256|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
33576836|NCT01990768|62973257|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
33576837|NCT01990768|62973258|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
33576838|NCT01990612|62973269|FG000|Overall Study|Lost to Follow-up|2|||
33576839|NCT01990612|62973270|FG001|Overall Study|Lost to Follow-up|1|||
33576840|NCT01990612|62973269|FG000|Overall Study|Withdrawal by Subject|5|||
33576841|NCT01990612|62973270|FG001|Overall Study|Withdrawal by Subject|2|||
33576842|NCT01990534|62973276|FG000|Overall Study|Death|22|||
33576843|NCT01990534|62973276|FG000|Overall Study|Progressive disease|3|||
33576844|NCT01990534|62973276|FG000|Overall Study|Protocol Violation|1|||
33576845|NCT01990534|62973276|FG000|Overall Study|Withdrawal of Informed Consent|2|||
33576846|NCT01990534|62973276|FG000|Overall Study|Symptomatic Deterioration|1|||
33576847|NCT01990534|62973276|FG000|Overall Study|Withdrawal by Subject|3|||
33576848|NCT01990534|62973276|FG000|Overall Study|Reason not Specified|2|||
33576849|NCT01990534|62973276|FG000|Overall Study|Lost to Follow-up|1|||
33576850|NCT01967134|62973283|FG000|Overall Study|Lost to Follow-up|0|||
33576851|NCT01967134|62973284|FG001|Overall Study|Lost to Follow-up|1|||
33576852|NCT01967134|62973285|FG002|Overall Study|Lost to Follow-up|0|||
33576853|NCT01966432|62973296|FG000|Overall Study|Lost to Follow-up|3|||
33576854|NCT01966432|62973297|FG001|Overall Study|Lost to Follow-up|2|||
33576855|NCT01966432|62973298|FG002|Overall Study|Lost to Follow-up|5|||
33576856|NCT01966432|62973296|FG000|Overall Study|Withdrawal by Subject|1|||
33576857|NCT01966432|62973297|FG001|Overall Study|Withdrawal by Subject|3|||
33576858|NCT01966432|62973298|FG002|Overall Study|Withdrawal by Subject|0|||
33576859|NCT01966432|62973296|FG000|Overall Study|Subject Incarcerated|0|||
33576860|NCT01966432|62973297|FG001|Overall Study|Subject Incarcerated|0|||
33576861|NCT01966432|62973298|FG002|Overall Study|Subject Incarcerated|1|||
33576862|NCT01966432|62973296|FG000|Overall Study|SBIRT program ended|1|||
33576863|NCT01966432|62973297|FG001|Overall Study|SBIRT program ended|8|||
33576864|NCT01966432|62973298|FG002|Overall Study|SBIRT program ended|20|||
33576865|NCT02702401|62973310|FG000|Overall Study|Death|242|||
33576866|NCT02702401|62973311|FG001|Overall Study|Death|125|||
33576867|NCT02702401|62973310|FG000|Overall Study|Withdrawal by Subject|15|||
33576868|NCT02702401|62973311|FG001|Overall Study|Withdrawal by Subject|5|||
33576869|NCT02702401|62973310|FG000|Overall Study|Sponsor Decision|19|||
33576870|NCT02702401|62973311|FG001|Overall Study|Sponsor Decision|3|||
33576871|NCT02702401|62973310|FG000|Overall Study|Physician Decision|1|||
33576872|NCT02702401|62973311|FG001|Overall Study|Physician Decision|2|||
33576873|NCT02702401|62973310|FG000|Overall Study|Lost to Follow-up|1|||
33576874|NCT02702401|62973311|FG001|Overall Study|Lost to Follow-up|0|||
33576875|NCT02703337|62973318|FG000|Period One (Part A)|Withdrawal by Subject|0|||
33576876|NCT02703337|62973319|FG001|Period One (Part A)|Withdrawal by Subject|0|||
33576877|NCT02703337|62973320|FG002|Period One (Part A)|Withdrawal by Subject|0|||
33576878|NCT02703337|62973321|FG003|Period One (Part A)|Withdrawal by Subject|0|||
33576879|NCT02703337|62973322|FG004|Period One (Part A)|Withdrawal by Subject|1|||
33576880|NCT02703337|62973323|FG005|Period One (Part A)|Withdrawal by Subject|0|||
33576881|NCT02703337|62973324|FG006|Period One (Part A)|Withdrawal by Subject|0|||
33576882|NCT02703337|62973325|FG007|Period One (Part A)|Withdrawal by Subject|0|||
33576883|NCT01680497|62973343|FG000|Overall Study|Lost to Follow-up|2|||
33576884|NCT01680341|62973349|FG000|Overall Study|Adverse Event|3|||
33576885|NCT01680341|62973350|FG001|Overall Study|Adverse Event|2|||
33576886|NCT01680341|62973349|FG000|Overall Study|Unclassified|18|||
33576887|NCT01680341|62973350|FG001|Overall Study|Unclassified|15|||
33576888|NCT01679405|62973358|FG000|Overall Study|Death|2|||
33576889|NCT01679405|62973359|FG001|Overall Study|Death|5|||
33576890|NCT01603355|62973365|FG000|Overall Study|Lack of Efficacy|2|||
33576891|NCT02703259|62973371|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
33576892|NCT02703259|62973372|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
33576893|NCT02703259|62973371|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
33576894|NCT02703259|62973372|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
33576895|NCT02703259|62973371|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
33576896|NCT02703259|62973372|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
33576897|NCT00701701|62973380|FG000|Overall Study|Withdrawal by Subject|0|||
33576898|NCT00701701|62973381|FG001|Overall Study|Withdrawal by Subject|1|||
33576899|NCT00701701|62973380|FG000|Overall Study|Adverse Event|0|||
33576900|NCT00701701|62973381|FG001|Overall Study|Adverse Event|1|||
33576901|NCT01989754|62973390|FG000|Overall Study|Withdrawal by Subject|10|||
33576902|NCT01989754|62973391|FG001|Overall Study|Withdrawal by Subject|14|||
33576903|NCT01989754|62973390|FG000|Overall Study|Lost to Follow-up|28|||
33576904|NCT01989754|62973391|FG001|Overall Study|Lost to Follow-up|20|||
33576905|NCT01989754|62973390|FG000|Overall Study|Closed Site|1|||
33576906|NCT01989754|62973391|FG001|Overall Study|Closed Site|1|||
33576907|NCT01619878|62973397|FG000|6 Week Follow-up Phase|Adverse Event|1|||
33576908|NCT01619878|62973397|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
33576909|NCT01619878|62973397|FG000|Follow-up at 12 Months of Age|Death|2|||
33576910|NCT02015104|62973403|FG000|Overall Study|Withdrew consent after first dose drug|1|||
33576911|NCT02015104|62973404|FG001|Overall Study|Withdrew consent after first dose drug|0|||
33576912|NCT02015104|62973403|FG000|Overall Study|Withdrew consent prior to treatment|0|||
33576913|NCT02015104|62973404|FG001|Overall Study|Withdrew consent prior to treatment|1|||
33576914|NCT01619800|62973415|FG000|Overall Study|study terminated|2|||
33576915|NCT01619800|62973416|FG001|Overall Study|study terminated|0|||
33576916|NCT01989208|62973424|FG000|200 mg (7 Days)|Protocol Violation|0|||
33576917|NCT01989208|62973425|FG001|200 mg (7 Days)|Protocol Violation|1|||
33576918|NCT01619410|62973445|FG000|Overall Study|Lost to Follow-up|7|||
33576919|NCT01619410|62973446|FG001|Overall Study|Lost to Follow-up|4|||
33576920|NCT01966042|62973452|FG000|Overall Study|Death|2|||
33576921|NCT02014480|62973456|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
33576922|NCT02014480|62973457|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
33576923|NCT02014480|62973458|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
33576924|NCT02014480|62973459|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
33576925|NCT02014480|62973460|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
33576926|NCT02014480|62973461|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
33576927|NCT02014480|62973456|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33576928|NCT02014480|62973457|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33576929|NCT02014480|62973458|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33576930|NCT02014480|62973459|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
33576931|NCT02014480|62973460|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33576932|NCT02014480|62973461|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33576933|NCT02014480|62973456|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33576934|NCT02014480|62973457|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33576935|NCT02014480|62973458|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
33576936|NCT02014480|62973459|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33576937|NCT02014480|62973460|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33576938|NCT02014480|62973461|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33576939|NCT02014480|62973456|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
33576940|NCT02014480|62973457|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
33576941|NCT02014480|62973458|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
33576942|NCT02014480|62973459|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
33576943|NCT02014480|62973460|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33576944|NCT02014480|62973461|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33576945|NCT02014480|62973456|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33576946|NCT02014480|62973457|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
33576947|NCT02014480|62973458|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33576948|NCT02014480|62973459|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33576949|NCT02014480|62973460|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33576950|NCT02014480|62973461|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33576951|NCT02014480|62973456|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
33576952|NCT02014480|62973457|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
33576953|NCT02014480|62973458|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
33576954|NCT02014480|62973459|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
33576955|NCT02014480|62973460|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
33576956|NCT02014480|62973461|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
33576957|NCT02014480|62973456|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33576958|NCT02014480|62973457|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33576959|NCT02014480|62973458|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33576960|NCT02014480|62973459|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33576961|NCT02014480|62973460|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33576962|NCT02014480|62973461|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
33576963|NCT01261247|62973469|FG000|Overall Study|Ineligible|2|||
33576964|NCT01677767|62973473|FG000|Overall Study|Adverse Event|1|||
33576965|NCT01677767|62973473|FG000|Overall Study|Death|4|||
33576966|NCT01677767|62973473|FG000|Overall Study|Protocol Violation|4|||
33576967|NCT01677767|62973473|FG000|Overall Study|Withdrawal by Subject|10|||
33576968|NCT01677767|62973473|FG000|Overall Study|Non-compliance by the participants|3|||
33576969|NCT01603277|62973494|FG000|Overall Study|Adverse Event|1|||
33576970|NCT01603277|62973495|FG001|Overall Study|Adverse Event|2|||
33576971|NCT01603277|62973494|FG000|Overall Study|Physician Decision|0|||
33576972|NCT01603277|62973495|FG001|Overall Study|Physician Decision|1|||
33576973|NCT01603277|62973494|FG000|Overall Study|Protocol Violation|6|||
33576974|NCT01603277|62973495|FG001|Overall Study|Protocol Violation|10|||
33576975|NCT01603277|62973494|FG000|Overall Study|Withdrawal by Subject|5|||
33576976|NCT01603277|62973495|FG001|Overall Study|Withdrawal by Subject|4|||
33576977|NCT01603277|62973494|FG000|Overall Study|Non-Compliance|2|||
33576978|NCT01603277|62973495|FG001|Overall Study|Non-Compliance|1|||
33576979|NCT01678313|62973503|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
33576980|NCT01678313|62973504|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
33576981|NCT01678313|62973503|FG000|Completed the 3-month Therapy|Physician Decision|3|||
33576982|NCT01678313|62973504|FG001|Completed the 3-month Therapy|Physician Decision|4|||
33576983|NCT01678313|62973503|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
33576984|NCT01678313|62973504|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
33576985|NCT01678313|62973503|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
33576986|NCT01678313|62973504|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
33576987|NCT01603121|62973510|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
33576988|NCT01603121|62973511|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
33576989|NCT01603043|62973519|FG000|Overall Study|Study Futility|7|||
33576990|NCT01603043|62973520|FG001|Overall Study|Study Futility|3|||
33576991|NCT02014402|62973530|FG000|Overall Study|Adverse Event|1|||
33576992|NCT02014402|62973531|FG001|Overall Study|Adverse Event|0|||
33576993|NCT02014402|62973532|FG002|Overall Study|Adverse Event|0|||
33576994|NCT02014402|62973533|FG003|Overall Study|Adverse Event|0|||
33576995|NCT02014402|62973530|FG000|Overall Study|Withdrawal by Subject|1|||
33576996|NCT02014402|62973531|FG001|Overall Study|Withdrawal by Subject|2|||
33576997|NCT02014402|62973532|FG002|Overall Study|Withdrawal by Subject|2|||
33576998|NCT02014402|62973533|FG003|Overall Study|Withdrawal by Subject|1|||
33576999|NCT02014402|62973530|FG000|Overall Study|Subject did not have transportation|0|||
33577000|NCT02014402|62973531|FG001|Overall Study|Subject did not have transportation|1|||
33577001|NCT02014402|62973532|FG002|Overall Study|Subject did not have transportation|0|||
33577002|NCT02014402|62973533|FG003|Overall Study|Subject did not have transportation|0|||
33577003|NCT02014402|62973530|FG000|Overall Study|Lost to Follow-up|0|||
33577004|NCT02014402|62973531|FG001|Overall Study|Lost to Follow-up|0|||
33577005|NCT02014402|62973532|FG002|Overall Study|Lost to Follow-up|1|||
33577006|NCT02014402|62973533|FG003|Overall Study|Lost to Follow-up|2|||
33577007|NCT01988662|62973552|FG000|Overall Study|Subject/guardian decision|1|||
33577008|NCT01988662|62973553|FG001|Overall Study|Subject/guardian decision|1|||
33577009|NCT01988662|62973552|FG000|Overall Study|Adverse Event|3|||
33577010|NCT01988662|62973553|FG001|Overall Study|Adverse Event|1|||
33577011|NCT02839343|62973562|FG000|Overall Study|Withdrawal by Subject|3|||
33577012|NCT02839343|62973563|FG001|Overall Study|Withdrawal by Subject|1|||
33577013|NCT02839343|62973562|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
33577014|NCT02839343|62973563|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
33577015|NCT02839343|62973562|FG000|Overall Study|Adverse Event|1|||
33577016|NCT02839343|62973563|FG001|Overall Study|Adverse Event|0|||
33577017|NCT01965652|62973592|FG000|Overall Study|Adverse Event|40|||
33577018|NCT01965652|62973593|FG001|Overall Study|Adverse Event|37|||
33577019|NCT01965652|62973592|FG000|Overall Study|Withdrawal by Subject|62|||
33577020|NCT01965652|62973593|FG001|Overall Study|Withdrawal by Subject|69|||
33577021|NCT01965652|62973592|FG000|Overall Study|Lost to Follow-up|53|||
33577022|NCT01965652|62973593|FG001|Overall Study|Lost to Follow-up|40|||
33577023|NCT01965652|62973592|FG000|Overall Study|Protocol Violation|34|||
33577024|NCT01965652|62973593|FG001|Overall Study|Protocol Violation|38|||
33577025|NCT01965652|62973592|FG000|Overall Study|Death|3|||
33577026|NCT01965652|62973593|FG001|Overall Study|Death|4|||
33577027|NCT01965652|62973592|FG000|Overall Study|Other - Miscellaneous|18|||
33577028|NCT01965652|62973593|FG001|Overall Study|Other - Miscellaneous|21|||
33577029|NCT01965652|62973592|FG000|Overall Study|Pregnancy|0|||
33577030|NCT01965652|62973593|FG001|Overall Study|Pregnancy|1|||
33577031|NCT01602965|62973601|FG000|Overall Study|Lost to Follow-up|4|||
33577032|NCT01602965|62973602|FG001|Overall Study|Lost to Follow-up|2|||
33577033|NCT01987960|62973610|FG000|Period 1|Adverse Event|24|||
33577034|NCT01987960|62973611|FG001|Period 1|Adverse Event|0|||
33577035|NCT01987960|62973612|FG002|Period 1|Adverse Event|0|||
33577036|NCT01987960|62973613|FG003|Period 1|Adverse Event|0|||
33577037|NCT01987960|62973610|FG000|Period 1|Lack of Efficacy|4|||
33577038|NCT01987960|62973611|FG001|Period 1|Lack of Efficacy|0|||
33577039|NCT01987960|62973612|FG002|Period 1|Lack of Efficacy|0|||
33577040|NCT01987960|62973613|FG003|Period 1|Lack of Efficacy|0|||
33577041|NCT01987960|62973610|FG000|Period 1|Non-compliance with IMP|6|||
33577042|NCT01987960|62973611|FG001|Period 1|Non-compliance with IMP|0|||
33577043|NCT01987960|62973612|FG002|Period 1|Non-compliance with IMP|0|||
33577044|NCT01987960|62973613|FG003|Period 1|Non-compliance with IMP|0|||
33577045|NCT01987960|62973610|FG000|Period 1|Protocol Violation|12|||
33577046|NCT01987960|62973611|FG001|Period 1|Protocol Violation|0|||
33577047|NCT01987960|62973612|FG002|Period 1|Protocol Violation|0|||
33577048|NCT01987960|62973613|FG003|Period 1|Protocol Violation|0|||
33577049|NCT01987960|62973610|FG000|Period 1|Withdrawal by Subject|21|||
33577050|NCT01987960|62973611|FG001|Period 1|Withdrawal by Subject|0|||
33577051|NCT01987960|62973612|FG002|Period 1|Withdrawal by Subject|0|||
33577052|NCT01987960|62973613|FG003|Period 1|Withdrawal by Subject|0|||
33577053|NCT01987960|62973610|FG000|Period 1|Lost to Follow-up|40|||
33577054|NCT01987960|62973611|FG001|Period 1|Lost to Follow-up|0|||
33577055|NCT01987960|62973612|FG002|Period 1|Lost to Follow-up|0|||
33577056|NCT01987960|62973613|FG003|Period 1|Lost to Follow-up|0|||
33577057|NCT01987960|62973610|FG000|Period 1|administrative or other reason|75|||
33577058|NCT01987960|62973611|FG001|Period 1|administrative or other reason|0|||
33577059|NCT01987960|62973612|FG002|Period 1|administrative or other reason|0|||
33577060|NCT01987960|62973613|FG003|Period 1|administrative or other reason|0|||
33577061|NCT01987960|62973610|FG000|Period 1|Withdrawal of consent before treatment|4|||
33577062|NCT01987960|62973611|FG001|Period 1|Withdrawal of consent before treatment|0|||
33577063|NCT01987960|62973612|FG002|Period 1|Withdrawal of consent before treatment|0|||
33577064|NCT01987960|62973613|FG003|Period 1|Withdrawal of consent before treatment|0|||
33577065|NCT01987960|62973610|FG000|Period 2|Adverse Event|0|||
33577066|NCT01987960|62973611|FG001|Period 2|Adverse Event|0|||
33577067|NCT01987960|62973612|FG002|Period 2|Adverse Event|1|||
33577068|NCT01987960|62973613|FG003|Period 2|Adverse Event|0|||
33577069|NCT01987960|62973610|FG000|Period 2|Withdrawal by Subject|0|||
33577070|NCT01987960|62973611|FG001|Period 2|Withdrawal by Subject|0|||
33577071|NCT01987960|62973612|FG002|Period 2|Withdrawal by Subject|1|||
33577072|NCT01987960|62973613|FG003|Period 2|Withdrawal by Subject|0|||
33577073|NCT01987960|62973610|FG000|Period 2|Administrative or other reason|0|||
33577074|NCT01987960|62973611|FG001|Period 2|Administrative or other reason|5|||
33577075|NCT01987960|62973612|FG002|Period 2|Administrative or other reason|7|||
33577076|NCT01987960|62973613|FG003|Period 2|Administrative or other reason|0|||
33577077|NCT01987960|62973610|FG000|Period 3|Adverse Event|0|||
33577078|NCT01987960|62973611|FG001|Period 3|Adverse Event|0|||
33577079|NCT01987960|62973612|FG002|Period 3|Adverse Event|0|||
33577080|NCT01987960|62973613|FG003|Period 3|Adverse Event|7|||
33577081|NCT01987960|62973610|FG000|Period 3|Non-compliance with IMP|0|||
33577082|NCT01987960|62973611|FG001|Period 3|Non-compliance with IMP|0|||
33577083|NCT01987960|62973612|FG002|Period 3|Non-compliance with IMP|0|||
33577084|NCT01987960|62973613|FG003|Period 3|Non-compliance with IMP|1|||
33577085|NCT01987960|62973610|FG000|Period 3|Protocol Violation|0|||
33577086|NCT01987960|62973611|FG001|Period 3|Protocol Violation|0|||
33577087|NCT01987960|62973612|FG002|Period 3|Protocol Violation|0|||
33577088|NCT01987960|62973613|FG003|Period 3|Protocol Violation|6|||
33577089|NCT01987960|62973610|FG000|Period 3|Withdrawal by Subject|0|||
33577090|NCT01987960|62973611|FG001|Period 3|Withdrawal by Subject|0|||
33577091|NCT01987960|62973612|FG002|Period 3|Withdrawal by Subject|0|||
33577092|NCT01987960|62973613|FG003|Period 3|Withdrawal by Subject|9|||
33577093|NCT01987960|62973610|FG000|Period 3|Lost to Follow-up|0|||
33577094|NCT01987960|62973611|FG001|Period 3|Lost to Follow-up|0|||
33577095|NCT01987960|62973612|FG002|Period 3|Lost to Follow-up|0|||
33577096|NCT01987960|62973613|FG003|Period 3|Lost to Follow-up|5|||
33577097|NCT01987960|62973610|FG000|Period 3|Administrative or other reason|0|||
33577098|NCT01987960|62973611|FG001|Period 3|Administrative or other reason|0|||
33577099|NCT01987960|62973612|FG002|Period 3|Administrative or other reason|0|||
33577100|NCT01987960|62973613|FG003|Period 3|Administrative or other reason|43|||
33577101|NCT02013778|62973623|FG000|Overall Study|Death|4|||
33577102|NCT02013778|62973623|FG000|Overall Study|Withdrawal by Subject|1|||
33577103|NCT02013778|62973623|FG000|Overall Study|Physician Decision|1|||
33577104|NCT02013778|62973623|FG000|Overall Study|Adverse Event|1|||
33577105|NCT02013622|62973627|FG000|Overall Study|Lost to Follow-up|10|||
33577106|NCT02013622|62973627|FG000|Overall Study|Adverse Event|3|||
33577107|NCT02013622|62973627|FG000|Overall Study|Met Withdrawal Criteria|3|||
33577108|NCT02013622|62973627|FG000|Overall Study|Withdrawal by Subject|6|||
33577109|NCT02013622|62973627|FG000|Overall Study|Protocol Deviation|1|||
33577110|NCT02013622|62973627|FG000|Overall Study|Lack of Efficacy|1|||
33577111|NCT01987102|62973633|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
33577112|NCT01987102|62973634|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
33577113|NCT01987102|62973633|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
33577114|NCT01987102|62973634|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
33577115|NCT01987102|62973633|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
33577116|NCT01987102|62973634|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
33577117|NCT01987102|62973633|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
33577118|NCT01987102|62973634|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
33577119|NCT01987102|62973633|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
33577120|NCT01987102|62973634|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
33577121|NCT01987102|62973633|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
33577122|NCT01987102|62973634|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
33577123|NCT02013544|62973643|FG000|Overall Study|Adverse Event|5|||
33577124|NCT02013544|62973644|FG001|Overall Study|Adverse Event|5|||
33577125|NCT02013544|62973643|FG000|Overall Study|Lost to Follow-up|2|||
33577126|NCT02013544|62973644|FG001|Overall Study|Lost to Follow-up|3|||
33577127|NCT02013544|62973643|FG000|Overall Study|Withdrawal by Subject|2|||
33577128|NCT02013544|62973644|FG001|Overall Study|Withdrawal by Subject|8|||
33577129|NCT02013544|62973643|FG000|Overall Study|Physician Decision|0|||
33577130|NCT02013544|62973644|FG001|Overall Study|Physician Decision|1|||
33577131|NCT02013544|62973643|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
33577132|NCT02013544|62973644|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
33577133|NCT02013388|62973658|FG000|Overall Study|work emergency|1|||
33577134|NCT02013388|62973659|FG001|Overall Study|work emergency|0|||
33577135|NCT02013388|62973660|FG002|Overall Study|work emergency|0|||
33577136|NCT02013388|62973661|FG003|Overall Study|work emergency|0|||
33577137|NCT02013388|62973662|FG004|Overall Study|work emergency|1|||
33577138|NCT02013388|62973663|FG005|Overall Study|work emergency|0|||
33577139|NCT02013388|62973664|FG006|Overall Study|work emergency|0|||
33577140|NCT02013388|62973665|FG007|Overall Study|work emergency|0|||
33577141|NCT02012686|62973689|FG000|Overall Study|muscle contraction|0|||
33577142|NCT02012686|62973690|FG001|Overall Study|muscle contraction|1|||
33577143|NCT02012686|62973689|FG000|Overall Study|electrocardiography monitoring noise|0|||
33577144|NCT02012686|62973690|FG001|Overall Study|electrocardiography monitoring noise|1|||
33577145|NCT02012452|62973698|FG000|Overall Study|Lost to Follow-up|2|||
33577146|NCT02012452|62973699|FG001|Overall Study|Lost to Follow-up|1|||
33577147|NCT02012452|62973698|FG000|Overall Study|Withdrawal by Subject|4|||
33577148|NCT02012452|62973699|FG001|Overall Study|Withdrawal by Subject|0|||
33577149|NCT01676909|62973707|FG000|Overall Study|Withdrawal by Subject|3|||
33577150|NCT01676909|62973708|FG001|Overall Study|Withdrawal by Subject|5|||
33577151|NCT01676909|62973707|FG000|Overall Study|Lost to Follow-up|15|||
33577152|NCT01676909|62973708|FG001|Overall Study|Lost to Follow-up|9|||
33577153|NCT02012296|62973719|FG000|Overall Study|Lack of Efficacy|0|||
33577154|NCT02012296|62973720|FG001|Overall Study|Lack of Efficacy|0|||
33577155|NCT02012296|62973721|FG002|Overall Study|Lack of Efficacy|15|||
33577156|NCT02012296|62973719|FG000|Overall Study|Adverse Event|0|||
33577157|NCT02012296|62973720|FG001|Overall Study|Adverse Event|0|||
33577158|NCT02012296|62973721|FG002|Overall Study|Adverse Event|2|||
33577159|NCT02012296|62973719|FG000|Overall Study|Early study closure|0|||
33577160|NCT02012296|62973720|FG001|Overall Study|Early study closure|0|||
33577161|NCT02012296|62973721|FG002|Overall Study|Early study closure|5|||
33577162|NCT02012296|62973719|FG000|Overall Study|Protocol Violation|0|||
33577163|NCT02012296|62973720|FG001|Overall Study|Protocol Violation|1|||
33577164|NCT02012296|62973721|FG002|Overall Study|Protocol Violation|0|||
33577165|NCT02012218|62973738|FG000|Overall Study|Withdrawal by Subject|1|||
33577166|NCT02012218|62973739|FG001|Overall Study|Withdrawal by Subject|0|||
33577167|NCT02012218|62973740|FG002|Overall Study|Withdrawal by Subject|1|||
33577168|NCT02012218|62973741|FG003|Overall Study|Withdrawal by Subject|1|||
33577169|NCT02012218|62973742|FG004|Overall Study|Withdrawal by Subject|1|||
33577170|NCT02012218|62973738|FG000|Overall Study|Adverse Event|1|||
33577171|NCT02012218|62973739|FG001|Overall Study|Adverse Event|0|||
33577172|NCT02012218|62973740|FG002|Overall Study|Adverse Event|0|||
33577173|NCT02012218|62973741|FG003|Overall Study|Adverse Event|1|||
33577174|NCT02012218|62973742|FG004|Overall Study|Adverse Event|0|||
33577175|NCT02012218|62973738|FG000|Overall Study|Lost to Follow-up|0|||
33577176|NCT02012218|62973739|FG001|Overall Study|Lost to Follow-up|1|||
33577177|NCT02012218|62973740|FG002|Overall Study|Lost to Follow-up|1|||
33577178|NCT02012218|62973741|FG003|Overall Study|Lost to Follow-up|0|||
33577179|NCT02012218|62973742|FG004|Overall Study|Lost to Follow-up|0|||
33577180|NCT02012218|62973738|FG000|Overall Study|Protocol Specified|1|||
33577181|NCT02012218|62973739|FG001|Overall Study|Protocol Specified|0|||
33577182|NCT02012218|62973740|FG002|Overall Study|Protocol Specified|0|||
33577183|NCT02012218|62973741|FG003|Overall Study|Protocol Specified|0|||
33577184|NCT02012218|62973742|FG004|Overall Study|Protocol Specified|0|||
33577185|NCT02012218|62973738|FG000|Overall Study|Protocol Deviation|1|||
33577186|NCT02012218|62973739|FG001|Overall Study|Protocol Deviation|0|||
33577187|NCT02012218|62973740|FG002|Overall Study|Protocol Deviation|0|||
33577188|NCT02012218|62973741|FG003|Overall Study|Protocol Deviation|0|||
33577189|NCT02012218|62973742|FG004|Overall Study|Protocol Deviation|0|||
33577190|NCT01965262|62973754|FG000|Second Intervention (7 Days)|Discontinued|0|||
33577191|NCT01965262|62973755|FG001|Second Intervention (7 Days)|Discontinued|1|||
33577192|NCT01965262|62973754|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
33577193|NCT01965262|62973755|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
33577194|NCT01965262|62973754|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
33577195|NCT01965262|62973755|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
33577196|NCT01677377|62973764|FG000|Overall Study|Protocol Violation|1|||
33577197|NCT01677377|62973765|FG001|Overall Study|Protocol Violation|0|||
33577198|NCT01677377|62973766|FG002|Overall Study|Protocol Violation|0|||
33577199|NCT01677377|62973764|FG000|Overall Study|Lost to Follow-up|0|||
33577200|NCT01677377|62973765|FG001|Overall Study|Lost to Follow-up|1|||
33577201|NCT01677377|62973766|FG002|Overall Study|Lost to Follow-up|1|||
33577202|NCT01677377|62973764|FG000|Overall Study|Withdrawal by Subject|0|||
33577203|NCT01677377|62973765|FG001|Overall Study|Withdrawal by Subject|0|||
33577204|NCT01677377|62973766|FG002|Overall Study|Withdrawal by Subject|3|||
33577205|NCT01677377|62973764|FG000|Overall Study|Lack of Efficacy|0|||
33577206|NCT01677377|62973765|FG001|Overall Study|Lack of Efficacy|0|||
33577207|NCT01677377|62973766|FG002|Overall Study|Lack of Efficacy|1|||
33577208|NCT01677377|62973764|FG000|Overall Study|Pregnancy|0|||
33577209|NCT01677377|62973765|FG001|Overall Study|Pregnancy|0|||
33577210|NCT01677377|62973766|FG002|Overall Study|Pregnancy|1|||
33577211|NCT01964950|62973776|FG000|Overall Study|Protocol Violation|25|||
33577212|NCT01964716|62973785|FG000|Overall Study|Withdrawal by Subject|2|||
33577213|NCT01964716|62973786|FG001|Overall Study|Withdrawal by Subject|3|||
33577214|NCT01964716|62973785|FG000|Overall Study|Lost to Follow-up|1|||
33577215|NCT01964716|62973786|FG001|Overall Study|Lost to Follow-up|2|||
33577216|NCT01964716|62973785|FG000|Overall Study|No longer met eligibility criteria|1|||
33577217|NCT01964716|62973786|FG001|Overall Study|No longer met eligibility criteria|1|||
33577218|NCT01964716|62973785|FG000|Overall Study|Death|1|||
33577219|NCT01964716|62973786|FG001|Overall Study|Death|0|||
33577220|NCT01964560|62973800|FG000|Overall Study|Adverse Event|23|||
33577221|NCT01964560|62973800|FG000|Overall Study|Lack of Efficacy|46|||
33577222|NCT01964560|62973800|FG000|Overall Study|Protocol deviation|2|||
33577223|NCT01964560|62973800|FG000|Overall Study|Lost to Follow-up|4|||
33577224|NCT01964560|62973800|FG000|Overall Study|Withdrawal by Subject|64|||
33577225|NCT01964560|62973800|FG000|Overall Study|Surgery-hemispherotomy|1|||
33577226|NCT01964560|62973800|FG000|Overall Study|Surgery|1|||
33577227|NCT01964560|62973800|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
33577228|NCT01964560|62973800|FG000|Overall Study|Patient and Investigator choice|1|||
33577229|NCT01964560|62973800|FG000|Overall Study|Patient was prescribed CBD|1|||
33577230|NCT01964560|62973800|FG000|Overall Study|Participant moved to another country|1|||
33577231|NCT02659943|62973811|FG000|Overall Study|Switched to alternative treatment|1|||
33577232|NCT02659943|62973812|FG001|Overall Study|Switched to alternative treatment|1|||
33577233|NCT02659943|62973813|FG002|Overall Study|Switched to alternative treatment|0|||
33577234|NCT02659943|62973814|FG003|Overall Study|Switched to alternative treatment|2|||
33577235|NCT02659943|62973815|FG004|Overall Study|Switched to alternative treatment|1|||
33577236|NCT02659943|62973816|FG005|Overall Study|Switched to alternative treatment|0|||
33577237|NCT02659943|62973817|FG006|Overall Study|Switched to alternative treatment|1|||
33577238|NCT02659943|62973811|FG000|Overall Study|Disease progression on study|0|||
33577239|NCT02659943|62973812|FG001|Overall Study|Disease progression on study|1|||
33577240|NCT02659943|62973813|FG002|Overall Study|Disease progression on study|1|||
33577241|NCT02659943|62973814|FG003|Overall Study|Disease progression on study|1|||
33577242|NCT02659943|62973815|FG004|Overall Study|Disease progression on study|1|||
33577243|NCT02659943|62973816|FG005|Overall Study|Disease progression on study|4|||
33577244|NCT02659943|62973817|FG006|Overall Study|Disease progression on study|0|||
33577245|NCT02659943|62973811|FG000|Overall Study|Patient's condition per principal investigator|0|||
33577246|NCT02659943|62973812|FG001|Overall Study|Patient's condition per principal investigator|0|||
33577247|NCT02659943|62973813|FG002|Overall Study|Patient's condition per principal investigator|0|||
33577248|NCT02659943|62973814|FG003|Overall Study|Patient's condition per principal investigator|0|||
33577249|NCT02659943|62973815|FG004|Overall Study|Patient's condition per principal investigator|0|||
33577250|NCT02659943|62973816|FG005|Overall Study|Patient's condition per principal investigator|1|||
33577251|NCT02659943|62973817|FG006|Overall Study|Patient's condition per principal investigator|0|||
33577252|NCT02659943|62973811|FG000|Overall Study|Ineligible|0|||
33577253|NCT02659943|62973812|FG001|Overall Study|Ineligible|0|||
33577254|NCT02659943|62973813|FG002|Overall Study|Ineligible|0|||
33577255|NCT02659943|62973814|FG003|Overall Study|Ineligible|0|||
33577256|NCT02659943|62973815|FG004|Overall Study|Ineligible|0|||
33577257|NCT02659943|62973816|FG005|Overall Study|Ineligible|0|||
33577258|NCT02659943|62973817|FG006|Overall Study|Ineligible|1|||
33577259|NCT02659943|62973811|FG000|Overall Study|No longer meets eligibility|0|||
33577260|NCT02659943|62973812|FG001|Overall Study|No longer meets eligibility|0|||
33577261|NCT02659943|62973813|FG002|Overall Study|No longer meets eligibility|0|||
33577262|NCT02659943|62973814|FG003|Overall Study|No longer meets eligibility|0|||
33577263|NCT02659943|62973815|FG004|Overall Study|No longer meets eligibility|0|||
33577264|NCT02659943|62973816|FG005|Overall Study|No longer meets eligibility|0|||
33577265|NCT02659943|62973817|FG006|Overall Study|No longer meets eligibility|1|||
33577266|NCT02659943|62973811|FG000|Overall Study|No treatment, per protocol|0|||
33577267|NCT02659943|62973812|FG001|Overall Study|No treatment, per protocol|0|||
33577268|NCT02659943|62973813|FG002|Overall Study|No treatment, per protocol|0|||
33577269|NCT02659943|62973814|FG003|Overall Study|No treatment, per protocol|0|||
33577270|NCT02659943|62973815|FG004|Overall Study|No treatment, per protocol|0|||
33577271|NCT02659943|62973816|FG005|Overall Study|No treatment, per protocol|0|||
33577272|NCT02659943|62973817|FG006|Overall Study|No treatment, per protocol|3|||
33577273|NCT01677299|62973842|FG000|Overall Study|Adverse Event|0|||
33577274|NCT01677299|62973843|FG001|Overall Study|Adverse Event|2|||
33577275|NCT01677299|62973844|FG002|Overall Study|Adverse Event|1|||
33577276|NCT01677299|62973845|FG003|Overall Study|Adverse Event|0|||
33577277|NCT01677299|62973842|FG000|Overall Study|Withdrawal by Subject|0|||
33577278|NCT01677299|62973843|FG001|Overall Study|Withdrawal by Subject|1|||
33577279|NCT01677299|62973844|FG002|Overall Study|Withdrawal by Subject|0|||
33577280|NCT01677299|62973845|FG003|Overall Study|Withdrawal by Subject|1|||
33577281|NCT01964326|62973859|FG000|Overall Study|Adverse Event|48|||
33577282|NCT01964326|62973859|FG000|Overall Study|Death|2|||
33577283|NCT01964326|62973859|FG000|Overall Study|Protocol Violation|4|||
33577284|NCT01964326|62973859|FG000|Overall Study|Lost to Follow-up|88|||
33577285|NCT01964326|62973859|FG000|Overall Study|Withdrawal by Subject|87|||
33577286|NCT01964326|62973859|FG000|Overall Study|Pregnancy|1|||
33577287|NCT01964326|62973859|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
33577288|NCT01964326|62973859|FG000|Overall Study|Physician Decision|55|||
33577289|NCT01964326|62973859|FG000|Overall Study|Investigator Discretion|1|||
33577290|NCT01964326|62973859|FG000|Overall Study|Other|9|||
33577291|NCT01964326|62973859|FG000|Overall Study|Did not meet eligibility criteria|1|||
33577292|NCT02699749|62973877|FG000|Overall Study|Other|0|||
33577293|NCT02699749|62973878|FG001|Overall Study|Other|0|||
33577294|NCT02699749|62973879|FG002|Overall Study|Other|2|||
33665973|NCT01522651|63098160|FG002|Overall Study|Adverse Event|4|||
33577295|NCT02699749|62973880|FG003|Overall Study|Other|0|||
33577296|NCT02699749|62973881|FG004|Overall Study|Other|0|||
33577297|NCT02699749|62973882|FG005|Overall Study|Other|1|||
33577298|NCT02699749|62973883|FG006|Overall Study|Other|1|||
33577299|NCT02699749|62973884|FG007|Overall Study|Other|0|||
33577300|NCT02699749|62973885|FG008|Overall Study|Other|0|||
33577301|NCT02699749|62973886|FG009|Overall Study|Other|0|||
33577302|NCT02699749|62973887|FG010|Overall Study|Other|1|||
33577303|NCT02699749|62973888|FG011|Overall Study|Other|0|||
33577304|NCT02699749|62973889|FG012|Overall Study|Other|0|||
33577305|NCT02699749|62973890|FG013|Overall Study|Other|0|||
33577306|NCT02699749|62973877|FG000|Overall Study|Progressive Disease|3|||
33577307|NCT02699749|62973878|FG001|Overall Study|Progressive Disease|3|||
33577308|NCT02699749|62973879|FG002|Overall Study|Progressive Disease|14|||
33577309|NCT02699749|62973880|FG003|Overall Study|Progressive Disease|3|||
33577310|NCT02699749|62973881|FG004|Overall Study|Progressive Disease|3|||
33577311|NCT02699749|62973882|FG005|Overall Study|Progressive Disease|7|||
33577312|NCT02699749|62973883|FG006|Overall Study|Progressive Disease|5|||
33577313|NCT02699749|62973884|FG007|Overall Study|Progressive Disease|5|||
33577314|NCT02699749|62973885|FG008|Overall Study|Progressive Disease|6|||
33577315|NCT02699749|62973886|FG009|Overall Study|Progressive Disease|6|||
33577316|NCT02699749|62973887|FG010|Overall Study|Progressive Disease|5|||
33577317|NCT02699749|62973888|FG011|Overall Study|Progressive Disease|4|||
33577318|NCT02699749|62973889|FG012|Overall Study|Progressive Disease|3|||
33577319|NCT02699749|62973890|FG013|Overall Study|Progressive Disease|5|||
33577320|NCT02699749|62973877|FG000|Overall Study|Death|0|||
33577321|NCT02699749|62973878|FG001|Overall Study|Death|0|||
33577322|NCT02699749|62973879|FG002|Overall Study|Death|0|||
33577323|NCT02699749|62973880|FG003|Overall Study|Death|0|||
33577324|NCT02699749|62973881|FG004|Overall Study|Death|0|||
33577325|NCT02699749|62973882|FG005|Overall Study|Death|0|||
33577326|NCT02699749|62973883|FG006|Overall Study|Death|0|||
33577327|NCT02699749|62973884|FG007|Overall Study|Death|0|||
33577328|NCT02699749|62973885|FG008|Overall Study|Death|0|||
33577329|NCT02699749|62973886|FG009|Overall Study|Death|0|||
33577330|NCT02699749|62973887|FG010|Overall Study|Death|0|||
33577331|NCT02699749|62973888|FG011|Overall Study|Death|0|||
33577332|NCT02699749|62973889|FG012|Overall Study|Death|0|||
33577333|NCT02699749|62973890|FG013|Overall Study|Death|1|||
33577334|NCT02699749|62973877|FG000|Overall Study|Lost to Follow-up|0|||
33577335|NCT02699749|62973878|FG001|Overall Study|Lost to Follow-up|0|||
33577336|NCT02699749|62973879|FG002|Overall Study|Lost to Follow-up|0|||
33577337|NCT02699749|62973880|FG003|Overall Study|Lost to Follow-up|0|||
33577338|NCT02699749|62973881|FG004|Overall Study|Lost to Follow-up|0|||
33577339|NCT02699749|62973882|FG005|Overall Study|Lost to Follow-up|1|||
33577340|NCT02699749|62973883|FG006|Overall Study|Lost to Follow-up|0|||
33577341|NCT02699749|62973884|FG007|Overall Study|Lost to Follow-up|1|||
33577342|NCT02699749|62973885|FG008|Overall Study|Lost to Follow-up|0|||
33577343|NCT02699749|62973886|FG009|Overall Study|Lost to Follow-up|0|||
33577344|NCT02699749|62973887|FG010|Overall Study|Lost to Follow-up|0|||
33577345|NCT02699749|62973888|FG011|Overall Study|Lost to Follow-up|0|||
33577346|NCT02699749|62973889|FG012|Overall Study|Lost to Follow-up|0|||
33577347|NCT02699749|62973890|FG013|Overall Study|Lost to Follow-up|0|||
33577348|NCT02699593|62973920|FG000|Period 1|Unsatisfactory Visual Response|0|||
33577349|NCT02699593|62973921|FG001|Period 1|Unsatisfactory Visual Response|1|||
33577350|NCT02699593|62973920|FG000|Period 1|Torn Contact Len|4|||
33577351|NCT02699593|62973921|FG001|Period 1|Torn Contact Len|3|||
33577352|NCT02699593|62973920|FG000|Period 1|Protocol Violation|0|||
33577353|NCT02699593|62973921|FG001|Period 1|Protocol Violation|1|||
33577354|NCT02699593|62973920|FG000|Period 1|Withdrawal by Subject|0|||
33577355|NCT02699593|62973921|FG001|Period 1|Withdrawal by Subject|1|||
33577356|NCT02699593|62973920|FG000|Period 1|Adverse Event|1|||
33577357|NCT02699593|62973921|FG001|Period 1|Adverse Event|1|||
33577358|NCT02699593|62973920|FG000|Period 2|Adverse Event|1|||
33577359|NCT02699593|62973921|FG001|Period 2|Adverse Event|1|||
33577360|NCT02699593|62973920|FG000|Period 2|Lost Contact Lens|0|||
33577361|NCT02699593|62973921|FG001|Period 2|Lost Contact Lens|1|||
33577362|NCT02699593|62973920|FG000|Period 2|Torn Contact Lens|1|||
33577363|NCT02699593|62973921|FG001|Period 2|Torn Contact Lens|0|||
33577364|NCT00708097|62973927|FG000|Period 1|Protocol Violation|0|||
33577365|NCT00708097|62973928|FG001|Period 1|Protocol Violation|1|||
33577366|NCT00708097|62973929|FG002|Period 1|Protocol Violation|0|||
33577367|NCT00708097|62973930|FG003|Period 1|Protocol Violation|2|||
33577368|NCT00708097|62973931|FG004|Period 1|Protocol Violation|0|||
33577369|NCT00708097|62973927|FG000|Period 1|Other Reason|0|||
33577370|NCT00708097|62973928|FG001|Period 1|Other Reason|0|||
33577371|NCT00708097|62973929|FG002|Period 1|Other Reason|0|||
33577372|NCT00708097|62973930|FG003|Period 1|Other Reason|0|||
33577373|NCT00708097|62973931|FG004|Period 1|Other Reason|1|||
33577374|NCT00708097|62973927|FG000|Period 2|Protocol Violation|0|||
33577375|NCT00708097|62973928|FG001|Period 2|Protocol Violation|1|||
33577376|NCT00708097|62973929|FG002|Period 2|Protocol Violation|1|||
33577377|NCT00708097|62973930|FG003|Period 2|Protocol Violation|1|||
33577378|NCT00708097|62973931|FG004|Period 2|Protocol Violation|0|||
33577379|NCT02659631|62973958|FG000|Overall Study|Lost to Follow-up|0|||
33577380|NCT02659631|62973959|FG001|Overall Study|Lost to Follow-up|0|||
33577381|NCT02659631|62973960|FG002|Overall Study|Lost to Follow-up|2|||
33577382|NCT02659631|62973961|FG003|Overall Study|Lost to Follow-up|0|||
33577383|NCT02659631|62973962|FG004|Overall Study|Lost to Follow-up|0|||
33577384|NCT02659631|62973963|FG005|Overall Study|Lost to Follow-up|1|||
33577385|NCT02659631|62973964|FG006|Overall Study|Lost to Follow-up|0|||
33577386|NCT02659631|62973965|FG007|Overall Study|Lost to Follow-up|0|||
33577387|NCT02659631|62973966|FG008|Overall Study|Lost to Follow-up|0|||
33577388|NCT02659631|62973967|FG009|Overall Study|Lost to Follow-up|0|||
33577389|NCT02659631|62973958|FG000|Overall Study|Withdrawal prior to treatment|0|||
33577390|NCT02659631|62973959|FG001|Overall Study|Withdrawal prior to treatment|0|||
33577391|NCT02659631|62973960|FG002|Overall Study|Withdrawal prior to treatment|0|||
33577392|NCT02659631|62973961|FG003|Overall Study|Withdrawal prior to treatment|0|||
33577393|NCT02659631|62973962|FG004|Overall Study|Withdrawal prior to treatment|1|||
33577394|NCT02659631|62973963|FG005|Overall Study|Withdrawal prior to treatment|0|||
33577395|NCT02659631|62973964|FG006|Overall Study|Withdrawal prior to treatment|0|||
33577396|NCT02659631|62973965|FG007|Overall Study|Withdrawal prior to treatment|0|||
33577397|NCT02659631|62973966|FG008|Overall Study|Withdrawal prior to treatment|0|||
33577398|NCT02659631|62973967|FG009|Overall Study|Withdrawal prior to treatment|0|||
33577399|NCT02659631|62973958|FG000|Overall Study|Participant refused further follow-up|0|||
33577400|NCT02659631|62973959|FG001|Overall Study|Participant refused further follow-up|0|||
33577401|NCT02659631|62973960|FG002|Overall Study|Participant refused further follow-up|0|||
33577402|NCT02659631|62973961|FG003|Overall Study|Participant refused further follow-up|1|||
33577403|NCT02659631|62973962|FG004|Overall Study|Participant refused further follow-up|0|||
33577404|NCT02659631|62973963|FG005|Overall Study|Participant refused further follow-up|0|||
33577405|NCT02659631|62973964|FG006|Overall Study|Participant refused further follow-up|0|||
33577406|NCT02659631|62973965|FG007|Overall Study|Participant refused further follow-up|0|||
33577407|NCT02659631|62973966|FG008|Overall Study|Participant refused further follow-up|1|||
33577408|NCT02659631|62973967|FG009|Overall Study|Participant refused further follow-up|0|||
33577409|NCT02659631|62973958|FG000|Overall Study|Death (follow-up phase)|1|||
33577410|NCT02659631|62973959|FG001|Overall Study|Death (follow-up phase)|2|||
33577411|NCT02659631|62973960|FG002|Overall Study|Death (follow-up phase)|1|||
33577412|NCT02659631|62973961|FG003|Overall Study|Death (follow-up phase)|1|||
33577413|NCT02659631|62973962|FG004|Overall Study|Death (follow-up phase)|3|||
33577414|NCT02659631|62973963|FG005|Overall Study|Death (follow-up phase)|2|||
33577415|NCT02659631|62973964|FG006|Overall Study|Death (follow-up phase)|0|||
33577416|NCT02659631|62973965|FG007|Overall Study|Death (follow-up phase)|3|||
33665974|NCT01522651|63098161|FG003|Overall Study|Adverse Event|5|||
33665975|NCT01522651|63098162|FG004|Overall Study|Adverse Event|4|||
33665976|NCT01522651|63098158|FG000|Overall Study|Cardioversion|1|||
33665977|NCT01522651|63098159|FG001|Overall Study|Cardioversion|0|||
33665978|NCT01522651|63098160|FG002|Overall Study|Cardioversion|0|||
33665979|NCT01522651|63098161|FG003|Overall Study|Cardioversion|0|||
33305531|NCT01296932|62681020|FG000|Overall Study|Dosage already reduced, AE still present|0|||
33305532|NCT01296932|62681021|FG001|Overall Study|Dosage already reduced, AE still present|0|||
33305533|NCT01296932|62681022|FG002|Overall Study|Dosage already reduced, AE still present|0|||
33305534|NCT01296932|62681023|FG003|Overall Study|Dosage already reduced, AE still present|0|||
33305535|NCT01296932|62681024|FG004|Overall Study|Dosage already reduced, AE still present|0|||
33305536|NCT01296932|62681025|FG005|Overall Study|Dosage already reduced, AE still present|0|||
33305537|NCT01296932|62681026|FG006|Overall Study|Dosage already reduced, AE still present|0|||
33305538|NCT01296932|62681027|FG007|Overall Study|Dosage already reduced, AE still present|0|||
33305539|NCT01296932|62681028|FG008|Overall Study|Dosage already reduced, AE still present|1|||
33305540|NCT01296698|62681051|FG000|Overall Study|Adverse Event|1|||
33305541|NCT01296698|62681052|FG001|Overall Study|Adverse Event|0|||
33305542|NCT01296698|62681051|FG000|Overall Study|Death|1|||
33305543|NCT01296698|62681052|FG001|Overall Study|Death|0|||
33305544|NCT01296698|62681051|FG000|Overall Study|Lost to Follow-up|19|||
33305545|NCT01296698|62681052|FG001|Overall Study|Lost to Follow-up|1|||
33305546|NCT01296698|62681051|FG000|Overall Study|Withdrawal by Subject|12|||
33577417|NCT02659631|62973966|FG008|Overall Study|Death (follow-up phase)|1|||
33577418|NCT02659631|62973967|FG009|Overall Study|Death (follow-up phase)|0|||
33577419|NCT02659631|62973958|FG000|Overall Study|Death (treatment phase)|0|||
33577420|NCT02659631|62973959|FG001|Overall Study|Death (treatment phase)|0|||
33577421|NCT02659631|62973960|FG002|Overall Study|Death (treatment phase)|0|||
33577422|NCT02659631|62973961|FG003|Overall Study|Death (treatment phase)|0|||
33577423|NCT02659631|62973962|FG004|Overall Study|Death (treatment phase)|1|||
33577424|NCT02659631|62973963|FG005|Overall Study|Death (treatment phase)|0|||
33577425|NCT02659631|62973964|FG006|Overall Study|Death (treatment phase)|1|||
33577426|NCT02659631|62973965|FG007|Overall Study|Death (treatment phase)|0|||
33577427|NCT02659631|62973966|FG008|Overall Study|Death (treatment phase)|0|||
33577428|NCT02659631|62973967|FG009|Overall Study|Death (treatment phase)|0|||
33577429|NCT02699125|62973991|FG000|Placebo|Lost to Follow-up|2|||
33577430|NCT02699125|62973992|FG001|Placebo|Lost to Follow-up|0|||
33665980|NCT01522651|63098162|FG004|Overall Study|Cardioversion|0|||
33665981|NCT01522651|63098158|FG000|Overall Study|Device Malfunction|0|||
33665982|NCT01522651|63098159|FG001|Overall Study|Device Malfunction|1|||
33665983|NCT01522651|63098160|FG002|Overall Study|Device Malfunction|0|||
33665984|NCT01522651|63098161|FG003|Overall Study|Device Malfunction|0|||
33665985|NCT01522651|63098162|FG004|Overall Study|Device Malfunction|0|||
33665986|NCT01522651|63098158|FG000|Overall Study|Investigator's Discretion|0|||
33577431|NCT02699125|62973991|FG000|Placebo|Protocol Violation|1|||
33577432|NCT02699125|62973992|FG001|Placebo|Protocol Violation|0|||
33577433|NCT02699125|62973991|FG000|Placebo|Withdrawal by Subject|0|||
33577434|NCT02699125|62973992|FG001|Placebo|Withdrawal by Subject|4|||
33577435|NCT02699125|62973991|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
33577436|NCT02699125|62973992|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
33577437|NCT02698891|62974002|FG000|Overall Study|Withdrawal by Subject|2|||
33577438|NCT02698891|62974002|FG000|Overall Study|deemed ineligible|1|||
33577439|NCT02698891|62974002|FG000|Overall Study|Adverse Event|9|||
33577440|NCT02698423|62974008|FG000|Overall Study|Lost to Follow-up|19|||
33577441|NCT02698423|62974009|FG001|Overall Study|Lost to Follow-up|24|||
33577442|NCT02700997|62974017|FG000|Overall Study|Did not undergo CT imaging|1|||
33577443|NCT02700997|62974017|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
33577444|NCT02658149|62974023|FG000|Overall Study|Physician Decision|1|||
33577445|NCT02658149|62974024|FG001|Overall Study|Physician Decision|0|||
33577446|NCT02698189|62974032|FG000|Overall Study|Physician Decision|3|||
33577447|NCT02698189|62974033|FG001|Overall Study|Physician Decision|0|||
33577448|NCT02698189|62974032|FG000|Overall Study|Progressive disease|0|||
33577449|NCT02698189|62974033|FG001|Overall Study|Progressive disease|5|||
33577450|NCT02698189|62974032|FG000|Overall Study|Study terminated by sponsor|0|||
33577451|NCT02698189|62974033|FG001|Overall Study|Study terminated by sponsor|1|||
33577452|NCT02702011|62974045|FG000|Overall Study|Withdrawal by Subject|0|||
33577453|NCT02702011|62974046|FG001|Overall Study|Withdrawal by Subject|1|||
33577454|NCT02702011|62974047|FG002|Overall Study|Withdrawal by Subject|0|||
33665987|NCT01522651|63098159|FG001|Overall Study|Investigator's Discretion|1|||
33665988|NCT01522651|63098160|FG002|Overall Study|Investigator's Discretion|0|||
33665989|NCT01522651|63098161|FG003|Overall Study|Investigator's Discretion|0|||
33665990|NCT01522651|63098162|FG004|Overall Study|Investigator's Discretion|0|||
33665991|NCT01522651|63098158|FG000|Overall Study|Protocol Violation|3|||
33665992|NCT01522651|63098159|FG001|Overall Study|Protocol Violation|0|||
33665993|NCT01522651|63098160|FG002|Overall Study|Protocol Violation|0|||
33665994|NCT01522651|63098161|FG003|Overall Study|Protocol Violation|0|||
33665995|NCT01522651|63098162|FG004|Overall Study|Protocol Violation|0|||
33665996|NCT01522651|63098158|FG000|Overall Study|Reason Not Specified|0|||
33665997|NCT01522651|63098159|FG001|Overall Study|Reason Not Specified|0|||
33665998|NCT01522651|63098160|FG002|Overall Study|Reason Not Specified|0|||
33665999|NCT01522651|63098161|FG003|Overall Study|Reason Not Specified|1|||
33666000|NCT01522651|63098162|FG004|Overall Study|Reason Not Specified|0|||
33666001|NCT01522651|63098158|FG000|Overall Study|Participant Non-Compliance|1|||
33666002|NCT01522651|63098159|FG001|Overall Study|Participant Non-Compliance|0|||
33666003|NCT01522651|63098160|FG002|Overall Study|Participant Non-Compliance|0|||
33666004|NCT01522651|63098161|FG003|Overall Study|Participant Non-Compliance|0|||
33666005|NCT01522651|63098162|FG004|Overall Study|Participant Non-Compliance|0|||
33666006|NCT01522651|63098158|FG000|Overall Study|Withdrew Consent|1|||
33666007|NCT01522651|63098159|FG001|Overall Study|Withdrew Consent|1|||
33666008|NCT01522651|63098160|FG002|Overall Study|Withdrew Consent|0|||
33666009|NCT01522651|63098161|FG003|Overall Study|Withdrew Consent|1|||
33666010|NCT01522651|63098162|FG004|Overall Study|Withdrew Consent|1|||
33666011|NCT01522651|63098158|FG000|Overall Study|Randomized but Never Treated|0|||
33666012|NCT01522651|63098159|FG001|Overall Study|Randomized but Never Treated|1|||
33666013|NCT01522651|63098160|FG002|Overall Study|Randomized but Never Treated|0|||
33666014|NCT01522651|63098161|FG003|Overall Study|Randomized but Never Treated|1|||
33666015|NCT01522651|63098162|FG004|Overall Study|Randomized but Never Treated|1|||
33666016|NCT01554241|63098189|FG000|Overall Study|Death|3|||
33666017|NCT01554241|63098190|FG001|Overall Study|Death|1|||
33666018|NCT01554241|63098191|FG002|Overall Study|Death|1|||
33666019|NCT01554241|63098192|FG003|Overall Study|Death|0|||
33666020|NCT01554241|63098189|FG000|Overall Study|protocol specified renal stone|0|||
33666021|NCT01554241|63098190|FG001|Overall Study|protocol specified renal stone|0|||
33666022|NCT01554241|63098191|FG002|Overall Study|protocol specified renal stone|0|||
33577455|NCT02702011|62974048|FG003|Overall Study|Withdrawal by Subject|0|||
33577456|NCT02657369|62974058|FG000|Overall Study|Death|27|||
33577457|NCT02657369|62974058|FG000|Overall Study|Study terminated by sponsor|7|||
33577458|NCT02701777|62974066|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
33577459|NCT02701777|62974067|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
33666023|NCT01554241|63098192|FG003|Overall Study|protocol specified renal stone|1|||
33666024|NCT01554241|63098189|FG000|Overall Study|protocol specified change in eGFR|0|||
33666025|NCT01554241|63098190|FG001|Overall Study|protocol specified change in eGFR|0|||
33666026|NCT01554241|63098191|FG002|Overall Study|protocol specified change in eGFR|1|||
33666027|NCT01554241|63098192|FG003|Overall Study|protocol specified change in eGFR|0|||
33666028|NCT01554241|63098189|FG000|Overall Study|Withdrawal by Subject|0|||
33577460|NCT02701777|62974068|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
33577461|NCT02701777|62974069|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
33577462|NCT02701777|62974066|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
33577463|NCT02701777|62974067|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
33577464|NCT02701777|62974068|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
33577465|NCT02701777|62974069|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
33577466|NCT01675661|62974094|FG000|Overall Study|Lost to Follow-up|22|||
33577467|NCT01675661|62974095|FG001|Overall Study|Lost to Follow-up|23|||
33577468|NCT01675661|62974094|FG000|Overall Study|Practical problems|9|||
33577469|NCT01675661|62974095|FG001|Overall Study|Practical problems|5|||
33577470|NCT01675661|62974094|FG000|Overall Study|Moved away|5|||
33577471|NCT01675661|62974095|FG001|Overall Study|Moved away|6|||
33577472|NCT01675661|62974094|FG000|Overall Study|Withdrawal by Subject|3|||
33577473|NCT01675661|62974095|FG001|Overall Study|Withdrawal by Subject|7|||
33577474|NCT01675661|62974094|FG000|Overall Study|Physician Decision|0|||
33577475|NCT01675661|62974095|FG001|Overall Study|Physician Decision|2|||
33577476|NCT01675661|62974094|FG000|Overall Study|Death|0|||
33577477|NCT01675661|62974095|FG001|Overall Study|Death|1|||
33577478|NCT01675661|62974094|FG000|Overall Study|Other reason|1|||
33577479|NCT01675661|62974095|FG001|Overall Study|Other reason|2|||
33577480|NCT01602341|62974103|FG000|Overall Study|Adverse Event|0|||
33577481|NCT01602341|62974104|FG001|Overall Study|Adverse Event|1|||
33577482|NCT02700919|62974117|FG000|Overall Study|Physician Decision|1|||
33577483|NCT02700919|62974118|FG001|Overall Study|Physician Decision|0|||
33577484|NCT02700919|62974119|FG002|Overall Study|Physician Decision|0|||
33577485|NCT02700919|62974117|FG000|Overall Study|Protocol Violation|1|||
33577486|NCT02700919|62974118|FG001|Overall Study|Protocol Violation|0|||
33577487|NCT02700919|62974119|FG002|Overall Study|Protocol Violation|0|||
33577488|NCT02700919|62974117|FG000|Overall Study|Adverse Event|1|||
33577489|NCT02700919|62974118|FG001|Overall Study|Adverse Event|3|||
33577490|NCT02700919|62974119|FG002|Overall Study|Adverse Event|1|||
33577491|NCT02700919|62974117|FG000|Overall Study|Withdrawal by Subject|5|||
33577492|NCT02700919|62974118|FG001|Overall Study|Withdrawal by Subject|8|||
33577493|NCT02700919|62974119|FG002|Overall Study|Withdrawal by Subject|2|||
33577494|NCT02700919|62974117|FG000|Overall Study|Lost to Follow-up|2|||
33577495|NCT02700919|62974118|FG001|Overall Study|Lost to Follow-up|0|||
33577496|NCT02700919|62974119|FG002|Overall Study|Lost to Follow-up|0|||
33577497|NCT02700919|62974117|FG000|Overall Study|Other|2|||
33577498|NCT02700919|62974118|FG001|Overall Study|Other|1|||
33577499|NCT02700919|62974119|FG002|Overall Study|Other|1|||
33577500|NCT01986010|62974144|FG000|Overall Study|Adverse Event|0|||
33577501|NCT01986010|62974145|FG001|Overall Study|Adverse Event|1|||
33577502|NCT01986010|62974146|FG002|Overall Study|Adverse Event|0|||
33577503|NCT01986010|62974147|FG003|Overall Study|Adverse Event|0|||
33577504|NCT01986010|62974148|FG004|Overall Study|Adverse Event|0|||
33577505|NCT01986010|62974149|FG005|Overall Study|Adverse Event|0|||
33577506|NCT01986010|62974150|FG006|Overall Study|Adverse Event|0|||
33577507|NCT01986010|62974151|FG007|Overall Study|Adverse Event|0|||
33577508|NCT01986010|62974152|FG008|Overall Study|Adverse Event|0|||
33577509|NCT01986010|62974153|FG009|Overall Study|Adverse Event|0|||
33577510|NCT01986010|62974154|FG010|Overall Study|Adverse Event|0|||
33577511|NCT01986010|62974155|FG011|Overall Study|Adverse Event|0|||
33577512|NCT01986010|62974156|FG012|Overall Study|Adverse Event|0|||
33577513|NCT01986010|62974157|FG013|Overall Study|Adverse Event|0|||
33577514|NCT01986010|62974158|FG014|Overall Study|Adverse Event|0|||
33577515|NCT01986010|62974159|FG015|Overall Study|Adverse Event|1|||
33577516|NCT01986010|62974160|FG016|Overall Study|Adverse Event|0|||
33577517|NCT01986010|62974144|FG000|Overall Study|Lost to Follow-up|2|||
33577518|NCT01986010|62974145|FG001|Overall Study|Lost to Follow-up|1|||
33577519|NCT01986010|62974146|FG002|Overall Study|Lost to Follow-up|2|||
33577520|NCT01986010|62974147|FG003|Overall Study|Lost to Follow-up|2|||
33577521|NCT01986010|62974148|FG004|Overall Study|Lost to Follow-up|2|||
33577522|NCT01986010|62974149|FG005|Overall Study|Lost to Follow-up|2|||
33577523|NCT01986010|62974150|FG006|Overall Study|Lost to Follow-up|0|||
33577524|NCT01986010|62974151|FG007|Overall Study|Lost to Follow-up|0|||
33577525|NCT01986010|62974152|FG008|Overall Study|Lost to Follow-up|4|||
33577526|NCT01986010|62974153|FG009|Overall Study|Lost to Follow-up|2|||
33577527|NCT01986010|62974154|FG010|Overall Study|Lost to Follow-up|0|||
33577528|NCT01986010|62974155|FG011|Overall Study|Lost to Follow-up|1|||
33577529|NCT01986010|62974156|FG012|Overall Study|Lost to Follow-up|1|||
33305547|NCT01296698|62681052|FG001|Overall Study|Withdrawal by Subject|0|||
33305548|NCT01296698|62681051|FG000|Overall Study|Difficulty Contacting Subject|2|||
33577530|NCT01986010|62974157|FG013|Overall Study|Lost to Follow-up|1|||
33577531|NCT01986010|62974158|FG014|Overall Study|Lost to Follow-up|2|||
33577532|NCT01986010|62974159|FG015|Overall Study|Lost to Follow-up|0|||
33577533|NCT01986010|62974160|FG016|Overall Study|Lost to Follow-up|0|||
33577534|NCT01986010|62974144|FG000|Overall Study|Physician Decision|0|||
33577535|NCT01986010|62974145|FG001|Overall Study|Physician Decision|0|||
33577536|NCT01986010|62974146|FG002|Overall Study|Physician Decision|0|||
33577537|NCT01986010|62974147|FG003|Overall Study|Physician Decision|0|||
33577538|NCT01986010|62974148|FG004|Overall Study|Physician Decision|0|||
33577539|NCT01986010|62974149|FG005|Overall Study|Physician Decision|0|||
33577540|NCT01986010|62974150|FG006|Overall Study|Physician Decision|0|||
33577541|NCT01986010|62974151|FG007|Overall Study|Physician Decision|0|||
33577542|NCT01986010|62974152|FG008|Overall Study|Physician Decision|0|||
33577543|NCT01986010|62974153|FG009|Overall Study|Physician Decision|0|||
33577544|NCT01986010|62974154|FG010|Overall Study|Physician Decision|0|||
33577545|NCT01986010|62974155|FG011|Overall Study|Physician Decision|0|||
33577546|NCT01986010|62974156|FG012|Overall Study|Physician Decision|0|||
33577547|NCT01986010|62974157|FG013|Overall Study|Physician Decision|0|||
33577548|NCT01986010|62974158|FG014|Overall Study|Physician Decision|1|||
33577549|NCT01986010|62974159|FG015|Overall Study|Physician Decision|0|||
33577550|NCT01986010|62974160|FG016|Overall Study|Physician Decision|0|||
33577551|NCT01986010|62974144|FG000|Overall Study|Withdrawal by Subject|2|||
33577552|NCT01986010|62974145|FG001|Overall Study|Withdrawal by Subject|2|||
33577553|NCT01986010|62974146|FG002|Overall Study|Withdrawal by Subject|3|||
33577554|NCT01986010|62974147|FG003|Overall Study|Withdrawal by Subject|0|||
33577555|NCT01986010|62974148|FG004|Overall Study|Withdrawal by Subject|2|||
33577556|NCT01986010|62974149|FG005|Overall Study|Withdrawal by Subject|4|||
33577557|NCT01986010|62974150|FG006|Overall Study|Withdrawal by Subject|0|||
33577558|NCT01986010|62974151|FG007|Overall Study|Withdrawal by Subject|0|||
33577559|NCT01986010|62974152|FG008|Overall Study|Withdrawal by Subject|0|||
33577560|NCT01986010|62974153|FG009|Overall Study|Withdrawal by Subject|0|||
33577561|NCT01986010|62974154|FG010|Overall Study|Withdrawal by Subject|0|||
33577562|NCT01986010|62974155|FG011|Overall Study|Withdrawal by Subject|2|||
33577563|NCT01986010|62974156|FG012|Overall Study|Withdrawal by Subject|0|||
33577564|NCT01986010|62974157|FG013|Overall Study|Withdrawal by Subject|1|||
33577565|NCT01986010|62974158|FG014|Overall Study|Withdrawal by Subject|2|||
33577566|NCT01986010|62974159|FG015|Overall Study|Withdrawal by Subject|0|||
33577567|NCT01986010|62974160|FG016|Overall Study|Withdrawal by Subject|0|||
33577568|NCT01986010|62974144|FG000|Overall Study|Status Not Recorded|2|||
33577569|NCT01986010|62974145|FG001|Overall Study|Status Not Recorded|4|||
33577570|NCT01986010|62974146|FG002|Overall Study|Status Not Recorded|2|||
33577571|NCT01986010|62974147|FG003|Overall Study|Status Not Recorded|0|||
33577572|NCT01986010|62974148|FG004|Overall Study|Status Not Recorded|1|||
33577573|NCT01986010|62974149|FG005|Overall Study|Status Not Recorded|2|||
33577574|NCT01986010|62974150|FG006|Overall Study|Status Not Recorded|0|||
33577575|NCT01986010|62974151|FG007|Overall Study|Status Not Recorded|0|||
33577576|NCT01986010|62974152|FG008|Overall Study|Status Not Recorded|2|||
33577577|NCT01986010|62974153|FG009|Overall Study|Status Not Recorded|1|||
33577578|NCT01986010|62974154|FG010|Overall Study|Status Not Recorded|7|||
33577579|NCT01986010|62974155|FG011|Overall Study|Status Not Recorded|7|||
33577580|NCT01986010|62974156|FG012|Overall Study|Status Not Recorded|9|||
33577581|NCT01986010|62974157|FG013|Overall Study|Status Not Recorded|9|||
33577582|NCT01986010|62974158|FG014|Overall Study|Status Not Recorded|5|||
33577583|NCT01986010|62974159|FG015|Overall Study|Status Not Recorded|10|||
33577584|NCT01986010|62974160|FG016|Overall Study|Status Not Recorded|4|||
33577585|NCT01963780|62974206|FG000|Overall Study|Death|7|||
33577586|NCT02009878|62974213|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
33577587|NCT02009878|62974214|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
33577588|NCT02009878|62974215|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
33577589|NCT02009722|62974225|FG000|Overall Study|Protocol Violation|1|||
33577590|NCT02009722|62974226|FG001|Overall Study|Protocol Violation|2|||
33577591|NCT02009722|62974225|FG000|Overall Study|Did not receive intervention|0|||
33577592|NCT02009722|62974226|FG001|Overall Study|Did not receive intervention|1|||
33577593|NCT02655419|62974234|FG000|Overall Study|Enrolled but not treated|1|||
33577594|NCT02655419|62974235|FG001|Overall Study|Enrolled but not treated|5|||
33577595|NCT02655419|62974234|FG000|Overall Study|Withdrawal by Subject|4|||
33577596|NCT02655419|62974235|FG001|Overall Study|Withdrawal by Subject|1|||
33577597|NCT02655419|62974234|FG000|Overall Study|Other|0|||
33577598|NCT02655419|62974235|FG001|Overall Study|Other|1|||
33577599|NCT01962922|62974247|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
33577600|NCT01962922|62974248|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
33577601|NCT01962922|62974247|FG000|PK Portion Day 7|non-compliance|1|||
33577602|NCT01962922|62974248|FG001|PK Portion Day 7|non-compliance|0|||
33577603|NCT01962922|62974247|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
33577604|NCT01962922|62974248|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
33577605|NCT01962922|62974247|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
33577606|NCT01962922|62974248|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
33577607|NCT01984684|62974256|FG000|Overall Study|Lost to Follow-up|25|||
33577608|NCT01984684|62974257|FG001|Overall Study|Lost to Follow-up|24|||
33577609|NCT01984684|62974256|FG000|Overall Study|Adverse Event|8|||
33577610|NCT01984684|62974257|FG001|Overall Study|Adverse Event|12|||
33577611|NCT01984684|62974256|FG000|Overall Study|Withdrawal by Subject|9|||
33577612|NCT01984684|62974257|FG001|Overall Study|Withdrawal by Subject|9|||
33577613|NCT01984684|62974256|FG000|Overall Study|Lack of Efficacy|3|||
33577614|NCT01984684|62974257|FG001|Overall Study|Lack of Efficacy|6|||
33577615|NCT01984684|62974256|FG000|Overall Study|Physician Decision|4|||
33577616|NCT01984684|62974257|FG001|Overall Study|Physician Decision|2|||
33577617|NCT01984684|62974256|FG000|Overall Study|Protocol Violation|4|||
33577618|NCT01984684|62974257|FG001|Overall Study|Protocol Violation|2|||
33577619|NCT01984684|62974256|FG000|Overall Study|Death|0|||
33577620|NCT01984684|62974257|FG001|Overall Study|Death|1|||
33577621|NCT01984684|62974256|FG000|Overall Study|Noncompliance with study drug|2|||
33577622|NCT01984684|62974257|FG001|Overall Study|Noncompliance with study drug|1|||
33577623|NCT01984684|62974256|FG000|Overall Study|Subject incarcerated|1|||
33577624|NCT01984684|62974257|FG001|Overall Study|Subject incarcerated|0|||
33577625|NCT01984684|62974256|FG000|Overall Study|Study drug not available at site|1|||
33577626|NCT01984684|62974257|FG001|Overall Study|Study drug not available at site|1|||
33577627|NCT01984684|62974256|FG000|Overall Study|Subject had inadequate IV access|0|||
33577628|NCT01984684|62974257|FG001|Overall Study|Subject had inadequate IV access|1|||
33577629|NCT02694523|62974265|FG000|Part A|Adverse Event|7|||
33577630|NCT02694523|62974266|FG001|Part A|Adverse Event|3|||
33577631|NCT02694523|62974267|FG002|Part A|Adverse Event|0|||
33577632|NCT02694523|62974268|FG003|Part A|Adverse Event|0|||
33577633|NCT02694523|62974269|FG004|Part A|Adverse Event|0|||
33577634|NCT02694523|62974270|FG005|Part A|Adverse Event|0|||
33577635|NCT02694523|62974271|FG006|Part A|Adverse Event|0|||
33577636|NCT02694523|62974265|FG000|Part A|Protocol Violation|1|||
33577637|NCT02694523|62974266|FG001|Part A|Protocol Violation|0|||
33577638|NCT02694523|62974267|FG002|Part A|Protocol Violation|0|||
33577639|NCT02694523|62974268|FG003|Part A|Protocol Violation|0|||
33577640|NCT02694523|62974269|FG004|Part A|Protocol Violation|0|||
33577641|NCT02694523|62974270|FG005|Part A|Protocol Violation|0|||
33577642|NCT02694523|62974271|FG006|Part A|Protocol Violation|0|||
33577643|NCT02694523|62974265|FG000|Part A|Lost to Follow-up|1|||
33577644|NCT02694523|62974266|FG001|Part A|Lost to Follow-up|2|||
33577645|NCT02694523|62974267|FG002|Part A|Lost to Follow-up|0|||
33577646|NCT02694523|62974268|FG003|Part A|Lost to Follow-up|0|||
33577647|NCT02694523|62974269|FG004|Part A|Lost to Follow-up|0|||
33577648|NCT02694523|62974270|FG005|Part A|Lost to Follow-up|0|||
33577649|NCT02694523|62974271|FG006|Part A|Lost to Follow-up|0|||
33577650|NCT02694523|62974265|FG000|Part A|Withdrawal by Subject|3|||
33577651|NCT02694523|62974266|FG001|Part A|Withdrawal by Subject|1|||
33577652|NCT02694523|62974267|FG002|Part A|Withdrawal by Subject|0|||
33577653|NCT02694523|62974268|FG003|Part A|Withdrawal by Subject|0|||
33577654|NCT02694523|62974269|FG004|Part A|Withdrawal by Subject|0|||
33577655|NCT02694523|62974270|FG005|Part A|Withdrawal by Subject|0|||
33577656|NCT02694523|62974271|FG006|Part A|Withdrawal by Subject|0|||
33577657|NCT02694523|62974265|FG000|Part A|Other|1|||
33577658|NCT02694523|62974266|FG001|Part A|Other|1|||
33577659|NCT02694523|62974267|FG002|Part A|Other|0|||
33577660|NCT02694523|62974268|FG003|Part A|Other|0|||
33577661|NCT02694523|62974269|FG004|Part A|Other|0|||
33577662|NCT02694523|62974270|FG005|Part A|Other|0|||
33577663|NCT02694523|62974271|FG006|Part A|Other|0|||
33577664|NCT02694523|62974265|FG000|Part B|Adverse Event|0|||
33577665|NCT02694523|62974266|FG001|Part B|Adverse Event|0|||
33577666|NCT02694523|62974267|FG002|Part B|Adverse Event|7|||
33577667|NCT02694523|62974268|FG003|Part B|Adverse Event|1|||
33577668|NCT02694523|62974269|FG004|Part B|Adverse Event|1|||
33577669|NCT02694523|62974270|FG005|Part B|Adverse Event|2|||
33577670|NCT02694523|62974271|FG006|Part B|Adverse Event|0|||
33577671|NCT02694523|62974265|FG000|Part B|Protocol Violation|0|||
33577672|NCT02694523|62974266|FG001|Part B|Protocol Violation|0|||
33577673|NCT02694523|62974267|FG002|Part B|Protocol Violation|1|||
33577674|NCT02694523|62974268|FG003|Part B|Protocol Violation|0|||
33577675|NCT02694523|62974269|FG004|Part B|Protocol Violation|0|||
33577676|NCT02694523|62974270|FG005|Part B|Protocol Violation|0|||
33577677|NCT02694523|62974271|FG006|Part B|Protocol Violation|0|||
33577678|NCT02694523|62974265|FG000|Part B|Lost to Follow-up|0|||
33577679|NCT02694523|62974266|FG001|Part B|Lost to Follow-up|0|||
33577680|NCT02694523|62974267|FG002|Part B|Lost to Follow-up|2|||
33577681|NCT02694523|62974268|FG003|Part B|Lost to Follow-up|3|||
33577682|NCT02694523|62974269|FG004|Part B|Lost to Follow-up|2|||
33577683|NCT02694523|62974270|FG005|Part B|Lost to Follow-up|0|||
33577684|NCT02694523|62974271|FG006|Part B|Lost to Follow-up|1|||
33577685|NCT02694523|62974265|FG000|Part B|Withdrawal by Subject|0|||
33577686|NCT02694523|62974266|FG001|Part B|Withdrawal by Subject|0|||
33577687|NCT02694523|62974267|FG002|Part B|Withdrawal by Subject|9|||
33577688|NCT02694523|62974268|FG003|Part B|Withdrawal by Subject|0|||
33577689|NCT02694523|62974269|FG004|Part B|Withdrawal by Subject|1|||
33577690|NCT02694523|62974270|FG005|Part B|Withdrawal by Subject|3|||
33577691|NCT02694523|62974271|FG006|Part B|Withdrawal by Subject|0|||
33577692|NCT02694523|62974265|FG000|Part B|Other|0|||
33577693|NCT02694523|62974266|FG001|Part B|Other|0|||
33577694|NCT02694523|62974267|FG002|Part B|Other|1|||
33577695|NCT02694523|62974268|FG003|Part B|Other|0|||
33577696|NCT02694523|62974269|FG004|Part B|Other|0|||
33577697|NCT02694523|62974270|FG005|Part B|Other|0|||
33577698|NCT02694523|62974271|FG006|Part B|Other|1|||
33577699|NCT01353703|62974285|FG000|Overall Study|Migrated/moved from study area|1|||
33577700|NCT01353703|62974286|FG001|Overall Study|Migrated/moved from study area|0|||
33577701|NCT02009332|62974300|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
33577702|NCT02009332|62974301|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
33577703|NCT02009332|62974302|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
33577704|NCT02009332|62974303|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
33577705|NCT02009332|62974304|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
33577706|NCT02009332|62974305|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
33577707|NCT02009332|62974300|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
33577708|NCT02009332|62974301|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
33577709|NCT02009332|62974302|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
33577710|NCT02009332|62974303|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
33577711|NCT02009332|62974304|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
33577712|NCT02009332|62974305|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
33577713|NCT02009332|62974300|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
33577714|NCT02009332|62974301|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
33577715|NCT02009332|62974302|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
33577716|NCT02009332|62974303|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
33577717|NCT02009332|62974304|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
33577718|NCT02009332|62974305|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
33577719|NCT01984294|62974322|FG000|Overall Study|Randomized but Never Treated|0|||
33577720|NCT01984294|62974323|FG001|Overall Study|Randomized but Never Treated|0|||
33577721|NCT01984294|62974324|FG002|Overall Study|Randomized but Never Treated|1|||
33577722|NCT01984294|62974322|FG000|Overall Study|Lack of Efficacy|4|||
33577723|NCT01984294|62974323|FG001|Overall Study|Lack of Efficacy|2|||
33577724|NCT01984294|62974324|FG002|Overall Study|Lack of Efficacy|6|||
33577725|NCT01984294|62974322|FG000|Overall Study|Adverse Event|0|||
33577726|NCT01984294|62974323|FG001|Overall Study|Adverse Event|1|||
33577727|NCT01984294|62974324|FG002|Overall Study|Adverse Event|0|||
33577728|NCT01962298|62974337|FG000|Overall Study|Protocol Violation|1|||
33577729|NCT01962298|62974338|FG001|Overall Study|Protocol Violation|0|||
33577730|NCT01962298|62974339|FG002|Overall Study|Protocol Violation|1|||
33577731|NCT01962298|62974340|FG003|Overall Study|Protocol Violation|1|||
33577732|NCT01962298|62974341|FG004|Overall Study|Protocol Violation|0|||
33577733|NCT01962298|62974337|FG000|Overall Study|Data quality insufficient|2|||
33577734|NCT01962298|62974338|FG001|Overall Study|Data quality insufficient|0|||
33577735|NCT01962298|62974339|FG002|Overall Study|Data quality insufficient|3|||
33577736|NCT01962298|62974340|FG003|Overall Study|Data quality insufficient|1|||
33577737|NCT01962298|62974341|FG004|Overall Study|Data quality insufficient|4|||
33577738|NCT01962298|62974337|FG000|Overall Study|Insufficient data|0|||
33577739|NCT01962298|62974338|FG001|Overall Study|Insufficient data|2|||
33577740|NCT01962298|62974339|FG002|Overall Study|Insufficient data|1|||
33577741|NCT01962298|62974340|FG003|Overall Study|Insufficient data|0|||
33577742|NCT01962298|62974341|FG004|Overall Study|Insufficient data|1|||
33577743|NCT01962298|62974337|FG000|Overall Study|Incorrect data recorded|0|||
33577744|NCT01962298|62974338|FG001|Overall Study|Incorrect data recorded|1|||
33577745|NCT01962298|62974339|FG002|Overall Study|Incorrect data recorded|0|||
33577746|NCT01962298|62974340|FG003|Overall Study|Incorrect data recorded|0|||
33577747|NCT01962298|62974341|FG004|Overall Study|Incorrect data recorded|0|||
33577748|NCT01962298|62974337|FG000|Overall Study|Physician Decision|0|||
33577749|NCT01962298|62974338|FG001|Overall Study|Physician Decision|1|||
33577750|NCT01962298|62974339|FG002|Overall Study|Physician Decision|0|||
33577751|NCT01962298|62974340|FG003|Overall Study|Physician Decision|0|||
33577752|NCT01962298|62974341|FG004|Overall Study|Physician Decision|1|||
33577753|NCT02693743|62974355|FG000|Overall Study|Physician Decision|1|||
33577754|NCT02693743|62974356|FG001|Overall Study|Physician Decision|0|||
33577755|NCT02655887|62974362|FG000|Overall Study|Lost to Follow-up|3|||
33577756|NCT02655887|62974362|FG000|Overall Study|Death|4|||
33577757|NCT02655887|62974362|FG000|Overall Study|Withdrawal by Subject|3|||
33666029|NCT01554241|63098190|FG001|Overall Study|Withdrawal by Subject|0|||
33666030|NCT01554241|63098191|FG002|Overall Study|Withdrawal by Subject|2|||
33666031|NCT01554241|63098192|FG003|Overall Study|Withdrawal by Subject|0|||
33666032|NCT01521559|63098204|FG000|Overall Study|Adverse Event|0|||
33577758|NCT02655887|62974362|FG000|Overall Study|Missed 12-month follow-up visit|4|||
33577759|NCT02008318|62974368|FG000|Overall Study|Adverse Event|4|||
33577760|NCT02008318|62974369|FG001|Overall Study|Adverse Event|0|||
33577761|NCT02008318|62974368|FG000|Overall Study|Physician Decision|2|||
33577762|NCT02008318|62974369|FG001|Overall Study|Physician Decision|0|||
33577763|NCT02008318|62974368|FG000|Overall Study|Progressive Disease|2|||
33577764|NCT02008318|62974369|FG001|Overall Study|Progressive Disease|0|||
33577765|NCT02008318|62974368|FG000|Overall Study|Protocol Violation|1|||
33577766|NCT02008318|62974369|FG001|Overall Study|Protocol Violation|1|||
33577767|NCT02008318|62974368|FG000|Overall Study|Withdrawal by Subject|3|||
33577768|NCT02008318|62974369|FG001|Overall Study|Withdrawal by Subject|0|||
33577769|NCT01982812|62974380|FG000|Overall Study|Death|1|||
33666033|NCT01521559|63098205|FG001|Overall Study|Adverse Event|4|||
33666034|NCT01521559|63098204|FG000|Overall Study|Death|1|||
33666035|NCT01521559|63098205|FG001|Overall Study|Death|0|||
33666036|NCT01521559|63098204|FG000|Overall Study|Withdrawal by Subject|9|||
33666037|NCT01521559|63098205|FG001|Overall Study|Withdrawal by Subject|11|||
33666038|NCT01521559|63098204|FG000|Overall Study|Lost to Follow-up|3|||
33666039|NCT01521559|63098205|FG001|Overall Study|Lost to Follow-up|1|||
33577770|NCT01982812|62974381|FG001|Overall Study|Death|5|||
33577771|NCT01982812|62974380|FG000|Overall Study|Adverse Event|0|||
33577772|NCT01982812|62974381|FG001|Overall Study|Adverse Event|5|||
33577773|NCT02007070|62974387|FG000|Overall Study|Adverse Event|4|||
33577774|NCT02007070|62974387|FG000|Overall Study|Clinical Progression|4|||
33577775|NCT02007070|62974387|FG000|Overall Study|Death|1|||
33577776|NCT02007070|62974387|FG000|Overall Study|Protocol Violation|2|||
33577777|NCT02007070|62974387|FG000|Overall Study|Physician Decision|1|||
33577778|NCT02007070|62974387|FG000|Overall Study|Progressive Disease|21|||
33577779|NCT02006758|62974391|FG000|Overall Study|Protocol Violation|1|||
33577780|NCT02006758|62974391|FG000|Overall Study|Death|1|||
33577781|NCT02006758|62974391|FG000|Overall Study|Lost to Follow-up|4|||
33577782|NCT02006758|62974391|FG000|Overall Study|Withdrawal by Subject|4|||
33577783|NCT02006758|62974391|FG000|Overall Study|Procedurally excluded|1|||
33577784|NCT02006758|62974391|FG000|Overall Study|Other|2|||
33577785|NCT01960816|62974396|FG000|Overall Study|Lost to Follow-up|1|||
33577786|NCT01602419|62974400|FG000|Overall Study|Not treated with Wilate|9|||
33577787|NCT01602419|62974400|FG000|Overall Study|Adverse Drug Reaction|4|||
33577788|NCT01602419|62974400|FG000|Overall Study|Insurance issues|3|||
33577789|NCT01602419|62974400|FG000|Overall Study|Changed treatment centre|1|||
33577790|NCT01602419|62974400|FG000|Overall Study|Treatment centre closed|1|||
33577791|NCT01602419|62974400|FG000|Overall Study|Withdrawal by Subject|5|||
33577792|NCT01602419|62974400|FG000|Overall Study|Lost to Follow-up|6|||
33577793|NCT01981954|62974445|FG000|Titration Period|Protocol Deviation|1|||
33577794|NCT01981954|62974445|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
33666040|NCT01521559|63098204|FG000|Overall Study|Protocol Violation|1|||
33666041|NCT01521559|63098205|FG001|Overall Study|Protocol Violation|0|||
33666042|NCT01521559|63098204|FG000|Overall Study|Other|1|||
33666043|NCT01521559|63098205|FG001|Overall Study|Other|2|||
33666044|NCT01554163|63098214|FG000|Overall Study|Adverse Event|3|||
33666045|NCT01554163|63098215|FG001|Overall Study|Adverse Event|0|||
33666046|NCT01554163|63098214|FG000|Overall Study|Lack of Efficacy|1|||
33666047|NCT01554163|63098215|FG001|Overall Study|Lack of Efficacy|0|||
33666048|NCT01554163|63098214|FG000|Overall Study|Lost to Follow-up|1|||
33666049|NCT01554163|63098215|FG001|Overall Study|Lost to Follow-up|0|||
33666050|NCT01554163|63098214|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33666051|NCT01554163|63098215|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33666052|NCT01554163|63098214|FG000|Overall Study|Protocol Violation|0|||
33666053|NCT01554163|63098215|FG001|Overall Study|Protocol Violation|4|||
33666054|NCT01554163|63098214|FG000|Overall Study|Withdrawal by Subject|1|||
33666055|NCT01554163|63098215|FG001|Overall Study|Withdrawal by Subject|5|||
33666056|NCT01554163|63098214|FG000|Overall Study|Not Treated|1|||
33666057|NCT01554163|63098215|FG001|Overall Study|Not Treated|0|||
33666058|NCT01553851|63098221|FG000|Overall Study|Adverse Event|2|||
33666059|NCT01553851|63098221|FG000|Overall Study|constipation|1|||
33666060|NCT01552915|63098241|FG000|Overall Study|Adverse Event|3|||
33666061|NCT01552915|63098242|FG001|Overall Study|Adverse Event|14|||
33666062|NCT01552915|63098243|FG002|Overall Study|Adverse Event|3|||
33666063|NCT01552915|63098241|FG000|Overall Study|Lost to Follow-up|4|||
33666064|NCT01552915|63098242|FG001|Overall Study|Lost to Follow-up|6|||
33666065|NCT01552915|63098243|FG002|Overall Study|Lost to Follow-up|5|||
33666066|NCT01552915|63098241|FG000|Overall Study|Withdrawal by Subject|6|||
33577795|NCT02693119|62974451|FG000|Open-Label Period|Withdrawal by Subject|0|||
33577796|NCT02693119|62974452|FG001|Open-Label Period|Withdrawal by Subject|1|||
33577797|NCT01960348|62974490|FG000|Overall Study|Adverse event, not serious|2|||
33666067|NCT01552915|63098242|FG001|Overall Study|Withdrawal by Subject|4|||
33666068|NCT01552915|63098243|FG002|Overall Study|Withdrawal by Subject|5|||
33666069|NCT01552915|63098241|FG000|Overall Study|Protocol Violation|0|||
33666070|NCT01552915|63098242|FG001|Overall Study|Protocol Violation|4|||
33666071|NCT01552915|63098243|FG002|Overall Study|Protocol Violation|4|||
33666072|NCT01552915|63098241|FG000|Overall Study|Lack of Efficacy|8|||
33666073|NCT01552915|63098242|FG001|Overall Study|Lack of Efficacy|1|||
33666074|NCT01552915|63098243|FG002|Overall Study|Lack of Efficacy|4|||
33666075|NCT01552915|63098241|FG000|Overall Study|Other|2|||
33666076|NCT01552915|63098242|FG001|Overall Study|Other|0|||
33666077|NCT01552915|63098243|FG002|Overall Study|Other|6|||
33666078|NCT01552681|63098272|FG000|Overall Study|Withdrawal by Subject|4|||
33577798|NCT01960348|62974491|FG001|Overall Study|Adverse event, not serious|2|||
33577799|NCT01960348|62974490|FG000|Overall Study|Adverse event, serious fatal|6|||
33577800|NCT01960348|62974491|FG001|Overall Study|Adverse event, serious fatal|5|||
33577801|NCT01960348|62974490|FG000|Overall Study|Adverse event, serious non-fatal|0|||
33666079|NCT01552681|63098273|FG001|Overall Study|Withdrawal by Subject|0|||
33666080|NCT01552681|63098272|FG000|Overall Study|Physician Decision|1|||
33666081|NCT01552681|63098273|FG001|Overall Study|Physician Decision|0|||
33577802|NCT01960348|62974491|FG001|Overall Study|Adverse event, serious non-fatal|3|||
33577803|NCT01960348|62974490|FG000|Overall Study|Withdrawal by Subject|1|||
33577804|NCT01960348|62974491|FG001|Overall Study|Withdrawal by Subject|11|||
33577805|NCT01960348|62974490|FG000|Overall Study|Physician Decision|0|||
33577806|NCT01960348|62974491|FG001|Overall Study|Physician Decision|1|||
33577807|NCT01960348|62974490|FG000|Overall Study|Protocol Violation|1|||
33577808|NCT01960348|62974491|FG001|Overall Study|Protocol Violation|0|||
33577809|NCT02653625|62974497|FG000|Overall Study|Adverse Event|1|||
33577810|NCT02653625|62974497|FG000|Overall Study|Non-compliance with Study Drug|1|||
33577811|NCT02653625|62974497|FG000|Overall Study|Protocol Violation|1|||
33577812|NCT02653625|62974497|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
33577813|NCT01981096|62974503|FG000|Overall Study|Parent illness|1|||
33577814|NCT01981096|62974504|FG001|Overall Study|Parent illness|0|||
33577815|NCT01981096|62974503|FG000|Overall Study|Withdrawal by Subject|0|||
33577816|NCT01981096|62974504|FG001|Overall Study|Withdrawal by Subject|1|||
33577817|NCT01981096|62974503|FG000|Overall Study|Lost to Follow-up|2|||
33577818|NCT01981096|62974504|FG001|Overall Study|Lost to Follow-up|0|||
33577819|NCT02652767|62974510|FG000|Overall Study|Death|2|||
33577820|NCT02652767|62974510|FG000|Overall Study|Lost to Follow-up|1|||
33577821|NCT02652767|62974510|FG000|Overall Study|Withdrawal by Subject|1|||
33577822|NCT01980940|62974524|FG000|Overall Study|Protocol Violation|0|||
33577823|NCT01980940|62974525|FG001|Overall Study|Protocol Violation|0|||
33577824|NCT01980940|62974526|FG002|Overall Study|Protocol Violation|0|||
33577825|NCT01980940|62974527|FG003|Overall Study|Protocol Violation|0|||
33577826|NCT01980940|62974528|FG004|Overall Study|Protocol Violation|0|||
33577827|NCT01980940|62974529|FG005|Overall Study|Protocol Violation|2|||
33577828|NCT01980940|62974530|FG006|Overall Study|Protocol Violation|0|||
33577829|NCT01980940|62974531|FG007|Overall Study|Protocol Violation|0|||
33577830|NCT02699983|62974557|FG000|Overall Study|Withdrawal by Subject|1|||
33577831|NCT02699983|62974558|FG001|Overall Study|Withdrawal by Subject|0|||
33577832|NCT01960114|62974570|FG000|Overall Study|Adverse Event|1|||
33577833|NCT01960114|62974571|FG001|Overall Study|Adverse Event|0|||
33577834|NCT01960114|62974570|FG000|Overall Study|Could not swallow study medication|0|||
33577835|NCT01960114|62974571|FG001|Overall Study|Could not swallow study medication|1|||
33577836|NCT02005276|62974581|FG000|Overall Study|No longer interested|5|||
33577837|NCT02005276|62974582|FG001|Overall Study|No longer interested|2|||
33577838|NCT02005276|62974583|FG002|Overall Study|No longer interested|3|||
33577839|NCT02005276|62974584|FG003|Overall Study|No longer interested|3|||
33577840|NCT01980706|62974599|FG000|Overall Study|Withdrawal by Subject|9|||
33577841|NCT01980706|62974600|FG001|Overall Study|Withdrawal by Subject|6|||
33577842|NCT01980706|62974601|FG002|Overall Study|Withdrawal by Subject|2|||
33577843|NCT01980706|62974599|FG000|Overall Study|Adverse Event|1|||
33577844|NCT01980706|62974600|FG001|Overall Study|Adverse Event|2|||
33577845|NCT01980706|62974601|FG002|Overall Study|Adverse Event|5|||
33577846|NCT01980706|62974599|FG000|Overall Study|Lost to Follow-up|3|||
33577847|NCT01980706|62974600|FG001|Overall Study|Lost to Follow-up|4|||
33577848|NCT01980706|62974601|FG002|Overall Study|Lost to Follow-up|3|||
33577849|NCT01980706|62974599|FG000|Overall Study|miscellaneous|4|||
33577850|NCT01980706|62974600|FG001|Overall Study|miscellaneous|5|||
33577851|NCT01980706|62974601|FG002|Overall Study|miscellaneous|3|||
33577852|NCT02692417|62974611|FG000|Overall Study|Withdrawal by Subject|5|||
33577853|NCT02692417|62974612|FG001|Overall Study|Withdrawal by Subject|1|||
33577854|NCT02692417|62974611|FG000|Overall Study|Adverse Event|1|||
33577855|NCT02692417|62974612|FG001|Overall Study|Adverse Event|0|||
33577856|NCT02004886|62974622|FG000|Overall Study|Adverse Event|0|||
33577857|NCT02004886|62974623|FG001|Overall Study|Adverse Event|1|||
33577858|NCT02004886|62974624|FG002|Overall Study|Adverse Event|0|||
33577859|NCT02004886|62974625|FG003|Overall Study|Adverse Event|0|||
33577860|NCT02004886|62974622|FG000|Overall Study|Unable to attend future visits|1|||
33577861|NCT02004886|62974623|FG001|Overall Study|Unable to attend future visits|0|||
33577862|NCT02004886|62974624|FG002|Overall Study|Unable to attend future visits|0|||
33577863|NCT02004886|62974625|FG003|Overall Study|Unable to attend future visits|0|||
33577864|NCT01959880|62974639|FG000|Overall Study|Withdrawal by Subject|11|||
33577865|NCT01959880|62974640|FG001|Overall Study|Withdrawal by Subject|13|||
33577866|NCT01959880|62974641|FG002|Overall Study|Withdrawal by Subject|8|||
33577867|NCT01959880|62974642|FG003|Overall Study|Withdrawal by Subject|7|||
33577868|NCT01959880|62974639|FG000|Overall Study|Death|1|||
33577869|NCT01959880|62974640|FG001|Overall Study|Death|10|||
33577870|NCT01959880|62974641|FG002|Overall Study|Death|1|||
33577871|NCT01959880|62974642|FG003|Overall Study|Death|2|||
33577872|NCT01959880|62974639|FG000|Overall Study|Lost to Follow-up|95|||
33577873|NCT01959880|62974640|FG001|Overall Study|Lost to Follow-up|18|||
33577874|NCT01959880|62974641|FG002|Overall Study|Lost to Follow-up|15|||
33577875|NCT01959880|62974642|FG003|Overall Study|Lost to Follow-up|8|||
33577876|NCT01959880|62974639|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
33577877|NCT01959880|62974640|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
33577878|NCT01959880|62974641|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
33577879|NCT01959880|62974642|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
33577880|NCT01959880|62974639|FG000|Overall Study|Study completed early-FDA approved|1003|||
33577881|NCT01959880|62974640|FG001|Overall Study|Study completed early-FDA approved|311|||
33577882|NCT01959880|62974641|FG002|Overall Study|Study completed early-FDA approved|179|||
33577883|NCT01959880|62974642|FG003|Overall Study|Study completed early-FDA approved|152|||
33577884|NCT01980628|62974652|FG000|Overall Study|Adverse Event|12|||
33577885|NCT01980628|62974652|FG000|Overall Study|Physician Decision|5|||
33577886|NCT01980628|62974652|FG000|Overall Study|Withdrawal by Subject|4|||
33577887|NCT01980628|62974652|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
33577888|NCT01979614|62974659|FG000|Overall Study|Adverse Event|1|||
33577889|NCT01979614|62974660|FG001|Overall Study|Adverse Event|1|||
33577890|NCT02654717|62974668|FG000|Overall Study|Adverse Event|2|||
33577891|NCT02654717|62974669|FG001|Overall Study|Adverse Event|2|||
33577892|NCT02654717|62974668|FG000|Overall Study|Protocol Violation|1|||
33577893|NCT02654717|62974669|FG001|Overall Study|Protocol Violation|2|||
33577894|NCT02654717|62974668|FG000|Overall Study|Withdrawal by Subject|0|||
33577895|NCT02654717|62974669|FG001|Overall Study|Withdrawal by Subject|1|||
33577896|NCT02654717|62974668|FG000|Overall Study|Non-permitted medication|3|||
33577897|NCT02654717|62974669|FG001|Overall Study|Non-permitted medication|0|||
33577898|NCT03343301|62974677|FG000|Overall Study|Withdrawal by Subject|1|||
33577899|NCT03343301|62974678|FG001|Overall Study|Withdrawal by Subject|1|||
33577900|NCT03343301|62974677|FG000|Overall Study|Death|0|||
33577901|NCT03343301|62974678|FG001|Overall Study|Death|2|||
33577902|NCT03343301|62974677|FG000|Overall Study|Other|0|||
33577903|NCT03343301|62974678|FG001|Overall Study|Other|6|||
33577904|NCT03343301|62974677|FG000|Overall Study|Missing|2|||
33577905|NCT03343301|62974678|FG001|Overall Study|Missing|0|||
33577906|NCT02696785|62974688|FG000|Blinded Treatment Period|Adverse Event|0|||
33577907|NCT02696785|62974689|FG001|Blinded Treatment Period|Adverse Event|1|||
33577908|NCT02696785|62974690|FG002|Blinded Treatment Period|Adverse Event|3|||
33577909|NCT02696785|62974691|FG003|Blinded Treatment Period|Adverse Event|0|||
33577910|NCT02696785|62974688|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
33577911|NCT02696785|62974689|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
33577912|NCT02696785|62974690|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
33577913|NCT02696785|62974691|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
33577914|NCT02696785|62974688|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
33577915|NCT02696785|62974689|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
33577916|NCT02696785|62974690|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
33577917|NCT02696785|62974691|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
33577918|NCT02696785|62974688|FG000|Blinded Treatment Period|Screen Failure|1|||
33577919|NCT02696785|62974689|FG001|Blinded Treatment Period|Screen Failure|0|||
33577920|NCT02696785|62974690|FG002|Blinded Treatment Period|Screen Failure|0|||
33577921|NCT02696785|62974691|FG003|Blinded Treatment Period|Screen Failure|0|||
33577922|NCT02696785|62974688|FG000|Washout Period|Withdrawal by Subject|0|||
33577923|NCT02696785|62974689|FG001|Washout Period|Withdrawal by Subject|1|||
33577924|NCT02696785|62974690|FG002|Washout Period|Withdrawal by Subject|0|||
33577925|NCT02696785|62974691|FG003|Washout Period|Withdrawal by Subject|0|||
33577926|NCT02696785|62974688|FG000|Washout Period|Lack of Efficacy|0|||
33577927|NCT02696785|62974689|FG001|Washout Period|Lack of Efficacy|1|||
33577928|NCT02696785|62974690|FG002|Washout Period|Lack of Efficacy|0|||
33577929|NCT02696785|62974691|FG003|Washout Period|Lack of Efficacy|0|||
33577930|NCT02696785|62974688|FG000|Extended Treatment Period|Adverse Event|2|||
33577931|NCT02696785|62974689|FG001|Extended Treatment Period|Adverse Event|3|||
33577932|NCT02696785|62974690|FG002|Extended Treatment Period|Adverse Event|2|||
33577933|NCT02696785|62974691|FG003|Extended Treatment Period|Adverse Event|1|||
33577934|NCT02696785|62974688|FG000|Extended Treatment Period|Lack of Efficacy|0|||
33398076|NCT00293293|62777420|FG000|Overall Study|Withdrawal by Subject|1|||
33398077|NCT00293293|62777421|FG001|Overall Study|Withdrawal by Subject|1|||
33577935|NCT02696785|62974689|FG001|Extended Treatment Period|Lack of Efficacy|1|||
33577936|NCT02696785|62974690|FG002|Extended Treatment Period|Lack of Efficacy|0|||
33577937|NCT02696785|62974691|FG003|Extended Treatment Period|Lack of Efficacy|0|||
33577938|NCT02696785|62974688|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
33577939|NCT02696785|62974689|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
33577940|NCT02696785|62974690|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
33577941|NCT02696785|62974691|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
33577942|NCT02696785|62974688|FG000|Follow-up Period|Adverse Event|0|||
33577943|NCT02696785|62974689|FG001|Follow-up Period|Adverse Event|0|||
33577944|NCT02696785|62974690|FG002|Follow-up Period|Adverse Event|8|||
33577945|NCT02696785|62974691|FG003|Follow-up Period|Adverse Event|2|||
33577946|NCT02696785|62974688|FG000|Follow-up Period|Lost to Follow-up|0|||
33577947|NCT02696785|62974689|FG001|Follow-up Period|Lost to Follow-up|0|||
33577948|NCT02696785|62974690|FG002|Follow-up Period|Lost to Follow-up|0|||
33577949|NCT02696785|62974691|FG003|Follow-up Period|Lost to Follow-up|1|||
33577950|NCT02696785|62974688|FG000|Follow-up Period|Lack of Efficacy|0|||
33577951|NCT02696785|62974689|FG001|Follow-up Period|Lack of Efficacy|0|||
33577952|NCT02696785|62974690|FG002|Follow-up Period|Lack of Efficacy|0|||
33577953|NCT02696785|62974691|FG003|Follow-up Period|Lack of Efficacy|1|||
33577954|NCT02696785|62974688|FG000|Follow-up Period|Withdrawal by Subject|1|||
33577955|NCT02696785|62974689|FG001|Follow-up Period|Withdrawal by Subject|0|||
33577956|NCT02696785|62974690|FG002|Follow-up Period|Withdrawal by Subject|5|||
33577957|NCT02696785|62974691|FG003|Follow-up Period|Withdrawal by Subject|4|||
33577958|NCT02004262|62974725|FG000|Overall Study|Death|67|||
33577959|NCT02004262|62974726|FG001|Overall Study|Death|64|||
33577960|NCT02004262|62974727|FG002|Overall Study|Death|66|||
33577961|NCT02004262|62974728|FG003|Overall Study|Death|28|||
33577962|NCT02004262|62974729|FG004|Overall Study|Death|29|||
33577963|NCT02004262|62974730|FG005|Overall Study|Death|22|||
33577964|NCT02004262|62974725|FG000|Overall Study|Withdrawal by Subject|1|||
33577965|NCT02004262|62974726|FG001|Overall Study|Withdrawal by Subject|0|||
33577966|NCT02004262|62974727|FG002|Overall Study|Withdrawal by Subject|4|||
33577967|NCT02004262|62974728|FG003|Overall Study|Withdrawal by Subject|0|||
33577968|NCT02004262|62974729|FG004|Overall Study|Withdrawal by Subject|1|||
33577969|NCT02004262|62974730|FG005|Overall Study|Withdrawal by Subject|3|||
33577970|NCT02004262|62974725|FG000|Overall Study|Lost to Follow-up|1|||
33577971|NCT02004262|62974726|FG001|Overall Study|Lost to Follow-up|1|||
33577972|NCT02004262|62974727|FG002|Overall Study|Lost to Follow-up|0|||
33577973|NCT02004262|62974728|FG003|Overall Study|Lost to Follow-up|0|||
33577974|NCT02004262|62974729|FG004|Overall Study|Lost to Follow-up|0|||
33577975|NCT02004262|62974730|FG005|Overall Study|Lost to Follow-up|0|||
33577976|NCT02004262|62974725|FG000|Overall Study|Study Terminated by Sponsor|4|||
33577977|NCT02004262|62974726|FG001|Overall Study|Study Terminated by Sponsor|3|||
33577978|NCT02004262|62974727|FG002|Overall Study|Study Terminated by Sponsor|2|||
33577979|NCT02004262|62974728|FG003|Overall Study|Study Terminated by Sponsor|1|||
33577980|NCT02004262|62974729|FG004|Overall Study|Study Terminated by Sponsor|1|||
33577981|NCT02004262|62974730|FG005|Overall Study|Study Terminated by Sponsor|5|||
33577982|NCT01675427|62974744|FG000|Overall Study|Withdrawal by Subject|7|||
33577983|NCT01675427|62974744|FG000|Overall Study|Participant Refused Sample Collection|18|||
33577984|NCT01675427|62974744|FG000|Overall Study|Sample not Collected by Mistake|2|||
33577985|NCT01675427|62974744|FG000|Overall Study|Lost to Follow-up|5|||
33577986|NCT01675427|62974744|FG000|Overall Study|Other|2|||
33577987|NCT01978912|62974782|FG000|Overall Study|Adverse Event|0|||
33577988|NCT01978912|62974783|FG001|Overall Study|Adverse Event|1|||
33577989|NCT01978912|62974784|FG002|Overall Study|Adverse Event|0|||
33577990|NCT01978912|62974785|FG003|Overall Study|Adverse Event|0|||
33577991|NCT01978912|62974782|FG000|Overall Study|Lost to Follow-up|1|||
33577992|NCT01978912|62974783|FG001|Overall Study|Lost to Follow-up|1|||
33577993|NCT01978912|62974784|FG002|Overall Study|Lost to Follow-up|0|||
33577994|NCT01978912|62974785|FG003|Overall Study|Lost to Follow-up|1|||
33577995|NCT01978912|62974782|FG000|Overall Study|Withdrawal by Subject|1|||
33577996|NCT01978912|62974783|FG001|Overall Study|Withdrawal by Subject|0|||
33577997|NCT01978912|62974784|FG002|Overall Study|Withdrawal by Subject|2|||
33577998|NCT01978912|62974785|FG003|Overall Study|Withdrawal by Subject|2|||
33577999|NCT01978912|62974782|FG000|Overall Study|Lumbar Surgery|1|||
33578000|NCT01978912|62974783|FG001|Overall Study|Lumbar Surgery|0|||
33578001|NCT01978912|62974784|FG002|Overall Study|Lumbar Surgery|1|||
33578002|NCT01978912|62974785|FG003|Overall Study|Lumbar Surgery|0|||
33578003|NCT01978912|62974782|FG000|Overall Study|Intradiscal Steroid Injection|0|||
33578004|NCT01978912|62974783|FG001|Overall Study|Intradiscal Steroid Injection|1|||
33578005|NCT01978912|62974784|FG002|Overall Study|Intradiscal Steroid Injection|0|||
33578006|NCT01978912|62974785|FG003|Overall Study|Intradiscal Steroid Injection|0|||
33578007|NCT01977898|62974797|FG000|Overall Study|Non functioning catheter|1|||
33578008|NCT01977898|62974798|FG001|Overall Study|Non functioning catheter|1|||
33578009|NCT02003638|62974806|FG000|Overall Study|Withdrawal by Subject|1|||
33578010|NCT02003638|62974807|FG001|Overall Study|Withdrawal by Subject|0|||
33578011|NCT02696317|62974813|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
33578012|NCT02696317|62974814|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
33578013|NCT02696317|62974813|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
33578014|NCT02696317|62974814|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
33578015|NCT01959412|62974822|FG000|Overall Study|Protocol deviation|1|||
33578016|NCT01959412|62974823|FG001|Overall Study|Protocol deviation|1|||
33578017|NCT01959412|62974824|FG002|Overall Study|Protocol deviation|0|||
33578018|NCT01959412|62974825|FG003|Overall Study|Protocol deviation|1|||
33578019|NCT01959412|62974826|FG004|Overall Study|Protocol deviation|3|||
33578020|NCT01959412|62974827|FG005|Overall Study|Protocol deviation|0|||
33578021|NCT01959412|62974822|FG000|Overall Study|Adverse Event|0|||
33578022|NCT01959412|62974823|FG001|Overall Study|Adverse Event|0|||
33578023|NCT01959412|62974824|FG002|Overall Study|Adverse Event|0|||
33578024|NCT01959412|62974825|FG003|Overall Study|Adverse Event|1|||
33578025|NCT01959412|62974826|FG004|Overall Study|Adverse Event|0|||
33578026|NCT01959412|62974827|FG005|Overall Study|Adverse Event|0|||
33578027|NCT01977820|62974843|FG000|Overall Study|Sponsor terminated the study|1|||
33578028|NCT01977820|62974844|FG001|Overall Study|Sponsor terminated the study|1|||
33578029|NCT02003014|62974850|FG000|Overall Study|Case report forms uncollected|9|||
33578030|NCT02003014|62974850|FG000|Overall Study|Treatment started after contract period|1|||
33578031|NCT02003014|62974850|FG000|Overall Study|Patient did not visit the study site|5|||
33578032|NCT02003014|62974850|FG000|Overall Study|Investigator's transfer|4|||
33578033|NCT01977352|62974856|FG000|Overall Study|Lost to Follow-up|1|||
33578034|NCT01977352|62974857|FG001|Overall Study|Lost to Follow-up|2|||
33578035|NCT02001688|62974866|FG000|Overall Study|Withdrawal by Subject|0|||
33578036|NCT02001688|62974867|FG001|Overall Study|Withdrawal by Subject|0|||
33578037|NCT02001688|62974868|FG002|Overall Study|Withdrawal by Subject|1|||
33578038|NCT02001688|62974866|FG000|Overall Study|Adverse Event|0|||
33578039|NCT02001688|62974867|FG001|Overall Study|Adverse Event|1|||
33578040|NCT02001688|62974868|FG002|Overall Study|Adverse Event|0|||
33578041|NCT02001064|62974879|FG000|Overall Study|Withdrawal by Subject|2|||
33578042|NCT02001064|62974880|FG001|Overall Study|Withdrawal by Subject|1|||
33578043|NCT02000752|62974888|FG000|Overall Study|Dystocic delivery|19|||
33578044|NCT02000752|62974889|FG001|Overall Study|Dystocic delivery|8|||
33578045|NCT02000752|62974888|FG000|Overall Study|Shift Changes|12|||
33578046|NCT02000752|62974889|FG001|Overall Study|Shift Changes|5|||
33578047|NCT02000440|62974895|FG000|Overall Study|Adverse Event|3|||
33578048|NCT02000440|62974895|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
33578049|NCT02687815|62974901|FG000|Overall Study|Lost to Follow-up|2|||
33578050|NCT02687815|62974902|FG001|Overall Study|Lost to Follow-up|4|||
33578051|NCT02687815|62974901|FG000|Overall Study|Withdrawal by Subject|2|||
33578052|NCT02687815|62974902|FG001|Overall Study|Withdrawal by Subject|4|||
33578053|NCT01959334|62974910|FG000|Second Dose|Adverse Event|1|||
33578054|NCT01959334|62974911|FG001|Second Dose|Adverse Event|0|||
33578055|NCT01959334|62974910|FG000|Third Dose|Adverse Event|0|||
33578056|NCT01959334|62974911|FG001|Third Dose|Adverse Event|1|||
33578057|NCT02687581|62974921|FG000|Overall Study|Withdrawal by Subject|1|||
33578058|NCT02687581|62974922|FG001|Overall Study|Withdrawal by Subject|0|||
33578059|NCT02687581|62974923|FG002|Overall Study|Withdrawal by Subject|0|||
33578060|NCT02687581|62974924|FG003|Overall Study|Withdrawal by Subject|1|||
33578061|NCT02687581|62974921|FG000|Overall Study|Lost to Follow-up|2|||
33578062|NCT02687581|62974922|FG001|Overall Study|Lost to Follow-up|2|||
33578063|NCT02687581|62974923|FG002|Overall Study|Lost to Follow-up|0|||
33578064|NCT02687581|62974924|FG003|Overall Study|Lost to Follow-up|0|||
33578065|NCT02687581|62974921|FG000|Overall Study|the device is too small for the patient.|1|||
33578066|NCT02687581|62974922|FG001|Overall Study|the device is too small for the patient.|0|||
33578067|NCT02687581|62974923|FG002|Overall Study|the device is too small for the patient.|0|||
33578068|NCT02687581|62974924|FG003|Overall Study|the device is too small for the patient.|0|||
33578069|NCT01977040|62974934|FG000|Overall Study|Vasa previa not confirmed|2|||
33578070|NCT01958476|62974944|FG000|Overall Study|Parent requested exclusion from analysis|1|||
33578071|NCT01958476|62974945|FG001|Overall Study|Parent requested exclusion from analysis|0|||
33578072|NCT02695537|62974981|FG000|Overall Study|Adverse Event|3|||
33578073|NCT02695537|62974981|FG000|Overall Study|Lack of Efficacy|28|||
33578074|NCT02695537|62974981|FG000|Overall Study|Withdrawal by Subject|4|||
33578075|NCT02695537|62974981|FG000|Overall Study|Protocol Violation|3|||
33578076|NCT01353313|62974987|FG000|Overall Study|Lost to Follow-up|22|||
33578077|NCT01353313|62974988|FG001|Overall Study|Lost to Follow-up|23|||
33578078|NCT01353313|62974987|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
33578079|NCT01353313|62974988|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
33578080|NCT02691247|62974997|FG000|Overall Study|Withdrawal by Subject|1|||
33578081|NCT02691247|62974998|FG001|Overall Study|Withdrawal by Subject|2|||
33578082|NCT02691247|62974999|FG002|Overall Study|Withdrawal by Subject|2|||
33578083|NCT02691247|62974997|FG000|Overall Study|Lost to Follow-up|2|||
33578084|NCT02691247|62974998|FG001|Overall Study|Lost to Follow-up|0|||
33578085|NCT02691247|62974999|FG002|Overall Study|Lost to Follow-up|1|||
33578086|NCT01362491|62975010|FG000|Overall Study|Ineligible|1|||
33578087|NCT01362491|62975011|FG001|Overall Study|Ineligible|0|||
33578088|NCT01362491|62975012|FG002|Overall Study|Ineligible|0|||
33578089|NCT02687191|62975027|FG000|Overall Study|Death|0|||
33578090|NCT02687191|62975028|FG001|Overall Study|Death|1|||
33578091|NCT02687191|62975029|FG002|Overall Study|Death|1|||
33578092|NCT02687191|62975030|FG003|Overall Study|Death|0|||
33578093|NCT02687191|62975031|FG004|Overall Study|Death|1|||
33578094|NCT02687191|62975032|FG005|Overall Study|Death|1|||
33578095|NCT02687191|62975027|FG000|Overall Study|Withdrawal by Subject|0|||
33578096|NCT02687191|62975028|FG001|Overall Study|Withdrawal by Subject|0|||
33578097|NCT02687191|62975029|FG002|Overall Study|Withdrawal by Subject|0|||
33578098|NCT02687191|62975030|FG003|Overall Study|Withdrawal by Subject|1|||
33578099|NCT02687191|62975031|FG004|Overall Study|Withdrawal by Subject|0|||
33578100|NCT02687191|62975032|FG005|Overall Study|Withdrawal by Subject|0|||
33578101|NCT02687035|62975046|FG000|Overall Study|Withdrawal by Subject|1|||
33578102|NCT02687035|62975046|FG000|Overall Study|Death|87|||
33578103|NCT02687035|62975046|FG000|Overall Study|Lost to Follow-up|1|||
33578104|NCT02687035|62975046|FG000|Overall Study|Missed Visit|87|||
33578105|NCT02687035|62975046|FG000|Overall Study|Did not receive Study Device|8|||
33578106|NCT02691013|62975052|FG000|Overall Study|Withdrawal by Subject|3|||
33578107|NCT02691013|62975053|FG001|Overall Study|Withdrawal by Subject|0|||
33578108|NCT02690701|62975063|FG000|Treatment Period 1|Adverse Event|2|||
33578109|NCT02690701|62975064|FG001|Treatment Period 1|Adverse Event|2|||
33578110|NCT02690701|62975063|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33578111|NCT02690701|62975064|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33578112|NCT02690701|62975063|FG000|Treatment Period 2|Adverse Event|2|||
33578113|NCT02690701|62975064|FG001|Treatment Period 2|Adverse Event|0|||
33578114|NCT02690701|62975063|FG000|Treatment Period 2|Lack of Efficacy|1|||
33578115|NCT02690701|62975064|FG001|Treatment Period 2|Lack of Efficacy|0|||
33578116|NCT02690701|62975063|FG000|Treatment Period 2|Lost to Follow-up|0|||
33578117|NCT02690701|62975064|FG001|Treatment Period 2|Lost to Follow-up|2|||
33578118|NCT02690701|62975063|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33578119|NCT02690701|62975064|FG001|Treatment Period 2|Withdrawal by Subject|2|||
33578120|NCT02690701|62975063|FG000|Treatment Period 2|Protocol Violation|0|||
33578121|NCT02690701|62975064|FG001|Treatment Period 2|Protocol Violation|1|||
33578122|NCT02694757|62975071|FG000|Overall Study|Lack of Efficacy|3|||
33578123|NCT03805841|62975078|FG000|Overall Study|Clinical Progression|2|||
33578124|NCT03805841|62975079|FG001|Overall Study|Clinical Progression|0|||
33578125|NCT03805841|62975080|FG002|Overall Study|Clinical Progression|0|||
33578126|NCT03805841|62975078|FG000|Overall Study|Death|0|||
33578127|NCT03805841|62975079|FG001|Overall Study|Death|3|||
33578128|NCT03805841|62975080|FG002|Overall Study|Death|1|||
33578129|NCT03805841|62975078|FG000|Overall Study|Lost to Follow-up|0|||
33578130|NCT03805841|62975079|FG001|Overall Study|Lost to Follow-up|0|||
33578131|NCT03805841|62975080|FG002|Overall Study|Lost to Follow-up|1|||
33578132|NCT03805841|62975078|FG000|Overall Study|Withdrawal by Subject|2|||
33578133|NCT03805841|62975079|FG001|Overall Study|Withdrawal by Subject|3|||
33578134|NCT03805841|62975080|FG002|Overall Study|Withdrawal by Subject|0|||
33578135|NCT03805841|62975078|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
33578136|NCT03805841|62975079|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
33578137|NCT03805841|62975080|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
33578138|NCT02684617|62975091|FG000|Overall Study|Adverse Event|1|||
33578139|NCT02684617|62975092|FG001|Overall Study|Adverse Event|0|||
33578140|NCT02684617|62975093|FG002|Overall Study|Adverse Event|1|||
33578141|NCT02684617|62975091|FG000|Overall Study|Death|8|||
33578142|NCT02684617|62975092|FG001|Overall Study|Death|16|||
33578143|NCT02684617|62975093|FG002|Overall Study|Death|28|||
33578144|NCT02684617|62975091|FG000|Overall Study|Withdrawal by Subject|2|||
33578145|NCT02684617|62975092|FG001|Overall Study|Withdrawal by Subject|0|||
33578146|NCT02684617|62975093|FG002|Overall Study|Withdrawal by Subject|4|||
33578147|NCT02684617|62975091|FG000|Overall Study|Screen Failure|1|||
33578148|NCT02684617|62975092|FG001|Overall Study|Screen Failure|0|||
33578149|NCT02684617|62975093|FG002|Overall Study|Screen Failure|2|||
33578150|NCT02684617|62975091|FG000|Overall Study|Study Terminated by Sponsor|6|||
33578151|NCT02684617|62975092|FG001|Overall Study|Study Terminated by Sponsor|1|||
33578152|NCT02684617|62975093|FG002|Overall Study|Study Terminated by Sponsor|5|||
33578153|NCT01999972|62975107|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
33578154|NCT01999972|62975108|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
33578155|NCT01999972|62975109|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
33578156|NCT01999972|62975110|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
33578157|NCT01999972|62975111|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
33578158|NCT01999972|62975112|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
33578159|NCT01999972|62975107|FG000|Dose Escalation Part|Death|0|||
33578160|NCT01999972|62975108|FG001|Dose Escalation Part|Death|1|||
33578161|NCT01999972|62975109|FG002|Dose Escalation Part|Death|0|||
33578162|NCT01999972|62975110|FG003|Dose Escalation Part|Death|0|||
33578163|NCT01999972|62975111|FG004|Dose Escalation Part|Death|0|||
33578164|NCT01999972|62975112|FG005|Dose Escalation Part|Death|0|||
33578165|NCT01999972|62975107|FG000|Dose Escalation Part|Enrolled but not treated|0|||
33578166|NCT01999972|62975108|FG001|Dose Escalation Part|Enrolled but not treated|0|||
33578167|NCT01999972|62975109|FG002|Dose Escalation Part|Enrolled but not treated|1|||
33578168|NCT01999972|62975110|FG003|Dose Escalation Part|Enrolled but not treated|1|||
33578169|NCT01999972|62975111|FG004|Dose Escalation Part|Enrolled but not treated|0|||
33578170|NCT01999972|62975112|FG005|Dose Escalation Part|Enrolled but not treated|0|||
33578171|NCT01999972|62975107|FG000|Dose Escalation Part|Disease progression|3|||
33578172|NCT01999972|62975108|FG001|Dose Escalation Part|Disease progression|2|||
33578173|NCT01999972|62975109|FG002|Dose Escalation Part|Disease progression|3|||
33578174|NCT01999972|62975110|FG003|Dose Escalation Part|Disease progression|6|||
33578175|NCT01999972|62975111|FG004|Dose Escalation Part|Disease progression|0|||
33578176|NCT01999972|62975112|FG005|Dose Escalation Part|Disease progression|0|||
33305549|NCT01296698|62681052|FG001|Overall Study|Difficulty Contacting Subject|0|||
33578177|NCT01999972|62975107|FG000|Dose Escalation Part|Adverse Event|0|||
33578178|NCT01999972|62975108|FG001|Dose Escalation Part|Adverse Event|0|||
33578179|NCT01999972|62975109|FG002|Dose Escalation Part|Adverse Event|0|||
33578180|NCT01999972|62975110|FG003|Dose Escalation Part|Adverse Event|2|||
33578181|NCT01999972|62975111|FG004|Dose Escalation Part|Adverse Event|0|||
33578182|NCT01999972|62975112|FG005|Dose Escalation Part|Adverse Event|0|||
33578183|NCT01999972|62975107|FG000|Dose Escalation Part|Global deterioration of health status|1|||
33578184|NCT01999972|62975108|FG001|Dose Escalation Part|Global deterioration of health status|0|||
33578185|NCT01999972|62975109|FG002|Dose Escalation Part|Global deterioration of health status|0|||
33578186|NCT01999972|62975110|FG003|Dose Escalation Part|Global deterioration of health status|1|||
33578187|NCT01999972|62975111|FG004|Dose Escalation Part|Global deterioration of health status|0|||
33578188|NCT01999972|62975112|FG005|Dose Escalation Part|Global deterioration of health status|0|||
33578189|NCT01999972|62975107|FG000|Dose Expansion Part|Death|0|||
33578190|NCT01999972|62975108|FG001|Dose Expansion Part|Death|0|||
33578191|NCT01999972|62975109|FG002|Dose Expansion Part|Death|0|||
33578192|NCT01999972|62975110|FG003|Dose Expansion Part|Death|0|||
33578193|NCT01999972|62975111|FG004|Dose Expansion Part|Death|2|||
33578194|NCT01999972|62975112|FG005|Dose Expansion Part|Death|1|||
33578195|NCT01999972|62975107|FG000|Dose Expansion Part|Disease progression|0|||
33578196|NCT01999972|62975108|FG001|Dose Expansion Part|Disease progression|0|||
33578197|NCT01999972|62975109|FG002|Dose Expansion Part|Disease progression|0|||
33578198|NCT01999972|62975110|FG003|Dose Expansion Part|Disease progression|0|||
33578199|NCT01999972|62975111|FG004|Dose Expansion Part|Disease progression|9|||
33578200|NCT01999972|62975112|FG005|Dose Expansion Part|Disease progression|3|||
33578201|NCT01999972|62975107|FG000|Dose Expansion Part|Sponsor decision|0|||
33578202|NCT01999972|62975108|FG001|Dose Expansion Part|Sponsor decision|0|||
33578203|NCT01999972|62975109|FG002|Dose Expansion Part|Sponsor decision|0|||
33578204|NCT01999972|62975110|FG003|Dose Expansion Part|Sponsor decision|0|||
33578205|NCT01999972|62975111|FG004|Dose Expansion Part|Sponsor decision|1|||
33578206|NCT01999972|62975112|FG005|Dose Expansion Part|Sponsor decision|0|||
33578207|NCT01999972|62975107|FG000|Dose Expansion Part|Adverse Event|0|||
33578208|NCT01999972|62975108|FG001|Dose Expansion Part|Adverse Event|0|||
33578209|NCT01999972|62975109|FG002|Dose Expansion Part|Adverse Event|0|||
33578210|NCT01999972|62975110|FG003|Dose Expansion Part|Adverse Event|0|||
33578211|NCT01999972|62975111|FG004|Dose Expansion Part|Adverse Event|4|||
33578212|NCT01999972|62975112|FG005|Dose Expansion Part|Adverse Event|2|||
33578213|NCT01999972|62975107|FG000|Dose Expansion Part|Participant's non-compliance|0|||
33578214|NCT01999972|62975108|FG001|Dose Expansion Part|Participant's non-compliance|0|||
33578215|NCT01999972|62975109|FG002|Dose Expansion Part|Participant's non-compliance|0|||
33578216|NCT01999972|62975110|FG003|Dose Expansion Part|Participant's non-compliance|0|||
33578217|NCT01999972|62975111|FG004|Dose Expansion Part|Participant's non-compliance|0|||
33666082|NCT01552681|63098272|FG000|Overall Study|Subject moved away|0|||
33666083|NCT01552681|63098273|FG001|Overall Study|Subject moved away|1|||
33666084|NCT01570387|63098305|FG000|Overall Study|Adverse Event|1|||
33666085|NCT01570387|63098306|FG001|Overall Study|Adverse Event|0|||
33666086|NCT01570387|63098307|FG002|Overall Study|Adverse Event|0|||
33666087|NCT01570387|63098308|FG003|Overall Study|Adverse Event|0|||
33666088|NCT01570387|63098305|FG000|Overall Study|Death|0|||
33666089|NCT01570387|63098306|FG001|Overall Study|Death|0|||
33578218|NCT01999972|62975112|FG005|Dose Expansion Part|Participant's non-compliance|1|||
33578219|NCT01999972|62975107|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
33578220|NCT01999972|62975108|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
33578221|NCT01999972|62975109|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
33578222|NCT01999972|62975110|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
33578223|NCT01999972|62975111|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
33578224|NCT01999972|62975112|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
33578225|NCT01999972|62975107|FG000|Dose Expansion Part|Changed to standard of care|0|||
33578226|NCT01999972|62975108|FG001|Dose Expansion Part|Changed to standard of care|0|||
33578227|NCT01999972|62975109|FG002|Dose Expansion Part|Changed to standard of care|0|||
33578228|NCT01999972|62975110|FG003|Dose Expansion Part|Changed to standard of care|0|||
33578229|NCT01999972|62975111|FG004|Dose Expansion Part|Changed to standard of care|1|||
33578230|NCT01999972|62975112|FG005|Dose Expansion Part|Changed to standard of care|0|||
33578231|NCT01999894|62975128|FG000|Overall Study|Adverse Event|9|||
33578232|NCT01999894|62975128|FG000|Overall Study|Lack of Efficacy|5|||
33578233|NCT01999894|62975128|FG000|Overall Study|Protocol Violation|1|||
33578234|NCT01999894|62975128|FG000|Overall Study|Withdrawal by Subject|7|||
33578235|NCT01999894|62975128|FG000|Overall Study|Lost to Follow-up|10|||
33578236|NCT01999894|62975128|FG000|Overall Study|Other Reason|3|||
33666090|NCT01570387|63098307|FG002|Overall Study|Death|0|||
33578237|NCT01999894|62975128|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
33578238|NCT02679235|62975133|FG000|Overall Study|Withdrawal by Subject|3|||
33578239|NCT02679235|62975133|FG000|Overall Study|Adverse Event|1|||
33578240|NCT01976806|62975139|FG000|Overall Study|Lost to Follow-up|1|||
33578241|NCT01976806|62975140|FG001|Overall Study|Lost to Follow-up|4|||
33578242|NCT01976806|62975139|FG000|Overall Study|Adverse Event|1|||
33578243|NCT01976806|62975140|FG001|Overall Study|Adverse Event|1|||
33578244|NCT01976806|62975139|FG000|Overall Study|Withdrawal by Subject|1|||
33578245|NCT01976806|62975140|FG001|Overall Study|Withdrawal by Subject|1|||
33666091|NCT01570387|63098308|FG003|Overall Study|Death|1|||
33666092|NCT01570387|63098305|FG000|Overall Study|Withdrawal by Subject|0|||
33666093|NCT01570387|63098306|FG001|Overall Study|Withdrawal by Subject|0|||
33666094|NCT01570387|63098307|FG002|Overall Study|Withdrawal by Subject|0|||
33666095|NCT01570387|63098308|FG003|Overall Study|Withdrawal by Subject|1|||
33666096|NCT01570309|63098317|FG000|Overall Study|Withdrawal by Subject|3|||
33666097|NCT01570309|63098318|FG001|Overall Study|Withdrawal by Subject|3|||
33666098|NCT01519921|63098330|FG000|Overall Study|Adverse Event|10|||
33666099|NCT01519921|63098331|FG001|Overall Study|Adverse Event|9|||
33666100|NCT01519921|63098330|FG000|Overall Study|Lack of Efficacy|4|||
33666101|NCT01519921|63098331|FG001|Overall Study|Lack of Efficacy|3|||
33666102|NCT01519921|63098330|FG000|Overall Study|Withdrawal by Subject|3|||
33666103|NCT01519921|63098331|FG001|Overall Study|Withdrawal by Subject|0|||
33666104|NCT01519921|63098330|FG000|Overall Study|Lost to Follow-up|2|||
33666105|NCT01519921|63098331|FG001|Overall Study|Lost to Follow-up|1|||
33666106|NCT01519921|63098330|FG000|Overall Study|Treatment refusal|2|||
33666107|NCT01519921|63098331|FG001|Overall Study|Treatment refusal|1|||
33666108|NCT01519921|63098330|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
33666109|NCT01519921|63098331|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
33666110|NCT01519765|63098339|FG000|Overall Study|Adverse Event|0|||
33666111|NCT01519765|63098340|FG001|Overall Study|Adverse Event|1|||
33666112|NCT01519765|63098339|FG000|Overall Study|Lack of Efficacy|2|||
33666113|NCT01519765|63098340|FG001|Overall Study|Lack of Efficacy|0|||
33666114|NCT01519765|63098339|FG000|Overall Study|Protocol Violation|1|||
33666115|NCT01519765|63098340|FG001|Overall Study|Protocol Violation|0|||
33666116|NCT01519765|63098339|FG000|Overall Study|Withdrawal by Subject|0|||
33666117|NCT01519765|63098340|FG001|Overall Study|Withdrawal by Subject|1|||
33666118|NCT01552603|63098347|FG000|Overall Study|Physician Decision|1|||
33666119|NCT01552369|63098353|FG000|Overall Study|Did not consent to extended follow up|8|||
33666120|NCT01552369|63098354|FG001|Overall Study|Did not consent to extended follow up|9|||
33666121|NCT01552057|63098364|FG000|Overall Study|Adverse Event|14|||
33666122|NCT01552057|63098365|FG001|Overall Study|Adverse Event|15|||
33666123|NCT01552057|63098364|FG000|Overall Study|Lack of Efficacy|8|||
33666124|NCT01552057|63098365|FG001|Overall Study|Lack of Efficacy|23|||
33666125|NCT01552057|63098364|FG000|Overall Study|Withdrawal by Subject|5|||
33666126|NCT01552057|63098365|FG001|Overall Study|Withdrawal by Subject|8|||
33666127|NCT01552057|63098364|FG000|Overall Study|Entry Criteria Not Met|2|||
33666128|NCT01552057|63098365|FG001|Overall Study|Entry Criteria Not Met|2|||
33666129|NCT01552057|63098364|FG000|Overall Study|Physician Decision|1|||
33666130|NCT01552057|63098365|FG001|Overall Study|Physician Decision|0|||
33666131|NCT01551745|63098371|FG000|Overall Study|Withdrawal by Subject|1|||
33666132|NCT01551745|63098371|FG000|Overall Study|Disease Progression|2|||
33666133|NCT01551355|63098381|FG000|Overall Study|Lost to Follow-up|51|||
33666134|NCT01551355|63098382|FG001|Overall Study|Lost to Follow-up|49|||
33666135|NCT01551355|63098383|FG002|Overall Study|Lost to Follow-up|34|||
33666136|NCT01551355|63098384|FG003|Overall Study|Lost to Follow-up|24|||
33666137|NCT01551355|63098385|FG004|Overall Study|Lost to Follow-up|9|||
33666138|NCT01551355|63098386|FG005|Overall Study|Lost to Follow-up|6|||
33666139|NCT01569841|63098394|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
33666140|NCT01569841|63098395|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
33666141|NCT01569763|63098405|FG000|Overall Study|Lack of Efficacy|2|||
33666142|NCT01569763|63098406|FG001|Overall Study|Lack of Efficacy|7|||
33666143|NCT01569763|63098405|FG000|Overall Study|Adverse Event|1|||
33666144|NCT01569763|63098406|FG001|Overall Study|Adverse Event|0|||
33666145|NCT01550965|63098412|FG000|Overall Study|Adverse Event|26|||
33666146|NCT01550965|63098412|FG000|Overall Study|Withdrawal by Subject|10|||
33666147|NCT01550965|63098412|FG000|Overall Study|Lost to Follow-up|2|||
33666148|NCT01550965|63098412|FG000|Overall Study|Lack of Efficacy|59|||
33666149|NCT01550965|63098412|FG000|Overall Study|Other|13|||
33666150|NCT01569295|63098533|FG000|Overall Study|Progressive Disease|75|||
33666151|NCT01569295|63098534|FG001|Overall Study|Progressive Disease|139|||
33666152|NCT01569295|63098533|FG000|Overall Study|Adverse Event|39|||
33666153|NCT01569295|63098534|FG001|Overall Study|Adverse Event|14|||
33666154|NCT01569295|63098533|FG000|Overall Study|Withdrawal by Subject|25|||
33666155|NCT01569295|63098534|FG001|Overall Study|Withdrawal by Subject|12|||
33666156|NCT01569295|63098533|FG000|Overall Study|Death|19|||
33666157|NCT01569295|63098534|FG001|Overall Study|Death|15|||
33666158|NCT01569295|63098533|FG000|Overall Study|Physician Decision|13|||
33666159|NCT01569295|63098534|FG001|Overall Study|Physician Decision|18|||
33666160|NCT01569295|63098533|FG000|Overall Study|Study Terminated by Sponsor|24|||
33666161|NCT01569295|63098534|FG001|Overall Study|Study Terminated by Sponsor|2|||
33666162|NCT01569295|63098533|FG000|Overall Study|Other Reason not Specified|3|||
33666163|NCT01569295|63098534|FG001|Overall Study|Other Reason not Specified|5|||
33666164|NCT01569295|63098533|FG000|Overall Study|Non-Compliance with Study Drug|6|||
33666165|NCT01569295|63098534|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33666166|NCT01569295|63098533|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
33666167|NCT01569295|63098534|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
33666168|NCT01569295|63098533|FG000|Overall Study|Lost to Follow-up|1|||
33666169|NCT01569295|63098534|FG001|Overall Study|Lost to Follow-up|1|||
33666170|NCT01549951|63098591|FG000|Overall Study|Adverse Event|15|||
33666171|NCT01549951|63098591|FG000|Overall Study|Withdrawal by Subject|2|||
33666172|NCT01549951|63098591|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
33666173|NCT01549951|63098591|FG000|Overall Study|Progressive disease|29|||
33666174|NCT01549951|63098591|FG000|Overall Study|Symptomatic deterioration|1|||
33666175|NCT01549951|63098591|FG000|Overall Study|Other|2|||
33666176|NCT01517893|63098597|FG000|Overall Study|Withdrawal by Subject|3|||
33666177|NCT01517893|63098598|FG001|Overall Study|Withdrawal by Subject|0|||
33666178|NCT01489891|63098606|FG000|Overall Study|Endoscopy failure|1|||
33666179|NCT01489891|63098607|FG001|Overall Study|Endoscopy failure|0|||
33666180|NCT04062240|63098689|FG000|Overall Study|equipment malfunction|1|||
33666181|NCT02790138|63098695|FG000|Overall Study|Adverse Event|5|||
33666182|NCT02790138|63098696|FG001|Overall Study|Adverse Event|2|||
33666183|NCT02790138|63098695|FG000|Overall Study|Significant Protocol Deviation|0|||
33666184|NCT02790138|63098696|FG001|Overall Study|Significant Protocol Deviation|1|||
33666185|NCT02790138|63098695|FG000|Overall Study|Lost to Follow-up|1|||
33666186|NCT02790138|63098696|FG001|Overall Study|Lost to Follow-up|0|||
33666187|NCT02790138|63098695|FG000|Overall Study|Voluntary Withdrawal|8|||
33666188|NCT02790138|63098696|FG001|Overall Study|Voluntary Withdrawal|9|||
33666189|NCT02790138|63098695|FG000|Overall Study|Lack of Efficacy|6|||
33666190|NCT02790138|63098696|FG001|Overall Study|Lack of Efficacy|7|||
33666191|NCT02790138|63098695|FG000|Overall Study|Reason not Specified|1|||
33666192|NCT02790138|63098696|FG001|Overall Study|Reason not Specified|0|||
33666193|NCT01489189|63098851|FG000|Overall Study|Withdrawal by Subject|20|||
33666194|NCT01489189|63098852|FG001|Overall Study|Withdrawal by Subject|23|||
33666195|NCT01489189|63098851|FG000|Overall Study|Death|10|||
33666196|NCT01489189|63098852|FG001|Overall Study|Death|8|||
33666197|NCT01489189|63098851|FG000|Overall Study|Missed Visit|1|||
33666198|NCT01489189|63098852|FG001|Overall Study|Missed Visit|4|||
33666199|NCT01549873|63098861|FG000|Overall Study|Physician Decision|0|||
33666200|NCT01549873|63098862|FG001|Overall Study|Physician Decision|1|||
33666201|NCT01489111|63098868|FG000|Overall Study|Withdrawal criterion|1|||
33666202|NCT01488487|63098872|FG000|Overall Study|Adverse Event|6|||
33666203|NCT01488487|63098872|FG000|Overall Study|Death|1|||
33666204|NCT01488487|63098872|FG000|Overall Study|Withdrawal by Subject|2|||
33666205|NCT01488097|63098876|FG000|Overall Study|Lost to Follow-up|1|||
33666206|NCT01516879|63098882|FG000|Overall Study|Withdrawal by Subject|9|||
33666207|NCT01516879|63098883|FG001|Overall Study|Withdrawal by Subject|11|||
33666208|NCT01516879|63098882|FG000|Overall Study|Death|0|||
33666209|NCT01516879|63098883|FG001|Overall Study|Death|2|||
33666210|NCT01516879|63098882|FG000|Overall Study|Lost to Follow-up|2|||
33666211|NCT01516879|63098883|FG001|Overall Study|Lost to Follow-up|11|||
33666212|NCT01516879|63098882|FG000|Overall Study|Other|5|||
33666213|NCT01516879|63098883|FG001|Overall Study|Other|10|||
33666214|NCT01515865|63098889|FG000|Part A (Open-label)|Other|3|||
33666215|NCT01515865|63098890|FG001|Part A (Open-label)|Other|0|||
33666216|NCT01515865|63098891|FG002|Part A (Open-label)|Other|0|||
33666217|NCT01515865|63098889|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
33666218|NCT01515865|63098890|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
33666219|NCT01515865|63098891|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
33666220|NCT01515865|63098889|FG000|Part B (Open-label)|Other|1|||
33666221|NCT01515865|63098890|FG001|Part B (Open-label)|Other|0|||
33666222|NCT01515865|63098891|FG002|Part B (Open-label)|Other|0|||
33666223|NCT01547299|63098901|FG000|Overall Study|Withdrawal by Subject|2|||
33666224|NCT01547299|63098902|FG001|Overall Study|Withdrawal by Subject|2|||
33666225|NCT01515475|63098912|FG000|Overall Study|Lost to Follow-up|20|||
33666226|NCT01515475|63098913|FG001|Overall Study|Lost to Follow-up|15|||
33666227|NCT01515475|63098914|FG002|Overall Study|Lost to Follow-up|12|||
33666228|NCT01515475|63098915|FG003|Overall Study|Lost to Follow-up|12|||
33666229|NCT01515319|63099001|FG000|Overall Study|Withdrawal by Subject|0|||
33666230|NCT01515319|63099002|FG001|Overall Study|Withdrawal by Subject|0|||
33666231|NCT01515319|63099003|FG002|Overall Study|Withdrawal by Subject|0|||
33666232|NCT01515319|63099004|FG003|Overall Study|Withdrawal by Subject|0|||
33666233|NCT01515319|63099005|FG004|Overall Study|Withdrawal by Subject|0|||
33666234|NCT01515319|63099006|FG005|Overall Study|Withdrawal by Subject|0|||
33666235|NCT01515319|63099007|FG006|Overall Study|Withdrawal by Subject|1|||
33305550|NCT01296698|62681051|FG000|Overall Study|Study Terminated by Sponsor|209|||
33666236|NCT01515319|63099008|FG007|Overall Study|Withdrawal by Subject|0|||
33666237|NCT01515319|63099009|FG008|Overall Study|Withdrawal by Subject|0|||
33666238|NCT01515319|63099010|FG009|Overall Study|Withdrawal by Subject|0|||
33666239|NCT01515319|63099001|FG000|Overall Study|Adverse Event|0|||
33666240|NCT01515319|63099002|FG001|Overall Study|Adverse Event|0|||
33666241|NCT01515319|63099003|FG002|Overall Study|Adverse Event|0|||
33666242|NCT01515319|63099004|FG003|Overall Study|Adverse Event|0|||
33666243|NCT01515319|63099005|FG004|Overall Study|Adverse Event|0|||
33666244|NCT01515319|63099006|FG005|Overall Study|Adverse Event|0|||
33666245|NCT01515319|63099007|FG006|Overall Study|Adverse Event|0|||
33666246|NCT01515319|63099008|FG007|Overall Study|Adverse Event|0|||
33666247|NCT01515319|63099009|FG008|Overall Study|Adverse Event|3|||
33666248|NCT01515319|63099010|FG009|Overall Study|Adverse Event|0|||
33305551|NCT01296698|62681052|FG001|Overall Study|Study Terminated by Sponsor|12|||
33578246|NCT02679079|62975149|FG000|Overall Study|Adverse Event|2|||
33578247|NCT02679079|62975150|FG001|Overall Study|Adverse Event|0|||
33578248|NCT02679079|62975151|FG002|Overall Study|Adverse Event|2|||
33578249|NCT02679079|62975149|FG000|Overall Study|Protocol Violation|0|||
33578250|NCT02679079|62975150|FG001|Overall Study|Protocol Violation|1|||
33578251|NCT02679079|62975151|FG002|Overall Study|Protocol Violation|0|||
33578252|NCT02679079|62975149|FG000|Overall Study|Withdrawal by Subject|2|||
33578253|NCT02679079|62975150|FG001|Overall Study|Withdrawal by Subject|1|||
33578254|NCT02679079|62975151|FG002|Overall Study|Withdrawal by Subject|0|||
33578255|NCT02678923|62975161|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
33578256|NCT02678923|62975162|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
33578257|NCT02678923|62975161|FG000|Overall Study|Withdrawal by Subject|3|||
33578258|NCT02678923|62975162|FG001|Overall Study|Withdrawal by Subject|2|||
33578259|NCT02678923|62975161|FG000|Overall Study|Lost to Follow-up|1|||
33578260|NCT02678923|62975162|FG001|Overall Study|Lost to Follow-up|0|||
33578261|NCT02678923|62975161|FG000|Overall Study|Did Not Return for Study Visits|1|||
33578262|NCT02678923|62975162|FG001|Overall Study|Did Not Return for Study Visits|0|||
33578263|NCT01976728|62975172|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
33578264|NCT01976728|62975173|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
33578265|NCT01976728|62975174|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
33578266|NCT01976728|62975175|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
33578267|NCT02689219|62975203|FG000|Overall Study|Death|1|||
33578268|NCT02689219|62975204|FG001|Overall Study|Death|1|||
33578269|NCT02689219|62975203|FG000|Overall Study|Disease Progression|10|||
33578270|NCT02689219|62975204|FG001|Overall Study|Disease Progression|6|||
33578271|NCT02683525|62975210|FG000|Overall Study|Lost to Follow-up|1|||
33578272|NCT02683525|62975210|FG000|Overall Study|Physician Decision|1|||
33578273|NCT02683525|62975210|FG000|Overall Study|Disease Progression|6|||
33578274|NCT01976338|62975216|FG000|Overall Study|Physician Decision|0|||
33578275|NCT01976338|62975217|FG001|Overall Study|Physician Decision|1|||
33578276|NCT01976338|62975216|FG000|Overall Study|Lost to Follow-up|3|||
33578277|NCT01976338|62975217|FG001|Overall Study|Lost to Follow-up|0|||
33578278|NCT01976338|62975216|FG000|Overall Study|Withdrawal by Subject|5|||
33578279|NCT01976338|62975217|FG001|Overall Study|Withdrawal by Subject|2|||
33578280|NCT01976338|62975216|FG000|Overall Study|Adverse Event|5|||
33578281|NCT01976338|62975217|FG001|Overall Study|Adverse Event|1|||
33578282|NCT02674633|62975226|FG000|Overall Study|Lost to Follow-up|3|||
33578283|NCT02674633|62975227|FG001|Overall Study|Lost to Follow-up|2|||
33578284|NCT02674633|62975226|FG000|Overall Study|Physician Decision|1|||
33578285|NCT02674633|62975227|FG001|Overall Study|Physician Decision|0|||
33578286|NCT02674633|62975226|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
33578287|NCT02674633|62975227|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
33578288|NCT02651987|62975235|FG000|Overall Study|Adverse Event|2|||
33578289|NCT02651987|62975236|FG001|Overall Study|Adverse Event|2|||
33578290|NCT02651987|62975235|FG000|Overall Study|Consent Withdrawn|2|||
33578291|NCT02651987|62975236|FG001|Overall Study|Consent Withdrawn|0|||
33578292|NCT02651987|62975235|FG000|Overall Study|Local PD|0|||
33578293|NCT02651987|62975236|FG001|Overall Study|Local PD|2|||
33578294|NCT02651987|62975235|FG000|Overall Study|Investigator Decision|1|||
33578295|NCT02651987|62975236|FG001|Overall Study|Investigator Decision|1|||
33578296|NCT02677987|62975247|FG000|Overall Study|Withdrawal by Subject|3|||
33578297|NCT02677987|62975248|FG001|Overall Study|Withdrawal by Subject|0|||
33578298|NCT02677987|62975247|FG000|Overall Study|Lost to Follow-up|1|||
33578299|NCT02677987|62975248|FG001|Overall Study|Lost to Follow-up|0|||
33578300|NCT01999114|62975267|FG000|Overall Study|Adverse Event|8|||
33578301|NCT01999114|62975268|FG001|Overall Study|Adverse Event|7|||
33578302|NCT01999114|62975269|FG002|Overall Study|Adverse Event|2|||
33578303|NCT01999114|62975270|FG003|Overall Study|Adverse Event|2|||
33578304|NCT01999114|62975271|FG004|Overall Study|Adverse Event|1|||
33578305|NCT01999114|62975267|FG000|Overall Study|Withdrawal by Subject|0|||
33578306|NCT01999114|62975268|FG001|Overall Study|Withdrawal by Subject|0|||
33578307|NCT01999114|62975269|FG002|Overall Study|Withdrawal by Subject|1|||
33578308|NCT01999114|62975270|FG003|Overall Study|Withdrawal by Subject|0|||
33578309|NCT01999114|62975271|FG004|Overall Study|Withdrawal by Subject|1|||
33578310|NCT01999114|62975267|FG000|Overall Study|Lost to Follow-up|0|||
33305552|NCT01001221|62681062|FG000|Overall Study|Adverse Event|1|||
33578311|NCT01999114|62975268|FG001|Overall Study|Lost to Follow-up|0|||
33578312|NCT01999114|62975269|FG002|Overall Study|Lost to Follow-up|1|||
33578313|NCT01999114|62975270|FG003|Overall Study|Lost to Follow-up|0|||
33578314|NCT01999114|62975271|FG004|Overall Study|Lost to Follow-up|0|||
33578315|NCT01999114|62975267|FG000|Overall Study|Administrative|0|||
33578316|NCT01999114|62975268|FG001|Overall Study|Administrative|0|||
33578317|NCT01999114|62975269|FG002|Overall Study|Administrative|1|||
33578318|NCT01999114|62975270|FG003|Overall Study|Administrative|1|||
33578319|NCT01999114|62975271|FG004|Overall Study|Administrative|2|||
33578320|NCT02682823|62975302|FG000|Overall Study|Withdrawal by Subject|0|||
33578321|NCT02682823|62975303|FG001|Overall Study|Withdrawal by Subject|0|||
33666249|NCT01515319|63099001|FG000|Overall Study|Protocol Violation|0|||
33666250|NCT01515319|63099002|FG001|Overall Study|Protocol Violation|0|||
33666251|NCT01515319|63099003|FG002|Overall Study|Protocol Violation|0|||
33666252|NCT01515319|63099004|FG003|Overall Study|Protocol Violation|0|||
33666253|NCT01515319|63099005|FG004|Overall Study|Protocol Violation|0|||
33666254|NCT01515319|63099006|FG005|Overall Study|Protocol Violation|0|||
33666255|NCT01515319|63099007|FG006|Overall Study|Protocol Violation|0|||
33666256|NCT01515319|63099008|FG007|Overall Study|Protocol Violation|0|||
33666257|NCT01515319|63099009|FG008|Overall Study|Protocol Violation|2|||
33666258|NCT01515319|63099010|FG009|Overall Study|Protocol Violation|0|||
33666259|NCT01492361|63099047|FG000|Overall Study|Withdrawal by Subject|281|||
33666260|NCT01492361|63099048|FG001|Overall Study|Withdrawal by Subject|297|||
33666261|NCT01492361|63099047|FG000|Overall Study|Physician Decision|12|||
33666262|NCT01492361|63099048|FG001|Overall Study|Physician Decision|12|||
33666263|NCT01492361|63099047|FG000|Overall Study|Lost to Follow-up|6|||
33666264|NCT01492361|63099048|FG001|Overall Study|Lost to Follow-up|13|||
33666265|NCT01492361|63099047|FG000|Overall Study|Other than specified above|106|||
33666266|NCT01492361|63099048|FG001|Overall Study|Other than specified above|138|||
33666267|NCT01514461|63099127|FG000|Overall Study|Adverse Event|2|||
33666268|NCT01514461|63099128|FG001|Overall Study|Adverse Event|1|||
33666269|NCT01514461|63099129|FG002|Overall Study|Adverse Event|3|||
33666270|NCT01514461|63099127|FG000|Overall Study|Physician Decision|1|||
33666271|NCT01514461|63099128|FG001|Overall Study|Physician Decision|1|||
33666272|NCT01514461|63099129|FG002|Overall Study|Physician Decision|0|||
33666273|NCT01514461|63099127|FG000|Overall Study|Patient/guardian decision|1|||
33666274|NCT01514461|63099128|FG001|Overall Study|Patient/guardian decision|1|||
33666275|NCT01514461|63099129|FG002|Overall Study|Patient/guardian decision|1|||
33666276|NCT01514461|63099127|FG000|Overall Study|Death|1|||
33666277|NCT01514461|63099128|FG001|Overall Study|Death|0|||
33666278|NCT01514461|63099129|FG002|Overall Study|Death|0|||
33666279|NCT01491737|63099175|FG000|Overall Study|Withdrawal by Subject|20|||
33666280|NCT01491737|63099176|FG001|Overall Study|Withdrawal by Subject|17|||
33666281|NCT01491737|63099175|FG000|Overall Study|Lost to Follow-up|2|||
33666282|NCT01491737|63099176|FG001|Overall Study|Lost to Follow-up|10|||
33666283|NCT01491737|63099175|FG000|Overall Study|Death|63|||
33666284|NCT01491737|63099176|FG001|Overall Study|Death|57|||
33666285|NCT01491737|63099175|FG000|Overall Study|Study Termination by Sponsor|36|||
33666286|NCT01491737|63099176|FG001|Overall Study|Study Termination by Sponsor|36|||
33666287|NCT01491737|63099175|FG000|Overall Study|Reason Not Specified|8|||
33666288|NCT01491737|63099176|FG001|Overall Study|Reason Not Specified|9|||
33666289|NCT01487863|63099188|FG000|Overall Study|Death|19|||
33305553|NCT01001221|62681063|FG001|Overall Study|Adverse Event|2|||
33578322|NCT02682823|62975304|FG002|Overall Study|Withdrawal by Subject|1|||
33578323|NCT02682823|62975305|FG003|Overall Study|Withdrawal by Subject|0|||
33578324|NCT02682823|62975306|FG004|Overall Study|Withdrawal by Subject|1|||
33578325|NCT02682823|62975302|FG000|Overall Study|Protocol Deviation|0|||
33578326|NCT02682823|62975303|FG001|Overall Study|Protocol Deviation|1|||
33578327|NCT02682823|62975304|FG002|Overall Study|Protocol Deviation|0|||
33578328|NCT02682823|62975305|FG003|Overall Study|Protocol Deviation|0|||
33578329|NCT02682823|62975306|FG004|Overall Study|Protocol Deviation|0|||
33578330|NCT02682823|62975302|FG000|Overall Study|Adverse Event|0|||
33578331|NCT02682823|62975303|FG001|Overall Study|Adverse Event|0|||
33578332|NCT02682823|62975304|FG002|Overall Study|Adverse Event|0|||
33578333|NCT02682823|62975305|FG003|Overall Study|Adverse Event|1|||
33578334|NCT02682823|62975306|FG004|Overall Study|Adverse Event|0|||
33578335|NCT01374451|62975320|FG000|Overall Study|Administrative problems|1|||
33578336|NCT01374451|62975321|FG001|Overall Study|Administrative problems|0|||
33578337|NCT02674477|62975329|FG000|Overall Study|Protocol Violation|8|||
33578338|NCT02674477|62975330|FG001|Overall Study|Protocol Violation|2|||
33578339|NCT01352845|62975338|FG000|Overall Study|Lost to Follow-up|313|||
33578340|NCT01352845|62975339|FG001|Overall Study|Lost to Follow-up|92|||
33578341|NCT01352845|62975338|FG000|Overall Study|No Longer Willing to Participate|205|||
33578342|NCT01352845|62975339|FG001|Overall Study|No Longer Willing to Participate|58|||
33578343|NCT01352845|62975338|FG000|Overall Study|Withdrawal by Subject|48|||
33578344|NCT01352845|62975339|FG001|Overall Study|Withdrawal by Subject|16|||
33578345|NCT01352845|62975338|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
33666290|NCT01487863|63099189|FG001|Overall Study|Death|19|||
33666291|NCT01487161|63099208|FG000|Overall Study|Adverse Event|1|||
33666292|NCT01487161|63099209|FG001|Overall Study|Adverse Event|0|||
33666293|NCT01487161|63099210|FG002|Overall Study|Adverse Event|0|||
33666294|NCT01487161|63099211|FG003|Overall Study|Adverse Event|0|||
33666295|NCT01487161|63099208|FG000|Overall Study|Withdrawal by Subject|1|||
33666296|NCT01487161|63099209|FG001|Overall Study|Withdrawal by Subject|1|||
33666297|NCT01487161|63099210|FG002|Overall Study|Withdrawal by Subject|1|||
33666298|NCT01487161|63099211|FG003|Overall Study|Withdrawal by Subject|2|||
33666299|NCT01487161|63099208|FG000|Overall Study|missing data|0|||
33305554|NCT01001221|62681064|FG002|Overall Study|Adverse Event|0|||
33578346|NCT01352845|62975339|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
33666300|NCT01487161|63099209|FG001|Overall Study|missing data|1|||
33666301|NCT01487161|63099210|FG002|Overall Study|missing data|0|||
33666302|NCT01487161|63099211|FG003|Overall Study|missing data|0|||
33666303|NCT01491035|63099266|FG000|Overall Study|Lost to Follow-up|0|||
33666304|NCT01491035|63099267|FG001|Overall Study|Lost to Follow-up|0|||
33666305|NCT01491035|63099268|FG002|Overall Study|Lost to Follow-up|0|||
33666306|NCT01491035|63099269|FG003|Overall Study|Lost to Follow-up|0|||
33666307|NCT01491035|63099270|FG004|Overall Study|Lost to Follow-up|1|||
33666308|NCT01491035|63099271|FG005|Overall Study|Lost to Follow-up|0|||
33666309|NCT01491035|63099272|FG006|Overall Study|Lost to Follow-up|0|||
33666310|NCT01491035|63099273|FG007|Overall Study|Lost to Follow-up|0|||
33666311|NCT01488071|63099297|FG000|Overall Study|Adverse Event|15|||
33666312|NCT01488071|63099298|FG001|Overall Study|Adverse Event|23|||
33666313|NCT01488071|63099297|FG000|Overall Study|Lack of Efficacy|11|||
33666314|NCT01488071|63099298|FG001|Overall Study|Lack of Efficacy|17|||
33666315|NCT01488071|63099297|FG000|Overall Study|Non-compliance with study drug|2|||
33666316|NCT01488071|63099298|FG001|Overall Study|Non-compliance with study drug|0|||
33666317|NCT01488071|63099297|FG000|Overall Study|Protocol Violation|5|||
33666318|NCT01488071|63099298|FG001|Overall Study|Protocol Violation|7|||
33666319|NCT01488071|63099297|FG000|Overall Study|Withdrawal of Consent|14|||
33666320|NCT01488071|63099298|FG001|Overall Study|Withdrawal of Consent|12|||
33666321|NCT01488071|63099297|FG000|Overall Study|Lost to Follow-up|1|||
33666322|NCT01488071|63099298|FG001|Overall Study|Lost to Follow-up|0|||
33666323|NCT01488071|63099297|FG000|Overall Study|Administrative or Other Reason(s)|5|||
33666324|NCT01488071|63099298|FG001|Overall Study|Administrative or Other Reason(s)|4|||
33666325|NCT01487525|63099306|FG000|Overall Study|Withdrawal by Subject|0|||
33666326|NCT01487525|63099307|FG001|Overall Study|Withdrawal by Subject|1|||
33666327|NCT01486199|63099315|FG000|Two Year Period Between Study Days|Physician Decision|1|||
33666328|NCT01486199|63099316|FG001|Two Year Period Between Study Days|Physician Decision|0|||
33666329|NCT01485887|63099322|FG000|Overall Study|Withdrawal by Subject|2|||
33666330|NCT01485887|63099322|FG000|Overall Study|Adverse Event|8|||
33666331|NCT01485887|63099322|FG000|Overall Study|Deterioration of primary disease|1|||
33666332|NCT01485887|63099322|FG000|Overall Study|Primary disease markedly improved|1|||
33666333|NCT01546519|63099330|FG000|Overall Study|Adverse Event|0|||
33666334|NCT01546519|63099331|FG001|Overall Study|Adverse Event|0|||
33666335|NCT01546519|63099332|FG002|Overall Study|Adverse Event|1|||
33666336|NCT01546519|63099333|FG003|Overall Study|Adverse Event|1|||
33666337|NCT01546519|63099330|FG000|Overall Study|Death|0|||
33666338|NCT01546519|63099331|FG001|Overall Study|Death|1|||
33666339|NCT01546519|63099332|FG002|Overall Study|Death|3|||
33666340|NCT01546519|63099333|FG003|Overall Study|Death|1|||
33666341|NCT01546519|63099330|FG000|Overall Study|related to disease progression|2|||
33666342|NCT01546519|63099331|FG001|Overall Study|related to disease progression|2|||
33666343|NCT01546519|63099332|FG002|Overall Study|related to disease progression|2|||
33666344|NCT01546519|63099333|FG003|Overall Study|related to disease progression|1|||
33666345|NCT01546519|63099330|FG000|Overall Study|Physician Decision|6|||
33666346|NCT01546519|63099331|FG001|Overall Study|Physician Decision|5|||
33666347|NCT01546519|63099332|FG002|Overall Study|Physician Decision|2|||
33666348|NCT01546519|63099333|FG003|Overall Study|Physician Decision|3|||
33666349|NCT01546519|63099330|FG000|Overall Study|Withdrawal by Subject|1|||
33666350|NCT01546519|63099331|FG001|Overall Study|Withdrawal by Subject|0|||
33666351|NCT01546519|63099332|FG002|Overall Study|Withdrawal by Subject|0|||
33666352|NCT01546519|63099333|FG003|Overall Study|Withdrawal by Subject|0|||
33666353|NCT01484951|63099347|FG000|Overall Study|Adverse Event|3|||
33305555|NCT01001221|62681065|FG003|Overall Study|Adverse Event|2|||
33398078|NCT00293293|62777420|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
33578347|NCT01352845|62975338|FG000|Overall Study|Pregnancy|27|||
33578348|NCT01352845|62975339|FG001|Overall Study|Pregnancy|7|||
33578349|NCT01352845|62975338|FG000|Overall Study|Adverse Event|22|||
33578350|NCT01352845|62975339|FG001|Overall Study|Adverse Event|6|||
33578351|NCT01352845|62975338|FG000|Overall Study|Other|17|||
33578352|NCT01352845|62975339|FG001|Overall Study|Other|7|||
33578353|NCT01352845|62975338|FG000|Overall Study|Protocol Violation|12|||
33578354|NCT01352845|62975339|FG001|Overall Study|Protocol Violation|6|||
33578355|NCT01352845|62975338|FG000|Overall Study|Death|3|||
33578356|NCT01352845|62975339|FG001|Overall Study|Death|0|||
33666354|NCT01484951|63099347|FG000|Overall Study|Personal Reasons|1|||
33666355|NCT01484951|63099347|FG000|Overall Study|Non-Compliance|1|||
33666356|NCT01484873|63099351|FG000|Overall Study|Withdrawal by Subject|2|||
33666357|NCT01486927|63099356|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
33666358|NCT01486927|63099356|FG000|Overall Study|Physician Decision|1|||
33666359|NCT01486927|63099356|FG000|Overall Study|50 Exposure days not reached|2|||
33666360|NCT01486927|63099356|FG000|Overall Study|Withdrawal by Subject|8|||
33666361|NCT01486927|63099356|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
33666362|NCT01513759|63099389|FG000|Overall Study|Protocol Violation|4|||
33666363|NCT01513759|63099389|FG000|Overall Study|Death during catheter placement|1|||
33666364|NCT01484561|63099395|FG000|Overall Study|Lack of Efficacy|3|||
33666365|NCT01484561|63099396|FG001|Overall Study|Lack of Efficacy|1|||
33578357|NCT02674399|62975347|FG000|Overall Study|Lost to Follow-up|2|||
33666366|NCT01484561|63099395|FG000|Overall Study|Lost to Follow-up|1|||
33666367|NCT01484561|63099396|FG001|Overall Study|Lost to Follow-up|0|||
33666368|NCT01484561|63099395|FG000|Overall Study|Withdrawal by Subject|3|||
33666369|NCT01484561|63099396|FG001|Overall Study|Withdrawal by Subject|0|||
33666370|NCT01484561|63099395|FG000|Overall Study|Other|1|||
33666371|NCT01484561|63099396|FG001|Overall Study|Other|1|||
33666372|NCT01484561|63099395|FG000|Overall Study|Adverse Event|1|||
33666373|NCT01484561|63099396|FG001|Overall Study|Adverse Event|4|||
33666374|NCT01546207|63099402|FG000|Overall Study|Death|1|||
33666375|NCT01513291|63099408|FG000|Treatment Period|Adverse Event|8|||
33666376|NCT01513291|63099409|FG001|Treatment Period|Adverse Event|4|||
33666377|NCT01513291|63099410|FG002|Treatment Period|Adverse Event|0|||
33666378|NCT01513291|63099411|FG003|Treatment Period|Adverse Event|0|||
33666379|NCT01513291|63099412|FG004|Treatment Period|Adverse Event|0|||
33666380|NCT01513291|63099408|FG000|Treatment Period|Lack of Efficacy|3|||
33666381|NCT01513291|63099409|FG001|Treatment Period|Lack of Efficacy|0|||
33666382|NCT01513291|63099410|FG002|Treatment Period|Lack of Efficacy|0|||
33666383|NCT01513291|63099411|FG003|Treatment Period|Lack of Efficacy|0|||
33666384|NCT01513291|63099412|FG004|Treatment Period|Lack of Efficacy|0|||
33666385|NCT01513291|63099408|FG000|Treatment Period|Lost to Follow-up|2|||
33666386|NCT01513291|63099409|FG001|Treatment Period|Lost to Follow-up|3|||
33666387|NCT01513291|63099410|FG002|Treatment Period|Lost to Follow-up|0|||
33666388|NCT01513291|63099411|FG003|Treatment Period|Lost to Follow-up|0|||
33666389|NCT01513291|63099412|FG004|Treatment Period|Lost to Follow-up|0|||
33666390|NCT01513291|63099408|FG000|Treatment Period|Physician Decision|1|||
33666391|NCT01513291|63099409|FG001|Treatment Period|Physician Decision|0|||
33666392|NCT01513291|63099410|FG002|Treatment Period|Physician Decision|0|||
33666393|NCT01513291|63099411|FG003|Treatment Period|Physician Decision|0|||
33666394|NCT01513291|63099412|FG004|Treatment Period|Physician Decision|0|||
33666395|NCT01513291|63099408|FG000|Treatment Period|Protocol Violation|1|||
33666396|NCT01513291|63099409|FG001|Treatment Period|Protocol Violation|2|||
33666397|NCT01513291|63099410|FG002|Treatment Period|Protocol Violation|0|||
33666398|NCT01513291|63099411|FG003|Treatment Period|Protocol Violation|0|||
33666399|NCT01513291|63099412|FG004|Treatment Period|Protocol Violation|0|||
33666400|NCT01513291|63099408|FG000|Treatment Period|Withdrawal by Subject|8|||
33666401|NCT01513291|63099409|FG001|Treatment Period|Withdrawal by Subject|5|||
33666402|NCT01513291|63099410|FG002|Treatment Period|Withdrawal by Subject|0|||
33666403|NCT01513291|63099411|FG003|Treatment Period|Withdrawal by Subject|0|||
33666404|NCT01513291|63099412|FG004|Treatment Period|Withdrawal by Subject|0|||
33666405|NCT01513291|63099408|FG000|Treatment Period|Randomized not treated|0|||
33666406|NCT01513291|63099409|FG001|Treatment Period|Randomized not treated|2|||
33666407|NCT01513291|63099410|FG002|Treatment Period|Randomized not treated|0|||
33666408|NCT01513291|63099411|FG003|Treatment Period|Randomized not treated|0|||
33666409|NCT01513291|63099412|FG004|Treatment Period|Randomized not treated|0|||
33666410|NCT01513291|63099408|FG000|Run-out Period|Lost to Follow-up|0|||
33666411|NCT01513291|63099409|FG001|Run-out Period|Lost to Follow-up|0|||
33666412|NCT01513291|63099410|FG002|Run-out Period|Lost to Follow-up|0|||
33666413|NCT01513291|63099411|FG003|Run-out Period|Lost to Follow-up|1|||
33666414|NCT01513291|63099412|FG004|Run-out Period|Lost to Follow-up|0|||
33666415|NCT01513291|63099408|FG000|Run-out Period|Withdrawal by Subject|0|||
33666416|NCT01513291|63099409|FG001|Run-out Period|Withdrawal by Subject|0|||
33666417|NCT01513291|63099410|FG002|Run-out Period|Withdrawal by Subject|0|||
33666418|NCT01513291|63099411|FG003|Run-out Period|Withdrawal by Subject|1|||
33666419|NCT01513291|63099412|FG004|Run-out Period|Withdrawal by Subject|0|||
33666420|NCT01483937|63099426|FG000|Overall Study|Withdrawal by Subject|4|||
33666421|NCT01483937|63099427|FG001|Overall Study|Withdrawal by Subject|3|||
33666422|NCT01483625|63099438|FG000|Overall Study|Adverse Event|1|||
33666423|NCT01483625|63099439|FG001|Overall Study|Adverse Event|1|||
33666424|NCT01483625|63099438|FG000|Overall Study|Refused to continue medication|2|||
33666425|NCT01483625|63099439|FG001|Overall Study|Refused to continue medication|1|||
33666426|NCT01483625|63099438|FG000|Overall Study|Due to other reason|1|||
33666427|NCT01483625|63099439|FG001|Overall Study|Due to other reason|0|||
33666428|NCT01485991|63099447|FG000|Overall Study|Adverse Event|0|||
33666429|NCT01485991|63099448|FG001|Overall Study|Adverse Event|4|||
33666430|NCT01485991|63099447|FG000|Overall Study|Lost to Follow-up|13|||
33666431|NCT01485991|63099448|FG001|Overall Study|Lost to Follow-up|10|||
33666432|NCT01485991|63099447|FG000|Overall Study|Withdrawal by Subject|13|||
33666433|NCT01485991|63099448|FG001|Overall Study|Withdrawal by Subject|20|||
33666434|NCT01485991|63099447|FG000|Overall Study|randomized but not treated|6|||
33666435|NCT01485991|63099448|FG001|Overall Study|randomized but not treated|2|||
33666436|NCT01482767|63099480|FG000|Overall Study|Death|1|||
33666437|NCT01482767|63099481|FG001|Overall Study|Death|1|||
33666438|NCT01482767|63099480|FG000|Overall Study|Withdrawal by Subject|7|||
33666439|NCT01482767|63099481|FG001|Overall Study|Withdrawal by Subject|5|||
33666440|NCT01482767|63099480|FG000|Overall Study|Lost to Follow-up|12|||
33666441|NCT01482767|63099481|FG001|Overall Study|Lost to Follow-up|6|||
33666442|NCT01482767|63099480|FG000|Overall Study|Adverse Event|0|||
33666443|NCT01482767|63099481|FG001|Overall Study|Adverse Event|3|||
33666444|NCT01482767|63099480|FG000|Overall Study|Site closure|22|||
33666445|NCT01482767|63099481|FG001|Overall Study|Site closure|14|||
33666446|NCT01482767|63099480|FG000|Overall Study|Non-adherence to study requirements|4|||
33666447|NCT01482767|63099481|FG001|Overall Study|Non-adherence to study requirements|7|||
33666448|NCT01482767|63099480|FG000|Overall Study|Alternate HCV treatment|7|||
33666449|NCT01482767|63099481|FG001|Overall Study|Alternate HCV treatment|8|||
33666450|NCT01482767|63099480|FG000|Overall Study|Ineligible|0|||
33666451|NCT01482767|63099481|FG001|Overall Study|Ineligible|5|||
33666452|NCT01482767|63099480|FG000|Overall Study|Nurse error|1|||
33666453|NCT01482767|63099481|FG001|Overall Study|Nurse error|0|||
33666454|NCT01482221|63099510|FG000|Overall Study|Lack of Efficacy|1|||
33666455|NCT01482221|63099511|FG001|Overall Study|Lack of Efficacy|0|||
33666456|NCT01482221|63099512|FG002|Overall Study|Lack of Efficacy|1|||
33666457|NCT01482221|63099510|FG000|Overall Study|Lost to Follow-up|3|||
33666458|NCT01482221|63099511|FG001|Overall Study|Lost to Follow-up|2|||
33666459|NCT01482221|63099512|FG002|Overall Study|Lost to Follow-up|1|||
33666460|NCT01482221|63099510|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
33666461|NCT01482221|63099511|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
33666462|NCT01482221|63099512|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
33666463|NCT01482221|63099510|FG000|Overall Study|Condition under Investigation Worsened|3|||
33666464|NCT01482221|63099511|FG001|Overall Study|Condition under Investigation Worsened|2|||
33666465|NCT01482221|63099512|FG002|Overall Study|Condition under Investigation Worsened|4|||
33666466|NCT01482221|63099510|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
33666467|NCT01482221|63099511|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
33666468|NCT01482221|63099512|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
33666469|NCT01482221|63099510|FG000|Overall Study|Adverse Event|1|||
33666470|NCT01482221|63099511|FG001|Overall Study|Adverse Event|7|||
33666471|NCT01482221|63099512|FG002|Overall Study|Adverse Event|3|||
33666472|NCT01482221|63099510|FG000|Overall Study|Withdrawal by Subject|10|||
33666473|NCT01482221|63099511|FG001|Overall Study|Withdrawal by Subject|7|||
33666474|NCT01482221|63099512|FG002|Overall Study|Withdrawal by Subject|12|||
33666475|NCT01482221|63099510|FG000|Overall Study|Incorrect randomization|0|||
33666476|NCT01482221|63099511|FG001|Overall Study|Incorrect randomization|1|||
33666477|NCT01482221|63099512|FG002|Overall Study|Incorrect randomization|0|||
33666478|NCT01482221|63099510|FG000|Overall Study|Physician Decision|0|||
33666479|NCT01482221|63099511|FG001|Overall Study|Physician Decision|1|||
33666480|NCT01482221|63099512|FG002|Overall Study|Physician Decision|0|||
33666481|NCT01482065|63099522|FG000|Overall Study|Withdrawal by Subject|0|||
33666482|NCT01482065|63099523|FG001|Overall Study|Withdrawal by Subject|1|||
33666483|NCT01545817|63099538|FG000|Pazopanib|Disease progression|51|||
33666484|NCT01545817|63099539|FG001|Pazopanib|Disease progression|0|||
33666485|NCT01545817|63099538|FG000|Pazopanib|Adverse Event|19|||
33666486|NCT01545817|63099539|FG001|Pazopanib|Adverse Event|0|||
33666487|NCT01545817|63099538|FG000|Pazopanib|Other reason|4|||
33666488|NCT01545817|63099539|FG001|Pazopanib|Other reason|0|||
33666489|NCT01545817|63099538|FG000|Everolimus|Other reason|0|||
33666490|NCT01545817|63099539|FG001|Everolimus|Other reason|7|||
33666491|NCT01545817|63099538|FG000|Everolimus|Disease progression|0|||
33666492|NCT01545817|63099539|FG001|Everolimus|Disease progression|25|||
33666493|NCT01545817|63099538|FG000|Everolimus|Adverse Event|0|||
33666494|NCT01545817|63099539|FG001|Everolimus|Adverse Event|6|||
33666495|NCT01512979|63099558|FG000|Overall Study|Adverse Event|2|||
33666496|NCT01512979|63099559|FG001|Overall Study|Adverse Event|2|||
33666497|NCT01512979|63099558|FG000|Overall Study|Protocol Violation|1|||
33666498|NCT01512979|63099559|FG001|Overall Study|Protocol Violation|4|||
33666499|NCT01512979|63099558|FG000|Overall Study|Lost to Follow-up|2|||
33666500|NCT01512979|63099559|FG001|Overall Study|Lost to Follow-up|5|||
33666501|NCT01512979|63099558|FG000|Overall Study|Withdrawal by Subject|1|||
33666502|NCT01512979|63099559|FG001|Overall Study|Withdrawal by Subject|2|||
33666503|NCT01512979|63099558|FG000|Overall Study|Reason other than stated above|13|||
33666504|NCT01512979|63099559|FG001|Overall Study|Reason other than stated above|9|||
33666505|NCT01512745|63099571|FG000|Overall Study|Adverse Event|22|||
33666506|NCT01512745|63099572|FG001|Overall Study|Adverse Event|3|||
33666507|NCT01512745|63099571|FG000|Overall Study|Death|9|||
33666508|NCT01512745|63099572|FG001|Overall Study|Death|13|||
33666509|NCT01512745|63099571|FG000|Overall Study|Withdrawal by Subject|2|||
33666510|NCT01512745|63099572|FG001|Overall Study|Withdrawal by Subject|2|||
33666511|NCT01512745|63099571|FG000|Overall Study|Lost to Follow-up|4|||
33666512|NCT01512745|63099572|FG001|Overall Study|Lost to Follow-up|0|||
33666513|NCT01512745|63099571|FG000|Overall Study|Lack of Efficacy|2|||
33666514|NCT01512745|63099572|FG001|Overall Study|Lack of Efficacy|2|||
33666515|NCT01512745|63099571|FG000|Overall Study|Protocol Violation|1|||
33666516|NCT01512745|63099572|FG001|Overall Study|Protocol Violation|0|||
33666517|NCT01478321|63099578|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
33666518|NCT01478321|63099578|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
33666519|NCT01478321|63099578|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
33666520|NCT01478321|63099578|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
33666521|NCT01478321|63099578|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
33666522|NCT01478321|63099578|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
33666523|NCT01478321|63099578|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
33666524|NCT01478321|63099578|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
33666525|NCT01544491|63099584|FG000|Overall Study|Withdrawal by Subject|3|||
33666526|NCT01544491|63099585|FG001|Overall Study|Withdrawal by Subject|2|||
33666527|NCT01544491|63099584|FG000|Overall Study|Lost to Follow-up|0|||
33666528|NCT01544491|63099585|FG001|Overall Study|Lost to Follow-up|1|||
33666529|NCT01544491|63099584|FG000|Overall Study|administrative problems|2|||
33666530|NCT01544491|63099585|FG001|Overall Study|administrative problems|0|||
33666531|NCT01478087|63099604|FG000|Overall Study|due to sponsor closing study|1|||
33666532|NCT01477853|63099622|FG000|Phase A|Adverse Event|1|||
33666533|NCT01477853|63099623|FG001|Phase A|Adverse Event|2|||
33666534|NCT01477853|63099624|FG002|Phase A|Adverse Event|2|||
33666535|NCT01477853|63099622|FG000|Phase A|Lost to Follow-up|4|||
33666536|NCT01477853|63099623|FG001|Phase A|Lost to Follow-up|3|||
33666537|NCT01477853|63099624|FG002|Phase A|Lost to Follow-up|2|||
33666538|NCT01477853|63099622|FG000|Phase A|Physician Decision|1|||
33666539|NCT01477853|63099623|FG001|Phase A|Physician Decision|0|||
33666540|NCT01477853|63099624|FG002|Phase A|Physician Decision|1|||
33666541|NCT01477853|63099622|FG000|Phase A|Study terminated by sponsor|37|||
33666542|NCT01477853|63099623|FG001|Phase A|Study terminated by sponsor|40|||
33666543|NCT01477853|63099624|FG002|Phase A|Study terminated by sponsor|39|||
33666544|NCT01477853|63099622|FG000|Phase B|Lost to Follow-up|0|||
33666545|NCT01477853|63099623|FG001|Phase B|Lost to Follow-up|1|||
33666546|NCT01477853|63099624|FG002|Phase B|Lost to Follow-up|0|||
33666547|NCT01477853|63099622|FG000|Phase B|Study terminated by sponsor|12|||
33666548|NCT01477853|63099623|FG001|Phase B|Study terminated by sponsor|10|||
33666549|NCT01477853|63099624|FG002|Phase B|Study terminated by sponsor|11|||
33666550|NCT01511419|63099656|FG000|Dose 2|Physician Decision|1|||
33666551|NCT01511419|63099657|FG001|Dose 2|Physician Decision|0|||
33666552|NCT01511107|63099719|FG000|Overall Study|Ineligible|3|||
33666553|NCT01511107|63099720|FG001|Overall Study|Ineligible|2|||
33666554|NCT01511107|63099719|FG000|Overall Study|Lost to Follow-up|10|||
33666555|NCT01511107|63099720|FG001|Overall Study|Lost to Follow-up|19|||
33666556|NCT01511107|63099719|FG000|Overall Study|Withdrawal by Subject|9|||
33666557|NCT01511107|63099720|FG001|Overall Study|Withdrawal by Subject|20|||
33666558|NCT01484977|63099755|FG000|Overall Study|Adverse Event|8|||
33666559|NCT01484977|63099755|FG000|Overall Study|Lack of Efficacy|4|||
33666560|NCT01484977|63099755|FG000|Overall Study|Protocol Violation|6|||
33666561|NCT01484977|63099755|FG000|Overall Study|Lost to Follow-up|1|||
33666562|NCT01484977|63099755|FG000|Overall Study|Withdrawal by Subject|4|||
33666563|NCT01484977|63099755|FG000|Overall Study|Subject Protocol Non-compliant|1|||
33666564|NCT01484977|63099755|FG000|Overall Study|Moving Overseas|1|||
33666565|NCT01484977|63099755|FG000|Overall Study|Low White Blood Cell Count|1|||
33666566|NCT01484977|63099755|FG000|Overall Study|Lack of Compliance|1|||
33666567|NCT01475825|63099835|FG000|Overall Study|Adverse Event|41|||
33666568|NCT01475825|63099836|FG001|Overall Study|Adverse Event|15|||
33666569|NCT01475825|63099837|FG002|Overall Study|Adverse Event|27|||
33666570|NCT01475825|63099838|FG003|Overall Study|Adverse Event|11|||
33666571|NCT01475825|63099835|FG000|Overall Study|Death|1|||
33666572|NCT01475825|63099836|FG001|Overall Study|Death|0|||
33666573|NCT01475825|63099837|FG002|Overall Study|Death|1|||
33666574|NCT01475825|63099838|FG003|Overall Study|Death|0|||
33666575|NCT01475825|63099835|FG000|Overall Study|Lack of Efficacy|0|||
33666576|NCT01475825|63099836|FG001|Overall Study|Lack of Efficacy|0|||
33666577|NCT01475825|63099837|FG002|Overall Study|Lack of Efficacy|1|||
33666578|NCT01475825|63099838|FG003|Overall Study|Lack of Efficacy|0|||
33666579|NCT01475825|63099835|FG000|Overall Study|Lost to Follow-up|0|||
33666580|NCT01475825|63099836|FG001|Overall Study|Lost to Follow-up|0|||
33666581|NCT01475825|63099837|FG002|Overall Study|Lost to Follow-up|3|||
33666582|NCT01475825|63099838|FG003|Overall Study|Lost to Follow-up|1|||
33666583|NCT01475825|63099835|FG000|Overall Study|Non-compliance with Study Drug|1|||
33666584|NCT01475825|63099836|FG001|Overall Study|Non-compliance with Study Drug|2|||
33666585|NCT01475825|63099837|FG002|Overall Study|Non-compliance with Study Drug|4|||
33666586|NCT01475825|63099838|FG003|Overall Study|Non-compliance with Study Drug|0|||
33666587|NCT01475825|63099835|FG000|Overall Study|Other: Not available|0|||
33666588|NCT01475825|63099836|FG001|Overall Study|Other: Not available|0|||
33666589|NCT01475825|63099837|FG002|Overall Study|Other: Not available|2|||
33666590|NCT01475825|63099838|FG003|Overall Study|Other: Not available|0|||
33666591|NCT01475825|63099835|FG000|Overall Study|Protocol Violation|1|||
33666592|NCT01475825|63099836|FG001|Overall Study|Protocol Violation|0|||
33666593|NCT01475825|63099837|FG002|Overall Study|Protocol Violation|0|||
33666594|NCT01475825|63099838|FG003|Overall Study|Protocol Violation|0|||
33666595|NCT01475825|63099835|FG000|Overall Study|Physician Decision|0|||
33666596|NCT01475825|63099836|FG001|Overall Study|Physician Decision|1|||
33666597|NCT01475825|63099837|FG002|Overall Study|Physician Decision|0|||
33666598|NCT01475825|63099838|FG003|Overall Study|Physician Decision|0|||
33666599|NCT01475825|63099835|FG000|Overall Study|Withdrawal by Subject|8|||
33666600|NCT01475825|63099836|FG001|Overall Study|Withdrawal by Subject|3|||
33666601|NCT01475825|63099837|FG002|Overall Study|Withdrawal by Subject|11|||
33666602|NCT01475825|63099838|FG003|Overall Study|Withdrawal by Subject|7|||
33666603|NCT01475825|63099835|FG000|Overall Study|Did not enter OLC|15|||
33666604|NCT01475825|63099836|FG001|Overall Study|Did not enter OLC|11|||
33666605|NCT01475825|63099837|FG002|Overall Study|Did not enter OLC|15|||
33666606|NCT01475825|63099838|FG003|Overall Study|Did not enter OLC|11|||
33666607|NCT01484431|63099860|FG000|Period 1: High Dose|Physician Decision|0|||
33666608|NCT01484431|63099861|FG001|Period 1: High Dose|Physician Decision|1|||
33666609|NCT01484431|63099862|FG002|Period 1: High Dose|Physician Decision|0|||
33666610|NCT01484431|63099860|FG000|Period 2|Death|0|||
33666611|NCT01484431|63099861|FG001|Period 2|Death|1|||
33666612|NCT01484431|63099862|FG002|Period 2|Death|1|||
33666613|NCT01484431|63099860|FG000|Period 2|Physician Decision|0|||
33666614|NCT01484431|63099861|FG001|Period 2|Physician Decision|0|||
33666615|NCT01484431|63099862|FG002|Period 2|Physician Decision|1|||
33666616|NCT01484431|63099860|FG000|Period 2|Non-Compliance with Study Drug|1|||
33666617|NCT01484431|63099861|FG001|Period 2|Non-Compliance with Study Drug|0|||
33666618|NCT01484431|63099862|FG002|Period 2|Non-Compliance with Study Drug|0|||
33666619|NCT01473953|63099910|FG000|Overall Study|Other|1|||
33666620|NCT01473953|63099911|FG001|Overall Study|Other|0|||
33666621|NCT01473953|63099912|FG002|Overall Study|Other|0|||
33666622|NCT01473953|63099913|FG003|Overall Study|Other|0|||
33666623|NCT01473953|63099914|FG004|Overall Study|Other|0|||
33666624|NCT01510717|63099928|FG000|Overall Study|Adverse Event|1|||
33666625|NCT01510717|63099929|FG001|Overall Study|Adverse Event|2|||
33666626|NCT01510717|63099928|FG000|Overall Study|Death|1|||
33666627|NCT01510717|63099929|FG001|Overall Study|Death|0|||
33666628|NCT01510717|63099928|FG000|Overall Study|Lost to Follow-up|0|||
33666629|NCT01510717|63099929|FG001|Overall Study|Lost to Follow-up|1|||
33666630|NCT01510717|63099928|FG000|Overall Study|Withdrawal by Subject|0|||
33666631|NCT01510717|63099929|FG001|Overall Study|Withdrawal by Subject|2|||
33666632|NCT01473563|63099945|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
33666633|NCT01484275|63099963|FG000|Overall Study|Study terminated by sponsor|28|||
33666634|NCT01484275|63099964|FG001|Overall Study|Study terminated by sponsor|32|||
33666635|NCT01484275|63099963|FG000|Overall Study|Other|10|||
33666636|NCT01484275|63099964|FG001|Overall Study|Other|0|||
33666637|NCT01484275|63099963|FG000|Overall Study|Death|3|||
33666638|NCT01484275|63099964|FG001|Overall Study|Death|4|||
33666639|NCT01484275|63099963|FG000|Overall Study|Withdrawal by Subject|1|||
33666640|NCT01484275|63099964|FG001|Overall Study|Withdrawal by Subject|5|||
33666641|NCT01484275|63099963|FG000|Overall Study|Lost to Follow-up|1|||
33666642|NCT01484275|63099964|FG001|Overall Study|Lost to Follow-up|1|||
33666643|NCT01544335|63099970|FG000|Overall Study|Lost to Follow-up|27|||
33666644|NCT01544335|63099970|FG000|Overall Study|Death|4|||
33666645|NCT01544335|63099970|FG000|Overall Study|Disease progression|3|||
33666646|NCT01544335|63099970|FG000|Overall Study|Baseline Measurements not Available|19|||
33666647|NCT01484197|63099974|FG000|Treatment Period 1|Adverse Event|1|||
33666648|NCT01484197|63099975|FG001|Treatment Period 1|Adverse Event|0|||
33666649|NCT01484197|63099976|FG002|Treatment Period 1|Adverse Event|0|||
33666650|NCT01484197|63099977|FG003|Treatment Period 1|Adverse Event|0|||
33666651|NCT01484197|63099974|FG000|Treatment Period 2|Subject withdrew consent|0|||
33666652|NCT01484197|63099975|FG001|Treatment Period 2|Subject withdrew consent|0|||
33666653|NCT01484197|63099976|FG002|Treatment Period 2|Subject withdrew consent|0|||
33666654|NCT01484197|63099977|FG003|Treatment Period 2|Subject withdrew consent|1|||
33666655|NCT01473407|63099989|FG000|Overall Study|Physician Decision|1|||
33666656|NCT01473407|63099990|FG001|Overall Study|Physician Decision|4|||
33666657|NCT01473407|63099989|FG000|Overall Study|Lost to Follow-up|10|||
33666658|NCT01473407|63099990|FG001|Overall Study|Lost to Follow-up|4|||
33666659|NCT01473407|63099989|FG000|Overall Study|Adverse Event|8|||
33666660|NCT01473407|63099990|FG001|Overall Study|Adverse Event|8|||
33666661|NCT01473407|63099989|FG000|Overall Study|Randomization Error|3|||
33666662|NCT01473407|63099990|FG001|Overall Study|Randomization Error|1|||
33666663|NCT01473407|63099989|FG000|Overall Study|Withdrawal by Subject|4|||
33666664|NCT01473407|63099990|FG001|Overall Study|Withdrawal by Subject|7|||
33666665|NCT01473407|63099989|FG000|Overall Study|Kidney Transplant|7|||
33666666|NCT01473407|63099990|FG001|Overall Study|Kidney Transplant|6|||
33666667|NCT01473407|63099989|FG000|Overall Study|Vacation/Travel|1|||
33666668|NCT01473407|63099990|FG001|Overall Study|Vacation/Travel|1|||
33666669|NCT01473407|63099989|FG000|Overall Study|Elevated Hemoglobin|1|||
33666670|NCT01473407|63099990|FG001|Overall Study|Elevated Hemoglobin|0|||
33666671|NCT01473407|63099989|FG000|Overall Study|Patient Received Aranesp|1|||
33666672|NCT01473407|63099990|FG001|Overall Study|Patient Received Aranesp|0|||
33666673|NCT01473407|63099989|FG000|Overall Study|Patient Lost Green Card Status|1|||
33666674|NCT01473407|63099990|FG001|Overall Study|Patient Lost Green Card Status|0|||
33666675|NCT01473407|63099989|FG000|Overall Study|Temperature Excursion|2|||
33666676|NCT01473407|63099990|FG001|Overall Study|Temperature Excursion|3|||
33666677|NCT01473407|63099989|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
33666678|NCT01473407|63099990|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
33666679|NCT01473407|63099989|FG000|Overall Study|Sponsor's Decision|10|||
33666680|NCT01473407|63099990|FG001|Overall Study|Sponsor's Decision|10|||
33666681|NCT01473407|63099989|FG000|Overall Study|Site Closure|1|||
33666682|NCT01473407|63099990|FG001|Overall Study|Site Closure|0|||
33666683|NCT01472939|63100000|FG000|Overall Study|Adverse Event|3|||
33666684|NCT01472939|63100001|FG001|Overall Study|Adverse Event|7|||
33666685|NCT01472939|63100002|FG002|Overall Study|Adverse Event|7|||
33666686|NCT01472939|63100003|FG003|Overall Study|Adverse Event|14|||
33666687|NCT01472939|63100000|FG000|Overall Study|Lack of Efficacy|1|||
33666688|NCT01472939|63100001|FG001|Overall Study|Lack of Efficacy|0|||
33666689|NCT01472939|63100002|FG002|Overall Study|Lack of Efficacy|0|||
33666690|NCT01472939|63100003|FG003|Overall Study|Lack of Efficacy|1|||
33666691|NCT01472939|63100000|FG000|Overall Study|Lost to Follow-up|3|||
33666692|NCT01472939|63100001|FG001|Overall Study|Lost to Follow-up|0|||
33666693|NCT01472939|63100002|FG002|Overall Study|Lost to Follow-up|2|||
33666694|NCT01472939|63100003|FG003|Overall Study|Lost to Follow-up|0|||
33666695|NCT01472939|63100000|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
33666696|NCT01472939|63100001|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
33666697|NCT01472939|63100002|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
33666698|NCT01472939|63100003|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
33666699|NCT01472939|63100000|FG000|Overall Study|Prohibited Medication|0|||
33666700|NCT01472939|63100001|FG001|Overall Study|Prohibited Medication|1|||
33666701|NCT01472939|63100002|FG002|Overall Study|Prohibited Medication|0|||
33666702|NCT01472939|63100003|FG003|Overall Study|Prohibited Medication|0|||
33666703|NCT01472939|63100000|FG000|Overall Study|Withdrawal By PI|1|||
33666704|NCT01472939|63100001|FG001|Overall Study|Withdrawal By PI|0|||
33666705|NCT01472939|63100002|FG002|Overall Study|Withdrawal By PI|0|||
33666706|NCT01472939|63100003|FG003|Overall Study|Withdrawal By PI|0|||
33666707|NCT01472939|63100000|FG000|Overall Study|Protocol Violation|3|||
33666708|NCT01472939|63100001|FG001|Overall Study|Protocol Violation|3|||
33666709|NCT01472939|63100002|FG002|Overall Study|Protocol Violation|0|||
33666710|NCT01472939|63100003|FG003|Overall Study|Protocol Violation|1|||
33666711|NCT01472939|63100000|FG000|Overall Study|Withdrawal by Subject|9|||
33666712|NCT01472939|63100001|FG001|Overall Study|Withdrawal by Subject|3|||
33666713|NCT01472939|63100002|FG002|Overall Study|Withdrawal by Subject|1|||
33666714|NCT01472939|63100003|FG003|Overall Study|Withdrawal by Subject|4|||
33666715|NCT01544179|63100018|FG000|Overall Study|Death|50|||
33666716|NCT01544179|63100019|FG001|Overall Study|Death|37|||
33666717|NCT01544179|63100018|FG000|Overall Study|Lost to Follow-up|0|||
33666718|NCT01544179|63100019|FG001|Overall Study|Lost to Follow-up|1|||
33666719|NCT01544179|63100018|FG000|Overall Study|Adverse Event|0|||
33666720|NCT01544179|63100019|FG001|Overall Study|Adverse Event|1|||
33666721|NCT01544179|63100018|FG000|Overall Study|Withdrawal by Subject|12|||
33666722|NCT01544179|63100019|FG001|Overall Study|Withdrawal by Subject|7|||
33666723|NCT01544179|63100018|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
33666724|NCT01544179|63100019|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33666725|NCT01483651|63100025|FG000|Overall Study|Withdrawal by Subject|0|||
33666726|NCT01483651|63100026|FG001|Overall Study|Withdrawal by Subject|1|||
33666727|NCT01483651|63100027|FG002|Overall Study|Withdrawal by Subject|1|||
33666728|NCT01483651|63100028|FG003|Overall Study|Withdrawal by Subject|0|||
33666729|NCT01483651|63100029|FG004|Overall Study|Withdrawal by Subject|0|||
33666730|NCT01483651|63100030|FG005|Overall Study|Withdrawal by Subject|1|||
33666731|NCT01464307|63100040|FG000|Main Period|Death|0|||
33666732|NCT01464307|63100041|FG001|Main Period|Death|1|||
33666733|NCT01464307|63100040|FG000|Main Period|Adverse Event|6|||
33666734|NCT01464307|63100041|FG001|Main Period|Adverse Event|1|||
33666735|NCT01464307|63100040|FG000|Main Period|Lack of Efficacy|2|||
33666736|NCT01464307|63100041|FG001|Main Period|Lack of Efficacy|0|||
33666737|NCT01464307|63100040|FG000|Main Period|Withdrawal by Subject|5|||
33666738|NCT01464307|63100041|FG001|Main Period|Withdrawal by Subject|2|||
33666739|NCT01464307|63100040|FG000|Main Period|Predefined discontinuation criteria|2|||
33666740|NCT01464307|63100041|FG001|Main Period|Predefined discontinuation criteria|1|||
33666741|NCT01464307|63100040|FG000|Open-Label Extension Period|Adverse Event|15|||
33666742|NCT01464307|63100041|FG001|Open-Label Extension Period|Adverse Event|0|||
33666743|NCT01464307|63100040|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
33666744|NCT01464307|63100041|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
33666745|NCT01464307|63100040|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
33666746|NCT01464307|63100041|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
33666747|NCT01464307|63100040|FG000|Open-Label Extension Period|Death|1|||
33666748|NCT01464307|63100041|FG001|Open-Label Extension Period|Death|0|||
33666749|NCT01464307|63100040|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
33666750|NCT01464307|63100041|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
33666751|NCT01464307|63100040|FG000|Open-Label Extension Period|Non-compliance|9|||
33666752|NCT01464307|63100041|FG001|Open-Label Extension Period|Non-compliance|0|||
33666753|NCT01464307|63100040|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
33666754|NCT01464307|63100041|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
33666755|NCT01483183|63100058|FG000|Overall Study|Physician Decision|0|||
33666756|NCT01483183|63100059|FG001|Overall Study|Physician Decision|0|||
33666757|NCT01483183|63100060|FG002|Overall Study|Physician Decision|0|||
33666758|NCT01483183|63100061|FG003|Overall Study|Physician Decision|0|||
33666759|NCT01483183|63100062|FG004|Overall Study|Physician Decision|0|||
33666760|NCT01483183|63100063|FG005|Overall Study|Physician Decision|0|||
33666761|NCT01483183|63100064|FG006|Overall Study|Physician Decision|2|||
33666762|NCT01483183|63100065|FG007|Overall Study|Physician Decision|0|||
33666763|NCT01483183|63100066|FG008|Overall Study|Physician Decision|0|||
33666764|NCT01483183|63100067|FG009|Overall Study|Physician Decision|0|||
33666765|NCT01483183|63100058|FG000|Overall Study|Withdrawal by Subject|0|||
33666766|NCT01483183|63100059|FG001|Overall Study|Withdrawal by Subject|0|||
33666767|NCT01483183|63100060|FG002|Overall Study|Withdrawal by Subject|0|||
33666768|NCT01483183|63100061|FG003|Overall Study|Withdrawal by Subject|0|||
33666769|NCT01483183|63100062|FG004|Overall Study|Withdrawal by Subject|0|||
33666770|NCT01483183|63100063|FG005|Overall Study|Withdrawal by Subject|0|||
33666771|NCT01483183|63100064|FG006|Overall Study|Withdrawal by Subject|0|||
33666772|NCT01483183|63100065|FG007|Overall Study|Withdrawal by Subject|0|||
33666773|NCT01483183|63100066|FG008|Overall Study|Withdrawal by Subject|0|||
33666774|NCT01483183|63100067|FG009|Overall Study|Withdrawal by Subject|1|||
33666775|NCT01483027|63100097|FG000|Overall Study|Administrative Reasons|2|||
33666776|NCT01483027|63100098|FG001|Overall Study|Administrative Reasons|1|||
33666777|NCT01483027|63100097|FG000|Overall Study|Withdrawal by Subject|21|||
33666778|NCT01483027|63100098|FG001|Overall Study|Withdrawal by Subject|32|||
33666779|NCT01483027|63100097|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
33666780|NCT01483027|63100098|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
33666781|NCT01483027|63100097|FG000|Overall Study|Lost to Follow-up|1|||
33666782|NCT01483027|63100098|FG001|Overall Study|Lost to Follow-up|1|||
33666783|NCT01483027|63100097|FG000|Overall Study|Adverse Event|0|||
33666784|NCT01483027|63100098|FG001|Overall Study|Adverse Event|1|||
33666785|NCT01483027|63100097|FG000|Overall Study|Withdrawal by Subject|0|||
33666786|NCT01483027|63100098|FG001|Overall Study|Withdrawal by Subject|1|||
33666787|NCT01463683|63100107|FG000|Overall Study|Adverse Event|2|||
33666788|NCT01463683|63100108|FG001|Overall Study|Adverse Event|0|||
33666789|NCT01463683|63100109|FG002|Overall Study|Adverse Event|0|||
33666790|NCT01463683|63100107|FG000|Overall Study|Lost to Follow-up|10|||
33666791|NCT01463683|63100108|FG001|Overall Study|Lost to Follow-up|9|||
33666792|NCT01463683|63100109|FG002|Overall Study|Lost to Follow-up|7|||
33666793|NCT01463683|63100107|FG000|Overall Study|Physician Decision|0|||
33666794|NCT01463683|63100108|FG001|Overall Study|Physician Decision|3|||
33578358|NCT02674399|62975348|FG001|Overall Study|Lost to Follow-up|0|||
33578359|NCT02676895|62975357|FG000|Overall Study|Administrative reason|1|||
33578360|NCT02676895|62975358|FG001|Overall Study|Administrative reason|0|||
33578361|NCT02676895|62975359|FG002|Overall Study|Administrative reason|0|||
33578362|NCT02676895|62975357|FG000|Overall Study|Protocol Violation|1|||
33578363|NCT02676895|62975358|FG001|Overall Study|Protocol Violation|0|||
33578364|NCT02676895|62975359|FG002|Overall Study|Protocol Violation|0|||
33578365|NCT02676895|62975357|FG000|Overall Study|Adverse Event|0|||
33578366|NCT02676895|62975358|FG001|Overall Study|Adverse Event|3|||
33578367|NCT02676895|62975359|FG002|Overall Study|Adverse Event|1|||
33578368|NCT02676895|62975357|FG000|Overall Study|Lost to Follow-up|0|||
33578369|NCT02676895|62975358|FG001|Overall Study|Lost to Follow-up|0|||
33578370|NCT02676895|62975359|FG002|Overall Study|Lost to Follow-up|1|||
33578371|NCT02676895|62975357|FG000|Overall Study|Withdrawal by Subject|0|||
33578372|NCT02676895|62975358|FG001|Overall Study|Withdrawal by Subject|0|||
33578373|NCT02676895|62975359|FG002|Overall Study|Withdrawal by Subject|1|||
33578374|NCT02673697|62975370|FG000|Overall Study|Adverse Event|2|||
33578375|NCT02673697|62975371|FG001|Overall Study|Adverse Event|0|||
33578376|NCT02673697|62975370|FG000|Overall Study|Death|32|||
33578377|NCT02673697|62975371|FG001|Overall Study|Death|24|||
33578378|NCT02673697|62975370|FG000|Overall Study|Lost to Follow-up|5|||
33578379|NCT02673697|62975371|FG001|Overall Study|Lost to Follow-up|2|||
33578380|NCT02673697|62975370|FG000|Overall Study|Physician Decision|2|||
33578381|NCT02673697|62975371|FG001|Overall Study|Physician Decision|1|||
33578382|NCT02673697|62975370|FG000|Overall Study|Withdrawal by Subject|10|||
33578383|NCT02673697|62975371|FG001|Overall Study|Withdrawal by Subject|7|||
33578384|NCT02673697|62975370|FG000|Overall Study|Change subj medical status|1|||
33578385|NCT02673697|62975371|FG001|Overall Study|Change subj medical status|2|||
33578386|NCT02673697|62975370|FG000|Overall Study|Explant|10|||
33578387|NCT02673697|62975371|FG001|Overall Study|Explant|5|||
33666795|NCT01463683|63100109|FG002|Overall Study|Physician Decision|1|||
33666796|NCT01463683|63100107|FG000|Overall Study|Pregnancy|2|||
33666797|NCT01463683|63100108|FG001|Overall Study|Pregnancy|2|||
33666798|NCT01463683|63100109|FG002|Overall Study|Pregnancy|1|||
33666799|NCT01463683|63100107|FG000|Overall Study|Withdrawal by Subject|5|||
33666800|NCT01463683|63100108|FG001|Overall Study|Withdrawal by Subject|17|||
33666801|NCT01463683|63100109|FG002|Overall Study|Withdrawal by Subject|2|||
33666802|NCT01482169|63100117|FG000|Overall Study|Physician Decision|2|||
33578388|NCT02673697|62975370|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
33666803|NCT01481779|63100126|FG000|Overall Study|Adverse Event|23|||
33666804|NCT01481779|63100127|FG001|Overall Study|Adverse Event|5|||
33666805|NCT01481779|63100126|FG000|Overall Study|Lost to Follow-up|3|||
33666806|NCT01481779|63100127|FG001|Overall Study|Lost to Follow-up|2|||
33666807|NCT01481779|63100126|FG000|Overall Study|Protocol Violation|2|||
33666808|NCT01481779|63100127|FG001|Overall Study|Protocol Violation|3|||
33666809|NCT01481779|63100126|FG000|Overall Study|Withdrawal by Subject|26|||
33666810|NCT01481779|63100127|FG001|Overall Study|Withdrawal by Subject|13|||
33666811|NCT01481779|63100126|FG000|Overall Study|Physician Decision|13|||
33666812|NCT01481779|63100127|FG001|Overall Study|Physician Decision|4|||
33666813|NCT01481779|63100126|FG000|Overall Study|Sponsor Decision|3|||
33666814|NCT01481779|63100127|FG001|Overall Study|Sponsor Decision|1|||
33666815|NCT01463527|63100135|FG000|Overall Study|Protocol Violation|1|||
33666816|NCT01463527|63100136|FG001|Overall Study|Protocol Violation|1|||
33666817|NCT01463527|63100135|FG000|Overall Study|Crying >20% of sedation|5|||
33666818|NCT01463527|63100136|FG001|Overall Study|Crying >20% of sedation|6|||
33666819|NCT01509547|63100144|FG000|Overall Study|Lost to Follow-up|24|||
33666820|NCT01509547|63100145|FG001|Overall Study|Lost to Follow-up|14|||
33666821|NCT01509547|63100144|FG000|Overall Study|Withdrawal by Subject|11|||
33666822|NCT01509547|63100145|FG001|Overall Study|Withdrawal by Subject|24|||
33666823|NCT01509547|63100144|FG000|Overall Study|Physician Decision|0|||
33666824|NCT01509547|63100145|FG001|Overall Study|Physician Decision|1|||
33666825|NCT01509079|63100153|FG000|Overall Study|Lack of Efficacy|0|||
33666826|NCT01509079|63100154|FG001|Overall Study|Lack of Efficacy|2|||
33666827|NCT01509079|63100153|FG000|Overall Study|started an excluded medication|0|||
33666828|NCT01509079|63100154|FG001|Overall Study|started an excluded medication|1|||
33666829|NCT01463293|63100163|FG000|Overall Study|Lost to Follow-up|1|||
33666830|NCT01463293|63100164|FG001|Overall Study|Lost to Follow-up|4|||
33666831|NCT01463293|63100165|FG002|Overall Study|Lost to Follow-up|5|||
33666832|NCT01463293|63100163|FG000|Overall Study|Adverse Event|1|||
33666833|NCT01463293|63100164|FG001|Overall Study|Adverse Event|2|||
33666834|NCT01463293|63100165|FG002|Overall Study|Adverse Event|0|||
33666835|NCT01463293|63100163|FG000|Overall Study|Withdrawal by Subject|4|||
33666836|NCT01463293|63100164|FG001|Overall Study|Withdrawal by Subject|10|||
33666837|NCT01463293|63100165|FG002|Overall Study|Withdrawal by Subject|5|||
33666838|NCT01463293|63100163|FG000|Overall Study|Other|0|||
33666839|NCT01463293|63100164|FG001|Overall Study|Other|0|||
33666840|NCT01463293|63100165|FG002|Overall Study|Other|2|||
33666841|NCT01479985|63100196|FG000|Overall Study|Tablet malfunction, no data saved|1|||
33666842|NCT01479985|63100197|FG001|Overall Study|Tablet malfunction, no data saved|1|||
33666843|NCT01479985|63100196|FG000|Overall Study|No decisional conflict scale responses|0|||
33666844|NCT01479985|63100197|FG001|Overall Study|No decisional conflict scale responses|2|||
33666845|NCT01479985|63100196|FG000|Overall Study|No post-visit survey|5|||
33666846|NCT01479985|63100197|FG001|Overall Study|No post-visit survey|3|||
33666847|NCT01462435|63100211|FG000|Overall Study|Lack of Efficacy|1|||
33666848|NCT01462435|63100212|FG001|Overall Study|Lack of Efficacy|0|||
33666849|NCT01462435|63100213|FG002|Overall Study|Lack of Efficacy|0|||
33666850|NCT01462435|63100214|FG003|Overall Study|Lack of Efficacy|3|||
33666851|NCT01462435|63100211|FG000|Overall Study|Physician Decision|0|||
33666852|NCT01462435|63100212|FG001|Overall Study|Physician Decision|0|||
33666853|NCT01462435|63100213|FG002|Overall Study|Physician Decision|1|||
33666854|NCT01462435|63100214|FG003|Overall Study|Physician Decision|0|||
33666855|NCT01462435|63100211|FG000|Overall Study|Withdrawal by Subject|0|||
33666856|NCT01462435|63100212|FG001|Overall Study|Withdrawal by Subject|0|||
33666857|NCT01462435|63100213|FG002|Overall Study|Withdrawal by Subject|0|||
33666858|NCT01462435|63100214|FG003|Overall Study|Withdrawal by Subject|1|||
33666859|NCT01462435|63100211|FG000|Overall Study|Lost to Follow-up|0|||
33666860|NCT01462435|63100212|FG001|Overall Study|Lost to Follow-up|0|||
33666861|NCT01462435|63100213|FG002|Overall Study|Lost to Follow-up|0|||
33666862|NCT01462435|63100214|FG003|Overall Study|Lost to Follow-up|1|||
33666863|NCT01472081|63100230|FG000|Overall Study|Continuing treatment at time of analysis|1|||
33666864|NCT01472081|63100231|FG001|Overall Study|Continuing treatment at time of analysis|4|||
33666865|NCT01472081|63100232|FG002|Overall Study|Continuing treatment at time of analysis|1|||
33666866|NCT01472081|63100233|FG003|Overall Study|Continuing treatment at time of analysis|8|||
33666867|NCT01472081|63100234|FG004|Overall Study|Continuing treatment at time of analysis|9|||
33666868|NCT01472081|63100235|FG005|Overall Study|Continuing treatment at time of analysis|0|||
33666869|NCT01472081|63100230|FG000|Overall Study|Disease Progression|4|||
33666870|NCT01472081|63100231|FG001|Overall Study|Disease Progression|10|||
33666871|NCT01472081|63100232|FG002|Overall Study|Disease Progression|12|||
33666872|NCT01472081|63100233|FG003|Overall Study|Disease Progression|31|||
33666873|NCT01472081|63100234|FG004|Overall Study|Disease Progression|22|||
33666874|NCT01472081|63100235|FG005|Overall Study|Disease Progression|3|||
33666875|NCT01472081|63100230|FG000|Overall Study|Study drug toxicity|2|||
33666876|NCT01472081|63100231|FG001|Overall Study|Study drug toxicity|9|||
33666877|NCT01472081|63100232|FG002|Overall Study|Study drug toxicity|4|||
33666878|NCT01472081|63100233|FG003|Overall Study|Study drug toxicity|6|||
33666879|NCT01472081|63100234|FG004|Overall Study|Study drug toxicity|13|||
33666880|NCT01472081|63100235|FG005|Overall Study|Study drug toxicity|2|||
33666881|NCT01472081|63100230|FG000|Overall Study|Death|0|||
33666882|NCT01472081|63100231|FG001|Overall Study|Death|0|||
33666883|NCT01472081|63100232|FG002|Overall Study|Death|0|||
33666884|NCT01472081|63100233|FG003|Overall Study|Death|0|||
33666885|NCT01472081|63100234|FG004|Overall Study|Death|1|||
33666886|NCT01472081|63100235|FG005|Overall Study|Death|0|||
33666887|NCT01472081|63100230|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
33666888|NCT01472081|63100231|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
33666889|NCT01472081|63100232|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
33666890|NCT01472081|63100233|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
33666891|NCT01472081|63100234|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
33666892|NCT01472081|63100235|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
33666893|NCT01472081|63100230|FG000|Overall Study|Withdrawal by Subject|0|||
33666894|NCT01472081|63100231|FG001|Overall Study|Withdrawal by Subject|0|||
33666895|NCT01472081|63100232|FG002|Overall Study|Withdrawal by Subject|0|||
33666896|NCT01472081|63100233|FG003|Overall Study|Withdrawal by Subject|0|||
33666897|NCT01472081|63100234|FG004|Overall Study|Withdrawal by Subject|0|||
33666898|NCT01472081|63100235|FG005|Overall Study|Withdrawal by Subject|1|||
33666899|NCT01472081|63100230|FG000|Overall Study|Poor/non-compliance|0|||
33666900|NCT01472081|63100231|FG001|Overall Study|Poor/non-compliance|0|||
33666901|NCT01472081|63100232|FG002|Overall Study|Poor/non-compliance|1|||
33666902|NCT01472081|63100233|FG003|Overall Study|Poor/non-compliance|0|||
33666903|NCT01472081|63100234|FG004|Overall Study|Poor/non-compliance|1|||
33666904|NCT01472081|63100235|FG005|Overall Study|Poor/non-compliance|0|||
33666905|NCT01472081|63100230|FG000|Overall Study|No longer meets study criteria|0|||
33666906|NCT01472081|63100231|FG001|Overall Study|No longer meets study criteria|0|||
33666907|NCT01472081|63100232|FG002|Overall Study|No longer meets study criteria|1|||
33666908|NCT01472081|63100233|FG003|Overall Study|No longer meets study criteria|0|||
33666909|NCT01472081|63100234|FG004|Overall Study|No longer meets study criteria|0|||
33666910|NCT01472081|63100235|FG005|Overall Study|No longer meets study criteria|0|||
33666911|NCT01472081|63100230|FG000|Overall Study|Subject request to discontinue treatment|0|||
33666912|NCT01472081|63100231|FG001|Overall Study|Subject request to discontinue treatment|3|||
33666913|NCT01472081|63100232|FG002|Overall Study|Subject request to discontinue treatment|1|||
33666914|NCT01472081|63100233|FG003|Overall Study|Subject request to discontinue treatment|1|||
33666915|NCT01472081|63100234|FG004|Overall Study|Subject request to discontinue treatment|0|||
33666916|NCT01472081|63100235|FG005|Overall Study|Subject request to discontinue treatment|0|||
33666917|NCT01471691|63100250|FG000|Overall Study|Lack of Efficacy|0|||
33666918|NCT01471691|63100251|FG001|Overall Study|Lack of Efficacy|1|||
33666919|NCT01471379|63100260|FG000|Overall Study|Adverse Event|1|||
33666920|NCT01471379|63100261|FG001|Overall Study|Adverse Event|0|||
33666921|NCT01471379|63100262|FG002|Overall Study|Adverse Event|0|||
33666922|NCT01471379|63100260|FG000|Overall Study|Study terminated|0|||
33666923|NCT01471379|63100261|FG001|Overall Study|Study terminated|1|||
33666924|NCT01471379|63100262|FG002|Overall Study|Study terminated|0|||
33666925|NCT01470989|63100273|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
33666926|NCT01470989|63100274|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
33666927|NCT01470989|63100273|FG000|Overall Study|Adverse Event|2|||
33666928|NCT01470989|63100274|FG001|Overall Study|Adverse Event|5|||
33666929|NCT01470989|63100273|FG000|Overall Study|Abnormal laboratory value|1|||
33666930|NCT01470989|63100274|FG001|Overall Study|Abnormal laboratory value|1|||
33666931|NCT01470989|63100273|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33666932|NCT01470989|63100274|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
33666933|NCT01470989|63100273|FG000|Overall Study|Withdrawal by Subject|19|||
33666934|NCT01470989|63100274|FG001|Overall Study|Withdrawal by Subject|17|||
33666935|NCT01470989|63100273|FG000|Overall Study|Lost to Follow-up|18|||
33666936|NCT01470989|63100274|FG001|Overall Study|Lost to Follow-up|13|||
33666937|NCT01470989|63100273|FG000|Overall Study|Administrative problems|2|||
33666938|NCT01470989|63100274|FG001|Overall Study|Administrative problems|4|||
33666939|NCT01470989|63100273|FG000|Overall Study|Death|2|||
33666940|NCT01470989|63100274|FG001|Overall Study|Death|2|||
33666941|NCT01470989|63100273|FG000|Overall Study|Protocol deviation|1|||
33666942|NCT01470989|63100274|FG001|Overall Study|Protocol deviation|2|||
33666943|NCT01470599|63100284|FG000|Overall Study|Did not meet entrance criteria|1|||
33666944|NCT01470599|63100285|FG001|Overall Study|Did not meet entrance criteria|0|||
33666945|NCT01470599|63100284|FG000|Overall Study|Lost to Follow-up|2|||
33666946|NCT01470599|63100285|FG001|Overall Study|Lost to Follow-up|1|||
33666947|NCT01470599|63100284|FG000|Overall Study|Withdrawal by Subject|3|||
33666948|NCT01470599|63100285|FG001|Overall Study|Withdrawal by Subject|4|||
33666949|NCT01470599|63100284|FG000|Overall Study|Other|1|||
33666950|NCT01470599|63100285|FG001|Overall Study|Other|0|||
33666951|NCT01470599|63100284|FG000|Overall Study|Protocol Violation|3|||
33666952|NCT01470599|63100285|FG001|Overall Study|Protocol Violation|1|||
33666953|NCT01470599|63100284|FG000|Overall Study|Adverse event related to study drug|2|||
33666954|NCT01470599|63100285|FG001|Overall Study|Adverse event related to study drug|5|||
33666955|NCT01470599|63100284|FG000|Overall Study|Insufficient clinical response|6|||
33666956|NCT01470599|63100285|FG001|Overall Study|Insufficient clinical response|27|||
33666957|NCT01470599|63100284|FG000|Overall Study|Adverse event not related to study drug|1|||
33666958|NCT01470599|63100285|FG001|Overall Study|Adverse event not related to study drug|5|||
33666959|NCT01469819|63100291|FG000|Overall Study|Withdrawal by Subject|1|||
33666960|NCT01469819|63100291|FG000|Overall Study|Did not meet inclusionary criteria|2|||
33666961|NCT01469819|63100291|FG000|Overall Study|Could not swallow SmartPill|2|||
33666962|NCT01469819|63100291|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
33666963|NCT01507831|63100303|FG000|Overall Study|Randomized but not treated|0|||
33666964|NCT01507831|63100304|FG001|Overall Study|Randomized but not treated|3|||
33666965|NCT01507831|63100303|FG000|Overall Study|Adverse Event|48|||
33666966|NCT01507831|63100304|FG001|Overall Study|Adverse Event|113|||
33666967|NCT01507831|63100303|FG000|Overall Study|Death|6|||
33666968|NCT01507831|63100304|FG001|Overall Study|Death|2|||
33666969|NCT01507831|63100303|FG000|Overall Study|Poor compliance to protocol|38|||
33666970|NCT01507831|63100304|FG001|Overall Study|Poor compliance to protocol|60|||
33666971|NCT01507831|63100303|FG000|Overall Study|Physician Decision|0|||
33666972|NCT01507831|63100304|FG001|Overall Study|Physician Decision|4|||
33666973|NCT01507831|63100303|FG000|Overall Study|Participant moved|5|||
33666974|NCT01507831|63100304|FG001|Overall Study|Participant moved|19|||
33666975|NCT01507831|63100303|FG000|Overall Study|Consent withdrawn by participant|34|||
33666976|NCT01507831|63100304|FG001|Overall Study|Consent withdrawn by participant|72|||
33666977|NCT01507831|63100303|FG000|Overall Study|Related to study drug administration|5|||
33666978|NCT01507831|63100304|FG001|Overall Study|Related to study drug administration|14|||
33666979|NCT01507831|63100303|FG000|Overall Study|Last visit outside protocol visit window|51|||
33666980|NCT01507831|63100304|FG001|Overall Study|Last visit outside protocol visit window|143|||
33666981|NCT01507831|63100303|FG000|Overall Study|Selection criteria finally not met|0|||
33666982|NCT01507831|63100304|FG001|Overall Study|Selection criteria finally not met|1|||
33666983|NCT01507831|63100303|FG000|Overall Study|Site closure|0|||
33666984|NCT01507831|63100304|FG001|Overall Study|Site closure|3|||
33666985|NCT01507831|63100303|FG000|Overall Study|Potential lost to follow-up|3|||
33666986|NCT01507831|63100304|FG001|Overall Study|Potential lost to follow-up|0|||
33666987|NCT01507831|63100303|FG000|Overall Study|Other|3|||
33666988|NCT01507831|63100304|FG001|Overall Study|Other|6|||
33666989|NCT01479595|63100312|FG000|Overall Study|Protocol deviation|0|||
33666990|NCT01479595|63100313|FG001|Overall Study|Protocol deviation|1|||
33666991|NCT01479595|63100312|FG000|Overall Study|Adverse Event|2|||
33666992|NCT01479595|63100313|FG001|Overall Study|Adverse Event|1|||
33666993|NCT01462357|63100322|FG000|Overall Study|Death|0|||
33666994|NCT01462357|63100323|FG001|Overall Study|Death|0|||
33666995|NCT01462357|63100324|FG002|Overall Study|Death|1|||
33666996|NCT01462357|63100322|FG000|Overall Study|Withdrawal by Subject|3|||
33666997|NCT01462357|63100323|FG001|Overall Study|Withdrawal by Subject|11|||
33666998|NCT01462357|63100324|FG002|Overall Study|Withdrawal by Subject|3|||
33666999|NCT01462357|63100322|FG000|Overall Study|Migrated/moved from study area|2|||
33667000|NCT01462357|63100323|FG001|Overall Study|Migrated/moved from study area|3|||
33667001|NCT01462357|63100324|FG002|Overall Study|Migrated/moved from study area|1|||
33667002|NCT01462357|63100322|FG000|Overall Study|Lost to Follow-up|3|||
33667003|NCT01462357|63100323|FG001|Overall Study|Lost to Follow-up|5|||
33667004|NCT01462357|63100324|FG002|Overall Study|Lost to Follow-up|7|||
33667005|NCT01479439|63100335|FG000|Overall Study|Adverse Event|1|||
33667006|NCT01479439|63100336|FG001|Overall Study|Adverse Event|0|||
33667007|NCT01479439|63100337|FG002|Overall Study|Adverse Event|0|||
33667008|NCT01479439|63100335|FG000|Overall Study|Lost to Follow-up|0|||
33667009|NCT01479439|63100336|FG001|Overall Study|Lost to Follow-up|1|||
33667010|NCT01479439|63100337|FG002|Overall Study|Lost to Follow-up|0|||
33667011|NCT01479439|63100335|FG000|Overall Study|Protocol Violation|0|||
33667012|NCT01479439|63100336|FG001|Overall Study|Protocol Violation|0|||
33667013|NCT01479439|63100337|FG002|Overall Study|Protocol Violation|2|||
33667014|NCT01478971|63100348|FG000|Standard of Care Period|Adverse Event|1|||
33667015|NCT01478971|63100348|FG000|Standard of Care Period|Withdrawal by Subject|3|||
33667016|NCT01478971|63100348|FG000|Standard of Care Period|Death|8|||
33667017|NCT01478971|63100348|FG000|Standard of Care Period|Lost to Follow-up|9|||
33667018|NCT01478971|63100348|FG000|Standard of Care Period|Other|4|||
33667019|NCT01478971|63100348|FG000|Peginesatide Treatment Period|Adverse Event|1|||
33667020|NCT01478971|63100348|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
33667021|NCT01478971|63100348|FG000|Peginesatide Treatment Period|Death|4|||
33667022|NCT01478971|63100348|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
33667023|NCT01478971|63100348|FG000|Peginesatide Treatment Period|Other|4|||
33667024|NCT01507051|63100360|FG000|Overall Study|Withdrawal by Subject|1|||
33667025|NCT01507051|63100361|FG001|Overall Study|Withdrawal by Subject|3|||
33667026|NCT01507051|63100362|FG002|Overall Study|Withdrawal by Subject|1|||
33667027|NCT01507051|63100363|FG003|Overall Study|Withdrawal by Subject|6|||
33667028|NCT01507051|63100360|FG000|Overall Study|Physician Decision|0|||
33667029|NCT01507051|63100361|FG001|Overall Study|Physician Decision|0|||
33667030|NCT01507051|63100362|FG002|Overall Study|Physician Decision|0|||
33667031|NCT01507051|63100363|FG003|Overall Study|Physician Decision|1|||
33667032|NCT01507051|63100360|FG000|Overall Study|Adverse Event|1|||
33667033|NCT01507051|63100361|FG001|Overall Study|Adverse Event|0|||
33667034|NCT01507051|63100362|FG002|Overall Study|Adverse Event|0|||
33667035|NCT01507051|63100363|FG003|Overall Study|Adverse Event|0|||
33667036|NCT01478347|63100373|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
33667037|NCT01478347|63100373|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
33667038|NCT01478347|63100373|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
33667039|NCT01478113|63100379|FG000|Overall Study|Withdrawal by Subject|0|||
33667040|NCT01478113|63100380|FG001|Overall Study|Withdrawal by Subject|1|||
33667041|NCT01478113|63100379|FG000|Overall Study|Physician Decision|1|||
33667042|NCT01478113|63100380|FG001|Overall Study|Physician Decision|0|||
33667043|NCT01506271|63100391|FG000|Overall Study|Progressive disease|0|||
33667044|NCT01506271|63100392|FG001|Overall Study|Progressive disease|1|||
33667045|NCT01506271|63100393|FG002|Overall Study|Progressive disease|0|||
33667046|NCT01506271|63100391|FG000|Overall Study|Protocol Violation|3|||
33667047|NCT01506271|63100392|FG001|Overall Study|Protocol Violation|1|||
33667048|NCT01506271|63100393|FG002|Overall Study|Protocol Violation|0|||
33667049|NCT01506271|63100391|FG000|Overall Study|Death|0|||
33667050|NCT01506271|63100392|FG001|Overall Study|Death|1|||
33667051|NCT01506271|63100393|FG002|Overall Study|Death|0|||
33667052|NCT01506271|63100391|FG000|Overall Study|Adverse Event|0|||
33667053|NCT01506271|63100392|FG001|Overall Study|Adverse Event|2|||
33667054|NCT01506271|63100393|FG002|Overall Study|Adverse Event|0|||
33667055|NCT01506271|63100391|FG000|Overall Study|Insufficient supply of study drug|1|||
33667056|NCT01506271|63100392|FG001|Overall Study|Insufficient supply of study drug|0|||
33667057|NCT01506271|63100393|FG002|Overall Study|Insufficient supply of study drug|0|||
33667058|NCT01506271|63100391|FG000|Overall Study|Withdrawal by Subject|0|||
33667059|NCT01506271|63100392|FG001|Overall Study|Withdrawal by Subject|1|||
33667060|NCT01506271|63100393|FG002|Overall Study|Withdrawal by Subject|1|||
33667061|NCT01506271|63100391|FG000|Overall Study|Lost to Follow-up|0|||
33667062|NCT01506271|63100392|FG001|Overall Study|Lost to Follow-up|1|||
33667063|NCT01506271|63100393|FG002|Overall Study|Lost to Follow-up|2|||
33667064|NCT01506193|63100404|FG000|Overall Study|Protocol Violation|1|||
33667065|NCT01506193|63100405|FG001|Overall Study|Protocol Violation|0|||
33667066|NCT01506193|63100406|FG002|Overall Study|Protocol Violation|1|||
33667067|NCT01506193|63100404|FG000|Overall Study|Migrated/moved from study area|0|||
33667068|NCT01506193|63100405|FG001|Overall Study|Migrated/moved from study area|0|||
33667069|NCT01506193|63100406|FG002|Overall Study|Migrated/moved from study area|1|||
33667070|NCT01506193|63100404|FG000|Overall Study|Adverse event, non-fatal|0|||
33667071|NCT01506193|63100405|FG001|Overall Study|Adverse event, non-fatal|0|||
33667072|NCT01506193|63100406|FG002|Overall Study|Adverse event, non-fatal|1|||
33667073|NCT01506193|63100404|FG000|Overall Study|Withdrawal by Subject|5|||
33667074|NCT01506193|63100405|FG001|Overall Study|Withdrawal by Subject|1|||
33667075|NCT01506193|63100406|FG002|Overall Study|Withdrawal by Subject|8|||
33667076|NCT01506193|63100404|FG000|Overall Study|Lost to Follow-up|8|||
33667077|NCT01506193|63100405|FG001|Overall Study|Lost to Follow-up|3|||
33667078|NCT01506193|63100406|FG002|Overall Study|Lost to Follow-up|3|||
33667079|NCT01505881|63100417|FG000|Overall Study|Adverse Event|0|||
33667080|NCT01505881|63100418|FG001|Overall Study|Adverse Event|1|||
33667081|NCT01505881|63100417|FG000|Overall Study|Lost to Follow-up|2|||
33667082|NCT01505881|63100418|FG001|Overall Study|Lost to Follow-up|0|||
33667083|NCT01505881|63100417|FG000|Overall Study|Withdrawal by Subject|2|||
33667084|NCT01505881|63100418|FG001|Overall Study|Withdrawal by Subject|0|||
33667085|NCT01462045|63100428|FG000|Overall Study|Family matter|0|||
33667086|NCT01462045|63100429|FG001|Overall Study|Family matter|1|||
33667087|NCT01462045|63100430|FG002|Overall Study|Family matter|0|||
33667088|NCT01505647|63100440|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
33667089|NCT01505647|63100441|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
33667090|NCT01505647|63100440|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
33667091|NCT01505647|63100441|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
33667092|NCT01505647|63100440|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
33667093|NCT01505647|63100441|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
33667094|NCT01505647|63100440|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
33667095|NCT01505647|63100441|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
33667096|NCT01505647|63100440|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
33667097|NCT01505647|63100441|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
33667098|NCT01477333|63100447|FG000|Overall Study|Adverse Event|1|||
33667099|NCT01477333|63100447|FG000|Overall Study|Withdrawal by Subject|1|||
33667100|NCT01477333|63100447|FG000|Overall Study|Clinical Deterioration|1|||
33667101|NCT01461811|63100457|FG000|Overall Study|Adverse Event|2|||
33667102|NCT01461811|63100458|FG001|Overall Study|Adverse Event|1|||
33667103|NCT01461811|63100457|FG000|Overall Study|Subject decision unrelated to an AE|1|||
33667104|NCT01461811|63100458|FG001|Overall Study|Subject decision unrelated to an AE|1|||
33667105|NCT01461811|63100457|FG000|Overall Study|Noncompliance|1|||
33667106|NCT01461811|63100458|FG001|Overall Study|Noncompliance|1|||
33667107|NCT01505491|63100467|FG000|Overall Study|Other reason not listed|1|||
33667108|NCT01505491|63100468|FG001|Overall Study|Other reason not listed|0|||
33667109|NCT01505491|63100469|FG002|Overall Study|Other reason not listed|0|||
33667110|NCT01505491|63100467|FG000|Overall Study|Withdrawal by Subject|1|||
33667111|NCT01505491|63100468|FG001|Overall Study|Withdrawal by Subject|1|||
33667112|NCT01505491|63100469|FG002|Overall Study|Withdrawal by Subject|4|||
33667113|NCT01505491|63100467|FG000|Overall Study|Lost to Follow-up|0|||
33667114|NCT01505491|63100468|FG001|Overall Study|Lost to Follow-up|0|||
33667115|NCT01505491|63100469|FG002|Overall Study|Lost to Follow-up|1|||
33667116|NCT01504867|63100479|FG000|Overall Study|Inclusion criteria not met|2|||
33667117|NCT01504867|63100480|FG001|Overall Study|Inclusion criteria not met|2|||
33667118|NCT01504867|63100479|FG000|Overall Study|Consent revoked|5|||
33667119|NCT01504867|63100480|FG001|Overall Study|Consent revoked|1|||
33667120|NCT01476475|63100488|FG000|Overall Study|Adverse Event|6|||
33667121|NCT01476475|63100489|FG001|Overall Study|Adverse Event|0|||
33667122|NCT01476475|63100488|FG000|Overall Study|Poor compliance to protocol|1|||
33667123|NCT01476475|63100489|FG001|Overall Study|Poor compliance to protocol|1|||
33667124|NCT01476475|63100488|FG000|Overall Study|Other reasons|4|||
33667125|NCT01476475|63100489|FG001|Overall Study|Other reasons|2|||
33667126|NCT01475851|63100498|FG000|Overall Study|Protocol defined stopping criteria|1|||
33667127|NCT01475851|63100499|FG001|Overall Study|Protocol defined stopping criteria|0|||
33667128|NCT01460719|63100505|FG000|Overall Study|Adverse Event|1|||
33667129|NCT01460719|63100505|FG000|Overall Study|Withdrawal by Subject|1|||
33667130|NCT01468181|63100575|FG000|Overall Study|Adverse Event|8|||
33667131|NCT01468181|63100576|FG001|Overall Study|Adverse Event|1|||
33667132|NCT01468181|63100577|FG002|Overall Study|Adverse Event|6|||
33667133|NCT01468181|63100578|FG003|Overall Study|Adverse Event|2|||
33667134|NCT01468181|63100579|FG004|Overall Study|Adverse Event|2|||
33667135|NCT01468181|63100575|FG000|Overall Study|Protocol Violation|2|||
33667136|NCT01468181|63100576|FG001|Overall Study|Protocol Violation|0|||
33667137|NCT01468181|63100577|FG002|Overall Study|Protocol Violation|1|||
33667138|NCT01468181|63100578|FG003|Overall Study|Protocol Violation|0|||
33667139|NCT01468181|63100579|FG004|Overall Study|Protocol Violation|1|||
33667140|NCT01468181|63100575|FG000|Overall Study|Physician Decision|0|||
33667141|NCT01468181|63100576|FG001|Overall Study|Physician Decision|0|||
33667142|NCT01468181|63100577|FG002|Overall Study|Physician Decision|0|||
33667143|NCT01468181|63100578|FG003|Overall Study|Physician Decision|1|||
33667144|NCT01468181|63100579|FG004|Overall Study|Physician Decision|1|||
33667145|NCT01468181|63100575|FG000|Overall Study|Lost to Follow-up|0|||
33667146|NCT01468181|63100576|FG001|Overall Study|Lost to Follow-up|0|||
33667147|NCT01468181|63100577|FG002|Overall Study|Lost to Follow-up|1|||
33667148|NCT01468181|63100578|FG003|Overall Study|Lost to Follow-up|0|||
33667149|NCT01468181|63100579|FG004|Overall Study|Lost to Follow-up|1|||
33667150|NCT01468181|63100575|FG000|Overall Study|Withdrawal by Subject|0|||
33667151|NCT01468181|63100576|FG001|Overall Study|Withdrawal by Subject|1|||
33667152|NCT01468181|63100577|FG002|Overall Study|Withdrawal by Subject|0|||
33667153|NCT01468181|63100578|FG003|Overall Study|Withdrawal by Subject|0|||
33667154|NCT01468181|63100579|FG004|Overall Study|Withdrawal by Subject|0|||
33667155|NCT01693562|63100614|FG000|Escalation Phase|Withdrawal by Subject|0|||
33667156|NCT01693562|63100615|FG001|Escalation Phase|Withdrawal by Subject|1|||
33667157|NCT01693562|63100616|FG002|Escalation Phase|Withdrawal by Subject|0|||
33667158|NCT01693562|63100617|FG003|Escalation Phase|Withdrawal by Subject|0|||
33667159|NCT01693562|63100618|FG004|Escalation Phase|Withdrawal by Subject|0|||
33667160|NCT01693562|63100619|FG005|Escalation Phase|Withdrawal by Subject|2|||
33667161|NCT01693562|63100620|FG006|Escalation Phase|Withdrawal by Subject|0|||
33667162|NCT01693562|63100621|FG007|Escalation Phase|Withdrawal by Subject|0|||
33667163|NCT01693562|63100622|FG008|Escalation Phase|Withdrawal by Subject|0|||
33667164|NCT01693562|63100623|FG009|Escalation Phase|Withdrawal by Subject|0|||
33667165|NCT01693562|63100624|FG010|Escalation Phase|Withdrawal by Subject|0|||
33667166|NCT01693562|63100625|FG011|Escalation Phase|Withdrawal by Subject|0|||
33667167|NCT01693562|63100626|FG012|Escalation Phase|Withdrawal by Subject|0|||
33667168|NCT01693562|63100627|FG013|Escalation Phase|Withdrawal by Subject|0|||
33667169|NCT01693562|63100628|FG014|Escalation Phase|Withdrawal by Subject|0|||
33667170|NCT01693562|63100629|FG015|Escalation Phase|Withdrawal by Subject|0|||
33667171|NCT01693562|63100630|FG016|Escalation Phase|Withdrawal by Subject|0|||
33667172|NCT01693562|63100631|FG017|Escalation Phase|Withdrawal by Subject|0|||
33305556|NCT01001221|62681066|FG004|Overall Study|Adverse Event|0|||
33305557|NCT01001221|62681062|FG000|Overall Study|Disease progression|3|||
33667173|NCT01693562|63100632|FG018|Escalation Phase|Withdrawal by Subject|0|||
33667174|NCT01693562|63100633|FG019|Escalation Phase|Withdrawal by Subject|0|||
33667175|NCT01693562|63100634|FG020|Escalation Phase|Withdrawal by Subject|0|||
33667176|NCT01693562|63100635|FG021|Escalation Phase|Withdrawal by Subject|0|||
33667177|NCT01693562|63100636|FG022|Escalation Phase|Withdrawal by Subject|0|||
33667178|NCT01693562|63100614|FG000|Escalation Phase|Death|4|||
33305558|NCT01001221|62681063|FG001|Overall Study|Disease progression|2|||
33305559|NCT01001221|62681064|FG002|Overall Study|Disease progression|2|||
33305560|NCT01001221|62681065|FG003|Overall Study|Disease progression|4|||
33305561|NCT01001221|62681066|FG004|Overall Study|Disease progression|0|||
33667179|NCT01693562|63100615|FG001|Escalation Phase|Death|2|||
33667180|NCT01693562|63100616|FG002|Escalation Phase|Death|0|||
33305562|NCT01001221|62681062|FG000|Overall Study|Other|1|||
33667181|NCT01693562|63100617|FG003|Escalation Phase|Death|3|||
33667182|NCT01693562|63100618|FG004|Escalation Phase|Death|6|||
33667183|NCT01693562|63100619|FG005|Escalation Phase|Death|4|||
33667184|NCT01693562|63100620|FG006|Escalation Phase|Death|0|||
33667185|NCT01693562|63100621|FG007|Escalation Phase|Death|0|||
33667186|NCT01693562|63100622|FG008|Escalation Phase|Death|0|||
33667187|NCT01693562|63100623|FG009|Escalation Phase|Death|0|||
33667188|NCT01693562|63100624|FG010|Escalation Phase|Death|0|||
33667189|NCT01693562|63100625|FG011|Escalation Phase|Death|0|||
33667190|NCT01693562|63100626|FG012|Escalation Phase|Death|0|||
33667191|NCT01693562|63100627|FG013|Escalation Phase|Death|0|||
33667192|NCT01693562|63100628|FG014|Escalation Phase|Death|0|||
33667193|NCT01693562|63100629|FG015|Escalation Phase|Death|0|||
33667194|NCT01693562|63100630|FG016|Escalation Phase|Death|0|||
33667195|NCT01693562|63100631|FG017|Escalation Phase|Death|0|||
33667196|NCT01693562|63100632|FG018|Escalation Phase|Death|0|||
33667197|NCT01693562|63100633|FG019|Escalation Phase|Death|0|||
33667198|NCT01693562|63100634|FG020|Escalation Phase|Death|0|||
33667199|NCT01693562|63100635|FG021|Escalation Phase|Death|0|||
33667200|NCT01693562|63100636|FG022|Escalation Phase|Death|0|||
33667201|NCT01693562|63100614|FG000|Escalation Phase|Lost to Follow-up|0|||
33667202|NCT01693562|63100615|FG001|Escalation Phase|Lost to Follow-up|1|||
33667203|NCT01693562|63100616|FG002|Escalation Phase|Lost to Follow-up|1|||
33667204|NCT01693562|63100617|FG003|Escalation Phase|Lost to Follow-up|0|||
33667205|NCT01693562|63100618|FG004|Escalation Phase|Lost to Follow-up|0|||
33667206|NCT01693562|63100619|FG005|Escalation Phase|Lost to Follow-up|0|||
33667207|NCT01693562|63100620|FG006|Escalation Phase|Lost to Follow-up|0|||
33667208|NCT01693562|63100621|FG007|Escalation Phase|Lost to Follow-up|0|||
33667209|NCT01693562|63100622|FG008|Escalation Phase|Lost to Follow-up|0|||
33667210|NCT01693562|63100623|FG009|Escalation Phase|Lost to Follow-up|0|||
33667211|NCT01693562|63100624|FG010|Escalation Phase|Lost to Follow-up|0|||
33667212|NCT01693562|63100625|FG011|Escalation Phase|Lost to Follow-up|0|||
33667213|NCT01693562|63100626|FG012|Escalation Phase|Lost to Follow-up|0|||
33667214|NCT01693562|63100627|FG013|Escalation Phase|Lost to Follow-up|0|||
33667215|NCT01693562|63100628|FG014|Escalation Phase|Lost to Follow-up|0|||
33667216|NCT01693562|63100629|FG015|Escalation Phase|Lost to Follow-up|0|||
33667217|NCT01693562|63100630|FG016|Escalation Phase|Lost to Follow-up|0|||
33667218|NCT01693562|63100631|FG017|Escalation Phase|Lost to Follow-up|0|||
33667219|NCT01693562|63100632|FG018|Escalation Phase|Lost to Follow-up|0|||
33667220|NCT01693562|63100633|FG019|Escalation Phase|Lost to Follow-up|0|||
33667221|NCT01693562|63100634|FG020|Escalation Phase|Lost to Follow-up|0|||
33667222|NCT01693562|63100635|FG021|Escalation Phase|Lost to Follow-up|0|||
33667223|NCT01693562|63100636|FG022|Escalation Phase|Lost to Follow-up|0|||
33667224|NCT01693562|63100614|FG000|Escalation Phase|Other|0|||
33667225|NCT01693562|63100615|FG001|Escalation Phase|Other|0|||
33667226|NCT01693562|63100616|FG002|Escalation Phase|Other|2|||
33667227|NCT01693562|63100617|FG003|Escalation Phase|Other|0|||
33667228|NCT01693562|63100618|FG004|Escalation Phase|Other|0|||
33667229|NCT01693562|63100619|FG005|Escalation Phase|Other|1|||
33667230|NCT01693562|63100620|FG006|Escalation Phase|Other|0|||
33667231|NCT01693562|63100621|FG007|Escalation Phase|Other|0|||
33667232|NCT01693562|63100622|FG008|Escalation Phase|Other|0|||
33667233|NCT01693562|63100623|FG009|Escalation Phase|Other|0|||
33667234|NCT01693562|63100624|FG010|Escalation Phase|Other|0|||
33667235|NCT01693562|63100625|FG011|Escalation Phase|Other|0|||
33667236|NCT01693562|63100626|FG012|Escalation Phase|Other|0|||
33667237|NCT01693562|63100627|FG013|Escalation Phase|Other|0|||
33667238|NCT01693562|63100628|FG014|Escalation Phase|Other|0|||
33667239|NCT01693562|63100629|FG015|Escalation Phase|Other|0|||
33667240|NCT01693562|63100630|FG016|Escalation Phase|Other|0|||
33667241|NCT01693562|63100631|FG017|Escalation Phase|Other|0|||
33305563|NCT01001221|62681063|FG001|Overall Study|Other|1|||
33667242|NCT01693562|63100632|FG018|Escalation Phase|Other|0|||
33667243|NCT01693562|63100633|FG019|Escalation Phase|Other|0|||
33667244|NCT01693562|63100634|FG020|Escalation Phase|Other|0|||
33667245|NCT01693562|63100635|FG021|Escalation Phase|Other|0|||
33667246|NCT01693562|63100636|FG022|Escalation Phase|Other|0|||
33305564|NCT01001221|62681064|FG002|Overall Study|Other|0|||
33667247|NCT01693562|63100614|FG000|Exploration Phase|Withdrawal by Subject|0|||
33667248|NCT01693562|63100615|FG001|Exploration Phase|Withdrawal by Subject|0|||
33667249|NCT01693562|63100616|FG002|Exploration Phase|Withdrawal by Subject|0|||
33667250|NCT01693562|63100617|FG003|Exploration Phase|Withdrawal by Subject|0|||
33667251|NCT01693562|63100618|FG004|Exploration Phase|Withdrawal by Subject|0|||
33667252|NCT01693562|63100619|FG005|Exploration Phase|Withdrawal by Subject|0|||
33667253|NCT01693562|63100620|FG006|Exploration Phase|Withdrawal by Subject|2|||
33667254|NCT01693562|63100621|FG007|Exploration Phase|Withdrawal by Subject|0|||
33667255|NCT01693562|63100622|FG008|Exploration Phase|Withdrawal by Subject|0|||
33667256|NCT01693562|63100623|FG009|Exploration Phase|Withdrawal by Subject|0|||
33667257|NCT01693562|63100624|FG010|Exploration Phase|Withdrawal by Subject|0|||
33667258|NCT01693562|63100625|FG011|Exploration Phase|Withdrawal by Subject|0|||
33667259|NCT01693562|63100626|FG012|Exploration Phase|Withdrawal by Subject|0|||
33667260|NCT01693562|63100627|FG013|Exploration Phase|Withdrawal by Subject|0|||
33667261|NCT01693562|63100628|FG014|Exploration Phase|Withdrawal by Subject|0|||
33667262|NCT01693562|63100629|FG015|Exploration Phase|Withdrawal by Subject|0|||
33667263|NCT01693562|63100630|FG016|Exploration Phase|Withdrawal by Subject|0|||
33667264|NCT01693562|63100631|FG017|Exploration Phase|Withdrawal by Subject|0|||
33667265|NCT01693562|63100632|FG018|Exploration Phase|Withdrawal by Subject|0|||
33667266|NCT01693562|63100633|FG019|Exploration Phase|Withdrawal by Subject|0|||
33667267|NCT01693562|63100634|FG020|Exploration Phase|Withdrawal by Subject|0|||
33667268|NCT01693562|63100635|FG021|Exploration Phase|Withdrawal by Subject|0|||
33667269|NCT01693562|63100636|FG022|Exploration Phase|Withdrawal by Subject|0|||
33667270|NCT01693562|63100614|FG000|Exploration Phase|Death|0|||
33667271|NCT01693562|63100615|FG001|Exploration Phase|Death|0|||
33667272|NCT01693562|63100616|FG002|Exploration Phase|Death|0|||
33667273|NCT01693562|63100617|FG003|Exploration Phase|Death|0|||
33667274|NCT01693562|63100618|FG004|Exploration Phase|Death|0|||
33667275|NCT01693562|63100619|FG005|Exploration Phase|Death|0|||
33667276|NCT01693562|63100620|FG006|Exploration Phase|Death|17|||
33667277|NCT01693562|63100621|FG007|Exploration Phase|Death|0|||
33667278|NCT01693562|63100622|FG008|Exploration Phase|Death|0|||
33667279|NCT01693562|63100623|FG009|Exploration Phase|Death|0|||
33667280|NCT01693562|63100624|FG010|Exploration Phase|Death|0|||
33667281|NCT01693562|63100625|FG011|Exploration Phase|Death|0|||
33667282|NCT01693562|63100626|FG012|Exploration Phase|Death|0|||
33667283|NCT01693562|63100627|FG013|Exploration Phase|Death|0|||
33667284|NCT01693562|63100628|FG014|Exploration Phase|Death|0|||
33667285|NCT01693562|63100629|FG015|Exploration Phase|Death|0|||
33667286|NCT01693562|63100630|FG016|Exploration Phase|Death|0|||
33667287|NCT01693562|63100631|FG017|Exploration Phase|Death|0|||
33667288|NCT01693562|63100632|FG018|Exploration Phase|Death|0|||
33667289|NCT01693562|63100633|FG019|Exploration Phase|Death|0|||
33667290|NCT01693562|63100634|FG020|Exploration Phase|Death|0|||
33667291|NCT01693562|63100635|FG021|Exploration Phase|Death|0|||
33667292|NCT01693562|63100636|FG022|Exploration Phase|Death|0|||
33667293|NCT01693562|63100614|FG000|Exploration Phase|Other|0|||
33667294|NCT01693562|63100615|FG001|Exploration Phase|Other|0|||
33667295|NCT01693562|63100616|FG002|Exploration Phase|Other|0|||
33667296|NCT01693562|63100617|FG003|Exploration Phase|Other|0|||
33667297|NCT01693562|63100618|FG004|Exploration Phase|Other|0|||
33667298|NCT01693562|63100619|FG005|Exploration Phase|Other|0|||
33667299|NCT01693562|63100620|FG006|Exploration Phase|Other|2|||
33667300|NCT01693562|63100621|FG007|Exploration Phase|Other|0|||
33667301|NCT01693562|63100622|FG008|Exploration Phase|Other|0|||
33667302|NCT01693562|63100623|FG009|Exploration Phase|Other|0|||
33667303|NCT01693562|63100624|FG010|Exploration Phase|Other|0|||
33667304|NCT01693562|63100625|FG011|Exploration Phase|Other|0|||
33667305|NCT01693562|63100626|FG012|Exploration Phase|Other|0|||
33667306|NCT01693562|63100627|FG013|Exploration Phase|Other|0|||
33667307|NCT01693562|63100628|FG014|Exploration Phase|Other|0|||
33667308|NCT01693562|63100629|FG015|Exploration Phase|Other|0|||
33667309|NCT01693562|63100630|FG016|Exploration Phase|Other|0|||
33667310|NCT01693562|63100631|FG017|Exploration Phase|Other|0|||
33667311|NCT01693562|63100632|FG018|Exploration Phase|Other|0|||
33667312|NCT01693562|63100633|FG019|Exploration Phase|Other|0|||
33667313|NCT01693562|63100634|FG020|Exploration Phase|Other|0|||
33667314|NCT01693562|63100635|FG021|Exploration Phase|Other|0|||
33667315|NCT01693562|63100636|FG022|Exploration Phase|Other|0|||
33667316|NCT01693562|63100614|FG000|Expansion Phase|Withdrawal by Subject|0|||
33667317|NCT01693562|63100615|FG001|Expansion Phase|Withdrawal by Subject|0|||
33667318|NCT01693562|63100616|FG002|Expansion Phase|Withdrawal by Subject|0|||
33667319|NCT01693562|63100617|FG003|Expansion Phase|Withdrawal by Subject|0|||
33667320|NCT01693562|63100618|FG004|Expansion Phase|Withdrawal by Subject|0|||
33667321|NCT01693562|63100619|FG005|Expansion Phase|Withdrawal by Subject|0|||
33667322|NCT01693562|63100620|FG006|Expansion Phase|Withdrawal by Subject|0|||
33667323|NCT01693562|63100621|FG007|Expansion Phase|Withdrawal by Subject|16|||
33667324|NCT01693562|63100622|FG008|Expansion Phase|Withdrawal by Subject|2|||
33667325|NCT01693562|63100623|FG009|Expansion Phase|Withdrawal by Subject|54|||
33667326|NCT01693562|63100624|FG010|Expansion Phase|Withdrawal by Subject|2|||
33667327|NCT01693562|63100625|FG011|Expansion Phase|Withdrawal by Subject|2|||
33667328|NCT01693562|63100626|FG012|Expansion Phase|Withdrawal by Subject|3|||
33667329|NCT01693562|63100627|FG013|Expansion Phase|Withdrawal by Subject|5|||
33667330|NCT01693562|63100628|FG014|Expansion Phase|Withdrawal by Subject|16|||
33667331|NCT01693562|63100629|FG015|Expansion Phase|Withdrawal by Subject|7|||
33667332|NCT01693562|63100630|FG016|Expansion Phase|Withdrawal by Subject|40|||
33667333|NCT01693562|63100631|FG017|Expansion Phase|Withdrawal by Subject|4|||
33667334|NCT01693562|63100632|FG018|Expansion Phase|Withdrawal by Subject|8|||
33667335|NCT01693562|63100633|FG019|Expansion Phase|Withdrawal by Subject|3|||
33667336|NCT01693562|63100634|FG020|Expansion Phase|Withdrawal by Subject|1|||
33667337|NCT01693562|63100635|FG021|Expansion Phase|Withdrawal by Subject|8|||
33667338|NCT01693562|63100636|FG022|Expansion Phase|Withdrawal by Subject|1|||
33667339|NCT01693562|63100614|FG000|Expansion Phase|Death|0|||
33667340|NCT01693562|63100615|FG001|Expansion Phase|Death|0|||
33667341|NCT01693562|63100616|FG002|Expansion Phase|Death|0|||
33667342|NCT01693562|63100617|FG003|Expansion Phase|Death|0|||
33667343|NCT01693562|63100618|FG004|Expansion Phase|Death|0|||
33667344|NCT01693562|63100619|FG005|Expansion Phase|Death|0|||
33667345|NCT01693562|63100620|FG006|Expansion Phase|Death|0|||
33667346|NCT01693562|63100621|FG007|Expansion Phase|Death|42|||
33667347|NCT01693562|63100622|FG008|Expansion Phase|Death|17|||
33667348|NCT01693562|63100623|FG009|Expansion Phase|Death|208|||
33667349|NCT01693562|63100624|FG010|Expansion Phase|Death|30|||
33667350|NCT01693562|63100625|FG011|Expansion Phase|Death|8|||
33667351|NCT01693562|63100626|FG012|Expansion Phase|Death|19|||
33667352|NCT01693562|63100627|FG013|Expansion Phase|Death|42|||
33667353|NCT01693562|63100628|FG014|Expansion Phase|Death|23|||
33667354|NCT01693562|63100629|FG015|Expansion Phase|Death|23|||
33667355|NCT01693562|63100630|FG016|Expansion Phase|Death|128|||
33667356|NCT01693562|63100631|FG017|Expansion Phase|Death|16|||
33667357|NCT01693562|63100632|FG018|Expansion Phase|Death|36|||
33667358|NCT01693562|63100633|FG019|Expansion Phase|Death|16|||
33667359|NCT01693562|63100634|FG020|Expansion Phase|Death|17|||
33667360|NCT01693562|63100635|FG021|Expansion Phase|Death|35|||
33667361|NCT01693562|63100636|FG022|Expansion Phase|Death|7|||
33667362|NCT01693562|63100614|FG000|Expansion Phase|Lost to Follow-up|0|||
33667363|NCT01693562|63100615|FG001|Expansion Phase|Lost to Follow-up|0|||
33667364|NCT01693562|63100616|FG002|Expansion Phase|Lost to Follow-up|0|||
33667365|NCT01693562|63100617|FG003|Expansion Phase|Lost to Follow-up|0|||
33667366|NCT01693562|63100618|FG004|Expansion Phase|Lost to Follow-up|0|||
33667367|NCT01693562|63100619|FG005|Expansion Phase|Lost to Follow-up|0|||
33667368|NCT01693562|63100620|FG006|Expansion Phase|Lost to Follow-up|0|||
33667369|NCT01693562|63100621|FG007|Expansion Phase|Lost to Follow-up|1|||
33667370|NCT01693562|63100622|FG008|Expansion Phase|Lost to Follow-up|2|||
33667371|NCT01693562|63100623|FG009|Expansion Phase|Lost to Follow-up|10|||
33667372|NCT01693562|63100624|FG010|Expansion Phase|Lost to Follow-up|4|||
33667373|NCT01693562|63100625|FG011|Expansion Phase|Lost to Follow-up|4|||
33667374|NCT01693562|63100626|FG012|Expansion Phase|Lost to Follow-up|1|||
33667375|NCT01693562|63100627|FG013|Expansion Phase|Lost to Follow-up|3|||
33667376|NCT01693562|63100628|FG014|Expansion Phase|Lost to Follow-up|0|||
33667377|NCT01693562|63100629|FG015|Expansion Phase|Lost to Follow-up|1|||
33667378|NCT01693562|63100630|FG016|Expansion Phase|Lost to Follow-up|1|||
33667379|NCT01693562|63100631|FG017|Expansion Phase|Lost to Follow-up|0|||
33667380|NCT01693562|63100632|FG018|Expansion Phase|Lost to Follow-up|2|||
33667381|NCT01693562|63100633|FG019|Expansion Phase|Lost to Follow-up|1|||
33667382|NCT01693562|63100634|FG020|Expansion Phase|Lost to Follow-up|2|||
33667383|NCT01693562|63100635|FG021|Expansion Phase|Lost to Follow-up|2|||
33667384|NCT01693562|63100636|FG022|Expansion Phase|Lost to Follow-up|1|||
33667385|NCT01693562|63100614|FG000|Expansion Phase|Other|0|||
33667386|NCT01693562|63100615|FG001|Expansion Phase|Other|0|||
33667387|NCT01693562|63100616|FG002|Expansion Phase|Other|0|||
33667388|NCT01693562|63100617|FG003|Expansion Phase|Other|0|||
33667389|NCT01693562|63100618|FG004|Expansion Phase|Other|0|||
33667390|NCT01693562|63100619|FG005|Expansion Phase|Other|0|||
33667391|NCT01693562|63100620|FG006|Expansion Phase|Other|0|||
33667392|NCT01693562|63100621|FG007|Expansion Phase|Other|3|||
33667393|NCT01693562|63100622|FG008|Expansion Phase|Other|1|||
33667394|NCT01693562|63100623|FG009|Expansion Phase|Other|28|||
33667395|NCT01693562|63100624|FG010|Expansion Phase|Other|4|||
33667396|NCT01693562|63100625|FG011|Expansion Phase|Other|7|||
33667397|NCT01693562|63100626|FG012|Expansion Phase|Other|0|||
33667398|NCT01693562|63100627|FG013|Expansion Phase|Other|1|||
33667399|NCT01693562|63100628|FG014|Expansion Phase|Other|1|||
33667400|NCT01693562|63100629|FG015|Expansion Phase|Other|0|||
33667401|NCT01693562|63100630|FG016|Expansion Phase|Other|28|||
33667402|NCT01693562|63100631|FG017|Expansion Phase|Other|0|||
33667403|NCT01693562|63100632|FG018|Expansion Phase|Other|1|||
33667404|NCT01693562|63100633|FG019|Expansion Phase|Other|0|||
33667405|NCT01693562|63100634|FG020|Expansion Phase|Other|1|||
33305565|NCT01001221|62681065|FG003|Overall Study|Other|0|||
33305566|NCT01001221|62681066|FG004|Overall Study|Other|0|||
33305567|NCT01001221|62681062|FG000|Overall Study|Not treated; protocol exclusion|0|||
33305568|NCT01001221|62681063|FG001|Overall Study|Not treated; protocol exclusion|0|||
33667406|NCT01693562|63100635|FG021|Expansion Phase|Other|17|||
33667407|NCT01693562|63100636|FG022|Expansion Phase|Other|1|||
33667408|NCT01467713|63100733|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
33667409|NCT01467713|63100734|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
33667410|NCT01467713|63100735|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
33667411|NCT01467713|63100736|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
33667412|NCT01467713|63100733|FG000|Overall Study|Major Protocol Deviation|2|||
33667413|NCT01467713|63100734|FG001|Overall Study|Major Protocol Deviation|4|||
33667414|NCT01467713|63100735|FG002|Overall Study|Major Protocol Deviation|4|||
33667415|NCT01467713|63100736|FG003|Overall Study|Major Protocol Deviation|1|||
33667416|NCT01467713|63100733|FG000|Overall Study|Lost to Follow-up|9|||
33667417|NCT01467713|63100734|FG001|Overall Study|Lost to Follow-up|12|||
33667418|NCT01467713|63100735|FG002|Overall Study|Lost to Follow-up|6|||
33667419|NCT01467713|63100736|FG003|Overall Study|Lost to Follow-up|9|||
33667420|NCT01467713|63100733|FG000|Overall Study|Voluntary Withdrawal|18|||
33667421|NCT01467713|63100734|FG001|Overall Study|Voluntary Withdrawal|14|||
33667422|NCT01467713|63100735|FG002|Overall Study|Voluntary Withdrawal|21|||
33667423|NCT01467713|63100736|FG003|Overall Study|Voluntary Withdrawal|20|||
33667424|NCT01467713|63100733|FG000|Overall Study|Study Termination|23|||
33667425|NCT01467713|63100734|FG001|Overall Study|Study Termination|33|||
33667426|NCT01467713|63100735|FG002|Overall Study|Study Termination|28|||
33667427|NCT01467713|63100736|FG003|Overall Study|Study Termination|29|||
33667428|NCT01467713|63100733|FG000|Overall Study|Pregnancy|0|||
33667429|NCT01467713|63100734|FG001|Overall Study|Pregnancy|1|||
33667430|NCT01467713|63100735|FG002|Overall Study|Pregnancy|1|||
33667431|NCT01467713|63100736|FG003|Overall Study|Pregnancy|3|||
33667432|NCT01467713|63100733|FG000|Overall Study|Relapse|35|||
33667433|NCT01467713|63100734|FG001|Overall Study|Relapse|25|||
33667434|NCT01467713|63100735|FG002|Overall Study|Relapse|28|||
33667435|NCT01467713|63100736|FG003|Overall Study|Relapse|35|||
33667436|NCT01467713|63100733|FG000|Overall Study|Reason not Specified|6|||
33667437|NCT01467713|63100734|FG001|Overall Study|Reason not Specified|11|||
33667438|NCT01467713|63100735|FG002|Overall Study|Reason not Specified|8|||
33667439|NCT01467713|63100736|FG003|Overall Study|Reason not Specified|7|||
33667440|NCT01693250|63100766|FG000|Overall Study|Lost to Follow-up|2|||
33667441|NCT01693250|63100767|FG001|Overall Study|Lost to Follow-up|2|||
33667442|NCT01590758|63100790|FG000|Overall Study|Withdrawal by Subject|0|||
33667443|NCT01590758|63100791|FG001|Overall Study|Withdrawal by Subject|3|||
33667444|NCT01590758|63100790|FG000|Overall Study|Physician Decision|1|||
33667445|NCT01590758|63100791|FG001|Overall Study|Physician Decision|2|||
33305569|NCT01001221|62681064|FG002|Overall Study|Not treated; protocol exclusion|1|||
33305570|NCT01001221|62681065|FG003|Overall Study|Not treated; protocol exclusion|0|||
33305571|NCT01001221|62681066|FG004|Overall Study|Not treated; protocol exclusion|0|||
33305572|NCT01296152|62681077|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
33305573|NCT01002547|62681084|FG000|Overall Study|Withdrawal by Subject|4|||
33305574|NCT01002547|62681085|FG001|Overall Study|Withdrawal by Subject|0|||
33305575|NCT01002547|62681086|FG002|Overall Study|Withdrawal by Subject|5|||
33305576|NCT01002547|62681084|FG000|Overall Study|Lost to Follow-up|2|||
33305577|NCT01002547|62681085|FG001|Overall Study|Lost to Follow-up|1|||
33305578|NCT01002547|62681086|FG002|Overall Study|Lost to Follow-up|1|||
33305579|NCT01002547|62681084|FG000|Overall Study|Physician Decision|1|||
33305580|NCT01002547|62681085|FG001|Overall Study|Physician Decision|0|||
33305581|NCT01002547|62681086|FG002|Overall Study|Physician Decision|0|||
33305582|NCT01002547|62681084|FG000|Overall Study|Death|0|||
33305583|NCT01002547|62681085|FG001|Overall Study|Death|2|||
33305584|NCT01002547|62681086|FG002|Overall Study|Death|2|||
33305585|NCT01002547|62681084|FG000|Overall Study|Adverse Event|1|||
33305586|NCT01002547|62681085|FG001|Overall Study|Adverse Event|0|||
33305587|NCT01002547|62681086|FG002|Overall Study|Adverse Event|0|||
33305588|NCT01225731|62681099|FG000|Part 1|Did not meet eligibility criteria|1|||
33305589|NCT01225731|62681100|FG001|Part 1|Did not meet eligibility criteria|0|||
33305590|NCT01225731|62681101|FG002|Part 1|Did not meet eligibility criteria|0|||
33305591|NCT01225731|62681102|FG003|Part 1|Did not meet eligibility criteria|0|||
33305592|NCT01225731|62681103|FG004|Part 1|Did not meet eligibility criteria|1|||
33305593|NCT01225731|62681104|FG005|Part 1|Did not meet eligibility criteria|0|||
33305594|NCT01225731|62681105|FG006|Part 1|Did not meet eligibility criteria|0|||
33305595|NCT01225731|62681106|FG007|Part 1|Did not meet eligibility criteria|0|||
33305596|NCT01225731|62681107|FG008|Part 1|Did not meet eligibility criteria|0|||
33305597|NCT01225731|62681108|FG009|Part 1|Did not meet eligibility criteria|0|||
33305598|NCT01225731|62681109|FG010|Part 1|Did not meet eligibility criteria|0|||
33305599|NCT01225731|62681110|FG011|Part 1|Did not meet eligibility criteria|0|||
33305600|NCT01225731|62681111|FG012|Part 1|Did not meet eligibility criteria|0|||
33305601|NCT01225731|62681099|FG000|Part 1|Adverse Event|1|||
33305602|NCT01225731|62681100|FG001|Part 1|Adverse Event|2|||
33305603|NCT01225731|62681101|FG002|Part 1|Adverse Event|1|||
33305604|NCT01225731|62681102|FG003|Part 1|Adverse Event|1|||
33305605|NCT01225731|62681103|FG004|Part 1|Adverse Event|1|||
33305606|NCT01225731|62681104|FG005|Part 1|Adverse Event|0|||
33305607|NCT01225731|62681105|FG006|Part 1|Adverse Event|0|||
33305608|NCT01225731|62681106|FG007|Part 1|Adverse Event|0|||
33305609|NCT01225731|62681107|FG008|Part 1|Adverse Event|0|||
33305610|NCT01225731|62681108|FG009|Part 1|Adverse Event|0|||
33305611|NCT01225731|62681109|FG010|Part 1|Adverse Event|0|||
33305612|NCT01225731|62681110|FG011|Part 1|Adverse Event|0|||
33667446|NCT01590758|63100790|FG000|Overall Study|Lost to Follow-up|4|||
33305613|NCT01225731|62681111|FG012|Part 1|Adverse Event|0|||
33305614|NCT01225731|62681099|FG000|Part 1|Withdrawal by Subject|0|||
33305615|NCT01225731|62681100|FG001|Part 1|Withdrawal by Subject|3|||
33305616|NCT01225731|62681101|FG002|Part 1|Withdrawal by Subject|0|||
33305617|NCT01225731|62681102|FG003|Part 1|Withdrawal by Subject|0|||
33305618|NCT01225731|62681103|FG004|Part 1|Withdrawal by Subject|4|||
33667447|NCT01590758|63100791|FG001|Overall Study|Lost to Follow-up|2|||
33667448|NCT01590212|63100800|FG000|Overall Study|Withdrawal by Subject|2|||
33667449|NCT01590212|63100801|FG001|Overall Study|Withdrawal by Subject|2|||
33667450|NCT01590212|63100802|FG002|Overall Study|Withdrawal by Subject|2|||
33305619|NCT01225731|62681104|FG005|Part 1|Withdrawal by Subject|0|||
33667451|NCT01590212|63100800|FG000|Overall Study|Lost to Follow-up|1|||
33667452|NCT01590212|63100801|FG001|Overall Study|Lost to Follow-up|2|||
33667453|NCT01590212|63100802|FG002|Overall Study|Lost to Follow-up|3|||
33667454|NCT01692938|63100813|FG000|Overall Study|Protocol Deviation|1|||
33667455|NCT01692938|63100814|FG001|Overall Study|Protocol Deviation|1|||
33667456|NCT01692938|63100813|FG000|Overall Study|Study completed prior to site completion|3|||
33667457|NCT01692938|63100814|FG001|Overall Study|Study completed prior to site completion|3|||
33667458|NCT01692782|63100827|FG000|Overall Study|Adverse Event|12|||
33667459|NCT01692782|63100828|FG001|Overall Study|Adverse Event|32|||
33667460|NCT01692782|63100829|FG002|Overall Study|Adverse Event|2|||
33667461|NCT01692782|63100827|FG000|Overall Study|Lack of Efficacy|1|||
33667462|NCT01692782|63100828|FG001|Overall Study|Lack of Efficacy|2|||
33667463|NCT01692782|63100829|FG002|Overall Study|Lack of Efficacy|0|||
33667464|NCT01692782|63100827|FG000|Overall Study|Lost to Follow-up|2|||
33667465|NCT01692782|63100828|FG001|Overall Study|Lost to Follow-up|7|||
33667466|NCT01692782|63100829|FG002|Overall Study|Lost to Follow-up|1|||
33667467|NCT01692782|63100827|FG000|Overall Study|Pregnancy|1|||
33667468|NCT01692782|63100828|FG001|Overall Study|Pregnancy|0|||
33667469|NCT01692782|63100829|FG002|Overall Study|Pregnancy|0|||
33667470|NCT01692782|63100827|FG000|Overall Study|Protocol Violation|1|||
33667471|NCT01692782|63100828|FG001|Overall Study|Protocol Violation|0|||
33667472|NCT01692782|63100829|FG002|Overall Study|Protocol Violation|2|||
33667473|NCT01692782|63100827|FG000|Overall Study|Non-complance with study drug|0|||
33667474|NCT01692782|63100828|FG001|Overall Study|Non-complance with study drug|4|||
33667475|NCT01692782|63100829|FG002|Overall Study|Non-complance with study drug|1|||
33667476|NCT01692782|63100827|FG000|Overall Study|Non-compliant with study visits|0|||
33667477|NCT01692782|63100828|FG001|Overall Study|Non-compliant with study visits|0|||
33667478|NCT01692782|63100829|FG002|Overall Study|Non-compliant with study visits|1|||
33667479|NCT01692782|63100827|FG000|Overall Study|SAE not related to study drug|0|||
33667480|NCT01692782|63100828|FG001|Overall Study|SAE not related to study drug|1|||
33667481|NCT01692782|63100829|FG002|Overall Study|SAE not related to study drug|0|||
33667482|NCT01692782|63100827|FG000|Overall Study|Withdrawal by Subject|3|||
33667483|NCT01692782|63100828|FG001|Overall Study|Withdrawal by Subject|10|||
33667484|NCT01692782|63100829|FG002|Overall Study|Withdrawal by Subject|3|||
33667485|NCT01692626|63100837|FG000|Overall Study|Death|0|||
33667486|NCT01692626|63100838|FG001|Overall Study|Death|1|||
33667487|NCT01692626|63100837|FG000|Overall Study|Adverse Event|2|||
33667488|NCT01692626|63100838|FG001|Overall Study|Adverse Event|3|||
33667489|NCT01692626|63100837|FG000|Overall Study|Protocol Violation|1|||
33667490|NCT01692626|63100838|FG001|Overall Study|Protocol Violation|2|||
33667491|NCT01692626|63100837|FG000|Overall Study|Withdrawal by Subject|1|||
33667492|NCT01692626|63100838|FG001|Overall Study|Withdrawal by Subject|0|||
33667493|NCT01475461|63100864|FG000|Run-in Period|Not meet eligibility criteria|16|||
33667494|NCT01475461|63100865|FG001|Run-in Period|Not meet eligibility criteria|0|||
33667495|NCT01475461|63100866|FG002|Run-in Period|Not meet eligibility criteria|0|||
33667496|NCT01475461|63100867|FG003|Run-in Period|Not meet eligibility criteria|0|||
33667497|NCT01475461|63100868|FG004|Run-in Period|Not meet eligibility criteria|0|||
33667498|NCT01475461|63100869|FG005|Run-in Period|Not meet eligibility criteria|0|||
33667499|NCT01475461|63100870|FG006|Run-in Period|Not meet eligibility criteria|0|||
33667500|NCT01475461|63100864|FG000|Run-in Period|Lost to Follow-up|7|||
33667501|NCT01475461|63100865|FG001|Run-in Period|Lost to Follow-up|0|||
33667502|NCT01475461|63100866|FG002|Run-in Period|Lost to Follow-up|0|||
33667503|NCT01475461|63100867|FG003|Run-in Period|Lost to Follow-up|0|||
33667504|NCT01475461|63100868|FG004|Run-in Period|Lost to Follow-up|0|||
33667505|NCT01475461|63100869|FG005|Run-in Period|Lost to Follow-up|0|||
33667506|NCT01475461|63100870|FG006|Run-in Period|Lost to Follow-up|0|||
33667507|NCT01475461|63100864|FG000|Run-in Period|Withdrawal by Subject|11|||
33667508|NCT01475461|63100865|FG001|Run-in Period|Withdrawal by Subject|0|||
33667509|NCT01475461|63100866|FG002|Run-in Period|Withdrawal by Subject|0|||
33667510|NCT01475461|63100867|FG003|Run-in Period|Withdrawal by Subject|0|||
33667511|NCT01475461|63100868|FG004|Run-in Period|Withdrawal by Subject|0|||
33667512|NCT01475461|63100869|FG005|Run-in Period|Withdrawal by Subject|0|||
33667513|NCT01475461|63100870|FG006|Run-in Period|Withdrawal by Subject|0|||
33667514|NCT01475461|63100864|FG000|Run-in Period|Other|3|||
33667515|NCT01475461|63100865|FG001|Run-in Period|Other|0|||
33667516|NCT01475461|63100866|FG002|Run-in Period|Other|0|||
33667517|NCT01475461|63100867|FG003|Run-in Period|Other|0|||
33667518|NCT01475461|63100868|FG004|Run-in Period|Other|0|||
33667519|NCT01475461|63100869|FG005|Run-in Period|Other|0|||
33667520|NCT01475461|63100870|FG006|Run-in Period|Other|0|||
33667521|NCT01475461|63100864|FG000|Run-in Period|Protocol Violation|4|||
33667522|NCT01475461|63100865|FG001|Run-in Period|Protocol Violation|0|||
33667523|NCT01475461|63100866|FG002|Run-in Period|Protocol Violation|0|||
33667524|NCT01475461|63100867|FG003|Run-in Period|Protocol Violation|0|||
33667525|NCT01475461|63100868|FG004|Run-in Period|Protocol Violation|0|||
33667526|NCT01475461|63100869|FG005|Run-in Period|Protocol Violation|0|||
33667527|NCT01475461|63100870|FG006|Run-in Period|Protocol Violation|0|||
33667528|NCT01475461|63100864|FG000|Treatment Period|Death|0|||
33667529|NCT01475461|63100865|FG001|Treatment Period|Death|0|||
33667530|NCT01475461|63100866|FG002|Treatment Period|Death|0|||
33667531|NCT01475461|63100867|FG003|Treatment Period|Death|1|||
33667532|NCT01475461|63100868|FG004|Treatment Period|Death|0|||
33667533|NCT01475461|63100869|FG005|Treatment Period|Death|0|||
33667534|NCT01475461|63100870|FG006|Treatment Period|Death|0|||
33667535|NCT01475461|63100864|FG000|Treatment Period|Lost to Follow-up|0|||
33667536|NCT01475461|63100865|FG001|Treatment Period|Lost to Follow-up|3|||
33667537|NCT01475461|63100866|FG002|Treatment Period|Lost to Follow-up|2|||
33667538|NCT01475461|63100867|FG003|Treatment Period|Lost to Follow-up|3|||
33667539|NCT01475461|63100868|FG004|Treatment Period|Lost to Follow-up|1|||
33667540|NCT01475461|63100869|FG005|Treatment Period|Lost to Follow-up|2|||
33667541|NCT01475461|63100870|FG006|Treatment Period|Lost to Follow-up|1|||
33667542|NCT01475461|63100864|FG000|Treatment Period|Withdrawal by Subject|0|||
33667543|NCT01475461|63100865|FG001|Treatment Period|Withdrawal by Subject|2|||
33667544|NCT01475461|63100866|FG002|Treatment Period|Withdrawal by Subject|2|||
33667545|NCT01475461|63100867|FG003|Treatment Period|Withdrawal by Subject|0|||
33667546|NCT01475461|63100868|FG004|Treatment Period|Withdrawal by Subject|2|||
33667547|NCT01475461|63100869|FG005|Treatment Period|Withdrawal by Subject|2|||
33667548|NCT01475461|63100870|FG006|Treatment Period|Withdrawal by Subject|0|||
33667549|NCT01475461|63100864|FG000|Treatment Period|Other|0|||
33667550|NCT01475461|63100865|FG001|Treatment Period|Other|1|||
33667551|NCT01475461|63100866|FG002|Treatment Period|Other|0|||
33667552|NCT01475461|63100867|FG003|Treatment Period|Other|0|||
33667553|NCT01475461|63100868|FG004|Treatment Period|Other|0|||
33667554|NCT01475461|63100869|FG005|Treatment Period|Other|0|||
33667555|NCT01475461|63100870|FG006|Treatment Period|Other|0|||
33667556|NCT01475461|63100864|FG000|Treatment Period|Protocol Violation|0|||
33667557|NCT01475461|63100865|FG001|Treatment Period|Protocol Violation|1|||
33667558|NCT01475461|63100866|FG002|Treatment Period|Protocol Violation|0|||
33667559|NCT01475461|63100867|FG003|Treatment Period|Protocol Violation|0|||
33667560|NCT01475461|63100868|FG004|Treatment Period|Protocol Violation|0|||
33667561|NCT01475461|63100869|FG005|Treatment Period|Protocol Violation|0|||
33667562|NCT01475461|63100870|FG006|Treatment Period|Protocol Violation|1|||
33667563|NCT01475461|63100864|FG000|Treatment Period|Lack of Efficacy|0|||
33667564|NCT01475461|63100865|FG001|Treatment Period|Lack of Efficacy|2|||
33667565|NCT01475461|63100866|FG002|Treatment Period|Lack of Efficacy|0|||
33667566|NCT01475461|63100867|FG003|Treatment Period|Lack of Efficacy|2|||
33667567|NCT01475461|63100868|FG004|Treatment Period|Lack of Efficacy|1|||
33667568|NCT01475461|63100869|FG005|Treatment Period|Lack of Efficacy|1|||
33667569|NCT01475461|63100870|FG006|Treatment Period|Lack of Efficacy|0|||
33667570|NCT01475461|63100864|FG000|Treatment Period|Medication Error|0|||
33667571|NCT01475461|63100865|FG001|Treatment Period|Medication Error|0|||
33667572|NCT01475461|63100866|FG002|Treatment Period|Medication Error|0|||
33667573|NCT01475461|63100867|FG003|Treatment Period|Medication Error|1|||
33667574|NCT01475461|63100868|FG004|Treatment Period|Medication Error|0|||
33667575|NCT01475461|63100869|FG005|Treatment Period|Medication Error|0|||
33667576|NCT01475461|63100870|FG006|Treatment Period|Medication Error|0|||
33667577|NCT01475461|63100864|FG000|Treatment Period|Adverse Event|0|||
33667578|NCT01475461|63100865|FG001|Treatment Period|Adverse Event|0|||
33667579|NCT01475461|63100866|FG002|Treatment Period|Adverse Event|0|||
33667580|NCT01475461|63100867|FG003|Treatment Period|Adverse Event|1|||
33667581|NCT01475461|63100868|FG004|Treatment Period|Adverse Event|0|||
33667582|NCT01475461|63100869|FG005|Treatment Period|Adverse Event|0|||
33667583|NCT01475461|63100870|FG006|Treatment Period|Adverse Event|0|||
33667584|NCT01589822|63100906|FG000|Overall Study|Withdrawal by Subject|1|||
33667585|NCT01589822|63100907|FG001|Overall Study|Withdrawal by Subject|2|||
33667586|NCT01589822|63100908|FG002|Overall Study|Withdrawal by Subject|0|||
33667587|NCT01589822|63100906|FG000|Overall Study|Death|1|||
33667588|NCT01589822|63100907|FG001|Overall Study|Death|0|||
33667589|NCT01589822|63100908|FG002|Overall Study|Death|0|||
33667590|NCT01589822|63100906|FG000|Overall Study|Missed 90 day visit|2|||
33667591|NCT01589822|63100907|FG001|Overall Study|Missed 90 day visit|1|||
33667592|NCT01589822|63100908|FG002|Overall Study|Missed 90 day visit|1|||
33667593|NCT01565642|63100920|FG000|Overall Study|Withdrawal by Subject|2|||
33667594|NCT01565642|63100921|FG001|Overall Study|Withdrawal by Subject|1|||
33667595|NCT01475071|63100927|FG000|Overall Study|Physician Decision|1|||
33667596|NCT01475071|63100927|FG000|Overall Study|Withdrawal by Subject|6|||
33667597|NCT01475071|63100927|FG000|Overall Study|Lost to Follow-up|1|||
33667598|NCT01474993|63100935|FG000|Overall Study|Lost to Follow-up|1|||
33667599|NCT01474993|63100936|FG001|Overall Study|Lost to Follow-up|2|||
33667600|NCT01474993|63100935|FG000|Overall Study|Adverse Event|0|||
33667601|NCT01474993|63100936|FG001|Overall Study|Adverse Event|1|||
33305620|NCT01225731|62681105|FG006|Part 1|Withdrawal by Subject|0|||
33667602|NCT01691768|63100946|FG000|Overall Study|Death|0|||
33667603|NCT01691768|63100947|FG001|Overall Study|Death|2|||
33667604|NCT01691768|63100946|FG000|Overall Study|Lost to Follow-up|4|||
33667605|NCT01691768|63100947|FG001|Overall Study|Lost to Follow-up|3|||
33667606|NCT01691768|63100946|FG000|Overall Study|Withdrawal by Subject|10|||
33667607|NCT01691768|63100947|FG001|Overall Study|Withdrawal by Subject|9|||
33667608|NCT01691768|63100946|FG000|Overall Study|Relocated|0|||
33667609|NCT01691768|63100947|FG001|Overall Study|Relocated|1|||
33667610|NCT01691768|63100946|FG000|Overall Study|Investigator decision|1|||
33667611|NCT01691768|63100947|FG001|Overall Study|Investigator decision|1|||
33667612|NCT01503229|63100954|FG000|Overall Study|Withdrew consent|1|||
33667613|NCT01691612|63100958|FG000|Overall Study|deemed ineligible after 1st visit|6|||
33667614|NCT01691612|63100958|FG000|Overall Study|Adverse Event|1|||
33667615|NCT01565564|63100964|FG000|Overall Study|Lost to Follow-up|5|||
33667616|NCT01565564|63100965|FG001|Overall Study|Lost to Follow-up|1|||
33667617|NCT01460407|63100971|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
33667618|NCT01460407|63100972|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
33667619|NCT01502371|63100984|FG000|Overall Study|Withdrawal by Subject|1|||
33667620|NCT01502371|63100985|FG001|Overall Study|Withdrawal by Subject|2|||
33667621|NCT01502371|63100986|FG002|Overall Study|Withdrawal by Subject|1|||
33667622|NCT01502371|63100987|FG003|Overall Study|Withdrawal by Subject|1|||
33667623|NCT01502371|63100988|FG004|Overall Study|Withdrawal by Subject|1|||
33667624|NCT01502371|63100984|FG000|Overall Study|Adverse Event|2|||
33667625|NCT01502371|63100985|FG001|Overall Study|Adverse Event|1|||
33667626|NCT01502371|63100986|FG002|Overall Study|Adverse Event|0|||
33667627|NCT01502371|63100987|FG003|Overall Study|Adverse Event|4|||
33667628|NCT01502371|63100988|FG004|Overall Study|Adverse Event|3|||
33667629|NCT01502371|63100984|FG000|Overall Study|Treatment Failure|22|||
33667630|NCT01502371|63100985|FG001|Overall Study|Treatment Failure|20|||
33667631|NCT01502371|63100986|FG002|Overall Study|Treatment Failure|12|||
33667632|NCT01502371|63100987|FG003|Overall Study|Treatment Failure|19|||
33667633|NCT01502371|63100988|FG004|Overall Study|Treatment Failure|30|||
33667634|NCT01502371|63100984|FG000|Overall Study|Lack of Efficacy|3|||
33667635|NCT01502371|63100985|FG001|Overall Study|Lack of Efficacy|3|||
33667636|NCT01502371|63100986|FG002|Overall Study|Lack of Efficacy|2|||
33667637|NCT01502371|63100987|FG003|Overall Study|Lack of Efficacy|2|||
33667638|NCT01502371|63100988|FG004|Overall Study|Lack of Efficacy|4|||
33667639|NCT01502371|63100984|FG000|Overall Study|Physician Decision|3|||
33667640|NCT01502371|63100985|FG001|Overall Study|Physician Decision|0|||
33667641|NCT01502371|63100986|FG002|Overall Study|Physician Decision|0|||
33667642|NCT01502371|63100987|FG003|Overall Study|Physician Decision|0|||
33667643|NCT01502371|63100988|FG004|Overall Study|Physician Decision|1|||
33667644|NCT01502371|63100984|FG000|Overall Study|Noncompliance with Study Drug|0|||
33667645|NCT01502371|63100985|FG001|Overall Study|Noncompliance with Study Drug|0|||
33667646|NCT01502371|63100986|FG002|Overall Study|Noncompliance with Study Drug|1|||
33667647|NCT01502371|63100987|FG003|Overall Study|Noncompliance with Study Drug|2|||
33667648|NCT01502371|63100988|FG004|Overall Study|Noncompliance with Study Drug|1|||
33667649|NCT01502371|63100984|FG000|Overall Study|Technical Problems|1|||
33667650|NCT01502371|63100985|FG001|Overall Study|Technical Problems|0|||
33667651|NCT01502371|63100986|FG002|Overall Study|Technical Problems|2|||
33667652|NCT01502371|63100987|FG003|Overall Study|Technical Problems|4|||
33667653|NCT01502371|63100988|FG004|Overall Study|Technical Problems|1|||
33667654|NCT01502371|63100984|FG000|Overall Study|Protocol Violation|9|||
33667655|NCT01502371|63100985|FG001|Overall Study|Protocol Violation|5|||
33667656|NCT01502371|63100986|FG002|Overall Study|Protocol Violation|6|||
33667657|NCT01502371|63100987|FG003|Overall Study|Protocol Violation|5|||
33667658|NCT01502371|63100988|FG004|Overall Study|Protocol Violation|10|||
33667659|NCT01502371|63100984|FG000|Overall Study|Excluded Medication|0|||
33667660|NCT01502371|63100985|FG001|Overall Study|Excluded Medication|1|||
33667661|NCT01502371|63100986|FG002|Overall Study|Excluded Medication|1|||
33578389|NCT02673697|62975371|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
33578390|NCT05168579|62975379|FG000|Overall Study|Lack of Consent|1|||
33578391|NCT05168579|62975380|FG001|Overall Study|Lack of Consent|0|||
33578392|NCT05168579|62975379|FG000|Overall Study|Conflicts with time|2|||
33578393|NCT05168579|62975380|FG001|Overall Study|Conflicts with time|0|||
33578394|NCT05168579|62975379|FG000|Overall Study|Time slots were full|3|||
33578395|NCT05168579|62975380|FG001|Overall Study|Time slots were full|0|||
33578396|NCT05168579|62975379|FG000|Overall Study|Lost to Follow-up|0|||
33578397|NCT05168579|62975380|FG001|Overall Study|Lost to Follow-up|15|||
33578398|NCT02673619|62975393|FG000|Overall Study|Lost to Follow-up|1|||
33578399|NCT02673619|62975394|FG001|Overall Study|Lost to Follow-up|0|||
33578400|NCT02673619|62975395|FG002|Overall Study|Lost to Follow-up|0|||
33578401|NCT02673619|62975396|FG003|Overall Study|Lost to Follow-up|0|||
33578402|NCT02673619|62975393|FG000|Overall Study|Withdrawal by Subject|1|||
33578403|NCT02673619|62975394|FG001|Overall Study|Withdrawal by Subject|1|||
33578404|NCT02673619|62975395|FG002|Overall Study|Withdrawal by Subject|1|||
33578405|NCT02673619|62975396|FG003|Overall Study|Withdrawal by Subject|0|||
33578406|NCT02673619|62975393|FG000|Overall Study|Adverse Event|0|||
33578407|NCT02673619|62975394|FG001|Overall Study|Adverse Event|0|||
33578408|NCT02673619|62975395|FG002|Overall Study|Adverse Event|1|||
33578409|NCT02673619|62975396|FG003|Overall Study|Adverse Event|0|||
33578410|NCT02673619|62975393|FG000|Overall Study|Lack of Efficacy|0|||
33667662|NCT01502371|63100987|FG003|Overall Study|Excluded Medication|0|||
33667663|NCT01502371|63100988|FG004|Overall Study|Excluded Medication|1|||
33578411|NCT02673619|62975394|FG001|Overall Study|Lack of Efficacy|0|||
33578412|NCT02673619|62975395|FG002|Overall Study|Lack of Efficacy|1|||
33667664|NCT01588496|63101004|FG000|Overall Study|Withdrawal by Subject|0|||
33667665|NCT01588496|63101005|FG001|Overall Study|Withdrawal by Subject|1|||
33667666|NCT01588496|63101006|FG002|Overall Study|Withdrawal by Subject|0|||
33667667|NCT01502293|63101017|FG000|Overall Study|Progressive Disease|20|||
33667668|NCT01502293|63101018|FG001|Overall Study|Progressive Disease|12|||
33667669|NCT01502293|63101019|FG002|Overall Study|Progressive Disease|2|||
33667670|NCT01502293|63101017|FG000|Overall Study|Withdrawal by Subject|3|||
33667671|NCT01502293|63101018|FG001|Overall Study|Withdrawal by Subject|3|||
33667672|NCT01502293|63101019|FG002|Overall Study|Withdrawal by Subject|1|||
33667673|NCT01502293|63101017|FG000|Overall Study|Adverse Event|0|||
33667674|NCT01502293|63101018|FG001|Overall Study|Adverse Event|2|||
33667675|NCT01502293|63101019|FG002|Overall Study|Adverse Event|0|||
33667676|NCT01502293|63101017|FG000|Overall Study|Reason Not Specified|2|||
33667677|NCT01502293|63101018|FG001|Overall Study|Reason Not Specified|0|||
33667678|NCT01502293|63101019|FG002|Overall Study|Reason Not Specified|0|||
33667679|NCT01502293|63101017|FG000|Overall Study|Physician Decision|0|||
33667680|NCT01502293|63101018|FG001|Overall Study|Physician Decision|0|||
33667681|NCT01502293|63101019|FG002|Overall Study|Physician Decision|1|||
33667682|NCT01474681|63101032|FG000|Overall Study|Death|0|||
33667683|NCT01474681|63101033|FG001|Overall Study|Death|3|||
33667684|NCT01474681|63101034|FG002|Overall Study|Death|2|||
33667685|NCT01474681|63101035|FG003|Overall Study|Death|6|||
33667686|NCT01459783|63101051|FG000|Baseline to 6 Months|Death|1|||
33667687|NCT01459783|63101052|FG001|Baseline to 6 Months|Death|0|||
33667688|NCT01459783|63101051|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
33667689|NCT01459783|63101052|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
33667690|NCT01459783|63101051|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
33667691|NCT01459783|63101052|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
33667692|NCT01459783|63101051|FG000|6 Months to 12 Months|Death|0|||
33667693|NCT01459783|63101052|FG001|6 Months to 12 Months|Death|1|||
33667694|NCT01459783|63101051|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
33667695|NCT01459783|63101052|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
33667696|NCT01459783|63101051|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
33667697|NCT01459783|63101052|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
33667698|NCT01459783|63101051|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
33667699|NCT01459783|63101052|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
33667700|NCT01588184|63101064|FG000|Overall Study|Death|1|||
33667701|NCT01588184|63101065|FG001|Overall Study|Death|0|||
33667702|NCT01588184|63101066|FG002|Overall Study|Death|0|||
33667703|NCT01588184|63101067|FG003|Overall Study|Death|1|||
33667704|NCT01588184|63101068|FG004|Overall Study|Death|1|||
33667705|NCT01588184|63101069|FG005|Overall Study|Death|1|||
33667706|NCT01588184|63101064|FG000|Overall Study|Withdrawal by Subject|2|||
33667707|NCT01588184|63101065|FG001|Overall Study|Withdrawal by Subject|4|||
33667708|NCT01588184|63101066|FG002|Overall Study|Withdrawal by Subject|0|||
33305621|NCT01225731|62681106|FG007|Part 1|Withdrawal by Subject|0|||
33398079|NCT00293293|62777421|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
33398080|NCT00293293|62777420|FG000|Overall Study|Patient discontinued chemotherapy|0|||
33398081|NCT00293293|62777421|FG001|Overall Study|Patient discontinued chemotherapy|1|||
33398082|NCT04864639|62777428|FG000|Overall Study|Death|1|||
33398083|NCT04864639|62777428|FG000|Overall Study|Lost to Follow-up|1|||
33667709|NCT01588184|63101067|FG003|Overall Study|Withdrawal by Subject|1|||
33667710|NCT01588184|63101068|FG004|Overall Study|Withdrawal by Subject|0|||
33667711|NCT01588184|63101069|FG005|Overall Study|Withdrawal by Subject|0|||
33667712|NCT01588184|63101064|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
33667713|NCT01588184|63101065|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
33667714|NCT01588184|63101066|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
33305622|NCT01225731|62681107|FG008|Part 1|Withdrawal by Subject|0|||
33305623|NCT01225731|62681108|FG009|Part 1|Withdrawal by Subject|0|||
33305624|NCT01225731|62681109|FG010|Part 1|Withdrawal by Subject|0|||
33305625|NCT01225731|62681110|FG011|Part 1|Withdrawal by Subject|0|||
33305626|NCT01225731|62681111|FG012|Part 1|Withdrawal by Subject|0|||
33305627|NCT01225731|62681099|FG000|Part 1|Protocol Violation|0|||
33305628|NCT01225731|62681100|FG001|Part 1|Protocol Violation|0|||
33305629|NCT01225731|62681101|FG002|Part 1|Protocol Violation|0|||
33305630|NCT01225731|62681102|FG003|Part 1|Protocol Violation|1|||
33305631|NCT01225731|62681103|FG004|Part 1|Protocol Violation|0|||
33305632|NCT01225731|62681104|FG005|Part 1|Protocol Violation|0|||
33305633|NCT01225731|62681105|FG006|Part 1|Protocol Violation|0|||
33305634|NCT01225731|62681106|FG007|Part 1|Protocol Violation|0|||
33305635|NCT01225731|62681107|FG008|Part 1|Protocol Violation|0|||
33398084|NCT04245449|62777454|FG000|Overall Study|COVID shutdown|7|||
33667715|NCT01588184|63101067|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
33667716|NCT01588184|63101068|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
33667717|NCT01588184|63101069|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
33667718|NCT01588184|63101064|FG000|Overall Study|multiple reasons|0|||
33305636|NCT01225731|62681108|FG009|Part 1|Protocol Violation|0|||
33305637|NCT01225731|62681109|FG010|Part 1|Protocol Violation|0|||
33667719|NCT01588184|63101065|FG001|Overall Study|multiple reasons|3|||
33667720|NCT01588184|63101066|FG002|Overall Study|multiple reasons|0|||
33667721|NCT01588184|63101067|FG003|Overall Study|multiple reasons|1|||
33667722|NCT01588184|63101068|FG004|Overall Study|multiple reasons|0|||
33667723|NCT01588184|63101069|FG005|Overall Study|multiple reasons|0|||
33667724|NCT01588106|63101085|FG000|Overall Study|Withdrawal by Subject|5|||
33667725|NCT01588106|63101086|FG001|Overall Study|Withdrawal by Subject|4|||
33667726|NCT01564862|63101095|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
33667727|NCT01564862|63101096|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
33667728|NCT01564862|63101097|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
33667729|NCT01564862|63101095|FG000|Overall Study|Major Protocol Deviation|3|||
33667730|NCT01564862|63101096|FG001|Overall Study|Major Protocol Deviation|3|||
33667731|NCT01564862|63101097|FG002|Overall Study|Major Protocol Deviation|4|||
33667732|NCT01564862|63101095|FG000|Overall Study|Lost to Follow-up|10|||
33667733|NCT01564862|63101096|FG001|Overall Study|Lost to Follow-up|8|||
33667734|NCT01564862|63101097|FG002|Overall Study|Lost to Follow-up|6|||
33667735|NCT01564862|63101095|FG000|Overall Study|Voluntary Withdrawal|9|||
33667736|NCT01564862|63101096|FG001|Overall Study|Voluntary Withdrawal|6|||
33667737|NCT01564862|63101097|FG002|Overall Study|Voluntary Withdrawal|8|||
33667738|NCT01564862|63101095|FG000|Overall Study|Lack of Efficacy|1|||
33667739|NCT01564862|63101096|FG001|Overall Study|Lack of Efficacy|5|||
33667740|NCT01564862|63101097|FG002|Overall Study|Lack of Efficacy|6|||
33667741|NCT01564862|63101095|FG000|Overall Study|Other reason(s)|1|||
33667742|NCT01564862|63101096|FG001|Overall Study|Other reason(s)|0|||
33667743|NCT01564862|63101097|FG002|Overall Study|Other reason(s)|0|||
33667744|NCT01691378|63101107|FG000|Overall Study|Withdrawal by Subject|2|||
33667745|NCT01691378|63101108|FG001|Overall Study|Withdrawal by Subject|0|||
33667746|NCT01691378|63101107|FG000|Overall Study|Lost to Follow-up|5|||
33667747|NCT01691378|63101108|FG001|Overall Study|Lost to Follow-up|2|||
33667748|NCT01467479|63101117|FG000|Overall Study|No Study Medication|1|||
33667749|NCT01467479|63101118|FG001|Overall Study|No Study Medication|0|||
33667750|NCT01467479|63101119|FG002|Overall Study|No Study Medication|2|||
33667751|NCT01467479|63101117|FG000|Overall Study|Adverse Event|1|||
33667752|NCT01467479|63101118|FG001|Overall Study|Adverse Event|2|||
33667753|NCT01467479|63101119|FG002|Overall Study|Adverse Event|0|||
33667754|NCT01467479|63101117|FG000|Overall Study|Death|0|||
33667755|NCT01467479|63101118|FG001|Overall Study|Death|0|||
33667756|NCT01467479|63101119|FG002|Overall Study|Death|1|||
33667757|NCT01467479|63101117|FG000|Overall Study|Lost to Follow-up|2|||
33667758|NCT01467479|63101118|FG001|Overall Study|Lost to Follow-up|5|||
33667759|NCT01467479|63101119|FG002|Overall Study|Lost to Follow-up|3|||
33667760|NCT01467479|63101117|FG000|Overall Study|Withdrawal of Consent|3|||
33667761|NCT01467479|63101118|FG001|Overall Study|Withdrawal of Consent|7|||
33667762|NCT01467479|63101119|FG002|Overall Study|Withdrawal of Consent|7|||
33667763|NCT01467479|63101117|FG000|Overall Study|Study Terminated by Sponsor|1|||
33667764|NCT01467479|63101118|FG001|Overall Study|Study Terminated by Sponsor|3|||
33667765|NCT01467479|63101119|FG002|Overall Study|Study Terminated by Sponsor|3|||
33667766|NCT01467479|63101117|FG000|Overall Study|Other|1|||
33667767|NCT01467479|63101118|FG001|Overall Study|Other|0|||
33667768|NCT01467479|63101119|FG002|Overall Study|Other|0|||
33667769|NCT01466387|63101134|FG000|Overall Study|Adverse Event|0|||
33667770|NCT01466387|63101135|FG001|Overall Study|Adverse Event|0|||
33667771|NCT01466387|63101136|FG002|Overall Study|Adverse Event|1|||
33667772|NCT01466387|63101137|FG003|Overall Study|Adverse Event|1|||
33667773|NCT01466387|63101138|FG004|Overall Study|Adverse Event|0|||
33667774|NCT01466387|63101139|FG005|Overall Study|Adverse Event|0|||
33667775|NCT01466387|63101134|FG000|Overall Study|Lost to Follow-up|0|||
33667776|NCT01466387|63101135|FG001|Overall Study|Lost to Follow-up|0|||
33667777|NCT01466387|63101136|FG002|Overall Study|Lost to Follow-up|0|||
33667778|NCT01466387|63101137|FG003|Overall Study|Lost to Follow-up|0|||
33667779|NCT01466387|63101138|FG004|Overall Study|Lost to Follow-up|0|||
33667780|NCT01466387|63101139|FG005|Overall Study|Lost to Follow-up|1|||
33667781|NCT01466387|63101134|FG000|Overall Study|Protocol Violation|1|||
33667782|NCT01466387|63101135|FG001|Overall Study|Protocol Violation|0|||
33667783|NCT01466387|63101136|FG002|Overall Study|Protocol Violation|0|||
33667784|NCT01466387|63101137|FG003|Overall Study|Protocol Violation|1|||
33667785|NCT01466387|63101138|FG004|Overall Study|Protocol Violation|0|||
33667786|NCT01466387|63101139|FG005|Overall Study|Protocol Violation|0|||
33667787|NCT01564784|63101270|FG000|Overall Study|Other|1|||
33667788|NCT01564784|63101271|FG001|Overall Study|Other|0|||
33667789|NCT01564784|63101270|FG000|Overall Study|Subject refused further follow-up|1|||
33667790|NCT01564784|63101271|FG001|Overall Study|Subject refused further follow-up|6|||
33667791|NCT01564784|63101270|FG000|Overall Study|Lost to Follow-up|1|||
33667792|NCT01564784|63101271|FG001|Overall Study|Lost to Follow-up|1|||
33667793|NCT01564784|63101270|FG000|Overall Study|Death|131|||
33667794|NCT01564784|63101271|FG001|Overall Study|Death|126|||
33667795|NCT01564394|63101322|FG000|Overall Study|Withdrawal by Subject|6|||
33667796|NCT01564394|63101323|FG001|Overall Study|Withdrawal by Subject|10|||
33667797|NCT01690988|63101337|FG000|Overall Study|Withdrawal by Subject|2|||
33667798|NCT01690988|63101338|FG001|Overall Study|Withdrawal by Subject|2|||
33667799|NCT01690988|63101339|FG002|Overall Study|Withdrawal by Subject|3|||
33667800|NCT01690988|63101337|FG000|Overall Study|Physician Decision|0|||
33667801|NCT01690988|63101338|FG001|Overall Study|Physician Decision|0|||
33667802|NCT01690988|63101339|FG002|Overall Study|Physician Decision|1|||
33667803|NCT01690988|63101337|FG000|Overall Study|Operation Cancelled|1|||
33667804|NCT01690988|63101338|FG001|Overall Study|Operation Cancelled|1|||
33667805|NCT01690988|63101339|FG002|Overall Study|Operation Cancelled|0|||
33667806|NCT01690988|63101337|FG000|Overall Study|Determined ineligible|1|||
33667807|NCT01690988|63101338|FG001|Overall Study|Determined ineligible|0|||
33667808|NCT01690988|63101339|FG002|Overall Study|Determined ineligible|0|||
33667809|NCT01690988|63101337|FG000|Overall Study|Death|1|||
33667810|NCT01690988|63101338|FG001|Overall Study|Death|1|||
33667811|NCT01690988|63101339|FG002|Overall Study|Death|1|||
33667812|NCT01690988|63101337|FG000|Overall Study|Sedated|1|||
33667813|NCT01690988|63101338|FG001|Overall Study|Sedated|1|||
33667814|NCT01690988|63101339|FG002|Overall Study|Sedated|2|||
33667815|NCT01466153|63101370|FG000|Overall Study|Disease Progression|2|||
33667816|NCT01466153|63101371|FG001|Overall Study|Disease Progression|2|||
33667817|NCT01466153|63101372|FG002|Overall Study|Disease Progression|0|||
33667818|NCT01466153|63101370|FG000|Overall Study|Adverse Event|14|||
33667819|NCT01466153|63101371|FG001|Overall Study|Adverse Event|13|||
33667820|NCT01466153|63101372|FG002|Overall Study|Adverse Event|17|||
33667821|NCT01466153|63101370|FG000|Overall Study|Withdrawal of Consent|2|||
33667822|NCT01466153|63101371|FG001|Overall Study|Withdrawal of Consent|0|||
33667823|NCT01466153|63101372|FG002|Overall Study|Withdrawal of Consent|0|||
33667824|NCT01466153|63101370|FG000|Overall Study|Investigator Discretion|3|||
33667825|NCT01466153|63101371|FG001|Overall Study|Investigator Discretion|2|||
33667826|NCT01466153|63101372|FG002|Overall Study|Investigator Discretion|2|||
33667827|NCT01466153|63101370|FG000|Overall Study|Randomized-Not Treated|2|||
33667828|NCT01466153|63101371|FG001|Overall Study|Randomized-Not Treated|3|||
33667829|NCT01466153|63101372|FG002|Overall Study|Randomized-Not Treated|4|||
33667830|NCT01466153|63101370|FG000|Overall Study|Other-Unspecified|6|||
33667831|NCT01466153|63101371|FG001|Overall Study|Other-Unspecified|4|||
33667832|NCT01466153|63101372|FG002|Overall Study|Other-Unspecified|2|||
33667833|NCT01474291|63101393|FG000|Overall Study|Not Evaluable for Efficacy|26|||
33667834|NCT01474291|63101393|FG000|Overall Study|Lack of Treatment Efficacy|88|||
33667835|NCT01474291|63101393|FG000|Overall Study|Adverse Event|53|||
33667836|NCT01474291|63101393|FG000|Overall Study|Lost to Follow-up|29|||
33667837|NCT01474291|63101393|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
33667838|NCT01474291|63101393|FG000|Overall Study|No Reason Reported|10|||
33667839|NCT01474291|63101393|FG000|Overall Study|Death|2|||
33667840|NCT01465997|63101402|FG000|Overall Study|Adverse Event|12|||
33667841|NCT01465997|63101403|FG001|Overall Study|Adverse Event|22|||
33667842|NCT01465997|63101402|FG000|Overall Study|Lack of Efficacy|13|||
33667843|NCT01465997|63101403|FG001|Overall Study|Lack of Efficacy|1|||
33667844|NCT01465997|63101402|FG000|Overall Study|Protocol Violation|1|||
33667845|NCT01465997|63101403|FG001|Overall Study|Protocol Violation|4|||
33667846|NCT01465997|63101402|FG000|Overall Study|Lost to Follow-up|6|||
33667847|NCT01465997|63101403|FG001|Overall Study|Lost to Follow-up|9|||
33667848|NCT01465997|63101402|FG000|Overall Study|Withdrawal by Subject|32|||
33667849|NCT01465997|63101403|FG001|Overall Study|Withdrawal by Subject|35|||
33667850|NCT01465997|63101402|FG000|Overall Study|investigator's decision|1|||
33667851|NCT01465997|63101403|FG001|Overall Study|investigator's decision|1|||
33667852|NCT01465997|63101402|FG000|Overall Study|Death|0|||
33667853|NCT01465997|63101403|FG001|Overall Study|Death|1|||
33667854|NCT01465997|63101402|FG000|Overall Study|sponsor's decision|1|||
33667855|NCT01465997|63101403|FG001|Overall Study|sponsor's decision|1|||
33667856|NCT01465997|63101402|FG000|Overall Study|subject withdrew consent|1|||
33667857|NCT01465997|63101403|FG001|Overall Study|subject withdrew consent|0|||
33667858|NCT01465997|63101402|FG000|Overall Study|local lab unblinded site|1|||
33667859|NCT01465997|63101403|FG001|Overall Study|local lab unblinded site|0|||
33667860|NCT01465997|63101402|FG000|Overall Study|withdrew before follow-up|0|||
33667861|NCT01465997|63101403|FG001|Overall Study|withdrew before follow-up|13|||
33667862|NCT01465997|63101402|FG000|Overall Study|decision by site staff|0|||
33667863|NCT01465997|63101403|FG001|Overall Study|decision by site staff|1|||
33667864|NCT01465997|63101402|FG000|Overall Study|subject left participation SP0993|0|||
33667865|NCT01465997|63101403|FG001|Overall Study|subject left participation SP0993|1|||
33667866|NCT01465763|63101424|FG000|Overall Study|Withdrawal by Subject|4|||
33667867|NCT01465763|63101425|FG001|Overall Study|Withdrawal by Subject|0|||
33667868|NCT01465763|63101426|FG002|Overall Study|Withdrawal by Subject|1|||
33667869|NCT01465763|63101424|FG000|Overall Study|Insufficient Clinical Response|11|||
33667870|NCT01465763|63101425|FG001|Overall Study|Insufficient Clinical Response|0|||
33667871|NCT01465763|63101426|FG002|Overall Study|Insufficient Clinical Response|1|||
33667872|NCT01465763|63101424|FG000|Overall Study|Adverse Event|9|||
33667873|NCT01465763|63101425|FG001|Overall Study|Adverse Event|0|||
33667874|NCT01465763|63101426|FG002|Overall Study|Adverse Event|1|||
33667875|NCT01465763|63101424|FG000|Overall Study|Other|2|||
33667876|NCT01465763|63101425|FG001|Overall Study|Other|0|||
33667877|NCT01465763|63101426|FG002|Overall Study|Other|0|||
33667878|NCT01465763|63101424|FG000|Overall Study|Protocol Violation|4|||
33667879|NCT01465763|63101425|FG001|Overall Study|Protocol Violation|1|||
33667880|NCT01465763|63101426|FG002|Overall Study|Protocol Violation|1|||
33667881|NCT01465763|63101424|FG000|Overall Study|Death|1|||
33667882|NCT01465763|63101425|FG001|Overall Study|Death|0|||
33667883|NCT01465763|63101426|FG002|Overall Study|Death|0|||
33667884|NCT01690520|63101459|FG000|Overall Study|Death|25|||
33667885|NCT01690520|63101460|FG001|Overall Study|Death|21|||
33667886|NCT01690520|63101459|FG000|Overall Study|Lost to Follow-up|2|||
33667887|NCT01690520|63101460|FG001|Overall Study|Lost to Follow-up|3|||
33667888|NCT01690520|63101459|FG000|Overall Study|Withdrawal by Subject|2|||
33667889|NCT01690520|63101460|FG001|Overall Study|Withdrawal by Subject|0|||
33667890|NCT01690520|63101459|FG000|Overall Study|Relapse|0|||
33667891|NCT01690520|63101460|FG001|Overall Study|Relapse|1|||
33667892|NCT01690520|63101459|FG000|Overall Study|Other|0|||
33667893|NCT01690520|63101460|FG001|Overall Study|Other|1|||
33667894|NCT01690520|63101459|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
33667895|NCT01690520|63101460|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
33667896|NCT01563536|63101481|FG000|Overall Study|Withdrawal by Subject|0|||
33667897|NCT01563536|63101482|FG001|Overall Study|Withdrawal by Subject|2|||
33667898|NCT01563536|63101481|FG000|Overall Study|Lost to Follow-up|1|||
33667899|NCT01563536|63101482|FG001|Overall Study|Lost to Follow-up|0|||
33667900|NCT01690130|63101490|FG000|Overall Study|Subject have cancelled visit.|1|||
33667901|NCT01690130|63101491|FG001|Overall Study|Subject have cancelled visit.|0|||
33667902|NCT01690052|63101497|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
33667903|NCT01690052|63101498|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
33667904|NCT01689974|63101525|FG000|Overall Study|Termination of Study|5|||
33667905|NCT01689974|63101526|FG001|Overall Study|Termination of Study|5|||
33667906|NCT01587014|63101532|FG000|Overall Study|Death|2|||
33667907|NCT01458535|63101644|FG000|Overall Study|Other|0|||
33667908|NCT01458535|63101645|FG001|Overall Study|Other|0|||
33667909|NCT01458535|63101646|FG002|Overall Study|Other|0|||
33667910|NCT01458535|63101647|FG003|Overall Study|Other|0|||
33667911|NCT01458535|63101648|FG004|Overall Study|Other|1|||
33667912|NCT01458535|63101649|FG005|Overall Study|Other|1|||
33667913|NCT01458535|63101644|FG000|Overall Study|Withdrawal by Subject|0|||
33667914|NCT01458535|63101645|FG001|Overall Study|Withdrawal by Subject|0|||
33667915|NCT01458535|63101646|FG002|Overall Study|Withdrawal by Subject|2|||
33667916|NCT01458535|63101647|FG003|Overall Study|Withdrawal by Subject|0|||
33667917|NCT01458535|63101648|FG004|Overall Study|Withdrawal by Subject|1|||
33667918|NCT01458535|63101649|FG005|Overall Study|Withdrawal by Subject|1|||
33667919|NCT01458535|63101644|FG000|Overall Study|Lost to Follow-up|0|||
33667920|NCT01458535|63101645|FG001|Overall Study|Lost to Follow-up|2|||
33667921|NCT01458535|63101646|FG002|Overall Study|Lost to Follow-up|0|||
33667922|NCT01458535|63101647|FG003|Overall Study|Lost to Follow-up|3|||
33667923|NCT01458535|63101648|FG004|Overall Study|Lost to Follow-up|2|||
33667924|NCT01458535|63101649|FG005|Overall Study|Lost to Follow-up|2|||
33667925|NCT01458535|63101644|FG000|Overall Study|Adverse Event|0|||
33667926|NCT01458535|63101645|FG001|Overall Study|Adverse Event|0|||
33667927|NCT01458535|63101646|FG002|Overall Study|Adverse Event|0|||
33667928|NCT01458535|63101647|FG003|Overall Study|Adverse Event|1|||
33667929|NCT01458535|63101648|FG004|Overall Study|Adverse Event|0|||
33667930|NCT01458535|63101649|FG005|Overall Study|Adverse Event|0|||
33667931|NCT01464827|63101677|FG000|Overall Study|Adverse Event|0|||
33667932|NCT01464827|63101678|FG001|Overall Study|Adverse Event|0|||
33667933|NCT01464827|63101679|FG002|Overall Study|Adverse Event|0|||
33667934|NCT01464827|63101680|FG003|Overall Study|Adverse Event|0|||
33667935|NCT01464827|63101681|FG004|Overall Study|Adverse Event|0|||
33667936|NCT01464827|63101682|FG005|Overall Study|Adverse Event|0|||
33667937|NCT01464827|63101683|FG006|Overall Study|Adverse Event|0|||
33667938|NCT01464827|63101684|FG007|Overall Study|Adverse Event|0|||
33667939|NCT01464827|63101685|FG008|Overall Study|Adverse Event|0|||
33667940|NCT01464827|63101686|FG009|Overall Study|Adverse Event|0|||
33667941|NCT01464827|63101687|FG010|Overall Study|Adverse Event|0|||
33667942|NCT01464827|63101688|FG011|Overall Study|Adverse Event|0|||
33667943|NCT01464827|63101689|FG012|Overall Study|Adverse Event|1|||
33667944|NCT01464827|63101690|FG013|Overall Study|Adverse Event|0|||
33667945|NCT01464827|63101677|FG000|Overall Study|Withdrawal by Subject|1|||
33667946|NCT01464827|63101678|FG001|Overall Study|Withdrawal by Subject|0|||
33667947|NCT01464827|63101679|FG002|Overall Study|Withdrawal by Subject|0|||
33667948|NCT01464827|63101680|FG003|Overall Study|Withdrawal by Subject|0|||
33667949|NCT01464827|63101681|FG004|Overall Study|Withdrawal by Subject|1|||
33667950|NCT01464827|63101682|FG005|Overall Study|Withdrawal by Subject|0|||
33667951|NCT01464827|63101683|FG006|Overall Study|Withdrawal by Subject|0|||
33667952|NCT01464827|63101684|FG007|Overall Study|Withdrawal by Subject|1|||
33667953|NCT01464827|63101685|FG008|Overall Study|Withdrawal by Subject|0|||
33667954|NCT01464827|63101686|FG009|Overall Study|Withdrawal by Subject|0|||
33667955|NCT01464827|63101687|FG010|Overall Study|Withdrawal by Subject|0|||
33667956|NCT01464827|63101688|FG011|Overall Study|Withdrawal by Subject|0|||
33667957|NCT01464827|63101689|FG012|Overall Study|Withdrawal by Subject|0|||
33667958|NCT01464827|63101690|FG013|Overall Study|Withdrawal by Subject|0|||
33667959|NCT01464827|63101677|FG000|Overall Study|Lost to Follow-up|0|||
33667960|NCT01464827|63101678|FG001|Overall Study|Lost to Follow-up|2|||
33667961|NCT01464827|63101679|FG002|Overall Study|Lost to Follow-up|0|||
33667962|NCT01464827|63101680|FG003|Overall Study|Lost to Follow-up|2|||
33305638|NCT01225731|62681110|FG011|Part 1|Protocol Violation|0|||
33305639|NCT01225731|62681111|FG012|Part 1|Protocol Violation|0|||
33305640|NCT01225731|62681099|FG000|Part 2|Protocol Violation|0|||
33305641|NCT01225731|62681100|FG001|Part 2|Protocol Violation|0|||
33305642|NCT01225731|62681101|FG002|Part 2|Protocol Violation|0|||
33305643|NCT01225731|62681102|FG003|Part 2|Protocol Violation|0|||
33305644|NCT01225731|62681103|FG004|Part 2|Protocol Violation|0|||
33305645|NCT01225731|62681104|FG005|Part 2|Protocol Violation|1|||
33305646|NCT01225731|62681105|FG006|Part 2|Protocol Violation|0|||
33305647|NCT01225731|62681106|FG007|Part 2|Protocol Violation|0|||
33305648|NCT01225731|62681107|FG008|Part 2|Protocol Violation|1|||
33305649|NCT01225731|62681108|FG009|Part 2|Protocol Violation|0|||
33305650|NCT01225731|62681109|FG010|Part 2|Protocol Violation|0|||
33305651|NCT01225731|62681110|FG011|Part 2|Protocol Violation|0|||
33305652|NCT01225731|62681111|FG012|Part 2|Protocol Violation|0|||
33305653|NCT01225731|62681099|FG000|Part 2|Adverse Event|0|||
33305654|NCT01225731|62681100|FG001|Part 2|Adverse Event|0|||
33305655|NCT01225731|62681101|FG002|Part 2|Adverse Event|0|||
33305656|NCT01225731|62681102|FG003|Part 2|Adverse Event|0|||
33305657|NCT01225731|62681103|FG004|Part 2|Adverse Event|0|||
33305658|NCT01225731|62681104|FG005|Part 2|Adverse Event|0|||
33305659|NCT01225731|62681105|FG006|Part 2|Adverse Event|4|||
33305660|NCT01225731|62681106|FG007|Part 2|Adverse Event|4|||
33305661|NCT01225731|62681107|FG008|Part 2|Adverse Event|2|||
33305662|NCT01225731|62681108|FG009|Part 2|Adverse Event|0|||
33305663|NCT01225731|62681109|FG010|Part 2|Adverse Event|0|||
33305664|NCT01225731|62681110|FG011|Part 2|Adverse Event|0|||
33305665|NCT01225731|62681111|FG012|Part 2|Adverse Event|0|||
33305666|NCT01225731|62681099|FG000|Part 2|Lack of Efficacy|0|||
33305667|NCT01225731|62681100|FG001|Part 2|Lack of Efficacy|0|||
33305668|NCT01225731|62681101|FG002|Part 2|Lack of Efficacy|0|||
33305669|NCT01225731|62681102|FG003|Part 2|Lack of Efficacy|0|||
33305670|NCT01225731|62681103|FG004|Part 2|Lack of Efficacy|0|||
33305671|NCT01225731|62681104|FG005|Part 2|Lack of Efficacy|1|||
33305672|NCT01225731|62681105|FG006|Part 2|Lack of Efficacy|0|||
33305673|NCT01225731|62681106|FG007|Part 2|Lack of Efficacy|12|||
33305674|NCT01225731|62681107|FG008|Part 2|Lack of Efficacy|3|||
33305675|NCT01225731|62681108|FG009|Part 2|Lack of Efficacy|0|||
33305676|NCT01225731|62681109|FG010|Part 2|Lack of Efficacy|0|||
33305677|NCT01225731|62681110|FG011|Part 2|Lack of Efficacy|0|||
33305678|NCT01225731|62681111|FG012|Part 2|Lack of Efficacy|0|||
33305679|NCT01225731|62681099|FG000|Part 2|Pregnancy|0|||
33305680|NCT01225731|62681100|FG001|Part 2|Pregnancy|0|||
33305681|NCT01225731|62681101|FG002|Part 2|Pregnancy|0|||
33305682|NCT01225731|62681102|FG003|Part 2|Pregnancy|0|||
33305683|NCT01225731|62681103|FG004|Part 2|Pregnancy|0|||
33305684|NCT01225731|62681104|FG005|Part 2|Pregnancy|0|||
33305685|NCT01225731|62681105|FG006|Part 2|Pregnancy|1|||
33398085|NCT03887221|62777464|FG000|Overall Study|Protocol Violation|1|||
33305686|NCT01225731|62681106|FG007|Part 2|Pregnancy|0|||
33305687|NCT01225731|62681107|FG008|Part 2|Pregnancy|1|||
33305688|NCT01225731|62681108|FG009|Part 2|Pregnancy|0|||
33305689|NCT01225731|62681109|FG010|Part 2|Pregnancy|0|||
33305690|NCT01225731|62681110|FG011|Part 2|Pregnancy|0|||
33305691|NCT01225731|62681111|FG012|Part 2|Pregnancy|0|||
33305692|NCT01225731|62681099|FG000|Part 2|Lost to Follow-up|0|||
33305693|NCT01225731|62681100|FG001|Part 2|Lost to Follow-up|0|||
33305694|NCT01225731|62681101|FG002|Part 2|Lost to Follow-up|0|||
33305695|NCT01225731|62681102|FG003|Part 2|Lost to Follow-up|0|||
33305696|NCT01225731|62681103|FG004|Part 2|Lost to Follow-up|0|||
33305697|NCT01225731|62681104|FG005|Part 2|Lost to Follow-up|0|||
33305698|NCT01225731|62681105|FG006|Part 2|Lost to Follow-up|0|||
33305699|NCT01225731|62681106|FG007|Part 2|Lost to Follow-up|3|||
33305700|NCT01225731|62681107|FG008|Part 2|Lost to Follow-up|1|||
33305701|NCT01225731|62681108|FG009|Part 2|Lost to Follow-up|0|||
33398086|NCT03887221|62777465|FG001|Overall Study|Protocol Violation|0|||
33398087|NCT02782741|62777485|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
33305702|NCT01225731|62681109|FG010|Part 2|Lost to Follow-up|0|||
33305703|NCT01225731|62681110|FG011|Part 2|Lost to Follow-up|0|||
33667963|NCT01464827|63101681|FG004|Overall Study|Lost to Follow-up|3|||
33667964|NCT01464827|63101682|FG005|Overall Study|Lost to Follow-up|1|||
33667965|NCT01464827|63101683|FG006|Overall Study|Lost to Follow-up|2|||
33305704|NCT01225731|62681111|FG012|Part 2|Lost to Follow-up|0|||
33305705|NCT01225731|62681099|FG000|Part 2|Physician Decision|0|||
33305706|NCT01225731|62681100|FG001|Part 2|Physician Decision|0|||
33305707|NCT01225731|62681101|FG002|Part 2|Physician Decision|0|||
33305708|NCT01225731|62681102|FG003|Part 2|Physician Decision|0|||
33305709|NCT01225731|62681103|FG004|Part 2|Physician Decision|0|||
33305710|NCT01225731|62681104|FG005|Part 2|Physician Decision|0|||
33305711|NCT01225731|62681105|FG006|Part 2|Physician Decision|0|||
33305712|NCT01225731|62681106|FG007|Part 2|Physician Decision|2|||
33305713|NCT01225731|62681107|FG008|Part 2|Physician Decision|2|||
33667966|NCT01464827|63101684|FG007|Overall Study|Lost to Follow-up|2|||
33667967|NCT01464827|63101685|FG008|Overall Study|Lost to Follow-up|0|||
33667968|NCT01464827|63101686|FG009|Overall Study|Lost to Follow-up|0|||
33667969|NCT01464827|63101687|FG010|Overall Study|Lost to Follow-up|0|||
33667970|NCT01464827|63101688|FG011|Overall Study|Lost to Follow-up|1|||
33667971|NCT01464827|63101689|FG012|Overall Study|Lost to Follow-up|0|||
33667972|NCT01464827|63101690|FG013|Overall Study|Lost to Follow-up|1|||
33667973|NCT01464827|63101677|FG000|Overall Study|Other|2|||
33667974|NCT01464827|63101678|FG001|Overall Study|Other|3|||
33667975|NCT01464827|63101679|FG002|Overall Study|Other|0|||
33667976|NCT01464827|63101680|FG003|Overall Study|Other|2|||
33667977|NCT01464827|63101681|FG004|Overall Study|Other|3|||
33667978|NCT01464827|63101682|FG005|Overall Study|Other|0|||
33667979|NCT01464827|63101683|FG006|Overall Study|Other|1|||
33667980|NCT01464827|63101684|FG007|Overall Study|Other|0|||
33667981|NCT01464827|63101685|FG008|Overall Study|Other|3|||
33667982|NCT01464827|63101686|FG009|Overall Study|Other|1|||
33667983|NCT01464827|63101687|FG010|Overall Study|Other|2|||
33667984|NCT01464827|63101688|FG011|Overall Study|Other|0|||
33667985|NCT01464827|63101689|FG012|Overall Study|Other|1|||
33667986|NCT01464827|63101690|FG013|Overall Study|Other|0|||
33667987|NCT01464827|63101677|FG000|Overall Study|Not Treated|0|||
33667988|NCT01464827|63101678|FG001|Overall Study|Not Treated|2|||
33667989|NCT01464827|63101679|FG002|Overall Study|Not Treated|0|||
33667990|NCT01464827|63101680|FG003|Overall Study|Not Treated|0|||
33667991|NCT01464827|63101681|FG004|Overall Study|Not Treated|1|||
33667992|NCT01464827|63101682|FG005|Overall Study|Not Treated|0|||
33667993|NCT01464827|63101683|FG006|Overall Study|Not Treated|1|||
33667994|NCT01464827|63101684|FG007|Overall Study|Not Treated|0|||
33667995|NCT01464827|63101685|FG008|Overall Study|Not Treated|0|||
33667996|NCT01464827|63101686|FG009|Overall Study|Not Treated|2|||
33667997|NCT01464827|63101687|FG010|Overall Study|Not Treated|0|||
33667998|NCT01464827|63101688|FG011|Overall Study|Not Treated|1|||
33667999|NCT01464827|63101689|FG012|Overall Study|Not Treated|0|||
33668000|NCT01464827|63101690|FG013|Overall Study|Not Treated|2|||
33668001|NCT01463111|63101731|FG000|Overall Study|Withdrawal by Subject|2|||
33668002|NCT01463111|63101731|FG000|Overall Study|Lost to Follow-up|5|||
33668003|NCT01463111|63101731|FG000|Overall Study|Physician Decision|2|||
33668004|NCT01463033|63101737|FG000|Overall Study|Lost to Follow-up|4|||
33668005|NCT01463033|63101738|FG001|Overall Study|Lost to Follow-up|4|||
33668006|NCT01463033|63101737|FG000|Overall Study|Death|3|||
33668007|NCT01463033|63101738|FG001|Overall Study|Death|2|||
33668008|NCT01461707|63101747|FG000|Overall Study|Withdrawal by Subject|1|||
33668009|NCT01461707|63101748|FG001|Overall Study|Withdrawal by Subject|0|||
33668010|NCT01461551|63101757|FG000|Overall Study|Physician Decision|2|||
33668011|NCT01461551|63101758|FG001|Overall Study|Physician Decision|1|||
33668012|NCT01461551|63101759|FG002|Overall Study|Physician Decision|2|||
33668013|NCT01461005|63101767|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
33668014|NCT01460381|63101774|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
33668015|NCT01460381|63101775|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
33668016|NCT01473589|63101859|FG000|Overall Study|Adverse Event|1|||
33668017|NCT01473589|63101860|FG001|Overall Study|Adverse Event|1|||
33668018|NCT01473589|63101859|FG000|Overall Study|Death|2|||
33668019|NCT01473589|63101860|FG001|Overall Study|Death|0|||
33668020|NCT01473589|63101859|FG000|Overall Study|Lost to Follow-up|2|||
33668021|NCT01473589|63101860|FG001|Overall Study|Lost to Follow-up|2|||
33668022|NCT01473589|63101859|FG000|Overall Study|Protocol Violation|1|||
33668023|NCT01473589|63101860|FG001|Overall Study|Protocol Violation|0|||
33668024|NCT01473589|63101859|FG000|Overall Study|Withdrawal by Subject|5|||
33668025|NCT01473589|63101860|FG001|Overall Study|Withdrawal by Subject|11|||
33668026|NCT01473589|63101859|FG000|Overall Study|Physician Decision|0|||
33668027|NCT01473589|63101860|FG001|Overall Study|Physician Decision|1|||
33305714|NCT01225731|62681108|FG009|Part 2|Physician Decision|0|||
33305715|NCT01225731|62681109|FG010|Part 2|Physician Decision|0|||
33668028|NCT01473589|63101859|FG000|Overall Study|Entry criteria not met|0|||
33668029|NCT01473589|63101860|FG001|Overall Study|Entry criteria not met|1|||
33668030|NCT01500187|63101879|FG000|Overall Study|Lost to Follow-up|6|||
33668031|NCT01500187|63101880|FG001|Overall Study|Lost to Follow-up|0|||
33668032|NCT01500031|63101898|FG000|Overall Study|Death|1|||
33668033|NCT01500031|63101898|FG000|Overall Study|Withdrawal by Subject|4|||
33668034|NCT01473355|63101911|FG000|Overall Study|Protocol Violation|2|||
33668035|NCT01473355|63101911|FG000|Overall Study|Adverse Event|2|||
33668036|NCT01473355|63101911|FG000|Overall Study|Lost to Follow-up|2|||
33668037|NCT01472965|63101921|FG000|Overall Study|Withdrawal by Subject|1|||
33668038|NCT01472965|63101922|FG001|Overall Study|Withdrawal by Subject|0|||
33668039|NCT01457053|63101932|FG000|Overall Study|Unable to undergo selected treatment|1|||
33668040|NCT01457053|63101933|FG001|Overall Study|Unable to undergo selected treatment|1|||
33668041|NCT01472341|63101948|FG000|Overall Study|Started insulin therapy|55|||
33668042|NCT01472341|63101948|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
33668043|NCT01472341|63101948|FG000|Overall Study|Withdrawal by Subject|39|||
33668044|NCT01472341|63101948|FG000|Overall Study|Lost to Follow-up|52|||
33668045|NCT01472341|63101948|FG000|Overall Study|Laboratory parameters unavailable|25|||
33668046|NCT01472341|63101948|FG000|Overall Study|Death|9|||
33668047|NCT01472185|63101954|FG000|Overall Study|Randomized but Not Treated|0|||
33668048|NCT01472185|63101955|FG001|Overall Study|Randomized but Not Treated|1|||
33668049|NCT01472185|63101954|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
33668050|NCT01472185|63101955|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
33668051|NCT01472185|63101954|FG000|Overall Study|Hyperglycemia|5|||
33668052|NCT01472185|63101955|FG001|Overall Study|Hyperglycemia|2|||
33668053|NCT01472185|63101954|FG000|Overall Study|Investigator's Discretion|3|||
33668054|NCT01472185|63101955|FG001|Overall Study|Investigator's Discretion|1|||
33668055|NCT01472185|63101954|FG000|Overall Study|Lost to Follow-up|4|||
33668056|NCT01472185|63101955|FG001|Overall Study|Lost to Follow-up|1|||
33668057|NCT01472185|63101954|FG000|Overall Study|Protocol Violation|5|||
33668058|NCT01472185|63101955|FG001|Overall Study|Protocol Violation|1|||
33668059|NCT01472185|63101954|FG000|Overall Study|Subject Noncompliance|8|||
33668060|NCT01472185|63101955|FG001|Overall Study|Subject Noncompliance|15|||
33668061|NCT01472185|63101954|FG000|Overall Study|Subject Withdrew Consent|6|||
33668062|NCT01472185|63101955|FG001|Overall Study|Subject Withdrew Consent|3|||
33668063|NCT01456897|63101976|FG000|Overall Study|Adverse Event|19|||
33668064|NCT01456897|63101977|FG001|Overall Study|Adverse Event|22|||
33668065|NCT01456897|63101976|FG000|Overall Study|Protocol Violation|3|||
33668066|NCT01456897|63101977|FG001|Overall Study|Protocol Violation|4|||
33668067|NCT01456897|63101976|FG000|Overall Study|Physician Decision|5|||
33668068|NCT01456897|63101977|FG001|Overall Study|Physician Decision|3|||
33668069|NCT01456897|63101976|FG000|Overall Study|Withdrawal by Subject|44|||
33668070|NCT01456897|63101977|FG001|Overall Study|Withdrawal by Subject|17|||
33668071|NCT01456897|63101976|FG000|Overall Study|Lack of Efficacy|4|||
33668072|NCT01456897|63101977|FG001|Overall Study|Lack of Efficacy|11|||
33668073|NCT01456195|63101990|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
33668074|NCT01456195|63101991|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
33668075|NCT01456195|63101992|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
33668076|NCT01456195|63101990|FG000|Overall Study|Lost to Follow-up|3|||
33668077|NCT01456195|63101991|FG001|Overall Study|Lost to Follow-up|1|||
33668078|NCT01456195|63101992|FG002|Overall Study|Lost to Follow-up|3|||
33668079|NCT01456195|63101990|FG000|Overall Study|Voluntary Withdrawal|5|||
33668080|NCT01456195|63101991|FG001|Overall Study|Voluntary Withdrawal|3|||
33668081|NCT01456195|63101992|FG002|Overall Study|Voluntary Withdrawal|7|||
33668082|NCT01456195|63101990|FG000|Overall Study|Lack of Efficacy|0|||
33668083|NCT01456195|63101991|FG001|Overall Study|Lack of Efficacy|1|||
33668084|NCT01456195|63101992|FG002|Overall Study|Lack of Efficacy|0|||
33668085|NCT01456195|63101990|FG000|Overall Study|Other Reasons|2|||
33668086|NCT01456195|63101991|FG001|Overall Study|Other Reasons|1|||
33668087|NCT01456195|63101992|FG002|Overall Study|Other Reasons|3|||
33668088|NCT01456039|63102056|FG000|Phase 1 (First Step)|Disease Progression|1|||
33668089|NCT01456039|63102057|FG001|Phase 1 (First Step)|Disease Progression|1|||
33668090|NCT01456039|63102058|FG002|Phase 1 (First Step)|Disease Progression|0|||
33668091|NCT01456039|63102056|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
33668092|NCT01456039|63102057|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
33668093|NCT01456039|63102058|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
33668094|NCT01456039|63102056|FG000|Phase 1 (First Step)|Adverse Event|0|||
33668095|NCT01456039|63102057|FG001|Phase 1 (First Step)|Adverse Event|3|||
33668096|NCT01456039|63102058|FG002|Phase 1 (First Step)|Adverse Event|0|||
33668097|NCT01456039|63102056|FG000|Phase 1 (First Step)|Other|0|||
33668098|NCT01456039|63102057|FG001|Phase 1 (First Step)|Other|1|||
33668099|NCT01456039|63102058|FG002|Phase 1 (First Step)|Other|0|||
33668100|NCT01456039|63102056|FG000|Phase 2 (Second Step)|Disease Progression|0|||
33668101|NCT01456039|63102057|FG001|Phase 2 (Second Step)|Disease Progression|0|||
33668102|NCT01456039|63102058|FG002|Phase 2 (Second Step)|Disease Progression|17|||
33668103|NCT01456039|63102056|FG000|Phase 2 (Second Step)|Adverse Event|0|||
33668104|NCT01456039|63102057|FG001|Phase 2 (Second Step)|Adverse Event|0|||
33668105|NCT01456039|63102058|FG002|Phase 2 (Second Step)|Adverse Event|10|||
33668106|NCT01456039|63102056|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
33668107|NCT01456039|63102057|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
33668108|NCT01456039|63102058|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
33668109|NCT01456039|63102056|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
33668110|NCT01456039|63102057|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
33668111|NCT01456039|63102058|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
33668112|NCT01456039|63102056|FG000|Phase 2 (Second Step)|Other|0|||
33668113|NCT01456039|63102057|FG001|Phase 2 (Second Step)|Other|0|||
33668114|NCT01456039|63102058|FG002|Phase 2 (Second Step)|Other|1|||
33305716|NCT01225731|62681110|FG011|Part 2|Physician Decision|0|||
33305717|NCT01225731|62681111|FG012|Part 2|Physician Decision|0|||
33668115|NCT01455415|63102076|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
33668116|NCT01455415|63102077|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
33305718|NCT01225731|62681099|FG000|Part 2|Withdrawal by Subject|0|||
33668117|NCT01455415|63102076|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
33668118|NCT01455415|63102077|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
33668119|NCT01455415|63102076|FG000|Period 1|Drug Error not Associated to AE|0|||
33668120|NCT01455415|63102077|FG001|Period 1|Drug Error not Associated to AE|1|||
33668121|NCT01455415|63102076|FG000|Period 1|AE Not Related to Study Drug|2|||
33668122|NCT01455415|63102077|FG001|Period 1|AE Not Related to Study Drug|6|||
33668123|NCT01455415|63102076|FG000|Period 1|Withdrawal by Subject|4|||
33668124|NCT01455415|63102077|FG001|Period 1|Withdrawal by Subject|5|||
33668125|NCT01455415|63102076|FG000|Period 1|Unspecified Reason|1|||
33668126|NCT01455415|63102077|FG001|Period 1|Unspecified Reason|1|||
33668127|NCT01455415|63102076|FG000|Period 1|Protocol Violation|0|||
33668128|NCT01455415|63102077|FG001|Period 1|Protocol Violation|2|||
33668129|NCT01455415|63102076|FG000|Washout|AE Related to Study Drug|2|||
33668130|NCT01455415|63102077|FG001|Washout|AE Related to Study Drug|0|||
33668131|NCT01455415|63102076|FG000|Washout|Lost to Follow-up|1|||
33668132|NCT01455415|63102077|FG001|Washout|Lost to Follow-up|0|||
33668133|NCT01455415|63102076|FG000|Washout|Drug Error not Associated to AE|2|||
33668134|NCT01455415|63102077|FG001|Washout|Drug Error not Associated to AE|1|||
33668135|NCT01455415|63102076|FG000|Washout|AE Not Related to Study Drug|2|||
33668136|NCT01455415|63102077|FG001|Washout|AE Not Related to Study Drug|3|||
33668137|NCT01455415|63102076|FG000|Washout|Unspecified Reason|1|||
33668138|NCT01455415|63102077|FG001|Washout|Unspecified Reason|2|||
33668139|NCT01455415|63102076|FG000|Washout|Protocol Violation|0|||
33668140|NCT01455415|63102077|FG001|Washout|Protocol Violation|1|||
33668141|NCT01455415|63102076|FG000|Period 2|AE Related to Study Drug|1|||
33668142|NCT01455415|63102077|FG001|Period 2|AE Related to Study Drug|2|||
33668143|NCT01455415|63102076|FG000|Period 2|Lost to Follow-up|2|||
33668144|NCT01455415|63102077|FG001|Period 2|Lost to Follow-up|1|||
33668145|NCT01455415|63102076|FG000|Period 2|AE Not Related to Study Drug|2|||
33668146|NCT01455415|63102077|FG001|Period 2|AE Not Related to Study Drug|1|||
33668147|NCT01455415|63102076|FG000|Period 2|Lack of Efficacy|2|||
33668148|NCT01455415|63102077|FG001|Period 2|Lack of Efficacy|0|||
33668149|NCT01455415|63102076|FG000|Period 2|Withdrawal by Subject|2|||
33668150|NCT01455415|63102077|FG001|Period 2|Withdrawal by Subject|3|||
33668151|NCT01455415|63102076|FG000|Period 2|Unspecified Reason|2|||
33668152|NCT01455415|63102077|FG001|Period 2|Unspecified Reason|3|||
33668153|NCT01455415|63102076|FG000|Period 2|Protocol Violation|2|||
33668154|NCT01455415|63102077|FG001|Period 2|Protocol Violation|0|||
33668155|NCT01455415|63102076|FG000|Follow-up|AE Related to Study Drug|0|||
33668156|NCT01455415|63102077|FG001|Follow-up|AE Related to Study Drug|1|||
33668157|NCT01455415|63102076|FG000|Follow-up|Lack of Efficacy|0|||
33668158|NCT01455415|63102077|FG001|Follow-up|Lack of Efficacy|1|||
33668159|NCT01455415|63102076|FG000|Follow-up|Withdrawal by Subject|2|||
33668160|NCT01455415|63102077|FG001|Follow-up|Withdrawal by Subject|0|||
33668161|NCT01455415|63102076|FG000|Follow-up|Unspecified Reason|1|||
33668162|NCT01455415|63102077|FG001|Follow-up|Unspecified Reason|0|||
33668163|NCT01471171|63102083|FG000|Treatment Period 1|Adverse Event|4|||
33668164|NCT01471171|63102084|FG001|Treatment Period 1|Adverse Event|1|||
33668165|NCT01471171|63102083|FG000|Treatment Period 2|Adverse Event|1|||
33668166|NCT01471171|63102084|FG001|Treatment Period 2|Adverse Event|0|||
33668167|NCT01471093|63102092|FG000|Overall Study|Adverse Event|1|||
33668168|NCT01471093|63102093|FG001|Overall Study|Adverse Event|0|||
33668169|NCT01471093|63102094|FG002|Overall Study|Adverse Event|0|||
33668170|NCT01471093|63102095|FG003|Overall Study|Adverse Event|0|||
33668171|NCT01471015|63102104|FG000|Overall Study|Death|0|||
33668172|NCT01471015|63102105|FG001|Overall Study|Death|1|||
33668173|NCT01471015|63102106|FG002|Overall Study|Death|1|||
33668174|NCT01497067|63102114|FG000|Overall Study|Lost to Follow-up|56|||
33668175|NCT01497067|63102114|FG000|Overall Study|Adverse Event|3|||
33668176|NCT01497067|63102114|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
33668177|NCT01497067|63102114|FG000|Overall Study|Other|13|||
33668178|NCT01470469|63102144|FG000|Overall Study|Withdrawal by Subject|4|||
33668179|NCT01470469|63102145|FG001|Overall Study|Withdrawal by Subject|6|||
33668180|NCT01470469|63102144|FG000|Overall Study|Lack of Efficacy|1|||
33668181|NCT01470469|63102145|FG001|Overall Study|Lack of Efficacy|7|||
33668182|NCT01470469|63102144|FG000|Overall Study|Adverse Event|0|||
33668183|NCT01470469|63102145|FG001|Overall Study|Adverse Event|7|||
33668184|NCT01470469|63102144|FG000|Overall Study|Lost to Follow-up|2|||
33668185|NCT01470469|63102145|FG001|Overall Study|Lost to Follow-up|2|||
33668186|NCT01470469|63102144|FG000|Overall Study|Protocol Violation|1|||
33668187|NCT01470469|63102145|FG001|Overall Study|Protocol Violation|1|||
33398088|NCT02782741|62777486|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
33668188|NCT01470469|63102144|FG000|Overall Study|Other|2|||
33668189|NCT01470469|63102145|FG001|Overall Study|Other|1|||
33398089|NCT02782741|62777485|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
33668190|NCT01470001|63102153|FG000|Overall Study|Lost to Follow-up|1|||
33668191|NCT01470001|63102154|FG001|Overall Study|Lost to Follow-up|1|||
33668192|NCT01470001|63102153|FG000|Overall Study|Physician Decision|2|||
33668193|NCT01470001|63102154|FG001|Overall Study|Physician Decision|0|||
33668194|NCT01470001|63102153|FG000|Overall Study|Withdrawal by Subject|2|||
33668195|NCT01470001|63102154|FG001|Overall Study|Withdrawal by Subject|1|||
33668196|NCT01469377|63102163|FG000|Overall Study|Protocol Deviation|7|||
33668197|NCT01469377|63102164|FG001|Overall Study|Protocol Deviation|10|||
33668198|NCT01469377|63102165|FG002|Overall Study|Protocol Deviation|10|||
33668199|NCT01469377|63102163|FG000|Overall Study|Lost to Follow-up|3|||
33668200|NCT01469377|63102164|FG001|Overall Study|Lost to Follow-up|2|||
33668201|NCT01469377|63102165|FG002|Overall Study|Lost to Follow-up|5|||
33668202|NCT01469377|63102163|FG000|Overall Study|Withdrawal of Consent|12|||
33668203|NCT01469377|63102164|FG001|Overall Study|Withdrawal of Consent|14|||
33668204|NCT01469377|63102165|FG002|Overall Study|Withdrawal of Consent|15|||
33668205|NCT01469377|63102163|FG000|Overall Study|Adverse Event|8|||
33668206|NCT01469377|63102164|FG001|Overall Study|Adverse Event|18|||
33668207|NCT01469377|63102165|FG002|Overall Study|Adverse Event|36|||
33668208|NCT01469377|63102163|FG000|Overall Study|Insufficient Therapeutic Response|3|||
33668209|NCT01469377|63102164|FG001|Overall Study|Insufficient Therapeutic Response|4|||
33668210|NCT01469377|63102165|FG002|Overall Study|Insufficient Therapeutic Response|0|||
33668211|NCT01469377|63102163|FG000|Overall Study|Other Miscellaneous Reasons|2|||
33668212|NCT01469377|63102164|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33668213|NCT01469377|63102165|FG002|Overall Study|Other Miscellaneous Reasons|0|||
33668214|NCT01469221|63102175|FG000|Double Blind Phase|Protocol Violation|1|||
33668215|NCT01469221|63102176|FG001|Double Blind Phase|Protocol Violation|0|||
33668216|NCT01469221|63102177|FG002|Double Blind Phase|Protocol Violation|0|||
33668217|NCT01469221|63102175|FG000|Double Blind Phase|Physician Decision|1|||
33668218|NCT01469221|63102176|FG001|Double Blind Phase|Physician Decision|1|||
33668219|NCT01469221|63102177|FG002|Double Blind Phase|Physician Decision|0|||
33668220|NCT01469221|63102175|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
33668221|NCT01469221|63102176|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
33668222|NCT01469221|63102177|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
33668223|NCT01453855|63102186|FG000|Overall Study|Adverse Event|3|||
33668224|NCT01453855|63102187|FG001|Overall Study|Adverse Event|4|||
33668225|NCT01453855|63102186|FG000|Overall Study|Lost to Follow-up|2|||
33668226|NCT01453855|63102187|FG001|Overall Study|Lost to Follow-up|1|||
33668227|NCT01453855|63102186|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
33668228|NCT01453855|63102187|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
33668229|NCT01453855|63102186|FG000|Overall Study|Noncompliance|1|||
33668230|NCT01453855|63102187|FG001|Overall Study|Noncompliance|0|||
33668231|NCT01453855|63102186|FG000|Overall Study|Inadequate Control of IOP|1|||
33668232|NCT01453855|63102187|FG001|Overall Study|Inadequate Control of IOP|5|||
33668233|NCT01453855|63102186|FG000|Overall Study|Other|0|||
33668234|NCT01453855|63102187|FG001|Overall Study|Other|1|||
33668235|NCT01469065|63102198|FG000|Overall Study|Lack of Efficacy|0|||
33668236|NCT01469065|63102199|FG001|Overall Study|Lack of Efficacy|0|||
33668237|NCT01469065|63102200|FG002|Overall Study|Lack of Efficacy|0|||
33668238|NCT01469065|63102201|FG003|Overall Study|Lack of Efficacy|0|||
33668239|NCT01469065|63102202|FG004|Overall Study|Lack of Efficacy|1|||
33668240|NCT01469065|63102198|FG000|Overall Study|Other|0|||
33668241|NCT01469065|63102199|FG001|Overall Study|Other|1|||
33668242|NCT01469065|63102200|FG002|Overall Study|Other|0|||
33668243|NCT01469065|63102201|FG003|Overall Study|Other|0|||
33668244|NCT01469065|63102202|FG004|Overall Study|Other|0|||
33668245|NCT01586624|63102226|FG000|Overall Study|Adverse Event|3|||
33668246|NCT01586624|63102227|FG001|Overall Study|Adverse Event|0|||
33668247|NCT01586624|63102228|FG002|Overall Study|Adverse Event|2|||
33668248|NCT01586624|63102229|FG003|Overall Study|Adverse Event|1|||
33668249|NCT01586624|63102230|FG004|Overall Study|Adverse Event|3|||
33668250|NCT01586624|63102231|FG005|Overall Study|Adverse Event|3|||
33668251|NCT01586624|63102232|FG006|Overall Study|Adverse Event|2|||
33668252|NCT01586624|63102233|FG007|Overall Study|Adverse Event|3|||
33668253|NCT01586624|63102226|FG000|Overall Study|Physician Decision|0|||
33668254|NCT01586624|63102227|FG001|Overall Study|Physician Decision|1|||
33668255|NCT01586624|63102228|FG002|Overall Study|Physician Decision|1|||
33668256|NCT01586624|63102229|FG003|Overall Study|Physician Decision|0|||
33668257|NCT01586624|63102230|FG004|Overall Study|Physician Decision|2|||
33668258|NCT01586624|63102231|FG005|Overall Study|Physician Decision|0|||
33668259|NCT01586624|63102232|FG006|Overall Study|Physician Decision|1|||
33668260|NCT01586624|63102233|FG007|Overall Study|Physician Decision|1|||
33668261|NCT01586624|63102226|FG000|Overall Study|Withdrawal by Subject|0|||
33668262|NCT01586624|63102227|FG001|Overall Study|Withdrawal by Subject|0|||
33668263|NCT01586624|63102228|FG002|Overall Study|Withdrawal by Subject|0|||
33668264|NCT01586624|63102229|FG003|Overall Study|Withdrawal by Subject|1|||
33668265|NCT01586624|63102230|FG004|Overall Study|Withdrawal by Subject|0|||
33305719|NCT01225731|62681100|FG001|Part 2|Withdrawal by Subject|0|||
33305720|NCT01225731|62681101|FG002|Part 2|Withdrawal by Subject|0|||
33668266|NCT01586624|63102231|FG005|Overall Study|Withdrawal by Subject|0|||
33668267|NCT01586624|63102232|FG006|Overall Study|Withdrawal by Subject|0|||
33668268|NCT01586624|63102233|FG007|Overall Study|Withdrawal by Subject|0|||
33668269|NCT01586624|63102226|FG000|Overall Study|Evidence of disease progression|1|||
33668270|NCT01586624|63102227|FG001|Overall Study|Evidence of disease progression|3|||
33668271|NCT01586624|63102228|FG002|Overall Study|Evidence of disease progression|2|||
33668272|NCT01586624|63102229|FG003|Overall Study|Evidence of disease progression|5|||
33668273|NCT01586624|63102230|FG004|Overall Study|Evidence of disease progression|3|||
33668274|NCT01586624|63102231|FG005|Overall Study|Evidence of disease progression|5|||
33668275|NCT01586624|63102232|FG006|Overall Study|Evidence of disease progression|4|||
33668276|NCT01586624|63102233|FG007|Overall Study|Evidence of disease progression|6|||
33668277|NCT01586624|63102226|FG000|Overall Study|Screen failure (no treatment received)|0|||
33668278|NCT01586624|63102227|FG001|Overall Study|Screen failure (no treatment received)|0|||
33668279|NCT01586624|63102228|FG002|Overall Study|Screen failure (no treatment received)|0|||
33668280|NCT01586624|63102229|FG003|Overall Study|Screen failure (no treatment received)|0|||
33668281|NCT01586624|63102230|FG004|Overall Study|Screen failure (no treatment received)|0|||
33668282|NCT01586624|63102231|FG005|Overall Study|Screen failure (no treatment received)|0|||
33668283|NCT01586624|63102232|FG006|Overall Study|Screen failure (no treatment received)|1|||
33668284|NCT01586624|63102233|FG007|Overall Study|Screen failure (no treatment received)|0|||
33668285|NCT01586156|63102255|FG000|Overall Study|Pregnancy|0|||
33305721|NCT01225731|62681102|FG003|Part 2|Withdrawal by Subject|0|||
33305722|NCT01225731|62681103|FG004|Part 2|Withdrawal by Subject|0|||
33305723|NCT01225731|62681104|FG005|Part 2|Withdrawal by Subject|1|||
33305724|NCT01225731|62681105|FG006|Part 2|Withdrawal by Subject|3|||
33305725|NCT01225731|62681106|FG007|Part 2|Withdrawal by Subject|4|||
33305726|NCT01225731|62681107|FG008|Part 2|Withdrawal by Subject|1|||
33305727|NCT01225731|62681108|FG009|Part 2|Withdrawal by Subject|0|||
33305728|NCT01225731|62681109|FG010|Part 2|Withdrawal by Subject|0|||
33305729|NCT01225731|62681110|FG011|Part 2|Withdrawal by Subject|0|||
33305730|NCT01225731|62681111|FG012|Part 2|Withdrawal by Subject|0|||
33305731|NCT01225731|62681099|FG000|Part 3|Adverse Event|0|||
33305732|NCT01225731|62681100|FG001|Part 3|Adverse Event|0|||
33305733|NCT01225731|62681101|FG002|Part 3|Adverse Event|0|||
33305734|NCT01225731|62681102|FG003|Part 3|Adverse Event|0|||
33305735|NCT01225731|62681103|FG004|Part 3|Adverse Event|0|||
33305736|NCT01225731|62681104|FG005|Part 3|Adverse Event|0|||
33305737|NCT01225731|62681105|FG006|Part 3|Adverse Event|0|||
33305738|NCT01225731|62681106|FG007|Part 3|Adverse Event|0|||
33305739|NCT01225731|62681107|FG008|Part 3|Adverse Event|0|||
33305740|NCT01225731|62681108|FG009|Part 3|Adverse Event|0|||
33305741|NCT01225731|62681109|FG010|Part 3|Adverse Event|1|||
33305742|NCT01225731|62681110|FG011|Part 3|Adverse Event|1|||
33305743|NCT01225731|62681111|FG012|Part 3|Adverse Event|0|||
33305744|NCT01225731|62681099|FG000|Part 3|Lost to Follow-up|0|||
33305745|NCT01225731|62681100|FG001|Part 3|Lost to Follow-up|0|||
33305746|NCT01225731|62681101|FG002|Part 3|Lost to Follow-up|0|||
33305747|NCT01225731|62681102|FG003|Part 3|Lost to Follow-up|0|||
33305748|NCT01225731|62681103|FG004|Part 3|Lost to Follow-up|0|||
33305749|NCT01225731|62681104|FG005|Part 3|Lost to Follow-up|0|||
33305750|NCT01225731|62681105|FG006|Part 3|Lost to Follow-up|0|||
33305751|NCT01225731|62681106|FG007|Part 3|Lost to Follow-up|0|||
33305752|NCT01225731|62681107|FG008|Part 3|Lost to Follow-up|0|||
33305753|NCT01225731|62681108|FG009|Part 3|Lost to Follow-up|0|||
33305754|NCT01225731|62681109|FG010|Part 3|Lost to Follow-up|1|||
33305755|NCT01225731|62681110|FG011|Part 3|Lost to Follow-up|2|||
33305756|NCT01225731|62681111|FG012|Part 3|Lost to Follow-up|1|||
33305757|NCT01225731|62681099|FG000|Part 3|Physician Decision|0|||
33305758|NCT01225731|62681100|FG001|Part 3|Physician Decision|0|||
33305759|NCT01225731|62681101|FG002|Part 3|Physician Decision|0|||
33305760|NCT01225731|62681102|FG003|Part 3|Physician Decision|0|||
33305761|NCT01225731|62681103|FG004|Part 3|Physician Decision|0|||
33305762|NCT01225731|62681104|FG005|Part 3|Physician Decision|0|||
33305763|NCT01225731|62681105|FG006|Part 3|Physician Decision|0|||
33305764|NCT01225731|62681106|FG007|Part 3|Physician Decision|0|||
33305765|NCT01225731|62681107|FG008|Part 3|Physician Decision|0|||
33305766|NCT01225731|62681108|FG009|Part 3|Physician Decision|0|||
33305767|NCT01225731|62681109|FG010|Part 3|Physician Decision|0|||
33305768|NCT01225731|62681110|FG011|Part 3|Physician Decision|1|||
33305769|NCT01225731|62681111|FG012|Part 3|Physician Decision|2|||
33305770|NCT01225731|62681099|FG000|Part 3|Withdrawal by Subject|0|||
33305771|NCT01225731|62681100|FG001|Part 3|Withdrawal by Subject|0|||
33305772|NCT01225731|62681101|FG002|Part 3|Withdrawal by Subject|0|||
33305773|NCT01225731|62681102|FG003|Part 3|Withdrawal by Subject|0|||
33305774|NCT01225731|62681103|FG004|Part 3|Withdrawal by Subject|0|||
33305775|NCT01225731|62681104|FG005|Part 3|Withdrawal by Subject|0|||
33305776|NCT01225731|62681105|FG006|Part 3|Withdrawal by Subject|0|||
33305777|NCT01225731|62681106|FG007|Part 3|Withdrawal by Subject|0|||
33305778|NCT01225731|62681107|FG008|Part 3|Withdrawal by Subject|0|||
33305779|NCT01225731|62681108|FG009|Part 3|Withdrawal by Subject|0|||
33398090|NCT02782741|62777486|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
33305780|NCT01225731|62681109|FG010|Part 3|Withdrawal by Subject|4|||
33305781|NCT01225731|62681110|FG011|Part 3|Withdrawal by Subject|6|||
33305782|NCT01225731|62681111|FG012|Part 3|Withdrawal by Subject|4|||
33305783|NCT01007149|62681142|FG000|Overall Study|Administrative problems|0|||
33305784|NCT01007149|62681143|FG001|Overall Study|Administrative problems|1|||
33305785|NCT00998335|62681151|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
33305786|NCT00998335|62681152|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
33305787|NCT01294670|62681169|FG000|Overall Study|Not treated|1|||
33305788|NCT01294670|62681170|FG001|Overall Study|Not treated|0|||
33305789|NCT01294670|62681171|FG002|Overall Study|Not treated|0|||
33305790|NCT01294670|62681172|FG003|Overall Study|Not treated|0|||
33305791|NCT01294670|62681173|FG004|Overall Study|Not treated|0|||
33305792|NCT01006603|62681187|FG000|Overall Study|Withdrawal by Subject|17|||
33305793|NCT01006603|62681188|FG001|Overall Study|Withdrawal by Subject|19|||
33305794|NCT01006603|62681187|FG000|Overall Study|Lost to Follow-up|0|||
33305795|NCT01006603|62681188|FG001|Overall Study|Lost to Follow-up|1|||
33305796|NCT01006603|62681187|FG000|Overall Study|Safety reason|1|||
33305797|NCT01006603|62681188|FG001|Overall Study|Safety reason|1|||
33305798|NCT01006603|62681187|FG000|Overall Study|Protocol Violation|1|||
33305799|NCT01006603|62681188|FG001|Overall Study|Protocol Violation|3|||
33305800|NCT01006603|62681187|FG000|Overall Study|Incorrect enrolment|0|||
33305801|NCT01006603|62681188|FG001|Overall Study|Incorrect enrolment|2|||
33305802|NCT01006603|62681187|FG000|Overall Study|Adverse Event|15|||
33305803|NCT01006603|62681188|FG001|Overall Study|Adverse Event|7|||
33305804|NCT01006603|62681187|FG000|Overall Study|Death|1|||
33305805|NCT01006603|62681188|FG001|Overall Study|Death|1|||
33305806|NCT01006603|62681187|FG000|Overall Study|Study specific discontinuation criteria|33|||
33305807|NCT01006603|62681188|FG001|Overall Study|Study specific discontinuation criteria|34|||
33305808|NCT01006603|62681187|FG000|Overall Study|Other|3|||
33305809|NCT01006603|62681188|FG001|Overall Study|Other|7|||
33305810|NCT00997321|62681196|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
33305811|NCT00997321|62681197|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
33305812|NCT01294592|62681211|FG000|Overall Study|Adverse Event|28|||
33305813|NCT01294592|62681212|FG001|Overall Study|Adverse Event|13|||
33305814|NCT01294592|62681211|FG000|Overall Study|Lack of Efficacy|7|||
33305815|NCT01294592|62681212|FG001|Overall Study|Lack of Efficacy|5|||
33305816|NCT01294592|62681211|FG000|Overall Study|Protocol Violation|1|||
33305817|NCT01294592|62681212|FG001|Overall Study|Protocol Violation|7|||
33305818|NCT01294592|62681211|FG000|Overall Study|Lost to Follow-up|7|||
33305819|NCT01294592|62681212|FG001|Overall Study|Lost to Follow-up|9|||
33305820|NCT01294592|62681211|FG000|Overall Study|Physician Decision|6|||
33305821|NCT01294592|62681212|FG001|Overall Study|Physician Decision|11|||
33305822|NCT01294592|62681211|FG000|Overall Study|Withdrawal by Subject|28|||
33305823|NCT01294592|62681212|FG001|Overall Study|Withdrawal by Subject|28|||
33305824|NCT00997243|62681221|FG000|Overall Study|Early termination of study by sponsor|7|||
33305825|NCT01294514|62681225|FG000|Overall Study|Excluded due to Arrhythmia|1|||
33305826|NCT00999661|62681233|FG000|Overall Study|Lost to Follow-up|59|||
33305827|NCT00999661|62681233|FG000|Overall Study|Adverse Event|1|||
33305828|NCT00999661|62681233|FG000|Overall Study|Withdrawal by Subject|1|||
33305829|NCT00999661|62681233|FG000|Overall Study|Not meeting eligibility criteria|9|||
33305830|NCT01294436|62681239|FG000|Overall Study|Adverse Event|10|||
33305831|NCT01294436|62681240|FG001|Overall Study|Adverse Event|17|||
33305832|NCT01294436|62681239|FG000|Overall Study|Withdrawal by Subject|11|||
33305833|NCT01294436|62681240|FG001|Overall Study|Withdrawal by Subject|28|||
33305834|NCT01294436|62681239|FG000|Overall Study|subject no longer meets study criteria|5|||
33305835|NCT01294436|62681240|FG001|Overall Study|subject no longer meets study criteria|20|||
33305836|NCT01294436|62681239|FG000|Overall Study|poor/non-compliance|2|||
33305837|NCT01294436|62681240|FG001|Overall Study|poor/non-compliance|5|||
33305838|NCT00995371|62681248|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
33305839|NCT00995371|62681249|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
33305840|NCT01294358|62681257|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
33305841|NCT01294358|62681258|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
33305842|NCT01294358|62681259|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
33305843|NCT01294358|62681260|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
33305844|NCT01294358|62681261|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
33305845|NCT01294358|62681257|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
33305846|NCT01294358|62681258|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
33305847|NCT01294358|62681259|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
33305848|NCT01294358|62681260|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
33305849|NCT01294358|62681261|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
33305850|NCT01294358|62681257|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
33305851|NCT01294358|62681258|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
33305852|NCT01294358|62681259|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
33305853|NCT01294358|62681260|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
33305854|NCT01294358|62681261|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
33305855|NCT01294358|62681257|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
33305856|NCT01294358|62681258|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
33305857|NCT01294358|62681259|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
33305858|NCT01294358|62681260|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
33305859|NCT01294358|62681261|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
33305860|NCT00994279|62681280|FG000|Overall Study|Withdrawal by Subject|2|||
33305861|NCT00994279|62681281|FG001|Overall Study|Withdrawal by Subject|2|||
33305862|NCT00994279|62681280|FG000|Overall Study|Toxicity|1|||
33305863|NCT00994279|62681281|FG001|Overall Study|Toxicity|0|||
33305864|NCT00994279|62681280|FG000|Overall Study|Multiple reasons|1|||
33305865|NCT00994279|62681281|FG001|Overall Study|Multiple reasons|3|||
33305866|NCT01294046|62681287|FG000|Overall Study|Infection and surgical explant|1|||
33305867|NCT01294046|62681287|FG000|Overall Study|Eligibility criteria expanded|1|||
33305868|NCT01294046|62681287|FG000|Overall Study|Stimulation response inadqequate|1|||
33305869|NCT01224639|62681302|FG000|Overall Study|Withdrawal by Subject|0|||
33305870|NCT01224639|62681303|FG001|Overall Study|Withdrawal by Subject|0|||
33305871|NCT01224639|62681304|FG002|Overall Study|Withdrawal by Subject|0|||
33305872|NCT01224639|62681305|FG003|Overall Study|Withdrawal by Subject|0|||
33305873|NCT01224639|62681306|FG004|Overall Study|Withdrawal by Subject|2|||
33305874|NCT01224639|62681307|FG005|Overall Study|Withdrawal by Subject|0|||
33305875|NCT01224639|62681308|FG006|Overall Study|Withdrawal by Subject|1|||
33305876|NCT01224639|62681309|FG007|Overall Study|Withdrawal by Subject|1|||
33305877|NCT01224639|62681302|FG000|Overall Study|Adverse Event|0|||
33305878|NCT01224639|62681303|FG001|Overall Study|Adverse Event|0|||
33305879|NCT01224639|62681304|FG002|Overall Study|Adverse Event|0|||
33305880|NCT01224639|62681305|FG003|Overall Study|Adverse Event|0|||
33305881|NCT01224639|62681306|FG004|Overall Study|Adverse Event|0|||
33305882|NCT01224639|62681307|FG005|Overall Study|Adverse Event|0|||
33305883|NCT01224639|62681308|FG006|Overall Study|Adverse Event|0|||
33305884|NCT01224639|62681309|FG007|Overall Study|Adverse Event|1|||
33305885|NCT01293968|62681329|FG000|Overall Study|non-cooperation|3|||
33305886|NCT01293968|62681330|FG001|Overall Study|non-cooperation|3|||
33305887|NCT01293032|62681340|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
33305888|NCT01293032|62681341|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
33305889|NCT01293032|62681342|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
33305890|NCT01293032|62681343|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
33305891|NCT01293032|62681340|FG000|Treatment|Adverse Event|0|||
33305892|NCT01293032|62681341|FG001|Treatment|Adverse Event|0|||
33305893|NCT01293032|62681342|FG002|Treatment|Adverse Event|1|||
33305894|NCT01293032|62681343|FG003|Treatment|Adverse Event|1|||
33305895|NCT01293032|62681340|FG000|Treatment|Withdrawal by Subject|2|||
33305896|NCT01293032|62681341|FG001|Treatment|Withdrawal by Subject|4|||
33305897|NCT01293032|62681342|FG002|Treatment|Withdrawal by Subject|0|||
33305898|NCT01293032|62681343|FG003|Treatment|Withdrawal by Subject|0|||
33305899|NCT01293032|62681340|FG000|Treatment|Disease Progression, relapse|0|||
33305900|NCT01293032|62681341|FG001|Treatment|Disease Progression, relapse|1|||
33305901|NCT01293032|62681342|FG002|Treatment|Disease Progression, relapse|0|||
33305902|NCT01293032|62681343|FG003|Treatment|Disease Progression, relapse|0|||
33305903|NCT01292876|62681350|FG000|Overall Study|Physician Decision|4|||
33305904|NCT01224171|62681358|FG000|Overall Study|Adverse Event|8|||
33305905|NCT01224171|62681359|FG001|Overall Study|Adverse Event|4|||
33305906|NCT01224171|62681358|FG000|Overall Study|Protocol Violation|0|||
33305907|NCT01224171|62681359|FG001|Overall Study|Protocol Violation|1|||
33305908|NCT01224171|62681358|FG000|Overall Study|Lack of Efficacy|5|||
33305909|NCT01224171|62681359|FG001|Overall Study|Lack of Efficacy|1|||
33305910|NCT01224171|62681358|FG000|Overall Study|Withdrawal of Consent|2|||
33305911|NCT01224171|62681359|FG001|Overall Study|Withdrawal of Consent|4|||
33305912|NCT01224171|62681358|FG000|Overall Study|Lost to Follow-up|0|||
33305913|NCT01224171|62681359|FG001|Overall Study|Lost to Follow-up|3|||
33305914|NCT01292486|62681365|FG000|Overall Study|Protocol Violation|2|||
33305915|NCT01292486|62681365|FG000|Overall Study|Did not meet screening criteria|2|||
33305916|NCT01292486|62681365|FG000|Overall Study|Adverse Event|1|||
33305917|NCT01292486|62681365|FG000|Overall Study|Physician Decision|1|||
33305918|NCT01223937|62681372|FG000|Overall Study|Withdrawal by Subject|3|||
33305919|NCT01223937|62681373|FG001|Overall Study|Withdrawal by Subject|2|||
33305920|NCT01223937|62681372|FG000|Overall Study|Lost to Follow-up|1|||
33305921|NCT01223937|62681373|FG001|Overall Study|Lost to Follow-up|4|||
33305922|NCT01223937|62681372|FG000|Overall Study|Adverse Event|1|||
33305923|NCT01223937|62681373|FG001|Overall Study|Adverse Event|4|||
33305924|NCT01223937|62681372|FG000|Overall Study|Protocol Violation|8|||
33305925|NCT01223937|62681373|FG001|Overall Study|Protocol Violation|7|||
33305926|NCT01223937|62681372|FG000|Overall Study|Other|4|||
33305927|NCT01223937|62681373|FG001|Overall Study|Other|1|||
33305928|NCT01290224|62681379|FG000|Overall Study|Adverse Event|1|||
33305929|NCT01290224|62681379|FG000|Overall Study|Refused Further Treatment|4|||
33305930|NCT01223235|62681385|FG000|Overall Study|Withdrawal by Subject|1|||
33305931|NCT01290068|62681391|FG000|Overall Study|Adverse Event|1|||
33305932|NCT01290068|62681392|FG001|Overall Study|Adverse Event|3|||
33305933|NCT01290068|62681391|FG000|Overall Study|Lost to Follow-up|3|||
33305934|NCT01290068|62681392|FG001|Overall Study|Lost to Follow-up|0|||
33305935|NCT01290068|62681391|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
33305936|NCT01290068|62681392|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
33305937|NCT01290068|62681391|FG000|Overall Study|Other|3|||
33305938|NCT01290068|62681392|FG001|Overall Study|Other|1|||
33305939|NCT00998881|62681400|FG000|Overall Study|Adverse Event|2|||
33305940|NCT00998881|62681401|FG001|Overall Study|Adverse Event|2|||
33305941|NCT00998881|62681400|FG000|Overall Study|Lack of Efficacy|1|||
33305942|NCT00998881|62681401|FG001|Overall Study|Lack of Efficacy|0|||
33305943|NCT00998881|62681400|FG000|Overall Study|Physician Decision|3|||
33305944|NCT00998881|62681401|FG001|Overall Study|Physician Decision|0|||
33305945|NCT00998881|62681400|FG000|Overall Study|Withdrawal by Subject|1|||
33305946|NCT00998881|62681401|FG001|Overall Study|Withdrawal by Subject|0|||
33305947|NCT00998881|62681400|FG000|Overall Study|Personal matter|1|||
33305948|NCT00998881|62681401|FG001|Overall Study|Personal matter|0|||
33305949|NCT01222767|62681407|FG000|Overall Study|Progressive disease|13|||
33305950|NCT01222767|62681407|FG000|Overall Study|Adverse Event|2|||
33305951|NCT01222767|62681407|FG000|Overall Study|Surgical resection|1|||
33305952|NCT01222767|62681407|FG000|Overall Study|Never treated|1|||
33305953|NCT00993967|62681411|FG000|Overall Study|Adverse Event|8|||
33305954|NCT00993967|62681411|FG000|Overall Study|Death|1|||
33305955|NCT00993967|62681411|FG000|Overall Study|Lost to Follow-up|14|||
33305956|NCT00993967|62681411|FG000|Overall Study|Withdrawal by Subject|36|||
33305957|NCT00993967|62681411|FG000|Overall Study|Protocol Violation|2|||
33305958|NCT01222533|62681415|FG000|Overall Study|Adverse Event|5|||
33305959|NCT01222533|62681415|FG000|Overall Study|Withdrawal by Subject|5|||
33305960|NCT01222533|62681415|FG000|Overall Study|Other|4|||
33305961|NCT01221753|62681427|FG000|Overall Study|Adverse Event|1|||
33305962|NCT01221597|62681433|FG000|Overall Study|Adverse Event|4|||
33305963|NCT01221597|62681434|FG001|Overall Study|Adverse Event|1|||
33305964|NCT01221597|62681433|FG000|Overall Study|Withdrawal by Subject|20|||
33305965|NCT01221597|62681434|FG001|Overall Study|Withdrawal by Subject|6|||
33305966|NCT01221597|62681433|FG000|Overall Study|Lost to Follow-up|6|||
33305967|NCT01221597|62681434|FG001|Overall Study|Lost to Follow-up|5|||
33305968|NCT01221597|62681433|FG000|Overall Study|Protocol Violation|1|||
33305969|NCT01221597|62681434|FG001|Overall Study|Protocol Violation|0|||
33305970|NCT01221597|62681433|FG000|Overall Study|Other|3|||
33305971|NCT01221597|62681434|FG001|Overall Study|Other|4|||
33305972|NCT01221597|62681433|FG000|Overall Study|Death|2|||
33305973|NCT01221597|62681434|FG001|Overall Study|Death|0|||
33305974|NCT01221363|62681443|FG000|Overall Study|Pregnancy|1|||
33305975|NCT01221363|62681444|FG001|Overall Study|Pregnancy|0|||
33305976|NCT01221363|62681443|FG000|Overall Study|Withdrawal by Subject|11|||
33305977|NCT01221363|62681444|FG001|Overall Study|Withdrawal by Subject|5|||
33305978|NCT01221285|62681450|FG000|Overall Study|Withdrawal by Subject|1|||
33305979|NCT01014988|62681460|FG000|Overall Study|Adverse Event|20|||
33305980|NCT01014988|62681461|FG001|Overall Study|Adverse Event|0|||
33305981|NCT01014988|62681462|FG002|Overall Study|Adverse Event|1|||
33305982|NCT01014988|62681463|FG003|Overall Study|Adverse Event|0|||
33305983|NCT01014988|62681464|FG004|Overall Study|Adverse Event|1|||
33305984|NCT01014988|62681465|FG005|Overall Study|Adverse Event|3|||
33305985|NCT01014988|62681460|FG000|Overall Study|Lost to Follow-up|1|||
33305986|NCT01014988|62681461|FG001|Overall Study|Lost to Follow-up|0|||
33305987|NCT01014988|62681462|FG002|Overall Study|Lost to Follow-up|1|||
33305988|NCT01014988|62681463|FG003|Overall Study|Lost to Follow-up|0|||
33305989|NCT01014988|62681464|FG004|Overall Study|Lost to Follow-up|0|||
33305990|NCT01014988|62681465|FG005|Overall Study|Lost to Follow-up|0|||
33305991|NCT01014988|62681460|FG000|Overall Study|Physician Decision|1|||
33305992|NCT01014988|62681461|FG001|Overall Study|Physician Decision|0|||
33305993|NCT01014988|62681462|FG002|Overall Study|Physician Decision|0|||
33305994|NCT01014988|62681463|FG003|Overall Study|Physician Decision|0|||
33305995|NCT01014988|62681464|FG004|Overall Study|Physician Decision|0|||
33305996|NCT01014988|62681465|FG005|Overall Study|Physician Decision|0|||
33305997|NCT01014988|62681460|FG000|Overall Study|Withdrawal by Subject|1|||
33305998|NCT01014988|62681461|FG001|Overall Study|Withdrawal by Subject|0|||
33305999|NCT01014988|62681462|FG002|Overall Study|Withdrawal by Subject|0|||
33306000|NCT01014988|62681463|FG003|Overall Study|Withdrawal by Subject|0|||
33306001|NCT01014988|62681464|FG004|Overall Study|Withdrawal by Subject|0|||
33306002|NCT01014988|62681465|FG005|Overall Study|Withdrawal by Subject|0|||
33306003|NCT01014910|62681489|FG000|Overall Study|Withdrawal by Subject|0|||
33306004|NCT01014910|62681490|FG001|Overall Study|Withdrawal by Subject|2|||
33306005|NCT01019980|62681498|FG000|Overall Study|Drug not available.|2|||
33306006|NCT01019980|62681499|FG001|Overall Study|Drug not available.|0|||
33306007|NCT00993499|62681511|FG000|Run-in Period (8 Days)|Adverse Event|0|||
33306008|NCT00993499|62681512|FG001|Run-in Period (8 Days)|Adverse Event|1|||
33306009|NCT00993499|62681513|FG002|Run-in Period (8 Days)|Adverse Event|0|||
33306010|NCT00993499|62681514|FG003|Run-in Period (8 Days)|Adverse Event|0|||
33306011|NCT00993499|62681515|FG004|Run-in Period (8 Days)|Adverse Event|0|||
33306012|NCT00993499|62681516|FG005|Run-in Period (8 Days)|Adverse Event|0|||
33306013|NCT00993499|62681511|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
33306014|NCT00993499|62681512|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
33306015|NCT00993499|62681513|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
33306016|NCT00993499|62681514|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
33306017|NCT00993499|62681515|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
33306018|NCT00993499|62681516|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
33306019|NCT00993499|62681511|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
33306020|NCT00993499|62681512|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
33306021|NCT00993499|62681513|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
33306022|NCT00993499|62681514|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
33306023|NCT00993499|62681515|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
33306024|NCT00993499|62681516|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
33306025|NCT00993499|62681511|FG000|Run-in Period (8 Days)|Progressive disease|0|||
33306026|NCT00993499|62681512|FG001|Run-in Period (8 Days)|Progressive disease|1|||
33306027|NCT00993499|62681513|FG002|Run-in Period (8 Days)|Progressive disease|1|||
33306028|NCT00993499|62681514|FG003|Run-in Period (8 Days)|Progressive disease|0|||
33306029|NCT00993499|62681515|FG004|Run-in Period (8 Days)|Progressive disease|0|||
33306030|NCT00993499|62681516|FG005|Run-in Period (8 Days)|Progressive disease|0|||
33306031|NCT00993499|62681511|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
33306032|NCT00993499|62681512|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
33306033|NCT00993499|62681513|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
33306034|NCT00993499|62681514|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
33306035|NCT00993499|62681515|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
33306036|NCT00993499|62681516|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
33306037|NCT00993499|62681511|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
33306038|NCT00993499|62681512|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
33306039|NCT00993499|62681513|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
33306040|NCT00993499|62681514|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
33306041|NCT00993499|62681515|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
33306042|NCT00993499|62681516|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
33306043|NCT00993499|62681511|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
33306044|NCT00993499|62681512|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
33306045|NCT00993499|62681513|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
33306046|NCT00993499|62681514|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
33306047|NCT00993499|62681515|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
33306048|NCT00993499|62681516|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
33306049|NCT00993499|62681511|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
33306050|NCT00993499|62681512|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
33306051|NCT00993499|62681513|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
33306052|NCT00993499|62681514|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
33306053|NCT00993499|62681515|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
33306054|NCT00993499|62681516|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
33306055|NCT00993499|62681511|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
33306056|NCT00993499|62681512|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
33306057|NCT00993499|62681513|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
33306058|NCT00993499|62681514|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
33306059|NCT00993499|62681515|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
33306060|NCT00993499|62681516|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
33306061|NCT00993499|62681511|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
33306062|NCT00993499|62681512|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
33306063|NCT00993499|62681513|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
33306064|NCT00993499|62681514|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
33306065|NCT00993499|62681515|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
33306066|NCT00993499|62681516|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
33306067|NCT00993499|62681511|FG000|Discontinued After Starting Course 3|DLT|1|||
33306068|NCT00993499|62681512|FG001|Discontinued After Starting Course 3|DLT|0|||
33306069|NCT00993499|62681513|FG002|Discontinued After Starting Course 3|DLT|2|||
33306070|NCT00993499|62681514|FG003|Discontinued After Starting Course 3|DLT|1|||
33306071|NCT00993499|62681515|FG004|Discontinued After Starting Course 3|DLT|0|||
33306072|NCT00993499|62681516|FG005|Discontinued After Starting Course 3|DLT|0|||
33306073|NCT00993499|62681511|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
33306074|NCT00993499|62681512|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
33306075|NCT00993499|62681513|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
33306076|NCT00993499|62681514|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
33306077|NCT00993499|62681515|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
33306078|NCT00993499|62681516|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
33306079|NCT01014442|62681532|FG000|Overall Study|Adverse Event|0|||
33306080|NCT01014442|62681533|FG001|Overall Study|Adverse Event|8|||
33306081|NCT01014442|62681532|FG000|Overall Study|Withdrawal by Subject|4|||
33306082|NCT01014442|62681533|FG001|Overall Study|Withdrawal by Subject|4|||
33306083|NCT01014442|62681532|FG000|Overall Study|Protocol Violation|2|||
33306084|NCT01014442|62681533|FG001|Overall Study|Protocol Violation|5|||
33306085|NCT01014442|62681532|FG000|Overall Study|Lack of Compliance|0|||
33306086|NCT01014442|62681533|FG001|Overall Study|Lack of Compliance|1|||
33306087|NCT01014442|62681532|FG000|Overall Study|Unspecified Reason|1|||
33306088|NCT01014442|62681533|FG001|Overall Study|Unspecified Reason|1|||
33306089|NCT00996307|62681547|FG000|Overall Study|Adverse Event|0|||
33306090|NCT00996307|62681548|FG001|Overall Study|Adverse Event|1|||
33306091|NCT00996307|62681549|FG002|Overall Study|Adverse Event|0|||
33306092|NCT00996307|62681550|FG003|Overall Study|Adverse Event|0|||
33306093|NCT00996307|62681547|FG000|Overall Study|Withdrawal by Subject|3|||
33306094|NCT00996307|62681548|FG001|Overall Study|Withdrawal by Subject|2|||
33306095|NCT00996307|62681549|FG002|Overall Study|Withdrawal by Subject|5|||
33306096|NCT00996307|62681550|FG003|Overall Study|Withdrawal by Subject|5|||
33306097|NCT00996307|62681547|FG000|Overall Study|Lost to Follow-up|13|||
33306098|NCT00996307|62681548|FG001|Overall Study|Lost to Follow-up|13|||
33306099|NCT00996307|62681549|FG002|Overall Study|Lost to Follow-up|7|||
33306100|NCT00996307|62681550|FG003|Overall Study|Lost to Follow-up|15|||
33306101|NCT00996307|62681547|FG000|Overall Study|Administrative reason|0|||
33306102|NCT00996307|62681548|FG001|Overall Study|Administrative reason|1|||
33306103|NCT00996307|62681549|FG002|Overall Study|Administrative reason|0|||
33306104|NCT00996307|62681550|FG003|Overall Study|Administrative reason|0|||
33306105|NCT00996307|62681547|FG000|Overall Study|Unable to classify|4|||
33306106|NCT00996307|62681548|FG001|Overall Study|Unable to classify|0|||
33306107|NCT00996307|62681549|FG002|Overall Study|Unable to classify|2|||
33306108|NCT00996307|62681550|FG003|Overall Study|Unable to classify|1|||
33306109|NCT01219959|62681580|FG000|Overall Study|Adverse Event|6|||
33306110|NCT01219959|62681581|FG001|Overall Study|Adverse Event|14|||
33306111|NCT01219959|62681580|FG000|Overall Study|Physician Decision|0|||
33306112|NCT01219959|62681581|FG001|Overall Study|Physician Decision|4|||
33306113|NCT01219959|62681580|FG000|Overall Study|Withdrawal by Subject|0|||
33306114|NCT01219959|62681581|FG001|Overall Study|Withdrawal by Subject|2|||
33306115|NCT01219959|62681580|FG000|Overall Study|Renal Transplantation|0|||
33306116|NCT01219959|62681581|FG001|Overall Study|Renal Transplantation|3|||
33306117|NCT01219959|62681580|FG000|Overall Study|Other|1|||
33306118|NCT01219959|62681581|FG001|Overall Study|Other|0|||
33306119|NCT00993421|62681594|FG000|Overall Study|Adverse Event|2|||
33306120|NCT00993421|62681595|FG001|Overall Study|Adverse Event|7|||
33306121|NCT00993421|62681596|FG002|Overall Study|Adverse Event|6|||
33306122|NCT00993421|62681597|FG003|Overall Study|Adverse Event|9|||
33306123|NCT00993421|62681598|FG004|Overall Study|Adverse Event|5|||
33306124|NCT00993421|62681599|FG005|Overall Study|Adverse Event|7|||
33306125|NCT00993421|62681600|FG006|Overall Study|Adverse Event|1|||
33306126|NCT00993421|62681594|FG000|Overall Study|Sponsor Decision|36|||
33306127|NCT00993421|62681595|FG001|Overall Study|Sponsor Decision|31|||
33306128|NCT00993421|62681596|FG002|Overall Study|Sponsor Decision|28|||
33306129|NCT00993421|62681597|FG003|Overall Study|Sponsor Decision|30|||
33306130|NCT00993421|62681598|FG004|Overall Study|Sponsor Decision|38|||
33306131|NCT00993421|62681599|FG005|Overall Study|Sponsor Decision|30|||
33306132|NCT00993421|62681600|FG006|Overall Study|Sponsor Decision|29|||
33306133|NCT00993421|62681594|FG000|Overall Study|Lost to Follow-up|3|||
33306134|NCT00993421|62681595|FG001|Overall Study|Lost to Follow-up|5|||
33306135|NCT00993421|62681596|FG002|Overall Study|Lost to Follow-up|5|||
33306136|NCT00993421|62681597|FG003|Overall Study|Lost to Follow-up|0|||
33306137|NCT00993421|62681598|FG004|Overall Study|Lost to Follow-up|0|||
33306138|NCT00993421|62681599|FG005|Overall Study|Lost to Follow-up|0|||
33306139|NCT00993421|62681600|FG006|Overall Study|Lost to Follow-up|6|||
33306140|NCT00993421|62681594|FG000|Overall Study|Withdrawal by Subject|3|||
33306141|NCT00993421|62681595|FG001|Overall Study|Withdrawal by Subject|2|||
33306142|NCT00993421|62681596|FG002|Overall Study|Withdrawal by Subject|3|||
33306143|NCT00993421|62681597|FG003|Overall Study|Withdrawal by Subject|3|||
33306144|NCT00993421|62681598|FG004|Overall Study|Withdrawal by Subject|3|||
33306145|NCT00993421|62681599|FG005|Overall Study|Withdrawal by Subject|5|||
33306146|NCT00993421|62681600|FG006|Overall Study|Withdrawal by Subject|3|||
33306147|NCT00993421|62681594|FG000|Overall Study|Death|0|||
33306148|NCT00993421|62681595|FG001|Overall Study|Death|0|||
33306149|NCT00993421|62681596|FG002|Overall Study|Death|0|||
33306150|NCT00993421|62681597|FG003|Overall Study|Death|0|||
33306151|NCT00993421|62681598|FG004|Overall Study|Death|0|||
33306152|NCT00993421|62681599|FG005|Overall Study|Death|0|||
33306153|NCT00993421|62681600|FG006|Overall Study|Death|1|||
33306154|NCT00993421|62681594|FG000|Overall Study|Entry Criteria Exclusion|0|||
33306155|NCT00993421|62681595|FG001|Overall Study|Entry Criteria Exclusion|0|||
33668286|NCT01586156|63102256|FG001|Overall Study|Pregnancy|1|||
33668287|NCT01586156|63102257|FG002|Overall Study|Pregnancy|0|||
33668288|NCT01459913|63102269|FG000|Overall Study|Adverse Event|0|||
33306156|NCT00993421|62681596|FG002|Overall Study|Entry Criteria Exclusion|1|||
33306157|NCT00993421|62681597|FG003|Overall Study|Entry Criteria Exclusion|3|||
33306158|NCT00993421|62681598|FG004|Overall Study|Entry Criteria Exclusion|0|||
33306159|NCT00993421|62681599|FG005|Overall Study|Entry Criteria Exclusion|1|||
33306160|NCT00993421|62681600|FG006|Overall Study|Entry Criteria Exclusion|0|||
33306161|NCT00993421|62681594|FG000|Overall Study|Physician Decision|0|||
33306162|NCT00993421|62681595|FG001|Overall Study|Physician Decision|0|||
33306163|NCT00993421|62681596|FG002|Overall Study|Physician Decision|0|||
33306164|NCT00993421|62681597|FG003|Overall Study|Physician Decision|0|||
33306165|NCT00993421|62681598|FG004|Overall Study|Physician Decision|0|||
33306166|NCT00993421|62681599|FG005|Overall Study|Physician Decision|1|||
33306167|NCT00993421|62681600|FG006|Overall Study|Physician Decision|1|||
33306168|NCT00993421|62681594|FG000|Overall Study|Protocol Violation|0|||
33306169|NCT00993421|62681595|FG001|Overall Study|Protocol Violation|0|||
33306170|NCT00993421|62681596|FG002|Overall Study|Protocol Violation|0|||
33306171|NCT00993421|62681597|FG003|Overall Study|Protocol Violation|0|||
33306172|NCT00993421|62681598|FG004|Overall Study|Protocol Violation|0|||
33306173|NCT00993421|62681599|FG005|Overall Study|Protocol Violation|2|||
33306174|NCT00993421|62681600|FG006|Overall Study|Protocol Violation|1|||
33306175|NCT01014208|62681618|FG000|Overall Study|Lost to Follow-up|2|||
33306176|NCT01014208|62681619|FG001|Overall Study|Lost to Follow-up|5|||
33306177|NCT01014208|62681618|FG000|Overall Study|Participant Withdrew Consent|12|||
33306178|NCT01014208|62681619|FG001|Overall Study|Participant Withdrew Consent|12|||
33306179|NCT01014208|62681618|FG000|Overall Study|Did Not Receive Study Drug|2|||
33306180|NCT01014208|62681619|FG001|Overall Study|Did Not Receive Study Drug|0|||
33306181|NCT01014208|62681618|FG000|Overall Study|Study Closed/terminated|78|||
33306182|NCT01014208|62681619|FG001|Overall Study|Study Closed/terminated|83|||
33306183|NCT00991939|62681627|FG000|Overall Study|Lost to Follow-up|0|||
33306184|NCT00991939|62681628|FG001|Overall Study|Lost to Follow-up|1|||
33306185|NCT00991939|62681627|FG000|Overall Study|Withdrawal by Subject|1|||
33306186|NCT00991939|62681628|FG001|Overall Study|Withdrawal by Subject|0|||
33306187|NCT00991939|62681627|FG000|Overall Study|Entire study terminated|4|||
33306188|NCT00991939|62681628|FG001|Overall Study|Entire study terminated|1|||
33306189|NCT00993265|62681638|FG000|Overall Study|Adverse Event|1|||
33306190|NCT00993265|62681639|FG001|Overall Study|Adverse Event|0|||
33306191|NCT00993265|62681638|FG000|Overall Study|Changed dose of concomitant drug|2|||
33306192|NCT00993265|62681639|FG001|Overall Study|Changed dose of concomitant drug|0|||
33306193|NCT00993265|62681638|FG000|Overall Study|Non-compliant with study medication|1|||
33306194|NCT00993265|62681639|FG001|Overall Study|Non-compliant with study medication|0|||
33306195|NCT04211389|62681647|FG000|Overall Study|Adverse Event|1|||
33306196|NCT04211389|62681648|FG001|Overall Study|Adverse Event|2|||
33306197|NCT04211389|62681647|FG000|Overall Study|Lost to Follow-up|15|||
33306198|NCT04211389|62681648|FG001|Overall Study|Lost to Follow-up|7|||
33306199|NCT04211389|62681647|FG000|Overall Study|Protocol Violation|0|||
33306200|NCT04211389|62681648|FG001|Overall Study|Protocol Violation|1|||
33306201|NCT04211389|62681647|FG000|Overall Study|Withdrawal by Subject|10|||
33306202|NCT04211389|62681648|FG001|Overall Study|Withdrawal by Subject|11|||
33306203|NCT00993031|62681656|FG000|Overall Study|Death|0|||
33306204|NCT00993031|62681657|FG001|Overall Study|Death|1|||
33306205|NCT00993031|62681656|FG000|Overall Study|Physician Decision|0|||
33306206|NCT00993031|62681657|FG001|Overall Study|Physician Decision|2|||
33306207|NCT00993031|62681656|FG000|Overall Study|Withdrawal by Subject|3|||
33306208|NCT00993031|62681657|FG001|Overall Study|Withdrawal by Subject|3|||
33306209|NCT00993031|62681656|FG000|Overall Study|Lost to Follow-up|19|||
33306210|NCT00993031|62681657|FG001|Overall Study|Lost to Follow-up|13|||
33306211|NCT01010776|62681667|FG000|Main Phase|Withdrawal by Subject|14|||
33306212|NCT01010776|62681667|FG000|Main Phase|Lack of Efficacy|8|||
33306213|NCT01010776|62681667|FG000|Main Phase|Adverse Event|7|||
33306214|NCT01010776|62681667|FG000|Main Phase|Lost to Follow-up|6|||
33306215|NCT01010776|62681667|FG000|Main Phase|Non-compliance to study medication|5|||
33306216|NCT01010776|62681667|FG000|Main Phase|Selection failure|2|||
33306217|NCT01010776|62681667|FG000|Main Phase|Inform consent withdrawal|1|||
33306218|NCT01010776|62681667|FG000|Main Phase|Other|1|||
33306219|NCT01010776|62681667|FG000|Main Phase|Did not received study medication|5|||
33306220|NCT01010776|62681667|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
33306221|NCT01010776|62681667|FG000|Extension Phase|Other|3|||
33306222|NCT01018810|62681687|FG000|Overall Study|Withdrawal by Subject|0|||
33306223|NCT01018810|62681688|FG001|Overall Study|Withdrawal by Subject|1|||
33306224|NCT01018810|62681689|FG002|Overall Study|Withdrawal by Subject|0|||
33306225|NCT01018810|62681690|FG003|Overall Study|Withdrawal by Subject|0|||
33306226|NCT01018810|62681691|FG004|Overall Study|Withdrawal by Subject|0|||
33306227|NCT01018810|62681687|FG000|Overall Study|Sponsor Decision|2|||
33306228|NCT01018810|62681688|FG001|Overall Study|Sponsor Decision|0|||
33306229|NCT01018810|62681689|FG002|Overall Study|Sponsor Decision|1|||
33306230|NCT01018810|62681690|FG003|Overall Study|Sponsor Decision|1|||
33306231|NCT01018810|62681691|FG004|Overall Study|Sponsor Decision|1|||
33306232|NCT01018732|62681706|FG000|Overall Study|Lost to Follow-up|0|||
33306233|NCT01018732|62681707|FG001|Overall Study|Lost to Follow-up|0|||
33306234|NCT01018732|62681708|FG002|Overall Study|Lost to Follow-up|3|||
33306235|NCT01018732|62681706|FG000|Overall Study|Protocol Violation|1|||
33306236|NCT01018732|62681707|FG001|Overall Study|Protocol Violation|1|||
33306237|NCT01018732|62681708|FG002|Overall Study|Protocol Violation|0|||
33306238|NCT01018732|62681706|FG000|Overall Study|Inappropriate Enrollment|0|||
33306239|NCT01018732|62681707|FG001|Overall Study|Inappropriate Enrollment|1|||
33306240|NCT01018732|62681708|FG002|Overall Study|Inappropriate Enrollment|0|||
33306241|NCT01018732|62681706|FG000|Overall Study|Unable to Classify|0|||
33306242|NCT01018732|62681707|FG001|Overall Study|Unable to Classify|0|||
33306243|NCT01018732|62681708|FG002|Overall Study|Unable to Classify|1|||
33306244|NCT01218867|62681727|FG000|Overall Study|Death during treatment|0|||
33306245|NCT01218867|62681728|FG001|Overall Study|Death during treatment|0|||
33306246|NCT01218867|62681729|FG002|Overall Study|Death during treatment|0|||
33306247|NCT01218867|62681730|FG003|Overall Study|Death during treatment|0|||
33306248|NCT01218867|62681731|FG004|Overall Study|Death during treatment|0|||
33306249|NCT01218867|62681732|FG005|Overall Study|Death during treatment|0|||
33306250|NCT01218867|62681733|FG006|Overall Study|Death during treatment|1|||
33306251|NCT01218867|62681734|FG007|Overall Study|Death during treatment|0|||
33306252|NCT01218867|62681735|FG008|Overall Study|Death during treatment|0|||
33306253|NCT01218867|62681736|FG009|Overall Study|Death during treatment|0|||
33306254|NCT01218867|62681737|FG010|Overall Study|Death during treatment|0|||
33306255|NCT01018264|62681774|FG000|Overall Study|Withdrawal by Subject|1|||
33306256|NCT01018264|62681775|FG001|Overall Study|Withdrawal by Subject|0|||
33306257|NCT01018264|62681774|FG000|Overall Study|Lost to Follow-up|0|||
33306258|NCT01018264|62681775|FG001|Overall Study|Lost to Follow-up|1|||
33306259|NCT01018186|62681784|FG000|2-week Run-in Period|Protocol Violation|1|||
33306260|NCT01018186|62681785|FG001|2-week Run-in Period|Protocol Violation|0|||
33306261|NCT01018186|62681786|FG002|2-week Run-in Period|Protocol Violation|0|||
33306262|NCT01018186|62681787|FG003|2-week Run-in Period|Protocol Violation|0|||
33306263|NCT01018186|62681784|FG000|2-week Run-in Period|Lost to Follow-up|2|||
33306264|NCT01018186|62681785|FG001|2-week Run-in Period|Lost to Follow-up|0|||
33306265|NCT01018186|62681786|FG002|2-week Run-in Period|Lost to Follow-up|0|||
33306266|NCT01018186|62681787|FG003|2-week Run-in Period|Lost to Follow-up|0|||
33306267|NCT01018186|62681784|FG000|2-week Run-in Period|Physician Decision|3|||
33306268|NCT01018186|62681785|FG001|2-week Run-in Period|Physician Decision|0|||
33306269|NCT01018186|62681786|FG002|2-week Run-in Period|Physician Decision|0|||
33306270|NCT01018186|62681787|FG003|2-week Run-in Period|Physician Decision|0|||
33306271|NCT01018186|62681784|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
33306272|NCT01018186|62681785|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
33306273|NCT01018186|62681786|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
33306274|NCT01018186|62681787|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
33306275|NCT01018186|62681784|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
33306276|NCT01018186|62681785|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
33306277|NCT01018186|62681786|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
33306278|NCT01018186|62681787|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
33306279|NCT01018186|62681784|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
33306280|NCT01018186|62681785|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
33306281|NCT01018186|62681786|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
33306282|NCT01018186|62681787|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
33306283|NCT01018186|62681784|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
33306284|NCT01018186|62681785|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
33306285|NCT01018186|62681786|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
33306286|NCT01018186|62681787|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
33306287|NCT01018186|62681784|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
33306288|NCT01018186|62681785|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
33306289|NCT01018186|62681786|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
33306290|NCT01018186|62681787|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
33306291|NCT01018186|62681784|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
33306292|NCT01018186|62681785|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
33306293|NCT01018186|62681786|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
33306294|NCT01018186|62681787|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
33306295|NCT01018186|62681784|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
33306296|NCT01018186|62681785|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
33306297|NCT01018186|62681786|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
33306298|NCT01018186|62681787|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
33306299|NCT01018186|62681784|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
33306300|NCT01018186|62681785|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
33306301|NCT01018186|62681786|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
33306302|NCT01018186|62681787|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
33306303|NCT01018186|62681784|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33306304|NCT01018186|62681785|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
33306305|NCT01018186|62681786|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
33306306|NCT01018186|62681787|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
33306307|NCT00987337|62681802|FG000|Overall Study|Adverse Event|10|||
33306308|NCT00987337|62681803|FG001|Overall Study|Adverse Event|9|||
33306309|NCT00987337|62681804|FG002|Overall Study|Adverse Event|8|||
33306310|NCT00987337|62681802|FG000|Overall Study|Insufficient Virologic Response|10|||
33306311|NCT00987337|62681803|FG001|Overall Study|Insufficient Virologic Response|7|||
33306312|NCT00987337|62681804|FG002|Overall Study|Insufficient Virologic Response|12|||
33306313|NCT00987337|62681802|FG000|Overall Study|Virologic Breakthrough|2|||
33306314|NCT00987337|62681803|FG001|Overall Study|Virologic Breakthrough|2|||
33306315|NCT00987337|62681804|FG002|Overall Study|Virologic Breakthrough|8|||
33306316|NCT00987337|62681802|FG000|Overall Study|Lost to Follow-up|10|||
33306317|NCT00987337|62681803|FG001|Overall Study|Lost to Follow-up|6|||
33306318|NCT00987337|62681804|FG002|Overall Study|Lost to Follow-up|2|||
33306319|NCT00987337|62681802|FG000|Overall Study|Withdrawal by Subject|6|||
33306320|NCT00987337|62681803|FG001|Overall Study|Withdrawal by Subject|9|||
33306321|NCT00987337|62681804|FG002|Overall Study|Withdrawal by Subject|9|||
33306322|NCT00987337|62681802|FG000|Overall Study|Other|0|||
33306323|NCT00987337|62681803|FG001|Overall Study|Other|2|||
33306324|NCT00987337|62681804|FG002|Overall Study|Other|5|||
33306325|NCT00987337|62681802|FG000|Overall Study|Protocol Violation|1|||
33306326|NCT00987337|62681803|FG001|Overall Study|Protocol Violation|0|||
33306327|NCT00987337|62681804|FG002|Overall Study|Protocol Violation|2|||
33306328|NCT00987337|62681802|FG000|Overall Study|Participant Relapsed|18|||
33306329|NCT00987337|62681803|FG001|Overall Study|Participant Relapsed|20|||
33306330|NCT00987337|62681804|FG002|Overall Study|Participant Relapsed|5|||
33306331|NCT00992407|62681816|FG000|Overall Study|Protocol Violation|2|||
33306332|NCT00992407|62681817|FG001|Overall Study|Protocol Violation|1|||
33306333|NCT00992407|62681816|FG000|Overall Study|Lost to Follow-up|3|||
33306334|NCT00992407|62681817|FG001|Overall Study|Lost to Follow-up|3|||
33306335|NCT00992407|62681816|FG000|Overall Study|Adverse Event|3|||
33306336|NCT00992407|62681817|FG001|Overall Study|Adverse Event|2|||
33306337|NCT00992407|62681816|FG000|Overall Study|protocol Violation & Adverse events|2|||
33306338|NCT00992407|62681817|FG001|Overall Study|protocol Violation & Adverse events|4|||
33306339|NCT00992407|62681816|FG000|Overall Study|Other|2|||
33306340|NCT00992407|62681817|FG001|Overall Study|Other|0|||
33306341|NCT00992407|62681816|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
33306342|NCT00992407|62681817|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
33306343|NCT00992407|62681816|FG000|Overall Study|Study medication not administered|17|||
33306344|NCT00992407|62681817|FG001|Overall Study|Study medication not administered|13|||
33306345|NCT00986479|62681828|FG000|Period 1|Improved mood|1|||
33306346|NCT00986479|62681829|FG001|Period 1|Improved mood|0|||
33306347|NCT00986479|62681828|FG000|Period 1|Administrative reasons|1|||
33306348|NCT00986479|62681829|FG001|Period 1|Administrative reasons|0|||
33306349|NCT00986245|62681835|FG000|First Intervention|Poor compliance|8|||
33306350|NCT00986245|62681836|FG001|First Intervention|Poor compliance|4|||
33306351|NCT00986245|62681835|FG000|First Intervention|Lack of Efficacy|1|||
33306352|NCT00986245|62681836|FG001|First Intervention|Lack of Efficacy|2|||
33306353|NCT00986245|62681835|FG000|First Intervention|Withdrawal by Subject|0|||
33306354|NCT00986245|62681836|FG001|First Intervention|Withdrawal by Subject|1|||
33306355|NCT00986245|62681835|FG000|First Intervention|Protocol Violation|0|||
33306356|NCT00986245|62681836|FG001|First Intervention|Protocol Violation|1|||
33306357|NCT00986245|62681835|FG000|First Intervention|Out of indication|1|||
33306358|NCT00986245|62681836|FG001|First Intervention|Out of indication|0|||
33668289|NCT01459913|63102270|FG001|Overall Study|Adverse Event|0|||
33668290|NCT01459913|63102271|FG002|Overall Study|Adverse Event|0|||
33668291|NCT01459913|63102272|FG003|Overall Study|Adverse Event|3|||
33668292|NCT01459913|63102269|FG000|Overall Study|Withdrawal by Subject|4|||
33668293|NCT01459913|63102270|FG001|Overall Study|Withdrawal by Subject|0|||
33668294|NCT01459913|63102271|FG002|Overall Study|Withdrawal by Subject|0|||
33668295|NCT01459913|63102272|FG003|Overall Study|Withdrawal by Subject|5|||
33668296|NCT01459913|63102269|FG000|Overall Study|Lost to Follow-up|7|||
33668297|NCT01459913|63102270|FG001|Overall Study|Lost to Follow-up|4|||
33668298|NCT01459913|63102271|FG002|Overall Study|Lost to Follow-up|1|||
33668299|NCT01459913|63102272|FG003|Overall Study|Lost to Follow-up|8|||
33668300|NCT01459913|63102269|FG000|Overall Study|Death|0|||
33668301|NCT01459913|63102270|FG001|Overall Study|Death|0|||
33668302|NCT01459913|63102271|FG002|Overall Study|Death|0|||
33668303|NCT01459913|63102272|FG003|Overall Study|Death|1|||
33668304|NCT01459913|63102269|FG000|Overall Study|Non- Compliance|0|||
33668305|NCT01459913|63102270|FG001|Overall Study|Non- Compliance|0|||
33668306|NCT01459913|63102271|FG002|Overall Study|Non- Compliance|0|||
33306359|NCT00986245|62681835|FG000|Second Intervention|Poor compliance|1|||
33306360|NCT00986245|62681836|FG001|Second Intervention|Poor compliance|0|||
33306361|NCT00986245|62681835|FG000|Second Intervention|Lost to Follow-up|1|||
33306362|NCT00986245|62681836|FG001|Second Intervention|Lost to Follow-up|0|||
33306363|NCT00986245|62681835|FG000|Second Intervention|Protocol Violation|0|||
33306364|NCT00986245|62681836|FG001|Second Intervention|Protocol Violation|1|||
33668307|NCT01459913|63102272|FG003|Overall Study|Non- Compliance|3|||
33668308|NCT01459913|63102269|FG000|Overall Study|Physician Decision|0|||
33668309|NCT01459913|63102270|FG001|Overall Study|Physician Decision|1|||
33306365|NCT00989833|62681850|FG000|Overall Study|Lost to Follow-up|0|||
33668310|NCT01459913|63102271|FG002|Overall Study|Physician Decision|0|||
33668311|NCT01459913|63102272|FG003|Overall Study|Physician Decision|0|||
33668312|NCT01459913|63102269|FG000|Overall Study|Study Terminated by Sponsor|30|||
33668313|NCT01459913|63102270|FG001|Overall Study|Study Terminated by Sponsor|15|||
33668314|NCT01459913|63102271|FG002|Overall Study|Study Terminated by Sponsor|9|||
33668315|NCT01459913|63102272|FG003|Overall Study|Study Terminated by Sponsor|11|||
33668316|NCT01459913|63102269|FG000|Overall Study|Other|0|||
33668317|NCT01459913|63102270|FG001|Overall Study|Other|0|||
33668318|NCT01459913|63102271|FG002|Overall Study|Other|3|||
33668319|NCT01459913|63102272|FG003|Overall Study|Other|1|||
33668320|NCT01459913|63102269|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
33668321|NCT01459913|63102270|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
33668322|NCT01459913|63102271|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
33668323|NCT01459913|63102272|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
33668324|NCT01458587|63102286|FG000|Overall Study|Withdrawal by Subject|1|||
33668325|NCT01458587|63102287|FG001|Overall Study|Withdrawal by Subject|0|||
33668326|NCT01458275|63102298|FG000|Overall Study|Adverse Event|3|||
33668327|NCT01458275|63102299|FG001|Overall Study|Adverse Event|4|||
33668328|NCT01458275|63102300|FG002|Overall Study|Adverse Event|1|||
33668329|NCT01458275|63102298|FG000|Overall Study|Lost to Follow-up|3|||
33668330|NCT01458275|63102299|FG001|Overall Study|Lost to Follow-up|2|||
33668331|NCT01458275|63102300|FG002|Overall Study|Lost to Follow-up|5|||
33668332|NCT01458275|63102298|FG000|Overall Study|Protocol Violation|5|||
33668333|NCT01458275|63102299|FG001|Overall Study|Protocol Violation|5|||
33668334|NCT01458275|63102300|FG002|Overall Study|Protocol Violation|2|||
33668335|NCT01458275|63102298|FG000|Overall Study|Withdrawal by Subject|3|||
33668336|NCT01458275|63102299|FG001|Overall Study|Withdrawal by Subject|2|||
33668337|NCT01458275|63102300|FG002|Overall Study|Withdrawal by Subject|1|||
33668338|NCT01458119|63102310|FG000|Overall Study|Physician Decision|4|||
33668339|NCT01458119|63102310|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
33668340|NCT01458119|63102310|FG000|Overall Study|Pregnancy|1|||
33668341|NCT01458119|63102310|FG000|Overall Study|Death|2|||
33668342|NCT01458119|63102310|FG000|Overall Study|Adverse Event|1|||
33668343|NCT01458119|63102310|FG000|Overall Study|Consent Withdrawn by Participant|8|||
33668344|NCT01458119|63102310|FG000|Overall Study|Non-compliance With Study Drug|3|||
33668345|NCT01688882|63102325|FG000|Overall Study|Adverse Event|1|||
33668346|NCT01688882|63102326|FG001|Overall Study|Adverse Event|0|||
33668347|NCT01688882|63102325|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33668348|NCT01688882|63102326|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33668349|NCT01688882|63102325|FG000|Overall Study|Administrative problems|1|||
33668350|NCT01688882|63102326|FG001|Overall Study|Administrative problems|0|||
33668351|NCT01688726|63102338|FG000|Overall Study|Adverse Event|1|||
33668352|NCT01688726|63102339|FG001|Overall Study|Adverse Event|0|||
33668353|NCT01688726|63102338|FG000|Overall Study|Relocated abroad|0|||
33668354|NCT01688726|63102339|FG001|Overall Study|Relocated abroad|1|||
33668355|NCT01585766|63102355|FG000|Overall Study|Withdrawal by Subject|0|||
33668356|NCT01585766|63102356|FG001|Overall Study|Withdrawal by Subject|1|||
33668357|NCT01585766|63102357|FG002|Overall Study|Withdrawal by Subject|1|||
33668358|NCT01585766|63102358|FG003|Overall Study|Withdrawal by Subject|0|||
33668359|NCT01585766|63102359|FG004|Overall Study|Withdrawal by Subject|0|||
33668360|NCT01585766|63102360|FG005|Overall Study|Withdrawal by Subject|0|||
33668361|NCT01585766|63102355|FG000|Overall Study|Death|0|||
33668362|NCT01585766|63102356|FG001|Overall Study|Death|1|||
33668363|NCT01585766|63102357|FG002|Overall Study|Death|0|||
33306366|NCT00989833|62681851|FG001|Overall Study|Lost to Follow-up|1|||
33306367|NCT00989833|62681852|FG002|Overall Study|Lost to Follow-up|0|||
33306368|NCT00989833|62681850|FG000|Overall Study|Protocol Violation|1|||
33306369|NCT00989833|62681851|FG001|Overall Study|Protocol Violation|2|||
33306370|NCT00989833|62681852|FG002|Overall Study|Protocol Violation|1|||
33306371|NCT00989833|62681850|FG000|Overall Study|Withdrawal by Subject|0|||
33306372|NCT00989833|62681851|FG001|Overall Study|Withdrawal by Subject|0|||
33306373|NCT00989833|62681852|FG002|Overall Study|Withdrawal by Subject|1|||
33306374|NCT00989833|62681850|FG000|Overall Study|Incorrectly randomized|1|||
33306375|NCT00989833|62681851|FG001|Overall Study|Incorrectly randomized|0|||
33306376|NCT00989833|62681852|FG002|Overall Study|Incorrectly randomized|0|||
33306377|NCT01218477|62681864|FG000|Overall Study|Disease progression|2|||
33668364|NCT01585766|63102358|FG003|Overall Study|Death|0|||
33668365|NCT01585766|63102359|FG004|Overall Study|Death|0|||
33668366|NCT01585766|63102360|FG005|Overall Study|Death|0|||
33668367|NCT01585766|63102355|FG000|Overall Study|Physician Decision|0|||
33668368|NCT01585766|63102356|FG001|Overall Study|Physician Decision|0|||
33668369|NCT01585766|63102357|FG002|Overall Study|Physician Decision|1|||
33668370|NCT01585766|63102358|FG003|Overall Study|Physician Decision|0|||
33668371|NCT01585766|63102359|FG004|Overall Study|Physician Decision|0|||
33306378|NCT01218477|62681865|FG001|Overall Study|Disease progression|3|||
33306379|NCT01218477|62681866|FG002|Overall Study|Disease progression|6|||
33306380|NCT01218477|62681867|FG003|Overall Study|Disease progression|2|||
33306381|NCT01218477|62681864|FG000|Overall Study|Study drug toxicity|0|||
33668372|NCT01585766|63102360|FG005|Overall Study|Physician Decision|0|||
33668373|NCT01562444|63102384|FG000|Overall Study|Did not meet entry criteria|2|||
33306382|NCT01218477|62681865|FG001|Overall Study|Study drug toxicity|2|||
33306383|NCT01218477|62681866|FG002|Overall Study|Study drug toxicity|5|||
33306384|NCT01218477|62681867|FG003|Overall Study|Study drug toxicity|0|||
33306385|NCT01218477|62681864|FG000|Overall Study|No longer meets study criteria|1|||
33306386|NCT01218477|62681865|FG001|Overall Study|No longer meets study criteria|0|||
33306387|NCT01218477|62681866|FG002|Overall Study|No longer meets study criteria|0|||
33306388|NCT01218477|62681867|FG003|Overall Study|No longer meets study criteria|0|||
33306389|NCT01218477|62681864|FG000|Overall Study|Withdrawal by Subject|0|||
33306390|NCT01218477|62681865|FG001|Overall Study|Withdrawal by Subject|0|||
33306391|NCT01218477|62681866|FG002|Overall Study|Withdrawal by Subject|1|||
33306392|NCT01218477|62681867|FG003|Overall Study|Withdrawal by Subject|0|||
33306393|NCT01218477|62681864|FG000|Overall Study|Prepared for cell transplantation|0|||
33306394|NCT01218477|62681865|FG001|Overall Study|Prepared for cell transplantation|1|||
33306395|NCT01218477|62681866|FG002|Overall Study|Prepared for cell transplantation|1|||
33306396|NCT01218477|62681867|FG003|Overall Study|Prepared for cell transplantation|0|||
33306397|NCT01218477|62681864|FG000|Overall Study|Administrative reason by sponsor|0|||
33306398|NCT01218477|62681865|FG001|Overall Study|Administrative reason by sponsor|0|||
33306399|NCT01218477|62681866|FG002|Overall Study|Administrative reason by sponsor|1|||
33306400|NCT01218477|62681867|FG003|Overall Study|Administrative reason by sponsor|0|||
33306401|NCT01218477|62681864|FG000|Overall Study|Maximum clinical benefit|0|||
33306402|NCT01218477|62681865|FG001|Overall Study|Maximum clinical benefit|2|||
33306403|NCT01218477|62681866|FG002|Overall Study|Maximum clinical benefit|0|||
33306404|NCT01218477|62681867|FG003|Overall Study|Maximum clinical benefit|0|||
33306405|NCT01218243|62681883|FG000|Overall Study|Lack of Efficacy|1|||
33306406|NCT01218243|62681884|FG001|Overall Study|Lack of Efficacy|1|||
33306407|NCT01218243|62681883|FG000|Overall Study|Lost to Follow-up|3|||
33306408|NCT01218243|62681884|FG001|Overall Study|Lost to Follow-up|3|||
33306409|NCT01218243|62681883|FG000|Overall Study|Protocol Violation|5|||
33306410|NCT01218243|62681884|FG001|Overall Study|Protocol Violation|10|||
33306411|NCT00989287|62681892|FG000|Overall Study|Adverse Event|1|||
33306412|NCT00989287|62681893|FG001|Overall Study|Adverse Event|0|||
33306413|NCT00989287|62681892|FG000|Overall Study|Lost to Follow-up|0|||
33306414|NCT00989287|62681893|FG001|Overall Study|Lost to Follow-up|1|||
33306415|NCT01218087|62681914|FG000|Overall Study|Death|2|||
33306416|NCT01218087|62681915|FG001|Overall Study|Death|1|||
33306417|NCT01218087|62681914|FG000|Overall Study|Withdrawal by Subject|5|||
33306418|NCT01218087|62681915|FG001|Overall Study|Withdrawal by Subject|0|||
33306419|NCT01218087|62681914|FG000|Overall Study|Transferred|8|||
33306420|NCT01218087|62681915|FG001|Overall Study|Transferred|5|||
33306421|NCT01218009|62681923|FG000|Overall Study|Protocol Violation|2|||
33306422|NCT01218009|62681924|FG001|Overall Study|Protocol Violation|1|||
33306423|NCT01218009|62681923|FG000|Overall Study|Withdrawal by Subject|3|||
33306424|NCT01218009|62681924|FG001|Overall Study|Withdrawal by Subject|1|||
33306425|NCT01218009|62681923|FG000|Overall Study|Sponsor terminated study|161|||
33306426|NCT01218009|62681924|FG001|Overall Study|Sponsor terminated study|163|||
33306427|NCT00992017|62681930|FG000|Overall Study|Lost to Follow-up|2|||
33306428|NCT00992017|62681930|FG000|Overall Study|Withdrawal by Subject|2|||
33306429|NCT00992017|62681930|FG000|Overall Study|Unable to get to clinic|5|||
33306430|NCT00992017|62681930|FG000|Overall Study|Not adhere to study requirements|1|||
33306431|NCT01217463|62681941|FG000|Overall Study|Adverse Event|8|||
33306432|NCT01217463|62681942|FG001|Overall Study|Adverse Event|5|||
33306433|NCT01217463|62681941|FG000|Overall Study|Physician Decision|0|||
33306434|NCT01217463|62681942|FG001|Overall Study|Physician Decision|1|||
33306435|NCT01217463|62681941|FG000|Overall Study|Withdrawal by Subject|3|||
33306436|NCT01217463|62681942|FG001|Overall Study|Withdrawal by Subject|0|||
33306437|NCT01217463|62681941|FG000|Overall Study|Surgery on the Target Limb|0|||
33306438|NCT01217463|62681942|FG001|Overall Study|Surgery on the Target Limb|1|||
33306439|NCT01217463|62681941|FG000|Overall Study|Patient Non-compliant|1|||
33306440|NCT01217463|62681942|FG001|Overall Study|Patient Non-compliant|0|||
33306441|NCT01217463|62681941|FG000|Overall Study|Other|1|||
33306442|NCT01217463|62681942|FG001|Overall Study|Other|1|||
33306443|NCT01217307|62681952|FG000|Overall Study|Withdrawal by Subject|0|||
33306444|NCT01217307|62681953|FG001|Overall Study|Withdrawal by Subject|1|||
33306445|NCT01217229|62681959|FG000|Overall Study|Adverse Event|1|||
33306446|NCT01217229|62681959|FG000|Overall Study|Disease progression, deterioration|2|||
33306447|NCT01217229|62681959|FG000|Overall Study|Disease progression, Cheson criteria|14|||
33306448|NCT01217229|62681959|FG000|Overall Study|Protocol Violation|1|||
33306449|NCT01217229|62681959|FG000|Overall Study|Disease progression not confirmed|2|||
33306450|NCT01013740|62681965|FG000|Overall Study|Lost to Follow-up|3|||
33306451|NCT01013740|62681966|FG001|Overall Study|Lost to Follow-up|5|||
33306452|NCT01013740|62681965|FG000|Overall Study|Physician Decision|2|||
33306453|NCT01013740|62681966|FG001|Overall Study|Physician Decision|0|||
33306454|NCT01013740|62681965|FG000|Overall Study|Withdrawal by Subject|2|||
33306455|NCT01013740|62681966|FG001|Overall Study|Withdrawal by Subject|10|||
33306456|NCT01013740|62681965|FG000|Overall Study|study close / terminated : done in error|2|||
33306457|NCT01013740|62681966|FG001|Overall Study|study close / terminated : done in error|1|||
33306458|NCT01013740|62681965|FG000|Overall Study|Missing|2|||
33306459|NCT01013740|62681966|FG001|Overall Study|Missing|1|||
33306460|NCT01013740|62681965|FG000|Overall Study|Ongoing: Study records not completed|0|||
33306461|NCT01013740|62681966|FG001|Overall Study|Ongoing: Study records not completed|2|||
33306462|NCT01013350|62681976|FG000|Overall Study|Lost to Follow-up|15|||
33306463|NCT01013350|62681977|FG001|Overall Study|Lost to Follow-up|95|||
33306464|NCT01013350|62681976|FG000|Overall Study|Adverse Event|0|||
33306465|NCT01013350|62681977|FG001|Overall Study|Adverse Event|1|||
33306466|NCT01013350|62681976|FG000|Overall Study|Physician Decision|4|||
33306467|NCT01013350|62681977|FG001|Overall Study|Physician Decision|20|||
33306468|NCT01013350|62681976|FG000|Overall Study|Withdrawal by Subject|15|||
33306469|NCT01013350|62681977|FG001|Overall Study|Withdrawal by Subject|38|||
33306470|NCT01013350|62681976|FG000|Overall Study|Death|3|||
33306471|NCT01013350|62681977|FG001|Overall Study|Death|5|||
33306472|NCT01013350|62681976|FG000|Overall Study|Participant entered interventional study|0|||
33306473|NCT01013350|62681977|FG001|Overall Study|Participant entered interventional study|8|||
33306474|NCT01013350|62681976|FG000|Overall Study|Other|1|||
33306475|NCT01013350|62681977|FG001|Overall Study|Other|25|||
33306476|NCT01018030|62681987|FG000|Overall Study|Adverse Event|10|||
33306477|NCT01018030|62681988|FG001|Overall Study|Adverse Event|5|||
33306478|NCT01018030|62681989|FG002|Overall Study|Adverse Event|5|||
33306479|NCT01018030|62681987|FG000|Overall Study|Withdrawal by Subject|2|||
33306480|NCT01018030|62681988|FG001|Overall Study|Withdrawal by Subject|2|||
33306481|NCT01018030|62681989|FG002|Overall Study|Withdrawal by Subject|4|||
33306482|NCT01018030|62681987|FG000|Overall Study|Lost to Follow-up|2|||
33306483|NCT01018030|62681988|FG001|Overall Study|Lost to Follow-up|0|||
33306484|NCT01018030|62681989|FG002|Overall Study|Lost to Follow-up|3|||
33306485|NCT01018030|62681987|FG000|Overall Study|Protocol Violation|2|||
33306486|NCT01018030|62681988|FG001|Overall Study|Protocol Violation|1|||
33306487|NCT01018030|62681989|FG002|Overall Study|Protocol Violation|0|||
33306488|NCT01018030|62681987|FG000|Overall Study|Physician Decision|1|||
33306489|NCT01018030|62681988|FG001|Overall Study|Physician Decision|0|||
33306490|NCT01018030|62681989|FG002|Overall Study|Physician Decision|1|||
33306491|NCT01018030|62681987|FG000|Overall Study|Lack of Efficacy|1|||
33306492|NCT01018030|62681988|FG001|Overall Study|Lack of Efficacy|0|||
33306493|NCT01018030|62681989|FG002|Overall Study|Lack of Efficacy|0|||
33306494|NCT01018030|62681987|FG000|Overall Study|Did Not Receive Study Drug|1|||
33306495|NCT01018030|62681988|FG001|Overall Study|Did Not Receive Study Drug|3|||
33306496|NCT01018030|62681989|FG002|Overall Study|Did Not Receive Study Drug|0|||
33306497|NCT01217073|62682005|FG000|Base Period|Adverse Event|1|||
33306498|NCT01217073|62682006|FG001|Base Period|Adverse Event|0|||
33306499|NCT01217073|62682007|FG002|Base Period|Adverse Event|1|||
33306500|NCT01217073|62682008|FG003|Base Period|Adverse Event|0|||
33306501|NCT01217073|62682009|FG004|Base Period|Adverse Event|4|||
33306502|NCT01217073|62682010|FG005|Base Period|Adverse Event|1|||
33306503|NCT01217073|62682011|FG006|Base Period|Adverse Event|0|||
33306504|NCT01217073|62682012|FG007|Base Period|Adverse Event|0|||
33306505|NCT01217073|62682005|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
33306506|NCT01217073|62682006|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
33306507|NCT01217073|62682007|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
33306508|NCT01217073|62682008|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
33306509|NCT01217073|62682009|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
33306510|NCT01217073|62682010|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
33306511|NCT01217073|62682011|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
33306512|NCT01217073|62682012|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
33306513|NCT01217073|62682005|FG000|Base Period|Excluded medication|0|||
33306514|NCT01217073|62682006|FG001|Base Period|Excluded medication|0|||
33306515|NCT01217073|62682007|FG002|Base Period|Excluded medication|0|||
33578413|NCT02673619|62975396|FG003|Overall Study|Lack of Efficacy|0|||
33578414|NCT02680639|62975418|FG000|Screening Period|Screen Failure|7|||
33578415|NCT02680639|62975419|FG001|Screening Period|Screen Failure|0|||
33578416|NCT02680639|62975420|FG002|Screening Period|Screen Failure|0|||
33578417|NCT01674725|62975432|FG000|Overall Study|Adverse Event|1|||
33578418|NCT01674725|62975433|FG001|Overall Study|Adverse Event|0|||
33578419|NCT01674725|62975432|FG000|Overall Study|Did not receive study drug|1|||
33578420|NCT01674725|62975433|FG001|Overall Study|Did not receive study drug|0|||
33578421|NCT01674725|62975432|FG000|Overall Study|Withdrawal by Subject|1|||
33578422|NCT01674725|62975433|FG001|Overall Study|Withdrawal by Subject|0|||
33578423|NCT01674725|62975432|FG000|Overall Study|Lost to Follow-up|0|||
33578424|NCT01674725|62975433|FG001|Overall Study|Lost to Follow-up|1|||
33578425|NCT01674569|62975439|FG000|Overall Study|Adverse Event|0|||
33306516|NCT01217073|62682008|FG003|Base Period|Excluded medication|0|||
33306517|NCT01217073|62682009|FG004|Base Period|Excluded medication|1|||
33306518|NCT01217073|62682010|FG005|Base Period|Excluded medication|0|||
33306519|NCT01217073|62682011|FG006|Base Period|Excluded medication|0|||
33306520|NCT01217073|62682012|FG007|Base Period|Excluded medication|0|||
33306521|NCT01217073|62682005|FG000|Base Period|Lack of Efficacy|0|||
33306522|NCT01217073|62682006|FG001|Base Period|Lack of Efficacy|0|||
33306523|NCT01217073|62682007|FG002|Base Period|Lack of Efficacy|0|||
33306524|NCT01217073|62682008|FG003|Base Period|Lack of Efficacy|0|||
33578426|NCT01674569|62975440|FG001|Overall Study|Adverse Event|2|||
33578427|NCT01674569|62975441|FG002|Overall Study|Adverse Event|0|||
33578428|NCT01674569|62975442|FG003|Overall Study|Adverse Event|1|||
33578429|NCT01674569|62975443|FG004|Overall Study|Adverse Event|2|||
33578430|NCT01674569|62975444|FG005|Overall Study|Adverse Event|2|||
33578431|NCT01674569|62975439|FG000|Overall Study|Protocol Violation|0|||
33578432|NCT01674569|62975440|FG001|Overall Study|Protocol Violation|1|||
33578433|NCT01674569|62975441|FG002|Overall Study|Protocol Violation|1|||
33578434|NCT01674569|62975442|FG003|Overall Study|Protocol Violation|0|||
33578435|NCT01674569|62975443|FG004|Overall Study|Protocol Violation|0|||
33578436|NCT01674569|62975444|FG005|Overall Study|Protocol Violation|0|||
33578437|NCT01674569|62975439|FG000|Overall Study|Withdrawal by Subject|0|||
33578438|NCT01674569|62975440|FG001|Overall Study|Withdrawal by Subject|0|||
33578439|NCT01674569|62975441|FG002|Overall Study|Withdrawal by Subject|1|||
33578440|NCT01674569|62975442|FG003|Overall Study|Withdrawal by Subject|0|||
33578441|NCT01674569|62975443|FG004|Overall Study|Withdrawal by Subject|0|||
33578442|NCT01674569|62975444|FG005|Overall Study|Withdrawal by Subject|0|||
33578443|NCT01374217|62975448|FG000|Overall Study|Lack of Efficacy|13|||
33578444|NCT01674647|62975454|FG000|Treatment Period|Death|4|||
33578445|NCT01674647|62975455|FG001|Treatment Period|Death|1|||
33578446|NCT01674647|62975454|FG000|Treatment Period|Efficacy outcome reached|0|||
33578447|NCT01674647|62975455|FG001|Treatment Period|Efficacy outcome reached|1|||
33578448|NCT01674647|62975454|FG000|Treatment Period|Physician Decision|3|||
33578449|NCT01674647|62975455|FG001|Treatment Period|Physician Decision|1|||
33578450|NCT01674647|62975454|FG000|Treatment Period|Adverse Event|60|||
33578451|NCT01674647|62975455|FG001|Treatment Period|Adverse Event|22|||
33578452|NCT01674647|62975454|FG000|Treatment Period|Non-compliance with study drug|3|||
33578453|NCT01674647|62975455|FG001|Treatment Period|Non-compliance with study drug|0|||
33578454|NCT01674647|62975454|FG000|Treatment Period|Lost to Follow-up|1|||
33668374|NCT01562444|63102385|FG001|Overall Study|Did not meet entry criteria|0|||
33306525|NCT01217073|62682009|FG004|Base Period|Lack of Efficacy|0|||
33306526|NCT01217073|62682010|FG005|Base Period|Lack of Efficacy|1|||
33306527|NCT01217073|62682011|FG006|Base Period|Lack of Efficacy|0|||
33306528|NCT01217073|62682012|FG007|Base Period|Lack of Efficacy|0|||
33306529|NCT01217073|62682005|FG000|Base Period|Lost to Follow-up|0|||
33306530|NCT01217073|62682006|FG001|Base Period|Lost to Follow-up|0|||
33306531|NCT01217073|62682007|FG002|Base Period|Lost to Follow-up|1|||
33306532|NCT01217073|62682008|FG003|Base Period|Lost to Follow-up|1|||
33306533|NCT01217073|62682009|FG004|Base Period|Lost to Follow-up|3|||
33306534|NCT01217073|62682010|FG005|Base Period|Lost to Follow-up|0|||
33306535|NCT01217073|62682011|FG006|Base Period|Lost to Follow-up|0|||
33306536|NCT01217073|62682012|FG007|Base Period|Lost to Follow-up|0|||
33668375|NCT01562444|63102386|FG002|Overall Study|Did not meet entry criteria|3|||
33668376|NCT01562444|63102384|FG000|Overall Study|Did not comply with blood draw schedule|1|||
33668377|NCT01562444|63102385|FG001|Overall Study|Did not comply with blood draw schedule|0|||
33668378|NCT01562444|63102386|FG002|Overall Study|Did not comply with blood draw schedule|1|||
33668379|NCT01562444|63102384|FG000|Overall Study|Unavailable serological results|0|||
33668380|NCT01562444|63102385|FG001|Overall Study|Unavailable serological results|2|||
33668381|NCT01562444|63102386|FG002|Overall Study|Unavailable serological results|2|||
33668382|NCT01562444|63102384|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
33668383|NCT01562444|63102385|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
33668384|NCT01562444|63102386|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
33306537|NCT01217073|62682005|FG000|Base Period|Physician Decision|0|||
33306538|NCT01217073|62682006|FG001|Base Period|Physician Decision|0|||
33306539|NCT01217073|62682007|FG002|Base Period|Physician Decision|0|||
33306540|NCT01217073|62682008|FG003|Base Period|Physician Decision|0|||
33306541|NCT01217073|62682009|FG004|Base Period|Physician Decision|1|||
33306542|NCT01217073|62682010|FG005|Base Period|Physician Decision|0|||
33306543|NCT01217073|62682011|FG006|Base Period|Physician Decision|0|||
33306544|NCT01217073|62682012|FG007|Base Period|Physician Decision|0|||
33306545|NCT01217073|62682005|FG000|Base Period|Protocol Violation|1|||
33306546|NCT01217073|62682006|FG001|Base Period|Protocol Violation|0|||
33306547|NCT01217073|62682007|FG002|Base Period|Protocol Violation|0|||
33306548|NCT01217073|62682008|FG003|Base Period|Protocol Violation|0|||
33306549|NCT01217073|62682009|FG004|Base Period|Protocol Violation|1|||
33306550|NCT01217073|62682010|FG005|Base Period|Protocol Violation|2|||
33306551|NCT01217073|62682011|FG006|Base Period|Protocol Violation|0|||
33306552|NCT01217073|62682012|FG007|Base Period|Protocol Violation|0|||
33306553|NCT01217073|62682005|FG000|Base Period|Withdrawal by Subject|4|||
33306554|NCT01217073|62682006|FG001|Base Period|Withdrawal by Subject|5|||
33306555|NCT01217073|62682007|FG002|Base Period|Withdrawal by Subject|5|||
33306556|NCT01217073|62682008|FG003|Base Period|Withdrawal by Subject|1|||
33306557|NCT01217073|62682009|FG004|Base Period|Withdrawal by Subject|5|||
33306558|NCT01217073|62682010|FG005|Base Period|Withdrawal by Subject|5|||
33578455|NCT01674647|62975455|FG001|Treatment Period|Lost to Follow-up|1|||
33578456|NCT01674647|62975454|FG000|Treatment Period|Withdrawal by Subject|19|||
33578457|NCT01674647|62975455|FG001|Treatment Period|Withdrawal by Subject|16|||
33578458|NCT01674647|62975454|FG000|Treatment Period|Switching to other therapy|5|||
33306559|NCT01217073|62682011|FG006|Base Period|Withdrawal by Subject|0|||
33306560|NCT01217073|62682012|FG007|Base Period|Withdrawal by Subject|0|||
33306561|NCT01217073|62682005|FG000|Extension Period|Adverse Event|0|||
33306562|NCT01217073|62682006|FG001|Extension Period|Adverse Event|0|||
33306563|NCT01217073|62682007|FG002|Extension Period|Adverse Event|0|||
33306564|NCT01217073|62682008|FG003|Extension Period|Adverse Event|0|||
33306565|NCT01217073|62682009|FG004|Extension Period|Adverse Event|0|||
33306566|NCT01217073|62682010|FG005|Extension Period|Adverse Event|0|||
33306567|NCT01217073|62682011|FG006|Extension Period|Adverse Event|19|||
33306568|NCT01217073|62682012|FG007|Extension Period|Adverse Event|5|||
33306569|NCT01217073|62682005|FG000|Extension Period|ALT/AST|0|||
33306570|NCT01217073|62682006|FG001|Extension Period|ALT/AST|0|||
33306571|NCT01217073|62682007|FG002|Extension Period|ALT/AST|0|||
33306572|NCT01217073|62682008|FG003|Extension Period|ALT/AST|0|||
33306573|NCT01217073|62682009|FG004|Extension Period|ALT/AST|0|||
33306574|NCT01217073|62682010|FG005|Extension Period|ALT/AST|0|||
33306575|NCT01217073|62682011|FG006|Extension Period|ALT/AST|2|||
33306576|NCT01217073|62682012|FG007|Extension Period|ALT/AST|0|||
33306577|NCT01217073|62682005|FG000|Extension Period|Contraindication to study medication|0|||
33306578|NCT01217073|62682006|FG001|Extension Period|Contraindication to study medication|0|||
33306579|NCT01217073|62682007|FG002|Extension Period|Contraindication to study medication|0|||
33306580|NCT01217073|62682008|FG003|Extension Period|Contraindication to study medication|0|||
33306581|NCT01217073|62682009|FG004|Extension Period|Contraindication to study medication|0|||
33306582|NCT01217073|62682010|FG005|Extension Period|Contraindication to study medication|0|||
33306583|NCT01217073|62682011|FG006|Extension Period|Contraindication to study medication|1|||
33306584|NCT01217073|62682012|FG007|Extension Period|Contraindication to study medication|0|||
33306585|NCT01217073|62682005|FG000|Extension Period|Creatinine/eGFR|0|||
33306586|NCT01217073|62682006|FG001|Extension Period|Creatinine/eGFR|0|||
33306587|NCT01217073|62682007|FG002|Extension Period|Creatinine/eGFR|0|||
33306588|NCT01217073|62682008|FG003|Extension Period|Creatinine/eGFR|0|||
33306589|NCT01217073|62682009|FG004|Extension Period|Creatinine/eGFR|0|||
33306590|NCT01217073|62682010|FG005|Extension Period|Creatinine/eGFR|0|||
33306591|NCT01217073|62682011|FG006|Extension Period|Creatinine/eGFR|11|||
33306592|NCT01217073|62682012|FG007|Extension Period|Creatinine/eGFR|1|||
33306593|NCT01217073|62682005|FG000|Extension Period|Death|0|||
33306594|NCT01217073|62682006|FG001|Extension Period|Death|0|||
33306595|NCT01217073|62682007|FG002|Extension Period|Death|0|||
33306596|NCT01217073|62682008|FG003|Extension Period|Death|0|||
33306597|NCT01217073|62682009|FG004|Extension Period|Death|0|||
33306598|NCT01217073|62682010|FG005|Extension Period|Death|0|||
33306599|NCT01217073|62682011|FG006|Extension Period|Death|1|||
33306600|NCT01217073|62682012|FG007|Extension Period|Death|0|||
33306601|NCT01217073|62682005|FG000|Extension Period|Excluded medication|0|||
33306602|NCT01217073|62682006|FG001|Extension Period|Excluded medication|0|||
33306603|NCT01217073|62682007|FG002|Extension Period|Excluded medication|0|||
33306604|NCT01217073|62682008|FG003|Extension Period|Excluded medication|0|||
33306605|NCT01217073|62682009|FG004|Extension Period|Excluded medication|0|||
33306606|NCT01217073|62682010|FG005|Extension Period|Excluded medication|0|||
33306607|NCT01217073|62682011|FG006|Extension Period|Excluded medication|2|||
33306608|NCT01217073|62682012|FG007|Extension Period|Excluded medication|0|||
33306609|NCT01217073|62682005|FG000|Extension Period|Lack of Efficacy|0|||
33306610|NCT01217073|62682006|FG001|Extension Period|Lack of Efficacy|0|||
33306611|NCT01217073|62682007|FG002|Extension Period|Lack of Efficacy|0|||
33306612|NCT01217073|62682008|FG003|Extension Period|Lack of Efficacy|0|||
33306613|NCT01217073|62682009|FG004|Extension Period|Lack of Efficacy|0|||
33306614|NCT01217073|62682010|FG005|Extension Period|Lack of Efficacy|0|||
33306615|NCT01217073|62682011|FG006|Extension Period|Lack of Efficacy|3|||
33306616|NCT01217073|62682012|FG007|Extension Period|Lack of Efficacy|0|||
33306617|NCT01217073|62682005|FG000|Extension Period|Lost to Follow-up|0|||
33306618|NCT01217073|62682006|FG001|Extension Period|Lost to Follow-up|0|||
33306619|NCT01217073|62682007|FG002|Extension Period|Lost to Follow-up|0|||
33306620|NCT01217073|62682008|FG003|Extension Period|Lost to Follow-up|0|||
33306621|NCT01217073|62682009|FG004|Extension Period|Lost to Follow-up|0|||
33306622|NCT01217073|62682010|FG005|Extension Period|Lost to Follow-up|0|||
33306623|NCT01217073|62682011|FG006|Extension Period|Lost to Follow-up|9|||
33306624|NCT01217073|62682012|FG007|Extension Period|Lost to Follow-up|1|||
33306625|NCT01217073|62682005|FG000|Extension Period|Non-compliance with study drug|0|||
33306626|NCT01217073|62682006|FG001|Extension Period|Non-compliance with study drug|0|||
33306627|NCT01217073|62682007|FG002|Extension Period|Non-compliance with study drug|0|||
33306628|NCT01217073|62682008|FG003|Extension Period|Non-compliance with study drug|0|||
33306629|NCT01217073|62682009|FG004|Extension Period|Non-compliance with study drug|0|||
33306630|NCT01217073|62682010|FG005|Extension Period|Non-compliance with study drug|0|||
33306631|NCT01217073|62682011|FG006|Extension Period|Non-compliance with study drug|0|||
33306632|NCT01217073|62682012|FG007|Extension Period|Non-compliance with study drug|1|||
33306633|NCT01217073|62682005|FG000|Extension Period|Physician Decision|0|||
33306634|NCT01217073|62682006|FG001|Extension Period|Physician Decision|0|||
33306635|NCT01217073|62682007|FG002|Extension Period|Physician Decision|0|||
33306636|NCT01217073|62682008|FG003|Extension Period|Physician Decision|0|||
33306637|NCT01217073|62682009|FG004|Extension Period|Physician Decision|0|||
33306638|NCT01217073|62682010|FG005|Extension Period|Physician Decision|0|||
33306639|NCT01217073|62682011|FG006|Extension Period|Physician Decision|4|||
33306640|NCT01217073|62682012|FG007|Extension Period|Physician Decision|1|||
33306641|NCT01217073|62682005|FG000|Extension Period|Protocol Violation|0|||
33306642|NCT01217073|62682006|FG001|Extension Period|Protocol Violation|0|||
33306643|NCT01217073|62682007|FG002|Extension Period|Protocol Violation|0|||
33306644|NCT01217073|62682008|FG003|Extension Period|Protocol Violation|0|||
33306645|NCT01217073|62682009|FG004|Extension Period|Protocol Violation|0|||
33306646|NCT01217073|62682010|FG005|Extension Period|Protocol Violation|0|||
33306647|NCT01217073|62682011|FG006|Extension Period|Protocol Violation|2|||
33306648|NCT01217073|62682012|FG007|Extension Period|Protocol Violation|1|||
33306649|NCT01217073|62682005|FG000|Extension Period|Site discontinued study participation|0|||
33306650|NCT01217073|62682006|FG001|Extension Period|Site discontinued study participation|0|||
33306651|NCT01217073|62682007|FG002|Extension Period|Site discontinued study participation|0|||
33306652|NCT01217073|62682008|FG003|Extension Period|Site discontinued study participation|0|||
33306653|NCT01217073|62682009|FG004|Extension Period|Site discontinued study participation|0|||
33306654|NCT01217073|62682010|FG005|Extension Period|Site discontinued study participation|0|||
33306655|NCT01217073|62682011|FG006|Extension Period|Site discontinued study participation|7|||
33306656|NCT01217073|62682012|FG007|Extension Period|Site discontinued study participation|2|||
33306657|NCT01217073|62682005|FG000|Extension Period|Withdrawal by Subject|0|||
33306658|NCT01217073|62682006|FG001|Extension Period|Withdrawal by Subject|0|||
33306659|NCT01217073|62682007|FG002|Extension Period|Withdrawal by Subject|0|||
33398091|NCT02782741|62777485|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2|||
33398092|NCT02782741|62777486|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1|||
33398093|NCT02782741|62777485|FG000|Open-label Long-term: Week 50 to 145|Other|1|||
33398094|NCT02782741|62777486|FG001|Open-label Long-term: Week 50 to 145|Other|0|||
33398095|NCT02782741|62777485|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48|||
33398096|NCT02782741|62777486|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43|||
33398097|NCT02771626|62777502|FG000|Overall Study|Adverse Event|1|||
33398098|NCT02771626|62777503|FG001|Overall Study|Adverse Event|5|||
33398099|NCT02771626|62777504|FG002|Overall Study|Adverse Event|3|||
33398100|NCT02771626|62777505|FG003|Overall Study|Adverse Event|0|||
33398101|NCT02771626|62777506|FG004|Overall Study|Adverse Event|1|||
33398102|NCT02771626|62777507|FG005|Overall Study|Adverse Event|1|||
33398103|NCT02771626|62777502|FG000|Overall Study|Radiologic Disease Progression|6|||
33398104|NCT02771626|62777503|FG001|Overall Study|Radiologic Disease Progression|13|||
33398105|NCT02771626|62777504|FG002|Overall Study|Radiologic Disease Progression|10|||
33398106|NCT02771626|62777505|FG003|Overall Study|Radiologic Disease Progression|7|||
33398107|NCT02771626|62777506|FG004|Overall Study|Radiologic Disease Progression|28|||
33398108|NCT02771626|62777507|FG005|Overall Study|Radiologic Disease Progression|15|||
33398109|NCT02771626|62777502|FG000|Overall Study|Symptomatic Deterioration|0|||
33398110|NCT02771626|62777503|FG001|Overall Study|Symptomatic Deterioration|4|||
33398111|NCT02771626|62777504|FG002|Overall Study|Symptomatic Deterioration|2|||
33398112|NCT02771626|62777505|FG003|Overall Study|Symptomatic Deterioration|0|||
33398113|NCT02771626|62777506|FG004|Overall Study|Symptomatic Deterioration|5|||
33398114|NCT02771626|62777507|FG005|Overall Study|Symptomatic Deterioration|2|||
33398115|NCT02771626|62777502|FG000|Overall Study|Participant Request|0|||
33398116|NCT02771626|62777503|FG001|Overall Study|Participant Request|1|||
33398117|NCT02771626|62777504|FG002|Overall Study|Participant Request|0|||
33398118|NCT02771626|62777505|FG003|Overall Study|Participant Request|2|||
33398119|NCT02771626|62777506|FG004|Overall Study|Participant Request|0|||
33398120|NCT02771626|62777507|FG005|Overall Study|Participant Request|1|||
33398121|NCT02771626|62777502|FG000|Overall Study|Investigator Decision|0|||
33398122|NCT02771626|62777503|FG001|Overall Study|Investigator Decision|1|||
33398123|NCT02771626|62777504|FG002|Overall Study|Investigator Decision|0|||
33398124|NCT02771626|62777505|FG003|Overall Study|Investigator Decision|0|||
33398125|NCT02771626|62777506|FG004|Overall Study|Investigator Decision|1|||
33398126|NCT02771626|62777507|FG005|Overall Study|Investigator Decision|0|||
33398127|NCT02771626|62777502|FG000|Overall Study|Study Termination by Sponsor|0|||
33398128|NCT02771626|62777503|FG001|Overall Study|Study Termination by Sponsor|2|||
33398129|NCT02771626|62777504|FG002|Overall Study|Study Termination by Sponsor|1|||
33398130|NCT02771626|62777505|FG003|Overall Study|Study Termination by Sponsor|0|||
33306660|NCT01217073|62682008|FG003|Extension Period|Withdrawal by Subject|0|||
33398131|NCT02771626|62777506|FG004|Overall Study|Study Termination by Sponsor|1|||
33306661|NCT01217073|62682009|FG004|Extension Period|Withdrawal by Subject|0|||
33306662|NCT01217073|62682010|FG005|Extension Period|Withdrawal by Subject|0|||
33306663|NCT01217073|62682011|FG006|Extension Period|Withdrawal by Subject|30|||
33306664|NCT01217073|62682012|FG007|Extension Period|Withdrawal by Subject|8|||
33306665|NCT00985621|62682040|FG000|Overall Study|Adverse Event|2|||
33306666|NCT00985621|62682041|FG001|Overall Study|Adverse Event|3|||
33306667|NCT00985621|62682042|FG002|Overall Study|Adverse Event|4|||
33398132|NCT02771626|62777507|FG005|Overall Study|Study Termination by Sponsor|0|||
33398133|NCT02771626|62777502|FG000|Overall Study|Informed Consent Withdrawn|0|||
33398134|NCT02771626|62777503|FG001|Overall Study|Informed Consent Withdrawn|0|||
33398135|NCT02771626|62777504|FG002|Overall Study|Informed Consent Withdrawn|1|||
33398136|NCT02771626|62777505|FG003|Overall Study|Informed Consent Withdrawn|0|||
33398137|NCT02771626|62777506|FG004|Overall Study|Informed Consent Withdrawn|1|||
33398138|NCT02771626|62777507|FG005|Overall Study|Informed Consent Withdrawn|1|||
33398139|NCT02771626|62777502|FG000|Overall Study|Other, Not Specified|1|||
33398140|NCT02771626|62777503|FG001|Overall Study|Other, Not Specified|0|||
33398141|NCT02771626|62777504|FG002|Overall Study|Other, Not Specified|0|||
33398142|NCT02771626|62777505|FG003|Overall Study|Other, Not Specified|0|||
33398143|NCT02771626|62777506|FG004|Overall Study|Other, Not Specified|0|||
33398144|NCT02771626|62777507|FG005|Overall Study|Other, Not Specified|1|||
33398145|NCT02272790|62777527|FG000|Overall Study|Physician Decision|0|||
33398146|NCT02272790|62777528|FG001|Overall Study|Physician Decision|1|||
33398147|NCT02272790|62777529|FG002|Overall Study|Physician Decision|0|||
33398148|NCT02272790|62777530|FG003|Overall Study|Physician Decision|0|||
33398149|NCT02272790|62777531|FG004|Overall Study|Physician Decision|0|||
33398150|NCT02272790|62777532|FG005|Overall Study|Physician Decision|0|||
33398151|NCT01464164|62777559|FG000|Overall Study|Screen failure|0|||
33398152|NCT01464164|62777560|FG001|Overall Study|Screen failure|1|||
33398153|NCT01464164|62777561|FG002|Overall Study|Screen failure|2|||
33398154|NCT01464164|62777562|FG003|Overall Study|Screen failure|0|||
33398155|NCT01464164|62777563|FG004|Overall Study|Screen failure|0|||
33398156|NCT01464164|62777564|FG005|Overall Study|Screen failure|0|||
33398157|NCT01464164|62777565|FG006|Overall Study|Screen failure|0|||
33398158|NCT01464164|62777559|FG000|Overall Study|Physician Decision|0|||
33398159|NCT01464164|62777560|FG001|Overall Study|Physician Decision|1|||
33398160|NCT01464164|62777561|FG002|Overall Study|Physician Decision|0|||
33398161|NCT01464164|62777562|FG003|Overall Study|Physician Decision|0|||
33398162|NCT01464164|62777563|FG004|Overall Study|Physician Decision|0|||
33398163|NCT01464164|62777564|FG005|Overall Study|Physician Decision|0|||
33398164|NCT01464164|62777565|FG006|Overall Study|Physician Decision|2|||
33398173|NCT00568776|62777620|FG000|Overall Study|Adverse Event|8|||
33398174|NCT00568776|62777621|FG001|Overall Study|Adverse Event|8|||
33398175|NCT00568776|62777622|FG002|Overall Study|Adverse Event|10|||
33398176|NCT00568776|62777623|FG003|Overall Study|Adverse Event|8|||
33398177|NCT00568776|62777620|FG000|Overall Study|Death|0|||
33398178|NCT00568776|62777621|FG001|Overall Study|Death|1|||
33398179|NCT00568776|62777622|FG002|Overall Study|Death|4|||
33398180|NCT00568776|62777623|FG003|Overall Study|Death|3|||
33398181|NCT00568776|62777620|FG000|Overall Study|Physician Decision|0|||
33398182|NCT00568776|62777621|FG001|Overall Study|Physician Decision|2|||
33398183|NCT00568776|62777622|FG002|Overall Study|Physician Decision|0|||
33398184|NCT00568776|62777623|FG003|Overall Study|Physician Decision|0|||
33398185|NCT00568776|62777620|FG000|Overall Study|Lack of Efficacy|2|||
33398186|NCT00568776|62777621|FG001|Overall Study|Lack of Efficacy|2|||
33398187|NCT00568776|62777622|FG002|Overall Study|Lack of Efficacy|2|||
33398188|NCT00568776|62777623|FG003|Overall Study|Lack of Efficacy|4|||
33398189|NCT00568776|62777620|FG000|Overall Study|Lost to Follow-up|1|||
33398190|NCT00568776|62777621|FG001|Overall Study|Lost to Follow-up|1|||
33398191|NCT00568776|62777622|FG002|Overall Study|Lost to Follow-up|1|||
33398192|NCT00568776|62777623|FG003|Overall Study|Lost to Follow-up|1|||
33398193|NCT00568776|62777620|FG000|Overall Study|Protocol Violation|1|||
33398194|NCT00568776|62777621|FG001|Overall Study|Protocol Violation|0|||
33398195|NCT00568776|62777622|FG002|Overall Study|Protocol Violation|1|||
33398196|NCT00568776|62777623|FG003|Overall Study|Protocol Violation|1|||
33398197|NCT00568776|62777620|FG000|Overall Study|Withdrawal by Subject|13|||
33398198|NCT00568776|62777621|FG001|Overall Study|Withdrawal by Subject|15|||
33398199|NCT00568776|62777622|FG002|Overall Study|Withdrawal by Subject|13|||
33398200|NCT00568776|62777623|FG003|Overall Study|Withdrawal by Subject|7|||
33398201|NCT00568776|62777620|FG000|Overall Study|Loss of Caregiver|0|||
33398202|NCT00568776|62777621|FG001|Overall Study|Loss of Caregiver|2|||
33398203|NCT00568776|62777622|FG002|Overall Study|Loss of Caregiver|1|||
33398204|NCT00568776|62777623|FG003|Overall Study|Loss of Caregiver|2|||
33398205|NCT00568776|62777620|FG000|Overall Study|Sponsor Decision|2|||
33398206|NCT00568776|62777621|FG001|Overall Study|Sponsor Decision|2|||
33398207|NCT00568776|62777622|FG002|Overall Study|Sponsor Decision|41|||
33398208|NCT00568776|62777623|FG003|Overall Study|Sponsor Decision|42|||
33398209|NCT00568776|62777620|FG000|Overall Study|Miscellaeneous|3|||
33398210|NCT00568776|62777621|FG001|Overall Study|Miscellaeneous|3|||
33398211|NCT00568776|62777622|FG002|Overall Study|Miscellaeneous|1|||
33398212|NCT00568776|62777623|FG003|Overall Study|Miscellaeneous|4|||
33398213|NCT00758771|62777635|FG000|Overall Study|Withdrawal by Subject|1|||
33398214|NCT00758771|62777636|FG001|Overall Study|Withdrawal by Subject|1|||
33398215|NCT00758771|62777635|FG000|Overall Study|Did not meet eligibility criteria|2|||
33398216|NCT00758771|62777636|FG001|Overall Study|Did not meet eligibility criteria|4|||
33398217|NCT00635154|62777642|FG000|Overall Study|Alternative Treatment|8|||
33398218|NCT00635154|62777642|FG000|Overall Study|Other|4|||
33398219|NCT00635154|62777642|FG000|Overall Study|Still on treatment|21|||
33398220|NCT00778895|62777651|FG000|Active Phase|Adverse Event|3|||
33398221|NCT00778895|62777652|FG001|Active Phase|Adverse Event|1|||
33398222|NCT00778895|62777653|FG002|Active Phase|Adverse Event|0|||
33398223|NCT00778895|62777651|FG000|Active Phase|Withdrawal by Subject|1|||
33398224|NCT00778895|62777652|FG001|Active Phase|Withdrawal by Subject|4|||
33398225|NCT00778895|62777653|FG002|Active Phase|Withdrawal by Subject|0|||
33398226|NCT00778895|62777651|FG000|Active Phase|Lost to Follow-up|1|||
33398227|NCT00778895|62777652|FG001|Active Phase|Lost to Follow-up|1|||
33398228|NCT00778895|62777653|FG002|Active Phase|Lost to Follow-up|0|||
33398229|NCT00778895|62777651|FG000|Active Phase|Other|2|||
33398230|NCT00778895|62777652|FG001|Active Phase|Other|0|||
33398231|NCT00778895|62777653|FG002|Active Phase|Other|0|||
33398232|NCT00778895|62777651|FG000|ESFU Phase|Adverse Event|2|||
33398233|NCT00778895|62777652|FG001|ESFU Phase|Adverse Event|1|||
33398234|NCT00778895|62777653|FG002|ESFU Phase|Adverse Event|0|||
33398235|NCT00778895|62777651|FG000|ESFU Phase|Withdrawal by Subject|1|||
33398236|NCT00778895|62777652|FG001|ESFU Phase|Withdrawal by Subject|4|||
33398237|NCT00778895|62777653|FG002|ESFU Phase|Withdrawal by Subject|0|||
33398238|NCT00778895|62777651|FG000|ESFU Phase|Lost to Follow-up|6|||
33398239|NCT00778895|62777652|FG001|ESFU Phase|Lost to Follow-up|7|||
33398240|NCT00778895|62777653|FG002|ESFU Phase|Lost to Follow-up|2|||
33398241|NCT00778895|62777651|FG000|ESFU Phase|Other|2|||
33398242|NCT00778895|62777652|FG001|ESFU Phase|Other|0|||
33398243|NCT00778895|62777653|FG002|ESFU Phase|Other|0|||
33398244|NCT00293215|62777664|FG000|Overall Study|Progressive disease|3|||
33398245|NCT00293215|62777665|FG001|Overall Study|Progressive disease|1|||
33398246|NCT00293215|62777664|FG000|Overall Study|Adverse Event|2|||
33398247|NCT00293215|62777665|FG001|Overall Study|Adverse Event|2|||
33398248|NCT00778817|62777671|FG000|Overall Study|Adverse Event|2|||
33398249|NCT00778817|62777671|FG000|Overall Study|Withdrawal by Subject|2|||
33398250|NCT00293059|62777677|FG000|Overall Study|Adverse Event|12|||
33398251|NCT00293059|62777678|FG001|Overall Study|Adverse Event|4|||
33398252|NCT00293059|62777677|FG000|Overall Study|Lack of Efficacy|2|||
33398253|NCT00293059|62777678|FG001|Overall Study|Lack of Efficacy|0|||
33398254|NCT00293059|62777677|FG000|Overall Study|Lost to Follow-up|2|||
33398255|NCT00293059|62777678|FG001|Overall Study|Lost to Follow-up|3|||
33398256|NCT00293059|62777677|FG000|Overall Study|Pregnancy|1|||
33398257|NCT00293059|62777678|FG001|Overall Study|Pregnancy|1|||
33398258|NCT00293059|62777677|FG000|Overall Study|Protocol Violation|2|||
33398259|NCT00293059|62777678|FG001|Overall Study|Protocol Violation|0|||
33398260|NCT00293059|62777677|FG000|Overall Study|Withdrawal by Subject|11|||
33398261|NCT00293059|62777678|FG001|Overall Study|Withdrawal by Subject|5|||
33398262|NCT00293059|62777677|FG000|Overall Study|Participant moved out of state|1|||
33398263|NCT00293059|62777678|FG001|Overall Study|Participant moved out of state|0|||
33398264|NCT00293059|62777677|FG000|Overall Study|Participant stopped study drug|1|||
33398265|NCT00293059|62777678|FG001|Overall Study|Participant stopped study drug|0|||
33398266|NCT00293059|62777677|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
33398267|NCT00293059|62777678|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
33398268|NCT00293059|62777677|FG000|Overall Study|missing|3|||
33398269|NCT00293059|62777678|FG001|Overall Study|missing|5|||
33398270|NCT00756275|62777686|FG000|Overall Study|Lost to Follow-up|25|||
33398271|NCT00756275|62777687|FG001|Overall Study|Lost to Follow-up|21|||
33398272|NCT00756275|62777686|FG000|Overall Study|Withdrawal by Subject|4|||
33398273|NCT00756275|62777687|FG001|Overall Study|Withdrawal by Subject|7|||
33398274|NCT00758459|62777695|FG000|Overall Study|Adverse Event|3|||
33398275|NCT00758459|62777696|FG001|Overall Study|Adverse Event|2|||
33398276|NCT00758459|62777695|FG000|Overall Study|Protocol Violation|0|||
33398277|NCT00758459|62777696|FG001|Overall Study|Protocol Violation|1|||
33398278|NCT00758459|62777695|FG000|Overall Study|Withdrawal by Subject|0|||
33398279|NCT00758459|62777696|FG001|Overall Study|Withdrawal by Subject|1|||
33398280|NCT00298831|62777702|FG000|Overall Study|Adverse Event|1|||
33398281|NCT00298831|62777702|FG000|Overall Study|Lost to Follow-up|3|||
33398282|NCT00298831|62777702|FG000|Overall Study|Withdrawal by Subject|1|||
33398283|NCT00298831|62777702|FG000|Overall Study|Participants did not receive treatment|27|||
33398284|NCT00758069|62777709|FG000|Overall Study|Lack of Efficacy|0|||
33398285|NCT00758069|62777710|FG001|Overall Study|Lack of Efficacy|0|||
33398286|NCT00758069|62777711|FG002|Overall Study|Lack of Efficacy|1|||
33398287|NCT00758069|62777709|FG000|Overall Study|Incorrect Study Drug|1|||
33398288|NCT00758069|62777710|FG001|Overall Study|Incorrect Study Drug|0|||
33398289|NCT00758069|62777711|FG002|Overall Study|Incorrect Study Drug|0|||
33398290|NCT00311623|62777722|FG000|Overall Study|Physician Decision|0|||
33398291|NCT00311623|62777723|FG001|Overall Study|Physician Decision|0|||
33398292|NCT00311623|62777724|FG002|Overall Study|Physician Decision|2|||
33398293|NCT00528112|62777735|FG000|Treatment up to 3 Years|Adverse Event|313|||
33398294|NCT00528112|62777736|FG001|Treatment up to 3 Years|Adverse Event|278|||
33398295|NCT00528112|62777735|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
33398296|NCT00528112|62777736|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
33398297|NCT00528112|62777735|FG000|Treatment up to 3 Years|Protocol Violation|16|||
33398298|NCT00528112|62777736|FG001|Treatment up to 3 Years|Protocol Violation|16|||
33398299|NCT00528112|62777735|FG000|Treatment up to 3 Years|Death|0|||
33398300|NCT00528112|62777736|FG001|Treatment up to 3 Years|Death|1|||
33398301|NCT00528112|62777735|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
33398302|NCT00528112|62777736|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
33398303|NCT00528112|62777735|FG000|Treatment up to 3 Years|Pregnancy|9|||
33398304|NCT00528112|62777736|FG001|Treatment up to 3 Years|Pregnancy|10|||
33398305|NCT00528112|62777735|FG000|Treatment up to 3 Years|Other reasons|186|||
33398306|NCT00528112|62777736|FG001|Treatment up to 3 Years|Other reasons|186|||
33398307|NCT00528112|62777735|FG000|Extension Phase|Withdrawal by Subject|0|||
33398308|NCT00528112|62777736|FG001|Extension Phase|Withdrawal by Subject|3|||
33398309|NCT00528112|62777735|FG000|Extension Phase|Other reasons|0|||
33398310|NCT00528112|62777736|FG001|Extension Phase|Other reasons|100|||
33398311|NCT00528112|62777735|FG000|Extension Phase|Pregnancy|0|||
33398312|NCT00528112|62777736|FG001|Extension Phase|Pregnancy|3|||
33398313|NCT00528112|62777735|FG000|Extension Phase|Lost to Follow-up|0|||
33398314|NCT00528112|62777736|FG001|Extension Phase|Lost to Follow-up|12|||
33398315|NCT00528112|62777735|FG000|Extension Phase|Death|0|||
33398316|NCT00528112|62777736|FG001|Extension Phase|Death|1|||
33398317|NCT00528112|62777735|FG000|Extension Phase|Adverse Event|0|||
33398318|NCT00528112|62777736|FG001|Extension Phase|Adverse Event|36|||
33398319|NCT00528112|62777735|FG000|Extension Phase|Protocol Violation|0|||
33398320|NCT00528112|62777736|FG001|Extension Phase|Protocol Violation|2|||
33398321|NCT00633594|62777747|FG000|Overall Study|Adverse Event|0|||
33398322|NCT00633594|62777748|FG001|Overall Study|Adverse Event|4|||
33398323|NCT00633594|62777749|FG002|Overall Study|Adverse Event|7|||
33398324|NCT00633594|62777747|FG000|Overall Study|Death|0|||
33398325|NCT00633594|62777748|FG001|Overall Study|Death|1|||
33398326|NCT00633594|62777749|FG002|Overall Study|Death|2|||
33398327|NCT00633594|62777747|FG000|Overall Study|Disease Progression|0|||
33398328|NCT00633594|62777748|FG001|Overall Study|Disease Progression|0|||
33398329|NCT00633594|62777749|FG002|Overall Study|Disease Progression|1|||
33398330|NCT00755807|62777762|FG000|Acute Phase|Adverse Event|16|||
33398331|NCT00755807|62777763|FG001|Acute Phase|Adverse Event|5|||
33398332|NCT00755807|62777762|FG000|Acute Phase|Protocol Violation|1|||
33398333|NCT00755807|62777763|FG001|Acute Phase|Protocol Violation|3|||
33398334|NCT00755807|62777762|FG000|Acute Phase|Withdrawal by Subject|1|||
33398335|NCT00755807|62777763|FG001|Acute Phase|Withdrawal by Subject|2|||
33398336|NCT00755807|62777762|FG000|Acute Phase|Lack of Efficacy|0|||
33398337|NCT00755807|62777763|FG001|Acute Phase|Lack of Efficacy|1|||
33398338|NCT00755807|62777762|FG000|Acute Phase|Physician Decision|0|||
33398339|NCT00755807|62777763|FG001|Acute Phase|Physician Decision|1|||
33398340|NCT00755807|62777762|FG000|Open-label Extension Phase|Adverse Event|7|||
33398341|NCT00755807|62777763|FG001|Open-label Extension Phase|Adverse Event|7|||
33398342|NCT00755807|62777762|FG000|Open-label Extension Phase|Protocol Violation|5|||
33398343|NCT00755807|62777763|FG001|Open-label Extension Phase|Protocol Violation|2|||
33398344|NCT00755807|62777762|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
33398345|NCT00755807|62777763|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
33398346|NCT00755807|62777762|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
33398347|NCT00755807|62777763|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
33398348|NCT00755807|62777762|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
33398349|NCT00755807|62777763|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
33398350|NCT00755807|62777762|FG000|Open-label Extension Phase|Sponsor Decision|0|||
33398351|NCT00755807|62777763|FG001|Open-label Extension Phase|Sponsor Decision|1|||
33398352|NCT00631410|62777775|FG000|Overall Study|Adverse Event|1|||
33398353|NCT00631410|62777776|FG001|Overall Study|Adverse Event|3|||
33398354|NCT00631410|62777775|FG000|Overall Study|Objective Progression or Relapse|4|||
33398355|NCT00631410|62777776|FG001|Overall Study|Objective Progression or Relapse|3|||
33398356|NCT00631410|62777775|FG000|Overall Study|Surgery|1|||
33398357|NCT00631410|62777776|FG001|Overall Study|Surgery|0|||
33398358|NCT03686176|62777788|FG000|Overall Study|Procedure cancelled|1|||
33398359|NCT03686176|62777789|FG001|Overall Study|Procedure cancelled|0|||
33398360|NCT03686176|62777790|FG002|Overall Study|Procedure cancelled|0|||
33398361|NCT03686176|62777788|FG000|Overall Study|VR Malfunction|1|||
33398362|NCT03686176|62777789|FG001|Overall Study|VR Malfunction|0|||
33398363|NCT03686176|62777790|FG002|Overall Study|VR Malfunction|0|||
33398364|NCT00755417|62777801|FG000|Overall Study|Adverse Event|28|||
33398365|NCT00755417|62777802|FG001|Overall Study|Adverse Event|20|||
33398366|NCT00755417|62777803|FG002|Overall Study|Adverse Event|7|||
33398367|NCT00755417|62777801|FG000|Overall Study|Lack of Efficacy|8|||
33398368|NCT00755417|62777802|FG001|Overall Study|Lack of Efficacy|4|||
33398369|NCT00755417|62777803|FG002|Overall Study|Lack of Efficacy|9|||
33398370|NCT00755417|62777801|FG000|Overall Study|Protocol Violation|2|||
33398371|NCT00755417|62777802|FG001|Overall Study|Protocol Violation|1|||
33398372|NCT00755417|62777803|FG002|Overall Study|Protocol Violation|1|||
33398373|NCT00755417|62777801|FG000|Overall Study|Lost to Follow-up|3|||
33398374|NCT00755417|62777802|FG001|Overall Study|Lost to Follow-up|0|||
33398375|NCT00755417|62777803|FG002|Overall Study|Lost to Follow-up|1|||
33398376|NCT00755417|62777801|FG000|Overall Study|Withdrawal by Subject|12|||
33398377|NCT00755417|62777802|FG001|Overall Study|Withdrawal by Subject|12|||
33398378|NCT00755417|62777803|FG002|Overall Study|Withdrawal by Subject|12|||
33398379|NCT00755417|62777801|FG000|Overall Study|Not specified or missing data|9|||
33398380|NCT00755417|62777802|FG001|Overall Study|Not specified or missing data|18|||
33398381|NCT00755417|62777803|FG002|Overall Study|Not specified or missing data|12|||
33398382|NCT03685708|62777814|FG000|Overall Study|Withdrawal by Subject|0|||
33398383|NCT03685708|62777815|FG001|Overall Study|Withdrawal by Subject|0|||
33398384|NCT03685708|62777816|FG002|Overall Study|Withdrawal by Subject|1|||
33398385|NCT03685708|62777814|FG000|Overall Study|Screen Fail|0|||
33398386|NCT03685708|62777815|FG001|Overall Study|Screen Fail|1|||
33398387|NCT03685708|62777816|FG002|Overall Study|Screen Fail|1|||
33398388|NCT03685708|62777814|FG000|Overall Study|COVID 19 Pandemic|1|||
33398389|NCT03685708|62777815|FG001|Overall Study|COVID 19 Pandemic|1|||
33398390|NCT03685708|62777816|FG002|Overall Study|COVID 19 Pandemic|6|||
33398391|NCT03685708|62777814|FG000|Overall Study|Disease Progression|0|||
33398392|NCT03685708|62777815|FG001|Overall Study|Disease Progression|0|||
33398393|NCT03685708|62777816|FG002|Overall Study|Disease Progression|1|||
33398394|NCT03684928|62777824|FG000|First Intervention|Lost to Follow-up|0|||
33398395|NCT03684928|62777825|FG001|First Intervention|Lost to Follow-up|1|||
33398396|NCT03684928|62777824|FG000|First Intervention|Withdrawal by Subject|0|||
33398397|NCT03684928|62777825|FG001|First Intervention|Withdrawal by Subject|2|||
33398398|NCT03684928|62777824|FG000|Second Intervention|Soft Tissue Injury|1|||
33398399|NCT03684928|62777825|FG001|Second Intervention|Soft Tissue Injury|0|||
33398400|NCT00777803|62777833|FG000|Overall Study|Lost to Follow-up|12|||
33398401|NCT00777803|62777834|FG001|Overall Study|Lost to Follow-up|5|||
33398402|NCT00777803|62777833|FG000|Overall Study|Adverse Event|1|||
33398403|NCT00777803|62777834|FG001|Overall Study|Adverse Event|0|||
33398404|NCT00777803|62777833|FG000|Overall Study|Non-compliance|2|||
33398405|NCT00777803|62777834|FG001|Overall Study|Non-compliance|2|||
33398406|NCT00527488|62777844|FG000|Overall Study|Withdrawn prior to dosing|0|||
33398407|NCT00527488|62777845|FG001|Overall Study|Withdrawn prior to dosing|1|||
33398408|NCT00527488|62777846|FG002|Overall Study|Withdrawn prior to dosing|1|||
33398409|NCT00527488|62777847|FG003|Overall Study|Withdrawn prior to dosing|0|||
33398410|NCT00527332|62777859|FG000|Overall Study|Protocol Violation|4|||
33398411|NCT00527332|62777860|FG001|Overall Study|Protocol Violation|8|||
33398412|NCT00527332|62777859|FG000|Overall Study|Withdrew consent|5|||
33398413|NCT00527332|62777860|FG001|Overall Study|Withdrew consent|1|||
33398414|NCT00752609|62777868|FG000|Overall Study|Adverse Event|2|||
33398415|NCT00752609|62777869|FG001|Overall Study|Adverse Event|2|||
33398416|NCT00752609|62777868|FG000|Overall Study|Withdrawal by Subject|3|||
33398417|NCT00752609|62777869|FG001|Overall Study|Withdrawal by Subject|0|||
33398418|NCT00752609|62777868|FG000|Overall Study|Physician Decision|1|||
33398419|NCT00752609|62777869|FG001|Overall Study|Physician Decision|0|||
33398420|NCT00752609|62777868|FG000|Overall Study|Death|1|||
33398421|NCT00752609|62777869|FG001|Overall Study|Death|0|||
33398422|NCT00752609|62777868|FG000|Overall Study|Met exclusion criteria|1|||
33398423|NCT00752609|62777869|FG001|Overall Study|Met exclusion criteria|0|||
33398424|NCT00752609|62777868|FG000|Overall Study|Received Aranesp in error|1|||
33398425|NCT00752609|62777869|FG001|Overall Study|Received Aranesp in error|0|||
33398426|NCT03684304|62777880|FG000|Overall Study|Lost to Follow-up|19|||
33398427|NCT03684304|62777881|FG001|Overall Study|Lost to Follow-up|17|||
33398428|NCT00629772|62777889|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
33306668|NCT00985621|62682043|FG003|Overall Study|Adverse Event|16|||
33306669|NCT00985621|62682040|FG000|Overall Study|Lack of Efficacy|10|||
33306670|NCT00985621|62682041|FG001|Overall Study|Lack of Efficacy|6|||
33306671|NCT00985621|62682042|FG002|Overall Study|Lack of Efficacy|5|||
33306672|NCT00985621|62682043|FG003|Overall Study|Lack of Efficacy|12|||
33306673|NCT00985621|62682040|FG000|Overall Study|Lost to Follow-up|2|||
33306674|NCT00985621|62682041|FG001|Overall Study|Lost to Follow-up|3|||
33306675|NCT00985621|62682042|FG002|Overall Study|Lost to Follow-up|4|||
33306676|NCT00985621|62682043|FG003|Overall Study|Lost to Follow-up|4|||
33306677|NCT00985621|62682040|FG000|Overall Study|Study Terminated by Sponsor|89|||
33306678|NCT00985621|62682041|FG001|Overall Study|Study Terminated by Sponsor|108|||
33306679|NCT00985621|62682042|FG002|Overall Study|Study Terminated by Sponsor|99|||
33398429|NCT00629772|62777890|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
33398430|NCT00629772|62777889|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
33398431|NCT00629772|62777890|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
33398432|NCT00526630|62777897|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
33398433|NCT00526630|62777898|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
33398434|NCT00526630|62777897|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
33398435|NCT00526630|62777898|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
33306680|NCT00985621|62682043|FG003|Overall Study|Study Terminated by Sponsor|92|||
33306681|NCT00985621|62682040|FG000|Overall Study|Protocol Violation|1|||
33398436|NCT00755183|62777908|FG000|Overall Study|Adverse Event|5|||
33398437|NCT00755183|62777909|FG001|Overall Study|Adverse Event|2|||
33398438|NCT00755183|62777908|FG000|Overall Study|Protocol Violation|0|||
33398439|NCT00755183|62777909|FG001|Overall Study|Protocol Violation|1|||
33398440|NCT00755183|62777908|FG000|Overall Study|Withdrawal by Subject|0|||
33398441|NCT00755183|62777909|FG001|Overall Study|Withdrawal by Subject|2|||
33398442|NCT00755183|62777908|FG000|Overall Study|Administrative|2|||
33398443|NCT00755183|62777909|FG001|Overall Study|Administrative|1|||
33398444|NCT00755105|62777920|FG000|Overall Study|Withdrawal by Subject|9|||
33398445|NCT00755105|62777921|FG001|Overall Study|Withdrawal by Subject|11|||
33398446|NCT00755105|62777922|FG002|Overall Study|Withdrawal by Subject|4|||
33398447|NCT00526162|62777930|FG000|Overall Study|Device not implanted|3|||
33398448|NCT03875482|62777940|FG000|Overall Study|Adverse Event|0|||
33398449|NCT03875482|62777941|FG001|Overall Study|Adverse Event|1|||
33398450|NCT03875482|62777940|FG000|Overall Study|Withdrew consent|5|||
33398451|NCT03875482|62777941|FG001|Overall Study|Withdrew consent|6|||
33398452|NCT03875482|62777940|FG000|Overall Study|Lost to Follow-up|8|||
33398453|NCT03875482|62777941|FG001|Overall Study|Lost to Follow-up|2|||
33398454|NCT03875482|62777940|FG000|Overall Study|Lack of Efficacy|0|||
33398455|NCT03875482|62777941|FG001|Overall Study|Lack of Efficacy|11|||
33398456|NCT00754793|62777949|FG000|Overall Study|voluntary withdrawn from study|0|||
33398457|NCT00754793|62777950|FG001|Overall Study|voluntary withdrawn from study|1|||
33398458|NCT00586469|62777958|FG000|Overall Study|Adverse Event|0|||
33398459|NCT00586469|62777959|FG001|Overall Study|Adverse Event|1|||
33398460|NCT00626028|62777967|FG000|Overall Study|Adverse Event|1|||
33398461|NCT00626028|62777968|FG001|Overall Study|Adverse Event|1|||
33398462|NCT00626028|62777967|FG000|Overall Study|Device Failure|0|||
33398463|NCT00626028|62777968|FG001|Overall Study|Device Failure|1|||
33398464|NCT00626028|62777967|FG000|Overall Study|Physician Decision|2|||
33398465|NCT00626028|62777968|FG001|Overall Study|Physician Decision|1|||
33398466|NCT00626028|62777967|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
33306682|NCT00985621|62682041|FG001|Overall Study|Protocol Violation|1|||
33306683|NCT00985621|62682042|FG002|Overall Study|Protocol Violation|1|||
33306684|NCT00985621|62682043|FG003|Overall Study|Protocol Violation|0|||
33306685|NCT00985621|62682040|FG000|Overall Study|Withdrawal by Subject|8|||
33306686|NCT00985621|62682041|FG001|Overall Study|Withdrawal by Subject|10|||
33306687|NCT00985621|62682042|FG002|Overall Study|Withdrawal by Subject|8|||
33306688|NCT00985621|62682043|FG003|Overall Study|Withdrawal by Subject|12|||
33306689|NCT00985621|62682040|FG000|Overall Study|Other|1|||
33306690|NCT00985621|62682041|FG001|Overall Study|Other|0|||
33306691|NCT00985621|62682042|FG002|Overall Study|Other|0|||
33306692|NCT00985621|62682043|FG003|Overall Study|Other|0|||
33306693|NCT00985621|62682040|FG000|Overall Study|Randomized but not Treated|1|||
33306694|NCT00985621|62682041|FG001|Overall Study|Randomized but not Treated|0|||
33306695|NCT00985621|62682042|FG002|Overall Study|Randomized but not Treated|2|||
33306696|NCT00985621|62682043|FG003|Overall Study|Randomized but not Treated|1|||
33306697|NCT01215981|62682057|FG000|Overall Study|Physician Decision|0|||
33306698|NCT01215981|62682058|FG001|Overall Study|Physician Decision|1|||
33306699|NCT01215981|62682057|FG000|Overall Study|Protocol Violation|1|||
33306700|NCT01215981|62682058|FG001|Overall Study|Protocol Violation|0|||
33306701|NCT01215981|62682057|FG000|Overall Study|Withdrawal by Subject|1|||
33306702|NCT01215981|62682058|FG001|Overall Study|Withdrawal by Subject|0|||
33306703|NCT01215513|62682064|FG000|Overall Study|Not completed CS42|9|||
33306704|NCT01215513|62682064|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
33306705|NCT01215513|62682064|FG000|Overall Study|Adverse event (CS42A)|2|||
33306706|NCT01215513|62682064|FG000|Overall Study|Physician decision (CS42A)|6|||
33306707|NCT01215513|62682064|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
33306708|NCT01215513|62682064|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
33306709|NCT01215435|62682071|FG000|Overall Study|Adverse Event|1|||
33306710|NCT01215435|62682072|FG001|Overall Study|Adverse Event|0|||
33306711|NCT01215435|62682071|FG000|Overall Study|Protocol Violation|2|||
33306712|NCT01215435|62682072|FG001|Overall Study|Protocol Violation|0|||
33306713|NCT01215435|62682071|FG000|Overall Study|Withdrawal Criteria|8|||
33306714|NCT01215435|62682072|FG001|Overall Study|Withdrawal Criteria|11|||
33306715|NCT01215435|62682071|FG000|Overall Study|Lost to Follow-up|3|||
33306716|NCT01215435|62682072|FG001|Overall Study|Lost to Follow-up|0|||
33398467|NCT00626028|62777968|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
33398468|NCT00777257|62777977|FG000|Overall Study|Adverse Event|3|||
33306717|NCT01215435|62682071|FG000|Overall Study|Unclassified|5|||
33306718|NCT01215435|62682072|FG001|Overall Study|Unclassified|5|||
33306719|NCT01215357|62682078|FG000|Overall Study|Withdrawal by Subject|3|||
33306720|NCT01215357|62682078|FG000|Overall Study|Protocol Violation|9|||
33398469|NCT00777257|62777978|FG001|Overall Study|Adverse Event|1|||
33398470|NCT00777257|62777979|FG002|Overall Study|Adverse Event|0|||
33398471|NCT00777257|62777977|FG000|Overall Study|Lost to Follow-up|3|||
33398472|NCT00777257|62777978|FG001|Overall Study|Lost to Follow-up|3|||
33306721|NCT00984295|62682085|FG000|Overall Study|Lost to Follow-up|31|||
33306722|NCT00984295|62682086|FG001|Overall Study|Lost to Follow-up|12|||
33306723|NCT00984295|62682087|FG002|Overall Study|Lost to Follow-up|13|||
33398473|NCT00777257|62777979|FG002|Overall Study|Lost to Follow-up|2|||
33398474|NCT00777257|62777977|FG000|Overall Study|Protocol Violation|2|||
33398475|NCT00777257|62777978|FG001|Overall Study|Protocol Violation|2|||
33398476|NCT00777257|62777979|FG002|Overall Study|Protocol Violation|2|||
33398477|NCT00777257|62777977|FG000|Overall Study|Withdrawal by Subject|3|||
33398478|NCT00777257|62777978|FG001|Overall Study|Withdrawal by Subject|6|||
33398479|NCT00777257|62777979|FG002|Overall Study|Withdrawal by Subject|5|||
33398480|NCT00628758|62777989|FG000|Overall Study|Adverse Event|2|||
33398481|NCT00628758|62777990|FG001|Overall Study|Adverse Event|3|||
33398482|NCT00628758|62777989|FG000|Overall Study|Withdrawal by Subject|6|||
33398483|NCT00628758|62777990|FG001|Overall Study|Withdrawal by Subject|3|||
33398484|NCT00628758|62777989|FG000|Overall Study|Death|1|||
33398485|NCT00628758|62777990|FG001|Overall Study|Death|0|||
33398486|NCT00628758|62777989|FG000|Overall Study|Protocol Violation|5|||
33398487|NCT00628758|62777990|FG001|Overall Study|Protocol Violation|1|||
33398488|NCT00628758|62777989|FG000|Overall Study|Lost to Follow-up|25|||
33398489|NCT00628758|62777990|FG001|Overall Study|Lost to Follow-up|31|||
33398490|NCT00628758|62777989|FG000|Overall Study|Pregnancy|2|||
33398491|NCT00628758|62777990|FG001|Overall Study|Pregnancy|2|||
33398492|NCT00628758|62777989|FG000|Overall Study|Investigator Moved|3|||
33398493|NCT00628758|62777990|FG001|Overall Study|Investigator Moved|0|||
33398494|NCT00628758|62777989|FG000|Overall Study|Treatment Failure|0|||
33398495|NCT00628758|62777990|FG001|Overall Study|Treatment Failure|2|||
33398496|NCT04491604|62777998|FG000|Overall Study|Withdrawal by Subject|3|||
33398497|NCT00628446|62778003|FG000|Overall Study|Lost to Follow-up|3|||
33398498|NCT00628446|62778003|FG000|Overall Study|Withdrawal by Subject|1|||
33398499|NCT00628446|62778003|FG000|Overall Study|Protocol Violation|3|||
33398500|NCT00754559|62778008|FG000|Overall Study|Adverse Event|15|||
33398501|NCT00754559|62778008|FG000|Overall Study|Protocol Violation|11|||
33398502|NCT00754559|62778008|FG000|Overall Study|Lack of Efficacy|10|||
33398503|NCT00754559|62778008|FG000|Overall Study|Lost to Follow-up|2|||
33398504|NCT00754559|62778008|FG000|Overall Study|Administrative reason|1|||
33398505|NCT00754559|62778008|FG000|Overall Study|Other|5|||
33398506|NCT00754559|62778008|FG000|Overall Study|Withdrawal by Subject|3|||
33398507|NCT00525148|62778019|FG000|Overall Study|Other Adverse Event|3|||
33398508|NCT00525148|62778020|FG001|Overall Study|Other Adverse Event|5|||
33398509|NCT00525148|62778021|FG002|Overall Study|Other Adverse Event|1|||
33398510|NCT00525148|62778022|FG003|Overall Study|Other Adverse Event|8|||
33398511|NCT00525148|62778019|FG000|Overall Study|Progressive disease|18|||
33398512|NCT00525148|62778020|FG001|Overall Study|Progressive disease|30|||
33398513|NCT00525148|62778021|FG002|Overall Study|Progressive disease|6|||
33398514|NCT00525148|62778022|FG003|Overall Study|Progressive disease|49|||
33398515|NCT00525148|62778019|FG000|Overall Study|Refused continuation of study medication|0|||
33398516|NCT00525148|62778020|FG001|Overall Study|Refused continuation of study medication|2|||
33398517|NCT00525148|62778021|FG002|Overall Study|Refused continuation of study medication|0|||
33398518|NCT00525148|62778022|FG003|Overall Study|Refused continuation of study medication|1|||
33398519|NCT00525148|62778019|FG000|Overall Study|Other than stated|2|||
33398520|NCT00525148|62778020|FG001|Overall Study|Other than stated|1|||
33398521|NCT00525148|62778021|FG002|Overall Study|Other than stated|0|||
33398522|NCT00525148|62778022|FG003|Overall Study|Other than stated|3|||
33398523|NCT00754325|62778034|FG000|Initial Treatment|Continuing Active Treatment|4|||
33398524|NCT00754325|62778035|FG001|Initial Treatment|Continuing Active Treatment|5|||
33398525|NCT00754325|62778034|FG000|Initial Treatment|Adverse Event|7|||
33398526|NCT00754325|62778035|FG001|Initial Treatment|Adverse Event|6|||
33398527|NCT00754325|62778034|FG000|Initial Treatment|Withdrawal by Subject|2|||
33398528|NCT00754325|62778035|FG001|Initial Treatment|Withdrawal by Subject|2|||
33398529|NCT00754325|62778034|FG000|Initial Treatment|Physician Decision|2|||
33398530|NCT00754325|62778035|FG001|Initial Treatment|Physician Decision|0|||
33398531|NCT00754325|62778034|FG000|Initial Treatment|Sponsor Request|0|||
33398532|NCT00754325|62778035|FG001|Initial Treatment|Sponsor Request|1|||
33398533|NCT00754325|62778034|FG000|Initial Treatment|Disease Progression|35|||
33398534|NCT00754325|62778035|FG001|Initial Treatment|Disease Progression|35|||
33398535|NCT00524680|62778046|FG000|Overall Study|progression|0|||
33398536|NCT00524680|62778047|FG001|Overall Study|progression|0|||
33398537|NCT00524680|62778048|FG002|Overall Study|progression|0|||
33398538|NCT00524680|62778049|FG003|Overall Study|progression|1|||
33398539|NCT00524680|62778046|FG000|Overall Study|Adverse Event|2|||
33398540|NCT00524680|62778047|FG001|Overall Study|Adverse Event|0|||
33398541|NCT00524680|62778048|FG002|Overall Study|Adverse Event|0|||
33398542|NCT00524680|62778049|FG003|Overall Study|Adverse Event|1|||
33398543|NCT00524680|62778046|FG000|Overall Study|Other|0|||
33398544|NCT00524680|62778047|FG001|Overall Study|Other|1|||
33398545|NCT00524680|62778048|FG002|Overall Study|Other|2|||
33398546|NCT00524680|62778049|FG003|Overall Study|Other|3|||
33398547|NCT00524680|62778046|FG000|Overall Study|Withdrawal by Subject|1|||
33398548|NCT00524680|62778047|FG001|Overall Study|Withdrawal by Subject|0|||
33398549|NCT00524680|62778048|FG002|Overall Study|Withdrawal by Subject|1|||
33398550|NCT00524680|62778049|FG003|Overall Study|Withdrawal by Subject|1|||
33398551|NCT00628212|62778063|FG000|Overall Study|Adverse Event|2|||
33398552|NCT00628212|62778064|FG001|Overall Study|Adverse Event|0|||
33398553|NCT00628212|62778065|FG002|Overall Study|Adverse Event|1|||
33398554|NCT00628212|62778066|FG003|Overall Study|Adverse Event|2|||
33398555|NCT00628212|62778063|FG000|Overall Study|Physician Decision|1|||
33398556|NCT00628212|62778064|FG001|Overall Study|Physician Decision|1|||
33398557|NCT00628212|62778065|FG002|Overall Study|Physician Decision|2|||
33398558|NCT00628212|62778066|FG003|Overall Study|Physician Decision|3|||
33306724|NCT00984295|62682085|FG000|Overall Study|Protocol Violation|2|||
33306725|NCT00984295|62682086|FG001|Overall Study|Protocol Violation|1|||
33306726|NCT00984295|62682087|FG002|Overall Study|Protocol Violation|4|||
33306727|NCT00984295|62682085|FG000|Overall Study|Withdrawal by Subject|18|||
33306728|NCT00984295|62682086|FG001|Overall Study|Withdrawal by Subject|9|||
33306729|NCT00984295|62682087|FG002|Overall Study|Withdrawal by Subject|12|||
33306730|NCT00984295|62682085|FG000|Overall Study|CAE - discontinued test vaccine|0|||
33306731|NCT00984295|62682086|FG001|Overall Study|CAE - discontinued test vaccine|1|||
33306732|NCT00984295|62682087|FG002|Overall Study|CAE - discontinued test vaccine|3|||
33306733|NCT00984295|62682085|FG000|Overall Study|Missed one or more blood samplings|3|||
33306734|NCT00984295|62682086|FG001|Overall Study|Missed one or more blood samplings|7|||
33306735|NCT00984295|62682087|FG002|Overall Study|Missed one or more blood samplings|2|||
33306736|NCT00984295|62682085|FG000|Overall Study|Incomplete safety follow-up|11|||
33306737|NCT00984295|62682086|FG001|Overall Study|Incomplete safety follow-up|2|||
33306738|NCT00984295|62682087|FG002|Overall Study|Incomplete safety follow-up|3|||
33306739|NCT01017952|62682099|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
33306740|NCT01017952|62682100|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33306741|NCT01017952|62682101|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33306742|NCT01017952|62682102|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33306743|NCT01017952|62682103|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33306744|NCT01017952|62682099|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
33306745|NCT01017952|62682100|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
33306746|NCT01017952|62682101|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
33306747|NCT01017952|62682102|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
33306748|NCT01017952|62682103|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
33306749|NCT01017952|62682099|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
33306750|NCT01017952|62682100|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
33306751|NCT01017952|62682101|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
33306752|NCT01017952|62682102|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
33306753|NCT01017952|62682103|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
33306754|NCT01017952|62682099|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
33306755|NCT01017952|62682100|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33306756|NCT01017952|62682101|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33306757|NCT01017952|62682102|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33306758|NCT01017952|62682103|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33306759|NCT01017952|62682099|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
33306760|NCT01017952|62682100|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
33306761|NCT01017952|62682101|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
33306762|NCT01017952|62682102|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
33306763|NCT01017952|62682103|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
33306764|NCT01017952|62682099|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
33306765|NCT01017952|62682100|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33306766|NCT01017952|62682101|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33306767|NCT01017952|62682102|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33306768|NCT01017952|62682103|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33306769|NCT01017952|62682099|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
33306770|NCT01017952|62682100|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
33306771|NCT01017952|62682101|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
33306772|NCT01017952|62682102|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
33306773|NCT01017952|62682103|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
33306774|NCT01017952|62682099|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
33306775|NCT01017952|62682100|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
33306776|NCT01017952|62682101|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
33306777|NCT01017952|62682102|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
33306778|NCT01017952|62682103|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
33306779|NCT01017952|62682099|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
33306780|NCT01017952|62682100|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
33398559|NCT00298363|62778079|FG000|Overall Study|Lost to Follow-up|0|||
33398560|NCT00298363|62778080|FG001|Overall Study|Lost to Follow-up|0|||
33306781|NCT01017952|62682101|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
33398561|NCT00298363|62778081|FG002|Overall Study|Lost to Follow-up|1|||
33306782|NCT01017952|62682102|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
33306783|NCT01017952|62682103|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
33306784|NCT01017952|62682099|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
33306785|NCT01017952|62682100|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
33306786|NCT01017952|62682101|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
33306787|NCT01017952|62682102|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
33306788|NCT01017952|62682103|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
33306789|NCT01017952|62682099|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
33306790|NCT01017952|62682100|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
33306791|NCT01017952|62682101|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
33306792|NCT01017952|62682102|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
33306793|NCT01017952|62682103|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
33306794|NCT01017952|62682099|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
33306795|NCT01017952|62682100|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
33306796|NCT01017952|62682101|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
33306797|NCT01017952|62682102|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
33306798|NCT01017952|62682103|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
33306799|NCT01017952|62682099|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33306800|NCT01017952|62682100|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
33306801|NCT01017952|62682101|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
33306802|NCT01017952|62682102|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
33306803|NCT01017952|62682103|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
33306804|NCT01017952|62682099|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
33306805|NCT01017952|62682100|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
33306806|NCT01017952|62682101|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
33306807|NCT01017952|62682102|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
33306808|NCT01017952|62682103|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
33306809|NCT01214655|62682116|FG000|Part A|Progressive Disease|7|||
33306810|NCT01214655|62682117|FG001|Part A|Progressive Disease|0|||
33306811|NCT01214655|62682118|FG002|Part A|Progressive Disease|0|||
33306812|NCT01214655|62682116|FG000|Part A|Physician Decision|1|||
33306813|NCT01214655|62682117|FG001|Part A|Physician Decision|0|||
33306814|NCT01214655|62682118|FG002|Part A|Physician Decision|0|||
33306815|NCT01214655|62682116|FG000|Part B|Progressive disease|0|||
33306816|NCT01214655|62682117|FG001|Part B|Progressive disease|10|||
33306817|NCT01214655|62682118|FG002|Part B|Progressive disease|0|||
33306818|NCT01214655|62682116|FG000|Part B|Death|0|||
33306819|NCT01214655|62682117|FG001|Part B|Death|1|||
33306820|NCT01214655|62682118|FG002|Part B|Death|0|||
33306821|NCT01214655|62682116|FG000|Part B|Withdrawal by Subject|0|||
33306822|NCT01214655|62682117|FG001|Part B|Withdrawal by Subject|2|||
33306823|NCT01214655|62682118|FG002|Part B|Withdrawal by Subject|0|||
33306824|NCT01214655|62682116|FG000|Part C|Progressive Disease|0|||
33306825|NCT01214655|62682117|FG001|Part C|Progressive Disease|0|||
33306826|NCT01214655|62682118|FG002|Part C|Progressive Disease|5|||
33306827|NCT01214655|62682116|FG000|Part C|Death|0|||
33306828|NCT01214655|62682117|FG001|Part C|Death|0|||
33306829|NCT01214655|62682118|FG002|Part C|Death|1|||
33306830|NCT01214655|62682116|FG000|Part C|Physician Decision|0|||
33306831|NCT01214655|62682117|FG001|Part C|Physician Decision|0|||
33306832|NCT01214655|62682118|FG002|Part C|Physician Decision|1|||
33306833|NCT01017874|62682166|FG000|Overall Study|Withdrawal by Subject|23|||
33306834|NCT01017874|62682167|FG001|Overall Study|Withdrawal by Subject|20|||
33306835|NCT01017874|62682166|FG000|Overall Study|Sponsor decision|3|||
33306836|NCT01017874|62682167|FG001|Overall Study|Sponsor decision|1|||
33306837|NCT01017874|62682166|FG000|Overall Study|Lost to Follow-up|3|||
33306838|NCT01017874|62682167|FG001|Overall Study|Lost to Follow-up|2|||
33306839|NCT01017874|62682166|FG000|Overall Study|Physician Decision|1|||
33306840|NCT01017874|62682167|FG001|Overall Study|Physician Decision|3|||
33306841|NCT01015768|62682173|FG000|Overall Study|Some subject data unuseable|4|||
33306842|NCT01015768|62682174|FG001|Overall Study|Some subject data unuseable|4|||
33306843|NCT04426630|62682182|FG000|Overall Study|Death|4|||
33306844|NCT04426630|62682182|FG000|Overall Study|Lost to Follow-up|2|||
33306845|NCT01010230|62682188|FG000|Overall Study|Withdrawal by Subject|6|||
33306846|NCT01010230|62682189|FG001|Overall Study|Withdrawal by Subject|5|||
33306847|NCT01010230|62682188|FG000|Overall Study|Lost to Follow-up|4|||
33306848|NCT01010230|62682189|FG001|Overall Study|Lost to Follow-up|2|||
33306849|NCT01009840|62682195|FG000|Overall Study|Lost to Follow-up|1|||
33306850|NCT01009840|62682195|FG000|Overall Study|Adverse Event|4|||
33306851|NCT01009840|62682195|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
33306852|NCT01009840|62682195|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
33306853|NCT01009840|62682195|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
33306854|NCT00982657|62682203|FG000|Overall Study|Death|1|||
33306855|NCT00982657|62682204|FG001|Overall Study|Death|0|||
33306856|NCT00982657|62682205|FG002|Overall Study|Death|1|||
33306857|NCT00982657|62682206|FG003|Overall Study|Death|1|||
33306858|NCT00982657|62682203|FG000|Overall Study|Withdrawal by Subject|0|||
33306859|NCT00982657|62682204|FG001|Overall Study|Withdrawal by Subject|0|||
33306860|NCT00982657|62682205|FG002|Overall Study|Withdrawal by Subject|1|||
33306861|NCT00982657|62682206|FG003|Overall Study|Withdrawal by Subject|3|||
33306862|NCT00982657|62682203|FG000|Overall Study|Other|0|||
33306863|NCT00982657|62682204|FG001|Overall Study|Other|0|||
33306864|NCT00982657|62682205|FG002|Overall Study|Other|0|||
33306865|NCT00982657|62682206|FG003|Overall Study|Other|4|||
33306866|NCT00982657|62682203|FG000|Overall Study|On going at date of cut-off|0|||
33306867|NCT00982657|62682204|FG001|Overall Study|On going at date of cut-off|0|||
33306868|NCT00982657|62682205|FG002|Overall Study|On going at date of cut-off|0|||
33306869|NCT00982657|62682206|FG003|Overall Study|On going at date of cut-off|1|||
33306870|NCT01005316|62682229|FG000|Overall Study|Adverse Event|0|||
33306871|NCT01005316|62682230|FG001|Overall Study|Adverse Event|0|||
33306872|NCT01005316|62682231|FG002|Overall Study|Adverse Event|0|||
33306873|NCT01005316|62682232|FG003|Overall Study|Adverse Event|1|||
33306874|NCT01005316|62682229|FG000|Overall Study|Death|20|||
33306875|NCT01005316|62682230|FG001|Overall Study|Death|5|||
33306876|NCT01005316|62682231|FG002|Overall Study|Death|1|||
33306877|NCT01005316|62682232|FG003|Overall Study|Death|15|||
33306878|NCT01005316|62682229|FG000|Overall Study|Study Termination|5|||
33306879|NCT01005316|62682230|FG001|Overall Study|Study Termination|63|||
33306880|NCT01005316|62682231|FG002|Overall Study|Study Termination|9|||
33306881|NCT01005316|62682232|FG003|Overall Study|Study Termination|85|||
33306882|NCT01005316|62682229|FG000|Overall Study|Lost to Follow-up|1|||
33306883|NCT01005316|62682230|FG001|Overall Study|Lost to Follow-up|3|||
33306884|NCT01005316|62682231|FG002|Overall Study|Lost to Follow-up|0|||
33306885|NCT01005316|62682232|FG003|Overall Study|Lost to Follow-up|2|||
33306886|NCT01005316|62682229|FG000|Overall Study|Physician Decision|6|||
33306887|NCT01005316|62682230|FG001|Overall Study|Physician Decision|0|||
33306888|NCT01005316|62682231|FG002|Overall Study|Physician Decision|0|||
33306889|NCT01005316|62682232|FG003|Overall Study|Physician Decision|0|||
33306890|NCT01005316|62682229|FG000|Overall Study|Sponsor Decision|6|||
33306891|NCT01005316|62682230|FG001|Overall Study|Sponsor Decision|3|||
33306892|NCT01005316|62682231|FG002|Overall Study|Sponsor Decision|0|||
33306893|NCT01005316|62682232|FG003|Overall Study|Sponsor Decision|0|||
33306894|NCT01005316|62682229|FG000|Overall Study|Withdrawal by Subject|1|||
33306895|NCT01005316|62682230|FG001|Overall Study|Withdrawal by Subject|1|||
33306896|NCT01005316|62682231|FG002|Overall Study|Withdrawal by Subject|0|||
33306897|NCT01005316|62682232|FG003|Overall Study|Withdrawal by Subject|2|||
33306898|NCT01005316|62682229|FG000|Overall Study|Consented to Another Study|2|||
33306899|NCT01005316|62682230|FG001|Overall Study|Consented to Another Study|0|||
33306900|NCT01005316|62682231|FG002|Overall Study|Consented to Another Study|0|||
33306901|NCT01005316|62682232|FG003|Overall Study|Consented to Another Study|0|||
33306902|NCT01005316|62682229|FG000|Overall Study|Delisted|8|||
33306903|NCT01005316|62682230|FG001|Overall Study|Delisted|0|||
33306904|NCT01005316|62682231|FG002|Overall Study|Delisted|0|||
33306905|NCT01005316|62682232|FG003|Overall Study|Delisted|0|||
33306906|NCT01005316|62682229|FG000|Overall Study|Transferred Care|1|||
33306907|NCT01005316|62682230|FG001|Overall Study|Transferred Care|0|||
33306908|NCT01005316|62682231|FG002|Overall Study|Transferred Care|1|||
33306909|NCT01005316|62682232|FG003|Overall Study|Transferred Care|3|||
33306910|NCT01005316|62682229|FG000|Overall Study|Retransplanted|0|||
33306911|NCT01005316|62682230|FG001|Overall Study|Retransplanted|1|||
33306912|NCT01005316|62682231|FG002|Overall Study|Retransplanted|0|||
33306913|NCT01005316|62682232|FG003|Overall Study|Retransplanted|0|||
33306914|NCT01004848|62682245|FG000|Overall Study|Lost to Follow-up|55|||
33306915|NCT01004848|62682246|FG001|Overall Study|Lost to Follow-up|45|||
33306916|NCT01009294|62682254|FG000|Overall Study|Study discontinued by Sponsor|6|||
33306917|NCT01009060|62682260|FG000|Overall Study|Adverse Event|1|||
33306918|NCT01009060|62682261|FG001|Overall Study|Adverse Event|2|||
33306919|NCT01009060|62682260|FG000|Overall Study|Protocol Violation|0|||
33306920|NCT01009060|62682261|FG001|Overall Study|Protocol Violation|1|||
33398562|NCT00298363|62778079|FG000|Overall Study|Physician Decision|4|||
33306921|NCT01009060|62682260|FG000|Overall Study|Lost to Follow-up|1|||
33306922|NCT01009060|62682261|FG001|Overall Study|Lost to Follow-up|0|||
33306923|NCT01009060|62682260|FG000|Overall Study|Physician Decision|1|||
33306924|NCT01009060|62682261|FG001|Overall Study|Physician Decision|1|||
33306925|NCT01009060|62682260|FG000|Overall Study|Withdrawal by Subject|1|||
33306926|NCT01009060|62682261|FG001|Overall Study|Withdrawal by Subject|1|||
33306927|NCT00988429|62682274|FG000|Overall Study|Adverse Event|9|||
33306928|NCT00988429|62682275|FG001|Overall Study|Adverse Event|21|||
33398563|NCT00298363|62778080|FG001|Overall Study|Physician Decision|1|||
33306929|NCT00988429|62682276|FG002|Overall Study|Adverse Event|45|||
33306930|NCT00988429|62682274|FG000|Overall Study|Lack of Efficacy|0|||
33306931|NCT00988429|62682275|FG001|Overall Study|Lack of Efficacy|0|||
33306932|NCT00988429|62682276|FG002|Overall Study|Lack of Efficacy|1|||
33306933|NCT00988429|62682274|FG000|Overall Study|Non-Compliance with Study Drug|5|||
33398564|NCT00298363|62778081|FG002|Overall Study|Physician Decision|0|||
33306934|NCT00988429|62682275|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33306935|NCT00988429|62682276|FG002|Overall Study|Non-Compliance with Study Drug|3|||
33306936|NCT00988429|62682274|FG000|Overall Study|Physician Decision|1|||
33306937|NCT00988429|62682275|FG001|Overall Study|Physician Decision|0|||
33306938|NCT00988429|62682276|FG002|Overall Study|Physician Decision|3|||
33306939|NCT00988429|62682274|FG000|Overall Study|Pregnancy|2|||
33306940|NCT00988429|62682275|FG001|Overall Study|Pregnancy|1|||
33306941|NCT00988429|62682276|FG002|Overall Study|Pregnancy|0|||
33306942|NCT00988429|62682274|FG000|Overall Study|Protocol Violation|4|||
33306943|NCT00988429|62682275|FG001|Overall Study|Protocol Violation|3|||
33306944|NCT00988429|62682276|FG002|Overall Study|Protocol Violation|3|||
33306945|NCT00988429|62682274|FG000|Overall Study|Withdrawal by Subject|7|||
33306946|NCT00988429|62682275|FG001|Overall Study|Withdrawal by Subject|7|||
33306947|NCT00988429|62682276|FG002|Overall Study|Withdrawal by Subject|12|||
33306948|NCT00988429|62682274|FG000|Overall Study|Administrative Reasons|1|||
33306949|NCT00988429|62682275|FG001|Overall Study|Administrative Reasons|2|||
33306950|NCT00988429|62682276|FG002|Overall Study|Administrative Reasons|1|||
33306951|NCT00988429|62682274|FG000|Overall Study|other reasons|8|||
33306952|NCT00988429|62682275|FG001|Overall Study|other reasons|8|||
33306953|NCT00988429|62682276|FG002|Overall Study|other reasons|1|||
33306954|NCT01008904|62682285|FG000|Overall Study|Lost to Follow-up|1|||
33306955|NCT01008904|62682285|FG000|Overall Study|Adverse Event|2|||
33306956|NCT01008904|62682285|FG000|Overall Study|unexpected unrelated surgery|1|||
33306957|NCT01004614|62682293|FG000|Washout|Withdrawal by Subject|0|||
33306958|NCT01004614|62682294|FG001|Washout|Withdrawal by Subject|1|||
33306959|NCT01004614|62682295|FG002|Washout|Withdrawal by Subject|0|||
33306960|NCT01004614|62682296|FG003|Washout|Withdrawal by Subject|0|||
33306961|NCT00981409|62682308|FG000|Overall Study|Adverse Event|4|||
33306962|NCT00981409|62682309|FG001|Overall Study|Adverse Event|0|||
33306963|NCT00981409|62682308|FG000|Overall Study|Protocol Violation|0|||
33306964|NCT00981409|62682309|FG001|Overall Study|Protocol Violation|1|||
33306965|NCT00981409|62682308|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
33306966|NCT00981409|62682309|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
33306967|NCT01008748|62682315|FG000|Overall Study|Lost to Follow-up|80|||
33306968|NCT01008748|62682315|FG000|Overall Study|Other|1|||
33306969|NCT01004146|62682321|FG000|Overall Study|Withdrawal by Subject|4|||
33306970|NCT01004146|62682322|FG001|Overall Study|Withdrawal by Subject|5|||
33306971|NCT01012414|62682328|FG000|Overall Study|Withdrawal by Subject|2|||
33306972|NCT01012414|62682328|FG000|Overall Study|Lost to Follow-up|1|||
33306973|NCT01012414|62682328|FG000|Overall Study|Trial was stopped before completed|7|||
33306974|NCT00975715|62682336|FG000|Titration Period|Adverse Event|6|||
33306975|NCT00975715|62682337|FG001|Titration Period|Adverse Event|0|||
33306976|NCT00975715|62682336|FG000|Titration Period|Protocol Violation|1|||
33306977|NCT00975715|62682337|FG001|Titration Period|Protocol Violation|0|||
33306978|NCT00975715|62682336|FG000|Maintenance Period|Adverse Event|2|||
33306979|NCT00975715|62682337|FG001|Maintenance Period|Adverse Event|1|||
33306980|NCT03962491|62682345|FG000|Overall Study|Lost to Follow-up|4|||
33306981|NCT03962491|62682346|FG001|Overall Study|Lost to Follow-up|5|||
33306982|NCT00978757|62682354|FG000|Overall Study|Physician Decision|1|||
33306983|NCT00978757|62682355|FG001|Overall Study|Physician Decision|3|||
33306984|NCT01214421|62682365|FG000|Overall Study|Lost to Follow-up|7|||
33306985|NCT01214421|62682366|FG001|Overall Study|Lost to Follow-up|3|||
33306986|NCT01214421|62682367|FG002|Overall Study|Lost to Follow-up|7|||
33306987|NCT01214421|62682368|FG003|Overall Study|Lost to Follow-up|3|||
33306988|NCT01214421|62682365|FG000|Overall Study|Adverse Event|16|||
33306989|NCT01214421|62682366|FG001|Overall Study|Adverse Event|35|||
33306990|NCT01214421|62682367|FG002|Overall Study|Adverse Event|14|||
33306991|NCT01214421|62682368|FG003|Overall Study|Adverse Event|3|||
33306992|NCT01214421|62682365|FG000|Overall Study|Sponsor Discontinued Site|1|||
33306993|NCT01214421|62682366|FG001|Overall Study|Sponsor Discontinued Site|2|||
33306994|NCT01214421|62682367|FG002|Overall Study|Sponsor Discontinued Site|0|||
33306995|NCT01214421|62682368|FG003|Overall Study|Sponsor Discontinued Site|0|||
33306996|NCT01214421|62682365|FG000|Overall Study|Withdrawal Criteria Met|3|||
33306997|NCT01214421|62682366|FG001|Overall Study|Withdrawal Criteria Met|0|||
33306998|NCT01214421|62682367|FG002|Overall Study|Withdrawal Criteria Met|2|||
33306999|NCT01214421|62682368|FG003|Overall Study|Withdrawal Criteria Met|1|||
33307000|NCT01214421|62682365|FG000|Overall Study|Physician Decision|2|||
33398565|NCT00298363|62778079|FG000|Overall Study|Protocol Violation|1|||
33307001|NCT01214421|62682366|FG001|Overall Study|Physician Decision|0|||
33307002|NCT01214421|62682367|FG002|Overall Study|Physician Decision|4|||
33307003|NCT01214421|62682368|FG003|Overall Study|Physician Decision|0|||
33307004|NCT01214421|62682365|FG000|Overall Study|Withdrawal by Subject|21|||
33307005|NCT01214421|62682366|FG001|Overall Study|Withdrawal by Subject|18|||
33307006|NCT01214421|62682367|FG002|Overall Study|Withdrawal by Subject|11|||
33307007|NCT01214421|62682368|FG003|Overall Study|Withdrawal by Subject|2|||
33307008|NCT04102111|62682380|FG000|Overall Study|Withdrawal by Subject|2|||
33307009|NCT04102111|62682381|FG001|Overall Study|Withdrawal by Subject|3|||
33307010|NCT04102111|62682380|FG000|Overall Study|Adverse Event|1|||
33307011|NCT04102111|62682381|FG001|Overall Study|Adverse Event|1|||
33307012|NCT04102111|62682380|FG000|Overall Study|Study terminated by sponsor|1|||
33307013|NCT04102111|62682381|FG001|Overall Study|Study terminated by sponsor|3|||
33307014|NCT01214187|62682389|FG000|Overall Study|Adverse Event|6|||
33307015|NCT01214187|62682390|FG001|Overall Study|Adverse Event|2|||
33307016|NCT01214187|62682389|FG000|Overall Study|Death|1|||
33307017|NCT01214187|62682390|FG001|Overall Study|Death|1|||
33307018|NCT01214187|62682389|FG000|Overall Study|Withdrawal by Subject|0|||
33307019|NCT01214187|62682390|FG001|Overall Study|Withdrawal by Subject|3|||
33307020|NCT01003990|62682399|FG000|Overall Study|Adverse Event|8|||
33307021|NCT01003990|62682400|FG001|Overall Study|Adverse Event|5|||
33307022|NCT01003990|62682401|FG002|Overall Study|Adverse Event|11|||
33307023|NCT01003990|62682399|FG000|Overall Study|Death|0|||
33307024|NCT01003990|62682400|FG001|Overall Study|Death|8|||
33307025|NCT01003990|62682401|FG002|Overall Study|Death|1|||
33307026|NCT01003990|62682399|FG000|Overall Study|Lack of Efficacy|10|||
33307027|NCT01003990|62682400|FG001|Overall Study|Lack of Efficacy|2|||
33307028|NCT01003990|62682401|FG002|Overall Study|Lack of Efficacy|3|||
33307029|NCT01003990|62682399|FG000|Overall Study|Lost to Follow-up|30|||
33307030|NCT01003990|62682400|FG001|Overall Study|Lost to Follow-up|12|||
33307031|NCT01003990|62682401|FG002|Overall Study|Lost to Follow-up|7|||
33307032|NCT01003990|62682399|FG000|Overall Study|Reasons Not Identified|14|||
33307033|NCT01003990|62682400|FG001|Overall Study|Reasons Not Identified|13|||
33307034|NCT01003990|62682401|FG002|Overall Study|Reasons Not Identified|8|||
33307035|NCT01003990|62682399|FG000|Overall Study|Poor/Non-compliance|4|||
33307036|NCT01003990|62682400|FG001|Overall Study|Poor/Non-compliance|3|||
33307037|NCT01003990|62682401|FG002|Overall Study|Poor/Non-compliance|2|||
33307038|NCT01003990|62682399|FG000|Overall Study|Pregnancy|10|||
33307039|NCT01003990|62682400|FG001|Overall Study|Pregnancy|2|||
33307040|NCT01003990|62682401|FG002|Overall Study|Pregnancy|4|||
33307041|NCT01003990|62682399|FG000|Overall Study|No Longer Met Study Criteria|4|||
33307042|NCT01003990|62682400|FG001|Overall Study|No Longer Met Study Criteria|1|||
33307043|NCT01003990|62682401|FG002|Overall Study|No Longer Met Study Criteria|0|||
33307044|NCT01003990|62682399|FG000|Overall Study|Subject Withdrew Consent|12|||
33307045|NCT01003990|62682400|FG001|Overall Study|Subject Withdrew Consent|5|||
33307046|NCT01003990|62682401|FG002|Overall Study|Subject Withdrew Consent|7|||
33307047|NCT01003210|62682411|FG000|Overall Study|Lost to Follow-up|1|||
33307048|NCT01003210|62682412|FG001|Overall Study|Lost to Follow-up|3|||
33307049|NCT01002820|62682418|FG000|Overall Study|Adverse Event|1|||
33307050|NCT01002820|62682418|FG000|Overall Study|Withdrawal by Subject|2|||
33307051|NCT01002820|62682418|FG000|Overall Study|Lack of Efficacy|1|||
33307052|NCT01012258|62682422|FG000|Overall Study|Death|14|||
33307053|NCT01012258|62682422|FG000|Overall Study|Lost to Follow-up|1|||
33307054|NCT01012258|62682422|FG000|Overall Study|Adverse Event|1|||
33307055|NCT01012258|62682422|FG000|Overall Study|Progressive Disease (PD)|18|||
33307056|NCT01012258|62682422|FG000|Overall Study|Symptomatic Deterioration|1|||
33307057|NCT01012258|62682422|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
33307058|NCT01012258|62682422|FG000|Overall Study|Another Tumor Discovered|1|||
33307059|NCT01012258|62682422|FG000|Overall Study|Ongoing|29|||
33307060|NCT01011946|62682427|FG000|Overall Study|Transferred to another hospital|2|||
33307061|NCT01011946|62682427|FG000|Overall Study|No pathological lab value|1|||
33307062|NCT00975481|62682431|FG000|Second Intervention Period|Adverse Event|2|||
33307063|NCT00975481|62682432|FG001|Second Intervention Period|Adverse Event|1|||
33307064|NCT00975481|62682433|FG002|Second Intervention Period|Adverse Event|0|||
33307065|NCT00975481|62682434|FG003|Second Intervention Period|Adverse Event|0|||
33307066|NCT00975481|62682435|FG004|Second Intervention Period|Adverse Event|0|||
33307067|NCT00975481|62682436|FG005|Second Intervention Period|Adverse Event|0|||
33307068|NCT00975481|62682431|FG000|Second Intervention Period|Withdrawal by Subject|0|||
33307069|NCT00975481|62682432|FG001|Second Intervention Period|Withdrawal by Subject|0|||
33307070|NCT00975481|62682433|FG002|Second Intervention Period|Withdrawal by Subject|1|||
33307071|NCT00975481|62682434|FG003|Second Intervention Period|Withdrawal by Subject|0|||
33307072|NCT00975481|62682435|FG004|Second Intervention Period|Withdrawal by Subject|0|||
33307073|NCT00975481|62682436|FG005|Second Intervention Period|Withdrawal by Subject|0|||
33307074|NCT00975481|62682431|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
33307075|NCT00975481|62682432|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
33307076|NCT00975481|62682433|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
33307077|NCT00975481|62682434|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
33307078|NCT00975481|62682435|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
33307079|NCT00975481|62682436|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
33307080|NCT00975481|62682431|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
33307081|NCT00975481|62682432|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
33307082|NCT00975481|62682433|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
33307083|NCT00975481|62682434|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
33307084|NCT00975481|62682435|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
33307085|NCT00975481|62682436|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
33307086|NCT01011868|62682457|FG000|After Week 18 Follow-up|Adverse Event|8|||
33398566|NCT00298363|62778080|FG001|Overall Study|Protocol Violation|1|||
33307087|NCT01011868|62682458|FG001|After Week 18 Follow-up|Adverse Event|6|||
33307088|NCT01011868|62682459|FG002|After Week 18 Follow-up|Adverse Event|13|||
33307089|NCT01011868|62682457|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
33307090|NCT01011868|62682458|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
33307091|NCT01011868|62682459|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
33307092|NCT01011868|62682457|FG000|After Week 18 Follow-up|Protocol Violation|1|||
33307093|NCT01011868|62682458|FG001|After Week 18 Follow-up|Protocol Violation|1|||
33307094|NCT01011868|62682459|FG002|After Week 18 Follow-up|Protocol Violation|1|||
33307095|NCT01011868|62682457|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
33307096|NCT01011868|62682458|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
33307097|NCT01011868|62682459|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
33307098|NCT01011868|62682457|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
33307099|NCT01011868|62682458|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
33307100|NCT01011868|62682459|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
33307101|NCT01011868|62682457|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
33307102|NCT01011868|62682458|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
33307103|NCT01011868|62682459|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
33307104|NCT01011868|62682457|FG000|After Week 78 Follow-up|Adverse Event|14|||
33307105|NCT01011868|62682458|FG001|After Week 78 Follow-up|Adverse Event|18|||
33307106|NCT01011868|62682459|FG002|After Week 78 Follow-up|Adverse Event|21|||
33307107|NCT01011868|62682457|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
33307108|NCT01011868|62682458|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
33307109|NCT01011868|62682459|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
33307110|NCT01011868|62682457|FG000|After Week 78 Follow-up|Protocol Violation|9|||
33307111|NCT01011868|62682458|FG001|After Week 78 Follow-up|Protocol Violation|1|||
33307112|NCT01011868|62682459|FG002|After Week 78 Follow-up|Protocol Violation|2|||
33307113|NCT01011868|62682457|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
33307114|NCT01011868|62682458|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
33307115|NCT01011868|62682459|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
33307116|NCT01011868|62682457|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
33307117|NCT01011868|62682458|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
33307118|NCT01011868|62682459|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
33307119|NCT01011868|62682457|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
33307120|NCT01011868|62682458|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
33307121|NCT01011868|62682459|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
33307122|NCT01213251|62682470|FG000|Overall Study|Death|2|||
33307123|NCT01213251|62682471|FG001|Overall Study|Death|1|||
33307124|NCT01213251|62682472|FG002|Overall Study|Death|2|||
33307125|NCT01213251|62682470|FG000|Overall Study|Exit|3|||
33307126|NCT01213251|62682471|FG001|Overall Study|Exit|2|||
33307127|NCT01213251|62682472|FG002|Overall Study|Exit|8|||
33307128|NCT01213251|62682470|FG000|Overall Study|Protocol Violation|1|||
33307129|NCT01213251|62682471|FG001|Overall Study|Protocol Violation|1|||
33307130|NCT01213251|62682472|FG002|Overall Study|Protocol Violation|0|||
33307131|NCT01213251|62682470|FG000|Overall Study|Missed 18-Month Follow-up|0|||
33307132|NCT01213251|62682471|FG001|Overall Study|Missed 18-Month Follow-up|0|||
33307133|NCT01213251|62682472|FG002|Overall Study|Missed 18-Month Follow-up|1|||
33307134|NCT01213173|62682487|FG000|Overall Study|Protocol Violation|2|||
33307135|NCT01213173|62682488|FG001|Overall Study|Protocol Violation|0|||
33307136|NCT01213173|62682487|FG000|Overall Study|Adverse Event|4|||
33307137|NCT01213173|62682488|FG001|Overall Study|Adverse Event|8|||
33307138|NCT01213173|62682487|FG000|Overall Study|Withdrawal by Subject|5|||
33307139|NCT01213173|62682488|FG001|Overall Study|Withdrawal by Subject|5|||
33307140|NCT01213173|62682487|FG000|Overall Study|Incorrect Enrollment|1|||
33307141|NCT01213173|62682488|FG001|Overall Study|Incorrect Enrollment|3|||
33307142|NCT01212159|62682496|FG000|Overall Study|Withdrawal by Subject|12|||
33307143|NCT01212159|62682497|FG001|Overall Study|Withdrawal by Subject|12|||
33307144|NCT00973765|62682505|FG000|Overall Study|Lost to Follow-up|8|||
33307145|NCT00973765|62682506|FG001|Overall Study|Lost to Follow-up|14|||
33307146|NCT01211769|62682516|FG000|Overall Study|Lost to Follow-up|7|||
33307147|NCT01211769|62682517|FG001|Overall Study|Lost to Follow-up|9|||
33307148|NCT01211769|62682518|FG002|Overall Study|Lost to Follow-up|5|||
33307149|NCT01211769|62682519|FG003|Overall Study|Lost to Follow-up|9|||
33307150|NCT01211769|62682516|FG000|Overall Study|Physician Decision|2|||
33307151|NCT01211769|62682517|FG001|Overall Study|Physician Decision|0|||
33307152|NCT01211769|62682518|FG002|Overall Study|Physician Decision|2|||
33307153|NCT01211769|62682519|FG003|Overall Study|Physician Decision|1|||
33307154|NCT01211769|62682516|FG000|Overall Study|Adverse Event|0|||
33307155|NCT01211769|62682517|FG001|Overall Study|Adverse Event|1|||
33307156|NCT01211769|62682518|FG002|Overall Study|Adverse Event|1|||
33398567|NCT00298363|62778081|FG002|Overall Study|Protocol Violation|0|||
33307157|NCT01211769|62682519|FG003|Overall Study|Adverse Event|1|||
33307158|NCT01211613|62682532|FG000|Overall Study|Lost to Follow-up|2|||
33307159|NCT01211613|62682533|FG001|Overall Study|Lost to Follow-up|2|||
33307160|NCT01211613|62682534|FG002|Overall Study|Lost to Follow-up|2|||
33398568|NCT00298363|62778079|FG000|Overall Study|Withdrawal by Subject|5|||
33307161|NCT01211613|62682532|FG000|Overall Study|Withdrawal by Subject|1|||
33307162|NCT01211613|62682533|FG001|Overall Study|Withdrawal by Subject|0|||
33307163|NCT01211613|62682534|FG002|Overall Study|Withdrawal by Subject|0|||
33307164|NCT01211535|62682544|FG000|Overall Study|Adverse Event|0|||
33307165|NCT01211535|62682545|FG001|Overall Study|Adverse Event|1|||
33307166|NCT01011556|62682555|FG000|Overall Study|Adverse Event|1|||
33307167|NCT01011556|62682556|FG001|Overall Study|Adverse Event|3|||
33307168|NCT01011556|62682557|FG002|Overall Study|Adverse Event|2|||
33307169|NCT01011556|62682558|FG003|Overall Study|Adverse Event|1|||
33307170|NCT01011556|62682555|FG000|Overall Study|Lost to Follow-up|1|||
33307171|NCT01011556|62682556|FG001|Overall Study|Lost to Follow-up|0|||
33307172|NCT01011556|62682557|FG002|Overall Study|Lost to Follow-up|0|||
33307173|NCT01011556|62682558|FG003|Overall Study|Lost to Follow-up|0|||
33307174|NCT01011556|62682555|FG000|Overall Study|Physician Decision|1|||
33307175|NCT01011556|62682556|FG001|Overall Study|Physician Decision|0|||
33307176|NCT01011556|62682557|FG002|Overall Study|Physician Decision|0|||
33307177|NCT01011556|62682558|FG003|Overall Study|Physician Decision|1|||
33307178|NCT01011556|62682555|FG000|Overall Study|Protocol Violation|0|||
33307179|NCT01011556|62682556|FG001|Overall Study|Protocol Violation|1|||
33307180|NCT01011556|62682557|FG002|Overall Study|Protocol Violation|0|||
33307181|NCT01011556|62682558|FG003|Overall Study|Protocol Violation|0|||
33307182|NCT01011556|62682555|FG000|Overall Study|Withdrawal by Subject|1|||
33307183|NCT01011556|62682556|FG001|Overall Study|Withdrawal by Subject|2|||
33307184|NCT01011556|62682557|FG002|Overall Study|Withdrawal by Subject|4|||
33307185|NCT01011556|62682558|FG003|Overall Study|Withdrawal by Subject|4|||
33307186|NCT01011556|62682555|FG000|Overall Study|Sponsor decision|0|||
33307187|NCT01011556|62682556|FG001|Overall Study|Sponsor decision|1|||
33307188|NCT01011556|62682557|FG002|Overall Study|Sponsor decision|1|||
33307189|NCT01011556|62682558|FG003|Overall Study|Sponsor decision|2|||
33307190|NCT01011556|62682555|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
33307191|NCT01011556|62682556|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
33307192|NCT01011556|62682557|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
33307193|NCT01011556|62682558|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
33307194|NCT01211145|62682575|FG000|Overall Study|Reason not specified|3|||
33307195|NCT01211145|62682576|FG001|Overall Study|Reason not specified|2|||
33307196|NCT01211145|62682577|FG002|Overall Study|Reason not specified|2|||
33307197|NCT01211145|62682578|FG003|Overall Study|Reason not specified|1|||
33307198|NCT01211145|62682575|FG000|Overall Study|Lost to Follow-up|3|||
33307199|NCT01211145|62682576|FG001|Overall Study|Lost to Follow-up|2|||
33307200|NCT01211145|62682577|FG002|Overall Study|Lost to Follow-up|1|||
33307201|NCT01211145|62682578|FG003|Overall Study|Lost to Follow-up|2|||
33307202|NCT01211145|62682575|FG000|Overall Study|Study-specific withdrawal criteria|1|||
33307203|NCT01211145|62682576|FG001|Overall Study|Study-specific withdrawal criteria|0|||
33398569|NCT00298363|62778080|FG001|Overall Study|Withdrawal by Subject|1|||
33398570|NCT00298363|62778081|FG002|Overall Study|Withdrawal by Subject|3|||
33398571|NCT00298363|62778079|FG000|Overall Study|Adverse Event|5|||
33398572|NCT00298363|62778080|FG001|Overall Study|Adverse Event|2|||
33398573|NCT00298363|62778081|FG002|Overall Study|Adverse Event|2|||
33398574|NCT00298363|62778079|FG000|Overall Study|Lack of Efficacy|2|||
33398575|NCT00298363|62778080|FG001|Overall Study|Lack of Efficacy|3|||
33398576|NCT00298363|62778081|FG002|Overall Study|Lack of Efficacy|0|||
33398577|NCT00524368|62778097|FG000|Overall Study|Adverse Event|10|||
33398578|NCT00524368|62778098|FG001|Overall Study|Adverse Event|12|||
33398579|NCT00524368|62778097|FG000|Overall Study|Lost to Follow-up|9|||
33307204|NCT01211145|62682577|FG002|Overall Study|Study-specific withdrawal criteria|0|||
33307205|NCT01211145|62682578|FG003|Overall Study|Study-specific withdrawal criteria|0|||
33307206|NCT01211145|62682575|FG000|Overall Study|Severe noncompliance to protocol|1|||
33307207|NCT01211145|62682576|FG001|Overall Study|Severe noncompliance to protocol|0|||
33307208|NCT01211145|62682577|FG002|Overall Study|Severe noncompliance to protocol|0|||
33307209|NCT01211145|62682578|FG003|Overall Study|Severe noncompliance to protocol|0|||
33307210|NCT01211145|62682575|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
33307211|NCT01211145|62682576|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
33307212|NCT01211145|62682577|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
33307213|NCT01211145|62682578|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
33307214|NCT01211145|62682575|FG000|Overall Study|Patient decision|2|||
33307215|NCT01211145|62682576|FG001|Overall Study|Patient decision|1|||
33307216|NCT01211145|62682577|FG002|Overall Study|Patient decision|0|||
33307217|NCT01211145|62682578|FG003|Overall Study|Patient decision|2|||
33307218|NCT00977665|62682590|FG000|Overall Study|Withdrawal by Subject|1|||
33307219|NCT00977665|62682591|FG001|Overall Study|Withdrawal by Subject|3|||
33307220|NCT00977665|62682590|FG000|Overall Study|Physician Decision|2|||
33307221|NCT00977665|62682591|FG001|Overall Study|Physician Decision|1|||
33307222|NCT00977665|62682590|FG000|Overall Study|Sponsor requested withdrawal|0|||
33307223|NCT00977665|62682591|FG001|Overall Study|Sponsor requested withdrawal|1|||
33307224|NCT00977665|62682590|FG000|Overall Study|Lost to Follow-up|1|||
33307225|NCT00977665|62682591|FG001|Overall Study|Lost to Follow-up|0|||
33398580|NCT00524368|62778098|FG001|Overall Study|Lost to Follow-up|13|||
33398581|NCT00524368|62778097|FG000|Overall Study|Withdrawal by Subject|4|||
33398582|NCT00524368|62778098|FG001|Overall Study|Withdrawal by Subject|5|||
33398583|NCT00524368|62778097|FG000|Overall Study|Non-compliant|8|||
33398584|NCT00524368|62778098|FG001|Overall Study|Non-compliant|9|||
33398585|NCT00524368|62778097|FG000|Overall Study|Reached a Virologic Endpoint|3|||
33398586|NCT00524368|62778098|FG001|Overall Study|Reached a Virologic Endpoint|2|||
33398587|NCT00524368|62778097|FG000|Overall Study|Sponsor's Decision|2|||
33398588|NCT00524368|62778098|FG001|Overall Study|Sponsor's Decision|0|||
33398589|NCT00524368|62778097|FG000|Overall Study|Ineligible to Continue the study|2|||
33398590|NCT00524368|62778098|FG001|Overall Study|Ineligible to Continue the study|5|||
33398591|NCT00524368|62778097|FG000|Overall Study|Other|3|||
33398592|NCT00524368|62778098|FG001|Overall Study|Other|2|||
33398593|NCT00777101|62778106|FG000|Overall Study|Death|48|||
33398594|NCT00777101|62778107|FG001|Overall Study|Death|43|||
33398595|NCT00777101|62778106|FG000|Overall Study|Withdrawal by Subject|11|||
33398596|NCT00777101|62778107|FG001|Overall Study|Withdrawal by Subject|6|||
33398597|NCT00777101|62778106|FG000|Overall Study|Lost to Follow-up|2|||
33398598|NCT00777101|62778107|FG001|Overall Study|Lost to Follow-up|1|||
33398599|NCT00777101|62778106|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
33398600|NCT00777101|62778107|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
33398601|NCT00777101|62778106|FG000|Overall Study|Failed to Return|0|||
33398602|NCT00777101|62778107|FG001|Overall Study|Failed to Return|1|||
33398603|NCT00297427|62778116|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
33398604|NCT00297427|62778117|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
33398605|NCT00297427|62778116|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
33398606|NCT00297427|62778117|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
33398607|NCT00297427|62778116|FG000|Phase 1: Initial Intervention|Death|0|||
33398608|NCT00297427|62778117|FG001|Phase 1: Initial Intervention|Death|1|||
33398609|NCT00297427|62778116|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
33398610|NCT00297427|62778117|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
33398611|NCT00297427|62778116|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
33398612|NCT00297427|62778117|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
33398613|NCT00297427|62778116|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
33398614|NCT00297427|62778117|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
33398615|NCT00297427|62778116|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
33398616|NCT00297427|62778117|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
33398617|NCT00297427|62778116|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
33398618|NCT00297427|62778117|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
33398619|NCT00524134|62778131|FG000|Overall Study|Withdrawal by Subject|1|||
33398620|NCT00524134|62778131|FG000|Overall Study|Physician Decision|1|||
33398621|NCT00777023|62778138|FG000|Overall Study|Adverse Event|15|||
33398622|NCT00777023|62778139|FG001|Overall Study|Adverse Event|21|||
33398623|NCT00777023|62778140|FG002|Overall Study|Adverse Event|8|||
33398624|NCT00777023|62778138|FG000|Overall Study|Lack of Efficacy|1|||
33398625|NCT00777023|62778139|FG001|Overall Study|Lack of Efficacy|0|||
33307226|NCT00977665|62682590|FG000|Overall Study|Death|3|||
33307227|NCT00977665|62682591|FG001|Overall Study|Death|2|||
33398626|NCT00777023|62778140|FG002|Overall Study|Lack of Efficacy|14|||
33398627|NCT00777023|62778138|FG000|Overall Study|Protocol Violation|2|||
33398628|NCT00777023|62778139|FG001|Overall Study|Protocol Violation|1|||
33307228|NCT00977665|62682590|FG000|Overall Study|Adverse Event|14|||
33307229|NCT00977665|62682591|FG001|Overall Study|Adverse Event|7|||
33307230|NCT00977665|62682590|FG000|Overall Study|Treatment failure|0|||
33307231|NCT00977665|62682591|FG001|Overall Study|Treatment failure|1|||
33307232|NCT01210443|62682597|FG000|Overall Study|Study terminated by sponsor|2|||
33307233|NCT01007812|62682601|FG000|Period 1, One Week|Lost to Follow-up|0|||
33307234|NCT01007812|62682602|FG001|Period 1, One Week|Lost to Follow-up|1|||
33307235|NCT01007812|62682601|FG000|Period 1, One Week|Discomfort|1|||
33307236|NCT01007812|62682602|FG001|Period 1, One Week|Discomfort|0|||
33307237|NCT01208961|62682608|FG000|High-Fat Period III|Protocol Violation|1|||
33307238|NCT01208961|62682609|FG001|High-Fat Period III|Protocol Violation|0|||
33307239|NCT01001572|62682616|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
33307240|NCT01001572|62682617|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
33307241|NCT01001572|62682618|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
33307242|NCT01001572|62682616|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
33307243|NCT01001572|62682617|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
33307244|NCT01001572|62682618|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
33398629|NCT00777023|62778140|FG002|Overall Study|Protocol Violation|1|||
33307245|NCT01001572|62682616|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
33307246|NCT01001572|62682617|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
33307247|NCT01001572|62682618|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
33398630|NCT00777023|62778138|FG000|Overall Study|Lost to Follow-up|2|||
33398631|NCT00777023|62778139|FG001|Overall Study|Lost to Follow-up|3|||
33398632|NCT00777023|62778140|FG002|Overall Study|Lost to Follow-up|3|||
33398633|NCT00777023|62778138|FG000|Overall Study|Death|0|||
33398634|NCT00777023|62778139|FG001|Overall Study|Death|1|||
33398635|NCT00777023|62778140|FG002|Overall Study|Death|0|||
33398636|NCT00777023|62778138|FG000|Overall Study|Withdrawal by Subject|7|||
33398637|NCT00777023|62778139|FG001|Overall Study|Withdrawal by Subject|7|||
33398638|NCT00777023|62778140|FG002|Overall Study|Withdrawal by Subject|8|||
33398639|NCT00777023|62778138|FG000|Overall Study|Missing data|1|||
33398640|NCT00777023|62778139|FG001|Overall Study|Missing data|1|||
33398641|NCT00777023|62778140|FG002|Overall Study|Missing data|0|||
33398642|NCT00777023|62778138|FG000|Overall Study|Reasons not specified|4|||
33398643|NCT00777023|62778139|FG001|Overall Study|Reasons not specified|4|||
33398644|NCT00777023|62778140|FG002|Overall Study|Reasons not specified|2|||
33398645|NCT00777023|62778138|FG000|Overall Study|Last dose date unknown|3|||
33398646|NCT00777023|62778139|FG001|Overall Study|Last dose date unknown|3|||
33398647|NCT00777023|62778140|FG002|Overall Study|Last dose date unknown|1|||
33398648|NCT00297037|62778150|FG000|Overall Study|Withdrawal by Subject|2|||
33398649|NCT00297037|62778151|FG001|Overall Study|Withdrawal by Subject|0|||
33398650|NCT00292981|62778159|FG000|Overall Study|Adverse Event|1|||
33398651|NCT00292981|62778159|FG000|Overall Study|Lost to Follow-up|13|||
33398652|NCT00292981|62778159|FG000|Overall Study|Withdrawal by Subject|22|||
33398653|NCT00292981|62778159|FG000|Overall Study|Other|3|||
33398654|NCT00296725|62778163|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
33398655|NCT00296725|62778163|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
33398656|NCT00296725|62778163|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
33398657|NCT00625872|62778171|FG000|Overall Study|Withdrawal by Subject|1|||
33398658|NCT00625872|62778172|FG001|Overall Study|Withdrawal by Subject|0|||
33398659|NCT00625872|62778171|FG000|Overall Study|Does not meet inclusion criteria|1|||
33398660|NCT00625872|62778172|FG001|Overall Study|Does not meet inclusion criteria|0|||
33398661|NCT00625872|62778171|FG000|Overall Study|Terminated by sponsor|2|||
33398662|NCT00625872|62778172|FG001|Overall Study|Terminated by sponsor|5|||
33398663|NCT00625872|62778171|FG000|Overall Study|Randomized but not treated|0|||
33398664|NCT00625872|62778172|FG001|Overall Study|Randomized but not treated|1|||
33398665|NCT00523978|62778180|FG000|Overall Study|Withdrawal by Subject|3|||
33398666|NCT00523978|62778181|FG001|Overall Study|Withdrawal by Subject|7|||
33398667|NCT00523978|62778180|FG000|Overall Study|Screen Failures|5|||
33398668|NCT00523978|62778181|FG001|Overall Study|Screen Failures|1|||
33398669|NCT00523978|62778180|FG000|Overall Study|Death|1|||
33398670|NCT00523978|62778181|FG001|Overall Study|Death|0|||
33398671|NCT00296647|62778193|FG000|Overall Study|Death|4|||
33398672|NCT00296647|62778194|FG001|Overall Study|Death|1|||
33398673|NCT00296647|62778195|FG002|Overall Study|Death|2|||
33398674|NCT00296647|62778196|FG003|Overall Study|Death|1|||
33398675|NCT00296647|62778197|FG004|Overall Study|Death|1|||
33398676|NCT00296647|62778193|FG000|Overall Study|Withdrawal by Subject|28|||
33398677|NCT00296647|62778194|FG001|Overall Study|Withdrawal by Subject|27|||
33398678|NCT00296647|62778195|FG002|Overall Study|Withdrawal by Subject|32|||
33398679|NCT00296647|62778196|FG003|Overall Study|Withdrawal by Subject|16|||
33398680|NCT00296647|62778197|FG004|Overall Study|Withdrawal by Subject|19|||
33398681|NCT00754013|62778211|FG000|Overall Study|Lost to Follow-up|1|||
33398682|NCT00754013|62778212|FG001|Overall Study|Lost to Follow-up|1|||
33398683|NCT00754013|62778211|FG000|Overall Study|didn't return after study termed|3|||
33398684|NCT00754013|62778212|FG001|Overall Study|didn't return after study termed|4|||
33398685|NCT00523744|62778218|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
33398686|NCT00523744|62778218|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
33398687|NCT00523744|62778218|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
33398688|NCT00523744|62778218|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
33398689|NCT00523744|62778218|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
33398690|NCT00523744|62778218|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
33398691|NCT00752219|62778236|FG000|Overall Study|Clinical failure|0|||
33398692|NCT00752219|62778237|FG001|Overall Study|Clinical failure|1|||
33398693|NCT00752219|62778236|FG000|Overall Study|Adverse Event|5|||
33398694|NCT00752219|62778237|FG001|Overall Study|Adverse Event|3|||
33398695|NCT00752219|62778236|FG000|Overall Study|Protocol deviation|1|||
33398696|NCT00752219|62778237|FG001|Overall Study|Protocol deviation|0|||
33398697|NCT00752219|62778236|FG000|Overall Study|Lost to Follow-up|1|||
33398698|NCT00752219|62778237|FG001|Overall Study|Lost to Follow-up|2|||
33398699|NCT00752219|62778236|FG000|Overall Study|Randomized but not treated|1|||
33398700|NCT00752219|62778237|FG001|Overall Study|Randomized but not treated|0|||
33398701|NCT00752219|62778236|FG000|Overall Study|Other|3|||
33398702|NCT00752219|62778237|FG001|Overall Study|Other|0|||
33398703|NCT00622908|62778245|FG000|Overall Study|Protocol Violation|1|||
33398704|NCT00622908|62778246|FG001|Overall Study|Protocol Violation|0|||
33398705|NCT00622908|62778245|FG000|Overall Study|Adverse Event|0|||
33398706|NCT00622908|62778246|FG001|Overall Study|Adverse Event|1|||
33398707|NCT00622908|62778245|FG000|Overall Study|Lack of Efficacy|1|||
33398708|NCT00622908|62778246|FG001|Overall Study|Lack of Efficacy|7|||
33398709|NCT00622908|62778245|FG000|Overall Study|Lost to Follow-up|1|||
33398710|NCT00622908|62778246|FG001|Overall Study|Lost to Follow-up|0|||
33398711|NCT00622908|62778245|FG000|Overall Study|Refusal|0|||
33398712|NCT00622908|62778246|FG001|Overall Study|Refusal|1|||
33398713|NCT00622908|62778245|FG000|Overall Study|Termination by study sponser|0|||
33398714|NCT00622908|62778246|FG001|Overall Study|Termination by study sponser|1|||
33398715|NCT00296491|62778256|FG000|Overall Study|Low Pollen Counts|18|||
33398716|NCT00296491|62778257|FG001|Overall Study|Low Pollen Counts|26|||
33398717|NCT00296491|62778258|FG002|Overall Study|Low Pollen Counts|25|||
33398718|NCT00296491|62778259|FG003|Overall Study|Low Pollen Counts|16|||
33398719|NCT00296491|62778256|FG000|Overall Study|Protocol Violation|4|||
33398720|NCT00296491|62778257|FG001|Overall Study|Protocol Violation|6|||
33398721|NCT00296491|62778258|FG002|Overall Study|Protocol Violation|2|||
33398722|NCT00296491|62778259|FG003|Overall Study|Protocol Violation|3|||
33398723|NCT00296491|62778256|FG000|Overall Study|Adverse Event|1|||
33398724|NCT00296491|62778257|FG001|Overall Study|Adverse Event|3|||
33398725|NCT00296491|62778258|FG002|Overall Study|Adverse Event|1|||
33398726|NCT00296491|62778259|FG003|Overall Study|Adverse Event|4|||
33398727|NCT00296491|62778256|FG000|Overall Study|Withdrawn due to Asthma|0|||
33398728|NCT00296491|62778257|FG001|Overall Study|Withdrawn due to Asthma|0|||
33398729|NCT00296491|62778258|FG002|Overall Study|Withdrawn due to Asthma|0|||
33398730|NCT00296491|62778259|FG003|Overall Study|Withdrawn due to Asthma|4|||
33398731|NCT00296491|62778256|FG000|Overall Study|Withdrawal by Subject|7|||
33398732|NCT00296491|62778257|FG001|Overall Study|Withdrawal by Subject|3|||
33398733|NCT00296491|62778258|FG002|Overall Study|Withdrawal by Subject|3|||
33398734|NCT00296491|62778259|FG003|Overall Study|Withdrawal by Subject|2|||
33398735|NCT00296491|62778256|FG000|Overall Study|Non-Compliance|12|||
33398736|NCT00296491|62778257|FG001|Overall Study|Non-Compliance|13|||
33398737|NCT00296491|62778258|FG002|Overall Study|Non-Compliance|10|||
33398738|NCT00296491|62778259|FG003|Overall Study|Non-Compliance|14|||
33398739|NCT00296491|62778256|FG000|Overall Study|Lost to Follow-up|0|||
33398740|NCT00296491|62778257|FG001|Overall Study|Lost to Follow-up|2|||
33398741|NCT00296491|62778258|FG002|Overall Study|Lost to Follow-up|2|||
33398742|NCT00296491|62778259|FG003|Overall Study|Lost to Follow-up|0|||
33398743|NCT00747617|62778278|FG000|Overall Study|Lost to Follow-up|3|||
33398744|NCT00747617|62778279|FG001|Overall Study|Lost to Follow-up|1|||
33398745|NCT00296335|62778287|FG000|Overall Study|Recurrence|3|||
33398746|NCT00296335|62778288|FG001|Overall Study|Recurrence|51|||
33398747|NCT00296335|62778287|FG000|Overall Study|Adverse Event|17|||
33398748|NCT00296335|62778288|FG001|Overall Study|Adverse Event|27|||
33398749|NCT00296335|62778287|FG000|Overall Study|Lost to Follow-up|7|||
33398750|NCT00296335|62778288|FG001|Overall Study|Lost to Follow-up|33|||
33398751|NCT00296335|62778287|FG000|Overall Study|Physician Decision|3|||
33398752|NCT00296335|62778288|FG001|Overall Study|Physician Decision|11|||
33398753|NCT00747461|62778296|FG000|Overall Study|study terminated by sponsor|5|||
33398754|NCT03683758|62778303|FG000|Overall Study|Non-study commitment conflict|1|||
33398755|NCT03683758|62778304|FG001|Overall Study|Non-study commitment conflict|3|||
33398756|NCT03683758|62778303|FG000|Overall Study|Illness preventing participation|1|||
33398757|NCT03683758|62778304|FG001|Overall Study|Illness preventing participation|0|||
33398758|NCT03683758|62778303|FG000|Overall Study|Adverse Event|1|||
33398759|NCT03683758|62778304|FG001|Overall Study|Adverse Event|0|||
33398760|NCT00522418|62778312|FG000|Overall Study|Local IRB Consent Violation|5|||
33398761|NCT00522418|62778313|FG001|Overall Study|Local IRB Consent Violation|5|||
33398762|NCT00522418|62778312|FG000|Overall Study|Early Study Termination|46|||
33398763|NCT00522418|62778313|FG001|Overall Study|Early Study Termination|47|||
33398764|NCT00522418|62778312|FG000|Overall Study|Noncompliance|2|||
33398765|NCT00522418|62778313|FG001|Overall Study|Noncompliance|2|||
33398766|NCT00522418|62778312|FG000|Overall Study|Reason Not Specified|3|||
33398767|NCT00522418|62778313|FG001|Overall Study|Reason Not Specified|1|||
33398768|NCT00522418|62778312|FG000|Overall Study|Consent Withdraw|1|||
33398769|NCT00522418|62778313|FG001|Overall Study|Consent Withdraw|2|||
33398770|NCT00522418|62778312|FG000|Overall Study|Lack of Efficacy|0|||
33398771|NCT00522418|62778313|FG001|Overall Study|Lack of Efficacy|1|||
33398772|NCT00624780|62778327|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
33398773|NCT00624780|62778328|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
33398774|NCT00624780|62778329|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
33398775|NCT00624780|62778330|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
33398776|NCT00624780|62778331|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
33398777|NCT00624780|62778332|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
33398778|NCT00624780|62778327|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
33398779|NCT00624780|62778328|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
33398780|NCT00624780|62778329|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
33398781|NCT00624780|62778330|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
33398782|NCT00624780|62778331|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
33398783|NCT00624780|62778332|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
33398784|NCT00624780|62778327|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
33398785|NCT00624780|62778328|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
33398786|NCT00624780|62778329|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
33398787|NCT00624780|62778330|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
33398788|NCT00624780|62778331|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
33398789|NCT00624780|62778332|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
33398790|NCT00624780|62778327|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
33398791|NCT00624780|62778328|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
33398792|NCT00624780|62778329|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
33398793|NCT00624780|62778330|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
33398794|NCT00624780|62778331|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
33398795|NCT00624780|62778332|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
33398796|NCT00624780|62778327|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
33398797|NCT00624780|62778328|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
33398798|NCT00624780|62778329|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
33398799|NCT00624780|62778330|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
33398800|NCT00624780|62778331|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
33398801|NCT00624780|62778332|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
33398802|NCT00624780|62778327|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
33398803|NCT00624780|62778328|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
33398804|NCT00624780|62778329|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
33398805|NCT00624780|62778330|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
33398806|NCT00624780|62778331|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
33398807|NCT00624780|62778332|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
33398808|NCT00624780|62778327|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
33398809|NCT00624780|62778328|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
33398810|NCT00624780|62778329|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
33398811|NCT00624780|62778330|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
33398812|NCT00624780|62778331|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
33398813|NCT00624780|62778332|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
33398814|NCT00624780|62778327|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
33398815|NCT00624780|62778328|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
33398816|NCT00624780|62778329|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
33398817|NCT00624780|62778330|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
33398818|NCT00624780|62778331|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
33398819|NCT00624780|62778332|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
33398820|NCT00624780|62778327|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
33398821|NCT00624780|62778328|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
33398822|NCT00624780|62778329|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
33398823|NCT00624780|62778330|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
33398824|NCT00624780|62778331|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
33398825|NCT00624780|62778332|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
33398826|NCT00624780|62778327|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
33398827|NCT00624780|62778328|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
33398828|NCT00624780|62778329|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
33398829|NCT00624780|62778330|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
33398830|NCT00624780|62778331|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
33398831|NCT00624780|62778332|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
33398832|NCT00624780|62778327|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
33398833|NCT00624780|62778328|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
33398834|NCT00624780|62778329|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
33398835|NCT00624780|62778330|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
33398836|NCT00624780|62778331|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
33398837|NCT00624780|62778332|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
33398838|NCT00624780|62778327|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
33398839|NCT00624780|62778328|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
33398840|NCT00624780|62778329|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
33398841|NCT00624780|62778330|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
33398842|NCT00624780|62778331|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
33398843|NCT00624780|62778332|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
33398844|NCT00624780|62778327|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
33398845|NCT00624780|62778328|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
33398846|NCT00624780|62778329|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
33398847|NCT00624780|62778330|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
33398848|NCT00624780|62778331|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
33398849|NCT00624780|62778332|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
33398850|NCT00624780|62778327|FG000|Follow-up (Week 26)|Death|0|||
33398851|NCT00624780|62778328|FG001|Follow-up (Week 26)|Death|0|||
33398852|NCT00624780|62778329|FG002|Follow-up (Week 26)|Death|1|||
33668385|NCT01562444|63102384|FG000|Overall Study|Protocol forbidden medication|1|||
33398853|NCT00624780|62778330|FG003|Follow-up (Week 26)|Death|0|||
33398854|NCT00624780|62778331|FG004|Follow-up (Week 26)|Death|0|||
33398855|NCT00624780|62778332|FG005|Follow-up (Week 26)|Death|0|||
33398856|NCT00624780|62778327|FG000|Follow-up (Week 26)|Adverse Event|0|||
33398857|NCT00624780|62778328|FG001|Follow-up (Week 26)|Adverse Event|0|||
33398858|NCT00624780|62778329|FG002|Follow-up (Week 26)|Adverse Event|0|||
33398859|NCT00624780|62778330|FG003|Follow-up (Week 26)|Adverse Event|0|||
33398860|NCT00624780|62778331|FG004|Follow-up (Week 26)|Adverse Event|1|||
33398861|NCT00624780|62778332|FG005|Follow-up (Week 26)|Adverse Event|0|||
33398862|NCT00624780|62778327|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
33398863|NCT00624780|62778328|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
33398864|NCT00624780|62778329|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
33398865|NCT00624780|62778330|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
33398866|NCT00624780|62778331|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
33398867|NCT00624780|62778332|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
33398868|NCT00624780|62778327|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
33398869|NCT00624780|62778328|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
33398870|NCT00624780|62778329|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
33398871|NCT00624780|62778330|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
33398872|NCT00624780|62778331|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
33398873|NCT00624780|62778332|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
33398874|NCT00624780|62778327|FG000|Follow-up (Week 26)|Other|1|||
33398875|NCT00624780|62778328|FG001|Follow-up (Week 26)|Other|1|||
33398876|NCT00624780|62778329|FG002|Follow-up (Week 26)|Other|0|||
33398877|NCT00624780|62778330|FG003|Follow-up (Week 26)|Other|0|||
33398878|NCT00624780|62778331|FG004|Follow-up (Week 26)|Other|0|||
33398879|NCT00624780|62778332|FG005|Follow-up (Week 26)|Other|0|||
33398880|NCT00750893|62778349|FG000|Overall Study|Adverse Event|5|||
33398881|NCT00750893|62778349|FG000|Overall Study|Withdrawal by Subject|10|||
33398882|NCT00750893|62778349|FG000|Overall Study|Lost to Follow-up|510|||
33398883|NCT00750893|62778349|FG000|Overall Study|Other|17|||
33398884|NCT00753623|62778355|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
33398885|NCT00753623|62778356|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
33398886|NCT00753623|62778355|FG000|Phase I (14 Days)|Physician Decision|1|||
33398887|NCT00753623|62778356|FG001|Phase I (14 Days)|Physician Decision|2|||
33398888|NCT00753623|62778355|FG000|Phase I (14 Days)|Adverse Event|0|||
33398889|NCT00753623|62778356|FG001|Phase I (14 Days)|Adverse Event|1|||
33398890|NCT00753623|62778355|FG000|Washout (7 Days)|Physician Decision|1|||
33398891|NCT00753623|62778356|FG001|Washout (7 Days)|Physician Decision|0|||
33398892|NCT00753623|62778355|FG000|Phase II (14 Days)|Physician Decision|0|||
33398893|NCT00753623|62778356|FG001|Phase II (14 Days)|Physician Decision|1|||
33398894|NCT00750737|62778364|FG000|Overall Study|Withdrawal by Subject|3|||
33398895|NCT00750737|62778365|FG001|Overall Study|Withdrawal by Subject|3|||
33398896|NCT00622440|62778373|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
33398897|NCT00622440|62778374|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
33398898|NCT00622440|62778373|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
33398899|NCT00622440|62778374|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
33398900|NCT00622440|62778373|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
33398901|NCT00622440|62778374|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
33398902|NCT00622440|62778373|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
33398903|NCT00622440|62778374|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
33398904|NCT00744653|62778380|FG000|Overall Study|antineoplastic treatment|11|||
33398905|NCT00744653|62778380|FG000|Overall Study|Death|1|||
33398906|NCT00744653|62778380|FG000|Overall Study|Lost to Follow-up|1|||
33398907|NCT00744653|62778380|FG000|Overall Study|Physician Decision|3|||
33398908|NCT00311311|62778387|FG000|Overall Study|Adverse Event|3|||
33398909|NCT00311311|62778388|FG001|Overall Study|Adverse Event|2|||
33398910|NCT00311311|62778387|FG000|Overall Study|Withdrawal by Subject|1|||
33398911|NCT00311311|62778388|FG001|Overall Study|Withdrawal by Subject|1|||
33398912|NCT00311311|62778387|FG000|Overall Study|Noncompliance|0|||
33398913|NCT00311311|62778388|FG001|Overall Study|Noncompliance|1|||
33398914|NCT00311311|62778387|FG000|Overall Study|Study Termination by Sponsor|3|||
33398915|NCT00311311|62778388|FG001|Overall Study|Study Termination by Sponsor|4|||
33398916|NCT00311311|62778387|FG000|Overall Study|Death|1|||
33398917|NCT00311311|62778388|FG001|Overall Study|Death|0|||
33398918|NCT00311311|62778387|FG000|Overall Study|Lack of ancillary assistance|0|||
33398919|NCT00311311|62778388|FG001|Overall Study|Lack of ancillary assistance|1|||
33398920|NCT00521404|62778394|FG000|Overall Study|Adverse Event|13|||
33398921|NCT00521404|62778394|FG000|Overall Study|Disease Progression|33|||
33398922|NCT00521404|62778394|FG000|Overall Study|Investigator decision|5|||
33398923|NCT00521404|62778394|FG000|Overall Study|Withdrawal of consent|3|||
33398924|NCT00521404|62778394|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
33398925|NCT00521404|62778394|FG000|Overall Study|Other|7|||
33398926|NCT00311155|62778398|FG000|Overall Study|Adverse Event|21|||
33398927|NCT00311155|62778398|FG000|Overall Study|Withdrawal by Subject|17|||
33398928|NCT00311155|62778398|FG000|Overall Study|Did not meet entry criteria|55|||
33398929|NCT00292045|62778402|FG000|Core Study (Through Week 13)|Adverse Event|1|||
33398930|NCT00292045|62778402|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
33398931|NCT00274651|62778408|FG000|Overall Study|Adverse Event|6|||
33398932|NCT00274651|62778409|FG001|Overall Study|Adverse Event|3|||
33398933|NCT00274651|62778408|FG000|Overall Study|Lack of Efficacy|13|||
33398934|NCT00274651|62778409|FG001|Overall Study|Lack of Efficacy|6|||
33398935|NCT00274651|62778408|FG000|Overall Study|Death|1|||
33398936|NCT00274651|62778409|FG001|Overall Study|Death|3|||
33398937|NCT00274651|62778408|FG000|Overall Study|Withdrawal by Subject|0|||
33398938|NCT00274651|62778409|FG001|Overall Study|Withdrawal by Subject|1|||
33398939|NCT00274651|62778408|FG000|Overall Study|Physician Decision|8|||
33578459|NCT01674647|62975455|FG001|Treatment Period|Switching to other therapy|2|||
33578460|NCT01674647|62975454|FG000|Treatment Period|Logistical difficulties|5|||
33578461|NCT01674647|62975455|FG001|Treatment Period|Logistical difficulties|8|||
33578462|NCT01674647|62975454|FG000|Treatment Period|Treatment failure|0|||
33578463|NCT01674647|62975455|FG001|Treatment Period|Treatment failure|14|||
33578464|NCT01674647|62975454|FG000|Treatment Period|Protocol Violation|56|||
33578465|NCT01674647|62975455|FG001|Treatment Period|Protocol Violation|36|||
33578466|NCT01674647|62975454|FG000|30-day Safety Follow-up Period|Death|3|||
33578467|NCT01674647|62975455|FG001|30-day Safety Follow-up Period|Death|2|||
33578468|NCT01674647|62975454|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
33578469|NCT01674647|62975455|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
33578470|NCT01674647|62975454|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
33578471|NCT01674647|62975455|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
33578472|NCT01674647|62975454|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
33578473|NCT01674647|62975455|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
33578474|NCT01674647|62975454|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
33578475|NCT01674647|62975455|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
33578476|NCT01674647|62975454|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
33578477|NCT01674647|62975455|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
33578478|NCT02669407|62975461|FG000|Overall Study|Physician Decision|3|||
33578479|NCT02667457|62975467|FG000|Overall Study|Withdrawal by Subject|1|||
33578480|NCT02667457|62975468|FG001|Overall Study|Withdrawal by Subject|0|||
33578481|NCT02667457|62975467|FG000|Overall Study|Other Reason|0|||
33578482|NCT02667457|62975468|FG001|Overall Study|Other Reason|2|||
33578483|NCT02669095|62975477|FG000|Overall Study|Adverse Event|1|||
33578484|NCT02669095|62975478|FG001|Overall Study|Adverse Event|0|||
33578485|NCT02669095|62975477|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
33578486|NCT02669095|62975478|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
33578487|NCT02669095|62975477|FG000|Overall Study|Torn Lens|0|||
33578488|NCT02669095|62975478|FG001|Overall Study|Torn Lens|1|||
33578489|NCT02669095|62975477|FG000|Overall Study|Visit 5 assessments not completed|0|||
33578490|NCT02669095|62975478|FG001|Overall Study|Visit 5 assessments not completed|1|||
33578491|NCT02667301|62975484|FG000|Overall Study|Adverse Event|1|||
33578492|NCT02667301|62975484|FG000|Overall Study|Lack of Efficacy|1|||
33578493|NCT05274165|62975492|FG000|Overall Study|Withdrawal by Subject|3|||
33578494|NCT05274165|62975493|FG001|Overall Study|Withdrawal by Subject|3|||
33578495|NCT04510090|62975535|FG000|FE-HS|Withdrawal by Subject|0|||
33578496|NCT04510090|62975536|FG001|FE-HS|Withdrawal by Subject|0|||
33578497|NCT04510090|62975537|FG002|FE-HS|Withdrawal by Subject|0|||
33578498|NCT04510090|62975538|FG003|FE-HS|Withdrawal by Subject|0|||
33578499|NCT04510090|62975539|FG004|FE-HS|Withdrawal by Subject|1|||
33578500|NCT04510090|62975540|FG005|FE-HS|Withdrawal by Subject|0|||
33578501|NCT04510090|62975541|FG006|FE-HS|Withdrawal by Subject|0|||
33578502|NCT04510090|62975542|FG007|FE-HS|Withdrawal by Subject|0|||
33578503|NCT04491006|62975572|FG000|Overall Study|Adverse Event|0|||
33578504|NCT04491006|62975573|FG001|Overall Study|Adverse Event|3|||
33578505|NCT04491006|62975574|FG002|Overall Study|Adverse Event|5|||
33578506|NCT04491006|62975572|FG000|Overall Study|Withdrawal by Subject|1|||
33578507|NCT04491006|62975573|FG001|Overall Study|Withdrawal by Subject|0|||
33578508|NCT04491006|62975574|FG002|Overall Study|Withdrawal by Subject|2|||
33578509|NCT04162470|62975617|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
33578510|NCT04122625|62975627|FG000|Part A (up to 2.92 Years)|Death|2|||
33398940|NCT00274651|62778409|FG001|Overall Study|Physician Decision|7|||
33398941|NCT00274261|62778418|FG000|Overall Study|Adverse Event|19|||
33398942|NCT00274261|62778419|FG001|Overall Study|Adverse Event|11|||
33398943|NCT00274261|62778418|FG000|Overall Study|Pregnancy|114|||
33398944|NCT00274261|62778419|FG001|Overall Study|Pregnancy|83|||
33578511|NCT04122625|62975628|FG001|Part A (up to 2.92 Years)|Death|4|||
33578512|NCT04122625|62975629|FG002|Part A (up to 2.92 Years)|Death|0|||
33578513|NCT04122625|62975630|FG003|Part A (up to 2.92 Years)|Death|0|||
33578514|NCT04122625|62975631|FG004|Part A (up to 2.92 Years)|Death|0|||
33578515|NCT04122625|62975632|FG005|Part A (up to 2.92 Years)|Death|0|||
33578516|NCT04122625|62975627|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
33578517|NCT04122625|62975628|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
33578518|NCT04122625|62975629|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
33668386|NCT01562444|63102385|FG001|Overall Study|Protocol forbidden medication|0|||
33668387|NCT01562444|63102386|FG002|Overall Study|Protocol forbidden medication|0|||
33668388|NCT01457339|63102396|FG000|Period 3 (100 mg)|Adverse Event|0|||
33668389|NCT01457339|63102397|FG001|Period 3 (100 mg)|Adverse Event|1|||
33668390|NCT01457339|63102396|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
33668391|NCT01457339|63102397|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
33668392|NCT01457339|63102396|FG000|Period 6 (250 mg)|Family Emergency|1|||
33668393|NCT01457339|63102397|FG001|Period 6 (250 mg)|Family Emergency|0|||
33668394|NCT01457339|63102396|FG000|Period 6 (250 mg)|Personal appointment|0|||
33668395|NCT01457339|63102397|FG001|Period 6 (250 mg)|Personal appointment|1|||
33668396|NCT01456949|63102420|FG000|Enrollment|PI death- incomplete data|6|||
33668397|NCT01456949|63102420|FG000|Enrollment|Death|1|||
33668398|NCT01456949|63102420|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
33668399|NCT01456949|63102420|FG000|Enrollment|Physician Decision|10|||
33668400|NCT01456949|63102420|FG000|Enrollment|Withdrawal by Subject|7|||
33668401|NCT01456949|63102420|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
33668402|NCT01456949|63102420|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
33668403|NCT01456949|63102420|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
33668404|NCT01456949|63102420|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
33668405|NCT01456949|63102420|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
33307248|NCT01001572|62682616|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
33307249|NCT01001572|62682617|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
33307250|NCT01001572|62682618|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
33307251|NCT01001572|62682616|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
33307252|NCT01001572|62682617|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
33307253|NCT01001572|62682618|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
33307254|NCT01001572|62682616|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
33307255|NCT01001572|62682617|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
33307256|NCT01001572|62682618|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
33307257|NCT01001572|62682616|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
33307258|NCT01001572|62682617|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
33307259|NCT01001572|62682618|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
33307260|NCT01001572|62682616|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
33307261|NCT01001572|62682617|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
33307262|NCT01001572|62682618|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
33307263|NCT01001572|62682616|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
33307264|NCT01001572|62682617|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
33307265|NCT01001572|62682618|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
33307266|NCT01001572|62682616|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
33307267|NCT01001572|62682617|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
33307268|NCT01001572|62682618|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
33307269|NCT01001572|62682616|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
33307270|NCT01001572|62682617|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
33307271|NCT01001572|62682618|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
33307272|NCT01001572|62682616|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
33578519|NCT04122625|62975630|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
33578520|NCT04122625|62975631|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
33578521|NCT04122625|62975632|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
33578522|NCT04122625|62975627|FG000|Part B (up to 2.33 Years)|Death|0|||
33578523|NCT04122625|62975628|FG001|Part B (up to 2.33 Years)|Death|0|||
33578524|NCT04122625|62975629|FG002|Part B (up to 2.33 Years)|Death|5|||
33578525|NCT04122625|62975630|FG003|Part B (up to 2.33 Years)|Death|7|||
33578526|NCT04122625|62975631|FG004|Part B (up to 2.33 Years)|Death|6|||
33578527|NCT04122625|62975632|FG005|Part B (up to 2.33 Years)|Death|7|||
33578528|NCT03824704|62975650|FG000|Overall Study|Study Terminated by Sponsor|1|||
33578529|NCT03766581|62975666|FG000|Randomization|Other reasons|2|||
33578530|NCT03766581|62975667|FG001|Randomization|Other reasons|1|||
33578531|NCT03766581|62975668|FG002|Randomization|Other reasons|0|||
33578532|NCT03766581|62975669|FG003|Randomization|Other reasons|1|||
33578533|NCT03766581|62975670|FG004|Randomization|Other reasons|0|||
33578534|NCT03766581|62975671|FG005|Randomization|Other reasons|0|||
33578535|NCT03766581|62975672|FG006|Randomization|Other reasons|0|||
33307273|NCT01001572|62682617|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
33307274|NCT01001572|62682618|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
33307275|NCT01001572|62682616|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
33578536|NCT03766581|62975673|FG007|Randomization|Other reasons|0|||
33578537|NCT03766581|62975666|FG000|Randomization|Participant no longer meets study criteria|5|||
33578538|NCT03766581|62975667|FG001|Randomization|Participant no longer meets study criteria|3|||
33578539|NCT03766581|62975668|FG002|Randomization|Participant no longer meets study criteria|4|||
33578540|NCT03766581|62975669|FG003|Randomization|Participant no longer meets study criteria|0|||
33578541|NCT03766581|62975670|FG004|Randomization|Participant no longer meets study criteria|2|||
33578542|NCT03766581|62975671|FG005|Randomization|Participant no longer meets study criteria|3|||
33578543|NCT03766581|62975672|FG006|Randomization|Participant no longer meets study criteria|0|||
33578544|NCT03766581|62975673|FG007|Randomization|Participant no longer meets study criteria|1|||
33578545|NCT03766581|62975666|FG000|Randomization|Participant request to discontinue study treatment|1|||
33578546|NCT03766581|62975667|FG001|Randomization|Participant request to discontinue study treatment|0|||
33578547|NCT03766581|62975668|FG002|Randomization|Participant request to discontinue study treatment|0|||
33578548|NCT03766581|62975669|FG003|Randomization|Participant request to discontinue study treatment|0|||
33578549|NCT03766581|62975670|FG004|Randomization|Participant request to discontinue study treatment|1|||
33578550|NCT03766581|62975671|FG005|Randomization|Participant request to discontinue study treatment|2|||
33578551|NCT03766581|62975672|FG006|Randomization|Participant request to discontinue study treatment|0|||
33578552|NCT03766581|62975673|FG007|Randomization|Participant request to discontinue study treatment|0|||
33578553|NCT03766581|62975666|FG000|Randomization|Participant withdrew consent|1|||
33578554|NCT03766581|62975667|FG001|Randomization|Participant withdrew consent|0|||
33578555|NCT03766581|62975668|FG002|Randomization|Participant withdrew consent|1|||
33578556|NCT03766581|62975669|FG003|Randomization|Participant withdrew consent|2|||
33578557|NCT03766581|62975670|FG004|Randomization|Participant withdrew consent|1|||
33578558|NCT03766581|62975671|FG005|Randomization|Participant withdrew consent|1|||
33578559|NCT03766581|62975672|FG006|Randomization|Participant withdrew consent|0|||
33578560|NCT03766581|62975673|FG007|Randomization|Participant withdrew consent|0|||
33578561|NCT03766581|62975666|FG000|Treatment|Adverse Event|82|||
33578562|NCT03766581|62975667|FG001|Treatment|Adverse Event|44|||
33578563|NCT03766581|62975668|FG002|Treatment|Adverse Event|47|||
33578564|NCT03766581|62975669|FG003|Treatment|Adverse Event|46|||
33578565|NCT03766581|62975670|FG004|Treatment|Adverse Event|50|||
33578566|NCT03766581|62975671|FG005|Treatment|Adverse Event|77|||
33578567|NCT03766581|62975672|FG006|Treatment|Adverse Event|5|||
33578568|NCT03766581|62975673|FG007|Treatment|Adverse Event|2|||
33578569|NCT03766581|62975666|FG000|Treatment|Participant request to discontinue treatment|34|||
33578570|NCT03766581|62975667|FG001|Treatment|Participant request to discontinue treatment|6|||
33578571|NCT03766581|62975668|FG002|Treatment|Participant request to discontinue treatment|10|||
33578572|NCT03766581|62975669|FG003|Treatment|Participant request to discontinue treatment|10|||
33578573|NCT03766581|62975670|FG004|Treatment|Participant request to discontinue treatment|14|||
33578574|NCT03766581|62975671|FG005|Treatment|Participant request to discontinue treatment|15|||
33578575|NCT03766581|62975672|FG006|Treatment|Participant request to discontinue treatment|0|||
33578576|NCT03766581|62975673|FG007|Treatment|Participant request to discontinue treatment|1|||
33578577|NCT03766581|62975666|FG000|Treatment|Participant withdrew consent|11|||
33578578|NCT03766581|62975667|FG001|Treatment|Participant withdrew consent|4|||
33578579|NCT03766581|62975668|FG002|Treatment|Participant withdrew consent|5|||
33578580|NCT03766581|62975669|FG003|Treatment|Participant withdrew consent|5|||
33578581|NCT03766581|62975670|FG004|Treatment|Participant withdrew consent|4|||
33578582|NCT03766581|62975671|FG005|Treatment|Participant withdrew consent|4|||
33578583|NCT03766581|62975672|FG006|Treatment|Participant withdrew consent|0|||
33578584|NCT03766581|62975673|FG007|Treatment|Participant withdrew consent|0|||
33578585|NCT03766581|62975666|FG000|Treatment|Death|1|||
33578586|NCT03766581|62975667|FG001|Treatment|Death|0|||
33578587|NCT03766581|62975668|FG002|Treatment|Death|0|||
33578588|NCT03766581|62975669|FG003|Treatment|Death|0|||
33578589|NCT03766581|62975670|FG004|Treatment|Death|0|||
33578590|NCT03766581|62975671|FG005|Treatment|Death|0|||
33578591|NCT03766581|62975672|FG006|Treatment|Death|0|||
33578592|NCT03766581|62975673|FG007|Treatment|Death|0|||
33578593|NCT03766581|62975666|FG000|Treatment|Lost to Follow-up|1|||
33578594|NCT03766581|62975667|FG001|Treatment|Lost to Follow-up|0|||
33578595|NCT03766581|62975668|FG002|Treatment|Lost to Follow-up|0|||
33578596|NCT03766581|62975669|FG003|Treatment|Lost to Follow-up|1|||
33578597|NCT03766581|62975670|FG004|Treatment|Lost to Follow-up|0|||
33578598|NCT03766581|62975671|FG005|Treatment|Lost to Follow-up|0|||
33578599|NCT03766581|62975672|FG006|Treatment|Lost to Follow-up|0|||
33578600|NCT03766581|62975673|FG007|Treatment|Lost to Follow-up|0|||
33578601|NCT03766581|62975666|FG000|Treatment|Poor/Non compliance|2|||
33578602|NCT03766581|62975667|FG001|Treatment|Poor/Non compliance|2|||
33668406|NCT01456949|63102420|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
33578603|NCT03766581|62975668|FG002|Treatment|Poor/Non compliance|1|||
33578604|NCT03766581|62975669|FG003|Treatment|Poor/Non compliance|1|||
33578605|NCT03766581|62975670|FG004|Treatment|Poor/Non compliance|1|||
33578606|NCT03766581|62975671|FG005|Treatment|Poor/Non compliance|1|||
33578607|NCT03766581|62975672|FG006|Treatment|Poor/Non compliance|0|||
33578608|NCT03766581|62975673|FG007|Treatment|Poor/Non compliance|0|||
33578609|NCT03766581|62975666|FG000|Treatment|Participant no longer meets study criteria|9|||
33578610|NCT03766581|62975667|FG001|Treatment|Participant no longer meets study criteria|1|||
33578611|NCT03766581|62975668|FG002|Treatment|Participant no longer meets study criteria|5|||
33578612|NCT03766581|62975669|FG003|Treatment|Participant no longer meets study criteria|4|||
33578613|NCT03766581|62975670|FG004|Treatment|Participant no longer meets study criteria|4|||
33578614|NCT03766581|62975671|FG005|Treatment|Participant no longer meets study criteria|4|||
33578615|NCT03766581|62975672|FG006|Treatment|Participant no longer meets study criteria|2|||
33578616|NCT03766581|62975673|FG007|Treatment|Participant no longer meets study criteria|0|||
33578617|NCT03766581|62975666|FG000|Treatment|Other reasons|13|||
33578618|NCT03766581|62975667|FG001|Treatment|Other reasons|8|||
33578619|NCT03766581|62975668|FG002|Treatment|Other reasons|3|||
33578620|NCT03766581|62975669|FG003|Treatment|Other reasons|7|||
33578621|NCT03766581|62975670|FG004|Treatment|Other reasons|3|||
33578622|NCT03766581|62975671|FG005|Treatment|Other reasons|3|||
33578623|NCT03766581|62975672|FG006|Treatment|Other reasons|0|||
33578624|NCT03766581|62975673|FG007|Treatment|Other reasons|0|||
33578625|NCT03675321|62975698|FG000|Overall Study|Lack of Efficacy|2|||
33578626|NCT03675321|62975699|FG001|Overall Study|Lack of Efficacy|2|||
33578627|NCT03675321|62975698|FG000|Overall Study|Withdrawal by Subject|1|||
33578628|NCT03675321|62975699|FG001|Overall Study|Withdrawal by Subject|3|||
33578629|NCT03527745|62975745|FG000|Overall Study|Lost to Follow-up|3|||
33578630|NCT03527745|62975746|FG001|Overall Study|Lost to Follow-up|6|||
33578631|NCT03527745|62975747|FG002|Overall Study|Lost to Follow-up|7|||
33578632|NCT03527745|62975748|FG003|Overall Study|Lost to Follow-up|9|||
33578633|NCT03527745|62975749|FG004|Overall Study|Lost to Follow-up|0|||
33578634|NCT03527745|62975750|FG005|Overall Study|Lost to Follow-up|2|||
33578635|NCT03527745|62975751|FG006|Overall Study|Lost to Follow-up|3|||
33578636|NCT03527745|62975752|FG007|Overall Study|Lost to Follow-up|2|||
33578637|NCT03527745|62975753|FG008|Overall Study|Lost to Follow-up|3|||
33578638|NCT03527745|62975754|FG009|Overall Study|Lost to Follow-up|2|||
33578639|NCT03527745|62975755|FG010|Overall Study|Lost to Follow-up|1|||
33578640|NCT03527745|62975756|FG011|Overall Study|Lost to Follow-up|1|||
33578641|NCT03527745|62975757|FG012|Overall Study|Lost to Follow-up|0|||
33578642|NCT03527745|62975758|FG013|Overall Study|Lost to Follow-up|0|||
33578643|NCT03527745|62975759|FG014|Overall Study|Lost to Follow-up|0|||
33578644|NCT03527745|62975760|FG015|Overall Study|Lost to Follow-up|0|||
33578645|NCT03527745|62975761|FG016|Overall Study|Lost to Follow-up|1|||
33578646|NCT03527745|62975762|FG017|Overall Study|Lost to Follow-up|0|||
33578647|NCT03527745|62975763|FG018|Overall Study|Lost to Follow-up|0|||
33578648|NCT03527745|62975764|FG019|Overall Study|Lost to Follow-up|1|||
33578649|NCT03527745|62975765|FG020|Overall Study|Lost to Follow-up|1|||
33578650|NCT03527745|62975766|FG021|Overall Study|Lost to Follow-up|5|||
33578651|NCT03527745|62975767|FG022|Overall Study|Lost to Follow-up|6|||
33578652|NCT03527745|62975768|FG023|Overall Study|Lost to Follow-up|8|||
33578653|NCT03527745|62975769|FG024|Overall Study|Lost to Follow-up|1|||
33578654|NCT03527745|62975770|FG025|Overall Study|Lost to Follow-up|3|||
33578655|NCT03330405|62975861|FG000|Overall Study|Other|0|||
33578656|NCT03330405|62975862|FG001|Overall Study|Other|1|||
33578657|NCT03330405|62975863|FG002|Overall Study|Other|0|||
33578658|NCT03330405|62975864|FG003|Overall Study|Other|0|||
33578659|NCT03330405|62975865|FG004|Overall Study|Other|0|||
33578660|NCT03330405|62975866|FG005|Overall Study|Other|0|||
33578661|NCT03330405|62975867|FG006|Overall Study|Other|1|||
33578662|NCT03330405|62975868|FG007|Overall Study|Other|0|||
33578663|NCT03330405|62975869|FG008|Overall Study|Other|0|||
33578664|NCT03330405|62975870|FG009|Overall Study|Other|0|||
33578665|NCT03330405|62975871|FG010|Overall Study|Other|0|||
33578666|NCT03330405|62975861|FG000|Overall Study|Ongoing|1|||
33578667|NCT03330405|62975862|FG001|Overall Study|Ongoing|4|||
33578668|NCT03330405|62975863|FG002|Overall Study|Ongoing|1|||
33578669|NCT03330405|62975864|FG003|Overall Study|Ongoing|0|||
33578670|NCT03330405|62975865|FG004|Overall Study|Ongoing|2|||
33578671|NCT03330405|62975866|FG005|Overall Study|Ongoing|0|||
33578672|NCT03330405|62975867|FG006|Overall Study|Ongoing|0|||
33578673|NCT03330405|62975868|FG007|Overall Study|Ongoing|2|||
33578674|NCT03330405|62975869|FG008|Overall Study|Ongoing|0|||
33578675|NCT03330405|62975870|FG009|Overall Study|Ongoing|0|||
33578676|NCT03330405|62975871|FG010|Overall Study|Ongoing|0|||
33578677|NCT03330405|62975861|FG000|Overall Study|Progressive disease|8|||
33578678|NCT03330405|62975862|FG001|Overall Study|Progressive disease|26|||
33578679|NCT03330405|62975863|FG002|Overall Study|Progressive disease|4|||
33578680|NCT03330405|62975864|FG003|Overall Study|Progressive disease|18|||
33578681|NCT03330405|62975865|FG004|Overall Study|Progressive disease|16|||
33578682|NCT03330405|62975866|FG005|Overall Study|Progressive disease|14|||
33578683|NCT03330405|62975867|FG006|Overall Study|Progressive disease|7|||
33578684|NCT03330405|62975868|FG007|Overall Study|Progressive disease|29|||
33578685|NCT03330405|62975869|FG008|Overall Study|Progressive disease|9|||
33578686|NCT03330405|62975870|FG009|Overall Study|Progressive disease|11|||
33578687|NCT03330405|62975871|FG010|Overall Study|Progressive disease|5|||
33578688|NCT03330405|62975861|FG000|Overall Study|Withdrawal by Subject|1|||
33578689|NCT03330405|62975862|FG001|Overall Study|Withdrawal by Subject|4|||
33578690|NCT03330405|62975863|FG002|Overall Study|Withdrawal by Subject|0|||
33578691|NCT03330405|62975864|FG003|Overall Study|Withdrawal by Subject|1|||
33578692|NCT03330405|62975865|FG004|Overall Study|Withdrawal by Subject|1|||
33578693|NCT03330405|62975866|FG005|Overall Study|Withdrawal by Subject|1|||
33578694|NCT03330405|62975867|FG006|Overall Study|Withdrawal by Subject|0|||
33578695|NCT03330405|62975868|FG007|Overall Study|Withdrawal by Subject|1|||
33578696|NCT03330405|62975869|FG008|Overall Study|Withdrawal by Subject|2|||
33578697|NCT03330405|62975870|FG009|Overall Study|Withdrawal by Subject|1|||
33578698|NCT03330405|62975871|FG010|Overall Study|Withdrawal by Subject|1|||
33578699|NCT03330405|62975861|FG000|Overall Study|Global deterioration of health status|2|||
33578700|NCT03330405|62975862|FG001|Overall Study|Global deterioration of health status|3|||
33578701|NCT03330405|62975863|FG002|Overall Study|Global deterioration of health status|0|||
33578702|NCT03330405|62975864|FG003|Overall Study|Global deterioration of health status|2|||
33578703|NCT03330405|62975865|FG004|Overall Study|Global deterioration of health status|3|||
33578704|NCT03330405|62975866|FG005|Overall Study|Global deterioration of health status|3|||
33578705|NCT03330405|62975867|FG006|Overall Study|Global deterioration of health status|0|||
33578706|NCT03330405|62975868|FG007|Overall Study|Global deterioration of health status|2|||
33578707|NCT03330405|62975869|FG008|Overall Study|Global deterioration of health status|8|||
33578708|NCT03330405|62975870|FG009|Overall Study|Global deterioration of health status|4|||
33578709|NCT03330405|62975871|FG010|Overall Study|Global deterioration of health status|1|||
33578710|NCT03330405|62975861|FG000|Overall Study|Adverse Event|0|||
33578711|NCT03330405|62975862|FG001|Overall Study|Adverse Event|0|||
33578712|NCT03330405|62975863|FG002|Overall Study|Adverse Event|0|||
33578713|NCT03330405|62975864|FG003|Overall Study|Adverse Event|1|||
33578714|NCT03330405|62975865|FG004|Overall Study|Adverse Event|1|||
33578715|NCT03330405|62975866|FG005|Overall Study|Adverse Event|1|||
33578716|NCT03330405|62975867|FG006|Overall Study|Adverse Event|3|||
33578717|NCT03330405|62975868|FG007|Overall Study|Adverse Event|3|||
33578718|NCT03330405|62975869|FG008|Overall Study|Adverse Event|2|||
33578719|NCT03330405|62975870|FG009|Overall Study|Adverse Event|2|||
33578720|NCT03330405|62975871|FG010|Overall Study|Adverse Event|2|||
33578721|NCT03330405|62975861|FG000|Overall Study|Death|0|||
33578722|NCT03330405|62975862|FG001|Overall Study|Death|4|||
33578723|NCT03330405|62975863|FG002|Overall Study|Death|0|||
33578724|NCT03330405|62975864|FG003|Overall Study|Death|0|||
33578725|NCT03330405|62975865|FG004|Overall Study|Death|0|||
33578726|NCT03330405|62975866|FG005|Overall Study|Death|1|||
33578727|NCT03330405|62975867|FG006|Overall Study|Death|0|||
33578728|NCT03330405|62975868|FG007|Overall Study|Death|2|||
33578729|NCT03330405|62975869|FG008|Overall Study|Death|0|||
33578730|NCT03330405|62975870|FG009|Overall Study|Death|0|||
33578731|NCT03330405|62975871|FG010|Overall Study|Death|0|||
33578732|NCT03330405|62975861|FG000|Overall Study|Physician Decision|0|||
33578733|NCT03330405|62975862|FG001|Overall Study|Physician Decision|0|||
33578734|NCT03330405|62975863|FG002|Overall Study|Physician Decision|0|||
33578735|NCT03330405|62975864|FG003|Overall Study|Physician Decision|0|||
33578736|NCT03330405|62975865|FG004|Overall Study|Physician Decision|0|||
33578737|NCT03330405|62975866|FG005|Overall Study|Physician Decision|0|||
33578738|NCT03330405|62975867|FG006|Overall Study|Physician Decision|0|||
33578739|NCT03330405|62975868|FG007|Overall Study|Physician Decision|1|||
33578740|NCT03330405|62975869|FG008|Overall Study|Physician Decision|0|||
33578741|NCT03330405|62975870|FG009|Overall Study|Physician Decision|0|||
33578742|NCT03330405|62975871|FG010|Overall Study|Physician Decision|0|||
33578743|NCT03174782|62975916|FG000|Overall Study|Protocol Violation|1|||
33578744|NCT03174782|62975917|FG001|Overall Study|Protocol Violation|0|||
33578745|NCT03174782|62975916|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
33578746|NCT03174782|62975917|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
33578747|NCT02919969|62975923|FG000|Overall Study|Lack of Efficacy|22|||
33578748|NCT02919969|62975923|FG000|Overall Study|Death|4|||
33578749|NCT02919969|62975923|FG000|Overall Study|Physician Decision|3|||
33578750|NCT02919969|62975923|FG000|Overall Study|Withdrawal by Subject|2|||
33578751|NCT01891344|62975945|FG000|Overall Study|Ongoing|6|||
33578752|NCT01891344|62975946|FG001|Overall Study|Ongoing|2|||
33578753|NCT01891344|62975947|FG002|Overall Study|Ongoing|0|||
33578754|NCT01891344|62975948|FG003|Overall Study|Ongoing|1|||
33578755|NCT01891344|62975949|FG004|Overall Study|Ongoing|4|||
33578756|NCT01891344|62975950|FG005|Overall Study|Ongoing|1|||
33578757|NCT01891344|62975951|FG006|Overall Study|Ongoing|0|||
33578758|NCT01891344|62975952|FG007|Overall Study|Ongoing|0|||
33578759|NCT01188096|62975970|FG000|Overall Study|progression of disease|4|||
33578760|NCT01188096|62975970|FG000|Overall Study|Withdrawal by Subject|2|||
33578761|NCT00579826|62975990|FG000|Overall Study|Withdrawal by Subject|5|||
33578762|NCT00579826|62975991|FG001|Overall Study|Withdrawal by Subject|3|||
33578763|NCT00106691|62975999|FG000|Overall Study|Adverse Event|60|||
33578764|NCT00106691|62976000|FG001|Overall Study|Adverse Event|64|||
33578765|NCT00106691|62975999|FG000|Overall Study|Lost to Follow-up|23|||
33578766|NCT00106691|62976000|FG001|Overall Study|Lost to Follow-up|18|||
33307276|NCT01001572|62682617|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
33578767|NCT00106691|62975999|FG000|Overall Study|Physician Decision|18|||
33578768|NCT00106691|62976000|FG001|Overall Study|Physician Decision|21|||
33578769|NCT00106691|62975999|FG000|Overall Study|Protocol Violation|13|||
33578770|NCT00106691|62976000|FG001|Overall Study|Protocol Violation|18|||
33578771|NCT00106691|62975999|FG000|Overall Study|Withdrawal by Subject|75|||
33578772|NCT00106691|62976000|FG001|Overall Study|Withdrawal by Subject|70|||
33578773|NCT00106691|62975999|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
33578774|NCT00106691|62976000|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
33578775|NCT00106691|62975999|FG000|Overall Study|QTc>480|3|||
33578776|NCT00106691|62976000|FG001|Overall Study|QTc>480|1|||
33578777|NCT00106691|62975999|FG000|Overall Study|mililtary deployment|2|||
33578778|NCT00106691|62976000|FG001|Overall Study|mililtary deployment|0|||
33578779|NCT00106691|62975999|FG000|Overall Study|Study Site Closing/PI Moved|1|||
33578780|NCT00106691|62976000|FG001|Overall Study|Study Site Closing/PI Moved|2|||
33578781|NCT00106691|62975999|FG000|Overall Study|Cardiologist recommendation|1|||
33578782|NCT00106691|62976000|FG001|Overall Study|Cardiologist recommendation|0|||
33578783|NCT00106691|62975999|FG000|Overall Study|Pt. moved to another state|1|||
33578784|NCT00106691|62976000|FG001|Overall Study|Pt. moved to another state|0|||
33578785|NCT00106691|62975999|FG000|Overall Study|Taking exclusionary avodart|1|||
33578786|NCT00106691|62976000|FG001|Overall Study|Taking exclusionary avodart|0|||
33578787|NCT00106691|62975999|FG000|Overall Study|Not able to discontinue plavix|0|||
33578788|NCT00106691|62976000|FG001|Overall Study|Not able to discontinue plavix|1|||
33578789|NCT04209725|62976008|FG000|Overall Study|Adverse Event|1|||
33578790|NCT02644967|62976101|FG000|Overall Study|Death|26|||
33578791|NCT02644967|62976101|FG000|Overall Study|Physician Decision|1|||
33578792|NCT02644967|62976101|FG000|Overall Study|Withdrawal by Subject|2|||
33578793|NCT02644967|62976101|FG000|Overall Study|Protocol Violation|1|||
33578794|NCT02644967|62976101|FG000|Overall Study|Progressive Disease|1|||
33578795|NCT02644967|62976101|FG000|Overall Study|Study Terminated by Sponsor|4|||
33578796|NCT02644343|62976105|FG000|Overall Study|Withdrawal by Subject|1|||
33578797|NCT02644109|62976111|FG000|Overall Study|Adverse Event|0|||
33578798|NCT02644109|62976112|FG001|Overall Study|Adverse Event|4|||
33578799|NCT02642159|62976120|FG000|Overall Study|Randomized but not treated|1|||
33578800|NCT02642159|62976121|FG001|Overall Study|Randomized but not treated|0|||
33578801|NCT02642159|62976120|FG000|Overall Study|Adverse Event|10|||
33578802|NCT02642159|62976121|FG001|Overall Study|Adverse Event|4|||
33578803|NCT02642159|62976120|FG000|Overall Study|Withdrawal by Subject|9|||
33578804|NCT02642159|62976121|FG001|Overall Study|Withdrawal by Subject|1|||
33578805|NCT02642159|62976120|FG000|Overall Study|Poor compliance to study protocol|1|||
33578806|NCT02642159|62976121|FG001|Overall Study|Poor compliance to study protocol|0|||
33578807|NCT02642159|62976120|FG000|Overall Study|Other than specified above|10|||
33578808|NCT02642159|62976121|FG001|Overall Study|Other than specified above|3|||
33578809|NCT02669017|62976137|FG000|Overall Study|Death|1|||
33578810|NCT02669017|62976138|FG001|Overall Study|Death|2|||
33578811|NCT02669017|62976139|FG002|Overall Study|Death|2|||
33578812|NCT02669017|62976140|FG003|Overall Study|Death|3|||
33578813|NCT02669017|62976141|FG004|Overall Study|Death|8|||
33578814|NCT02669017|62976142|FG005|Overall Study|Death|18|||
33578815|NCT02669017|62976143|FG006|Overall Study|Death|10|||
33578816|NCT02669017|62976144|FG007|Overall Study|Death|47|||
33578817|NCT02669017|62976145|FG008|Overall Study|Death|20|||
33578818|NCT02669017|62976137|FG000|Overall Study|Withdrawal by Subject|0|||
33578819|NCT02669017|62976138|FG001|Overall Study|Withdrawal by Subject|0|||
33578820|NCT02669017|62976139|FG002|Overall Study|Withdrawal by Subject|0|||
33578821|NCT02669017|62976140|FG003|Overall Study|Withdrawal by Subject|1|||
33578822|NCT02669017|62976141|FG004|Overall Study|Withdrawal by Subject|2|||
33578823|NCT02669017|62976142|FG005|Overall Study|Withdrawal by Subject|0|||
33578824|NCT02669017|62976143|FG006|Overall Study|Withdrawal by Subject|0|||
33578825|NCT02669017|62976144|FG007|Overall Study|Withdrawal by Subject|2|||
33578826|NCT02669017|62976145|FG008|Overall Study|Withdrawal by Subject|2|||
33578827|NCT02669017|62976137|FG000|Overall Study|Lost to Follow-up|0|||
33578828|NCT02669017|62976138|FG001|Overall Study|Lost to Follow-up|0|||
33578829|NCT02669017|62976139|FG002|Overall Study|Lost to Follow-up|0|||
33578830|NCT02669017|62976140|FG003|Overall Study|Lost to Follow-up|0|||
33578831|NCT02669017|62976141|FG004|Overall Study|Lost to Follow-up|0|||
33578832|NCT02669017|62976142|FG005|Overall Study|Lost to Follow-up|0|||
33578833|NCT02669017|62976143|FG006|Overall Study|Lost to Follow-up|0|||
33578834|NCT02669017|62976144|FG007|Overall Study|Lost to Follow-up|0|||
33578835|NCT02669017|62976145|FG008|Overall Study|Lost to Follow-up|1|||
33578836|NCT02669017|62976137|FG000|Overall Study|Miscellaneous|0|||
33578837|NCT02669017|62976138|FG001|Overall Study|Miscellaneous|0|||
33578838|NCT02669017|62976139|FG002|Overall Study|Miscellaneous|0|||
33578839|NCT02669017|62976140|FG003|Overall Study|Miscellaneous|0|||
33578840|NCT02669017|62976141|FG004|Overall Study|Miscellaneous|2|||
33578841|NCT02669017|62976142|FG005|Overall Study|Miscellaneous|1|||
33578842|NCT02669017|62976143|FG006|Overall Study|Miscellaneous|1|||
33578843|NCT02669017|62976144|FG007|Overall Study|Miscellaneous|13|||
33578844|NCT02669017|62976145|FG008|Overall Study|Miscellaneous|2|||
33578845|NCT02668393|62976175|FG000|Overall Study|Progressive disease|6|||
33578846|NCT02668393|62976176|FG001|Overall Study|Progressive disease|3|||
33578847|NCT02668393|62976175|FG000|Overall Study|Adverse Event|0|||
33578848|NCT02668393|62976176|FG001|Overall Study|Adverse Event|2|||
33578849|NCT02668393|62976175|FG000|Overall Study|Withdrawal from the trial|0|||
33578850|NCT02668393|62976176|FG001|Overall Study|Withdrawal from the trial|1|||
33578851|NCT02668393|62976175|FG000|Overall Study|Lack of benefit and side effects|1|||
33578852|NCT02668393|62976176|FG001|Overall Study|Lack of benefit and side effects|0|||
33578853|NCT01998958|62976190|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578854|NCT01998958|62976191|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
33578855|NCT01998958|62976192|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578856|NCT01998958|62976193|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578857|NCT01998958|62976194|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578858|NCT01998958|62976195|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578859|NCT01998958|62976196|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578860|NCT01998958|62976197|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578861|NCT01998958|62976198|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578862|NCT01998958|62976199|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578863|NCT01998958|62976200|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578864|NCT01998958|62976201|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578865|NCT01998958|62976202|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578866|NCT01998958|62976203|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578867|NCT01998958|62976204|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578868|NCT01998958|62976205|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578869|NCT01998958|62976206|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578870|NCT01998958|62976207|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578871|NCT01998958|62976208|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578872|NCT01998958|62976209|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578873|NCT01998958|62976210|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578874|NCT01998958|62976211|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578875|NCT01998958|62976212|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578876|NCT01998958|62976213|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578877|NCT01998958|62976214|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578878|NCT01998958|62976215|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578879|NCT01998958|62976216|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578880|NCT01998958|62976217|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578881|NCT01998958|62976218|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578882|NCT01998958|62976219|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578883|NCT01998958|62976220|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578884|NCT01998958|62976221|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33578885|NCT01998958|62976190|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578886|NCT01998958|62976191|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
33578887|NCT01998958|62976192|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578888|NCT01998958|62976193|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578889|NCT01998958|62976194|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578890|NCT01998958|62976195|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578891|NCT01998958|62976196|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578892|NCT01998958|62976197|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578893|NCT01998958|62976198|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578894|NCT01998958|62976199|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578895|NCT01998958|62976200|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578896|NCT01998958|62976201|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578897|NCT01998958|62976202|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578898|NCT01998958|62976203|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578899|NCT01998958|62976204|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578900|NCT01998958|62976205|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578901|NCT01998958|62976206|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578902|NCT01998958|62976207|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578903|NCT01998958|62976208|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578904|NCT01998958|62976209|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578905|NCT01998958|62976210|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578906|NCT01998958|62976211|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578907|NCT01998958|62976212|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578908|NCT01998958|62976213|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578909|NCT01998958|62976214|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578910|NCT01998958|62976215|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578911|NCT01998958|62976216|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578912|NCT01998958|62976217|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578913|NCT01998958|62976218|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578914|NCT01998958|62976219|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578915|NCT01998958|62976220|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578916|NCT01998958|62976221|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33578917|NCT01998958|62976190|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
33578918|NCT01998958|62976191|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
33307277|NCT01001572|62682618|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
33578919|NCT01998958|62976192|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
33578920|NCT01998958|62976193|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
33578921|NCT01998958|62976194|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
33578922|NCT01998958|62976195|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
33578923|NCT01998958|62976196|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
33578924|NCT01998958|62976197|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
33578925|NCT01998958|62976198|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
33578926|NCT01998958|62976199|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
33578927|NCT01998958|62976200|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
33578928|NCT01998958|62976201|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
33578929|NCT01998958|62976202|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
33578930|NCT01998958|62976203|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
33578931|NCT01998958|62976204|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
33578932|NCT01998958|62976205|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
33578933|NCT01998958|62976206|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
33578934|NCT01998958|62976207|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
33578935|NCT01998958|62976208|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
33578936|NCT01998958|62976209|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
33578937|NCT01998958|62976210|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
33578938|NCT01998958|62976211|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
33578939|NCT01998958|62976212|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
33578940|NCT01998958|62976213|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
33578941|NCT01998958|62976214|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
33578942|NCT01998958|62976215|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
33578943|NCT01998958|62976216|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
33578944|NCT01998958|62976217|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
33578945|NCT01998958|62976218|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
33578946|NCT01998958|62976219|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
33578947|NCT01998958|62976220|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
33578948|NCT01998958|62976221|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
33578949|NCT01998958|62976190|FG000|Period 1 (Panel A and B)|Other|1|||
33578950|NCT01998958|62976191|FG001|Period 1 (Panel A and B)|Other|0|||
33578951|NCT01998958|62976192|FG002|Period 1 (Panel A and B)|Other|0|||
33578952|NCT01998958|62976193|FG003|Period 1 (Panel A and B)|Other|0|||
33578953|NCT01998958|62976194|FG004|Period 1 (Panel A and B)|Other|0|||
33578954|NCT01998958|62976195|FG005|Period 1 (Panel A and B)|Other|0|||
33578955|NCT01998958|62976196|FG006|Period 1 (Panel A and B)|Other|0|||
33578956|NCT01998958|62976197|FG007|Period 1 (Panel A and B)|Other|0|||
33578957|NCT01998958|62976198|FG008|Period 1 (Panel A and B)|Other|0|||
33578958|NCT01998958|62976199|FG009|Period 1 (Panel A and B)|Other|0|||
33578959|NCT01998958|62976200|FG010|Period 1 (Panel A and B)|Other|0|||
33578960|NCT01998958|62976201|FG011|Period 1 (Panel A and B)|Other|0|||
33578961|NCT01998958|62976202|FG012|Period 1 (Panel A and B)|Other|0|||
33578962|NCT01998958|62976203|FG013|Period 1 (Panel A and B)|Other|0|||
33578963|NCT01998958|62976204|FG014|Period 1 (Panel A and B)|Other|0|||
33668407|NCT01456949|63102420|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
33668408|NCT01456949|63102420|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
33668409|NCT01456169|63102427|FG000|Overall Study|Adverse Event|1|||
33668410|NCT01456169|63102428|FG001|Overall Study|Adverse Event|2|||
33668411|NCT01456169|63102429|FG002|Overall Study|Adverse Event|7|||
33668412|NCT01456169|63102427|FG000|Overall Study|Major Protocol Deviation|3|||
33668413|NCT01456169|63102428|FG001|Overall Study|Major Protocol Deviation|2|||
33668414|NCT01456169|63102429|FG002|Overall Study|Major Protocol Deviation|3|||
33668415|NCT01456169|63102427|FG000|Overall Study|Voluntary Withdrawal|3|||
33668416|NCT01456169|63102428|FG001|Overall Study|Voluntary Withdrawal|0|||
33668417|NCT01456169|63102429|FG002|Overall Study|Voluntary Withdrawal|2|||
33668418|NCT01456169|63102427|FG000|Overall Study|Lack of Efficacy|2|||
33668419|NCT01456169|63102428|FG001|Overall Study|Lack of Efficacy|0|||
33668420|NCT01456169|63102429|FG002|Overall Study|Lack of Efficacy|0|||
33668421|NCT01456169|63102427|FG000|Overall Study|Other|1|||
33668422|NCT01456169|63102428|FG001|Overall Study|Other|1|||
33668423|NCT01456169|63102429|FG002|Overall Study|Other|0|||
33668424|NCT01454531|63102438|FG000|Overall Study|Adverse Event|14|||
33668425|NCT01454531|63102438|FG000|Overall Study|Withdrawal by Subject|5|||
33668426|NCT01454531|63102438|FG000|Overall Study|Lost to Follow-up|1|||
33668427|NCT01454531|63102438|FG000|Overall Study|Physician Decision|1|||
33668428|NCT01454531|63102438|FG000|Overall Study|Delay in IMP administration|1|||
33668429|NCT01454531|63102438|FG000|Overall Study|Other|1|||
33668430|NCT01454063|63102444|FG000|Randomized|Adverse Event|1|||
33668431|NCT01454063|63102445|FG001|Randomized|Adverse Event|1|||
33668432|NCT01454063|63102444|FG000|Randomized|Protocol Violation|0|||
33668433|NCT01454063|63102445|FG001|Randomized|Protocol Violation|1|||
33668434|NCT01453595|63102454|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
33668435|NCT01453595|63102455|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
33668436|NCT01453595|63102456|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
33578964|NCT01998958|62976205|FG015|Period 1 (Panel A and B)|Other|0|||
33578965|NCT01998958|62976206|FG016|Period 1 (Panel A and B)|Other|0|||
33578966|NCT01998958|62976207|FG017|Period 1 (Panel A and B)|Other|0|||
33668437|NCT01453439|63102464|FG000|Treatment Phase|Withdrawal by Subject|13|||
33578967|NCT01998958|62976208|FG018|Period 1 (Panel A and B)|Other|0|||
33668438|NCT01453439|63102465|FG001|Treatment Phase|Withdrawal by Subject|10|||
33668439|NCT01453439|63102464|FG000|Treatment Phase|Suicidal Ideation|2|||
33668440|NCT01453439|63102465|FG001|Treatment Phase|Suicidal Ideation|0|||
33668441|NCT01453439|63102464|FG000|Treatment Phase|Need for higher level of care|1|||
33668442|NCT01453439|63102465|FG001|Treatment Phase|Need for higher level of care|1|||
33668443|NCT01453439|63102464|FG000|Treatment Phase|Therapist conflict of interest|1|||
33668444|NCT01453439|63102465|FG001|Treatment Phase|Therapist conflict of interest|0|||
33668445|NCT01453439|63102464|FG000|Follow-up|Withdrawal by Subject|0|||
33668446|NCT01453439|63102465|FG001|Follow-up|Withdrawal by Subject|1|||
33668447|NCT01453439|63102464|FG000|Follow-up|Lost to Follow-up|5|||
33668448|NCT01453439|63102465|FG001|Follow-up|Lost to Follow-up|10|||
33668449|NCT01453361|63102471|FG000|Overall Study|Disease Progression|6|||
33668450|NCT01453361|63102471|FG000|Overall Study|Screen-Failures|10|||
33668451|NCT01585298|63102475|FG000|Overall Study|Study completion was not documented.|1|||
33668452|NCT01585298|63102475|FG000|Overall Study|Protocol deviation|1|||
33668453|NCT01585298|63102475|FG000|Overall Study|Administrative problems|4|||
33668454|NCT01585298|63102475|FG000|Overall Study|Lost to Follow-up|2|||
33668455|NCT01585298|63102475|FG000|Overall Study|Withdrawal by Subject|4|||
33668456|NCT01585298|63102475|FG000|Overall Study|Abnormal test procedure results|1|||
33668457|NCT01585298|63102475|FG000|Overall Study|Adverse Event|24|||
33668458|NCT01453205|63102482|FG000|Overall Study|Lost to Follow-up|3|||
33668459|NCT01453205|63102483|FG001|Overall Study|Lost to Follow-up|0|||
33668460|NCT01453205|63102484|FG002|Overall Study|Lost to Follow-up|1|||
33668461|NCT01453205|63102482|FG000|Overall Study|Withdrawal by Subject|8|||
33668462|NCT01453205|63102483|FG001|Overall Study|Withdrawal by Subject|3|||
33668463|NCT01453205|63102484|FG002|Overall Study|Withdrawal by Subject|0|||
33668464|NCT01453205|63102482|FG000|Overall Study|Death|24|||
33668465|NCT01453205|63102483|FG001|Overall Study|Death|22|||
33668466|NCT01453205|63102484|FG002|Overall Study|Death|18|||
33668467|NCT01453205|63102482|FG000|Overall Study|Other|45|||
33668468|NCT01453205|63102483|FG001|Overall Study|Other|27|||
33668469|NCT01453205|63102484|FG002|Overall Study|Other|35|||
33668470|NCT01453049|63102497|FG000|Overall Study|Protocol Violation|2|||
33668471|NCT01453049|63102498|FG001|Overall Study|Protocol Violation|5|||
33668472|NCT01453049|63102497|FG000|Overall Study|Lost to Follow-up|2|||
33668473|NCT01453049|63102498|FG001|Overall Study|Lost to Follow-up|1|||
33668474|NCT01453049|63102497|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
33668475|NCT01453049|63102498|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
33668476|NCT01453049|63102497|FG000|Overall Study|Withdrawal by Subject|1|||
33668477|NCT01453049|63102498|FG001|Overall Study|Withdrawal by Subject|0|||
33668478|NCT01453049|63102497|FG000|Overall Study|Randomized in Error|1|||
33668479|NCT01453049|63102498|FG001|Overall Study|Randomized in Error|0|||
33668480|NCT01452347|63102506|FG000|Overall Study|Adverse Event|2|||
33668481|NCT01452347|63102507|FG001|Overall Study|Adverse Event|1|||
33668482|NCT01452347|63102506|FG000|Overall Study|Non compliance protocol|2|||
33668483|NCT01452347|63102507|FG001|Overall Study|Non compliance protocol|0|||
33668484|NCT01452347|63102506|FG000|Overall Study|Lost to Follow-up|2|||
33668485|NCT01452347|63102507|FG001|Overall Study|Lost to Follow-up|0|||
33668486|NCT01452347|63102506|FG000|Overall Study|Withdrawal by Subject|3|||
33668487|NCT01452347|63102507|FG001|Overall Study|Withdrawal by Subject|3|||
33668488|NCT01452347|63102506|FG000|Overall Study|Not treated|6|||
33668489|NCT01452347|63102507|FG001|Overall Study|Not treated|3|||
33668490|NCT01452347|63102506|FG000|Overall Study|Other reason not defined above|2|||
33668491|NCT01452347|63102507|FG001|Overall Study|Other reason not defined above|0|||
33668492|NCT01451723|63102517|FG000|Overall Study|study halted|6|||
33668493|NCT01451723|63102518|FG001|Overall Study|study halted|5|||
33668494|NCT01451645|63102526|FG000|Overall Study|Protocol Violation|1|||
33668495|NCT01451645|63102527|FG001|Overall Study|Protocol Violation|0|||
33668496|NCT01451645|63102526|FG000|Overall Study|Adverse Event|0|||
33668497|NCT01451645|63102527|FG001|Overall Study|Adverse Event|3|||
33668498|NCT01451645|63102526|FG000|Overall Study|Withdrawal by Subject|4|||
33668499|NCT01451645|63102527|FG001|Overall Study|Withdrawal by Subject|2|||
33668500|NCT01451645|63102526|FG000|Overall Study|Lost to Follow-up|4|||
33668501|NCT01451645|63102527|FG001|Overall Study|Lost to Follow-up|3|||
33668502|NCT01450943|63102536|FG000|Overall Study|Screen failure, loss to follow-up|2|||
33668503|NCT01450943|63102537|FG001|Overall Study|Screen failure, loss to follow-up|7|||
33668504|NCT01450943|63102538|FG002|Overall Study|Screen failure, loss to follow-up|6|||
33668505|NCT01450631|63102552|FG000|Overall Study|Lost to Follow-up|2|||
33668506|NCT01450631|63102553|FG001|Overall Study|Lost to Follow-up|4|||
33668507|NCT01450631|63102552|FG000|Overall Study|Withdrawal by Subject|1|||
33668508|NCT01450631|63102553|FG001|Overall Study|Withdrawal by Subject|0|||
33668509|NCT01450007|63102562|FG000|Overall Study|Late exclusion before treatment|2|||
33668510|NCT01450007|63102563|FG001|Overall Study|Late exclusion before treatment|3|||
33668511|NCT01450007|63102564|FG002|Overall Study|Late exclusion before treatment|2|||
33668512|NCT01450007|63102562|FG000|Overall Study|Protocol Violation|0|||
33668513|NCT01450007|63102563|FG001|Overall Study|Protocol Violation|1|||
33668514|NCT01450007|63102564|FG002|Overall Study|Protocol Violation|1|||
33668515|NCT01450007|63102562|FG000|Overall Study|Adverse Event|0|||
33668516|NCT01450007|63102563|FG001|Overall Study|Adverse Event|1|||
33668517|NCT01450007|63102564|FG002|Overall Study|Adverse Event|0|||
33668518|NCT01496365|63102579|FG000|Overall Study|Adverse Event|2|||
33668519|NCT01496365|63102580|FG001|Overall Study|Adverse Event|3|||
33668520|NCT01496365|63102581|FG002|Overall Study|Adverse Event|3|||
33668521|NCT01496365|63102582|FG003|Overall Study|Adverse Event|2|||
33668522|NCT01496365|63102583|FG004|Overall Study|Adverse Event|5|||
33668523|NCT01496365|63102584|FG005|Overall Study|Adverse Event|6|||
33668524|NCT01496365|63102585|FG006|Overall Study|Adverse Event|4|||
33668525|NCT01496365|63102579|FG000|Overall Study|Withdrawal by Subject|6|||
33668526|NCT01496365|63102580|FG001|Overall Study|Withdrawal by Subject|6|||
33668527|NCT01496365|63102581|FG002|Overall Study|Withdrawal by Subject|0|||
33668528|NCT01496365|63102582|FG003|Overall Study|Withdrawal by Subject|1|||
33668529|NCT01496365|63102583|FG004|Overall Study|Withdrawal by Subject|3|||
33668530|NCT01496365|63102584|FG005|Overall Study|Withdrawal by Subject|2|||
33668531|NCT01496365|63102585|FG006|Overall Study|Withdrawal by Subject|1|||
33668532|NCT01496365|63102579|FG000|Overall Study|Protocol Violation|2|||
33668533|NCT01496365|63102580|FG001|Overall Study|Protocol Violation|1|||
33668534|NCT01496365|63102581|FG002|Overall Study|Protocol Violation|1|||
33668535|NCT01496365|63102582|FG003|Overall Study|Protocol Violation|0|||
33668536|NCT01496365|63102583|FG004|Overall Study|Protocol Violation|0|||
33668537|NCT01496365|63102584|FG005|Overall Study|Protocol Violation|1|||
33668538|NCT01496365|63102585|FG006|Overall Study|Protocol Violation|0|||
33668539|NCT01496365|63102579|FG000|Overall Study|Lack of Efficacy|1|||
33668540|NCT01496365|63102580|FG001|Overall Study|Lack of Efficacy|0|||
33668541|NCT01496365|63102581|FG002|Overall Study|Lack of Efficacy|0|||
33668542|NCT01496365|63102582|FG003|Overall Study|Lack of Efficacy|0|||
33668543|NCT01496365|63102583|FG004|Overall Study|Lack of Efficacy|0|||
33668544|NCT01496365|63102584|FG005|Overall Study|Lack of Efficacy|1|||
33668545|NCT01496365|63102585|FG006|Overall Study|Lack of Efficacy|0|||
33668546|NCT01496365|63102579|FG000|Overall Study|Lost to Follow-up|0|||
33668547|NCT01496365|63102580|FG001|Overall Study|Lost to Follow-up|1|||
33668548|NCT01496365|63102581|FG002|Overall Study|Lost to Follow-up|0|||
33668549|NCT01496365|63102582|FG003|Overall Study|Lost to Follow-up|0|||
33668550|NCT01496365|63102583|FG004|Overall Study|Lost to Follow-up|2|||
33668551|NCT01496365|63102584|FG005|Overall Study|Lost to Follow-up|0|||
33668552|NCT01496365|63102585|FG006|Overall Study|Lost to Follow-up|0|||
33668553|NCT01496365|63102579|FG000|Overall Study|Other|4|||
33668554|NCT01496365|63102580|FG001|Overall Study|Other|4|||
33668555|NCT01496365|63102581|FG002|Overall Study|Other|2|||
33668556|NCT01496365|63102582|FG003|Overall Study|Other|1|||
33668557|NCT01496365|63102583|FG004|Overall Study|Other|3|||
33668558|NCT01496365|63102584|FG005|Overall Study|Other|0|||
33668559|NCT01496365|63102585|FG006|Overall Study|Other|1|||
33668560|NCT01496287|63102601|FG000|Overall Study|Lost to Follow-up|1|||
33307278|NCT01001572|62682616|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33307279|NCT01001572|62682617|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33307280|NCT01001572|62682618|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
33307281|NCT01208415|62682624|FG000|Overall Study|Death|1|||
33307282|NCT01208415|62682624|FG000|Overall Study|Lost to Follow-up|2|||
33307283|NCT01208415|62682624|FG000|Overall Study|Withdrawal by Subject|3|||
33307284|NCT01208415|62682624|FG000|Overall Study|Device not placed|1|||
33307285|NCT01208415|62682624|FG000|Overall Study|Still be eligible for follow-up|33|||
33307286|NCT01208337|62682628|FG000|Overall Study|Death|3|||
33307287|NCT01208181|62682644|FG000|Part 1|Withdrawal by Subject|11|||
33307288|NCT01208181|62682645|FG001|Part 1|Withdrawal by Subject|10|||
33307289|NCT01208181|62682646|FG002|Part 1|Withdrawal by Subject|0|||
33307290|NCT01208181|62682647|FG003|Part 1|Withdrawal by Subject|0|||
33307291|NCT01208181|62682648|FG004|Part 1|Withdrawal by Subject|0|||
33307292|NCT01208181|62682644|FG000|Part 1|Technical problem|5|||
33307293|NCT01208181|62682645|FG001|Part 1|Technical problem|0|||
33307294|NCT01208181|62682646|FG002|Part 1|Technical problem|0|||
33307295|NCT01208181|62682647|FG003|Part 1|Technical problem|0|||
33307296|NCT01208181|62682648|FG004|Part 1|Technical problem|0|||
33307297|NCT01208181|62682644|FG000|Part 1|Protocol Violation|10|||
33307298|NCT01208181|62682645|FG001|Part 1|Protocol Violation|5|||
33307299|NCT01208181|62682646|FG002|Part 1|Protocol Violation|0|||
33307300|NCT01208181|62682647|FG003|Part 1|Protocol Violation|0|||
33307301|NCT01208181|62682648|FG004|Part 1|Protocol Violation|0|||
33307302|NCT01208181|62682644|FG000|Part 1|Physician Decision|4|||
33307303|NCT01208181|62682645|FG001|Part 1|Physician Decision|0|||
33307304|NCT01208181|62682646|FG002|Part 1|Physician Decision|0|||
33307305|NCT01208181|62682647|FG003|Part 1|Physician Decision|0|||
33307306|NCT01208181|62682648|FG004|Part 1|Physician Decision|0|||
33307307|NCT01208181|62682644|FG000|Part 1|Non-compliance with study drug|1|||
33307308|NCT01208181|62682645|FG001|Part 1|Non-compliance with study drug|1|||
33668561|NCT01496287|63102601|FG000|Overall Study|Incomplete anesthesia|5|||
33668562|NCT01495975|63102608|FG000|Overall Study|Lost to Follow-up|1|||
33307309|NCT01208181|62682646|FG002|Part 1|Non-compliance with study drug|0|||
33668563|NCT01495975|63102609|FG001|Overall Study|Lost to Follow-up|0|||
33668564|NCT01468987|63102617|FG000|Overall Study|Adverse Event|12|||
33668565|NCT01468987|63102618|FG001|Overall Study|Adverse Event|9|||
33307310|NCT01208181|62682647|FG003|Part 1|Non-compliance with study drug|0|||
33307311|NCT01208181|62682648|FG004|Part 1|Non-compliance with study drug|0|||
33307312|NCT01208181|62682644|FG000|Part 1|Lost to Follow-up|5|||
33307313|NCT01208181|62682645|FG001|Part 1|Lost to Follow-up|3|||
33307314|NCT01208181|62682646|FG002|Part 1|Lost to Follow-up|0|||
33307315|NCT01208181|62682647|FG003|Part 1|Lost to Follow-up|0|||
33307316|NCT01208181|62682648|FG004|Part 1|Lost to Follow-up|1|||
33307317|NCT01208181|62682644|FG000|Part 1|Lack of Efficacy|37|||
33307318|NCT01208181|62682645|FG001|Part 1|Lack of Efficacy|12|||
33307319|NCT01208181|62682646|FG002|Part 1|Lack of Efficacy|0|||
33307320|NCT01208181|62682647|FG003|Part 1|Lack of Efficacy|0|||
33307321|NCT01208181|62682648|FG004|Part 1|Lack of Efficacy|17|||
33307322|NCT01208181|62682644|FG000|Part 1|Adverse Event|26|||
33307323|NCT01208181|62682645|FG001|Part 1|Adverse Event|24|||
33307324|NCT01208181|62682646|FG002|Part 1|Adverse Event|0|||
33307325|NCT01208181|62682647|FG003|Part 1|Adverse Event|0|||
33307326|NCT01208181|62682648|FG004|Part 1|Adverse Event|4|||
33307327|NCT01208181|62682644|FG000|Part 2|Adverse Event|0|||
33307328|NCT01208181|62682645|FG001|Part 2|Adverse Event|0|||
33307329|NCT01208181|62682646|FG002|Part 2|Adverse Event|6|||
33307330|NCT01208181|62682647|FG003|Part 2|Adverse Event|7|||
33307331|NCT01208181|62682648|FG004|Part 2|Adverse Event|0|||
33307332|NCT01208181|62682644|FG000|Part 2|Withdrawal by Subject|0|||
33307333|NCT01208181|62682645|FG001|Part 2|Withdrawal by Subject|0|||
33307334|NCT01208181|62682646|FG002|Part 2|Withdrawal by Subject|1|||
33307335|NCT01208181|62682647|FG003|Part 2|Withdrawal by Subject|1|||
33307336|NCT01208181|62682648|FG004|Part 2|Withdrawal by Subject|0|||
33307337|NCT01208181|62682644|FG000|Part 2|Protocol Violation|0|||
33307338|NCT01208181|62682645|FG001|Part 2|Protocol Violation|0|||
33307339|NCT01208181|62682646|FG002|Part 2|Protocol Violation|1|||
33307340|NCT01208181|62682647|FG003|Part 2|Protocol Violation|0|||
33307341|NCT01208181|62682648|FG004|Part 2|Protocol Violation|0|||
33307342|NCT01208181|62682644|FG000|Part 2|Physician Decision|0|||
33307343|NCT01208181|62682645|FG001|Part 2|Physician Decision|0|||
33307344|NCT01208181|62682646|FG002|Part 2|Physician Decision|1|||
33307345|NCT01208181|62682647|FG003|Part 2|Physician Decision|2|||
33307346|NCT01208181|62682648|FG004|Part 2|Physician Decision|0|||
33307347|NCT01208181|62682644|FG000|Part 2|Non-compliance with study drug|0|||
33307348|NCT01208181|62682645|FG001|Part 2|Non-compliance with study drug|0|||
33307349|NCT01208181|62682646|FG002|Part 2|Non-compliance with study drug|1|||
33307350|NCT01208181|62682647|FG003|Part 2|Non-compliance with study drug|1|||
33307351|NCT01208181|62682648|FG004|Part 2|Non-compliance with study drug|0|||
33307352|NCT01208181|62682644|FG000|Part 2|Lost to Follow-up|0|||
33307353|NCT01208181|62682645|FG001|Part 2|Lost to Follow-up|0|||
33307354|NCT01208181|62682646|FG002|Part 2|Lost to Follow-up|1|||
33307355|NCT01208181|62682647|FG003|Part 2|Lost to Follow-up|2|||
33307356|NCT01208181|62682648|FG004|Part 2|Lost to Follow-up|0|||
33307357|NCT01208181|62682644|FG000|Part 2|Lack of Efficacy|0|||
33307358|NCT01208181|62682645|FG001|Part 2|Lack of Efficacy|0|||
33307359|NCT01208181|62682646|FG002|Part 2|Lack of Efficacy|5|||
33307360|NCT01208181|62682647|FG003|Part 2|Lack of Efficacy|7|||
33307361|NCT01208181|62682648|FG004|Part 2|Lack of Efficacy|0|||
33307362|NCT01208103|62682665|FG000|Overall Study|Adverse Event|1|||
33307363|NCT01208103|62682665|FG000|Overall Study|Withdrawal by Subject|1|||
33307364|NCT01206777|62682670|FG000|Overall Study|Death|1|||
33307365|NCT01206777|62682670|FG000|Overall Study|Adverse Event|1|||
33307366|NCT01001494|62682677|FG000|Overall Study|Adverse Event|8|||
33307367|NCT01001494|62682678|FG001|Overall Study|Adverse Event|4|||
33307368|NCT01001494|62682679|FG002|Overall Study|Adverse Event|6|||
33307369|NCT01001494|62682677|FG000|Overall Study|Protocol Violation|0|||
33307370|NCT01001494|62682678|FG001|Overall Study|Protocol Violation|1|||
33307371|NCT01001494|62682679|FG002|Overall Study|Protocol Violation|1|||
33307372|NCT01001494|62682677|FG000|Overall Study|Lost to Follow-up|2|||
33307373|NCT01001494|62682678|FG001|Overall Study|Lost to Follow-up|0|||
33307374|NCT01001494|62682679|FG002|Overall Study|Lost to Follow-up|1|||
33307375|NCT01001494|62682677|FG000|Overall Study|Withdrawal by Subject|9|||
33307376|NCT01001494|62682678|FG001|Overall Study|Withdrawal by Subject|7|||
33307377|NCT01001494|62682679|FG002|Overall Study|Withdrawal by Subject|17|||
33307378|NCT01001494|62682677|FG000|Overall Study|COPD exacerbation|3|||
33307379|NCT01001494|62682678|FG001|Overall Study|COPD exacerbation|4|||
33307380|NCT01001494|62682679|FG002|Overall Study|COPD exacerbation|5|||
33307381|NCT01001494|62682677|FG000|Overall Study|Lack of Efficacy|2|||
33307382|NCT01001494|62682678|FG001|Overall Study|Lack of Efficacy|0|||
33307383|NCT01001494|62682679|FG002|Overall Study|Lack of Efficacy|8|||
33307384|NCT01001494|62682677|FG000|Overall Study|Other|0|||
33307385|NCT01001494|62682678|FG001|Overall Study|Other|1|||
33307386|NCT01001494|62682679|FG002|Overall Study|Other|3|||
33307387|NCT01205685|62682687|FG000|Overall Study|Disease Progression|10|||
33307388|NCT01205685|62682687|FG000|Overall Study|Withdrawal by Subject|1|||
33307389|NCT01205529|62682691|FG000|Overall Study|Procedure Cancelled|4|||
33307390|NCT01205529|62682691|FG000|Overall Study|Withdrawal by Subject|2|||
33307391|NCT01205529|62682691|FG000|Overall Study|Physician Decision|4|||
33307392|NCT01205529|62682691|FG000|Overall Study|Unstable post op|15|||
33307393|NCT01205529|62682691|FG000|Overall Study|No longer met criteria|30|||
33307394|NCT01205451|62682697|FG000|Overall Study|Lost to Follow-up|1|||
33307395|NCT01205451|62682698|FG001|Overall Study|Lost to Follow-up|1|||
33307396|NCT01205451|62682697|FG000|Overall Study|Withdrawal by Subject|5|||
33307397|NCT01205451|62682698|FG001|Overall Study|Withdrawal by Subject|9|||
33307398|NCT01001104|62682708|FG000|Overall Study|Adverse Event|2|||
33307399|NCT01001104|62682709|FG001|Overall Study|Adverse Event|1|||
33307400|NCT01001104|62682710|FG002|Overall Study|Adverse Event|0|||
33307401|NCT01001104|62682711|FG003|Overall Study|Adverse Event|0|||
33307402|NCT01001104|62682708|FG000|Overall Study|Lost to Follow-up|0|||
33307403|NCT01001104|62682709|FG001|Overall Study|Lost to Follow-up|0|||
33307404|NCT01001104|62682710|FG002|Overall Study|Lost to Follow-up|1|||
33307405|NCT01001104|62682711|FG003|Overall Study|Lost to Follow-up|0|||
33307406|NCT01001104|62682708|FG000|Overall Study|Entry Criteria Not Met|0|||
33307407|NCT01001104|62682709|FG001|Overall Study|Entry Criteria Not Met|0|||
33307408|NCT01001104|62682710|FG002|Overall Study|Entry Criteria Not Met|0|||
33307409|NCT01001104|62682711|FG003|Overall Study|Entry Criteria Not Met|1|||
33307410|NCT01001104|62682708|FG000|Overall Study|Withdrawal by Subject|0|||
33307411|NCT01001104|62682709|FG001|Overall Study|Withdrawal by Subject|0|||
33307412|NCT01001104|62682710|FG002|Overall Study|Withdrawal by Subject|0|||
33307413|NCT01001104|62682711|FG003|Overall Study|Withdrawal by Subject|2|||
33307414|NCT00998764|62682726|FG000|Overall Study|Lack of Efficacy|3|||
33307415|NCT00998764|62682727|FG001|Overall Study|Lack of Efficacy|6|||
33307416|NCT00998764|62682726|FG000|Overall Study|Adverse Event|17|||
33307417|NCT00998764|62682727|FG001|Overall Study|Adverse Event|12|||
33307418|NCT00998764|62682726|FG000|Overall Study|Withdrawal by Subject|19|||
33307419|NCT00998764|62682727|FG001|Overall Study|Withdrawal by Subject|25|||
33307420|NCT00998764|62682726|FG000|Overall Study|Physician Decision|3|||
33307421|NCT00998764|62682727|FG001|Overall Study|Physician Decision|3|||
33307422|NCT00998764|62682726|FG000|Overall Study|Death|3|||
33307423|NCT00998764|62682727|FG001|Overall Study|Death|1|||
33307424|NCT00998764|62682726|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
33307425|NCT00998764|62682727|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
33307426|NCT00998764|62682726|FG000|Overall Study|Protocol Violation|0|||
33307427|NCT00998764|62682727|FG001|Overall Study|Protocol Violation|1|||
33307428|NCT00998764|62682726|FG000|Overall Study|Failed to Return|1|||
33307429|NCT00998764|62682727|FG001|Overall Study|Failed to Return|1|||
33307430|NCT00998764|62682726|FG000|Overall Study|Lost to Follow-up|1|||
33307431|NCT00998764|62682727|FG001|Overall Study|Lost to Follow-up|1|||
33307432|NCT00998764|62682726|FG000|Overall Study|Loss of Caregiver|0|||
33307433|NCT00998764|62682727|FG001|Overall Study|Loss of Caregiver|3|||
33307434|NCT00998764|62682726|FG000|Overall Study|Other|4|||
33307435|NCT00998764|62682727|FG001|Overall Study|Other|4|||
33307436|NCT00998764|62682726|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
33307437|NCT00998764|62682727|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
33307438|NCT01204671|62682740|FG000|Overall Study|Adverse Event|4|||
33307439|NCT01204671|62682741|FG001|Overall Study|Adverse Event|3|||
33307440|NCT01204671|62682742|FG002|Overall Study|Adverse Event|3|||
33307441|NCT01204671|62682743|FG003|Overall Study|Adverse Event|3|||
33307442|NCT01204671|62682744|FG004|Overall Study|Adverse Event|1|||
33307443|NCT01204671|62682740|FG000|Overall Study|Withdrawal by Subject|2|||
33307444|NCT01204671|62682741|FG001|Overall Study|Withdrawal by Subject|3|||
33307445|NCT01204671|62682742|FG002|Overall Study|Withdrawal by Subject|4|||
33307446|NCT01204671|62682743|FG003|Overall Study|Withdrawal by Subject|5|||
33307447|NCT01204671|62682744|FG004|Overall Study|Withdrawal by Subject|3|||
33307448|NCT01204671|62682740|FG000|Overall Study|Lost to Follow-up|7|||
33307449|NCT01204671|62682741|FG001|Overall Study|Lost to Follow-up|8|||
33307450|NCT01204671|62682742|FG002|Overall Study|Lost to Follow-up|6|||
33307451|NCT01204671|62682743|FG003|Overall Study|Lost to Follow-up|4|||
33307452|NCT01204671|62682744|FG004|Overall Study|Lost to Follow-up|0|||
33307453|NCT01204671|62682740|FG000|Overall Study|Unknown Completion Status|1|||
33307454|NCT01204671|62682741|FG001|Overall Study|Unknown Completion Status|1|||
33307455|NCT01204671|62682742|FG002|Overall Study|Unknown Completion Status|0|||
33307456|NCT01204671|62682743|FG003|Overall Study|Unknown Completion Status|0|||
33307457|NCT01204671|62682744|FG004|Overall Study|Unknown Completion Status|0|||
33307458|NCT01204671|62682740|FG000|Overall Study|Physician Decision|0|||
33307459|NCT01204671|62682741|FG001|Overall Study|Physician Decision|0|||
33307460|NCT01204671|62682742|FG002|Overall Study|Physician Decision|0|||
33307461|NCT01204671|62682743|FG003|Overall Study|Physician Decision|1|||
33307462|NCT01204671|62682744|FG004|Overall Study|Physician Decision|0|||
33307463|NCT01202955|62682762|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
33307464|NCT01202955|62682763|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
33307465|NCT01202877|62682772|FG000|Overall Study|Disease Progression|0|||
33307466|NCT01202877|62682773|FG001|Overall Study|Disease Progression|1|||
33307467|NCT01202877|62682774|FG002|Overall Study|Disease Progression|2|||
33307468|NCT01202877|62682772|FG000|Overall Study|Adverse Event|0|||
33307469|NCT01202877|62682773|FG001|Overall Study|Adverse Event|0|||
33307470|NCT01202877|62682774|FG002|Overall Study|Adverse Event|2|||
33307471|NCT01202877|62682772|FG000|Overall Study|Withdrawal by Subject|0|||
33307472|NCT01202877|62682773|FG001|Overall Study|Withdrawal by Subject|0|||
33307473|NCT01202877|62682774|FG002|Overall Study|Withdrawal by Subject|1|||
33307474|NCT01202877|62682772|FG000|Overall Study|Death|0|||
33307475|NCT01202877|62682773|FG001|Overall Study|Death|0|||
33307476|NCT01202877|62682774|FG002|Overall Study|Death|1|||
33307477|NCT01202409|62682782|FG000|Overall Study|Adverse Event|1|||
33307478|NCT01202409|62682782|FG000|Overall Study|Ineligible - KRAS mutants|7|||
33307479|NCT01202175|62682788|FG000|Overall Study|Lost to Follow-up|2|||
33307480|NCT01202175|62682788|FG000|Overall Study|Withdrawal by Subject|1|||
33307481|NCT01202175|62682788|FG000|Overall Study|Adverse Event|2|||
33307482|NCT01201785|62682793|FG000|Overall Study|Lost to Follow-up|16|||
33307483|NCT01201317|62682800|FG000|Overall Study|Withdrawal by Subject|5|||
33307484|NCT01201317|62682801|FG001|Overall Study|Withdrawal by Subject|0|||
33307485|NCT01201317|62682802|FG002|Overall Study|Withdrawal by Subject|3|||
33307486|NCT01201317|62682800|FG000|Overall Study|Adverse Event|2|||
33307487|NCT01201317|62682801|FG001|Overall Study|Adverse Event|2|||
33307488|NCT01201317|62682802|FG002|Overall Study|Adverse Event|2|||
33307489|NCT01201317|62682800|FG000|Overall Study|Screen failure|1|||
33307490|NCT01201317|62682801|FG001|Overall Study|Screen failure|1|||
33307491|NCT01201317|62682802|FG002|Overall Study|Screen failure|0|||
33307492|NCT01201317|62682800|FG000|Overall Study|Protocol Violation|0|||
33307493|NCT01201317|62682801|FG001|Overall Study|Protocol Violation|1|||
33307494|NCT01201317|62682802|FG002|Overall Study|Protocol Violation|1|||
33307495|NCT01201317|62682800|FG000|Overall Study|Death|0|||
33307496|NCT01201317|62682801|FG001|Overall Study|Death|1|||
33307497|NCT01201317|62682802|FG002|Overall Study|Death|0|||
33307498|NCT01201317|62682800|FG000|Overall Study|Study-specific withdrawal criteria|0|||
33307499|NCT01201317|62682801|FG001|Overall Study|Study-specific withdrawal criteria|0|||
33307500|NCT01201317|62682802|FG002|Overall Study|Study-specific withdrawal criteria|1|||
33307501|NCT01201317|62682800|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
33307502|NCT01201317|62682801|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
33307503|NCT01201317|62682802|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
33307504|NCT01201317|62682800|FG000|Overall Study|Decrease in renal function|0|||
33307505|NCT01201317|62682801|FG001|Overall Study|Decrease in renal function|1|||
33307506|NCT01201317|62682802|FG002|Overall Study|Decrease in renal function|0|||
33307507|NCT01201317|62682800|FG000|Overall Study|Lack of Efficacy|1|||
33307508|NCT01201317|62682801|FG001|Overall Study|Lack of Efficacy|0|||
33307509|NCT01201317|62682802|FG002|Overall Study|Lack of Efficacy|0|||
33307510|NCT01201317|62682800|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
33307511|NCT01201317|62682801|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
33307512|NCT01201317|62682802|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
33307513|NCT01200069|62682812|FG000|Overall Study|Withdrawal by Subject|0|||
33307514|NCT01200069|62682813|FG001|Overall Study|Withdrawal by Subject|1|||
33307515|NCT01199601|62682864|FG000|Overall Study|Lost to Follow-up|47|||
33307516|NCT01199601|62682865|FG001|Overall Study|Lost to Follow-up|66|||
33307517|NCT01199601|62682864|FG000|Overall Study|Withdrawal by Subject|15|||
33307518|NCT01199601|62682865|FG001|Overall Study|Withdrawal by Subject|3|||
33307519|NCT01199601|62682864|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
33307520|NCT01199601|62682865|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
33307521|NCT01199289|62682875|FG000|Overall Study|Ineligibility determined|2|||
33307522|NCT01199289|62682876|FG001|Overall Study|Ineligibility determined|1|||
33307523|NCT01199289|62682877|FG002|Overall Study|Ineligibility determined|0|||
33307524|NCT01199289|62682878|FG003|Overall Study|Ineligibility determined|0|||
33307525|NCT01199289|62682875|FG000|Overall Study|Protocol Violation|1|||
33307526|NCT01199289|62682876|FG001|Overall Study|Protocol Violation|0|||
33307527|NCT01199289|62682877|FG002|Overall Study|Protocol Violation|0|||
33307528|NCT01199289|62682878|FG003|Overall Study|Protocol Violation|1|||
33307529|NCT01199289|62682875|FG000|Overall Study|Noncompliance|1|||
33307530|NCT01199289|62682876|FG001|Overall Study|Noncompliance|0|||
33307531|NCT01199289|62682877|FG002|Overall Study|Noncompliance|2|||
33307532|NCT01199289|62682878|FG003|Overall Study|Noncompliance|0|||
33307533|NCT01199289|62682875|FG000|Overall Study|Adverse Event|0|||
33307534|NCT01199289|62682876|FG001|Overall Study|Adverse Event|3|||
33307535|NCT01199289|62682877|FG002|Overall Study|Adverse Event|1|||
33307536|NCT01199289|62682878|FG003|Overall Study|Adverse Event|4|||
33307537|NCT01199289|62682875|FG000|Overall Study|Full consent withdrawn|2|||
33307538|NCT01199289|62682876|FG001|Overall Study|Full consent withdrawn|2|||
33307539|NCT01199289|62682877|FG002|Overall Study|Full consent withdrawn|2|||
33307540|NCT01199289|62682878|FG003|Overall Study|Full consent withdrawn|3|||
33307541|NCT01199289|62682875|FG000|Overall Study|Administrative decision|0|||
33398945|NCT00274261|62778418|FG000|Overall Study|Withdrawal by Subject|179|||
33307542|NCT01199289|62682876|FG001|Overall Study|Administrative decision|0|||
33307543|NCT01199289|62682877|FG002|Overall Study|Administrative decision|0|||
33307544|NCT01199289|62682878|FG003|Overall Study|Administrative decision|1|||
33307545|NCT01199289|62682875|FG000|Overall Study|Lost to Follow-up|0|||
33307546|NCT01199289|62682876|FG001|Overall Study|Lost to Follow-up|0|||
33307547|NCT01199289|62682877|FG002|Overall Study|Lost to Follow-up|0|||
33307548|NCT01199289|62682878|FG003|Overall Study|Lost to Follow-up|1|||
33307549|NCT01199289|62682875|FG000|Overall Study|Protocol-specified criteria|3|||
33307550|NCT01199289|62682876|FG001|Overall Study|Protocol-specified criteria|0|||
33307551|NCT01199289|62682877|FG002|Overall Study|Protocol-specified criteria|0|||
33307552|NCT01199289|62682878|FG003|Overall Study|Protocol-specified criteria|1|||
33307553|NCT01199289|62682875|FG000|Overall Study|Pregnancy|0|||
33307554|NCT01199289|62682876|FG001|Overall Study|Pregnancy|1|||
33307555|NCT01199289|62682877|FG002|Overall Study|Pregnancy|0|||
33307556|NCT01199289|62682878|FG003|Overall Study|Pregnancy|1|||
33307557|NCT01199055|62682894|FG000|Overall Study|Death|0|||
33307558|NCT01199055|62682895|FG001|Overall Study|Death|1|||
33307559|NCT01199055|62682896|FG002|Overall Study|Death|0|||
33307560|NCT01199055|62682894|FG000|Overall Study|Physician Decision|0|||
33307561|NCT01199055|62682895|FG001|Overall Study|Physician Decision|1|||
33307562|NCT01199055|62682896|FG002|Overall Study|Physician Decision|1|||
33307563|NCT01199055|62682894|FG000|Overall Study|Progressive disease|2|||
33307564|NCT01199055|62682895|FG001|Overall Study|Progressive disease|1|||
33307565|NCT01199055|62682896|FG002|Overall Study|Progressive disease|2|||
33307566|NCT01199055|62682894|FG000|Overall Study|Withdrawal by Subject|0|||
33307567|NCT01199055|62682895|FG001|Overall Study|Withdrawal by Subject|0|||
33307568|NCT01199055|62682896|FG002|Overall Study|Withdrawal by Subject|1|||
33307569|NCT01198977|62682908|FG000|Overall Study|Lost to Follow-up|1|||
33307570|NCT01198977|62682909|FG001|Overall Study|Lost to Follow-up|0|||
33307571|NCT01198587|62682921|FG000|Overall Study|Lost to Follow-up|8|||
33307572|NCT01198587|62682922|FG001|Overall Study|Lost to Follow-up|0|||
33307573|NCT01198587|62682923|FG002|Overall Study|Lost to Follow-up|9|||
33307574|NCT01198587|62682924|FG003|Overall Study|Lost to Follow-up|0|||
33307575|NCT01198509|62682945|FG000|Overall Study|Withdrawal by Subject|1|||
33307576|NCT01198509|62682946|FG001|Overall Study|Withdrawal by Subject|0|||
33307577|NCT01198509|62682947|FG002|Overall Study|Withdrawal by Subject|0|||
33307578|NCT01198509|62682948|FG003|Overall Study|Withdrawal by Subject|0|||
33307579|NCT01198509|62682949|FG004|Overall Study|Withdrawal by Subject|0|||
33307580|NCT01198509|62682950|FG005|Overall Study|Withdrawal by Subject|0|||
33307581|NCT01198275|62682964|FG000|Overall Study|Adverse Event|2|||
33307582|NCT01198275|62682965|FG001|Overall Study|Adverse Event|3|||
33307583|NCT01198275|62682964|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
33307584|NCT01198275|62682965|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
33307585|NCT01197417|62682973|FG000|Overall Study|Physician Decision|3|||
33307586|NCT01197417|62682974|FG001|Overall Study|Physician Decision|2|||
33307587|NCT01197417|62682973|FG000|Overall Study|Withdrawal by Subject|2|||
33307588|NCT01197417|62682974|FG001|Overall Study|Withdrawal by Subject|4|||
33307589|NCT01197417|62682973|FG000|Overall Study|Site miscommunication|0|||
33307590|NCT01197417|62682974|FG001|Overall Study|Site miscommunication|1|||
33307591|NCT01197417|62682973|FG000|Overall Study|Subject transferred to intensive care|0|||
33307592|NCT01197417|62682974|FG001|Overall Study|Subject transferred to intensive care|1|||
33307593|NCT01197417|62682973|FG000|Overall Study|Not consented in time to receive drug|0|||
33307594|NCT01197417|62682974|FG001|Overall Study|Not consented in time to receive drug|1|||
33307595|NCT01197417|62682973|FG000|Overall Study|Hypotension|1|||
33307596|NCT01197417|62682974|FG001|Overall Study|Hypotension|2|||
33307597|NCT01197417|62682973|FG000|Overall Study|Found to be ineligible|2|||
33307598|NCT01197417|62682974|FG001|Overall Study|Found to be ineligible|5|||
33307599|NCT01197417|62682973|FG000|Overall Study|No 25-hour magnesium level|0|||
33307600|NCT01197417|62682974|FG001|Overall Study|No 25-hour magnesium level|2|||
33307601|NCT00977431|62682985|FG000|Overall Study|Other than listed|1|||
33307602|NCT00977431|62682986|FG001|Overall Study|Other than listed|0|||
33307603|NCT00977431|62682987|FG002|Overall Study|Other than listed|0|||
33307604|NCT00977431|62682988|FG003|Overall Study|Other than listed|0|||
33307605|NCT00977431|62682989|FG004|Overall Study|Other than listed|2|||
33307606|NCT00977431|62682985|FG000|Overall Study|Protocol Violation|0|||
33307607|NCT00977431|62682986|FG001|Overall Study|Protocol Violation|0|||
33307608|NCT00977431|62682987|FG002|Overall Study|Protocol Violation|1|||
33307609|NCT00977431|62682988|FG003|Overall Study|Protocol Violation|0|||
33307610|NCT00977431|62682989|FG004|Overall Study|Protocol Violation|0|||
33307611|NCT00977431|62682985|FG000|Overall Study|Adverse Event|3|||
33307612|NCT00977431|62682986|FG001|Overall Study|Adverse Event|0|||
33307613|NCT00977431|62682987|FG002|Overall Study|Adverse Event|4|||
33307614|NCT00977431|62682988|FG003|Overall Study|Adverse Event|0|||
33307615|NCT00977431|62682989|FG004|Overall Study|Adverse Event|6|||
33307616|NCT00977431|62682985|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
33307617|NCT00977431|62682986|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
33307618|NCT00977431|62682987|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
33307619|NCT00977431|62682988|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
33307620|NCT00977431|62682989|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
33307621|NCT00977431|62682985|FG000|Overall Study|Progressive disease|2|||
33307622|NCT00977431|62682986|FG001|Overall Study|Progressive disease|6|||
33307623|NCT00977431|62682987|FG002|Overall Study|Progressive disease|1|||
33307624|NCT00977431|62682988|FG003|Overall Study|Progressive disease|3|||
33307625|NCT00977431|62682989|FG004|Overall Study|Progressive disease|5|||
33307626|NCT00977197|62683007|FG000|Overall Study|Withdrawal by Subject|3|||
33307627|NCT00977197|62683008|FG001|Overall Study|Withdrawal by Subject|4|||
33307628|NCT00977197|62683007|FG000|Overall Study|Adverse Event|3|||
33307629|NCT00977197|62683008|FG001|Overall Study|Adverse Event|1|||
33307630|NCT00977197|62683007|FG000|Overall Study|Lack of Efficacy|1|||
33307631|NCT00977197|62683008|FG001|Overall Study|Lack of Efficacy|0|||
33307632|NCT00977197|62683007|FG000|Overall Study|Lost to Follow-up|1|||
33307633|NCT00977197|62683008|FG001|Overall Study|Lost to Follow-up|3|||
33307634|NCT00977197|62683007|FG000|Overall Study|Nonadherence|1|||
33307635|NCT00977197|62683008|FG001|Overall Study|Nonadherence|1|||
33307636|NCT00974311|62683016|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
33307637|NCT00974311|62683017|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
33307638|NCT00974311|62683016|FG000|DB Phase (up to 24 Months)|Death|561|||
33307639|NCT00974311|62683017|FG001|DB Phase (up to 24 Months)|Death|298|||
33307640|NCT00974311|62683016|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
33307641|NCT00974311|62683017|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
33307642|NCT00974311|62683016|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
33307643|NCT00974311|62683017|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
33307644|NCT00974311|62683016|FG000|DB Phase (up to 24 Months)|Other|1|||
33307645|NCT00974311|62683017|FG001|DB Phase (up to 24 Months)|Other|0|||
33307646|NCT00974311|62683016|FG000|OLE Phase (up to 77 Months)|Death|14|||
33307647|NCT00974311|62683017|FG001|OLE Phase (up to 77 Months)|Death|21|||
33307648|NCT00974311|62683016|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
33307649|NCT00974311|62683017|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
33307650|NCT00974311|62683016|FG000|OLE Phase (up to 77 Months)|Other|15|||
33307651|NCT00974311|62683017|FG001|OLE Phase (up to 77 Months)|Other|2|||
33307652|NCT00974311|62683016|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
33307653|NCT00974311|62683017|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
33307654|NCT00974233|62683026|FG000|Induction Chemoimmunotherapy|Death|2|||
33307655|NCT00974233|62683026|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
33307656|NCT00974233|62683026|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
33307657|NCT00974233|62683026|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
33307658|NCT00974233|62683026|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
33307659|NCT00974233|62683026|FG000|Maintenance Lenalidomide|Adverse Event|8|||
33307660|NCT00973921|62683038|FG000|Overall Study|IVUS results were not available|9|||
33307661|NCT00972595|62683042|FG000|Period 1|Adverse Event|1|||
33307662|NCT00972595|62683043|FG001|Period 1|Adverse Event|0|||
33307663|NCT01196091|62683052|FG000|Overall Study|Adverse Event|22|||
33307664|NCT01196091|62683053|FG001|Overall Study|Adverse Event|27|||
33307665|NCT01196091|62683054|FG002|Overall Study|Adverse Event|26|||
33307666|NCT01196091|62683052|FG000|Overall Study|Death|3|||
33307667|NCT01196091|62683053|FG001|Overall Study|Death|2|||
33307668|NCT01196091|62683054|FG002|Overall Study|Death|2|||
33307669|NCT01196091|62683052|FG000|Overall Study|Entry Criteria Not Met|11|||
33307670|NCT01196091|62683053|FG001|Overall Study|Entry Criteria Not Met|11|||
33307671|NCT01196091|62683054|FG002|Overall Study|Entry Criteria Not Met|10|||
33307672|NCT01196091|62683052|FG000|Overall Study|Lack of Efficacy|15|||
33307673|NCT01196091|62683053|FG001|Overall Study|Lack of Efficacy|12|||
33307674|NCT01196091|62683054|FG002|Overall Study|Lack of Efficacy|17|||
33307675|NCT01196091|62683052|FG000|Overall Study|Lost to Follow-up|5|||
33307676|NCT01196091|62683053|FG001|Overall Study|Lost to Follow-up|5|||
33307677|NCT01196091|62683054|FG002|Overall Study|Lost to Follow-up|6|||
33307678|NCT01196091|62683052|FG000|Overall Study|Parent/Caregiver Decision|0|||
33307679|NCT01196091|62683053|FG001|Overall Study|Parent/Caregiver Decision|0|||
33307680|NCT01196091|62683054|FG002|Overall Study|Parent/Caregiver Decision|1|||
33307681|NCT01196091|62683052|FG000|Overall Study|Withdrawal by Subject|16|||
33307682|NCT01196091|62683053|FG001|Overall Study|Withdrawal by Subject|19|||
33307683|NCT01196091|62683054|FG002|Overall Study|Withdrawal by Subject|22|||
33307684|NCT01196091|62683052|FG000|Overall Study|Physician Decision|3|||
33307685|NCT01196091|62683053|FG001|Overall Study|Physician Decision|3|||
33307686|NCT01196091|62683054|FG002|Overall Study|Physician Decision|4|||
33307687|NCT01196091|62683052|FG000|Overall Study|Protocol Violation|1|||
33307688|NCT01196091|62683053|FG001|Overall Study|Protocol Violation|3|||
33307689|NCT01196091|62683054|FG002|Overall Study|Protocol Violation|3|||
33307690|NCT01196091|62683052|FG000|Overall Study|Sponsor Decision|6|||
33307691|NCT01196091|62683053|FG001|Overall Study|Sponsor Decision|5|||
33307692|NCT01196091|62683054|FG002|Overall Study|Sponsor Decision|4|||
33307693|NCT01196091|62683052|FG000|Overall Study|Excluded Site|5|||
33307694|NCT01196091|62683053|FG001|Overall Study|Excluded Site|11|||
33307695|NCT01196091|62683054|FG002|Overall Study|Excluded Site|8|||
33307696|NCT01196091|62683052|FG000|Overall Study|Randomized, No Study Drug Received|1|||
33307697|NCT01196091|62683053|FG001|Overall Study|Randomized, No Study Drug Received|0|||
33307698|NCT01196091|62683054|FG002|Overall Study|Randomized, No Study Drug Received|1|||
33307699|NCT01195623|62683069|FG000|Overall Study|Lost to Follow-up|35|||
33307700|NCT01195623|62683070|FG001|Overall Study|Lost to Follow-up|37|||
33307701|NCT01195545|62683076|FG000|Overall Study|Protocol Violation|4|||
33307702|NCT01194999|62683080|FG000|Overall Study|Lost to Follow-up|17|||
33307703|NCT01194531|62683086|FG000|Overall Study|Withdrawal by Subject|1|||
33307704|NCT01194531|62683087|FG001|Overall Study|Withdrawal by Subject|0|||
33307705|NCT01194531|62683086|FG000|Overall Study|Protocol Violation|4|||
33307706|NCT01194531|62683087|FG001|Overall Study|Protocol Violation|1|||
33307707|NCT01194531|62683086|FG000|Overall Study|Physician Decision|0|||
33307708|NCT01194531|62683087|FG001|Overall Study|Physician Decision|2|||
33307709|NCT00972517|62683093|FG000|Overall Study|Adverse Event|0|||
33307710|NCT00972517|62683094|FG001|Overall Study|Adverse Event|0|||
33307711|NCT00972517|62683095|FG002|Overall Study|Adverse Event|0|||
33307712|NCT00972517|62683096|FG003|Overall Study|Adverse Event|1|||
33307713|NCT00972517|62683097|FG004|Overall Study|Adverse Event|0|||
33307714|NCT00972517|62683098|FG005|Overall Study|Adverse Event|0|||
33307715|NCT00972517|62683093|FG000|Overall Study|Withdrawal by Subject|0|||
33307716|NCT00972517|62683094|FG001|Overall Study|Withdrawal by Subject|1|||
33307717|NCT00972517|62683095|FG002|Overall Study|Withdrawal by Subject|0|||
33307718|NCT00972517|62683096|FG003|Overall Study|Withdrawal by Subject|2|||
33307719|NCT00972517|62683097|FG004|Overall Study|Withdrawal by Subject|1|||
33307720|NCT00972517|62683098|FG005|Overall Study|Withdrawal by Subject|0|||
33307721|NCT00972283|62683120|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
33307722|NCT00972283|62683121|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
33307723|NCT00972283|62683120|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
33307724|NCT00972283|62683121|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
33307725|NCT00972283|62683120|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
33307726|NCT00972283|62683121|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
33307727|NCT00972283|62683120|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
33307728|NCT00972283|62683121|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
33307729|NCT00972283|62683120|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
33307730|NCT00972283|62683121|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
33307731|NCT00972283|62683120|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
33307732|NCT00972283|62683121|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
33307733|NCT00972283|62683120|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
33307734|NCT00972283|62683121|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
33307735|NCT00972283|62683120|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
33307736|NCT00972283|62683121|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
33307737|NCT00972283|62683120|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
33307738|NCT00972283|62683121|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
33307739|NCT00972283|62683120|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
33307740|NCT00972283|62683121|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
33307741|NCT00969709|62683131|FG000|Overall Study|Adverse Event|3|||
33307742|NCT00969709|62683132|FG001|Overall Study|Adverse Event|13|||
33307743|NCT00969709|62683133|FG002|Overall Study|Adverse Event|26|||
33307744|NCT00969709|62683134|FG003|Overall Study|Adverse Event|12|||
33307745|NCT00969709|62683131|FG000|Overall Study|Lack of Efficacy|7|||
33307746|NCT00969709|62683132|FG001|Overall Study|Lack of Efficacy|4|||
33307747|NCT00969709|62683133|FG002|Overall Study|Lack of Efficacy|1|||
33307748|NCT00969709|62683134|FG003|Overall Study|Lack of Efficacy|3|||
33307749|NCT00969709|62683131|FG000|Overall Study|Protocol Violation|9|||
33307750|NCT00969709|62683132|FG001|Overall Study|Protocol Violation|5|||
33307751|NCT00969709|62683133|FG002|Overall Study|Protocol Violation|9|||
33307752|NCT00969709|62683134|FG003|Overall Study|Protocol Violation|10|||
33307753|NCT00969709|62683131|FG000|Overall Study|Withdrawal by Subject|9|||
33307754|NCT00969709|62683132|FG001|Overall Study|Withdrawal by Subject|12|||
33307755|NCT00969709|62683133|FG002|Overall Study|Withdrawal by Subject|11|||
33307756|NCT00969709|62683134|FG003|Overall Study|Withdrawal by Subject|23|||
33307757|NCT00969709|62683131|FG000|Overall Study|Lost to Follow-up|10|||
33307758|NCT00969709|62683132|FG001|Overall Study|Lost to Follow-up|14|||
33307759|NCT00969709|62683133|FG002|Overall Study|Lost to Follow-up|8|||
33307760|NCT00969709|62683134|FG003|Overall Study|Lost to Follow-up|15|||
33307761|NCT00969709|62683131|FG000|Overall Study|Other reasons|0|||
33307762|NCT00969709|62683132|FG001|Overall Study|Other reasons|0|||
33307763|NCT00969709|62683133|FG002|Overall Study|Other reasons|3|||
33307764|NCT00969709|62683134|FG003|Overall Study|Other reasons|0|||
33307765|NCT01193517|62683151|FG000|Overall Study|Early Progression|1|||
33307766|NCT01193517|62683152|FG001|Overall Study|Early Progression|0|||
33307767|NCT01193517|62683153|FG002|Overall Study|Early Progression|0|||
33307768|NCT01193283|62683162|FG000|Overall Study|Death|1|||
33668566|NCT01468987|63102617|FG000|Overall Study|Death|4|||
33307769|NCT00971425|62683168|FG000|Overall Study|Adverse Event|1|||
33307770|NCT00971425|62683169|FG001|Overall Study|Adverse Event|1|||
33307771|NCT00971425|62683168|FG000|Overall Study|Withdrawal by Subject|0|||
33307772|NCT00971425|62683169|FG001|Overall Study|Withdrawal by Subject|1|||
33307773|NCT01193127|62683179|FG000|Randomized|Surgery Cancelled|0|||
33307774|NCT01193127|62683180|FG001|Randomized|Surgery Cancelled|0|||
33307775|NCT01193127|62683181|FG002|Randomized|Surgery Cancelled|0|||
33578968|NCT01998958|62976209|FG019|Period 1 (Panel A and B)|Other|0|||
33307776|NCT01193127|62683182|FG003|Randomized|Surgery Cancelled|1|||
33307777|NCT01193127|62683179|FG000|Treated|Withdrawal by Subject|0|||
33307778|NCT01193127|62683180|FG001|Treated|Withdrawal by Subject|0|||
33307779|NCT01193127|62683181|FG002|Treated|Withdrawal by Subject|0|||
33307780|NCT01193127|62683182|FG003|Treated|Withdrawal by Subject|1|||
33307781|NCT01192815|62683194|FG000|Overall Study|Withdrawal by Subject|1|||
33307782|NCT01192815|62683194|FG000|Overall Study|Lack of Efficacy|1|||
33307783|NCT01192347|62683198|FG000|Overall Study|Death|3|||
33307784|NCT01192347|62683198|FG000|Overall Study|Lost to Follow-up|3|||
33307785|NCT01192347|62683198|FG000|Overall Study|Withdrawal by Subject|1|||
33307786|NCT01192347|62683198|FG000|Overall Study|Adverse Event|1|||
33307787|NCT01192347|62683198|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
33307788|NCT01192347|62683198|FG000|Overall Study|Patient seen in different hospital|1|||
33307789|NCT01192347|62683198|FG000|Overall Study|Patient not visiting hospital regularly|1|||
33307790|NCT01192347|62683198|FG000|Overall Study|Patient did not show up for visits|1|||
33307791|NCT01192191|62683204|FG000|Overall Study|Adverse Event|7|||
33307792|NCT01192191|62683205|FG001|Overall Study|Adverse Event|12|||
33307793|NCT01192191|62683204|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
33307794|NCT01192191|62683205|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
33307795|NCT01192191|62683204|FG000|Overall Study|Lost to Follow-up|0|||
33307796|NCT01192191|62683205|FG001|Overall Study|Lost to Follow-up|1|||
33307797|NCT01192191|62683204|FG000|Overall Study|Withdrawal by Subject|1|||
33307798|NCT01192191|62683205|FG001|Overall Study|Withdrawal by Subject|6|||
33307799|NCT01307267|62683234|FG000|Overall Study|Death|4|||
33307800|NCT01307267|62683235|FG001|Overall Study|Death|3|||
33307801|NCT01307267|62683236|FG002|Overall Study|Death|5|||
33307802|NCT01307267|62683237|FG003|Overall Study|Death|3|||
33307803|NCT01307267|62683238|FG004|Overall Study|Death|1|||
33307804|NCT01307267|62683239|FG005|Overall Study|Death|26|||
33307805|NCT01307267|62683240|FG006|Overall Study|Death|2|||
33307806|NCT01307267|62683241|FG007|Overall Study|Death|2|||
33307807|NCT01307267|62683242|FG008|Overall Study|Death|21|||
33307808|NCT01307267|62683243|FG009|Overall Study|Death|2|||
33307809|NCT01307267|62683244|FG010|Overall Study|Death|3|||
33307810|NCT01307267|62683245|FG011|Overall Study|Death|9|||
33307811|NCT01307267|62683246|FG012|Overall Study|Death|0|||
33307812|NCT01307267|62683247|FG013|Overall Study|Death|0|||
33307813|NCT01307267|62683248|FG014|Overall Study|Death|0|||
33307814|NCT01307267|62683249|FG015|Overall Study|Death|0|||
33307815|NCT01307267|62683250|FG016|Overall Study|Death|1|||
33307816|NCT01307267|62683251|FG017|Overall Study|Death|1|||
33307817|NCT01307267|62683252|FG018|Overall Study|Death|2|||
33307818|NCT01307267|62683253|FG019|Overall Study|Death|8|||
33307819|NCT01307267|62683254|FG020|Overall Study|Death|1|||
33307820|NCT01307267|62683255|FG021|Overall Study|Death|2|||
33307821|NCT01307267|62683256|FG022|Overall Study|Death|2|||
33307822|NCT01307267|62683234|FG000|Overall Study|Lost to Follow-up|0|||
33307823|NCT01307267|62683235|FG001|Overall Study|Lost to Follow-up|0|||
33307824|NCT01307267|62683236|FG002|Overall Study|Lost to Follow-up|0|||
33307825|NCT01307267|62683237|FG003|Overall Study|Lost to Follow-up|0|||
33307826|NCT01307267|62683238|FG004|Overall Study|Lost to Follow-up|0|||
33307827|NCT01307267|62683239|FG005|Overall Study|Lost to Follow-up|7|||
33307828|NCT01307267|62683240|FG006|Overall Study|Lost to Follow-up|0|||
33307829|NCT01307267|62683241|FG007|Overall Study|Lost to Follow-up|0|||
33307830|NCT01307267|62683242|FG008|Overall Study|Lost to Follow-up|1|||
33307831|NCT01307267|62683243|FG009|Overall Study|Lost to Follow-up|2|||
33307832|NCT01307267|62683244|FG010|Overall Study|Lost to Follow-up|1|||
33307833|NCT01307267|62683245|FG011|Overall Study|Lost to Follow-up|0|||
33307834|NCT01307267|62683246|FG012|Overall Study|Lost to Follow-up|0|||
33307835|NCT01307267|62683247|FG013|Overall Study|Lost to Follow-up|0|||
33307836|NCT01307267|62683248|FG014|Overall Study|Lost to Follow-up|0|||
33307837|NCT01307267|62683249|FG015|Overall Study|Lost to Follow-up|0|||
33307838|NCT01307267|62683250|FG016|Overall Study|Lost to Follow-up|0|||
33307839|NCT01307267|62683251|FG017|Overall Study|Lost to Follow-up|0|||
33307840|NCT01307267|62683252|FG018|Overall Study|Lost to Follow-up|0|||
33307841|NCT01307267|62683253|FG019|Overall Study|Lost to Follow-up|2|||
33307842|NCT01307267|62683254|FG020|Overall Study|Lost to Follow-up|0|||
33307843|NCT01307267|62683255|FG021|Overall Study|Lost to Follow-up|0|||
33307844|NCT01307267|62683256|FG022|Overall Study|Lost to Follow-up|0|||
33307845|NCT01307267|62683234|FG000|Overall Study|Withdrawal by Subject|0|||
33307846|NCT01307267|62683235|FG001|Overall Study|Withdrawal by Subject|0|||
33307847|NCT01307267|62683236|FG002|Overall Study|Withdrawal by Subject|0|||
33307848|NCT01307267|62683237|FG003|Overall Study|Withdrawal by Subject|0|||
33307849|NCT01307267|62683238|FG004|Overall Study|Withdrawal by Subject|0|||
33578969|NCT01998958|62976210|FG020|Period 1 (Panel A and B)|Other|0|||
33307850|NCT01307267|62683239|FG005|Overall Study|Withdrawal by Subject|1|||
33307851|NCT01307267|62683240|FG006|Overall Study|Withdrawal by Subject|0|||
33578970|NCT01998958|62976211|FG021|Period 1 (Panel A and B)|Other|0|||
33307852|NCT01307267|62683241|FG007|Overall Study|Withdrawal by Subject|1|||
33307853|NCT01307267|62683242|FG008|Overall Study|Withdrawal by Subject|5|||
33307854|NCT01307267|62683243|FG009|Overall Study|Withdrawal by Subject|1|||
33307855|NCT01307267|62683244|FG010|Overall Study|Withdrawal by Subject|1|||
33307856|NCT01307267|62683245|FG011|Overall Study|Withdrawal by Subject|1|||
33307857|NCT01307267|62683246|FG012|Overall Study|Withdrawal by Subject|0|||
33307858|NCT01307267|62683247|FG013|Overall Study|Withdrawal by Subject|0|||
33307859|NCT01307267|62683248|FG014|Overall Study|Withdrawal by Subject|0|||
33307860|NCT01307267|62683249|FG015|Overall Study|Withdrawal by Subject|0|||
33307861|NCT01307267|62683250|FG016|Overall Study|Withdrawal by Subject|0|||
33307862|NCT01307267|62683251|FG017|Overall Study|Withdrawal by Subject|0|||
33307863|NCT01307267|62683252|FG018|Overall Study|Withdrawal by Subject|0|||
33307864|NCT01307267|62683253|FG019|Overall Study|Withdrawal by Subject|3|||
33307865|NCT01307267|62683254|FG020|Overall Study|Withdrawal by Subject|0|||
33307866|NCT01307267|62683255|FG021|Overall Study|Withdrawal by Subject|0|||
33307867|NCT01307267|62683256|FG022|Overall Study|Withdrawal by Subject|0|||
33307868|NCT01307267|62683234|FG000|Overall Study|Other|0|||
33307869|NCT01307267|62683235|FG001|Overall Study|Other|0|||
33307870|NCT01307267|62683236|FG002|Overall Study|Other|0|||
33307871|NCT01307267|62683237|FG003|Overall Study|Other|0|||
33307872|NCT01307267|62683238|FG004|Overall Study|Other|0|||
33307873|NCT01307267|62683239|FG005|Overall Study|Other|7|||
33307874|NCT01307267|62683240|FG006|Overall Study|Other|0|||
33307875|NCT01307267|62683241|FG007|Overall Study|Other|1|||
33307876|NCT01307267|62683242|FG008|Overall Study|Other|3|||
33307877|NCT01307267|62683243|FG009|Overall Study|Other|0|||
33307878|NCT01307267|62683244|FG010|Overall Study|Other|1|||
33307879|NCT01307267|62683245|FG011|Overall Study|Other|1|||
33307880|NCT01307267|62683246|FG012|Overall Study|Other|1|||
33307881|NCT01307267|62683247|FG013|Overall Study|Other|0|||
33307882|NCT01307267|62683248|FG014|Overall Study|Other|2|||
33307883|NCT01307267|62683249|FG015|Overall Study|Other|1|||
33307884|NCT01307267|62683250|FG016|Overall Study|Other|0|||
33307885|NCT01307267|62683251|FG017|Overall Study|Other|0|||
33307886|NCT01307267|62683252|FG018|Overall Study|Other|0|||
33307887|NCT01307267|62683253|FG019|Overall Study|Other|19|||
33307888|NCT01307267|62683254|FG020|Overall Study|Other|2|||
33307889|NCT01307267|62683255|FG021|Overall Study|Other|3|||
33307890|NCT01307267|62683256|FG022|Overall Study|Other|2|||
33307891|NCT01307111|62683318|FG000|IUD Insertion|Lost to Follow-up|2|||
33307892|NCT01307111|62683319|FG001|IUD Insertion|Lost to Follow-up|0|||
33307893|NCT01307111|62683318|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
33307894|NCT01307111|62683319|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
33307895|NCT01306877|62683327|FG000|Overall Study|Lost to Follow-up|3|||
33307896|NCT01306877|62683328|FG001|Overall Study|Lost to Follow-up|3|||
33307897|NCT01306877|62683327|FG000|Overall Study|Physician Decision|0|||
33307898|NCT01306877|62683328|FG001|Overall Study|Physician Decision|1|||
33307899|NCT01191801|62683336|FG000|Overall Study|Death|36|||
33307900|NCT01191801|62683337|FG001|Overall Study|Death|12|||
33307901|NCT01191801|62683336|FG000|Overall Study|Lack of Efficacy|176|||
33307902|NCT01191801|62683337|FG001|Overall Study|Lack of Efficacy|258|||
33307903|NCT01191801|62683336|FG000|Overall Study|Adverse Event|9|||
33307904|NCT01191801|62683337|FG001|Overall Study|Adverse Event|8|||
33307905|NCT01191801|62683336|FG000|Overall Study|Protocol Violation|2|||
33307906|NCT01191801|62683337|FG001|Overall Study|Protocol Violation|4|||
33307907|NCT01191801|62683336|FG000|Overall Study|Physician Decision|47|||
33307908|NCT01191801|62683337|FG001|Overall Study|Physician Decision|24|||
33307909|NCT01191801|62683336|FG000|Overall Study|Withdrawal by Subject|1|||
33307910|NCT01191801|62683337|FG001|Overall Study|Withdrawal by Subject|4|||
33307911|NCT01191801|62683336|FG000|Overall Study|Not Provided|45|||
33307912|NCT01191801|62683337|FG001|Overall Study|Not Provided|27|||
33307913|NCT01306643|62683343|FG000|Overall Study|Adverse Event|5|||
33307914|NCT01306643|62683343|FG000|Overall Study|Disease Progression|7|||
33307915|NCT01306643|62683343|FG000|Overall Study|Other: Change in Eligibility Status|1|||
33307916|NCT01306331|62683349|FG000|Overall Study|Adverse Event|28|||
33307917|NCT01306331|62683350|FG001|Overall Study|Adverse Event|25|||
33307918|NCT01306331|62683349|FG000|Overall Study|Lost to Follow-up|321|||
33307919|NCT01306331|62683350|FG001|Overall Study|Lost to Follow-up|323|||
33307920|NCT01306331|62683349|FG000|Overall Study|Physician Decision|26|||
33307921|NCT01306331|62683350|FG001|Overall Study|Physician Decision|22|||
33307922|NCT01306331|62683349|FG000|Overall Study|Pregnancy|136|||
33307923|NCT01306331|62683350|FG001|Overall Study|Pregnancy|151|||
33307924|NCT01306331|62683349|FG000|Overall Study|Protocol Violation|154|||
33307925|NCT01306331|62683350|FG001|Overall Study|Protocol Violation|124|||
33307926|NCT01306331|62683349|FG000|Overall Study|Withdrawal by Subject|163|||
33307927|NCT01306331|62683350|FG001|Overall Study|Withdrawal by Subject|152|||
33307928|NCT01306331|62683349|FG000|Overall Study|Not sexually active|29|||
33307929|NCT01306331|62683350|FG001|Overall Study|Not sexually active|28|||
33307930|NCT01306331|62683349|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
33307931|NCT01306331|62683350|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
33307932|NCT01306331|62683349|FG000|Overall Study|Other|34|||
33307933|NCT01306331|62683350|FG001|Overall Study|Other|32|||
33307934|NCT01306253|62683358|FG000|Overall Study|Lost to Follow-up|1|||
33307935|NCT01306253|62683359|FG001|Overall Study|Lost to Follow-up|1|||
33307936|NCT01305941|62683365|FG000|Overall Study|Adverse Event|6|||
33307937|NCT01305941|62683365|FG000|Overall Study|Clinical decline|2|||
33307938|NCT01305941|62683365|FG000|Overall Study|Withdrawal by Subject|1|||
33307939|NCT01305941|62683365|FG000|Overall Study|Death|1|||
33307940|NCT01305239|62683369|FG000|Overall Study|Adverse Event|22|||
33307941|NCT01305239|62683369|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
33307942|NCT01194219|62683375|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
33307943|NCT01194219|62683376|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
33307944|NCT01194219|62683377|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33307945|NCT01194219|62683378|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33307946|NCT01194219|62683379|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33307947|NCT01194219|62683380|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33307948|NCT01194219|62683381|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33307949|NCT01194219|62683382|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33307950|NCT01194219|62683383|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33307951|NCT01194219|62683384|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33307952|NCT01194219|62683375|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
33307953|NCT01194219|62683376|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
33307954|NCT01194219|62683377|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33307955|NCT01194219|62683378|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33307956|NCT01194219|62683379|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33307957|NCT01194219|62683380|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33307958|NCT01194219|62683381|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33307959|NCT01194219|62683382|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33307960|NCT01194219|62683383|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33307961|NCT01194219|62683384|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33307962|NCT01194219|62683375|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
33307963|NCT01194219|62683376|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33307964|NCT01194219|62683377|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33307965|NCT01194219|62683378|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33307966|NCT01194219|62683379|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33307967|NCT01194219|62683380|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33307968|NCT01194219|62683381|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33307969|NCT01194219|62683382|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33307970|NCT01194219|62683383|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33307971|NCT01194219|62683384|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33307972|NCT01194219|62683375|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
33307973|NCT01194219|62683376|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
33307974|NCT01194219|62683377|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33307975|NCT01194219|62683378|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33307976|NCT01194219|62683379|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33307977|NCT01194219|62683380|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33307978|NCT01194219|62683381|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33307979|NCT01194219|62683382|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33307980|NCT01194219|62683383|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33307981|NCT01194219|62683384|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33307982|NCT01194219|62683375|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33307983|NCT01194219|62683376|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
33307984|NCT01194219|62683377|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33307985|NCT01194219|62683378|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33307986|NCT01194219|62683379|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33307987|NCT01194219|62683380|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33307988|NCT01194219|62683381|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33307989|NCT01194219|62683382|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33307990|NCT01194219|62683383|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33307991|NCT01194219|62683384|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33307992|NCT01194219|62683375|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
33307993|NCT01194219|62683376|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
33307994|NCT01194219|62683377|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33307995|NCT01194219|62683378|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33307996|NCT01194219|62683379|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33578971|NCT01998958|62976212|FG022|Period 1 (Panel A and B)|Other|0|||
33578972|NCT01998958|62976213|FG023|Period 1 (Panel A and B)|Other|0|||
33578973|NCT01998958|62976214|FG024|Period 1 (Panel A and B)|Other|0|||
33578974|NCT01998958|62976215|FG025|Period 1 (Panel A and B)|Other|0|||
33578975|NCT01998958|62976216|FG026|Period 1 (Panel A and B)|Other|0|||
33578976|NCT01998958|62976217|FG027|Period 1 (Panel A and B)|Other|0|||
33578977|NCT01998958|62976218|FG028|Period 1 (Panel A and B)|Other|0|||
33578978|NCT01998958|62976219|FG029|Period 1 (Panel A and B)|Other|0|||
33578979|NCT01998958|62976220|FG030|Period 1 (Panel A and B)|Other|0|||
33578980|NCT01998958|62976221|FG031|Period 1 (Panel A and B)|Other|0|||
33578981|NCT01998958|62976190|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
33578982|NCT01998958|62976191|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
33668567|NCT01468987|63102618|FG001|Overall Study|Death|1|||
33668568|NCT01468987|63102617|FG000|Overall Study|Lost to Follow-up|10|||
33668569|NCT01468987|63102618|FG001|Overall Study|Lost to Follow-up|5|||
33668570|NCT01468987|63102617|FG000|Overall Study|Protocol Violation|8|||
33668571|NCT01468987|63102618|FG001|Overall Study|Protocol Violation|2|||
33668572|NCT01468987|63102617|FG000|Overall Study|Withdrawal by Subject|28|||
33668573|NCT01468987|63102618|FG001|Overall Study|Withdrawal by Subject|28|||
33668574|NCT01468987|63102617|FG000|Overall Study|Physician Decision|8|||
33668575|NCT01468987|63102618|FG001|Overall Study|Physician Decision|15|||
33668576|NCT01468987|63102617|FG000|Overall Study|Sponsor Decision|1|||
33668577|NCT01468987|63102618|FG001|Overall Study|Sponsor Decision|0|||
33668578|NCT01687712|63102628|FG000|Cycle 1|Not Biochemically Pregnant|386|||
33668579|NCT01687712|63102629|FG001|Cycle 1|Not Biochemically Pregnant|348|||
33668580|NCT01687712|63102628|FG000|Cycle 1|Early Pregnancy Loss|43|||
33668581|NCT01687712|63102629|FG001|Cycle 1|Early Pregnancy Loss|60|||
33668582|NCT01687712|63102628|FG000|Cycle 1|Ectopic Pregnancy|5|||
33668583|NCT01687712|63102629|FG001|Cycle 1|Ectopic Pregnancy|5|||
33668584|NCT01687712|63102628|FG000|Cycle 1|Heterotropic Pregnancy|1|||
33668585|NCT01687712|63102629|FG001|Cycle 1|Heterotropic Pregnancy|0|||
33668586|NCT01687712|63102628|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
33668587|NCT01687712|63102629|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
33668588|NCT01687712|63102628|FG000|Cycle 1|Abortion|3|||
33668589|NCT01687712|63102629|FG001|Cycle 1|Abortion|0|||
33668590|NCT01687712|63102628|FG000|Cycle 1|Intrauterine Fetal Death|0|||
33668591|NCT01687712|63102629|FG001|Cycle 1|Intrauterine Fetal Death|1|||
33668592|NCT01687712|63102628|FG000|Cycle 1|Lost to Follow-up|1|||
33668593|NCT01687712|63102629|FG001|Cycle 1|Lost to Follow-up|1|||
33668594|NCT01687712|63102628|FG000|Cycle 2|Not Biochemically Pregnant|74|||
33668595|NCT01687712|63102629|FG001|Cycle 2|Not Biochemically Pregnant|77|||
33668596|NCT01687712|63102628|FG000|Cycle 2|Early Pregnancy Loss|18|||
33668597|NCT01687712|63102629|FG001|Cycle 2|Early Pregnancy Loss|16|||
33668598|NCT01687712|63102628|FG000|Cycle 2|Ectopic Pregnancy|0|||
33668599|NCT01687712|63102629|FG001|Cycle 2|Ectopic Pregnancy|1|||
33668600|NCT01687712|63102628|FG000|Cycle 2|Still Birth|1|||
33668601|NCT01687712|63102629|FG001|Cycle 2|Still Birth|0|||
33668602|NCT01687712|63102628|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
33668603|NCT01687712|63102629|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
33668604|NCT01687712|63102628|FG000|Cycle 3|Not Biochemically Pregnant|21|||
33668605|NCT01687712|63102629|FG001|Cycle 3|Not Biochemically Pregnant|22|||
33668606|NCT01687712|63102628|FG000|Cycle 3|Early Pregnancy Loss|1|||
33668607|NCT01687712|63102629|FG001|Cycle 3|Early Pregnancy Loss|2|||
33668608|NCT01687712|63102628|FG000|Cycle 3|Ectopic Pregnancy|1|||
33668609|NCT01687712|63102629|FG001|Cycle 3|Ectopic Pregnancy|0|||
33668610|NCT01687712|63102628|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
33668611|NCT01687712|63102629|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
33668612|NCT01603628|63102642|FG000|Overall Study|Personal Reasons|1|||
33668613|NCT01603628|63102643|FG001|Overall Study|Personal Reasons|1|||
33668614|NCT01603628|63102644|FG002|Overall Study|Personal Reasons|2|||
33668615|NCT01603628|63102642|FG000|Overall Study|Protocol Violation|1|||
33668616|NCT01603628|63102643|FG001|Overall Study|Protocol Violation|1|||
33668617|NCT01603628|63102644|FG002|Overall Study|Protocol Violation|0|||
33668618|NCT01603628|63102642|FG000|Overall Study|Lost to Follow-up|0|||
33668619|NCT01603628|63102643|FG001|Overall Study|Lost to Follow-up|1|||
33668620|NCT01603628|63102644|FG002|Overall Study|Lost to Follow-up|0|||
33668621|NCT01603628|63102642|FG000|Overall Study|Other Miscellaneous Reason|1|||
33668622|NCT01603628|63102643|FG001|Overall Study|Other Miscellaneous Reason|0|||
33668623|NCT01603628|63102644|FG002|Overall Study|Other Miscellaneous Reason|0|||
33668624|NCT01453153|63102655|FG000|Overall Study|Physician Decision|0|||
33668625|NCT01453153|63102656|FG001|Overall Study|Physician Decision|0|||
33668626|NCT01453153|63102657|FG002|Overall Study|Physician Decision|1|||
33578983|NCT01998958|62976192|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
33578984|NCT01998958|62976193|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
33578985|NCT01998958|62976194|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
33578986|NCT01998958|62976195|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
33578987|NCT01998958|62976196|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
33578988|NCT01998958|62976197|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
33578989|NCT01998958|62976198|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
33578990|NCT01998958|62976199|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
33578991|NCT01998958|62976200|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
33578992|NCT01998958|62976201|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
33578993|NCT01998958|62976202|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
33578994|NCT01998958|62976203|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
33578995|NCT01998958|62976204|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
33668627|NCT01453153|63102655|FG000|Overall Study|Progressive Disease|3|||
33668628|NCT01453153|63102656|FG001|Overall Study|Progressive Disease|2|||
33668629|NCT01453153|63102657|FG002|Overall Study|Progressive Disease|16|||
33668630|NCT01453153|63102655|FG000|Overall Study|Withdrawal by Subject|0|||
33668631|NCT01453153|63102656|FG001|Overall Study|Withdrawal by Subject|1|||
33668632|NCT01453153|63102657|FG002|Overall Study|Withdrawal by Subject|2|||
33668633|NCT01453153|63102655|FG000|Overall Study|Adverse Event|1|||
33668634|NCT01453153|63102656|FG001|Overall Study|Adverse Event|1|||
33668635|NCT01453153|63102657|FG002|Overall Study|Adverse Event|1|||
33668636|NCT01584440|63102671|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
33668637|NCT01584440|63102672|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
33668638|NCT01584440|63102673|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
33668639|NCT01584440|63102674|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
33668640|NCT01584440|63102675|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
33668641|NCT01584440|63102671|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
33668642|NCT01584440|63102672|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
33668643|NCT01584440|63102673|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
33668644|NCT01584440|63102674|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
33668645|NCT01584440|63102675|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
33668646|NCT01584440|63102671|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
33668647|NCT01584440|63102672|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
33668648|NCT01584440|63102673|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
33668649|NCT01584440|63102674|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
33668650|NCT01584440|63102675|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
33668651|NCT01584440|63102671|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
33668652|NCT01584440|63102672|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
33668653|NCT01584440|63102673|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
33668654|NCT01584440|63102674|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
33668655|NCT01584440|63102675|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
33668656|NCT01584440|63102671|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
33668657|NCT01584440|63102672|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
33668658|NCT01584440|63102673|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
33668659|NCT01584440|63102674|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
33668660|NCT01584440|63102675|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
33668661|NCT01584440|63102671|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
33668662|NCT01584440|63102672|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
33668663|NCT01584440|63102673|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
33668664|NCT01584440|63102674|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
33668665|NCT01584440|63102675|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
33668666|NCT01584440|63102671|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
33668667|NCT01584440|63102672|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
33668668|NCT01584440|63102673|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
33668669|NCT01584440|63102674|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
33668670|NCT01584440|63102675|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
33668671|NCT01584440|63102671|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
33668672|NCT01584440|63102672|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
33668673|NCT01584440|63102673|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
33668674|NCT01584440|63102674|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
33668675|NCT01584440|63102675|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
33668676|NCT01584440|63102671|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
33668677|NCT01584440|63102672|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
33668678|NCT01584440|63102673|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
33668679|NCT01584440|63102674|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
33668680|NCT01584440|63102675|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
33668681|NCT01687478|63102690|FG000|Overall Study|Adverse Event|3|||
33668682|NCT01687478|63102691|FG001|Overall Study|Adverse Event|10|||
33668683|NCT01687478|63102690|FG000|Overall Study|Lost to Follow-up|1|||
33668684|NCT01687478|63102691|FG001|Overall Study|Lost to Follow-up|3|||
33668685|NCT01687478|63102690|FG000|Overall Study|Protocol Violation|0|||
33668686|NCT01687478|63102691|FG001|Overall Study|Protocol Violation|2|||
33668687|NCT01687478|63102690|FG000|Overall Study|Withdrawal by Subject|21|||
33668688|NCT01687478|63102691|FG001|Overall Study|Withdrawal by Subject|19|||
33668689|NCT01687478|63102690|FG000|Overall Study|Physician Decision|1|||
33668690|NCT01687478|63102691|FG001|Overall Study|Physician Decision|3|||
33668691|NCT01687478|63102690|FG000|Overall Study|Entry Criteria Not Met|6|||
33668692|NCT01687478|63102691|FG001|Overall Study|Entry Criteria Not Met|2|||
33668693|NCT01468909|63102699|FG000|Overall Study|Never Treated|2|||
33668694|NCT01468909|63102700|FG001|Overall Study|Never Treated|2|||
33307997|NCT01194219|62683380|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33307998|NCT01194219|62683381|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33578996|NCT01998958|62976205|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
33578997|NCT01998958|62976206|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
33578998|NCT01998958|62976207|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
33578999|NCT01998958|62976208|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
33579000|NCT01998958|62976209|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
33579001|NCT01998958|62976210|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
33579002|NCT01998958|62976211|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
33579003|NCT01998958|62976212|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
33579004|NCT01998958|62976213|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
33668695|NCT01468597|63102706|FG000|Overall Study|Found ineligible|17|||
33668696|NCT01468597|63102706|FG000|Overall Study|concomitant valves|12|||
33668697|NCT01468597|63102706|FG000|Overall Study|off-pump CABG|1|||
33668698|NCT01468597|63102706|FG000|Overall Study|no platelet function data|5|||
33668699|NCT01687166|63102714|FG000|Overall Study|Attempt subject|2|||
33307999|NCT01194219|62683382|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33308000|NCT01194219|62683383|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33308001|NCT01194219|62683384|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33308002|NCT01194219|62683375|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
33308003|NCT01194219|62683376|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
33308004|NCT01194219|62683377|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33308005|NCT01194219|62683378|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33308006|NCT01194219|62683379|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33308007|NCT01194219|62683380|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33308008|NCT01194219|62683381|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33308009|NCT01194219|62683382|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33308010|NCT01194219|62683383|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33308011|NCT01194219|62683384|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33308012|NCT01194219|62683375|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
33308013|NCT01194219|62683376|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
33308014|NCT01194219|62683377|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33308015|NCT01194219|62683378|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33308016|NCT01194219|62683379|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33308017|NCT01194219|62683380|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33308018|NCT01194219|62683381|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33308019|NCT01194219|62683382|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33308020|NCT01194219|62683383|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33308021|NCT01194219|62683384|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33308022|NCT01194219|62683375|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
33308023|NCT01194219|62683376|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
33308024|NCT01194219|62683377|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
33308025|NCT01194219|62683378|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
33308026|NCT01194219|62683379|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
33308027|NCT01194219|62683380|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
33308028|NCT01194219|62683381|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
33308029|NCT01194219|62683382|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
33308030|NCT01194219|62683383|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
33308031|NCT01194219|62683384|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
33308032|NCT01194219|62683375|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33308033|NCT01194219|62683376|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33308034|NCT01194219|62683377|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
33308035|NCT01194219|62683378|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
33308036|NCT01194219|62683379|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33308037|NCT01194219|62683380|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33308038|NCT01194219|62683381|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33308039|NCT01194219|62683382|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33308040|NCT01194219|62683383|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33668700|NCT01687166|63102715|FG001|Overall Study|Attempt subject|3|||
33668701|NCT01687166|63102716|FG002|Overall Study|Attempt subject|2|||
33668702|NCT01687166|63102717|FG003|Overall Study|Attempt subject|0|||
33668703|NCT01687166|63102714|FG000|Overall Study|Did not meet eligibility criteria|4|||
33668704|NCT01687166|63102715|FG001|Overall Study|Did not meet eligibility criteria|6|||
33668705|NCT01687166|63102716|FG002|Overall Study|Did not meet eligibility criteria|1|||
33668706|NCT01687166|63102717|FG003|Overall Study|Did not meet eligibility criteria|1|||
33668707|NCT01687166|63102714|FG000|Overall Study|Adverse Event|2|||
33668708|NCT01687166|63102715|FG001|Overall Study|Adverse Event|1|||
33668709|NCT01687166|63102716|FG002|Overall Study|Adverse Event|0|||
33668710|NCT01687166|63102717|FG003|Overall Study|Adverse Event|0|||
33668711|NCT01687166|63102714|FG000|Overall Study|Physician Decision|3|||
33668712|NCT01687166|63102715|FG001|Overall Study|Physician Decision|2|||
33668713|NCT01687166|63102716|FG002|Overall Study|Physician Decision|1|||
33668714|NCT01687166|63102717|FG003|Overall Study|Physician Decision|0|||
33668715|NCT01687166|63102714|FG000|Overall Study|Withdrawal by Subject|11|||
33668716|NCT01687166|63102715|FG001|Overall Study|Withdrawal by Subject|4|||
33668717|NCT01687166|63102716|FG002|Overall Study|Withdrawal by Subject|3|||
33668718|NCT01687166|63102717|FG003|Overall Study|Withdrawal by Subject|0|||
33668719|NCT01687166|63102714|FG000|Overall Study|Lost to Follow-up|2|||
33308041|NCT01194219|62683384|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33308042|NCT01194219|62683375|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33308043|NCT01194219|62683376|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33668720|NCT01687166|63102715|FG001|Overall Study|Lost to Follow-up|5|||
33668721|NCT01687166|63102716|FG002|Overall Study|Lost to Follow-up|1|||
33308044|NCT01194219|62683377|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
33308045|NCT01194219|62683378|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
33308046|NCT01194219|62683379|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33308047|NCT01194219|62683380|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33308048|NCT01194219|62683381|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33308049|NCT01194219|62683382|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33308050|NCT01194219|62683383|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33308051|NCT01194219|62683384|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33308052|NCT01194219|62683375|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33308053|NCT01194219|62683376|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33308054|NCT01194219|62683377|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
33308055|NCT01194219|62683378|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
33308056|NCT01194219|62683379|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33308057|NCT01194219|62683380|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33308058|NCT01194219|62683381|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33308059|NCT01194219|62683382|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33308060|NCT01194219|62683383|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33308061|NCT01194219|62683384|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33308062|NCT01194219|62683375|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33308063|NCT01194219|62683376|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33308064|NCT01194219|62683377|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
33308065|NCT01194219|62683378|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33308066|NCT01194219|62683379|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33308067|NCT01194219|62683380|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33308068|NCT01194219|62683381|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33308069|NCT01194219|62683382|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33308070|NCT01194219|62683383|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33308071|NCT01194219|62683384|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33308072|NCT01194219|62683375|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33308073|NCT01194219|62683376|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33308074|NCT01194219|62683377|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33308075|NCT01194219|62683378|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
33308076|NCT01194219|62683379|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33308077|NCT01194219|62683380|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33308078|NCT01194219|62683381|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33308079|NCT01194219|62683382|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33308080|NCT01194219|62683383|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33308081|NCT01194219|62683384|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33308082|NCT01194219|62683375|FG000|Maintenance Phase Weeks16-32|Other|0|||
33308083|NCT01194219|62683376|FG001|Maintenance Phase Weeks16-32|Other|0|||
33308084|NCT01194219|62683377|FG002|Maintenance Phase Weeks16-32|Other|2|||
33308085|NCT01194219|62683378|FG003|Maintenance Phase Weeks16-32|Other|1|||
33308086|NCT01194219|62683379|FG004|Maintenance Phase Weeks16-32|Other|0|||
33308087|NCT01194219|62683380|FG005|Maintenance Phase Weeks16-32|Other|0|||
33308088|NCT01194219|62683381|FG006|Maintenance Phase Weeks16-32|Other|0|||
33308089|NCT01194219|62683382|FG007|Maintenance Phase Weeks16-32|Other|0|||
33308090|NCT01194219|62683383|FG008|Maintenance Phase Weeks16-32|Other|0|||
33308091|NCT01194219|62683384|FG009|Maintenance Phase Weeks16-32|Other|0|||
33308092|NCT01194219|62683375|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
33308093|NCT01194219|62683376|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
33308094|NCT01194219|62683377|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
33308095|NCT01194219|62683378|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
33308096|NCT01194219|62683379|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
33308097|NCT01194219|62683380|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
33308098|NCT01194219|62683381|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
33308099|NCT01194219|62683382|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
33308100|NCT01194219|62683383|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
33308101|NCT01194219|62683384|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
33308102|NCT01194219|62683375|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
33308103|NCT01194219|62683376|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
33308104|NCT01194219|62683377|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
33308105|NCT01194219|62683378|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
33308106|NCT01194219|62683379|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
33308107|NCT01194219|62683380|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
33308108|NCT01194219|62683381|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
33308109|NCT01194219|62683382|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
33398946|NCT00274261|62778419|FG001|Overall Study|Withdrawal by Subject|126|||
33398947|NCT00274261|62778418|FG000|Overall Study|Protocol Violation|71|||
33308110|NCT01194219|62683383|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
33308111|NCT01194219|62683384|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
33308112|NCT01194219|62683375|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33308113|NCT01194219|62683376|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33308114|NCT01194219|62683377|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33308115|NCT01194219|62683378|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33308116|NCT01194219|62683379|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
33308117|NCT01194219|62683380|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33308118|NCT01194219|62683381|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
33308119|NCT01194219|62683382|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33308120|NCT01194219|62683383|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33308121|NCT01194219|62683384|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33308122|NCT01194219|62683375|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
33308123|NCT01194219|62683376|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
33308124|NCT01194219|62683377|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
33308125|NCT01194219|62683378|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
33308126|NCT01194219|62683379|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
33308127|NCT01194219|62683380|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
33308128|NCT01194219|62683381|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
33308129|NCT01194219|62683382|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
33308130|NCT01194219|62683383|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
33308131|NCT01194219|62683384|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
33308132|NCT01194219|62683375|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
33308133|NCT01194219|62683376|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
33308134|NCT01194219|62683377|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
33308135|NCT01194219|62683378|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
33308136|NCT01194219|62683379|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
33308137|NCT01194219|62683380|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
33308138|NCT01194219|62683381|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
33308139|NCT01194219|62683382|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
33308140|NCT01194219|62683383|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
33308141|NCT01194219|62683384|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
33308142|NCT01194219|62683375|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33308143|NCT01194219|62683376|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33308144|NCT01194219|62683377|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33308145|NCT01194219|62683378|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33308146|NCT01194219|62683379|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33308147|NCT01194219|62683380|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33308148|NCT01194219|62683381|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33308149|NCT01194219|62683382|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
33308150|NCT01194219|62683383|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33308151|NCT01194219|62683384|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33398948|NCT00274261|62778419|FG001|Overall Study|Protocol Violation|42|||
33398949|NCT00274261|62778418|FG000|Overall Study|Lost to Follow-up|106|||
33398950|NCT00274261|62778419|FG001|Overall Study|Lost to Follow-up|75|||
33398951|NCT00624468|62778429|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
33398952|NCT00624468|62778430|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
33398953|NCT00624468|62778431|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
33398954|NCT00624468|62778432|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
33398955|NCT00624468|62778429|FG000|Double-blind Period|Withdrew Prematurely|1|||
33398956|NCT00624468|62778430|FG001|Double-blind Period|Withdrew Prematurely|1|||
33398957|NCT00624468|62778431|FG002|Double-blind Period|Withdrew Prematurely|0|||
33398958|NCT00624468|62778432|FG003|Double-blind Period|Withdrew Prematurely|0|||
33398959|NCT00624468|62778429|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
33398960|NCT00624468|62778430|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
33398961|NCT00624468|62778431|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
33398962|NCT00624468|62778432|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
33398963|NCT00624468|62778429|FG000|Safety Follow-up (SFU) Period|Other|0|||
33398964|NCT00624468|62778430|FG001|Safety Follow-up (SFU) Period|Other|0|||
33398965|NCT00624468|62778431|FG002|Safety Follow-up (SFU) Period|Other|1|||
33398966|NCT00624468|62778432|FG003|Safety Follow-up (SFU) Period|Other|1|||
33398967|NCT00521014|62778440|FG000|Overall Study|Inevaluable, not treated|1|||
33398968|NCT00560235|62778447|FG000|Phase 1|Discontinued|8|||
33398969|NCT00560235|62778448|FG001|Phase 1|Discontinued|0|||
33398970|NCT00560235|62778449|FG002|Phase 1|Discontinued|0|||
33398971|NCT00560235|62778447|FG000|Phase 1B|Discontinued|0|||
33398972|NCT00560235|62778448|FG001|Phase 1B|Discontinued|19|||
33398973|NCT00560235|62778449|FG002|Phase 1B|Discontinued|0|||
33398974|NCT00560235|62778447|FG000|Phase 2|Discontinued|0|||
33398975|NCT00560235|62778448|FG001|Phase 2|Discontinued|0|||
33398976|NCT00560235|62778449|FG002|Phase 2|Discontinued|96|||
33398977|NCT00560235|62778447|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
33398978|NCT00560235|62778448|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
33398979|NCT00560235|62778449|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
33398980|NCT00291577|62778467|FG000|Overall Study|Adverse Event|1|||
33398981|NCT00291577|62778467|FG000|Overall Study|Other|4|||
33398982|NCT00291577|62778467|FG000|Overall Study|Withdrawal by Subject|2|||
33398983|NCT00291577|62778467|FG000|Overall Study|Lack of Efficacy|14|||
33398984|NCT00520936|62778479|FG000|Overall Study|Physician Decision|0|||
33398985|NCT00520936|62778480|FG001|Overall Study|Physician Decision|2|||
33398986|NCT00520936|62778481|FG002|Overall Study|Physician Decision|1|||
33398987|NCT00520936|62778482|FG003|Overall Study|Physician Decision|0|||
33398988|NCT00520936|62778483|FG004|Overall Study|Physician Decision|0|||
33398989|NCT00520936|62778484|FG005|Overall Study|Physician Decision|0|||
33398990|NCT00520936|62778485|FG006|Overall Study|Physician Decision|0|||
33398991|NCT00520936|62778486|FG007|Overall Study|Physician Decision|0|||
33398992|NCT00520936|62778479|FG000|Overall Study|Withdrawal by Subject|0|||
33398993|NCT00520936|62778480|FG001|Overall Study|Withdrawal by Subject|0|||
33398994|NCT00520936|62778481|FG002|Overall Study|Withdrawal by Subject|0|||
33398995|NCT00520936|62778482|FG003|Overall Study|Withdrawal by Subject|0|||
33398996|NCT00520936|62778483|FG004|Overall Study|Withdrawal by Subject|0|||
33668722|NCT01687166|63102717|FG003|Overall Study|Lost to Follow-up|0|||
33668723|NCT01687166|63102714|FG000|Overall Study|Equipment/Device Availability|0|||
33668724|NCT01687166|63102715|FG001|Overall Study|Equipment/Device Availability|1|||
33668725|NCT01687166|63102716|FG002|Overall Study|Equipment/Device Availability|0|||
33668726|NCT01687166|63102717|FG003|Overall Study|Equipment/Device Availability|0|||
33668727|NCT01687166|63102714|FG000|Overall Study|Death|1|||
33668728|NCT01687166|63102715|FG001|Overall Study|Death|1|||
33668729|NCT01687166|63102716|FG002|Overall Study|Death|0|||
33668730|NCT01687166|63102717|FG003|Overall Study|Death|0|||
33668731|NCT01687166|63102714|FG000|Overall Study|Protocol Violation|1|||
33668732|NCT01687166|63102715|FG001|Overall Study|Protocol Violation|1|||
33668733|NCT01687166|63102716|FG002|Overall Study|Protocol Violation|1|||
33668734|NCT01687166|63102717|FG003|Overall Study|Protocol Violation|0|||
33668735|NCT01687166|63102714|FG000|Overall Study|Subject moved out of state|0|||
33668736|NCT01687166|63102715|FG001|Overall Study|Subject moved out of state|1|||
33668737|NCT01687166|63102716|FG002|Overall Study|Subject moved out of state|0|||
33668738|NCT01687166|63102717|FG003|Overall Study|Subject moved out of state|0|||
33668739|NCT01687166|63102714|FG000|Overall Study|Patient unable to be compliant|1|||
33668740|NCT01687166|63102715|FG001|Overall Study|Patient unable to be compliant|0|||
33668741|NCT01687166|63102716|FG002|Overall Study|Patient unable to be compliant|0|||
33668742|NCT01687166|63102717|FG003|Overall Study|Patient unable to be compliant|0|||
33668743|NCT01687166|63102714|FG000|Overall Study|Physician choice to use different device|1|||
33668744|NCT01687166|63102715|FG001|Overall Study|Physician choice to use different device|2|||
33668745|NCT01687166|63102716|FG002|Overall Study|Physician choice to use different device|4|||
33668746|NCT01687166|63102717|FG003|Overall Study|Physician choice to use different device|0|||
33668747|NCT01687166|63102714|FG000|Overall Study|Insurance|0|||
33668748|NCT01687166|63102715|FG001|Overall Study|Insurance|0|||
33668749|NCT01687166|63102716|FG002|Overall Study|Insurance|1|||
33668750|NCT01687166|63102717|FG003|Overall Study|Insurance|1|||
33668751|NCT01561976|63102731|FG000|Period 1|Adverse Event|0|||
33668752|NCT01561976|63102732|FG001|Period 1|Adverse Event|0|||
33668753|NCT01561976|63102733|FG002|Period 1|Adverse Event|1|||
33668754|NCT01561976|63102734|FG003|Period 1|Adverse Event|0|||
33668755|NCT01561976|63102735|FG004|Period 1|Adverse Event|0|||
33668756|NCT01561976|63102736|FG005|Period 1|Adverse Event|0|||
33668757|NCT01561976|63102731|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
33668758|NCT01561976|63102732|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
33668759|NCT01561976|63102733|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
33668760|NCT01561976|63102734|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
33668761|NCT01561976|63102735|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
33668762|NCT01561976|63102736|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
33668763|NCT01561976|63102731|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33398997|NCT00520936|62778484|FG005|Overall Study|Withdrawal by Subject|0|||
33398998|NCT00520936|62778485|FG006|Overall Study|Withdrawal by Subject|0|||
33398999|NCT00520936|62778486|FG007|Overall Study|Withdrawal by Subject|1|||
33668764|NCT01561976|63102732|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33668765|NCT01561976|63102733|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33668766|NCT01561976|63102734|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33399000|NCT00520936|62778479|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
33399001|NCT00520936|62778480|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
33399002|NCT00520936|62778481|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
33668767|NCT01561976|63102735|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33668768|NCT01561976|63102736|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
33668769|NCT01561976|63102731|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
33668770|NCT01561976|63102732|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
33668771|NCT01561976|63102733|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
33668772|NCT01561976|63102734|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
33668773|NCT01561976|63102735|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
33668774|NCT01561976|63102736|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
33668775|NCT01686932|63102746|FG000|Period 1|Adverse Event|1|||
33668776|NCT01686932|63102747|FG001|Period 1|Adverse Event|1|||
33668777|NCT01468207|63102755|FG000|Treatment Period 1|Adverse Event|1|||
33668778|NCT01468207|63102756|FG001|Treatment Period 1|Adverse Event|0|||
33668779|NCT01468207|63102757|FG002|Treatment Period 1|Adverse Event|0|||
33668780|NCT01468207|63102758|FG003|Treatment Period 1|Adverse Event|0|||
33668781|NCT01468207|63102759|FG004|Treatment Period 1|Adverse Event|0|||
33668782|NCT01468207|63102760|FG005|Treatment Period 1|Adverse Event|0|||
33668783|NCT01468207|63102755|FG000|Treatment Period 1|Protocol Violation|1|||
33668784|NCT01468207|63102756|FG001|Treatment Period 1|Protocol Violation|1|||
33668785|NCT01468207|63102757|FG002|Treatment Period 1|Protocol Violation|0|||
33668786|NCT01468207|63102758|FG003|Treatment Period 1|Protocol Violation|0|||
33668787|NCT01468207|63102759|FG004|Treatment Period 1|Protocol Violation|0|||
33668788|NCT01468207|63102760|FG005|Treatment Period 1|Protocol Violation|0|||
33668789|NCT01468207|63102755|FG000|Treatment Period 1|Withdrawal by Subject|5|||
33668790|NCT01468207|63102756|FG001|Treatment Period 1|Withdrawal by Subject|4|||
33668791|NCT01468207|63102757|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33668792|NCT01468207|63102758|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33668793|NCT01468207|63102759|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33668794|NCT01468207|63102760|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33668795|NCT01468207|63102755|FG000|Treatment Period 1|Lost to Follow-up|2|||
33668796|NCT01468207|63102756|FG001|Treatment Period 1|Lost to Follow-up|1|||
33668797|NCT01468207|63102757|FG002|Treatment Period 1|Lost to Follow-up|0|||
33668798|NCT01468207|63102758|FG003|Treatment Period 1|Lost to Follow-up|0|||
33668799|NCT01468207|63102759|FG004|Treatment Period 1|Lost to Follow-up|0|||
33668800|NCT01468207|63102760|FG005|Treatment Period 1|Lost to Follow-up|0|||
33668801|NCT01468207|63102755|FG000|Treatment Period 1|Other|0|||
33668802|NCT01468207|63102756|FG001|Treatment Period 1|Other|2|||
33668803|NCT01468207|63102757|FG002|Treatment Period 1|Other|0|||
33668804|NCT01468207|63102758|FG003|Treatment Period 1|Other|0|||
33668805|NCT01468207|63102759|FG004|Treatment Period 1|Other|0|||
33668806|NCT01468207|63102760|FG005|Treatment Period 1|Other|0|||
33668807|NCT01468207|63102755|FG000|Treatment Period 2|Adverse Event|0|||
33668808|NCT01468207|63102756|FG001|Treatment Period 2|Adverse Event|0|||
33668809|NCT01468207|63102757|FG002|Treatment Period 2|Adverse Event|6|||
33668810|NCT01468207|63102758|FG003|Treatment Period 2|Adverse Event|1|||
33668811|NCT01468207|63102759|FG004|Treatment Period 2|Adverse Event|2|||
33668812|NCT01468207|63102760|FG005|Treatment Period 2|Adverse Event|1|||
33668813|NCT01468207|63102755|FG000|Treatment Period 2|Lack of Efficacy|0|||
33668814|NCT01468207|63102756|FG001|Treatment Period 2|Lack of Efficacy|0|||
33668815|NCT01468207|63102757|FG002|Treatment Period 2|Lack of Efficacy|1|||
33668816|NCT01468207|63102758|FG003|Treatment Period 2|Lack of Efficacy|1|||
33668817|NCT01468207|63102759|FG004|Treatment Period 2|Lack of Efficacy|0|||
33668818|NCT01468207|63102760|FG005|Treatment Period 2|Lack of Efficacy|2|||
33668819|NCT01468207|63102755|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33668820|NCT01468207|63102756|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33668821|NCT01468207|63102757|FG002|Treatment Period 2|Withdrawal by Subject|5|||
33668822|NCT01468207|63102758|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33668823|NCT01468207|63102759|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33668824|NCT01468207|63102760|FG005|Treatment Period 2|Withdrawal by Subject|2|||
33668825|NCT01468207|63102755|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
33668826|NCT01468207|63102756|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
33668827|NCT01468207|63102757|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
33668828|NCT01468207|63102758|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
33668829|NCT01468207|63102759|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
33668830|NCT01468207|63102760|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
33668831|NCT01468207|63102755|FG000|Treatment Period 2|Lost to Follow-up|0|||
33668832|NCT01468207|63102756|FG001|Treatment Period 2|Lost to Follow-up|0|||
33668833|NCT01468207|63102757|FG002|Treatment Period 2|Lost to Follow-up|5|||
33668834|NCT01468207|63102758|FG003|Treatment Period 2|Lost to Follow-up|1|||
33668835|NCT01468207|63102759|FG004|Treatment Period 2|Lost to Follow-up|0|||
33668836|NCT01468207|63102760|FG005|Treatment Period 2|Lost to Follow-up|0|||
33668837|NCT01468207|63102755|FG000|Treatment Period 2|Other|0|||
33668838|NCT01468207|63102756|FG001|Treatment Period 2|Other|0|||
33668839|NCT01468207|63102757|FG002|Treatment Period 2|Other|5|||
33668840|NCT01468207|63102758|FG003|Treatment Period 2|Other|1|||
33668841|NCT01468207|63102759|FG004|Treatment Period 2|Other|1|||
33668842|NCT01468207|63102760|FG005|Treatment Period 2|Other|2|||
33668843|NCT01494649|63102780|FG000|Overall Study|Lost to Follow-up|0|||
33668844|NCT01494649|63102781|FG001|Overall Study|Lost to Follow-up|1|||
33668845|NCT01686152|63102792|FG000|Overall Study|Withdrawal by Subject|11|||
33668846|NCT01686152|63102793|FG001|Overall Study|Withdrawal by Subject|11|||
33668847|NCT01686152|63102794|FG002|Overall Study|Withdrawal by Subject|3|||
33668848|NCT01686152|63102792|FG000|Overall Study|Drug Code Unblinded|0|||
33668849|NCT01686152|63102793|FG001|Overall Study|Drug Code Unblinded|1|||
33668850|NCT01686152|63102794|FG002|Overall Study|Drug Code Unblinded|0|||
33668851|NCT01686152|63102792|FG000|Overall Study|Protocol Violation|6|||
33668852|NCT01686152|63102793|FG001|Overall Study|Protocol Violation|1|||
33668853|NCT01686152|63102794|FG002|Overall Study|Protocol Violation|0|||
33668854|NCT01686152|63102792|FG000|Overall Study|Adverse Event|12|||
33668855|NCT01686152|63102793|FG001|Overall Study|Adverse Event|11|||
33668856|NCT01686152|63102794|FG002|Overall Study|Adverse Event|0|||
33668857|NCT01686152|63102792|FG000|Overall Study|Lack of Efficacy|0|||
33668858|NCT01686152|63102793|FG001|Overall Study|Lack of Efficacy|0|||
33668859|NCT01686152|63102794|FG002|Overall Study|Lack of Efficacy|1|||
33668860|NCT01686152|63102792|FG000|Overall Study|IP Non-compliance|5|||
33668861|NCT01686152|63102793|FG001|Overall Study|IP Non-compliance|5|||
33668862|NCT01686152|63102794|FG002|Overall Study|IP Non-compliance|0|||
33668863|NCT01686152|63102792|FG000|Overall Study|Lost to Follow-up|7|||
33668864|NCT01686152|63102793|FG001|Overall Study|Lost to Follow-up|6|||
33668865|NCT01686152|63102794|FG002|Overall Study|Lost to Follow-up|5|||
33668866|NCT01452919|63102802|FG000|Open-Label Treatment|Adverse Event|5|||
33668867|NCT01452919|63102803|FG001|Open-Label Treatment|Adverse Event|0|||
33668868|NCT01452919|63102804|FG002|Open-Label Treatment|Adverse Event|0|||
33668869|NCT01452919|63102802|FG000|Open-Label Treatment|Lost to Follow-up|4|||
33668870|NCT01452919|63102803|FG001|Open-Label Treatment|Lost to Follow-up|0|||
33668871|NCT01452919|63102804|FG002|Open-Label Treatment|Lost to Follow-up|0|||
33668872|NCT01452919|63102802|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
33668873|NCT01452919|63102803|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
33668874|NCT01452919|63102804|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
33668875|NCT01452919|63102802|FG000|Open-Label Treatment|Protocol Violation|4|||
33668876|NCT01452919|63102803|FG001|Open-Label Treatment|Protocol Violation|0|||
33668877|NCT01452919|63102804|FG002|Open-Label Treatment|Protocol Violation|0|||
33668878|NCT01452919|63102802|FG000|Open-Label Treatment|Sponsor Decision|1|||
33668879|NCT01452919|63102803|FG001|Open-Label Treatment|Sponsor Decision|0|||
33668880|NCT01452919|63102804|FG002|Open-Label Treatment|Sponsor Decision|0|||
33668881|NCT01452919|63102802|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
33668882|NCT01452919|63102803|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
33668883|NCT01452919|63102804|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
33668884|NCT01452919|63102802|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
33668885|NCT01452919|63102803|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
33668886|NCT01452919|63102804|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
33668887|NCT01452919|63102802|FG000|Randomization Treatment|Adverse Event|0|||
33668888|NCT01452919|63102803|FG001|Randomization Treatment|Adverse Event|0|||
33668889|NCT01452919|63102804|FG002|Randomization Treatment|Adverse Event|2|||
33668890|NCT01452919|63102802|FG000|Randomization Treatment|Sponsor Decision|0|||
33668891|NCT01452919|63102803|FG001|Randomization Treatment|Sponsor Decision|1|||
33668892|NCT01452919|63102804|FG002|Randomization Treatment|Sponsor Decision|0|||
33668893|NCT01452919|63102802|FG000|Randomization Treatment|Withdrawal by Subject|0|||
33668894|NCT01452919|63102803|FG001|Randomization Treatment|Withdrawal by Subject|1|||
33668895|NCT01452919|63102804|FG002|Randomization Treatment|Withdrawal by Subject|0|||
33668896|NCT01452919|63102802|FG000|Randomization Treatment|Subject is moving or has moved|0|||
33668897|NCT01452919|63102803|FG001|Randomization Treatment|Subject is moving or has moved|1|||
33668898|NCT01452919|63102804|FG002|Randomization Treatment|Subject is moving or has moved|0|||
33668899|NCT01582178|63102816|FG000|Overall Study|Physician Decision|6|||
33668900|NCT01582178|63102817|FG001|Overall Study|Physician Decision|5|||
33668901|NCT01561898|63102827|FG000|Overall Study|Withdrawal by Subject|0|||
33668902|NCT01561898|63102828|FG001|Overall Study|Withdrawal by Subject|8|||
33668903|NCT01561898|63102829|FG002|Overall Study|Withdrawal by Subject|12|||
33668904|NCT01561898|63102830|FG003|Overall Study|Withdrawal by Subject|5|||
33668905|NCT01561898|63102827|FG000|Overall Study|Lack of Efficacy|0|||
33668906|NCT01561898|63102828|FG001|Overall Study|Lack of Efficacy|8|||
33668907|NCT01561898|63102829|FG002|Overall Study|Lack of Efficacy|10|||
33668908|NCT01561898|63102830|FG003|Overall Study|Lack of Efficacy|5|||
33668909|NCT01561898|63102827|FG000|Overall Study|Worsening of complications|0|||
33668910|NCT01561898|63102828|FG001|Overall Study|Worsening of complications|1|||
33668911|NCT01561898|63102829|FG002|Overall Study|Worsening of complications|0|||
33668912|NCT01561898|63102830|FG003|Overall Study|Worsening of complications|0|||
33668913|NCT01561898|63102827|FG000|Overall Study|Lost to Follow-up|0|||
33668914|NCT01561898|63102828|FG001|Overall Study|Lost to Follow-up|0|||
33668915|NCT01561898|63102829|FG002|Overall Study|Lost to Follow-up|1|||
33668916|NCT01561898|63102830|FG003|Overall Study|Lost to Follow-up|0|||
33668917|NCT01561898|63102827|FG000|Overall Study|Adverse Event|1|||
33668918|NCT01561898|63102828|FG001|Overall Study|Adverse Event|19|||
33668919|NCT01561898|63102829|FG002|Overall Study|Adverse Event|14|||
33668920|NCT01561898|63102830|FG003|Overall Study|Adverse Event|9|||
33668921|NCT01561898|63102827|FG000|Overall Study|Physician Decision|1|||
33668922|NCT01561898|63102828|FG001|Overall Study|Physician Decision|5|||
33668923|NCT01561898|63102829|FG002|Overall Study|Physician Decision|7|||
33668924|NCT01561898|63102830|FG003|Overall Study|Physician Decision|1|||
33668925|NCT01685840|63102840|FG000|Overall Study|Death|77|||
33668926|NCT01685840|63102841|FG001|Overall Study|Death|66|||
33668927|NCT01685840|63102840|FG000|Overall Study|Lost to Follow-up|27|||
33668928|NCT01685840|63102841|FG001|Overall Study|Lost to Follow-up|25|||
33668929|NCT01685840|63102840|FG000|Overall Study|Physician Decision|3|||
33668930|NCT01685840|63102841|FG001|Overall Study|Physician Decision|7|||
33668931|NCT01685840|63102840|FG000|Overall Study|Withdrawal by Subject|14|||
33668932|NCT01685840|63102841|FG001|Overall Study|Withdrawal by Subject|17|||
33668933|NCT01685840|63102840|FG000|Overall Study|Futility|197|||
33668934|NCT01685840|63102841|FG001|Overall Study|Futility|200|||
33668935|NCT01685840|63102840|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
33668936|NCT01685840|63102841|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
33668937|NCT01452529|63102851|FG000|Run-in Period|Adverse Event|96|||
33668938|NCT01452529|63102852|FG001|Run-in Period|Adverse Event|0|||
33668939|NCT01452529|63102853|FG002|Run-in Period|Adverse Event|0|||
33668940|NCT01452529|63102851|FG000|Run-in Period|Withdrawal by Subject|49|||
33668941|NCT01452529|63102852|FG001|Run-in Period|Withdrawal by Subject|0|||
33668942|NCT01452529|63102853|FG002|Run-in Period|Withdrawal by Subject|0|||
33668943|NCT01452529|63102851|FG000|Run-in Period|Lost to Follow-up|19|||
33668944|NCT01452529|63102852|FG001|Run-in Period|Lost to Follow-up|0|||
33668945|NCT01452529|63102853|FG002|Run-in Period|Lost to Follow-up|0|||
33668946|NCT01452529|63102851|FG000|Run-in Period|Lack of Efficacy|46|||
33668947|NCT01452529|63102852|FG001|Run-in Period|Lack of Efficacy|0|||
33668948|NCT01452529|63102853|FG002|Run-in Period|Lack of Efficacy|0|||
33668949|NCT01452529|63102851|FG000|Run-in Period|Confirmed or suspected diversion|23|||
33668950|NCT01452529|63102852|FG001|Run-in Period|Confirmed or suspected diversion|0|||
33668951|NCT01452529|63102853|FG002|Run-in Period|Confirmed or suspected diversion|0|||
33668952|NCT01452529|63102851|FG000|Run-in Period|Administrative|21|||
33668953|NCT01452529|63102852|FG001|Run-in Period|Administrative|0|||
33668954|NCT01452529|63102853|FG002|Run-in Period|Administrative|0|||
33668955|NCT01452529|63102851|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
33668956|NCT01452529|63102852|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
33668957|NCT01452529|63102853|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
33668958|NCT01452529|63102851|FG000|Double-blind (DB) Period|Adverse Event|0|||
33668959|NCT01452529|63102852|FG001|Double-blind (DB) Period|Adverse Event|18|||
33668960|NCT01452529|63102853|FG002|Double-blind (DB) Period|Adverse Event|11|||
33668961|NCT01452529|63102851|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
33668962|NCT01452529|63102852|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
33668963|NCT01452529|63102853|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
33668964|NCT01452529|63102851|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
33668965|NCT01452529|63102852|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
33668966|NCT01452529|63102853|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
33668967|NCT01452529|63102851|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
33668968|NCT01452529|63102852|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
33668969|NCT01452529|63102853|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
33668970|NCT01452529|63102851|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
33668971|NCT01452529|63102852|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
33668972|NCT01452529|63102853|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
33668973|NCT01452529|63102851|FG000|Double-blind (DB) Period|Administrative|0|||
33668974|NCT01452529|63102852|FG001|Double-blind (DB) Period|Administrative|11|||
33668975|NCT01452529|63102853|FG002|Double-blind (DB) Period|Administrative|7|||
33668976|NCT01560416|63102862|FG000|Randomized Phase|Crossover Participants|7|||
33668977|NCT01560416|63102863|FG001|Randomized Phase|Crossover Participants|0|||
33668978|NCT01685606|63102871|FG000|Overall Study|Withdrawal by Subject|1|||
33668979|NCT01685372|63102877|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
33668980|NCT01685372|63102878|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
33668981|NCT01685216|63102884|FG000|Overall Study|Did not receive study drug|1|||
33668982|NCT01685138|63102888|FG000|Overall Study|Lost to Follow-up|1|||
33668983|NCT01685138|63102888|FG000|Overall Study|Protocol Violation|1|||
33668984|NCT01685138|63102888|FG000|Overall Study|No longer requires treatment|1|||
33668985|NCT01685138|63102888|FG000|Overall Study|Subject/guardian decision|2|||
33668986|NCT01685138|63102888|FG000|Overall Study|Physician Decision|6|||
33668987|NCT01685138|63102888|FG000|Overall Study|Death|10|||
33668988|NCT01685138|63102888|FG000|Overall Study|Adverse Event|18|||
33668989|NCT01685138|63102888|FG000|Overall Study|Progressive disease|53|||
33668990|NCT01685060|63102892|FG000|Overall Study|Rollover patients|16|||
33668991|NCT01685060|63102892|FG000|Overall Study|Adverse Event|12|||
33668992|NCT01685060|63102892|FG000|Overall Study|Progressive disease|69|||
33668993|NCT01685060|63102892|FG000|Overall Study|Physician Decision|14|||
33668994|NCT01685060|63102892|FG000|Overall Study|Subject/guardian decision|20|||
33668995|NCT01685060|63102892|FG000|Overall Study|Lost to Follow-up|1|||
33668996|NCT01685060|63102892|FG000|Overall Study|Death|8|||
33668997|NCT01582100|63102896|FG000|Overall Study|Adverse Event|1|||
33668998|NCT01582100|63102896|FG000|Overall Study|Withdrawal by Subject|1|||
33668999|NCT01579916|63102902|FG000|Overall Study|Lost to Follow-up|6|||
33669000|NCT01579916|63102903|FG001|Overall Study|Lost to Follow-up|1|||
33669001|NCT01579916|63102902|FG000|Overall Study|Withdrawal by Subject|1|||
33669002|NCT01579916|63102903|FG001|Overall Study|Withdrawal by Subject|1|||
33669003|NCT01579916|63102902|FG000|Overall Study|Death|1|||
33669004|NCT01579916|63102903|FG001|Overall Study|Death|0|||
33669005|NCT01684202|63102913|FG000|Dose-escalation Period|Adverse Event|0|||
33669006|NCT01684202|63102914|FG001|Dose-escalation Period|Adverse Event|1|||
33669007|NCT01684202|63102915|FG002|Dose-escalation Period|Adverse Event|0|||
33669008|NCT01684202|63102916|FG003|Dose-escalation Period|Adverse Event|0|||
33669009|NCT01684202|63102913|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
33669010|NCT01684202|63102914|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
33669011|NCT01684202|63102915|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
33669012|NCT01684202|63102916|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
33669013|NCT01684202|63102913|FG000|Maintenance Period|Adverse Event|1|||
33669014|NCT01684202|63102914|FG001|Maintenance Period|Adverse Event|1|||
33669015|NCT01684202|63102915|FG002|Maintenance Period|Adverse Event|1|||
33669016|NCT01684202|63102916|FG003|Maintenance Period|Adverse Event|1|||
33669017|NCT01684202|63102913|FG000|Maintenance Period|Physician Decision|0|||
33669018|NCT01684202|63102914|FG001|Maintenance Period|Physician Decision|1|||
33669019|NCT01684202|63102915|FG002|Maintenance Period|Physician Decision|0|||
33669020|NCT01684202|63102916|FG003|Maintenance Period|Physician Decision|0|||
33399003|NCT00520936|62778482|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
33399004|NCT00520936|62778483|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
33399005|NCT00520936|62778484|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
33399006|NCT00520936|62778485|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
33399007|NCT00520936|62778486|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
33399008|NCT00520936|62778479|FG000|Overall Study|Death|0|||
33399009|NCT00520936|62778480|FG001|Overall Study|Death|0|||
33399010|NCT00520936|62778481|FG002|Overall Study|Death|0|||
33399011|NCT00520936|62778482|FG003|Overall Study|Death|0|||
33399012|NCT00520936|62778483|FG004|Overall Study|Death|0|||
33399013|NCT00520936|62778484|FG005|Overall Study|Death|0|||
33399014|NCT00520936|62778485|FG006|Overall Study|Death|1|||
33399015|NCT00520936|62778486|FG007|Overall Study|Death|0|||
33399016|NCT00520936|62778479|FG000|Overall Study|Protocol Violation|0|||
33399017|NCT00520936|62778480|FG001|Overall Study|Protocol Violation|1|||
33399018|NCT00520936|62778481|FG002|Overall Study|Protocol Violation|1|||
33399019|NCT00520936|62778482|FG003|Overall Study|Protocol Violation|0|||
33399020|NCT00520936|62778483|FG004|Overall Study|Protocol Violation|1|||
33399021|NCT00520936|62778484|FG005|Overall Study|Protocol Violation|0|||
33399022|NCT00520936|62778485|FG006|Overall Study|Protocol Violation|1|||
33399023|NCT00520936|62778486|FG007|Overall Study|Protocol Violation|0|||
33399024|NCT03867760|62778499|FG000|Overall Study|Lost to Follow-up|2|||
33399025|NCT03867760|62778500|FG001|Overall Study|Lost to Follow-up|3|||
33399026|NCT03867760|62778499|FG000|Overall Study|Withdrawal by Subject|1|||
33399027|NCT03867760|62778500|FG001|Overall Study|Withdrawal by Subject|2|||
33399028|NCT03867760|62778499|FG000|Overall Study|subject could not meet study logistics|3|||
33399029|NCT03867760|62778500|FG001|Overall Study|subject could not meet study logistics|3|||
33399030|NCT03865732|62778510|FG000|Overall Study|Adverse Event|0|||
33399031|NCT03865732|62778511|FG001|Overall Study|Adverse Event|1|||
33399032|NCT00520546|62778518|FG000|Overall Study|Withdrawal by Subject|1|||
33399033|NCT00520546|62778518|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
33399034|NCT00555009|62778529|FG000|Overall Study|Withdrawal by Subject|0|||
33399035|NCT00555009|62778530|FG001|Overall Study|Withdrawal by Subject|1|||
33399036|NCT00555009|62778529|FG000|Overall Study|Terminated by Sponsor|2|||
33399037|NCT00555009|62778530|FG001|Overall Study|Terminated by Sponsor|5|||
33399038|NCT00623766|62778538|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
33399039|NCT00623766|62778539|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
33399040|NCT00623766|62778538|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
33399041|NCT00623766|62778539|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
33399042|NCT00623766|62778538|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
33399043|NCT00623766|62778539|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
33669021|NCT01684202|63102913|FG000|Maintenance Period|Withdrawal by Subject|0|||
33669022|NCT01684202|63102914|FG001|Maintenance Period|Withdrawal by Subject|1|||
33669023|NCT01684202|63102915|FG002|Maintenance Period|Withdrawal by Subject|0|||
33669024|NCT01684202|63102916|FG003|Maintenance Period|Withdrawal by Subject|0|||
33399044|NCT00623766|62778538|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
33399045|NCT00623766|62778539|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
33399046|NCT00623766|62778538|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
33399047|NCT00623766|62778539|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
33669025|NCT01684046|63102926|FG000|Period 1, First 30 Days|Adverse Event|0|||
33669026|NCT01684046|63102927|FG001|Period 1, First 30 Days|Adverse Event|2|||
33399048|NCT00550407|62778551|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
33399049|NCT00550407|62778552|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
33399050|NCT00550407|62778553|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
33399051|NCT00550407|62778551|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
33399052|NCT00550407|62778552|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
33399053|NCT00550407|62778553|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
33399054|NCT00550407|62778551|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
33399055|NCT00550407|62778552|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
33399056|NCT00550407|62778553|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
33399057|NCT00550407|62778551|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
33399058|NCT00550407|62778552|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
33399059|NCT00550407|62778553|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
33399060|NCT00550407|62778551|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
33399061|NCT00550407|62778552|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
33399062|NCT00550407|62778553|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
33399063|NCT00550407|62778551|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
33399064|NCT00550407|62778552|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
33399065|NCT00550407|62778553|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
33399066|NCT00550407|62778551|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
33399067|NCT00550407|62778552|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
33399068|NCT00550407|62778553|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
33399069|NCT00550407|62778551|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
33399070|NCT00550407|62778552|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
33399071|NCT00550407|62778553|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
33399072|NCT00550407|62778551|FG000|26-Week Randomized Phase|Adverse Event|0|||
33399073|NCT00550407|62778552|FG001|26-Week Randomized Phase|Adverse Event|5|||
33399074|NCT00550407|62778553|FG002|26-Week Randomized Phase|Adverse Event|2|||
33399075|NCT00550407|62778551|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
33399076|NCT00550407|62778552|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
33399077|NCT00550407|62778553|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
33399078|NCT00550407|62778551|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
33399079|NCT00550407|62778552|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
33399080|NCT00550407|62778553|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
33399081|NCT00550407|62778551|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
33399082|NCT00550407|62778552|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
33399083|NCT00550407|62778553|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
33399084|NCT00531934|62778563|FG000|Overall Study|Adverse Event|4|||
33399085|NCT00531934|62778564|FG001|Overall Study|Adverse Event|8|||
33399086|NCT00531934|62778563|FG000|Overall Study|Progression|52|||
33399087|NCT00531934|62778564|FG001|Overall Study|Progression|42|||
33399088|NCT00531934|62778563|FG000|Overall Study|Death|7|||
33399089|NCT00531934|62778564|FG001|Overall Study|Death|10|||
33399090|NCT00531934|62778563|FG000|Overall Study|Withdrawal by Subject|1|||
33399091|NCT00531934|62778564|FG001|Overall Study|Withdrawal by Subject|1|||
33399092|NCT00531934|62778563|FG000|Overall Study|Other|2|||
33399093|NCT00531934|62778564|FG001|Overall Study|Other|2|||
33399094|NCT00549939|62778573|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
33399095|NCT00549939|62778574|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
33399096|NCT00549939|62778575|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
33399097|NCT00549939|62778573|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
33399098|NCT00549939|62778574|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
33399099|NCT00549939|62778575|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
33399100|NCT00549939|62778573|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
33399101|NCT00549939|62778574|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
33399102|NCT00549939|62778575|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
33399103|NCT00549939|62778573|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
33399104|NCT00549939|62778574|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
33399105|NCT00549939|62778575|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
33399106|NCT00549939|62778573|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
33399107|NCT00549939|62778574|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
33399108|NCT00549939|62778575|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
33399109|NCT00549939|62778573|FG000|40-week Open Label Treatment Period|Other|0|||
33399110|NCT00549939|62778574|FG001|40-week Open Label Treatment Period|Other|1|||
33399111|NCT00549939|62778575|FG002|40-week Open Label Treatment Period|Other|4|||
33399112|NCT00272779|62778587|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
33399113|NCT00272779|62778588|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
33399114|NCT00272779|62778587|FG000|Baseline Through Week 48|Death before Week 48|4|||
33399115|NCT00272779|62778588|FG001|Baseline Through Week 48|Death before Week 48|4|||
33399116|NCT00272779|62778587|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
33399117|NCT00272779|62778588|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
33399118|NCT00272779|62778587|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
33399119|NCT00272779|62778588|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
33399120|NCT00272779|62778587|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
33399121|NCT00272779|62778588|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
33399122|NCT00272779|62778587|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
33399123|NCT00272779|62778588|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
33399124|NCT00272779|62778587|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
33399125|NCT00272779|62778588|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
33399126|NCT00272779|62778587|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
33399127|NCT00272779|62778588|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
33399128|NCT00272779|62778587|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
33399129|NCT00272779|62778588|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
33399130|NCT00272779|62778587|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
33399131|NCT00272779|62778588|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
33399132|NCT00272779|62778587|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
33399133|NCT00272779|62778588|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
33399134|NCT00272779|62778587|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
33399135|NCT00272779|62778588|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
33399136|NCT00272779|62778587|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
33399137|NCT00272779|62778588|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
33399138|NCT00272779|62778587|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
33399139|NCT00272779|62778588|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
33399140|NCT00272779|62778587|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
33399141|NCT00272779|62778588|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
33399142|NCT00272779|62778587|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
33399143|NCT00272779|62778588|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
33399144|NCT00272779|62778587|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
33399145|NCT00272779|62778588|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
33399146|NCT00272779|62778587|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
33399147|NCT00272779|62778588|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
33399148|NCT00272779|62778587|FG000|Baseline Through Week 48|Continuing treatment|385|||
33399149|NCT00272779|62778588|FG001|Baseline Through Week 48|Continuing treatment|368|||
33399150|NCT00272779|62778587|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
33399151|NCT00272779|62778588|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
33399152|NCT00272779|62778587|FG000|Baseline Through Week 48|Never treated|2|||
33399153|NCT00272779|62778588|FG001|Baseline Through Week 48|Never treated|3|||
33399154|NCT00272779|62778587|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
33399155|NCT00272779|62778588|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
33399156|NCT00272779|62778587|FG000|Baseline Through Week 96|Death before Week 96|6|||
33399157|NCT00272779|62778588|FG001|Baseline Through Week 96|Death before Week 96|5|||
33399158|NCT00272779|62778587|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
33399159|NCT00272779|62778588|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
33399160|NCT00272779|62778587|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
33399161|NCT00272779|62778588|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
33399162|NCT00272779|62778587|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
33399163|NCT00272779|62778588|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
33399164|NCT00272779|62778587|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
33399165|NCT00272779|62778588|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
33399166|NCT00272779|62778587|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
33399167|NCT00272779|62778588|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
33399168|NCT00272779|62778587|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
33399169|NCT00272779|62778588|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
33399170|NCT00272779|62778587|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
33399171|NCT00272779|62778588|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
33399172|NCT00272779|62778587|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
33399173|NCT00272779|62778588|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
33399174|NCT00272779|62778587|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
33399175|NCT00272779|62778588|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
33399176|NCT00272779|62778587|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
33399177|NCT00272779|62778588|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
33399178|NCT00272779|62778587|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
33399179|NCT00272779|62778588|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
33669027|NCT01559090|63102936|FG000|Stage I|Withdrawal by Subject|2|||
33399180|NCT00272779|62778587|FG000|Baseline Through Week 96|Never treated|2|||
33399181|NCT00272779|62778588|FG001|Baseline Through Week 96|Never treated|3|||
33399182|NCT00272779|62778587|FG000|Baseline Through Week 96|Continuing on treatment|61|||
33399183|NCT00272779|62778588|FG001|Baseline Through Week 96|Continuing on treatment|38|||
33399184|NCT00511810|62778597|FG000|Overall Study|Lost to Follow-up|1|||
33399185|NCT00511810|62778598|FG001|Overall Study|Lost to Follow-up|2|||
33399186|NCT00511810|62778597|FG000|Overall Study|Lack of Efficacy|0|||
33399187|NCT00511810|62778598|FG001|Overall Study|Lack of Efficacy|2|||
33399188|NCT00511810|62778597|FG000|Overall Study|Refused second scn|0|||
33399189|NCT00511810|62778598|FG001|Overall Study|Refused second scn|1|||
33399190|NCT00291499|62778606|FG000|Overall Study|Adverse Event|3|||
33399191|NCT00291499|62778607|FG001|Overall Study|Adverse Event|8|||
33399192|NCT00291499|62778606|FG000|Overall Study|Change to other therapy|2|||
33399193|NCT00291499|62778607|FG001|Overall Study|Change to other therapy|1|||
33399194|NCT00291499|62778606|FG000|Overall Study|Intercurrent illness|1|||
33399195|NCT00291499|62778607|FG001|Overall Study|Intercurrent illness|0|||
33399196|NCT00291499|62778606|FG000|Overall Study|Protocol Violation|2|||
33399197|NCT00291499|62778607|FG001|Overall Study|Protocol Violation|2|||
33399198|NCT00291499|62778606|FG000|Overall Study|Other reasons|1|||
33399199|NCT00291499|62778607|FG001|Overall Study|Other reasons|4|||
33399200|NCT00553605|62778615|FG000|Overall Study|Did not meet entrance criteria|1|||
33399201|NCT00553605|62778616|FG001|Overall Study|Did not meet entrance criteria|3|||
33399202|NCT00553605|62778615|FG000|Overall Study|Did not receive full dose|1|||
33399203|NCT00553605|62778616|FG001|Overall Study|Did not receive full dose|0|||
33399204|NCT00553605|62778615|FG000|Overall Study|Randomized but not treated|2|||
33399205|NCT00553605|62778616|FG001|Overall Study|Randomized but not treated|0|||
33399206|NCT00621582|62778622|FG000|Overall Study|Adverse Event|7|||
33399207|NCT00621582|62778622|FG000|Overall Study|Protocol Violation|57|||
33399208|NCT00621582|62778622|FG000|Overall Study|Lost to Follow-up|24|||
33399209|NCT00621582|62778622|FG000|Overall Study|issues not identified by investigators|18|||
33399210|NCT00744497|62778628|FG000|Overall Study|Withdrawal by Subject|21|||
33399211|NCT00744497|62778629|FG001|Overall Study|Withdrawal by Subject|18|||
33399212|NCT00744497|62778628|FG000|Overall Study|Death|11|||
33399213|NCT00744497|62778629|FG001|Overall Study|Death|9|||
33399214|NCT00744497|62778628|FG000|Overall Study|Lost to Follow-up|4|||
33399215|NCT00744497|62778629|FG001|Overall Study|Lost to Follow-up|2|||
33399216|NCT00744497|62778628|FG000|Overall Study|Poor compliance/noncompliance|9|||
33399217|NCT00744497|62778629|FG001|Overall Study|Poor compliance/noncompliance|5|||
33399218|NCT00744497|62778628|FG000|Overall Study|No longer meets study criteria|7|||
33399219|NCT00744497|62778629|FG001|Overall Study|No longer meets study criteria|3|||
33399220|NCT00744497|62778628|FG000|Overall Study|Administrative Reason By Sponsor|25|||
33399221|NCT00744497|62778629|FG001|Overall Study|Administrative Reason By Sponsor|8|||
33399222|NCT00744497|62778628|FG000|Overall Study|Disease progression|312|||
33399223|NCT00744497|62778629|FG001|Overall Study|Disease progression|219|||
33399224|NCT00744497|62778628|FG000|Overall Study|Study drug toxicity|68|||
33399225|NCT00744497|62778629|FG001|Overall Study|Study drug toxicity|141|||
33399226|NCT00744497|62778628|FG000|Overall Study|Adverse event unrelated to study drug|78|||
33399227|NCT00744497|62778629|FG001|Overall Study|Adverse event unrelated to study drug|122|||
33399228|NCT00744497|62778628|FG000|Overall Study|Patient requested to stop study drug|65|||
33399229|NCT00744497|62778629|FG001|Overall Study|Patient requested to stop study drug|80|||
33399230|NCT00744497|62778628|FG000|Overall Study|Maximum clinical benefit|141|||
33399231|NCT00744497|62778629|FG001|Overall Study|Maximum clinical benefit|142|||
33399232|NCT00744497|62778628|FG000|Overall Study|Not defined|19|||
33399233|NCT00744497|62778629|FG001|Overall Study|Not defined|13|||
33399234|NCT00747227|62778637|FG000|Overall Study|Death|3|||
33399235|NCT00747227|62778638|FG001|Overall Study|Death|1|||
33399236|NCT00747227|62778637|FG000|Overall Study|Withdrawal by Subject|1|||
33399237|NCT00747227|62778638|FG001|Overall Study|Withdrawal by Subject|0|||
33399238|NCT00747227|62778637|FG000|Overall Study|Lost to Follow-up|1|||
33399239|NCT00747227|62778638|FG001|Overall Study|Lost to Follow-up|2|||
33399240|NCT00747227|62778637|FG000|Overall Study|Illness|1|||
33399241|NCT00747227|62778638|FG001|Overall Study|Illness|1|||
33399242|NCT00747149|62778646|FG000|Overall Study|Adverse Event|0|||
33399243|NCT00747149|62778647|FG001|Overall Study|Adverse Event|15|||
33399244|NCT00747149|62778646|FG000|Overall Study|Lost to Follow-up|0|||
33399245|NCT00747149|62778647|FG001|Overall Study|Lost to Follow-up|10|||
33399246|NCT00747149|62778646|FG000|Overall Study|Withdrawal by Subject|0|||
33399247|NCT00747149|62778647|FG001|Overall Study|Withdrawal by Subject|6|||
33399248|NCT00747149|62778646|FG000|Overall Study|Did not receive treatment|0|||
33399249|NCT00747149|62778647|FG001|Overall Study|Did not receive treatment|1|||
33399250|NCT00747149|62778646|FG000|Overall Study|Incorrect enrollment|0|||
33399251|NCT00747149|62778647|FG001|Overall Study|Incorrect enrollment|6|||
33399252|NCT00747149|62778646|FG000|Overall Study|Severe non-compliance to protocol|0|||
33399253|NCT00747149|62778647|FG001|Overall Study|Severe non-compliance to protocol|1|||
33399254|NCT00747149|62778646|FG000|Overall Study|Not reported|1|||
33399255|NCT00747149|62778647|FG001|Overall Study|Not reported|4|||
33399256|NCT00271609|62778661|FG000|Overall Study|Adverse Event|11|||
33399257|NCT00271609|62778662|FG001|Overall Study|Adverse Event|3|||
33399258|NCT00271609|62778661|FG000|Overall Study|Withdrawal by Subject|2|||
33399259|NCT00271609|62778662|FG001|Overall Study|Withdrawal by Subject|0|||
33399260|NCT00548847|62778668|FG000|Overall Study|Disease progression|7|||
33399261|NCT00290407|62778672|FG000|Overall Study|Physician Decision|2|||
33399262|NCT00749411|62778678|FG000|Overall Study|Adverse Event|0|||
33399263|NCT00749411|62778679|FG001|Overall Study|Adverse Event|2|||
33399264|NCT00749411|62778678|FG000|Overall Study|Lack of Efficacy|0|||
33399265|NCT00749411|62778679|FG001|Overall Study|Lack of Efficacy|1|||
33399266|NCT00749411|62778678|FG000|Overall Study|Protocol Violation|1|||
33399267|NCT00749411|62778679|FG001|Overall Study|Protocol Violation|1|||
33399268|NCT00749411|62778678|FG000|Overall Study|Protocol-defined stopping criteria|0|||
33399269|NCT00749411|62778679|FG001|Overall Study|Protocol-defined stopping criteria|1|||
33399270|NCT03958149|62778687|FG000|Overall Study|Withdrawal by Subject|0|||
33399271|NCT03958149|62778688|FG001|Overall Study|Withdrawal by Subject|1|||
33399272|NCT00549549|62778702|FG000|Overall Study|Adverse Event|5|||
33399273|NCT00549549|62778703|FG001|Overall Study|Adverse Event|3|||
33399274|NCT00549549|62778704|FG002|Overall Study|Adverse Event|1|||
33399275|NCT00549549|62778705|FG003|Overall Study|Adverse Event|9|||
33399276|NCT00549549|62778702|FG000|Overall Study|Lack of Efficacy|9|||
33399277|NCT00549549|62778703|FG001|Overall Study|Lack of Efficacy|6|||
33399278|NCT00549549|62778704|FG002|Overall Study|Lack of Efficacy|4|||
33399279|NCT00549549|62778705|FG003|Overall Study|Lack of Efficacy|2|||
33399280|NCT00549549|62778702|FG000|Overall Study|Lost to Follow-up|1|||
33399281|NCT00549549|62778703|FG001|Overall Study|Lost to Follow-up|0|||
33399282|NCT00549549|62778704|FG002|Overall Study|Lost to Follow-up|1|||
33399283|NCT00549549|62778705|FG003|Overall Study|Lost to Follow-up|2|||
33399284|NCT00549549|62778702|FG000|Overall Study|Withdrawal by Subject|0|||
33399285|NCT00549549|62778703|FG001|Overall Study|Withdrawal by Subject|4|||
33399286|NCT00549549|62778704|FG002|Overall Study|Withdrawal by Subject|1|||
33399287|NCT00549549|62778705|FG003|Overall Study|Withdrawal by Subject|0|||
33399288|NCT00549549|62778702|FG000|Overall Study|Other|9|||
33399289|NCT00549549|62778703|FG001|Overall Study|Other|9|||
33399290|NCT00549549|62778704|FG002|Overall Study|Other|9|||
33399291|NCT00549549|62778705|FG003|Overall Study|Other|11|||
33399292|NCT00549549|62778702|FG000|Overall Study|Randomized but not treated|0|||
33399293|NCT00549549|62778703|FG001|Overall Study|Randomized but not treated|0|||
33399294|NCT00549549|62778704|FG002|Overall Study|Randomized but not treated|1|||
33399295|NCT00549549|62778705|FG003|Overall Study|Randomized but not treated|1|||
33399296|NCT00270205|62778719|FG000|Overall Study|Lost to Follow-up|1|||
33399297|NCT00270205|62778720|FG001|Overall Study|Lost to Follow-up|0|||
33399298|NCT00270205|62778721|FG002|Overall Study|Lost to Follow-up|0|||
33399299|NCT00270205|62778722|FG003|Overall Study|Lost to Follow-up|1|||
33399300|NCT00622284|62778734|FG000|Overall Study|Lack of Efficacy|45|||
33399301|NCT00622284|62778735|FG001|Overall Study|Lack of Efficacy|15|||
33399302|NCT00622284|62778734|FG000|Overall Study|Adverse Event|61|||
33399303|NCT00622284|62778735|FG001|Overall Study|Adverse Event|90|||
33399304|NCT00622284|62778734|FG000|Overall Study|Protocol Violation|12|||
33399305|NCT00622284|62778735|FG001|Overall Study|Protocol Violation|5|||
33399306|NCT00622284|62778734|FG000|Overall Study|Lost to Follow-up|11|||
33399307|NCT00622284|62778735|FG001|Overall Study|Lost to Follow-up|13|||
33399308|NCT00622284|62778734|FG000|Overall Study|Withdrawal by Subject|27|||
33399309|NCT00622284|62778735|FG001|Overall Study|Withdrawal by Subject|24|||
33399310|NCT00622284|62778734|FG000|Overall Study|Other reason (not specified)|33|||
33399311|NCT00622284|62778735|FG001|Overall Study|Other reason (not specified)|24|||
33399312|NCT00269113|62778743|FG000|Overall Study|Adverse Event|14|||
33399313|NCT00269113|62778744|FG001|Overall Study|Adverse Event|7|||
33399314|NCT00269113|62778743|FG000|Overall Study|Lack of Efficacy|35|||
33399315|NCT00269113|62778744|FG001|Overall Study|Lack of Efficacy|18|||
33399316|NCT00269113|62778743|FG000|Overall Study|Early Improvement|2|||
33399317|NCT00269113|62778744|FG001|Overall Study|Early Improvement|0|||
33399318|NCT00269113|62778743|FG000|Overall Study|Withdrawal by Subject|0|||
33399319|NCT00269113|62778744|FG001|Overall Study|Withdrawal by Subject|2|||
33399320|NCT00269113|62778743|FG000|Overall Study|Death|6|||
33399321|NCT00269113|62778744|FG001|Overall Study|Death|2|||
33399322|NCT00269113|62778743|FG000|Overall Study|Lost to Follow-up|2|||
33399323|NCT00269113|62778744|FG001|Overall Study|Lost to Follow-up|1|||
33399324|NCT00269113|62778743|FG000|Overall Study|Protocol Violation|15|||
33399325|NCT00269113|62778744|FG001|Overall Study|Protocol Violation|5|||
33399326|NCT00269113|62778743|FG000|Overall Study|Other|0|||
33399327|NCT00269113|62778744|FG001|Overall Study|Other|2|||
33399328|NCT00291187|62778754|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
33399329|NCT00291187|62778755|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
33399330|NCT00291187|62778756|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
33399331|NCT00291187|62778757|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
33399332|NCT00546819|62778773|FG000|Overall Study|Adverse Event|2|||
33399333|NCT00546819|62778774|FG001|Overall Study|Adverse Event|3|||
33399334|NCT00546819|62778773|FG000|Overall Study|Lost to Follow-up|2|||
33399335|NCT00546819|62778774|FG001|Overall Study|Lost to Follow-up|1|||
33669028|NCT01559090|63102937|FG001|Stage I|Withdrawal by Subject|2|||
33669029|NCT01559090|63102938|FG002|Stage I|Withdrawal by Subject|3|||
33669030|NCT01559090|63102936|FG000|Stage II|Withdrawal by Subject|1|||
33669031|NCT01559090|63102937|FG001|Stage II|Withdrawal by Subject|0|||
33669032|NCT01559090|63102938|FG002|Stage II|Withdrawal by Subject|0|||
33669033|NCT01683266|63102948|FG000|Overall Study|Adverse Event|5|||
33669034|NCT01683266|63102949|FG001|Overall Study|Adverse Event|4|||
33669035|NCT01683266|63102948|FG000|Overall Study|Lack of Efficacy|5|||
33669036|NCT01683266|63102949|FG001|Overall Study|Lack of Efficacy|2|||
33669037|NCT01683266|63102948|FG000|Overall Study|Protocol Violation|13|||
33669038|NCT01683266|63102949|FG001|Overall Study|Protocol Violation|6|||
33669039|NCT01683266|63102948|FG000|Overall Study|Personal Reason|17|||
33669040|NCT01683266|63102949|FG001|Overall Study|Personal Reason|25|||
33669041|NCT01683266|63102948|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
33669042|NCT01683266|63102949|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
33669043|NCT01683266|63102948|FG000|Overall Study|Lost to Follow-up|5|||
33669044|NCT01683266|63102949|FG001|Overall Study|Lost to Follow-up|0|||
33669045|NCT01683266|63102948|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
33669046|NCT01683266|63102949|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
33669047|NCT01683266|63102948|FG000|Overall Study|Nonserious Hypoglycemia|0|||
33669048|NCT01683266|63102949|FG001|Overall Study|Nonserious Hypoglycemia|3|||
33669049|NCT01683266|63102948|FG000|Overall Study|Perceived Lack of Efficacy|1|||
33669050|NCT01683266|63102949|FG001|Overall Study|Perceived Lack of Efficacy|1|||
33669051|NCT01683266|63102948|FG000|Overall Study|Possibly Hypoglycemia|1|||
33669052|NCT01683266|63102949|FG001|Overall Study|Possibly Hypoglycemia|0|||
33669053|NCT01683266|63102948|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
33669054|NCT01683266|63102949|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
33669055|NCT01467661|63102955|FG000|Overall Study|Adverse Event|16|||
33669056|NCT01467661|63102955|FG000|Overall Study|Withdrawal by Subject|1|||
33669057|NCT01467661|63102955|FG000|Overall Study|Lack of Efficacy|3|||
33669058|NCT01467661|63102955|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
33669059|NCT01577186|63102961|FG000|Overall Study|Adverse Event|23|||
33669060|NCT01577186|63102961|FG000|Overall Study|Death|1|||
33669061|NCT01577186|63102961|FG000|Overall Study|Lost to Follow-up|28|||
33669062|NCT01577186|63102961|FG000|Overall Study|Withdrawal by Subject|35|||
33669063|NCT01577186|63102961|FG000|Overall Study|Insufficient Response|18|||
33669064|NCT01577186|63102961|FG000|Overall Study|Ineligible to Continue|15|||
33669065|NCT01577186|63102961|FG000|Overall Study|Non-Compliant|8|||
33669066|NCT01577186|63102961|FG000|Overall Study|Other|2|||
33669067|NCT01559012|63102967|FG000|Overall Study|Withdrawal by Subject|0|||
33669068|NCT01559012|63102968|FG001|Overall Study|Withdrawal by Subject|1|||
33669069|NCT01451827|63102993|FG000|Overall Study|Adverse Event|2|||
33669070|NCT01451827|63102994|FG001|Overall Study|Adverse Event|0|||
33669071|NCT01451827|63102995|FG002|Overall Study|Adverse Event|1|||
33669072|NCT01451827|63102996|FG003|Overall Study|Adverse Event|1|||
33669073|NCT01451827|63102993|FG000|Overall Study|Protocol deviation|1|||
33669074|NCT01451827|63102994|FG001|Overall Study|Protocol deviation|0|||
33669075|NCT01451827|63102995|FG002|Overall Study|Protocol deviation|0|||
33669076|NCT01451827|63102996|FG003|Overall Study|Protocol deviation|0|||
33669077|NCT01451827|63102993|FG000|Overall Study|Lost to Follow-up|0|||
33669078|NCT01451827|63102994|FG001|Overall Study|Lost to Follow-up|3|||
33669079|NCT01451827|63102995|FG002|Overall Study|Lost to Follow-up|0|||
33669080|NCT01451827|63102996|FG003|Overall Study|Lost to Follow-up|2|||
33669081|NCT01451827|63102993|FG000|Overall Study|Participant met withdrawal criteria|0|||
33669082|NCT01451827|63102994|FG001|Overall Study|Participant met withdrawal criteria|2|||
33669083|NCT01451827|63102995|FG002|Overall Study|Participant met withdrawal criteria|0|||
33669084|NCT01451827|63102996|FG003|Overall Study|Participant met withdrawal criteria|0|||
33669085|NCT01451827|63102993|FG000|Overall Study|Withdrawal by Subject|0|||
33669086|NCT01451827|63102994|FG001|Overall Study|Withdrawal by Subject|0|||
33669087|NCT01451827|63102995|FG002|Overall Study|Withdrawal by Subject|1|||
33669088|NCT01451827|63102996|FG003|Overall Study|Withdrawal by Subject|1|||
33669089|NCT01557920|63103006|FG000|Overall Study|Withdrawal by Subject|2|||
33669090|NCT01557920|63103007|FG001|Overall Study|Withdrawal by Subject|3|||
33669091|NCT01557920|63103006|FG000|Overall Study|Lack of Efficacy|1|||
33669092|NCT01557920|63103007|FG001|Overall Study|Lack of Efficacy|0|||
33669093|NCT01467583|63103043|FG000|Overall Study|Death|1|||
33669094|NCT01467583|63103044|FG001|Overall Study|Death|1|||
33669095|NCT01467583|63103045|FG002|Overall Study|Death|0|||
33669096|NCT01467583|63103043|FG000|Overall Study|Withdrawal by Subject|1|||
33669097|NCT01467583|63103044|FG001|Overall Study|Withdrawal by Subject|0|||
33669098|NCT01467583|63103045|FG002|Overall Study|Withdrawal by Subject|0|||
33669099|NCT01467583|63103043|FG000|Overall Study|Protocol Violation|0|||
33669100|NCT01467583|63103044|FG001|Overall Study|Protocol Violation|0|||
33399336|NCT00546819|62778773|FG000|Overall Study|Withdrawal by Subject|4|||
33669101|NCT01467583|63103045|FG002|Overall Study|Protocol Violation|2|||
33669102|NCT01576718|63103062|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
33669103|NCT01576718|63103063|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33669104|NCT01576718|63103064|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33669105|NCT01576718|63103065|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33669106|NCT01576718|63103066|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33669107|NCT01576718|63103067|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33669108|NCT01576718|63103068|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33669109|NCT01576718|63103062|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
33669110|NCT01576718|63103063|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33669111|NCT01576718|63103064|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33669112|NCT01576718|63103065|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33669113|NCT01576718|63103066|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33669114|NCT01576718|63103067|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33669115|NCT01576718|63103068|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33669116|NCT01576718|63103062|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
33669117|NCT01576718|63103063|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33669118|NCT01576718|63103064|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33669119|NCT01576718|63103065|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33669120|NCT01576718|63103066|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33669121|NCT01576718|63103067|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33669122|NCT01576718|63103068|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33669123|NCT01576718|63103062|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
33669124|NCT01576718|63103063|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33669125|NCT01576718|63103064|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33669126|NCT01576718|63103065|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33669127|NCT01576718|63103066|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33669128|NCT01576718|63103067|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33669129|NCT01576718|63103068|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33669130|NCT01576718|63103062|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
33669131|NCT01576718|63103063|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33669132|NCT01576718|63103064|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33669133|NCT01576718|63103065|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33669134|NCT01576718|63103066|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33669135|NCT01576718|63103067|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33669136|NCT01576718|63103068|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33669137|NCT01576718|63103062|FG000|Treatment Period|Adverse Event|0|||
33669138|NCT01576718|63103063|FG001|Treatment Period|Adverse Event|1|||
33669139|NCT01576718|63103064|FG002|Treatment Period|Adverse Event|1|||
33669140|NCT01576718|63103065|FG003|Treatment Period|Adverse Event|1|||
33669141|NCT01576718|63103066|FG004|Treatment Period|Adverse Event|1|||
33669142|NCT01576718|63103067|FG005|Treatment Period|Adverse Event|1|||
33669143|NCT01576718|63103068|FG006|Treatment Period|Adverse Event|0|||
33669144|NCT01576718|63103062|FG000|Treatment Period|Withdrawal by Subject|0|||
33669145|NCT01576718|63103063|FG001|Treatment Period|Withdrawal by Subject|1|||
33669146|NCT01576718|63103064|FG002|Treatment Period|Withdrawal by Subject|1|||
33669147|NCT01576718|63103065|FG003|Treatment Period|Withdrawal by Subject|0|||
33669148|NCT01576718|63103066|FG004|Treatment Period|Withdrawal by Subject|2|||
33669149|NCT01576718|63103067|FG005|Treatment Period|Withdrawal by Subject|4|||
33669150|NCT01576718|63103068|FG006|Treatment Period|Withdrawal by Subject|2|||
33669151|NCT01576718|63103062|FG000|Treatment Period|Physician Decision|0|||
33669152|NCT01576718|63103063|FG001|Treatment Period|Physician Decision|1|||
33669153|NCT01576718|63103064|FG002|Treatment Period|Physician Decision|1|||
33669154|NCT01576718|63103065|FG003|Treatment Period|Physician Decision|1|||
33669155|NCT01576718|63103066|FG004|Treatment Period|Physician Decision|1|||
33669156|NCT01576718|63103067|FG005|Treatment Period|Physician Decision|0|||
33669157|NCT01576718|63103068|FG006|Treatment Period|Physician Decision|0|||
33669158|NCT01576718|63103062|FG000|Treatment Period|Protocol Violation|0|||
33669159|NCT01576718|63103063|FG001|Treatment Period|Protocol Violation|5|||
33669160|NCT01576718|63103064|FG002|Treatment Period|Protocol Violation|4|||
33669161|NCT01576718|63103065|FG003|Treatment Period|Protocol Violation|10|||
33669162|NCT01576718|63103066|FG004|Treatment Period|Protocol Violation|6|||
33669163|NCT01576718|63103067|FG005|Treatment Period|Protocol Violation|8|||
33669164|NCT01576718|63103068|FG006|Treatment Period|Protocol Violation|12|||
33308152|NCT01194219|62683375|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33308153|NCT01194219|62683376|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33308154|NCT01194219|62683377|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33308155|NCT01194219|62683378|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33308156|NCT01194219|62683379|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33308157|NCT01194219|62683380|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33308158|NCT01194219|62683381|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
33308159|NCT01194219|62683382|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33308160|NCT01194219|62683383|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33308161|NCT01194219|62683384|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33308162|NCT01194219|62683375|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33308163|NCT01194219|62683376|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33308164|NCT01194219|62683377|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33308165|NCT01194219|62683378|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33308166|NCT01194219|62683379|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33308167|NCT01194219|62683380|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33308168|NCT01194219|62683381|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33308169|NCT01194219|62683382|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33308170|NCT01194219|62683383|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
33308171|NCT01194219|62683384|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
33308172|NCT01194219|62683375|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33308173|NCT01194219|62683376|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33308174|NCT01194219|62683377|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33308175|NCT01194219|62683378|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33308176|NCT01194219|62683379|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33308177|NCT01194219|62683380|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33308178|NCT01194219|62683381|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33308179|NCT01194219|62683382|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33308180|NCT01194219|62683383|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
33308181|NCT01194219|62683384|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
33308182|NCT01194219|62683375|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33308183|NCT01194219|62683376|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33308184|NCT01194219|62683377|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33308185|NCT01194219|62683378|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33308186|NCT01194219|62683379|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33308187|NCT01194219|62683380|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33308188|NCT01194219|62683381|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33308189|NCT01194219|62683382|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33308190|NCT01194219|62683383|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
33308191|NCT01194219|62683384|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
33308192|NCT01194219|62683375|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33308193|NCT01194219|62683376|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33308194|NCT01194219|62683377|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33308195|NCT01194219|62683378|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33308196|NCT01194219|62683379|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33308197|NCT01194219|62683380|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33308198|NCT01194219|62683381|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33308199|NCT01194219|62683382|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33308200|NCT01194219|62683383|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
33308201|NCT01194219|62683384|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
33308202|NCT01194219|62683375|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
33308203|NCT01194219|62683376|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
33308204|NCT01194219|62683377|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
33308205|NCT01194219|62683378|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
33308206|NCT01194219|62683379|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
33308207|NCT01194219|62683380|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
33308208|NCT01194219|62683381|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
33308209|NCT01194219|62683382|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
33308210|NCT01194219|62683383|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
33308211|NCT01194219|62683384|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
33308212|NCT01194219|62683375|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33308213|NCT01194219|62683376|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33308214|NCT01194219|62683377|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33308215|NCT01194219|62683378|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33308216|NCT01194219|62683379|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33308217|NCT01194219|62683380|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33308218|NCT01194219|62683381|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33308219|NCT01194219|62683382|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33308220|NCT01194219|62683383|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
33308221|NCT01194219|62683384|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
33308222|NCT01194219|62683375|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33308223|NCT01194219|62683376|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33308224|NCT01194219|62683377|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33308225|NCT01194219|62683378|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33308226|NCT01194219|62683379|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33308227|NCT01194219|62683380|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33308228|NCT01194219|62683381|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33308229|NCT01194219|62683382|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33308230|NCT01194219|62683383|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
33308231|NCT01194219|62683384|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33308232|NCT01194219|62683375|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33308233|NCT01194219|62683376|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33308234|NCT01194219|62683377|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33308235|NCT01194219|62683378|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33308236|NCT01194219|62683379|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33308237|NCT01194219|62683380|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33308238|NCT01194219|62683381|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33308239|NCT01194219|62683382|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33308240|NCT01194219|62683383|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
33308241|NCT01194219|62683384|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
33308242|NCT01304693|62683412|FG000|Overall Study|Adverse Event|0|||
33308243|NCT01304693|62683413|FG001|Overall Study|Adverse Event|0|||
33308244|NCT01304693|62683414|FG002|Overall Study|Adverse Event|0|||
33308245|NCT01304693|62683415|FG003|Overall Study|Adverse Event|0|||
33308246|NCT01304693|62683416|FG004|Overall Study|Adverse Event|1|||
33308247|NCT01304693|62683412|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
33308248|NCT01304693|62683413|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
33308249|NCT01304693|62683414|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
33308250|NCT01304693|62683415|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
33308251|NCT01304693|62683416|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
33308252|NCT01304147|62683428|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
33308253|NCT01304147|62683429|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
33308254|NCT01303445|62683435|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
33308255|NCT01303445|62683436|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
33308256|NCT01303445|62683435|FG000|Second Intervention (7 Days)|Adverse Event|0|||
33308257|NCT01303445|62683436|FG001|Second Intervention (7 Days)|Adverse Event|2|||
33308258|NCT01303445|62683435|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
33308259|NCT01303445|62683436|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
33308260|NCT01303445|62683435|FG000|Washout (14 Days)|Protocol Violation|1|||
33308261|NCT01303445|62683436|FG001|Washout (14 Days)|Protocol Violation|0|||
33308262|NCT01303445|62683435|FG000|Washout (14 Days)|Lost to Follow-up|0|||
33308263|NCT01303445|62683436|FG001|Washout (14 Days)|Lost to Follow-up|2|||
33308264|NCT01303445|62683435|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
33308265|NCT01303445|62683436|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
33308266|NCT01303445|62683435|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
33308267|NCT01303445|62683436|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
33308268|NCT01188681|62683450|FG000|Overall Study|bladder cancer|0|||
33308269|NCT01188681|62683451|FG001|Overall Study|bladder cancer|0|||
33308270|NCT01188681|62683452|FG002|Overall Study|bladder cancer|1|||
33308271|NCT01188681|62683453|FG003|Overall Study|bladder cancer|0|||
33308272|NCT01188681|62683450|FG000|Overall Study|Withdrawal by Subject|0|||
33308273|NCT01188681|62683451|FG001|Overall Study|Withdrawal by Subject|0|||
33308274|NCT01188681|62683452|FG002|Overall Study|Withdrawal by Subject|0|||
33308275|NCT01188681|62683453|FG003|Overall Study|Withdrawal by Subject|1|||
33308276|NCT01302899|62683469|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
33308277|NCT01302899|62683470|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
33308278|NCT01302899|62683469|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
33308279|NCT01302899|62683470|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
33308280|NCT01187901|62683482|FG000|Overall Study|Protocol Violation|1|||
33308281|NCT01187901|62683483|FG001|Overall Study|Protocol Violation|0|||
33308282|NCT01187901|62683482|FG000|Overall Study|Lost to Follow-up|1|||
33308283|NCT01187901|62683483|FG001|Overall Study|Lost to Follow-up|2|||
33308284|NCT01187901|62683482|FG000|Overall Study|Unrelated Health Reasons|1|||
33308285|NCT01187901|62683483|FG001|Overall Study|Unrelated Health Reasons|2|||
33308286|NCT01187901|62683482|FG000|Overall Study|Suspected Allergic Reaction|1|||
33308287|NCT01187901|62683483|FG001|Overall Study|Suspected Allergic Reaction|1|||
33308288|NCT01187901|62683482|FG000|Overall Study|Adverse Event|3|||
33308289|NCT01187901|62683483|FG001|Overall Study|Adverse Event|0|||
33308290|NCT01187901|62683482|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
33308291|NCT01187901|62683483|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
33308292|NCT01187901|62683482|FG000|Overall Study|Pregnancy|0|||
33308293|NCT01187901|62683483|FG001|Overall Study|Pregnancy|2|||
33308294|NCT01302119|62683491|FG000|Overall Study|Withdrawal by Subject|30|||
33308295|NCT01302119|62683492|FG001|Overall Study|Withdrawal by Subject|20|||
33308296|NCT01302119|62683491|FG000|Overall Study|Lost to Follow-up|10|||
33308297|NCT01302119|62683492|FG001|Overall Study|Lost to Follow-up|4|||
33308298|NCT01302119|62683491|FG000|Overall Study|Adverse Event|2|||
33308299|NCT01302119|62683492|FG001|Overall Study|Adverse Event|1|||
33308300|NCT01302119|62683491|FG000|Overall Study|Non-compliance|4|||
33308301|NCT01302119|62683492|FG001|Overall Study|Non-compliance|2|||
33308302|NCT01302119|62683491|FG000|Overall Study|Non-specific|4|||
33308303|NCT01302119|62683492|FG001|Overall Study|Non-specific|1|||
33308304|NCT05038982|62683500|FG000|Overall Study|Withdrawal by Subject|0|||
33308305|NCT05038982|62683501|FG001|Overall Study|Withdrawal by Subject|2|||
33308306|NCT04867785|62683520|FG000|Overall Study|Adverse Event|1|||
33308307|NCT04867785|62683521|FG001|Overall Study|Adverse Event|0|||
33308308|NCT04867785|62683522|FG002|Overall Study|Adverse Event|1|||
33308309|NCT04867785|62683523|FG003|Overall Study|Adverse Event|0|||
33308310|NCT04867785|62683524|FG004|Overall Study|Adverse Event|0|||
33308311|NCT04867785|62683525|FG005|Overall Study|Adverse Event|0|||
33308312|NCT04867785|62683526|FG006|Overall Study|Adverse Event|0|||
33308313|NCT04867785|62683527|FG007|Overall Study|Adverse Event|2|||
33308314|NCT04867785|62683520|FG000|Overall Study|Lost to Follow-up|4|||
33308315|NCT04867785|62683521|FG001|Overall Study|Lost to Follow-up|4|||
33308316|NCT04867785|62683522|FG002|Overall Study|Lost to Follow-up|3|||
33308317|NCT04867785|62683523|FG003|Overall Study|Lost to Follow-up|2|||
33308318|NCT04867785|62683524|FG004|Overall Study|Lost to Follow-up|0|||
33308319|NCT04867785|62683525|FG005|Overall Study|Lost to Follow-up|1|||
33308320|NCT04867785|62683526|FG006|Overall Study|Lost to Follow-up|0|||
33308321|NCT04867785|62683527|FG007|Overall Study|Lost to Follow-up|1|||
33308322|NCT04867785|62683520|FG000|Overall Study|Withdrawal by Subject|6|||
33308323|NCT04867785|62683521|FG001|Overall Study|Withdrawal by Subject|2|||
33308324|NCT04867785|62683522|FG002|Overall Study|Withdrawal by Subject|2|||
33308325|NCT04867785|62683523|FG003|Overall Study|Withdrawal by Subject|1|||
33308326|NCT04867785|62683524|FG004|Overall Study|Withdrawal by Subject|2|||
33308327|NCT04867785|62683525|FG005|Overall Study|Withdrawal by Subject|0|||
33308328|NCT04867785|62683526|FG006|Overall Study|Withdrawal by Subject|2|||
33308329|NCT04867785|62683527|FG007|Overall Study|Withdrawal by Subject|5|||
33308330|NCT04867785|62683520|FG000|Overall Study|Physician Decision|0|||
33308331|NCT04867785|62683521|FG001|Overall Study|Physician Decision|0|||
33308332|NCT04867785|62683522|FG002|Overall Study|Physician Decision|0|||
33308333|NCT04867785|62683523|FG003|Overall Study|Physician Decision|0|||
33308334|NCT04867785|62683524|FG004|Overall Study|Physician Decision|0|||
33308335|NCT04867785|62683525|FG005|Overall Study|Physician Decision|0|||
33308336|NCT04867785|62683526|FG006|Overall Study|Physician Decision|0|||
33308337|NCT04867785|62683527|FG007|Overall Study|Physician Decision|1|||
33308338|NCT04867785|62683520|FG000|Overall Study|Inadvertent Enrollment|0|||
33308339|NCT04867785|62683521|FG001|Overall Study|Inadvertent Enrollment|0|||
33308340|NCT04867785|62683522|FG002|Overall Study|Inadvertent Enrollment|0|||
33308341|NCT04867785|62683523|FG003|Overall Study|Inadvertent Enrollment|1|||
33308342|NCT04867785|62683524|FG004|Overall Study|Inadvertent Enrollment|1|||
33308343|NCT04867785|62683525|FG005|Overall Study|Inadvertent Enrollment|0|||
33308344|NCT04867785|62683526|FG006|Overall Study|Inadvertent Enrollment|0|||
33308345|NCT04867785|62683527|FG007|Overall Study|Inadvertent Enrollment|1|||
33308346|NCT04867785|62683520|FG000|Overall Study|Eligibility Criteria Not Met|0|||
33308347|NCT04867785|62683521|FG001|Overall Study|Eligibility Criteria Not Met|0|||
33308348|NCT04867785|62683522|FG002|Overall Study|Eligibility Criteria Not Met|0|||
33308349|NCT04867785|62683523|FG003|Overall Study|Eligibility Criteria Not Met|0|||
33399337|NCT00546819|62778774|FG001|Overall Study|Withdrawal by Subject|2|||
33399338|NCT00621504|62778782|FG000|Overall Study|Adverse Event|1|||
33399339|NCT00621504|62778783|FG001|Overall Study|Adverse Event|3|||
33399340|NCT00621504|62778782|FG000|Overall Study|At the request of sponsor/investigator|1|||
33399341|NCT00621504|62778783|FG001|Overall Study|At the request of sponsor/investigator|0|||
33399342|NCT00621504|62778782|FG000|Overall Study|Withdrew consent|9|||
33399343|NCT00621504|62778783|FG001|Overall Study|Withdrew consent|6|||
33399344|NCT00621504|62778782|FG000|Overall Study|Lost to Follow-up|8|||
33399345|NCT00621504|62778783|FG001|Overall Study|Lost to Follow-up|10|||
33399346|NCT00621504|62778782|FG000|Overall Study|Other|1|||
33399347|NCT00621504|62778783|FG001|Overall Study|Other|0|||
33399348|NCT00621504|62778782|FG000|Overall Study|Death|6|||
33399349|NCT00621504|62778783|FG001|Overall Study|Death|6|||
33669165|NCT01576718|63103062|FG000|Treatment Period|Sponsor request|0|||
33669166|NCT01576718|63103063|FG001|Treatment Period|Sponsor request|1|||
33308350|NCT04867785|62683524|FG004|Overall Study|Eligibility Criteria Not Met|0|||
33308351|NCT04867785|62683525|FG005|Overall Study|Eligibility Criteria Not Met|0|||
33308352|NCT04867785|62683526|FG006|Overall Study|Eligibility Criteria Not Met|0|||
33308353|NCT04867785|62683527|FG007|Overall Study|Eligibility Criteria Not Met|1|||
33308354|NCT04541004|62683554|FG000|Overall Study|Adverse Event|2|||
33308355|NCT04295499|62683561|FG000|Overall Study|moving out of state|1|||
33308356|NCT04295499|62683562|FG001|Overall Study|moving out of state|0|||
33399350|NCT00548145|62778791|FG000|Overall Study|Death|0|||
33399351|NCT00548145|62778792|FG001|Overall Study|Death|1|||
33308357|NCT04295499|62683561|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
33308358|NCT04295499|62683562|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
33399352|NCT00548145|62778791|FG000|Overall Study|Withdrawal by Subject|0|||
33399353|NCT00548145|62778792|FG001|Overall Study|Withdrawal by Subject|2|||
33399354|NCT00548145|62778791|FG000|Overall Study|Physician Decision|1|||
33399355|NCT00548145|62778792|FG001|Overall Study|Physician Decision|1|||
33399356|NCT00547911|62778802|FG000|Overall Study|Adverse Event|0|||
33399357|NCT00547911|62778803|FG001|Overall Study|Adverse Event|0|||
33399358|NCT00547911|62778804|FG002|Overall Study|Adverse Event|0|||
33399359|NCT00547911|62778805|FG003|Overall Study|Adverse Event|1|||
33399360|NCT00547911|62778806|FG004|Overall Study|Adverse Event|0|||
33399361|NCT00547911|62778807|FG005|Overall Study|Adverse Event|0|||
33399362|NCT00289783|62778822|FG000|Primary Phase|Adverse Event|10|||
33399363|NCT00289783|62778823|FG001|Primary Phase|Adverse Event|1|||
33399364|NCT00289783|62778822|FG000|Primary Phase|Protocol Violation|27|||
33399365|NCT00289783|62778823|FG001|Primary Phase|Protocol Violation|6|||
33399366|NCT00289783|62778822|FG000|Primary Phase|Withdrawal by Subject|93|||
33399367|NCT00289783|62778823|FG001|Primary Phase|Withdrawal by Subject|40|||
33399368|NCT00289783|62778822|FG000|Primary Phase|Lost to Follow-up|60|||
33399369|NCT00289783|62778823|FG001|Primary Phase|Lost to Follow-up|14|||
33399370|NCT00289783|62778822|FG000|Primary Phase|Migration from the study area|26|||
33399371|NCT00289783|62778823|FG001|Primary Phase|Migration from the study area|10|||
33399372|NCT00289783|62778822|FG000|Primary Phase|Other|32|||
33399373|NCT00289783|62778823|FG001|Primary Phase|Other|12|||
33399374|NCT00289783|62778822|FG000|Fourth Dose Phase|Adverse Event|1|||
33399375|NCT00289783|62778823|FG001|Fourth Dose Phase|Adverse Event|0|||
33399376|NCT00289783|62778822|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
33399377|NCT00289783|62778823|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
33399378|NCT00289783|62778822|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
33399379|NCT00289783|62778823|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
33399380|NCT00289783|62778822|FG000|Fourth Dose Phase|Migration from the study area|1|||
33399381|NCT00289783|62778823|FG001|Fourth Dose Phase|Migration from the study area|1|||
33399382|NCT00289783|62778822|FG000|Fourth Dose Phase|Other|22|||
33399383|NCT00289783|62778823|FG001|Fourth Dose Phase|Other|10|||
33399384|NCT00574080|62778839|FG000|Overall Study|Death|10|||
33399385|NCT00574080|62778840|FG001|Overall Study|Death|10|||
33399386|NCT00267865|62778846|FG000|Induction Treatment|Died before completing.|2|||
33399387|NCT00267865|62778846|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
33399388|NCT00546117|62778852|FG000|Overall Study|Withdrawal by Subject|3|||
33399389|NCT00546117|62778853|FG001|Overall Study|Withdrawal by Subject|0|||
33399390|NCT00546117|62778852|FG000|Overall Study|Inability to schedule follow-up visit|1|||
33399391|NCT00546117|62778853|FG001|Overall Study|Inability to schedule follow-up visit|0|||
33399392|NCT00251719|62778864|FG000|Overall Study|Adverse Event|14|||
33399393|NCT00251719|62778865|FG001|Overall Study|Adverse Event|8|||
33399394|NCT00251719|62778866|FG002|Overall Study|Adverse Event|7|||
33399395|NCT00251719|62778864|FG000|Overall Study|Protocol Violation|1|||
33399396|NCT00251719|62778865|FG001|Overall Study|Protocol Violation|1|||
33399397|NCT00251719|62778866|FG002|Overall Study|Protocol Violation|1|||
33399398|NCT00251719|62778864|FG000|Overall Study|Lost to Follow-up|5|||
33399399|NCT00251719|62778865|FG001|Overall Study|Lost to Follow-up|11|||
33399400|NCT00251719|62778866|FG002|Overall Study|Lost to Follow-up|8|||
33399401|NCT00251719|62778864|FG000|Overall Study|Withdrawal by Subject|14|||
33399402|NCT00251719|62778865|FG001|Overall Study|Withdrawal by Subject|12|||
33399403|NCT00251719|62778866|FG002|Overall Study|Withdrawal by Subject|11|||
33399404|NCT00251719|62778864|FG000|Overall Study|Lack of Efficacy|2|||
33399405|NCT00251719|62778865|FG001|Overall Study|Lack of Efficacy|1|||
33399406|NCT00251719|62778866|FG002|Overall Study|Lack of Efficacy|0|||
33399407|NCT00251719|62778864|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
33399408|NCT00251719|62778865|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
33399409|NCT00251719|62778866|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
33399410|NCT00251719|62778864|FG000|Overall Study|Investigator decision|1|||
33399411|NCT00251719|62778865|FG001|Overall Study|Investigator decision|1|||
33399412|NCT00251719|62778866|FG002|Overall Study|Investigator decision|0|||
33399413|NCT00251719|62778864|FG000|Overall Study|Noncompliance|2|||
33399414|NCT00251719|62778865|FG001|Overall Study|Noncompliance|3|||
33399415|NCT00251719|62778866|FG002|Overall Study|Noncompliance|1|||
33399416|NCT00251719|62778864|FG000|Overall Study|Barrett's esophagus|2|||
33399417|NCT00251719|62778865|FG001|Overall Study|Barrett's esophagus|2|||
33399418|NCT00251719|62778866|FG002|Overall Study|Barrett's esophagus|0|||
33399419|NCT03952143|62778876|FG000|Lead-In Period|Adverse Event|2|||
33399420|NCT03952143|62778877|FG001|Lead-In Period|Adverse Event|0|||
33399421|NCT03952143|62778878|FG002|Lead-In Period|Adverse Event|0|||
33399422|NCT03952143|62778876|FG000|Lead-In Period|Lack of Efficacy|2|||
33399423|NCT03952143|62778877|FG001|Lead-In Period|Lack of Efficacy|0|||
33399424|NCT03952143|62778878|FG002|Lead-In Period|Lack of Efficacy|0|||
33399425|NCT03952143|62778876|FG000|Lead-In Period|Physician Decision|5|||
33399426|NCT03952143|62778877|FG001|Lead-In Period|Physician Decision|0|||
33399427|NCT03952143|62778878|FG002|Lead-In Period|Physician Decision|0|||
33399428|NCT03952143|62778876|FG000|Lead-In Period|Protocol Violation|5|||
33399429|NCT03952143|62778877|FG001|Lead-In Period|Protocol Violation|0|||
33579005|NCT01998958|62976214|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
33399430|NCT03952143|62778878|FG002|Lead-In Period|Protocol Violation|0|||
33399431|NCT03952143|62778876|FG000|Lead-In Period|Withdrawal by Subject|19|||
33399432|NCT03952143|62778877|FG001|Lead-In Period|Withdrawal by Subject|0|||
33399433|NCT03952143|62778878|FG002|Lead-In Period|Withdrawal by Subject|0|||
33399434|NCT03952143|62778876|FG000|Treatment Period|Adverse Event|0|||
33399435|NCT03952143|62778877|FG001|Treatment Period|Adverse Event|0|||
33399436|NCT03952143|62778878|FG002|Treatment Period|Adverse Event|1|||
33399437|NCT03952143|62778876|FG000|Treatment Period|Lost to Follow-up|0|||
33399438|NCT03952143|62778877|FG001|Treatment Period|Lost to Follow-up|2|||
33399439|NCT03952143|62778878|FG002|Treatment Period|Lost to Follow-up|0|||
33399440|NCT03952143|62778876|FG000|Treatment Period|Physician Decision|0|||
33399441|NCT03952143|62778877|FG001|Treatment Period|Physician Decision|0|||
33399442|NCT03952143|62778878|FG002|Treatment Period|Physician Decision|2|||
33399443|NCT03952143|62778876|FG000|Treatment Period|Protocol Violation|0|||
33399444|NCT03952143|62778877|FG001|Treatment Period|Protocol Violation|0|||
33399445|NCT03952143|62778878|FG002|Treatment Period|Protocol Violation|1|||
33399446|NCT03952143|62778876|FG000|Treatment Period|Withdrawal by Subject|0|||
33399447|NCT03952143|62778877|FG001|Treatment Period|Withdrawal by Subject|5|||
33399448|NCT03952143|62778878|FG002|Treatment Period|Withdrawal by Subject|26|||
33399449|NCT03952143|62778876|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
33399450|NCT03952143|62778877|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
33399451|NCT03952143|62778878|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
33399452|NCT03952143|62778876|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
33399453|NCT03952143|62778877|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
33399454|NCT03952143|62778878|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
33399455|NCT00267007|62778887|FG000|Overall Study|Withdrawal by Subject|6|||
33399456|NCT00267007|62778888|FG001|Overall Study|Withdrawal by Subject|0|||
33399457|NCT00267007|62778887|FG000|Overall Study|Lost to Follow-up|1|||
33399458|NCT00267007|62778888|FG001|Overall Study|Lost to Follow-up|0|||
33399459|NCT00267007|62778887|FG000|Overall Study|Non-compliance|0|||
33399460|NCT00267007|62778888|FG001|Overall Study|Non-compliance|1|||
33399461|NCT00267007|62778887|FG000|Overall Study|Adverse Event|1|||
33399462|NCT00267007|62778888|FG001|Overall Study|Adverse Event|0|||
33399463|NCT03943095|62778896|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
33399464|NCT03943095|62778897|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
33399465|NCT03943095|62778896|FG000|Overall Study|Withdrawal by Subject|1|||
33399466|NCT03943095|62778897|FG001|Overall Study|Withdrawal by Subject|0|||
33399467|NCT00251641|62778906|FG000|Overall Study|Adverse Event|80|||
33399468|NCT00251641|62778907|FG001|Overall Study|Adverse Event|8|||
33399469|NCT00251641|62778906|FG000|Overall Study|Lack of Efficacy|2|||
33399470|NCT00251641|62778907|FG001|Overall Study|Lack of Efficacy|1|||
33399471|NCT00251641|62778906|FG000|Overall Study|Progression of Disease|0|||
33399472|NCT00251641|62778907|FG001|Overall Study|Progression of Disease|2|||
33399473|NCT00251641|62778906|FG000|Overall Study|Lost to Follow-up|3|||
33399474|NCT00251641|62778907|FG001|Overall Study|Lost to Follow-up|3|||
33399475|NCT00251641|62778906|FG000|Overall Study|Withdrawal by Subject|6|||
33399476|NCT00251641|62778907|FG001|Overall Study|Withdrawal by Subject|8|||
33399477|NCT00251641|62778906|FG000|Overall Study|Protocol Violation|10|||
33399478|NCT00251641|62778907|FG001|Overall Study|Protocol Violation|2|||
33399479|NCT00251641|62778906|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
33399480|NCT00251641|62778907|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
33399481|NCT00251641|62778906|FG000|Overall Study|Switched Treatment|9|||
33399482|NCT00251641|62778907|FG001|Overall Study|Switched Treatment|63|||
33399483|NCT00250705|62778915|FG000|Overall Study|Lack of Efficacy|2|||
33399484|NCT00266695|62778921|FG000|Overall Study|Adverse Event|1|||
33399485|NCT00266695|62778921|FG000|Overall Study|Death|9|||
33399486|NCT00266695|62778921|FG000|Overall Study|Physician Decision|1|||
33399487|NCT00266695|62778921|FG000|Overall Study|Lost to Follow-up|3|||
33399488|NCT00266695|62778921|FG000|Overall Study|Withdrawal by Subject|15|||
33399489|NCT00620022|62778925|FG000|Treatment Period 1|Adverse Event|4|||
33399490|NCT00620022|62778926|FG001|Treatment Period 1|Adverse Event|6|||
33399491|NCT00620022|62778925|FG000|Treatment Period 1|Subject withdrew consent|1|||
33399492|NCT00620022|62778926|FG001|Treatment Period 1|Subject withdrew consent|0|||
33399493|NCT00620022|62778925|FG000|Treatment Period 2|Adverse Event|2|||
33399494|NCT00620022|62778926|FG001|Treatment Period 2|Adverse Event|2|||
33399495|NCT00547521|62778934|FG000|Short Term Study (4 Months)|Adverse Event|1|||
33399496|NCT00547521|62778935|FG001|Short Term Study (4 Months)|Adverse Event|0|||
33399497|NCT00547521|62778934|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
33308359|NCT04091646|62683570|FG000|Overall Study|Adverse Event|2|||
33308360|NCT04091646|62683571|FG001|Overall Study|Adverse Event|1|||
33308361|NCT04091646|62683570|FG000|Overall Study|Lost to Follow-up|6|||
33308362|NCT04091646|62683571|FG001|Overall Study|Lost to Follow-up|2|||
33308363|NCT04091646|62683570|FG000|Overall Study|Protocol Violation|0|||
33308364|NCT04091646|62683571|FG001|Overall Study|Protocol Violation|1|||
33308365|NCT04091646|62683570|FG000|Overall Study|Withdrawal by Subject|4|||
33308366|NCT04091646|62683571|FG001|Overall Study|Withdrawal by Subject|1|||
33399498|NCT00547521|62778935|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
33399499|NCT00547521|62778934|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
33399500|NCT00547521|62778935|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
33399501|NCT00547521|62778934|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
33399502|NCT00547521|62778935|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
33399503|NCT00547521|62778934|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
33399504|NCT00547521|62778935|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
33399505|NCT00547521|62778934|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
33399506|NCT00547521|62778935|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
33399507|NCT00547521|62778934|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
33399508|NCT00547521|62778935|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
33399509|NCT00547521|62778934|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
33399510|NCT00547521|62778935|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
33399511|NCT00547521|62778934|FG000|Long Term Extension (LTE) Study|Other|0|||
33399512|NCT00547521|62778935|FG001|Long Term Extension (LTE) Study|Other|2|||
33399513|NCT00547521|62778934|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
33399514|NCT00547521|62778935|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
33399515|NCT00266227|62778950|FG000|Initial Treatment|Adverse Event|0|||
33399516|NCT00266227|62778951|FG001|Initial Treatment|Adverse Event|0|||
33399517|NCT00266227|62778952|FG002|Initial Treatment|Adverse Event|13|||
33399518|NCT00266227|62778950|FG000|Initial Treatment|Lost to Follow-up|0|||
33399519|NCT00266227|62778951|FG001|Initial Treatment|Lost to Follow-up|0|||
33399520|NCT00266227|62778952|FG002|Initial Treatment|Lost to Follow-up|6|||
33399521|NCT00266227|62778950|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
33399522|NCT00266227|62778951|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
33399523|NCT00266227|62778952|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
33399524|NCT00266227|62778950|FG000|Initial Treatment|Physician decision to withdraw|0|||
33399525|NCT00266227|62778951|FG001|Initial Treatment|Physician decision to withdraw|0|||
33399526|NCT00266227|62778952|FG002|Initial Treatment|Physician decision to withdraw|12|||
33399527|NCT00266227|62778950|FG000|Initial Treatment|Pregnancy|0|||
33399528|NCT00266227|62778951|FG001|Initial Treatment|Pregnancy|0|||
33399529|NCT00266227|62778952|FG002|Initial Treatment|Pregnancy|1|||
33399530|NCT00266227|62778950|FG000|Retreatment: Up to Week 48|Death|1|||
33399531|NCT00266227|62778951|FG001|Retreatment: Up to Week 48|Death|0|||
33399532|NCT00266227|62778952|FG002|Retreatment: Up to Week 48|Death|0|||
33399533|NCT00266227|62778950|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
33399534|NCT00266227|62778951|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
33399535|NCT00266227|62778952|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
33399536|NCT00266227|62778950|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
33399537|NCT00266227|62778951|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
33399538|NCT00266227|62778952|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
33399539|NCT00266227|62778950|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
33399540|NCT00266227|62778951|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
33399541|NCT00266227|62778952|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
33399542|NCT00266227|62778950|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
33399543|NCT00266227|62778951|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
33399544|NCT00266227|62778952|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
33399545|NCT00266227|62778950|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
33399546|NCT00266227|62778951|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
33399547|NCT00266227|62778952|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
33399548|NCT00266227|62778950|FG000|Retreatment: Week 48 to Week 72|Death|1|||
33399549|NCT00266227|62778951|FG001|Retreatment: Week 48 to Week 72|Death|1|||
33399550|NCT00266227|62778952|FG002|Retreatment: Week 48 to Week 72|Death|0|||
33399551|NCT00266227|62778950|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
33399552|NCT00266227|62778951|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
33399553|NCT00266227|62778952|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
33399554|NCT00266227|62778950|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
33399555|NCT00266227|62778951|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
33399556|NCT00266227|62778952|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
33399557|NCT00266227|62778950|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
33399558|NCT00266227|62778951|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
33399559|NCT00266227|62778952|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
33399560|NCT00266227|62778950|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
33399561|NCT00266227|62778951|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
33399562|NCT00266227|62778952|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
33399563|NCT00287365|62778961|FG000|Overall Study|sample not acquired|13|||
33399564|NCT00573768|62778969|FG000|Overall Study|Adverse Event|1|||
33399565|NCT00573768|62778970|FG001|Overall Study|Adverse Event|1|||
33399566|NCT00573768|62778971|FG002|Overall Study|Adverse Event|2|||
33579006|NCT01998958|62976215|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
33399567|NCT00573768|62778969|FG000|Overall Study|Protocol Violation|1|||
33399568|NCT00573768|62778970|FG001|Overall Study|Protocol Violation|0|||
33399569|NCT00573768|62778971|FG002|Overall Study|Protocol Violation|1|||
33399570|NCT00573768|62778969|FG000|Overall Study|Withdrawal by Subject|0|||
33399571|NCT00573768|62778970|FG001|Overall Study|Withdrawal by Subject|1|||
33399572|NCT00573768|62778971|FG002|Overall Study|Withdrawal by Subject|0|||
33399573|NCT00573768|62778969|FG000|Overall Study|Lost to Follow-up|0|||
33399574|NCT00573768|62778970|FG001|Overall Study|Lost to Follow-up|0|||
33399575|NCT00573768|62778971|FG002|Overall Study|Lost to Follow-up|1|||
33399576|NCT00547365|62778979|FG000|Overall Study|Physician Decision|1|||
33399577|NCT00547365|62778979|FG000|Overall Study|Lost to Follow-up|1|||
33399578|NCT00547365|62778979|FG000|Overall Study|Protocol Violation|2|||
33399579|NCT00547365|62778979|FG000|Overall Study|death (not related to study)|4|||
33399580|NCT00619866|62778987|FG000|Weeks 1 - 12|Adverse Event|0|||
33399581|NCT00619866|62778988|FG001|Weeks 1 - 12|Adverse Event|1|||
33399582|NCT00619866|62778989|FG002|Weeks 1 - 12|Adverse Event|2|||
33399583|NCT00619866|62778990|FG003|Weeks 1 - 12|Adverse Event|0|||
33399584|NCT00619866|62778991|FG004|Weeks 1 - 12|Adverse Event|0|||
33399585|NCT00619866|62778987|FG000|Weeks 1 - 12|Non-compliance|0|||
33399586|NCT00619866|62778988|FG001|Weeks 1 - 12|Non-compliance|0|||
33399587|NCT00619866|62778989|FG002|Weeks 1 - 12|Non-compliance|1|||
33399588|NCT00619866|62778990|FG003|Weeks 1 - 12|Non-compliance|0|||
33399589|NCT00619866|62778991|FG004|Weeks 1 - 12|Non-compliance|0|||
33399590|NCT00619866|62778987|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
33399591|NCT00619866|62778988|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
33399592|NCT00619866|62778989|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
33399593|NCT00619866|62778990|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
33399594|NCT00619866|62778991|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
33399595|NCT00619866|62778987|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
33399596|NCT00619866|62778988|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
33399597|NCT00619866|62778989|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
33399598|NCT00619866|62778990|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
33399599|NCT00619866|62778991|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
33399600|NCT00619866|62778987|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
33399601|NCT00619866|62778988|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
33399602|NCT00619866|62778989|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
33399603|NCT00619866|62778990|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
33399604|NCT00619866|62778991|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
33399605|NCT00619866|62778987|FG000|Weeks 1 - 12|Sponsor Decision|0|||
33399606|NCT00619866|62778988|FG001|Weeks 1 - 12|Sponsor Decision|1|||
33399607|NCT00619866|62778989|FG002|Weeks 1 - 12|Sponsor Decision|0|||
33399608|NCT00619866|62778990|FG003|Weeks 1 - 12|Sponsor Decision|0|||
33399609|NCT00619866|62778991|FG004|Weeks 1 - 12|Sponsor Decision|0|||
33399610|NCT00619866|62778987|FG000|Weeks 13 - 24|Adverse Event|0|||
33399611|NCT00619866|62778988|FG001|Weeks 13 - 24|Adverse Event|0|||
33399612|NCT00619866|62778989|FG002|Weeks 13 - 24|Adverse Event|2|||
33399613|NCT00619866|62778990|FG003|Weeks 13 - 24|Adverse Event|1|||
33399614|NCT00619866|62778991|FG004|Weeks 13 - 24|Adverse Event|0|||
33399615|NCT00619866|62778987|FG000|Weeks 13 - 24|Protocol Deviation|0|||
33399616|NCT00619866|62778988|FG001|Weeks 13 - 24|Protocol Deviation|0|||
33399617|NCT00619866|62778989|FG002|Weeks 13 - 24|Protocol Deviation|0|||
33399618|NCT00619866|62778990|FG003|Weeks 13 - 24|Protocol Deviation|1|||
33399619|NCT00619866|62778991|FG004|Weeks 13 - 24|Protocol Deviation|0|||
33399620|NCT00619866|62778987|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
33399621|NCT00619866|62778988|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
33399622|NCT00619866|62778989|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
33399623|NCT00619866|62778990|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
33399624|NCT00619866|62778991|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
33399625|NCT00619866|62778987|FG000|Weeks 13 - 24|Non-compliance|0|||
33399626|NCT00619866|62778988|FG001|Weeks 13 - 24|Non-compliance|1|||
33399627|NCT00619866|62778989|FG002|Weeks 13 - 24|Non-compliance|1|||
33399628|NCT00619866|62778990|FG003|Weeks 13 - 24|Non-compliance|0|||
33399629|NCT00619866|62778991|FG004|Weeks 13 - 24|Non-compliance|0|||
33399630|NCT00619866|62778987|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
33399631|NCT00619866|62778988|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
33399632|NCT00619866|62778989|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
33399633|NCT00619866|62778990|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
33399634|NCT00619866|62778991|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
33399635|NCT03937479|62779019|FG000|Overall Study|Adverse Event|2|||
33399636|NCT03937479|62779020|FG001|Overall Study|Adverse Event|3|||
33399637|NCT03937479|62779021|FG002|Overall Study|Adverse Event|0|||
33399638|NCT03937479|62779022|FG003|Overall Study|Adverse Event|0|||
33399639|NCT03937479|62779023|FG004|Overall Study|Adverse Event|1|||
33399640|NCT03937479|62779019|FG000|Overall Study|Withdrawal by Subject|3|||
33399641|NCT03937479|62779020|FG001|Overall Study|Withdrawal by Subject|5|||
33399642|NCT03937479|62779021|FG002|Overall Study|Withdrawal by Subject|2|||
33399643|NCT03937479|62779022|FG003|Overall Study|Withdrawal by Subject|2|||
33399644|NCT03937479|62779023|FG004|Overall Study|Withdrawal by Subject|1|||
33399645|NCT03937479|62779019|FG000|Overall Study|Protocol Violation|5|||
33399646|NCT03937479|62779020|FG001|Overall Study|Protocol Violation|6|||
33399647|NCT03937479|62779021|FG002|Overall Study|Protocol Violation|4|||
33399648|NCT03937479|62779022|FG003|Overall Study|Protocol Violation|3|||
33399649|NCT03937479|62779023|FG004|Overall Study|Protocol Violation|2|||
33399650|NCT03937479|62779019|FG000|Overall Study|Lost to Follow-up|0|||
33399651|NCT03937479|62779020|FG001|Overall Study|Lost to Follow-up|1|||
33399652|NCT03937479|62779021|FG002|Overall Study|Lost to Follow-up|0|||
33399653|NCT03937479|62779022|FG003|Overall Study|Lost to Follow-up|1|||
33399654|NCT03937479|62779023|FG004|Overall Study|Lost to Follow-up|0|||
33399655|NCT03937479|62779019|FG000|Overall Study|Physician Decision|0|||
33399656|NCT03937479|62779020|FG001|Overall Study|Physician Decision|0|||
33399657|NCT03937479|62779021|FG002|Overall Study|Physician Decision|1|||
33399658|NCT03937479|62779022|FG003|Overall Study|Physician Decision|0|||
33399659|NCT03937479|62779023|FG004|Overall Study|Physician Decision|1|||
33399660|NCT00619476|62779039|FG000|Overall Study|Adverse Event|12|||
33399661|NCT00619476|62779040|FG001|Overall Study|Adverse Event|6|||
33399662|NCT00619476|62779041|FG002|Overall Study|Adverse Event|12|||
33399663|NCT00619476|62779042|FG003|Overall Study|Adverse Event|16|||
33399664|NCT00619476|62779039|FG000|Overall Study|Lack of Efficacy|6|||
33399665|NCT00619476|62779040|FG001|Overall Study|Lack of Efficacy|1|||
33399666|NCT00619476|62779041|FG002|Overall Study|Lack of Efficacy|1|||
33399667|NCT00619476|62779042|FG003|Overall Study|Lack of Efficacy|4|||
33399668|NCT00619476|62779039|FG000|Overall Study|Protocol Violation|5|||
33399669|NCT00619476|62779040|FG001|Overall Study|Protocol Violation|4|||
33399670|NCT00619476|62779041|FG002|Overall Study|Protocol Violation|4|||
33399671|NCT00619476|62779042|FG003|Overall Study|Protocol Violation|9|||
33399672|NCT00619476|62779039|FG000|Overall Study|Lost to Follow-up|1|||
33399673|NCT00619476|62779040|FG001|Overall Study|Lost to Follow-up|2|||
33399674|NCT00619476|62779041|FG002|Overall Study|Lost to Follow-up|0|||
33399675|NCT00619476|62779042|FG003|Overall Study|Lost to Follow-up|1|||
33399676|NCT00619476|62779039|FG000|Overall Study|Investigator Discretion|2|||
33399677|NCT00619476|62779040|FG001|Overall Study|Investigator Discretion|2|||
33399678|NCT00619476|62779041|FG002|Overall Study|Investigator Discretion|2|||
33399679|NCT00619476|62779042|FG003|Overall Study|Investigator Discretion|0|||
33399680|NCT00619476|62779039|FG000|Overall Study|Withdrawal by Subject|5|||
33399681|NCT00619476|62779040|FG001|Overall Study|Withdrawal by Subject|7|||
33399682|NCT00619476|62779041|FG002|Overall Study|Withdrawal by Subject|5|||
33399683|NCT00619476|62779042|FG003|Overall Study|Withdrawal by Subject|4|||
33399684|NCT00618072|62779055|FG000|Overall Study|Lost to Follow-up|2|||
33399685|NCT00618072|62779056|FG001|Overall Study|Lost to Follow-up|0|||
33399686|NCT00618072|62779057|FG002|Overall Study|Lost to Follow-up|3|||
33399687|NCT00618072|62779055|FG000|Overall Study|Physician Decision|0|||
33399688|NCT00618072|62779056|FG001|Overall Study|Physician Decision|1|||
33399689|NCT00618072|62779057|FG002|Overall Study|Physician Decision|1|||
33399690|NCT00666926|62779065|FG000|Overall Study|Adverse Event|0|||
33399691|NCT00666926|62779066|FG001|Overall Study|Adverse Event|0|||
33399692|NCT00666926|62779067|FG002|Overall Study|Adverse Event|0|||
33399693|NCT00666926|62779068|FG003|Overall Study|Adverse Event|0|||
33399694|NCT00666926|62779069|FG004|Overall Study|Adverse Event|0|||
33399695|NCT00666926|62779070|FG005|Overall Study|Adverse Event|0|||
33399696|NCT00666926|62779071|FG006|Overall Study|Adverse Event|0|||
33399697|NCT00666926|62779072|FG007|Overall Study|Adverse Event|0|||
33399698|NCT00666926|62779073|FG008|Overall Study|Adverse Event|0|||
33399699|NCT00666926|62779074|FG009|Overall Study|Adverse Event|2|||
33399700|NCT00666926|62779075|FG010|Overall Study|Adverse Event|2|||
33399701|NCT00666926|62779076|FG011|Overall Study|Adverse Event|2|||
33399702|NCT00666926|62779077|FG012|Overall Study|Adverse Event|0|||
33399703|NCT00666926|62779078|FG013|Overall Study|Adverse Event|1|||
33399704|NCT00666926|62779079|FG014|Overall Study|Adverse Event|0|||
33399705|NCT00666926|62779080|FG015|Overall Study|Adverse Event|0|||
33399706|NCT00666926|62779065|FG000|Overall Study|Laboratory abnormality|0|||
33399707|NCT00666926|62779066|FG001|Overall Study|Laboratory abnormality|0|||
33399708|NCT00666926|62779067|FG002|Overall Study|Laboratory abnormality|0|||
33399709|NCT00666926|62779068|FG003|Overall Study|Laboratory abnormality|0|||
33399710|NCT00666926|62779069|FG004|Overall Study|Laboratory abnormality|0|||
33399711|NCT00666926|62779070|FG005|Overall Study|Laboratory abnormality|0|||
33399712|NCT00666926|62779071|FG006|Overall Study|Laboratory abnormality|0|||
33399713|NCT00666926|62779072|FG007|Overall Study|Laboratory abnormality|0|||
33399714|NCT00666926|62779073|FG008|Overall Study|Laboratory abnormality|0|||
33399715|NCT00666926|62779074|FG009|Overall Study|Laboratory abnormality|0|||
33669167|NCT01576718|63103064|FG002|Treatment Period|Sponsor request|0|||
33399716|NCT00666926|62779075|FG010|Overall Study|Laboratory abnormality|1|||
33399717|NCT00666926|62779076|FG011|Overall Study|Laboratory abnormality|0|||
33399718|NCT00666926|62779077|FG012|Overall Study|Laboratory abnormality|0|||
33579007|NCT01998958|62976216|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
33399719|NCT00666926|62779078|FG013|Overall Study|Laboratory abnormality|0|||
33399720|NCT00666926|62779079|FG014|Overall Study|Laboratory abnormality|0|||
33579008|NCT01998958|62976217|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
33399721|NCT00666926|62779080|FG015|Overall Study|Laboratory abnormality|1|||
33399722|NCT00666926|62779065|FG000|Overall Study|Lack of Efficacy|0|||
33579009|NCT01998958|62976218|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
33579010|NCT01998958|62976219|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
33579011|NCT01998958|62976220|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
33579012|NCT01998958|62976221|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
33579013|NCT01998958|62976190|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579014|NCT01998958|62976191|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579015|NCT01998958|62976192|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579016|NCT01998958|62976193|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579017|NCT01998958|62976194|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579018|NCT01998958|62976195|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579019|NCT01998958|62976196|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579020|NCT01998958|62976197|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579021|NCT01998958|62976198|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579022|NCT01998958|62976199|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579023|NCT01998958|62976200|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579024|NCT01998958|62976201|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579025|NCT01998958|62976202|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579026|NCT01998958|62976203|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579027|NCT01998958|62976204|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
33579028|NCT01998958|62976205|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579029|NCT01998958|62976206|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33399723|NCT00666926|62779066|FG001|Overall Study|Lack of Efficacy|0|||
33399724|NCT00666926|62779067|FG002|Overall Study|Lack of Efficacy|0|||
33399725|NCT00666926|62779068|FG003|Overall Study|Lack of Efficacy|0|||
33399726|NCT00666926|62779069|FG004|Overall Study|Lack of Efficacy|0|||
33579030|NCT01998958|62976207|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579031|NCT01998958|62976208|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
33579032|NCT01998958|62976209|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33669168|NCT01576718|63103065|FG003|Treatment Period|Sponsor request|0|||
33669169|NCT01576718|63103066|FG004|Treatment Period|Sponsor request|0|||
33669170|NCT01576718|63103067|FG005|Treatment Period|Sponsor request|1|||
33669171|NCT01576718|63103068|FG006|Treatment Period|Sponsor request|0|||
33669172|NCT01576718|63103062|FG000|Treatment Period|Met stopping criteria|0|||
33669173|NCT01576718|63103063|FG001|Treatment Period|Met stopping criteria|16|||
33669174|NCT01576718|63103064|FG002|Treatment Period|Met stopping criteria|13|||
33669175|NCT01576718|63103065|FG003|Treatment Period|Met stopping criteria|19|||
33669176|NCT01576718|63103066|FG004|Treatment Period|Met stopping criteria|16|||
33669177|NCT01576718|63103067|FG005|Treatment Period|Met stopping criteria|33|||
33669178|NCT01576718|63103068|FG006|Treatment Period|Met stopping criteria|15|||
33669179|NCT01576718|63103062|FG000|Treatment Period|Lost to Follow-up|0|||
33669180|NCT01576718|63103063|FG001|Treatment Period|Lost to Follow-up|0|||
33669181|NCT01576718|63103064|FG002|Treatment Period|Lost to Follow-up|0|||
33669182|NCT01576718|63103065|FG003|Treatment Period|Lost to Follow-up|0|||
33669183|NCT01576718|63103066|FG004|Treatment Period|Lost to Follow-up|1|||
33669184|NCT01576718|63103067|FG005|Treatment Period|Lost to Follow-up|0|||
33669185|NCT01576718|63103068|FG006|Treatment Period|Lost to Follow-up|0|||
33669186|NCT01576718|63103062|FG000|Treatment Period|Noncompliance to study medication|0|||
33669187|NCT01576718|63103063|FG001|Treatment Period|Noncompliance to study medication|0|||
33669188|NCT01576718|63103064|FG002|Treatment Period|Noncompliance to study medication|0|||
33669189|NCT01576718|63103065|FG003|Treatment Period|Noncompliance to study medication|0|||
33669190|NCT01576718|63103066|FG004|Treatment Period|Noncompliance to study medication|0|||
33669191|NCT01576718|63103067|FG005|Treatment Period|Noncompliance to study medication|1|||
33669192|NCT01576718|63103068|FG006|Treatment Period|Noncompliance to study medication|1|||
33669193|NCT01493557|63103085|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
33669194|NCT01493557|63103086|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
33669195|NCT01493557|63103087|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
33669196|NCT01493557|63103085|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
33399727|NCT00666926|62779070|FG005|Overall Study|Lack of Efficacy|1|||
33399728|NCT00666926|62779071|FG006|Overall Study|Lack of Efficacy|0|||
33399729|NCT00666926|62779072|FG007|Overall Study|Lack of Efficacy|0|||
33399730|NCT00666926|62779073|FG008|Overall Study|Lack of Efficacy|0|||
33399731|NCT00666926|62779074|FG009|Overall Study|Lack of Efficacy|0|||
33399732|NCT00666926|62779075|FG010|Overall Study|Lack of Efficacy|0|||
33399733|NCT00666926|62779076|FG011|Overall Study|Lack of Efficacy|1|||
33399734|NCT00666926|62779077|FG012|Overall Study|Lack of Efficacy|0|||
33399735|NCT00666926|62779078|FG013|Overall Study|Lack of Efficacy|0|||
33399736|NCT00666926|62779079|FG014|Overall Study|Lack of Efficacy|0|||
33399737|NCT00666926|62779080|FG015|Overall Study|Lack of Efficacy|0|||
33399738|NCT00666926|62779065|FG000|Overall Study|Lost to Follow-up|0|||
33399739|NCT00666926|62779066|FG001|Overall Study|Lost to Follow-up|0|||
33399740|NCT00666926|62779067|FG002|Overall Study|Lost to Follow-up|0|||
33399741|NCT00666926|62779068|FG003|Overall Study|Lost to Follow-up|1|||
33399742|NCT00666926|62779069|FG004|Overall Study|Lost to Follow-up|0|||
33669197|NCT01493557|63103086|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
33669198|NCT01493557|63103087|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
33669199|NCT01493557|63103085|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
33669200|NCT01493557|63103086|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
33669201|NCT01493557|63103087|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
33669202|NCT01493557|63103085|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
33669203|NCT01493557|63103086|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
33669204|NCT01493557|63103087|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
33669205|NCT01493557|63103085|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
33669206|NCT01493557|63103086|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
33669207|NCT01493557|63103087|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
33669208|NCT01493557|63103085|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
33669209|NCT01493557|63103086|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
33669210|NCT01493557|63103087|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
33669211|NCT01493557|63103085|FG000|Not Randomized to Management Strategies|Early termination|0|||
33669212|NCT01493557|63103086|FG001|Not Randomized to Management Strategies|Early termination|0|||
33669213|NCT01493557|63103087|FG002|Not Randomized to Management Strategies|Early termination|34|||
33669214|NCT01493557|63103085|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
33669215|NCT01493557|63103086|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
33669216|NCT01493557|63103087|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
33669217|NCT01493557|63103085|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
33669218|NCT01493557|63103086|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
33669219|NCT01493557|63103087|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
33669220|NCT01493557|63103085|FG000|Randomized to Management Strategies|Other adverse event|8|||
33669221|NCT01493557|63103086|FG001|Randomized to Management Strategies|Other adverse event|5|||
33669222|NCT01493557|63103087|FG002|Randomized to Management Strategies|Other adverse event|0|||
33669223|NCT01493557|63103085|FG000|Randomized to Management Strategies|Protocol Violation|3|||
33669224|NCT01493557|63103086|FG001|Randomized to Management Strategies|Protocol Violation|0|||
33669225|NCT01493557|63103087|FG002|Randomized to Management Strategies|Protocol Violation|0|||
33669226|NCT01493557|63103085|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
33669227|NCT01493557|63103086|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
33669228|NCT01493557|63103087|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
33669229|NCT01493557|63103085|FG000|Randomized to Management Strategies|Other than stated above|1|||
33669230|NCT01493557|63103086|FG001|Randomized to Management Strategies|Other than stated above|3|||
33669231|NCT01493557|63103087|FG002|Randomized to Management Strategies|Other than stated above|0|||
33669232|NCT01493557|63103085|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
33669233|NCT01493557|63103086|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
33669234|NCT01493557|63103087|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
33669235|NCT01493557|63103085|FG000|Adding the Second Strategy|Other adverse event|1|||
33669236|NCT01493557|63103086|FG001|Adding the Second Strategy|Other adverse event|2|||
33669237|NCT01493557|63103087|FG002|Adding the Second Strategy|Other adverse event|0|||
33669238|NCT01493557|63103085|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
33669239|NCT01493557|63103086|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
33669240|NCT01493557|63103087|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
33669241|NCT01451749|63103096|FG000|Overall Study|Protocol Violation|14|||
33669242|NCT01451749|63103097|FG001|Overall Study|Protocol Violation|7|||
33669243|NCT01451749|63103096|FG000|Overall Study|Lost to Follow-up|15|||
33669244|NCT01451749|63103097|FG001|Overall Study|Lost to Follow-up|5|||
33669245|NCT01451749|63103096|FG000|Overall Study|Meet the exclusion criteria,and|1|||
33669246|NCT01451749|63103097|FG001|Overall Study|Meet the exclusion criteria,and|1|||
33669247|NCT01451749|63103096|FG000|Overall Study|Adverse Event|2|||
33669248|NCT01451749|63103097|FG001|Overall Study|Adverse Event|0|||
33669249|NCT01451749|63103096|FG000|Overall Study|Withdrawal by Subject|0|||
33669250|NCT01451749|63103097|FG001|Overall Study|Withdrawal by Subject|1|||
33669251|NCT01576484|63103107|FG000|Overall Study|Adverse Event|1|||
33669252|NCT01576484|63103108|FG001|Overall Study|Adverse Event|1|||
33669253|NCT01576484|63103107|FG000|Overall Study|Protocol Violation|0|||
33669254|NCT01576484|63103108|FG001|Overall Study|Protocol Violation|2|||
33669255|NCT01576484|63103107|FG000|Overall Study|Sponsor Decision|2|||
33669256|NCT01576484|63103108|FG001|Overall Study|Sponsor Decision|8|||
33669257|NCT01576484|63103107|FG000|Overall Study|Withdrawal by Subject|0|||
33669258|NCT01576484|63103108|FG001|Overall Study|Withdrawal by Subject|3|||
33669259|NCT01576484|63103107|FG000|Overall Study|Other|2|||
33669260|NCT01576484|63103108|FG001|Overall Study|Other|5|||
33669261|NCT01467505|63103118|FG000|Overall Study|Adverse Event|1|||
33669262|NCT01467505|63103119|FG001|Overall Study|Adverse Event|0|||
33669263|NCT01467505|63103118|FG000|Overall Study|Withdrawal by Subject|4|||
33669264|NCT01467505|63103119|FG001|Overall Study|Withdrawal by Subject|0|||
33669265|NCT01467505|63103118|FG000|Overall Study|Study Terminated by Sponsor|28|||
33669266|NCT01467505|63103119|FG001|Overall Study|Study Terminated by Sponsor|3|||
33669267|NCT01467271|63103125|FG000|Overall Study|Death|84|||
33669268|NCT01467271|63103125|FG000|Overall Study|Lost to Follow-up|83|||
33669269|NCT01467271|63103125|FG000|Overall Study|Retraction of patient's consent|21|||
33669270|NCT01467271|63103125|FG000|Overall Study|Other reason|14|||
33669271|NCT01449929|63103131|FG000|Randomization Phase 96 Week|Adverse Event|5|||
33669272|NCT01449929|63103132|FG001|Randomization Phase 96 Week|Adverse Event|13|||
33669273|NCT01449929|63103133|FG002|Randomization Phase 96 Week|Adverse Event|0|||
33669274|NCT01449929|63103131|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
33669275|NCT01449929|63103132|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
33669276|NCT01449929|63103133|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
33669277|NCT01449929|63103131|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
33669278|NCT01449929|63103132|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
33669279|NCT01449929|63103133|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
33669280|NCT01449929|63103131|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
33669281|NCT01449929|63103132|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
33669282|NCT01449929|63103133|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
33669283|NCT01449929|63103131|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
33669284|NCT01449929|63103132|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
33669285|NCT01449929|63103133|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
33669286|NCT01449929|63103131|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
33669287|NCT01449929|63103132|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
33669288|NCT01449929|63103133|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
33669289|NCT01449929|63103131|FG000|Randomization Phase 96 Week|Physician Decision|2|||
33669290|NCT01449929|63103132|FG001|Randomization Phase 96 Week|Physician Decision|3|||
33669291|NCT01449929|63103133|FG002|Randomization Phase 96 Week|Physician Decision|0|||
33669292|NCT01449929|63103131|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
33669293|NCT01449929|63103132|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
33669294|NCT01449929|63103133|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
33669295|NCT01449929|63103131|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
33669296|NCT01449929|63103132|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
33669297|NCT01449929|63103133|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
33669298|NCT01449929|63103131|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
33669299|NCT01449929|63103132|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
33669300|NCT01449929|63103133|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
33669301|NCT01449929|63103131|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
33669302|NCT01449929|63103132|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
33669303|NCT01449929|63103133|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
33308367|NCT04091646|62683570|FG000|Overall Study|Participant Incarcerated|1|||
33308368|NCT04091646|62683571|FG001|Overall Study|Participant Incarcerated|0|||
33308369|NCT04040933|62683583|FG000|Overall Study|Protocol Violation|1|||
33308370|NCT04040933|62683583|FG000|Overall Study|Withdrawal by Subject|2|||
33308371|NCT03995355|62683596|FG000|Overall Study|Adverse Event|1|||
33308372|NCT03995355|62683597|FG001|Overall Study|Adverse Event|0|||
33308373|NCT03995355|62683596|FG000|Overall Study|Withdrawal by Subject|1|||
33308374|NCT03995355|62683597|FG001|Overall Study|Withdrawal by Subject|0|||
33308375|NCT03995355|62683596|FG000|Overall Study|Scheduling Issues|0|||
33308376|NCT03995355|62683597|FG001|Overall Study|Scheduling Issues|1|||
33308377|NCT03933397|62683605|FG000|Overall Study|No emergency department visit|65|||
33308378|NCT03933397|62683606|FG001|Overall Study|No emergency department visit|71|||
33308379|NCT03933397|62683605|FG000|Overall Study|Missed emergency department visit|25|||
33308380|NCT03933397|62683606|FG001|Overall Study|Missed emergency department visit|30|||
33308381|NCT03933397|62683605|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
33308382|NCT03933397|62683606|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
33308383|NCT03933397|62683605|FG000|Overall Study|Withdrawal by Subject|1|||
33308384|NCT03933397|62683606|FG001|Overall Study|Withdrawal by Subject|0|||
33308385|NCT03933397|62683605|FG000|Overall Study|Physician Decision|1|||
33308386|NCT03933397|62683606|FG001|Overall Study|Physician Decision|1|||
33308387|NCT03933397|62683605|FG000|Overall Study|missing pain score|1|||
33308388|NCT03933397|62683606|FG001|Overall Study|missing pain score|1|||
33308389|NCT03933397|62683605|FG000|Overall Study|Confirmed COVID-19|1|||
33308390|NCT03933397|62683606|FG001|Overall Study|Confirmed COVID-19|2|||
33308391|NCT03775486|62683638|FG000|Initial Therapy Phase|Other reason provided|0|||
33308392|NCT03775486|62683639|FG001|Initial Therapy Phase|Other reason provided|15|||
33308393|NCT03775486|62683638|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
33308394|NCT03775486|62683639|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
33308395|NCT03775486|62683638|FG000|Initial Therapy Phase|Protocol Violation|0|||
33308396|NCT03775486|62683639|FG001|Initial Therapy Phase|Protocol Violation|2|||
33308397|NCT03775486|62683638|FG000|Initial Therapy Phase|Adverse Event|0|||
33308398|NCT03775486|62683639|FG001|Initial Therapy Phase|Adverse Event|34|||
33308399|NCT03775486|62683638|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
33308400|NCT03775486|62683639|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
33308401|NCT03775486|62683638|FG000|Maintenance Phase|Withdrawal by Subject|13|||
33308402|NCT03775486|62683639|FG001|Maintenance Phase|Withdrawal by Subject|12|||
33308403|NCT03775486|62683638|FG000|Maintenance Phase|Death|44|||
33308404|NCT03775486|62683639|FG001|Maintenance Phase|Death|45|||
33308405|NCT03624881|62683657|FG000|Overall Study|Screen Failure|14|||
33308406|NCT03624881|62683658|FG001|Overall Study|Screen Failure|0|||
33308407|NCT03624881|62683657|FG000|Overall Study|No Catheter Inserted|6|||
33308408|NCT03624881|62683658|FG001|Overall Study|No Catheter Inserted|1|||
33308409|NCT03624881|62683657|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
33308410|NCT03624881|62683658|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
33308411|NCT03624881|62683657|FG000|Overall Study|Death|2|||
33308412|NCT03624881|62683658|FG001|Overall Study|Death|0|||
33308413|NCT03624881|62683657|FG000|Overall Study|Lost to Follow-up|10|||
33399743|NCT00666926|62779070|FG005|Overall Study|Lost to Follow-up|0|||
33399744|NCT00666926|62779071|FG006|Overall Study|Lost to Follow-up|0|||
33399745|NCT00666926|62779072|FG007|Overall Study|Lost to Follow-up|0|||
33399746|NCT00666926|62779073|FG008|Overall Study|Lost to Follow-up|0|||
33399747|NCT00666926|62779074|FG009|Overall Study|Lost to Follow-up|0|||
33399748|NCT00666926|62779075|FG010|Overall Study|Lost to Follow-up|0|||
33399749|NCT00666926|62779076|FG011|Overall Study|Lost to Follow-up|0|||
33399750|NCT00666926|62779077|FG012|Overall Study|Lost to Follow-up|0|||
33399751|NCT00666926|62779078|FG013|Overall Study|Lost to Follow-up|0|||
33399752|NCT00666926|62779079|FG014|Overall Study|Lost to Follow-up|0|||
33399753|NCT00666926|62779080|FG015|Overall Study|Lost to Follow-up|0|||
33399754|NCT00666926|62779065|FG000|Overall Study|Other|2|||
33399755|NCT00666926|62779066|FG001|Overall Study|Other|4|||
33399756|NCT00666926|62779067|FG002|Overall Study|Other|3|||
33399757|NCT00666926|62779068|FG003|Overall Study|Other|3|||
33399758|NCT00666926|62779069|FG004|Overall Study|Other|3|||
33399759|NCT00666926|62779070|FG005|Overall Study|Other|3|||
33399760|NCT00666926|62779071|FG006|Overall Study|Other|4|||
33399761|NCT00666926|62779072|FG007|Overall Study|Other|0|||
33399762|NCT00666926|62779073|FG008|Overall Study|Other|3|||
33399763|NCT00666926|62779074|FG009|Overall Study|Other|5|||
33399764|NCT00666926|62779075|FG010|Overall Study|Other|3|||
33669304|NCT01449539|63103143|FG000|Overall Study|Withdrawal by Subject|3|||
33669305|NCT01449539|63103143|FG000|Overall Study|Toxicity not study related|1|||
33669306|NCT01451515|63103150|FG000|Overall Study|Death|0|||
33669307|NCT01451515|63103151|FG001|Overall Study|Death|1|||
33669308|NCT01451515|63103152|FG002|Overall Study|Death|0|||
33669309|NCT01451515|63103150|FG000|Overall Study|Withdrawal by Subject|0|||
33669310|NCT01451515|63103151|FG001|Overall Study|Withdrawal by Subject|1|||
33669311|NCT01451515|63103152|FG002|Overall Study|Withdrawal by Subject|0|||
33669312|NCT01451515|63103150|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
33669313|NCT01451515|63103151|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
33669314|NCT01451515|63103152|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
33669315|NCT01451515|63103150|FG000|Overall Study|Relapse (except CNS)|1|||
33669316|NCT01451515|63103151|FG001|Overall Study|Relapse (except CNS)|1|||
33669317|NCT01451515|63103152|FG002|Overall Study|Relapse (except CNS)|0|||
33669318|NCT01466881|63103163|FG000|Overall Study|Ineligible|5|||
33669319|NCT01466881|63103163|FG000|Overall Study|Adverse Event|6|||
33669320|NCT01466881|63103163|FG000|Overall Study|Progression/relapse|20|||
33669321|NCT01466881|63103163|FG000|Overall Study|Death|4|||
33669322|NCT01466881|63103163|FG000|Overall Study|Other reason not protocol specified|5|||
33669323|NCT01576406|63103175|FG000|Overall Study|Lost to Follow-up|1|||
33669324|NCT01576406|63103176|FG001|Overall Study|Lost to Follow-up|2|||
33669325|NCT01576406|63103177|FG002|Overall Study|Lost to Follow-up|0|||
33669326|NCT01576406|63103178|FG003|Overall Study|Lost to Follow-up|0|||
33669327|NCT01576406|63103179|FG004|Overall Study|Lost to Follow-up|0|||
33669328|NCT01576406|63103180|FG005|Overall Study|Lost to Follow-up|0|||
33669329|NCT01576406|63103175|FG000|Overall Study|Death|3|||
33669330|NCT01576406|63103176|FG001|Overall Study|Death|4|||
33669331|NCT01576406|63103177|FG002|Overall Study|Death|8|||
33669332|NCT01576406|63103178|FG003|Overall Study|Death|5|||
33669333|NCT01576406|63103179|FG004|Overall Study|Death|7|||
33669334|NCT01576406|63103180|FG005|Overall Study|Death|9|||
33669335|NCT01576406|63103175|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
33669336|NCT01576406|63103176|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
33669337|NCT01576406|63103177|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
33669338|NCT01576406|63103178|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
33669339|NCT01576406|63103179|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
33669340|NCT01576406|63103180|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
33399765|NCT00666926|62779076|FG011|Overall Study|Other|26|||
33399766|NCT00666926|62779077|FG012|Overall Study|Other|3|||
33308414|NCT03624881|62683658|FG001|Overall Study|Lost to Follow-up|4|||
33399767|NCT00666926|62779078|FG013|Overall Study|Other|2|||
33399768|NCT00666926|62779079|FG014|Overall Study|Other|4|||
33399769|NCT00666926|62779080|FG015|Overall Study|Other|4|||
33399770|NCT00666926|62779065|FG000|Overall Study|Withdrawal by Subject|0|||
33399771|NCT00666926|62779066|FG001|Overall Study|Withdrawal by Subject|0|||
33399772|NCT00666926|62779067|FG002|Overall Study|Withdrawal by Subject|0|||
33399773|NCT00666926|62779068|FG003|Overall Study|Withdrawal by Subject|0|||
33399774|NCT00666926|62779069|FG004|Overall Study|Withdrawal by Subject|0|||
33399775|NCT00666926|62779070|FG005|Overall Study|Withdrawal by Subject|0|||
33399776|NCT00666926|62779071|FG006|Overall Study|Withdrawal by Subject|0|||
33399777|NCT00666926|62779072|FG007|Overall Study|Withdrawal by Subject|1|||
33399778|NCT00666926|62779073|FG008|Overall Study|Withdrawal by Subject|0|||
33399779|NCT00666926|62779074|FG009|Overall Study|Withdrawal by Subject|3|||
33399780|NCT00666926|62779075|FG010|Overall Study|Withdrawal by Subject|0|||
33399781|NCT00666926|62779076|FG011|Overall Study|Withdrawal by Subject|3|||
33399782|NCT00666926|62779077|FG012|Overall Study|Withdrawal by Subject|0|||
33399783|NCT00666926|62779078|FG013|Overall Study|Withdrawal by Subject|1|||
33399784|NCT00666926|62779079|FG014|Overall Study|Withdrawal by Subject|3|||
33399785|NCT00666926|62779080|FG015|Overall Study|Withdrawal by Subject|3|||
33399786|NCT00666926|62779065|FG000|Overall Study|Death|0|||
33399787|NCT00666926|62779066|FG001|Overall Study|Death|0|||
33399788|NCT00666926|62779067|FG002|Overall Study|Death|0|||
33399789|NCT00666926|62779068|FG003|Overall Study|Death|0|||
33399790|NCT00666926|62779069|FG004|Overall Study|Death|0|||
33399791|NCT00666926|62779070|FG005|Overall Study|Death|0|||
33399792|NCT00666926|62779071|FG006|Overall Study|Death|0|||
33399793|NCT00666926|62779072|FG007|Overall Study|Death|0|||
33399794|NCT00666926|62779073|FG008|Overall Study|Death|0|||
33399795|NCT00666926|62779074|FG009|Overall Study|Death|0|||
33399796|NCT00666926|62779075|FG010|Overall Study|Death|0|||
33399797|NCT00666926|62779076|FG011|Overall Study|Death|1|||
33399798|NCT00666926|62779077|FG012|Overall Study|Death|0|||
33399799|NCT00666926|62779078|FG013|Overall Study|Death|0|||
33399800|NCT00666926|62779079|FG014|Overall Study|Death|0|||
33399801|NCT00666926|62779080|FG015|Overall Study|Death|0|||
33399802|NCT03861052|62779135|FG000|Overall Study|Adverse Event|1|||
33399803|NCT03861052|62779136|FG001|Overall Study|Adverse Event|1|||
33399804|NCT03861052|62779137|FG002|Overall Study|Adverse Event|2|||
33399805|NCT03861052|62779138|FG003|Overall Study|Adverse Event|4|||
33399806|NCT03861052|62779135|FG000|Overall Study|Lost to Follow-up|0|||
33399807|NCT03861052|62779136|FG001|Overall Study|Lost to Follow-up|0|||
33399808|NCT03861052|62779137|FG002|Overall Study|Lost to Follow-up|0|||
33399809|NCT03861052|62779138|FG003|Overall Study|Lost to Follow-up|1|||
33399810|NCT03861052|62779135|FG000|Overall Study|Physician Decision|0|||
33399811|NCT03861052|62779136|FG001|Overall Study|Physician Decision|1|||
33399812|NCT03861052|62779137|FG002|Overall Study|Physician Decision|0|||
33399813|NCT03861052|62779138|FG003|Overall Study|Physician Decision|0|||
33399814|NCT03861052|62779135|FG000|Overall Study|Withdrawal by Subject|2|||
33399815|NCT03861052|62779136|FG001|Overall Study|Withdrawal by Subject|5|||
33399816|NCT03861052|62779137|FG002|Overall Study|Withdrawal by Subject|3|||
33399817|NCT03861052|62779138|FG003|Overall Study|Withdrawal by Subject|0|||
33399818|NCT03861052|62779135|FG000|Overall Study|Relocation to other city|1|||
33399819|NCT03861052|62779136|FG001|Overall Study|Relocation to other city|0|||
33399820|NCT03861052|62779137|FG002|Overall Study|Relocation to other city|0|||
33399821|NCT03861052|62779138|FG003|Overall Study|Relocation to other city|0|||
33399822|NCT00664742|62779153|FG000|Overall Study|Withdrawn due to adverse events|3|||
33399823|NCT00664742|62779153|FG000|Overall Study|Withdrawal by Subject|31|||
33399824|NCT00664742|62779153|FG000|Overall Study|Lost to Follow-up|92|||
33399825|NCT00511342|62779159|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
33399826|NCT00511342|62779160|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
33399827|NCT00511342|62779159|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
33399828|NCT00511342|62779160|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
33399829|NCT00511342|62779159|FG000|Overall Study|Pregnancy|0|||
33399830|NCT00511342|62779160|FG001|Overall Study|Pregnancy|1|||
33399831|NCT00511342|62779159|FG000|Overall Study|Pregnancy wish|0|||
33399832|NCT00511342|62779160|FG001|Overall Study|Pregnancy wish|1|||
33399833|NCT00511342|62779159|FG000|Overall Study|Lost to Follow-up|1|||
33399834|NCT00511342|62779160|FG001|Overall Study|Lost to Follow-up|5|||
33399835|NCT00511342|62779159|FG000|Overall Study|Other Reason|2|||
33399836|NCT00511342|62779160|FG001|Overall Study|Other Reason|2|||
33399837|NCT03931785|62779170|FG000|Overall Study|Lost to Follow-up|4|||
33399838|NCT03931785|62779171|FG001|Overall Study|Lost to Follow-up|1|||
33399839|NCT03931785|62779172|FG002|Overall Study|Lost to Follow-up|4|||
33399840|NCT03931785|62779173|FG003|Overall Study|Lost to Follow-up|3|||
33399841|NCT03931785|62779170|FG000|Overall Study|Adverse Event|1|||
33399842|NCT03931785|62779171|FG001|Overall Study|Adverse Event|0|||
33399843|NCT03931785|62779172|FG002|Overall Study|Adverse Event|3|||
33399844|NCT03931785|62779173|FG003|Overall Study|Adverse Event|4|||
33399845|NCT03931785|62779170|FG000|Overall Study|Protocol Violation|0|||
33399846|NCT03931785|62779171|FG001|Overall Study|Protocol Violation|1|||
33399847|NCT03931785|62779172|FG002|Overall Study|Protocol Violation|0|||
33399848|NCT03931785|62779173|FG003|Overall Study|Protocol Violation|0|||
33399849|NCT03931785|62779170|FG000|Overall Study|Noncompliance With Study drug|0|||
33399850|NCT03931785|62779171|FG001|Overall Study|Noncompliance With Study drug|1|||
33399851|NCT03931785|62779172|FG002|Overall Study|Noncompliance With Study drug|0|||
33399852|NCT03931785|62779173|FG003|Overall Study|Noncompliance With Study drug|0|||
33399853|NCT03931785|62779170|FG000|Overall Study|Other Not specified|0|||
33399854|NCT03931785|62779171|FG001|Overall Study|Other Not specified|2|||
33399855|NCT03931785|62779172|FG002|Overall Study|Other Not specified|2|||
33399856|NCT03931785|62779173|FG003|Overall Study|Other Not specified|2|||
33399857|NCT03931785|62779170|FG000|Overall Study|Withdrawal by Subject|0|||
33399858|NCT03931785|62779171|FG001|Overall Study|Withdrawal by Subject|2|||
33399859|NCT03931785|62779172|FG002|Overall Study|Withdrawal by Subject|4|||
33399860|NCT03931785|62779173|FG003|Overall Study|Withdrawal by Subject|1|||
33399861|NCT03931785|62779170|FG000|Overall Study|Pregnancy|0|||
33399862|NCT03931785|62779171|FG001|Overall Study|Pregnancy|0|||
33399863|NCT03931785|62779172|FG002|Overall Study|Pregnancy|0|||
33399864|NCT03931785|62779173|FG003|Overall Study|Pregnancy|1|||
33399865|NCT00666536|62779185|FG000|Overall Study|Adverse Event|9|||
33399866|NCT00666536|62779186|FG001|Overall Study|Adverse Event|19|||
33399867|NCT00666536|62779185|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33399868|NCT00666536|62779186|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33399869|NCT00666536|62779185|FG000|Overall Study|Protocol deviation(s)|8|||
33399870|NCT00666536|62779186|FG001|Overall Study|Protocol deviation(s)|6|||
33399871|NCT00666536|62779185|FG000|Overall Study|Withdrawal by Subject|10|||
33399872|NCT00666536|62779186|FG001|Overall Study|Withdrawal by Subject|9|||
33399873|NCT00666536|62779185|FG000|Overall Study|Lost to Follow-up|4|||
33399874|NCT00666536|62779186|FG001|Overall Study|Lost to Follow-up|3|||
33399875|NCT00519532|62779192|FG000|Overall Study|Adverse Event|11|||
33399876|NCT00519532|62779192|FG000|Overall Study|Withdrawal by Subject|5|||
33399877|NCT00519532|62779192|FG000|Overall Study|Lost to Follow-up|2|||
33399878|NCT00666458|62779198|FG000|Overall Study|Adverse Event|8|||
33399879|NCT00666458|62779199|FG001|Overall Study|Adverse Event|7|||
33399880|NCT00666458|62779198|FG000|Overall Study|Withdrawal by Subject|5|||
33399881|NCT00666458|62779199|FG001|Overall Study|Withdrawal by Subject|4|||
33399882|NCT00666458|62779198|FG000|Overall Study|Lost to Follow-up|0|||
33399883|NCT00666458|62779199|FG001|Overall Study|Lost to Follow-up|3|||
33399884|NCT00666458|62779198|FG000|Overall Study|Administrative reason by sponsor|1|||
33399885|NCT00666458|62779199|FG001|Overall Study|Administrative reason by sponsor|1|||
33399886|NCT00666458|62779198|FG000|Overall Study|Incorrect enrollment|7|||
33399887|NCT00666458|62779199|FG001|Overall Study|Incorrect enrollment|1|||
33579033|NCT01998958|62976210|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579034|NCT01998958|62976211|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579035|NCT01998958|62976212|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579036|NCT01998958|62976213|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579037|NCT01998958|62976214|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579038|NCT01998958|62976215|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579039|NCT01998958|62976216|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579040|NCT01998958|62976217|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579041|NCT01998958|62976218|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579042|NCT01998958|62976219|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579043|NCT01998958|62976220|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579044|NCT01998958|62976221|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33579045|NCT01998958|62976190|FG000|Open Label Phase (Optional)|Adverse Event|0|||
33579046|NCT01998958|62976191|FG001|Open Label Phase (Optional)|Adverse Event|0|||
33579047|NCT01998958|62976192|FG002|Open Label Phase (Optional)|Adverse Event|0|||
33579048|NCT01998958|62976193|FG003|Open Label Phase (Optional)|Adverse Event|0|||
33579049|NCT01998958|62976194|FG004|Open Label Phase (Optional)|Adverse Event|0|||
33579050|NCT01998958|62976195|FG005|Open Label Phase (Optional)|Adverse Event|0|||
33579051|NCT01998958|62976196|FG006|Open Label Phase (Optional)|Adverse Event|0|||
33579052|NCT01998958|62976197|FG007|Open Label Phase (Optional)|Adverse Event|0|||
33579053|NCT01998958|62976198|FG008|Open Label Phase (Optional)|Adverse Event|0|||
33579054|NCT01998958|62976199|FG009|Open Label Phase (Optional)|Adverse Event|0|||
33579055|NCT01998958|62976200|FG010|Open Label Phase (Optional)|Adverse Event|0|||
33579056|NCT01998958|62976201|FG011|Open Label Phase (Optional)|Adverse Event|0|||
33579057|NCT01998958|62976202|FG012|Open Label Phase (Optional)|Adverse Event|0|||
33579058|NCT01998958|62976203|FG013|Open Label Phase (Optional)|Adverse Event|0|||
33579059|NCT01998958|62976204|FG014|Open Label Phase (Optional)|Adverse Event|0|||
33579060|NCT01998958|62976205|FG015|Open Label Phase (Optional)|Adverse Event|0|||
33579061|NCT01998958|62976206|FG016|Open Label Phase (Optional)|Adverse Event|0|||
33579062|NCT01998958|62976207|FG017|Open Label Phase (Optional)|Adverse Event|0|||
33399888|NCT00666458|62779198|FG000|Overall Study|Study specific discontinuation criteria|14|||
33399889|NCT00666458|62779199|FG001|Overall Study|Study specific discontinuation criteria|7|||
33399890|NCT00666458|62779198|FG000|Overall Study|Severe non-compliance to the protocol|1|||
33399891|NCT00666458|62779199|FG001|Overall Study|Severe non-compliance to the protocol|1|||
33399892|NCT00666458|62779198|FG000|Overall Study|Safety reasons|1|||
33579063|NCT01998958|62976208|FG018|Open Label Phase (Optional)|Adverse Event|0|||
33579064|NCT01998958|62976209|FG019|Open Label Phase (Optional)|Adverse Event|0|||
33579065|NCT01998958|62976210|FG020|Open Label Phase (Optional)|Adverse Event|0|||
33579066|NCT01998958|62976211|FG021|Open Label Phase (Optional)|Adverse Event|0|||
33579067|NCT01998958|62976212|FG022|Open Label Phase (Optional)|Adverse Event|0|||
33579068|NCT01998958|62976213|FG023|Open Label Phase (Optional)|Adverse Event|1|||
33579069|NCT01998958|62976214|FG024|Open Label Phase (Optional)|Adverse Event|0|||
33579070|NCT01998958|62976215|FG025|Open Label Phase (Optional)|Adverse Event|0|||
33579071|NCT01998958|62976216|FG026|Open Label Phase (Optional)|Adverse Event|0|||
33579072|NCT01998958|62976217|FG027|Open Label Phase (Optional)|Adverse Event|0|||
33579073|NCT01998958|62976218|FG028|Open Label Phase (Optional)|Adverse Event|0|||
33579074|NCT01998958|62976219|FG029|Open Label Phase (Optional)|Adverse Event|0|||
33579075|NCT01998958|62976220|FG030|Open Label Phase (Optional)|Adverse Event|0|||
33579076|NCT01998958|62976221|FG031|Open Label Phase (Optional)|Adverse Event|0|||
33579077|NCT01998958|62976190|FG000|Open Label Phase (Optional)|Other|0|||
33579078|NCT01998958|62976191|FG001|Open Label Phase (Optional)|Other|0|||
33579079|NCT01998958|62976192|FG002|Open Label Phase (Optional)|Other|0|||
33579080|NCT01998958|62976193|FG003|Open Label Phase (Optional)|Other|0|||
33579081|NCT01998958|62976194|FG004|Open Label Phase (Optional)|Other|0|||
33579082|NCT01998958|62976195|FG005|Open Label Phase (Optional)|Other|0|||
33579083|NCT01998958|62976196|FG006|Open Label Phase (Optional)|Other|0|||
33579084|NCT01998958|62976197|FG007|Open Label Phase (Optional)|Other|0|||
33579085|NCT01998958|62976198|FG008|Open Label Phase (Optional)|Other|0|||
33579086|NCT01998958|62976199|FG009|Open Label Phase (Optional)|Other|0|||
33579087|NCT01998958|62976200|FG010|Open Label Phase (Optional)|Other|0|||
33579088|NCT01998958|62976201|FG011|Open Label Phase (Optional)|Other|0|||
33579089|NCT01998958|62976202|FG012|Open Label Phase (Optional)|Other|0|||
33579090|NCT01998958|62976203|FG013|Open Label Phase (Optional)|Other|0|||
33579091|NCT01998958|62976204|FG014|Open Label Phase (Optional)|Other|0|||
33579092|NCT01998958|62976205|FG015|Open Label Phase (Optional)|Other|0|||
33579093|NCT01998958|62976206|FG016|Open Label Phase (Optional)|Other|0|||
33579094|NCT01998958|62976207|FG017|Open Label Phase (Optional)|Other|0|||
33579095|NCT01998958|62976208|FG018|Open Label Phase (Optional)|Other|0|||
33579096|NCT01998958|62976209|FG019|Open Label Phase (Optional)|Other|0|||
33579097|NCT01998958|62976210|FG020|Open Label Phase (Optional)|Other|0|||
33579098|NCT01998958|62976211|FG021|Open Label Phase (Optional)|Other|0|||
33579099|NCT01998958|62976212|FG022|Open Label Phase (Optional)|Other|5|||
33579100|NCT01998958|62976213|FG023|Open Label Phase (Optional)|Other|1|||
33579101|NCT01998958|62976214|FG024|Open Label Phase (Optional)|Other|0|||
33579102|NCT01998958|62976215|FG025|Open Label Phase (Optional)|Other|0|||
33579103|NCT01998958|62976216|FG026|Open Label Phase (Optional)|Other|0|||
33579104|NCT01998958|62976217|FG027|Open Label Phase (Optional)|Other|0|||
33579105|NCT01998958|62976218|FG028|Open Label Phase (Optional)|Other|0|||
33579106|NCT01998958|62976219|FG029|Open Label Phase (Optional)|Other|0|||
33579107|NCT01998958|62976220|FG030|Open Label Phase (Optional)|Other|0|||
33579108|NCT01998958|62976221|FG031|Open Label Phase (Optional)|Other|0|||
33579109|NCT01998958|62976190|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579110|NCT01998958|62976191|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579111|NCT01998958|62976192|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579112|NCT01998958|62976193|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579113|NCT01998958|62976194|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579114|NCT01998958|62976195|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579115|NCT01998958|62976196|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579116|NCT01998958|62976197|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579117|NCT01998958|62976198|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579118|NCT01998958|62976199|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579119|NCT01998958|62976200|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579120|NCT01998958|62976201|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579121|NCT01998958|62976202|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579122|NCT01998958|62976203|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579123|NCT01998958|62976204|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
33669341|NCT01576406|63103175|FG000|Overall Study|Withdrawal the consent|2|||
33669342|NCT01576406|63103176|FG001|Overall Study|Withdrawal the consent|2|||
33669343|NCT01576406|63103177|FG002|Overall Study|Withdrawal the consent|5|||
33669344|NCT01576406|63103178|FG003|Overall Study|Withdrawal the consent|1|||
33669345|NCT01576406|63103179|FG004|Overall Study|Withdrawal the consent|1|||
33669346|NCT01576406|63103180|FG005|Overall Study|Withdrawal the consent|3|||
33669347|NCT01576406|63103175|FG000|Overall Study|Other|0|||
33669348|NCT01576406|63103176|FG001|Overall Study|Other|0|||
33579124|NCT01998958|62976205|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579125|NCT01998958|62976206|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579126|NCT01998958|62976207|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579127|NCT01998958|62976208|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579128|NCT01998958|62976209|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579129|NCT01998958|62976210|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
33669349|NCT01576406|63103177|FG002|Overall Study|Other|2|||
33669350|NCT01576406|63103178|FG003|Overall Study|Other|2|||
33669351|NCT01576406|63103179|FG004|Overall Study|Other|0|||
33669352|NCT01576406|63103180|FG005|Overall Study|Other|0|||
33669353|NCT01576172|63103196|FG000|Overall Study|Ineligible|2|||
33669354|NCT01576172|63103197|FG001|Overall Study|Ineligible|1|||
33669355|NCT01576172|63103196|FG000|Overall Study|Withdrawal by Subject|2|||
33669356|NCT01576172|63103197|FG001|Overall Study|Withdrawal by Subject|0|||
33669357|NCT01576172|63103196|FG000|Overall Study|Insurance issue|1|||
33669358|NCT01576172|63103197|FG001|Overall Study|Insurance issue|0|||
33669359|NCT01542788|63103207|FG000|Overall Study|Randomized but Not Treated|2|||
33669360|NCT01542788|63103208|FG001|Overall Study|Randomized but Not Treated|0|||
33669361|NCT01542788|63103207|FG000|Overall Study|Lack of Efficacy|41|||
33669362|NCT01542788|63103208|FG001|Overall Study|Lack of Efficacy|71|||
33669363|NCT01542788|63103207|FG000|Overall Study|Lost to Follow-up|5|||
33669364|NCT01542788|63103208|FG001|Overall Study|Lost to Follow-up|0|||
33669365|NCT01542788|63103207|FG000|Overall Study|Death|3|||
33669366|NCT01542788|63103208|FG001|Overall Study|Death|0|||
33669367|NCT01542788|63103207|FG000|Overall Study|Protocol Violation|2|||
33669368|NCT01542788|63103208|FG001|Overall Study|Protocol Violation|0|||
33669369|NCT01542788|63103207|FG000|Overall Study|Physician Decision|1|||
33669370|NCT01542788|63103208|FG001|Overall Study|Physician Decision|0|||
33669371|NCT01542788|63103207|FG000|Overall Study|Withdrawal by Subject|1|||
33669372|NCT01542788|63103208|FG001|Overall Study|Withdrawal by Subject|0|||
33669373|NCT01542632|63103220|FG000|Overall Study|Withdrawal of Consent|0|||
33669374|NCT01542632|63103221|FG001|Overall Study|Withdrawal of Consent|0|||
33669375|NCT01542632|63103222|FG002|Overall Study|Withdrawal of Consent|0|||
33669376|NCT01542632|63103223|FG003|Overall Study|Withdrawal of Consent|2|||
33669377|NCT01542632|63103224|FG004|Overall Study|Withdrawal of Consent|3|||
33669378|NCT01542632|63103225|FG005|Overall Study|Withdrawal of Consent|0|||
33669379|NCT01542632|63103220|FG000|Overall Study|Adverse Event|0|||
33669380|NCT01542632|63103221|FG001|Overall Study|Adverse Event|0|||
33669381|NCT01542632|63103222|FG002|Overall Study|Adverse Event|1|||
33669382|NCT01542632|63103223|FG003|Overall Study|Adverse Event|0|||
33669383|NCT01542632|63103224|FG004|Overall Study|Adverse Event|0|||
33669384|NCT01542632|63103225|FG005|Overall Study|Adverse Event|0|||
33669385|NCT01542632|63103220|FG000|Overall Study|Lost to Follow-up|0|||
33669386|NCT01542632|63103221|FG001|Overall Study|Lost to Follow-up|1|||
33669387|NCT01542632|63103222|FG002|Overall Study|Lost to Follow-up|0|||
33669388|NCT01542632|63103223|FG003|Overall Study|Lost to Follow-up|0|||
33669389|NCT01542632|63103224|FG004|Overall Study|Lost to Follow-up|0|||
33669390|NCT01542632|63103225|FG005|Overall Study|Lost to Follow-up|0|||
33669391|NCT01542632|63103220|FG000|Overall Study|Sponsor/Investigator Decision|0|||
33669392|NCT01542632|63103221|FG001|Overall Study|Sponsor/Investigator Decision|0|||
33669393|NCT01542632|63103222|FG002|Overall Study|Sponsor/Investigator Decision|0|||
33669394|NCT01542632|63103223|FG003|Overall Study|Sponsor/Investigator Decision|0|||
33669395|NCT01542632|63103224|FG004|Overall Study|Sponsor/Investigator Decision|1|||
33669396|NCT01542632|63103225|FG005|Overall Study|Sponsor/Investigator Decision|0|||
33669397|NCT01557842|63103246|FG000|Overall Study|Lost to Follow-up|0|||
33669398|NCT01557842|63103247|FG001|Overall Study|Lost to Follow-up|1|||
33669399|NCT01557842|63103246|FG000|Overall Study|Death|1|||
33669400|NCT01557842|63103247|FG001|Overall Study|Death|0|||
33669401|NCT01557842|63103246|FG000|Overall Study|Lack of Efficacy|0|||
33669402|NCT01557842|63103247|FG001|Overall Study|Lack of Efficacy|1|||
33669403|NCT01557842|63103246|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
33669404|NCT01557842|63103247|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
33669405|NCT01557842|63103246|FG000|Overall Study|Study Terminated by Sponsor|3|||
33669406|NCT01557842|63103247|FG001|Overall Study|Study Terminated by Sponsor|4|||
33669407|NCT01557842|63103246|FG000|Overall Study|Not Ablated|2|||
33669408|NCT01557842|63103247|FG001|Overall Study|Not Ablated|0|||
33669409|NCT01541930|63103253|FG000|Overall Study|Withdrawal by Subject|1|||
33669410|NCT01576016|63103270|FG000|Lead Safety|Death|132|||
33669411|NCT01576016|63103271|FG001|Lead Safety|Death|0|||
33669412|NCT01576016|63103270|FG000|Lead Safety|Withdrawal by Subject|81|||
33669413|NCT01576016|63103271|FG001|Lead Safety|Withdrawal by Subject|0|||
33669414|NCT01576016|63103270|FG000|Lead Safety|System Explanted without Replacement|24|||
33669415|NCT01576016|63103271|FG001|Lead Safety|System Explanted without Replacement|0|||
33669416|NCT01576016|63103270|FG000|Lead Safety|Physician Decision|14|||
33579130|NCT01998958|62976211|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579131|NCT01998958|62976212|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
33579132|NCT01998958|62976213|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579133|NCT01998958|62976214|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579134|NCT01998958|62976215|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579135|NCT01998958|62976216|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579136|NCT01998958|62976217|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579137|NCT01998958|62976218|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
33669417|NCT01576016|63103271|FG001|Lead Safety|Physician Decision|0|||
33669418|NCT01576016|63103270|FG000|Lead Safety|Lost to Follow-up|13|||
33669419|NCT01576016|63103271|FG001|Lead Safety|Lost to Follow-up|0|||
33669420|NCT01576016|63103270|FG000|Lead Safety|Unsuccessful implant|2|||
33669421|NCT01576016|63103271|FG001|Lead Safety|Unsuccessful implant|0|||
33669422|NCT01576016|63103270|FG000|Lead Safety|Sponsor request|1|||
33669423|NCT01576016|63103271|FG001|Lead Safety|Sponsor request|0|||
33669424|NCT01576016|63103270|FG000|Lead Safety|Device replaced with CRT-D|1|||
33669425|NCT01576016|63103271|FG001|Lead Safety|Device replaced with CRT-D|0|||
33669426|NCT01576016|63103270|FG000|Lead Safety|Patient on Palliative Care|1|||
33669427|NCT01576016|63103271|FG001|Lead Safety|Patient on Palliative Care|0|||
33669428|NCT01576016|63103270|FG000|Lead Safety|Patient noncompliance|1|||
33669429|NCT01576016|63103271|FG001|Lead Safety|Patient noncompliance|0|||
33669430|NCT01576016|63103270|FG000|Lead Safety|Too far from study site|1|||
33669431|NCT01576016|63103271|FG001|Lead Safety|Too far from study site|0|||
33669432|NCT01576016|63103270|FG000|Lead Safety|System deactivated|1|||
33669433|NCT01576016|63103271|FG001|Lead Safety|System deactivated|0|||
33669434|NCT01576016|63103270|FG000|Lead Safety|Patient no longer followed by study PI|1|||
33669435|NCT01576016|63103271|FG001|Lead Safety|Patient no longer followed by study PI|0|||
33669436|NCT01576016|63103270|FG000|MRI Safety|Withdrawal by Subject|0|||
33669437|NCT01576016|63103271|FG001|MRI Safety|Withdrawal by Subject|10|||
33669438|NCT01576016|63103270|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
33669439|NCT01576016|63103271|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
33669440|NCT01576016|63103270|FG000|MRI Safety|Has not yet completed MRI scan|0|||
33669441|NCT01576016|63103271|FG001|MRI Safety|Has not yet completed MRI scan|56|||
33669442|NCT01576016|63103270|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
33669443|NCT01576016|63103271|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
33669444|NCT01540838|63103281|FG000|Overall Study|Open nasogastric tube|9|||
33669445|NCT01540838|63103282|FG001|Overall Study|Open nasogastric tube|7|||
33669446|NCT01540838|63103281|FG000|Overall Study|Treatment doses missing|8|||
33669447|NCT01540838|63103282|FG001|Overall Study|Treatment doses missing|12|||
33669448|NCT01540838|63103281|FG000|Overall Study|Additional antibiotic treatment|1|||
33669449|NCT01540838|63103282|FG001|Overall Study|Additional antibiotic treatment|2|||
33669450|NCT01540838|63103281|FG000|Overall Study|Died before treatment initiation|1|||
33669451|NCT01540838|63103282|FG001|Overall Study|Died before treatment initiation|1|||
33669452|NCT01540838|63103281|FG000|Overall Study|Not BM. Other treatment|3|||
33669453|NCT01540838|63103282|FG001|Overall Study|Not BM. Other treatment|1|||
33669454|NCT01451437|63103297|FG000|Overall Study|Adverse Event|0|||
33669455|NCT01451437|63103298|FG001|Overall Study|Adverse Event|0|||
33669456|NCT01451437|63103299|FG002|Overall Study|Adverse Event|0|||
33669457|NCT01451437|63103300|FG003|Overall Study|Adverse Event|0|||
33669458|NCT01451437|63103301|FG004|Overall Study|Adverse Event|0|||
33669459|NCT01451437|63103302|FG005|Overall Study|Adverse Event|1|||
33669460|NCT01451437|63103303|FG006|Overall Study|Adverse Event|1|||
33669461|NCT01451437|63103304|FG007|Overall Study|Adverse Event|2|||
33669462|NCT01451437|63103305|FG008|Overall Study|Adverse Event|1|||
33669463|NCT01451437|63103297|FG000|Overall Study|Physician Decision|1|||
33669464|NCT01451437|63103298|FG001|Overall Study|Physician Decision|1|||
33669465|NCT01451437|63103299|FG002|Overall Study|Physician Decision|2|||
33669466|NCT01451437|63103300|FG003|Overall Study|Physician Decision|0|||
33669467|NCT01451437|63103301|FG004|Overall Study|Physician Decision|0|||
33669468|NCT01451437|63103302|FG005|Overall Study|Physician Decision|0|||
33669469|NCT01451437|63103303|FG006|Overall Study|Physician Decision|0|||
33669470|NCT01451437|63103304|FG007|Overall Study|Physician Decision|0|||
33669471|NCT01451437|63103305|FG008|Overall Study|Physician Decision|0|||
33669472|NCT01451437|63103297|FG000|Overall Study|Disease Progression|0|||
33669473|NCT01451437|63103298|FG001|Overall Study|Disease Progression|0|||
33669474|NCT01451437|63103299|FG002|Overall Study|Disease Progression|1|||
33669475|NCT01451437|63103300|FG003|Overall Study|Disease Progression|1|||
33669476|NCT01451437|63103301|FG004|Overall Study|Disease Progression|3|||
33669477|NCT01451437|63103302|FG005|Overall Study|Disease Progression|2|||
33669478|NCT01451437|63103303|FG006|Overall Study|Disease Progression|3|||
33669479|NCT01451437|63103304|FG007|Overall Study|Disease Progression|1|||
33669480|NCT01451437|63103305|FG008|Overall Study|Disease Progression|3|||
33669481|NCT01451437|63103297|FG000|Overall Study|Protocol Violation|0|||
33669482|NCT01451437|63103298|FG001|Overall Study|Protocol Violation|0|||
33669483|NCT01451437|63103299|FG002|Overall Study|Protocol Violation|0|||
33669484|NCT01451437|63103300|FG003|Overall Study|Protocol Violation|0|||
33669485|NCT01451437|63103301|FG004|Overall Study|Protocol Violation|0|||
33669486|NCT01451437|63103302|FG005|Overall Study|Protocol Violation|0|||
33669487|NCT01451437|63103303|FG006|Overall Study|Protocol Violation|1|||
33669488|NCT01451437|63103304|FG007|Overall Study|Protocol Violation|0|||
33669489|NCT01451437|63103305|FG008|Overall Study|Protocol Violation|0|||
33669490|NCT01451437|63103297|FG000|Overall Study|Withdrawal by Subject|0|||
33669491|NCT01451437|63103298|FG001|Overall Study|Withdrawal by Subject|0|||
33669492|NCT01451437|63103299|FG002|Overall Study|Withdrawal by Subject|0|||
33669493|NCT01451437|63103300|FG003|Overall Study|Withdrawal by Subject|0|||
33669494|NCT01451437|63103301|FG004|Overall Study|Withdrawal by Subject|1|||
33669495|NCT01451437|63103302|FG005|Overall Study|Withdrawal by Subject|0|||
33669496|NCT01451437|63103303|FG006|Overall Study|Withdrawal by Subject|1|||
33669497|NCT01451437|63103304|FG007|Overall Study|Withdrawal by Subject|0|||
33669498|NCT01451437|63103305|FG008|Overall Study|Withdrawal by Subject|0|||
33669499|NCT01451203|63103336|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
33669500|NCT01451203|63103337|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
33669501|NCT01451203|63103336|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
33669502|NCT01451203|63103337|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
33669503|NCT01451203|63103336|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
33669504|NCT01451203|63103337|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
33669505|NCT01451203|63103336|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
33669506|NCT01451203|63103337|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
33669507|NCT01451203|63103336|FG000|Double-blind Treatment Period|Adverse Event|6|||
33669508|NCT01451203|63103337|FG001|Double-blind Treatment Period|Adverse Event|9|||
33669509|NCT01451203|63103336|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
33669510|NCT01451203|63103337|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
33669511|NCT01451203|63103336|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
33669512|NCT01451203|63103337|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
33669513|NCT01451203|63103336|FG000|Double-blind Treatment Period|Investigator decision|2|||
33669514|NCT01451203|63103337|FG001|Double-blind Treatment Period|Investigator decision|0|||
33669515|NCT01451203|63103336|FG000|Post-treatment Period|Consent withdrawn|2|||
33669516|NCT01451203|63103337|FG001|Post-treatment Period|Consent withdrawn|4|||
33669517|NCT01451203|63103336|FG000|Post-treatment Period|Lack of Efficacy|12|||
33669518|NCT01451203|63103337|FG001|Post-treatment Period|Lack of Efficacy|28|||
33669519|NCT01451203|63103336|FG000|Post-treatment Period|Adverse Event|0|||
33669520|NCT01451203|63103337|FG001|Post-treatment Period|Adverse Event|1|||
33669521|NCT01451203|63103336|FG000|Post-treatment Period|Investigator decision|0|||
33669522|NCT01451203|63103337|FG001|Post-treatment Period|Investigator decision|1|||
33669523|NCT01556438|63103345|FG000|Overall Study|Adverse Event|4|||
33669524|NCT01556438|63103346|FG001|Overall Study|Adverse Event|2|||
33669525|NCT01556438|63103345|FG000|Overall Study|Sponsor Decision|0|||
33669526|NCT01556438|63103346|FG001|Overall Study|Sponsor Decision|2|||
33669527|NCT01556438|63103345|FG000|Overall Study|Progressive Disease|0|||
33669528|NCT01556438|63103346|FG001|Overall Study|Progressive Disease|6|||
33669529|NCT01556438|63103345|FG000|Overall Study|Death|0|||
33669530|NCT01556438|63103346|FG001|Overall Study|Death|1|||
33669531|NCT01554176|63103372|FG000|Treatment Phase|Protocol Violation|1|||
33669532|NCT01554176|63103373|FG001|Treatment Phase|Protocol Violation|2|||
33669533|NCT01554176|63103374|FG002|Treatment Phase|Protocol Violation|0|||
33669534|NCT01554176|63103375|FG003|Treatment Phase|Protocol Violation|0|||
33669535|NCT01554176|63103376|FG004|Treatment Phase|Protocol Violation|0|||
33669536|NCT01554176|63103372|FG000|Treatment Phase|Physician Decision|1|||
33669537|NCT01554176|63103373|FG001|Treatment Phase|Physician Decision|1|||
33669538|NCT01554176|63103374|FG002|Treatment Phase|Physician Decision|0|||
33669539|NCT01554176|63103375|FG003|Treatment Phase|Physician Decision|0|||
33669540|NCT01554176|63103376|FG004|Treatment Phase|Physician Decision|0|||
33669541|NCT01554176|63103372|FG000|Treatment Phase|Lack of Efficacy|0|||
33669542|NCT01554176|63103373|FG001|Treatment Phase|Lack of Efficacy|1|||
33669543|NCT01554176|63103374|FG002|Treatment Phase|Lack of Efficacy|0|||
33669544|NCT01554176|63103375|FG003|Treatment Phase|Lack of Efficacy|0|||
33669545|NCT01554176|63103376|FG004|Treatment Phase|Lack of Efficacy|0|||
33669546|NCT01554176|63103372|FG000|Treatment Phase|Adverse event, non-fatal|1|||
33669547|NCT01554176|63103373|FG001|Treatment Phase|Adverse event, non-fatal|1|||
33669548|NCT01554176|63103374|FG002|Treatment Phase|Adverse event, non-fatal|0|||
33669549|NCT01554176|63103375|FG003|Treatment Phase|Adverse event, non-fatal|0|||
33669550|NCT01554176|63103376|FG004|Treatment Phase|Adverse event, non-fatal|0|||
33399893|NCT00666458|62779199|FG001|Overall Study|Safety reasons|0|||
33399894|NCT00666458|62779198|FG000|Overall Study|Medical history of anemia|1|||
33399895|NCT00666458|62779199|FG001|Overall Study|Medical history of anemia|0|||
33399896|NCT00511108|62779209|FG000|Overall Study|Adverse Event|2|||
33399897|NCT00511108|62779210|FG001|Overall Study|Adverse Event|0|||
33669551|NCT01554176|63103372|FG000|Treatment Phase|Non-compliance with study drug|1|||
33669552|NCT01554176|63103373|FG001|Treatment Phase|Non-compliance with study drug|0|||
33669553|NCT01554176|63103374|FG002|Treatment Phase|Non-compliance with study drug|0|||
33669554|NCT01554176|63103375|FG003|Treatment Phase|Non-compliance with study drug|0|||
33669555|NCT01554176|63103376|FG004|Treatment Phase|Non-compliance with study drug|0|||
33669556|NCT01554176|63103372|FG000|Treatment Phase|Withdrawal by Subject|1|||
33669557|NCT01554176|63103373|FG001|Treatment Phase|Withdrawal by Subject|0|||
33669558|NCT01554176|63103374|FG002|Treatment Phase|Withdrawal by Subject|0|||
33669559|NCT01554176|63103375|FG003|Treatment Phase|Withdrawal by Subject|0|||
33669560|NCT01554176|63103376|FG004|Treatment Phase|Withdrawal by Subject|0|||
33669561|NCT01554176|63103372|FG000|Treatment Phase|Lost to Follow-up|3|||
33669562|NCT01554176|63103373|FG001|Treatment Phase|Lost to Follow-up|0|||
33669563|NCT01554176|63103374|FG002|Treatment Phase|Lost to Follow-up|0|||
33669564|NCT01554176|63103375|FG003|Treatment Phase|Lost to Follow-up|0|||
33669565|NCT01554176|63103376|FG004|Treatment Phase|Lost to Follow-up|0|||
33669566|NCT01554176|63103372|FG000|Run-out Phase|Protocol Violation|0|||
33399898|NCT00511108|62779211|FG002|Overall Study|Adverse Event|1|||
33669567|NCT01554176|63103373|FG001|Run-out Phase|Protocol Violation|0|||
33669568|NCT01554176|63103374|FG002|Run-out Phase|Protocol Violation|0|||
33669569|NCT01554176|63103375|FG003|Run-out Phase|Protocol Violation|1|||
33669570|NCT01554176|63103376|FG004|Run-out Phase|Protocol Violation|0|||
33669571|NCT01466491|63103392|FG000|Overall Study|Protocol Violation|0|||
33669572|NCT01466491|63103393|FG001|Overall Study|Protocol Violation|3|||
33669573|NCT01466491|63103394|FG002|Overall Study|Protocol Violation|2|||
33669574|NCT01466491|63103395|FG003|Overall Study|Protocol Violation|0|||
33669575|NCT01466491|63103392|FG000|Overall Study|Missing Data|0|||
33669576|NCT01466491|63103393|FG001|Overall Study|Missing Data|0|||
33669577|NCT01466491|63103394|FG002|Overall Study|Missing Data|1|||
33669578|NCT01466491|63103395|FG003|Overall Study|Missing Data|0|||
33669579|NCT01466179|63103405|FG000|Overall Study|Ongoing in core study|2|||
33669580|NCT01466179|63103405|FG000|Overall Study|Physician Decision|46|||
33669581|NCT01466179|63103405|FG000|Overall Study|Progressive disease|43|||
33669582|NCT01466179|63103405|FG000|Overall Study|Adverse Event|32|||
33669583|NCT01466179|63103405|FG000|Overall Study|Disease relapse|23|||
33399899|NCT00511108|62779212|FG003|Overall Study|Adverse Event|2|||
33399900|NCT00511108|62779209|FG000|Overall Study|Lost to Follow-up|0|||
33399901|NCT00511108|62779210|FG001|Overall Study|Lost to Follow-up|2|||
33399902|NCT00511108|62779211|FG002|Overall Study|Lost to Follow-up|1|||
33399903|NCT00511108|62779212|FG003|Overall Study|Lost to Follow-up|0|||
33399904|NCT00511108|62779209|FG000|Overall Study|Physician Decision|0|||
33399905|NCT00511108|62779210|FG001|Overall Study|Physician Decision|0|||
33399906|NCT00511108|62779211|FG002|Overall Study|Physician Decision|0|||
33399907|NCT00511108|62779212|FG003|Overall Study|Physician Decision|1|||
33399908|NCT00511108|62779209|FG000|Overall Study|Withdrawal by Subject|4|||
33399909|NCT00511108|62779210|FG001|Overall Study|Withdrawal by Subject|0|||
33399910|NCT00511108|62779211|FG002|Overall Study|Withdrawal by Subject|3|||
33399911|NCT00511108|62779212|FG003|Overall Study|Withdrawal by Subject|2|||
33399912|NCT00510952|62779224|FG000|Overall Study|Adverse Event|1|||
33399913|NCT00510952|62779225|FG001|Overall Study|Adverse Event|0|||
33399914|NCT00510952|62779224|FG000|Overall Study|Entry Criteria Not Met|3|||
33399915|NCT00510952|62779225|FG001|Overall Study|Entry Criteria Not Met|1|||
33399916|NCT00510952|62779224|FG000|Overall Study|Lost to Follow-up|5|||
33399917|NCT00510952|62779225|FG001|Overall Study|Lost to Follow-up|3|||
33399918|NCT00510952|62779224|FG000|Overall Study|Physician Decision|1|||
33399919|NCT00510952|62779225|FG001|Overall Study|Physician Decision|1|||
33399920|NCT00510952|62779224|FG000|Overall Study|Protocol Violation|7|||
33579138|NCT01998958|62976219|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579139|NCT01998958|62976220|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579140|NCT01998958|62976221|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
33579141|NCT01998958|62976190|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579142|NCT01998958|62976191|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579143|NCT01998958|62976192|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579144|NCT01998958|62976193|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579145|NCT01998958|62976194|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579146|NCT01998958|62976195|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579147|NCT01998958|62976196|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579148|NCT01998958|62976197|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
33308415|NCT03624881|62683657|FG000|Overall Study|Withdrawal by Subject|12|||
33308416|NCT03624881|62683658|FG001|Overall Study|Withdrawal by Subject|1|||
33308417|NCT03428997|62683681|FG000|Overall Study|Sponsor decision.|1|||
33308418|NCT03428997|62683681|FG000|Overall Study|Withdrawal by Subject|3|||
33579149|NCT01998958|62976198|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579150|NCT01998958|62976199|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579151|NCT01998958|62976200|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579152|NCT01998958|62976201|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579153|NCT01998958|62976202|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579154|NCT01998958|62976203|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579155|NCT01998958|62976204|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579156|NCT01998958|62976205|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579157|NCT01998958|62976206|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
33669584|NCT01466179|63103405|FG000|Overall Study|Lack of Efficacy|14|||
33308419|NCT03428997|62683681|FG000|Overall Study|Lost to Follow-up|4|||
33308420|NCT03118674|62683714|FG000|Overall Study|Lost to Follow-up|2|||
33308421|NCT03118674|62683714|FG000|Overall Study|Screen Faliure|8|||
33308422|NCT03118674|62683714|FG000|Overall Study|Withdrawal by Subject|5|||
33308423|NCT03069352|62683720|FG000|Overall Study|Ongoing|12|||
33308424|NCT03069352|62683721|FG001|Overall Study|Ongoing|40|||
33308425|NCT02993523|62683732|FG000|Overall Study|Withdrew Consent|0|||
33308426|NCT02993523|62683733|FG001|Overall Study|Withdrew Consent|0|||
33399921|NCT00510952|62779225|FG001|Overall Study|Protocol Violation|4|||
33399922|NCT00510952|62779224|FG000|Overall Study|Sponsor Decision|1|||
33399923|NCT00510952|62779225|FG001|Overall Study|Sponsor Decision|0|||
33399924|NCT00510952|62779224|FG000|Overall Study|Withdrawal by Subject|6|||
33399925|NCT00510952|62779225|FG001|Overall Study|Withdrawal by Subject|7|||
33579158|NCT01998958|62976207|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579159|NCT01998958|62976208|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579160|NCT01998958|62976209|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579161|NCT01998958|62976210|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579162|NCT01998958|62976211|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
33579163|NCT01998958|62976212|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
33579164|NCT01998958|62976213|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579165|NCT01998958|62976214|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579166|NCT01998958|62976215|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579167|NCT01998958|62976216|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579168|NCT01998958|62976217|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579169|NCT01998958|62976218|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579170|NCT01998958|62976219|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579171|NCT01998958|62976220|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579172|NCT01998958|62976221|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
33579173|NCT01998958|62976190|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579174|NCT01998958|62976191|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579175|NCT01998958|62976192|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579176|NCT01998958|62976193|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579177|NCT01998958|62976194|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579178|NCT01998958|62976195|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579179|NCT01998958|62976196|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579180|NCT01998958|62976197|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579181|NCT01998958|62976198|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579182|NCT01998958|62976199|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579183|NCT01998958|62976200|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579184|NCT01998958|62976201|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579185|NCT01998958|62976202|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579186|NCT01998958|62976203|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579187|NCT01998958|62976204|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579188|NCT01998958|62976205|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579189|NCT01998958|62976206|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579190|NCT01998958|62976207|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579191|NCT01998958|62976208|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579192|NCT01998958|62976209|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579193|NCT01998958|62976210|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579194|NCT01998958|62976211|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
33579195|NCT01998958|62976212|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
33579196|NCT01998958|62976213|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
33579197|NCT01998958|62976214|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579198|NCT01998958|62976215|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579199|NCT01998958|62976216|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579200|NCT01998958|62976217|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579201|NCT01998958|62976218|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579202|NCT01998958|62976219|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579203|NCT01998958|62976220|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579204|NCT01998958|62976221|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33579205|NCT01958164|62976273|FG000|Overall Study|Adverse Event|0|||
33579206|NCT01958164|62976274|FG001|Overall Study|Adverse Event|2|||
33579207|NCT01958164|62976273|FG000|Overall Study|Lost to Follow-up|2|||
33579208|NCT01958164|62976274|FG001|Overall Study|Lost to Follow-up|3|||
33579209|NCT01976104|62976284|FG000|Overall Study|Adverse Event|0|||
33579210|NCT01976104|62976285|FG001|Overall Study|Adverse Event|0|||
33579211|NCT01976104|62976286|FG002|Overall Study|Adverse Event|1|||
33579212|NCT01976104|62976287|FG003|Overall Study|Adverse Event|0|||
33579213|NCT01976104|62976284|FG000|Overall Study|Lost to Follow-up|3|||
33579214|NCT01976104|62976285|FG001|Overall Study|Lost to Follow-up|0|||
33579215|NCT01976104|62976286|FG002|Overall Study|Lost to Follow-up|1|||
33579216|NCT01976104|62976287|FG003|Overall Study|Lost to Follow-up|1|||
33579217|NCT01976104|62976284|FG000|Overall Study|Subject Choice|0|||
33579218|NCT01976104|62976285|FG001|Overall Study|Subject Choice|1|||
33579219|NCT01976104|62976286|FG002|Overall Study|Subject Choice|0|||
33579220|NCT01976104|62976287|FG003|Overall Study|Subject Choice|1|||
33579221|NCT01976104|62976284|FG000|Overall Study|Withdrawal by Subject|3|||
33579222|NCT01976104|62976285|FG001|Overall Study|Withdrawal by Subject|0|||
33579223|NCT01976104|62976286|FG002|Overall Study|Withdrawal by Subject|0|||
33579224|NCT01976104|62976287|FG003|Overall Study|Withdrawal by Subject|1|||
33579225|NCT01976104|62976284|FG000|Overall Study|Other|0|||
33579226|NCT01976104|62976285|FG001|Overall Study|Other|1|||
33579227|NCT01976104|62976286|FG002|Overall Study|Other|0|||
33579228|NCT01976104|62976287|FG003|Overall Study|Other|0|||
33579229|NCT01372501|62976298|FG000|Overall Study|Adverse Event|4|||
33579230|NCT01372501|62976298|FG000|Overall Study|Device migration|1|||
33579231|NCT01958008|62976307|FG000|Overall Study|Worsening of disease under study|0|||
33579232|NCT01958008|62976308|FG001|Overall Study|Worsening of disease under study|0|||
33579233|NCT01958008|62976309|FG002|Overall Study|Worsening of disease under study|1|||
33579234|NCT01958008|62976310|FG003|Overall Study|Worsening of disease under study|0|||
33579235|NCT01958008|62976307|FG000|Overall Study|Other adverse event|1|||
33579236|NCT01958008|62976308|FG001|Overall Study|Other adverse event|0|||
33579237|NCT01958008|62976309|FG002|Overall Study|Other adverse event|0|||
33579238|NCT01958008|62976310|FG003|Overall Study|Other adverse event|0|||
33579239|NCT01998880|62976338|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
33579240|NCT01998880|62976339|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
33579241|NCT01998880|62976338|FG000|Overall Study|Disease Progression|1|||
33579242|NCT01998880|62976339|FG001|Overall Study|Disease Progression|8|||
33579243|NCT01998880|62976338|FG000|Overall Study|Withdrew Consent|2|||
33579244|NCT01998880|62976339|FG001|Overall Study|Withdrew Consent|1|||
33579245|NCT01998880|62976338|FG000|Overall Study|Death|3|||
33579246|NCT01998880|62976339|FG001|Overall Study|Death|6|||
33579247|NCT01998880|62976338|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33579248|NCT01998880|62976339|FG001|Overall Study|Insufficient Therapeutic Response|5|||
33579249|NCT01998880|62976338|FG000|Overall Study|Administrative/Other|1|||
33579250|NCT01998880|62976339|FG001|Overall Study|Administrative/Other|1|||
33579251|NCT01998880|62976338|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
33579252|NCT01998880|62976339|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
33579253|NCT01998880|62976338|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
33579254|NCT01998880|62976339|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
33579255|NCT01998880|62976338|FG000|Overall Study|Did Not Receive Treatment|3|||
33579256|NCT01998880|62976339|FG001|Overall Study|Did Not Receive Treatment|2|||
33579257|NCT01975948|62976349|FG000|Overall Study|Withdrawal by Subject|17|||
33579258|NCT01975948|62976350|FG001|Overall Study|Withdrawal by Subject|21|||
33579259|NCT01975948|62976351|FG002|Overall Study|Withdrawal by Subject|7|||
33579260|NCT01975948|62976352|FG003|Overall Study|Withdrawal by Subject|6|||
33579261|NCT01975246|62976364|FG000|Overall Study|Adverse Event|2|||
33579262|NCT01975246|62976365|FG001|Overall Study|Adverse Event|1|||
33579263|NCT01975246|62976364|FG000|Overall Study|Lack of Efficacy|1|||
33579264|NCT01975246|62976365|FG001|Overall Study|Lack of Efficacy|0|||
33579265|NCT01975246|62976364|FG000|Overall Study|Protocol Violation|1|||
33579266|NCT01975246|62976365|FG001|Overall Study|Protocol Violation|0|||
33579267|NCT01975246|62976364|FG000|Overall Study|Other than stated|0|||
33579268|NCT01975246|62976365|FG001|Overall Study|Other than stated|1|||
33579269|NCT01621126|62976371|FG000|Overall Study|Physician Decision|6|||
33579270|NCT01973998|62976377|FG000|Overall Study|Death|2|||
33579271|NCT01973998|62976378|FG001|Overall Study|Death|2|||
33579272|NCT02664415|62976386|FG000|Overall Study|Adverse Event|1|||
33579273|NCT02664415|62976387|FG001|Overall Study|Adverse Event|0|||
33579274|NCT02661061|62976395|FG000|Overall Study|Lack of Efficacy|1|||
33579275|NCT02661061|62976396|FG001|Overall Study|Lack of Efficacy|1|||
33579276|NCT02661061|62976395|FG000|Overall Study|Withdrawal by Subject|1|||
33579277|NCT02661061|62976396|FG001|Overall Study|Withdrawal by Subject|1|||
33579278|NCT01995838|62976409|FG000|Overall Study|Lost to Follow-up|0|||
33579279|NCT01995838|62976410|FG001|Overall Study|Lost to Follow-up|1|||
33579280|NCT01995838|62976411|FG002|Overall Study|Lost to Follow-up|0|||
33579281|NCT01995838|62976412|FG003|Overall Study|Lost to Follow-up|0|||
33579282|NCT01995838|62976413|FG004|Overall Study|Lost to Follow-up|0|||
33579283|NCT01995838|62976414|FG005|Overall Study|Lost to Follow-up|0|||
33579284|NCT01995838|62976415|FG006|Overall Study|Lost to Follow-up|1|||
33579285|NCT01995838|62976409|FG000|Overall Study|Participant choice|2|||
33579286|NCT01995838|62976410|FG001|Overall Study|Participant choice|0|||
33579287|NCT01995838|62976411|FG002|Overall Study|Participant choice|0|||
33579288|NCT01995838|62976412|FG003|Overall Study|Participant choice|0|||
33579289|NCT01995838|62976413|FG004|Overall Study|Participant choice|0|||
33579290|NCT01995838|62976414|FG005|Overall Study|Participant choice|1|||
33579291|NCT01995838|62976415|FG006|Overall Study|Participant choice|1|||
33579292|NCT01995838|62976409|FG000|Overall Study|Adverse Event|0|||
33579293|NCT01995838|62976410|FG001|Overall Study|Adverse Event|0|||
33579294|NCT01995838|62976411|FG002|Overall Study|Adverse Event|0|||
33579295|NCT01995838|62976412|FG003|Overall Study|Adverse Event|0|||
33579296|NCT01995838|62976413|FG004|Overall Study|Adverse Event|0|||
33579297|NCT01995838|62976414|FG005|Overall Study|Adverse Event|0|||
33579298|NCT01995838|62976415|FG006|Overall Study|Adverse Event|1|||
33579299|NCT01995838|62976409|FG000|Overall Study|Withdrawal by Subject|0|||
33579300|NCT01995838|62976410|FG001|Overall Study|Withdrawal by Subject|0|||
33579301|NCT01995838|62976411|FG002|Overall Study|Withdrawal by Subject|0|||
33579302|NCT01995838|62976412|FG003|Overall Study|Withdrawal by Subject|0|||
33579303|NCT01995838|62976413|FG004|Overall Study|Withdrawal by Subject|1|||
33579304|NCT01995838|62976414|FG005|Overall Study|Withdrawal by Subject|0|||
33579305|NCT01995838|62976415|FG006|Overall Study|Withdrawal by Subject|0|||
33579306|NCT01995838|62976409|FG000|Overall Study|Other|3|||
33579307|NCT01995838|62976410|FG001|Overall Study|Other|1|||
33579308|NCT01995838|62976411|FG002|Overall Study|Other|0|||
33579309|NCT01995838|62976412|FG003|Overall Study|Other|2|||
33579310|NCT01995838|62976413|FG004|Overall Study|Other|1|||
33579311|NCT01995838|62976414|FG005|Overall Study|Other|1|||
33579312|NCT01995838|62976415|FG006|Overall Study|Other|2|||
33579313|NCT01957462|62976436|FG000|Test Period 1|Withdrawal by Subject|1|||
33579314|NCT01957462|62976437|FG001|Test Period 1|Withdrawal by Subject|0|||
33579315|NCT01957462|62976436|FG000|Test Period 1|Adverse Event|1|||
33579316|NCT01957462|62976437|FG001|Test Period 1|Adverse Event|0|||
33579317|NCT01957150|62976445|FG000|Overall Study|Adverse Event|23|||
33579318|NCT01957150|62976446|FG001|Overall Study|Adverse Event|20|||
33579319|NCT01957150|62976445|FG000|Overall Study|Withdrawal by Subject|13|||
33579320|NCT01957150|62976446|FG001|Overall Study|Withdrawal by Subject|17|||
33579321|NCT01957150|62976445|FG000|Overall Study|Physician Decision|3|||
33579322|NCT01957150|62976446|FG001|Overall Study|Physician Decision|6|||
33579323|NCT01957150|62976445|FG000|Overall Study|Lost to Follow-up|4|||
33579324|NCT01957150|62976446|FG001|Overall Study|Lost to Follow-up|4|||
33579325|NCT01957150|62976445|FG000|Overall Study|Protocol Violation|1|||
33579326|NCT01957150|62976446|FG001|Overall Study|Protocol Violation|0|||
33579327|NCT01957150|62976445|FG000|Overall Study|Lack of Efficacy|11|||
33579328|NCT01957150|62976446|FG001|Overall Study|Lack of Efficacy|11|||
33579329|NCT01955122|62976454|FG000|Overall Study|Physician Decision|5|||
33579330|NCT01955122|62976455|FG001|Overall Study|Physician Decision|5|||
33579331|NCT01995526|62976467|FG000|Overall Study|Physician Decision|1|||
33579332|NCT01955044|62976474|FG000|Overall Study|Death|1|||
33579333|NCT01955044|62976475|FG001|Overall Study|Death|1|||
33579334|NCT01955044|62976476|FG002|Overall Study|Death|0|||
33579335|NCT01973218|62976486|FG000|Overall Study|Adverse Event|1|||
33579336|NCT01973218|62976487|FG001|Overall Study|Adverse Event|0|||
33579337|NCT01973218|62976486|FG000|Overall Study|Withdrawal by Subject|1|||
33579338|NCT01973218|62976487|FG001|Overall Study|Withdrawal by Subject|0|||
33579339|NCT01954342|62976499|FG000|Overall Study|Missing data from 13-16week study visit|0|||
33579340|NCT01954342|62976500|FG001|Overall Study|Missing data from 13-16week study visit|0|||
33579341|NCT01954342|62976501|FG002|Overall Study|Missing data from 13-16week study visit|0|||
33579342|NCT01954342|62976502|FG003|Overall Study|Missing data from 13-16week study visit|1|||
33579343|NCT01954342|62976499|FG000|Overall Study|Miscarriage|0|||
33579344|NCT01954342|62976500|FG001|Overall Study|Miscarriage|0|||
33579345|NCT01954342|62976501|FG002|Overall Study|Miscarriage|0|||
33579346|NCT01954342|62976502|FG003|Overall Study|Miscarriage|3|||
33579347|NCT01954342|62976499|FG000|Overall Study|Lost to Follow-up|0|||
33579348|NCT01954342|62976500|FG001|Overall Study|Lost to Follow-up|0|||
33579349|NCT01954342|62976501|FG002|Overall Study|Lost to Follow-up|0|||
33579350|NCT01954342|62976502|FG003|Overall Study|Lost to Follow-up|5|||
33579351|NCT01954342|62976499|FG000|Overall Study|Preterm delivery|0|||
33579352|NCT01954342|62976500|FG001|Overall Study|Preterm delivery|0|||
33579353|NCT01954342|62976501|FG002|Overall Study|Preterm delivery|0|||
33579354|NCT01954342|62976502|FG003|Overall Study|Preterm delivery|3|||
33579355|NCT01954342|62976499|FG000|Overall Study|Pre-eclampsia|0|||
33579356|NCT01954342|62976500|FG001|Overall Study|Pre-eclampsia|0|||
33579357|NCT01954342|62976501|FG002|Overall Study|Pre-eclampsia|0|||
33579358|NCT01954342|62976502|FG003|Overall Study|Pre-eclampsia|4|||
33579359|NCT01954342|62976499|FG000|Overall Study|Unreliable Data|0|||
33579360|NCT01954342|62976500|FG001|Overall Study|Unreliable Data|0|||
33579361|NCT01954342|62976501|FG002|Overall Study|Unreliable Data|0|||
33579362|NCT01954342|62976502|FG003|Overall Study|Unreliable Data|2|||
33579363|NCT01972438|62976514|FG000|Baseline-Month 3 Crossover Period|Death|1|||
33579364|NCT01972438|62976515|FG001|Baseline-Month 3 Crossover Period|Death|0|||
33579365|NCT01972438|62976514|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
33579366|NCT01972438|62976515|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
33579367|NCT01972438|62976514|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
33579368|NCT01972438|62976515|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
33579369|NCT01972438|62976514|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
33579370|NCT01972438|62976515|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
33579371|NCT01972438|62976514|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
33579372|NCT01972438|62976515|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
33579373|NCT01972438|62976514|FG000|Months 6-12 Study Period|Death|1|||
33579374|NCT01972438|62976515|FG001|Months 6-12 Study Period|Death|0|||
33579375|NCT01972438|62976514|FG000|Months 6-12 Study Period|Early Study Closure|2|||
33579376|NCT01972438|62976515|FG001|Months 6-12 Study Period|Early Study Closure|2|||
33579377|NCT01972438|62976514|FG000|Post Month 12 Study Period|Early Study Closure|3|||
33579378|NCT01972438|62976515|FG001|Post Month 12 Study Period|Early Study Closure|4|||
33579379|NCT01946152|62976527|FG000|Overall Study|Adverse Event|1|||
33579380|NCT01946152|62976528|FG001|Overall Study|Adverse Event|0|||
33579381|NCT01946152|62976529|FG002|Overall Study|Adverse Event|0|||
33579382|NCT01946152|62976530|FG003|Overall Study|Adverse Event|0|||
33579383|NCT01946152|62976527|FG000|Overall Study|Withdrawal by Subject|0|||
33579384|NCT01946152|62976528|FG001|Overall Study|Withdrawal by Subject|2|||
33579385|NCT01946152|62976529|FG002|Overall Study|Withdrawal by Subject|0|||
33579386|NCT01946152|62976530|FG003|Overall Study|Withdrawal by Subject|0|||
33579387|NCT01946152|62976527|FG000|Overall Study|Progression|0|||
33579388|NCT01946152|62976528|FG001|Overall Study|Progression|1|||
33579389|NCT01946152|62976529|FG002|Overall Study|Progression|4|||
33579390|NCT01946152|62976530|FG003|Overall Study|Progression|7|||
33579391|NCT01946152|62976527|FG000|Overall Study|Physician Decision|0|||
33579392|NCT01946152|62976528|FG001|Overall Study|Physician Decision|0|||
33579393|NCT01946152|62976529|FG002|Overall Study|Physician Decision|1|||
33579394|NCT01946152|62976530|FG003|Overall Study|Physician Decision|0|||
33579395|NCT01946152|62976527|FG000|Overall Study|Second malignancy|0|||
33579396|NCT01946152|62976528|FG001|Overall Study|Second malignancy|0|||
33579397|NCT01946152|62976529|FG002|Overall Study|Second malignancy|1|||
33579398|NCT01946152|62976530|FG003|Overall Study|Second malignancy|0|||
33579399|NCT01946152|62976527|FG000|Overall Study|Adverse Event|0|||
33579400|NCT01946152|62976528|FG001|Overall Study|Adverse Event|0|||
33579401|NCT01946152|62976529|FG002|Overall Study|Adverse Event|0|||
33579402|NCT01946152|62976530|FG003|Overall Study|Adverse Event|1|||
33579403|NCT01945996|62976544|FG000|Overall Study|Lost to Follow-up|3|||
33579404|NCT01945996|62976545|FG001|Overall Study|Lost to Follow-up|5|||
33579405|NCT01971346|62976553|FG000|Overall Study|Protocol Violation|3|||
33579406|NCT01971346|62976553|FG000|Overall Study|Lost to Follow-up|2|||
33579407|NCT01971346|62976553|FG000|Overall Study|Withdrawal by Subject|2|||
33579408|NCT01971346|62976553|FG000|Overall Study|Physician Decision|1|||
33579409|NCT01945216|62976568|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
33579410|NCT01945216|62976568|FG000|Overall Study|Protocol Violation|42|||
33579411|NCT01945216|62976568|FG000|Overall Study|CRF not assured by investigators|5|||
33579412|NCT02641379|62976587|FG000|Overall Study|Exclusion criterion during screening|1|||
33579413|NCT02641379|62976588|FG001|Overall Study|Exclusion criterion during screening|0|||
33579414|NCT02641379|62976589|FG002|Overall Study|Exclusion criterion during screening|0|||
33579415|NCT02641379|62976590|FG003|Overall Study|Exclusion criterion during screening|1|||
33579416|NCT02641379|62976591|FG004|Overall Study|Exclusion criterion during screening|2|||
33579417|NCT02641379|62976592|FG005|Overall Study|Exclusion criterion during screening|0|||
33579418|NCT02641379|62976593|FG006|Overall Study|Exclusion criterion during screening|0|||
33579419|NCT02641379|62976594|FG007|Overall Study|Exclusion criterion during screening|0|||
33579420|NCT02641379|62976595|FG008|Overall Study|Exclusion criterion during screening|0|||
33579421|NCT02641379|62976596|FG009|Overall Study|Exclusion criterion during screening|0|||
33579422|NCT02641379|62976597|FG010|Overall Study|Exclusion criterion during screening|0|||
33579423|NCT02641379|62976587|FG000|Overall Study|Withdrawal of informed consent|0|||
33579424|NCT02641379|62976588|FG001|Overall Study|Withdrawal of informed consent|1|||
33579425|NCT02641379|62976589|FG002|Overall Study|Withdrawal of informed consent|0|||
33579426|NCT02641379|62976590|FG003|Overall Study|Withdrawal of informed consent|0|||
33669585|NCT01466179|63103405|FG000|Overall Study|Death|7|||
33669586|NCT01466179|63103405|FG000|Overall Study|Withdrawal by Subject|7|||
33669587|NCT01466179|63103405|FG000|Overall Study|Protocol Violation|2|||
33669588|NCT01466179|63103405|FG000|Overall Study|Other|3|||
33669589|NCT01493089|63103414|FG000|Overall Study|Protocol Violation|2|||
33669590|NCT01493089|63103415|FG001|Overall Study|Protocol Violation|2|||
33669591|NCT01493089|63103414|FG000|Overall Study|Withdrawal by Subject|1|||
33669592|NCT01493089|63103415|FG001|Overall Study|Withdrawal by Subject|0|||
33669593|NCT01493089|63103414|FG000|Overall Study|Physician Decision|0|||
33579427|NCT02641379|62976591|FG004|Overall Study|Withdrawal of informed consent|0|||
33579428|NCT02641379|62976592|FG005|Overall Study|Withdrawal of informed consent|0|||
33579429|NCT02641379|62976593|FG006|Overall Study|Withdrawal of informed consent|0|||
33579430|NCT02641379|62976594|FG007|Overall Study|Withdrawal of informed consent|1|||
33579431|NCT02641379|62976595|FG008|Overall Study|Withdrawal of informed consent|0|||
33579432|NCT02641379|62976596|FG009|Overall Study|Withdrawal of informed consent|0|||
33579433|NCT02641379|62976597|FG010|Overall Study|Withdrawal of informed consent|0|||
33579434|NCT02641379|62976587|FG000|Overall Study|Adverse Event|7|||
33579435|NCT02641379|62976588|FG001|Overall Study|Adverse Event|8|||
33579436|NCT02641379|62976589|FG002|Overall Study|Adverse Event|2|||
33579437|NCT02641379|62976590|FG003|Overall Study|Adverse Event|2|||
33579438|NCT02641379|62976591|FG004|Overall Study|Adverse Event|5|||
33579439|NCT02641379|62976592|FG005|Overall Study|Adverse Event|1|||
33579440|NCT02641379|62976593|FG006|Overall Study|Adverse Event|5|||
33579441|NCT02641379|62976594|FG007|Overall Study|Adverse Event|0|||
33579442|NCT02641379|62976595|FG008|Overall Study|Adverse Event|1|||
33579443|NCT02641379|62976596|FG009|Overall Study|Adverse Event|1|||
33579444|NCT02641379|62976597|FG010|Overall Study|Adverse Event|5|||
33579445|NCT02641379|62976587|FG000|Overall Study|Lack of Efficacy|0|||
33579446|NCT02641379|62976588|FG001|Overall Study|Lack of Efficacy|0|||
33579447|NCT02641379|62976589|FG002|Overall Study|Lack of Efficacy|2|||
33579448|NCT02641379|62976590|FG003|Overall Study|Lack of Efficacy|0|||
33579449|NCT02641379|62976591|FG004|Overall Study|Lack of Efficacy|0|||
33579450|NCT02641379|62976592|FG005|Overall Study|Lack of Efficacy|2|||
33579451|NCT02641379|62976593|FG006|Overall Study|Lack of Efficacy|0|||
33579452|NCT02641379|62976594|FG007|Overall Study|Lack of Efficacy|5|||
33579453|NCT02641379|62976595|FG008|Overall Study|Lack of Efficacy|0|||
33669594|NCT01493089|63103415|FG001|Overall Study|Physician Decision|1|||
33579454|NCT02641379|62976596|FG009|Overall Study|Lack of Efficacy|0|||
33579455|NCT02641379|62976597|FG010|Overall Study|Lack of Efficacy|0|||
33579456|NCT02641379|62976587|FG000|Overall Study|Participant unable to attend study visit|4|||
33579457|NCT02641379|62976588|FG001|Overall Study|Participant unable to attend study visit|10|||
33579458|NCT02641379|62976589|FG002|Overall Study|Participant unable to attend study visit|1|||
33579459|NCT02641379|62976590|FG003|Overall Study|Participant unable to attend study visit|2|||
33579460|NCT02641379|62976591|FG004|Overall Study|Participant unable to attend study visit|5|||
33579461|NCT02641379|62976592|FG005|Overall Study|Participant unable to attend study visit|1|||
33579462|NCT02641379|62976593|FG006|Overall Study|Participant unable to attend study visit|1|||
33579463|NCT02641379|62976594|FG007|Overall Study|Participant unable to attend study visit|1|||
33579464|NCT02641379|62976595|FG008|Overall Study|Participant unable to attend study visit|0|||
33579465|NCT02641379|62976596|FG009|Overall Study|Participant unable to attend study visit|2|||
33579466|NCT02641379|62976597|FG010|Overall Study|Participant unable to attend study visit|0|||
33579467|NCT02641379|62976587|FG000|Overall Study|Participant's compliance|0|||
33579468|NCT02641379|62976588|FG001|Overall Study|Participant's compliance|1|||
33579469|NCT02641379|62976589|FG002|Overall Study|Participant's compliance|0|||
33579470|NCT02641379|62976590|FG003|Overall Study|Participant's compliance|1|||
33579471|NCT02641379|62976591|FG004|Overall Study|Participant's compliance|0|||
33579472|NCT02641379|62976592|FG005|Overall Study|Participant's compliance|2|||
33579473|NCT02641379|62976593|FG006|Overall Study|Participant's compliance|0|||
33579474|NCT02641379|62976594|FG007|Overall Study|Participant's compliance|0|||
33579475|NCT02641379|62976595|FG008|Overall Study|Participant's compliance|1|||
33579476|NCT02641379|62976596|FG009|Overall Study|Participant's compliance|1|||
33579477|NCT02641379|62976597|FG010|Overall Study|Participant's compliance|1|||
33579478|NCT02641379|62976587|FG000|Overall Study|Participant cannot be reached|4|||
33579479|NCT02641379|62976588|FG001|Overall Study|Participant cannot be reached|4|||
33579480|NCT02641379|62976589|FG002|Overall Study|Participant cannot be reached|0|||
33579481|NCT02641379|62976590|FG003|Overall Study|Participant cannot be reached|8|||
33579482|NCT02641379|62976591|FG004|Overall Study|Participant cannot be reached|2|||
33579483|NCT02641379|62976592|FG005|Overall Study|Participant cannot be reached|1|||
33579484|NCT02641379|62976593|FG006|Overall Study|Participant cannot be reached|0|||
33579485|NCT02641379|62976594|FG007|Overall Study|Participant cannot be reached|1|||
33579486|NCT02641379|62976595|FG008|Overall Study|Participant cannot be reached|0|||
33579487|NCT02641379|62976596|FG009|Overall Study|Participant cannot be reached|2|||
33579488|NCT02641379|62976597|FG010|Overall Study|Participant cannot be reached|1|||
33579489|NCT02641379|62976587|FG000|Overall Study|PCR positive at Week 24|15|||
33579490|NCT02641379|62976588|FG001|Overall Study|PCR positive at Week 24|21|||
33579491|NCT02641379|62976589|FG002|Overall Study|PCR positive at Week 24|62|||
33579492|NCT02641379|62976590|FG003|Overall Study|PCR positive at Week 24|0|||
33579493|NCT02641379|62976591|FG004|Overall Study|PCR positive at Week 24|0|||
33579494|NCT02641379|62976592|FG005|Overall Study|PCR positive at Week 24|6|||
33579495|NCT02641379|62976593|FG006|Overall Study|PCR positive at Week 24|3|||
33579496|NCT02641379|62976594|FG007|Overall Study|PCR positive at Week 24|8|||
33579497|NCT02641379|62976595|FG008|Overall Study|PCR positive at Week 24|0|||
33579498|NCT02641379|62976596|FG009|Overall Study|PCR positive at Week 24|1|||
33579499|NCT02641379|62976597|FG010|Overall Study|PCR positive at Week 24|0|||
33579500|NCT02641379|62976587|FG000|Overall Study|PCR positive at follow up 2|1|||
33579501|NCT02641379|62976588|FG001|Overall Study|PCR positive at follow up 2|0|||
33579502|NCT02641379|62976589|FG002|Overall Study|PCR positive at follow up 2|0|||
33579503|NCT02641379|62976590|FG003|Overall Study|PCR positive at follow up 2|0|||
33579504|NCT02641379|62976591|FG004|Overall Study|PCR positive at follow up 2|0|||
33579505|NCT02641379|62976592|FG005|Overall Study|PCR positive at follow up 2|0|||
33579506|NCT02641379|62976593|FG006|Overall Study|PCR positive at follow up 2|0|||
33579507|NCT02641379|62976594|FG007|Overall Study|PCR positive at follow up 2|0|||
33579508|NCT02641379|62976595|FG008|Overall Study|PCR positive at follow up 2|0|||
33579509|NCT02641379|62976596|FG009|Overall Study|PCR positive at follow up 2|0|||
33579510|NCT02641379|62976597|FG010|Overall Study|PCR positive at follow up 2|0|||
33579511|NCT02641379|62976587|FG000|Overall Study|Participant showed relapse|1|||
33579512|NCT02641379|62976588|FG001|Overall Study|Participant showed relapse|0|||
33579513|NCT02641379|62976589|FG002|Overall Study|Participant showed relapse|0|||
33579514|NCT02641379|62976590|FG003|Overall Study|Participant showed relapse|0|||
33579515|NCT02641379|62976591|FG004|Overall Study|Participant showed relapse|0|||
33579516|NCT02641379|62976592|FG005|Overall Study|Participant showed relapse|0|||
33579517|NCT02641379|62976593|FG006|Overall Study|Participant showed relapse|1|||
33579518|NCT02641379|62976594|FG007|Overall Study|Participant showed relapse|0|||
33579519|NCT02641379|62976595|FG008|Overall Study|Participant showed relapse|0|||
33579520|NCT02641379|62976596|FG009|Overall Study|Participant showed relapse|0|||
33579521|NCT02641379|62976597|FG010|Overall Study|Participant showed relapse|0|||
33579522|NCT02641379|62976587|FG000|Overall Study|Participant stopped study/treatment|1|||
33579523|NCT02641379|62976588|FG001|Overall Study|Participant stopped study/treatment|3|||
33579524|NCT02641379|62976589|FG002|Overall Study|Participant stopped study/treatment|1|||
33669595|NCT01450813|63103427|FG000|Overall Study|Physician Decision|1|||
33669596|NCT01450813|63103428|FG001|Overall Study|Physician Decision|1|||
33579525|NCT02641379|62976590|FG003|Overall Study|Participant stopped study/treatment|0|||
33579526|NCT02641379|62976591|FG004|Overall Study|Participant stopped study/treatment|0|||
33579527|NCT02641379|62976592|FG005|Overall Study|Participant stopped study/treatment|1|||
33579528|NCT02641379|62976593|FG006|Overall Study|Participant stopped study/treatment|2|||
33579529|NCT02641379|62976594|FG007|Overall Study|Participant stopped study/treatment|0|||
33579530|NCT02641379|62976595|FG008|Overall Study|Participant stopped study/treatment|1|||
33579531|NCT02641379|62976596|FG009|Overall Study|Participant stopped study/treatment|0|||
33579532|NCT02641379|62976597|FG010|Overall Study|Participant stopped study/treatment|0|||
33579533|NCT02641379|62976587|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
33579534|NCT02641379|62976588|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
33579535|NCT02641379|62976589|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
33579536|NCT02641379|62976590|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
33579537|NCT02641379|62976591|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
33579538|NCT02641379|62976592|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
33579539|NCT02641379|62976593|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
33579540|NCT02641379|62976594|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
33579541|NCT02641379|62976595|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
33579542|NCT02641379|62976596|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
33579543|NCT02641379|62976597|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
33579544|NCT02641379|62976587|FG000|Overall Study|Financial problems|0|||
33579545|NCT02641379|62976588|FG001|Overall Study|Financial problems|1|||
33579546|NCT02641379|62976589|FG002|Overall Study|Financial problems|0|||
33579547|NCT02641379|62976590|FG003|Overall Study|Financial problems|0|||
33579548|NCT02641379|62976591|FG004|Overall Study|Financial problems|0|||
33579549|NCT02641379|62976592|FG005|Overall Study|Financial problems|0|||
33579550|NCT02641379|62976593|FG006|Overall Study|Financial problems|0|||
33579551|NCT02641379|62976594|FG007|Overall Study|Financial problems|0|||
33579552|NCT02641379|62976595|FG008|Overall Study|Financial problems|0|||
33579553|NCT02641379|62976596|FG009|Overall Study|Financial problems|0|||
33579554|NCT02641379|62976597|FG010|Overall Study|Financial problems|0|||
33579555|NCT02641379|62976587|FG000|Overall Study|PCR positive at Week 68|0|||
33579556|NCT02641379|62976588|FG001|Overall Study|PCR positive at Week 68|1|||
33579557|NCT02641379|62976589|FG002|Overall Study|PCR positive at Week 68|0|||
33579558|NCT02641379|62976590|FG003|Overall Study|PCR positive at Week 68|0|||
33579559|NCT02641379|62976591|FG004|Overall Study|PCR positive at Week 68|0|||
33579560|NCT02641379|62976592|FG005|Overall Study|PCR positive at Week 68|0|||
33579561|NCT02641379|62976593|FG006|Overall Study|PCR positive at Week 68|0|||
33579562|NCT02641379|62976594|FG007|Overall Study|PCR positive at Week 68|0|||
33579563|NCT02641379|62976595|FG008|Overall Study|PCR positive at Week 68|0|||
33579564|NCT02641379|62976596|FG009|Overall Study|PCR positive at Week 68|0|||
33579565|NCT02641379|62976597|FG010|Overall Study|PCR positive at Week 68|0|||
33579566|NCT02641379|62976587|FG000|Overall Study|PCR positive at Week 48|0|||
33579567|NCT02641379|62976588|FG001|Overall Study|PCR positive at Week 48|1|||
33579568|NCT02641379|62976589|FG002|Overall Study|PCR positive at Week 48|0|||
33579569|NCT02641379|62976590|FG003|Overall Study|PCR positive at Week 48|0|||
33579570|NCT02641379|62976591|FG004|Overall Study|PCR positive at Week 48|0|||
33579571|NCT02641379|62976592|FG005|Overall Study|PCR positive at Week 48|0|||
33579572|NCT02641379|62976593|FG006|Overall Study|PCR positive at Week 48|0|||
33579573|NCT02641379|62976594|FG007|Overall Study|PCR positive at Week 48|0|||
33579574|NCT02641379|62976595|FG008|Overall Study|PCR positive at Week 48|0|||
33579575|NCT02641379|62976596|FG009|Overall Study|PCR positive at Week 48|0|||
33579576|NCT02641379|62976597|FG010|Overall Study|PCR positive at Week 48|0|||
33579577|NCT02641379|62976587|FG000|Overall Study|PCR not performed at Week 12|0|||
33579578|NCT02641379|62976588|FG001|Overall Study|PCR not performed at Week 12|0|||
33579579|NCT02641379|62976589|FG002|Overall Study|PCR not performed at Week 12|1|||
33579580|NCT02641379|62976590|FG003|Overall Study|PCR not performed at Week 12|0|||
33579581|NCT02641379|62976591|FG004|Overall Study|PCR not performed at Week 12|0|||
33579582|NCT02641379|62976592|FG005|Overall Study|PCR not performed at Week 12|0|||
33579583|NCT02641379|62976593|FG006|Overall Study|PCR not performed at Week 12|0|||
33579584|NCT02641379|62976594|FG007|Overall Study|PCR not performed at Week 12|0|||
33579585|NCT02641379|62976595|FG008|Overall Study|PCR not performed at Week 12|0|||
33579586|NCT02641379|62976596|FG009|Overall Study|PCR not performed at Week 12|0|||
33579587|NCT02641379|62976597|FG010|Overall Study|PCR not performed at Week 12|0|||
33579588|NCT02641379|62976587|FG000|Overall Study|No PCR at baseline|0|||
33579589|NCT02641379|62976588|FG001|Overall Study|No PCR at baseline|0|||
33579590|NCT02641379|62976589|FG002|Overall Study|No PCR at baseline|1|||
33579591|NCT02641379|62976590|FG003|Overall Study|No PCR at baseline|0|||
33579592|NCT02641379|62976591|FG004|Overall Study|No PCR at baseline|0|||
33579593|NCT02641379|62976592|FG005|Overall Study|No PCR at baseline|0|||
33579594|NCT02641379|62976593|FG006|Overall Study|No PCR at baseline|0|||
33579595|NCT02641379|62976594|FG007|Overall Study|No PCR at baseline|0|||
33579596|NCT02641379|62976595|FG008|Overall Study|No PCR at baseline|0|||
33579597|NCT02641379|62976596|FG009|Overall Study|No PCR at baseline|0|||
33579598|NCT02641379|62976597|FG010|Overall Study|No PCR at baseline|0|||
33579599|NCT02641379|62976587|FG000|Overall Study|PCR positive at Week 28|0|||
33579600|NCT02641379|62976588|FG001|Overall Study|PCR positive at Week 28|0|||
33579601|NCT02641379|62976589|FG002|Overall Study|PCR positive at Week 28|1|||
33579602|NCT02641379|62976590|FG003|Overall Study|PCR positive at Week 28|0|||
33579603|NCT02641379|62976591|FG004|Overall Study|PCR positive at Week 28|0|||
33579604|NCT02641379|62976592|FG005|Overall Study|PCR positive at Week 28|0|||
33579605|NCT02641379|62976593|FG006|Overall Study|PCR positive at Week 28|0|||
33579606|NCT02641379|62976594|FG007|Overall Study|PCR positive at Week 28|0|||
33579607|NCT02641379|62976595|FG008|Overall Study|PCR positive at Week 28|0|||
33579608|NCT02641379|62976596|FG009|Overall Study|PCR positive at Week 28|0|||
33579609|NCT02641379|62976597|FG010|Overall Study|PCR positive at Week 28|0|||
33579610|NCT02641379|62976587|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
33579611|NCT02641379|62976588|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
33579612|NCT02641379|62976589|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
33579613|NCT02641379|62976590|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
33579614|NCT02641379|62976591|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
33579615|NCT02641379|62976592|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
33579616|NCT02641379|62976593|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
33579617|NCT02641379|62976594|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
33579618|NCT02641379|62976595|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
33579619|NCT02641379|62976596|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
33579620|NCT02641379|62976597|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
33579621|NCT02641379|62976587|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
33579622|NCT02641379|62976588|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
33579623|NCT02641379|62976589|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
33579624|NCT02641379|62976590|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
33579625|NCT02641379|62976591|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
33579626|NCT02641379|62976592|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
33579627|NCT02641379|62976593|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
33579628|NCT02641379|62976594|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
33579629|NCT02641379|62976595|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
33579630|NCT02641379|62976596|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
33579631|NCT02641379|62976597|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
33579632|NCT02641379|62976587|FG000|Overall Study|Baseline viral load unavailable|0|||
33579633|NCT02641379|62976588|FG001|Overall Study|Baseline viral load unavailable|0|||
33579634|NCT02641379|62976589|FG002|Overall Study|Baseline viral load unavailable|0|||
33579635|NCT02641379|62976590|FG003|Overall Study|Baseline viral load unavailable|1|||
33579636|NCT02641379|62976591|FG004|Overall Study|Baseline viral load unavailable|0|||
33579637|NCT02641379|62976592|FG005|Overall Study|Baseline viral load unavailable|0|||
33579638|NCT02641379|62976593|FG006|Overall Study|Baseline viral load unavailable|0|||
33579639|NCT02641379|62976594|FG007|Overall Study|Baseline viral load unavailable|0|||
33579640|NCT02641379|62976595|FG008|Overall Study|Baseline viral load unavailable|0|||
33579641|NCT02641379|62976596|FG009|Overall Study|Baseline viral load unavailable|0|||
33579642|NCT02641379|62976597|FG010|Overall Study|Baseline viral load unavailable|0|||
33579643|NCT02641379|62976587|FG000|Overall Study|Blood could not be drawn|0|||
33579644|NCT02641379|62976588|FG001|Overall Study|Blood could not be drawn|0|||
33579645|NCT02641379|62976589|FG002|Overall Study|Blood could not be drawn|0|||
33579646|NCT02641379|62976590|FG003|Overall Study|Blood could not be drawn|0|||
33579647|NCT02641379|62976591|FG004|Overall Study|Blood could not be drawn|1|||
33579648|NCT02641379|62976592|FG005|Overall Study|Blood could not be drawn|0|||
33579649|NCT02641379|62976593|FG006|Overall Study|Blood could not be drawn|0|||
33579650|NCT02641379|62976594|FG007|Overall Study|Blood could not be drawn|0|||
33579651|NCT02641379|62976595|FG008|Overall Study|Blood could not be drawn|0|||
33579652|NCT02641379|62976596|FG009|Overall Study|Blood could not be drawn|0|||
33579653|NCT02641379|62976597|FG010|Overall Study|Blood could not be drawn|0|||
33579654|NCT02641379|62976587|FG000|Overall Study|Protocol Violation|0|||
33579655|NCT02641379|62976588|FG001|Overall Study|Protocol Violation|0|||
33579656|NCT02641379|62976589|FG002|Overall Study|Protocol Violation|0|||
33579657|NCT02641379|62976590|FG003|Overall Study|Protocol Violation|0|||
33579658|NCT02641379|62976591|FG004|Overall Study|Protocol Violation|2|||
33579659|NCT02641379|62976592|FG005|Overall Study|Protocol Violation|0|||
33579660|NCT02641379|62976593|FG006|Overall Study|Protocol Violation|0|||
33579661|NCT02641379|62976594|FG007|Overall Study|Protocol Violation|0|||
33579662|NCT02641379|62976595|FG008|Overall Study|Protocol Violation|1|||
33579663|NCT02641379|62976596|FG009|Overall Study|Protocol Violation|0|||
33579664|NCT02641379|62976597|FG010|Overall Study|Protocol Violation|0|||
33579665|NCT02641379|62976587|FG000|Overall Study|Participation in sili rescue study|0|||
33579666|NCT02641379|62976588|FG001|Overall Study|Participation in sili rescue study|0|||
33579667|NCT02641379|62976589|FG002|Overall Study|Participation in sili rescue study|0|||
33579668|NCT02641379|62976590|FG003|Overall Study|Participation in sili rescue study|0|||
33579669|NCT02641379|62976591|FG004|Overall Study|Participation in sili rescue study|0|||
33579670|NCT02641379|62976592|FG005|Overall Study|Participation in sili rescue study|1|||
33579671|NCT02641379|62976593|FG006|Overall Study|Participation in sili rescue study|0|||
33579672|NCT02641379|62976594|FG007|Overall Study|Participation in sili rescue study|0|||
33579673|NCT02641379|62976595|FG008|Overall Study|Participation in sili rescue study|0|||
33579674|NCT02641379|62976596|FG009|Overall Study|Participation in sili rescue study|0|||
33579675|NCT02641379|62976597|FG010|Overall Study|Participation in sili rescue study|0|||
33579676|NCT02641379|62976587|FG000|Overall Study|Lost to Follow-up|0|||
33579677|NCT02641379|62976588|FG001|Overall Study|Lost to Follow-up|0|||
33579678|NCT02641379|62976589|FG002|Overall Study|Lost to Follow-up|0|||
33579679|NCT02641379|62976590|FG003|Overall Study|Lost to Follow-up|0|||
33579680|NCT02641379|62976591|FG004|Overall Study|Lost to Follow-up|0|||
33579681|NCT02641379|62976592|FG005|Overall Study|Lost to Follow-up|0|||
33579682|NCT02641379|62976593|FG006|Overall Study|Lost to Follow-up|0|||
33579683|NCT02641379|62976594|FG007|Overall Study|Lost to Follow-up|0|||
33579684|NCT02641379|62976595|FG008|Overall Study|Lost to Follow-up|1|||
33579685|NCT02641379|62976596|FG009|Overall Study|Lost to Follow-up|0|||
33579686|NCT02641379|62976597|FG010|Overall Study|Lost to Follow-up|0|||
33579687|NCT02641379|62976587|FG000|Overall Study|Source data not found|0|||
33579688|NCT02641379|62976588|FG001|Overall Study|Source data not found|0|||
33579689|NCT02641379|62976589|FG002|Overall Study|Source data not found|0|||
33579690|NCT02641379|62976590|FG003|Overall Study|Source data not found|0|||
33579691|NCT02641379|62976591|FG004|Overall Study|Source data not found|0|||
33579692|NCT02641379|62976592|FG005|Overall Study|Source data not found|1|||
33579693|NCT02641379|62976593|FG006|Overall Study|Source data not found|0|||
33579694|NCT02641379|62976594|FG007|Overall Study|Source data not found|0|||
33579695|NCT02641379|62976595|FG008|Overall Study|Source data not found|0|||
33579696|NCT02641379|62976596|FG009|Overall Study|Source data not found|0|||
33579697|NCT02641379|62976597|FG010|Overall Study|Source data not found|0|||
33579698|NCT02641379|62976587|FG000|Overall Study|Participant showed weight reduction|0|||
33579699|NCT02641379|62976588|FG001|Overall Study|Participant showed weight reduction|0|||
33579700|NCT02641379|62976589|FG002|Overall Study|Participant showed weight reduction|0|||
33579701|NCT02641379|62976590|FG003|Overall Study|Participant showed weight reduction|0|||
33579702|NCT02641379|62976591|FG004|Overall Study|Participant showed weight reduction|0|||
33579703|NCT02641379|62976592|FG005|Overall Study|Participant showed weight reduction|0|||
33579704|NCT02641379|62976593|FG006|Overall Study|Participant showed weight reduction|0|||
33579705|NCT02641379|62976594|FG007|Overall Study|Participant showed weight reduction|1|||
33579706|NCT02641379|62976595|FG008|Overall Study|Participant showed weight reduction|0|||
33579707|NCT02641379|62976596|FG009|Overall Study|Participant showed weight reduction|0|||
33579708|NCT02641379|62976597|FG010|Overall Study|Participant showed weight reduction|0|||
33579709|NCT02641379|62976587|FG000|Overall Study|Non-response Week 12|0|||
33579710|NCT02641379|62976588|FG001|Overall Study|Non-response Week 12|0|||
33579711|NCT02641379|62976589|FG002|Overall Study|Non-response Week 12|0|||
33579712|NCT02641379|62976590|FG003|Overall Study|Non-response Week 12|0|||
33579713|NCT02641379|62976591|FG004|Overall Study|Non-response Week 12|0|||
33579714|NCT02641379|62976592|FG005|Overall Study|Non-response Week 12|0|||
33579715|NCT02641379|62976593|FG006|Overall Study|Non-response Week 12|0|||
33579716|NCT02641379|62976594|FG007|Overall Study|Non-response Week 12|1|||
33579717|NCT02641379|62976595|FG008|Overall Study|Non-response Week 12|0|||
33579718|NCT02641379|62976596|FG009|Overall Study|Non-response Week 12|0|||
33579719|NCT02641379|62976597|FG010|Overall Study|Non-response Week 12|0|||
33579720|NCT02641379|62976587|FG000|Overall Study|No 2 Log drop at Week 12|0|||
33579721|NCT02641379|62976588|FG001|Overall Study|No 2 Log drop at Week 12|0|||
33579722|NCT02641379|62976589|FG002|Overall Study|No 2 Log drop at Week 12|0|||
33579723|NCT02641379|62976590|FG003|Overall Study|No 2 Log drop at Week 12|0|||
33579724|NCT02641379|62976591|FG004|Overall Study|No 2 Log drop at Week 12|0|||
33579725|NCT02641379|62976592|FG005|Overall Study|No 2 Log drop at Week 12|0|||
33579726|NCT02641379|62976593|FG006|Overall Study|No 2 Log drop at Week 12|0|||
33579727|NCT02641379|62976594|FG007|Overall Study|No 2 Log drop at Week 12|0|||
33579728|NCT02641379|62976595|FG008|Overall Study|No 2 Log drop at Week 12|0|||
33579729|NCT02641379|62976596|FG009|Overall Study|No 2 Log drop at Week 12|0|||
33579730|NCT02641379|62976597|FG010|Overall Study|No 2 Log drop at Week 12|1|||
33579731|NCT02641379|62976587|FG000|Overall Study|Negative PCR result|0|||
33579732|NCT02641379|62976588|FG001|Overall Study|Negative PCR result|0|||
33579733|NCT02641379|62976589|FG002|Overall Study|Negative PCR result|0|||
33579734|NCT02641379|62976590|FG003|Overall Study|Negative PCR result|0|||
33579735|NCT02641379|62976591|FG004|Overall Study|Negative PCR result|0|||
33579736|NCT02641379|62976592|FG005|Overall Study|Negative PCR result|0|||
33308427|NCT02993523|62683734|FG002|Overall Study|Withdrew Consent|2|||
33579737|NCT02641379|62976593|FG006|Overall Study|Negative PCR result|0|||
33579738|NCT02641379|62976594|FG007|Overall Study|Negative PCR result|0|||
33579739|NCT02641379|62976595|FG008|Overall Study|Negative PCR result|0|||
33579740|NCT02641379|62976596|FG009|Overall Study|Negative PCR result|1|||
33579741|NCT02641379|62976597|FG010|Overall Study|Negative PCR result|0|||
33579742|NCT02641379|62976587|FG000|Overall Study|Participant's PCR high|0|||
33579743|NCT02641379|62976588|FG001|Overall Study|Participant's PCR high|0|||
33579744|NCT02641379|62976589|FG002|Overall Study|Participant's PCR high|0|||
33579745|NCT02641379|62976590|FG003|Overall Study|Participant's PCR high|0|||
33579746|NCT02641379|62976591|FG004|Overall Study|Participant's PCR high|0|||
33579747|NCT02641379|62976592|FG005|Overall Study|Participant's PCR high|0|||
33579748|NCT02641379|62976593|FG006|Overall Study|Participant's PCR high|0|||
33579749|NCT02641379|62976594|FG007|Overall Study|Participant's PCR high|1|||
33579750|NCT02641379|62976595|FG008|Overall Study|Participant's PCR high|0|||
33579751|NCT02641379|62976596|FG009|Overall Study|Participant's PCR high|0|||
33579752|NCT02641379|62976597|FG010|Overall Study|Participant's PCR high|0|||
33579753|NCT02641379|62976587|FG000|Overall Study|Participant treated after Week 24|0|||
33579754|NCT02641379|62976588|FG001|Overall Study|Participant treated after Week 24|0|||
33579755|NCT02641379|62976589|FG002|Overall Study|Participant treated after Week 24|0|||
33579756|NCT02641379|62976590|FG003|Overall Study|Participant treated after Week 24|0|||
33579757|NCT02641379|62976591|FG004|Overall Study|Participant treated after Week 24|0|||
33579758|NCT02641379|62976592|FG005|Overall Study|Participant treated after Week 24|0|||
33579759|NCT02641379|62976593|FG006|Overall Study|Participant treated after Week 24|0|||
33579760|NCT02641379|62976594|FG007|Overall Study|Participant treated after Week 24|0|||
33579761|NCT02641379|62976595|FG008|Overall Study|Participant treated after Week 24|1|||
33579762|NCT02641379|62976596|FG009|Overall Study|Participant treated after Week 24|0|||
33579763|NCT02641379|62976597|FG010|Overall Study|Participant treated after Week 24|0|||
33579764|NCT02641379|62976587|FG000|Overall Study|Missing PCR result at Week 8|0|||
33579765|NCT02641379|62976588|FG001|Overall Study|Missing PCR result at Week 8|0|||
33579766|NCT02641379|62976589|FG002|Overall Study|Missing PCR result at Week 8|0|||
33579767|NCT02641379|62976590|FG003|Overall Study|Missing PCR result at Week 8|0|||
33579768|NCT02641379|62976591|FG004|Overall Study|Missing PCR result at Week 8|0|||
33579769|NCT02641379|62976592|FG005|Overall Study|Missing PCR result at Week 8|0|||
33579770|NCT02641379|62976593|FG006|Overall Study|Missing PCR result at Week 8|0|||
33579771|NCT02641379|62976594|FG007|Overall Study|Missing PCR result at Week 8|0|||
33579772|NCT02641379|62976595|FG008|Overall Study|Missing PCR result at Week 8|0|||
33579773|NCT02641379|62976596|FG009|Overall Study|Missing PCR result at Week 8|1|||
33579774|NCT02641379|62976597|FG010|Overall Study|Missing PCR result at Week 8|0|||
33579775|NCT02641379|62976587|FG000|Overall Study|PCR positive|0|||
33579776|NCT02641379|62976588|FG001|Overall Study|PCR positive|0|||
33579777|NCT02641379|62976589|FG002|Overall Study|PCR positive|0|||
33579778|NCT02641379|62976590|FG003|Overall Study|PCR positive|0|||
33579779|NCT02641379|62976591|FG004|Overall Study|PCR positive|0|||
33579780|NCT02641379|62976592|FG005|Overall Study|PCR positive|0|||
33579781|NCT02641379|62976593|FG006|Overall Study|PCR positive|1|||
33579782|NCT02641379|62976594|FG007|Overall Study|PCR positive|0|||
33579783|NCT02641379|62976595|FG008|Overall Study|PCR positive|0|||
33579784|NCT02641379|62976596|FG009|Overall Study|PCR positive|0|||
33579785|NCT02641379|62976597|FG010|Overall Study|PCR positive|0|||
33579786|NCT02660983|62976628|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
33579787|NCT02660983|62976629|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
33579788|NCT02660983|62976628|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
33579789|NCT02660983|62976629|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
33579790|NCT02660983|62976628|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
33579791|NCT02660983|62976629|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
33579792|NCT02660983|62976628|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
33579793|NCT02660983|62976629|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
33579794|NCT02660983|62976628|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
33579795|NCT02660983|62976629|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
33579796|NCT02660983|62976628|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
33579797|NCT02660983|62976629|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
33579798|NCT02660983|62976628|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
33579799|NCT02660983|62976629|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
33579800|NCT01953328|62976644|FG000|Overall Study|Withdrawal by Subject|0|||
33579801|NCT01953328|62976645|FG001|Overall Study|Withdrawal by Subject|0|||
33579802|NCT01953328|62976646|FG002|Overall Study|Withdrawal by Subject|0|||
33579803|NCT01953328|62976647|FG003|Overall Study|Withdrawal by Subject|0|||
33579804|NCT01953328|62976648|FG004|Overall Study|Withdrawal by Subject|1|||
33579805|NCT01953328|62976649|FG005|Overall Study|Withdrawal by Subject|0|||
33579806|NCT01953328|62976650|FG006|Overall Study|Withdrawal by Subject|0|||
33579807|NCT01953328|62976651|FG007|Overall Study|Withdrawal by Subject|0|||
33579808|NCT01953328|62976644|FG000|Overall Study|Lost to Follow-up|0|||
33579809|NCT01953328|62976645|FG001|Overall Study|Lost to Follow-up|0|||
33579810|NCT01953328|62976646|FG002|Overall Study|Lost to Follow-up|0|||
33579811|NCT01953328|62976647|FG003|Overall Study|Lost to Follow-up|0|||
33579812|NCT01953328|62976648|FG004|Overall Study|Lost to Follow-up|1|||
33579813|NCT01953328|62976649|FG005|Overall Study|Lost to Follow-up|0|||
33579814|NCT01953328|62976650|FG006|Overall Study|Lost to Follow-up|0|||
33579815|NCT01953328|62976651|FG007|Overall Study|Lost to Follow-up|0|||
33579816|NCT02640755|62976671|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
33579817|NCT02640755|62976672|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
33579818|NCT02640755|62976671|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
33579819|NCT02640755|62976672|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
33579820|NCT02640755|62976671|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
33579821|NCT02640755|62976672|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
33579822|NCT02640677|62976679|FG000|Overall Study|Lost to Follow-up|1|||
33579823|NCT02640677|62976679|FG000|Overall Study|Withdrawal by Subject|1|||
33579824|NCT02643251|62976696|FG000|Overall Study|Adverse Event|3|||
33579825|NCT02643251|62976697|FG001|Overall Study|Adverse Event|1|||
33579826|NCT02643251|62976696|FG000|Overall Study|Withdrawal by Subject|2|||
33579827|NCT02643251|62976697|FG001|Overall Study|Withdrawal by Subject|0|||
33579828|NCT02643251|62976696|FG000|Overall Study|Lost to Follow-up|4|||
33579829|NCT02643251|62976697|FG001|Overall Study|Lost to Follow-up|1|||
33579830|NCT02643251|62976696|FG000|Overall Study|Protocol Violation|1|||
33579831|NCT02643251|62976697|FG001|Overall Study|Protocol Violation|0|||
33579832|NCT02643251|62976696|FG000|Overall Study|PI Decision to terminate patient|1|||
33579833|NCT02643251|62976697|FG001|Overall Study|PI Decision to terminate patient|0|||
33579834|NCT01970878|62976707|FG000|Overall Study|Withdrawal by Subject|11|||
33579835|NCT01970878|62976708|FG001|Overall Study|Withdrawal by Subject|10|||
33579836|NCT01970878|62976709|FG002|Overall Study|Withdrawal by Subject|14|||
33579837|NCT01970878|62976710|FG003|Overall Study|Withdrawal by Subject|7|||
33579838|NCT01970878|62976707|FG000|Overall Study|Lost to Follow-up|1|||
33579839|NCT01970878|62976708|FG001|Overall Study|Lost to Follow-up|3|||
33579840|NCT01970878|62976709|FG002|Overall Study|Lost to Follow-up|2|||
33579841|NCT01970878|62976710|FG003|Overall Study|Lost to Follow-up|4|||
33579842|NCT01970878|62976707|FG000|Overall Study|Administrative Reasons|1|||
33579843|NCT01970878|62976708|FG001|Overall Study|Administrative Reasons|0|||
33579844|NCT01970878|62976709|FG002|Overall Study|Administrative Reasons|0|||
33579845|NCT01970878|62976710|FG003|Overall Study|Administrative Reasons|4|||
33579846|NCT01970878|62976707|FG000|Overall Study|Lack of Efficacy|2|||
33579847|NCT01970878|62976708|FG001|Overall Study|Lack of Efficacy|1|||
33579848|NCT01970878|62976709|FG002|Overall Study|Lack of Efficacy|2|||
33579849|NCT01970878|62976710|FG003|Overall Study|Lack of Efficacy|0|||
33579850|NCT01970878|62976707|FG000|Overall Study|Adverse Event|12|||
33579851|NCT01970878|62976708|FG001|Overall Study|Adverse Event|7|||
33579852|NCT01970878|62976709|FG002|Overall Study|Adverse Event|4|||
33579853|NCT01970878|62976710|FG003|Overall Study|Adverse Event|3|||
33579854|NCT01970878|62976707|FG000|Overall Study|Protocol Specified Criteria|10|||
33579855|NCT01970878|62976708|FG001|Overall Study|Protocol Specified Criteria|4|||
33579856|NCT01970878|62976709|FG002|Overall Study|Protocol Specified Criteria|3|||
33579857|NCT01970878|62976710|FG003|Overall Study|Protocol Specified Criteria|6|||
33579858|NCT01970878|62976707|FG000|Overall Study|Physician Decision|0|||
33579859|NCT01970878|62976708|FG001|Overall Study|Physician Decision|1|||
33579860|NCT01970878|62976709|FG002|Overall Study|Physician Decision|1|||
33579861|NCT01970878|62976710|FG003|Overall Study|Physician Decision|0|||
33579862|NCT01970878|62976707|FG000|Overall Study|No Completion Status|0|||
33579863|NCT01970878|62976708|FG001|Overall Study|No Completion Status|1|||
33579864|NCT01970878|62976709|FG002|Overall Study|No Completion Status|0|||
33579865|NCT01970878|62976710|FG003|Overall Study|No Completion Status|0|||
33579866|NCT01970488|62976722|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
33579867|NCT01970488|62976723|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
33579868|NCT01970488|62976724|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
33579869|NCT01970488|62976725|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
33579870|NCT01970488|62976726|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
33579871|NCT01970488|62976722|FG000|Part 1: Through Week 16|Protocol Violation|1|||
33579872|NCT01970488|62976723|FG001|Part 1: Through Week 16|Protocol Violation|2|||
33579873|NCT01970488|62976724|FG002|Part 1: Through Week 16|Protocol Violation|0|||
33579874|NCT01970488|62976725|FG003|Part 1: Through Week 16|Protocol Violation|0|||
33579875|NCT01970488|62976726|FG004|Part 1: Through Week 16|Protocol Violation|0|||
33579876|NCT01970488|62976722|FG000|Part 1: Through Week 16|Adverse Event|6|||
33579877|NCT01970488|62976723|FG001|Part 1: Through Week 16|Adverse Event|5|||
33579878|NCT01970488|62976724|FG002|Part 1: Through Week 16|Adverse Event|0|||
33579879|NCT01970488|62976725|FG003|Part 1: Through Week 16|Adverse Event|0|||
33579880|NCT01970488|62976726|FG004|Part 1: Through Week 16|Adverse Event|0|||
33579881|NCT01970488|62976722|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
33579882|NCT01970488|62976723|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
33579883|NCT01970488|62976724|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
33579884|NCT01970488|62976725|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
33579885|NCT01970488|62976726|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
33579886|NCT01970488|62976722|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
33579887|NCT01970488|62976723|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
33579888|NCT01970488|62976724|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
33579889|NCT01970488|62976725|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
33579890|NCT01970488|62976726|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
33579891|NCT01970488|62976722|FG000|Part 2: Post Week 16|Physician Decision|0|||
33579892|NCT01970488|62976723|FG001|Part 2: Post Week 16|Physician Decision|0|||
33579893|NCT01970488|62976724|FG002|Part 2: Post Week 16|Physician Decision|0|||
33579894|NCT01970488|62976725|FG003|Part 2: Post Week 16|Physician Decision|0|||
33579895|NCT01970488|62976726|FG004|Part 2: Post Week 16|Physician Decision|1|||
33579896|NCT01970488|62976722|FG000|Part 2: Post Week 16|Non-compliance|0|||
33579897|NCT01970488|62976723|FG001|Part 2: Post Week 16|Non-compliance|0|||
33579898|NCT01970488|62976724|FG002|Part 2: Post Week 16|Non-compliance|1|||
33579899|NCT01970488|62976725|FG003|Part 2: Post Week 16|Non-compliance|0|||
33579900|NCT01970488|62976726|FG004|Part 2: Post Week 16|Non-compliance|0|||
33579901|NCT01970488|62976722|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
33579902|NCT01970488|62976723|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
33579903|NCT01970488|62976724|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
33579904|NCT01970488|62976725|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
33579905|NCT01970488|62976726|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
33579906|NCT01970488|62976722|FG000|Part 2: Post Week 16|Adverse Event|0|||
33579907|NCT01970488|62976723|FG001|Part 2: Post Week 16|Adverse Event|0|||
33579908|NCT01970488|62976724|FG002|Part 2: Post Week 16|Adverse Event|5|||
33579909|NCT01970488|62976725|FG003|Part 2: Post Week 16|Adverse Event|1|||
33579910|NCT01970488|62976726|FG004|Part 2: Post Week 16|Adverse Event|1|||
33579911|NCT01970488|62976722|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
33579912|NCT01970488|62976723|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
33579913|NCT01970488|62976724|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
33579914|NCT01970488|62976725|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
33579915|NCT01970488|62976726|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
33579916|NCT01970488|62976722|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
33579917|NCT01970488|62976723|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
33579918|NCT01970488|62976724|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
33579919|NCT01970488|62976725|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
33579920|NCT01970488|62976726|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
33579921|NCT02661217|62976743|FG000|Overall Study|Physician Decision|12|||
33579922|NCT02661217|62976744|FG001|Overall Study|Physician Decision|15|||
33579923|NCT02661217|62976743|FG000|Overall Study|Lost to Follow-up|1|||
33579924|NCT02661217|62976744|FG001|Overall Study|Lost to Follow-up|4|||
33579925|NCT02661217|62976743|FG000|Overall Study|Protocol Deviation|0|||
33579926|NCT02661217|62976744|FG001|Overall Study|Protocol Deviation|4|||
33579927|NCT02661217|62976743|FG000|Overall Study|Non-compliance with study treatment|5|||
33579928|NCT02661217|62976744|FG001|Overall Study|Non-compliance with study treatment|5|||
33579929|NCT02661217|62976743|FG000|Overall Study|Death|21|||
33579930|NCT02661217|62976744|FG001|Overall Study|Death|15|||
33579931|NCT02661217|62976743|FG000|Overall Study|Adverse Event|10|||
33579932|NCT02661217|62976744|FG001|Overall Study|Adverse Event|8|||
33579933|NCT02661217|62976743|FG000|Overall Study|Withdrawal by Subject|15|||
33579934|NCT02661217|62976744|FG001|Overall Study|Withdrawal by Subject|19|||
33579935|NCT02661217|62976743|FG000|Overall Study|Did not enter follow-up epoch|7|||
33579936|NCT02661217|62976744|FG001|Overall Study|Did not enter follow-up epoch|10|||
33579937|NCT02661217|62976743|FG000|Overall Study|Death - no study drug received|1|||
33579938|NCT02661217|62976744|FG001|Overall Study|Death - no study drug received|2|||
33579939|NCT02661217|62976743|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
33579940|NCT02661217|62976744|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
33579941|NCT01952080|62976755|FG000|Overall Study|Withdrawal by Subject|0|||
33579942|NCT01952080|62976756|FG001|Overall Study|Withdrawal by Subject|0|||
33579943|NCT01952080|62976757|FG002|Overall Study|Withdrawal by Subject|0|||
33579944|NCT01952080|62976758|FG003|Overall Study|Withdrawal by Subject|1|||
33579945|NCT01952080|62976755|FG000|Overall Study|Protocol Non-compliance|0|||
33579946|NCT01952080|62976756|FG001|Overall Study|Protocol Non-compliance|1|||
33579947|NCT01952080|62976757|FG002|Overall Study|Protocol Non-compliance|0|||
33579948|NCT01952080|62976758|FG003|Overall Study|Protocol Non-compliance|0|||
33579949|NCT01951378|62976770|FG000|Overall Study|Study Terminated-Not completed|23|||
33579950|NCT01951378|62976771|FG001|Overall Study|Study Terminated-Not completed|17|||
33579951|NCT01944670|62976777|FG000|Overall Study|Lost to Follow-up|2|||
33579952|NCT01361009|62976781|FG000|Overall Study|Protocol Violation|116|||
33579953|NCT01944046|62976787|FG000|Randomized to DB|Adverse Event|5|||
33579954|NCT01944046|62976788|FG001|Randomized to DB|Adverse Event|2|||
33579955|NCT01944046|62976787|FG000|Randomized to DB|Clinical Worsening|3|||
33579956|NCT01944046|62976788|FG001|Randomized to DB|Clinical Worsening|2|||
33579957|NCT01944046|62976787|FG000|Randomized to DB|Lost to Follow-up|3|||
33579958|NCT01944046|62976788|FG001|Randomized to DB|Lost to Follow-up|3|||
33579959|NCT01944046|62976787|FG000|Randomized to DB|Withdrawal by Subject|2|||
33579960|NCT01944046|62976788|FG001|Randomized to DB|Withdrawal by Subject|4|||
33579961|NCT01944046|62976787|FG000|Randomized to DB|Physician Decision|1|||
33579962|NCT01944046|62976788|FG001|Randomized to DB|Physician Decision|2|||
33579963|NCT01944046|62976787|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
33579964|NCT01944046|62976788|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
33579965|NCT01944046|62976787|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
33579966|NCT01944046|62976788|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
33579967|NCT01944046|62976787|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
33308428|NCT02993523|62683735|FG003|Overall Study|Withdrew Consent|9|||
33579968|NCT01944046|62976788|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
33579969|NCT01944046|62976787|FG000|Open Label Eligible and Consented|Adverse Event|6|||
33579970|NCT01944046|62976788|FG001|Open Label Eligible and Consented|Adverse Event|1|||
33579971|NCT01944046|62976787|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
33579972|NCT01944046|62976788|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
33579973|NCT01944046|62976787|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
33579974|NCT01944046|62976788|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
33579975|NCT01969084|62976800|FG000|Overall Study|Adverse Event|0|||
33579976|NCT01969084|62976801|FG001|Overall Study|Adverse Event|1|||
33579977|NCT01942486|62976811|FG000|Overall Study|Lost to Follow-up|27|||
33579978|NCT01941940|62976815|FG000|Overall Study|Adverse Event|11|||
33579979|NCT01941940|62976815|FG000|Overall Study|Lost to Follow-up|2|||
33579980|NCT01941940|62976815|FG000|Overall Study|Physician Decision|2|||
33579981|NCT01941940|62976815|FG000|Overall Study|Withdrawal by Subject|15|||
33579982|NCT01941940|62976815|FG000|Overall Study|Death|1|||
33579983|NCT01941940|62976815|FG000|Overall Study|Other|1|||
33579984|NCT01941940|62976815|FG000|Overall Study|Other|1|||
33579985|NCT01968694|62976821|FG000|Washout (1 Month)|Lost to Follow-up|0|||
33579986|NCT01968694|62976822|FG001|Washout (1 Month)|Lost to Follow-up|1|||
33579987|NCT01968226|62976830|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
33579988|NCT02640053|62976836|FG000|Overall Study|Withdrawal by Subject|2|||
33579989|NCT02640053|62976837|FG001|Overall Study|Withdrawal by Subject|1|||
33579990|NCT02640053|62976836|FG000|Overall Study|Adverse Event|1|||
33579991|NCT02640053|62976837|FG001|Overall Study|Adverse Event|1|||
33579992|NCT02640053|62976836|FG000|Overall Study|Alternative Therapy|1|||
33579993|NCT02640053|62976837|FG001|Overall Study|Alternative Therapy|1|||
33579994|NCT02640053|62976836|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
33579995|NCT02640053|62976837|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
33579996|NCT01950364|62976845|FG000|Overall Study|Adverse Event|3|||
33579997|NCT01950364|62976846|FG001|Overall Study|Adverse Event|0|||
33579998|NCT01950364|62976845|FG000|Overall Study|Stem Cell Transplant|2|||
33579999|NCT01950364|62976846|FG001|Overall Study|Stem Cell Transplant|6|||
33580000|NCT01950364|62976845|FG000|Overall Study|Disease Progression|5|||
33580001|NCT01950364|62976846|FG001|Overall Study|Disease Progression|2|||
33580002|NCT01950364|62976845|FG000|Overall Study|Withdrawal by Subject|0|||
33580003|NCT01950364|62976846|FG001|Overall Study|Withdrawal by Subject|1|||
33580004|NCT01950364|62976845|FG000|Overall Study|Protocol Violation|0|||
33580005|NCT01950364|62976846|FG001|Overall Study|Protocol Violation|1|||
33580006|NCT01968070|62976870|FG000|Period 1|Withdrawal by Subject|0|||
33580007|NCT01968070|62976871|FG001|Period 1|Withdrawal by Subject|1|||
33580008|NCT01968070|62976872|FG002|Period 1|Withdrawal by Subject|0|||
33580009|NCT01968070|62976873|FG003|Period 1|Withdrawal by Subject|0|||
33580010|NCT01968070|62976874|FG004|Period 1|Withdrawal by Subject|0|||
33580011|NCT01968070|62976875|FG005|Period 1|Withdrawal by Subject|0|||
33580012|NCT01968070|62976876|FG006|Period 1|Withdrawal by Subject|1|||
33580013|NCT01968070|62976877|FG007|Period 1|Withdrawal by Subject|0|||
33580014|NCT01968070|62976878|FG008|Period 1|Withdrawal by Subject|0|||
33580015|NCT01968070|62976879|FG009|Period 1|Withdrawal by Subject|0|||
33580016|NCT01968070|62976880|FG010|Period 1|Withdrawal by Subject|0|||
33580017|NCT01968070|62976881|FG011|Period 1|Withdrawal by Subject|0|||
33580018|NCT01968070|62976882|FG012|Period 1|Withdrawal by Subject|0|||
33580019|NCT01968070|62976883|FG013|Period 1|Withdrawal by Subject|0|||
33580020|NCT01968070|62976884|FG014|Period 1|Withdrawal by Subject|0|||
33580021|NCT01968070|62976885|FG015|Period 1|Withdrawal by Subject|1|||
33580022|NCT01968070|62976886|FG016|Period 1|Withdrawal by Subject|0|||
33580023|NCT01968070|62976887|FG017|Period 1|Withdrawal by Subject|0|||
33580024|NCT01968070|62976870|FG000|Period 1|Protocol Violation|0|||
33580025|NCT01968070|62976871|FG001|Period 1|Protocol Violation|0|||
33580026|NCT01968070|62976872|FG002|Period 1|Protocol Violation|0|||
33580027|NCT01968070|62976873|FG003|Period 1|Protocol Violation|1|||
33580028|NCT01968070|62976874|FG004|Period 1|Protocol Violation|1|||
33580029|NCT01968070|62976875|FG005|Period 1|Protocol Violation|0|||
33580030|NCT01968070|62976876|FG006|Period 1|Protocol Violation|0|||
33580031|NCT01968070|62976877|FG007|Period 1|Protocol Violation|0|||
33580032|NCT01968070|62976878|FG008|Period 1|Protocol Violation|0|||
33580033|NCT01968070|62976879|FG009|Period 1|Protocol Violation|0|||
33580034|NCT01968070|62976880|FG010|Period 1|Protocol Violation|0|||
33580035|NCT01968070|62976881|FG011|Period 1|Protocol Violation|0|||
33580036|NCT01968070|62976882|FG012|Period 1|Protocol Violation|0|||
33580037|NCT01968070|62976883|FG013|Period 1|Protocol Violation|0|||
33580038|NCT01968070|62976884|FG014|Period 1|Protocol Violation|0|||
33580039|NCT01968070|62976885|FG015|Period 1|Protocol Violation|0|||
33580040|NCT01968070|62976886|FG016|Period 1|Protocol Violation|0|||
33580041|NCT01968070|62976887|FG017|Period 1|Protocol Violation|0|||
33580042|NCT01968070|62976870|FG000|Period 1|Lost to Follow-up|0|||
33580043|NCT01968070|62976871|FG001|Period 1|Lost to Follow-up|0|||
33580044|NCT01968070|62976872|FG002|Period 1|Lost to Follow-up|0|||
33580045|NCT01968070|62976873|FG003|Period 1|Lost to Follow-up|1|||
33580046|NCT01968070|62976874|FG004|Period 1|Lost to Follow-up|0|||
33580047|NCT01968070|62976875|FG005|Period 1|Lost to Follow-up|0|||
33580048|NCT01968070|62976876|FG006|Period 1|Lost to Follow-up|0|||
33580049|NCT01968070|62976877|FG007|Period 1|Lost to Follow-up|0|||
33580050|NCT01968070|62976878|FG008|Period 1|Lost to Follow-up|0|||
33580051|NCT01968070|62976879|FG009|Period 1|Lost to Follow-up|0|||
33580052|NCT01968070|62976880|FG010|Period 1|Lost to Follow-up|0|||
33580053|NCT01968070|62976881|FG011|Period 1|Lost to Follow-up|0|||
33580054|NCT01968070|62976882|FG012|Period 1|Lost to Follow-up|0|||
33580055|NCT01968070|62976883|FG013|Period 1|Lost to Follow-up|0|||
33580056|NCT01968070|62976884|FG014|Period 1|Lost to Follow-up|0|||
33580057|NCT01968070|62976885|FG015|Period 1|Lost to Follow-up|0|||
33580058|NCT01968070|62976886|FG016|Period 1|Lost to Follow-up|0|||
33580059|NCT01968070|62976887|FG017|Period 1|Lost to Follow-up|0|||
33580060|NCT01968070|62976870|FG000|Period 1|Adverse Event|0|||
33580061|NCT01968070|62976871|FG001|Period 1|Adverse Event|0|||
33580062|NCT01968070|62976872|FG002|Period 1|Adverse Event|0|||
33669597|NCT01450813|63103429|FG002|Overall Study|Physician Decision|0|||
33669598|NCT01450813|63103430|FG003|Overall Study|Physician Decision|3|||
33669599|NCT01539512|63103444|FG000|Overall Study|Adverse Event|9|||
33669600|NCT01539512|63103445|FG001|Overall Study|Adverse Event|7|||
33669601|NCT01539512|63103444|FG000|Overall Study|Physician Decision|1|||
33669602|NCT01539512|63103445|FG001|Overall Study|Physician Decision|1|||
33669603|NCT01539512|63103444|FG000|Overall Study|Withdrawal by Subject|12|||
33669604|NCT01539512|63103445|FG001|Overall Study|Withdrawal by Subject|5|||
33669605|NCT01539512|63103444|FG000|Overall Study|Richter's Transformation|1|||
33669606|NCT01539512|63103445|FG001|Overall Study|Richter's Transformation|0|||
33669607|NCT01449955|63103453|FG000|Overall Study|Withdrawal by Subject|1|||
33669608|NCT01449955|63103454|FG001|Overall Study|Withdrawal by Subject|2|||
33669609|NCT01574612|63103467|FG000|Overall Study|Adverse Event|3|||
33669610|NCT01574612|63103467|FG000|Overall Study|non compliant with drug|2|||
33669611|NCT01574612|63103467|FG000|Overall Study|Withdrawal by Subject|1|||
33669612|NCT01574612|63103467|FG000|Overall Study|Lost to Follow-up|2|||
33669613|NCT01573910|63103473|FG000|Overall Study|Adverse Event|4|||
33669614|NCT01573910|63103474|FG001|Overall Study|Adverse Event|4|||
33669615|NCT01573910|63103473|FG000|Overall Study|Lost to Follow-up|2|||
33669616|NCT01573910|63103474|FG001|Overall Study|Lost to Follow-up|1|||
33669617|NCT01573910|63103473|FG000|Overall Study|Withdrawal by Subject|0|||
33669618|NCT01573910|63103474|FG001|Overall Study|Withdrawal by Subject|1|||
33669619|NCT01573910|63103473|FG000|Overall Study|Protocol Violation|3|||
33669620|NCT01573910|63103474|FG001|Overall Study|Protocol Violation|0|||
33669621|NCT01573910|63103473|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
33669622|NCT01573910|63103474|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
33669623|NCT01491919|63103483|FG000|Overall Study|Insufficient PK sampling|1|||
33669624|NCT01491919|63103484|FG001|Overall Study|Insufficient PK sampling|2|||
33669625|NCT01491919|63103485|FG002|Overall Study|Insufficient PK sampling|1|||
33669626|NCT01573442|63103497|FG000|Overall Study|Cancels|9|||
33669627|NCT01573442|63103498|FG001|Overall Study|Cancels|10|||
33669628|NCT01491841|63103567|FG000|Overall Study|Screen Failure|10|||
33669629|NCT01491841|63103567|FG000|Overall Study|Withdrawal by Subject|1|||
33669630|NCT01553318|63103586|FG000|Overall Study|Protocol Violation|3|||
33669631|NCT01553318|63103587|FG001|Overall Study|Protocol Violation|2|||
33669632|NCT01572740|63103606|FG000|Overall Study|Adverse Event|1|||
33669633|NCT01572740|63103607|FG001|Overall Study|Adverse Event|1|||
33669634|NCT01572740|63103606|FG000|Overall Study|Withdrawal by Subject|1|||
33669635|NCT01572740|63103607|FG001|Overall Study|Withdrawal by Subject|1|||
33669636|NCT01572740|63103606|FG000|Overall Study|unclassified|4|||
33669637|NCT01572740|63103607|FG001|Overall Study|unclassified|3|||
33669638|NCT01491607|63103617|FG000|Overall Study|Lost to Follow-up|7|||
33669639|NCT01491607|63103617|FG000|Overall Study|Withdrawal by Subject|3|||
33669640|NCT01449721|63103700|FG000|Overall Study|Physician Decision|0|||
33669641|NCT01449721|63103701|FG001|Overall Study|Physician Decision|1|||
33669642|NCT01449721|63103700|FG000|Overall Study|Physician Decision|0|||
33669643|NCT01449721|63103701|FG001|Overall Study|Physician Decision|1|||
33669644|NCT01553084|63103710|FG000|Overall Study|Withdrawal by Subject|15|||
33669645|NCT01553084|63103711|FG001|Overall Study|Withdrawal by Subject|13|||
33669646|NCT01553084|63103712|FG002|Overall Study|Withdrawal by Subject|35|||
33669647|NCT01536860|63103722|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
33669648|NCT01536860|63103723|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
33669649|NCT01536860|63103724|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
33669650|NCT01552928|63103736|FG000|Period 3|Adverse Event|0|||
33669651|NCT01552928|63103737|FG001|Period 3|Adverse Event|0|||
33580063|NCT01968070|62976873|FG003|Period 1|Adverse Event|0|||
33580064|NCT01968070|62976874|FG004|Period 1|Adverse Event|0|||
33580065|NCT01968070|62976875|FG005|Period 1|Adverse Event|0|||
33580066|NCT01968070|62976876|FG006|Period 1|Adverse Event|1|||
33669652|NCT01552928|63103738|FG002|Period 3|Adverse Event|1|||
33669653|NCT01552928|63103739|FG003|Period 3|Adverse Event|0|||
33669654|NCT01448707|63103758|FG000|Overall Study|Adverse Event|3|||
33669655|NCT01448707|63103759|FG001|Overall Study|Adverse Event|1|||
33669656|NCT01448707|63103758|FG000|Overall Study|Lost to Follow-up|2|||
33669657|NCT01448707|63103759|FG001|Overall Study|Lost to Follow-up|6|||
33669658|NCT01448707|63103758|FG000|Overall Study|Withdrawal by Subject|6|||
33669659|NCT01448707|63103759|FG001|Overall Study|Withdrawal by Subject|7|||
33669660|NCT01448707|63103758|FG000|Overall Study|Other|7|||
33669661|NCT01448707|63103759|FG001|Overall Study|Other|4|||
33669662|NCT01536704|63103765|FG000|Washout Period 1|Withdrawal by Subject|1|||
33669663|NCT01536704|63103766|FG001|Washout Period 1|Withdrawal by Subject|2|||
33669664|NCT01536704|63103767|FG002|Washout Period 1|Withdrawal by Subject|0|||
33669665|NCT01536704|63103768|FG003|Washout Period 1|Withdrawal by Subject|0|||
33669666|NCT01536704|63103765|FG000|Washout Period 2|Adverse Event|1|||
33669667|NCT01536704|63103766|FG001|Washout Period 2|Adverse Event|0|||
33669668|NCT01536704|63103767|FG002|Washout Period 2|Adverse Event|0|||
33669669|NCT01536704|63103768|FG003|Washout Period 2|Adverse Event|0|||
33669670|NCT01536704|63103765|FG000|Washout Period 2|Withdrawal by Subject|0|||
33669671|NCT01536704|63103766|FG001|Washout Period 2|Withdrawal by Subject|0|||
33669672|NCT01536704|63103767|FG002|Washout Period 2|Withdrawal by Subject|0|||
33669673|NCT01536704|63103768|FG003|Washout Period 2|Withdrawal by Subject|1|||
33669674|NCT01536704|63103765|FG000|Period 3|Adverse Event|0|||
33669675|NCT01536704|63103766|FG001|Period 3|Adverse Event|0|||
33669676|NCT01536704|63103767|FG002|Period 3|Adverse Event|0|||
33669677|NCT01536704|63103768|FG003|Period 3|Adverse Event|1|||
33669678|NCT01536704|63103765|FG000|Washout Period 3|Adverse Event|0|||
33669679|NCT01536704|63103766|FG001|Washout Period 3|Adverse Event|0|||
33669680|NCT01536704|63103767|FG002|Washout Period 3|Adverse Event|1|||
33669681|NCT01536704|63103768|FG003|Washout Period 3|Adverse Event|0|||
33669682|NCT01552772|63103782|FG000|Overall Study|Lost to Follow-up|2|||
33669683|NCT01552772|63103782|FG000|Overall Study|Adverse Event|1|||
33669684|NCT01552772|63103782|FG000|Overall Study|Protocol Deviation|1|||
33669685|NCT01552694|63103789|FG000|Overall Study|Lost to Follow-up|0|||
33669686|NCT01552694|63103790|FG001|Overall Study|Lost to Follow-up|1|||
33669687|NCT01552694|63103789|FG000|Overall Study|Protocol Violation|0|||
33669688|NCT01552694|63103790|FG001|Overall Study|Protocol Violation|1|||
33669689|NCT01464931|63103798|FG000|Overall Study|Withdrawal by Subject|1|||
33669690|NCT01464931|63103799|FG001|Overall Study|Withdrawal by Subject|0|||
33669691|NCT01536392|63103824|FG000|Overall Study|Adverse Event|2|||
33669692|NCT01536392|63103825|FG001|Overall Study|Adverse Event|2|||
33669693|NCT01536392|63103824|FG000|Overall Study|Physician Decision|2|||
33669694|NCT01536392|63103825|FG001|Overall Study|Physician Decision|3|||
33669695|NCT01536392|63103824|FG000|Overall Study|Withdrawal by Subject|3|||
33669696|NCT01536392|63103825|FG001|Overall Study|Withdrawal by Subject|6|||
33669697|NCT01536392|63103824|FG000|Overall Study|Non Compliance|3|||
33669698|NCT01536392|63103825|FG001|Overall Study|Non Compliance|4|||
33669699|NCT01536392|63103824|FG000|Overall Study|Completed therapy early|3|||
33669700|NCT01536392|63103825|FG001|Overall Study|Completed therapy early|0|||
33669701|NCT01464619|63103833|FG000|Overall Study|Lost to Follow-up|3|||
33669702|NCT01464619|63103834|FG001|Overall Study|Lost to Follow-up|4|||
33669703|NCT01490125|63103900|FG000|Period I|Adverse Event|4|||
33669704|NCT01490125|63103901|FG001|Period I|Adverse Event|1|||
33669705|NCT01490125|63103902|FG002|Period I|Adverse Event|1|||
33669706|NCT01490125|63103903|FG003|Period I|Adverse Event|3|||
33669707|NCT01490125|63103904|FG004|Period I|Adverse Event|2|||
33669708|NCT01490125|63103905|FG005|Period I|Adverse Event|4|||
33669709|NCT01490125|63103900|FG000|Period I|Protocol Violation|1|||
33669710|NCT01490125|63103901|FG001|Period I|Protocol Violation|1|||
33669711|NCT01490125|63103902|FG002|Period I|Protocol Violation|1|||
33669712|NCT01490125|63103903|FG003|Period I|Protocol Violation|1|||
33669713|NCT01490125|63103904|FG004|Period I|Protocol Violation|0|||
33669714|NCT01490125|63103905|FG005|Period I|Protocol Violation|0|||
33669715|NCT01490125|63103900|FG000|Period I|Withdrawal by Subject|1|||
33669716|NCT01490125|63103901|FG001|Period I|Withdrawal by Subject|3|||
33669717|NCT01490125|63103902|FG002|Period I|Withdrawal by Subject|2|||
33669718|NCT01490125|63103903|FG003|Period I|Withdrawal by Subject|1|||
33669719|NCT01490125|63103904|FG004|Period I|Withdrawal by Subject|2|||
33669720|NCT01490125|63103905|FG005|Period I|Withdrawal by Subject|1|||
33669721|NCT01490125|63103900|FG000|Period II|Adverse Event|2|||
33669722|NCT01490125|63103901|FG001|Period II|Adverse Event|3|||
33669723|NCT01490125|63103902|FG002|Period II|Adverse Event|2|||
33669724|NCT01490125|63103903|FG003|Period II|Adverse Event|2|||
33669725|NCT01490125|63103904|FG004|Period II|Adverse Event|4|||
33669726|NCT01490125|63103905|FG005|Period II|Adverse Event|2|||
33669727|NCT01490125|63103900|FG000|Period II|Protocol Violation|0|||
33669728|NCT01490125|63103901|FG001|Period II|Protocol Violation|0|||
33669729|NCT01490125|63103902|FG002|Period II|Protocol Violation|1|||
33669730|NCT01490125|63103903|FG003|Period II|Protocol Violation|1|||
33669731|NCT01490125|63103904|FG004|Period II|Protocol Violation|0|||
33669732|NCT01490125|63103905|FG005|Period II|Protocol Violation|0|||
33669733|NCT01490125|63103900|FG000|Period II|Lost to Follow-up|0|||
33669734|NCT01490125|63103901|FG001|Period II|Lost to Follow-up|1|||
33669735|NCT01490125|63103902|FG002|Period II|Lost to Follow-up|0|||
33669736|NCT01490125|63103903|FG003|Period II|Lost to Follow-up|0|||
33669737|NCT01490125|63103904|FG004|Period II|Lost to Follow-up|0|||
33669738|NCT01490125|63103905|FG005|Period II|Lost to Follow-up|0|||
33669739|NCT01490125|63103900|FG000|Period II|Withdrawal by Subject|1|||
33669740|NCT01490125|63103901|FG001|Period II|Withdrawal by Subject|0|||
33669741|NCT01490125|63103902|FG002|Period II|Withdrawal by Subject|0|||
33669742|NCT01490125|63103903|FG003|Period II|Withdrawal by Subject|0|||
33669743|NCT01490125|63103904|FG004|Period II|Withdrawal by Subject|0|||
33669744|NCT01490125|63103905|FG005|Period II|Withdrawal by Subject|0|||
33669745|NCT01490125|63103900|FG000|Period III|Adverse Event|3|||
33669746|NCT01490125|63103901|FG001|Period III|Adverse Event|1|||
33669747|NCT01490125|63103902|FG002|Period III|Adverse Event|0|||
33669748|NCT01490125|63103903|FG003|Period III|Adverse Event|1|||
33669749|NCT01490125|63103904|FG004|Period III|Adverse Event|0|||
33669750|NCT01490125|63103905|FG005|Period III|Adverse Event|0|||
33669751|NCT01490125|63103900|FG000|Period III|Death|0|||
33669752|NCT01490125|63103901|FG001|Period III|Death|0|||
33669753|NCT01490125|63103902|FG002|Period III|Death|0|||
33669754|NCT01490125|63103903|FG003|Period III|Death|1|||
33669755|NCT01490125|63103904|FG004|Period III|Death|0|||
33669756|NCT01490125|63103905|FG005|Period III|Death|0|||
33669757|NCT01490125|63103900|FG000|Period III|Lack of Efficacy|0|||
33669758|NCT01490125|63103901|FG001|Period III|Lack of Efficacy|0|||
33669759|NCT01490125|63103902|FG002|Period III|Lack of Efficacy|0|||
33669760|NCT01490125|63103903|FG003|Period III|Lack of Efficacy|0|||
33669761|NCT01490125|63103904|FG004|Period III|Lack of Efficacy|1|||
33669762|NCT01490125|63103905|FG005|Period III|Lack of Efficacy|0|||
33669763|NCT01446913|63103916|FG000|Overall Study|Significant illness|1|||
33669764|NCT01446913|63103917|FG001|Overall Study|Significant illness|1|||
33669765|NCT01446913|63103918|FG002|Overall Study|Significant illness|1|||
33669766|NCT01446913|63103916|FG000|Overall Study|Withdrawal by Subject|5|||
33669767|NCT01446913|63103917|FG001|Overall Study|Withdrawal by Subject|3|||
33669768|NCT01446913|63103918|FG002|Overall Study|Withdrawal by Subject|5|||
33669769|NCT01446913|63103916|FG000|Overall Study|Physician Decision|0|||
33669770|NCT01446913|63103917|FG001|Overall Study|Physician Decision|0|||
33669771|NCT01446913|63103918|FG002|Overall Study|Physician Decision|2|||
33669772|NCT01446913|63103916|FG000|Overall Study|Lost to Follow-up|3|||
33669773|NCT01446913|63103917|FG001|Overall Study|Lost to Follow-up|5|||
33669774|NCT01446913|63103918|FG002|Overall Study|Lost to Follow-up|3|||
33669775|NCT01420549|63103949|FG000|Overall Study|Adverse Event|1|||
33669776|NCT01420549|63103950|FG001|Overall Study|Adverse Event|1|||
33669777|NCT01420549|63103949|FG000|Overall Study|Lost to Follow-up|2|||
33669778|NCT01420549|63103950|FG001|Overall Study|Lost to Follow-up|2|||
33669779|NCT01420549|63103949|FG000|Overall Study|Protocol Violation|0|||
33669780|NCT01420549|63103950|FG001|Overall Study|Protocol Violation|1|||
33669781|NCT01420549|63103949|FG000|Overall Study|Non-adherence to medication|4|||
33669782|NCT01420549|63103950|FG001|Overall Study|Non-adherence to medication|1|||
33669783|NCT01440595|63103971|FG000|Overall Study|Lost to Follow-up|0|||
33669784|NCT01440595|63103972|FG001|Overall Study|Lost to Follow-up|1|||
33669785|NCT01440595|63103973|FG002|Overall Study|Lost to Follow-up|0|||
33669786|NCT01440595|63103971|FG000|Overall Study|Study terminated by sponsor.|1|||
33669787|NCT01440595|63103972|FG001|Overall Study|Study terminated by sponsor.|2|||
33669788|NCT01440595|63103973|FG002|Overall Study|Study terminated by sponsor.|1|||
33669789|NCT01440517|63103979|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
33669790|NCT01440283|63103983|FG000|Overall Study|Death|3|||
33669791|NCT01440283|63103983|FG000|Overall Study|Withdrawal by Subject|4|||
33669792|NCT01440283|63103983|FG000|Overall Study|Physician Decision|3|||
33669793|NCT01440049|63103993|FG000|Overall Study|Adverse Event|5|||
33669794|NCT01439971|63104054|FG000|Overall Study|Required number in cohort dosed|0|||
33669795|NCT01439971|63104055|FG001|Overall Study|Required number in cohort dosed|1|||
33669796|NCT01439971|63104056|FG002|Overall Study|Required number in cohort dosed|2|||
33669797|NCT01439971|63104057|FG003|Overall Study|Required number in cohort dosed|0|||
33669798|NCT01439971|63104058|FG004|Overall Study|Required number in cohort dosed|1|||
33669799|NCT01447927|63104121|FG000|Overall Study|Adverse Event|4|||
33669800|NCT01447927|63104122|FG001|Overall Study|Adverse Event|3|||
33669801|NCT01447927|63104121|FG000|Overall Study|Withdrawal by Subject|1|||
33669802|NCT01447927|63104122|FG001|Overall Study|Withdrawal by Subject|0|||
33669803|NCT01551758|63104144|FG000|Overall Study|Adverse Event|29|||
33669804|NCT01551758|63104145|FG001|Overall Study|Adverse Event|43|||
33669805|NCT01551758|63104144|FG000|Overall Study|Lack of Efficacy|0|||
33669806|NCT01551758|63104145|FG001|Overall Study|Lack of Efficacy|1|||
33669807|NCT01551758|63104144|FG000|Overall Study|Protocol Violation|5|||
33669808|NCT01551758|63104145|FG001|Overall Study|Protocol Violation|6|||
33669809|NCT01551758|63104144|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
33669810|NCT01551758|63104145|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
33669811|NCT01551758|63104144|FG000|Overall Study|Lost to Follow-up|29|||
33669812|NCT01551758|63104145|FG001|Overall Study|Lost to Follow-up|25|||
33669813|NCT01551758|63104144|FG000|Overall Study|Physician Decision|9|||
33669814|NCT01551758|63104145|FG001|Overall Study|Physician Decision|3|||
33669815|NCT01551758|63104144|FG000|Overall Study|Withdrawal by Subject|14|||
33669816|NCT01551758|63104145|FG001|Overall Study|Withdrawal by Subject|17|||
33669817|NCT01449461|63104348|FG000|Overall Study|Adverse Event|0|||
33669818|NCT01449461|63104349|FG001|Overall Study|Adverse Event|3|||
33669819|NCT01449461|63104350|FG002|Overall Study|Adverse Event|2|||
33669820|NCT01449461|63104351|FG003|Overall Study|Adverse Event|3|||
33669821|NCT01449461|63104352|FG004|Overall Study|Adverse Event|4|||
33669822|NCT01449461|63104353|FG005|Overall Study|Adverse Event|4|||
33669823|NCT01449461|63104348|FG000|Overall Study|Death|0|||
33669824|NCT01449461|63104349|FG001|Overall Study|Death|2|||
33669825|NCT01449461|63104350|FG002|Overall Study|Death|0|||
33669826|NCT01449461|63104351|FG003|Overall Study|Death|0|||
33669827|NCT01449461|63104352|FG004|Overall Study|Death|7|||
33669828|NCT01449461|63104353|FG005|Overall Study|Death|1|||
33669829|NCT01449461|63104348|FG000|Overall Study|Physician Decision|0|||
33669830|NCT01449461|63104349|FG001|Overall Study|Physician Decision|1|||
33669831|NCT01449461|63104350|FG002|Overall Study|Physician Decision|0|||
33669832|NCT01449461|63104351|FG003|Overall Study|Physician Decision|4|||
33669833|NCT01449461|63104352|FG004|Overall Study|Physician Decision|1|||
33669834|NCT01449461|63104353|FG005|Overall Study|Physician Decision|0|||
33669835|NCT01449461|63104348|FG000|Overall Study|Documented Progressive Disease|4|||
33669836|NCT01449461|63104349|FG001|Overall Study|Documented Progressive Disease|7|||
33669837|NCT01449461|63104350|FG002|Overall Study|Documented Progressive Disease|14|||
33669838|NCT01449461|63104351|FG003|Overall Study|Documented Progressive Disease|15|||
33669839|NCT01449461|63104352|FG004|Overall Study|Documented Progressive Disease|24|||
33669840|NCT01449461|63104353|FG005|Overall Study|Documented Progressive Disease|5|||
33669841|NCT01449461|63104348|FG000|Overall Study|Clinical Progressive Disease|2|||
33669842|NCT01449461|63104349|FG001|Overall Study|Clinical Progressive Disease|2|||
33669843|NCT01449461|63104350|FG002|Overall Study|Clinical Progressive Disease|0|||
33669844|NCT01449461|63104351|FG003|Overall Study|Clinical Progressive Disease|3|||
33669845|NCT01449461|63104352|FG004|Overall Study|Clinical Progressive Disease|4|||
33669846|NCT01449461|63104353|FG005|Overall Study|Clinical Progressive Disease|2|||
33669847|NCT01449461|63104348|FG000|Overall Study|Protocol Violation|0|||
33669848|NCT01449461|63104349|FG001|Overall Study|Protocol Violation|0|||
33669849|NCT01449461|63104350|FG002|Overall Study|Protocol Violation|0|||
33669850|NCT01449461|63104351|FG003|Overall Study|Protocol Violation|1|||
33669851|NCT01449461|63104352|FG004|Overall Study|Protocol Violation|0|||
33669852|NCT01449461|63104353|FG005|Overall Study|Protocol Violation|0|||
33669853|NCT01449461|63104348|FG000|Overall Study|Site Terminated by Sponsor|0|||
33669854|NCT01449461|63104349|FG001|Overall Study|Site Terminated by Sponsor|1|||
33669855|NCT01449461|63104350|FG002|Overall Study|Site Terminated by Sponsor|2|||
33669856|NCT01449461|63104351|FG003|Overall Study|Site Terminated by Sponsor|3|||
33669857|NCT01449461|63104352|FG004|Overall Study|Site Terminated by Sponsor|4|||
33669858|NCT01449461|63104353|FG005|Overall Study|Site Terminated by Sponsor|1|||
33669859|NCT01449461|63104348|FG000|Overall Study|Withdrawal by Subject|0|||
33669860|NCT01449461|63104349|FG001|Overall Study|Withdrawal by Subject|1|||
33669861|NCT01449461|63104350|FG002|Overall Study|Withdrawal by Subject|0|||
33669862|NCT01449461|63104351|FG003|Overall Study|Withdrawal by Subject|0|||
33669863|NCT01449461|63104352|FG004|Overall Study|Withdrawal by Subject|2|||
33669864|NCT01449461|63104353|FG005|Overall Study|Withdrawal by Subject|1|||
33669865|NCT01449461|63104348|FG000|Overall Study|Reason not Specified|0|||
33669866|NCT01449461|63104349|FG001|Overall Study|Reason not Specified|1|||
33669867|NCT01449461|63104350|FG002|Overall Study|Reason not Specified|0|||
33669868|NCT01449461|63104351|FG003|Overall Study|Reason not Specified|3|||
33669869|NCT01449461|63104352|FG004|Overall Study|Reason not Specified|2|||
33669870|NCT01449461|63104353|FG005|Overall Study|Reason not Specified|1|||
33669871|NCT01572038|63104389|FG000|Overall Study|Death|648|||
33669872|NCT01572038|63104389|FG000|Overall Study|Withdrawal by Subject|204|||
33669873|NCT01572038|63104389|FG000|Overall Study|Lost to Follow-up|81|||
33669874|NCT01572038|63104389|FG000|Overall Study|Physician Decision|20|||
33669875|NCT01572038|63104389|FG000|Overall Study|Patient Decision|14|||
33669876|NCT01572038|63104389|FG000|Overall Study|Progressive Disease|8|||
33669877|NCT01572038|63104389|FG000|Overall Study|Site Closed Before Completing Form|6|||
33669878|NCT01572038|63104389|FG000|Overall Study|Enrolled into Another Trial|3|||
33669879|NCT01572038|63104389|FG000|Overall Study|Participated in Another Trial|3|||
33669880|NCT01572038|63104389|FG000|Overall Study|Termination by Sponsor|2|||
33669881|NCT01572038|63104389|FG000|Overall Study|Patient Deterioration|1|||
33669882|NCT01572038|63104389|FG000|Overall Study|Sponsor Decision|1|||
33669883|NCT01448213|63104417|FG000|Overall Study|Lost to Follow-up|12|||
33669884|NCT01448213|63104418|FG001|Overall Study|Lost to Follow-up|10|||
33669885|NCT01448213|63104417|FG000|Overall Study|Adverse Event|4|||
33669886|NCT01448213|63104418|FG001|Overall Study|Adverse Event|10|||
33669887|NCT01448213|63104417|FG000|Overall Study|Protocol Violation|1|||
33669888|NCT01448213|63104418|FG001|Overall Study|Protocol Violation|2|||
33669889|NCT01448057|63104435|FG000|Overall Study|Protocol Violation|3|||
33669890|NCT01448057|63104436|FG001|Overall Study|Protocol Violation|2|||
33669891|NCT01448057|63104435|FG000|Overall Study|Lost to Follow-up|3|||
33669892|NCT01448057|63104436|FG001|Overall Study|Lost to Follow-up|0|||
33669893|NCT01448057|63104435|FG000|Overall Study|Adverse Event|0|||
33669894|NCT01448057|63104436|FG001|Overall Study|Adverse Event|2|||
33669895|NCT01448057|63104435|FG000|Overall Study|Withdrawal by Subject|2|||
33669896|NCT01448057|63104436|FG001|Overall Study|Withdrawal by Subject|0|||
33669897|NCT01447433|63104444|FG000|Overall Study|Lost to Follow-up|0|||
33669898|NCT01447433|63104445|FG001|Overall Study|Lost to Follow-up|2|||
33669899|NCT01447433|63104444|FG000|Overall Study|Withdrawal by Subject|3|||
33669900|NCT01447433|63104445|FG001|Overall Study|Withdrawal by Subject|3|||
33669901|NCT01447433|63104444|FG000|Overall Study|Protocol Violation|1|||
33669902|NCT01447433|63104445|FG001|Overall Study|Protocol Violation|1|||
33669903|NCT01446965|63104453|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
33669904|NCT01446965|63104454|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
33669905|NCT01446965|63104453|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
33669906|NCT01446965|63104454|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
33669907|NCT01446809|63104462|FG000|Overall Study|Adverse Event|0|||
33669908|NCT01446809|63104463|FG001|Overall Study|Adverse Event|0|||
33669909|NCT01446809|63104464|FG002|Overall Study|Adverse Event|1|||
33669910|NCT01446809|63104462|FG000|Overall Study|Failure to complete study procedures|0|||
33669911|NCT01446809|63104463|FG001|Overall Study|Failure to complete study procedures|0|||
33669912|NCT01446809|63104464|FG002|Overall Study|Failure to complete study procedures|1|||
33669913|NCT01446419|63104475|FG000|Overall Study|Death|1|||
33669914|NCT01446419|63104476|FG001|Overall Study|Death|0|||
33669915|NCT01446419|63104475|FG000|Overall Study|Withdrawal by Subject|1|||
33669916|NCT01446419|63104476|FG001|Overall Study|Withdrawal by Subject|1|||
33669917|NCT01446419|63104475|FG000|Overall Study|Terminated per protocol|3|||
33669918|NCT01446419|63104476|FG001|Overall Study|Terminated per protocol|0|||
33669919|NCT01445951|63104485|FG000|Overall Study|Adverse Event|16|||
33669920|NCT01445951|63104486|FG001|Overall Study|Adverse Event|9|||
33669921|NCT01445951|63104487|FG002|Overall Study|Adverse Event|0|||
33669922|NCT01445951|63104485|FG000|Overall Study|Protocol Violation|2|||
33669923|NCT01445951|63104486|FG001|Overall Study|Protocol Violation|2|||
33669924|NCT01445951|63104487|FG002|Overall Study|Protocol Violation|2|||
33669925|NCT01445951|63104485|FG000|Overall Study|Withdrawal by Subject|21|||
33669926|NCT01445951|63104486|FG001|Overall Study|Withdrawal by Subject|16|||
33669927|NCT01445951|63104487|FG002|Overall Study|Withdrawal by Subject|8|||
33669928|NCT01445951|63104485|FG000|Overall Study|Physician Decision|3|||
33669929|NCT01445951|63104486|FG001|Overall Study|Physician Decision|1|||
33669930|NCT01445951|63104487|FG002|Overall Study|Physician Decision|0|||
33669931|NCT01445951|63104485|FG000|Overall Study|Lost to Follow-up|1|||
33669932|NCT01445951|63104486|FG001|Overall Study|Lost to Follow-up|2|||
33669933|NCT01445951|63104487|FG002|Overall Study|Lost to Follow-up|4|||
33669934|NCT01445951|63104485|FG000|Overall Study|Pregnancy|0|||
33669935|NCT01445951|63104486|FG001|Overall Study|Pregnancy|1|||
33669936|NCT01445951|63104487|FG002|Overall Study|Pregnancy|4|||
33669937|NCT01445951|63104485|FG000|Overall Study|Death|0|||
33669938|NCT01445951|63104486|FG001|Overall Study|Death|0|||
33669939|NCT01445951|63104487|FG002|Overall Study|Death|1|||
33669940|NCT01445951|63104485|FG000|Overall Study|Non-compliance with study drug|1|||
33669941|NCT01445951|63104486|FG001|Overall Study|Non-compliance with study drug|2|||
33669942|NCT01445951|63104487|FG002|Overall Study|Non-compliance with study drug|0|||
33669943|NCT01445951|63104485|FG000|Overall Study|Non-compliance with protocol|0|||
33669944|NCT01445951|63104486|FG001|Overall Study|Non-compliance with protocol|1|||
33669945|NCT01445951|63104487|FG002|Overall Study|Non-compliance with protocol|0|||
33669946|NCT01445951|63104485|FG000|Overall Study|Sponsor decision - subject travel|0|||
33669947|NCT01445951|63104486|FG001|Overall Study|Sponsor decision - subject travel|1|||
33669948|NCT01445951|63104487|FG002|Overall Study|Sponsor decision - subject travel|0|||
33669949|NCT01445951|63104485|FG000|Overall Study|Cough|0|||
33669950|NCT01445951|63104486|FG001|Overall Study|Cough|1|||
33669951|NCT01445951|63104487|FG002|Overall Study|Cough|0|||
33669952|NCT01444781|63104502|FG000|Overall Study|Lost to Follow-up|0|||
33669953|NCT01444781|63104503|FG001|Overall Study|Lost to Follow-up|3|||
33669954|NCT01444781|63104504|FG002|Overall Study|Lost to Follow-up|1|||
33669955|NCT01444781|63104502|FG000|Overall Study|Withdrawal by Subject|3|||
33669956|NCT01444781|63104503|FG001|Overall Study|Withdrawal by Subject|1|||
33669957|NCT01444781|63104504|FG002|Overall Study|Withdrawal by Subject|2|||
33669958|NCT01444391|63104519|FG000|Overall Study|Death|1|||
33669959|NCT01443923|63104525|FG000|Overall Study|Adverse Event|1|||
33669960|NCT01443923|63104526|FG001|Overall Study|Adverse Event|0|||
33669961|NCT01551212|63104538|FG000|Overall Study|Graft loss/Retransplantation|0|||
33669962|NCT01551212|63104539|FG001|Overall Study|Graft loss/Retransplantation|1|||
33669963|NCT01551212|63104538|FG000|Overall Study|Administrative problems|1|||
33669964|NCT01551212|63104539|FG001|Overall Study|Administrative problems|2|||
33669965|NCT01551212|63104538|FG000|Overall Study|Lost to Follow-up|0|||
33669966|NCT01551212|63104539|FG001|Overall Study|Lost to Follow-up|1|||
33669967|NCT01551212|63104538|FG000|Overall Study|Protocol Violation|0|||
33669968|NCT01551212|63104539|FG001|Overall Study|Protocol Violation|1|||
33669969|NCT01551212|63104538|FG000|Overall Study|Withdrawal by Subject|0|||
33669970|NCT01551212|63104539|FG001|Overall Study|Withdrawal by Subject|7|||
33669971|NCT01551212|63104538|FG000|Overall Study|Death|2|||
33669972|NCT01551212|63104539|FG001|Overall Study|Death|4|||
33669973|NCT01551212|63104538|FG000|Overall Study|Never Received Study Treatment|2|||
33669974|NCT01551212|63104539|FG001|Overall Study|Never Received Study Treatment|4|||
33669975|NCT01550744|63104599|FG000|Open-Label|Lost to Follow-up|7|||
33669976|NCT01550744|63104600|FG001|Open-Label|Lost to Follow-up|0|||
33669977|NCT01550744|63104601|FG002|Open-Label|Lost to Follow-up|0|||
33669978|NCT01550744|63104599|FG000|Open-Label|Withdrawal by Subject|13|||
33669979|NCT01550744|63104600|FG001|Open-Label|Withdrawal by Subject|0|||
33669980|NCT01550744|63104601|FG002|Open-Label|Withdrawal by Subject|0|||
33669981|NCT01550744|63104599|FG000|Open-Label|Adverse Event|11|||
33669982|NCT01550744|63104600|FG001|Open-Label|Adverse Event|0|||
33669983|NCT01550744|63104601|FG002|Open-Label|Adverse Event|0|||
33669984|NCT01550744|63104599|FG000|Open-Label|Lack of Efficacy|4|||
33669985|NCT01550744|63104600|FG001|Open-Label|Lack of Efficacy|0|||
33669986|NCT01550744|63104601|FG002|Open-Label|Lack of Efficacy|0|||
33669987|NCT01550744|63104599|FG000|Open-Label|Protocol Violation|4|||
33669988|NCT01550744|63104600|FG001|Open-Label|Protocol Violation|0|||
33669989|NCT01550744|63104601|FG002|Open-Label|Protocol Violation|0|||
33669990|NCT01550744|63104599|FG000|Open-Label|Not all 3 study drug injections received|2|||
33669991|NCT01550744|63104600|FG001|Open-Label|Not all 3 study drug injections received|0|||
33669992|NCT01550744|63104601|FG002|Open-Label|Not all 3 study drug injections received|0|||
33669993|NCT01550744|63104599|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
33669994|NCT01550744|63104600|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
33669995|NCT01550744|63104601|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
33669996|NCT01550744|63104599|FG000|Open-Label|Other|1|||
33669997|NCT01550744|63104600|FG001|Open-Label|Other|0|||
33669998|NCT01550744|63104601|FG002|Open-Label|Other|0|||
33669999|NCT01550744|63104599|FG000|Double-Blind|Lost to Follow-up|0|||
33670000|NCT01550744|63104600|FG001|Double-Blind|Lost to Follow-up|6|||
33670001|NCT01550744|63104601|FG002|Double-Blind|Lost to Follow-up|12|||
33670002|NCT01550744|63104599|FG000|Double-Blind|Withdrawal by Subject|0|||
33670003|NCT01550744|63104600|FG001|Double-Blind|Withdrawal by Subject|2|||
33670004|NCT01550744|63104601|FG002|Double-Blind|Withdrawal by Subject|15|||
33670005|NCT01550744|63104599|FG000|Double-Blind|Adverse Event|0|||
33670006|NCT01550744|63104600|FG001|Double-Blind|Adverse Event|4|||
33670007|NCT01550744|63104601|FG002|Double-Blind|Adverse Event|15|||
33670008|NCT01550744|63104599|FG000|Double-Blind|Death|0|||
33670009|NCT01550744|63104600|FG001|Double-Blind|Death|1|||
33670010|NCT01550744|63104601|FG002|Double-Blind|Death|0|||
33670011|NCT01550744|63104599|FG000|Double-Blind|Lack of Efficacy|0|||
33670012|NCT01550744|63104600|FG001|Double-Blind|Lack of Efficacy|2|||
33670013|NCT01550744|63104601|FG002|Double-Blind|Lack of Efficacy|8|||
33670014|NCT01550744|63104599|FG000|Double-Blind|Protocol Violation|0|||
33670015|NCT01550744|63104600|FG001|Double-Blind|Protocol Violation|0|||
33670016|NCT01550744|63104601|FG002|Double-Blind|Protocol Violation|4|||
33670017|NCT01550744|63104599|FG000|Double-Blind|Pregnancy|0|||
33670018|NCT01550744|63104600|FG001|Double-Blind|Pregnancy|0|||
33670019|NCT01550744|63104601|FG002|Double-Blind|Pregnancy|3|||
33670020|NCT01550744|63104599|FG000|Double-Blind|Other|0|||
33670021|NCT01550744|63104600|FG001|Double-Blind|Other|2|||
33670022|NCT01550744|63104601|FG002|Double-Blind|Other|10|||
33670023|NCT01549964|63104662|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
33670024|NCT01549964|63104663|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
33670025|NCT01549964|63104664|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
33670026|NCT01549964|63104665|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
33670027|NCT01549964|63104662|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
33670028|NCT01549964|63104663|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
33670029|NCT01549964|63104664|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
33670030|NCT01549964|63104665|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
33670031|NCT01549964|63104662|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
33670032|NCT01549964|63104663|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
33670033|NCT01549964|63104664|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
33670034|NCT01549964|63104665|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
33670035|NCT01549964|63104662|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
33670036|NCT01549964|63104663|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
33670037|NCT01549964|63104664|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
33670038|NCT01549964|63104665|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
33670039|NCT01549964|63104662|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
33670040|NCT01549964|63104663|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
33670041|NCT01549964|63104664|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
33670042|NCT01549964|63104665|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
33670043|NCT01549964|63104662|FG000|24-Week Treatment Period|Other|1|||
33670044|NCT01549964|63104663|FG001|24-Week Treatment Period|Other|0|||
33670045|NCT01549964|63104664|FG002|24-Week Treatment Period|Other|1|||
33670046|NCT01549964|63104665|FG003|24-Week Treatment Period|Other|0|||
33670047|NCT01549964|63104662|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
33670048|NCT01549964|63104663|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
33670049|NCT01549964|63104664|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
33670050|NCT01549964|63104665|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
33670051|NCT01549964|63104662|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
33670052|NCT01549964|63104663|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
33670053|NCT01549964|63104664|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
33670054|NCT01549964|63104665|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
33670055|NCT01549964|63104662|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
33670056|NCT01549964|63104663|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
33670057|NCT01549964|63104664|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
33670058|NCT01549964|63104665|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
33670059|NCT01549964|63104662|FG000|80-Week Extension Period|Pregnancy|0|||
33670060|NCT01549964|63104663|FG001|80-Week Extension Period|Pregnancy|0|||
33670061|NCT01549964|63104664|FG002|80-Week Extension Period|Pregnancy|1|||
33670062|NCT01549964|63104665|FG003|80-Week Extension Period|Pregnancy|0|||
33670063|NCT01549964|63104662|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
33670064|NCT01549964|63104663|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
33670065|NCT01549964|63104664|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
33670066|NCT01549964|63104665|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
33670067|NCT01549964|63104662|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
33670068|NCT01549964|63104663|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
33670069|NCT01549964|63104664|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
33670070|NCT01549964|63104665|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
33670071|NCT01549964|63104662|FG000|80-Week Extension Period|Lost to Follow-up|1|||
33670072|NCT01549964|63104663|FG001|80-Week Extension Period|Lost to Follow-up|0|||
33670073|NCT01549964|63104664|FG002|80-Week Extension Period|Lost to Follow-up|2|||
33670074|NCT01549964|63104665|FG003|80-Week Extension Period|Lost to Follow-up|1|||
33670075|NCT01549964|63104662|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
33670076|NCT01549964|63104663|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
33670077|NCT01549964|63104664|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
33670078|NCT01549964|63104665|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
33670079|NCT01570244|63104747|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
33670080|NCT01535222|63104782|FG000|Overall Study|Inclusion/exclusion|0|||
33670081|NCT01535222|63104783|FG001|Overall Study|Inclusion/exclusion|0|||
33670082|NCT01535222|63104784|FG002|Overall Study|Inclusion/exclusion|1|||
33670083|NCT01535222|63104785|FG003|Overall Study|Inclusion/exclusion|0|||
33670084|NCT01535222|63104786|FG004|Overall Study|Inclusion/exclusion|0|||
33670085|NCT01535222|63104787|FG005|Overall Study|Inclusion/exclusion|0|||
33670086|NCT01549886|63104803|FG000|Overall Study|Sponsor's decision|2|||
33670087|NCT01549886|63104804|FG001|Overall Study|Sponsor's decision|3|||
33670088|NCT01443845|63104833|FG000|Overall Study|Protocol Violation|43|||
33670089|NCT01443845|63104834|FG001|Overall Study|Protocol Violation|45|||
33670090|NCT01443845|63104833|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
33670091|NCT01443845|63104834|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
33670092|NCT01443845|63104833|FG000|Overall Study|Deterioration in pulmonary function|1|||
33670093|NCT01443845|63104834|FG001|Overall Study|Deterioration in pulmonary function|4|||
33670094|NCT01443845|63104833|FG000|Overall Study|Lack of Efficacy|10|||
33670095|NCT01443845|63104834|FG001|Overall Study|Lack of Efficacy|5|||
33670096|NCT01443845|63104833|FG000|Overall Study|Adverse Event|64|||
33670097|NCT01443845|63104834|FG001|Overall Study|Adverse Event|138|||
33670098|NCT01443845|63104833|FG000|Overall Study|Withdrawal by Subject|63|||
33670099|NCT01443845|63104834|FG001|Overall Study|Withdrawal by Subject|67|||
33670100|NCT01443845|63104833|FG000|Overall Study|Military Conflict - Site Terminated|20|||
33670101|NCT01443845|63104834|FG001|Overall Study|Military Conflict - Site Terminated|21|||
33670102|NCT01443845|63104833|FG000|Overall Study|Lost to Follow-up|9|||
33670103|NCT01443845|63104834|FG001|Overall Study|Lost to Follow-up|13|||
33670104|NCT01549652|63104843|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
33670105|NCT01549652|63104844|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
33670106|NCT01549652|63104845|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
33670107|NCT01549652|63104846|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
33670108|NCT01549652|63104843|FG000|Overall Study|Study Drug Titration Failure|5|||
33670109|NCT01549652|63104844|FG001|Overall Study|Study Drug Titration Failure|6|||
33670110|NCT01549652|63104845|FG002|Overall Study|Study Drug Titration Failure|0|||
33670111|NCT01549652|63104846|FG003|Overall Study|Study Drug Titration Failure|0|||
33670112|NCT01549652|63104843|FG000|Overall Study|Withdrawal Effect|0|||
33670113|NCT01549652|63104844|FG001|Overall Study|Withdrawal Effect|2|||
33670114|NCT01549652|63104845|FG002|Overall Study|Withdrawal Effect|0|||
33670115|NCT01549652|63104846|FG003|Overall Study|Withdrawal Effect|0|||
33670116|NCT01549652|63104843|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
33670117|NCT01549652|63104844|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
33670118|NCT01549652|63104845|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
33670119|NCT01549652|63104846|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
33670120|NCT01549652|63104843|FG000|Overall Study|Problem with Infusion|1|||
33670121|NCT01549652|63104844|FG001|Overall Study|Problem with Infusion|0|||
33670122|NCT01549652|63104845|FG002|Overall Study|Problem with Infusion|0|||
33670123|NCT01549652|63104846|FG003|Overall Study|Problem with Infusion|0|||
33670124|NCT01549652|63104843|FG000|Overall Study|Titration Non-Compliance|1|||
33670125|NCT01549652|63104844|FG001|Overall Study|Titration Non-Compliance|3|||
33670126|NCT01549652|63104845|FG002|Overall Study|Titration Non-Compliance|4|||
33670127|NCT01549652|63104846|FG003|Overall Study|Titration Non-Compliance|5|||
33670128|NCT01549652|63104843|FG000|Overall Study|Titration Side Effects|0|||
33670129|NCT01549652|63104844|FG001|Overall Study|Titration Side Effects|0|||
33670130|NCT01549652|63104845|FG002|Overall Study|Titration Side Effects|6|||
33670131|NCT01549652|63104846|FG003|Overall Study|Titration Side Effects|3|||
33670132|NCT01549652|63104843|FG000|Overall Study|Withdrawal by Subject|0|||
33670133|NCT01549652|63104844|FG001|Overall Study|Withdrawal by Subject|0|||
33670134|NCT01549652|63104845|FG002|Overall Study|Withdrawal by Subject|5|||
33670135|NCT01549652|63104846|FG003|Overall Study|Withdrawal by Subject|3|||
33670136|NCT01569464|63104854|FG000|Overall Study|Adverse Event|4|||
33670137|NCT01569464|63104855|FG001|Overall Study|Adverse Event|0|||
33670138|NCT01569464|63104854|FG000|Overall Study|Lack of Efficacy|1|||
33670139|NCT01569464|63104855|FG001|Overall Study|Lack of Efficacy|0|||
33670140|NCT01569464|63104854|FG000|Overall Study|Protocol Violation|1|||
33670141|NCT01569464|63104855|FG001|Overall Study|Protocol Violation|0|||
33670142|NCT01569464|63104854|FG000|Overall Study|Lost to Follow-up|2|||
33670143|NCT01569464|63104855|FG001|Overall Study|Lost to Follow-up|3|||
33670144|NCT01569464|63104854|FG000|Overall Study|Withdrawal by Subject|1|||
33670145|NCT01569464|63104855|FG001|Overall Study|Withdrawal by Subject|1|||
33670146|NCT01569464|63104854|FG000|Overall Study|Other|1|||
33670147|NCT01569464|63104855|FG001|Overall Study|Other|1|||
33670148|NCT01534676|63104865|FG000|Overall Study|Study closed due to poor enrollment|2|||
33670149|NCT01534676|63104866|FG001|Overall Study|Study closed due to poor enrollment|1|||
33670150|NCT01442675|63104872|FG000|Overall Study|Protocol Violation|6|||
33670151|NCT01442675|63104872|FG000|Overall Study|Lost to Follow-up|2|||
33670152|NCT01442675|63104872|FG000|Overall Study|Withdrawal by Subject|4|||
33670153|NCT01534520|63104879|FG000|Overall Study|Adverse Event|0|||
33670154|NCT01534520|63104880|FG001|Overall Study|Adverse Event|1|||
33670155|NCT01534208|63104910|FG000|Overall Study|Lost to Follow-up|19|||
33670156|NCT01534208|63104911|FG001|Overall Study|Lost to Follow-up|14|||
33670157|NCT01534208|63104910|FG000|Overall Study|Withdrawal by Subject|6|||
33670158|NCT01534208|63104911|FG001|Overall Study|Withdrawal by Subject|20|||
33670159|NCT01534208|63104910|FG000|Overall Study|Adverse Event|15|||
33670160|NCT01534208|63104911|FG001|Overall Study|Adverse Event|8|||
33670161|NCT01534208|63104910|FG000|Overall Study|Physician Decision|2|||
33670162|NCT01534208|63104911|FG001|Overall Study|Physician Decision|0|||
33670163|NCT01534208|63104910|FG000|Overall Study|Lack of Efficacy|0|||
33670164|NCT01534208|63104911|FG001|Overall Study|Lack of Efficacy|3|||
33670165|NCT01534208|63104910|FG000|Overall Study|Protocol Violation|2|||
33670166|NCT01534208|63104911|FG001|Overall Study|Protocol Violation|2|||
33670167|NCT01534208|63104910|FG000|Overall Study|Sponsor decision|4|||
33670168|NCT01534208|63104911|FG001|Overall Study|Sponsor decision|1|||
33670169|NCT01534208|63104910|FG000|Overall Study|Subject relocation|2|||
33670170|NCT01534208|63104911|FG001|Overall Study|Subject relocation|0|||
33670171|NCT01534208|63104910|FG000|Overall Study|Lab assessment|2|||
33670172|NCT01534208|63104911|FG001|Overall Study|Lab assessment|1|||
33670173|NCT01534208|63104910|FG000|Overall Study|Eligibility error|3|||
33670174|NCT01534208|63104911|FG001|Overall Study|Eligibility error|0|||
33670175|NCT01534208|63104910|FG000|Overall Study|PCP decision|1|||
33670176|NCT01534208|63104911|FG001|Overall Study|PCP decision|0|||
33670177|NCT01534208|63104910|FG000|Overall Study|Needed prohibited meds|1|||
33670178|NCT01534208|63104911|FG001|Overall Study|Needed prohibited meds|0|||
33670179|NCT01548638|63104917|FG000|Overall Study|Protocol Violation|3|||
33670180|NCT01548638|63104917|FG000|Overall Study|Withdrawal by Subject|1|||
33670181|NCT01533428|63104941|FG000|Overall Study|Adverse Event|0|||
33670182|NCT01533428|63104942|FG001|Overall Study|Adverse Event|1|||
33670183|NCT01533428|63104941|FG000|Overall Study|Lost to Follow-up|2|||
33670184|NCT01533428|63104942|FG001|Overall Study|Lost to Follow-up|1|||
33670185|NCT01533428|63104941|FG000|Overall Study|Withdrawal by Subject|7|||
33670186|NCT01533428|63104942|FG001|Overall Study|Withdrawal by Subject|6|||
33670187|NCT01517984|63104951|FG000|Overall Study|Lost to Follow-up|0|||
33670188|NCT01517984|63104952|FG001|Overall Study|Lost to Follow-up|1|||
33670189|NCT01517984|63104953|FG002|Overall Study|Lost to Follow-up|0|||
33670190|NCT01517984|63104954|FG003|Overall Study|Lost to Follow-up|0|||
33670191|NCT01517984|63104951|FG000|Overall Study|Withdrawal by Subject|1|||
33670192|NCT01517984|63104952|FG001|Overall Study|Withdrawal by Subject|8|||
33670193|NCT01517984|63104953|FG002|Overall Study|Withdrawal by Subject|4|||
33670194|NCT01517984|63104954|FG003|Overall Study|Withdrawal by Subject|1|||
33670195|NCT01517984|63104951|FG000|Overall Study|Screen Failure|4|||
33670196|NCT01517984|63104952|FG001|Overall Study|Screen Failure|0|||
33670197|NCT01517984|63104953|FG002|Overall Study|Screen Failure|0|||
33670198|NCT01517984|63104954|FG003|Overall Study|Screen Failure|0|||
33670199|NCT01517984|63104951|FG000|Overall Study|Ineligible for randomization|0|||
33670200|NCT01517984|63104952|FG001|Overall Study|Ineligible for randomization|14|||
33670201|NCT01517984|63104953|FG002|Overall Study|Ineligible for randomization|0|||
33670202|NCT01517984|63104954|FG003|Overall Study|Ineligible for randomization|0|||
33670203|NCT01517750|63104982|FG000|Overall Study|Lost to Follow-up|1|||
33670204|NCT01517750|63104983|FG001|Overall Study|Lost to Follow-up|2|||
33670205|NCT01517750|63104984|FG002|Overall Study|Lost to Follow-up|4|||
33670206|NCT01517750|63104985|FG003|Overall Study|Lost to Follow-up|1|||
33670207|NCT01548404|63105010|FG000|Overall Study|Adverse Event|3|||
33670208|NCT01548404|63105011|FG001|Overall Study|Adverse Event|1|||
33670209|NCT01548404|63105010|FG000|Overall Study|Physician Decision|2|||
33670210|NCT01548404|63105011|FG001|Overall Study|Physician Decision|1|||
33670211|NCT01548404|63105010|FG000|Overall Study|Inadequate response to study treatment|23|||
33670212|NCT01548404|63105011|FG001|Overall Study|Inadequate response to study treatment|7|||
33670213|NCT01548404|63105010|FG000|Overall Study|Lost to Follow-up|2|||
33670214|NCT01548404|63105011|FG001|Overall Study|Lost to Follow-up|0|||
33670215|NCT01548404|63105010|FG000|Overall Study|Withdrawal by Subject|0|||
33670216|NCT01548404|63105011|FG001|Overall Study|Withdrawal by Subject|3|||
33670217|NCT01548404|63105010|FG000|Overall Study|Other than specified above|0|||
33670218|NCT01548404|63105011|FG001|Overall Study|Other than specified above|2|||
33670219|NCT01547780|63105025|FG000|Baseline PET Scan|Physician Decision|1|||
33670220|NCT01547780|63105026|FG001|Baseline PET Scan|Physician Decision|0|||
33670221|NCT01547780|63105027|FG002|Baseline PET Scan|Physician Decision|1|||
33670222|NCT01547780|63105028|FG003|Baseline PET Scan|Physician Decision|0|||
33670223|NCT01547780|63105025|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
33670224|NCT01547780|63105026|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
33670225|NCT01547780|63105027|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
33670226|NCT01547780|63105028|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
33670227|NCT01547390|63105050|FG000|Overall Study|Withdrawal by Subject|10|||
33670228|NCT01547390|63105051|FG001|Overall Study|Withdrawal by Subject|7|||
33670229|NCT01547390|63105050|FG000|Overall Study|termination of pregnancy|0|||
33670230|NCT01547390|63105051|FG001|Overall Study|termination of pregnancy|1|||
33670231|NCT01547390|63105050|FG000|Overall Study|Lost to Follow-up|0|||
33670232|NCT01547390|63105051|FG001|Overall Study|Lost to Follow-up|2|||
33670233|NCT01547390|63105050|FG000|Overall Study|Adverse Event|3|||
33670234|NCT01547390|63105051|FG001|Overall Study|Adverse Event|0|||
33670235|NCT01546922|63105057|FG000|First Period of 10 Weeks|Protocol Violation|3|||
33670236|NCT01546922|63105058|FG001|First Period of 10 Weeks|Protocol Violation|1|||
33670237|NCT01546922|63105057|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
33670238|NCT01546922|63105058|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
33670239|NCT01546922|63105057|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
33670240|NCT01546922|63105058|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
33670241|NCT01546922|63105057|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
33670242|NCT01546922|63105058|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
33670243|NCT01546922|63105057|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
33670244|NCT01546922|63105058|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
33670245|NCT01532648|63105075|FG000|Overall Study|Lost to Follow-up|3|||
33670246|NCT01532648|63105076|FG001|Overall Study|Lost to Follow-up|4|||
33670247|NCT01532648|63105075|FG000|Overall Study|Lack of Efficacy|4|||
33670248|NCT01532648|63105076|FG001|Overall Study|Lack of Efficacy|1|||
33670249|NCT01532648|63105075|FG000|Overall Study|Protocol Violation|1|||
33670250|NCT01532648|63105076|FG001|Overall Study|Protocol Violation|1|||
33670251|NCT01532648|63105075|FG000|Overall Study|Adverse Event|12|||
33670252|NCT01532648|63105076|FG001|Overall Study|Adverse Event|9|||
33670253|NCT01532648|63105075|FG000|Overall Study|Withdrawal by Subject|16|||
33670254|NCT01532648|63105076|FG001|Overall Study|Withdrawal by Subject|2|||
33670255|NCT01532570|63105106|FG000|Overall Study|Lack of Efficacy|1|||
33670256|NCT01532570|63105107|FG001|Overall Study|Lack of Efficacy|0|||
33670257|NCT01532570|63105108|FG002|Overall Study|Lack of Efficacy|0|||
33670258|NCT01532570|63105109|FG003|Overall Study|Lack of Efficacy|0|||
33670259|NCT01532570|63105106|FG000|Overall Study|Withdrawal by Subject|0|||
33670260|NCT01532570|63105107|FG001|Overall Study|Withdrawal by Subject|1|||
33670261|NCT01532570|63105108|FG002|Overall Study|Withdrawal by Subject|0|||
33670262|NCT01532570|63105109|FG003|Overall Study|Withdrawal by Subject|0|||
33670263|NCT01532414|63105142|FG000|Overall Study|Lost to Follow-up|3|||
33670264|NCT01532414|63105143|FG001|Overall Study|Lost to Follow-up|0|||
33670265|NCT01532414|63105144|FG002|Overall Study|Lost to Follow-up|1|||
33670266|NCT01532414|63105142|FG000|Overall Study|Withdrawal by Subject|3|||
33670267|NCT01532414|63105143|FG001|Overall Study|Withdrawal by Subject|0|||
33670268|NCT01532414|63105144|FG002|Overall Study|Withdrawal by Subject|0|||
33670269|NCT01532414|63105142|FG000|Overall Study|No V6 semen sample|0|||
33670270|NCT01532414|63105143|FG001|Overall Study|No V6 semen sample|1|||
33670271|NCT01532414|63105144|FG002|Overall Study|No V6 semen sample|0|||
33670272|NCT01532414|63105142|FG000|Overall Study|Adverse Event|0|||
33670273|NCT01532414|63105143|FG001|Overall Study|Adverse Event|1|||
33670274|NCT01532414|63105144|FG002|Overall Study|Adverse Event|1|||
33670275|NCT01532414|63105142|FG000|Overall Study|Unable to complete 24 hour PK|0|||
33670276|NCT01532414|63105143|FG001|Overall Study|Unable to complete 24 hour PK|0|||
33670277|NCT01532414|63105144|FG002|Overall Study|Unable to complete 24 hour PK|1|||
33670278|NCT01532414|63105142|FG000|Overall Study|Withdrawn by sponsor|1|||
33670279|NCT01532414|63105143|FG001|Overall Study|Withdrawn by sponsor|0|||
33670280|NCT01532414|63105144|FG002|Overall Study|Withdrawn by sponsor|0|||
33670281|NCT01441973|63105154|FG000|Overall Study|Disease progression|8|||
33670282|NCT01441973|63105155|FG001|Overall Study|Disease progression|6|||
33670283|NCT01441973|63105154|FG000|Overall Study|Adverse event unrelated to study drug|3|||
33670284|NCT01441973|63105155|FG001|Overall Study|Adverse event unrelated to study drug|2|||
33670285|NCT01441973|63105154|FG000|Overall Study|Participant request to discontinue|1|||
33670286|NCT01441973|63105155|FG001|Overall Study|Participant request to discontinue|1|||
33670287|NCT01441973|63105154|FG000|Overall Study|Poor compliance/noncompliance|0|||
33670288|NCT01441973|63105155|FG001|Overall Study|Poor compliance/noncompliance|1|||
33670289|NCT01441973|63105154|FG000|Overall Study|Administrative reason by sponsor|3|||
33670290|NCT01441973|63105155|FG001|Overall Study|Administrative reason by sponsor|5|||
33670291|NCT01441973|63105154|FG000|Overall Study|Participant withdrew consent|0|||
33670292|NCT01441973|63105155|FG001|Overall Study|Participant withdrew consent|1|||
33670293|NCT01575899|63105174|FG000|Overall Study|Lost to Follow-up|3|||
33670294|NCT01575899|63105175|FG001|Overall Study|Lost to Follow-up|4|||
33670295|NCT01575899|63105176|FG002|Overall Study|Lost to Follow-up|2|||
33670296|NCT01575899|63105174|FG000|Overall Study|Protocol Violation|2|||
33670297|NCT01575899|63105175|FG001|Overall Study|Protocol Violation|1|||
33670298|NCT01575899|63105176|FG002|Overall Study|Protocol Violation|0|||
33670299|NCT01440881|63105188|FG000|Overall Study|Death|0|||
33670300|NCT01440881|63105189|FG001|Overall Study|Death|1|||
33670301|NCT01575197|63105204|FG000|Overall Study|Migration out of study area|1|||
33670302|NCT01575197|63105205|FG001|Overall Study|Migration out of study area|5|||
33670303|NCT01575197|63105206|FG002|Overall Study|Migration out of study area|4|||
33670304|NCT01575197|63105204|FG000|Overall Study|SAE|0|||
33670305|NCT01575197|63105205|FG001|Overall Study|SAE|1|||
33670306|NCT01575197|63105206|FG002|Overall Study|SAE|0|||
33670307|NCT01575197|63105204|FG000|Overall Study|Lost to Follow-up|0|||
33670308|NCT01575197|63105205|FG001|Overall Study|Lost to Follow-up|1|||
33670309|NCT01575197|63105206|FG002|Overall Study|Lost to Follow-up|0|||
33670310|NCT01575197|63105204|FG000|Overall Study|Withdrawal by Subject|0|||
33670311|NCT01575197|63105205|FG001|Overall Study|Withdrawal by Subject|1|||
33670312|NCT01575197|63105206|FG002|Overall Study|Withdrawal by Subject|1|||
33670313|NCT01575197|63105204|FG000|Overall Study|Protocol Violation|2|||
33670314|NCT01575197|63105205|FG001|Overall Study|Protocol Violation|1|||
33670315|NCT01575197|63105206|FG002|Overall Study|Protocol Violation|1|||
33670316|NCT01574651|63105237|FG000|Overall Study|Lost to Follow-up|2|||
33670317|NCT01574651|63105238|FG001|Overall Study|Lost to Follow-up|4|||
33670318|NCT01574651|63105237|FG000|Overall Study|Administrative problems|0|||
33670319|NCT01574651|63105238|FG001|Overall Study|Administrative problems|1|||
33670320|NCT01574651|63105237|FG000|Overall Study|Death|3|||
33670321|NCT01574651|63105238|FG001|Overall Study|Death|3|||
33670322|NCT01574651|63105237|FG000|Overall Study|Patient's inability to use the device|0|||
33670323|NCT01574651|63105238|FG001|Overall Study|Patient's inability to use the device|1|||
33670324|NCT01574651|63105237|FG000|Overall Study|Adverse Event|36|||
33670325|NCT01574651|63105238|FG001|Overall Study|Adverse Event|27|||
33670326|NCT01574651|63105237|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33670327|NCT01574651|63105238|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33670328|NCT01574651|63105237|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33670329|NCT01574651|63105238|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33670330|NCT01574651|63105237|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
33670331|NCT01574651|63105238|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33670332|NCT01574651|63105237|FG000|Overall Study|Protocol Violation|3|||
33670333|NCT01574651|63105238|FG001|Overall Study|Protocol Violation|5|||
33670334|NCT01574651|63105237|FG000|Overall Study|Withdrawal by Subject|9|||
33670335|NCT01574651|63105238|FG001|Overall Study|Withdrawal by Subject|10|||
33670336|NCT01440803|63105250|FG000|Overall Study|Met study stopping rule|2|||
33670337|NCT01440803|63105251|FG001|Overall Study|Met study stopping rule|1|||
33670338|NCT01440803|63105250|FG000|Overall Study|Lost to Follow-up|0|||
33670339|NCT01440803|63105251|FG001|Overall Study|Lost to Follow-up|2|||
33670340|NCT01440803|63105250|FG000|Overall Study|Withdrawal by Subject|0|||
33670341|NCT01440803|63105251|FG001|Overall Study|Withdrawal by Subject|1|||
33670342|NCT01517282|63105262|FG000|Overall Study|Consent withdrawn|0|||
33670343|NCT01517282|63105263|FG001|Overall Study|Consent withdrawn|1|||
33670344|NCT01517282|63105264|FG002|Overall Study|Consent withdrawn|1|||
33670345|NCT01517282|63105265|FG003|Overall Study|Consent withdrawn|1|||
33670346|NCT01517282|63105262|FG000|Overall Study|Physician Decision|1|||
33670347|NCT01517282|63105263|FG001|Overall Study|Physician Decision|0|||
33670348|NCT01517282|63105264|FG002|Overall Study|Physician Decision|0|||
33670349|NCT01517282|63105265|FG003|Overall Study|Physician Decision|0|||
33670350|NCT01440647|63105286|FG000|Overall Study|Death|2|||
33670351|NCT01440647|63105287|FG001|Overall Study|Death|3|||
33670352|NCT01516970|63105295|FG000|Overall Study|Lost to Follow-up|7|||
33670353|NCT01516970|63105296|FG001|Overall Study|Lost to Follow-up|8|||
33670354|NCT01516970|63105295|FG000|Overall Study|Adverse Event|1|||
33670355|NCT01516970|63105296|FG001|Overall Study|Adverse Event|5|||
33670356|NCT01516970|63105295|FG000|Overall Study|Withdrawal by Subject|1|||
33670357|NCT01516970|63105296|FG001|Overall Study|Withdrawal by Subject|1|||
33670358|NCT01516970|63105295|FG000|Overall Study|Other|9|||
33670359|NCT01516970|63105296|FG001|Overall Study|Other|7|||
33670360|NCT01516892|63105317|FG000|Overall Study|Adverse Event|25|||
33670361|NCT01516892|63105317|FG000|Overall Study|Lack of Efficacy|35|||
33670362|NCT01516892|63105317|FG000|Overall Study|Pregnancy|5|||
33670363|NCT01516892|63105317|FG000|Overall Study|Lost to Follow-up|82|||
33670364|NCT01516892|63105317|FG000|Overall Study|Subject Withdrew Consent|92|||
33670365|NCT01516892|63105317|FG000|Overall Study|Protocol Violation|60|||
33670366|NCT01516892|63105317|FG000|Overall Study|Other Miscellaneous Reasons|43|||
33670367|NCT01516892|63105317|FG000|Overall Study|Missing|1|||
33670368|NCT01516736|63105342|FG000|Overall Study|Withdrawal by Subject|10|||
33670369|NCT01516736|63105343|FG001|Overall Study|Withdrawal by Subject|4|||
33670370|NCT01516736|63105342|FG000|Overall Study|Adverse Event|4|||
33670371|NCT01516736|63105343|FG001|Overall Study|Adverse Event|5|||
33670372|NCT01516736|63105342|FG000|Overall Study|Death|3|||
33670373|NCT01516736|63105343|FG001|Overall Study|Death|1|||
33670374|NCT01516736|63105342|FG000|Overall Study|Physician Decision|2|||
33670375|NCT01516736|63105343|FG001|Overall Study|Physician Decision|1|||
33670376|NCT01516736|63105342|FG000|Overall Study|Lack of Efficacy|1|||
33670377|NCT01516736|63105343|FG001|Overall Study|Lack of Efficacy|0|||
33670378|NCT01516736|63105342|FG000|Overall Study|Protocol Violation|0|||
33670379|NCT01516736|63105343|FG001|Overall Study|Protocol Violation|1|||
33670380|NCT01516736|63105342|FG000|Overall Study|Other (not specified)|0|||
33670381|NCT01516736|63105343|FG001|Overall Study|Other (not specified)|1|||
33670382|NCT01546688|63105355|FG000|Overall Study|Adverse Event|0|||
33670383|NCT01546688|63105356|FG001|Overall Study|Adverse Event|4|||
33670384|NCT01546688|63105355|FG000|Overall Study|Withdrawal by Subject|2|||
33670385|NCT01546688|63105356|FG001|Overall Study|Withdrawal by Subject|1|||
33670386|NCT01546688|63105355|FG000|Overall Study|Lack of Efficacy|1|||
33670387|NCT01546688|63105356|FG001|Overall Study|Lack of Efficacy|0|||
33670388|NCT01516034|63105362|FG000|Overall Study|Physician Decision|1|||
33670389|NCT01516034|63105362|FG000|Overall Study|Lack of Efficacy|7|||
33670390|NCT01440569|63105373|FG000|Main Study|Enrolled but not treated|1|||
33670391|NCT01440569|63105374|FG001|Main Study|Enrolled but not treated|0|||
33670392|NCT01440569|63105373|FG000|Main Study|Adverse Event|9|||
33670393|NCT01440569|63105374|FG001|Main Study|Adverse Event|0|||
33670394|NCT01440569|63105373|FG000|Main Study|Pregnancy|1|||
33670395|NCT01440569|63105374|FG001|Main Study|Pregnancy|0|||
33670396|NCT01440569|63105373|FG000|Main Study|Investigator's Discretion|1|||
33670397|NCT01440569|63105374|FG001|Main Study|Investigator's Discretion|1|||
33670398|NCT01440569|63105373|FG000|Main Study|Withdrew Consent|7|||
33670399|NCT01440569|63105374|FG001|Main Study|Withdrew Consent|1|||
33670400|NCT01440569|63105373|FG000|Main Study|Lost to Follow-up|13|||
33670401|NCT01440569|63105374|FG001|Main Study|Lost to Follow-up|2|||
33670402|NCT01440569|63105373|FG000|Main Study|Subject Non-Compliance|3|||
33670403|NCT01440569|63105374|FG001|Main Study|Subject Non-Compliance|0|||
33670404|NCT01440569|63105373|FG000|Main Study|Protocol Violation|1|||
33670405|NCT01440569|63105374|FG001|Main Study|Protocol Violation|0|||
33670406|NCT01440569|63105373|FG000|Open-Label Rollover Phase|Adverse Event|3|||
33670407|NCT01440569|63105374|FG001|Open-Label Rollover Phase|Adverse Event|0|||
33670408|NCT01440569|63105373|FG000|Open-Label Rollover Phase|Pregnancy|1|||
33670409|NCT01440569|63105374|FG001|Open-Label Rollover Phase|Pregnancy|0|||
33670410|NCT01440569|63105373|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
33670411|NCT01440569|63105374|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
33670412|NCT01440569|63105373|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
33670413|NCT01440569|63105374|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
33670414|NCT01440569|63105373|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
33670415|NCT01440569|63105374|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
33670416|NCT01440569|63105373|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
33670417|NCT01440569|63105374|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
33670418|NCT01440569|63105373|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
33670419|NCT01440569|63105374|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
33670420|NCT01546142|63105397|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
33670421|NCT01546142|63105398|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
33670422|NCT01546142|63105397|FG000|Overall Study|Subject Noncompliance|1|||
33670423|NCT01546142|63105398|FG001|Overall Study|Subject Noncompliance|1|||
33670424|NCT01546142|63105397|FG000|Overall Study|Adverse Event|6|||
33670425|NCT01546142|63105398|FG001|Overall Study|Adverse Event|3|||
33670426|NCT01546142|63105397|FG000|Overall Study|Lost to Follow-up|20|||
33670427|NCT01546142|63105398|FG001|Overall Study|Lost to Follow-up|15|||
33670428|NCT01546142|63105397|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
33670429|NCT01546142|63105398|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
33670430|NCT01546142|63105397|FG000|Overall Study|Subject Randomized but Not Treated|1|||
33670431|NCT01546142|63105398|FG001|Overall Study|Subject Randomized but Not Treated|0|||
33670432|NCT01440101|63105432|FG000|Overall Study|Adverse Event|2|||
33670433|NCT01440101|63105433|FG001|Overall Study|Adverse Event|0|||
33670434|NCT01440101|63105434|FG002|Overall Study|Adverse Event|0|||
33670435|NCT01440101|63105432|FG000|Overall Study|Withdrawal by Subject|0|||
33670436|NCT01440101|63105433|FG001|Overall Study|Withdrawal by Subject|3|||
33670437|NCT01440101|63105434|FG002|Overall Study|Withdrawal by Subject|1|||
33670438|NCT01440101|63105432|FG000|Overall Study|Other|0|||
33670439|NCT01440101|63105433|FG001|Overall Study|Other|1|||
33670440|NCT01440101|63105434|FG002|Overall Study|Other|0|||
33670441|NCT01530464|63105445|FG000|Washout (24h)|Withdrawal by Subject|1|||
33670442|NCT01530464|63105446|FG001|Washout (24h)|Withdrawal by Subject|0|||
33670443|NCT01530464|63105445|FG000|Washout (24h)|Withdrawal by Subject|0|||
33670444|NCT01530464|63105446|FG001|Washout (24h)|Withdrawal by Subject|1|||
33670445|NCT01439945|63105513|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
33670446|NCT01439945|63105514|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
33670447|NCT01439945|63105515|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
33670448|NCT01439945|63105516|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
33670449|NCT01439945|63105513|FG000|Double-Blind Treatment Phase|Ineligible|1|||
33670450|NCT01439945|63105514|FG001|Double-Blind Treatment Phase|Ineligible|2|||
33670451|NCT01439945|63105515|FG002|Double-Blind Treatment Phase|Ineligible|0|||
33670452|NCT01439945|63105516|FG003|Double-Blind Treatment Phase|Ineligible|1|||
33670453|NCT01420081|63105621|FG000|Overall Study|Death|1|||
33670454|NCT01420081|63105622|FG001|Overall Study|Death|0|||
33670455|NCT01420081|63105623|FG002|Overall Study|Death|8|||
33670456|NCT01420081|63105624|FG003|Overall Study|Death|0|||
33670457|NCT01420081|63105625|FG004|Overall Study|Death|7|||
33670458|NCT01420081|63105626|FG005|Overall Study|Death|12|||
33670459|NCT01420081|63105627|FG006|Overall Study|Death|0|||
33670460|NCT01420081|63105628|FG007|Overall Study|Death|1|||
33670461|NCT01420081|63105629|FG008|Overall Study|Death|1|||
33670462|NCT01420081|63105621|FG000|Overall Study|Lost to Follow-up|0|||
33670463|NCT01420081|63105622|FG001|Overall Study|Lost to Follow-up|0|||
33670464|NCT01420081|63105623|FG002|Overall Study|Lost to Follow-up|0|||
33670465|NCT01420081|63105624|FG003|Overall Study|Lost to Follow-up|0|||
33670466|NCT01420081|63105625|FG004|Overall Study|Lost to Follow-up|1|||
33670467|NCT01420081|63105626|FG005|Overall Study|Lost to Follow-up|1|||
33670468|NCT01420081|63105627|FG006|Overall Study|Lost to Follow-up|0|||
33670469|NCT01420081|63105628|FG007|Overall Study|Lost to Follow-up|0|||
33670470|NCT01420081|63105629|FG008|Overall Study|Lost to Follow-up|0|||
33670471|NCT01420081|63105621|FG000|Overall Study|Study Terminated by Sponsor|2|||
33670472|NCT01420081|63105622|FG001|Overall Study|Study Terminated by Sponsor|1|||
33670473|NCT01420081|63105623|FG002|Overall Study|Study Terminated by Sponsor|1|||
33670474|NCT01420081|63105624|FG003|Overall Study|Study Terminated by Sponsor|3|||
33670475|NCT01420081|63105625|FG004|Overall Study|Study Terminated by Sponsor|11|||
33670476|NCT01420081|63105626|FG005|Overall Study|Study Terminated by Sponsor|7|||
33670477|NCT01420081|63105627|FG006|Overall Study|Study Terminated by Sponsor|3|||
33670478|NCT01420081|63105628|FG007|Overall Study|Study Terminated by Sponsor|2|||
33670479|NCT01420081|63105629|FG008|Overall Study|Study Terminated by Sponsor|2|||
33670480|NCT01420081|63105621|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
33670481|NCT01420081|63105622|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
33670482|NCT01420081|63105623|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
33670483|NCT01420081|63105624|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
33670484|NCT01420081|63105625|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
33670485|NCT01420081|63105626|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
33670486|NCT01420081|63105627|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
33670487|NCT01420081|63105628|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
33670488|NCT01420081|63105629|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
33670489|NCT01420081|63105621|FG000|Overall Study|Other Reasons|0|||
33670490|NCT01420081|63105622|FG001|Overall Study|Other Reasons|0|||
33670491|NCT01420081|63105623|FG002|Overall Study|Other Reasons|1|||
33670492|NCT01420081|63105624|FG003|Overall Study|Other Reasons|0|||
33670493|NCT01420081|63105625|FG004|Overall Study|Other Reasons|0|||
33670494|NCT01420081|63105626|FG005|Overall Study|Other Reasons|0|||
33670495|NCT01420081|63105627|FG006|Overall Study|Other Reasons|0|||
33670496|NCT01420081|63105628|FG007|Overall Study|Other Reasons|0|||
33670497|NCT01420081|63105629|FG008|Overall Study|Other Reasons|0|||
33670498|NCT01439867|63105647|FG000|Overall Study|Non-compliance|0|||
33670499|NCT01439867|63105648|FG001|Overall Study|Non-compliance|1|||
33670500|NCT01439867|63105647|FG000|Overall Study|Withdrawal by Subject|1|||
33670501|NCT01439867|63105648|FG001|Overall Study|Withdrawal by Subject|2|||
33670502|NCT01439867|63105647|FG000|Overall Study|Administrative Decision|4|||
33670503|NCT01439867|63105648|FG001|Overall Study|Administrative Decision|5|||
33670504|NCT01439867|63105647|FG000|Overall Study|Protocol-specified Criteria|1|||
33670505|NCT01439867|63105648|FG001|Overall Study|Protocol-specified Criteria|0|||
33670506|NCT01439711|63105665|FG000|Overall Study|Ineligible|13|||
33670507|NCT01439711|63105665|FG000|Overall Study|Cancel|3|||
33670508|NCT01439711|63105665|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
33670509|NCT01439711|63105665|FG000|Overall Study|Adverse Event|5|||
33670510|NCT01439711|63105665|FG000|Overall Study|Withdrawal by Subject|3|||
33670511|NCT01439711|63105665|FG000|Overall Study|Progression During Active Tx|3|||
33670512|NCT01439711|63105665|FG000|Overall Study|Noncompliance|3|||
33670513|NCT01439711|63105665|FG000|Overall Study|No MRI|9|||
33670514|NCT01439555|63105669|FG000|Overall Study|Protocol Violation|1|||
33670515|NCT01544582|63105689|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
33670516|NCT01544582|63105690|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
33670517|NCT01544582|63105691|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
33670518|NCT01544582|63105692|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
33670519|NCT01544582|63105689|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
33670520|NCT01544582|63105690|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
33670521|NCT01544582|63105691|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
33670522|NCT01544582|63105692|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
33670523|NCT01544582|63105689|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
33670524|NCT01544582|63105690|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
33670525|NCT01544582|63105691|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
33670526|NCT01544582|63105692|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
33670527|NCT01544582|63105689|FG000|Analysis Population|Physician Decision|0|||
33670528|NCT01544582|63105690|FG001|Analysis Population|Physician Decision|13|||
33670529|NCT01544582|63105691|FG002|Analysis Population|Physician Decision|10|||
33670530|NCT01544582|63105692|FG003|Analysis Population|Physician Decision|9|||
33670531|NCT01544582|63105689|FG000|Analysis Population|Safety Reason|0|||
33670532|NCT01544582|63105690|FG001|Analysis Population|Safety Reason|33|||
33670533|NCT01544582|63105691|FG002|Analysis Population|Safety Reason|31|||
33670534|NCT01544582|63105692|FG003|Analysis Population|Safety Reason|8|||
33670535|NCT01544582|63105689|FG000|Analysis Population|Effectiveness Reason|0|||
33670536|NCT01544582|63105690|FG001|Analysis Population|Effectiveness Reason|48|||
33670537|NCT01544582|63105691|FG002|Analysis Population|Effectiveness Reason|29|||
33670538|NCT01544582|63105692|FG003|Analysis Population|Effectiveness Reason|12|||
33670539|NCT01544582|63105689|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
33670540|NCT01544582|63105690|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
33670541|NCT01544582|63105691|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
33670542|NCT01544582|63105692|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
33670543|NCT01544582|63105689|FG000|Analysis Population|Lost to Follow-up|0|||
33670544|NCT01544582|63105690|FG001|Analysis Population|Lost to Follow-up|6|||
33670545|NCT01544582|63105691|FG002|Analysis Population|Lost to Follow-up|6|||
33670546|NCT01544582|63105692|FG003|Analysis Population|Lost to Follow-up|5|||
33670547|NCT01544582|63105689|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
33670548|NCT01544582|63105690|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
33670549|NCT01544582|63105691|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
33670550|NCT01544582|63105692|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
33670551|NCT01544582|63105689|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
33670552|NCT01544582|63105690|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
33670553|NCT01544582|63105691|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
33670554|NCT01544582|63105692|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
33670555|NCT01544582|63105689|FG000|Analysis Population|Intolerance|0|||
33670556|NCT01544582|63105690|FG001|Analysis Population|Intolerance|1|||
33670557|NCT01544582|63105691|FG002|Analysis Population|Intolerance|0|||
33670558|NCT01544582|63105692|FG003|Analysis Population|Intolerance|0|||
33670559|NCT01544582|63105689|FG000|Analysis Population|Liver Transplantation|0|||
33670560|NCT01544582|63105690|FG001|Analysis Population|Liver Transplantation|0|||
33670561|NCT01544582|63105691|FG002|Analysis Population|Liver Transplantation|1|||
33670562|NCT01544582|63105692|FG003|Analysis Population|Liver Transplantation|0|||
33670563|NCT01544582|63105689|FG000|Analysis Population|No Social Insurance|0|||
33670564|NCT01544582|63105690|FG001|Analysis Population|No Social Insurance|0|||
33670565|NCT01544582|63105691|FG002|Analysis Population|No Social Insurance|1|||
33670566|NCT01544582|63105692|FG003|Analysis Population|No Social Insurance|0|||
33670567|NCT01544582|63105689|FG000|Analysis Population|Poor Adherence|0|||
33670568|NCT01544582|63105690|FG001|Analysis Population|Poor Adherence|0|||
33670569|NCT01544582|63105691|FG002|Analysis Population|Poor Adherence|1|||
33670570|NCT01544582|63105692|FG003|Analysis Population|Poor Adherence|0|||
33670571|NCT01544582|63105689|FG000|Analysis Population|Poor Participant Compliance|0|||
33670572|NCT01544582|63105690|FG001|Analysis Population|Poor Participant Compliance|1|||
33670573|NCT01544582|63105691|FG002|Analysis Population|Poor Participant Compliance|0|||
33670574|NCT01544582|63105692|FG003|Analysis Population|Poor Participant Compliance|0|||
33670575|NCT01544582|63105689|FG000|Analysis Population|Programmed Surgery|0|||
33670576|NCT01544582|63105690|FG001|Analysis Population|Programmed Surgery|1|||
33670577|NCT01544582|63105691|FG002|Analysis Population|Programmed Surgery|0|||
33670578|NCT01544582|63105692|FG003|Analysis Population|Programmed Surgery|0|||
33308429|NCT02993523|62683736|FG004|Overall Study|Withdrew Consent|0|||
33670579|NCT01544582|63105689|FG000|Analysis Population|Participant in Jail|0|||
33670580|NCT01544582|63105690|FG001|Analysis Population|Participant in Jail|0|||
33670581|NCT01544582|63105691|FG002|Analysis Population|Participant in Jail|1|||
33670582|NCT01544582|63105692|FG003|Analysis Population|Participant in Jail|0|||
33670583|NCT01439165|63105720|FG000|Overall Study|Protocol Violation|3|||
33670584|NCT01439165|63105721|FG001|Overall Study|Protocol Violation|0|||
33670585|NCT01439165|63105720|FG000|Overall Study|Lost to Follow-up|11|||
33670586|NCT01439165|63105721|FG001|Overall Study|Lost to Follow-up|1|||
33670587|NCT01439165|63105720|FG000|Overall Study|Withdrawal by Subject|7|||
33670588|NCT01439165|63105721|FG001|Overall Study|Withdrawal by Subject|1|||
33670589|NCT01529606|63105735|FG000|Overall Study|Lost to Follow-up|21|||
33670590|NCT01529606|63105736|FG001|Overall Study|Lost to Follow-up|18|||
33670591|NCT01439009|63105753|FG000|Overall Study|Physician Decision|5|||
33670592|NCT01439009|63105754|FG001|Overall Study|Physician Decision|3|||
33670593|NCT01439009|63105753|FG000|Overall Study|Protocol Violation|2|||
33670594|NCT01439009|63105754|FG001|Overall Study|Protocol Violation|0|||
33670595|NCT01439009|63105753|FG000|Overall Study|Deviation of exclusion criteria|1|||
33670596|NCT01439009|63105754|FG001|Overall Study|Deviation of exclusion criteria|0|||
33670597|NCT01572389|63105773|FG000|Overall Study|Death|1|||
33670598|NCT01572389|63105774|FG001|Overall Study|Death|3|||
33670599|NCT01572389|63105773|FG000|Overall Study|Withdrawal by Subject|14|||
33670600|NCT01572389|63105774|FG001|Overall Study|Withdrawal by Subject|2|||
33670601|NCT01572389|63105773|FG000|Overall Study|Lost to Follow-up|25|||
33670602|NCT01572389|63105774|FG001|Overall Study|Lost to Follow-up|14|||
33670603|NCT01572389|63105773|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
33670604|NCT01572389|63105774|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
33670605|NCT01571453|63105786|FG000|Overall Study|Adverse Event|14|||
33670606|NCT01571453|63105787|FG001|Overall Study|Adverse Event|32|||
33670607|NCT01571453|63105786|FG000|Overall Study|Lack of Efficacy|8|||
33670608|NCT01571453|63105787|FG001|Overall Study|Lack of Efficacy|3|||
33670609|NCT01571453|63105786|FG000|Overall Study|Non-compliance|2|||
33670610|NCT01571453|63105787|FG001|Overall Study|Non-compliance|4|||
33670611|NCT01571453|63105786|FG000|Overall Study|Protocol Violation|1|||
33670612|NCT01571453|63105787|FG001|Overall Study|Protocol Violation|5|||
33670613|NCT01571453|63105786|FG000|Overall Study|Withdrawal of consent|5|||
33670614|NCT01571453|63105787|FG001|Overall Study|Withdrawal of consent|13|||
33670615|NCT01571453|63105786|FG000|Overall Study|Lost to Follow-up|4|||
33670616|NCT01571453|63105787|FG001|Overall Study|Lost to Follow-up|2|||
33670617|NCT01571453|63105786|FG000|Overall Study|Administrative or other reason(s)|4|||
33670618|NCT01571453|63105787|FG001|Overall Study|Administrative or other reason(s)|3|||
33670619|NCT01446289|63105797|FG000|Overall Study|Withdrawal by Subject|1|||
33670620|NCT01446289|63105798|FG001|Overall Study|Withdrawal by Subject|0|||
33670621|NCT01446289|63105799|FG002|Overall Study|Withdrawal by Subject|1|||
33670622|NCT01446289|63105800|FG003|Overall Study|Withdrawal by Subject|0|||
33670623|NCT01438541|63105812|FG000|Overall Study|Physician Decision|1|||
33670624|NCT01438541|63105812|FG000|Overall Study|Withdrawal by Subject|1|||
33670625|NCT01438541|63105812|FG000|Overall Study|discharge from the hospital|5|||
33670626|NCT01419769|63105816|FG000|Overall Study|Did not receive the AXIOS stent|3|||
33670627|NCT01419769|63105816|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
33670628|NCT01438307|63105822|FG000|Overall Study|Death|1|||
33670629|NCT01438307|63105823|FG001|Overall Study|Death|1|||
33670630|NCT01444651|63105831|FG000|Overall Study|Adverse Event|3|||
33670631|NCT01444651|63105832|FG001|Overall Study|Adverse Event|2|||
33670632|NCT01444651|63105831|FG000|Overall Study|Lost to Follow-up|5|||
33670633|NCT01444651|63105832|FG001|Overall Study|Lost to Follow-up|5|||
33670634|NCT01444651|63105831|FG000|Overall Study|Non-fasting|2|||
33670635|NCT01444651|63105832|FG001|Overall Study|Non-fasting|1|||
33670636|NCT01444651|63105831|FG000|Overall Study|Missing data|1|||
33670637|NCT01444651|63105832|FG001|Overall Study|Missing data|1|||
33670638|NCT01570751|63105840|FG000|Period A (16 Weeks)|Protocol Violation|1|||
33670639|NCT01570751|63105841|FG001|Period A (16 Weeks)|Protocol Violation|1|||
33670640|NCT01570751|63105840|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
33670641|NCT01570751|63105841|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
33670642|NCT01570751|63105840|FG000|Period A (16 Weeks)|Unclassified|2|||
33670643|NCT01570751|63105841|FG001|Period A (16 Weeks)|Unclassified|3|||
33670644|NCT01570751|63105840|FG000|Period B (16 Weeks)|Adverse Event|1|||
33670645|NCT01570751|63105841|FG001|Period B (16 Weeks)|Adverse Event|0|||
33670646|NCT01570751|63105840|FG000|Period B (16 Weeks)|Protocol Violation|0|||
33670647|NCT01570751|63105841|FG001|Period B (16 Weeks)|Protocol Violation|1|||
33670648|NCT01419535|63105851|FG000|Overall Study|could not maintain iv line|1|||
33670649|NCT01419535|63105852|FG001|Overall Study|could not maintain iv line|1|||
33670650|NCT01419535|63105851|FG000|Overall Study|Withdrawal by Subject|0|||
33670651|NCT01419535|63105852|FG001|Overall Study|Withdrawal by Subject|1|||
33670652|NCT01438151|63105858|FG000|Overall Study|study terminated|8|||
33670653|NCT01418365|63105884|FG000|First Intervention|Withdrawal by Subject|0|||
33670654|NCT01418365|63105885|FG001|First Intervention|Withdrawal by Subject|1|||
33670655|NCT01418365|63105884|FG000|First Intervention|Non-compliance|1|||
33670656|NCT01418365|63105885|FG001|First Intervention|Non-compliance|0|||
33670657|NCT01418365|63105884|FG000|Second Intervention|Withdrawal by Subject|0|||
33670658|NCT01418365|63105885|FG001|Second Intervention|Withdrawal by Subject|1|||
33670659|NCT01437995|63105920|FG000|Overall Study|Lost to Follow-up|11|||
33670660|NCT01437995|63105921|FG001|Overall Study|Lost to Follow-up|18|||
33670661|NCT01437995|63105922|FG002|Overall Study|Lost to Follow-up|20|||
33670662|NCT01439347|63105971|FG000|Overall Study|Death|10|||
33670663|NCT01439347|63105972|FG001|Overall Study|Death|9|||
33670664|NCT01439347|63105971|FG000|Overall Study|Withdrawal by Subject|0|||
33670665|NCT01439347|63105972|FG001|Overall Study|Withdrawal by Subject|1|||
33670666|NCT01439347|63105971|FG000|Overall Study|Physician Decision|1|||
33670667|NCT01439347|63105972|FG001|Overall Study|Physician Decision|0|||
33670668|NCT01439347|63105971|FG000|Overall Study|Sponsor Terminated Study|2|||
33670669|NCT01439347|63105972|FG001|Overall Study|Sponsor Terminated Study|3|||
33670670|NCT01438957|63106019|FG000|Overall Study|Physician Decision|1|||
33670671|NCT01438957|63106020|FG001|Overall Study|Physician Decision|1|||
33670672|NCT01438957|63106021|FG002|Overall Study|Physician Decision|0|||
33670673|NCT01438957|63106022|FG003|Overall Study|Physician Decision|1|||
33670674|NCT01438957|63106023|FG004|Overall Study|Physician Decision|0|||
33670675|NCT01444417|63106072|FG000|Overall Study|Ineligibility Determined|0|||
33670676|NCT01444417|63106073|FG001|Overall Study|Ineligibility Determined|1|||
33670677|NCT01444417|63106072|FG000|Overall Study|Withdrawal by Subject|2|||
33670678|NCT01444417|63106073|FG001|Overall Study|Withdrawal by Subject|0|||
33670679|NCT01444027|63106100|FG000|Overall Study|Withdrawal by Subject|4|||
33670680|NCT01444027|63106101|FG001|Overall Study|Withdrawal by Subject|10|||
33670681|NCT01444027|63106102|FG002|Overall Study|Withdrawal by Subject|24|||
33670682|NCT01444027|63106100|FG000|Overall Study|Lost to Follow-up|26|||
33670683|NCT01444027|63106101|FG001|Overall Study|Lost to Follow-up|20|||
33670684|NCT01444027|63106102|FG002|Overall Study|Lost to Follow-up|14|||
33670685|NCT01438489|63106144|FG000|Overall Study|Lost to Follow-up|4|||
33670686|NCT01438489|63106145|FG001|Overall Study|Lost to Follow-up|2|||
33670687|NCT01438489|63106146|FG002|Overall Study|Lost to Follow-up|2|||
33670688|NCT01438489|63106144|FG000|Overall Study|Withdrawal by Subject|11|||
33670689|NCT01438489|63106145|FG001|Overall Study|Withdrawal by Subject|3|||
33670690|NCT01438489|63106146|FG002|Overall Study|Withdrawal by Subject|8|||
33670691|NCT01438489|63106144|FG000|Overall Study|Death|0|||
33670692|NCT01438489|63106145|FG001|Overall Study|Death|0|||
33670693|NCT01438489|63106146|FG002|Overall Study|Death|1|||
33670694|NCT01438489|63106144|FG000|Overall Study|Sponsor decision|4|||
33670695|NCT01438489|63106145|FG001|Overall Study|Sponsor decision|1|||
33670696|NCT01438489|63106146|FG002|Overall Study|Sponsor decision|4|||
33670697|NCT01438489|63106144|FG000|Overall Study|Subject choice/Subject moved|2|||
33670698|NCT01438489|63106145|FG001|Overall Study|Subject choice/Subject moved|1|||
33670699|NCT01438489|63106146|FG002|Overall Study|Subject choice/Subject moved|1|||
33670700|NCT01438489|63106144|FG000|Overall Study|Investigator decision|0|||
33670701|NCT01438489|63106145|FG001|Overall Study|Investigator decision|1|||
33670702|NCT01438489|63106146|FG002|Overall Study|Investigator decision|0|||
33670703|NCT01438489|63106144|FG000|Overall Study|AE/SAEs|2|||
33670704|NCT01438489|63106145|FG001|Overall Study|AE/SAEs|1|||
33670705|NCT01438489|63106146|FG002|Overall Study|AE/SAEs|1|||
33670706|NCT01438489|63106144|FG000|Overall Study|Received prohibited medication|1|||
33670707|NCT01438489|63106145|FG001|Overall Study|Received prohibited medication|0|||
33670708|NCT01438489|63106146|FG002|Overall Study|Received prohibited medication|0|||
33670709|NCT01438489|63106144|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
33670710|NCT01438489|63106145|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
33670711|NCT01438489|63106146|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
33670712|NCT01438489|63106144|FG000|Overall Study|Inadequate venous access|0|||
33670713|NCT01438489|63106145|FG001|Overall Study|Inadequate venous access|2|||
33670714|NCT01438489|63106146|FG002|Overall Study|Inadequate venous access|0|||
33670715|NCT01418209|63106172|FG000|Overall Study|Withdrawal by Subject|1|||
33670716|NCT01418209|63106173|FG001|Overall Study|Withdrawal by Subject|0|||
33670717|NCT01418209|63106174|FG002|Overall Study|Withdrawal by Subject|1|||
33670718|NCT01418209|63106172|FG000|Overall Study|Did not provide hot flash diary data|1|||
33670719|NCT01418209|63106173|FG001|Overall Study|Did not provide hot flash diary data|3|||
33670720|NCT01418209|63106174|FG002|Overall Study|Did not provide hot flash diary data|3|||
33670721|NCT01570361|63106193|FG000|Overall Study|Subject discontinued|1|||
33670722|NCT01570361|63106194|FG001|Overall Study|Subject discontinued|2|||
33670723|NCT01570361|63106193|FG000|Overall Study|Sponsor closing the study|51|||
33670724|NCT01570361|63106194|FG001|Overall Study|Sponsor closing the study|50|||
33670725|NCT01570361|63106193|FG000|Overall Study|Subject excluded|5|||
33670726|NCT01570361|63106194|FG001|Overall Study|Subject excluded|3|||
33670727|NCT01570361|63106193|FG000|Overall Study|Subject withdrew consent|14|||
33670728|NCT01570361|63106194|FG001|Overall Study|Subject withdrew consent|9|||
33670729|NCT01570361|63106193|FG000|Overall Study|Adverse Event|2|||
33670730|NCT01570361|63106194|FG001|Overall Study|Adverse Event|1|||
33670731|NCT01570361|63106193|FG000|Overall Study|Lost to Follow-up|4|||
33670732|NCT01570361|63106194|FG001|Overall Study|Lost to Follow-up|4|||
33670733|NCT01570361|63106193|FG000|Overall Study|Death|5|||
33670734|NCT01570361|63106194|FG001|Overall Study|Death|4|||
33670735|NCT01570361|63106193|FG000|Overall Study|Other|0|||
33670736|NCT01570361|63106194|FG001|Overall Study|Other|2|||
33670737|NCT01417195|63106205|FG000|Overall Study|Stimulation failure|1|||
33670738|NCT01417195|63106206|FG001|Overall Study|Stimulation failure|0|||
33670739|NCT01417195|63106205|FG000|Overall Study|No embryos for transfer|0|||
33670740|NCT01417195|63106206|FG001|Overall Study|No embryos for transfer|1|||
33670741|NCT01417195|63106205|FG000|Overall Study|No transfer due to risk of OHSS|1|||
33670742|NCT01417195|63106206|FG001|Overall Study|No transfer due to risk of OHSS|0|||
33670743|NCT01417195|63106205|FG000|Overall Study|No transfer due to elevated progesterone|1|||
33670744|NCT01417195|63106206|FG001|Overall Study|No transfer due to elevated progesterone|0|||
33670745|NCT01438411|63106231|FG000|Overall Study|Adverse Event|8|||
33670746|NCT01438411|63106231|FG000|Overall Study|Lost to Follow-up|1|||
33670747|NCT01438411|63106231|FG000|Overall Study|Lack of Efficacy|1|||
33670748|NCT01438411|63106231|FG000|Overall Study|Withdrawal by Subject|3|||
33670749|NCT01443403|63106243|FG000|Overall Study|Adverse Event|1|||
33670750|NCT01443403|63106244|FG001|Overall Study|Adverse Event|1|||
33670751|NCT01443403|63106245|FG002|Overall Study|Adverse Event|4|||
33670752|NCT01443403|63106246|FG003|Overall Study|Adverse Event|5|||
33670753|NCT01443403|63106243|FG000|Overall Study|Withdrawal by Subject|0|||
33670754|NCT01443403|63106244|FG001|Overall Study|Withdrawal by Subject|1|||
33670755|NCT01443403|63106245|FG002|Overall Study|Withdrawal by Subject|2|||
33670756|NCT01443403|63106246|FG003|Overall Study|Withdrawal by Subject|1|||
33670757|NCT01443403|63106243|FG000|Overall Study|Lost to Follow-up|0|||
33670758|NCT01443403|63106244|FG001|Overall Study|Lost to Follow-up|0|||
33670759|NCT01443403|63106245|FG002|Overall Study|Lost to Follow-up|0|||
33670760|NCT01443403|63106246|FG003|Overall Study|Lost to Follow-up|1|||
33670761|NCT01443403|63106243|FG000|Overall Study|Protocol Violation|2|||
33670762|NCT01443403|63106244|FG001|Overall Study|Protocol Violation|1|||
33670763|NCT01443403|63106245|FG002|Overall Study|Protocol Violation|1|||
33670764|NCT01443403|63106246|FG003|Overall Study|Protocol Violation|1|||
33670765|NCT01443403|63106243|FG000|Overall Study|Use of Prohibited Treatment|2|||
33670766|NCT01443403|63106244|FG001|Overall Study|Use of Prohibited Treatment|3|||
33670767|NCT01443403|63106245|FG002|Overall Study|Use of Prohibited Treatment|0|||
33670768|NCT01443403|63106246|FG003|Overall Study|Use of Prohibited Treatment|0|||
33670769|NCT01443403|63106243|FG000|Overall Study|Other - Miscellaneous|1|||
33670770|NCT01443403|63106244|FG001|Overall Study|Other - Miscellaneous|0|||
33670771|NCT01443403|63106245|FG002|Overall Study|Other - Miscellaneous|0|||
33670772|NCT01443403|63106246|FG003|Overall Study|Other - Miscellaneous|1|||
33670773|NCT01438177|63106259|FG000|Overall Study|Withdrawal by Subject|1|||
33670774|NCT01438177|63106259|FG000|Overall Study|Initiation of new therapy|1|||
33670775|NCT01442779|63106263|FG000|Overall Study|Withdrawal by Subject|3|||
33670776|NCT01442779|63106263|FG000|Overall Study|Death|3|||
33670777|NCT01442779|63106263|FG000|Overall Study|Non-compliance|1|||
33670778|NCT01416805|63106269|FG000|Overall Study|Lost to Follow-up|4|||
33670779|NCT01416805|63106270|FG001|Overall Study|Lost to Follow-up|4|||
33670780|NCT01437943|63106278|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
33670781|NCT01437943|63106279|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
33670782|NCT01437943|63106278|FG000|Overall Study|Subject expressed pregnancy plans|1|||
33670783|NCT01437943|63106279|FG001|Overall Study|Subject expressed pregnancy plans|0|||
33670784|NCT01437943|63106278|FG000|Overall Study|Adverse Event|2|||
33670785|NCT01437943|63106279|FG001|Overall Study|Adverse Event|0|||
33670786|NCT01570283|63106288|FG000|Cohort 1: Dose Level 1|Death|0|||
33670787|NCT01570283|63106289|FG001|Cohort 1: Dose Level 1|Death|1|||
33670788|NCT01570283|63106290|FG002|Cohort 1: Dose Level 1|Death|0|||
33670789|NCT01570283|63106291|FG003|Cohort 1: Dose Level 1|Death|0|||
33670790|NCT01570283|63106292|FG004|Cohort 1: Dose Level 1|Death|0|||
33670791|NCT01570283|63106293|FG005|Cohort 1: Dose Level 1|Death|0|||
33670792|NCT01570283|63106288|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
33670793|NCT01570283|63106289|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
33670794|NCT01570283|63106290|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
33670795|NCT01570283|63106291|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
33670796|NCT01570283|63106292|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
33670797|NCT01570283|63106293|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
33670798|NCT01570283|63106288|FG000|Cohort 2: Dose Level 2|Death|0|||
33670799|NCT01570283|63106289|FG001|Cohort 2: Dose Level 2|Death|0|||
33670800|NCT01570283|63106290|FG002|Cohort 2: Dose Level 2|Death|1|||
33580067|NCT01968070|62976877|FG007|Period 1|Adverse Event|0|||
33580068|NCT01968070|62976878|FG008|Period 1|Adverse Event|0|||
33580069|NCT01968070|62976879|FG009|Period 1|Adverse Event|0|||
33580070|NCT01968070|62976880|FG010|Period 1|Adverse Event|0|||
33580071|NCT01968070|62976881|FG011|Period 1|Adverse Event|0|||
33580072|NCT01968070|62976882|FG012|Period 1|Adverse Event|0|||
33580073|NCT01968070|62976883|FG013|Period 1|Adverse Event|0|||
33580074|NCT01968070|62976884|FG014|Period 1|Adverse Event|0|||
33580075|NCT01968070|62976885|FG015|Period 1|Adverse Event|0|||
33580076|NCT01968070|62976886|FG016|Period 1|Adverse Event|0|||
33580077|NCT01968070|62976887|FG017|Period 1|Adverse Event|0|||
33670801|NCT01570283|63106291|FG003|Cohort 2: Dose Level 2|Death|0|||
33670802|NCT01570283|63106292|FG004|Cohort 2: Dose Level 2|Death|0|||
33670803|NCT01570283|63106293|FG005|Cohort 2: Dose Level 2|Death|0|||
33670804|NCT01570283|63106288|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
33670805|NCT01570283|63106289|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
33670806|NCT01570283|63106290|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
33670807|NCT01570283|63106291|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
33670808|NCT01570283|63106292|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
33670809|NCT01570283|63106293|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
33670810|NCT01570283|63106288|FG000|Cohort 3: Dose Level 3|Death|0|||
33670811|NCT01570283|63106289|FG001|Cohort 3: Dose Level 3|Death|0|||
33670812|NCT01570283|63106290|FG002|Cohort 3: Dose Level 3|Death|0|||
33670813|NCT01570283|63106291|FG003|Cohort 3: Dose Level 3|Death|0|||
33670814|NCT01570283|63106292|FG004|Cohort 3: Dose Level 3|Death|0|||
33670815|NCT01570283|63106293|FG005|Cohort 3: Dose Level 3|Death|1|||
33670816|NCT01570283|63106288|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
33670817|NCT01570283|63106289|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
33670818|NCT01570283|63106290|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
33670819|NCT01570283|63106291|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
33670820|NCT01570283|63106292|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
33670821|NCT01570283|63106293|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
33670822|NCT01436357|63106309|FG000|Overall Study|Death|5|||
33670823|NCT01436357|63106310|FG001|Overall Study|Death|1|||
33670824|NCT01436357|63106309|FG000|Overall Study|Enrolled but not vaccinated|1|||
33670825|NCT01436357|63106310|FG001|Overall Study|Enrolled but not vaccinated|1|||
33670826|NCT01436357|63106309|FG000|Overall Study|Incarceration|18|||
33670827|NCT01436357|63106310|FG001|Overall Study|Incarceration|20|||
33670828|NCT01436357|63106309|FG000|Overall Study|Lost to Follow-up|67|||
33670829|NCT01436357|63106310|FG001|Overall Study|Lost to Follow-up|61|||
33670830|NCT01436357|63106309|FG000|Overall Study|Protocol Violation|1|||
33670831|NCT01436357|63106310|FG001|Overall Study|Protocol Violation|0|||
33670832|NCT01436357|63106309|FG000|Overall Study|Withdrawal by Subject|26|||
33670833|NCT01436357|63106310|FG001|Overall Study|Withdrawal by Subject|38|||
33670834|NCT01436357|63106309|FG000|Overall Study|Physician Decision|3|||
33670835|NCT01436357|63106310|FG001|Overall Study|Physician Decision|4|||
33670836|NCT01436357|63106309|FG000|Overall Study|Moved out of area|1|||
33670837|NCT01436357|63106310|FG001|Overall Study|Moved out of area|2|||
33670838|NCT01436357|63106309|FG000|Overall Study|Subject in rehab|0|||
33670839|NCT01436357|63106310|FG001|Overall Study|Subject in rehab|1|||
33670840|NCT01436201|63106316|FG000|Overall Study|Adverse Event|2|||
33670841|NCT01436201|63106316|FG000|Overall Study|Withdrawal by Subject|1|||
33670842|NCT01436201|63106316|FG000|Overall Study|Protocol Violation|1|||
33670843|NCT01437397|63106327|FG000|Overall Study|Lost to Follow-up|9|||
33670844|NCT01437397|63106328|FG001|Overall Study|Lost to Follow-up|4|||
33670845|NCT01437397|63106329|FG002|Overall Study|Lost to Follow-up|2|||
33670846|NCT01437397|63106330|FG003|Overall Study|Lost to Follow-up|4|||
33670847|NCT01437397|63106331|FG004|Overall Study|Lost to Follow-up|5|||
33670848|NCT01437397|63106327|FG000|Overall Study|Withdrawal by Subject|11|||
33670849|NCT01437397|63106328|FG001|Overall Study|Withdrawal by Subject|12|||
33670850|NCT01437397|63106329|FG002|Overall Study|Withdrawal by Subject|24|||
33670851|NCT01437397|63106330|FG003|Overall Study|Withdrawal by Subject|11|||
33670852|NCT01437397|63106331|FG004|Overall Study|Withdrawal by Subject|22|||
33670853|NCT01437397|63106327|FG000|Overall Study|Protocol Violation|10|||
33670854|NCT01437397|63106328|FG001|Overall Study|Protocol Violation|12|||
33670855|NCT01437397|63106329|FG002|Overall Study|Protocol Violation|13|||
33670856|NCT01437397|63106330|FG003|Overall Study|Protocol Violation|21|||
33670857|NCT01437397|63106331|FG004|Overall Study|Protocol Violation|19|||
33670858|NCT01437397|63106327|FG000|Overall Study|Lack of Efficacy|5|||
33670859|NCT01437397|63106328|FG001|Overall Study|Lack of Efficacy|4|||
33670860|NCT01437397|63106329|FG002|Overall Study|Lack of Efficacy|8|||
33670861|NCT01437397|63106330|FG003|Overall Study|Lack of Efficacy|10|||
33670862|NCT01437397|63106331|FG004|Overall Study|Lack of Efficacy|20|||
33670863|NCT01437397|63106327|FG000|Overall Study|Adverse Event|21|||
33670864|NCT01437397|63106328|FG001|Overall Study|Adverse Event|22|||
33670865|NCT01437397|63106329|FG002|Overall Study|Adverse Event|16|||
33308430|NCT02993523|62683732|FG000|Overall Study|Lost to Follow-up|0|||
33670866|NCT01437397|63106330|FG003|Overall Study|Adverse Event|14|||
33670867|NCT01437397|63106331|FG004|Overall Study|Adverse Event|21|||
33670868|NCT01437397|63106327|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
33670869|NCT01437397|63106328|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
33670870|NCT01437397|63106329|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
33670871|NCT01437397|63106330|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
33670872|NCT01437397|63106331|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
33670873|NCT01437319|63106343|FG000|Phase I|Lost to Follow-up|2|||
33670874|NCT01437319|63106344|FG001|Phase I|Lost to Follow-up|0|||
33670875|NCT01437319|63106345|FG002|Phase I|Lost to Follow-up|0|||
33670876|NCT01437319|63106343|FG000|Phase I|Protocol Violation|1|||
33670877|NCT01437319|63106344|FG001|Phase I|Protocol Violation|0|||
33670878|NCT01437319|63106345|FG002|Phase I|Protocol Violation|0|||
33670879|NCT01437319|63106343|FG000|Phase I|Study related symptoms/complaints|27|||
33670880|NCT01437319|63106344|FG001|Phase I|Study related symptoms/complaints|0|||
33670881|NCT01437319|63106345|FG002|Phase I|Study related symptoms/complaints|0|||
33670882|NCT01437319|63106343|FG000|Phase I|Withdrawal by Subject|25|||
33670883|NCT01437319|63106344|FG001|Phase I|Withdrawal by Subject|0|||
33670884|NCT01437319|63106345|FG002|Phase I|Withdrawal by Subject|0|||
33670885|NCT01437319|63106343|FG000|Phase II|Withdrawal by Subject|0|||
33670886|NCT01437319|63106344|FG001|Phase II|Withdrawal by Subject|8|||
33670887|NCT01437319|63106345|FG002|Phase II|Withdrawal by Subject|16|||
33670888|NCT01437319|63106343|FG000|Phase II|Lost to Follow-up|0|||
33670889|NCT01437319|63106344|FG001|Phase II|Lost to Follow-up|7|||
33670890|NCT01437319|63106345|FG002|Phase II|Lost to Follow-up|2|||
33670891|NCT01437319|63106343|FG000|Phase II|Study related symptoms/complaints|0|||
33670892|NCT01437319|63106344|FG001|Phase II|Study related symptoms/complaints|28|||
33670893|NCT01437319|63106345|FG002|Phase II|Study related symptoms/complaints|19|||
33670894|NCT01437319|63106343|FG000|Phase II|Protocol Violation|0|||
33670895|NCT01437319|63106344|FG001|Phase II|Protocol Violation|1|||
33670896|NCT01437319|63106345|FG002|Phase II|Protocol Violation|0|||
33670897|NCT01416571|63106354|FG000|Overall Study|Lost to Follow-up|2|||
33670898|NCT01442155|63106375|FG000|Overall Study|Complete remission|35|||
33670899|NCT01442155|63106375|FG000|Overall Study|Recurrence|26|||
33670900|NCT01442155|63106375|FG000|Overall Study|Adverse Event|2|||
33670901|NCT01442155|63106375|FG000|Overall Study|Lost to Follow-up|2|||
33670902|NCT01416181|63106381|FG000|Part 1|Other|10|||
33670903|NCT01416181|63106382|FG001|Part 1|Other|24|||
33670904|NCT01416181|63106381|FG000|Part 1|Death|0|||
33670905|NCT01416181|63106382|FG001|Part 1|Death|1|||
33670906|NCT01416181|63106381|FG000|Part 1|Investigator Decision|7|||
33670907|NCT01416181|63106382|FG001|Part 1|Investigator Decision|6|||
33670908|NCT01416181|63106381|FG000|Part 1|Withdrawal by Subject|74|||
33670909|NCT01416181|63106382|FG001|Part 1|Withdrawal by Subject|48|||
33670910|NCT01416181|63106381|FG000|Part 1|Lack of Efficacy|16|||
33670911|NCT01416181|63106382|FG001|Part 1|Lack of Efficacy|8|||
33670912|NCT01416181|63106381|FG000|Part 1|Lost to Follow-up|1|||
33670913|NCT01416181|63106382|FG001|Part 1|Lost to Follow-up|1|||
33670914|NCT01416181|63106381|FG000|Part 1|Adverse Event|15|||
33670915|NCT01416181|63106382|FG001|Part 1|Adverse Event|18|||
33670916|NCT01416181|63106381|FG000|Part 1|Ongoing in Follow-Up|14|||
33670917|NCT01416181|63106382|FG001|Part 1|Ongoing in Follow-Up|8|||
33670918|NCT01416181|63106381|FG000|Part 2|Adverse Event|11|||
33670919|NCT01416181|63106382|FG001|Part 2|Adverse Event|4|||
33670920|NCT01416181|63106381|FG000|Part 2|Other|234|||
33670921|NCT01416181|63106382|FG001|Part 2|Other|267|||
33670922|NCT01416181|63106381|FG000|Part 2|Investigator Decision|6|||
33670923|NCT01416181|63106382|FG001|Part 2|Investigator Decision|7|||
33670924|NCT01416181|63106381|FG000|Part 2|Withdrawal by Subject|14|||
33670925|NCT01416181|63106382|FG001|Part 2|Withdrawal by Subject|5|||
33670926|NCT01416181|63106381|FG000|Part 2|Lack of Efficacy|4|||
33670927|NCT01416181|63106382|FG001|Part 2|Lack of Efficacy|1|||
33670928|NCT01416181|63106381|FG000|Part 2|Lost to Follow-up|2|||
33670929|NCT01416181|63106382|FG001|Part 2|Lost to Follow-up|2|||
33670930|NCT01441765|63106390|FG000|Overall Study|Death|1|||
33670931|NCT01441765|63106391|FG001|Overall Study|Death|0|||
33670932|NCT01419665|63106399|FG000|Combination Treatment|Adverse Event|7|||
33670933|NCT01419665|63106400|FG001|Combination Treatment|Adverse Event|10|||
33670934|NCT01419665|63106399|FG000|Combination Treatment|Physician Decision|5|||
33670935|NCT01419665|63106400|FG001|Combination Treatment|Physician Decision|8|||
33670936|NCT01419665|63106399|FG000|Combination Treatment|Protocol Violation|6|||
33670937|NCT01419665|63106400|FG001|Combination Treatment|Protocol Violation|2|||
33670938|NCT01419665|63106399|FG000|Combination Treatment|disease progression|10|||
33670939|NCT01419665|63106400|FG001|Combination Treatment|disease progression|9|||
33670940|NCT01419665|63106399|FG000|Combination Treatment|Death|5|||
33670941|NCT01419665|63106400|FG001|Combination Treatment|Death|7|||
33670942|NCT01419665|63106399|FG000|Combination Treatment|administrative problems|0|||
33670943|NCT01419665|63106400|FG001|Combination Treatment|administrative problems|1|||
33670944|NCT01419665|63106399|FG000|Combination Treatment|Withdrawal by Subject|5|||
33670945|NCT01419665|63106400|FG001|Combination Treatment|Withdrawal by Subject|4|||
33670946|NCT01419665|63106399|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
33670947|NCT01419665|63106400|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
33670948|NCT01419665|63106399|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
33670949|NCT01419665|63106400|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
33670950|NCT01419665|63106399|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
33670951|NCT01419665|63106400|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
33670952|NCT01419665|63106399|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
33670953|NCT01419665|63106400|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
33670954|NCT01419665|63106399|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
33670955|NCT01419665|63106400|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
33670956|NCT01419665|63106399|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
33670957|NCT01419665|63106400|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
33670958|NCT01419665|63106399|FG000|Maintenance Treatment and/or Follow up|Death|1|||
33670959|NCT01419665|63106400|FG001|Maintenance Treatment and/or Follow up|Death|2|||
33670960|NCT01419665|63106399|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
33670961|NCT01419665|63106400|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
33670962|NCT01419665|63106399|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
33670963|NCT01419665|63106400|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
33670964|NCT01419665|63106399|FG000|Open Label Phase|Death|1|||
33670965|NCT01419665|63106400|FG001|Open Label Phase|Death|0|||
33670966|NCT01419665|63106399|FG000|Open Label Phase|disease progression|0|||
33670967|NCT01419665|63106400|FG001|Open Label Phase|disease progression|1|||
33670968|NCT01436305|63106411|FG000|Overall Study|Death|1|||
33670969|NCT01436305|63106412|FG001|Overall Study|Death|0|||
33670970|NCT01436305|63106413|FG002|Overall Study|Death|0|||
33670971|NCT01436305|63106411|FG000|Overall Study|Lost to Follow-up|0|||
33670972|NCT01436305|63106412|FG001|Overall Study|Lost to Follow-up|1|||
33670973|NCT01436305|63106413|FG002|Overall Study|Lost to Follow-up|0|||
33670974|NCT01436305|63106411|FG000|Overall Study|Withdrawal by Subject|1|||
33670975|NCT01436305|63106412|FG001|Overall Study|Withdrawal by Subject|3|||
33670976|NCT01436305|63106413|FG002|Overall Study|Withdrawal by Subject|0|||
33670977|NCT01436149|63106423|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
33670978|NCT01436149|63106424|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
33670979|NCT01436149|63106425|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
33670980|NCT01436149|63106423|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
33670981|NCT01436149|63106424|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
33670982|NCT01436149|63106425|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
33670983|NCT01436149|63106423|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
33670984|NCT01436149|63106424|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
33670985|NCT01436149|63106425|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
33670986|NCT01436149|63106423|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
33670987|NCT01436149|63106424|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
33670988|NCT01436149|63106425|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
33670989|NCT01436149|63106423|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
33670990|NCT01436149|63106424|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
33670991|NCT01436149|63106425|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
33670992|NCT01436149|63106423|FG000|Antidepressant Lead-in Phase|Other|119|||
33670993|NCT01436149|63106424|FG001|Antidepressant Lead-in Phase|Other|0|||
33670994|NCT01436149|63106425|FG002|Antidepressant Lead-in Phase|Other|0|||
33670995|NCT01436149|63106423|FG000|Randomized Phase|Adverse Event|9|||
33670996|NCT01436149|63106424|FG001|Randomized Phase|Adverse Event|10|||
33670997|NCT01436149|63106425|FG002|Randomized Phase|Adverse Event|11|||
33670998|NCT01436149|63106423|FG000|Randomized Phase|Protocol Violation|4|||
33670999|NCT01436149|63106424|FG001|Randomized Phase|Protocol Violation|5|||
33671000|NCT01436149|63106425|FG002|Randomized Phase|Protocol Violation|0|||
33671001|NCT01436149|63106423|FG000|Randomized Phase|Withdrawal by Subject|16|||
33671002|NCT01436149|63106424|FG001|Randomized Phase|Withdrawal by Subject|10|||
33671003|NCT01436149|63106425|FG002|Randomized Phase|Withdrawal by Subject|10|||
33671004|NCT01436149|63106423|FG000|Randomized Phase|Lost to Follow-up|34|||
33671005|NCT01436149|63106424|FG001|Randomized Phase|Lost to Follow-up|5|||
33671006|NCT01436149|63106425|FG002|Randomized Phase|Lost to Follow-up|6|||
33671007|NCT01436149|63106423|FG000|Randomized Phase|Lack of Efficacy|0|||
33671008|NCT01436149|63106424|FG001|Randomized Phase|Lack of Efficacy|0|||
33671009|NCT01436149|63106425|FG002|Randomized Phase|Lack of Efficacy|1|||
33671010|NCT01436149|63106423|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
33671011|NCT01436149|63106424|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
33671012|NCT01436149|63106425|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
33671013|NCT01436149|63106423|FG000|Randomized Phase|Other|12|||
33671014|NCT01436149|63106424|FG001|Randomized Phase|Other|5|||
33671015|NCT01436149|63106425|FG002|Randomized Phase|Other|11|||
33671016|NCT01415401|63106431|FG000|Overall Study|Adverse Event|5|||
33671017|NCT01415401|63106431|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
33671018|NCT01415401|63106431|FG000|Overall Study|Terminated by Sponsor|1|||
33671019|NCT01414855|63106435|FG000|Overall Study|Death|17|||
33671020|NCT01414855|63106435|FG000|Overall Study|Lost to Follow-up|5|||
33671021|NCT01414855|63106435|FG000|Overall Study|Withdrawal by Subject|7|||
33671022|NCT01527500|63106443|FG000|Part A|Administrative|11|||
33671023|NCT01527500|63106444|FG001|Part A|Administrative|7|||
33671024|NCT01527500|63106443|FG000|Part A|Adverse Event|4|||
33671025|NCT01527500|63106444|FG001|Part A|Adverse Event|2|||
33671026|NCT01527500|63106443|FG000|Part A|Death|4|||
33671027|NCT01527500|63106444|FG001|Part A|Death|1|||
33671028|NCT01527500|63106443|FG000|Part A|Lost to Follow-up|0|||
33671029|NCT01527500|63106444|FG001|Part A|Lost to Follow-up|1|||
33671030|NCT01527500|63106443|FG000|Part A|Protocol Deviation|9|||
33671031|NCT01527500|63106444|FG001|Part A|Protocol Deviation|2|||
33671032|NCT01527500|63106443|FG000|Part A|Withdrawal by Subject|2|||
33671033|NCT01527500|63106444|FG001|Part A|Withdrawal by Subject|0|||
33671034|NCT01527500|63106443|FG000|Part B|Adverse Event|1|||
33671035|NCT01527500|63106444|FG001|Part B|Adverse Event|0|||
33671036|NCT01527110|63106469|FG000|Overall Study|Adverse Event|1|||
33671037|NCT01441063|63106473|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
33671038|NCT01441063|63106473|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
33671039|NCT01436071|63106482|FG000|Overall Study|Adverse Event|1|||
33671040|NCT01436071|63106483|FG001|Overall Study|Adverse Event|0|||
33671041|NCT01436071|63106482|FG000|Overall Study|Lack of Efficacy|16|||
33671042|NCT01436071|63106483|FG001|Overall Study|Lack of Efficacy|7|||
33671043|NCT01436071|63106482|FG000|Overall Study|Protocol Violation|0|||
33671044|NCT01436071|63106483|FG001|Overall Study|Protocol Violation|1|||
33671045|NCT01436071|63106482|FG000|Overall Study|Lost to Follow-up|3|||
33671046|NCT01436071|63106483|FG001|Overall Study|Lost to Follow-up|1|||
33671047|NCT01436071|63106482|FG000|Overall Study|Physician Decision|1|||
33671048|NCT01436071|63106483|FG001|Overall Study|Physician Decision|0|||
33671049|NCT01436071|63106482|FG000|Overall Study|Withdrawal by Subject|2|||
33671050|NCT01436071|63106483|FG001|Overall Study|Withdrawal by Subject|2|||
33671051|NCT01436071|63106482|FG000|Overall Study|Did Not Receive Trial Medication|3|||
33671052|NCT01436071|63106483|FG001|Overall Study|Did Not Receive Trial Medication|3|||
33671053|NCT01514864|63106491|FG000|Overall Study|Disease progression|7|||
33671054|NCT01514864|63106492|FG001|Overall Study|Disease progression|5|||
33671055|NCT01514864|63106491|FG000|Overall Study|Study drug toxicity|2|||
33671056|NCT01514864|63106492|FG001|Overall Study|Study drug toxicity|0|||
33671057|NCT01514240|63106501|FG000|Overall Study|Adverse Event|4|||
33671058|NCT01514240|63106502|FG001|Overall Study|Adverse Event|4|||
33671059|NCT01514240|63106501|FG000|Overall Study|Subject Decision|2|||
33671060|NCT01514240|63106502|FG001|Overall Study|Subject Decision|7|||
33671061|NCT01435759|63106513|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
33671062|NCT01435759|63106514|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
33671063|NCT01435759|63106515|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
33671064|NCT01435759|63106516|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
33671065|NCT01435759|63106517|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
33671066|NCT01435759|63106518|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
33671067|NCT01435759|63106513|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
33671068|NCT01435759|63106514|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
33671069|NCT01435759|63106515|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
33671070|NCT01435759|63106516|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
33671071|NCT01435759|63106517|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
33671072|NCT01435759|63106518|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
33671073|NCT01435759|63106513|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
33671074|NCT01435759|63106514|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
33671075|NCT01435759|63106515|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
33671076|NCT01435759|63106516|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
33671077|NCT01435759|63106517|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
33671078|NCT01435759|63106518|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
33671079|NCT01435759|63106513|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
33671080|NCT01435759|63106514|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
33671081|NCT01435759|63106515|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
33671082|NCT01435759|63106516|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
33671083|NCT01435759|63106517|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
33671084|NCT01435759|63106518|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
33671085|NCT01435759|63106513|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
33671086|NCT01435759|63106514|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
33671087|NCT01435759|63106515|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
33671088|NCT01435759|63106516|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
33671089|NCT01435759|63106517|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
33671090|NCT01435759|63106518|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
33671091|NCT01435759|63106513|FG000|Antidepressant Lead-in Phase|Other|119|||
33671092|NCT01435759|63106514|FG001|Antidepressant Lead-in Phase|Other|0|||
33671093|NCT01435759|63106515|FG002|Antidepressant Lead-in Phase|Other|0|||
33671094|NCT01435759|63106516|FG003|Antidepressant Lead-in Phase|Other|0|||
33671095|NCT01435759|63106517|FG004|Antidepressant Lead-in Phase|Other|0|||
33671096|NCT01435759|63106518|FG005|Antidepressant Lead-in Phase|Other|0|||
33671097|NCT01435759|63106513|FG000|Double-blind Phase|Adverse Event|7|||
33671098|NCT01435759|63106514|FG001|Double-blind Phase|Adverse Event|0|||
33671099|NCT01435759|63106515|FG002|Double-blind Phase|Adverse Event|1|||
33671100|NCT01435759|63106516|FG003|Double-blind Phase|Adverse Event|1|||
33671101|NCT01435759|63106517|FG004|Double-blind Phase|Adverse Event|1|||
33671102|NCT01435759|63106518|FG005|Double-blind Phase|Adverse Event|3|||
33671103|NCT01435759|63106513|FG000|Double-blind Phase|Protocol Violation|2|||
33671104|NCT01435759|63106514|FG001|Double-blind Phase|Protocol Violation|0|||
33671105|NCT01435759|63106515|FG002|Double-blind Phase|Protocol Violation|1|||
33671106|NCT01435759|63106516|FG003|Double-blind Phase|Protocol Violation|2|||
33671107|NCT01435759|63106517|FG004|Double-blind Phase|Protocol Violation|0|||
33671108|NCT01435759|63106518|FG005|Double-blind Phase|Protocol Violation|1|||
33671109|NCT01435759|63106513|FG000|Double-blind Phase|Withdrawal by Subject|17|||
33671110|NCT01435759|63106514|FG001|Double-blind Phase|Withdrawal by Subject|4|||
33671111|NCT01435759|63106515|FG002|Double-blind Phase|Withdrawal by Subject|3|||
33671112|NCT01435759|63106516|FG003|Double-blind Phase|Withdrawal by Subject|4|||
33671113|NCT01435759|63106517|FG004|Double-blind Phase|Withdrawal by Subject|2|||
33671114|NCT01435759|63106518|FG005|Double-blind Phase|Withdrawal by Subject|2|||
33671115|NCT01435759|63106513|FG000|Double-blind Phase|Lost to Follow-up|31|||
33671116|NCT01435759|63106514|FG001|Double-blind Phase|Lost to Follow-up|1|||
33671117|NCT01435759|63106515|FG002|Double-blind Phase|Lost to Follow-up|2|||
33671118|NCT01435759|63106516|FG003|Double-blind Phase|Lost to Follow-up|0|||
33671119|NCT01435759|63106517|FG004|Double-blind Phase|Lost to Follow-up|3|||
33671120|NCT01435759|63106518|FG005|Double-blind Phase|Lost to Follow-up|3|||
33671121|NCT01435759|63106513|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
33671122|NCT01435759|63106514|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
33671123|NCT01435759|63106515|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
33671124|NCT01435759|63106516|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
33671125|NCT01435759|63106517|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
33671126|NCT01435759|63106518|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
33671127|NCT01435759|63106513|FG000|Double-blind Phase|Other|8|||
33671128|NCT01435759|63106514|FG001|Double-blind Phase|Other|2|||
33671129|NCT01435759|63106515|FG002|Double-blind Phase|Other|0|||
33671130|NCT01435759|63106516|FG003|Double-blind Phase|Other|2|||
33671131|NCT01435759|63106517|FG004|Double-blind Phase|Other|0|||
33671132|NCT01435759|63106518|FG005|Double-blind Phase|Other|0|||
33671133|NCT01393405|63106530|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
33671134|NCT01393405|63106531|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
33671135|NCT01393405|63106532|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
33671136|NCT01393405|63106530|FG000|Induction Period (week1-16)|Adverse Event|16|||
33671137|NCT01393405|63106531|FG001|Induction Period (week1-16)|Adverse Event|0|||
33671138|NCT01393405|63106532|FG002|Induction Period (week1-16)|Adverse Event|0|||
33671139|NCT01393405|63106530|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
33671140|NCT01393405|63106531|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
33671141|NCT01393405|63106532|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
33671142|NCT01393405|63106530|FG000|Maintenance Period Week|Lack of Efficacy|0|||
33671143|NCT01393405|63106531|FG001|Maintenance Period Week|Lack of Efficacy|22|||
33671144|NCT01393405|63106532|FG002|Maintenance Period Week|Lack of Efficacy|22|||
33671145|NCT01393405|63106530|FG000|Maintenance Period Week|Adverse Event|0|||
33671146|NCT01393405|63106531|FG001|Maintenance Period Week|Adverse Event|5|||
33671147|NCT01393405|63106532|FG002|Maintenance Period Week|Adverse Event|2|||
33671148|NCT01393405|63106530|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
33671149|NCT01393405|63106531|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
33671150|NCT01393405|63106532|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
33671151|NCT01393405|63106530|FG000|Maintenance Period Week|Lost to Follow-up|0|||
33671152|NCT01393405|63106531|FG001|Maintenance Period Week|Lost to Follow-up|1|||
33671153|NCT01393405|63106532|FG002|Maintenance Period Week|Lost to Follow-up|0|||
33671154|NCT01419197|63106544|FG000|Overall Study|Death|247|||
33671155|NCT01419197|63106545|FG001|Overall Study|Death|122|||
33671156|NCT01419197|63106544|FG000|Overall Study|Physician Decision|4|||
33671157|NCT01419197|63106545|FG001|Overall Study|Physician Decision|4|||
33671158|NCT01419197|63106544|FG000|Overall Study|Non-compliance|3|||
33671159|NCT01419197|63106545|FG001|Overall Study|Non-compliance|1|||
33671160|NCT01419197|63106544|FG000|Overall Study|Withdrawal by Subject|33|||
33671161|NCT01419197|63106545|FG001|Overall Study|Withdrawal by Subject|32|||
33671162|NCT01419197|63106544|FG000|Overall Study|Study Completed by Sponsor|103|||
33671163|NCT01419197|63106545|FG001|Overall Study|Study Completed by Sponsor|34|||
33671164|NCT01419197|63106544|FG000|Overall Study|Reason Not Specified|0|||
33671165|NCT01419197|63106545|FG001|Overall Study|Reason Not Specified|1|||
33671166|NCT01419197|63106544|FG000|Overall Study|Lost to Follow-up|14|||
33671167|NCT01419197|63106545|FG001|Overall Study|Lost to Follow-up|4|||
33671168|NCT01414075|63106556|FG000|Overall Study|Adverse Event|1|||
33671169|NCT01414075|63106557|FG001|Overall Study|Adverse Event|0|||
33671170|NCT01414075|63106558|FG002|Overall Study|Adverse Event|1|||
33671171|NCT01414075|63106559|FG003|Overall Study|Adverse Event|0|||
33671172|NCT01414075|63106556|FG000|Overall Study|Death|1|||
33671173|NCT01414075|63106557|FG001|Overall Study|Death|0|||
33671174|NCT01414075|63106558|FG002|Overall Study|Death|0|||
33671175|NCT01414075|63106559|FG003|Overall Study|Death|1|||
33671176|NCT01414075|63106556|FG000|Overall Study|Withdrawal by Subject|0|||
33671177|NCT01414075|63106557|FG001|Overall Study|Withdrawal by Subject|0|||
33671178|NCT01414075|63106558|FG002|Overall Study|Withdrawal by Subject|0|||
33671179|NCT01414075|63106559|FG003|Overall Study|Withdrawal by Subject|1|||
33671180|NCT01414075|63106556|FG000|Overall Study|Other than specified|1|||
33671181|NCT01414075|63106557|FG001|Overall Study|Other than specified|0|||
33671182|NCT01414075|63106558|FG002|Overall Study|Other than specified|1|||
33671183|NCT01414075|63106559|FG003|Overall Study|Other than specified|0|||
33671184|NCT01434823|63106571|FG000|Overall Study|Incomplete data in medical record|4|||
33671185|NCT01434823|63106572|FG001|Overall Study|Incomplete data in medical record|7|||
33671186|NCT01513460|63106582|FG000|Overall Study|Death|0|||
33671187|NCT01513460|63106583|FG001|Overall Study|Death|0|||
33671188|NCT01513460|63106584|FG002|Overall Study|Death|1|||
33671189|NCT01513460|63106582|FG000|Overall Study|Lost to Follow-up|0|||
33671190|NCT01513460|63106583|FG001|Overall Study|Lost to Follow-up|0|||
33671191|NCT01513460|63106584|FG002|Overall Study|Lost to Follow-up|2|||
33671192|NCT01513460|63106582|FG000|Overall Study|Abnormal laboratory value|1|||
33671193|NCT01513460|63106583|FG001|Overall Study|Abnormal laboratory value|0|||
33671194|NCT01513460|63106584|FG002|Overall Study|Abnormal laboratory value|1|||
33671195|NCT01513460|63106582|FG000|Overall Study|Lack of Efficacy|1|||
33671196|NCT01513460|63106583|FG001|Overall Study|Lack of Efficacy|2|||
33671197|NCT01513460|63106584|FG002|Overall Study|Lack of Efficacy|5|||
33671198|NCT01513460|63106582|FG000|Overall Study|Protocol deviations|3|||
33671199|NCT01513460|63106583|FG001|Overall Study|Protocol deviations|4|||
33671200|NCT01513460|63106584|FG002|Overall Study|Protocol deviations|3|||
33671201|NCT01513460|63106582|FG000|Overall Study|Withdrawal by Subject|7|||
33671202|NCT01513460|63106583|FG001|Overall Study|Withdrawal by Subject|8|||
33671203|NCT01513460|63106584|FG002|Overall Study|Withdrawal by Subject|21|||
33671204|NCT01513460|63106582|FG000|Overall Study|Adverse Event|16|||
33671205|NCT01513460|63106583|FG001|Overall Study|Adverse Event|18|||
33671206|NCT01513460|63106584|FG002|Overall Study|Adverse Event|23|||
33671207|NCT01513460|63106582|FG000|Overall Study|Abnormal test procedure|1|||
33671208|NCT01513460|63106583|FG001|Overall Study|Abnormal test procedure|0|||
33671209|NCT01513460|63106584|FG002|Overall Study|Abnormal test procedure|0|||
33671210|NCT01392547|63106594|FG000|Overall Study|Adverse Event|2|||
33671211|NCT01392547|63106594|FG000|Overall Study|Non-compliance|2|||
33671212|NCT01392547|63106594|FG000|Overall Study|Withdrawal criteria|3|||
33671213|NCT01392547|63106594|FG000|Overall Study|Unclassified|1|||
33671214|NCT01435655|63106600|FG000|Overall Study|Death|2|||
33671215|NCT01435655|63106600|FG000|Overall Study|Other|1|||
33671216|NCT01434667|63106606|FG000|Overall Study|Lost to Follow-up|5|||
33671217|NCT01434667|63106607|FG001|Overall Study|Lost to Follow-up|10|||
33671218|NCT01513148|63106615|FG000|Overall Study|Protocol Violation|2|||
33671219|NCT01513148|63106616|FG001|Overall Study|Protocol Violation|2|||
33671220|NCT01418339|63106664|FG000|Overall Study|Adverse Event|5|||
33671221|NCT01418339|63106665|FG001|Overall Study|Adverse Event|2|||
33671222|NCT01418339|63106664|FG000|Overall Study|Subject Withdrew Consent|1|||
33580078|NCT01968070|62976870|FG000|Period 1|Physician Decision|0|||
33580079|NCT01968070|62976871|FG001|Period 1|Physician Decision|0|||
33580080|NCT01968070|62976872|FG002|Period 1|Physician Decision|0|||
33580081|NCT01968070|62976873|FG003|Period 1|Physician Decision|0|||
33580082|NCT01968070|62976874|FG004|Period 1|Physician Decision|0|||
33580083|NCT01968070|62976875|FG005|Period 1|Physician Decision|0|||
33580084|NCT01968070|62976876|FG006|Period 1|Physician Decision|0|||
33580085|NCT01968070|62976877|FG007|Period 1|Physician Decision|0|||
33580086|NCT01968070|62976878|FG008|Period 1|Physician Decision|0|||
33580087|NCT01968070|62976879|FG009|Period 1|Physician Decision|0|||
33580088|NCT01968070|62976880|FG010|Period 1|Physician Decision|0|||
33580089|NCT01968070|62976881|FG011|Period 1|Physician Decision|1|||
33580090|NCT01968070|62976882|FG012|Period 1|Physician Decision|0|||
33580091|NCT01968070|62976883|FG013|Period 1|Physician Decision|0|||
33580092|NCT01968070|62976884|FG014|Period 1|Physician Decision|0|||
33580093|NCT01968070|62976885|FG015|Period 1|Physician Decision|0|||
33580094|NCT01968070|62976886|FG016|Period 1|Physician Decision|0|||
33580095|NCT01968070|62976887|FG017|Period 1|Physician Decision|0|||
33580096|NCT01968070|62976870|FG000|Period 2|Withdrawal by Subject|0|||
33580097|NCT01968070|62976871|FG001|Period 2|Withdrawal by Subject|0|||
33580098|NCT01968070|62976872|FG002|Period 2|Withdrawal by Subject|0|||
33580099|NCT01968070|62976873|FG003|Period 2|Withdrawal by Subject|0|||
33580100|NCT01968070|62976874|FG004|Period 2|Withdrawal by Subject|1|||
33580101|NCT01968070|62976875|FG005|Period 2|Withdrawal by Subject|0|||
33580102|NCT01968070|62976876|FG006|Period 2|Withdrawal by Subject|0|||
33580103|NCT01968070|62976877|FG007|Period 2|Withdrawal by Subject|0|||
33580104|NCT01968070|62976878|FG008|Period 2|Withdrawal by Subject|0|||
33580105|NCT01968070|62976879|FG009|Period 2|Withdrawal by Subject|0|||
33580106|NCT01968070|62976880|FG010|Period 2|Withdrawal by Subject|0|||
33580107|NCT01968070|62976881|FG011|Period 2|Withdrawal by Subject|0|||
33580108|NCT01968070|62976882|FG012|Period 2|Withdrawal by Subject|0|||
33580109|NCT01968070|62976883|FG013|Period 2|Withdrawal by Subject|0|||
33580110|NCT01968070|62976884|FG014|Period 2|Withdrawal by Subject|0|||
33580111|NCT01968070|62976885|FG015|Period 2|Withdrawal by Subject|0|||
33580112|NCT01968070|62976886|FG016|Period 2|Withdrawal by Subject|0|||
33671223|NCT01418339|63106665|FG001|Overall Study|Subject Withdrew Consent|2|||
33671224|NCT01418339|63106664|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
33671225|NCT01418339|63106665|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
33671226|NCT01512368|63106671|FG000|Overall Study|Protocol Violation|3|||
33671227|NCT01412983|63106675|FG000|1st Period|Ineligible|0|||
33671228|NCT01412983|63106676|FG001|1st Period|Ineligible|1|||
33671229|NCT01412983|63106675|FG000|1st Period|Positive slit lamp finding|0|||
33671230|NCT01412983|63106676|FG001|1st Period|Positive slit lamp finding|1|||
33671231|NCT01412983|63106675|FG000|1st Period|Unacceptable lens movement|0|||
33671232|NCT01412983|63106676|FG001|1st Period|Unacceptable lens movement|1|||
33671233|NCT01412983|63106675|FG000|1st Period|Inability to maintain wear|0|||
33671234|NCT01412983|63106676|FG001|1st Period|Inability to maintain wear|1|||
33671235|NCT01417481|63106685|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
33671236|NCT01417481|63106686|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
33671237|NCT01392469|63106692|FG000|Overall Study|Adverse Event|2|||
33671238|NCT01392469|63106692|FG000|Overall Study|Withdrawal by Subject|1|||
33671239|NCT01392469|63106692|FG000|Overall Study|Protocol Violation|1|||
33671240|NCT01435577|63106709|FG000|Overall Study|Adverse Event|10|||
33671241|NCT01435577|63106710|FG001|Overall Study|Adverse Event|0|||
33671242|NCT01435577|63106709|FG000|Overall Study|Lack of Efficacy|7|||
33671243|NCT01435577|63106710|FG001|Overall Study|Lack of Efficacy|51|||
33671244|NCT01435577|63106709|FG000|Overall Study|Alternative treatment started|0|||
33671245|NCT01435577|63106710|FG001|Overall Study|Alternative treatment started|1|||
33671246|NCT01411891|63106722|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
33671247|NCT01411891|63106723|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
33671248|NCT01416389|63106731|FG000|Overall Study|Lost to Follow-up|1|||
33671249|NCT01416389|63106732|FG001|Overall Study|Lost to Follow-up|0|||
33671250|NCT01416389|63106731|FG000|Overall Study|Started New Therapy|2|||
33671251|NCT01416389|63106732|FG001|Overall Study|Started New Therapy|0|||
33671252|NCT01544348|63106748|FG000|Overall Study|Lost to Follow-up|1|||
33671253|NCT01544348|63106749|FG001|Overall Study|Lost to Follow-up|0|||
33671254|NCT01544348|63106750|FG002|Overall Study|Lost to Follow-up|0|||
33671255|NCT01544348|63106751|FG003|Overall Study|Lost to Follow-up|0|||
33671256|NCT01544348|63106752|FG004|Overall Study|Lost to Follow-up|0|||
33671257|NCT01544348|63106753|FG005|Overall Study|Lost to Follow-up|0|||
33671258|NCT01544348|63106754|FG006|Overall Study|Lost to Follow-up|1|||
33671259|NCT01544348|63106755|FG007|Overall Study|Lost to Follow-up|0|||
33671260|NCT01544348|63106748|FG000|Overall Study|Withdrawal by Subject|1|||
33671261|NCT01544348|63106749|FG001|Overall Study|Withdrawal by Subject|0|||
33671262|NCT01544348|63106750|FG002|Overall Study|Withdrawal by Subject|0|||
33671263|NCT01544348|63106751|FG003|Overall Study|Withdrawal by Subject|0|||
33671264|NCT01544348|63106752|FG004|Overall Study|Withdrawal by Subject|1|||
33671265|NCT01544348|63106753|FG005|Overall Study|Withdrawal by Subject|2|||
33671266|NCT01544348|63106754|FG006|Overall Study|Withdrawal by Subject|1|||
33671267|NCT01544348|63106755|FG007|Overall Study|Withdrawal by Subject|0|||
33671268|NCT01544348|63106748|FG000|Overall Study|Physician Decision|0|||
33671269|NCT01544348|63106749|FG001|Overall Study|Physician Decision|0|||
33671270|NCT01544348|63106750|FG002|Overall Study|Physician Decision|0|||
33671271|NCT01544348|63106751|FG003|Overall Study|Physician Decision|0|||
33671272|NCT01544348|63106752|FG004|Overall Study|Physician Decision|0|||
33671273|NCT01544348|63106753|FG005|Overall Study|Physician Decision|1|||
33671274|NCT01544348|63106754|FG006|Overall Study|Physician Decision|0|||
33671275|NCT01544348|63106755|FG007|Overall Study|Physician Decision|0|||
33671276|NCT01416155|63106780|FG000|Overall Study|Adverse Event|8|||
33671277|NCT01416155|63106780|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
33671278|NCT01416155|63106780|FG000|Overall Study|Withdrawal by Subject|33|||
33671279|NCT01416155|63106780|FG000|Overall Study|Investigator decision|8|||
33671280|NCT01416155|63106780|FG000|Overall Study|Other|7|||
33671281|NCT01415921|63106786|FG000|Overall Study|Adverse Event|0|||
33671282|NCT01415921|63106787|FG001|Overall Study|Adverse Event|1|||
33671283|NCT01415921|63106786|FG000|Overall Study|Physician Decision|1|||
33671284|NCT01415921|63106787|FG001|Overall Study|Physician Decision|1|||
33671285|NCT01415921|63106786|FG000|Overall Study|Withdrawal by Subject|0|||
33671286|NCT01415921|63106787|FG001|Overall Study|Withdrawal by Subject|1|||
33671287|NCT01415921|63106786|FG000|Overall Study|Other|2|||
33671288|NCT01415921|63106787|FG001|Overall Study|Other|0|||
33671289|NCT01415531|63106795|FG000|Overall Study|Adverse Event|7|||
33671290|NCT01415531|63106796|FG001|Overall Study|Adverse Event|10|||
33671291|NCT01415531|63106795|FG000|Overall Study|Lack of Efficacy|3|||
33671292|NCT01415531|63106796|FG001|Overall Study|Lack of Efficacy|2|||
33671293|NCT01415531|63106795|FG000|Overall Study|Protocol Violation|0|||
33671294|NCT01415531|63106796|FG001|Overall Study|Protocol Violation|1|||
33671295|NCT01415531|63106795|FG000|Overall Study|Withdrawal by Subject|5|||
33671296|NCT01415531|63106796|FG001|Overall Study|Withdrawal by Subject|4|||
33671297|NCT01415531|63106795|FG000|Overall Study|Lost to Follow-up|6|||
33671298|NCT01415531|63106796|FG001|Overall Study|Lost to Follow-up|14|||
33671299|NCT01415531|63106795|FG000|Overall Study|Lack of Compliance|1|||
33671300|NCT01415531|63106796|FG001|Overall Study|Lack of Compliance|4|||
33671301|NCT01415531|63106795|FG000|Overall Study|Other Reasons|3|||
33671302|NCT01415531|63106796|FG001|Overall Study|Other Reasons|2|||
33671303|NCT01544114|63106805|FG000|Overall Study|Withdrawal by Subject|0|||
33671304|NCT01544114|63106806|FG001|Overall Study|Withdrawal by Subject|0|||
33671305|NCT01544114|63106807|FG002|Overall Study|Withdrawal by Subject|3|||
33671306|NCT01544114|63106805|FG000|Overall Study|Lost to Follow-up|0|||
33671307|NCT01544114|63106806|FG001|Overall Study|Lost to Follow-up|2|||
33671308|NCT01544114|63106807|FG002|Overall Study|Lost to Follow-up|0|||
33671309|NCT01544114|63106805|FG000|Overall Study|Adverse Event|1|||
33671310|NCT01544114|63106806|FG001|Overall Study|Adverse Event|1|||
33671311|NCT01544114|63106807|FG002|Overall Study|Adverse Event|2|||
33671312|NCT01544114|63106805|FG000|Overall Study|Protocol Violation|0|||
33671313|NCT01544114|63106806|FG001|Overall Study|Protocol Violation|1|||
33671314|NCT01544114|63106807|FG002|Overall Study|Protocol Violation|0|||
33671315|NCT01435265|63106819|FG000|Overall Study|Lost to Follow-up|0|||
33671316|NCT01435265|63106820|FG001|Overall Study|Lost to Follow-up|1|||
33671317|NCT01433263|63106828|FG000|Overall Study|Adverse Event|3|||
33671318|NCT01433263|63106829|FG001|Overall Study|Adverse Event|1|||
33671319|NCT01433263|63106828|FG000|Overall Study|Death|5|||
33671320|NCT01433263|63106829|FG001|Overall Study|Death|3|||
33671321|NCT01433263|63106828|FG000|Overall Study|Lost to Follow-up|0|||
33671322|NCT01433263|63106829|FG001|Overall Study|Lost to Follow-up|1|||
33671323|NCT01433263|63106828|FG000|Overall Study|Protocol Deviation|1|||
33671324|NCT01433263|63106829|FG001|Overall Study|Protocol Deviation|0|||
33399926|NCT00510952|62779224|FG000|Overall Study|Did Not Receive Study Drug|2|||
33399927|NCT00510952|62779225|FG001|Overall Study|Did Not Receive Study Drug|0|||
33399928|NCT00617604|62779233|FG000|Overall Study|Death|2|||
33671325|NCT01433263|63106828|FG000|Overall Study|Withdrawal by Subject|10|||
33671326|NCT01433263|63106829|FG001|Overall Study|Withdrawal by Subject|7|||
33671327|NCT01432951|63106838|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
33671328|NCT01432327|63106847|FG000|Posttest 3 Months|depression|3|||
33671329|NCT01432327|63106848|FG001|Posttest 3 Months|depression|0|||
33671330|NCT01432327|63106849|FG002|Posttest 3 Months|depression|0|||
33671331|NCT01432327|63106850|FG003|Posttest 3 Months|depression|0|||
33671332|NCT01432327|63106847|FG000|Posttest 3 Months|Lost to Follow-up|1|||
33671333|NCT01432327|63106848|FG001|Posttest 3 Months|Lost to Follow-up|0|||
33671334|NCT01432327|63106849|FG002|Posttest 3 Months|Lost to Follow-up|2|||
33671335|NCT01432327|63106850|FG003|Posttest 3 Months|Lost to Follow-up|1|||
33671336|NCT01432327|63106847|FG000|Posttest 3 Months|Allergic reaction|0|||
33671337|NCT01432327|63106848|FG001|Posttest 3 Months|Allergic reaction|2|||
33671338|NCT01432327|63106849|FG002|Posttest 3 Months|Allergic reaction|0|||
33671339|NCT01432327|63106850|FG003|Posttest 3 Months|Allergic reaction|0|||
33671340|NCT01432327|63106847|FG000|Posttest 6 Months|Lost to Follow-up|0|||
33671341|NCT01432327|63106848|FG001|Posttest 6 Months|Lost to Follow-up|0|||
33671342|NCT01432327|63106849|FG002|Posttest 6 Months|Lost to Follow-up|3|||
33671343|NCT01432327|63106850|FG003|Posttest 6 Months|Lost to Follow-up|2|||
33671344|NCT01432327|63106847|FG000|Posttest 6 Months|Allergic reaction|0|||
33671345|NCT01432327|63106848|FG001|Posttest 6 Months|Allergic reaction|0|||
33671346|NCT01432327|63106849|FG002|Posttest 6 Months|Allergic reaction|1|||
33671347|NCT01432327|63106850|FG003|Posttest 6 Months|Allergic reaction|0|||
33671348|NCT01432327|63106847|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
33671349|NCT01432327|63106848|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
33671350|NCT01432327|63106849|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
33671351|NCT01432327|63106850|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
33671352|NCT01432327|63106847|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
33671353|NCT01432327|63106848|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
33671354|NCT01432327|63106849|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
33671355|NCT01432327|63106850|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
33671356|NCT01432327|63106847|FG000|Posttest 1 Year|Lost to Follow-up|0|||
33671357|NCT01432327|63106848|FG001|Posttest 1 Year|Lost to Follow-up|0|||
33671358|NCT01432327|63106849|FG002|Posttest 1 Year|Lost to Follow-up|4|||
33671359|NCT01432327|63106850|FG003|Posttest 1 Year|Lost to Follow-up|2|||
33671360|NCT01432327|63106847|FG000|Posttest 1 Year|Allergic reaction|0|||
33671361|NCT01432327|63106848|FG001|Posttest 1 Year|Allergic reaction|0|||
33671362|NCT01432327|63106849|FG002|Posttest 1 Year|Allergic reaction|1|||
33671363|NCT01432327|63106850|FG003|Posttest 1 Year|Allergic reaction|1|||
33671364|NCT01410799|63106860|FG000|Overall Study|PI decision|13|||
33671365|NCT01432171|63106866|FG000|Overall Study|Death|1|||
33671366|NCT01432171|63106867|FG001|Overall Study|Death|2|||
33671367|NCT01432171|63106866|FG000|Overall Study|Lost to Follow-up|6|||
33671368|NCT01432171|63106867|FG001|Overall Study|Lost to Follow-up|5|||
33671369|NCT01432171|63106866|FG000|Overall Study|Withdrawal by Subject|3|||
33671370|NCT01432171|63106867|FG001|Overall Study|Withdrawal by Subject|1|||
33671371|NCT01432171|63106866|FG000|Overall Study|Noncompliance|2|||
33671372|NCT01432171|63106867|FG001|Overall Study|Noncompliance|3|||
33671373|NCT01432171|63106866|FG000|Overall Study|Insurance denial trial coverage|1|||
33671374|NCT01432171|63106867|FG001|Overall Study|Insurance denial trial coverage|0|||
33671375|NCT01432171|63106866|FG000|Overall Study|Patient moved to palliative care|1|||
33671376|NCT01432171|63106867|FG001|Overall Study|Patient moved to palliative care|0|||
33671377|NCT01435031|63106877|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
33671378|NCT01435031|63106877|FG000|ITT at 1 Month|Death|1|||
33671379|NCT01435031|63106877|FG000|ITT at 1 Month|Lost to Follow-up|4|||
33671380|NCT01435031|63106877|FG000|ITT at 6 Months|Death|2|||
33671381|NCT01435031|63106877|FG000|ITT at 6 Months|Lost to Follow-up|3|||
33671382|NCT01435031|63106877|FG000|ITT at 1 Year|Death|1|||
33671383|NCT01435031|63106877|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
33671384|NCT01435031|63106877|FG000|ITT at 1 Year|Lost to Follow-up|6|||
33671385|NCT01435031|63106877|FG000|ITT at 2 Years|Death|7|||
33671386|NCT01435031|63106877|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
33671387|NCT01435031|63106877|FG000|ITT at 2 Years|Lost to Follow-up|4|||
33671388|NCT01435031|63106877|FG000|ITT at 3 Years|Death|5|||
33671389|NCT01435031|63106877|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
33671390|NCT01435031|63106877|FG000|ITT at 3 Years|Lost to Follow-up|4|||
33671391|NCT01435031|63106877|FG000|ITT at 4 Years|Death|4|||
33671392|NCT01435031|63106877|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
33671393|NCT01435031|63106877|FG000|ITT at 4 Years|Lost to Follow-up|1|||
33671394|NCT01433549|63106881|FG000|Phase 2: Second Study Product|Adverse Event|0|||
33671395|NCT01433549|63106882|FG001|Phase 2: Second Study Product|Adverse Event|1|||
33671396|NCT01414205|63106890|FG000|Overall Study|Death|5|||
33671397|NCT01414205|63106891|FG001|Overall Study|Death|1|||
33671398|NCT01414205|63106890|FG000|Overall Study|Lost to Follow-up|1|||
33671399|NCT01414205|63106891|FG001|Overall Study|Lost to Follow-up|4|||
33671400|NCT01414205|63106890|FG000|Overall Study|Physician Decision|0|||
33671401|NCT01414205|63106891|FG001|Overall Study|Physician Decision|1|||
33671402|NCT01414205|63106890|FG000|Overall Study|Randomized but not Treated|1|||
33671403|NCT01414205|63106891|FG001|Overall Study|Randomized but not Treated|1|||
33671404|NCT01433471|63106899|FG000|Overall Study|Withdrawal by Subject|0|||
33671405|NCT01433471|63106900|FG001|Overall Study|Withdrawal by Subject|1|||
33671406|NCT01433159|63106910|FG000|Overall Study|Adverse Event|1|||
33671407|NCT01433159|63106911|FG001|Overall Study|Adverse Event|0|||
33671408|NCT01433159|63106910|FG000|Overall Study|Physician Decision|1|||
33671409|NCT01433159|63106911|FG001|Overall Study|Physician Decision|0|||
33671410|NCT01433159|63106910|FG000|Overall Study|Protocol Violation|0|||
33671411|NCT01433159|63106911|FG001|Overall Study|Protocol Violation|1|||
33671412|NCT01413503|63106926|FG000|Overall Study|Lost to Follow-up|1|||
33671413|NCT01413191|63106930|FG000|Overall Study|Lost to Follow-up|5|||
33671414|NCT01413191|63106930|FG000|Overall Study|Disease Progression|5|||
33671415|NCT01413191|63106930|FG000|Overall Study|Death|1|||
33671416|NCT02036970|63106944|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
33671417|NCT02036970|63106945|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
33671418|NCT02036970|63106946|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
33671419|NCT02036970|63106947|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
33671420|NCT02036970|63106948|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
33671421|NCT02036970|63106949|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
33671422|NCT02036970|63106950|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
33671423|NCT02036970|63106951|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
33671424|NCT02036970|63106952|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
33671425|NCT02036970|63106953|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
33671426|NCT02036970|63106944|FG000|Part 1: Day 1 Through Week 16|Death|0|||
33671427|NCT02036970|63106945|FG001|Part 1: Day 1 Through Week 16|Death|0|||
33671428|NCT02036970|63106946|FG002|Part 1: Day 1 Through Week 16|Death|0|||
33671429|NCT02036970|63106947|FG003|Part 1: Day 1 Through Week 16|Death|0|||
33671430|NCT02036970|63106948|FG004|Part 1: Day 1 Through Week 16|Death|0|||
33671431|NCT02036970|63106949|FG005|Part 1: Day 1 Through Week 16|Death|0|||
33671432|NCT02036970|63106950|FG006|Part 1: Day 1 Through Week 16|Death|0|||
33671433|NCT02036970|63106951|FG007|Part 1: Day 1 Through Week 16|Death|0|||
33671434|NCT02036970|63106952|FG008|Part 1: Day 1 Through Week 16|Death|1|||
33671435|NCT02036970|63106953|FG009|Part 1: Day 1 Through Week 16|Death|0|||
33671436|NCT02036970|63106944|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
33671437|NCT02036970|63106945|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
33671438|NCT02036970|63106946|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
33671439|NCT02036970|63106947|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
33671440|NCT02036970|63106948|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
33399929|NCT00617604|62779234|FG001|Overall Study|Death|1|||
33399930|NCT00617604|62779233|FG000|Overall Study|Lost to Follow-up|1|||
33399931|NCT00617604|62779234|FG001|Overall Study|Lost to Follow-up|0|||
33399932|NCT00617604|62779233|FG000|Overall Study|Miscellaneous Reasons|8|||
33399933|NCT00617604|62779234|FG001|Overall Study|Miscellaneous Reasons|10|||
33399934|NCT00617604|62779233|FG000|Overall Study|Withdrawal by Subject|4|||
33399935|NCT00617604|62779234|FG001|Overall Study|Withdrawal by Subject|6|||
33671441|NCT02036970|63106949|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
33671442|NCT02036970|63106950|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
33671443|NCT02036970|63106951|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
33671444|NCT02036970|63106952|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
33671445|NCT02036970|63106953|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
33671446|NCT02036970|63106944|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
33671447|NCT02036970|63106945|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
33671448|NCT02036970|63106946|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
33671449|NCT02036970|63106947|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
33671450|NCT02036970|63106948|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
33671451|NCT02036970|63106949|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
33671452|NCT02036970|63106950|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
33671453|NCT02036970|63106951|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
33671454|NCT02036970|63106952|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
33671455|NCT02036970|63106953|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
33671456|NCT02036970|63106944|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33308431|NCT02993523|62683733|FG001|Overall Study|Lost to Follow-up|0|||
33308432|NCT02993523|62683734|FG002|Overall Study|Lost to Follow-up|3|||
33308433|NCT02993523|62683735|FG003|Overall Study|Lost to Follow-up|6|||
33308434|NCT02993523|62683736|FG004|Overall Study|Lost to Follow-up|0|||
33308435|NCT02993523|62683732|FG000|Overall Study|Death|1|||
33308436|NCT02993523|62683733|FG001|Overall Study|Death|1|||
33308437|NCT02993523|62683734|FG002|Overall Study|Death|138|||
33308438|NCT02993523|62683735|FG003|Overall Study|Death|222|||
33308439|NCT02993523|62683736|FG004|Overall Study|Death|6|||
33308440|NCT02993523|62683732|FG000|Overall Study|Reason not Specified|0|||
33308441|NCT02993523|62683733|FG001|Overall Study|Reason not Specified|0|||
33308442|NCT02993523|62683734|FG002|Overall Study|Reason not Specified|1|||
33308443|NCT02993523|62683735|FG003|Overall Study|Reason not Specified|1|||
33308444|NCT02993523|62683736|FG004|Overall Study|Reason not Specified|0|||
33308445|NCT02795429|62683749|FG000|Overall Study|Adverse Event|1|||
33308446|NCT02795429|62683750|FG001|Overall Study|Adverse Event|2|||
33308447|NCT02795429|62683751|FG002|Overall Study|Adverse Event|1|||
33308448|NCT02795429|62683752|FG003|Overall Study|Adverse Event|2|||
33308449|NCT02795429|62683753|FG004|Overall Study|Adverse Event|1|||
33308450|NCT02795429|62683749|FG000|Overall Study|Death|1|||
33308451|NCT02795429|62683750|FG001|Overall Study|Death|0|||
33308452|NCT02795429|62683751|FG002|Overall Study|Death|1|||
33308453|NCT02795429|62683752|FG003|Overall Study|Death|2|||
33308454|NCT02795429|62683753|FG004|Overall Study|Death|1|||
33308455|NCT02795429|62683749|FG000|Overall Study|Physician Decision|0|||
33308456|NCT02795429|62683750|FG001|Overall Study|Physician Decision|0|||
33308457|NCT02795429|62683751|FG002|Overall Study|Physician Decision|2|||
33308458|NCT02795429|62683752|FG003|Overall Study|Physician Decision|1|||
33308459|NCT02795429|62683753|FG004|Overall Study|Physician Decision|5|||
33308460|NCT02795429|62683749|FG000|Overall Study|Progressive disease|3|||
33308461|NCT02795429|62683750|FG001|Overall Study|Progressive disease|7|||
33308462|NCT02795429|62683751|FG002|Overall Study|Progressive disease|6|||
33308463|NCT02795429|62683752|FG003|Overall Study|Progressive disease|26|||
33308464|NCT02795429|62683753|FG004|Overall Study|Progressive disease|20|||
33308465|NCT02795429|62683749|FG000|Overall Study|Subject/guardian decision|1|||
33308466|NCT02795429|62683750|FG001|Overall Study|Subject/guardian decision|1|||
33308467|NCT02795429|62683751|FG002|Overall Study|Subject/guardian decision|1|||
33308468|NCT02795429|62683752|FG003|Overall Study|Subject/guardian decision|1|||
33308469|NCT02795429|62683753|FG004|Overall Study|Subject/guardian decision|3|||
33308470|NCT02652949|62683776|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
33308471|NCT02652949|62683776|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
33308472|NCT02652949|62683776|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
33308473|NCT02652949|62683776|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
33308474|NCT02652949|62683776|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
33308475|NCT02652949|62683776|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
33308476|NCT02652949|62683776|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
33308477|NCT02652949|62683776|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
33308478|NCT02652949|62683776|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
33308479|NCT02652949|62683776|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
33308480|NCT02652949|62683776|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
33308481|NCT02652949|62683776|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
33308482|NCT02652949|62683776|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
33308483|NCT02652949|62683776|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
33308484|NCT02652949|62683776|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
33308485|NCT02632344|62683787|FG000|Overall Study|Adverse Event|3|||
33308486|NCT02632344|62683787|FG000|Overall Study|Lack of Efficacy|3|||
33308487|NCT02632344|62683787|FG000|Overall Study|Withdrawal by Subject|2|||
33308488|NCT02625324|62683791|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
33308489|NCT02625324|62683791|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
33308490|NCT02625324|62683791|FG000|6-Month Follow-up Subject Accountability|Death|5|||
33308491|NCT02625324|62683791|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
33308492|NCT02625324|62683791|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
33308493|NCT02625324|62683791|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
33308494|NCT02625324|62683791|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
33308495|NCT02625324|62683791|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
33308496|NCT02625324|62683791|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
33308497|NCT02625324|62683791|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
33308498|NCT02625324|62683791|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
33308499|NCT02625324|62683791|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
33308500|NCT02625324|62683791|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
33308501|NCT02625324|62683791|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
33308502|NCT02625324|62683791|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
33308503|NCT02477696|62683820|FG000|Overall Study|Adverse Event|40|||
33308504|NCT02477696|62683821|FG001|Overall Study|Adverse Event|59|||
33308505|NCT02477696|62683820|FG000|Overall Study|CLL Disease Progression|82|||
33308506|NCT02477696|62683821|FG001|Overall Study|CLL Disease Progression|68|||
33308507|NCT02477696|62683820|FG000|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|2|||
33308508|NCT02477696|62683821|FG001|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|10|||
33308509|NCT02477696|62683820|FG000|Overall Study|Death|5|||
33308510|NCT02477696|62683821|FG001|Overall Study|Death|6|||
33308511|NCT02477696|62683820|FG000|Overall Study|Withdrawal by Subject|7|||
33308512|NCT02477696|62683821|FG001|Overall Study|Withdrawal by Subject|7|||
33308513|NCT02477696|62683820|FG000|Overall Study|Physician Decision|5|||
33308514|NCT02477696|62683821|FG001|Overall Study|Physician Decision|5|||
33308515|NCT02471144|62683831|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
33308516|NCT02471144|62683832|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
33308517|NCT02471144|62683833|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
33308518|NCT02471144|62683834|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
33308519|NCT02471144|62683835|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
33308520|NCT02471144|62683836|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
33308521|NCT02471144|62683837|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
33308522|NCT02471144|62683838|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
33308523|NCT02471144|62683839|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
33308524|NCT02471144|62683840|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
33308525|NCT02471144|62683841|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
33308526|NCT02471144|62683831|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33308527|NCT02471144|62683832|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33308528|NCT02471144|62683833|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33308529|NCT02471144|62683834|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
33308530|NCT02471144|62683835|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33308531|NCT02471144|62683836|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33308532|NCT02471144|62683837|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33308533|NCT02471144|62683838|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33308534|NCT02471144|62683839|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33308535|NCT02471144|62683840|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33308536|NCT02471144|62683841|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33308537|NCT02471144|62683831|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33308538|NCT02471144|62683832|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33308539|NCT02471144|62683833|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
33308540|NCT02471144|62683834|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33308541|NCT02471144|62683835|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33308542|NCT02471144|62683836|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33308543|NCT02471144|62683837|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33308544|NCT02471144|62683838|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33308545|NCT02471144|62683839|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33308546|NCT02471144|62683840|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33308547|NCT02471144|62683841|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33308548|NCT02471144|62683831|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
33308549|NCT02471144|62683832|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
33308550|NCT02471144|62683833|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33308551|NCT02471144|62683834|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33308552|NCT02471144|62683835|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33308553|NCT02471144|62683836|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33580113|NCT01968070|62976887|FG017|Period 2|Withdrawal by Subject|0|||
33308554|NCT02471144|62683837|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33308555|NCT02471144|62683838|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33308556|NCT02471144|62683839|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33308557|NCT02471144|62683840|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33308558|NCT02471144|62683841|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33308559|NCT02471144|62683831|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33308560|NCT02471144|62683832|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33308561|NCT02471144|62683833|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33308562|NCT02471144|62683834|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33308563|NCT02471144|62683835|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
33308564|NCT02471144|62683836|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33308565|NCT02471144|62683837|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
33308566|NCT02471144|62683838|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33308567|NCT02471144|62683839|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
33308568|NCT02471144|62683840|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33308569|NCT02471144|62683841|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33308570|NCT02471144|62683831|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33308571|NCT02471144|62683832|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33308572|NCT02471144|62683833|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33308573|NCT02471144|62683834|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33308574|NCT02471144|62683835|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33308575|NCT02471144|62683836|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
33308576|NCT02471144|62683837|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33308577|NCT02471144|62683838|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33308578|NCT02471144|62683839|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
33308579|NCT02471144|62683840|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33308580|NCT02471144|62683841|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33308581|NCT02471144|62683831|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33308582|NCT02471144|62683832|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33308583|NCT02471144|62683833|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33308584|NCT02471144|62683834|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33308585|NCT02471144|62683835|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33308586|NCT02471144|62683836|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33308587|NCT02471144|62683837|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33308588|NCT02471144|62683838|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33308589|NCT02471144|62683839|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
33308590|NCT02471144|62683840|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33308591|NCT02471144|62683841|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33308592|NCT02471144|62683831|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33308593|NCT02471144|62683832|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33308594|NCT02471144|62683833|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33308595|NCT02471144|62683834|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33308596|NCT02471144|62683835|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33308597|NCT02471144|62683836|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33308598|NCT02471144|62683837|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33308599|NCT02471144|62683838|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
33308600|NCT02471144|62683839|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
33308601|NCT02471144|62683840|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33308602|NCT02471144|62683841|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33308603|NCT02471144|62683831|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33308604|NCT02471144|62683832|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33308605|NCT02471144|62683833|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33308606|NCT02471144|62683834|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33308607|NCT02471144|62683835|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33308608|NCT02471144|62683836|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33308609|NCT02471144|62683837|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33308610|NCT02471144|62683838|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33308611|NCT02471144|62683839|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33308612|NCT02471144|62683840|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|5|||
33308613|NCT02471144|62683841|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|2|||
33308614|NCT02471144|62683831|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33308615|NCT02471144|62683832|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33308616|NCT02471144|62683833|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33308617|NCT02471144|62683834|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33308618|NCT02471144|62683835|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33308619|NCT02471144|62683836|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33308620|NCT02471144|62683837|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33308621|NCT02471144|62683838|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33308622|NCT02471144|62683839|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33308623|NCT02471144|62683840|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
33308624|NCT02471144|62683841|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33308625|NCT02471144|62683831|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33308626|NCT02471144|62683832|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33308627|NCT02471144|62683833|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33308628|NCT02471144|62683834|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33308629|NCT02471144|62683835|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33308630|NCT02471144|62683836|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33308631|NCT02471144|62683837|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33308632|NCT02471144|62683838|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33308633|NCT02471144|62683839|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33308634|NCT02471144|62683840|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33308635|NCT02471144|62683841|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
33308636|NCT02470585|62683860|FG000|Overall Study|Death|82|||
33308637|NCT02470585|62683861|FG001|Overall Study|Death|87|||
33308638|NCT02470585|62683862|FG002|Overall Study|Death|86|||
33308639|NCT02470585|62683860|FG000|Overall Study|Withdrawal by Subject|19|||
33308640|NCT02470585|62683861|FG001|Overall Study|Withdrawal by Subject|21|||
33308641|NCT02470585|62683862|FG002|Overall Study|Withdrawal by Subject|29|||
33308642|NCT02470585|62683860|FG000|Overall Study|Lost to Follow-up|2|||
33308643|NCT02470585|62683861|FG001|Overall Study|Lost to Follow-up|5|||
33308644|NCT02470585|62683862|FG002|Overall Study|Lost to Follow-up|4|||
33308645|NCT02470585|62683860|FG000|Overall Study|Other|4|||
33308646|NCT02470585|62683861|FG001|Overall Study|Other|4|||
33308647|NCT02470585|62683862|FG002|Overall Study|Other|6|||
33308648|NCT02213328|62683879|FG000|Overall Study|Withdrawal by Subject|10|||
33308649|NCT02213328|62683879|FG000|Overall Study|Physician Decision|2|||
33308650|NCT02213328|62683879|FG000|Overall Study|Lost to Follow-up|16|||
33308651|NCT02085408|62683908|FG000|Step 1: Induction|Disease Progression|19|||
33308652|NCT02085408|62683909|FG001|Step 1: Induction|Disease Progression|19|||
33308653|NCT02085408|62683908|FG000|Step 1: Induction|Adverse Event|18|||
33308654|NCT02085408|62683909|FG001|Step 1: Induction|Adverse Event|17|||
33308655|NCT02085408|62683908|FG000|Step 1: Induction|Death|33|||
33308656|NCT02085408|62683909|FG001|Step 1: Induction|Death|30|||
33308657|NCT02085408|62683908|FG000|Step 1: Induction|Withdrawal by Subject|16|||
33308658|NCT02085408|62683909|FG001|Step 1: Induction|Withdrawal by Subject|8|||
33308659|NCT02085408|62683908|FG000|Step 1: Induction|Alternative Therapy|15|||
33308660|NCT02085408|62683909|FG001|Step 1: Induction|Alternative Therapy|19|||
33308661|NCT02085408|62683908|FG000|Step 1: Induction|Complicating Disease|2|||
33308662|NCT02085408|62683909|FG001|Step 1: Induction|Complicating Disease|3|||
33308663|NCT02085408|62683908|FG000|Step 1: Induction|Other|27|||
33308664|NCT02085408|62683909|FG001|Step 1: Induction|Other|39|||
33308665|NCT02085408|62683908|FG000|Step 1: Induction|Never started treatment|6|||
33308666|NCT02085408|62683909|FG001|Step 1: Induction|Never started treatment|4|||
33308667|NCT02085408|62683908|FG000|Step 2: Consolidation|Disease Progression|5|||
33308668|NCT02085408|62683909|FG001|Step 2: Consolidation|Disease Progression|20|||
33308669|NCT02085408|62683908|FG000|Step 2: Consolidation|Adverse Event|9|||
33308670|NCT02085408|62683909|FG001|Step 2: Consolidation|Adverse Event|8|||
33308671|NCT02085408|62683908|FG000|Step 2: Consolidation|Death|4|||
33308672|NCT02085408|62683909|FG001|Step 2: Consolidation|Death|3|||
33308673|NCT02085408|62683908|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
33308674|NCT02085408|62683909|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
33308675|NCT02085408|62683908|FG000|Step 2: Consolidation|Alternative Therapy|9|||
33308676|NCT02085408|62683909|FG001|Step 2: Consolidation|Alternative Therapy|3|||
33308677|NCT02085408|62683908|FG000|Step 2: Consolidation|Complicating Disease|0|||
33308678|NCT02085408|62683909|FG001|Step 2: Consolidation|Complicating Disease|2|||
33308679|NCT02085408|62683908|FG000|Step 2: Consolidation|Other|6|||
33308680|NCT02085408|62683909|FG001|Step 2: Consolidation|Other|6|||
33308681|NCT02085408|62683908|FG000|Step 2: Consolidation|Never started treatment|4|||
33308682|NCT02085408|62683909|FG001|Step 2: Consolidation|Never started treatment|3|||
33308683|NCT02085408|62683908|FG000|Step 3: Maintenance|Disease Progression|13|||
33308684|NCT02085408|62683909|FG001|Step 3: Maintenance|Disease Progression|11|||
33308685|NCT02085408|62683908|FG000|Step 3: Maintenance|Adverse Event|2|||
33308686|NCT02085408|62683909|FG001|Step 3: Maintenance|Adverse Event|4|||
33308687|NCT02085408|62683908|FG000|Step 3: Maintenance|Death|1|||
33308688|NCT02085408|62683909|FG001|Step 3: Maintenance|Death|2|||
33308689|NCT02085408|62683908|FG000|Step 3: Maintenance|Alternative Therapy|1|||
33308690|NCT02085408|62683909|FG001|Step 3: Maintenance|Alternative Therapy|1|||
33308691|NCT02085408|62683908|FG000|Step 3: Maintenance|Complicating Disease|0|||
33308692|NCT02085408|62683909|FG001|Step 3: Maintenance|Complicating Disease|1|||
33308693|NCT02085408|62683908|FG000|Step 3: Maintenance|Other|3|||
33308694|NCT02085408|62683909|FG001|Step 3: Maintenance|Other|2|||
33308695|NCT02085408|62683908|FG000|Step 3: Maintenance|Never started treatment|5|||
33308696|NCT02085408|62683909|FG001|Step 3: Maintenance|Never started treatment|1|||
33308697|NCT01867606|62683926|FG000|Overall Study|Withdrawal by Subject|10|||
33308698|NCT01867606|62683927|FG001|Overall Study|Withdrawal by Subject|14|||
33308699|NCT01867606|62683926|FG000|Overall Study|Protocol Violation|0|||
33308700|NCT01867606|62683927|FG001|Overall Study|Protocol Violation|1|||
33308701|NCT01730937|62683941|FG000|Overall Study|Protocol Violation|5|||
33308702|NCT01730937|62683942|FG001|Overall Study|Protocol Violation|11|||
33308703|NCT01475786|62683951|FG000|Overall Study|Adverse Event|0|||
33308704|NCT01475786|62683952|FG001|Overall Study|Adverse Event|1|||
33308705|NCT01475786|62683953|FG002|Overall Study|Adverse Event|0|||
33308706|NCT01475786|62683951|FG000|Overall Study|Lost to Follow-up|1|||
33308707|NCT01475786|62683952|FG001|Overall Study|Lost to Follow-up|2|||
33308708|NCT01475786|62683953|FG002|Overall Study|Lost to Follow-up|1|||
33308709|NCT01475786|62683951|FG000|Overall Study|Withdrawal by Subject|0|||
33308710|NCT01475786|62683952|FG001|Overall Study|Withdrawal by Subject|1|||
33308711|NCT01475786|62683953|FG002|Overall Study|Withdrawal by Subject|1|||
33308712|NCT01475786|62683951|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
33308713|NCT01475786|62683952|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
33308714|NCT01475786|62683953|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
33308715|NCT01290692|62683961|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
33308716|NCT00700882|62683997|FG000|Overall Study|Never received treatment|6|||
33308717|NCT00700882|62683997|FG000|Overall Study|Ineligible|2|||
33308718|NCT00700882|62683997|FG000|Overall Study|No KIT mutation|51|||
33308719|NCT00666835|62684035|FG000|Overall Study|Withdrawal by Subject|5|||
33308720|NCT00666835|62684036|FG001|Overall Study|Withdrawal by Subject|2|||
33308721|NCT00666835|62684035|FG000|Overall Study|Lack of Efficacy|0|||
33308722|NCT00666835|62684036|FG001|Overall Study|Lack of Efficacy|1|||
33308723|NCT00666835|62684035|FG000|Overall Study|Incl./excl. not fulfilled|7|||
33308724|NCT00666835|62684036|FG001|Overall Study|Incl./excl. not fulfilled|2|||
33308725|NCT00666835|62684035|FG000|Overall Study|Adverse Event|7|||
33308726|NCT00666835|62684036|FG001|Overall Study|Adverse Event|6|||
33308727|NCT00666835|62684035|FG000|Overall Study|Protocol Violation|2|||
33308728|NCT00666835|62684036|FG001|Overall Study|Protocol Violation|0|||
33308729|NCT00666835|62684035|FG000|Overall Study|Death|15|||
33308730|NCT00666835|62684036|FG001|Overall Study|Death|4|||
33308731|NCT00666835|62684035|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
33308732|NCT00666835|62684036|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
33308733|NCT00666835|62684035|FG000|Overall Study|Hemoglobulin concentration|4|||
33308734|NCT00666835|62684036|FG001|Overall Study|Hemoglobulin concentration|3|||
33308735|NCT00666835|62684035|FG000|Overall Study|Planned operation|2|||
33308736|NCT00666835|62684036|FG001|Overall Study|Planned operation|0|||
33308737|NCT00666835|62684035|FG000|Overall Study|Physician Decision|1|||
33308738|NCT00666835|62684036|FG001|Overall Study|Physician Decision|2|||
33308739|NCT00551759|62684043|FG000|Overall Study|Adverse Event|7|||
33308740|NCT00551759|62684043|FG000|Overall Study|Death|5|||
33308741|NCT00551759|62684043|FG000|Overall Study|Ineligible|1|||
33308742|NCT00335140|62684047|FG000|Overall Study|Ineligible|1|||
33308743|NCT00304239|62684053|FG000|Overall Study|Protocol Deviations/Violations|15|||
33308744|NCT00304239|62684054|FG001|Overall Study|Protocol Deviations/Violations|0|||
33308745|NCT00304239|62684053|FG000|Overall Study|Adverse Event|2|||
33308746|NCT00304239|62684054|FG001|Overall Study|Adverse Event|0|||
33308747|NCT00101283|62684062|FG000|Overall Study|Withdrawal by Subject|0|||
33308748|NCT00101283|62684063|FG001|Overall Study|Withdrawal by Subject|1|||
33308749|NCT00101283|62684062|FG000|Overall Study|Insurance Refusal|0|||
33308750|NCT00101283|62684063|FG001|Overall Study|Insurance Refusal|1|||
33308751|NCT00101283|62684062|FG000|Overall Study|Prostate Cancer Recurrence|0|||
33308752|NCT00101283|62684063|FG001|Overall Study|Prostate Cancer Recurrence|1|||
33308753|NCT01302041|62684069|FG000|Overall Study|Death|5|||
33308754|NCT01302041|62684069|FG000|Overall Study|Withdrawal by Subject|4|||
33308755|NCT01302041|62684069|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
33308756|NCT01302041|62684069|FG000|Overall Study|Other-Miscellaneous Reason|2|||
33308757|NCT01301729|62684074|FG000|Overall Study|Withdrawal by Subject|2|||
33308758|NCT01301729|62684074|FG000|Overall Study|Participant did not Return for Treatment|1|||
33308759|NCT01301729|62684074|FG000|Overall Study|Violated Selection Criteria|1|||
33308760|NCT01187043|62684084|FG000|Overall Study|Adverse Event|0|||
33308761|NCT01187043|62684085|FG001|Overall Study|Adverse Event|0|||
33308762|NCT01187043|62684086|FG002|Overall Study|Adverse Event|0|||
33308763|NCT01187043|62684087|FG003|Overall Study|Adverse Event|0|||
33308764|NCT01187043|62684088|FG004|Overall Study|Adverse Event|1|||
33308765|NCT01187043|62684084|FG000|Overall Study|Unable to make scheduled visits|1|||
33308766|NCT01187043|62684085|FG001|Overall Study|Unable to make scheduled visits|0|||
33308767|NCT01187043|62684086|FG002|Overall Study|Unable to make scheduled visits|4|||
33308768|NCT01187043|62684087|FG003|Overall Study|Unable to make scheduled visits|0|||
33308769|NCT01187043|62684088|FG004|Overall Study|Unable to make scheduled visits|1|||
33308770|NCT01186809|62684100|FG000|Overall Study|Death|30|||
33308771|NCT01186419|62684106|FG000|Overall Study|Withdrawal by Subject|5|||
33308772|NCT01186419|62684107|FG001|Overall Study|Withdrawal by Subject|3|||
33308773|NCT01186419|62684106|FG000|Overall Study|Adverse Event|1|||
33308774|NCT01186419|62684107|FG001|Overall Study|Adverse Event|2|||
33308775|NCT01186419|62684106|FG000|Overall Study|Physician Decision|0|||
33308776|NCT01186419|62684107|FG001|Overall Study|Physician Decision|3|||
33308777|NCT01186419|62684106|FG000|Overall Study|Other|1|||
33308778|NCT01186419|62684107|FG001|Overall Study|Other|1|||
33308779|NCT01301027|62684114|FG000|Overall Study|Physician Decision|2|||
33308780|NCT01301027|62684115|FG001|Overall Study|Physician Decision|0|||
33308781|NCT01301027|62684114|FG000|Overall Study|Withdrawal by Subject|2|||
33308782|NCT01301027|62684115|FG001|Overall Study|Withdrawal by Subject|3|||
33308783|NCT01301027|62684114|FG000|Overall Study|Adverse Event|0|||
33308784|NCT01301027|62684115|FG001|Overall Study|Adverse Event|2|||
33308785|NCT01301027|62684114|FG000|Overall Study|Fracture|1|||
33308786|NCT01301027|62684115|FG001|Overall Study|Fracture|3|||
33308787|NCT01301027|62684114|FG000|Overall Study|Transplant|0|||
33308788|NCT01301027|62684115|FG001|Overall Study|Transplant|2|||
33308789|NCT01301027|62684114|FG000|Overall Study|Volume Overload|3|||
33308790|NCT01301027|62684115|FG001|Overall Study|Volume Overload|0|||
33308791|NCT01185639|62684121|FG000|Overall Study|Progressed and didn't receive therapy|2|||
33308792|NCT01185561|62684127|FG000|Overall Study|Lost to Follow-up|0|||
33308793|NCT01185561|62684128|FG001|Overall Study|Lost to Follow-up|4|||
33308794|NCT01185561|62684127|FG000|Overall Study|Withdrawal by Subject|2|||
33308795|NCT01185561|62684128|FG001|Overall Study|Withdrawal by Subject|8|||
33308796|NCT01185249|62684134|FG000|Overall Study|Patients discharged or change in status|42|||
33308797|NCT01184859|62684144|FG000|Period 1: Single Dose|Insufficient urine production|0|||
33308798|NCT01184859|62684145|FG001|Period 1: Single Dose|Insufficient urine production|1|||
33308799|NCT01184859|62684146|FG002|Period 1: Single Dose|Insufficient urine production|0|||
33308800|NCT01184859|62684147|FG003|Period 1: Single Dose|Insufficient urine production|0|||
33308801|NCT01184859|62684148|FG004|Period 1: Single Dose|Insufficient urine production|0|||
33308802|NCT01184859|62684144|FG000|Period 1: Single Dose|Protocol Violation|0|||
33308803|NCT01184859|62684145|FG001|Period 1: Single Dose|Protocol Violation|1|||
33308804|NCT01184859|62684146|FG002|Period 1: Single Dose|Protocol Violation|0|||
33308805|NCT01184859|62684147|FG003|Period 1: Single Dose|Protocol Violation|0|||
33308806|NCT01184859|62684148|FG004|Period 1: Single Dose|Protocol Violation|0|||
33308807|NCT01184859|62684144|FG000|Period 1: Single Dose|Adverse Event|0|||
33308808|NCT01184859|62684145|FG001|Period 1: Single Dose|Adverse Event|0|||
33308809|NCT01184859|62684146|FG002|Period 1: Single Dose|Adverse Event|0|||
33308810|NCT01184859|62684147|FG003|Period 1: Single Dose|Adverse Event|0|||
33308811|NCT01184859|62684148|FG004|Period 1: Single Dose|Adverse Event|1|||
33308812|NCT01184859|62684144|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
33308813|NCT01184859|62684145|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
33308814|NCT01184859|62684146|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
33308815|NCT01184859|62684147|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
33308816|NCT01184859|62684148|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
33308817|NCT01184859|62684144|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
33308818|NCT01184859|62684145|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
33308819|NCT01184859|62684146|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
33308820|NCT01184859|62684147|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
33308821|NCT01184859|62684148|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
33308822|NCT01184079|62684167|FG000|Overall Study|Lost to Follow-up|14|||
33308823|NCT01184079|62684168|FG001|Overall Study|Lost to Follow-up|2|||
33308824|NCT01190865|62684176|FG000|Overall Study|Withdrawal by Subject|1|||
33308825|NCT01190865|62684176|FG000|Overall Study|Non-compliance|2|||
33308826|NCT01190475|62684183|FG000|Overall Study|Withdrawal by Subject|0|||
33308827|NCT01190475|62684184|FG001|Overall Study|Withdrawal by Subject|0|||
33308828|NCT01190475|62684185|FG002|Overall Study|Withdrawal by Subject|1|||
33308829|NCT01289990|62684208|FG000|Overall Study|Death|0|||
33308830|NCT01289990|62684209|FG001|Overall Study|Death|0|||
33308831|NCT01289990|62684210|FG002|Overall Study|Death|0|||
33308832|NCT01289990|62684211|FG003|Overall Study|Death|1|||
33308833|NCT01289990|62684212|FG004|Overall Study|Death|2|||
33308834|NCT01289990|62684213|FG005|Overall Study|Death|1|||
33308835|NCT01289990|62684214|FG006|Overall Study|Death|0|||
33308836|NCT01289990|62684215|FG007|Overall Study|Death|0|||
33308837|NCT01289990|62684216|FG008|Overall Study|Death|0|||
33308838|NCT01289990|62684217|FG009|Overall Study|Death|0|||
33308839|NCT01289990|62684218|FG010|Overall Study|Death|0|||
33308840|NCT01289990|62684219|FG011|Overall Study|Death|1|||
33308841|NCT01289990|62684220|FG012|Overall Study|Death|0|||
33308842|NCT01289990|62684208|FG000|Overall Study|Lost to Follow-up|3|||
33308843|NCT01289990|62684209|FG001|Overall Study|Lost to Follow-up|2|||
33308844|NCT01289990|62684210|FG002|Overall Study|Lost to Follow-up|5|||
33308845|NCT01289990|62684211|FG003|Overall Study|Lost to Follow-up|5|||
33308846|NCT01289990|62684212|FG004|Overall Study|Lost to Follow-up|3|||
33308847|NCT01289990|62684213|FG005|Overall Study|Lost to Follow-up|4|||
33308848|NCT01289990|62684214|FG006|Overall Study|Lost to Follow-up|2|||
33308849|NCT01289990|62684215|FG007|Overall Study|Lost to Follow-up|2|||
33308850|NCT01289990|62684216|FG008|Overall Study|Lost to Follow-up|1|||
33308851|NCT01289990|62684217|FG009|Overall Study|Lost to Follow-up|4|||
33308852|NCT01289990|62684218|FG010|Overall Study|Lost to Follow-up|2|||
33308853|NCT01289990|62684219|FG011|Overall Study|Lost to Follow-up|1|||
33308854|NCT01289990|62684220|FG012|Overall Study|Lost to Follow-up|2|||
33308855|NCT01289990|62684208|FG000|Overall Study|Withdrawal by Subject|15|||
33308856|NCT01289990|62684209|FG001|Overall Study|Withdrawal by Subject|14|||
33308857|NCT01289990|62684210|FG002|Overall Study|Withdrawal by Subject|12|||
33308858|NCT01289990|62684211|FG003|Overall Study|Withdrawal by Subject|13|||
33308859|NCT01289990|62684212|FG004|Overall Study|Withdrawal by Subject|8|||
33308860|NCT01289990|62684213|FG005|Overall Study|Withdrawal by Subject|7|||
33308861|NCT01289990|62684214|FG006|Overall Study|Withdrawal by Subject|13|||
33308862|NCT01289990|62684215|FG007|Overall Study|Withdrawal by Subject|9|||
33308863|NCT01289990|62684216|FG008|Overall Study|Withdrawal by Subject|12|||
33308864|NCT01289990|62684217|FG009|Overall Study|Withdrawal by Subject|13|||
33308865|NCT01289990|62684218|FG010|Overall Study|Withdrawal by Subject|11|||
33308866|NCT01289990|62684219|FG011|Overall Study|Withdrawal by Subject|13|||
33308867|NCT01289990|62684220|FG012|Overall Study|Withdrawal by Subject|16|||
33308868|NCT01289990|62684208|FG000|Overall Study|discontinued in preceding trial|18|||
33308869|NCT01289990|62684209|FG001|Overall Study|discontinued in preceding trial|20|||
33308870|NCT01289990|62684210|FG002|Overall Study|discontinued in preceding trial|41|||
33308871|NCT01289990|62684211|FG003|Overall Study|discontinued in preceding trial|17|||
33308872|NCT01289990|62684212|FG004|Overall Study|discontinued in preceding trial|11|||
33308873|NCT01289990|62684213|FG005|Overall Study|discontinued in preceding trial|12|||
33308874|NCT01289990|62684214|FG006|Overall Study|discontinued in preceding trial|18|||
33308875|NCT01289990|62684215|FG007|Overall Study|discontinued in preceding trial|8|||
33308876|NCT01289990|62684216|FG008|Overall Study|discontinued in preceding trial|17|||
33308877|NCT01289990|62684217|FG009|Overall Study|discontinued in preceding trial|21|||
33308878|NCT01289990|62684218|FG010|Overall Study|discontinued in preceding trial|17|||
33308879|NCT01289990|62684219|FG011|Overall Study|discontinued in preceding trial|17|||
33308880|NCT01289990|62684220|FG012|Overall Study|discontinued in preceding trial|24|||
33308881|NCT01289990|62684208|FG000|Overall Study|did not continue in extension|41|||
33308882|NCT01289990|62684209|FG001|Overall Study|did not continue in extension|45|||
33308883|NCT01289990|62684210|FG002|Overall Study|did not continue in extension|51|||
33308884|NCT01289990|62684211|FG003|Overall Study|did not continue in extension|51|||
33308885|NCT01289990|62684212|FG004|Overall Study|did not continue in extension|48|||
33308886|NCT01289990|62684213|FG005|Overall Study|did not continue in extension|50|||
33308887|NCT01289990|62684214|FG006|Overall Study|did not continue in extension|54|||
33308888|NCT01289990|62684215|FG007|Overall Study|did not continue in extension|36|||
33308889|NCT01289990|62684216|FG008|Overall Study|did not continue in extension|44|||
33308890|NCT01289990|62684217|FG009|Overall Study|did not continue in extension|48|||
33308891|NCT01289990|62684218|FG010|Overall Study|did not continue in extension|45|||
33308892|NCT01289990|62684219|FG011|Overall Study|did not continue in extension|34|||
33308893|NCT01289990|62684220|FG012|Overall Study|did not continue in extension|56|||
33308894|NCT01289990|62684208|FG000|Overall Study|Not treated|0|||
33308895|NCT01289990|62684209|FG001|Overall Study|Not treated|0|||
33308896|NCT01289990|62684210|FG002|Overall Study|Not treated|0|||
33308897|NCT01289990|62684211|FG003|Overall Study|Not treated|0|||
33308898|NCT01289990|62684212|FG004|Overall Study|Not treated|0|||
33308899|NCT01289990|62684213|FG005|Overall Study|Not treated|0|||
33308900|NCT01289990|62684214|FG006|Overall Study|Not treated|1|||
33308901|NCT01289990|62684215|FG007|Overall Study|Not treated|0|||
33308902|NCT01289990|62684216|FG008|Overall Study|Not treated|1|||
33308903|NCT01289990|62684217|FG009|Overall Study|Not treated|0|||
33308904|NCT01289990|62684218|FG010|Overall Study|Not treated|1|||
33308905|NCT01289990|62684219|FG011|Overall Study|Not treated|2|||
33308906|NCT01289990|62684220|FG012|Overall Study|Not treated|0|||
33308907|NCT01190007|62684248|FG000|Overall Study|Withdrawal by Subject|4|||
33308908|NCT01190007|62684248|FG000|Overall Study|Adverse Event|8|||
33308909|NCT01190007|62684248|FG000|Overall Study|Difficulty of visit for complications|1|||
33308910|NCT01190007|62684248|FG000|Overall Study|Participant was arrested|1|||
33308911|NCT01189461|62684252|FG000|Overall Study|Lack of Efficacy|13|||
33308912|NCT01189461|62684252|FG000|Overall Study|Lost to Follow-up|1|||
33308913|NCT01189461|62684252|FG000|Overall Study|Withdrawal by Subject|6|||
33308914|NCT01189461|62684252|FG000|Overall Study|Protocol Violation|1|||
33308915|NCT01189461|62684252|FG000|Overall Study|Adverse Event|2|||
33308916|NCT01189461|62684252|FG000|Overall Study|Did not meet entrance criteria|3|||
33308917|NCT01189461|62684252|FG000|Overall Study|Other|8|||
33308918|NCT01189227|62684258|FG000|Overall Study|Study terminated due to low accrual|6|||
33308919|NCT01189227|62684259|FG001|Overall Study|Study terminated due to low accrual|3|||
33308920|NCT01300247|62684267|FG000|Overall Study|Death|1|||
33308921|NCT01300247|62684268|FG001|Overall Study|Death|1|||
33308922|NCT01300247|62684267|FG000|Overall Study|Lost to Follow-up|2|||
33308923|NCT01300247|62684268|FG001|Overall Study|Lost to Follow-up|0|||
33308924|NCT01300247|62684267|FG000|Overall Study|Withdrawal by Subject|1|||
33308925|NCT01300247|62684268|FG001|Overall Study|Withdrawal by Subject|0|||
33308926|NCT01300247|62684267|FG000|Overall Study|Non-Compliance|0|||
33308927|NCT01300247|62684268|FG001|Overall Study|Non-Compliance|1|||
33308928|NCT01289678|62684274|FG000|Overall Study|Physician Decision|6|||
33308929|NCT01289210|62684278|FG000|Overall Study|Adverse Event|1|||
33308930|NCT01183221|62684284|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
33308931|NCT01183221|62684285|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
33308932|NCT01183143|62684291|FG000|Overall Study|Protocol Violation|115|||
33308933|NCT01183143|62684291|FG000|Overall Study|Withdrawal by Subject|19|||
33308934|NCT01183143|62684291|FG000|Overall Study|Subject Questionnaires not returned|5|||
33308935|NCT01183143|62684291|FG000|Overall Study|Subjects enrolled, but not treated|11|||
33308936|NCT01183065|62684295|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
33308937|NCT01182441|62684301|FG000|Overall Study|Patient Still in Follow-up|152|||
33308938|NCT01182441|62684302|FG001|Overall Study|Patient Still in Follow-up|72|||
33308939|NCT01182441|62684301|FG000|Overall Study|Death|37|||
33308940|NCT01182441|62684302|FG001|Overall Study|Death|25|||
33308941|NCT01182441|62684301|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
33308942|NCT01182441|62684302|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
33308943|NCT01182441|62684301|FG000|Overall Study|Lost to Follow-up|5|||
33308944|NCT01182441|62684302|FG001|Overall Study|Lost to Follow-up|8|||
33308945|NCT01182441|62684301|FG000|Overall Study|Withdrawal by Subject|6|||
33308946|NCT01182441|62684302|FG001|Overall Study|Withdrawal by Subject|13|||
33308947|NCT01182441|62684301|FG000|Overall Study|Implant Not Attempted|4|||
33308948|NCT01182441|62684302|FG001|Overall Study|Implant Not Attempted|0|||
33308949|NCT01182441|62684301|FG000|Overall Study|Adverse Event|2|||
33308950|NCT01182441|62684302|FG001|Overall Study|Adverse Event|0|||
33308951|NCT01182441|62684301|FG000|Overall Study|Physician Decision|1|||
33308952|NCT01182441|62684302|FG001|Overall Study|Physician Decision|1|||
33308953|NCT01182285|62684308|FG000|First Intervention Week 1-10|Disease progression|1|||
33308954|NCT01182285|62684309|FG001|First Intervention Week 1-10|Disease progression|0|||
33308955|NCT01182285|62684310|FG002|First Intervention Week 1-10|Disease progression|0|||
33308956|NCT01182285|62684308|FG000|First Intervention Week 1-10|Adverse Event|1|||
33308957|NCT01182285|62684309|FG001|First Intervention Week 1-10|Adverse Event|0|||
33308958|NCT01182285|62684310|FG002|First Intervention Week 1-10|Adverse Event|0|||
33308959|NCT01182285|62684308|FG000|First Intervention Week 1-10|Non-compliance|1|||
33308960|NCT01182285|62684309|FG001|First Intervention Week 1-10|Non-compliance|0|||
33308961|NCT01182285|62684310|FG002|First Intervention Week 1-10|Non-compliance|0|||
33308962|NCT01182285|62684308|FG000|Third Intervention Week 11-52|Disease Progression|0|||
33308963|NCT01182285|62684309|FG001|Third Intervention Week 11-52|Disease Progression|0|||
33308964|NCT01182285|62684310|FG002|Third Intervention Week 11-52|Disease Progression|6|||
33308965|NCT01182285|62684308|FG000|Third Intervention Week 11-52|Other|0|||
33308966|NCT01182285|62684309|FG001|Third Intervention Week 11-52|Other|0|||
33308967|NCT01182285|62684310|FG002|Third Intervention Week 11-52|Other|2|||
33308968|NCT01182207|62684319|FG000|First Intervention|Positive Hepatitis Results|0|||
33308969|NCT01182207|62684320|FG001|First Intervention|Positive Hepatitis Results|1|||
33308970|NCT01182207|62684319|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
33308971|NCT01182207|62684320|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
33308972|NCT01181895|62684329|FG000|Overall Study|Adverse Event|3|||
33308973|NCT01181895|62684330|FG001|Overall Study|Adverse Event|1|||
33308974|NCT01181895|62684331|FG002|Overall Study|Adverse Event|1|||
33308975|NCT01181895|62684329|FG000|Overall Study|Lack of Efficacy|8|||
33308976|NCT01181895|62684330|FG001|Overall Study|Lack of Efficacy|9|||
33308977|NCT01181895|62684331|FG002|Overall Study|Lack of Efficacy|9|||
33308978|NCT01181895|62684329|FG000|Overall Study|Protocol Violation|2|||
33308979|NCT01181895|62684330|FG001|Overall Study|Protocol Violation|1|||
33308980|NCT01181895|62684331|FG002|Overall Study|Protocol Violation|0|||
33308981|NCT01181895|62684329|FG000|Overall Study|Lost to Follow-up|0|||
33308982|NCT01181895|62684330|FG001|Overall Study|Lost to Follow-up|1|||
33308983|NCT01181895|62684331|FG002|Overall Study|Lost to Follow-up|2|||
33308984|NCT01181895|62684329|FG000|Overall Study|Investigator Discretion|1|||
33308985|NCT01181895|62684330|FG001|Overall Study|Investigator Discretion|2|||
33308986|NCT01181895|62684331|FG002|Overall Study|Investigator Discretion|1|||
33308987|NCT01181895|62684329|FG000|Overall Study|Withdrawal by Subject|3|||
33308988|NCT01181895|62684330|FG001|Overall Study|Withdrawal by Subject|0|||
33308989|NCT01181895|62684331|FG002|Overall Study|Withdrawal by Subject|5|||
33308990|NCT01181271|62684339|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
33308991|NCT01181271|62684339|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
33308992|NCT01181271|62684339|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
33308993|NCT01181271|62684339|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
33308994|NCT01180647|62684345|FG000|Overall Study|Lost to Follow-up|5|||
33308995|NCT01180647|62684346|FG001|Overall Study|Lost to Follow-up|6|||
33308996|NCT00969553|62684361|FG000|Overall Study|Progressive disease (PD)|2|||
33308997|NCT00969553|62684362|FG001|Overall Study|Progressive disease (PD)|2|||
33308998|NCT00969553|62684363|FG002|Overall Study|Progressive disease (PD)|6|||
33308999|NCT00969553|62684364|FG003|Overall Study|Progressive disease (PD)|9|||
33309000|NCT00969553|62684365|FG004|Overall Study|Progressive disease (PD)|2|||
33309001|NCT00969553|62684366|FG005|Overall Study|Progressive disease (PD)|4|||
33309002|NCT00969553|62684367|FG006|Overall Study|Progressive disease (PD)|2|||
33309003|NCT00969553|62684368|FG007|Overall Study|Progressive disease (PD)|12|||
33309004|NCT00969553|62684369|FG008|Overall Study|Progressive disease (PD)|3|||
33309005|NCT00969553|62684361|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
33309006|NCT00969553|62684362|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
33309007|NCT00969553|62684363|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
33309008|NCT00969553|62684364|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
33309009|NCT00969553|62684365|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
33309010|NCT00969553|62684366|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
33309011|NCT00969553|62684367|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
33309012|NCT00969553|62684368|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
33309013|NCT00969553|62684369|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
33309014|NCT00969553|62684361|FG000|Overall Study|Other Adverse Event|0|||
33309015|NCT00969553|62684362|FG001|Overall Study|Other Adverse Event|0|||
33309016|NCT00969553|62684363|FG002|Overall Study|Other Adverse Event|0|||
33309017|NCT00969553|62684364|FG003|Overall Study|Other Adverse Event|1|||
33309018|NCT00969553|62684365|FG004|Overall Study|Other Adverse Event|0|||
33309019|NCT00969553|62684366|FG005|Overall Study|Other Adverse Event|0|||
33309020|NCT00969553|62684367|FG006|Overall Study|Other Adverse Event|1|||
33309021|NCT00969553|62684368|FG007|Overall Study|Other Adverse Event|0|||
33309022|NCT00969553|62684369|FG008|Overall Study|Other Adverse Event|0|||
33309023|NCT00969553|62684361|FG000|Overall Study|Refused cont. medication|1|||
33309024|NCT00969553|62684362|FG001|Overall Study|Refused cont. medication|1|||
33309025|NCT00969553|62684363|FG002|Overall Study|Refused cont. medication|0|||
33309026|NCT00969553|62684364|FG003|Overall Study|Refused cont. medication|2|||
33309027|NCT00969553|62684365|FG004|Overall Study|Refused cont. medication|0|||
33309028|NCT00969553|62684366|FG005|Overall Study|Refused cont. medication|0|||
33309029|NCT00969553|62684367|FG006|Overall Study|Refused cont. medication|0|||
33309030|NCT00969553|62684368|FG007|Overall Study|Refused cont. medication|1|||
33309031|NCT00969553|62684369|FG008|Overall Study|Refused cont. medication|0|||
33309032|NCT00969553|62684361|FG000|Overall Study|Not specified above|0|||
33309033|NCT00969553|62684362|FG001|Overall Study|Not specified above|0|||
33309034|NCT00969553|62684363|FG002|Overall Study|Not specified above|0|||
33309035|NCT00969553|62684364|FG003|Overall Study|Not specified above|4|||
33309036|NCT00969553|62684365|FG004|Overall Study|Not specified above|0|||
33309037|NCT00969553|62684366|FG005|Overall Study|Not specified above|0|||
33309038|NCT00969553|62684367|FG006|Overall Study|Not specified above|1|||
33309039|NCT00969553|62684368|FG007|Overall Study|Not specified above|1|||
33309040|NCT00969553|62684369|FG008|Overall Study|Not specified above|0|||
33309041|NCT01179477|62684397|FG000|Overall Study|Death|542|||
33309042|NCT01179477|62684397|FG000|Overall Study|Unsuccessful implant|80|||
33309043|NCT01179477|62684397|FG000|Overall Study|Non-death withdrawal|438|||
33309044|NCT01179477|62684397|FG000|Overall Study|Did not complete final visit|27|||
33309045|NCT01179399|62684401|FG000|Overall Study|Adverse Event|1|||
33309046|NCT01179399|62684401|FG000|Overall Study|Lack of Efficacy|30|||
33309047|NCT01179399|62684401|FG000|Overall Study|Withdrawal by Subject|1|||
33309048|NCT01178853|62684407|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
33309049|NCT01178853|62684408|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
33309050|NCT01178853|62684407|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
33309051|NCT01178853|62684408|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
33309052|NCT01178853|62684407|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
33309053|NCT01178853|62684408|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
33309054|NCT01178853|62684407|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
33309055|NCT01178853|62684408|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
33309056|NCT01178853|62684407|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
33309057|NCT01178853|62684408|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
33309058|NCT01178385|62684416|FG000|Overall Study|Withdrawal by Subject|2|||
33309059|NCT01178385|62684417|FG001|Overall Study|Withdrawal by Subject|0|||
33309060|NCT01288976|62684426|FG000|Overall Study|Withdrawal by Subject|58|||
33309061|NCT01288976|62684427|FG001|Overall Study|Withdrawal by Subject|12|||
33309062|NCT01288976|62684428|FG002|Overall Study|Withdrawal by Subject|9|||
33309063|NCT01288976|62684426|FG000|Overall Study|Death|98|||
33309064|NCT01288976|62684427|FG001|Overall Study|Death|6|||
33309065|NCT01288976|62684428|FG002|Overall Study|Death|4|||
33309066|NCT01288976|62684426|FG000|Overall Study|Data unavailable|22|||
33309067|NCT01288976|62684427|FG001|Overall Study|Data unavailable|9|||
33309068|NCT01288976|62684428|FG002|Overall Study|Data unavailable|7|||
33309069|NCT00970489|62684436|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
33309070|NCT00970489|62684437|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
33309071|NCT00968617|62684443|FG000|Overall Study|Study terminated by sponsor|6|||
33309072|NCT00968539|62684449|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
33309073|NCT00968539|62684450|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
33309074|NCT00976573|62684459|FG000|Overall Study|Ineligible|0|||
33309075|NCT00976573|62684460|FG001|Overall Study|Ineligible|1|||
33309076|NCT00976573|62684459|FG000|Overall Study|Cancel prior to receiving treatment|4|||
33309077|NCT00976573|62684460|FG001|Overall Study|Cancel prior to receiving treatment|2|||
33309078|NCT00976495|62684469|FG000|Overall Study|Withdrawal by Subject|0|||
33309079|NCT00976495|62684470|FG001|Overall Study|Withdrawal by Subject|1|||
33309080|NCT00976495|62684471|FG002|Overall Study|Withdrawal by Subject|0|||
33309081|NCT01288430|62684489|FG000|Part 1|Progressive disease|2|||
33309082|NCT01288430|62684490|FG001|Part 1|Progressive disease|1|||
33309083|NCT01288430|62684491|FG002|Part 1|Progressive disease|1|||
33309084|NCT01288430|62684492|FG003|Part 1|Progressive disease|6|||
33309085|NCT01288430|62684493|FG004|Part 1|Progressive disease|2|||
33309086|NCT01288430|62684494|FG005|Part 1|Progressive disease|4|||
33309087|NCT01288430|62684495|FG006|Part 1|Progressive disease|2|||
33309088|NCT01288430|62684496|FG007|Part 1|Progressive disease|0|||
33309089|NCT01288430|62684497|FG008|Part 1|Progressive disease|0|||
33309090|NCT01288430|62684498|FG009|Part 1|Progressive disease|0|||
33309091|NCT01288430|62684489|FG000|Part 1|Clinical disease progression|0|||
33309092|NCT01288430|62684490|FG001|Part 1|Clinical disease progression|0|||
33309093|NCT01288430|62684491|FG002|Part 1|Clinical disease progression|1|||
33309094|NCT01288430|62684492|FG003|Part 1|Clinical disease progression|0|||
33309095|NCT01288430|62684493|FG004|Part 1|Clinical disease progression|0|||
33309096|NCT01288430|62684494|FG005|Part 1|Clinical disease progression|2|||
33309097|NCT01288430|62684495|FG006|Part 1|Clinical disease progression|2|||
33309098|NCT01288430|62684496|FG007|Part 1|Clinical disease progression|0|||
33309099|NCT01288430|62684497|FG008|Part 1|Clinical disease progression|0|||
33309100|NCT01288430|62684498|FG009|Part 1|Clinical disease progression|0|||
33309101|NCT01288430|62684489|FG000|Part 1|Death due to disease progression|0|||
33309102|NCT01288430|62684490|FG001|Part 1|Death due to disease progression|0|||
33309103|NCT01288430|62684491|FG002|Part 1|Death due to disease progression|0|||
33309104|NCT01288430|62684492|FG003|Part 1|Death due to disease progression|0|||
33309105|NCT01288430|62684493|FG004|Part 1|Death due to disease progression|1|||
33309106|NCT01288430|62684494|FG005|Part 1|Death due to disease progression|0|||
33309107|NCT01288430|62684495|FG006|Part 1|Death due to disease progression|0|||
33309108|NCT01288430|62684496|FG007|Part 1|Death due to disease progression|0|||
33309109|NCT01288430|62684497|FG008|Part 1|Death due to disease progression|0|||
33309110|NCT01288430|62684498|FG009|Part 1|Death due to disease progression|0|||
33309111|NCT01288430|62684489|FG000|Part 1|Adverse Event|0|||
33309112|NCT01288430|62684490|FG001|Part 1|Adverse Event|0|||
33309113|NCT01288430|62684491|FG002|Part 1|Adverse Event|3|||
33309114|NCT01288430|62684492|FG003|Part 1|Adverse Event|1|||
33309115|NCT01288430|62684493|FG004|Part 1|Adverse Event|0|||
33309116|NCT01288430|62684494|FG005|Part 1|Adverse Event|0|||
33309117|NCT01288430|62684495|FG006|Part 1|Adverse Event|2|||
33309118|NCT01288430|62684496|FG007|Part 1|Adverse Event|0|||
33309119|NCT01288430|62684497|FG008|Part 1|Adverse Event|0|||
33309120|NCT01288430|62684498|FG009|Part 1|Adverse Event|0|||
33309121|NCT01288430|62684489|FG000|Part 1|Other|0|||
33309122|NCT01288430|62684490|FG001|Part 1|Other|2|||
33309123|NCT01288430|62684491|FG002|Part 1|Other|0|||
33309124|NCT01288430|62684492|FG003|Part 1|Other|0|||
33309125|NCT01288430|62684493|FG004|Part 1|Other|0|||
33309126|NCT01288430|62684494|FG005|Part 1|Other|0|||
33309127|NCT01288430|62684495|FG006|Part 1|Other|1|||
33309128|NCT01288430|62684496|FG007|Part 1|Other|0|||
33309129|NCT01288430|62684497|FG008|Part 1|Other|0|||
33309130|NCT01288430|62684498|FG009|Part 1|Other|0|||
33309131|NCT01288430|62684489|FG000|Part 2|Progressive disease|0|||
33309132|NCT01288430|62684490|FG001|Part 2|Progressive disease|0|||
33309133|NCT01288430|62684491|FG002|Part 2|Progressive disease|0|||
33309134|NCT01288430|62684492|FG003|Part 2|Progressive disease|0|||
33309135|NCT01288430|62684493|FG004|Part 2|Progressive disease|0|||
33309136|NCT01288430|62684494|FG005|Part 2|Progressive disease|0|||
33309137|NCT01288430|62684495|FG006|Part 2|Progressive disease|0|||
33309138|NCT01288430|62684496|FG007|Part 2|Progressive disease|8|||
33309139|NCT01288430|62684497|FG008|Part 2|Progressive disease|7|||
33309140|NCT01288430|62684498|FG009|Part 2|Progressive disease|2|||
33309141|NCT01288430|62684489|FG000|Part 2|Clinical disease progression|0|||
33309142|NCT01288430|62684490|FG001|Part 2|Clinical disease progression|0|||
33309143|NCT01288430|62684491|FG002|Part 2|Clinical disease progression|0|||
33309144|NCT01288430|62684492|FG003|Part 2|Clinical disease progression|0|||
33309145|NCT01288430|62684493|FG004|Part 2|Clinical disease progression|0|||
33309146|NCT01288430|62684494|FG005|Part 2|Clinical disease progression|0|||
33309147|NCT01288430|62684495|FG006|Part 2|Clinical disease progression|0|||
33309148|NCT01288430|62684496|FG007|Part 2|Clinical disease progression|2|||
33309149|NCT01288430|62684497|FG008|Part 2|Clinical disease progression|0|||
33309150|NCT01288430|62684498|FG009|Part 2|Clinical disease progression|0|||
33309151|NCT01288430|62684489|FG000|Part 2|Withdrawal by Subject|0|||
33309152|NCT01288430|62684490|FG001|Part 2|Withdrawal by Subject|0|||
33309153|NCT01288430|62684491|FG002|Part 2|Withdrawal by Subject|0|||
33309154|NCT01288430|62684492|FG003|Part 2|Withdrawal by Subject|0|||
33309155|NCT01288430|62684493|FG004|Part 2|Withdrawal by Subject|0|||
33309156|NCT01288430|62684494|FG005|Part 2|Withdrawal by Subject|0|||
33309157|NCT01288430|62684495|FG006|Part 2|Withdrawal by Subject|0|||
33309158|NCT01288430|62684496|FG007|Part 2|Withdrawal by Subject|1|||
33309159|NCT01288430|62684497|FG008|Part 2|Withdrawal by Subject|4|||
33309160|NCT01288430|62684498|FG009|Part 2|Withdrawal by Subject|0|||
33309161|NCT01288430|62684489|FG000|Part 2|Adverse Event|0|||
33309162|NCT01288430|62684490|FG001|Part 2|Adverse Event|0|||
33309163|NCT01288430|62684491|FG002|Part 2|Adverse Event|0|||
33309164|NCT01288430|62684492|FG003|Part 2|Adverse Event|0|||
33309165|NCT01288430|62684493|FG004|Part 2|Adverse Event|0|||
33309166|NCT01288430|62684494|FG005|Part 2|Adverse Event|0|||
33309167|NCT01288430|62684495|FG006|Part 2|Adverse Event|0|||
33309168|NCT01288430|62684496|FG007|Part 2|Adverse Event|1|||
33309169|NCT01288430|62684497|FG008|Part 2|Adverse Event|1|||
33309170|NCT01288430|62684498|FG009|Part 2|Adverse Event|0|||
33309171|NCT01288430|62684489|FG000|Part 2|Other|0|||
33309172|NCT01288430|62684490|FG001|Part 2|Other|0|||
33309173|NCT01288430|62684491|FG002|Part 2|Other|0|||
33309174|NCT01288430|62684492|FG003|Part 2|Other|0|||
33309175|NCT01288430|62684493|FG004|Part 2|Other|0|||
33309176|NCT01288430|62684494|FG005|Part 2|Other|0|||
33309177|NCT01288430|62684495|FG006|Part 2|Other|0|||
33309178|NCT01288430|62684496|FG007|Part 2|Other|0|||
33309179|NCT01288430|62684497|FG008|Part 2|Other|0|||
33309180|NCT01288430|62684498|FG009|Part 2|Other|1|||
33309181|NCT01287416|62684527|FG000|Pre-post Training|Withdrawal by Subject|17|||
33309182|NCT01287416|62684528|FG001|Pre-post Training|Withdrawal by Subject|24|||
33309183|NCT01287416|62684527|FG000|Pre-post Training|Lost to Follow-up|5|||
33309184|NCT01287416|62684528|FG001|Pre-post Training|Lost to Follow-up|1|||
33309185|NCT01287416|62684527|FG000|6 Month Follow-up|Lost to Follow-up|3|||
33309186|NCT01287416|62684528|FG001|6 Month Follow-up|Lost to Follow-up|2|||
33309187|NCT00998296|62684545|FG000|Overall Study|Progressive disease|0|||
33309188|NCT00998296|62684546|FG001|Overall Study|Progressive disease|1|||
33309189|NCT00998296|62684547|FG002|Overall Study|Progressive disease|0|||
33309190|NCT00998296|62684548|FG003|Overall Study|Progressive disease|0|||
33309191|NCT00998296|62684549|FG004|Overall Study|Progressive disease|0|||
33309192|NCT00998296|62684550|FG005|Overall Study|Progressive disease|0|||
33309193|NCT00998296|62684551|FG006|Overall Study|Progressive disease|1|||
33309194|NCT00998296|62684552|FG007|Overall Study|Progressive disease|0|||
33309195|NCT00998296|62684553|FG008|Overall Study|Progressive disease|0|||
33309196|NCT00998296|62684554|FG009|Overall Study|Progressive disease|14|||
33309197|NCT00998296|62684555|FG010|Overall Study|Progressive disease|5|||
33309198|NCT00998296|62684545|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
33309199|NCT00998296|62684546|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
33309200|NCT00998296|62684547|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
33309201|NCT00998296|62684548|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
33309202|NCT00998296|62684549|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
33309203|NCT00998296|62684550|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
33309204|NCT00998296|62684551|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
33309205|NCT00998296|62684552|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
33309206|NCT00998296|62684553|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
33309207|NCT00998296|62684554|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
33309208|NCT00998296|62684555|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
33309209|NCT00998296|62684545|FG000|Overall Study|Other adverse event|0|||
33309210|NCT00998296|62684546|FG001|Overall Study|Other adverse event|0|||
33309211|NCT00998296|62684547|FG002|Overall Study|Other adverse event|0|||
33309212|NCT00998296|62684548|FG003|Overall Study|Other adverse event|0|||
33309213|NCT00998296|62684549|FG004|Overall Study|Other adverse event|1|||
33309214|NCT00998296|62684550|FG005|Overall Study|Other adverse event|0|||
33309215|NCT00998296|62684551|FG006|Overall Study|Other adverse event|0|||
33309216|NCT00998296|62684552|FG007|Overall Study|Other adverse event|0|||
33309217|NCT00998296|62684553|FG008|Overall Study|Other adverse event|0|||
33309218|NCT00998296|62684554|FG009|Overall Study|Other adverse event|1|||
33309219|NCT00998296|62684555|FG010|Overall Study|Other adverse event|2|||
33309220|NCT00998296|62684545|FG000|Overall Study|Refused to continue taking trial med.|0|||
33309221|NCT00998296|62684546|FG001|Overall Study|Refused to continue taking trial med.|0|||
33309222|NCT00998296|62684547|FG002|Overall Study|Refused to continue taking trial med.|0|||
33309223|NCT00998296|62684548|FG003|Overall Study|Refused to continue taking trial med.|0|||
33309224|NCT00998296|62684549|FG004|Overall Study|Refused to continue taking trial med.|0|||
33309225|NCT00998296|62684550|FG005|Overall Study|Refused to continue taking trial med.|0|||
33309226|NCT00998296|62684551|FG006|Overall Study|Refused to continue taking trial med.|0|||
33309227|NCT00998296|62684552|FG007|Overall Study|Refused to continue taking trial med.|0|||
33309228|NCT00998296|62684553|FG008|Overall Study|Refused to continue taking trial med.|0|||
33309229|NCT00998296|62684554|FG009|Overall Study|Refused to continue taking trial med.|2|||
33309230|NCT00998296|62684555|FG010|Overall Study|Refused to continue taking trial med.|0|||
33309231|NCT00998296|62684545|FG000|Overall Study|Reason other than those specified above|0|||
33309232|NCT00998296|62684546|FG001|Overall Study|Reason other than those specified above|0|||
33309233|NCT00998296|62684547|FG002|Overall Study|Reason other than those specified above|0|||
33309234|NCT00998296|62684548|FG003|Overall Study|Reason other than those specified above|0|||
33309235|NCT00998296|62684549|FG004|Overall Study|Reason other than those specified above|0|||
33309236|NCT00998296|62684550|FG005|Overall Study|Reason other than those specified above|0|||
33309237|NCT00998296|62684551|FG006|Overall Study|Reason other than those specified above|0|||
33309238|NCT00998296|62684552|FG007|Overall Study|Reason other than those specified above|0|||
33309239|NCT00998296|62684553|FG008|Overall Study|Reason other than those specified above|0|||
33309240|NCT00998296|62684554|FG009|Overall Study|Reason other than those specified above|1|||
33309241|NCT00998296|62684555|FG010|Overall Study|Reason other than those specified above|0|||
33309242|NCT01178073|62684587|FG000|Overall Study|Adverse Event|34|||
33309243|NCT01178073|62684588|FG001|Overall Study|Adverse Event|27|||
33309244|NCT01178073|62684589|FG002|Overall Study|Adverse Event|24|||
33309245|NCT01178073|62684587|FG000|Overall Study|Protocol Violation|1|||
33309246|NCT01178073|62684588|FG001|Overall Study|Protocol Violation|1|||
33309247|NCT01178073|62684589|FG002|Overall Study|Protocol Violation|1|||
33309248|NCT01178073|62684587|FG000|Overall Study|Lost to Follow-up|2|||
33309249|NCT01178073|62684588|FG001|Overall Study|Lost to Follow-up|0|||
33309250|NCT01178073|62684589|FG002|Overall Study|Lost to Follow-up|3|||
33309251|NCT01178073|62684587|FG000|Overall Study|Physician Decision|14|||
33309252|NCT01178073|62684588|FG001|Overall Study|Physician Decision|10|||
33309253|NCT01178073|62684589|FG002|Overall Study|Physician Decision|10|||
33309254|NCT01178073|62684587|FG000|Overall Study|Withdrawal by Subject|10|||
33309255|NCT01178073|62684588|FG001|Overall Study|Withdrawal by Subject|6|||
33309256|NCT01178073|62684589|FG002|Overall Study|Withdrawal by Subject|8|||
33309257|NCT01178073|62684587|FG000|Overall Study|Missing Completion Status|1|||
33309258|NCT01178073|62684588|FG001|Overall Study|Missing Completion Status|0|||
33309259|NCT01178073|62684589|FG002|Overall Study|Missing Completion Status|0|||
33309260|NCT00997984|62684601|FG000|Overall Study|Adverse Event|1|||
33309261|NCT00997984|62684602|FG001|Overall Study|Adverse Event|8|||
33309262|NCT00997984|62684603|FG002|Overall Study|Adverse Event|8|||
33309263|NCT00997984|62684601|FG000|Overall Study|Protocol Violation|1|||
33309264|NCT00997984|62684602|FG001|Overall Study|Protocol Violation|3|||
33309265|NCT00997984|62684603|FG002|Overall Study|Protocol Violation|0|||
33309266|NCT00997984|62684601|FG000|Overall Study|Withdrawal by Subject|6|||
33309267|NCT00997984|62684602|FG001|Overall Study|Withdrawal by Subject|9|||
33309268|NCT00997984|62684603|FG002|Overall Study|Withdrawal by Subject|5|||
33309269|NCT00997984|62684601|FG000|Overall Study|Lost to Follow-up|8|||
33309270|NCT00997984|62684602|FG001|Overall Study|Lost to Follow-up|5|||
33309271|NCT00997984|62684603|FG002|Overall Study|Lost to Follow-up|4|||
33309272|NCT00997984|62684601|FG000|Overall Study|Lack of Efficacy|20|||
33309273|NCT00997984|62684602|FG001|Overall Study|Lack of Efficacy|6|||
33309274|NCT00997984|62684603|FG002|Overall Study|Lack of Efficacy|3|||
33309275|NCT00997984|62684601|FG000|Overall Study|Met exclusion criteria|1|||
33309276|NCT00997984|62684602|FG001|Overall Study|Met exclusion criteria|0|||
33309277|NCT00997984|62684603|FG002|Overall Study|Met exclusion criteria|0|||
33309278|NCT00997984|62684601|FG000|Overall Study|non-compliance|0|||
33309279|NCT00997984|62684602|FG001|Overall Study|non-compliance|2|||
33309280|NCT00997984|62684603|FG002|Overall Study|non-compliance|3|||
33309281|NCT00997984|62684601|FG000|Overall Study|Wrong medication dispensed|0|||
33309282|NCT00997984|62684602|FG001|Overall Study|Wrong medication dispensed|1|||
33309283|NCT00997984|62684603|FG002|Overall Study|Wrong medication dispensed|0|||
33309284|NCT00997984|62684601|FG000|Overall Study|Suicidal ideation|0|||
33309285|NCT00997984|62684602|FG001|Overall Study|Suicidal ideation|0|||
33309286|NCT00997984|62684603|FG002|Overall Study|Suicidal ideation|1|||
33309287|NCT00997984|62684601|FG000|Overall Study|Work schedule|0|||
33309288|NCT00997984|62684602|FG001|Overall Study|Work schedule|0|||
33309289|NCT00997984|62684603|FG002|Overall Study|Work schedule|2|||
33309290|NCT01177293|62684613|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
33309291|NCT01177293|62684614|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
33309292|NCT01177137|62684623|FG000|Overall Study|Withdrawal by Subject|10|||
33309293|NCT01177137|62684624|FG001|Overall Study|Withdrawal by Subject|10|||
33309294|NCT01177137|62684625|FG002|Overall Study|Withdrawal by Subject|2|||
33309295|NCT01177059|62684636|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
33309296|NCT01177059|62684636|FG000|Overall Study|Withdrew consent|2|||
33309297|NCT01177059|62684636|FG000|Overall Study|Lost to Follow-up|18|||
33309298|NCT01176513|62684640|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
33309299|NCT01299389|62684646|FG000|Double-blind|Adverse Event|45|||
33309300|NCT01299389|62684647|FG001|Double-blind|Adverse Event|27|||
33309301|NCT01299389|62684648|FG002|Double-blind|Adverse Event|0|||
33309302|NCT01299389|62684649|FG003|Double-blind|Adverse Event|0|||
33309303|NCT01299389|62684646|FG000|Double-blind|Lack of Efficacy|45|||
33309304|NCT01299389|62684647|FG001|Double-blind|Lack of Efficacy|21|||
33309305|NCT01299389|62684648|FG002|Double-blind|Lack of Efficacy|0|||
33309306|NCT01299389|62684649|FG003|Double-blind|Lack of Efficacy|0|||
33309307|NCT01299389|62684646|FG000|Double-blind|Lost to Follow-up|2|||
33309308|NCT01299389|62684647|FG001|Double-blind|Lost to Follow-up|1|||
33309309|NCT01299389|62684648|FG002|Double-blind|Lost to Follow-up|0|||
33309310|NCT01299389|62684649|FG003|Double-blind|Lost to Follow-up|0|||
33309311|NCT01299389|62684646|FG000|Double-blind|Withdrawal by Subject|16|||
33309312|NCT01299389|62684647|FG001|Double-blind|Withdrawal by Subject|13|||
33309313|NCT01299389|62684648|FG002|Double-blind|Withdrawal by Subject|0|||
33309314|NCT01299389|62684649|FG003|Double-blind|Withdrawal by Subject|0|||
33309315|NCT01299389|62684646|FG000|Double-blind|Other|1|||
33309316|NCT01299389|62684647|FG001|Double-blind|Other|1|||
33309317|NCT01299389|62684648|FG002|Double-blind|Other|0|||
33580114|NCT01918774|62976925|FG000|Overall Study|Lost prior to first CBTw session|4|||
33309318|NCT01299389|62684649|FG003|Double-blind|Other|0|||
33309319|NCT01299389|62684646|FG000|Double-blind|"fail to meet study population criteria"|0|||
33309320|NCT01299389|62684647|FG001|Double-blind|"fail to meet study population criteria"|1|||
33309321|NCT01299389|62684648|FG002|Double-blind|"fail to meet study population criteria"|0|||
33309322|NCT01299389|62684649|FG003|Double-blind|"fail to meet study population criteria"|0|||
33309323|NCT01299389|62684646|FG000|Post-observational|Other|0|||
33309324|NCT01299389|62684647|FG001|Post-observational|Other|0|||
33309325|NCT01299389|62684648|FG002|Post-observational|Other|12|||
33309326|NCT01299389|62684649|FG003|Post-observational|Other|6|||
33309327|NCT01298999|62684660|FG000|Overall Study|Physician Decision|0|||
33309328|NCT01298999|62684661|FG001|Overall Study|Physician Decision|1|||
33309329|NCT01298999|62684660|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
33309330|NCT01298999|62684661|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
33309331|NCT01007032|62684671|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
33309332|NCT01007032|62684672|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
33309333|NCT01007032|62684673|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
33309334|NCT01007032|62684674|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
33309335|NCT01007032|62684671|FG000|Overall Study|Withdrawal by Subject|0|||
33309336|NCT01007032|62684672|FG001|Overall Study|Withdrawal by Subject|0|||
33309337|NCT01007032|62684673|FG002|Overall Study|Withdrawal by Subject|0|||
33309338|NCT01007032|62684674|FG003|Overall Study|Withdrawal by Subject|1|||
33309339|NCT00976027|62684691|FG000|Overall Study|Serious Adverse Event|36|||
33309340|NCT00976027|62684692|FG001|Overall Study|Serious Adverse Event|17|||
33309341|NCT00976027|62684691|FG000|Overall Study|Adverse Event|0|||
33309342|NCT00976027|62684692|FG001|Overall Study|Adverse Event|2|||
33309343|NCT00976027|62684691|FG000|Overall Study|Protocol Violation|60|||
33309344|NCT00976027|62684692|FG001|Overall Study|Protocol Violation|27|||
33309345|NCT00976027|62684691|FG000|Overall Study|Lost to Follow-up|208|||
33309346|NCT00976027|62684692|FG001|Overall Study|Lost to Follow-up|103|||
33309347|NCT00976027|62684691|FG000|Overall Study|Withdrawal by Subject|107|||
33309348|NCT00976027|62684692|FG001|Overall Study|Withdrawal by Subject|66|||
33309349|NCT01298765|62684698|FG000|Titration Period|Adverse Event|26|||
33309350|NCT01298765|62684698|FG000|Titration Period|Death|1|||
33309351|NCT01298765|62684698|FG000|Titration Period|Lack of Efficacy|21|||
33309352|NCT01298765|62684698|FG000|Titration Period|Lost to Follow-up|9|||
33309353|NCT01298765|62684698|FG000|Titration Period|Physician Decision|1|||
33309354|NCT01298765|62684698|FG000|Titration Period|Withdrawal by Subject|10|||
33309355|NCT01298765|62684698|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
33309356|NCT01298765|62684698|FG000|Long-Term Treatment Period|Adverse Event|19|||
33309357|NCT01298765|62684698|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
33309358|NCT01298765|62684698|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
33309359|NCT01298765|62684698|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
33309360|NCT01298765|62684698|FG000|Long-Term Treatment Period|Physician Decision|1|||
33309361|NCT01298765|62684698|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
33309362|NCT00997438|62684705|FG000|Overall Study|Blood draw difficulty|2|||
33309363|NCT00997438|62684706|FG001|Overall Study|Blood draw difficulty|0|||
33309364|NCT00997438|62684707|FG002|Overall Study|Blood draw difficulty|1|||
33309365|NCT00997438|62684705|FG000|Overall Study|Withdrawal by Subject|1|||
33309366|NCT00997438|62684706|FG001|Overall Study|Withdrawal by Subject|1|||
33309367|NCT00997438|62684707|FG002|Overall Study|Withdrawal by Subject|0|||
33309368|NCT00997438|62684705|FG000|Overall Study|Exclusion criteria at visit 1|2|||
33309369|NCT00997438|62684706|FG001|Overall Study|Exclusion criteria at visit 1|2|||
33309370|NCT00997438|62684707|FG002|Overall Study|Exclusion criteria at visit 1|3|||
33309371|NCT00997126|62684718|FG000|Overall Study|Physician Decision|7|||
33309372|NCT00997126|62684719|FG001|Overall Study|Physician Decision|11|||
33309373|NCT01000636|62684725|FG000|Overall Study|Withdrawal by Subject|1|||
33309374|NCT01000636|62684725|FG000|Overall Study|Adverse Event|1|||
33309375|NCT00965419|62684729|FG000|Open Label Treatment for Responders|Adverse Event|33|||
33309376|NCT00965419|62684729|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
33309377|NCT00965419|62684729|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
33309378|NCT00965419|62684729|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
33309379|NCT00965419|62684729|FG000|Open Label Treatment for Responders|Physician Decision|6|||
33309380|NCT00965419|62684729|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
33309381|NCT00965419|62684729|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
33309382|NCT00965419|62684729|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
33309383|NCT00965419|62684729|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
33309384|NCT00965419|62684729|FG000|Follow-up Phase|Adverse Event|9|||
33309385|NCT00965419|62684729|FG000|Follow-up Phase|Protocol Violation|4|||
33309386|NCT00965419|62684729|FG000|Follow-up Phase|Withdrawal by Subject|8|||
33309387|NCT00965419|62684729|FG000|Follow-up Phase|Physician Decision|4|||
33309388|NCT00965419|62684729|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
33309389|NCT00965419|62684729|FG000|Follow-up Phase|Lack of Efficacy|28|||
33309390|NCT01000480|62684734|FG000|Induction Phase|Adverse Event|2|||
33309391|NCT01000480|62684734|FG000|Induction Phase|Lost to Follow-up|1|||
33309392|NCT01000480|62684734|FG000|Induction Phase|Physician Decision|1|||
33309393|NCT01000480|62684734|FG000|Induction Phase|Entry Criteria Not Met|3|||
33309394|NCT01000480|62684734|FG000|Concurrent Therapy Phase|Adverse Event|4|||
33309395|NCT01000480|62684734|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
33309396|NCT01000480|62684734|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
33309397|NCT01000480|62684734|FG000|Concurrent Therapy Phase|Physician Decision|1|||
33309398|NCT00965341|62684740|FG000|Overall Study|Withdrew consent|1|||
33309399|NCT00965341|62684741|FG001|Overall Study|Withdrew consent|5|||
33309400|NCT00965341|62684740|FG000|Overall Study|Lost to Follow-up|1|||
33309401|NCT00965341|62684741|FG001|Overall Study|Lost to Follow-up|0|||
33309402|NCT00965341|62684740|FG000|Overall Study|Transportation issues|4|||
33309403|NCT00965341|62684741|FG001|Overall Study|Transportation issues|3|||
33309404|NCT01175811|62684749|FG000|Overall Study|Adverse Event|1|||
33309405|NCT01175811|62684750|FG001|Overall Study|Adverse Event|1|||
33309406|NCT01175811|62684749|FG000|Overall Study|Entry criteria not met|3|||
33309407|NCT01175811|62684750|FG001|Overall Study|Entry criteria not met|1|||
33309408|NCT01175811|62684749|FG000|Overall Study|Lack of Efficacy|1|||
33309409|NCT01175811|62684750|FG001|Overall Study|Lack of Efficacy|0|||
33309410|NCT01175811|62684749|FG000|Overall Study|Lost to Follow-up|3|||
33309411|NCT01175811|62684750|FG001|Overall Study|Lost to Follow-up|2|||
33309412|NCT01175811|62684749|FG000|Overall Study|Physician Decision|1|||
33309413|NCT01175811|62684750|FG001|Overall Study|Physician Decision|1|||
33309414|NCT01175811|62684749|FG000|Overall Study|Protocol Violation|1|||
33309415|NCT01175811|62684750|FG001|Overall Study|Protocol Violation|2|||
33309416|NCT01175811|62684749|FG000|Overall Study|Withdrawal by Subject|6|||
33309417|NCT01175811|62684750|FG001|Overall Study|Withdrawal by Subject|7|||
33309418|NCT00965263|62684758|FG000|Overall Study|Physician Decision|2|||
33309419|NCT00965263|62684759|FG001|Overall Study|Physician Decision|0|||
33309420|NCT00965263|62684758|FG000|Overall Study|Family emergency|0|||
33309421|NCT00965263|62684759|FG001|Overall Study|Family emergency|1|||
33309422|NCT00965263|62684758|FG000|Overall Study|Protocol Violation|0|||
33309423|NCT00965263|62684759|FG001|Overall Study|Protocol Violation|2|||
33309424|NCT00965185|62684785|FG000|Overall Study|Lost to Follow-up|2|||
33309425|NCT00965185|62684786|FG001|Overall Study|Lost to Follow-up|0|||
33309426|NCT00965185|62684785|FG000|Overall Study|Withdrawal by Subject|0|||
33309427|NCT00965185|62684786|FG001|Overall Study|Withdrawal by Subject|1|||
33309428|NCT01174563|62684794|FG000|Overall Study|Progressive Disease|45|||
33309429|NCT01174563|62684794|FG000|Overall Study|Death|5|||
33309430|NCT01174563|62684794|FG000|Overall Study|Investigator's Discretion|5|||
33309431|NCT01174563|62684794|FG000|Overall Study|Participant Withdrew Consent|3|||
33309432|NCT01174563|62684794|FG000|Overall Study|Rash Adverse Event|1|||
33309433|NCT01174563|62684794|FG000|Overall Study|Sponsor's decision|1|||
33309434|NCT01298531|62684800|FG000|Overall Study|Lack of Efficacy|0|||
33309435|NCT01298531|62684801|FG001|Overall Study|Lack of Efficacy|1|||
33309436|NCT01298531|62684800|FG000|Overall Study|Lost to Follow-up|2|||
33309437|NCT01298531|62684801|FG001|Overall Study|Lost to Follow-up|0|||
33309438|NCT01298531|62684800|FG000|Overall Study|Protocol Violation|1|||
33309439|NCT01298531|62684801|FG001|Overall Study|Protocol Violation|1|||
33309440|NCT01298531|62684800|FG000|Overall Study|Adverse Event|4|||
33309441|NCT01298531|62684801|FG001|Overall Study|Adverse Event|3|||
33309442|NCT01298531|62684800|FG000|Overall Study|Does not meet entrance criteria|0|||
33309443|NCT01298531|62684801|FG001|Overall Study|Does not meet entrance criteria|1|||
33309444|NCT01298531|62684800|FG000|Overall Study|Other|2|||
33309445|NCT01298531|62684801|FG001|Overall Study|Other|1|||
33309446|NCT01174173|62684808|FG000|Overall Study|drug-drug interaction|1|||
33309447|NCT00964795|62684813|FG000|Overall Study|Withdrawal by Subject|79|||
33309448|NCT00964795|62684813|FG000|Overall Study|Adverse Event|12|||
33309449|NCT00964795|62684813|FG000|Overall Study|Death|14|||
33309450|NCT00964795|62684813|FG000|Overall Study|Lost to Follow-up|7|||
33309451|NCT00964795|62684813|FG000|Overall Study|Termination of Study by Sponsor|169|||
33309452|NCT00964795|62684813|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
33309453|NCT00964795|62684813|FG000|Overall Study|Other|23|||
33309454|NCT01173471|62684822|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33309455|NCT01173471|62684823|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33309456|NCT01173471|62684824|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
33309457|NCT01173471|62684825|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
33309458|NCT01173471|62684822|FG000|Overall Study|Condition under investigation worsened|2|||
33309459|NCT01173471|62684823|FG001|Overall Study|Condition under investigation worsened|0|||
33309460|NCT01173471|62684824|FG002|Overall Study|Condition under investigation worsened|0|||
33309461|NCT01173471|62684825|FG003|Overall Study|Condition under investigation worsened|0|||
33309462|NCT01173471|62684822|FG000|Overall Study|Lost to Follow-up|0|||
33309463|NCT01173471|62684823|FG001|Overall Study|Lost to Follow-up|0|||
33309464|NCT01173471|62684824|FG002|Overall Study|Lost to Follow-up|1|||
33309465|NCT01173471|62684825|FG003|Overall Study|Lost to Follow-up|0|||
33309466|NCT01173471|62684822|FG000|Overall Study|Reason given as Other|0|||
33309467|NCT01173471|62684823|FG001|Overall Study|Reason given as Other|0|||
33309468|NCT01173471|62684824|FG002|Overall Study|Reason given as Other|1|||
33309469|NCT01173471|62684825|FG003|Overall Study|Reason given as Other|0|||
33309470|NCT01172847|62684835|FG000|Overall Study|Withdrawal by Subject|3|||
33309471|NCT00966355|62684848|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
33309472|NCT00966355|62684849|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
33309473|NCT00966355|62684850|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
33309474|NCT00966355|62684848|FG000|Overall Study|newly diagnosed advanced HCC|11|||
33309475|NCT00966355|62684849|FG001|Overall Study|newly diagnosed advanced HCC|12|||
33309476|NCT00966355|62684850|FG002|Overall Study|newly diagnosed advanced HCC|10|||
33309477|NCT00966355|62684848|FG000|Overall Study|Lost to Follow-up|5|||
33309478|NCT00966355|62684849|FG001|Overall Study|Lost to Follow-up|4|||
33309479|NCT00966355|62684850|FG002|Overall Study|Lost to Follow-up|3|||
33309480|NCT01172535|62684858|FG000|Overall Study|Death|3|||
33309481|NCT01172535|62684858|FG000|Overall Study|Withdrawal by Subject|2|||
33309482|NCT01172535|62684858|FG000|Overall Study|Lost to Follow-up|1|||
33309483|NCT01172535|62684858|FG000|Overall Study|Ineligible at study entry|1|||
33309484|NCT01172535|62684858|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
33309485|NCT00966277|62684867|FG000|Overall Study|Withdrawal by Subject|3|||
33309486|NCT00966277|62684868|FG001|Overall Study|Withdrawal by Subject|0|||
33309487|NCT00966277|62684867|FG000|Overall Study|Ineligible|1|||
33309488|NCT00966277|62684868|FG001|Overall Study|Ineligible|3|||
33309489|NCT00966277|62684867|FG000|Overall Study|Treatment Plan Changed|0|||
33309490|NCT00966277|62684868|FG001|Overall Study|Treatment Plan Changed|1|||
33309491|NCT01298141|62684874|FG000|Overall Study|Adverse Event|3|||
33309492|NCT01298141|62684874|FG000|Overall Study|Refusal of Required Study Procedures|1|||
33309493|NCT01298141|62684874|FG000|Overall Study|Withdrawal by Subject|6|||
33309494|NCT01298141|62684874|FG000|Overall Study|Termination of Study by the Investigator|5|||
33309495|NCT01298141|62684874|FG000|Overall Study|Other|5|||
33309496|NCT01298141|62684874|FG000|Overall Study|Lost to Follow-up|1|||
33309497|NCT01298141|62684874|FG000|Overall Study|Death|6|||
33309498|NCT01298141|62684874|FG000|Overall Study|Not treated|4|||
33309499|NCT01171989|62684881|FG000|Overall Study|Lost to Follow-up|0|||
33309500|NCT01171989|62684882|FG001|Overall Study|Lost to Follow-up|0|||
33309501|NCT01171989|62684883|FG002|Overall Study|Lost to Follow-up|1|||
33309502|NCT01297517|62684894|FG000|Overall Study|Adverse Event|21|||
33309503|NCT01297517|62684895|FG001|Overall Study|Adverse Event|7|||
33309504|NCT01297517|62684896|FG002|Overall Study|Adverse Event|16|||
33309505|NCT01297517|62684894|FG000|Overall Study|Lost to Follow-up|1|||
33309506|NCT01297517|62684895|FG001|Overall Study|Lost to Follow-up|0|||
33309507|NCT01297517|62684896|FG002|Overall Study|Lost to Follow-up|1|||
33309508|NCT01297517|62684894|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
33309509|NCT01297517|62684895|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
33309510|NCT01297517|62684896|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
33309511|NCT01297517|62684894|FG000|Overall Study|Noncompliance|1|||
33309512|NCT01297517|62684895|FG001|Overall Study|Noncompliance|0|||
33309513|NCT01297517|62684896|FG002|Overall Study|Noncompliance|0|||
33309514|NCT01297517|62684894|FG000|Overall Study|Protocol Violation|1|||
33309515|NCT01297517|62684895|FG001|Overall Study|Protocol Violation|1|||
33309516|NCT01297517|62684896|FG002|Overall Study|Protocol Violation|1|||
33309517|NCT01297517|62684894|FG000|Overall Study|Inadequate Control of IOP|1|||
33309518|NCT01297517|62684895|FG001|Overall Study|Inadequate Control of IOP|1|||
33309519|NCT01297517|62684896|FG002|Overall Study|Inadequate Control of IOP|2|||
33309520|NCT01171677|62684906|FG000|Overall Study|Withdrawal by Subject|0|||
33309521|NCT01171677|62684907|FG001|Overall Study|Withdrawal by Subject|3|||
33309522|NCT01171677|62684906|FG000|Overall Study|Adverse Event|1|||
33309523|NCT01171677|62684907|FG001|Overall Study|Adverse Event|0|||
33309524|NCT01171677|62684906|FG000|Overall Study|completed <70% IntenSati classes|5|||
33309525|NCT01171677|62684907|FG001|Overall Study|completed <70% IntenSati classes|0|||
33309526|NCT01171521|62684913|FG000|Overall Study|Lost to Follow-up|5|||
33309527|NCT01171521|62684913|FG000|Overall Study|screen failure|1|||
33309528|NCT01296347|62684919|FG000|Allocation|Withdrawal by Subject|1|||
33309529|NCT01296347|62684920|FG001|Allocation|Withdrawal by Subject|2|||
33309530|NCT01296347|62684919|FG000|Allocation|Lack of Efficacy|1|||
33309531|NCT01296347|62684920|FG001|Allocation|Lack of Efficacy|2|||
33309532|NCT01296347|62684919|FG000|Allocation|not received infusion|1|||
33309533|NCT01296347|62684920|FG001|Allocation|not received infusion|0|||
33309534|NCT01296347|62684919|FG000|6 Week Follow up|Death|0|||
33309535|NCT01296347|62684920|FG001|6 Week Follow up|Death|1|||
33309536|NCT01296347|62684919|FG000|3 Month Follow up|Death|1|||
33309537|NCT01296347|62684920|FG001|3 Month Follow up|Death|0|||
33309538|NCT01296347|62684919|FG000|3 Month Follow up|Lost to Follow-up|0|||
33309539|NCT01296347|62684920|FG001|3 Month Follow up|Lost to Follow-up|1|||
33309540|NCT01296347|62684919|FG000|6 Month Follow up|Death|2|||
33309541|NCT01296347|62684920|FG001|6 Month Follow up|Death|1|||
33309542|NCT01296347|62684919|FG000|6 Month Follow up|Lost to Follow-up|0|||
33309543|NCT01296347|62684920|FG001|6 Month Follow up|Lost to Follow-up|1|||
33309544|NCT01296347|62684919|FG000|12 Month Follow up|Lost to Follow-up|3|||
33309545|NCT01296347|62684920|FG001|12 Month Follow up|Lost to Follow-up|1|||
33309546|NCT01296347|62684919|FG000|12 Month Follow up|Death|1|||
33309547|NCT01296347|62684920|FG001|12 Month Follow up|Death|1|||
33309548|NCT01296347|62684919|FG000|12 Month Follow up|Withdrawal by Subject|0|||
33309549|NCT01296347|62684920|FG001|12 Month Follow up|Withdrawal by Subject|1|||
33309550|NCT01296035|62684929|FG000|Overall Study|Withdrawal by Subject|1|||
33309551|NCT01294787|62684933|FG000|Period 1|Adverse Event|0|||
33309552|NCT01294787|62684934|FG001|Period 1|Adverse Event|0|||
33309553|NCT01294787|62684935|FG002|Period 1|Adverse Event|0|||
33309554|NCT01294787|62684936|FG003|Period 1|Adverse Event|0|||
33309555|NCT01294787|62684937|FG004|Period 1|Adverse Event|1|||
33309556|NCT01294787|62684938|FG005|Period 1|Adverse Event|0|||
33309557|NCT01294787|62684933|FG000|Period 1|Withdrawal by Subject|0|||
33309558|NCT01294787|62684934|FG001|Period 1|Withdrawal by Subject|0|||
33309559|NCT01294787|62684935|FG002|Period 1|Withdrawal by Subject|0|||
33309560|NCT01294787|62684936|FG003|Period 1|Withdrawal by Subject|1|||
33309561|NCT01294787|62684937|FG004|Period 1|Withdrawal by Subject|1|||
33309562|NCT01294787|62684938|FG005|Period 1|Withdrawal by Subject|1|||
33309563|NCT01294787|62684933|FG000|Period 1|Administrative problem|0|||
33309564|NCT01294787|62684934|FG001|Period 1|Administrative problem|0|||
33309565|NCT01294787|62684935|FG002|Period 1|Administrative problem|1|||
33309566|NCT01294787|62684936|FG003|Period 1|Administrative problem|0|||
33309567|NCT01294787|62684937|FG004|Period 1|Administrative problem|0|||
33309568|NCT01294787|62684938|FG005|Period 1|Administrative problem|1|||
33309569|NCT01294787|62684933|FG000|Period 2|Adverse Event|0|||
33309570|NCT01294787|62684934|FG001|Period 2|Adverse Event|3|||
33309571|NCT01294787|62684935|FG002|Period 2|Adverse Event|0|||
33309572|NCT01294787|62684936|FG003|Period 2|Adverse Event|1|||
33309573|NCT01294787|62684937|FG004|Period 2|Adverse Event|0|||
33309574|NCT01294787|62684938|FG005|Period 2|Adverse Event|0|||
33309575|NCT01294787|62684933|FG000|Period 2|No longer needs study drug|0|||
33309576|NCT01294787|62684934|FG001|Period 2|No longer needs study drug|0|||
33309577|NCT01294787|62684935|FG002|Period 2|No longer needs study drug|0|||
33309578|NCT01294787|62684936|FG003|Period 2|No longer needs study drug|1|||
33309579|NCT01294787|62684937|FG004|Period 2|No longer needs study drug|0|||
33309580|NCT01294787|62684938|FG005|Period 2|No longer needs study drug|0|||
33309581|NCT01294787|62684933|FG000|Period 3|Adverse Event|0|||
33309582|NCT01294787|62684934|FG001|Period 3|Adverse Event|0|||
33309583|NCT01294787|62684935|FG002|Period 3|Adverse Event|0|||
33309584|NCT01294787|62684936|FG003|Period 3|Adverse Event|0|||
33309585|NCT01294787|62684937|FG004|Period 3|Adverse Event|1|||
33309586|NCT01294787|62684938|FG005|Period 3|Adverse Event|0|||
33309587|NCT01294553|62684949|FG000|Overall Study|Duplicated Participants|1|||
33309588|NCT01294553|62684949|FG000|Overall Study|Protocol Violation|268|||
33309589|NCT01294397|62684954|FG000|Overall Study|Withdrawal by Subject|1|||
33309590|NCT01294397|62684954|FG000|Overall Study|Administrative Decision|1|||
33309591|NCT01293695|62684962|FG000|Overall Study|Withdrawal by Subject|7|||
33309592|NCT01293695|62684963|FG001|Overall Study|Withdrawal by Subject|1|||
33309593|NCT01293695|62684962|FG000|Overall Study|Lost to Follow-up|8|||
33309594|NCT01293695|62684963|FG001|Overall Study|Lost to Follow-up|6|||
33309595|NCT01293539|62684972|FG000|Overall Study|Physician Decision|1|||
33309596|NCT01292837|62684976|FG000|Overall Study|Adverse Event|1|||
33309597|NCT01292837|62684976|FG000|Overall Study|Further treatment determined|1|||
33309598|NCT00965731|62684982|FG000|Overall Study|Death|0|||
33309599|NCT00965731|62684983|FG001|Overall Study|Death|4|||
33309600|NCT00965731|62684982|FG000|Overall Study|Withdrawal by Subject|0|||
33309601|NCT00965731|62684983|FG001|Overall Study|Withdrawal by Subject|1|||
33309602|NCT00965731|62684982|FG000|Overall Study|Other|7|||
33309603|NCT00965731|62684983|FG001|Overall Study|Other|15|||
33309604|NCT00965575|62684996|FG000|Overall Study|subject unwillingness to swallow study c|1|||
33309605|NCT00965575|62684997|FG001|Overall Study|subject unwillingness to swallow study c|0|||
33309606|NCT00965497|62685005|FG000|Overall Study|Physician Decision|1|||
33309607|NCT00963937|62685012|FG000|Overall Study|Protocol Violation|1|||
33309608|NCT00963937|62685013|FG001|Overall Study|Protocol Violation|1|||
33309609|NCT00963937|62685014|FG002|Overall Study|Protocol Violation|0|||
33309610|NCT00963937|62685012|FG000|Overall Study|Physician Decision|18|||
33309611|NCT00963937|62685013|FG001|Overall Study|Physician Decision|10|||
33309612|NCT00963937|62685014|FG002|Overall Study|Physician Decision|4|||
33309613|NCT01170663|62685027|FG000|Overall Study|Lost to Follow-up|3|||
33309614|NCT01170663|62685028|FG001|Overall Study|Lost to Follow-up|9|||
33309615|NCT01170663|62685027|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
33309616|NCT01170663|62685028|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
33309617|NCT01170273|62685036|FG000|Overall Study|Lost to Follow-up|6|||
33399936|NCT00617604|62779233|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
33399937|NCT00617604|62779234|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
33399938|NCT00661622|62779242|FG000|Overall Study|Protocol Violation|1|||
33580115|NCT01918774|62976925|FG000|Overall Study|Lost to Follow-up|1|||
33309618|NCT01170273|62685037|FG001|Overall Study|Lost to Follow-up|8|||
33309619|NCT01170273|62685036|FG000|Overall Study|Protocol Violation|1|||
33309620|NCT01170273|62685037|FG001|Overall Study|Protocol Violation|0|||
33309621|NCT01170273|62685036|FG000|Overall Study|Death|1|||
33309622|NCT01170273|62685037|FG001|Overall Study|Death|0|||
33309623|NCT01170273|62685036|FG000|Overall Study|Adverse Event|0|||
33309624|NCT01170273|62685037|FG001|Overall Study|Adverse Event|1|||
33399939|NCT00661622|62779243|FG001|Overall Study|Protocol Violation|0|||
33399940|NCT04093752|62779254|FG000|Overall Study|Adverse Event|7|||
33399941|NCT04093752|62779255|FG001|Overall Study|Adverse Event|19|||
33399942|NCT04093752|62779256|FG002|Overall Study|Adverse Event|18|||
33399943|NCT04093752|62779257|FG003|Overall Study|Adverse Event|4|||
33399944|NCT04093752|62779254|FG000|Overall Study|Withdrawal by Subject|6|||
33399945|NCT04093752|62779255|FG001|Overall Study|Withdrawal by Subject|6|||
33399946|NCT04093752|62779256|FG002|Overall Study|Withdrawal by Subject|8|||
33399947|NCT04093752|62779257|FG003|Overall Study|Withdrawal by Subject|20|||
33399948|NCT04093752|62779254|FG000|Overall Study|Lost to Follow-up|2|||
33399949|NCT04093752|62779255|FG001|Overall Study|Lost to Follow-up|1|||
33399950|NCT04093752|62779256|FG002|Overall Study|Lost to Follow-up|1|||
33399951|NCT04093752|62779257|FG003|Overall Study|Lost to Follow-up|1|||
33399952|NCT04093752|62779254|FG000|Overall Study|Death|0|||
33399953|NCT04093752|62779255|FG001|Overall Study|Death|0|||
33399954|NCT04093752|62779256|FG002|Overall Study|Death|1|||
33399955|NCT04093752|62779257|FG003|Overall Study|Death|2|||
33399956|NCT04093752|62779254|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
33399957|NCT04093752|62779255|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
33399958|NCT04093752|62779256|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
33399959|NCT04093752|62779257|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
33399960|NCT04093752|62779254|FG000|Overall Study|Covid 19|0|||
33399961|NCT04093752|62779255|FG001|Overall Study|Covid 19|0|||
33399962|NCT04093752|62779256|FG002|Overall Study|Covid 19|0|||
33399963|NCT04093752|62779257|FG003|Overall Study|Covid 19|1|||
33399964|NCT04093752|62779254|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
33399965|NCT04093752|62779255|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
33399966|NCT04093752|62779256|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
33399967|NCT04093752|62779257|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
33399968|NCT04093752|62779254|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
33399969|NCT04093752|62779255|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
33399970|NCT04093752|62779256|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
33399971|NCT04093752|62779257|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
33399972|NCT04093752|62779254|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
33399973|NCT04093752|62779255|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
33399974|NCT04093752|62779256|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
33399975|NCT04093752|62779257|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
33399976|NCT03928821|62779275|FG000|Overall Study|Death|0|||
33399977|NCT03928821|62779276|FG001|Overall Study|Death|1|||
33399978|NCT03928821|62779277|FG002|Overall Study|Death|0|||
33399979|NCT03928821|62779278|FG003|Overall Study|Death|0|||
33399980|NCT03928821|62779275|FG000|Overall Study|Lost to Follow-up|0|||
33399981|NCT03928821|62779276|FG001|Overall Study|Lost to Follow-up|2|||
33399982|NCT03928821|62779277|FG002|Overall Study|Lost to Follow-up|3|||
33399983|NCT03928821|62779278|FG003|Overall Study|Lost to Follow-up|0|||
33399984|NCT03928821|62779275|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
33399985|NCT03928821|62779276|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
33399986|NCT03928821|62779277|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
33399987|NCT03928821|62779278|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
33399988|NCT00666224|62779290|FG000|Double-Blind|Adverse Event|15|||
33399989|NCT00666224|62779291|FG001|Double-Blind|Adverse Event|5|||
33399990|NCT00666224|62779290|FG000|Double-Blind|Lost to Follow-up|2|||
33399991|NCT00666224|62779291|FG001|Double-Blind|Lost to Follow-up|2|||
33399992|NCT00666224|62779290|FG000|Double-Blind|Withdrawal by Subject|18|||
33399993|NCT00666224|62779291|FG001|Double-Blind|Withdrawal by Subject|14|||
33399994|NCT00666224|62779290|FG000|Double-Blind|Physician Decision|0|||
33399995|NCT00666224|62779291|FG001|Double-Blind|Physician Decision|3|||
33399996|NCT00666224|62779290|FG000|Double-Blind|Sponsor decision|1|||
33399997|NCT00666224|62779291|FG001|Double-Blind|Sponsor decision|0|||
33399998|NCT00666224|62779290|FG000|Double-Blind|Pregnancy|3|||
33399999|NCT00666224|62779291|FG001|Double-Blind|Pregnancy|2|||
33400000|NCT00666224|62779290|FG000|Double-Blind|Noncompliance|1|||
33400001|NCT00666224|62779291|FG001|Double-Blind|Noncompliance|0|||
33400002|NCT00666224|62779290|FG000|Double-Blind|Death|1|||
33400003|NCT00666224|62779291|FG001|Double-Blind|Death|0|||
33400004|NCT00666224|62779290|FG000|Double-Blind|Undefined/Unknown|4|||
33400005|NCT00666224|62779291|FG001|Double-Blind|Undefined/Unknown|1|||
33400006|NCT00666224|62779290|FG000|Open-Label|Adverse Event|8|||
33400007|NCT00666224|62779291|FG001|Open-Label|Adverse Event|43|||
33400008|NCT00666224|62779290|FG000|Open-Label|Lost to Follow-up|4|||
33400009|NCT00666224|62779291|FG001|Open-Label|Lost to Follow-up|5|||
33400010|NCT00666224|62779290|FG000|Open-Label|Withdrawal by Subject|12|||
33400011|NCT00666224|62779291|FG001|Open-Label|Withdrawal by Subject|25|||
33400012|NCT00666224|62779290|FG000|Open-Label|Physician Decision|7|||
33400013|NCT00666224|62779291|FG001|Open-Label|Physician Decision|5|||
33400014|NCT00666224|62779290|FG000|Open-Label|Pregnancy|1|||
33400015|NCT00666224|62779291|FG001|Open-Label|Pregnancy|5|||
33400016|NCT00666224|62779290|FG000|Open-Label|Noncompliance|2|||
33400017|NCT00666224|62779291|FG001|Open-Label|Noncompliance|1|||
33400018|NCT00666224|62779290|FG000|Open-Label|Undefined/Unknown|1|||
33400019|NCT00666224|62779291|FG001|Open-Label|Undefined/Unknown|1|||
33400020|NCT00663962|62779300|FG000|Overall Study|somnolence|1|||
33400021|NCT00663962|62779301|FG001|Overall Study|somnolence|0|||
33400022|NCT00265759|62779313|FG000|Overall Study|Withdrawal by Subject|0|||
33400023|NCT00265759|62779314|FG001|Overall Study|Withdrawal by Subject|1|||
33400024|NCT00265759|62779315|FG002|Overall Study|Withdrawal by Subject|2|||
33400025|NCT00265759|62779316|FG003|Overall Study|Withdrawal by Subject|2|||
33400026|NCT00265759|62779313|FG000|Overall Study|Cancel|0|||
33400027|NCT00265759|62779314|FG001|Overall Study|Cancel|0|||
33400028|NCT00265759|62779315|FG002|Overall Study|Cancel|0|||
33400029|NCT00265759|62779316|FG003|Overall Study|Cancel|3|||
33400030|NCT00265759|62779313|FG000|Overall Study|Ineligible|0|||
33400031|NCT00265759|62779314|FG001|Overall Study|Ineligible|0|||
33400032|NCT00265759|62779315|FG002|Overall Study|Ineligible|0|||
33400033|NCT00265759|62779316|FG003|Overall Study|Ineligible|1|||
33400034|NCT00265759|62779313|FG000|Overall Study|Bilateral disease|0|||
33400035|NCT00265759|62779314|FG001|Overall Study|Bilateral disease|0|||
33400036|NCT00265759|62779315|FG002|Overall Study|Bilateral disease|0|||
33400037|NCT00265759|62779316|FG003|Overall Study|Bilateral disease|2|||
33400038|NCT00265759|62779313|FG000|Overall Study|Discontinued due to intolerability|0|||
33400039|NCT00265759|62779314|FG001|Overall Study|Discontinued due to intolerability|0|||
33400040|NCT00265759|62779315|FG002|Overall Study|Discontinued due to intolerability|0|||
33400041|NCT00265759|62779316|FG003|Overall Study|Discontinued due to intolerability|1|||
33400042|NCT00744263|62779329|FG000|Overall Study|Death|3006|||
33400043|NCT00744263|62779330|FG001|Overall Study|Death|3005|||
33400044|NCT00744263|62779329|FG000|Overall Study|Lost to Follow-up|2038|||
33400045|NCT00744263|62779330|FG001|Overall Study|Lost to Follow-up|2135|||
33400046|NCT00744263|62779329|FG000|Overall Study|Withdrawal by Subject|166|||
33400047|NCT00744263|62779330|FG001|Overall Study|Withdrawal by Subject|150|||
33400048|NCT00744263|62779329|FG000|Overall Study|Physician Decision|20|||
33400049|NCT00744263|62779330|FG001|Overall Study|Physician Decision|23|||
33400050|NCT00744263|62779329|FG000|Overall Study|Protocol Violation|3|||
33400051|NCT00744263|62779330|FG001|Overall Study|Protocol Violation|5|||
33400052|NCT00744263|62779329|FG000|Overall Study|Adverse Event|1|||
33400053|NCT00744263|62779330|FG001|Overall Study|Adverse Event|0|||
33400054|NCT00744263|62779329|FG000|Overall Study|Other|2|||
33400055|NCT00744263|62779330|FG001|Overall Study|Other|2|||
33400056|NCT00618774|62779340|FG000|Overall Study|Adverse Event|5|||
33400057|NCT00618774|62779341|FG001|Overall Study|Adverse Event|3|||
33400058|NCT00618774|62779340|FG000|Overall Study|Withdrawal by Subject|1|||
33400059|NCT00618774|62779341|FG001|Overall Study|Withdrawal by Subject|0|||
33400060|NCT00545571|62779347|FG000|Overall Study|Administrative Reasons|1|||
33400061|NCT00545571|62779347|FG000|Overall Study|Adverse Event|2|||
33400062|NCT00545571|62779347|FG000|Overall Study|Death|5|||
33400063|NCT00545571|62779347|FG000|Overall Study|Lack of Efficacy|1|||
33400064|NCT00545571|62779347|FG000|Overall Study|Protocol Violation|2|||
33400065|NCT00545571|62779347|FG000|Overall Study|Refused Treatment|1|||
33400066|NCT00545571|62779347|FG000|Overall Study|Screen Failure|16|||
33400067|NCT00545571|62779347|FG000|Overall Study|Transfusion|12|||
33400068|NCT00545571|62779347|FG000|Overall Study|Early Termination of Study|24|||
33400069|NCT00545571|62779347|FG000|Overall Study|Kidney Transplantation|3|||
33400070|NCT00748709|62779351|FG000|Overall Study|Progressive disease|15|||
33400071|NCT00748709|62779351|FG000|Overall Study|Drug reducing Toxity|2|||
33400072|NCT00748709|62779351|FG000|Overall Study|Other Adverse Event|1|||
33400073|NCT00748709|62779351|FG000|Overall Study|Withdrawal by Subject|1|||
33400074|NCT00748709|62779351|FG000|Overall Study|Other Reasons|1|||
33400075|NCT00263887|62779357|FG000|Overall Study|Withdrawal by Subject|1|||
33400076|NCT00263887|62779358|FG001|Overall Study|Withdrawal by Subject|1|||
33400077|NCT00263887|62779357|FG000|Overall Study|Lung transplantation|1|||
33400078|NCT00263887|62779358|FG001|Overall Study|Lung transplantation|2|||
33400079|NCT00263887|62779357|FG000|Overall Study|Too ill to attend visit|1|||
33400080|NCT00263887|62779358|FG001|Overall Study|Too ill to attend visit|0|||
33400081|NCT00263887|62779357|FG000|Overall Study|Adverse Event|0|||
33400082|NCT00263887|62779358|FG001|Overall Study|Adverse Event|2|||
33400083|NCT00263887|62779357|FG000|Overall Study|Disease progression|0|||
33400084|NCT00263887|62779358|FG001|Overall Study|Disease progression|1|||
33400085|NCT00263887|62779357|FG000|Overall Study|Lack of Efficacy|0|||
33400086|NCT00263887|62779358|FG001|Overall Study|Lack of Efficacy|1|||
33400087|NCT00748553|62779366|FG000|Overall Study|Adverse Event|0|||
33400088|NCT00748553|62779367|FG001|Overall Study|Adverse Event|1|||
33400089|NCT00748553|62779366|FG000|Overall Study|disease progression|2|||
33400090|NCT00748553|62779367|FG001|Overall Study|disease progression|0|||
33400091|NCT00748553|62779366|FG000|Overall Study|noncompliance|1|||
33400092|NCT00748553|62779367|FG001|Overall Study|noncompliance|0|||
33400093|NCT00661388|62779372|FG000|Overall Study|Adverse Event|14|||
33400094|NCT00661388|62779372|FG000|Overall Study|Protocol Violation|7|||
33580116|NCT01949116|62976931|FG000|Overall Study|Death|2|||
33400095|NCT00661388|62779372|FG000|Overall Study|Renal transplantation|1|||
33400096|NCT00661388|62779372|FG000|Overall Study|Dialysis initiation|1|||
33400097|NCT00661388|62779372|FG000|Overall Study|Administrative reasons|1|||
33400098|NCT00743483|62779376|FG000|Baseline Period|Physician Decision|1|||
33400099|NCT00743483|62779376|FG000|Treatment Period|Adverse Event|1|||
33400100|NCT00263575|62779380|FG000|Titration Period|Adverse Event|14|||
33400101|NCT00263575|62779380|FG000|Titration Period|Withdrawal by Subject|10|||
33400102|NCT00263575|62779380|FG000|Titration Period|Protocol Violation|9|||
33400103|NCT00263575|62779380|FG000|Titration Period|Sponsor Decision|2|||
33400104|NCT00263575|62779380|FG000|Titration Period|Other|2|||
33400105|NCT00263575|62779380|FG000|Titration Period|Lack of Efficacy|6|||
33400106|NCT00263575|62779380|FG000|Maintence Period|Adverse Event|23|||
33400107|NCT00263575|62779380|FG000|Maintence Period|Withdrawal by Subject|8|||
33400108|NCT00263575|62779380|FG000|Maintence Period|Protocol Violation|4|||
33400109|NCT00263575|62779380|FG000|Maintence Period|Lack of Efficacy|4|||
33400110|NCT00263575|62779380|FG000|Maintence Period|Physician Decision|6|||
33400111|NCT00263575|62779380|FG000|Maintence Period|Lost to Follow-up|1|||
33400112|NCT00263575|62779380|FG000|Maintence Period|Sponsor Decision|24|||
33400113|NCT00263575|62779380|FG000|Maintence Period|Other|7|||
33400114|NCT00748241|62779386|FG000|Overall Study|Implant failure|1|||
33400115|NCT00748241|62779386|FG000|Overall Study|Lost to Follow-up|5|||
33400116|NCT00748241|62779386|FG000|Overall Study|Death|2|||
33400117|NCT00570128|62779392|FG000|Overall Study|Adverse Event|1|||
33400118|NCT00570128|62779393|FG001|Overall Study|Adverse Event|0|||
33400119|NCT00570128|62779392|FG000|Overall Study|Lost to Follow-up|1|||
33400120|NCT00570128|62779393|FG001|Overall Study|Lost to Follow-up|0|||
33400121|NCT00570128|62779392|FG000|Overall Study|Withdrawal by Subject|2|||
33400122|NCT00570128|62779393|FG001|Overall Study|Withdrawal by Subject|0|||
33400123|NCT00743249|62779401|FG000|Overall Study|Adverse Event|0|||
33400124|NCT00743249|62779402|FG001|Overall Study|Adverse Event|4|||
33400125|NCT00743249|62779401|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
33400126|NCT00743249|62779402|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
33400127|NCT00743249|62779401|FG000|Overall Study|Unsuccessful insertion of stent|2|||
33400128|NCT00743249|62779402|FG001|Overall Study|Unsuccessful insertion of stent|1|||
33400129|NCT00262951|62779408|FG000|Overall Study|Progressive disease/relapse|3|||
33400130|NCT00262951|62779408|FG000|Overall Study|Adverse Event|7|||
33400131|NCT00262951|62779408|FG000|Overall Study|Death|1|||
33400132|NCT00262951|62779408|FG000|Overall Study|Withdrawal by Subject|1|||
33400133|NCT00262951|62779408|FG000|Overall Study|Alternative treatment|3|||
33400134|NCT00262951|62779408|FG000|Overall Study|Off treatment for other disease|1|||
33400135|NCT00262873|62779412|FG000|Overall Study|Adverse Event|3|||
33400136|NCT00262873|62779412|FG000|Overall Study|Withdrawal by Subject|5|||
33400137|NCT00573534|62779416|FG000|Overall Study|oppositional behavior|3|||
33400138|NCT00260533|62779423|FG000|Overall Study|Other|3|||
33400139|NCT00260533|62779424|FG001|Overall Study|Other|3|||
33400140|NCT03945981|62779430|FG000|Overall Study|Lost to Follow-up|12|||
33400141|NCT03945981|62779430|FG000|Overall Study|Physician Decision|4|||
33400142|NCT03945981|62779430|FG000|Overall Study|Withdrawal by Subject|6|||
33400143|NCT03945981|62779430|FG000|Overall Study|Protocol Violation|1|||
33400144|NCT00745901|62779457|FG000|Overall Study|Adverse Event|3|||
33400145|NCT00745901|62779458|FG001|Overall Study|Adverse Event|4|||
33400146|NCT00745901|62779457|FG000|Overall Study|Protocol Violation|0|||
33400147|NCT00745901|62779458|FG001|Overall Study|Protocol Violation|1|||
33400148|NCT00745901|62779457|FG000|Overall Study|Withdrawal by Subject|1|||
33400149|NCT00745901|62779458|FG001|Overall Study|Withdrawal by Subject|0|||
33400150|NCT00745901|62779457|FG000|Overall Study|Lost to Follow-up|7|||
33400151|NCT00745901|62779458|FG001|Overall Study|Lost to Follow-up|4|||
33400152|NCT00745901|62779457|FG000|Overall Study|Pregnancy|2|||
33400153|NCT00745901|62779458|FG001|Overall Study|Pregnancy|4|||
33400154|NCT00745901|62779457|FG000|Overall Study|Lack of compliance|2|||
33400155|NCT00745901|62779458|FG001|Overall Study|Lack of compliance|2|||
33400156|NCT00745901|62779457|FG000|Overall Study|Patient's next menses did not start with|1|||
33400157|NCT00745901|62779458|FG001|Overall Study|Patient's next menses did not start with|0|||
33400158|NCT00745901|62779457|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
33400159|NCT00745901|62779458|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
33400160|NCT00745901|62779457|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
33400161|NCT00745901|62779458|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
33400162|NCT00745901|62779457|FG000|Overall Study|Patient didn't take any study medication|7|||
33400163|NCT00745901|62779458|FG001|Overall Study|Patient didn't take any study medication|3|||
33400164|NCT00286429|62779467|FG000|Overall Study|Adverse Event|4|||
33400165|NCT00286429|62779468|FG001|Overall Study|Adverse Event|1|||
33400166|NCT00286429|62779469|FG002|Overall Study|Adverse Event|6|||
33400167|NCT00286429|62779467|FG000|Overall Study|Lack of Efficacy|52|||
33400168|NCT00286429|62779468|FG001|Overall Study|Lack of Efficacy|27|||
33400169|NCT00286429|62779469|FG002|Overall Study|Lack of Efficacy|25|||
33400170|NCT00286429|62779467|FG000|Overall Study|Lost to Follow-up|2|||
33400171|NCT00286429|62779468|FG001|Overall Study|Lost to Follow-up|4|||
33400172|NCT00286429|62779469|FG002|Overall Study|Lost to Follow-up|3|||
33400173|NCT00286429|62779467|FG000|Overall Study|Physician Decision|10|||
33400174|NCT00286429|62779468|FG001|Overall Study|Physician Decision|7|||
33400175|NCT00286429|62779469|FG002|Overall Study|Physician Decision|7|||
33400176|NCT00286429|62779467|FG000|Overall Study|Protocol Violation|3|||
33400177|NCT00286429|62779468|FG001|Overall Study|Protocol Violation|5|||
33400178|NCT00286429|62779469|FG002|Overall Study|Protocol Violation|4|||
33400179|NCT00286429|62779467|FG000|Overall Study|Withdrawal by Subject|3|||
33400180|NCT00286429|62779468|FG001|Overall Study|Withdrawal by Subject|2|||
33400181|NCT00286429|62779469|FG002|Overall Study|Withdrawal by Subject|6|||
33400182|NCT00286429|62779467|FG000|Overall Study|Administrative Error|1|||
33400183|NCT00286429|62779468|FG001|Overall Study|Administrative Error|1|||
33400184|NCT00286429|62779469|FG002|Overall Study|Administrative Error|1|||
33400185|NCT00286429|62779467|FG000|Overall Study|Administrative Decision|0|||
33400186|NCT00286429|62779468|FG001|Overall Study|Administrative Decision|1|||
33400187|NCT00286429|62779469|FG002|Overall Study|Administrative Decision|0|||
33400188|NCT00665444|62779477|FG000|Overall Study|Physician Decision|1|||
33400189|NCT00665444|62779477|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
33400190|NCT03926169|62779484|FG000|Period A|Adverse Event|2|||
33400191|NCT03926169|62779485|FG001|Period A|Adverse Event|2|||
33400192|NCT03926169|62779486|FG002|Period A|Adverse Event|1|||
33400193|NCT03926169|62779484|FG000|Period A|Withdrawal by Subject|2|||
33400194|NCT03926169|62779485|FG001|Period A|Withdrawal by Subject|2|||
33400195|NCT03926169|62779486|FG002|Period A|Withdrawal by Subject|2|||
33400196|NCT03926169|62779484|FG000|Period A|Lost to Follow-up|3|||
33400197|NCT03926169|62779485|FG001|Period A|Lost to Follow-up|1|||
33400198|NCT03926169|62779486|FG002|Period A|Lost to Follow-up|0|||
33400199|NCT03926169|62779484|FG000|Period A|Lack of Efficacy|0|||
33400200|NCT03926169|62779485|FG001|Period A|Lack of Efficacy|2|||
33400201|NCT03926169|62779486|FG002|Period A|Lack of Efficacy|2|||
33400202|NCT03926169|62779484|FG000|Period A|COVID-19 Infection|0|||
33400203|NCT03926169|62779485|FG001|Period A|COVID-19 Infection|1|||
33400204|NCT03926169|62779486|FG002|Period A|COVID-19 Infection|0|||
33400205|NCT03926169|62779484|FG000|Period A|COVID-19 Logistical Restrictions|0|||
33400206|NCT03926169|62779485|FG001|Period A|COVID-19 Logistical Restrictions|2|||
33400207|NCT03926169|62779486|FG002|Period A|COVID-19 Logistical Restrictions|1|||
33400208|NCT03926169|62779484|FG000|Period A|Other, Not Specified|1|||
33400209|NCT03926169|62779485|FG001|Period A|Other, Not Specified|0|||
33400210|NCT03926169|62779486|FG002|Period A|Other, Not Specified|0|||
33400211|NCT03926169|62779484|FG000|Period B|Adverse Event|3|||
33400212|NCT03926169|62779485|FG001|Period B|Adverse Event|1|||
33400213|NCT03926169|62779486|FG002|Period B|Adverse Event|1|||
33400214|NCT03926169|62779484|FG000|Period B|Withdrawal by Subject|1|||
33400215|NCT03926169|62779485|FG001|Period B|Withdrawal by Subject|3|||
33400216|NCT03926169|62779486|FG002|Period B|Withdrawal by Subject|0|||
33400217|NCT03926169|62779484|FG000|Period B|Lack of Efficacy|3|||
33400218|NCT03926169|62779485|FG001|Period B|Lack of Efficacy|1|||
33400219|NCT03926169|62779486|FG002|Period B|Lack of Efficacy|1|||
33400220|NCT03926169|62779484|FG000|Period B|Lost to Follow-up|1|||
33400221|NCT03926169|62779485|FG001|Period B|Lost to Follow-up|1|||
33400222|NCT03926169|62779486|FG002|Period B|Lost to Follow-up|4|||
33400223|NCT03926169|62779484|FG000|Period B|Other, Not Specified|62|||
33400224|NCT03926169|62779485|FG001|Period B|Other, Not Specified|57|||
33400225|NCT03926169|62779486|FG002|Period B|Other, Not Specified|65|||
33400226|NCT00285649|62779500|FG000|Overall Study|Lost to Follow-up|6|||
33400227|NCT00285649|62779501|FG001|Overall Study|Lost to Follow-up|4|||
33400228|NCT00285649|62779502|FG002|Overall Study|Lost to Follow-up|4|||
33400229|NCT00285649|62779500|FG000|Overall Study|Withdrawal by Subject|3|||
33400230|NCT00285649|62779501|FG001|Overall Study|Withdrawal by Subject|2|||
33400231|NCT00285649|62779502|FG002|Overall Study|Withdrawal by Subject|2|||
33400232|NCT00745823|62779512|FG000|Overall Study|Adverse Event|5|||
33400233|NCT00745823|62779513|FG001|Overall Study|Adverse Event|3|||
33400234|NCT00745823|62779512|FG000|Overall Study|Lack of Efficacy|20|||
33400235|NCT00745823|62779513|FG001|Overall Study|Lack of Efficacy|6|||
33400236|NCT00745823|62779512|FG000|Overall Study|Lost to Follow-up|10|||
33400237|NCT00745823|62779513|FG001|Overall Study|Lost to Follow-up|11|||
33400238|NCT00745823|62779512|FG000|Overall Study|Physician Decision|10|||
33400239|NCT00745823|62779513|FG001|Overall Study|Physician Decision|5|||
33400240|NCT00745823|62779512|FG000|Overall Study|Pregnancy|0|||
33400241|NCT00745823|62779513|FG001|Overall Study|Pregnancy|4|||
33400242|NCT00745823|62779512|FG000|Overall Study|Withdrawal by Subject|14|||
33400243|NCT00745823|62779513|FG001|Overall Study|Withdrawal by Subject|8|||
33400244|NCT00745823|62779512|FG000|Overall Study|Study Terminated by Sponsor|326|||
33400245|NCT00745823|62779513|FG001|Overall Study|Study Terminated by Sponsor|349|||
33400246|NCT00663260|62779524|FG000|Overall Study|Lack of Efficacy|2|||
33400247|NCT00663260|62779525|FG001|Overall Study|Lack of Efficacy|0|||
33400248|NCT00663260|62779526|FG002|Overall Study|Lack of Efficacy|0|||
33400249|NCT00663260|62779524|FG000|Overall Study|Adverse Event|12|||
33400250|NCT00663260|62779525|FG001|Overall Study|Adverse Event|7|||
33400251|NCT00663260|62779526|FG002|Overall Study|Adverse Event|6|||
33400252|NCT00663260|62779524|FG000|Overall Study|Withdrawal by Subject|3|||
33400253|NCT00663260|62779525|FG001|Overall Study|Withdrawal by Subject|1|||
33400254|NCT00663260|62779526|FG002|Overall Study|Withdrawal by Subject|6|||
33400255|NCT00663260|62779524|FG000|Overall Study|Death|1|||
33400256|NCT00663260|62779525|FG001|Overall Study|Death|0|||
33400257|NCT00663260|62779526|FG002|Overall Study|Death|1|||
33400258|NCT00663260|62779524|FG000|Overall Study|Lost to Follow-up|0|||
33400259|NCT00663260|62779525|FG001|Overall Study|Lost to Follow-up|1|||
33400260|NCT00663260|62779526|FG002|Overall Study|Lost to Follow-up|0|||
33400261|NCT00663260|62779524|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
33400262|NCT00663260|62779525|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
33400263|NCT00663260|62779526|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
33400264|NCT00740597|62779534|FG000|Overall Study|insurance would not cover treatment|1|||
33400265|NCT00284089|62779542|FG000|Multiple Dose Phase|Adverse Event|1|||
33400266|NCT00284089|62779543|FG001|Multiple Dose Phase|Adverse Event|0|||
33400267|NCT00284089|62779544|FG002|Multiple Dose Phase|Adverse Event|1|||
33400268|NCT00284089|62779545|FG003|Multiple Dose Phase|Adverse Event|1|||
33400269|NCT00284089|62779542|FG000|Multiple Dose Phase|Protocol Violation|0|||
33400270|NCT00284089|62779543|FG001|Multiple Dose Phase|Protocol Violation|0|||
33400271|NCT00284089|62779544|FG002|Multiple Dose Phase|Protocol Violation|1|||
33400272|NCT00284089|62779545|FG003|Multiple Dose Phase|Protocol Violation|0|||
33400273|NCT00284089|62779542|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
33400274|NCT00284089|62779543|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
33400275|NCT00284089|62779544|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
33400276|NCT00284089|62779545|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
33400277|NCT00284089|62779542|FG000|Multiple Dose Phase|Death|0|||
33400278|NCT00284089|62779543|FG001|Multiple Dose Phase|Death|0|||
33400279|NCT00284089|62779544|FG002|Multiple Dose Phase|Death|1|||
33400280|NCT00284089|62779545|FG003|Multiple Dose Phase|Death|1|||
33400281|NCT00284089|62779542|FG000|Extension Phase|Adverse Event|0|||
33400282|NCT00284089|62779543|FG001|Extension Phase|Adverse Event|0|||
33400283|NCT00284089|62779544|FG002|Extension Phase|Adverse Event|2|||
33400284|NCT00284089|62779545|FG003|Extension Phase|Adverse Event|2|||
33400285|NCT00284089|62779542|FG000|Extension Phase|condition no longer requires study drug|2|||
33400286|NCT00284089|62779543|FG001|Extension Phase|condition no longer requires study drug|0|||
33400287|NCT00284089|62779544|FG002|Extension Phase|condition no longer requires study drug|2|||
33400288|NCT00284089|62779545|FG003|Extension Phase|condition no longer requires study drug|7|||
33400289|NCT00284089|62779542|FG000|Extension Phase|Protocol Violation|0|||
33400290|NCT00284089|62779543|FG001|Extension Phase|Protocol Violation|0|||
33400291|NCT00284089|62779544|FG002|Extension Phase|Protocol Violation|1|||
33400292|NCT00284089|62779545|FG003|Extension Phase|Protocol Violation|0|||
33400293|NCT00284089|62779542|FG000|Extension Phase|Withdrawal by Subject|0|||
33400294|NCT00284089|62779543|FG001|Extension Phase|Withdrawal by Subject|0|||
33400295|NCT00284089|62779544|FG002|Extension Phase|Withdrawal by Subject|1|||
33400296|NCT00284089|62779545|FG003|Extension Phase|Withdrawal by Subject|3|||
33400297|NCT00659984|62779555|FG000|Overall Study|Adverse Event|1|||
33400298|NCT00283387|62779569|FG000|First Intervention|Subject non-compliant|1|||
33400299|NCT00283387|62779570|FG001|First Intervention|Subject non-compliant|1|||
33400300|NCT00283387|62779569|FG000|First Intervention|Withdrawal by Subject|0|||
33400301|NCT00283387|62779570|FG001|First Intervention|Withdrawal by Subject|1|||
33400302|NCT00282919|62779576|FG000|Overall Study|Lack of Efficacy|4|||
33400303|NCT00282919|62779576|FG000|Overall Study|Withdrawal by Subject|1|||
33400304|NCT00282919|62779576|FG000|Overall Study|Asymptomatic Parasitemia|2|||
33400305|NCT00282295|62779583|FG000|Overall Study|Adverse Event|0|||
33400306|NCT00282295|62779584|FG001|Overall Study|Adverse Event|1|||
33400307|NCT00282295|62779585|FG002|Overall Study|Adverse Event|0|||
33400308|NCT00282295|62779583|FG000|Overall Study|Serious Adverse Events|0|||
33400309|NCT00282295|62779584|FG001|Overall Study|Serious Adverse Events|0|||
33400310|NCT00282295|62779585|FG002|Overall Study|Serious Adverse Events|1|||
33400311|NCT00282295|62779583|FG000|Overall Study|Protocol Violation|0|||
33400312|NCT00282295|62779584|FG001|Overall Study|Protocol Violation|2|||
33400313|NCT00282295|62779585|FG002|Overall Study|Protocol Violation|1|||
33400314|NCT00282295|62779583|FG000|Overall Study|Withdrawal by Subject|2|||
33400315|NCT00282295|62779584|FG001|Overall Study|Withdrawal by Subject|6|||
33400316|NCT00282295|62779585|FG002|Overall Study|Withdrawal by Subject|4|||
33400317|NCT00282295|62779583|FG000|Overall Study|Lost to Follow-up|1|||
33400318|NCT00282295|62779584|FG001|Overall Study|Lost to Follow-up|7|||
33400319|NCT00282295|62779585|FG002|Overall Study|Lost to Follow-up|2|||
33400320|NCT00282295|62779583|FG000|Overall Study|Other|0|||
33400321|NCT00282295|62779584|FG001|Overall Study|Other|1|||
33400322|NCT00282295|62779585|FG002|Overall Study|Other|0|||
33400323|NCT00742781|62779598|FG000|Overall Study|Withdrawal by Subject|3|||
33400324|NCT00663026|62779606|FG000|Overall Study|Lost to Follow-up|1|||
33400325|NCT00663026|62779607|FG001|Overall Study|Lost to Follow-up|0|||
33400326|NCT00663026|62779608|FG002|Overall Study|Lost to Follow-up|0|||
33400327|NCT00663026|62779606|FG000|Overall Study|Other|1|||
33400328|NCT00663026|62779607|FG001|Overall Study|Other|2|||
33400329|NCT00663026|62779608|FG002|Overall Study|Other|0|||
33400330|NCT00663026|62779606|FG000|Overall Study|Adverse Event|0|||
33400331|NCT00663026|62779607|FG001|Overall Study|Adverse Event|2|||
33400332|NCT00663026|62779608|FG002|Overall Study|Adverse Event|3|||
33400333|NCT00663026|62779606|FG000|Overall Study|Caregiver Request|0|||
33400334|NCT00663026|62779607|FG001|Overall Study|Caregiver Request|2|||
33400335|NCT00663026|62779608|FG002|Overall Study|Caregiver Request|0|||
33400336|NCT00663026|62779606|FG000|Overall Study|Withdrawal by Subject|0|||
33400337|NCT00663026|62779607|FG001|Overall Study|Withdrawal by Subject|0|||
33400338|NCT00663026|62779608|FG002|Overall Study|Withdrawal by Subject|1|||
33400339|NCT00280735|62779618|FG000|Overall Study|Adverse Event|5|||
33400340|NCT00280735|62779618|FG000|Overall Study|Lack of Efficacy|3|||
33400341|NCT00280735|62779618|FG000|Overall Study|Withdrawal by Subject|8|||
33400342|NCT00280735|62779618|FG000|Overall Study|Intercurrent Illness|2|||
33400343|NCT00260065|62779626|FG000|Overall Study|Progressive Disease|22|||
33400344|NCT00260065|62779626|FG000|Overall Study|Adverse Event|17|||
33400345|NCT00260065|62779626|FG000|Overall Study|Death|13|||
33400346|NCT00260065|62779626|FG000|Overall Study|Withdrawal by Subject|13|||
33400347|NCT00260065|62779626|FG000|Overall Study|Physician Decision|19|||
33400348|NCT00260065|62779626|FG000|Overall Study|Not otherwise specified|8|||
33400349|NCT00260065|62779626|FG000|Overall Study|Medication Noncompliance|1|||
33400350|NCT00506350|62779639|FG000|Overall Study|Serious Adverse Event|1|||
33400351|NCT00506350|62779640|FG001|Overall Study|Serious Adverse Event|0|||
33400352|NCT00506350|62779641|FG002|Overall Study|Serious Adverse Event|0|||
33400353|NCT00506350|62779642|FG003|Overall Study|Serious Adverse Event|0|||
33400354|NCT00506350|62779643|FG004|Overall Study|Serious Adverse Event|0|||
33400355|NCT00506350|62779644|FG005|Overall Study|Serious Adverse Event|0|||
33400356|NCT00506350|62779645|FG006|Overall Study|Serious Adverse Event|0|||
33400357|NCT00506350|62779646|FG007|Overall Study|Serious Adverse Event|0|||
33400358|NCT00506350|62779647|FG008|Overall Study|Serious Adverse Event|0|||
33400359|NCT00506350|62779639|FG000|Overall Study|Adverse Event|0|||
33400360|NCT00506350|62779640|FG001|Overall Study|Adverse Event|0|||
33400361|NCT00506350|62779641|FG002|Overall Study|Adverse Event|0|||
33400362|NCT00506350|62779642|FG003|Overall Study|Adverse Event|0|||
33400363|NCT00506350|62779643|FG004|Overall Study|Adverse Event|0|||
33400364|NCT00506350|62779644|FG005|Overall Study|Adverse Event|0|||
33400365|NCT00506350|62779645|FG006|Overall Study|Adverse Event|0|||
33400366|NCT00506350|62779646|FG007|Overall Study|Adverse Event|1|||
33400367|NCT00506350|62779647|FG008|Overall Study|Adverse Event|1|||
33400368|NCT00506350|62779639|FG000|Overall Study|Protocol Violation|0|||
33400369|NCT00506350|62779640|FG001|Overall Study|Protocol Violation|0|||
33400370|NCT00506350|62779641|FG002|Overall Study|Protocol Violation|1|||
33400371|NCT00506350|62779642|FG003|Overall Study|Protocol Violation|0|||
33400372|NCT00506350|62779643|FG004|Overall Study|Protocol Violation|0|||
33400373|NCT00506350|62779644|FG005|Overall Study|Protocol Violation|0|||
33400374|NCT00506350|62779645|FG006|Overall Study|Protocol Violation|1|||
33400375|NCT00506350|62779646|FG007|Overall Study|Protocol Violation|0|||
33400376|NCT00506350|62779647|FG008|Overall Study|Protocol Violation|0|||
33400377|NCT00506350|62779639|FG000|Overall Study|Withdrawal by Subject|0|||
33400378|NCT00506350|62779640|FG001|Overall Study|Withdrawal by Subject|1|||
33400379|NCT00506350|62779641|FG002|Overall Study|Withdrawal by Subject|1|||
33400380|NCT00506350|62779642|FG003|Overall Study|Withdrawal by Subject|1|||
33400381|NCT00506350|62779643|FG004|Overall Study|Withdrawal by Subject|4|||
33400382|NCT00506350|62779644|FG005|Overall Study|Withdrawal by Subject|1|||
33400383|NCT00506350|62779645|FG006|Overall Study|Withdrawal by Subject|1|||
33400384|NCT00506350|62779646|FG007|Overall Study|Withdrawal by Subject|2|||
33400385|NCT00506350|62779647|FG008|Overall Study|Withdrawal by Subject|0|||
33400386|NCT00506350|62779639|FG000|Overall Study|Lost to Follow-up|1|||
33400387|NCT00506350|62779640|FG001|Overall Study|Lost to Follow-up|1|||
33400388|NCT00506350|62779641|FG002|Overall Study|Lost to Follow-up|1|||
33400389|NCT00506350|62779642|FG003|Overall Study|Lost to Follow-up|1|||
33400390|NCT00506350|62779643|FG004|Overall Study|Lost to Follow-up|2|||
33400391|NCT00506350|62779644|FG005|Overall Study|Lost to Follow-up|1|||
33400392|NCT00506350|62779645|FG006|Overall Study|Lost to Follow-up|0|||
33400393|NCT00506350|62779646|FG007|Overall Study|Lost to Follow-up|0|||
33400394|NCT00506350|62779647|FG008|Overall Study|Lost to Follow-up|2|||
33400395|NCT00506350|62779639|FG000|Overall Study|Medical Reason|0|||
33400396|NCT00506350|62779640|FG001|Overall Study|Medical Reason|0|||
33400397|NCT00506350|62779641|FG002|Overall Study|Medical Reason|0|||
33400398|NCT00506350|62779642|FG003|Overall Study|Medical Reason|0|||
33400399|NCT00506350|62779643|FG004|Overall Study|Medical Reason|1|||
33400400|NCT00506350|62779644|FG005|Overall Study|Medical Reason|0|||
33400401|NCT00506350|62779645|FG006|Overall Study|Medical Reason|0|||
33400402|NCT00506350|62779646|FG007|Overall Study|Medical Reason|0|||
33400403|NCT00506350|62779647|FG008|Overall Study|Medical Reason|0|||
33400404|NCT00506350|62779639|FG000|Overall Study|Other|1|||
33400405|NCT00506350|62779640|FG001|Overall Study|Other|1|||
33400406|NCT00506350|62779641|FG002|Overall Study|Other|3|||
33580117|NCT01949116|62976932|FG001|Overall Study|Death|0|||
33400407|NCT00506350|62779642|FG003|Overall Study|Other|0|||
33400408|NCT00506350|62779643|FG004|Overall Study|Other|3|||
33400409|NCT00506350|62779644|FG005|Overall Study|Other|0|||
33400410|NCT00506350|62779645|FG006|Overall Study|Other|0|||
33400411|NCT00506350|62779646|FG007|Overall Study|Other|2|||
33400412|NCT00506350|62779647|FG008|Overall Study|Other|2|||
33400413|NCT00258895|62779676|FG000|Overall Study|Lost to Follow-up|3|||
33400414|NCT00258895|62779677|FG001|Overall Study|Lost to Follow-up|1|||
33400415|NCT00258895|62779676|FG000|Overall Study|Protocol Violation|6|||
33400416|NCT00258895|62779677|FG001|Overall Study|Protocol Violation|2|||
33400417|NCT00258895|62779676|FG000|Overall Study|Withdrawal by Subject|1|||
33400418|NCT00258895|62779677|FG001|Overall Study|Withdrawal by Subject|0|||
33400419|NCT00742625|62779683|FG000|Remission Induction|Progression|6|||
33400420|NCT00742625|62779683|FG000|Remission Induction|Failed induction|8|||
33400421|NCT00742625|62779683|FG000|Remission Induction|Adverse Event|3|||
33400422|NCT00742625|62779683|FG000|Remission Induction|Death|10|||
33400423|NCT00742625|62779683|FG000|Remission Induction|Refusal|5|||
33400424|NCT00742625|62779683|FG000|Remission Induction|Non protocol treatment|17|||
33400425|NCT00742625|62779683|FG000|Remission Induction|Other, not specified|5|||
33400426|NCT00742625|62779683|FG000|Consolidation|Progression|5|||
33400427|NCT00742625|62779683|FG000|Consolidation|Adverse Event|1|||
33400428|NCT00742625|62779683|FG000|Consolidation|Death|1|||
33400429|NCT00742625|62779683|FG000|Consolidation|Refused|1|||
33400430|NCT00742625|62779683|FG000|Consolidation|Non protocol therapy|13|||
33400431|NCT00618618|62779694|FG000|Overall Study|Patient Request|0|||
33400432|NCT00618618|62779695|FG001|Overall Study|Patient Request|0|||
33400433|NCT00618618|62779696|FG002|Overall Study|Patient Request|2|||
33400434|NCT00618618|62779697|FG003|Overall Study|Patient Request|0|||
33400435|NCT00618618|62779694|FG000|Overall Study|Inability to Complete Study Procedures|0|||
33400436|NCT00618618|62779695|FG001|Overall Study|Inability to Complete Study Procedures|1|||
33400437|NCT00618618|62779696|FG002|Overall Study|Inability to Complete Study Procedures|0|||
33400438|NCT00618618|62779697|FG003|Overall Study|Inability to Complete Study Procedures|0|||
33400439|NCT00618618|62779694|FG000|Overall Study|Lost to Follow-up|3|||
33400440|NCT00618618|62779695|FG001|Overall Study|Lost to Follow-up|0|||
33400441|NCT00618618|62779696|FG002|Overall Study|Lost to Follow-up|0|||
33400442|NCT00618618|62779697|FG003|Overall Study|Lost to Follow-up|1|||
33400443|NCT00618618|62779694|FG000|Overall Study|Non-compliance|1|||
33400444|NCT00618618|62779695|FG001|Overall Study|Non-compliance|1|||
33400445|NCT00618618|62779696|FG002|Overall Study|Non-compliance|0|||
33400446|NCT00618618|62779697|FG003|Overall Study|Non-compliance|0|||
33400447|NCT00618618|62779694|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
33400448|NCT00618618|62779695|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
33400449|NCT00618618|62779696|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
33400450|NCT00618618|62779697|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
33400451|NCT00618618|62779694|FG000|Overall Study|Death|0|||
33400452|NCT00618618|62779695|FG001|Overall Study|Death|1|||
33400453|NCT00618618|62779696|FG002|Overall Study|Death|0|||
33400454|NCT00618618|62779697|FG003|Overall Study|Death|0|||
33400455|NCT00246805|62779710|FG000|Phase 1|Lost to Follow-up|1|||
33400456|NCT00246805|62779711|FG001|Phase 1|Lost to Follow-up|0|||
33400457|NCT00519376|62779717|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33400458|NCT00519376|62779718|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33400459|NCT00519376|62779719|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33400460|NCT00519376|62779720|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33400461|NCT00519376|62779721|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33400462|NCT00519376|62779722|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33400463|NCT00519376|62779723|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33400464|NCT00519376|62779724|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33400465|NCT00519376|62779725|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33400466|NCT00519376|62779726|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33400467|NCT00519376|62779727|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33400468|NCT00519376|62779728|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33400469|NCT00519376|62779729|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
33400470|NCT00519376|62779730|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33400471|NCT00519376|62779731|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33400472|NCT00519376|62779732|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33400473|NCT00519376|62779717|FG000|Treatment Period 4|Lost to Follow-up|0|||
33400474|NCT00519376|62779718|FG001|Treatment Period 4|Lost to Follow-up|0|||
33400475|NCT00519376|62779719|FG002|Treatment Period 4|Lost to Follow-up|1|||
33400476|NCT00519376|62779720|FG003|Treatment Period 4|Lost to Follow-up|0|||
33400477|NCT00519376|62779721|FG004|Treatment Period 4|Lost to Follow-up|0|||
33400478|NCT00519376|62779722|FG005|Treatment Period 4|Lost to Follow-up|0|||
33400479|NCT00519376|62779723|FG006|Treatment Period 4|Lost to Follow-up|0|||
33400480|NCT00519376|62779724|FG007|Treatment Period 4|Lost to Follow-up|0|||
33400481|NCT00519376|62779725|FG008|Treatment Period 4|Lost to Follow-up|0|||
33400482|NCT00519376|62779726|FG009|Treatment Period 4|Lost to Follow-up|0|||
33400483|NCT00519376|62779727|FG010|Treatment Period 4|Lost to Follow-up|0|||
33400484|NCT00519376|62779728|FG011|Treatment Period 4|Lost to Follow-up|0|||
33400485|NCT00519376|62779729|FG012|Treatment Period 4|Lost to Follow-up|0|||
33400486|NCT00519376|62779730|FG013|Treatment Period 4|Lost to Follow-up|0|||
33400487|NCT00519376|62779731|FG014|Treatment Period 4|Lost to Follow-up|0|||
33400488|NCT00519376|62779732|FG015|Treatment Period 4|Lost to Follow-up|0|||
33400489|NCT00745121|62779746|FG000|Overall Study|Death|3|||
33400490|NCT00745121|62779747|FG001|Overall Study|Death|0|||
33400491|NCT00745121|62779746|FG000|Overall Study|Adverse Event|1|||
33400492|NCT00745121|62779747|FG001|Overall Study|Adverse Event|0|||
33400493|NCT00745121|62779746|FG000|Overall Study|Lost to Follow-up|1|||
33400494|NCT00745121|62779747|FG001|Overall Study|Lost to Follow-up|0|||
33400495|NCT00745121|62779746|FG000|Overall Study|Withdrawal by Subject|4|||
33400496|NCT00745121|62779747|FG001|Overall Study|Withdrawal by Subject|2|||
33400497|NCT00740051|62779755|FG000|Overall Study|Lack of Efficacy|2|||
33400498|NCT00740051|62779756|FG001|Overall Study|Lack of Efficacy|5|||
33400499|NCT00740051|62779755|FG000|Overall Study|Adverse Event|1|||
33400500|NCT00740051|62779756|FG001|Overall Study|Adverse Event|4|||
33400501|NCT00740051|62779755|FG000|Overall Study|Protocol Violation|2|||
33400502|NCT00740051|62779756|FG001|Overall Study|Protocol Violation|6|||
33400503|NCT00740051|62779755|FG000|Overall Study|Lost to Follow-up|3|||
33400504|NCT00740051|62779756|FG001|Overall Study|Lost to Follow-up|8|||
33400505|NCT00740051|62779755|FG000|Overall Study|Withdrawal by Subject|6|||
33400506|NCT00740051|62779756|FG001|Overall Study|Withdrawal by Subject|8|||
33400507|NCT00740051|62779755|FG000|Overall Study|Other reason (not specified)|4|||
33400508|NCT00740051|62779756|FG001|Overall Study|Other reason (not specified)|1|||
33400509|NCT00518986|62779765|FG000|Overall Study|Adverse Event|12|||
33400510|NCT00518986|62779766|FG001|Overall Study|Adverse Event|7|||
33400511|NCT00518986|62779765|FG000|Overall Study|Lack of Efficacy|0|||
33400512|NCT00518986|62779766|FG001|Overall Study|Lack of Efficacy|2|||
33400513|NCT00518986|62779765|FG000|Overall Study|Lost to Follow-up|3|||
33400514|NCT00518986|62779766|FG001|Overall Study|Lost to Follow-up|2|||
33400515|NCT00518986|62779765|FG000|Overall Study|Physician Decision|0|||
33400516|NCT00518986|62779766|FG001|Overall Study|Physician Decision|3|||
33400517|NCT00518986|62779765|FG000|Overall Study|Protocol Violation|5|||
33400518|NCT00518986|62779766|FG001|Overall Study|Protocol Violation|7|||
33400519|NCT00518986|62779765|FG000|Overall Study|Withdrawal by Subject|4|||
33400520|NCT00518986|62779766|FG001|Overall Study|Withdrawal by Subject|4|||
33400521|NCT00518986|62779765|FG000|Overall Study|Non-Specific|2|||
33400522|NCT00518986|62779766|FG001|Overall Study|Non-Specific|1|||
33400523|NCT00742391|62779774|FG000|Overall Study|Adverse Event|2|||
33400524|NCT00742391|62779775|FG001|Overall Study|Adverse Event|1|||
33400525|NCT00742391|62779774|FG000|Overall Study|Lost to Follow-up|1|||
33400526|NCT00742391|62779775|FG001|Overall Study|Lost to Follow-up|0|||
33400527|NCT00742391|62779774|FG000|Overall Study|Protocol Violation|1|||
33400528|NCT00742391|62779775|FG001|Overall Study|Protocol Violation|0|||
33490403|NCT00069095|62868444|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
33490404|NCT00069095|62868445|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
33490405|NCT00069095|62868446|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
33490406|NCT00069095|62868447|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
33490407|NCT00069095|62868448|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
33490408|NCT00069095|62868443|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
33490409|NCT00069095|62868444|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
33490410|NCT00069095|62868445|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
33490411|NCT00069095|62868446|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
33490412|NCT00069095|62868447|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
33490413|NCT00069095|62868448|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
33490414|NCT00069095|62868443|FG000|Post-study Treatment Phase|Participant had complete response|1|||
33490415|NCT00069095|62868444|FG001|Post-study Treatment Phase|Participant had complete response|1|||
33490416|NCT00069095|62868445|FG002|Post-study Treatment Phase|Participant had complete response|0|||
33490417|NCT00069095|62868446|FG003|Post-study Treatment Phase|Participant had complete response|0|||
33490418|NCT00069095|62868447|FG004|Post-study Treatment Phase|Participant had complete response|0|||
33490419|NCT00069095|62868448|FG005|Post-study Treatment Phase|Participant had complete response|0|||
33490420|NCT00069095|62868443|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
33490421|NCT00069095|62868444|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
33490422|NCT00069095|62868445|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
33490423|NCT00069095|62868446|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
33490424|NCT00069095|62868447|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
33490425|NCT00069095|62868448|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
33490426|NCT00069095|62868443|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
33490427|NCT00069095|62868444|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
33490428|NCT00069095|62868445|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
33580118|NCT01949116|62976931|FG000|Overall Study|Lost to Follow-up|1|||
33490429|NCT00069095|62868446|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
33490430|NCT00069095|62868447|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
33490431|NCT00069095|62868448|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
33490432|NCT00069095|62868443|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
33490433|NCT00069095|62868444|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
33490434|NCT00069095|62868445|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
33490435|NCT00069095|62868446|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
33490436|NCT00069095|62868447|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
33490437|NCT00069095|62868448|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
33490438|NCT00069095|62868443|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
33490439|NCT00069095|62868444|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
33490440|NCT00069095|62868445|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
33490441|NCT00069095|62868446|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
33490442|NCT00069095|62868447|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
33490443|NCT00069095|62868448|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
33490444|NCT00069095|62868443|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
33490445|NCT00069095|62868444|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
33490446|NCT00069095|62868445|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
33490447|NCT00069095|62868446|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
33490448|NCT00069095|62868447|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
33490449|NCT00069095|62868448|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
33490450|NCT00069095|62868443|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
33490451|NCT00069095|62868444|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
33490452|NCT00069095|62868445|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
33309625|NCT01170039|62685045|FG000|Overall Study|Withdrawal by Subject|5|||
33309626|NCT01170039|62685046|FG001|Overall Study|Withdrawal by Subject|3|||
33309627|NCT01170039|62685045|FG000|Overall Study|Lack of funding, drug not available|3|||
33309628|NCT01170039|62685046|FG001|Overall Study|Lack of funding, drug not available|3|||
33309629|NCT01169649|62685052|FG000|Overall Study|Patient Not Treated|3|||
33309630|NCT01169493|62685062|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
33309631|NCT01169493|62685063|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
33309632|NCT01169493|62685064|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
33309633|NCT01169493|62685065|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
33309634|NCT01169493|62685066|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
33309635|NCT01169493|62685067|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
33309636|NCT01169493|62685062|FG000|Period 3 (6 Months)|Adverse Event|0|||
33309637|NCT01169493|62685063|FG001|Period 3 (6 Months)|Adverse Event|1|||
33309638|NCT01169493|62685064|FG002|Period 3 (6 Months)|Adverse Event|0|||
33309639|NCT01169493|62685065|FG003|Period 3 (6 Months)|Adverse Event|0|||
33309640|NCT01169493|62685066|FG004|Period 3 (6 Months)|Adverse Event|0|||
33309641|NCT01169493|62685067|FG005|Period 3 (6 Months)|Adverse Event|0|||
33309642|NCT01169493|62685062|FG000|Period 3 (6 Months)|Physician Decision|0|||
33309643|NCT01169493|62685063|FG001|Period 3 (6 Months)|Physician Decision|1|||
33309644|NCT01169493|62685064|FG002|Period 3 (6 Months)|Physician Decision|1|||
33309645|NCT01169493|62685065|FG003|Period 3 (6 Months)|Physician Decision|0|||
33309646|NCT01169493|62685066|FG004|Period 3 (6 Months)|Physician Decision|0|||
33309647|NCT01169493|62685067|FG005|Period 3 (6 Months)|Physician Decision|0|||
33309648|NCT01287104|62685079|FG000|Overall Study|Patient developed progressive disease|1|||
33309649|NCT01287104|62685080|FG001|Overall Study|Patient developed progressive disease|1|||
33309650|NCT01287104|62685081|FG002|Overall Study|Patient developed progressive disease|3|||
33309651|NCT01287104|62685082|FG003|Overall Study|Patient developed progressive disease|2|||
33309652|NCT01287104|62685079|FG000|Overall Study|Donor anaphylaxis|0|||
33309653|NCT01287104|62685080|FG001|Overall Study|Donor anaphylaxis|1|||
33309654|NCT01287104|62685081|FG002|Overall Study|Donor anaphylaxis|0|||
33309655|NCT01287104|62685082|FG003|Overall Study|Donor anaphylaxis|1|||
33309656|NCT01287104|62685079|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
33309657|NCT01287104|62685080|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
33309658|NCT01287104|62685081|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
33309659|NCT01287104|62685082|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
33309660|NCT01287104|62685079|FG000|Overall Study|Low donor chimerism|0|||
33309661|NCT01287104|62685080|FG001|Overall Study|Low donor chimerism|1|||
33309662|NCT01287104|62685081|FG002|Overall Study|Low donor chimerism|0|||
33309663|NCT01287104|62685082|FG003|Overall Study|Low donor chimerism|0|||
33309664|NCT01287104|62685079|FG000|Overall Study|NK cells did not meet release criteria|0|||
33309665|NCT01287104|62685080|FG001|Overall Study|NK cells did not meet release criteria|1|||
33309666|NCT01287104|62685081|FG002|Overall Study|NK cells did not meet release criteria|0|||
33309667|NCT01287104|62685082|FG003|Overall Study|NK cells did not meet release criteria|0|||
33309668|NCT01286558|62685101|FG000|Overall Study|Adverse Event|1|||
33490453|NCT00069095|62868446|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
33490454|NCT00069095|62868447|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
33490455|NCT00069095|62868448|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
33490456|NCT00069095|62868443|FG000|Post-study Treatment Phase|Surgery|0|||
33490457|NCT00069095|62868444|FG001|Post-study Treatment Phase|Surgery|0|||
33490458|NCT00069095|62868445|FG002|Post-study Treatment Phase|Surgery|0|||
33490459|NCT00069095|62868446|FG003|Post-study Treatment Phase|Surgery|1|||
33490460|NCT00069095|62868447|FG004|Post-study Treatment Phase|Surgery|1|||
33490461|NCT00069095|62868448|FG005|Post-study Treatment Phase|Surgery|0|||
33490462|NCT00069095|62868443|FG000|Post-study Treatment Phase|Death|0|||
33490463|NCT00069095|62868444|FG001|Post-study Treatment Phase|Death|0|||
33490464|NCT00069095|62868445|FG002|Post-study Treatment Phase|Death|0|||
33490465|NCT00069095|62868446|FG003|Post-study Treatment Phase|Death|0|||
33490466|NCT00069095|62868447|FG004|Post-study Treatment Phase|Death|1|||
33490467|NCT00069095|62868448|FG005|Post-study Treatment Phase|Death|0|||
33490468|NCT00069095|62868443|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
33490469|NCT00069095|62868444|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
33490470|NCT00069095|62868445|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
33490471|NCT00069095|62868446|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
33490472|NCT00069095|62868447|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
33490473|NCT00069095|62868448|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
33490474|NCT00069095|62868443|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
33490475|NCT00069095|62868444|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
33490476|NCT00069095|62868445|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
33490477|NCT00069095|62868446|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
33490478|NCT00069095|62868447|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
33490479|NCT00069095|62868448|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
33490480|NCT00069095|62868443|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
33490481|NCT00069095|62868444|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
33490482|NCT00069095|62868445|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
33490483|NCT00069095|62868446|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
33490484|NCT00069095|62868447|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
33490485|NCT00069095|62868448|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
33490486|NCT00069095|62868443|FG000|Post-study Treatment Phase|Investigator decision|0|||
33490487|NCT00069095|62868444|FG001|Post-study Treatment Phase|Investigator decision|0|||
33490488|NCT00069095|62868445|FG002|Post-study Treatment Phase|Investigator decision|0|||
33490489|NCT00069095|62868446|FG003|Post-study Treatment Phase|Investigator decision|0|||
33490490|NCT00069095|62868447|FG004|Post-study Treatment Phase|Investigator decision|0|||
33490491|NCT00069095|62868448|FG005|Post-study Treatment Phase|Investigator decision|1|||
33490492|NCT00069095|62868443|FG000|Follow-up Phase|Death|174|||
33490493|NCT00069095|62868444|FG001|Follow-up Phase|Death|206|||
33490494|NCT00069095|62868445|FG002|Follow-up Phase|Death|120|||
33490495|NCT00069095|62868446|FG003|Follow-up Phase|Death|112|||
33490496|NCT00069095|62868447|FG004|Follow-up Phase|Death|92|||
33490497|NCT00069095|62868448|FG005|Follow-up Phase|Death|101|||
33490498|NCT00086411|62868464|FG000|Overall Study|Lost to Follow-up|11|||
33490499|NCT00086411|62868465|FG001|Overall Study|Lost to Follow-up|11|||
33490500|NCT00086411|62868466|FG002|Overall Study|Lost to Follow-up|13|||
33490501|NCT00086411|62868467|FG003|Overall Study|Lost to Follow-up|12|||
33490502|NCT00068237|62868478|FG000|Overall Study|Ineligible|3|||
33490503|NCT00068237|62868478|FG000|Overall Study|No protocol treatment received|2|||
33490504|NCT00055601|62868484|FG000|Overall Study|Protocol Violation|1|||
33490505|NCT00055601|62868485|FG001|Overall Study|Protocol Violation|1|||
33490506|NCT00055601|62868484|FG000|Overall Study|No protocol treatment received|1|||
33490507|NCT00055601|62868485|FG001|Overall Study|No protocol treatment received|1|||
33490508|NCT03806231|62868493|FG000|Overall Study|Physician Decision|1|||
33490509|NCT03806231|62868494|FG001|Overall Study|Physician Decision|0|||
33490510|NCT03806231|62868493|FG000|Overall Study|Withdrawal by Subject|1|||
33490511|NCT03806231|62868494|FG001|Overall Study|Withdrawal by Subject|0|||
33490512|NCT00054275|62868500|FG000|Overall Study|Withdrawal by Subject|4|||
33490513|NCT00054275|62868500|FG000|Overall Study|Adverse Event|5|||
33490514|NCT00054275|62868500|FG000|Overall Study|Progressive disease in cycle 1|1|||
33490515|NCT00054275|62868500|FG000|Overall Study|Physician Decision|1|||
33490516|NCT00053417|62868508|FG000|Overall Study|Adverse Event|1|||
33490517|NCT00053417|62868509|FG001|Overall Study|Adverse Event|0|||
33490518|NCT00053417|62868510|FG002|Overall Study|Adverse Event|1|||
33490519|NCT00053417|62868511|FG003|Overall Study|Adverse Event|5|||
33490520|NCT00053417|62868508|FG000|Overall Study|Non-Compliance|0|||
33490521|NCT00053417|62868509|FG001|Overall Study|Non-Compliance|0|||
33490522|NCT00053417|62868510|FG002|Overall Study|Non-Compliance|0|||
33490523|NCT00053417|62868511|FG003|Overall Study|Non-Compliance|1|||
33490524|NCT00053417|62868508|FG000|Overall Study|Withdrawal by Subject|0|||
33490525|NCT00053417|62868509|FG001|Overall Study|Withdrawal by Subject|1|||
33490526|NCT00053417|62868510|FG002|Overall Study|Withdrawal by Subject|0|||
33490527|NCT00053417|62868511|FG003|Overall Study|Withdrawal by Subject|0|||
33490528|NCT00053417|62868508|FG000|Overall Study|Lost to Follow-up|1|||
33490529|NCT00053417|62868509|FG001|Overall Study|Lost to Follow-up|1|||
33490530|NCT00053417|62868510|FG002|Overall Study|Lost to Follow-up|0|||
33490531|NCT00053417|62868511|FG003|Overall Study|Lost to Follow-up|0|||
33490532|NCT00052715|62868521|FG000|Overall Study|wrong histology|1|||
33490533|NCT00051311|62868527|FG000|Overall Study|Starting new study|0|||
33490534|NCT00051311|62868528|FG001|Overall Study|Starting new study|1|||
33490535|NCT00051311|62868527|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
33490536|NCT00051311|62868528|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
33490537|NCT00051311|62868527|FG000|Overall Study|Death of recipient|8|||
33490538|NCT00051311|62868528|FG001|Overall Study|Death of recipient|8|||
33490539|NCT00051311|62868527|FG000|Overall Study|Recipient taken off study|4|||
33490540|NCT00051311|62868528|FG001|Overall Study|Recipient taken off study|4|||
33490541|NCT00049673|62868534|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
33490542|NCT00049673|62868535|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
33490543|NCT00049127|62868546|FG000|Overall Study|Withdrawal by Subject|0|||
33490544|NCT00049127|62868547|FG001|Overall Study|Withdrawal by Subject|0|||
33490545|NCT00049127|62868548|FG002|Overall Study|Withdrawal by Subject|1|||
33490546|NCT00049127|62868549|FG003|Overall Study|Withdrawal by Subject|0|||
33490547|NCT00049127|62868550|FG004|Overall Study|Withdrawal by Subject|0|||
33490548|NCT00066365|62868564|FG000|Overall Study|Adverse Event|1|||
33490549|NCT00066365|62868565|FG001|Overall Study|Adverse Event|0|||
33490550|NCT00066365|62868564|FG000|Overall Study|Lack of Efficacy|15|||
33490551|NCT00066365|62868565|FG001|Overall Study|Lack of Efficacy|12|||
33490552|NCT00066365|62868564|FG000|Overall Study|Physician Decision|1|||
33490553|NCT00066365|62868565|FG001|Overall Study|Physician Decision|0|||
33490554|NCT00066365|62868564|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
33490555|NCT00066365|62868565|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
33490556|NCT00066365|62868564|FG000|Overall Study|Ineligible|4|||
33490557|NCT00066365|62868565|FG001|Overall Study|Ineligible|2|||
33490558|NCT00048581|62868575|FG000|Double-Blind Period|Adverse Event|9|||
33490559|NCT00048581|62868576|FG001|Double-Blind Period|Adverse Event|5|||
33490560|NCT00048581|62868577|FG002|Double-Blind Period|Adverse Event|0|||
33490561|NCT00048581|62868575|FG000|Double-Blind Period|Lack of Efficacy|14|||
33490562|NCT00048581|62868576|FG001|Double-Blind Period|Lack of Efficacy|27|||
33490563|NCT00048581|62868577|FG002|Double-Blind Period|Lack of Efficacy|0|||
33490564|NCT00048581|62868575|FG000|Double-Blind Period|Lost to Follow-up|5|||
33490565|NCT00048581|62868576|FG001|Double-Blind Period|Lost to Follow-up|0|||
33490566|NCT00048581|62868577|FG002|Double-Blind Period|Lost to Follow-up|0|||
33490567|NCT00048581|62868575|FG000|Double-Blind Period|Withdrawal by Subject|5|||
33490568|NCT00048581|62868576|FG001|Double-Blind Period|Withdrawal by Subject|2|||
33490569|NCT00048581|62868577|FG002|Double-Blind Period|Withdrawal by Subject|0|||
33490570|NCT00048581|62868575|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
33490571|NCT00048581|62868576|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
33490572|NCT00048581|62868577|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
33490573|NCT00048581|62868575|FG000|Double-Blind Period|Investigator Decision|1|||
33490574|NCT00048581|62868576|FG001|Double-Blind Period|Investigator Decision|0|||
33490575|NCT00048581|62868577|FG002|Double-Blind Period|Investigator Decision|0|||
33490576|NCT00048581|62868575|FG000|Open-Label Period|Death|0|||
33490577|NCT00048581|62868576|FG001|Open-Label Period|Death|0|||
33490578|NCT00048581|62868577|FG002|Open-Label Period|Death|4|||
33490579|NCT00048581|62868575|FG000|Open-Label Period|Adverse Event|0|||
33490580|NCT00048581|62868576|FG001|Open-Label Period|Adverse Event|0|||
33490581|NCT00048581|62868577|FG002|Open-Label Period|Adverse Event|37|||
33490582|NCT00048581|62868575|FG000|Open-Label Period|Lack of Efficacy|0|||
33490583|NCT00048581|62868576|FG001|Open-Label Period|Lack of Efficacy|0|||
33490584|NCT00048581|62868577|FG002|Open-Label Period|Lack of Efficacy|69|||
33490585|NCT00048581|62868575|FG000|Open-Label Period|Lost to Follow-up|0|||
33490586|NCT00048581|62868576|FG001|Open-Label Period|Lost to Follow-up|0|||
33490587|NCT00048581|62868577|FG002|Open-Label Period|Lost to Follow-up|14|||
33490588|NCT00048581|62868575|FG000|Open-Label Period|Withdrawal by Subject|0|||
33490589|NCT00048581|62868576|FG001|Open-Label Period|Withdrawal by Subject|0|||
33490590|NCT00048581|62868577|FG002|Open-Label Period|Withdrawal by Subject|20|||
33490591|NCT00048581|62868575|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
33490592|NCT00048581|62868576|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
33490593|NCT00048581|62868577|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
33490594|NCT00048581|62868575|FG000|Open-Label Period|Poor/Non-compliance|0|||
33490595|NCT00048581|62868576|FG001|Open-Label Period|Poor/Non-compliance|0|||
33490596|NCT00048581|62868577|FG002|Open-Label Period|Poor/Non-compliance|5|||
33490597|NCT00048581|62868575|FG000|Open-Label Period|Pregnancy|0|||
33490598|NCT00048581|62868576|FG001|Open-Label Period|Pregnancy|0|||
33490599|NCT00048581|62868577|FG002|Open-Label Period|Pregnancy|7|||
33490600|NCT00048581|62868575|FG000|Open-Label Period|Study Site Closure|0|||
33490601|NCT00048581|62868576|FG001|Open-Label Period|Study Site Closure|0|||
33490602|NCT00048581|62868577|FG002|Open-Label Period|Study Site Closure|2|||
33490603|NCT00048581|62868575|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
33490604|NCT00048581|62868576|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
33490605|NCT00048581|62868577|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
33490606|NCT00048581|62868575|FG000|Open-Label Period|Problem With Transportation To Site|0|||
33490607|NCT00048581|62868576|FG001|Open-Label Period|Problem With Transportation To Site|0|||
33490608|NCT00048581|62868577|FG002|Open-Label Period|Problem With Transportation To Site|1|||
33490609|NCT00048581|62868575|FG000|Open-Label Period|Primary Investigator Retired|0|||
33490610|NCT00048581|62868576|FG001|Open-Label Period|Primary Investigator Retired|0|||
33490611|NCT00048581|62868577|FG002|Open-Label Period|Primary Investigator Retired|2|||
33490612|NCT00048581|62868575|FG000|Open-Label Period|Study Ended By Sponsor|0|||
33490613|NCT00048581|62868576|FG001|Open-Label Period|Study Ended By Sponsor|0|||
33490614|NCT00048581|62868577|FG002|Open-Label Period|Study Ended By Sponsor|1|||
33490615|NCT00048347|62868590|FG000|Overall Study|Screen failure|2|||
33490616|NCT00065507|62868596|FG000|Overall Study|Death|16|||
33490617|NCT00065507|62868597|FG001|Overall Study|Death|17|||
33490618|NCT00065507|62868596|FG000|Overall Study|Adverse Event|4|||
33490619|NCT00065507|62868597|FG001|Overall Study|Adverse Event|3|||
33490620|NCT00065507|62868596|FG000|Overall Study|Lack of Efficacy|0|||
33490621|NCT00065507|62868597|FG001|Overall Study|Lack of Efficacy|6|||
33490622|NCT00065507|62868596|FG000|Overall Study|Poor/Non-compliance|3|||
33490623|NCT00065507|62868597|FG001|Overall Study|Poor/Non-compliance|2|||
33490624|NCT00065507|62868596|FG000|Overall Study|Lost to Follow-up|3|||
33490625|NCT00065507|62868597|FG001|Overall Study|Lost to Follow-up|0|||
33490626|NCT00065507|62868596|FG000|Overall Study|Subject Withdrew Consent|2|||
33490627|NCT00065507|62868597|FG001|Overall Study|Subject Withdrew Consent|1|||
33490628|NCT00065507|62868596|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
33490629|NCT00065507|62868597|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
33490630|NCT00065429|62868614|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
33490631|NCT00065429|62868615|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
33490632|NCT00065429|62868616|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
33490633|NCT00065429|62868617|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
33490634|NCT00065429|62868618|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
33490635|NCT00065429|62868619|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
33490636|NCT00065429|62868620|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
33490637|NCT00065429|62868614|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
33490638|NCT00065429|62868615|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
33490639|NCT00065429|62868616|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
33490640|NCT00065429|62868617|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
33490641|NCT00065429|62868618|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
33490642|NCT00065429|62868619|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
33490643|NCT00065429|62868620|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
33490644|NCT00065429|62868614|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
33490645|NCT00065429|62868615|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
33490646|NCT00065429|62868616|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
33490647|NCT00065429|62868617|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
33490648|NCT00065429|62868618|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
33490649|NCT00065429|62868619|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
33490650|NCT00065429|62868620|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
33490651|NCT00065429|62868614|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
33490652|NCT00065429|62868615|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
33490653|NCT00065429|62868616|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
33490654|NCT00065429|62868617|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
33490655|NCT00065429|62868618|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
33490656|NCT00065429|62868619|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
33490657|NCT00065429|62868620|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
33490658|NCT00065429|62868614|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
33490659|NCT00065429|62868615|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
33490660|NCT00065429|62868616|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
33490661|NCT00065429|62868617|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
33490662|NCT00065429|62868618|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
33490663|NCT00065429|62868619|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
33490664|NCT00065429|62868620|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
33490665|NCT00065429|62868614|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
33490666|NCT00065429|62868615|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
33490667|NCT00065429|62868616|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
33490668|NCT00065429|62868617|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
33490669|NCT00065429|62868618|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
33490670|NCT00065429|62868619|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
33490671|NCT00065429|62868620|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
33490672|NCT00065429|62868614|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
33490673|NCT00065429|62868615|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
33490674|NCT00065429|62868616|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
33490675|NCT00065429|62868617|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
33490676|NCT00065429|62868618|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
33490677|NCT00065429|62868619|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
33490678|NCT00065429|62868620|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
33490679|NCT00048035|62868637|FG000|Core Period|Early Withdrawals|4|||
33490680|NCT00048035|62868638|FG001|Core Period|Early Withdrawals|2|||
33490681|NCT00048035|62868639|FG002|Core Period|Early Withdrawals|1|||
33490682|NCT00048035|62868640|FG003|Core Period|Early Withdrawals|1|||
33490683|NCT00048035|62868641|FG004|Core Period|Early Withdrawals|1|||
33490684|NCT00048035|62868642|FG005|Core Period|Early Withdrawals|1|||
33490685|NCT00048035|62868643|FG006|Core Period|Early Withdrawals|0|||
33490686|NCT00048035|62868644|FG007|Core Period|Early Withdrawals|0|||
33490687|NCT00048035|62868637|FG000|Extension Year 1|Early Withdrawals|0|||
33490688|NCT00048035|62868638|FG001|Extension Year 1|Early Withdrawals|0|||
33490689|NCT00048035|62868639|FG002|Extension Year 1|Early Withdrawals|0|||
33490690|NCT00048035|62868640|FG003|Extension Year 1|Early Withdrawals|0|||
33490691|NCT00048035|62868641|FG004|Extension Year 1|Early Withdrawals|0|||
33490692|NCT00048035|62868642|FG005|Extension Year 1|Early Withdrawals|0|||
33490693|NCT00048035|62868643|FG006|Extension Year 1|Early Withdrawals|11|||
33490694|NCT00048035|62868644|FG007|Extension Year 1|Early Withdrawals|11|||
33490695|NCT00048035|62868637|FG000|Extension Year 2|Early Withdrawals|0|||
33490696|NCT00048035|62868638|FG001|Extension Year 2|Early Withdrawals|0|||
33490697|NCT00048035|62868639|FG002|Extension Year 2|Early Withdrawals|0|||
33490698|NCT00048035|62868640|FG003|Extension Year 2|Early Withdrawals|0|||
33490699|NCT00048035|62868641|FG004|Extension Year 2|Early Withdrawals|0|||
33490700|NCT00048035|62868642|FG005|Extension Year 2|Early Withdrawals|0|||
33490701|NCT00048035|62868643|FG006|Extension Year 2|Early Withdrawals|3|||
33490702|NCT00048035|62868644|FG007|Extension Year 2|Early Withdrawals|3|||
33490703|NCT00047879|62868661|FG000|Overall Study|Progressive disease|4|||
33490704|NCT00047879|62868662|FG001|Overall Study|Progressive disease|3|||
33490705|NCT00064337|62868668|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
33490706|NCT00064337|62868668|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
33490707|NCT00064337|62868668|FG000|PBSCC or Induction/PBSCC|Progression|3|||
33490708|NCT00064337|62868668|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
33490709|NCT00064337|62868668|FG000|PBSCC or Induction/PBSCC|Death|2|||
33490710|NCT00064337|62868668|FG000|Transplant|Adverse Event|9|||
33490711|NCT00064337|62868668|FG000|Transplant|Not protocol-specified|5|||
33490712|NCT00064337|62868668|FG000|Transplant|Death|3|||
33490713|NCT00064337|62868668|FG000|Transplant|Patient Refusal|2|||
33490714|NCT00064337|62868668|FG000|Transplant|Progression|2|||
33490715|NCT00064337|62868668|FG000|Maintenance|Adverse Event|3|||
33490716|NCT00064337|62868668|FG000|Maintenance|Progression|2|||
33490717|NCT00064337|62868668|FG000|Maintenance|On treatment at time of analysis|2|||
33490718|NCT00064337|62868668|FG000|Maintenance|Not protocol-specified|2|||
33490719|NCT00064337|62868668|FG000|Maintenance|Death|1|||
33490720|NCT00064259|62868675|FG000|Overall Study|Adverse Event|1|||
33490721|NCT00064259|62868676|FG001|Overall Study|Adverse Event|0|||
33490722|NCT00064259|62868677|FG002|Overall Study|Adverse Event|0|||
33490723|NCT00064259|62868678|FG003|Overall Study|Adverse Event|1|||
33490724|NCT00044213|62868687|FG000|Overall Study|Withdrawal by Subject|50|||
33490725|NCT00044213|62868688|FG001|Overall Study|Withdrawal by Subject|65|||
33490726|NCT00044213|62868689|FG002|Overall Study|Withdrawal by Subject|91|||
33490727|NCT00044213|62868690|FG003|Overall Study|Withdrawal by Subject|83|||
33490728|NCT00044213|62868687|FG000|Overall Study|Death|42|||
33490729|NCT00044213|62868688|FG001|Overall Study|Death|42|||
33490730|NCT00044213|62868689|FG002|Overall Study|Death|42|||
33490731|NCT00044213|62868690|FG003|Overall Study|Death|49|||
33490732|NCT00044213|62868687|FG000|Overall Study|Lost to Follow-up|8|||
33490733|NCT00044213|62868688|FG001|Overall Study|Lost to Follow-up|5|||
33490734|NCT00044213|62868689|FG002|Overall Study|Lost to Follow-up|5|||
33490735|NCT00044213|62868690|FG003|Overall Study|Lost to Follow-up|4|||
33490736|NCT00064025|62868700|FG000|Overall Study|Ineligible|4|||
33490737|NCT00064025|62868700|FG000|Overall Study|Inevaluable|3|||
33490738|NCT00043979|62868708|FG000|Period 1|recipient with progressive disease|7|||
33490739|NCT00043979|62868709|FG001|Period 1|recipient with progressive disease|4|||
33490740|NCT00043979|62868710|FG002|Period 1|recipient with progressive disease|3|||
33580119|NCT01949116|62976932|FG001|Overall Study|Lost to Follow-up|3|||
33580120|NCT01949116|62976931|FG000|Overall Study|Withdrawal by Subject|5|||
33580121|NCT01949116|62976932|FG001|Overall Study|Withdrawal by Subject|3|||
33580122|NCT01673009|62976942|FG000|Overall Study|Physician Decision|5|||
33580123|NCT01673009|62976942|FG000|Overall Study|Withdrawal by Subject|8|||
33580124|NCT01939366|62976951|FG000|Overall Study|Adverse Event|8|||
33580125|NCT01939366|62976952|FG001|Overall Study|Adverse Event|17|||
33580126|NCT01939366|62976953|FG002|Overall Study|Adverse Event|30|||
33580127|NCT01939366|62976954|FG003|Overall Study|Adverse Event|8|||
33580128|NCT01939366|62976955|FG004|Overall Study|Adverse Event|5|||
33580129|NCT01939366|62976951|FG000|Overall Study|Lack of Efficacy|2|||
33580130|NCT01939366|62976952|FG001|Overall Study|Lack of Efficacy|1|||
33580131|NCT01939366|62976953|FG002|Overall Study|Lack of Efficacy|1|||
33580132|NCT01939366|62976954|FG003|Overall Study|Lack of Efficacy|1|||
33580133|NCT01939366|62976955|FG004|Overall Study|Lack of Efficacy|3|||
33580134|NCT01939366|62976951|FG000|Overall Study|Lost to Follow-up|1|||
33580135|NCT01939366|62976952|FG001|Overall Study|Lost to Follow-up|1|||
33580136|NCT01939366|62976953|FG002|Overall Study|Lost to Follow-up|0|||
33580137|NCT01939366|62976954|FG003|Overall Study|Lost to Follow-up|0|||
33580138|NCT01939366|62976955|FG004|Overall Study|Lost to Follow-up|0|||
33580139|NCT01939366|62976951|FG000|Overall Study|Withdrawal by Subject|1|||
33580140|NCT01939366|62976952|FG001|Overall Study|Withdrawal by Subject|0|||
33580141|NCT01939366|62976953|FG002|Overall Study|Withdrawal by Subject|2|||
33580142|NCT01939366|62976954|FG003|Overall Study|Withdrawal by Subject|2|||
33580143|NCT01939366|62976955|FG004|Overall Study|Withdrawal by Subject|3|||
33580144|NCT01939366|62976951|FG000|Overall Study|Inclusion criteria not met|0|||
33580145|NCT01939366|62976952|FG001|Overall Study|Inclusion criteria not met|1|||
33580146|NCT01939366|62976953|FG002|Overall Study|Inclusion criteria not met|1|||
33580147|NCT01939366|62976954|FG003|Overall Study|Inclusion criteria not met|0|||
33580148|NCT01939366|62976955|FG004|Overall Study|Inclusion criteria not met|1|||
33580149|NCT01939366|62976951|FG000|Overall Study|Other|0|||
33580150|NCT01939366|62976952|FG001|Overall Study|Other|0|||
33580151|NCT01939366|62976953|FG002|Overall Study|Other|2|||
33580152|NCT01939366|62976954|FG003|Overall Study|Other|2|||
33580153|NCT01939366|62976955|FG004|Overall Study|Other|1|||
33580154|NCT01939366|62976951|FG000|Overall Study|Protocol Violation|0|||
33580155|NCT01939366|62976952|FG001|Overall Study|Protocol Violation|0|||
33580156|NCT01939366|62976953|FG002|Overall Study|Protocol Violation|0|||
33580157|NCT01939366|62976954|FG003|Overall Study|Protocol Violation|1|||
33580158|NCT01939366|62976955|FG004|Overall Study|Protocol Violation|0|||
33580159|NCT01939366|62976951|FG000|Overall Study|Sponsor decision|0|||
33580160|NCT01939366|62976952|FG001|Overall Study|Sponsor decision|0|||
33580161|NCT01939366|62976953|FG002|Overall Study|Sponsor decision|0|||
33580162|NCT01939366|62976954|FG003|Overall Study|Sponsor decision|0|||
33580163|NCT01939366|62976955|FG004|Overall Study|Sponsor decision|2|||
33580164|NCT01939366|62976951|FG000|Overall Study|GCP non-compliance at site|2|||
33580165|NCT01939366|62976952|FG001|Overall Study|GCP non-compliance at site|3|||
33580166|NCT01939366|62976953|FG002|Overall Study|GCP non-compliance at site|2|||
33580167|NCT01939366|62976954|FG003|Overall Study|GCP non-compliance at site|3|||
33580168|NCT01939366|62976955|FG004|Overall Study|GCP non-compliance at site|3|||
33580169|NCT01918306|62976969|FG000|Overall Study|progresive disease|4|||
33580170|NCT01918306|62976970|FG001|Overall Study|progresive disease|0|||
33580171|NCT01918306|62976971|FG002|Overall Study|progresive disease|1|||
33580172|NCT01918306|62976972|FG003|Overall Study|progresive disease|1|||
33580173|NCT01918306|62976969|FG000|Overall Study|Withdrawal by Subject|0|||
33580174|NCT01918306|62976970|FG001|Overall Study|Withdrawal by Subject|0|||
33580175|NCT01918306|62976971|FG002|Overall Study|Withdrawal by Subject|0|||
33580176|NCT01918306|62976972|FG003|Overall Study|Withdrawal by Subject|2|||
33580177|NCT01918306|62976969|FG000|Overall Study|neutropenia|1|||
33580178|NCT01918306|62976970|FG001|Overall Study|neutropenia|0|||
33580179|NCT01918306|62976971|FG002|Overall Study|neutropenia|0|||
33580180|NCT01918306|62976972|FG003|Overall Study|neutropenia|0|||
33580181|NCT01918306|62976969|FG000|Overall Study|Lack of Efficacy|1|||
33580182|NCT01918306|62976970|FG001|Overall Study|Lack of Efficacy|0|||
33580183|NCT01918306|62976971|FG002|Overall Study|Lack of Efficacy|0|||
33580184|NCT01918306|62976972|FG003|Overall Study|Lack of Efficacy|0|||
33580185|NCT01918306|62976969|FG000|Overall Study|progress disease, crossover|0|||
33580186|NCT01918306|62976970|FG001|Overall Study|progress disease, crossover|0|||
33580187|NCT01918306|62976971|FG002|Overall Study|progress disease, crossover|1|||
33580188|NCT01918306|62976972|FG003|Overall Study|progress disease, crossover|0|||
33580189|NCT01917526|62976994|FG000|Overall Study|Protocol Violation|1|||
33580190|NCT01917526|62976995|FG001|Overall Study|Protocol Violation|1|||
33580191|NCT01948258|62977001|FG000|Overall Study|Pregnancy|41|||
33580192|NCT01948258|62977001|FG000|Overall Study|Did not complete by cut-off date|35|||
33580193|NCT01948258|62977001|FG000|Overall Study|Lost to Follow-up|27|||
33580194|NCT01948258|62977001|FG000|Overall Study|Withdrawal by SPD|8|||
33580195|NCT01948258|62977001|FG000|Overall Study|Withdrawal by Subject|6|||
33580196|NCT01948258|62977001|FG000|Overall Study|Health Care Professional|43|||
33580197|NCT01948258|62977001|FG000|Overall Study|Removed from statistical analysis|2|||
33580198|NCT01916980|62977007|FG000|Overall Study|Adverse Event|4|||
33580199|NCT01916980|62977008|FG001|Overall Study|Adverse Event|2|||
33580200|NCT01916980|62977007|FG000|Overall Study|Lack of Efficacy|2|||
33580201|NCT01916980|62977008|FG001|Overall Study|Lack of Efficacy|2|||
33580202|NCT01916980|62977007|FG000|Overall Study|Withdrawal by Subject|1|||
33580203|NCT01916980|62977008|FG001|Overall Study|Withdrawal by Subject|0|||
33580204|NCT05940077|62977014|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
33580205|NCT05011513|62977028|FG000|Overall Study|Death|0|||
33580206|NCT05011513|62977029|FG001|Overall Study|Death|1|||
33580207|NCT05011513|62977028|FG000|Overall Study|Lost to Follow-up|4|||
33580208|NCT05011513|62977029|FG001|Overall Study|Lost to Follow-up|0|||
33580209|NCT05011513|62977028|FG000|Overall Study|Withdrawal by Subject|18|||
33580210|NCT05011513|62977029|FG001|Overall Study|Withdrawal by Subject|17|||
33580211|NCT05011513|62977028|FG000|Overall Study|Other|4|||
33580212|NCT05011513|62977029|FG001|Overall Study|Other|2|||
33580213|NCT04750239|62977035|FG000|Overall Study|Withdrawal by Subject|2|||
33580214|NCT04750239|62977035|FG000|Overall Study|Trial terminated by sponsor|1|||
33580215|NCT04668209|62977042|FG000|Overall Study|Withdrawal by Subject|2|||
33580216|NCT04668209|62977043|FG001|Overall Study|Withdrawal by Subject|2|||
33580217|NCT04668209|62977042|FG000|Overall Study|Lost to Follow-up|3|||
33580218|NCT04668209|62977043|FG001|Overall Study|Lost to Follow-up|4|||
33580219|NCT04668209|62977042|FG000|Overall Study|Subject Expired|2|||
33580220|NCT04668209|62977043|FG001|Overall Study|Subject Expired|0|||
33580221|NCT04668209|62977042|FG000|Overall Study|Withdrawn from study|0|||
33580222|NCT04668209|62977043|FG001|Overall Study|Withdrawn from study|1|||
33580223|NCT04668209|62977042|FG000|Overall Study|Adverse Event|0|||
33580224|NCT04668209|62977043|FG001|Overall Study|Adverse Event|1|||
33580225|NCT04590248|62977049|FG000|Overall Study|Lost to Follow-up|1|||
33580226|NCT04590248|62977049|FG000|Overall Study|Withdrawal by Subject|16|||
33580227|NCT04590248|62977049|FG000|Overall Study|Other|2|||
33580228|NCT04560816|62977053|FG000|Overall Study|Withdrawal by Subject|1|||
33580229|NCT04560816|62977054|FG001|Overall Study|Withdrawal by Subject|1|||
33580230|NCT04560816|62977055|FG002|Overall Study|Withdrawal by Subject|1|||
33580231|NCT04560816|62977056|FG003|Overall Study|Withdrawal by Subject|0|||
33580232|NCT04560816|62977057|FG004|Overall Study|Withdrawal by Subject|3|||
33580233|NCT04560816|62977058|FG005|Overall Study|Withdrawal by Subject|0|||
33580234|NCT04560816|62977053|FG000|Overall Study|Lost to Follow-up|1|||
33580235|NCT04560816|62977054|FG001|Overall Study|Lost to Follow-up|0|||
33580236|NCT04560816|62977055|FG002|Overall Study|Lost to Follow-up|0|||
33580237|NCT04560816|62977056|FG003|Overall Study|Lost to Follow-up|0|||
33580238|NCT04560816|62977057|FG004|Overall Study|Lost to Follow-up|0|||
33580239|NCT04560816|62977058|FG005|Overall Study|Lost to Follow-up|0|||
33580240|NCT04560816|62977053|FG000|Overall Study|Protocol Violation|1|||
33580241|NCT04560816|62977054|FG001|Overall Study|Protocol Violation|0|||
33580242|NCT04560816|62977055|FG002|Overall Study|Protocol Violation|0|||
33580243|NCT04560816|62977056|FG003|Overall Study|Protocol Violation|0|||
33580244|NCT04560816|62977057|FG004|Overall Study|Protocol Violation|0|||
33580245|NCT04560816|62977058|FG005|Overall Study|Protocol Violation|0|||
33580246|NCT04092582|62977072|FG000|Overall Study|Death|1|||
33580247|NCT04092582|62977073|FG001|Overall Study|Death|1|||
33580248|NCT04092582|62977072|FG000|Overall Study|Withdrawal by Subject|4|||
33580249|NCT04092582|62977073|FG001|Overall Study|Withdrawal by Subject|1|||
33580250|NCT04092582|62977072|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
33580251|NCT04092582|62977073|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
33580252|NCT03636256|62977109|FG000|Overall Study|Lost to Follow-up|3|||
33580253|NCT03636256|62977110|FG001|Overall Study|Lost to Follow-up|0|||
33580254|NCT03636256|62977111|FG002|Overall Study|Lost to Follow-up|2|||
33580255|NCT03636256|62977112|FG003|Overall Study|Lost to Follow-up|1|||
33580256|NCT03636256|62977113|FG004|Overall Study|Lost to Follow-up|0|||
33580257|NCT03636256|62977114|FG005|Overall Study|Lost to Follow-up|4|||
33580258|NCT03636256|62977115|FG006|Overall Study|Lost to Follow-up|2|||
33580259|NCT03636256|62977116|FG007|Overall Study|Lost to Follow-up|0|||
33580260|NCT03636256|62977117|FG008|Overall Study|Lost to Follow-up|4|||
33580261|NCT03636256|62977109|FG000|Overall Study|Withdrawal by Subject|0|||
33580262|NCT03636256|62977110|FG001|Overall Study|Withdrawal by Subject|0|||
33580263|NCT03636256|62977111|FG002|Overall Study|Withdrawal by Subject|0|||
33580264|NCT03636256|62977112|FG003|Overall Study|Withdrawal by Subject|0|||
33580265|NCT03636256|62977113|FG004|Overall Study|Withdrawal by Subject|0|||
33580266|NCT03636256|62977114|FG005|Overall Study|Withdrawal by Subject|0|||
33580267|NCT03636256|62977115|FG006|Overall Study|Withdrawal by Subject|0|||
33580268|NCT03636256|62977116|FG007|Overall Study|Withdrawal by Subject|0|||
33580269|NCT03636256|62977117|FG008|Overall Study|Withdrawal by Subject|1|||
33580270|NCT03614676|62977148|FG000|Overall Study|Delivery before planned visit|2|||
33580271|NCT03614676|62977149|FG001|Overall Study|Delivery before planned visit|0|||
33580272|NCT03614676|62977148|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
33580273|NCT03614676|62977149|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
33580274|NCT03614676|62977148|FG000|Overall Study|Migrated / moved from the study area|30|||
33580275|NCT03614676|62977149|FG001|Overall Study|Migrated / moved from the study area|22|||
33580276|NCT03614676|62977148|FG000|Overall Study|Lost to Follow-up|17|||
33580277|NCT03614676|62977149|FG001|Overall Study|Lost to Follow-up|42|||
33580278|NCT03614676|62977148|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
33580279|NCT03614676|62977149|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
33580280|NCT03614676|62977148|FG000|Overall Study|Other|16|||
33580281|NCT03614676|62977149|FG001|Overall Study|Other|47|||
33580282|NCT03614676|62977148|FG000|Overall Study|Protocol Violation|0|||
33580283|NCT03614676|62977149|FG001|Overall Study|Protocol Violation|2|||
33580284|NCT03614676|62977148|FG000|Overall Study|Neonatal event of interest|0|||
33580285|NCT03614676|62977149|FG001|Overall Study|Neonatal event of interest|6|||
33580286|NCT03614676|62977148|FG000|Overall Study|Death in infant greater than 28 days old|0|||
33580287|NCT03614676|62977149|FG001|Overall Study|Death in infant greater than 28 days old|12|||
33580288|NCT03614676|62977148|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
33580289|NCT03614676|62977149|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
33580290|NCT02937818|62977163|FG000|Overall Study|Participants decision|1|||
33580291|NCT02937818|62977164|FG001|Overall Study|Participants decision|0|||
33580292|NCT02937818|62977165|FG002|Overall Study|Participants decision|1|||
33580293|NCT02937818|62977166|FG003|Overall Study|Participants decision|1|||
33580294|NCT02937818|62977163|FG000|Overall Study|Adverse Event|2|||
33580295|NCT02937818|62977164|FG001|Overall Study|Adverse Event|4|||
33580296|NCT02937818|62977165|FG002|Overall Study|Adverse Event|1|||
33580297|NCT02937818|62977166|FG003|Overall Study|Adverse Event|1|||
33580298|NCT02937818|62977163|FG000|Overall Study|Disease progression|17|||
33580299|NCT02937818|62977164|FG001|Overall Study|Disease progression|14|||
33580300|NCT02937818|62977165|FG002|Overall Study|Disease progression|7|||
33580301|NCT02937818|62977166|FG003|Overall Study|Disease progression|18|||
33580302|NCT02937818|62977163|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1|||
33580303|NCT02937818|62977164|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2|||
33580304|NCT02937818|62977165|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
33580305|NCT02937818|62977166|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
33580306|NCT02937818|62977163|FG000|Overall Study|Condition under investigation worsened|0|||
33580307|NCT02937818|62977164|FG001|Overall Study|Condition under investigation worsened|0|||
33580308|NCT02937818|62977165|FG002|Overall Study|Condition under investigation worsened|1|||
33580309|NCT02937818|62977166|FG003|Overall Study|Condition under investigation worsened|0|||
33580310|NCT02937818|62977163|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
33580311|NCT02937818|62977164|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
33580312|NCT02937818|62977165|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
33580313|NCT02937818|62977166|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1|||
33580314|NCT02727478|62977181|FG000|Overall Study|Withdrawal by Subject|8|||
33580315|NCT02727478|62977182|FG001|Overall Study|Withdrawal by Subject|10|||
33580316|NCT02614794|62977190|FG000|Overall Study|Death|258|||
33580317|NCT02614794|62977191|FG001|Overall Study|Death|151|||
33580318|NCT02614794|62977190|FG000|Overall Study|Study closure by Sponsor|119|||
33580319|NCT02614794|62977191|FG001|Overall Study|Study closure by Sponsor|45|||
33580320|NCT02614794|62977190|FG000|Overall Study|Withdrawal by Subject|24|||
33580321|NCT02614794|62977191|FG001|Overall Study|Withdrawal by Subject|5|||
33580322|NCT02614794|62977190|FG000|Overall Study|Lost to Follow-up|7|||
33580323|NCT02614794|62977191|FG001|Overall Study|Lost to Follow-up|0|||
33580324|NCT02614794|62977190|FG000|Overall Study|Physician Decision|1|||
33580325|NCT02614794|62977191|FG001|Overall Study|Physician Decision|1|||
33580326|NCT02614794|62977190|FG000|Overall Study|Hospital closure|1|||
33580327|NCT02614794|62977191|FG001|Overall Study|Hospital closure|0|||
33580328|NCT02361944|62977199|FG000|Overall Study|surgery cancellation|0|||
33580329|NCT02361944|62977200|FG001|Overall Study|surgery cancellation|1|||
33580330|NCT01649232|62977213|FG000|Overall Study|Physician Decision|2|||
33580331|NCT01649232|62977214|FG001|Overall Study|Physician Decision|0|||
33580332|NCT00955968|62977228|FG000|Overall Study|Death|2|||
33580333|NCT00955968|62977229|FG001|Overall Study|Death|4|||
33580334|NCT00955968|62977228|FG000|Overall Study|Withdrawal by Subject|35|||
33580335|NCT00955968|62977229|FG001|Overall Study|Withdrawal by Subject|31|||
33580336|NCT00955968|62977228|FG000|Overall Study|Lost to Follow-up|45|||
33580337|NCT00955968|62977229|FG001|Overall Study|Lost to Follow-up|39|||
33580338|NCT00955968|62977228|FG000|Overall Study|Site closed|55|||
33580339|NCT00955968|62977229|FG001|Overall Study|Site closed|52|||
33580340|NCT05062759|62977253|FG000|Overall Study|Death|0|||
33580341|NCT05062759|62977254|FG001|Overall Study|Death|1|||
33580342|NCT05062759|62977253|FG000|Overall Study|Lost to Follow-up|1|||
33580343|NCT05062759|62977254|FG001|Overall Study|Lost to Follow-up|0|||
33580344|NCT05033262|62977273|FG000|Overall Study|Lost to Follow-up|1|||
33580345|NCT05033262|62977274|FG001|Overall Study|Lost to Follow-up|0|||
33580346|NCT05033262|62977275|FG002|Overall Study|Lost to Follow-up|0|||
33580347|NCT05033262|62977276|FG003|Overall Study|Lost to Follow-up|1|||
33580348|NCT04963062|62977290|FG000|Overall Study|withdrew by the study team|4|||
33580349|NCT04963062|62977291|FG001|Overall Study|withdrew by the study team|2|||
33580350|NCT04900220|62977303|FG000|Overall Study|Lost to Follow-up|1|||
33580351|NCT04900220|62977304|FG001|Overall Study|Lost to Follow-up|1|||
33580352|NCT04599062|62977316|FG000|Overall Study|Physician Decision|1|||
33580353|NCT04599062|62977317|FG001|Overall Study|Physician Decision|0|||
33580354|NCT04585815|62977325|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
33580355|NCT04585815|62977326|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
33580356|NCT04585815|62977325|FG000|Sub-study A- Treatment Phase|Death|0|||
33580357|NCT04585815|62977326|FG001|Sub-study A- Treatment Phase|Death|1|||
33580358|NCT04585815|62977325|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
33580359|NCT04585815|62977326|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
33580360|NCT04585815|62977325|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
33580361|NCT04585815|62977326|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
33580362|NCT04585815|62977325|FG000|Sub-study A- Treatment Phase|Other|1|||
33580363|NCT04585815|62977326|FG001|Sub-study A- Treatment Phase|Other|0|||
33580364|NCT04585815|62977325|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
33580365|NCT04585815|62977326|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
33580366|NCT04585815|62977325|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
33580367|NCT04585815|62977326|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
33580368|NCT04537208|62977345|FG000|Overall Study|Adverse Event|0|||
33580369|NCT04537208|62977346|FG001|Overall Study|Adverse Event|0|||
33580370|NCT04537208|62977347|FG002|Overall Study|Adverse Event|0|||
33580371|NCT04537208|62977348|FG003|Overall Study|Adverse Event|0|||
33580372|NCT04537208|62977349|FG004|Overall Study|Adverse Event|0|||
33580373|NCT04537208|62977350|FG005|Overall Study|Adverse Event|0|||
33580374|NCT04537208|62977351|FG006|Overall Study|Adverse Event|0|||
33580375|NCT04537208|62977352|FG007|Overall Study|Adverse Event|0|||
33580376|NCT04537208|62977353|FG008|Overall Study|Adverse Event|1|||
33580377|NCT04537208|62977354|FG009|Overall Study|Adverse Event|0|||
33580378|NCT04537208|62977355|FG010|Overall Study|Adverse Event|0|||
33580379|NCT04537208|62977345|FG000|Overall Study|Protocol deviation|0|||
33580380|NCT04537208|62977346|FG001|Overall Study|Protocol deviation|0|||
33580381|NCT04537208|62977347|FG002|Overall Study|Protocol deviation|2|||
33580382|NCT04537208|62977348|FG003|Overall Study|Protocol deviation|0|||
33580383|NCT04537208|62977349|FG004|Overall Study|Protocol deviation|0|||
33580384|NCT04537208|62977350|FG005|Overall Study|Protocol deviation|2|||
33580385|NCT04537208|62977351|FG006|Overall Study|Protocol deviation|4|||
33580386|NCT04537208|62977352|FG007|Overall Study|Protocol deviation|0|||
33580387|NCT04537208|62977353|FG008|Overall Study|Protocol deviation|1|||
33580388|NCT04537208|62977354|FG009|Overall Study|Protocol deviation|0|||
33580389|NCT04537208|62977355|FG010|Overall Study|Protocol deviation|2|||
33580390|NCT04537208|62977345|FG000|Overall Study|Withdrawal by Subject|4|||
33580391|NCT04537208|62977346|FG001|Overall Study|Withdrawal by Subject|2|||
33580392|NCT04537208|62977347|FG002|Overall Study|Withdrawal by Subject|1|||
33580393|NCT04537208|62977348|FG003|Overall Study|Withdrawal by Subject|3|||
33580394|NCT04537208|62977349|FG004|Overall Study|Withdrawal by Subject|5|||
33580395|NCT04537208|62977350|FG005|Overall Study|Withdrawal by Subject|1|||
33580396|NCT04537208|62977351|FG006|Overall Study|Withdrawal by Subject|6|||
33580397|NCT04537208|62977352|FG007|Overall Study|Withdrawal by Subject|1|||
33580398|NCT04537208|62977353|FG008|Overall Study|Withdrawal by Subject|7|||
33580399|NCT04537208|62977354|FG009|Overall Study|Withdrawal by Subject|2|||
33580400|NCT04537208|62977355|FG010|Overall Study|Withdrawal by Subject|4|||
33580401|NCT04537208|62977345|FG000|Overall Study|Lost to Follow-up|4|||
33580402|NCT04537208|62977346|FG001|Overall Study|Lost to Follow-up|1|||
33580403|NCT04537208|62977347|FG002|Overall Study|Lost to Follow-up|3|||
33580404|NCT04537208|62977348|FG003|Overall Study|Lost to Follow-up|4|||
33580405|NCT04537208|62977349|FG004|Overall Study|Lost to Follow-up|3|||
33580406|NCT04537208|62977350|FG005|Overall Study|Lost to Follow-up|2|||
33580407|NCT04537208|62977351|FG006|Overall Study|Lost to Follow-up|3|||
33580408|NCT04537208|62977352|FG007|Overall Study|Lost to Follow-up|2|||
33580409|NCT04537208|62977353|FG008|Overall Study|Lost to Follow-up|7|||
33580410|NCT04537208|62977354|FG009|Overall Study|Lost to Follow-up|2|||
33580411|NCT04537208|62977355|FG010|Overall Study|Lost to Follow-up|2|||
33580412|NCT04502433|62977384|FG000|Overall Study|Death|2|||
33580413|NCT04502433|62977385|FG001|Overall Study|Death|4|||
33580414|NCT04502433|62977384|FG000|Overall Study|Lost to Follow-up|1|||
33580415|NCT04502433|62977385|FG001|Overall Study|Lost to Follow-up|0|||
33580416|NCT04502433|62977384|FG000|Overall Study|Physician Decision|0|||
33580417|NCT04502433|62977385|FG001|Overall Study|Physician Decision|1|||
33580418|NCT04442503|62977393|FG000|Overall Study|Adverse Event|1|||
33580419|NCT04442503|62977394|FG001|Overall Study|Adverse Event|1|||
33580420|NCT04442503|62977393|FG000|Overall Study|Lost to Follow-up|8|||
33580421|NCT04442503|62977394|FG001|Overall Study|Lost to Follow-up|6|||
33580422|NCT04442503|62977393|FG000|Overall Study|Physician Decision|0|||
33580423|NCT04442503|62977394|FG001|Overall Study|Physician Decision|2|||
33580424|NCT04442503|62977393|FG000|Overall Study|Withdrawal by Subject|3|||
33580425|NCT04442503|62977394|FG001|Overall Study|Withdrawal by Subject|4|||
33580426|NCT04442503|62977393|FG000|Overall Study|Reason not Specified|0|||
33580427|NCT04442503|62977394|FG001|Overall Study|Reason not Specified|1|||
33580428|NCT04442503|62977393|FG000|Overall Study|Randomized but not Treated|3|||
33580429|NCT04442503|62977394|FG001|Overall Study|Randomized but not Treated|1|||
33580430|NCT04411914|62977402|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
33580431|NCT04411914|62977403|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
33580432|NCT04389671|62977422|FG000|Overall Study|Death|7|||
33580433|NCT04381494|62977426|FG000|Overall Study|Early termination of trial|19|||
33580434|NCT04381494|62977426|FG000|Overall Study|Investigator's discretion|1|||
33580435|NCT04381494|62977426|FG000|Overall Study|Withdrawal by Subject|9|||
33580436|NCT04381494|62977426|FG000|Overall Study|NSCLC disease progression|4|||
33671457|NCT02036970|63106945|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33671458|NCT02036970|63106946|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33671459|NCT02036970|63106947|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
33671460|NCT02036970|63106948|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33671461|NCT02036970|63106949|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33671462|NCT02036970|63106950|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33671463|NCT02036970|63106951|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33671464|NCT02036970|63106952|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33671465|NCT02036970|63106953|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33671466|NCT02036970|63106944|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
33671467|NCT02036970|63106945|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
33671468|NCT02036970|63106946|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
33671469|NCT02036970|63106947|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
33671470|NCT02036970|63106948|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
33671471|NCT02036970|63106949|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
33671472|NCT02036970|63106950|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
33671473|NCT02036970|63106951|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
33671474|NCT02036970|63106952|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
33671475|NCT02036970|63106953|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
33671476|NCT02036970|63106944|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
33671477|NCT02036970|63106945|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
33671478|NCT02036970|63106946|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
33671479|NCT02036970|63106947|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
33671480|NCT02036970|63106948|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
33671481|NCT02036970|63106949|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
33671482|NCT02036970|63106950|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
33671483|NCT02036970|63106951|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
33671484|NCT02036970|63106952|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
33671485|NCT02036970|63106953|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
33671486|NCT02036970|63106944|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
33671487|NCT02036970|63106945|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
33671488|NCT02036970|63106946|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
33671489|NCT02036970|63106947|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
33671490|NCT02036970|63106948|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
33671491|NCT02036970|63106949|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
33671492|NCT02036970|63106950|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
33671493|NCT02036970|63106951|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
33671494|NCT02036970|63106952|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
33671495|NCT02036970|63106953|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
33671496|NCT02036970|63106944|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
33671497|NCT02036970|63106945|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
33671498|NCT02036970|63106946|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
33671499|NCT02036970|63106947|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
33671500|NCT02036970|63106948|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
33671501|NCT02036970|63106949|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
33671502|NCT02036970|63106950|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
33671503|NCT02036970|63106951|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
33671504|NCT02036970|63106952|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
33671505|NCT02036970|63106953|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
33671506|NCT01412957|63106987|FG000|Overall Study|Withdrawal by Subject|6|||
33671507|NCT01412957|63106988|FG001|Overall Study|Withdrawal by Subject|22|||
33671508|NCT01412957|63106987|FG000|Overall Study|Lost to Follow-up|7|||
33671509|NCT01412957|63106988|FG001|Overall Study|Lost to Follow-up|2|||
33671510|NCT01412957|63106987|FG000|Overall Study|Death|136|||
33671511|NCT01412957|63106988|FG001|Overall Study|Death|133|||
33671512|NCT01432457|63107001|FG000|Overall Study|Adverse Event|7|||
33671513|NCT01432457|63107002|FG001|Overall Study|Adverse Event|10|||
33671514|NCT01432457|63107003|FG002|Overall Study|Adverse Event|16|||
33671515|NCT01432457|63107001|FG000|Overall Study|Lack of Efficacy|2|||
33671516|NCT01432457|63107002|FG001|Overall Study|Lack of Efficacy|1|||
33671517|NCT01432457|63107003|FG002|Overall Study|Lack of Efficacy|1|||
33671518|NCT01432457|63107001|FG000|Overall Study|Lost to Follow-up|11|||
33671519|NCT01432457|63107002|FG001|Overall Study|Lost to Follow-up|15|||
33671520|NCT01432457|63107003|FG002|Overall Study|Lost to Follow-up|20|||
33671521|NCT01432457|63107001|FG000|Overall Study|Protocol Violation|3|||
33671522|NCT01432457|63107002|FG001|Overall Study|Protocol Violation|2|||
33671523|NCT01432457|63107003|FG002|Overall Study|Protocol Violation|6|||
33671524|NCT01432457|63107001|FG000|Overall Study|Withdrawal by Subject|6|||
33671525|NCT01432457|63107002|FG001|Overall Study|Withdrawal by Subject|11|||
33671526|NCT01432457|63107003|FG002|Overall Study|Withdrawal by Subject|9|||
33671527|NCT01432457|63107001|FG000|Overall Study|Reasons not defined|2|||
33671528|NCT01432457|63107002|FG001|Overall Study|Reasons not defined|3|||
33671529|NCT01432457|63107003|FG002|Overall Study|Reasons not defined|4|||
33671530|NCT01432457|63107001|FG000|Overall Study|Did not take study drug|6|||
33671531|NCT01432457|63107002|FG001|Overall Study|Did not take study drug|6|||
33671532|NCT01432457|63107003|FG002|Overall Study|Did not take study drug|3|||
33671533|NCT01390441|63107025|FG000|Treatment Period|Protocol Violation|0|||
33671534|NCT01390441|63107026|FG001|Treatment Period|Protocol Violation|1|||
33671535|NCT01390441|63107027|FG002|Treatment Period|Protocol Violation|0|||
33671536|NCT01390441|63107028|FG003|Treatment Period|Protocol Violation|0|||
33671537|NCT01390441|63107029|FG004|Treatment Period|Protocol Violation|0|||
33671538|NCT01390441|63107025|FG000|Treatment Period|Physician Decision|0|||
33671539|NCT01390441|63107026|FG001|Treatment Period|Physician Decision|0|||
33671540|NCT01390441|63107027|FG002|Treatment Period|Physician Decision|0|||
33671541|NCT01390441|63107028|FG003|Treatment Period|Physician Decision|1|||
33671542|NCT01390441|63107029|FG004|Treatment Period|Physician Decision|0|||
33671543|NCT01390441|63107025|FG000|Treatment Period|Lack of Efficacy|0|||
33671544|NCT01390441|63107026|FG001|Treatment Period|Lack of Efficacy|0|||
33671545|NCT01390441|63107027|FG002|Treatment Period|Lack of Efficacy|0|||
33671546|NCT01390441|63107028|FG003|Treatment Period|Lack of Efficacy|0|||
33671547|NCT01390441|63107029|FG004|Treatment Period|Lack of Efficacy|1|||
33671548|NCT01390441|63107025|FG000|Treatment Period|Unknown due to early stopping of study|0|||
33671549|NCT01390441|63107026|FG001|Treatment Period|Unknown due to early stopping of study|0|||
33671550|NCT01390441|63107027|FG002|Treatment Period|Unknown due to early stopping of study|8|||
33671551|NCT01390441|63107028|FG003|Treatment Period|Unknown due to early stopping of study|11|||
33671552|NCT01390441|63107029|FG004|Treatment Period|Unknown due to early stopping of study|7|||
33671553|NCT01390441|63107025|FG000|Treatment Period|Adverse Event|0|||
33671554|NCT01390441|63107026|FG001|Treatment Period|Adverse Event|0|||
33671555|NCT01390441|63107027|FG002|Treatment Period|Adverse Event|1|||
33671556|NCT01390441|63107028|FG003|Treatment Period|Adverse Event|1|||
33671557|NCT01390441|63107029|FG004|Treatment Period|Adverse Event|2|||
33671558|NCT01390441|63107025|FG000|Treatment Period|Withdrawal by Subject|0|||
33671559|NCT01390441|63107026|FG001|Treatment Period|Withdrawal by Subject|0|||
33671560|NCT01390441|63107027|FG002|Treatment Period|Withdrawal by Subject|1|||
33671561|NCT01390441|63107028|FG003|Treatment Period|Withdrawal by Subject|0|||
33671562|NCT01390441|63107029|FG004|Treatment Period|Withdrawal by Subject|1|||
33671563|NCT01390441|63107025|FG000|Treatment Period|Lost to Follow-up|1|||
33671564|NCT01390441|63107026|FG001|Treatment Period|Lost to Follow-up|0|||
33671565|NCT01390441|63107027|FG002|Treatment Period|Lost to Follow-up|0|||
33671566|NCT01390441|63107028|FG003|Treatment Period|Lost to Follow-up|0|||
33671567|NCT01390441|63107029|FG004|Treatment Period|Lost to Follow-up|0|||
33671568|NCT01390441|63107025|FG000|Extension Period|Protocol Violation|3|||
33671569|NCT01390441|63107026|FG001|Extension Period|Protocol Violation|1|||
33671570|NCT01390441|63107027|FG002|Extension Period|Protocol Violation|0|||
33671571|NCT01390441|63107028|FG003|Extension Period|Protocol Violation|1|||
33671572|NCT01390441|63107029|FG004|Extension Period|Protocol Violation|0|||
33671573|NCT01412879|63107078|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
33671574|NCT01412879|63107079|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
33671575|NCT01412879|63107080|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
33671576|NCT01412879|63107078|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
33671577|NCT01412879|63107079|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
33671578|NCT01412879|63107080|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
33671579|NCT01412879|63107078|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
33671580|NCT01412879|63107079|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
33671581|NCT01412879|63107080|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
33671582|NCT01412879|63107078|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
33671583|NCT01412879|63107079|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
33671584|NCT01412879|63107080|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
33671585|NCT01412879|63107078|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
33671586|NCT01412879|63107079|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
33671587|NCT01412879|63107080|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
33671588|NCT01431079|63107092|FG000|Overall Study|Lost to Follow-up|35|||
33671589|NCT01431079|63107093|FG001|Overall Study|Lost to Follow-up|39|||
33671590|NCT01430611|63107125|FG000|Overall Study|Adverse Event|0|||
33671591|NCT01430611|63107126|FG001|Overall Study|Adverse Event|1|||
33671592|NCT01430611|63107125|FG000|Overall Study|Protocol Violation|1|||
33671593|NCT01430611|63107126|FG001|Overall Study|Protocol Violation|0|||
33671594|NCT01430611|63107125|FG000|Overall Study|Lost to Follow-up|1|||
33671595|NCT01430611|63107126|FG001|Overall Study|Lost to Follow-up|0|||
33671596|NCT01430611|63107125|FG000|Overall Study|Withdrawal by Subject|15|||
33671597|NCT01430611|63107126|FG001|Overall Study|Withdrawal by Subject|14|||
33671598|NCT01409707|63107135|FG000|Overall Study|Withdrawal by Subject|5|||
33671599|NCT01409707|63107136|FG001|Overall Study|Withdrawal by Subject|17|||
33671600|NCT01409707|63107137|FG002|Overall Study|Withdrawal by Subject|16|||
33671601|NCT01389973|63107144|FG000|Overall Study|Lost to Follow-up|1|||
33671602|NCT01389973|63107144|FG000|Overall Study|Trial Stopped by Sponsor|9|||
33671603|NCT01389973|63107144|FG000|Overall Study|Other|10|||
33671604|NCT01389817|63107164|FG000|Overall Study|Physician Decision|1|||
33671605|NCT01389817|63107165|FG001|Overall Study|Physician Decision|0|||
33671606|NCT01389817|63107164|FG000|Overall Study|Lost to Follow-up|1|||
33671607|NCT01389817|63107165|FG001|Overall Study|Lost to Follow-up|0|||
33671608|NCT01389817|63107164|FG000|Overall Study|Withdrawal by Subject|2|||
33671609|NCT01389817|63107165|FG001|Overall Study|Withdrawal by Subject|0|||
33671610|NCT01430455|63107180|FG000|Overall Study|Withdrawal by Subject|1|||
33671611|NCT01430455|63107180|FG000|Overall Study|Switched to follow-up phase|1|||
33671612|NCT01429441|63107208|FG000|Overall Study|Adverse Event|5|||
33671613|NCT01429441|63107209|FG001|Overall Study|Adverse Event|1|||
33671614|NCT01429441|63107208|FG000|Overall Study|Death|0|||
33671615|NCT01429441|63107209|FG001|Overall Study|Death|2|||
33671616|NCT01429441|63107208|FG000|Overall Study|Lost to Follow-up|5|||
33671617|NCT01429441|63107209|FG001|Overall Study|Lost to Follow-up|2|||
33671618|NCT01429441|63107208|FG000|Overall Study|Physician Decision|1|||
33671619|NCT01429441|63107209|FG001|Overall Study|Physician Decision|0|||
33671620|NCT01429441|63107208|FG000|Overall Study|Withdrawal by Subject|27|||
33671621|NCT01429441|63107209|FG001|Overall Study|Withdrawal by Subject|18|||
33671622|NCT01429285|63107244|FG000|Overall Study|Protocol Violation|9|||
33671623|NCT01429285|63107245|FG001|Overall Study|Protocol Violation|4|||
33671624|NCT01429285|63107244|FG000|Overall Study|Missing Data|5|||
33671625|NCT01429285|63107245|FG001|Overall Study|Missing Data|3|||
33671626|NCT01429285|63107244|FG000|Overall Study|Erroneously Enrolled Twice|8|||
33671627|NCT01429285|63107245|FG001|Overall Study|Erroneously Enrolled Twice|2|||
33671628|NCT01429051|63107322|FG000|Titration Phase|Death|1|||
33671629|NCT01429051|63107322|FG000|Titration Phase|Withdrawal by Subject|7|||
33671630|NCT01429051|63107322|FG000|Titration Phase|Physician Decision|1|||
33671631|NCT01429051|63107322|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
33671632|NCT01429051|63107322|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
33671633|NCT01429051|63107322|FG000|Efficacy Phase|Adverse Event|1|||
33671634|NCT01429051|63107322|FG000|Efficacy Phase|Death|1|||
33671635|NCT01429051|63107322|FG000|Tolerability Phase|Death|5|||
33671636|NCT01429051|63107322|FG000|Tolerability Phase|Adverse Event|2|||
33671637|NCT01429051|63107322|FG000|Tolerability Phase|Withdrawal by Subject|5|||
33671638|NCT01429051|63107322|FG000|Tolerability Phase|Physician Decision|1|||
33671639|NCT01429051|63107322|FG000|Tolerability Phase|Other|2|||
33671640|NCT01428661|63107355|FG000|Double-Masked Phase|Protocol Violation|9|||
33671641|NCT01428661|63107356|FG001|Double-Masked Phase|Protocol Violation|4|||
33671642|NCT01428661|63107357|FG002|Double-Masked Phase|Protocol Violation|0|||
33671643|NCT01428661|63107355|FG000|Double-Masked Phase|Adverse Event|13|||
33671644|NCT01428661|63107356|FG001|Double-Masked Phase|Adverse Event|4|||
33671645|NCT01428661|63107357|FG002|Double-Masked Phase|Adverse Event|0|||
33671646|NCT01428661|63107355|FG000|Double-Masked Phase|Lost to Follow-up|14|||
33671647|NCT01428661|63107356|FG001|Double-Masked Phase|Lost to Follow-up|14|||
33671648|NCT01428661|63107357|FG002|Double-Masked Phase|Lost to Follow-up|0|||
33671649|NCT01428661|63107355|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
33671650|NCT01428661|63107356|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
33671651|NCT01428661|63107357|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
33671652|NCT01428661|63107355|FG000|Double-Masked Phase|Lack of Efficacy|2|||
33671653|NCT01428661|63107356|FG001|Double-Masked Phase|Lack of Efficacy|1|||
33671654|NCT01428661|63107357|FG002|Double-Masked Phase|Lack of Efficacy|0|||
33671655|NCT01428661|63107355|FG000|Double-Masked Phase|*Various|1|||
33671656|NCT01428661|63107356|FG001|Double-Masked Phase|*Various|6|||
33671657|NCT01428661|63107357|FG002|Double-Masked Phase|*Various|0|||
33671658|NCT01428661|63107355|FG000|Open Label Extension|Protocol Violation|0|||
33671659|NCT01428661|63107356|FG001|Open Label Extension|Protocol Violation|0|||
33671660|NCT01428661|63107357|FG002|Open Label Extension|Protocol Violation|9|||
33671661|NCT01428661|63107355|FG000|Open Label Extension|Adverse Event|0|||
33671662|NCT01428661|63107356|FG001|Open Label Extension|Adverse Event|0|||
33671663|NCT01428661|63107357|FG002|Open Label Extension|Adverse Event|15|||
33671664|NCT01428661|63107355|FG000|Open Label Extension|Lost to Follow-up|0|||
33671665|NCT01428661|63107356|FG001|Open Label Extension|Lost to Follow-up|0|||
33671666|NCT01428661|63107357|FG002|Open Label Extension|Lost to Follow-up|38|||
33671667|NCT01428661|63107355|FG000|Open Label Extension|Withdrawal by Subject|0|||
33671668|NCT01428661|63107356|FG001|Open Label Extension|Withdrawal by Subject|0|||
33671669|NCT01428661|63107357|FG002|Open Label Extension|Withdrawal by Subject|49|||
33671670|NCT01428661|63107355|FG000|Open Label Extension|Lack of Efficacy|0|||
33671671|NCT01428661|63107356|FG001|Open Label Extension|Lack of Efficacy|0|||
33671672|NCT01428661|63107357|FG002|Open Label Extension|Lack of Efficacy|24|||
33671673|NCT01428661|63107355|FG000|Open Label Extension|**Various|0|||
33671674|NCT01428661|63107356|FG001|Open Label Extension|**Various|0|||
33671675|NCT01428661|63107357|FG002|Open Label Extension|**Various|185|||
33671676|NCT01428583|63107365|FG000|Overall Study|Adverse Event|75|||
33671677|NCT01428583|63107365|FG000|Overall Study|Withdrawal by Subject|51|||
33671678|NCT01428583|63107365|FG000|Overall Study|Lack of Efficacy|37|||
33671679|NCT01428583|63107365|FG000|Overall Study|Lost to Follow-up|17|||
33671680|NCT01428583|63107365|FG000|Overall Study|Death|1|||
33671681|NCT01428583|63107365|FG000|Overall Study|Pregnancy|1|||
33671682|NCT01428583|63107365|FG000|Overall Study|Protocol Violation|1|||
33671683|NCT01428583|63107365|FG000|Overall Study|Physician Decision|12|||
33671684|NCT01428583|63107365|FG000|Overall Study|Non-compliant|25|||
33671685|NCT01428583|63107365|FG000|Overall Study|Confirmed positive urine drug test|8|||
33671686|NCT01428583|63107365|FG000|Overall Study|Sponsor's request|3|||
33671687|NCT01428583|63107365|FG000|Overall Study|Other|6|||
33671688|NCT01428193|63107382|FG000|Overall Study|Physician Decision|1|||
33671689|NCT01428193|63107382|FG000|Overall Study|Elevated screening liver enzymes|1|||
33671690|NCT01428115|63107386|FG000|Overall Study|Lack of Efficacy|3|||
33671691|NCT01428115|63107386|FG000|Overall Study|Lost to Follow-up|10|||
33671692|NCT01428115|63107386|FG000|Overall Study|Pregnancy|1|||
33671693|NCT01428115|63107386|FG000|Overall Study|Protocol Violation|3|||
33671694|NCT01428115|63107386|FG000|Overall Study|Withdrawal by Subject|4|||
33671695|NCT01427803|63107393|FG000|Overall Study|Lost to Follow-up|32|||
33671696|NCT01427803|63107394|FG001|Overall Study|Lost to Follow-up|26|||
33671697|NCT01427803|63107393|FG000|Overall Study|Withdrawal by Subject|20|||
33671698|NCT01427803|63107394|FG001|Overall Study|Withdrawal by Subject|0|||
33671699|NCT01427803|63107393|FG000|Overall Study|Unable to complete full treatment period|6|||
33671700|NCT01427803|63107394|FG001|Overall Study|Unable to complete full treatment period|0|||
33671701|NCT01427803|63107393|FG000|Overall Study|Protocol Violation|1|||
33671702|NCT01427803|63107394|FG001|Overall Study|Protocol Violation|0|||
33671703|NCT01427803|63107393|FG000|Overall Study|Physician Decision|3|||
33671704|NCT01427803|63107394|FG001|Overall Study|Physician Decision|0|||
33671705|NCT01427803|63107393|FG000|Overall Study|did not take product|1|||
33671706|NCT01427803|63107394|FG001|Overall Study|did not take product|0|||
33671707|NCT01408537|63107398|FG000|Overall Study|Withdrawal by Subject|2|||
33671708|NCT01408537|63107398|FG000|Overall Study|Protocol Violation|3|||
33671709|NCT01408537|63107398|FG000|Overall Study|Lost to Follow-up|3|||
33671710|NCT01408459|63107431|FG000|Overall Study|Withdrawal by Subject|1|||
33671711|NCT01408459|63107432|FG001|Overall Study|Withdrawal by Subject|1|||
33671712|NCT01408303|63107451|FG000|Overall Study|Adverse Event|3|||
33671713|NCT01408303|63107452|FG001|Overall Study|Adverse Event|7|||
33671714|NCT01408303|63107453|FG002|Overall Study|Adverse Event|2|||
33671715|NCT01408303|63107451|FG000|Overall Study|Lost to Follow-up|0|||
33671716|NCT01408303|63107452|FG001|Overall Study|Lost to Follow-up|1|||
33671717|NCT01408303|63107453|FG002|Overall Study|Lost to Follow-up|2|||
33671718|NCT01408303|63107451|FG000|Overall Study|Withdrawal by Subject|2|||
33671719|NCT01408303|63107452|FG001|Overall Study|Withdrawal by Subject|3|||
33671720|NCT01408303|63107453|FG002|Overall Study|Withdrawal by Subject|1|||
33671721|NCT01408303|63107451|FG000|Overall Study|Protocol Violation|0|||
33671722|NCT01408303|63107452|FG001|Overall Study|Protocol Violation|1|||
33671723|NCT01408303|63107453|FG002|Overall Study|Protocol Violation|0|||
33671724|NCT01408303|63107451|FG000|Overall Study|Noncompliance|1|||
33671725|NCT01408303|63107452|FG001|Overall Study|Noncompliance|0|||
33671726|NCT01408303|63107453|FG002|Overall Study|Noncompliance|1|||
33671727|NCT01408147|63107474|FG000|Overall Study|Withdrawal by Subject|0|||
33671728|NCT01408147|63107475|FG001|Overall Study|Withdrawal by Subject|1|||
33671729|NCT01407367|63107483|FG000|Overall Study|Death|24|||
33671730|NCT01407367|63107484|FG001|Overall Study|Death|32|||
33671731|NCT01407367|63107483|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
33671732|NCT01407367|63107484|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
33671733|NCT01407367|63107483|FG000|Overall Study|Withdrawal by Subject|4|||
33671734|NCT01407367|63107484|FG001|Overall Study|Withdrawal by Subject|15|||
33671735|NCT01407367|63107483|FG000|Overall Study|Lost to Follow-up|0|||
33671736|NCT01407367|63107484|FG001|Overall Study|Lost to Follow-up|2|||
33671737|NCT01405027|63107520|FG000|Overall Study|Withdrawn consent|3|||
33671738|NCT01405027|63107521|FG001|Overall Study|Withdrawn consent|0|||
33671739|NCT01405027|63107520|FG000|Overall Study|Lost to Follow-up|16|||
33671740|NCT01405027|63107521|FG001|Overall Study|Lost to Follow-up|24|||
33671741|NCT01405027|63107520|FG000|Overall Study|Investigator judgement|0|||
33671742|NCT01405027|63107521|FG001|Overall Study|Investigator judgement|2|||
33671743|NCT01405027|63107520|FG000|Overall Study|Death|1|||
33671744|NCT01405027|63107521|FG001|Overall Study|Death|0|||
33671745|NCT01405027|63107520|FG000|Overall Study|Other or Unknown|12|||
33671746|NCT01405027|63107521|FG001|Overall Study|Other or Unknown|25|||
33671747|NCT01412801|63107542|FG000|Overall Study|Death|0|||
33671748|NCT01412801|63107543|FG001|Overall Study|Death|1|||
33671749|NCT01412801|63107544|FG002|Overall Study|Death|0|||
33671750|NCT01412801|63107545|FG003|Overall Study|Death|4|||
33671751|NCT01412801|63107546|FG004|Overall Study|Death|2|||
33671752|NCT01412801|63107547|FG005|Overall Study|Death|2|||
33671753|NCT01412801|63107542|FG000|Overall Study|Lost to Follow-up|1|||
33671754|NCT01412801|63107543|FG001|Overall Study|Lost to Follow-up|2|||
33671755|NCT01412801|63107544|FG002|Overall Study|Lost to Follow-up|4|||
33671756|NCT01412801|63107545|FG003|Overall Study|Lost to Follow-up|0|||
33671757|NCT01412801|63107546|FG004|Overall Study|Lost to Follow-up|1|||
33671758|NCT01412801|63107547|FG005|Overall Study|Lost to Follow-up|1|||
33671759|NCT01412801|63107542|FG000|Overall Study|Withdrawal by Subject|3|||
33671760|NCT01412801|63107543|FG001|Overall Study|Withdrawal by Subject|2|||
33671761|NCT01412801|63107544|FG002|Overall Study|Withdrawal by Subject|1|||
33671762|NCT01412801|63107545|FG003|Overall Study|Withdrawal by Subject|0|||
33671763|NCT01412801|63107546|FG004|Overall Study|Withdrawal by Subject|0|||
33671764|NCT01412801|63107547|FG005|Overall Study|Withdrawal by Subject|0|||
33671765|NCT01412801|63107542|FG000|Overall Study|Relocated to another area|0|||
33671766|NCT01412801|63107543|FG001|Overall Study|Relocated to another area|0|||
33671767|NCT01412801|63107544|FG002|Overall Study|Relocated to another area|2|||
33671768|NCT01412801|63107545|FG003|Overall Study|Relocated to another area|0|||
33671769|NCT01412801|63107546|FG004|Overall Study|Relocated to another area|0|||
33671770|NCT01412801|63107547|FG005|Overall Study|Relocated to another area|0|||
33671771|NCT01525628|63107595|FG000|Overall Study|Adverse Event|1|||
33671772|NCT01525628|63107596|FG001|Overall Study|Adverse Event|1|||
33671773|NCT01525628|63107597|FG002|Overall Study|Adverse Event|2|||
33671774|NCT01525628|63107598|FG003|Overall Study|Adverse Event|0|||
33671775|NCT01525628|63107599|FG004|Overall Study|Adverse Event|1|||
33671776|NCT01525628|63107595|FG000|Overall Study|Lack of Efficacy|0|||
33671777|NCT01525628|63107596|FG001|Overall Study|Lack of Efficacy|2|||
33671778|NCT01525628|63107597|FG002|Overall Study|Lack of Efficacy|2|||
33671779|NCT01525628|63107598|FG003|Overall Study|Lack of Efficacy|1|||
33671780|NCT01525628|63107599|FG004|Overall Study|Lack of Efficacy|2|||
33671781|NCT01525628|63107595|FG000|Overall Study|Protocol Violation|0|||
33671782|NCT01525628|63107596|FG001|Overall Study|Protocol Violation|0|||
33671783|NCT01525628|63107597|FG002|Overall Study|Protocol Violation|1|||
33671784|NCT01525628|63107598|FG003|Overall Study|Protocol Violation|0|||
33671785|NCT01525628|63107599|FG004|Overall Study|Protocol Violation|0|||
33671786|NCT01525628|63107595|FG000|Overall Study|Lost to Follow-up|1|||
33671787|NCT01525628|63107596|FG001|Overall Study|Lost to Follow-up|1|||
33671788|NCT01525628|63107597|FG002|Overall Study|Lost to Follow-up|0|||
33671789|NCT01525628|63107598|FG003|Overall Study|Lost to Follow-up|0|||
33671790|NCT01525628|63107599|FG004|Overall Study|Lost to Follow-up|0|||
33671791|NCT01525628|63107595|FG000|Overall Study|Withdrawal by Subject|0|||
33671792|NCT01525628|63107596|FG001|Overall Study|Withdrawal by Subject|1|||
33671793|NCT01525628|63107597|FG002|Overall Study|Withdrawal by Subject|0|||
33671794|NCT01525628|63107598|FG003|Overall Study|Withdrawal by Subject|0|||
33671795|NCT01525628|63107599|FG004|Overall Study|Withdrawal by Subject|0|||
33671796|NCT01525628|63107595|FG000|Overall Study|Other reason not defined above|0|||
33671797|NCT01525628|63107596|FG001|Overall Study|Other reason not defined above|0|||
33671798|NCT01525628|63107597|FG002|Overall Study|Other reason not defined above|0|||
33671799|NCT01525628|63107598|FG003|Overall Study|Other reason not defined above|3|||
33671800|NCT01525628|63107599|FG004|Overall Study|Other reason not defined above|0|||
33671801|NCT01412021|63107613|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
33671802|NCT01412021|63107613|FG000|Overall Study|Treatment Prior to Approval|3|||
33671803|NCT01412021|63107613|FG000|Overall Study|Transferred to Other Hospital|9|||
33671804|NCT01426789|63107619|FG000|Part 1|Protocol deviation|0|||
33671805|NCT01426789|63107620|FG001|Part 1|Protocol deviation|1|||
33671806|NCT01426789|63107621|FG002|Part 1|Protocol deviation|0|||
33671807|NCT01426789|63107622|FG003|Part 1|Protocol deviation|0|||
33671808|NCT01426789|63107623|FG004|Part 1|Protocol deviation|0|||
33671809|NCT01426789|63107624|FG005|Part 1|Protocol deviation|0|||
33671810|NCT01426789|63107619|FG000|Part 1|Lost to Follow-up|1|||
33671811|NCT01426789|63107620|FG001|Part 1|Lost to Follow-up|2|||
33671812|NCT01426789|63107621|FG002|Part 1|Lost to Follow-up|0|||
33671813|NCT01426789|63107622|FG003|Part 1|Lost to Follow-up|0|||
33671814|NCT01426789|63107623|FG004|Part 1|Lost to Follow-up|0|||
33671815|NCT01426789|63107624|FG005|Part 1|Lost to Follow-up|0|||
33671816|NCT01426789|63107619|FG000|Part 1|Lack of Efficacy|2|||
33671817|NCT01426789|63107620|FG001|Part 1|Lack of Efficacy|1|||
33671818|NCT01426789|63107621|FG002|Part 1|Lack of Efficacy|0|||
33671819|NCT01426789|63107622|FG003|Part 1|Lack of Efficacy|0|||
33671820|NCT01426789|63107623|FG004|Part 1|Lack of Efficacy|0|||
33671821|NCT01426789|63107624|FG005|Part 1|Lack of Efficacy|0|||
33671822|NCT01426789|63107619|FG000|Part 1|Adverse Event|3|||
33671823|NCT01426789|63107620|FG001|Part 1|Adverse Event|0|||
33671824|NCT01426789|63107621|FG002|Part 1|Adverse Event|0|||
33671825|NCT01426789|63107622|FG003|Part 1|Adverse Event|0|||
33671826|NCT01426789|63107623|FG004|Part 1|Adverse Event|0|||
33671827|NCT01426789|63107624|FG005|Part 1|Adverse Event|0|||
33671828|NCT01426789|63107619|FG000|Part 2|Protocol deviation|0|||
33671829|NCT01426789|63107620|FG001|Part 2|Protocol deviation|0|||
33671830|NCT01426789|63107621|FG002|Part 2|Protocol deviation|1|||
33671831|NCT01426789|63107622|FG003|Part 2|Protocol deviation|0|||
33671832|NCT01426789|63107623|FG004|Part 2|Protocol deviation|0|||
33671833|NCT01426789|63107624|FG005|Part 2|Protocol deviation|0|||
33671834|NCT01426789|63107619|FG000|Part 2|Death|0|||
33671835|NCT01426789|63107620|FG001|Part 2|Death|0|||
33671836|NCT01426789|63107621|FG002|Part 2|Death|1|||
33671837|NCT01426789|63107622|FG003|Part 2|Death|0|||
33671838|NCT01426789|63107623|FG004|Part 2|Death|1|||
33671839|NCT01426789|63107624|FG005|Part 2|Death|0|||
33671840|NCT01426789|63107619|FG000|Part 2|Administrative problems|0|||
33671841|NCT01426789|63107620|FG001|Part 2|Administrative problems|0|||
33671842|NCT01426789|63107621|FG002|Part 2|Administrative problems|2|||
33671843|NCT01426789|63107622|FG003|Part 2|Administrative problems|0|||
33671844|NCT01426789|63107623|FG004|Part 2|Administrative problems|1|||
33671845|NCT01426789|63107624|FG005|Part 2|Administrative problems|0|||
33671846|NCT01426789|63107619|FG000|Part 2|Lost to Follow-up|0|||
33671847|NCT01426789|63107620|FG001|Part 2|Lost to Follow-up|0|||
33671848|NCT01426789|63107621|FG002|Part 2|Lost to Follow-up|4|||
33671849|NCT01426789|63107622|FG003|Part 2|Lost to Follow-up|0|||
33671850|NCT01426789|63107623|FG004|Part 2|Lost to Follow-up|1|||
33671851|NCT01426789|63107624|FG005|Part 2|Lost to Follow-up|0|||
33671852|NCT01426789|63107619|FG000|Part 2|Withdrawal by Subject|0|||
33671853|NCT01426789|63107620|FG001|Part 2|Withdrawal by Subject|0|||
33671854|NCT01426789|63107621|FG002|Part 2|Withdrawal by Subject|0|||
33671855|NCT01426789|63107622|FG003|Part 2|Withdrawal by Subject|1|||
33671856|NCT01426789|63107623|FG004|Part 2|Withdrawal by Subject|2|||
33671857|NCT01426789|63107624|FG005|Part 2|Withdrawal by Subject|0|||
33671858|NCT01426789|63107619|FG000|Part 2|Lack of Efficacy|0|||
33671859|NCT01426789|63107620|FG001|Part 2|Lack of Efficacy|0|||
33671860|NCT01426789|63107621|FG002|Part 2|Lack of Efficacy|5|||
33671861|NCT01426789|63107622|FG003|Part 2|Lack of Efficacy|0|||
33671862|NCT01426789|63107623|FG004|Part 2|Lack of Efficacy|2|||
33671863|NCT01426789|63107624|FG005|Part 2|Lack of Efficacy|0|||
33671864|NCT01426789|63107619|FG000|Part 2|Adverse Event|0|||
33671865|NCT01426789|63107620|FG001|Part 2|Adverse Event|0|||
33671866|NCT01426789|63107621|FG002|Part 2|Adverse Event|2|||
33671867|NCT01426789|63107622|FG003|Part 2|Adverse Event|0|||
33309669|NCT01286558|62685102|FG001|Overall Study|Adverse Event|1|||
33309670|NCT01286558|62685101|FG000|Overall Study|Withdrawal by Subject|0|||
33309671|NCT01286558|62685102|FG001|Overall Study|Withdrawal by Subject|1|||
33309672|NCT01169103|62685110|FG000|Overall Study|Lost to Follow-up|3|||
33309673|NCT01169103|62685111|FG001|Overall Study|Lost to Follow-up|3|||
33309674|NCT01169103|62685110|FG000|Overall Study|Withdrawal by Subject|3|||
33309675|NCT01169103|62685111|FG001|Overall Study|Withdrawal by Subject|1|||
33309676|NCT01286480|62685119|FG000|Overall Study|Withdrawal by Subject|5|||
33309677|NCT01286480|62685120|FG001|Overall Study|Withdrawal by Subject|3|||
33309678|NCT01286168|62685126|FG000|Overall Study|Withdrawal by Subject|1|||
33309679|NCT01286168|62685126|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
33309680|NCT01286012|62685133|FG000|Overall Study|Adverse Event|3|||
33309681|NCT01286012|62685134|FG001|Overall Study|Adverse Event|3|||
33309682|NCT01286012|62685133|FG000|Overall Study|Death|2|||
33309683|NCT01286012|62685134|FG001|Overall Study|Death|3|||
33309684|NCT01286012|62685133|FG000|Overall Study|Protocol Violation|1|||
33309685|NCT01286012|62685134|FG001|Overall Study|Protocol Violation|1|||
33309686|NCT01286012|62685133|FG000|Overall Study|Withdrawal by Subject|4|||
33309687|NCT01286012|62685134|FG001|Overall Study|Withdrawal by Subject|4|||
33309688|NCT01286012|62685133|FG000|Overall Study|Physician Decision|2|||
33309689|NCT01286012|62685134|FG001|Overall Study|Physician Decision|0|||
33309690|NCT01286012|62685133|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
33309691|NCT01286012|62685134|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
33309692|NCT00963547|62685145|FG000|Overall Study|Adverse Event|0|||
33309693|NCT00963547|62685146|FG001|Overall Study|Adverse Event|1|||
33309694|NCT00963547|62685147|FG002|Overall Study|Adverse Event|0|||
33309695|NCT00963547|62685148|FG003|Overall Study|Adverse Event|1|||
33309696|NCT00963547|62685149|FG004|Overall Study|Adverse Event|0|||
33309697|NCT00963547|62685150|FG005|Overall Study|Adverse Event|0|||
33309698|NCT00963547|62685151|FG006|Overall Study|Adverse Event|0|||
33309699|NCT00963547|62685145|FG000|Overall Study|Physician Decision|1|||
33309700|NCT00963547|62685146|FG001|Overall Study|Physician Decision|1|||
33309701|NCT00963547|62685147|FG002|Overall Study|Physician Decision|0|||
33309702|NCT00963547|62685148|FG003|Overall Study|Physician Decision|0|||
33309703|NCT00963547|62685149|FG004|Overall Study|Physician Decision|0|||
33309704|NCT00963547|62685150|FG005|Overall Study|Physician Decision|0|||
33309705|NCT00963547|62685151|FG006|Overall Study|Physician Decision|0|||
33309706|NCT00963547|62685145|FG000|Overall Study|Progressive Disease|3|||
33309707|NCT00963547|62685146|FG001|Overall Study|Progressive Disease|8|||
33309708|NCT00963547|62685147|FG002|Overall Study|Progressive Disease|9|||
33309709|NCT00963547|62685148|FG003|Overall Study|Progressive Disease|5|||
33309710|NCT00963547|62685149|FG004|Overall Study|Progressive Disease|0|||
33309711|NCT00963547|62685150|FG005|Overall Study|Progressive Disease|0|||
33309712|NCT00963547|62685151|FG006|Overall Study|Progressive Disease|0|||
33671868|NCT01426789|63107623|FG004|Part 2|Adverse Event|1|||
33671869|NCT01426789|63107624|FG005|Part 2|Adverse Event|0|||
33309713|NCT00963547|62685145|FG000|Overall Study|Withdrawal by Subject|0|||
33309714|NCT00963547|62685146|FG001|Overall Study|Withdrawal by Subject|0|||
33309715|NCT00963547|62685147|FG002|Overall Study|Withdrawal by Subject|3|||
33309716|NCT00963547|62685148|FG003|Overall Study|Withdrawal by Subject|0|||
33309717|NCT00963547|62685149|FG004|Overall Study|Withdrawal by Subject|0|||
33309718|NCT00963547|62685150|FG005|Overall Study|Withdrawal by Subject|0|||
33309719|NCT00963547|62685151|FG006|Overall Study|Withdrawal by Subject|0|||
33671870|NCT01426009|63107645|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
33671871|NCT01426009|63107645|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
33309720|NCT00963547|62685145|FG000|Overall Study|Reason Unknown|0|||
33309721|NCT00963547|62685146|FG001|Overall Study|Reason Unknown|1|||
33309722|NCT00963547|62685147|FG002|Overall Study|Reason Unknown|0|||
33309723|NCT00963547|62685148|FG003|Overall Study|Reason Unknown|0|||
33309724|NCT00963547|62685149|FG004|Overall Study|Reason Unknown|0|||
33309725|NCT00963547|62685150|FG005|Overall Study|Reason Unknown|0|||
33309726|NCT00963547|62685151|FG006|Overall Study|Reason Unknown|0|||
33309727|NCT01285310|62685167|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
33309728|NCT01285310|62685168|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
33309729|NCT01285310|62685169|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
33309730|NCT01285310|62685170|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
33309731|NCT01285310|62685171|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
33309732|NCT01285310|62685167|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
33309733|NCT01285310|62685168|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
33309734|NCT01285310|62685169|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
33309735|NCT01285310|62685170|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
33309736|NCT01285310|62685171|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
33309737|NCT01285310|62685167|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
33309738|NCT01285310|62685168|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
33309739|NCT01285310|62685169|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
33309740|NCT01285310|62685170|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
33309741|NCT01285310|62685171|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
33309742|NCT01285310|62685167|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
33309743|NCT01285310|62685168|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
33309744|NCT01285310|62685169|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
33309745|NCT01285310|62685170|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
33309746|NCT01285310|62685171|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
33309747|NCT01285310|62685167|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
33309748|NCT01285310|62685168|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
33309749|NCT01285310|62685169|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
33309750|NCT01285310|62685170|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
33309751|NCT01285310|62685171|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
33309752|NCT01285310|62685167|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
33309753|NCT01285310|62685168|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
33309754|NCT01285310|62685169|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
33309755|NCT01285310|62685170|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
33309756|NCT01285310|62685171|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
33309757|NCT01285310|62685167|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
33309758|NCT01285310|62685168|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
33309759|NCT01285310|62685169|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
33309760|NCT01285310|62685170|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
33309761|NCT01285310|62685171|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
33309762|NCT01285310|62685167|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
33309763|NCT01285310|62685168|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
33309764|NCT01285310|62685169|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
33309765|NCT01285310|62685170|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
33309766|NCT01285310|62685171|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
33309767|NCT01285310|62685167|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
33309768|NCT01285310|62685168|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
33309769|NCT01285310|62685169|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
33309770|NCT01285310|62685170|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
33309771|NCT01285310|62685171|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
33309772|NCT01285310|62685167|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
33309773|NCT01285310|62685168|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
33309774|NCT01285310|62685169|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
33309775|NCT01285310|62685170|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
33309776|NCT01285310|62685171|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
33309777|NCT01285310|62685167|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
33309778|NCT01285310|62685168|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
33309779|NCT01285310|62685169|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
33309780|NCT01285310|62685170|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
33309781|NCT01285310|62685171|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
33309782|NCT01285310|62685167|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
33309783|NCT01285310|62685168|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
33309784|NCT01285310|62685169|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
33309785|NCT01285310|62685170|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
33309786|NCT01285310|62685171|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
33309787|NCT01254630|62685213|FG000|Overall Study|Adverse Event|36|||
33309788|NCT01254630|62685214|FG001|Overall Study|Adverse Event|15|||
33309789|NCT01254630|62685215|FG002|Overall Study|Adverse Event|40|||
33309790|NCT01254630|62685216|FG003|Overall Study|Adverse Event|8|||
33309791|NCT01254630|62685213|FG000|Overall Study|Death|461|||
33309792|NCT01254630|62685214|FG001|Overall Study|Death|151|||
33309793|NCT01254630|62685215|FG002|Overall Study|Death|478|||
33309794|NCT01254630|62685216|FG003|Overall Study|Death|139|||
33309795|NCT01254630|62685213|FG000|Overall Study|Lost to Follow-up|80|||
33309796|NCT01254630|62685214|FG001|Overall Study|Lost to Follow-up|26|||
33309797|NCT01254630|62685215|FG002|Overall Study|Lost to Follow-up|89|||
33309798|NCT01254630|62685216|FG003|Overall Study|Lost to Follow-up|32|||
33309799|NCT01254630|62685213|FG000|Overall Study|Physician Decision|24|||
33309800|NCT01254630|62685214|FG001|Overall Study|Physician Decision|8|||
33309801|NCT01254630|62685215|FG002|Overall Study|Physician Decision|16|||
33309802|NCT01254630|62685216|FG003|Overall Study|Physician Decision|7|||
33309803|NCT01254630|62685213|FG000|Overall Study|Withdrawal by Subject|201|||
33309804|NCT01254630|62685214|FG001|Overall Study|Withdrawal by Subject|94|||
33309805|NCT01254630|62685215|FG002|Overall Study|Withdrawal by Subject|188|||
33309806|NCT01254630|62685216|FG003|Overall Study|Withdrawal by Subject|89|||
33309807|NCT01254630|62685213|FG000|Overall Study|Study terminated by sponsor|0|||
33309808|NCT01254630|62685214|FG001|Overall Study|Study terminated by sponsor|994|||
33309809|NCT01254630|62685215|FG002|Overall Study|Study terminated by sponsor|0|||
33309810|NCT01254630|62685216|FG003|Overall Study|Study terminated by sponsor|1010|||
33309811|NCT01254630|62685213|FG000|Overall Study|Status not recorded|0|||
33309812|NCT01254630|62685214|FG001|Overall Study|Status not recorded|0|||
33309813|NCT01254630|62685215|FG002|Overall Study|Status not recorded|1|||
33309814|NCT01254630|62685216|FG003|Overall Study|Status not recorded|0|||
33309815|NCT01284140|62685226|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
33309816|NCT01284140|62685227|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
33309817|NCT01284140|62685226|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
33309818|NCT01284140|62685227|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
33309819|NCT01254318|62685233|FG000|Overall Study|Lost to Follow-up|5|||
33309820|NCT01254318|62685233|FG000|Overall Study|Death|47|||
33309821|NCT01284062|62685241|FG000|Overall Study|Adverse Event|4|||
33309822|NCT01284062|62685242|FG001|Overall Study|Adverse Event|5|||
33309823|NCT01284062|62685243|FG002|Overall Study|Adverse Event|0|||
33309824|NCT01284062|62685244|FG003|Overall Study|Adverse Event|5|||
33309825|NCT01284062|62685241|FG000|Overall Study|Lack of Efficacy|3|||
33309826|NCT01284062|62685242|FG001|Overall Study|Lack of Efficacy|2|||
33309827|NCT01284062|62685243|FG002|Overall Study|Lack of Efficacy|2|||
33309828|NCT01284062|62685244|FG003|Overall Study|Lack of Efficacy|1|||
33309829|NCT01284062|62685241|FG000|Overall Study|Medication error without adverse event|0|||
33309830|NCT01284062|62685242|FG001|Overall Study|Medication error without adverse event|0|||
33309831|NCT01284062|62685243|FG002|Overall Study|Medication error without adverse event|1|||
33309832|NCT01284062|62685244|FG003|Overall Study|Medication error without adverse event|0|||
33309833|NCT01284062|62685241|FG000|Overall Study|Protocol Violation|1|||
33309834|NCT01284062|62685242|FG001|Overall Study|Protocol Violation|0|||
33309835|NCT01284062|62685243|FG002|Overall Study|Protocol Violation|0|||
33309836|NCT01284062|62685244|FG003|Overall Study|Protocol Violation|2|||
33309837|NCT01284062|62685241|FG000|Overall Study|Withdrawal by Subject|3|||
33309838|NCT01284062|62685242|FG001|Overall Study|Withdrawal by Subject|1|||
33309839|NCT01284062|62685243|FG002|Overall Study|Withdrawal by Subject|2|||
33309840|NCT01284062|62685244|FG003|Overall Study|Withdrawal by Subject|5|||
33309841|NCT01284062|62685241|FG000|Overall Study|Other|0|||
33309842|NCT01284062|62685242|FG001|Overall Study|Other|0|||
33309843|NCT01284062|62685243|FG002|Overall Study|Other|0|||
33309844|NCT01284062|62685244|FG003|Overall Study|Other|1|||
33309845|NCT01284062|62685241|FG000|Overall Study|Site Closed|0|||
33309846|NCT01284062|62685242|FG001|Overall Study|Site Closed|0|||
33309847|NCT01284062|62685243|FG002|Overall Study|Site Closed|1|||
33309848|NCT01284062|62685244|FG003|Overall Study|Site Closed|0|||
33309849|NCT01253304|62685261|FG000|Overall Study|Adverse Event|0|||
33309850|NCT01253304|62685262|FG001|Overall Study|Adverse Event|0|||
33309851|NCT01253304|62685263|FG002|Overall Study|Adverse Event|0|||
33309852|NCT01253304|62685264|FG003|Overall Study|Adverse Event|1|||
33309853|NCT01253226|62685279|FG000|Overall Study|Adverse Event|0|||
33309854|NCT01253226|62685280|FG001|Overall Study|Adverse Event|0|||
33309855|NCT01253226|62685281|FG002|Overall Study|Adverse Event|1|||
33309856|NCT01253226|62685282|FG003|Overall Study|Adverse Event|0|||
33309857|NCT01253226|62685283|FG004|Overall Study|Adverse Event|0|||
33309858|NCT01253226|62685279|FG000|Overall Study|Death|0|||
33309859|NCT01253226|62685280|FG001|Overall Study|Death|1|||
33309860|NCT01253226|62685281|FG002|Overall Study|Death|0|||
33309861|NCT01253226|62685282|FG003|Overall Study|Death|0|||
33309862|NCT01253226|62685283|FG004|Overall Study|Death|0|||
33309863|NCT01253226|62685279|FG000|Overall Study|Physician Decision|0|||
33309864|NCT01253226|62685280|FG001|Overall Study|Physician Decision|0|||
33309865|NCT01253226|62685281|FG002|Overall Study|Physician Decision|0|||
33309866|NCT01253226|62685282|FG003|Overall Study|Physician Decision|0|||
33309867|NCT01253226|62685283|FG004|Overall Study|Physician Decision|2|||
33309868|NCT01253226|62685279|FG000|Overall Study|Withdrawal by Subject|0|||
33309869|NCT01253226|62685280|FG001|Overall Study|Withdrawal by Subject|0|||
33309870|NCT01253226|62685281|FG002|Overall Study|Withdrawal by Subject|0|||
33309871|NCT01253226|62685282|FG003|Overall Study|Withdrawal by Subject|1|||
33309872|NCT01253226|62685283|FG004|Overall Study|Withdrawal by Subject|0|||
33309873|NCT01252290|62685295|FG000|Overall Study|Withdrawal by Subject|1|||
33309874|NCT01252134|62685299|FG000|Period 1, 8 Hours|Personal Reasons|0|||
33309875|NCT01252134|62685300|FG001|Period 1, 8 Hours|Personal Reasons|1|||
33309876|NCT01252134|62685301|FG002|Period 1, 8 Hours|Personal Reasons|1|||
33309877|NCT01252134|62685302|FG003|Period 1, 8 Hours|Personal Reasons|0|||
33309878|NCT01252134|62685303|FG004|Period 1, 8 Hours|Personal Reasons|0|||
33309879|NCT01252134|62685304|FG005|Period 1, 8 Hours|Personal Reasons|0|||
33309880|NCT01251744|62685314|FG000|Overall Study|Lost to Follow-up|1|||
33309881|NCT01251744|62685315|FG001|Overall Study|Lost to Follow-up|0|||
33309882|NCT01251354|62685328|FG000|Overall Study|Adverse Event|1|||
33309883|NCT01251354|62685328|FG000|Overall Study|Investigator's Decision|1|||
33309884|NCT01251354|62685328|FG000|Overall Study|Disease Progression|4|||
33309885|NCT01251276|62685334|FG000|Overall Study|Protocol Violation|1|||
33309886|NCT01251276|62685335|FG001|Overall Study|Protocol Violation|0|||
33309887|NCT01251276|62685334|FG000|Overall Study|Lost to Follow-up|0|||
33309888|NCT01251276|62685335|FG001|Overall Study|Lost to Follow-up|1|||
33309889|NCT01251120|62685343|FG000|Overall Study|Lack of Efficacy|0|||
33309890|NCT01251120|62685344|FG001|Overall Study|Lack of Efficacy|1|||
33309891|NCT01250418|62685352|FG000|Overall Study|monitor data failure|1|||
33309892|NCT01250418|62685353|FG001|Overall Study|monitor data failure|1|||
33309893|NCT01292603|62685364|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
33309894|NCT01292603|62685365|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
33309895|NCT01292603|62685366|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
33309896|NCT01292603|62685367|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
33309897|NCT01292603|62685368|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
33309898|NCT01292603|62685369|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
33309899|NCT01292603|62685364|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
33309900|NCT01292603|62685365|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
33309901|NCT01292603|62685366|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
33309902|NCT01292603|62685367|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
33309903|NCT01292603|62685368|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
33309904|NCT01292603|62685369|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
33309905|NCT01292603|62685364|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
33309906|NCT01292603|62685365|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
33309907|NCT01292603|62685366|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
33309908|NCT01292603|62685367|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
33309909|NCT01292603|62685368|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
33309910|NCT01292603|62685369|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
33309911|NCT01292603|62685364|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
33309912|NCT01292603|62685365|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
33309913|NCT01292603|62685366|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
33309914|NCT01292603|62685367|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
33309915|NCT01292603|62685368|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
33309916|NCT01292603|62685369|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
33309917|NCT01292603|62685364|FG000|Part 1: Regular Follow-Up Period|Death|3|||
33309918|NCT01292603|62685365|FG001|Part 1: Regular Follow-Up Period|Death|1|||
33309919|NCT01292603|62685366|FG002|Part 1: Regular Follow-Up Period|Death|3|||
33309920|NCT01292603|62685367|FG003|Part 1: Regular Follow-Up Period|Death|1|||
33309921|NCT01292603|62685368|FG004|Part 1: Regular Follow-Up Period|Death|0|||
33309922|NCT01292603|62685369|FG005|Part 1: Regular Follow-Up Period|Death|0|||
33309923|NCT01292603|62685364|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
33309924|NCT01292603|62685365|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
33309925|NCT01292603|62685366|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
33309926|NCT01292603|62685367|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
33309927|NCT01292603|62685368|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
33309928|NCT01292603|62685369|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
33309929|NCT01292603|62685364|FG000|Part 2: Dose Confirmation Period|Death|0|||
33309930|NCT01292603|62685365|FG001|Part 2: Dose Confirmation Period|Death|0|||
33309931|NCT01292603|62685366|FG002|Part 2: Dose Confirmation Period|Death|0|||
33309932|NCT01292603|62685367|FG003|Part 2: Dose Confirmation Period|Death|0|||
33309933|NCT01292603|62685368|FG004|Part 2: Dose Confirmation Period|Death|1|||
33309934|NCT01292603|62685369|FG005|Part 2: Dose Confirmation Period|Death|0|||
33309935|NCT01292603|62685364|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
33309936|NCT01292603|62685365|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
33309937|NCT01292603|62685366|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
33309938|NCT01292603|62685367|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
33309939|NCT01292603|62685368|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
33309940|NCT01292603|62685369|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
33309941|NCT01292603|62685364|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
33309942|NCT01292603|62685365|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
33309943|NCT01292603|62685366|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
33309944|NCT01292603|62685367|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
33309945|NCT01292603|62685368|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
33309946|NCT01292603|62685369|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
33309947|NCT01292603|62685364|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
33309948|NCT01292603|62685365|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
33309949|NCT01292603|62685366|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
33309950|NCT01292603|62685367|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
33309951|NCT01292603|62685368|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
33309952|NCT01292603|62685369|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
33309953|NCT01292603|62685364|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
33309954|NCT01292603|62685365|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
33309955|NCT01292603|62685366|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
33309956|NCT01292603|62685367|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
33309957|NCT01292603|62685368|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
33309958|NCT01292603|62685369|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
33309959|NCT01292603|62685364|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
33309960|NCT01292603|62685365|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
33309961|NCT01292603|62685366|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
33309962|NCT01292603|62685367|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
33309963|NCT01292603|62685368|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
33309964|NCT01292603|62685369|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
33309965|NCT01292603|62685364|FG000|Part 2: Regular Follow-Up|Death|0|||
33309966|NCT01292603|62685365|FG001|Part 2: Regular Follow-Up|Death|0|||
33309967|NCT01292603|62685366|FG002|Part 2: Regular Follow-Up|Death|0|||
33309968|NCT01292603|62685367|FG003|Part 2: Regular Follow-Up|Death|0|||
33309969|NCT01292603|62685368|FG004|Part 2: Regular Follow-Up|Death|6|||
33309970|NCT01292603|62685369|FG005|Part 2: Regular Follow-Up|Death|3|||
33309971|NCT01292603|62685364|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
33309972|NCT01292603|62685365|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
33309973|NCT01292603|62685366|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
33309974|NCT01292603|62685367|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
33309975|NCT01292603|62685368|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
33309976|NCT01292603|62685369|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
33309977|NCT01292603|62685364|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
33309978|NCT01292603|62685365|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
33309979|NCT01292603|62685366|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
33309980|NCT01292603|62685367|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
33309981|NCT01292603|62685368|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
33309982|NCT01292603|62685369|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
33309983|NCT01292603|62685364|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
33309984|NCT01292603|62685365|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
33309985|NCT01292603|62685366|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
33309986|NCT01292603|62685367|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
33309987|NCT01292603|62685368|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
33309988|NCT01292603|62685369|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
33309989|NCT01292603|62685364|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
33309990|NCT01292603|62685365|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
33309991|NCT01292603|62685366|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
33309992|NCT01292603|62685367|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
33309993|NCT01292603|62685368|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
33309994|NCT01292603|62685369|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
33309995|NCT01292603|62685364|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
33309996|NCT01292603|62685365|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
33309997|NCT01292603|62685366|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
33309998|NCT01292603|62685367|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
33309999|NCT01292603|62685368|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
33310000|NCT01292603|62685369|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
33310001|NCT01292603|62685364|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
33310002|NCT01292603|62685365|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
33310003|NCT01292603|62685366|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
33310004|NCT01292603|62685367|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
33310005|NCT01292603|62685368|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
33310006|NCT01292603|62685369|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
33310007|NCT01292603|62685364|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
33310008|NCT01292603|62685365|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
33310009|NCT01292603|62685366|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
33310010|NCT01292603|62685367|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
33310011|NCT01292603|62685368|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
33310012|NCT01292603|62685369|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
33310013|NCT01292603|62685364|FG000|Overall Survival Status|Death|3|||
33310014|NCT01292603|62685365|FG001|Overall Survival Status|Death|1|||
33310015|NCT01292603|62685366|FG002|Overall Survival Status|Death|3|||
33310016|NCT01292603|62685367|FG003|Overall Survival Status|Death|1|||
33310017|NCT01292603|62685368|FG004|Overall Survival Status|Death|16|||
33310018|NCT01292603|62685369|FG005|Overall Survival Status|Death|10|||
33310019|NCT01292057|62685392|FG000|Overall Study|Protocol Violation|1|||
33310020|NCT01292057|62685393|FG001|Overall Study|Protocol Violation|1|||
33310021|NCT01292057|62685392|FG000|Overall Study|Lost to Follow-up|1|||
33310022|NCT01292057|62685393|FG001|Overall Study|Lost to Follow-up|1|||
33310023|NCT01291277|62685401|FG000|Overall Study|Death|2|||
33310024|NCT01291277|62685402|FG001|Overall Study|Death|2|||
33310025|NCT01291277|62685401|FG000|Overall Study|Lost to Follow-up|3|||
33310026|NCT01291277|62685402|FG001|Overall Study|Lost to Follow-up|1|||
33310027|NCT01290887|62685410|FG000|Overall Study|Adverse Event|6|||
33310028|NCT01290887|62685411|FG001|Overall Study|Adverse Event|11|||
33310029|NCT01290887|62685410|FG000|Overall Study|Lack of Efficacy|4|||
33310030|NCT01290887|62685411|FG001|Overall Study|Lack of Efficacy|5|||
33310031|NCT01290887|62685410|FG000|Overall Study|Withdrawal by Subject|26|||
33310032|NCT01290887|62685411|FG001|Overall Study|Withdrawal by Subject|32|||
33310033|NCT01290887|62685410|FG000|Overall Study|Protocol Violation|2|||
33310034|NCT01290887|62685411|FG001|Overall Study|Protocol Violation|1|||
33310035|NCT01290887|62685410|FG000|Overall Study|Lost to Follow-up|4|||
33310036|NCT01290887|62685411|FG001|Overall Study|Lost to Follow-up|4|||
33310037|NCT01290887|62685410|FG000|Overall Study|Non-compliance to study procedures|0|||
33310038|NCT01290887|62685411|FG001|Overall Study|Non-compliance to study procedures|1|||
33310039|NCT01290887|62685410|FG000|Overall Study|Non-compliance to study medications|1|||
33310040|NCT01290887|62685411|FG001|Overall Study|Non-compliance to study medications|0|||
33310041|NCT01290887|62685410|FG000|Overall Study|Sponsor closure of study|420|||
33310042|NCT01290887|62685411|FG001|Overall Study|Sponsor closure of study|476|||
33310043|NCT01290887|62685410|FG000|Overall Study|Other|3|||
33310044|NCT01290887|62685411|FG001|Overall Study|Other|6|||
33310045|NCT01290731|62685417|FG000|Overall Study|Withdrawal by Subject|1|||
33310046|NCT01290341|62685423|FG000|Overall Study|Protocol Violation|7|||
33310047|NCT01290341|62685424|FG001|Overall Study|Protocol Violation|3|||
33310048|NCT01290341|62685423|FG000|Overall Study|Adverse Event|1|||
33310049|NCT01290341|62685424|FG001|Overall Study|Adverse Event|0|||
33310050|NCT01290341|62685423|FG000|Overall Study|Lost to Follow-up|21|||
33310051|NCT01290341|62685424|FG001|Overall Study|Lost to Follow-up|10|||
33310052|NCT01290341|62685423|FG000|Overall Study|Withdrawal by Subject|19|||
33310053|NCT01290341|62685424|FG001|Overall Study|Withdrawal by Subject|5|||
33310054|NCT01290341|62685423|FG000|Overall Study|Negative baseline culture and others|44|||
33310055|NCT01290341|62685424|FG001|Overall Study|Negative baseline culture and others|11|||
33310056|NCT01290263|62685432|FG000|Overall Study|Adverse Event|0|||
33310057|NCT01290263|62685433|FG001|Overall Study|Adverse Event|0|||
33310058|NCT01290263|62685434|FG002|Overall Study|Adverse Event|0|||
33310059|NCT01290263|62685435|FG003|Overall Study|Adverse Event|1|||
33310060|NCT01290263|62685436|FG004|Overall Study|Adverse Event|1|||
33310061|NCT01290263|62685432|FG000|Overall Study|Lack of Efficacy|8|||
33310062|NCT01290263|62685433|FG001|Overall Study|Lack of Efficacy|2|||
33580437|NCT04381494|62977426|FG000|Overall Study|Device-Related Adverse Event|2|||
33580438|NCT04094584|62977481|FG000|Overall Study|No interest in study|88|||
33580439|NCT04094584|62977481|FG000|Overall Study|Unwilling to undergo screening tests|36|||
33580440|NCT04094584|62977481|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
33580441|NCT04094584|62977481|FG000|Overall Study|Opioid use|7|||
33580442|NCT04094584|62977481|FG000|Overall Study|Need for major surgery in study period|4|||
33580443|NCT04094584|62977481|FG000|Overall Study|eligible but declined enrollment|4|||
33580444|NCT04094584|62977481|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
33580445|NCT04094584|62977481|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
33580446|NCT04094584|62977481|FG000|Overall Study|Lost to Follow-up|3|||
33580447|NCT04094584|62977481|FG000|Overall Study|Withdrawal by Subject|2|||
33580448|NCT04021290|62977496|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
33580449|NCT04021290|62977497|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
33580450|NCT04021290|62977498|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
33580451|NCT04021290|62977496|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
33580452|NCT04021290|62977497|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
33580453|NCT04021290|62977498|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
33580454|NCT04021290|62977496|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
33310063|NCT01290263|62685434|FG002|Overall Study|Lack of Efficacy|7|||
33310064|NCT01290263|62685435|FG003|Overall Study|Lack of Efficacy|24|||
33310065|NCT01290263|62685436|FG004|Overall Study|Lack of Efficacy|33|||
33580455|NCT04021290|62977497|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
33580456|NCT04021290|62977498|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
33580457|NCT04021290|62977496|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
33580458|NCT04021290|62977497|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
33580459|NCT04021290|62977498|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
33580460|NCT04021290|62977496|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
33580461|NCT04021290|62977497|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
33580462|NCT04021290|62977498|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
33580463|NCT04021290|62977496|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
33580464|NCT04021290|62977497|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
33580465|NCT04021290|62977498|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
33580466|NCT04021290|62977496|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
33580467|NCT04021290|62977497|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
33580468|NCT04021290|62977498|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
33580469|NCT04021290|62977496|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
33580470|NCT04021290|62977497|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
33580471|NCT04021290|62977498|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
33580472|NCT04021290|62977496|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
33580473|NCT04021290|62977497|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
33580474|NCT04021290|62977498|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
33580475|NCT04021290|62977496|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
33580476|NCT04021290|62977497|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
33580477|NCT04021290|62977498|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
33580478|NCT04021290|62977496|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
33580479|NCT04021290|62977497|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
33580480|NCT04021290|62977498|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
33580481|NCT04021290|62977496|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
33580482|NCT04021290|62977497|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
33580483|NCT04021290|62977498|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
33580484|NCT04020341|62977508|FG000|Overall Study|Adverse Event|8|||
33580485|NCT04020341|62977509|FG001|Overall Study|Adverse Event|6|||
33580486|NCT04020341|62977508|FG000|Overall Study|Lost to Follow-up|8|||
33580487|NCT04020341|62977509|FG001|Overall Study|Lost to Follow-up|2|||
33580488|NCT04020341|62977508|FG000|Overall Study|Withdrawal by Subject|16|||
33580489|NCT04020341|62977509|FG001|Overall Study|Withdrawal by Subject|16|||
33580490|NCT04020341|62977508|FG000|Overall Study|Participant not able to swallow the tablet|1|||
33580491|NCT04020341|62977509|FG001|Overall Study|Participant not able to swallow the tablet|0|||
33580492|NCT04020341|62977508|FG000|Overall Study|Physician Decision|0|||
33580493|NCT04020341|62977509|FG001|Overall Study|Physician Decision|2|||
33580494|NCT04020341|62977508|FG000|Overall Study|Protocol Deviation|0|||
33580495|NCT04020341|62977509|FG001|Overall Study|Protocol Deviation|2|||
33580496|NCT03868891|62977531|FG000|Overall Study|Adverse Event|1|||
33580497|NCT03868891|62977532|FG001|Overall Study|Adverse Event|0|||
33580498|NCT03868891|62977531|FG000|Overall Study|Lost to Follow-up|2|||
33580499|NCT03868891|62977532|FG001|Overall Study|Lost to Follow-up|1|||
33580500|NCT03868891|62977531|FG000|Overall Study|COVID-19 Restrictions|1|||
33580501|NCT03868891|62977532|FG001|Overall Study|COVID-19 Restrictions|2|||
33580502|NCT03827655|62977552|FG000|Overall Study|Death|0|||
33580503|NCT03827655|62977553|FG001|Overall Study|Death|0|||
33580504|NCT03827655|62977554|FG002|Overall Study|Death|0|||
33580505|NCT03827655|62977555|FG003|Overall Study|Death|0|||
33580506|NCT03827655|62977556|FG004|Overall Study|Death|1|||
33580507|NCT03827655|62977552|FG000|Overall Study|Protocol Deviation|1|||
33580508|NCT03827655|62977553|FG001|Overall Study|Protocol Deviation|0|||
33580509|NCT03827655|62977554|FG002|Overall Study|Protocol Deviation|1|||
33580510|NCT03827655|62977555|FG003|Overall Study|Protocol Deviation|1|||
33580511|NCT03827655|62977556|FG004|Overall Study|Protocol Deviation|0|||
33580512|NCT03827655|62977552|FG000|Overall Study|Withdrawal by Subject|3|||
33580513|NCT03827655|62977553|FG001|Overall Study|Withdrawal by Subject|2|||
33580514|NCT03827655|62977554|FG002|Overall Study|Withdrawal by Subject|2|||
33580515|NCT03827655|62977555|FG003|Overall Study|Withdrawal by Subject|0|||
33580516|NCT03827655|62977556|FG004|Overall Study|Withdrawal by Subject|1|||
33580517|NCT03827655|62977552|FG000|Overall Study|Reason not Specified|3|||
33580518|NCT03827655|62977553|FG001|Overall Study|Reason not Specified|1|||
33580519|NCT03827655|62977554|FG002|Overall Study|Reason not Specified|1|||
33580520|NCT03827655|62977555|FG003|Overall Study|Reason not Specified|1|||
33580521|NCT03827655|62977556|FG004|Overall Study|Reason not Specified|1|||
33580522|NCT03782064|62977591|FG000|Overall Study|Lack of Efficacy|2|||
33580523|NCT03782064|62977591|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
33580524|NCT03772522|62977597|FG000|Pre-intervention|Withdrawal by Subject|3|||
33580525|NCT03772522|62977598|FG001|Pre-intervention|Withdrawal by Subject|4|||
33580526|NCT03772522|62977597|FG000|Intervention|Withdrawal by Subject|1|||
33580527|NCT03772522|62977598|FG001|Intervention|Withdrawal by Subject|0|||
33580528|NCT03772522|62977597|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
33580529|NCT03772522|62977598|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
33580530|NCT03755518|62977608|FG000|Overall Study|Adverse Event|6|||
33580531|NCT03755518|62977608|FG000|Overall Study|Lack of Efficacy|6|||
33580532|NCT03755518|62977608|FG000|Overall Study|Bone Marrow Transplant|4|||
33580533|NCT03755518|62977608|FG000|Overall Study|Withdrawal by participant|4|||
33580534|NCT03755518|62977608|FG000|Overall Study|Progressive Disease|2|||
33580535|NCT03755518|62977608|FG000|Overall Study|Death|1|||
33580536|NCT03755518|62977608|FG000|Overall Study|Physician Decision|1|||
33580537|NCT03755518|62977608|FG000|Overall Study|Withdrawal by investigator for non compliance|1|||
33580538|NCT03739112|62977614|FG000|Overall Study|Adverse Event|2|||
33580539|NCT03739112|62977615|FG001|Overall Study|Adverse Event|2|||
33580540|NCT03739112|62977614|FG000|Overall Study|Withdrawal by Subject|38|||
33580541|NCT03739112|62977615|FG001|Overall Study|Withdrawal by Subject|19|||
33580542|NCT03739112|62977614|FG000|Overall Study|Lost to Follow-up|31|||
33580543|NCT03739112|62977615|FG001|Overall Study|Lost to Follow-up|33|||
33580544|NCT03739112|62977614|FG000|Overall Study|Protocol Deviation|12|||
33580545|NCT03739112|62977615|FG001|Overall Study|Protocol Deviation|9|||
33580546|NCT03739112|62977614|FG000|Overall Study|Physician Decision|1|||
33580547|NCT03739112|62977615|FG001|Overall Study|Physician Decision|0|||
33580548|NCT03739112|62977614|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
33580549|NCT03739112|62977615|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
33580550|NCT03739112|62977614|FG000|Overall Study|Site went on hold|65|||
33580551|NCT03739112|62977615|FG001|Overall Study|Site went on hold|67|||
33580552|NCT03739112|62977614|FG000|Overall Study|Other than specified|8|||
33580553|NCT03739112|62977615|FG001|Overall Study|Other than specified|5|||
33580554|NCT03739112|62977614|FG000|Overall Study|Randomized but not vaccinated|31|||
33580555|NCT03739112|62977615|FG001|Overall Study|Randomized but not vaccinated|25|||
33580556|NCT03622593|62977624|FG000|Overall Study|Withdrawal by Subject|11|||
33580557|NCT03622593|62977625|FG001|Overall Study|Withdrawal by Subject|9|||
33580558|NCT03622593|62977626|FG002|Overall Study|Withdrawal by Subject|13|||
33580559|NCT03622593|62977624|FG000|Overall Study|Death|12|||
33580560|NCT03622593|62977625|FG001|Overall Study|Death|9|||
33580561|NCT03622593|62977626|FG002|Overall Study|Death|10|||
33580562|NCT03622593|62977624|FG000|Overall Study|Lost to Follow-up|11|||
33580563|NCT03622593|62977625|FG001|Overall Study|Lost to Follow-up|5|||
33580564|NCT03622593|62977626|FG002|Overall Study|Lost to Follow-up|8|||
33580565|NCT03622593|62977624|FG000|Overall Study|Adverse Event|4|||
33580566|NCT03622593|62977625|FG001|Overall Study|Adverse Event|5|||
33580567|NCT03622593|62977626|FG002|Overall Study|Adverse Event|6|||
33580568|NCT03622593|62977624|FG000|Overall Study|Physician Decision|2|||
33580569|NCT03622593|62977625|FG001|Overall Study|Physician Decision|1|||
33580570|NCT03622593|62977626|FG002|Overall Study|Physician Decision|6|||
33580571|NCT03622593|62977624|FG000|Overall Study|Other|2|||
33580572|NCT03622593|62977625|FG001|Overall Study|Other|2|||
33580573|NCT03622593|62977626|FG002|Overall Study|Other|3|||
33580574|NCT03622593|62977624|FG000|Overall Study|Protocol Violation|0|||
33580575|NCT03622593|62977625|FG001|Overall Study|Protocol Violation|0|||
33580576|NCT03622593|62977626|FG002|Overall Study|Protocol Violation|1|||
33580577|NCT03622593|62977624|FG000|Overall Study|Pregnancy|0|||
33580578|NCT03622593|62977625|FG001|Overall Study|Pregnancy|0|||
33580579|NCT03622593|62977626|FG002|Overall Study|Pregnancy|1|||
33580580|NCT03593655|62977637|FG000|First Product Use Period|Withdrawal by Subject|1|||
33580581|NCT03593655|62977638|FG001|First Product Use Period|Withdrawal by Subject|1|||
33580582|NCT03593655|62977637|FG000|First Product Use Period|Lost to Follow-up|1|||
33580583|NCT03593655|62977638|FG001|First Product Use Period|Lost to Follow-up|3|||
33580584|NCT03593655|62977637|FG000|Second Product Use Period|Withdrawal by Subject|1|||
33580585|NCT03593655|62977638|FG001|Second Product Use Period|Withdrawal by Subject|1|||
33580586|NCT03593655|62977637|FG000|Second Product Use Period|Lost to Follow-up|1|||
33580587|NCT03593655|62977638|FG001|Second Product Use Period|Lost to Follow-up|0|||
33580588|NCT03593655|62977637|FG000|Third Product Use Period|Lost to Follow-up|1|||
33580589|NCT03593655|62977638|FG001|Third Product Use Period|Lost to Follow-up|2|||
33580590|NCT03593655|62977637|FG000|Third Product Use Period|Physician Decision|0|||
33580591|NCT03593655|62977638|FG001|Third Product Use Period|Physician Decision|1|||
33580592|NCT03593655|62977637|FG000|Third Product Use Period|Withdrawal by Subject|0|||
33580593|NCT03593655|62977638|FG001|Third Product Use Period|Withdrawal by Subject|1|||
33580594|NCT03577106|62977647|FG000|Overall Study|Withdrawal by Subject|3|||
33580595|NCT03534180|62977651|FG000|Overall Study|Withdrawal by Subject|1|||
33580596|NCT03364231|62977661|FG000|Overall Study|Adverse Event|1|||
33580597|NCT03364231|62977662|FG001|Overall Study|Adverse Event|4|||
33580598|NCT03364231|62977661|FG000|Overall Study|Death|1|||
33580599|NCT03364231|62977662|FG001|Overall Study|Death|0|||
33580600|NCT03364231|62977661|FG000|Overall Study|Investigator Decision|2|||
33580601|NCT03364231|62977662|FG001|Overall Study|Investigator Decision|2|||
33671872|NCT01426009|63107645|FG000|Washout 1|Withdrawal by Subject|1|||
33580602|NCT03364231|62977661|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
33580603|NCT03364231|62977662|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
33580604|NCT03364231|62977661|FG000|Overall Study|Withdrawal of Subject Consent|1|||
33580605|NCT03364231|62977662|FG001|Overall Study|Withdrawal of Subject Consent|0|||
33580606|NCT03364231|62977661|FG000|Overall Study|Reason Not Specified|1|||
33580607|NCT03364231|62977662|FG001|Overall Study|Reason Not Specified|0|||
33580608|NCT03364231|62977661|FG000|Overall Study|Disease Progression|0|||
33580609|NCT03364231|62977662|FG001|Overall Study|Disease Progression|6|||
33580610|NCT03303625|62977673|FG000|Overall Study|Withdrawal by Subject|2|||
33580611|NCT03303625|62977674|FG001|Overall Study|Withdrawal by Subject|0|||
33580612|NCT03303625|62977675|FG002|Overall Study|Withdrawal by Subject|0|||
33580613|NCT03303625|62977676|FG003|Overall Study|Withdrawal by Subject|0|||
33580614|NCT03299816|62977688|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
33580615|NCT03299816|62977689|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
33580616|NCT03299816|62977688|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
33580617|NCT03299816|62977689|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
33580618|NCT03299816|62977688|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
33580619|NCT03299816|62977689|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
33580620|NCT03291431|62977697|FG000|Overall Study|Protocol Violation|2|||
33580621|NCT03291431|62977698|FG001|Overall Study|Protocol Violation|1|||
33580622|NCT03291431|62977697|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
33580623|NCT03291431|62977698|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
33580624|NCT03291431|62977697|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
33580625|NCT03291431|62977698|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
33580626|NCT03288493|62977711|FG000|Overall Study|Withdrawal by Subject|4|||
33580627|NCT03288493|62977712|FG001|Overall Study|Withdrawal by Subject|0|||
33580628|NCT03288493|62977713|FG002|Overall Study|Withdrawal by Subject|0|||
33580629|NCT03288493|62977714|FG003|Overall Study|Withdrawal by Subject|0|||
33580630|NCT03288493|62977715|FG004|Overall Study|Withdrawal by Subject|0|||
33580631|NCT03288493|62977716|FG005|Overall Study|Withdrawal by Subject|2|||
33580632|NCT03288493|62977717|FG006|Overall Study|Withdrawal by Subject|0|||
33580633|NCT03288493|62977711|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
33580634|NCT03288493|62977712|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
33580635|NCT03288493|62977713|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
33580636|NCT03288493|62977714|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
33580637|NCT03288493|62977715|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
33580638|NCT03288493|62977716|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
33580639|NCT03288493|62977717|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
33580640|NCT03288493|62977711|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
33580641|NCT03288493|62977712|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
33580642|NCT03288493|62977713|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
33580643|NCT03288493|62977714|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
33580644|NCT03288493|62977715|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
33580645|NCT03288493|62977716|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
33580646|NCT03288493|62977717|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
33580647|NCT03288493|62977711|FG000|Overall Study|Death|2|||
33580648|NCT03288493|62977712|FG001|Overall Study|Death|0|||
33580649|NCT03288493|62977713|FG002|Overall Study|Death|0|||
33580650|NCT03288493|62977714|FG003|Overall Study|Death|0|||
33580651|NCT03288493|62977715|FG004|Overall Study|Death|0|||
33580652|NCT03288493|62977716|FG005|Overall Study|Death|0|||
33580653|NCT03288493|62977717|FG006|Overall Study|Death|0|||
33580654|NCT03288493|62977711|FG000|Overall Study|other reason not listed above|2|||
33580655|NCT03288493|62977712|FG001|Overall Study|other reason not listed above|0|||
33580656|NCT03288493|62977713|FG002|Overall Study|other reason not listed above|0|||
33580657|NCT03288493|62977714|FG003|Overall Study|other reason not listed above|0|||
33580658|NCT03288493|62977715|FG004|Overall Study|other reason not listed above|0|||
33580659|NCT03288493|62977716|FG005|Overall Study|other reason not listed above|0|||
33580660|NCT03288493|62977717|FG006|Overall Study|other reason not listed above|0|||
33580661|NCT03238300|62977737|FG000|Baseline (Before Intervention)|Physician Decision|0|||
33580662|NCT03238300|62977738|FG001|Baseline (Before Intervention)|Physician Decision|1|||
33671873|NCT01426009|63107645|FG000|Washout 1|Personal Reasons|1|||
33580663|NCT03238300|62977737|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
33580664|NCT03238300|62977738|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
33580665|NCT03238300|62977737|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
33580666|NCT03238300|62977738|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
33580667|NCT03238300|62977737|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
33580668|NCT03238300|62977738|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
33580669|NCT03235544|62977752|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
33580670|NCT03235544|62977753|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
33580671|NCT03235544|62977754|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
33580672|NCT03235544|62977755|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
33580673|NCT03235544|62977752|FG000|Overall Study|Death|11|||
33580674|NCT03235544|62977753|FG001|Overall Study|Death|23|||
33580675|NCT03235544|62977754|FG002|Overall Study|Death|11|||
33580676|NCT03235544|62977755|FG003|Overall Study|Death|20|||
33580677|NCT03235544|62977752|FG000|Overall Study|Lost to Follow-up|0|||
33580678|NCT03235544|62977753|FG001|Overall Study|Lost to Follow-up|1|||
33580679|NCT03235544|62977754|FG002|Overall Study|Lost to Follow-up|0|||
33580680|NCT03235544|62977755|FG003|Overall Study|Lost to Follow-up|1|||
33580681|NCT03235544|62977752|FG000|Overall Study|Withdrawal by Participant|0|||
33580682|NCT03235544|62977753|FG001|Overall Study|Withdrawal by Participant|0|||
33580683|NCT03235544|62977754|FG002|Overall Study|Withdrawal by Participant|1|||
33580684|NCT03235544|62977755|FG003|Overall Study|Withdrawal by Participant|0|||
33580685|NCT03235544|62977752|FG000|Overall Study|Reason not Specified|0|||
33580686|NCT03235544|62977753|FG001|Overall Study|Reason not Specified|4|||
33580687|NCT03235544|62977754|FG002|Overall Study|Reason not Specified|0|||
33580688|NCT03235544|62977755|FG003|Overall Study|Reason not Specified|1|||
33580689|NCT03178045|62977768|FG000|Overall Study|Withdrawal by Subject|5|||
33580690|NCT03178045|62977769|FG001|Overall Study|Withdrawal by Subject|7|||
33580691|NCT03178045|62977768|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
33580692|NCT03178045|62977769|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
33580693|NCT03178045|62977768|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
33580694|NCT03178045|62977769|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
33580695|NCT03113500|62977793|FG000|Overall Study|Withdrawal by Subject|1|||
33580696|NCT02924727|62977814|FG000|Overall Study|Withdrawal by Subject|2|||
33580697|NCT02924727|62977815|FG001|Overall Study|Withdrawal by Subject|4|||
33580698|NCT02924727|62977814|FG000|Overall Study|Lost to Follow-up|2|||
33580699|NCT02924727|62977815|FG001|Overall Study|Lost to Follow-up|5|||
33580700|NCT02924727|62977814|FG000|Overall Study|Death|221|||
33580701|NCT02924727|62977815|FG001|Overall Study|Death|247|||
33580702|NCT02924727|62977814|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
33580703|NCT02924727|62977815|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
33580704|NCT02901626|62977825|FG000|Overall Study|Lost to Follow-up|1|||
33580705|NCT02901626|62977826|FG001|Overall Study|Lost to Follow-up|1|||
33580706|NCT02720692|62977865|FG000|Overall Study|Withdrawal by Subject|3|||
33580707|NCT02720692|62977866|FG001|Overall Study|Withdrawal by Subject|0|||
33580708|NCT02720692|62977865|FG000|Overall Study|Physician Decision|1|||
33580709|NCT02720692|62977866|FG001|Overall Study|Physician Decision|0|||
33580710|NCT02720692|62977865|FG000|Overall Study|Lost to Follow-up|8|||
33580711|NCT02720692|62977866|FG001|Overall Study|Lost to Follow-up|3|||
33580712|NCT02720692|62977865|FG000|Overall Study|Subject unable to return for visit|1|||
33580713|NCT02720692|62977866|FG001|Overall Study|Subject unable to return for visit|0|||
33580714|NCT02656303|62977875|FG000|Overall Study|Adverse Event|3|||
33580715|NCT02656303|62977876|FG001|Overall Study|Adverse Event|2|||
33580716|NCT02656303|62977877|FG002|Overall Study|Adverse Event|0|||
33580717|NCT02656303|62977875|FG000|Overall Study|Death|12|||
33580718|NCT02656303|62977876|FG001|Overall Study|Death|4|||
33580719|NCT02656303|62977877|FG002|Overall Study|Death|1|||
33580720|NCT02656303|62977875|FG000|Overall Study|Lack of Efficacy|1|||
33580721|NCT02656303|62977876|FG001|Overall Study|Lack of Efficacy|0|||
33580722|NCT02656303|62977877|FG002|Overall Study|Lack of Efficacy|0|||
33580723|NCT02656303|62977875|FG000|Overall Study|Non-Compliance with Study|1|||
33580724|NCT02656303|62977876|FG001|Overall Study|Non-Compliance with Study|1|||
33580725|NCT02656303|62977877|FG002|Overall Study|Non-Compliance with Study|0|||
33580726|NCT02656303|62977875|FG000|Overall Study|Investigator Decision|2|||
33580727|NCT02656303|62977876|FG001|Overall Study|Investigator Decision|1|||
33580728|NCT02656303|62977877|FG002|Overall Study|Investigator Decision|0|||
33580729|NCT02656303|62977875|FG000|Overall Study|Progressive Disease|25|||
33580730|NCT02656303|62977876|FG001|Overall Study|Progressive Disease|14|||
33580731|NCT02656303|62977877|FG002|Overall Study|Progressive Disease|10|||
33580732|NCT02656303|62977875|FG000|Overall Study|Study Terminated by Sponsor|20|||
33580733|NCT02656303|62977876|FG001|Overall Study|Study Terminated by Sponsor|7|||
33580734|NCT02656303|62977877|FG002|Overall Study|Study Terminated by Sponsor|5|||
33580735|NCT02656303|62977875|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
33580736|NCT02656303|62977876|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
33580737|NCT02656303|62977877|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
33580738|NCT02656303|62977875|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
33580739|NCT02656303|62977876|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
33580740|NCT02656303|62977877|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
33580741|NCT02656303|62977875|FG000|Overall Study|Reason not Specified|1|||
33580742|NCT02656303|62977876|FG001|Overall Study|Reason not Specified|1|||
33580743|NCT02656303|62977877|FG002|Overall Study|Reason not Specified|2|||
33580744|NCT02628626|62977887|FG000|Overall Study|Withdrawal by Subject|2|||
33580745|NCT02628626|62977888|FG001|Overall Study|Withdrawal by Subject|2|||
33580746|NCT02527707|62977920|FG000|Overall Study|Adverse Event|1|||
33580747|NCT02527707|62977920|FG000|Overall Study|Adverse Event|1|||
33580748|NCT02453191|62977931|FG000|Overall Study|Withdrawal by Subject|1|||
33580749|NCT02352090|62977939|FG000|Overall Study|general malaise|1|||
33580750|NCT02352090|62977940|FG001|Overall Study|general malaise|0|||
33580751|NCT02352090|62977941|FG002|Overall Study|general malaise|0|||
33580752|NCT02352090|62977939|FG000|Overall Study|non-specified mild side-effects|0|||
33580753|NCT02352090|62977940|FG001|Overall Study|non-specified mild side-effects|0|||
33580754|NCT02352090|62977941|FG002|Overall Study|non-specified mild side-effects|2|||
33580755|NCT02135107|62977951|FG000|Treatment Period|Withdrawal by Subject|11|||
33580756|NCT02135107|62977952|FG001|Treatment Period|Withdrawal by Subject|0|||
33580757|NCT02135107|62977953|FG002|Treatment Period|Withdrawal by Subject|0|||
33580758|NCT02135107|62977954|FG003|Treatment Period|Withdrawal by Subject|0|||
33580759|NCT02135107|62977951|FG000|Treatment Period|Adverse Event|5|||
33580760|NCT02135107|62977952|FG001|Treatment Period|Adverse Event|2|||
33580761|NCT02135107|62977953|FG002|Treatment Period|Adverse Event|0|||
33580762|NCT02135107|62977954|FG003|Treatment Period|Adverse Event|0|||
33580763|NCT02135107|62977951|FG000|Treatment Period|Pregnancy|1|||
33580764|NCT02135107|62977952|FG001|Treatment Period|Pregnancy|0|||
33580765|NCT02135107|62977953|FG002|Treatment Period|Pregnancy|0|||
33580766|NCT02135107|62977954|FG003|Treatment Period|Pregnancy|0|||
33580767|NCT02135107|62977951|FG000|Treatment Period|Other|115|||
33580768|NCT02135107|62977952|FG001|Treatment Period|Other|24|||
33580769|NCT02135107|62977953|FG002|Treatment Period|Other|0|||
33580770|NCT02135107|62977954|FG003|Treatment Period|Other|0|||
33580771|NCT02135107|62977951|FG000|Maintenance Therapy Period|Adverse Event|0|||
33580772|NCT02135107|62977952|FG001|Maintenance Therapy Period|Adverse Event|0|||
33580773|NCT02135107|62977953|FG002|Maintenance Therapy Period|Adverse Event|3|||
33580774|NCT02135107|62977954|FG003|Maintenance Therapy Period|Adverse Event|7|||
33580775|NCT02135107|62977951|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
33580776|NCT02135107|62977952|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
33580777|NCT02135107|62977953|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
33580778|NCT02135107|62977954|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
33580779|NCT02135107|62977951|FG000|Maintenance Therapy Period|Pregnancy|0|||
33580780|NCT02135107|62977952|FG001|Maintenance Therapy Period|Pregnancy|0|||
33580781|NCT02135107|62977953|FG002|Maintenance Therapy Period|Pregnancy|0|||
33580782|NCT02135107|62977954|FG003|Maintenance Therapy Period|Pregnancy|1|||
33580783|NCT02135107|62977951|FG000|Maintenance Therapy Period|Other|0|||
33580784|NCT02135107|62977952|FG001|Maintenance Therapy Period|Other|0|||
33580785|NCT02135107|62977953|FG002|Maintenance Therapy Period|Other|7|||
33580786|NCT02135107|62977954|FG003|Maintenance Therapy Period|Other|8|||
33580787|NCT02030847|62977966|FG000|Overall Study|Death|10|||
33580788|NCT02030847|62977966|FG000|Overall Study|Disease Progression|15|||
33580789|NCT02030847|62977966|FG000|Overall Study|New Cancer Therapy|8|||
33580790|NCT02030847|62977966|FG000|Overall Study|Physician Decision|3|||
33580791|NCT02030847|62977966|FG000|Overall Study|Withdrawal by Subject|1|||
33580792|NCT02030834|62977974|FG000|Overall Study|Death|4|||
33580793|NCT02030834|62977975|FG001|Overall Study|Death|0|||
33580794|NCT02030834|62977976|FG002|Overall Study|Death|0|||
33580795|NCT02030834|62977974|FG000|Overall Study|Manufacturing failure|2|||
33580796|NCT02030834|62977975|FG001|Overall Study|Manufacturing failure|0|||
33580797|NCT02030834|62977976|FG002|Overall Study|Manufacturing failure|1|||
33580798|NCT02030834|62977974|FG000|Overall Study|Disease progression|2|||
33580799|NCT02030834|62977975|FG001|Overall Study|Disease progression|0|||
33580800|NCT02030834|62977976|FG002|Overall Study|Disease progression|2|||
33580801|NCT02030834|62977974|FG000|Overall Study|Lost to Follow-up|1|||
33580802|NCT02030834|62977975|FG001|Overall Study|Lost to Follow-up|0|||
33580803|NCT02030834|62977976|FG002|Overall Study|Lost to Follow-up|0|||
33580804|NCT02030834|62977974|FG000|Overall Study|Withdrawal by Subject|1|||
33580805|NCT02030834|62977975|FG001|Overall Study|Withdrawal by Subject|0|||
33580806|NCT02030834|62977976|FG002|Overall Study|Withdrawal by Subject|0|||
33580807|NCT02030834|62977974|FG000|Overall Study|Lack of funding|1|||
33580808|NCT02030834|62977975|FG001|Overall Study|Lack of funding|0|||
33580809|NCT02030834|62977976|FG002|Overall Study|Lack of funding|0|||
33580810|NCT01982448|62977986|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
33580811|NCT01982448|62977987|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
33580812|NCT01982448|62977986|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
33580813|NCT01982448|62977987|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
33580814|NCT01982448|62977986|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
33580815|NCT01982448|62977987|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
33580816|NCT01982448|62977986|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
33580817|NCT01982448|62977987|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
33580818|NCT01773421|62978001|FG000|Treatment Phase|Other|0|||
33580819|NCT01773421|62978002|FG001|Treatment Phase|Other|0|||
33580820|NCT01773421|62978003|FG002|Treatment Phase|Other|2|||
33580821|NCT01773421|62978004|FG003|Treatment Phase|Other|0|||
33580822|NCT01773421|62978005|FG004|Treatment Phase|Other|0|||
33580823|NCT01773421|62978006|FG005|Treatment Phase|Other|0|||
33580824|NCT01773421|62978007|FG006|Treatment Phase|Other|0|||
33580825|NCT01773421|62978001|FG000|Treatment Phase|Adverse Event|0|||
33580826|NCT01773421|62978002|FG001|Treatment Phase|Adverse Event|0|||
33580827|NCT01773421|62978003|FG002|Treatment Phase|Adverse Event|3|||
33580828|NCT01773421|62978004|FG003|Treatment Phase|Adverse Event|1|||
33580829|NCT01773421|62978005|FG004|Treatment Phase|Adverse Event|0|||
33580830|NCT01773421|62978006|FG005|Treatment Phase|Adverse Event|0|||
33580831|NCT01773421|62978007|FG006|Treatment Phase|Adverse Event|0|||
33580832|NCT01773421|62978001|FG000|Treatment Phase|Withdrawal by Subject|0|||
33580833|NCT01773421|62978002|FG001|Treatment Phase|Withdrawal by Subject|0|||
33580834|NCT01773421|62978003|FG002|Treatment Phase|Withdrawal by Subject|1|||
33580835|NCT01773421|62978004|FG003|Treatment Phase|Withdrawal by Subject|1|||
33580836|NCT01773421|62978005|FG004|Treatment Phase|Withdrawal by Subject|0|||
33580837|NCT01773421|62978006|FG005|Treatment Phase|Withdrawal by Subject|0|||
33580838|NCT01773421|62978007|FG006|Treatment Phase|Withdrawal by Subject|0|||
33580839|NCT01773421|62978001|FG000|Extension Phase|Other|0|||
33580840|NCT01773421|62978002|FG001|Extension Phase|Other|0|||
33580841|NCT01773421|62978003|FG002|Extension Phase|Other|0|||
33580842|NCT01773421|62978004|FG003|Extension Phase|Other|0|||
33580843|NCT01773421|62978005|FG004|Extension Phase|Other|1|||
33580844|NCT01773421|62978006|FG005|Extension Phase|Other|2|||
33580845|NCT01773421|62978007|FG006|Extension Phase|Other|0|||
33580846|NCT01773421|62978001|FG000|Extension Phase|Adverse Event|0|||
33580847|NCT01773421|62978002|FG001|Extension Phase|Adverse Event|0|||
33580848|NCT01773421|62978003|FG002|Extension Phase|Adverse Event|0|||
33580849|NCT01773421|62978004|FG003|Extension Phase|Adverse Event|0|||
33580850|NCT01773421|62978005|FG004|Extension Phase|Adverse Event|2|||
33580851|NCT01773421|62978006|FG005|Extension Phase|Adverse Event|0|||
33580852|NCT01773421|62978007|FG006|Extension Phase|Adverse Event|0|||
33580853|NCT01747486|62978025|FG000|Stage 1|Physician Decision|3|||
33580854|NCT01747486|62978026|FG001|Stage 1|Physician Decision|0|||
33580855|NCT01747486|62978025|FG000|Stage 1|Withdrawal by Subject|4|||
33580856|NCT01747486|62978026|FG001|Stage 1|Withdrawal by Subject|3|||
33580857|NCT01747486|62978025|FG000|Stage 1|Disease progression|4|||
33580858|NCT01747486|62978026|FG001|Stage 1|Disease progression|9|||
33580859|NCT01747486|62978025|FG000|Stage 1|Death|1|||
33580860|NCT01747486|62978026|FG001|Stage 1|Death|1|||
33580861|NCT01747486|62978025|FG000|Stage 2|Physician Decision|2|||
33580862|NCT01747486|62978026|FG001|Stage 2|Physician Decision|0|||
33580863|NCT01747486|62978025|FG000|Stage 2|Withdrawal by Subject|1|||
33580864|NCT01747486|62978026|FG001|Stage 2|Withdrawal by Subject|0|||
33580865|NCT01747486|62978025|FG000|Stage 2|New Cancer Therapy|3|||
33580866|NCT01747486|62978026|FG001|Stage 2|New Cancer Therapy|0|||
33580867|NCT01747486|62978025|FG000|Stage 2|Disease Progression|3|||
33580868|NCT01747486|62978026|FG001|Stage 2|Disease Progression|0|||
33580869|NCT01659151|62978036|FG000|Overall Study|Inadequate TIL growth|1|||
33580870|NCT01593254|62978042|FG000|Overall Study|Disease progression|2|||
33580871|NCT01593254|62978043|FG001|Overall Study|Disease progression|7|||
33580872|NCT01593254|62978042|FG000|Overall Study|Study drug toxicity|6|||
33580873|NCT01593254|62978043|FG001|Overall Study|Study drug toxicity|20|||
33580874|NCT01593254|62978042|FG000|Overall Study|Death|3|||
33580875|NCT01593254|62978043|FG001|Overall Study|Death|3|||
33580876|NCT01593254|62978042|FG000|Overall Study|AE unrelated to study drug|0|||
33580877|NCT01593254|62978043|FG001|Overall Study|AE unrelated to study drug|1|||
33580878|NCT01593254|62978042|FG000|Overall Study|participant request to discontinue study treatment|1|||
33580879|NCT01593254|62978043|FG001|Overall Study|participant request to discontinue study treatment|3|||
33580880|NCT01593254|62978042|FG000|Overall Study|participant withdrew consent|0|||
33580881|NCT01593254|62978043|FG001|Overall Study|participant withdrew consent|9|||
33580882|NCT01593254|62978042|FG000|Overall Study|lost to follow up|1|||
33580883|NCT01593254|62978043|FG001|Overall Study|lost to follow up|6|||
33580884|NCT01593254|62978042|FG000|Overall Study|maximum clinical benefit|1|||
33580885|NCT01593254|62978043|FG001|Overall Study|maximum clinical benefit|2|||
33580886|NCT01593254|62978042|FG000|Overall Study|Poor/non compliance|1|||
33580887|NCT01593254|62978043|FG001|Overall Study|Poor/non compliance|1|||
33580888|NCT01593254|62978042|FG000|Overall Study|Pregnancy|0|||
33580889|NCT01593254|62978043|FG001|Overall Study|Pregnancy|3|||
33580890|NCT01593254|62978042|FG000|Overall Study|participant no longer meets study criteria|1|||
33580891|NCT01593254|62978043|FG001|Overall Study|participant no longer meets study criteria|1|||
33580892|NCT01593254|62978042|FG000|Overall Study|Admin reason by sponsor|7|||
33580893|NCT01593254|62978043|FG001|Overall Study|Admin reason by sponsor|3|||
33580894|NCT01593254|62978042|FG000|Overall Study|Imatinib treatment failure|2|||
33580895|NCT01593254|62978043|FG001|Overall Study|Imatinib treatment failure|0|||
33580896|NCT01593254|62978042|FG000|Overall Study|Other Reasons|61|||
33580897|NCT01593254|62978043|FG001|Overall Study|Other Reasons|115|||
33580898|NCT01559818|62978050|FG000|Overall Study|Physician Decision|1|||
33580899|NCT01559818|62978050|FG000|Overall Study|Pregnancy|1|||
33580900|NCT01559818|62978050|FG000|Overall Study|Study terminated by Sponsor|4|||
33580901|NCT01559818|62978050|FG000|Overall Study|Withdrawal by Subject|1|||
33310066|NCT01290263|62685432|FG000|Overall Study|Withdrawal by Subject|3|||
33310067|NCT01290263|62685433|FG001|Overall Study|Withdrawal by Subject|1|||
33310068|NCT01290263|62685434|FG002|Overall Study|Withdrawal by Subject|0|||
33310069|NCT01290263|62685435|FG003|Overall Study|Withdrawal by Subject|1|||
33310070|NCT01290263|62685436|FG004|Overall Study|Withdrawal by Subject|2|||
33310071|NCT01290263|62685432|FG000|Overall Study|Participant Non-Compliance|0|||
33310072|NCT01290263|62685433|FG001|Overall Study|Participant Non-Compliance|0|||
33310073|NCT01290263|62685434|FG002|Overall Study|Participant Non-Compliance|0|||
33310074|NCT01290263|62685435|FG003|Overall Study|Participant Non-Compliance|1|||
33310075|NCT01290263|62685436|FG004|Overall Study|Participant Non-Compliance|1|||
33310076|NCT01290029|62685444|FG000|Overall Study|Other|2|||
33310077|NCT01289639|62685451|FG000|Overall Study|Lost to Follow-up|1|||
33310078|NCT01289639|62685452|FG001|Overall Study|Lost to Follow-up|0|||
33310079|NCT01289639|62685453|FG002|Overall Study|Lost to Follow-up|0|||
33310080|NCT01289015|62685463|FG000|Overall Study|Protocol Violation|12|||
33310081|NCT01289015|62685464|FG001|Overall Study|Protocol Violation|9|||
33310082|NCT01289015|62685463|FG000|Overall Study|Adverse Event|3|||
33310083|NCT01289015|62685464|FG001|Overall Study|Adverse Event|0|||
33310084|NCT01289015|62685463|FG000|Overall Study|Lost to Follow-up|33|||
33310085|NCT01289015|62685464|FG001|Overall Study|Lost to Follow-up|17|||
33310086|NCT01289015|62685463|FG000|Overall Study|Withdrawal by Subject|17|||
33310087|NCT01289015|62685464|FG001|Overall Study|Withdrawal by Subject|8|||
33310088|NCT01289015|62685463|FG000|Overall Study|Disease progression|1|||
33310089|NCT01289015|62685464|FG001|Overall Study|Disease progression|0|||
33310090|NCT01289015|62685463|FG000|Overall Study|Negative baseline culture and others|33|||
33310091|NCT01289015|62685464|FG001|Overall Study|Negative baseline culture and others|20|||
33310092|NCT01288937|62685472|FG000|Overall Study|Adverse Event|1|||
33310093|NCT01288937|62685473|FG001|Overall Study|Adverse Event|0|||
33310094|NCT01288469|62685482|FG000|Overall Study|Adverse Event|4|||
33310095|NCT01288469|62685483|FG001|Overall Study|Adverse Event|1|||
33310096|NCT01288469|62685484|FG002|Overall Study|Adverse Event|1|||
33310097|NCT01288469|62685482|FG000|Overall Study|Poor compliance to protocol|0|||
33310098|NCT01288469|62685483|FG001|Overall Study|Poor compliance to protocol|1|||
33310099|NCT01288469|62685484|FG002|Overall Study|Poor compliance to protocol|0|||
33310100|NCT01288469|62685482|FG000|Overall Study|Participant Moved|1|||
33310101|NCT01288469|62685483|FG001|Overall Study|Participant Moved|0|||
33310102|NCT01288469|62685484|FG002|Overall Study|Participant Moved|0|||
33310103|NCT01288469|62685482|FG000|Overall Study|Consent withdrawn by subject|1|||
33310104|NCT01288469|62685483|FG001|Overall Study|Consent withdrawn by subject|1|||
33310105|NCT01288469|62685484|FG002|Overall Study|Consent withdrawn by subject|1|||
33310106|NCT01288469|62685482|FG000|Overall Study|Exclusion criteria finally met|1|||
33310107|NCT01288469|62685483|FG001|Overall Study|Exclusion criteria finally met|0|||
33310108|NCT01288469|62685484|FG002|Overall Study|Exclusion criteria finally met|0|||
33310109|NCT01288079|62685496|FG000|Overall Study|Withdrawal by Subject|2|||
33310110|NCT01288079|62685497|FG001|Overall Study|Withdrawal by Subject|4|||
33310111|NCT01288079|62685498|FG002|Overall Study|Withdrawal by Subject|1|||
33310112|NCT01288079|62685499|FG003|Overall Study|Withdrawal by Subject|0|||
33310113|NCT01288079|62685496|FG000|Overall Study|Adverse Event|2|||
33310114|NCT01288079|62685497|FG001|Overall Study|Adverse Event|1|||
33310115|NCT01288079|62685498|FG002|Overall Study|Adverse Event|2|||
33310116|NCT01288079|62685499|FG003|Overall Study|Adverse Event|3|||
33310117|NCT01288079|62685496|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
33310118|NCT01288079|62685497|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
33310119|NCT01288079|62685498|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
33310120|NCT01288079|62685499|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
33310121|NCT01288079|62685496|FG000|Overall Study|Condition under Investigation Worsened|0|||
33310122|NCT01288079|62685497|FG001|Overall Study|Condition under Investigation Worsened|0|||
33310123|NCT01288079|62685498|FG002|Overall Study|Condition under Investigation Worsened|0|||
33310124|NCT01288079|62685499|FG003|Overall Study|Condition under Investigation Worsened|1|||
33310125|NCT01288079|62685496|FG000|Overall Study|Lack of Efficacy|2|||
33310126|NCT01288079|62685497|FG001|Overall Study|Lack of Efficacy|2|||
33310127|NCT01288079|62685498|FG002|Overall Study|Lack of Efficacy|0|||
33310128|NCT01288079|62685499|FG003|Overall Study|Lack of Efficacy|2|||
33310129|NCT01288079|62685496|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
33310130|NCT01288079|62685497|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
33310131|NCT01288079|62685498|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
33310132|NCT01288079|62685499|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
33310133|NCT01288079|62685496|FG000|Overall Study|Lost to Follow-up|1|||
33310134|NCT01288079|62685497|FG001|Overall Study|Lost to Follow-up|1|||
33671874|NCT01426009|63107645|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
33671875|NCT01426009|63107645|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
33671876|NCT01426009|63107645|FG000|Washout 2|electrive surgery|1|||
33671877|NCT01426009|63107645|FG000|Washout 3|personal reasons|1|||
33671878|NCT01426009|63107645|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
33671879|NCT01426009|63107645|FG000|Washout 4|Lost to Follow-up|1|||
33671880|NCT01411319|63107674|FG000|Overall Study|Lost to Follow-up|1|||
33671881|NCT01543958|63107678|FG000|Overall Study|Loss to follow-up|3|||
33671882|NCT01543958|63107678|FG000|Overall Study|ART initiation|1|||
33671883|NCT01411085|63107682|FG000|Overall Study|Physician Decision|1|||
33671884|NCT01411085|63107682|FG000|Overall Study|Protocol Violation|1|||
33671885|NCT01411085|63107682|FG000|Overall Study|Adverse Event|1|||
33671886|NCT01543490|63107688|FG000|Overall Study|Adverse Event|4|||
33671887|NCT01543490|63107689|FG001|Overall Study|Adverse Event|0|||
33671888|NCT01543490|63107688|FG000|Overall Study|Physician Decision|1|||
33671889|NCT01543490|63107689|FG001|Overall Study|Physician Decision|0|||
33671890|NCT01543490|63107688|FG000|Overall Study|Lack of Efficacy|3|||
33671891|NCT01543490|63107689|FG001|Overall Study|Lack of Efficacy|3|||
33671892|NCT01543490|63107688|FG000|Overall Study|Lost to Follow-up|5|||
33671893|NCT01543490|63107689|FG001|Overall Study|Lost to Follow-up|0|||
33671894|NCT01543490|63107688|FG000|Overall Study|Withdrawal by Subject|2|||
33671895|NCT01543490|63107689|FG001|Overall Study|Withdrawal by Subject|0|||
33671896|NCT01543490|63107688|FG000|Overall Study|Other-Various Administrative Reasons|1|||
33671897|NCT01543490|63107689|FG001|Overall Study|Other-Various Administrative Reasons|2|||
33671898|NCT01404949|63107695|FG000|Overall Study|Not Treated|1|||
33671899|NCT01431521|63107703|FG000|Overall Study|Withdrawal by Subject|0|||
33671900|NCT01431521|63107704|FG001|Overall Study|Withdrawal by Subject|0|||
33671901|NCT01431521|63107705|FG002|Overall Study|Withdrawal by Subject|1|||
33671902|NCT01431521|63107706|FG003|Overall Study|Withdrawal by Subject|0|||
33310135|NCT01288079|62685498|FG002|Overall Study|Lost to Follow-up|1|||
33310136|NCT01288079|62685499|FG003|Overall Study|Lost to Follow-up|0|||
33310137|NCT01288079|62685496|FG000|Overall Study|Other or Study Termination|11|||
33310138|NCT01288079|62685497|FG001|Overall Study|Other or Study Termination|15|||
33310139|NCT01288079|62685498|FG002|Overall Study|Other or Study Termination|14|||
33310140|NCT01288079|62685499|FG003|Overall Study|Other or Study Termination|8|||
33310141|NCT01287221|62685511|FG000|Overall Study|Lack of Perceived Benefit|1|||
33310142|NCT01287221|62685512|FG001|Overall Study|Lack of Perceived Benefit|1|||
33581023|NCT01111461|62978156|FG000|Overall Study|Withdrawal by Subject|1|||
33581024|NCT01111461|62978156|FG000|Overall Study|Other|6|||
33581025|NCT01104155|62978162|FG000|Overall Study|Adverse Event|15|||
33581026|NCT01104155|62978163|FG001|Overall Study|Adverse Event|8|||
33581027|NCT01104155|62978162|FG000|Overall Study|Participant choice|6|||
33581028|NCT01104155|62978163|FG001|Overall Study|Participant choice|5|||
33581029|NCT01104155|62978162|FG000|Overall Study|Withdrawal of consent|1|||
33581030|NCT01104155|62978163|FG001|Overall Study|Withdrawal of consent|1|||
33581031|NCT01104155|62978162|FG000|Overall Study|Other|3|||
33581032|NCT01104155|62978163|FG001|Overall Study|Other|4|||
33581033|NCT01065597|62978169|FG000|Overall Study|Adverse Event|1|||
33581034|NCT01051856|62978175|FG000|Overall Study|Withdrawal by Subject|1|||
33581035|NCT01051856|62978176|FG001|Overall Study|Withdrawal by Subject|0|||
33581036|NCT01029366|62978184|FG000|Overall Study|Withdrawal by Subject|1|||
33581037|NCT01029366|62978185|FG001|Overall Study|Withdrawal by Subject|0|||
33581038|NCT01029366|62978184|FG000|Overall Study|Death|1|||
33581039|NCT01029366|62978185|FG001|Overall Study|Death|1|||
33581040|NCT01029366|62978184|FG000|Overall Study|disease progression|2|||
33581041|NCT01029366|62978185|FG001|Overall Study|disease progression|0|||
33581042|NCT01029366|62978184|FG000|Overall Study|manufacturing failure|0|||
33581043|NCT01029366|62978185|FG001|Overall Study|manufacturing failure|1|||
33581044|NCT01005745|62978192|FG000|Overall Study|No TIL growth|1|||
33581045|NCT01005745|62978192|FG000|Overall Study|Disease progressed during TIL growth|3|||
33581046|NCT01005745|62978192|FG000|Overall Study|Death prior to treatment|1|||
33581047|NCT01005745|62978192|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
33581048|NCT00879086|62978198|FG000|Overall Study|Adverse Event|3|||
33581049|NCT00879086|62978199|FG001|Overall Study|Adverse Event|15|||
33581050|NCT00879086|62978198|FG000|Overall Study|Participant choice|2|||
33581051|NCT00879086|62978199|FG001|Overall Study|Participant choice|2|||
33581052|NCT00879086|62978198|FG000|Overall Study|Progression of disease|40|||
33581053|NCT00879086|62978199|FG001|Overall Study|Progression of disease|26|||
33581054|NCT00879086|62978198|FG000|Overall Study|Withdrawal of consent|2|||
33581055|NCT00879086|62978199|FG001|Overall Study|Withdrawal of consent|1|||
33581056|NCT00879086|62978198|FG000|Overall Study|Other|4|||
33581057|NCT00879086|62978199|FG001|Overall Study|Other|6|||
33581058|NCT00879086|62978198|FG000|Overall Study|Death|1|||
33581059|NCT00879086|62978199|FG001|Overall Study|Death|2|||
33581060|NCT00244933|62978215|FG000|Overall Study|Not response evaluable|2|||
33581061|NCT02637557|62978296|FG000|Overall Study|Adverse Event|3|||
33581062|NCT02637557|62978297|FG001|Overall Study|Adverse Event|1|||
33581063|NCT02637557|62978298|FG002|Overall Study|Adverse Event|3|||
33581064|NCT02637557|62978299|FG003|Overall Study|Adverse Event|3|||
33581065|NCT02637557|62978296|FG000|Overall Study|Lost to Follow-up|1|||
33581066|NCT02637557|62978297|FG001|Overall Study|Lost to Follow-up|1|||
33581067|NCT02637557|62978298|FG002|Overall Study|Lost to Follow-up|0|||
33581068|NCT02637557|62978299|FG003|Overall Study|Lost to Follow-up|1|||
33581069|NCT02637557|62978296|FG000|Overall Study|Physician Decision|1|||
33581070|NCT02637557|62978297|FG001|Overall Study|Physician Decision|0|||
33581071|NCT02637557|62978298|FG002|Overall Study|Physician Decision|0|||
33581072|NCT02637557|62978299|FG003|Overall Study|Physician Decision|0|||
33581073|NCT02637557|62978296|FG000|Overall Study|Protocol Violation|2|||
33581074|NCT02637557|62978297|FG001|Overall Study|Protocol Violation|0|||
33581075|NCT02637557|62978298|FG002|Overall Study|Protocol Violation|2|||
33581076|NCT02637557|62978299|FG003|Overall Study|Protocol Violation|1|||
33581077|NCT02637557|62978296|FG000|Overall Study|Withdrawal by Subject|1|||
33581078|NCT02637557|62978297|FG001|Overall Study|Withdrawal by Subject|3|||
33581079|NCT02637557|62978298|FG002|Overall Study|Withdrawal by Subject|4|||
33581080|NCT02637557|62978299|FG003|Overall Study|Withdrawal by Subject|2|||
33581081|NCT02638493|62978312|FG000|Overall Study|Inability to provide semen samples|2|||
33581082|NCT02638493|62978313|FG001|Overall Study|Inability to provide semen samples|0|||
33581083|NCT02638493|62978314|FG002|Overall Study|Inability to provide semen samples|0|||
33581084|NCT02638337|62978324|FG000|Overall Study|Adverse Event|6|||
33581085|NCT02638337|62978325|FG001|Overall Study|Adverse Event|10|||
33581086|NCT02638337|62978324|FG000|Overall Study|Protocol Violation|3|||
33581087|NCT02638337|62978325|FG001|Overall Study|Protocol Violation|0|||
33581088|NCT02638337|62978324|FG000|Overall Study|Withdrawal by Subject|13|||
33581089|NCT02638337|62978325|FG001|Overall Study|Withdrawal by Subject|16|||
33581090|NCT02638337|62978324|FG000|Overall Study|Lost to Follow-up|7|||
33581091|NCT02638337|62978325|FG001|Overall Study|Lost to Follow-up|7|||
33581092|NCT02638337|62978324|FG000|Overall Study|Other - Miscellaneous|4|||
33581093|NCT02638337|62978325|FG001|Overall Study|Other - Miscellaneous|3|||
33581094|NCT02638259|62978333|FG000|Treatment Period 1|Adverse Event|1|||
33581095|NCT02638259|62978334|FG001|Treatment Period 1|Adverse Event|5|||
33581096|NCT02638259|62978333|FG000|Treatment Period 1|Death|0|||
33581097|NCT02638259|62978334|FG001|Treatment Period 1|Death|1|||
33581098|NCT02638259|62978333|FG000|Treatment Period 1|Lack of Efficacy|0|||
33581099|NCT02638259|62978334|FG001|Treatment Period 1|Lack of Efficacy|1|||
33581100|NCT02638259|62978333|FG000|Treatment Period 1|Protocol Violation|0|||
33581101|NCT02638259|62978334|FG001|Treatment Period 1|Protocol Violation|3|||
33581102|NCT02638259|62978333|FG000|Treatment Period 1|Withdrawal by Subject|4|||
33581103|NCT02638259|62978334|FG001|Treatment Period 1|Withdrawal by Subject|6|||
33581104|NCT02638259|62978333|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
33581105|NCT02638259|62978334|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
33581106|NCT02638259|62978333|FG000|Treatment Period 2|Adverse Event|5|||
33581107|NCT02638259|62978334|FG001|Treatment Period 2|Adverse Event|4|||
33581108|NCT02638259|62978333|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33581109|NCT02638259|62978334|FG001|Treatment Period 2|Withdrawal by Subject|7|||
33581110|NCT02637323|62978346|FG000|Overall Study|Lost to Follow-up|2|||
33581111|NCT02637323|62978347|FG001|Overall Study|Lost to Follow-up|0|||
33581112|NCT02637323|62978346|FG000|Overall Study|Protocol Violation|0|||
33581113|NCT02637323|62978347|FG001|Overall Study|Protocol Violation|1|||
33581114|NCT03573817|62978356|FG000|Overall Study|Adverse Event|0|||
33581115|NCT03573817|62978357|FG001|Overall Study|Adverse Event|2|||
33581116|NCT03573817|62978356|FG000|Overall Study|Protocol Violation|0|||
33581117|NCT03573817|62978357|FG001|Overall Study|Protocol Violation|1|||
33581118|NCT03573817|62978356|FG000|Overall Study|Withdrawal by Subject|1|||
33581119|NCT03573817|62978357|FG001|Overall Study|Withdrawal by Subject|1|||
33581120|NCT02638103|62978372|FG000|Overall Study|Adverse Event|13|||
33581121|NCT02638103|62978373|FG001|Overall Study|Adverse Event|12|||
33581122|NCT02638103|62978374|FG002|Overall Study|Adverse Event|19|||
33581123|NCT02638103|62978375|FG003|Overall Study|Adverse Event|12|||
33581124|NCT02638103|62978372|FG000|Overall Study|Withdrawal by Subject|43|||
33581125|NCT02638103|62978373|FG001|Overall Study|Withdrawal by Subject|53|||
33581126|NCT02638103|62978374|FG002|Overall Study|Withdrawal by Subject|30|||
33581127|NCT02638103|62978375|FG003|Overall Study|Withdrawal by Subject|61|||
33581128|NCT02638103|62978372|FG000|Overall Study|Protocol Violation|1|||
33581129|NCT02638103|62978373|FG001|Overall Study|Protocol Violation|2|||
33581130|NCT02638103|62978374|FG002|Overall Study|Protocol Violation|1|||
33581131|NCT02638103|62978375|FG003|Overall Study|Protocol Violation|4|||
33581132|NCT02638103|62978372|FG000|Overall Study|Pregnancy|2|||
33581133|NCT02638103|62978373|FG001|Overall Study|Pregnancy|3|||
33581134|NCT02638103|62978374|FG002|Overall Study|Pregnancy|0|||
33581135|NCT02638103|62978375|FG003|Overall Study|Pregnancy|1|||
33581136|NCT02638103|62978372|FG000|Overall Study|Non-compliance to Study Procedures|2|||
33581137|NCT02638103|62978373|FG001|Overall Study|Non-compliance to Study Procedures|1|||
33581138|NCT02638103|62978374|FG002|Overall Study|Non-compliance to Study Procedures|1|||
33581139|NCT02638103|62978375|FG003|Overall Study|Non-compliance to Study Procedures|1|||
33581140|NCT02638103|62978372|FG000|Overall Study|Lost to Follow-up|26|||
33581141|NCT02638103|62978373|FG001|Overall Study|Lost to Follow-up|33|||
33581142|NCT02638103|62978374|FG002|Overall Study|Lost to Follow-up|20|||
33581143|NCT02638103|62978375|FG003|Overall Study|Lost to Follow-up|37|||
33581144|NCT02638103|62978372|FG000|Overall Study|Lack of Efficacy|14|||
33581145|NCT02638103|62978373|FG001|Overall Study|Lack of Efficacy|10|||
33581146|NCT02638103|62978374|FG002|Overall Study|Lack of Efficacy|12|||
33581147|NCT02638103|62978375|FG003|Overall Study|Lack of Efficacy|22|||
33581148|NCT02638103|62978372|FG000|Overall Study|Other than specified|5|||
33581149|NCT02638103|62978373|FG001|Overall Study|Other than specified|4|||
33581150|NCT02638103|62978374|FG002|Overall Study|Other than specified|2|||
33581151|NCT02638103|62978375|FG003|Overall Study|Other than specified|4|||
33581152|NCT03551743|62978397|FG000|Overall Study|Adverse Event|1|||
33581153|NCT03551743|62978398|FG001|Overall Study|Adverse Event|0|||
33581154|NCT03551743|62978399|FG002|Overall Study|Adverse Event|0|||
33581155|NCT03551743|62978400|FG003|Overall Study|Adverse Event|0|||
33581156|NCT03551743|62978397|FG000|Overall Study|Withdrawal by Subject|1|||
33581157|NCT03551743|62978398|FG001|Overall Study|Withdrawal by Subject|0|||
33581158|NCT03551743|62978399|FG002|Overall Study|Withdrawal by Subject|0|||
33581159|NCT03551743|62978400|FG003|Overall Study|Withdrawal by Subject|0|||
33581160|NCT02636699|62978412|FG000|Overall Study|Adverse Event|4|||
33581161|NCT02636699|62978413|FG001|Overall Study|Adverse Event|0|||
33581162|NCT02636699|62978412|FG000|Overall Study|Lost to Follow-up|3|||
33581163|NCT02636699|62978413|FG001|Overall Study|Lost to Follow-up|3|||
33581164|NCT02636699|62978412|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
33581165|NCT02636699|62978413|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
33581166|NCT02636699|62978412|FG000|Overall Study|Physician Decision|0|||
33581167|NCT02636699|62978413|FG001|Overall Study|Physician Decision|1|||
33581168|NCT02636699|62978412|FG000|Overall Study|Withdrawal by Subject|13|||
33581169|NCT02636699|62978413|FG001|Overall Study|Withdrawal by Subject|6|||
33581170|NCT02636699|62978412|FG000|Overall Study|Other|3|||
33581171|NCT02636699|62978413|FG001|Overall Study|Other|1|||
33581172|NCT02634983|62978419|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
33581173|NCT02634983|62978420|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
33581174|NCT02633501|62978432|FG000|Overall Study|Adverse Event|0|||
33581175|NCT02633501|62978433|FG001|Overall Study|Adverse Event|0|||
33581176|NCT02633501|62978434|FG002|Overall Study|Adverse Event|1|||
33581177|NCT02633501|62978435|FG003|Overall Study|Adverse Event|0|||
33581178|NCT02633501|62978436|FG004|Overall Study|Adverse Event|1|||
33581179|NCT02633501|62978437|FG005|Overall Study|Adverse Event|1|||
33581180|NCT02633501|62978432|FG000|Overall Study|Withdrawal by Subject|2|||
33581181|NCT02633501|62978433|FG001|Overall Study|Withdrawal by Subject|1|||
33581182|NCT02633501|62978434|FG002|Overall Study|Withdrawal by Subject|2|||
33581183|NCT02633501|62978435|FG003|Overall Study|Withdrawal by Subject|2|||
33581184|NCT02633501|62978436|FG004|Overall Study|Withdrawal by Subject|1|||
33581185|NCT02633501|62978437|FG005|Overall Study|Withdrawal by Subject|3|||
33581186|NCT02633501|62978432|FG000|Overall Study|Various other reasons|0|||
33581187|NCT02633501|62978433|FG001|Overall Study|Various other reasons|2|||
33581188|NCT02633501|62978434|FG002|Overall Study|Various other reasons|4|||
33581189|NCT02633501|62978435|FG003|Overall Study|Various other reasons|1|||
33581190|NCT02633501|62978436|FG004|Overall Study|Various other reasons|7|||
33581191|NCT02633501|62978437|FG005|Overall Study|Various other reasons|11|||
33581192|NCT02633501|62978432|FG000|Overall Study|Lost to Follow-up|0|||
33581193|NCT02633501|62978433|FG001|Overall Study|Lost to Follow-up|0|||
33581194|NCT02633501|62978434|FG002|Overall Study|Lost to Follow-up|0|||
33581195|NCT02633501|62978435|FG003|Overall Study|Lost to Follow-up|1|||
33581196|NCT02633501|62978436|FG004|Overall Study|Lost to Follow-up|2|||
33581197|NCT02633501|62978437|FG005|Overall Study|Lost to Follow-up|0|||
33581198|NCT03138499|62978458|FG000|Overall Study|Lost to Follow-up|1|||
33581199|NCT03138499|62978459|FG001|Overall Study|Lost to Follow-up|0|||
33581200|NCT03138499|62978458|FG000|Overall Study|Participants withdrew consent|1|||
33581201|NCT03138499|62978459|FG001|Overall Study|Participants withdrew consent|0|||
33581202|NCT03138499|62978458|FG000|Overall Study|Participant discontinued study before treatment|0|||
33581203|NCT03138499|62978459|FG001|Overall Study|Participant discontinued study before treatment|1|||
33581204|NCT03138499|62978458|FG000|Overall Study|Disease Progression|2|||
33581205|NCT03138499|62978459|FG001|Overall Study|Disease Progression|6|||
33581206|NCT03138499|62978458|FG000|Overall Study|Study drug toxicity|2|||
33581207|NCT03138499|62978459|FG001|Overall Study|Study drug toxicity|2|||
33581208|NCT03138499|62978458|FG000|Overall Study|Participant request to discontinue study treatment|1|||
33581209|NCT03138499|62978459|FG001|Overall Study|Participant request to discontinue study treatment|1|||
33581210|NCT03138499|62978458|FG000|Overall Study|Other reasons|2|||
33581211|NCT03138499|62978459|FG001|Overall Study|Other reasons|0|||
33581212|NCT04508621|62978468|FG000|Overall Study|Adverse Event|39|||
33581213|NCT04508621|62978469|FG001|Overall Study|Adverse Event|16|||
33581214|NCT04508621|62978468|FG000|Overall Study|Lack of Efficacy|2|||
33581215|NCT04508621|62978469|FG001|Overall Study|Lack of Efficacy|8|||
33581216|NCT04508621|62978468|FG000|Overall Study|Physician Decision|0|||
33581217|NCT04508621|62978469|FG001|Overall Study|Physician Decision|1|||
33581218|NCT04508621|62978468|FG000|Overall Study|Withdrawal by Subject|10|||
33581219|NCT04508621|62978469|FG001|Overall Study|Withdrawal by Subject|14|||
33581220|NCT04508621|62978468|FG000|Overall Study|Lost to Follow-up|12|||
33581221|NCT04508621|62978469|FG001|Overall Study|Lost to Follow-up|9|||
33581222|NCT04508621|62978468|FG000|Overall Study|COVID-19 related crisis|3|||
33581223|NCT04508621|62978469|FG001|Overall Study|COVID-19 related crisis|0|||
33581224|NCT04508621|62978468|FG000|Overall Study|Subject non-compliance|1|||
33581225|NCT04508621|62978469|FG001|Overall Study|Subject non-compliance|0|||
33581226|NCT03591107|62978477|FG000|Overall Study|Same patient in both arms|1|||
33581227|NCT03591107|62978478|FG001|Overall Study|Same patient in both arms|1|||
33581228|NCT03591107|62978477|FG000|Overall Study|Sought care at other clinics|0|||
33581229|NCT03591107|62978478|FG001|Overall Study|Sought care at other clinics|2|||
33581230|NCT03591107|62978477|FG000|Overall Study|Discharged from clinic|0|||
33581231|NCT03591107|62978478|FG001|Overall Study|Discharged from clinic|1|||
33581232|NCT03591107|62978477|FG000|Overall Study|Withdrawal by Subject|0|||
33581233|NCT03591107|62978478|FG001|Overall Study|Withdrawal by Subject|1|||
33581234|NCT02922023|62978491|FG000|Overall Study|Lost to Follow-up|2|||
33581235|NCT02922023|62978492|FG001|Overall Study|Lost to Follow-up|0|||
33581236|NCT01672853|62978501|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
33581237|NCT01672853|62978502|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
33581238|NCT01672853|62978503|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
33581239|NCT01672853|62978501|FG000|Overall Study|Pregnancy|0|||
33581240|NCT01672853|62978502|FG001|Overall Study|Pregnancy|1|||
33581241|NCT01672853|62978503|FG002|Overall Study|Pregnancy|0|||
33581242|NCT01672853|62978501|FG000|Overall Study|Investigator's Discretion|1|||
33581243|NCT01672853|62978502|FG001|Overall Study|Investigator's Discretion|0|||
33581244|NCT01672853|62978503|FG002|Overall Study|Investigator's Discretion|0|||
33581245|NCT01672853|62978501|FG000|Overall Study|Withdrew Consent|5|||
33581246|NCT01672853|62978502|FG001|Overall Study|Withdrew Consent|5|||
33581247|NCT01672853|62978503|FG002|Overall Study|Withdrew Consent|5|||
33581248|NCT01672853|62978501|FG000|Overall Study|Adverse Event|4|||
33581249|NCT01672853|62978502|FG001|Overall Study|Adverse Event|6|||
33581250|NCT01672853|62978503|FG002|Overall Study|Adverse Event|8|||
33581251|NCT01672853|62978501|FG000|Overall Study|Lost to Follow-up|0|||
33581252|NCT01672853|62978502|FG001|Overall Study|Lost to Follow-up|1|||
33581253|NCT01672853|62978503|FG002|Overall Study|Lost to Follow-up|0|||
33581254|NCT01672853|62978501|FG000|Overall Study|Randomized but Never Treated|0|||
33581255|NCT01672853|62978502|FG001|Overall Study|Randomized but Never Treated|0|||
33581256|NCT01672853|62978503|FG002|Overall Study|Randomized but Never Treated|1|||
33581257|NCT01603459|62978511|FG000|Overall Study|Adverse Event|5|||
33581258|NCT01603459|62978511|FG000|Overall Study|Withdrawal by Subject|5|||
33581259|NCT01603459|62978511|FG000|Overall Study|Lost to Follow-up|3|||
33581260|NCT01603459|62978511|FG000|Overall Study|Predefined discontinuation criteria|3|||
33581261|NCT01603459|62978511|FG000|Overall Study|Non-compliance|1|||
33581262|NCT01603459|62978511|FG000|Overall Study|Administrative reason|1|||
33581263|NCT01678807|62978550|FG000|Overall Study|Adverse Event|4|||
33581264|NCT01678807|62978551|FG001|Overall Study|Adverse Event|4|||
33581265|NCT01678807|62978552|FG002|Overall Study|Adverse Event|0|||
33581266|NCT01678807|62978550|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
33581267|NCT01678807|62978551|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
33581268|NCT01678807|62978552|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
33581269|NCT03073525|62978563|FG000|Overall Study|Withdrawal by Subject|0|||
33581270|NCT03073525|62978564|FG001|Overall Study|Withdrawal by Subject|0|||
33581271|NCT03073525|62978565|FG002|Overall Study|Withdrawal by Subject|3|||
33581272|NCT02631551|62978586|FG000|Overall Study|Adverse Event|1|||
33581273|NCT02631551|62978587|FG001|Overall Study|Adverse Event|2|||
33581274|NCT02631551|62978588|FG002|Overall Study|Adverse Event|4|||
33581275|NCT02631551|62978589|FG003|Overall Study|Adverse Event|0|||
33581276|NCT02631551|62978586|FG000|Overall Study|Lack of Efficacy|0|||
33581277|NCT02631551|62978587|FG001|Overall Study|Lack of Efficacy|0|||
33581278|NCT02631551|62978588|FG002|Overall Study|Lack of Efficacy|1|||
33581279|NCT02631551|62978589|FG003|Overall Study|Lack of Efficacy|0|||
33581280|NCT02631551|62978586|FG000|Overall Study|Lost to Follow-up|1|||
33581281|NCT02631551|62978587|FG001|Overall Study|Lost to Follow-up|2|||
33581282|NCT02631551|62978588|FG002|Overall Study|Lost to Follow-up|0|||
33581283|NCT02631551|62978589|FG003|Overall Study|Lost to Follow-up|3|||
33581284|NCT02631551|62978586|FG000|Overall Study|Withdrawal by Subject|2|||
33581285|NCT02631551|62978587|FG001|Overall Study|Withdrawal by Subject|2|||
33581286|NCT02631551|62978588|FG002|Overall Study|Withdrawal by Subject|0|||
33581287|NCT02631551|62978589|FG003|Overall Study|Withdrawal by Subject|5|||
33581288|NCT02631551|62978586|FG000|Overall Study|Protocol deviation|3|||
33581289|NCT02631551|62978587|FG001|Overall Study|Protocol deviation|6|||
33581290|NCT02631551|62978588|FG002|Overall Study|Protocol deviation|3|||
33581291|NCT02631551|62978589|FG003|Overall Study|Protocol deviation|0|||
33581292|NCT02631551|62978586|FG000|Overall Study|Non-compliance with study procedures|0|||
33581293|NCT02631551|62978587|FG001|Overall Study|Non-compliance with study procedures|0|||
33581294|NCT02631551|62978588|FG002|Overall Study|Non-compliance with study procedures|1|||
33581295|NCT02631551|62978589|FG003|Overall Study|Non-compliance with study procedures|1|||
33581296|NCT02631551|62978586|FG000|Overall Study|Non-compliance with study drug|1|||
33581297|NCT02631551|62978587|FG001|Overall Study|Non-compliance with study drug|0|||
33581298|NCT02631551|62978588|FG002|Overall Study|Non-compliance with study drug|0|||
33581299|NCT02631551|62978589|FG003|Overall Study|Non-compliance with study drug|0|||
33581300|NCT02631551|62978586|FG000|Overall Study|Other, specific reasons not collected|5|||
33581301|NCT02631551|62978587|FG001|Overall Study|Other, specific reasons not collected|7|||
33581302|NCT02631551|62978588|FG002|Overall Study|Other, specific reasons not collected|2|||
33581303|NCT02631551|62978589|FG003|Overall Study|Other, specific reasons not collected|2|||
33581304|NCT01680991|62978602|FG000|Overall Study|Adverse Event|1|||
33581305|NCT01680991|62978603|FG001|Overall Study|Adverse Event|0|||
33581306|NCT01680991|62978604|FG002|Overall Study|Adverse Event|0|||
33581307|NCT01680991|62978602|FG000|Overall Study|Death|1|||
33581308|NCT01680991|62978603|FG001|Overall Study|Death|0|||
33581309|NCT01680991|62978604|FG002|Overall Study|Death|1|||
33581310|NCT01680991|62978602|FG000|Overall Study|Protocol Violation|0|||
33581311|NCT01680991|62978603|FG001|Overall Study|Protocol Violation|1|||
33581312|NCT01680991|62978604|FG002|Overall Study|Protocol Violation|0|||
33581313|NCT01680991|62978602|FG000|Overall Study|Withdrawal by Subject|5|||
33581314|NCT01680991|62978603|FG001|Overall Study|Withdrawal by Subject|1|||
33581315|NCT01680991|62978604|FG002|Overall Study|Withdrawal by Subject|0|||
33581316|NCT01680991|62978602|FG000|Overall Study|Progressive disease (PD)|0|||
33581317|NCT01680991|62978603|FG001|Overall Study|Progressive disease (PD)|10|||
33581318|NCT01680991|62978604|FG002|Overall Study|Progressive disease (PD)|0|||
33581319|NCT01680991|62978602|FG000|Overall Study|Physician Decision|0|||
33581320|NCT01680991|62978603|FG001|Overall Study|Physician Decision|7|||
33581321|NCT01680991|62978604|FG002|Overall Study|Physician Decision|2|||
33581322|NCT01680991|62978602|FG000|Overall Study|Bad physical condition|0|||
33581323|NCT01680991|62978603|FG001|Overall Study|Bad physical condition|0|||
33581324|NCT01680991|62978604|FG002|Overall Study|Bad physical condition|1|||
33581325|NCT01680991|62978602|FG000|Overall Study|PD confirmed in other hospital|1|||
33581326|NCT01680991|62978603|FG001|Overall Study|PD confirmed in other hospital|0|||
33581327|NCT01680991|62978604|FG002|Overall Study|PD confirmed in other hospital|0|||
33581328|NCT02819479|62978614|FG000|Overall Study|Adverse Event|2|||
33581329|NCT04064411|62978621|FG000|Overall Study|Adverse Event|29|||
33581330|NCT04064411|62978622|FG001|Overall Study|Adverse Event|19|||
33581331|NCT04064411|62978621|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
33581332|NCT04064411|62978622|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
33581333|NCT04064411|62978621|FG000|Overall Study|Protocol Deviation|0|||
33581334|NCT04064411|62978622|FG001|Overall Study|Protocol Deviation|2|||
33581335|NCT04064411|62978621|FG000|Overall Study|Withdrawal by Subject|25|||
33581336|NCT04064411|62978622|FG001|Overall Study|Withdrawal by Subject|29|||
33581337|NCT04064411|62978621|FG000|Overall Study|Lost to Follow-up|5|||
33581338|NCT04064411|62978622|FG001|Overall Study|Lost to Follow-up|2|||
33581339|NCT04064411|62978621|FG000|Overall Study|Other than Specified|4|||
33581340|NCT04064411|62978622|FG001|Overall Study|Other than Specified|1|||
33581341|NCT04064411|62978621|FG000|Overall Study|Death|1|||
33581342|NCT04064411|62978622|FG001|Overall Study|Death|0|||
33581343|NCT02629133|62978630|FG000|Overall Study|Lost to Follow-up|3|||
33581344|NCT02629133|62978631|FG001|Overall Study|Lost to Follow-up|1|||
33581345|NCT02629133|62978630|FG000|Overall Study|Withdrawal by Subject|1|||
33581346|NCT02629133|62978631|FG001|Overall Study|Withdrawal by Subject|1|||
33581347|NCT02660359|62978640|FG000|Overall Study|Protocol Deviation|0|||
33581348|NCT02660359|62978641|FG001|Overall Study|Protocol Deviation|0|||
33581349|NCT02660359|62978642|FG002|Overall Study|Protocol Deviation|1|||
33581350|NCT02660359|62978640|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
33581351|NCT02660359|62978641|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
33581352|NCT02660359|62978642|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
33581353|NCT02660359|62978640|FG000|Overall Study|Lack of Efficacy|1|||
33581354|NCT02660359|62978641|FG001|Overall Study|Lack of Efficacy|1|||
33581355|NCT02660359|62978642|FG002|Overall Study|Lack of Efficacy|1|||
33581356|NCT02660359|62978640|FG000|Overall Study|Adverse Event|0|||
33581357|NCT02660359|62978641|FG001|Overall Study|Adverse Event|1|||
33581358|NCT02660359|62978642|FG002|Overall Study|Adverse Event|0|||
33581359|NCT02660359|62978640|FG000|Overall Study|Other|2|||
33581360|NCT02660359|62978641|FG001|Overall Study|Other|1|||
33581361|NCT02660359|62978642|FG002|Overall Study|Other|3|||
33581362|NCT02660359|62978640|FG000|Overall Study|Withdrawal by Subject|7|||
33581363|NCT02660359|62978641|FG001|Overall Study|Withdrawal by Subject|5|||
33581364|NCT02660359|62978642|FG002|Overall Study|Withdrawal by Subject|8|||
33581365|NCT02660359|62978640|FG000|Overall Study|Lost to Follow-up|3|||
33581366|NCT02660359|62978641|FG001|Overall Study|Lost to Follow-up|3|||
33581367|NCT02660359|62978642|FG002|Overall Study|Lost to Follow-up|0|||
33581368|NCT02628743|62978650|FG000|Overall Study|Other|3|||
33581369|NCT02628743|62978650|FG000|Overall Study|Withdrawal by Subject|50|||
33581370|NCT02628743|62978650|FG000|Overall Study|Study Terminated by Sponsor|76|||
33581371|NCT02628743|62978650|FG000|Overall Study|Physician Decision|2|||
